{"meta":{"query_hash":"4ef5173adc0b","filters":{"venue":"Neuro-Oncology"},"cohort_total":1994,"direct_labels_cover":3,"predictions_cover":1994,"exported":1994,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4ef5173adc0b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neuro-Oncology"},"results":[{"id":"W1493373686","doi":"10.1093/neuonc/nou255.3","title":"ET-03 * CAVITATION-BASED THIRD VENTRICULOSTOMY USING MRI-GUIDED FOCUSED ULTRASOUND","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cavitation; Ultrasound; Medicine; Ventriculostomy; Radiology; Acoustics; Physics; Hydrocephalus","score_opus":0.041038423588780806,"score_gpt":0.3228319592679401,"score_spread":0.2817935356791593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493373686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94744694,0.0012961855,0.041343465,0.00022415041,0.00012348928,0.000154355,0.00017970397,0.0003609814,0.008870784],"genre_scores_gemma":[0.9681931,0.00051208417,0.025272751,0.00013501552,0.00003245732,0.00012329218,0.0002014534,0.00006756795,0.0054623922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999136,0.000012406458,0.0000054757948,0.000021306121,0.000031143492,0.00001613672],"domain_scores_gemma":[0.99993825,0.000018675877,0.000017246091,0.000007644009,0.0000073430015,0.0000108053055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000165224,0.00018030785,0.0001759488,0.0001593097,0.00012543018,0.00021266154,0.00027311454,0.00040350924,0.0017919367],"category_scores_gemma":[0.00017986861,0.00010494371,0.00025078907,0.000099333956,0.0002785319,0.00022386927,0.00024977323,0.000357883,0.00043372656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042422512,0.00006553314,0.00031687747,0.000074411975,0.000012694067,0.00039093953,0.000029494415,0.00058848166,0.982407,0.00036075554,0.00035196508,0.014977773],"study_design_scores_gemma":[0.00013049773,0.0018533403,0.003610662,0.000016313887,0.000031369043,0.003550552,0.000032820095,0.006793663,0.97200567,0.00017496147,0.011780244,0.000019927707],"about_ca_topic_score_codex":0.00049618114,"about_ca_topic_score_gemma":0.000504737,"teacher_disagreement_score":0.0017919367,"about_ca_system_score_codex":0.00017092118,"about_ca_system_score_gemma":0.00018246105,"threshold_uncertainty_score":0.0059945583},"labels":[],"label_agreement":null},{"id":"W1847738841","doi":"10.1093/neuonc/nov087","title":"Point/Counterpoint: Stereotactic radiosurgery without whole-brain radiation for patients with a limited number of brain metastases: the current standard of care?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Counterpoint; Medicine; Medical physics; Radiology; Nuclear medicine; Radiation therapy; Psychology","score_opus":0.021836433189772745,"score_gpt":0.3223935530821006,"score_spread":0.30055711989232786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1847738841","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24866304,0.19550444,0.25547495,0.13505304,0.028887711,0.0015066187,0.0034992888,0.009300535,0.12211041],"genre_scores_gemma":[0.70804244,0.09887483,0.120932356,0.031559974,0.009128093,0.0005544859,0.003275714,0.0013988061,0.026233314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948114,0.00010479416,0.000057578804,0.00011843463,0.0001871123,0.00005103287],"domain_scores_gemma":[0.99906737,0.00022182064,0.00023474038,0.000115103176,0.00020035353,0.00016068718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001357629,0.00055580883,0.0013094166,0.0007095602,0.0003389224,0.0017260828,0.0015173575,0.0011361912,0.012197643],"category_scores_gemma":[0.003598797,0.00016601125,0.00059267605,0.0009897094,0.00092702673,0.0024548385,0.00068230485,0.0021527512,0.004740367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003303426,0.00035089898,0.004143535,0.0012418176,0.00026502987,0.0003432225,0.00009422501,0.0017946906,0.004730342,0.007372698,0.058473796,0.9178863],"study_design_scores_gemma":[0.009572327,0.023129188,0.07599811,0.005020601,0.0021908109,0.022530273,0.00089694106,0.020648591,0.031218026,0.13128816,0.67673916,0.0007678582],"about_ca_topic_score_codex":0.0017039372,"about_ca_topic_score_gemma":0.003995556,"teacher_disagreement_score":0.012197643,"about_ca_system_score_codex":0.0006333768,"about_ca_system_score_gemma":0.0010285057,"threshold_uncertainty_score":0.04080516},"labels":[],"label_agreement":null},{"id":"W1856115540","doi":"10.1093/neuonc/nov143","title":"Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Calgary","funders":"Terry Fox Research Institute; Consorzio per la Ricerca Sanitaria; Health Research Board","keywords":"Biology; Copy-number variation; Gene; Computational biology; Genetics; Single-nucleotide polymorphism; Glioma; Subtyping; Glioblastoma; SNP; Cancer research; Genome; Genotype","score_opus":0.040932862392032685,"score_gpt":0.30520936905730744,"score_spread":0.26427650666527475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856115540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536693,0.00029583575,0.0023983272,0.000008234196,0.000004149921,0.000026826492,0.0012882901,0.000036144116,0.0005752056],"genre_scores_gemma":[0.98753417,0.00052678597,0.0045348625,0.000025770085,0.0000051976317,0.000081112026,0.006817293,0.000021270695,0.00045360113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998627,0.000014618417,0.000014000381,0.00003585208,0.00005245941,0.000020448875],"domain_scores_gemma":[0.9998172,0.000044506032,0.000049314454,0.00002693513,0.000037779955,0.000024260497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014240903,0.00015838788,0.00016612557,0.0007632559,0.00014180929,0.00019017381,0.00013937587,0.00014337794,0.0005914183],"category_scores_gemma":[0.00027576246,0.00007894765,0.00019930035,0.00055909296,0.00010929931,0.00006630369,0.00014359041,0.00021108723,0.00017593738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013896453,0.00003263207,0.007206536,0.000027743437,0.000030557912,0.00016322137,0.000048551952,0.00014207001,0.98934793,0.000082756014,0.00003189908,0.002747203],"study_design_scores_gemma":[0.00003554471,0.0012883685,0.45911866,0.000013375706,0.0002958783,0.0028096777,0.00019502972,0.0028823044,0.5282986,0.00024577152,0.004796447,0.000020350113],"about_ca_topic_score_codex":0.0015445146,"about_ca_topic_score_gemma":0.0016298378,"teacher_disagreement_score":0.0015445146,"about_ca_system_score_codex":0.00024200059,"about_ca_system_score_gemma":0.00016423744,"threshold_uncertainty_score":0.0030710697},"labels":[],"label_agreement":null},{"id":"W1915802091","doi":"10.1093/neuonc/nov122","title":"Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Blood–brain barrier; Efflux; Abcg2; ATP-binding cassette transporter; P-glycoprotein; Cell biology; Transporter; Tight junction; Drug delivery; Drug delivery to the brain; Extracellular matrix; Biology; Drug; Chemistry; Drug resistance; Neuroscience; Cancer research; Pharmacology; Central nervous system; Multiple drug resistance; Biochemistry; Gene","score_opus":0.02114080686092477,"score_gpt":0.26225721460580836,"score_spread":0.2411164077448836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915802091","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003797995,0.02919343,0.0007525256,0.9482415,0.011959569,0.000026814972,0.00004665807,0.00006594737,0.005915523],"genre_scores_gemma":[0.08553992,0.06325034,0.0017852943,0.66738343,0.17274779,0.00008495754,0.00008141864,0.000051891864,0.009074945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991559,0.00027908135,0.000078496756,0.000096408396,0.0002501316,0.00014002585],"domain_scores_gemma":[0.997663,0.0013169395,0.00029280546,0.0000939762,0.00033720816,0.0002961471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957298,0.0005220218,0.0011611411,0.0004903467,0.0013538188,0.0019318039,0.00077880704,0.016105814,0.0025987346],"category_scores_gemma":[0.0069558364,0.00030344835,0.0006495905,0.0005704497,0.0018818304,0.0019401504,0.0007822787,0.011052005,0.0026564368],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040821594,0.00013862878,0.0027561581,0.00058846164,0.00004285886,0.1009179,0.00034230176,0.00049464864,0.0025232795,0.016673299,0.75253385,0.12258032],"study_design_scores_gemma":[0.00041103715,0.00052531523,0.0034657272,0.0015779686,0.000110119305,0.13543443,0.0006821581,0.003110028,0.0024113061,0.048633277,0.8035485,0.000090190326],"about_ca_topic_score_codex":0.0016439643,"about_ca_topic_score_gemma":0.0029022594,"teacher_disagreement_score":0.016105814,"about_ca_system_score_codex":0.0034604182,"about_ca_system_score_gemma":0.0016281024,"threshold_uncertainty_score":0.025107265},"labels":[],"label_agreement":null},{"id":"W1918959143","doi":"10.1093/neuonc/nov059","title":"Extent of surgical resection of high-grade glioma among the elderly","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Surgical resection; Resection; Glioma; Medicine; Surgery; Cancer research","score_opus":0.031363040133051724,"score_gpt":0.30370773858448297,"score_spread":0.2723446984514312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918959143","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06762398,0.8869414,0.0051811454,0.026993454,0.004585353,0.00016930678,0.0042842254,0.0000996287,0.0041215536],"genre_scores_gemma":[0.85594374,0.105573915,0.0037550326,0.024009334,0.00732001,0.00025963644,0.0017644857,0.00011490431,0.0012589555],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9914358,0.004884934,0.0013563731,0.0010833478,0.0009471408,0.00029236363],"domain_scores_gemma":[0.97022295,0.02215104,0.0038331412,0.0020640458,0.0013562044,0.00037247353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016894048,0.00063248345,0.0022195955,0.000968941,0.0002449186,0.0014796646,0.0007527812,0.001546912,0.0020789306],"category_scores_gemma":[0.041304518,0.0004469146,0.012835109,0.0016796555,0.00041442786,0.0012888801,0.00062595075,0.002019014,0.00025316264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022969682,0.00011666898,0.20937912,0.08048869,0.4994797,0.000780919,0.0005222492,0.0026305746,0.0016389539,0.002517527,0.03484102,0.14463489],"study_design_scores_gemma":[0.0036017846,0.0013214047,0.2103019,0.013850045,0.7047859,0.0007325457,0.00026692342,0.0014398767,0.0014279603,0.007796526,0.054268718,0.00020644517],"about_ca_topic_score_codex":0.005631841,"about_ca_topic_score_gemma":0.009348314,"teacher_disagreement_score":0.016894048,"about_ca_system_score_codex":0.0008187076,"about_ca_system_score_gemma":0.0012090419,"threshold_uncertainty_score":0.08934528},"labels":[],"label_agreement":null},{"id":"W1969981749","doi":"10.1215/s1152851702000297","title":"Leptomeningeal dissemination at diagnosis of pediatric low-gradeneuroepithelial tumors","year":2003,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Children's Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Neuroepithelial cell; Medicine; Biology; Genetics; Embryonic stem cell","score_opus":0.015031234257074607,"score_gpt":0.29728399648744186,"score_spread":0.28225276223036727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969981749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994061,0.0002406822,0.00006252559,0.000017930342,0.000002038187,0.0000025947968,0.00008915489,0.000002158416,0.00017680707],"genre_scores_gemma":[0.99958366,0.00013177023,0.00006306435,0.0000082430015,0.0000069993284,0.000003895423,0.00016751706,0.000001262073,0.00003365806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961215,0.00009076624,0.000037502075,0.00008044695,0.00008976106,0.00008944293],"domain_scores_gemma":[0.99794525,0.00055468205,0.0010390003,0.000052095726,0.00013979165,0.000269108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039933054,0.00021933265,0.0002306637,0.00062223827,0.0002749245,0.0004587677,0.0002464614,0.00028868625,0.00096964947],"category_scores_gemma":[0.002806541,0.00018510832,0.00019967239,0.00050782727,0.00036481675,0.00065987743,0.0003254926,0.00038664206,0.00015897707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030539064,0.0000032780124,0.9985341,0.0000035447347,0.000003728408,0.00029882186,0.000025033747,0.000035341374,0.00013826287,0.000007061901,0.000028753358,0.00089154404],"study_design_scores_gemma":[0.0000033871397,0.000053867858,0.9951292,0.0000073905208,0.000010916224,0.0042030825,0.0001512686,0.00014449137,0.00013782599,0.000018954372,0.00013677168,0.0000028490415],"about_ca_topic_score_codex":0.0029097702,"about_ca_topic_score_gemma":0.0055664163,"teacher_disagreement_score":0.0029097702,"about_ca_system_score_codex":0.00043417583,"about_ca_system_score_gemma":0.00032440957,"threshold_uncertainty_score":0.0057857037},"labels":[],"label_agreement":null},{"id":"W1971316264","doi":"10.1093/neuonc/nou174.90","title":"O10.09 * REDUCTION IN NEUTROPHIL-LYMPHOCYTE RATIO DURING INITIAL CONCURRENT CHEMORADIOTHERAPY IS PROGNOSTIC FOR SURVIVAL OF GLIOBLASTOMA PATIENTS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Context (archaeology); Hazard ratio; Proportional hazards model; Retrospective cohort study; Univariate analysis; Dexamethasone; Chemoradiotherapy; Neutrophil to lymphocyte ratio; Radiation therapy; Surgery; Survival analysis; Gastroenterology; Multivariate analysis; Lymphocyte; Confidence interval","score_opus":0.01892400630301171,"score_gpt":0.30484886690228746,"score_spread":0.28592486059927574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971316264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981706,0.00028996117,0.00010033566,0.0001344041,0.000023778004,0.000007049938,0.00045304687,0.000010171157,0.0008105948],"genre_scores_gemma":[0.9993767,0.000048929796,0.00007188073,0.000021220483,0.000015100622,0.0000047557746,0.00025463355,0.000002135658,0.00020458038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974185,0.000052204552,0.00003157555,0.000050437327,0.000052255156,0.00007165862],"domain_scores_gemma":[0.9980878,0.0003285835,0.0009716273,0.0000563476,0.00018737359,0.00036819614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045805867,0.00019111542,0.00022490603,0.00037487692,0.00030638443,0.00046991333,0.0003232463,0.0002923342,0.0050118035],"category_scores_gemma":[0.0021204946,0.00009486305,0.00029558095,0.0005706395,0.00022145185,0.00032625874,0.00025610675,0.0004883533,0.0006043205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020097061,0.000016157599,0.99774724,0.000005271582,0.000021259675,0.00006461449,0.000009906091,0.000026171105,0.00018601248,0.000006016651,0.00016418705,0.0015523282],"study_design_scores_gemma":[0.0000063172447,0.00013970069,0.99870265,0.0000046189134,0.000029505009,0.0004551662,0.000050278148,0.00020248977,0.00010169006,0.000020941508,0.00028452146,0.0000021478118],"about_ca_topic_score_codex":0.0021820134,"about_ca_topic_score_gemma":0.0021330887,"teacher_disagreement_score":0.0050118035,"about_ca_system_score_codex":0.00025726703,"about_ca_system_score_gemma":0.00043033942,"threshold_uncertainty_score":0.01676613},"labels":[],"label_agreement":null},{"id":"W1971850391","doi":"10.1093/neuonc/nou264.57","title":"NI-59 * TABLET TECHNOLOGY FOR IMPROVED PREOPERATIVE SPEECH MAPPING USING FUNCTIONAL MRI IN PATIENTS WITH LOW-GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Hospital","funders":"","keywords":"Broca's area; Copying; Functional magnetic resonance imaging; Glioma; Brain mapping; Motor area; Aphasia; Medicine; Awake craniotomy; Neuroscience; Computer science; Craniotomy; Psychology; Radiology","score_opus":0.01613538378701314,"score_gpt":0.2634749658363168,"score_spread":0.24733958204930367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971850391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899393,0.0014522201,0.0036482238,0.00037465506,0.000050728155,0.0001657662,0.00033918268,0.00020885981,0.0038210766],"genre_scores_gemma":[0.99248695,0.0006507668,0.005071455,0.00014985375,0.000027637427,0.00012824529,0.00022782253,0.000017814784,0.0012394123],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999473,0.000013926537,0.0000048813135,0.0000124775015,0.000013701855,0.0000077292425],"domain_scores_gemma":[0.9998983,0.000038423354,0.000021297972,0.000011083427,0.000010726619,0.000020053956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001312848,0.00029109823,0.0002858377,0.00026652642,0.00012375457,0.00021639938,0.00016765785,0.00023266974,0.0036600465],"category_scores_gemma":[0.00043214593,0.000083439685,0.00013806635,0.00016956331,0.0001430914,0.00019047598,0.00018589258,0.00024229521,0.0006981289],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019841447,0.0018727988,0.16568834,0.0006555373,0.00012324606,0.0071268054,0.0003546372,0.0008257098,0.2687748,0.0003444425,0.004830783,0.52956146],"study_design_scores_gemma":[0.0018402628,0.04492508,0.7283124,0.00010850682,0.00048953446,0.031061087,0.00033843235,0.011127095,0.16249897,0.00041720457,0.01874824,0.00013326548],"about_ca_topic_score_codex":0.0007196801,"about_ca_topic_score_gemma":0.0015508987,"teacher_disagreement_score":0.0036600465,"about_ca_system_score_codex":0.00013983194,"about_ca_system_score_gemma":0.00016522197,"threshold_uncertainty_score":0.012244105},"labels":[],"label_agreement":null},{"id":"W1973156933","doi":"10.1093/neuonc/nos220","title":"LAB-CELL BIOLOGY AND SIGNALING","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diatoms and Algae Research","field":"Materials Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Cell biology; Biology","score_opus":0.0334672393872021,"score_gpt":0.33314865018790213,"score_spread":0.29968141080070004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973156933","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2131339,0.15085949,0.059006132,0.034530945,0.008350713,0.00045973842,0.0070001367,0.0035809246,0.52307796],"genre_scores_gemma":[0.5467399,0.032183703,0.019867249,0.00419128,0.0015690238,0.00028480866,0.0036281773,0.00026879233,0.39126715],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966216,0.00004632723,0.000020557703,0.00007544232,0.00012294739,0.00007242739],"domain_scores_gemma":[0.9998087,0.000018480809,0.000020042562,0.000035991663,0.000034810404,0.000082050305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006936378,0.0012253544,0.00048131304,0.00095582753,0.0010652752,0.0025819587,0.00088042964,0.0011532914,0.04687703],"category_scores_gemma":[0.00024072365,0.00033958736,0.00059705303,0.00058064016,0.0011832775,0.0015129672,0.0011729248,0.0018575125,0.014516556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073600817,0.00044064506,0.0015686105,0.00057640346,0.00006813006,0.00047514273,0.00016708899,0.00041731852,0.73444504,0.090105355,0.02227791,0.14872245],"study_design_scores_gemma":[0.00012305396,0.00046065348,0.00491958,0.0000812351,0.00007837563,0.00095122884,0.00026413737,0.0011872379,0.55564046,0.015635034,0.42062542,0.000033623342],"about_ca_topic_score_codex":0.00065031863,"about_ca_topic_score_gemma":0.0011881662,"teacher_disagreement_score":0.953123,"about_ca_system_score_codex":0.0014929916,"about_ca_system_score_gemma":0.0011354922,"threshold_uncertainty_score":0.15681928},"labels":[],"label_agreement":null},{"id":"W1973986864","doi":"10.1093/neuonc/nov022","title":"Response to \"The epidemiology of glioma in adults: a 'state of the science' review\"","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; World Health Organization","keywords":"International agency; Incidence (geometry); Glioma; Population; Danish; Epidemiology; Medicine; Cancer; Demography; Pathology; Internal medicine; Environmental health; Sociology; Cancer research; Mathematics","score_opus":0.020224603630742403,"score_gpt":0.30735747055197554,"score_spread":0.28713286692123313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973986864","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016379176,0.0036918228,0.0002019172,0.8797839,0.11509975,0.000054535194,0.00043641537,0.00009748791,0.00047023574],"genre_scores_gemma":[0.00084399583,0.0031228652,0.00022094772,0.9314912,0.061935693,0.00012129969,0.00016021029,0.00005335835,0.0020503604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400055,0.0017434997,0.0012070755,0.0007919585,0.001584173,0.00067276775],"domain_scores_gemma":[0.95946056,0.018903885,0.004745205,0.00080127205,0.0132849235,0.0028040744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010482457,0.0017645486,0.0037067123,0.00258833,0.0022768811,0.004360955,0.0039774557,0.025700636,0.01442044],"category_scores_gemma":[0.0689988,0.0011817372,0.0029495936,0.0022643039,0.0026736583,0.0050168233,0.003663846,0.024962297,0.008879127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062173494,0.0000079952,0.00009037188,0.00041738185,0.000018497598,0.000071310955,0.000037989805,0.000020883028,0.00005745717,0.00019533417,0.9946333,0.004387412],"study_design_scores_gemma":[0.00021866655,0.00011817378,0.0016053396,0.004586423,0.00014129083,0.0007642876,0.00041029215,0.00020286418,0.00027317816,0.0017759749,0.98979354,0.000110100395],"about_ca_topic_score_codex":0.005253506,"about_ca_topic_score_gemma":0.0047140694,"teacher_disagreement_score":0.025700636,"about_ca_system_score_codex":0.005120658,"about_ca_system_score_gemma":0.0064015584,"threshold_uncertainty_score":0.055437207},"labels":[],"label_agreement":null},{"id":"W1974778790","doi":"10.1093/neuonc/nov018","title":"End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Confounding; Medicine; Core (optical fiber); Oncology; Internal medicine; Computer science; Cancer research","score_opus":0.0791450354618834,"score_gpt":0.37028690454280716,"score_spread":0.29114186908092377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974778790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018535735,0.09477206,0.014135115,0.6671936,0.15686297,0.003601704,0.004564998,0.00078076095,0.039553154],"genre_scores_gemma":[0.18748905,0.031729594,0.037530404,0.5868973,0.117683984,0.007158533,0.004116869,0.0025026407,0.024891542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9169548,0.062194925,0.008404621,0.0032546634,0.0072579095,0.0019330949],"domain_scores_gemma":[0.8183277,0.08749585,0.02089902,0.024998674,0.03400932,0.014269356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.091978125,0.0008138671,0.0040184762,0.001110011,0.0020044262,0.00837762,0.0021915357,0.005336711,0.028194178],"category_scores_gemma":[0.2689064,0.00042647612,0.0026475627,0.0017132701,0.0023542754,0.0070740073,0.004286673,0.009677891,0.0077838684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028465426,0.00048730572,0.006013057,0.0047399355,0.0027129815,0.00016942929,0.00050451397,0.00043713395,0.0009584324,0.022421597,0.46218893,0.47090122],"study_design_scores_gemma":[0.008862794,0.0064145373,0.012309249,0.022811936,0.0035553034,0.0003498046,0.0006371894,0.0021385758,0.0015802449,0.075004965,0.866023,0.00031234304],"about_ca_topic_score_codex":0.0017933344,"about_ca_topic_score_gemma":0.0037218377,"teacher_disagreement_score":0.091978125,"about_ca_system_score_codex":0.004453607,"about_ca_system_score_gemma":0.007398127,"threshold_uncertainty_score":0.4864326},"labels":[],"label_agreement":null},{"id":"W1976206289","doi":"10.1093/neuonc/nov061.72","title":"LG-03 * RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Kingston General Hospital; McMaster Children's Hospital; London Health Sciences Centre; Agricultural Research Institute of Ontario; Pediatric Oncology Group; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Radiation therapy; Term (time); Childhood cancer; Population; Demography; Pediatrics; Internal medicine; Environmental health; Cancer; Physics; Cancer research","score_opus":0.02522225617413484,"score_gpt":0.3063105496595588,"score_spread":0.28108829348542397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976206289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990545,0.00010495611,0.000021404054,0.00002507557,0.000001205463,0.0000020966884,0.00055765914,0.0000024161382,0.00023064476],"genre_scores_gemma":[0.99922824,0.00006172031,0.000018449975,0.0000145087015,0.0000020500813,0.0000023160185,0.00055593514,0.000001492254,0.00011533633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.000013985873,0.00001037124,0.00003438453,0.000031358268,0.000033030752],"domain_scores_gemma":[0.9993987,0.000045709567,0.0003282206,0.000042625266,0.00008077383,0.000103934086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014726119,0.00014948277,0.00019203112,0.00035075445,0.00033751028,0.00036895243,0.00033264045,0.0002402772,0.0010740755],"category_scores_gemma":[0.0006739477,0.00012462247,0.00026709828,0.00090744713,0.00024962515,0.00017934301,0.00022767355,0.00029017965,0.00014861058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003631757,0.0000036227889,0.99935037,0.000002789241,0.000012710608,0.000027723678,0.000025131076,0.0000121435805,0.00009611078,0.0000029016408,0.000050804916,0.0003794225],"study_design_scores_gemma":[0.0000013729286,0.000017026767,0.99970007,0.0000015824511,0.000008914154,0.00008021836,0.0000542306,0.00002842018,0.000021527174,0.000003243296,0.000082617844,7.8414746e-7],"about_ca_topic_score_codex":0.14182994,"about_ca_topic_score_gemma":0.20280442,"teacher_disagreement_score":0.14182994,"about_ca_system_score_codex":0.0011410258,"about_ca_system_score_gemma":0.0008697241,"threshold_uncertainty_score":0.28200877},"labels":[],"label_agreement":null},{"id":"W1979467387","doi":"10.1215/15228517-2008-014","title":"FDG-PET imaging for the evaluation of antiglioma agents in a rat model","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"U.S. Food and Drug Administration","keywords":"Pet imaging; Nuclear medicine; Computer science; Positron emission tomography; Medicine","score_opus":0.059496857716451544,"score_gpt":0.3494684272412395,"score_spread":0.289971569524788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979467387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90744346,0.02235085,0.05994037,0.00066046335,0.00029723233,0.00056654116,0.002221241,0.0017236588,0.004796053],"genre_scores_gemma":[0.920215,0.017521843,0.049825456,0.00020207894,0.00006690996,0.000816152,0.0025478385,0.00020392936,0.008600764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997285,0.000059094047,0.00001643902,0.00006593096,0.00006379215,0.000066276996],"domain_scores_gemma":[0.9997656,0.000028674807,0.00007416982,0.000045750945,0.000036747584,0.00004921954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005648082,0.001308974,0.0007453543,0.0010559754,0.00024041995,0.0005115482,0.00069977314,0.00083310175,0.0018702656],"category_scores_gemma":[0.0002050636,0.00040230242,0.00054865464,0.0008101862,0.0004754154,0.00075282645,0.00028291688,0.0017660771,0.0008993719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016076512,0.00062069256,0.00086085266,0.00013745418,0.00003064573,0.00013823555,0.000031213647,0.0004502753,0.984312,0.00025040822,0.00025198428,0.011308612],"study_design_scores_gemma":[0.00011643833,0.007944855,0.0041701114,0.00002448728,0.00014089468,0.0008688085,0.00006777294,0.005035041,0.975938,0.00015100391,0.005513252,0.00002932192],"about_ca_topic_score_codex":0.0018744228,"about_ca_topic_score_gemma":0.002812836,"teacher_disagreement_score":0.0018744228,"about_ca_system_score_codex":0.000575763,"about_ca_system_score_gemma":0.0005230617,"threshold_uncertainty_score":0.0062566996},"labels":[],"label_agreement":null},{"id":"W1985252937","doi":"10.1093/neuonc/nos310","title":"In reference to WKA Yung (Neuro-Oncology 2012; 14:1115)","year":2012,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Impact factor; Clinical Oncology; Bibliometrics; Publishing; Oncology; Medicine; Internal medicine; Library science; Surgical oncology; Cancer; Political science; Computer science","score_opus":0.04566680652855494,"score_gpt":0.33042388083549334,"score_spread":0.2847570743069384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985252937","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017642902,0.01698976,0.00040656203,0.16533929,0.8106728,0.00004788806,0.0002577841,0.00013490669,0.0059746215],"genre_scores_gemma":[0.0022870542,0.024625232,0.00074416643,0.19511724,0.70795643,0.00010445369,0.00041870505,0.00026667534,0.068480104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778396,0.00042286914,0.00039236186,0.00041909306,0.00075990794,0.00022175213],"domain_scores_gemma":[0.98953235,0.003365677,0.0011307998,0.00027845937,0.0044950456,0.0011976885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028843828,0.001536223,0.0017135573,0.0031648658,0.0015469718,0.0056374297,0.0023800973,0.008409712,0.046118386],"category_scores_gemma":[0.026192032,0.000576301,0.0010974533,0.0021548336,0.0013264695,0.004198281,0.0018654508,0.007942836,0.041231338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009545021,0.000004975234,0.00008505163,0.00013880582,0.000004818309,0.000107713706,0.000016443806,0.0000068926743,0.00002352566,0.0001829611,0.9923149,0.007104459],"study_design_scores_gemma":[0.000011399843,0.000012890506,0.00052528194,0.00045772453,0.000013506313,0.00061587815,0.000070513364,0.000041473388,0.000072828545,0.00052156765,0.99764097,0.000015951902],"about_ca_topic_score_codex":0.0027478952,"about_ca_topic_score_gemma":0.0053106663,"teacher_disagreement_score":0.046118386,"about_ca_system_score_codex":0.0018445696,"about_ca_system_score_gemma":0.002225742,"threshold_uncertainty_score":0.15428132},"labels":[],"label_agreement":null},{"id":"W1986494368","doi":"10.1093/neuonc/nou268.13","title":"PM-13 * IDENTIFICATION OF THERAPEUTIC TARGETS IN AN INTRACRANIAL XENOGRAFT MODEL OF PITUITARY ADENOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibroblast growth factor receptor 4; Cancer research; PI3K/AKT/mTOR pathway; Pituitary tumors; Prolactin; Biology; Internal medicine; Medicine; Endocrinology; Receptor; Hormone; Fibroblast growth factor receptor; Signal transduction; Fibroblast growth factor; Cell biology","score_opus":0.023157612856664515,"score_gpt":0.2980853938730076,"score_spread":0.2749277810163431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986494368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722494,0.001621486,0.0042648395,0.0003590117,0.00016456704,0.00021197351,0.0017844165,0.00034339004,0.0040254886],"genre_scores_gemma":[0.97776204,0.0016851978,0.008458209,0.00011925802,0.00003550027,0.0004241092,0.0032829584,0.00006371088,0.008169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998697,0.000010695577,0.00000975136,0.000029011688,0.000047221845,0.0000335628],"domain_scores_gemma":[0.9999149,0.000012875422,0.000020849979,0.0000101151945,0.0000108212125,0.000030360043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001646481,0.0004852696,0.00046678088,0.0003120477,0.00020575909,0.00027624215,0.0002986894,0.0003987166,0.0021299405],"category_scores_gemma":[0.000076471304,0.00013623417,0.00033735152,0.00023343926,0.00023014481,0.00021444296,0.00015296832,0.0010984228,0.0007277209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067350897,0.00037605353,0.00026348294,0.00010302516,0.000015471223,0.00015171964,0.000030646173,0.00019303792,0.99320626,0.00014692766,0.0005075779,0.0043323906],"study_design_scores_gemma":[0.00016537681,0.005379155,0.0032924162,0.000013052243,0.000049047616,0.0009053912,0.00006970527,0.001837848,0.9799759,0.0000614724,0.008239786,0.0000108685645],"about_ca_topic_score_codex":0.0013392332,"about_ca_topic_score_gemma":0.0020259772,"teacher_disagreement_score":0.0021299405,"about_ca_system_score_codex":0.00035015776,"about_ca_system_score_gemma":0.00051042915,"threshold_uncertainty_score":0.0071253777},"labels":[],"label_agreement":null},{"id":"W1987135361","doi":"10.1093/neuonc/noq016","title":"Temozolomide and MGMT forever?","year":2010,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Dacarbazine; Oncology; Internal medicine; Clinical trial; Glioma; Chemotherapy; Clinical endpoint; Progression-free survival; Cancer; Phases of clinical research; Cancer research","score_opus":0.012644030092745465,"score_gpt":0.30513828542901383,"score_spread":0.2924942553362684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987135361","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00202234,0.22294548,0.0006827218,0.6764834,0.08804048,0.000026233267,0.00014417362,0.0000845892,0.009570562],"genre_scores_gemma":[0.018685527,0.18026412,0.00086731074,0.4800531,0.28835106,0.000047211583,0.00024890114,0.00010037112,0.031382456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990125,0.00019983895,0.00009037812,0.00017727356,0.00039814875,0.00012191574],"domain_scores_gemma":[0.9972881,0.0009800514,0.00040247585,0.00016960589,0.0005470973,0.00061267725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021902681,0.0005486092,0.00095872476,0.00067302084,0.0007232033,0.002733741,0.0012506798,0.005905409,0.010399472],"category_scores_gemma":[0.0052886587,0.00028138838,0.000447006,0.00062716176,0.0019936545,0.005016559,0.0011684418,0.0080373725,0.0046057906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036013822,0.00007329596,0.00070867117,0.000510581,0.00004653713,0.0004349566,0.00009494751,0.000073672505,0.0010210603,0.010402839,0.7576384,0.22863494],"study_design_scores_gemma":[0.00003803939,0.000064688305,0.0005387883,0.00020961708,0.000025016623,0.0004461812,0.00007903231,0.000059200764,0.0003479955,0.006659106,0.99152195,0.000010353622],"about_ca_topic_score_codex":0.0007316609,"about_ca_topic_score_gemma":0.0022785563,"teacher_disagreement_score":0.010399472,"about_ca_system_score_codex":0.001336401,"about_ca_system_score_gemma":0.0013449693,"threshold_uncertainty_score":0.03478968},"labels":[],"label_agreement":null},{"id":"W1988652699","doi":"10.1215/15228517-2007-002","title":"Survey of treatment recommendations for anaplastic oligodendroglioma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Oligodendroglioma; Temozolomide; Medicine; Radiation therapy; Oncology; Internal medicine; Clinical trial; Glioma; Lomustine; Chemotherapy; Family medicine; Astrocytoma; Cancer research; Vincristine","score_opus":0.06895933856419427,"score_gpt":0.36791477270379874,"score_spread":0.29895543413960446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988652699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728764,0.00084783393,0.00044923846,0.0040231342,0.000045661265,0.00011915856,0.003052934,0.000032872584,0.0041414415],"genre_scores_gemma":[0.9925398,0.0016163965,0.001482863,0.0013839557,0.000049135724,0.00014162638,0.0019106102,0.000012439901,0.0008632155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696547,0.001358138,0.000615046,0.00020701403,0.0006435004,0.00021076508],"domain_scores_gemma":[0.98413956,0.0062892274,0.0057793963,0.0002930693,0.0025783556,0.0009205082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003965659,0.00010748753,0.00024814397,0.00090372143,0.0003128117,0.0003885642,0.0003048178,0.00064247544,0.0018499177],"category_scores_gemma":[0.016343087,0.00016189585,0.0002741845,0.0010188338,0.00016712397,0.000566191,0.00035916557,0.0005951407,0.0006251438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010346425,0.00017098241,0.9580349,0.00018435754,0.000055597488,0.00010945796,0.0011416555,0.00024673904,0.00037245653,0.00008661175,0.008843658,0.03065013],"study_design_scores_gemma":[0.000024478879,0.00037339385,0.97474945,0.0002350043,0.00004303271,0.00059084356,0.003766707,0.0010964078,0.00033065438,0.00005893756,0.018708007,0.000023057311],"about_ca_topic_score_codex":0.005767526,"about_ca_topic_score_gemma":0.0068016336,"teacher_disagreement_score":0.005767526,"about_ca_system_score_codex":0.0008080586,"about_ca_system_score_gemma":0.0010115278,"threshold_uncertainty_score":0.02097267},"labels":[],"label_agreement":null},{"id":"W1988992782","doi":"10.1093/neuonc/nox029","title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Interquartile range; Metric (unit); Clinical trial; Cohen's kappa; Medical physics; Internal medicine; Oncology; Statistics","score_opus":0.10843280071922588,"score_gpt":0.4474707964100835,"score_spread":0.33903799569085763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988992782","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.868916,0.0048602116,0.069810525,0.002890733,0.0005505251,0.0057810005,0.006873782,0.0012076035,0.039109524],"genre_scores_gemma":[0.8792071,0.0016283201,0.10684001,0.0006470385,0.0001448206,0.0042475066,0.003779111,0.000097054435,0.0034089952],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9961797,0.0012673954,0.0008259079,0.0001876947,0.0014373366,0.0001020564],"domain_scores_gemma":[0.99010557,0.0020259556,0.0035416433,0.0004681896,0.0032598688,0.0005988656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006296591,0.0005681945,0.0007359613,0.0034787864,0.0003227302,0.00084986165,0.0008762384,0.00049529865,0.0017265766],"category_scores_gemma":[0.01603065,0.00013120234,0.0007994503,0.0011280043,0.00045234477,0.0011491681,0.0013244925,0.00064282794,0.0005959887],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017015402,0.00072951516,0.6667362,0.00088722655,0.00041029966,0.0005419552,0.0007842473,0.002697518,0.0063530575,0.0018219746,0.021887364,0.29544914],"study_design_scores_gemma":[0.0003569837,0.0028168417,0.9479321,0.000565726,0.00028758732,0.0037294251,0.00088337215,0.01336822,0.00449147,0.0022140238,0.023189455,0.00016472345],"about_ca_topic_score_codex":0.0016319427,"about_ca_topic_score_gemma":0.0045862272,"teacher_disagreement_score":0.006296591,"about_ca_system_score_codex":0.0009395222,"about_ca_system_score_gemma":0.0017573216,"threshold_uncertainty_score":0.033299923},"labels":[],"label_agreement":null},{"id":"W1990415925","doi":"10.1093/neuonc/3.1.1","title":"Expression and hypoxic regulation of angiopoietins in humanastrocytomas","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Angiopoietin receptor; Angiogenesis; Astrocytoma; Angiopoietin; Vascular endothelial growth factor; Biology; Cancer research; Receptor; Vascular endothelial growth factor A; Tumor progression; Pathology; Glioma; Medicine; Cancer; VEGF receptors; Biochemistry","score_opus":0.017493034651148612,"score_gpt":0.2830974153286691,"score_spread":0.2656043806775205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990415925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691737,0.0009217291,0.0005864325,0.000022457767,0.000012367632,0.0000136677,0.0002851351,0.000023438548,0.0012173887],"genre_scores_gemma":[0.9968836,0.00052486896,0.00061211345,0.000018998617,0.0000053761078,0.000023944624,0.0004172076,0.000005530917,0.0015082681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992204,0.000008610494,0.0000074918503,0.000014191269,0.000023891618,0.000023831768],"domain_scores_gemma":[0.9999335,0.0000105201,0.000013535826,0.0000073979754,0.00001798045,0.000016950291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007389837,0.00010100484,0.000111729976,0.00022589807,0.00013237062,0.00022467456,0.00004677626,0.000086774344,0.00070814055],"category_scores_gemma":[0.00008703149,0.0000731936,0.000091128204,0.00016134075,0.00011507374,0.000079111785,0.00010168965,0.0001220109,0.00028809893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099021236,0.000014159262,0.0010510923,0.00002023879,0.0000030500862,0.000120642624,0.00004863709,0.000028000764,0.9976278,0.00006488133,0.000041537798,0.0008809434],"study_design_scores_gemma":[0.00002086939,0.0004261125,0.065029584,0.0000063518037,0.000024542192,0.0009537734,0.00015824435,0.0008589332,0.9260963,0.00008921243,0.0063294824,0.0000066655075],"about_ca_topic_score_codex":0.0020419746,"about_ca_topic_score_gemma":0.0017724347,"teacher_disagreement_score":0.0020419746,"about_ca_system_score_codex":0.00026948994,"about_ca_system_score_gemma":0.00020414728,"threshold_uncertainty_score":0.004060209},"labels":[],"label_agreement":null},{"id":"W1991805542","doi":"10.1093/neuonc/nos232","title":"CLIN-ONGOING CLINICAL TRIALS","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Medicine; Medical physics; Internal medicine","score_opus":0.39135124536517873,"score_gpt":0.5724785342185139,"score_spread":0.18112728885333518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991805542","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013992533,0.12578118,0.0142032625,0.100071914,0.04221977,0.04157474,0.077452205,0.0040057935,0.5806986],"genre_scores_gemma":[0.09372669,0.07510003,0.049150314,0.14833944,0.021302534,0.0838574,0.10933456,0.0019569376,0.41723213],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99206924,0.004398734,0.000732186,0.0010109072,0.0012080033,0.0005810363],"domain_scores_gemma":[0.98619115,0.0023842596,0.0019695756,0.0020751583,0.0047096373,0.0026702657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01305981,0.001411955,0.0019694543,0.001369448,0.0014973704,0.0055505643,0.0024806997,0.005318417,0.24736649],"category_scores_gemma":[0.018417252,0.0006909582,0.0018973842,0.0017122991,0.0011165885,0.0034022068,0.0028867275,0.0054890322,0.113409765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014195366,0.0016339278,0.0016822083,0.0068446132,0.00051890436,0.00021623282,0.00011734464,0.00021491796,0.0018980377,0.006787256,0.5290566,0.4368345],"study_design_scores_gemma":[0.010399078,0.0017809941,0.0013268209,0.0024337568,0.0002218365,0.00021258864,0.00005265,0.00012586081,0.00060114975,0.0033762038,0.9794475,0.000021492715],"about_ca_topic_score_codex":0.00084673223,"about_ca_topic_score_gemma":0.0016060087,"teacher_disagreement_score":0.24736649,"about_ca_system_score_codex":0.002292005,"about_ca_system_score_gemma":0.007437523,"threshold_uncertainty_score":0.82752335},"labels":[],"label_agreement":null},{"id":"W1994228028","doi":"10.1093/neuonc/nov318","title":"Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Focused ultrasound; Cancer research; Targeted therapy; Medicine; Oncology; Ultrasound; Internal medicine; Radiology; Cancer","score_opus":0.011125601802728364,"score_gpt":0.22232378930529628,"score_spread":0.2111981875025679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994228028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342406,0.0032019953,0.0022576211,0.000091167094,0.000029438119,0.00006769886,0.000048309666,0.00014085385,0.0007387951],"genre_scores_gemma":[0.99517715,0.0019327006,0.0016463809,0.000083150146,0.000024523504,0.000073940886,0.00014318158,0.000016210715,0.0009026311],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999491,0.0000069097746,0.0000029948742,0.000011442378,0.000010454225,0.000019063169],"domain_scores_gemma":[0.99993694,0.0000128336815,0.000016670952,0.000007169445,0.0000067155147,0.0000197408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011314403,0.00040137256,0.00050063286,0.00017739805,0.00007268023,0.00018190814,0.00021015422,0.00022429935,0.001167801],"category_scores_gemma":[0.00011860665,0.00006548643,0.00019212635,0.00009121984,0.00020311687,0.00021342757,0.00020096949,0.00055748806,0.00019778476],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027688418,0.0011936025,0.0011626567,0.00020407254,0.000054360753,0.00010881045,0.00006520634,0.0005170357,0.94653994,0.00008126832,0.0003296651,0.046974465],"study_design_scores_gemma":[0.0011866748,0.039076783,0.03459244,0.00007128328,0.00028745685,0.0012018945,0.00013118304,0.002957137,0.9130167,0.00021649334,0.007230871,0.00003113931],"about_ca_topic_score_codex":0.00040499828,"about_ca_topic_score_gemma":0.00065079855,"teacher_disagreement_score":0.001167801,"about_ca_system_score_codex":0.0001367587,"about_ca_system_score_gemma":0.00018173666,"threshold_uncertainty_score":0.003906667},"labels":[],"label_agreement":null},{"id":"W1994689818","doi":"10.1093/neuonc/nou209.26","title":"A 3-DIMENSIONAL MATRIX ASSAY THAT MAY HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; Glioblastoma; Dacarbazine; Internal medicine; Oncology; Subgroup analysis; Chemotherapy; Drug response; Drug; Cancer research; Pharmacology; Confidence interval","score_opus":0.016905005584578723,"score_gpt":0.27788324809335085,"score_spread":0.2609782425087721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994689818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996407,0.00009581715,0.000060706185,0.000012117708,0.0000018434167,0.000006949085,0.00008711704,0.000002206157,0.000092647046],"genre_scores_gemma":[0.99960166,0.000026510052,0.00008397243,0.000009853977,0.000005126207,0.00000814379,0.0002271047,0.000001582564,0.000036035482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997482,0.00005545967,0.000045476012,0.000056127436,0.00004561205,0.000049120863],"domain_scores_gemma":[0.99929106,0.00018695687,0.00028140916,0.000056818702,0.000061613035,0.00012222078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035275897,0.0002837651,0.0005627177,0.00084083923,0.0002270767,0.00031852446,0.00017615106,0.00029201107,0.00080660457],"category_scores_gemma":[0.0015302583,0.00012211018,0.00046583562,0.00048198635,0.0001513317,0.00023043399,0.00023764049,0.00021521807,0.00017047863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005971312,0.000028063965,0.9955179,0.000006711089,0.000044579407,0.00015839704,0.00002818966,0.00004165987,0.0014269976,0.000005068425,0.000055616485,0.0020895256],"study_design_scores_gemma":[0.000024197589,0.0004161574,0.9971494,0.000003745132,0.00007344815,0.0010385767,0.000077624885,0.0004685958,0.0005562707,0.000020329575,0.00016713493,0.000004497614],"about_ca_topic_score_codex":0.00094182463,"about_ca_topic_score_gemma":0.0015640365,"teacher_disagreement_score":0.00094182463,"about_ca_system_score_codex":0.0002177507,"about_ca_system_score_gemma":0.0001605204,"threshold_uncertainty_score":0.0026983619},"labels":[],"label_agreement":null},{"id":"W1999197607","doi":"10.1093/neuonc/nos229","title":"CLIN-NEURO/MEDICAL ONCOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Neurological Institute and Hospital; Western University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Medical physics","score_opus":0.05223163820791155,"score_gpt":0.4116295984714325,"score_spread":0.35939796026352094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197607","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22382292,0.22124131,0.0076083527,0.02875518,0.0061255437,0.0006358362,0.004374926,0.001151107,0.50628483],"genre_scores_gemma":[0.7163192,0.07305847,0.012135838,0.02266869,0.006151707,0.0005797544,0.0059038107,0.00027915955,0.16290332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995734,0.00012767751,0.000040767958,0.00007774742,0.00009158203,0.00008871814],"domain_scores_gemma":[0.9994066,0.000082407205,0.00013014085,0.00005134847,0.00017892798,0.00015062334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005277578,0.00045326632,0.00036995256,0.0008542801,0.0004929617,0.0013747514,0.0003987949,0.00067155616,0.029822502],"category_scores_gemma":[0.0013462316,0.00013617365,0.00029082055,0.00058858015,0.00043949654,0.0005563126,0.0006802415,0.0008199715,0.015186481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006520149,0.00047347776,0.0966002,0.0015412607,0.00014611371,0.007274331,0.00023936073,0.0003898064,0.005928219,0.005702459,0.12303475,0.758018],"study_design_scores_gemma":[0.00020910328,0.00072672573,0.08829449,0.0013912932,0.00016990528,0.067317024,0.00044013266,0.00089368765,0.004529777,0.0046428614,0.8313527,0.000032387987],"about_ca_topic_score_codex":0.00070144905,"about_ca_topic_score_gemma":0.0014023287,"teacher_disagreement_score":0.9701775,"about_ca_system_score_codex":0.0009347025,"about_ca_system_score_gemma":0.0013511594,"threshold_uncertainty_score":0.099766195},"labels":[],"label_agreement":null},{"id":"W2000497085","doi":"10.1093/neuonc/nou174.385","title":"P17.56 * A 3-DIMENSIONAL MATRIX ASSAY TO HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: UPDATE OF RESULTS AND SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Temozolomide; Medicine; Dacarbazine; Oncology; Subgroup analysis; Chemotherapy; Internal medicine; Adjuvant; Glioblastoma; Radiation therapy; Cancer research; Confidence interval","score_opus":0.011298805959380678,"score_gpt":0.2697305420073057,"score_spread":0.258431736047925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000497085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967199,0.0010569553,0.0006340296,0.00011625639,0.000022765009,0.000033766584,0.00070423714,0.000026664278,0.0006854007],"genre_scores_gemma":[0.99785644,0.00026530214,0.0006824685,0.00003585324,0.00002878788,0.00002629338,0.0008819493,0.00000814583,0.00021478551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997756,0.00006244233,0.000033211516,0.000042469834,0.00006076715,0.00002548733],"domain_scores_gemma":[0.9991615,0.00019785998,0.00028501535,0.00006662276,0.00015671295,0.0001322151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043257,0.00032457447,0.00048418817,0.0007458001,0.00019677069,0.00043808733,0.00029790594,0.0002704905,0.0009164194],"category_scores_gemma":[0.0015097808,0.00011960336,0.0004471353,0.00074565085,0.00012260898,0.00020929598,0.0002368587,0.0002681784,0.00030591714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008112491,0.000028342605,0.9824783,0.000023105309,0.000104797306,0.00026943622,0.000023272562,0.00008977759,0.0022642554,0.000013076853,0.00040238252,0.013491926],"study_design_scores_gemma":[0.00006187233,0.00057340413,0.9916266,0.0000123946975,0.00022421617,0.0027516338,0.000077412435,0.0014274976,0.0018528971,0.0000653345,0.0013183567,0.000008239807],"about_ca_topic_score_codex":0.0008893209,"about_ca_topic_score_gemma":0.0008640807,"teacher_disagreement_score":0.0009164194,"about_ca_system_score_codex":0.00018423374,"about_ca_system_score_gemma":0.0001841677,"threshold_uncertainty_score":0.0031960607},"labels":[],"label_agreement":null},{"id":"W2005333216","doi":"10.1093/neuonc/nov061.9","title":"BI-03 * DLX HOMEOBOX GENES REGULATE NEURONAL VS OLIGODENDROGLIAL CELL FATE DECISIONS: POTENTIAL RELEVANCE TO PEDIATRIC GLIONEURONAL TUMORS AND HIGH GRADE GLIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Homeobox; Oligodendroglial Tumor; Biology; Oligodendroglioma; Cell fate determination; DLX5; Glioma; Gene; Neuroscience; Cancer research; Genetics; Transcription factor","score_opus":0.024700836927808747,"score_gpt":0.27975028632441995,"score_spread":0.2550494493966112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005333216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778616,0.004984887,0.004146939,0.00040343826,0.000050015053,0.000049383358,0.0033279357,0.00025653013,0.008919338],"genre_scores_gemma":[0.97600275,0.0015273124,0.003626099,0.0002721104,0.000015189753,0.00007309935,0.0054086233,0.00008491164,0.012989896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985266,0.0000123292975,0.0000105677145,0.000040081093,0.00004216983,0.000042073905],"domain_scores_gemma":[0.99983823,0.000012856877,0.00004705017,0.000008338896,0.000024182493,0.00006928965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014241257,0.00029784456,0.00017227826,0.00020732648,0.00022402492,0.0005427931,0.00027356512,0.00027810014,0.0046843006],"category_scores_gemma":[0.000105545056,0.0001350543,0.00015658814,0.00026795734,0.00019191799,0.00015535404,0.00026933043,0.00048092532,0.0016751926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042413434,0.000053525866,0.0047921888,0.000090594454,0.00001071271,0.00014082834,0.000025790378,0.000083419895,0.9874535,0.00019073163,0.00044585305,0.0062887864],"study_design_scores_gemma":[0.00005651925,0.00036304424,0.18332255,0.00004422965,0.00006336427,0.0021721357,0.00023352745,0.0016895327,0.7901501,0.00027643773,0.021611731,0.000016741174],"about_ca_topic_score_codex":0.0012329022,"about_ca_topic_score_gemma":0.0020903542,"teacher_disagreement_score":0.0046843006,"about_ca_system_score_codex":0.00055534835,"about_ca_system_score_gemma":0.00035214875,"threshold_uncertainty_score":0.015670538},"labels":[],"label_agreement":null},{"id":"W2006306117","doi":"10.1093/neuonc/nov061.97","title":"MB-21 * INTEGRATED GENOMICS ELUCIDATES RELATIVE SPATIAL HOMOGENEITY OF EMBRYONAL BRAIN TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; University of Toronto; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children","funders":"","keywords":"Homogeneity (statistics); Genomics; Computational biology; Biology; Evolutionary biology; Genetics; Genome; Computer science; Gene; Machine learning","score_opus":0.03163584154387048,"score_gpt":0.30107758385039673,"score_spread":0.26944174230652623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006306117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921394,0.0004704939,0.005796423,0.000019510797,0.0000026572727,0.000013373903,0.00092061854,0.00007042865,0.0005670563],"genre_scores_gemma":[0.9919904,0.00019628336,0.0061700135,0.000015186165,0.00000222596,0.000015919031,0.0012654655,0.000025780066,0.00031870964],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988174,0.00001111767,0.0000061935707,0.00004725034,0.000033430344,0.000020297946],"domain_scores_gemma":[0.99986136,0.00003112462,0.000044981956,0.000020631904,0.000020540436,0.000021418356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001490491,0.00016442343,0.00017882681,0.0004045328,0.00017004061,0.0003348214,0.00016547217,0.00014495081,0.0006064585],"category_scores_gemma":[0.00022428096,0.0001032305,0.00010841388,0.00028260957,0.00017831362,0.00011171923,0.00020052407,0.00018922873,0.00019469186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011328077,0.000008408943,0.016296213,0.00003145858,0.000023555795,0.00009785428,0.000059241458,0.00046834926,0.97789556,0.0001289037,0.00007699988,0.0048002247],"study_design_scores_gemma":[0.000010715004,0.00020661857,0.4602819,0.00000975561,0.00008543214,0.0017359623,0.0001355821,0.0068647806,0.5250138,0.0002562479,0.0053869975,0.00001210579],"about_ca_topic_score_codex":0.0020479097,"about_ca_topic_score_gemma":0.0037886093,"teacher_disagreement_score":0.0020479097,"about_ca_system_score_codex":0.00027467508,"about_ca_system_score_gemma":0.00019316566,"threshold_uncertainty_score":0.004071951},"labels":[],"label_agreement":null},{"id":"W2022784634","doi":"10.1093/neuonc/nou274.3","title":"SO-04 * INTERNATIONAL CONSENSUS GUIDELINES FOR POST-OPERATIVE STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR MALIGNANT SPINE TUMORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Spinal cord; Radiation therapy; Cord; Spinal cord compression; Radiology; Nuclear medicine; Surgery","score_opus":0.0560357802697202,"score_gpt":0.38827364017901217,"score_spread":0.332237859909292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022784634","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11989131,0.06176888,0.18771738,0.15409718,0.030321738,0.025069714,0.042925216,0.0027267556,0.3754818],"genre_scores_gemma":[0.2298046,0.044324856,0.504228,0.024686985,0.003102288,0.018894952,0.07211115,0.0013605768,0.10148659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99054843,0.0035271726,0.0030992473,0.00027286864,0.0020486405,0.0005036856],"domain_scores_gemma":[0.966056,0.004867678,0.0041155457,0.0012291723,0.022012312,0.0017192907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01192467,0.0006862126,0.00065616297,0.003200324,0.0009705751,0.0015811876,0.0017982834,0.0016680888,0.006154424],"category_scores_gemma":[0.014823847,0.0003751901,0.001955815,0.0031996656,0.0006193282,0.00076196087,0.0016833585,0.0020776214,0.004387426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004944134,0.00071195187,0.029841026,0.0053512496,0.0002055404,0.0005509471,0.0012379333,0.0019009878,0.007023799,0.005619417,0.46046004,0.4866028],"study_design_scores_gemma":[0.0001320283,0.0004178393,0.029612523,0.0040457654,0.00015129067,0.0013841193,0.0017085978,0.0011727301,0.0032115222,0.0030130714,0.9550889,0.00006154449],"about_ca_topic_score_codex":0.004569479,"about_ca_topic_score_gemma":0.0074055507,"teacher_disagreement_score":0.01192467,"about_ca_system_score_codex":0.0016389686,"about_ca_system_score_gemma":0.008841858,"threshold_uncertainty_score":0.063064456},"labels":[],"label_agreement":null},{"id":"W2024505394","doi":"10.1215/15228517-2007-035","title":"Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Cancer Institute; University of Manitoba","keywords":"Human cytomegalovirus; Immunosuppression; Medicine; Pathology; Polymerase chain reaction; Viremia; Subclinical infection; In situ hybridization; Cytomegalovirus; Immunology; Immunohistochemistry; Virus; Herpesviridae; Viral disease; Biology; Gene; Gene expression","score_opus":0.013532090483231852,"score_gpt":0.2980262181841068,"score_spread":0.28449412770087495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024505394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992594,0.0002639885,0.00006637712,0.000014067423,0.0000042867346,0.000003999667,0.00005188995,0.0000040331674,0.00033189476],"genre_scores_gemma":[0.9996093,0.00010525283,0.00008164346,0.000026165668,0.000005994463,0.0000031596587,0.00007866002,8.962771e-7,0.00008896177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998466,0.000034153676,0.000016362566,0.000040732775,0.000028411932,0.00003379372],"domain_scores_gemma":[0.9996369,0.000095400006,0.00010914938,0.000018137913,0.000047525707,0.00009284748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012665609,0.00023427559,0.00026575808,0.0008457208,0.0002443362,0.00032666617,0.00011641904,0.0002930254,0.0008905763],"category_scores_gemma":[0.0011320803,0.00014622255,0.00007995767,0.0003904525,0.00022534886,0.00024182141,0.00018557523,0.00022556105,0.00017553188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029687394,0.00003058997,0.9838104,0.000018168157,0.000011298769,0.0012199577,0.00020358832,0.000021333786,0.009825838,0.000012748453,0.000080973965,0.004468226],"study_design_scores_gemma":[0.000008900651,0.00032226584,0.98837876,0.000010752978,0.00002117925,0.008043898,0.00028115953,0.00016004733,0.0024199649,0.00002768572,0.0003202875,0.00000510603],"about_ca_topic_score_codex":0.001260065,"about_ca_topic_score_gemma":0.001189114,"teacher_disagreement_score":0.001260065,"about_ca_system_score_codex":0.00014256596,"about_ca_system_score_gemma":0.00011844345,"threshold_uncertainty_score":0.0029792786},"labels":[],"label_agreement":null},{"id":"W2026356631","doi":"10.1093/neuonc/nou237.33","title":"AT-33A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"","keywords":"Temozolomide; Medicine; Valproic Acid; Internal medicine; Phases of clinical research; Radiation therapy; Oncology; Toxicity; Gastroenterology; Epilepsy","score_opus":0.010233742081879358,"score_gpt":0.3051719867733026,"score_spread":0.2949382446914232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026356631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480444,0.0016521032,0.0003843402,0.00034706685,0.000063016814,0.0015663003,0.00048935076,0.000047379974,0.0006461155],"genre_scores_gemma":[0.9908999,0.0017395568,0.0016277044,0.00044137807,0.00014132296,0.0023294433,0.0014155613,0.000021224449,0.0013839512],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995858,0.00021076798,0.000016624906,0.00006580421,0.000034341367,0.00008663555],"domain_scores_gemma":[0.9993319,0.000064150256,0.000103096536,0.000036762445,0.00004258361,0.00042160353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001465475,0.0017276453,0.0021180192,0.00052457507,0.00048410211,0.0007835313,0.0009831303,0.0010929608,0.003559514],"category_scores_gemma":[0.0005990221,0.0007434205,0.0014211606,0.00056900637,0.0010960993,0.0005903159,0.00036286862,0.0028157707,0.00078965747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77031034,0.07658495,0.015191438,0.0008935264,0.0017310398,0.00051574304,0.00047382095,0.0033461708,0.049778577,0.000449612,0.003268973,0.07745581],"study_design_scores_gemma":[0.39020768,0.5849279,0.01737611,0.00004881423,0.0005278105,0.00039973092,0.00006130669,0.00093735027,0.002663478,0.00018671654,0.002634698,0.000028297078],"about_ca_topic_score_codex":0.0024951834,"about_ca_topic_score_gemma":0.0054964563,"teacher_disagreement_score":0.003559514,"about_ca_system_score_codex":0.0012131389,"about_ca_system_score_gemma":0.0028588155,"threshold_uncertainty_score":0.011907697},"labels":[],"label_agreement":null},{"id":"W2028516615","doi":"10.1093/neuonc/noq116.s20","title":"Tumor Models (In Vivo/In Vitro)","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of Calgary","funders":"","keywords":"In vivo; In vitro; Computer science; Computational biology; Biology; Genetics","score_opus":0.015657561006434756,"score_gpt":0.3075053968068196,"score_spread":0.29184783580038487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028516615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54128647,0.029956644,0.25511438,0.0035120277,0.0038431191,0.0027633314,0.052296385,0.0070819245,0.10414568],"genre_scores_gemma":[0.74967253,0.023374664,0.073671706,0.0012671582,0.0005312656,0.0023706106,0.027775193,0.0013571855,0.119979694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989925,0.00022689856,0.000119923214,0.00023062517,0.0002679954,0.00016207455],"domain_scores_gemma":[0.9990989,0.00015267787,0.00016645111,0.00024592632,0.00017672052,0.00015922094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009403743,0.0014812929,0.00083292584,0.0018872315,0.0007066712,0.0012862607,0.001147096,0.0010605712,0.01119207],"category_scores_gemma":[0.00034324828,0.00046577788,0.0011247365,0.0009607473,0.00049723295,0.0009658388,0.000547431,0.0030787808,0.008120582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000584907,0.00079912285,0.00066754984,0.0004638651,0.000044267064,0.0004636815,0.00013934093,0.00069023867,0.9842673,0.0017513883,0.0030605025,0.007067845],"study_design_scores_gemma":[0.000037666512,0.00071685604,0.001048536,0.00004183745,0.00008975,0.0007385059,0.00006772392,0.0008005889,0.9814291,0.00028944094,0.014726496,0.000013555044],"about_ca_topic_score_codex":0.0036012738,"about_ca_topic_score_gemma":0.005153212,"teacher_disagreement_score":0.01119207,"about_ca_system_score_codex":0.00085705053,"about_ca_system_score_gemma":0.0008104912,"threshold_uncertainty_score":0.037441254},"labels":[],"label_agreement":null},{"id":"W2029534758","doi":"10.1093/neuonc/nos240","title":"CLIN-SYMPTOM MANAGEMENT/QUALITY OF LIFE","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Quality (philosophy); Psychology; Business; Philosophy; Epistemology","score_opus":0.12508388512826277,"score_gpt":0.44706101564974915,"score_spread":0.32197713052148635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029534758","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59010625,0.07253906,0.012152418,0.06628968,0.0023919558,0.0013281587,0.010367596,0.0005910284,0.24423386],"genre_scores_gemma":[0.9676049,0.0072518606,0.007023498,0.006437872,0.0007236095,0.0004662943,0.002603235,0.000052892487,0.007835741],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673826,0.0016642319,0.0003890255,0.00020443878,0.0007523397,0.00025173344],"domain_scores_gemma":[0.99239606,0.0014204405,0.0023399247,0.0003428868,0.0024027503,0.0010979978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041160504,0.0003921496,0.00066342065,0.0015937126,0.00074395526,0.002151035,0.0005815981,0.0006060832,0.009585091],"category_scores_gemma":[0.01175316,0.00011512051,0.0008125439,0.0015279592,0.0004576426,0.0008878819,0.000989197,0.0009301831,0.0014019695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052427495,0.0012922137,0.4770113,0.0011553991,0.0007335142,0.0001696504,0.0006934104,0.0007748174,0.0007381921,0.0036950388,0.042910684,0.47030163],"study_design_scores_gemma":[0.0003152902,0.0013819891,0.918468,0.0012499939,0.0004941585,0.0011813077,0.0014197339,0.0017364611,0.0012010153,0.004655618,0.06782177,0.000074690775],"about_ca_topic_score_codex":0.002578308,"about_ca_topic_score_gemma":0.0051560486,"teacher_disagreement_score":0.009585091,"about_ca_system_score_codex":0.0024447143,"about_ca_system_score_gemma":0.0024550848,"threshold_uncertainty_score":0.032065272},"labels":[],"label_agreement":null},{"id":"W2031120760","doi":"10.1093/neuonc/nou253.4","title":"ED-04 * SURVIVAL RATES AMONG CANADIAN PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMOURS: AN ANALYSIS BASED ON STATISTICS CANADA DATA, 1992-2010","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Survival analysis; Demography; Proportional hazards model; Population; Confidence interval; Brain tumor; Brain cancer; Cancer; Pathology; Internal medicine; Environmental health","score_opus":0.008608183512767128,"score_gpt":0.264361654253417,"score_spread":0.25575347074064986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031120760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63725376,0.002969631,0.00046830956,0.0009262052,0.000052516174,0.00016331671,0.34350255,0.00016015512,0.014503556],"genre_scores_gemma":[0.8953841,0.0019630354,0.00068772986,0.00018966814,0.000021028844,0.00008570727,0.097489096,0.000035949786,0.004143719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896574,0.000048050522,0.000087633154,0.000112010996,0.00051175046,0.00027484616],"domain_scores_gemma":[0.99686664,0.00014456622,0.0005017239,0.00008303703,0.0019595164,0.00044452818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075654354,0.00044068063,0.00046424556,0.0034738504,0.0010192649,0.0007460329,0.0009841988,0.0002913084,0.0043230127],"category_scores_gemma":[0.0026487052,0.0002424186,0.0009425782,0.008193849,0.0003839427,0.0002605012,0.0005864666,0.00045505317,0.0005624297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043527992,0.000028440134,0.9617322,0.00037523173,0.00026177464,0.0001086879,0.00022135738,0.0011450761,0.00016452614,0.00034874806,0.02301228,0.012166374],"study_design_scores_gemma":[0.00001987988,0.000027378535,0.9926642,0.000054826072,0.000070441994,0.00009166556,0.00028420985,0.0005675771,0.00009642274,0.00003799332,0.00606889,0.00001645744],"about_ca_topic_score_codex":0.99403584,"about_ca_topic_score_gemma":0.99504966,"teacher_disagreement_score":0.033858772,"about_ca_system_score_codex":0.033858772,"about_ca_system_score_gemma":0.035479557,"threshold_uncertainty_score":0.24566376},"labels":[],"label_agreement":null},{"id":"W2033633603","doi":"10.1093/neuonc/nor147","title":"ANGIOGENESIS AND INVASION","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Angiogenesis; Cancer research; Biology","score_opus":0.05369308801299511,"score_gpt":0.27358096457176845,"score_spread":0.21988787655877334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033633603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44991073,0.28417715,0.018270722,0.022118373,0.002886819,0.00016895616,0.000728189,0.00027768526,0.22146142],"genre_scores_gemma":[0.8852845,0.041150987,0.0034821467,0.00110983,0.0010038528,0.00010065702,0.00037398865,0.000023888284,0.06747021],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996038,0.00008740326,0.000015400426,0.00004813352,0.00011998767,0.00012529948],"domain_scores_gemma":[0.9997008,0.000048540638,0.000060757156,0.000024253277,0.00007472802,0.00009090397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042155583,0.00043120215,0.00027034123,0.0009755553,0.0005844351,0.0015128222,0.00026224784,0.0009369418,0.004427709],"category_scores_gemma":[0.0003870322,0.00020449073,0.00028274997,0.00045182154,0.000704909,0.0010877469,0.0006510414,0.0009845425,0.0007157895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007969964,0.00030423308,0.005610146,0.0011060609,0.000111040965,0.0027627961,0.0009728753,0.0008591962,0.4340079,0.32264325,0.03137344,0.199452],"study_design_scores_gemma":[0.000104262086,0.0009869379,0.0596881,0.00049917673,0.00016244287,0.012058554,0.0016678339,0.005288404,0.23573287,0.097135775,0.5865695,0.000106224725],"about_ca_topic_score_codex":0.0012311982,"about_ca_topic_score_gemma":0.001210957,"teacher_disagreement_score":0.004427709,"about_ca_system_score_codex":0.0010720474,"about_ca_system_score_gemma":0.00067233614,"threshold_uncertainty_score":0.014812112},"labels":[],"label_agreement":null},{"id":"W2038579109","doi":"10.1093/neuonc/nou070","title":"GERM CELL TUMOURS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Germ cell; Biology; Genetics","score_opus":0.01379146272724066,"score_gpt":0.28936557910305843,"score_spread":0.2755741163758178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038579109","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10543499,0.14248064,0.008025586,0.0155560635,0.007138498,0.00018108146,0.0021043264,0.000980354,0.71809834],"genre_scores_gemma":[0.67289156,0.05530518,0.007810458,0.0072809183,0.0051481053,0.00006477314,0.0024202086,0.0002521058,0.24882671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986124,0.000014437645,0.000010398034,0.000021736463,0.00005623076,0.000035975987],"domain_scores_gemma":[0.9997441,0.000034305158,0.000041081872,0.000036248955,0.000061169325,0.00008305504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001983674,0.00020834226,0.0001997434,0.0009745312,0.0006092715,0.00088198006,0.00030244785,0.00049953983,0.019508597],"category_scores_gemma":[0.0007046124,0.000091136026,0.00022222707,0.00092158857,0.00045575792,0.0004698414,0.0004842703,0.0008490498,0.006665155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017322454,0.0000855604,0.02305922,0.0007382573,0.00007939682,0.038245585,0.00042424077,0.00045921456,0.016264385,0.022187883,0.1336534,0.76462966],"study_design_scores_gemma":[0.000019173296,0.00006673242,0.013762493,0.0001723531,0.00003907285,0.105345875,0.00018877257,0.0001429618,0.004569831,0.003955134,0.87172645,0.0000111366],"about_ca_topic_score_codex":0.0011949189,"about_ca_topic_score_gemma":0.002424613,"teacher_disagreement_score":0.019508597,"about_ca_system_score_codex":0.0006246881,"about_ca_system_score_gemma":0.0007567627,"threshold_uncertainty_score":0.065262794},"labels":[],"label_agreement":null},{"id":"W2042861076","doi":"10.1093/neuonc/nou240.16","title":"BM-16 * INCREASED ACUTE RADIATION EFFECT (ARE) WITH IPILUMUMAB AND RADIOSURGERY IN PATIENTS WITH MELANOMA BRAIN METASTASES","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Melanoma; Radiation therapy; Incidence (geometry); Brain metastasis; Retrospective cohort study; Surgery; Internal medicine; Nuclear medicine; Metastasis; Cancer","score_opus":0.005356560049197767,"score_gpt":0.24016122860155123,"score_spread":0.23480466855235346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042861076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984836,0.00076731,0.00010531764,0.00003349476,0.0000038499056,0.00000805108,0.000047836074,0.0000060629004,0.0005445281],"genre_scores_gemma":[0.9996637,0.00012222602,0.00006662968,0.000013707144,0.000010235684,0.0000036220933,0.000053168034,0.0000018454381,0.000064811684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996227,0.00010591459,0.000050353225,0.00006989505,0.00008365917,0.00006739098],"domain_scores_gemma":[0.9980228,0.00029798035,0.001305382,0.00006207545,0.000116869756,0.00019498283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000418735,0.00020843922,0.00039442745,0.00060308597,0.0003071788,0.0003890184,0.00020407196,0.00029453644,0.0014938691],"category_scores_gemma":[0.0018501987,0.00017911267,0.00037026568,0.00064538716,0.0002750674,0.00026487373,0.0002498454,0.00043880267,0.00022457346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041622508,0.00003502405,0.99339795,0.00002610052,0.000054231827,0.0013176758,0.000055143464,0.00006642817,0.0013370363,0.000013783198,0.000063731335,0.0032165959],"study_design_scores_gemma":[0.000013547411,0.0005012265,0.9886912,0.000010275118,0.000051867348,0.009563382,0.00007077772,0.00019265729,0.00052723475,0.000021342012,0.0003515758,0.0000048789566],"about_ca_topic_score_codex":0.00090716284,"about_ca_topic_score_gemma":0.0010588418,"teacher_disagreement_score":0.0014938691,"about_ca_system_score_codex":0.0003132507,"about_ca_system_score_gemma":0.00024226609,"threshold_uncertainty_score":0.004997492},"labels":[],"label_agreement":null},{"id":"W2044800165","doi":"10.1093/neuonc/2.3.145","title":"Localization of gelatinase-A and gelatinase-B mRNA and protein in humangliomas","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gelatinase A; MMP9; Gelatinase; Glioma; Matrix metalloproteinase; MMP2; Fibroblast activation protein, alpha; Angiogenesis; In situ hybridization; Neovascularization; Biology; Immunohistochemistry; Tumor progression; Cancer research; Pathology; Proteases; Molecular biology; Messenger RNA; Medicine; Enzyme; Immunology; Cancer; Downregulation and upregulation; Gene; Biochemistry","score_opus":0.008914538293406682,"score_gpt":0.2450833308535085,"score_spread":0.23616879256010181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044800165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942532,0.002930308,0.0012722033,0.00009242382,0.000015425725,0.000013520607,0.00042262947,0.00006089838,0.0009393938],"genre_scores_gemma":[0.993507,0.0021162776,0.0013310245,0.000035258818,0.000021374115,0.00003773056,0.00077991467,0.000013039805,0.0021583664],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994516,0.000005582321,0.000004836818,0.000014654912,0.000014949028,0.000014831817],"domain_scores_gemma":[0.99990904,0.00002000964,0.000026309828,0.000010246107,0.000010637413,0.000023687078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007867259,0.00018692472,0.00011536577,0.00063982373,0.00016409984,0.00024960705,0.00007718444,0.00019265688,0.00093935744],"category_scores_gemma":[0.00024657563,0.0001517302,0.00011645247,0.0002025699,0.00027766565,0.00014635187,0.00013615197,0.00020610525,0.0003340833],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000266737,0.000021212361,0.0014664334,0.00004047792,0.00000798165,0.00039374005,0.000062920386,0.000040842533,0.9959787,0.00012911519,0.000056237644,0.0015355045],"study_design_scores_gemma":[0.00020124624,0.001576332,0.30211785,0.00004284179,0.00015378094,0.012835016,0.0008417361,0.0017495935,0.66429263,0.0013236098,0.014828042,0.00003731272],"about_ca_topic_score_codex":0.0012360364,"about_ca_topic_score_gemma":0.0006725579,"teacher_disagreement_score":0.0012360364,"about_ca_system_score_codex":0.00022915685,"about_ca_system_score_gemma":0.00016629515,"threshold_uncertainty_score":0.003142476},"labels":[],"label_agreement":null},{"id":"W2047163880","doi":"10.1093/neuonc/nou275.25","title":"SC-25 * INVESTIGATING THE ROLE OF ASCL1 IN REGULATING DIFFERENTIATION OF GLIOBLASTOMA PRECURSOR CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurogenesis; Biology; Immunocytochemistry; Precursor cell; Lineage markers; Cellular differentiation; Neural stem cell; Cell biology; Stem cell; Notch signaling pathway; Cancer research; Signal transduction; Cell; Endocrinology; Genetics; Gene","score_opus":0.00619137974754398,"score_gpt":0.2309472653139939,"score_spread":0.22475588556644993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047163880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912025,0.0026045707,0.0013596193,0.00012278785,0.000027928296,0.00006173985,0.00055924075,0.000049225742,0.00401253],"genre_scores_gemma":[0.98951787,0.0015561011,0.0017703089,0.000089457986,0.000007919958,0.00006276934,0.0012659564,0.000010246812,0.005719382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994314,0.000008181319,0.000005157906,0.000010122332,0.000016680346,0.000016748343],"domain_scores_gemma":[0.9999428,0.000008466931,0.000006981892,0.0000066407024,0.000009389036,0.000025650541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096737655,0.00020849926,0.00013711529,0.00023794724,0.00017822134,0.00023691406,0.00016379813,0.00018261926,0.0013536982],"category_scores_gemma":[0.00004977364,0.000060525505,0.0002209636,0.00018655331,0.00015273353,0.000084099265,0.00009779389,0.00032650674,0.0004667504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020478835,0.000081785554,0.00039131174,0.00005772856,0.0000061662863,0.00009235755,0.000013604121,0.00015123232,0.99560046,0.00012824165,0.000119123324,0.0031532634],"study_design_scores_gemma":[0.000023819635,0.00092685275,0.0045518596,0.000009061286,0.000020970578,0.00019923005,0.00003813663,0.00068854267,0.98793715,0.000051650404,0.00554943,0.0000033905465],"about_ca_topic_score_codex":0.0017742147,"about_ca_topic_score_gemma":0.0029646312,"teacher_disagreement_score":0.0017742147,"about_ca_system_score_codex":0.00035989512,"about_ca_system_score_gemma":0.000372994,"threshold_uncertainty_score":0.0045286417},"labels":[],"label_agreement":null},{"id":"W2052524261","doi":"10.1093/neuonc/nou273.6","title":"RM-06 * IN VITRO CLONAL EVOLUTION OF GLIOBLASTOMA (GBM) BRAIN TUMOUR INITIATING CELLS (BTIC) TO MODEL TUMOUR RECURRENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Temozolomide; Biology; Somatic evolution in cancer; Transcriptome; SOX2; Stem cell; Glioblastoma; Cancer research; Radiation therapy; Genetic heterogeneity; Cancer stem cell; Brain tumor; Oncology; Internal medicine; Pathology; Medicine; Cancer; Gene; Phenotype; Gene expression; Genetics","score_opus":0.022510374755134368,"score_gpt":0.29777659829174596,"score_spread":0.2752662235366116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052524261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94684625,0.0034523043,0.026100038,0.00058113417,0.00033162322,0.00075389724,0.0050976877,0.0007048966,0.016132167],"genre_scores_gemma":[0.93093866,0.002036443,0.038350947,0.00038958382,0.000046915196,0.000998653,0.007276974,0.00020442391,0.01975734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947447,0.00011260563,0.000064869404,0.00009774003,0.00017721538,0.000073281364],"domain_scores_gemma":[0.99965036,0.00006853761,0.00006122978,0.00006957869,0.00007040988,0.000079876656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044399887,0.00044492056,0.0004320996,0.00042217172,0.00022216543,0.00041280597,0.00044598852,0.0005456481,0.0017190023],"category_scores_gemma":[0.00017941126,0.0002010287,0.00048284492,0.00028106663,0.00018893846,0.00015533317,0.0003164188,0.0011646376,0.00122836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019689933,0.0002748425,0.0004263405,0.000090040456,0.000013283754,0.00013118099,0.0000572736,0.0008031167,0.9933436,0.000584921,0.0007663667,0.0033120732],"study_design_scores_gemma":[0.000049763687,0.0021978538,0.0036249978,0.000029311308,0.000047139132,0.00053679675,0.0000492641,0.007500497,0.9665519,0.00016243182,0.019234143,0.000015912927],"about_ca_topic_score_codex":0.002554939,"about_ca_topic_score_gemma":0.003728619,"teacher_disagreement_score":0.002554939,"about_ca_system_score_codex":0.00043458908,"about_ca_system_score_gemma":0.00039417745,"threshold_uncertainty_score":0.0057505965},"labels":[],"label_agreement":null},{"id":"W2052591253","doi":"10.1093/neuonc/nou254.16","title":"EG-16 * ABERRANT Myst4/Brpf1 SIGNALING MISDIRECTS REGIONAL NEUROGENESIS PROGRAMS, SUSTAINING EXPRESSION OF SELF-RENEWAL GENES IN PEDIATRIC BRAIN CANCERS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hospital for Sick Children","funders":"","keywords":"Neurogenesis; Biology; Epigenetics; Chromatin; Neural stem cell; DNA methylation; Histone; Neural development; Cancer research; Genetics; Cell biology; Gene expression; Gene; Stem cell","score_opus":0.01447188031355788,"score_gpt":0.2625785312720758,"score_spread":0.24810665095851792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052591253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956126,0.0010071769,0.0011937867,0.0000898457,0.000019148361,0.000011337112,0.00074273563,0.000109599074,0.0012138392],"genre_scores_gemma":[0.99377704,0.0007240299,0.001302371,0.000079798774,0.0000053494127,0.000020374016,0.0012039479,0.00003369239,0.0028533523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984896,0.000010945386,0.000018498411,0.00003584585,0.00003589511,0.000049829436],"domain_scores_gemma":[0.9999306,0.000008479936,0.000021139285,0.0000129560585,0.0000057707325,0.000021157517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012170797,0.0002663039,0.000285595,0.00029568464,0.00012918463,0.00031831046,0.00020555202,0.00028847056,0.0016756736],"category_scores_gemma":[0.00009682468,0.00014156583,0.00022410163,0.00030378328,0.00021648749,0.00019591236,0.00021110717,0.00048417112,0.0005288505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015548369,0.000021667984,0.0016666488,0.000034175173,0.000014408492,0.0003842746,0.00001793797,0.0001282778,0.99494016,0.00015265081,0.00012430998,0.0023601162],"study_design_scores_gemma":[0.000020222295,0.00019048984,0.026008893,0.000005768765,0.00004073027,0.0049631456,0.00006933092,0.0010012449,0.9610127,0.0001231457,0.0065591983,0.0000049714686],"about_ca_topic_score_codex":0.0006535545,"about_ca_topic_score_gemma":0.00071765255,"teacher_disagreement_score":0.0016756736,"about_ca_system_score_codex":0.000359521,"about_ca_system_score_gemma":0.00022940278,"threshold_uncertainty_score":0.005605638},"labels":[],"label_agreement":null},{"id":"W2053284631","doi":"10.1093/neuonc/nou266.8","title":"PT-08 * VERY ENCOURAGING LONG TERM SURVIVAL AND NEUROCOGNITIVE OUTCOME OF YOUNG CHILDREN TREATED FOR MEDULLOBLASTOMA WITH SEQUENTIAL HIGH DOSE CHEMOTHERAPY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Carboplatin; Chemotherapy; Neurocognitive; ThioTEPA; Radiation therapy; Induction chemotherapy; Internal medicine; Retrospective cohort study; Surgery; Oncology; Pediatrics; Cisplatin; Cyclophosphamide; Pathology","score_opus":0.01663704749605081,"score_gpt":0.28929903276872393,"score_spread":0.2726619852726731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053284631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987011,0.00029266908,0.00015342626,0.00003331291,0.000006207592,0.000011141138,0.00020976826,0.000010128848,0.000582173],"genre_scores_gemma":[0.99915755,0.00011354352,0.0001620327,0.000023285036,0.000009058857,0.00000952705,0.00032970132,0.0000035924427,0.00019177592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998677,0.00003236623,0.000014393637,0.000020152422,0.000026316167,0.00003902482],"domain_scores_gemma":[0.9994235,0.00009163407,0.00024234313,0.000035802652,0.00005592735,0.00015093345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020009109,0.00012550208,0.0002064963,0.00022660196,0.00022216265,0.00021109992,0.00009307383,0.00015139535,0.00073896535],"category_scores_gemma":[0.0006700149,0.000052088293,0.00021156782,0.00023785605,0.00018467766,0.00013553113,0.00017436601,0.000201077,0.00019642111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072444096,0.00012251495,0.9716061,0.00003989349,0.000059413924,0.0031725133,0.0001420942,0.00018642019,0.0030262996,0.000026216416,0.00057145744,0.020322643],"study_design_scores_gemma":[0.00005234934,0.0025971178,0.98085326,0.000018486506,0.000072869196,0.01160008,0.00012755979,0.00017528037,0.002137744,0.00003312004,0.0023266054,0.0000055008145],"about_ca_topic_score_codex":0.001678308,"about_ca_topic_score_gemma":0.0030011283,"teacher_disagreement_score":0.001678308,"about_ca_system_score_codex":0.00037914468,"about_ca_system_score_gemma":0.00035958955,"threshold_uncertainty_score":0.0033370256},"labels":[],"label_agreement":null},{"id":"W2053550046","doi":"10.1093/neuonc/nov061.6","title":"AT-07 * SUCCESSFUL TREATMENT OF ATRT PATIENTS WITHOUT ADJUVANT RADIATION: A MULTI INSTITUTIONAL CANADIAN EXPERIENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Adjuvant; Adjuvant radiotherapy; Medicine; Radiation therapy; Medical physics; Oncology; Internal medicine","score_opus":0.043956571502167585,"score_gpt":0.3232962226601592,"score_spread":0.27933965115799164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053550046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779454,0.003303434,0.0009831995,0.00091135874,0.00005613211,0.00014226345,0.00049097446,0.000055307995,0.0161121],"genre_scores_gemma":[0.98964894,0.003717442,0.002280342,0.0006010368,0.00007026245,0.00003446689,0.0007488881,0.00008174828,0.002816815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963665,0.000052355503,0.000024159432,0.000054390202,0.00010097381,0.00013147405],"domain_scores_gemma":[0.9992378,0.000066379485,0.000111027184,0.00004869774,0.0001743544,0.00036173064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038345312,0.00042027564,0.00025125578,0.00047388862,0.0023648704,0.00074858527,0.0007778139,0.0004982701,0.0020670178],"category_scores_gemma":[0.00077123626,0.00018134892,0.0004836623,0.0014270731,0.00074616977,0.00022229784,0.00063743023,0.00066739204,0.00046629392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018019802,0.0019006503,0.58404607,0.0005818519,0.00045562975,0.05445296,0.0079624485,0.0030389936,0.021285366,0.0013933543,0.016812421,0.30626827],"study_design_scores_gemma":[0.00043237765,0.0042320653,0.7594789,0.00032623153,0.00044075708,0.14294791,0.0043999255,0.002025241,0.0063273963,0.00048754015,0.078723624,0.00017809725],"about_ca_topic_score_codex":0.4658992,"about_ca_topic_score_gemma":0.7079635,"teacher_disagreement_score":0.5341008,"about_ca_system_score_codex":0.0066798097,"about_ca_system_score_gemma":0.009146309,"threshold_uncertainty_score":0.92637473},"labels":[],"label_agreement":null},{"id":"W2054601242","doi":"10.1093/neuonc/nos136","title":"Response to Weltman and Fleury Malheiros, re Lassman et al.","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"Eisai; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Art","score_opus":0.033870006807490964,"score_gpt":0.3411107219320665,"score_spread":0.3072407151245755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054601242","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017467479,0.0026005863,0.00017081405,0.8955888,0.10048311,0.000040724397,0.00017202132,0.00009090338,0.0006783394],"genre_scores_gemma":[0.0010644644,0.0015983322,0.00020558025,0.9372516,0.05683478,0.00008291133,0.000081577884,0.00004558538,0.0028352765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939122,0.001357225,0.00085751404,0.0010310671,0.002279969,0.0005620787],"domain_scores_gemma":[0.97536147,0.009074302,0.0021230944,0.0009890582,0.009645296,0.0028068554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009335671,0.0015985676,0.0026762916,0.0017751507,0.0031497169,0.0053037032,0.0046108547,0.03227725,0.009438322],"category_scores_gemma":[0.061315775,0.0011345207,0.0022951597,0.0016618504,0.0035803467,0.0054934775,0.0031105753,0.045193676,0.011058224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020026871,0.000008457483,0.0001425931,0.00008571859,0.000010421807,0.00013081134,0.000034987555,0.000018036693,0.000028088638,0.00020041403,0.9967429,0.0025775584],"study_design_scores_gemma":[0.00007907512,0.000052525094,0.0010336336,0.0007200287,0.00004619943,0.0012394309,0.00039626646,0.00023637275,0.00024631296,0.0016978731,0.9941379,0.00011439705],"about_ca_topic_score_codex":0.0045729503,"about_ca_topic_score_gemma":0.0064617903,"teacher_disagreement_score":0.03227725,"about_ca_system_score_codex":0.004982724,"about_ca_system_score_gemma":0.004945113,"threshold_uncertainty_score":0.049372315},"labels":[],"label_agreement":null},{"id":"W2055809488","doi":"10.1093/neuonc/nor152","title":"MEDICAL AND NEURO-ONCOLOGY","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.06514576540051202,"score_gpt":0.32648774596965874,"score_spread":0.2613419805691467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055809488","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14138897,0.35001808,0.0043893284,0.017864522,0.0038037274,0.00018762039,0.00064113387,0.0003888284,0.48131776],"genre_scores_gemma":[0.64348924,0.18174277,0.0059727198,0.0098356465,0.0031017358,0.00016184257,0.0011655245,0.00006935213,0.15446116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998715,0.000029551516,0.000013402916,0.000015469297,0.000038239657,0.000031907315],"domain_scores_gemma":[0.99979526,0.000030315967,0.000039653893,0.000017501718,0.000054462886,0.000062731786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016548985,0.00034769898,0.00031828557,0.00051758613,0.00080930814,0.00069836347,0.0003081174,0.00063113665,0.025492769],"category_scores_gemma":[0.00079262594,0.00008281765,0.00023434151,0.00049507915,0.00044597386,0.00037177617,0.0005357879,0.0008879047,0.0077592987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033123183,0.00035499202,0.033380043,0.0010929009,0.00010958634,0.054465227,0.00033913396,0.0003053168,0.00726702,0.006571553,0.058321644,0.8374614],"study_design_scores_gemma":[0.000081351616,0.0005876838,0.048671942,0.0008279715,0.00009206319,0.23468798,0.00045211683,0.0003246712,0.003682884,0.004276225,0.7062899,0.00002522834],"about_ca_topic_score_codex":0.0010180571,"about_ca_topic_score_gemma":0.002593091,"teacher_disagreement_score":0.9745072,"about_ca_system_score_codex":0.00070172787,"about_ca_system_score_gemma":0.0011151327,"threshold_uncertainty_score":0.08528179},"labels":[],"label_agreement":null},{"id":"W2060237761","doi":"10.1093/neuonc/nos102","title":"HIGH GRADE GLIOMAS","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of Manitoba; BC Cancer Agency; University of Alberta; University of British Columbia; University of Calgary; McGill University","funders":"","keywords":"Glioma; Medicine; Cancer research","score_opus":0.03150875263397761,"score_gpt":0.31260760397976445,"score_spread":0.2810988513457868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060237761","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5313246,0.02474783,0.00734826,0.0034612168,0.0006607713,0.00025275827,0.004836819,0.0008695467,0.4264983],"genre_scores_gemma":[0.93553936,0.0069150627,0.0028563861,0.00081784953,0.00035218586,0.0000460548,0.0025819181,0.00014253751,0.050748695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982893,0.000011679749,0.000012073452,0.000022022637,0.00005969692,0.0000655658],"domain_scores_gemma":[0.99977607,0.00002629755,0.000057982066,0.000025637266,0.000056586057,0.00005752103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012522032,0.000336794,0.00022770847,0.0011320054,0.0005369403,0.001203341,0.00021687405,0.0003962721,0.011747905],"category_scores_gemma":[0.00061728974,0.000100953606,0.00028658018,0.0012374045,0.00030302742,0.00048459633,0.00039020673,0.0004470122,0.0043438813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087198877,0.00017652553,0.24333243,0.0008823949,0.00019813297,0.033250883,0.0005662236,0.00065447384,0.035211597,0.009211935,0.049490396,0.626153],"study_design_scores_gemma":[0.00006285694,0.00047531258,0.3721939,0.00028370848,0.00038513835,0.19076945,0.001257724,0.0009617401,0.03884848,0.01017659,0.38453194,0.0000531909],"about_ca_topic_score_codex":0.004417277,"about_ca_topic_score_gemma":0.009933173,"teacher_disagreement_score":0.011747905,"about_ca_system_score_codex":0.0009088291,"about_ca_system_score_gemma":0.00075342786,"threshold_uncertainty_score":0.03930062},"labels":[],"label_agreement":null},{"id":"W2062039318","doi":"10.1215/15228517-2007-029","title":"Synovial sarcoma of the sellar region","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Synovial sarcoma; Cavernous sinus; Medicine; Sarcoma; Resection; Radiosurgery; Pathology; Radiology; Anatomy; Radiation therapy; Surgery","score_opus":0.029731124875033325,"score_gpt":0.308320786164908,"score_spread":0.27858966128987467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062039318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809583,0.0067652813,0.0018663405,0.00036425644,0.00003825095,0.000021553085,0.00016483103,0.000056411787,0.009764806],"genre_scores_gemma":[0.99753463,0.0014777774,0.00037611887,0.000041351046,0.000027972608,0.0000025365373,0.000037993505,0.0000038101614,0.00049795094],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99990773,0.000008426086,0.000009288251,0.000010611541,0.000037052654,0.000026802903],"domain_scores_gemma":[0.9997819,0.00006121447,0.00004925955,0.000011247318,0.00001786029,0.00007851149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006520296,0.00027302757,0.00024647242,0.00061579695,0.00039482565,0.00041277293,0.00014729096,0.00031401977,0.001716279],"category_scores_gemma":[0.0005103513,0.00016584987,0.00019736335,0.00026564964,0.00045226756,0.0002679379,0.00036623242,0.0002816831,0.00043154883],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019675335,0.00006692784,0.05570478,0.00029677237,0.000064062275,0.7938282,0.0008817637,0.00043110992,0.11272427,0.0023564736,0.001100459,0.03234842],"study_design_scores_gemma":[0.000048546186,0.0003555899,0.045857444,0.000066349334,0.000048941685,0.9335579,0.00056211645,0.0005585189,0.011464863,0.0013875078,0.006074383,0.000017853488],"about_ca_topic_score_codex":0.0019311245,"about_ca_topic_score_gemma":0.0025950577,"teacher_disagreement_score":0.0019311245,"about_ca_system_score_codex":0.00032316896,"about_ca_system_score_gemma":0.00046432944,"threshold_uncertainty_score":0.0057415366},"labels":[],"label_agreement":null},{"id":"W2062453374","doi":"10.1093/neuonc/nov061.70","title":"LG-01 * BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Hospital for Sick Children","funders":"","keywords":"ATRX; CDKN2A; Glioma; Cancer research; IDH1; Biology; Somatic cell; Oncology; Mutation; Subgroup analysis; Malignant transformation; Medicine; Internal medicine; Gene; Genetics; Confidence interval","score_opus":0.024620677296112774,"score_gpt":0.30267390835281405,"score_spread":0.27805323105670127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062453374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995092,0.00004673052,0.00008062814,0.000006213178,6.810315e-7,0.000005230743,0.00010750875,0.000007338535,0.00023642757],"genre_scores_gemma":[0.9995666,0.00002923926,0.00008503427,0.00000481587,0.0000013156869,0.000003868111,0.0002562954,0.0000034159143,0.000049324106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998155,0.000022047265,0.000019135789,0.000058117945,0.000039635757,0.000045424462],"domain_scores_gemma":[0.99955314,0.0000619916,0.00021112703,0.000043422348,0.000036214045,0.00009404575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013690365,0.00027859508,0.00025351433,0.00071594375,0.00024102289,0.0003995506,0.00024354707,0.0002728772,0.0012112383],"category_scores_gemma":[0.0008702277,0.0001277966,0.00018533067,0.00062366464,0.00033999604,0.00019930223,0.0004332301,0.00020076265,0.00030917287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714961,0.000013345389,0.98722386,0.00001983162,0.000020833724,0.0021716424,0.00009328465,0.000087614695,0.006632317,0.000043370637,0.00011049782,0.0034119296],"study_design_scores_gemma":[0.000005668272,0.000112189904,0.9834327,0.0000046306836,0.000020984744,0.014352484,0.00022855157,0.00020763173,0.0012261961,0.00007642629,0.00032997885,0.0000025093555],"about_ca_topic_score_codex":0.0013065303,"about_ca_topic_score_gemma":0.00254844,"teacher_disagreement_score":0.0013065303,"about_ca_system_score_codex":0.00022184536,"about_ca_system_score_gemma":0.00023795315,"threshold_uncertainty_score":0.0040519834},"labels":[],"label_agreement":null},{"id":"W2067398672","doi":"10.1093/neuonc/nou174.218","title":"P09.02 * ORTERONEL (TAK-700) AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Posterior reversible encephalopathy syndrome; Headaches; Internal medicine; Urology; Endocrinology; Magnetic resonance imaging; Surgery; Radiology","score_opus":0.015984118229160238,"score_gpt":0.269079081431608,"score_spread":0.2530949632024478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067398672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6048032,0.007874234,0.0042422297,0.044320073,0.0036699364,0.0004892609,0.0038782703,0.00075688073,0.32996592],"genre_scores_gemma":[0.93843895,0.001579351,0.0019355154,0.00562961,0.0020199781,0.00011512969,0.0015869794,0.00010198349,0.048592553],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99980134,0.000038292517,0.000012446755,0.0000524611,0.000024446566,0.000071098555],"domain_scores_gemma":[0.9997464,0.00007385451,0.000038968472,0.000012379944,0.000030311016,0.000098192046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017120288,0.0008251919,0.00042823047,0.00039303757,0.0007275996,0.00047861738,0.0005142284,0.001963381,0.034823086],"category_scores_gemma":[0.00047866828,0.00020068628,0.00038533504,0.00036933285,0.00040279442,0.00053658267,0.0002516295,0.001225892,0.003851185],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051653483,0.0018089358,0.076663986,0.0003862776,0.00035079542,0.7418193,0.00024418373,0.00035696468,0.014377934,0.0071474724,0.06511074,0.08656812],"study_design_scores_gemma":[0.0011600705,0.0026398653,0.19427183,0.0004270582,0.00023775741,0.680778,0.00051092583,0.0026814626,0.004379825,0.0057165944,0.107119,0.00007763865],"about_ca_topic_score_codex":0.0021167407,"about_ca_topic_score_gemma":0.0013715005,"teacher_disagreement_score":0.034823086,"about_ca_system_score_codex":0.0003101947,"about_ca_system_score_gemma":0.00053187204,"threshold_uncertainty_score":0.116494834},"labels":[],"label_agreement":null},{"id":"W2070212974","doi":"10.1093/neuonc/nou260.12","title":"MS-13 * NON-CONTIGUOUS LEPTOMENINGEAL METASTASIS OF OLFACTORY NEUROBLASTOMAS: A LONG-TERM MULTI-INSTITUTIONAL EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Head and Neck Surgical Oncology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cribriform plate; Metastasis; Esthesioneuroblastoma; Nasal cavity; Brain metastasis; Radiology; Cancer; Pathology; Surgery; Internal medicine","score_opus":0.047218558161192366,"score_gpt":0.33451698559237353,"score_spread":0.28729842743118117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070212974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991922,0.0002285564,0.000096983,0.000026897196,0.000004275089,0.000007981885,0.000031456417,0.0000032877456,0.0004084677],"genre_scores_gemma":[0.9990031,0.00031327986,0.00012422599,0.000037875554,0.000017525517,0.0000092145,0.00012930548,0.0000036281604,0.00036186856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971384,0.000042089654,0.000042241816,0.000055720608,0.00005506714,0.000091062815],"domain_scores_gemma":[0.9992607,0.00010050924,0.00019040701,0.000077361634,0.00006843952,0.0003025796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041793723,0.00041533043,0.00025929615,0.0007347017,0.0010973712,0.0005667393,0.00032872276,0.00037497326,0.0010359974],"category_scores_gemma":[0.0008699185,0.00020847203,0.00039333478,0.00065701717,0.00043436975,0.0005433135,0.0011347056,0.0004570067,0.00036821753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028128183,0.00054083444,0.9195455,0.000049737533,0.00008559522,0.050285112,0.0017661897,0.0001961139,0.0033000556,0.000067921195,0.00030340266,0.023578228],"study_design_scores_gemma":[0.000045624172,0.0034043565,0.8335404,0.0000621847,0.00011903712,0.15333663,0.00349073,0.00056943885,0.002258977,0.00011087144,0.0030147985,0.000047036],"about_ca_topic_score_codex":0.0029389593,"about_ca_topic_score_gemma":0.0072495295,"teacher_disagreement_score":0.0029389593,"about_ca_system_score_codex":0.00058212713,"about_ca_system_score_gemma":0.00063429953,"threshold_uncertainty_score":0.005843699},"labels":[],"label_agreement":null},{"id":"W2070721270","doi":"10.1093/neuonc/nou265.5","title":"NT-05 * PATIENT ACCEPTANCE OF ROUTINE RESAMPLING OF GLIOBLASTOMA: A QUALITATIVE STUDY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Qualitative research; Medicine; Thematic analysis; Feeling; Glioblastoma; Protocol (science); Grounded theory; Medical physics; Medical education; Psychology; Oncology; Alternative medicine; Pathology; Social psychology","score_opus":0.1265102336613465,"score_gpt":0.46801092470710454,"score_spread":0.34150069104575803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070721270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94511116,0.00056187133,0.0052205785,0.016767725,0.00045592204,0.0023397666,0.00120993,0.00007836448,0.028254606],"genre_scores_gemma":[0.9764969,0.00071757246,0.0035892213,0.003428143,0.00003784691,0.004474055,0.00026010253,0.000056876906,0.010939306],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9908913,0.0071276114,0.00031415222,0.00032893213,0.00054012844,0.0007977657],"domain_scores_gemma":[0.9709335,0.017679287,0.0011847412,0.00067897845,0.0047568544,0.004766582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012754546,0.00018402761,0.00038672294,0.0008330648,0.0053481036,0.0030339053,0.0011166214,0.0015010244,0.013237171],"category_scores_gemma":[0.02418526,0.00038237244,0.00043553155,0.0011910263,0.0036972715,0.0024774666,0.0036627268,0.0027059666,0.0013226488],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012015576,0.0001796195,0.0057217423,0.0008829377,0.0000069039756,0.000992403,0.96782404,0.000106973355,0.0011154052,0.003178041,0.0057011996,0.014170587],"study_design_scores_gemma":[0.000018351851,0.00019023319,0.00427929,0.0006105311,0.0000052113974,0.00028685262,0.9724691,0.00023716211,0.0004477027,0.0006544853,0.02078171,0.000019469997],"about_ca_topic_score_codex":0.0071793483,"about_ca_topic_score_gemma":0.0062317876,"teacher_disagreement_score":0.013237171,"about_ca_system_score_codex":0.0062372615,"about_ca_system_score_gemma":0.010165857,"threshold_uncertainty_score":0.067453265},"labels":[],"label_agreement":null},{"id":"W2073235968","doi":"10.1093/neuonc/nou243.14","title":"CN-14 * RETROSPECTIVE ANALYSIS OF ISCHEMIC CEREBRAL STROKES IN PATIENTS DIAGNOSED WITH A GLIOBLASTOMA DURING THE COURSE OF A BEVACIZUMAB TREATMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bevacizumab; Stroke (engine); Patent foramen ovale; Internal medicine; Glioma; Oncology; Angiogenesis; Population; Vascular endothelial growth factor; Cardiology; Chemotherapy; VEGF receptors; Cancer research","score_opus":0.006444876826624243,"score_gpt":0.25363041555798244,"score_spread":0.2471855387313582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073235968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964625,0.00059093646,0.00009505255,0.000020797697,0.000013049232,0.000028996108,0.001331134,0.0000049660594,0.0014525596],"genre_scores_gemma":[0.9972301,0.00029175545,0.000052400588,0.000036134534,0.000016690325,0.00003149946,0.001979339,0.0000035239373,0.0003585588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960095,0.00005339716,0.0000853019,0.00010202828,0.00008585393,0.000072482864],"domain_scores_gemma":[0.99926215,0.00008107982,0.00027681803,0.0000623748,0.00016032677,0.00015720718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026023755,0.00021615789,0.00043160477,0.0010511952,0.00046096937,0.00044803426,0.00023612051,0.00027152558,0.0019051064],"category_scores_gemma":[0.00094651233,0.00021675063,0.0004776496,0.0016062219,0.00020090837,0.00026571297,0.00034092154,0.00023976801,0.00037545452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023138517,0.000024274814,0.99788874,0.000014503298,0.000048380993,0.00047348402,0.000023719116,0.000032007054,0.000105941814,0.000014355671,0.00016181642,0.0009815585],"study_design_scores_gemma":[0.000016712622,0.00017231771,0.99678516,0.000009625795,0.000070711154,0.0017081766,0.00013300577,0.00012156425,0.00010369551,0.000021459515,0.0008508243,0.000006919355],"about_ca_topic_score_codex":0.010523022,"about_ca_topic_score_gemma":0.009152491,"teacher_disagreement_score":0.010523022,"about_ca_system_score_codex":0.00049644604,"about_ca_system_score_gemma":0.0007469292,"threshold_uncertainty_score":0.020923555},"labels":[],"label_agreement":null},{"id":"W2074099687","doi":"10.1093/neuonc/nou357","title":"Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medulloblastoma; Medicine; Cohort; Internal medicine; Radiation therapy; Oncology; Cohort study; Chemotherapy; Pediatrics; Pathology","score_opus":0.018042075287536277,"score_gpt":0.262348600671625,"score_spread":0.24430652538408876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074099687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839896,0.0005423853,0.00012876424,0.00016040809,0.0000041608955,0.00000691056,0.0003489117,0.000005541227,0.000403926],"genre_scores_gemma":[0.99924695,0.0002109728,0.00010505807,0.000036724145,0.00001266821,0.0000060060847,0.00032801242,0.000004127595,0.00004957095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996562,0.000064226544,0.000033649398,0.00009316912,0.00007042707,0.00008236351],"domain_scores_gemma":[0.9988237,0.00019140859,0.0006757537,0.00007438556,0.00006981815,0.00016500702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005175149,0.00017043993,0.0004184525,0.0005468316,0.0002639211,0.0006269559,0.00028800667,0.00031190075,0.0009787724],"category_scores_gemma":[0.0021200124,0.000109894165,0.0003657873,0.0008733673,0.00027849205,0.0007436834,0.00046821937,0.00041010467,0.00020094612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009250576,0.0000058731835,0.9953891,0.000008055029,0.00002922458,0.0001199288,0.0001452256,0.00006805503,0.00025038348,0.000049457616,0.0001391485,0.0037029595],"study_design_scores_gemma":[0.000008089832,0.000086082924,0.99607724,0.000017027352,0.00007030522,0.0012090708,0.0009801831,0.00024854462,0.00022637844,0.0004058682,0.00066292885,0.000008176587],"about_ca_topic_score_codex":0.0024317247,"about_ca_topic_score_gemma":0.0042463047,"teacher_disagreement_score":0.0024317247,"about_ca_system_score_codex":0.0004387173,"about_ca_system_score_gemma":0.00041656874,"threshold_uncertainty_score":0.0048351884},"labels":[],"label_agreement":null},{"id":"W2075172990","doi":"10.1093/neuonc/nou261.2","title":"ME-03 * BONE MARROW DERIVED MICROGLIA AND THEIR FUNCTION WITHIN TUMOR MICROENVIRONMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Microglia; Minocycline; Glioma; Biology; Tumor microenvironment; Cancer research; Bone marrow; Cell biology; Immunology; Pathology; Medicine; Inflammation; Immune system","score_opus":0.018015014412224487,"score_gpt":0.2287000725872624,"score_spread":0.2106850581750379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075172990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290776,0.0017866414,0.0026298373,0.00013188907,0.000030135963,0.000030981613,0.00049734156,0.00005959107,0.0019257307],"genre_scores_gemma":[0.98954844,0.00077662163,0.003089566,0.00010116823,0.000013452073,0.00009473399,0.0009821791,0.00002124099,0.005372639],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989545,0.000014764949,0.000006179201,0.000019158373,0.00002625403,0.000038162318],"domain_scores_gemma":[0.99995077,0.000008699987,0.000010620128,0.0000053113226,0.000008110866,0.000016527776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013098732,0.00020969588,0.00022087933,0.00016983095,0.00013130058,0.0002611069,0.00012403574,0.00022481065,0.0020908625],"category_scores_gemma":[0.00008154902,0.00007422983,0.00017082668,0.000089070905,0.00013500023,0.00010777841,0.00010397164,0.0006547939,0.0005684686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034163112,0.00007457026,0.000290614,0.000027024691,0.0000034350894,0.000046264166,0.000016162345,0.00004229939,0.99657947,0.00009837005,0.000047622434,0.0024324877],"study_design_scores_gemma":[0.000029847397,0.0008470759,0.0048373914,0.000010591358,0.000013554551,0.0003890231,0.000041420597,0.0005226229,0.98893213,0.00010422516,0.0042687403,0.0000033912468],"about_ca_topic_score_codex":0.00048244142,"about_ca_topic_score_gemma":0.00069966255,"teacher_disagreement_score":0.0020908625,"about_ca_system_score_codex":0.00014575094,"about_ca_system_score_gemma":0.00014342621,"threshold_uncertainty_score":0.0069946647},"labels":[],"label_agreement":null},{"id":"W2077269148","doi":"10.1093/neuonc/nou206.72","title":"COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS AND NOVEL TARGETS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Phosphoproteomics; Cytotoxicity; Biology; Computational biology; Drug discovery; High-content screening; Drug; Cyclin-dependent kinase; Pharmacology; Bioinformatics; Cancer research; Kinase; Cell; Genetics; In vitro; Cell cycle; Protein kinase A","score_opus":0.011000918706793879,"score_gpt":0.25254291518713007,"score_spread":0.2415419964803362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077269148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777679,0.0042328904,0.006392364,0.00018685572,0.000024389656,0.00026770466,0.008045417,0.00029205484,0.0027903917],"genre_scores_gemma":[0.96248055,0.0051348275,0.014265871,0.00019381249,0.000019249495,0.00025337044,0.01432946,0.00006444819,0.0032583652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974555,0.000023688875,0.00002120092,0.000056860106,0.000096982214,0.000055653334],"domain_scores_gemma":[0.9998534,0.000033101085,0.000023140388,0.000013412135,0.00004985618,0.000027146432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034494643,0.00076055754,0.0010142259,0.0010981241,0.0003301417,0.0005637624,0.00038999162,0.00033601144,0.002056423],"category_scores_gemma":[0.00019953764,0.0002189532,0.000597742,0.0010867469,0.00023400325,0.0001979338,0.00027392164,0.00051044615,0.0006597498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029510434,0.00012073601,0.001930661,0.00013425024,0.000038308743,0.00006216978,0.000015893902,0.0006161493,0.99080044,0.00003505214,0.00017733221,0.0057739927],"study_design_scores_gemma":[0.00005817606,0.0015561775,0.02683412,0.000009798736,0.00014625126,0.00041485362,0.000040619052,0.0020553526,0.9668897,0.000051868843,0.0019300361,0.0000130387125],"about_ca_topic_score_codex":0.003705443,"about_ca_topic_score_gemma":0.012590633,"teacher_disagreement_score":0.003705443,"about_ca_system_score_codex":0.0008181986,"about_ca_system_score_gemma":0.0007018867,"threshold_uncertainty_score":0.00736773},"labels":[],"label_agreement":null},{"id":"W2078913545","doi":"10.1093/neuonc/nou263.8","title":"NC-08 * PREDICTORS OF SURVIVAL AFTER SECOND SURGERY FOR RECURRENT GLIOBLASTOMA MULTIFORME TUMOURS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mann–Whitney U test; Surgery; Survival analysis; Log-rank test; Chemotherapy; Proportional hazards model; Retrospective cohort study; Pathological; Internal medicine","score_opus":0.018414958483701185,"score_gpt":0.281143144605249,"score_spread":0.2627281861215478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078913545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973425,0.0005517618,0.00010491496,0.0001105563,0.00002252078,0.000006312029,0.00085065403,0.000015035819,0.0009958629],"genre_scores_gemma":[0.9984665,0.00010213627,0.00011680247,0.000021553722,0.00001842329,0.000008615567,0.0009153695,0.000004874945,0.00034559454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980956,0.000023259823,0.000031140822,0.000028856057,0.00005419006,0.00005298798],"domain_scores_gemma":[0.99704427,0.0004568415,0.0013288977,0.000058543363,0.0003849085,0.000726552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030395508,0.0002248666,0.00022034,0.0006515336,0.00031188322,0.00033121704,0.00025250769,0.00027806807,0.0032897461],"category_scores_gemma":[0.002000856,0.0000570481,0.00027709574,0.000657648,0.00022121445,0.00019037322,0.00025281313,0.00041049853,0.00043483794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013295075,0.000012771716,0.9966018,0.000014899999,0.000024558143,0.00019037144,0.000011983965,0.000059090744,0.00017492753,0.000006499458,0.00028989004,0.0024802503],"study_design_scores_gemma":[0.0000051435936,0.00013517779,0.9974082,0.000008900106,0.000035514942,0.0013510118,0.00005498364,0.00017823196,0.00020574524,0.000023934323,0.000589721,0.0000035091755],"about_ca_topic_score_codex":0.00532693,"about_ca_topic_score_gemma":0.010925311,"teacher_disagreement_score":0.00532693,"about_ca_system_score_codex":0.0004877943,"about_ca_system_score_gemma":0.00072201126,"threshold_uncertainty_score":0.011005342},"labels":[],"label_agreement":null},{"id":"W2079839220","doi":"10.1093/neuonc/nou242.1","title":"CS-01 * THE PHOSPHORYLATION OF ATOH1 LEADS TO ITS DEGRADATION MEDIATED BY THE E3 UBIQUITIN LIGASE HUWE1 IN GRANULE NEURON PROGENITORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Ubiquitin ligase; Patched; Medulloblastoma; Biology; GLI2; Cancer research; Hedgehog signaling pathway; Progenitor cell; Cell biology; Mdm2; Ubiquitin; Signal transduction; Stem cell; Genetics; Cell culture; Gene","score_opus":0.016710118293349886,"score_gpt":0.27039798510562735,"score_spread":0.25368786681227745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079839220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321085,0.0017364856,0.0017821983,0.0001422938,0.000050165072,0.000018707386,0.0005850269,0.000059232705,0.0024150747],"genre_scores_gemma":[0.9911514,0.000679474,0.0010477277,0.000054767846,0.00001038512,0.000021599475,0.0015391761,0.000017597331,0.0054778894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999207,0.000010706011,0.000006854644,0.000018599227,0.000016981043,0.000026086924],"domain_scores_gemma":[0.999949,0.0000082955485,0.000011577147,0.000007609716,0.0000062399363,0.000017334563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008199967,0.0002070803,0.0001510529,0.0001263509,0.00014913638,0.00023897628,0.0002020146,0.00015672584,0.0027526726],"category_scores_gemma":[0.00009147516,0.000096875665,0.0001801391,0.0001340726,0.00017053602,0.00015586163,0.00016097148,0.0003748946,0.00066371664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042794246,0.000047589514,0.00022378679,0.000048664107,0.000010954034,0.00006525112,0.000007755627,0.00006795942,0.9971354,0.0002231466,0.0001266505,0.0016150094],"study_design_scores_gemma":[0.00002310928,0.0001632427,0.002954668,0.0000043435834,0.000009531178,0.00019985107,0.0000145528265,0.0006856031,0.9929616,0.00006351486,0.0029168827,0.0000031232921],"about_ca_topic_score_codex":0.0007746267,"about_ca_topic_score_gemma":0.00084319175,"teacher_disagreement_score":0.0027526726,"about_ca_system_score_codex":0.00031122053,"about_ca_system_score_gemma":0.0001788074,"threshold_uncertainty_score":0.00920856},"labels":[],"label_agreement":null},{"id":"W2081042655","doi":"10.1093/neuonc/nou242.16","title":"CS-16 * THE eEF2 KINASE IS CRITICAL FOR BRAIN TUMOURS ADAPTATION TO METABOLIC STRESS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Biology; Kinase; Cancer research; Glioma; Downregulation and upregulation; Translation (biology); Elongation factor; Cell biology; Gene; Messenger RNA; Genetics","score_opus":0.018324121711003286,"score_gpt":0.3090542664178081,"score_spread":0.2907301447068048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081042655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776773,0.010121473,0.0033613613,0.0008559198,0.00026498624,0.000033145163,0.0017425995,0.00022450522,0.005718725],"genre_scores_gemma":[0.9867582,0.001680587,0.0014979207,0.00012219325,0.000029006287,0.000028669856,0.002003142,0.00004676511,0.007833484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999318,0.000006758147,0.000006673974,0.00002079257,0.000014334325,0.000019606457],"domain_scores_gemma":[0.9998642,0.000013661236,0.00003782792,0.000011635978,0.000016210794,0.000056489404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008545563,0.00031636297,0.00019793794,0.00019224014,0.00023923915,0.00040487823,0.00018767749,0.000283133,0.0026015812],"category_scores_gemma":[0.00012864277,0.00007979824,0.00019472995,0.00015298247,0.00021682151,0.0001666388,0.00019852178,0.00041097394,0.000990297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005487059,0.000030138013,0.001096943,0.00007500368,0.000011578334,0.00025579814,0.000010606855,0.00011974996,0.9935929,0.0003253878,0.0005005364,0.0034324778],"study_design_scores_gemma":[0.000044659144,0.00024322346,0.030396702,0.00003464458,0.000028742084,0.0017935892,0.00006680733,0.0017090343,0.9284663,0.0004044713,0.036796626,0.000015159988],"about_ca_topic_score_codex":0.0008647516,"about_ca_topic_score_gemma":0.0008810015,"teacher_disagreement_score":0.0026015812,"about_ca_system_score_codex":0.0004963545,"about_ca_system_score_gemma":0.00031989912,"threshold_uncertainty_score":0.008703172},"labels":[],"label_agreement":null},{"id":"W2081102061","doi":"10.1093/neuonc/4.4.253","title":"Leptomeningeal dissemination in children with progressive low-gradeneuroepithelial tumors","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Children's Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Neuroepithelial cell; Medicine; Radiology; Biology","score_opus":0.010742842905783825,"score_gpt":0.28048321175020574,"score_spread":0.26974036884442193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081102061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890745,0.00059805106,0.00010377596,0.000030267272,0.0000022921258,0.0000042122956,0.00010118481,0.0000060907705,0.00024668832],"genre_scores_gemma":[0.9993279,0.00037326108,0.00010949822,0.000011711854,0.000007641951,0.0000041611697,0.00013098461,0.0000016599794,0.000033257198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997081,0.00006179249,0.00002915682,0.00006397331,0.00006429865,0.00007250128],"domain_scores_gemma":[0.9988739,0.00027358375,0.0005982905,0.00003798901,0.000074554206,0.00014175834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028861276,0.00024174925,0.00023026289,0.0007356097,0.0003225487,0.00044731563,0.0001966803,0.0002730648,0.000536632],"category_scores_gemma":[0.0020812151,0.00019287672,0.00020637704,0.0007192725,0.00043614476,0.00052962714,0.00030542782,0.0003730772,0.000114053626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023353881,0.0000046954024,0.9964491,0.000008602924,0.00000763214,0.0010737394,0.00007167507,0.000051668965,0.00018122651,0.000014900543,0.00006258018,0.0020507658],"study_design_scores_gemma":[0.000006085548,0.00011367918,0.9799938,0.00001489046,0.000020972077,0.018831326,0.00024684166,0.00016124883,0.00016676867,0.000028682989,0.0004108654,0.00000483594],"about_ca_topic_score_codex":0.0056009493,"about_ca_topic_score_gemma":0.006411969,"teacher_disagreement_score":0.0056009493,"about_ca_system_score_codex":0.0004937732,"about_ca_system_score_gemma":0.00037670988,"threshold_uncertainty_score":0.011136711},"labels":[],"label_agreement":null},{"id":"W2082213986","doi":"10.1093/neuonc/nou310","title":"Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Lethbridge; Calgary Laboratory Services","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Druggability; Neuroblastoma RAS viral oncogene homolog; Cancer research; In vivo; In vitro; Cell culture; Medicine; Leptomeninges; Ex vivo; Drug discovery; Biology; Bioinformatics; Gene; Mutation; Genetics; Internal medicine; Central nervous system","score_opus":0.02157681325720592,"score_gpt":0.31810879356908406,"score_spread":0.29653198031187816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082213986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98771405,0.0041163634,0.0051711607,0.0001085899,0.000029941812,0.00019737941,0.000891016,0.000075757445,0.001695703],"genre_scores_gemma":[0.9816828,0.004011459,0.01104797,0.000040418712,0.000016668044,0.00020026286,0.0014151633,0.00003355024,0.0015517699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998066,0.000064196094,0.000023731634,0.000032857115,0.000048058326,0.000024658271],"domain_scores_gemma":[0.99973816,0.00011353282,0.0000399853,0.000051727016,0.000029058068,0.000027463733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004915405,0.0003656078,0.000486115,0.00033575896,0.00017201119,0.00025901818,0.00030637332,0.00028887513,0.001553949],"category_scores_gemma":[0.0002124127,0.000121929246,0.00026380262,0.0002841918,0.00017989261,0.0003228499,0.00013115568,0.00076586136,0.00044646428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023726067,0.00050523947,0.00095045747,0.00011939253,0.000015240659,0.00013289522,0.00006604003,0.0007200586,0.99311876,0.00015608742,0.00014061252,0.0038378998],"study_design_scores_gemma":[0.00003511582,0.0028611037,0.004161903,0.000009372363,0.000035395355,0.0006373146,0.000039216844,0.0017232224,0.9879408,0.00003161794,0.0025198802,0.000005082512],"about_ca_topic_score_codex":0.0009034106,"about_ca_topic_score_gemma":0.0013992698,"teacher_disagreement_score":0.001553949,"about_ca_system_score_codex":0.00035404204,"about_ca_system_score_gemma":0.00022872792,"threshold_uncertainty_score":0.0051984787},"labels":[],"label_agreement":null},{"id":"W2083199748","doi":"10.1093/neuonc/nou208.47","title":"FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Medicine; Oncology; Cohort; Targeted therapy; Cancer research; In vivo; Internal medicine; Cancer; Biology; Signal transduction","score_opus":0.01911079522570764,"score_gpt":0.30964007314438663,"score_spread":0.290529277918679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083199748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459833,0.028027873,0.0015281187,0.002337276,0.0002996316,0.0004258473,0.0025413255,0.00043718587,0.01841952],"genre_scores_gemma":[0.97399205,0.00900268,0.00284367,0.0013959409,0.00019277757,0.00014496419,0.004435597,0.000036966092,0.007955433],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999348,0.000009456862,0.000003951059,0.000016433556,0.000021899845,0.00001349958],"domain_scores_gemma":[0.999946,0.0000073975452,0.000015972559,0.0000050149956,0.000007301265,0.000018307774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002469843,0.00032789208,0.0002705359,0.0002522815,0.00018644251,0.00024441007,0.00020380576,0.00029052098,0.0033411346],"category_scores_gemma":[0.0001496024,0.00010081114,0.0002186182,0.00013067768,0.00013184307,0.00013524904,0.00014327065,0.0003993846,0.00045778786],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0106179295,0.0014271956,0.022731455,0.0011585564,0.00034271512,0.0020578152,0.00008850186,0.00094172684,0.37848243,0.0008387226,0.024648892,0.55666405],"study_design_scores_gemma":[0.014523046,0.03362345,0.4672875,0.0005150597,0.0011515063,0.033315144,0.00016177761,0.0052651544,0.23226596,0.0013406766,0.2104784,0.00007238545],"about_ca_topic_score_codex":0.00073976046,"about_ca_topic_score_gemma":0.0050122766,"teacher_disagreement_score":0.0033411346,"about_ca_system_score_codex":0.00048298828,"about_ca_system_score_gemma":0.0004991276,"threshold_uncertainty_score":0.011177242},"labels":[],"label_agreement":null},{"id":"W2087675111","doi":"10.1093/neuonc/nov061.138","title":"PM-16 * AN ANIMAL MODEL OF 17p DELETION IN MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Chromosome 17 (human); Biology; Gene duplication; Genetics; Chromosome 22; Chromosome 21; Chromosome 12; Isochromosome; Chromosome; Molecular biology; Gene; Karyotype","score_opus":0.0524927945389718,"score_gpt":0.32729014625219743,"score_spread":0.2747973517132256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087675111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93652403,0.004116112,0.026404535,0.0015626611,0.0009719617,0.0013689154,0.010154239,0.0022834383,0.016614085],"genre_scores_gemma":[0.8793813,0.004789907,0.028996563,0.00048550448,0.00008592242,0.0031979906,0.008631001,0.000628775,0.07380303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993824,0.00006608424,0.000060669263,0.00019097414,0.00020708924,0.00009281366],"domain_scores_gemma":[0.99943274,0.00007288834,0.00016649245,0.00008791879,0.000033799293,0.0002061894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005991882,0.001123839,0.00061093,0.0017040118,0.00061912544,0.0006118964,0.0010726659,0.0014974773,0.008568391],"category_scores_gemma":[0.00024699184,0.00075258716,0.0008405705,0.0006087561,0.0010226206,0.0008005748,0.0007391583,0.0025002572,0.0036376594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012073562,0.0007312138,0.001301735,0.00025232663,0.000049514445,0.0014661659,0.00015209574,0.000598449,0.9847557,0.0018370199,0.0012704433,0.006377876],"study_design_scores_gemma":[0.0005926789,0.006044445,0.0059286007,0.00017776195,0.00012936961,0.0066858996,0.0002409242,0.0030913414,0.9216508,0.0009146174,0.054497186,0.000046431272],"about_ca_topic_score_codex":0.0011313478,"about_ca_topic_score_gemma":0.0017976502,"teacher_disagreement_score":0.008568391,"about_ca_system_score_codex":0.0008997808,"about_ca_system_score_gemma":0.00077703566,"threshold_uncertainty_score":0.028664052},"labels":[],"label_agreement":null},{"id":"W2088446974","doi":"10.1215/15228517-2008-058","title":"A novel tool to analyze MRI recurrence patterns in glioblastoma","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Gemeinnützige Hertie-Stiftung; Bundesministerium für Bildung und Forschung","keywords":"Temozolomide; Medicine; Radiation therapy; Glioblastoma; Oncology; Internal medicine; Cancer; Glioma; Cohort; Neurology; Clinical trial; Chemotherapy; Cancer research","score_opus":0.02675756273669337,"score_gpt":0.30562463354620145,"score_spread":0.27886707080950807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088446974","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20578255,0.0007449956,0.7665318,0.0003096278,0.00008988625,0.00048354763,0.0035304048,0.019455045,0.0030721063],"genre_scores_gemma":[0.34088814,0.00040334667,0.6527485,0.0001262789,0.000085864776,0.0008872824,0.0020928467,0.0008360125,0.001931698],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993988,0.00013898492,0.000075446915,0.00013996175,0.00019807748,0.000048719157],"domain_scores_gemma":[0.99720037,0.0013524368,0.00048916106,0.00023094368,0.00060451444,0.0001225789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015087144,0.000734189,0.0005743325,0.0045048757,0.0001844881,0.00092287327,0.00039746935,0.0004323979,0.0032353126],"category_scores_gemma":[0.005284747,0.0003383181,0.0005473838,0.0014470277,0.00017414121,0.0009989319,0.00069319014,0.0004487806,0.0009658792],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017813047,0.00036881468,0.052785322,0.00047413088,0.00044596836,0.00054430286,0.00041514073,0.004818441,0.1960348,0.0015118034,0.005909257,0.73491067],"study_design_scores_gemma":[0.00043026585,0.0025133975,0.336042,0.00018272335,0.0008401803,0.0073276768,0.0005905434,0.40933442,0.20742187,0.0043178736,0.03068477,0.00031430295],"about_ca_topic_score_codex":0.00076752645,"about_ca_topic_score_gemma":0.0010236099,"teacher_disagreement_score":0.0045048757,"about_ca_system_score_codex":0.0002185736,"about_ca_system_score_gemma":0.00033831678,"threshold_uncertainty_score":0.01082319},"labels":[],"label_agreement":null},{"id":"W2089640963","doi":"10.1093/neuonc/nou349","title":"Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Confidence interval; Meta-analysis; Glioma; Relative risk; Internal medicine; Biopsy; Resection; Surgery; Cohort; Cohort study; Gastroenterology","score_opus":0.09481905605422455,"score_gpt":0.37424179547723535,"score_spread":0.27942273942301077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089640963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0092863655,0.9891935,0.0003920152,0.0001586317,0.00013010614,0.00018089394,0.0004261267,0.000017976294,0.00021434967],"genre_scores_gemma":[0.35243896,0.6417672,0.0020440558,0.0011707572,0.00036498622,0.0009426063,0.00087366055,0.000030020956,0.00036769873],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99372673,0.0032439532,0.0016004854,0.0007258793,0.00049160136,0.00021125792],"domain_scores_gemma":[0.9880404,0.00865497,0.002120504,0.00030120896,0.00069244206,0.00019059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009506888,0.0021764548,0.01525188,0.0035675382,0.00046540023,0.0022940591,0.0016609423,0.0019530188,0.0027797946],"category_scores_gemma":[0.019840492,0.0011018603,0.032762192,0.00431317,0.00056067173,0.0013015851,0.0010440771,0.0014709479,0.0002610997],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044707274,0.000034666544,0.005279769,0.25882694,0.7203663,0.000118513046,0.00007606348,0.00050794514,0.0002346574,0.00009563189,0.00043691767,0.009551856],"study_design_scores_gemma":[0.00077118125,0.00027522436,0.003983426,0.01185664,0.9818118,0.00007022442,0.000031392974,0.00013506207,0.00006938291,0.00012361,0.00085621333,0.000015867547],"about_ca_topic_score_codex":0.0054680454,"about_ca_topic_score_gemma":0.013357781,"teacher_disagreement_score":0.01525188,"about_ca_system_score_codex":0.001705755,"about_ca_system_score_gemma":0.0018172356,"threshold_uncertainty_score":0.05027777},"labels":[],"label_agreement":null},{"id":"W2091048582","doi":"10.1093/neuonc/nou208.23","title":"C19MC ONCOMIRS CONVERGE ON MULTIPLE CELL CYCLE REGULATORS TO MODULATE NEURAL DIFFERENTIATION AND THE TUMOR EPIGENOME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Gene; microRNA; Embryonic stem cell; Epigenetics; Locus (genetics); Cancer research; Genetics","score_opus":0.00758868828872562,"score_gpt":0.2368903498736504,"score_spread":0.2293016615849248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091048582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131496,0.004376586,0.0067628277,0.0001532094,0.000038538863,0.000066502755,0.0014939316,0.0003049494,0.005488545],"genre_scores_gemma":[0.98924553,0.0016867099,0.003757322,0.00010894201,0.000016922038,0.000053574804,0.0015585002,0.00007575973,0.0034968294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998826,0.000008654528,0.0000052022606,0.000033132306,0.000042473202,0.000027993216],"domain_scores_gemma":[0.9999008,0.000014868007,0.000035248482,0.000010267562,0.000015953463,0.000022762646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011126144,0.00051240413,0.00021700082,0.00046661717,0.00024047268,0.00035747228,0.00020699462,0.0002013074,0.0024233172],"category_scores_gemma":[0.00015847987,0.00013315235,0.00024978325,0.00022117479,0.00017685168,0.00020082448,0.00038397053,0.0002635256,0.00044060856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022223558,0.00002004283,0.0043795104,0.00006825355,0.000020465523,0.00015564397,0.000030219438,0.0005303619,0.98223007,0.0005360413,0.00033331016,0.011473929],"study_design_scores_gemma":[0.00003352491,0.0003067166,0.10737171,0.000028470435,0.000060262086,0.00067391957,0.000073327865,0.0049363095,0.87173235,0.00051045726,0.014256691,0.00001618872],"about_ca_topic_score_codex":0.0013022065,"about_ca_topic_score_gemma":0.0029310042,"teacher_disagreement_score":0.0024233172,"about_ca_system_score_codex":0.0005704342,"about_ca_system_score_gemma":0.0002556798,"threshold_uncertainty_score":0.008106828},"labels":[],"label_agreement":null},{"id":"W2092502301","doi":"10.1093/neuonc/nou237.39","title":"AT-40PROGNOSIS FACTORS IN GLIOBLASTOMA MULTIFORME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Chemotherapy; Biopsy; Internal medicine; Multivariate analysis; Oncology; Surgery","score_opus":0.020894628254573323,"score_gpt":0.29159677943639356,"score_spread":0.2707021511818202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092502301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693525,0.0020113047,0.00006446538,0.00009725528,0.000010383894,0.000009674303,0.00036677902,0.000004840781,0.0005001093],"genre_scores_gemma":[0.9991873,0.00030871842,0.00007202697,0.000019225123,0.000023801542,0.000007349168,0.0002841808,0.0000015166111,0.00009582129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997372,0.000066566485,0.00004506112,0.000037317917,0.00007001782,0.000043732125],"domain_scores_gemma":[0.9971048,0.00042862713,0.0017507086,0.00007379106,0.00019643042,0.00044551748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007893979,0.00018185732,0.00031436663,0.00067018316,0.00034214256,0.00035992084,0.00024561642,0.0002337662,0.0015550368],"category_scores_gemma":[0.0019990525,0.00007683598,0.0003175315,0.0010028391,0.00033390816,0.00031063304,0.00023369935,0.00033869775,0.00023189813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000499515,0.000023722772,0.9954817,0.000040748448,0.000032288855,0.00022165483,0.000019279325,0.00008439007,0.0002142045,0.000026512054,0.00013458336,0.0032215193],"study_design_scores_gemma":[0.00001338424,0.00034129393,0.9974866,0.000014206448,0.000059291222,0.0010444788,0.000048552723,0.00014001699,0.00017378926,0.00010642163,0.00056769437,0.0000042346965],"about_ca_topic_score_codex":0.0014816575,"about_ca_topic_score_gemma":0.0024136947,"teacher_disagreement_score":0.0015550368,"about_ca_system_score_codex":0.00038965678,"about_ca_system_score_gemma":0.00059820275,"threshold_uncertainty_score":0.005202055},"labels":[],"label_agreement":null},{"id":"W2096557421","doi":"10.1093/neuonc/nos152","title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Brain metastasis; Medicine; Cancer; Incidence (geometry); Metastasis; Population; Oncology; Epidemiology; Lung cancer; Breast cancer; Brain tumor; Internal medicine; Disease; Primary tumor; Pathology; Environmental health","score_opus":0.13296199146793491,"score_gpt":0.4003928831452415,"score_spread":0.2674308916773066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096557421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8740434,0.0055627767,0.075998366,0.00091703876,0.0000665093,0.00026327776,0.03206253,0.00029164494,0.010794373],"genre_scores_gemma":[0.93712807,0.002677422,0.038659364,0.00016445444,0.000039971957,0.00025894705,0.020330407,0.000027439175,0.0007139706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989322,0.00049083086,0.00015510482,0.00018330362,0.00019664747,0.000041934953],"domain_scores_gemma":[0.99472576,0.0024751765,0.0012370171,0.00032546878,0.0011400975,0.000096388394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029889785,0.00027060093,0.00025772097,0.0025470378,0.00018000157,0.0005605721,0.0003615902,0.00024909686,0.000812064],"category_scores_gemma":[0.014846218,0.00020430401,0.0006755698,0.0015623486,0.00010260633,0.000780075,0.00047819468,0.0004544567,0.00037291914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000556482,0.000030434767,0.9590121,0.000111916976,0.00021903632,0.00004527486,0.00016131191,0.009415026,0.00023682274,0.0009296999,0.0017943368,0.027988447],"study_design_scores_gemma":[0.000022620767,0.00023060027,0.9030111,0.00028610128,0.00034527783,0.0010496145,0.0009199435,0.06876033,0.001547087,0.0033979143,0.020371458,0.000057953963],"about_ca_topic_score_codex":0.013095838,"about_ca_topic_score_gemma":0.015908228,"teacher_disagreement_score":0.013095838,"about_ca_system_score_codex":0.0007101534,"about_ca_system_score_gemma":0.00058327295,"threshold_uncertainty_score":0.026039183},"labels":[],"label_agreement":null},{"id":"W2096791202","doi":"10.1093/neuonc/not246","title":"Adult pilocytic astrocytomas: clinical features and molecular analysis","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Medicine; Pilocytic astrocytoma; Biopsy; Gene duplication; Internal medicine; Fluorescence in situ hybridization; Oncology; Pathology; Astrocytoma; Cancer research; Glioma; Biology; Gene","score_opus":0.017288700125959552,"score_gpt":0.3341513987799334,"score_spread":0.3168626986539738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096791202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989618,0.00019450721,0.00019176322,0.0000137291545,0.0000015887043,0.000012972076,0.00016047923,0.000009864964,0.00045334434],"genre_scores_gemma":[0.99945694,0.00006645948,0.00023186574,0.000009965484,0.0000044913977,0.000007326124,0.00018520765,0.0000016530621,0.000035963567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975556,0.000030546813,0.0000501128,0.00005595234,0.000051417028,0.0000564907],"domain_scores_gemma":[0.99942905,0.00010079199,0.00021524244,0.000043092477,0.00008508535,0.00012669365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028532092,0.00028431645,0.00023919877,0.0012032517,0.0003004728,0.00044625878,0.00023710252,0.00036775044,0.0011279301],"category_scores_gemma":[0.0012109246,0.0001623689,0.00015393022,0.001078641,0.0002859448,0.0003629224,0.00037065663,0.0001620543,0.0003341451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013652843,0.000024371539,0.9859656,0.00001794248,0.000015969244,0.006884543,0.000055741748,0.000112051246,0.0024378304,0.00002242607,0.0001442546,0.004182811],"study_design_scores_gemma":[0.000012157002,0.00019334891,0.926937,0.000009878022,0.000033522414,0.07076422,0.00019852823,0.00046766954,0.00089835713,0.000063791755,0.00041616696,0.000005454876],"about_ca_topic_score_codex":0.0010675326,"about_ca_topic_score_gemma":0.0015638383,"teacher_disagreement_score":0.0012032517,"about_ca_system_score_codex":0.00027082957,"about_ca_system_score_gemma":0.00030933265,"threshold_uncertainty_score":0.003773272},"labels":[],"label_agreement":null},{"id":"W2097210837","doi":"10.1093/neuonc/nov061.87","title":"MB-11 * IMPACT OF MOLECULAR SUB-TYPE AND CRANIOSPINAL IRRADIATION (CSI) DOSE ON RELAPSE OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medulloblastoma; Medicine; Subtyping; Wnt signaling pathway; Internal medicine; Oncology; Nuclear medicine; Pathology; Biology; Genetics","score_opus":0.0250930240704483,"score_gpt":0.32237961042518354,"score_spread":0.29728658635473526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097210837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985464,0.0006487658,0.00012312467,0.00001698791,0.000003888046,0.000008527845,0.00011535165,0.00001448335,0.0005224202],"genre_scores_gemma":[0.9993413,0.00010931126,0.000093424,0.000008167425,0.000003102291,0.0000042290617,0.00013901867,0.000006016364,0.00029546116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998448,0.000039157316,0.00000949208,0.000028738403,0.000043692224,0.000033955832],"domain_scores_gemma":[0.9998085,0.000049925355,0.00005414366,0.00002085713,0.00001511575,0.00005152534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002339098,0.00014229868,0.00032909244,0.00015389279,0.00008210436,0.00015504741,0.00014434036,0.000114306014,0.0013674162],"category_scores_gemma":[0.00042977286,0.000070493516,0.00023819193,0.00009816229,0.0001119708,0.000079155776,0.00012263868,0.00019194398,0.00023346707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022223968,0.00070022646,0.70600194,0.0001863094,0.00052745565,0.00065150345,0.0001383007,0.002670671,0.15951538,0.0001388122,0.00069078576,0.10655458],"study_design_scores_gemma":[0.00013948664,0.008293018,0.95761067,0.0000147608735,0.00023936325,0.001366635,0.000050099483,0.0010399567,0.02929704,0.000044548655,0.0018985368,0.0000058937535],"about_ca_topic_score_codex":0.0015782537,"about_ca_topic_score_gemma":0.0023709543,"teacher_disagreement_score":0.0015782537,"about_ca_system_score_codex":0.0003062241,"about_ca_system_score_gemma":0.00013951177,"threshold_uncertainty_score":0.0045744777},"labels":[],"label_agreement":null},{"id":"W2097420808","doi":"10.1093/neuonc/noq008","title":"Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Temozolomide; Tolerability; Regimen; Radiation therapy; Internal medicine; Oncology; Toxicity; Phases of clinical research; Glioma; Surgery; Adverse effect","score_opus":0.009461035278219218,"score_gpt":0.2609985549501183,"score_spread":0.2515375196718991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097420808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982691,0.0011180694,0.00018775681,0.00006855109,0.000019194636,0.000029705714,0.0000704827,0.000007932277,0.0002292512],"genre_scores_gemma":[0.99894375,0.00041426034,0.00013719568,0.00009815393,0.000026321755,0.00003398391,0.0002265984,0.0000017130124,0.00011796074],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990606,0.000023328183,0.000007904081,0.000017281758,0.000015756137,0.000029660621],"domain_scores_gemma":[0.9997384,0.000045293265,0.00007854934,0.000014524888,0.000012739625,0.00011050885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034836473,0.0002484169,0.0008636988,0.000160068,0.00025253659,0.0002738274,0.0001492216,0.00022798765,0.00051797356],"category_scores_gemma":[0.00048042592,0.00008567691,0.0005522694,0.0002374482,0.00016287924,0.00028095412,0.00017004742,0.00045013402,0.000112502836],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09947562,0.0034735848,0.5619711,0.0004327562,0.00084583665,0.0026445722,0.00050397246,0.004458702,0.07078255,0.00021122817,0.0026285953,0.2525715],"study_design_scores_gemma":[0.005732331,0.096721195,0.88072085,0.00005273734,0.0007219857,0.0030970932,0.00012497716,0.002759214,0.005266534,0.00034822084,0.004396187,0.000058773032],"about_ca_topic_score_codex":0.00068344275,"about_ca_topic_score_gemma":0.0024078165,"teacher_disagreement_score":0.0008636988,"about_ca_system_score_codex":0.0003601321,"about_ca_system_score_gemma":0.00047443353,"threshold_uncertainty_score":0.0026129484},"labels":[],"label_agreement":null},{"id":"W2097499299","doi":"10.1093/neuonc/nov061.81","title":"MB-05 * PHARMACOLOGICAL INHIBITION OF MRK/ZAK KINASE FOR THE TREATMENT OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Cell cycle; Kinase; Cell cycle checkpoint; Malignancy; Medicine; Cell; Biology; Chemistry; Internal medicine; Cell biology; Biochemistry","score_opus":0.06553781742733895,"score_gpt":0.3649615139227598,"score_spread":0.29942369649542083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097499299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686373,0.01246446,0.003913702,0.0007004659,0.00032460273,0.00052283535,0.0016717397,0.0007270177,0.011037924],"genre_scores_gemma":[0.9811249,0.0054434645,0.0038973368,0.00018097968,0.00003148785,0.0003467421,0.0021020959,0.000027375778,0.006845636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991727,0.000012607023,0.000007707754,0.000011182527,0.000021058135,0.000030080992],"domain_scores_gemma":[0.9999739,0.0000027163496,0.0000057002735,0.0000020734483,0.000003125092,0.0000124373455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012705103,0.0004618167,0.00039710558,0.00027936537,0.00020553966,0.00025692658,0.00027249657,0.0002999576,0.0031161755],"category_scores_gemma":[0.000063348336,0.00015302698,0.00034255884,0.00021995758,0.00017812874,0.00013065376,0.00016087558,0.0010123333,0.00084573886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020454756,0.0010368393,0.00043405296,0.00037781082,0.000080599675,0.00017645264,0.000044764707,0.0005904736,0.962409,0.00066817156,0.002365958,0.029770339],"study_design_scores_gemma":[0.0020285302,0.019694064,0.011961883,0.000055784636,0.00016576114,0.0012984042,0.00008985766,0.0031175106,0.9181016,0.0002164495,0.043234136,0.0000360462],"about_ca_topic_score_codex":0.0011281557,"about_ca_topic_score_gemma":0.002432464,"teacher_disagreement_score":0.0031161755,"about_ca_system_score_codex":0.0003829209,"about_ca_system_score_gemma":0.00051727763,"threshold_uncertainty_score":0.010424614},"labels":[],"label_agreement":null},{"id":"W2097537392","doi":"10.1093/neuonc/noq094","title":"Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Hospital for Sick Children; American Lebanese Syrian Associated Charities; Children's Hospital of Philadelphia","keywords":"Medulloblastoma; Neurocognitive; Pediatrics; Medicine; Cognition; Psychiatry; Pathology","score_opus":0.011816453205970624,"score_gpt":0.2562433562938949,"score_spread":0.24442690308792425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097537392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99977773,0.000055969325,0.00001398486,0.000005237506,9.816629e-7,0.0000027714816,0.000050418843,0.0000011676171,0.00009177178],"genre_scores_gemma":[0.9996395,0.000059884307,0.00003501843,0.000008023198,0.0000035835312,0.0000055128903,0.00018961445,8.4485447e-7,0.000058005284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979895,0.000035640493,0.000025526117,0.00004102125,0.00004502082,0.00005383571],"domain_scores_gemma":[0.99908614,0.00012111073,0.0004971709,0.00002732188,0.0000780846,0.0001901723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788058,0.00031018435,0.00038434722,0.0007560815,0.00038036433,0.00038820392,0.00023187161,0.00032325863,0.00042892032],"category_scores_gemma":[0.0012789809,0.00014106039,0.00031655672,0.0004645366,0.0003128794,0.00040419123,0.00038675003,0.00037166258,0.00014379101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016052979,0.000034770386,0.9975151,0.00000485809,0.0000120859,0.0006381724,0.0000862539,0.0000375191,0.000355526,0.0000040772707,0.000021534253,0.0011297291],"study_design_scores_gemma":[0.0000035578573,0.00032294137,0.9978969,0.000001768238,0.000012359965,0.001452882,0.00010042981,0.00003353762,0.00012169369,0.0000051124252,0.000046429792,0.0000023791658],"about_ca_topic_score_codex":0.0045231576,"about_ca_topic_score_gemma":0.0059017623,"teacher_disagreement_score":0.0045231576,"about_ca_system_score_codex":0.0004277197,"about_ca_system_score_gemma":0.00030612457,"threshold_uncertainty_score":0.008993685},"labels":[],"label_agreement":null},{"id":"W2098063347","doi":"10.1093/neuonc/nov113","title":"High-definition fiber tractography for the evaluation of perilesional white matter tracts in high-grade glioma surgery","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tractography; Diffusion MRI; White matter; Fiber tract; Medicine; Glioma; Radiology; Magnetic resonance imaging","score_opus":0.28399379551971277,"score_gpt":0.44856462093393445,"score_spread":0.1645708254142217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098063347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018764766,0.99869114,0.00023930473,0.0001415908,0.00006903653,0.0000047073854,0.000010646325,0.0000059543263,0.00064993865],"genre_scores_gemma":[0.0011876555,0.9979085,0.00046313976,0.00006703192,0.00008333622,0.000005834238,0.000022304088,0.0000018470848,0.0002603729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998394,0.000027588165,0.000036648937,0.000025655328,0.00005897966,0.000011696971],"domain_scores_gemma":[0.9995018,0.00022550252,0.000093922965,0.000013957966,0.0001332343,0.000031629323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072331703,0.000874551,0.0010582771,0.0051216395,0.00023725766,0.0008391396,0.00071609864,0.0009012609,0.0023211807],"category_scores_gemma":[0.0010421675,0.0003191409,0.0006343636,0.0028883694,0.00063639286,0.0014155458,0.0006028894,0.0012382765,0.0017012948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048784314,0.000048123482,0.0005776765,0.016392948,0.00010358206,0.00048304486,0.000062695275,0.00039587394,0.0014791889,0.0014364778,0.009786637,0.969185],"study_design_scores_gemma":[0.000033215474,0.0002035756,0.008143294,0.0145855425,0.00048443425,0.017271893,0.00021875558,0.00068742427,0.0022070282,0.004456679,0.95162,0.00008819243],"about_ca_topic_score_codex":0.0017767198,"about_ca_topic_score_gemma":0.0035788347,"teacher_disagreement_score":0.0051216395,"about_ca_system_score_codex":0.0004905206,"about_ca_system_score_gemma":0.0011335593,"threshold_uncertainty_score":0.0077651143},"labels":[],"label_agreement":null},{"id":"W2099184601","doi":"10.1093/neuonc/nov061.78","title":"MB-02 * SONIC HEDGEHOG INDUCES YB-1 IN A YAP-DEPENDENT MANNER TO REGULATE Igf2 EXPRESSION AND PROLIFERATION IN CEREBELLAR GRANULE NEURON PROGENITORS AND MEDULLOBLASTOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Biology; Cancer research; Progenitor cell; Cerebellum; Gene knockdown; Oncogene; Granule cell; Cell biology; Stem cell; Cell culture; Cell; Neuroscience; Signal transduction; Hippocampal formation; Genetics; Cell cycle","score_opus":0.020695737860071263,"score_gpt":0.27249291537395315,"score_spread":0.25179717751388186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099184601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238646,0.0016304014,0.0017999029,0.00016106897,0.000050502153,0.000040127627,0.0010628556,0.00015505667,0.0027136593],"genre_scores_gemma":[0.98601574,0.00074261567,0.001653283,0.000094117575,0.000013351525,0.000078649806,0.0027512927,0.0000419552,0.008608933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998895,0.000009835067,0.000009907518,0.000022654,0.000032447475,0.00003565732],"domain_scores_gemma":[0.99994147,0.000007891903,0.000013349866,0.00000650708,0.0000060639754,0.00002470842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007090686,0.00025094862,0.00017616567,0.00019770199,0.00014912344,0.00020627788,0.00014878016,0.00014873121,0.0017058646],"category_scores_gemma":[0.000064435575,0.00015873775,0.00020901837,0.00012224207,0.00015028055,0.00009647263,0.0001703725,0.0005319965,0.00061154773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076942975,0.00002750266,0.000144105,0.000020399062,0.000003198143,0.000029112161,0.000008123958,0.000021304213,0.9988206,0.000060961596,0.000083028586,0.0007046313],"study_design_scores_gemma":[0.000022639431,0.00033730047,0.008509185,0.0000055209125,0.000012193959,0.00015252839,0.00003551595,0.0008170671,0.98524845,0.00002838194,0.004827945,0.0000033651218],"about_ca_topic_score_codex":0.0020985324,"about_ca_topic_score_gemma":0.0031438817,"teacher_disagreement_score":0.0020985324,"about_ca_system_score_codex":0.00031622613,"about_ca_system_score_gemma":0.00023074244,"threshold_uncertainty_score":0.005706668},"labels":[],"label_agreement":null},{"id":"W2099297620","doi":"10.1093/neuonc/2.4.239","title":"Primary Hodgkin's disease of the CNS in an immunocompetent patient: Acase study and review of the literature","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Disease; Radiation therapy; Cerebrospinal fluid; Histopathology; Craniotomy; Surgery; Pathology","score_opus":0.013252919533568736,"score_gpt":0.2900304960723284,"score_spread":0.2767775765387597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099297620","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1875286,0.80008525,0.0010932129,0.0011722781,0.0006282246,0.00014658194,0.0003418966,0.00011034174,0.008893625],"genre_scores_gemma":[0.28110868,0.7115941,0.0012140443,0.0013117074,0.0023601989,0.00007863995,0.00052986527,0.0000130299495,0.0017897501],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999736,0.000035520643,0.00009455583,0.000040972805,0.00005751741,0.000035471963],"domain_scores_gemma":[0.9991954,0.00035178044,0.00018121996,0.000033271128,0.00014735383,0.00009099225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029748413,0.0005549203,0.0008559651,0.0046764216,0.00055039517,0.0008838232,0.00070496905,0.0011884052,0.0017556846],"category_scores_gemma":[0.0010982862,0.00025892755,0.00046756887,0.0034279241,0.00065978436,0.0011278238,0.00035027976,0.00039050798,0.000829392],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004219628,0.00051665556,0.10165872,0.012947509,0.00045941785,0.5777582,0.0009165444,0.0005040615,0.006751103,0.00050772016,0.014486411,0.28307176],"study_design_scores_gemma":[0.000037912163,0.00045645554,0.06851737,0.001995389,0.00048481958,0.88912356,0.0007105373,0.00025942436,0.00068482436,0.00036276024,0.037321556,0.000045395354],"about_ca_topic_score_codex":0.0010365187,"about_ca_topic_score_gemma":0.0013849951,"teacher_disagreement_score":0.0046764216,"about_ca_system_score_codex":0.0003195961,"about_ca_system_score_gemma":0.00050872454,"threshold_uncertainty_score":0.0058733225},"labels":[],"label_agreement":null},{"id":"W2099513630","doi":"10.1215/15228517-2007-027","title":"Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Radiosurgery; Acoustic neuroma; Radiology; Pathological; Neurofibromatosis type 2; Neurofibromatosis; Oncology; Surgery; Pathology","score_opus":0.015275040700310832,"score_gpt":0.3121390362018543,"score_spread":0.29686399550154347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099513630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54142493,0.3980486,0.008421103,0.0048272065,0.003205787,0.00055539643,0.0007386908,0.00079297804,0.041985296],"genre_scores_gemma":[0.8682974,0.11398188,0.0035022357,0.0030165045,0.00436939,0.00015655173,0.00057062233,0.00006996754,0.006035452],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995289,0.000058520018,0.00010113773,0.000086821674,0.00008736354,0.00013728495],"domain_scores_gemma":[0.9990614,0.0002555056,0.00036084733,0.00008096286,0.00007725656,0.00016399867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437913,0.0016837959,0.0010895572,0.0034319775,0.0010585589,0.0013787578,0.0018860903,0.0037500495,0.0034637742],"category_scores_gemma":[0.0015420076,0.0005337007,0.0007529025,0.0029614305,0.0013451165,0.0017681876,0.00077072927,0.0012047499,0.003091239],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003265402,0.00008047799,0.005835152,0.00045016015,0.000042794887,0.9743525,0.00016477585,0.00009834412,0.00067226397,0.00017331749,0.0021536278,0.01594385],"study_design_scores_gemma":[0.000008093702,0.00003853417,0.0040679807,0.00009130528,0.00003751001,0.9922294,0.00014108985,0.00008385086,0.00016720532,0.0001324877,0.0029905248,0.000011965025],"about_ca_topic_score_codex":0.0015971267,"about_ca_topic_score_gemma":0.0029827296,"teacher_disagreement_score":0.0037500495,"about_ca_system_score_codex":0.0007932516,"about_ca_system_score_gemma":0.0009072773,"threshold_uncertainty_score":0.011587501},"labels":[],"label_agreement":null},{"id":"W2099577209","doi":"10.1093/neuonc/not163","title":"Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Medulloblastoma; Ependymoma; Medicine; Chemotherapy; Regimen; Chemotherapy regimen; Brain tumor; Internal medicine; Randomized controlled trial; Radiation therapy; Surgery; Oncology; Pathology","score_opus":0.010126360374471033,"score_gpt":0.2641499669893451,"score_spread":0.2540236066148741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099577209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97262484,0.015317477,0.0015873256,0.0013497499,0.00057256094,0.005292723,0.0013890659,0.00010756162,0.0017587234],"genre_scores_gemma":[0.979749,0.0055135684,0.0032108447,0.0016135259,0.0006675596,0.0071342443,0.0010571185,0.00003197259,0.0010221648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99488455,0.003988095,0.00032949296,0.00038399672,0.00021335104,0.00020045553],"domain_scores_gemma":[0.99479055,0.003106739,0.0010513169,0.00041900936,0.00018745888,0.00044489396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006839909,0.0011008689,0.0026980003,0.00032364007,0.0002916769,0.0009992456,0.0007308665,0.0016518342,0.0032004323],"category_scores_gemma":[0.008255568,0.00052324723,0.0028442943,0.00058854703,0.00090568984,0.0007650086,0.00041025344,0.002482685,0.00027264285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97825044,0.0017294139,0.0018775796,0.0008768389,0.0023987188,0.00003468524,0.000040021157,0.00022731729,0.00092993747,0.00015440698,0.00053423643,0.012946475],"study_design_scores_gemma":[0.9560881,0.036973163,0.0030574717,0.00010333616,0.00223896,0.000037532678,0.000019904903,0.0003084336,0.00031575418,0.0001449647,0.0007003837,0.000012042196],"about_ca_topic_score_codex":0.001196162,"about_ca_topic_score_gemma":0.0017961926,"teacher_disagreement_score":0.006839909,"about_ca_system_score_codex":0.00065759063,"about_ca_system_score_gemma":0.0014270908,"threshold_uncertainty_score":0.036173344},"labels":[],"label_agreement":null},{"id":"W2099596371","doi":"10.1093/neuonc/3.2.89","title":"Expression and localization of cyclin-dependent kinase 5 in apoptotichuman glioma cells","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cyclin-dependent kinase 5; Cell biology; Biology; ASK1; Activator (genetics); Cyclin-dependent kinase 2; Kinase; Cyclin-dependent kinase 4; Apoptosis; Neurite; Protein kinase A; Cancer research; Gene; Biochemistry; In vitro","score_opus":0.015953619766845287,"score_gpt":0.2857056757996642,"score_spread":0.26975205603281893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099596371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906042,0.004150795,0.0028595096,0.000055147302,0.000017702112,0.000016627215,0.00063205685,0.000055960856,0.0016080663],"genre_scores_gemma":[0.99351996,0.0014591356,0.0018949419,0.000023209719,0.000005558594,0.000015053702,0.0012575003,0.0000071501295,0.0018175227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998696,0.000009880843,0.000009871838,0.000025393838,0.00004199476,0.00004330089],"domain_scores_gemma":[0.99993694,0.000009447661,0.000013178932,0.000010677716,0.0000129617,0.000016716134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007211694,0.00018207454,0.00014601997,0.0003852081,0.00025982747,0.000308321,0.00016502343,0.00017177632,0.00096418464],"category_scores_gemma":[0.00010718069,0.00010476992,0.00016987484,0.00035089324,0.00017863016,0.00017963209,0.00014123657,0.00027471935,0.00043120977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000175608,0.000037076632,0.0011040957,0.000054114164,0.000008471299,0.00019132844,0.00007298347,0.0000533984,0.9953746,0.0004567318,0.00006947084,0.0024022385],"study_design_scores_gemma":[0.000023223949,0.00038228976,0.028815312,0.000010096624,0.000025680372,0.0013235845,0.00011246815,0.0007717456,0.96092397,0.00019943262,0.00740596,0.0000061276965],"about_ca_topic_score_codex":0.0033030834,"about_ca_topic_score_gemma":0.0028485141,"teacher_disagreement_score":0.0033030834,"about_ca_system_score_codex":0.00064824504,"about_ca_system_score_gemma":0.00028403712,"threshold_uncertainty_score":0.0065677166},"labels":[],"label_agreement":null},{"id":"W2100064092","doi":"10.1093/neuonc/3.1.46","title":"Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Oncology; Brain tumor; Glioma; Neurooncology; Chemotherapy; Lymphoma; Cancer; Internal medicine; Intensive care medicine; Pathology; Cancer research","score_opus":0.07350066814401848,"score_gpt":0.3996207331363772,"score_spread":0.3261200649923587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100064092","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013353716,0.27364033,0.022902844,0.54068583,0.07196212,0.029924685,0.0041204067,0.00065160554,0.042758405],"genre_scores_gemma":[0.090482585,0.27670115,0.11266709,0.2671688,0.11908506,0.06604196,0.008426065,0.00078057323,0.058646813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8977991,0.068408735,0.016199978,0.002414472,0.012608327,0.0025694384],"domain_scores_gemma":[0.82341415,0.069415666,0.029480468,0.006526836,0.052486245,0.018676722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19708422,0.0020983047,0.0031283053,0.0015934047,0.0016208623,0.01014503,0.0022543706,0.00805021,0.0062491843],"category_scores_gemma":[0.11094683,0.0013398329,0.002653341,0.0031326876,0.001362594,0.004599772,0.0030148663,0.0076249223,0.0025861594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010448244,0.00091588096,0.00450763,0.0068631424,0.00082003727,0.00016312549,0.00038631086,0.0014051312,0.0044326656,0.0054259207,0.3919484,0.57268345],"study_design_scores_gemma":[0.0077755046,0.007686197,0.014896337,0.00743355,0.00094028853,0.00016154931,0.00019678003,0.0018409763,0.003330838,0.005472071,0.95008004,0.00018594955],"about_ca_topic_score_codex":0.0013211356,"about_ca_topic_score_gemma":0.0041479394,"teacher_disagreement_score":0.19708422,"about_ca_system_score_codex":0.005861392,"about_ca_system_score_gemma":0.017583415,"threshold_uncertainty_score":0.9901381},"labels":[],"label_agreement":null},{"id":"W2101246344","doi":"10.1093/neuonc/not243","title":"Lactate dehydrogenase A silencing in IDH mutant gliomas","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Foothills Medical Centre","funders":"National Cancer Institute","keywords":"Mutant; Gene silencing; Lactate dehydrogenase; Isocitrate dehydrogenase; Cancer research; Genetics; Biology; Molecular biology; Enzyme; Biochemistry; Gene","score_opus":0.010866409258198205,"score_gpt":0.2599607531004015,"score_spread":0.2490943438422033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101246344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939089,0.00068983994,0.0034354923,0.00006208462,0.00003108282,0.00003778998,0.00075899763,0.00017495287,0.0009008246],"genre_scores_gemma":[0.9942298,0.0004085358,0.002767156,0.000036862282,0.0000068285326,0.000039816106,0.0007562301,0.00003495027,0.0017197221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998871,0.000009714606,0.000013469989,0.000031351894,0.00003767358,0.000020690168],"domain_scores_gemma":[0.99991274,0.000011506305,0.000030489733,0.0000111281115,0.000009911075,0.000024174957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104254475,0.0002855634,0.00024002166,0.00020559336,0.0001136813,0.00022973811,0.00020469984,0.00019474626,0.0008190314],"category_scores_gemma":[0.00009411385,0.00009635761,0.00019081736,0.00015549408,0.00019576092,0.0000972431,0.00016218013,0.00035946324,0.00024167342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038765054,0.000010825573,0.00014197949,0.000023138691,0.0000035647884,0.00003303303,0.000010020204,0.000030022236,0.9989641,0.000037808466,0.000022376069,0.00068440713],"study_design_scores_gemma":[0.000008835603,0.0001508857,0.0026366857,0.000002401886,0.000016709018,0.00023278213,0.00001785755,0.00060368236,0.99491125,0.000023143772,0.0013933642,0.0000024303654],"about_ca_topic_score_codex":0.00084228674,"about_ca_topic_score_gemma":0.001288547,"teacher_disagreement_score":0.00084228674,"about_ca_system_score_codex":0.00026072605,"about_ca_system_score_gemma":0.00019546192,"threshold_uncertainty_score":0.0027399063},"labels":[],"label_agreement":null},{"id":"W2101887300","doi":"10.1093/neuonc/not176","title":"EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacology; Clinical pharmacology; Systems pharmacology; Medicine; Drug","score_opus":0.11912994090894631,"score_gpt":0.45912819782955216,"score_spread":0.33999825692060587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101887300","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02897108,0.21477862,0.04485842,0.07403547,0.011049784,0.0008138568,0.0023101547,0.00096046686,0.6222221],"genre_scores_gemma":[0.40290192,0.26067215,0.036829457,0.02767099,0.014863718,0.0016333514,0.0019891246,0.00020635477,0.253233],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856734,0.00046274622,0.00009423988,0.0002377894,0.0005264395,0.00011139928],"domain_scores_gemma":[0.9983376,0.00045790267,0.00016460617,0.00056332716,0.00030303092,0.00017349803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022870242,0.0007545811,0.0006861479,0.0014635099,0.00081480487,0.0025263545,0.0010917551,0.0016601424,0.033675734],"category_scores_gemma":[0.0024579722,0.00029960892,0.00051629887,0.00087860523,0.0038974318,0.0020985145,0.0021308854,0.0029799885,0.008007451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004647719,0.00083703554,0.0020229535,0.0021407835,0.00008410693,0.0003818043,0.00045921787,0.000434814,0.03640243,0.5316744,0.06046382,0.3646339],"study_design_scores_gemma":[0.00013023852,0.00082643406,0.0036447693,0.0005984773,0.00007123997,0.000948798,0.00030544618,0.00042593095,0.0152231585,0.13561864,0.842177,0.000030015683],"about_ca_topic_score_codex":0.00079619105,"about_ca_topic_score_gemma":0.0007771253,"teacher_disagreement_score":0.033675734,"about_ca_system_score_codex":0.0018663558,"about_ca_system_score_gemma":0.0030845192,"threshold_uncertainty_score":0.11265653},"labels":[],"label_agreement":null},{"id":"W2103165299","doi":"10.1093/neuonc/nov061.90","title":"MB-14 * DISCOVERING THE TREATMENT REFRACTORY BTIC POPULATION IN GROUP 3 MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Refractory (planetary science); Population; Oncology; Internal medicine; Medicine; Psychology; Biology; Genetics; Environmental health","score_opus":0.035204321916885085,"score_gpt":0.31522327378314124,"score_spread":0.28001895186625614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103165299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533856,0.000944402,0.0020395087,0.00004156019,0.000007369671,0.00007332658,0.00037909433,0.00008355444,0.0010925941],"genre_scores_gemma":[0.9943521,0.0005361114,0.0028303822,0.00006089294,0.0000064765723,0.000058764028,0.0008842043,0.000027757525,0.0012433731],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991775,0.000007559663,0.0000052016694,0.000020230842,0.000029262254,0.00002004387],"domain_scores_gemma":[0.99994504,0.0000071573836,0.000015684176,0.0000059514978,0.000008917026,0.00001717383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118133816,0.00014457163,0.00026342913,0.000477301,0.00014489955,0.00023462545,0.00011226942,0.00023367752,0.0010003805],"category_scores_gemma":[0.00010179142,0.00009132777,0.00017940666,0.00020371677,0.00014775504,0.000100562174,0.00015711099,0.00023743667,0.00021767203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714262,0.00003299183,0.0067523653,0.00003288791,0.000006694111,0.00014256092,0.000035130408,0.00008922197,0.9887961,0.00006775807,0.00008299906,0.0037898368],"study_design_scores_gemma":[0.000038907376,0.0018679665,0.15187427,0.000024383213,0.000120435725,0.004898333,0.00020169247,0.0058159963,0.8210358,0.00018936199,0.01391718,0.000015632142],"about_ca_topic_score_codex":0.0020360306,"about_ca_topic_score_gemma":0.0028804373,"teacher_disagreement_score":0.0020360306,"about_ca_system_score_codex":0.00026514762,"about_ca_system_score_gemma":0.00015409719,"threshold_uncertainty_score":0.0040483475},"labels":[],"label_agreement":null},{"id":"W2104513740","doi":"10.1093/neuonc/nos284","title":"Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"CDKN2A; CDKN2B; Single-nucleotide polymorphism; Biology; Glioma; Allele; Cancer research; IDH1; Mutation; Genetics; Cancer; Genotype; Gene","score_opus":0.03082614546898455,"score_gpt":0.30018493173444205,"score_spread":0.2693587862654575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104513740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715155,0.0007574123,0.00053498184,0.00008249498,0.0000054239076,0.000009585098,0.00052985305,0.000020436239,0.00090825657],"genre_scores_gemma":[0.9990306,0.00020398088,0.00020638022,0.000020669884,0.0000066544344,0.000004739962,0.00038772277,0.0000056319523,0.00013361785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996538,0.000054922384,0.000037751095,0.00012437,0.00007423179,0.000054908927],"domain_scores_gemma":[0.9987618,0.00032449493,0.0006263029,0.00010155323,0.00008717071,0.00009873629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030952058,0.00034069363,0.0003452063,0.001069001,0.00020145102,0.00043025432,0.0002946443,0.0003948998,0.0026869718],"category_scores_gemma":[0.0014583715,0.0001309164,0.00034840178,0.0010168349,0.0004075055,0.00014459052,0.00044463458,0.0003603708,0.0003208842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006507819,0.000031561398,0.9735643,0.00007702804,0.00040117704,0.0006194674,0.000091655565,0.00038550844,0.016118156,0.00023105626,0.00016524109,0.007663976],"study_design_scores_gemma":[0.00002027551,0.00007594096,0.9937524,0.000014134462,0.00019887151,0.0019658403,0.000058221343,0.00035287614,0.0025399933,0.00049172423,0.00052260794,0.000007116261],"about_ca_topic_score_codex":0.0014411693,"about_ca_topic_score_gemma":0.0020273747,"teacher_disagreement_score":0.0026869718,"about_ca_system_score_codex":0.0002446922,"about_ca_system_score_gemma":0.00030297137,"threshold_uncertainty_score":0.008988857},"labels":[],"label_agreement":null},{"id":"W2105932257","doi":"10.1093/neuonc/nou356","title":"Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Merck KGaA","keywords":"Medicine; Temozolomide; Internal medicine; Tolerability; Hazard ratio; Clinical endpoint; Oncology; Chemoradiotherapy; Gastroenterology; Progression-free survival; Phases of clinical research; Randomized controlled trial; Chemotherapy; Adverse effect; Confidence interval","score_opus":0.03371996017441568,"score_gpt":0.33467041564900746,"score_spread":0.30095045547459176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105932257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556327,0.0019175995,0.0003499376,0.00022957064,0.00012189858,0.0010226553,0.00029714484,0.000045163684,0.00045287923],"genre_scores_gemma":[0.9932054,0.0017011162,0.0011997223,0.00058277015,0.0002960419,0.0015570044,0.000778735,0.000018150819,0.0006611014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990357,0.0005457574,0.000070450384,0.00014653381,0.0000740571,0.00012749375],"domain_scores_gemma":[0.99846494,0.00038787798,0.00044768958,0.00013011933,0.00007386071,0.000495464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022080326,0.0014961725,0.0031169488,0.0006638454,0.00031025033,0.000844712,0.00094454305,0.0012162275,0.0023460903],"category_scores_gemma":[0.0019466025,0.00082273356,0.0017181917,0.0005112063,0.001198774,0.0011720675,0.0004172706,0.0026122562,0.00039720663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95555794,0.01926743,0.0017378334,0.00024937995,0.00092377356,0.000022163407,0.000045663754,0.00042150007,0.002996002,0.000044224398,0.0003712007,0.018362869],"study_design_scores_gemma":[0.8244505,0.16979012,0.0038187967,0.000017842083,0.00056567235,0.000027229316,0.000018292982,0.00047960013,0.00047077547,0.000056694556,0.00028863628,0.000015863023],"about_ca_topic_score_codex":0.00101829,"about_ca_topic_score_gemma":0.0025214506,"teacher_disagreement_score":0.0031169488,"about_ca_system_score_codex":0.0009962593,"about_ca_system_score_gemma":0.0013777732,"threshold_uncertainty_score":0.011677384},"labels":[],"label_agreement":null},{"id":"W2106343920","doi":"10.1093/neuonc/noq205","title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Internal medicine; Chemoradiotherapy; Adjuvant; Glioma; Oncology; Radiation therapy; Surgery","score_opus":0.02049609708056621,"score_gpt":0.26428218798057207,"score_spread":0.24378609090000586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106343920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97432876,0.023380062,0.0003712274,0.00050641276,0.000031949305,0.0000892187,0.000416127,0.000021059379,0.0008551516],"genre_scores_gemma":[0.9850698,0.011830208,0.0012236909,0.00035516405,0.00007540872,0.000093838185,0.0008880524,0.0000071854934,0.00045669358],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996798,0.0001352947,0.000040010316,0.00004575444,0.000069554866,0.000029497622],"domain_scores_gemma":[0.9992731,0.00035693622,0.00016786621,0.000033377222,0.000072209856,0.0000965885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014555294,0.00022450669,0.00053701835,0.00018305947,0.0000977566,0.00020136115,0.00018634814,0.0002616886,0.00021997456],"category_scores_gemma":[0.0012162316,0.000073979805,0.00031067213,0.0002244583,0.00023355568,0.00017296115,0.00009396168,0.0004346226,0.00004719646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047096234,0.00222263,0.26337013,0.0027334553,0.0015590579,0.0021168364,0.0006613805,0.0029307383,0.048653606,0.00032352647,0.0047702095,0.6235623],"study_design_scores_gemma":[0.011057708,0.1092859,0.81942517,0.00019040503,0.0018474227,0.0054167793,0.00019266509,0.0012327773,0.026671413,0.0001275585,0.02449983,0.000052487623],"about_ca_topic_score_codex":0.0019318251,"about_ca_topic_score_gemma":0.0036046715,"teacher_disagreement_score":0.0019318251,"about_ca_system_score_codex":0.00045173694,"about_ca_system_score_gemma":0.000551222,"threshold_uncertainty_score":0.0076977015},"labels":[],"label_agreement":null},{"id":"W2106824860","doi":"10.1093/neuonc/nor040","title":"International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Calgary; Western University","funders":"","keywords":"Medicine; Temozolomide; Nuclear medicine; Oligodendroglial Tumor; Radiation therapy; Overall survival; Retrospective cohort study; Internal medicine; Glioblastoma; Gastroenterology; Oligodendroglioma; Astrocytoma; Cancer research","score_opus":0.016955196476005404,"score_gpt":0.2768803051008456,"score_spread":0.2599251086248402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106824860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974843,0.0005781477,0.000115505005,0.000020588805,0.0000053519557,0.000040111736,0.00097076106,0.000005029472,0.00078011584],"genre_scores_gemma":[0.9976,0.0004003512,0.00014635475,0.000062930136,0.000017740596,0.00006113788,0.0015300236,0.0000042064853,0.00017734719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994758,0.00008163318,0.00010797769,0.0002040778,0.00007498244,0.000055611796],"domain_scores_gemma":[0.9986462,0.00021668007,0.00067101413,0.00012242787,0.00016664565,0.00017692991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043602134,0.0003510495,0.0005208227,0.00097162195,0.0005489157,0.00059799786,0.00027403867,0.00040598804,0.001633781],"category_scores_gemma":[0.0013944242,0.00039144704,0.00030446317,0.001913334,0.00028810938,0.00064247975,0.0003855906,0.00035193952,0.0004451692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049161485,0.000015863097,0.99877495,0.000013812441,0.000019045905,0.00018585048,0.00006713423,0.000014180614,0.00009054814,0.0000073747465,0.00007801154,0.0006841487],"study_design_scores_gemma":[0.000011426686,0.00013590902,0.99680233,0.000012403669,0.00003763232,0.0017394539,0.00029673288,0.00006794767,0.00006134581,0.000012985254,0.0008176544,0.000004171503],"about_ca_topic_score_codex":0.0065407054,"about_ca_topic_score_gemma":0.006266107,"teacher_disagreement_score":0.0065407054,"about_ca_system_score_codex":0.0005128571,"about_ca_system_score_gemma":0.00044585738,"threshold_uncertainty_score":0.013005316},"labels":[],"label_agreement":null},{"id":"W2107381090","doi":"10.1093/neuonc/nos330","title":"A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method","year":2013,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Clinical trial; Radiation therapy; Biopsy; Glioma; Oncology; Internal medicine","score_opus":0.37602408685821115,"score_gpt":0.48626100427911223,"score_spread":0.11023691742090108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107381090","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08898103,0.019530453,0.1703742,0.47371233,0.03314538,0.14035718,0.0046605812,0.000536347,0.06870258],"genre_scores_gemma":[0.29519704,0.023723463,0.4583709,0.077150546,0.00607508,0.11288465,0.0060502356,0.00031950162,0.020228647],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.84003913,0.114833064,0.02637218,0.0034929414,0.01046909,0.0047935927],"domain_scores_gemma":[0.84682494,0.07680988,0.0098720575,0.004519928,0.052215017,0.009758101],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20129062,0.0017969367,0.0014179548,0.004758507,0.004911946,0.003794645,0.0036121877,0.0076694847,0.0051071104],"category_scores_gemma":[0.15716183,0.0014920038,0.0031895542,0.0025395055,0.0039475285,0.0034686676,0.012640211,0.008877298,0.0020392362],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010045953,0.0005998118,0.012570746,0.0150573775,0.00046976795,0.0043560667,0.1068759,0.0058781784,0.014198573,0.02876475,0.46959803,0.34062624],"study_design_scores_gemma":[0.00039734645,0.00085145,0.014284571,0.023055188,0.00021723914,0.003562049,0.06228961,0.004201647,0.0029383416,0.03202732,0.85563207,0.00054314005],"about_ca_topic_score_codex":0.004310454,"about_ca_topic_score_gemma":0.005157208,"teacher_disagreement_score":0.20129062,"about_ca_system_score_codex":0.009302535,"about_ca_system_score_gemma":0.04669918,"threshold_uncertainty_score":0.98495084},"labels":[],"label_agreement":null},{"id":"W2108101104","doi":"10.1093/neuonc/nor202","title":"CD166/Activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"ALCAM; Cancer research; Progenitor cell; Biology; Cell; Cell adhesion molecule; Stem cell; Cell growth; Cell biology","score_opus":0.0327689800479867,"score_gpt":0.2601149394333148,"score_spread":0.22734595938532812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108101104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947402,0.0020650863,0.001921841,0.000045876426,0.000007667071,0.000011984965,0.00007740714,0.000019134064,0.0011107704],"genre_scores_gemma":[0.99447167,0.0010708332,0.0022783214,0.000027114627,0.000008281482,0.000010728969,0.00028144798,0.000004291282,0.0018473931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999522,0.00000793561,0.0000029205173,0.0000064831097,0.000020139869,0.000010313805],"domain_scores_gemma":[0.99995923,0.0000038724875,0.000012082156,0.0000025733523,0.0000091423135,0.000013115069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046207784,0.00016245268,0.00009885081,0.00023591684,0.00011700533,0.00020731916,0.000052841962,0.00011352131,0.0011025144],"category_scores_gemma":[0.00008517162,0.00005180978,0.0000826865,0.0001597356,0.00007015726,0.00011294396,0.00015489609,0.00023271677,0.00031088898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003689158,0.000008070093,0.0011629394,0.000024836027,0.00000331536,0.00008096268,0.000016647808,0.000019176756,0.9938876,0.00015221747,0.000031040625,0.0045763184],"study_design_scores_gemma":[0.000019969983,0.0004514626,0.06403853,0.000020375586,0.00004818545,0.0028745218,0.00014078463,0.002324398,0.91792226,0.00042511534,0.011720049,0.000014370676],"about_ca_topic_score_codex":0.00030425252,"about_ca_topic_score_gemma":0.0004712761,"teacher_disagreement_score":0.0011025144,"about_ca_system_score_codex":0.00011287097,"about_ca_system_score_gemma":0.00014643464,"threshold_uncertainty_score":0.0036882758},"labels":[],"label_agreement":null},{"id":"W2108402757","doi":"10.1093/neuonc/nor183","title":"Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; University of Ottawa; National Research Council Canada; National Research Council Institute for Biodiagnostics","funders":"FP7 People: Marie-Curie Actions; Canadian Institutes of Health Research","keywords":"In vivo; Magnetic resonance imaging; Glioma; Fluorescence-lifetime imaging microscopy; Dextran; Glioblastoma; Contrast (vision); Chemistry; Pathology; Imaging agent; Iron oxide nanoparticles; Gadolinium; Brain tumor; Antibody; MRI contrast agent; Nanoparticle; Nuclear magnetic resonance; Fluorescence; Cancer research; Materials science; Medicine; Biology; Immunology; Biochemistry; Nanotechnology; Radiology","score_opus":0.05494187221509492,"score_gpt":0.3088994956444496,"score_spread":0.2539576234293547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108402757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691953,0.004725475,0.016858166,0.00007215335,0.00003282246,0.00016153409,0.00014051708,0.00013190442,0.0009578537],"genre_scores_gemma":[0.9552639,0.005399426,0.03581901,0.000084718,0.000020796846,0.00020867185,0.00039930802,0.00004064159,0.0027634567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999132,0.000020942192,0.0000032660773,0.000012282032,0.000030305406,0.000020113268],"domain_scores_gemma":[0.9999155,0.0000139993845,0.000022796372,0.0000035003436,0.000026438527,0.000017820852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026773184,0.00041833168,0.00024215873,0.00025588978,0.00006713224,0.0001322866,0.00015667162,0.00031077815,0.00029276093],"category_scores_gemma":[0.00015608204,0.00014168359,0.00014264388,0.000111784124,0.000110714805,0.00017050839,0.00009913731,0.00023843777,0.00009789401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053711905,0.000019285364,0.000056827303,0.000029475626,0.000003404384,0.000016896543,0.000003795808,0.00003919123,0.9984505,0.00001723688,0.000014615573,0.001294983],"study_design_scores_gemma":[0.000013386101,0.0014441722,0.0015777437,0.000005712781,0.000043226937,0.00014104528,0.000007649336,0.0013884958,0.9943691,0.000017663859,0.0009872298,0.000004488629],"about_ca_topic_score_codex":0.00078547245,"about_ca_topic_score_gemma":0.0017400468,"teacher_disagreement_score":0.00078547245,"about_ca_system_score_codex":0.00019116407,"about_ca_system_score_gemma":0.00016410938,"threshold_uncertainty_score":0.0015618205},"labels":[],"label_agreement":null},{"id":"W2108677211","doi":"10.1215/15228517-2006-002","title":"Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ","year":2006,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"White matter; Fractional anisotropy; Internal capsule; Diffusion MRI; Corpus callosum; Effective diffusion coefficient; Nuclear medicine; Medicine; Intelligence quotient; Correlation; Psychology; Magnetic resonance imaging; Pathology; Radiology; Neuroscience; Cognition","score_opus":0.008528242953704352,"score_gpt":0.28372072296481327,"score_spread":0.2751924800111089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108677211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996055,0.00011352393,0.000042743148,0.000019829298,0.0000011220775,0.000002249103,0.000048591584,0.000004133043,0.00016243805],"genre_scores_gemma":[0.99968994,0.00009215733,0.0000705907,0.000004748014,0.000002576996,0.0000024039284,0.00009414495,0.0000021404771,0.000041319083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979323,0.000039621154,0.000030799594,0.00003852958,0.00005761535,0.000040360326],"domain_scores_gemma":[0.9987068,0.00015220964,0.0008521207,0.000049388196,0.00012500094,0.00011453176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003088167,0.00028975503,0.0002504531,0.0009009977,0.00021178093,0.00029412564,0.00021187385,0.0002033339,0.00041547118],"category_scores_gemma":[0.0027357568,0.0001648385,0.00022249887,0.0005012758,0.00034837003,0.00027581688,0.00027592762,0.0003450982,0.00008710223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006524069,0.000015430089,0.99630105,0.000007163337,0.000029985755,0.00027291343,0.00013711044,0.00009674417,0.00096597767,0.000013978078,0.000041393836,0.002053004],"study_design_scores_gemma":[0.0000019616662,0.00007092214,0.99860543,0.0000026649006,0.000015444393,0.00078923587,0.000080259466,0.000115921786,0.00024302132,0.0000085343545,0.000064816275,0.0000018668682],"about_ca_topic_score_codex":0.008136475,"about_ca_topic_score_gemma":0.006479058,"teacher_disagreement_score":0.008136475,"about_ca_system_score_codex":0.00035519912,"about_ca_system_score_gemma":0.00023300895,"threshold_uncertainty_score":0.01617825},"labels":[],"label_agreement":null},{"id":"W2108933679","doi":"10.1093/neuonc/noq145","title":"Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Glial fibrillary acidic protein; Biology; DNA methylation; Glioma; GFAP stain; Bisulfite sequencing; Molecular biology; Methylation; Epigenetics; Cancer research; Gene silencing; Gene expression; Gene; Genetics; Immunology; Immunohistochemistry","score_opus":0.01111158654251908,"score_gpt":0.27923652522332343,"score_spread":0.26812493868080434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108933679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937803,0.0024438656,0.0022828907,0.000074256845,0.000014366408,0.000016551285,0.00025717862,0.000037427708,0.0010931988],"genre_scores_gemma":[0.9976248,0.00078429596,0.00071932486,0.000017561357,0.0000039485385,0.000011722464,0.00017277697,0.000005371513,0.00066031876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999374,0.000013650528,0.000003962647,0.00001787186,0.000016359947,0.000010740295],"domain_scores_gemma":[0.99993813,0.000014722046,0.000019024801,0.0000066248203,0.000014483619,0.000006962723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009968657,0.00014914421,0.00015286,0.0002956224,0.00010856234,0.000108735774,0.00009257134,0.00010935645,0.0005971327],"category_scores_gemma":[0.00024151125,0.00008605274,0.000115893374,0.00016104472,0.00011829096,0.00006111663,0.000110460765,0.00013439055,0.00012579586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026428208,0.00002422779,0.0067514707,0.000063673695,0.000028513601,0.00019106876,0.00013773983,0.00013437994,0.9831412,0.00019233809,0.00007045261,0.009000729],"study_design_scores_gemma":[0.000028344783,0.00041360903,0.16886954,0.000016014419,0.00010230395,0.0012049624,0.00015198508,0.0016276768,0.8229651,0.0004687539,0.0041397028,0.000011967008],"about_ca_topic_score_codex":0.0011856525,"about_ca_topic_score_gemma":0.0016508114,"teacher_disagreement_score":0.0011856525,"about_ca_system_score_codex":0.00015419831,"about_ca_system_score_gemma":0.00012400949,"threshold_uncertainty_score":0.002357483},"labels":[],"label_agreement":null},{"id":"W2110012351","doi":"10.1093/neuonc/not244","title":"A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Diana Helis Henry Medical Research Foundation","keywords":"Primitive neuroectodermal tumor; Cancer research; Medicine; Oncology; Internal medicine; Immunohistochemistry","score_opus":0.014226446399778273,"score_gpt":0.26223197406634263,"score_spread":0.24800552766656436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110012351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920026,0.000613623,0.0037400543,0.000064064865,0.000043259373,0.00021303531,0.0017308957,0.00012358131,0.0014688548],"genre_scores_gemma":[0.9863755,0.0011727106,0.007120389,0.000031461095,0.000011664108,0.0002620749,0.0027780805,0.00003137833,0.002216767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998443,0.000019111898,0.00001739531,0.000039335304,0.000053027583,0.000026721118],"domain_scores_gemma":[0.9998398,0.00003001599,0.000042711315,0.000036926212,0.000014488549,0.000036019017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031080662,0.00059872784,0.0004130707,0.0006100953,0.00022610904,0.0002625921,0.00028556804,0.00038614694,0.0020743476],"category_scores_gemma":[0.00010565935,0.00021413324,0.000397361,0.0004312585,0.00031155004,0.00034780524,0.00023954407,0.00084145885,0.0005086069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088002806,0.00049965247,0.005604,0.00016229294,0.00005239497,0.0012848541,0.000121816614,0.0008612941,0.9851089,0.0004885638,0.00048042493,0.0044557056],"study_design_scores_gemma":[0.00025506353,0.008004169,0.032045916,0.000045925382,0.00024058773,0.014394093,0.00023878517,0.0052675563,0.92796266,0.0002060126,0.011305992,0.000033192668],"about_ca_topic_score_codex":0.0014477182,"about_ca_topic_score_gemma":0.0022727728,"teacher_disagreement_score":0.0020743476,"about_ca_system_score_codex":0.00043198635,"about_ca_system_score_gemma":0.0005712005,"threshold_uncertainty_score":0.006939411},"labels":[],"label_agreement":null},{"id":"W2110016800","doi":"10.1093/neuonc/nos197","title":"Thromboembolic disease in patients with high-grade glioma","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Glioma; Disease; Angiogenesis; Thrombosis; Oncology; Coagulation; Heparin; Anticoagulant; Internal medicine; Immunology; Cancer research; Chemotherapy","score_opus":0.014973374852350266,"score_gpt":0.27478641822282557,"score_spread":0.2598130433704753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110016800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75801206,0.20323735,0.0015234995,0.0041965637,0.000380673,0.00009726626,0.0018088494,0.00008066325,0.030663032],"genre_scores_gemma":[0.9637086,0.032755803,0.0003725356,0.00053386425,0.00024432648,0.000022451672,0.00090267486,0.0000053940153,0.0014543314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998977,0.00001847664,0.000012942775,0.000014284695,0.00003188032,0.000024709223],"domain_scores_gemma":[0.99986315,0.00002273827,0.000059117505,0.000004626587,0.000021956994,0.00002846415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119148724,0.00012116661,0.00023676861,0.00043048384,0.0002234006,0.00034174876,0.00010127749,0.00023451183,0.0012695851],"category_scores_gemma":[0.0006069926,0.000056372162,0.00016502295,0.0009659491,0.000110261135,0.0002442957,0.00015861687,0.00041302326,0.00023062543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003193786,0.000052206877,0.86548316,0.00042991026,0.00014627697,0.0072107906,0.0002408156,0.00017141417,0.0015022896,0.00054063083,0.0074643358,0.11643885],"study_design_scores_gemma":[0.00005132092,0.00027293182,0.87599164,0.000509807,0.000333086,0.07521428,0.00050034095,0.0005570597,0.00092210376,0.0013639291,0.044254497,0.000029039962],"about_ca_topic_score_codex":0.0022295148,"about_ca_topic_score_gemma":0.0024596106,"teacher_disagreement_score":0.0022295148,"about_ca_system_score_codex":0.00030859862,"about_ca_system_score_gemma":0.00036027547,"threshold_uncertainty_score":0.0044330955},"labels":[],"label_agreement":null},{"id":"W2110254666","doi":"10.1093/neuonc/noq203","title":"Clinical trial end points for high-grade glioma: the evolving landscape","year":2011,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Clinical trial; Medicine; End point; Clinical study design; Medical physics; Clinical endpoint; Surrogate endpoint; Glioma; Intensive care medicine; Oncology; Internal medicine; Computer science","score_opus":0.1380726027225687,"score_gpt":0.42097942613129896,"score_spread":0.2829068234087303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110254666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007235485,0.99662113,0.00039034232,0.0017999122,0.00044816348,0.000037199894,0.00002518137,0.000012315437,0.00059337745],"genre_scores_gemma":[0.0010986758,0.9926179,0.0015371083,0.003129487,0.00077281083,0.00016373553,0.00007104264,0.000012493956,0.00059663964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966305,0.0016513888,0.0005816873,0.00020829006,0.0008600126,0.000068073256],"domain_scores_gemma":[0.9770458,0.017873742,0.0018373698,0.00024946214,0.0026280228,0.00036576073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008475375,0.0011852814,0.0032335941,0.0030187515,0.00034850408,0.0020153834,0.0016264508,0.0026708243,0.0027949987],"category_scores_gemma":[0.020988801,0.00031433845,0.0012192403,0.003594393,0.0009936747,0.0024508738,0.0006521269,0.0036700165,0.0018209257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020251863,0.00007531375,0.0002920454,0.03017137,0.00028197622,0.0001162543,0.00006872689,0.00041468773,0.00031618396,0.0047278367,0.05700093,0.90633214],"study_design_scores_gemma":[0.00041794157,0.00041586556,0.0022017518,0.06758293,0.00074749225,0.0018922082,0.00019009723,0.0005326738,0.00046329977,0.014041971,0.911441,0.00007279472],"about_ca_topic_score_codex":0.0008968334,"about_ca_topic_score_gemma":0.0020855176,"teacher_disagreement_score":0.008475375,"about_ca_system_score_codex":0.0018079946,"about_ca_system_score_gemma":0.003172787,"threshold_uncertainty_score":0.044822633},"labels":[],"label_agreement":null},{"id":"W2110700778","doi":"10.1093/neuonc/nos065","title":"Initial treatment patterns over time for anaplastic oligodendroglial tumors","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute; National Brain Tumor Society","keywords":"Oligodendroglial Tumor; Medicine; Cancer research; Glioblastoma; Oligodendroglioma","score_opus":0.029662333022044733,"score_gpt":0.3281192126982717,"score_spread":0.29845687967622697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110700778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983432,0.0007630742,0.00008180777,0.000044953682,0.000003821449,0.000008820977,0.00028515782,0.000004770033,0.0004644323],"genre_scores_gemma":[0.9989532,0.0002656396,0.00010587717,0.00002254784,0.000008032153,0.000008977417,0.00048275036,0.0000045620204,0.00014843729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999605,0.000050601302,0.000052105042,0.000104186896,0.00008112621,0.00010701666],"domain_scores_gemma":[0.997968,0.00028832466,0.0011106819,0.00007130876,0.0002208641,0.00034075388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003353578,0.00016522354,0.00026649592,0.0010002437,0.00034558316,0.0004327272,0.0003575803,0.00039913433,0.0008026766],"category_scores_gemma":[0.002090186,0.00016073439,0.00037730703,0.0010064519,0.00023536483,0.000376007,0.00029924893,0.00052123994,0.00019477877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013108102,0.000024302348,0.99620736,0.000007218813,0.00001587145,0.00014776144,0.00005816297,0.00009090192,0.00047171867,0.00001180624,0.000076254044,0.0027574648],"study_design_scores_gemma":[0.0000040946593,0.0000735469,0.9983406,0.000005933737,0.000014082528,0.00072084117,0.00014004282,0.00014516903,0.00025124665,0.000014766134,0.00028594164,0.0000036127142],"about_ca_topic_score_codex":0.008090071,"about_ca_topic_score_gemma":0.0125903245,"teacher_disagreement_score":0.008090071,"about_ca_system_score_codex":0.00082145,"about_ca_system_score_gemma":0.00059787306,"threshold_uncertainty_score":0.016085982},"labels":[],"label_agreement":null},{"id":"W2111335317","doi":"10.1093/neuonc/nou091","title":"Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Toronto","funders":"","keywords":"Nimotuzumab; Medicine; Adverse effect; Internal medicine; Clinical trial; Phases of clinical research; Radiation therapy; Oncology; Glioma; Surgery; Epidermal growth factor receptor; Cancer","score_opus":0.00936498273563688,"score_gpt":0.28408256319033337,"score_spread":0.27471758045469646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111335317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968958,0.001171123,0.00037686995,0.00012216701,0.000017671728,0.00063149026,0.00027952442,0.00003476232,0.0004706247],"genre_scores_gemma":[0.99359596,0.0010945582,0.0018484228,0.00024492727,0.000065838474,0.0012343297,0.0014002249,0.000019505462,0.00049615063],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996094,0.00022154702,0.000020781028,0.000053845015,0.000040209652,0.000054382857],"domain_scores_gemma":[0.9993249,0.0001299815,0.00019796198,0.000046583846,0.00004103943,0.00025962444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012381036,0.001098975,0.0014229423,0.00021219873,0.0002122234,0.00040327464,0.00053369487,0.0005372024,0.0014972776],"category_scores_gemma":[0.0010012387,0.00025258234,0.0005341445,0.00026851537,0.0005013343,0.00042168907,0.00029092483,0.0018415519,0.0003234109],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5104414,0.064219326,0.077428274,0.0012810966,0.0020393776,0.0026937723,0.001139123,0.0064701145,0.07926232,0.00067834766,0.006669783,0.24767701],"study_design_scores_gemma":[0.28606668,0.6232496,0.06471872,0.00006746496,0.0005575648,0.002980908,0.0001144185,0.0027930278,0.0112130195,0.0002473023,0.007962665,0.000028595132],"about_ca_topic_score_codex":0.0006883066,"about_ca_topic_score_gemma":0.0013170475,"teacher_disagreement_score":0.0014972776,"about_ca_system_score_codex":0.0009076089,"about_ca_system_score_gemma":0.0016793773,"threshold_uncertainty_score":0.0065852404},"labels":[],"label_agreement":null},{"id":"W2111406583","doi":"10.1093/neuonc/not114","title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Memantine; Medicine; Placebo; Hazard ratio; Randomized controlled trial; Cognition; Clinical endpoint; Cognitive decline; Anesthesia; Internal medicine; Confidence interval; Dementia; Psychiatry","score_opus":0.0253382172890971,"score_gpt":0.3220702013908722,"score_spread":0.29673198410177515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111406583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94459426,0.043436598,0.0009497102,0.001118958,0.0015602169,0.0045123543,0.0010450963,0.00024386679,0.0025390405],"genre_scores_gemma":[0.97501683,0.012081601,0.0017515311,0.0015464824,0.0013601903,0.005663267,0.00045725444,0.000017880966,0.0021051113],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956685,0.00023309876,0.00004900482,0.00007511825,0.000033204673,0.000042669653],"domain_scores_gemma":[0.9994261,0.00020965344,0.00017327176,0.000038848768,0.000041235013,0.00011096184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012082752,0.0011204899,0.002765658,0.00048954855,0.00043821204,0.00072905753,0.00077475136,0.0020820224,0.005886474],"category_scores_gemma":[0.0017027055,0.00046282497,0.0015258763,0.00040998173,0.0006692883,0.0006428077,0.00020442737,0.0014632834,0.000630753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96575433,0.0038009195,0.00039050466,0.00258865,0.001125178,0.000061395265,0.000037126978,0.00015075396,0.002679784,0.00006208764,0.000607945,0.022741292],"study_design_scores_gemma":[0.965032,0.032461558,0.001000657,0.000105006264,0.0004619269,0.000033360848,0.000008974225,0.00015000955,0.00026427617,0.000057748955,0.00041706592,0.000007420804],"about_ca_topic_score_codex":0.00036878156,"about_ca_topic_score_gemma":0.00086712575,"teacher_disagreement_score":0.005886474,"about_ca_system_score_codex":0.000336192,"about_ca_system_score_gemma":0.00063830387,"threshold_uncertainty_score":0.019692183},"labels":[],"label_agreement":null},{"id":"W2112655953","doi":"10.1215/s1152851704000602","title":"Phase 2 study of T138067-sodium in patients with malignant glioma: Trialof the National Cancer Institute of Canada Clinical Trials Group","year":2005,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); Queen's University; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; Ottawa Regional Cancer Foundation; Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Anaplastic astrocytoma; Glioma; Chemotherapy; Lomustine; Radiation therapy; Nitrosourea; Internal medicine; Nausea; Oncology; Neutropenia; Phases of clinical research; Surgery; Cancer; Population; Toxicity; Gastroenterology; Astrocytoma; Vincristine; Cyclophosphamide; Cancer research","score_opus":0.08788982790644878,"score_gpt":0.4126054623280511,"score_spread":0.32471563442160234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112655953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97265977,0.0092540495,0.00055800594,0.0022007206,0.00017536999,0.005886477,0.0026812053,0.00015491646,0.006429504],"genre_scores_gemma":[0.9623813,0.01040864,0.003390172,0.0029052899,0.00022773685,0.0053007067,0.006204342,0.000049148086,0.009132704],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958163,0.00015959455,0.000013362738,0.000043312702,0.00007216171,0.00012993085],"domain_scores_gemma":[0.999521,0.000036544272,0.00006834072,0.000019021798,0.00006148011,0.00029357636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011637859,0.0016170001,0.0016891371,0.00035651372,0.00055421575,0.0007836833,0.0011951074,0.0014797617,0.0035994109],"category_scores_gemma":[0.0006813698,0.00046366843,0.0009908312,0.0006176199,0.0006237651,0.0003217867,0.00032342508,0.0023266221,0.0007431584],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.565524,0.03554048,0.0150977615,0.0022433947,0.002916956,0.0009729685,0.00065156363,0.004001661,0.041472074,0.0013325334,0.027081763,0.303165],"study_design_scores_gemma":[0.741335,0.21550734,0.021610295,0.000106122374,0.0006120838,0.0004406358,0.00009568184,0.0019780744,0.0031679976,0.00032334935,0.01477537,0.000048000165],"about_ca_topic_score_codex":0.069773614,"about_ca_topic_score_gemma":0.20693009,"teacher_disagreement_score":0.069773614,"about_ca_system_score_codex":0.0042403243,"about_ca_system_score_gemma":0.010059029,"threshold_uncertainty_score":0.138735},"labels":[],"label_agreement":null},{"id":"W2112684191","doi":"10.1093/neuonc/nos098","title":"DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pons; Glioma; Medicine; Cancer research; Internal medicine","score_opus":0.023259172035065973,"score_gpt":0.2996466590429815,"score_spread":0.2763874870079155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112684191","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837685,0.0009939591,0.00018922963,0.00002430942,0.000004431847,0.000029446508,0.000060421928,0.0000071093978,0.00031418476],"genre_scores_gemma":[0.99789006,0.001017733,0.00052841735,0.00004866435,0.0000148279805,0.000048299873,0.00024625502,0.0000021987594,0.0002034878],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998876,0.00002506522,0.000010021111,0.000025377298,0.000022065513,0.000029934523],"domain_scores_gemma":[0.9998276,0.000047616533,0.00005338595,0.000015397296,0.000010848269,0.000045040528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023752314,0.00024235989,0.00042901866,0.00010344463,0.00012517233,0.00010966586,0.00017165467,0.00014795396,0.0009821745],"category_scores_gemma":[0.00028838587,0.0000652747,0.00012136551,0.00015032296,0.00034520103,0.0001337392,0.00015244297,0.00021863195,0.00011886343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048600543,0.0030683219,0.4320336,0.002629275,0.0005630119,0.008198794,0.00034157294,0.0029291555,0.18485248,0.00097211346,0.0016664575,0.31414464],"study_design_scores_gemma":[0.0057873917,0.1427495,0.77069366,0.00013992332,0.0007557448,0.034887772,0.00041907254,0.001018091,0.03081561,0.00038138725,0.012319454,0.000032429973],"about_ca_topic_score_codex":0.00055343,"about_ca_topic_score_gemma":0.0010623286,"teacher_disagreement_score":0.0009821745,"about_ca_system_score_codex":0.00022654214,"about_ca_system_score_gemma":0.00044859134,"threshold_uncertainty_score":0.0032856464},"labels":[],"label_agreement":null},{"id":"W2113788299","doi":"10.1093/neuonc/not229","title":"Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop","year":2013,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Glioblastoma; Epigenomics; Clinical trial; Medicine; Brain cancer; Oncology; Cancer; Medical physics; Internal medicine; Psychology; Biology; Cancer research; DNA methylation","score_opus":0.15664274759446073,"score_gpt":0.43526641928163123,"score_spread":0.2786236716871705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113788299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025107022,0.98084325,0.00019474293,0.00725727,0.0076609044,0.00003037774,0.00011199507,0.000025786763,0.0036246092],"genre_scores_gemma":[0.0013369407,0.9831049,0.00030895034,0.005621907,0.0025691765,0.000029525643,0.00021158872,0.000010819757,0.006806209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997429,0.000036221474,0.000024483119,0.000040442825,0.00012280521,0.0000331751],"domain_scores_gemma":[0.9995503,0.000117811614,0.000048865724,0.000009353524,0.00018361918,0.000090049165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012034905,0.00070836593,0.0006675266,0.001311914,0.00028757507,0.0010582922,0.0005119577,0.0012469105,0.0043726065],"category_scores_gemma":[0.0012576693,0.0002737274,0.0005281724,0.0014320012,0.00031408982,0.0014383867,0.0008687493,0.0028316423,0.0033707735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011925059,0.000055766563,0.00012740574,0.006077965,0.000041009873,0.00016487262,0.000096997304,0.00014919949,0.0012626348,0.002280463,0.5387543,0.4508702],"study_design_scores_gemma":[0.000011474465,0.00003777764,0.00036566245,0.0011769164,0.000032056083,0.00028817618,0.000033329492,0.000025324665,0.0002206045,0.0003055648,0.997494,0.000009264098],"about_ca_topic_score_codex":0.0022929255,"about_ca_topic_score_gemma":0.004169019,"teacher_disagreement_score":0.0043726065,"about_ca_system_score_codex":0.0011353099,"about_ca_system_score_gemma":0.0020950572,"threshold_uncertainty_score":0.014627814},"labels":[],"label_agreement":null},{"id":"W2113894146","doi":"10.1093/neuonc/nos312","title":"Optic pathway gliomas in adolescence--time to challenge treatment choices?","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; SickKids Foundation; McMaster Children's Hospital; Pediatric Oncology Group","funders":"","keywords":"Medicine; Carboplatin; Neurofibromatosis; Chemotherapy; Cohort; Pediatrics; Natural history; Retrospective cohort study; Radiation therapy; Progression-free survival; Oncology; Internal medicine; Pathology","score_opus":0.02521580444228332,"score_gpt":0.2871038746838031,"score_spread":0.2618880702415198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113894146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969145,0.028554566,0.00050148217,0.063091025,0.000424579,0.00002200141,0.00031560726,0.00003240132,0.010143903],"genre_scores_gemma":[0.9773771,0.016834995,0.0004952919,0.003954417,0.00044056162,0.00001660358,0.00019649748,0.000014811508,0.0006698551],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998035,0.000046053603,0.00001719411,0.00002272382,0.000036627007,0.0000740536],"domain_scores_gemma":[0.999041,0.00014459899,0.0003699451,0.000012818196,0.00012509596,0.00030657536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004184194,0.0000954829,0.00025571176,0.00021216132,0.00056752766,0.0008765299,0.00021355886,0.00070217875,0.0015792451],"category_scores_gemma":[0.0020171653,0.00006236645,0.00011457937,0.00036551314,0.0004378757,0.001008431,0.00033972418,0.0009359234,0.00031711612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011521184,0.00012916904,0.849947,0.00021256524,0.000030581836,0.007813339,0.0021118305,0.00019771543,0.00078750734,0.0022920133,0.013854446,0.12250865],"study_design_scores_gemma":[0.00005269041,0.0006459191,0.79041743,0.0023422875,0.00009749541,0.07884527,0.043642126,0.00047641853,0.00065218075,0.008141588,0.074635945,0.000050586455],"about_ca_topic_score_codex":0.0036605194,"about_ca_topic_score_gemma":0.01111786,"teacher_disagreement_score":0.0036605194,"about_ca_system_score_codex":0.0006170319,"about_ca_system_score_gemma":0.0014219087,"threshold_uncertainty_score":0.0072784424},"labels":[],"label_agreement":null},{"id":"W2114752419","doi":"10.1093/neuonc/nos076","title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Chemotherapy; Retrospective cohort study; Visual acuity; Pediatrics; Surgery; Radiology","score_opus":0.012895811532343865,"score_gpt":0.29106390099792934,"score_spread":0.27816808946558547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114752419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878925,0.0005624303,0.00004865212,0.000015501422,0.000002190754,0.00001589296,0.00038325216,0.0000032018877,0.00017975236],"genre_scores_gemma":[0.9993124,0.00017832173,0.000048153503,0.00001172429,0.0000040172354,0.000014658604,0.000403443,0.000002070374,0.000025086016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882835,0.00031162685,0.0002108062,0.0002469856,0.00026701388,0.00013522369],"domain_scores_gemma":[0.9963576,0.0005760425,0.002220032,0.00022994647,0.00034959763,0.00026678253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011313311,0.00027715176,0.00047499212,0.0011189262,0.00032819886,0.000568185,0.0003468344,0.00036224784,0.0005598811],"category_scores_gemma":[0.0034365116,0.00024422465,0.0005327279,0.0016527128,0.00040207722,0.00046299928,0.00045628482,0.0003491617,0.00014426454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006368769,0.000010122665,0.9990466,0.000010288469,0.000037446345,0.00011646244,0.000037713053,0.000018543878,0.000042466636,0.000004266614,0.000040476298,0.0005717921],"study_design_scores_gemma":[0.000008046816,0.00014277654,0.99858785,0.0000080316595,0.00004237345,0.00082752155,0.00013327504,0.00005200777,0.00005296201,0.0000062351874,0.00013545349,0.0000034420516],"about_ca_topic_score_codex":0.0056922943,"about_ca_topic_score_gemma":0.0047322395,"teacher_disagreement_score":0.0056922943,"about_ca_system_score_codex":0.00072761346,"about_ca_system_score_gemma":0.00039890193,"threshold_uncertainty_score":0.011318326},"labels":[],"label_agreement":null},{"id":"W2115408879","doi":"10.1215/15228517-2006-033","title":"Brain and Spinal Tumors of Childhood","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Craniopharyngioma; Psychosocial; Cover (algebra); Psychology; Psychoanalysis; Cognitive science; Neuroscience; Medicine; Psychotherapist; Radiology","score_opus":0.01788991397429802,"score_gpt":0.339118790306305,"score_spread":0.321228876332007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115408879","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02392032,0.6079115,0.0031477152,0.02788665,0.018013667,0.00006132651,0.00029409432,0.00018485564,0.31857985],"genre_scores_gemma":[0.13147412,0.5474587,0.0044286293,0.010464202,0.008456166,0.00008005365,0.00035144217,0.00010530835,0.2971813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984324,0.000025241445,0.000009433461,0.000018322293,0.00007350855,0.000030179704],"domain_scores_gemma":[0.99981886,0.00008585897,0.000029394138,0.0000064922187,0.000022804474,0.000036577476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114884715,0.00037032075,0.0003514031,0.00079015206,0.00063427386,0.0008752409,0.00017800803,0.000464644,0.0032614542],"category_scores_gemma":[0.0006602118,0.00015643219,0.00024646093,0.0007187277,0.0007306447,0.0006802716,0.00053096056,0.0016454738,0.00085438386],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094008225,0.000041499246,0.003069652,0.00090697734,0.000039601688,0.016368076,0.0018164881,0.00070318754,0.0030093493,0.067398764,0.52221775,0.3843347],"study_design_scores_gemma":[0.0000045591905,0.000035026856,0.0038590205,0.00040670848,0.000011412111,0.037170965,0.0006012849,0.00006139711,0.00044049838,0.0065652975,0.95083404,0.000009774356],"about_ca_topic_score_codex":0.0034426276,"about_ca_topic_score_gemma":0.010534349,"teacher_disagreement_score":0.0034426276,"about_ca_system_score_codex":0.00073737203,"about_ca_system_score_gemma":0.0012180998,"threshold_uncertainty_score":0.01091063},"labels":[],"label_agreement":null},{"id":"W2116357006","doi":"10.1093/neuonc/nou083","title":"Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute; Sigma-Tau Pharmaceuticals; Bristol-Myers Squibb","keywords":"Oligodendroglial Tumor; Medicine; Internal medicine; Hazard ratio; Nuclear medicine; Survival analysis; Glioma; Oncology; Oligodendroglioma; Cancer research; Astrocytoma; Confidence interval","score_opus":0.015411115799521001,"score_gpt":0.28146138192603626,"score_spread":0.2660502661265153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116357006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939691,0.00032922995,0.004674571,0.00007300229,0.0000063009106,0.000044921995,0.00063257344,0.0000329553,0.00023738184],"genre_scores_gemma":[0.99505424,0.00008048608,0.002948972,0.000009977807,0.000008819251,0.000035456404,0.0017844012,0.000010084704,0.00006747194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992047,0.00040692787,0.00005304989,0.0001251463,0.000113026625,0.00009719587],"domain_scores_gemma":[0.99484986,0.0036261787,0.0006597266,0.00026120766,0.0004147884,0.00018817758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014655307,0.00040986604,0.0005154799,0.001485793,0.00026462536,0.00051507616,0.00065080164,0.00024369525,0.00084437523],"category_scores_gemma":[0.007035201,0.00015570891,0.0007831201,0.00086150016,0.00018541518,0.00019301652,0.00039045344,0.00044906666,0.0002018523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011666862,0.000075048054,0.9469737,0.000054182983,0.0003178188,0.00032189005,0.00017326917,0.014738481,0.0016991177,0.0002873053,0.00075266097,0.033439845],"study_design_scores_gemma":[0.0001480273,0.0004989232,0.8457855,0.000043974276,0.00033639214,0.0015353883,0.000310172,0.14540373,0.0017382588,0.00251856,0.0016321179,0.000048968133],"about_ca_topic_score_codex":0.0065757707,"about_ca_topic_score_gemma":0.005951958,"teacher_disagreement_score":0.0065757707,"about_ca_system_score_codex":0.0005780424,"about_ca_system_score_gemma":0.00064564426,"threshold_uncertainty_score":0.013074994},"labels":[],"label_agreement":null},{"id":"W2116533092","doi":"10.1093/neuonc/nor140","title":"High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"National Cancer Institute","keywords":"Biology; Gene expression profiling; Gene; Choroid plexus; Downregulation and upregulation; Gene expression; Cancer research; DNA microarray; Bioinformatics; Pathology; Genetics; Medicine; Endocrinology; Central nervous system","score_opus":0.022551593659744924,"score_gpt":0.24856637682079932,"score_spread":0.2260147831610544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116533092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995745,0.0000510316,0.00013665062,0.0000050558006,5.574892e-7,0.0000020545422,0.00013465746,0.000004015952,0.000091350186],"genre_scores_gemma":[0.99929154,0.00003682693,0.00021983162,0.000003890498,0.0000017010583,0.000005271525,0.00031968966,0.0000024734113,0.0001188237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998839,0.000016536997,0.000014419342,0.000032301872,0.000027158525,0.000025686191],"domain_scores_gemma":[0.9995702,0.000071378025,0.00018883421,0.000039480165,0.000042020965,0.00008805406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014325537,0.00011427004,0.00027517285,0.00054111343,0.00016760654,0.0002483049,0.00009433163,0.00011609445,0.0006869727],"category_scores_gemma":[0.0003231779,0.00006800564,0.00014562548,0.00031771287,0.00016848206,0.00009760188,0.00014182348,0.0001659799,0.00017618081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011179907,0.000031251442,0.6768963,0.000036239344,0.00007460963,0.00038505037,0.00015776085,0.0002773935,0.31468573,0.00006996157,0.000115826304,0.0061518876],"study_design_scores_gemma":[0.000006756875,0.00015107427,0.983621,0.000002395142,0.000032003,0.0011608946,0.00017075913,0.00043435243,0.0139470585,0.00011553336,0.00035280755,0.000005455721],"about_ca_topic_score_codex":0.0005301794,"about_ca_topic_score_gemma":0.0009977197,"teacher_disagreement_score":0.0006869727,"about_ca_system_score_codex":0.00012459561,"about_ca_system_score_gemma":0.00015756887,"threshold_uncertainty_score":0.0022981763},"labels":[],"label_agreement":null},{"id":"W2116833686","doi":"10.1093/neuonc/nou208.52","title":"GLIOMA SPECIFIC PEPTIDES: A PLATFORM FOR MOLECULAR IMAGING AND THERAPEUTIC TARGETING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Biopanning; In vivo; Cancer research; Cancer stem cell; Stem cell; Clonogenic assay; Phage display; Biology; Medicine; Peptide library; Immunology; Antibody; Cell biology","score_opus":0.031213077599937036,"score_gpt":0.3313488975852148,"score_spread":0.3001358199852778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116833686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8339679,0.027246097,0.12024415,0.0010799526,0.00035565914,0.0006171332,0.00095458666,0.0005679256,0.014966663],"genre_scores_gemma":[0.91821325,0.0077643064,0.06685477,0.0005379203,0.000112902606,0.00027993167,0.0007855979,0.000048599206,0.0054028225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998903,0.000022952072,0.000003958925,0.000023356712,0.000036562236,0.00002287199],"domain_scores_gemma":[0.99993587,0.000012254126,0.000015306923,0.00000602027,0.000010795042,0.000019770132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018886804,0.0005712419,0.00024114265,0.00025143285,0.00011060654,0.00036369354,0.0002783113,0.00052905927,0.0011026405],"category_scores_gemma":[0.00013592755,0.00014293526,0.00016980391,0.00014044154,0.00019988573,0.0002557315,0.0002948112,0.0006717168,0.00066548283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039605275,0.000025637091,0.00005698245,0.00005989842,0.0000041653625,0.000081048274,0.0000063788025,0.0003452535,0.9927366,0.00038686694,0.00013512872,0.0061224997],"study_design_scores_gemma":[0.000042008174,0.0009311894,0.0011078039,0.000024323226,0.000025925123,0.0011097828,0.000017420069,0.0031557283,0.97603047,0.0004927714,0.01704659,0.000015906808],"about_ca_topic_score_codex":0.00010200723,"about_ca_topic_score_gemma":0.00012771167,"teacher_disagreement_score":0.0011026405,"about_ca_system_score_codex":0.00024602024,"about_ca_system_score_gemma":0.00014413928,"threshold_uncertainty_score":0.0036886334},"labels":[],"label_agreement":null},{"id":"W2117036448","doi":"10.1093/neuonc/not064","title":"Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line","year":2013,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Loss of heterozygosity; Mutant; IDH1; Line (geometry); Genetics; Biology; Gene; Mathematics; Allele","score_opus":0.018505605623414623,"score_gpt":0.26809480366051996,"score_spread":0.24958919803710533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117036448","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038442824,0.0036199242,0.0016614159,0.9011569,0.04276555,0.0000743932,0.0003647531,0.00025230457,0.011661963],"genre_scores_gemma":[0.24347821,0.004887103,0.0033622875,0.6709865,0.05578887,0.00011880134,0.0002503723,0.00017714486,0.02095073],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990502,0.0002783698,0.00011760274,0.00013422806,0.00028738097,0.00013229685],"domain_scores_gemma":[0.998304,0.00093272486,0.0002445503,0.00007116228,0.00024706748,0.00020044843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010830392,0.00048401995,0.00072648725,0.00034211008,0.0010087206,0.0013430575,0.00074454315,0.011433872,0.0013267745],"category_scores_gemma":[0.008086919,0.00038582314,0.0006181517,0.00036967333,0.00087174977,0.00078489963,0.0005018155,0.007803146,0.0018246346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037286401,0.00014391607,0.0077177365,0.00010684668,0.0001270502,0.24634458,0.00040752348,0.00042614355,0.004890385,0.0045516803,0.7169567,0.017954607],"study_design_scores_gemma":[0.00054317096,0.0006626441,0.012085203,0.00031108147,0.00028140747,0.34490713,0.0011707222,0.004861666,0.009063017,0.00828253,0.6176488,0.00018262459],"about_ca_topic_score_codex":0.0009739514,"about_ca_topic_score_gemma":0.0019699016,"teacher_disagreement_score":0.011433872,"about_ca_system_score_codex":0.0017492657,"about_ca_system_score_gemma":0.0006544699,"threshold_uncertainty_score":0.012691855},"labels":[],"label_agreement":null},{"id":"W2118286342","doi":"10.1093/neuonc/not299","title":"Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Toronto Western Hospital; SickKids Foundation; Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Brain Tumor Funders' Collaborative","keywords":"PTEN; Internal medicine; Glioma; Medicine; Oncology; Tumor progression; Cancer research; Cancer; Biology; Genetics","score_opus":0.025179496498501534,"score_gpt":0.34138489037211844,"score_spread":0.3162053938736169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118286342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99976915,0.000044227058,0.000048067297,0.000004803854,4.684455e-7,0.0000015914355,0.0000636137,0.0000015670539,0.00006645412],"genre_scores_gemma":[0.9997297,0.000020588739,0.00005047718,0.0000027008944,0.0000014718438,0.0000018461583,0.00017043638,8.078186e-7,0.0000218946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998267,0.000038792277,0.000020170708,0.0000363062,0.000042073938,0.00003598452],"domain_scores_gemma":[0.99911386,0.00025875203,0.00033499562,0.000059395366,0.0000782104,0.00015467612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044191972,0.00019810295,0.00025318004,0.0008278716,0.00018604402,0.00035065968,0.0001952157,0.00019229148,0.0006450197],"category_scores_gemma":[0.0013554088,0.00009987105,0.0001915036,0.0004974799,0.0002471909,0.00021625313,0.00028797868,0.00021650958,0.00016549947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014512443,0.0000077974355,0.9980386,0.0000030871631,0.000009526778,0.000056572306,0.000013351364,0.00006979235,0.00049175514,0.0000042655415,0.000020608319,0.0011396713],"study_design_scores_gemma":[0.000006245404,0.000114847186,0.99815816,0.0000019068126,0.000021051543,0.0006082123,0.00005826981,0.00053213036,0.0003727561,0.00003350311,0.00009051207,0.0000022839151],"about_ca_topic_score_codex":0.0016002115,"about_ca_topic_score_gemma":0.003049145,"teacher_disagreement_score":0.0016002115,"about_ca_system_score_codex":0.00024152438,"about_ca_system_score_gemma":0.0002194136,"threshold_uncertainty_score":0.0031817555},"labels":[],"label_agreement":null},{"id":"W2119000874","doi":"10.1093/neuonc/nop007","title":"A multigene predictor of outcome in glioblastoma","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Dr. Marnie Rose Foundation; National Cancer Institute; Rose Foundation for Communities and the Environment; V Foundation for Cancer Research","keywords":"Glioma; Oncology; Biology; Gene; Microarray; Biomarker; Internal medicine; Cancer research; Gene expression; Medicine; Bioinformatics; Genetics","score_opus":0.02444063387779733,"score_gpt":0.3186730734403417,"score_spread":0.29423243956254436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119000874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924636,0.00015284756,0.00016086164,0.00005251986,0.0000041448775,0.000002160641,0.0002499575,0.000005582566,0.00012557523],"genre_scores_gemma":[0.9991998,0.000063051186,0.00015626109,0.000019974845,0.0000064195965,0.000005242541,0.00044491977,0.0000023954353,0.000102020895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998697,0.000026680369,0.0000132991345,0.00002540765,0.00003350581,0.000031406707],"domain_scores_gemma":[0.9994665,0.00012816132,0.00019856676,0.0000289012,0.00005836071,0.00011950176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027329844,0.00017827164,0.00025561522,0.0006760426,0.00019112926,0.00026674452,0.000109708744,0.00023498386,0.000872928],"category_scores_gemma":[0.000921287,0.000073074065,0.00015994563,0.00050755165,0.00016656955,0.00015667087,0.00028271464,0.00029987266,0.00018893594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003867511,0.000041498468,0.9841851,0.000012736462,0.00006050142,0.00012737246,0.000027735125,0.0003067436,0.008591208,0.000033018452,0.00022482371,0.0060026622],"study_design_scores_gemma":[0.0000043754417,0.00009155983,0.9975762,0.0000036253145,0.00003160016,0.00024653092,0.00003217082,0.0006890469,0.00097089814,0.00017969268,0.0001701911,0.0000040616624],"about_ca_topic_score_codex":0.00082580664,"about_ca_topic_score_gemma":0.0017275482,"teacher_disagreement_score":0.000872928,"about_ca_system_score_codex":0.00018269589,"about_ca_system_score_gemma":0.00018718833,"threshold_uncertainty_score":0.00292027},"labels":[],"label_agreement":null},{"id":"W2120482752","doi":"10.1093/neuonc/nou006","title":"Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medulloblastoma; Medicine; Intellectual disability; Pediatrics; Hearing loss; Borderline intellectual functioning; Psychological intervention; Cognition; Psychiatry; Audiology; Pathology","score_opus":0.03817207200876447,"score_gpt":0.3307903995224173,"score_spread":0.2926183275136528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120482752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965084,0.00007766415,0.000025327825,0.000015088537,0.0000011449612,0.0000035764704,0.00009752112,0.0000014214758,0.00012742452],"genre_scores_gemma":[0.9996631,0.00004326846,0.00003649346,0.0000061505357,0.0000033670192,0.000004147405,0.0002027953,6.052083e-7,0.000039995306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996878,0.000066026245,0.000040924242,0.00004473285,0.0000985703,0.000061982755],"domain_scores_gemma":[0.9970848,0.0004530552,0.0018305391,0.000086797736,0.0002123759,0.00033238402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006447856,0.00017942787,0.0002515573,0.0006168907,0.00028856326,0.0003683557,0.0002920804,0.00023086942,0.00069356215],"category_scores_gemma":[0.0036251973,0.000098284705,0.00031156727,0.00053178635,0.00025208984,0.00042618008,0.00036340588,0.0004416405,0.00012608299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043319793,0.000014612199,0.99906665,0.0000023004936,0.0000089932355,0.000035812405,0.000021761047,0.00002322014,0.00004423254,0.0000021927883,0.000014772379,0.00072208745],"study_design_scores_gemma":[0.0000011235894,0.00007934019,0.99960357,0.0000010073463,0.0000054047473,0.00015824086,0.000039903087,0.00003640727,0.000044298497,0.0000038727126,0.00002598156,8.160135e-7],"about_ca_topic_score_codex":0.003909186,"about_ca_topic_score_gemma":0.0052937157,"teacher_disagreement_score":0.003909186,"about_ca_system_score_codex":0.00040424385,"about_ca_system_score_gemma":0.00046444964,"threshold_uncertainty_score":0.007772863},"labels":[],"label_agreement":null},{"id":"W2120820093","doi":"10.1093/neuonc/not035","title":"Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; In vivo; Neurosphere; Temozolomide; Biology; Virotherapy; Cancer research; Stem cell; In vitro; Population; Brain tumor; Glioma; Immunology; Medicine; Virus; Pathology; Cell biology; Tumor cells","score_opus":0.023838565774938793,"score_gpt":0.3136653750383318,"score_spread":0.289826809263393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120820093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341017,0.0033414494,0.0017267949,0.00007882884,0.00003882614,0.000084838386,0.00017740043,0.000059946495,0.0010817188],"genre_scores_gemma":[0.9937331,0.0015890669,0.0037480958,0.000027486492,0.000024378125,0.00007359738,0.00028707707,0.000011019732,0.0005061505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998547,0.00002210493,0.000018360022,0.000037217094,0.000038627753,0.000029002731],"domain_scores_gemma":[0.999925,0.000017125829,0.000017852542,0.000014213687,0.00000748743,0.000018218634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019029934,0.00044567193,0.00046824396,0.00036909408,0.00016573272,0.0003889574,0.00028431293,0.0002707676,0.00066504],"category_scores_gemma":[0.000101251804,0.0001258478,0.00034004837,0.00022918242,0.00022681965,0.00017833574,0.00021309512,0.00047106476,0.00025751148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002715863,0.00015262327,0.0009645784,0.00011670681,0.000043255346,0.00008392484,0.00004050471,0.0004276778,0.99079365,0.00010977369,0.00012471012,0.0068711173],"study_design_scores_gemma":[0.000066926936,0.0030903956,0.004875467,0.000011453628,0.000110798464,0.0009675185,0.000035610083,0.0014593987,0.9855552,0.000035928242,0.0037830821,0.000008228508],"about_ca_topic_score_codex":0.0004506634,"about_ca_topic_score_gemma":0.0009702368,"teacher_disagreement_score":0.00066504,"about_ca_system_score_codex":0.00025438162,"about_ca_system_score_gemma":0.00026057992,"threshold_uncertainty_score":0.002224803},"labels":[],"label_agreement":null},{"id":"W2121396361","doi":"10.1093/neuonc/nos273","title":"Standards of care for treatment of recurrent glioblastoma—are we there yet?","year":2012,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":771,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Glioblastoma; Adjuvant; Concomitant; Clinical trial; Internal medicine; Standard of care; Radiation therapy; Chemotherapy; Cancer research","score_opus":0.07411255517976502,"score_gpt":0.4022211541986221,"score_spread":0.3281085990188571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121396361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045979614,0.99358714,0.00011588303,0.0048699765,0.00066018244,0.000011680098,0.000020645255,0.000007449827,0.00068097684],"genre_scores_gemma":[0.00066267187,0.9962758,0.00061438174,0.0018682592,0.00029506706,0.000022586659,0.00003895634,0.0000027454087,0.00021962055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777895,0.0005770453,0.000554358,0.000131881,0.0008763166,0.00008150789],"domain_scores_gemma":[0.9955205,0.0016300012,0.0011063266,0.00014387757,0.0014092012,0.00019014528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004611868,0.00096442766,0.0024023594,0.0027061857,0.0004811991,0.0021883857,0.0020930176,0.00230116,0.0027317929],"category_scores_gemma":[0.010290481,0.0004058683,0.0009961553,0.004139612,0.0012879113,0.0039120372,0.0010260146,0.0033570633,0.0014256672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005891653,0.00004972491,0.00027343957,0.036219444,0.00016437109,0.00007741308,0.00013970176,0.000187415,0.00025540657,0.007662563,0.08195978,0.87295175],"study_design_scores_gemma":[0.000051637042,0.000062116334,0.0012998183,0.06816211,0.0002985738,0.00046241394,0.00028055158,0.00007992738,0.000122606,0.006066564,0.92307943,0.000034194705],"about_ca_topic_score_codex":0.004516213,"about_ca_topic_score_gemma":0.0075315274,"teacher_disagreement_score":0.004611868,"about_ca_system_score_codex":0.00276748,"about_ca_system_score_gemma":0.008721367,"threshold_uncertainty_score":0.024390161},"labels":[],"label_agreement":null},{"id":"W2123369892","doi":"10.1093/neuonc/nor195","title":"Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; U.S. Department of Defense","keywords":"Biology; Comparative genomic hybridization; Stem cell; Phenotype; Cancer research; Fluorescence in situ hybridization; Pathology; Neurosphere; Gene; Genetics; Medicine; Chromosome; Cellular differentiation","score_opus":0.023019584431594242,"score_gpt":0.24826747927005874,"score_spread":0.2252478948384645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123369892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926005,0.0017491605,0.0026901804,0.00004946334,0.000021443324,0.000060438382,0.0013458397,0.0001198087,0.0013631625],"genre_scores_gemma":[0.99544585,0.0005843248,0.0012757304,0.000046409972,0.0000066469165,0.000056066598,0.001682099,0.0000247995,0.00087802456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998406,0.000020618318,0.000020222416,0.000040539537,0.000044256634,0.000033679105],"domain_scores_gemma":[0.9997894,0.000026666523,0.000029675579,0.000054859895,0.00004094355,0.000058388196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020704577,0.00017682606,0.0003963949,0.00034064587,0.0001658056,0.00042881997,0.0001941776,0.00019944196,0.0005424212],"category_scores_gemma":[0.0001884658,0.00013654708,0.00021344628,0.00022528828,0.00018826284,0.00015291903,0.00024732057,0.00037693224,0.0003020522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020542061,0.00009056423,0.0041151764,0.000058557038,0.000023346201,0.000176637,0.00009842531,0.00037890143,0.9870112,0.00037052558,0.00022416915,0.0072471118],"study_design_scores_gemma":[0.000054980683,0.0013003253,0.09787044,0.00003129874,0.000120304474,0.0013796454,0.00019163698,0.0031839807,0.88738024,0.00031072635,0.00815946,0.000017007485],"about_ca_topic_score_codex":0.001647413,"about_ca_topic_score_gemma":0.0030729717,"teacher_disagreement_score":0.001647413,"about_ca_system_score_codex":0.00041854306,"about_ca_system_score_gemma":0.00029493772,"threshold_uncertainty_score":0.0032756329},"labels":[],"label_agreement":null},{"id":"W2123970979","doi":"10.1093/neuonc/nou040","title":"MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"University of Toronto; AstraZeneca","keywords":"Medicine; Sunitinib; Glioma; Vascularity; Bevacizumab; Effective diffusion coefficient; Radiation therapy; Imaging biomarker; Perfusion; Angiogenesis; Vascular permeability; Magnetic resonance imaging; Pathology; Cancer research; Cancer; Internal medicine; Radiology; Chemotherapy","score_opus":0.018589465615267104,"score_gpt":0.31375092532443666,"score_spread":0.29516145970916957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123970979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923511,0.0033152422,0.0023983538,0.000112451955,0.00001724426,0.00005395102,0.0003221521,0.00011932698,0.0013101755],"genre_scores_gemma":[0.9949825,0.0012650058,0.0024461886,0.00009421938,0.000016243956,0.00006375117,0.0005277102,0.000015298778,0.000588993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999136,0.0000136103745,0.0000068751324,0.000017656757,0.000023913937,0.000024313751],"domain_scores_gemma":[0.9997179,0.000045940615,0.00011083345,0.000011688702,0.00006511202,0.000048555732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003540888,0.00034398568,0.00036637855,0.00061404513,0.000074852935,0.0002782025,0.00015362259,0.0003552743,0.00079620775],"category_scores_gemma":[0.0005085708,0.00012701239,0.00018324808,0.00023182452,0.0001564262,0.00025877703,0.00011950281,0.00034645305,0.00022676299],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011613129,0.00018249414,0.030408718,0.00018857357,0.00010654214,0.00017762452,0.00005026248,0.0007830049,0.9428874,0.0000961572,0.0004138698,0.023544002],"study_design_scores_gemma":[0.000072984934,0.0040539103,0.367022,0.000041836807,0.00035158228,0.001584442,0.0001263279,0.005096954,0.61735,0.00021603069,0.0040514003,0.000032569304],"about_ca_topic_score_codex":0.0011075384,"about_ca_topic_score_gemma":0.0010210212,"teacher_disagreement_score":0.0011075384,"about_ca_system_score_codex":0.00043266307,"about_ca_system_score_gemma":0.00020503424,"threshold_uncertainty_score":0.0031392574},"labels":[],"label_agreement":null},{"id":"W2124556650","doi":"10.1093/neuonc/nos302","title":"On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Cancer research; STAT3; Small hairpin RNA; PTEN; STAT protein; Stem cell; Cancer stem cell; Janus kinase 2; Biology; Medicine; PI3K/AKT/mTOR pathway; Gene knockdown; Cell culture; Signal transduction; Cell biology","score_opus":0.01765711850265834,"score_gpt":0.30953239390315995,"score_spread":0.2918752754005016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124556650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677604,0.0007528222,0.0006286686,0.00006288865,0.000035216966,0.00003342945,0.00052578974,0.000090610105,0.0010944481],"genre_scores_gemma":[0.996238,0.0005279903,0.0005950677,0.00005424448,0.000006313607,0.000030375018,0.001085973,0.000018720897,0.0014433197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999275,0.000007015077,0.0000054652237,0.000012301762,0.000023629778,0.000024092733],"domain_scores_gemma":[0.9999423,0.0000079887905,0.000014639461,0.000005880002,0.0000066435437,0.000022430087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009289836,0.0004049989,0.00030682347,0.0002308265,0.000101394515,0.00020010235,0.00019597195,0.00017093569,0.0010877101],"category_scores_gemma":[0.00005672905,0.00008291437,0.00020382303,0.00019783984,0.00013138712,0.00010779249,0.00009640677,0.00053484755,0.00020151386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006294128,0.0004619552,0.00053316884,0.00006912639,0.000020327694,0.000033355973,0.000023692435,0.00041197165,0.9922782,0.000069136346,0.00044631033,0.005023288],"study_design_scores_gemma":[0.00010690453,0.0023068325,0.008028139,0.000010220673,0.00004162964,0.00016992191,0.00004071574,0.0030161748,0.9839581,0.00004740269,0.0022686815,0.000005365528],"about_ca_topic_score_codex":0.0017823032,"about_ca_topic_score_gemma":0.00398705,"teacher_disagreement_score":0.0017823032,"about_ca_system_score_codex":0.00036382844,"about_ca_system_score_gemma":0.00029930685,"threshold_uncertainty_score":0.0036386847},"labels":[],"label_agreement":null},{"id":"W2125940163","doi":"10.1093/neuonc/nou359","title":"In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Calgary; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; Glioma; Biology; Cancer research; Virus; Virology; Pharmacology","score_opus":0.029046311817346085,"score_gpt":0.2854235973629419,"score_spread":0.25637728554559586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125940163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94938797,0.018843012,0.006936053,0.00055573235,0.00008983857,0.0014256531,0.006497792,0.0006765794,0.015587326],"genre_scores_gemma":[0.9574977,0.016581558,0.008728597,0.00033153198,0.00004640566,0.00048760217,0.008173513,0.000069523834,0.008083498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986494,0.000021696136,0.000010933103,0.000031061863,0.000038579736,0.00003273726],"domain_scores_gemma":[0.999876,0.000033036424,0.000021365957,0.000008988196,0.000027678647,0.00003290995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022007673,0.0010690861,0.0009381254,0.0013746409,0.0003369213,0.0004464726,0.00047741522,0.00033318345,0.0043075015],"category_scores_gemma":[0.00020554985,0.0002657497,0.00053747,0.00097320066,0.00022969193,0.00024722933,0.00025951726,0.0005104046,0.0009571749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014247306,0.0020735422,0.0021752089,0.0009723363,0.00024514252,0.00072551647,0.0001288051,0.0042361603,0.92946124,0.000505418,0.0021341022,0.055917837],"study_design_scores_gemma":[0.0020272883,0.024427991,0.014320189,0.00020554315,0.0011937298,0.0023465238,0.00015450596,0.00602747,0.9173964,0.0003087717,0.03150656,0.00008509332],"about_ca_topic_score_codex":0.0013309086,"about_ca_topic_score_gemma":0.0046874587,"teacher_disagreement_score":0.0043075015,"about_ca_system_score_codex":0.0004498904,"about_ca_system_score_gemma":0.0007605583,"threshold_uncertainty_score":0.0144100785},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2128083719","doi":"10.1093/neuonc/nor207","title":"An in vivo patient-derived model of endogenous IDH1-mutant glioma","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; Cancer research; Endogeny; Cell culture; IDH1; Biology; Mutation; In vivo; Mutant; Biochemistry; Genetics; Enzyme; Gene","score_opus":0.06041709320469471,"score_gpt":0.2824694758448996,"score_spread":0.2220523826402049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128083719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116534,0.00047989693,0.0044022556,0.00016044774,0.000072805946,0.00020214388,0.0014058275,0.00020038572,0.0019108953],"genre_scores_gemma":[0.9893394,0.0005921741,0.005014598,0.00006816334,0.000013942375,0.00017077498,0.0017877729,0.000029212672,0.0029839296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985194,0.000023809564,0.000014052318,0.000038868213,0.000046090063,0.000025199311],"domain_scores_gemma":[0.9999145,0.000011638117,0.000018309625,0.000018044164,0.0000067001456,0.000030740353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001940969,0.0006292438,0.00034793274,0.00036683324,0.00019814433,0.00028727966,0.00038287856,0.0005158539,0.0015101417],"category_scores_gemma":[0.000072141156,0.00019586753,0.0002819604,0.00031867513,0.00024844485,0.00020976705,0.0002401542,0.0010035766,0.0006042499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003561692,0.0003568887,0.0002582399,0.00003672852,0.000013178255,0.0004036875,0.000039843762,0.00024714877,0.99669147,0.0002769255,0.00015162534,0.0011680161],"study_design_scores_gemma":[0.0001372641,0.0049725594,0.0031981433,0.0000075427743,0.000055581593,0.0031247064,0.00006597042,0.0029243014,0.979511,0.00018983588,0.0057990723,0.000013904876],"about_ca_topic_score_codex":0.0011247311,"about_ca_topic_score_gemma":0.0013588539,"teacher_disagreement_score":0.0015101417,"about_ca_system_score_codex":0.00048590652,"about_ca_system_score_gemma":0.00041624485,"threshold_uncertainty_score":0.005051911},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2130495311","doi":"10.1093/neuonc/noq031","title":"Oligodendroglioma cell lines containing t(1;19)(q10;p10)","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Science Council","keywords":"Oligodendroglioma; Temozolomide; Chromosomal translocation; Cell culture; Cancer research; Biology; Glioma; Genetics; Gene; Astrocytoma","score_opus":0.022648893968583862,"score_gpt":0.30956828045704465,"score_spread":0.28691938648846077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130495311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815388,0.0006140317,0.0116138,0.00016552386,0.00008842432,0.00030562663,0.0021811023,0.00013445616,0.0033582388],"genre_scores_gemma":[0.9607159,0.001256001,0.024084441,0.000101136175,0.00004784611,0.00038931405,0.0065829554,0.00007796245,0.0067444732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997398,0.000032035583,0.00004376236,0.000044344015,0.00009545998,0.0000445998],"domain_scores_gemma":[0.99964774,0.00009386486,0.000048191854,0.00008070763,0.00006547001,0.000064125445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000318728,0.00033041375,0.00029392634,0.0004868481,0.0003312259,0.00037053475,0.00047363646,0.00033288248,0.0019229851],"category_scores_gemma":[0.0003266945,0.00016215508,0.00020784188,0.00040309248,0.00024925437,0.00025293924,0.0003567888,0.00081785023,0.0010253892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016181523,0.00015808878,0.0017035288,0.00004722872,0.000012004341,0.00044718003,0.000216612,0.00015438661,0.9922426,0.0009158041,0.00045424636,0.0034865583],"study_design_scores_gemma":[0.00011395452,0.0015785653,0.009176063,0.000014238319,0.00007558529,0.0026271439,0.00015538673,0.0020295836,0.9696279,0.00028295722,0.014294749,0.000023778297],"about_ca_topic_score_codex":0.002028052,"about_ca_topic_score_gemma":0.005697049,"teacher_disagreement_score":0.002028052,"about_ca_system_score_codex":0.00028698103,"about_ca_system_score_gemma":0.0003108167,"threshold_uncertainty_score":0.0064330697},"labels":[],"label_agreement":null},{"id":"W2130591352","doi":"10.1093/neuonc/nor074","title":"Neurocytomas: Long-term experience of a single institution","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Central neurocytoma; Perioperative; Radiation therapy; Surgery; Retrospective cohort study; Radiology; Magnetic resonance imaging","score_opus":0.0641008755961378,"score_gpt":0.31643132499709875,"score_spread":0.25233044940096094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130591352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937218,0.0027836715,0.0010751063,0.0004032902,0.000028239505,0.000048666523,0.00018973314,0.00006757232,0.0016820659],"genre_scores_gemma":[0.9943224,0.0021695504,0.0019645465,0.0002772203,0.000086307344,0.000056251152,0.00041637765,0.00004865908,0.0006586849],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9980786,0.0005236229,0.00028535994,0.000339209,0.00043741197,0.00033585675],"domain_scores_gemma":[0.9920936,0.00112955,0.0022359206,0.00091029634,0.0010941691,0.0025363402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022879622,0.00054697256,0.0004217777,0.0009005145,0.0011341933,0.0014810023,0.0009732989,0.00058947277,0.0018832504],"category_scores_gemma":[0.0059214877,0.0002889324,0.0004952656,0.0014548787,0.00062850956,0.0010693892,0.0015461184,0.0007677246,0.0009768417],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038652736,0.0013007198,0.88770497,0.0001945794,0.00021030464,0.012454751,0.0025742713,0.000808896,0.002599297,0.00021240735,0.0021080282,0.08944524],"study_design_scores_gemma":[0.00017445945,0.0059755417,0.8452553,0.0005840949,0.00043033806,0.112748146,0.008762105,0.0025748066,0.0073781437,0.0005426542,0.015361534,0.00021288353],"about_ca_topic_score_codex":0.0026454872,"about_ca_topic_score_gemma":0.005499812,"teacher_disagreement_score":0.0026454872,"about_ca_system_score_codex":0.0015822245,"about_ca_system_score_gemma":0.0020663706,"threshold_uncertainty_score":0.0121001005},"labels":[],"label_agreement":null},{"id":"W2130848213","doi":"10.1215/15228517-2008-011","title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurofibromatosis; Medicine; Neurofibroma; Plexiform neurofibroma; Radiology; Magnetic resonance imaging","score_opus":0.012515482150267057,"score_gpt":0.2689377881506768,"score_spread":0.25642230600040977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130848213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994854,0.00016425097,0.000036006903,0.000011360943,0.0000012450589,0.0000029596263,0.000031976797,0.0000028862014,0.000263909],"genre_scores_gemma":[0.99962556,0.00011146555,0.00009026729,0.00001240602,0.000005738436,0.0000030330207,0.000079920705,0.0000014629641,0.00007018047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998524,0.000037141417,0.00001857768,0.00003559355,0.00002839135,0.000027840751],"domain_scores_gemma":[0.9994954,0.0000878053,0.00024539497,0.00002321467,0.000044359902,0.00010382891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024537765,0.00037238962,0.00036777148,0.0010202748,0.00032491007,0.00036686592,0.00018846417,0.00027376632,0.00069223647],"category_scores_gemma":[0.001573895,0.00029168246,0.00014166428,0.00041436884,0.00025894016,0.00055505335,0.00032781204,0.0002357381,0.00020238553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023356553,0.000037612,0.9939429,0.000010237266,0.000022655127,0.0008797665,0.0002254481,0.00008066799,0.002360344,0.000010912437,0.000047700763,0.002148105],"study_design_scores_gemma":[0.000005037905,0.0001293339,0.9963527,0.0000033709287,0.000013402522,0.0029541212,0.00012113177,0.00012924017,0.0001868275,0.000015642561,0.000085255386,0.000003951628],"about_ca_topic_score_codex":0.0015604211,"about_ca_topic_score_gemma":0.0016750221,"teacher_disagreement_score":0.0015604211,"about_ca_system_score_codex":0.00016047848,"about_ca_system_score_gemma":0.000110144276,"threshold_uncertainty_score":0.0031027198},"labels":[],"label_agreement":null},{"id":"W2131896426","doi":"10.1093/neuonc/nov117","title":"Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"University of Texas MD Anderson Cancer Center","keywords":"Glioblastoma; Atlas (anatomy); Medicine; Oncology; Cohort; Progression-free survival; Overall survival; Neuroimaging; Internal medicine; Magnetic resonance imaging; Radiology; Cancer research; Psychiatry","score_opus":0.015959315808974972,"score_gpt":0.3054914232176733,"score_spread":0.28953210740869834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131896426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359375,0.00028243664,0.00018037422,0.000121081815,0.000007680469,0.000030837444,0.005310427,0.00001329194,0.00046020874],"genre_scores_gemma":[0.992253,0.00013362258,0.0002024547,0.000045948233,0.000017285081,0.000048597467,0.0071163173,0.00000843406,0.00017433988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968565,0.00009192019,0.000027479371,0.00007768855,0.000060804636,0.00005648874],"domain_scores_gemma":[0.9990043,0.00008762785,0.0004343927,0.00011964373,0.00012424367,0.00022975373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006749054,0.00029580816,0.0005648674,0.0008181589,0.0004112502,0.0005164234,0.00045235895,0.00030710443,0.0009063666],"category_scores_gemma":[0.0016560118,0.0002087925,0.0003068062,0.0011751828,0.00021477816,0.00031732692,0.0005980503,0.000421221,0.00023382663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006902596,0.000041286585,0.9958228,0.000013155687,0.00014660122,0.00009717493,0.000038126716,0.000109956105,0.00040208807,0.000039566607,0.00089030096,0.0017086754],"study_design_scores_gemma":[0.000045588644,0.00006805449,0.99871683,0.000004253799,0.00007720981,0.0002128061,0.00004465992,0.00020262903,0.000118900076,0.00002928827,0.0004753924,0.000004435387],"about_ca_topic_score_codex":0.010868274,"about_ca_topic_score_gemma":0.0126868505,"teacher_disagreement_score":0.010868274,"about_ca_system_score_codex":0.000542904,"about_ca_system_score_gemma":0.00055891153,"threshold_uncertainty_score":0.021610022},"labels":[],"label_agreement":null},{"id":"W2132260377","doi":"10.1093/neuonc/nou368","title":"Much debated controversies of diffuse low-grade gliomas","year":2015,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Intervention (counseling); Medicine; Intensive care medicine; Psychology; Psychiatry","score_opus":0.018255075580783906,"score_gpt":0.30664264157433213,"score_spread":0.2883875659935482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132260377","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014504236,0.24338235,0.00024511968,0.12663127,0.6279297,0.000017155313,0.000048975264,0.00004247512,0.0015579001],"genre_scores_gemma":[0.0014359978,0.124963336,0.00024785634,0.059732273,0.811472,0.00002240506,0.00002844755,0.000027707165,0.0020700644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952887,0.0015534641,0.000917026,0.0006084332,0.0013930636,0.00023928021],"domain_scores_gemma":[0.9635421,0.026825631,0.0015631061,0.00059078925,0.0059511457,0.0015272485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009690425,0.0014609089,0.0027051794,0.0030496973,0.0015574018,0.005091722,0.00212611,0.008616831,0.0037939763],"category_scores_gemma":[0.03266828,0.0006284554,0.0015172081,0.001343007,0.0036807833,0.0059883343,0.001491089,0.014149507,0.0022640862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094967676,0.000023776154,0.00007583725,0.0033612996,0.000077338904,0.0003284757,0.00022704042,0.00007789592,0.00013997123,0.003851074,0.93731225,0.054429993],"study_design_scores_gemma":[0.000052838608,0.000035144334,0.00022603062,0.003999651,0.00010072281,0.00072026474,0.00012966606,0.00006548723,0.00008142481,0.0033008156,0.99126667,0.000021232467],"about_ca_topic_score_codex":0.0009994812,"about_ca_topic_score_gemma":0.0015745155,"teacher_disagreement_score":0.009690425,"about_ca_system_score_codex":0.0025836823,"about_ca_system_score_gemma":0.0034219038,"threshold_uncertainty_score":0.05124843},"labels":[],"label_agreement":null},{"id":"W2133195344","doi":"10.1093/neuonc/nos106","title":"QUALITY OF LIFE/AFTERCARE","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Quality (philosophy); Quality of life (healthcare); Psychology; Medicine; Psychotherapist; Physics","score_opus":0.029708902673446985,"score_gpt":0.3120218554905155,"score_spread":0.2823129528170685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133195344","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27108902,0.05180341,0.0060190684,0.06608903,0.0044425484,0.0011702141,0.040732834,0.00081257307,0.5578413],"genre_scores_gemma":[0.89251894,0.015398563,0.005663999,0.0131313745,0.0015338961,0.00083706004,0.019921027,0.00022707302,0.05076801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732816,0.00074164866,0.00026615456,0.00022946211,0.0008464217,0.0005881741],"domain_scores_gemma":[0.9923252,0.0006115791,0.002000357,0.00026216486,0.0018548878,0.0029458902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019303848,0.000518447,0.00065969286,0.0013774742,0.0012345162,0.0016633866,0.0012258062,0.0007532322,0.06843932],"category_scores_gemma":[0.011028103,0.00009335365,0.0012015691,0.0015525683,0.00039884486,0.0012942719,0.0024226534,0.0017783509,0.010648085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043423695,0.0008804278,0.27106404,0.0015108683,0.0006691024,0.0004624337,0.00089502457,0.0008371668,0.00030791215,0.0051550143,0.23091735,0.48686647],"study_design_scores_gemma":[0.00022715365,0.0010356779,0.517099,0.0036416664,0.00037036825,0.0024815258,0.0027050262,0.0013895022,0.00040281212,0.010094811,0.46039286,0.00015955498],"about_ca_topic_score_codex":0.00448651,"about_ca_topic_score_gemma":0.0049691014,"teacher_disagreement_score":0.06843932,"about_ca_system_score_codex":0.0023719717,"about_ca_system_score_gemma":0.0021458084,"threshold_uncertainty_score":0.22895235},"labels":[],"label_agreement":null},{"id":"W2133449257","doi":"10.1215/15228517-2006-029","title":"Malignant and benign ganglioglioma: A pathological and molecular study1","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"","keywords":"Ganglioglioma; Malignant transformation; Biology; Malignancy; Comparative genomic hybridization; Pathology; Cancer research; Gene; Genetics; Medicine; Neuroscience; Genome; Epilepsy","score_opus":0.019748180447118704,"score_gpt":0.30348766105758634,"score_spread":0.28373948061046766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133449257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817832,0.011653493,0.0014483808,0.00025222969,0.000056671117,0.000054364184,0.0002694074,0.00003575723,0.0044465344],"genre_scores_gemma":[0.9942741,0.003117936,0.0014147304,0.00006286213,0.0001332117,0.000029757612,0.00030764958,0.000008393519,0.00065131806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977344,0.000029392017,0.00003162799,0.000043007996,0.000063889325,0.000058743826],"domain_scores_gemma":[0.99960095,0.00012564877,0.000070111644,0.000046219546,0.000051772622,0.00010545842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003995011,0.00041277666,0.00032283974,0.0021503875,0.0005237599,0.00051050796,0.0005315935,0.0007013712,0.0015216252],"category_scores_gemma":[0.0008536433,0.00029043318,0.00021417958,0.0007828171,0.001067881,0.0005784668,0.0006450637,0.0003523988,0.0005539345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024594534,0.0005059407,0.24974112,0.0006891606,0.00008167283,0.22919026,0.0012320598,0.00029803196,0.47218743,0.006984379,0.0009195514,0.035710994],"study_design_scores_gemma":[0.000082261584,0.0010704094,0.25840944,0.00005491145,0.00012842016,0.6757917,0.0013218812,0.0010477935,0.039156996,0.002928858,0.019967975,0.00003939692],"about_ca_topic_score_codex":0.00050523115,"about_ca_topic_score_gemma":0.0005337353,"teacher_disagreement_score":0.0021503875,"about_ca_system_score_codex":0.00030685565,"about_ca_system_score_gemma":0.0002661897,"threshold_uncertainty_score":0.0050902963},"labels":[],"label_agreement":null},{"id":"W2134221589","doi":"10.1093/neuonc/nos222","title":"LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of British Columbia","funders":"","keywords":"Pharmacology; Clinical pharmacology; Medicine","score_opus":0.039738524084344695,"score_gpt":0.39115454891691565,"score_spread":0.35141602483257095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134221589","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29166502,0.0785067,0.1339375,0.014331533,0.013828256,0.053747047,0.060204417,0.01032271,0.3434569],"genre_scores_gemma":[0.46631435,0.04281127,0.10150139,0.015157876,0.0050600413,0.061729085,0.05047098,0.0011697034,0.25578538],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981846,0.0003948005,0.00019432475,0.000420046,0.00049157615,0.00031462466],"domain_scores_gemma":[0.99823546,0.00014638486,0.00017268004,0.0005386601,0.00050676207,0.00039994964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033967416,0.001367906,0.0014204227,0.0007606992,0.00082191627,0.0013431604,0.0012456166,0.0011838384,0.0625686],"category_scores_gemma":[0.0016644155,0.00049531757,0.0013099867,0.00071954326,0.0012944266,0.0010230313,0.001220368,0.0026812789,0.033116058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029816953,0.01323265,0.010454371,0.0061568734,0.00053267373,0.0019616296,0.0004888252,0.0010080156,0.22587839,0.010163014,0.12740545,0.5729012],"study_design_scores_gemma":[0.0033125072,0.03846416,0.016563172,0.0008967969,0.00054770714,0.0037649954,0.00025224278,0.00072658254,0.13138111,0.0037214065,0.8002447,0.00012474641],"about_ca_topic_score_codex":0.00061001035,"about_ca_topic_score_gemma":0.0009247062,"teacher_disagreement_score":0.0625686,"about_ca_system_score_codex":0.001093906,"about_ca_system_score_gemma":0.0029893962,"threshold_uncertainty_score":0.20931286},"labels":[],"label_agreement":null},{"id":"W2134543408","doi":"10.1093/neuonc/nou239.2","title":"BI-02 * FUNCTIONAL CHARACTERIZATION OF NOVEL BIOMARKERS IN SELECTING FOR SUBTYPE SPECIFIC MEDULLOBLASTOMA PHENOTYPES","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Phenotype; Biology; Cancer research; Flow cytometry; Cell sorting; Wnt signaling pathway; Population; Transcriptome; Cell; Computational biology; Molecular biology; Genetics; Gene expression; Gene; Medicine","score_opus":0.02694358005785323,"score_gpt":0.2629105043238488,"score_spread":0.23596692426599558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134543408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97115695,0.0016449511,0.012462909,0.00026805908,0.00003998724,0.00023753157,0.0033919048,0.0005547219,0.010243027],"genre_scores_gemma":[0.92476165,0.0010040733,0.035618786,0.00027705447,0.00001817353,0.0005085194,0.016031396,0.00021376302,0.02156665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997074,0.000040857427,0.000024833804,0.00006487024,0.00011110045,0.000051041938],"domain_scores_gemma":[0.9998642,0.00001907819,0.000016614635,0.000016711729,0.000045659086,0.000037756414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032041434,0.000374749,0.00027763497,0.0005139026,0.00020966408,0.00072331773,0.00032630478,0.00030176237,0.0037897758],"category_scores_gemma":[0.00024098452,0.00020444121,0.00026690253,0.00052360643,0.000112832764,0.00018441124,0.00027786137,0.00053010846,0.002045947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001351276,0.000044161447,0.0009186459,0.000028150347,0.0000076053752,0.000017624303,0.000009940738,0.00008566433,0.99422437,0.00008569653,0.0003467983,0.0040961835],"study_design_scores_gemma":[0.000020743057,0.00035098245,0.010082131,0.0000077078585,0.000029924828,0.0002504517,0.000035419853,0.004464761,0.974462,0.00006097979,0.010225624,0.000009204114],"about_ca_topic_score_codex":0.001514224,"about_ca_topic_score_gemma":0.0019690823,"teacher_disagreement_score":0.0037897758,"about_ca_system_score_codex":0.00043818672,"about_ca_system_score_gemma":0.00032375424,"threshold_uncertainty_score":0.012678087},"labels":[],"label_agreement":null},{"id":"W2135285906","doi":"10.1093/neuonc/not179","title":"MEDICAL RADIATION THERAPIES","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sunnybrook Health Science Centre; Western University; Mount Sinai Hospital","funders":"","keywords":"Medical radiation; Medicine; Medical physics","score_opus":0.012891558357255953,"score_gpt":0.296822660967957,"score_spread":0.28393110261070104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135285906","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012439124,0.0633791,0.020388609,0.0072238278,0.003918161,0.0003808928,0.0017973607,0.0013156671,0.88915724],"genre_scores_gemma":[0.16379179,0.070770904,0.020887753,0.013538775,0.004411241,0.00050297205,0.002631894,0.00053041894,0.72293425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996247,0.0000693169,0.000021070833,0.00006260074,0.00018164636,0.000040674287],"domain_scores_gemma":[0.9996358,0.00007084977,0.00006254945,0.00007182562,0.00009996509,0.00005896309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047890862,0.00047461488,0.00037057942,0.0009982132,0.00076738745,0.0010644378,0.0006422098,0.00065045344,0.10097999],"category_scores_gemma":[0.0012028305,0.00014019561,0.0006705604,0.0007187209,0.00044984388,0.0006054582,0.0008801365,0.0009854907,0.040038306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025751902,0.00029966733,0.0027289183,0.0012214334,0.00010503548,0.00074673526,0.00022337948,0.00060478,0.015666908,0.027644914,0.17832294,0.7721778],"study_design_scores_gemma":[0.000032384112,0.00018281875,0.0027215495,0.00033851966,0.00005074873,0.0025111847,0.00005931499,0.00013534338,0.005482275,0.00365848,0.9848161,0.000011305596],"about_ca_topic_score_codex":0.0005636764,"about_ca_topic_score_gemma":0.00091034535,"teacher_disagreement_score":0.10097999,"about_ca_system_score_codex":0.00067545037,"about_ca_system_score_gemma":0.0010045221,"threshold_uncertainty_score":0.3378117},"labels":[],"label_agreement":null},{"id":"W2135404870","doi":"10.1093/neuonc/nou035","title":"GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Geography; Environmental planning; Economic geography","score_opus":0.024952359616641943,"score_gpt":0.3057051957899572,"score_spread":0.28075283617331526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135404870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017115595,0.99767774,0.0002222629,0.00047897588,0.00022571026,0.000003965421,0.000020395375,0.0000088790675,0.0011909977],"genre_scores_gemma":[0.000817622,0.99813926,0.00020589407,0.00019614406,0.0001265789,0.000004079506,0.000027332451,0.0000014829328,0.0004815974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998779,0.000019556976,0.00001815492,0.000023481894,0.000045708683,0.000015283209],"domain_scores_gemma":[0.99980706,0.000074717,0.00002490183,0.0000056214926,0.00006558539,0.00002210624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041950215,0.0006322884,0.0011327264,0.0020920956,0.00030190425,0.0010225845,0.0006334281,0.0011131649,0.0019633062],"category_scores_gemma":[0.0005154902,0.000255653,0.0004144524,0.0017680672,0.0004445293,0.0014174046,0.00068817736,0.0013466785,0.0012756882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005463553,0.000038201666,0.00033334724,0.015531381,0.00008889594,0.00041752416,0.0001113651,0.00040557157,0.003300884,0.006737079,0.03162821,0.94135284],"study_design_scores_gemma":[0.0000071448594,0.000055535886,0.00094890455,0.0020150447,0.00009056829,0.0025907326,0.00009109157,0.00010282678,0.0007817928,0.0020840205,0.9912116,0.00002075078],"about_ca_topic_score_codex":0.0014068319,"about_ca_topic_score_gemma":0.0025920295,"teacher_disagreement_score":0.0020920956,"about_ca_system_score_codex":0.00074891595,"about_ca_system_score_gemma":0.0011719117,"threshold_uncertainty_score":0.006567955},"labels":[],"label_agreement":null},{"id":"W2135465849","doi":"10.1093/neuonc/nou087","title":"The epidemiology of glioma in adults: a \"state of the science\" review","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Government of Canada; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Glioma; Oncology; Medicine; Internal medicine; DNA methylation; Biology; Cancer research; Genetics; Gene","score_opus":0.060195946125080474,"score_gpt":0.3987883958102149,"score_spread":0.33859244968513447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135465849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006178711,0.9994362,0.000024291483,0.00021689307,0.00008640073,0.0000020017535,0.00002770563,0.0000022681043,0.00014249394],"genre_scores_gemma":[0.00035803084,0.99936825,0.000038687685,0.0000869072,0.00008208888,0.0000020304467,0.000022513408,4.7484215e-7,0.000041069798],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995726,0.00009252842,0.00012300252,0.00007597438,0.00010887581,0.00002705565],"domain_scores_gemma":[0.99834037,0.0009952872,0.00030201388,0.000024064402,0.00028297488,0.000055165452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076379074,0.00083956274,0.0017676255,0.00311711,0.00022432416,0.0009011612,0.0007580781,0.0009785608,0.002826134],"category_scores_gemma":[0.0027292466,0.00031229408,0.0009107079,0.004509561,0.00034391502,0.0012516917,0.0005262067,0.0009491918,0.00061961624],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088773915,0.000029891316,0.0013074588,0.095704354,0.00040566895,0.0002645257,0.00011505314,0.00025492156,0.00031832725,0.0011469332,0.039590374,0.8607737],"study_design_scores_gemma":[0.000027800943,0.00015515351,0.0093266675,0.082981154,0.0020493227,0.0047725155,0.00026682072,0.00012691539,0.0003155201,0.001849174,0.89806944,0.000059552218],"about_ca_topic_score_codex":0.0035170205,"about_ca_topic_score_gemma":0.0046859905,"teacher_disagreement_score":0.0035170205,"about_ca_system_score_codex":0.000773319,"about_ca_system_score_gemma":0.0020805744,"threshold_uncertainty_score":0.00945431},"labels":[],"label_agreement":null},{"id":"W2135637880","doi":"10.1093/neuonc/not052","title":"Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Biomedical Imaging and Bioengineering; Health Canada; National Institutes of Health","keywords":"Microbubbles; Gliosarcoma; Ultrasound; Collateral damage; Neutron capture; Focused ultrasound; Drug delivery; Brain tumor; Medicine; Chemistry; Nuclear medicine; Glioma; Boron; Cancer research; Pathology; Radiology","score_opus":0.014119299725019612,"score_gpt":0.2718150870366111,"score_spread":0.2576957873115915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135637880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96768963,0.0051006493,0.024938231,0.00020121023,0.0000428745,0.00012091147,0.00009196582,0.00020440048,0.0016101525],"genre_scores_gemma":[0.9707391,0.0033151621,0.023946758,0.00011892144,0.000024915995,0.00014584168,0.00012589172,0.000032445678,0.0015509547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999279,0.000010735513,0.0000031713148,0.000017841838,0.0000210805,0.000019267227],"domain_scores_gemma":[0.9999449,0.000012654929,0.000022000315,0.0000026210507,0.000008031009,0.0000098019955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001705801,0.0004672425,0.0002700347,0.00031258332,0.00011785411,0.00020191331,0.00025748665,0.000351095,0.0010860126],"category_scores_gemma":[0.00012266944,0.00014899041,0.00021754568,0.00013938358,0.00025394786,0.00025614022,0.00024176331,0.00031148532,0.0002722439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007739425,0.000034045566,0.00008032049,0.000054465654,0.000004813088,0.000023021952,0.000011318328,0.00013276562,0.99650383,0.000055681496,0.000044720095,0.0029775265],"study_design_scores_gemma":[0.000032262076,0.0009916573,0.0013362468,0.000011332551,0.0000325797,0.00023317497,0.000014625466,0.0020624152,0.99306,0.00003849367,0.002179691,0.000007586122],"about_ca_topic_score_codex":0.0013830496,"about_ca_topic_score_gemma":0.0016476914,"teacher_disagreement_score":0.0013830496,"about_ca_system_score_codex":0.0004121432,"about_ca_system_score_gemma":0.000283389,"threshold_uncertainty_score":0.0036331415},"labels":[],"label_agreement":null},{"id":"W2138178015","doi":"10.1093/neuonc/nou362","title":"ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Cancer Foundation; University of Calgary","keywords":"Glioma; Biology; Gene knockdown; Tenascin C; Cancer research; CYR61; Proteases; Microarray analysis techniques; Extracellular matrix; Cell culture; Gene expression; Cell biology; Molecular biology; Gene; Genetics; Growth factor; Biochemistry","score_opus":0.07177215241205709,"score_gpt":0.3545024900550746,"score_spread":0.2827303376430175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138178015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843168,0.003666144,0.008092336,0.00019111688,0.00006584704,0.00009379078,0.0016556842,0.00014682508,0.0017714405],"genre_scores_gemma":[0.98517114,0.0019740604,0.006848786,0.000071982126,0.000041758467,0.000059037215,0.0038256773,0.000018483472,0.001989009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998373,0.000020928721,0.00002056048,0.00003661672,0.000052594234,0.000031920983],"domain_scores_gemma":[0.9998242,0.000025257967,0.00006538846,0.000015004449,0.000029660117,0.000040394654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002133289,0.00060438213,0.00031084247,0.00033675018,0.00026485126,0.00045811373,0.00023811132,0.00025580465,0.0014361735],"category_scores_gemma":[0.00014330713,0.00013101257,0.00040693214,0.00020712217,0.00022176755,0.00022738305,0.0002091294,0.0005895422,0.0005941137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007342249,0.000017142818,0.0003168633,0.000042866144,0.000006091697,0.00022580805,0.000013686595,0.00003447513,0.998524,0.00006579898,0.000039830888,0.0006399331],"study_design_scores_gemma":[0.000017248785,0.00020195023,0.009488604,0.000009690598,0.000029609879,0.0015952978,0.000038645016,0.00093356223,0.98411256,0.00009328066,0.0034726872,0.0000069497664],"about_ca_topic_score_codex":0.00027089543,"about_ca_topic_score_gemma":0.00029379522,"teacher_disagreement_score":0.0014361735,"about_ca_system_score_codex":0.00033521364,"about_ca_system_score_gemma":0.00022239177,"threshold_uncertainty_score":0.004804492},"labels":[],"label_agreement":null},{"id":"W2138964047","doi":"10.1093/neuonc/noq032","title":"Sensitivity to temozolomide in brain tumor initiating cells","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Fondation pour la Recherche Médicale; Brain Tumour Research; Alberta Cancer Foundation","keywords":"Temozolomide; Methyltransferase; Methylation; Glioblastoma; Cancer research; O-6-methylguanine-DNA methyltransferase; DNA methylation; Brain tumor; Biology; DNA; Medicine; Gene; Gene expression; Genetics; Pathology","score_opus":0.019030961405090408,"score_gpt":0.3058555663106247,"score_spread":0.2868246049055343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138964047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977457,0.00088612613,0.0005068709,0.000028170576,0.0000032957284,0.000008927725,0.0003098892,0.00002155904,0.00048946094],"genre_scores_gemma":[0.9981755,0.0005648572,0.00043012045,0.000019732015,0.0000028733728,0.000011257533,0.00041127737,0.000004316373,0.00038001264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999841,0.000032771808,0.000018446523,0.000024797075,0.00006018307,0.000022706172],"domain_scores_gemma":[0.9997099,0.000079781224,0.00009371121,0.000030828294,0.0000460312,0.000039796283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019498225,0.00015262041,0.00026646187,0.0003869824,0.000119116456,0.00023390891,0.000066535766,0.00015431173,0.0007820063],"category_scores_gemma":[0.00045706338,0.000087533714,0.00011497262,0.00027457217,0.00011699629,0.00013776336,0.00013618573,0.0002449569,0.00018912555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030283455,0.000038876697,0.028895969,0.000044109613,0.000031637897,0.00010962921,0.00006922264,0.00029366516,0.9630303,0.00005101335,0.0000927691,0.007039936],"study_design_scores_gemma":[0.0000127002995,0.0015883145,0.45029572,0.000007234391,0.000055040837,0.0011547985,0.00010707997,0.0015026075,0.5433883,0.000119909935,0.0017588837,0.000009425074],"about_ca_topic_score_codex":0.0013346646,"about_ca_topic_score_gemma":0.00158703,"teacher_disagreement_score":0.0013346646,"about_ca_system_score_codex":0.000232499,"about_ca_system_score_gemma":0.00010008032,"threshold_uncertainty_score":0.0026537776},"labels":[],"label_agreement":null},{"id":"W2139004759","doi":"10.1093/neuonc/nou160","title":"Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; CancerCare Manitoba; Centre Hospitalier Universitaire de Sherbrooke; McGill University; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Temozolomide; Afatinib; Medicine; Internal medicine; Rash; Dacarbazine; Phases of clinical research; Oncology; Clinical endpoint; Adverse effect; Pharmacokinetics; Epidermal growth factor receptor; Pharmacology; Randomized controlled trial; Clinical trial; Chemotherapy; Erlotinib; Cancer","score_opus":0.022807404650763828,"score_gpt":0.3333385568777372,"score_spread":0.3105311522269734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139004759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862023,0.0048770914,0.00071784656,0.00093808956,0.00031655707,0.0042091883,0.0011077045,0.00017099363,0.0014602107],"genre_scores_gemma":[0.9832829,0.0033739705,0.0022922799,0.0015713352,0.0002650962,0.005586179,0.0016281981,0.00003807443,0.0019619218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99948007,0.00020996931,0.000046859957,0.00012259519,0.000044069075,0.00009648677],"domain_scores_gemma":[0.99904853,0.00012507568,0.00023583927,0.000050393268,0.000068400914,0.0004717971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017128184,0.0015345059,0.003261116,0.00035377048,0.00041116378,0.00088988536,0.0010655036,0.0013267335,0.004889394],"category_scores_gemma":[0.0013172313,0.0006072911,0.0013349615,0.00048706142,0.0009027812,0.0012027462,0.00038280903,0.0036218436,0.000927921],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9223558,0.017054934,0.0017959516,0.00093603483,0.0015366671,0.00012764451,0.00015020261,0.00074878894,0.011428077,0.00015184001,0.0028885184,0.040825557],"study_design_scores_gemma":[0.8619472,0.13241526,0.0027966115,0.000027744802,0.00043787682,0.000121592624,0.000026226147,0.00038632588,0.0007171786,0.00012970046,0.0009788488,0.000015356043],"about_ca_topic_score_codex":0.0012383626,"about_ca_topic_score_gemma":0.0041340212,"teacher_disagreement_score":0.004889394,"about_ca_system_score_codex":0.0011341587,"about_ca_system_score_gemma":0.002112597,"threshold_uncertainty_score":0.016356647},"labels":[],"label_agreement":null},{"id":"W2139872224","doi":"10.1215/15228517-2008-110","title":"The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Ezrin; Medulloblastoma; Filopodia; Cell migration; Cytoskeleton; Biology; Transfection; Cancer research; Cell adhesion; Cerebellum; Cell biology; Blot; Cell culture; Cell; Molecular biology; Actin; Gene; Genetics; Neuroscience","score_opus":0.017277212279783245,"score_gpt":0.3132121613440472,"score_spread":0.295934949064264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139872224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638367,0.0017652235,0.000723509,0.00005438067,0.000005185302,0.0000067049955,0.00013384374,0.000017144615,0.0009103366],"genre_scores_gemma":[0.997421,0.00080246315,0.0005449606,0.000013031984,0.0000028379507,0.000008833738,0.00019502756,0.0000035230123,0.0010083114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999374,0.000010268683,0.0000040841874,0.0000111799045,0.000021292592,0.000015782332],"domain_scores_gemma":[0.999964,0.0000066255157,0.000010285814,0.000004055581,0.000005461567,0.000009580185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000633959,0.00015888372,0.00012133369,0.0001727655,0.00025679482,0.00030459557,0.000087025765,0.00015762672,0.0005145344],"category_scores_gemma":[0.00010054924,0.000068157235,0.0000812522,0.000109241686,0.00011574085,0.00020670393,0.00016354297,0.00017220566,0.00016851307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006727359,0.0000057208945,0.00090425817,0.000016936507,0.0000030250387,0.000081121514,0.000020085476,0.000036695506,0.99761593,0.00012766175,0.000024139032,0.0010972016],"study_design_scores_gemma":[0.000014128621,0.0001547913,0.061056416,0.000007833895,0.000020501693,0.00061733,0.0001440207,0.0009227444,0.9322225,0.00007296617,0.004761725,0.000005061254],"about_ca_topic_score_codex":0.0024015207,"about_ca_topic_score_gemma":0.0030818325,"teacher_disagreement_score":0.0024015207,"about_ca_system_score_codex":0.0004654069,"about_ca_system_score_gemma":0.00016078817,"threshold_uncertainty_score":0.004775107},"labels":[],"label_agreement":null},{"id":"W2139920423","doi":"10.1093/neuonc/nou052","title":"Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council; University of Texas MD Anderson Cancer Center; University of Illinois at Urbana-Champaign; National Institutes of Health; Rigshospitalet; Lunds Universitet; Case Comprehensive Cancer Center, Case Western Reserve University; Memorial Sloan-Kettering Cancer Center; Dan L. Duncan Cancer Center, Baylor College of Medicine; School of Medicine, Case Western Reserve University; National Cancer Institute; National Brain Tumor Society; Case Western Reserve University; Brigham and Women's Hospital; University of Southern California; University of California, San Francisco; Cancer Research UK; Yale University","keywords":"Germline; Melanoma; Breast cancer; Family history; Oncology; Colorectal cancer; Medicine; Internal medicine; Cancer; Cancer research; Biology; Genetics; Gene","score_opus":0.016547200599579242,"score_gpt":0.26458794008446856,"score_spread":0.24804073948488933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139920423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936026,0.00013963704,0.00007681448,0.00002820739,0.0000020846076,0.0000029577038,0.000039096554,0.0000057498996,0.00034529154],"genre_scores_gemma":[0.9997702,0.00006746794,0.000071651026,0.00000829257,0.0000044071844,0.0000017019818,0.000031611064,0.0000013121991,0.000043373453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972314,0.00006607834,0.000021240798,0.00008229679,0.00005523585,0.000052120944],"domain_scores_gemma":[0.9992704,0.00025604133,0.0002848209,0.000032625972,0.000032351523,0.00012375214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027014103,0.00042516054,0.00020038322,0.0015056359,0.00067819335,0.00025971653,0.0002128847,0.00037028137,0.0021169742],"category_scores_gemma":[0.00195273,0.0002629907,0.00014685244,0.0008158661,0.0005360852,0.00021505458,0.00039258614,0.00024366063,0.00012821562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037135056,0.00005738476,0.94006383,0.000032683816,0.00007687951,0.04408883,0.0006072584,0.00027563475,0.008613065,0.00012856918,0.00033441352,0.0053501213],"study_design_scores_gemma":[0.000036130714,0.00023541792,0.81693524,0.000027401215,0.00011810492,0.17759927,0.00062307215,0.0005601756,0.003020597,0.00024094275,0.0005868877,0.000016857219],"about_ca_topic_score_codex":0.0021673134,"about_ca_topic_score_gemma":0.0032030481,"teacher_disagreement_score":0.0021673134,"about_ca_system_score_codex":0.0003050978,"about_ca_system_score_gemma":0.00022549997,"threshold_uncertainty_score":0.0070819855},"labels":[],"label_agreement":null},{"id":"W2141349487","doi":"10.1093/neuonc/nou283","title":"The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Public Health Agency; Public Health Agency of Canada","keywords":"Meta-analysis; Incidence (geometry); Systematic review; Medicine; MEDLINE; Internal medicine; Biology; Mathematics","score_opus":0.057158942761239964,"score_gpt":0.36022683068263095,"score_spread":0.303067887921391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141349487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059419344,0.9919214,0.0005449242,0.00022760499,0.000114329814,0.0001901994,0.0007835223,0.000019486579,0.0002564448],"genre_scores_gemma":[0.17993174,0.81461257,0.0021795784,0.0006194565,0.00024501042,0.0009315591,0.0012224764,0.0000251045,0.00023259346],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99092346,0.0039102416,0.0026162958,0.0010426849,0.0011433882,0.000363943],"domain_scores_gemma":[0.9834609,0.011594512,0.0025164844,0.0005884776,0.0016568613,0.00018272358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012050605,0.0023082604,0.012416994,0.008121781,0.0005554511,0.0025420357,0.0016248378,0.0017333908,0.0027769357],"category_scores_gemma":[0.031707805,0.0013243322,0.032477286,0.009467062,0.0005974862,0.0014104532,0.0012464634,0.0014061796,0.0002829158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011629188,0.000021775393,0.013024467,0.33399403,0.63622326,0.0002654079,0.00009466055,0.00089265185,0.00022819558,0.00016821691,0.0011720938,0.012752334],"study_design_scores_gemma":[0.00033640547,0.00013847141,0.0097799925,0.03103652,0.9557942,0.00026278183,0.00005655282,0.00026574382,0.000137643,0.0002365121,0.0019274988,0.00002765274],"about_ca_topic_score_codex":0.00793938,"about_ca_topic_score_gemma":0.015811682,"teacher_disagreement_score":0.012416994,"about_ca_system_score_codex":0.0025364622,"about_ca_system_score_gemma":0.0036951676,"threshold_uncertainty_score":0.06373042},"labels":[],"label_agreement":null},{"id":"W2143173265","doi":"10.1093/neuonc/nov061.14","title":"BT-04 * A STANDARDIZED AUTOPSY PROCUREMENT ALLOWS FOR THE COMPREHENSIVE STUDY OF DIPG BIOLOGY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autopsy; Procurement; Biology; Medicine; Pathology; Business","score_opus":0.08772335652876306,"score_gpt":0.37872251970592413,"score_spread":0.29099916317716107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143173265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5212235,0.0055916016,0.2622528,0.0034378427,0.0013891201,0.013289815,0.016751356,0.006239917,0.16982408],"genre_scores_gemma":[0.464707,0.00559916,0.39979511,0.001681783,0.00018244014,0.007209561,0.034994204,0.0018414456,0.083989315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913496,0.00018501171,0.0001324525,0.00014196154,0.00031945732,0.00008617681],"domain_scores_gemma":[0.9986029,0.00011145,0.00016993124,0.00040767613,0.00048399763,0.00022404199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001943442,0.00058617344,0.00043391288,0.0015212419,0.0016471205,0.0010240537,0.00096317613,0.0007554733,0.01527703],"category_scores_gemma":[0.0012227864,0.0005374385,0.00044271452,0.0010816791,0.0008709564,0.0006560395,0.00087866763,0.0014809641,0.009133756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020374348,0.0010896486,0.022550795,0.0005696588,0.00011915602,0.0056508016,0.0009088956,0.0019664345,0.7391205,0.0097672725,0.055261254,0.16095823],"study_design_scores_gemma":[0.00044663486,0.003929733,0.10308159,0.00051734905,0.00019140201,0.037915744,0.0009610628,0.0058540846,0.31629896,0.003090208,0.5275799,0.00013335203],"about_ca_topic_score_codex":0.0071451734,"about_ca_topic_score_gemma":0.025377579,"teacher_disagreement_score":0.01527703,"about_ca_system_score_codex":0.0015931202,"about_ca_system_score_gemma":0.0037109423,"threshold_uncertainty_score":0.05110675},"labels":[],"label_agreement":null},{"id":"W2143915403","doi":"10.1093/neuonc/nou108","title":"Straying from the path in neuro-oncology","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Oncology; Internal medicine; Adjuvant; Clinical trial; Regimen; Radiation therapy; Adjuvant therapy; Cancer; Breast cancer","score_opus":0.05783105793299543,"score_gpt":0.36216589274521915,"score_spread":0.30433483481222373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143915403","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080962246,0.14138922,0.0042077354,0.8151765,0.023365749,0.000021032758,0.00010290544,0.00015813581,0.014769097],"genre_scores_gemma":[0.03676788,0.2793359,0.009480302,0.58972484,0.058529172,0.000105542575,0.00023905112,0.00047707953,0.025340306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99391514,0.0020997792,0.00044270846,0.0010373226,0.002033897,0.00047126162],"domain_scores_gemma":[0.97605056,0.010403274,0.0009042478,0.0016846128,0.0065167556,0.004440474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013278366,0.000938479,0.0015750072,0.0020815816,0.0028544378,0.007992009,0.0017490049,0.008736286,0.014110423],"category_scores_gemma":[0.022662392,0.00040022616,0.0007523083,0.0019712595,0.015812,0.019819165,0.005013468,0.03440585,0.0077878097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018139496,0.00011127542,0.0012089157,0.0009871904,0.000057576624,0.00037065407,0.0010732512,0.00035989098,0.00052215625,0.17520875,0.479572,0.34034687],"study_design_scores_gemma":[0.000033118824,0.00014506614,0.0006121863,0.0018798133,0.000019410798,0.00066196406,0.0007033717,0.00016993674,0.00016497009,0.1509072,0.8446614,0.000041576615],"about_ca_topic_score_codex":0.0040259683,"about_ca_topic_score_gemma":0.0066418457,"teacher_disagreement_score":0.014110423,"about_ca_system_score_codex":0.006003223,"about_ca_system_score_gemma":0.010283229,"threshold_uncertainty_score":0.07022357},"labels":[],"label_agreement":null},{"id":"W2144448977","doi":"10.1093/neuonc/not162","title":"A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Toronto; SickKids Foundation; Alberta Children's Hospital","funders":"Alberta Innovates; Brain Tumour Foundation of Canada; University of Calgary","keywords":"LIN28; Gene knockdown; microRNA; PI3K/AKT/mTOR pathway; Cancer research; Biology; Cell culture; Cell biology; Signal transduction; Gene; Genetics; Transcription factor","score_opus":0.013912135614253222,"score_gpt":0.2550834511194518,"score_spread":0.24117131550519857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144448977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903289,0.0006192111,0.0038307442,0.00017043253,0.000027284083,0.00009109477,0.0025089115,0.00016907316,0.002254415],"genre_scores_gemma":[0.9891888,0.00033358543,0.0049232463,0.000055669938,0.00000719535,0.00007382331,0.0030096031,0.000023359938,0.002384656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987984,0.000008865758,0.000015578804,0.000024455385,0.000049965878,0.000021299002],"domain_scores_gemma":[0.9998739,0.000030561325,0.000027846421,0.00001962717,0.000015615451,0.00003245991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011589514,0.00029758827,0.0001932504,0.00025543055,0.00020585838,0.00019136233,0.0002707485,0.00030269392,0.0015560366],"category_scores_gemma":[0.00011936058,0.00010629489,0.0002390214,0.00021259424,0.00013161032,0.00011028637,0.00012690174,0.00048801288,0.0007161737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110181456,0.00006327454,0.001082105,0.000025341395,0.0000095401165,0.00061925116,0.00002578159,0.00013337031,0.99629945,0.00014483134,0.00024291214,0.0012440808],"study_design_scores_gemma":[0.000055719785,0.0006606926,0.015313309,0.0000055989126,0.00004109683,0.0041262973,0.000052087787,0.0030856463,0.971009,0.00006952371,0.0055712988,0.0000098567325],"about_ca_topic_score_codex":0.002335818,"about_ca_topic_score_gemma":0.0027441084,"teacher_disagreement_score":0.002335818,"about_ca_system_score_codex":0.00037212827,"about_ca_system_score_gemma":0.00023043177,"threshold_uncertainty_score":0.0052054524},"labels":[],"label_agreement":null},{"id":"W2145256943","doi":"10.1093/neuonc/nos225","title":"LAB-MOLECULAR EPIDEMIOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"thermodynamics and calorimetric analyses","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epidemiology; Computer science; Computational biology; Medicine; Biology; Internal medicine","score_opus":0.03668922759514117,"score_gpt":0.3275943521789436,"score_spread":0.29090512458380247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145256943","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2840891,0.028995764,0.059569936,0.04094573,0.005033933,0.0032850578,0.23516688,0.0016972496,0.34121642],"genre_scores_gemma":[0.7758885,0.013233142,0.017155387,0.013271385,0.004002098,0.004116802,0.03854028,0.000388241,0.13340409],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623495,0.0016881124,0.0003071746,0.00077804865,0.0005337248,0.00045790276],"domain_scores_gemma":[0.9931513,0.0013527641,0.0018481667,0.0010966818,0.0016971428,0.00085398636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026031719,0.0005620918,0.0006144392,0.0038025104,0.001154015,0.0019182429,0.0009124368,0.0007874659,0.048644543],"category_scores_gemma":[0.011984236,0.0003770539,0.0006373048,0.004618869,0.0006369966,0.0013467836,0.0017539974,0.0015576385,0.0132190585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004269361,0.0002771097,0.7229626,0.00074700307,0.00035256072,0.0004952017,0.00050273095,0.0004813202,0.0010828924,0.021700302,0.113989435,0.136982],"study_design_scores_gemma":[0.00010561752,0.0005332319,0.5267445,0.0009682853,0.00036440475,0.002946751,0.001917771,0.0014512241,0.0023430607,0.023711633,0.4388385,0.00007503566],"about_ca_topic_score_codex":0.0073352503,"about_ca_topic_score_gemma":0.00487539,"teacher_disagreement_score":0.048644543,"about_ca_system_score_codex":0.0016750148,"about_ca_system_score_gemma":0.0029296235,"threshold_uncertainty_score":0.16273218},"labels":[],"label_agreement":null},{"id":"W2145559849","doi":"10.1093/neuonc/nos062","title":"The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Cost–utility analysis; Quality of life (healthcare); Spinal cord compression; Quality-adjusted life year; Willingness to pay; Surgery; Cost effectiveness; Spinal cord","score_opus":0.05638970984172216,"score_gpt":0.33026087447607083,"score_spread":0.2738711646343487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145559849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9175249,0.0377331,0.014823635,0.0029159125,0.00015455177,0.0030951463,0.012295678,0.00009633879,0.011360825],"genre_scores_gemma":[0.99013877,0.0031803378,0.003437724,0.00024874095,0.00003901984,0.00041254458,0.0019156081,0.000013750481,0.00061356596],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9966723,0.0022624456,0.00017726303,0.00018594661,0.00041645914,0.0002855466],"domain_scores_gemma":[0.990198,0.008209768,0.00057153654,0.00015434614,0.00058930524,0.00027701404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055115293,0.001399471,0.002894538,0.0028679264,0.00026029957,0.0017106419,0.0013023776,0.0011656287,0.0045377123],"category_scores_gemma":[0.016786324,0.00068649225,0.00822159,0.0032318684,0.00043383223,0.0012075059,0.0009926718,0.001372204,0.0002027674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03478962,0.0015340665,0.06367,0.006227839,0.032146763,0.00096158916,0.00020219325,0.7717305,0.0017296379,0.006175574,0.0043879044,0.0764443],"study_design_scores_gemma":[0.0061696353,0.009427478,0.08762766,0.0015729065,0.04903978,0.0013844509,0.0007052986,0.8295315,0.00113045,0.006472894,0.006589837,0.00034821808],"about_ca_topic_score_codex":0.038265146,"about_ca_topic_score_gemma":0.02795,"teacher_disagreement_score":0.038265146,"about_ca_system_score_codex":0.008108248,"about_ca_system_score_gemma":0.0040496443,"threshold_uncertainty_score":0.07608479},"labels":[],"label_agreement":null},{"id":"W2145637828","doi":"10.1093/neuonc/4.4.242","title":"Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentiallyregulate expression of vascular endothelial growth factor in human malignantastrocytoma cells","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children","funders":"National Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Angiogenesis; MAPK/ERK pathway; Vascular endothelial growth factor; Cancer research; Kinase; Biology; Cell growth; Signal transduction; Vascular endothelial growth factor A; Cell culture; Cell biology; Biochemistry","score_opus":0.0112069211047521,"score_gpt":0.23989723686627287,"score_spread":0.22869031576152077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145637828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965389,0.0011727927,0.0008517184,0.000034946388,0.000018331275,0.000012729057,0.00015278344,0.000022910377,0.0011950164],"genre_scores_gemma":[0.9960282,0.0010111065,0.0012770697,0.00003309113,0.000009657715,0.00004530801,0.00034670564,0.000006695748,0.0012422473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986196,0.000020759238,0.000014021589,0.000020120966,0.000040147996,0.00004286328],"domain_scores_gemma":[0.99993587,0.000013174194,0.000011575184,0.000010889736,0.000010814929,0.000017658533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010989952,0.00018751936,0.00018825225,0.00020668954,0.00014533501,0.00024569183,0.0000850734,0.00013786652,0.0005020605],"category_scores_gemma":[0.00012656313,0.00015031664,0.0001671772,0.00019056116,0.00015544427,0.000099180346,0.0001010801,0.00017710819,0.00021623293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000204072,0.000030419153,0.00045266113,0.000019741316,0.0000044407225,0.000064622385,0.000025405734,0.000046150963,0.9980129,0.00010525394,0.000031923293,0.0010024211],"study_design_scores_gemma":[0.00003786695,0.00060446037,0.013701932,0.0000033592996,0.00003022142,0.00047261725,0.000048618695,0.00083885645,0.9811662,0.00006620572,0.0030242626,0.0000054349834],"about_ca_topic_score_codex":0.0008582624,"about_ca_topic_score_gemma":0.0013611232,"teacher_disagreement_score":0.0008582624,"about_ca_system_score_codex":0.00028710417,"about_ca_system_score_gemma":0.00023143782,"threshold_uncertainty_score":0.0020830631},"labels":[],"label_agreement":null},{"id":"W2146824695","doi":"10.1093/neuonc/nor086","title":" -aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; DUSA Pharmaceuticals","keywords":"Protoporphyrin IX; Malignancy; Ex vivo; Pathology; Glioma; Biopsy; In vivo; Immunohistochemistry; Medicine; Biomarker; Photodynamic therapy; Chemistry; Cancer research; Biology","score_opus":0.10730021034249637,"score_gpt":0.3928206880087695,"score_spread":0.28552047766627314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146824695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620277,0.00071567204,0.0027784298,0.000015272659,0.0000011794149,0.000008280216,0.000056348013,0.00002093424,0.00020112582],"genre_scores_gemma":[0.99795026,0.00025480462,0.0015134471,0.000009847835,0.0000017178705,0.000010689693,0.00007883585,0.000003850066,0.00017664736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986017,0.00004105292,0.000014095438,0.000033163997,0.000038927996,0.0000126086],"domain_scores_gemma":[0.99962234,0.000089601366,0.00016408981,0.00003093668,0.0000623104,0.000030714727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029560603,0.00017881967,0.00014734153,0.0005576244,0.00008780198,0.00031207356,0.000092356204,0.00024785692,0.00060229155],"category_scores_gemma":[0.00053184695,0.00013448643,0.00006137766,0.00025422886,0.00024940414,0.00022918417,0.00013309345,0.00020591785,0.00012874597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064417865,0.00004249548,0.14128698,0.00009573902,0.00004333173,0.00015125846,0.0001042689,0.00027699067,0.8491843,0.000052895302,0.000028741597,0.008089021],"study_design_scores_gemma":[0.000008192993,0.000672647,0.70155066,0.000009891669,0.000049879924,0.0020175762,0.00020619776,0.0015475876,0.2933554,0.00009081621,0.0004793599,0.000011778574],"about_ca_topic_score_codex":0.00043670036,"about_ca_topic_score_gemma":0.0005016785,"teacher_disagreement_score":0.00060229155,"about_ca_system_score_codex":0.00016590315,"about_ca_system_score_gemma":0.00007544925,"threshold_uncertainty_score":0.002014935},"labels":[],"label_agreement":null},{"id":"W2146892073","doi":"10.1093/neuonc/not241","title":"Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Amifostine; Medicine; Ototoxicity; Medulloblastoma; Hearing loss; Cisplatin; Internal medicine; Oncology; Anesthesia; Audiology; Chemotherapy; Pathology","score_opus":0.05333984520535781,"score_gpt":0.32034138558886,"score_spread":0.2670015403835022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146892073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978005,0.0017370112,0.00011932498,0.000045087072,0.00000552001,0.000029465175,0.0000929046,0.000005931822,0.00016425062],"genre_scores_gemma":[0.999241,0.00037348765,0.00021194071,0.000026407268,0.000008549197,0.00001176653,0.00009634417,0.0000014636207,0.00002908073],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99897075,0.0004676344,0.00011468742,0.00013582008,0.00024306594,0.00006812394],"domain_scores_gemma":[0.99603736,0.0018619075,0.001356725,0.00011227299,0.00020268219,0.00042900044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020049221,0.0002573902,0.00073127996,0.0003097423,0.00015151507,0.00035518914,0.00037646524,0.0002784626,0.0007898016],"category_scores_gemma":[0.0038283821,0.00011882762,0.0009474241,0.00034906037,0.00033138035,0.00038538003,0.00027479243,0.00051498995,0.00006991522],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016525866,0.00030459327,0.9513941,0.0002755308,0.0009929553,0.00017001142,0.000082691644,0.0002931204,0.0025515384,0.000032942506,0.0001280122,0.027248608],"study_design_scores_gemma":[0.0010351049,0.035130724,0.9550629,0.00006532183,0.0013711317,0.0013416476,0.00013107502,0.0008715768,0.0038595167,0.00005074584,0.001067107,0.000013135851],"about_ca_topic_score_codex":0.0009037593,"about_ca_topic_score_gemma":0.0022231648,"teacher_disagreement_score":0.0020049221,"about_ca_system_score_codex":0.000721119,"about_ca_system_score_gemma":0.0009054168,"threshold_uncertainty_score":0.0106031895},"labels":[],"label_agreement":null},{"id":"W2147149348","doi":"10.1093/neuonc/nov061.161","title":"TR-16 * PERSONALIZED TARGETED THERAPY IN REFRACTORY OR RELAPSED CANCER IN CHILDHOOD (TRICEPS STUDY)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Refractory (planetary science); Childhood cancer; Medicine; Oncology; Cancer; Internal medicine; Biology","score_opus":0.06703108966690846,"score_gpt":0.37467007608657604,"score_spread":0.3076389864196676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147149348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9356684,0.00542246,0.0010907372,0.002331208,0.0001764713,0.0012312894,0.030706855,0.00017899492,0.02319364],"genre_scores_gemma":[0.9162548,0.008918583,0.009961684,0.00367672,0.00025132578,0.0019222306,0.044939417,0.00020351914,0.013871748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99962974,0.00019273067,0.000023613351,0.000041317224,0.000051907053,0.0000606907],"domain_scores_gemma":[0.99934644,0.000109033106,0.00018843471,0.000080721715,0.000060107828,0.00021516842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009754475,0.0002760026,0.00048041882,0.00020602746,0.00026001333,0.0005433195,0.00036743208,0.0003871097,0.0029609138],"category_scores_gemma":[0.00085674884,0.00013399463,0.0006889412,0.00046752387,0.00022815663,0.00027742962,0.0003457575,0.0007752529,0.0005824513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13265328,0.0065824906,0.21282206,0.0026097135,0.003187854,0.0015609056,0.0005946104,0.009719568,0.032857873,0.005117541,0.10052192,0.49177226],"study_design_scores_gemma":[0.09324016,0.1252139,0.5669876,0.0014630115,0.0030710406,0.0050328067,0.00059641787,0.004106102,0.013342582,0.0015254077,0.18529864,0.00012240694],"about_ca_topic_score_codex":0.0040731793,"about_ca_topic_score_gemma":0.0075032944,"teacher_disagreement_score":0.0040731793,"about_ca_system_score_codex":0.00061769085,"about_ca_system_score_gemma":0.0012723368,"threshold_uncertainty_score":0.009905279},"labels":[],"label_agreement":null},{"id":"W2147818127","doi":"10.1093/neuonc/nou154","title":"Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Accelerate Brain Cancer Cure","keywords":"Clinical trial; Medicine; Malignancy; Steering committee; Oncology; Internal medicine; Intensive care medicine","score_opus":0.24002136536680324,"score_gpt":0.46672973236684123,"score_spread":0.226708367000038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147818127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031600716,0.46396393,0.011269509,0.32736865,0.11006893,0.029384851,0.013030268,0.00042780951,0.041326005],"genre_scores_gemma":[0.022704458,0.55034685,0.029109601,0.2205688,0.04406221,0.05043303,0.015888238,0.00046374946,0.066423126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98338014,0.0080326265,0.0022684294,0.00077862566,0.0047381176,0.0008019935],"domain_scores_gemma":[0.96319306,0.010096168,0.0054305354,0.00094230927,0.016144773,0.0041931523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06678135,0.0013205581,0.0023247965,0.001848485,0.00085318997,0.00412175,0.003619628,0.0063838945,0.00979214],"category_scores_gemma":[0.046943184,0.00082442595,0.0042523555,0.0020361722,0.0007841663,0.0025226767,0.0030089896,0.006547932,0.0065208743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011729926,0.00015147818,0.0004935026,0.013773351,0.00056072726,0.00023501662,0.00025734105,0.00042830515,0.0009526056,0.0025056703,0.81781226,0.16165668],"study_design_scores_gemma":[0.0010859668,0.00024828332,0.0010011164,0.017463267,0.00069629925,0.00022838142,0.00011517981,0.00014791328,0.0006450527,0.0016176245,0.9767005,0.000050473187],"about_ca_topic_score_codex":0.00228811,"about_ca_topic_score_gemma":0.003555383,"teacher_disagreement_score":0.06678135,"about_ca_system_score_codex":0.0031313775,"about_ca_system_score_gemma":0.024421783,"threshold_uncertainty_score":0.35317773},"labels":[],"label_agreement":null},{"id":"W2148601670","doi":"10.1093/neuonc/2.4.221","title":"Effect of disease burden on health-related quality of life in patientswith malignant gliomas","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Anaplastic astrocytoma; Radiation therapy; Cancer; Physical therapy; Glioma; Internal medicine; Glioblastoma; Astrocytoma; Oncology","score_opus":0.021737943600023013,"score_gpt":0.3278164074486318,"score_spread":0.30607846384860876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148601670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977584,0.0013786,0.000026140866,0.00018549035,0.0000074306326,0.000004867094,0.000111701636,0.0000025507527,0.0005249334],"genre_scores_gemma":[0.99949944,0.00024862582,0.000026630634,0.00003425584,0.000012101492,0.0000037054497,0.00013061987,6.312136e-7,0.000043872715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993529,0.0002781842,0.00006374775,0.000045522498,0.00013667846,0.00012307578],"domain_scores_gemma":[0.9966215,0.00079572125,0.0017707973,0.0000733139,0.00024714365,0.0004914926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052103255,0.00020447903,0.00048316855,0.0004223621,0.00029579943,0.00047456287,0.00015792491,0.00029335075,0.0008031019],"category_scores_gemma":[0.006328034,0.000088228764,0.00047345678,0.0006005782,0.00019122205,0.0003744294,0.00039906963,0.00041362495,0.000113946015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028914536,0.000059978312,0.989398,0.00003640638,0.0001306126,0.00015543577,0.00011691869,0.00012389595,0.00011727392,0.000016864182,0.00023004298,0.009325528],"study_design_scores_gemma":[0.000010715172,0.0001708651,0.9990656,0.000008052931,0.000041542084,0.00028263946,0.000092137714,0.00014517612,0.000017026608,0.000018135604,0.00014375555,0.000004309605],"about_ca_topic_score_codex":0.0024802312,"about_ca_topic_score_gemma":0.0046828003,"teacher_disagreement_score":0.0024802312,"about_ca_system_score_codex":0.00038073765,"about_ca_system_score_gemma":0.00019582998,"threshold_uncertainty_score":0.004931569},"labels":[],"label_agreement":null},{"id":"W2148970735","doi":"10.1215/15228517-2008-007","title":"Patients' perception of the informed consent process for neurooncology clinical trials","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Informed consent; Clinical trial; Context (archaeology); Autonomy; Qualitative research; Medicine; Safeguarding; Research ethics; Coercion (linguistics); Voluntariness; Deception; Psychology; Alternative medicine; Nursing; Social psychology; Psychiatry","score_opus":0.7314667956714098,"score_gpt":0.6610723385141715,"score_spread":0.07039445715723835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148970735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7476723,0.012411355,0.026188677,0.17173614,0.0011677522,0.0017461193,0.00015155639,0.00013034412,0.038795736],"genre_scores_gemma":[0.98144126,0.0020544967,0.005496716,0.009547436,0.00019508348,0.0004348256,0.000027408145,0.000018562618,0.0007842088],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.5595343,0.4001651,0.016579729,0.0025355148,0.016600609,0.0045848056],"domain_scores_gemma":[0.5067075,0.4265264,0.035439115,0.0069926386,0.014189645,0.01014477],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.20059276,0.0004084629,0.0008451894,0.0014886865,0.0067665935,0.010865378,0.0017451838,0.0068965023,0.0032106235],"category_scores_gemma":[0.37554172,0.00077964837,0.0010297054,0.00115599,0.01372485,0.006800874,0.006628187,0.008829239,0.00056064955],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008317681,0.00024218555,0.016675739,0.0016219341,0.00010701794,0.0041469545,0.85986596,0.0006947741,0.0020719229,0.036627233,0.006523647,0.07059084],"study_design_scores_gemma":[0.00039849957,0.0017287441,0.009094901,0.004022894,0.00013537523,0.010528916,0.80457085,0.0018076404,0.0017380442,0.040690415,0.12485568,0.00042810192],"about_ca_topic_score_codex":0.0016203483,"about_ca_topic_score_gemma":0.0014170578,"teacher_disagreement_score":0.9931035,"about_ca_system_score_codex":0.0050553842,"about_ca_system_score_gemma":0.014033859,"threshold_uncertainty_score":0.9858115},"labels":[],"label_agreement":null},{"id":"W2149500930","doi":"10.1093/neuonc/not138","title":"Physical functioning in pediatric survivors of childhood posterior fossa brain tumors","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cohort; Medulloblastoma; Normative; Balance (ability); Gross motor skill; Medicine; Psychology; Motor coordination; Physical therapy; Motor skill; Physical medicine and rehabilitation; Developmental psychology; Psychiatry; Internal medicine; Pathology","score_opus":0.0108666998443102,"score_gpt":0.2630655447072013,"score_spread":0.25219884486289107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149500930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916446,0.00030557692,0.000028996312,0.000029775973,0.0000035473174,0.000006948875,0.0002785033,0.0000026583946,0.00017946304],"genre_scores_gemma":[0.9987914,0.0003916959,0.00007020153,0.000018561557,0.0000067406863,0.000021115462,0.00061692507,0.0000019193046,0.00008146278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996306,0.00008121514,0.000027444858,0.00006654504,0.000106234176,0.000088094486],"domain_scores_gemma":[0.9987987,0.00016006577,0.0006709982,0.00003038037,0.00015005514,0.00018974935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006790746,0.000281598,0.00034018,0.0006722961,0.00028638053,0.00034885877,0.0002464245,0.00022306113,0.0011008852],"category_scores_gemma":[0.002043037,0.0001429617,0.00032230743,0.00062926573,0.00024877553,0.0003460985,0.00045193272,0.00047078848,0.0001435176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027783304,0.000015243431,0.9982052,0.000009904364,0.00001351591,0.00006158407,0.00007537412,0.000020346033,0.000054352266,0.0000031641218,0.00007153361,0.0014420031],"study_design_scores_gemma":[0.0000014663871,0.000091235874,0.999382,0.0000052677656,0.000007730711,0.0002483532,0.00011607834,0.000020423262,0.00002816255,0.0000032688406,0.00009506303,9.205797e-7],"about_ca_topic_score_codex":0.0060042674,"about_ca_topic_score_gemma":0.008300888,"teacher_disagreement_score":0.0060042674,"about_ca_system_score_codex":0.00038864068,"about_ca_system_score_gemma":0.00039743903,"threshold_uncertainty_score":0.011938632},"labels":[],"label_agreement":null},{"id":"W2151178589","doi":"10.1093/neuonc/nop001","title":"Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; Loss of heterozygosity; SNP array; Genetics; Single-nucleotide polymorphism; Computational biology; SNP; Copy-number variation; Gene; SNP genotyping; Genome; Cancer research; Genotype; Allele","score_opus":0.024823293944930658,"score_gpt":0.2787654453868649,"score_spread":0.2539421514419342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151178589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968432,0.0006193356,0.0013320756,0.00003911851,0.000002797414,0.000006624394,0.00094288203,0.00003429944,0.0001797263],"genre_scores_gemma":[0.99319917,0.0008476235,0.0037925227,0.000052869673,0.000007668938,0.00002576834,0.0018715473,0.000020994054,0.0001817609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997106,0.00003894969,0.000027951857,0.00008191295,0.00009509501,0.00004540848],"domain_scores_gemma":[0.99969685,0.00009224571,0.00012835453,0.000019118268,0.00003451721,0.00002885041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021700082,0.00019143241,0.00028811212,0.00088208506,0.00011657947,0.00036145962,0.0001478441,0.00020669763,0.00047606434],"category_scores_gemma":[0.0006388138,0.00013685628,0.00018081178,0.00090476306,0.00015621753,0.00010824777,0.0002257269,0.00022295056,0.0001572231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048527782,0.000038974576,0.63694596,0.00012382386,0.00015852484,0.000985755,0.000221226,0.0010691569,0.3269498,0.00016311706,0.00045389117,0.03240442],"study_design_scores_gemma":[0.000005672252,0.000083680396,0.9695025,0.000007876824,0.00007119956,0.0015455673,0.00012063466,0.0007434924,0.026608959,0.00013173578,0.0011720596,0.0000066092152],"about_ca_topic_score_codex":0.0012513293,"about_ca_topic_score_gemma":0.0025936968,"teacher_disagreement_score":0.0012513293,"about_ca_system_score_codex":0.00020679242,"about_ca_system_score_gemma":0.00022316641,"threshold_uncertainty_score":0.0024881363},"labels":[],"label_agreement":null},{"id":"W2151874651","doi":"10.1215/15228517-2005-009","title":"High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up","year":2006,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; ThioTEPA; Lomustine; Procarbazine; Oligodendroglioma; Surgery; Internal medicine; Vincristine; Oncology; Chemotherapy; Glioma; Astrocytoma; Cyclophosphamide","score_opus":0.018358193755660997,"score_gpt":0.2909703553038736,"score_spread":0.2726121615482126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151874651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973164,0.001623117,0.0002940173,0.00006176246,0.000017461087,0.00010772222,0.00012370535,0.000011702367,0.00044401467],"genre_scores_gemma":[0.9978411,0.0004734928,0.000264102,0.00019704319,0.000050009683,0.00016166465,0.0006837043,0.0000039293927,0.00032491825],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995252,0.0001919052,0.000040714553,0.000058092537,0.000072362935,0.00011170879],"domain_scores_gemma":[0.99910647,0.00023300806,0.00018684249,0.0000859575,0.00006980648,0.00031786342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014152271,0.00042496866,0.001342773,0.00026887067,0.000575115,0.00056458835,0.00028279363,0.00044059684,0.00053548673],"category_scores_gemma":[0.00093402725,0.00016937764,0.0008604902,0.00029269312,0.00032469825,0.0004239769,0.00034179437,0.0010495886,0.00017219252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23802227,0.029293586,0.27312526,0.00073448237,0.0037776125,0.002065131,0.00085372664,0.005532257,0.085952014,0.00018638809,0.0018938928,0.35856345],"study_design_scores_gemma":[0.036000345,0.47370422,0.45553493,0.000082427694,0.0027543756,0.0022399663,0.00014806382,0.002577748,0.020548198,0.00029321,0.0060495273,0.00006708875],"about_ca_topic_score_codex":0.00041132804,"about_ca_topic_score_gemma":0.0008756821,"teacher_disagreement_score":0.0014152271,"about_ca_system_score_codex":0.00037135408,"about_ca_system_score_gemma":0.00043887235,"threshold_uncertainty_score":0.0074844956},"labels":[],"label_agreement":null},{"id":"W2152840183","doi":"10.1093/neuonc/nop017","title":"A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Toxicity; Pharmacokinetics; Gastroenterology; Diarrhea; Pharmacology; Internal medicine; Chemotherapy; Phases of clinical research; Oncology; Cancer; Epidermal growth factor receptor","score_opus":0.01769246670536518,"score_gpt":0.3037294282658909,"score_spread":0.2860369615605257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152840183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914287,0.0031014911,0.00041565835,0.00047179832,0.000119667704,0.0018475977,0.0004237114,0.000082028804,0.002109246],"genre_scores_gemma":[0.98994887,0.002222128,0.0011473141,0.0008917274,0.00013554758,0.002250629,0.0013284031,0.000018864837,0.0020564864],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99968207,0.00014410446,0.000021630896,0.00004816594,0.000026283471,0.00007760615],"domain_scores_gemma":[0.9994431,0.000078624376,0.00013612451,0.000036719655,0.000035546087,0.0002698295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001186952,0.0012512691,0.0020579414,0.00041806477,0.00033741668,0.00065638096,0.0007373334,0.0010805206,0.0018732098],"category_scores_gemma":[0.00081077236,0.00044619985,0.0011829265,0.00042487204,0.0006128334,0.0006639526,0.0002686329,0.002095837,0.00049932103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7898781,0.03982093,0.0066870213,0.0009946155,0.00184928,0.00064101623,0.00036655224,0.00274094,0.024649307,0.00045394077,0.0049325204,0.12698567],"study_design_scores_gemma":[0.6219435,0.3571107,0.012414537,0.00004136159,0.0005443459,0.00062982785,0.00007373268,0.0012123353,0.0026041563,0.00028475007,0.0031143453,0.000026481766],"about_ca_topic_score_codex":0.0008297655,"about_ca_topic_score_gemma":0.002930851,"teacher_disagreement_score":0.0020579414,"about_ca_system_score_codex":0.0007430405,"about_ca_system_score_gemma":0.001245304,"threshold_uncertainty_score":0.006277263},"labels":[],"label_agreement":null},{"id":"W2152981221","doi":"10.1093/neuonc/nop023","title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Myeloid-derived Suppressor Cell; CD14; Glioma; Immunosuppression; Cancer research; Immunology; Integrin alpha M; Flow cytometry; In vitro; Microglia; Myeloid; Monocyte; Medicine; Cytokine; Biology; Suppressor; Cancer; Inflammation; Internal medicine","score_opus":0.023413105470987645,"score_gpt":0.25911991642882437,"score_spread":0.23570681095783672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152981221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954006,0.002180105,0.0008423646,0.00004268066,0.000019470834,0.00003509921,0.00034478286,0.000030445093,0.0011043788],"genre_scores_gemma":[0.9963875,0.0008765508,0.0009379686,0.00005863875,0.00001393349,0.000037520855,0.00072106195,0.0000033701463,0.00096350454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998276,0.000035257166,0.000018344299,0.000025371277,0.00003580866,0.000057592228],"domain_scores_gemma":[0.99991167,0.000014301293,0.000015697538,0.000012096546,0.000021433003,0.00002479145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010839879,0.0002119868,0.00021675827,0.00021505909,0.00016544474,0.00020194874,0.00006826776,0.00013832306,0.0020233537],"category_scores_gemma":[0.0001662758,0.000075202086,0.00012407442,0.00022320365,0.00009174973,0.00006547244,0.00017185841,0.00015715385,0.00067425607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023040166,0.00022370675,0.058254223,0.00023751383,0.000035880264,0.0012303655,0.00027410692,0.000109597655,0.909762,0.0003808001,0.0007017077,0.026486054],"study_design_scores_gemma":[0.00016823663,0.005451122,0.38560945,0.000082011225,0.00014881148,0.010938226,0.0007464128,0.0009348244,0.5730262,0.00043534616,0.022425745,0.000033650053],"about_ca_topic_score_codex":0.00080699206,"about_ca_topic_score_gemma":0.0009989438,"teacher_disagreement_score":0.0020233537,"about_ca_system_score_codex":0.000160714,"about_ca_system_score_gemma":0.00016463695,"threshold_uncertainty_score":0.006768763},"labels":[],"label_agreement":null},{"id":"W2155161651","doi":"10.1093/neuonc/nov061.142","title":"SG-04 * THE eEF2 KINASE, A MEDIATOR OF MEDULLOBLASTOMA ADAPTATION TO METABOLIC STRESS, SUPPORTS FATTY ACID OXIDATION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Mediator; Adaptation (eye); Beta oxidation; Metabolic adaptation; Kinase; Fatty acid; Chemistry; Biochemistry; Cell biology; Biology; Metabolism; Neuroscience","score_opus":0.017104200326810714,"score_gpt":0.2740844967710045,"score_spread":0.2569802964441938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155161651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853389,0.0028968686,0.00265059,0.00024657432,0.00009489385,0.000043566553,0.0036753814,0.00028878418,0.004764353],"genre_scores_gemma":[0.9799595,0.0012390529,0.0026619718,0.00008486132,0.000013668977,0.000032786917,0.008010263,0.00003851736,0.007959389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999361,0.0000054714033,0.0000047576873,0.000015153606,0.000020311249,0.00001826741],"domain_scores_gemma":[0.99994075,0.0000061170012,0.000013449044,0.00000688903,0.000007867181,0.000024909059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051330142,0.0003778412,0.0002406688,0.00020006135,0.00021191123,0.0002912731,0.00016703348,0.00016683595,0.0014049333],"category_scores_gemma":[0.000077927194,0.00008608344,0.00023861926,0.0002194929,0.00019979599,0.000109140376,0.00022925805,0.00035067287,0.00080271857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032687283,0.000023329389,0.0012350165,0.00004342137,0.0000067955743,0.00009884481,0.000006466406,0.000085008505,0.99452823,0.00010602983,0.00029291693,0.0032471237],"study_design_scores_gemma":[0.00003787512,0.00037040235,0.03365233,0.000013376636,0.000022879914,0.0007237506,0.000056501078,0.0015725932,0.9447671,0.00016768728,0.018607527,0.000008065402],"about_ca_topic_score_codex":0.0017308779,"about_ca_topic_score_gemma":0.0020775483,"teacher_disagreement_score":0.0017308779,"about_ca_system_score_codex":0.00039782646,"about_ca_system_score_gemma":0.00029134616,"threshold_uncertainty_score":0.004700005},"labels":[],"label_agreement":null},{"id":"W2155592661","doi":"10.1093/neuonc/4.2.123","title":"Metastatic papillary craniopharyngioma: Case study and study of tumorangiogenesis","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Craniopharyngioma; Vascularity; Pathology; Medicine; Papillary tumor; Craniotomy; Immunohistochemistry; Radiology","score_opus":0.04283373726850656,"score_gpt":0.31071076470264797,"score_spread":0.26787702743414143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155592661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909642,0.0023732556,0.0016506037,0.0005448122,0.00007510224,0.00006659937,0.00012118928,0.00009093284,0.004113317],"genre_scores_gemma":[0.99733716,0.0007661502,0.000826025,0.000107955755,0.00019103351,0.000018182542,0.00006115611,0.000013329326,0.00067901163],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99967265,0.000031100884,0.000029955612,0.00008155293,0.000057970927,0.00012691876],"domain_scores_gemma":[0.9988422,0.000321995,0.0002120449,0.0001955895,0.00007977783,0.00034844098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038692096,0.0013045097,0.0006895915,0.0015516335,0.002338502,0.0011730398,0.00082077953,0.0033747547,0.0017564093],"category_scores_gemma":[0.0020830878,0.000957179,0.0008809411,0.000856646,0.0012744841,0.0012090304,0.0011666102,0.0018702238,0.00085607474],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041245363,0.000043236763,0.008464702,0.000021280855,0.0000094221205,0.98787594,0.00030877403,0.00006843442,0.0016979504,0.00015966686,0.000108557986,0.0012007316],"study_design_scores_gemma":[0.000008435252,0.00006235329,0.0041192225,0.000004164395,0.0000083640725,0.99462944,0.00008652358,0.00012750202,0.0004455927,0.00009421793,0.0004066302,0.0000075896824],"about_ca_topic_score_codex":0.002630165,"about_ca_topic_score_gemma":0.0026237906,"teacher_disagreement_score":0.0033747547,"about_ca_system_score_codex":0.00080415414,"about_ca_system_score_gemma":0.00064360985,"threshold_uncertainty_score":0.0058757663},"labels":[],"label_agreement":null},{"id":"W2156531035","doi":"10.1093/neuonc/nou145","title":"SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer stem cell; Neural stem cell; Cancer research; Glioma; Biology; Stem cell; Cancer; Cancer cell; Neurosphere; Cell biology; Cellular differentiation; Adult stem cell; Genetics; Gene","score_opus":0.0335870261447588,"score_gpt":0.3149489624551224,"score_spread":0.2813619363103636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156531035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937512,0.0012495952,0.0026089868,0.00011787341,0.00003291143,0.000012257917,0.00060913415,0.00014992406,0.0014681031],"genre_scores_gemma":[0.9960517,0.0003667599,0.0012798029,0.000028023476,0.0000058336327,0.000009492935,0.0010650088,0.000020097674,0.0011732562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989676,0.000014200875,0.000010746487,0.000026217134,0.000030669296,0.000021496184],"domain_scores_gemma":[0.99981564,0.00001605174,0.00008136779,0.0000197647,0.000018823923,0.000048281792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093482464,0.00023997178,0.00018854543,0.0002026758,0.00017171916,0.00025474155,0.0002433827,0.00020508529,0.0016806129],"category_scores_gemma":[0.00013312657,0.00010112974,0.00025930358,0.00014218542,0.0002687638,0.00014802424,0.00015086246,0.00028566198,0.000592908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014337274,0.000024132947,0.0007136558,0.00004023852,0.0000073475867,0.00011228436,0.000014418263,0.000041976527,0.99739397,0.00017920637,0.000082985294,0.0012464498],"study_design_scores_gemma":[0.000015030868,0.00013628812,0.021782786,0.0000071515224,0.000029046016,0.00074299,0.00004157056,0.0009879771,0.97141653,0.00013001566,0.0047041066,0.000006445409],"about_ca_topic_score_codex":0.0004910027,"about_ca_topic_score_gemma":0.0008800518,"teacher_disagreement_score":0.0016806129,"about_ca_system_score_codex":0.00030771169,"about_ca_system_score_gemma":0.00022696459,"threshold_uncertainty_score":0.005622208},"labels":[],"label_agreement":null},{"id":"W2158585200","doi":"10.1215/15228517-2007-028","title":"Neurocognitive function in same-sex twins following focal radiation for medulloblastoma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurocognitive; Medulloblastoma; Cognition; Medicine; Social competence; Radiation therapy; Psychology; Pediatrics; Surgery; Psychiatry; Pathology; Social change","score_opus":0.021312282685982502,"score_gpt":0.3162762710732093,"score_spread":0.2949639883872268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158585200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99971694,0.000069835216,0.000044906024,0.000016746262,0.000006210411,0.0000042234838,0.00002010466,0.0000011450172,0.00011974026],"genre_scores_gemma":[0.9996594,0.000078197234,0.00008265066,0.000011369935,0.0000043532223,0.0000037180366,0.000037042144,0.0000019304377,0.0001213471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958974,0.0000863976,0.000052522028,0.0000794498,0.00011270286,0.00007912269],"domain_scores_gemma":[0.9991667,0.00015379554,0.00033068715,0.00007577215,0.000095626696,0.00017748498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049069856,0.00039943025,0.00052105734,0.0013016684,0.0010962235,0.00053566793,0.00041153491,0.000455429,0.0005789461],"category_scores_gemma":[0.0038677445,0.0003499305,0.00040046618,0.0005585627,0.0007453379,0.0002319753,0.0006844237,0.00054370775,0.00009619758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012475136,0.00030354585,0.92331606,0.000035481426,0.00014125122,0.05378417,0.0029073171,0.00017991445,0.0093170395,0.00029231893,0.00017596544,0.008299429],"study_design_scores_gemma":[0.0000405393,0.0012086444,0.87545115,0.00002056239,0.0001470354,0.116568364,0.0020665007,0.0004750543,0.0033091002,0.00022144275,0.00045955385,0.000032214884],"about_ca_topic_score_codex":0.013954371,"about_ca_topic_score_gemma":0.017534371,"teacher_disagreement_score":0.013954371,"about_ca_system_score_codex":0.00093457167,"about_ca_system_score_gemma":0.00048139726,"threshold_uncertainty_score":0.02774632},"labels":[],"label_agreement":null},{"id":"W2158757736","doi":"10.1093/neuonc/not026","title":"Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Craniopharyngioma; Medicine; Diabetes insipidus; Body mass index; Pediatrics; Endocrine system; Obesity; Surgery; Internal medicine","score_opus":0.021566036764271407,"score_gpt":0.2972277741918184,"score_spread":0.27566173742754696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158757736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799314,0.013592387,0.00025174743,0.00070179714,0.000037442547,0.000015549542,0.0031738982,0.000034030305,0.0022617308],"genre_scores_gemma":[0.984133,0.010990995,0.00037950475,0.00016492947,0.000070099035,0.000025367493,0.0038651535,0.000014906439,0.0003559108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992816,0.000062426894,0.00018578082,0.00011657119,0.000223871,0.00012982423],"domain_scores_gemma":[0.99650276,0.0003999795,0.0022332894,0.00005683697,0.00051001203,0.00029715252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006318246,0.00020027108,0.00021346459,0.0021664165,0.00037909986,0.0005714494,0.00040099164,0.00037268334,0.0009450084],"category_scores_gemma":[0.0034387135,0.00016386875,0.00038644415,0.003043043,0.00034982522,0.0006299867,0.00038448686,0.00054546143,0.00021874956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006724841,0.000029989711,0.9835332,0.000099881276,0.000046926987,0.0003607244,0.00018233179,0.00021550851,0.00022899405,0.000067507615,0.0008898073,0.014277932],"study_design_scores_gemma":[0.0000036207161,0.000057405687,0.99567634,0.00005095572,0.000026404212,0.0020309333,0.00029665927,0.00008425915,0.00017209994,0.000012783192,0.0015839619,0.0000045595784],"about_ca_topic_score_codex":0.019746002,"about_ca_topic_score_gemma":0.03320916,"teacher_disagreement_score":0.019746002,"about_ca_system_score_codex":0.0020918008,"about_ca_system_score_gemma":0.0012801406,"threshold_uncertainty_score":0.039262116},"labels":[],"label_agreement":null},{"id":"W2159481232","doi":"10.1093/neuonc/nos160","title":"Clinical and neuroanatomical predictors of cerebellar mutism syndrome","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children; University of Calgary","funders":"Pediatric Oncology Group of Ontario; C17 Council","keywords":"Cerebellum; Medicine; White matter; Medulloblastoma; Magnetic resonance imaging; Psychology; Pathology; Radiology; Internal medicine","score_opus":0.06592830632750624,"score_gpt":0.39698570053557347,"score_spread":0.33105739420806723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159481232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959606,0.00008556637,0.000037669583,0.0000167259,0.0000014230471,0.0000032623489,0.000055919463,0.0000026056264,0.00020077353],"genre_scores_gemma":[0.9997267,0.00005803746,0.00006734011,0.0000052628675,0.0000045673773,0.0000048611273,0.00009681369,0.0000013283259,0.00003513771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996989,0.000059276746,0.00004075372,0.00006770844,0.00007158847,0.000061747676],"domain_scores_gemma":[0.99766845,0.0006006235,0.0011072218,0.00005338234,0.00016743528,0.0004027914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027235423,0.00039730646,0.00022358494,0.0009917435,0.00036303158,0.000389488,0.00026826534,0.00042119308,0.0015227324],"category_scores_gemma":[0.003188584,0.00021054091,0.0001593334,0.0005772463,0.00052874617,0.00040275237,0.00042487917,0.0004166249,0.00017630079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002606913,0.0000070674914,0.99898916,0.0000018477524,0.000004340258,0.00028641568,0.000015521258,0.000030598472,0.00022269113,0.000008126002,0.00002004505,0.00038820953],"study_design_scores_gemma":[0.0000023154396,0.000047649428,0.997776,0.000002996853,0.0000059175845,0.0018202466,0.00009284846,0.000120586345,0.00008271339,0.000015725525,0.000031180676,0.0000018069728],"about_ca_topic_score_codex":0.0031953186,"about_ca_topic_score_gemma":0.0040099295,"teacher_disagreement_score":0.0031953186,"about_ca_system_score_codex":0.00026452672,"about_ca_system_score_gemma":0.00045250388,"threshold_uncertainty_score":0.006353438},"labels":[],"label_agreement":null},{"id":"W2160069052","doi":"10.1093/neuonc/nou099","title":"Incidence of brain metastasis at initial presentation of lung cancer","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"National Cancer Institute","keywords":"Lung cancer; Medicine; Cancer registry; Incidence (geometry); Brain metastasis; Cancer; Metastasis; Population; Stage (stratigraphy); Oncology; Internal medicine; Lung; Presentation (obstetrics); Surgery; Biology","score_opus":0.031008955155488592,"score_gpt":0.3815949542672334,"score_spread":0.3505859991117448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160069052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347275,0.00086649245,0.0003318366,0.00009047223,0.00000467961,0.000023813205,0.0032225694,0.00003757199,0.0019496833],"genre_scores_gemma":[0.9982304,0.00018842937,0.000101300575,0.000012251392,0.000004718785,0.0000056145977,0.0013506421,0.0000022759873,0.00010432927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995559,0.00006831853,0.000036516,0.00008631431,0.00016836316,0.00008467301],"domain_scores_gemma":[0.9977089,0.0002637441,0.001278888,0.00010357071,0.00036690547,0.0002779486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005026107,0.00012969945,0.0001681633,0.0015595477,0.00020357968,0.00044655136,0.00038415106,0.00018078729,0.0014911068],"category_scores_gemma":[0.002037625,0.00009392352,0.00018722583,0.0012130494,0.00022006455,0.00019885428,0.00031425906,0.00029283407,0.00018764636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016613549,0.0000027219623,0.99830496,0.000010249348,0.000016788847,0.00005507876,0.000014681569,0.00008662494,0.00012813843,0.000018244187,0.00016004355,0.0011859013],"study_design_scores_gemma":[0.000001405731,0.000017280907,0.99906653,0.00000919201,0.000009689836,0.0003556909,0.00004132038,0.00012440186,0.00008940246,0.000022262524,0.00026076063,0.000002159906],"about_ca_topic_score_codex":0.098031044,"about_ca_topic_score_gemma":0.119192064,"teacher_disagreement_score":0.098031044,"about_ca_system_score_codex":0.0013092073,"about_ca_system_score_gemma":0.001422863,"threshold_uncertainty_score":0.1949209},"labels":[],"label_agreement":null},{"id":"W2160137787","doi":"10.1093/neuonc/nop015","title":"A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Glioma; Internal medicine; Epidermal growth factor receptor; Oncology; Anaplastic astrocytoma; Erlotinib Hydrochloride; Gastroenterology; Cancer research; Cancer; Astrocytoma","score_opus":0.016010579187137056,"score_gpt":0.3083108920151955,"score_spread":0.29230031282805846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160137787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518174,0.0013783148,0.000297252,0.0002772919,0.000078531724,0.0013432798,0.0003934075,0.00007976979,0.0009703503],"genre_scores_gemma":[0.9917754,0.0014327283,0.00087216106,0.0005295643,0.00012203617,0.0020010017,0.0012684581,0.000019271873,0.0019793496],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996741,0.00015528827,0.000018481142,0.000046656332,0.00002359074,0.00008195066],"domain_scores_gemma":[0.99951375,0.00007120871,0.00009911784,0.00004208067,0.000030031337,0.00024375395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011260562,0.0015663742,0.0019244519,0.0003844656,0.00030693496,0.0007383733,0.0007935786,0.0010570523,0.0025960207],"category_scores_gemma":[0.0007051387,0.00043476766,0.0009580234,0.00040137736,0.0006341424,0.0006395714,0.00029235595,0.001976487,0.00076807477],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84677726,0.03185,0.005419678,0.0008282086,0.0011939335,0.00048230586,0.00032234684,0.0017439888,0.02354183,0.00030368764,0.0031848373,0.08435196],"study_design_scores_gemma":[0.69628716,0.2873013,0.010405334,0.000029016428,0.00033403805,0.00047903942,0.00006842126,0.0012767065,0.0016714935,0.00017144062,0.0019485168,0.000027480743],"about_ca_topic_score_codex":0.0009824346,"about_ca_topic_score_gemma":0.003092047,"teacher_disagreement_score":0.0025960207,"about_ca_system_score_codex":0.0006377575,"about_ca_system_score_gemma":0.0009328764,"threshold_uncertainty_score":0.008684576},"labels":[],"label_agreement":null},{"id":"W2163578269","doi":"10.1093/neuonc/nou263.10","title":"NC-10 * TRAINING THE BRAIN TO REPAIR ITSELF: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"White matter; Atrophy; Medicine; Fractional anisotropy; Hippocampal formation; Effects of sleep deprivation on cognitive performance; Cognition; Randomized controlled trial; Aerobic exercise; Working memory; Psychology; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Neuroscience; Magnetic resonance imaging","score_opus":0.03290559737874166,"score_gpt":0.3259786453511155,"score_spread":0.2930730479723738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163578269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984931,0.00043867726,0.000074093565,0.000095998665,0.00004905279,0.00046350146,0.00012946708,0.000021208796,0.00023496011],"genre_scores_gemma":[0.9931213,0.0013547153,0.00083669194,0.00021721153,0.00011695557,0.0028070942,0.0005220759,0.00000871544,0.0010152064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997718,0.0000886493,0.000021486485,0.000051992465,0.00002334085,0.000042746226],"domain_scores_gemma":[0.9994783,0.00010835645,0.00009949607,0.000045609784,0.000040289855,0.00022803262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005968579,0.000875275,0.0015019465,0.00029862137,0.00033850054,0.00038043704,0.0006479572,0.0008930583,0.0029650186],"category_scores_gemma":[0.0007883068,0.00035985498,0.00074338936,0.000346405,0.00066711067,0.00040977582,0.00034886907,0.001470504,0.00036983617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87627155,0.06731356,0.004067081,0.001092273,0.0009207352,0.00014077625,0.00016633497,0.0007234805,0.005236309,0.000121382414,0.00082288287,0.043123685],"study_design_scores_gemma":[0.53592575,0.4401998,0.019740796,0.00011429689,0.0006885337,0.00008875707,0.000115843315,0.0011328578,0.0011968169,0.00009029711,0.00068949105,0.000016825512],"about_ca_topic_score_codex":0.0032608511,"about_ca_topic_score_gemma":0.0044485675,"teacher_disagreement_score":0.0032608511,"about_ca_system_score_codex":0.0005312602,"about_ca_system_score_gemma":0.001142295,"threshold_uncertainty_score":0.009919047},"labels":[],"label_agreement":null},{"id":"W2165074304","doi":"10.1093/neuonc/nou253.28","title":"ED-28 * EFFECT OF VALPROIC ACID EXPOSURE ON SURVIVAL IN LOW-GRADE GLIOMA PATIENTS: A RETROSPECTIVE ANALYSIS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Valproic Acid; Medicine; Retrospective cohort study; Anticonvulsant; Glioma; Internal medicine; Medical prescription; Histone deacetylase inhibitor; Oncology; Epilepsy; Pediatrics; Pharmacology; Histone deacetylase; Psychiatry; Cancer research","score_opus":0.005730372881801133,"score_gpt":0.27745380481209575,"score_spread":0.27172343193029463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165074304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966151,0.00035510957,0.00003506009,0.000017140734,0.0000030403255,0.000010245699,0.0023525662,0.0000030153108,0.00060868793],"genre_scores_gemma":[0.998338,0.00012420284,0.00002604511,0.000019451878,0.0000032715038,0.0000102278245,0.0013548867,0.0000015296059,0.00012245687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996333,0.000050870993,0.00006660859,0.000098134784,0.00007172044,0.00007930905],"domain_scores_gemma":[0.99890256,0.00015050244,0.0004896588,0.00007753107,0.00021910196,0.00016059495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837177,0.00017179533,0.00028491643,0.0010642908,0.0003903621,0.00040939043,0.00032638444,0.00026528467,0.0016671395],"category_scores_gemma":[0.0011535458,0.00016512338,0.0004746927,0.0018201839,0.00024494407,0.0002523005,0.00028691234,0.00027487366,0.00027157634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000726006,0.0000055584937,0.99947876,0.0000063661087,0.000025676223,0.000046239642,0.000012651611,0.000014785958,0.000036992173,0.0000033556346,0.00004565546,0.00025144385],"study_design_scores_gemma":[0.0000046089253,0.000054658198,0.9992601,0.0000057114735,0.000032039607,0.00020368052,0.00009012885,0.0000615294,0.000041283678,0.000005982908,0.00023813052,0.000002147505],"about_ca_topic_score_codex":0.031365324,"about_ca_topic_score_gemma":0.028809173,"teacher_disagreement_score":0.031365324,"about_ca_system_score_codex":0.0008721689,"about_ca_system_score_gemma":0.00062625745,"threshold_uncertainty_score":0.062365532},"labels":[],"label_agreement":null},{"id":"W2166237244","doi":"10.1093/neuonc/2.2.114","title":"Myeloablative chemotherapy for recurrent aggressiveoligodendroglioma","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services; Ottawa Regional Cancer Foundation; Western University","funders":"","keywords":"Medicine; ThioTEPA; Procarbazine; Lomustine; Chemotherapy; Etoposide; Surgery; Vincristine; Induction chemotherapy; Internal medicine; Gastroenterology; Cyclophosphamide","score_opus":0.02391226627360078,"score_gpt":0.32695566301959467,"score_spread":0.3030433967459939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166237244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957598,0.0031096041,0.00030342015,0.000071377006,0.000012425178,0.00005057046,0.000042535892,0.0000150116,0.0006353242],"genre_scores_gemma":[0.9976279,0.0011899595,0.00043481536,0.00013272652,0.00006485084,0.000063160245,0.00016481656,0.000004797206,0.0003170687],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99980885,0.00007537198,0.000024464847,0.000017533563,0.000035644105,0.00003822348],"domain_scores_gemma":[0.9997408,0.00006419658,0.000088799534,0.000018931645,0.000014131412,0.000073101786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036336257,0.00022403924,0.0005145376,0.00016580653,0.00022193909,0.00020968929,0.00019901455,0.00020571475,0.00053004373],"category_scores_gemma":[0.000642241,0.000074895994,0.00021155228,0.00018464806,0.00015966251,0.00015180241,0.00013803542,0.00027449575,0.00017350873],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03498783,0.0042780065,0.24399875,0.0008948229,0.0004173146,0.008904574,0.0013599354,0.0029379593,0.16626845,0.0006712275,0.0031052376,0.5321759],"study_design_scores_gemma":[0.00978128,0.15104184,0.7121247,0.00029885359,0.0010274049,0.042088784,0.00032805876,0.005720199,0.038048346,0.00067969423,0.038779754,0.00008123052],"about_ca_topic_score_codex":0.00050731003,"about_ca_topic_score_gemma":0.0018059363,"teacher_disagreement_score":0.00053004373,"about_ca_system_score_codex":0.00038808052,"about_ca_system_score_gemma":0.00031805353,"threshold_uncertainty_score":0.002815783},"labels":[],"label_agreement":null},{"id":"W2166733396","doi":"10.1093/neuonc/nor089","title":"Evolution of Mouse Models for Studying CNS Cancer: a Decade of Progress","year":2011,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Oncogene; Glioblastoma; Cancer research; Cancer cell; Biology; Neuroscience; Sophistication; Medicine; Bioinformatics; Cell cycle; Genetics","score_opus":0.04377436391679893,"score_gpt":0.344886863664218,"score_spread":0.30111249974741905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166733396","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014531203,0.8424987,0.08503489,0.042613763,0.002313804,0.0004562947,0.0012308677,0.0010549602,0.010265481],"genre_scores_gemma":[0.03573135,0.7626584,0.17123461,0.017147854,0.0026387249,0.0013217205,0.0034779487,0.00067048136,0.005118908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945028,0.002019346,0.0007130789,0.0006792582,0.0017043522,0.00038114347],"domain_scores_gemma":[0.97942984,0.010750075,0.0016577048,0.0018198706,0.0046864254,0.0016560489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044266745,0.0024723527,0.0027067235,0.0054041008,0.0011819601,0.0048794216,0.00416257,0.003941925,0.0030827702],"category_scores_gemma":[0.011272768,0.0015231256,0.0016877482,0.0023715792,0.005234286,0.007716387,0.0037425784,0.013854101,0.00111674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001064798,0.0013965846,0.0067593916,0.006392777,0.00038088087,0.00048111408,0.0015212069,0.0021475968,0.07736879,0.1013173,0.073538184,0.72763145],"study_design_scores_gemma":[0.00024044098,0.0021707246,0.00871721,0.0049695135,0.0004587555,0.0021843559,0.00081552414,0.002599177,0.029191365,0.030101767,0.9182045,0.00034665063],"about_ca_topic_score_codex":0.0031554787,"about_ca_topic_score_gemma":0.0038589528,"teacher_disagreement_score":0.044266745,"about_ca_system_score_codex":0.002959191,"about_ca_system_score_gemma":0.0027379468,"threshold_uncertainty_score":0.23410773},"labels":[],"label_agreement":null},{"id":"W2167082098","doi":"10.1093/neuonc/not174","title":"CELL BIOLOGY AND SIGNALING","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cell biology; Biology; Signal transduction; Cell; Computational biology; Genetics","score_opus":0.01753913539146212,"score_gpt":0.31213581658037276,"score_spread":0.29459668118891064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167082098","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020162953,0.26189432,0.036003888,0.031619046,0.032216795,0.0009959562,0.014713635,0.00486005,0.5975334],"genre_scores_gemma":[0.1463489,0.13112104,0.014871966,0.01549994,0.006560743,0.0012833469,0.024725903,0.000856198,0.658732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987488,0.00010444828,0.000074932184,0.00030368616,0.00055475923,0.00021346741],"domain_scores_gemma":[0.99940443,0.00003681592,0.00006247203,0.000097223834,0.0002128379,0.00018628481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006059446,0.0013725302,0.0011802685,0.0011809759,0.0016436091,0.005641031,0.0017605997,0.0023707366,0.071942456],"category_scores_gemma":[0.0009674868,0.0004933712,0.0012333633,0.0011671615,0.00076343236,0.0018434427,0.0024463371,0.0031453362,0.069343135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043271048,0.00028050147,0.0014871536,0.0027634068,0.00021097655,0.001135352,0.00031480324,0.0006704616,0.17585565,0.07722479,0.33544135,0.40418288],"study_design_scores_gemma":[0.000046124365,0.000084301064,0.0008393954,0.00014661845,0.000024634806,0.0005775361,0.000070236754,0.00027183405,0.011109101,0.006525928,0.98028415,0.000020114532],"about_ca_topic_score_codex":0.0009655328,"about_ca_topic_score_gemma":0.0009922264,"teacher_disagreement_score":0.92805755,"about_ca_system_score_codex":0.0017397205,"about_ca_system_score_gemma":0.0018520771,"threshold_uncertainty_score":0.24067146},"labels":[],"label_agreement":null},{"id":"W2170174897","doi":"10.1093/neuonc/nor015","title":"Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neurocognitive; Medicine; Pediatrics; Neuropsychology; Medulloblastoma; Cohort; Cognition; Psychiatry; Internal medicine","score_opus":0.023105340413426587,"score_gpt":0.2784390769293476,"score_spread":0.255333736515921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170174897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995665,0.00016660448,0.00002478871,0.0000137703755,0.0000023104149,0.0000057434017,0.0001309784,0.0000011393012,0.0000881486],"genre_scores_gemma":[0.999451,0.0001550246,0.000040581053,0.000015903002,0.0000053226795,0.000005076883,0.00024677525,6.774822e-7,0.00007960888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998041,0.000031015217,0.000026117134,0.000037519112,0.00004006027,0.00006128353],"domain_scores_gemma":[0.99911076,0.000060413775,0.00041541248,0.0000519353,0.00013567637,0.0002257417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050748565,0.0002447433,0.00025990405,0.00054695277,0.00043962116,0.0004690013,0.00020139187,0.00028438127,0.0005084041],"category_scores_gemma":[0.0013597789,0.00017931788,0.00025838232,0.000638469,0.00022131171,0.0005083195,0.00044995575,0.0004627425,0.00013518882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047109057,0.000029868672,0.9987562,0.0000024769379,0.000012173083,0.00005361293,0.000055837532,0.000011910024,0.00005658497,0.0000027919245,0.000024135414,0.00094734435],"study_design_scores_gemma":[0.0000035482126,0.00020853039,0.99912494,0.000004624265,0.000015979029,0.0002829141,0.00017857978,0.000048289272,0.000040666517,0.000009486847,0.00008041112,0.000002119935],"about_ca_topic_score_codex":0.013133539,"about_ca_topic_score_gemma":0.016861625,"teacher_disagreement_score":0.013133539,"about_ca_system_score_codex":0.0003099523,"about_ca_system_score_gemma":0.00038548472,"threshold_uncertainty_score":0.026114166},"labels":[],"label_agreement":null},{"id":"W2170554416","doi":"10.1093/neuonc/nor171","title":"Tumor pseudoprogression following radiosurgery for vestibular schwannoma","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Adverse effect; Surgery; Schwannoma; Radiology; Neurosurgery; Nuclear medicine; Internal medicine","score_opus":0.057367253044611745,"score_gpt":0.311265809697507,"score_spread":0.25389855665289524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170554416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917823,0.00045523467,0.0001231967,0.0000096218155,0.0000027663116,0.000010984926,0.0000379581,0.00000560484,0.0001764528],"genre_scores_gemma":[0.99966466,0.00012280636,0.00004509254,0.000008963853,0.000006272081,0.0000033398694,0.000076058364,0.0000016237874,0.00007109616],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99965847,0.00006356905,0.00005044337,0.000047607573,0.000101867794,0.00007805843],"domain_scores_gemma":[0.9975962,0.000519062,0.0012803322,0.00014952157,0.0001831297,0.00027176784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005281123,0.00021692697,0.0003008377,0.001113794,0.00037728078,0.00037483816,0.00034873423,0.00025179703,0.00078720524],"category_scores_gemma":[0.0025683944,0.00018705007,0.00032806466,0.0006435108,0.00035617026,0.00040853934,0.0003735762,0.00029812497,0.00025340536],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034846278,0.000045966543,0.97478193,0.000043808905,0.000030054713,0.011156515,0.0002326151,0.00016106032,0.0029751074,0.00002464432,0.00006558695,0.010134275],"study_design_scores_gemma":[0.000009857336,0.00091453077,0.95105195,0.000017737233,0.000042017207,0.045350492,0.00027080803,0.00048259855,0.0013287913,0.000053510386,0.0004682096,0.000009470588],"about_ca_topic_score_codex":0.0017355144,"about_ca_topic_score_gemma":0.002523004,"teacher_disagreement_score":0.0017355144,"about_ca_system_score_codex":0.00029896604,"about_ca_system_score_gemma":0.00034489002,"threshold_uncertainty_score":0.003450811},"labels":[],"label_agreement":null},{"id":"W2171155897","doi":"10.1093/neuonc/not101","title":"Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Radiosurgery; Surgery; Disease control; Radiation therapy; Epidural space; Overall survival; Spinal cord","score_opus":0.013121163603996764,"score_gpt":0.3086607069565182,"score_spread":0.2955395433525214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171155897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991015,0.0004925966,0.00012913805,0.000017892444,0.000002703577,0.000005344416,0.0000248331,0.000007823149,0.00021804696],"genre_scores_gemma":[0.99967694,0.00013009018,0.00007462638,0.0000072007206,0.0000050630983,0.000001939843,0.00005802406,0.0000012277355,0.00004492119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998951,0.000022786038,0.0000145012245,0.000010959449,0.000033930537,0.000022603002],"domain_scores_gemma":[0.99909663,0.00024212572,0.0004794629,0.000030436566,0.000047922083,0.000103424376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001994104,0.00012225978,0.00018546045,0.0001814053,0.000091104484,0.00018957167,0.00013339761,0.00006701443,0.0009127994],"category_scores_gemma":[0.001500452,0.000037644808,0.00015021465,0.00013401546,0.00017569496,0.00011389908,0.00015049148,0.00012585333,0.00009288773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013079945,0.00019307755,0.926278,0.00010426217,0.00007587252,0.0005671962,0.00008086839,0.0007037925,0.009937724,0.000027620006,0.00029732278,0.060426306],"study_design_scores_gemma":[0.000025696243,0.0014014856,0.99397624,0.000012270671,0.000049382987,0.001653351,0.000051003026,0.0004003117,0.0020481555,0.000029508774,0.0003494174,0.0000031502839],"about_ca_topic_score_codex":0.00047504512,"about_ca_topic_score_gemma":0.0014640063,"teacher_disagreement_score":0.0009127994,"about_ca_system_score_codex":0.00015736603,"about_ca_system_score_gemma":0.00020392684,"threshold_uncertainty_score":0.003053546},"labels":[],"label_agreement":null},{"id":"W2171237157","doi":"10.1093/neuonc/noq017","title":"MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; The Metabolomics Innovation Centre","funders":"Pfizer","keywords":"Sunitinib; Angiogenesis; Temozolomide; Cancer research; Methyltransferase; Tyrosine-kinase inhibitor; Receptor tyrosine kinase; Vascular endothelial growth factor A; Vascular endothelial growth factor; Receptor; Medicine; Biology; Glioma; Internal medicine; Methylation; Cancer; VEGF receptors; Gene","score_opus":0.014411995022644855,"score_gpt":0.2836404248236927,"score_spread":0.2692284298010479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171237157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756515,0.0017249088,0.00015222847,0.000039052953,0.000012565978,0.000009877748,0.00010121463,0.000018585448,0.00037637423],"genre_scores_gemma":[0.9987073,0.0006478779,0.00013585824,0.000021118192,0.0000062521485,0.000009125471,0.0001351065,0.000004157388,0.00033316028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985623,0.000027319218,0.000011916856,0.000016555348,0.000043140222,0.00004480875],"domain_scores_gemma":[0.9999453,0.0000060998786,0.000021912338,0.0000030188526,0.0000071697914,0.000016484177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009621859,0.00019808521,0.00040654477,0.0002693194,0.00012039577,0.00031883712,0.00009548491,0.00026867693,0.0006065701],"category_scores_gemma":[0.00014012719,0.0000952968,0.00022920055,0.00020624857,0.00012280028,0.00015517356,0.00012385243,0.00026224807,0.00012402379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040899802,0.000058942605,0.0022985688,0.000039083792,0.000016985232,0.000075857366,0.000025852354,0.00012584559,0.99364555,0.00003890711,0.00007297546,0.0031924997],"study_design_scores_gemma":[0.000066967834,0.0016313446,0.13793422,0.0000116082465,0.000083943065,0.0005271826,0.00012130125,0.0021699318,0.85429007,0.000092953196,0.0030567152,0.000013798616],"about_ca_topic_score_codex":0.0010115028,"about_ca_topic_score_gemma":0.001412711,"teacher_disagreement_score":0.0010115028,"about_ca_system_score_codex":0.0003667444,"about_ca_system_score_gemma":0.00014903376,"threshold_uncertainty_score":0.0026609302},"labels":[],"label_agreement":null},{"id":"W2171777157","doi":"10.1093/neuonc/not033","title":"Can the prognosis of individual patients with glioblastoma be predicted using an online calculator?","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"World Health Organization","keywords":"Calculator; Medicine; Glioblastoma; Oncology; Internal medicine; Nomogram; Cancer; Computer science","score_opus":0.03407097024436354,"score_gpt":0.28458604800807713,"score_spread":0.25051507776371357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171777157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832886,0.0011994388,0.007608158,0.0008803832,0.000088767585,0.00010419027,0.0025841885,0.00040444112,0.0038418132],"genre_scores_gemma":[0.99221194,0.00033606577,0.0052069155,0.00013575797,0.00005336683,0.000090635825,0.0017612333,0.000027084769,0.00017704608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982651,0.0008738574,0.00021863016,0.00021677015,0.000344716,0.00008092611],"domain_scores_gemma":[0.9801533,0.011245149,0.005341512,0.0013145695,0.0014367362,0.00050878513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039068307,0.0005869897,0.0008153147,0.0021783633,0.000206567,0.0011784149,0.0006073386,0.00043379128,0.0014701078],"category_scores_gemma":[0.030773522,0.0001610375,0.00052630674,0.0021280018,0.00029424147,0.00097625365,0.0005545991,0.0005655096,0.0008336417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007985251,0.00007292044,0.95143765,0.00004671241,0.00010265108,0.000050042214,0.00007124463,0.0019191239,0.000106409105,0.000097845965,0.0015976565,0.043699153],"study_design_scores_gemma":[0.00021319021,0.0011495727,0.94462687,0.00012944483,0.00041382745,0.000735224,0.00032073705,0.043650247,0.0018246276,0.0019362768,0.0049038404,0.00009614764],"about_ca_topic_score_codex":0.0013190995,"about_ca_topic_score_gemma":0.0016170817,"teacher_disagreement_score":0.0039068307,"about_ca_system_score_codex":0.00042639565,"about_ca_system_score_gemma":0.00048524234,"threshold_uncertainty_score":0.020661533},"labels":[],"label_agreement":null},{"id":"W2171839817","doi":"10.1093/neuonc/nou208.33","title":"IDENTIFYING DRUG COMPOUNDS TARGETING TUMOR METABOLISM IN GLIOBLASTOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Warburg effect; Gene knockdown; Glycolysis; Cancer research; Hexokinase; Anaerobic glycolysis; Biology; Reprogramming; In vivo; Cell culture; Oxidative phosphorylation; Cell biology; Gene; Enzyme; Biochemistry; Genetics","score_opus":0.010587034855781571,"score_gpt":0.26833537957977455,"score_spread":0.257748344723993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171839817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560639,0.023871332,0.007590954,0.00060829817,0.000069585374,0.00047123732,0.0065016584,0.000581489,0.0042414437],"genre_scores_gemma":[0.9605996,0.017071974,0.010531373,0.00034672872,0.0000228091,0.00027078533,0.008473785,0.000036833917,0.0026462083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993205,0.0000062947643,0.000005897092,0.000015520314,0.000021793445,0.00001844203],"domain_scores_gemma":[0.99992466,0.000012930405,0.000024419658,0.0000040676964,0.000021093041,0.000012784466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013590734,0.0005103375,0.00071671547,0.0012089837,0.0001782895,0.00044462315,0.00020842193,0.00030292227,0.0013253645],"category_scores_gemma":[0.00015450489,0.00016603325,0.00048143236,0.0007667095,0.00015027724,0.00020809924,0.00020622613,0.00027889913,0.000322261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011112673,0.00022820292,0.008050001,0.0011794026,0.00011785637,0.00034428624,0.0000362934,0.003047888,0.92046386,0.00037935883,0.0010343008,0.06400738],"study_design_scores_gemma":[0.00051532796,0.004703806,0.048922576,0.00021624986,0.00091082486,0.0013989296,0.000109296794,0.009714418,0.90315884,0.00078033947,0.02952595,0.000043497985],"about_ca_topic_score_codex":0.0012472139,"about_ca_topic_score_gemma":0.0037780683,"teacher_disagreement_score":0.0013253645,"about_ca_system_score_codex":0.0007170964,"about_ca_system_score_gemma":0.0007044838,"threshold_uncertainty_score":0.005202949},"labels":[],"label_agreement":null},{"id":"W2171964132","doi":"10.1093/neuonc/nov054","title":"The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire–Chronic","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cronbach's alpha; Medicine; Corticosteroid; Analysis of variance; Construct validity; Internal medicine; Dexamethasone; Psychometrics; Physical therapy; Clinical psychology","score_opus":0.024201121743294016,"score_gpt":0.28281930809083605,"score_spread":0.258618186347542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171964132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848,0.000703425,0.000057793255,0.00009808834,0.000008766639,0.000022766922,0.00021547201,0.0000021934745,0.00041140697],"genre_scores_gemma":[0.9995326,0.00012452995,0.00010949172,0.00002366184,0.00000853739,0.000011194696,0.00015060928,4.3368888e-7,0.000039012262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992668,0.0002756899,0.00013171339,0.000063448664,0.00018014041,0.00008223184],"domain_scores_gemma":[0.9953852,0.0017686228,0.0017202542,0.00006561048,0.00052361167,0.00053674186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012762158,0.00023146076,0.00036769998,0.00069318316,0.0001957977,0.00043151504,0.00020395077,0.0003364041,0.0012049507],"category_scores_gemma":[0.0063374196,0.000111522626,0.0003555781,0.0005708903,0.00022827674,0.00030799725,0.00038756643,0.000506375,0.00013242883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007107351,0.000045454053,0.9976313,0.000019712383,0.000036754598,0.000030767424,0.000052817606,0.000028207669,0.00006748224,0.0000041548265,0.00008286956,0.001929389],"study_design_scores_gemma":[0.0000185053,0.0002216207,0.9989525,0.000013944722,0.000021569067,0.00026635552,0.00017279685,0.00017117862,0.000033016113,0.000009020492,0.000115793555,0.000003727716],"about_ca_topic_score_codex":0.002179348,"about_ca_topic_score_gemma":0.00374499,"teacher_disagreement_score":0.002179348,"about_ca_system_score_codex":0.0002774738,"about_ca_system_score_gemma":0.00035120468,"threshold_uncertainty_score":0.006749332},"labels":[],"label_agreement":null},{"id":"W2175100525","doi":"10.1093/neuonc/nov244","title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institute on Aging; National Cancer Institute; National Institutes of Health; Common Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute of Allergy and Infectious Diseases; Voices Against Brain Cancer","keywords":"Microglia; Extracellular vesicles; Glioblastoma; Extracellular; Chemistry; Cell biology; Microvesicles; Vesicle; RNA; Biophysics; microRNA; Biology; Cancer research; Immunology; Gene; Inflammation; Biochemistry; Membrane","score_opus":0.018230575410621435,"score_gpt":0.30373661421769554,"score_spread":0.2855060388070741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175100525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947681,0.006679262,0.0404201,0.00034069514,0.000120485776,0.00013536557,0.0006310682,0.0003006988,0.003691292],"genre_scores_gemma":[0.95637673,0.0037050417,0.03383347,0.00024270454,0.000060853516,0.00023288239,0.0007499455,0.00012522882,0.0046730665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998437,0.000024688645,0.000007721732,0.00003981687,0.000031580934,0.000052451414],"domain_scores_gemma":[0.9999372,0.0000127016965,0.000016168666,0.0000075343237,0.000017643171,0.000008773121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020349583,0.00044424675,0.00027619055,0.0002726686,0.00021979216,0.00034518854,0.00021499349,0.00047111782,0.00083039154],"category_scores_gemma":[0.000121978905,0.00014859713,0.00035168848,0.00010569159,0.00022912562,0.0002634133,0.0003124889,0.00044435347,0.00062226877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005067635,0.0000099359195,0.0001554755,0.000069295565,0.000006098861,0.00010736392,0.000027244116,0.000037349513,0.99806947,0.00014653079,0.000040434545,0.0012801148],"study_design_scores_gemma":[0.00001306022,0.00019595685,0.0025074393,0.000021650487,0.000025149899,0.00070989825,0.000060044647,0.00078497373,0.99241453,0.00014380217,0.0031165166,0.000007075491],"about_ca_topic_score_codex":0.000674743,"about_ca_topic_score_gemma":0.00072167424,"teacher_disagreement_score":0.00083039154,"about_ca_system_score_codex":0.00032032482,"about_ca_system_score_gemma":0.00026016808,"threshold_uncertainty_score":0.002777934},"labels":[],"label_agreement":null},{"id":"W2186297468","doi":"10.1093/neuonc/nov266","title":"Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Life Science Foundation of Japan; Aichi Cancer Research Foundation","keywords":"Epidermal growth factor receptor; Pathology; Lung cancer; Medicine; Exon; Adenocarcinoma; Lung; White matter; Brain metastasis; Cancer; Oncology; Biology; Internal medicine; Magnetic resonance imaging; Radiology; Metastasis; Gene","score_opus":0.03701392400619031,"score_gpt":0.32824155044515824,"score_spread":0.29122762643896793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186297468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992772,0.00017341091,0.00014194167,0.0000098316705,0.0000011483971,0.0000040943396,0.00012551839,0.0000034731745,0.00026334048],"genre_scores_gemma":[0.999741,0.00003327406,0.000067903085,0.0000043749205,0.0000022104136,0.0000028854947,0.00010876277,0.0000018276731,0.000037822283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998109,0.00004394347,0.0000210573,0.000044550598,0.000045994726,0.000033508953],"domain_scores_gemma":[0.9989231,0.00030679506,0.00048399495,0.00005998584,0.00012540728,0.00010071964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002925832,0.00015012901,0.00015938825,0.0006572329,0.000121693105,0.00028698787,0.00020548754,0.0002313498,0.0018950603],"category_scores_gemma":[0.0016901772,0.00013306642,0.00021387693,0.00034370707,0.0002349375,0.00022532372,0.00019704556,0.00016534474,0.00033147068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022927261,0.000011367132,0.9929282,0.000013171877,0.000050592836,0.00035926353,0.000036664904,0.000102187674,0.0035827896,0.000016478498,0.000048169884,0.002621755],"study_design_scores_gemma":[0.0000062966838,0.00004899237,0.9971596,0.0000020416155,0.000019071493,0.001960797,0.000058459416,0.00013229328,0.00050960213,0.000020734906,0.00007981978,0.000002387068],"about_ca_topic_score_codex":0.0020884878,"about_ca_topic_score_gemma":0.0033718115,"teacher_disagreement_score":0.0020884878,"about_ca_system_score_codex":0.00024429616,"about_ca_system_score_gemma":0.00015924136,"threshold_uncertainty_score":0.006339669},"labels":[],"label_agreement":null},{"id":"W2215255387","doi":"10.1093/neuonc/nov290","title":"Response to “Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?”","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Morgan Family Foundation; Silicon Valley Community Foundation","keywords":"Protein kinase B; Insulin receptor; Insulin-like growth factor; Cancer research; Growth factor; Signal transduction; Insulin; Receptor; Medicine; Biology; Cell biology; Internal medicine; Insulin resistance","score_opus":0.023775811184897133,"score_gpt":0.2844800602335965,"score_spread":0.2607042490486994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215255387","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09180929,0.038843095,0.0032443372,0.75340074,0.02590967,0.00025807146,0.00044978617,0.0006891021,0.085395865],"genre_scores_gemma":[0.5715271,0.016989203,0.0031722265,0.27835244,0.031124363,0.00031991422,0.0003785196,0.00009281852,0.098043285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997663,0.00007120585,0.000019534908,0.000038877264,0.000048986927,0.00005507738],"domain_scores_gemma":[0.9998103,0.00008045085,0.000025288586,0.000018705481,0.000031939093,0.000033378292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033688586,0.00039521654,0.0003634804,0.00015295607,0.0004684578,0.0007017617,0.00041195296,0.004890056,0.0060268487],"category_scores_gemma":[0.0007828802,0.00012373958,0.00040938007,0.00013498569,0.0006485395,0.00047151625,0.00018670759,0.0038202603,0.0030453466],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028589421,0.0006360982,0.009805539,0.00090369734,0.00014022677,0.09548604,0.00027400022,0.0006390384,0.07379332,0.026939485,0.6446961,0.14382754],"study_design_scores_gemma":[0.00080665393,0.0013288432,0.012756713,0.00024411594,0.00013499323,0.10083692,0.00035552515,0.0031496538,0.04310701,0.014742131,0.8224678,0.000069669375],"about_ca_topic_score_codex":0.00024477317,"about_ca_topic_score_gemma":0.00044928523,"teacher_disagreement_score":0.0060268487,"about_ca_system_score_codex":0.001123542,"about_ca_system_score_gemma":0.00024728922,"threshold_uncertainty_score":0.020161748},"labels":[],"label_agreement":null},{"id":"W2258249884","doi":"10.1093/neuonc/nov321","title":"Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; National Science Council; Damon Runyon Cancer Research Foundation; National Institute of Environmental Health Sciences; Cancer Research Society; American Association for Cancer Research; Howard Hughes Medical Institute; U.S. Department of Defense","keywords":"Biology; Temozolomide; Transcriptome; Cancer research; Stem cell; Chromatin; Cellular differentiation; Glioma; Cell biology; Molecular biology; Genetics; Gene expression; Gene","score_opus":0.028498984397421028,"score_gpt":0.28197416509867446,"score_spread":0.2534751807012534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258249884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967913,0.00032975944,0.0014804762,0.000029169229,0.000013180971,0.000024391149,0.0005022442,0.000100749785,0.0007286541],"genre_scores_gemma":[0.9956644,0.00031938037,0.0015968608,0.00004286658,0.0000028961872,0.000038210303,0.00073740876,0.000037543,0.0015604447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998857,0.000009570285,0.000013532882,0.000027199501,0.00003635328,0.000027547507],"domain_scores_gemma":[0.9998896,0.000009693085,0.000046684327,0.000015288506,0.00001090322,0.000027816335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007602421,0.00028987578,0.00016494887,0.00026594184,0.00008970636,0.00017792998,0.00012210413,0.00016484006,0.0010181769],"category_scores_gemma":[0.000060299153,0.0001289155,0.00021857588,0.000119844255,0.00013054816,0.00007910974,0.0001746294,0.0003743316,0.00028135514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048273854,0.000016221396,0.00021530117,0.000015271062,0.000004525687,0.000019915095,0.000008921627,0.000058371606,0.999027,0.00003768327,0.00002726963,0.00052120857],"study_design_scores_gemma":[0.000009137803,0.00021499499,0.0062286993,0.0000059048593,0.000014487139,0.00013200399,0.000022300226,0.0006667253,0.99169475,0.000034159275,0.00097443006,0.0000024383876],"about_ca_topic_score_codex":0.0006388142,"about_ca_topic_score_gemma":0.001541587,"teacher_disagreement_score":0.0010181769,"about_ca_system_score_codex":0.00020744906,"about_ca_system_score_gemma":0.00019583765,"threshold_uncertainty_score":0.0034061074},"labels":[],"label_agreement":null},{"id":"W2271764074","doi":"10.1093/neuonc/nov327","title":"Exploiting drug repositioning and the brain microenvironment to treat brain metastases","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; Israel Cancer Research Fund","keywords":"Drug; Brain cancer; Medicine; Brain metastasis; Drug repositioning; Neuroscience; Psychology; Pharmacology; Internal medicine; Metastasis; Cancer","score_opus":0.01845121143797394,"score_gpt":0.27971043668156786,"score_spread":0.2612592252435939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271764074","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017148811,0.062384352,0.0023726434,0.8592635,0.024312967,0.00009552493,0.00014738143,0.00018559521,0.03408927],"genre_scores_gemma":[0.25565705,0.073659174,0.006031124,0.49262786,0.12747829,0.0002543985,0.00020360983,0.00011048801,0.04397806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970454,0.00008684272,0.000026932348,0.000033280743,0.00009520887,0.000053129555],"domain_scores_gemma":[0.9994869,0.00029262577,0.00004758311,0.000030807372,0.000051440435,0.00009060888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728745,0.0003637426,0.000849395,0.00030408578,0.0006591741,0.0012571884,0.0005401426,0.006811159,0.002739971],"category_scores_gemma":[0.0021589724,0.00017200792,0.0007066904,0.00023325214,0.000961928,0.0011801729,0.000512243,0.00887596,0.0015955945],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000826175,0.0005462889,0.0030513152,0.00077739067,0.00012884858,0.056127068,0.00023752927,0.0022015034,0.009707566,0.026621882,0.6269557,0.27281886],"study_design_scores_gemma":[0.000839289,0.00085502013,0.0018932843,0.00037534896,0.00012572088,0.061598238,0.00028002844,0.0034933141,0.005211925,0.044783257,0.8804667,0.0000779488],"about_ca_topic_score_codex":0.00052529585,"about_ca_topic_score_gemma":0.0027665826,"teacher_disagreement_score":0.006811159,"about_ca_system_score_codex":0.0009689235,"about_ca_system_score_gemma":0.00062772626,"threshold_uncertainty_score":0.0091661215},"labels":[],"label_agreement":null},{"id":"W2273808592","doi":"10.1093/neuonc/nov102","title":"Controversies in neuro-oncology: role of whole-brain radiation therapy in the treatment of newly diagnosed brain metastases","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Radiation oncology; Oncology; Internal medicine; Brain tumor; Pathology","score_opus":0.034421594087028815,"score_gpt":0.3224086690616717,"score_spread":0.2879870749746429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273808592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081996806,0.544345,0.0006422985,0.43930352,0.01163347,0.000019024968,0.00008409137,0.000023174473,0.003129497],"genre_scores_gemma":[0.028746234,0.5926829,0.0018562557,0.28244787,0.09297971,0.00010963492,0.00013281054,0.00006272276,0.0009818005],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9878763,0.006021769,0.0019212629,0.0013132523,0.0025260411,0.00034129538],"domain_scores_gemma":[0.8734243,0.099124454,0.005033827,0.0024283598,0.017566644,0.0024224315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037636165,0.0008798481,0.0025376268,0.0020979634,0.0021095271,0.0046078064,0.004109711,0.008590394,0.0050086183],"category_scores_gemma":[0.07541951,0.00041505691,0.0016474137,0.0025764534,0.0087211365,0.009909454,0.0028152287,0.019207533,0.0016772824],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070689875,0.00017947705,0.002111232,0.009130082,0.0006115266,0.0004217862,0.0008343103,0.00080776494,0.00053211226,0.04788661,0.22908232,0.7076958],"study_design_scores_gemma":[0.00030565407,0.00039618378,0.0032887321,0.019226514,0.00076846697,0.0009802856,0.0013344043,0.00051636534,0.000563081,0.05237035,0.92011505,0.00013488218],"about_ca_topic_score_codex":0.005859703,"about_ca_topic_score_gemma":0.009856043,"teacher_disagreement_score":0.037636165,"about_ca_system_score_codex":0.00536163,"about_ca_system_score_gemma":0.0075682173,"threshold_uncertainty_score":0.19904143},"labels":[],"label_agreement":null},{"id":"W2276391444","doi":"10.1093/neuonc/nov300","title":"Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Bevacizumab; Temozolomide; Medicine; Placebo; Radiation therapy; Adverse effect; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","score_opus":0.01716518308352756,"score_gpt":0.28547534996101476,"score_spread":0.2683101668774872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276391444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7835412,0.20506413,0.0015855726,0.0016672366,0.00009289512,0.0007037291,0.0025522795,0.00014921898,0.0046436377],"genre_scores_gemma":[0.9383265,0.051746313,0.0014641703,0.0010425451,0.00023022728,0.0003257627,0.0056720097,0.0000390303,0.0011535179],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997957,0.0009508636,0.0001799551,0.00012866822,0.00063197233,0.00015158161],"domain_scores_gemma":[0.9955687,0.00094165275,0.00212463,0.0001675763,0.0007579808,0.0004394837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050113443,0.000311951,0.0012081583,0.0005919278,0.00022417193,0.00075335713,0.00034681457,0.0003790274,0.0006336225],"category_scores_gemma":[0.0054923757,0.00016004144,0.0013028528,0.0007792677,0.00017871977,0.00051696785,0.0003237669,0.0007056023,0.00013278605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050417986,0.0027036725,0.13201569,0.0025582435,0.005267805,0.00019703158,0.00032173988,0.0042740633,0.0076456694,0.00025555256,0.007086538,0.7872562],"study_design_scores_gemma":[0.005723213,0.07632443,0.8790408,0.00084440864,0.0074708834,0.0010366903,0.00013964884,0.0023359584,0.006145073,0.00039526378,0.02045609,0.00008748005],"about_ca_topic_score_codex":0.0029532993,"about_ca_topic_score_gemma":0.0064699724,"teacher_disagreement_score":0.0050113443,"about_ca_system_score_codex":0.0015322573,"about_ca_system_score_gemma":0.0020507367,"threshold_uncertainty_score":0.026502848},"labels":[],"label_agreement":null},{"id":"W2283437114","doi":"10.1093/neuonc/nov165","title":"Neddylation in glioblastomas","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neddylation; NEDD8; Cullin; Ubiquitin ligase; Ubiquitin; Cell biology; Cell cycle; Biology; Cancer cell; Protein degradation; Chemistry; Biochemistry; Cancer; Cell; Genetics","score_opus":0.025477685778436256,"score_gpt":0.2814523645490649,"score_spread":0.2559746787706287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283437114","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13269939,0.7673913,0.0034368676,0.019849418,0.003433816,0.00019542084,0.0025333816,0.00043332283,0.07002706],"genre_scores_gemma":[0.6571703,0.29514492,0.003906444,0.012466231,0.0021849005,0.00013466804,0.004436944,0.0000760424,0.024479542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999021,0.000018182462,0.000014222853,0.000013187148,0.000022820273,0.000029566912],"domain_scores_gemma":[0.99989605,0.0000070262313,0.000028423636,0.0000085686415,0.000023524683,0.00003648783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031759293,0.00027992207,0.00034682432,0.0004322607,0.00023624278,0.00036948695,0.00023143583,0.00061788544,0.0020300227],"category_scores_gemma":[0.0002556535,0.000080791324,0.00025648283,0.00048893905,0.00026075589,0.00023864886,0.00037047014,0.0007116344,0.00095491856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020083953,0.00026341647,0.019849682,0.002865963,0.00016274542,0.028599616,0.00030418506,0.00061709166,0.03356727,0.036049534,0.106696784,0.7690154],"study_design_scores_gemma":[0.00032345875,0.00064013485,0.052790333,0.0010708469,0.0001850142,0.0649632,0.00019576929,0.00068112306,0.010034066,0.011639741,0.85743254,0.000043868185],"about_ca_topic_score_codex":0.004294055,"about_ca_topic_score_gemma":0.006268928,"teacher_disagreement_score":0.004294055,"about_ca_system_score_codex":0.0010740868,"about_ca_system_score_gemma":0.0008668697,"threshold_uncertainty_score":0.008538127},"labels":[],"label_agreement":null},{"id":"W2288156681","doi":"10.1093/neuonc/nox025","title":"Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"EMD Serono; National Cancer Institute; NRG Oncology; Merck KGaA","keywords":"Temozolomide; Glioblastoma; Oncology; Internal medicine; Medicine; Adjuvant; Cancer research","score_opus":0.020283679572136837,"score_gpt":0.34666982465970225,"score_spread":0.3263861450875654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288156681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97766054,0.016742442,0.00035669128,0.00023398119,0.00008370207,0.00023895995,0.003867151,0.000020998103,0.000795514],"genre_scores_gemma":[0.9939089,0.0020023289,0.00018171102,0.00025216193,0.00012889739,0.00017809038,0.0030325342,0.000014469597,0.00030099836],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99663734,0.001918356,0.00038256013,0.00052193366,0.00032375904,0.00021603603],"domain_scores_gemma":[0.98928666,0.004634458,0.003620401,0.00086991023,0.0008020098,0.0007864697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070679365,0.00086191524,0.0031613128,0.0010129962,0.00025153309,0.001145844,0.0006770813,0.0007136226,0.0020379412],"category_scores_gemma":[0.0097053,0.00032428742,0.008436125,0.001179656,0.00033363834,0.0007631901,0.00084547466,0.0009888484,0.00024690284],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4937927,0.0015914706,0.33306295,0.005775493,0.11218452,0.00035971368,0.0001898754,0.0021344356,0.0034587306,0.00014827623,0.0029387618,0.04436304],"study_design_scores_gemma":[0.04877368,0.037385106,0.80499214,0.00048361678,0.100411005,0.00070959213,0.00017536287,0.0018528929,0.0014312756,0.00042493854,0.003262966,0.000097501616],"about_ca_topic_score_codex":0.001632443,"about_ca_topic_score_gemma":0.00369705,"teacher_disagreement_score":0.0070679365,"about_ca_system_score_codex":0.00072030514,"about_ca_system_score_gemma":0.00083815196,"threshold_uncertainty_score":0.037379265},"labels":[],"label_agreement":null},{"id":"W2290142603","doi":"10.1093/neuonc/nov284.73","title":"PO84WHOLE BRAIN RADIOTHERAPY (WBRT) FOLLOWING RESECTION OF BRAIN METASTASES: WHO DECIDES? AN AUDIT OF OUTCOMES AND CLINICIAN CONFIDENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Whole brain radiotherapy; Confidence interval; Radiation therapy; Demographics; Audit; Brain metastasis; Internal medicine; Surgery; Oncology; Cancer; Metastasis","score_opus":0.05973711623780459,"score_gpt":0.3947136780242664,"score_spread":0.3349765617864618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290142603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129456,0.00076587015,0.00024210275,0.001473339,0.00003547212,0.00010086754,0.0008690098,0.000024466413,0.0051943134],"genre_scores_gemma":[0.9978156,0.0006066465,0.00031108738,0.0001735663,0.00002360838,0.00006752278,0.0004320959,0.000010309665,0.0005594959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915696,0.0043928684,0.0013596975,0.00027900471,0.0017116183,0.0006872653],"domain_scores_gemma":[0.93635345,0.018997528,0.02504071,0.0018952749,0.013638536,0.0040744767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0084212795,0.0001229566,0.0002593466,0.0016679141,0.0006711073,0.0012927696,0.0003975169,0.00043121245,0.0021482215],"category_scores_gemma":[0.04425983,0.00023173193,0.00023896535,0.002206454,0.00074634794,0.0011557087,0.0017474522,0.0006275471,0.0008245387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020734743,0.000077694356,0.97313595,0.00008669168,0.000015186761,0.00017419457,0.0014431931,0.000047415815,0.00011835592,0.00006156215,0.0024599258,0.022172386],"study_design_scores_gemma":[0.000026513146,0.0005671837,0.98546267,0.00018252525,0.00002719687,0.0006669299,0.0052372273,0.000443211,0.0005021099,0.00015745197,0.006705674,0.000021378035],"about_ca_topic_score_codex":0.0020198114,"about_ca_topic_score_gemma":0.002487929,"teacher_disagreement_score":0.0084212795,"about_ca_system_score_codex":0.001070489,"about_ca_system_score_gemma":0.0018212517,"threshold_uncertainty_score":0.04453653},"labels":[],"label_agreement":null},{"id":"W2291628201","doi":"10.1093/neuonc/nov125","title":"Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Warburg effect; Reprogramming; Oxidative phosphorylation; Citric acid cycle; Biology; Anaerobic glycolysis; Glycolysis; Epigenetics; Metabolism; Metabolic pathway; Cancer research; Cell biology; Biochemistry; Cell; Gene","score_opus":0.026860976900807056,"score_gpt":0.34926303973691314,"score_spread":0.32240206283610606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291628201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012111638,0.9983956,0.00013168267,0.00052776624,0.00017609277,0.0000014957261,0.000014479976,0.0000073808164,0.0006243602],"genre_scores_gemma":[0.00091246545,0.9981495,0.00012075304,0.00024060825,0.0001760816,0.0000025690283,0.000019413574,0.0000013288802,0.00037732464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998846,0.000023000608,0.000018009705,0.000023986104,0.000035101955,0.000015337366],"domain_scores_gemma":[0.9997286,0.00012083409,0.00003724919,0.000010441926,0.0000694379,0.000033266442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005035719,0.0005437378,0.000983828,0.0015466389,0.00030640283,0.000909802,0.00055006606,0.0010663174,0.0024535402],"category_scores_gemma":[0.000656097,0.00018264417,0.0003482817,0.0015052223,0.000574032,0.0014526837,0.000740185,0.0013695863,0.0010697911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053234042,0.000034047534,0.000308734,0.010023441,0.00007209252,0.00033828386,0.00009497038,0.0004023311,0.0023981035,0.009065205,0.029223952,0.9479856],"study_design_scores_gemma":[0.0000061607407,0.000053751362,0.0009804071,0.0023875546,0.00007585581,0.0018595527,0.000087903696,0.000109632805,0.00072064117,0.0057824384,0.9879153,0.00002082477],"about_ca_topic_score_codex":0.0008891899,"about_ca_topic_score_gemma":0.0018400705,"teacher_disagreement_score":0.0024535402,"about_ca_system_score_codex":0.00082776864,"about_ca_system_score_gemma":0.0010214716,"threshold_uncertainty_score":0.008207917},"labels":[],"label_agreement":null},{"id":"W2293049256","doi":"10.1093/neuonc/now005","title":"Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Deutsche Krebshilfe","keywords":"Glioma; Cancer research; VEGF receptors; Medicine; Myeloid cells; Myeloid","score_opus":0.01893953465725567,"score_gpt":0.3116228432250211,"score_spread":0.2926833085677654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293049256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481887,0.0019194029,0.0018715966,0.00013799538,0.00004935467,0.00005443816,0.0003311606,0.00017236974,0.00064485957],"genre_scores_gemma":[0.99297076,0.0015933596,0.0025349248,0.000056941833,0.00002674015,0.00011895481,0.0006344726,0.000030162604,0.0020337482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998772,0.00001908963,0.000014774595,0.000020108784,0.000030356872,0.00003841225],"domain_scores_gemma":[0.99984646,0.000012409957,0.000053608124,0.000015535408,0.000013247648,0.00005871115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018363795,0.0005338607,0.00042390963,0.00037243578,0.000121619334,0.00018927385,0.0002457687,0.000314842,0.0012426481],"category_scores_gemma":[0.00009186144,0.000112089925,0.00025263845,0.00018491957,0.00028552528,0.00018462536,0.00014973886,0.00078881555,0.00037003562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058281637,0.00021425777,0.00016021551,0.00006129983,0.0000075174653,0.000041080795,0.00001621753,0.00005633165,0.9966983,0.0000729218,0.00008226717,0.0020067617],"study_design_scores_gemma":[0.00009666141,0.0035209926,0.0029985888,0.000014360832,0.00004468647,0.0002900878,0.000031289528,0.00095315906,0.98963505,0.000055505967,0.0023528384,0.0000067857254],"about_ca_topic_score_codex":0.00049380644,"about_ca_topic_score_gemma":0.0005810781,"teacher_disagreement_score":0.0012426481,"about_ca_system_score_codex":0.00022969431,"about_ca_system_score_gemma":0.00030960175,"threshold_uncertainty_score":0.0041570663},"labels":[],"label_agreement":null},{"id":"W2295866100","doi":"10.1093/neuonc/now006","title":"M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Alberta Innovates; Killam Trusts; Terry Fox Foundation; Canadian Institutes of Health Research; Moffitt Cancer Center; Accelerate Brain Cancer Cure; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; Apoptosis; Temozolomide; Glioma; Biology; Cancer research; Programmed cell death; Virus; Cell culture; Virology; Genetics","score_opus":0.026498889121921547,"score_gpt":0.29708520331538457,"score_spread":0.270586314193463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295866100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648213,0.0005299748,0.0014162399,0.000111188485,0.000029006495,0.00007566367,0.00048422374,0.00010138137,0.00077010895],"genre_scores_gemma":[0.9942826,0.0005137221,0.0021885836,0.000047539466,0.000012207153,0.00010841184,0.0006462824,0.000028120709,0.0021725958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997608,0.000032073094,0.00003223334,0.00005236535,0.00005851485,0.00006402203],"domain_scores_gemma":[0.9997869,0.000021976688,0.00008763396,0.000024180952,0.0000122116,0.00006723026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027934564,0.00080722896,0.00039180063,0.00062315987,0.00020874351,0.0003992095,0.00048263412,0.00061167515,0.0010581575],"category_scores_gemma":[0.0001115755,0.00022987726,0.0003873762,0.00022351652,0.00053064176,0.0003978234,0.00019181243,0.0012932209,0.00037635758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003158853,0.00021618021,0.00022323083,0.000028821609,0.000007423966,0.00009340481,0.000025410976,0.00008748509,0.9981256,0.00017882463,0.000049393548,0.0006483681],"study_design_scores_gemma":[0.00014943015,0.0030258023,0.0036578916,0.000014916157,0.000031483774,0.0007901965,0.00004537604,0.0017520812,0.98899287,0.0000904191,0.001441552,0.000008002582],"about_ca_topic_score_codex":0.0007343979,"about_ca_topic_score_gemma":0.000991494,"teacher_disagreement_score":0.0010581575,"about_ca_system_score_codex":0.00059342274,"about_ca_system_score_gemma":0.00033724846,"threshold_uncertainty_score":0.004305601},"labels":[],"label_agreement":null},{"id":"W2299198409","doi":"10.1093/neuonc/nov234.15","title":"STEM-15LONG NONCODING RNA REGULATION OF THE CANCER STEM CELL PHENOTYPE IN GLIOBLASTOMA MULTIFORME","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Stem cell; Cancer stem cell; Embryonic stem cell; Neural stem cell; Glioma; In silico; Gene knockdown; Cancer research; Cellular differentiation; Phenotype; Long non-coding RNA; Cell biology; RNA; Genetics; Cell culture; Gene","score_opus":0.02437929323960931,"score_gpt":0.29507317186455795,"score_spread":0.27069387862494865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299198409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915377,0.0022957707,0.0038244755,0.000039877246,0.000017316956,0.000019391184,0.00082974904,0.00010563381,0.0013299516],"genre_scores_gemma":[0.99389243,0.00047460667,0.0033634761,0.00004017542,0.0000024391184,0.000015883328,0.0013908831,0.000013828277,0.00080612063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999187,0.000009453608,0.0000076003034,0.00002212514,0.000030448538,0.000011706167],"domain_scores_gemma":[0.9999248,0.000011502581,0.000031024465,0.0000042800066,0.000014809903,0.000013603571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103552404,0.0001568809,0.00021234971,0.00027395898,0.0001679364,0.00021430949,0.00009771987,0.00014374412,0.00070560933],"category_scores_gemma":[0.00014889824,0.00007962364,0.0002748173,0.0002044188,0.00016936763,0.00013455018,0.00016178814,0.00010819019,0.00022957477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013573498,0.000013972023,0.0092311185,0.00015225813,0.000017821016,0.00017048734,0.000054564716,0.0008679743,0.98315376,0.00031888825,0.00013199783,0.0057514384],"study_design_scores_gemma":[0.000021839614,0.00041743694,0.18107812,0.000038688115,0.000093613504,0.00068160857,0.00015670585,0.01985452,0.78755647,0.00042697566,0.009640787,0.000033221408],"about_ca_topic_score_codex":0.0022962987,"about_ca_topic_score_gemma":0.00447286,"teacher_disagreement_score":0.0022962987,"about_ca_system_score_codex":0.0004007188,"about_ca_system_score_gemma":0.00024891883,"threshold_uncertainty_score":0.004565835},"labels":[],"label_agreement":null},{"id":"W2299501240","doi":"10.1093/neuonc/nov207.10","title":"ANGI-10GLIOMA-ASSOCIATED MACROPHAGES PROMOTE ENDOTHELIAL CELL DYSFUNCTION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Angiogenesis; Glioma; Microglia; Endothelial stem cell; Biology; Vasculogenesis; Stromal cell; Cancer research; Downregulation and upregulation; Population; Chemokine; Cell biology; Immunology; Angiopoietin; Neovascularization; Inflammation; Medicine; Vascular endothelial growth factor; Stem cell; Gene; Progenitor cell","score_opus":0.026785272955733647,"score_gpt":0.2874912415900188,"score_spread":0.2607059686342852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299501240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950058,0.0025145235,0.0008460318,0.0001274564,0.00004126715,0.000023353326,0.00022770758,0.000070909395,0.00114303],"genre_scores_gemma":[0.995218,0.0012187519,0.00076541957,0.000117953976,0.000020952933,0.00003178266,0.00037399246,0.000009075697,0.0022440031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999044,0.000018462002,0.000006721351,0.000011635092,0.000021945674,0.000036879577],"domain_scores_gemma":[0.9999454,0.0000069177136,0.000014073146,0.0000053239214,0.000008045332,0.000020295058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010622568,0.00027513847,0.00017555397,0.0001567112,0.0000836036,0.00015650365,0.00007388667,0.0001826966,0.0012032837],"category_scores_gemma":[0.00006392093,0.00007025729,0.00020882374,0.00007575862,0.00009865674,0.00008679843,0.00014185351,0.00042459086,0.00033581132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002020583,0.00005472476,0.00031185942,0.000062748644,0.0000056547783,0.0001045577,0.000017784243,0.000020420637,0.9980755,0.000029712446,0.00007711388,0.0010378589],"study_design_scores_gemma":[0.000042753356,0.0014685028,0.015944704,0.000017460177,0.000033052074,0.00081402983,0.00009775072,0.000629998,0.9763708,0.00009773824,0.0044790627,0.000004182689],"about_ca_topic_score_codex":0.0004105185,"about_ca_topic_score_gemma":0.000671077,"teacher_disagreement_score":0.0012032837,"about_ca_system_score_codex":0.0001145513,"about_ca_system_score_gemma":0.000127766,"threshold_uncertainty_score":0.00402534},"labels":[],"label_agreement":null},{"id":"W2302893028","doi":"10.1093/neuonc/nov216.14","title":"HCP-14GLIOBLASTOMA MULTIFORME AMONG ELDERLY: A SINGLE INSTITUTION EXPERIENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Temozolomide; Tolerability; Chemoradiotherapy; Concomitant; Proportional hazards model; Glioblastoma; Oncology; Cohort; Log-rank test; Radiation therapy; Surgery; Adverse effect; Confidence interval","score_opus":0.046327098455236033,"score_gpt":0.3162380070478562,"score_spread":0.2699109085926202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302893028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894506,0.00042569748,0.00009548148,0.000048741036,0.0000063810608,0.000015584648,0.00006437886,0.000004419315,0.00039424535],"genre_scores_gemma":[0.99910754,0.00039659737,0.00012501162,0.000065394524,0.000020520234,0.000009734435,0.00010686715,0.0000034365596,0.0001648829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969745,0.000052102612,0.000039701474,0.0000635222,0.00005353117,0.00009374196],"domain_scores_gemma":[0.9993156,0.00006532467,0.00025577153,0.000041202504,0.00004754062,0.00027461382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000364746,0.0002764466,0.0003065378,0.0004686228,0.00062599755,0.0004424873,0.00022420869,0.00023648278,0.0011191276],"category_scores_gemma":[0.00090188836,0.00017705145,0.00030114074,0.00074956106,0.00033081215,0.00031387282,0.0007230069,0.00028853546,0.0002891217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014025588,0.00015383484,0.9771917,0.000045550707,0.00003427969,0.008435876,0.0005044529,0.0000743547,0.00085412024,0.00004506685,0.00035510302,0.0121656135],"study_design_scores_gemma":[0.00003782906,0.0010911837,0.95326185,0.000050250514,0.00008174826,0.0404022,0.0018556883,0.00022943315,0.0005641811,0.00008616339,0.0023196635,0.000019795309],"about_ca_topic_score_codex":0.0030096008,"about_ca_topic_score_gemma":0.006839494,"teacher_disagreement_score":0.0030096008,"about_ca_system_score_codex":0.0006672159,"about_ca_system_score_gemma":0.0008165276,"threshold_uncertainty_score":0.0059841275},"labels":[],"label_agreement":null},{"id":"W2304052286","doi":"10.1093/neuonc/nov204.52","title":"ATPS-52A PRE-CLINICAL COMBINATORIAL STRATEGY TO TARGET THE JAK/STAT AND EGFR PATHWAYS IN GBM","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"EGFR inhibitors; Erlotinib; Temozolomide; Cancer research; Lapatinib; Medicine; Gefitinib; Epidermal growth factor receptor; Neurosphere; Biology; Pharmacology; Oncology; Cancer; Glioma; Internal medicine; In vitro; Breast cancer","score_opus":0.09386709093330496,"score_gpt":0.38399712240198525,"score_spread":0.29013003146868027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304052286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781666,0.004996226,0.0026941989,0.00057656615,0.00026193872,0.0006263077,0.001709696,0.0004661589,0.010502433],"genre_scores_gemma":[0.9857583,0.0033406145,0.0024581107,0.00038962884,0.000048385573,0.00034386836,0.0025318586,0.0000483153,0.0050808867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998648,0.00002091308,0.000009398213,0.000019311374,0.000031834796,0.000053703978],"domain_scores_gemma":[0.9999441,0.0000037130317,0.000008731772,0.0000054546185,0.000008570883,0.000029513498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020325094,0.00062288437,0.00067132455,0.00044154894,0.00017688103,0.0005112479,0.00034061764,0.00028758057,0.0032158897],"category_scores_gemma":[0.00009352589,0.00019716809,0.0003173959,0.00030646945,0.00022576026,0.0001956618,0.00021112127,0.0010375225,0.00068100914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003570075,0.0036013643,0.0011647852,0.0006043339,0.00012322715,0.0004134375,0.00006686888,0.0034744823,0.8794295,0.001301478,0.0053125722,0.100937985],"study_design_scores_gemma":[0.0046225158,0.06172083,0.023596518,0.000093688235,0.0005146111,0.002942999,0.000120200144,0.0076297848,0.8443889,0.0006481638,0.05363626,0.00008547334],"about_ca_topic_score_codex":0.0012621256,"about_ca_topic_score_gemma":0.005907548,"teacher_disagreement_score":0.0032158897,"about_ca_system_score_codex":0.00045172274,"about_ca_system_score_gemma":0.00059857324,"threshold_uncertainty_score":0.010758162},"labels":[],"label_agreement":null},{"id":"W2306472141","doi":"10.1093/neuonc/nov222.22","title":"MPTH-22INTEGRATING MOLECULAR MARKERS INTO THE WORLD HEALTH ORGANIZATION (WHO) CLASSIFICATION OF GLIOMAS: SURVEY RESULTS FROM THE SNO MEMBERSHIP","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Subspecialty; Medicine; Glioma; Family medicine; Oncology; Cancer research","score_opus":0.064574434945345,"score_gpt":0.3356107767125805,"score_spread":0.2710363417672355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306472141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136305,0.00014106726,0.0002124534,0.0006777553,0.000027800395,0.00010581179,0.0047871405,0.000013599797,0.0026713856],"genre_scores_gemma":[0.9927806,0.00031036863,0.00041891434,0.00044647968,0.000037922768,0.00026327107,0.0048680543,0.000010119361,0.0008643245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976701,0.0008983569,0.00033850342,0.00016618075,0.00059465546,0.00033216487],"domain_scores_gemma":[0.99095774,0.0022452623,0.003221485,0.00035105486,0.0020580061,0.0011665253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005131647,0.00021053027,0.00020310176,0.0014108454,0.00031247607,0.00075592124,0.00030276665,0.00058485696,0.0018878919],"category_scores_gemma":[0.009921808,0.00013728891,0.00035736393,0.0016471071,0.00032804278,0.0007985675,0.0011802489,0.00049606996,0.0009124338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006530874,0.00007263461,0.98993486,0.00007948578,0.0000202507,0.000027585953,0.0012983582,0.00007141201,0.00017657004,0.00004330329,0.0025829272,0.005627387],"study_design_scores_gemma":[0.0000060470156,0.00014069625,0.9919207,0.000055915276,0.000009297526,0.0000635522,0.004697366,0.0001942955,0.00009892328,0.000024011071,0.002782312,0.000006883382],"about_ca_topic_score_codex":0.0070650703,"about_ca_topic_score_gemma":0.0051994086,"teacher_disagreement_score":0.0070650703,"about_ca_system_score_codex":0.0005093951,"about_ca_system_score_gemma":0.00068427215,"threshold_uncertainty_score":0.027139068},"labels":[],"label_agreement":null},{"id":"W2307113881","doi":"10.1093/neuonc/nov208.05","title":"BMET-05NCCTG N0574 (ALLIANCE): A PHASE III RANDOMIZED TRIAL OF WHOLE BRAIN RADIATION THERAPY (WBRT) IN ADDITION TO RADIOSURGERY (SRS) IN PATIENTS WITH 1 TO 3 BRAIN METASTASES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Internal medicine; Neurocognitive; Quality of life (healthcare); Randomized controlled trial; Oncology; Radiation therapy; Cognition","score_opus":0.02988153141582374,"score_gpt":0.32918399172132823,"score_spread":0.2993024603055045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307113881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905771,0.0026376846,0.0003457557,0.0005944215,0.00023452981,0.0021869694,0.0010657243,0.00014952829,0.0022083526],"genre_scores_gemma":[0.9834198,0.0026106765,0.0017176637,0.0010970394,0.00036303583,0.004341087,0.0021993967,0.000033815435,0.004217487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995987,0.00024336862,0.00001379023,0.000044278557,0.000033311262,0.00006654254],"domain_scores_gemma":[0.9996593,0.000054123866,0.000094044255,0.000019901527,0.000017173623,0.00015548232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012083189,0.0016042367,0.0016436294,0.0006355845,0.00039122617,0.000637787,0.0009110468,0.0009653332,0.0067024953],"category_scores_gemma":[0.0007634399,0.00039058746,0.0010717793,0.0005443069,0.0007951493,0.0005383385,0.00036544245,0.0020414218,0.0009774086],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9080695,0.022381691,0.0022215557,0.00086432096,0.0012776194,0.00012341593,0.00010556234,0.0014119991,0.0075919703,0.00034142466,0.004798796,0.05081223],"study_design_scores_gemma":[0.8608198,0.13159993,0.003928367,0.000045477533,0.00047476272,0.000094236304,0.000024698344,0.0006302082,0.0005613179,0.00015718676,0.00164741,0.000016597884],"about_ca_topic_score_codex":0.0021608204,"about_ca_topic_score_gemma":0.0069655827,"teacher_disagreement_score":0.0067024953,"about_ca_system_score_codex":0.0010027708,"about_ca_system_score_gemma":0.0016290561,"threshold_uncertainty_score":0.022422016},"labels":[],"label_agreement":null},{"id":"W2307118212","doi":"10.1093/neuonc/nov206.12","title":"ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Université de Montréal; University of Calgary","funders":"","keywords":"Temozolomide; Nitrosourea; Anaplastic astrocytoma; Medicine; Radiation therapy; Oncology; Internal medicine; Astrocytoma; O-6-methylguanine-DNA methyltransferase; Glioma; Chemotherapy; Cancer research; Biology; Methyltransferase","score_opus":0.051692184720617665,"score_gpt":0.36309870387545695,"score_spread":0.3114065191548393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307118212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530539,0.0054219253,0.0013596008,0.0018850563,0.0010080006,0.024240155,0.0061856024,0.00018382017,0.0066619273],"genre_scores_gemma":[0.93073237,0.0039638025,0.0075993026,0.0026125382,0.0010880235,0.034121912,0.005717055,0.0001323087,0.014032731],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976799,0.0018149337,0.000085933294,0.00013826942,0.00015794975,0.00012304272],"domain_scores_gemma":[0.9976445,0.0006757716,0.0006710165,0.00012870523,0.00015864172,0.00072132365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005078266,0.001627229,0.0025395488,0.0005795369,0.00050231325,0.00081612624,0.000984106,0.0014546923,0.011541487],"category_scores_gemma":[0.003559467,0.0006403313,0.0017858776,0.00079807185,0.00083231495,0.00047057244,0.0003614129,0.0026995724,0.0015361629],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97269315,0.005441981,0.0012773449,0.000497263,0.00074286043,0.000043384436,0.00003943682,0.0004276214,0.0024354851,0.00009839823,0.0026804805,0.013622498],"study_design_scores_gemma":[0.932142,0.06229003,0.0020615566,0.00003582845,0.0005853072,0.000046497942,0.000008694629,0.0003961926,0.00045285487,0.00009785434,0.0018741237,0.000009021881],"about_ca_topic_score_codex":0.0009733309,"about_ca_topic_score_gemma":0.0027343729,"teacher_disagreement_score":0.011541487,"about_ca_system_score_codex":0.0010179476,"about_ca_system_score_gemma":0.0028018623,"threshold_uncertainty_score":0.0386101},"labels":[],"label_agreement":null},{"id":"W2307494918","doi":"10.1093/neuonc/now046","title":"Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bevacizumab; Internal medicine; Temozolomide; Hazard ratio; Oncology; Proportional hazards model; Post-hoc analysis; Radiation therapy; Progression-free survival; Population; Multivariate analysis; Surgery; Overall survival; Chemotherapy; Confidence interval","score_opus":0.03451598792110212,"score_gpt":0.3149871013163817,"score_spread":0.2804711133952796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307494918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767894,0.0011873189,0.00023864259,0.00012956548,0.000018995144,0.00011795158,0.00020928035,0.000010024909,0.00040920003],"genre_scores_gemma":[0.9982053,0.00023043927,0.00040293147,0.0001218615,0.00005134195,0.0001295525,0.00061320415,0.0000060323428,0.00023936608],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987349,0.00076836615,0.00005026735,0.00015813923,0.00013777308,0.00015064186],"domain_scores_gemma":[0.99773216,0.001109423,0.0004931847,0.00021534266,0.00010898225,0.00034080754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034690418,0.0006339206,0.0012163491,0.00025863101,0.00017751953,0.00080179283,0.0005311696,0.00058457884,0.0012498916],"category_scores_gemma":[0.0032723274,0.000172319,0.0031176896,0.0002199282,0.00027271308,0.0006353375,0.00043805814,0.0011710977,0.00017157252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6007083,0.0070883674,0.26760328,0.00084999553,0.011295093,0.0007399178,0.00028299572,0.0043321433,0.014530216,0.00049919117,0.001907175,0.09016326],"study_design_scores_gemma":[0.061617684,0.30709514,0.59202945,0.0001673185,0.012701779,0.0012321423,0.00025353982,0.010378792,0.006737867,0.0016058638,0.006095346,0.00008514529],"about_ca_topic_score_codex":0.0002514976,"about_ca_topic_score_gemma":0.0008820464,"teacher_disagreement_score":0.0034690418,"about_ca_system_score_codex":0.00059704937,"about_ca_system_score_gemma":0.0007954563,"threshold_uncertainty_score":0.01834625},"labels":[],"label_agreement":null},{"id":"W2308410138","doi":"10.1093/neuonc/nov214.13","title":"EPIG-13ROBUST MGMT METHYLATION DETECTION USING 450k ARRAY IN CIMP-NEGATIVE GBM","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Concordance; DNA methylation; Methyltransferase; Biomarker; Computational biology; Oncology; Confounding; Biology; Bioinformatics; Medicine; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.07507715708103423,"score_gpt":0.3457348808064647,"score_spread":0.27065772372543045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308410138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457205,0.00041824215,0.01241985,0.00007097532,0.000011117082,0.000021622685,0.0014592108,0.0003610364,0.00066593353],"genre_scores_gemma":[0.9861123,0.00014763778,0.010604672,0.000060055234,0.000005769579,0.000036403737,0.0023470458,0.000043881908,0.00064214645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961025,0.000091564354,0.00002066699,0.0001355848,0.00008645114,0.000055658544],"domain_scores_gemma":[0.9998149,0.00005408967,0.000026608572,0.00003880862,0.000048445454,0.000017224129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057423173,0.00032740383,0.00038860828,0.00048815532,0.00018347765,0.00037996168,0.00025858096,0.00035453402,0.00082349475],"category_scores_gemma":[0.0009102659,0.0002712027,0.0003338725,0.0003240337,0.00019780682,0.00017057698,0.00026032142,0.00027415942,0.0003326566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021896919,0.00017127318,0.2761272,0.00024651343,0.00031256833,0.00042331696,0.00034272327,0.014606601,0.6162984,0.00035096583,0.0018161676,0.087114565],"study_design_scores_gemma":[0.000039307313,0.0005392664,0.6133019,0.000021246868,0.00029969763,0.0011906815,0.00017162245,0.10476407,0.27529275,0.0008217822,0.0034968117,0.000060939197],"about_ca_topic_score_codex":0.003584178,"about_ca_topic_score_gemma":0.0070494553,"teacher_disagreement_score":0.003584178,"about_ca_system_score_codex":0.0002828249,"about_ca_system_score_gemma":0.00021071864,"threshold_uncertainty_score":0.0071266294},"labels":[],"label_agreement":null},{"id":"W2312417698","doi":"10.1093/neuonc/3.4.258","title":"IMMUNOTHERAPY TASK FORCE FOR MALIGNANT BRAIN TUMORS April 21, 2001,Toronto, Ontario","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Task force; Immunotherapy; Task (project management); Medicine; Oncology; Internal medicine; Political science; Management; Cancer; Economics","score_opus":0.02270342587934088,"score_gpt":0.29757294200660395,"score_spread":0.27486951612726307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312417698","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010890022,0.09255282,0.004696736,0.37255546,0.14353287,0.004988557,0.054169737,0.0008056195,0.31580818],"genre_scores_gemma":[0.016684989,0.051524952,0.0031140374,0.020266704,0.017715354,0.0013496005,0.025678271,0.0003553583,0.8633108],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978523,0.00012891731,0.00013740122,0.00012327376,0.001212657,0.00054551876],"domain_scores_gemma":[0.99283946,0.00039196017,0.0005137186,0.00016618383,0.0040166914,0.0020720537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003654698,0.0013341289,0.0012928939,0.0016767491,0.0036676775,0.0026350769,0.001518308,0.0037375465,0.02662129],"category_scores_gemma":[0.004212614,0.0008969893,0.0008388574,0.0019754835,0.00091418024,0.0007642071,0.0012995698,0.0033092,0.013950902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056197223,0.000013279751,0.0008322256,0.00009549693,0.000005641929,0.00004945978,0.000037300997,0.000088400775,0.00022210646,0.00019215682,0.988162,0.010245737],"study_design_scores_gemma":[0.000049758808,0.000022470444,0.009892419,0.00019542992,0.000018603087,0.000050461196,0.00008641142,0.000091630325,0.00010820843,0.0001237082,0.9893496,0.000011317785],"about_ca_topic_score_codex":0.5821634,"about_ca_topic_score_gemma":0.86550844,"teacher_disagreement_score":0.5821634,"about_ca_system_score_codex":0.013153616,"about_ca_system_score_gemma":0.04612344,"threshold_uncertainty_score":0.84059465},"labels":[],"label_agreement":null},{"id":"W2312847545","doi":"10.1093/neuonc/nou237.31","title":"AT-31A CANADIAN QUESTIONNAIRE ON THE MANAGEMENT OF ADULT DIFFUSE LOW GRADE GLIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Magnetic resonance imaging; Perioperative; Neurocognitive; Craniotomy; Surgery; General surgery; Radiology; Cognition; Psychiatry","score_opus":0.013418667239834476,"score_gpt":0.2625075014358827,"score_spread":0.24908883419604821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312847545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74372196,0.00356458,0.0014520838,0.020749586,0.0007102124,0.0037931113,0.09988234,0.00021991222,0.12590612],"genre_scores_gemma":[0.9191539,0.0061206655,0.0060750325,0.0076801833,0.00023762563,0.002235112,0.026034651,0.000060635663,0.03240211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929655,0.00008759599,0.00009192763,0.00005079758,0.00023420584,0.00023882856],"domain_scores_gemma":[0.9955711,0.000510562,0.00052301266,0.00004485182,0.0025045625,0.000845981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010041652,0.00029000707,0.00027504773,0.0009879867,0.0014258003,0.00046439984,0.00041578105,0.0004933235,0.010777046],"category_scores_gemma":[0.003887965,0.00013699598,0.00034885178,0.0013262717,0.0003718061,0.00036705745,0.00045324903,0.0005606568,0.0017690471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043478014,0.0005663577,0.5356057,0.0013038001,0.00005912939,0.00073288486,0.005779812,0.0009662177,0.0018472826,0.00103983,0.33738238,0.114281744],"study_design_scores_gemma":[0.00005442967,0.0002949703,0.80998117,0.00053600874,0.00002007302,0.00063135073,0.005097104,0.0005551149,0.00022411371,0.00016830688,0.18236914,0.00006815015],"about_ca_topic_score_codex":0.70972824,"about_ca_topic_score_gemma":0.83465433,"teacher_disagreement_score":0.29027176,"about_ca_system_score_codex":0.011159483,"about_ca_system_score_gemma":0.011402117,"threshold_uncertainty_score":0.58396244},"labels":[],"label_agreement":null},{"id":"W2312888579","doi":"10.1093/neuonc/nou238.2","title":"AI-02 * HYPOXIA AS A MEASURE OF FUNCTIONAL STATUS OF GLIOBLASTOMA VASCULATURE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Hypoxia (environmental); Pathology; CD31; Tumor microenvironment; Glioblastoma; Neovascularization; Tumor hypoxia; Microvessel; Angiogenesis; Blood vessel; Medicine; Biology; Immunohistochemistry; Cancer research; Tumor cells; Chemistry; Internal medicine","score_opus":0.00932098661912247,"score_gpt":0.25092890743919827,"score_spread":0.2416079208200758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312888579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96193993,0.007167298,0.01085668,0.00021830879,0.00013777139,0.00010692394,0.002097091,0.0003855625,0.01709035],"genre_scores_gemma":[0.9800008,0.0017496218,0.006648664,0.00015410135,0.00003504836,0.0002760358,0.0025223715,0.00003930793,0.008574088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997873,0.000044876946,0.000016271622,0.000044332966,0.00007309069,0.00003418821],"domain_scores_gemma":[0.99982053,0.000021922417,0.00004396649,0.000010358992,0.000049506023,0.000053824548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019832561,0.0002653317,0.0001628626,0.00047152414,0.00021731202,0.00026912996,0.0001770918,0.00033839227,0.003902637],"category_scores_gemma":[0.00014561633,0.00010250237,0.00010720973,0.0006160309,0.00022842652,0.00022894458,0.00018857581,0.0005183027,0.00065771694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012103549,0.00023102581,0.013968282,0.00025178384,0.00005231593,0.000244139,0.00010211488,0.00018105068,0.9673292,0.00050446845,0.0013750759,0.014550239],"study_design_scores_gemma":[0.000054804517,0.0024996377,0.2254084,0.000044425626,0.00011672034,0.0035682905,0.0002640613,0.0045724977,0.7462512,0.0005641706,0.016614223,0.000041513267],"about_ca_topic_score_codex":0.00089956686,"about_ca_topic_score_gemma":0.0009786852,"teacher_disagreement_score":0.003902637,"about_ca_system_score_codex":0.00027078026,"about_ca_system_score_gemma":0.00014906842,"threshold_uncertainty_score":0.013055623},"labels":[],"label_agreement":null},{"id":"W2313026868","doi":"10.1093/neuonc/nou255.44","title":"ET-46 * ONCOLYTIC VIRAL THERAPY FOR MALIGNANT GLIOMAS USING MYXOMA VIRUS DELETED FOR ANTI-APOPTOTIC M11L GENE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Myxoma virus; Oncolytic virus; Biology; Apoptosis; Programmed cell death; Small interfering RNA; Virology; Virus; Cancer research; Gene silencing; Cell culture; Gene; Transfection; Genetics","score_opus":0.0413328903918742,"score_gpt":0.3550147754217088,"score_spread":0.3136818850298346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313026868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338114,0.0015325473,0.00210215,0.00014801162,0.00007194577,0.000066581866,0.00036643224,0.00009566571,0.0022354163],"genre_scores_gemma":[0.9916958,0.00062959135,0.0025665276,0.0000523306,0.000010769791,0.000050908973,0.0006823821,0.000017200708,0.004294526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998759,0.000024062854,0.00001518184,0.000020666153,0.000035341916,0.000028818453],"domain_scores_gemma":[0.9999459,0.000009079104,0.00001481817,0.000008512378,0.000004619572,0.00001708827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011902029,0.00031501948,0.00032213447,0.00016751117,0.00012501702,0.00030284864,0.00017353968,0.00046934973,0.0014765939],"category_scores_gemma":[0.00007392586,0.00012093541,0.0002328584,0.00015081972,0.00018954763,0.00027846816,0.0001677722,0.00081453356,0.0005055876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005292429,0.0001840249,0.00022967184,0.00006529537,0.000015330357,0.00009596928,0.000024789355,0.0004171157,0.99350536,0.0004924907,0.00015596379,0.0042848177],"study_design_scores_gemma":[0.00012271985,0.0015843207,0.0011641803,0.0000065131007,0.000017683757,0.0005275197,0.000014591193,0.0023943195,0.9883095,0.00007726842,0.005773359,0.000007941753],"about_ca_topic_score_codex":0.000386209,"about_ca_topic_score_gemma":0.0003914426,"teacher_disagreement_score":0.0014765939,"about_ca_system_score_codex":0.00029995045,"about_ca_system_score_gemma":0.00020813817,"threshold_uncertainty_score":0.0049396753},"labels":[],"label_agreement":null},{"id":"W2313158881","doi":"10.1093/neuonc/nou208.43","title":"TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cofilin; Biology; Cancer research; Gene expression profiling; Glioma; Gene; Microarray analysis techniques; Immunohistochemistry; Astrocytoma; Microarray; Pathology; Gene expression; Medicine; Actin cytoskeleton; Genetics; Immunology; Cell; Cytoskeleton","score_opus":0.007836307454265322,"score_gpt":0.2506211578571817,"score_spread":0.24278485040291636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313158881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975327,0.00072462147,0.00054107787,0.000038263748,0.00000560229,0.000017458948,0.0006939072,0.000024481327,0.00042189573],"genre_scores_gemma":[0.9954535,0.0005302953,0.0014520001,0.00005638312,0.000007947067,0.00004188791,0.0018171688,0.000010196153,0.00063061935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998691,0.000010679292,0.00000746622,0.000026996577,0.00004254426,0.000043162672],"domain_scores_gemma":[0.999889,0.00002278088,0.000034112676,0.000006545544,0.000021829283,0.000025728541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014704595,0.00020316296,0.00033210777,0.00041621248,0.00018128548,0.0003436884,0.00008757737,0.00014131996,0.0008041403],"category_scores_gemma":[0.00015866222,0.00009854213,0.00021481153,0.0003602521,0.00016182238,0.00010231166,0.0001247209,0.00024165431,0.00021220197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006734563,0.00008858559,0.011943413,0.00010147346,0.000022565027,0.000054127282,0.000040249688,0.00016396122,0.98249567,0.000041984018,0.00017069964,0.0042037065],"study_design_scores_gemma":[0.000054278564,0.0011339773,0.28937218,0.000017081038,0.0001169364,0.0005168415,0.00019334423,0.002150033,0.7030348,0.0000921645,0.0033074426,0.000010885465],"about_ca_topic_score_codex":0.00040548408,"about_ca_topic_score_gemma":0.0009441916,"teacher_disagreement_score":0.0008041403,"about_ca_system_score_codex":0.00027620318,"about_ca_system_score_gemma":0.00022040725,"threshold_uncertainty_score":0.0026900768},"labels":[],"label_agreement":null},{"id":"W2313382222","doi":"10.1093/neuonc/nou270.16","title":"RT-19 * PROGNOSTIC VALUE OF EARLY CHANGES IN NEUTROPHIL AND LYMPHOCYTE MEASURES DURING CHEMORADIOTHERAPY FOR GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Dexamethasone; Univariate analysis; Hazard ratio; Proportional hazards model; Chemoradiotherapy; Neutrophil to lymphocyte ratio; Gastroenterology; Lymphocyte; Multivariate analysis; Radiation therapy; Surgery; Confidence interval","score_opus":0.01500429910816527,"score_gpt":0.2792741752585206,"score_spread":0.26426987615035535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313382222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987538,0.0006240058,0.00007834157,0.0000377626,0.000010057613,0.0000044794633,0.00018939497,0.0000071175778,0.00029506904],"genre_scores_gemma":[0.99954504,0.00006776475,0.00004879641,0.00000919664,0.000007829742,0.0000032283458,0.00020800323,0.0000014848911,0.000108692606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998258,0.00003695226,0.000024427562,0.0000391615,0.000034653003,0.000038989554],"domain_scores_gemma":[0.99897575,0.00017078083,0.0005560871,0.000032135253,0.000097306496,0.00016794754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003073162,0.0001633466,0.000263699,0.00026169932,0.00014515275,0.0003291524,0.00017947952,0.00022422685,0.0011202365],"category_scores_gemma":[0.0014043488,0.00006525167,0.0002657525,0.00033744916,0.00013270251,0.00020225764,0.00017072375,0.00030660504,0.00023778758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079565216,0.000024074723,0.9920277,0.000013562816,0.000046807716,0.00009060682,0.00001225754,0.00011074552,0.0006525891,0.0000052096925,0.00011780022,0.006103032],"study_design_scores_gemma":[0.000011202275,0.00041561038,0.99784374,0.000005722594,0.000043211923,0.0005320959,0.000021811737,0.00034238744,0.00044495796,0.000015582007,0.0003202034,0.0000034428342],"about_ca_topic_score_codex":0.0012498368,"about_ca_topic_score_gemma":0.0021213253,"teacher_disagreement_score":0.0012498368,"about_ca_system_score_codex":0.00034788964,"about_ca_system_score_gemma":0.00020755036,"threshold_uncertainty_score":0.0037475824},"labels":[],"label_agreement":null},{"id":"W2313984778","doi":"10.1093/neuonc/nov204.30","title":"ATPS-30INTRATUMORAL MODULATION THERAPY FOR GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioblastoma; Modulation (music); Cancer research; Chemistry; Medicine; Physics","score_opus":0.04661633066988025,"score_gpt":0.3322674481069172,"score_spread":0.28565111743703697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313984778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712196,0.014855563,0.0065216403,0.00047204865,0.00020093315,0.000281211,0.00037150842,0.00039534157,0.0056822603],"genre_scores_gemma":[0.98773986,0.007162878,0.002174346,0.00012729118,0.000033897966,0.00012723121,0.00041664747,0.000019260751,0.0021984945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996483,0.0000031613372,0.0000033909503,0.0000055817445,0.0000120695095,0.000011084269],"domain_scores_gemma":[0.9999862,9.511433e-7,0.000004926226,0.0000015278139,0.0000025614877,0.000003951172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064345615,0.00041538192,0.00029528013,0.00031749214,0.000120287215,0.00018972321,0.00022558469,0.00023817581,0.001329455],"category_scores_gemma":[0.00003675583,0.000069773756,0.00024158451,0.00018313454,0.00014417159,0.00013677486,0.00021334089,0.00031774834,0.00035945143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059525383,0.0003742842,0.0004805299,0.00040070672,0.000030279007,0.0003304187,0.00003835079,0.0005554409,0.9232346,0.00033222148,0.00094153243,0.072686456],"study_design_scores_gemma":[0.00033262206,0.008768536,0.00943858,0.00009645721,0.00018773638,0.002261446,0.000062615356,0.0030178775,0.944814,0.00046900066,0.03052634,0.00002474605],"about_ca_topic_score_codex":0.00065265386,"about_ca_topic_score_gemma":0.0018013658,"teacher_disagreement_score":0.001329455,"about_ca_system_score_codex":0.00024259502,"about_ca_system_score_gemma":0.00025066716,"threshold_uncertainty_score":0.00444746},"labels":[],"label_agreement":null},{"id":"W2314422247","doi":"10.1093/neuonc/nou264.8","title":"NI-08 * OPTIMIZATION OF MOLECULAR MR IMAGING OF GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta; University of Calgary","funders":"","keywords":"Glioma; Pulse sequence; Magnetic resonance imaging; Gradient echo; Contrast (vision); Pulse (music); Nuclear medicine; Spin echo; Medicine; Nuclear magnetic resonance; Radiology; Physics; Cancer research; Optics","score_opus":0.008974620497344847,"score_gpt":0.2496329735080082,"score_spread":0.24065835301066335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314422247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085128,0.005399083,0.06214442,0.0004817154,0.00008080232,0.00027068314,0.000559423,0.0007998545,0.02175131],"genre_scores_gemma":[0.882632,0.0018027786,0.10416939,0.00017870798,0.000016804377,0.00022908534,0.0009463416,0.00023691653,0.00978789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990106,0.000022709399,0.000005044009,0.000022212593,0.000035507604,0.0000135246],"domain_scores_gemma":[0.99992216,0.000011254187,0.000019014049,0.0000050074686,0.000030715215,0.000011706934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021525357,0.00037854566,0.00017397094,0.00015884827,0.00010990916,0.0002806326,0.00024396447,0.00026733443,0.0015793181],"category_scores_gemma":[0.0002312157,0.00014101574,0.00012089354,0.00017072214,0.00011058776,0.0001618977,0.00019312072,0.0003124561,0.00070507394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000260292,0.000051010524,0.0004650547,0.00015365302,0.0000086728105,0.00004577336,0.000018663279,0.0012825794,0.9845712,0.00028818924,0.00038406442,0.012470662],"study_design_scores_gemma":[0.000023378225,0.0005369195,0.0016046625,0.000011869447,0.00002469972,0.00025701788,0.000021113074,0.00769346,0.98115623,0.00007538375,0.008582732,0.000012504024],"about_ca_topic_score_codex":0.0010876484,"about_ca_topic_score_gemma":0.0016838977,"teacher_disagreement_score":0.0015793181,"about_ca_system_score_codex":0.00031664543,"about_ca_system_score_gemma":0.00029141174,"threshold_uncertainty_score":0.0052833557},"labels":[],"label_agreement":null},{"id":"W2314720922","doi":"10.1093/neuonc/nov061.118","title":"OT-05 * H3.3-K27M IS A NEGATIVE PROGNOSTIC MARKER IN THALAMIC PEDIATRIC GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Glioma; Medicine; Internal medicine; Oncology; Neuroscience; Psychology; Cancer research","score_opus":0.030934133725999534,"score_gpt":0.3080997552019092,"score_spread":0.2771656214759097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314720922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981787,0.0003458256,0.00044797693,0.000024894634,0.000003969925,0.0000053391636,0.00026865088,0.000012857333,0.00071188994],"genre_scores_gemma":[0.99911743,0.00009436314,0.00031802824,0.000009213551,0.0000029714447,0.000004156383,0.00027616808,0.000003967868,0.00017363387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998542,0.000022688071,0.000011933607,0.00003393864,0.000044579134,0.000032663815],"domain_scores_gemma":[0.99964106,0.00007862841,0.00014174035,0.000018623505,0.00005124813,0.000068703324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022786137,0.00013765648,0.0001895686,0.00031347535,0.00012722403,0.00033462897,0.00012369404,0.00014668016,0.0014579375],"category_scores_gemma":[0.00057203276,0.00007668578,0.000115074836,0.0003039675,0.00021590701,0.00009557902,0.00018785689,0.00021313594,0.00034273183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008716531,0.000034204728,0.9294904,0.000040003415,0.000040491646,0.0005566423,0.00009178591,0.00019801155,0.05629637,0.000068458445,0.0003363395,0.0119758155],"study_design_scores_gemma":[0.0000129857635,0.00046474524,0.9728056,0.000007672181,0.00004905541,0.0029649022,0.00019968553,0.0009952155,0.02100415,0.00007956482,0.0014110547,0.000005291586],"about_ca_topic_score_codex":0.0015583193,"about_ca_topic_score_gemma":0.001874263,"teacher_disagreement_score":0.0015583193,"about_ca_system_score_codex":0.00026869206,"about_ca_system_score_gemma":0.00018183963,"threshold_uncertainty_score":0.0048772693},"labels":[],"label_agreement":null},{"id":"W2314980639","doi":"10.1093/neuonc/nou268.8","title":"PM-08 * INVESTIGATING THE DETERMINANTS OF GBM SUBTYPES USING NOVEL MOUSE MODELS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Electroporation; Biology; Gene expression; Cancer research; Gene; Cre recombinase; Transgene; Genetics; Genetically modified mouse","score_opus":0.07031756219139779,"score_gpt":0.3254315452799781,"score_spread":0.2551139830885803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314980639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93075013,0.0015188282,0.04644646,0.0009837165,0.0002311326,0.0004674268,0.005663484,0.0016372579,0.01230157],"genre_scores_gemma":[0.87336946,0.0030880645,0.05522506,0.00059479626,0.000075860175,0.0014263795,0.006884732,0.0011566584,0.058178965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950683,0.00007810266,0.000050351227,0.00014306024,0.00013942346,0.0000822494],"domain_scores_gemma":[0.9994721,0.0000816142,0.00015934272,0.0000774146,0.000060398,0.0001492567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005897479,0.0010020541,0.00045577838,0.0019279885,0.00038348677,0.00076006993,0.0007277351,0.0010548668,0.005692197],"category_scores_gemma":[0.00022749408,0.0005304074,0.00073418586,0.00043133847,0.00066379696,0.0007047195,0.00063417316,0.0021036912,0.0021469044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052015117,0.00042701603,0.0007387124,0.00009534387,0.00002479033,0.0002423271,0.000071062444,0.00042880056,0.9883157,0.0019912072,0.00061903056,0.0065259165],"study_design_scores_gemma":[0.00014641834,0.0023250522,0.0053213444,0.00006753204,0.000101279235,0.0017136545,0.00014116976,0.006495785,0.9630497,0.0008702398,0.019744081,0.000023832328],"about_ca_topic_score_codex":0.0011203187,"about_ca_topic_score_gemma":0.0013554908,"teacher_disagreement_score":0.005692197,"about_ca_system_score_codex":0.00059251144,"about_ca_system_score_gemma":0.0003803152,"threshold_uncertainty_score":0.019042253},"labels":[],"label_agreement":null},{"id":"W2315053722","doi":"10.1093/neuonc/nou237.13","title":"AT-13 * R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Procarbazine; Internal medicine; Oligodendroglioma; Progression-free survival; Vincristine; Biopsy; Radiation therapy; Histology; Gastroenterology; Temozolomide; Astrocytoma; Overall survival; Glioma; Chemotherapy; Cyclophosphamide","score_opus":0.024425885069715398,"score_gpt":0.32050210966867543,"score_spread":0.29607622459896005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315053722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935342,0.0016590339,0.00047258596,0.00027715488,0.00005767653,0.0013853264,0.0012140252,0.00009788072,0.0013020827],"genre_scores_gemma":[0.98608845,0.002060667,0.003039155,0.00051468005,0.00016219719,0.0025379362,0.0029826413,0.0000698544,0.0025444177],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995227,0.00025627093,0.000031970976,0.000062815365,0.00005356327,0.00007274199],"domain_scores_gemma":[0.9992656,0.00009997105,0.00017195198,0.000058240625,0.000048826423,0.0003555006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020985075,0.0012807082,0.0017627403,0.00043563428,0.0005199946,0.0009206636,0.001400181,0.000864119,0.0030697053],"category_scores_gemma":[0.00064899394,0.00054406055,0.0014315541,0.0006787533,0.0010409382,0.0005554942,0.0003482271,0.0029823738,0.0009117429],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7944915,0.049608894,0.013841404,0.001178586,0.0020065582,0.00021653889,0.00026267808,0.002875611,0.057517543,0.00037070084,0.0047871326,0.07284285],"study_design_scores_gemma":[0.5893726,0.37699538,0.015437491,0.00006549541,0.0016267005,0.0005811325,0.00008075774,0.0014649872,0.010943214,0.00025965302,0.003128886,0.000043742173],"about_ca_topic_score_codex":0.0013085951,"about_ca_topic_score_gemma":0.0041773217,"teacher_disagreement_score":0.0030697053,"about_ca_system_score_codex":0.0009264533,"about_ca_system_score_gemma":0.0018215185,"threshold_uncertainty_score":0.011098087},"labels":[],"label_agreement":null},{"id":"W2315630015","doi":"10.1093/neuonc/nou275.32","title":"SC-33 * POLYCOMB GROUP PROTEIN Bmi1 CONTROLS NEURAL STEM AND PROGENITOR CELL MAINTENANCE AND GLIOBLASTOMA TUMOUR DEVELOPMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"BMI1; Neural stem cell; Progenitor cell; Biology; Stem cell; Clonogenic assay; Cancer research; Carcinogenesis; Gene knockdown; Cell biology; Cell; Cell culture; Cancer; Genetics","score_opus":0.00703507861088516,"score_gpt":0.23308362928129275,"score_spread":0.2260485506704076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315630015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025327,0.0015335277,0.0027754474,0.00015190087,0.00004301223,0.000035366153,0.0022213121,0.00026471372,0.002721511],"genre_scores_gemma":[0.99004304,0.0004421473,0.0011734719,0.00005783014,0.000004254774,0.00003063975,0.0019105619,0.00006608404,0.0062719965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998869,0.0000081127455,0.00000846051,0.000027347636,0.000034864595,0.000034330384],"domain_scores_gemma":[0.9998896,0.00000957276,0.000028736047,0.000012705502,0.000011803467,0.000047547335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005479754,0.00021138614,0.00016526876,0.0002792365,0.00017944703,0.00026243567,0.00018759216,0.0001582392,0.002989861],"category_scores_gemma":[0.00008882086,0.00013082754,0.00018117142,0.00027032217,0.0003077677,0.0001223658,0.00020334107,0.00043428055,0.00081454316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012647054,0.000016247386,0.00057668466,0.000028112321,0.0000035368266,0.00003370221,0.000013062514,0.000083655796,0.99731797,0.00012324665,0.00014544638,0.0015317734],"study_design_scores_gemma":[0.000031377138,0.00017920976,0.036280405,0.000012551759,0.000021218508,0.00022831264,0.000099689816,0.0043051564,0.9493321,0.00014520324,0.009352925,0.0000119452725],"about_ca_topic_score_codex":0.0049755936,"about_ca_topic_score_gemma":0.008911569,"teacher_disagreement_score":0.0049755936,"about_ca_system_score_codex":0.0004573556,"about_ca_system_score_gemma":0.0003313055,"threshold_uncertainty_score":0.010002077},"labels":[],"label_agreement":null},{"id":"W2316239168","doi":"10.1093/neuonc/nov061.22","title":"EP-03 * MOLECULAR CLASSIFICATION OF EPENDYMAL TUMORS ACROSS ALL CNS COMPARTMENTS, HISTOPATHOLOGICAL GRADES AND AGE GROUPS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Biology; Concordance; Pathology; Histopathology; Brain tumor; Medicine; Bioinformatics","score_opus":0.07876514631944909,"score_gpt":0.3407474629227296,"score_spread":0.26198231660328053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316239168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88377917,0.0048238114,0.017480887,0.0007580543,0.00030969258,0.0005400169,0.03235835,0.00080237415,0.059147708],"genre_scores_gemma":[0.8565827,0.0023710614,0.026454985,0.000572079,0.00008830135,0.0005549551,0.06471494,0.00025854443,0.04840241],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998036,0.00001534932,0.000026410422,0.000065887136,0.000054962475,0.000033766428],"domain_scores_gemma":[0.9996563,0.0000487397,0.00006882523,0.0000474548,0.000113493,0.00006519941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027945222,0.00038690458,0.00026582752,0.0012494589,0.00039037847,0.0007305103,0.0005377308,0.0004064894,0.008963867],"category_scores_gemma":[0.00049528945,0.0001461771,0.0004740429,0.0012109661,0.0002825853,0.00036589353,0.000396905,0.00081116107,0.003720876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036301143,0.00026904728,0.26485142,0.00091999467,0.0004487824,0.0040702024,0.0005783577,0.001991005,0.4066092,0.0066093844,0.04899401,0.26102853],"study_design_scores_gemma":[0.00014352241,0.0007690225,0.74507266,0.0001756206,0.0002469303,0.01352027,0.0004275204,0.00428582,0.08652886,0.0031088744,0.1456787,0.000042219184],"about_ca_topic_score_codex":0.0030507979,"about_ca_topic_score_gemma":0.0026379507,"teacher_disagreement_score":0.008963867,"about_ca_system_score_codex":0.0007241064,"about_ca_system_score_gemma":0.0004256658,"threshold_uncertainty_score":0.029987097},"labels":[],"label_agreement":null},{"id":"W2316561842","doi":"10.1093/neuonc/nou262.4","title":"MR-04 * DICER REGULATES GLIOMA STEM CELL STATE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Dicer; Biology; Gene knockdown; microRNA; Stem cell; Drosha; Cancer research; Stem cell marker; Phenotype; Molecular biology; RNA interference; Cell biology; Genetics; Cell culture; Gene; RNA","score_opus":0.01021850737443752,"score_gpt":0.2698809551889988,"score_spread":0.25966244781456127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316561842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780406,0.0014927475,0.0044173636,0.00021190356,0.000032371714,0.000032229495,0.001485983,0.00029759423,0.0042257784],"genre_scores_gemma":[0.9896752,0.00038043442,0.0033071323,0.00012500503,0.000007648414,0.00002506745,0.0015908644,0.000072641196,0.0048159785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979,0.00002758975,0.000023842988,0.00006941051,0.000044436245,0.000044716176],"domain_scores_gemma":[0.99977785,0.00002810659,0.00007226976,0.00003180656,0.000023636654,0.000066381166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016067017,0.00021135874,0.000254734,0.00028002242,0.00020542348,0.00036543547,0.00024566372,0.0002949861,0.0026452937],"category_scores_gemma":[0.0001619386,0.00014514542,0.00020578911,0.00015289847,0.00028088232,0.00019567301,0.00019666941,0.00057507824,0.0012195824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087275555,0.000011716327,0.00023202543,0.000024936877,0.000004076925,0.000047519323,0.000013404642,0.0000660074,0.99810237,0.00014575246,0.00010156858,0.0011634344],"study_design_scores_gemma":[0.000010538476,0.00012553604,0.0044570765,0.0000028572317,0.000010141318,0.0003161814,0.000022711174,0.000880034,0.9900253,0.000051047977,0.004093803,0.0000047851813],"about_ca_topic_score_codex":0.0006613195,"about_ca_topic_score_gemma":0.0007206643,"teacher_disagreement_score":0.0026452937,"about_ca_system_score_codex":0.00042387948,"about_ca_system_score_gemma":0.00021052906,"threshold_uncertainty_score":0.008849382},"labels":[],"label_agreement":null},{"id":"W2316854871","doi":"10.1093/neuonc/nou208.29","title":"THOR METHYLATION PROVIDES INSIGHT INTO THE TELOMERE MAINTENANCE LANDSCAPE OF MALIGNANT GLIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Telomere; Telomerase; Methylation; Cancer research; DNA methylation; Glioma; Biology; Gene; Molecular biology; Gene expression; Genetics","score_opus":0.015022629298450581,"score_gpt":0.28839404061337937,"score_spread":0.27337141131492876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316854871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948014,0.0029424727,0.0051691527,0.00009981577,0.000007232548,0.000008981415,0.00045329804,0.000089282665,0.0017495817],"genre_scores_gemma":[0.99507844,0.0012796996,0.0022595378,0.00002036392,0.0000055234455,0.0000055844994,0.00038417891,0.000010631855,0.0009560238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999733,0.0000027390024,0.0000012648331,0.000006885248,0.000008059656,0.000007683686],"domain_scores_gemma":[0.9999634,0.0000071767213,0.000011458004,0.0000040446016,0.0000063517746,0.000007637643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073601026,0.0001758827,0.00009533933,0.00033531495,0.000067317,0.00015280621,0.00009854024,0.000178034,0.0012538043],"category_scores_gemma":[0.00007550323,0.00010599792,0.00012276306,0.00014390142,0.000121195495,0.00013083329,0.000133822,0.00019926539,0.00024247571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012352709,0.0000055391943,0.0030426476,0.000058120804,0.0000065111426,0.000049512273,0.000029084398,0.00013366248,0.99275476,0.00011279591,0.000035605397,0.0036482064],"study_design_scores_gemma":[0.000013406066,0.00036885252,0.12882243,0.000017535118,0.00008269882,0.0019634208,0.00015094572,0.003462839,0.8587533,0.0007122448,0.005641006,0.000011315619],"about_ca_topic_score_codex":0.00042632228,"about_ca_topic_score_gemma":0.00063742785,"teacher_disagreement_score":0.0012538043,"about_ca_system_score_codex":0.00012930825,"about_ca_system_score_gemma":0.00008733011,"threshold_uncertainty_score":0.0041944385},"labels":[],"label_agreement":null},{"id":"W2317469671","doi":"10.1093/neuonc/nou260.14","title":"MS-15 * THE IMPACT OF HISTOPATHOLOGIC AND RADIOLOGIC CHARACTERISTICS IN CLINICAL OUTCOME OF PATIENTS WHO UNDERWENT SURGERY FOR INTRACRANIAL MENINGIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Meningioma; Incidence (geometry); Pathological; Edema; Surgery; Radiology; Internal medicine","score_opus":0.06489266807695558,"score_gpt":0.36144518560820843,"score_spread":0.29655251753125283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317469671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993432,0.000115679984,0.00001427028,0.000022771788,0.0000044711906,0.000002021462,0.0001717285,0.0000017804225,0.0003240865],"genre_scores_gemma":[0.9996649,0.0000356591,0.000020204501,0.0000053499084,0.000005527561,0.0000016842391,0.00018172905,7.6335675e-7,0.000084176274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980694,0.000026918826,0.000028678072,0.000035923596,0.000051895313,0.000049700626],"domain_scores_gemma":[0.99835473,0.0002057324,0.0007587063,0.00004301944,0.00016187826,0.00047586652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031216047,0.00023655473,0.0001994121,0.0006377098,0.0004247273,0.00047287132,0.00022566623,0.0002285106,0.0018395705],"category_scores_gemma":[0.0015724929,0.000115704985,0.00027312676,0.0006047572,0.0003162695,0.0002562008,0.0002628318,0.00025587223,0.00029611404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004987036,0.0000035304188,0.99943215,0.0000022559414,0.000009196628,0.0000897776,0.000011301985,0.000010316466,0.00008206533,0.0000017440211,0.000027420027,0.00028029547],"study_design_scores_gemma":[0.0000018421383,0.000054925313,0.998998,0.00000286519,0.000010837644,0.00063651684,0.0000785468,0.000053886437,0.00006757823,0.000006922954,0.00008651692,0.0000015662978],"about_ca_topic_score_codex":0.0047090696,"about_ca_topic_score_gemma":0.008596033,"teacher_disagreement_score":0.0047090696,"about_ca_system_score_codex":0.0005107764,"about_ca_system_score_gemma":0.0004962324,"threshold_uncertainty_score":0.009363294},"labels":[],"label_agreement":null},{"id":"W2317611189","doi":"10.1093/neuonc/nou208.14","title":"DETAILED MOLECULAR CHARACTERISATION OF DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIES THREE MOLECULAR SUBGROUPS AND A NOVEL CANCER DRIVER, ACVR1","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"DNA methylation; CpG site; Cancer; Exome sequencing; Methylation; Computational biology; Medicine; Genome; Genetics; Biology; Mutation; Gene; Gene expression","score_opus":0.013628538316084973,"score_gpt":0.27024406593603395,"score_spread":0.256615527619949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317611189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936557,0.00038488948,0.004287486,0.000038338254,0.0000029180405,0.00003110918,0.0009886749,0.00008024505,0.0005307214],"genre_scores_gemma":[0.989578,0.00020983812,0.006834778,0.000030542353,0.0000034930604,0.000035248897,0.0028554553,0.00004426248,0.00040832802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998147,0.000009946536,0.000010833871,0.0000750475,0.00005734529,0.000032199318],"domain_scores_gemma":[0.9998141,0.000030805553,0.000053214484,0.000027877384,0.000035065652,0.000039040897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021512185,0.0002743542,0.0002404823,0.000808268,0.00025345755,0.00038277873,0.00024856805,0.000240821,0.0007542497],"category_scores_gemma":[0.00053398,0.00011583725,0.0003007967,0.00043770127,0.00023005136,0.000167805,0.0003065691,0.00036880458,0.00023055772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048632483,0.000036182166,0.13426767,0.00018090547,0.00012124345,0.00046127377,0.00043252477,0.0011058999,0.8290898,0.00042752366,0.00043269148,0.032957844],"study_design_scores_gemma":[0.000049504943,0.00057408755,0.7688808,0.000044473345,0.0002856493,0.007842967,0.0006989947,0.011258128,0.19586347,0.0017102042,0.012744611,0.000047142676],"about_ca_topic_score_codex":0.0031614827,"about_ca_topic_score_gemma":0.0068125534,"teacher_disagreement_score":0.0031614827,"about_ca_system_score_codex":0.00037415553,"about_ca_system_score_gemma":0.00038944976,"threshold_uncertainty_score":0.006286204},"labels":[],"label_agreement":null},{"id":"W2318100480","doi":"10.1093/neuonc/nov061.134","title":"PM-12 * USING A ZEBRAFISH PEDIATRIC BRAIN TUMOR MODEL FOR PRE-CLINICAL DRUG SCREENING","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Zebrafish; Drug; Medicine; Computational biology; Oncology; Pharmacology; Biology; Genetics; Gene","score_opus":0.08179235148346989,"score_gpt":0.40675492001818836,"score_spread":0.3249625685347185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318100480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85266286,0.0034766877,0.09554177,0.00291686,0.000434764,0.003816853,0.012803945,0.0038782929,0.02446811],"genre_scores_gemma":[0.8135443,0.005551064,0.13469128,0.0007396709,0.000037343187,0.0038969854,0.007545585,0.0005355783,0.03345827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997391,0.000032643828,0.000019282852,0.000061100814,0.0001002826,0.000047629757],"domain_scores_gemma":[0.9998097,0.000031902084,0.000045319397,0.000024891497,0.000035295856,0.000052983338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005056351,0.0008802434,0.00054287736,0.0006217933,0.00046921687,0.0004548008,0.0006954571,0.00080908136,0.0040346733],"category_scores_gemma":[0.00023159519,0.00029708594,0.00059376,0.0002684872,0.00050777034,0.00046030307,0.00034895854,0.0013262167,0.0009992636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029274606,0.00019061961,0.00045252583,0.00011836824,0.000021864602,0.00028828855,0.000038287373,0.0007282163,0.9872953,0.0007122014,0.0013970524,0.008464558],"study_design_scores_gemma":[0.00017912446,0.002912982,0.0021484073,0.0000328616,0.00007738611,0.00069627113,0.000041108626,0.003037402,0.9730641,0.00019155514,0.01758958,0.00002924422],"about_ca_topic_score_codex":0.009235417,"about_ca_topic_score_gemma":0.020883664,"teacher_disagreement_score":0.009235417,"about_ca_system_score_codex":0.0014044183,"about_ca_system_score_gemma":0.0016045604,"threshold_uncertainty_score":0.018363297},"labels":[],"label_agreement":null},{"id":"W2318376928","doi":"10.1093/neuonc/nou256.26","title":"GE-27 * THERAPEUTIC IMPLICATIONS OF MEDULLOBLASTOMA SUBGROUPS IN CHILDREN OVER AGE 3: A SINGLE CENTRE POPULATION BASED EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Cohort; Internal medicine; Progression-free survival; Overall survival; Population; Oncology; Chemotherapy; Radiation therapy; Cohort study; Survival analysis; Pediatrics; Pathology","score_opus":0.017895215074458206,"score_gpt":0.29100895516235303,"score_spread":0.27311374008789485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318376928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872094,0.00020710658,0.00007509549,0.000078487436,0.0000026577795,0.000024323712,0.00010442854,0.0000075339703,0.00077948684],"genre_scores_gemma":[0.9988469,0.00028577467,0.00022791834,0.00006606534,0.000008249496,0.000018357072,0.00014575079,0.000008624794,0.00039247656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998061,0.0000408889,0.000017769453,0.00004942252,0.000031187963,0.000054643333],"domain_scores_gemma":[0.9996438,0.00004677369,0.00010360158,0.000022588229,0.000029569113,0.00015367013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031736415,0.00019841299,0.00023833006,0.00039907,0.0006900461,0.0004740427,0.00021939102,0.00037123554,0.0011422015],"category_scores_gemma":[0.0007611075,0.00014384695,0.0003184856,0.0005504214,0.00041605163,0.00025279916,0.00055433536,0.00038813287,0.0002520807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031794605,0.00012758507,0.96012455,0.000044153734,0.000027787139,0.0068328953,0.0033609555,0.00019410034,0.004088042,0.00012647935,0.00074323284,0.024012167],"study_design_scores_gemma":[0.000040321513,0.001233986,0.9652394,0.00003765288,0.000037615802,0.02383682,0.0036800406,0.00025712184,0.0012616888,0.00014189532,0.0042125615,0.000020923471],"about_ca_topic_score_codex":0.01589599,"about_ca_topic_score_gemma":0.03601277,"teacher_disagreement_score":0.01589599,"about_ca_system_score_codex":0.0014273797,"about_ca_system_score_gemma":0.0009265808,"threshold_uncertainty_score":0.031606913},"labels":[],"label_agreement":null},{"id":"W2318421360","doi":"10.1093/neuonc/nov061.112","title":"MB-36 * WIP1 AUGMENTS SONIC HEDGEHOG (SHH) SIGNALING AND IS A TARGET IN SHH MEDULLOBLASTOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Hedgehog signaling pathway; Cell biology; Hedgehog; Cancer research; Biology; Chemistry; Signal transduction","score_opus":0.0306727920107308,"score_gpt":0.29558523264531783,"score_spread":0.264912440634587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318421360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798674,0.0028577666,0.0027723438,0.00039346173,0.00008295239,0.00006553719,0.0022215594,0.00029476258,0.0033249778],"genre_scores_gemma":[0.9811141,0.001301261,0.0036204758,0.00008864944,0.000018823323,0.00006994287,0.0026419421,0.000041394116,0.011103375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998652,0.000011562208,0.000012408389,0.000027368644,0.000045343786,0.00003819601],"domain_scores_gemma":[0.999925,0.00000646736,0.000014063938,0.0000064404385,0.0000062079725,0.000041791172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008324688,0.0003434992,0.00025345053,0.00035136155,0.00020540821,0.00021106811,0.0002001325,0.00022266037,0.0029809452],"category_scores_gemma":[0.00006738977,0.00015819258,0.00024139152,0.00015130833,0.00019133714,0.00012492633,0.0001852789,0.0005361044,0.0008476041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010966348,0.00003074138,0.00017195029,0.00002335358,0.000003088347,0.000040546787,0.000005374325,0.000036061578,0.99845946,0.00007378962,0.00009839156,0.0009477107],"study_design_scores_gemma":[0.000025909136,0.00039430286,0.005202937,0.000004718098,0.000016467715,0.00033740327,0.000019562314,0.0004676268,0.9858683,0.00004099825,0.0076177334,0.000004081087],"about_ca_topic_score_codex":0.0020267053,"about_ca_topic_score_gemma":0.002375809,"teacher_disagreement_score":0.0029809452,"about_ca_system_score_codex":0.00041763854,"about_ca_system_score_gemma":0.00023805117,"threshold_uncertainty_score":0.009972274},"labels":[],"label_agreement":null},{"id":"W2318702586","doi":"10.1093/neuonc/nou057","title":"Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Hospital","funders":"American Society of Hematology","keywords":"Medicine; Primary central nervous system lymphoma; Life expectancy; Chemotherapy; Regimen; Quality-adjusted life year; Cost effectiveness; Quality of life (healthcare); Oncology; Chemotherapy regimen; Induction chemotherapy; Internal medicine; Pediatrics; Population","score_opus":0.03151012307357634,"score_gpt":0.3231779386837084,"score_spread":0.2916678156101321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318702586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6938156,0.23315741,0.026786331,0.0049843,0.00075235526,0.009578572,0.01122695,0.00022126504,0.019477246],"genre_scores_gemma":[0.96735597,0.020541716,0.0076405792,0.0006498692,0.000112305475,0.001515866,0.0014264105,0.00001976094,0.0007375861],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9932147,0.005219246,0.0002811137,0.00028909332,0.00060626067,0.00038961126],"domain_scores_gemma":[0.9912088,0.0074026496,0.0006785144,0.000103501014,0.00029861057,0.00030797903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081019495,0.0017196146,0.0043154275,0.003363176,0.00030000106,0.002134191,0.0012829425,0.0016375117,0.00532743],"category_scores_gemma":[0.02012266,0.000854414,0.012327581,0.002866056,0.00040378858,0.0015841284,0.0010924402,0.0018217484,0.0001949235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08781287,0.002381581,0.023720384,0.03376203,0.10473241,0.00078858214,0.00021327792,0.5364341,0.0015422581,0.010785463,0.0046551004,0.19317192],"study_design_scores_gemma":[0.03275415,0.034949496,0.04672901,0.013927945,0.22646366,0.0017940404,0.0007679033,0.613384,0.0017605372,0.015704786,0.011325726,0.0004386984],"about_ca_topic_score_codex":0.025134413,"about_ca_topic_score_gemma":0.02178609,"teacher_disagreement_score":0.025134413,"about_ca_system_score_codex":0.011129006,"about_ca_system_score_gemma":0.0053749946,"threshold_uncertainty_score":0.08074695},"labels":[],"label_agreement":null},{"id":"W2318760583","doi":"10.1093/neuonc/nou275.15","title":"SC-15 * ISOLATING GLIOBLASTOMA TUMOR INITIATING PROGENITOR CELLS FROM THE SUBVENTRICULAR ZONE USING A NOVEL MINIMALLY INVASIVE APPROACH","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Synaptive (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Subventricular zone; PTEN; Magnetic resonance imaging; Neural stem cell; Glioblastoma; Cancer research; Brain tumor; Pathology; Medicine; Stem cell; Biology; Radiology; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.028411320291805077,"score_gpt":0.27011295602981616,"score_spread":0.2417016357380111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318760583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475024,0.000556075,0.04865911,0.000076946504,0.000048493093,0.00026299257,0.00043276962,0.0002302919,0.0022308535],"genre_scores_gemma":[0.9363548,0.00043840526,0.057457197,0.00010199903,0.000015657939,0.00025640448,0.0015141788,0.000040964704,0.0038204417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998784,0.000010072605,0.000013911268,0.00003303657,0.00004802833,0.000016432925],"domain_scores_gemma":[0.99990904,0.000018395971,0.000019432555,0.000015561292,0.000015851905,0.00002165261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016814294,0.0001961258,0.0001946039,0.00022464094,0.00017012008,0.0003089139,0.0002081173,0.00022503475,0.0007143973],"category_scores_gemma":[0.0001289396,0.00009373186,0.00023982015,0.00013748121,0.00017982196,0.00009240545,0.0002644014,0.00036796997,0.00036924327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028940018,0.000027522607,0.00039581844,0.000017530074,0.0000028714899,0.000058462225,0.000028712751,0.00014773117,0.9963691,0.00010564439,0.000055723263,0.0027619528],"study_design_scores_gemma":[0.000014698512,0.0006243756,0.0031057606,0.000009021872,0.000013059246,0.00045521645,0.00003881949,0.0038137224,0.98674625,0.00009481682,0.005076745,0.000007544401],"about_ca_topic_score_codex":0.0005863441,"about_ca_topic_score_gemma":0.0013452036,"teacher_disagreement_score":0.0007143973,"about_ca_system_score_codex":0.000106613326,"about_ca_system_score_gemma":0.00032054816,"threshold_uncertainty_score":0.0023898482},"labels":[],"label_agreement":null},{"id":"W2319011908","doi":"10.1093/neuonc/nou208.46","title":"BRAIN TUMOUR INITIATING CELLS AND TARGETING STAT3 ONCOGENIC SIGNALLING IN GBM","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"STAT3; Neurosphere; Cancer research; Biology; STAT protein; Stem cell; Janus kinase; Cell growth; Signal transduction; Medicine; Cellular differentiation; Cell biology; Adult stem cell; Gene","score_opus":0.009283255831808371,"score_gpt":0.2528290315541234,"score_spread":0.24354577572231503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319011908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96711606,0.016429638,0.0052895597,0.000544576,0.000062877196,0.00023431015,0.0033937423,0.00029881598,0.006630388],"genre_scores_gemma":[0.9689867,0.012961874,0.007643787,0.00025663507,0.00003133365,0.00014094422,0.0068266373,0.000039738236,0.0031123674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998872,0.000011634337,0.000011138999,0.000011242134,0.000051984534,0.000026835016],"domain_scores_gemma":[0.99994624,0.000008480069,0.000014208324,0.000006358981,0.000009135292,0.00001557146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021184071,0.0003525013,0.0002466337,0.0007093851,0.00016877358,0.00033339064,0.00026986044,0.0002311963,0.0017044222],"category_scores_gemma":[0.000081865284,0.00010454329,0.00024729676,0.00062666077,0.0002075767,0.00017443203,0.00027259687,0.0005316944,0.00064899947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026593576,0.00018737168,0.0012182924,0.00023824736,0.000021008591,0.00018430164,0.000042196058,0.0005628105,0.98373747,0.0004712361,0.00076012727,0.012311056],"study_design_scores_gemma":[0.00011537688,0.0019025619,0.011741907,0.00003067952,0.00008445211,0.0017168833,0.000051199015,0.000976325,0.95909595,0.00029269254,0.023977915,0.0000139343],"about_ca_topic_score_codex":0.0010963712,"about_ca_topic_score_gemma":0.0030263742,"teacher_disagreement_score":0.0017044222,"about_ca_system_score_codex":0.00031132915,"about_ca_system_score_gemma":0.0005290792,"threshold_uncertainty_score":0.00570184},"labels":[],"label_agreement":null},{"id":"W2319033605","doi":"10.1093/neuonc/nou275.33","title":"SC-34 * A NOVEL VEGF-RESPONSIVE lincRNA ORCHESTRATES GLIOMA STEM CELL-MEDIATED ANGIOGENESIS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Angiogenesis; Biology; Glioma; Cancer research; Transdifferentiation; Neovascularization; Pericyte; Progenitor cell; Stem cell; Cell biology; Endothelial stem cell; Genetics; In vitro","score_opus":0.013384943158218553,"score_gpt":0.2738160506370202,"score_spread":0.26043110747880166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319033605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862119,0.0029606926,0.006030449,0.0002165262,0.00005384312,0.00007082041,0.0007111082,0.0005849241,0.0031597004],"genre_scores_gemma":[0.99367225,0.00047822105,0.0029174439,0.00008569682,0.000013327949,0.00002956822,0.00077174377,0.000039506478,0.0019921488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999516,0.0000056420067,0.0000033210536,0.000012332305,0.000013596257,0.0000135176115],"domain_scores_gemma":[0.9999459,0.000008185244,0.000015896,0.000004022405,0.0000061945825,0.000019839968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061844265,0.00016184399,0.0001430577,0.00019748174,0.00020517917,0.00019067495,0.00010312316,0.00014838573,0.0008855556],"category_scores_gemma":[0.00007384427,0.00006288578,0.00012110054,0.0001263779,0.00018851415,0.00006731495,0.0001143759,0.00019467183,0.00029899285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110524314,0.000011903183,0.00031389628,0.00003077673,0.0000025391284,0.00014292219,0.00001184405,0.00016095125,0.9953857,0.00019724411,0.00020768798,0.00342422],"study_design_scores_gemma":[0.000052749918,0.0004111227,0.014215868,0.000014619124,0.000024663526,0.0008412629,0.000045578687,0.0044299234,0.96418357,0.00029994763,0.015464385,0.000016359623],"about_ca_topic_score_codex":0.0008821565,"about_ca_topic_score_gemma":0.0017357382,"teacher_disagreement_score":0.0008855556,"about_ca_system_score_codex":0.0003613981,"about_ca_system_score_gemma":0.0001947498,"threshold_uncertainty_score":0.00296247},"labels":[],"label_agreement":null},{"id":"W2320193046","doi":"10.1093/neuonc/nou365","title":"Phase II study of PX-866 in recurrent glioblastoma","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Nausea; Internal medicine; Adverse effect; Gastroenterology; Vomiting; Clinical endpoint; Diarrhea; Phases of clinical research; Progression-free survival; Oncology; PTEN; Toxicity; Chemotherapy; PI3K/AKT/mTOR pathway; Clinical trial","score_opus":0.051859229300058984,"score_gpt":0.36931980569683337,"score_spread":0.3174605763967744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320193046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434054,0.001646769,0.0005974394,0.00022205054,0.00006979824,0.0018766666,0.0005245077,0.00009795493,0.00062424265],"genre_scores_gemma":[0.98944795,0.0020873225,0.0015561843,0.00045368943,0.00009049988,0.0022881636,0.0018560578,0.000028543582,0.0021916423],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996031,0.0001786719,0.00002503556,0.00005658566,0.000050442493,0.00008624153],"domain_scores_gemma":[0.9995034,0.000045689165,0.00010714926,0.000045231944,0.000057556637,0.00024109043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015195603,0.0014131475,0.0019021608,0.0004760723,0.00036332294,0.000582895,0.00083632336,0.0009476154,0.0034794689],"category_scores_gemma":[0.0005930798,0.0005001535,0.0008103209,0.00037502777,0.0005978166,0.0004346788,0.0004133908,0.0021102158,0.00093391736],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5045141,0.114910334,0.021045703,0.0021829451,0.002578177,0.0008231081,0.00076903857,0.0044918777,0.14482726,0.00057039835,0.008225494,0.19506156],"study_design_scores_gemma":[0.28036729,0.68642735,0.016467955,0.000052372045,0.0006289751,0.0007389693,0.00009686908,0.0017144568,0.00975187,0.00021376854,0.0035065962,0.00003346968],"about_ca_topic_score_codex":0.0010032285,"about_ca_topic_score_gemma":0.002282018,"teacher_disagreement_score":0.0034794689,"about_ca_system_score_codex":0.0005792003,"about_ca_system_score_gemma":0.0015060524,"threshold_uncertainty_score":0.011640012},"labels":[],"label_agreement":null},{"id":"W2321118242","doi":"10.1093/neuonc/nou206.51","title":"SINGLE CELL DERIVED CLONAL ANALYSIS OF HUMAN GLIOBLASTOMA LINKS FUNCTIONAL AND GENOMIC HETEROGENEITY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Temozolomide; clone (Java method); Biology; Autocrine signalling; Cancer research; Paracrine signalling; Glioblastoma; Genetics; Gene; Somatic evolution in cancer; Drug resistance; Computational biology; Receptor","score_opus":0.024605639899398343,"score_gpt":0.2779543514618333,"score_spread":0.25334871156243494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321118242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914596,0.0006792488,0.006039098,0.000041382078,0.00000987538,0.000097110504,0.00079822936,0.00006306133,0.00081229606],"genre_scores_gemma":[0.9919958,0.00042720308,0.0049829106,0.000045059824,0.000008649464,0.0001069858,0.0017377486,0.000019521241,0.0006761678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998983,0.000013674228,0.000009688679,0.000024795188,0.00003633277,0.000017141678],"domain_scores_gemma":[0.9997904,0.00006296026,0.000021500375,0.000031878903,0.00007188326,0.000021516023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021258755,0.00010602986,0.00019307945,0.000524178,0.00017503783,0.00022390428,0.0001486239,0.00020161513,0.00081816746],"category_scores_gemma":[0.0002940306,0.00008334283,0.00014635535,0.00029659126,0.0001179066,0.000090228066,0.00017251974,0.00021674733,0.00027288057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019044903,0.000054525244,0.013106747,0.000043777552,0.000022195945,0.00015983426,0.00008791871,0.00026460426,0.9763713,0.00015681083,0.00017932233,0.009362567],"study_design_scores_gemma":[0.00004391525,0.0011186003,0.19438261,0.000018035607,0.0001761873,0.0031167318,0.00018787444,0.007135358,0.78893304,0.00039051453,0.0044777365,0.00001946944],"about_ca_topic_score_codex":0.0009565627,"about_ca_topic_score_gemma":0.001860327,"teacher_disagreement_score":0.0009565627,"about_ca_system_score_codex":0.0001916576,"about_ca_system_score_gemma":0.00013390688,"threshold_uncertainty_score":0.0027370453},"labels":[],"label_agreement":null},{"id":"W2321212845","doi":"10.1093/neuonc/nou347","title":"Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Chordoma; Chondrosarcoma; Medicine; Radiation therapy; Radiology; Malignancy; Surgery; Internal medicine","score_opus":0.027367922206637786,"score_gpt":0.31624736349548194,"score_spread":0.28887944128884413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321212845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983348,0.00062465575,0.0002880535,0.000020002923,0.0000037503996,0.000040349714,0.00009589964,0.000006923441,0.00058554974],"genre_scores_gemma":[0.9988607,0.000290464,0.0002861637,0.000026980077,0.000012255714,0.000016089103,0.00035097846,0.000003453028,0.00015294005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980646,0.00004271421,0.000029381608,0.000027618265,0.00005115079,0.000042621516],"domain_scores_gemma":[0.9995995,0.000077365126,0.00015292535,0.00004265262,0.00004790046,0.00007973469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004439028,0.00029079753,0.00025987605,0.00023812857,0.0002938885,0.00031286836,0.00025303452,0.00021471734,0.0006543617],"category_scores_gemma":[0.0009637255,0.00008284285,0.0003112262,0.00021305731,0.0002525397,0.00018332305,0.0003398011,0.00022076417,0.00021687384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054389783,0.0018752444,0.7741119,0.00035626735,0.00038209299,0.008762989,0.00088189595,0.0019367215,0.03265729,0.00005630553,0.00064995396,0.17289032],"study_design_scores_gemma":[0.00047643823,0.02495475,0.9289853,0.000057291873,0.00033137272,0.030335566,0.00037795928,0.001084989,0.011086299,0.00007578917,0.0022088035,0.000025520669],"about_ca_topic_score_codex":0.0012787562,"about_ca_topic_score_gemma":0.0025271308,"teacher_disagreement_score":0.0012787562,"about_ca_system_score_codex":0.0002909986,"about_ca_system_score_gemma":0.00022225863,"threshold_uncertainty_score":0.002542615},"labels":[],"label_agreement":null},{"id":"W2321318692","doi":"10.1093/neuonc/nou278.5","title":"TM-05 * PTEN INDUCED KINASE1 (PINK1) NEGATIVELY REGULATES AEROBIC GLYCOLYSIS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"PINK1; Warburg effect; Anaerobic glycolysis; PTEN; Glycolysis; Cell biology; Biology; Cancer research; Kinase; Reprogramming; Cancer cell; Chemistry; Signal transduction; Cell; Apoptosis; Biochemistry; Mitophagy; PI3K/AKT/mTOR pathway; Cancer; Autophagy; Metabolism; Genetics","score_opus":0.011237470775332895,"score_gpt":0.25949066446359614,"score_spread":0.24825319368826326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321318692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954065,0.0011726762,0.0010771755,0.00022189273,0.000028205974,0.000011469349,0.00038137924,0.00010306243,0.0015975698],"genre_scores_gemma":[0.9966413,0.000649282,0.00046355827,0.00005157263,0.000003839648,0.0000119003535,0.00038095968,0.000011222,0.0017864428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999405,0.000007179241,0.000004762725,0.000008949753,0.000017669125,0.000020906884],"domain_scores_gemma":[0.9999651,0.000003030754,0.0000111233685,0.0000021554956,0.0000032171972,0.000015490545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006483566,0.00020092599,0.00015419081,0.00022355167,0.00015490643,0.0002569344,0.00014104236,0.00012064665,0.0012132844],"category_scores_gemma":[0.0000644344,0.000080879974,0.00012041011,0.00017895407,0.00017696791,0.00013143862,0.00013629928,0.0003472208,0.00033814315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002176456,0.000045186138,0.0005282117,0.000033734323,0.0000049736686,0.00009794435,0.000011076781,0.0001525102,0.9963014,0.0002223569,0.00020769316,0.0021772275],"study_design_scores_gemma":[0.000030554605,0.00036313556,0.012935459,0.0000070412984,0.00002425839,0.0005361803,0.000048420286,0.002101533,0.98022455,0.00017381778,0.0035508517,0.0000041063226],"about_ca_topic_score_codex":0.0013060563,"about_ca_topic_score_gemma":0.0015629423,"teacher_disagreement_score":0.0013060563,"about_ca_system_score_codex":0.00035351794,"about_ca_system_score_gemma":0.00027441725,"threshold_uncertainty_score":0.004058838},"labels":[],"label_agreement":null},{"id":"W2321475660","doi":"10.1093/neuonc/nou251.23","title":"OP23 * AN AUDIT TO ASSESS PSYCHIATRIC CONDITIONS THAT MANIFEST IN PATIENTS WITH HIGH-GRADE BRAIN TUMOURS DURING TREATMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Psychiatry; Psychiatric history; Referral; Audit; Psychiatric medication; Psychiatric assessment; Family medicine; Mental health; Anxiety","score_opus":0.0257748351272654,"score_gpt":0.3071824537802189,"score_spread":0.2814076186529535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321475660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908818,0.0010121388,0.00025477825,0.00017290728,0.000039967446,0.00067756005,0.0023861763,0.000052829582,0.004521883],"genre_scores_gemma":[0.9950663,0.00093108445,0.0007570609,0.00017382718,0.000025998603,0.00042108144,0.0017080491,0.000019292112,0.0008973283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900025,0.00023781422,0.00028204801,0.00010114683,0.00021941573,0.00015937582],"domain_scores_gemma":[0.9966671,0.00039880516,0.0016683844,0.000091423884,0.0006622447,0.000512054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008367275,0.00026959943,0.00035281596,0.0012468772,0.0006795404,0.0006518227,0.0004362452,0.0003217962,0.001819853],"category_scores_gemma":[0.00317676,0.00029895065,0.00035685257,0.0014636061,0.00023898653,0.00048677155,0.0009111219,0.00058766257,0.00051026593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025935035,0.00014092983,0.975744,0.0002914236,0.000026484122,0.0022939977,0.0009739658,0.000055509478,0.00064550445,0.000021307276,0.0018943828,0.017653203],"study_design_scores_gemma":[0.00001695195,0.00033552496,0.9939453,0.00008573254,0.000019496843,0.0023164342,0.00075407594,0.0000938452,0.00024520155,0.000011981556,0.0021656593,0.000009736033],"about_ca_topic_score_codex":0.006581605,"about_ca_topic_score_gemma":0.01120694,"teacher_disagreement_score":0.006581605,"about_ca_system_score_codex":0.00095554476,"about_ca_system_score_gemma":0.0011850614,"threshold_uncertainty_score":0.013086617},"labels":[],"label_agreement":null},{"id":"W2321856824","doi":"10.1093/neuonc/nou264.50","title":"NI-52 * TOWARDS IMPROVED INTEGRATION OF ADVANCED IMAGING TECHNIQUES INTO THE NEUROSURGICAL OPERATING SUITE: A CANADIAN EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Anatomy and Medical Technology","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; London Health Sciences Centre; Western University","funders":"","keywords":"Workflow; Neuronavigation; Health care; Computer science; Medical imaging; Medicine; Medical physics; Artificial intelligence; Radiology; Magnetic resonance imaging","score_opus":0.006797778676993523,"score_gpt":0.2656670459714109,"score_spread":0.25886926729441734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321856824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7291814,0.005555877,0.020002741,0.042843014,0.0011223031,0.0014253895,0.0016133967,0.0009284475,0.19732744],"genre_scores_gemma":[0.8178434,0.008880238,0.06582948,0.007736102,0.0001455085,0.00041296546,0.0012720857,0.00084743614,0.09703292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99590045,0.0007767067,0.00018511353,0.00037205912,0.0018859283,0.00087982946],"domain_scores_gemma":[0.9873582,0.00068437145,0.00027977183,0.00036499882,0.0049553327,0.0063572987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075206924,0.0007002765,0.00030779414,0.0010630843,0.008723953,0.0032714335,0.0019992038,0.00097126147,0.013323117],"category_scores_gemma":[0.007880826,0.00064233335,0.0005733658,0.0020629584,0.003931058,0.001409002,0.0038101221,0.0024555859,0.0018552525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010344228,0.0030321502,0.11840747,0.0017532228,0.00012171403,0.009158528,0.13725166,0.0033652536,0.018262602,0.015676083,0.14707084,0.5448661],"study_design_scores_gemma":[0.00018406316,0.0018662816,0.16360936,0.000672237,0.00010893001,0.0065006022,0.07847634,0.003996469,0.0059325327,0.0014167267,0.73686355,0.00037285395],"about_ca_topic_score_codex":0.95233524,"about_ca_topic_score_gemma":0.97210026,"teacher_disagreement_score":0.04766476,"about_ca_system_score_codex":0.044335853,"about_ca_system_score_gemma":0.13930161,"threshold_uncertainty_score":0.32168067},"labels":[],"label_agreement":null},{"id":"W2322061949","doi":"10.1093/neuonc/nou242.8","title":"CS-08 * SONIC HEDGEHOG SIGNALING PROTECTS ATOH1 FROM DEGRADATION MEDIATED BY THE HECT DOMAIN E3 UBIQUITIN LIGASE HUWE1 IN CEREBELLAR GRANULE NEURON PROGENITORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ubiquitin ligase; Sonic hedgehog; Transcription factor; Cell biology; Biology; GLI2; Cerebellum; Ubiquitin; Molecular biology; Genetics; Signal transduction; Neuroscience; Gene","score_opus":0.013060896070525319,"score_gpt":0.2491607958643796,"score_spread":0.23609989979385426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322061949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960576,0.00083614164,0.001217623,0.00012287592,0.000021743106,0.000010610597,0.00058651273,0.000055269913,0.0010916638],"genre_scores_gemma":[0.9935161,0.000340159,0.0009451948,0.00006412603,0.0000054065763,0.000019754738,0.001470851,0.00002106299,0.0036172532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989545,0.000012247029,0.0000126916975,0.000024647317,0.000025169325,0.000029860967],"domain_scores_gemma":[0.9999112,0.000012066009,0.000024255422,0.000013844027,0.000008784732,0.000029868273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084906605,0.00019874965,0.00017723234,0.000120941295,0.00013595761,0.00028498002,0.00027063806,0.00020055332,0.001596384],"category_scores_gemma":[0.000089537316,0.00011873734,0.0002064337,0.00013501156,0.00020898768,0.0001624956,0.00016301316,0.00050207914,0.00057529315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022693863,0.000038649294,0.00022275223,0.00003134058,0.000007100214,0.000041401854,0.000008930966,0.00005267128,0.99806803,0.00016444297,0.00007442518,0.0010633505],"study_design_scores_gemma":[0.00001844495,0.00014304579,0.0066640647,0.0000045511133,0.000011429064,0.0001545809,0.000025926032,0.0010959907,0.9891538,0.00006460684,0.002659307,0.00000417893],"about_ca_topic_score_codex":0.00088669074,"about_ca_topic_score_gemma":0.001150541,"teacher_disagreement_score":0.001596384,"about_ca_system_score_codex":0.00037338195,"about_ca_system_score_gemma":0.00025590783,"threshold_uncertainty_score":0.005340457},"labels":[],"label_agreement":null},{"id":"W2322556147","doi":"10.1093/neuonc/nou258.26","title":"IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Oncology; Epidermal growth factor receptor; Progressive disease; Gastroenterology; Cancer; Radiation therapy; Chemotherapy","score_opus":0.025980043796520597,"score_gpt":0.2979942413213975,"score_spread":0.27201419752487693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322556147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859406,0.004597051,0.0016729394,0.00067015446,0.00007603283,0.0001288332,0.000056476623,0.00004730428,0.0041570878],"genre_scores_gemma":[0.9905025,0.005145357,0.0013579119,0.0010193313,0.000097932025,0.00006824986,0.00029096493,0.000027368747,0.0014905191],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998779,0.000055020057,0.000007213799,0.000015588435,0.000013737513,0.00003051945],"domain_scores_gemma":[0.999892,0.00003120826,0.000015581594,0.000009867505,0.000014622512,0.000036645273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048285574,0.0003216174,0.0002453608,0.000114033304,0.0001453497,0.00026737724,0.00019469002,0.00035912637,0.00055345264],"category_scores_gemma":[0.00033150768,0.000066526314,0.00021688663,0.00011832908,0.00023059444,0.00028167022,0.00016396768,0.0005665964,0.00026005003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073067914,0.005632091,0.011092805,0.0002190041,0.00014570658,0.0022266377,0.0008061664,0.0015186248,0.08607603,0.0006964178,0.004758762,0.8795211],"study_design_scores_gemma":[0.010144369,0.40529844,0.1653468,0.0005302251,0.0005919298,0.02549858,0.0008209218,0.009292249,0.16542569,0.0026594328,0.2142563,0.00013508825],"about_ca_topic_score_codex":0.00034911477,"about_ca_topic_score_gemma":0.00033949627,"teacher_disagreement_score":0.00055345264,"about_ca_system_score_codex":0.00021855129,"about_ca_system_score_gemma":0.00019220074,"threshold_uncertainty_score":0.0025536418},"labels":[],"label_agreement":null},{"id":"W2322670822","doi":"10.1093/neuonc/nou306","title":"White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"White matter; Neurocognitive; Medicine; Diffusion MRI; Cohort; Pediatrics; Neurofibromatosis; Borderline intellectual functioning; Magnetic resonance imaging; Cognition; Radiology; Internal medicine; Psychiatry","score_opus":0.023352206177516245,"score_gpt":0.2866055093431301,"score_spread":0.26325330316561385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322670822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997559,0.00005565046,0.000014563981,0.000013591148,9.288996e-7,0.0000017419909,0.000049496688,0.000001635516,0.00010637058],"genre_scores_gemma":[0.999782,0.000049905564,0.000024295254,0.000004562375,0.0000024659814,0.0000020593673,0.0001091822,6.591594e-7,0.000024732934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999918,0.00001420879,0.000008898402,0.000014617496,0.000019476385,0.000024809866],"domain_scores_gemma":[0.9988294,0.00015028303,0.00073732855,0.00002995399,0.00007733826,0.00017569278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020347063,0.00027857968,0.00018591847,0.0006535608,0.0002401716,0.00031317992,0.00022801546,0.00023646477,0.0013526658],"category_scores_gemma":[0.0018965898,0.00009553819,0.00015392185,0.00051179057,0.00031267456,0.00026838813,0.00030856684,0.00032715985,0.00014609878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023940167,0.0000057337124,0.99924964,0.0000023683435,0.0000041540166,0.000090124646,0.00002121552,0.000020831578,0.00011178818,0.0000029793068,0.000019373161,0.00044782268],"study_design_scores_gemma":[0.0000010289365,0.000051501876,0.9992341,0.0000021790977,0.0000063330235,0.0004819434,0.000079587655,0.00005285909,0.000057466495,0.000008775067,0.000023640994,7.335629e-7],"about_ca_topic_score_codex":0.0026805599,"about_ca_topic_score_gemma":0.0036868453,"teacher_disagreement_score":0.0026805599,"about_ca_system_score_codex":0.0002499879,"about_ca_system_score_gemma":0.0002650263,"threshold_uncertainty_score":0.0053298473},"labels":[],"label_agreement":null},{"id":"W2323591096","doi":"10.1093/neuonc/nov061.124","title":"PM-01 * NEURAL DERIVATIVES FROM HUMAN EMBRYONIC STEM CELLS: A CELLULAR SYSTEM TO STUDY THE ROLE OF Otx2 IN MEDULLOBLASTOMA PROGRESSION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"SOX2; Homeobox protein NANOG; Biology; Sonic hedgehog; Neural stem cell; Embryonic stem cell; Medulloblastoma; H3K4me3; KLF4; Cancer research; Wnt signaling pathway; Induced pluripotent stem cell; Tumor initiation; Stem cell; Chromatin immunoprecipitation; Cell biology; Gene; Genetics; Promoter; Gene expression; Carcinogenesis","score_opus":0.025879826660594712,"score_gpt":0.31179974253799925,"score_spread":0.2859199158774045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323591096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90178007,0.0053306874,0.030133815,0.0007819941,0.00049151044,0.00088096375,0.014916487,0.0012761729,0.044408355],"genre_scores_gemma":[0.88851106,0.0027906278,0.026671158,0.00034300258,0.000074564035,0.00086182874,0.020740341,0.00042319857,0.05958432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968135,0.000056689478,0.000038156188,0.000071380375,0.00011597853,0.000036475474],"domain_scores_gemma":[0.9997664,0.00006190262,0.000033680208,0.00006374342,0.000019993111,0.00005417253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030829015,0.00050351507,0.00032127876,0.00040796454,0.00024620185,0.00040582538,0.0005045451,0.00046981027,0.0051594838],"category_scores_gemma":[0.00016620543,0.00026267822,0.00034258253,0.00028579356,0.00024232453,0.00025751907,0.0003607188,0.0012754531,0.002331443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002577779,0.00012479312,0.00024112152,0.000065903805,0.000009431793,0.00018078192,0.000031559717,0.00009835441,0.9942074,0.00065574015,0.00043264424,0.0036944475],"study_design_scores_gemma":[0.00006284213,0.00097061,0.004009123,0.000015527292,0.000029862724,0.0008956246,0.000033824213,0.0012760793,0.95891756,0.00013346937,0.03364861,0.0000068483523],"about_ca_topic_score_codex":0.00089794275,"about_ca_topic_score_gemma":0.0012190052,"teacher_disagreement_score":0.0051594838,"about_ca_system_score_codex":0.00026706237,"about_ca_system_score_gemma":0.00027491795,"threshold_uncertainty_score":0.017260253},"labels":[],"label_agreement":null},{"id":"W2323627059","doi":"10.1093/neuonc/nou275.35","title":"SC-36 * RECIPROCAL INTERACTION OF PGE2 AND WNT SIGNALING REGULATES CANCER STEM CELLS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; SickKids Foundation","funders":"","keywords":"Wnt signaling pathway; Cancer stem cell; Cancer research; Stem cell; Neural stem cell; Biology; Cancer; Oncogene; Glioma; Signal transduction; Cell cycle; Cell biology; Genetics","score_opus":0.007772035712621044,"score_gpt":0.26096428675331773,"score_spread":0.2531922510406967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323627059","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10859302,0.87616134,0.0012288113,0.0008483647,0.00013307523,0.00027550722,0.004363627,0.0001487749,0.008247415],"genre_scores_gemma":[0.29139915,0.689743,0.0033359337,0.0009418083,0.00007273862,0.00017220867,0.0064600315,0.000030418647,0.007844767],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985445,0.000027303855,0.000027140404,0.000015960257,0.000060119,0.000015060139],"domain_scores_gemma":[0.9998049,0.00006190919,0.000057736703,0.000008396921,0.000048933114,0.000018180312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029420416,0.00023473597,0.0004933357,0.0016420995,0.0001551814,0.0003955365,0.00018810996,0.00023719725,0.0018428558],"category_scores_gemma":[0.00030580282,0.000110333494,0.0005723008,0.0016666165,0.0001484521,0.00018650902,0.00016128861,0.00023942695,0.00049946073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016003879,0.00012839968,0.007522473,0.0502925,0.00085662794,0.001196346,0.000205206,0.00080248126,0.2207505,0.0016102848,0.010351028,0.7046837],"study_design_scores_gemma":[0.00061765,0.0037949588,0.048942007,0.014084349,0.0063447263,0.0064385287,0.0003930939,0.0012220528,0.24206337,0.0017543688,0.67426836,0.00007650318],"about_ca_topic_score_codex":0.0015612548,"about_ca_topic_score_gemma":0.0057734214,"teacher_disagreement_score":0.0018428558,"about_ca_system_score_codex":0.00049746875,"about_ca_system_score_gemma":0.0008522828,"threshold_uncertainty_score":0.006164968},"labels":[],"label_agreement":null},{"id":"W2324633735","doi":"10.1093/neuonc/nov061.12","title":"BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Neuroscience; Cancer research; Medicine; Biology","score_opus":0.03668093878874632,"score_gpt":0.2957468147592787,"score_spread":0.2590658759705324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324633735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985889,0.0016454281,0.005697839,0.0001475434,0.000011175968,0.000045893757,0.0010098784,0.00023662606,0.0053165443],"genre_scores_gemma":[0.9936801,0.00065668306,0.003618554,0.000030440213,0.0000015215072,0.000022023509,0.00084186875,0.00003118789,0.0011174934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999399,0.000008542109,0.0000023202226,0.000010245467,0.00002882508,0.000010221089],"domain_scores_gemma":[0.9999771,0.0000060451484,0.0000054410516,0.0000021489823,0.000004892113,0.0000043492764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119422286,0.00028402873,0.00028885916,0.00014909131,0.0001045726,0.00034447448,0.00024832477,0.00019044093,0.001168177],"category_scores_gemma":[0.00011859126,0.00008335825,0.00024261743,0.00023445483,0.00014650349,0.00014185987,0.00016299047,0.00031342453,0.00020741505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043155387,0.00021026099,0.002928117,0.00027103195,0.000057394787,0.00021844779,0.000034279314,0.05723851,0.91092664,0.0018802441,0.00081135886,0.024992106],"study_design_scores_gemma":[0.00014572951,0.0019257352,0.007864243,0.0000133550175,0.00009933371,0.00059218635,0.00009243947,0.13679478,0.8384345,0.00097107486,0.013044182,0.000022436885],"about_ca_topic_score_codex":0.004141279,"about_ca_topic_score_gemma":0.0078005693,"teacher_disagreement_score":0.004141279,"about_ca_system_score_codex":0.0006267067,"about_ca_system_score_gemma":0.00038875794,"threshold_uncertainty_score":0.008234322},"labels":[],"label_agreement":null},{"id":"W2325456385","doi":"10.1093/neuonc/nou238.26","title":"AI-26 * OVERCOMING RESISTANCE TO VEGF-BLOCKADE BY TARGETING THE ANGIOPOIETIN/TIE2 AXIS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Angiopoietin receptor; Angiogenesis; Bevacizumab; Cancer research; Angiopoietin; Medicine; Receptor tyrosine kinase; Monoclonal antibody; Blockade; Pharmacology; Vascular endothelial growth factor; Immunology; Receptor; Antibody; Internal medicine; Chemotherapy; VEGF receptors","score_opus":0.008825700170887827,"score_gpt":0.26781614054760217,"score_spread":0.2589904403767143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325456385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664542,0.007950456,0.006543042,0.0006975318,0.00037285307,0.00027189244,0.000615327,0.00036562645,0.016729115],"genre_scores_gemma":[0.9733661,0.0054945634,0.0073668673,0.0003438779,0.00009723823,0.00013645996,0.0009341283,0.000041858395,0.012218994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999659,0.000004069727,0.0000031242475,0.0000056861277,0.000008377274,0.00001288222],"domain_scores_gemma":[0.99997187,0.0000028408379,0.000004606885,0.0000023544299,0.0000037401273,0.000014576785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006828071,0.00023900044,0.0001947004,0.00023416484,0.00010844086,0.00021452601,0.00014338121,0.0001440442,0.0018456725],"category_scores_gemma":[0.000057315567,0.00007342038,0.00015364031,0.00013656166,0.0001274923,0.00014242562,0.00010715597,0.0006194126,0.0005756362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067074323,0.00030911973,0.00026648244,0.00012009563,0.00001711249,0.00027071842,0.000018303048,0.00063944195,0.9615316,0.0009155169,0.00132373,0.033917148],"study_design_scores_gemma":[0.00033346732,0.003648895,0.0034842365,0.000017644406,0.00005015267,0.0016930805,0.000033023432,0.0038254792,0.94446653,0.00046699823,0.041960336,0.000020162886],"about_ca_topic_score_codex":0.0004404358,"about_ca_topic_score_gemma":0.0007318269,"teacher_disagreement_score":0.0018456725,"about_ca_system_score_codex":0.00016831714,"about_ca_system_score_gemma":0.00021912907,"threshold_uncertainty_score":0.006174326},"labels":[],"label_agreement":null},{"id":"W2325798815","doi":"10.1093/neuonc/nou264.65","title":"NI-67 * THE ROLE OF FLAIR VOLUME AS A PROGNOSTICATING FACTOR IN PATIENTS WITH GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fluid-attenuated inversion recovery; Magnetic resonance imaging; Nuclear medicine; Medicine; Glioblastoma; Volume (thermodynamics); Radiology","score_opus":0.006353008328689139,"score_gpt":0.2434102231051928,"score_spread":0.23705721477650366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325798815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990864,0.0003553797,0.00006935049,0.000053666925,0.0000062427644,0.0000021565613,0.00007168325,0.0000042622655,0.00035101004],"genre_scores_gemma":[0.99970144,0.000059514008,0.00005593096,0.000008456642,0.000007456287,0.000002119116,0.00010207162,0.0000012803516,0.00006161907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998894,0.000025667747,0.000017141294,0.000018217082,0.00002504297,0.000024518533],"domain_scores_gemma":[0.9987437,0.00032297752,0.00052461686,0.00005092518,0.00015671438,0.00020114041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000375056,0.00023102775,0.00018890569,0.00063059764,0.00022278224,0.0003352277,0.00021072227,0.000258237,0.0008171787],"category_scores_gemma":[0.0029086417,0.00010336299,0.00015028182,0.00044229312,0.00018814387,0.00040794123,0.00021423555,0.00029182096,0.00020249093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019711131,0.000007938345,0.99716705,0.000004523736,0.00001137456,0.000112476344,0.00002004531,0.000044806995,0.0002599228,0.000007466301,0.0000530818,0.0021142107],"study_design_scores_gemma":[0.0000045619113,0.00013167117,0.99811053,0.000005206931,0.00002813383,0.00072335254,0.00010390292,0.00044109896,0.00022573714,0.00004675025,0.00017465987,0.000004448482],"about_ca_topic_score_codex":0.0014638355,"about_ca_topic_score_gemma":0.002087705,"teacher_disagreement_score":0.0014638355,"about_ca_system_score_codex":0.00024481985,"about_ca_system_score_gemma":0.00019364843,"threshold_uncertainty_score":0.002910614},"labels":[],"label_agreement":null},{"id":"W2326031646","doi":"10.1093/neuonc/nov061.24","title":"EP-05 * POSTERIOR FOSSA EPENDYMOMA SUBGROUPS HAVE DISTINCT THERAPEUTIC AND PROGNOSTIC IMPLICATIONS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Internal medicine; Pathology; Radiology","score_opus":0.023791925440884716,"score_gpt":0.29001840567642334,"score_spread":0.26622648023553863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326031646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962676,0.00033317055,0.00044522982,0.00007472052,0.000005466396,0.000011474214,0.0014310142,0.000018391625,0.001412896],"genre_scores_gemma":[0.9970476,0.00011712806,0.00041882333,0.000031065843,0.000008230553,0.000012671225,0.0018765007,0.000008755833,0.0004791897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998386,0.00001699277,0.00001972704,0.00005475878,0.00003787922,0.000032000335],"domain_scores_gemma":[0.9996008,0.000096900694,0.00014219308,0.000046951198,0.00005589803,0.00005727717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003030783,0.00026227633,0.00025944156,0.00042529593,0.00023223733,0.000538091,0.00025780528,0.00027644107,0.0025247147],"category_scores_gemma":[0.0013135343,0.00008533616,0.00029054453,0.00063325604,0.00022912452,0.00033905232,0.0004985777,0.0003696668,0.00056199194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054605905,0.0000253465,0.95339686,0.000056897727,0.0001386623,0.0010673102,0.00016103958,0.00041229275,0.012589908,0.00026138907,0.0008210419,0.030523196],"study_design_scores_gemma":[0.000012578326,0.00013452268,0.990275,0.0000130215285,0.00008379959,0.003322942,0.0001753299,0.00044842865,0.0026632622,0.00070592685,0.0021593398,0.000005843538],"about_ca_topic_score_codex":0.0017182267,"about_ca_topic_score_gemma":0.0022903744,"teacher_disagreement_score":0.0025247147,"about_ca_system_score_codex":0.0003249779,"about_ca_system_score_gemma":0.00022289934,"threshold_uncertainty_score":0.008445978},"labels":[],"label_agreement":null},{"id":"W2326440885","doi":"10.1093/neuonc/nou253.15","title":"ED-15 * LONG-TERM PROPHYLACTIC ANTIEPILEPTIC DRUGS USE IN PATIENTS WITH GLIOMAS: A 7 YEAR RETROSPECTIVE ANALYSIS IN A TERTIARY CARE CENTER","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Retrospective cohort study; Perioperative; Neurology; Prophylactic treatment; Epilepsy; Epilepsy surgery; Pediatrics; Surgery; Anesthesia","score_opus":0.005962246150723307,"score_gpt":0.24939971417410506,"score_spread":0.24343746802338176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326440885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987727,0.00040806868,0.000033703218,0.00003300082,0.000003277939,0.000008319298,0.00047274132,0.0000026118657,0.00026548066],"genre_scores_gemma":[0.99921036,0.00021089065,0.00003750531,0.0000412276,0.0000065927748,0.000007644886,0.0004233007,0.0000012529066,0.0000612715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993401,0.00009731099,0.00016453043,0.00014648202,0.00013273033,0.000118794356],"domain_scores_gemma":[0.99771345,0.0002913437,0.0014580013,0.000096229545,0.00019570676,0.00024532524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059522176,0.00017864481,0.00036779602,0.0010962855,0.00046148576,0.0006870915,0.00036191338,0.00033159426,0.0014578063],"category_scores_gemma":[0.0014412496,0.00030342146,0.0004293351,0.0018135579,0.0003501372,0.0005159491,0.00055532216,0.00041207115,0.0002585235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034975717,0.000011942863,0.9992337,0.000012864958,0.000017878285,0.00016673733,0.000040215862,0.000011350189,0.000042943437,0.000005783905,0.00006079918,0.00036083334],"study_design_scores_gemma":[0.000007182823,0.00008789093,0.997863,0.000020165293,0.000027483211,0.0012008622,0.00043102104,0.00007759085,0.0000636985,0.000007453315,0.00021016807,0.000003545316],"about_ca_topic_score_codex":0.0065660905,"about_ca_topic_score_gemma":0.008359687,"teacher_disagreement_score":0.0065660905,"about_ca_system_score_codex":0.00082465145,"about_ca_system_score_gemma":0.0008140051,"threshold_uncertainty_score":0.013055742},"labels":[],"label_agreement":null},{"id":"W2327002222","doi":"10.1093/neuonc/nov061.91","title":"MB-15 * ACTIVATED Wnt SIGNALING TARGETS Sox2+ TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; SOX2; Wnt signaling pathway; Cancer research; Stem cell; Refractory (planetary science); Chemistry; Cell biology; Biology; Signal transduction; Biochemistry; Transcription factor; Astrobiology; Gene","score_opus":0.02224597898360645,"score_gpt":0.27185283960649587,"score_spread":0.24960686062288942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327002222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970029,0.00054017146,0.0007298294,0.000047655485,0.0000128509955,0.00007803921,0.00048299177,0.000049276197,0.0010563695],"genre_scores_gemma":[0.9955953,0.00031789267,0.0009795465,0.00004275195,0.0000048075945,0.00005517307,0.0010700511,0.000012105636,0.0019222946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.000021687158,0.000022759397,0.000028337874,0.000045496858,0.000033899014],"domain_scores_gemma":[0.999926,0.000014553905,0.000015963164,0.000012427513,0.0000071149307,0.00002391168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016821848,0.00018259158,0.00033076043,0.00018143712,0.00011097472,0.00033945774,0.00014961496,0.00016874107,0.0010308533],"category_scores_gemma":[0.00011281771,0.00011858132,0.00023844597,0.00011643859,0.00011999154,0.00008625896,0.000133419,0.00040722862,0.0003919082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022298415,0.00017554933,0.0011984208,0.000047721052,0.000012413428,0.000086508386,0.000045921435,0.00022324437,0.99423766,0.00013426348,0.00021075807,0.003404528],"study_design_scores_gemma":[0.00006711617,0.002311252,0.017568445,0.000008794922,0.00003809647,0.0005117041,0.00005429736,0.0020488084,0.97142226,0.000041214662,0.0059223287,0.0000056345393],"about_ca_topic_score_codex":0.0017043647,"about_ca_topic_score_gemma":0.003316712,"teacher_disagreement_score":0.0017043647,"about_ca_system_score_codex":0.00023662872,"about_ca_system_score_gemma":0.0002302765,"threshold_uncertainty_score":0.0034486055},"labels":[],"label_agreement":null},{"id":"W2327242544","doi":"10.1093/neuonc/nou206.16","title":"SOX2 IDENTIFIES THE TREATMENT-REFRACTORY STEM CELL POPULATION IN GROUP 2 MEDULLOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; SOX2; Biology; Cancer research; Cancer stem cell; GLI1; Gene knockdown; Chromatin immunoprecipitation; Stem cell; Hedgehog signaling pathway; Signal transduction; Apoptosis; Transcription factor; Cell biology; Gene expression; Gene; Genetics","score_opus":0.017091770971449063,"score_gpt":0.27934100731551537,"score_spread":0.2622492363440663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327242544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984548,0.00032903926,0.000581853,0.000010131702,0.0000022045906,0.00001856378,0.00019999861,0.000016647069,0.00038674395],"genre_scores_gemma":[0.99829644,0.00020229183,0.00055191654,0.000010487562,0.0000036834472,0.000017067992,0.00046182697,0.000004833275,0.00045151357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994373,0.000004826839,0.000005289277,0.000013485173,0.00002150402,0.0000112656935],"domain_scores_gemma":[0.99994326,0.000008686989,0.000017255525,0.0000066204834,0.000008316864,0.000015857951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010196589,0.000109999535,0.00013561179,0.00042491924,0.00009226782,0.00021941715,0.00007656427,0.00014050369,0.0009409071],"category_scores_gemma":[0.000097544296,0.00007357864,0.0000993656,0.00020167568,0.00015676547,0.00007708375,0.00010676899,0.00012091546,0.00019094693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028788013,0.000022605938,0.025156416,0.000032653104,0.000010231535,0.00016956429,0.00007508678,0.00005205888,0.9718112,0.000050557966,0.00004504595,0.0022867678],"study_design_scores_gemma":[0.000028829902,0.00077439984,0.5176848,0.000009965153,0.000065984445,0.0030232333,0.0002716801,0.0016287825,0.47266886,0.00008733401,0.003749282,0.0000067831543],"about_ca_topic_score_codex":0.0008532896,"about_ca_topic_score_gemma":0.001591889,"teacher_disagreement_score":0.0009409071,"about_ca_system_score_codex":0.0001519949,"about_ca_system_score_gemma":0.00009594071,"threshold_uncertainty_score":0.0031476617},"labels":[],"label_agreement":null},{"id":"W2327595442","doi":"10.1093/neuonc/nou260.2","title":"MS-02 * TRANSCRIPTOME ANALYSIS IDENTIFIES THE PI3K/AKT/mTOR PATHWAY AS A TARGETABLE PATHWAY IN SCHWANNOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Schwannoma; PI3K/AKT/mTOR pathway; Transcriptome; Biology; Cancer research; Gene expression profiling; Medicine; Gene; Pathology; Gene expression; Signal transduction; Genetics","score_opus":0.018675225032723602,"score_gpt":0.27265766524453666,"score_spread":0.25398244021181304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327595442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831329,0.0008612757,0.003019537,0.000106786654,0.000031148138,0.00003897333,0.009730773,0.00018520294,0.0028934388],"genre_scores_gemma":[0.96434075,0.00087398646,0.006216251,0.00016125872,0.000021771524,0.00010408062,0.023757422,0.00007229902,0.0044522644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998884,0.000007084433,0.000007383503,0.000033400418,0.00003758481,0.000026142314],"domain_scores_gemma":[0.9999323,0.0000135690525,0.000013085408,0.0000064000747,0.000017039187,0.00001759946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006886419,0.0001920769,0.00026215432,0.00034962106,0.00032389903,0.00039778982,0.00011206535,0.00018368821,0.002008052],"category_scores_gemma":[0.000103043734,0.000094735406,0.00036334476,0.00043343168,0.00012305347,0.00013611549,0.00016304394,0.00030916667,0.00066808186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005342635,0.000040498813,0.005169891,0.000075339245,0.000016858845,0.000115110575,0.000027567108,0.0002908646,0.9883543,0.00007249029,0.00036037588,0.0049422965],"study_design_scores_gemma":[0.000052273233,0.0010410055,0.2763993,0.000025406982,0.00013325289,0.0016331973,0.00039451395,0.008292807,0.6992705,0.000405401,0.012329638,0.000022690556],"about_ca_topic_score_codex":0.001012453,"about_ca_topic_score_gemma":0.0016708807,"teacher_disagreement_score":0.002008052,"about_ca_system_score_codex":0.0002447685,"about_ca_system_score_gemma":0.00025351337,"threshold_uncertainty_score":0.0067176223},"labels":[],"label_agreement":null},{"id":"W2327624302","doi":"10.1093/neuonc/nou255.12","title":"ET-12 * PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Bevacizumab; Medicine; Clinical endpoint; Internal medicine; Placebo; Oncology; Phases of clinical research; Adverse effect; Gastroenterology; Surgery; Chemotherapy; Clinical trial; Pathology","score_opus":0.022350712068395985,"score_gpt":0.31508402696549154,"score_spread":0.29273331489709553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327624302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892033,0.002599015,0.0005309266,0.00041316048,0.00028077565,0.0031823944,0.0011075597,0.00011786926,0.0025649806],"genre_scores_gemma":[0.9828334,0.0025945497,0.0015439739,0.0010112085,0.00029594736,0.004361477,0.0025132697,0.00004220434,0.004803913],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994772,0.00030297463,0.000032405158,0.00006453809,0.00004024838,0.00008263197],"domain_scores_gemma":[0.99928373,0.00013953104,0.00016061992,0.00006507822,0.00006310871,0.00028798953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017649939,0.0013713412,0.003118813,0.0004891479,0.00032916336,0.0011113278,0.0009921853,0.0012146784,0.005086394],"category_scores_gemma":[0.0012019125,0.0006187523,0.001503575,0.0005119687,0.0008124293,0.0008834515,0.00035698834,0.003060993,0.0009605999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9419583,0.015745252,0.0011978857,0.00042813623,0.0009427513,0.000040057625,0.000062736566,0.00058458734,0.00441243,0.00011452653,0.0012047989,0.03330838],"study_design_scores_gemma":[0.79942656,0.19351408,0.0031686889,0.000034887,0.0004840847,0.000093149014,0.000028396329,0.0007165342,0.00086873496,0.00017088374,0.0014736403,0.000020344984],"about_ca_topic_score_codex":0.0012530898,"about_ca_topic_score_gemma":0.0031639223,"teacher_disagreement_score":0.005086394,"about_ca_system_score_codex":0.0008185472,"about_ca_system_score_gemma":0.0015613255,"threshold_uncertainty_score":0.017015696},"labels":[],"label_agreement":null},{"id":"W2327965348","doi":"10.1093/neuonc/nov061.62","title":"IM-07 * NK CELL IMMUNOTHERAPY FOR PEDIATRIC BRAIN TUMORS: OVERCOMING RESISTANCE TO EXPAND THERAPEUTIC SUCCESS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Immunotherapy; Medicine; Resistance (ecology); Cancer research; Immunology; Biology; Immune system; Ecology","score_opus":0.034008418333085134,"score_gpt":0.32691693461399834,"score_spread":0.2929085162809132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327965348","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81845266,0.1089476,0.011359881,0.010539891,0.0020524997,0.0008047786,0.0010203087,0.0010947452,0.0457276],"genre_scores_gemma":[0.910807,0.045196246,0.013738635,0.0036192893,0.00090326,0.00064236514,0.002597606,0.0001868799,0.022308674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980634,0.000041718402,0.000014194229,0.000030134588,0.0000394262,0.00006815453],"domain_scores_gemma":[0.999864,0.00001792192,0.000020789554,0.000018764216,0.000032353022,0.000046261433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042742808,0.00041748746,0.0005512591,0.00032297056,0.0001728385,0.0006682182,0.0003980472,0.00047643774,0.0037467016],"category_scores_gemma":[0.00024140695,0.00010674201,0.00032278683,0.00021363748,0.0002750257,0.000554184,0.00033511716,0.0016152913,0.0015767539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022118734,0.0027718418,0.005773633,0.001142697,0.00012575902,0.0009294337,0.0002710826,0.0017285413,0.3760391,0.005564914,0.031680815,0.5717604],"study_design_scores_gemma":[0.0019633065,0.018919336,0.015910741,0.00044678958,0.00035411207,0.009616445,0.00032914223,0.006734773,0.50633454,0.0027912355,0.43654457,0.000054923523],"about_ca_topic_score_codex":0.0003161598,"about_ca_topic_score_gemma":0.0007015845,"teacher_disagreement_score":0.0037467016,"about_ca_system_score_codex":0.00054671377,"about_ca_system_score_gemma":0.0006326371,"threshold_uncertainty_score":0.012533903},"labels":[],"label_agreement":null},{"id":"W2329476154","doi":"10.1093/neuonc/nov061.51","title":"HG-14 * CLINICAL, RADIOGRAPHIC, AND HISTOLOGIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Incidence (geometry); Radiation therapy; Radiography; Chemotherapy; Glioma; Biopsy; Radiology; Internal medicine","score_opus":0.047822177833130426,"score_gpt":0.3311451341584273,"score_spread":0.28332295632529686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329476154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964976,0.00016800835,0.00011924476,0.000025354824,0.0000033585054,0.000011621998,0.0023332334,0.0000138701425,0.00082781265],"genre_scores_gemma":[0.9961932,0.00008287599,0.000086494394,0.000017746655,0.00000535096,0.000013179093,0.0033903797,0.0000042709858,0.00020646577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997769,0.000027365237,0.0000394467,0.000053726762,0.000060780447,0.000041821262],"domain_scores_gemma":[0.99910396,0.00013015642,0.00033732166,0.000094272276,0.00012463893,0.00020974224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037527847,0.00017927926,0.00020936901,0.0007766204,0.00025479498,0.00030218155,0.00023811495,0.00017446281,0.0010946117],"category_scores_gemma":[0.0009857354,0.0001036336,0.00014531352,0.00096940505,0.00023471695,0.00024173726,0.0002655362,0.0002098711,0.00032160114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028156564,0.0000056065933,0.99831235,0.0000040500177,0.000008024429,0.00009960754,0.000029455363,0.00001949004,0.000115329116,0.000004668647,0.00021437011,0.0011588556],"study_design_scores_gemma":[0.0000034175703,0.000051116098,0.9982407,0.0000022708334,0.000010476121,0.00085775217,0.000082928964,0.000049208622,0.00011318398,0.0000059149743,0.00058106985,0.0000018910515],"about_ca_topic_score_codex":0.004961534,"about_ca_topic_score_gemma":0.0049801636,"teacher_disagreement_score":0.004961534,"about_ca_system_score_codex":0.00031413624,"about_ca_system_score_gemma":0.0002731596,"threshold_uncertainty_score":0.009865284},"labels":[],"label_agreement":null},{"id":"W2329604683","doi":"10.1093/neuonc/nou255.7","title":"ET-07 * DOES OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION ALLOWS EFFLUX PUMP SUBSTRATES DELIVERY TO THE TUMOR AND CNS?","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Parenchyma; P-glycoprotein; Efflux; Drug delivery; Glioma; Blood–brain barrier; Medicine; Nuclear medicine; Pharmacology; Chemistry; Internal medicine; Pathology; Cancer research; Central nervous system; Biochemistry","score_opus":0.013088768464048618,"score_gpt":0.27738852729559954,"score_spread":0.26429975883155093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329604683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98643446,0.0042856536,0.001741782,0.0012665323,0.00015570023,0.000049477625,0.0004453063,0.00007533602,0.005545741],"genre_scores_gemma":[0.9889525,0.003770984,0.0010385755,0.00057318073,0.000055474033,0.000047224996,0.0007550104,0.000018374558,0.004788509],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998963,0.000022615404,0.000009649285,0.000015811089,0.000023699227,0.000031904787],"domain_scores_gemma":[0.9999255,0.00001741073,0.000020098807,0.0000090926005,0.000009500653,0.000018337629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001960454,0.00013978822,0.0004008095,0.00011160657,0.00011013788,0.00030228932,0.00023715114,0.00041915395,0.0035286222],"category_scores_gemma":[0.0002067049,0.00009247068,0.00029119482,0.00015062657,0.00030668222,0.00049200834,0.00012938361,0.00058117585,0.00089166017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014892128,0.0016239304,0.006482787,0.000513946,0.00012422871,0.0009101991,0.00006676292,0.0006422644,0.86783963,0.0028773232,0.0025143446,0.101512454],"study_design_scores_gemma":[0.0010916009,0.02704448,0.02154659,0.00008527261,0.00024539937,0.0052874913,0.0002583942,0.002924308,0.8945491,0.0018581927,0.045061335,0.00004793361],"about_ca_topic_score_codex":0.00051876117,"about_ca_topic_score_gemma":0.0005984708,"teacher_disagreement_score":0.0035286222,"about_ca_system_score_codex":0.00024291419,"about_ca_system_score_gemma":0.00027022578,"threshold_uncertainty_score":0.011804402},"labels":[],"label_agreement":null},{"id":"W2330017471","doi":"10.1093/neuonc/nou260.4","title":"MS-05 * UTILIZING A VIRTUAL REALITY SIMULATOR, NEUROTOUCH, TO DETERMINE PROFICIENCY PERFORMANCE BENCHMARKS FOR RESECTION OF SIMULATED BRAIN TUMORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Psychomotor learning; Virtual reality; Neurosurgery; Metric (unit); Computer science; Medical physics; Resection; Duration (music); Medicine; Simulation; Cognition; Physical medicine and rehabilitation; Human–computer interaction; Surgery; Operations management; Engineering","score_opus":0.05368099055873142,"score_gpt":0.35252216575143874,"score_spread":0.2988411751927073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330017471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746644,0.000008713236,0.0016876158,0.00000662144,0.0000030478077,0.00008474336,0.00011138678,0.000037996528,0.000593477],"genre_scores_gemma":[0.99203366,0.000014534125,0.0065100202,0.000017118802,0.0000025728614,0.0002552518,0.00045485984,0.000010493056,0.0007013741],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995357,0.00014363925,0.000049102087,0.00009008555,0.0001272049,0.000054292414],"domain_scores_gemma":[0.99809283,0.0005562018,0.000343177,0.00016318396,0.0004342307,0.0004103681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012872724,0.00045960286,0.00020902713,0.0004234956,0.00021827868,0.00030692236,0.00036156643,0.0003190658,0.0018470602],"category_scores_gemma":[0.0033900265,0.00016186683,0.00031790102,0.00014481515,0.00026486363,0.00034124037,0.0007128739,0.0002970392,0.0004773083],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009857182,0.008547289,0.6632319,0.00037753212,0.00031500083,0.00036162222,0.0033130439,0.030157028,0.13100341,0.0007988388,0.0022779384,0.14975916],"study_design_scores_gemma":[0.0002597983,0.067208484,0.7998908,0.00005020126,0.00008536859,0.0007054512,0.0012796987,0.051736638,0.07395182,0.00040604643,0.0043450436,0.000080617654],"about_ca_topic_score_codex":0.0015740651,"about_ca_topic_score_gemma":0.003010283,"teacher_disagreement_score":0.0018470602,"about_ca_system_score_codex":0.00036142944,"about_ca_system_score_gemma":0.00068985374,"threshold_uncertainty_score":0.006807804},"labels":[],"label_agreement":null},{"id":"W2330539180","doi":"10.1093/neuonc/nou238.5","title":"AI-05 * IMPACT OF GBM MICROENVIRONMENT ON EXPRESSION PROFILE OF BONE MARROW DERIVED PROGENITOR CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Progenitor cell; Tumor microenvironment; Cancer research; Bone marrow; Glioma; Stem cell; Cell biology; Immunology; Immune system","score_opus":0.01264049588114713,"score_gpt":0.2826086422830478,"score_spread":0.26996814640190064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330539180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91314477,0.002854919,0.003107873,0.0015359491,0.0009389909,0.00024597085,0.00845162,0.00042324368,0.069296815],"genre_scores_gemma":[0.8968099,0.0015993728,0.004389888,0.0008550598,0.0001870428,0.00056766695,0.010327233,0.000155341,0.08510857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99960214,0.000053823263,0.000028536944,0.00007902451,0.00010894331,0.00012768556],"domain_scores_gemma":[0.99974066,0.000028539349,0.000020651203,0.000021322314,0.000049918257,0.00013894391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022201127,0.00033528075,0.0005433702,0.0004339189,0.00033586816,0.0007488264,0.00020767884,0.00044966422,0.031551164],"category_scores_gemma":[0.00020641027,0.00012790838,0.00034361775,0.0003775643,0.00030091943,0.00018719904,0.0003171043,0.0012966112,0.0068893214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004919661,0.0010045195,0.0025203284,0.0002459326,0.000046834884,0.0004702943,0.00009851955,0.000107817104,0.95800394,0.0009152257,0.0038186666,0.02784829],"study_design_scores_gemma":[0.0006746193,0.013671722,0.105610415,0.0001310781,0.00017912082,0.0031943119,0.0008728699,0.0019731885,0.75150186,0.001520816,0.12062415,0.00004595503],"about_ca_topic_score_codex":0.00058894523,"about_ca_topic_score_gemma":0.0005091422,"teacher_disagreement_score":0.031551164,"about_ca_system_score_codex":0.00029932824,"about_ca_system_score_gemma":0.000508088,"threshold_uncertainty_score":0.1055491},"labels":[],"label_agreement":null},{"id":"W2330616842","doi":"10.1093/neuonc/nou209.25","title":"PROFICIENCY PERFORMANCE BENCHMARKS FOR REMOVAL OF SIMULATED BRAIN TUMORS USING NEUROTOUCH","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neurosurgery; Metric (unit); Virtual reality; Medical physics; Computer science; Set (abstract data type); Task (project management); Quality (philosophy); Medicine; Human–computer interaction; Operations management; Surgery; Engineering; Systems engineering","score_opus":0.04493891550099699,"score_gpt":0.3464016866500638,"score_spread":0.30146277114906683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330616842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276274,0.00004943374,0.005168334,0.000029273831,0.00000706326,0.00015014216,0.00016991966,0.000042832406,0.0016201799],"genre_scores_gemma":[0.98965144,0.000055937217,0.0092493,0.000012853602,0.0000036263652,0.0002409615,0.00044789456,0.000007394702,0.00033056553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827325,0.0005730515,0.0002493238,0.00017151701,0.00060697575,0.00012588344],"domain_scores_gemma":[0.9941783,0.0019410525,0.0014683139,0.00033790886,0.0015299239,0.0005445623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023221083,0.00052704243,0.00027293936,0.00089329033,0.00023070307,0.0004750811,0.00057188584,0.00033175776,0.0016218309],"category_scores_gemma":[0.008102812,0.0001260033,0.0003226053,0.000273484,0.00031191917,0.0004477529,0.0010251865,0.00029694152,0.00032201625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021063408,0.003120709,0.77177995,0.00064208446,0.00019072153,0.00027166418,0.0043562455,0.02507513,0.03773109,0.0009558854,0.0019731983,0.15179698],"study_design_scores_gemma":[0.00011806401,0.016670924,0.89152044,0.00014486653,0.00006906745,0.00062937895,0.0027633486,0.03914691,0.043514244,0.00086345145,0.0044489014,0.0001104712],"about_ca_topic_score_codex":0.0008601029,"about_ca_topic_score_gemma":0.0017653779,"teacher_disagreement_score":0.0023221083,"about_ca_system_score_codex":0.00038924764,"about_ca_system_score_gemma":0.000654111,"threshold_uncertainty_score":0.012280643},"labels":[],"label_agreement":null},{"id":"W2331637821","doi":"10.1093/neuonc/nou208.10","title":"TRANSCRIPTIONAL REGULATION OF OLIGODENDROGLIAL CELL FATE BY DLX HOMEOBOX GENES: POTENTIAL RELEVANCE TO HISTONE H3.3 MUTATIONS IN PEDIATRIC HIGH GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Homeobox; Chromatin immunoprecipitation; Transcription factor; DLX5; Genetics; Chromatin; ChIP-on-chip; Promoter; Gene; Cell biology; Gene expression; Chromatin remodeling","score_opus":0.011549033156943818,"score_gpt":0.26919508560648625,"score_spread":0.2576460524495424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331637821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631363,0.0013770829,0.0014149279,0.000056742952,0.0000040388654,0.000010952849,0.0005438681,0.00003492746,0.0002438431],"genre_scores_gemma":[0.9975229,0.0007719963,0.0009820253,0.000034360815,0.0000037907955,0.000011077107,0.00044920619,0.0000089569485,0.00021575483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999366,0.0000053927374,0.000004192792,0.000017527811,0.00002005482,0.000016303009],"domain_scores_gemma":[0.9999168,0.000020007144,0.000035815512,0.0000033834774,0.000007448376,0.000016709646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010412601,0.00015958642,0.000162037,0.00019965981,0.00007590968,0.00018402445,0.00012639971,0.00014906403,0.00062583445],"category_scores_gemma":[0.00012960723,0.00006375626,0.00012583377,0.00023719251,0.0002058829,0.0000734159,0.000113681526,0.0001874148,0.000114914306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072064984,0.00004969236,0.046621207,0.0002143581,0.000026171803,0.00080092705,0.00010648152,0.00073763117,0.9417337,0.00016304285,0.00013712718,0.008689029],"study_design_scores_gemma":[0.00003570446,0.00027617044,0.49289343,0.000024826495,0.0000958425,0.0028410647,0.0002845114,0.0036056875,0.49598694,0.00032709388,0.0036147654,0.000014038574],"about_ca_topic_score_codex":0.00094743713,"about_ca_topic_score_gemma":0.0014036748,"teacher_disagreement_score":0.00094743713,"about_ca_system_score_codex":0.000356344,"about_ca_system_score_gemma":0.0001911342,"threshold_uncertainty_score":0.0025854707},"labels":[],"label_agreement":null},{"id":"W2331657830","doi":"10.1093/neuonc/nou278.8","title":"TM-08 * DIFFERENTIAL VASCULAR PATTERN OF GLIOMA STEM CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; Vascularity; Biology; Cancer research; Stem cell; Gene knockdown; Angiogenesis; Tumor microenvironment; Brain tumor; In vivo; Pathology; Cell culture; Medicine; Tumor cells; Cell biology; Genetics","score_opus":0.0092734908667788,"score_gpt":0.23843990570939638,"score_spread":0.22916641484261757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331657830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883193,0.0005832036,0.0026851005,0.00014702421,0.000054973734,0.000060182756,0.0027629023,0.00017429012,0.0052130376],"genre_scores_gemma":[0.9839191,0.00035797467,0.0025488576,0.00015799924,0.000012450948,0.000110971974,0.0052240817,0.000058157326,0.0076104268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998323,0.00001358121,0.00001820253,0.000042339998,0.000052705538,0.000040842504],"domain_scores_gemma":[0.99990296,0.000013212084,0.000015716038,0.00001415294,0.000020181866,0.00003381987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000886802,0.00017778599,0.00023226546,0.0003006499,0.00014263776,0.0003007898,0.00012577919,0.00023376844,0.0024480738],"category_scores_gemma":[0.00009640172,0.00011015185,0.0002797385,0.00040993426,0.00015637462,0.00015011097,0.0001494235,0.0006900211,0.0007071903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019523245,0.000069773916,0.00066446996,0.00003526894,0.000008349598,0.00007764285,0.00003387837,0.000080194404,0.9944359,0.0002458859,0.00032136924,0.0038320343],"study_design_scores_gemma":[0.00004751043,0.0013466876,0.025185315,0.0000092832015,0.000047047288,0.00092633296,0.00014532148,0.0022816234,0.9547666,0.00018491762,0.015045939,0.000013459991],"about_ca_topic_score_codex":0.001576561,"about_ca_topic_score_gemma":0.001304562,"teacher_disagreement_score":0.0024480738,"about_ca_system_score_codex":0.00028252657,"about_ca_system_score_gemma":0.0001825881,"threshold_uncertainty_score":0.008189678},"labels":[],"label_agreement":null},{"id":"W2332077409","doi":"10.1093/neuonc/nou262.5","title":"MR-05 * GLIOMA STEM CELL SPECIFIC microRNA-mRNA INTERACTION NETWORK","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Interactome; microRNA; RNA; Biology; Gene silencing; Computational biology; Small RNA; Non-coding RNA; RNA silencing; Argonaute; RNA interference; Messenger RNA; Gene; Small interfering RNA; Genetics; Cell biology","score_opus":0.012854397123284867,"score_gpt":0.2523576612491761,"score_spread":0.2395032641258912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332077409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.529458,0.004673457,0.11196216,0.0009836107,0.0002380252,0.00051459845,0.2473181,0.017049784,0.08780222],"genre_scores_gemma":[0.7332276,0.001472356,0.053879663,0.0002480855,0.000052768595,0.00040713444,0.19015002,0.00047453635,0.0200877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971,0.00003218084,0.000013988449,0.0001332722,0.00006980404,0.00004071583],"domain_scores_gemma":[0.9998412,0.000029369352,0.000045141293,0.000019164552,0.00003562623,0.000029397708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012555905,0.00050487777,0.00034329918,0.00090471393,0.00040381844,0.000559424,0.0004793902,0.00030828104,0.012415972],"category_scores_gemma":[0.00038316593,0.00016944323,0.00056204014,0.00096524303,0.00015629621,0.00032736605,0.0003984377,0.00025989016,0.0035567605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025406484,0.00041417373,0.06969112,0.0051284954,0.00074382895,0.0020650649,0.000573427,0.12294302,0.3083177,0.05482473,0.1501164,0.2826414],"study_design_scores_gemma":[0.00017029325,0.0009069318,0.098289855,0.00020727738,0.0005320144,0.0037566843,0.00038799114,0.34918892,0.09414365,0.03419594,0.41807532,0.00014500342],"about_ca_topic_score_codex":0.0031095978,"about_ca_topic_score_gemma":0.003610808,"teacher_disagreement_score":0.012415972,"about_ca_system_score_codex":0.0005805865,"about_ca_system_score_gemma":0.00060610427,"threshold_uncertainty_score":0.041535556},"labels":[],"label_agreement":null},{"id":"W2332145434","doi":"10.1093/neuonc/nou278.10","title":"TM-10 * ALTERATIONS IN METABOLIC PATHWAYS IN GLIOBLASTOMA MULTIFORME CELLS IN RESPONSE TO HEXOKINASE-2 INHIBITION","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Glycolysis; Gene knockdown; Pentose phosphate pathway; Metabolic pathway; Citric acid cycle; Glioma; Hexokinase; Anaerobic glycolysis; Biology; Metabolomics; Biochemistry; Cancer research; Chemistry; Cell biology; Metabolism; Apoptosis; Bioinformatics","score_opus":0.0110285302901276,"score_gpt":0.25984926403877534,"score_spread":0.24882073374864774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332145434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232084,0.0013349805,0.00092530093,0.00028162778,0.00017654954,0.000046552796,0.002501621,0.00020204207,0.002210388],"genre_scores_gemma":[0.9849156,0.001171157,0.0015328204,0.00025184636,0.000017228984,0.00013702,0.0066345274,0.000032183125,0.005307594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986434,0.0000112832495,0.000014913148,0.000021838425,0.000040072086,0.000047543686],"domain_scores_gemma":[0.999933,0.000007844921,0.000011581003,0.0000070076667,0.000013543825,0.000026966367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103870356,0.0003782515,0.0004686451,0.00018820129,0.00013474007,0.00026252127,0.00021348253,0.00023296919,0.0027125257],"category_scores_gemma":[0.000083076375,0.00009837574,0.00029203002,0.00032226348,0.00015073332,0.0001308223,0.00013196481,0.0007823223,0.00059534947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010572039,0.000362273,0.0010081783,0.00013933654,0.000037590613,0.00014804724,0.0000413481,0.00022937269,0.9904074,0.00010883472,0.0013385087,0.0051219906],"study_design_scores_gemma":[0.00012661997,0.0037330457,0.022640593,0.000017260652,0.000056364697,0.00043364754,0.00015487726,0.0021359918,0.9628167,0.00008152426,0.0077895233,0.000013808917],"about_ca_topic_score_codex":0.0032835277,"about_ca_topic_score_gemma":0.003912225,"teacher_disagreement_score":0.0032835277,"about_ca_system_score_codex":0.00035593688,"about_ca_system_score_gemma":0.00038584578,"threshold_uncertainty_score":0.009074271},"labels":[],"label_agreement":null},{"id":"W2332217343","doi":"10.1093/neuonc/nov061.77","title":"MB-01 * NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Flow cytometry; Metastasis; Population; Cell; Downregulation and upregulation; Primary tumor; Cerebrospinal fluid; Western blot; Medicine; Cancer stem cell; Cell culture; Biology; Cancer; Pathology; Oncology; Internal medicine; Immunology; Genetics","score_opus":0.04058908769832843,"score_gpt":0.31218049395169634,"score_spread":0.2715914062533679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332217343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517137,0.0010127645,0.0008626994,0.00009022592,0.000023391563,0.00002174681,0.00042159445,0.000059963153,0.0023362173],"genre_scores_gemma":[0.995883,0.00034764598,0.00049014535,0.000032727577,0.000005511367,0.000016370259,0.0004436273,0.000012131745,0.0027689422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.000011695693,0.000009078253,0.000013655562,0.000024117147,0.000029194442],"domain_scores_gemma":[0.9999291,0.000010885602,0.000009732938,0.00000888951,0.0000083459945,0.000033034114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081996695,0.0001347276,0.00015369541,0.00022189043,0.0001494044,0.00026583433,0.00013473685,0.00014527085,0.0017844186],"category_scores_gemma":[0.00009972365,0.000083044615,0.00015152288,0.000115471215,0.0001328419,0.00013781093,0.00017438598,0.00050038786,0.0005774557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022578877,0.0001197305,0.0006354505,0.000030027148,0.000003779307,0.00008463333,0.00002938572,0.00005283556,0.9960232,0.00024050727,0.0001817906,0.0023728365],"study_design_scores_gemma":[0.000035457037,0.000823335,0.01954065,0.000011800591,0.000015324,0.0004587381,0.000100359,0.0016307881,0.9697175,0.000084400875,0.007578154,0.000003506703],"about_ca_topic_score_codex":0.0031435129,"about_ca_topic_score_gemma":0.003473964,"teacher_disagreement_score":0.0031435129,"about_ca_system_score_codex":0.0003197244,"about_ca_system_score_gemma":0.00023377711,"threshold_uncertainty_score":0.006250441},"labels":[],"label_agreement":null},{"id":"W2333308044","doi":"10.1093/neuonc/nou254.9","title":"EG-09 * EPIGENETIC PROFILING REVEALS A CpG HYPERMETHYLATION PHENOTYPE (CIMP) ASSOCIATED WITH WORSE PROGRESSION-FREE SURVIVAL IN MENINGIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA methylation; Epigenetics; Methylation; Phenotype; Biology; CpG site; Computational biology; Oncology; Internal medicine; Medicine; Genetics; Gene; Gene expression","score_opus":0.023718342180934833,"score_gpt":0.3102180812113175,"score_spread":0.28649973903038267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333308044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991918,0.00008131726,0.00014948433,0.000012824411,0.0000014317604,0.00000268568,0.0004017477,0.000010267879,0.0001483755],"genre_scores_gemma":[0.998485,0.000039186267,0.00025717283,0.000016125781,0.0000017278104,0.000005917759,0.0009926908,0.0000049967634,0.0001970912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989355,0.000015158164,0.000009654045,0.000031153057,0.000025742007,0.000024752233],"domain_scores_gemma":[0.9997563,0.000050314058,0.00007546886,0.00004194682,0.00003244965,0.000043609518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026224958,0.00022883897,0.00025878195,0.00045636247,0.00021931047,0.0002718219,0.0001852487,0.00022732886,0.00082979875],"category_scores_gemma":[0.00061755633,0.00008568272,0.00023367531,0.00027985827,0.00015103818,0.0000632987,0.00021192901,0.0002899424,0.00022359237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002245469,0.000092981565,0.7939844,0.00006055044,0.00019275749,0.00071598426,0.000175466,0.000481984,0.18990259,0.000065619155,0.0005816033,0.011500578],"study_design_scores_gemma":[0.000019742642,0.00022735035,0.9701985,0.0000056528784,0.000113472466,0.0014904023,0.000080131984,0.0008290051,0.026109684,0.00008778295,0.00083252473,0.0000057994184],"about_ca_topic_score_codex":0.0016786491,"about_ca_topic_score_gemma":0.0023949984,"teacher_disagreement_score":0.0016786491,"about_ca_system_score_codex":0.00027256308,"about_ca_system_score_gemma":0.00014050021,"threshold_uncertainty_score":0.003337741},"labels":[],"label_agreement":null},{"id":"W2333458705","doi":"10.1093/neuonc/nou266.1","title":"PT-01 * THE IMPACT OF INITIAL RADIATION IN INFANTS AND THE RE-IRRADIATION OF RECURRENT DISEASE ON THE SURVIVAL OF EPENDYMOMA PATIENTS AT THE HOSPITAL FOR SICK CHILDREN, TORONTO","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Radiation therapy; Surgery; Chemotherapy; Overall survival; Retrospective cohort study; Pediatrics","score_opus":0.018357205945140592,"score_gpt":0.34421014244559983,"score_spread":0.3258529365004592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333458705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914779,0.0037175808,0.000062505234,0.00024367624,0.000027073509,0.000009886653,0.0007714545,0.000009118363,0.0036807593],"genre_scores_gemma":[0.9968676,0.0011917977,0.00010176599,0.000056958183,0.000021068721,0.000005969368,0.00066418323,0.0000076202446,0.0010831181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979323,0.000028754495,0.000020709564,0.000028172097,0.000059097194,0.00006998724],"domain_scores_gemma":[0.9989833,0.00019357077,0.00036302398,0.00003067514,0.00015252821,0.00027690182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024868586,0.000121110475,0.00014494224,0.00027882174,0.00034076817,0.00038465785,0.00027304448,0.0001748035,0.002921353],"category_scores_gemma":[0.0011288959,0.00006688323,0.00020232148,0.00039160793,0.00033259383,0.00012494385,0.00025362047,0.00023106804,0.00026568916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040505518,0.000014418006,0.9751848,0.00013277898,0.00005973784,0.0022417312,0.00024667592,0.00015679916,0.000994553,0.00005042068,0.00222559,0.018287439],"study_design_scores_gemma":[0.0000045037627,0.0001333184,0.9941988,0.000036839905,0.000027747292,0.0028939976,0.00017114374,0.00004102994,0.00040218417,0.0000073369542,0.002080528,0.0000024808087],"about_ca_topic_score_codex":0.053452805,"about_ca_topic_score_gemma":0.09845993,"teacher_disagreement_score":0.053452805,"about_ca_system_score_codex":0.002786853,"about_ca_system_score_gemma":0.0013996724,"threshold_uncertainty_score":0.10628331},"labels":[],"label_agreement":null},{"id":"W2333948856","doi":"10.1093/neuonc/nov061.94","title":"MB-18 * POST-TRANSLATIONAL REGULATION OF ATOH1: FROM CEREBELLAR DEVELOPMENT TO MEDULLOBLASTOMA FORMATION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Transcription factor; Medulloblastoma; Cerebellum; Biology; Ubiquitin ligase; GLI2; Cell biology; Cancer research; Genetics; Ubiquitin; Signal transduction; Neuroscience; Gene","score_opus":0.03505896558823104,"score_gpt":0.28472124382768976,"score_spread":0.24966227823945872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333948856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959875,0.005368576,0.0027011556,0.00010569139,0.000031476666,0.000016613632,0.0004490169,0.00006538614,0.0016633722],"genre_scores_gemma":[0.99329984,0.0018423545,0.0014517675,0.000036538106,0.000010979029,0.000011926002,0.00053628744,0.00001602965,0.0027941312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999498,0.0000043468685,0.0000034547297,0.000016053098,0.0000105192785,0.000015824655],"domain_scores_gemma":[0.999956,0.0000032635455,0.000015966201,0.0000031318593,0.000005965724,0.00001569521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062113606,0.00020333564,0.000118505806,0.00016993153,0.00016702885,0.00027385663,0.00016067369,0.0001352333,0.0008029014],"category_scores_gemma":[0.0000600516,0.00008274344,0.00016159848,0.00010149202,0.00014083326,0.00019977217,0.00015840103,0.00020118614,0.0003382076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001256699,0.000010307972,0.00083760277,0.00003387308,0.0000042982238,0.0001092542,0.000015469981,0.000028434582,0.9965676,0.00020979077,0.000047533482,0.0020100875],"study_design_scores_gemma":[0.0000061710343,0.0001141261,0.02751736,0.00000648228,0.000016955713,0.00030639867,0.000028585806,0.000335175,0.9658391,0.00007487578,0.005751491,0.0000032901073],"about_ca_topic_score_codex":0.0009617543,"about_ca_topic_score_gemma":0.0012355208,"teacher_disagreement_score":0.0009617543,"about_ca_system_score_codex":0.0003499385,"about_ca_system_score_gemma":0.00013437503,"threshold_uncertainty_score":0.002685964},"labels":[],"label_agreement":null},{"id":"W2334286689","doi":"10.1093/neuonc/not182","title":"NEURO/MEDICAL ONCOLOGY","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut Gustave-Roussy; Hospital for Sick Children; Children's Healthcare of Atlanta; Seattle Children's Research Institute; Sidney Kimmel Comprehensive Cancer Center; Novartis Pharmaceuticals Corporation; Johns Hopkins University","keywords":"Medicine; Medical physics; Internal medicine; Oncology","score_opus":0.02381053194504296,"score_gpt":0.31914169082461746,"score_spread":0.2953311588795745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334286689","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012285175,0.07848074,0.002631003,0.03341925,0.008458754,0.00027807025,0.0028393257,0.0009891936,0.86061853],"genre_scores_gemma":[0.12924077,0.098268524,0.0075330012,0.036300797,0.010490041,0.00043047738,0.006967412,0.00047753315,0.71029156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961036,0.000094818075,0.000033999775,0.00006773073,0.000105710045,0.000087511435],"domain_scores_gemma":[0.99939597,0.00006586103,0.00008247851,0.0000634263,0.0001880898,0.00020418473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040547462,0.00067057513,0.00040882494,0.0009179268,0.0009175456,0.001700321,0.0008135356,0.0012439591,0.16372697],"category_scores_gemma":[0.0014049722,0.00016589525,0.00034098284,0.0007460073,0.0004676295,0.0007283887,0.0011555975,0.0014584854,0.09240817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022529841,0.00016210343,0.0042850706,0.0008658045,0.00005505685,0.0038491632,0.0001296977,0.00017624644,0.0014432126,0.006493729,0.42654985,0.55576485],"study_design_scores_gemma":[0.000051351344,0.000093924384,0.0026562237,0.00048802712,0.0000222138,0.008351514,0.000084999476,0.0000872972,0.00047878872,0.002834128,0.9848423,0.000009256409],"about_ca_topic_score_codex":0.0009525093,"about_ca_topic_score_gemma":0.0017789953,"teacher_disagreement_score":0.836273,"about_ca_system_score_codex":0.0013254572,"about_ca_system_score_gemma":0.0017259028,"threshold_uncertainty_score":0.54772127},"labels":[],"label_agreement":null},{"id":"W2334423299","doi":"10.1093/neuonc/nou240.32","title":"BM-32 * CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ceritinib; Medicine; Internal medicine; non-small cell lung cancer (NSCLC); Lung cancer; Cohort; Anaplastic lymphoma kinase; ALK inhibitor; Gastroenterology; Oncology","score_opus":0.020618376259350306,"score_gpt":0.34023702853253257,"score_spread":0.31961865227318226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334423299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890591,0.0065908465,0.00023122161,0.0005958148,0.000111220375,0.00061449147,0.00094278203,0.0000884612,0.0017661543],"genre_scores_gemma":[0.9940347,0.0017288119,0.00036702547,0.00031703166,0.000106351625,0.00033959688,0.0019760153,0.000009930562,0.0011206573],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996748,0.00017541139,0.000018407647,0.000045446144,0.00003212145,0.000053849973],"domain_scores_gemma":[0.9996711,0.00004329758,0.000088481,0.00001537556,0.000021188793,0.00016063546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014377595,0.0008169841,0.001376178,0.00023054914,0.00025720696,0.0005005567,0.00042361292,0.0005033142,0.0022414331],"category_scores_gemma":[0.0006401385,0.00019866702,0.00084750727,0.00023758634,0.00036747183,0.00048231406,0.000317639,0.0015320668,0.0004432233],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81330717,0.005644441,0.018921271,0.001345575,0.0018085516,0.0003400322,0.00016103157,0.0026415999,0.016380856,0.00024797377,0.010043543,0.12915792],"study_design_scores_gemma":[0.69364774,0.19567415,0.08791867,0.00018894266,0.0016890797,0.0013234337,0.0000848193,0.003679109,0.0052570594,0.0005243905,0.00995987,0.000052783915],"about_ca_topic_score_codex":0.0007004845,"about_ca_topic_score_gemma":0.0030140693,"teacher_disagreement_score":0.0022414331,"about_ca_system_score_codex":0.0007409881,"about_ca_system_score_gemma":0.00084856007,"threshold_uncertainty_score":0.0076036453},"labels":[],"label_agreement":null},{"id":"W2334697425","doi":"10.1093/neuonc/nou275.5","title":"SC-05 * DOPAMINE RECEPTOR ANTAGONISTS ARE SELECTIVE INHIBITORS OF GLIOBLASTOMA STEM CELLS THROUGH IMPAIRMENT OF AUTOPHAGY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neural stem cell; Clonogenic assay; Cancer research; Cancer stem cell; Stem cell; Downregulation and upregulation; Autophagy; Biology; Temozolomide; Cell biology; Cell culture; Glioma; Gene; Biochemistry; Genetics","score_opus":0.00806125200810196,"score_gpt":0.24907741021210505,"score_spread":0.2410161582040031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334697425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856391,0.005593424,0.00093304936,0.0001568475,0.000038576607,0.00010657633,0.0010517612,0.00015010606,0.0063306796],"genre_scores_gemma":[0.98555773,0.0046208655,0.0019534512,0.00017504755,0.000011579612,0.000106033585,0.0022529406,0.000019925857,0.0053023673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999598,0.0000056234026,0.000004321496,0.0000055703044,0.000010398564,0.000014355534],"domain_scores_gemma":[0.999977,0.00000396232,0.000004059333,0.0000021605222,0.00000386702,0.000008998898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005220968,0.00029090207,0.00025372035,0.00030045075,0.00011706884,0.00017018562,0.00013210809,0.00015091799,0.0015593946],"category_scores_gemma":[0.000047768346,0.000078400204,0.00019031622,0.00021759234,0.00009545842,0.000076497636,0.00008721701,0.0003505933,0.0004040905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074765674,0.0004077097,0.00066223746,0.00019597259,0.00003592625,0.00016824612,0.000020889272,0.00030190093,0.9731501,0.00038517354,0.0010247264,0.022899399],"study_design_scores_gemma":[0.00029284606,0.005452742,0.0073496588,0.000029993269,0.00007001819,0.00055779144,0.00003736241,0.0011125666,0.9717283,0.00013866379,0.013218735,0.000011290225],"about_ca_topic_score_codex":0.001120277,"about_ca_topic_score_gemma":0.0049748784,"teacher_disagreement_score":0.0015593946,"about_ca_system_score_codex":0.00024400052,"about_ca_system_score_gemma":0.0003858827,"threshold_uncertainty_score":0.0052167177},"labels":[],"label_agreement":null},{"id":"W2334751121","doi":"10.1093/neuonc/nou256.16","title":"GE-16 * JAPANESE PEDIATRIC MOLECULAR NEURO-ONCOLOGY GROUP (JPMNG): ESTABLISHMENT OF A NATIONWIDE MOLECULAR DIAGNOSTIC NETWORK FOR PEDIATRIC MALIGNANT BRAIN TUMORS IN JAPAN","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Wnt signaling pathway; Molecular pathology; Fluorescence in situ hybridization; Surgical oncology; Biology; Molecular genetics; Gene; Oncology; Pathology; Internal medicine; Medicine; Cancer research; Genetics; Chromosome","score_opus":0.00966171987199607,"score_gpt":0.26557863059445064,"score_spread":0.2559169107224546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334751121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231221,0.00926515,0.021707509,0.0029562954,0.00047278285,0.0017398235,0.021110129,0.00086981634,0.018756488],"genre_scores_gemma":[0.8208305,0.008099282,0.080276944,0.0010630377,0.00042229946,0.0039086407,0.06469668,0.00040057465,0.020302035],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993443,0.00014471574,0.00009189599,0.00018760857,0.000110866975,0.00012062141],"domain_scores_gemma":[0.99772733,0.00009657658,0.0003313641,0.00017431962,0.00091683585,0.0007536546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012521918,0.0006313875,0.00058243435,0.001936526,0.00086512574,0.0005455509,0.0006882413,0.0004420699,0.0038383445],"category_scores_gemma":[0.00088575896,0.00035044493,0.00041690446,0.002045834,0.00035918166,0.000467021,0.0013350919,0.00045175332,0.0015418233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000884216,0.00019298332,0.6936676,0.0010403112,0.00020950958,0.0024741166,0.001217108,0.0021642654,0.037548363,0.0017092768,0.044878583,0.2140136],"study_design_scores_gemma":[0.00028395295,0.00052439404,0.80569905,0.00016845459,0.00041628926,0.005210116,0.0010581763,0.004239666,0.0092934845,0.0005048909,0.17254813,0.00005346524],"about_ca_topic_score_codex":0.017763585,"about_ca_topic_score_gemma":0.016555365,"teacher_disagreement_score":0.017763585,"about_ca_system_score_codex":0.0019195664,"about_ca_system_score_gemma":0.006503912,"threshold_uncertainty_score":0.0353204},"labels":[],"label_agreement":null},{"id":"W2334874614","doi":"10.1093/neuonc/nov061.33","title":"GE-09 * COMBINED HEREDITARY AND SOMATIC MUTATIONS OF REPLICATION ERROR REPAIR GENES RESULT IN RAPID ONSET OF ULTRA-HYPERMUTATED MALIGNANT BRAIN TUMORS IN CHILDREN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Somatic cell; Replication (statistics); Genetics; Gene; Biology; Mutation; Germline mutation; Cancer research; Medicine; Virology","score_opus":0.03043287086740363,"score_gpt":0.3078961192213144,"score_spread":0.27746324835391073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334874614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923745,0.00044099824,0.00065604795,0.00007049064,0.000011171303,0.000016588936,0.0033004447,0.00008591053,0.0030440183],"genre_scores_gemma":[0.99131495,0.00047446895,0.0024733357,0.000060158683,0.000007928116,0.000018684072,0.0034811797,0.000057671976,0.00211168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998042,0.00001927076,0.00001148425,0.00006489625,0.000050008533,0.000050150615],"domain_scores_gemma":[0.9998534,0.000039338884,0.000041828767,0.000012935008,0.000014190498,0.000038313578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011275941,0.0004917022,0.0002661897,0.000607391,0.00028162808,0.00027637626,0.00018326729,0.0003140805,0.0042763217],"category_scores_gemma":[0.00025908512,0.00020615105,0.00026106858,0.0004341698,0.00026512032,0.000114816816,0.000348528,0.0003746454,0.000954915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013882027,0.00019196104,0.5807637,0.00024699865,0.00037167608,0.032452773,0.0004584478,0.00061206374,0.33689702,0.001087217,0.0043223524,0.041207578],"study_design_scores_gemma":[0.000034456432,0.00051976996,0.8287992,0.000045500536,0.000109675064,0.09888027,0.00034746184,0.00047253372,0.048797395,0.00019092715,0.021784421,0.000018312083],"about_ca_topic_score_codex":0.0018168765,"about_ca_topic_score_gemma":0.0029308563,"teacher_disagreement_score":0.0042763217,"about_ca_system_score_codex":0.00032259116,"about_ca_system_score_gemma":0.0002728613,"threshold_uncertainty_score":0.01430577},"labels":[],"label_agreement":null},{"id":"W2335372520","doi":"10.1093/neuonc/nou255.35","title":"ET-35 * PACRITINIB: A NOVEL JAK/STAT INHIBITOR WITH TRANSLATIONAL RELEVANCE FOR GBM","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Ruxolitinib; STAT protein; Janus kinase; STAT3; JAK-STAT signaling pathway; stat; Cancer research; PTEN; Myelofibrosis; Medicine; Signal transduction; Biology; Pharmacology; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Tyrosine kinase; Receptor; Bone marrow","score_opus":0.028356472759601962,"score_gpt":0.3231796751110784,"score_spread":0.29482320235147647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335372520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95968866,0.023078302,0.002743656,0.0013033,0.0002310595,0.0002780345,0.0015579577,0.00039024197,0.010728769],"genre_scores_gemma":[0.9745842,0.010006234,0.005112956,0.0009118915,0.000103115504,0.00014917072,0.0026442632,0.000030982214,0.0064570913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.000013243074,0.000004984392,0.000014190954,0.00001794274,0.000019234905],"domain_scores_gemma":[0.99997795,0.000002921289,0.000004579697,0.000001872837,0.000002573118,0.000010117829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015620397,0.00036072583,0.0003251859,0.00028907653,0.00014113911,0.0003811998,0.00020277145,0.00031879122,0.0017106378],"category_scores_gemma":[0.00005955124,0.00010235625,0.0002208806,0.00026671222,0.00016020023,0.00026047238,0.00013632007,0.0008642433,0.000536004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004926512,0.0014220222,0.0015344531,0.0005171002,0.00009810016,0.0005747402,0.00008038853,0.0028622285,0.8477274,0.0017351307,0.0059037637,0.13261807],"study_design_scores_gemma":[0.0047311843,0.020589111,0.025658365,0.00009084744,0.00035820008,0.0065994128,0.00007709026,0.011523628,0.8125934,0.0010109892,0.116669625,0.00009810929],"about_ca_topic_score_codex":0.00077503786,"about_ca_topic_score_gemma":0.0020274373,"teacher_disagreement_score":0.0017106378,"about_ca_system_score_codex":0.0003949561,"about_ca_system_score_gemma":0.0003518162,"threshold_uncertainty_score":0.0057225823},"labels":[],"label_agreement":null},{"id":"W2336100438","doi":"10.1093/neuonc/nov209.42","title":"CBIO-42DOWN REGULATION OF PYRUVATE DEHYDROGENASE ACTIVITY IS ESSENTIAL FOR CELL PROLIFERATION IN IDH1 MUTANT GLIOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mutant; Pyruvate dehydrogenase complex; Glioma; IDH1; Isocitrate dehydrogenase; Chemistry; Cell growth; Cell biology; Biochemistry; Cell; Enzyme; Biology; Cancer research; Gene","score_opus":0.01569037873649329,"score_gpt":0.27733027065294036,"score_spread":0.26163989191644704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336100438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913864,0.0019902717,0.0017351125,0.00023218892,0.00009474626,0.000044247394,0.0013990182,0.00024299193,0.0028750666],"genre_scores_gemma":[0.9912794,0.00096749706,0.00190369,0.00008088425,0.00001171327,0.00008441586,0.001643282,0.00004762555,0.003981532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999778,0.000018207966,0.000027527365,0.000043137996,0.000077542936,0.000055577595],"domain_scores_gemma":[0.9998995,0.000012077287,0.000018743936,0.000019328072,0.000014717829,0.000035668152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086409615,0.0003939228,0.00047505167,0.0002529882,0.00020632724,0.0003220749,0.00031440498,0.00026150103,0.0011618044],"category_scores_gemma":[0.000076200726,0.00014137292,0.00032387464,0.00027981427,0.00019433467,0.00013228747,0.00020418153,0.0006019438,0.0005871027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010532931,0.00004466325,0.0001247638,0.000025110792,0.0000033775361,0.00005603844,0.000013698918,0.000030163026,0.99872667,0.000057626057,0.000066501365,0.00074603356],"study_design_scores_gemma":[0.00001478837,0.0002078225,0.0036224844,0.0000033995416,0.000009024237,0.00013634401,0.000026999734,0.00053811236,0.992737,0.000027828917,0.0026719621,0.0000042338365],"about_ca_topic_score_codex":0.0030384532,"about_ca_topic_score_gemma":0.0029955932,"teacher_disagreement_score":0.0030384532,"about_ca_system_score_codex":0.00037082433,"about_ca_system_score_gemma":0.00039698105,"threshold_uncertainty_score":0.0060415864},"labels":[],"label_agreement":null},{"id":"W2336547352","doi":"10.1093/neuonc/nov204.28","title":"ATPS-28COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Ontario Brain Institute; Ontario Institute for Cancer Research; Genome British Columbia; Hospital for Sick Children","funders":"","keywords":"Phosphoproteomics; Brain tumor; Drug; Primary (astronomy); Medicine; Tumor cells; Human brain; Pharmacology; Cancer research; Neuroscience; Pathology; Biology; Cell biology","score_opus":0.030993674258538852,"score_gpt":0.3001466175386531,"score_spread":0.2691529432801143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336547352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98056674,0.0021806853,0.0037385877,0.00015587344,0.00003088769,0.00016655616,0.010107913,0.00028077752,0.002772047],"genre_scores_gemma":[0.95248705,0.0027831101,0.010215613,0.00015736144,0.000013788474,0.00029090946,0.027156603,0.00007489049,0.0068206657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998067,0.000013222837,0.00001554961,0.00004328644,0.00008793851,0.000033372664],"domain_scores_gemma":[0.9999236,0.000011668752,0.000012280649,0.0000103559605,0.000026816497,0.00001529334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017786653,0.0004208816,0.0007240936,0.0004946789,0.00023230555,0.00043830852,0.00028546024,0.00026277694,0.0020473485],"category_scores_gemma":[0.00014605476,0.00014796568,0.0004387523,0.00076299853,0.0001687586,0.00014103229,0.00021370001,0.00038186304,0.00068769814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025823113,0.00012335325,0.0014876014,0.00009431574,0.0000243402,0.00007715348,0.000013209303,0.00071772374,0.9892846,0.000056212688,0.00044237266,0.007420875],"study_design_scores_gemma":[0.000046703044,0.0014061587,0.028512323,0.000007576443,0.00006524997,0.00037626346,0.00004251862,0.0039980654,0.959995,0.00008090839,0.00545845,0.00001082344],"about_ca_topic_score_codex":0.0025646396,"about_ca_topic_score_gemma":0.005234266,"teacher_disagreement_score":0.0025646396,"about_ca_system_score_codex":0.00041118983,"about_ca_system_score_gemma":0.00041203952,"threshold_uncertainty_score":0.00684911},"labels":[],"label_agreement":null},{"id":"W2337058838","doi":"10.1093/neuonc/nov231.03","title":"RTRB-03SHORT DELAY IN INITIATION OF RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR GLIOBLASTOMA: A SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0525 AND 0825","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Medicine; Oncology; Radiation therapy; Internal medicine; Hazard ratio; Chemoradiotherapy; Proportional hazards model; Glioblastoma; Confidence interval; Cancer research","score_opus":0.025549606718185732,"score_gpt":0.32969594668032404,"score_spread":0.3041463399621383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337058838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954727,0.0016763959,0.00026112227,0.00006434319,0.000039105467,0.00018412045,0.0014878676,0.000024326566,0.0007900087],"genre_scores_gemma":[0.99607,0.00029433394,0.00020533071,0.00012690815,0.00006609166,0.0002035225,0.0023632878,0.000011716413,0.00065877713],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974039,0.0014370177,0.00018746317,0.00041831043,0.0002822574,0.0002709454],"domain_scores_gemma":[0.9963643,0.0012119323,0.0012154313,0.00043576333,0.0002466721,0.00052589667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042217555,0.00076039083,0.0016950268,0.0006334948,0.00019607026,0.00094425824,0.0007082975,0.00064245705,0.0030772064],"category_scores_gemma":[0.0032842846,0.00028552665,0.0040407553,0.00069066486,0.0003344083,0.0003761854,0.00043015648,0.0014147601,0.00044290232],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8375235,0.004666417,0.098873444,0.0010420477,0.0138618825,0.00020400409,0.00011621363,0.0019047005,0.0073699285,0.0001622521,0.0017216514,0.03255393],"study_design_scores_gemma":[0.09861505,0.2636751,0.5911322,0.00020426145,0.027033126,0.0005808308,0.00018539671,0.0035928937,0.006926686,0.00032232102,0.0076558134,0.000076397715],"about_ca_topic_score_codex":0.002311259,"about_ca_topic_score_gemma":0.0032272958,"teacher_disagreement_score":0.0042217555,"about_ca_system_score_codex":0.0009827511,"about_ca_system_score_gemma":0.0013425855,"threshold_uncertainty_score":0.022327006},"labels":[],"label_agreement":null},{"id":"W2337458062","doi":"10.1093/neuonc/nov222.26","title":"MPTH-26MOLECULAR REFINEMENT OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2015,"lang":"es","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Medulloblastoma; Pathology; Oncology; Internal medicine; Genetics; Medicine","score_opus":0.016900530523097073,"score_gpt":0.2814769180351891,"score_spread":0.264576387512092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337458062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836064,0.0032426894,0.004315409,0.00014147865,0.000021361142,0.00004837268,0.0013339202,0.00008063079,0.0024555451],"genre_scores_gemma":[0.99064904,0.0013060475,0.005083213,0.000049579914,0.000016438258,0.00003709432,0.0020534082,0.000022738575,0.0007824837],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997507,0.000018694218,0.00002455402,0.00007779221,0.00008236737,0.00004597131],"domain_scores_gemma":[0.9996829,0.000051657902,0.000115213195,0.00003158754,0.00007817246,0.000040459687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002273425,0.00037597315,0.0003055691,0.0011473354,0.00037210147,0.0004269042,0.0003330107,0.00028102484,0.00093798107],"category_scores_gemma":[0.0006799722,0.00017160116,0.000334118,0.0008998159,0.00034106392,0.0002950868,0.00045163403,0.00050176005,0.0002970678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005521163,0.000051335184,0.5531001,0.00039253253,0.00019852583,0.012933412,0.0005460729,0.0019707119,0.3596533,0.0018131863,0.0013472664,0.06744152],"study_design_scores_gemma":[0.000024808138,0.00019930696,0.8732516,0.0000443531,0.00016692295,0.03513942,0.00039846855,0.0039179884,0.07084569,0.0014079767,0.01457356,0.000029843986],"about_ca_topic_score_codex":0.0031664968,"about_ca_topic_score_gemma":0.004544349,"teacher_disagreement_score":0.0031664968,"about_ca_system_score_codex":0.00048381378,"about_ca_system_score_gemma":0.00045573886,"threshold_uncertainty_score":0.006296158},"labels":[],"label_agreement":null},{"id":"W2337562041","doi":"10.1093/neuonc/nov219.08","title":"MTR-08MODELING TMZ RESISTANCE IN PATIENT-DERIVED BRAIN TUMOR- INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Brain tumor; Temozolomide; Internal medicine; Glioblastoma; Cancer research; Pathology","score_opus":0.04195692803620214,"score_gpt":0.3043310493408496,"score_spread":0.26237412130464743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337562041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161655,0.0006471876,0.0026439081,0.00025576938,0.00007111175,0.00025541373,0.0020582473,0.00020740864,0.0022443417],"genre_scores_gemma":[0.98557764,0.00063166255,0.0037881942,0.00011683279,0.000016922715,0.00033826876,0.0031742414,0.00004985688,0.0063063544],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99953175,0.00005982928,0.00005800235,0.00007722256,0.00016707918,0.00010608791],"domain_scores_gemma":[0.9998128,0.00001821921,0.0000552593,0.000034836317,0.00002279305,0.00005617176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028705655,0.00047628017,0.0005999111,0.00042935376,0.00024432596,0.00054781075,0.00038102936,0.0005260073,0.0030414767],"category_scores_gemma":[0.000121478384,0.00021179083,0.0004803128,0.00039340564,0.00026807742,0.00022870569,0.00027797345,0.0017752134,0.0011148109],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034491342,0.00046620588,0.0004386703,0.000055879893,0.0000133647245,0.00013779772,0.000049743092,0.00025401526,0.9951681,0.0002870267,0.0004695305,0.0023147727],"study_design_scores_gemma":[0.00012752732,0.00453618,0.0068280017,0.000014281557,0.000043408272,0.0010192003,0.00010705664,0.0033284072,0.9760532,0.0001365659,0.007794887,0.000011297469],"about_ca_topic_score_codex":0.0014887204,"about_ca_topic_score_gemma":0.0018791346,"teacher_disagreement_score":0.0030414767,"about_ca_system_score_codex":0.00056807,"about_ca_system_score_gemma":0.00053424784,"threshold_uncertainty_score":0.010174751},"labels":[],"label_agreement":null},{"id":"W2337727575","doi":"10.1093/neuonc/nov215.10","title":"GENO-10LOSS OF IDH MUTATION IN PATIENT-DERIVED BRAIN TUMOR INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Biology; IDH1; Glioma; Mutation; Cancer research; Mutant; Epigenetics; Isocitrate dehydrogenase; Phenotype; Genetics; Molecular biology; Gene","score_opus":0.03483767146161917,"score_gpt":0.30767519752115285,"score_spread":0.2728375260595337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337727575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928012,0.0005754591,0.0021439479,0.0000794734,0.000028470957,0.00009457252,0.0015866087,0.000106266154,0.0025839575],"genre_scores_gemma":[0.99172133,0.0003562144,0.0017630327,0.000063400825,0.000007630896,0.00008918415,0.003674364,0.000029202434,0.0022955085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998247,0.000028171104,0.00002820936,0.00003805488,0.000051379313,0.000029493318],"domain_scores_gemma":[0.99982685,0.000047226844,0.000017886405,0.00004718106,0.000017908065,0.000042984175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019441436,0.00024072778,0.00033487444,0.0004381487,0.00017082978,0.00037036013,0.00018692312,0.0003811925,0.0033288572],"category_scores_gemma":[0.00023346372,0.00012336328,0.00025264037,0.00026923956,0.00013112366,0.00013396551,0.00024438702,0.00053459196,0.0010215694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021247586,0.00016111661,0.004387312,0.00003279719,0.000016549917,0.0011010033,0.000069181886,0.00014597765,0.98933524,0.0002825086,0.00020855667,0.0040472955],"study_design_scores_gemma":[0.00006689879,0.0018531709,0.0413778,0.0000126009,0.000060119026,0.01582166,0.00013833794,0.0020571947,0.92586356,0.00022813638,0.012508512,0.000011985944],"about_ca_topic_score_codex":0.00065648573,"about_ca_topic_score_gemma":0.00071719266,"teacher_disagreement_score":0.0033288572,"about_ca_system_score_codex":0.00023681718,"about_ca_system_score_gemma":0.00021062726,"threshold_uncertainty_score":0.011136174},"labels":[],"label_agreement":null},{"id":"W2337877636","doi":"10.1093/neuonc/nov204.08","title":"ATPS-08DISCOVERY OF NOVEL GLIOMA-TARGETING PEPTIDES USING A HIGH-THROUGHPUT MICROFLUIDIC MAGNETIC-ACTIVATED SORTER","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Peptide; Bead; Peptide library; Microfluidics; Brain tissue; Brain cancer; Chemistry; Molecular biology; Cancer research; Cancer; Nanotechnology; Biochemistry; Biology; Materials science; Neuroscience; Peptide sequence; Gene; Genetics","score_opus":0.030398893485916297,"score_gpt":0.3055855659847469,"score_spread":0.2751866724988306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337877636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357751,0.002939426,0.05216169,0.0006332612,0.00023528161,0.00031637677,0.0025849342,0.0012280258,0.004125989],"genre_scores_gemma":[0.89158124,0.0018821756,0.08700691,0.00072737987,0.000075410746,0.00040960975,0.005507995,0.0001347398,0.012674448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980134,0.000015167727,0.000016637407,0.00003567601,0.00009479396,0.000036381218],"domain_scores_gemma":[0.99991584,0.00002009524,0.000017757544,0.0000075897647,0.000016154097,0.00002254857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026123764,0.00040731637,0.00044036863,0.00041422548,0.00024377147,0.00040421725,0.00033232121,0.0004040853,0.0012001283],"category_scores_gemma":[0.00024307985,0.00014398419,0.00038063747,0.00031079532,0.00014654778,0.0001950687,0.00025334494,0.00041416154,0.00057274196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014749882,0.00006464649,0.00037204823,0.0000796682,0.000019208497,0.00007968727,0.000019491848,0.00045446007,0.98904103,0.00018614026,0.0006690733,0.008866941],"study_design_scores_gemma":[0.000045245695,0.00025275498,0.0020658723,0.000005369051,0.000018014736,0.00024753154,0.000014909125,0.0055231093,0.9859714,0.00006972492,0.0057699243,0.000016077358],"about_ca_topic_score_codex":0.0005462996,"about_ca_topic_score_gemma":0.0010074716,"teacher_disagreement_score":0.0012001283,"about_ca_system_score_codex":0.0003420496,"about_ca_system_score_gemma":0.00043353086,"threshold_uncertainty_score":0.0040148497},"labels":[],"label_agreement":null},{"id":"W2337880004","doi":"10.1093/neuonc/nov206.09","title":"ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Procarbazine; Medicine; Oncology; Lomustine; Vincristine; Internal medicine; Radiation therapy; Glioma; Cancer research; Chemotherapy; Cyclophosphamide","score_opus":0.03359925267274657,"score_gpt":0.35874757381443195,"score_spread":0.3251483211416854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337880004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961958,0.0012231973,0.0001780075,0.0001898188,0.000058297956,0.00071562926,0.0004708871,0.000044234,0.00092414184],"genre_scores_gemma":[0.99358314,0.0013060594,0.001071156,0.00033612957,0.000109529734,0.00089467375,0.0012418703,0.0000251476,0.0014322612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999622,0.00019984152,0.000020304946,0.000060099694,0.000046441623,0.000051258445],"domain_scores_gemma":[0.999406,0.00010250935,0.00013614829,0.000053041607,0.000025956391,0.00027634454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014365743,0.001064239,0.0014840573,0.00045162826,0.00022339144,0.00062717457,0.0010178457,0.00083734724,0.0024735713],"category_scores_gemma":[0.0008176121,0.00043788715,0.0008872358,0.0005793019,0.00079696346,0.00040783602,0.00023420707,0.0016466085,0.0006729003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7837156,0.039864153,0.012389147,0.00077299355,0.0014426403,0.00024537244,0.0002921284,0.003173889,0.04027219,0.00023825877,0.0029701144,0.11462358],"study_design_scores_gemma":[0.5184648,0.4505224,0.022121046,0.000052346975,0.0008449647,0.0005232674,0.000069334186,0.001729962,0.0035429823,0.00017239274,0.0019271064,0.00002937203],"about_ca_topic_score_codex":0.0020178738,"about_ca_topic_score_gemma":0.0060216323,"teacher_disagreement_score":0.0024735713,"about_ca_system_score_codex":0.0011634489,"about_ca_system_score_gemma":0.0011642345,"threshold_uncertainty_score":0.008441508},"labels":[],"label_agreement":null},{"id":"W2338509796","doi":"10.1093/neuonc/nov218.04","title":"IMCT-04TOCA 5: PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 WITH TOCA FC VERSUS STANDARD OF CARE IN PATIENTS UNDERGOING PLANNED RESECTION FOR RECURRENT HIGH GRADE GLIOMA (NCT02414165)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Temozolomide; Medicine; Glioma; Phases of clinical research; Clinical endpoint; Anaplastic astrocytoma; Internal medicine; Oncology; Bevacizumab; Lomustine; Cancer research; Astrocytoma; Clinical trial; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.054354416624144836,"score_gpt":0.38625072241558306,"score_spread":0.33189630579143825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338509796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698019,0.0033239983,0.0010677606,0.0013291498,0.0007163323,0.0140186325,0.004421876,0.0004387726,0.0048816158],"genre_scores_gemma":[0.95714825,0.0028835132,0.0036964992,0.003319288,0.0006495823,0.017420817,0.0062413393,0.000089342015,0.008551434],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994842,0.00026011813,0.000023040564,0.000079639925,0.00004164995,0.00011132953],"domain_scores_gemma":[0.99918574,0.00015511001,0.0001955247,0.000047477173,0.00005883984,0.00035729204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002227509,0.002478038,0.002205154,0.00070216204,0.0005380105,0.001391199,0.001420978,0.0025147183,0.010095899],"category_scores_gemma":[0.0014785624,0.0007676467,0.0018797697,0.00063226826,0.0013879092,0.0012790419,0.00040739676,0.004394737,0.0016699551],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9443299,0.023775918,0.0008012271,0.00064961385,0.00072363444,0.00007785406,0.000082176346,0.00061567756,0.0059143836,0.0002911085,0.0035567125,0.019181903],"study_design_scores_gemma":[0.85688615,0.13917218,0.0012236026,0.000024819268,0.00022254116,0.000044784905,0.000028502956,0.0005553479,0.0005726641,0.00016191868,0.0010905283,0.000016831187],"about_ca_topic_score_codex":0.0019980406,"about_ca_topic_score_gemma":0.0061797593,"teacher_disagreement_score":0.010095899,"about_ca_system_score_codex":0.0015876369,"about_ca_system_score_gemma":0.002496919,"threshold_uncertainty_score":0.033774137},"labels":[],"label_agreement":null},{"id":"W2338709534","doi":"10.1093/neuonc/nov215.21","title":"GENO-21BRCA1 PROTEIN EXPRESSION PREDICTS SURVIVAL IN GLIOBLASTOMA PATIENTS FROM A NRG ONCOLOGY/RTOG COHORT","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Oncology; Medicine; Internal medicine; Hazard ratio; Proportional hazards model; PTEN; Tissue microarray; Survival analysis; Cohort; Biomarker; Glioblastoma; Radiation therapy; Immunohistochemistry; Cancer research; Biology; Confidence interval","score_opus":0.025615418067965134,"score_gpt":0.29080549830708824,"score_spread":0.2651900802391231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338709534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907184,0.000083208826,0.000046239027,0.0000182025,0.000002189066,0.0000048214624,0.0005761044,0.000002678825,0.00019481417],"genre_scores_gemma":[0.99848086,0.000058645615,0.00005878975,0.000014121897,0.0000039188667,0.000008346275,0.0012538411,0.000002334772,0.00011914062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999045,0.0000107604765,0.000008482593,0.00003286992,0.000020007892,0.000023317205],"domain_scores_gemma":[0.99983,0.000015672234,0.00004836738,0.000019868436,0.000025964559,0.000059996564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024535382,0.00016298129,0.0002152936,0.0004732052,0.00022573808,0.00029141005,0.000166038,0.00016141584,0.0010482675],"category_scores_gemma":[0.00046791197,0.000103667204,0.00018760252,0.0003282702,0.00012574441,0.00013062486,0.00026573983,0.00018195686,0.00027911965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029314548,0.000018491744,0.9956963,0.000005604523,0.00002945628,0.00012604543,0.00004196659,0.00005525202,0.0017947451,0.00000831359,0.00023365176,0.0016970102],"study_design_scores_gemma":[0.0000105542285,0.00008120847,0.99861765,0.0000025293648,0.000032582593,0.00042288317,0.000060576833,0.00017119208,0.00021890164,0.00001539382,0.00036475222,0.0000018263684],"about_ca_topic_score_codex":0.0037471484,"about_ca_topic_score_gemma":0.006029926,"teacher_disagreement_score":0.0037471484,"about_ca_system_score_codex":0.00026507556,"about_ca_system_score_gemma":0.00023517529,"threshold_uncertainty_score":0.00745064},"labels":[],"label_agreement":null},{"id":"W2338792363","doi":"10.1093/neuonc/nov206.16","title":"ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Progression-free survival; Gastroenterology; Glioma; Phases of clinical research; Toxicity; Randomized controlled trial; Surgery; Oncology; Chemotherapy","score_opus":0.05897382743445861,"score_gpt":0.35906162376719264,"score_spread":0.300087796332734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338792363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585633,0.002579933,0.0015903072,0.0008013874,0.0004600888,0.02428266,0.0050327415,0.00021099465,0.006478678],"genre_scores_gemma":[0.94802225,0.0023081831,0.0044933367,0.0014843922,0.00046980986,0.030465944,0.003924029,0.000074796866,0.008757241],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99926776,0.0004803685,0.00003308195,0.00007595715,0.000068720256,0.00007401661],"domain_scores_gemma":[0.9990594,0.00019236775,0.00024394914,0.00006661944,0.000047462207,0.00039017526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019527773,0.0012920388,0.0015993782,0.0005055619,0.00029819176,0.0006544811,0.0009572255,0.0010223965,0.0054527055],"category_scores_gemma":[0.0015469748,0.00043489967,0.0008672845,0.00061215274,0.00088562554,0.00044965974,0.0004621148,0.0016342967,0.00093631045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93254656,0.016684951,0.0026410457,0.0010305229,0.00076333893,0.00009040368,0.00009010827,0.0013982328,0.007242306,0.00036830356,0.0046517863,0.03249245],"study_design_scores_gemma":[0.8986022,0.093306705,0.003550038,0.00003437256,0.000281649,0.000079384736,0.000016566884,0.0006735926,0.00084892777,0.00018326254,0.002409429,0.0000139434],"about_ca_topic_score_codex":0.0016685614,"about_ca_topic_score_gemma":0.004372816,"teacher_disagreement_score":0.0054527055,"about_ca_system_score_codex":0.0012863936,"about_ca_system_score_gemma":0.0025765735,"threshold_uncertainty_score":0.018241048},"labels":[],"label_agreement":null},{"id":"W2338827745","doi":"10.1093/neuonc/nov206.22","title":"ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Gliosarcoma; Medicine; Bevacizumab; Glioblastoma; Placebo; Double blinded; Oncology; Internal medicine; Phases of clinical research; Clinical trial; Chemotherapy; Pathology; Cancer research","score_opus":0.04835993962501408,"score_gpt":0.3525851682394304,"score_spread":0.30422522861441637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338827745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804099,0.0033513256,0.0011701299,0.0006519017,0.00060084526,0.009241165,0.0015978548,0.00036242968,0.002614355],"genre_scores_gemma":[0.97288305,0.0027381245,0.0031457667,0.0014821874,0.00066858786,0.012079144,0.0016807914,0.000066974964,0.0052553215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99929774,0.00036873372,0.000043770844,0.00013222417,0.00006568733,0.00009192801],"domain_scores_gemma":[0.99943024,0.00010495664,0.0001343821,0.000051786195,0.000052541247,0.0002260839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001933583,0.0023777448,0.0028415746,0.0005784569,0.00048147666,0.0010690892,0.0010597445,0.0021046235,0.0054383078],"category_scores_gemma":[0.0015282313,0.000861395,0.001285963,0.0004854324,0.0011397608,0.0009382371,0.0003052456,0.0026004703,0.0010848002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92659956,0.028482925,0.00059580803,0.0008657142,0.0008009568,0.00006402422,0.00008842154,0.0004676214,0.015081746,0.00016966292,0.0018201316,0.024963368],"study_design_scores_gemma":[0.8716013,0.12525839,0.0008903249,0.000018188079,0.00017955065,0.00003313084,0.000011994583,0.0003816534,0.00072842056,0.00008986146,0.0007925475,0.000014658669],"about_ca_topic_score_codex":0.0010368979,"about_ca_topic_score_gemma":0.0030007989,"teacher_disagreement_score":0.0054383078,"about_ca_system_score_codex":0.00070910255,"about_ca_system_score_gemma":0.0015840544,"threshold_uncertainty_score":0.018192947},"labels":[],"label_agreement":null},{"id":"W2339255309","doi":"10.1093/neuonc/nov213.20","title":"EPID-20SKULL BASE MENINGIOMAS ARE BIOLOGICALLY MORE BENIGN AND HAVE A LONG-TERM DIVERGING POSTOPERATIVE RECURRENCE PATTERN COMPARED WITH SUPERFICIAL MENINGIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Meningioma; Term (time); Base (topology); Radiology; Surgery; Mathematics; Physics","score_opus":0.06886303433676025,"score_gpt":0.3165141168456774,"score_spread":0.24765108250891713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339255309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992092,0.00027380325,0.00009041524,0.00000611252,0.0000011692468,0.0000033503304,0.00010902603,0.000005185571,0.00030168836],"genre_scores_gemma":[0.9994159,0.00014635532,0.00009075586,0.0000037420925,0.0000024256624,0.0000028024947,0.00017922731,0.0000015472875,0.00015738138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975735,0.000021238326,0.00004784716,0.000039270042,0.00008290254,0.00005137766],"domain_scores_gemma":[0.99901724,0.00011246549,0.0006389713,0.000052374184,0.00008483254,0.00009415538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027830678,0.00019416166,0.00021589237,0.0012870254,0.00024427916,0.00045006088,0.00015251189,0.00015986634,0.0017436376],"category_scores_gemma":[0.0012079661,0.00012526009,0.00028135674,0.00077402964,0.00020688887,0.00025681857,0.0003408013,0.00015798937,0.00039735055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016034179,0.00001477857,0.98941654,0.000027974225,0.0000339928,0.0008659897,0.00010149412,0.000028009783,0.0036038442,0.00002209468,0.00004044865,0.0056844447],"study_design_scores_gemma":[0.0000027549042,0.000102959064,0.99381083,0.0000071432587,0.000024026123,0.0044527524,0.0001749935,0.00006498193,0.001065193,0.000023521476,0.000267978,0.0000028803329],"about_ca_topic_score_codex":0.0014450138,"about_ca_topic_score_gemma":0.0030659211,"teacher_disagreement_score":0.0017436376,"about_ca_system_score_codex":0.00023284883,"about_ca_system_score_gemma":0.00022442237,"threshold_uncertainty_score":0.0058330894},"labels":[],"label_agreement":null},{"id":"W2339357024","doi":"10.1093/neuonc/nov228.20","title":"PTPS-20THE GD3 ACETYLATION PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR PAEDIATRIC MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Neural crest; Apoptosis; Cancer research; Flow cytometry; Ganglioside; Biology; Medicine; Immunology; Gene; Genetics","score_opus":0.01657375298029374,"score_gpt":0.2760096761176531,"score_spread":0.25943592313735936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339357024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6964188,0.28095436,0.004799113,0.0025305857,0.00048546534,0.00018619702,0.0010144358,0.000473852,0.013137195],"genre_scores_gemma":[0.91772705,0.07199897,0.0023710802,0.0005052837,0.0001242741,0.00011428769,0.0013632041,0.000037763133,0.005757993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999505,0.000007931261,0.000003934081,0.000008019924,0.0000117970285,0.000017804525],"domain_scores_gemma":[0.9999676,0.0000031534025,0.000010510349,0.0000022952938,0.0000064623573,0.000010078021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014157595,0.00022721551,0.00039512178,0.00022388401,0.00010779259,0.00042377727,0.00018051479,0.00025705522,0.0017495197],"category_scores_gemma":[0.00009247358,0.000090698544,0.0003518469,0.00023800852,0.00014836805,0.00015857798,0.00020974004,0.0007932743,0.00046906926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048155347,0.0007625189,0.0075825644,0.0023330497,0.00035234162,0.0014477534,0.0001797585,0.0025035234,0.57841206,0.0029041308,0.0077548586,0.3909519],"study_design_scores_gemma":[0.0029873173,0.012789673,0.08023106,0.0005825319,0.0014944465,0.011319789,0.00045168836,0.006557971,0.45805627,0.0031799357,0.4222654,0.000083911844],"about_ca_topic_score_codex":0.0008269752,"about_ca_topic_score_gemma":0.0026414492,"teacher_disagreement_score":0.0017495197,"about_ca_system_score_codex":0.00043887692,"about_ca_system_score_gemma":0.0003733252,"threshold_uncertainty_score":0.0058526993},"labels":[],"label_agreement":null},{"id":"W2339942369","doi":"10.1093/neuonc/nov205.26","title":"ATNT-26PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Medicine; Glioma; Cancer research","score_opus":0.028690499762107004,"score_gpt":0.3070681937722499,"score_spread":0.2783776940101429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339942369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429435,0.002027248,0.00034318966,0.00034286696,0.00008896584,0.00090839615,0.00057201966,0.0000874319,0.0013354387],"genre_scores_gemma":[0.9920723,0.0016572438,0.0010256681,0.0004732839,0.000078293815,0.00095616595,0.0014863502,0.000026953443,0.0022237047],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997652,0.00010225859,0.000011479313,0.000040992883,0.000025795174,0.00005435203],"domain_scores_gemma":[0.99977404,0.000016848544,0.00004585521,0.000017867951,0.000020531612,0.00012487285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078658585,0.0013474053,0.0014151057,0.00027254774,0.0002529361,0.0006479615,0.0005412803,0.00058814586,0.0019042025],"category_scores_gemma":[0.00034256783,0.00033809996,0.000792396,0.00030692705,0.0005040627,0.00038331936,0.0002557449,0.0019519401,0.00062486436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4486689,0.08354853,0.016537763,0.0016161014,0.002239346,0.0006802552,0.000718294,0.0058294227,0.19715688,0.0006564254,0.012654797,0.22969323],"study_design_scores_gemma":[0.23949477,0.6991792,0.02979661,0.00006508407,0.0007587512,0.00075326994,0.00010354692,0.0021923997,0.01485152,0.00030038485,0.012455541,0.000048967264],"about_ca_topic_score_codex":0.0012315988,"about_ca_topic_score_gemma":0.003463789,"teacher_disagreement_score":0.0019042025,"about_ca_system_score_codex":0.00085775804,"about_ca_system_score_gemma":0.0011383633,"threshold_uncertainty_score":0.006370127},"labels":[],"label_agreement":null},{"id":"W2340257747","doi":"10.1093/neuonc/nov223.14","title":"NCO-14PRE-TREATMENT HIPPOCAMPAL VOLUME PREDICTS NEUROCOGNITIVE FUNCTION (NCF) FOR PATIENTS TREATED WITH HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY (HA-WBRT) FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0933","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Nuclear medicine; Radiation therapy; Neurocognitive; Cognition","score_opus":0.02640032616460126,"score_gpt":0.30917014195790976,"score_spread":0.2827698157933085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340257747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899536,0.00008248154,0.000033215452,0.000009524277,0.0000019262654,0.000020197633,0.000688534,0.0000044464637,0.00016421803],"genre_scores_gemma":[0.998909,0.000016968648,0.000036914364,0.000009123205,0.000004097666,0.000018250597,0.0009135473,0.0000019741044,0.00009013611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973136,0.00007579603,0.00002731841,0.000064423395,0.000058875223,0.00004221924],"domain_scores_gemma":[0.9990676,0.0002000874,0.00039297945,0.00009399397,0.00009965191,0.00014561138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066392607,0.00033964144,0.000399808,0.0004318809,0.00017354231,0.00036690405,0.00037340957,0.0002392624,0.0014332216],"category_scores_gemma":[0.0011806637,0.00010853584,0.00073433353,0.00048810948,0.00017478933,0.0001958705,0.00030385423,0.0004422781,0.00023204456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066781645,0.00014915828,0.9880091,0.00004072063,0.00036094274,0.000049719834,0.000031985106,0.00020339146,0.00086073246,0.000009455465,0.0003346132,0.0032720137],"study_design_scores_gemma":[0.0001223638,0.0014822806,0.99732625,0.000003302024,0.0001488292,0.00012609066,0.000022190537,0.0003030619,0.00025718444,0.00000935217,0.00019623397,0.0000028284785],"about_ca_topic_score_codex":0.004291165,"about_ca_topic_score_gemma":0.006858313,"teacher_disagreement_score":0.004291165,"about_ca_system_score_codex":0.00043814606,"about_ca_system_score_gemma":0.00043821265,"threshold_uncertainty_score":0.008532405},"labels":[],"label_agreement":null},{"id":"W2340401950","doi":"10.1093/neuonc/now029","title":"PIK3CA mutations in meningioma","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"","keywords":"Meningioma; Medicine; Genetics; Biology; Pathology","score_opus":0.03513426135567041,"score_gpt":0.3114820821103039,"score_spread":0.2763478207546335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340401950","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04898944,0.012885604,0.00070497906,0.8612922,0.01877578,0.000058796937,0.00032653988,0.00014843265,0.056818154],"genre_scores_gemma":[0.60659015,0.014256928,0.0022549434,0.24731115,0.10571472,0.00006836759,0.00027388745,0.00011628632,0.02341349],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.999255,0.0001272086,0.0001656302,0.00009065466,0.0001655219,0.00019593436],"domain_scores_gemma":[0.9985221,0.00057153107,0.00024216957,0.000064609136,0.00019401559,0.0004056842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005772386,0.0005738859,0.0008148472,0.0008310279,0.0021575275,0.0021631217,0.00089628884,0.013352767,0.004257927],"category_scores_gemma":[0.00951758,0.0006200612,0.0010522171,0.0008177906,0.0014539204,0.0016677171,0.00094293844,0.009672697,0.002115913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026735122,0.00011919651,0.02618138,0.0001968328,0.00007694981,0.707779,0.00037646337,0.00093348074,0.001878114,0.004929787,0.22936629,0.027895141],"study_design_scores_gemma":[0.00022769925,0.00019854202,0.012105935,0.00070439826,0.00020352808,0.8588255,0.00090721756,0.0036749358,0.0017209258,0.014144202,0.10718587,0.00010134414],"about_ca_topic_score_codex":0.005444044,"about_ca_topic_score_gemma":0.008217979,"teacher_disagreement_score":0.013352767,"about_ca_system_score_codex":0.0034093861,"about_ca_system_score_gemma":0.0023124646,"threshold_uncertainty_score":0.02473694},"labels":[],"label_agreement":null},{"id":"W2340939949","doi":"10.1093/neuonc/nov222.25","title":"MPTH-25AN 18-GENE EXPRESSION SIGNATURE PREDICTS RECURRENCE-FREE SURVIVAL IN MENINGIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Radiosurgery; Meningioma; Oncology; Artificial intelligence; Radiation therapy; Pathology; Computer science","score_opus":0.062317341077395776,"score_gpt":0.31663116362407295,"score_spread":0.25431382254667717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340939949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978004,0.0001641972,0.0012391296,0.00003898672,0.0000029082385,0.000006192939,0.0005688991,0.00002961643,0.00014971771],"genre_scores_gemma":[0.9966903,0.00007985011,0.0011973046,0.0000149100915,0.0000038010232,0.000011170274,0.0017829454,0.000008550859,0.00021112288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998518,0.000031001382,0.000010342199,0.000049964627,0.00002726366,0.000029532848],"domain_scores_gemma":[0.9997607,0.000091456466,0.00005298241,0.00003386527,0.00003146495,0.000029479901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057069527,0.0002649323,0.00034279632,0.0005496494,0.00014653883,0.00048472936,0.00025265652,0.00022981742,0.0004968243],"category_scores_gemma":[0.0011779582,0.00011742873,0.00056744955,0.00033481824,0.00015003828,0.00012365301,0.00029549107,0.00033780094,0.00023089869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011917625,0.0001437764,0.8921086,0.00006249518,0.00028381715,0.0005627066,0.00013304462,0.03091454,0.034800723,0.00012857441,0.0011142581,0.03855556],"study_design_scores_gemma":[0.00004934444,0.00036869638,0.8126506,0.000024916726,0.00024297475,0.0007978985,0.00018402192,0.16865188,0.0146277845,0.00060645025,0.0017643215,0.000031115007],"about_ca_topic_score_codex":0.0040586996,"about_ca_topic_score_gemma":0.0042843474,"teacher_disagreement_score":0.0040586996,"about_ca_system_score_codex":0.00038632684,"about_ca_system_score_gemma":0.00031597418,"threshold_uncertainty_score":0.008070111},"labels":[],"label_agreement":null},{"id":"W2341286435","doi":"10.1093/neuonc/nov213.01","title":"EPID-01CHICKEN POX AND GLIOMA RISK: PRELIMINARY RESULTS FROM THE GLIOGENE INTERNATIONAL CASE-CONTROL STUDY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Shingles; Medicine; Virology; Internal medicine; Oncology; Immunology; Virus; Cancer research","score_opus":0.03630141238346843,"score_gpt":0.3261973745498068,"score_spread":0.2898959621663384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341286435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7485043,0.22435546,0.006082215,0.0016467171,0.00035025837,0.00040421556,0.013885797,0.00011010349,0.0046609086],"genre_scores_gemma":[0.97593635,0.016250532,0.0019421752,0.0005068402,0.00016181689,0.00025143826,0.00412516,0.000036527523,0.00078920927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967244,0.0016597138,0.00041221688,0.00070597365,0.00029365005,0.0002041219],"domain_scores_gemma":[0.9941174,0.0030789971,0.001059592,0.00081453176,0.0007147977,0.00021465089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005142077,0.00080010033,0.0013312148,0.0009924037,0.00047987275,0.0013378137,0.0006358781,0.0008105252,0.0044931984],"category_scores_gemma":[0.013669379,0.00053808047,0.004660338,0.002557211,0.00043198038,0.0005556245,0.0007084166,0.0012113388,0.00035220166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025512358,0.00026365457,0.78352606,0.012732905,0.13758163,0.0011916682,0.000746558,0.00079740194,0.0017216689,0.0009142895,0.0048259664,0.030185774],"study_design_scores_gemma":[0.002695897,0.0011680922,0.8350549,0.0012577268,0.1473769,0.0010792713,0.0003156372,0.00086648104,0.0004777352,0.0009357558,0.008706364,0.00006533512],"about_ca_topic_score_codex":0.008208995,"about_ca_topic_score_gemma":0.010828225,"teacher_disagreement_score":0.008208995,"about_ca_system_score_codex":0.0004678027,"about_ca_system_score_gemma":0.00056375214,"threshold_uncertainty_score":0.027194202},"labels":[],"label_agreement":null},{"id":"W2341492001","doi":"10.1093/neuonc/nov210.06","title":"CSIG-06EGFRvIII REQUIRES OSMR AS A CO-RECEPTOR TO DRIVE GLIOBLASTOMA PATHOGENESIS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital","funders":"","keywords":"Glioblastoma; Pathogenesis; Receptor; Cancer research; Neuroscience; Biology; Medicine; Internal medicine; Immunology","score_opus":0.04335322430103913,"score_gpt":0.3515248312104941,"score_spread":0.308171606909455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341492001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406475,0.00075336546,0.0022713768,0.00025469926,0.000030084193,0.0000401179,0.000504275,0.00015254124,0.001928748],"genre_scores_gemma":[0.9956905,0.00027949602,0.0017491324,0.00007365569,0.000005626855,0.000027919485,0.00043660056,0.000022897882,0.0017141761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970514,0.000043352105,0.000026023607,0.000034115186,0.00010862576,0.000082879786],"domain_scores_gemma":[0.9998951,0.000011144526,0.000034091456,0.00001349046,0.00000940133,0.000036747715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016606807,0.00023127237,0.00025642978,0.00025814568,0.00013727516,0.00037853487,0.0002169276,0.00030783052,0.0012607204],"category_scores_gemma":[0.000097064025,0.00013481834,0.00025254933,0.00018051841,0.0002387326,0.0001657501,0.00029803146,0.00080553995,0.0005623917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006549282,0.000040031297,0.00037692528,0.000013630214,0.000004251711,0.00008916016,0.00000806363,0.00007018539,0.9980696,0.00020805381,0.000075644566,0.0009789782],"study_design_scores_gemma":[0.000027451255,0.00044525843,0.0051655686,0.0000059338413,0.000018419782,0.00088967656,0.00005508878,0.0021879927,0.98739713,0.000109128436,0.003693678,0.0000047849844],"about_ca_topic_score_codex":0.0007054194,"about_ca_topic_score_gemma":0.0018312765,"teacher_disagreement_score":0.0012607204,"about_ca_system_score_codex":0.00045022136,"about_ca_system_score_gemma":0.000371189,"threshold_uncertainty_score":0.004217565},"labels":[],"label_agreement":null},{"id":"W2342006085","doi":"10.1093/neuonc/nov205.10","title":"ATNT-10DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Hazard ratio; Oncology; Valproic Acid; Progression-free survival; Chemoradiotherapy; Post-hoc analysis; Confidence interval; Cancer; Epilepsy; Overall survival; Chemotherapy; Psychiatry","score_opus":0.06600521054757182,"score_gpt":0.36325196459402653,"score_spread":0.29724675404645473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342006085","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14247963,0.8513087,0.0017085824,0.0010593267,0.0009776291,0.00028315018,0.0010735564,0.00009565332,0.001013717],"genre_scores_gemma":[0.9189902,0.07599864,0.0014187999,0.0011707115,0.0005472364,0.00029775448,0.0009532413,0.00005437415,0.0005689988],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.988555,0.007863203,0.0015848117,0.0011323941,0.0005357221,0.00032889226],"domain_scores_gemma":[0.98719203,0.00882922,0.002049166,0.0009791625,0.0005222145,0.00042828242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015066739,0.0019253687,0.009028339,0.0016326163,0.0004052412,0.002681826,0.0012479394,0.0018833731,0.002421637],"category_scores_gemma":[0.01680831,0.0010983862,0.031594764,0.002229294,0.0006885421,0.0013847821,0.0010103662,0.0024410158,0.0003048306],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041876506,0.000053280215,0.011207612,0.019577248,0.916182,0.000077842,0.000039172857,0.00065926753,0.00047819255,0.000117568525,0.00050333736,0.009227918],"study_design_scores_gemma":[0.008170596,0.0011558392,0.011740887,0.0011767392,0.97523075,0.00006572964,0.000042624135,0.0005854585,0.00021301887,0.00035900532,0.0012361546,0.000023194349],"about_ca_topic_score_codex":0.003884735,"about_ca_topic_score_gemma":0.008642789,"teacher_disagreement_score":0.015066739,"about_ca_system_score_codex":0.0012961878,"about_ca_system_score_gemma":0.0009728497,"threshold_uncertainty_score":0.079681516},"labels":[],"label_agreement":null},{"id":"W2342230022","doi":"10.1093/neuonc/nov237.14","title":"TMOD-14CHARACTERIZING SIGNALING PATHWAYS IN A MOUSE MODEL OF GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioblastoma; Signal transduction; Neuroscience; Biology; Cell biology; Cancer research","score_opus":0.07130521739598808,"score_gpt":0.3041075111655582,"score_spread":0.2328022937695701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342230022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696432,0.0028122326,0.012349073,0.0009943325,0.0003337926,0.00058293936,0.0063754087,0.0010960446,0.005812961],"genre_scores_gemma":[0.9377577,0.0034175948,0.016271418,0.00056593074,0.00006137472,0.0019254667,0.00857096,0.00026626018,0.03116337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993942,0.00006449509,0.00007147566,0.0001633204,0.00014987822,0.00015666606],"domain_scores_gemma":[0.9996933,0.00002548353,0.00010433351,0.00003352908,0.000033538225,0.00010996362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043945297,0.001356234,0.00061589404,0.0017280163,0.00043070756,0.0006750758,0.0007100729,0.0014108703,0.0041784723],"category_scores_gemma":[0.00013070286,0.00054191373,0.0007875515,0.00069608603,0.0007028737,0.00063430105,0.00033344945,0.002268264,0.0015379515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008004217,0.0006624695,0.00034286216,0.00010585652,0.000020402422,0.0002886708,0.000044328925,0.00022711295,0.9942007,0.00052383245,0.00043815532,0.0023451736],"study_design_scores_gemma":[0.0003294931,0.004464317,0.0042683883,0.000052945674,0.0000727237,0.0015749924,0.00011199614,0.0029427188,0.9725265,0.00034449028,0.013288106,0.000023385144],"about_ca_topic_score_codex":0.0010870937,"about_ca_topic_score_gemma":0.0017989555,"teacher_disagreement_score":0.0041784723,"about_ca_system_score_codex":0.001073785,"about_ca_system_score_gemma":0.00050316384,"threshold_uncertainty_score":0.013978362},"labels":[],"label_agreement":null},{"id":"W2344218142","doi":"10.1093/neuonc/nov223.10","title":"NCO-10INTELLECTUAL OUTCOME IN MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Outcome (game theory); Medicine; Oncology; Internal medicine; Cancer research; Mathematics","score_opus":0.0401961044356289,"score_gpt":0.32417700568881447,"score_spread":0.2839809012531856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344218142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993418,0.00015764189,0.000036493388,0.000018445351,0.0000011640257,0.0000067862156,0.00010686591,0.000002641251,0.00032823038],"genre_scores_gemma":[0.99963164,0.0000305562,0.00003165214,0.0000053100734,0.0000020328341,0.000006001364,0.00022415476,0.0000010253484,0.00006753275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998155,0.000038186645,0.000020876836,0.000037381822,0.000043095,0.000044882967],"domain_scores_gemma":[0.9991756,0.000117155374,0.00042072515,0.00004374192,0.00007758607,0.00016527814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004229693,0.00018191732,0.00027910713,0.0005663748,0.00029313576,0.00034289737,0.00029140146,0.00020050551,0.00090506265],"category_scores_gemma":[0.0016465613,0.000068286114,0.00026719327,0.0003650516,0.00026748076,0.0003645734,0.00046857144,0.0002449165,0.0001204595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014966568,0.000052759195,0.98932195,0.000011244818,0.000063202686,0.00010679057,0.00008510352,0.00030431346,0.0011948998,0.000024173676,0.00008913849,0.0072497767],"study_design_scores_gemma":[0.000018314098,0.0005033674,0.99826247,0.0000034116301,0.0000336605,0.00026946323,0.00013036244,0.00019328744,0.00037678983,0.000060463593,0.00014566537,0.0000028491781],"about_ca_topic_score_codex":0.007295387,"about_ca_topic_score_gemma":0.011709348,"teacher_disagreement_score":0.007295387,"about_ca_system_score_codex":0.0009492379,"about_ca_system_score_gemma":0.00045037462,"threshold_uncertainty_score":0.014505863},"labels":[],"label_agreement":null},{"id":"W2345664732","doi":"10.1093/neuonc/nov204.65","title":"ATPS-65AN ONCOLYTIC MYXOMA VIRUS CONSTRUCT (M011L KNOCK-OUT) INDUCES APOPTOSIS AND IS A POTENT PRO-APOPTOTIC THERAPY IN BOTH HUMAN AND IMMUNOCOMPETENT MURINE GLIOBLASTOMA CANCER STEM CELLS MODELS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Myxoma virus; Oncolytic virus; Apoptosis; Cancer research; Glioblastoma; Cancer therapy; Virus; Biology; Virology; Cancer; Tumor cells; Genetics","score_opus":0.04976793458508824,"score_gpt":0.32463249997423554,"score_spread":0.2748645653891473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345664732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970156,0.00041999,0.0014306172,0.000039493818,0.000016277598,0.000031422427,0.0002848802,0.000047618385,0.0007141052],"genre_scores_gemma":[0.9961976,0.00029243535,0.0015688895,0.000016128964,0.0000037519517,0.00003702521,0.0005276183,0.0000090037865,0.0013475209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987304,0.000014808248,0.000019225423,0.00002681133,0.000040785624,0.00002538429],"domain_scores_gemma":[0.99992096,0.000011233682,0.00002605334,0.0000085677675,0.0000065171002,0.000026572186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014983412,0.0003153963,0.00018933738,0.00020925327,0.00010001315,0.00019042459,0.00015704703,0.00021583188,0.0010163152],"category_scores_gemma":[0.00005009946,0.000090267735,0.00020523806,0.00012519394,0.00022666226,0.0001602592,0.000111887675,0.000540919,0.00019332743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013631543,0.00006797391,0.00024318795,0.000030964944,0.000005008968,0.000025019825,0.000015298541,0.000090520836,0.9984414,0.00010404844,0.000040986848,0.0007993954],"study_design_scores_gemma":[0.000020864882,0.0006650561,0.0014137969,0.0000036476504,0.000010358014,0.00013826025,0.000011841493,0.0005591339,0.9962172,0.000016062633,0.00094202213,0.0000017568208],"about_ca_topic_score_codex":0.0006950324,"about_ca_topic_score_gemma":0.0007442889,"teacher_disagreement_score":0.0010163152,"about_ca_system_score_codex":0.00027913056,"about_ca_system_score_gemma":0.00018677222,"threshold_uncertainty_score":0.0033999085},"labels":[],"label_agreement":null},{"id":"W2345959150","doi":"10.1093/neuonc/nov208.31","title":"BMET-31DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO-BRAIN METASTASIS TO IDENTIFY UNIQUE METASTATIC GENE SIGNATURES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Human lung; Medicine; Lung; Gene; Computational biology; Oncology; Cancer research; Internal medicine; Biology; Cancer; Genetics","score_opus":0.07047624249938339,"score_gpt":0.38803375351255237,"score_spread":0.317557511013169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345959150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426696,0.0031004385,0.031587306,0.00088237063,0.00031282826,0.0021224539,0.0072739716,0.00053900544,0.011512059],"genre_scores_gemma":[0.9363198,0.002467828,0.027833218,0.00036936929,0.00003435656,0.0016902316,0.006279383,0.00012620122,0.024879605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996649,0.000045506757,0.00002910844,0.00007118518,0.00012959418,0.00005974886],"domain_scores_gemma":[0.9998796,0.000021860618,0.000027053175,0.000018541297,0.00001309579,0.00003984535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042030087,0.0005247081,0.00032447884,0.000655058,0.0003387924,0.00037852113,0.00041825647,0.0006282395,0.0037011008],"category_scores_gemma":[0.00014949817,0.00024367573,0.00034057884,0.00032164654,0.00030014612,0.00025317038,0.00026677173,0.001532949,0.0010936736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020047715,0.00017859908,0.00008832463,0.000040914205,0.000005451035,0.00007614074,0.00001920641,0.00024920248,0.99684674,0.0005929219,0.00019189979,0.0015101035],"study_design_scores_gemma":[0.00011993309,0.0011597378,0.0021848418,0.000014482475,0.00001926991,0.0005336618,0.000025259982,0.0022697286,0.9792614,0.00018088798,0.014221545,0.000009201602],"about_ca_topic_score_codex":0.0014284662,"about_ca_topic_score_gemma":0.0022193126,"teacher_disagreement_score":0.0037011008,"about_ca_system_score_codex":0.0005403028,"about_ca_system_score_gemma":0.00047527766,"threshold_uncertainty_score":0.012381375},"labels":[],"label_agreement":null},{"id":"W2346226649","doi":"10.1093/neuonc/nov206.29","title":"ATCT-29INVESTIGATING THE EFFECT OF REIRRADIATION OR SYSTEMIC THERAPY IN PATIENTS WITH GBM AFTER TUMOR PROGRESSION: A SECONDARY ANALYSIS OF THE NRG ONCOLOGY/RTOG 0525","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Concordia University; McGill University","funders":"","keywords":"Medicine; Systemic therapy; Oncology; Internal medicine; Cancer","score_opus":0.015740877460417347,"score_gpt":0.2956206174277451,"score_spread":0.27987973996732773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346226649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528164,0.0010604202,0.00034071828,0.000074829535,0.000023609455,0.0002242773,0.0021137348,0.000022174863,0.00085851166],"genre_scores_gemma":[0.9950128,0.00018699505,0.00028799992,0.00014357152,0.000052568466,0.000226736,0.0035292078,0.000013228668,0.00054681924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978788,0.0010582624,0.0001665268,0.00033918602,0.0003867867,0.00017047327],"domain_scores_gemma":[0.9958366,0.0012105306,0.0014670059,0.0005465162,0.00038690158,0.00055235653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037700336,0.0006166306,0.0013457681,0.00077960896,0.00024734464,0.00075278373,0.0005074904,0.00039049328,0.002086389],"category_scores_gemma":[0.0036668326,0.00017562513,0.003515308,0.0007070899,0.00026231783,0.00029253215,0.00057528407,0.0009922633,0.00031674508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19159256,0.0023667733,0.7414647,0.0010260133,0.012420693,0.0004069768,0.00021892635,0.0023143769,0.0054407213,0.00021029037,0.0042558676,0.03828213],"study_design_scores_gemma":[0.0063039153,0.034561243,0.945349,0.0000777212,0.0058493433,0.00031220424,0.00008037116,0.001663795,0.0017624936,0.00013452386,0.0038791765,0.000026346092],"about_ca_topic_score_codex":0.0027522878,"about_ca_topic_score_gemma":0.0055295243,"teacher_disagreement_score":0.0037700336,"about_ca_system_score_codex":0.0009936402,"about_ca_system_score_gemma":0.0013637149,"threshold_uncertainty_score":0.019938111},"labels":[],"label_agreement":null},{"id":"W2346516822","doi":"10.1093/neuonc/nov221.08","title":"METB-08INHIBITION OF HEXOKINASE 2 USING TUMOR GLYCOLYSIS INHIBITORS IDENTIFIED THROUGH A DRUG SCREEN INHIBITS GLIOBLASTOMA GROWTH IN VITRO AND IN VIVO","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"In vivo; Glioblastoma; Hexokinase; In vitro; Glycolysis; Drug; Pharmacology; Chemistry; Cancer research; Biochemistry; Enzyme; Biology; Genetics","score_opus":0.01664678465682504,"score_gpt":0.2724587597896256,"score_spread":0.2558119751328005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346516822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987056,0.0053861,0.0031522952,0.00019869771,0.000057328776,0.00014082376,0.0011925717,0.00021839414,0.0025978587],"genre_scores_gemma":[0.9869539,0.004937836,0.003434708,0.000093033515,0.000014262363,0.0001092054,0.0021643364,0.000027134782,0.002265588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990547,0.000012745946,0.0000113810875,0.000018320517,0.00003077193,0.000021362184],"domain_scores_gemma":[0.9999478,0.000010048472,0.000015536805,0.0000049379887,0.000009049747,0.000012706096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010157074,0.0005060196,0.00051589595,0.00049503223,0.0001294342,0.0003442406,0.00023586399,0.00020167242,0.0010737011],"category_scores_gemma":[0.00009606989,0.00014438,0.00031358446,0.0003996104,0.00011429772,0.0001262749,0.00013742238,0.00043532584,0.00021809312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034988107,0.00020452747,0.0005513104,0.000097188116,0.00003251004,0.00006298108,0.000011046069,0.0004282366,0.98885787,0.00009729867,0.00023353894,0.009073515],"study_design_scores_gemma":[0.00012593338,0.0029598738,0.006859127,0.00001621941,0.00008332933,0.0003020207,0.000019970144,0.0017424718,0.9846897,0.000042281194,0.003149827,0.000009225945],"about_ca_topic_score_codex":0.0013640021,"about_ca_topic_score_gemma":0.004299225,"teacher_disagreement_score":0.0013640021,"about_ca_system_score_codex":0.00036089408,"about_ca_system_score_gemma":0.0002893382,"threshold_uncertainty_score":0.0035918355},"labels":[],"label_agreement":null},{"id":"W2396892013","doi":"10.1093/neuonc/nov209.22","title":"CBIO-22DICER AND miRNAs REGULATE GLIOMA STEM CELL CHARACTERISTICS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Dicer; Biology; microRNA; Gene knockdown; Cancer research; SOX2; Stem cell; Glioma; Gene silencing; Stem cell marker; Drosha; Cell growth; Oncomir; BMI1; Cancer stem cell; Small hairpin RNA; RNA interference; Cell culture; Cell biology; Genetics; RNA; Transcription factor; Gene","score_opus":0.01783623406905588,"score_gpt":0.26143247905500505,"score_spread":0.24359624498594917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396892013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97976947,0.006835706,0.0041344073,0.00033234188,0.000083831124,0.000059191003,0.0012796528,0.00026244426,0.007242996],"genre_scores_gemma":[0.9864699,0.0014214121,0.0021456985,0.00021720152,0.000015308575,0.000060702463,0.0016790621,0.000055486064,0.007935266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997676,0.000018736908,0.00002216908,0.00006450589,0.0000670855,0.000059951584],"domain_scores_gemma":[0.99987745,0.000011932929,0.00003627821,0.00001586659,0.00001589285,0.00004268389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000160815,0.0002839456,0.00031211312,0.00041011992,0.00018965919,0.00034440815,0.00024697135,0.00034241567,0.002391235],"category_scores_gemma":[0.000105816136,0.0001583299,0.00026376388,0.00017078874,0.0002924683,0.00019528458,0.0002238473,0.00052813214,0.0006830586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010056651,0.000016697491,0.00015620822,0.000026078786,0.0000045450834,0.000049585116,0.000011434232,0.000036918,0.9981761,0.00013441073,0.000076492084,0.0012109197],"study_design_scores_gemma":[0.000027202215,0.00021382961,0.010049404,0.0000062576605,0.000019139788,0.00034311332,0.00003172252,0.0006067722,0.9813812,0.000089032175,0.007223384,0.000008767639],"about_ca_topic_score_codex":0.001199733,"about_ca_topic_score_gemma":0.0017438004,"teacher_disagreement_score":0.002391235,"about_ca_system_score_codex":0.00043726273,"about_ca_system_score_gemma":0.0003357564,"threshold_uncertainty_score":0.007999539},"labels":[],"label_agreement":null},{"id":"W2399161841","doi":"10.1093/neuonc/nov205.12","title":"ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Concomitant; Internal medicine; Adjuvant; Temozolomide; Gastroenterology; Surgery; Oncology; Chemotherapy","score_opus":0.02916867244633596,"score_gpt":0.31367587327141927,"score_spread":0.2845072008250833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399161841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838668,0.001871901,0.0011190709,0.00072846696,0.00022157276,0.0067537064,0.0025787214,0.00031088755,0.0025488548],"genre_scores_gemma":[0.97022086,0.0021816324,0.004516903,0.001331702,0.00025845596,0.010857592,0.004729114,0.000105505846,0.0057982886],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99922395,0.00037012185,0.000032988817,0.00012757373,0.000089979585,0.00015545049],"domain_scores_gemma":[0.99914634,0.00007086628,0.00019951169,0.00008083696,0.00007102366,0.00043148565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021424906,0.0031031112,0.0029465999,0.0007062178,0.00069459405,0.0013991966,0.0016048056,0.0018870393,0.004854242],"category_scores_gemma":[0.00096481224,0.0013223479,0.0017024777,0.00070522854,0.0014152008,0.0015786686,0.0005079604,0.004834794,0.0015574441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70551497,0.16085102,0.0045172246,0.0010758853,0.0011391623,0.00016210716,0.0003883693,0.0032218897,0.047091987,0.00034318937,0.0072223293,0.06847189],"study_design_scores_gemma":[0.57372254,0.4113554,0.0072215805,0.00003199132,0.00032125585,0.00021232641,0.000045842193,0.0013700387,0.0029374827,0.0001826429,0.002556225,0.00004266781],"about_ca_topic_score_codex":0.0015477143,"about_ca_topic_score_gemma":0.005145515,"teacher_disagreement_score":0.004854242,"about_ca_system_score_codex":0.0020446018,"about_ca_system_score_gemma":0.0026756881,"threshold_uncertainty_score":0.016239047},"labels":[],"label_agreement":null},{"id":"W2403179046","doi":"10.1093/neuonc/nov228.08","title":"PTPS-08HEMATOGENOUS DISSEMINATION OF MEDULLOBLASTOMA METASTASES TO THE LEPTOMENINGES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Circulating tumor cell; Primary tumor; Medicine; Pathology; Bone marrow; Haematopoiesis; Cancer research; Cancer; Biology; Stem cell; Metastasis; Internal medicine","score_opus":0.03384460933201084,"score_gpt":0.34060870482053357,"score_spread":0.30676409548852274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403179046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957054,0.00033721526,0.0011316608,0.00009181819,0.000024333393,0.000046324072,0.00046852094,0.000060986862,0.0021337066],"genre_scores_gemma":[0.9955876,0.00026567714,0.0006341119,0.000035856872,0.0000064464334,0.000034781224,0.0005441908,0.000014932877,0.0028763611],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983895,0.000014777695,0.000012327295,0.000040360632,0.00005164399,0.00004194905],"domain_scores_gemma":[0.9998498,0.000016546623,0.000039769526,0.000021995556,0.000009239424,0.000062526335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110425375,0.00021169029,0.00016180155,0.00032016487,0.00016694303,0.0002943004,0.00016646665,0.00024779074,0.0026337875],"category_scores_gemma":[0.00013275236,0.00012092491,0.00020386132,0.00014376413,0.00023629413,0.00018039091,0.00023230778,0.0007494193,0.00044490214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003291577,0.00018871423,0.0032481847,0.00004256078,0.000012272474,0.001403424,0.0000546755,0.00019040648,0.98952734,0.00075092225,0.00026372017,0.003988736],"study_design_scores_gemma":[0.00022096814,0.005494502,0.09861519,0.00004056727,0.00008506505,0.018099196,0.0003089471,0.006295952,0.8559018,0.00063121575,0.01428498,0.000021561043],"about_ca_topic_score_codex":0.0013501451,"about_ca_topic_score_gemma":0.0020015836,"teacher_disagreement_score":0.0026337875,"about_ca_system_score_codex":0.0004377803,"about_ca_system_score_gemma":0.0002438661,"threshold_uncertainty_score":0.008810878},"labels":[],"label_agreement":null},{"id":"W2404441765","doi":"10.1093/neuonc/nov223.09","title":"NCO-09THE EFFICACY OF THERAPEUTIC DISCOURSE ANALYSIS DURING BRAIN TUMOUR RESECTION IN AWAKE CRANIOTOMIES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Anesthetic; Hemiparesis; Resection; Surgical team; Anesthesia; Surgery","score_opus":0.03625146002066268,"score_gpt":0.35142016589073366,"score_spread":0.31516870587007095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404441765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883027,0.0014804887,0.0015736455,0.00013315836,0.00007743355,0.0001647325,0.00014364497,0.000060383274,0.0075363303],"genre_scores_gemma":[0.9955381,0.00042793324,0.0023971114,0.0000576889,0.000045326335,0.00006518606,0.00022195825,0.00003429166,0.0012124196],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995964,0.0001466415,0.000037081587,0.000054972417,0.00011851179,0.000046324407],"domain_scores_gemma":[0.9989278,0.0005514356,0.00013071108,0.0000924116,0.00017615152,0.00012154809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008821885,0.00025734602,0.00018934894,0.00043034722,0.0002415177,0.00047608797,0.00024062267,0.00023522529,0.0027068176],"category_scores_gemma":[0.0037237743,0.00009609572,0.0001504183,0.0001543535,0.00031249007,0.00034723108,0.0004192918,0.0003259634,0.0005659013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019248623,0.0021441393,0.07070946,0.0008740511,0.00012405415,0.0071786037,0.0033127621,0.0008695825,0.14426005,0.00032556706,0.0036688824,0.7472842],"study_design_scores_gemma":[0.0006786361,0.029652247,0.80932325,0.00038907997,0.00031273696,0.021535926,0.0034427785,0.008344028,0.10029653,0.00081230904,0.02506795,0.00014455234],"about_ca_topic_score_codex":0.0017938406,"about_ca_topic_score_gemma":0.004467271,"teacher_disagreement_score":0.0027068176,"about_ca_system_score_codex":0.00038805962,"about_ca_system_score_gemma":0.0005526488,"threshold_uncertainty_score":0.009055257},"labels":[],"label_agreement":null},{"id":"W2411936105","doi":"10.1093/neuonc/now110","title":"Medulloblastoma in adults: they're not just big kids","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Psychology; Pathology","score_opus":0.026978501158919418,"score_gpt":0.2803059266224309,"score_spread":0.2533274254635115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411936105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053374623,0.007271603,0.00024395969,0.972148,0.010463586,0.0000136264825,0.000049556325,0.000034361838,0.00443771],"genre_scores_gemma":[0.072992995,0.0160581,0.0012790898,0.81545144,0.082082875,0.000041628566,0.00008107004,0.00003955249,0.011973236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933225,0.00016573071,0.00010418449,0.00010526039,0.00018994579,0.00010259724],"domain_scores_gemma":[0.99792117,0.0008823637,0.00025232852,0.000093633236,0.0002526437,0.0005978739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008065131,0.0003904836,0.00070571585,0.00032865664,0.001363084,0.0013952252,0.0007072267,0.014418604,0.0018591771],"category_scores_gemma":[0.0062296265,0.00040455107,0.0005390042,0.00039394214,0.0015243966,0.0023512086,0.00072721974,0.015190098,0.001296836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019964356,0.00009043506,0.01573892,0.00021479462,0.00006127948,0.08380931,0.0005043007,0.000136519,0.0018066065,0.005620333,0.84695244,0.04486532],"study_design_scores_gemma":[0.00021083989,0.00027704894,0.016813643,0.0006456249,0.00013298723,0.22565615,0.0019860908,0.0008426316,0.0016957916,0.024203673,0.72741926,0.0001162867],"about_ca_topic_score_codex":0.0021519267,"about_ca_topic_score_gemma":0.005247083,"teacher_disagreement_score":0.014418604,"about_ca_system_score_codex":0.001919612,"about_ca_system_score_gemma":0.0011659975,"threshold_uncertainty_score":0.013927817},"labels":[],"label_agreement":null},{"id":"W2412480588","doi":"10.1093/neuonc/nov234.23","title":"STEM-23PYRVINIUM TARGETS CD133 IN HUMAN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Glioblastoma; Brain tumor; Stem cell; Human brain; Neural stem cell; Neuroscience; Cancer research; Biology; Medicine; Pathology; Cell biology","score_opus":0.019348667823917125,"score_gpt":0.30357683739481583,"score_spread":0.2842281695708987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412480588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929143,0.0015771431,0.0018436252,0.00013038373,0.000023640727,0.00013737318,0.0010933045,0.00012890811,0.0021511952],"genre_scores_gemma":[0.99326396,0.001044264,0.001815499,0.000067637884,0.0000044040244,0.00007118902,0.001614984,0.000016370834,0.002101733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991894,0.000008386072,0.000006199528,0.000017619124,0.00002946624,0.000019432691],"domain_scores_gemma":[0.9999683,0.0000063380094,0.000008762173,0.000004600436,0.0000052304563,0.00000675329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009324929,0.0003280287,0.00030705845,0.00028462784,0.00013348045,0.00027768948,0.00021164549,0.00022346088,0.0011681136],"category_scores_gemma":[0.000102732825,0.00013242757,0.00025120188,0.00019954125,0.00012894231,0.000091483096,0.00018202368,0.0003156869,0.00026583739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014407645,0.00007723567,0.00034805792,0.00006813236,0.000010462754,0.0000700274,0.000015701287,0.00079277356,0.99250925,0.00009197645,0.00009979761,0.005772473],"study_design_scores_gemma":[0.00004514129,0.0009698469,0.0020579197,0.000006768085,0.00002347158,0.00015039466,0.00001421339,0.0012803269,0.99307126,0.000044182605,0.002333035,0.0000035270537],"about_ca_topic_score_codex":0.0013473495,"about_ca_topic_score_gemma":0.0028253386,"teacher_disagreement_score":0.0013473495,"about_ca_system_score_codex":0.00045004737,"about_ca_system_score_gemma":0.00035899185,"threshold_uncertainty_score":0.0039076805},"labels":[],"label_agreement":null},{"id":"W2413758964","doi":"10.1093/neuonc/nov236.10","title":"TMIC-10PLEIOTROPY OF TUMOR-ASSOCIATED MYELOID CELLS WITHIN HUMAN GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glioblastoma; Tumor cells; Myeloid cells; Myeloid; Myeloid leukemia; Cancer research; Medicine; Biology","score_opus":0.01749551330310746,"score_gpt":0.2763200366382071,"score_spread":0.25882452333509964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413758964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949098,0.0013274346,0.0009839095,0.00005318495,0.000011788377,0.0000374536,0.0009803695,0.00004787634,0.0016481903],"genre_scores_gemma":[0.9951934,0.0006989173,0.0009688535,0.00005932972,0.0000057516645,0.000054134554,0.0016144564,0.000010700069,0.0013944015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994814,0.0000044173617,0.0000028990935,0.000013053532,0.00001518986,0.000016340742],"domain_scores_gemma":[0.99997056,0.0000025886968,0.000007788181,0.0000034447605,0.000007392748,0.000008255902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007446215,0.00012396443,0.00013343361,0.00037362782,0.00016506623,0.00020429156,0.000064256215,0.00013318396,0.0012212674],"category_scores_gemma":[0.000065863765,0.00007709154,0.00009778857,0.00028192197,0.00013854216,0.000060531158,0.00015664831,0.00016405589,0.00036253338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043964307,0.000028873867,0.008737916,0.000057052504,0.000011350688,0.00025316543,0.00007574789,0.00007219214,0.98347,0.00011803011,0.0002526551,0.0064832736],"study_design_scores_gemma":[0.000054785185,0.0010536396,0.4349888,0.000032764307,0.00007903163,0.0037010203,0.00050983054,0.0015748233,0.54408956,0.00035318313,0.013549047,0.0000134942065],"about_ca_topic_score_codex":0.0015058288,"about_ca_topic_score_gemma":0.0015598364,"teacher_disagreement_score":0.0015058288,"about_ca_system_score_codex":0.00022316109,"about_ca_system_score_gemma":0.00024402238,"threshold_uncertainty_score":0.004085541},"labels":[],"label_agreement":null},{"id":"W2415694895","doi":"10.1093/neuonc/nov228.29","title":"PTPS-29UBIQUITIN CARBOXYL TERMINAL HYDROLASE-L1 (UCH-L1) IS A TUMOR SUPPRESSOR IN ATYPICAL TERATOID RHABDOID TUMORS (ATRTs)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Winnipeg; Children's Hospital Research Institute of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Suppressor; Terminal (telecommunication); Cancer research; Hydrolase; Chemistry; Biology; Biochemistry; Enzyme; Computer science; Gene","score_opus":0.019535197296346785,"score_gpt":0.29014322143738575,"score_spread":0.27060802414103896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415694895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921475,0.0026467608,0.0036082678,0.00010049602,0.000020438883,0.000017072898,0.00034743914,0.000118942036,0.000993048],"genre_scores_gemma":[0.99707425,0.00054595387,0.0008865767,0.000016196762,0.0000048782927,0.000010474783,0.0003601871,0.0000074386217,0.0010940732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990463,0.000009369349,0.000008802033,0.000026883843,0.000032320757,0.000017996434],"domain_scores_gemma":[0.99990094,0.000011321475,0.000042398824,0.000009098735,0.000009574147,0.000026605989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012068289,0.0002368558,0.00017878659,0.00014072104,0.00014570716,0.00022701026,0.00020264371,0.00018125851,0.0011246498],"category_scores_gemma":[0.00009037609,0.00008196958,0.00017837707,0.00013662314,0.00023879133,0.00012435157,0.00016043625,0.00032629204,0.00034555665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059178492,0.000012133128,0.0012417737,0.00004431715,0.0000044367403,0.00012646339,0.000010391998,0.0000467026,0.99700385,0.000067764406,0.00004314892,0.0013398231],"study_design_scores_gemma":[0.00001653665,0.00014513689,0.009741178,0.000006890045,0.000021673139,0.0012508825,0.000030908144,0.0007453631,0.98485166,0.000048214642,0.003138189,0.0000033157685],"about_ca_topic_score_codex":0.00035645222,"about_ca_topic_score_gemma":0.00042163138,"teacher_disagreement_score":0.0011246498,"about_ca_system_score_codex":0.00031471148,"about_ca_system_score_gemma":0.0001481704,"threshold_uncertainty_score":0.0037623048},"labels":[],"label_agreement":null},{"id":"W2417583025","doi":"10.1093/neuonc/now101","title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","year":2016,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children","funders":"University of California, San Francisco; Cancer Research UK; Brain Tumour Charity; Rosetrees Trust; Deutsches Krebsforschungszentrum; National Brain Tumor Society","keywords":"Clinical trial; Glioma; Pace; Disease; Perspective (graphical); Bioinformatics; Medicine; Neuroscience; Biology; Internal medicine; Cancer research; Computer science","score_opus":0.06719057590261662,"score_gpt":0.3775193674760006,"score_spread":0.310328791573384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417583025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009334377,0.9971871,0.0001343762,0.0016941469,0.00026823377,0.000001967768,0.000009384008,0.000007105057,0.0006042966],"genre_scores_gemma":[0.00063902594,0.9978923,0.0002668891,0.00052987924,0.00036452778,0.000002971222,0.00001617475,0.000001879471,0.00028641734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998011,0.00004259991,0.000039423732,0.000030146963,0.00006799433,0.00001881385],"domain_scores_gemma":[0.9994167,0.00027619707,0.00007315318,0.000016317763,0.0001619003,0.000055736888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072364346,0.00060083036,0.001173839,0.0016351428,0.00031682994,0.0012657637,0.0005469814,0.0011502178,0.00270419],"category_scores_gemma":[0.0010563366,0.00017571525,0.0004958605,0.001628956,0.0007799906,0.0025857254,0.00070662575,0.0028763863,0.0014678423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060404192,0.000046109013,0.00039414974,0.010102253,0.000056425568,0.0004799719,0.00012514344,0.00029796248,0.001079019,0.0069224336,0.041398488,0.9390376],"study_design_scores_gemma":[0.000010540024,0.000068053814,0.0008158312,0.0048109647,0.00008567627,0.0026940973,0.00018922308,0.00008511953,0.00027155768,0.0054268413,0.98552066,0.00002147341],"about_ca_topic_score_codex":0.0010522127,"about_ca_topic_score_gemma":0.00268779,"teacher_disagreement_score":0.00270419,"about_ca_system_score_codex":0.0007527059,"about_ca_system_score_gemma":0.0015696156,"threshold_uncertainty_score":0.009046435},"labels":[],"label_agreement":null},{"id":"W2419000433","doi":"10.1093/neuonc/nov234.20","title":"STEM-20MAPPING DYNAMICS OF CELL DIVISION AND GENE EXPRESSION AT THE SINGLE CELL LEVEL TO UNDERSTAND GLIOMA CELL STATES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Glioma; Epigenetics; Biology; Cell growth; Cell; Cell division; Cancer research; Stem cell; Cancer cell; Cancer stem cell; Cancer; Cell biology; Gene; Genetics","score_opus":0.06289953077619981,"score_gpt":0.28772796588757416,"score_spread":0.22482843511137435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419000433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88911295,0.0018684672,0.09602693,0.00011452779,0.000037907266,0.00015070972,0.006666232,0.0008009047,0.0052214265],"genre_scores_gemma":[0.9116516,0.0023457129,0.07238498,0.00018492634,0.000024212102,0.0004450292,0.0055858283,0.00020506994,0.007172551],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998598,0.000010902311,0.0000079338015,0.000055249096,0.00004708395,0.000018954855],"domain_scores_gemma":[0.9998425,0.000037011636,0.000045379962,0.000019319858,0.00003506976,0.00002062457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020672304,0.0002291658,0.00033118326,0.0008773638,0.00017775208,0.00043326704,0.00017506587,0.00024331753,0.0020340483],"category_scores_gemma":[0.0002242337,0.00017583743,0.00027002953,0.0007185456,0.00025657285,0.00032528446,0.00024746353,0.0004478084,0.00051516475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005197284,0.000014927206,0.0033348708,0.00005830699,0.000009801758,0.000020785892,0.000078653466,0.0005123468,0.986452,0.00027265135,0.00007437556,0.00911947],"study_design_scores_gemma":[0.0000065235017,0.00022661085,0.08592769,0.000021103035,0.000049551265,0.00014806274,0.00018027598,0.010743812,0.89298517,0.0008258269,0.008863883,0.000021574715],"about_ca_topic_score_codex":0.00092198607,"about_ca_topic_score_gemma":0.0028870872,"teacher_disagreement_score":0.0020340483,"about_ca_system_score_codex":0.00037765125,"about_ca_system_score_gemma":0.00022908651,"threshold_uncertainty_score":0.006804526},"labels":[],"label_agreement":null},{"id":"W2419781531","doi":"10.1093/neuonc/now076.83","title":"MB-87INTEGRATED GENOMICS REVEALS NOVEL SUBTYPES OF MEDULLOBLASTOMA SUBGROUPS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Genomics; Biology; Computational biology; Genetics; Genome; Gene","score_opus":0.0128714110155434,"score_gpt":0.2700454518134656,"score_spread":0.2571740407979222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419781531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951271,0.00051075325,0.0020490084,0.00005354098,0.0000025201175,0.000015332143,0.0010898781,0.00009949959,0.0010524056],"genre_scores_gemma":[0.9933962,0.00019092193,0.0023640746,0.00003490372,0.0000062265726,0.00002435648,0.0034461208,0.000045869616,0.0004913298],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999767,0.000019545076,0.000014797106,0.000074162715,0.00007242262,0.000052051455],"domain_scores_gemma":[0.9997831,0.00003513456,0.0000866486,0.000037650625,0.000023627537,0.000033833105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020347702,0.00031843004,0.00045154794,0.0009458074,0.00029550825,0.0004876458,0.00030162718,0.00024882436,0.0010539246],"category_scores_gemma":[0.0004935944,0.00014801817,0.00036980057,0.0009227435,0.0002946002,0.00014699044,0.00049669173,0.00036510293,0.00045703308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009947418,0.000092320035,0.23671158,0.00012694091,0.00031351822,0.00035063736,0.00044261714,0.00171006,0.72493535,0.00082780997,0.0008589502,0.03263553],"study_design_scores_gemma":[0.000041193027,0.00021406102,0.9389589,0.0000152525,0.00030165742,0.0015758971,0.00021054484,0.005179539,0.046183903,0.0011786978,0.006122841,0.000017483426],"about_ca_topic_score_codex":0.0027234708,"about_ca_topic_score_gemma":0.0042077927,"teacher_disagreement_score":0.0027234708,"about_ca_system_score_codex":0.00045014586,"about_ca_system_score_gemma":0.00028573553,"threshold_uncertainty_score":0.005415201},"labels":[],"label_agreement":null},{"id":"W2420161469","doi":"10.1093/neuonc/now067.28","title":"PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychology; Medicine","score_opus":0.06176851200249761,"score_gpt":0.3793030858820122,"score_spread":0.3175345738795146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420161469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915609,0.00178649,0.0010173306,0.00021434507,0.000030326728,0.00005192115,0.0004048182,0.000051187893,0.004882744],"genre_scores_gemma":[0.99682415,0.0005479574,0.0011588283,0.00006335304,0.00001598707,0.000016509332,0.00086417457,0.000014056605,0.000494932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953485,0.00009214355,0.000051785395,0.00010002603,0.0001399876,0.00008119419],"domain_scores_gemma":[0.9990237,0.000104543506,0.00031067137,0.000094211224,0.00028775266,0.00017909428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009602476,0.0002610927,0.00040521342,0.0008432207,0.00041915235,0.0006677305,0.00044308518,0.00028561294,0.0012449007],"category_scores_gemma":[0.002194593,0.00011479646,0.00030954657,0.0007010257,0.0003837795,0.00054091,0.00064116827,0.00054899027,0.00033473718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005873801,0.00004218467,0.93783087,0.00006827914,0.00005502307,0.0069503565,0.0002822771,0.00043433724,0.008001093,0.00020858378,0.00097117043,0.04456849],"study_design_scores_gemma":[0.00002206262,0.00036494245,0.9508027,0.00010791135,0.00017330029,0.032650303,0.0011845399,0.0019607544,0.005245805,0.0006259296,0.006835373,0.000026281543],"about_ca_topic_score_codex":0.003641856,"about_ca_topic_score_gemma":0.0057668756,"teacher_disagreement_score":0.003641856,"about_ca_system_score_codex":0.00075858616,"about_ca_system_score_gemma":0.00046797507,"threshold_uncertainty_score":0.0072413087},"labels":[],"label_agreement":null},{"id":"W2420294546","doi":"10.1093/neuonc/now073.34","title":"HG-37SECOND RE-IRRADIATION FOR DIPG PROGRESSION, RE-CONSIDERING “OLD STRATEGIES” WITH NEW APPROACHES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Tumor progression; Glioma; Radiation therapy; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.07313755008810024,"score_gpt":0.32063548650890306,"score_spread":0.2474979364208028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420294546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8283336,0.12501281,0.018025216,0.0052673877,0.0010327025,0.00034802643,0.00029649705,0.0005711866,0.021112576],"genre_scores_gemma":[0.96908396,0.017127946,0.0068084635,0.001116089,0.0004902388,0.000075708405,0.00035604477,0.00006646652,0.0048749996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999324,0.00000821023,0.000004949737,0.000016018656,0.000011748694,0.00002652249],"domain_scores_gemma":[0.99993956,0.000008336608,0.000011775205,0.000012502776,0.000007027482,0.000020773168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014419811,0.0004299552,0.00039441072,0.00032596808,0.0002868002,0.00031795286,0.00037189884,0.00045335488,0.0019944669],"category_scores_gemma":[0.00017865434,0.00010363064,0.0004809636,0.00016732902,0.0002984597,0.000387242,0.00028787903,0.0009784647,0.0004588897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041916613,0.0015075166,0.031395763,0.002514571,0.00062221213,0.08592914,0.0006705775,0.003614515,0.10496613,0.004082202,0.012245081,0.74826074],"study_design_scores_gemma":[0.0017121071,0.017195279,0.10154034,0.001131521,0.0015011962,0.48107144,0.00059390086,0.00736935,0.1162397,0.009111374,0.2623351,0.0001986579],"about_ca_topic_score_codex":0.0005906395,"about_ca_topic_score_gemma":0.0020983436,"teacher_disagreement_score":0.0019944669,"about_ca_system_score_codex":0.00045958775,"about_ca_system_score_gemma":0.00037821653,"threshold_uncertainty_score":0.006672144},"labels":[],"label_agreement":null},{"id":"W2420507009","doi":"10.1093/neuonc/now067.24","title":"PNR-28PRIMARY DISSEMINATED LEPTOMENINGEAL NEUROECTODERMAL TUMORS IN CHILDREN: A CASE SERIES AND REPORT OF A LONG TERM SURVIVOR","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Series (stratigraphy); Term (time); Medicine; Pediatrics; Physics; Geology","score_opus":0.012616267517200118,"score_gpt":0.2910656890369929,"score_spread":0.2784494215197928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420507009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680746,0.0007949249,0.00043689154,0.00015813041,0.000025347184,0.00003372559,0.00016866157,0.00002665719,0.0015482593],"genre_scores_gemma":[0.99852103,0.0004464395,0.0003084402,0.00007037159,0.000037163943,0.000012686876,0.00013235166,0.000008541318,0.00046299334],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996573,0.000031434076,0.000040486095,0.000086524,0.0000632801,0.00012094109],"domain_scores_gemma":[0.99905807,0.00016964121,0.00034371135,0.00007770511,0.000070104375,0.0002806725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025304803,0.00073118665,0.00047054936,0.0008069244,0.0012299599,0.0007159263,0.0004766097,0.0008940729,0.0015637768],"category_scores_gemma":[0.0012189618,0.00036663006,0.0005007445,0.00073091313,0.0010648556,0.000676931,0.0008249183,0.00094241754,0.00045336827],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004902497,0.00006465553,0.25661957,0.000067426445,0.000033461216,0.7347046,0.0009039235,0.00012207628,0.0014481061,0.00018010555,0.00048679468,0.0053202277],"study_design_scores_gemma":[0.000009448239,0.00019666008,0.079607375,0.000022757024,0.00003211766,0.9174075,0.00059015834,0.00010665093,0.000647771,0.00005277505,0.0013162934,0.0000104336505],"about_ca_topic_score_codex":0.0028722973,"about_ca_topic_score_gemma":0.0050230534,"teacher_disagreement_score":0.0028722973,"about_ca_system_score_codex":0.0008479337,"about_ca_system_score_gemma":0.0008075394,"threshold_uncertainty_score":0.0061522126},"labels":[],"label_agreement":null},{"id":"W2420857723","doi":"10.1093/neuonc/nox107","title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Children's National Hospital; Seattle Children's Research Institute; St. Jude Children's Research Hospital; Morgan Adams Foundation; Children's Hospital Colorado; National Cancer Institute; Cincinnati Children's Hospital Medical Center; Texas Children's Hospital; Children's Hospital of Philadelphia","keywords":"Medicine; Glioma; Cancer research","score_opus":0.054751013226552014,"score_gpt":0.3403483265277993,"score_spread":0.28559731330124727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420857723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481273,0.0021194916,0.0011184923,0.0070316154,0.00022357925,0.00020165078,0.030015523,0.000046721067,0.011115662],"genre_scores_gemma":[0.9689743,0.0013258181,0.00090600376,0.0028630067,0.00040432875,0.00040443442,0.023741804,0.000029692781,0.0013506718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912804,0.00025394242,0.00013329655,0.00015978843,0.00016451042,0.00016052875],"domain_scores_gemma":[0.997586,0.00045492034,0.0008397603,0.00044319368,0.00035187867,0.00032433835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020453348,0.00022793331,0.00064178114,0.00046786468,0.0004082379,0.0013950604,0.0005447058,0.0007135525,0.00095698104],"category_scores_gemma":[0.0037094636,0.00022847619,0.0005064616,0.0024182322,0.00027530038,0.0011122889,0.0011218655,0.001118607,0.0005091944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022201554,0.00017069782,0.9519958,0.00011181299,0.00043519435,0.0010118064,0.00028015097,0.0004383113,0.000358445,0.0009315741,0.02519254,0.01685352],"study_design_scores_gemma":[0.0009718385,0.00055889605,0.9665862,0.00015474013,0.0009778908,0.0021846895,0.00090390875,0.0010945519,0.00040281715,0.0017643822,0.024341859,0.00005817605],"about_ca_topic_score_codex":0.0026859804,"about_ca_topic_score_gemma":0.008184561,"teacher_disagreement_score":0.0026859804,"about_ca_system_score_codex":0.0010880377,"about_ca_system_score_gemma":0.001543697,"threshold_uncertainty_score":0.010816872},"labels":[],"label_agreement":null},{"id":"W2421016690","doi":"10.1093/neuonc/now076.56","title":"MB-59IMAGING OF METASTATIC MEDULLOBLASTOMA IN THE MOLECULAR ERA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Cancer research; Oncology","score_opus":0.018694153933512134,"score_gpt":0.30759999810666017,"score_spread":0.288905844173148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421016690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743017,0.018186936,0.0034712867,0.00031734258,0.000027616687,0.00003974729,0.0002408815,0.00012704355,0.0032875387],"genre_scores_gemma":[0.9909576,0.003836585,0.00397004,0.00006503719,0.000035613277,0.000033193992,0.00031698542,0.000024053135,0.00076097436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987936,0.000025871983,0.000007649786,0.000022878678,0.000036949095,0.000027243306],"domain_scores_gemma":[0.99986315,0.000036332047,0.000042268923,0.000011655246,0.000022104654,0.000024439334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036000836,0.00025314672,0.0003266593,0.0010990661,0.00017675121,0.00039482713,0.00027994608,0.00028200907,0.0013016714],"category_scores_gemma":[0.00063746213,0.0001649141,0.00017134234,0.00028039806,0.00025721727,0.00026294784,0.0002876299,0.0002720249,0.00034728486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001448936,0.00007252771,0.10148663,0.00040748488,0.00014239905,0.001820076,0.00009726221,0.0005225811,0.84686667,0.00043190352,0.0008185197,0.045885038],"study_design_scores_gemma":[0.00017670983,0.0023936317,0.43368152,0.00017423018,0.00068541005,0.02515248,0.00027737487,0.006044951,0.5097132,0.0013490606,0.020312445,0.000039004055],"about_ca_topic_score_codex":0.0015879687,"about_ca_topic_score_gemma":0.0020261826,"teacher_disagreement_score":0.0015879687,"about_ca_system_score_codex":0.000530662,"about_ca_system_score_gemma":0.00020361017,"threshold_uncertainty_score":0.0043545365},"labels":[],"label_agreement":null},{"id":"W2422274351","doi":"10.1093/neuonc/now076.20","title":"MB-22ACTIVATED Wnt SIGNALING FOR THE THERAPEUTIC TARGETING OF TREATMENT-REFRACTORY MEDULLOBLASTOMA STEM CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Refractory (planetary science); Stem cell; Cancer research; Medicine; Biology; Signal transduction; Cell biology","score_opus":0.024150893038898922,"score_gpt":0.2769191817095702,"score_spread":0.25276828867067125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422274351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842382,0.006541746,0.004228271,0.00022620348,0.000065346714,0.0001676997,0.00047562132,0.00017123019,0.0038856526],"genre_scores_gemma":[0.99254334,0.0030734288,0.0022217627,0.000045491106,0.000010208063,0.00008007806,0.00039172856,0.0000143514,0.001619716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999471,0.000008425638,0.0000040969753,0.0000081100225,0.000020184607,0.000012198365],"domain_scores_gemma":[0.9999819,0.0000022821841,0.0000059701692,0.0000019135148,0.0000017336248,0.000006192862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092589624,0.00021616099,0.00021102928,0.0002473661,0.00010714892,0.00024142078,0.00013961144,0.00014796808,0.00094210333],"category_scores_gemma":[0.00005121973,0.00009024003,0.00018304463,0.00015250068,0.00012305581,0.00011696819,0.00013192683,0.00039116244,0.00019812639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021985259,0.00012892227,0.00025667757,0.00010403182,0.000015874557,0.0001203735,0.00004107534,0.00044247266,0.9836864,0.00040112296,0.0002721715,0.014311035],"study_design_scores_gemma":[0.00014534095,0.0016936361,0.0037993668,0.000018206807,0.00007700478,0.00065482844,0.000033923374,0.0026227832,0.97480303,0.00008505576,0.016056178,0.00001050871],"about_ca_topic_score_codex":0.00089554564,"about_ca_topic_score_gemma":0.0026391328,"teacher_disagreement_score":0.00094210333,"about_ca_system_score_codex":0.0002599085,"about_ca_system_score_gemma":0.0002795359,"threshold_uncertainty_score":0.0031516552},"labels":[],"label_agreement":null},{"id":"W2422294165","doi":"10.1093/neuonc/now067.33","title":"PNR-39DISTINCT GENE FUSIONS SEGREGATE SUB-CLASSES OF CNS-PNETs","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Computational biology; Gene; Biology; Evolutionary biology; Genetics; Neuroscience; Computer science","score_opus":0.019205406672762732,"score_gpt":0.2719143811960665,"score_spread":0.25270897452330376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422294165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983802,0.00011023165,0.00044651356,0.000007622329,0.0000023872244,0.000013358927,0.00037891214,0.000021529322,0.00063935237],"genre_scores_gemma":[0.99772674,0.00011948627,0.00042132876,0.000015200917,0.0000021614308,0.000021191147,0.0009421643,0.000017211496,0.00073454867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983346,0.000008695864,0.0000149173675,0.000053515996,0.00005597645,0.000033430864],"domain_scores_gemma":[0.99985194,0.000029385608,0.00005897089,0.0000143310335,0.000012699401,0.00003255061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007895472,0.0001687343,0.00020141684,0.00079756585,0.000115947645,0.00016373489,0.00014014456,0.00016651888,0.0015096817],"category_scores_gemma":[0.00023503383,0.00009688001,0.0002174824,0.00027224934,0.0002213193,0.000103129954,0.0002959653,0.00021296815,0.0003476317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044069454,0.000030717518,0.04963835,0.000025851723,0.000048201393,0.0011860188,0.000118066564,0.00016956958,0.9433534,0.00019937144,0.0001021818,0.0046875267],"study_design_scores_gemma":[0.00002392107,0.00026804907,0.8729928,0.000008435371,0.0000755497,0.013040144,0.0002092248,0.0012129536,0.11005354,0.00038257983,0.0017156752,0.000017124712],"about_ca_topic_score_codex":0.000741272,"about_ca_topic_score_gemma":0.0016385706,"teacher_disagreement_score":0.0015096817,"about_ca_system_score_codex":0.00018454404,"about_ca_system_score_gemma":0.0001138867,"threshold_uncertainty_score":0.0050504208},"labels":[],"label_agreement":null},{"id":"W2422549628","doi":"10.1093/neuonc/now081.41","title":"QOS-41NEURAL NETWORK DISTURBANCES IN CHILDREN TREATED FOR BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Neuroscience; Computer science; Medicine; Psychology","score_opus":0.03004026631933782,"score_gpt":0.2932533753929637,"score_spread":0.2632131090736259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422549628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994259,0.00010804235,0.000080817554,0.000014414221,0.0000012792543,0.0000041434328,0.00012684244,0.000003996216,0.00023456209],"genre_scores_gemma":[0.99920756,0.00015956587,0.00016268899,0.000008261665,0.000001844691,0.000012465703,0.00025997448,0.000002951746,0.00018489375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999897,0.000016187949,0.000008397597,0.000022226359,0.0000253423,0.00003084389],"domain_scores_gemma":[0.9995827,0.000051698265,0.0002369558,0.00001471652,0.00005160836,0.00006232564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013884039,0.00020274072,0.00019661446,0.0003487123,0.00028413438,0.0002776548,0.00014033726,0.00015355171,0.0016946155],"category_scores_gemma":[0.0007836505,0.000081370046,0.00017585386,0.00041101442,0.00021364339,0.00017170033,0.00024944765,0.00023153207,0.00015472456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020900565,0.000042324697,0.97744924,0.000059595754,0.000044530905,0.0012461811,0.0007045453,0.00022845408,0.0045307484,0.00005567791,0.0002913252,0.015138421],"study_design_scores_gemma":[0.000002504887,0.00012790455,0.9971445,0.0000047332023,0.000012773504,0.0016498889,0.00027358922,0.00009167955,0.000397319,0.000019309224,0.00027364612,0.0000021070905],"about_ca_topic_score_codex":0.006725308,"about_ca_topic_score_gemma":0.010218629,"teacher_disagreement_score":0.006725308,"about_ca_system_score_codex":0.00042488362,"about_ca_system_score_gemma":0.00038344343,"threshold_uncertainty_score":0.013372302},"labels":[],"label_agreement":null},{"id":"W2423210002","doi":"10.1093/neuonc/now076.51","title":"MB-53hTERT EXPRESSION AND REGULATION IN PEDIATRIC MEDULLOBLASTOMA (MB)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Expression (computer science); Internal medicine; Biology; Cancer research; Medicine; Computer science; Programming language","score_opus":0.0175855002619027,"score_gpt":0.2892958481699219,"score_spread":0.2717103479080192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423210002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985158,0.0008955251,0.00016137671,0.000010352006,8.402933e-7,0.0000027183548,0.00029366513,0.0000068448426,0.00011288441],"genre_scores_gemma":[0.99916315,0.00035717798,0.00015418917,0.000004313061,0.000001644235,0.0000043566083,0.0002651077,0.0000023834846,0.000047633428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998642,0.000018114792,0.000012886562,0.00003931883,0.000037120608,0.00002840734],"domain_scores_gemma":[0.999764,0.000026265103,0.00015106842,0.000011537204,0.000021450736,0.000025590496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017269517,0.00014493894,0.00021756144,0.00045598194,0.00016156028,0.00026703437,0.00013116543,0.0001278117,0.00037974678],"category_scores_gemma":[0.00045766417,0.00012262745,0.00014066657,0.0005340386,0.00020321178,0.00017361017,0.00018810082,0.00017876136,0.000091516245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004452172,0.00001279244,0.96990347,0.000044390505,0.00004500144,0.00036161728,0.00011282159,0.00018353856,0.021132855,0.000042189837,0.00009978257,0.0076163146],"study_design_scores_gemma":[0.0000045598345,0.00007451801,0.99373806,0.0000053349886,0.00004034882,0.0012668653,0.000061799874,0.00016990225,0.004258532,0.000024900894,0.00035351995,0.0000016938309],"about_ca_topic_score_codex":0.0042332476,"about_ca_topic_score_gemma":0.0045393473,"teacher_disagreement_score":0.0042332476,"about_ca_system_score_codex":0.00050940964,"about_ca_system_score_gemma":0.00020644766,"threshold_uncertainty_score":0.008417189},"labels":[],"label_agreement":null},{"id":"W2423401654","doi":"10.1093/neuonc/now070.37","title":"EPN-38RELAPSE PATTERNS IN PEDIATRIC INTRACRANIAL EPENDYMOMA: A CANADIAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; BC Children's Hospital; Children's Hospital of Western Ontario; Children's Hospital of Eastern Ontario; McGill University; Alberta Children's Hospital; Stollery Children's Hospital; Hospital for Sick Children; Vancouver General Hospital","funders":"","keywords":"Ependymoma; Medicine; Radiology","score_opus":0.016705701052413646,"score_gpt":0.2834924554221071,"score_spread":0.26678675436969346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423401654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959294,0.0010643902,0.00014337742,0.00012789325,0.000009649466,0.00003217538,0.00022554628,0.0000093154285,0.0024583554],"genre_scores_gemma":[0.9970606,0.0017790812,0.00035571886,0.00006380431,0.000012106251,0.000012023259,0.0002681522,0.000008334203,0.0004400785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995598,0.000024616615,0.00002601955,0.00006160492,0.00017247403,0.00015553195],"domain_scores_gemma":[0.9992773,0.00006162241,0.00019278312,0.00004027369,0.00019351329,0.0002346789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031274252,0.000528661,0.00028965363,0.0009500685,0.0017862737,0.00049921754,0.0006018104,0.0003493673,0.0011290084],"category_scores_gemma":[0.0011938278,0.00021618347,0.00023453085,0.0024414083,0.00080377376,0.00026765783,0.00067053235,0.000507965,0.00020565592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015033831,0.00009564582,0.9212225,0.00012602861,0.00003733152,0.034163453,0.0023369992,0.0002752282,0.0019039382,0.0002742441,0.0015815153,0.03783281],"study_design_scores_gemma":[0.000025298932,0.0002622573,0.90155095,0.00007370083,0.00005020116,0.08782463,0.00255711,0.00025583955,0.0009143811,0.00008207617,0.006372509,0.000031083844],"about_ca_topic_score_codex":0.61615765,"about_ca_topic_score_gemma":0.76568294,"teacher_disagreement_score":0.38384235,"about_ca_system_score_codex":0.006205087,"about_ca_system_score_gemma":0.008043396,"threshold_uncertainty_score":0.7722057},"labels":[],"label_agreement":null},{"id":"W2423512374","doi":"10.1093/neuonc/now066.02","title":"CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psychology","score_opus":0.028018140841541722,"score_gpt":0.2829596496953843,"score_spread":0.2549415088538426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423512374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979705,0.00016910766,0.0000705662,0.00004811715,0.0000058868936,0.000011395673,0.0006329695,0.000005263477,0.0010862313],"genre_scores_gemma":[0.9992994,0.000052652587,0.00010765052,0.000011536748,0.000004992442,0.000007851519,0.0003841723,0.0000014482355,0.00013014887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996779,0.00004415631,0.000067361805,0.00004912575,0.000098818746,0.00006276057],"domain_scores_gemma":[0.99770856,0.00033202974,0.0012962488,0.000079467216,0.00023463294,0.00034900062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036284458,0.00021875852,0.00026667028,0.0016036624,0.00035712856,0.0005932186,0.0003627989,0.00040162914,0.0030061502],"category_scores_gemma":[0.002936533,0.0001544694,0.00032285484,0.0010237191,0.0002948441,0.00039925112,0.0004125538,0.00044017448,0.00037058385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003636192,0.000005414245,0.9993253,0.0000036681147,0.000008827473,0.00010177142,0.000012735344,0.000013983732,0.00010589054,0.0000064248375,0.000043784366,0.0003358694],"study_design_scores_gemma":[0.0000017268954,0.000042520816,0.99875987,0.0000049040327,0.0000114506,0.00080092764,0.00007890869,0.00006891149,0.00010559855,0.000010345861,0.000112503454,0.0000022986887],"about_ca_topic_score_codex":0.004519374,"about_ca_topic_score_gemma":0.006994953,"teacher_disagreement_score":0.004519374,"about_ca_system_score_codex":0.00048678825,"about_ca_system_score_gemma":0.00062082865,"threshold_uncertainty_score":0.010056615},"labels":[],"label_agreement":null},{"id":"W2424325921","doi":"10.1093/neuonc/now073.102","title":"HG-106A NOVEL TOOL TO PREDICT THE SURVIVAL OF DIFFUSE INTRINSIC PONTINE GLIOMA PATIENTS: EXTERNAL VALIDATION OF THE SURVIVAL PREDICTION MODEL USING THE INTERNATIONAL DIPG REGISTRY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioma; Medicine; Overall survival; Oncology; Internal medicine; Cancer research","score_opus":0.05479011071907322,"score_gpt":0.31575292182284154,"score_spread":0.2609628111037683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424325921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077637,0.0004172608,0.015241333,0.00022020101,0.00004129803,0.000119559765,0.0017242477,0.00018588091,0.0012738503],"genre_scores_gemma":[0.9903549,0.00014009714,0.00614742,0.00005064154,0.000022338163,0.0000722449,0.0029433363,0.00002281431,0.00024625738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998563,0.0005721861,0.00011047561,0.00033699616,0.0003352637,0.00008212591],"domain_scores_gemma":[0.9965245,0.0010764784,0.00085356866,0.0006562512,0.00066394644,0.00022527807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006714159,0.0007707716,0.0006248596,0.0014148753,0.00028160712,0.0010078767,0.00092312513,0.00040925076,0.00088632246],"category_scores_gemma":[0.0119747035,0.00017549306,0.00080343185,0.00092816196,0.00032604265,0.00065302965,0.001067716,0.0010697457,0.00045206156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040773008,0.00010847225,0.95740235,0.000060913084,0.00026088627,0.00015750637,0.0001156225,0.0067209676,0.0006491345,0.00019214106,0.0010357392,0.032888602],"study_design_scores_gemma":[0.00013464785,0.00097521744,0.8269491,0.0001247093,0.0005821462,0.0017533269,0.0002429208,0.1605573,0.0031065599,0.00085355353,0.004661262,0.000059379934],"about_ca_topic_score_codex":0.0032540422,"about_ca_topic_score_gemma":0.0041411277,"teacher_disagreement_score":0.006714159,"about_ca_system_score_codex":0.0006056845,"about_ca_system_score_gemma":0.001266854,"threshold_uncertainty_score":0.035508335},"labels":[],"label_agreement":null},{"id":"W2424472415","doi":"10.1093/neuonc/now083.09","title":"RA-10SUBTLE FINDINGS ON SPINAL MRIs IN CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiology; Pathology","score_opus":0.011910673217263412,"score_gpt":0.2733677644108358,"score_spread":0.2614570911935724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424472415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993105,0.00029658695,0.00003596306,0.000010959247,0.000002355814,0.000008703335,0.000120369696,0.0000030500455,0.00021161432],"genre_scores_gemma":[0.9995146,0.00018345003,0.000086087544,0.000009709337,0.000005346106,0.0000066346183,0.0001574511,0.0000019346235,0.00003484271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999511,0.00006983941,0.00008544721,0.00010511168,0.00014596124,0.000082633196],"domain_scores_gemma":[0.9979924,0.0004042965,0.0011691418,0.000083825325,0.0001440649,0.00020634082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044723295,0.00024154832,0.0003085548,0.0010747889,0.0003517879,0.00041809166,0.00033364183,0.00027056737,0.000802113],"category_scores_gemma":[0.0028612346,0.0003018838,0.00025804972,0.0007953206,0.0004767744,0.00044114713,0.00040332272,0.00027849045,0.0001520436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003088799,0.0000034544532,0.99811006,0.000009712,0.0000069152184,0.0008813402,0.000065645996,0.000013178411,0.00023745281,0.0000053618137,0.00002619131,0.00060982286],"study_design_scores_gemma":[0.0000034480638,0.00007825619,0.990112,0.000010550561,0.000020135532,0.009100172,0.00022357606,0.00005925131,0.00022975387,0.000008389352,0.00015176595,0.0000027629292],"about_ca_topic_score_codex":0.0060808184,"about_ca_topic_score_gemma":0.01172754,"teacher_disagreement_score":0.0060808184,"about_ca_system_score_codex":0.00055014185,"about_ca_system_score_gemma":0.00053050753,"threshold_uncertainty_score":0.012090802},"labels":[],"label_agreement":null},{"id":"W2425583840","doi":"10.1093/neuonc/now075.68","title":"LG-68THE GENETIC AND CLINICAL LANDSCAPE IN PEDIATRIC LOW GRADE GLIOMA; PRELIMINARY RESULTS FROM PLGG TASKFORCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Geography; Internal medicine; Cancer research","score_opus":0.02606347067942976,"score_gpt":0.31517520268498284,"score_spread":0.28911173200555307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2425583840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764366,0.0038417934,0.00060929055,0.0008152027,0.000018528614,0.00018208724,0.013693581,0.000062855754,0.004340001],"genre_scores_gemma":[0.96927935,0.0029111449,0.001190198,0.0002940239,0.000042132706,0.00023941846,0.024921646,0.00002833343,0.0010938137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999577,0.00011298433,0.0000382702,0.00008383225,0.00011285414,0.00007505021],"domain_scores_gemma":[0.998708,0.00019758787,0.00035670542,0.000058783615,0.00043240463,0.00024652667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014268339,0.00027647798,0.00014088578,0.001222688,0.00021543301,0.00046071547,0.0002824552,0.00024426356,0.0010034842],"category_scores_gemma":[0.0019006052,0.00011406907,0.00017501079,0.0011954346,0.00014416827,0.00026417992,0.00056914246,0.000185505,0.0005256372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031820472,0.00003909995,0.96717227,0.000098402306,0.000023866516,0.0002968054,0.00018884604,0.00022791309,0.0007910642,0.000047616337,0.004259878,0.026536137],"study_design_scores_gemma":[0.000023744858,0.00019629512,0.9912998,0.00006120292,0.00003366968,0.0006626894,0.00021427678,0.00014005827,0.00043158184,0.000036428977,0.0068955706,0.0000046343807],"about_ca_topic_score_codex":0.015695654,"about_ca_topic_score_gemma":0.017649457,"teacher_disagreement_score":0.015695654,"about_ca_system_score_codex":0.00083560124,"about_ca_system_score_gemma":0.0011142291,"threshold_uncertainty_score":0.031208634},"labels":[],"label_agreement":null},{"id":"W2426916527","doi":"10.1093/neuonc/now076.42","title":"MB-44SUBGROUP-SPECIFIC QUANTITATIVE PROTEOMIC ANALYSIS OF MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Computational biology; Biology; Cancer research","score_opus":0.024396137609051693,"score_gpt":0.31828356214749126,"score_spread":0.2938874245384396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426916527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985742,0.0023296988,0.0071865483,0.00008118395,0.00003360554,0.00007778763,0.0024299747,0.0002611068,0.0018582101],"genre_scores_gemma":[0.9634668,0.0020014304,0.021358112,0.000098714365,0.00002906443,0.000190062,0.008326142,0.00012835072,0.0044011883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997917,0.00002101192,0.000012619152,0.00004080643,0.000100080746,0.000033730365],"domain_scores_gemma":[0.9999256,0.000009454179,0.000019319494,0.000009621101,0.000021344733,0.000014652417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002522098,0.00031115557,0.0002576232,0.0009581987,0.00031014506,0.00027316637,0.00016294292,0.00014670339,0.000739159],"category_scores_gemma":[0.00019493503,0.00012749498,0.00021675166,0.0004276404,0.00013334726,0.00013436683,0.00023076113,0.00022657539,0.0002921489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006617906,0.000012493994,0.0007507311,0.000021294549,0.000009885438,0.000022525895,0.000014978315,0.00003535058,0.9975128,0.000045223263,0.00006648613,0.0014419804],"study_design_scores_gemma":[0.000019384293,0.0002746065,0.11520326,0.000010552735,0.00008208934,0.0007213532,0.00010038889,0.002757871,0.8666867,0.00020761642,0.013921346,0.0000147227065],"about_ca_topic_score_codex":0.0022163603,"about_ca_topic_score_gemma":0.003636588,"teacher_disagreement_score":0.0022163603,"about_ca_system_score_codex":0.00035384737,"about_ca_system_score_gemma":0.00031779165,"threshold_uncertainty_score":0.0044068694},"labels":[],"label_agreement":null},{"id":"W2426931417","doi":"10.1093/neuonc/now076.92","title":"MB-96IMPAIRED NEURAL FUNCTION DURING VISUAL-MOTOR PERFORMANCE IN CHILDREN TREATED FOR BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Memory and Neural Computing","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Magnetoencephalography; Motor cortex; Medicine; Audiology; Sick child; Visual cortex; Motor function; Psychology; Neuroscience; Pediatrics; Physical medicine and rehabilitation; Electroencephalography; Internal medicine","score_opus":0.011286423622696344,"score_gpt":0.2500631970886195,"score_spread":0.23877677346592316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426931417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99984336,0.000035526624,0.000029932227,0.0000029650573,4.195263e-7,0.0000012030002,0.000031038748,0.0000020695902,0.000053430034],"genre_scores_gemma":[0.99973434,0.00004374756,0.00005719879,0.000003147356,8.180614e-7,0.000003874882,0.00007811037,0.000001644121,0.000077096476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998847,0.000020216365,0.000010643933,0.000030495597,0.000025657102,0.000028359578],"domain_scores_gemma":[0.99975663,0.000048012775,0.00012452426,0.0000128952315,0.000020062364,0.000037910373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012807778,0.00031538878,0.0002817046,0.00035599968,0.0001608394,0.0002456087,0.00015685085,0.00019859581,0.000724321],"category_scores_gemma":[0.0006860103,0.00012280227,0.00017575898,0.0002567828,0.000282668,0.00013496187,0.00019743147,0.00019723843,0.000133804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007038092,0.00008274026,0.95071954,0.000055858574,0.00007622805,0.0017292954,0.0009238472,0.00024829738,0.03542249,0.000033930053,0.00008735572,0.009916648],"study_design_scores_gemma":[0.000004602699,0.0004430182,0.99512464,0.0000027635017,0.000027086619,0.0018002834,0.0002008934,0.000073801515,0.00218714,0.0000093828185,0.00012331325,0.0000032480687],"about_ca_topic_score_codex":0.0036389644,"about_ca_topic_score_gemma":0.0034508316,"teacher_disagreement_score":0.0036389644,"about_ca_system_score_codex":0.00021820585,"about_ca_system_score_gemma":0.00014064497,"threshold_uncertainty_score":0.007235527},"labels":[],"label_agreement":null},{"id":"W2427379911","doi":"10.1093/neuonc/now070.36","title":"EPN-37PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Vancouver Hospital and Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Stollery Children's Hospital; Hospital for Sick Children; Izaak Walton Killam Health Centre; BC Cancer Agency; Children's Hospital of Western Ontario; BC Children's Hospital","funders":"","keywords":"Medicine; Ependymoma; Retrospective cohort study; Interquartile range; Pediatrics; Surgery","score_opus":0.016035501306314873,"score_gpt":0.28261371885261516,"score_spread":0.2665782175463003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427379911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996786,0.00069087127,0.00007002009,0.00006496795,0.000005070846,0.000045929326,0.0014072888,0.00000501657,0.00092466077],"genre_scores_gemma":[0.9979917,0.0006435927,0.000111459354,0.00006726858,0.00000610792,0.000023083232,0.00091288344,0.000004088925,0.00023989091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989986,0.0000557779,0.00008150166,0.00019626856,0.00035200175,0.0003158855],"domain_scores_gemma":[0.99763644,0.00013027697,0.00076634646,0.00009214738,0.0008769864,0.00049783196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043700167,0.0005096224,0.00060831965,0.0013852293,0.0021058996,0.0010236918,0.0009740656,0.00046266927,0.0015097751],"category_scores_gemma":[0.0012671099,0.0005064307,0.00044744933,0.004217969,0.0008374553,0.0003260986,0.0009932356,0.00060320494,0.00025005036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005392197,0.000013794541,0.99684346,0.000042974476,0.00003294694,0.0007305919,0.0003040712,0.00003947601,0.00017789591,0.000032876917,0.00024327087,0.0014847157],"study_design_scores_gemma":[0.000008623146,0.000055249242,0.9968015,0.000032166936,0.000041003947,0.0012225102,0.0007606101,0.00009301193,0.00007342245,0.00001023236,0.0008934439,0.000008149038],"about_ca_topic_score_codex":0.91359824,"about_ca_topic_score_gemma":0.9352235,"teacher_disagreement_score":0.08640176,"about_ca_system_score_codex":0.012719707,"about_ca_system_score_gemma":0.018303914,"threshold_uncertainty_score":0.17382115},"labels":[],"label_agreement":null},{"id":"W2427652150","doi":"10.1093/neuonc/now071.01","title":"EPI-01REVIEW OF CLINICAL PRESENTATION AND TRAJECTORY OF PEDIATRIC PATIENTS (0-18 YEARS OF AGE) WITH A DIAGNOSIS OF PRIMARY BRAIN TUMOUR (BT) IN A PEDIATRIC TERTIARY CENTER","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neonatal and fetal brain pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Presentation (obstetrics); Center (category theory); Medicine; Pediatrics; Tertiary care; General surgery; Radiology","score_opus":0.032051793791902955,"score_gpt":0.3225421878940098,"score_spread":0.29049039410210686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427652150","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96612364,0.0041773007,0.00044995826,0.0009529456,0.000062515785,0.0001261598,0.019752322,0.00010640917,0.008248736],"genre_scores_gemma":[0.9790308,0.0048771687,0.0007440128,0.0002934246,0.00006843788,0.00009752881,0.013685691,0.000022383008,0.0011804707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994824,0.00011289255,0.0001356989,0.00007290907,0.000096481104,0.00009958894],"domain_scores_gemma":[0.99755764,0.0004111467,0.0012149863,0.000058155052,0.0004575061,0.0003006072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005182415,0.0001456734,0.0002248325,0.0020695284,0.00029528156,0.00055921153,0.00029596276,0.00024380494,0.0063994327],"category_scores_gemma":[0.00286809,0.00015852568,0.00029199352,0.0020528808,0.00020098098,0.00065401563,0.00047589288,0.00027696186,0.00068121555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040849853,0.00001658418,0.98858225,0.000120241886,0.000026888018,0.00090527907,0.00013959188,0.00004277518,0.00016627565,0.00006269743,0.003690783,0.0062056636],"study_design_scores_gemma":[0.000002221196,0.000032713557,0.99500656,0.0000987588,0.000010688769,0.0024681285,0.00041980518,0.000056667046,0.00009720173,0.000020205298,0.0017836479,0.0000034759516],"about_ca_topic_score_codex":0.005886401,"about_ca_topic_score_gemma":0.0066242474,"teacher_disagreement_score":0.0063994327,"about_ca_system_score_codex":0.0006146225,"about_ca_system_score_gemma":0.00084744184,"threshold_uncertainty_score":0.0214082},"labels":[],"label_agreement":null},{"id":"W2427937521","doi":"10.1093/neuonc/now072.17","title":"GC-17THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) LOCALIZED GERMINOMA (ACNS1123 STRATUM 2)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Central nervous system; Germinoma; Medicine; Stratum; Oncology; Pediatrics; Internal medicine; Pathology; Chemotherapy; Biology","score_opus":0.020570507630243734,"score_gpt":0.277393225005239,"score_spread":0.2568227173749953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427937521","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80587375,0.018920647,0.0017823078,0.005802896,0.0008177677,0.0015502978,0.028600605,0.00056860707,0.13608314],"genre_scores_gemma":[0.91286725,0.010274874,0.0073898523,0.0040465873,0.000260099,0.0015643437,0.02794803,0.00019363806,0.035455383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998791,0.000025823565,0.000010281744,0.000020863514,0.000027848586,0.000036065292],"domain_scores_gemma":[0.9997557,0.000022052925,0.00005485972,0.000018701694,0.000029611707,0.00011920527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025700888,0.0003253155,0.00036400402,0.0004437139,0.00042918962,0.00051249407,0.00032470352,0.00034416938,0.013873503],"category_scores_gemma":[0.000317212,0.00011408647,0.0004140569,0.00060442503,0.00020123218,0.00019702321,0.00036380626,0.00059340266,0.002249633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051813037,0.0014073247,0.36675817,0.0009020824,0.00043087563,0.0017025999,0.00037104863,0.0016234381,0.01606746,0.0037211084,0.18798654,0.41384807],"study_design_scores_gemma":[0.0023143552,0.003928896,0.3983287,0.00039690465,0.0003758266,0.0048560617,0.00022974564,0.00073135283,0.0052530933,0.0012511094,0.582308,0.000025934285],"about_ca_topic_score_codex":0.0043071886,"about_ca_topic_score_gemma":0.020646824,"teacher_disagreement_score":0.013873503,"about_ca_system_score_codex":0.0018054749,"about_ca_system_score_gemma":0.0022560295,"threshold_uncertainty_score":0.046411455},"labels":[],"label_agreement":null},{"id":"W2427975996","doi":"10.1093/neuonc/now066.03","title":"CMS-03RISK FACTORS FOR LONG TERM SPEECH DEFICITS IN CHILDREN WITH CEREBELLAR MUTISM SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Children's Physical and Motor Development","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children","funders":"","keywords":"Term (time); Psychology; Audiology; Medicine; Physics","score_opus":0.017014883502145018,"score_gpt":0.2762731209147251,"score_spread":0.2592582374125801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427975996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993087,0.00018104615,0.00004156182,0.000038482558,0.000004000796,0.000004937662,0.00012809037,0.0000042517313,0.00028883622],"genre_scores_gemma":[0.9995202,0.00008755712,0.000073598,0.000011035579,0.0000078077,0.000007262123,0.00022090868,0.0000018643366,0.00006970618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995042,0.00008109691,0.00006434515,0.00009695307,0.00015450415,0.000098824865],"domain_scores_gemma":[0.9984281,0.00029543703,0.0007750071,0.000040013078,0.000101727965,0.00035980457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032259608,0.00042137963,0.00034345695,0.001194755,0.00050728465,0.0005137682,0.0003005857,0.00055781123,0.0024693017],"category_scores_gemma":[0.002298043,0.0002813409,0.00043956732,0.0009926528,0.00043106655,0.00045934995,0.0005596576,0.0005830022,0.00027985667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002160657,0.000007715773,0.9986016,0.0000030738736,0.000006917443,0.00079296017,0.000028198237,0.000015247858,0.00011769441,0.00000857562,0.000031578027,0.0003649304],"study_design_scores_gemma":[0.0000025346696,0.000057590038,0.99507153,0.000005378191,0.000010584516,0.004514969,0.00014335821,0.000056552028,0.000050988234,0.000012931063,0.000070588576,0.000003014269],"about_ca_topic_score_codex":0.004629964,"about_ca_topic_score_gemma":0.004690269,"teacher_disagreement_score":0.004629964,"about_ca_system_score_codex":0.00038240541,"about_ca_system_score_gemma":0.00060363545,"threshold_uncertainty_score":0.009206057},"labels":[],"label_agreement":null},{"id":"W2428638242","doi":"10.1093/neuonc/now081.06","title":"QOS-06REPAIRING THE BRAIN WITH PHYSICAL EXERCISE: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS. INSIGHTS FROM CORTICAL THICKNESS ANALYSIS AND DEFORMATION BASED MORPHOMETRY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Physical medicine and rehabilitation; Brain morphometry; Psychology; Medicine; Physical therapy; Neuroscience; Magnetic resonance imaging; Radiology","score_opus":0.01363966597213219,"score_gpt":0.2738022869398728,"score_spread":0.2601626209677406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428638242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990941,0.00036248664,0.00007350715,0.00006079051,0.00001624134,0.00015787524,0.000085033316,0.000008917889,0.00014112344],"genre_scores_gemma":[0.994364,0.0015020346,0.0015191772,0.00016205992,0.0000819317,0.0013588115,0.00042662508,0.000008276425,0.0005769859],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982375,0.000054011074,0.00001883494,0.000036866473,0.00002883372,0.00003777761],"domain_scores_gemma":[0.99973184,0.000031128242,0.00004864577,0.000019491861,0.000020908443,0.0001480015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037047258,0.0005940554,0.0009395003,0.00025588443,0.00026176494,0.00036219053,0.00036233955,0.00063861115,0.0011068634],"category_scores_gemma":[0.00049742777,0.00022520732,0.0008084983,0.00026400667,0.00029807296,0.00033305548,0.00042405067,0.0013729701,0.00016502422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5577078,0.17884701,0.028400585,0.0026879115,0.0016685228,0.000570914,0.00060966035,0.0028976875,0.030712659,0.00041600448,0.0014071787,0.19407408],"study_design_scores_gemma":[0.17219825,0.69656634,0.1179843,0.0002597882,0.0011327821,0.00026342113,0.00034099695,0.0032452585,0.005853985,0.0002059736,0.0019032729,0.0000457147],"about_ca_topic_score_codex":0.0015850969,"about_ca_topic_score_gemma":0.0024697327,"teacher_disagreement_score":0.0015850969,"about_ca_system_score_codex":0.00022778926,"about_ca_system_score_gemma":0.00069292524,"threshold_uncertainty_score":0.0037028193},"labels":[],"label_agreement":null},{"id":"W2429350315","doi":"10.1093/neuonc/now076.14","title":"MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Electron and X-Ray Spectroscopy Techniques","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Group (periodic table); Medicine; Biology; Oncology; Cancer research; Chemistry","score_opus":0.013046173712582852,"score_gpt":0.2856148729585675,"score_spread":0.27256869924598465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429350315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295527,0.002181466,0.0011242818,0.00018170605,0.0000735336,0.000049937295,0.00057894946,0.00014973241,0.0027052523],"genre_scores_gemma":[0.99322516,0.0007627425,0.0005391443,0.00006173653,0.000009771388,0.000033122797,0.000801555,0.000020577636,0.0045461664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998859,0.000011176098,0.000008683401,0.000016454518,0.0000345107,0.000043193082],"domain_scores_gemma":[0.99991345,0.000012728435,0.000015199375,0.0000111040345,0.000009160885,0.000038249505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009123559,0.00021102365,0.00019509885,0.00022582356,0.00016312292,0.00021543691,0.00015294805,0.00017842435,0.0020448372],"category_scores_gemma":[0.00011518561,0.00009189551,0.00019346223,0.00010825459,0.00017309858,0.00012463411,0.00017120548,0.000571691,0.00046983318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002826096,0.0001758207,0.00057176495,0.000058174202,0.000007593937,0.00007245739,0.000041991512,0.00015252917,0.9952506,0.00024160737,0.00035039193,0.0027945582],"study_design_scores_gemma":[0.000055792207,0.0011728335,0.010744511,0.000011308983,0.000022918772,0.00019193385,0.00007827324,0.001601643,0.9770758,0.00011010424,0.008928504,0.0000064224673],"about_ca_topic_score_codex":0.0048389416,"about_ca_topic_score_gemma":0.0076174927,"teacher_disagreement_score":0.0048389416,"about_ca_system_score_codex":0.00035797377,"about_ca_system_score_gemma":0.00041881844,"threshold_uncertainty_score":0.009621561},"labels":[],"label_agreement":null},{"id":"W2429582314","doi":"10.1093/neuonc/now075.46","title":"LG-46INFERIOR OUTCOME AND POOR RESPONSE TO CONVENTIONAL THERAPIES IN PEDIATRIC LOW-GRADE GLIOMAS HARBORING THE BRAF V600E MUTATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Mutation; Oncology; Cancer research; Internal medicine; Genetics; Biology; Gene","score_opus":0.026184051549662392,"score_gpt":0.32052237137071854,"score_spread":0.2943383198210561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429582314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926215,0.00032909028,0.000054975633,0.000024071236,0.0000015977558,0.0000021166259,0.00011056107,0.000004101375,0.00021132296],"genre_scores_gemma":[0.9995981,0.000083819235,0.000040339175,0.000009161535,0.0000025463673,0.0000024619094,0.00021392215,0.0000017461017,0.000047873124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998041,0.000042571162,0.000018667673,0.0000455424,0.000044177174,0.00004491671],"domain_scores_gemma":[0.9989699,0.00014570035,0.0005747583,0.000032869124,0.00007145759,0.00020540107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032825582,0.0002062057,0.0001735784,0.0003141629,0.00014282748,0.000393245,0.00017030576,0.0002392665,0.0007518378],"category_scores_gemma":[0.0010500832,0.00007131876,0.00020548263,0.000387367,0.00025270975,0.00031019206,0.00022386627,0.0002937546,0.00019192787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042032934,0.000019712126,0.99295324,0.0000140017,0.000023805977,0.000412946,0.0000390139,0.00009386291,0.0007788688,0.000012616542,0.00009578003,0.0051358],"study_design_scores_gemma":[0.0000074105387,0.000316977,0.9964657,0.000007254887,0.000030903288,0.0021689394,0.00007803852,0.00016038663,0.0004927041,0.00003550707,0.00023393848,0.0000023727782],"about_ca_topic_score_codex":0.0012266185,"about_ca_topic_score_gemma":0.0021037413,"teacher_disagreement_score":0.0012266185,"about_ca_system_score_codex":0.00053861184,"about_ca_system_score_gemma":0.00025088617,"threshold_uncertainty_score":0.0039079785},"labels":[],"label_agreement":null},{"id":"W2429925096","doi":"10.1093/neuonc/now076.102","title":"MB-107REST ELEVATION UNRESTRAINS SHH SIGNALING IN MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Elevation (ballistics); Biology; Cancer research; Physics; Astronomy","score_opus":0.012492819816505497,"score_gpt":0.26709323942063046,"score_spread":0.25460041960412494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429925096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765295,0.000946915,0.0003208632,0.000044629705,0.000011190088,0.0000129119335,0.00016984796,0.000053143838,0.0007875046],"genre_scores_gemma":[0.9979189,0.00054194924,0.00026889256,0.000024889197,0.000004897516,0.000015872856,0.00026549134,0.0000095728265,0.00094949483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999131,0.000009897438,0.000009305004,0.000013928412,0.00003089564,0.000022848595],"domain_scores_gemma":[0.9999608,0.0000045762563,0.0000112182515,0.0000046215528,0.0000023078946,0.000016554492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063129184,0.00018847927,0.00023852692,0.00028955837,0.00009272684,0.00018873013,0.00012316898,0.00019973578,0.0006395378],"category_scores_gemma":[0.0000639452,0.0001349194,0.00016222885,0.00010467595,0.00016858829,0.0001019868,0.00012863676,0.00048155835,0.00022718952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015572867,0.00005745664,0.00052919425,0.000020442998,0.0000042342335,0.00012845514,0.0000101276755,0.0000467137,0.997724,0.000066069275,0.000046902795,0.0012106096],"study_design_scores_gemma":[0.00006510733,0.0022278812,0.029119447,0.000011258548,0.00004715323,0.0017193223,0.000055010543,0.0013202506,0.96208656,0.00006726188,0.0032741209,0.0000065665768],"about_ca_topic_score_codex":0.0013855208,"about_ca_topic_score_gemma":0.0019182139,"teacher_disagreement_score":0.0013855208,"about_ca_system_score_codex":0.00025090197,"about_ca_system_score_gemma":0.0001624008,"threshold_uncertainty_score":0.002754867},"labels":[],"label_agreement":null},{"id":"W2430220433","doi":"10.1093/neuonc/now065.02","title":"AT-03ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Saskatchewan Cancer Agency; Children's Hospital of Eastern Ontario; Montreal Children's Hospital; BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster Children's Hospital; Hospital for Sick Children; Stollery Children's Hospital; Alberta Children's Hospital","funders":"","keywords":"Medicine; Atypical teratoid rhabdoid tumor; Pathology; Oncology; Medulloblastoma","score_opus":0.021566359668255184,"score_gpt":0.2799995239044143,"score_spread":0.2584331642361591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430220433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71269584,0.24354878,0.0009707392,0.031608082,0.0008590223,0.000056097513,0.0010575254,0.00006637349,0.0091376295],"genre_scores_gemma":[0.9226402,0.06996136,0.0010269042,0.0035171804,0.0007741063,0.000016400962,0.0007937075,0.000021670176,0.0012485057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981457,0.000020281374,0.00001499532,0.000027207841,0.00004731399,0.00007560913],"domain_scores_gemma":[0.999258,0.00007750453,0.00024820212,0.000015390313,0.00013379838,0.000267115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032126345,0.00019543659,0.0004341934,0.0004223907,0.0007280337,0.0008051076,0.00058828684,0.0008074047,0.0012825674],"category_scores_gemma":[0.0017478308,0.000078200836,0.0002257211,0.00062306516,0.0005209471,0.0007034088,0.00025385563,0.0009952442,0.0003708498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003884468,0.00011074186,0.77773064,0.00076688925,0.00010852019,0.023877587,0.0006260902,0.0003028451,0.0020674374,0.0008399237,0.019937973,0.17324293],"study_design_scores_gemma":[0.000050798037,0.0004100991,0.79575,0.0034899584,0.00019440126,0.1445767,0.0064120386,0.00044813703,0.0009650416,0.0023003104,0.045322154,0.00008038257],"about_ca_topic_score_codex":0.03185418,"about_ca_topic_score_gemma":0.061030187,"teacher_disagreement_score":0.03185418,"about_ca_system_score_codex":0.001349435,"about_ca_system_score_gemma":0.0028598257,"threshold_uncertainty_score":0.063337564},"labels":[],"label_agreement":null},{"id":"W2430680726","doi":"10.1093/neuonc/now071.03","title":"EPI-04DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Affect (linguistics); Medicine; Pediatrics; Audiology; Psychology; Communication","score_opus":0.013317532501619052,"score_gpt":0.28237341118077847,"score_spread":0.2690558786791594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430680726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805581,0.002609123,0.000104903964,0.00215381,0.00007245856,0.000022426011,0.006035822,0.000015326441,0.008428009],"genre_scores_gemma":[0.9971396,0.000835239,0.0000755361,0.00019156335,0.000042579355,0.000014540559,0.0012357867,0.0000045952997,0.00046059306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930906,0.00016957657,0.00009773075,0.0000764795,0.00013528478,0.00021185572],"domain_scores_gemma":[0.99662495,0.0006458119,0.001959698,0.0000712348,0.000297164,0.00040121982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005113412,0.00011481715,0.00017656271,0.0008130384,0.00026087227,0.00068703055,0.0003144011,0.00038552185,0.005880536],"category_scores_gemma":[0.008312766,0.00011212125,0.00045466272,0.0017414439,0.00024817092,0.00068374997,0.0004640469,0.00052939396,0.00046254185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050200746,0.000013358928,0.99377126,0.000042913718,0.000022343744,0.000119946795,0.00011883293,0.000020640418,0.000019583336,0.00004190623,0.0008089355,0.0049700425],"study_design_scores_gemma":[0.0000025779004,0.000029312392,0.9984047,0.000034368502,0.000014687264,0.0003770306,0.00023979368,0.000021305297,0.000029537981,0.000027864435,0.0008164726,0.0000023801085],"about_ca_topic_score_codex":0.016724626,"about_ca_topic_score_gemma":0.021996528,"teacher_disagreement_score":0.016724626,"about_ca_system_score_codex":0.000824095,"about_ca_system_score_gemma":0.0009405002,"threshold_uncertainty_score":0.033254564},"labels":[],"label_agreement":null},{"id":"W2430949246","doi":"10.1093/neuonc/now067.34","title":"PNR-40EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: A UNIQUE NEW CLINICAL ENTITY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Computer science","score_opus":0.0649653169824969,"score_gpt":0.38463471663029764,"score_spread":0.3196693996478007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430949246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925707,0.0025205126,0.002172963,0.00022912059,0.000020500476,0.00005534453,0.00030472665,0.000041252697,0.0020848152],"genre_scores_gemma":[0.9966858,0.00077234616,0.0016105,0.0000706516,0.00006214964,0.000017223343,0.00026994667,0.0000061514174,0.0005051793],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997441,0.000042537886,0.00006483631,0.000051778454,0.000056518023,0.000040233677],"domain_scores_gemma":[0.99890566,0.000316959,0.00045274428,0.00014508204,0.000048355578,0.00013126584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003872933,0.00035297728,0.00033222302,0.0012711091,0.00033822906,0.0004956694,0.00031577027,0.00046864158,0.0013093887],"category_scores_gemma":[0.001477127,0.0002353552,0.00021579258,0.00088355964,0.000645796,0.00069985655,0.0008611759,0.00043444763,0.00043441966],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033562878,0.00006998671,0.5674296,0.0003340765,0.00008025646,0.35906294,0.00068412593,0.0005336384,0.0164256,0.0011335361,0.0010612839,0.052849267],"study_design_scores_gemma":[0.0000142960835,0.000155235,0.1355492,0.000036704685,0.00003910101,0.85621405,0.00027516836,0.0005350332,0.0020132044,0.0004559074,0.004693753,0.00001833727],"about_ca_topic_score_codex":0.00026377395,"about_ca_topic_score_gemma":0.00063700485,"teacher_disagreement_score":0.0013093887,"about_ca_system_score_codex":0.00013779147,"about_ca_system_score_gemma":0.00024828856,"threshold_uncertainty_score":0.0043803453},"labels":[],"label_agreement":null},{"id":"W2431153579","doi":"10.1093/neuonc/now075.52","title":"LG-52THEOPHYLLINE IN VISION IMPAIRED CHILDREN WITH OPTIC PATHWAY GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Impaired Vision; Medicine; Ophthalmology; Optometry; Neuroscience; Psychology; Cancer research","score_opus":0.011394476047438073,"score_gpt":0.2725541881520989,"score_spread":0.2611597121046608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431153579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955551,0.003080571,0.00026652496,0.000116773284,0.000009492283,0.00010689549,0.00014626217,0.000015805672,0.0007025473],"genre_scores_gemma":[0.9972275,0.0015490712,0.00045381216,0.000071001064,0.00001035995,0.000055603236,0.00026310974,0.000004767802,0.0003646897],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982196,0.00006626859,0.0000163138,0.000022798826,0.000035818124,0.000036846686],"domain_scores_gemma":[0.9996462,0.000082083054,0.00013487149,0.000023240746,0.000026993983,0.00008654879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003390349,0.00025318196,0.00050139264,0.00013265354,0.00014201565,0.0002700661,0.00024174302,0.00023635026,0.0007488171],"category_scores_gemma":[0.00042688122,0.000079357575,0.00032994378,0.00022766592,0.00032915428,0.00019233713,0.00018283498,0.0007234673,0.00015528458],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071206,0.010442049,0.2113763,0.0027075182,0.0011300427,0.0043503754,0.0010124403,0.004390383,0.24766666,0.0005505708,0.003749484,0.4414182],"study_design_scores_gemma":[0.01722296,0.36442506,0.48448223,0.00024118,0.0008336187,0.01079966,0.00072711246,0.0017787935,0.0940278,0.0002357575,0.025181483,0.00004429809],"about_ca_topic_score_codex":0.0027248182,"about_ca_topic_score_gemma":0.007858785,"teacher_disagreement_score":0.0027248182,"about_ca_system_score_codex":0.0006650973,"about_ca_system_score_gemma":0.000967922,"threshold_uncertainty_score":0.005417943},"labels":[],"label_agreement":null},{"id":"W2431302499","doi":"10.1093/neuonc/now076.64","title":"MB-68HEALTH-RELATED QUALITY OF LIFE IN MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Quality (philosophy); Psychology; Medicine; Cancer research; Philosophy; Epistemology","score_opus":0.020721521298372576,"score_gpt":0.295058266010102,"score_spread":0.2743367447117294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431302499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989675,0.00039373964,0.000042269257,0.000035552017,0.0000020897708,0.000011962751,0.00023644169,0.0000023953148,0.00030803683],"genre_scores_gemma":[0.9995061,0.000054576063,0.000047645644,0.00000858211,0.0000022550798,0.000010766862,0.00031274607,9.2065534e-7,0.00005632321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999676,0.00007148525,0.000040363368,0.000044858516,0.000081704995,0.00008556537],"domain_scores_gemma":[0.99926573,0.00009529631,0.00039505327,0.000021534019,0.000072160095,0.00015022814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052721275,0.00022070714,0.00042698864,0.0009202667,0.00031364785,0.0004188442,0.00022790722,0.0002013335,0.001225352],"category_scores_gemma":[0.00209162,0.00007944276,0.0005043052,0.00087126443,0.00015564391,0.000339411,0.00060204475,0.00030737274,0.00015392875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021265839,0.000020428944,0.9956982,0.000014066247,0.00005910877,0.00003647407,0.000084682404,0.0000616382,0.00023883641,0.0000142711715,0.00009856466,0.0034611316],"study_design_scores_gemma":[0.00000752034,0.00013029565,0.9991136,0.0000056472063,0.000026319378,0.00015743013,0.000148744,0.00012649916,0.000056418263,0.00003610858,0.00018917145,0.0000021603892],"about_ca_topic_score_codex":0.007388928,"about_ca_topic_score_gemma":0.009342738,"teacher_disagreement_score":0.007388928,"about_ca_system_score_codex":0.00071437546,"about_ca_system_score_gemma":0.0002736233,"threshold_uncertainty_score":0.01469183},"labels":[],"label_agreement":null},{"id":"W2431568160","doi":"10.1093/neuonc/now084.11","title":"TB-16EXPLORATION OF eEF2K AS A NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA AND NEUROBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Medulloblastoma; Neuroblastoma; Medicine; Computer science; Cancer research; Biology","score_opus":0.028044071829422496,"score_gpt":0.30249892812661566,"score_spread":0.2744548562971932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431568160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8605235,0.111087054,0.00781993,0.0018112966,0.0005794734,0.00031454337,0.0059098615,0.00072492537,0.011229293],"genre_scores_gemma":[0.91145027,0.05525061,0.01014338,0.000609856,0.00009818932,0.00036889798,0.011291137,0.00015269172,0.0106350435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998528,0.000016827518,0.000015783555,0.00003092499,0.000047663532,0.000036029378],"domain_scores_gemma":[0.99991417,0.000010035016,0.000023809,0.000011374741,0.000017645054,0.000022915941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036912184,0.000414066,0.0005521423,0.00044814192,0.00020633353,0.00066006614,0.0003328406,0.0003390187,0.0020168955],"category_scores_gemma":[0.00018895305,0.00016214458,0.000480319,0.00056083396,0.0002490736,0.0002748933,0.00030822726,0.00080686825,0.0005880601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024416235,0.00035740944,0.006025668,0.0014449167,0.00021162645,0.00043691648,0.00009876615,0.0016554279,0.8878691,0.0010775599,0.0037583068,0.09462265],"study_design_scores_gemma":[0.00068973994,0.003484884,0.027194306,0.00035381765,0.00048749972,0.0027177874,0.00017915103,0.0031461557,0.8238572,0.0007549571,0.13709104,0.000043437405],"about_ca_topic_score_codex":0.0016596359,"about_ca_topic_score_gemma":0.004253276,"teacher_disagreement_score":0.0020168955,"about_ca_system_score_codex":0.0007590497,"about_ca_system_score_gemma":0.00074743794,"threshold_uncertainty_score":0.006747186},"labels":[],"label_agreement":null},{"id":"W2431999485","doi":"10.1093/neuonc/now079.18","title":"NU-18NEWLY DIAGNOSED HIGH GRADE GLIOMA AND DIPG: COLLABORATIVE EFFORTS OF PEDIATRIC NEURO-ONCOLOGY AND PALLIATIVE CARE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Stollery Children's Hospital","funders":"","keywords":"Pediatric oncology; Medicine; Palliative care; Glioma; Oncology; Internal medicine; Cancer; Cancer research; Nursing","score_opus":0.024104502930491694,"score_gpt":0.32566333839239925,"score_spread":0.30155883546190754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431999485","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572863,0.005402893,0.0020047638,0.018863909,0.0002419864,0.0001942021,0.00010730015,0.00012748748,0.015771056],"genre_scores_gemma":[0.98954713,0.0025501954,0.0041957456,0.001155425,0.00007559054,0.000089598696,0.00012634332,0.00001535362,0.0022446527],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982187,0.00070608495,0.00011474686,0.0001588895,0.00023117005,0.00057035795],"domain_scores_gemma":[0.9951787,0.00046845936,0.0008288975,0.00016628794,0.0003130362,0.0030445855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020543858,0.0001886087,0.00022981742,0.0006971379,0.0021794995,0.0016615007,0.0007432126,0.0004993137,0.0029910752],"category_scores_gemma":[0.0053566075,0.00022676472,0.00035675883,0.0006994632,0.00090306334,0.0012868788,0.004909562,0.0014514716,0.00026768615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011323131,0.00052533014,0.66562986,0.00038699288,0.00013044321,0.011118481,0.020897727,0.00047412212,0.001053766,0.002525571,0.015018087,0.28212634],"study_design_scores_gemma":[0.000077702774,0.0013129456,0.7543195,0.0014460132,0.00014647566,0.038398445,0.09249631,0.0012728217,0.0013160695,0.0029367707,0.106191985,0.0000848991],"about_ca_topic_score_codex":0.008854403,"about_ca_topic_score_gemma":0.02974838,"teacher_disagreement_score":0.008854403,"about_ca_system_score_codex":0.002860968,"about_ca_system_score_gemma":0.009165049,"threshold_uncertainty_score":0.020757854},"labels":[],"label_agreement":null},{"id":"W2432030052","doi":"10.1093/neuonc/now065.21","title":"AT-22ALISERTIB MONOTHERAPY IN THE TREATMENT OF RELAPSED ATYPICAL TERATOID RHABDOID TUMOR (ATRT)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital of Winnipeg; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Etoposide; Chemotherapy; Internal medicine; Oncology; Surgery; Medulloblastoma; Pathology","score_opus":0.015045315156321536,"score_gpt":0.284976254907342,"score_spread":0.2699309397510205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432030052","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8892114,0.08611031,0.0018468312,0.0020200945,0.00024301535,0.00018410377,0.00058572646,0.00041695914,0.019381518],"genre_scores_gemma":[0.9821186,0.012245729,0.001196481,0.0006178989,0.00010471718,0.000072067014,0.0008177532,0.000019161605,0.0028076312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999169,0.000019219173,0.000011971059,0.000011122217,0.000018055087,0.000022797469],"domain_scores_gemma":[0.9999336,0.000008184737,0.000015479409,0.000005213333,0.000007714027,0.000029734454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001778606,0.00023003007,0.00042597982,0.0002880034,0.00024577478,0.00026018397,0.00034253646,0.00038593996,0.0011727242],"category_scores_gemma":[0.00014479706,0.00007563186,0.00026267223,0.00024164323,0.00015981482,0.00020551261,0.00017552637,0.0006851798,0.00068407226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006679708,0.0014352758,0.015047615,0.0016463083,0.0005037684,0.023770338,0.00043770098,0.0036520697,0.1303151,0.0014239883,0.012965944,0.80212224],"study_design_scores_gemma":[0.007874822,0.054770254,0.14640757,0.00093593844,0.0012129686,0.2531495,0.0005129818,0.011990691,0.15661427,0.0033582067,0.36298534,0.0001874527],"about_ca_topic_score_codex":0.00050557486,"about_ca_topic_score_gemma":0.0023609956,"teacher_disagreement_score":0.0011727242,"about_ca_system_score_codex":0.00040143184,"about_ca_system_score_gemma":0.00025558207,"threshold_uncertainty_score":0.003923118},"labels":[],"label_agreement":null},{"id":"W2432034468","doi":"10.1093/neuonc/now065.18","title":"AT-19SYSTEMATIC RADIOLOGICAL PHENOTYPING OF ATYPICAL TERATOID RHABDOID TUMOURS USING LANGUAGE MODELLED MACHINE LEARNING APPROACHES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Radiological weapon; Computer science; Artificial intelligence; Natural language processing; Medicine; Radiology","score_opus":0.03967846761888544,"score_gpt":0.2786656196088555,"score_spread":0.23898715198997006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432034468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49579972,0.0009327561,0.4485527,0.0019445219,0.000077178156,0.0008668283,0.041562364,0.0047507426,0.0055131475],"genre_scores_gemma":[0.8077086,0.00026389447,0.15610622,0.00020130617,0.000031293042,0.00065690285,0.032923374,0.00014880876,0.0019596466],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99812573,0.0007928847,0.00020284968,0.00046984348,0.00031605104,0.000092686874],"domain_scores_gemma":[0.99464524,0.0029183018,0.000770737,0.000737971,0.00074103737,0.00018671378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028653068,0.00063531235,0.0005065666,0.0018330833,0.00037041734,0.0020081238,0.0010262546,0.00073981896,0.0019676303],"category_scores_gemma":[0.00918919,0.0002722605,0.0018543095,0.0011129031,0.00048180725,0.00086458685,0.0011929452,0.0008787919,0.0008893302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009055138,0.00053869886,0.23625362,0.0008100594,0.00060080475,0.0013790763,0.00075853575,0.47072184,0.013192216,0.011306284,0.010967442,0.25256598],"study_design_scores_gemma":[0.000049179704,0.00027789566,0.036303844,0.00012717169,0.00010757489,0.00079351355,0.00021336607,0.92464787,0.0067398627,0.021568485,0.00910184,0.000069343456],"about_ca_topic_score_codex":0.007371891,"about_ca_topic_score_gemma":0.013176135,"teacher_disagreement_score":0.007371891,"about_ca_system_score_codex":0.0022665132,"about_ca_system_score_gemma":0.0023866154,"threshold_uncertainty_score":0.016444743},"labels":[],"label_agreement":null},{"id":"W2432084722","doi":"10.1093/neuonc/now075.58","title":"LG-58THERAPEUTIC IMPLICATIONS OF MOLECULAR BIOMARKERS IN INFANTS WITH PEDIATRIC LOW-GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Cancer research","score_opus":0.016110921346911312,"score_gpt":0.2963061148436274,"score_spread":0.28019519349671607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432084722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948822,0.0038986434,0.00022005626,0.00008829688,0.0000071602885,0.000009320856,0.00020416027,0.000009471323,0.0006807566],"genre_scores_gemma":[0.99810326,0.0012239795,0.00032625636,0.00002417299,0.000004488404,0.0000068929626,0.00023015984,0.0000021249043,0.00007863198],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998161,0.000044348795,0.000023358853,0.000023219283,0.000046150908,0.000046868026],"domain_scores_gemma":[0.9995828,0.00009141465,0.00019182899,0.000013074635,0.00006961368,0.00005123972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039396805,0.00016888029,0.00023404522,0.00042625077,0.00014533653,0.0003564981,0.00015850285,0.00018647594,0.000429478],"category_scores_gemma":[0.0011214147,0.000057823327,0.00014342279,0.00046269243,0.00017687496,0.00023288658,0.00022799264,0.00021635687,0.00012636572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034124774,0.000020761665,0.9683461,0.000071088805,0.000020748561,0.0018197901,0.00014510193,0.00023892714,0.0029499358,0.00006589013,0.00029265226,0.025687734],"study_design_scores_gemma":[0.0000058653095,0.00043916953,0.9859417,0.00006384942,0.000041700117,0.006646201,0.00038127773,0.0003999893,0.004027121,0.00007467017,0.001973279,0.0000052465602],"about_ca_topic_score_codex":0.0032550662,"about_ca_topic_score_gemma":0.0044902535,"teacher_disagreement_score":0.0032550662,"about_ca_system_score_codex":0.0008675448,"about_ca_system_score_gemma":0.00045237836,"threshold_uncertainty_score":0.00647223},"labels":[],"label_agreement":null},{"id":"W2432316501","doi":"10.1093/neuonc/now077.01","title":"LMI-01DEVELOPMENT OF CLINICAL GUIDELINES FOR THE TREATMENT OF LOW GRADE GLIOMAS IN LOWER AND LOWER MIDDLE INCOME COUNTRIES – A SIOP PODC INITIATIVE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Low and middle income countries; Middle income country; Medicine; Middle income; Developing country; Economics; Socioeconomics; Economic growth; Demographic economics","score_opus":0.10883218417283468,"score_gpt":0.4574309827104888,"score_spread":0.34859879853765413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432316501","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008032351,0.05492696,0.042141613,0.48871776,0.035442572,0.018055763,0.026735317,0.0037710434,0.32217652],"genre_scores_gemma":[0.035393305,0.08333851,0.3692604,0.15542531,0.011782836,0.023407727,0.11457666,0.0017905023,0.20502476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98190135,0.0085204,0.0034469748,0.0004986815,0.0043112915,0.0013214449],"domain_scores_gemma":[0.93722576,0.006626906,0.0056355055,0.0016150399,0.041112076,0.007784848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025972245,0.0011542207,0.0013666169,0.006940311,0.0014182553,0.0054405313,0.0051316055,0.0059481836,0.022395432],"category_scores_gemma":[0.041723695,0.00090791815,0.0021406137,0.004418982,0.0013868674,0.0026769955,0.0053080367,0.005592046,0.017798094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006346071,0.00015857941,0.0012125109,0.0017759745,0.000029065184,0.00031472952,0.0003407402,0.0003327889,0.0005456691,0.004043434,0.8962345,0.09494862],"study_design_scores_gemma":[0.000075676835,0.0000677702,0.0035698987,0.0068694,0.000026828246,0.0003162049,0.00034772756,0.000289826,0.00028322107,0.0013240408,0.98679674,0.000032735883],"about_ca_topic_score_codex":0.018649833,"about_ca_topic_score_gemma":0.028906638,"teacher_disagreement_score":0.025972245,"about_ca_system_score_codex":0.009363287,"about_ca_system_score_gemma":0.04592128,"threshold_uncertainty_score":0.13735598},"labels":[],"label_agreement":null},{"id":"W2432570899","doi":"10.1093/neuonc/now075.19","title":"LG-19IMMUNOHISTOCHEMISTRY IS HIGHLY SENSITIVE AND SPECIFIC FOR THE DETECTION OF BRAF V600E STATUS IN PEDIATRIC LOW-GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Cancer research; Medicine; Oncology; Internal medicine","score_opus":0.00985870928108466,"score_gpt":0.25103360087558635,"score_spread":0.2411748915945017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432570899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697976,0.006052521,0.01571625,0.00015161873,0.000043652453,0.000069550166,0.00031121896,0.0006072134,0.007250308],"genre_scores_gemma":[0.98137903,0.0017139112,0.015133568,0.00007831834,0.00004006554,0.000049905088,0.0006450403,0.00007154768,0.0008886289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994085,0.000105732855,0.00008892855,0.0001457632,0.0001624618,0.00008858718],"domain_scores_gemma":[0.99920976,0.00026770087,0.00020860479,0.00007085085,0.00017572148,0.000067352354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010807402,0.00049920374,0.00026217155,0.002383263,0.00018168728,0.00045837884,0.0004562894,0.00043607058,0.0031956073],"category_scores_gemma":[0.0015138693,0.00034331653,0.00021375726,0.00066947006,0.000667194,0.00054190523,0.0003570331,0.0002796673,0.0012641359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067948893,0.00007833495,0.3886535,0.00030510398,0.000085575135,0.0037190975,0.00021226823,0.00031783592,0.54814446,0.00023373477,0.0010361952,0.05653434],"study_design_scores_gemma":[0.00006655833,0.0008972247,0.53555644,0.00013685669,0.00021803487,0.052100603,0.00038868378,0.0033494146,0.39117935,0.0006063965,0.015465228,0.000035214973],"about_ca_topic_score_codex":0.00045695034,"about_ca_topic_score_gemma":0.00083420303,"teacher_disagreement_score":0.0031956073,"about_ca_system_score_codex":0.00039403827,"about_ca_system_score_gemma":0.0001900424,"threshold_uncertainty_score":0.010690391},"labels":[],"label_agreement":null},{"id":"W2433128876","doi":"10.1093/neuonc/now081.22","title":"QOS-22IS A SEPARATE AFTERCARE CLINIC FOR PEDIATRIC CNS TUMOR PATIENTS NECESSARY?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine","score_opus":0.037537654531968445,"score_gpt":0.34171858505013525,"score_spread":0.3041809305181668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433128876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9004894,0.011318835,0.00247674,0.03564283,0.0031390097,0.0003912073,0.0011233761,0.00054733944,0.044871245],"genre_scores_gemma":[0.9707847,0.0045145764,0.005776924,0.0069888816,0.0015675231,0.00023425635,0.0010682506,0.000117617725,0.008947159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895895,0.00023723583,0.00009160372,0.00013426573,0.0001812073,0.00039673128],"domain_scores_gemma":[0.9939843,0.0005415567,0.0013429641,0.00015029035,0.0003913306,0.003589533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005084962,0.0002640593,0.00030466414,0.00038497755,0.0017760297,0.001153343,0.0008603832,0.000977941,0.032201648],"category_scores_gemma":[0.0027593,0.00017285053,0.00046359905,0.00045395226,0.0005524054,0.0011349499,0.0013438002,0.0015004905,0.002466598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000584753,0.0015616465,0.54834825,0.0009143024,0.00011187624,0.055212054,0.002958785,0.00027988822,0.0035199395,0.0013628615,0.12485288,0.2602928],"study_design_scores_gemma":[0.00013243957,0.0013498262,0.7119054,0.002042853,0.00013755614,0.09767993,0.022418546,0.00041410932,0.0017076132,0.0011179732,0.16099149,0.000102192425],"about_ca_topic_score_codex":0.002728882,"about_ca_topic_score_gemma":0.0101544,"teacher_disagreement_score":0.032201648,"about_ca_system_score_codex":0.0011534062,"about_ca_system_score_gemma":0.0029047264,"threshold_uncertainty_score":0.10772526},"labels":[],"label_agreement":null},{"id":"W2433847111","doi":"10.1093/neuonc/now073.49","title":"HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Izaak Walton Killam Health Centre; University of Manitoba; Mount Sinai Hospital; CancerCare Manitoba; Research Institute in Oncology and Hematology; SickKids Foundation; Université Laval; Hospital for Sick Children","funders":"","keywords":"Glioblastoma; DNA mismatch repair; Immune system; Medicine; Cancer research; DNA repair; Immunology; Biology; Genetics; Gene","score_opus":0.01615819160788658,"score_gpt":0.29986809272157305,"score_spread":0.2837099011136865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433847111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967647,0.0000997425,0.000053940214,0.0000056634267,5.5854457e-7,0.0000015337719,0.000053972224,0.000003935494,0.0001040981],"genre_scores_gemma":[0.9996506,0.000055910623,0.00009627949,0.000006049333,6.1918524e-7,0.0000019760712,0.00013513626,0.0000022484135,0.00005128514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998679,0.000023507919,0.000016866235,0.000027930033,0.000028831279,0.00003482907],"domain_scores_gemma":[0.99950755,0.000111801026,0.00023874939,0.000019128653,0.000036483954,0.00008623427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018786834,0.00019410154,0.00024429848,0.0005247796,0.000115704985,0.00026555773,0.00012317368,0.0002435963,0.0008590422],"category_scores_gemma":[0.0010933559,0.00014246716,0.00014452751,0.00040039155,0.00017470669,0.00016758418,0.00022023731,0.00019524456,0.00018693774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036674982,0.000022392813,0.9848396,0.000012243247,0.000020239733,0.00042330864,0.00006178362,0.00028588815,0.008697015,0.000020197274,0.00008915884,0.00516145],"study_design_scores_gemma":[0.0000035431683,0.000116624105,0.99602,0.0000034729478,0.00001409529,0.0013704523,0.00006267809,0.00043968527,0.0018242698,0.000017591059,0.00012512179,0.0000024282244],"about_ca_topic_score_codex":0.0031980479,"about_ca_topic_score_gemma":0.004123816,"teacher_disagreement_score":0.0031980479,"about_ca_system_score_codex":0.00034159893,"about_ca_system_score_gemma":0.00015815684,"threshold_uncertainty_score":0.006358862},"labels":[],"label_agreement":null},{"id":"W2434544329","doi":"10.1093/neuonc/now068.12","title":"CR-12INTRACYSTIC INTERFERON-ALPHA IN PAEDIATRIC CRANIOPHARYNGIOMA PATIENTS: AN INTERNATIONAL MULTI-CENTRE ASSESSMENT ON BEHALF OF SIOP-E AND ISPN","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; Children's Hospital of Winnipeg","funders":"","keywords":"Craniopharyngioma; Medicine; Alpha interferon; Pediatrics; Alpha (finance); Internal medicine; Interferon; Virology; Surgery","score_opus":0.01609451955740978,"score_gpt":0.3146385904288811,"score_spread":0.29854407087147133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434544329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946232,0.0025828776,0.00016127796,0.0004746452,0.000020772142,0.00006332467,0.0003661951,0.00000959589,0.0016981432],"genre_scores_gemma":[0.99597013,0.0024048807,0.0006251211,0.00016428647,0.000042034335,0.000074917654,0.000533616,0.0000068258432,0.00017821754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861646,0.0005711391,0.00020842844,0.0001637425,0.00030868745,0.00013156817],"domain_scores_gemma":[0.99537045,0.00058397977,0.0026031095,0.00015293997,0.00067820866,0.0006112601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029138098,0.00024122912,0.00034026534,0.00079336425,0.000408509,0.0010771655,0.00034799945,0.00038029542,0.00086378725],"category_scores_gemma":[0.0046354965,0.00017992435,0.00029443792,0.0015395288,0.00038103556,0.0005186089,0.0008787237,0.00044318932,0.00022251415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033274243,0.00004696913,0.9778209,0.00011227289,0.000039259638,0.0005939955,0.001175389,0.00007825916,0.0005227085,0.000048849157,0.00066552265,0.018563047],"study_design_scores_gemma":[0.000030468997,0.0005319318,0.9895315,0.00015892186,0.00005573359,0.0042274226,0.0019723908,0.00018721876,0.00017592472,0.000020077528,0.0030972867,0.000011002586],"about_ca_topic_score_codex":0.002084593,"about_ca_topic_score_gemma":0.0020156126,"teacher_disagreement_score":0.0029138098,"about_ca_system_score_codex":0.00051569904,"about_ca_system_score_gemma":0.0010640221,"threshold_uncertainty_score":0.015409827},"labels":[],"label_agreement":null},{"id":"W2434976182","doi":"10.1093/neuonc/now076.99","title":"MB-104GENETIC PREDICTORS OF INTELLECTUAL OUTCOME IN CHILDREN TREATED FOR MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Outcome (game theory); Pediatrics; Medicine; Psychology; Pathology; Mathematics","score_opus":0.01828709177023061,"score_gpt":0.30129577749920133,"score_spread":0.2830086857289707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434976182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990308,0.00028048558,0.000051225932,0.000039084975,0.00000339829,0.0000038094372,0.00046005112,0.0000054182638,0.00012564624],"genre_scores_gemma":[0.99889874,0.00016649364,0.00012925327,0.000014294601,0.0000054379834,0.000010482527,0.0006792439,0.000004887024,0.000091138034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997733,0.000040036888,0.000022409535,0.00004045964,0.00006659588,0.00005713227],"domain_scores_gemma":[0.9989784,0.00022283892,0.00050171954,0.00003619046,0.000068991474,0.00019197409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027809353,0.00030728427,0.00030231496,0.0008298027,0.00036372562,0.00037439333,0.00039900118,0.00034381016,0.0015122815],"category_scores_gemma":[0.0016361986,0.00015145527,0.0002482914,0.0010558164,0.0003323016,0.00016905688,0.00036848706,0.0006253485,0.00020521537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000915554,0.000014887141,0.99814737,0.00000555725,0.000018588284,0.00009158543,0.000028908153,0.00005367256,0.00046437947,0.000007680224,0.00006533249,0.0010105551],"study_design_scores_gemma":[0.0000044832636,0.00005327423,0.99910456,0.0000031341804,0.000018418335,0.00034226588,0.000057370617,0.00009576677,0.0001652637,0.000012588021,0.00014152574,0.0000013484442],"about_ca_topic_score_codex":0.008831459,"about_ca_topic_score_gemma":0.0076578585,"teacher_disagreement_score":0.008831459,"about_ca_system_score_codex":0.00049835176,"about_ca_system_score_gemma":0.00038584007,"threshold_uncertainty_score":0.017560124},"labels":[],"label_agreement":null},{"id":"W2434988104","doi":"10.1093/neuonc/now073.81","title":"HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Bevacizumab; Pediatrics; Surgery","score_opus":0.04760235000277003,"score_gpt":0.3328194419502419,"score_spread":0.28521709194747186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434988104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72242653,0.06101842,0.1051258,0.011722459,0.0041715885,0.0620872,0.0036246085,0.0020109212,0.027812492],"genre_scores_gemma":[0.9280258,0.0026504935,0.037417263,0.0027852624,0.00078107545,0.02280336,0.0015795155,0.00043335758,0.0035239116],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.4260045,0.5100269,0.022963008,0.015699351,0.022776594,0.0025297035],"domain_scores_gemma":[0.4408858,0.3185852,0.090068065,0.07375011,0.07099684,0.005714048],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.501342,0.0008586196,0.00394832,0.0013574822,0.0018592452,0.0037400245,0.00268309,0.002834029,0.0034619886],"category_scores_gemma":[0.44542372,0.0014499852,0.0018135865,0.001828103,0.0028226129,0.0025153188,0.0050073355,0.0022795147,0.0013890808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19504021,0.0016484426,0.11698686,0.01387222,0.006124328,0.00082143204,0.019194402,0.004166006,0.008325868,0.0057450463,0.035125256,0.5929498],"study_design_scores_gemma":[0.12054604,0.0643429,0.4720797,0.014238464,0.0113646425,0.0033933846,0.0047846613,0.032008268,0.031173334,0.015982822,0.22867763,0.0014080816],"about_ca_topic_score_codex":0.0027264706,"about_ca_topic_score_gemma":0.0031152456,"teacher_disagreement_score":0.501342,"about_ca_system_score_codex":0.004044753,"about_ca_system_score_gemma":0.009601346,"threshold_uncertainty_score":0.61493415},"labels":[],"label_agreement":null},{"id":"W2435047036","doi":"10.1093/neuonc/now067.07","title":"PNR-08NEWLY DISCOVERED ONCOGENES DRIVING AND MAINTAINING CHOROID PLEXUS CARCINOMA PROVIDE POTENTIALLY DRUGGABLE TARGETS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Druggability; Choroid plexus; Biology; Cancer research; Computational biology; Neuroscience; Biochemistry; Gene","score_opus":0.03258160936721553,"score_gpt":0.2625942363159084,"score_spread":0.23001262694869284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435047036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490562,0.018912233,0.011157963,0.0011220188,0.00022360586,0.00030443908,0.0034059896,0.00094248576,0.01487517],"genre_scores_gemma":[0.9596731,0.009499744,0.010687639,0.00028967208,0.000043140248,0.00018969749,0.004916035,0.000089881134,0.014611232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999869,0.000016201073,0.000010841674,0.00003154784,0.000042988526,0.000029373949],"domain_scores_gemma":[0.9999182,0.000010558233,0.000023774131,0.000014719339,0.000010275146,0.00002251566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020303419,0.000380118,0.00027928816,0.00034915205,0.00014834979,0.00043006218,0.00030663106,0.00039315017,0.0033792707],"category_scores_gemma":[0.00013158347,0.0001461718,0.00033254275,0.0002391039,0.00021305283,0.0002993154,0.00027754102,0.00081914413,0.0011636169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001571572,0.000069229776,0.0010379646,0.00011700192,0.00001438921,0.00028020816,0.000016212387,0.00015887726,0.9874893,0.0007467809,0.00039238136,0.009520625],"study_design_scores_gemma":[0.00008888979,0.0009788398,0.012735887,0.000040022656,0.000090399546,0.0028329152,0.00007346137,0.0013975642,0.9291067,0.00043979118,0.05220232,0.000013136478],"about_ca_topic_score_codex":0.0005820207,"about_ca_topic_score_gemma":0.001123906,"teacher_disagreement_score":0.0033792707,"about_ca_system_score_codex":0.0004639516,"about_ca_system_score_gemma":0.00038801416,"threshold_uncertainty_score":0.011304855},"labels":[],"label_agreement":null},{"id":"W2435059843","doi":"10.1093/neuonc/now075.73","title":"LG-73CHARACTERIZATION OF GANGLIOGLIOMA AS A NEURODEVELOPMENTAL DISORDER","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Ganglioglioma; Neurodevelopmental disorder; Medicine; Psychology; Neuroscience; Psychiatry; Epilepsy","score_opus":0.013215023937970461,"score_gpt":0.2796210293097645,"score_spread":0.26640600537179404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435059843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852615,0.00215448,0.00039439628,0.00021561993,0.000019555235,0.000047764544,0.0017015178,0.0000684896,0.010136743],"genre_scores_gemma":[0.9952636,0.0011778413,0.00039618264,0.00007842307,0.000015513713,0.000019829497,0.0016725988,0.000016711094,0.0013593704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998349,0.000009438088,0.000012287772,0.000028603485,0.00006384215,0.00005082499],"domain_scores_gemma":[0.99983644,0.000013122592,0.000054117507,0.000007734071,0.000036683065,0.000051890613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012613375,0.00069107575,0.00020890024,0.0017139455,0.00049115106,0.00040447857,0.00041719287,0.00032234646,0.0029227508],"category_scores_gemma":[0.0003882702,0.000076356686,0.00018671577,0.0015159169,0.00041975372,0.00016610244,0.00041279595,0.00021086156,0.00069252687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041287328,0.000060941402,0.8200579,0.0001732546,0.000072115276,0.08397287,0.0005466655,0.00030869423,0.05617554,0.00084509485,0.003577354,0.03379664],"study_design_scores_gemma":[0.0000103644825,0.000103938866,0.9069377,0.00008689346,0.00009114568,0.07283031,0.00052048644,0.00030141522,0.009323491,0.00037774653,0.0094043845,0.00001215905],"about_ca_topic_score_codex":0.021410454,"about_ca_topic_score_gemma":0.019026635,"teacher_disagreement_score":0.021410454,"about_ca_system_score_codex":0.0010056869,"about_ca_system_score_gemma":0.0010618491,"threshold_uncertainty_score":0.042571664},"labels":[],"label_agreement":null},{"id":"W2435135167","doi":"10.1093/neuonc/now075.02","title":"LG-02MYB-QKI REARRANGEMENTS IN ANGIOCENTRIC GLIOMA DRIVE TUMORIGENICITY THROUGH A TRIPARTITE MECHANISM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Mechanism (biology); Glioma; Biology; Genetics; Philosophy; Epistemology","score_opus":0.02755740331996481,"score_gpt":0.31406896547571256,"score_spread":0.28651156215574775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435135167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956071,0.00045259562,0.002001863,0.000046020043,0.0000027031851,0.00001580288,0.0008302142,0.00007162797,0.0009720676],"genre_scores_gemma":[0.9974591,0.00017336236,0.0010625928,0.00003774945,0.000002769451,0.000010963466,0.00104515,0.000013794349,0.00019448597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984527,0.00002095739,0.00001208714,0.000046602236,0.000039189053,0.00003584691],"domain_scores_gemma":[0.9997453,0.000049851504,0.0001228561,0.000025253275,0.00002267922,0.000034020908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025623597,0.00022296056,0.0001605204,0.0005117428,0.00015163489,0.00035840468,0.0001953358,0.00020597303,0.0012151708],"category_scores_gemma":[0.0005578277,0.00014091426,0.00017829698,0.00044493141,0.00025113026,0.00019795494,0.00042484328,0.00021098503,0.0005029708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004848792,0.000041209656,0.36715287,0.0002117428,0.00013903472,0.0018115959,0.00027638875,0.0015094429,0.6067477,0.0008566379,0.00068570557,0.020082777],"study_design_scores_gemma":[0.0000419223,0.0003021868,0.9060704,0.000063922045,0.00015723796,0.007826819,0.0002774508,0.0053070793,0.072054856,0.0011732327,0.0067008836,0.000024059997],"about_ca_topic_score_codex":0.0010175975,"about_ca_topic_score_gemma":0.0022214423,"teacher_disagreement_score":0.0012151708,"about_ca_system_score_codex":0.00031853328,"about_ca_system_score_gemma":0.000253237,"threshold_uncertainty_score":0.0040650964},"labels":[],"label_agreement":null},{"id":"W2435392671","doi":"10.1093/neuonc/now075.66","title":"LG-66CLINICAL AND TREATMENT FACTORS DETERMINING LONG-TERM OUTCOMES FOR ADULT SURVIVORS OF CHILDHOOD LOW-GRADE GLIOMA: A POPULATION-BASED STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Glioma; Term (time); Medicine; Pediatrics; Physics; Cancer research","score_opus":0.034365346073860555,"score_gpt":0.3590180884324387,"score_spread":0.32465274235857816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435392671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919564,0.00014168341,0.000026337108,0.000020165282,0.0000012540931,0.0000043745945,0.00041630166,0.0000016560537,0.00019263083],"genre_scores_gemma":[0.9992955,0.00008738572,0.000020712861,0.000010874069,0.0000023820278,0.0000030187473,0.0005044299,8.968796e-7,0.00007484875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997845,0.00002239135,0.000017561786,0.000051570216,0.000062046645,0.00006193067],"domain_scores_gemma":[0.99942267,0.00003414408,0.00029916168,0.000043387583,0.00009016956,0.00011042603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026634682,0.00023761195,0.00023241832,0.0004286029,0.0004276306,0.00045494628,0.00040877855,0.00028199158,0.0008773843],"category_scores_gemma":[0.00095025456,0.00018214434,0.00028555767,0.0009873107,0.00029751193,0.00032316186,0.00030627724,0.00033429803,0.00018981403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002580102,0.0000057570355,0.9994837,0.0000023186021,0.000009391315,0.000022273965,0.000028226996,0.000008528543,0.00005448622,0.0000025196312,0.000028785396,0.00032807045],"study_design_scores_gemma":[0.0000016251768,0.000024088695,0.99971896,0.0000015959166,0.000007950012,0.00006760798,0.00007020791,0.00002426827,0.000011068099,0.0000031753,0.00006860084,8.708898e-7],"about_ca_topic_score_codex":0.1446944,"about_ca_topic_score_gemma":0.21723847,"teacher_disagreement_score":0.1446944,"about_ca_system_score_codex":0.00146639,"about_ca_system_score_gemma":0.001226389,"threshold_uncertainty_score":0.28770435},"labels":[],"label_agreement":null},{"id":"W2435539542","doi":"10.1093/neuonc/now073.69","title":"HG-73SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Biopsy; Pediatrics; Radiology; Oncology","score_opus":0.020527483600202904,"score_gpt":0.2981912618108964,"score_spread":0.2776637782106935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435539542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618983,0.0006438576,0.0002914172,0.00073891785,0.00008168372,0.00059435784,0.00058093463,0.000033880006,0.0008450154],"genre_scores_gemma":[0.9958198,0.00043089167,0.00079938327,0.0006962826,0.000057932568,0.00066009973,0.000954313,0.000015884973,0.00056536886],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991768,0.00038005132,0.000028924418,0.000126285,0.00006438581,0.00022340522],"domain_scores_gemma":[0.999102,0.00020829386,0.00012164525,0.00007963042,0.00004325325,0.0004453109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019115319,0.0007500391,0.0008233218,0.00023217867,0.00043096137,0.0011972352,0.0007085831,0.0016421706,0.002710196],"category_scores_gemma":[0.0018446267,0.000360817,0.0013612069,0.0002997349,0.0011665635,0.00083921675,0.00044469396,0.0027332068,0.0005018492],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78014004,0.03674032,0.026364902,0.00027381608,0.0015843739,0.00036772998,0.0004352466,0.004027038,0.020421362,0.00089988485,0.0045101955,0.124235064],"study_design_scores_gemma":[0.49106994,0.45876497,0.038692355,0.00006758776,0.0009373412,0.00033996752,0.00023782768,0.001967958,0.003392825,0.0006964114,0.003782321,0.00005058938],"about_ca_topic_score_codex":0.003463542,"about_ca_topic_score_gemma":0.00815869,"teacher_disagreement_score":0.003463542,"about_ca_system_score_codex":0.0013273414,"about_ca_system_score_gemma":0.0029937723,"threshold_uncertainty_score":0.010109305},"labels":[],"label_agreement":null},{"id":"W2435972166","doi":"10.1093/neuonc/now072.03","title":"GC-03AREAS OF NON-CONSENSUS CHALLENGING THE MANAGEMENT OF INTRACRANIAL GERM CELL TUMOURS (ICGCT)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germ cell; Consensus conference; Germ; Medicine; Internal medicine; Biology; Cell biology","score_opus":0.01758511183545345,"score_gpt":0.27679278278108105,"score_spread":0.2592076709456276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435972166","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12968664,0.1455412,0.040093467,0.46761268,0.017436996,0.005701465,0.0013838779,0.00042824284,0.19211543],"genre_scores_gemma":[0.73099554,0.05935709,0.0643738,0.10828917,0.005694551,0.0059901555,0.0022722194,0.00043429682,0.022593131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9050327,0.07515418,0.0068488116,0.0025664312,0.007539633,0.0028581885],"domain_scores_gemma":[0.9350165,0.03736654,0.004394655,0.003143301,0.015558145,0.0045208703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07123648,0.00061060104,0.00073593884,0.0015834038,0.0029237957,0.0057463767,0.0017961415,0.0043795872,0.00890113],"category_scores_gemma":[0.07262458,0.00045279125,0.0011201985,0.002125139,0.005470769,0.0045473548,0.009119496,0.004575658,0.0019556808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031185514,0.00018342251,0.025564086,0.014684868,0.00018441862,0.0035052318,0.049606983,0.000854477,0.005019545,0.056711443,0.20463915,0.6387345],"study_design_scores_gemma":[0.00009918658,0.00037733157,0.02265248,0.033511896,0.000103441416,0.008175425,0.0922474,0.0012747159,0.0020376877,0.05041187,0.7889586,0.00014990503],"about_ca_topic_score_codex":0.0030605157,"about_ca_topic_score_gemma":0.0035897202,"teacher_disagreement_score":0.07123648,"about_ca_system_score_codex":0.005805691,"about_ca_system_score_gemma":0.019238451,"threshold_uncertainty_score":0.37673903},"labels":[],"label_agreement":null},{"id":"W2436034443","doi":"10.1093/neuonc/now078.09","title":"NS-09NARCOLEPSY AND BRAIN TUMORS: PRESENTATION AND EVOLUTION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Presentation (obstetrics); Neuroscience; Brain tumor; Cognitive science; Psychology; History; Computer science; Medicine; Pathology; Radiology","score_opus":0.0270223884742118,"score_gpt":0.35236595476827015,"score_spread":0.32534356629405836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436034443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992926,0.0022475538,0.0006295679,0.00037401702,0.00007129562,0.000039510025,0.00017864263,0.00004706187,0.0034864303],"genre_scores_gemma":[0.9971168,0.0011700684,0.0004527734,0.00018833857,0.00018256089,0.0000150567075,0.00017115827,0.000013117973,0.0006901903],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99975437,0.000020434418,0.00003375144,0.00007316102,0.000038015827,0.00008027659],"domain_scores_gemma":[0.99923897,0.00014237875,0.00032130282,0.000053824035,0.000047435802,0.00019616718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000165259,0.0010965155,0.00060319464,0.0012588516,0.0011544576,0.00087772956,0.00045698235,0.0018252885,0.0020465292],"category_scores_gemma":[0.0010948745,0.00065012346,0.0004814319,0.00074965606,0.0008095888,0.00080645934,0.00088916154,0.0012341988,0.00073043373],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000266243,0.000028305552,0.03822585,0.00003544263,0.000011752611,0.9586666,0.00013493499,0.000039347906,0.0015133607,0.0000655,0.00018378426,0.0010684691],"study_design_scores_gemma":[0.000004570531,0.000055441393,0.017000195,0.000008689737,0.000008874548,0.9821016,0.00009570793,0.0000537527,0.00021062745,0.000035053956,0.00042108799,0.0000043679534],"about_ca_topic_score_codex":0.0013329599,"about_ca_topic_score_gemma":0.0021451886,"teacher_disagreement_score":0.0020465292,"about_ca_system_score_codex":0.00048001666,"about_ca_system_score_gemma":0.00046042414,"threshold_uncertainty_score":0.0068463087},"labels":[],"label_agreement":null},{"id":"W2436093430","doi":"10.1093/neuonc/now081.57","title":"QOS-57BEHAVIOR IN SURVIVORS OF PEDIATRIC MEDULLOBLASTOMA: THE IMPACT OF COGNITIVE FLEXIBILITY, INTELLIGENCE, AND NEGATIVE AFFECT","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Affect (linguistics); Medulloblastoma; Flexibility (engineering); Cognition; Cognitive flexibility; Psychology; Medicine; Neuroscience; Cancer research; Communication","score_opus":0.03962540558939532,"score_gpt":0.3626321325291585,"score_spread":0.3230067269397632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436093430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99951816,0.00011626944,0.00003809259,0.000031824515,0.0000017259846,0.000003065346,0.000085371095,0.000003234879,0.00020226355],"genre_scores_gemma":[0.9995505,0.000095012714,0.00005387353,0.000007654873,0.00000212909,0.000004848835,0.00017088985,0.0000011512689,0.00011389701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997509,0.000095157186,0.000022106093,0.000027841668,0.000056456993,0.00004759196],"domain_scores_gemma":[0.99893206,0.00016791602,0.000595878,0.00004056834,0.00008131007,0.00018219586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004830249,0.000246589,0.00021232138,0.00060139154,0.00026514207,0.00038442967,0.00014277535,0.0001700252,0.0011297615],"category_scores_gemma":[0.002177308,0.0001147249,0.00048472433,0.00051956234,0.00020473987,0.00018067047,0.00038654695,0.00040243033,0.00010074406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005164111,0.000023460909,0.99684685,0.0000061644514,0.00002816034,0.00003800531,0.00008089804,0.00006903072,0.00012125983,0.000010429597,0.000027284932,0.0026967237],"study_design_scores_gemma":[0.0000012834541,0.00008321948,0.9994429,0.0000030484866,0.000016407637,0.000075269345,0.000089566995,0.00013739271,0.000057222864,0.000012902303,0.00007954236,0.0000011307351],"about_ca_topic_score_codex":0.0095181195,"about_ca_topic_score_gemma":0.012670347,"teacher_disagreement_score":0.0095181195,"about_ca_system_score_codex":0.00043675493,"about_ca_system_score_gemma":0.00044365216,"threshold_uncertainty_score":0.018925428},"labels":[],"label_agreement":null},{"id":"W2436476450","doi":"10.1093/neuonc/now076.87","title":"MB-91OUTCOMES FOR YOUNG CHILDREN WITH BRAIN TUMOURS TREATED ACCORDING TO THE HEAD START PROTOCOLS: A SINGLE-CENTRE EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Head start; Head (geology); Medicine; Pediatrics; Psychology; Developmental psychology; Biology","score_opus":0.046497437582261984,"score_gpt":0.33984237233395276,"score_spread":0.29334493475169077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436476450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975908,0.0009969159,0.00009491608,0.00005839775,0.000005340071,0.00004406513,0.0003084263,0.0000110644,0.00088997587],"genre_scores_gemma":[0.99673414,0.0016717571,0.000421895,0.00008301776,0.0000123525815,0.00005304666,0.00060406444,0.000011943772,0.00040782575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996216,0.000093090755,0.00004375969,0.00004399301,0.000101367776,0.00009611762],"domain_scores_gemma":[0.99865425,0.00023200808,0.0006562272,0.00005540168,0.00011434599,0.00028782597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046372612,0.00019763337,0.0002964174,0.0004598719,0.00049297325,0.000495045,0.00034502402,0.00020130548,0.0016869475],"category_scores_gemma":[0.0018714936,0.00016474185,0.00021428763,0.0009414406,0.00036691368,0.00025046695,0.0004769817,0.00030262122,0.00030675475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028179956,0.000117144526,0.9685061,0.00012406957,0.00005127113,0.0026646287,0.0012289978,0.0001518159,0.00091917807,0.0000665334,0.0011861726,0.02470229],"study_design_scores_gemma":[0.000075200915,0.0012465224,0.97099745,0.000105943334,0.00008565205,0.016997749,0.0018856827,0.00012627721,0.0012918503,0.000043361128,0.0071268054,0.000017434491],"about_ca_topic_score_codex":0.018784601,"about_ca_topic_score_gemma":0.05106935,"teacher_disagreement_score":0.018784601,"about_ca_system_score_codex":0.00184146,"about_ca_system_score_gemma":0.0018360968,"threshold_uncertainty_score":0.037350535},"labels":[],"label_agreement":null},{"id":"W2436556474","doi":"10.1093/neuonc/now073.71","title":"HG-75CLINICAL, RADIOLOGICAL, AND HISTO-GENETIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A COLLABORATIVE REPORT FROM THE INTERNATIONAL AND SIOP-E DIPG REGISTRIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Radiological weapon; Term (time); Glioma; Medicine; Oncology; Pediatrics; Radiology; Physics; Cancer research","score_opus":0.02394404100340454,"score_gpt":0.29784512720077844,"score_spread":0.2739010861973739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436556474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707675,0.00028503546,0.00012718163,0.00003211959,0.000003559513,0.000013684676,0.001993307,0.000006798806,0.0004614889],"genre_scores_gemma":[0.9959947,0.00023636229,0.000076775934,0.000016601269,0.000005804475,0.00001781384,0.003572182,0.0000033764084,0.000076296834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931884,0.0001334772,0.000096351585,0.00015924021,0.00017698732,0.000115021525],"domain_scores_gemma":[0.9979267,0.00026504896,0.0009283765,0.0001942423,0.00033623248,0.00034936116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00165885,0.00019933132,0.00035170992,0.0012860273,0.00031730422,0.0005954391,0.0004469674,0.00020543151,0.00047048656],"category_scores_gemma":[0.0024943112,0.00013180196,0.00032098975,0.0019244702,0.00021981291,0.00032228284,0.0007232322,0.00020556142,0.00015740235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035485038,0.0000055650094,0.9985863,0.0000065420672,0.00002383373,0.000047954556,0.000070656286,0.000027311959,0.00005532611,0.0000065013414,0.00012489744,0.0010096628],"study_design_scores_gemma":[0.000002328282,0.000022167029,0.99934036,0.000005114267,0.00002326532,0.00017860126,0.00014204693,0.00003779036,0.000025746738,0.0000051443167,0.0002157844,0.0000016641657],"about_ca_topic_score_codex":0.013256618,"about_ca_topic_score_gemma":0.009557215,"teacher_disagreement_score":0.013256618,"about_ca_system_score_codex":0.0004907563,"about_ca_system_score_gemma":0.0007125822,"threshold_uncertainty_score":0.026358902},"labels":[],"label_agreement":null},{"id":"W2436761352","doi":"10.1093/neuonc/now065.10","title":"AT-11CRIBRIFORM NEUROEPITHELIAL TUMOR (CRINET): MOLECULAR CHARACTERIZATION OF A SMARCB1-DEFICIENT NON-RHABDOID TUMOR WITH FAVORABLE LONG-TERM OUTCOME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"SMARCB1; Neuroepithelial cell; Term (time); Outcome (game theory); Biology; Genetics; Physics; Embryonic stem cell; Astronomy; Gene","score_opus":0.01047996471295197,"score_gpt":0.25944317275410983,"score_spread":0.24896320804115785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436761352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855965,0.0002310255,0.00034346114,0.000009665507,0.0000018256441,0.000025517924,0.00020384332,0.000010583601,0.00061447284],"genre_scores_gemma":[0.9981686,0.00012687329,0.00083510956,0.000008023044,0.000003831515,0.000015276812,0.00049228704,0.0000070707297,0.00034305497],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998405,0.000014045244,0.000017164602,0.00005196585,0.00003957352,0.00003674589],"domain_scores_gemma":[0.99953496,0.00006181909,0.00010529238,0.000052656662,0.00004290807,0.00020236343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023627252,0.00025209296,0.0003656071,0.0006063204,0.00032305683,0.0003617461,0.00028189184,0.0002742653,0.0012250318],"category_scores_gemma":[0.00041285477,0.00013879657,0.00017119813,0.00046454946,0.0003120694,0.0001913397,0.00040103254,0.00031537557,0.0003585166],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016992862,0.00029768288,0.7391885,0.00018755754,0.00010411886,0.057272624,0.0003167511,0.00062522397,0.17265643,0.00017885178,0.00044273352,0.027030202],"study_design_scores_gemma":[0.00005349724,0.0014069384,0.79036295,0.000017439977,0.000075414355,0.18859708,0.0002306326,0.0014386172,0.016048577,0.000074436015,0.0016774241,0.000016876267],"about_ca_topic_score_codex":0.0019019879,"about_ca_topic_score_gemma":0.0041399854,"teacher_disagreement_score":0.0019019879,"about_ca_system_score_codex":0.00053806097,"about_ca_system_score_gemma":0.00038203466,"threshold_uncertainty_score":0.0040981174},"labels":[],"label_agreement":null},{"id":"W2436846717","doi":"10.1093/neuonc/now065.09","title":"AT-10ATYPICAL TERATOID RHABDOID TUMORS AND POORLY DIFFERENTIATED CHORDOMAS: DISTINCT MOLECULAR ENTITIES WITH SMARCB1/INI1 LOSS AND DISMAL PROGNOSIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.0066009340988724035,"score_gpt":0.23163886382254845,"score_spread":0.22503792972367603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436846717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988943,0.00018054081,0.00043323432,0.0000100312545,0.0000016970853,0.000008873521,0.00014654644,0.0000067756123,0.00031809337],"genre_scores_gemma":[0.9990163,0.00007707925,0.00047616073,0.0000068230065,0.0000019796976,0.0000064087903,0.00025045706,0.0000039366705,0.00016093184],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975735,0.00003065005,0.000033564404,0.00006542352,0.00006337159,0.00004960545],"domain_scores_gemma":[0.99942124,0.00006737046,0.00024425422,0.000046889294,0.000044791006,0.00017552834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002275737,0.00019308887,0.00024663465,0.0006698284,0.00021572264,0.00048244488,0.00022203856,0.00020407527,0.00092660467],"category_scores_gemma":[0.00041985957,0.00015955507,0.00021498713,0.0003589549,0.00042432544,0.00020020254,0.0003601625,0.00031075682,0.0002760447],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011984083,0.0000328494,0.8662445,0.000044694785,0.00005001804,0.0061366023,0.00034791525,0.00019720038,0.11807715,0.00021878006,0.000083501254,0.0073683453],"study_design_scores_gemma":[0.000023002616,0.00033345458,0.9656153,0.000008434876,0.000038862716,0.023114935,0.00035694166,0.00060837046,0.009020774,0.00019223962,0.00067555247,0.000012055469],"about_ca_topic_score_codex":0.0012756779,"about_ca_topic_score_gemma":0.0019078336,"teacher_disagreement_score":0.0012756779,"about_ca_system_score_codex":0.0003068109,"about_ca_system_score_gemma":0.00020548774,"threshold_uncertainty_score":0.0030998588},"labels":[],"label_agreement":null},{"id":"W2437260606","doi":"10.1093/neuonc/now067.27","title":"PNR-32UPDATE OF DIAGNOSTICS OF PRIMITIVE NEUROECTODERMAL TUMOURS OF THE CNS - NEUROPATHOLOGICAL RE-EVALUATION OF 99 CASES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pathology; Primitive neuroectodermal tumor; Medicine; Sarcoma","score_opus":0.06094340963463505,"score_gpt":0.33819631169282166,"score_spread":0.2772529020581866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2437260606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983133,0.0029445211,0.0016257158,0.00015512126,0.000066325585,0.00012839012,0.0010718239,0.00010485354,0.010770215],"genre_scores_gemma":[0.99258125,0.0017156594,0.0019668303,0.00010834437,0.000030546034,0.00005256427,0.0018969412,0.000048473732,0.0015993885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831676,0.0002827181,0.0003369203,0.0003378914,0.0004932338,0.00023244938],"domain_scores_gemma":[0.9970687,0.00045734248,0.00067036954,0.00072719366,0.00087123667,0.00020520166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019657088,0.0003218812,0.0002456574,0.0032451244,0.00060371397,0.00072599127,0.00081394735,0.0003747188,0.0016715084],"category_scores_gemma":[0.004186878,0.00023791617,0.00042255945,0.001750661,0.0007267898,0.0005741406,0.00086002506,0.00028837047,0.0010230336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004092858,0.000050601444,0.83620936,0.00037072477,0.00008334052,0.06206017,0.0012982606,0.00052536925,0.019235788,0.0005026558,0.0018212837,0.0774331],"study_design_scores_gemma":[0.000023215185,0.00022059378,0.7691192,0.00027058122,0.00018639922,0.17232302,0.0020625836,0.0011763257,0.024137476,0.0002825746,0.030162971,0.00003502311],"about_ca_topic_score_codex":0.0053784247,"about_ca_topic_score_gemma":0.006125907,"teacher_disagreement_score":0.0053784247,"about_ca_system_score_codex":0.00085511483,"about_ca_system_score_gemma":0.0009219723,"threshold_uncertainty_score":0.010694265},"labels":[],"label_agreement":null},{"id":"W2438121086","doi":"10.1093/neuonc/now065.08","title":"AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Chemotherapy; Medicine; Radiation therapy; Atypical teratoid rhabdoid tumor; Central nervous system; Oncology; Internal medicine","score_opus":0.005730640002571127,"score_gpt":0.21882018653247345,"score_spread":0.21308954652990234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438121086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951212,0.0014602062,0.000577829,0.00010883324,0.000015461575,0.000096101714,0.00025570337,0.000035017954,0.0023297383],"genre_scores_gemma":[0.99652255,0.00072662835,0.0011279378,0.00011574765,0.000018157109,0.000048067865,0.00076653104,0.000005438806,0.00066909695],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99989617,0.00002318419,0.000010252955,0.000023043513,0.00002446178,0.000022857404],"domain_scores_gemma":[0.99986136,0.000021511169,0.00003450521,0.000017449975,0.000011161497,0.000053949883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018339297,0.0001711136,0.00016702343,0.00020334203,0.00025165567,0.0001726229,0.00026562178,0.00016276247,0.0011374175],"category_scores_gemma":[0.00016697981,0.000084813146,0.0002530468,0.0002076341,0.00020643449,0.00015774596,0.00015844664,0.0004382845,0.00033838116],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005866675,0.003976136,0.53941154,0.00037287746,0.0005950586,0.011753376,0.00035443125,0.002424832,0.095049635,0.0005758218,0.0067529785,0.3328666],"study_design_scores_gemma":[0.001186394,0.025406362,0.85694253,0.00008017995,0.00028267168,0.056009836,0.00016055905,0.0018246373,0.031760596,0.00023686426,0.026079409,0.00002990525],"about_ca_topic_score_codex":0.0009906382,"about_ca_topic_score_gemma":0.0046277232,"teacher_disagreement_score":0.0011374175,"about_ca_system_score_codex":0.00047920793,"about_ca_system_score_gemma":0.0005174932,"threshold_uncertainty_score":0.0038049817},"labels":[],"label_agreement":null},{"id":"W2438390390","doi":"10.1093/neuonc/now076.95","title":"MB-100DIVERGENT CLONAL SELECTION DOMINATES MEDULLOBLASTOMA AT RECURRENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Selection (genetic algorithm); Biology; Clonal selection; Genetics; Computer science; Artificial intelligence; Immunology","score_opus":0.019034423263387792,"score_gpt":0.2942355282133359,"score_spread":0.2752011049499481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438390390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967908,0.00057305896,0.0011461289,0.000033487762,0.000003662659,0.000012914784,0.000110576104,0.000057087625,0.0012722056],"genre_scores_gemma":[0.99721825,0.00020438182,0.0006672425,0.00002581824,0.0000023345833,0.000011237174,0.0002060357,0.000021425007,0.0016432412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998258,0.000026477512,0.00000800714,0.000047416335,0.000057383568,0.000035088877],"domain_scores_gemma":[0.9998473,0.00003187832,0.00004125042,0.000022493416,0.00001820749,0.000038872517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016826324,0.00015280752,0.00028409754,0.00031062055,0.000114075934,0.0002678876,0.00016990594,0.0001923775,0.0013081757],"category_scores_gemma":[0.00016816218,0.00010692947,0.00010639589,0.0001245582,0.00021700372,0.00012772105,0.00017716983,0.00030974436,0.00023699403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014863048,0.000028385215,0.003619686,0.000013408738,0.000007809992,0.00006814527,0.00002985112,0.00008969897,0.9929455,0.000183904,0.000058616577,0.0028063739],"study_design_scores_gemma":[0.000037267924,0.0011506166,0.13283388,0.000008507351,0.000059446837,0.002121427,0.000119072785,0.0033991975,0.8522599,0.0002738448,0.0077269077,0.000009941889],"about_ca_topic_score_codex":0.0020862224,"about_ca_topic_score_gemma":0.0040793857,"teacher_disagreement_score":0.0020862224,"about_ca_system_score_codex":0.00038764605,"about_ca_system_score_gemma":0.00017981767,"threshold_uncertainty_score":0.004376292},"labels":[],"label_agreement":null},{"id":"W2438632591","doi":"10.1093/neuonc/now081.58","title":"QOS-58IMPACT OF CRANIAL RADIATION THERAPY ON HIPPOCAMPAL SUBFIELD VOLUMES AND DECLARATIVE MEMORY IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hippocampal formation; Radiation therapy; Medicine; Quality of life (healthcare); Neuroscience; Psychology; Oncology; Internal medicine; Psychotherapist","score_opus":0.01945249584809524,"score_gpt":0.296042248970589,"score_spread":0.2765897531224938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438632591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915004,0.00027044793,0.000045613026,0.000013983906,0.0000020621935,0.0000023384857,0.00008501716,0.0000033083902,0.00042726952],"genre_scores_gemma":[0.9995103,0.00013114153,0.000051813266,0.000007840887,0.0000029829641,0.00000424702,0.00014680754,0.0000018865712,0.0001429669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990606,0.000018059625,0.00000927142,0.000016936221,0.000029640092,0.000019930223],"domain_scores_gemma":[0.9996026,0.00007623075,0.00018912977,0.000017668312,0.00005365591,0.000060824583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019047796,0.00015268955,0.00018358072,0.00039337078,0.00016767945,0.00025837024,0.00013822982,0.000118169206,0.001835811],"category_scores_gemma":[0.0007957899,0.00005500361,0.00018592965,0.00032827616,0.00021627294,0.0001656689,0.00022072693,0.00017264397,0.0001558224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004304922,0.00003076253,0.9844321,0.000023466146,0.00005159011,0.0003426056,0.0001511716,0.00016811868,0.0018460653,0.00003215699,0.00013344332,0.012357992],"study_design_scores_gemma":[0.0000056054664,0.0003371628,0.99732095,0.000006828384,0.000030214476,0.00085392664,0.00014042859,0.00013208688,0.00081668224,0.00002959438,0.0003245538,0.0000018870005],"about_ca_topic_score_codex":0.0027704847,"about_ca_topic_score_gemma":0.0034654548,"teacher_disagreement_score":0.0027704847,"about_ca_system_score_codex":0.0003151916,"about_ca_system_score_gemma":0.00027227166,"threshold_uncertainty_score":0.006141424},"labels":[],"label_agreement":null},{"id":"W2438991415","doi":"10.1093/neuonc/now070.09","title":"EPN-10UPDATING THE PROGNOSTIC IMPORTANCE OF RESECTION STATUS AND CHROMOSOME 1q GAIN IN CHILDREN TREATED ACCORDING TO THE FIRST SIOP 1999-04 TRIAL FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Particle accelerators and beam dynamics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Medicine; Resection; Pediatrics; Surgery","score_opus":0.011645902050972897,"score_gpt":0.24976902485712116,"score_spread":0.23812312280614825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438991415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982419,0.0010169833,0.000055377488,0.00007486102,0.000008062222,0.000013943125,0.0001913927,0.0000031040838,0.00039439002],"genre_scores_gemma":[0.9986241,0.00030656054,0.00010406658,0.00005586072,0.000013947345,0.000021574648,0.0007281489,0.0000031872232,0.00014259489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993568,0.00032136645,0.00004386449,0.00007369228,0.00011309203,0.00009124054],"domain_scores_gemma":[0.9988625,0.00040592492,0.00042996745,0.00008130767,0.000039277646,0.00018098534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014922695,0.00017835513,0.000492014,0.00025582928,0.00014855505,0.0004436029,0.00024271233,0.00029345928,0.0005079863],"category_scores_gemma":[0.0018533876,0.00010969054,0.00042473376,0.00037547044,0.00039301225,0.00027838667,0.00026125184,0.000639213,0.000068950605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036012262,0.0003260233,0.9256628,0.0001204944,0.00052311434,0.0005039645,0.00015593937,0.0016888303,0.0036573852,0.00014838277,0.0010070878,0.03019365],"study_design_scores_gemma":[0.0022472346,0.008173858,0.9839947,0.00004236327,0.00036827006,0.0008499775,0.00008994189,0.0010447536,0.0011776305,0.00014337339,0.0018530263,0.000014841679],"about_ca_topic_score_codex":0.0013580065,"about_ca_topic_score_gemma":0.0032299443,"teacher_disagreement_score":0.0014922695,"about_ca_system_score_codex":0.0005332807,"about_ca_system_score_gemma":0.0004249413,"threshold_uncertainty_score":0.007892013},"labels":[],"label_agreement":null},{"id":"W2439102632","doi":"10.1093/neuonc/now073.124","title":"HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bevacizumab; Medicine; Open label; Glioma; Randomized controlled trial; Surgery; Chemotherapy; Cancer research","score_opus":0.0468354923453731,"score_gpt":0.3368309216276485,"score_spread":0.2899954292822754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439102632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914262,0.0022591765,0.00047727252,0.00023450129,0.00011966901,0.0038269877,0.00073797023,0.00004661732,0.0008714994],"genre_scores_gemma":[0.9862607,0.002909312,0.0021390715,0.00081859715,0.00017694662,0.0046931417,0.0017331826,0.00002003362,0.0012490923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999328,0.000419138,0.00003813186,0.00008524999,0.00005407075,0.000075414515],"domain_scores_gemma":[0.9992506,0.00016424198,0.00023541997,0.000051059207,0.00005973629,0.00023907646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019945675,0.0011588191,0.0018592267,0.00035857232,0.00025576467,0.00075206993,0.0007234542,0.001025057,0.0035719327],"category_scores_gemma":[0.001435394,0.0006144412,0.0013188431,0.0004004471,0.0009147858,0.00069837214,0.00034456185,0.0018832522,0.00041658542],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9127656,0.029766705,0.0058798706,0.0010481952,0.0020302304,0.0001948823,0.00016876294,0.0010628063,0.010490623,0.00028976603,0.0015310623,0.034771495],"study_design_scores_gemma":[0.7203125,0.2672275,0.008857882,0.000042700947,0.00055122783,0.00015271832,0.00004638788,0.0004870534,0.0007756149,0.00012438027,0.0014026376,0.00001944171],"about_ca_topic_score_codex":0.0010642516,"about_ca_topic_score_gemma":0.0031645512,"teacher_disagreement_score":0.0035719327,"about_ca_system_score_codex":0.0010052746,"about_ca_system_score_gemma":0.0020243658,"threshold_uncertainty_score":0.011949301},"labels":[],"label_agreement":null},{"id":"W2439339516","doi":"10.1093/neuonc/now072.20","title":"GC-20THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Central nervous system; Germ cell tumors; Germ cell; Medicine; Oncology; Pediatric oncology; Internal medicine; Pediatrics; Biology; Chemotherapy; Genetics; Cancer; Computer science; Artificial intelligence; Gene","score_opus":0.014591079027657071,"score_gpt":0.25799895580686005,"score_spread":0.24340787677920298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439339516","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8679639,0.02063301,0.0012217561,0.004187853,0.0007898627,0.0012500973,0.02872233,0.00037962146,0.07485149],"genre_scores_gemma":[0.93163496,0.009955727,0.005772996,0.0030032997,0.00027351707,0.0015502508,0.031161979,0.0001552598,0.016491981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983096,0.00005079988,0.000012234683,0.000032828782,0.000037067653,0.000036091285],"domain_scores_gemma":[0.9996207,0.000039691156,0.000090945854,0.000031308704,0.00003413779,0.00018327747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042947714,0.00027093908,0.0004749878,0.000383283,0.000360157,0.0004920494,0.00036373275,0.00035688147,0.009020066],"category_scores_gemma":[0.0005433195,0.00010144393,0.00042756277,0.0005953251,0.00024634227,0.00030857566,0.00034825996,0.000688263,0.0012734775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023854036,0.0028647508,0.27136114,0.0015650723,0.00080091355,0.00063957454,0.00035742772,0.002048224,0.012447935,0.0037217196,0.18260573,0.49773347],"study_design_scores_gemma":[0.016110443,0.01662807,0.51416874,0.00058440096,0.0008621288,0.0032058083,0.00024653276,0.0010764777,0.0048331004,0.0019932045,0.4402507,0.000040408122],"about_ca_topic_score_codex":0.0036550192,"about_ca_topic_score_gemma":0.021282556,"teacher_disagreement_score":0.009020066,"about_ca_system_score_codex":0.0015494971,"about_ca_system_score_gemma":0.0015971968,"threshold_uncertainty_score":0.03017509},"labels":[],"label_agreement":null},{"id":"W2440039868","doi":"10.1093/neuonc/now080.20","title":"PCM-20PRE-CLINICAL DRUG SCREEN IN A PDX ETMR MOUSE MODEL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Drug; Chemistry; Pharmacology; Medicine","score_opus":0.02893391120150003,"score_gpt":0.3156152104725266,"score_spread":0.2866812992710266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440039868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94509304,0.006919246,0.010659246,0.0010294928,0.0003507463,0.0010429493,0.022465212,0.0017115396,0.010728611],"genre_scores_gemma":[0.91729695,0.008322184,0.016460238,0.0006332487,0.000060759907,0.0014351165,0.02861465,0.00021762322,0.026959207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960214,0.000050624614,0.000036202837,0.000085904074,0.00014978694,0.00007529175],"domain_scores_gemma":[0.99980503,0.000027474687,0.000041030577,0.000033566776,0.000033448345,0.000059434813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046928955,0.0009184539,0.0010824142,0.0008787182,0.000280328,0.000544855,0.0007364717,0.0007577914,0.0038363978],"category_scores_gemma":[0.00015895328,0.00026822317,0.0006577179,0.0006738584,0.0003413001,0.00048218676,0.00023221121,0.0020354541,0.001768706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011517882,0.0014920421,0.00052051985,0.00023321465,0.000050683513,0.00025142916,0.000040110175,0.0008812772,0.98406833,0.00038436847,0.0019089662,0.009017271],"study_design_scores_gemma":[0.00044298358,0.008627615,0.003918278,0.00003122674,0.00014632197,0.00068675284,0.00005288304,0.0028307964,0.9579061,0.00014110752,0.025189478,0.000026468979],"about_ca_topic_score_codex":0.0013993011,"about_ca_topic_score_gemma":0.002331768,"teacher_disagreement_score":0.0038363978,"about_ca_system_score_codex":0.0006213789,"about_ca_system_score_gemma":0.00071156933,"threshold_uncertainty_score":0.0128340125},"labels":[],"label_agreement":null},{"id":"W2440280149","doi":"10.1093/neuonc/now076.46","title":"MB-48PEROXIREDOXIN 1 IS A POTENTIAL THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children; University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Group (periodic table); Medicine; Chemistry","score_opus":0.009969998070211556,"score_gpt":0.2683085753923063,"score_spread":0.25833857732209475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440280149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886458,0.005713475,0.002858082,0.00033427976,0.00004335481,0.000081291044,0.00044296338,0.00015541539,0.0017253808],"genre_scores_gemma":[0.9942451,0.001953249,0.0015888769,0.000052836087,0.0000084499925,0.00003772339,0.00058678444,0.000011112064,0.0015159601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999528,0.000005011497,0.0000031637783,0.000010040974,0.000015789863,0.000013225552],"domain_scores_gemma":[0.99997103,0.0000030539513,0.0000099733315,0.000003434783,0.000003288125,0.0000090858375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110668996,0.0002460545,0.00028066282,0.00015425053,0.00014309249,0.00017957969,0.00015667983,0.00021970877,0.0011823114],"category_scores_gemma":[0.00006393703,0.00007473703,0.00024680165,0.0001443343,0.00013313242,0.00014122957,0.00013678099,0.0005021615,0.00022417578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030643243,0.00007098009,0.0010823203,0.0001082602,0.000014078225,0.00013418216,0.000025311772,0.0001836801,0.9899921,0.00014379124,0.00023539846,0.0077034975],"study_design_scores_gemma":[0.000103084145,0.001971838,0.01865064,0.000016183012,0.00007040355,0.0011761241,0.00006141902,0.0010363191,0.96206045,0.00019670062,0.014647734,0.000009082532],"about_ca_topic_score_codex":0.000664051,"about_ca_topic_score_gemma":0.0013290333,"teacher_disagreement_score":0.0011823114,"about_ca_system_score_codex":0.00029809313,"about_ca_system_score_gemma":0.00017630818,"threshold_uncertainty_score":0.003955245},"labels":[],"label_agreement":null},{"id":"W2440400959","doi":"10.1093/neuonc/now065.20","title":"AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Princess Margaret Cancer Centre; Structural Genomics Consortium; McGill University; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Computational biology; Biology; Medicine; Genetics","score_opus":0.03443928670773086,"score_gpt":0.32575074632890627,"score_spread":0.29131145962117544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440400959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98342276,0.004210254,0.004028014,0.00014288642,0.000023682678,0.000061131315,0.0040016375,0.00019894632,0.0039106617],"genre_scores_gemma":[0.9869393,0.0019973991,0.0033724436,0.00016591098,0.0000102212125,0.000063643594,0.004868719,0.00004992243,0.002532315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998541,0.000010760898,0.000007610605,0.000041934323,0.000059797454,0.000025771276],"domain_scores_gemma":[0.99991333,0.000012069545,0.000030585798,0.000009369466,0.000017483664,0.000017008924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001309892,0.00019848923,0.00031951262,0.00044119067,0.00014887382,0.00041557083,0.00017650145,0.00021273294,0.0017437406],"category_scores_gemma":[0.0001627651,0.00011771664,0.0002383137,0.00036166227,0.00013171716,0.00014300286,0.00024306802,0.00034311775,0.00041008572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019897132,0.000024118355,0.008642055,0.00008863907,0.00004629,0.00015160546,0.00003559139,0.00074288814,0.9726376,0.00015600037,0.00031759343,0.016958738],"study_design_scores_gemma":[0.00003123974,0.00068294565,0.25763738,0.000019437972,0.0002449692,0.0019310733,0.00014643537,0.004257469,0.71303105,0.0005455597,0.021448566,0.00002380902],"about_ca_topic_score_codex":0.0010769803,"about_ca_topic_score_gemma":0.0024477805,"teacher_disagreement_score":0.0017437406,"about_ca_system_score_codex":0.00030900314,"about_ca_system_score_gemma":0.00023719184,"threshold_uncertainty_score":0.0058333874},"labels":[],"label_agreement":null},{"id":"W2440690658","doi":"10.1093/neuonc/now076.08","title":"MB-08FUNCTIONAL ROLES OF CCL2 IN MEDULLOBLASTOMA LEPTOMENINGEAL METASTASIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Metastasis; Medicine; Pathology; Internal medicine; Cancer","score_opus":0.026772565073239933,"score_gpt":0.32840645066902835,"score_spread":0.3016338855957884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440690658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954768,0.0016852439,0.0010076001,0.000097691336,0.000014988368,0.000017691784,0.00044594766,0.000036967096,0.0012170773],"genre_scores_gemma":[0.99650145,0.00046536146,0.0006717646,0.00002769605,0.000005997539,0.000016414797,0.0005619627,0.000007711193,0.0017416507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999025,0.000013434403,0.00000644436,0.000014286548,0.000031192878,0.000032119086],"domain_scores_gemma":[0.99992204,0.000010843841,0.00002168269,0.0000061350556,0.000012133482,0.000027087832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082733895,0.00021335024,0.0001116763,0.0003147739,0.00019695953,0.0002570709,0.00006866353,0.0001400405,0.0016046896],"category_scores_gemma":[0.0001386479,0.0000740542,0.00013801699,0.00011406363,0.00015908353,0.00014707007,0.000122045465,0.00027963854,0.00021386716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010157663,0.000017495062,0.002372257,0.000031156655,0.0000050156655,0.00015981313,0.000017107921,0.0000466072,0.99602294,0.00012308064,0.00006439576,0.0010385641],"study_design_scores_gemma":[0.000039222523,0.00045690525,0.106466405,0.00002111794,0.000048910606,0.0017820267,0.0001582224,0.001455551,0.8819365,0.00018485234,0.0074406182,0.000009572245],"about_ca_topic_score_codex":0.0020620928,"about_ca_topic_score_gemma":0.0029758362,"teacher_disagreement_score":0.0020620928,"about_ca_system_score_codex":0.0003746547,"about_ca_system_score_gemma":0.00023945181,"threshold_uncertainty_score":0.005368173},"labels":[],"label_agreement":null},{"id":"W2441491525","doi":"10.1093/neuonc/now076.76","title":"MB-80OUTCOME OF CHILDREN WITH POSTERIOR FOSSA MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medulloblastoma; Posterior fossa; Medicine; Anatomy; Pathology","score_opus":0.013573182261581771,"score_gpt":0.27778987312442316,"score_spread":0.2642166908628414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441491525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899405,0.0004499957,0.00004615608,0.000029394743,0.000003942173,0.000003631835,0.00017429442,0.0000026973373,0.00029584364],"genre_scores_gemma":[0.99918956,0.0002543752,0.000042041756,0.000014756016,0.0000059621343,0.0000038303388,0.0003628753,0.0000021813876,0.00012447393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998062,0.000022303582,0.000016129972,0.000046772544,0.000048820144,0.00005970735],"domain_scores_gemma":[0.999561,0.000055737175,0.00024702822,0.000015273921,0.00002848748,0.0000924351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013768916,0.00013753996,0.00026062044,0.00037564462,0.00027123166,0.00032733235,0.00019842848,0.00019011744,0.000788902],"category_scores_gemma":[0.00085887074,0.00013310945,0.0002247491,0.00030244584,0.00020835061,0.00026983806,0.00033311802,0.00032210778,0.00014397663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007363972,0.000016150248,0.99489576,0.0000149179905,0.000014109651,0.0010180951,0.0000994795,0.00006282332,0.00069624884,0.000021365671,0.000092159105,0.0029953085],"study_design_scores_gemma":[0.0000060843226,0.00015417197,0.993054,0.000008561046,0.00001641962,0.0056981267,0.00016441912,0.00008045354,0.00020213447,0.000020632682,0.0005920582,0.0000029144662],"about_ca_topic_score_codex":0.004578221,"about_ca_topic_score_gemma":0.009734983,"teacher_disagreement_score":0.004578221,"about_ca_system_score_codex":0.0005081541,"about_ca_system_score_gemma":0.000465964,"threshold_uncertainty_score":0.009103179},"labels":[],"label_agreement":null},{"id":"W2441823205","doi":"10.1093/neuonc/now075.50","title":"LG-50MULTIPLEX DETECTION OF PEDIATRIC LOW GRADE GLIOMA SIGNATURE FUSION AND DUPLICATION TRANSCRIPTS USING THE NANOSTRING NCOUNTER SYSTEM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Graphene and Nanomaterials Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene duplication; Signature (topology); Computational biology; Computer science; Biology; Cancer research; Genetics; Gene; Mathematics","score_opus":0.013068390478032856,"score_gpt":0.2267489061227185,"score_spread":0.21368051564468565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441823205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96279746,0.0013428056,0.027234104,0.00016601902,0.000020925467,0.00018489982,0.002525232,0.0011501908,0.004578506],"genre_scores_gemma":[0.9162706,0.00087801844,0.072513506,0.00024217942,0.000015974148,0.00055139104,0.0056816917,0.00016589441,0.0036807198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990632,0.00014503532,0.00008648891,0.00027843658,0.0002949415,0.00013199748],"domain_scores_gemma":[0.9998035,0.00006347777,0.00003904703,0.000040592156,0.0000330072,0.000020316498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081583776,0.00039722142,0.00037216305,0.0018480477,0.00025155707,0.00042148994,0.00042665808,0.0004880369,0.0022658987],"category_scores_gemma":[0.00066528784,0.0002627832,0.00026442888,0.0007463337,0.00030272626,0.00023709211,0.00043944293,0.00027219873,0.0005472669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000270654,0.000040289524,0.06196782,0.00018630219,0.00006468909,0.001213406,0.00026135123,0.00090546615,0.9053999,0.00036771575,0.0012750191,0.028047396],"study_design_scores_gemma":[0.0000435558,0.00047422704,0.23906162,0.0000539916,0.00014169636,0.00913849,0.00021329462,0.014252372,0.7222134,0.0005096428,0.0138591975,0.00003845436],"about_ca_topic_score_codex":0.0017706411,"about_ca_topic_score_gemma":0.0045002997,"teacher_disagreement_score":0.0022658987,"about_ca_system_score_codex":0.0005143991,"about_ca_system_score_gemma":0.00034386714,"threshold_uncertainty_score":0.0075802207},"labels":[],"label_agreement":null},{"id":"W2441874167","doi":"10.1093/neuonc/now073.76","title":"HG-80ISSUES IN THE MANAGEMENT OF CHILDREN WITH BRAIN TUMORS AND BIALLELIC MISMATCH GENE REPAIR DEFICIENCY SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gene; Genetics; Biology","score_opus":0.01556900489081961,"score_gpt":0.2750987134543119,"score_spread":0.25952970856349233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441874167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418605,0.043259125,0.002374023,0.003026335,0.00025004114,0.00008663354,0.000113234906,0.00017183306,0.008858243],"genre_scores_gemma":[0.98472995,0.010014206,0.0022413542,0.0007528883,0.0001665035,0.000046703095,0.00017505421,0.000020715717,0.0018525972],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999163,0.000021290212,0.000008778663,0.000012295724,0.000020131964,0.000021168637],"domain_scores_gemma":[0.9998988,0.000014779593,0.00001958981,0.0000037349496,0.0000075890853,0.000055523225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015068,0.00028896824,0.00032632655,0.00036107883,0.00040746745,0.00015724289,0.00030671965,0.00054787134,0.00084773987],"category_scores_gemma":[0.00050249835,0.00005736768,0.00014503529,0.00021084203,0.00020589429,0.00020503583,0.0003442388,0.0005567433,0.00021556247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018217023,0.0009920638,0.25542966,0.00093478686,0.00020423668,0.29699692,0.0012709233,0.0014766917,0.024864454,0.0014906522,0.014808453,0.39970946],"study_design_scores_gemma":[0.0003974241,0.005790201,0.31187746,0.0009692975,0.0003741887,0.57725805,0.0017906654,0.0016212234,0.014374892,0.0029706182,0.08251742,0.000058489524],"about_ca_topic_score_codex":0.00093060423,"about_ca_topic_score_gemma":0.0016825118,"teacher_disagreement_score":0.00093060423,"about_ca_system_score_codex":0.00025511658,"about_ca_system_score_gemma":0.00032886004,"threshold_uncertainty_score":0.0028359294},"labels":[],"label_agreement":null},{"id":"W2442030078","doi":"10.1093/neuonc/now081.21","title":"QOS-21A MODEL OF CARE FOR PEDIATRIC CNS TUMOR PATIENTS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tracheal and airway disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Computer science","score_opus":0.01922385871963425,"score_gpt":0.28172666478149555,"score_spread":0.26250280606186127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442030078","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3832409,0.017298145,0.059932377,0.15892932,0.0073075625,0.002942237,0.0052738152,0.0043539116,0.36072168],"genre_scores_gemma":[0.8106107,0.010958522,0.11196581,0.013150877,0.0018384223,0.0024305126,0.004835177,0.00043227882,0.043777693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988366,0.00042264423,0.00009465517,0.00015317075,0.0002474316,0.00024549157],"domain_scores_gemma":[0.99640214,0.00023003989,0.00029255205,0.00010858628,0.0003936185,0.0025729963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013004445,0.00036587226,0.00024878143,0.00049640157,0.0017330511,0.0021851864,0.001754993,0.0012257886,0.020457916],"category_scores_gemma":[0.0038442656,0.0001394216,0.00082416635,0.0004402039,0.0005729492,0.0011504907,0.005057399,0.0020842873,0.003985225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010002233,0.0025924898,0.09615765,0.0015696185,0.00020134482,0.0070633166,0.0047827377,0.00812632,0.0019624368,0.03313682,0.31369206,0.529715],"study_design_scores_gemma":[0.00094295194,0.0042912536,0.069015004,0.003187107,0.00026853554,0.021507757,0.0071628815,0.017842103,0.0014262354,0.030766962,0.84335136,0.0002378476],"about_ca_topic_score_codex":0.0049934825,"about_ca_topic_score_gemma":0.0103509445,"teacher_disagreement_score":0.020457916,"about_ca_system_score_codex":0.0029077537,"about_ca_system_score_gemma":0.010201218,"threshold_uncertainty_score":0.06843859},"labels":[],"label_agreement":null},{"id":"W2442181867","doi":"10.1093/neuonc/now073.67","title":"HG-71ULTRA-SENSITIVE DETECTION OF HOTSPOT MUTATIONS IN PEDIATRIC THALAMIC TUMOURS TO REVEAL NEGATIVE PROGNOSTIC MARKERS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Hotspot (geology); Biology; Medicine; Computational biology; Genetics; Geology","score_opus":0.015588353714222262,"score_gpt":0.2911796878861485,"score_spread":0.27559133417192627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442181867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970061,0.0005850948,0.0011909116,0.000017096889,0.000005551701,0.00002883088,0.000522014,0.000033841057,0.0006104854],"genre_scores_gemma":[0.99784386,0.00021330331,0.0010612498,0.000016785125,0.0000038821104,0.000019963154,0.00060252956,0.000008112492,0.00023030661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996505,0.000057039895,0.00002723128,0.000087864166,0.00011897378,0.000058371563],"domain_scores_gemma":[0.99968314,0.00006797905,0.00009369771,0.000039721126,0.00007295244,0.00004257876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037755852,0.0002251721,0.00025556647,0.000861251,0.00016722838,0.0004572828,0.0002642648,0.00019833146,0.0009686683],"category_scores_gemma":[0.0007525976,0.00015659962,0.00019693119,0.0007239956,0.0002467986,0.00014822706,0.00028249828,0.00019857688,0.000327673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004279272,0.000046917623,0.82166666,0.00008623121,0.000076716395,0.0010618102,0.00027747304,0.00037363116,0.15848999,0.00011021495,0.0003812839,0.017001126],"study_design_scores_gemma":[0.000014145058,0.000531956,0.933453,0.000009828636,0.00008163334,0.0062652715,0.00026368056,0.0014284811,0.055757545,0.0000853507,0.0020969599,0.000012003244],"about_ca_topic_score_codex":0.0016899051,"about_ca_topic_score_gemma":0.002983202,"teacher_disagreement_score":0.0016899051,"about_ca_system_score_codex":0.00034857236,"about_ca_system_score_gemma":0.00020193835,"threshold_uncertainty_score":0.0033601522},"labels":[],"label_agreement":null},{"id":"W2442220068","doi":"10.1093/neuonc/now066.08","title":"CMS-09BEHAVIOR AND TEMPERAMENT IN CHILDREN TREATED FOR PEDIATRIC MEDULLOBLASTOMA WITH POSTOPERATIVE CEREBELLAR MUTISM SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Temperament; Psychology; Cerebellum; Pediatrics; Medicine; Neuroscience; Psychoanalysis; Pathology; Personality","score_opus":0.01025112827025603,"score_gpt":0.2660706033468444,"score_spread":0.25581947507658837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442220068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997682,0.000053289998,0.000020702648,0.000008193723,0.0000014746121,0.0000037707932,0.00003993563,0.0000016718533,0.00010268566],"genre_scores_gemma":[0.9996854,0.00005595156,0.000058509206,0.000009825908,0.000001504989,0.0000066749644,0.00013888431,8.610242e-7,0.000042437296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997241,0.00006513931,0.00003827926,0.000037926497,0.000066780085,0.00006781018],"domain_scores_gemma":[0.99931145,0.00007750292,0.0003980173,0.000020175044,0.000052249652,0.00014059793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002139102,0.00019215676,0.00027192014,0.00054034265,0.00033002088,0.0003074331,0.00014134287,0.00020700628,0.00048492276],"category_scores_gemma":[0.0013224619,0.0001322885,0.0004098633,0.00045294472,0.0002505071,0.00018200373,0.00037303133,0.00043204872,0.00008391102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052603165,0.00003356206,0.99766564,0.0000055550763,0.000012521208,0.00035145914,0.00011448319,0.000022671511,0.00039546058,0.0000035015657,0.00002537745,0.001317152],"study_design_scores_gemma":[0.0000015501346,0.00012307224,0.9985,0.000002247861,0.000008461789,0.0010659164,0.00010975058,0.000028445058,0.00010527127,0.000002357923,0.00005147744,0.0000014657105],"about_ca_topic_score_codex":0.006685979,"about_ca_topic_score_gemma":0.011295639,"teacher_disagreement_score":0.006685979,"about_ca_system_score_codex":0.00060693675,"about_ca_system_score_gemma":0.0003816012,"threshold_uncertainty_score":0.013294101},"labels":[],"label_agreement":null},{"id":"W2442825390","doi":"10.1093/neuonc/now073.61","title":"HG-65END-OF-LIFE CARE OF CHILDREN WITH MALIGNANT PONTINE TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.01327742374877014,"score_gpt":0.27895476617136955,"score_spread":0.26567734242259944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442825390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986494,0.00038046943,0.00003604815,0.00012268212,0.000006309033,0.000009271795,0.00018483472,0.0000033492934,0.0006077722],"genre_scores_gemma":[0.9991523,0.00031337776,0.0001016475,0.0000556487,0.0000087517255,0.000011954812,0.00021254712,0.000002505284,0.00014131995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966586,0.0000559991,0.000034055014,0.000042069736,0.000055742756,0.00014624499],"domain_scores_gemma":[0.99875116,0.00018837277,0.0006335357,0.00002314369,0.00007534152,0.0003284518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024266647,0.00016955766,0.00020503622,0.00039399043,0.00063709286,0.0003721689,0.0002803855,0.00029232807,0.002172091],"category_scores_gemma":[0.0017514811,0.00012396646,0.00021766269,0.00049927464,0.00042795687,0.00044717325,0.0005469509,0.00052874745,0.00023966789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046496018,0.000022648099,0.99251324,0.00003620989,0.0000092055225,0.0033925918,0.00072163664,0.0000640197,0.00018342993,0.00003210831,0.00037908976,0.0025993602],"study_design_scores_gemma":[0.000010854871,0.00031909795,0.9674327,0.00007554214,0.000018825747,0.026514774,0.0027745385,0.00011539979,0.0003068425,0.000073729396,0.0023481252,0.00000949907],"about_ca_topic_score_codex":0.005094368,"about_ca_topic_score_gemma":0.008877424,"teacher_disagreement_score":0.005094368,"about_ca_system_score_codex":0.00087374967,"about_ca_system_score_gemma":0.00092456175,"threshold_uncertainty_score":0.010129452},"labels":[],"label_agreement":null},{"id":"W2443301065","doi":"10.1093/neuonc/now076.21","title":"MB-23RECURRENT SHH/TP53 MUTANT MEDULLOBLASTOMA TREATED WITH A COMBINATION OF LITHIUM AND RADIATION THERAPY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Chemotherapy; Temozolomide; Oncology; Internal medicine; Surgery; Cancer research","score_opus":0.015319334357111206,"score_gpt":0.2778775796366477,"score_spread":0.26255824527953653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443301065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98501205,0.0078731235,0.0009492666,0.0011441631,0.0001711401,0.00023918001,0.0002606605,0.00013214406,0.004218327],"genre_scores_gemma":[0.99508494,0.0017247282,0.0005510171,0.0003072551,0.00010650481,0.00006401765,0.00032868673,0.000010940728,0.0018218734],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99992514,0.00001149856,0.000010259433,0.000017861963,0.00001609237,0.000019105935],"domain_scores_gemma":[0.99991953,0.000010801157,0.000013633774,0.000008550735,0.0000077726845,0.00003973844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011563882,0.00038526946,0.0010579323,0.00033623178,0.00046806096,0.00021523367,0.00041564868,0.00048331736,0.00087967416],"category_scores_gemma":[0.00025457158,0.00014347135,0.00051051093,0.00033049536,0.0002697172,0.00022359495,0.00025162424,0.0007374669,0.00035231837],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037479434,0.010667604,0.07349685,0.0015187294,0.0013132525,0.39127165,0.0011361422,0.00386895,0.13086905,0.0013254237,0.007888929,0.33916405],"study_design_scores_gemma":[0.008958112,0.12133561,0.308719,0.00052319973,0.0025929639,0.40845257,0.0006225535,0.009253289,0.08525824,0.0014637496,0.052604627,0.00021606404],"about_ca_topic_score_codex":0.0023134032,"about_ca_topic_score_gemma":0.005755227,"teacher_disagreement_score":0.0023134032,"about_ca_system_score_codex":0.00071185385,"about_ca_system_score_gemma":0.00047594277,"threshold_uncertainty_score":0.0051649213},"labels":[],"label_agreement":null},{"id":"W2443386476","doi":"10.1093/neuonc/now073.72","title":"HG-76SPATIAL AND TEMPORAL HOMOGENEITY OF DRIVER MUTATIONS IN DIFFUSE INTRINSIC PONTINE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Homogeneity (statistics); Glioma; Neuroscience; Medicine; Psychology; Computer science; Cancer research","score_opus":0.017131208790723065,"score_gpt":0.2852469108530824,"score_spread":0.26811570206235935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443386476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986645,0.00014564859,0.00033305766,0.000009570555,0.0000014161741,0.0000055992077,0.0003612422,0.00003022706,0.00044868953],"genre_scores_gemma":[0.9989612,0.00007648759,0.0002757599,0.000007057339,8.2264023e-7,0.000003314251,0.00037941372,0.000013482424,0.0002823737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998988,0.0000053308363,0.0000053236836,0.000040337804,0.000027616417,0.000022506163],"domain_scores_gemma":[0.99991477,0.000014962837,0.000024471381,0.000011441244,0.000013590584,0.000020821404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006700887,0.00013823867,0.00014192346,0.00056086626,0.00016095844,0.0002629368,0.00011086228,0.00015446865,0.0013139973],"category_scores_gemma":[0.00024694004,0.00012719273,0.00012960413,0.00030169706,0.00020733023,0.00009870632,0.00023577854,0.00016110815,0.00024499054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007607309,0.0000365632,0.30357534,0.0001320124,0.00014004616,0.0068637617,0.0007341993,0.0010278277,0.65253115,0.00020687851,0.0003631456,0.03362838],"study_design_scores_gemma":[0.0000064536885,0.00011236777,0.95559496,0.0000064578016,0.000052326926,0.009101355,0.00020529477,0.00093170063,0.032307412,0.00013453755,0.0015353129,0.000011753528],"about_ca_topic_score_codex":0.004036266,"about_ca_topic_score_gemma":0.00755511,"teacher_disagreement_score":0.004036266,"about_ca_system_score_codex":0.00027758043,"about_ca_system_score_gemma":0.00013586367,"threshold_uncertainty_score":0.008025587},"labels":[],"label_agreement":null},{"id":"W2443447464","doi":"10.1093/neuonc/now076.97","title":"MB-102HEMATOGENOUS DISSEMINATION OF MEDULLOBLASTOMA DRIVES LEPTOMENINGEAL DISEASE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Cancer research","score_opus":0.012751110245929292,"score_gpt":0.30492024255753614,"score_spread":0.29216913231160685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443447464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561846,0.00056119176,0.0014242694,0.00013213504,0.000023564618,0.000031903182,0.00052776403,0.00006660841,0.0016140233],"genre_scores_gemma":[0.99552274,0.00035504813,0.00082108844,0.000053876673,0.0000073895803,0.000026298743,0.00056918757,0.000028700319,0.0026156849],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998253,0.000022986833,0.000015076442,0.00003984683,0.000052707685,0.00004418237],"domain_scores_gemma":[0.9998658,0.000024960715,0.00003800567,0.000018458015,0.000009501027,0.000043268647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009757034,0.00019349008,0.00016842938,0.0002602048,0.00017471518,0.00038116056,0.00013799555,0.00027705057,0.002630543],"category_scores_gemma":[0.00016888723,0.00013007573,0.0001289439,0.00012080874,0.00023039401,0.00017322936,0.00023416082,0.0006522118,0.0005075954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053764907,0.000048122904,0.0009854484,0.000014977464,0.0000032783983,0.00017270526,0.000026582456,0.000055212662,0.9970701,0.0003228369,0.000086632885,0.001160391],"study_design_scores_gemma":[0.000052986143,0.00090571615,0.047983248,0.000026392741,0.000035683643,0.002963772,0.00029635767,0.0045083626,0.92847383,0.00045537556,0.014284011,0.000014211635],"about_ca_topic_score_codex":0.0014873871,"about_ca_topic_score_gemma":0.0030561425,"teacher_disagreement_score":0.002630543,"about_ca_system_score_codex":0.000441437,"about_ca_system_score_gemma":0.00019950264,"threshold_uncertainty_score":0.00880003},"labels":[],"label_agreement":null},{"id":"W2443665052","doi":"10.1093/neuonc/now084.05","title":"TB-08MECHANISMS OF IMMUNE RESISTANCE IN PEDIATRIC POSTERIOR FOSSA TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Atypical teratoid rhabdoid tumor; Cancer; Brain tumor; Fourth ventricle; Internal medicine; Oncology; Cancer research; Pathology; Surgery","score_opus":0.017676016911977174,"score_gpt":0.3032424558516932,"score_spread":0.285566438939716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443665052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779674,0.01357755,0.0028193053,0.0005494079,0.00009078455,0.00015150389,0.00030393232,0.00012994975,0.004410062],"genre_scores_gemma":[0.99299663,0.0036995397,0.000950452,0.00022762365,0.000028746612,0.00012384065,0.00037548575,0.000013356411,0.0015842945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997757,0.00004888649,0.000014946125,0.000035469446,0.00006005187,0.00006492666],"domain_scores_gemma":[0.99988914,0.00001788445,0.000047216367,0.000014567894,0.00001272565,0.000018411925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033209892,0.00022312983,0.00032166587,0.00019646305,0.00013231473,0.0005119333,0.0002595695,0.0003617316,0.0020824533],"category_scores_gemma":[0.00025232142,0.000117414966,0.00034441275,0.00015277039,0.00029365072,0.000291944,0.00032144604,0.0008999801,0.00046055892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016398184,0.000639622,0.015927639,0.0010612903,0.00010143541,0.0010907187,0.00023048083,0.0016000167,0.88611877,0.002478718,0.0018934456,0.08721808],"study_design_scores_gemma":[0.0009851581,0.015988113,0.07764921,0.0002833737,0.00031326193,0.018639516,0.0007226071,0.0062941886,0.80613774,0.0026285078,0.070318356,0.000039985254],"about_ca_topic_score_codex":0.0002542056,"about_ca_topic_score_gemma":0.0003570952,"teacher_disagreement_score":0.0020824533,"about_ca_system_score_codex":0.00043786815,"about_ca_system_score_gemma":0.00026866797,"threshold_uncertainty_score":0.0069665313},"labels":[],"label_agreement":null},{"id":"W2443911332","doi":"10.1093/neuonc/now073.53","title":"HG-57RE-IRRADIATION IN PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMAS, AN UPDATE ON THE CANADIAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; BC Children's Hospital; Alberta Children's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Irradiation; Physics","score_opus":0.013743315237158566,"score_gpt":0.2572755814521441,"score_spread":0.2435322662149855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443911332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71676993,0.23979281,0.0014314427,0.0073984494,0.0004225771,0.0001392069,0.00091740664,0.00007303591,0.033055034],"genre_scores_gemma":[0.809824,0.18189739,0.0019497426,0.002231246,0.00044004107,0.000036417267,0.0011326768,0.000059255097,0.00242927],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99964356,0.000053946107,0.000032852196,0.00004932564,0.00013556708,0.00008468351],"domain_scores_gemma":[0.99916184,0.00013153924,0.00014115588,0.000040830142,0.00037083586,0.00015389794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076188426,0.00038622392,0.00037118475,0.00063331705,0.0006513666,0.00077625783,0.0005909292,0.00040958836,0.0014585229],"category_scores_gemma":[0.0014807965,0.00014723353,0.0002968294,0.0023472167,0.00080590846,0.00036785562,0.00036571515,0.0005538453,0.00032284067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012477415,0.00029668162,0.3724605,0.001664645,0.00020507933,0.009439778,0.0030070886,0.0012039142,0.008115188,0.0010206103,0.016134765,0.585204],"study_design_scores_gemma":[0.0002860051,0.0013704184,0.7271723,0.0015074128,0.0004283219,0.048874166,0.0033316156,0.00060836505,0.0036201598,0.00034225892,0.21234101,0.000118019656],"about_ca_topic_score_codex":0.4625845,"about_ca_topic_score_gemma":0.5939954,"teacher_disagreement_score":0.5374155,"about_ca_system_score_codex":0.0058707763,"about_ca_system_score_gemma":0.006734386,"threshold_uncertainty_score":0.9197839},"labels":[],"label_agreement":null},{"id":"W2465821987","doi":"10.1093/neuonc/nov229.03","title":"PTCT-03RELAPSE MEDULLOBLASTOMA IN INFANT: COMPLETE RESPONSE WITH TEMOZOLOMIDE AND IRINOTECAN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Temozolomide; Medulloblastoma; Irinotecan; Chemotherapy; Radiation therapy; Vincristine; Surgery; Internal medicine; Oncology; Cyclophosphamide; Cancer; Pathology","score_opus":0.03170246051936402,"score_gpt":0.29653284553476783,"score_spread":0.2648303850154038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465821987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931946,0.0031889272,0.0008868621,0.0006160915,0.000035370434,0.00004300546,0.00016065393,0.000069943424,0.0018046355],"genre_scores_gemma":[0.99746275,0.0010193273,0.0005452522,0.00016873318,0.000028467804,0.000011619815,0.00015544503,0.000012208299,0.00059618463],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99990606,0.000011105753,0.000015691987,0.000018530438,0.000022957445,0.000025552063],"domain_scores_gemma":[0.9998024,0.0000411483,0.000041333114,0.00001336388,0.000018066848,0.0000836798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119985125,0.00030730272,0.00050057226,0.00024139845,0.00021712232,0.00015876848,0.00021801621,0.000558959,0.0002804403],"category_scores_gemma":[0.00052053214,0.00013523008,0.00031562673,0.00014441938,0.00017861245,0.00015631036,0.0001652902,0.00067756546,0.0001519694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012170568,0.000236213,0.043003224,0.00031815094,0.00007819421,0.86293334,0.00046948262,0.00083419454,0.046924297,0.00026010678,0.00089311355,0.042832553],"study_design_scores_gemma":[0.00009504376,0.0032363085,0.14753659,0.000061527244,0.000112973765,0.8208842,0.00015123068,0.0018680572,0.021438098,0.00020495277,0.0043833875,0.00002757211],"about_ca_topic_score_codex":0.001560066,"about_ca_topic_score_gemma":0.0029234206,"teacher_disagreement_score":0.001560066,"about_ca_system_score_codex":0.00046054114,"about_ca_system_score_gemma":0.00020782226,"threshold_uncertainty_score":0.0033414364},"labels":[],"label_agreement":null},{"id":"W2506900921","doi":"10.1093/neuonc/nov228.17","title":"PTPS-17LEPTOMENINGEAL METASTASIS IN MYC-DRIVEN MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Metastasis; Cancer research; Biology; Medicine; Cancer; Genetics","score_opus":0.055891065716406126,"score_gpt":0.344591528599142,"score_spread":0.2887004628827359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506900921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976942,0.00053983094,0.00081166695,0.00003970468,0.000010380743,0.00002722014,0.00026345413,0.0000340953,0.0005793983],"genre_scores_gemma":[0.99798393,0.0005219574,0.0004848601,0.000013528634,0.0000032905566,0.000016693099,0.00029462736,0.000006151188,0.00067491387],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999263,0.000007326308,0.000006699484,0.000013998682,0.000028818366,0.000016845037],"domain_scores_gemma":[0.9999448,0.0000066035564,0.00001787588,0.000003606245,0.000004741165,0.000022343764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091386304,0.0001940238,0.00019354452,0.0003543112,0.00016143985,0.00022675606,0.00009659118,0.00018322484,0.0009907896],"category_scores_gemma":[0.00011235307,0.00010879645,0.00019820631,0.00015839755,0.0001696927,0.0001364328,0.00013715531,0.00036463683,0.0001674278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002306465,0.000094808376,0.0064960374,0.000063707324,0.000013419246,0.0016623179,0.000038823062,0.00025744786,0.98826677,0.00029407052,0.000107735556,0.0024741834],"study_design_scores_gemma":[0.00012862902,0.0029249394,0.2084603,0.000031646992,0.00010697558,0.02265066,0.00045511627,0.007096268,0.7481453,0.00046664054,0.009510487,0.000023109515],"about_ca_topic_score_codex":0.0032234339,"about_ca_topic_score_gemma":0.004998164,"teacher_disagreement_score":0.0032234339,"about_ca_system_score_codex":0.0005054038,"about_ca_system_score_gemma":0.00029492902,"threshold_uncertainty_score":0.0064092875},"labels":[],"label_agreement":null},{"id":"W2508035026","doi":"10.1093/neuonc/now177","title":"Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto; University of Alberta","funders":"Canadian Cancer Society","keywords":"Hippocampal formation; White matter; Medicine; Crossover study; Fractional anisotropy; Cognition; Physical therapy; Psychology; Internal medicine; Magnetic resonance imaging; Pathology","score_opus":0.11946614150034127,"score_gpt":0.38698387421663943,"score_spread":0.2675177327162982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508035026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921481,0.0011786955,0.00044054794,0.00014019979,0.00022438436,0.0051983097,0.00028950532,0.00004622434,0.00033401334],"genre_scores_gemma":[0.9763783,0.0015623107,0.0024483756,0.00038633833,0.00047107943,0.016987162,0.0005527358,0.000018932376,0.0011947654],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986237,0.000573216,0.00013192117,0.00035833128,0.00010812492,0.00020469505],"domain_scores_gemma":[0.99850625,0.00033737108,0.00037571945,0.00019941317,0.00015018198,0.00043110433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025344254,0.0021054007,0.0036994412,0.0006317297,0.0008186861,0.0008642075,0.0010804156,0.002064904,0.004492673],"category_scores_gemma":[0.002371957,0.00070906774,0.0017766545,0.00056644523,0.0014333478,0.0008934499,0.0005887569,0.0023886587,0.0005812157],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95299685,0.03401757,0.0010021711,0.00040410357,0.000704278,0.00004738643,0.000071775954,0.00019684841,0.0021689846,0.000042117994,0.00024158906,0.008106383],"study_design_scores_gemma":[0.66566646,0.32877475,0.004170682,0.000043521857,0.00035370793,0.000029829382,0.000041189403,0.00020711363,0.0003847817,0.00006655184,0.00024847034,0.000013042258],"about_ca_topic_score_codex":0.0015990029,"about_ca_topic_score_gemma":0.0025532478,"teacher_disagreement_score":0.004492673,"about_ca_system_score_codex":0.00094262266,"about_ca_system_score_gemma":0.0014020777,"threshold_uncertainty_score":0.01502949},"labels":[],"label_agreement":null},{"id":"W2508714157","doi":"10.1093/neuonc/now180","title":"MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Branch Out Neurological Foundation; Alberta Innovates; Alberta Cancer Foundation","keywords":"Immune system; Innate immune system; Microglia; Histopathology; Medicine; Brain tumor; Monocyte; Cancer research; Ferumoxytol; Magnetic resonance imaging; Pathology; Inflammation; Immunology","score_opus":0.026924053841745166,"score_gpt":0.30641636894979374,"score_spread":0.27949231510804856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508714157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704544,0.006552413,0.020106783,0.00022628406,0.000054929842,0.00015443393,0.0003052582,0.00022566898,0.0019197062],"genre_scores_gemma":[0.96908754,0.0031948606,0.025343841,0.00017555003,0.000047255497,0.00023469646,0.00032310523,0.00002162524,0.0015714577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999157,0.000024050072,0.0000059052177,0.00001714724,0.000019030143,0.000018047096],"domain_scores_gemma":[0.99986446,0.00002427896,0.000041432177,0.0000065906447,0.00003448094,0.000028762277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029376973,0.00020765448,0.00018211309,0.00034469378,0.00009966242,0.0001391865,0.00012433807,0.00031950776,0.000646272],"category_scores_gemma":[0.00018795794,0.000097258315,0.0001082488,0.00014104224,0.00014339804,0.00014716532,0.000112750386,0.00035151918,0.00020161607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004335422,0.000059927756,0.0028550741,0.00008614237,0.00000689368,0.00008394635,0.000024023888,0.000082527986,0.99077636,0.00005167653,0.000119991215,0.005420025],"study_design_scores_gemma":[0.000047963604,0.002016063,0.02181675,0.000020162766,0.00005776931,0.0008025153,0.000057490986,0.00327526,0.96972084,0.00009207576,0.0020804014,0.000012564846],"about_ca_topic_score_codex":0.000379316,"about_ca_topic_score_gemma":0.0005275619,"teacher_disagreement_score":0.000646272,"about_ca_system_score_codex":0.00015344941,"about_ca_system_score_gemma":0.00016898564,"threshold_uncertainty_score":0.0021619797},"labels":[],"label_agreement":null},{"id":"W2512098582","doi":"10.1093/neuonc/now187","title":"Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ziering Family Foundation; National Brain Tumor Society; American Cancer Society","keywords":"Medicine; Cabozantinib; Bevacizumab; Context (archaeology); Univariate analysis; Oncology; Internal medicine; Clinical trial; Glioblastoma; Multivariate analysis; Cancer; Chemotherapy; Cancer research","score_opus":0.06216123701157624,"score_gpt":0.3336370899040717,"score_spread":0.2714758528924955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512098582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8517029,0.14373945,0.0007780588,0.0008626633,0.00013727517,0.00027158615,0.0011157343,0.00004666381,0.0013456927],"genre_scores_gemma":[0.9861913,0.011737719,0.00070803904,0.00027152436,0.00017325235,0.00012686999,0.0006790233,0.000015866442,0.00009635913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950623,0.0025944484,0.0009282896,0.00065312587,0.0006165111,0.00014529882],"domain_scores_gemma":[0.959042,0.017806256,0.017038288,0.002674493,0.0024823884,0.0009565572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01412211,0.0005740523,0.002432112,0.0006477893,0.00029009252,0.00127972,0.0008391033,0.0006698396,0.0013661471],"category_scores_gemma":[0.021458713,0.00027869924,0.003770972,0.0015555604,0.00075240945,0.0009112109,0.00051185593,0.00074962573,0.00019864299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14679474,0.0007982966,0.56358284,0.007866149,0.07203214,0.00012730231,0.00037607297,0.0016893025,0.0029165642,0.00023994483,0.0022087009,0.20136802],"study_design_scores_gemma":[0.024144225,0.048219033,0.7958616,0.0036669464,0.11026306,0.0009927518,0.0003821556,0.0021951012,0.0041858754,0.0009892705,0.008925555,0.0001744569],"about_ca_topic_score_codex":0.00086815056,"about_ca_topic_score_gemma":0.002134252,"teacher_disagreement_score":0.01412211,"about_ca_system_score_codex":0.00070738746,"about_ca_system_score_gemma":0.0011123064,"threshold_uncertainty_score":0.07468575},"labels":[],"label_agreement":null},{"id":"W2516791304","doi":"10.1093/neuonc/now157","title":"The complex role of transglutaminase 2 in glioblastoma proliferation","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Context (archaeology); Biology; Cell growth; Cell culture; Cancer research; Tissue transglutaminase; Gene knockdown; Genetics; Biochemistry; Enzyme","score_opus":0.021141702125629568,"score_gpt":0.2745235191540507,"score_spread":0.25338181702842116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516791304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9097788,0.077075,0.0063522663,0.00083965104,0.00014694562,0.000075181204,0.0005956306,0.00017820143,0.0049583414],"genre_scores_gemma":[0.98183745,0.01272827,0.002562144,0.00016050668,0.00004072326,0.000039522467,0.00042545798,0.000019636293,0.0021864118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982846,0.000037468755,0.000017010741,0.00003415573,0.00004832558,0.00003460584],"domain_scores_gemma":[0.99984205,0.000025995567,0.00004886475,0.0000162718,0.00002962576,0.000037058384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031617002,0.0005492799,0.0002748404,0.00046448282,0.0001994857,0.0006748536,0.00023737714,0.00040321468,0.00084345933],"category_scores_gemma":[0.00017706057,0.00013819517,0.0003634908,0.00031181867,0.00030924391,0.0004565352,0.00038540628,0.0005849102,0.00027493894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004116188,0.000057139187,0.0033402739,0.00034338093,0.000045816574,0.0003941044,0.00006817255,0.00036244985,0.9773375,0.00070539955,0.00033775117,0.016596379],"study_design_scores_gemma":[0.0000466578,0.0011352523,0.09323702,0.00009234783,0.0001727107,0.0028824827,0.00032902003,0.0028642737,0.8712904,0.0013192607,0.026600763,0.000029829538],"about_ca_topic_score_codex":0.0008090995,"about_ca_topic_score_gemma":0.0012412393,"teacher_disagreement_score":0.00084345933,"about_ca_system_score_codex":0.00055949145,"about_ca_system_score_gemma":0.00037119942,"threshold_uncertainty_score":0.004059434},"labels":[],"label_agreement":null},{"id":"W2520463192","doi":"","title":"A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Concomitant; Glioblastoma; Radiation therapy; Adjuvant; Medicine; Randomized controlled trial; Adjuvant radiotherapy; Internal medicine; Oncology; Cancer research","score_opus":0.009429832833274985,"score_gpt":0.3018228089678068,"score_spread":0.2923929761345318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520463192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808075,0.0074142483,0.00075671857,0.001106567,0.001232328,0.005244399,0.0012832478,0.00009185371,0.0020631768],"genre_scores_gemma":[0.9756654,0.004831861,0.0024956907,0.0016518722,0.00071109313,0.009066398,0.0016258544,0.000024824794,0.003927031],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993338,0.00037368675,0.000051354917,0.00012032178,0.000042594867,0.000078220684],"domain_scores_gemma":[0.9988324,0.00032416434,0.00026164626,0.000090741894,0.000082368424,0.00040870847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017674371,0.0013891932,0.0026147445,0.00031792014,0.0004768735,0.00074494234,0.0009205486,0.0013749753,0.0055955737],"category_scores_gemma":[0.0023666192,0.000560108,0.001869268,0.00038117488,0.00094029546,0.00086954224,0.0004025829,0.0027051524,0.0006586993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9882211,0.0029586947,0.0002618933,0.00035183033,0.00089548674,0.000019468725,0.000028227752,0.00016900478,0.00077907334,0.00007597241,0.0006363874,0.0056028487],"study_design_scores_gemma":[0.97123635,0.026602345,0.0009631028,0.000018710813,0.0003930694,0.000013006675,0.000014993923,0.00018800882,0.00008937741,0.00007825304,0.00039473525,0.000008089856],"about_ca_topic_score_codex":0.0024051275,"about_ca_topic_score_gemma":0.006427588,"teacher_disagreement_score":0.0055955737,"about_ca_system_score_codex":0.00094869453,"about_ca_system_score_gemma":0.0015809813,"threshold_uncertainty_score":0.018719018},"labels":[],"label_agreement":null},{"id":"W2521163995","doi":"10.1093/neuonc/now200","title":"Old chemotherapy makes a comeback: dual alkylator therapy for pediatric high-grade glioma","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Chemotherapy; Medicine; Glioma; Internal medicine; Cancer research","score_opus":0.025006827192347432,"score_gpt":0.2979366192287641,"score_spread":0.27292979203641665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521163995","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007718665,0.0055670133,0.00041363685,0.9702011,0.0118285045,0.000017192187,0.000053294145,0.000033902223,0.004166805],"genre_scores_gemma":[0.10057048,0.014262098,0.00201663,0.75887734,0.11412909,0.00005589993,0.00011723874,0.00007336011,0.009897842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911124,0.00028898797,0.00014266063,0.000091241694,0.00021818803,0.00014769031],"domain_scores_gemma":[0.9980002,0.00096327695,0.00023379475,0.00006634047,0.00020718125,0.00052926224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000970086,0.00053648395,0.00083586684,0.0004834109,0.0016060591,0.0016526128,0.00080795307,0.014451744,0.001784851],"category_scores_gemma":[0.009079128,0.000322641,0.00083202,0.0004360209,0.0012209156,0.0022934047,0.0007617354,0.015560468,0.0010899522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030601543,0.00025623542,0.00980829,0.0002924657,0.000101493904,0.23390032,0.00050561456,0.0010833334,0.0016469258,0.008547736,0.6713325,0.07221916],"study_design_scores_gemma":[0.00041118098,0.00070323853,0.0076621147,0.00065348146,0.00020737425,0.32572287,0.0012755267,0.0029876404,0.0017235705,0.034822445,0.62368584,0.0001447355],"about_ca_topic_score_codex":0.0021234672,"about_ca_topic_score_gemma":0.0055851056,"teacher_disagreement_score":0.014451744,"about_ca_system_score_codex":0.0028392193,"about_ca_system_score_gemma":0.001671888,"threshold_uncertainty_score":0.02060008},"labels":[],"label_agreement":null},{"id":"W2521500918","doi":"10.1093/neuonc/now156","title":"Spinal column chordoma: prognostic significance of clinical variables and<i>T (brachyury</i>) gene SNP rs2305089 for local recurrence and overall survival","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia; Vancouver Coastal Health","funders":"AOSpine; AO Foundation","keywords":"Brachyury; Medicine; Hazard ratio; SNP; Chordoma; Internal medicine; Oncology; Single-nucleotide polymorphism; Overall survival; Gastroenterology; Clinical significance; Surgery; Confidence interval; Genotype; Biology; Gene","score_opus":0.06497158917130955,"score_gpt":0.36775571272676266,"score_spread":0.30278412355545314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521500918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992086,0.00026409875,0.00008916993,0.00006251086,0.0000103312095,0.0000024328199,0.00019493303,0.0000059043014,0.0001620419],"genre_scores_gemma":[0.9997749,0.000022391667,0.000042097283,0.000008407869,0.000010036402,0.0000016802402,0.000092469505,0.0000011747185,0.000046981724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997265,0.0000708904,0.000027828697,0.00009439598,0.000035329525,0.000045005105],"domain_scores_gemma":[0.9984353,0.00044023414,0.00054890744,0.00009342533,0.000082062485,0.0004000875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048059536,0.00028496288,0.00025342082,0.00037526863,0.0002638187,0.000491211,0.00032360211,0.0004364642,0.0021391017],"category_scores_gemma":[0.0021545372,0.00009827336,0.00072167144,0.0004246295,0.00030499866,0.00016411846,0.00020328678,0.00042446092,0.00025047196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004601576,0.000014448093,0.99662304,0.000007489606,0.00012974534,0.00013857828,0.000019924168,0.0001360656,0.0008187456,0.000011156703,0.00013510526,0.0015054757],"study_design_scores_gemma":[0.0000355284,0.00016987776,0.99717355,0.0000075236176,0.000171217,0.0008077909,0.00005623331,0.0010562949,0.00024624838,0.0000750255,0.00019200756,0.000008746389],"about_ca_topic_score_codex":0.0028518059,"about_ca_topic_score_gemma":0.0030821285,"teacher_disagreement_score":0.0028518059,"about_ca_system_score_codex":0.00025134682,"about_ca_system_score_gemma":0.00034093473,"threshold_uncertainty_score":0.007155955},"labels":[],"label_agreement":null},{"id":"W2525432357","doi":"10.1093/neuonc/now181","title":"Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Subspecialty; Specialty; Enthusiasm; Medicine; Oncology; Brain tumor; Internal medicine; Bioinformatics; Family medicine; Psychology; Pathology; Biology","score_opus":0.03696214214732105,"score_gpt":0.3247141807313051,"score_spread":0.287752038583984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525432357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589396,0.00039226533,0.00012409793,0.0023793753,0.00003066508,0.000048506834,0.0003056542,0.000006577564,0.0008189585],"genre_scores_gemma":[0.997735,0.0007004093,0.0002452889,0.00078962214,0.000027602027,0.00006282842,0.00027164628,0.0000043611317,0.00016313419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941216,0.0024659135,0.00071517716,0.00042941314,0.0015233922,0.00074443046],"domain_scores_gemma":[0.98349285,0.0040648193,0.006100935,0.00047061982,0.0031627154,0.0027080348],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008832418,0.00018337375,0.0002945912,0.0017870179,0.0007625445,0.0012866486,0.00048804597,0.0010782661,0.0015157842],"category_scores_gemma":[0.023716893,0.00028020563,0.00036141204,0.0019782211,0.0008893319,0.0017280543,0.0020382951,0.0010776354,0.00030121364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004649199,0.000100608566,0.97479624,0.00013642048,0.00003265036,0.0001345507,0.009618361,0.00005392872,0.00029954902,0.00008520188,0.0021131332,0.012582826],"study_design_scores_gemma":[0.000012039637,0.0003201136,0.95213646,0.00026535065,0.000017267279,0.0004326025,0.04238761,0.00040597888,0.00010299879,0.000077300356,0.003816411,0.000025705853],"about_ca_topic_score_codex":0.012054858,"about_ca_topic_score_gemma":0.008919671,"teacher_disagreement_score":0.9911676,"about_ca_system_score_codex":0.0009902074,"about_ca_system_score_gemma":0.0017110662,"threshold_uncertainty_score":0.04671091},"labels":[],"label_agreement":null},{"id":"W2547720966","doi":"10.1093/neuonc/nov213.21","title":"EPID-21ONE-YEAR INSTITUTIONAL REPORT OF THE FIRST CANADIAN ADULT NF1 MULTIDISCIPLINARY CLINIC, REPORTED IN THE CONTEXT OF SYSTEMATICALLY-IDENTIFIED EXPERIENCES OF PREVIOUSLY ESTABLISHED CENTERS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Multidisciplinary approach; Medicine; Family medicine; Context (archaeology); Biopsychosocial model; MEDLINE; Population; Health care; Gerontology; Psychiatry","score_opus":0.04892053521143061,"score_gpt":0.32048166412468815,"score_spread":0.27156112891325757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547720966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9033039,0.03341185,0.00040775805,0.006256871,0.00046134132,0.00036213043,0.009126865,0.000076252094,0.04659301],"genre_scores_gemma":[0.95929873,0.025105154,0.000597018,0.0024783472,0.00017946292,0.00014720982,0.002880889,0.000028022594,0.00928517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983779,0.00019280938,0.00016330657,0.00013851548,0.0007430023,0.00038446006],"domain_scores_gemma":[0.9945662,0.00080012553,0.0013425567,0.000113817216,0.0021946367,0.0009825137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010160054,0.0003607181,0.00028628635,0.0033037537,0.004551108,0.0022284014,0.0008980403,0.0008441194,0.0051347227],"category_scores_gemma":[0.007240293,0.00021863465,0.0003215947,0.0062187226,0.0009129542,0.00081143045,0.0014050953,0.0005369618,0.00044711973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004938447,0.00039793216,0.5808072,0.0069408915,0.00031164163,0.07701518,0.09939859,0.00031425006,0.0035022642,0.0015390399,0.06443542,0.16484365],"study_design_scores_gemma":[0.0000445052,0.00039288346,0.6654596,0.0029965315,0.0002057939,0.040885616,0.09612795,0.00016229165,0.0011709518,0.00015510911,0.1922278,0.00017100463],"about_ca_topic_score_codex":0.6066682,"about_ca_topic_score_gemma":0.79822874,"teacher_disagreement_score":0.39333183,"about_ca_system_score_codex":0.013888326,"about_ca_system_score_gemma":0.023770096,"threshold_uncertainty_score":0.7912965},"labels":[],"label_agreement":null},{"id":"W2548753106","doi":"10.1093/neuonc/nov207.09","title":"ANGI-09COMPARISON OF PROGRESSION PATTERN (PP) AND ADVERSE EVENTS (AES) WITH USE OF BEVACIZUMAB (BEV) ACROSS MULTIPLE LINES IN THE TREATMENT IN GLIOBLASTOMA (GBM)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bevacizumab; Neutropenia; Glioblastoma; Internal medicine; Adverse effect; First line treatment; Oncology; Chemotherapy","score_opus":0.04996421393103583,"score_gpt":0.3494714222726928,"score_spread":0.29950720834165695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548753106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403507,0.0019799178,0.00018139194,0.00014455125,0.000019664845,0.00005451757,0.0016863038,0.000022406806,0.0018762654],"genre_scores_gemma":[0.9975847,0.0003522808,0.00021857805,0.00007136339,0.000018255749,0.000025429463,0.0014951592,0.000004788739,0.00022939881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987179,0.00043009466,0.00018563069,0.00017830916,0.00039113424,0.0000969758],"domain_scores_gemma":[0.99757224,0.00056649157,0.0012936933,0.000081230835,0.0002629839,0.00022335467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013816193,0.00013923932,0.0003290871,0.0007473218,0.00015488369,0.0005374595,0.0002699181,0.000208575,0.0019115745],"category_scores_gemma":[0.0025854106,0.00008068439,0.0005874651,0.0010590667,0.00018955016,0.00030900314,0.0004144283,0.00045583834,0.00022479927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031704186,0.00014448444,0.9544896,0.00020251819,0.0004009302,0.00009011982,0.000064025,0.00036631373,0.0010513206,0.000051287745,0.00097305654,0.03899581],"study_design_scores_gemma":[0.00006033773,0.0014183156,0.99653983,0.000018684183,0.00014033465,0.00030952445,0.00004855644,0.00037076505,0.00029570257,0.000036150697,0.0007555402,0.000006231801],"about_ca_topic_score_codex":0.0022994473,"about_ca_topic_score_gemma":0.0050417865,"teacher_disagreement_score":0.0022994473,"about_ca_system_score_codex":0.0010450622,"about_ca_system_score_gemma":0.00076307415,"threshold_uncertainty_score":0.0075824857},"labels":[],"label_agreement":null},{"id":"W2549115354","doi":"10.1093/neuonc/now260","title":"LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Temozolomide; Glioblastoma; Medicine; Oncology; Internal medicine; Center (category theory); Cancer research","score_opus":0.015644065425058112,"score_gpt":0.28934558989492687,"score_spread":0.27370152446986873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549115354","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915549,0.0021640132,0.00040526077,0.0005535931,0.0002839851,0.0018950694,0.0013821797,0.00010489997,0.0016560724],"genre_scores_gemma":[0.9867072,0.001828833,0.0011388538,0.0011755811,0.00028473572,0.0026621497,0.0025382298,0.000035192024,0.0036291983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995159,0.00024384375,0.000025751777,0.00008813564,0.000034469318,0.000091952985],"domain_scores_gemma":[0.999302,0.00010609186,0.00020207775,0.00004978888,0.00003468744,0.00030536906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019112208,0.0022795754,0.0021798883,0.00051234773,0.00053469156,0.0014330511,0.0011486794,0.0012815448,0.0058007855],"category_scores_gemma":[0.00092474325,0.0007749784,0.0015556293,0.0005250561,0.0011626807,0.0011629332,0.0006041365,0.0033806795,0.0014174397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96482277,0.01190993,0.002091209,0.00040691695,0.0007008424,0.000050934883,0.00009805089,0.0005104144,0.004164251,0.0001497505,0.0013085977,0.01378635],"study_design_scores_gemma":[0.8275487,0.16488867,0.0047900635,0.000039216124,0.00044312805,0.00009249622,0.000068641,0.0004988056,0.0007083428,0.00020699362,0.00069006457,0.0000249236],"about_ca_topic_score_codex":0.001385327,"about_ca_topic_score_gemma":0.004133185,"teacher_disagreement_score":0.0058007855,"about_ca_system_score_codex":0.0011368699,"about_ca_system_score_gemma":0.0016867266,"threshold_uncertainty_score":0.019405544},"labels":[],"label_agreement":null},{"id":"W2549359586","doi":"10.1093/neuonc/nov219.13","title":"MTR-13EVALUATION OF p75 EXPRESSION AND PATTERNS OF RECURRENCE IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Univariate analysis; Immunohistochemistry; Neuroradiology; Progression-free survival; Glioblastoma; Oncology; Glioma; Neurology; Gastroenterology; Overall survival; Pathology; Multivariate analysis; Chemotherapy; Cancer research","score_opus":0.029585323006597636,"score_gpt":0.29354574191458965,"score_spread":0.26396041890799204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549359586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934334,0.0002692651,0.000060824987,0.00001317636,0.0000014591753,0.0000042856022,0.00004587009,0.0000036258396,0.0002581188],"genre_scores_gemma":[0.99978703,0.0000456455,0.00005426879,0.0000041765225,0.0000027911306,0.0000028481031,0.00006110147,6.939932e-7,0.000041533007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975866,0.00005626844,0.00002783031,0.000041975334,0.0000725589,0.000042645577],"domain_scores_gemma":[0.99878937,0.00018756503,0.0007329971,0.000030478725,0.00012607481,0.00013357912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044357625,0.00017217577,0.00027644951,0.0006793406,0.00017373454,0.00030206892,0.00021696441,0.00020085875,0.00075082254],"category_scores_gemma":[0.001908108,0.00009360672,0.00024186082,0.0004705072,0.00016406964,0.00021946194,0.00020165686,0.00021771707,0.00013898278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004807349,0.000015688178,0.995204,0.000010415744,0.00002578359,0.00031137172,0.00003764536,0.00005247057,0.00094886153,0.0000062250792,0.000049116272,0.002857862],"study_design_scores_gemma":[0.000008729238,0.00031859794,0.9967,0.000005686652,0.000042225747,0.0018373833,0.00006131607,0.00033390181,0.00056441285,0.000013718686,0.00011068725,0.0000033617323],"about_ca_topic_score_codex":0.0015113781,"about_ca_topic_score_gemma":0.0020623018,"teacher_disagreement_score":0.0015113781,"about_ca_system_score_codex":0.00029995447,"about_ca_system_score_gemma":0.00016114149,"threshold_uncertainty_score":0.0030052066},"labels":[],"label_agreement":null},{"id":"W2551095427","doi":"10.1093/neuonc/now245","title":"Atypical meningioma—is it time to standardize surgical sampling techniques?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto; National Institute for Health and Care Research","keywords":"Meningioma; Sampling (signal processing); Medicine; Computer science; Medical physics; Radiology; Computer vision","score_opus":0.045138378026306186,"score_gpt":0.350101644243096,"score_spread":0.3049632662167898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551095427","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034175165,0.32065615,0.1029744,0.49433792,0.030962732,0.0009875232,0.0010162189,0.0015310849,0.013358806],"genre_scores_gemma":[0.26380166,0.18410665,0.28731763,0.20572686,0.048354916,0.0025292751,0.0027527802,0.0014889047,0.003921376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97793657,0.008846778,0.0040259,0.002246094,0.0061092298,0.0008353939],"domain_scores_gemma":[0.8908054,0.044299066,0.010460327,0.013546936,0.03391998,0.0069682593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09415297,0.0010413885,0.0027774982,0.0029923937,0.0015079187,0.0067954753,0.0049378756,0.003954583,0.0036847878],"category_scores_gemma":[0.14622134,0.000589817,0.0012946571,0.0020463793,0.0044457363,0.009425394,0.0030749796,0.008931068,0.0040920186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009926568,0.00020306281,0.016270332,0.0015013472,0.00022878873,0.0003625946,0.0009819518,0.0012151949,0.0018240847,0.008112658,0.10545737,0.86285],"study_design_scores_gemma":[0.00059233024,0.0023531828,0.058443606,0.015338722,0.00053649524,0.006456256,0.005600307,0.004738737,0.004448083,0.089270495,0.81172013,0.00050166465],"about_ca_topic_score_codex":0.006841642,"about_ca_topic_score_gemma":0.010611767,"teacher_disagreement_score":0.09415297,"about_ca_system_score_codex":0.0046982137,"about_ca_system_score_gemma":0.006849559,"threshold_uncertainty_score":0.49793446},"labels":[],"label_agreement":null},{"id":"W2551691100","doi":"10.1093/neuonc/nov225.27","title":"NIMG-27USING MR PERFUSION TO STRATIFY PATIENTS WITH TREATED HIGH-GRADE GLIOMAS: DOES IT CORRELATE WITH OVERALL SURVIVAL?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Perfusion; Internal medicine; Radiology; Oncology","score_opus":0.023509079228834145,"score_gpt":0.27948855110707777,"score_spread":0.2559794718782436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551691100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814093,0.0010721214,0.00016183294,0.000080253965,0.000008637154,0.0000055684773,0.00013601407,0.0000050189597,0.00038957928],"genre_scores_gemma":[0.9995067,0.00015392185,0.00009083953,0.000014554492,0.000011351297,0.0000027731996,0.00016103419,0.0000015137575,0.000057280136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999808,0.000060534916,0.00001864364,0.00003192425,0.000040083625,0.000040878065],"domain_scores_gemma":[0.9987165,0.00030446186,0.0006259455,0.00005735681,0.000114621165,0.00018109854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089756976,0.00022233558,0.0002675828,0.0004934768,0.0001336738,0.00045765628,0.00024798786,0.00027768154,0.00095104706],"category_scores_gemma":[0.0022213333,0.000088593566,0.00034656122,0.0005393388,0.00026849436,0.00034973622,0.00021988398,0.00035394487,0.00019907016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039300352,0.000012824066,0.99637884,0.00001022105,0.000040860694,0.000037885336,0.000014492986,0.000052718908,0.00018743292,0.0000072615985,0.000057715155,0.0028067697],"study_design_scores_gemma":[0.00001227753,0.0003530608,0.99837387,0.000008662518,0.00010023844,0.00028029762,0.00006612164,0.00042068752,0.00016104539,0.000036744615,0.00018293578,0.0000038855546],"about_ca_topic_score_codex":0.0011531997,"about_ca_topic_score_gemma":0.002420869,"teacher_disagreement_score":0.0011531997,"about_ca_system_score_codex":0.00026163994,"about_ca_system_score_gemma":0.0002419194,"threshold_uncertainty_score":0.0047468543},"labels":[],"label_agreement":null},{"id":"W2553354624","doi":"10.1093/neuonc/nov209.10","title":"CBIO-10Bcl-2 FAMILY MEMBER Mcl-1 EXPRESSION IS REDUCED UNDER HYPOXIA BY THE E3 LIGASE FBW7 CONTRIBUTING TO BNIP3 INDUCED CELL DEATH IN GLIOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba","funders":"","keywords":"Ubiquitin ligase; Hypoxia (environmental); Glioma; Chemistry; Cell biology; Family member; DNA ligase; Programmed cell death; Cancer research; Biology; Biochemistry; Ubiquitin; Gene; Oxygen; Medicine; Apoptosis","score_opus":0.033434470887272895,"score_gpt":0.2908826612798435,"score_spread":0.2574481903925706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553354624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946168,0.0017926036,0.0019782737,0.0001227862,0.000015860123,0.0000104258925,0.00033302666,0.000056896442,0.001073291],"genre_scores_gemma":[0.99573994,0.000598625,0.00081289717,0.00005603093,0.0000033514905,0.00001817182,0.00070838485,0.000010521015,0.0020521109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999262,0.000006086037,0.0000047468407,0.000011592858,0.00002306531,0.000028256061],"domain_scores_gemma":[0.999969,0.000002772784,0.000009981942,0.000002975339,0.000005533077,0.000009801559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053557535,0.00015503883,0.00015487144,0.000111949455,0.00011720175,0.0001921914,0.000117403644,0.00015701364,0.0013779484],"category_scores_gemma":[0.000047039284,0.00008551351,0.00016006769,0.000097785676,0.00011853734,0.00012318743,0.00013978289,0.0004357265,0.00035600158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058219368,0.000011784824,0.0001528304,0.00002067806,0.000003610511,0.00002867116,0.000005928116,0.000021560794,0.9990742,0.000036363883,0.000036311827,0.00054974545],"study_design_scores_gemma":[0.0000067913293,0.00009006058,0.0075105266,0.0000033156898,0.000008727943,0.00027909645,0.000023263196,0.0005524559,0.99000275,0.000029697727,0.0014910613,0.0000022887457],"about_ca_topic_score_codex":0.0012523952,"about_ca_topic_score_gemma":0.0010957547,"teacher_disagreement_score":0.0013779484,"about_ca_system_score_codex":0.00025713193,"about_ca_system_score_gemma":0.00013923348,"threshold_uncertainty_score":0.0046096444},"labels":[],"label_agreement":null},{"id":"W2553699491","doi":"10.1093/neuonc/nov204.95","title":"ATPS-95THE PROGNOSTIC AND PREDICTIVE VALUE OF AN EXPLANT ASSAY OF GLIOMAS IN RESPONSE TO TEMOZOLOMIDE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Glioma; Explant culture; Medicine; Pathological; Anaplastic astrocytoma; Pathology; Brain tumor; IDH1; Dacarbazine; Predictive marker; Glioblastoma; Cancer research; Oncology; Chemotherapy; Internal medicine; Biology; Astrocytoma; In vitro; Cancer; Mutation","score_opus":0.030364983491246222,"score_gpt":0.3164130155164132,"score_spread":0.286048032025167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553699491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979387,0.00081734237,0.00053121935,0.000028155397,0.000024108438,0.0000090222065,0.0003508863,0.000021672355,0.00027882645],"genre_scores_gemma":[0.9983437,0.00022899781,0.0005097474,0.000011084128,0.0000113548185,0.000010176443,0.00067854574,0.0000025399506,0.00020390966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977833,0.00004804808,0.000020330135,0.000046950176,0.00008068724,0.000025651361],"domain_scores_gemma":[0.9992113,0.00018874805,0.00028188332,0.00007616516,0.00012227609,0.00011962733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033401034,0.0003028521,0.00030392173,0.00048869726,0.00013471977,0.00054804445,0.00023472615,0.00023259367,0.00090932584],"category_scores_gemma":[0.0010249526,0.00010914371,0.00016576101,0.00032622018,0.0002053246,0.00012848525,0.00019928381,0.00040951572,0.00030196784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030578554,0.00016013812,0.82404786,0.00007910065,0.00012615391,0.00039061232,0.000116497846,0.0005527142,0.15551715,0.00003465804,0.0003846683,0.01553254],"study_design_scores_gemma":[0.00004375883,0.002578901,0.89473695,0.000020913165,0.000154281,0.0025113001,0.0002417836,0.0036842448,0.09455797,0.00007198784,0.0013770827,0.00002086426],"about_ca_topic_score_codex":0.000606795,"about_ca_topic_score_gemma":0.00069750246,"teacher_disagreement_score":0.00090932584,"about_ca_system_score_codex":0.00019620884,"about_ca_system_score_gemma":0.00011718454,"threshold_uncertainty_score":0.0030419827},"labels":[],"label_agreement":null},{"id":"W2555250050","doi":"10.1093/neuonc/nov216.17","title":"HCP-17RETROSPECTIVE ANALYSIS OF PNEUMOCYSTIS JIROVECI IN BRAIN TUMOR PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prednisone; Incidence (geometry); Population; Internal medicine; Cohort; Corticosteroid; Pneumonia; Retrospective cohort study; Contraindication; Pediatrics; Pathology","score_opus":0.021319200323444986,"score_gpt":0.30519448300685786,"score_spread":0.2838752826834129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555250050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961671,0.0007538609,0.00010330253,0.00011130715,0.000023051865,0.00003281259,0.0009772972,0.000010540677,0.0018206404],"genre_scores_gemma":[0.9978206,0.00040030302,0.00019113977,0.00010563979,0.000031532545,0.000029331864,0.0010731694,0.0000044640074,0.00034373414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995134,0.000056975856,0.0000623174,0.00008245611,0.00013451498,0.00015035238],"domain_scores_gemma":[0.9986646,0.00012021656,0.00045779545,0.000052388863,0.00039309863,0.0003118864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000400457,0.00021190272,0.0003077372,0.001719216,0.0005385356,0.0007760474,0.0002972704,0.0003650772,0.0015972097],"category_scores_gemma":[0.0013631287,0.00015532708,0.00030855893,0.0012408451,0.00033540145,0.0004302908,0.0004384504,0.0005295312,0.00038293845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009545734,0.000022831395,0.99615186,0.000017639151,0.000011964455,0.0006419735,0.00008408108,0.00001638152,0.00074801274,0.000015848618,0.00023197893,0.0019619113],"study_design_scores_gemma":[0.0000033692204,0.0001272225,0.9963342,0.000016515418,0.000015077897,0.0017768512,0.00032864115,0.000078598234,0.00047294912,0.000017863744,0.0008247341,0.000003939814],"about_ca_topic_score_codex":0.004794557,"about_ca_topic_score_gemma":0.0053442344,"teacher_disagreement_score":0.004794557,"about_ca_system_score_codex":0.0005321603,"about_ca_system_score_gemma":0.0005106075,"threshold_uncertainty_score":0.009533346},"labels":[],"label_agreement":null},{"id":"W2557786287","doi":"10.1093/neuonc/now212.100","title":"ATIM-35. RESULTS OF THE PHASE IB KEYNOTE-028 MULTI-COHORT TRIAL OF PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT PD-L1-POSITIVE GLIOBLASTOMA MULTIFORME (GBM)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Rash; Clinical endpoint; Cohort; Oncology; Surgery; Clinical trial; Gastroenterology; Immunotherapy; Cancer","score_opus":0.015537324857194883,"score_gpt":0.3030960722070924,"score_spread":0.2875587473498975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557786287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9434376,0.013926982,0.0012232569,0.002222292,0.0006106633,0.0040003336,0.0181628,0.00049387035,0.015922178],"genre_scores_gemma":[0.96952224,0.003507432,0.0020600937,0.0023275078,0.0003299361,0.0017844106,0.015660228,0.000050539278,0.004757546],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995492,0.00021714339,0.0000317848,0.000082629886,0.000049443574,0.00006972775],"domain_scores_gemma":[0.9995364,0.00007911024,0.00012546872,0.000031742224,0.000028056582,0.00019935978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022676156,0.0009840792,0.00082341756,0.00041849536,0.000396496,0.00086001266,0.0006028075,0.0008915505,0.0054242],"category_scores_gemma":[0.0014508291,0.00032361507,0.0010898333,0.00033947197,0.00038737216,0.00065513665,0.00037561439,0.0020216655,0.0010492497],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6163922,0.016126726,0.02492283,0.0025158594,0.006078141,0.0004489108,0.00034823312,0.004391069,0.035354014,0.0013773676,0.05543138,0.23661321],"study_design_scores_gemma":[0.6878206,0.16977304,0.08617101,0.0002827073,0.004626492,0.0009523327,0.00010719977,0.0027152027,0.0050422233,0.0012690995,0.041159805,0.00008027452],"about_ca_topic_score_codex":0.0007117823,"about_ca_topic_score_gemma":0.0035746982,"teacher_disagreement_score":0.0054242,"about_ca_system_score_codex":0.00079752447,"about_ca_system_score_gemma":0.00070143,"threshold_uncertainty_score":0.01814574},"labels":[],"label_agreement":null},{"id":"W2558450726","doi":"10.1093/neuonc/now212.048","title":"ACTR-50. MARIZOMIB (MRZ) WITH BEVACIZUMAB (BEV) IN WHO GRADE IV MALIGNANT GLIOMA (G4 MG): FULL ENROLLMENT RESULTS FROM THE PHASE 1, MULTICENTER, OPEN-LABEL STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Internal medicine; Population; Progressive disease; Cohort; Surgery; Tolerability; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.05990842500613037,"score_gpt":0.3412815241594815,"score_spread":0.2813730991533511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558450726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929007,0.0024896862,0.00032440043,0.00031576498,0.00007749711,0.0006929137,0.0007658041,0.00015228256,0.0022808851],"genre_scores_gemma":[0.99149865,0.002337512,0.00063012866,0.0004469364,0.00008883633,0.0005023857,0.0018280754,0.000030979245,0.0026364499],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997508,0.00010201409,0.000014232531,0.000034231467,0.000033584805,0.00006513361],"domain_scores_gemma":[0.9998154,0.00002101254,0.00004158924,0.0000154155,0.00001186517,0.00009470168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069892243,0.00082852546,0.0009423008,0.00035694614,0.00022842543,0.0006204702,0.0005700271,0.00070527045,0.0027602566],"category_scores_gemma":[0.00039696647,0.00042714007,0.00080837624,0.0002837332,0.00041992942,0.0005468271,0.00019135301,0.0015653111,0.00094751845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52537084,0.06675051,0.01047737,0.0011685537,0.0017614968,0.00056405854,0.00043270274,0.003458583,0.13483621,0.0005074086,0.0143161025,0.24035618],"study_design_scores_gemma":[0.30198392,0.6188098,0.045353584,0.00008711498,0.001034157,0.0007044604,0.00011198882,0.002245381,0.017385432,0.0003078599,0.011930725,0.00004553262],"about_ca_topic_score_codex":0.0021735725,"about_ca_topic_score_gemma":0.006111093,"teacher_disagreement_score":0.0027602566,"about_ca_system_score_codex":0.0008096158,"about_ca_system_score_gemma":0.0009530576,"threshold_uncertainty_score":0.009234011},"labels":[],"label_agreement":null},{"id":"W2558690325","doi":"10.1093/neuonc/now212.068","title":"ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Interim analysis; Temozolomide; Hazard ratio; Internal medicine; Oncology; Cohort; Clinical endpoint; Confidence interval; Randomized controlled trial; Chemotherapy","score_opus":0.052725915880982036,"score_gpt":0.37631285673129805,"score_spread":0.32358694085031603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558690325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724629,0.0058470224,0.0017051618,0.0011267879,0.00060904335,0.006297969,0.0038233642,0.00094248116,0.0071852114],"genre_scores_gemma":[0.9679252,0.0035483597,0.0035212666,0.0026969716,0.00032172175,0.008314193,0.004507675,0.00010387657,0.009060695],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999744,0.000109250854,0.00001093858,0.00004292805,0.000018885685,0.000074037336],"domain_scores_gemma":[0.99972016,0.000042457676,0.000054558914,0.000025349784,0.000019094663,0.00013833657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010870518,0.0019067761,0.0016674196,0.00063956255,0.00038845456,0.0009901272,0.001090993,0.001317801,0.0049069165],"category_scores_gemma":[0.00058061717,0.0005210171,0.0013088383,0.0004227925,0.00084304786,0.00067392166,0.00028164417,0.0031715536,0.0013683185],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83973134,0.030653715,0.001314323,0.0010818603,0.0010353619,0.00015226493,0.00018272713,0.0017964991,0.024281582,0.0007895062,0.009842736,0.08913811],"study_design_scores_gemma":[0.86307335,0.12717772,0.0025781502,0.000040930438,0.00028413575,0.00014083968,0.000028454077,0.0009653777,0.0024387352,0.00039575747,0.0028472606,0.000029207064],"about_ca_topic_score_codex":0.0011179316,"about_ca_topic_score_gemma":0.0026014885,"teacher_disagreement_score":0.0049069165,"about_ca_system_score_codex":0.000814537,"about_ca_system_score_gemma":0.0014637482,"threshold_uncertainty_score":0.016415298},"labels":[],"label_agreement":null},{"id":"W2559197523","doi":"10.1093/neuonc/now212.070","title":"ATIM-05. COMPLEMENTARY CLINICAL AND ANCILLARY DATA FROM 123 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Immune system; Tumor microenvironment; Glioma; Cancer research; Medicine; Immunology","score_opus":0.17535777439306974,"score_gpt":0.4485427401079663,"score_spread":0.2731849657148966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559197523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82608294,0.030903555,0.004593995,0.0072133597,0.00080444897,0.0064080968,0.07602587,0.0013039856,0.0466637],"genre_scores_gemma":[0.8904556,0.0071610142,0.005343686,0.0065001952,0.00056634564,0.0048338557,0.07536051,0.00021456344,0.009564255],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990107,0.0005158803,0.000070568705,0.00012402261,0.00013636427,0.00014240609],"domain_scores_gemma":[0.99831843,0.00054742076,0.00034836223,0.0002089427,0.00015514722,0.00042175557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029203075,0.0011653661,0.0021453714,0.00072507723,0.0005416336,0.0012705723,0.0011295048,0.0013856014,0.009833737],"category_scores_gemma":[0.0026894046,0.0004059252,0.0019676585,0.000893957,0.00046978254,0.000977179,0.0004501791,0.0022448003,0.0025759805],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30864725,0.012211473,0.027568698,0.0032551074,0.0069318353,0.000659527,0.00035291657,0.0034710516,0.03407366,0.0011405939,0.09735847,0.5043295],"study_design_scores_gemma":[0.39925668,0.290641,0.12570752,0.0005222623,0.008849439,0.0034897218,0.00021789766,0.0031422132,0.01513932,0.0023939353,0.15045373,0.00018628551],"about_ca_topic_score_codex":0.0015102905,"about_ca_topic_score_gemma":0.0048692515,"teacher_disagreement_score":0.009833737,"about_ca_system_score_codex":0.0013169089,"about_ca_system_score_gemma":0.0010833606,"threshold_uncertainty_score":0.032897055},"labels":[],"label_agreement":null},{"id":"W2559587137","doi":"10.1093/neuonc/now212.003","title":"ACTR-04. RESULTS OF THE INTERIM ANALYSIS OF THE EORTC RANDOMIZED PHASE III CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CO-DELETION, AN INTERGROUP TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Interim analysis; Medicine; Internal medicine; Oncology; Glioma; Adjuvant; Clinical endpoint; Randomized controlled trial; Chemotherapy; Cancer research","score_opus":0.03145773734539179,"score_gpt":0.3595383140764256,"score_spread":0.3280805767310338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559587137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7448214,0.02278298,0.007368976,0.010743608,0.006228036,0.017523779,0.1037604,0.0015128717,0.08525795],"genre_scores_gemma":[0.8419907,0.0043395855,0.010058978,0.009036786,0.001468611,0.016466908,0.077317566,0.0005315539,0.038789257],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971866,0.002204397,0.00008224886,0.00015181718,0.0002103401,0.00016464705],"domain_scores_gemma":[0.9972063,0.0010352939,0.00050593185,0.0003263171,0.0002495607,0.0006766337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005630826,0.0010760834,0.001797407,0.00042305517,0.0003222057,0.0011141187,0.00070663955,0.0013466958,0.013655127],"category_scores_gemma":[0.0055203727,0.00039074355,0.001681558,0.00043692,0.00042506613,0.0005924572,0.00033207485,0.0027969487,0.0027269842],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8921163,0.0044664256,0.0030621663,0.00088569836,0.0020177069,0.00014828054,0.0000423307,0.0020132428,0.0028639243,0.000984451,0.04654697,0.04485241],"study_design_scores_gemma":[0.8272107,0.10453869,0.021532584,0.0001930176,0.0045376555,0.00030153623,0.00003851651,0.0033711924,0.0023233492,0.0019729033,0.03392757,0.00005223524],"about_ca_topic_score_codex":0.00077216176,"about_ca_topic_score_gemma":0.0026532474,"teacher_disagreement_score":0.013655127,"about_ca_system_score_codex":0.00068085955,"about_ca_system_score_gemma":0.001429497,"threshold_uncertainty_score":0.04568094},"labels":[],"label_agreement":null},{"id":"W2561692137","doi":"10.1093/neuonc/now265","title":"Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Institute for Health and Care Research","keywords":"Nivolumab; Glioblastoma; Medicine; Oncology; Term (time); Internal medicine; Cancer; Immunotherapy; Cancer research","score_opus":0.010175273140638838,"score_gpt":0.290065638029209,"score_spread":0.27989036488857016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561692137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987956,0.012814563,0.0027857404,0.001396579,0.00022714776,0.00019992817,0.00016834275,0.00020850395,0.0023195979],"genre_scores_gemma":[0.9960949,0.0014155612,0.0005304504,0.00072208146,0.0001442049,0.000036874244,0.0004030163,0.000014905448,0.00063814595],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998604,0.000020596555,0.000020735226,0.000025164294,0.000020202786,0.000052974156],"domain_scores_gemma":[0.9997191,0.000049937033,0.00004894166,0.000038519447,0.000020234347,0.00012314931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025387813,0.00042728262,0.00066337956,0.00040590565,0.00038203926,0.00029785818,0.00047594844,0.0007305503,0.00034264932],"category_scores_gemma":[0.00069022964,0.00015743957,0.00050344114,0.000193472,0.00032761614,0.00029674228,0.0003303703,0.0012716274,0.00025626872],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012763838,0.0028167325,0.060113434,0.0009953589,0.00046499228,0.41037154,0.00086384977,0.0034442316,0.11683091,0.0010663657,0.004997224,0.38527167],"study_design_scores_gemma":[0.0019257714,0.0344722,0.37573248,0.0003371419,0.000507234,0.49252194,0.0003073536,0.012092523,0.05152076,0.002469147,0.027909033,0.0002044355],"about_ca_topic_score_codex":0.0009513938,"about_ca_topic_score_gemma":0.002753305,"teacher_disagreement_score":0.0009513938,"about_ca_system_score_codex":0.00052747794,"about_ca_system_score_gemma":0.00032366876,"threshold_uncertainty_score":0.003827095},"labels":[],"label_agreement":null},{"id":"W2562988259","doi":"10.1093/neuonc/now188.180","title":"P08.47 Dianhydrogalactitol (VAL-083) causes bifunctional alkylation leading to irreparable DNA double-strand breaks, S/G2 phase cell-cycle arrest and tumor cell death in an MGMT independent manner offering a unique treatment paradigm for GBM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Cell cycle checkpoint; Double strand; Cell cycle; Cell biology; DNA; Programmed cell death; Cancer research; DNA repair; Chemistry; Biology; Cell; Apoptosis; Genetics","score_opus":0.03600810494761814,"score_gpt":0.3269535239535203,"score_spread":0.29094541900590215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562988259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762958,0.006215462,0.007871822,0.00053507247,0.00016393435,0.00018042068,0.0013999762,0.00022896926,0.0071084383],"genre_scores_gemma":[0.9727352,0.00564464,0.004870241,0.00018807015,0.0000499848,0.00008297549,0.0029524378,0.00004720205,0.013429256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999151,0.000015918691,0.0000055318765,0.0000135719765,0.000025786694,0.000024196741],"domain_scores_gemma":[0.99996257,0.0000038850994,0.000010651302,0.000005305705,0.000007766439,0.000009878709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014813183,0.00034019072,0.00013740468,0.00014003209,0.00013567529,0.00017805607,0.00020022431,0.0002213554,0.0018179163],"category_scores_gemma":[0.00007808742,0.00008497012,0.00016094325,0.00013763101,0.0001526191,0.00016517597,0.00019309144,0.00043365176,0.0006027013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016412753,0.000101433216,0.00031741094,0.00008220088,0.000006318469,0.000095540105,0.000018056811,0.00009957117,0.9900193,0.00032838454,0.00043685586,0.008330669],"study_design_scores_gemma":[0.000026895603,0.0006410792,0.0020710244,0.0000047605126,0.000016503709,0.00031567682,0.000016119942,0.0003866577,0.9826415,0.000059908787,0.013814943,0.0000048222723],"about_ca_topic_score_codex":0.0006279917,"about_ca_topic_score_gemma":0.0007108932,"teacher_disagreement_score":0.0018179163,"about_ca_system_score_codex":0.00017509692,"about_ca_system_score_gemma":0.00025543882,"threshold_uncertainty_score":0.0060815215},"labels":[],"label_agreement":null},{"id":"W2564916912","doi":"10.1093/neuonc/now212.106","title":"BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Hazard ratio; Performance status; Lung; Brain metastasis; Cancer; Metastasis; Confidence interval","score_opus":0.013344724573392022,"score_gpt":0.36020624101857973,"score_spread":0.3468615164451877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564916912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44180048,0.23608387,0.04893254,0.056678884,0.010946509,0.0035103443,0.107226945,0.0025730426,0.092247374],"genre_scores_gemma":[0.64864445,0.06805799,0.08153962,0.0128241265,0.0049687754,0.003661288,0.16308148,0.00057569495,0.016646516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854916,0.0006565106,0.00017374541,0.00009636492,0.00044145444,0.00008261604],"domain_scores_gemma":[0.99813664,0.00043589697,0.00026653014,0.00013860897,0.0007174092,0.00030488463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004365842,0.0005609117,0.0010054144,0.0014264706,0.00024621666,0.0015541131,0.0010694044,0.0005641596,0.0016784662],"category_scores_gemma":[0.006258009,0.00018145288,0.00085403473,0.0021276027,0.00021873642,0.0007672975,0.0007610266,0.0012247062,0.0010778969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034460886,0.00024010817,0.088232785,0.0015949709,0.0006821245,0.00017884058,0.00006296428,0.0030627998,0.0019579544,0.0017155396,0.09550623,0.8033197],"study_design_scores_gemma":[0.0035901486,0.003770792,0.34345153,0.0020139054,0.0019838572,0.0030593104,0.00012662387,0.01966015,0.0043687355,0.0052359225,0.61255723,0.00018182748],"about_ca_topic_score_codex":0.0026348173,"about_ca_topic_score_gemma":0.006164141,"teacher_disagreement_score":0.004365842,"about_ca_system_score_codex":0.0010983491,"about_ca_system_score_gemma":0.001815299,"threshold_uncertainty_score":0.023089051},"labels":[],"label_agreement":null},{"id":"W2565057278","doi":"10.1093/neuonc/now236","title":"Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"University of California, San Francisco; National Cancer Institute; NRG Oncology; Ohio State University","keywords":"Temozolomide; Medicine; Anaplastic astrocytoma; Internal medicine; Nitrosourea; Radiation therapy; Hazard ratio; Oncology; Progression-free survival; Dacarbazine; Phases of clinical research; Toxicity; Astrocytoma; Gastroenterology; Glioma; Chemotherapy; Confidence interval; Cancer research","score_opus":0.027742158024968402,"score_gpt":0.3396604815050475,"score_spread":0.31191832348007914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565057278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871197,0.0028616348,0.0010582063,0.0006050783,0.00028677392,0.0053869816,0.0011586213,0.000092945105,0.0014301094],"genre_scores_gemma":[0.9788253,0.0027947614,0.0035289526,0.0013459314,0.00034303466,0.008691855,0.0016659906,0.000054762986,0.0027494654],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987418,0.0009566583,0.000043998996,0.00009007059,0.000071738395,0.00009565735],"domain_scores_gemma":[0.9982686,0.0005514681,0.00041611717,0.00012400119,0.00010424376,0.0005355625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041178255,0.0014021671,0.002958429,0.0004740644,0.00041422172,0.00085956906,0.0009646363,0.0012417472,0.0039694672],"category_scores_gemma":[0.0021261747,0.00059137854,0.0020353845,0.00058409263,0.00087604433,0.0005170117,0.000408892,0.0027839257,0.00067442405],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97160363,0.009115287,0.0011640649,0.0002124376,0.0008563448,0.00003292186,0.000050078004,0.0005483422,0.0027078253,0.000060184226,0.00075286767,0.012895976],"study_design_scores_gemma":[0.88600385,0.1089145,0.0026181317,0.00002184138,0.0005601962,0.00004460667,0.000017850301,0.00054812204,0.0004556328,0.00009817086,0.0007070985,0.000010056828],"about_ca_topic_score_codex":0.0013218423,"about_ca_topic_score_gemma":0.0033407009,"teacher_disagreement_score":0.0041178255,"about_ca_system_score_codex":0.0009782438,"about_ca_system_score_gemma":0.002660142,"threshold_uncertainty_score":0.021777451},"labels":[],"label_agreement":null},{"id":"W2565096807","doi":"10.1093/neuonc/now212.111","title":"BMET-11. DURAL METASTASES FROM BREAST CANCER - CASE SERIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Breast cancer; Headaches; Radiology; Asymptomatic; Cancer; Weakness; Surgery; Quadrantectomy; Radiation therapy; Craniotomy; Internal medicine; Mastectomy","score_opus":0.016235027392855036,"score_gpt":0.319584573768783,"score_spread":0.303349546375928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565096807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919621,0.014591472,0.003309426,0.002251808,0.00091058435,0.00079738186,0.0020219304,0.00044868368,0.056047693],"genre_scores_gemma":[0.985851,0.003523636,0.0013452179,0.00076020363,0.0008345486,0.00010581064,0.0008932129,0.000075314514,0.006611125],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99928325,0.0000787691,0.00011614659,0.00016034514,0.00012359461,0.00023785232],"domain_scores_gemma":[0.9988105,0.00022043019,0.0003272594,0.0001712699,0.000080166246,0.00039034363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026772672,0.0022997765,0.00078927155,0.002286454,0.0024399816,0.0018941135,0.0009210909,0.0029390808,0.011276547],"category_scores_gemma":[0.0023452109,0.00082694483,0.0009638393,0.0017497403,0.0011427351,0.0010866703,0.0013085342,0.001857051,0.0059554144],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011664439,0.00011932083,0.012142958,0.0001402734,0.00002596307,0.97903204,0.00017382698,0.00010668588,0.00076735026,0.00015311458,0.0011493805,0.0060724807],"study_design_scores_gemma":[0.000024250749,0.00004699239,0.0059825745,0.00003612393,0.000025266669,0.99026006,0.000073674826,0.00012938253,0.00041190235,0.000106463725,0.0028943387,0.000008925429],"about_ca_topic_score_codex":0.0022227776,"about_ca_topic_score_gemma":0.0031106714,"teacher_disagreement_score":0.011276547,"about_ca_system_score_codex":0.00090389495,"about_ca_system_score_gemma":0.00045820302,"threshold_uncertainty_score":0.03772378},"labels":[],"label_agreement":null},{"id":"W2565306870","doi":"10.1093/neuonc/now212.202","title":"DDIS-11. MOLECULAR MECHANISMS OF DIANHYDROGALACTITOL (VAL-083) IN OVERCOMING CHEMO-RESISTANCE IN GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Bevacizumab; Medicine; Cell cycle; DNA damage; Methyltransferase; Cancer; Glioma; Chemotherapy; Biology; Internal medicine; DNA; Methylation; Genetics","score_opus":0.008470725462263734,"score_gpt":0.24621537600547874,"score_spread":0.237744650543215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565306870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7729019,0.15709805,0.00693247,0.0030699638,0.000979069,0.0012602429,0.004660836,0.0009850166,0.052112438],"genre_scores_gemma":[0.9298521,0.044485502,0.002550758,0.0006836397,0.00010765989,0.00031389119,0.002726749,0.000043784625,0.01923587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999249,0.00001190561,0.0000063854072,0.000013378397,0.000014488443,0.000028777953],"domain_scores_gemma":[0.99997246,0.0000027542344,0.0000070708124,0.0000026666255,0.0000043040295,0.000010847513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017223868,0.0005014844,0.00036395265,0.0003322842,0.00018073956,0.00037153417,0.00039996504,0.00044558675,0.0030480016],"category_scores_gemma":[0.00006313117,0.00015880678,0.0003630866,0.0002668516,0.00020800406,0.00022080312,0.00022683069,0.00074289186,0.0008130245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042515267,0.001934699,0.0019750656,0.0020439308,0.0001235039,0.00080724125,0.00012495603,0.003059027,0.74909705,0.0077501554,0.008061681,0.22077113],"study_design_scores_gemma":[0.0010964203,0.012452367,0.011632913,0.00018107187,0.00019312867,0.0021841081,0.00007391043,0.003940725,0.8446604,0.0017958275,0.1217519,0.000037238824],"about_ca_topic_score_codex":0.0009219465,"about_ca_topic_score_gemma":0.0021681478,"teacher_disagreement_score":0.0030480016,"about_ca_system_score_codex":0.00071629963,"about_ca_system_score_gemma":0.00037991913,"threshold_uncertainty_score":0.010196567},"labels":[],"label_agreement":null},{"id":"W2565483775","doi":"10.1093/neuonc/nov225.46","title":"NIMG-46THE USE OF CLINICAL FUNCTIONAL MAGNETIC RESONANCE IMAGING IN BRAIN TUMOUR PATIENTS FOR SURGICAL PLANNING: A SINGLE-SURGEON RETROSPECTIVE COHORT STUDY AT A CANADIAN CENTER","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Magnetic resonance imaging; Retrospective cohort study; Functional magnetic resonance imaging; Cohort; Radiology; Single Center; Craniotomy; Surgery; Internal medicine","score_opus":0.07991805477323974,"score_gpt":0.34432109621601004,"score_spread":0.26440304144277027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565483775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970132,0.00032365418,0.00008834933,0.00008532402,0.000008954737,0.00007753069,0.0011336497,0.000007380479,0.0012619519],"genre_scores_gemma":[0.99813557,0.00036734183,0.0001528258,0.0001132214,0.000011484792,0.000037307585,0.0008705153,0.000010861135,0.0003007478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983296,0.00012301157,0.00011880264,0.00033846288,0.0006355309,0.00045462206],"domain_scores_gemma":[0.99623376,0.00023890198,0.0015899776,0.00022989705,0.00095005124,0.0007574519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009814715,0.0005321281,0.00054920197,0.0025120822,0.0025955525,0.0015221294,0.0009854875,0.00048192323,0.003111334],"category_scores_gemma":[0.0029146052,0.0007547505,0.0006864694,0.0037143733,0.0008779679,0.00063266035,0.0011743075,0.00072408776,0.00064161385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003515775,0.00002483291,0.9978865,0.000013227229,0.00002275122,0.00026935403,0.00030685277,0.000015197031,0.00017019565,0.000016727927,0.00022242157,0.0010167109],"study_design_scores_gemma":[0.0000063412367,0.00008680459,0.99664354,0.000028680177,0.000028097438,0.0010106429,0.0014486279,0.000088355824,0.00008473087,0.000014697083,0.0005437838,0.00001564501],"about_ca_topic_score_codex":0.6143959,"about_ca_topic_score_gemma":0.7331218,"teacher_disagreement_score":0.6143959,"about_ca_system_score_codex":0.008362704,"about_ca_system_score_gemma":0.013345796,"threshold_uncertainty_score":0.7757499},"labels":[],"label_agreement":null},{"id":"W2566232150","doi":"10.1093/neuonc/now212.133","title":"BMET-33. MORBIDITY AND MORTALITY OF OMMAYA RESERVOIR PLACEMENT FOR INTRAVENTRICULAR CHEMOTHERAPY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Ommaya reservoir; Surgery; Neurosurgery; Catheter; Asymptomatic; Chemotherapy","score_opus":0.046723084578629455,"score_gpt":0.3482639015584887,"score_spread":0.30154081697985924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566232150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802805,0.0039258124,0.0005686174,0.000432967,0.00013543587,0.000030893636,0.00083316496,0.00004723591,0.005997961],"genre_scores_gemma":[0.9974704,0.00089832867,0.0001519557,0.00011915986,0.00009956587,0.000024072478,0.0006681723,0.000012306422,0.00055612664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996691,0.00006086855,0.000037033107,0.000038738253,0.00011753931,0.0000767578],"domain_scores_gemma":[0.99855274,0.00032268732,0.00059730536,0.00005373918,0.00008965884,0.00038382117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022619247,0.00019226325,0.00031162286,0.0005347,0.00046785112,0.0004906815,0.00026675215,0.0003232469,0.00407445],"category_scores_gemma":[0.0020071608,0.000089250214,0.00032511458,0.00067860744,0.00023964436,0.00031225628,0.0003867285,0.00065846555,0.00076787284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041766974,0.00009409048,0.9607345,0.000077206445,0.00006121195,0.005598858,0.00005565842,0.00018054254,0.0005984295,0.000101183476,0.0022668994,0.029813843],"study_design_scores_gemma":[0.000046230085,0.0006619834,0.9452387,0.00012251092,0.00005867731,0.049505558,0.00015949675,0.00073772145,0.0007093732,0.0001817223,0.0025650251,0.000013066857],"about_ca_topic_score_codex":0.00067432574,"about_ca_topic_score_gemma":0.0010553524,"teacher_disagreement_score":0.00407445,"about_ca_system_score_codex":0.0005880682,"about_ca_system_score_gemma":0.00043398797,"threshold_uncertainty_score":0.01363039},"labels":[],"label_agreement":null},{"id":"W2566482839","doi":"10.1093/neuonc/nov215.25","title":"GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Somatic hypermutation; Oncology; Medicine; Exome sequencing; Glioma; Cancer research; Cohort; Internal medicine; Mutation; Frameshift mutation; IDH1; DNA mismatch repair; Biology; Gene; Genetics; Cancer; Immunology; Antibody","score_opus":0.0279153896075524,"score_gpt":0.3266087347027697,"score_spread":0.2986933450952173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566482839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997757,0.00004692588,0.000012902095,0.0000069143634,6.822865e-7,0.00000232949,0.00007010671,0.0000013402827,0.000083126215],"genre_scores_gemma":[0.99946684,0.000061884006,0.00003117248,0.000017068962,0.0000037353482,0.000003280824,0.00030468305,0.0000014969212,0.00010980679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999243,0.000009047282,0.0000062818763,0.00003094172,0.000014649968,0.000014781324],"domain_scores_gemma":[0.99983954,0.000017757528,0.000045178127,0.000017572485,0.000017552387,0.000062374005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010889452,0.00018599951,0.00028890598,0.00037945184,0.00023285016,0.00030938606,0.00015448102,0.00015653274,0.0008022166],"category_scores_gemma":[0.00036470912,0.00011476549,0.00017216298,0.0002775664,0.00013234804,0.00018353679,0.00026066316,0.00028584886,0.00014691212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008257105,0.000115124276,0.9805234,0.000010034602,0.000064832,0.001129531,0.00025211033,0.00014179447,0.008456139,0.00002164834,0.00025264078,0.008207037],"study_design_scores_gemma":[0.000015018457,0.00032379737,0.99657,0.0000026113999,0.000032421558,0.0018797043,0.00010653079,0.00023959557,0.00042771304,0.000016122165,0.00038223725,0.0000041944795],"about_ca_topic_score_codex":0.0019798628,"about_ca_topic_score_gemma":0.0029568723,"teacher_disagreement_score":0.0019798628,"about_ca_system_score_codex":0.00017490737,"about_ca_system_score_gemma":0.00012051569,"threshold_uncertainty_score":0.003936708},"labels":[],"label_agreement":null},{"id":"W2566967253","doi":"10.1093/neuonc/now212.040","title":"ACTR-42. CLINICAL TRIALS OF VAL-083 IN PATIENTS WITH CHEMORESISTANT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Clinical trial; Internal medicine; Phases of clinical research; Biomarker; Chemotherapy; Biology","score_opus":0.05183609190472253,"score_gpt":0.37806067276732785,"score_spread":0.3262245808626053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566967253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96156883,0.010045705,0.0005917235,0.0024702875,0.000653439,0.006716891,0.0026153843,0.0005427087,0.014795063],"genre_scores_gemma":[0.9733691,0.004671498,0.0015603071,0.003277874,0.00029014706,0.005959376,0.003271032,0.000059203176,0.007541458],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992748,0.00043697687,0.000028607152,0.00008222389,0.000056076733,0.00012137644],"domain_scores_gemma":[0.99947494,0.00006031413,0.000074997675,0.00004186457,0.000044147935,0.0003037276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019558968,0.0015659342,0.0015899272,0.00073659804,0.00055486214,0.0010232754,0.00080372475,0.0017371137,0.005683988],"category_scores_gemma":[0.0009252275,0.00057308,0.0012853201,0.0006438454,0.00079541834,0.00071583595,0.00041294176,0.0032684417,0.0015188573],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76020485,0.040958673,0.0024243672,0.0012703727,0.0012335582,0.00035666267,0.00034137483,0.0020403403,0.023572747,0.0010255699,0.0121577205,0.15441386],"study_design_scores_gemma":[0.6097693,0.36697695,0.008051119,0.00010754268,0.00029682938,0.00023956536,0.000076118355,0.0009857548,0.0019956615,0.00073112553,0.0107236765,0.000046442798],"about_ca_topic_score_codex":0.0015155171,"about_ca_topic_score_gemma":0.004687352,"teacher_disagreement_score":0.005683988,"about_ca_system_score_codex":0.00081924326,"about_ca_system_score_gemma":0.0017073489,"threshold_uncertainty_score":0.019014835},"labels":[],"label_agreement":null},{"id":"W2573071046","doi":"10.1093/neuonc/nov235.28","title":"SURG-28NEUROSURGICAL INTRAOPERATIVE SPECTROSCOPY: TOWARDS REAL-TIME CNS TUMOUR BIOPSIES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Gold standard (test); Biomarker; In vivo; Radiology; In vivo magnetic resonance spectroscopy; Pathology; Medical physics; Magnetic resonance imaging; Biology","score_opus":0.024620185100000518,"score_gpt":0.3502899729657816,"score_spread":0.3256697878657811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573071046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9186057,0.006465965,0.07005438,0.0005044798,0.0001698952,0.00014450535,0.00079628924,0.000300471,0.00295829],"genre_scores_gemma":[0.9326099,0.0036987162,0.059890244,0.00031897577,0.00011548065,0.00017126054,0.0010022005,0.000081173486,0.0021119607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891746,0.00043825683,0.0000856119,0.00017313025,0.000319584,0.00006591204],"domain_scores_gemma":[0.9989452,0.00020782744,0.0002881018,0.00018019204,0.000272214,0.00010658131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017581601,0.00046091952,0.0003175357,0.0009875539,0.00020744372,0.0010648009,0.00044621094,0.00056380377,0.001745006],"category_scores_gemma":[0.001855331,0.0003222343,0.00047234423,0.0005209824,0.00050289894,0.00061203697,0.0008407784,0.00048629454,0.0010612058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024134996,0.00037146945,0.25811872,0.0009898391,0.0003203996,0.0024595952,0.00074279617,0.0030213317,0.44697002,0.0010461088,0.00222303,0.28132328],"study_design_scores_gemma":[0.00013760645,0.005155495,0.5564546,0.0004291565,0.0003695553,0.0277758,0.0017388548,0.024234746,0.33916092,0.0033033483,0.04108136,0.00015861985],"about_ca_topic_score_codex":0.00060753344,"about_ca_topic_score_gemma":0.0017441815,"teacher_disagreement_score":0.0017581601,"about_ca_system_score_codex":0.00025710373,"about_ca_system_score_gemma":0.00047653972,"threshold_uncertainty_score":0.009298146},"labels":[],"label_agreement":null},{"id":"W2579106870","doi":"10.1093/neuonc/now212.066","title":"ANGI-11. BONE MARROW-DERIVED MESENCHYMAL STEM CELLS-MEDIATED RADIORESISTANCE IN GLIOBLASTOMA ANGIOGENESIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diatoms and Algae Research","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Mesenchymal stem cell; Radioresistance; Stromal cell; Cancer research; Angiogenesis; Bone marrow; Tumor microenvironment; Stem cell; Protein kinase B; Umbilical vein; Chemistry; Biology; Medicine; Cell culture; Immunology; Phosphorylation; Cell biology; In vitro","score_opus":0.016252650068417744,"score_gpt":0.2633304459732753,"score_spread":0.24707779590485757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579106870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839841,0.0067271097,0.0014941272,0.00025608423,0.0001449316,0.00014144067,0.0007636439,0.00027843736,0.0062100417],"genre_scores_gemma":[0.9902782,0.0028960374,0.0015759146,0.00011334898,0.000037009842,0.000083718216,0.0010690413,0.000016153068,0.0039305673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990964,0.000017198037,0.0000078842195,0.000012373112,0.000023175417,0.000029761286],"domain_scores_gemma":[0.99994457,0.000006160234,0.000012589166,0.0000043312375,0.000005656945,0.000026702628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013816144,0.00031692028,0.00024697065,0.00027216162,0.00010214379,0.00024082005,0.00014931767,0.00020780324,0.0015739092],"category_scores_gemma":[0.00005631854,0.00009103032,0.00028211475,0.00016749345,0.00019568646,0.00012893396,0.00015054444,0.0007113964,0.0004408056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010458638,0.0004046392,0.0005099645,0.00027956592,0.000013412524,0.00014673981,0.00004420259,0.00027849514,0.98608035,0.00027309265,0.0004669528,0.010456719],"study_design_scores_gemma":[0.00008224807,0.002670464,0.009086086,0.00003134006,0.0000558681,0.00035224704,0.000042232346,0.0012791671,0.97973263,0.00009638259,0.0065615242,0.000009800376],"about_ca_topic_score_codex":0.0010156013,"about_ca_topic_score_gemma":0.0022507815,"teacher_disagreement_score":0.0015739092,"about_ca_system_score_codex":0.00024147831,"about_ca_system_score_gemma":0.00031396886,"threshold_uncertainty_score":0.0052652955},"labels":[],"label_agreement":null},{"id":"W2583337052","doi":"10.1093/neuonc/nov230.13","title":"QOL-13GLIOBLASTOMAS LOCATED IN THE RIGHT HEMISPHERE ARE ASSOCIATED WITH WORSE QUALITY OF LIFE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Quality of life (healthcare); Medicine; Glioblastoma; Postcentral gyrus; Brain tumor; Gyrus; Anxiety; Posterior cingulate; Audiology; Radiology; Pathology; Magnetic resonance imaging; Cognition; Psychiatry","score_opus":0.0442714561224834,"score_gpt":0.3164150495918001,"score_spread":0.2721435934693167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583337052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999084,0.0001965667,0.00011799756,0.000044623834,0.0000049588984,0.000002682751,0.0001396589,0.0000117901,0.00039766647],"genre_scores_gemma":[0.99963534,0.0000401972,0.000055221208,0.000008928371,0.000003869188,0.0000020510984,0.00011163739,0.0000024797803,0.00014034376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999094,0.000013855006,0.000011155937,0.00002341032,0.000021207734,0.000020911757],"domain_scores_gemma":[0.9992175,0.000050854775,0.0005445937,0.000028531678,0.000050709776,0.000107743996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015449281,0.00027458085,0.00023514032,0.00049140886,0.0002123637,0.00029294132,0.00013555761,0.00020239405,0.0052124625],"category_scores_gemma":[0.00095427886,0.000081430604,0.00036229863,0.00040502223,0.00029595825,0.0001837434,0.00030970183,0.00021981334,0.00036395338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019660337,0.000023448076,0.9922943,0.000027562503,0.00009461397,0.0005673924,0.000054336582,0.00010930007,0.0022780437,0.00002785035,0.00020825409,0.0041182884],"study_design_scores_gemma":[0.0000046167656,0.000043664226,0.9985611,0.0000037050368,0.00002583053,0.0009558583,0.000045138568,0.000084793166,0.00013420686,0.000039535356,0.00009960499,0.000002010227],"about_ca_topic_score_codex":0.0020072993,"about_ca_topic_score_gemma":0.00213596,"teacher_disagreement_score":0.0052124625,"about_ca_system_score_codex":0.00022904437,"about_ca_system_score_gemma":0.00025820205,"threshold_uncertainty_score":0.017437398},"labels":[],"label_agreement":null},{"id":"W2583786955","doi":"10.1093/neuonc/nov209.14","title":"CBIO-14TARGETING PROTEASOME ACTIVITY WITH MARIZOMIB AS A THERAPEUTIC PERSPECTIVE FOR GLIOMA PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Proteasome; Glioma; Cancer research; Proteasome inhibitor; Bortezomib; In vitro; Biology; Tolerability; Pharmacology; Immunology; Multiple myeloma; Biochemistry","score_opus":0.02663175990436989,"score_gpt":0.29623449634139887,"score_spread":0.269602736437029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583786955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6213367,0.31773058,0.0068836785,0.02621717,0.0010365985,0.00028344378,0.00074636337,0.00075632235,0.025009222],"genre_scores_gemma":[0.89791197,0.07828097,0.0073503605,0.005014614,0.0005477318,0.0001624541,0.0011020846,0.00005396647,0.009575877],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999633,0.000006360806,0.0000025796728,0.00000618008,0.0000064650667,0.000015057814],"domain_scores_gemma":[0.99996746,0.0000027972494,0.0000063507277,0.00000189347,0.0000068949394,0.000014566576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014000673,0.0002744416,0.00036853377,0.00021371774,0.00010759604,0.00047002576,0.00024880326,0.0002627396,0.0015872854],"category_scores_gemma":[0.00009056519,0.00007955298,0.00024177114,0.00019330326,0.00016853734,0.00016159464,0.00014931368,0.00054525846,0.00044644895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062476504,0.0008918691,0.014558289,0.0011092358,0.0002360652,0.001907121,0.00015339229,0.0010531811,0.1908369,0.0030944413,0.027789986,0.75212187],"study_design_scores_gemma":[0.005440172,0.019231733,0.10849993,0.00086163817,0.0013279811,0.018539328,0.0005676125,0.006430528,0.19227399,0.006043157,0.6406515,0.00013242527],"about_ca_topic_score_codex":0.0011271654,"about_ca_topic_score_gemma":0.0040575988,"teacher_disagreement_score":0.0015872854,"about_ca_system_score_codex":0.0006119072,"about_ca_system_score_gemma":0.00043819574,"threshold_uncertainty_score":0.0053099394},"labels":[],"label_agreement":null},{"id":"W2584272241","doi":"10.1093/neuonc/nov214.06","title":"EPIG-06ATRX DEFICIENCY PROMOTES MIGRATORY BEHAVIOR IN GLIOMA CELLS OF ORIGIN BY DYSREGULATING GENOME-WIDE CHROMATIN ACCESSIBILITY AND MODULATING TRANSCRIPTIONAL PROGRAMS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Chromatin; Epigenetics; Genome instability; Carcinogenesis; Genetics; Cancer research; Cell biology; Gene; Mutation; DNA damage; DNA","score_opus":0.029916195504711578,"score_gpt":0.29730958693397663,"score_spread":0.26739339142926505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584272241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960492,0.00059672556,0.0011279603,0.000057817135,0.000009119445,0.000010846023,0.0006429835,0.00011402814,0.0013913155],"genre_scores_gemma":[0.99407613,0.00044128325,0.0010273425,0.000057111334,0.0000032607395,0.00002894717,0.0009575259,0.000028418945,0.003379813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991715,0.000010514672,0.000007794728,0.000021380205,0.000022381575,0.00002075884],"domain_scores_gemma":[0.9999424,0.000007648365,0.000015082967,0.000008302197,0.00000504878,0.000021502863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006759179,0.00022423839,0.00017176404,0.00021206119,0.00007128402,0.00019467108,0.00014005866,0.00015131857,0.0014842899],"category_scores_gemma":[0.00005019678,0.00011138543,0.00014306698,0.000121765894,0.00015455455,0.00008910913,0.00014808564,0.0003556437,0.0003446946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084063366,0.000014582967,0.0002651254,0.000015542317,0.0000029865814,0.000037395643,0.000011719565,0.000043937835,0.99843067,0.0000442458,0.000032933942,0.0010167473],"study_design_scores_gemma":[0.000013141564,0.00032993272,0.026032057,0.0000054606717,0.000018573004,0.0002658544,0.000060439135,0.001181845,0.9694009,0.000047715734,0.0026390892,0.0000049281],"about_ca_topic_score_codex":0.0006774282,"about_ca_topic_score_gemma":0.0013763786,"teacher_disagreement_score":0.0014842899,"about_ca_system_score_codex":0.00011945098,"about_ca_system_score_gemma":0.00012185824,"threshold_uncertainty_score":0.004965484},"labels":[],"label_agreement":null},{"id":"W2584950415","doi":"10.1093/neuonc/nov208.02","title":"BMET-02EVALUATION OF DIFFERENT THERAPEUTIC MODALITIES FOR PRIMARY TREATMENT AND SALVAGE THERAPY AND THEIR RELATIVE COST IN PATIENTS WITH BRAIN METASTASES: A SINGLE INSTITUTION REPORT","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Context (archaeology); Brain metastasis; Craniotomy; Salvage therapy; Radiation therapy; Multivariate analysis; Univariate analysis; Modalities; Metastasis; Surgery; Internal medicine; Chemotherapy; Cancer","score_opus":0.0814461831767413,"score_gpt":0.3226828285227238,"score_spread":0.2412366453459825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584950415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547017,0.0011422314,0.00016755365,0.00015306941,0.000010552022,0.000040442632,0.00106593,0.0000131586685,0.0019369533],"genre_scores_gemma":[0.9978824,0.00049852964,0.0003167352,0.00006557928,0.000034479905,0.000031712312,0.00081255636,0.000011385315,0.00034659103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992094,0.00020541505,0.00014769046,0.000080578284,0.0002518959,0.00010491354],"domain_scores_gemma":[0.99756384,0.0006885651,0.0010410795,0.00008613144,0.0003137119,0.0003066465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008263068,0.00028570936,0.00049232383,0.0018114167,0.00049430085,0.0009539457,0.00033938108,0.0003909792,0.0024395706],"category_scores_gemma":[0.0037098848,0.00021062604,0.00047576227,0.002516409,0.00026913997,0.00047204853,0.00041645757,0.00050064165,0.00046102982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004767304,0.00013395153,0.98780805,0.000045422672,0.000077298784,0.0011120259,0.00004511245,0.00017868646,0.00028768007,0.000039232375,0.00055711647,0.009238779],"study_design_scores_gemma":[0.00007966516,0.00076168263,0.985781,0.00003819126,0.00016592281,0.008954971,0.00030229543,0.0009823034,0.0010169031,0.00006440932,0.0018362436,0.000016435242],"about_ca_topic_score_codex":0.003917705,"about_ca_topic_score_gemma":0.0050431765,"teacher_disagreement_score":0.003917705,"about_ca_system_score_codex":0.0017018708,"about_ca_system_score_gemma":0.0008516114,"threshold_uncertainty_score":0.012348056},"labels":[],"label_agreement":null},{"id":"W2584956237","doi":"10.1093/neuonc/nov204.92","title":"ATPS-92Bmi1 IDENTIFIES TREATMENT-REFRACTORY STEM CELLS IN HUMAN GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Glioblastoma; Stem cell; Refractory (planetary science); Cancer research; Chemistry; Medicine; Biology; Cell biology","score_opus":0.05098833965755475,"score_gpt":0.3317710211318321,"score_spread":0.2807826814742774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584956237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559903,0.0012603909,0.0012275038,0.000043631837,0.0000081586595,0.000059994698,0.00077140104,0.000078953504,0.000950938],"genre_scores_gemma":[0.99518037,0.00042985714,0.0012936696,0.00004528456,0.0000051416973,0.000053651907,0.0021952463,0.000019233641,0.00077770185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999372,0.0000051821135,0.0000051946663,0.000014002813,0.000025433123,0.000013037402],"domain_scores_gemma":[0.9999505,0.0000060324796,0.000014071138,0.0000052173705,0.000008997905,0.000015192866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009015023,0.00015779304,0.00022953823,0.0007252708,0.00012829878,0.00025063107,0.00011324679,0.00030107668,0.001580544],"category_scores_gemma":[0.00012647433,0.00009686568,0.00013304752,0.00033209447,0.00014230018,0.00007649442,0.00019299828,0.00018077609,0.00057400274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031307523,0.000034825734,0.012169016,0.000055932243,0.000010714602,0.00034371013,0.000055525143,0.0001103103,0.9813431,0.00007389304,0.00015051856,0.0053393277],"study_design_scores_gemma":[0.0000826535,0.0018050199,0.38195705,0.000041792435,0.00012572772,0.010528472,0.00033525357,0.0039282157,0.58742803,0.0002873304,0.013460765,0.000019777885],"about_ca_topic_score_codex":0.0005410675,"about_ca_topic_score_gemma":0.00081001676,"teacher_disagreement_score":0.001580544,"about_ca_system_score_codex":0.00014813423,"about_ca_system_score_gemma":0.000093789975,"threshold_uncertainty_score":0.005287409},"labels":[],"label_agreement":null},{"id":"W2585041210","doi":"10.1093/neuonc/nov225.51","title":"NIMG-51T1-HYPERINTENSE LESIONS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ON BEVACIZUMAB","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Bevacizumab; Glioma; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy","score_opus":0.03453585762652659,"score_gpt":0.29665705357606587,"score_spread":0.26212119594953925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585041210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994398,0.0002426845,0.00002710608,0.000017889577,0.0000020925938,0.0000033578694,0.000084998675,0.0000024866288,0.00017950905],"genre_scores_gemma":[0.9997515,0.000069969035,0.000026677264,0.0000065054774,0.000003246917,0.000002025878,0.00011410366,7.67107e-7,0.000025240046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998311,0.00003341899,0.000022879361,0.000034075976,0.000042592088,0.00003595957],"domain_scores_gemma":[0.9984316,0.00021824516,0.0009461396,0.00004591696,0.00013131018,0.00022676468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031578896,0.000133455,0.00021106671,0.0005505473,0.00019759004,0.00031102804,0.00023772843,0.00026790597,0.0007915975],"category_scores_gemma":[0.0018240189,0.000112670205,0.00023089827,0.00054736057,0.00017773751,0.00019008499,0.00021040143,0.00029808376,0.00013244184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012073496,0.00000775931,0.99872464,0.000003896703,0.000010043439,0.00013088282,0.000019901303,0.0000298838,0.00017571641,0.0000027041815,0.0000314617,0.0007424672],"study_design_scores_gemma":[0.000004261535,0.000103392595,0.9986791,0.0000045292263,0.000023273464,0.00075162353,0.00006047977,0.00018117053,0.00009656496,0.000006605483,0.000086455744,0.0000025535132],"about_ca_topic_score_codex":0.0042090314,"about_ca_topic_score_gemma":0.0049105105,"teacher_disagreement_score":0.0042090314,"about_ca_system_score_codex":0.00035468562,"about_ca_system_score_gemma":0.00031743493,"threshold_uncertainty_score":0.008369088},"labels":[],"label_agreement":null},{"id":"W2585271471","doi":"10.1093/neuonc/nov236.02","title":"TMIC-02CELL AUTONOMOUS AND CELL NON-AUTONOMOUS ROLES OF p75 NEUROTROPHIN RECEPTOR (p75<sup>NTR</sup>) IN GLIOMA INVASION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; University of Calgary","funders":"","keywords":"Low-affinity nerve growth factor receptor; Neurotrophin; Receptor; Neuroscience; Cell biology; Glioma; Biology; Cancer research; Genetics","score_opus":0.022279289432142912,"score_gpt":0.26806779380799056,"score_spread":0.24578850437584765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585271471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745111,0.0037993246,0.0012113356,0.00031629275,0.00009232416,0.00012145785,0.0031644572,0.00014504032,0.016638696],"genre_scores_gemma":[0.9694287,0.0025032512,0.0027360043,0.00032140082,0.000039465343,0.00014203927,0.0119478805,0.000042204596,0.012839131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988425,0.00001505806,0.000012224243,0.000013193946,0.00003576011,0.00003946666],"domain_scores_gemma":[0.9999232,0.000010893773,0.000007158852,0.000011266269,0.000016781521,0.000030616542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010098105,0.00025021777,0.00020809092,0.00020648213,0.00016198818,0.00027260362,0.00021477854,0.00026355902,0.0035850008],"category_scores_gemma":[0.00009868769,0.000089997426,0.00024713247,0.00026942932,0.00010604624,0.000082314305,0.00012445253,0.00078011584,0.0014695149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046465738,0.00016715299,0.00035613944,0.0000660262,0.000009247264,0.00010332032,0.000023936216,0.00014375421,0.99312097,0.00018341313,0.00065005413,0.0047113393],"study_design_scores_gemma":[0.00008775113,0.001916395,0.010762172,0.000016454458,0.000040189185,0.0007752481,0.000051570285,0.0011445275,0.97036666,0.00006755824,0.0147655355,0.00000605675],"about_ca_topic_score_codex":0.0028578409,"about_ca_topic_score_gemma":0.0025059052,"teacher_disagreement_score":0.0035850008,"about_ca_system_score_codex":0.000270358,"about_ca_system_score_gemma":0.00045779833,"threshold_uncertainty_score":0.011993051},"labels":[],"label_agreement":null},{"id":"W2585674367","doi":"10.1093/neuonc/nov210.10","title":"CSIG-10IMMUNIHISTOCHEMICAL STUDY OF THE EXPRESSION LEVELS OF NF-kB AND ITS REGULATORS ING-4, AEG-1 IN GLIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Expression (computer science); Biology; Cancer research; Cell biology; Chemistry; Computer science","score_opus":0.055482021989065156,"score_gpt":0.33480989660382743,"score_spread":0.2793278746147623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585674367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403954,0.002604373,0.0010534095,0.00003749653,0.000020530733,0.000012158562,0.00020228066,0.00003595766,0.001994195],"genre_scores_gemma":[0.9943169,0.0010718822,0.0013166596,0.00002717818,0.000014416475,0.000025413668,0.0007842338,0.00000833948,0.0024350146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999224,0.000013160329,0.000008413378,0.00001689378,0.000013307638,0.00002575262],"domain_scores_gemma":[0.9999372,0.0000104620685,0.000013224398,0.000006532545,0.000014678013,0.000017873783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014358891,0.00019624663,0.00009697734,0.0007061253,0.00020151,0.00018866196,0.00010867264,0.00019550926,0.0041249436],"category_scores_gemma":[0.000093968214,0.00011394916,0.00013348821,0.00024984396,0.00016848928,0.00014558411,0.0002027763,0.00017610371,0.00060765474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057788176,0.00006884268,0.047149014,0.00023826602,0.00006268867,0.0010909961,0.0001313141,0.000060447266,0.94297856,0.00012643573,0.00030981173,0.007205719],"study_design_scores_gemma":[0.00013464743,0.002075019,0.46750516,0.00011692538,0.00034376833,0.02217947,0.000997261,0.0020214084,0.48807207,0.000536325,0.01599847,0.000019464364],"about_ca_topic_score_codex":0.0007055656,"about_ca_topic_score_gemma":0.0010358499,"teacher_disagreement_score":0.0041249436,"about_ca_system_score_codex":0.00020927262,"about_ca_system_score_gemma":0.00009865222,"threshold_uncertainty_score":0.01379931},"labels":[],"label_agreement":null},{"id":"W2586150132","doi":"10.1093/neuonc/now212.343","title":"GENT-37. THE GENETICS DRIVING RADIATION INDUCED MENINGIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Biology; Exome; Exome sequencing; Carcinogenesis; Meninges; Transcriptome; Cancer research; Cancer; Genetics; Computational biology; Bioinformatics; Gene; Medicine; Mutation; Pathology; Neuroscience; Gene expression","score_opus":0.016005560297162102,"score_gpt":0.3026621306921911,"score_spread":0.286656570395029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586150132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96299833,0.0047861417,0.004012257,0.000535897,0.00010461972,0.000108098015,0.010997643,0.00053083483,0.015926154],"genre_scores_gemma":[0.97740775,0.0023461652,0.0044496604,0.0002498963,0.00002868261,0.000052643976,0.004934999,0.00025374492,0.010276484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998171,0.000020294196,0.000013653181,0.000045927078,0.000064597436,0.00003845986],"domain_scores_gemma":[0.9998235,0.000028757586,0.000050179333,0.000028058057,0.000022952707,0.000046543308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011566638,0.00036149475,0.00030409562,0.0007660153,0.00042016307,0.000423103,0.00022931925,0.00035180582,0.007536569],"category_scores_gemma":[0.0004255569,0.00018172263,0.0004502467,0.0006885887,0.0002622046,0.00014116576,0.0003885864,0.00038950713,0.0021793179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006276947,0.00009562028,0.10141847,0.00028244592,0.00015962229,0.005887226,0.00044043668,0.0006077433,0.8376067,0.0028274655,0.0029509477,0.04709554],"study_design_scores_gemma":[0.000036049067,0.00037517375,0.6734976,0.00012659212,0.00030464435,0.032797713,0.0004121417,0.0010271085,0.20010659,0.0030110506,0.08823474,0.00007060239],"about_ca_topic_score_codex":0.0066911136,"about_ca_topic_score_gemma":0.009634826,"teacher_disagreement_score":0.007536569,"about_ca_system_score_codex":0.00065181777,"about_ca_system_score_gemma":0.00063342904,"threshold_uncertainty_score":0.025212288},"labels":[],"label_agreement":null},{"id":"W2586264038","doi":"10.1093/neuonc/now212.609","title":"PDCT-05. STEADY-STATE VISUAL EVOKED POTENTIALS TO BETTER ASSESS VISUAL FUNCTIONS IN CHILDREN WITH OPTIC PATHWAY GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Force Microscopy Techniques and Applications","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Visual field; Evoked potential; Visual acuity; Medicine; Visual evoked potentials; Contrast (vision); Audiology; Magnetic resonance imaging; Neuroscience; Ophthalmology; Computer science; Psychology; Radiology; Artificial intelligence","score_opus":0.010561665268033153,"score_gpt":0.2964277544339188,"score_spread":0.28586608916588563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586264038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9304194,0.0054436643,0.009625111,0.000940976,0.000269141,0.00219095,0.027491983,0.0010570334,0.022561662],"genre_scores_gemma":[0.953187,0.0019627397,0.017930768,0.0006072942,0.00011310762,0.0019265254,0.015762275,0.0001636658,0.00834665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996824,0.00011451875,0.0000342286,0.000053966367,0.00007919646,0.0000356167],"domain_scores_gemma":[0.9990706,0.00016759803,0.00014242782,0.00005199541,0.0003884093,0.0001789883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082129,0.00037271602,0.0003488212,0.0004788782,0.00019329222,0.00041420868,0.0003223772,0.00054527406,0.004979514],"category_scores_gemma":[0.00119184,0.000119701595,0.000246005,0.00043586982,0.00020154612,0.00030478006,0.00031783953,0.0005447169,0.0013941035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015337892,0.003012015,0.6086226,0.0016131337,0.0002631651,0.0031795294,0.00027116277,0.0018007618,0.06674843,0.00050975184,0.029475162,0.26916644],"study_design_scores_gemma":[0.0015591698,0.010046765,0.9310314,0.00022797294,0.00014961841,0.008298635,0.00014154,0.0018288547,0.022915497,0.00023107613,0.023531055,0.000038419108],"about_ca_topic_score_codex":0.0034575565,"about_ca_topic_score_gemma":0.003359944,"teacher_disagreement_score":0.004979514,"about_ca_system_score_codex":0.0004913817,"about_ca_system_score_gemma":0.00095843605,"threshold_uncertainty_score":0.016658187},"labels":[],"label_agreement":null},{"id":"W2586398206","doi":"10.1093/neuonc/now188.212","title":"P09.03 Subependymal giant cell astrocytoma (SEGA) in adults without tuberous sclerosis","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Tuberous sclerosis; Subependymal giant cell astrocytoma; Subependymal zone; Medicine; Astrocytoma; Pathology; Glioblastoma; Cancer research","score_opus":0.04450269965826249,"score_gpt":0.3045882948991372,"score_spread":0.2600855952408747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586398206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7357589,0.014931281,0.0022441025,0.017898517,0.0027699708,0.00024481758,0.0032980898,0.0010948715,0.2217595],"genre_scores_gemma":[0.97921604,0.0026304103,0.0014418332,0.0030712986,0.0012497688,0.000057806086,0.0015290986,0.00011061842,0.010693149],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997876,0.000020445095,0.000028401533,0.00005284723,0.00004771409,0.00006301991],"domain_scores_gemma":[0.9995809,0.00006073203,0.000076898585,0.000017992837,0.000081584025,0.00018182854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015604991,0.000474249,0.00031909833,0.00062228006,0.0011404912,0.00071267964,0.00052422145,0.0015943476,0.015459772],"category_scores_gemma":[0.0011577735,0.00018945169,0.0002569888,0.00066361926,0.00049622584,0.00075957685,0.00051198085,0.00078977755,0.00651443],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006466439,0.00012318508,0.14428984,0.00023475838,0.00004171057,0.7353629,0.0003055842,0.00016945432,0.00444036,0.0014241071,0.056650754,0.056310672],"study_design_scores_gemma":[0.00006096832,0.0001924114,0.05811816,0.00022813513,0.000040529496,0.9144831,0.0003400703,0.00033136917,0.0008113181,0.0010300901,0.024344197,0.00001966088],"about_ca_topic_score_codex":0.003044694,"about_ca_topic_score_gemma":0.0035860264,"teacher_disagreement_score":0.015459772,"about_ca_system_score_codex":0.00037780896,"about_ca_system_score_gemma":0.00055831764,"threshold_uncertainty_score":0.051718116},"labels":[],"label_agreement":null},{"id":"W2587000238","doi":"10.1093/neuonc/now212.409","title":"IMST-53. THE EFFICACY OF CD133 BiTEs AND CAR-T CELLS IN PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Chimeric antigen receptor; Antigen; Cytotoxic T cell; Monoclonal antibody; Cancer research; Antibody; T cell; Glioma; Biology; Immunology; Immune system; In vitro","score_opus":0.05883081224816337,"score_gpt":0.37817687441619924,"score_spread":0.31934606216803585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587000238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97981536,0.0030486274,0.0034184188,0.0007215329,0.00042639882,0.0007225724,0.0036747977,0.0011008581,0.0070714313],"genre_scores_gemma":[0.97439945,0.0034090977,0.003391934,0.00032008364,0.00006717705,0.001552832,0.0052457284,0.00013133476,0.011482297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995988,0.00004680032,0.00003113384,0.000075700016,0.00008443031,0.00016315065],"domain_scores_gemma":[0.9998636,0.000010626902,0.000028035163,0.000018637158,0.000019529301,0.00005953752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005113298,0.0013489961,0.0014313149,0.0008304838,0.00033334264,0.000502851,0.000681003,0.00091216515,0.0032109057],"category_scores_gemma":[0.00015927765,0.0003708298,0.0009049101,0.0005032533,0.00045958709,0.00045384845,0.00026030478,0.002934861,0.00107862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004259419,0.0073128,0.00043734134,0.00048494156,0.00013074337,0.00029270342,0.00020353084,0.0012807763,0.9628524,0.00096391665,0.003285835,0.018495608],"study_design_scores_gemma":[0.0011488021,0.04323826,0.004413443,0.00006314771,0.00029580013,0.0005014932,0.00012558456,0.004156389,0.93545747,0.00031735512,0.010243108,0.000039148734],"about_ca_topic_score_codex":0.0034100278,"about_ca_topic_score_gemma":0.004132435,"teacher_disagreement_score":0.0034100278,"about_ca_system_score_codex":0.0006663021,"about_ca_system_score_gemma":0.0010313616,"threshold_uncertainty_score":0.010741532},"labels":[],"label_agreement":null},{"id":"W2587113208","doi":"10.1093/neuonc/now212.731","title":"RTHP-05. INTRAOPERATIVE RADIOTHERAPY (IORT) USING LOW-ENERGY X-RAYS IN A COHORT OF PREDOMINANTLY INCOMPLETELY RESECTED NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (INTRAGO TRIAL)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tolerability; Radiation therapy; Clinical endpoint; Progression-free survival; Surgery; Radiosurgery; Adverse effect; Chemotherapy; Urology; Internal medicine; Randomized controlled trial","score_opus":0.021988548393148073,"score_gpt":0.30153959285890936,"score_spread":0.2795510444657613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587113208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576676,0.0018817957,0.00031645637,0.00013160425,0.000034424193,0.00041082443,0.0005415208,0.00005159696,0.0008649683],"genre_scores_gemma":[0.99159056,0.0017917997,0.001175533,0.00035109333,0.0000918511,0.0010350851,0.00220201,0.000019080575,0.0017430475],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997075,0.00017529186,0.000011520105,0.000041625306,0.000017045772,0.000046981695],"domain_scores_gemma":[0.99975973,0.00003787616,0.00007945096,0.00002584285,0.000011607499,0.000085470834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001110772,0.00067599583,0.0008596633,0.00020567102,0.00015055075,0.00063929224,0.0004586203,0.0004626018,0.0019372487],"category_scores_gemma":[0.0005012082,0.00021032503,0.00081660075,0.00024360023,0.00037603395,0.00038120305,0.00040717624,0.0011841631,0.0003303999],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.686409,0.013581303,0.022075608,0.0013412287,0.0026803415,0.00036823726,0.00044534792,0.0043308153,0.04365588,0.0005149221,0.0040137162,0.22058363],"study_design_scores_gemma":[0.34871545,0.56900334,0.06361379,0.00012334184,0.002259824,0.00075256964,0.00014145393,0.0021886888,0.0066524204,0.00053230475,0.0059738746,0.000042919743],"about_ca_topic_score_codex":0.0007890813,"about_ca_topic_score_gemma":0.0020448822,"teacher_disagreement_score":0.0019372487,"about_ca_system_score_codex":0.00053050165,"about_ca_system_score_gemma":0.00073051243,"threshold_uncertainty_score":0.006480694},"labels":[],"label_agreement":null},{"id":"W2587128244","doi":"10.1093/neuonc/now212.303","title":"EXTH-61. NANOPARTICLE DELIVERY TO THE SPINAL CORD VIA DIRECT ADMINISTRATION TO CEREBROSPINAL FLUID","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Spinal cord; Drug delivery; Medicine; Nanocarriers; Cerebrospinal fluid; Nanoparticle; Central nervous system; Pharmacology; Biomedical engineering; Pathology; Materials science; Nanotechnology; Drug; Internal medicine","score_opus":0.029011009130346495,"score_gpt":0.3195401863804476,"score_spread":0.29052917725010113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587128244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598228,0.005953979,0.020094816,0.0005065462,0.00018607728,0.00058125035,0.001116813,0.00064094656,0.011096919],"genre_scores_gemma":[0.9538038,0.0048681316,0.019233024,0.000435486,0.0000416359,0.00033427338,0.0014420153,0.000093846116,0.019747855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983263,0.000016538137,0.000013036387,0.00004457562,0.0000561067,0.00003711494],"domain_scores_gemma":[0.9999057,0.000020677475,0.000022205071,0.000011498107,0.000018893279,0.000020928797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020335773,0.0003252801,0.0002511705,0.0002630045,0.00021240844,0.00025265315,0.00023717011,0.00041289156,0.0017656938],"category_scores_gemma":[0.00016700513,0.00014120265,0.00024049905,0.00011996545,0.0003006129,0.0002835074,0.00021835176,0.00062437804,0.0006994265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010977454,0.00009574067,0.00016416979,0.0001254454,0.0000060012335,0.00010104961,0.000044709104,0.00029630677,0.98986346,0.00021894951,0.00024348602,0.008730858],"study_design_scores_gemma":[0.00003439888,0.0010178564,0.001151888,0.000010147307,0.00001265353,0.00017142323,0.0000114230115,0.0011009667,0.9917755,0.00004121041,0.004664922,0.0000076210804],"about_ca_topic_score_codex":0.002008792,"about_ca_topic_score_gemma":0.0027970555,"teacher_disagreement_score":0.002008792,"about_ca_system_score_codex":0.0004075263,"about_ca_system_score_gemma":0.0005226496,"threshold_uncertainty_score":0.0059068203},"labels":[],"label_agreement":null},{"id":"W2587227059","doi":"10.1093/neuonc/now212.844","title":"TMIC-04. GLIOBLASTOMA-ASSOCIATED MYELOID CELLS DISPLAY NONPOLARIZED M0 MACROPHAGE PHENOTYPE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Microglia; Integrin alpha M; Immune system; Myeloid; Flow cytometry; Myeloid-derived Suppressor Cell; Cancer research; Biology; Macrophage; Phenotype; Tumor microenvironment; Immunology; Pathology; Inflammation; Medicine; Cancer; Gene; Suppressor; In vitro","score_opus":0.009582246029461538,"score_gpt":0.2437707076756113,"score_spread":0.23418846164614976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587227059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97457266,0.0017123792,0.002231556,0.00021761387,0.000053643394,0.0001900248,0.009986771,0.0003290748,0.010706295],"genre_scores_gemma":[0.94469166,0.0016248077,0.005102587,0.0004448198,0.000019768619,0.00049211667,0.036272693,0.00008413743,0.011267318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982953,0.0000167382,0.000016907943,0.000038198657,0.0000436614,0.000055003544],"domain_scores_gemma":[0.9999232,0.000007722986,0.000014481138,0.000011146838,0.000016355676,0.000027109134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014333845,0.0002500146,0.00025179173,0.00042560213,0.0003163796,0.00036951952,0.00014982025,0.00028873442,0.0030116173],"category_scores_gemma":[0.00011419215,0.00011272792,0.00022654817,0.0006693164,0.00019291624,0.00009989602,0.00016412551,0.00058160693,0.001235878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006448932,0.00018867862,0.0032874688,0.00015160651,0.000018200979,0.0002617091,0.00007753515,0.00019020449,0.9843413,0.00040415066,0.0021941552,0.008240079],"study_design_scores_gemma":[0.0001950065,0.0031607659,0.081155755,0.00006283398,0.00011344889,0.0060007004,0.0002961341,0.0029654684,0.85066617,0.00048250626,0.054878492,0.000022682381],"about_ca_topic_score_codex":0.0015072196,"about_ca_topic_score_gemma":0.0017669972,"teacher_disagreement_score":0.0030116173,"about_ca_system_score_codex":0.00032062182,"about_ca_system_score_gemma":0.00039450062,"threshold_uncertainty_score":0.010074854},"labels":[],"label_agreement":null},{"id":"W2587520421","doi":"10.1093/neuonc/now212.103","title":"BMET-03. METIS: A PHASE III STUDY OF RADIOSURGERY WITH TTFIELDS FOR 1-10 BRAIN METASTASES FROM NSCLC","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Neurocognitive; Clinical endpoint; Internal medicine; Oncology; Hazard ratio; Lung cancer; Population; Quality of life (healthcare); Clinical trial; Radiation therapy; Confidence interval; Cognition","score_opus":0.03445901906586992,"score_gpt":0.33311318493526576,"score_spread":0.29865416586939586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587520421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742226,0.0061620483,0.00083923934,0.0016737544,0.00034895798,0.0060230596,0.0040366077,0.00049393624,0.00619967],"genre_scores_gemma":[0.9431138,0.00783447,0.0038208652,0.0036401905,0.00038094752,0.011562639,0.01273521,0.00015887179,0.016753104],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995766,0.00020280309,0.000017624097,0.000050220075,0.000049900213,0.00010272925],"domain_scores_gemma":[0.99958545,0.000052105566,0.00009119642,0.000022658884,0.000024187193,0.00022440833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015890707,0.002276306,0.002244084,0.00076387846,0.00053187966,0.0013925856,0.0017438101,0.002034543,0.0058827135],"category_scores_gemma":[0.00074657024,0.0006363413,0.0015054002,0.0005735272,0.0008908372,0.0007040637,0.00041156728,0.0033919152,0.0018676112],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49692908,0.13123545,0.007423919,0.003561115,0.0022498204,0.0008331933,0.00041339273,0.008519828,0.099482544,0.0017150379,0.02681293,0.2208238],"study_design_scores_gemma":[0.5943028,0.3782142,0.0088706445,0.00013826083,0.00039610828,0.00070627977,0.00006411057,0.002553536,0.0069475956,0.00044657156,0.007309469,0.0000504356],"about_ca_topic_score_codex":0.0036778727,"about_ca_topic_score_gemma":0.008744359,"teacher_disagreement_score":0.0058827135,"about_ca_system_score_codex":0.0016859046,"about_ca_system_score_gemma":0.0026440434,"threshold_uncertainty_score":0.019679606},"labels":[],"label_agreement":null},{"id":"W2587566976","doi":"10.1093/neuonc/now188.219","title":"P09.10 Clinical fMRI in low grade glioma patients: impact on surgical decision making and patient outcomes","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Surgical excision; Glioma; Clinical decision making; Physical medicine and rehabilitation; Surgery; Intensive care medicine","score_opus":0.030751750455037627,"score_gpt":0.3819201279125609,"score_spread":0.3511683774575233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587566976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985663,0.00013604038,0.00010008638,0.00028834786,0.000009446451,0.000006636914,0.00016583364,0.00000278335,0.0007245547],"genre_scores_gemma":[0.9994967,0.00007329703,0.0001019869,0.00006241199,0.000014410047,0.0000066540542,0.00016905532,0.0000018467617,0.00007368722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956566,0.00016283235,0.000038702823,0.000069551825,0.000085089676,0.00007818163],"domain_scores_gemma":[0.99570906,0.0013840967,0.0021029082,0.000107901295,0.00019102401,0.00050508673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080985005,0.000149901,0.00017723843,0.00029104218,0.00023131275,0.00060612685,0.00025339425,0.00031368135,0.0035274322],"category_scores_gemma":[0.005803572,0.000070425725,0.00032036944,0.00045069153,0.00033057918,0.00036149356,0.0003403114,0.00043357819,0.0004675461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043817758,0.0000743576,0.9875673,0.000023458295,0.000043964934,0.00027035314,0.000050106206,0.00020312474,0.0002088366,0.000031559302,0.0003882762,0.010700502],"study_design_scores_gemma":[0.000030192674,0.0005294229,0.99609584,0.000028347358,0.000050686034,0.0012152694,0.00022028878,0.0008588507,0.00027374362,0.00021986838,0.00046927176,0.0000083234],"about_ca_topic_score_codex":0.0010004743,"about_ca_topic_score_gemma":0.0015621418,"teacher_disagreement_score":0.0035274322,"about_ca_system_score_codex":0.0003819757,"about_ca_system_score_gemma":0.000538865,"threshold_uncertainty_score":0.011800408},"labels":[],"label_agreement":null},{"id":"W2587599577","doi":"10.1093/neuonc/now212.018","title":"ACTR-19. BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA: RETROSPECTIVE ANALYSIS OF AVAglio","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Temozolomide; Medicine; Internal medicine; Placebo; Oncology; MMP9; MMP2; Univariate analysis; Post-hoc analysis; Retrospective cohort study; Gastroenterology; Multivariate analysis; Chemotherapy; Pathology; Cancer; Biology","score_opus":0.01112914385499897,"score_gpt":0.27374356113905596,"score_spread":0.262614417284057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587599577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986481,0.0005273145,0.00015575226,0.000013508168,0.0000054493057,0.000024325904,0.00039122257,0.0000038794296,0.00023032393],"genre_scores_gemma":[0.99912363,0.00008180412,0.00009813874,0.000018050934,0.000008175511,0.00002576832,0.0005079211,0.0000029041853,0.0001336349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999466,0.00012364751,0.000065079905,0.00017262355,0.00012276931,0.000049986327],"domain_scores_gemma":[0.9991856,0.00017575662,0.00035166784,0.00008209267,0.00005966784,0.00014519731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073669775,0.00017913058,0.00045796376,0.00028347957,0.00014312346,0.00032755744,0.000264748,0.00023641584,0.0007599544],"category_scores_gemma":[0.0009995356,0.0002008329,0.0004962211,0.00032526275,0.00022378413,0.00021951384,0.00017350377,0.00033871827,0.00018545796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011658629,0.00017680449,0.96782446,0.00007327431,0.0004972901,0.00033534577,0.00006747455,0.00017579686,0.009056224,0.000040210933,0.00032130626,0.009773178],"study_design_scores_gemma":[0.00028206626,0.002287005,0.9937596,0.000006365712,0.00024872253,0.00091432093,0.00002912564,0.0005351041,0.0011296812,0.00005534824,0.00074654666,0.000006012674],"about_ca_topic_score_codex":0.0007582624,"about_ca_topic_score_gemma":0.0016807833,"teacher_disagreement_score":0.0007599544,"about_ca_system_score_codex":0.00029888455,"about_ca_system_score_gemma":0.00019828438,"threshold_uncertainty_score":0.0038960576},"labels":[],"label_agreement":null},{"id":"W2587747127","doi":"10.1093/neuonc/now212.594","title":"NTOX-08. SAFETY OF INTRA-ARTERIAL CHEMOTHERAPY IN THE TREATMENT OF BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Etoposide; Carboplatin; Dissection (medical); Stroke (engine); Internal medicine; Surgery; Radiology; Oncology","score_opus":0.01823928216494433,"score_gpt":0.300666217903724,"score_spread":0.28242693573877964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587747127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83910555,0.049429145,0.010335752,0.0024435,0.0007991809,0.0014563309,0.0069197393,0.0015626646,0.08794817],"genre_scores_gemma":[0.9339163,0.01411782,0.00942046,0.0015134694,0.00024376147,0.0011292117,0.0075475806,0.00023644994,0.031874873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996518,0.00013651361,0.000034209053,0.000045411263,0.00010243184,0.000029653644],"domain_scores_gemma":[0.99968684,0.00008477832,0.00007956026,0.000029394432,0.00006284402,0.000056571404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005689749,0.00020958394,0.00034368772,0.00021189183,0.0001757491,0.0004038146,0.0002657312,0.00040001693,0.00664623],"category_scores_gemma":[0.0009324609,0.000074076524,0.00027862485,0.00019893392,0.00023098348,0.00031911294,0.00016406199,0.0006648391,0.0020181993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039636232,0.0027063359,0.00830624,0.0024924828,0.00014432194,0.0011466141,0.00024858618,0.0008221362,0.17152889,0.0019165364,0.016479041,0.7545725],"study_design_scores_gemma":[0.009521347,0.09196346,0.046123445,0.0009937285,0.00071194954,0.013835919,0.0002266309,0.006567046,0.36312705,0.0019546405,0.4648702,0.000104544124],"about_ca_topic_score_codex":0.00047171945,"about_ca_topic_score_gemma":0.000736993,"teacher_disagreement_score":0.00664623,"about_ca_system_score_codex":0.00026234236,"about_ca_system_score_gemma":0.000635395,"threshold_uncertainty_score":0.022233784},"labels":[],"label_agreement":null},{"id":"W2587891556","doi":"10.1093/neuonc/now212.906","title":"TMOD-37. CHARACTERIZATION OF A UNIQUE BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Cancer research; Primary tumor; Cancer; Melanoma; Mesenchymal stem cell; Biology; Population; Pathology; Medicine; Internal medicine","score_opus":0.019288815707571794,"score_gpt":0.3142241034144528,"score_spread":0.294935287706881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587891556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881245,0.00093841954,0.005716216,0.0000577173,0.000014194476,0.0001197784,0.0027510936,0.00006903056,0.0022088673],"genre_scores_gemma":[0.9783797,0.0008866906,0.008578661,0.00006014139,0.000008449918,0.00015149795,0.008422224,0.000036077385,0.003476701],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994314,0.0000038289677,0.0000044734693,0.000014281639,0.000022685806,0.000011573413],"domain_scores_gemma":[0.99994564,0.0000068377735,0.0000057979987,0.0000048776014,0.00001374839,0.000023070335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007933147,0.00015040583,0.00012889018,0.0005327757,0.000112489855,0.0001944965,0.00012216398,0.00012708399,0.0014042979],"category_scores_gemma":[0.00013526065,0.00007522159,0.00012514048,0.00032485463,0.000110128945,0.00006118346,0.00013417503,0.00016508214,0.0005222748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080041806,0.000011273346,0.0015502953,0.000019209647,0.0000028587465,0.00007768601,0.00002106052,0.00010401814,0.99593985,0.00005887296,0.000044408163,0.0020904606],"study_design_scores_gemma":[0.000022564054,0.00050195475,0.07404729,0.000013498563,0.00004317032,0.0015258054,0.00014779414,0.004338914,0.90908015,0.00019321448,0.010074352,0.0000113781225],"about_ca_topic_score_codex":0.002031105,"about_ca_topic_score_gemma":0.002088766,"teacher_disagreement_score":0.002031105,"about_ca_system_score_codex":0.0001625018,"about_ca_system_score_gemma":0.00018952668,"threshold_uncertainty_score":0.0046977997},"labels":[],"label_agreement":null},{"id":"W2587908412","doi":"10.1093/neuonc/now212.317","title":"GENT-11. SMALL MOLECULE EPIGENETIC SCREEN IDENTIFIES NOVEL EZH2 AND HDAC INHIBITORS THAT TARGET GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Hospital for Sick Children","funders":"","keywords":"Epigenetics; In vivo; Cancer research; Biology; In vitro; EZH2; Cytotoxicity; Genetics; Gene","score_opus":0.017561237278052002,"score_gpt":0.2555079050579245,"score_spread":0.23794666777987247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587908412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762491,0.00528198,0.0048715533,0.00029318724,0.000060358587,0.00044287244,0.003851181,0.00051817985,0.008431462],"genre_scores_gemma":[0.9728971,0.004378439,0.008032736,0.0002509286,0.000020485693,0.00018127498,0.0073396494,0.000057166937,0.006842199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998592,0.00002054004,0.000010999409,0.000027717248,0.00004695326,0.000034583278],"domain_scores_gemma":[0.999944,0.000010610125,0.000009220083,0.0000056140375,0.0000104103265,0.000020287598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019303565,0.0006372152,0.00077121163,0.0006310281,0.00017151561,0.00029606774,0.00035938717,0.00034289047,0.0025806306],"category_scores_gemma":[0.00013781789,0.00022432076,0.00036833077,0.00041271705,0.00016194186,0.00014289164,0.00025055077,0.00044246725,0.0005761753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004904248,0.0002851573,0.0012927512,0.0001183876,0.00005893438,0.00013816252,0.000016231115,0.00071505137,0.9780126,0.00016224284,0.00047308387,0.018237017],"study_design_scores_gemma":[0.00026196943,0.0038270748,0.008721344,0.000010409214,0.00018464522,0.0005765705,0.00002429831,0.0018049396,0.9771642,0.000054608146,0.007355408,0.00001449545],"about_ca_topic_score_codex":0.0015650518,"about_ca_topic_score_gemma":0.0093865935,"teacher_disagreement_score":0.0025806306,"about_ca_system_score_codex":0.000461687,"about_ca_system_score_gemma":0.0005096187,"threshold_uncertainty_score":0.008633137},"labels":[],"label_agreement":null},{"id":"W2587923643","doi":"10.1093/neuonc/now212.484","title":"MPTH-49. IS GANGLIOGLIOMA A CNS TUMOR WITH ARRESTED DEVELOPMENT?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Synaptophysin; Biology; NeuN; Glial fibrillary acidic protein; Neuroepithelial cell; Neurosphere; OLIG2; Cancer research; Neural stem cell; Progenitor cell; Forebrain; Pathology; Molecular biology; Immunohistochemistry; Stem cell; Embryonic stem cell; Genetics; Central nervous system; Medicine; Oligodendrocyte; Neuroscience; Immunology; Gene; Adult stem cell","score_opus":0.020638729831866983,"score_gpt":0.2785125228437662,"score_spread":0.2578737930118992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587923643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594636,0.0019837962,0.00032132014,0.00043724422,0.00003223374,0.000021986933,0.0012851873,0.000055245942,0.009916726],"genre_scores_gemma":[0.9964211,0.0007761099,0.0002539393,0.00013215534,0.00002859802,0.0000094599645,0.0011611005,0.000018114255,0.0011993042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998254,0.000011777107,0.000012394307,0.00005370893,0.000051967447,0.000044711793],"domain_scores_gemma":[0.99977404,0.000033438315,0.000075506054,0.000030251034,0.000036044377,0.000050777955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016337728,0.00025241164,0.0002252232,0.000594009,0.00030457845,0.00052376994,0.00042751752,0.0003969341,0.0024584446],"category_scores_gemma":[0.0008100762,0.00011538404,0.00014071258,0.0005117194,0.00043745682,0.00030344143,0.0002443523,0.00026172178,0.0013819607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057973876,0.000046176527,0.7851673,0.00019095918,0.000043398733,0.09687637,0.00043890206,0.0001623468,0.061565224,0.0007107624,0.0031142922,0.05110453],"study_design_scores_gemma":[0.000017319455,0.00020481834,0.7877317,0.00009498975,0.00007920933,0.18051285,0.00049306994,0.0003738903,0.01092314,0.0006738304,0.018882971,0.000012178763],"about_ca_topic_score_codex":0.0026872824,"about_ca_topic_score_gemma":0.0028922574,"teacher_disagreement_score":0.0026872824,"about_ca_system_score_codex":0.00046572884,"about_ca_system_score_gemma":0.00022773106,"threshold_uncertainty_score":0.008224368},"labels":[],"label_agreement":null},{"id":"W2587925217","doi":"10.1093/neuonc/now212.893","title":"TMOD-23. DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO- BRAIN METASTASIS TO IDENTIFY GENETIC REGULATORS OF BRAIN METASTASIS INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; Hospital for Sick Children; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Biology; Cancer research; Cancer; Gene knockdown; Lung cancer; Cancer stem cell; Pathology; Medicine; Gene; Genetics","score_opus":0.022830547520213424,"score_gpt":0.3167498356188324,"score_spread":0.293919288098619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587925217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8639909,0.008053994,0.08559748,0.0015825193,0.00075818127,0.00200694,0.015254932,0.0014463679,0.021308731],"genre_scores_gemma":[0.91549504,0.0047677774,0.040059917,0.0005227784,0.00005315042,0.0020067035,0.008949286,0.00024663706,0.027898753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995906,0.000046141424,0.000041069765,0.00011924164,0.0001297104,0.000073189294],"domain_scores_gemma":[0.9998468,0.000021332857,0.000034629848,0.000022840175,0.000017300323,0.00005700568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004224374,0.0005706792,0.00037035183,0.00060371397,0.0003614553,0.0006183844,0.0007119539,0.000583107,0.0035547293],"category_scores_gemma":[0.00016048904,0.0002907485,0.00058130326,0.00033227276,0.00042096045,0.00028582488,0.00038721858,0.0013666266,0.0010427242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023068626,0.00013673145,0.00019607591,0.00007831672,0.000013102898,0.00015450586,0.000027434893,0.0004743949,0.9933036,0.0008972978,0.0003588007,0.00412895],"study_design_scores_gemma":[0.00011650549,0.001278583,0.0017794599,0.000016995535,0.000033669457,0.00072514766,0.000037345148,0.0027327053,0.9664083,0.00025218475,0.026605003,0.000014099215],"about_ca_topic_score_codex":0.0021525433,"about_ca_topic_score_gemma":0.0026645344,"teacher_disagreement_score":0.0035547293,"about_ca_system_score_codex":0.0006478658,"about_ca_system_score_gemma":0.0007471951,"threshold_uncertainty_score":0.011891782},"labels":[],"label_agreement":null},{"id":"W2587948547","doi":"10.1093/neuonc/nox083.164","title":"MEDU-13. CONVERGENCE OF BMI1 AND CHD7 ON ERK SIGNALLING IN MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"BMI1; Medulloblastoma; Biology; Cancer research; Carcinogenesis; Polycomb-group proteins; Neural stem cell; Gene silencing; Stem cell; Cell biology; Cancer; Genetics; Repressor; Transcription factor","score_opus":0.02329733139993394,"score_gpt":0.3142940085486856,"score_spread":0.29099667714875166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587948547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97636104,0.0070987884,0.0020118814,0.00043974974,0.000093307266,0.000041353942,0.0015988679,0.00024549593,0.012109535],"genre_scores_gemma":[0.98954177,0.001474881,0.0010998336,0.000097777614,0.000013002336,0.000023723054,0.0014961173,0.00002651045,0.006226245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998765,0.000012565938,0.000006171605,0.000018775476,0.000048711958,0.000037159352],"domain_scores_gemma":[0.9999205,0.0000068421546,0.000017790053,0.0000041705043,0.000012561722,0.000038201546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090318885,0.00027574116,0.00020359791,0.00046726526,0.00027625533,0.00039526098,0.00022817076,0.000281912,0.0032404407],"category_scores_gemma":[0.00012961254,0.00015736122,0.00029767337,0.00017638436,0.00021065376,0.00018333686,0.0004416849,0.0003861996,0.00092720345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172787,0.000031966327,0.0033839361,0.00016736287,0.000017520528,0.00039312974,0.000030737494,0.00018963686,0.98684907,0.0006956688,0.0003860016,0.007237665],"study_design_scores_gemma":[0.000088388595,0.0003798542,0.16099298,0.000048833586,0.000058621434,0.0024136507,0.00020050412,0.0030871772,0.8101209,0.00069620024,0.02188925,0.000023666233],"about_ca_topic_score_codex":0.0017919085,"about_ca_topic_score_gemma":0.0041370806,"teacher_disagreement_score":0.0032404407,"about_ca_system_score_codex":0.0007437961,"about_ca_system_score_gemma":0.00032069825,"threshold_uncertainty_score":0.010840356},"labels":[],"label_agreement":null},{"id":"W2588046727","doi":"10.1093/neuonc/now212.834","title":"SURG-36. IMPACT OF MULTIMODALITY MONITORING USING DIRECT ELECTRICAL STIMULATION TO DETERMINE CORTICOSPINAL TRACT SHIFT AND INTEGRITY IN THE iMRI suite","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Corticospinal tract; Resection; Neurological deficit; Motor cortex; Deep brain stimulation; Surgery; Intraoperative MRI; Stimulation; Brain tumor; Interventional magnetic resonance imaging; Radiology; Magnetic resonance imaging; Diffusion MRI; Internal medicine; Pathology","score_opus":0.07608805098096767,"score_gpt":0.42885488401624416,"score_spread":0.3527668330352765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588046727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089945,0.002353267,0.0066348473,0.00034049293,0.00011484466,0.000051564504,0.0004009432,0.00020696461,0.008997603],"genre_scores_gemma":[0.99223083,0.0008341849,0.004158287,0.00014980308,0.00007503319,0.00004852608,0.00039784797,0.000024667312,0.0020808054],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99989605,0.000029555624,0.000013231651,0.00001956722,0.000025621865,0.000016000819],"domain_scores_gemma":[0.9996519,0.000092227056,0.000072054965,0.000037846654,0.000048833703,0.00009705362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043368252,0.0003075759,0.00015917729,0.00035403145,0.00011978039,0.00028730158,0.00009625787,0.00014226558,0.0046194545],"category_scores_gemma":[0.0007385714,0.00009619199,0.00024201398,0.00013645414,0.00019657756,0.0002461554,0.00029334653,0.00026791773,0.001275449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075488198,0.00069472875,0.3281963,0.00037079706,0.0003183538,0.002947702,0.00018619368,0.0046150177,0.08905566,0.00034122408,0.0047455053,0.56097966],"study_design_scores_gemma":[0.0007936761,0.016236126,0.8660793,0.00022766324,0.00037991256,0.031445824,0.00027219573,0.014644356,0.05540391,0.0008835818,0.013545883,0.000087630906],"about_ca_topic_score_codex":0.0006605054,"about_ca_topic_score_gemma":0.0016493418,"teacher_disagreement_score":0.0046194545,"about_ca_system_score_codex":0.00022102197,"about_ca_system_score_gemma":0.00028296383,"threshold_uncertainty_score":0.015453577},"labels":[],"label_agreement":null},{"id":"W2588056316","doi":"10.1093/neuonc/now212.180","title":"CSIG-19. RECEPTOR TYROSINE KINASE PHOSPHORYLATION IN A MODEL SYSTEM OF GBM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Receptor tyrosine kinase; Platelet-derived growth factor receptor; Phosphorylation; Tyrosine phosphorylation; Cancer research; Growth factor receptor; Tyrosine kinase; Receptor Protein-Tyrosine Kinases; Biology; Epidermal growth factor receptor; Signal transduction; Receptor; Cell biology; Growth factor; Biochemistry","score_opus":0.019677255701058296,"score_gpt":0.2591808319515719,"score_spread":0.23950357625051358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588056316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93172324,0.0072605344,0.011942375,0.0010409141,0.00055058,0.00066614174,0.015112365,0.0012849105,0.03041886],"genre_scores_gemma":[0.93670875,0.006033354,0.017913958,0.00037745343,0.000039352428,0.0007119314,0.014945853,0.00017828966,0.02309103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971896,0.000041793643,0.000022140157,0.00005700682,0.00010058997,0.00005944404],"domain_scores_gemma":[0.99992263,0.000010086268,0.000016762191,0.000014582129,0.000010544232,0.000025386444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025800124,0.0005991634,0.00039161855,0.00076895143,0.00027477462,0.00040972442,0.00062429294,0.00047208002,0.0032436904],"category_scores_gemma":[0.00009402397,0.00027825212,0.00040312822,0.0008143158,0.00022523888,0.0002477943,0.00028611824,0.0012103975,0.0016370283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028629345,0.00019863863,0.00020021052,0.00009490696,0.000014340974,0.0001267602,0.000021886131,0.00047847102,0.9947437,0.0006311787,0.00089033,0.002313308],"study_design_scores_gemma":[0.00011259252,0.0016115779,0.0038326913,0.000019807007,0.00003690153,0.000727809,0.00003924541,0.0038466083,0.96168023,0.00027064825,0.02780409,0.000017791073],"about_ca_topic_score_codex":0.003734485,"about_ca_topic_score_gemma":0.0062505766,"teacher_disagreement_score":0.003734485,"about_ca_system_score_codex":0.0008819998,"about_ca_system_score_gemma":0.0006709024,"threshold_uncertainty_score":0.010851204},"labels":[],"label_agreement":null},{"id":"W2588078539","doi":"10.1093/neuonc/now212.171","title":"CSIG-10. SHH-MEDULLOBLASTOMA PREFERENTIALLY ARISES FROM GRANULE CELL PRECURSORS IN THE LATERAL CEREBELLUM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebellum; PTCH1; Biology; Sonic hedgehog; Granule cell; Wnt signaling pathway; Cancer research; Population; Cerebellar vermis; Neuroscience; Pathology; Cell biology; Medicine; Central nervous system; Signal transduction; Dentate gyrus","score_opus":0.019022805831571784,"score_gpt":0.26886878116482454,"score_spread":0.24984597533325276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588078539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313605,0.00044660416,0.0020205604,0.00005663528,0.000015023681,0.000050967985,0.001981364,0.00015630852,0.0021364598],"genre_scores_gemma":[0.9858307,0.00043117843,0.0034549008,0.000086166256,0.000007557424,0.00006247893,0.004296744,0.00009754926,0.0057327687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998031,0.000008603675,0.000014068501,0.00006282886,0.00007037847,0.00004105289],"domain_scores_gemma":[0.99985456,0.000014091623,0.000049313425,0.000014340396,0.000010903606,0.000056800236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058059097,0.0002724407,0.00025448884,0.00048482852,0.00016168435,0.00027896347,0.00022181659,0.0002582173,0.0012921705],"category_scores_gemma":[0.0001064106,0.00024371059,0.00022633141,0.00023658607,0.00026643064,0.00011597705,0.00026322802,0.0004456804,0.00092038204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029582729,0.000009717586,0.00089418626,0.000010263307,0.000001937314,0.00013988552,0.000011954874,0.000011924267,0.99842215,0.000038313505,0.000036538815,0.00039356787],"study_design_scores_gemma":[0.000018079552,0.00022599947,0.117402494,0.00000923031,0.000022755781,0.0022076264,0.00011974844,0.0007413839,0.87300587,0.00011028145,0.006126719,0.000009723291],"about_ca_topic_score_codex":0.0026806288,"about_ca_topic_score_gemma":0.005632388,"teacher_disagreement_score":0.0026806288,"about_ca_system_score_codex":0.00040787007,"about_ca_system_score_gemma":0.0003082702,"threshold_uncertainty_score":0.0053299665},"labels":[],"label_agreement":null},{"id":"W2588083012","doi":"10.1093/neuonc/now212.333","title":"GENT-27. COMPREHENSIVE MOLECULAR CHARACTERIZATION OF N-ETHYL-N-NITROSOUREA INDUCED RAT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"ATRX; Glioma; Offspring; In utero; Immunohistochemistry; Epigenetics; Biology; DNA methylation; Astrocytoma; Pathology; Medicine; Pregnancy; Cancer research; Fetus; Gene; Mutation; Gene expression; Genetics","score_opus":0.023045339494997395,"score_gpt":0.276262590162423,"score_spread":0.2532172506674256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588083012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539407,0.0033807245,0.019828899,0.0001616893,0.00006243757,0.00048629506,0.008008405,0.0006548991,0.013475985],"genre_scores_gemma":[0.8897541,0.0064182756,0.02967357,0.00019145054,0.000018697556,0.00046816075,0.030016428,0.00027920678,0.043180097],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984646,0.000018042609,0.000013132075,0.000026726402,0.000049124566,0.000046564706],"domain_scores_gemma":[0.99991167,0.000010958564,0.000019830306,0.00001512439,0.000019726902,0.000022781982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015547393,0.00053025194,0.00026689767,0.0009484387,0.0001777648,0.00017455465,0.00029973063,0.00021190496,0.0030438604],"category_scores_gemma":[0.000093248935,0.00021723144,0.00038370182,0.0003344976,0.00016432344,0.00011687787,0.0001975842,0.0003520457,0.0010377928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006823517,0.000025416144,0.00026059162,0.000022717795,0.000005552913,0.000051955943,0.000007489819,0.00005032257,0.99754435,0.000057651443,0.000054703356,0.0018509792],"study_design_scores_gemma":[0.0000120666,0.0005517119,0.0118684685,0.000007105864,0.00003079678,0.0005692929,0.000022647826,0.0002999086,0.9803649,0.00004244585,0.006224807,0.0000058138194],"about_ca_topic_score_codex":0.0027783792,"about_ca_topic_score_gemma":0.007933065,"teacher_disagreement_score":0.0030438604,"about_ca_system_score_codex":0.00032483385,"about_ca_system_score_gemma":0.00039058746,"threshold_uncertainty_score":0.010182738},"labels":[],"label_agreement":null},{"id":"W2588085473","doi":"10.1093/neuonc/now212.700","title":"RARE-37. SURGICAL MANAGEMENT OF INCIDENTAL DIFFUSELY INFILTRATING GLIOMAS: A SINGLE INSTITUTIONAL EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Asymptomatic; Astrocytoma; Retrospective cohort study; Oligodendroglioma; Cohort; Glioma; Radiology; Lesion; Surgical pathology; Surgery; Pathology","score_opus":0.03749152960203581,"score_gpt":0.3220791477125561,"score_spread":0.28458761811052025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588085473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613875,0.0011116312,0.00053379056,0.00015948944,0.00002235355,0.000023374456,0.0001057873,0.000032805085,0.0018721174],"genre_scores_gemma":[0.9983102,0.00067870575,0.0003702077,0.00010432926,0.000029940704,0.0000110783885,0.00012957478,0.000011488565,0.00035437424],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99961483,0.00007372847,0.000069231646,0.00006749194,0.00006986145,0.00010490168],"domain_scores_gemma":[0.99886024,0.00013867057,0.00040812197,0.000107068256,0.0000814506,0.00040450323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003622758,0.0003200196,0.00017690701,0.00071015174,0.0005779667,0.00064033654,0.00027579715,0.00034161357,0.00152444],"category_scores_gemma":[0.001858909,0.0001973355,0.0003399907,0.00078520185,0.00047893895,0.00043725106,0.0006464321,0.00036106096,0.0006472231],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011504076,0.00014334802,0.9215392,0.00009666685,0.000042436393,0.04003717,0.0008941305,0.00019421325,0.0019217122,0.00021081809,0.001113161,0.03369221],"study_design_scores_gemma":[0.000032688476,0.00095579214,0.62029123,0.00017903927,0.000068416426,0.36253148,0.004065027,0.0007596796,0.0032056044,0.00045716137,0.007403688,0.000050171613],"about_ca_topic_score_codex":0.0015565553,"about_ca_topic_score_gemma":0.0036811694,"teacher_disagreement_score":0.0015565553,"about_ca_system_score_codex":0.00044597196,"about_ca_system_score_gemma":0.00061924406,"threshold_uncertainty_score":0.0050997734},"labels":[],"label_agreement":null},{"id":"W2588133079","doi":"10.1093/neuonc/now212.641","title":"PDTB-22. THE ROLE OF THE CHROMOSOME 19 microRNA CLUSTER (C19MC) IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Neuroepithelial cell; Biology; Embryonic stem cell; Stem cell; Progenitor cell; Neural stem cell; Cell biology; microRNA; Cancer research; Pathology; Genetics; Gene; Medicine","score_opus":0.006132023113742439,"score_gpt":0.23214144638753026,"score_spread":0.2260094232737878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588133079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974642,0.008995448,0.00780252,0.00041290346,0.00012238628,0.000104942425,0.0013137477,0.00035458524,0.006251676],"genre_scores_gemma":[0.98916537,0.0019416976,0.0033109367,0.00009304513,0.000007842178,0.00006713407,0.0011980108,0.00005426224,0.0041616885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999094,0.000014902247,0.0000064025285,0.000025582873,0.000025443964,0.000018320272],"domain_scores_gemma":[0.9999455,0.000009308731,0.000013613639,0.0000061943674,0.0000058004534,0.000019535128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112256035,0.00026608587,0.00017355225,0.00014222815,0.00021318899,0.00023502624,0.00018712053,0.00034866657,0.001431599],"category_scores_gemma":[0.00010035755,0.00014433553,0.00015945864,0.000110160036,0.00016896662,0.00014868898,0.00016595695,0.0005040649,0.0006474155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078761346,0.000014274131,0.00016022725,0.000038954906,0.0000039102506,0.00005764931,0.000008620656,0.00004591564,0.9971878,0.0002059469,0.00010880007,0.002089028],"study_design_scores_gemma":[0.000024470699,0.00026704665,0.0051678224,0.0000066305165,0.00001569336,0.000587406,0.000016027949,0.0008239041,0.9842433,0.00005804227,0.008785159,0.0000044691365],"about_ca_topic_score_codex":0.0008489455,"about_ca_topic_score_gemma":0.0009226736,"teacher_disagreement_score":0.001431599,"about_ca_system_score_codex":0.00030261342,"about_ca_system_score_gemma":0.00024350248,"threshold_uncertainty_score":0.004789114},"labels":[],"label_agreement":null},{"id":"W2588208026","doi":"10.1093/neuonc/now212.816","title":"SURG-15. INTEGRATING MOLECULAR MARKERS AND EXTENT OF RESECTION FOR RISK STRATIFICATION OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: A MULTICENTRE STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Institute of Cancer Research; University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Risk stratification; Glioblastoma; Medicine; Stratification (seeds); Internal medicine; Oncology; Resection; Surgery; Cancer research; Biology","score_opus":0.010321595971339328,"score_gpt":0.2749552976788803,"score_spread":0.26463370170754097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588208026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989988,0.00035801696,0.000097684475,0.000024764426,0.000010013149,0.000059586182,0.0002539897,0.000003845964,0.00019324823],"genre_scores_gemma":[0.9986889,0.00016902552,0.00024866406,0.000041163665,0.000024128425,0.000051432457,0.00065613666,0.00000365295,0.00011686124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998944,0.00040443646,0.00016175908,0.00020607814,0.00015599435,0.00012785621],"domain_scores_gemma":[0.99763477,0.00032252356,0.0008902808,0.000289574,0.00030268187,0.00056017254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002252341,0.0006077054,0.0005707771,0.0011690641,0.00040950498,0.00070301676,0.00047144483,0.0004728062,0.00087657914],"category_scores_gemma":[0.0030281602,0.00035499668,0.0015422403,0.0009826664,0.0002926203,0.0005421351,0.000686261,0.00039499148,0.00050309213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016301099,0.00012299072,0.9951207,0.00002500565,0.00018746317,0.00015697423,0.00006152454,0.000058685742,0.00030941927,0.000006926536,0.00007517361,0.0022449405],"study_design_scores_gemma":[0.0001507286,0.0014530446,0.9969797,0.000013224009,0.00020192022,0.0004498509,0.00010053663,0.0002457778,0.00011325899,0.00001316969,0.000268377,0.000010407239],"about_ca_topic_score_codex":0.0037157142,"about_ca_topic_score_gemma":0.0052672443,"teacher_disagreement_score":0.0037157142,"about_ca_system_score_codex":0.0006706917,"about_ca_system_score_gemma":0.0006331309,"threshold_uncertainty_score":0.011911631},"labels":[],"label_agreement":null},{"id":"W2588218255","doi":"10.1093/neuonc/now212.478","title":"MPTH-41. MGMT STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 0424: A PHASE II TRIAL OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY FOR HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; London Health Sciences Centre; Western University","funders":"","keywords":"Temozolomide; Oncology; Glioma; Internal medicine; Medicine; Chemoradiotherapy; Hazard ratio; Methyltransferase; Methylation; Proportional hazards model; Biomarker; Radiation therapy; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Astrocytoma; Cancer research; Biology; Confidence interval; Gene","score_opus":0.03660164644227795,"score_gpt":0.3806421536693743,"score_spread":0.34404050722709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588218255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851054,0.00075144647,0.00007934275,0.000091961985,0.000014437199,0.00011025667,0.00020971184,0.000020617887,0.00021171692],"genre_scores_gemma":[0.9966402,0.0005016372,0.00051770004,0.00013007739,0.000040075152,0.0002518684,0.00076829543,0.000014337873,0.00113582],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995859,0.0002665092,0.000013003027,0.0000456264,0.000041669882,0.00004725105],"domain_scores_gemma":[0.99960226,0.000060138867,0.00014215437,0.000031369964,0.000017352431,0.00014670544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014717004,0.0008025209,0.0009766374,0.00030214095,0.00013828915,0.000609854,0.0005195658,0.00045858274,0.0014745003],"category_scores_gemma":[0.0009244278,0.0002852918,0.0006988325,0.00029309886,0.0003213808,0.00026780102,0.0002725818,0.0009813309,0.0004255106],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5594775,0.02115772,0.14927006,0.0007154801,0.0027360658,0.00026509765,0.0002754766,0.006066599,0.059347276,0.00014113671,0.0038483744,0.19669919],"study_design_scores_gemma":[0.1348888,0.4180544,0.41205534,0.00007151961,0.0025906365,0.00075738743,0.0001543448,0.009092611,0.013580451,0.000383637,0.008284358,0.00008635818],"about_ca_topic_score_codex":0.00084523536,"about_ca_topic_score_gemma":0.0025715246,"teacher_disagreement_score":0.0014745003,"about_ca_system_score_codex":0.0005732395,"about_ca_system_score_gemma":0.0008106952,"threshold_uncertainty_score":0.0077831745},"labels":[],"label_agreement":null},{"id":"W2588241938","doi":"10.1093/neuonc/now212.794","title":"STMC-31. STIMULATION OF MICROGLIA AND MACROPHAGES AND GROWTH ATTENUATION OF BRAIN TUMOR-INITIATING CELLS WITH TUMOR NECROSIS FACTOR-ALPHA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Microglia; Tumor necrosis factor alpha; Cancer research; Biology; Stem cell; Population; Immunology; Cytotoxic T cell; Cell biology; Inflammation; In vitro; Medicine; Genetics","score_opus":0.012801553038251543,"score_gpt":0.25102689195137634,"score_spread":0.2382253389131248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588241938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520226,0.007253697,0.0012521084,0.0008425047,0.00034590717,0.0001832493,0.0029657467,0.00020186605,0.011752648],"genre_scores_gemma":[0.9799897,0.0037128904,0.0021609627,0.00039735477,0.00007595497,0.00034403164,0.0050741453,0.000028376995,0.0082165655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997286,0.000036217953,0.00002905948,0.00003349798,0.00006771653,0.00010492152],"domain_scores_gemma":[0.9998547,0.000029333161,0.000024624442,0.000016066931,0.000022843316,0.00005233377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016227867,0.00047573276,0.00046405222,0.00030572878,0.0002442489,0.00031288058,0.0002262518,0.00039836703,0.003764584],"category_scores_gemma":[0.00018850372,0.00014499214,0.0004267592,0.00035412426,0.00024212709,0.00018940201,0.000235659,0.0009954248,0.0013871137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023215492,0.0005229222,0.00046975762,0.00038033316,0.000016895565,0.00042385995,0.00006499725,0.00036529815,0.9864543,0.0005547712,0.0015025901,0.006922727],"study_design_scores_gemma":[0.0004860954,0.0030182758,0.0070927995,0.00004732699,0.000033902004,0.0007711462,0.00009833623,0.001989091,0.973821,0.000275401,0.012348786,0.000017957032],"about_ca_topic_score_codex":0.0019090471,"about_ca_topic_score_gemma":0.0029745586,"teacher_disagreement_score":0.003764584,"about_ca_system_score_codex":0.00030285039,"about_ca_system_score_gemma":0.00092660415,"threshold_uncertainty_score":0.012593746},"labels":[],"label_agreement":null},{"id":"W2588309790","doi":"10.1093/neuonc/now212.444","title":"MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Internal medicine; Medicine; Oligodendroglioma; Oncology; Hazard ratio; Glioma; Statistical significance; Proportional hazards model; Astrocytoma; Confidence interval; Cancer research","score_opus":0.027275415017648658,"score_gpt":0.3409171157286852,"score_spread":0.3136417007110366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588309790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985393,0.000534518,0.000091051814,0.00012292564,0.000015025707,0.000093989795,0.00022620571,0.00001232532,0.00036470778],"genre_scores_gemma":[0.9972928,0.00036980028,0.00043023075,0.00016260873,0.000043007298,0.00017593116,0.00078859547,0.000009185251,0.0007278741],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996524,0.0001988791,0.00001635112,0.000045745852,0.000047324815,0.00003935049],"domain_scores_gemma":[0.9994717,0.000115393144,0.00016137921,0.00004104781,0.000020875968,0.00018964593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013811436,0.00045775383,0.0007166854,0.00022613988,0.00012591442,0.00046302556,0.0004679198,0.00042009258,0.0014557755],"category_scores_gemma":[0.0008570129,0.0001915268,0.00052909204,0.00019894112,0.0002742708,0.00034231824,0.00021790563,0.0011077821,0.00032474223],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5307562,0.02075195,0.18979979,0.00065217813,0.0012305175,0.00025679017,0.00023836578,0.0041456604,0.04417736,0.00022730863,0.0039509227,0.20381296],"study_design_scores_gemma":[0.10879762,0.50410867,0.35987464,0.000074405,0.0013854118,0.00096297555,0.00014900335,0.0072382693,0.011658483,0.00047144626,0.005224614,0.000054487537],"about_ca_topic_score_codex":0.00054202223,"about_ca_topic_score_gemma":0.0021675683,"teacher_disagreement_score":0.0014557755,"about_ca_system_score_codex":0.00044751866,"about_ca_system_score_gemma":0.0007606185,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2588370865","doi":"10.1093/neuonc/now212.438","title":"MNGO-18. MANAGEMENT OF MULTIPLE MENINGIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital","funders":"","keywords":"Medicine; Asymptomatic; Meningioma; Radiation therapy; Neurofibromatosis; Surgery; Radiology; Epidemiology; Presentation (obstetrics); Disease; Internal medicine","score_opus":0.04275084993859543,"score_gpt":0.30927890025374877,"score_spread":0.26652805031515336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588370865","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87414,0.063640565,0.0028135797,0.0073248902,0.00044460612,0.000120258555,0.0004508077,0.00037368175,0.05069151],"genre_scores_gemma":[0.96846616,0.014485708,0.003038187,0.0014294154,0.00047391024,0.000041989744,0.00042798786,0.000052867625,0.011583787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999106,0.000014208115,0.0000103692755,0.000015819913,0.000023374767,0.000025603867],"domain_scores_gemma":[0.99977154,0.000015732654,0.00009169843,0.0000060088137,0.000017773109,0.00009729897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013356232,0.00029291085,0.00014206156,0.00035959846,0.0003423478,0.0002545546,0.00022775038,0.0003640342,0.002781068],"category_scores_gemma":[0.0003563856,0.00006862786,0.00022099057,0.0001860348,0.00017958191,0.00022027384,0.00038175544,0.00046480683,0.00096521364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088524184,0.00039576553,0.30928767,0.0010925431,0.00011500548,0.07194029,0.0005474108,0.0007166692,0.022723274,0.000995457,0.025992285,0.5653084],"study_design_scores_gemma":[0.00018469675,0.0018822142,0.41390854,0.0010511056,0.00013675108,0.39704522,0.0005517588,0.00089358236,0.007107139,0.0008893172,0.17630735,0.000042341137],"about_ca_topic_score_codex":0.0011986261,"about_ca_topic_score_gemma":0.003609264,"teacher_disagreement_score":0.002781068,"about_ca_system_score_codex":0.00043920398,"about_ca_system_score_gemma":0.00046435514,"threshold_uncertainty_score":0.00930357},"labels":[],"label_agreement":null},{"id":"W2588543544","doi":"10.1093/neuonc/now212.611","title":"PDCT-07. HERBY (BO25041): A PHASE II OPEN-LABEL, RANDOMIZED, MULTICENTER, COMPARATIVE STUDY OF BEVACIZUMAB (BEV)-BASED THERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Temozolomide; Bevacizumab; Internal medicine; Hazard ratio; Glioma; Clinical endpoint; Oncology; Confidence interval; Radiation therapy; Surgery; Randomized controlled trial; Chemotherapy","score_opus":0.037798600402264224,"score_gpt":0.34259248905380585,"score_spread":0.3047938886515416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588543544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924303,0.0022623166,0.00056277245,0.00028357058,0.00012296635,0.004089498,0.0016009023,0.000094989315,0.0017398457],"genre_scores_gemma":[0.9850096,0.00244665,0.0024158559,0.0009376442,0.00015984332,0.004355947,0.0025569077,0.000025630845,0.0020919894],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997323,0.000119358454,0.000014902693,0.000052535677,0.000030905816,0.000050066017],"domain_scores_gemma":[0.99958426,0.000054177483,0.00011063606,0.000024346084,0.000032120013,0.00019450538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010982398,0.0010225212,0.0013843398,0.0003766562,0.00030692355,0.00064575445,0.000708937,0.00091728993,0.003790456],"category_scores_gemma":[0.00063192303,0.00051780546,0.00075421407,0.0004648456,0.00067521806,0.0006645297,0.00025428872,0.0018683102,0.0006552225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8410178,0.046543457,0.006845352,0.0012584222,0.0018771718,0.00017577561,0.00018617146,0.0014454295,0.025940897,0.00049600244,0.0052242116,0.06898928],"study_design_scores_gemma":[0.7590102,0.2242975,0.010343269,0.000036871443,0.0006008723,0.00022973142,0.000045937915,0.00084042596,0.0018003638,0.00015318043,0.0026178493,0.00002380502],"about_ca_topic_score_codex":0.001546633,"about_ca_topic_score_gemma":0.006102647,"teacher_disagreement_score":0.003790456,"about_ca_system_score_codex":0.0009365553,"about_ca_system_score_gemma":0.0018322505,"threshold_uncertainty_score":0.012680352},"labels":[],"label_agreement":null},{"id":"W2588554523","doi":"10.1093/neuonc/now188.278","title":"P17.04 Radiomics analysis of primary central nervous system lymphoma (PCNSL) - A LOC network study","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Advanced Remanufacturing and Technology Centre; Institut National Du Cancer","keywords":"Primary central nervous system lymphoma; Radiomics; Medicine; Lymphoma; Oncology; Internal medicine; Radiology","score_opus":0.016443559147202684,"score_gpt":0.2644862068795697,"score_spread":0.248042647732367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588554523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945768,0.00028554033,0.0008345205,0.00013518942,0.00001045321,0.000038437523,0.0021629378,0.00003844229,0.0019176616],"genre_scores_gemma":[0.99713147,0.000100696176,0.00038888995,0.000027964743,0.000020092462,0.000050900613,0.001643566,0.000026881917,0.00060943153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947375,0.00014000307,0.00003480701,0.00017234836,0.000072760144,0.00010631135],"domain_scores_gemma":[0.99849415,0.0002644309,0.0005412999,0.00014764357,0.00024231411,0.00031003353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006665457,0.00032653537,0.00028349253,0.0022046494,0.0006068968,0.0010951802,0.00062681217,0.00040988054,0.0070188907],"category_scores_gemma":[0.002159549,0.00018855369,0.00039335294,0.0016668721,0.00034689938,0.0005051736,0.00094412826,0.00034011193,0.0012063719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004977823,0.000066433,0.98530376,0.0000661026,0.00016525864,0.0012110977,0.00020761749,0.00023741231,0.001898059,0.00022364013,0.0011514231,0.00897127],"study_design_scores_gemma":[0.000038159287,0.00022138093,0.98874843,0.000032109383,0.00030136906,0.003975243,0.00060284423,0.0022530316,0.0006287648,0.000362391,0.0028233365,0.000012962544],"about_ca_topic_score_codex":0.0059465715,"about_ca_topic_score_gemma":0.0060451836,"teacher_disagreement_score":0.0070188907,"about_ca_system_score_codex":0.0007105776,"about_ca_system_score_gemma":0.00050532963,"threshold_uncertainty_score":0.023480535},"labels":[],"label_agreement":null},{"id":"W2588587990","doi":"10.1093/neuonc/now212.606","title":"PDCT-02. MARKED RECOVERY OF VISION IN A CHILD WITH OPTIC PATHWAY GLIOMA TREATED UPFRONT WITH BEVACIZUMAB AND VINBLASTINE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Bevacizumab; Pilocytic astrocytoma; Optic chiasm; Optic tract; Optic nerve; Glioma; Ophthalmology; Surgery; Astrocytoma; Chemotherapy","score_opus":0.006906730345174112,"score_gpt":0.24713083352935877,"score_spread":0.24022410318418466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588587990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609525,0.002155129,0.000754811,0.0018442625,0.000088945846,0.000093732015,0.00039643544,0.000115165094,0.008456224],"genre_scores_gemma":[0.99655354,0.0005570743,0.00057302695,0.00046663862,0.00003844951,0.000016471688,0.00022880682,0.000012628883,0.0015533429],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998727,0.000013498755,0.000012243364,0.000036121306,0.000028358101,0.00003709063],"domain_scores_gemma":[0.99972624,0.000041145126,0.000045600962,0.000011189253,0.000020208534,0.00015555636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008166739,0.00043644378,0.00034538275,0.00042058906,0.0005624185,0.00035863026,0.00041067292,0.00110179,0.0007997783],"category_scores_gemma":[0.00044504914,0.00019595101,0.00034425748,0.00028796165,0.00039145956,0.00035116932,0.00030693,0.0010679608,0.0003252969],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015980715,0.000117455646,0.01831414,0.00006313366,0.000017132734,0.96553946,0.00017602241,0.0001755798,0.0061647273,0.00026087544,0.00072077324,0.008290893],"study_design_scores_gemma":[0.000038738708,0.0006785398,0.03355023,0.000028936936,0.000020681025,0.960013,0.00008302896,0.00053809356,0.002272734,0.00009564378,0.0026687454,0.000011566317],"about_ca_topic_score_codex":0.0053463997,"about_ca_topic_score_gemma":0.008309084,"teacher_disagreement_score":0.0053463997,"about_ca_system_score_codex":0.0008601528,"about_ca_system_score_gemma":0.0006241136,"threshold_uncertainty_score":0.010630548},"labels":[],"label_agreement":null},{"id":"W2588612590","doi":"10.1093/neuonc/now212.293","title":"EXTH-51. BREVICAN-SPECIFIC PEPTIDES FOR THE DEVELOPMENT OF NEXT-GENERATION TARGETED THERANOSTICS FOR MALIGNANT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Flow cytometry; Peptide library; Peptide; Cancer research; Cancer cell; Biology; Molecular biology; Chemistry; Cancer; Biochemistry; Peptide sequence; Gene","score_opus":0.07028637340521543,"score_gpt":0.29122579347149935,"score_spread":0.22093942006628392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588612590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206319,0.013595614,0.046629883,0.00046414856,0.00017247333,0.0008810419,0.0022214379,0.0009671006,0.0144363325],"genre_scores_gemma":[0.9410741,0.0053410428,0.038194627,0.00044776226,0.000038245427,0.00042817308,0.002534282,0.000078320874,0.0118635865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978846,0.000030176325,0.0000122277115,0.000036340072,0.000076961,0.00005578198],"domain_scores_gemma":[0.999943,0.000010337491,0.00001163452,0.000005110967,0.000010045906,0.000019787853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002962199,0.00057246716,0.0003378248,0.00042287717,0.0001886409,0.0003663595,0.00025935328,0.00044250817,0.0018319356],"category_scores_gemma":[0.00015236827,0.00019656912,0.0002673199,0.00031725373,0.00019988173,0.00023124371,0.0003510254,0.00052419846,0.0010867406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013605159,0.000073084215,0.00015404746,0.00011757879,0.000010465312,0.00011423309,0.00001759899,0.00067591947,0.9842383,0.00032228805,0.00032574954,0.013814622],"study_design_scores_gemma":[0.000058135327,0.0005809612,0.0011531007,0.000014844548,0.00001782649,0.00034032617,0.00001138387,0.0020805902,0.9868758,0.00010747993,0.0087437425,0.000015782647],"about_ca_topic_score_codex":0.0004282787,"about_ca_topic_score_gemma":0.0009867521,"teacher_disagreement_score":0.0018319356,"about_ca_system_score_codex":0.0004141355,"about_ca_system_score_gemma":0.0003249008,"threshold_uncertainty_score":0.00612849},"labels":[],"label_agreement":null},{"id":"W2588614488","doi":"10.1093/neuonc/now212.159","title":"CBIO-21. STAT3 REGULATES AN SL/PL TRANSITION IN BTICs THROUGH AN EMT-LIKE PROCESS MEDIATED BY SLUG","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"Slug; Epithelial–mesenchymal transition; Biology; STAT3; Transcription factor; Cancer research; Transcriptome; Twist transcription factor; Cell biology; Signal transduction; Downregulation and upregulation; Gene; Gene expression; Genetics","score_opus":0.015525706795313302,"score_gpt":0.31343715552350254,"score_spread":0.29791144872818925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588614488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95481855,0.005456577,0.0045407037,0.0015397273,0.00048502994,0.00016062675,0.016360056,0.0011865881,0.015452238],"genre_scores_gemma":[0.95767504,0.0016035428,0.003314078,0.0006848402,0.00003837491,0.00032426225,0.013320075,0.00021896992,0.02282085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958533,0.00004307772,0.00003914969,0.00007939604,0.00009582838,0.00015720283],"domain_scores_gemma":[0.99984324,0.000020843037,0.000031289524,0.000016489144,0.00001820136,0.00006983145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017082292,0.00036258678,0.00036678987,0.0005299028,0.00042744662,0.00056907797,0.0003981438,0.00045579273,0.009720238],"category_scores_gemma":[0.000117963966,0.00021813616,0.0006809959,0.00047097795,0.00043522147,0.0002649432,0.00025320536,0.0020087527,0.0028503241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007969773,0.00028008557,0.00035614232,0.00015204074,0.000019736844,0.00008172313,0.000042124226,0.00018333511,0.99405044,0.00037263238,0.0011718116,0.0024928118],"study_design_scores_gemma":[0.000194551,0.00068975304,0.014977282,0.000029898363,0.000053091604,0.00039228264,0.00013240214,0.0024758247,0.96096253,0.00021989453,0.019853376,0.00001922304],"about_ca_topic_score_codex":0.0050664623,"about_ca_topic_score_gemma":0.007464235,"teacher_disagreement_score":0.009720238,"about_ca_system_score_codex":0.0007842496,"about_ca_system_score_gemma":0.00078784686,"threshold_uncertainty_score":0.032517433},"labels":[],"label_agreement":null},{"id":"W2588634924","doi":"10.1093/neuonc/now212.288","title":"EXTH-44. NONE MGMT AND MMR DEPENDENT RADIOSENSITIZATION TO TREAT MALIGNANT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Medicine; Radiation therapy; Chemotherapy; Oncology; DNA damage; Internal medicine; Biology; Glioma; Methylation; Gene; DNA","score_opus":0.018118567256439982,"score_gpt":0.2825633519288493,"score_spread":0.2644447846724093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588634924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82638943,0.095387965,0.0067203045,0.0022140627,0.001324427,0.000850571,0.00329065,0.0017756879,0.06204692],"genre_scores_gemma":[0.8974156,0.035947498,0.00384438,0.0010112884,0.00020655192,0.00038429632,0.00399174,0.00012519002,0.057073534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999287,0.000007792453,0.0000034929667,0.000010884425,0.000026185338,0.000022903885],"domain_scores_gemma":[0.9999794,9.900676e-7,0.000004009193,0.00000248679,0.0000034077439,0.000009583083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010111576,0.00036980075,0.00032630478,0.000458668,0.00015832431,0.00021035851,0.0002682679,0.00032080253,0.00645007],"category_scores_gemma":[0.000050691728,0.00011777154,0.0002396165,0.00024905367,0.00013654616,0.00014325099,0.00027061382,0.00090149435,0.0020824396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015358457,0.001573309,0.0007244413,0.001231051,0.00011977946,0.00053303136,0.00009468029,0.000779104,0.72630745,0.0023792963,0.007700323,0.25702164],"study_design_scores_gemma":[0.0013027096,0.011361952,0.020745533,0.00020713142,0.00023140459,0.003535992,0.000076547985,0.0012847648,0.63204736,0.0010001049,0.32815483,0.000051711006],"about_ca_topic_score_codex":0.0006034951,"about_ca_topic_score_gemma":0.0014061341,"teacher_disagreement_score":0.00645007,"about_ca_system_score_codex":0.00021142302,"about_ca_system_score_gemma":0.0003060405,"threshold_uncertainty_score":0.021577597},"labels":[],"label_agreement":null},{"id":"W2588666144","doi":"10.1093/neuonc/now212.184","title":"CSIG-23. CYTOPLASMIC RNA STRESS GRANULES: A PUTATIVE TRANSLATIONAL MECHANISM OF mTOR REGULATION IN GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protist diversity and phylogeny","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Dalhousie University","funders":"","keywords":"Stress granule; PI3K/AKT/mTOR pathway; Messenger RNA; P-bodies; RNA-binding protein; Cell biology; Molecular biology; Protein biosynthesis; RNA; Translation (biology); Biology; Chemistry; Signal transduction; Gene; Biochemistry","score_opus":0.010780412319912582,"score_gpt":0.24515338094425598,"score_spread":0.2343729686243434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588666144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851377,0.0034833213,0.0019412637,0.00021852048,0.00004439039,0.000054373148,0.0035699734,0.00021663909,0.0019576761],"genre_scores_gemma":[0.9871357,0.0012026466,0.0027371864,0.00019913758,0.000021786309,0.00008909304,0.005238934,0.000047128713,0.0033284354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999908,0.000007126632,0.000007553817,0.000025840027,0.00002533388,0.000026207303],"domain_scores_gemma":[0.999949,0.0000037279626,0.000016847764,0.000004317264,0.000007877044,0.000018307095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078717836,0.00028497973,0.00028649523,0.00038705213,0.00023263137,0.00037153787,0.00016459331,0.00023457175,0.0011586131],"category_scores_gemma":[0.000073446216,0.00013310742,0.00030028063,0.00030473646,0.0001628272,0.00010333421,0.00014556885,0.00026575808,0.00050928345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014140655,0.000009712545,0.0007944119,0.000047206166,0.0000070636747,0.00008264832,0.000011486665,0.000029565103,0.9975551,0.000048165883,0.00011566565,0.0011576315],"study_design_scores_gemma":[0.000028960227,0.00045548863,0.1331606,0.00001958781,0.000059906975,0.000686498,0.00009843458,0.0013773836,0.85686374,0.00014544331,0.007089551,0.000014410441],"about_ca_topic_score_codex":0.001593136,"about_ca_topic_score_gemma":0.0030212782,"teacher_disagreement_score":0.001593136,"about_ca_system_score_codex":0.00044695698,"about_ca_system_score_gemma":0.00026207662,"threshold_uncertainty_score":0.0038759708},"labels":[],"label_agreement":null},{"id":"W2588669390","doi":"10.1093/neuonc/now212.543","title":"NIMG-31. RESIDUAL ENHANCING TUMOR VOLUME IS A STRONG PROGNOSTIC BIOMARKER FOR SURVIVAL IN BOTH NEWLY DIAGNOSED AND RECURRENT GBM REGARDLESS OF THERAPY: EVIDENCE FROM 1,535 PATIENTS IN SINGLE AND MULTICENTER TRIALS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Context (archaeology); Oncology; Internal medicine; Biomarker; Chemotherapy; Clinical trial; Overall survival","score_opus":0.108605759923458,"score_gpt":0.3812831153246559,"score_spread":0.2726773554011979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588669390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8926179,0.09934967,0.0010100693,0.0008627941,0.00021857051,0.00054256944,0.0030574417,0.00006417535,0.002276769],"genre_scores_gemma":[0.9887184,0.007277219,0.0007710113,0.0004643569,0.00015899386,0.00029475984,0.002012772,0.0000169867,0.00028544213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938275,0.0035712165,0.0007516042,0.0008723502,0.00072291476,0.0002543744],"domain_scores_gemma":[0.9936381,0.0022727142,0.0023860892,0.0007888375,0.00043596743,0.00047827573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013479666,0.00064626115,0.0029469274,0.0008108381,0.00032370086,0.0015050203,0.0006745472,0.00091306603,0.0011991446],"category_scores_gemma":[0.009129256,0.00033022984,0.0038324997,0.001545698,0.0007154761,0.0009022192,0.0009788306,0.00069046946,0.00031719715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15825348,0.0008695205,0.49731135,0.005499581,0.12878488,0.00024956078,0.00033923064,0.0018696488,0.006921773,0.00027928402,0.0035398856,0.19608189],"study_design_scores_gemma":[0.027256012,0.033948906,0.8053678,0.0009344264,0.10797364,0.0009965011,0.00023304998,0.001515864,0.0033058824,0.0010416632,0.01729563,0.00013073342],"about_ca_topic_score_codex":0.00079143455,"about_ca_topic_score_gemma":0.002856602,"teacher_disagreement_score":0.013479666,"about_ca_system_score_codex":0.0005530203,"about_ca_system_score_gemma":0.00076766504,"threshold_uncertainty_score":0.07128811},"labels":[],"label_agreement":null},{"id":"W2588684378","doi":"10.1093/neuonc/now212.471","title":"MPTH-34. THE PROGNOSTIC VALUE OF POLYSOMY IN OLIGODENDROGLIAL TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Polysomy; Oligodendroglial Tumor; Internal medicine; Oligodendroglioma; Oncology; Chemotherapy; Medicine; Fluorescence in situ hybridization; Pathology; Cancer research; Biology; Glioma; Astrocytoma; Genetics; Gene","score_opus":0.017654812481901015,"score_gpt":0.28993772677229457,"score_spread":0.27228291429039353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588684378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830353,0.0005685054,0.00010103157,0.000048136324,0.0000055719825,0.0000041651624,0.0004216813,0.000008692533,0.0005386141],"genre_scores_gemma":[0.9991918,0.0001171765,0.00014098495,0.0000070051974,0.000009129201,0.0000030117774,0.00039007125,0.0000027395909,0.00013807436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998234,0.000026282098,0.000020745534,0.00003523594,0.00004832681,0.00004606032],"domain_scores_gemma":[0.9989052,0.00015419023,0.00051340944,0.00004166717,0.00011288514,0.00027256517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036919504,0.00023534801,0.00014804922,0.0009401445,0.00024282178,0.00035942212,0.0002494201,0.00024324676,0.0016253509],"category_scores_gemma":[0.0015471176,0.00011406788,0.00015842156,0.0006748748,0.00027084895,0.00036890147,0.0004264316,0.00023723867,0.0003803743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017931369,0.0000036462686,0.99400854,0.000009997043,0.000009854056,0.00038796768,0.000019468987,0.00009583008,0.00147135,0.000012908149,0.00011416682,0.0036871412],"study_design_scores_gemma":[0.0000044118033,0.00005774105,0.9957541,0.0000061816177,0.00001575824,0.0023504042,0.000054229873,0.0005063774,0.0007597834,0.000046168174,0.00044031953,0.0000045173865],"about_ca_topic_score_codex":0.0018768848,"about_ca_topic_score_gemma":0.003032126,"teacher_disagreement_score":0.0018768848,"about_ca_system_score_codex":0.00034312496,"about_ca_system_score_gemma":0.00023061357,"threshold_uncertainty_score":0.005437374},"labels":[],"label_agreement":null},{"id":"W2588711318","doi":"10.1093/neuonc/now212.178","title":"CSIG-17. COMPENSATORY ACTIVATION OF STAT3 TRIGGERED BY EGFR INHIBITION: A MECHANISM OF RESISTANCE IN GBM BRAIN TUMOR INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"Afatinib; Cancer research; STAT3; EGFR inhibitors; Signal transduction; In vivo; Biology; Erlotinib; Epidermal growth factor receptor; Cancer; Medicine; Cell biology; Genetics","score_opus":0.026308622111289516,"score_gpt":0.29275581110172444,"score_spread":0.2664471889904349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588711318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890914,0.0025993718,0.0010893339,0.00032616098,0.00009023178,0.00010997078,0.0021902404,0.00021697022,0.0042863935],"genre_scores_gemma":[0.9907958,0.0013797714,0.0012718446,0.00018607116,0.000013372845,0.000097187556,0.0035673797,0.000026635691,0.0026620317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.000019791218,0.00001692797,0.00002224168,0.000053655152,0.000062421066],"domain_scores_gemma":[0.9999298,0.000011157058,0.000012573705,0.000012821259,0.000010670085,0.000023029479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017198888,0.00036910563,0.0006455339,0.00032954142,0.0001485338,0.00041351828,0.0003098749,0.00037224765,0.0020339787],"category_scores_gemma":[0.00012529534,0.00014522557,0.00043654197,0.0004932647,0.00021285082,0.00015245388,0.00016479997,0.0009427916,0.0008168957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009069072,0.00039235523,0.0014082387,0.00019727308,0.000038646427,0.0003824293,0.000060193754,0.00075201853,0.98128545,0.0004221017,0.0009181595,0.013236245],"study_design_scores_gemma":[0.00018525888,0.0028397043,0.013027495,0.00001617856,0.000056369816,0.0011788271,0.00007765211,0.0022641728,0.970349,0.00022253125,0.009769578,0.0000131270335],"about_ca_topic_score_codex":0.0014215249,"about_ca_topic_score_gemma":0.0020210634,"teacher_disagreement_score":0.0020339787,"about_ca_system_score_codex":0.0004228076,"about_ca_system_score_gemma":0.00056396343,"threshold_uncertainty_score":0.006804347},"labels":[],"label_agreement":null},{"id":"W2588786146","doi":"10.1093/neuonc/now188.137","title":"P08.04 Antitumor effects of medroxyprogesterone on glial tumor growth in vitro and in vivo and an unexpected contribution of PI3Kinase on anti-invasive effects of steroids","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medroxyprogesterone; In vivo; Medicine; In vitro; Cancer research; Pharmacology; Medroxyprogesterone acetate; Oncology; Internal medicine; Chemistry; Biology; Hormone; Biochemistry","score_opus":0.0055843025220749295,"score_gpt":0.25144012844442337,"score_spread":0.24585582592234845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588786146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119223,0.007096214,0.0009408943,0.00034312857,0.00015446654,0.000067261055,0.0011758466,0.00013281454,0.008897167],"genre_scores_gemma":[0.98397416,0.0028960747,0.0013071895,0.00012993066,0.000046602938,0.0000993112,0.0012979164,0.00001597736,0.010232877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999373,0.000008217837,0.000005927616,0.000008627525,0.0000195199,0.000020299325],"domain_scores_gemma":[0.9999511,0.0000106975585,0.000007852774,0.0000064275487,0.000008689004,0.0000151322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007900963,0.00029524186,0.0001889689,0.00023396422,0.00012463494,0.00018982563,0.00015812049,0.00024683223,0.005133042],"category_scores_gemma":[0.00007414882,0.0000699838,0.0002218367,0.00016202278,0.00016204751,0.00011676714,0.00008573159,0.00055762014,0.0009474358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028890336,0.00049051124,0.00103871,0.00025627855,0.000020385974,0.00038532994,0.00003961403,0.000109190456,0.97235197,0.00024900795,0.0007545553,0.021415412],"study_design_scores_gemma":[0.00016381544,0.0076315315,0.012437519,0.000024324505,0.00005661672,0.0013481415,0.000057099744,0.000470966,0.9654906,0.00015115655,0.012163193,0.000005014612],"about_ca_topic_score_codex":0.00041535104,"about_ca_topic_score_gemma":0.00039610988,"teacher_disagreement_score":0.005133042,"about_ca_system_score_codex":0.00013382851,"about_ca_system_score_gemma":0.00027314006,"threshold_uncertainty_score":0.01717168},"labels":[],"label_agreement":null},{"id":"W2588793449","doi":"10.1093/neuonc/now212.656","title":"QLIF-10. FAMILY CAMP: A MULTI-DISCIPLINARY, HOLISTIC INTERVENTION FOR BRAIN TUMOR PATIENTS AND THEIR FAMILIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital","funders":"","keywords":"Psychological intervention; Anxiety; Psychosocial; Coping (psychology); Medicine; Intervention (counseling); Clinical psychology; Psychology; Psychiatry","score_opus":0.058166473869346244,"score_gpt":0.3619905565929547,"score_spread":0.30382408272360845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588793449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8919396,0.0028157057,0.0047321646,0.013720155,0.00072862464,0.012574345,0.008629487,0.0007075315,0.064152405],"genre_scores_gemma":[0.91773105,0.0022777128,0.03044812,0.003651742,0.000103097285,0.022005288,0.004178577,0.00005664932,0.019547762],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99961287,0.0001733638,0.00003122086,0.000027387217,0.000043567263,0.00011156304],"domain_scores_gemma":[0.99940825,0.000100134755,0.00008373988,0.000015997955,0.00010552511,0.00028629272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011004978,0.00032323183,0.00049592485,0.00028678626,0.0010482356,0.0002378012,0.00047941235,0.00037124704,0.014554197],"category_scores_gemma":[0.0019227004,0.00015752095,0.0006821488,0.0002678904,0.00023380121,0.00034839328,0.001244064,0.000903957,0.0007393707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006664027,0.010396192,0.03267681,0.0029346258,0.00025596443,0.0012021062,0.003930811,0.0015618325,0.0027316897,0.0010306074,0.13520527,0.80141],"study_design_scores_gemma":[0.02263209,0.022237713,0.67055506,0.0037526009,0.00045017104,0.0025556113,0.012526786,0.0032063983,0.0023119324,0.0049279355,0.25458097,0.00026280966],"about_ca_topic_score_codex":0.0071495827,"about_ca_topic_score_gemma":0.023784552,"teacher_disagreement_score":0.014554197,"about_ca_system_score_codex":0.0014649134,"about_ca_system_score_gemma":0.0032613303,"threshold_uncertainty_score":0.04868865},"labels":[],"label_agreement":null},{"id":"W2588796936","doi":"10.1093/neuonc/now212.613","title":"PDCT-09. HYPERMUTATION AND NEOANTIGEN FORMATION IS DIAGNOSTIC AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT BRAIN TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University Health Centre; Hôpital de l'Enfant-Jésus; Mount Sinai Hospital; CancerCare Manitoba; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Université Laval; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; DNA mismatch repair; Immune system; Medicine; Cancer research; Immunology; DNA repair; Biology; Genetics; Antibody; Gene; B cell","score_opus":0.011363064178926135,"score_gpt":0.2617202123091235,"score_spread":0.2503571481301974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588796936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983468,0.00023955441,0.00023671676,0.000027996904,0.0000040355994,0.000009647967,0.00038173466,0.000016849413,0.0007365205],"genre_scores_gemma":[0.9985721,0.00009545993,0.00039441214,0.000020647338,0.0000036988356,0.000008122913,0.0006844645,0.0000052463874,0.00021586007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998586,0.000024875511,0.000018482015,0.00004291979,0.00003446532,0.00002067946],"domain_scores_gemma":[0.99957234,0.000103376566,0.00015527573,0.000016806602,0.00004049748,0.00011164803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018349898,0.00016284102,0.00020064878,0.00047746618,0.00017051114,0.00036659796,0.0002050712,0.00024929526,0.0011053629],"category_scores_gemma":[0.0006558479,0.00008436136,0.00008870431,0.00031913238,0.00019465308,0.0001245582,0.00022696286,0.00023236581,0.0002447685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009869669,0.000052026986,0.9727787,0.000018928855,0.000022556504,0.0009981125,0.00003124912,0.0002137454,0.015067192,0.000034587843,0.00032481877,0.009471214],"study_design_scores_gemma":[0.00002535089,0.00048032144,0.9803695,0.0000074947375,0.000031904543,0.008439034,0.00006261189,0.0012743011,0.008081957,0.00004397682,0.001178112,0.0000053081467],"about_ca_topic_score_codex":0.0010427535,"about_ca_topic_score_gemma":0.0013810463,"teacher_disagreement_score":0.0011053629,"about_ca_system_score_codex":0.0002618196,"about_ca_system_score_gemma":0.00014222489,"threshold_uncertainty_score":0.0036978126},"labels":[],"label_agreement":null},{"id":"W2588820796","doi":"10.1093/neuonc/now212.499","title":"NCOG-04. IMPAIRED FLUID COGNITION IN PATIENTS WITH GLIOMA OF THE FRONTAL AND PARIETAL LOBES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cognition; Working memory; Psychology; Audiology; Wisconsin Card Sorting Test; Cognitive test; Cognitive psychology; Medicine; Neuroscience; Neuropsychology","score_opus":0.009617411132015292,"score_gpt":0.2482412547801868,"score_spread":0.23862384364817152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588820796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523073,0.00025979738,0.0000399035,0.00008472099,0.00001421935,0.000020590733,0.0008349071,0.000010693003,0.0035042607],"genre_scores_gemma":[0.9969332,0.00008918214,0.000086085536,0.00006262211,0.000012819484,0.000020773023,0.0017813079,0.0000036353963,0.0010102774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989104,0.000019117533,0.000013382181,0.000023341541,0.000029679275,0.000023493583],"domain_scores_gemma":[0.9994863,0.000060295668,0.00019815378,0.000022791366,0.00007732835,0.0001550765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020998639,0.00024823268,0.00024417785,0.00039745343,0.00033599528,0.00043971403,0.00017950247,0.00027179444,0.0031105266],"category_scores_gemma":[0.00093287276,0.000072391726,0.00013864049,0.0004907177,0.00019792718,0.00020512108,0.00025184505,0.00021610556,0.000620391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015466925,0.0001295158,0.98536754,0.000037315884,0.000042161388,0.0012064427,0.00011592629,0.000045436456,0.0017622433,0.000048725007,0.0012702753,0.008427859],"study_design_scores_gemma":[0.000051805364,0.00029551794,0.996536,0.000008239639,0.000021625967,0.0018002691,0.000106024556,0.000054888325,0.00019132036,0.00004889249,0.000881471,0.0000039919023],"about_ca_topic_score_codex":0.006966784,"about_ca_topic_score_gemma":0.009253012,"teacher_disagreement_score":0.006966784,"about_ca_system_score_codex":0.0004023636,"about_ca_system_score_gemma":0.00042832684,"threshold_uncertainty_score":0.0138524175},"labels":[],"label_agreement":null},{"id":"W2588835593","doi":"10.1093/neuonc/now212.152","title":"CBIO-14. EXPLORING THE OTX2 REGULATORY NETWORK: TARGETING THE “GROW AND GO” ARMS OF THE MOST AGGRESSIVE MEDULLOBLASTOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medicinal Plants and Bioactive Compounds","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"","keywords":"Semaphorin; Biology; Gene knockdown; Axon guidance; Gene; Cancer research; Downregulation and upregulation; Signal transduction; Transcription factor; Progenitor cell; Stem cell; Cell biology; Axon; Genetics; Receptor","score_opus":0.01906391179740932,"score_gpt":0.2471173092619949,"score_spread":0.22805339746458558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588835593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8039574,0.020017287,0.06843571,0.0042439615,0.0013262259,0.0013087359,0.03716959,0.010289608,0.053251524],"genre_scores_gemma":[0.81842196,0.00952106,0.075547345,0.0031809728,0.00016770135,0.001512946,0.043579724,0.0018715746,0.04619667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966335,0.000025676214,0.000012446924,0.00009713473,0.00012595921,0.00007553795],"domain_scores_gemma":[0.99981624,0.000023930272,0.000032273583,0.000017176662,0.000029239673,0.00008117493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079911,0.00062271877,0.00069892575,0.0005996321,0.00050369406,0.0009019352,0.0009160832,0.0006213617,0.0071693566],"category_scores_gemma":[0.00020902097,0.00039506532,0.0005597114,0.00048067575,0.00043503073,0.00029725084,0.00060162746,0.0017386996,0.0019615064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276679,0.0002063195,0.0014479599,0.00038973187,0.000056492037,0.0001135873,0.00004420697,0.0011690847,0.97014916,0.0013748214,0.004709058,0.019312033],"study_design_scores_gemma":[0.0006918913,0.0014595494,0.021165095,0.00015920588,0.000293741,0.0007041136,0.00015023009,0.019510001,0.8217335,0.0011650934,0.132895,0.000072604766],"about_ca_topic_score_codex":0.0033144525,"about_ca_topic_score_gemma":0.007850483,"teacher_disagreement_score":0.0071693566,"about_ca_system_score_codex":0.0010239806,"about_ca_system_score_gemma":0.0014157319,"threshold_uncertainty_score":0.023983896},"labels":[],"label_agreement":null},{"id":"W2588866514","doi":"10.1093/neuonc/now212.238","title":"EPID-12. DEMOGRAPHICS AND LIFESTYLE FACTORS IN GLIOMA RISK: A REPORT FROM THE GLIOMA INTERNATIONAL CASE-CONTROL STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Demography; Medicine; Overweight; Underweight; Family history; Body mass index; Ethnic group; Internal medicine; Oncology; Gerontology","score_opus":0.0337535961370827,"score_gpt":0.3500503436558549,"score_spread":0.31629674751877224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588866514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53841525,0.08951056,0.014076644,0.0028510683,0.00059954636,0.0019974934,0.32751372,0.0006262052,0.024409538],"genre_scores_gemma":[0.8383048,0.019127596,0.0054701436,0.0011940983,0.00029201445,0.0028534941,0.12752205,0.00016638324,0.0050693233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965385,0.00095573434,0.00081593526,0.000772666,0.00073123083,0.00018601424],"domain_scores_gemma":[0.99350786,0.0017484826,0.0019769333,0.0009775112,0.0015391835,0.00025002327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054736882,0.0006336959,0.00096123904,0.0038454614,0.0006413751,0.0011893281,0.0008776263,0.0008604385,0.00454376],"category_scores_gemma":[0.016132038,0.00066636724,0.0026112327,0.007960334,0.00021656306,0.00055634545,0.00078832713,0.00067988277,0.0010273585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010126244,0.00008880007,0.9622222,0.0016331563,0.0045428947,0.0005344687,0.00027358948,0.00014474933,0.0004490394,0.00024812564,0.010707472,0.018142924],"study_design_scores_gemma":[0.00025887482,0.00012504552,0.97033656,0.00037818533,0.0058927615,0.0011537368,0.00016858711,0.00018816022,0.00036514236,0.0001331269,0.02095903,0.000040862407],"about_ca_topic_score_codex":0.015026409,"about_ca_topic_score_gemma":0.0116279125,"teacher_disagreement_score":0.015026409,"about_ca_system_score_codex":0.00070178777,"about_ca_system_score_gemma":0.0008634634,"threshold_uncertainty_score":0.029877901},"labels":[],"label_agreement":null},{"id":"W2588903294","doi":"10.1093/neuonc/now212.342","title":"GENT-36. THE GENOMIC LANDSCAPE OF SCHWANNOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Schwannoma; Biology; Cancer research; Fusion gene; Exome; Schwann cell; MAPK/ERK pathway; Gene; Exome sequencing; Genetics; Medicine; Pathology; Mutation; Signal transduction; Cell biology","score_opus":0.02429780488512628,"score_gpt":0.27985683982979426,"score_spread":0.255559034944668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588903294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97647744,0.0036585785,0.0048708087,0.0003732549,0.000025663441,0.000049627713,0.0023375833,0.00026888528,0.011938269],"genre_scores_gemma":[0.9901854,0.0010340598,0.003713124,0.00011830864,0.000009764988,0.000018035742,0.0019374233,0.00004295763,0.0029409274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999027,0.0000122585125,0.00000437764,0.000029154517,0.000029759265,0.00002159014],"domain_scores_gemma":[0.99993813,0.000016814514,0.000011456185,0.0000066536295,0.000010258158,0.000016695443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001060518,0.00017014117,0.00018060757,0.0005661141,0.00022607994,0.00034016318,0.0001441775,0.00019457367,0.0045039267],"category_scores_gemma":[0.00026276917,0.000083942556,0.00015145354,0.00052702083,0.00021697124,0.000111906775,0.00025567104,0.00016077531,0.0006650907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084293453,0.00005277412,0.092712745,0.00027469412,0.000082603605,0.0055540274,0.00047908805,0.0010838966,0.7884431,0.0023599751,0.0015233484,0.10659085],"study_design_scores_gemma":[0.00008496261,0.00076070457,0.62788916,0.000085498505,0.00027365316,0.0522932,0.0009541355,0.0034304815,0.22796379,0.0072848215,0.07893512,0.000044468787],"about_ca_topic_score_codex":0.001364375,"about_ca_topic_score_gemma":0.0030168176,"teacher_disagreement_score":0.0045039267,"about_ca_system_score_codex":0.00029818155,"about_ca_system_score_gemma":0.00020084018,"threshold_uncertainty_score":0.01506716},"labels":[],"label_agreement":null},{"id":"W2588927945","doi":"10.1093/neuonc/now212.891","title":"TMOD-21. DEFINING THE GROWTH FACTOR NICHE THAT SUPPORTS GBM INITIATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Platelet-derived growth factor receptor; Biology; Growth factor; Platelet-derived growth factor; Cancer research; Cell biology; Subventricular zone; Stem cell; Immunology; Genetics; Receptor; Neural stem cell","score_opus":0.01857176280874703,"score_gpt":0.27030945880536417,"score_spread":0.25173769599661716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588927945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93895984,0.013441411,0.009365321,0.00075061916,0.00020115924,0.0002476369,0.0032245729,0.00023804448,0.033571407],"genre_scores_gemma":[0.97109973,0.004792351,0.009308976,0.00028522802,0.00004699828,0.00015179886,0.0030126097,0.00008034606,0.011221933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987614,0.000011612194,0.0000092981845,0.000025123252,0.000040463878,0.0000373667],"domain_scores_gemma":[0.9999187,0.000006344087,0.000018653494,0.000005053516,0.000010864622,0.000040507228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013375872,0.00026810195,0.00020018517,0.0005438256,0.00027839938,0.00058268587,0.00027758256,0.00034505068,0.0027770055],"category_scores_gemma":[0.00009926634,0.00011512818,0.00019667129,0.0002919746,0.0002815717,0.00029635552,0.00036553812,0.00059754745,0.0010804675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018067015,0.000029622835,0.000816283,0.000103552535,0.000004409984,0.00016110872,0.0000306054,0.00014319553,0.9915963,0.0010489034,0.00026104404,0.0056243814],"study_design_scores_gemma":[0.00004835804,0.00066898396,0.014535256,0.000040655006,0.000026940033,0.0017566028,0.00014732787,0.0018381969,0.91801155,0.0006249196,0.062287357,0.000013874222],"about_ca_topic_score_codex":0.00091710687,"about_ca_topic_score_gemma":0.0032168925,"teacher_disagreement_score":0.0027770055,"about_ca_system_score_codex":0.0006401037,"about_ca_system_score_gemma":0.00056124973,"threshold_uncertainty_score":0.00929004},"labels":[],"label_agreement":null},{"id":"W2588933643","doi":"10.1093/neuonc/now212.475","title":"MPTH-38. TRANSFORMING GROWTH FACTOR-BETA GENE EXPRESSION AS A NEW PROGNOSTIC BIOMARKER FOR GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Gene isoform; Biomarker; Downregulation and upregulation; Hazard ratio; Glioblastoma; Phenotype; Proportional hazards model; Medicine; Transforming growth factor; Oncology; Transforming growth factor beta; Cancer research; Internal medicine; Immunohistochemistry; Multivariate analysis; Pathology; Biology; Gene","score_opus":0.019241696195346155,"score_gpt":0.28651515028716795,"score_spread":0.2672734540918218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588933643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95154613,0.0376996,0.0045034694,0.0007751275,0.00014625596,0.00008853791,0.0018435718,0.00015326601,0.0032440706],"genre_scores_gemma":[0.98717505,0.004975206,0.004182743,0.0001506359,0.000117410724,0.0000886983,0.001328054,0.0000131775905,0.0019690143],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997242,0.000057820696,0.000017492732,0.00005346842,0.00010848146,0.000038531034],"domain_scores_gemma":[0.9997502,0.00004649318,0.00011102365,0.000013771238,0.00003838152,0.000040101382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000707814,0.00032759056,0.0004221176,0.00090466085,0.00013588867,0.00045449915,0.0002589962,0.00024299943,0.0014470036],"category_scores_gemma":[0.0006970649,0.00014180604,0.0002843856,0.0006654774,0.00025331185,0.000328615,0.0003287657,0.00043095252,0.0005264184],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034124225,0.00017712104,0.6466094,0.0009138153,0.0003992771,0.00099209,0.00021856806,0.0017071626,0.1400345,0.000670198,0.00303563,0.2018298],"study_design_scores_gemma":[0.00008876671,0.0015371602,0.925211,0.00015673839,0.00036550142,0.004115037,0.00017853339,0.008651781,0.036269445,0.0016878387,0.021692645,0.000045404624],"about_ca_topic_score_codex":0.0008313523,"about_ca_topic_score_gemma":0.0010569955,"teacher_disagreement_score":0.0014470036,"about_ca_system_score_codex":0.00044286117,"about_ca_system_score_gemma":0.0003226259,"threshold_uncertainty_score":0.004840672},"labels":[],"label_agreement":null},{"id":"W2588958064","doi":"10.1093/neuonc/now212.074","title":"ATIM-09. SUCCESSFUL EXPERIENCE WITH CLINICAL TRIALS FOR HIGH GRADE GLIOMA IN A COMMUNITY SETTING","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Medicine; Internal medicine; Cancer; Clinical research; Oncology","score_opus":0.13797656034456424,"score_gpt":0.441641530545952,"score_spread":0.3036649702013878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588958064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82733315,0.024075512,0.019150918,0.017483693,0.0012328043,0.012409694,0.004975639,0.0028680374,0.09047056],"genre_scores_gemma":[0.9296135,0.0068538818,0.03262533,0.0056802174,0.0010760686,0.006318769,0.0066209463,0.00039763126,0.0108136665],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9887897,0.0084433975,0.00044036796,0.0006185913,0.00090441783,0.0008035364],"domain_scores_gemma":[0.9874973,0.0035317105,0.0014155688,0.0015076055,0.0012893684,0.0047584474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025427036,0.0008385929,0.0007909905,0.0008317441,0.001362217,0.0021780792,0.0020379801,0.0019151288,0.006351167],"category_scores_gemma":[0.0124758445,0.0004779851,0.00076349673,0.00091840705,0.0012457501,0.0012034802,0.0019412587,0.002521435,0.0030407985],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026912339,0.034951523,0.035696954,0.0011169562,0.0007202089,0.0030129992,0.0015863754,0.0023719096,0.03497081,0.0056522815,0.06621082,0.7867968],"study_design_scores_gemma":[0.059231415,0.25363052,0.1652638,0.00039581346,0.00069481507,0.011174429,0.00074451236,0.0043284395,0.037345316,0.005072734,0.4618544,0.00026380658],"about_ca_topic_score_codex":0.0016535438,"about_ca_topic_score_gemma":0.003011351,"teacher_disagreement_score":0.025427036,"about_ca_system_score_codex":0.0013808913,"about_ca_system_score_gemma":0.003421616,"threshold_uncertainty_score":0.13447261},"labels":[],"label_agreement":null},{"id":"W2588967704","doi":"10.1093/neuonc/now212.430","title":"MNGO-09. PROGNOSTIC SIGNIFICANCE OF PRE-OPERATIVE ANEMIA AND LEUKOCYTOSIS ON RECURRENCE-FREE SURVIVAL IN MENINGIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanowire Synthesis and Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Leukocytosis; Neutrophilia; Medicine; Anemia; Monocytosis; Gastroenterology; Meningioma; Internal medicine; Univariate analysis; Surgery; Pathology; Multivariate analysis","score_opus":0.019076731040216052,"score_gpt":0.2676742650152167,"score_spread":0.24859753397500062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588967704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967257,0.00021732629,0.000065473854,0.00012057895,0.000011610476,0.0000055951746,0.0019891933,0.000016653268,0.0008479401],"genre_scores_gemma":[0.9976174,0.00006584993,0.00009661486,0.000017794213,0.000013229439,0.000005243611,0.0017461212,0.0000050884273,0.00043265638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999864,0.000024626948,0.000015658634,0.000023059742,0.000031014948,0.000041676907],"domain_scores_gemma":[0.99898785,0.00014026745,0.00038080933,0.000045731056,0.00011943803,0.00032582475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002812556,0.00014185987,0.0001487596,0.00044768912,0.00029010305,0.00044229793,0.0002833766,0.00018632735,0.003323734],"category_scores_gemma":[0.0014690498,0.000094582676,0.00026229882,0.00046971987,0.00014126027,0.0001659685,0.00033030793,0.00036505298,0.0003252519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021333386,0.000008345685,0.9975547,0.0000072664598,0.000020172642,0.00004948346,0.000011913806,0.000038507635,0.0003030287,0.000010899669,0.00033489673,0.0014474426],"study_design_scores_gemma":[0.000003999759,0.00002426588,0.99936026,0.0000031298803,0.0000151788445,0.00008260717,0.000022957262,0.00017027011,0.000073167896,0.000010280025,0.00023258342,0.0000013684013],"about_ca_topic_score_codex":0.014460596,"about_ca_topic_score_gemma":0.027498145,"teacher_disagreement_score":0.014460596,"about_ca_system_score_codex":0.0004742728,"about_ca_system_score_gemma":0.0006028156,"threshold_uncertainty_score":0.028752863},"labels":[],"label_agreement":null},{"id":"W2589012814","doi":"10.1093/neuonc/now188.231","title":"P10.07 Sialate O-acetylesterase (SIAE) 
over-expression leads to a collapse of the mitochondrial membrane potential and predisposes cells to etoposide treatment in RES256 medulloblastoma cells","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Etoposide; Medulloblastoma; Cell biology; Medicine; Chemistry; Biology; Cancer research; Molecular biology; Internal medicine; Chemotherapy","score_opus":0.007553555770482347,"score_gpt":0.2497022079037211,"score_spread":0.24214865213323877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589012814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920959,0.00070874806,0.0016333784,0.00019124238,0.0000929427,0.00004879735,0.002694451,0.00012902782,0.002405577],"genre_scores_gemma":[0.9864477,0.0006090501,0.0012931615,0.00006265376,0.000009644454,0.0000699526,0.0033266342,0.000039766135,0.008141425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997775,0.000028011022,0.000034910816,0.00004499813,0.00006615653,0.000048413152],"domain_scores_gemma":[0.9998653,0.000027668611,0.00003121058,0.000023502476,0.000011622471,0.00004057225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001479098,0.00035194488,0.00034823388,0.00024371546,0.00014604614,0.0002771079,0.00025077857,0.00039535726,0.0039402833],"category_scores_gemma":[0.00014280285,0.00018808217,0.00042617111,0.00026572336,0.00024917122,0.00013795843,0.0001673263,0.0008351416,0.0014025304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018487913,0.00007457641,0.0002842259,0.000023539782,0.000007715097,0.00018660657,0.00002228942,0.00005620392,0.99829704,0.00008756197,0.0001471395,0.000628198],"study_design_scores_gemma":[0.000049726885,0.0013557377,0.015801031,0.000012558317,0.000029555578,0.0011936729,0.00015841708,0.001526388,0.97312355,0.00006535491,0.006673213,0.000010778003],"about_ca_topic_score_codex":0.003419992,"about_ca_topic_score_gemma":0.002279954,"teacher_disagreement_score":0.0039402833,"about_ca_system_score_codex":0.00035421934,"about_ca_system_score_gemma":0.00022265507,"threshold_uncertainty_score":0.013181567},"labels":[],"label_agreement":null},{"id":"W2589019650","doi":"10.1093/neuonc/now212.685","title":"RARE-22. MEDULLOBLASTOMA IN A CHILD WITH NEUROFIBROMATOSIS-1: CASE REPORT AND REVIEW","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Medulloblastoma; Medicine; Neurofibromatosis; Fourth ventricle; Plexiform neurofibroma; Pathology; Ataxia; Surgery; Neurofibroma","score_opus":0.012669445286428804,"score_gpt":0.27596568427584095,"score_spread":0.2632962389894121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589019650","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07138064,0.89648247,0.0034579437,0.0023654317,0.0023084516,0.00031516055,0.0009859265,0.00028537764,0.022418601],"genre_scores_gemma":[0.28730106,0.69097936,0.0040238407,0.0032669727,0.005537823,0.00014697261,0.0017707491,0.000119749355,0.0068535265],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994205,0.000066777706,0.00019679312,0.00013803302,0.000101102756,0.000076737764],"domain_scores_gemma":[0.99917644,0.00025932482,0.00031654703,0.00004308919,0.000086566055,0.00011797383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027899034,0.0013244925,0.0011220259,0.005361437,0.00078705035,0.0015563456,0.001368237,0.0024423979,0.003282337],"category_scores_gemma":[0.0012224837,0.0004631807,0.00060894823,0.004218351,0.0011325193,0.001641229,0.0010299142,0.0011651858,0.0028093865],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075954245,0.00011147964,0.014063342,0.0065051517,0.000118059674,0.86681294,0.0006865462,0.00022298768,0.0029338233,0.00086912356,0.014836854,0.0927638],"study_design_scores_gemma":[0.0000049666533,0.00002478037,0.00424409,0.00078515225,0.00007133796,0.95970666,0.0002310396,0.000051037383,0.00035458367,0.00016993991,0.03434155,0.00001490237],"about_ca_topic_score_codex":0.0014117077,"about_ca_topic_score_gemma":0.0020280492,"teacher_disagreement_score":0.005361437,"about_ca_system_score_codex":0.000678775,"about_ca_system_score_gemma":0.00068001036,"threshold_uncertainty_score":0.010980487},"labels":[],"label_agreement":null},{"id":"W2589058173","doi":"10.1093/neuonc/now212.155","title":"CBIO-17. STAT3 IS A CENTRAL REGULATOR OF PROLIFERATION, INVASION, MIGRATION AND METABOLISM IN GBM TUMOR INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"STAT3; STAT protein; Cancer research; Biology; Regulator; Signal transduction; Cell growth; Gene signature; Activator (genetics); Gene expression; Cell biology; Gene; Genetics","score_opus":0.020701241956481303,"score_gpt":0.27673655077037157,"score_spread":0.25603530881389025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589058173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8970813,0.0383238,0.009257142,0.0021133625,0.00078433636,0.00034149148,0.025129467,0.0013159285,0.025653258],"genre_scores_gemma":[0.925329,0.014018242,0.0061533237,0.00088869483,0.00008633506,0.00040900533,0.026901225,0.00016727774,0.026046893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998294,0.000011249376,0.000012883533,0.000029310862,0.00007078426,0.000046362875],"domain_scores_gemma":[0.9999243,0.000006090479,0.00001870913,0.000007765387,0.0000118823955,0.000031235115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017514502,0.00037833283,0.00033919167,0.0004952651,0.00035823337,0.00044443336,0.00031236408,0.00025230023,0.0052291043],"category_scores_gemma":[0.00007598218,0.00018568446,0.00043482633,0.00055615645,0.0003017592,0.00015027853,0.00022537078,0.00081101846,0.0021393613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005606919,0.0001112395,0.0012041917,0.00026869678,0.000018109109,0.00017171534,0.000022375205,0.000200352,0.9852297,0.00045947364,0.0018810501,0.009872499],"study_design_scores_gemma":[0.00016482222,0.00066974596,0.023913812,0.00006267005,0.00006166961,0.001092188,0.000059824935,0.0011437412,0.9146502,0.00034456272,0.05781907,0.000017626313],"about_ca_topic_score_codex":0.002442678,"about_ca_topic_score_gemma":0.004299382,"teacher_disagreement_score":0.0052291043,"about_ca_system_score_codex":0.00078457623,"about_ca_system_score_gemma":0.0008278645,"threshold_uncertainty_score":0.017493129},"labels":[],"label_agreement":null},{"id":"W2589106972","doi":"10.1093/neuonc/now212.327","title":"GENT-21. ATRX DEFICIENCY PROMOTES INVASION AND ALTERS THE DIFFERENTIATION CAPACITY OF GLIOMA CELLS OF ORIGIN BY DYSREGULATING GENOME-WIDE CHROMATIN ACCESSIBILITY AND MODULATING TRANSCRIPTIONAL PROGRAMS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Chromatin; Genome instability; Epigenetics; Carcinogenesis; Cell biology; Cancer research; Genetics; Gene; Mutation; DNA damage; DNA","score_opus":0.0231008421553646,"score_gpt":0.2589544808320386,"score_spread":0.235853638676674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589106972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899983,0.0016084473,0.0014086217,0.00019202543,0.000058652426,0.000048677088,0.00092673994,0.00029599038,0.0054625017],"genre_scores_gemma":[0.983648,0.0011814309,0.0018957208,0.00011638851,0.000012175532,0.00005952985,0.0023613765,0.00006227773,0.010663048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981874,0.000035351157,0.000019217783,0.000028229699,0.00004605202,0.000052448806],"domain_scores_gemma":[0.9998878,0.000018193614,0.000022866045,0.000016263763,0.0000074540158,0.000047303696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009825968,0.000435078,0.0003158215,0.00036225215,0.00016521677,0.00026986818,0.00020268466,0.00030435115,0.0028051294],"category_scores_gemma":[0.00007468402,0.00017752784,0.00033151716,0.00019579042,0.0002283958,0.0001388347,0.00023973166,0.0007459625,0.0007680166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017288598,0.000092069124,0.00012350857,0.00002754766,0.0000071055897,0.00009021338,0.00002197284,0.000083899955,0.99781835,0.00016474948,0.000115439376,0.0012822598],"study_design_scores_gemma":[0.00002851705,0.0007947391,0.0032263398,0.0000065212425,0.000023052926,0.00034246952,0.00002053865,0.0008360328,0.98953176,0.000074013114,0.005110588,0.0000054297793],"about_ca_topic_score_codex":0.0013986336,"about_ca_topic_score_gemma":0.0029202006,"teacher_disagreement_score":0.0028051294,"about_ca_system_score_codex":0.0002992692,"about_ca_system_score_gemma":0.000313912,"threshold_uncertainty_score":0.009384155},"labels":[],"label_agreement":null},{"id":"W2589107494","doi":"10.1093/neuonc/now188.249","title":"P13.05 Success Rate and Early Morbidity from Image-Guided Ommaya Reservoir Placement for Intraventricular Chemotherapy: Case Series and Systematic Review","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Ommaya reservoir; Medicine; Chemotherapy; Series (stratigraphy); Surgery; Geology","score_opus":0.028803636539223968,"score_gpt":0.31696499684220786,"score_spread":0.2881613603029839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589107494","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050247335,0.99224055,0.00020095981,0.0004011792,0.0001551297,0.00027082127,0.0010365188,0.000009804723,0.00066015276],"genre_scores_gemma":[0.10829599,0.8875376,0.0010134105,0.0009017587,0.00036063933,0.00087632646,0.0008085372,0.000016228933,0.0001894766],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98984665,0.0021319212,0.005099788,0.00081047934,0.0018683338,0.00024283097],"domain_scores_gemma":[0.9375536,0.045059614,0.012989186,0.00058329,0.003437419,0.00037684725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005865283,0.00089866173,0.0046108565,0.014474214,0.00051685725,0.002493444,0.0018296787,0.0021679683,0.0058814255],"category_scores_gemma":[0.039208695,0.0005798551,0.0052382597,0.015171463,0.001228635,0.0027067813,0.0011404646,0.00086637965,0.00043038288],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004159534,0.00003670657,0.013646563,0.93135446,0.012102464,0.00060309324,0.0002738447,0.00008431708,0.00018918788,0.00025188157,0.001662253,0.03937936],"study_design_scores_gemma":[0.0004776826,0.0005743108,0.0453252,0.79278296,0.12718481,0.005290274,0.001083336,0.00035644296,0.00050147006,0.0009942004,0.025315914,0.00011336611],"about_ca_topic_score_codex":0.0023342662,"about_ca_topic_score_gemma":0.0045565725,"teacher_disagreement_score":0.014474214,"about_ca_system_score_codex":0.0017713526,"about_ca_system_score_gemma":0.0051006703,"threshold_uncertainty_score":0.031018913},"labels":[],"label_agreement":null},{"id":"W2589110481","doi":"10.1093/neuonc/now212.872","title":"TMOD-02. Developing models of therapy resistance for the identification of treatment-refractory cell population(s) in human glioblastoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"SOX2; Biology; Transcriptome; Population; Chemoradiotherapy; BMI1; Stem cell; Glioma; Cancer research; Stem cell marker; Temozolomide; Bioinformatics; Oncology; Cancer; Medicine; Gene expression; Gene; Transcription factor; Genetics","score_opus":0.044592507210841896,"score_gpt":0.3296225224710782,"score_spread":0.2850300152602363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589110481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94570196,0.0020674975,0.023784317,0.0009060992,0.0003332307,0.0019267062,0.013922668,0.0009177501,0.010439721],"genre_scores_gemma":[0.9024659,0.0024070665,0.0378149,0.0005171437,0.000039091134,0.005307111,0.017072441,0.00043203082,0.033944417],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992073,0.00014526375,0.00010233768,0.0001657914,0.00024068322,0.00013856102],"domain_scores_gemma":[0.9996834,0.000040276842,0.000075223084,0.000075232194,0.000039032067,0.00008689705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077507814,0.0006328153,0.0005564905,0.0009207596,0.00046713097,0.00069332856,0.00091741525,0.0009475089,0.0050850906],"category_scores_gemma":[0.0002712384,0.00039809218,0.00067271496,0.0006615934,0.00057769293,0.00041154414,0.0004853152,0.0020620045,0.0019682485],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009792679,0.0011212591,0.0007735839,0.00016600618,0.00003517974,0.00017688902,0.00019443271,0.0010578893,0.9847068,0.0016210654,0.0012389724,0.007928596],"study_design_scores_gemma":[0.00027263386,0.0040954854,0.004324785,0.000034401673,0.000061017905,0.00054882496,0.0001330672,0.0063548437,0.962729,0.0003840056,0.021042626,0.00001924189],"about_ca_topic_score_codex":0.003233408,"about_ca_topic_score_gemma":0.0047613126,"teacher_disagreement_score":0.0050850906,"about_ca_system_score_codex":0.0009461151,"about_ca_system_score_gemma":0.00077481894,"threshold_uncertainty_score":0.017011285},"labels":[],"label_agreement":null},{"id":"W2589113031","doi":"10.1093/neuonc/now212.176","title":"CSIG-15. CIC REGULATES NEURAL STEM/PROGENITOR PROLIFERATION AND DIFFERENTIATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Progenitor cell; Neural stem cell; Biology; Stem cell; Progenitor; Lineage (genetic); Cell biology; Oligodendrocyte; Cell fate determination; Neural development; Cancer research; Loss function; Regulator; Genetics; Gene; Phenotype; Neuroscience; Transcription factor; Central nervous system; Myelin","score_opus":0.03510211227290744,"score_gpt":0.26822492547476284,"score_spread":0.2331228132018554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589113031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481861,0.011709946,0.0047356,0.0006175777,0.00025759105,0.00018796888,0.006461674,0.0012534808,0.02659011],"genre_scores_gemma":[0.9771741,0.0014536284,0.0027782621,0.00043042094,0.000026326326,0.00008125692,0.00539275,0.0001010796,0.01256205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986994,0.000013070486,0.0000088853485,0.000031741067,0.000034562876,0.000041723484],"domain_scores_gemma":[0.99988246,0.000006868391,0.000017886974,0.000008907112,0.000013172385,0.00007068804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089668225,0.00038314256,0.00030528952,0.00039680192,0.00032951345,0.00041145823,0.00041080662,0.00032382525,0.0023158642],"category_scores_gemma":[0.000092279704,0.00013541694,0.0002266815,0.00030431896,0.00035898518,0.00011397578,0.0003623463,0.00053133565,0.0012623023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003124488,0.00006498322,0.00150642,0.00013194635,0.000009619457,0.00022280784,0.000029325729,0.00020368052,0.9883807,0.00051754084,0.0012199732,0.0074005807],"study_design_scores_gemma":[0.00009449464,0.000338034,0.035112422,0.00002728155,0.0000390108,0.0005635399,0.000068439585,0.0030361658,0.9209168,0.00022097224,0.039565265,0.000017577879],"about_ca_topic_score_codex":0.0034282843,"about_ca_topic_score_gemma":0.0051447265,"teacher_disagreement_score":0.0034282843,"about_ca_system_score_codex":0.0011396637,"about_ca_system_score_gemma":0.00085871684,"threshold_uncertainty_score":0.008268952},"labels":[],"label_agreement":null},{"id":"W2590076094","doi":"10.1093/neuonc/now277","title":"A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Polysomy; Isocitrate dehydrogenase; IDH1; Glioma; Oligodendroglioma; Oncology; Astrocytoma; Medicine; Pathology; Internal medicine; Biology; Bioinformatics; Chromosome; Gene; Mutation; Genetics; Cancer research; Fluorescence in situ hybridization","score_opus":0.13405935324453538,"score_gpt":0.4532913436008192,"score_spread":0.3192319903562838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590076094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009909887,0.98921376,0.00020695326,0.004660818,0.0034603355,0.000009843346,0.000051894764,0.000012629299,0.0022847366],"genre_scores_gemma":[0.00083368167,0.9912498,0.00038477682,0.0039524,0.002308605,0.000014679346,0.00012078753,0.000005615752,0.0011297481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928313,0.0001698261,0.0001584515,0.00009968995,0.00023685294,0.000052101237],"domain_scores_gemma":[0.9983053,0.0006838299,0.0002143414,0.000042406158,0.0006510779,0.000102970596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013309441,0.0010867231,0.0013036764,0.004358546,0.00038413148,0.001353285,0.0011668997,0.0016721125,0.0038754812],"category_scores_gemma":[0.0032564343,0.00031679097,0.0008339241,0.004330295,0.0009955686,0.002729889,0.0010948157,0.0038385228,0.0025857587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059625967,0.000033517226,0.00033832513,0.01459149,0.0000719726,0.00037090157,0.00016695952,0.0002875359,0.00056501076,0.008685818,0.2286457,0.7461832],"study_design_scores_gemma":[0.0000076910965,0.000032511518,0.00069145946,0.008092067,0.000046318004,0.0015779112,0.000082785074,0.000035818342,0.00005547225,0.0016420602,0.9877209,0.000014988346],"about_ca_topic_score_codex":0.002994282,"about_ca_topic_score_gemma":0.004603306,"teacher_disagreement_score":0.004358546,"about_ca_system_score_codex":0.0014480879,"about_ca_system_score_gemma":0.0030978438,"threshold_uncertainty_score":0.012964845},"labels":[],"label_agreement":null},{"id":"W2593895879","doi":"10.1093/neuonc/now293.000","title":"PP01. TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Synthetic lethality; Cancer research; Kinome; Biology; Gene; ATRX; Downregulation and upregulation; Kinase; Temozolomide; Mutation; Genetics; DNA repair; Glioma","score_opus":0.013021575895404282,"score_gpt":0.27626478331677856,"score_spread":0.2632432074213743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593895879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909677,0.0020159597,0.0009101655,0.00021086774,0.00008124127,0.00009661939,0.0013110602,0.00021014965,0.004196149],"genre_scores_gemma":[0.99169827,0.0013720397,0.0009395985,0.00010209692,0.000012528451,0.00008277859,0.0026384497,0.000022593187,0.0031316546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999187,0.000009201455,0.000008671851,0.000014675978,0.000021718004,0.000026995776],"domain_scores_gemma":[0.99995446,0.000009019943,0.000010486693,0.0000052522273,0.0000047781,0.000016039308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010282946,0.00026375055,0.00031748883,0.00018469174,0.00012904035,0.00031775195,0.0002458765,0.00023173438,0.002146219],"category_scores_gemma":[0.00009651348,0.0001316791,0.0002031498,0.0002224452,0.0001576589,0.00012278833,0.00014649762,0.0006535938,0.0006241778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011691597,0.00041526137,0.0011508641,0.0001822057,0.000032514356,0.00014379963,0.000043573833,0.0005258728,0.98159033,0.0003088447,0.0011743386,0.013263207],"study_design_scores_gemma":[0.00029762756,0.0044604875,0.021982662,0.000017995482,0.00005265431,0.00074015657,0.00007708354,0.0021888076,0.9603383,0.00010005039,0.009733073,0.000011098373],"about_ca_topic_score_codex":0.00142932,"about_ca_topic_score_gemma":0.0027077817,"teacher_disagreement_score":0.002146219,"about_ca_system_score_codex":0.00032665653,"about_ca_system_score_gemma":0.00033715396,"threshold_uncertainty_score":0.0071797967},"labels":[],"label_agreement":null},{"id":"W2594810701","doi":"10.1093/neuonc/now293.021","title":"PP22. PROGRESSING RADIOTHERAPY-DRUG COMBINATIONS TOWARDS EARLY PHASE CLINICAL TRIALS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Context (archaeology); Radiation therapy; Alliance; Clinical trial; Medicine; Drug development; Quality (philosophy); Medical physics; Drug; Pharmacology; Political science; Surgery; Pathology","score_opus":0.0994381586591382,"score_gpt":0.4701017286600177,"score_spread":0.3706635700008795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594810701","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014223087,0.021391643,0.00973137,0.093469284,0.025692625,0.0026093659,0.009254862,0.0028895997,0.83353883],"genre_scores_gemma":[0.013901759,0.03939258,0.021336805,0.075921826,0.023740182,0.0035571044,0.01529031,0.00272295,0.8041365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98861784,0.0038548685,0.00078283175,0.0006376537,0.0051815426,0.00092535856],"domain_scores_gemma":[0.97657657,0.0047654165,0.001320205,0.0019467835,0.008908657,0.00648236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022626353,0.0009893473,0.00090201467,0.0016281736,0.0013268522,0.010996641,0.001855603,0.005685225,0.30624273],"category_scores_gemma":[0.021976346,0.0007308522,0.0013261428,0.00183523,0.0019425729,0.0052507785,0.0050887037,0.0052565574,0.27018902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013146148,0.00006992381,0.0001988954,0.0004826158,0.0000072585062,0.00009442933,0.000056325167,0.000094056435,0.0005034649,0.010656385,0.89459693,0.09310822],"study_design_scores_gemma":[0.00006403847,0.00011577736,0.0005471484,0.00021672634,0.0000043113923,0.000108369946,0.000022922224,0.00005019099,0.0001914755,0.0028409206,0.99582916,0.000008883831],"about_ca_topic_score_codex":0.0026368306,"about_ca_topic_score_gemma":0.006199799,"teacher_disagreement_score":0.30624273,"about_ca_system_score_codex":0.004260771,"about_ca_system_score_gemma":0.011599018,"threshold_uncertainty_score":0.98956054},"labels":[],"label_agreement":null},{"id":"W2598017183","doi":"10.1093/neuonc/nox021","title":"Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Institut National Du Cancer","keywords":"Neuroscience; Current (fluid); Medicine; Psychology; Engineering; Electrical engineering","score_opus":0.1135008495295115,"score_gpt":0.37857136347351195,"score_spread":0.26507051394400044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598017183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006808274,0.9987581,0.000051196857,0.0005805158,0.00012392223,0.0000013446947,0.000010345003,0.000004559598,0.00040199672],"genre_scores_gemma":[0.0005574969,0.99868673,0.00009229807,0.00026266935,0.0001494152,0.0000022924937,0.000020905856,0.0000011730439,0.00022711203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985373,0.000025876207,0.000026630192,0.000024202687,0.000051859948,0.000017759627],"domain_scores_gemma":[0.999683,0.00013769847,0.000047460006,0.00000905924,0.00009106279,0.000031816347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053796277,0.00054548227,0.0010491762,0.0017156907,0.0002529038,0.0009049609,0.0007901411,0.00091012765,0.00260454],"category_scores_gemma":[0.0008478606,0.00020825172,0.00043065086,0.0013941422,0.0005542762,0.0015201429,0.0005433868,0.0019047953,0.0013935937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070863316,0.000040703006,0.00022987564,0.012126535,0.000074399446,0.00031197382,0.000075675714,0.0003418144,0.00075483375,0.0038924664,0.03993798,0.94214284],"study_design_scores_gemma":[0.00001581121,0.00006793242,0.000694902,0.004382115,0.000095314994,0.0023987738,0.00010903028,0.00008840418,0.00021941659,0.0033181477,0.9885922,0.000017862742],"about_ca_topic_score_codex":0.0013426444,"about_ca_topic_score_gemma":0.0028851207,"teacher_disagreement_score":0.00260454,"about_ca_system_score_codex":0.0006734462,"about_ca_system_score_gemma":0.0010600843,"threshold_uncertainty_score":0.008713067},"labels":[],"label_agreement":null},{"id":"W2604574478","doi":"10.1093/neuonc/nox001","title":"Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Quality of life (healthcare); Randomized controlled trial; Radiation therapy; Clinical trial; Adverse effect; Medical physics; Oncology; Intensive care medicine; Internal medicine","score_opus":0.23309846628000067,"score_gpt":0.5094125392764587,"score_spread":0.27631407299645805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604574478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003595948,0.99956554,0.000024772875,0.0001580198,0.0000487835,0.000002971193,0.000007913666,0.0000012835687,0.00015468111],"genre_scores_gemma":[0.0002559182,0.9994481,0.000069234884,0.00011515122,0.000056315912,0.000003893825,0.000009188332,5.536192e-7,0.000041649597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950075,0.00009260227,0.00014897203,0.000081135775,0.00015535776,0.000021165026],"domain_scores_gemma":[0.99854517,0.0010066297,0.00018906275,0.000021490067,0.00020262803,0.000035137098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013190008,0.0008668962,0.0020621212,0.0033635998,0.00029971034,0.0010440999,0.0011987734,0.0011401067,0.0029849878],"category_scores_gemma":[0.002863792,0.0003850255,0.0012555227,0.0033059085,0.00064709043,0.0015959343,0.0006130408,0.0013540037,0.00074746046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079115554,0.000052778978,0.00029508272,0.10868381,0.00033397926,0.000210867,0.00009837812,0.0002925095,0.0005029642,0.0022038112,0.020073816,0.86717284],"study_design_scores_gemma":[0.000059756865,0.00023404663,0.0028071979,0.09618117,0.0014985043,0.0037743216,0.00020700629,0.00018306696,0.00039204746,0.003180343,0.8914327,0.00004985579],"about_ca_topic_score_codex":0.0017236458,"about_ca_topic_score_gemma":0.0039190003,"teacher_disagreement_score":0.0033635998,"about_ca_system_score_codex":0.00084026216,"about_ca_system_score_gemma":0.0021947871,"threshold_uncertainty_score":0.009985805},"labels":[],"label_agreement":null},{"id":"W2604818452","doi":"10.1093/neuonc/nox030","title":"Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Counterpoint; Glioblastoma; Medicine; Clinical trial; Randomized controlled trial; Internal medicine; Psychology; Cancer research","score_opus":0.093080814177779,"score_gpt":0.41719902858938845,"score_spread":0.3241182144116095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604818452","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6055871,0.17237577,0.068333484,0.03437813,0.033348083,0.066319965,0.0014337586,0.0008341633,0.017389487],"genre_scores_gemma":[0.89552706,0.019748809,0.040162664,0.010814275,0.0045109326,0.026603887,0.00047375128,0.00006824964,0.0020903605],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9752696,0.020918587,0.0013853979,0.0011875402,0.00084220094,0.00039669988],"domain_scores_gemma":[0.9805319,0.014043713,0.0028444692,0.0008945016,0.000663615,0.0010218953],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025821442,0.0013513725,0.0036385234,0.001363554,0.00053147064,0.002476663,0.0014378163,0.0040246625,0.0052070655],"category_scores_gemma":[0.039340135,0.00041331138,0.003548103,0.0008309733,0.0017162063,0.0035812706,0.0012961111,0.0048947055,0.0005994213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7101474,0.005088332,0.0014928086,0.005936913,0.00460105,0.00017729512,0.00028482886,0.0037501035,0.0021664198,0.009709168,0.0023903977,0.25425526],"study_design_scores_gemma":[0.75963056,0.19500586,0.0020360039,0.0018061423,0.0032807288,0.00022112968,0.00019306155,0.0062907836,0.0012666776,0.019497285,0.010658735,0.000112982496],"about_ca_topic_score_codex":0.0001609718,"about_ca_topic_score_gemma":0.0003867268,"teacher_disagreement_score":0.97417855,"about_ca_system_score_codex":0.00095366617,"about_ca_system_score_gemma":0.0012854744,"threshold_uncertainty_score":0.13655847},"labels":[],"label_agreement":null},{"id":"W2605161784","doi":"10.1093/neuonc/nox006","title":"MR-guided radiation therapy: transformative technology and its role in the central nervous system","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Transformative learning; Magnetic resonance imaging; Radiation therapy; Adaptation (eye); Medical physics; Radiation oncology; Medicine; Central nervous system; Neuroscience; Psychology; Radiology; Pedagogy","score_opus":0.07351655175438969,"score_gpt":0.4049868972735333,"score_spread":0.3314703455191436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605161784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001374321,0.99734193,0.00024231465,0.00048171275,0.00023263936,0.0000029082137,0.000008211521,0.000007196223,0.0015457977],"genre_scores_gemma":[0.00084800395,0.9980531,0.00022908927,0.00024856313,0.00026190875,0.0000028785632,0.000009812136,0.0000017429871,0.0003449165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971,0.00005808056,0.000038642207,0.00004729804,0.00012131819,0.000024626303],"domain_scores_gemma":[0.99937576,0.00038442796,0.00007029648,0.000019221288,0.00012029792,0.00002998959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006582795,0.000585143,0.0007680978,0.0020921503,0.00030842068,0.0012306893,0.0006388251,0.0011013262,0.0026525536],"category_scores_gemma":[0.0010779281,0.00018474422,0.0004125489,0.0020842499,0.0009157346,0.0016764571,0.0007666174,0.0016673139,0.0011888025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029370472,0.000035348847,0.00028718179,0.011870858,0.000056872377,0.00026586128,0.00011991709,0.00036374587,0.0016793689,0.009852759,0.019689633,0.955749],"study_design_scores_gemma":[0.000004248599,0.000057863414,0.0006805831,0.0032972551,0.000056033212,0.003081946,0.00010112358,0.00008407635,0.00055889116,0.003577935,0.98848265,0.000017286795],"about_ca_topic_score_codex":0.001026862,"about_ca_topic_score_gemma":0.0017439914,"teacher_disagreement_score":0.0026525536,"about_ca_system_score_codex":0.00066340104,"about_ca_system_score_gemma":0.0014276807,"threshold_uncertainty_score":0.008873701},"labels":[],"label_agreement":null},{"id":"W2605166353","doi":"10.1093/neuonc/nox033","title":"The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Pediatric Brain Tumor Foundation","keywords":"Vascularity; Angiogenesis; Medulloblastoma; Vascular endothelial growth factor A; Pathogenesis; Neovascularization; Pathology; Medicine; Vascular endothelial growth factor; Cancer research; Oncology; VEGF receptors","score_opus":0.015593175853226776,"score_gpt":0.28333121728378186,"score_spread":0.2677380414305551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605166353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985525,0.0007791075,0.00025995125,0.00003251609,0.0000014185293,0.0000062412255,0.00008966847,0.0000145206,0.00026402102],"genre_scores_gemma":[0.99923575,0.0002583947,0.00024383352,0.000008048644,0.0000029885678,0.0000057793136,0.00013351142,0.0000031391332,0.00010853356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993587,0.000013377651,0.0000037188768,0.0000140850025,0.000018105951,0.000014877323],"domain_scores_gemma":[0.99979764,0.000027576229,0.00010692037,0.000010035445,0.00001646922,0.000041382773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019823674,0.0002036055,0.00018587169,0.00050157093,0.00019410856,0.00029678812,0.000103995626,0.00015731111,0.00045573167],"category_scores_gemma":[0.00024738873,0.000072044764,0.00022361138,0.00022646676,0.00024889628,0.00011678486,0.00017575613,0.00018514453,0.000091637456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020012977,0.000069619644,0.7225174,0.000093694194,0.00011990186,0.0006792391,0.00030621662,0.00059461506,0.24950701,0.0002486663,0.00039238308,0.02346993],"study_design_scores_gemma":[0.00001714908,0.00034960458,0.9791799,0.000015291886,0.000087787244,0.0015808194,0.00017174572,0.0008976444,0.01640612,0.00025206158,0.0010354125,0.000006536651],"about_ca_topic_score_codex":0.0016406915,"about_ca_topic_score_gemma":0.002014092,"teacher_disagreement_score":0.0016406915,"about_ca_system_score_codex":0.0004727503,"about_ca_system_score_gemma":0.000297965,"threshold_uncertainty_score":0.0034300685},"labels":[],"label_agreement":null},{"id":"W2605314376","doi":"10.1093/neuonc/nox055","title":"Advanced radiation therapeutics for the central nervous system","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Central nervous system; Nervous system; Neuroscience; Medicine; Biology","score_opus":0.035752947788498655,"score_gpt":0.33446188871387067,"score_spread":0.29870894092537204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605314376","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002370681,0.83426017,0.01789512,0.011335737,0.012049614,0.00021016403,0.0005801221,0.00092146755,0.120376945],"genre_scores_gemma":[0.032913666,0.808269,0.018432155,0.008321259,0.0053134556,0.00042332127,0.0013640734,0.00030262672,0.12466044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959487,0.00006805835,0.000023720728,0.000055638793,0.00021280276,0.000044921744],"domain_scores_gemma":[0.99960095,0.000061238075,0.00005896323,0.000048280865,0.00015991056,0.000070607915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925546,0.0007578694,0.00064949854,0.001125393,0.0005487545,0.0014316031,0.00084052124,0.0013720656,0.031998727],"category_scores_gemma":[0.0008509925,0.00022447051,0.0007797869,0.0007581132,0.0005939122,0.0011520699,0.001506115,0.0034809175,0.014368127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013433206,0.00012854878,0.00031660253,0.00361713,0.000103502476,0.00040819967,0.00015028361,0.0004665807,0.020162104,0.031573173,0.2537062,0.68923336],"study_design_scores_gemma":[0.00003230716,0.00013621256,0.0003344453,0.00068053947,0.000031552267,0.0012792589,0.000019748237,0.0001233507,0.0024886513,0.0051092766,0.98975116,0.000013470507],"about_ca_topic_score_codex":0.0008803319,"about_ca_topic_score_gemma":0.0019235436,"teacher_disagreement_score":0.031998727,"about_ca_system_score_codex":0.0009554264,"about_ca_system_score_gemma":0.0019139514,"threshold_uncertainty_score":0.107046366},"labels":[],"label_agreement":null},{"id":"W2607912694","doi":"10.1093/neuonc/nox036.339","title":"P10.21 2-hydroxyglutarate as a biomarker for IDH mutation in low grade gliomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; IDH1; Medicine; Biomarker; Internal medicine; Oncology; Metabolite; Cancer research; Pathology; Mutant; Biology; Enzyme; Gene; Genetics","score_opus":0.03857342127761618,"score_gpt":0.35239658617477204,"score_spread":0.3138231648971559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607912694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597436,0.0018568584,0.0009929744,0.000056699995,0.000014333269,0.000021083455,0.00021900913,0.000059086837,0.0008055732],"genre_scores_gemma":[0.9969995,0.00047676667,0.0016796638,0.000055712062,0.000009864026,0.0000136155495,0.000254006,0.000008459901,0.00050242187],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982494,0.000034113455,0.000012095427,0.000034944016,0.00007045267,0.000023572347],"domain_scores_gemma":[0.99977535,0.00003786942,0.000068177316,0.000010870515,0.00004543633,0.0000623559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026974725,0.00039491715,0.00023230708,0.0014583784,0.00016261231,0.0005361517,0.00020003198,0.00034948724,0.00059149467],"category_scores_gemma":[0.0004960142,0.00015183093,0.00011340976,0.0005476964,0.00035626942,0.00017030413,0.00017465588,0.000309022,0.00027180454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016607179,0.00015358295,0.29482073,0.00012941976,0.00011303165,0.0015294969,0.00017466793,0.00035982588,0.67682254,0.00010440467,0.00035092546,0.023780653],"study_design_scores_gemma":[0.000033530123,0.0021057117,0.77295387,0.000033126562,0.00013913988,0.006935852,0.00036797533,0.0048028817,0.21009855,0.00025291616,0.0022405472,0.00003575985],"about_ca_topic_score_codex":0.0021224834,"about_ca_topic_score_gemma":0.002714287,"teacher_disagreement_score":0.0021224834,"about_ca_system_score_codex":0.00026585438,"about_ca_system_score_gemma":0.00024097372,"threshold_uncertainty_score":0.0042201877},"labels":[],"label_agreement":null},{"id":"W2608349617","doi":"10.1093/neuonc/nox036.114","title":"P02.02 Treatment and Outcomes in Glioblastoma Multiforme: A multi-country chart review study","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Cohort; Censoring (clinical trials); Retrospective cohort study; Demographics; Internal medicine; Pediatrics; Radiation therapy; Demography; Pathology","score_opus":0.041377423338972145,"score_gpt":0.3715245864451838,"score_spread":0.33014716310621167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608349617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953028,0.015177695,0.0003556041,0.0009625451,0.000037101687,0.000442582,0.026541796,0.000039006318,0.003415698],"genre_scores_gemma":[0.98502296,0.0056347367,0.00060769037,0.00029575705,0.000034643763,0.00023874009,0.007916247,0.000010582227,0.00023877926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975866,0.0007671813,0.0005409523,0.00033928774,0.0005745413,0.0001914094],"domain_scores_gemma":[0.98160535,0.0029894814,0.010459526,0.00051563536,0.0037328198,0.00069718336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025380333,0.00014950245,0.00033944641,0.00361422,0.0005346653,0.0012104062,0.0005316594,0.00032831152,0.0013737744],"category_scores_gemma":[0.009314152,0.0001807861,0.00047268026,0.0078580445,0.00031198878,0.000629395,0.00060476444,0.00027030747,0.0001988376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009610584,0.000030539297,0.9866513,0.0005822544,0.00015390423,0.00021309144,0.00043405528,0.00004545428,0.00007607057,0.0000650336,0.0028562618,0.008796018],"study_design_scores_gemma":[0.000021444286,0.00006599368,0.9937078,0.00046705775,0.0001320951,0.0004683682,0.0011107415,0.000105175066,0.00007047806,0.00001292205,0.0038254068,0.00001253368],"about_ca_topic_score_codex":0.06648403,"about_ca_topic_score_gemma":0.10332739,"teacher_disagreement_score":0.06648403,"about_ca_system_score_codex":0.0025283657,"about_ca_system_score_gemma":0.0046306523,"threshold_uncertainty_score":0.1321941},"labels":[],"label_agreement":null},{"id":"W2608404108","doi":"10.1093/neuonc/nox036.038","title":"OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Exon; Cohort; Trk receptor; Immunohistochemistry; Lesion; Fusion gene; Clinical trial; Oncology; Pathology; Internal medicine; Gene; Biology; Receptor","score_opus":0.026617131222439614,"score_gpt":0.3155662285961126,"score_spread":0.28894909737367297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608404108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986551,0.00018048588,0.00017889218,0.000032260396,0.0000052789555,0.000010630843,0.00016504746,0.000010495073,0.00076180865],"genre_scores_gemma":[0.9987173,0.00007414421,0.0002716833,0.000024050038,0.000002980717,0.000005974812,0.0004864173,0.0000044498447,0.00041303516],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998634,0.000016385857,0.000018337436,0.000021482676,0.000047137495,0.00003326417],"domain_scores_gemma":[0.9997898,0.000036264926,0.000058141835,0.00002313082,0.00003497726,0.00005777692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022994762,0.00014230031,0.00030022653,0.00029888627,0.00016497968,0.00037826467,0.00013738804,0.00028943422,0.0007081004],"category_scores_gemma":[0.00039903485,0.00007905801,0.00020153595,0.00020427986,0.0001618517,0.00015233035,0.00013453362,0.00027557876,0.00024631855],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067353193,0.00093262736,0.49775037,0.00010770319,0.00019506099,0.030397275,0.0004407294,0.0015534757,0.4024692,0.00031642872,0.0018353643,0.05726643],"study_design_scores_gemma":[0.00019696499,0.0075703366,0.7478766,0.000021920989,0.00017911765,0.06912316,0.00040096603,0.005429172,0.16128899,0.00033746034,0.007539557,0.000035815843],"about_ca_topic_score_codex":0.0007456697,"about_ca_topic_score_gemma":0.0014063704,"teacher_disagreement_score":0.0007456697,"about_ca_system_score_codex":0.00028548556,"about_ca_system_score_gemma":0.00016795531,"threshold_uncertainty_score":0.0023688674},"labels":[],"label_agreement":null},{"id":"W2608465412","doi":"10.1093/neuonc/nox036.246","title":"P08.57 Distinct mechanism-of-action of dianhydrogalactitol (VAL-083) overcomes chemoresistance in glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Chemotherapy; Bevacizumab; Medicine; Cancer; Glioma; Methyltransferase; DNA damage; Cell cycle; Oncology; Biology; Internal medicine; DNA; Genetics","score_opus":0.028217559550051036,"score_gpt":0.3258876726299398,"score_spread":0.2976701130798888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608465412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96926963,0.011373352,0.0022235273,0.000737974,0.0002487236,0.00016937972,0.0010588754,0.00041081177,0.014507574],"genre_scores_gemma":[0.9879219,0.004286483,0.001550637,0.00026919547,0.000033999087,0.00008882968,0.0010204293,0.000051111732,0.0047773845],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999597,0.0000046092896,0.000002775544,0.0000064867763,0.000011764251,0.000014601694],"domain_scores_gemma":[0.9999758,0.0000018446344,0.000005261835,0.0000021467713,0.0000034418529,0.000011486483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072313895,0.00026928933,0.00025590343,0.00018361783,0.00012463589,0.00029651404,0.00026028792,0.00027913376,0.002578318],"category_scores_gemma":[0.000067715664,0.00009155081,0.00022415974,0.00018858677,0.00017115619,0.00014155936,0.00022891948,0.0006182878,0.00066875364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020103601,0.00039187894,0.0006085777,0.0002983054,0.00003768156,0.00062042644,0.00004620083,0.0005369804,0.9429682,0.0017118339,0.0020143613,0.04875516],"study_design_scores_gemma":[0.00083769753,0.007437489,0.007316046,0.000059965965,0.00012117827,0.0032780815,0.00006128022,0.0022438688,0.9184289,0.0006896004,0.05949974,0.000026127655],"about_ca_topic_score_codex":0.0008253692,"about_ca_topic_score_gemma":0.0009480326,"teacher_disagreement_score":0.002578318,"about_ca_system_score_codex":0.00031355667,"about_ca_system_score_gemma":0.00033253737,"threshold_uncertainty_score":0.008625329},"labels":[],"label_agreement":null},{"id":"W2608572471","doi":"10.1093/neuonc/nox036.057","title":"OS08.7 The somatic landscape of Schwannoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Schwannoma; Biology; Fusion gene; Cancer research; Somatic cell; Schwann cell; Gene; Exome; MAPK/ERK pathway; Exome sequencing; Genetics; Pathology; Mutation; Cell biology; Medicine; Signal transduction","score_opus":0.03415723211864221,"score_gpt":0.31459880903984044,"score_spread":0.28044157692119825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608572471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76318115,0.009292062,0.0048220656,0.0027976967,0.00048587343,0.00014064061,0.008500043,0.0015699749,0.20921041],"genre_scores_gemma":[0.9255047,0.0038561162,0.005318105,0.00088399637,0.00021046643,0.000068207286,0.011402306,0.00033710245,0.052418955],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99985933,0.000011564544,0.000012863293,0.000024823652,0.00005950922,0.000031887917],"domain_scores_gemma":[0.99986327,0.000023147373,0.000026557684,0.000013848554,0.000029871911,0.000043213244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024971992,0.00020905265,0.00016764394,0.0007171353,0.00026324386,0.0008744848,0.00016311841,0.0003863053,0.013897797],"category_scores_gemma":[0.0003965457,0.00009219789,0.000118811986,0.0005451927,0.00025978935,0.00023455835,0.00030565387,0.00023414497,0.0053265784],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026833233,0.0002545723,0.10595004,0.00059668854,0.00007775331,0.022648437,0.00038206787,0.001062046,0.20167534,0.013474589,0.061956957,0.5892381],"study_design_scores_gemma":[0.00036220957,0.0011035228,0.15335388,0.00032073897,0.00016133214,0.1233591,0.00062645116,0.0027269493,0.07028257,0.010879675,0.6367738,0.000049677135],"about_ca_topic_score_codex":0.00055230624,"about_ca_topic_score_gemma":0.0012269439,"teacher_disagreement_score":0.013897797,"about_ca_system_score_codex":0.0003906016,"about_ca_system_score_gemma":0.00037800404,"threshold_uncertainty_score":0.046492815},"labels":[],"label_agreement":null},{"id":"W2608950466","doi":"10.1093/neuonc/nox036.336","title":"P10.18 The impact of clinical functional MRI on surgical decision making in low grade glioma - a survey of Canadian neurosurgeons","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Neurosurgery; Magnetic resonance imaging; Glioma; Functional magnetic resonance imaging; Medical physics; Radiology","score_opus":0.09249053095513517,"score_gpt":0.3932097951153146,"score_spread":0.30071926416017947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608950466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98454446,0.0008398312,0.00007287855,0.0053412863,0.00006829351,0.00015301057,0.0025953737,0.000014118521,0.006370794],"genre_scores_gemma":[0.9961572,0.0009550826,0.00017363085,0.0010141387,0.000027391656,0.00006901863,0.00070576,0.000007217176,0.00089051254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649847,0.00058482785,0.00024809263,0.00026251128,0.0012255426,0.0011805884],"domain_scores_gemma":[0.9815284,0.002674536,0.0035105671,0.00021160489,0.006155244,0.0059195734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034859562,0.00027331902,0.00035742868,0.0020874834,0.002726232,0.0018185491,0.0011453741,0.0008105592,0.004556559],"category_scores_gemma":[0.015734969,0.0003163223,0.00050932594,0.0035382158,0.0016153381,0.0007640896,0.0011667124,0.0010094062,0.00055688823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011561236,0.000088434004,0.96483964,0.00020916174,0.000023380355,0.00024022101,0.010372478,0.00007483204,0.00016427333,0.00012995237,0.009347212,0.014394861],"study_design_scores_gemma":[0.000010651039,0.00011800981,0.96928954,0.00015963423,0.000008992576,0.00015326113,0.024706673,0.00016683925,0.000039396204,0.000026698275,0.0052882554,0.00003194083],"about_ca_topic_score_codex":0.9248283,"about_ca_topic_score_gemma":0.9165042,"teacher_disagreement_score":0.07517171,"about_ca_system_score_codex":0.018834084,"about_ca_system_score_gemma":0.027309531,"threshold_uncertainty_score":0.15122879},"labels":[],"label_agreement":null},{"id":"W2610049046","doi":"10.1093/neuonc/nox048","title":"NANO, a practical scale for neurologic assessments in patients with brain tumors?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Scale (ratio); Medicine; Psychology; Cartography; Geography","score_opus":0.03335382686063776,"score_gpt":0.3541556910950491,"score_spread":0.3208018642344113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610049046","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009594821,0.002353604,0.00048865663,0.9877329,0.0057710446,0.00001725684,0.00006733504,0.000025758192,0.0025839559],"genre_scores_gemma":[0.03483612,0.005041731,0.004525727,0.9041267,0.045995943,0.0002746474,0.00018772657,0.000046348745,0.0049650837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960192,0.0018369707,0.00079479977,0.0003281355,0.00073595205,0.00028503634],"domain_scores_gemma":[0.98512936,0.008143108,0.0008951591,0.0006101443,0.0038955652,0.0013266676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005613839,0.0006247873,0.0010982,0.0007403715,0.0023098951,0.0031366393,0.0017268948,0.017825006,0.005553682],"category_scores_gemma":[0.056864973,0.0004025042,0.0006743788,0.00060409243,0.0028486252,0.005474052,0.0017708881,0.020381194,0.0051375683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014373948,0.00010172214,0.008608801,0.00015208361,0.000030076693,0.0035063345,0.00038904714,0.00021589111,0.0004284525,0.009646914,0.8959861,0.08079094],"study_design_scores_gemma":[0.0005285092,0.0004498255,0.009863395,0.0022512872,0.000095512325,0.018359654,0.0053680823,0.0027740498,0.0009823944,0.09839666,0.860691,0.0002396556],"about_ca_topic_score_codex":0.0037590389,"about_ca_topic_score_gemma":0.006898472,"teacher_disagreement_score":0.017825006,"about_ca_system_score_codex":0.0032779954,"about_ca_system_score_gemma":0.003912123,"threshold_uncertainty_score":0.029689133},"labels":[],"label_agreement":null},{"id":"W2610105836","doi":"10.1093/neuonc/nox036.006","title":"OS01.7 MGMT promoter methylation status independently predicts progression-free survival in NRG Oncology/RTOG 9802: a phase III trial of RT vs RT + PCV in high-risk low-grade gliomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oncology; Internal medicine; Medicine; Hazard ratio; Glioma; Progression-free survival; Methylation; Proportional hazards model; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Biomarker; Statistical significance; Methyltransferase; Astrocytoma; Overall survival; Confidence interval; Biology; Cancer research; Gene; Genetics","score_opus":0.03174397573926484,"score_gpt":0.359153957720616,"score_spread":0.32740998198135113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610105836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858606,0.00037859002,0.00012205269,0.000110120716,0.00001724802,0.0001928183,0.00024789595,0.000018322742,0.00032690106],"genre_scores_gemma":[0.99708706,0.00025452813,0.00057575334,0.00016915401,0.000046428715,0.00033024666,0.0007245057,0.000012450571,0.0007998347],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994974,0.00032818635,0.000025093817,0.00006559002,0.000043092386,0.000040502553],"domain_scores_gemma":[0.99924004,0.00016905961,0.0002647903,0.000070558126,0.00003925189,0.00021629098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002043007,0.0006966604,0.0008187851,0.00019868731,0.00017793725,0.00054312503,0.00048900757,0.00053839217,0.0022720397],"category_scores_gemma":[0.0011731632,0.00027824097,0.0007608381,0.00024080423,0.00042027564,0.0003131874,0.000216555,0.0011588664,0.00043098704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.811728,0.015713854,0.07480315,0.0003955229,0.0010824668,0.00007715305,0.00016454137,0.0024218664,0.022104615,0.0001118981,0.002020144,0.06937692],"study_design_scores_gemma":[0.29569468,0.54149246,0.1431151,0.000061783074,0.0018140837,0.0004107858,0.00007814157,0.0060741855,0.0077443244,0.00031697567,0.0031575619,0.000039929124],"about_ca_topic_score_codex":0.00058147724,"about_ca_topic_score_gemma":0.001941925,"teacher_disagreement_score":0.0022720397,"about_ca_system_score_codex":0.0005158962,"about_ca_system_score_gemma":0.00090372964,"threshold_uncertainty_score":0.010804594},"labels":[],"label_agreement":null},{"id":"W2610149674","doi":"10.1093/neuonc/nox036.054","title":"OS08.4 NF2 Disruption by Genomic Rearrangements Drives A Subset of Radiation Induced Meningiomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Exon; Intron; Genetics; Exome sequencing; Neurofibromatosis type 2; Cancer research; Population; Monosomy; Chromosome; Gene; Neurofibromatosis; Medicine; Mutation; Karyotype","score_opus":0.03930666789610876,"score_gpt":0.3311242513452401,"score_spread":0.29181758344913133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610149674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889755,0.000094486706,0.00015667199,0.000010327687,0.0000012316339,0.0000055040096,0.00026259501,0.000023953675,0.0005476474],"genre_scores_gemma":[0.9984694,0.000078918245,0.00030499097,0.0000130770595,0.0000033437686,0.000009335437,0.0006482439,0.00001755053,0.0004549907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987245,0.00001185483,0.0000128039055,0.00003367459,0.00004056361,0.000028682574],"domain_scores_gemma":[0.99976367,0.000027366388,0.00012821873,0.000025209705,0.000013523386,0.000042011063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001065298,0.0002421368,0.00017831415,0.00047702124,0.00020115773,0.00024065157,0.00017443187,0.00018484978,0.002104398],"category_scores_gemma":[0.00032296352,0.00014505853,0.00016168204,0.0003019264,0.0002188232,0.00007547077,0.00017278265,0.00022447587,0.00056019763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075607677,0.000091377035,0.19047596,0.00008602665,0.000056533663,0.0052612172,0.00034674033,0.00028853447,0.79298204,0.00018399773,0.0004427882,0.009028758],"study_design_scores_gemma":[0.00004360664,0.00062003074,0.84293795,0.000020840826,0.00008483427,0.039691057,0.00039777218,0.0011158218,0.10962536,0.0001597709,0.0052929497,0.000010134511],"about_ca_topic_score_codex":0.0007994575,"about_ca_topic_score_gemma":0.0014341124,"teacher_disagreement_score":0.002104398,"about_ca_system_score_codex":0.00021513068,"about_ca_system_score_gemma":0.00015876106,"threshold_uncertainty_score":0.0070399046},"labels":[],"label_agreement":null},{"id":"W2611536191","doi":"10.1093/neuonc/nox086","title":"Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Oligodendroglioma; Oligodendroglial Tumor; Oncology; Internal medicine; Lomustine; Progression-free survival; ThioTEPA; Chemotherapy; Glioma; Vincristine; Cancer research; Astrocytoma; Cyclophosphamide","score_opus":0.022672943648378085,"score_gpt":0.31053443560305255,"score_spread":0.2878614919546745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611536191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552625,0.0010120621,0.0003921394,0.00023318517,0.000086530665,0.0018332131,0.00039395472,0.000040516446,0.00048213618],"genre_scores_gemma":[0.99191296,0.0009270678,0.0017224881,0.00046031922,0.0001223834,0.0025782173,0.0014579347,0.000021637437,0.0007969852],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99921525,0.00046480246,0.000038391503,0.00011788753,0.000057043828,0.00010661124],"domain_scores_gemma":[0.9986039,0.00017621151,0.00026811528,0.00013131129,0.00008384278,0.0007367576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307986,0.0013971585,0.0019496777,0.000411852,0.00045769598,0.0010076459,0.0011059939,0.0010741323,0.0020704288],"category_scores_gemma":[0.0011319149,0.00063183694,0.0009023292,0.00043900957,0.0011347834,0.00071354775,0.00040946712,0.0025867757,0.0006570961],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7986685,0.09023133,0.012525127,0.00047696327,0.0016986525,0.0002380666,0.0003255147,0.0023044199,0.036411338,0.00024870486,0.0025371646,0.054334164],"study_design_scores_gemma":[0.55953604,0.4237418,0.0109074935,0.000021976071,0.00040763183,0.00020931083,0.000045014203,0.0010043917,0.0025740396,0.00011659795,0.0014202073,0.000015525604],"about_ca_topic_score_codex":0.0011883327,"about_ca_topic_score_gemma":0.0022333665,"teacher_disagreement_score":0.003307986,"about_ca_system_score_codex":0.001179538,"about_ca_system_score_gemma":0.002587599,"threshold_uncertainty_score":0.0174945},"labels":[],"label_agreement":null},{"id":"W2611753127","doi":"10.1093/neuonc/nox091","title":"Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Centers for Disease Control and Prevention","keywords":"Incidence (geometry); Medicine; Cancer; Epidemiology; Histology; Cancer registry; Demography; Pathology; Internal medicine","score_opus":0.01623004465886374,"score_gpt":0.2964569871739458,"score_spread":0.28022694251508207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611753127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.868151,0.013068925,0.0015174175,0.00088931876,0.00010487969,0.00012123957,0.10503362,0.0003462966,0.010767235],"genre_scores_gemma":[0.921728,0.007553294,0.0018366101,0.0004844011,0.00008275413,0.00013625529,0.0664706,0.000053277792,0.0016548112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966025,0.00005935699,0.000060036913,0.000073944975,0.00009261687,0.00005378073],"domain_scores_gemma":[0.99870014,0.00006859926,0.0006555912,0.00004074742,0.0004508705,0.00008402472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054647104,0.0003110224,0.00028230873,0.0021089271,0.00013886091,0.00046202537,0.00047527018,0.0002582833,0.0011361181],"category_scores_gemma":[0.0010807007,0.00013743325,0.0006158424,0.0031800764,0.000233688,0.00037984506,0.00036936844,0.0003758024,0.0005031065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013334045,0.000014896148,0.98420423,0.00018479522,0.00022555226,0.00007324684,0.00011315518,0.0004135393,0.00027585475,0.00009136143,0.00653862,0.0077314926],"study_design_scores_gemma":[0.000008350208,0.000033404398,0.9941445,0.000042671498,0.00009158705,0.00048236456,0.00012285882,0.00016919448,0.00019782217,0.000037995913,0.004663506,0.000005776557],"about_ca_topic_score_codex":0.03874652,"about_ca_topic_score_gemma":0.044295654,"teacher_disagreement_score":0.03874652,"about_ca_system_score_codex":0.0012891601,"about_ca_system_score_gemma":0.00089446735,"threshold_uncertainty_score":0.07704198},"labels":[],"label_agreement":null},{"id":"W2613777097","doi":"10.1093/neuonc/now256","title":"MRI features predict survival and molecular markers in diffuse lower-grade gliomas","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"IDH1; Isocitrate dehydrogenase; Proportional hazards model; Medicine; Logistic regression; Glioma; Magnetic resonance imaging; Pathology; Receiver operating characteristic; Progression-free survival; Histology; Survival analysis; Multivariate analysis; Oncology; Nuclear medicine; Internal medicine; Overall survival; Radiology; Biology; Mutation; Cancer research","score_opus":0.011334952769764674,"score_gpt":0.27173107873712293,"score_spread":0.2603961259673583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613777097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921095,0.00019212886,0.00030493524,0.00001416069,0.0000016910435,0.0000026821253,0.00007233335,0.000008056546,0.00019304479],"genre_scores_gemma":[0.99964535,0.000045334207,0.00013281697,0.0000031492611,0.000002951964,0.0000013569293,0.00011567292,0.000001655529,0.00005172088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999026,0.000024805939,0.000011645039,0.000021279022,0.000022892173,0.000016691698],"domain_scores_gemma":[0.9989222,0.0002815503,0.000479951,0.00006720761,0.00013973234,0.00010947893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005061588,0.0002766201,0.0001620265,0.000807965,0.0000959065,0.00035369207,0.00010267641,0.000176142,0.0006524091],"category_scores_gemma":[0.0021730463,0.00007866628,0.00022447095,0.00033620195,0.00018768286,0.00019950455,0.00026250925,0.0001894479,0.00018638067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031941515,0.000015553776,0.9884157,0.000020259791,0.000046426718,0.00006287066,0.000055224395,0.00067780697,0.0012571047,0.0000146414395,0.00008993372,0.009025085],"study_design_scores_gemma":[0.000007800621,0.00012893822,0.9959015,0.000007955976,0.000050797258,0.00035263685,0.00008160153,0.0026325365,0.0005280148,0.000102960985,0.00019968778,0.000005650743],"about_ca_topic_score_codex":0.0015501671,"about_ca_topic_score_gemma":0.0024290415,"teacher_disagreement_score":0.0015501671,"about_ca_system_score_codex":0.00015025603,"about_ca_system_score_gemma":0.00010568121,"threshold_uncertainty_score":0.0030822158},"labels":[],"label_agreement":null},{"id":"W2614088513","doi":"10.1093/neuonc/nox093","title":"Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Topotecan; Medicine; Panobinostat; Decitabine; Pharmacology; Paclitaxel; Vincristine; Combination therapy; Cancer research; PLK1; In vivo; Oncology; Internal medicine; Chemotherapy; Cancer; Cell cycle; Biology; Histone deacetylase; Cyclophosphamide; DNA methylation","score_opus":0.031539553965986115,"score_gpt":0.3513405280390305,"score_spread":0.31980097407304436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614088513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318696,0.008009039,0.0023336748,0.0003308739,0.000051598567,0.00029659047,0.002105613,0.00015648309,0.0035292916],"genre_scores_gemma":[0.9855914,0.0050900434,0.0037993144,0.00011899423,0.000024737135,0.00010729676,0.0031990155,0.000027052964,0.0020420728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999892,0.000022298775,0.000010818209,0.000022095808,0.00002919435,0.000023501469],"domain_scores_gemma":[0.999859,0.000023862127,0.000030676387,0.000012977437,0.00002638575,0.00004718735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023976184,0.0005217556,0.0005910993,0.00048711154,0.00017821998,0.00045479453,0.0004074012,0.00026801098,0.0026276645],"category_scores_gemma":[0.00016773301,0.0001269343,0.00040311652,0.00036477327,0.00017948142,0.0002133948,0.0001749976,0.00067908363,0.0005188517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027533802,0.0016038154,0.004335146,0.00040189156,0.00017547299,0.00056623097,0.00006537641,0.0030961956,0.94415367,0.00033644514,0.0013099563,0.04120249],"study_design_scores_gemma":[0.0010765073,0.034265272,0.01317212,0.000057871057,0.0005631586,0.0025899673,0.00009424239,0.0046944586,0.9240321,0.00017470379,0.019238709,0.000040812192],"about_ca_topic_score_codex":0.00085218536,"about_ca_topic_score_gemma":0.0028049308,"teacher_disagreement_score":0.0026276645,"about_ca_system_score_codex":0.00045348672,"about_ca_system_score_gemma":0.0005401308,"threshold_uncertainty_score":0.008790433},"labels":[],"label_agreement":null},{"id":"W2614125124","doi":"10.1093/neuonc/nox061","title":"NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Colorado Denver; Hospital for Sick Children; University of California, San Francisco; St. Jude Children's Research Hospital","keywords":"Gene knockdown; Biology; Downregulation and upregulation; Cancer research; Gene silencing; Tumor necrosis factor alpha; NF-κB; Transcription factor; IκBα; Molecular biology; NFKB1; Cell culture; Signal transduction; Cell biology; Immunology; Gene","score_opus":0.02919074406659024,"score_gpt":0.31895571694718333,"score_spread":0.2897649728805931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614125124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986533,0.00026729115,0.0005337283,0.000015121556,0.0000049373753,0.000005700786,0.00017802457,0.000024442585,0.00031746906],"genre_scores_gemma":[0.99878114,0.00019123274,0.00030967462,0.0000149724365,0.0000026904174,0.000012638067,0.0002367265,0.000008457475,0.00044238818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994254,0.0000038811113,0.0000040991295,0.000019213818,0.000014202745,0.00001610378],"domain_scores_gemma":[0.9999144,0.000010629216,0.00003979987,0.000008492018,0.000005963178,0.0000206403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063084415,0.00014097958,0.00011417332,0.00016636365,0.00011640406,0.00020528604,0.00010178191,0.00009656751,0.0010261382],"category_scores_gemma":[0.00011603657,0.00006560419,0.00011778782,0.00012755784,0.00016495609,0.00010327728,0.00018025353,0.0002889134,0.00017675862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001513348,0.000022756174,0.0050636074,0.000034768385,0.0000065708637,0.00014620152,0.000027824657,0.00005902266,0.9918394,0.000055996334,0.00005608559,0.0025363057],"study_design_scores_gemma":[0.00003554291,0.00057683344,0.2067202,0.000016321657,0.00005694222,0.0020022723,0.00020754123,0.0012226024,0.7846129,0.00014335656,0.0043962575,0.000009223962],"about_ca_topic_score_codex":0.0002625215,"about_ca_topic_score_gemma":0.00051395845,"teacher_disagreement_score":0.0010261382,"about_ca_system_score_codex":0.00017542914,"about_ca_system_score_gemma":0.00011448359,"threshold_uncertainty_score":0.0034327507},"labels":[],"label_agreement":null},{"id":"W2614784821","doi":"10.1093/neuonc/nox059","title":"Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Telomerase; Medicine; Neuroscience; Oncology; Internal medicine; Biology; Pathology; Genetics","score_opus":0.048250475224516,"score_gpt":0.3210736453711343,"score_spread":0.27282317014661833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614784821","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016795682,0.02625815,0.0007631252,0.9377686,0.011502205,0.000033427787,0.00023328402,0.00007233442,0.0065731853],"genre_scores_gemma":[0.26291955,0.041545037,0.0036131537,0.5078879,0.17283314,0.00017417507,0.0005294581,0.00006908433,0.010428489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992466,0.00021359441,0.00015500693,0.000091536975,0.00016793284,0.00012532783],"domain_scores_gemma":[0.9966181,0.0018494164,0.0002794735,0.00017539864,0.00066467206,0.00041301906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020072963,0.00038675632,0.0015514009,0.00072500505,0.0008969846,0.0014959496,0.0007723468,0.0074624554,0.0025548197],"category_scores_gemma":[0.013850864,0.00021311197,0.0006841476,0.00057424133,0.0010050582,0.0021990896,0.00067558914,0.00930094,0.0019032847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015445745,0.00022682761,0.11596013,0.0005402737,0.00024337847,0.015228131,0.0005548949,0.0010113774,0.0036151304,0.009188832,0.40983927,0.44204703],"study_design_scores_gemma":[0.0012305224,0.0013658585,0.062208477,0.0020614183,0.0007260217,0.052491684,0.002985619,0.0046121804,0.0037088674,0.12461905,0.7437442,0.00024616305],"about_ca_topic_score_codex":0.0014817034,"about_ca_topic_score_gemma":0.0028896318,"teacher_disagreement_score":0.0074624554,"about_ca_system_score_codex":0.0010697967,"about_ca_system_score_gemma":0.0011944694,"threshold_uncertainty_score":0.010615706},"labels":[],"label_agreement":null},{"id":"W2615266562","doi":"10.1093/neuonc/nox053","title":"Citation classics in neuro-oncology: assessment of historical trends and scientific progress","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Citation; Medicine; Oncology; Radiation therapy; Clinical trial; Citation analysis; MEDLINE; Internal medicine; Library science; Computer science; Political science","score_opus":0.4991945846804617,"score_gpt":0.58779065215596,"score_spread":0.08859606747549836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615266562","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082110204,0.8571175,0.0064864554,0.015371583,0.0045597865,0.0010039081,0.016055303,0.00045482643,0.016840475],"genre_scores_gemma":[0.41733202,0.5207122,0.03069184,0.0025912274,0.0085213855,0.0015670798,0.014910161,0.0002742308,0.0033999265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9625931,0.0073040216,0.012329852,0.0031325414,0.013604369,0.0010359775],"domain_scores_gemma":[0.59150326,0.22558638,0.093690455,0.0072767097,0.07696163,0.0049814736],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.058545303,0.0012192386,0.0025348426,0.16748728,0.0018694291,0.01249397,0.0022933816,0.0019525887,0.0048620477],"category_scores_gemma":[0.24817175,0.0007061825,0.0023437198,0.18984488,0.0026964354,0.012837295,0.003949128,0.0015776752,0.0010887345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009657723,0.00010284235,0.1872529,0.104182616,0.0039555733,0.0008092395,0.0072852997,0.0014516215,0.0013506872,0.020111682,0.06309938,0.6094325],"study_design_scores_gemma":[0.00023715406,0.00071336684,0.37490374,0.07919325,0.007242443,0.0060864803,0.011773485,0.0037709766,0.0021816497,0.03386148,0.47951305,0.0005229696],"about_ca_topic_score_codex":0.0029878318,"about_ca_topic_score_gemma":0.005198938,"teacher_disagreement_score":0.9414547,"about_ca_system_score_codex":0.006386069,"about_ca_system_score_gemma":0.009121762,"threshold_uncertainty_score":0.30962086},"labels":[],"label_agreement":null},{"id":"W2615747491","doi":"10.1093/neuonc/nox089","title":"Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Neutrophilia; Medicine; Meningioma; Leukocytosis; Internal medicine; Proportional hazards model; Univariate analysis; Surgical oncology; Anemia; Hazard ratio; Gastroenterology; Surgery; Multivariate analysis; Oncology; Confidence interval","score_opus":0.051604883940859395,"score_gpt":0.32835767448737,"score_spread":0.27675279054651064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615747491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984047,0.0011254321,0.00008870006,0.000050412975,0.0000058061596,0.000002492216,0.0001224453,0.000004386265,0.00019571425],"genre_scores_gemma":[0.9996965,0.00013079646,0.000037234353,0.0000046873392,0.0000072245302,0.000001423634,0.00008934689,7.228248e-7,0.000032108852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998141,0.000047052083,0.000023821563,0.000027272825,0.00004491253,0.00004288494],"domain_scores_gemma":[0.9981495,0.0005707659,0.0007884291,0.00007560352,0.00014697907,0.00026882984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042298503,0.0001603402,0.00017624111,0.00037653395,0.00013791872,0.00027163356,0.0001487769,0.00017911915,0.001065259],"category_scores_gemma":[0.0027496768,0.000078519915,0.00019178407,0.00027878454,0.00016430323,0.00019778665,0.0002089259,0.0002912917,0.00010223569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032779787,0.000008500386,0.99636453,0.0000076266338,0.000021208602,0.00012240517,0.000011571499,0.00010714894,0.00033934863,0.000008062354,0.000062662766,0.0026191552],"study_design_scores_gemma":[0.000006505365,0.0001088305,0.99794334,0.000008994276,0.00004298826,0.00083993893,0.00003290271,0.0005490876,0.00026245404,0.000028356768,0.00017241284,0.000004145137],"about_ca_topic_score_codex":0.001273203,"about_ca_topic_score_gemma":0.0016477854,"teacher_disagreement_score":0.001273203,"about_ca_system_score_codex":0.00022767636,"about_ca_system_score_gemma":0.00024682024,"threshold_uncertainty_score":0.0035636425},"labels":[],"label_agreement":null},{"id":"W2616974222","doi":"10.1093/neuonc/nox083.165","title":"MEDU-14. OTX2 CONTROLS AN AXON GUIDANCE GENE EXPRESSION NETWORK TO REGULATE MEDULLOBLASTOMA SELF-RENEWAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital; SickKids Foundation; University of Manitoba","funders":"","keywords":"Semaphorin; Biology; Axon guidance; Gene knockdown; Signal transduction; Cancer research; Gene; Medulloblastoma; Downregulation and upregulation; Progenitor cell; Stem cell; Axon; Cell biology; Genetics; Receptor","score_opus":0.025085812610992096,"score_gpt":0.3223981051470549,"score_spread":0.29731229253606284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616974222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673636,0.0017568269,0.0033451074,0.00012205568,0.000054755714,0.00004643451,0.0042982227,0.0003496846,0.0032905403],"genre_scores_gemma":[0.983949,0.0005253042,0.0022930782,0.00016654274,0.000012932326,0.000053598807,0.006198096,0.0000631352,0.0067383205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.000013021332,0.000008314433,0.000058879188,0.00003908835,0.000029584922],"domain_scores_gemma":[0.9999291,0.000007825307,0.000026422806,0.0000057150028,0.000010325081,0.000020539946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010462616,0.00030217637,0.00029131837,0.00026004904,0.00031699066,0.00038923597,0.00014576511,0.00018470212,0.0019830784],"category_scores_gemma":[0.000115436094,0.00016464826,0.00029667892,0.00020987669,0.00018460758,0.00013595322,0.00037863987,0.0002661176,0.0004663868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037023603,0.000034368073,0.006871524,0.00009221904,0.000025412604,0.00012498649,0.000038179445,0.000354316,0.9868152,0.00024536857,0.00041479024,0.004613437],"study_design_scores_gemma":[0.000111673966,0.00048742726,0.31800193,0.00004210082,0.000114151626,0.0007722601,0.00017150151,0.014558889,0.6454571,0.00038508195,0.019871188,0.000026734357],"about_ca_topic_score_codex":0.0021600495,"about_ca_topic_score_gemma":0.004899683,"teacher_disagreement_score":0.0021600495,"about_ca_system_score_codex":0.00052785967,"about_ca_system_score_gemma":0.00037288785,"threshold_uncertainty_score":0.0066340566},"labels":[],"label_agreement":null},{"id":"W2617029719","doi":"10.1093/neuonc/nox083.065","title":"EPND-07. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Genetic heterogeneity; Medulloblastoma; Gene; Histogenesis; Disease; Genome; Genetics; Bioinformatics; Pathology; Oncology; Immunohistochemistry; Medicine; Immunology","score_opus":0.02538188241965737,"score_gpt":0.3188123562769149,"score_spread":0.2934304738572575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617029719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693775,0.000397493,0.0007310342,0.000028776794,0.0000039427046,0.000019715102,0.00083538017,0.000021534395,0.001024433],"genre_scores_gemma":[0.9961738,0.0002617529,0.0011449963,0.000022397142,0.000005225757,0.00003018928,0.0020262725,0.000013435666,0.0003219161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976665,0.000014171755,0.000023865772,0.00009015511,0.00006623826,0.000038924838],"domain_scores_gemma":[0.99969864,0.00006797965,0.00010640983,0.000025876781,0.000045299414,0.00005582284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018464579,0.00027874386,0.00028785077,0.0006523298,0.00029819293,0.0003521523,0.00028913686,0.00026481162,0.0011182736],"category_scores_gemma":[0.00072300935,0.0001287364,0.0002532544,0.00071962416,0.00027111557,0.00026381016,0.00032045526,0.00037485012,0.0002629714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005419321,0.000054221815,0.85161155,0.0001225018,0.00009673831,0.006859165,0.00031745085,0.0008857363,0.10638098,0.0004821271,0.00059528166,0.032052275],"study_design_scores_gemma":[0.000025299087,0.00013372028,0.96006256,0.000013259129,0.00007507261,0.020227889,0.0002708183,0.0011730348,0.013544668,0.00051100366,0.003950358,0.000012366885],"about_ca_topic_score_codex":0.0015686697,"about_ca_topic_score_gemma":0.0029557112,"teacher_disagreement_score":0.0015686697,"about_ca_system_score_codex":0.00031548532,"about_ca_system_score_gemma":0.00026815513,"threshold_uncertainty_score":0.0037409663},"labels":[],"label_agreement":null},{"id":"W2617056390","doi":"10.1093/neuonc/nox083.179","title":"MEDU-29. A NOVEL MOUSE MODEL OF PI3 KINASE PATHWAY IN METASTATIC SHH MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Sonic hedgehog; PTEN; PI3K/AKT/mTOR pathway; Biology; Metastasis; Spinal cord; Medicine; Neuroscience; Signal transduction; Cell biology; Cancer; Genetics","score_opus":0.05278049828140863,"score_gpt":0.32812503171438356,"score_spread":0.27534453343297494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617056390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87748057,0.0064042336,0.0625153,0.0026460658,0.00095719885,0.0017242073,0.020795984,0.0032706505,0.024205783],"genre_scores_gemma":[0.8318041,0.0046278364,0.038737927,0.00082814397,0.00011608843,0.002882805,0.014940093,0.00073396397,0.105329014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991615,0.000098346434,0.00010366286,0.00021726335,0.00024774895,0.00017158892],"domain_scores_gemma":[0.99965525,0.00002978196,0.00009847089,0.00004073904,0.00003006786,0.00014577695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005807586,0.0012626505,0.00068763684,0.0026225583,0.0009951153,0.0006988305,0.0012635648,0.0021215999,0.011055841],"category_scores_gemma":[0.00017978252,0.0008195614,0.0010155874,0.0007275826,0.0009985474,0.0009571963,0.00069715857,0.0023500267,0.0052220975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045583642,0.0005300237,0.00039767328,0.00016743821,0.00002607075,0.00077044644,0.00010387327,0.00028530342,0.9881344,0.0028490252,0.0012308117,0.0050489902],"study_design_scores_gemma":[0.00055020856,0.0022099908,0.0059597213,0.000120159,0.00011254184,0.0045304913,0.00015966951,0.004018109,0.9033202,0.0011829583,0.07777373,0.000062319654],"about_ca_topic_score_codex":0.0014562038,"about_ca_topic_score_gemma":0.002995707,"teacher_disagreement_score":0.011055841,"about_ca_system_score_codex":0.0010665043,"about_ca_system_score_gemma":0.0007511535,"threshold_uncertainty_score":0.036985397},"labels":[],"label_agreement":null},{"id":"W2617370963","doi":"10.1093/neuonc/nox083.225","title":"TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"BMI1; Medulloblastoma; Stem cell; Medicine; In vivo; Cancer research; Metastasis; Oncology; Internal medicine; Biology; Cancer; Genetics","score_opus":0.028078780707230046,"score_gpt":0.33161809138904486,"score_spread":0.30353931068181483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617370963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95977885,0.022555944,0.0050453893,0.0008316687,0.00021937561,0.00030947808,0.0017446085,0.000512809,0.009001921],"genre_scores_gemma":[0.972514,0.010068459,0.0064037917,0.00029373227,0.000041794756,0.00017049733,0.0028762126,0.00006218879,0.007569306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999238,0.0000069976786,0.000005244664,0.000012562244,0.00002797646,0.00002338366],"domain_scores_gemma":[0.9999652,0.0000029812898,0.000009715531,0.0000033064352,0.0000048834495,0.000013903948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012748635,0.0002743958,0.00033899042,0.0003067486,0.00014904,0.0002373769,0.00032518615,0.0003075747,0.0017144106],"category_scores_gemma":[0.00007650398,0.00011060126,0.0002983564,0.00022099561,0.00018956517,0.0001255247,0.00018398253,0.00088690454,0.00058564235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000818641,0.0002697324,0.0010568481,0.00032006082,0.000039341598,0.0002763555,0.00004232015,0.00057478825,0.9596407,0.00046458386,0.0009312391,0.035565324],"study_design_scores_gemma":[0.0003452353,0.004044043,0.014671633,0.00003748664,0.00014864594,0.0017876042,0.00004384062,0.0020754596,0.9432199,0.0001759743,0.033430357,0.000019932259],"about_ca_topic_score_codex":0.001940927,"about_ca_topic_score_gemma":0.0048513985,"teacher_disagreement_score":0.001940927,"about_ca_system_score_codex":0.000498304,"about_ca_system_score_gemma":0.0003914327,"threshold_uncertainty_score":0.005735278},"labels":[],"label_agreement":null},{"id":"W2617425553","doi":"10.1093/neuonc/nox083.151","title":"LGG-18. MOLECULAR ALTERATIONS PREDICT RESPONSE TO CHEMOTHERAPY AND OUTCOME OF PEDIATRIC LOW-GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Internal medicine; Oncology; Chemotherapy; Glioma; Cohort; Pathology; Cancer research","score_opus":0.031149528030149216,"score_gpt":0.3487051521526879,"score_spread":0.3175556241225387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617425553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924195,0.00023752153,0.000055438988,0.000023825509,0.0000019155193,0.0000036822028,0.00021321201,0.000004417678,0.000218098],"genre_scores_gemma":[0.9994326,0.000072237155,0.00007654106,0.0000074421787,0.0000027796716,0.0000036748222,0.0003323787,0.0000018461837,0.00007049276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988496,0.000018350565,0.000011807949,0.000029995028,0.000029104744,0.000025792457],"domain_scores_gemma":[0.99923205,0.00011720379,0.00043525608,0.00002221908,0.00005603611,0.00013733662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022962515,0.00019611813,0.00016274276,0.00043548422,0.00012079295,0.00032279053,0.0002039601,0.00025854693,0.0014653152],"category_scores_gemma":[0.0012373833,0.00010233692,0.00016850005,0.00052387005,0.00019190591,0.0002546223,0.00020925506,0.00029187746,0.00031380725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012706188,0.000007694469,0.99756765,0.0000068450577,0.000009725802,0.000093971066,0.0000117975715,0.00005860617,0.00034073184,0.000005046685,0.00006088605,0.0017101037],"study_design_scores_gemma":[0.0000046308355,0.00008584472,0.9984723,0.0000042190222,0.000017103654,0.00073851715,0.00003779814,0.00018062776,0.00024902346,0.000018491253,0.00019022229,0.0000011497506],"about_ca_topic_score_codex":0.0017533329,"about_ca_topic_score_gemma":0.002215133,"teacher_disagreement_score":0.0017533329,"about_ca_system_score_codex":0.00041465418,"about_ca_system_score_gemma":0.00027405642,"threshold_uncertainty_score":0.004902005},"labels":[],"label_agreement":null},{"id":"W2617492910","doi":"10.1093/neuonc/nox083.091","title":"HGG-02. DIANHYDROGALACTITOL (VAL-083) OVERCOMES MGMT- AND P53-MEDIATED CHEMO-RESISTANCE AND DISPLAYS SYNERGY WITH TOPOISOMERASE INHIBITORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; Topoisomerase; DNA repair; Medicine; DNA damage; Methyltransferase; Cancer; Cell cycle; Oncology; Internal medicine; Glioma; Biology; In vitro; DNA; Genetics","score_opus":0.010315923296813327,"score_gpt":0.26947952763531335,"score_spread":0.25916360433850005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617492910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651475,0.0053450023,0.0008862253,0.00026813534,0.00005717496,0.00007778835,0.0009018475,0.00041588413,0.0055333255],"genre_scores_gemma":[0.9932059,0.0019145482,0.0009818063,0.00011181351,0.000011900993,0.000033975277,0.0014224817,0.000029201363,0.002288324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995816,0.000007772851,0.0000023143023,0.000006701984,0.000009504244,0.000015577425],"domain_scores_gemma":[0.9999701,0.0000023060682,0.0000070504734,0.0000029817647,0.0000027228984,0.000014907431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042174233,0.00039675366,0.00021467618,0.00021233271,0.000078369034,0.00016599795,0.00025269,0.00019855285,0.001437125],"category_scores_gemma":[0.000048773105,0.000092739654,0.00022316346,0.00021625047,0.000117744145,0.00009132881,0.00016535341,0.00060440286,0.0004095454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013294119,0.0006470265,0.00063503976,0.00017356766,0.00004101953,0.00018230217,0.000037021535,0.0008015465,0.95465565,0.00033171588,0.0013708882,0.03979469],"study_design_scores_gemma":[0.0005978644,0.008048982,0.009190889,0.000018398438,0.00007614313,0.0012717412,0.00003586061,0.0014735393,0.95323825,0.00011953058,0.025909517,0.000019311798],"about_ca_topic_score_codex":0.0012084479,"about_ca_topic_score_gemma":0.0019952187,"teacher_disagreement_score":0.001437125,"about_ca_system_score_codex":0.00021180617,"about_ca_system_score_gemma":0.00022136635,"threshold_uncertainty_score":0.004807651},"labels":[],"label_agreement":null},{"id":"W2617575965","doi":"10.1093/neuonc/nox083.196","title":"MEDU-47. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Cancer research; DNA damage; Sensitization; Oxidative stress; Reactive oxygen species; Apoptosis; Ionizing radiation; Radiation therapy; RNA interference; Biology; Medicine; Immunology; DNA; Gene; Irradiation; Internal medicine; Biochemistry; RNA","score_opus":0.018460291911635927,"score_gpt":0.3088351542156031,"score_spread":0.29037486230396714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617575965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908246,0.003607272,0.0026856407,0.0003569289,0.00007742722,0.000087866654,0.0011042648,0.0002165228,0.0027815157],"genre_scores_gemma":[0.9934517,0.0012779007,0.0015186203,0.0000677349,0.0000075707617,0.000048894148,0.0009831082,0.000017619142,0.0026268875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989176,0.0000110073015,0.00000739713,0.000024951583,0.00003666491,0.000028157307],"domain_scores_gemma":[0.99995685,0.0000034137365,0.00001431392,0.0000052431114,0.0000040193204,0.000016168644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013978382,0.00026585336,0.000287378,0.00020667004,0.00021816613,0.0002503774,0.00014934345,0.00028441055,0.001647864],"category_scores_gemma":[0.000072620795,0.00011684088,0.00038494583,0.0001826111,0.00021329471,0.00017339097,0.00016145526,0.00063042063,0.00031318679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020520034,0.000056484525,0.0008101957,0.00008566301,0.000010559437,0.00009968824,0.00002656319,0.00011872845,0.99435306,0.00017982186,0.0001982817,0.003855716],"study_design_scores_gemma":[0.000030639407,0.00062846096,0.008928409,0.000010423965,0.000027136053,0.00050220476,0.00003651409,0.00050795573,0.9817842,0.0000796986,0.0074599255,0.0000043533237],"about_ca_topic_score_codex":0.0011838276,"about_ca_topic_score_gemma":0.0022359076,"teacher_disagreement_score":0.001647864,"about_ca_system_score_codex":0.0004821964,"about_ca_system_score_gemma":0.00027688924,"threshold_uncertainty_score":0.005512655},"labels":[],"label_agreement":null},{"id":"W2617609684","doi":"10.1093/neuonc/nox083.178","title":"MEDU-28. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI, IN GROUP 3 MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Neural stem cell; Gene knockdown; Biology; Medulloblastoma; Carcinogenesis; Cancer research; Stem cell; Progenitor cell; RNA-binding protein; Cell fate determination; Cancer stem cell; Glioma; Transcriptional regulation; Cell; RNA; Cancer; Gene; Gene expression; Cell biology; Genetics; Transcription factor","score_opus":0.016803526197931504,"score_gpt":0.28814721258951864,"score_spread":0.2713436863915871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617609684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898259,0.004974895,0.0014356325,0.00015340064,0.000029963625,0.000030249621,0.000667946,0.000032999018,0.0028491095],"genre_scores_gemma":[0.9894688,0.002849383,0.0023511231,0.00009570706,0.000015630067,0.000023505077,0.0013962582,0.000012170341,0.003787234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995434,0.000005014884,0.0000027788162,0.000012515464,0.000012108801,0.000013170305],"domain_scores_gemma":[0.9999591,0.0000056948643,0.000009970322,0.0000022488198,0.000005791699,0.000017087435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113373,0.00017169937,0.00011687698,0.00034780955,0.00019968877,0.00016627612,0.00012823347,0.00019008065,0.0014340011],"category_scores_gemma":[0.0000821277,0.000076295546,0.0002127313,0.00016942126,0.00014241665,0.00015184468,0.00014924166,0.0002032765,0.00033695681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002724419,0.000023442402,0.0049179974,0.00011854742,0.000009531954,0.00014323188,0.00004035362,0.00006074851,0.9892162,0.00019130367,0.00010416922,0.0049020466],"study_design_scores_gemma":[0.000039809118,0.0007243315,0.17376937,0.000025335416,0.00007006676,0.0012705838,0.00021254312,0.0014797471,0.79812455,0.00026749694,0.024006559,0.000009689921],"about_ca_topic_score_codex":0.0018728595,"about_ca_topic_score_gemma":0.0036734284,"teacher_disagreement_score":0.0018728595,"about_ca_system_score_codex":0.00043056055,"about_ca_system_score_gemma":0.0001977314,"threshold_uncertainty_score":0.00479722},"labels":[],"label_agreement":null},{"id":"W2617655947","doi":"10.1093/neuonc/nox083.107","title":"HGG-18. GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS SHARE SEVERAL MOLECULAR FEATURES WITH THEIR PEDIATRIC COUNTERPARTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; IDH1; Cohort; Population; Internal medicine; Pathology; Young adult; Oncology; Glioma; Gastroenterology; Pediatrics; Mutation; Biology; Cancer research; Genetics","score_opus":0.012602608713378427,"score_gpt":0.2755069452501196,"score_spread":0.26290433653674117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617655947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969217,0.0005290787,0.00032138114,0.000043437332,0.000007342315,0.00002662076,0.0007921028,0.000024184612,0.0013341581],"genre_scores_gemma":[0.99545896,0.00058582233,0.00086182443,0.000089442365,0.000018114271,0.00005212218,0.002223882,0.00001560598,0.0006942533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981934,0.00002332367,0.00002249667,0.000050335566,0.00004153954,0.000042849522],"domain_scores_gemma":[0.9995271,0.000044711243,0.00024979297,0.000023825763,0.00005874061,0.00009594909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019270336,0.00020469751,0.00023446734,0.0007057391,0.00025754017,0.00038919423,0.00012248475,0.00020556788,0.0017972131],"category_scores_gemma":[0.0006669695,0.0001283645,0.00016466789,0.000733698,0.00022546727,0.00022506434,0.0003207695,0.00023963979,0.0006029351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001263138,0.00003020058,0.9798717,0.000036964568,0.000019819534,0.0023671577,0.00017584061,0.00004306653,0.0029168553,0.0001236594,0.0005412045,0.013747253],"study_design_scores_gemma":[0.0000064460605,0.00013400368,0.98436445,0.000016096144,0.000015119314,0.011324854,0.00027724588,0.000058729933,0.00072734326,0.00011527552,0.0029573794,0.00000303542],"about_ca_topic_score_codex":0.002027558,"about_ca_topic_score_gemma":0.0029866872,"teacher_disagreement_score":0.002027558,"about_ca_system_score_codex":0.0002306637,"about_ca_system_score_gemma":0.0002955984,"threshold_uncertainty_score":0.0060122013},"labels":[],"label_agreement":null},{"id":"W2617712430","doi":"10.1093/neuonc/nox083.095","title":"HGG-06. CHARACTERIZING TEMPORAL GENOMIC HETEROGENEITY IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"ATRX; Biology; IDH1; Epigenetics; Cancer research; Mutation; Histone; Genetics; Somatic evolution in cancer; Cancer; Gene","score_opus":0.03799632797195328,"score_gpt":0.3160771669475253,"score_spread":0.278080838975572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617712430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578328,0.00052404247,0.00275481,0.00014542714,0.000025684109,0.0001281816,0.032904167,0.00041815348,0.005266703],"genre_scores_gemma":[0.881234,0.00050905347,0.0063669626,0.00018707065,0.000046633384,0.00020510511,0.10874044,0.00030041102,0.0024103473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972004,0.000050866915,0.000021279866,0.000074485266,0.00006608047,0.00006722692],"domain_scores_gemma":[0.999433,0.000111958274,0.00009538573,0.00012177494,0.000089121764,0.0001486975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046667346,0.00022074774,0.00029389103,0.0009281302,0.00031954554,0.00048410575,0.0003405696,0.00034632822,0.0034319356],"category_scores_gemma":[0.00087331777,0.00017182334,0.00020968907,0.0013031276,0.00015649485,0.00015224672,0.00046242392,0.00026304112,0.0009850806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028237954,0.0001601795,0.8285868,0.00028897138,0.00019335841,0.0026023823,0.00066456344,0.0016325599,0.07579564,0.0007100398,0.022692295,0.063849404],"study_design_scores_gemma":[0.000102634935,0.00025378173,0.9594909,0.000024642839,0.00008564976,0.004156218,0.00021399996,0.0011136498,0.008964738,0.000303578,0.025278872,0.000011417582],"about_ca_topic_score_codex":0.0037806951,"about_ca_topic_score_gemma":0.00638107,"teacher_disagreement_score":0.0037806951,"about_ca_system_score_codex":0.00031903718,"about_ca_system_score_gemma":0.00048936077,"threshold_uncertainty_score":0.011480987},"labels":[],"label_agreement":null},{"id":"W2617945496","doi":"10.1093/neuonc/nox083.199","title":"MEDU-50. TRANSCRIPTIONAL REGULATION OF THE HOMEOBOX GENES CRX AND OTX2 - IMPLICATIONS FOR MEDULLOBLASTOMA GROUP 3","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Homeobox; Chromatin immunoprecipitation; Biology; Reporter gene; Enhancer; Psychological repression; Promoter; Regulation of gene expression; DLX5; Cell biology; Transcription factor; Genetics; Molecular biology; Gene; Gene expression","score_opus":0.03666894329806066,"score_gpt":0.3203396037393318,"score_spread":0.28367066044127115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617945496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614999,0.010192813,0.008405451,0.0006252617,0.00018711129,0.00009418961,0.0027928588,0.0005156404,0.015686708],"genre_scores_gemma":[0.9754622,0.001894469,0.0035807213,0.00026083837,0.000044182892,0.00006688555,0.0022316638,0.00007140895,0.016387705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998734,0.000010227789,0.0000050700373,0.000039339673,0.00003800665,0.00003385259],"domain_scores_gemma":[0.9999157,0.000009008684,0.00002440247,0.000006792004,0.000008321603,0.000035685367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010286692,0.00044841753,0.00016944985,0.00022094695,0.00031228398,0.00030095474,0.00019708165,0.00027093754,0.004419534],"category_scores_gemma":[0.00008051476,0.0001029524,0.00028207118,0.00009457501,0.00026630948,0.00013299045,0.0003260924,0.00037615545,0.0010828953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014969656,0.000024447663,0.0010747678,0.00006793914,0.0000049333644,0.00015793339,0.000024363362,0.000052961837,0.99474466,0.00047138063,0.00021920273,0.0030078085],"study_design_scores_gemma":[0.00006972683,0.00033912685,0.09891739,0.00005252106,0.000032590582,0.0011320249,0.00013146359,0.0014874802,0.86982274,0.0004380791,0.027565455,0.000011477951],"about_ca_topic_score_codex":0.0016795739,"about_ca_topic_score_gemma":0.0034505855,"teacher_disagreement_score":0.004419534,"about_ca_system_score_codex":0.00065114663,"about_ca_system_score_gemma":0.00028762472,"threshold_uncertainty_score":0.014784813},"labels":[],"label_agreement":null},{"id":"W2618097753","doi":"10.1093/neuonc/nox083.047","title":"DIPG-32. MRI GUIDED FOCUSED ULTRASOUND FOR BRAINSTEM BLOOD BRAIN BARRIER PENETRATION: A DEMONSTRATION OF SAFETY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Microbubbles; Blood–brain barrier; Brainstem; Magnetic resonance imaging; Ultrasound; Pathology; Anesthesia; Radiology; Central nervous system; Internal medicine","score_opus":0.03723628543925391,"score_gpt":0.36314785574727154,"score_spread":0.32591157030801765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618097753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86780125,0.013710693,0.10530475,0.00067249674,0.00016063204,0.0008942498,0.0005259405,0.000759868,0.010170055],"genre_scores_gemma":[0.9543356,0.003579683,0.038164318,0.0001820602,0.000024361918,0.00039320206,0.0003212311,0.00007569621,0.0029239238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999851,0.000031399115,0.000007114641,0.000033367778,0.00005411664,0.000022956621],"domain_scores_gemma":[0.9998066,0.000070678296,0.000047040514,0.000021911135,0.000023371464,0.000030382358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039372736,0.00044965974,0.00018933773,0.00024737883,0.00011772988,0.00014183756,0.00026107105,0.00043301663,0.001634995],"category_scores_gemma":[0.0004274291,0.00014486915,0.00014828234,0.00011582686,0.0004685826,0.00028074122,0.00023405145,0.00048746736,0.00046725495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025316837,0.000042553165,0.00012965829,0.00014545988,0.0000051310094,0.00015137339,0.000034655346,0.0001474832,0.9891589,0.0002512315,0.00013922768,0.009541112],"study_design_scores_gemma":[0.00011483048,0.0031216526,0.0021396552,0.000036541507,0.000023139202,0.0012959632,0.000021230284,0.0013687499,0.9864347,0.00023278168,0.0051998603,0.000010789315],"about_ca_topic_score_codex":0.00053450227,"about_ca_topic_score_gemma":0.0006065328,"teacher_disagreement_score":0.001634995,"about_ca_system_score_codex":0.00020911565,"about_ca_system_score_gemma":0.00029967376,"threshold_uncertainty_score":0.0054695606},"labels":[],"label_agreement":null},{"id":"W2618433710","doi":"10.1093/neuonc/nox083.239","title":"TRTH-29. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL WNT PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cancer research; In vivo; Biology; SOX2; Medicine; Signal transduction; Cell biology; Transcription factor; Gene; Genetics","score_opus":0.032554061361765634,"score_gpt":0.308984839351115,"score_spread":0.27643077798934934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618433710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881604,0.003491019,0.0029733456,0.00023231478,0.000043785072,0.00008876397,0.00070516515,0.00018503882,0.0041202195],"genre_scores_gemma":[0.99176323,0.0020745872,0.0022065844,0.00006699848,0.000013450782,0.000048217455,0.0009711393,0.000039483595,0.0028162957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999341,0.000009572474,0.00000680435,0.000013012134,0.000017700788,0.000018873],"domain_scores_gemma":[0.99996114,0.000004223069,0.000010748204,0.0000063600764,0.0000032738117,0.0000143418965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011604597,0.00020017143,0.00023327193,0.0001599734,0.000119154065,0.00021901815,0.00021390794,0.00013898464,0.0020584154],"category_scores_gemma":[0.00007324702,0.00008697674,0.00022135749,0.00011804182,0.00014515372,0.00011514992,0.00015653274,0.0005208684,0.0005229525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025971554,0.00009538506,0.00078504015,0.00008100144,0.0000116277715,0.0002680357,0.000022583972,0.00031333324,0.9845479,0.0004093829,0.00027936688,0.012926624],"study_design_scores_gemma":[0.00013355071,0.0022892065,0.012406281,0.000021184987,0.00008782734,0.0032918032,0.00008017984,0.0019034786,0.9577448,0.00018497754,0.02184746,0.000009184115],"about_ca_topic_score_codex":0.0011341193,"about_ca_topic_score_gemma":0.0030897814,"teacher_disagreement_score":0.0020584154,"about_ca_system_score_codex":0.00028415926,"about_ca_system_score_gemma":0.00034434447,"threshold_uncertainty_score":0.006886065},"labels":[],"label_agreement":null},{"id":"W2618663579","doi":"10.1093/neuonc/nox168.785","title":"PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Exome sequencing; Cancer research; Genetics; Biology; DNA mismatch repair; Exome; Cancer; Brain tumor; Medicine; Gene; DNA repair; Pathology; Antibody","score_opus":0.011989964628118854,"score_gpt":0.2901294253353224,"score_spread":0.2781394607072035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618663579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933687,0.002041543,0.021646539,0.00032189745,0.000040004852,0.0002477179,0.032614928,0.0021689115,0.007231595],"genre_scores_gemma":[0.91905665,0.0008381342,0.0424499,0.00016028888,0.000019484825,0.0004175697,0.032598436,0.00030032362,0.004159073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997955,0.000026106227,0.000012155526,0.00007588588,0.00006708462,0.000023265664],"domain_scores_gemma":[0.9997737,0.00005366212,0.00007292468,0.00003119451,0.000030839965,0.00003762073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033330327,0.00034850623,0.0004497403,0.0007495829,0.00026362386,0.0004616701,0.00025589246,0.00032993057,0.003018209],"category_scores_gemma":[0.0006977667,0.00026127277,0.00029445783,0.00063751015,0.00015807406,0.00016983435,0.0004670497,0.0003728093,0.00096478144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013813672,0.00009252201,0.3715449,0.00045993016,0.00027478434,0.0011656298,0.00022436144,0.0062524527,0.42231482,0.0011438079,0.010837003,0.18430847],"study_design_scores_gemma":[0.00014773787,0.0008376017,0.6968017,0.000064826214,0.00020127579,0.0058861533,0.000088961024,0.03261129,0.2075082,0.0016275074,0.05417931,0.00004540691],"about_ca_topic_score_codex":0.0009160413,"about_ca_topic_score_gemma":0.0027333458,"teacher_disagreement_score":0.003018209,"about_ca_system_score_codex":0.0004932964,"about_ca_system_score_gemma":0.00033997252,"threshold_uncertainty_score":0.010096908},"labels":[],"label_agreement":null},{"id":"W2618842028","doi":"10.1093/neuonc/nox083.180","title":"MEDU-30. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Biology; Stem cell; Population; Downregulation and upregulation; Cancer research; Gene; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.024109840207844062,"score_gpt":0.2892152730980958,"score_spread":0.26510543289025174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618842028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954489,0.00092099124,0.0007846708,0.00006211295,0.000011494519,0.00002800315,0.0011224609,0.000070004906,0.0015514008],"genre_scores_gemma":[0.9946843,0.00036962374,0.00071968697,0.00007048928,0.0000061040023,0.000054934866,0.0014147804,0.0000228481,0.002657275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999043,0.000010261725,0.000006477225,0.000018675491,0.000030237094,0.000030069843],"domain_scores_gemma":[0.9999193,0.000010303065,0.000024532268,0.000008567354,0.000010836989,0.000026469836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011022612,0.00015949119,0.00024389492,0.00033088378,0.00018944048,0.0003343197,0.00009502357,0.00021999574,0.0019342869],"category_scores_gemma":[0.00011533058,0.000058090274,0.0001939134,0.00020014757,0.00016957382,0.000116577794,0.00017863867,0.00031801107,0.00047392322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022030558,0.000030243367,0.0037351807,0.000032643322,0.000006819449,0.00013334306,0.00008473424,0.00004928393,0.9905494,0.00013669279,0.00011766249,0.0049037007],"study_design_scores_gemma":[0.000028625673,0.00149019,0.22101921,0.000025703901,0.00007208569,0.0018364827,0.00040221814,0.0013493381,0.7579363,0.00030022772,0.015530039,0.0000095190635],"about_ca_topic_score_codex":0.0006383519,"about_ca_topic_score_gemma":0.0010548458,"teacher_disagreement_score":0.0019342869,"about_ca_system_score_codex":0.0002773532,"about_ca_system_score_gemma":0.00018442479,"threshold_uncertainty_score":0.006470859},"labels":[],"label_agreement":null},{"id":"W2618858474","doi":"10.1093/neuonc/nox083.059","title":"EPND-01. THE ACTIVE REGULATORY LANDSCAPE OF EPENDYMAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Chromatin; Enhancer; Computational biology; Ependymoma; Lineage (genetic); Epigenomics; Transcription factor; Targeted therapy; Cancer research; DNA methylation; Gene; Genetics; Cancer; Gene expression; Medicine; Pathology","score_opus":0.012587204519635216,"score_gpt":0.27356881161493335,"score_spread":0.2609816070952981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618858474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7654569,0.008216743,0.039708555,0.0025080487,0.0010045919,0.0006483863,0.09699054,0.003874942,0.08159135],"genre_scores_gemma":[0.776405,0.003755032,0.024148883,0.0013705784,0.00010040892,0.00071079587,0.13520527,0.0007890011,0.05751494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974066,0.000018284649,0.00001431582,0.000084375795,0.00010398661,0.000038295813],"domain_scores_gemma":[0.999754,0.000059314512,0.000032178054,0.00004439758,0.00004221279,0.00006789789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042318023,0.00035173807,0.00028957773,0.00041913416,0.00053160614,0.0009545584,0.000609879,0.0005739029,0.008290869],"category_scores_gemma":[0.0006098656,0.00027341364,0.0003168058,0.00041745126,0.00036086587,0.0003494101,0.0007932479,0.001242454,0.0026538281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036130422,0.0004722224,0.057323173,0.0016126988,0.00021028935,0.0033864875,0.00036445374,0.0042045075,0.6644335,0.009296855,0.04742005,0.20766273],"study_design_scores_gemma":[0.00039887644,0.00078711053,0.11551583,0.00017335599,0.00023403787,0.007955496,0.00022198021,0.0065262318,0.42638034,0.0044655767,0.4372806,0.00006066941],"about_ca_topic_score_codex":0.0016222579,"about_ca_topic_score_gemma":0.0025270202,"teacher_disagreement_score":0.008290869,"about_ca_system_score_codex":0.0007259083,"about_ca_system_score_gemma":0.0008493771,"threshold_uncertainty_score":0.02773565},"labels":[],"label_agreement":null},{"id":"W2618957446","doi":"10.1093/neuonc/nox058","title":"Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer’s disease","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pericyte; Glioma; Neuroscience; Disease; Biology; Cell type; Blood–brain barrier; Inflammation; Central nervous system; Pathology; Cell; Medicine; Endothelial stem cell; Cancer research; Immunology; In vitro","score_opus":0.10066816102987128,"score_gpt":0.35593048738543376,"score_spread":0.25526232635556245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618957446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013940928,0.9991518,0.000036538437,0.00034442256,0.00009365291,6.922102e-7,0.00000555292,0.000002025851,0.00022582228],"genre_scores_gemma":[0.00083669246,0.9987943,0.000049661747,0.00009546078,0.00010858808,0.0000013168512,0.000007896542,4.4370148e-7,0.00010564812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998833,0.000020145819,0.00002348753,0.000020757621,0.000036523154,0.000015793767],"domain_scores_gemma":[0.9996729,0.00014995047,0.000046045916,0.000008975766,0.00009038666,0.000031831747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049607875,0.000522812,0.0009808377,0.0014055074,0.00024895917,0.0010107042,0.0005386126,0.0010368441,0.0013004576],"category_scores_gemma":[0.000741802,0.00016984795,0.00040257443,0.0014740841,0.0005491454,0.0017068719,0.0005310939,0.0013224266,0.0005557323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000925501,0.000034129953,0.00045181884,0.01927606,0.000090988986,0.00035661546,0.0001410911,0.00025617538,0.0021515312,0.004705865,0.016891139,0.95555204],"study_design_scores_gemma":[0.000020576164,0.00015614212,0.003979225,0.0073974025,0.00022996584,0.0042253165,0.0002677994,0.00016371516,0.00094459235,0.0058145467,0.97676325,0.000037502246],"about_ca_topic_score_codex":0.0012784048,"about_ca_topic_score_gemma":0.0019478848,"teacher_disagreement_score":0.0014055074,"about_ca_system_score_codex":0.000486673,"about_ca_system_score_gemma":0.0012579311,"threshold_uncertainty_score":0.004350424},"labels":[],"label_agreement":null},{"id":"W2619000912","doi":"10.1093/neuonc/nox083.184","title":"MEDU-34. INTELLECTUAL OUTCOME IN CHILDREN WITH SENSORINEURAL HEARING LOSS FOLLOWING TREATMENT FOR EMBRYONAL BRAIN TUMORS.","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Sensorineural hearing loss; Hearing loss; Neurocognitive; Audiology; Intellectual disability; Unilateral hearing loss; Pediatrics; Cognition; Psychiatry","score_opus":0.052435687920220055,"score_gpt":0.350994090986927,"score_spread":0.29855840306670695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619000912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816626,0.00093237916,0.000034931887,0.00003195714,0.000004656266,0.000011063004,0.00048044798,0.00000310729,0.0003353207],"genre_scores_gemma":[0.9993443,0.00025056294,0.0000384328,0.000012091688,0.000004181088,0.000008618306,0.0002997442,0.000001061441,0.00004097836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996195,0.000076594806,0.00005384833,0.000063024585,0.0001235154,0.00006339024],"domain_scores_gemma":[0.99803466,0.0003507628,0.0013044231,0.00003673998,0.00010726929,0.00016608331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005151093,0.00016336156,0.00023048936,0.00077902974,0.00032379653,0.0003744237,0.0002676277,0.00017038827,0.0009302566],"category_scores_gemma":[0.0023636713,0.00009723865,0.0003667068,0.00089535664,0.00031952906,0.0002508766,0.0003526201,0.0002930829,0.000114426846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006222471,0.000008685284,0.99730456,0.000025666051,0.000021273725,0.00034053234,0.000051835526,0.000022493543,0.0000889822,0.0000051823886,0.00005531831,0.0020132994],"study_design_scores_gemma":[0.0000038187377,0.00008700048,0.9979766,0.000010293418,0.000015257422,0.0015917943,0.000071652124,0.000026993139,0.000096813754,0.0000048192223,0.000113735674,0.0000012788265],"about_ca_topic_score_codex":0.0047977935,"about_ca_topic_score_gemma":0.0065537905,"teacher_disagreement_score":0.0047977935,"about_ca_system_score_codex":0.00060374447,"about_ca_system_score_gemma":0.0004985128,"threshold_uncertainty_score":0.009539723},"labels":[],"label_agreement":null},{"id":"W2619229835","doi":"10.1093/neuonc/nox083.044","title":"DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Biopsy; Medicine; Cohort; KRAS; Glioma; Pathology; Autopsy; Oncology; Biology; Internal medicine; Mutation; Cancer research; Gene; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.017598438854617576,"score_gpt":0.295787125691173,"score_spread":0.2781886868365554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619229835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968323,0.00015078667,0.00009561223,0.00003656527,0.000002414017,0.000022119895,0.0024084672,0.0000060800535,0.00044570825],"genre_scores_gemma":[0.9953955,0.000077542754,0.00011871584,0.000031155625,0.000004416435,0.000023306462,0.0041603395,0.00000840685,0.00018072611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996594,0.000049002716,0.00001908966,0.00015468826,0.000071787945,0.00004610963],"domain_scores_gemma":[0.9996137,0.000049075632,0.00008053098,0.00007902075,0.00004016594,0.00013754258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005004327,0.00018978507,0.000392725,0.0003437816,0.0003115652,0.0004883352,0.00027194063,0.00023687996,0.0015455862],"category_scores_gemma":[0.0008978962,0.0001529237,0.0002732685,0.0005026723,0.0002909775,0.00025973038,0.0006707761,0.000307795,0.0003092274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012992148,0.00003802569,0.988698,0.000023058446,0.00013430614,0.00060161913,0.00011868086,0.0003072118,0.002742572,0.00011657509,0.00087764184,0.0050431765],"study_design_scores_gemma":[0.00006719486,0.00042213485,0.9952964,0.000005712728,0.00005972828,0.0016182931,0.00014078007,0.0003067056,0.0002573927,0.000058655987,0.0017615098,0.000005441572],"about_ca_topic_score_codex":0.003301167,"about_ca_topic_score_gemma":0.0043921657,"teacher_disagreement_score":0.003301167,"about_ca_system_score_codex":0.0003153422,"about_ca_system_score_gemma":0.00032941953,"threshold_uncertainty_score":0.006563902},"labels":[],"label_agreement":null},{"id":"W2619372708","doi":"10.1093/neuonc/nox083.150","title":"LGG-17. IMPACT OF STROKE AND STROKE RECURRENCE ON LATE MORTALITY AS WELL AS PSYCHOLOGICAL AND SOCIOECONOMIC OUTCOMES IN CHILDHOOD CANCER SURVIVORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Socioeconomic status; Cohort; Odds ratio; Neurocognitive; Pediatrics; Physical therapy; Population; Internal medicine; Psychiatry; Cognition","score_opus":0.03316292017084609,"score_gpt":0.3892392467509061,"score_spread":0.35607632658006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619372708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896797,0.0027042197,0.00009717172,0.0006262923,0.00004116598,0.0000146688335,0.004300889,0.000023483824,0.0025125397],"genre_scores_gemma":[0.9951981,0.00084145466,0.00016210848,0.000119563905,0.000024575575,0.0000219566,0.002762561,0.0000150540545,0.00085473416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995641,0.000155943,0.000027813168,0.00006206445,0.00008396551,0.00010605837],"domain_scores_gemma":[0.99813724,0.00029362013,0.0009904258,0.00007393287,0.00013956941,0.00036520258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063927734,0.00030316063,0.00029900938,0.00063992804,0.00026950665,0.00071903464,0.0003345939,0.00035515323,0.003838472],"category_scores_gemma":[0.0027753054,0.00013824168,0.00077574427,0.0014588708,0.00026144943,0.00023921656,0.00058401056,0.0005762524,0.00047786295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002687656,0.000019405068,0.9934729,0.000041309413,0.0001722306,0.00008350932,0.00003725068,0.00009383262,0.000077692486,0.00003734547,0.00062916696,0.005066445],"study_design_scores_gemma":[0.000011367825,0.000086107524,0.9986935,0.000029939461,0.00012169737,0.00015870195,0.000074624964,0.00010230068,0.000060636292,0.000051014104,0.00060779846,0.0000022885642],"about_ca_topic_score_codex":0.01869522,"about_ca_topic_score_gemma":0.0203429,"teacher_disagreement_score":0.01869522,"about_ca_system_score_codex":0.0006016398,"about_ca_system_score_gemma":0.0010494781,"threshold_uncertainty_score":0.037172854},"labels":[],"label_agreement":null},{"id":"W2619609401","doi":"10.1093/neuonc/nox083.116","title":"IMMU-05. MOLECULAR ANALYSES DEMONSTRATE AN IMMUNOSUPPRESSIVE PHENOTYPE IN THE CYST AND SOLID TUMOR COMPARTMENTS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Pathology; Immunohistochemistry; Craniopharyngioma; Cyst; CD163; CD8; Biology; Flow cytometry; Cancer research; Phenotype; Immunology; Medicine; Immune system; Gene; Endocrinology","score_opus":0.043213804506924115,"score_gpt":0.3732326288584201,"score_spread":0.330018824351496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619609401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043185,0.001659714,0.0023557413,0.00010740141,0.000029182744,0.00004589339,0.0027084374,0.00017411202,0.0024877542],"genre_scores_gemma":[0.978128,0.0010969896,0.009156505,0.0001624388,0.0000352658,0.00013124057,0.009377642,0.00004295543,0.0018690217],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999673,0.000021147609,0.000029775932,0.00007941452,0.0001141243,0.000082432314],"domain_scores_gemma":[0.9997969,0.000031326894,0.00007453221,0.000024477251,0.000023940696,0.000048809594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027367417,0.00037278462,0.00025075895,0.00082997273,0.00034787902,0.0006358284,0.00028380245,0.00034996666,0.0023152737],"category_scores_gemma":[0.0002735946,0.00013297738,0.0002660311,0.0005510471,0.00030519467,0.00019765919,0.0002848917,0.0004612909,0.001052524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005980548,0.00010531718,0.01930726,0.00016479948,0.000039796676,0.0008919973,0.0001140425,0.00014607223,0.9697715,0.00024788905,0.00030578935,0.008307502],"study_design_scores_gemma":[0.000046033052,0.0008629399,0.16497582,0.000051116065,0.00012200004,0.008293867,0.00030632093,0.002496878,0.8029809,0.0005141719,0.019335186,0.000014697858],"about_ca_topic_score_codex":0.00037963275,"about_ca_topic_score_gemma":0.0006257163,"teacher_disagreement_score":0.0023152737,"about_ca_system_score_codex":0.00038996706,"about_ca_system_score_gemma":0.0002756628,"threshold_uncertainty_score":0.007745385},"labels":[],"label_agreement":null},{"id":"W2619698836","doi":"10.1093/neuonc/nox083.066","title":"EPND-08. EPIGENETIC H3K27ME3 DEREGULATION IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Epigenetics; Biology; DNA methylation; CDKN2A; Genetics; Cancer research; Pathology; Bioinformatics; Cancer; Medicine; Gene; Gene expression","score_opus":0.030541969771129402,"score_gpt":0.32184959386543527,"score_spread":0.2913076240943059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619698836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919897,0.0008813468,0.0015411847,0.00008988909,0.000021581696,0.000019335672,0.0023063063,0.00007998043,0.0030706013],"genre_scores_gemma":[0.9927805,0.00046066384,0.0011642231,0.00005005089,0.000008625075,0.000021825883,0.003321442,0.000026298434,0.002166373],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998734,0.0000079828405,0.000011162473,0.000041165236,0.0000452216,0.000021045065],"domain_scores_gemma":[0.99977607,0.000041186042,0.00007483877,0.000022801996,0.00004066706,0.000044478234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016469913,0.00025585684,0.00028225625,0.00039513665,0.00027677204,0.00031394552,0.00026008152,0.00024866904,0.0024397378],"category_scores_gemma":[0.00060525717,0.00011962402,0.0002265175,0.0005481278,0.00025532197,0.0001462181,0.00029489104,0.0003601551,0.00041643178],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021854702,0.00015991191,0.5620932,0.0003881404,0.00019724578,0.013807987,0.0003114146,0.0013725208,0.34120694,0.0007805509,0.0029249857,0.074571654],"study_design_scores_gemma":[0.000045644294,0.00018237375,0.90798175,0.000021031958,0.00007545255,0.014771507,0.000097318974,0.00066197984,0.0661637,0.00025330883,0.009734734,0.000011232104],"about_ca_topic_score_codex":0.0018149078,"about_ca_topic_score_gemma":0.0021994412,"teacher_disagreement_score":0.0024397378,"about_ca_system_score_codex":0.00044918526,"about_ca_system_score_gemma":0.00033146312,"threshold_uncertainty_score":0.008161724},"labels":[],"label_agreement":null},{"id":"W2619763457","doi":"10.1093/neuonc/nox083.191","title":"MEDU-41. MANAGEMENT OF MEDULLOBLASTOMA PATIENTS IN PRAGUE PEDIATRIC HEMATOLOGY AND ONCOLOGY CENTER","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Internal medicine; Hematology; Radiation therapy; Incidence (geometry); Chemotherapy; Demographics; Single Center; Oncology; Pediatrics; Pathology","score_opus":0.021463238729196456,"score_gpt":0.30004425347937996,"score_spread":0.2785810147501835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619763457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970651,0.0016249892,0.00011322765,0.00009621399,0.000005892309,0.000016181206,0.00025674637,0.000007672951,0.00081383076],"genre_scores_gemma":[0.9987005,0.0005579336,0.00013673975,0.000029900466,0.000007724887,0.000013955331,0.00040247125,0.0000025594486,0.00014821843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978596,0.000030816296,0.000028905037,0.000047692945,0.00004909462,0.000057449724],"domain_scores_gemma":[0.9996321,0.00003293501,0.00021895878,0.000011524333,0.000022371396,0.000082150116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020231011,0.00011587116,0.00020537747,0.0005412238,0.00030383278,0.00035675478,0.00027034097,0.00017189085,0.0007201305],"category_scores_gemma":[0.0005953889,0.00009719897,0.00019204759,0.00045834237,0.00022177429,0.00022103061,0.0004081248,0.00027187142,0.00014550015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011689584,0.00003901914,0.98623174,0.000054386295,0.000022548673,0.0013986457,0.00017639721,0.0001703688,0.0013917349,0.00005288587,0.0002915352,0.010053783],"study_design_scores_gemma":[0.000013746939,0.00025143236,0.99034065,0.000034997403,0.000019562429,0.00693219,0.00025177427,0.0001998449,0.0005325232,0.00004386051,0.0013749377,0.0000044557946],"about_ca_topic_score_codex":0.002530163,"about_ca_topic_score_gemma":0.005530164,"teacher_disagreement_score":0.002530163,"about_ca_system_score_codex":0.00075226993,"about_ca_system_score_gemma":0.00076725363,"threshold_uncertainty_score":0.0054581165},"labels":[],"label_agreement":null},{"id":"W2620303175","doi":"10.1093/neuonc/nox083.149","title":"LGG-16. LOCATION AND HISTOLOGY DICTATE THE LIKELIHOOD OF MOLECULAR EVENTS IN PEDIATRIC LOW-GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pilocytic astrocytoma; Medicine; Glioma; Cohort; Astrocytoma; Ganglioglioma; Oncology; Pathology; Histology; Internal medicine; Ependymoma; Incidence (geometry); Cancer research","score_opus":0.014194853004454989,"score_gpt":0.2907672175529607,"score_spread":0.2765723645485057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620303175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954535,0.0008730086,0.00079655746,0.00006416357,0.000006524865,0.000018800369,0.0011715527,0.00004907146,0.0015668954],"genre_scores_gemma":[0.997101,0.00029757316,0.00081450527,0.000028291899,0.0000065468557,0.000019936806,0.0012857293,0.000036114252,0.0004103538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994301,0.00009441049,0.00006714271,0.00014460828,0.00014727926,0.000116420626],"domain_scores_gemma":[0.99847716,0.00026430286,0.00084151427,0.00008039593,0.00014611678,0.0001904018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380028,0.0002887826,0.0002792104,0.0011503904,0.0002448313,0.0008190898,0.00031468057,0.00043156857,0.003387416],"category_scores_gemma":[0.0024252809,0.00020047877,0.0002957997,0.0011260251,0.00038273312,0.0004987961,0.00040691276,0.00041412364,0.0011810182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019272446,0.000008012966,0.98707414,0.000032723237,0.000020047199,0.000545676,0.00007361022,0.00022857283,0.0043601845,0.00006474482,0.00023165169,0.0071678837],"study_design_scores_gemma":[0.0000058817836,0.00007783189,0.98835844,0.000027001508,0.000042674033,0.0045935516,0.00024391586,0.000555317,0.0035825183,0.00030849443,0.0021977734,0.0000067079773],"about_ca_topic_score_codex":0.0016376231,"about_ca_topic_score_gemma":0.003023978,"teacher_disagreement_score":0.003387416,"about_ca_system_score_codex":0.00048327772,"about_ca_system_score_gemma":0.00032197052,"threshold_uncertainty_score":0.011332035},"labels":[],"label_agreement":null},{"id":"W2620330600","doi":"10.1093/neuonc/nox083.009","title":"ATRT-10. EARLY POST RADIATION CHANGES AND EFFICACY IN CHILDREN WITH ATRT TREATED ON COG ACNS 0333: A COMPARISON OF PROTON VS PHOTON THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Radiation therapy; Prospective cohort study; Proton therapy; Nuclear medicine; Cog; Radiology; Internal medicine","score_opus":0.02660505966296628,"score_gpt":0.33486905830473795,"score_spread":0.3082639986417717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620330600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991466,0.0003860443,0.000053625903,0.000016569034,0.0000031317068,0.000020456593,0.00013362942,0.0000055542473,0.00023439368],"genre_scores_gemma":[0.9991316,0.0001480871,0.00018981587,0.000021148799,0.000008658804,0.000033002012,0.0003622711,0.0000053111335,0.00010003881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996513,0.00014700422,0.0000287877,0.000056273137,0.0000657887,0.00005081663],"domain_scores_gemma":[0.99895203,0.00031489957,0.0004543432,0.000044416236,0.000046860892,0.00018743373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091500895,0.0002542633,0.0004916244,0.00033292468,0.00014564535,0.00026757718,0.00033297643,0.00031836628,0.0013747364],"category_scores_gemma":[0.0009985998,0.00013048941,0.000566833,0.00037305214,0.00034755448,0.00025402824,0.00017847233,0.00048923347,0.00022623884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08064559,0.0035533563,0.83358246,0.0004149331,0.0007188331,0.00081323675,0.00035499266,0.0026446548,0.0122890975,0.000120007906,0.00092626567,0.063936554],"study_design_scores_gemma":[0.0038211772,0.106165,0.8787142,0.00006650071,0.0005409051,0.0026950713,0.00019828923,0.0013976747,0.0048613357,0.00005501705,0.001463604,0.000021272304],"about_ca_topic_score_codex":0.0022164034,"about_ca_topic_score_gemma":0.0031712037,"teacher_disagreement_score":0.0022164034,"about_ca_system_score_codex":0.00079401163,"about_ca_system_score_gemma":0.0005066072,"threshold_uncertainty_score":0.0057609677},"labels":[],"label_agreement":null},{"id":"W2620791330","doi":"10.1093/neuonc/nox106","title":"miR miR on the wall, who’s the most malignant medulloblastoma miR of them all?","year":2017,"lang":"de","type":"review","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medulloblastoma; microRNA; Biology; Cancer; Disease; Cancer research; Computational biology; Neuroscience; Bioinformatics; Gene; Genetics; Medicine; Pathology","score_opus":0.054968647001393776,"score_gpt":0.3264144711151832,"score_spread":0.2714458241137894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620791330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004620855,0.98874366,0.00037442835,0.0047198418,0.0015742469,0.0000063597954,0.00004227511,0.00002785668,0.0040492155],"genre_scores_gemma":[0.0036331979,0.9895583,0.00046165037,0.0024668886,0.00082776806,0.00000766331,0.00007011599,0.000010636611,0.0029638666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981815,0.000038572816,0.000028475522,0.000029800425,0.000067047506,0.000017929919],"domain_scores_gemma":[0.99986243,0.000049316874,0.000023298086,0.0000044171265,0.000041589414,0.000018925643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032339548,0.0003696432,0.0006073056,0.00084680616,0.00034169192,0.0009764824,0.00037521854,0.0007965565,0.002170812],"category_scores_gemma":[0.00089994754,0.0001360502,0.00027059755,0.0006450302,0.0006042658,0.0012830982,0.0005000989,0.0016184673,0.0020923214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008454049,0.000020567331,0.00072387385,0.0053656264,0.000072543255,0.00059476873,0.00022054136,0.00012726735,0.0033765584,0.008221079,0.09867653,0.882516],"study_design_scores_gemma":[0.0000056449376,0.00002393626,0.0007048868,0.0012887457,0.000030184716,0.0023618871,0.00011453435,0.000029003952,0.0006685051,0.0021480834,0.9926152,0.000009358105],"about_ca_topic_score_codex":0.0012374276,"about_ca_topic_score_gemma":0.0023399198,"teacher_disagreement_score":0.002170812,"about_ca_system_score_codex":0.0007374384,"about_ca_system_score_gemma":0.0008966185,"threshold_uncertainty_score":0.007262051},"labels":[],"label_agreement":null},{"id":"W2622523903","doi":"10.1093/neuonc/nox109","title":"Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Smoothened; Medulloblastoma; Internal medicine; Pharmacokinetics; Oncology; Adverse effect; Hedgehog; Pathology","score_opus":0.013360371952660523,"score_gpt":0.3147277899684112,"score_spread":0.3013674180157507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622523903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963205,0.0007964715,0.00046008924,0.00014116394,0.000015579943,0.0010727338,0.0006282108,0.000038827566,0.0005265613],"genre_scores_gemma":[0.9883986,0.001419419,0.0034116465,0.00043068826,0.000055230183,0.002558402,0.0025338859,0.000028319979,0.0011638163],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996897,0.00013628996,0.000022743388,0.000055758283,0.00004513028,0.00005030831],"domain_scores_gemma":[0.9994307,0.000071843075,0.00013435115,0.00004241641,0.00004972999,0.0002709714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097015256,0.0008432089,0.0011350866,0.00022779404,0.00021011557,0.00037060984,0.00040067756,0.00047592053,0.0018418974],"category_scores_gemma":[0.00061025925,0.00030888562,0.00068770663,0.00023129772,0.0004968122,0.00030215533,0.00024529744,0.0014264283,0.00036932284],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48536125,0.06280623,0.07844178,0.0011000743,0.0021872018,0.0012788252,0.00072671723,0.005231867,0.14247599,0.00061050983,0.00674661,0.213033],"study_design_scores_gemma":[0.24894768,0.625164,0.08782035,0.000078047015,0.000827806,0.0023566252,0.00016182949,0.0032216264,0.022335865,0.00027572343,0.008771733,0.000038795508],"about_ca_topic_score_codex":0.0011633758,"about_ca_topic_score_gemma":0.0031258513,"teacher_disagreement_score":0.0018418974,"about_ca_system_score_codex":0.00084313424,"about_ca_system_score_gemma":0.0018838376,"threshold_uncertainty_score":0.0061617494},"labels":[],"label_agreement":null},{"id":"W2626604659","doi":"10.1093/neuonc/nox112","title":"PET imaging in patients with meningioma—report of the RANO/PET Group","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Radiosurgery; Meningioma; Neuroimaging; Radiology; Radiation therapy; Magnetic resonance imaging; Positron emission tomography; Functional imaging; Medical imaging; Brain tumor; Pet imaging; Modalities; Nuclear medicine; Medical physics; Pathology","score_opus":0.045132691653021785,"score_gpt":0.34367790068421616,"score_spread":0.29854520903119436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626604659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015387391,0.99665487,0.00011787378,0.00026837713,0.00008211685,0.000004532041,0.000035012905,0.0000054279,0.0012929622],"genre_scores_gemma":[0.014685981,0.98399526,0.00027314984,0.00033165052,0.00020729056,0.000008453378,0.00009755688,0.0000033984284,0.00039728172],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997811,0.000043971755,0.000048922895,0.000047142694,0.00005870977,0.000020255451],"domain_scores_gemma":[0.9996295,0.00016546097,0.000082787345,0.000014509891,0.00008767249,0.000020008245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005535737,0.00045611325,0.0008271284,0.0020979573,0.00017880107,0.00069959013,0.0004936189,0.000679206,0.0009953547],"category_scores_gemma":[0.0012324625,0.00019460631,0.00062243664,0.0018084256,0.00032459552,0.00072277023,0.00032593045,0.0008823301,0.0005137831],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023425829,0.00006788241,0.0145824095,0.017049195,0.0005709279,0.008766254,0.00023539529,0.00038785295,0.0025237377,0.0015270871,0.023540461,0.9305144],"study_design_scores_gemma":[0.00007288792,0.00020777364,0.042917304,0.020662002,0.0022581972,0.16834211,0.0005121143,0.0004163607,0.0034587125,0.0016645853,0.7593811,0.00010681683],"about_ca_topic_score_codex":0.002098942,"about_ca_topic_score_gemma":0.0027459413,"teacher_disagreement_score":0.002098942,"about_ca_system_score_codex":0.00041291697,"about_ca_system_score_gemma":0.0006425223,"threshold_uncertainty_score":0.004173398},"labels":[],"label_agreement":null},{"id":"W2738871481","doi":"10.1093/neuonc/nox135","title":"Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Neurocognitive; Neuropsychology; Working memory; Medicine; Psychology; Pediatrics; Cognition; Psychiatry","score_opus":0.04034337721608699,"score_gpt":0.38593050187779904,"score_spread":0.34558712466171204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738871481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999708,0.000053888027,0.000014967163,0.000012698518,0.0000013853912,0.000006043383,0.00012340034,0.0000011582167,0.000078474695],"genre_scores_gemma":[0.9995901,0.00005755016,0.000033450695,0.0000093955405,0.0000028505524,0.000009249223,0.0002560957,0.0000010414569,0.000040222647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994929,0.00010865616,0.000055613327,0.00009044013,0.00012791682,0.000124452],"domain_scores_gemma":[0.99834526,0.00016413357,0.0009307925,0.00007418773,0.00014206501,0.00034356836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005302876,0.00037203653,0.0004056546,0.00096445705,0.00091546896,0.0007206612,0.00043318325,0.00039780082,0.0009508627],"category_scores_gemma":[0.0017440079,0.0003410781,0.00051030243,0.0010631705,0.00047779144,0.00073624327,0.0008438593,0.000803575,0.00015028856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028050164,0.000022857857,0.9994412,0.0000019019398,0.000013526337,0.00011043334,0.00007830695,0.000010547762,0.00006029473,0.000002691931,0.000018035142,0.00021218664],"study_design_scores_gemma":[0.0000039208444,0.00010335523,0.9989668,0.0000028651334,0.000010070469,0.00050578424,0.00029131465,0.000026409414,0.000030956428,0.0000031950685,0.0000531948,0.000002214295],"about_ca_topic_score_codex":0.011304546,"about_ca_topic_score_gemma":0.012784818,"teacher_disagreement_score":0.011304546,"about_ca_system_score_codex":0.00069773116,"about_ca_system_score_gemma":0.00066770986,"threshold_uncertainty_score":0.022477508},"labels":[],"label_agreement":null},{"id":"W2739747835","doi":"10.1093/neuonc/nox142","title":"Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Temozolomide; Extracellular vesicles; Glioblastoma; Cancer research; Microvesicles; Stem cell; Extracellular; Vesicle; Resistance (ecology); Radiation tolerance; Chemistry; Biology; Cell biology; Medicine; Radiation therapy; Internal medicine; Gene; Biochemistry; microRNA; Ecology","score_opus":0.015601166019688023,"score_gpt":0.2664914305790017,"score_spread":0.2508902645593137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739747835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986093,0.00028092926,0.0006938368,0.0000105446525,0.0000021841997,0.0000073280407,0.0001656503,0.000010716439,0.00021954165],"genre_scores_gemma":[0.9987338,0.00016011292,0.0004566966,0.000007923643,0.0000010410938,0.000009739743,0.00029529957,0.0000046608866,0.00033076116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994636,0.0000061581604,0.0000064656106,0.00001178905,0.000017757884,0.000011492325],"domain_scores_gemma":[0.99992836,0.000009175781,0.000025241043,0.0000076889555,0.000015591006,0.00001393342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008082593,0.00012879091,0.00014079391,0.00017800073,0.000080610946,0.00028775143,0.00006280338,0.000119811004,0.00032034866],"category_scores_gemma":[0.0000912744,0.000063022904,0.00015872669,0.00011451427,0.00012556552,0.00013468754,0.0001886785,0.00018017311,0.000096711185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009411159,0.0000057518864,0.0020201153,0.000016291922,0.000005583198,0.00004321351,0.000035691035,0.00007313756,0.9967981,0.00007563132,0.0000096881595,0.00082280074],"study_design_scores_gemma":[0.000006866359,0.00037061956,0.0677254,0.0000062189947,0.000029328989,0.00051060546,0.00014234477,0.0010727766,0.9285655,0.0000888948,0.0014740723,0.000007340615],"about_ca_topic_score_codex":0.00030115107,"about_ca_topic_score_gemma":0.00035654465,"teacher_disagreement_score":0.00032034866,"about_ca_system_score_codex":0.00016318189,"about_ca_system_score_gemma":0.000098365526,"threshold_uncertainty_score":0.0011839867},"labels":[],"label_agreement":null},{"id":"W2740873526","doi":"10.1093/neuonc/nox141","title":"Pediatric low-grade gliomas: next biologically driven steps","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Pediatric Low Grade Astrocytoma Foundation; Neurofibromatosis","keywords":"Medicine; Clinical trial; Pediatric oncology; Targeted therapy; Glioma; Oncology; Pace; Intensive care medicine; Internal medicine; Cancer; Cancer research","score_opus":0.13351496864950968,"score_gpt":0.3985664536496137,"score_spread":0.265051485000104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740873526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010641782,0.99459654,0.00019818655,0.0032875612,0.00074673945,0.0000066733705,0.000022451984,0.00001125652,0.0010242133],"genre_scores_gemma":[0.00085459463,0.99641585,0.00040168554,0.0012436341,0.00050871115,0.000009540103,0.00003818557,0.0000023280909,0.00052549597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997155,0.000072006995,0.00005444047,0.000037610796,0.00008590546,0.000034453555],"domain_scores_gemma":[0.99897623,0.00052044797,0.0000971667,0.000024397752,0.00032004414,0.00006175879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014083547,0.0006309595,0.0010304512,0.0015031305,0.0003064975,0.0013108242,0.0007757546,0.0015041321,0.0038368113],"category_scores_gemma":[0.0016465833,0.0002181813,0.0008373321,0.0014253822,0.0005110664,0.0027998697,0.00076397305,0.0031912285,0.0014249919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120979166,0.00006117277,0.00025971056,0.029229997,0.00009332112,0.00045817925,0.00017083412,0.00047042087,0.0015420292,0.011150355,0.07701053,0.87943256],"study_design_scores_gemma":[0.000013605319,0.000051656098,0.000469962,0.008981177,0.000112435875,0.0011841499,0.00014796948,0.00008540457,0.0002862787,0.004684697,0.98396784,0.000014904647],"about_ca_topic_score_codex":0.001326309,"about_ca_topic_score_gemma":0.003113365,"teacher_disagreement_score":0.0038368113,"about_ca_system_score_codex":0.0010314353,"about_ca_system_score_gemma":0.002873614,"threshold_uncertainty_score":0.012835383},"labels":[],"label_agreement":null},{"id":"W2750409203","doi":"10.1093/neuonc/nox123","title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Craniopharyngioma; Alpha interferon; Alpha (finance); Medicine; Interferon; Internal medicine; Radiology; Virology; Surgery","score_opus":0.01796820990187612,"score_gpt":0.28847173900155654,"score_spread":0.2705035290996804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750409203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92322063,0.045341555,0.000523043,0.025848288,0.0012561852,0.000043449647,0.00090801524,0.00004540046,0.0028133967],"genre_scores_gemma":[0.9835295,0.00979325,0.00051358296,0.0039827563,0.0015691092,0.000040599654,0.00036257115,0.000017667762,0.00019089683],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994167,0.00018267927,0.00008962967,0.000094647854,0.00012360275,0.00009278145],"domain_scores_gemma":[0.9973162,0.0011600228,0.0010173515,0.000064650674,0.00019319725,0.0002486296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070706295,0.0001628064,0.0004161377,0.00045867087,0.00035618828,0.0005251907,0.0002805475,0.0008344515,0.00055050326],"category_scores_gemma":[0.004789552,0.00014659,0.00026326644,0.0008366526,0.00028133448,0.0007102997,0.00021397669,0.0013836339,0.00013254481],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009917689,0.0000684468,0.9216141,0.0002943222,0.0001252673,0.014364235,0.00081801246,0.0001675557,0.0008971198,0.0003041684,0.020232627,0.040122323],"study_design_scores_gemma":[0.000181587,0.0008082892,0.84660393,0.0007451815,0.00035573493,0.11361071,0.0018941822,0.0008725533,0.0015276307,0.0008055582,0.03251694,0.00007769717],"about_ca_topic_score_codex":0.0010156619,"about_ca_topic_score_gemma":0.0010802607,"teacher_disagreement_score":0.0010156619,"about_ca_system_score_codex":0.00050129945,"about_ca_system_score_gemma":0.00044076276,"threshold_uncertainty_score":0.003739357},"labels":[],"label_agreement":null},{"id":"W2754256645","doi":"10.1093/neuonc/nox147","title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients-reply","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Alpha interferon; Alpha (finance); Medicine; Dermatology; Interferon; Immunology; Endocrinology; Surgery","score_opus":0.017173050761528016,"score_gpt":0.28578250013391865,"score_spread":0.2686094493723906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754256645","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025463763,0.002320962,0.000079775804,0.9817986,0.011136964,0.000011027413,0.00009559959,0.00001885968,0.0019917963],"genre_scores_gemma":[0.03444855,0.0040202327,0.0003539055,0.9054212,0.051360235,0.000057645662,0.00013262188,0.000031439773,0.0041741696],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9992337,0.0002598938,0.00016192734,0.000084027146,0.00012277508,0.00013769881],"domain_scores_gemma":[0.9957908,0.002472586,0.00045391332,0.00010286415,0.0005950684,0.0005847696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009981523,0.00040955868,0.0007847179,0.00046835086,0.0015677917,0.0018575833,0.0007223227,0.018465271,0.00346291],"category_scores_gemma":[0.015369188,0.00034342665,0.0006243355,0.0004918266,0.0011087254,0.0016349917,0.0008154025,0.015373756,0.001878414],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018176113,0.000051051746,0.011564217,0.00016010484,0.000055467433,0.030461328,0.00044821206,0.00030251127,0.00039659333,0.0017770013,0.93564236,0.018959422],"study_design_scores_gemma":[0.0003596724,0.0003129427,0.012608272,0.0011104362,0.00022110835,0.0830165,0.0030580026,0.0014848568,0.0013385082,0.013501944,0.8827714,0.00021646642],"about_ca_topic_score_codex":0.0031368851,"about_ca_topic_score_gemma":0.0038055063,"teacher_disagreement_score":0.018465271,"about_ca_system_score_codex":0.0025124361,"about_ca_system_score_gemma":0.002098268,"threshold_uncertainty_score":0.018229127},"labels":[],"label_agreement":null},{"id":"W2759217131","doi":"10.1093/neuonc/nox178","title":"CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre","funders":"Cancer Research Society","keywords":"Temozolomide; AP site; Gene knockdown; DNA-(apurinic or apyrimidinic site) lyase; Cancer research; Base excision repair; DNA repair; DNA damage; Molecular biology; Methyltransferase; Glioblastoma; DNA; Biology; Chemistry; Gene; Biochemistry; Methylation","score_opus":0.013458208212282243,"score_gpt":0.27580349522216363,"score_spread":0.2623452870098814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759217131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952755,0.0028008085,0.0008011212,0.00008296413,0.00002190865,0.000016227725,0.00036851768,0.00009080018,0.00054214126],"genre_scores_gemma":[0.99547184,0.0011290811,0.00090147654,0.000049343373,0.000008407365,0.000036059646,0.00082898047,0.00002006788,0.0015547965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989283,0.000012204383,0.000011271075,0.000028100976,0.000027245778,0.000028214485],"domain_scores_gemma":[0.99990416,0.0000133843205,0.000029168323,0.000011221328,0.000014038987,0.000027909637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000882461,0.00032324414,0.00034655724,0.0002157292,0.00010098105,0.00023554712,0.000119212695,0.0001951489,0.001385592],"category_scores_gemma":[0.000113413655,0.00012462294,0.00017880004,0.00015728892,0.00013698514,0.00011633615,0.0002076915,0.00041481547,0.00031703088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010090002,0.000031497355,0.00033067632,0.00004884383,0.000007278872,0.000014887793,0.000010185392,0.000035110173,0.9980159,0.0000122300125,0.00007419934,0.001318251],"study_design_scores_gemma":[0.000016609236,0.0003419211,0.019708652,0.000008222466,0.000018039442,0.00013883937,0.000028658586,0.0005955907,0.97714144,0.00001434594,0.0019841248,0.0000034938384],"about_ca_topic_score_codex":0.00060112274,"about_ca_topic_score_gemma":0.0007799002,"teacher_disagreement_score":0.001385592,"about_ca_system_score_codex":0.00022887932,"about_ca_system_score_gemma":0.00013428435,"threshold_uncertainty_score":0.0046352744},"labels":[],"label_agreement":null},{"id":"W2767204445","doi":"10.1093/neuonc/nox168.154","title":"CMET-05. HEALTH-ECONOMIC ANALYSES OF RADIOTHERAPY FOR PATIENTS WITH BRAIN METASTASES: CAN ECONOMICS GUIDE THE ESTABLISHMENT OF PATIENT CARE PATHWAYS?","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; MEDLINE; Salvage therapy; Brachytherapy; Surgery; Chemotherapy","score_opus":0.028522268532497418,"score_gpt":0.38427036659704034,"score_spread":0.35574809806454294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767204445","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040956927,0.08542458,0.006565318,0.18408196,0.02763566,0.010475572,0.3131189,0.0023549693,0.36624733],"genre_scores_gemma":[0.10961651,0.20457068,0.04843775,0.11056061,0.039477143,0.04780591,0.22286032,0.004391371,0.21227962],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9888102,0.0066858586,0.0016785652,0.00034140027,0.0020382882,0.00044566588],"domain_scores_gemma":[0.9160097,0.056568857,0.008369628,0.0014256312,0.014245258,0.0033809163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019439029,0.0011794519,0.00257478,0.0037610373,0.0005883443,0.00677625,0.0023335046,0.0053135133,0.24789862],"category_scores_gemma":[0.10644872,0.0006837411,0.0028121474,0.0062420308,0.0008602455,0.0037350138,0.0030402334,0.0032400708,0.027402708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009279761,0.00013611978,0.000783292,0.018809043,0.00026076476,0.00009376928,0.00007695507,0.0006408643,0.00006914919,0.0069321254,0.8788781,0.09239181],"study_design_scores_gemma":[0.004812517,0.000534472,0.010228349,0.05094654,0.00052321795,0.00029315875,0.00020658325,0.0034626238,0.00043838107,0.01820162,0.91025686,0.00009559407],"about_ca_topic_score_codex":0.0048045376,"about_ca_topic_score_gemma":0.004667475,"teacher_disagreement_score":0.24789862,"about_ca_system_score_codex":0.005777348,"about_ca_system_score_gemma":0.0096116355,"threshold_uncertainty_score":0.8293035},"labels":[],"label_agreement":null},{"id":"W2767214300","doi":"10.1093/neuonc/nox168.247","title":"DDIS-11. TTI-2341: A NOVEL, ORALLY BIOAVAILABLE, BRAIN-PENETRANT, COVALENT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR FOR TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) AND BRAIN METASTASES OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Erlotinib; Afatinib; Epidermal growth factor receptor; Pharmacology; Bioavailability; EGFR inhibitors; Blood–brain barrier; Cancer research; Gefitinib; Medicine; Cancer; Central nervous system; Internal medicine","score_opus":0.03715621773001542,"score_gpt":0.34614006948822057,"score_spread":0.30898385175820514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767214300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89128315,0.05334811,0.01655096,0.0013175367,0.000609018,0.00074822217,0.006659724,0.0009738626,0.028509388],"genre_scores_gemma":[0.94271064,0.02018666,0.0061067548,0.000362123,0.00007403414,0.0002018415,0.0061227907,0.00004138283,0.024193855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.000010330708,0.00000912295,0.000026050853,0.000036420563,0.000020977213],"domain_scores_gemma":[0.9999783,0.00000194735,0.000007631153,0.0000014695389,0.0000035904252,0.000007132043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010202075,0.00052062643,0.00035469496,0.00032882902,0.00018356513,0.00027213048,0.00032047604,0.00039741688,0.0016005978],"category_scores_gemma":[0.000090030735,0.0001442131,0.0002541082,0.00035307353,0.0001722014,0.00023465832,0.00020589371,0.00062647683,0.00073762785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011326427,0.0004163854,0.0009803645,0.0010346442,0.00005798807,0.0009784647,0.00007190666,0.0014358393,0.86785495,0.0014908378,0.00509945,0.11944647],"study_design_scores_gemma":[0.0005273872,0.0040253326,0.004862273,0.000035408706,0.000101943864,0.006448537,0.00002860907,0.0017103029,0.9147852,0.00025047702,0.06718571,0.000038688104],"about_ca_topic_score_codex":0.001104325,"about_ca_topic_score_gemma":0.002389752,"teacher_disagreement_score":0.0016005978,"about_ca_system_score_codex":0.00062395894,"about_ca_system_score_gemma":0.00050158193,"threshold_uncertainty_score":0.0053545237},"labels":[],"label_agreement":null},{"id":"W2767235977","doi":"10.1093/neuonc/nox168.752","title":"PDCT-08. TRAMETINIB AND DABRAFENIB FOR REFRACTORY/INOPERABLE PEDIATRIC LOW GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Dabrafenib; Trametinib; Ganglioglioma; Medicine; Pilocytic astrocytoma; Oncology; Refractory (planetary science); Glioma; Internal medicine; Progressive disease; Anaplastic astrocytoma; Astrocytoma; Chemotherapy; Cancer research; Epilepsy; Cancer; MAPK/ERK pathway; Vemurafenib; Metastatic melanoma; Kinase; Biology","score_opus":0.03633574242593025,"score_gpt":0.3325535657413391,"score_spread":0.29621782331540886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767235977","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9001014,0.043397047,0.0021160592,0.002113241,0.00027565722,0.000386913,0.0038965766,0.00048580253,0.047227245],"genre_scores_gemma":[0.97394896,0.008664909,0.002657871,0.0009056094,0.000106893305,0.00020439163,0.0043268907,0.000044619464,0.009139796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991226,0.000018339239,0.000011468788,0.000014249472,0.000019974299,0.000023653904],"domain_scores_gemma":[0.9998772,0.000015687061,0.000031473388,0.000007157444,0.000010536494,0.000057946527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014218583,0.00023290722,0.00026980927,0.00030587427,0.00017104622,0.00027065095,0.00022666507,0.00031653407,0.002968737],"category_scores_gemma":[0.00021871658,0.00006837414,0.00023306851,0.00029927233,0.00013469678,0.00018502859,0.00019502205,0.0006294738,0.0010447124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009149602,0.0009593246,0.07254918,0.0009800367,0.00024956625,0.0150953755,0.00017220029,0.0016740304,0.031027485,0.0016895307,0.037359826,0.82909375],"study_design_scores_gemma":[0.008124308,0.022562964,0.31486666,0.00063381507,0.00039978142,0.1443415,0.00017721354,0.004007038,0.04857612,0.001202531,0.45501843,0.000089670786],"about_ca_topic_score_codex":0.0010722394,"about_ca_topic_score_gemma":0.0038012986,"teacher_disagreement_score":0.002968737,"about_ca_system_score_codex":0.00041654252,"about_ca_system_score_gemma":0.00061544403,"threshold_uncertainty_score":0.0099313855},"labels":[],"label_agreement":null},{"id":"W2767242523","doi":"10.1093/neuonc/nox168.065","title":"ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Temozolomide; Lomustine; Internal medicine; Clinical endpoint; Placebo; Randomization; Adverse effect; Progression-free survival; Oncology; Phases of clinical research; Randomized controlled trial; Chemotherapy; Surgery; Cyclophosphamide; Vincristine; Pathology","score_opus":0.0750547322509103,"score_gpt":0.4181039271747186,"score_spread":0.3430491949238083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767242523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899961,0.0034838587,0.00053478184,0.00039682363,0.00015548256,0.0027520836,0.0010009862,0.0001883461,0.0014915804],"genre_scores_gemma":[0.9864244,0.0026306012,0.0017243384,0.0006499996,0.00028195532,0.0042183995,0.0016998162,0.000043758075,0.0023267749],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959713,0.00019389189,0.000022739721,0.00007014368,0.00004263495,0.000073483665],"domain_scores_gemma":[0.99948174,0.00008083371,0.0001279963,0.000036371635,0.000027419504,0.00024569582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012233969,0.0016478153,0.0018065227,0.0005880276,0.00034799497,0.00070241035,0.0010690276,0.0012482812,0.004510495],"category_scores_gemma":[0.0008365059,0.0006150154,0.0010086928,0.00041881925,0.00086069846,0.0006229422,0.00031551963,0.00231034,0.0011487532],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82481956,0.040139325,0.0030217592,0.0010910437,0.0011067137,0.00028545188,0.00016470804,0.0009934511,0.04612334,0.000324161,0.0040030126,0.07792742],"study_design_scores_gemma":[0.77923197,0.2122654,0.003741772,0.000024869147,0.00039036534,0.00018964945,0.000020330577,0.0005038154,0.002142286,0.00008032814,0.0013907606,0.00001845089],"about_ca_topic_score_codex":0.001128626,"about_ca_topic_score_gemma":0.0032828348,"teacher_disagreement_score":0.004510495,"about_ca_system_score_codex":0.00070603983,"about_ca_system_score_gemma":0.0013549105,"threshold_uncertainty_score":0.015089095},"labels":[],"label_agreement":null},{"id":"W2767269234","doi":"10.1093/neuonc/nox168.787","title":"PDTM-23. THE ACTIVE REGULATORY LANDSCAPE OF EPENDYMAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Chromatin; Computational biology; Enhancer; Ependymoma; Epigenomics; Lineage (genetic); Transcription factor; Targeted therapy; Cancer research; DNA methylation; Gene; Genetics; Cancer; Gene expression; Medicine; Pathology","score_opus":0.01228482971737915,"score_gpt":0.2726316945119013,"score_spread":0.2603468647945221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767269234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91550213,0.012084367,0.029612508,0.0008720781,0.00017718397,0.0002593651,0.019274876,0.0019130798,0.0203043],"genre_scores_gemma":[0.9554798,0.0028261815,0.010599732,0.00037207338,0.000015968,0.00023389848,0.014690954,0.00019342956,0.015587999],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998926,0.000007154183,0.00000423839,0.00004033555,0.00003627011,0.000019419045],"domain_scores_gemma":[0.9999511,0.000009514116,0.000009813581,0.000008362168,0.000007939022,0.000013293891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012184719,0.00023015622,0.00021004245,0.00026681574,0.00030091286,0.00046328537,0.00023651007,0.00026571372,0.0025306733],"category_scores_gemma":[0.00016308701,0.00018043013,0.0002121791,0.00024996788,0.0001818079,0.00015258593,0.00024391632,0.00066663115,0.0008430242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027354402,0.000044307155,0.0036036102,0.00023310354,0.000033387052,0.0002667203,0.000044080745,0.001328557,0.9533464,0.0009634826,0.0024570595,0.03740578],"study_design_scores_gemma":[0.000056619265,0.00026571087,0.028032139,0.000026460544,0.00006669942,0.0010264458,0.00005939932,0.0037907262,0.8776811,0.000955672,0.0880223,0.000016830063],"about_ca_topic_score_codex":0.0016466217,"about_ca_topic_score_gemma":0.0031042488,"teacher_disagreement_score":0.0025306733,"about_ca_system_score_codex":0.000569136,"about_ca_system_score_gemma":0.00042366076,"threshold_uncertainty_score":0.008465886},"labels":[],"label_agreement":null},{"id":"W2767282654","doi":"10.1093/neuonc/nox168.294","title":"EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Refractory (planetary science); Medulloblastoma; Retrospective cohort study; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","score_opus":0.053346709267348205,"score_gpt":0.36108596814771104,"score_spread":0.30773925888036285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767282654","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008781613,0.9805894,0.00026346772,0.00074040046,0.00044133185,0.00007771085,0.0019590203,0.00005273471,0.007094273],"genre_scores_gemma":[0.034556493,0.9587132,0.0007723694,0.0011165033,0.00051144406,0.00008618453,0.0025884337,0.000030259733,0.0016251557],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99948263,0.00009847698,0.00019940134,0.000065225395,0.00011893157,0.0000353036],"domain_scores_gemma":[0.99833906,0.000659711,0.00049352,0.0000457201,0.00034877102,0.00011312122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082904124,0.00028718053,0.0005967811,0.006711313,0.0002487034,0.0007809265,0.0005454422,0.00037587355,0.005538717],"category_scores_gemma":[0.002726428,0.00022766093,0.0005912745,0.006519151,0.00024364344,0.00086185685,0.0005293288,0.00036901628,0.0011478355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004145415,0.00008307434,0.0177272,0.056883484,0.00049278705,0.0029598665,0.00052809954,0.00019455497,0.0030055258,0.0009908404,0.06890118,0.8478188],"study_design_scores_gemma":[0.00006454439,0.00043090922,0.058486618,0.03299639,0.0013690873,0.026504483,0.0005613878,0.00007554803,0.0012708575,0.00020373978,0.8780073,0.000029049908],"about_ca_topic_score_codex":0.0024753225,"about_ca_topic_score_gemma":0.004560443,"teacher_disagreement_score":0.006711313,"about_ca_system_score_codex":0.0009288848,"about_ca_system_score_gemma":0.0021416538,"threshold_uncertainty_score":0.018528879},"labels":[],"label_agreement":null},{"id":"W2767284193","doi":"10.1093/neuonc/nox168.389","title":"GENE-15. CHARACTERIZATION OF DIFFERENTIAL 5-HYDROXYMETHYLCYTOSINE IN IDH1 MUTANT VERSUS IDH1 WILD-TYPE HIGH-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Biology; Mutant; IDH1; Epigenetics; Wild type; 5-Hydroxymethylcytosine; Gene; DNA methylation; Glioma; CpG site; Phenotype; Molecular biology; Methylation; Genetics; Gene expression; Cancer research","score_opus":0.022445154476185263,"score_gpt":0.2960721161908539,"score_spread":0.2736269617146686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767284193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9281217,0.0022634845,0.011624833,0.00022609097,0.00008818844,0.000066081346,0.05081214,0.00071612606,0.0060813185],"genre_scores_gemma":[0.90658665,0.0009865033,0.03005341,0.0003831938,0.000021032653,0.00029360657,0.048218764,0.0003133451,0.013143479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979264,0.000011698275,0.000010622024,0.00009188981,0.00005633699,0.000036805923],"domain_scores_gemma":[0.9997985,0.000050707724,0.000061470084,0.000017021363,0.000033105516,0.00003920318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013941483,0.00024247105,0.00037097264,0.0008224714,0.00025007347,0.00039529984,0.00021483406,0.00028460668,0.005376621],"category_scores_gemma":[0.00027233397,0.00017812398,0.00035110087,0.0010409609,0.0002113412,0.00012437743,0.00016295644,0.0003594838,0.0011513903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005588178,0.000033340468,0.012713791,0.00022186134,0.00005255937,0.00014921199,0.00012772834,0.000244906,0.97402203,0.00044886046,0.0014276938,0.009999164],"study_design_scores_gemma":[0.000053252705,0.0004689486,0.42587534,0.000052961183,0.00013916123,0.0011919307,0.00022012206,0.0052639097,0.54240197,0.0005048632,0.023797309,0.000030217725],"about_ca_topic_score_codex":0.0017706866,"about_ca_topic_score_gemma":0.004869346,"teacher_disagreement_score":0.005376621,"about_ca_system_score_codex":0.00041325207,"about_ca_system_score_gemma":0.00030657463,"threshold_uncertainty_score":0.017986536},"labels":[],"label_agreement":null},{"id":"W2767284462","doi":"10.1093/neuonc/nox168.411","title":"GENE-38. DISRUPTED ENDOTHELIAL CELL GENE EXPRESSION PROFILE PREDICTS GBM CLINICAL RESPONSE TO ANTI-ANGIOGENIC THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Angiogenesis; Cancer research; Genetic enhancement; Mesenchymal stem cell; Vascular endothelial growth factor; Biology; Gene expression; Medicine; Pathology; Gene; Immunology; VEGF receptors; Genetics","score_opus":0.02902645458003236,"score_gpt":0.33759156540951646,"score_spread":0.3085651108294841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767284462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759054,0.0002846533,0.00040082162,0.00005975393,0.000008510911,0.000009835905,0.0010835197,0.000015360807,0.0005469371],"genre_scores_gemma":[0.998123,0.00009798092,0.00040525026,0.00003555283,0.0000043801456,0.00001637872,0.00086863554,0.0000040858063,0.0004447515],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998765,0.000013730695,0.0000127654785,0.000034136006,0.000033814784,0.000028977014],"domain_scores_gemma":[0.99979955,0.0000334857,0.00008211883,0.000008149031,0.000028634051,0.000048143313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001305906,0.00012888797,0.00018569897,0.0005106834,0.0001378493,0.0003247995,0.00008383192,0.00024386353,0.0017741042],"category_scores_gemma":[0.00033308406,0.000063140746,0.00023189568,0.0006444633,0.0001388106,0.000094437484,0.00012695839,0.00025457572,0.00033104408],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001203954,0.00016885504,0.894136,0.00006771528,0.0001123238,0.00020811537,0.0000677742,0.0006261547,0.08659411,0.000117655756,0.0007454654,0.01595183],"study_design_scores_gemma":[0.000008897931,0.00016962332,0.98919684,0.0000057013917,0.00005669816,0.0003576829,0.000061211744,0.0012577148,0.007929415,0.00011665148,0.00083344994,0.000006142064],"about_ca_topic_score_codex":0.0009318313,"about_ca_topic_score_gemma":0.0012704505,"teacher_disagreement_score":0.0017741042,"about_ca_system_score_codex":0.00018542154,"about_ca_system_score_gemma":0.00018458118,"threshold_uncertainty_score":0.0059349537},"labels":[],"label_agreement":null},{"id":"W2767301503","doi":"10.1093/neuonc/nox168.561","title":"NCMP-12. GLIOMA RELATED EPILEPSY: CLINICAL AND PATHOLOGICAL CORRELATES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Epilepsy; Glioma; Oligodendroglioma; IDH1; Pathological; Astrocytoma; Temporal lobe; Semiology; Incidence (geometry); Brain tumor; Retrospective cohort study; Neuroimaging; Internal medicine; Radiology; Pathology; Psychiatry","score_opus":0.05411658435647271,"score_gpt":0.36584818869682656,"score_spread":0.31173160434035385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767301503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160963,0.0017794336,0.000114378716,0.00018321731,0.000014620773,0.000043037435,0.0017228556,0.000024719648,0.004508132],"genre_scores_gemma":[0.99652326,0.00047984975,0.00021946612,0.000037584345,0.000032946,0.00003092276,0.0016868602,0.0000074784434,0.0009816833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998252,0.000019046212,0.000021387292,0.000036414887,0.00006229678,0.00003568401],"domain_scores_gemma":[0.9984054,0.00017123406,0.0009457882,0.000047717334,0.00019915756,0.00023070976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025673973,0.00025110945,0.00022806502,0.0011337504,0.00037358562,0.00045042072,0.00043555856,0.0003094784,0.0046897708],"category_scores_gemma":[0.0018308582,0.00011370126,0.00013755675,0.0017504793,0.0003637841,0.00040374915,0.00034315244,0.00039221076,0.0010595052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002703096,0.000045681223,0.9922907,0.000041417912,0.0000128208,0.00087312574,0.0000286346,0.000028021768,0.0005777311,0.000031785363,0.00034752375,0.0054522213],"study_design_scores_gemma":[0.0000049309415,0.00006241685,0.99501497,0.000010307039,0.000010984705,0.004086324,0.000065852124,0.00007740031,0.000095859614,0.000051418163,0.00051683886,0.0000028046722],"about_ca_topic_score_codex":0.0044646654,"about_ca_topic_score_gemma":0.005168908,"teacher_disagreement_score":0.0046897708,"about_ca_system_score_codex":0.00039883135,"about_ca_system_score_gemma":0.00043897398,"threshold_uncertainty_score":0.015688896},"labels":[],"label_agreement":null},{"id":"W2767309224","doi":"10.1093/neuonc/nox168.1125","title":"SCDT-45. ANTIBODY-BASED PET IMAGING OF BRAIN CANCER CELLS INFILTRATION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Université de Sherbrooke","funders":"","keywords":"Antibody; Blood–brain barrier; Transcytosis; Parenchyma; Cancer research; Infiltration (HVAC); Pathology; Medicine; Immunology; Central nervous system; Receptor; Internal medicine; Endocytosis","score_opus":0.017713653375409078,"score_gpt":0.3687227991134237,"score_spread":0.3510091457380146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767309224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90281194,0.018605536,0.06826169,0.00042570068,0.00015425555,0.00016550042,0.0006538887,0.0006678591,0.0082536945],"genre_scores_gemma":[0.95400196,0.0052041346,0.03355557,0.0002584811,0.000035912075,0.00011451734,0.0006032634,0.000058213605,0.006167899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989915,0.00002219855,0.0000056584254,0.000032485994,0.00002078196,0.000019777135],"domain_scores_gemma":[0.9999691,0.0000063513507,0.0000065693953,0.000003056638,0.0000063089597,0.000008569153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018773333,0.00026394828,0.00021973455,0.00028286915,0.00008388998,0.0003580154,0.00017524908,0.00045649603,0.0005821846],"category_scores_gemma":[0.0001325649,0.00017325084,0.0001557713,0.00027117066,0.00013750639,0.00019995891,0.00016087973,0.00029339603,0.00031372232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018835257,0.00003690975,0.00063539686,0.00014190153,0.000012813996,0.00014444756,0.00001700038,0.0003043443,0.9876621,0.00032162305,0.00024413741,0.010290873],"study_design_scores_gemma":[0.000041040883,0.00074759463,0.007103219,0.000021414298,0.000074216565,0.0018865208,0.000024680356,0.011151739,0.97010976,0.0002333933,0.008588529,0.000017801225],"about_ca_topic_score_codex":0.0012045319,"about_ca_topic_score_gemma":0.0011464757,"teacher_disagreement_score":0.0012045319,"about_ca_system_score_codex":0.0002566269,"about_ca_system_score_gemma":0.00027194503,"threshold_uncertainty_score":0.0023950934},"labels":[],"label_agreement":null},{"id":"W2767312190","doi":"10.1093/neuonc/nox168.903","title":"RTHP-19. DIFFUSE INTRINSIC PONTINE GLIOMA AS A LATE COMPLICATION OF MEDULLOBLASTOMA THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Malignancy; Oncology; Internal medicine; Pathology","score_opus":0.02686834350270848,"score_gpt":0.3172100132677751,"score_spread":0.2903416697650666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767312190","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21799855,0.7619357,0.001137294,0.0007925774,0.00018239506,0.00031434654,0.01080078,0.00006312452,0.006775196],"genre_scores_gemma":[0.68254983,0.30376804,0.0025555224,0.0009805156,0.00037890347,0.00030116178,0.007900924,0.000038589882,0.0015264148],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99846303,0.00039493287,0.0004745331,0.00023752182,0.00037791126,0.000052023934],"domain_scores_gemma":[0.9934762,0.0023731133,0.0034232358,0.0001548781,0.0004351554,0.00013745906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010754429,0.00019994634,0.00056300336,0.00250785,0.00019345965,0.00059848424,0.00036046014,0.00032543179,0.0014112345],"category_scores_gemma":[0.004893484,0.00012274549,0.00084012095,0.004205991,0.00042124087,0.0004589993,0.0003366189,0.00028702096,0.00026169134],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011692143,0.00007510954,0.5079071,0.10986175,0.0036881894,0.010012825,0.000711379,0.00041448727,0.0057605677,0.0010197508,0.0073180473,0.3520615],"study_design_scores_gemma":[0.00017513087,0.00091367937,0.8059768,0.022808265,0.006293532,0.07178103,0.0005027631,0.00024674507,0.0041376227,0.00069735135,0.08641361,0.000053443186],"about_ca_topic_score_codex":0.0023580245,"about_ca_topic_score_gemma":0.004613512,"teacher_disagreement_score":0.00250785,"about_ca_system_score_codex":0.00039465653,"about_ca_system_score_gemma":0.0013333979,"threshold_uncertainty_score":0.0056875944},"labels":[],"label_agreement":null},{"id":"W2767313442","doi":"10.1093/neuonc/nox168.207","title":"CSIG-12. EXPLORING THE FUNCTIONAL RELATIONSHIP BETWEEN CAPICUA (CIC) AND ATAXIN-1-LIKE (ATXN1L) IN GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Genome British Columbia; University of British Columbia","funders":"","keywords":"Biology; Glioma; Gene expression profiling; Microarray analysis techniques; Cancer research; Gene; Gene expression; Genetics","score_opus":0.15486557637539858,"score_gpt":0.33205996342151545,"score_spread":0.17719438704611687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767313442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.471694,0.009723234,0.009630742,0.0027699417,0.0010488811,0.0010448636,0.43178487,0.015174516,0.057128936],"genre_scores_gemma":[0.36942023,0.0048792907,0.014736784,0.0031935228,0.0000946159,0.0014947527,0.57359385,0.0015800417,0.0310069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972683,0.000025839043,0.000012628662,0.00006136734,0.00009574821,0.00007759653],"domain_scores_gemma":[0.99971133,0.000025772759,0.000033029974,0.000037027254,0.00005853623,0.00013434993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014495,0.0004504669,0.00070061366,0.00060811883,0.000509797,0.0007726881,0.000674179,0.000853318,0.010766839],"category_scores_gemma":[0.00034344764,0.000277819,0.00056711945,0.0009331289,0.00022195982,0.00024833213,0.0008158008,0.0011411194,0.0060909768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053214356,0.00076864456,0.028909322,0.0028468387,0.00027511458,0.0008106343,0.0003899386,0.003062145,0.6235479,0.0032782916,0.21070108,0.120088704],"study_design_scores_gemma":[0.0018094233,0.0044483505,0.15001754,0.00047450876,0.00070279895,0.0027993151,0.0004451603,0.010753173,0.25637338,0.0026260365,0.5693729,0.00017732722],"about_ca_topic_score_codex":0.0044965735,"about_ca_topic_score_gemma":0.009651909,"teacher_disagreement_score":0.010766839,"about_ca_system_score_codex":0.00067675166,"about_ca_system_score_gemma":0.0016396898,"threshold_uncertainty_score":0.03601867},"labels":[],"label_agreement":null},{"id":"W2767332947","doi":"10.1093/neuonc/nox168.811","title":"PDTM-49. GLOBAL REDUCTION IN H3K27me3, SIMILAR TO H3K27M MUTANT GLIOMAS, IS A MOLECULAR SURROGATE FOR PEDIATRIC POSTERIOR FOSSA- GROUP A EPENDYMOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Vancouver General Hospital; Children's & Women's Health Centre of British Columbia; Hospital for Sick Children","funders":"","keywords":"Epigenetics; Immunohistochemistry; DNA methylation; Ependymoma; Biology; Methylation; Pathology; Oncology; Medicine; Genetics; Gene","score_opus":0.024773382624533057,"score_gpt":0.3334404731730753,"score_spread":0.30866709054854224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767332947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943863,0.0005411544,0.0014137668,0.000061115294,0.000012647916,0.0000622455,0.0015597345,0.000091263224,0.0018717072],"genre_scores_gemma":[0.9958494,0.0002899376,0.00084856595,0.00003481002,0.0000034919458,0.000102151265,0.0017630558,0.000016621134,0.0010919968],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984777,0.00002119868,0.00000946091,0.000049957845,0.000034809906,0.000036853893],"domain_scores_gemma":[0.99990976,0.000014736407,0.000025468613,0.00001614608,0.0000070351043,0.000026836005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015681628,0.00023678647,0.00024190579,0.00030020307,0.0002621796,0.00020725296,0.000196218,0.00024112333,0.0017615745],"category_scores_gemma":[0.0001857025,0.000121226585,0.00014501925,0.00036602264,0.0003278755,0.00013348363,0.00020195778,0.00044621006,0.00031792044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027014418,0.0003066049,0.07249248,0.00015388052,0.000069964,0.0016299619,0.00013023986,0.00046272014,0.89932436,0.00039186614,0.0015180482,0.020818437],"study_design_scores_gemma":[0.00022370348,0.0034981933,0.6088108,0.000014619512,0.00008457312,0.009944644,0.00017559608,0.0014001016,0.36242598,0.0002802526,0.013127124,0.000014404227],"about_ca_topic_score_codex":0.001949045,"about_ca_topic_score_gemma":0.002925797,"teacher_disagreement_score":0.001949045,"about_ca_system_score_codex":0.00036824317,"about_ca_system_score_gemma":0.00019104619,"threshold_uncertainty_score":0.005893111},"labels":[],"label_agreement":null},{"id":"W2767357331","doi":"10.1093/neuonc/nox168.002","title":"ACTR-02. DCC-2618, A NOVEL pan-KIT AND PDGFRa KINASE SWITCH CONTROL INHIBITOR, SHOWS ENCOURAGING SIGNAL IN A PATIENT (PT) WITH GLIOBLASTOMA (GBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PDGFRA; Temozolomide; Medicine; Cancer research; Kinase; Internal medicine; Glioma; Oncology; Chemistry","score_opus":0.013906961054350183,"score_gpt":0.2680006799037273,"score_spread":0.2540937188493771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767357331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884865,0.0022496707,0.0008411281,0.00022002067,0.000052077845,0.00060753105,0.0009812416,0.00017995982,0.0063818675],"genre_scores_gemma":[0.9896354,0.0015479473,0.0010937431,0.0002459675,0.00002997192,0.0003340143,0.0019262972,0.000020814943,0.005165814],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9999039,0.00001944931,0.000006575373,0.000021649072,0.00002104402,0.000027269163],"domain_scores_gemma":[0.9999285,0.000007433852,0.000014794091,0.0000073911397,0.0000059582817,0.0000359946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016559876,0.00033173215,0.00052446907,0.00021988501,0.00013214539,0.00030641365,0.00026315628,0.00031696318,0.0025357578],"category_scores_gemma":[0.00011577949,0.00014091856,0.00022090673,0.00021203673,0.00022861238,0.00012266032,0.00012204605,0.0007938981,0.0007286213],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048465893,0.011845332,0.0168466,0.00092528213,0.0003071993,0.0028056747,0.0002570293,0.0033406601,0.5892521,0.0008725202,0.01412325,0.3109584],"study_design_scores_gemma":[0.042930312,0.30108157,0.1282804,0.00009593604,0.00076684635,0.021878785,0.00015764547,0.007548213,0.39655647,0.00041342305,0.10018851,0.00010182939],"about_ca_topic_score_codex":0.00088676513,"about_ca_topic_score_gemma":0.0028642672,"teacher_disagreement_score":0.0025357578,"about_ca_system_score_codex":0.00037035588,"about_ca_system_score_gemma":0.00037239533,"threshold_uncertainty_score":0.008482993},"labels":[],"label_agreement":null},{"id":"W2767364701","doi":"10.1093/neuonc/nox168.116","title":"ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Cytosine deaminase; Molecular biology; Immunohistochemistry; Biology; Pathology; Cancer research; Genetic enhancement; Medicine; Gene","score_opus":0.01625679268987702,"score_gpt":0.2933595000695888,"score_spread":0.27710270737971177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767364701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968106,0.00090049894,0.00034788187,0.000088637265,0.000009639803,0.000059963026,0.00015447916,0.00004752735,0.0015806472],"genre_scores_gemma":[0.99852777,0.00022173508,0.00032450585,0.00005732651,0.000007858679,0.000029775449,0.00026921654,0.000004404,0.0005572881],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999416,0.000011793402,0.0000030595984,0.000014393712,0.000011667526,0.000017389406],"domain_scores_gemma":[0.9999374,0.000010833465,0.000015684487,0.0000043210653,0.000004961166,0.000026668105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011364163,0.00020679698,0.0003736492,0.00014310954,0.00013465594,0.00021229446,0.00010285162,0.00024164944,0.0008716883],"category_scores_gemma":[0.00016044054,0.000090976864,0.00011572231,0.00017239936,0.00015305777,0.00011838202,0.00006963842,0.00031033403,0.0002658237],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031417027,0.002733609,0.16993141,0.0003784585,0.00022203344,0.0042532473,0.0002336724,0.0011853992,0.6035205,0.00028946472,0.0039004704,0.18193465],"study_design_scores_gemma":[0.0037089663,0.12132524,0.6981612,0.000043545377,0.0003964379,0.015643314,0.00015485496,0.0046627237,0.14076105,0.00020540731,0.014895147,0.000042096286],"about_ca_topic_score_codex":0.0008771569,"about_ca_topic_score_gemma":0.0021612337,"teacher_disagreement_score":0.0008771569,"about_ca_system_score_codex":0.00046510773,"about_ca_system_score_gemma":0.00024480143,"threshold_uncertainty_score":0.0033746362},"labels":[],"label_agreement":null},{"id":"W2767364728","doi":"10.1093/neuonc/nox168.477","title":"IMMU-19. QUANTITATION AND CHARACTERIZATION OF GLIOBLASTOMA-ASSOCIATED MICROGLIA AND MACROPHAGES REVEALS HIGHLY VARIABLE INFLAMMATORY PROFILES AND AN INVERSE RELATIONSHIP TO PERITUMORAL EDEMA VOLUME","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microglia; Infiltration (HVAC); Immune system; Immunotherapy; Inflammation; Pathology; Flow cytometry; Cancer research; Glioblastoma; CD8; Tumor microenvironment; Phenotype; Medicine; Biology; Immunology","score_opus":0.021612279891535625,"score_gpt":0.29875420961840055,"score_spread":0.2771419297268649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767364728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573668,0.005711657,0.03145299,0.000116759285,0.00004870622,0.000069935915,0.0016651206,0.0003192799,0.0032487107],"genre_scores_gemma":[0.9387206,0.0028758803,0.049313985,0.0001554229,0.00004887507,0.00031382038,0.004175948,0.00012640865,0.004269166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99955136,0.000075194635,0.00004273297,0.00009850263,0.00013374681,0.000098427976],"domain_scores_gemma":[0.99970454,0.0000475946,0.00009186488,0.000024549021,0.000071922615,0.00005937479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053886726,0.00047908528,0.00024671367,0.0011944353,0.00025890808,0.0004508125,0.00023646746,0.0002634525,0.0007483542],"category_scores_gemma":[0.00028432327,0.00021133333,0.00017843065,0.00062297285,0.0002775283,0.00028362745,0.00028369718,0.00039405763,0.00035748453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016790845,0.000030921798,0.0027654555,0.000062019215,0.000015436435,0.00004960506,0.00004843771,0.00007740369,0.99267733,0.00017278256,0.00006890015,0.0038637733],"study_design_scores_gemma":[0.000013154808,0.00027258554,0.05381719,0.000019616913,0.00003994339,0.00077739,0.000060188944,0.003244101,0.9379777,0.00021894237,0.0035470119,0.00001217986],"about_ca_topic_score_codex":0.00075581676,"about_ca_topic_score_gemma":0.0014009004,"teacher_disagreement_score":0.0011944353,"about_ca_system_score_codex":0.00027935524,"about_ca_system_score_gemma":0.00020664342,"threshold_uncertainty_score":0.0028498769},"labels":[],"label_agreement":null},{"id":"W2767370381","doi":"10.1093/neuonc/nox164","title":"IDH mutation testing in gliomas—where do we draw the line?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Line (geometry); Mutation; Genetics; Biology; Mathematics","score_opus":0.04592891768764163,"score_gpt":0.32955756888985777,"score_spread":0.28362865120221614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767370381","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014853983,0.0067723817,0.00019266363,0.98166865,0.006315658,0.000007818586,0.000047207097,0.0000264216,0.0034837758],"genre_scores_gemma":[0.042692456,0.017978061,0.0012331635,0.8223911,0.11100951,0.00003476402,0.0001487399,0.000047945625,0.0044642724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981692,0.0006622517,0.0003073791,0.0001974632,0.00039820818,0.00026545033],"domain_scores_gemma":[0.9947107,0.0027853297,0.00035173117,0.00013826,0.0009649044,0.0010491033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014462672,0.0005888596,0.001236555,0.0010496791,0.0020453355,0.003008857,0.0014543101,0.022441724,0.004466234],"category_scores_gemma":[0.018243877,0.0004732968,0.00089374115,0.00076850783,0.002177063,0.005110487,0.0010707302,0.020496465,0.002935595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019963208,0.00013616477,0.013315744,0.00025264203,0.0000672868,0.044652335,0.0002738433,0.0006388065,0.00074137276,0.008575096,0.86352587,0.06762128],"study_design_scores_gemma":[0.00043603944,0.00039928604,0.009164087,0.0038340578,0.00025145218,0.17158546,0.003318123,0.004113299,0.001330376,0.09226848,0.71304065,0.0002587603],"about_ca_topic_score_codex":0.0050560557,"about_ca_topic_score_gemma":0.0072451173,"teacher_disagreement_score":0.022441724,"about_ca_system_score_codex":0.0036351075,"about_ca_system_score_gemma":0.0028156783,"threshold_uncertainty_score":0.026374698},"labels":[],"label_agreement":null},{"id":"W2767378856","doi":"10.1093/neuonc/nox168.721","title":"PATH-31. ELEVATION OF YKL-40, NORMALIZED TO CERULOPLASMIN, IN CEREBROSPINAL FLUID IS ASSOCIATED WITH GLIOBLASTOMA RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ceruloplasmin; Glioblastoma; Cerebrospinal fluid; Elevation (ballistics); Medicine; Internal medicine; Path (computing); Gastroenterology; Oncology; Cancer research; Mathematics; Computer science","score_opus":0.02098088210676914,"score_gpt":0.3094852910920464,"score_spread":0.2885044089852773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767378856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872595,0.0004903825,0.00014050765,0.000035085628,0.000008408474,0.000007227566,0.00026571366,0.000016951779,0.0003096838],"genre_scores_gemma":[0.9989506,0.000092419,0.00013058799,0.000021731728,0.0000054114776,0.000010718558,0.0003785814,0.0000030091614,0.00040690938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998468,0.000016306023,0.00002192895,0.000035876823,0.000040419305,0.000038627782],"domain_scores_gemma":[0.9996921,0.000021611442,0.00017405066,0.000011458654,0.000044960827,0.000055916727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001366711,0.00032637353,0.00022078375,0.0005547283,0.00023035755,0.0003116781,0.00016669395,0.00021527409,0.001438743],"category_scores_gemma":[0.0006143452,0.000110164765,0.00022307812,0.00031687738,0.00018943037,0.00013387867,0.00023889929,0.00025890855,0.00036596018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015806464,0.0001137167,0.8935165,0.00016280315,0.00014377893,0.0037928892,0.00029859555,0.0001139788,0.079859205,0.000086163964,0.0009655264,0.019366225],"study_design_scores_gemma":[0.00001771351,0.00041959516,0.98227775,0.000013699392,0.000057995625,0.007650963,0.00010861971,0.00034290281,0.008015996,0.00008245899,0.0010035784,0.000008616573],"about_ca_topic_score_codex":0.0017718045,"about_ca_topic_score_gemma":0.0016864359,"teacher_disagreement_score":0.0017718045,"about_ca_system_score_codex":0.00029809566,"about_ca_system_score_gemma":0.0002072162,"threshold_uncertainty_score":0.004813075},"labels":[],"label_agreement":null},{"id":"W2767379037","doi":"10.1093/neuonc/nox168.808","title":"PDTM-46. TARGETING METABOLIC ADAPTATION IN MYC DRIVEN PEDIATRIC NEURONAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Gene knockdown; Cancer research; Neuroblastoma; N-Myc; Biology; Pediatric cancer; Synthetic lethality; Cell culture; Cancer; Gene; Genetics; Mutant","score_opus":0.03600549443758412,"score_gpt":0.3385870060092045,"score_spread":0.3025815115716204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767379037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650522,0.013969072,0.0072434456,0.00046936475,0.00011593509,0.00026131605,0.0061293347,0.00082973763,0.0059296945],"genre_scores_gemma":[0.97365487,0.0085660815,0.006695846,0.00018373222,0.000013678342,0.00026463193,0.006065784,0.00007299197,0.0044823345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999926,0.000010292468,0.0000047677454,0.00001814141,0.000018330731,0.000022442966],"domain_scores_gemma":[0.99997675,0.0000034138013,0.0000064733035,0.0000031321395,0.0000021731812,0.000008125182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008787569,0.00026144495,0.00035483885,0.00025918838,0.00009482171,0.00024520882,0.00020765865,0.00025731217,0.0013913997],"category_scores_gemma":[0.000066104,0.00014384284,0.00021399505,0.00030741756,0.00009816547,0.00011327357,0.00017583727,0.0006257989,0.00046460706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088271155,0.00031480112,0.00077311456,0.00028820278,0.000046505847,0.00019376402,0.000026297263,0.00083289517,0.9678733,0.0004444618,0.0013686002,0.026955325],"study_design_scores_gemma":[0.00032073105,0.00234794,0.0134116355,0.000038132148,0.00008028476,0.0013770608,0.00004062291,0.0028983653,0.94056684,0.00018250532,0.038720675,0.000015269809],"about_ca_topic_score_codex":0.00090224587,"about_ca_topic_score_gemma":0.002197715,"teacher_disagreement_score":0.0013913997,"about_ca_system_score_codex":0.00036885415,"about_ca_system_score_gemma":0.00033479018,"threshold_uncertainty_score":0.0046547055},"labels":[],"label_agreement":null},{"id":"W2767382827","doi":"10.1093/neuonc/nox168.479","title":"IMMU-21. GLIOBLASTOMA CELLS EXPORT TENASCIN-C VIA MICROVESICLES TO SUPPRESS T CELL RESPONSES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microvesicles; Tenascin C; Microvesicle; Immune system; Exosome; Cell biology; Cancer research; Stem cell; Biology; Secretion; Cytotoxic T cell; Extracellular matrix; Immunology; microRNA; In vitro; Gene; Biochemistry","score_opus":0.014698198737843459,"score_gpt":0.31314343391781435,"score_spread":0.2984452351799709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767382827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916923,0.0022001786,0.0017061322,0.00015775028,0.00006110955,0.000054693057,0.0009022022,0.00014694508,0.003078699],"genre_scores_gemma":[0.9912282,0.0006781602,0.0015162114,0.00011878639,0.000013165864,0.00004610232,0.0015374888,0.000025217721,0.0048366473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998907,0.000013028792,0.00000850266,0.000016122478,0.00002832531,0.00004337397],"domain_scores_gemma":[0.99995506,0.0000045085185,0.000010873237,0.0000049579753,0.000007615352,0.000016973934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009543912,0.00026137067,0.00022242039,0.00020938419,0.00015676876,0.00027114918,0.000106578365,0.00020610387,0.0015415002],"category_scores_gemma":[0.000061593775,0.00009217417,0.00023537809,0.00014759874,0.00012356412,0.00011113219,0.00020895363,0.0005726323,0.00063812715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007138048,0.000028332817,0.00015182723,0.000023924496,0.0000029782,0.000031607364,0.000010374844,0.000030484729,0.9983127,0.00006486152,0.00010329514,0.001168175],"study_design_scores_gemma":[0.000033104337,0.00052295113,0.00986935,0.000009017639,0.000020116935,0.00042570115,0.00003087147,0.001513547,0.97974706,0.000083961386,0.0077389805,0.0000054002803],"about_ca_topic_score_codex":0.002043315,"about_ca_topic_score_gemma":0.0023003453,"teacher_disagreement_score":0.002043315,"about_ca_system_score_codex":0.00033351462,"about_ca_system_score_gemma":0.00025210186,"threshold_uncertainty_score":0.005156815},"labels":[],"label_agreement":null},{"id":"W2767387519","doi":"10.1093/neuonc/nox168.041","title":"ACTR-50. CLINICAL TRIALS WITH DIANHYDROGALACTITOL (VAL-083) IN MGMT-UNMETHYLATED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Medicine; Cancer; Bevacizumab; Radiation therapy; Glioma; Oncology; Internal medicine; Biology; Chemotherapy; DNA; Genetics; Methylation","score_opus":0.09585768033336821,"score_gpt":0.439147125699677,"score_spread":0.3432894453663088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767387519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7958708,0.14717078,0.0035527528,0.005685274,0.0012731099,0.0052392012,0.005180763,0.0015002862,0.034527022],"genre_scores_gemma":[0.85233545,0.09292051,0.007057649,0.008995993,0.00060976984,0.0047272956,0.0107406825,0.00018964207,0.022423036],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997305,0.00013385476,0.000024376926,0.000024330917,0.000036361784,0.00005050202],"domain_scores_gemma":[0.99980456,0.00003507321,0.000040830077,0.000015139104,0.000018628345,0.00008583531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097617455,0.00080184976,0.00095350767,0.00052148936,0.000293877,0.00069730903,0.00070173293,0.0009887593,0.0036059853],"category_scores_gemma":[0.00038876868,0.0002362833,0.00077804556,0.0004823435,0.00032662443,0.00045394085,0.00033034352,0.0020250904,0.0010368985],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090021186,0.017120512,0.002385641,0.005166881,0.0014994267,0.0006976746,0.00040028983,0.0033638407,0.1540104,0.0022108625,0.028041538,0.6950817],"study_design_scores_gemma":[0.17048186,0.5647114,0.02930258,0.0012142593,0.002069317,0.0022870798,0.00020917556,0.0032168762,0.040005125,0.0020679873,0.18427977,0.0001545344],"about_ca_topic_score_codex":0.0010643739,"about_ca_topic_score_gemma":0.0044964007,"teacher_disagreement_score":0.0036059853,"about_ca_system_score_codex":0.00045885713,"about_ca_system_score_gemma":0.00062199216,"threshold_uncertainty_score":0.012063265},"labels":[],"label_agreement":null},{"id":"W2767408185","doi":"10.1093/neuonc/nox168.268","title":"DRES-10. THE DISTINCT CYTOTOXIC MECHANISM OF DIANHYDROGALACTITOL (VAL-083) OVERCOMES CHEMORESISTANCE AND PROVIDES NEW OPPORTUNITIES FOR COMBINATION THERAPY IN THE TREATMENT OF GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Bevacizumab; Cancer research; DNA repair; Glioma; Medicine; Pharmacology; Chemistry; Chemotherapy; Internal medicine; DNA","score_opus":0.06082184004682845,"score_gpt":0.3227176996416961,"score_spread":0.26189585959486766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767408185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90350425,0.057806246,0.006897445,0.0016558572,0.0005905115,0.00028886387,0.0034814738,0.0013763345,0.024398992],"genre_scores_gemma":[0.96868795,0.011283225,0.0046485444,0.0005379559,0.00005649519,0.000104084516,0.0036136755,0.000061717576,0.01100642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999454,0.000008286197,0.0000032701812,0.000012086414,0.000013092032,0.000017862565],"domain_scores_gemma":[0.9999603,0.0000022338684,0.000009100725,0.0000028752129,0.0000048712855,0.000020647902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001018794,0.0004739914,0.00021584444,0.00023519613,0.00011892115,0.0002562152,0.00023723075,0.00025987407,0.0027547234],"category_scores_gemma":[0.000058786583,0.000111825604,0.0002604031,0.00024550568,0.00017016924,0.00018559878,0.00024509896,0.0007042268,0.0010849661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013973985,0.00040367735,0.0009665296,0.00051399844,0.000052626663,0.00029018903,0.000034920708,0.0006355708,0.87796694,0.0015015801,0.0034373854,0.11279913],"study_design_scores_gemma":[0.0007511283,0.005776477,0.009323894,0.000058501082,0.00010864853,0.002978844,0.0000478818,0.0015223714,0.82784045,0.0005540068,0.1509945,0.00004333841],"about_ca_topic_score_codex":0.00067161216,"about_ca_topic_score_gemma":0.0015266946,"teacher_disagreement_score":0.0027547234,"about_ca_system_score_codex":0.00042072817,"about_ca_system_score_gemma":0.00026952723,"threshold_uncertainty_score":0.009215474},"labels":[],"label_agreement":null},{"id":"W2767419466","doi":"10.1093/neuonc/nox168.1129","title":"SCDT-50. SURFACE MODIFIED LIPOSOMES FOR EFFECTIVE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE BLOOD BRAIN BARRIER","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of Toronto; Scottish Cot Death Trust; Focused Ultrasound Foundation","keywords":"Blood–brain barrier; Liposome; Doxorubicin; Pharmacology; Glioma; In vitro; Cytotoxicity; Drug delivery; Chemistry; Cancer research; Medicine; Biochemistry; Chemotherapy; Central nervous system; Internal medicine","score_opus":0.029883882044487373,"score_gpt":0.3213690789203492,"score_spread":0.29148519687586183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767419466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9054508,0.017626124,0.064958274,0.00083030923,0.0003369407,0.0007681174,0.0020848576,0.0009286637,0.007015897],"genre_scores_gemma":[0.95315754,0.0047601797,0.033147927,0.00025172633,0.000031979976,0.00024750974,0.0020594983,0.00007414976,0.006269445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999869,0.000021632053,0.000018563234,0.00003317182,0.000036391975,0.000021188822],"domain_scores_gemma":[0.9999521,0.000008071438,0.000011346656,0.000004785381,0.00001308785,0.000010591811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017731213,0.00032687455,0.00022739345,0.00027697266,0.0001293746,0.00022136424,0.00018750489,0.00042302313,0.0011673811],"category_scores_gemma":[0.00015506189,0.0001480742,0.00020823145,0.00019806216,0.00016685821,0.00024106335,0.00016731418,0.00042214736,0.0006301461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008599023,0.00003421336,0.00006634369,0.000080003025,0.0000040748128,0.000045629586,0.0000131002525,0.0002266537,0.99472576,0.00026056825,0.00022403321,0.0042337608],"study_design_scores_gemma":[0.000025558465,0.00013170311,0.0002678909,0.0000045384586,0.000008572075,0.00011369912,0.000002678467,0.0012048467,0.99382234,0.000041793515,0.004370783,0.00000553115],"about_ca_topic_score_codex":0.00088923314,"about_ca_topic_score_gemma":0.00074630417,"teacher_disagreement_score":0.0011673811,"about_ca_system_score_codex":0.00042024118,"about_ca_system_score_gemma":0.00033785493,"threshold_uncertainty_score":0.0039052963},"labels":[],"label_agreement":null},{"id":"W2767419812","doi":"10.1093/neuonc/nox168.542","title":"MNGI-03. VOXEL-BASED LESION MAPPING TECHNIQUE REVEALS THE SPATIAL DISTRIBUTION OF MENINGIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lesion; Medicine; Skull; Meningioma; Magnetic resonance imaging; Anatomy; Neuroradiologist; Voxel; Radiology; Pathology","score_opus":0.05166820794431628,"score_gpt":0.3263073841680365,"score_spread":0.27463917622372025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767419812","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3252479,0.002208745,0.5463115,0.0019135006,0.00038193626,0.0026903073,0.04409317,0.05260617,0.024546696],"genre_scores_gemma":[0.2784687,0.00061442296,0.6845341,0.0002563218,0.000072574614,0.0053194296,0.016633252,0.0050176308,0.009083523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99960595,0.00012536191,0.00004355209,0.00010668334,0.00008738328,0.000031150223],"domain_scores_gemma":[0.99926907,0.00025664165,0.00013576169,0.0001691,0.000114979935,0.00005447177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018571889,0.001419303,0.00079689623,0.0030870626,0.0006115862,0.001568902,0.0015491947,0.0008458674,0.009390283],"category_scores_gemma":[0.004526857,0.00083432,0.00074028724,0.0013118127,0.0004899694,0.00091586506,0.001893833,0.001224056,0.0028690556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026241853,0.0005572297,0.072578594,0.0020484766,0.001721241,0.0030938243,0.002927031,0.03718059,0.047058024,0.01751662,0.14505419,0.66764],"study_design_scores_gemma":[0.0010662733,0.0013696678,0.2457068,0.00041407332,0.00078672834,0.013530512,0.0008208228,0.29411873,0.040536366,0.050518144,0.35078317,0.00034872608],"about_ca_topic_score_codex":0.010093935,"about_ca_topic_score_gemma":0.012787274,"teacher_disagreement_score":0.010093935,"about_ca_system_score_codex":0.00067820307,"about_ca_system_score_gemma":0.0023238068,"threshold_uncertainty_score":0.031413674},"labels":[],"label_agreement":null},{"id":"W2767444421","doi":"10.1093/neuonc/nox168.956","title":"STEM-42. GENOME-WIDE CRISPR SCREENS IN BRAIN TUMOR INITIATING CELLS (BTICS) IDENTIFY POTENT SENSITIZERS OF CONVENTIONAL CHEMORADIOTHERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"CRISPR; Chemoradiotherapy; Cancer research; Genome editing; Frameshift mutation; Temozolomide; Biology; Medicine; Gene; Mutation; Cancer; Genetics; Glioma","score_opus":0.01719811970316495,"score_gpt":0.328887365967081,"score_spread":0.3116892462639161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767444421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218171,0.0026546302,0.041542612,0.00047431543,0.00013772545,0.00079258776,0.01934317,0.0028089737,0.010428887],"genre_scores_gemma":[0.941621,0.002134157,0.028144218,0.00030905253,0.000017472938,0.0005043585,0.013915737,0.0003114331,0.013042601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955565,0.000051983207,0.00004745278,0.00010294904,0.00018777052,0.000054229433],"domain_scores_gemma":[0.99985516,0.000032138458,0.00004050921,0.000022895105,0.000021146945,0.000028122597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032394475,0.0005858015,0.0005887836,0.00040586578,0.0002834282,0.000543321,0.00034423303,0.00056751794,0.002990586],"category_scores_gemma":[0.00023399077,0.00023778056,0.00049827056,0.0004212664,0.0003067752,0.00012879043,0.00031315722,0.0006618895,0.0010090619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046887617,0.000025545094,0.00018910493,0.000046676236,0.000009042864,0.00004366357,0.000013759586,0.0003264986,0.99705505,0.00011460052,0.00012849714,0.00200073],"study_design_scores_gemma":[0.000016195494,0.00030048072,0.002928954,0.000007766727,0.000038281636,0.00028051322,0.000020809235,0.0018730457,0.98685175,0.00008268644,0.007588845,0.00001072652],"about_ca_topic_score_codex":0.0012869965,"about_ca_topic_score_gemma":0.002723498,"teacher_disagreement_score":0.002990586,"about_ca_system_score_codex":0.00044664394,"about_ca_system_score_gemma":0.0003585889,"threshold_uncertainty_score":0.010004461},"labels":[],"label_agreement":null},{"id":"W2767484600","doi":"10.1093/neuonc/nox168.913","title":"RTHP-31. A 40-YEAR MULTI-INSTITUTIONAL REVIEW OF INTRACRANIAL GERM CELL TUMORS IN ADOLESCENTS AND YOUNG ADULT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Germ cell tumors; Germinoma; Radiation therapy; Internal medicine; Cancer; Surgery; Pediatrics","score_opus":0.03156829688521367,"score_gpt":0.3459923063730421,"score_spread":0.31442400948782845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767484600","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940698,0.02893248,0.0009932391,0.00035530186,0.00012083201,0.00050878257,0.019047797,0.00011036621,0.0092330985],"genre_scores_gemma":[0.9705573,0.010946366,0.0016507583,0.00027574392,0.000110942405,0.00033606682,0.014053523,0.00003533887,0.00203403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993253,0.00012664014,0.00021410703,0.000086106964,0.00017530374,0.00007258135],"domain_scores_gemma":[0.9963321,0.00055131456,0.0017728461,0.00017103809,0.0009046457,0.00026807023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092336227,0.00016005228,0.0002451646,0.002300222,0.00037010916,0.00043123955,0.00038236135,0.0002136281,0.0018350729],"category_scores_gemma":[0.002742239,0.0001613529,0.00028488683,0.0023536796,0.00019211975,0.00037965502,0.00040284893,0.00018236817,0.0005179067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019720805,0.0000385962,0.9210365,0.0011845286,0.00012300907,0.009285771,0.00077939854,0.00011027094,0.0022926682,0.0000982219,0.0069429087,0.057910804],"study_design_scores_gemma":[0.000015020729,0.00012895152,0.95457417,0.0004591747,0.00009510728,0.020207567,0.00065478554,0.0001094794,0.0010516132,0.000027255372,0.02266678,0.000010163484],"about_ca_topic_score_codex":0.007181807,"about_ca_topic_score_gemma":0.009601046,"teacher_disagreement_score":0.007181807,"about_ca_system_score_codex":0.0006216004,"about_ca_system_score_gemma":0.0015555301,"threshold_uncertainty_score":0.014279962},"labels":[],"label_agreement":null},{"id":"W2767488657","doi":"10.1093/neuonc/nox168.566","title":"NCOG-05. TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Glioblastoma; Cognitive decline; Radiation therapy; Disease; Dementia","score_opus":0.018029607386638117,"score_gpt":0.2984840010863795,"score_spread":0.2804543936997414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767488657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97972614,0.0043774876,0.0003445798,0.0014958046,0.0004930416,0.001742653,0.0049200635,0.00014438594,0.00675581],"genre_scores_gemma":[0.9768016,0.0019050383,0.0015610493,0.0020235162,0.0002655044,0.003554326,0.007584652,0.000032661912,0.006271632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999337,0.00042387226,0.00002915456,0.00006448943,0.000060197035,0.00008525205],"domain_scores_gemma":[0.99880016,0.00026504046,0.0002623369,0.000055887038,0.00009213555,0.00052443345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017818223,0.00069566525,0.0012111017,0.00033807484,0.00032627367,0.0006960638,0.00071279815,0.0009115687,0.0044404254],"category_scores_gemma":[0.0018336638,0.00021156276,0.0013055053,0.00044687564,0.00047116654,0.00056331174,0.0003037242,0.001967049,0.00067534356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91105753,0.011632815,0.007642903,0.0005918319,0.0015350748,0.00009030041,0.00009847178,0.0010577126,0.0033447612,0.00033708836,0.009461359,0.053150162],"study_design_scores_gemma":[0.71267587,0.23811884,0.037118614,0.000121083256,0.0012377375,0.00015748844,0.000086641645,0.0018913153,0.000889575,0.0005407182,0.007119618,0.00004250892],"about_ca_topic_score_codex":0.0044622114,"about_ca_topic_score_gemma":0.018450392,"teacher_disagreement_score":0.0044622114,"about_ca_system_score_codex":0.0012827115,"about_ca_system_score_gemma":0.0026140013,"threshold_uncertainty_score":0.014854729},"labels":[],"label_agreement":null},{"id":"W2767506942","doi":"10.1093/neuonc/nox168.022","title":"ACTR-27. COMPLIANCE AND TREATMENT DURATION PREDICT SURVIVAL IN A PHASE 3 EF-14 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Temozolomide; Medicine; Glioblastoma; Internal medicine; Oncology; Progression-free survival; Adjuvant; Clinical trial; Overall survival; Chemotherapy","score_opus":0.0269714515350125,"score_gpt":0.3109597972464867,"score_spread":0.2839883457114742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767506942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960283,0.0022481317,0.00024893973,0.00024880678,0.000057546815,0.000084819934,0.000403701,0.000022061642,0.0006575983],"genre_scores_gemma":[0.9972952,0.0004278031,0.00028551312,0.00019658955,0.00006966159,0.000104681014,0.00096607924,0.000012920851,0.0006415695],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980667,0.001339916,0.00008876573,0.00019227598,0.00017803628,0.0001343623],"domain_scores_gemma":[0.9965587,0.0013357797,0.0011447856,0.00022149546,0.00015747597,0.0005817181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005183016,0.00053135416,0.0010421044,0.00023263691,0.000217655,0.00067117484,0.0004618266,0.000785044,0.0018130394],"category_scores_gemma":[0.0038303449,0.00027581767,0.0019571772,0.00040482654,0.00034439767,0.00073574844,0.00039944932,0.0018738796,0.00035222128],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7592318,0.004328062,0.15658253,0.00041481454,0.005011149,0.00014576851,0.00015130403,0.0035715045,0.006361672,0.00018855285,0.0026352308,0.061377622],"study_design_scores_gemma":[0.07753759,0.15103713,0.7466454,0.0000968321,0.0047875387,0.0004799902,0.00011053069,0.011261795,0.0024967636,0.00077826413,0.0046842773,0.000083915],"about_ca_topic_score_codex":0.0006878676,"about_ca_topic_score_gemma":0.001494653,"teacher_disagreement_score":0.005183016,"about_ca_system_score_codex":0.00039185738,"about_ca_system_score_gemma":0.00063857157,"threshold_uncertainty_score":0.027410686},"labels":[],"label_agreement":null},{"id":"W2767510756","doi":"10.1093/neuonc/nox168.578","title":"NCOG-17. COGNITION AND BRAIN STEREOTACTIC RADIOTHERAPY: A PILOT TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Quality of life (healthcare); Stereotactic radiotherapy; Montreal Cognitive Assessment; Mini–Mental State Examination; Cognition; Cognitive impairment; Internal medicine; Radiation therapy; Randomized controlled trial; Radiosurgery; Psychiatry","score_opus":0.05814636025567579,"score_gpt":0.359342087700006,"score_spread":0.3011957274443302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767510756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884608,0.0035575503,0.0002240924,0.00050698355,0.0003053379,0.0031258622,0.0018044381,0.00009061425,0.0019243145],"genre_scores_gemma":[0.9663,0.004877529,0.0020349212,0.0013875109,0.0006816876,0.014250124,0.0059791775,0.000030877403,0.0044580037],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995382,0.00022352522,0.000036137673,0.00005850349,0.000053679883,0.000089983],"domain_scores_gemma":[0.99904746,0.00019473177,0.00022155175,0.00007628468,0.00008886057,0.00037113833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013179912,0.0014805801,0.002266481,0.0005042686,0.00031146096,0.0006258675,0.001039944,0.0011823385,0.0045122355],"category_scores_gemma":[0.0015303959,0.0003931556,0.0011839557,0.000765444,0.00077505974,0.0006514085,0.00046369142,0.0020751157,0.0010402189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9283529,0.027814975,0.007414154,0.000741379,0.001007984,0.00012374525,0.000077851124,0.00034687,0.0013837753,0.00010776394,0.001974803,0.030653805],"study_design_scores_gemma":[0.8232957,0.1595498,0.01377432,0.00007612003,0.0006780633,0.000105026906,0.000044921697,0.0005036707,0.00038210378,0.00010593224,0.0014652852,0.000019027631],"about_ca_topic_score_codex":0.0030210887,"about_ca_topic_score_gemma":0.0047438648,"teacher_disagreement_score":0.0045122355,"about_ca_system_score_codex":0.00075540564,"about_ca_system_score_gemma":0.0028827528,"threshold_uncertainty_score":0.015094876},"labels":[],"label_agreement":null},{"id":"W2767515057","doi":"10.1093/neuonc/nox168.1043","title":"TMOD-04. A COMPREHENSIVE GENOMIC LANDSCAPE OF GLIOMA SPHEROID CULTURES RECAPITULATES THE HETEROGENEITY OF GLIOBLASTOMA AND IDENTIFIES DNA METHYLATION PREDICTORS OF RADIOTHERAPY RESPONSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"DNA methylation; Methylation; Glioma; Biology; Cancer research; Radiation therapy; CpG site; Molecular biology; Oncology; Genetics; Gene; Internal medicine; Medicine; Gene expression","score_opus":0.020316187430553308,"score_gpt":0.3127252702862144,"score_spread":0.2924090828556611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767515057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840447,0.00043368872,0.005203935,0.00006424794,0.000018360148,0.0001003143,0.008178835,0.00024260196,0.0017132957],"genre_scores_gemma":[0.9480485,0.00054180296,0.011926977,0.0001099166,0.0000063142757,0.00032468454,0.0348325,0.0001330043,0.004076407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998492,0.000015858912,0.000014293691,0.000047863603,0.000047697376,0.000025071715],"domain_scores_gemma":[0.9999366,0.000008609635,0.000012764346,0.000015966225,0.000009247779,0.000016767171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013964075,0.0002807664,0.000387225,0.00037686358,0.00020673881,0.0003014587,0.00020839511,0.00022009708,0.0017448316],"category_scores_gemma":[0.0001409109,0.00014457093,0.0002361383,0.00050689,0.00019238298,0.00011120088,0.00019230816,0.0003770149,0.00043388538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024524162,0.000054607888,0.005215231,0.00006317179,0.000022618471,0.000057624206,0.000053543103,0.00050727365,0.98790705,0.00010070707,0.00046689875,0.005306141],"study_design_scores_gemma":[0.00006585702,0.0010427734,0.069064684,0.0000073498354,0.00008531371,0.000863106,0.000107751126,0.0045945654,0.9117535,0.00014379776,0.01225533,0.000015993766],"about_ca_topic_score_codex":0.0020126528,"about_ca_topic_score_gemma":0.0040147123,"teacher_disagreement_score":0.0020126528,"about_ca_system_score_codex":0.000337862,"about_ca_system_score_gemma":0.00028432757,"threshold_uncertainty_score":0.005837083},"labels":[],"label_agreement":null},{"id":"W2767525887","doi":"10.1093/neuonc/nox168.943","title":"STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"Biology; Cancer research; Epigenetics; Stem cell; Carcinogenesis; DNA methylation; Gene silencing; Histone; Cancer stem cell; Cancer; Cell biology; Genetics; Gene expression; Gene","score_opus":0.01976916725985499,"score_gpt":0.2873144401354264,"score_spread":0.2675452728755714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767525887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795547,0.0052726343,0.0039798548,0.00042049654,0.00007940417,0.00006656248,0.0048001194,0.0004076113,0.0054185903],"genre_scores_gemma":[0.98711514,0.0012965362,0.0012392441,0.00022962056,0.0000068806225,0.000047937403,0.003569629,0.000034890207,0.006460287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999149,0.0000073488263,0.000006798154,0.000026242824,0.00002934794,0.000015450005],"domain_scores_gemma":[0.99995327,0.000004191167,0.000018555755,0.0000031975462,0.000007686243,0.000013141045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006360924,0.00017352562,0.00019449317,0.00018481752,0.00014664297,0.00024385237,0.00011543059,0.00017276303,0.0024512936],"category_scores_gemma":[0.00006525677,0.00008870033,0.00019979065,0.00013739735,0.00016463695,0.00010005523,0.00015769483,0.00033471006,0.0006211125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016920111,0.00003547003,0.0007914732,0.00009093735,0.000007799465,0.00005656258,0.000026787107,0.00016120651,0.99219716,0.00023162631,0.00034868674,0.005883059],"study_design_scores_gemma":[0.000041160965,0.00039860787,0.03312359,0.00001894122,0.000032413096,0.00024778798,0.00006128311,0.0016525208,0.94979465,0.00014637012,0.014475236,0.0000074568675],"about_ca_topic_score_codex":0.0011270484,"about_ca_topic_score_gemma":0.0022342657,"teacher_disagreement_score":0.0024512936,"about_ca_system_score_codex":0.00037324906,"about_ca_system_score_gemma":0.0002588276,"threshold_uncertainty_score":0.008200407},"labels":[],"label_agreement":null},{"id":"W2767545176","doi":"10.1093/neuonc/nox168.194","title":"CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University; Princess Margaret Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Quality of life (healthcare); Clinical trial; Internal medicine; Oncology; Brain metastasis; Radiation therapy; Randomized controlled trial; Cancer; Metastasis","score_opus":0.331819077702643,"score_gpt":0.5391654500192089,"score_spread":0.20734637231656589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767545176","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010496046,0.03452458,0.003980561,0.06769161,0.01448959,0.040863752,0.1259612,0.002866456,0.6991262],"genre_scores_gemma":[0.095360085,0.022657199,0.030322425,0.07860144,0.0070050363,0.0658349,0.10979171,0.0015138276,0.58891344],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935201,0.00270593,0.00023901633,0.0005491643,0.0022153445,0.0007704079],"domain_scores_gemma":[0.9866541,0.002383028,0.0019021317,0.00066605775,0.0025638451,0.005830901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009114955,0.0017070578,0.0021681995,0.0013811943,0.0013013354,0.0041526794,0.0027121555,0.0073214127,0.124119535],"category_scores_gemma":[0.02080044,0.000734145,0.001375219,0.0021585482,0.0012320182,0.0016004506,0.0013200691,0.006953156,0.037485868],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032694135,0.00089617295,0.00051324576,0.0017454172,0.00032873455,0.00017209409,0.00006433717,0.00034799788,0.0017201566,0.003482738,0.85309684,0.10493807],"study_design_scores_gemma":[0.12185409,0.0033518863,0.007960374,0.0016870465,0.0002348927,0.00016373309,0.00003741825,0.00078412873,0.000675891,0.00382115,0.8593368,0.000092570444],"about_ca_topic_score_codex":0.026162434,"about_ca_topic_score_gemma":0.11602891,"teacher_disagreement_score":0.124119535,"about_ca_system_score_codex":0.0072819907,"about_ca_system_score_gemma":0.020594455,"threshold_uncertainty_score":0.4152212},"labels":[],"label_agreement":null},{"id":"W2767564843","doi":"10.1093/neuonc/nox168.099","title":"ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 &amp; TOCA FC TREATMENT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Bevacizumab; Medicine; Cancer; Cytosine deaminase; Cancer research; Immune system; Wild type; Glioma; Internal medicine; Mutant; Immunology; Biology; Chemotherapy; Genetic enhancement; Gene","score_opus":0.03998439439065296,"score_gpt":0.29958813938308226,"score_spread":0.25960374499242933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767564843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945628,0.0010093084,0.00033161635,0.00015384912,0.000048079826,0.00021671763,0.0006630794,0.00018218152,0.0028322996],"genre_scores_gemma":[0.9950525,0.0003499973,0.0005638699,0.00020513347,0.00001923552,0.0001564837,0.0016510139,0.000026577009,0.0019753058],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998512,0.000027987935,0.0000073596293,0.000023323411,0.000023404004,0.00006663239],"domain_scores_gemma":[0.9998852,0.00001496482,0.000018319935,0.000019273497,0.0000075343346,0.000054734133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033913797,0.00047397698,0.0009341915,0.0002888685,0.00018628845,0.000380286,0.00039135994,0.00055597996,0.0018713342],"category_scores_gemma":[0.00022260347,0.000157282,0.00042779636,0.0002520663,0.00024888653,0.00021523282,0.00016207919,0.0010882439,0.0005719076],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095184565,0.024063196,0.011512771,0.0007112646,0.0006653417,0.0026510113,0.00038393532,0.004976388,0.59674734,0.00092215993,0.012093284,0.25008872],"study_design_scores_gemma":[0.046309445,0.5604521,0.10803876,0.0000765714,0.00076302164,0.00942086,0.00027392546,0.0080977,0.23359309,0.0005852577,0.03229425,0.00009508675],"about_ca_topic_score_codex":0.0020882972,"about_ca_topic_score_gemma":0.005392618,"teacher_disagreement_score":0.0020882972,"about_ca_system_score_codex":0.0007129452,"about_ca_system_score_gemma":0.0005038415,"threshold_uncertainty_score":0.006260276},"labels":[],"label_agreement":null},{"id":"W2767571548","doi":"10.1093/neuonc/nox168.370","title":"EXTH-80. ENHANCED THERAPEUTIC RESPONSE IN MURINE MEDULLOBLASTOMA TUMOR MODEL USING ADENANTHIN AND TRANSIENT MODULATION OF THE BLOOD-BRAIN BARRIER WITH CADHERIN PEPTIDE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Blood–brain barrier; Medulloblastoma; Medicine; Pathology; Cancer research; Internal medicine; Central nervous system","score_opus":0.035785801748048615,"score_gpt":0.3391809613017363,"score_spread":0.3033951595536877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767571548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939121,0.0014714997,0.0014012862,0.0002471504,0.00009190552,0.00009420279,0.00057662337,0.00023849007,0.0019667344],"genre_scores_gemma":[0.9910324,0.0011304605,0.0021385564,0.000079296486,0.000026940012,0.00014820583,0.00074867596,0.000032061816,0.0046633123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998753,0.000015433608,0.000007933682,0.000025982305,0.000031026422,0.000044244494],"domain_scores_gemma":[0.999923,0.0000069738485,0.000018637536,0.000008330294,0.0000064065916,0.000036669484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017212686,0.0005650168,0.00039479256,0.00038097744,0.00013662927,0.00018835298,0.00022438962,0.00040892218,0.001571107],"category_scores_gemma":[0.000071017574,0.00015265228,0.00026028743,0.00020635164,0.00028115456,0.00037849354,0.00016678567,0.0009977868,0.000437932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007987866,0.00046895584,0.000120302655,0.00006192332,0.000009980847,0.00007544706,0.000036843252,0.00013761378,0.99563366,0.00013614669,0.0001934979,0.0023268783],"study_design_scores_gemma":[0.00019510795,0.0047463914,0.0018283174,0.000005799931,0.0000274492,0.00021572335,0.000025412664,0.00096859434,0.9896327,0.00006198711,0.0022854207,0.0000070402252],"about_ca_topic_score_codex":0.00090977864,"about_ca_topic_score_gemma":0.0011989967,"teacher_disagreement_score":0.001571107,"about_ca_system_score_codex":0.00034498653,"about_ca_system_score_gemma":0.00030133256,"threshold_uncertainty_score":0.0052559376},"labels":[],"label_agreement":null},{"id":"W2767576218","doi":"10.1093/neuonc/nox168.563","title":"NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Verbal learning; Cognitive decline; Internal medicine; Verbal memory; Oncology; Dementia; Cognition; Disease; Psychiatry","score_opus":0.02179629636757778,"score_gpt":0.35901355443787347,"score_spread":0.3372172580702957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767576218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420387,0.00011416104,0.00008721169,0.00003035506,0.0000063933007,0.00016744075,0.004110774,0.000013793564,0.001265846],"genre_scores_gemma":[0.99032295,0.000039041803,0.00016893579,0.00006614169,0.000010834757,0.00022989929,0.008103781,0.000012247941,0.0010460577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997396,0.00006713994,0.000024103369,0.000055678483,0.00006255588,0.000050984374],"domain_scores_gemma":[0.9989116,0.00021792736,0.0003217359,0.00012050436,0.00015543628,0.0002727552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007598621,0.00033474356,0.00047892137,0.00037109895,0.00025708412,0.00047581326,0.0005357499,0.0003175975,0.0027989617],"category_scores_gemma":[0.0013980689,0.00013768693,0.0004900652,0.00062297075,0.00018765924,0.00024663744,0.0002654357,0.00060478173,0.00060161715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014836046,0.0007967247,0.9736007,0.00005625017,0.00029243232,0.00009160053,0.000051533945,0.00022115943,0.0022212204,0.000027791202,0.0017801896,0.0060243662],"study_design_scores_gemma":[0.0003867762,0.0022845042,0.99549246,0.0000051155143,0.00009907945,0.00015910287,0.000033141787,0.0003098169,0.0003711961,0.000026599106,0.0008279523,0.0000042649945],"about_ca_topic_score_codex":0.0076426156,"about_ca_topic_score_gemma":0.014064281,"teacher_disagreement_score":0.0076426156,"about_ca_system_score_codex":0.00053634844,"about_ca_system_score_gemma":0.0006219104,"threshold_uncertainty_score":0.015196264},"labels":[],"label_agreement":null},{"id":"W2767581051","doi":"10.1093/neuonc/nox168.1089","title":"SCDT-06. QUANTIFIABLE LEVELS OF THE TRANSGENE, CYTOSINE DEAMINASE, IN TUMOR SAMPLES FOLLOWING INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Cytosine deaminase; Molecular biology; Glioma; Immunohistochemistry; Biology; Genetic enhancement; Pathology; Cancer research; Medicine; Gene","score_opus":0.03189538344428734,"score_gpt":0.2989544667792111,"score_spread":0.2670590833349238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767581051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984029,0.0004051668,0.0003419081,0.00002163955,0.0000035528444,0.000028883995,0.00019620372,0.000031424705,0.00056835404],"genre_scores_gemma":[0.9987684,0.000081380684,0.0003566542,0.000026208085,0.000002639922,0.000016422371,0.00030645312,0.000006499378,0.00043539488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993384,0.000010424437,0.0000038634257,0.00002005205,0.000018554225,0.00001332674],"domain_scores_gemma":[0.9999021,0.000019723102,0.000027050814,0.000006534129,0.000014218433,0.000030386915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012144747,0.00015133689,0.00025745304,0.00024240752,0.00010506786,0.00025185297,0.00007981711,0.00021193386,0.0006089787],"category_scores_gemma":[0.00022027573,0.00009681157,0.00007941102,0.00018120545,0.000118712334,0.00010345243,0.000055078453,0.00028321022,0.00015477635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011409698,0.00052143505,0.11187384,0.00015188946,0.000064050415,0.0023791955,0.00026612138,0.0005491597,0.8263327,0.000082683786,0.0006438415,0.04572539],"study_design_scores_gemma":[0.0006464918,0.025988214,0.57943535,0.000021524102,0.00023855828,0.009816432,0.00020808318,0.0051145246,0.3746422,0.00008587304,0.0037780555,0.000024742569],"about_ca_topic_score_codex":0.0008553817,"about_ca_topic_score_gemma":0.0014158398,"teacher_disagreement_score":0.0008553817,"about_ca_system_score_codex":0.00030746567,"about_ca_system_score_gemma":0.00014888462,"threshold_uncertainty_score":0.0022308826},"labels":[],"label_agreement":null},{"id":"W2767581845","doi":"10.1093/neuonc/nox168.033","title":"ACTR-42. INITIAL EXPERIENCE OF BLOOD-BRAIN BARRIER OPENING FOR CHEMOTHERAPEUTIC-DRUG DELIVERY TO BRAIN TUMOURS BY MR-GUIDED FOCUSED ULTRASOUND","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Microbubbles; Blood–brain barrier; Extravasation; Magnetic resonance imaging; Glioma; Focused ultrasound; Ultrasound; Drug delivery; Radiology; Nuclear medicine; Pathology; Central nervous system; Internal medicine; Cancer research","score_opus":0.027152577380353718,"score_gpt":0.3096478137641074,"score_spread":0.2824952363837537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767581845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944756,0.013624121,0.013511847,0.0018461494,0.00020664097,0.001105319,0.00059664325,0.0006780596,0.023675341],"genre_scores_gemma":[0.96530396,0.00894863,0.012487719,0.0026396797,0.00031773667,0.0009531051,0.0016917972,0.0002459068,0.007411539],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905795,0.00047322598,0.00005199941,0.00016173712,0.00013489254,0.00012011856],"domain_scores_gemma":[0.99963653,0.00012267416,0.000033643344,0.000058271802,0.000039520455,0.00010934157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017671627,0.000820543,0.0008511822,0.00037579704,0.00055407366,0.00060646754,0.00047339156,0.0007675542,0.0021713513],"category_scores_gemma":[0.0011870181,0.00029403451,0.0004125481,0.00029582,0.0005251337,0.0005695913,0.0005297394,0.0013249184,0.0015222244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0149035575,0.013496701,0.010629225,0.0010421048,0.00028505988,0.00472647,0.0025685907,0.002873362,0.58477086,0.0019495054,0.007990849,0.35476378],"study_design_scores_gemma":[0.007907545,0.26376063,0.05359892,0.00023886655,0.0005580338,0.035771143,0.00042110836,0.0060276906,0.45004845,0.001311456,0.18013132,0.00022484291],"about_ca_topic_score_codex":0.000541189,"about_ca_topic_score_gemma":0.0009143388,"teacher_disagreement_score":0.0021713513,"about_ca_system_score_codex":0.00034815606,"about_ca_system_score_gemma":0.0005695593,"threshold_uncertainty_score":0.00934571},"labels":[],"label_agreement":null},{"id":"W2767591027","doi":"10.1093/neuonc/nox168.444","title":"HOUT-13. PATIENT REPORTED OUTCOME MEASURES IN BRAIN METASTASES PATIENTS – A SYSTEMATIC REVIEW","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Grading (engineering); Quality of life (healthcare); Patient-reported outcome; Physical therapy; MEDLINE; Breast cancer; Data extraction; Palliative care; Internal medicine; Cancer; Nursing","score_opus":0.19431350558285893,"score_gpt":0.42684879130251385,"score_spread":0.23253528571965493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767591027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015947804,0.9907645,0.00043289788,0.00062508025,0.0003002966,0.0025816588,0.0029896102,0.000039131093,0.000672057],"genre_scores_gemma":[0.037615452,0.941518,0.0037525913,0.001720529,0.00025492115,0.012215641,0.002400803,0.000040101833,0.00048191802],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9665519,0.014344324,0.012012503,0.0018843402,0.0046688356,0.00053823413],"domain_scores_gemma":[0.92253685,0.05608833,0.014611839,0.0010394193,0.005267498,0.00045615446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020370182,0.0018509607,0.010853279,0.013930831,0.0009003241,0.0032697266,0.0023915423,0.0024360395,0.010194235],"category_scores_gemma":[0.101275094,0.0011181867,0.012958153,0.015165131,0.0012349848,0.0039303303,0.0023931775,0.0018977238,0.00057138456],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019011868,0.000012464464,0.00078503875,0.9729279,0.00650573,0.000031783897,0.00010762562,0.000079451296,0.00005051836,0.00017144614,0.0013105746,0.017827278],"study_design_scores_gemma":[0.0008108438,0.00019921358,0.005752966,0.93419063,0.045030504,0.00018676068,0.00018065474,0.0001357076,0.000104740575,0.00037475,0.012993511,0.00003961493],"about_ca_topic_score_codex":0.0074295294,"about_ca_topic_score_gemma":0.017334005,"teacher_disagreement_score":0.020370182,"about_ca_system_score_codex":0.0056392876,"about_ca_system_score_gemma":0.013738695,"threshold_uncertainty_score":0.10772914},"labels":[],"label_agreement":null},{"id":"W2767599002","doi":"10.1093/neuonc/nox168.1101","title":"SCDT-18. EXPRESSION OF ABC TRANSPORTERS AS PROGNOSTIC BIOMARKERS FOR GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Glioblastoma; ATP-binding cassette transporter; Transporter; Expression (computer science); Computational biology; Cancer research; Biology; Computer science; Genetics; Gene","score_opus":0.02543192807226448,"score_gpt":0.31868888940940115,"score_spread":0.2932569613371367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767599002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183054,0.012189299,0.0019900657,0.00043977328,0.00011247169,0.000045716253,0.0017949482,0.00007151945,0.0015256812],"genre_scores_gemma":[0.99528426,0.0011824409,0.0011048185,0.00008873962,0.000062253,0.000040236893,0.0013020311,0.000010993275,0.0009241323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999461,0.00015269838,0.000049753417,0.00010163702,0.00016196229,0.00007297052],"domain_scores_gemma":[0.99848217,0.0004101838,0.00063226605,0.0000516439,0.00024011137,0.00018361917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013411267,0.00033430313,0.0005486944,0.0009932001,0.0001600361,0.0005602695,0.00020714331,0.00037849406,0.0015587192],"category_scores_gemma":[0.0018602152,0.00014209177,0.0005668714,0.0012583954,0.0002973588,0.00028946952,0.00027514267,0.00056288636,0.00046335338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034679314,0.000080972415,0.9399293,0.00024410103,0.00039688786,0.0002660666,0.00006868816,0.00066051376,0.011983347,0.00014050602,0.0011265207,0.041635126],"study_design_scores_gemma":[0.00011546402,0.0009718971,0.976926,0.000054231696,0.00048245923,0.0012721608,0.000075608994,0.0061007254,0.0077793817,0.000757661,0.005437668,0.000026703743],"about_ca_topic_score_codex":0.0013316104,"about_ca_topic_score_gemma":0.0015506387,"teacher_disagreement_score":0.0015587192,"about_ca_system_score_codex":0.0004991374,"about_ca_system_score_gemma":0.00042371912,"threshold_uncertainty_score":0.007092595},"labels":[],"label_agreement":null},{"id":"W2767613513","doi":"10.1093/neuonc/nox168.036","title":"ACTR-45. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Concomitant; Medicine; Temozolomide; Nausea; Glioma; Internal medicine; Vomiting; Interim analysis; Tolerability; Surgery; Radiation therapy; Adverse effect; Gastroenterology; Clinical trial","score_opus":0.03918978322584706,"score_gpt":0.3592807108428105,"score_spread":0.32009092761696345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767613513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725792,0.0044191782,0.0021893936,0.00079586933,0.00030887107,0.008332916,0.0041205627,0.0008496794,0.0064044627],"genre_scores_gemma":[0.963342,0.0028866925,0.0063249604,0.0017535144,0.0002475918,0.009752739,0.008429441,0.00017154534,0.0070914803],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99912196,0.0004225272,0.000039558126,0.00016194288,0.00009713158,0.00015689517],"domain_scores_gemma":[0.9993494,0.00005673468,0.00013989319,0.00006788738,0.000039770777,0.00034626076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017493764,0.0023467278,0.0017088563,0.000866788,0.00067065976,0.0012490007,0.0014321622,0.001631009,0.0039908984],"category_scores_gemma":[0.0008630234,0.0010150399,0.0016093174,0.00061481085,0.0010587662,0.0010323412,0.00044548226,0.0032185456,0.0020187756],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62710065,0.1001145,0.006845636,0.0012404773,0.002065264,0.00029630112,0.00055411056,0.005477415,0.1146141,0.001370957,0.015217653,0.12510294],"study_design_scores_gemma":[0.59695196,0.36558408,0.012135854,0.000051731586,0.0009184207,0.00046651988,0.00007387635,0.002634983,0.010636282,0.0005702288,0.0099106785,0.000065411325],"about_ca_topic_score_codex":0.0022198628,"about_ca_topic_score_gemma":0.0068691955,"teacher_disagreement_score":0.0039908984,"about_ca_system_score_codex":0.0012236498,"about_ca_system_score_gemma":0.0023259192,"threshold_uncertainty_score":0.013350844},"labels":[],"label_agreement":null},{"id":"W2767617427","doi":"10.1093/neuonc/nox168.567","title":"NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Neurocognitive; Clinical endpoint; Radiation therapy; Brain metastasis; Internal medicine; Oncology; Randomized controlled trial; Surgery; Cancer; Metastasis; Cognition","score_opus":0.2090155266997285,"score_gpt":0.5062000524411235,"score_spread":0.29718452574139503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767617427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92761797,0.017331205,0.0013401033,0.0039031657,0.0013426912,0.014246388,0.014637536,0.00038949406,0.01919144],"genre_scores_gemma":[0.9290924,0.0092760585,0.0040403963,0.0044879788,0.0009100369,0.02185382,0.011318262,0.00008373269,0.018937243],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991823,0.00054975384,0.000033648972,0.00005997766,0.00008614211,0.00008832202],"domain_scores_gemma":[0.99919266,0.00019991712,0.00021184054,0.000055422617,0.000072746065,0.0002674809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023922464,0.0012026369,0.0016834465,0.00035832424,0.0007360349,0.0008992039,0.0008267774,0.0014108764,0.0055032396],"category_scores_gemma":[0.0021047345,0.00035333904,0.0011209447,0.00050882297,0.00087494066,0.0005242232,0.0002890148,0.0022858493,0.0011044308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9213942,0.009284627,0.0023730341,0.0014441502,0.0012333978,0.00010832908,0.000111174944,0.00057354715,0.003349816,0.00051528425,0.017515663,0.042096756],"study_design_scores_gemma":[0.93500626,0.050038192,0.00590724,0.000105095685,0.0005285433,0.00008561184,0.00003320426,0.00060079066,0.0005610224,0.00028646295,0.006817147,0.00003052628],"about_ca_topic_score_codex":0.008745827,"about_ca_topic_score_gemma":0.037617266,"teacher_disagreement_score":0.008745827,"about_ca_system_score_codex":0.0013029198,"about_ca_system_score_gemma":0.003036384,"threshold_uncertainty_score":0.018410146},"labels":[],"label_agreement":null},{"id":"W2767623417","doi":"10.1093/neuonc/nox168.212","title":"CSIG-18. RALOXIFENE SENSITIZES GLIOBLASTOMA CELLS TO HYPOXIA-INDUCED DEATH THROUGH INHIBITION OF RNA STRESS GRANULE DISSOLUTION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Raloxifene; Stress granule; Hypoxia (environmental); Autophagy; Programmed cell death; Apoptosis; Cancer research; Chemistry; Selective estrogen receptor modulator; Downregulation and upregulation; Pharmacology; Medicine; Cell biology; Biology; Estrogen receptor; Internal medicine; Messenger RNA; Translation (biology); Biochemistry; Gene","score_opus":0.030636578417558593,"score_gpt":0.3197846394331111,"score_spread":0.2891480610155525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767623417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98064214,0.008260086,0.0018491432,0.0002775441,0.000059424394,0.00024455792,0.0032269915,0.0005357303,0.0049045053],"genre_scores_gemma":[0.97646856,0.006417314,0.0038072467,0.00025554173,0.000017781045,0.00019010979,0.006398882,0.00004169226,0.0064028683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999044,0.000009658588,0.000009424272,0.000018478631,0.000025499683,0.000032479133],"domain_scores_gemma":[0.99996233,0.0000052967553,0.000008970071,0.0000042106117,0.000007651582,0.000011550855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089705674,0.00038646164,0.0006714935,0.0005472875,0.00017432512,0.00029554658,0.00024095787,0.0002478985,0.0017596798],"category_scores_gemma":[0.000083037565,0.00016770247,0.00045046755,0.0004858558,0.00014381405,0.00010952216,0.0001655991,0.0004064026,0.00047769627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006750471,0.00024090997,0.0008884322,0.00021257614,0.000045219385,0.0001222283,0.00003053051,0.0002581256,0.9771517,0.00009434088,0.00072984776,0.01955108],"study_design_scores_gemma":[0.00037996375,0.0042854417,0.015637197,0.000019718756,0.00013403257,0.0006454365,0.00004131548,0.0010892116,0.96310157,0.00006876952,0.01457759,0.000019922636],"about_ca_topic_score_codex":0.0023827404,"about_ca_topic_score_gemma":0.008210295,"teacher_disagreement_score":0.0023827404,"about_ca_system_score_codex":0.00032342784,"about_ca_system_score_gemma":0.0003891785,"threshold_uncertainty_score":0.0058867335},"labels":[],"label_agreement":null},{"id":"W2767624622","doi":"10.1093/neuonc/nox168.546","title":"MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McGill University Health Centre; Juravinski Cancer Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Meningioma; Oncology; Surgery","score_opus":0.05114736688437131,"score_gpt":0.3490353599664027,"score_spread":0.2978879930820314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767624622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772906,0.0036463551,0.00032699137,0.0009734464,0.000059658574,0.0012644967,0.0072509274,0.00007934645,0.009108241],"genre_scores_gemma":[0.9817045,0.0015187433,0.0010842939,0.0010418836,0.00009476552,0.0011027849,0.010237963,0.000042659376,0.0031723743],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99939394,0.00030678342,0.00003234392,0.00005606695,0.000112096204,0.00009877862],"domain_scores_gemma":[0.9993856,0.00009777077,0.00013091898,0.00007225677,0.000037299596,0.00027612183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027499998,0.000570132,0.0009406181,0.00033238175,0.00029718166,0.0005530991,0.0004443361,0.00046822854,0.002053251],"category_scores_gemma":[0.0010934831,0.00017989706,0.0008159963,0.0004229723,0.00033501428,0.00028979758,0.00047280174,0.0012120104,0.00046539668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41450214,0.017474672,0.21195161,0.0015107723,0.0027617004,0.00044108517,0.00042771257,0.0066252844,0.014454073,0.0009439693,0.034381434,0.2945256],"study_design_scores_gemma":[0.11095233,0.29650456,0.5470298,0.00034037328,0.0024494892,0.0009063387,0.00024468778,0.0034342862,0.007430421,0.00094485853,0.029696094,0.000066735374],"about_ca_topic_score_codex":0.0028404563,"about_ca_topic_score_gemma":0.0121466955,"teacher_disagreement_score":0.0028404563,"about_ca_system_score_codex":0.0013940266,"about_ca_system_score_gemma":0.0014460497,"threshold_uncertainty_score":0.014543533},"labels":[],"label_agreement":null},{"id":"W2767629883","doi":"10.1093/neuonc/nox168.173","title":"CMET-25. PROGRESSION-FREE SURVIVAL (PFS) AND SITE OF FIRST PROGRESSION IN HER2+ METASTATIC BREAST CANCER PATIENTS WITH OR WITHOUT BRAIN METASTASES: A POOLED ANALYSIS OF TUCATINIB PHASE I STUDIES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Capecitabine; Progression-free survival; Breast cancer; Oncology; Cohort; Brain metastasis; Cancer; Gastroenterology; Overall survival; Metastasis; Colorectal cancer","score_opus":0.03978196753042855,"score_gpt":0.4096761115870824,"score_spread":0.36989414405665383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767629883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7699135,0.21587965,0.0013122516,0.00035126833,0.00016315955,0.0006151608,0.009554663,0.00011770673,0.0020926318],"genre_scores_gemma":[0.98460674,0.010218872,0.00040983353,0.00016901281,0.00010080346,0.00026146203,0.0038086576,0.000015991092,0.00040854886],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99722147,0.0015077214,0.00040048198,0.0003966071,0.0003282923,0.00014540291],"domain_scores_gemma":[0.9972434,0.0011996434,0.0010134669,0.00016749841,0.00017624468,0.00019968378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065491637,0.00092168996,0.0038527183,0.0018235536,0.0001839599,0.0013275822,0.00042678314,0.00059726846,0.001659582],"category_scores_gemma":[0.00493109,0.00039055175,0.01001706,0.0021196334,0.00024339014,0.0005485378,0.00051272835,0.0007452981,0.00022518971],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32363573,0.00039791738,0.14277822,0.011436023,0.3989622,0.00030776835,0.000110254616,0.004418227,0.008236075,0.00015353756,0.0028694978,0.10669453],"study_design_scores_gemma":[0.051033042,0.03745053,0.5355335,0.00094911706,0.3577453,0.0010961716,0.00013119324,0.0034792332,0.0030132174,0.0005072589,0.008931752,0.0001296904],"about_ca_topic_score_codex":0.0007606047,"about_ca_topic_score_gemma":0.0017677433,"teacher_disagreement_score":0.0065491637,"about_ca_system_score_codex":0.000692289,"about_ca_system_score_gemma":0.0005045213,"threshold_uncertainty_score":0.034635723},"labels":[],"label_agreement":null},{"id":"W2767635736","doi":"10.1093/neuonc/nox168.410","title":"GENE-37. PATHWAY ANALYSIS OF RADIATION-INDUCED MENINGIOMAS REVEALS THAT TUMOURS WITH NF2-FUSION HAVE UPREGULATION OF INFLAMMATORY PATHWAYS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Fusion gene; Gene; Downregulation and upregulation; Biology; Cancer research; CDKN2A; Bioconductor; Fold change; Gene expression; Molecular biology; Bioinformatics; Genetics","score_opus":0.03990963570850977,"score_gpt":0.3138341214171201,"score_spread":0.27392448570861033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767635736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52763987,0.012197363,0.013408662,0.0009320912,0.00037596916,0.00021394636,0.42772537,0.0043373397,0.013169416],"genre_scores_gemma":[0.6599584,0.0052140746,0.029979996,0.000865067,0.000052824613,0.0007755612,0.2857334,0.0007207981,0.016699906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995989,0.000026483445,0.000019131898,0.00016609824,0.000095234944,0.00009411717],"domain_scores_gemma":[0.9998221,0.000041975793,0.000046327223,0.000013262621,0.0000372282,0.00003918074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026006988,0.00065636,0.0007339728,0.0014935604,0.000680553,0.0007642807,0.00028272867,0.00036250387,0.010667859],"category_scores_gemma":[0.00039887434,0.00023143385,0.0014099757,0.0021512122,0.00024576797,0.0002902541,0.00054817245,0.0006999256,0.0029869487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004575857,0.00030041917,0.12818518,0.007445199,0.0014630577,0.0014663808,0.00085966696,0.0077370764,0.66491914,0.0037607537,0.04535298,0.13393423],"study_design_scores_gemma":[0.00031637948,0.0012848538,0.6856362,0.00056317705,0.0011862789,0.0029974254,0.00077030563,0.024382934,0.14520499,0.0045951824,0.13286178,0.00020044229],"about_ca_topic_score_codex":0.004538968,"about_ca_topic_score_gemma":0.007654373,"teacher_disagreement_score":0.010667859,"about_ca_system_score_codex":0.00059002475,"about_ca_system_score_gemma":0.0009823312,"threshold_uncertainty_score":0.035687566},"labels":[],"label_agreement":null},{"id":"W2767639660","doi":"10.1093/neuonc/nox168.182","title":"CMET-35. PRELIMINARY SCREENING OF A NOVEL EpCAM BISPECIFIC T-CELL ENGAGER (BiTE) ANTIBODY TO TARGET A BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Epithelial cell adhesion molecule; Antigen; Population; Monoclonal antibody; Cancer research; Flow cytometry; Antibody; Cancer stem cell; Cancer; Metastasis; Biology; Immunology; Medicine; Genetics","score_opus":0.08009285261940259,"score_gpt":0.40502036812942266,"score_spread":0.3249275155100201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767639660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500855,0.002235413,0.015768481,0.00023155818,0.000061160106,0.00065935287,0.0013799036,0.00016660053,0.0044890093],"genre_scores_gemma":[0.97502327,0.0012857902,0.011818044,0.00026777346,0.000018234521,0.0003780519,0.0043601636,0.000028567625,0.0068200855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985814,0.000026986267,0.000009016184,0.000030611598,0.00004059232,0.000034536606],"domain_scores_gemma":[0.9999497,0.00001213361,0.0000053735153,0.000004271639,0.000013124466,0.000015449188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022453173,0.0003875801,0.00028460883,0.00021524639,0.000104938,0.00018931643,0.00023162435,0.00048288493,0.0016878663],"category_scores_gemma":[0.00017014408,0.000128442,0.0002716408,0.00013502521,0.00007659443,0.000095194075,0.00016284878,0.0005951401,0.00043095314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008111839,0.00009354067,0.000105117055,0.0000486531,0.0000073394203,0.000032536707,0.000012720093,0.0002418104,0.9968747,0.00004496013,0.00012443308,0.0023329235],"study_design_scores_gemma":[0.00005175892,0.0016935375,0.0023291495,0.000010161084,0.000029965851,0.0003041733,0.000013764317,0.0023550477,0.9893596,0.000037447066,0.0038097145,0.000005711921],"about_ca_topic_score_codex":0.00047362313,"about_ca_topic_score_gemma":0.0008495107,"teacher_disagreement_score":0.0016878663,"about_ca_system_score_codex":0.0001789655,"about_ca_system_score_gemma":0.00011363373,"threshold_uncertainty_score":0.0056464076},"labels":[],"label_agreement":null},{"id":"W2767646803","doi":"10.1093/neuonc/nox168.1041","title":"TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Radiation therapy; Cancer stem cell; Chemoradiotherapy; Cancer research; Stem cell; Glioblastoma; Transcriptome; Temozolomide; Brain tumor; Medicine; Chemotherapy; Oncology; Cancer; Biology; Internal medicine; Pathology; Gene; Gene expression","score_opus":0.03639664062267455,"score_gpt":0.33700299826841007,"score_spread":0.3006063576457355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767646803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777465,0.0018394819,0.0071351533,0.00038018113,0.00012736415,0.00016880929,0.00727685,0.00077329465,0.004552462],"genre_scores_gemma":[0.9688514,0.0010013352,0.010823303,0.00044313204,0.000020999867,0.00018715496,0.013092402,0.00014117663,0.0054391497],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997708,0.000012516843,0.000017345761,0.000073101895,0.00008312295,0.000043071792],"domain_scores_gemma":[0.999869,0.000016942895,0.00004802724,0.000010292942,0.00002242284,0.00003326445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001875444,0.00026318387,0.0004407388,0.0003282702,0.0001545951,0.0006256561,0.00020621908,0.0002958386,0.0016100691],"category_scores_gemma":[0.00029515882,0.0001124446,0.0002459255,0.00031985732,0.0001602861,0.00012444043,0.0001749544,0.0004627939,0.0006064131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044086765,0.00008732806,0.0036717167,0.00013216598,0.000027473176,0.0001462248,0.000040020917,0.0003273411,0.97626865,0.00019675591,0.001077043,0.017584333],"study_design_scores_gemma":[0.00015491199,0.0015219583,0.070681654,0.00004786951,0.0001931356,0.0024909452,0.0001623405,0.011915575,0.87916565,0.00024415719,0.033366065,0.00005577119],"about_ca_topic_score_codex":0.0016653572,"about_ca_topic_score_gemma":0.0024545663,"teacher_disagreement_score":0.0016653572,"about_ca_system_score_codex":0.0004676868,"about_ca_system_score_gemma":0.00039121165,"threshold_uncertainty_score":0.0053862333},"labels":[],"label_agreement":null},{"id":"W2767664052","doi":"10.1093/neuonc/nox168.028","title":"ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Internal medicine; Oncology; Medicine; Hazard ratio; IDH1; Univariate analysis; Biopsy; Proportional hazards model; Post-hoc analysis; Multivariate analysis; Confidence interval; Biology; Gene; Mutation","score_opus":0.0197238445767333,"score_gpt":0.34599998348462097,"score_spread":0.32627613890788765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767664052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774975,0.00056453096,0.00017468401,0.00019930315,0.000042229327,0.00021591444,0.00044111555,0.000022953076,0.00058959145],"genre_scores_gemma":[0.99678075,0.00025801832,0.000517568,0.00018303203,0.00006051294,0.0002922025,0.0008147901,0.000012742689,0.0010803804],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99871576,0.0009308045,0.000052979707,0.00013111591,0.000089411486,0.00007994],"domain_scores_gemma":[0.99843055,0.0005673909,0.0003757791,0.00015336453,0.00006280528,0.00041010743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002238429,0.0006171639,0.0010551473,0.00026261088,0.000116810916,0.0004793105,0.0005167028,0.0005832977,0.0021461556],"category_scores_gemma":[0.0017807437,0.00023053969,0.0011891446,0.00028706776,0.00038675487,0.00032958572,0.00017120059,0.0012154869,0.00045841886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90305674,0.0057148077,0.028393723,0.00019712439,0.0011785072,0.00013302978,0.00007841224,0.0016145518,0.017179253,0.00008593768,0.0012112639,0.04115667],"study_design_scores_gemma":[0.23667563,0.58784306,0.1501993,0.00004158837,0.0029568665,0.0004687743,0.00009600433,0.006402468,0.010475352,0.0004017028,0.004386956,0.000052340107],"about_ca_topic_score_codex":0.00070125796,"about_ca_topic_score_gemma":0.002525044,"teacher_disagreement_score":0.002238429,"about_ca_system_score_codex":0.00058272807,"about_ca_system_score_gemma":0.0008742144,"threshold_uncertainty_score":0.0118380785},"labels":[],"label_agreement":null},{"id":"W2767667543","doi":"10.1093/neuonc/nox168.705","title":"PATH-14. SIZE OF INCIDENTALLY DISCOVERED DIFFUSELY INFILTRATING GLIOMAS PREDICTS FUTURE GROWTH RATE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Glioma; Oligodendroglioma; Asymptomatic; Astrocytoma; Fluid-attenuated inversion recovery; Lesion; Radiology; Nuclear medicine; Pathology; Magnetic resonance imaging","score_opus":0.015952444765943638,"score_gpt":0.28653679596712983,"score_spread":0.2705843512011862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767667543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812573,0.00010904624,0.00024408354,0.00004109595,0.000006665898,0.0000052524206,0.0006211336,0.000018306788,0.0008285882],"genre_scores_gemma":[0.9987525,0.000050052782,0.00024011568,0.0000059107083,0.0000066794278,0.000004990947,0.0006202234,0.0000073693495,0.0003121272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998355,0.000027394755,0.000026870759,0.000038068505,0.000038251448,0.00003388958],"domain_scores_gemma":[0.9972248,0.00072083046,0.0013155559,0.00010922225,0.00023943403,0.00039024715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037908685,0.00024806967,0.00014628656,0.0006561827,0.00015990064,0.00045037657,0.00028949132,0.00034025265,0.0035559947],"category_scores_gemma":[0.002659845,0.00013893562,0.00031305783,0.0004067803,0.00022720969,0.00043759253,0.00023691272,0.00041862746,0.0007908104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007012649,0.000007535483,0.99808913,0.0000042410584,0.0000071302,0.00014851823,0.000008762805,0.00006342636,0.00033192462,0.00000603072,0.000072762865,0.0011902557],"study_design_scores_gemma":[0.0000027450599,0.00006516683,0.99697614,0.0000037059071,0.000015580386,0.0015233031,0.00005207294,0.00070851145,0.00045565685,0.00002986732,0.00016463098,0.0000027174553],"about_ca_topic_score_codex":0.0021299599,"about_ca_topic_score_gemma":0.0022341593,"teacher_disagreement_score":0.0035559947,"about_ca_system_score_codex":0.00021551212,"about_ca_system_score_gemma":0.00020390857,"threshold_uncertainty_score":0.011895955},"labels":[],"label_agreement":null},{"id":"W2767695428","doi":"10.1093/neuonc/nox168.562","title":"NCOG-01. PATIENT-REPORTED COGNITIVE CONCERNS AND QUALITY OF LIFE IN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Cognition; Anxiety; Quality of life (healthcare); Depression (economics); Distress; Medicine; Intrusiveness; Clinical psychology; Executive functions; Psychiatry; Psychology; Developmental psychology","score_opus":0.10612063900626331,"score_gpt":0.3981331473694413,"score_spread":0.29201250836317794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767695428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8830078,0.0020335165,0.0002557366,0.0028777039,0.00026800024,0.0009758925,0.06323337,0.00014966102,0.0471982],"genre_scores_gemma":[0.9267427,0.0011159895,0.0010343012,0.0011750549,0.00012278068,0.002042617,0.055077944,0.00006946085,0.012619207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991929,0.0002563792,0.000096018135,0.00006879989,0.00024323247,0.00014266468],"domain_scores_gemma":[0.99320364,0.0017003088,0.0020322609,0.00016526284,0.0013346513,0.0015640245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018124768,0.0002696097,0.0003931033,0.0009547799,0.00044440432,0.0009300631,0.0005732466,0.0004326985,0.010423368],"category_scores_gemma":[0.007767913,0.00012189856,0.0004965324,0.002282512,0.00027952204,0.000493233,0.00089973916,0.00084211817,0.0017032316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086665014,0.0004042398,0.95361274,0.00020380864,0.000083827275,0.00008409696,0.00021557028,0.0001563038,0.00014377001,0.00010975113,0.021556389,0.022562847],"study_design_scores_gemma":[0.000094726354,0.00022623102,0.99298614,0.000040865623,0.000021019498,0.00008411022,0.00014995056,0.000085813255,0.00002883554,0.0000497891,0.0062256064,0.000006875874],"about_ca_topic_score_codex":0.02686988,"about_ca_topic_score_gemma":0.05720696,"teacher_disagreement_score":0.02686988,"about_ca_system_score_codex":0.0017797489,"about_ca_system_score_gemma":0.0019530868,"threshold_uncertainty_score":0.05342698},"labels":[],"label_agreement":null},{"id":"W2767697997","doi":"10.1093/neuonc/nox168.217","title":"CSIG-23. CIC PROTEIN INSTABILITY DRIVES CANCER PHENOTYPES IN GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"MAPK/ERK pathway; Cancer research; Signal transduction; Biology; Receptor tyrosine kinase; Ubiquitin ligase; Kinase; Cell biology; Carcinogenesis; Cancer; Ubiquitin; Genetics; Gene","score_opus":0.016221524313195654,"score_gpt":0.3197615835393039,"score_spread":0.3035400592261082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767697997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189574,0.00078931736,0.0011271469,0.00023618153,0.00006709056,0.000056948902,0.0023439305,0.00029629,0.0031875144],"genre_scores_gemma":[0.99141884,0.00033972235,0.0011048788,0.00011210431,0.000009924852,0.00004624396,0.0022676534,0.00008559883,0.004614891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998049,0.00002586172,0.000025461233,0.000036844795,0.000056408913,0.000050506693],"domain_scores_gemma":[0.9997937,0.00002419235,0.000057050078,0.000026052634,0.000011943404,0.00008703397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011410867,0.00034100216,0.00033805353,0.00039114716,0.0002395596,0.00033186405,0.0002988153,0.00034132416,0.0024424526],"category_scores_gemma":[0.000115442264,0.00015860521,0.00023992649,0.00034807075,0.00032976203,0.00007377374,0.00024101393,0.0005331417,0.0011552222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083604624,0.00003693672,0.00022253697,0.00001915954,0.0000066910206,0.0001799451,0.000012672526,0.00006572122,0.9982566,0.0001300453,0.0001619428,0.00082412106],"study_design_scores_gemma":[0.000025778463,0.00036377393,0.015477488,0.000010456226,0.000021562924,0.0013567815,0.00007493713,0.0017956111,0.97323304,0.000112256144,0.007516843,0.000011499776],"about_ca_topic_score_codex":0.0030245234,"about_ca_topic_score_gemma":0.0047574504,"teacher_disagreement_score":0.0030245234,"about_ca_system_score_codex":0.00067938433,"about_ca_system_score_gemma":0.00041993245,"threshold_uncertainty_score":0.0081707835},"labels":[],"label_agreement":null},{"id":"W2767699464","doi":"10.1093/neuonc/nox168.462","title":"IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"EPH receptor A2; Cancer research; Population; Gene knockdown; Receptor tyrosine kinase; Protein kinase B; Biology; Medicine; Receptor; Cell culture; Phosphorylation; Internal medicine; Cell biology","score_opus":0.03993740797815651,"score_gpt":0.3378708080221566,"score_spread":0.29793340004400004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767699464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734841,0.004905261,0.0069721336,0.00040552468,0.00018170188,0.0005034372,0.0013382807,0.0008077022,0.011401778],"genre_scores_gemma":[0.9719338,0.0033881317,0.011494972,0.00032806952,0.000037634327,0.00068842043,0.0036677993,0.00007945531,0.0083816685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998516,0.000031497926,0.000008167459,0.000024147625,0.00003268576,0.000051906296],"domain_scores_gemma":[0.99996567,0.0000057167435,0.000004966892,0.000005170108,0.0000057242178,0.000012683936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031706868,0.00061174016,0.0004498554,0.00044548634,0.0001678674,0.00036958506,0.0004069232,0.00058528385,0.001447484],"category_scores_gemma":[0.00009657065,0.00017962918,0.00043244325,0.00031499303,0.00018394692,0.00014529758,0.00023173657,0.00086925476,0.0008755295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012004914,0.0013227131,0.000519489,0.00023172896,0.0000648195,0.00026282785,0.00006478062,0.00076208066,0.9724939,0.0009871152,0.0012778959,0.020812126],"study_design_scores_gemma":[0.00038999453,0.0045434027,0.0038533702,0.000019652325,0.00009303889,0.0006447183,0.000024804374,0.004374493,0.9750553,0.0001355611,0.010856642,0.000009162097],"about_ca_topic_score_codex":0.0017477126,"about_ca_topic_score_gemma":0.002386049,"teacher_disagreement_score":0.0017477126,"about_ca_system_score_codex":0.00045505146,"about_ca_system_score_gemma":0.0005854311,"threshold_uncertainty_score":0.004842341},"labels":[],"label_agreement":null},{"id":"W2767712841","doi":"10.1093/neuonc/nox168.859","title":"RARE-06. CANADIAN PATTERNS OF PRACTICE FOR INTRACRANIAL GERM CELL TUMOURS IN ADOLESCENTS AND YOUNG ADULTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Germinoma; Germ cell tumors; Chemotherapy; Specialty; Pediatrics; Surgery; Pathology","score_opus":0.014145325714358219,"score_gpt":0.29411916067015353,"score_spread":0.2799738349557953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767712841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81797063,0.006522493,0.0004027528,0.012230527,0.00028525997,0.00038862394,0.067186795,0.00022083771,0.094792135],"genre_scores_gemma":[0.95996565,0.004923923,0.0017677393,0.0028647431,0.00009263284,0.00017045556,0.013150473,0.000059985683,0.017004432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990227,0.00005667742,0.00006849719,0.00009269331,0.00041262634,0.00034682758],"domain_scores_gemma":[0.9939249,0.00022893374,0.0013344657,0.000057152767,0.0021685464,0.0022860128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050773966,0.00018887901,0.00014114073,0.002073645,0.002009836,0.0011504682,0.00074485363,0.00047236859,0.01364388],"category_scores_gemma":[0.002958361,0.0001836875,0.00034194984,0.0037351716,0.00037156994,0.0004048665,0.0007000363,0.0005116011,0.0011423603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058257672,0.000060485163,0.9093705,0.00031678996,0.00002662214,0.0003107775,0.0029781666,0.00008029145,0.00027566528,0.00058746856,0.04455455,0.041380472],"study_design_scores_gemma":[0.00001006349,0.00002902087,0.96462184,0.00019417887,0.000012505765,0.0003578217,0.0045014056,0.000095604664,0.00005952998,0.00003970255,0.030063504,0.000014945333],"about_ca_topic_score_codex":0.9628818,"about_ca_topic_score_gemma":0.98178965,"teacher_disagreement_score":0.037118196,"about_ca_system_score_codex":0.015591043,"about_ca_system_score_gemma":0.026607677,"threshold_uncertainty_score":0.11312145},"labels":[],"label_agreement":null},{"id":"W2767715561","doi":"10.1093/neuonc/nox168.627","title":"NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Multivariate analysis; Proportional hazards model; Bevacizumab; Database; Surgery; Chemotherapy","score_opus":0.05642568698006856,"score_gpt":0.34264099931898173,"score_spread":0.2862153123389132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767715561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637205,0.0077868793,0.0003922018,0.00024823152,0.000029081008,0.000119057586,0.00393273,0.00002507097,0.0010947852],"genre_scores_gemma":[0.99448836,0.001138917,0.00031410478,0.00016433909,0.000041332238,0.00008163431,0.0036503468,0.000010220695,0.00011056462],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955096,0.0025430378,0.00047131907,0.000720134,0.00058100204,0.00017479733],"domain_scores_gemma":[0.99187684,0.002354623,0.0038156502,0.0010445822,0.00044288643,0.00046541932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01096544,0.00042987205,0.0011229919,0.0012254869,0.00029552684,0.0012329151,0.00065702747,0.00042477244,0.00095040846],"category_scores_gemma":[0.010841681,0.00022828803,0.0016411203,0.0020652933,0.0005206646,0.0004951212,0.00077602046,0.00034051115,0.00024528996],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025402252,0.0002963998,0.9089071,0.00063216646,0.014121234,0.00012450042,0.00016089011,0.0005970073,0.001701224,0.00006417833,0.0016515087,0.046341524],"study_design_scores_gemma":[0.0017348122,0.0017913599,0.9847719,0.000093403265,0.007980959,0.00024357068,0.00007394291,0.0005484461,0.00063645124,0.000105420906,0.0019944455,0.000025303814],"about_ca_topic_score_codex":0.0025801642,"about_ca_topic_score_gemma":0.005771396,"teacher_disagreement_score":0.01096544,"about_ca_system_score_codex":0.00050409226,"about_ca_system_score_gemma":0.0006988239,"threshold_uncertainty_score":0.057991445},"labels":[],"label_agreement":null},{"id":"W2767747918","doi":"10.1093/neuonc/nox168.254","title":"DDIS-19. NOVEL PEPTIDE HOMING TO GLIOMA-SPECIFIC ISOFORM OF BREVICAN SELECTIVELY TARGETS MALIGNANT BRAIN TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Gene isoform; Peptide library; Peptide; Biology; B cell; Cancer research; Molecular biology; Chemistry; Biochemistry; Peptide sequence; Antibody; Immunology; Gene","score_opus":0.027552941740150844,"score_gpt":0.29263625262546733,"score_spread":0.2650833108853165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767747918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94784033,0.009807498,0.022950847,0.0005401787,0.00024241877,0.0005544004,0.0021389902,0.00077183486,0.015153501],"genre_scores_gemma":[0.9500698,0.0062892353,0.022042869,0.00053631165,0.000062843515,0.00046332268,0.004921083,0.0000733569,0.015541197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998783,0.000012609682,0.0000099082,0.000029034467,0.000037891274,0.000032216354],"domain_scores_gemma":[0.99996567,0.000003897075,0.000008746847,0.000002932625,0.0000047263297,0.000013998606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011729678,0.0005006228,0.00031910258,0.00031041424,0.00013693512,0.00032956843,0.00037575868,0.00036721968,0.0011634745],"category_scores_gemma":[0.000096641765,0.0001661262,0.00022802288,0.00021663883,0.00016769064,0.00019290796,0.00028004887,0.00058190915,0.0006651801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014907311,0.0000839057,0.00015605871,0.000101392674,0.000009613119,0.0000981835,0.000012457419,0.0002607726,0.98812884,0.00032248287,0.00049863075,0.010178433],"study_design_scores_gemma":[0.00005800128,0.00052573706,0.00085791195,0.0000065059494,0.000015088403,0.0004252245,0.0000069433636,0.0010133673,0.9841411,0.00006938304,0.01287348,0.00000722763],"about_ca_topic_score_codex":0.00041322922,"about_ca_topic_score_gemma":0.00062721554,"teacher_disagreement_score":0.0011634745,"about_ca_system_score_codex":0.0005109349,"about_ca_system_score_gemma":0.00028949825,"threshold_uncertainty_score":0.003892243},"labels":[],"label_agreement":null},{"id":"W2767766110","doi":"10.1093/neuonc/nox168.1104","title":"SCDT-21. CEREBRAL INTRAARTERIAL CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT GLIOMAS: READY TO RISE AGAIN","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Temozolomide; Carboplatin; Chemotherapy; Complication; Glioma; Concomitant; Cohort; Surgery; Radiation therapy; Oncology; Internal medicine; Cisplatin","score_opus":0.04201072693010514,"score_gpt":0.3734141479719171,"score_spread":0.3314034210418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767766110","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.510581,0.4457945,0.0033736655,0.00893753,0.0013440956,0.00023713522,0.0010160038,0.00031791566,0.028398182],"genre_scores_gemma":[0.8435042,0.13092719,0.005249953,0.0022063733,0.0011224819,0.00012882966,0.0023049267,0.00009998361,0.014456121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997857,0.00007575649,0.000019331588,0.000027529155,0.000055981676,0.000035634923],"domain_scores_gemma":[0.99979514,0.000027013506,0.000046050493,0.000018115577,0.00003827534,0.0000754551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042374153,0.00020183364,0.00030963306,0.00047209059,0.00014492041,0.0003710006,0.00020200305,0.00035554098,0.0016886708],"category_scores_gemma":[0.0003292836,0.0000687933,0.0002674354,0.0007563121,0.00023434708,0.00016673321,0.00021384085,0.00049226725,0.00086749025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021252157,0.00027216706,0.012653596,0.0008086431,0.00010441347,0.0015972907,0.00009550001,0.0008316613,0.019724177,0.0013188034,0.010010334,0.95045817],"study_design_scores_gemma":[0.0016451288,0.0144461095,0.1374651,0.00053183635,0.0004497249,0.024902984,0.00013097817,0.0017327811,0.05202974,0.0020666,0.76450944,0.000089634144],"about_ca_topic_score_codex":0.00091198744,"about_ca_topic_score_gemma":0.0028175132,"teacher_disagreement_score":0.0016886708,"about_ca_system_score_codex":0.0006150883,"about_ca_system_score_gemma":0.0008215107,"threshold_uncertainty_score":0.0056491494},"labels":[],"label_agreement":null},{"id":"W2767800648","doi":"10.1093/neuonc/nox168.654","title":"NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Database; Internal medicine; Clinical trial; Proportional hazards model; Oncology; Confidence interval","score_opus":0.07433397006595907,"score_gpt":0.35124403931378784,"score_spread":0.2769100692478288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767800648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97319657,0.017062815,0.0009028987,0.00038018622,0.00006198934,0.00017640335,0.0065014227,0.00003653923,0.0016811342],"genre_scores_gemma":[0.99203074,0.0019917923,0.0005646553,0.00021708479,0.00007484648,0.00013506843,0.0048287623,0.000019679339,0.00013730947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911953,0.0055534714,0.00089698733,0.001272013,0.00086953293,0.00021266127],"domain_scores_gemma":[0.98586303,0.0045616864,0.006371386,0.0019590869,0.00071083533,0.00053402793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013905223,0.000499994,0.0014270418,0.0017357508,0.0003525453,0.0012483525,0.00078025594,0.0005079134,0.00094551546],"category_scores_gemma":[0.018711805,0.00027806702,0.0022002638,0.0034092455,0.0004774145,0.0007427864,0.0013855055,0.0003568638,0.00026333347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022368677,0.00020636016,0.873116,0.0012659092,0.032880906,0.0001867877,0.0002660709,0.0011433419,0.0009463263,0.00014117625,0.002841303,0.06463716],"study_design_scores_gemma":[0.0030056436,0.0017426945,0.9680761,0.00030210323,0.020002117,0.0004334413,0.00017722392,0.0009770705,0.0005026981,0.00041681022,0.00431384,0.000050207982],"about_ca_topic_score_codex":0.0021792806,"about_ca_topic_score_gemma":0.0055633946,"teacher_disagreement_score":0.013905223,"about_ca_system_score_codex":0.00043700228,"about_ca_system_score_gemma":0.0006075757,"threshold_uncertainty_score":0.07353872},"labels":[],"label_agreement":null},{"id":"W2767830059","doi":"10.1093/neuonc/nox168.193","title":"CMET-47. PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Brain metastasis; Population; Cancer research; In vivo; Medicine; Metastasis; Transplantation; Cancer; In silico; Melanoma; Biology; Internal medicine; Gene","score_opus":0.1234532284471749,"score_gpt":0.4313841695183151,"score_spread":0.30793094107114016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767830059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866317,0.0022603332,0.0031913694,0.00020965819,0.00007678517,0.00069798605,0.0021826217,0.00014403263,0.004605461],"genre_scores_gemma":[0.98242307,0.0026354536,0.0039933478,0.00014407831,0.000022015303,0.00069999497,0.0039254758,0.00003914903,0.006117456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998492,0.00002712365,0.000011237225,0.000028309662,0.000044590386,0.00003958107],"domain_scores_gemma":[0.9999019,0.000018010773,0.000015360172,0.000011829813,0.000020453032,0.000032403037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003521115,0.00042765427,0.00045868443,0.00051911187,0.00016777428,0.00030246863,0.00022766572,0.00034452407,0.0024378365],"category_scores_gemma":[0.00019495212,0.00013852645,0.00035657047,0.0002679042,0.00018535365,0.00016903107,0.00014210072,0.000862824,0.0005375048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013234981,0.0026641325,0.0006321584,0.0002423035,0.000046250425,0.00012247998,0.00004437861,0.002246453,0.97603214,0.00028682253,0.0007633741,0.015595964],"study_design_scores_gemma":[0.0004005303,0.017156499,0.004004157,0.00002765006,0.00008409722,0.00023155374,0.00003228916,0.0033732068,0.96908665,0.00008620105,0.005505756,0.000011376905],"about_ca_topic_score_codex":0.00085714774,"about_ca_topic_score_gemma":0.0017081748,"teacher_disagreement_score":0.0024378365,"about_ca_system_score_codex":0.00028376348,"about_ca_system_score_gemma":0.00053612207,"threshold_uncertainty_score":0.008155346},"labels":[],"label_agreement":null},{"id":"W2767847048","doi":"10.1093/neuonc/nox168.834","title":"QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Weakness; Clinical trial; Glioblastoma; Internal medicine; Randomized controlled trial; Physical therapy; Surgery","score_opus":0.03203434641964683,"score_gpt":0.36635146413125597,"score_spread":0.33431711771160916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767847048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96782607,0.010935682,0.0008017339,0.0013332498,0.0002885104,0.0039554285,0.00876072,0.00015967879,0.005939014],"genre_scores_gemma":[0.9716285,0.0020964795,0.0018640732,0.0016862934,0.00015400973,0.009368391,0.009697071,0.000023736771,0.0034814484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99932384,0.00035444542,0.000039067847,0.000079675454,0.00008588131,0.00011707391],"domain_scores_gemma":[0.9995321,0.000089386485,0.00020359496,0.000018930545,0.000033079843,0.00012280824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018671508,0.0010232267,0.0012820855,0.00044360186,0.00028109504,0.00046596132,0.00063383573,0.00083646167,0.0037727512],"category_scores_gemma":[0.0014225229,0.00028474617,0.0014978147,0.00045066877,0.00046816448,0.00046736613,0.0003908184,0.0013442105,0.0004752727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87343466,0.0072621917,0.018706983,0.0012063062,0.0020968425,0.00007835459,0.0000795784,0.0026504477,0.0034968532,0.00037940027,0.008640675,0.08196773],"study_design_scores_gemma":[0.74095565,0.108385,0.13440031,0.0002977338,0.0018581877,0.00022692683,0.00007780907,0.0034621272,0.0012930661,0.0008497102,0.00812621,0.000067329274],"about_ca_topic_score_codex":0.0032651841,"about_ca_topic_score_gemma":0.004001517,"teacher_disagreement_score":0.0037727512,"about_ca_system_score_codex":0.0013326894,"about_ca_system_score_gemma":0.00081937993,"threshold_uncertainty_score":0.012621164},"labels":[],"label_agreement":null},{"id":"W2767859460","doi":"10.1093/neuonc/nox168.1100","title":"SCDT-17. DECREASED OPERATIVE COMPLICATIONS WITH IMAGE-GUIDED OMMAYA RESERVOIR INSERTION: SYSTEMATIC REVIEW AND META-ANALYSIS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Ommaya reservoir; Meta-analysis; Surgery; Catheter; MEDLINE; Systematic review; Internal medicine; Chemotherapy","score_opus":0.11738547197742422,"score_gpt":0.3855625910165072,"score_spread":0.268177119039083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767859460","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006076056,0.991778,0.0002610416,0.00020359432,0.00013399046,0.00025359503,0.0008841314,0.000020097563,0.00038952657],"genre_scores_gemma":[0.1613205,0.8332591,0.001449099,0.0009638023,0.00028165113,0.0009157702,0.0012591828,0.000029724704,0.000521113],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99540687,0.0018181478,0.0015247285,0.0005348318,0.00052350777,0.00019194267],"domain_scores_gemma":[0.9917868,0.005597084,0.0016068323,0.00018207265,0.00065321097,0.00017396605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580418,0.0016002823,0.011713421,0.004567755,0.00050081685,0.0028639855,0.0015214245,0.0020267323,0.005497285],"category_scores_gemma":[0.015899757,0.00078155147,0.025661424,0.005794376,0.0005515605,0.0015147281,0.0010623893,0.0019106632,0.00037213025],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036339646,0.000058823392,0.004114891,0.62995374,0.33886528,0.00014958438,0.00010184729,0.00043297317,0.00023569446,0.00016176426,0.0010071744,0.021284236],"study_design_scores_gemma":[0.0018425726,0.00050324295,0.007198923,0.05222405,0.93331426,0.00019275726,0.00008672919,0.00023334532,0.00018089298,0.00030060788,0.0038833257,0.000039202194],"about_ca_topic_score_codex":0.0047264467,"about_ca_topic_score_gemma":0.011051973,"teacher_disagreement_score":0.011713421,"about_ca_system_score_codex":0.0017056795,"about_ca_system_score_gemma":0.002795949,"threshold_uncertainty_score":0.030695796},"labels":[],"label_agreement":null},{"id":"W2767868848","doi":"10.1093/neuonc/nox168.978","title":"SURG-22. QUALITY BASED ASSESSMENT OF THE COST-EFFECTIVENESS OF 5-ALA IN HIGH GRADE GLIOMA SURGERY: A SYSTEMATIC REVIEW","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Glioma; MEDLINE; Cost effectiveness; Systematic review; Quality-adjusted life year; Quality of life (healthcare); Surgery; Evidence-based medicine; Cost–benefit analysis; Pathology; Alternative medicine","score_opus":0.6133098890715591,"score_gpt":0.5592492630020298,"score_spread":0.05406062606952933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767868848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018373986,0.9920161,0.000418103,0.0005880623,0.00020555712,0.0010751673,0.0030611805,0.00002831673,0.00077017315],"genre_scores_gemma":[0.04922668,0.9426853,0.002014662,0.0010609286,0.00017666044,0.0028773162,0.0016646644,0.0000304186,0.00026338425],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9761456,0.0088005075,0.009484397,0.0012774871,0.0038275833,0.00046435252],"domain_scores_gemma":[0.94247836,0.036497988,0.014768662,0.0009383361,0.00476071,0.0005558651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016126372,0.0019433923,0.01413207,0.014563378,0.000714158,0.004196509,0.0020811588,0.0020112856,0.011490469],"category_scores_gemma":[0.07474293,0.0011480696,0.022015225,0.014475669,0.001068404,0.0024471262,0.002110683,0.0018036745,0.00056450174],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004813264,0.000016886084,0.001082717,0.94319844,0.028402654,0.00003152982,0.000057195866,0.0001529135,0.00005666218,0.0002068805,0.0010691726,0.025243582],"study_design_scores_gemma":[0.0015158049,0.00028598617,0.008024285,0.79150873,0.18526569,0.0002537491,0.0001581325,0.00024515245,0.00015198754,0.0006648686,0.011869663,0.000055984212],"about_ca_topic_score_codex":0.012409611,"about_ca_topic_score_gemma":0.021012815,"teacher_disagreement_score":0.016126372,"about_ca_system_score_codex":0.007717322,"about_ca_system_score_gemma":0.012299616,"threshold_uncertainty_score":0.085285485},"labels":[],"label_agreement":null},{"id":"W2767872427","doi":"10.1093/neuonc/nox168.838","title":"QLIF-29. FUNCTIONAL AND EMPLOYMENT OUTCOMES IN IDH MUTANT GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Glioblastoma; Cohort; Internal medicine; IDH1; Confidence interval; Oncology; Performance status; Radiation therapy; Chemotherapy; Surgery; Mutation; Biology","score_opus":0.021158529618510905,"score_gpt":0.33065285029169,"score_spread":0.3094943206731791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767872427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851585,0.00021055235,0.00015171651,0.00016807602,0.000012889694,0.0000625583,0.007805043,0.000018770406,0.003054564],"genre_scores_gemma":[0.9926755,0.0000727442,0.0001808666,0.000062587,0.000007086577,0.00007317002,0.006189102,0.000009152932,0.0007299456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996537,0.0000681724,0.000050136758,0.000039757288,0.00008621415,0.00010209586],"domain_scores_gemma":[0.9986706,0.00014238979,0.00066638435,0.000030312605,0.0002883816,0.00020206082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090625184,0.00014973729,0.0002789382,0.0011582721,0.00032528417,0.00045590504,0.00028335283,0.00020007088,0.0028333217],"category_scores_gemma":[0.0028240588,0.00007424753,0.00031020536,0.0012522587,0.00020878174,0.00026476895,0.00049319345,0.000271472,0.0006589455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005967392,0.00008012826,0.9837578,0.000040209103,0.000037078415,0.00013540285,0.000106786894,0.00032269492,0.00030666482,0.00006658926,0.0020676407,0.012482165],"study_design_scores_gemma":[0.000022806313,0.00017200709,0.99778676,0.000014859371,0.000013126123,0.00016651604,0.0000803467,0.00028162161,0.000106267624,0.00008124311,0.0012682192,0.000006273501],"about_ca_topic_score_codex":0.012811748,"about_ca_topic_score_gemma":0.018624246,"teacher_disagreement_score":0.012811748,"about_ca_system_score_codex":0.0013671715,"about_ca_system_score_gemma":0.0007016072,"threshold_uncertainty_score":0.02547437},"labels":[],"label_agreement":null},{"id":"W2767882231","doi":"10.1093/neuonc/nox168.796","title":"PDTM-33. FOCUSED ULTRASOUND DISRUPTION OF THE BLOOD BRAIN BARRIER IN THE BRAINSTEM: A FEASIBILITY AND SAFETY STUDY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Brainstem; Microbubbles; Ultrasound; Blood–brain barrier; Pathology; Central nervous system; Radiology; Internal medicine","score_opus":0.0245647011193576,"score_gpt":0.28371133266297693,"score_spread":0.25914663154361933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767882231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810127,0.0034065973,0.013296544,0.00017680755,0.00002935388,0.0003162727,0.0002069125,0.00013908681,0.0014157215],"genre_scores_gemma":[0.99127287,0.0021319373,0.0047239475,0.000053488613,0.000012563881,0.00012315875,0.00021416615,0.000018739454,0.0014491588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999032,0.000021567534,0.000004287386,0.00001814534,0.00002982642,0.000023000157],"domain_scores_gemma":[0.99991965,0.000020045398,0.00002447736,0.000008769078,0.000013302286,0.000013703789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020650555,0.00042157044,0.00025970093,0.00021801828,0.0001276973,0.00012352313,0.00019506145,0.00031074762,0.00064232975],"category_scores_gemma":[0.00021032784,0.00012651064,0.00015847218,0.00012630042,0.00018979123,0.00022748475,0.00010365763,0.00032672938,0.00020302006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002535721,0.0001297909,0.0001731705,0.00010215658,0.000006199753,0.00018188449,0.000023432147,0.00024283864,0.99422616,0.0000982521,0.000089240915,0.0044734026],"study_design_scores_gemma":[0.000096498254,0.011278337,0.003791575,0.000019678688,0.00006052221,0.0010160401,0.00004511091,0.0029206597,0.97667056,0.000093403985,0.0039948714,0.000012675259],"about_ca_topic_score_codex":0.0015636054,"about_ca_topic_score_gemma":0.0014493329,"teacher_disagreement_score":0.0015636054,"about_ca_system_score_codex":0.00020597028,"about_ca_system_score_gemma":0.00030539872,"threshold_uncertainty_score":0.0031090379},"labels":[],"label_agreement":null},{"id":"W2767890423","doi":"10.1093/neuonc/nox168.543","title":"MNGI-04. PATHWAY ANALYSIS OF RADIATION-INDUCED MENINGIOMAS REVEALS UPREGULATION OF INFLAMMATORY PATHWAYS IN TUMORS WITH NF2-FUSION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fusion gene; Downregulation and upregulation; Gene; CDKN2A; Cancer research; Biology; Fold change; Bioconductor; Gene expression; Bioinformatics; Molecular biology; Genetics","score_opus":0.024512767448386215,"score_gpt":0.2897903234897071,"score_spread":0.2652775560413209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767890423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49133497,0.008561126,0.009645825,0.0012369221,0.0006183923,0.00039408976,0.46204454,0.009683543,0.016480543],"genre_scores_gemma":[0.4295839,0.0042545456,0.026278779,0.0011878079,0.00008270177,0.0011376479,0.5204796,0.0012166377,0.015778365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970156,0.000034489236,0.000012378728,0.00008478701,0.000087791595,0.00007895108],"domain_scores_gemma":[0.999803,0.00003444704,0.00003516459,0.000027043983,0.000035417517,0.00006499987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046100584,0.0006199692,0.0008396327,0.0010532476,0.0006590145,0.00094609347,0.0005690983,0.00050679967,0.012925971],"category_scores_gemma":[0.0003607006,0.00030576726,0.0011251823,0.0010634343,0.00019606484,0.00031731906,0.0007997989,0.000991334,0.0040190085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00798142,0.0008185769,0.104736686,0.006388116,0.0018777858,0.0011704657,0.0007256118,0.007266011,0.5845636,0.0031079855,0.17286609,0.10849764],"study_design_scores_gemma":[0.0012694709,0.0024527123,0.52118796,0.0006276853,0.0013852195,0.0033466367,0.00067794864,0.026373578,0.15316461,0.004043746,0.2852327,0.00023767886],"about_ca_topic_score_codex":0.0039067455,"about_ca_topic_score_gemma":0.00853358,"teacher_disagreement_score":0.012925971,"about_ca_system_score_codex":0.0005837793,"about_ca_system_score_gemma":0.0011689506,"threshold_uncertainty_score":0.04324174},"labels":[],"label_agreement":null},{"id":"W2767903200","doi":"10.1093/neuonc/nox168.1050","title":"TMOD-11. HUMAN STEM CELL BASED MODEL OF MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Stem cell; Biology; Cell biology; Cancer research","score_opus":0.05451383462477289,"score_gpt":0.33058177717688647,"score_spread":0.2760679425521136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767903200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8867811,0.005022071,0.04006146,0.0013949717,0.00082749943,0.0026574912,0.027697297,0.0016998475,0.033858128],"genre_scores_gemma":[0.9016757,0.003705931,0.02943645,0.000553489,0.00005107592,0.0029912204,0.018606747,0.0001911875,0.042788178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943274,0.000058983846,0.00007202721,0.0001505862,0.00021482058,0.00007073648],"domain_scores_gemma":[0.99983287,0.000022771237,0.000032684526,0.00002869066,0.000019872967,0.000063101965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004810232,0.0005456211,0.0005111471,0.0007505078,0.00037448562,0.00048765558,0.00068224926,0.0011091019,0.0060574845],"category_scores_gemma":[0.00016523914,0.00029885976,0.00057129585,0.00051193207,0.000438437,0.00036099282,0.00042545222,0.002075243,0.0021592346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007238598,0.00084461895,0.00088007865,0.00037441673,0.000032432978,0.00098089,0.00022658035,0.0014693005,0.9794922,0.0036565708,0.002776883,0.008542199],"study_design_scores_gemma":[0.00034307706,0.0043000886,0.004565244,0.0000926623,0.00012006337,0.0029506565,0.00020602073,0.007841898,0.855081,0.0009273095,0.12353049,0.000041460004],"about_ca_topic_score_codex":0.0015361886,"about_ca_topic_score_gemma":0.0021408896,"teacher_disagreement_score":0.0060574845,"about_ca_system_score_codex":0.0006353532,"about_ca_system_score_gemma":0.00067339966,"threshold_uncertainty_score":0.020264268},"labels":[],"label_agreement":null},{"id":"W2767922381","doi":"10.1093/neuonc/nox168.008","title":"ACTR-10. PATTERNS OF TTFIELDS-RELATED SEVERE SKIN TOXICITY IN GBM PATIENTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Rash; Erythema; Adverse effect; Toxicity; Dermatology; Temozolomide; Internal medicine; Surgery; Chemotherapy","score_opus":0.02514469099222186,"score_gpt":0.3416115326190843,"score_spread":0.3164668416268624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767922381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997449,0.00071621314,0.00013696635,0.00003190045,0.0000042033585,0.000028350181,0.00060476176,0.000013259817,0.0010153312],"genre_scores_gemma":[0.99863476,0.00018028969,0.00019074083,0.00004989667,0.0000059978042,0.00001762071,0.00064616953,0.0000059081062,0.0002686793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994598,0.000144047,0.0000756208,0.000115672075,0.00012983031,0.00007491248],"domain_scores_gemma":[0.9982363,0.00027997905,0.0010632753,0.00006646446,0.00013746563,0.00021651926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005783524,0.00018418103,0.00041394087,0.0005714499,0.00021933223,0.0003539066,0.00015583384,0.00019036685,0.001476795],"category_scores_gemma":[0.0011235158,0.00009064235,0.0005809258,0.000777243,0.00016050511,0.00032518245,0.00023992898,0.00050574937,0.00024358096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033232511,0.00020514807,0.95681906,0.00013023587,0.00020701929,0.0008430914,0.00018831997,0.00042850783,0.0060089766,0.00006060731,0.0007993785,0.03098651],"study_design_scores_gemma":[0.00006585963,0.0013528045,0.9925598,0.000014200597,0.000079380836,0.003261781,0.00010988393,0.0003976773,0.0009409745,0.000056771354,0.001148466,0.000012412468],"about_ca_topic_score_codex":0.00081466354,"about_ca_topic_score_gemma":0.0017462939,"teacher_disagreement_score":0.001476795,"about_ca_system_score_codex":0.0002964397,"about_ca_system_score_gemma":0.00020324356,"threshold_uncertainty_score":0.0049403906},"labels":[],"label_agreement":null},{"id":"W2767936668","doi":"10.1093/neuonc/nox168.573","title":"NCOG-12. NEUROCOGNITIVE OUTCOME IN CHILDREN WITH SENSORINEURAL HEARING LOSS FOLLOWING TREATMENT FOR MALIGNANT EMBRYONAL BRAIN TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Pediatric Oncology Group","funders":"","keywords":"Medicine; Sensorineural hearing loss; Hearing loss; Neurocognitive; Audiology; Neuropsychology; Wechsler Adult Intelligence Scale; Radiation therapy; Intelligence quotient; Pediatrics; Surgery; Cognition","score_opus":0.056629030911943906,"score_gpt":0.3558313937713683,"score_spread":0.29920236285942436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767936668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985922,0.0002188009,0.00002460503,0.00001868524,0.0000022114896,0.0000062806134,0.00060402777,0.000003034191,0.0005300777],"genre_scores_gemma":[0.998833,0.0001100141,0.000033371558,0.000008158205,0.0000025674012,0.000007822718,0.00088814524,0.000001690117,0.00011521311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972683,0.000045107,0.000029742823,0.000027697988,0.00009933184,0.00007122743],"domain_scores_gemma":[0.99827766,0.0002569013,0.0010138486,0.00003801006,0.00019389448,0.0002198047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033406515,0.00016346143,0.00021345403,0.0006486131,0.00027545606,0.00035687877,0.0002492197,0.00016716174,0.000606754],"category_scores_gemma":[0.0022057907,0.00009292698,0.00026789756,0.00094713527,0.00024909474,0.00019267084,0.00029081167,0.00026469422,0.00010147944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006782824,0.000008589904,0.99817526,0.0000061411706,0.00001192125,0.00011196453,0.00004603652,0.00006295351,0.00005716762,0.0000032561652,0.000068169604,0.0013806999],"study_design_scores_gemma":[0.0000026223497,0.000060510967,0.9993876,0.0000027752685,0.000008840121,0.0002963638,0.00005347703,0.00003653772,0.000052548927,0.000002159492,0.00009555512,0.0000010190917],"about_ca_topic_score_codex":0.049893983,"about_ca_topic_score_gemma":0.084122136,"teacher_disagreement_score":0.049893983,"about_ca_system_score_codex":0.0010703544,"about_ca_system_score_gemma":0.0007708942,"threshold_uncertainty_score":0.0992071},"labels":[],"label_agreement":null},{"id":"W2767946275","doi":"10.1093/neuonc/nox168.398","title":"GENE-24. ATRX DEFICIENCY IN GLIOMA CELLS OF ORIGIN PROMOTES DISEASE-DEFINING PHENOTYPES BY WAY OF GLOBAL EPIGENOMIC REMODELING","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Epigenomics; Epigenetics; Genetics; Carcinogenesis; Histone; Cancer research; DNA methylation; Mutation; Gene; Gene expression","score_opus":0.016781593084476156,"score_gpt":0.290826121728091,"score_spread":0.2740445286436149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767946275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888362,0.0017149261,0.0041601686,0.000118232885,0.000049028302,0.000050221235,0.0020821197,0.00025326054,0.0027358285],"genre_scores_gemma":[0.98627603,0.0008608015,0.0031813201,0.00004388928,0.0000057124475,0.00006263103,0.0023675542,0.000044237848,0.0071577383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985635,0.000024102323,0.000021204603,0.00003770279,0.00003512571,0.00002545919],"domain_scores_gemma":[0.9999031,0.000014314229,0.000028842112,0.000016834014,0.0000063539424,0.0000305436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010385629,0.0003191695,0.0001973846,0.00024895015,0.00012958473,0.00028616108,0.00020829061,0.00022315005,0.0023116353],"category_scores_gemma":[0.000049659287,0.00012434305,0.00032698677,0.00013908978,0.00023511295,0.00013042049,0.00019482688,0.00049195555,0.0008068033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006095105,0.000020705083,0.00012563173,0.00001978687,0.0000042662937,0.00008124299,0.000012123593,0.00005187041,0.9987231,0.00012755247,0.000031899523,0.0007408439],"study_design_scores_gemma":[0.00000912453,0.00023721429,0.0029907231,0.000005436978,0.000015561425,0.000335466,0.000023501916,0.0005772887,0.9921353,0.000037809274,0.0036301818,0.000002444252],"about_ca_topic_score_codex":0.0007510497,"about_ca_topic_score_gemma":0.001206172,"teacher_disagreement_score":0.0023116353,"about_ca_system_score_codex":0.00023989262,"about_ca_system_score_gemma":0.00022324239,"threshold_uncertainty_score":0.007733226},"labels":[],"label_agreement":null},{"id":"W2767952516","doi":"10.1093/neuonc/nox168.735","title":"PATH-45. INTEGRATION OF MULTI-REGION (EPI)GENOMICS WITH MULTIMODALITY ADVANCED IMAGING HIGHLIGHTS GLIOMA INTRATUMORAL HETEROGENEITY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Concordance; Radiogenomics; Genetic heterogeneity; Subtyping; Tumour heterogeneity; Biopsy; Magnetic resonance imaging; DNA methylation; Medicine; Pathology; Biology; Cancer research; Bioinformatics; Radiology; Gene; Internal medicine; Genetics; Cancer; Phenotype; Computer science","score_opus":0.0239340452823193,"score_gpt":0.33150609134248915,"score_spread":0.30757204606016986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767952516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984706,0.00019318031,0.007412064,0.00013313645,0.0000060314496,0.000019269115,0.006447114,0.00029913452,0.00078411255],"genre_scores_gemma":[0.9797284,0.00006292208,0.008232894,0.000042626158,0.000004651818,0.00002816525,0.011485528,0.000053337353,0.00036134783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997471,0.000050797466,0.000013106674,0.00012260843,0.00002910964,0.000037300495],"domain_scores_gemma":[0.9995963,0.0001905545,0.00007508171,0.00006090761,0.000040758863,0.000036460406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004225127,0.00020769765,0.00025663132,0.00041862624,0.00022713754,0.0003567024,0.00019177256,0.00028359363,0.001602671],"category_scores_gemma":[0.0011125728,0.00011841002,0.00039733163,0.00037848236,0.00024710209,0.00024277573,0.0004598478,0.00034100865,0.0003769858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018306123,0.00017128854,0.71636564,0.0002988109,0.00054336974,0.0009462718,0.0004343748,0.044644296,0.099148616,0.0017372754,0.0072449744,0.12663445],"study_design_scores_gemma":[0.000071161856,0.00044579525,0.75589484,0.00002805083,0.0002456781,0.0029799787,0.00026094896,0.19967507,0.024493497,0.005094556,0.01076792,0.000042483774],"about_ca_topic_score_codex":0.0030039572,"about_ca_topic_score_gemma":0.0050642276,"teacher_disagreement_score":0.0030039572,"about_ca_system_score_codex":0.0003689674,"about_ca_system_score_gemma":0.00031785681,"threshold_uncertainty_score":0.005972922},"labels":[],"label_agreement":null},{"id":"W2767957180","doi":"10.1093/neuonc/nox168.1068","title":"TMOD-31. RARE SOX9+ CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; SOX9; Metastasis; Atypical teratoid rhabdoid tumor; Medicine; Biology; Primary tumor; Transcription factor; Pathology; Cancer; Internal medicine; Gene","score_opus":0.01561191008283405,"score_gpt":0.2870952394963436,"score_spread":0.27148332941350956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767957180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299824,0.00054884213,0.00217893,0.00014286657,0.00004369856,0.000068308895,0.0012589063,0.00021018561,0.0025499722],"genre_scores_gemma":[0.9871186,0.00030800753,0.0018622921,0.00006400506,0.000008716703,0.00006202773,0.0017233506,0.000054380198,0.0087986365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998043,0.000014542146,0.000023633424,0.000053825934,0.000059646794,0.000044180597],"domain_scores_gemma":[0.99982846,0.000024193907,0.000043756143,0.000026373347,0.0000133387875,0.00006387615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012045479,0.00019736805,0.00025946854,0.00030615754,0.00019051811,0.00028337986,0.00019850742,0.00043247087,0.002895963],"category_scores_gemma":[0.00010846858,0.00016335533,0.00026215456,0.00018777576,0.0002352475,0.00018565914,0.00019430705,0.00074415625,0.0010229679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011500432,0.00006194033,0.0004996348,0.0000222144,0.0000039106517,0.00032677056,0.00002450632,0.000052661806,0.997118,0.00016592508,0.0001106947,0.0014986058],"study_design_scores_gemma":[0.00004935896,0.0010498727,0.008160841,0.000008024171,0.000019744006,0.0030762816,0.000059046215,0.0013744993,0.97948265,0.00011250671,0.006600617,0.0000064248125],"about_ca_topic_score_codex":0.0011877709,"about_ca_topic_score_gemma":0.0016843068,"teacher_disagreement_score":0.002895963,"about_ca_system_score_codex":0.00031118968,"about_ca_system_score_gemma":0.0002574933,"threshold_uncertainty_score":0.009687901},"labels":[],"label_agreement":null},{"id":"W2767960979","doi":"10.1093/neuonc/nox168.964","title":"SURG-07. CIRCUMFERENTIAL RESECTION OF GLIOBLASTOMA: A NOVEL SURGICAL TECHNIQUE FOR MAXIMISING EXTENT OF RESECTION AND PROLONGING SURVIVAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Glioblastoma; Debulking; Resection; Cohort; Surgery; Overall survival; Tumor Debulking; Surgical resection; Survival analysis; Survival rate; Cancer; Internal medicine; Chemotherapy; Ovarian cancer","score_opus":0.04197864441699255,"score_gpt":0.3413437573461191,"score_spread":0.29936511292912654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767960979","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617357,0.0064870925,0.01587249,0.0006103519,0.00019560498,0.00013222262,0.0007494823,0.00043954328,0.013777501],"genre_scores_gemma":[0.94949794,0.0035444426,0.037603233,0.0003392793,0.0002815263,0.00013278033,0.0017095566,0.0000698282,0.0068214345],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999374,0.000013883608,0.000007686291,0.000010389975,0.000021875896,0.0000088027755],"domain_scores_gemma":[0.9997805,0.00003568796,0.00007673993,0.000025905001,0.000024053148,0.000057133333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028070295,0.0001906244,0.0000974226,0.00035679052,0.00008457594,0.00015831948,0.00010503972,0.00013642474,0.001753908],"category_scores_gemma":[0.00027709655,0.00007734175,0.00017515286,0.0001777348,0.0001431569,0.00011877336,0.00022758413,0.00018580878,0.0005941984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031306488,0.0003386075,0.22512701,0.00053776527,0.00014349497,0.0020450675,0.00012259153,0.0023889309,0.1538802,0.0010743829,0.010546219,0.60066515],"study_design_scores_gemma":[0.00055168575,0.0072000786,0.79484326,0.00014484648,0.00020389222,0.03225942,0.0001343872,0.00757605,0.082644686,0.0009445731,0.073442325,0.00005476298],"about_ca_topic_score_codex":0.00042147483,"about_ca_topic_score_gemma":0.001933026,"teacher_disagreement_score":0.001753908,"about_ca_system_score_codex":0.00016548054,"about_ca_system_score_gemma":0.00030076198,"threshold_uncertainty_score":0.005867362},"labels":[],"label_agreement":null},{"id":"W2767969226","doi":"10.1093/neuonc/nox168.791","title":"PDTM-27. DIANHYDROGALACTITOL (VAL-083) OVERCOMES CHEMORESISTANCE IN PEDIATRIC MALIGNANT BRAIN TUMORS AND DISPLAYS SYNERGY WITH TOPOISOMERASE INHIBITORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; Medulloblastoma; DNA repair; Glioma; Methyltransferase; Cancer; Topoisomerase; Medicine; Cell cycle; Cell cycle checkpoint; Biology; Internal medicine; DNA; Genetics; Methylation","score_opus":0.010187270261392243,"score_gpt":0.2693073971770693,"score_spread":0.25912012691567704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767969226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933256,0.0045486577,0.00081972865,0.00019059336,0.00003730546,0.00006962063,0.00054711965,0.00037851455,0.004075924],"genre_scores_gemma":[0.99402606,0.0021563782,0.0010335756,0.00008833321,0.000010962898,0.00004964177,0.0010420496,0.000036422407,0.001556616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996233,0.0000062596528,0.0000022645938,0.0000062639524,0.000007175585,0.000015766193],"domain_scores_gemma":[0.9999714,0.0000029359774,0.0000057539974,0.0000025219401,0.000002363148,0.00001502374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005182999,0.0003533714,0.0002965039,0.0002194201,0.000087604436,0.00016264891,0.00023651817,0.0001751118,0.0012859539],"category_scores_gemma":[0.00005693022,0.0001115805,0.00020586603,0.00020892073,0.000106479725,0.00009494187,0.000168651,0.0006129117,0.0003694734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022680038,0.0007883801,0.00091570115,0.00023951092,0.000056736357,0.00034233098,0.0000643873,0.0013124703,0.92408407,0.00044756662,0.0020196815,0.067461245],"study_design_scores_gemma":[0.0012434258,0.01367097,0.01765951,0.000029504703,0.000115374096,0.0024567563,0.00006137332,0.0027923519,0.9285968,0.00016513564,0.03318239,0.000026422811],"about_ca_topic_score_codex":0.001410491,"about_ca_topic_score_gemma":0.0021924481,"teacher_disagreement_score":0.001410491,"about_ca_system_score_codex":0.0002511255,"about_ca_system_score_gemma":0.00027472718,"threshold_uncertainty_score":0.0043019056},"labels":[],"label_agreement":null},{"id":"W2767969574","doi":"10.1093/neuonc/nox168.048","title":"ACTR-57. DOES THE ADDITION OF VALPROIC ACID TO CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IMPROVE PATIENT OUTCOME? – CORRELATIVE ANALYSIS OF RTOG 0525, SEER AND A PHASE II NCI TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Oncology; Radiation therapy; Cohort; Valproic Acid; Population; Proportional hazards model; Dacarbazine; Univariate analysis; Clinical trial; Multivariate analysis; Chemotherapy; Epilepsy","score_opus":0.04166062845634414,"score_gpt":0.36648391616680465,"score_spread":0.3248232877104605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767969574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956513,0.0021484098,0.00016215091,0.00018672092,0.000040505114,0.00025446527,0.00045623982,0.000022207336,0.0010780165],"genre_scores_gemma":[0.9967828,0.000823819,0.00036071287,0.00024354248,0.00008482495,0.00013408813,0.0010836537,0.0000066937314,0.0004799322],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99830073,0.0012188007,0.00008217256,0.00014660401,0.00014935473,0.00010243906],"domain_scores_gemma":[0.9978911,0.0006187676,0.00080722856,0.0002471326,0.000091706206,0.0003439742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004568839,0.00042165667,0.0010219282,0.00040171322,0.0001420307,0.0006626327,0.00057511416,0.00038838273,0.0017674413],"category_scores_gemma":[0.0026665917,0.0002054088,0.0015353967,0.0004452322,0.00048620536,0.0004521016,0.00029250956,0.0012071737,0.00032925815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7451564,0.016902586,0.083710894,0.00074441155,0.0050363233,0.00032011245,0.00023091095,0.0030537746,0.015782649,0.00054992526,0.0033064391,0.12520567],"study_design_scores_gemma":[0.15985581,0.46725842,0.3481531,0.00013752647,0.005555364,0.00065925,0.00017253411,0.005569982,0.0055923713,0.0005195836,0.006469372,0.000056683162],"about_ca_topic_score_codex":0.0009896901,"about_ca_topic_score_gemma":0.0031599428,"teacher_disagreement_score":0.004568839,"about_ca_system_score_codex":0.0006394683,"about_ca_system_score_gemma":0.0010613783,"threshold_uncertainty_score":0.02416265},"labels":[],"label_agreement":null},{"id":"W2767987788","doi":"10.1093/neuonc/nox168.1049","title":"TMOD-10. MOLECULAR CHARACTERIZATION OF A NOVEL HUMAN CLIVAL CHORDOMA XENOGRAFT MODEL DEMONSTRATES INHERENT TUMOR GENOMIC INSTABILITY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chordoma; Brachyury; Biology; Cancer research; CDKN2A; Genome instability; Primary tumor; FHIT; Tumor suppressor gene; Cancer; Pathology; Gene; Medicine; Genetics; Metastasis; Embryonic stem cell; Carcinogenesis; DNA; DNA damage","score_opus":0.050055093122862694,"score_gpt":0.33601466790559426,"score_spread":0.28595957478273154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767987788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936132,0.0003351158,0.0036294267,0.00008548228,0.000032884334,0.00009000006,0.0006552063,0.000053005024,0.0015057492],"genre_scores_gemma":[0.99096674,0.00028753953,0.0039542457,0.000026315858,0.0000050692042,0.00008053128,0.0010972274,0.000015094325,0.0035672977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998901,0.00001705264,0.000011279624,0.00002639669,0.000030942727,0.000024076855],"domain_scores_gemma":[0.9998901,0.00002536009,0.00001473911,0.000025110574,0.000010416001,0.00003423121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021780594,0.00022991933,0.00018928971,0.00020505342,0.00014567951,0.00023170299,0.00024435556,0.00028606888,0.0023617921],"category_scores_gemma":[0.000111929716,0.0001119941,0.00017239756,0.00012753873,0.00018430964,0.00019945452,0.00013642643,0.0006200251,0.00041612424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015135242,0.00013650255,0.0005205469,0.000020666334,0.0000050024737,0.0002472546,0.000028206503,0.00007922925,0.9976376,0.00014322395,0.00007375329,0.0009566579],"study_design_scores_gemma":[0.00007520425,0.0027654478,0.008387958,0.0000066838084,0.000021783693,0.0030614734,0.00009420671,0.0022005693,0.97840923,0.00008041475,0.004891749,0.000005231762],"about_ca_topic_score_codex":0.0011198758,"about_ca_topic_score_gemma":0.0017536702,"teacher_disagreement_score":0.0023617921,"about_ca_system_score_codex":0.00029890193,"about_ca_system_score_gemma":0.00019076021,"threshold_uncertainty_score":0.007901013},"labels":[],"label_agreement":null},{"id":"W2767988375","doi":"10.1093/neuonc/nox168.955","title":"STEM-41. A SUBSET OF GBM BRAIN TUMOR STEM CELL LINES ARE UNIQUELY DEPENDENT ON GLUTAMINE METABOLISM FOR AMINO ACID SYNTHESIS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Glutamine; Glutaminase; Stem cell; Biology; Cancer research; Glutamate receptor; Metabolism; Cancer stem cell; Cell culture; Glutamine synthetase; Amino acid; Biochemistry; Cell biology; Genetics","score_opus":0.022552415273870013,"score_gpt":0.27721480341737686,"score_spread":0.25466238814350683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767988375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9264495,0.011735371,0.014352604,0.0015218754,0.0004112086,0.0010205547,0.018197874,0.001554626,0.02475646],"genre_scores_gemma":[0.91353,0.0070304195,0.012002897,0.0013908925,0.00008309079,0.0012880937,0.040569533,0.00011795983,0.02398717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996499,0.00003134852,0.00004530144,0.00005106188,0.00017655226,0.00004575652],"domain_scores_gemma":[0.9998634,0.000023490602,0.000024685294,0.000023890034,0.00002827407,0.00003626822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024699443,0.00059711625,0.00059250573,0.0005162054,0.00039980895,0.00050684094,0.000275424,0.0004879504,0.0041659516],"category_scores_gemma":[0.00018196624,0.00018460899,0.00045679745,0.0005122083,0.0002646198,0.00024513283,0.00023788691,0.0008408873,0.0018355882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002928306,0.00031295326,0.0026575911,0.0002356971,0.00003340649,0.00041974074,0.00015817105,0.0002747669,0.9727349,0.001325955,0.0024201877,0.019133918],"study_design_scores_gemma":[0.00011144175,0.0017895533,0.01863632,0.000050666426,0.00009806042,0.0017353897,0.00014815791,0.001680564,0.89255416,0.00072078605,0.082445115,0.000029822548],"about_ca_topic_score_codex":0.0010290296,"about_ca_topic_score_gemma":0.0021889075,"teacher_disagreement_score":0.0041659516,"about_ca_system_score_codex":0.00025138707,"about_ca_system_score_gemma":0.0004872179,"threshold_uncertainty_score":0.01393646},"labels":[],"label_agreement":null},{"id":"W2767998816","doi":"10.1093/neuonc/nox168.987","title":"SURG-33. GLIOBLASTOMA IN THE ELDERLY: THE IMPACT OF EXTENT OF RESECTION ON SURVIVAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Radiation therapy; Univariate analysis; Retrospective cohort study; Surgery; Cohort; Multivariate analysis; Biopsy; Overall survival; Survival analysis; Internal medicine","score_opus":0.04096120519906606,"score_gpt":0.3646573981336439,"score_spread":0.32369619293457785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767998816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793703,0.01148651,0.00084643404,0.0007979368,0.00009872096,0.00002169857,0.0031712186,0.000052820356,0.0041544167],"genre_scores_gemma":[0.9939049,0.0029604577,0.00047117542,0.00013475708,0.00010232195,0.000014314241,0.0013848597,0.000012247566,0.0010149349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997788,0.000059041246,0.000035194134,0.000029162415,0.00005645211,0.000041339194],"domain_scores_gemma":[0.9989229,0.00016858935,0.00055398967,0.000040599625,0.0001266093,0.00018738322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005966392,0.0002632308,0.0002540028,0.0007011383,0.00017982778,0.0003097603,0.00016075736,0.00013939808,0.0028716307],"category_scores_gemma":[0.001387894,0.000072947005,0.0006687651,0.0007339893,0.00016679935,0.00031314767,0.0003893187,0.0002076537,0.0006291434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003420408,0.000022445482,0.9713846,0.000095525524,0.00014626245,0.0004713609,0.000037634014,0.00034433886,0.0004983062,0.000046667443,0.0009528565,0.025657931],"study_design_scores_gemma":[0.000007350126,0.00024654026,0.9956779,0.000048972688,0.00014508967,0.0015332578,0.00007198472,0.00039658067,0.00026916777,0.00008196808,0.0015153602,0.000005925767],"about_ca_topic_score_codex":0.002556293,"about_ca_topic_score_gemma":0.007863537,"teacher_disagreement_score":0.0028716307,"about_ca_system_score_codex":0.00030449888,"about_ca_system_score_gemma":0.00042881997,"threshold_uncertainty_score":0.00960654},"labels":[],"label_agreement":null},{"id":"W2768011387","doi":"10.1093/neuonc/nox168.170","title":"CMET-22. PCV VS TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH LGG: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Temozolomide; Medicine; Lomustine; Internal medicine; Procarbazine; Oncology; IDH1; Context (archaeology); Chemotherapy; Progression-free survival; Vincristine; Cyclophosphamide; Mutation","score_opus":0.10376185774952087,"score_gpt":0.3950014492157143,"score_spread":0.2912395914661934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768011387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053496454,0.9924866,0.00027628997,0.00021254674,0.00013789248,0.00028286307,0.00084588403,0.000023985278,0.0003842321],"genre_scores_gemma":[0.16973065,0.82471544,0.0012214456,0.0012650501,0.00023588064,0.0009176796,0.0012610035,0.000034047094,0.00061876065],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969994,0.0011899506,0.0008979615,0.0003840991,0.00038273484,0.00014594255],"domain_scores_gemma":[0.9951971,0.0029504108,0.0011364748,0.00011819045,0.0004506025,0.00014727596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004483074,0.0015952376,0.013519126,0.0043791174,0.00049649144,0.0024485376,0.0016602862,0.0016700109,0.005193003],"category_scores_gemma":[0.009982052,0.0008843421,0.023701869,0.0058708997,0.00048171263,0.0014325127,0.0010746507,0.0015742216,0.00039707794],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039024607,0.00004580031,0.0029315902,0.54956084,0.42280376,0.00013704046,0.00008788239,0.0004245184,0.0003623398,0.00015009611,0.0012221694,0.01837147],"study_design_scores_gemma":[0.0016134649,0.00036188096,0.004649066,0.03222366,0.9574017,0.00011341365,0.00006124168,0.00019340319,0.000121195524,0.00022062179,0.0030114113,0.000028893395],"about_ca_topic_score_codex":0.0070545236,"about_ca_topic_score_gemma":0.017775886,"teacher_disagreement_score":0.013519126,"about_ca_system_score_codex":0.0022414983,"about_ca_system_score_gemma":0.0025035047,"threshold_uncertainty_score":0.023709059},"labels":[],"label_agreement":null},{"id":"W2768037202","doi":"10.1093/neuonc/nox168.216","title":"CSIG-22. A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McMaster University","funders":"","keywords":"Wnt signaling pathway; Cancer research; Protein kinase B; Beta-catenin; Biology; LRP5; LRP6; Cell culture; Context (archaeology); Signal transduction; Stem cell; Cell biology; Chemistry; Genetics","score_opus":0.021117243486009272,"score_gpt":0.28466382831586007,"score_spread":0.26354658482985077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768037202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97004896,0.003653826,0.004912744,0.00063823233,0.00007840994,0.00015445231,0.0052310447,0.0005639102,0.014718343],"genre_scores_gemma":[0.97354025,0.0022944377,0.007363799,0.00021587027,0.000011116824,0.00012729705,0.005562506,0.00007418192,0.010810574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989986,0.000009416736,0.000006986694,0.000016539263,0.00004113195,0.00002595585],"domain_scores_gemma":[0.99996483,0.0000024539129,0.0000059590666,0.0000027363633,0.0000036156632,0.000020492647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098647324,0.00031526646,0.0002204346,0.00057710573,0.00024501156,0.00037317644,0.00019539801,0.00020537178,0.0032590353],"category_scores_gemma":[0.000039526516,0.0001908188,0.00021011216,0.00040401617,0.00018208219,0.00020139974,0.00019877598,0.00054122176,0.0010618141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008250952,0.000029682216,0.00032390712,0.000034018496,0.0000036759918,0.00006612947,0.000011242711,0.000068558686,0.9961637,0.00036954175,0.00023031299,0.002616665],"study_design_scores_gemma":[0.000044196895,0.0002540076,0.013424892,0.000012170582,0.000029763962,0.00063501694,0.000037295365,0.0016367084,0.96503806,0.00020125588,0.018679118,0.000007499108],"about_ca_topic_score_codex":0.0019263505,"about_ca_topic_score_gemma":0.0058304537,"teacher_disagreement_score":0.0032590353,"about_ca_system_score_codex":0.0006835115,"about_ca_system_score_gemma":0.00064046774,"threshold_uncertainty_score":0.010902524},"labels":[],"label_agreement":null},{"id":"W2768038963","doi":"10.1093/neuonc/nox168.736","title":"PATH-46. AUTOMATED HISTOPATHOLOGIC CLASSIFICATION OF BRAIN TUMORS USING ARTIFICIAL INTELLIGENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Convolutional neural network; Artificial intelligence; Classifier (UML); Computer science; Digital pathology; Glioblastoma; Brain tumor; Workflow; Pathology; Pattern recognition (psychology); Medicine; Database","score_opus":0.07108547680609452,"score_gpt":0.3889134789199807,"score_spread":0.3178280021138862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768038963","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12807545,0.0010713021,0.7264604,0.0018391,0.0005837871,0.0009960653,0.0141512165,0.08371225,0.043110486],"genre_scores_gemma":[0.43322656,0.0006970626,0.50606734,0.00067257066,0.000091848495,0.0007077488,0.02624185,0.0016510404,0.030644035],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99951017,0.000060877217,0.0000373903,0.00014738506,0.00019389093,0.00005030623],"domain_scores_gemma":[0.9993036,0.00016350226,0.00008464832,0.000121694626,0.00028652168,0.00004006906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007656406,0.00065301877,0.00023850964,0.0009632784,0.00034822876,0.0010404766,0.00064404274,0.0006405965,0.010429268],"category_scores_gemma":[0.0020626208,0.00030641013,0.000581778,0.0004985984,0.0003480195,0.0005847792,0.0008528978,0.0005847307,0.006822013],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005091876,0.00028811203,0.033422366,0.0004709907,0.00015072543,0.00073451025,0.00022441921,0.09679206,0.05276339,0.008493784,0.10633808,0.69981235],"study_design_scores_gemma":[0.00006036671,0.000210004,0.014351039,0.00009635814,0.000048613354,0.0008552215,0.00007914188,0.8429264,0.047560304,0.009370703,0.08438831,0.000053575764],"about_ca_topic_score_codex":0.0043978305,"about_ca_topic_score_gemma":0.0044373283,"teacher_disagreement_score":0.010429268,"about_ca_system_score_codex":0.00084826344,"about_ca_system_score_gemma":0.0013746154,"threshold_uncertainty_score":0.03488934},"labels":[],"label_agreement":null},{"id":"W2768057131","doi":"10.1093/neuonc/nox168.058","title":"ACTR-71. FULL ENROLLMENT RESULTS FROM THE PHASE 1/2, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) ± BEVACIZUMAB (BEV) IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, RGBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Lethargy; Bevacizumab; Adverse effect; Internal medicine; Phases of clinical research; Surgery; Gastroenterology; Toxicity; Chemotherapy","score_opus":0.0698189916436657,"score_gpt":0.3799224895923255,"score_spread":0.31010349794865977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768057131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88980424,0.0060104867,0.0030091135,0.0019199406,0.0005664006,0.017320579,0.049248073,0.0018410841,0.03028014],"genre_scores_gemma":[0.85491484,0.004127684,0.0057220357,0.0040397523,0.00052747503,0.015396955,0.07798829,0.00043897983,0.036843948],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993278,0.00026959262,0.000033258115,0.00009077746,0.00011630296,0.0001624078],"domain_scores_gemma":[0.9995466,0.000051503095,0.000054154778,0.0000326116,0.000046829748,0.00026839937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015954215,0.0016656211,0.0017885743,0.00041013554,0.00063298515,0.0008268806,0.00091418234,0.0011726465,0.01816122],"category_scores_gemma":[0.00067494565,0.0005441744,0.0006983684,0.00046971135,0.0004267378,0.0005530374,0.00032799054,0.0023624909,0.0069134994],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43442708,0.056597862,0.0068960525,0.0016459618,0.0009823577,0.0006379585,0.0003450964,0.0030112148,0.11587054,0.000808797,0.10334402,0.27543312],"study_design_scores_gemma":[0.5307574,0.3277388,0.040041532,0.0001035429,0.0009028082,0.001243765,0.00008788126,0.001695305,0.015376966,0.00040051804,0.08156458,0.000086877124],"about_ca_topic_score_codex":0.0012950647,"about_ca_topic_score_gemma":0.0037628533,"teacher_disagreement_score":0.01816122,"about_ca_system_score_codex":0.0008454476,"about_ca_system_score_gemma":0.0024728242,"threshold_uncertainty_score":0.060755312},"labels":[],"label_agreement":null},{"id":"W2768067250","doi":"10.1093/neuonc/nox168.933","title":"STEM-17. CHARACTERIZATION OF THE CELL SURFACE PROTEOME IN RECURRENT GLIOBLASTOMA INITIATING CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McMaster University","funders":"","keywords":"Cancer research; Proteome; Temozolomide; Biology; Stem cell; Glioblastoma; Proteomics; Medicine; Bioinformatics; Computational biology; Gene; Genetics","score_opus":0.02019094331397455,"score_gpt":0.26558763587814643,"score_spread":0.24539669256417188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768067250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880575,0.001344865,0.0049908217,0.00010720147,0.000027272174,0.000048676873,0.003600056,0.00008561123,0.0017379796],"genre_scores_gemma":[0.9663204,0.0022967742,0.011102772,0.000198149,0.000024025367,0.00012119273,0.016104622,0.00006238223,0.0037696036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994254,0.0000053327685,0.000005595205,0.000012545765,0.000020114261,0.000013888618],"domain_scores_gemma":[0.9999361,0.000006660561,0.000018972363,0.0000054215707,0.000016648948,0.000016211958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012051017,0.0003219966,0.00021534637,0.00039411325,0.00014163618,0.00031554519,0.00015851646,0.00022543462,0.0007032463],"category_scores_gemma":[0.00012280168,0.00007565466,0.00023423406,0.0003942718,0.00010808954,0.00012860488,0.00016952306,0.00021660085,0.00047250948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042010364,0.000008946741,0.0007243269,0.00002430977,0.0000043888044,0.0000728194,0.000017417422,0.00003140867,0.9975756,0.000037186834,0.00004104714,0.0014206124],"study_design_scores_gemma":[0.0000099826575,0.00030723913,0.06289097,0.0000139493195,0.000051852436,0.001100856,0.00008876005,0.0015872088,0.9267937,0.00014262392,0.007004039,0.000008880031],"about_ca_topic_score_codex":0.0007545566,"about_ca_topic_score_gemma":0.0009670519,"teacher_disagreement_score":0.0007545566,"about_ca_system_score_codex":0.00015616392,"about_ca_system_score_gemma":0.00018194281,"threshold_uncertainty_score":0.0023525953},"labels":[],"label_agreement":null},{"id":"W2768078130","doi":"10.1093/neuonc/nox168.1006","title":"TMIC-16. THE IMMUNO-PROTECTIVE FUNCTION OF GLIOMA-ASSOCIATED BONE MARROW DERIVED CELLS DEPENDS ON THE STAGE OF TUMOR GROWTH AND IS INFLUENCED BY TREATMENT WITH MINOCYCLINE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Microglia; Minocycline; Glioma; Immune system; Bone marrow; Cancer research; Macrophage; Angiogenesis; Monocyte; Cytotoxic T cell; Immunology; Medicine; Biology; Inflammation; Antibiotics; In vitro; Microbiology","score_opus":0.012878817596248288,"score_gpt":0.24647474518465412,"score_spread":0.23359592758840583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768078130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671836,0.004580027,0.0016851596,0.00025005656,0.00022221028,0.00017003204,0.0019736078,0.00017937635,0.004221142],"genre_scores_gemma":[0.97907156,0.002868632,0.003472891,0.00017914866,0.00004336969,0.0003313715,0.005041873,0.00004078863,0.008950219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997869,0.000025265552,0.000025349398,0.000039440925,0.000047120317,0.00007591569],"domain_scores_gemma":[0.9998834,0.000009413223,0.00003022493,0.000014753989,0.000015229882,0.00004687771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018196208,0.0004024106,0.0004414385,0.00022894282,0.0001628106,0.00028556012,0.00022668278,0.00032174654,0.0026083235],"category_scores_gemma":[0.00010878129,0.00011988861,0.00033942555,0.00026478234,0.00025984904,0.00016446249,0.0001557973,0.0010125653,0.0008713188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084389857,0.0003556827,0.00044102737,0.00013899438,0.000010082044,0.000060140635,0.000029887957,0.00011938571,0.99229527,0.00014455912,0.0003032296,0.005257986],"study_design_scores_gemma":[0.00010824688,0.0037641935,0.0047142697,0.000022685494,0.00002915065,0.00043745435,0.00003325266,0.00056663784,0.9819225,0.00005909121,0.0083364,0.0000060951584],"about_ca_topic_score_codex":0.0006020425,"about_ca_topic_score_gemma":0.00085909176,"teacher_disagreement_score":0.0026083235,"about_ca_system_score_codex":0.0002637659,"about_ca_system_score_gemma":0.0005793278,"threshold_uncertainty_score":0.008725703},"labels":[],"label_agreement":null},{"id":"W2768086853","doi":"10.1093/neuonc/nox168.209","title":"CSIG-15. PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF HUMAN MEDULLOBLASTOMA REVEALS DISTINCT ACTIVATED PATHWAYS BETWEEN SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Biology; Wnt signaling pathway; Phosphorylation; Computational biology; RNA; Signal transduction; Gene; Genetics; Bioinformatics","score_opus":0.017618228351958257,"score_gpt":0.2745906689369452,"score_spread":0.25697244058498697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768086853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97241163,0.001935287,0.0027508037,0.00012114476,0.000037657035,0.000098161334,0.019826744,0.0004294185,0.0023890862],"genre_scores_gemma":[0.91532725,0.0013636246,0.011554097,0.00011275219,0.000012215061,0.0001230648,0.06797873,0.000118679396,0.0034095803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989843,0.000008268221,0.000009637864,0.000028476394,0.000031922693,0.00002322629],"domain_scores_gemma":[0.99993277,0.000008506546,0.000009739242,0.000012799112,0.000013047145,0.000023155164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015694315,0.0004109639,0.00042564876,0.0008871259,0.0002892949,0.00029800562,0.00031592746,0.0002472647,0.0014040099],"category_scores_gemma":[0.00021214917,0.0001783218,0.0004135711,0.00087757065,0.00016122249,0.00012043997,0.0002865452,0.00027373552,0.00067692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007310249,0.00004102929,0.011742148,0.00013072361,0.000047101043,0.00020561652,0.000058344078,0.00024370711,0.9792028,0.000094939525,0.000689355,0.00681304],"study_design_scores_gemma":[0.000069557565,0.0007424134,0.52006567,0.00002483562,0.00021006489,0.0018085572,0.00017335701,0.005338522,0.45647585,0.00029244108,0.014772216,0.00002656083],"about_ca_topic_score_codex":0.006831385,"about_ca_topic_score_gemma":0.009315353,"teacher_disagreement_score":0.006831385,"about_ca_system_score_codex":0.0004755353,"about_ca_system_score_gemma":0.0004966969,"threshold_uncertainty_score":0.013583243},"labels":[],"label_agreement":null},{"id":"W2768087876","doi":"10.1093/neuonc/nox168.1045","title":"TMOD-06. CLONAL DYNAMICS OF HUMAN GLIOBLASTOMA IN RESPONSE TO CHEMORADIOTHERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; McMaster University","funders":"","keywords":"Chemoradiotherapy; In vivo; Biology; Glioblastoma; Cell therapy; U87; Cancer research; Medicine; Bioinformatics; Stem cell; Oncology; Chemotherapy; Genetics","score_opus":0.021847730523955267,"score_gpt":0.3445237378440317,"score_spread":0.3226760073200764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768087876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609274,0.00040586252,0.0010011663,0.000040532967,0.0000075128046,0.000026009468,0.0007914735,0.00006143406,0.0015732752],"genre_scores_gemma":[0.9952058,0.0002232841,0.0012819859,0.00005471541,0.0000035614235,0.000048430713,0.0014804393,0.000019641027,0.0016820022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987555,0.000014484951,0.000007468632,0.000026219028,0.000049162085,0.000027126382],"domain_scores_gemma":[0.99981886,0.000038783543,0.00003346355,0.000020532709,0.00006031757,0.000028081566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014973557,0.00006777277,0.00016889849,0.00027254646,0.00012841028,0.0002608986,0.000097897086,0.00020200458,0.0011249412],"category_scores_gemma":[0.00035748506,0.0000830279,0.00009761771,0.00021845962,0.00009641854,0.00008416169,0.00013756212,0.00022010128,0.00027458003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044386758,0.000074757,0.015417208,0.000046906556,0.000019728866,0.00009204078,0.000167189,0.0012058141,0.9577284,0.00026119247,0.0005561279,0.02398663],"study_design_scores_gemma":[0.00003748621,0.0019732495,0.2451433,0.000014846027,0.00005598185,0.0009664793,0.00022780217,0.011921543,0.7300005,0.00029789054,0.00933894,0.000021991345],"about_ca_topic_score_codex":0.0032870362,"about_ca_topic_score_gemma":0.004192014,"teacher_disagreement_score":0.0032870362,"about_ca_system_score_codex":0.00034074724,"about_ca_system_score_gemma":0.00014632297,"threshold_uncertainty_score":0.006535828},"labels":[],"label_agreement":null},{"id":"W2770221757","doi":"10.1093/neuonc/nox209","title":"A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"National Cancer Institute; Novartis","keywords":"Everolimus; Temozolomide; Medicine; Internal medicine; Randomized controlled trial; Clinical endpoint; Oncology; Radiation therapy; Fluorouracil; Chemotherapy","score_opus":0.02356305569362439,"score_gpt":0.3342553056209731,"score_spread":0.31069224992734873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770221757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654014,0.0024616641,0.0008587985,0.00068421476,0.0002648058,0.007004842,0.0010805422,0.000084480016,0.001020579],"genre_scores_gemma":[0.97123736,0.0036542316,0.004257047,0.0021164333,0.00042741591,0.012763355,0.0027231465,0.000057540823,0.0027633968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99902534,0.0006483634,0.00005142227,0.00009630886,0.00006626576,0.00011234077],"domain_scores_gemma":[0.99859565,0.00026535336,0.00032990362,0.00011726103,0.000095420866,0.00059642305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031290862,0.0016240745,0.002824765,0.00046359506,0.0003950796,0.00071838946,0.0010052726,0.0014058307,0.003552109],"category_scores_gemma":[0.0015214686,0.0007570916,0.0015838878,0.0005081817,0.0010597046,0.0006843654,0.00042272703,0.0027101121,0.00070071843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9437048,0.02367414,0.0018727572,0.00030593644,0.0009990556,0.0000774415,0.00006318584,0.00044755187,0.0076598143,0.00008420855,0.0012172546,0.019893827],"study_design_scores_gemma":[0.84849,0.14687684,0.0026152954,0.000017129842,0.00036306266,0.000052245286,0.000011057652,0.0002365013,0.0005636615,0.000055966775,0.0007062473,0.000011994181],"about_ca_topic_score_codex":0.0011813911,"about_ca_topic_score_gemma":0.0034153957,"teacher_disagreement_score":0.003552109,"about_ca_system_score_codex":0.0010145656,"about_ca_system_score_gemma":0.002733602,"threshold_uncertainty_score":0.016548336},"labels":[],"label_agreement":null},{"id":"W2774008421","doi":"10.1093/neuonc/nox211","title":"Altered brain morphology after focal radiation reveals impact of off-target effects: implications for white matter development and neurogenesis","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; McGill University; Health Sciences Centre; University of Waterloo; Sunnybrook Health Science Centre; Hospital for Sick Children; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"Anterior commissure; Subventricular zone; Neurogenesis; White matter; Corpus callosum; Doublecortin; Brain size; Neuroscience; Biology; Anatomy; Medicine; Central nervous system; Magnetic resonance imaging; Neural stem cell; Dentate gyrus; Stem cell; Radiology","score_opus":0.03149845053249184,"score_gpt":0.32536106771125817,"score_spread":0.2938626171787663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774008421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479055,0.0016141953,0.002187013,0.000028567429,0.000011200819,0.000022246617,0.0002621926,0.00006562176,0.0010184492],"genre_scores_gemma":[0.9955232,0.0012097117,0.0013302888,0.000032705742,0.0000063216526,0.00004145092,0.00040488492,0.00004157349,0.0014099255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992037,0.00000779902,0.000004976695,0.000024887655,0.000024524858,0.000017417151],"domain_scores_gemma":[0.99986625,0.000022144684,0.000059460563,0.000017429202,0.000014088186,0.000020611884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012720244,0.0004173104,0.00030017731,0.000356263,0.00009733411,0.0001890417,0.00024111367,0.00027377126,0.0017766469],"category_scores_gemma":[0.00016922542,0.00012874512,0.00028375644,0.00015927842,0.00034890915,0.00019612616,0.00023829052,0.00051455107,0.0002531023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018411357,0.000037978367,0.0026975628,0.00009205095,0.000023688326,0.00040701038,0.00004400982,0.00014894154,0.9918847,0.000065832224,0.00004894401,0.004365191],"study_design_scores_gemma":[0.00001954396,0.00202034,0.20866893,0.000034453296,0.00013027649,0.0052064224,0.000196009,0.0004899634,0.7809151,0.00017235178,0.0021325748,0.000014097204],"about_ca_topic_score_codex":0.0005533132,"about_ca_topic_score_gemma":0.0007020058,"teacher_disagreement_score":0.0017766469,"about_ca_system_score_codex":0.00022233599,"about_ca_system_score_gemma":0.00017073842,"threshold_uncertainty_score":0.0059434175},"labels":[],"label_agreement":null},{"id":"W2790593643","doi":"10.1093/neuonc/noy017","title":"Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; NRG Oncology","keywords":"Radiation therapy; Oncology; Glioblastoma; Medicine; Chemotherapy; Internal medicine; Radiation oncology; Cancer research","score_opus":0.01526650856507893,"score_gpt":0.3146568014977567,"score_spread":0.29939029293267777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790593643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860351,0.0015471751,0.00017718322,0.00005258361,0.000016242453,0.000102344326,0.011278908,0.0000090641315,0.000781374],"genre_scores_gemma":[0.98843634,0.00025174083,0.00015539682,0.000071462266,0.00003206578,0.00012589844,0.010709302,0.0000071984527,0.00021058481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975763,0.00065756566,0.00052512344,0.0006058651,0.00043440185,0.00020077162],"domain_scores_gemma":[0.9922214,0.002350407,0.0036945227,0.0006516451,0.0005377721,0.00054413354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067598,0.00033273842,0.001083098,0.0015093654,0.00027757222,0.00082474615,0.0005510931,0.0004370331,0.0021400738],"category_scores_gemma":[0.004942554,0.00022668473,0.002185933,0.0023270382,0.00017859678,0.00047314164,0.0005698699,0.0005966853,0.00025402824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075715543,0.00011881269,0.9851226,0.00029758192,0.0024126698,0.00012620087,0.000048348193,0.00020723733,0.00041687515,0.00003115842,0.0006386297,0.003008267],"study_design_scores_gemma":[0.00040347583,0.0007842954,0.9954951,0.000030286876,0.00129985,0.00026141942,0.00007014127,0.00034691257,0.00018670212,0.000023692886,0.0010874039,0.000010818878],"about_ca_topic_score_codex":0.0049534165,"about_ca_topic_score_gemma":0.008542533,"teacher_disagreement_score":0.0049534165,"about_ca_system_score_codex":0.00084028457,"about_ca_system_score_gemma":0.0008719595,"threshold_uncertainty_score":0.010934651},"labels":[],"label_agreement":null},{"id":"W2793420290","doi":"10.1093/neuonc/noy047","title":"Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of British Columbia; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Population; MEDLINE; Physical therapy; Oncology; Clinical Oncology; Radiation therapy; Internal medicine; Medical physics; Cancer","score_opus":0.07819303377128087,"score_gpt":0.44114222550863613,"score_spread":0.3629491917373553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793420290","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16835365,0.12359758,0.103311956,0.03375017,0.0043579945,0.29575032,0.19835688,0.0020612956,0.07046022],"genre_scores_gemma":[0.3120394,0.038886555,0.11861555,0.0068203458,0.0013846486,0.43776157,0.07855607,0.00052611093,0.005409733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8605487,0.07338058,0.041348718,0.0026494465,0.02080041,0.0012721425],"domain_scores_gemma":[0.7678052,0.10695043,0.06839999,0.010326834,0.043818835,0.002698746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16352127,0.0011069862,0.003610513,0.0061649266,0.0009170269,0.0023707524,0.0023728353,0.0018216218,0.0036802867],"category_scores_gemma":[0.20711929,0.0004997008,0.0058780615,0.007576846,0.0010831867,0.0021560467,0.002702515,0.002152863,0.0021685709],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074810428,0.0011868876,0.32466277,0.06638465,0.008076572,0.00016689222,0.0038506484,0.0022633371,0.0014303536,0.00525024,0.13867994,0.44056657],"study_design_scores_gemma":[0.0057765646,0.0062678303,0.6338492,0.037724365,0.007085186,0.0006149968,0.002151803,0.0025856046,0.0035434796,0.0065384214,0.2934126,0.00045000005],"about_ca_topic_score_codex":0.0022013988,"about_ca_topic_score_gemma":0.003354188,"teacher_disagreement_score":0.16352127,"about_ca_system_score_codex":0.0033017162,"about_ca_system_score_gemma":0.0088304235,"threshold_uncertainty_score":0.8647935},"labels":[],"label_agreement":null},{"id":"W2795148659","doi":"10.1093/neuonc/noy025","title":"The multiforme of glioblastoma","year":2018,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Medicine; Cancer research","score_opus":0.02024346833750616,"score_gpt":0.298153919884979,"score_spread":0.27791045154747285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795148659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023578633,0.010530501,0.0004741399,0.9312769,0.013121915,0.00005512951,0.000138979,0.00005074663,0.020773016],"genre_scores_gemma":[0.34249648,0.013651026,0.0013510995,0.50863063,0.119511746,0.00010463927,0.00019714505,0.00006549819,0.013991783],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99920696,0.0002224722,0.000111089,0.00008426113,0.00014052987,0.0002345919],"domain_scores_gemma":[0.99832875,0.0007145869,0.0002633285,0.00008173593,0.00021154921,0.00039993224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070042734,0.0005223841,0.0007912747,0.00078448356,0.0020928383,0.0014583638,0.00076257694,0.01660659,0.002726931],"category_scores_gemma":[0.00995435,0.00050004263,0.0008446045,0.00066551426,0.0019427143,0.0021677052,0.0013541946,0.0128131965,0.0010602205],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020174442,0.00006823445,0.009557386,0.0002269971,0.000067172026,0.6578762,0.0005764053,0.00036839664,0.0010574135,0.0149166435,0.29293782,0.02214562],"study_design_scores_gemma":[0.00027165923,0.00016346839,0.011221815,0.00078672974,0.00016901552,0.72264826,0.0016306479,0.0025042286,0.0008185299,0.028920421,0.23075268,0.00011256112],"about_ca_topic_score_codex":0.006179938,"about_ca_topic_score_gemma":0.012806057,"teacher_disagreement_score":0.01660659,"about_ca_system_score_codex":0.0039353343,"about_ca_system_score_gemma":0.0027466489,"threshold_uncertainty_score":0.028553009},"labels":[],"label_agreement":null},{"id":"W2795436270","doi":"10.1093/neuonc/noy053","title":"Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Oncology; Bevacizumab; Internal medicine; Clinical trial; Hazard ratio; Chemoradiotherapy; Radiation therapy; Chemotherapy; Confidence interval","score_opus":0.021608684250580254,"score_gpt":0.31122815373392815,"score_spread":0.2896194694833479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795436270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693006,0.0010890883,0.0006622548,0.00003688711,0.0000059391177,0.00004555832,0.0009449686,0.000011361114,0.000273969],"genre_scores_gemma":[0.997844,0.000114365284,0.0004792517,0.000022368402,0.000007280652,0.000035459707,0.0014667542,0.0000043182167,0.000026198715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996801,0.0013554118,0.00066096475,0.0004936923,0.0005121658,0.00017677167],"domain_scores_gemma":[0.9873904,0.003028158,0.006589178,0.0013973368,0.0011313237,0.00046366354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103268465,0.00037541,0.0007151322,0.0017108122,0.00022642314,0.0009757599,0.0007123849,0.00028261842,0.0005822195],"category_scores_gemma":[0.01168712,0.00014257427,0.0010134939,0.0019968324,0.00044025504,0.0005095284,0.0008328116,0.0003253065,0.00010701138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012527434,0.00002918562,0.99221706,0.000049737493,0.0005761455,0.000033308428,0.000038798597,0.00033002123,0.0005206128,0.000017246353,0.00008338038,0.0048517217],"study_design_scores_gemma":[0.00009456388,0.000663152,0.99469596,0.000033774075,0.0010194523,0.00040399292,0.00008839855,0.0009328155,0.0013379268,0.000068864756,0.00064914936,0.000012097863],"about_ca_topic_score_codex":0.0015937756,"about_ca_topic_score_gemma":0.0028377832,"teacher_disagreement_score":0.0103268465,"about_ca_system_score_codex":0.0005295655,"about_ca_system_score_gemma":0.0011475654,"threshold_uncertainty_score":0.054614246},"labels":[],"label_agreement":null},{"id":"W2801833597","doi":"10.1093/neuonc/noy064","title":"Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Brain Tumor Society; National Institutes of Health; American Cancer Society","keywords":"Medicine; Temozolomide; Bevacizumab; Placebo; Internal medicine; Glioblastoma; Hazard ratio; Chemoradiotherapy; Oncology; Radiation therapy; Proportional hazards model; Nuclear medicine; Urology; Chemotherapy; Pathology; Confidence interval; Cancer research","score_opus":0.013235475480703791,"score_gpt":0.2745462852982913,"score_spread":0.2613108098175875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801833597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994879,0.0003015211,0.000051660485,0.000018541705,0.0000042191023,0.0000057894886,0.000040035342,0.0000021218702,0.00008819842],"genre_scores_gemma":[0.99971443,0.00007090685,0.000055614997,0.000011230162,0.000006026547,0.0000058892224,0.00009676911,7.0638424e-7,0.00003831242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998276,0.00006285551,0.000015993926,0.000034481218,0.000032865046,0.000026115807],"domain_scores_gemma":[0.9993724,0.0001554623,0.00030442863,0.000024042483,0.00004532637,0.00009844416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005503446,0.00017502214,0.00039355515,0.00021769901,0.00008665296,0.00026532463,0.00017766227,0.00019179286,0.0005061921],"category_scores_gemma":[0.0012277775,0.00008661405,0.00034779642,0.00018124761,0.00014502367,0.00016211336,0.00014862815,0.00025912712,0.00007811542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029439287,0.00042413292,0.93379235,0.00007706244,0.00043137444,0.0000788821,0.00008670661,0.00070804736,0.00708147,0.000027398042,0.00022305455,0.027630163],"study_design_scores_gemma":[0.00039026054,0.004412622,0.9918413,0.000008749541,0.00025837042,0.00015771831,0.00005401039,0.0012163771,0.0012902312,0.000044618,0.00031876264,0.0000070042865],"about_ca_topic_score_codex":0.0011024893,"about_ca_topic_score_gemma":0.0019396371,"teacher_disagreement_score":0.0011024893,"about_ca_system_score_codex":0.00035740872,"about_ca_system_score_gemma":0.00026244693,"threshold_uncertainty_score":0.0029105544},"labels":[],"label_agreement":null},{"id":"W2804790935","doi":"10.1093/neuonc/noy056","title":"Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Corticosteroid; Dexamethasone; Clinical trial; Clinical endpoint; Internal medicine; Oncology","score_opus":0.09571002492667882,"score_gpt":0.3967424660630512,"score_spread":0.3010324411363724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804790935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11115859,0.24849987,0.24296924,0.08987249,0.010590259,0.09675626,0.020021547,0.0031260399,0.17700583],"genre_scores_gemma":[0.3253687,0.05785997,0.39250177,0.030391993,0.004466613,0.14153399,0.03262799,0.0010446104,0.014204459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9055209,0.0593525,0.01846866,0.0021280157,0.0130656455,0.0014643187],"domain_scores_gemma":[0.8701947,0.045431297,0.03561661,0.008597981,0.035962995,0.0041964683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12689787,0.0022466455,0.0034023812,0.003529645,0.0011246193,0.0033890214,0.004024131,0.0024620688,0.0018614908],"category_scores_gemma":[0.09176328,0.00045258153,0.004731117,0.0034682737,0.0016474153,0.0020386113,0.0047713057,0.0044764965,0.00208724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007865435,0.0015989083,0.110750005,0.017309653,0.005254391,0.0003205309,0.0011996543,0.006755486,0.0029407528,0.0122499475,0.13935089,0.6944044],"study_design_scores_gemma":[0.007834616,0.010272959,0.18751062,0.030366013,0.006350165,0.0015084152,0.0010262663,0.008910533,0.010092649,0.03204093,0.70365554,0.00043122988],"about_ca_topic_score_codex":0.0015262025,"about_ca_topic_score_gemma":0.0019351626,"teacher_disagreement_score":0.12689787,"about_ca_system_score_codex":0.004107434,"about_ca_system_score_gemma":0.010159683,"threshold_uncertainty_score":0.6711081},"labels":[],"label_agreement":null},{"id":"W2808721921","doi":"10.1093/neuonc/noy059.037","title":"ATRT-40. IMPACT OF MOLECULAR SUBTYPES ON TREATMENT OUTCOMES IN RHABDOID TUMORS - A REPORT FROM THE RARE TUMOR CONSORTIUM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University; BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Oncology; Internal medicine; Medicine; Cancer research; Immunohistochemistry; Bioinformatics; Biology","score_opus":0.015882570690064674,"score_gpt":0.31630204613119367,"score_spread":0.300419475441129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808721921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918697,0.003880039,0.00023896954,0.00023261468,0.000014457492,0.00002112535,0.0014806152,0.000026282525,0.002236304],"genre_scores_gemma":[0.99739563,0.0005209205,0.00013714448,0.000070918555,0.00001297399,0.00001248038,0.0014762257,0.000009616565,0.00036401572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995633,0.000103943465,0.00003255788,0.00011789149,0.00011515988,0.00006723023],"domain_scores_gemma":[0.99936205,0.00012659674,0.00023363113,0.00005273313,0.00006163492,0.00016343466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082271785,0.00015771935,0.00032845367,0.0003570508,0.0001686423,0.00037199826,0.00017331658,0.00018904604,0.00097479724],"category_scores_gemma":[0.0011411541,0.00006643274,0.00044369805,0.00047022293,0.00016140738,0.00023986952,0.00032474342,0.00030573492,0.00024201816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051194355,0.00015496855,0.87414753,0.00013138747,0.00056678546,0.00069855497,0.00014338101,0.000975667,0.010763534,0.00015299859,0.0016732656,0.10547261],"study_design_scores_gemma":[0.000120731645,0.001098975,0.9907203,0.000017048305,0.00027110067,0.0015240378,0.00007235058,0.0006192086,0.0023399442,0.00017350359,0.003032329,0.000010549253],"about_ca_topic_score_codex":0.00203731,"about_ca_topic_score_gemma":0.0029439477,"teacher_disagreement_score":0.00203731,"about_ca_system_score_codex":0.0005670257,"about_ca_system_score_gemma":0.00030798814,"threshold_uncertainty_score":0.00435102},"labels":[],"label_agreement":null},{"id":"W2808731623","doi":"10.1093/neuonc/noy059.089","title":"DEV-14. IMPACT OF A LATIN AMERICA-WIDE TELECONFERENCED BRAIN TUMOR BOARD","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Latin Americans; Pediatric cancer; Pediatric oncology; Cancer; Session (web analytics); Family medicine; Internal medicine; Political science","score_opus":0.03861067467447335,"score_gpt":0.3602474940593308,"score_spread":0.32163681938485744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808731623","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12053454,0.005080898,0.0029003473,0.36161065,0.03244996,0.0007101681,0.01119119,0.0022989784,0.46322325],"genre_scores_gemma":[0.4520465,0.0041086664,0.0075836927,0.15718813,0.009608351,0.0010230601,0.013556254,0.0013108583,0.35357448],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99723345,0.0010314211,0.00010881689,0.00024239114,0.0005737428,0.00081021735],"domain_scores_gemma":[0.97904795,0.0018239347,0.0009644156,0.0005280884,0.0046605063,0.012975181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058722435,0.00034490137,0.00015240881,0.00065190106,0.0015220649,0.0030889148,0.0012410802,0.0016995862,0.06467174],"category_scores_gemma":[0.011031817,0.00017037381,0.0005590296,0.00046583806,0.0006408573,0.0013355612,0.0037559473,0.002123437,0.009612557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017161094,0.00034787643,0.029559206,0.00025219138,0.0000282506,0.0008424232,0.00076484116,0.00018423304,0.00090478087,0.0044359043,0.8485967,0.11391196],"study_design_scores_gemma":[0.000079358106,0.00017785351,0.04352775,0.00028089128,0.000018645456,0.00046295158,0.0026553513,0.00018544597,0.00040541915,0.00047425134,0.9517128,0.000019368654],"about_ca_topic_score_codex":0.020712364,"about_ca_topic_score_gemma":0.030563924,"teacher_disagreement_score":0.06467174,"about_ca_system_score_codex":0.00408551,"about_ca_system_score_gemma":0.012066579,"threshold_uncertainty_score":0.21634853},"labels":[],"label_agreement":null},{"id":"W2808751302","doi":"10.1093/neuonc/noy059.255","title":"GERM-08. EARLIER RECOGNITION OF SYMPTOMS AND DIAGNOSIS MAY REDUCE TREATMENT AND LATE EFFECT BURDEN IN CHILDREN, TEENAGERS AND YOUNG ADULTS WITH INTRACRANIAL GERM CELL TUMOURS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germinoma; Diabetes insipidus; Germ cell tumors; Pediatrics; Cohort; Craniopharyngioma; Disease; Internal medicine; Surgery; Radiation therapy; Chemotherapy","score_opus":0.006965573859664291,"score_gpt":0.24921229508734702,"score_spread":0.24224672122768273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808751302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839182,0.010564777,0.00021342587,0.0006485365,0.00007352133,0.000036029698,0.0005953113,0.000030083907,0.0039201058],"genre_scores_gemma":[0.9960741,0.0024373436,0.0002735229,0.00017409866,0.00005456983,0.000017921355,0.00043376032,0.0000053655317,0.00052921445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979824,0.000057020585,0.000019783629,0.000030111132,0.00004746842,0.00004748354],"domain_scores_gemma":[0.9991155,0.00011459754,0.0004635207,0.00001869061,0.00006779618,0.00021983565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041160514,0.00014597848,0.0003014498,0.00031822186,0.00021590474,0.00042375305,0.00016728515,0.00021322598,0.0038728975],"category_scores_gemma":[0.0022177885,0.000081505954,0.0003621434,0.00036916634,0.00016630022,0.00042756277,0.00033197258,0.00036578454,0.0004421251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038376625,0.0001582137,0.93550813,0.00019674489,0.000070144255,0.00061222556,0.0002134369,0.00006056076,0.0006181399,0.00007901015,0.0015626798,0.060536917],"study_design_scores_gemma":[0.000028733903,0.00058316655,0.9941871,0.000111150664,0.000057527875,0.0016557375,0.00030393002,0.000066471366,0.00019871046,0.00006043376,0.0027426374,0.000004498757],"about_ca_topic_score_codex":0.0028731893,"about_ca_topic_score_gemma":0.006924023,"teacher_disagreement_score":0.0038728975,"about_ca_system_score_codex":0.00035823902,"about_ca_system_score_gemma":0.00047263608,"threshold_uncertainty_score":0.012956142},"labels":[],"label_agreement":null},{"id":"W2808763881","doi":"10.1093/neuonc/noy059.430","title":"MBCL-34. STRUCTURAL CONNECTIVITY ABNORMALITY IN CHILDREN TREATED FOR MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Connectome; White matter; Neuropsychology; Abnormality; Neuroscience; Magnetic resonance imaging; Psychology; Diffusion MRI; Human Connectome Project; Medicine; Functional connectivity; Pathology; Psychiatry; Cognition; Radiology","score_opus":0.015643772045529063,"score_gpt":0.31930079029889813,"score_spread":0.30365701825336905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808763881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989961,0.00006918496,0.00006844444,0.00007782756,0.0000022114136,0.0000069520056,0.00047069488,0.000010163232,0.00029838647],"genre_scores_gemma":[0.9988747,0.00007973054,0.00019390335,0.000017575112,0.000002441558,0.000012404234,0.00053388684,0.00000839034,0.00027687702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998939,0.000015683763,0.0000066281355,0.000026159416,0.000030393909,0.000027120803],"domain_scores_gemma":[0.9996587,0.0000392134,0.00019393658,0.000011417433,0.000024450772,0.00007232878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012274162,0.00018059862,0.00017544352,0.00055639056,0.00042470018,0.00020135155,0.00022324239,0.00025408273,0.0018745245],"category_scores_gemma":[0.00089783064,0.00011439956,0.00017878317,0.0005945952,0.00029975348,0.00014920182,0.00024094776,0.00033371468,0.00015271925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005697128,0.00006648783,0.97759426,0.000050707433,0.000039288963,0.0034320692,0.0006043556,0.0003990444,0.0076603666,0.00018153245,0.00093258,0.00846974],"study_design_scores_gemma":[0.0000069098687,0.00008330089,0.9965146,0.0000060611965,0.000013588994,0.0021725749,0.00016890153,0.00020381247,0.00039152935,0.000047200345,0.0003887491,0.0000028264517],"about_ca_topic_score_codex":0.050785173,"about_ca_topic_score_gemma":0.06059568,"teacher_disagreement_score":0.050785173,"about_ca_system_score_codex":0.0008108914,"about_ca_system_score_gemma":0.0005882843,"threshold_uncertainty_score":0.10097915},"labels":[],"label_agreement":null},{"id":"W2808767859","doi":"10.1093/neuonc/noy059.175","title":"EAPH-06. HYPERMUTANT PEDIATRIC HIGH GRADE GLIOMAS ARE DRIVEN BY RAS/MAPK MUTATIONS AND RESPOND TO MEK INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Trametinib; Selumetinib; MAPK/ERK pathway; Medicine; Cancer research; MEK inhibitor; Mutation; Biology; Signal transduction; Genetics; Gene","score_opus":0.018277417631873568,"score_gpt":0.29205844359764394,"score_spread":0.27378102596577036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808767859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854532,0.000979558,0.0009914497,0.00021319446,0.00003586626,0.00006556986,0.007160734,0.00025723226,0.0048432406],"genre_scores_gemma":[0.97666013,0.00080068124,0.0024982055,0.00032584934,0.000009632818,0.000103876504,0.015333584,0.00009458207,0.0041734297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998615,0.000015328982,0.000010164629,0.000029896168,0.00004190729,0.000041231106],"domain_scores_gemma":[0.99985635,0.00001951728,0.000029322779,0.000017197644,0.000016262058,0.0000614253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001326853,0.0002933485,0.00024909235,0.000207216,0.00017095394,0.0004055786,0.00016994466,0.00030173417,0.00281291],"category_scores_gemma":[0.00019327711,0.00012654986,0.00027039848,0.00024342378,0.00014192995,0.00012302167,0.00019409617,0.0007323676,0.0008920654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021083702,0.00047672258,0.015969273,0.00022638825,0.00008610833,0.0019129255,0.00010688991,0.00085867936,0.93250614,0.0005465867,0.0061384025,0.039063506],"study_design_scores_gemma":[0.0003506322,0.0039117215,0.20357504,0.000059722108,0.00013176903,0.025084764,0.00031967962,0.004104229,0.70215064,0.0005728553,0.0597001,0.000038852093],"about_ca_topic_score_codex":0.0015209225,"about_ca_topic_score_gemma":0.0024443702,"teacher_disagreement_score":0.00281291,"about_ca_system_score_codex":0.0003435293,"about_ca_system_score_gemma":0.0003543188,"threshold_uncertainty_score":0.009410143},"labels":[],"label_agreement":null},{"id":"W2808768324","doi":"10.1093/neuonc/noy059.596","title":"QOL-14. IMPACT OF RADIATION DOSE ON PHYSICAL AND EMOTIONAL OUTCOMES IN PEDIATRIC BRAIN TUMOR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Psychosocial; Neurocognitive; Brain tumor; Quality of life (healthcare); Depression (economics); Radiation therapy; Psychological intervention; Pediatrics; Physical therapy; Psychiatry; Cognition; Internal medicine","score_opus":0.02541853202136992,"score_gpt":0.36709740553769815,"score_spread":0.34167887351632825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808768324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975865,0.00043052944,0.00010824205,0.00007879013,0.0000064171395,0.000024596407,0.000546633,0.000008328745,0.0012099533],"genre_scores_gemma":[0.99870944,0.00022730658,0.0002616547,0.00002350116,0.000003882252,0.000031405943,0.0005121669,0.0000036492333,0.00022691564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928707,0.00027305246,0.000074186224,0.000055347937,0.00022018292,0.000090187],"domain_scores_gemma":[0.9972036,0.0007826982,0.0014197462,0.00009044061,0.00024207016,0.0002614728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013300463,0.00021683415,0.00033050354,0.00038233746,0.00018786888,0.0003725684,0.0002250281,0.00013704458,0.0018451993],"category_scores_gemma":[0.0048021534,0.00010090655,0.0007329244,0.00048824347,0.00023318076,0.00027710528,0.00040629334,0.0005570753,0.00015151146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018097315,0.00021378968,0.97181827,0.00008233473,0.0002060903,0.000095740856,0.000331962,0.0003526178,0.0003276372,0.000060319002,0.00051042344,0.025819914],"study_design_scores_gemma":[0.000007588009,0.0003001309,0.9987249,0.000013051434,0.00003164207,0.00014062184,0.00013057777,0.00012731984,0.0001154862,0.000017090484,0.0003884788,0.0000029677599],"about_ca_topic_score_codex":0.001630406,"about_ca_topic_score_gemma":0.0029074664,"teacher_disagreement_score":0.0018451993,"about_ca_system_score_codex":0.00048615504,"about_ca_system_score_gemma":0.00037725127,"threshold_uncertainty_score":0.0070340633},"labels":[],"label_agreement":null},{"id":"W2808774077","doi":"10.1093/neuonc/noy059.497","title":"MBRS-52. TARGETING PRUNE-1 IN A GEMM OF METASTATIC MEDULLOBLASTOMA: A POTENTIAL ROUTE OF INHIBITION FOR NEW FUTURE THERAPIES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; In vivo; Biology; Metastasis; PTEN; Cancer; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.013760489795522258,"score_gpt":0.2890519646922945,"score_spread":0.27529147489677225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808774077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496283,0.025058191,0.013131559,0.00088951684,0.00016869385,0.00031128855,0.001488075,0.0008254167,0.008498979],"genre_scores_gemma":[0.97652787,0.0076382887,0.006747381,0.00016482748,0.000020693871,0.00011808291,0.001722756,0.000054701497,0.0070052245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999329,0.000009877795,0.0000044409317,0.000015294914,0.000021385844,0.000016214968],"domain_scores_gemma":[0.999969,0.000003869941,0.0000098676055,0.0000037152106,0.0000042539846,0.00000919413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013090104,0.0002950162,0.00029660735,0.00025344183,0.00009662232,0.0002392761,0.00024952332,0.00030175372,0.0012345144],"category_scores_gemma":[0.00007991932,0.00013194935,0.00028869836,0.00013445168,0.00018623305,0.00018932005,0.000120266915,0.00075961126,0.00038551507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003182938,0.0000974654,0.00018880525,0.00017103965,0.000023423976,0.00014284765,0.00003072916,0.00040453766,0.98590994,0.0005874212,0.00062305946,0.011502444],"study_design_scores_gemma":[0.00020667451,0.0016862171,0.0034637607,0.000034857374,0.000084268926,0.0010025969,0.00003251367,0.0020176508,0.9575268,0.00022653665,0.03370374,0.000014338052],"about_ca_topic_score_codex":0.0012645856,"about_ca_topic_score_gemma":0.0028997613,"teacher_disagreement_score":0.0012645856,"about_ca_system_score_codex":0.00035792784,"about_ca_system_score_gemma":0.00019153062,"threshold_uncertainty_score":0.004129827},"labels":[],"label_agreement":null},{"id":"W2808794853","doi":"10.1093/neuonc/noy059.672","title":"RONC-10. OUTCOMES OF STEREOTACTIC RADIOSURGERY FOR PILOCYTIC ASTROCYTOMA: AN INTERNATIONAL MULTICENTER STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pilocytic astrocytoma; Radiosurgery; Radiation therapy; Progression-free survival; Multivariate analysis; Astrocytoma; Chemotherapy; Internal medicine; Surgery; Radiology; Oncology; Glioma","score_opus":0.04505295938036096,"score_gpt":0.3632696258776428,"score_spread":0.3182166664972818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808794853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965848,0.0013662099,0.00010594523,0.00016277697,0.000025064135,0.00019403512,0.00056640623,0.000008958917,0.0009858645],"genre_scores_gemma":[0.99639016,0.0005272984,0.00020402386,0.00024113317,0.00011645491,0.0003306468,0.0017502521,0.000011961612,0.00042813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980203,0.0012472998,0.00011354004,0.00021345234,0.0002211946,0.00018430494],"domain_scores_gemma":[0.99774146,0.00034700867,0.0010107398,0.00022411188,0.00018223505,0.00049445056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00446078,0.0007620738,0.00076930394,0.00045167064,0.00026481794,0.0007557069,0.00052044657,0.00072700036,0.0014310176],"category_scores_gemma":[0.00222472,0.00022095854,0.0011649361,0.00072475633,0.0005936643,0.000521146,0.00041331217,0.0008043373,0.00047450222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36983585,0.013652587,0.54469424,0.0006287782,0.0051586023,0.00030390915,0.00033462976,0.0016834097,0.006223442,0.00030108923,0.0029002936,0.054283198],"study_design_scores_gemma":[0.060592994,0.119493805,0.8064341,0.00013779778,0.0032188445,0.00060510007,0.00026409313,0.0013361234,0.0019363683,0.00019312974,0.0057185628,0.00006911676],"about_ca_topic_score_codex":0.0010955897,"about_ca_topic_score_gemma":0.0016351294,"teacher_disagreement_score":0.00446078,"about_ca_system_score_codex":0.0006109518,"about_ca_system_score_gemma":0.00082002155,"threshold_uncertainty_score":0.02359116},"labels":[],"label_agreement":null},{"id":"W2808821352","doi":"10.1093/neuonc/noy059.010","title":"ATRT-11. MOLECULAR SUBGROUPS OF ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): TOWARDS A CONSENSUS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; SickKids Foundation; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; DNA methylation; SMARCB1; Biology; Cancer research; Transcriptome; Wnt signaling pathway; Bioinformatics; Epigenetics; Gene; Genetics; Gene expression; Chromatin remodeling; Medulloblastoma","score_opus":0.012532817835923868,"score_gpt":0.2871141989230279,"score_spread":0.27458138108710406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808821352","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15110403,0.39764553,0.20604809,0.12491448,0.016391926,0.002909937,0.01977903,0.0057534636,0.07545343],"genre_scores_gemma":[0.24273531,0.20488012,0.3398028,0.02165307,0.011877957,0.0028635007,0.13215424,0.0014806086,0.042552356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974221,0.0004348984,0.00075708516,0.00045964267,0.000495904,0.00043044228],"domain_scores_gemma":[0.9933055,0.00092560146,0.00071206386,0.00039743542,0.0032933399,0.0013660926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054115183,0.001647286,0.0029105742,0.0067754705,0.0013770865,0.0028343254,0.0049658413,0.0029314654,0.003004016],"category_scores_gemma":[0.0040847436,0.0008051248,0.0029072685,0.0038991263,0.0014568995,0.0031813749,0.0024980213,0.0052864267,0.005963191],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031068488,0.00070795545,0.054289788,0.011203743,0.00073566596,0.004950447,0.0014153204,0.0057204245,0.04792261,0.009755299,0.13884947,0.72134244],"study_design_scores_gemma":[0.0004131501,0.0018703927,0.113805495,0.006846109,0.0017238039,0.016629217,0.0037843084,0.007604572,0.015747283,0.012659284,0.81868243,0.00023395935],"about_ca_topic_score_codex":0.0040879166,"about_ca_topic_score_gemma":0.0040405807,"teacher_disagreement_score":0.0067754705,"about_ca_system_score_codex":0.0023224861,"about_ca_system_score_gemma":0.0060998253,"threshold_uncertainty_score":0.02861917},"labels":[],"label_agreement":null},{"id":"W2808835217","doi":"10.1093/neuonc/noy059.390","title":"LGG-49. MOLECULAR ALTERATIONS IN PREGNANT ADOLESCENT AND YOUNG ADULT WOMEN WITH GLIOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Graphene and Nanomaterials Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Pregnancy; Anaplastic astrocytoma; Astrocytoma; Loss of heterozygosity; Oncology; Brain tumor; Pilocytic astrocytoma; Population; ATRX; Malignant transformation; Internal medicine; Pathology; Cancer research; Mutation; Biology; Allele; Genetics","score_opus":0.006373913996005289,"score_gpt":0.22388131362768773,"score_spread":0.21750739963168245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808835217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753964,0.0006352149,0.00008321665,0.000055552253,0.0000042304932,0.000013456935,0.0003256271,0.000009157424,0.0013338493],"genre_scores_gemma":[0.9987953,0.00043506874,0.0001839467,0.000045813857,0.0000057146394,0.000011504795,0.00025823104,0.0000026439639,0.00026171017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999347,0.0000099159815,0.000006929327,0.000015257092,0.0000140320935,0.000019198427],"domain_scores_gemma":[0.99988115,0.000023120827,0.00005733647,0.0000052892888,0.000012243129,0.000020812844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008815417,0.0001167608,0.00011511687,0.00054966565,0.00022769351,0.00019744954,0.000083739236,0.00017486184,0.0011259575],"category_scores_gemma":[0.00045607283,0.00007547192,0.00008846229,0.00045170958,0.00012001328,0.00010839332,0.00012844677,0.00010373979,0.00025429044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000132764,0.000025278523,0.97923374,0.00002150865,0.000008937932,0.0056272885,0.00014350215,0.000034202523,0.0046636737,0.0000430766,0.00036050988,0.009705579],"study_design_scores_gemma":[0.000003891982,0.0001083273,0.9804756,0.000012316431,0.000016135371,0.016096082,0.00027525844,0.00010966988,0.0012261297,0.000053429674,0.0016204922,0.0000027027372],"about_ca_topic_score_codex":0.0021392799,"about_ca_topic_score_gemma":0.0025132834,"teacher_disagreement_score":0.0021392799,"about_ca_system_score_codex":0.00018372816,"about_ca_system_score_gemma":0.00014696072,"threshold_uncertainty_score":0.004253626},"labels":[],"label_agreement":null},{"id":"W2808836329","doi":"10.1093/neuonc/noy059.713","title":"TBIO-25. CHOROID PLEXUS PAPILLOMAS IN FAMILIES WITH DICER1 MUTATION ASSOCIATED DISEASE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University Health Centre; McGill University","funders":"","keywords":"Choroid plexus; Germline mutation; Medicine; Pathology; Germline; Transthyretin; Mutation; Biology; Genetics; Internal medicine; Central nervous system; Gene","score_opus":0.024154737125577995,"score_gpt":0.3186135426539791,"score_spread":0.29445880552840115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808836329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845898,0.0018960307,0.0012472566,0.00026784142,0.000056721474,0.00006077716,0.0012892548,0.00012079239,0.010471501],"genre_scores_gemma":[0.9954835,0.00073253136,0.00083597493,0.00008072772,0.000035002788,0.00002453164,0.00076943595,0.000022654891,0.002015573],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99972564,0.000036324418,0.000023444756,0.00009510343,0.00005142765,0.00006799341],"domain_scores_gemma":[0.9997018,0.000054260025,0.0000768123,0.000020635242,0.000030661828,0.0001158372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016028136,0.0009975757,0.000314749,0.0018747984,0.001095753,0.0004713453,0.0003352913,0.0006985555,0.006081608],"category_scores_gemma":[0.00060572574,0.00023781978,0.00033649904,0.0009983145,0.00052225764,0.00023064873,0.0005282928,0.0003295471,0.00081616745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010311676,0.00017187715,0.2349487,0.00046619176,0.00017314246,0.5600577,0.002093549,0.0006377101,0.1555975,0.0021244562,0.0036669942,0.039031025],"study_design_scores_gemma":[0.00007529826,0.00034235395,0.37648696,0.00021158178,0.00039689447,0.55842686,0.0008232515,0.0011877647,0.032419622,0.0011641937,0.028382128,0.00008311572],"about_ca_topic_score_codex":0.004819826,"about_ca_topic_score_gemma":0.003871441,"teacher_disagreement_score":0.006081608,"about_ca_system_score_codex":0.0005272675,"about_ca_system_score_gemma":0.00044193424,"threshold_uncertainty_score":0.020345032},"labels":[],"label_agreement":null},{"id":"W2808866479","doi":"10.1093/neuonc/noy059.148","title":"DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"BMI1; Cancer research; Senescence; Apoptosis; Cell culture; Cell growth; Radioresistance; In vivo; Growth inhibition; Programmed cell death; Biology; Cell biology; Genetics","score_opus":0.01562984796073893,"score_gpt":0.26915196416689763,"score_spread":0.2535221162061587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808866479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322456,0.00239368,0.0015050891,0.00014240666,0.00007813666,0.00007552825,0.0007370153,0.0001701351,0.0016734294],"genre_scores_gemma":[0.99245304,0.0015020868,0.0016195679,0.00009880049,0.000012423805,0.000064464206,0.0012991001,0.000025211297,0.0029253792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999925,0.000008652782,0.0000073791416,0.000015481311,0.000019372985,0.000024074436],"domain_scores_gemma":[0.999936,0.000006039149,0.0000128882,0.000006799264,0.0000048485217,0.000033409593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106734275,0.00040064027,0.000333507,0.00028676275,0.00013014185,0.000212766,0.00018921231,0.0002457579,0.0013628087],"category_scores_gemma":[0.000054398715,0.00012471258,0.00034599737,0.00020602313,0.00023023589,0.00014953097,0.00017414868,0.0008093012,0.00038538076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027600804,0.00011461274,0.00015486767,0.00006743817,0.000008240659,0.000082160775,0.000014030968,0.00009950114,0.9972023,0.000079141675,0.00011080916,0.0017908833],"study_design_scores_gemma":[0.00008100065,0.0023415852,0.006530322,0.000011919214,0.000032246484,0.0003487197,0.00002956148,0.0006845396,0.98659307,0.000039852566,0.003301212,0.000005925957],"about_ca_topic_score_codex":0.0010659716,"about_ca_topic_score_gemma":0.0016595767,"teacher_disagreement_score":0.0013628087,"about_ca_system_score_codex":0.0002546296,"about_ca_system_score_gemma":0.00020355619,"threshold_uncertainty_score":0.00455904},"labels":[],"label_agreement":null},{"id":"W2808892392","doi":"10.1093/neuonc/noy059.236","title":"EPID-02. MALIGNANT PRIMARY BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMOURS DIAGNOSED AMONG THE CANADIAN PAEDIATRIC POPULATION FROM 2009 TO 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Pilocytic astrocytoma; Incidence (geometry); Population; Astrocytoma; Confidence interval; Pediatrics; Cancer; Glioma; Internal medicine; Environmental health","score_opus":0.012632431262066184,"score_gpt":0.25065487186158314,"score_spread":0.23802244059951697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808892392","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12650567,0.0043425728,0.00042029432,0.0011690401,0.00012200372,0.00029642423,0.8398087,0.00031877437,0.027016522],"genre_scores_gemma":[0.5726379,0.007790526,0.0018343056,0.0013629465,0.000106152715,0.0004197076,0.4061361,0.00013520272,0.009577052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985246,0.000044272838,0.00010559522,0.00022269989,0.0007359544,0.00036688516],"domain_scores_gemma":[0.9965405,0.00009521613,0.0005165077,0.00006914653,0.002333058,0.00044551145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006210074,0.0005423224,0.000519464,0.004217494,0.002081978,0.0012212598,0.0016220093,0.00038340784,0.01080014],"category_scores_gemma":[0.0038800118,0.00046909053,0.00069870264,0.008580742,0.00039095682,0.00043729437,0.0009266303,0.0007994096,0.001399447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028795816,0.000049186416,0.7246013,0.0010732893,0.00024416167,0.00033959383,0.00083206163,0.0005284064,0.00032713593,0.0010946662,0.23241115,0.03821116],"study_design_scores_gemma":[0.000029865307,0.000020144975,0.9640355,0.00030893262,0.000076884004,0.0003671399,0.00046082019,0.0002288011,0.00015334765,0.0000767266,0.034213845,0.000027993316],"about_ca_topic_score_codex":0.99280655,"about_ca_topic_score_gemma":0.99444985,"teacher_disagreement_score":0.032499056,"about_ca_system_score_codex":0.032499056,"about_ca_system_score_gemma":0.050122384,"threshold_uncertainty_score":0.2357983},"labels":[],"label_agreement":null},{"id":"W2808895529","doi":"10.1093/neuonc/noy059.082","title":"DEV-07. THE LATIN-AMERICAN BRAIN TUMOR BOARD (LATB) TELECONFERENCE: RESULTS OF A WEB-BASED SURVEY TO EVALUATE PARTICIPANT EXPERIENCE AND THE PROGRAM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Teleconference; Attendance; Workload; Medicine; The Internet; Family medicine; Medical education; Multimedia; World Wide Web; Computer science; Political science","score_opus":0.06499398182790816,"score_gpt":0.4315416312288959,"score_spread":0.3665476494009877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808895529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856316,0.00012542166,0.00026675418,0.0005381075,0.000044254375,0.0005274067,0.0058686035,0.000047076832,0.006950697],"genre_scores_gemma":[0.98235726,0.00037121744,0.0013909221,0.0007476704,0.00004414502,0.0018102367,0.0061068577,0.000056355773,0.007115235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983078,0.0008515431,0.00017563488,0.00011000965,0.00027795398,0.0002769374],"domain_scores_gemma":[0.991952,0.0023788097,0.0016594118,0.00023733,0.0021438934,0.001628516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004972186,0.00024705732,0.00030200154,0.00083419634,0.00053954317,0.0010031224,0.0005176875,0.00049666164,0.0045701945],"category_scores_gemma":[0.008575344,0.00025625844,0.0004582633,0.0006487027,0.0002858862,0.000850402,0.0014106977,0.0009193579,0.0016827167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036138904,0.0016771737,0.92179143,0.00038679905,0.000056096287,0.00028356042,0.01683888,0.00013950632,0.00078645936,0.00010271484,0.01018764,0.047388416],"study_design_scores_gemma":[0.000027827302,0.0007132875,0.9717855,0.00008971821,0.00001563005,0.00016007962,0.018900914,0.00020618165,0.00028560124,0.000034553876,0.007761363,0.000019358307],"about_ca_topic_score_codex":0.005338752,"about_ca_topic_score_gemma":0.0069339876,"teacher_disagreement_score":0.005338752,"about_ca_system_score_codex":0.00077665626,"about_ca_system_score_gemma":0.00080265244,"threshold_uncertainty_score":0.026295781},"labels":[],"label_agreement":null},{"id":"W2808896472","doi":"10.1093/neuonc/noy059.718","title":"TBIO-30. MOLECULAR LANDSCAPE AND CLINICAL CORRELATIONS OF CNS SARCOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Central nervous system; Pathology; Biology; Cancer research; Sarcoma; Mesenchymal stem cell; Immunohistochemistry; Medicine; Internal medicine","score_opus":0.035274858904583074,"score_gpt":0.35987761696791404,"score_spread":0.32460275806333094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808896472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947245,0.0022654992,0.00031988963,0.00021253653,0.0000108839195,0.000032005515,0.0010771522,0.000020519252,0.0065890914],"genre_scores_gemma":[0.99665415,0.00056401617,0.00029758562,0.0000525083,0.000010274113,0.000016135356,0.0012728047,0.0000071537074,0.001125315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998623,0.000018283352,0.000012347137,0.000029817322,0.0000369724,0.000040256476],"domain_scores_gemma":[0.99963665,0.000031083306,0.00014397922,0.0000126149325,0.000061878054,0.00011381713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021676839,0.00015014519,0.00019458015,0.00066448975,0.0002198798,0.000327733,0.00018656683,0.00017009348,0.0024460591],"category_scores_gemma":[0.0006413898,0.00008341685,0.00010869751,0.0005501961,0.00022519701,0.00015573134,0.00019780152,0.00023911643,0.0005658641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010066795,0.000074643554,0.89989686,0.00008314354,0.00005275146,0.0014121487,0.00015902589,0.00033121943,0.059475575,0.0003165287,0.0011988134,0.035992634],"study_design_scores_gemma":[0.000011747049,0.00019151968,0.98796916,0.000014000945,0.000032557582,0.0042811525,0.00014713494,0.0003612841,0.0034138039,0.0002402408,0.003331295,0.0000061355236],"about_ca_topic_score_codex":0.0033915767,"about_ca_topic_score_gemma":0.005481881,"teacher_disagreement_score":0.0033915767,"about_ca_system_score_codex":0.00052870385,"about_ca_system_score_gemma":0.0003343876,"threshold_uncertainty_score":0.008182883},"labels":[],"label_agreement":null},{"id":"W2808919439","doi":"10.1093/neuonc/noy059.197","title":"EMBR-13. FAVORABLE OUTCOMES IN CHILDREN WITH PINEOBLASTOMA TREATED WITH RISK-ADAPTED CRANIOSPINAL IRRADIATION AND CHEMOTHERAPY: RESULTS AND MOLECULAR ANALYSIS FROM THE SJYC07 AND SJMB03 TRIALS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Prospective cohort study; Oncology; Internal medicine; Progression-free survival","score_opus":0.013692587069761666,"score_gpt":0.2793480186785539,"score_spread":0.26565543160879224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808919439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886629,0.008128706,0.00020204988,0.00029057552,0.00004648144,0.00015364666,0.0014846172,0.000021951004,0.0010090568],"genre_scores_gemma":[0.9892581,0.00329691,0.00095601723,0.0006267233,0.000060477945,0.00053418503,0.0046877405,0.000023049364,0.000556821],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9991565,0.0004541953,0.00007825553,0.00012319944,0.00011485399,0.00007306889],"domain_scores_gemma":[0.9990662,0.00023298689,0.00037342927,0.00009493163,0.00005832231,0.00017418023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022660852,0.00032268066,0.000798321,0.0002488984,0.0002034101,0.00060807593,0.00040177486,0.00047862998,0.0013652432],"category_scores_gemma":[0.0012046237,0.00019246664,0.0013225166,0.0004966015,0.00035553315,0.0003117643,0.00034269848,0.0008224385,0.00019516898],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42307302,0.0040579382,0.3326626,0.0023934178,0.009185323,0.00031083619,0.0003740894,0.002876829,0.02971645,0.0005577146,0.0051495954,0.18964224],"study_design_scores_gemma":[0.11542842,0.13772503,0.6960972,0.0007082444,0.0118635595,0.0017696159,0.0004092095,0.0020611836,0.012454977,0.0008885107,0.020506958,0.00008708186],"about_ca_topic_score_codex":0.000893135,"about_ca_topic_score_gemma":0.0032992205,"teacher_disagreement_score":0.0022660852,"about_ca_system_score_codex":0.00050535565,"about_ca_system_score_gemma":0.0008321793,"threshold_uncertainty_score":0.011984289},"labels":[],"label_agreement":null},{"id":"W2808935777","doi":"10.1093/neuonc/noy059.635","title":"QOL-54. THE RELATIONSHIP BETWEEN MATHEMATICS AND WORKING MEMORY IN PAEDIATRIC BRAIN TUMOUR SURVIVORS TREATED WITH RADIATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Adler; SickKids Foundation","funders":"","keywords":"Working memory; Working memory training; Verbal fluency test; Cognition; Fluency; Cognitive skill; Verbal memory; Psychology; Developmental psychology; Neuropsychology; Psychiatry; Mathematics education","score_opus":0.053491160180930704,"score_gpt":0.32436639140838297,"score_spread":0.2708752312274523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808935777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943118,0.0009624019,0.00017041982,0.00016062218,0.000009574643,0.000056979814,0.0019531543,0.000019114756,0.0023559562],"genre_scores_gemma":[0.9976209,0.00035971656,0.00020717084,0.000024446066,0.000003978255,0.000050022205,0.0011483802,0.0000046375158,0.0005807896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931824,0.000163253,0.000115997675,0.000062914136,0.00021635763,0.00012328838],"domain_scores_gemma":[0.996657,0.00062427897,0.0018703345,0.00012729553,0.00034720055,0.0003739638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015927372,0.00030584072,0.00052025093,0.0007806289,0.00026618232,0.00066500006,0.00037942274,0.00024216794,0.003159489],"category_scores_gemma":[0.0071419976,0.00012450072,0.0009996555,0.0011526358,0.00037368873,0.00038896294,0.0007521807,0.0006430562,0.0002269542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010236817,0.00009722907,0.98129797,0.00009848144,0.00024560757,0.00009514711,0.00047146334,0.00038318953,0.00013304234,0.0000943407,0.0005055469,0.016475592],"study_design_scores_gemma":[0.00000825024,0.00012698548,0.99863213,0.000018222427,0.000042130367,0.00011615872,0.00011433615,0.0001225813,0.00004968367,0.000032604017,0.00073203404,0.0000048227193],"about_ca_topic_score_codex":0.006138668,"about_ca_topic_score_gemma":0.006117505,"teacher_disagreement_score":0.006138668,"about_ca_system_score_codex":0.0007959241,"about_ca_system_score_gemma":0.00065482454,"threshold_uncertainty_score":0.012205899},"labels":[],"label_agreement":null},{"id":"W2808959977","doi":"10.1093/neuonc/noy059.455","title":"MBRS-10. RISK STRATIFICATION OF MEDULLOBLASTOMA ON THE BASIS OF MOLECULAR SUBGROUPING; AN EXPERIENCE FROM A SINGLE TERTIARY CARE CENTER FROM A DEVELOPING COUNTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Risk stratification; Single Center; Internal medicine; Pediatrics; Oncology; Pathology","score_opus":0.0309419376267085,"score_gpt":0.3223927517377767,"score_spread":0.2914508141110682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808959977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964618,0.0010533457,0.00035968603,0.00019421648,0.000014857539,0.00007747687,0.00017709433,0.000030082114,0.0016314174],"genre_scores_gemma":[0.99484515,0.0013233151,0.0020508044,0.00016080508,0.000031706222,0.000041432526,0.00047428344,0.000026954976,0.0010455537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996165,0.00011715299,0.000042715703,0.00006444191,0.00008883592,0.000070445436],"domain_scores_gemma":[0.99892956,0.00013469446,0.00024820265,0.00006092965,0.00015920248,0.00046737085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008142347,0.0003211569,0.00019201133,0.00045307298,0.00042852617,0.00039557536,0.00031091302,0.00018290523,0.0011223038],"category_scores_gemma":[0.0016473534,0.00017783837,0.00024345999,0.00053884496,0.00029657345,0.00030215475,0.0006066889,0.00032816228,0.00041024893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005289719,0.00035870532,0.8783914,0.00015087577,0.000049065267,0.006023118,0.0044984054,0.00024333457,0.0055428585,0.00012088897,0.0015897884,0.102502644],"study_design_scores_gemma":[0.00012188129,0.0029487398,0.9526751,0.00017149016,0.0000811375,0.020972425,0.0052736416,0.0006629134,0.0040625045,0.00010700216,0.012873875,0.00004933032],"about_ca_topic_score_codex":0.010111437,"about_ca_topic_score_gemma":0.016371058,"teacher_disagreement_score":0.010111437,"about_ca_system_score_codex":0.0009182093,"about_ca_system_score_gemma":0.0016885196,"threshold_uncertainty_score":0.020105183},"labels":[],"label_agreement":null},{"id":"W2808988165","doi":"10.1093/neuonc/noy059.399","title":"LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Glioma; Chemotherapy; V600E; Internal medicine; Pilocytic astrocytoma; Discontinuation; Radiation therapy; Cancer research; Astrocytoma; Mutation; Biology","score_opus":0.01906882292449606,"score_gpt":0.30965390601087256,"score_spread":0.2905850830863765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808988165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919985,0.0022515107,0.00040223583,0.00023807879,0.000035351164,0.00004442812,0.0010741153,0.0000652848,0.003890633],"genre_scores_gemma":[0.9966809,0.00050704397,0.00022691498,0.00014091394,0.000015020186,0.000019666877,0.0016663419,0.000016578395,0.00072651234],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997793,0.00005398251,0.00001582013,0.00005456813,0.00004122139,0.00005507715],"domain_scores_gemma":[0.9997384,0.000050992185,0.000052074287,0.000031374566,0.000017264267,0.000109909655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036176437,0.00017949339,0.00042296125,0.00025244412,0.00012706035,0.00035400916,0.00013247418,0.00016166121,0.0017064478],"category_scores_gemma":[0.0005196881,0.000059428417,0.00025830028,0.0002280433,0.00014462347,0.0001627912,0.00024272503,0.0003718332,0.00040542017],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045026507,0.002171522,0.4351197,0.000496694,0.00070494553,0.0027150367,0.0003056322,0.0016689999,0.13296375,0.0004938275,0.006134933,0.37219852],"study_design_scores_gemma":[0.0011601889,0.025053289,0.9326343,0.00005016915,0.00039944146,0.003516341,0.0001816127,0.0008541123,0.021790804,0.00032006265,0.014017905,0.00002179476],"about_ca_topic_score_codex":0.002020796,"about_ca_topic_score_gemma":0.003803616,"teacher_disagreement_score":0.002020796,"about_ca_system_score_codex":0.00056098175,"about_ca_system_score_gemma":0.00033476972,"threshold_uncertainty_score":0.005708635},"labels":[],"label_agreement":null},{"id":"W2808990415","doi":"10.1093/neuonc/noy059.149","title":"DIPG-56. PRECLINICAL STUDIES OF DIANHYDROGALACTITOL (VAL-083) IN DIPG, AS SINGLE AGENT OR AS A COMBINATION WITH RADIATION OR AZD1775","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Cell cycle; Cell cycle checkpoint; DNA damage; Topoisomerase; In vivo; Chemistry; Cancer; Glioma; Biology; DNA; Biochemistry; Genetics","score_opus":0.07938375954229857,"score_gpt":0.40123342556990105,"score_spread":0.32184966602760245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808990415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97646606,0.009581726,0.00158138,0.00051518297,0.00027408655,0.0008287431,0.0032390228,0.00036741808,0.0071464134],"genre_scores_gemma":[0.98059344,0.0067549204,0.0022765985,0.00030799746,0.000038066737,0.0005239498,0.004369114,0.00004619651,0.005089633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987876,0.00001893556,0.000006878113,0.000026385065,0.000023379127,0.000045673034],"domain_scores_gemma":[0.9999068,0.00000705033,0.00001571046,0.00001122046,0.00000804892,0.00005112978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022307303,0.00095789885,0.00057596166,0.00042111822,0.0002003641,0.00033682352,0.0005076663,0.0005450392,0.0022963316],"category_scores_gemma":[0.000108325316,0.00021351184,0.00043775045,0.0004343116,0.0003628219,0.000335128,0.00017054658,0.0018573437,0.0007562789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010807047,0.0092940675,0.000823873,0.0009440756,0.00015876544,0.00037007217,0.00011904598,0.0016481654,0.92092925,0.0007561108,0.0032230346,0.050926574],"study_design_scores_gemma":[0.005035535,0.13362421,0.010183319,0.00008203818,0.00040806667,0.0013819456,0.00012324989,0.0017967214,0.8051914,0.00040035672,0.04172018,0.000053033542],"about_ca_topic_score_codex":0.0012722252,"about_ca_topic_score_gemma":0.002608249,"teacher_disagreement_score":0.0022963316,"about_ca_system_score_codex":0.0004759434,"about_ca_system_score_gemma":0.0006856593,"threshold_uncertainty_score":0.007681966},"labels":[],"label_agreement":null},{"id":"W2808991402","doi":"10.1093/neuonc/noy059.634","title":"QOL-53. METFORMIN RESULTS IN HIPPOCAMPAL REMODELING AND IMPROVED MEMORY ENCODING IN PAEDIATRIC BRAIN TUMOR SURVIVORS TREATED WITH CRANIAL RADIATION: A PILOT RANDOMIZED CONTROLLED CROSSOVER STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hippocampal formation; Medicine; Placebo; Crossover study; Metformin; Brain size; Internal medicine; Anesthesia; Neuroscience; Psychology; Pathology; Magnetic resonance imaging; Radiology","score_opus":0.01816303726408535,"score_gpt":0.29347047248415165,"score_spread":0.2753074352200663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808991402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937686,0.0011858485,0.00028159496,0.00016645505,0.00016386923,0.0033721747,0.0005994997,0.00006715867,0.00039479436],"genre_scores_gemma":[0.98338103,0.0016810183,0.00252418,0.00052708545,0.0002152207,0.009383048,0.0006267908,0.000023208993,0.0016383992],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99945647,0.00022408085,0.00006184177,0.000112342095,0.000050195846,0.000095118005],"domain_scores_gemma":[0.99925965,0.00015131698,0.00017967724,0.00007916999,0.000063680614,0.00026650325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00124089,0.001333476,0.0027618036,0.00048533388,0.00045148813,0.0007587745,0.00071334105,0.0014321526,0.0066673523],"category_scores_gemma":[0.0013035156,0.0005478828,0.0017234522,0.00043577197,0.0008279091,0.00075084576,0.0003809462,0.0019759529,0.0005708013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94190013,0.034609232,0.0009689271,0.0007349399,0.0010314273,0.000067954265,0.00006467536,0.00013899367,0.004922927,0.00006030114,0.00041781674,0.015082628],"study_design_scores_gemma":[0.7005563,0.2915494,0.0053745965,0.000045927558,0.0006663981,0.000036835194,0.000042144693,0.0002596322,0.0008505054,0.00006017704,0.00053845823,0.000019659305],"about_ca_topic_score_codex":0.0010340834,"about_ca_topic_score_gemma":0.0020075392,"teacher_disagreement_score":0.0066673523,"about_ca_system_score_codex":0.00047970153,"about_ca_system_score_gemma":0.0010312457,"threshold_uncertainty_score":0.022304475},"labels":[],"label_agreement":null},{"id":"W2809011355","doi":"10.1093/neuonc/noy059.506","title":"MBRS-62. REPRESSIVE CHROMATIN REMODELERS IN SHH-DRIVEN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Biology; Cancer research; Chromatin; Neurogenesis; Cell biology; Genetics; Gene; Signal transduction","score_opus":0.02089980429247157,"score_gpt":0.2997165889659222,"score_spread":0.2788167846734506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809011355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574983,0.0011007631,0.0011328406,0.000081715414,0.000023226432,0.000038759463,0.00046889897,0.00015541699,0.0012484397],"genre_scores_gemma":[0.994859,0.0006848711,0.00070673693,0.000036027544,0.000008639605,0.000034235272,0.0006384574,0.000028339307,0.003003639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998828,0.000013821407,0.000011639502,0.000027414791,0.000042775973,0.00002145396],"domain_scores_gemma":[0.9999435,0.000005521777,0.000020167967,0.000005896743,0.000002923557,0.000021990823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010808594,0.00023275761,0.00020280259,0.00038377018,0.00012991011,0.00018377072,0.00013773145,0.000219262,0.0009875919],"category_scores_gemma":[0.00006772651,0.0001533011,0.00022804047,0.0001144215,0.00026448964,0.000098053206,0.00015894357,0.0003647187,0.0004445914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008740771,0.00003029312,0.00027336294,0.000011939648,0.0000024934855,0.00012583361,0.000010315841,0.000047000816,0.9984999,0.000077855395,0.00003096416,0.00080279884],"study_design_scores_gemma":[0.000082471146,0.0012664107,0.021117274,0.000009101917,0.00003314896,0.001686018,0.000048623184,0.0016036397,0.9691628,0.000108739674,0.0048736557,0.000008088822],"about_ca_topic_score_codex":0.0012882444,"about_ca_topic_score_gemma":0.0019199919,"teacher_disagreement_score":0.0012882444,"about_ca_system_score_codex":0.00025733132,"about_ca_system_score_gemma":0.00014996104,"threshold_uncertainty_score":0.0033038259},"labels":[],"label_agreement":null},{"id":"W2809066522","doi":"10.1093/neuonc/noy059.630","title":"QOL-48. SEIZURE IN PEDIATRIC PATIENTS WITH BRAIN TUMORS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epilepsy; Medicine; Brain tumor; Retrospective cohort study; Pediatrics; Logistic regression; Single Center; Anesthesia; Surgery; Internal medicine; Pathology; Psychiatry","score_opus":0.010831030798720935,"score_gpt":0.2717483018481258,"score_spread":0.2609172710494049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809066522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555475,0.0010251068,0.00014459534,0.00015632545,0.000011652466,0.000015004016,0.001243005,0.000010477249,0.0018390951],"genre_scores_gemma":[0.9985464,0.00035616165,0.00015774852,0.000024974941,0.0000071524523,0.000014552578,0.0007162258,0.0000029453377,0.0001737456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997243,0.00008264657,0.000033628592,0.000034209283,0.000069722344,0.00005551412],"domain_scores_gemma":[0.99883467,0.0002023484,0.00070563116,0.000026646394,0.000090994705,0.00013974714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037376123,0.00022218724,0.0002954057,0.0004908693,0.00020306536,0.00034971556,0.00012481857,0.00014260295,0.0023426877],"category_scores_gemma":[0.0025977609,0.000080675614,0.00033934208,0.00090132694,0.00015827737,0.00031099925,0.00031330087,0.00043766137,0.00024966538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024430448,0.000014661437,0.9955584,0.000011791754,0.000020139798,0.000087489476,0.0000304763,0.000044453092,0.00003105777,0.000014674656,0.00024320625,0.003919247],"study_design_scores_gemma":[0.0000045989364,0.00008917231,0.9980515,0.000009910227,0.000015705675,0.0008346367,0.00009081391,0.00012982974,0.00003170819,0.000021772257,0.0007179137,0.0000024846152],"about_ca_topic_score_codex":0.001898282,"about_ca_topic_score_gemma":0.0025526031,"teacher_disagreement_score":0.0023426877,"about_ca_system_score_codex":0.0002927294,"about_ca_system_score_gemma":0.00035641974,"threshold_uncertainty_score":0.007837117},"labels":[],"label_agreement":null},{"id":"W2809103371","doi":"10.1093/neuonc/noy059.012","title":"ATRT-13. CANCER PREDISPOSITION AMONG CHILDREN WITH RHABDOID TUMORS: A SINGLE-CENTRE RETROSPECTIVE REVIEW","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"SMARCB1; Germline; Genetic testing; Medicine; Atypical teratoid rhabdoid tumor; Family history; Referral; Germline mutation; Retrospective cohort study; Genetic predisposition; Cancer; Medical genetics; Pediatrics; Oncology; Mutation; Internal medicine; Genetics; Biology; Family medicine; Gene; Immunohistochemistry","score_opus":0.008607573678507962,"score_gpt":0.26147640994216104,"score_spread":0.2528688362636531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809103371","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61425334,0.3668383,0.0007064104,0.0003551116,0.00016137629,0.00053272414,0.012509539,0.00006764077,0.004575488],"genre_scores_gemma":[0.83187985,0.15709533,0.001090784,0.00055903045,0.00018535892,0.00035584517,0.00821603,0.000054708606,0.00056304573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769527,0.0003206162,0.0008826874,0.0004691294,0.00050006714,0.00013216592],"domain_scores_gemma":[0.99401593,0.001428476,0.0031987177,0.0002756138,0.00076161954,0.00031975354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014732393,0.00029840393,0.000882931,0.003737037,0.0005089423,0.00091985165,0.00076652947,0.0005679947,0.0025325129],"category_scores_gemma":[0.0046722954,0.0005513805,0.0009375553,0.0065669646,0.00044161943,0.00069380243,0.00063809217,0.00047932306,0.0008221795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002753114,0.00005878911,0.93644375,0.009968884,0.0007170536,0.013252355,0.0007264122,0.000078922814,0.00094270473,0.00020228009,0.003915766,0.033417784],"study_design_scores_gemma":[0.00006252044,0.00030070407,0.8639095,0.0066880123,0.0013604506,0.10531677,0.001384767,0.000114477436,0.0005625504,0.000056478853,0.020199794,0.00004393622],"about_ca_topic_score_codex":0.0055878316,"about_ca_topic_score_gemma":0.00551913,"teacher_disagreement_score":0.0055878316,"about_ca_system_score_codex":0.00075167447,"about_ca_system_score_gemma":0.0014586624,"threshold_uncertainty_score":0.011110663},"labels":[],"label_agreement":null},{"id":"W2809181226","doi":"10.1093/neuonc/noy059.324","title":"IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Medicine; Oncology; HSL and HSV; Internal medicine; Adverse effect; Immunology","score_opus":0.014841984475284791,"score_gpt":0.31841463782666113,"score_spread":0.30357265335137634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809181226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842301,0.0031859472,0.00090847694,0.00039666245,0.00007847548,0.002193393,0.0029998946,0.00021921328,0.0057878466],"genre_scores_gemma":[0.9822604,0.0019408806,0.003414927,0.0006612229,0.00009148515,0.0030362708,0.0045254417,0.000050785013,0.004018577],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997627,0.00012641087,0.000008350799,0.000025913212,0.000027548194,0.00004904621],"domain_scores_gemma":[0.9997985,0.000035477864,0.000052337018,0.000015675865,0.000013832004,0.00008427427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007895988,0.0006664736,0.0007801095,0.0002103124,0.00021026346,0.000501073,0.00044579766,0.0006096375,0.002804008],"category_scores_gemma":[0.0003634544,0.00023424144,0.0005632135,0.00021366701,0.00040443675,0.00024789968,0.00024869392,0.0016748953,0.00062808953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44996572,0.040441442,0.022152394,0.0022458828,0.0011632516,0.0013508473,0.0005917708,0.0048061623,0.16839233,0.0024716929,0.021643931,0.2847746],"study_design_scores_gemma":[0.27489972,0.63100517,0.031076653,0.00017776137,0.0005656848,0.0021793437,0.00012180271,0.0026879306,0.032363806,0.00056746794,0.02431754,0.000037169342],"about_ca_topic_score_codex":0.0013025227,"about_ca_topic_score_gemma":0.0034772954,"teacher_disagreement_score":0.002804008,"about_ca_system_score_codex":0.00087137026,"about_ca_system_score_gemma":0.0012263352,"threshold_uncertainty_score":0.009380341},"labels":[],"label_agreement":null},{"id":"W2809184189","doi":"10.1093/neuonc/noy059.196","title":"EMBR-12. IMPROVED DIAGNOSTIC ALGORITHM FOR DIFFERENTIAL DIAGNOSTICS OF CNS EMBRYONAL TUMORS (FORMER CNS-PNET) BY NEUROPATHOLOGICAL RE-EVALUATION OF 256 CASES AND CROSSVALIDATION BY METHYLATION CLASSIFICATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Pathological; Medical diagnosis; Pathology; Atypical teratoid rhabdoid tumor; Differential diagnosis; Immunohistochemistry; Biology; Medicine","score_opus":0.05697243646509697,"score_gpt":0.3509857363044983,"score_spread":0.29401329983940133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809184189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8000992,0.000848135,0.17166659,0.0004577222,0.00009977574,0.0019778379,0.01523313,0.0050829267,0.0045346403],"genre_scores_gemma":[0.6531955,0.0002954591,0.30527985,0.0002188401,0.000053698725,0.0026116667,0.03367559,0.00047109925,0.0041982653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904984,0.00026201815,0.00017261454,0.0002825259,0.00015235126,0.00008074533],"domain_scores_gemma":[0.9986297,0.00040764446,0.00029629187,0.00012502588,0.0004333344,0.000108091954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031216226,0.0006070533,0.0005420767,0.003363421,0.0003202064,0.0006178113,0.0008082353,0.0005043266,0.0042270934],"category_scores_gemma":[0.0040721833,0.00032033309,0.00076778687,0.0008734297,0.00018735565,0.00042227874,0.0010091205,0.00046424178,0.0014211452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002682457,0.00027061976,0.71799767,0.00048467953,0.00046604063,0.0013300163,0.00046945357,0.006762576,0.032978754,0.00069837726,0.015614997,0.2202444],"study_design_scores_gemma":[0.0005714947,0.00095437374,0.7698507,0.0002765483,0.00060228317,0.011403258,0.00043724617,0.15243016,0.030348323,0.0030704539,0.029927239,0.0001279623],"about_ca_topic_score_codex":0.00158897,"about_ca_topic_score_gemma":0.003055005,"teacher_disagreement_score":0.0042270934,"about_ca_system_score_codex":0.00038947444,"about_ca_system_score_gemma":0.00069538126,"threshold_uncertainty_score":0.016508937},"labels":[],"label_agreement":null},{"id":"W2809198755","doi":"10.1093/neuonc/noy059.481","title":"MBRS-36. IDENTIFICATION OF TWO PROTEIN-SIGNALING STATES DELINEATING TRANSCRIPTIONALLY HETEROGENEOUS HUMAN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medulloblastoma; Biology; Signal transduction; Phosphoprotein; Phosphorylation; Cancer research; Cell cycle; Apoptosis; DNA damage; Cell biology; DNA; Genetics","score_opus":0.024225151844704498,"score_gpt":0.3111506951164242,"score_spread":0.2869255432717197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809198755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882585,0.000257496,0.00026178706,0.000010902188,0.0000012875531,0.000010391844,0.00034050437,0.000015353626,0.0002764727],"genre_scores_gemma":[0.99741673,0.00012509321,0.0006100252,0.000009967029,0.0000020139394,0.00001542355,0.0013097246,0.0000063248463,0.00050466124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993706,0.0000071840104,0.0000050616104,0.000014132273,0.000016382564,0.000020288522],"domain_scores_gemma":[0.9999455,0.000007899232,0.000016307446,0.0000075948556,0.000005270163,0.000017372286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008352295,0.00022822189,0.00019740756,0.00046393878,0.00014613892,0.00018296907,0.000087051085,0.0001261969,0.0007726405],"category_scores_gemma":[0.00013968255,0.000081013364,0.00021017146,0.00021609155,0.00014597681,0.00008231242,0.00013345985,0.00013972424,0.00023534082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004690368,0.000022256778,0.018441694,0.000023371796,0.000013131713,0.00018100959,0.00006912575,0.00013058013,0.97724503,0.00007971804,0.000059094313,0.0032658675],"study_design_scores_gemma":[0.00004316911,0.001057704,0.50419015,0.000007640182,0.00008139865,0.0032654868,0.0001652545,0.0015364644,0.48473805,0.00033564604,0.0045679193,0.000011116007],"about_ca_topic_score_codex":0.0017060669,"about_ca_topic_score_gemma":0.0026401344,"teacher_disagreement_score":0.0017060669,"about_ca_system_score_codex":0.00025832345,"about_ca_system_score_gemma":0.00017100073,"threshold_uncertainty_score":0.0033922791},"labels":[],"label_agreement":null},{"id":"W2809211258","doi":"10.1093/neuonc/noab140","title":"Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Dalhousie University; University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; ATRX; Young adult; Radiological weapon; IDH1; Pediatrics; Glioma; Internal medicine; Overall survival; Surgery","score_opus":0.013914175283265417,"score_gpt":0.2630091208160526,"score_spread":0.2490949455327872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809211258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702674,0.00023593643,0.0000651228,0.00003564775,0.000005306651,0.000009739987,0.002007331,0.000005741147,0.0006084025],"genre_scores_gemma":[0.99699605,0.00022480015,0.00007744969,0.000045147015,0.000010693485,0.000022842614,0.002520626,0.0000031414602,0.00009923761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969566,0.00003860953,0.000046936268,0.00008841384,0.000066208806,0.00006410498],"domain_scores_gemma":[0.9988563,0.00017027272,0.00059556233,0.00006415973,0.00010951431,0.00020410621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044836433,0.00018965612,0.00038015025,0.0007937545,0.00027421222,0.0004679307,0.00027870588,0.0002651835,0.0010041513],"category_scores_gemma":[0.0013066758,0.00014079419,0.00023708037,0.0012294299,0.00019505904,0.0005513776,0.00032932815,0.00032610854,0.0003090998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027913902,0.000007553595,0.99897885,0.0000039832935,0.000007753835,0.00009514765,0.000025747368,0.000017783119,0.000071884184,0.000007278236,0.00014441594,0.0006117216],"study_design_scores_gemma":[0.0000035909902,0.000047622256,0.9983688,0.000004975128,0.000010458279,0.00094068516,0.00016185755,0.00005913074,0.00003586084,0.000009281104,0.00035506167,0.0000028047748],"about_ca_topic_score_codex":0.0027037503,"about_ca_topic_score_gemma":0.0032378756,"teacher_disagreement_score":0.0027037503,"about_ca_system_score_codex":0.0002849012,"about_ca_system_score_gemma":0.0003538526,"threshold_uncertainty_score":0.0053759813},"labels":[],"label_agreement":null},{"id":"W2809211544","doi":"10.1093/neuonc/noy059.501","title":"MBRS-57. TARGETING METABOLIC ADAPTATION IN MYC/MYCN AMPLIFIED PEDIATRIC MEDULLOBLASTOMA AND NEUROBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Neuroblastoma; Cancer research; Gene knockdown; Medulloblastoma; Pediatric cancer; Biology; Mediator; Synthetic lethality; Cell culture; Gene; Cell biology; Cancer; Genetics; Mutant","score_opus":0.027257636485434604,"score_gpt":0.31862792166595216,"score_spread":0.29137028518051755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809211544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514869,0.021356143,0.003986478,0.0006567005,0.00022820017,0.0003759553,0.010828467,0.0010433999,0.010037734],"genre_scores_gemma":[0.93963104,0.016483521,0.00631965,0.00032367266,0.00003702835,0.00045000325,0.025000552,0.00014481544,0.011609645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998022,0.000015351276,0.000014710362,0.000035625413,0.00009096088,0.000041260126],"domain_scores_gemma":[0.9999397,0.000004996232,0.000018506918,0.0000071330596,0.00000880791,0.000020863783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020696167,0.00044527528,0.00057606,0.00044460257,0.00017976642,0.00042727165,0.0003665062,0.0002948604,0.0028055015],"category_scores_gemma":[0.00014473301,0.000265936,0.00039123496,0.00043800988,0.00019028899,0.00015518688,0.00030155617,0.0006590723,0.0011005669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022386408,0.0004023536,0.0029144953,0.00055966555,0.000112584334,0.00028596778,0.00005309249,0.0013232238,0.9491192,0.0005864713,0.003474754,0.038929608],"study_design_scores_gemma":[0.0007278295,0.0029955574,0.047651928,0.00018069244,0.00031994234,0.0015337085,0.00012817058,0.004292092,0.8237451,0.00025726898,0.118128456,0.000039249964],"about_ca_topic_score_codex":0.0047509433,"about_ca_topic_score_gemma":0.0120297205,"teacher_disagreement_score":0.0047509433,"about_ca_system_score_codex":0.00070919713,"about_ca_system_score_gemma":0.0008313218,"threshold_uncertainty_score":0.009446561},"labels":[],"label_agreement":null},{"id":"W2809215572","doi":"10.1093/neuonc/noy059.469","title":"MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medulloblastoma; Gene knockdown; Biology; RNA-binding protein; Neural stem cell; Cancer research; Stem cell; Progenitor cell; Translation (biology); microRNA; Messenger RNA; Gene; Cell biology; Genetics","score_opus":0.013225354246410534,"score_gpt":0.25606950424331254,"score_spread":0.24284414999690201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809215572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308383,0.002772572,0.001151392,0.00009264099,0.000010831133,0.00005267622,0.0010544512,0.000044521585,0.0017370841],"genre_scores_gemma":[0.99096996,0.002359207,0.0023502156,0.00005955071,0.000011682308,0.00003796441,0.002187117,0.000020860512,0.0020033647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999114,0.00001035766,0.000005775362,0.000021587137,0.000029405493,0.000021403708],"domain_scores_gemma":[0.99993753,0.000008614783,0.000021955173,0.0000035166286,0.000009389614,0.000019031322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016230345,0.0002018321,0.00018864451,0.00040275542,0.00017541327,0.00018040382,0.00014908236,0.0002167901,0.001159465],"category_scores_gemma":[0.0001479438,0.0001213581,0.0002278453,0.00027342068,0.00016211288,0.00016687969,0.00013651987,0.0002406626,0.00033965535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049490144,0.00003193584,0.014712275,0.00014217476,0.000017333417,0.0003010589,0.00007527549,0.00012631243,0.977716,0.0001253512,0.00017559472,0.00608167],"study_design_scores_gemma":[0.000047026715,0.0013473728,0.32185107,0.000026944714,0.000105552695,0.0041244156,0.00038120968,0.0014151066,0.64885676,0.00014849388,0.021685528,0.000010451312],"about_ca_topic_score_codex":0.0037604817,"about_ca_topic_score_gemma":0.0047578975,"teacher_disagreement_score":0.0037604817,"about_ca_system_score_codex":0.0004307447,"about_ca_system_score_gemma":0.00026696993,"threshold_uncertainty_score":0.007477224},"labels":[],"label_agreement":null},{"id":"W2809234664","doi":"10.1093/neuonc/noy059.228","title":"EPEN-28. HETEROGENEITY WITHIN THE PFB EPENDYMOMA SUBGROUP","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Proportional hazards model; Oncology; Internal medicine; Survival analysis; Medicine; Biology","score_opus":0.021669296637481406,"score_gpt":0.3301284806921344,"score_spread":0.308459184054653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809234664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688077,0.0003904881,0.00097615283,0.000067287125,0.0000029916869,0.000020839987,0.00054365164,0.000016883514,0.001100966],"genre_scores_gemma":[0.99789906,0.000106006984,0.00044606268,0.000025169982,0.0000053735225,0.000015318912,0.00097034354,0.0000122814545,0.0005203396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997433,0.000020395077,0.000022943444,0.0001034262,0.00006356481,0.000046309873],"domain_scores_gemma":[0.9997433,0.000053362968,0.000072302275,0.00003673026,0.00003950003,0.000054789238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027282306,0.00022859036,0.0004635933,0.00067680003,0.00030702096,0.0005094286,0.0002620986,0.00026548153,0.0016299],"category_scores_gemma":[0.0009634785,0.00012765189,0.0003071715,0.0004885596,0.00023535542,0.00034336004,0.00044060522,0.00040532122,0.00036922586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015546844,0.00009962284,0.756588,0.00016941455,0.00035942753,0.0069104917,0.00050416373,0.0023526691,0.15539561,0.0009943547,0.0013119908,0.0737595],"study_design_scores_gemma":[0.00003108909,0.00016682064,0.9696714,0.000017254182,0.00011920793,0.011412299,0.00024032437,0.003328739,0.008068454,0.002513787,0.004411905,0.000018732955],"about_ca_topic_score_codex":0.0023691617,"about_ca_topic_score_gemma":0.0032941378,"teacher_disagreement_score":0.0023691617,"about_ca_system_score_codex":0.0004184563,"about_ca_system_score_gemma":0.00027852843,"threshold_uncertainty_score":0.0054525137},"labels":[],"label_agreement":null},{"id":"W2809237232","doi":"10.1093/neuonc/noy059.065","title":"CRAN-29. CONSERVATIVE SURGERY FOLLOWED BY PROTON THERAPY FOR CRANIOPHARYNGIOMA IN CHILDREN: A PHASE II STUDY TO EXAMINE THE FEASIBILITY OF DOSE ESCALATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Surgery; Nuclear medicine","score_opus":0.05481630075162465,"score_gpt":0.373434532159879,"score_spread":0.31861823140825435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809237232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621165,0.0014684055,0.0002460397,0.000112228605,0.000037807233,0.00097441906,0.00031329924,0.000036220776,0.0005999201],"genre_scores_gemma":[0.9905041,0.0023040902,0.0022093607,0.00029326143,0.00006079385,0.0021527777,0.00141369,0.00003575897,0.0010260401],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994733,0.00024123702,0.000035985457,0.00008955016,0.00006721468,0.00009274927],"domain_scores_gemma":[0.9993266,0.00013399478,0.00011978463,0.000086594584,0.000038302227,0.00029466214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012210609,0.00093385554,0.0016731317,0.00039927496,0.00035220868,0.00049216714,0.0006468139,0.00076265936,0.002091553],"category_scores_gemma":[0.00078642584,0.00048055252,0.0012095799,0.00038457132,0.00089372025,0.0003581603,0.00034063094,0.0022773955,0.00040579386],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5863499,0.10262383,0.023927687,0.002063536,0.002074765,0.0010746405,0.0007121797,0.0069144065,0.09561842,0.0005018856,0.0025040924,0.17563461],"study_design_scores_gemma":[0.27515078,0.68365455,0.026195578,0.00008295018,0.0005251685,0.0007413525,0.0000913583,0.0012012299,0.009458119,0.000108885695,0.0027592992,0.000030669973],"about_ca_topic_score_codex":0.0028300243,"about_ca_topic_score_gemma":0.006772496,"teacher_disagreement_score":0.0028300243,"about_ca_system_score_codex":0.000914578,"about_ca_system_score_gemma":0.0020292415,"threshold_uncertainty_score":0.0069969296},"labels":[],"label_agreement":null},{"id":"W2809258232","doi":"10.1093/neuonc/noy059.243","title":"EPID-10. EVOLVING SURVIVAL TRENDS IN INFANTS WITH BRAIN TUMORS: A LONGITUDINAL POPULATION BASED STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Choroid plexus; Medicine; Medulloblastoma; Astrocytoma; Oligodendroglioma; Ependymoma; Population; Radiation therapy; Brain tumor; Survival analysis; Pilocytic astrocytoma; Glioma; Oncology; Pathology; Internal medicine; Central nervous system; Cancer research","score_opus":0.037671086532065856,"score_gpt":0.3442986786295365,"score_spread":0.30662759209747065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809258232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845279,0.00026746266,0.00037838935,0.00006484088,0.000009026503,0.000043284097,0.013775363,0.000017661407,0.00091604824],"genre_scores_gemma":[0.98436004,0.00022737202,0.0005458794,0.00004666543,0.000010006411,0.00013657076,0.0142731145,0.000009820883,0.00039050824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939656,0.00016694432,0.00010079093,0.00014425082,0.000089730755,0.000101769554],"domain_scores_gemma":[0.9978236,0.00028701228,0.0009927794,0.00021818964,0.0004578603,0.0002205865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016710081,0.00020677804,0.00025414888,0.001011011,0.00028712768,0.00055934774,0.00042898636,0.0003207802,0.0011665757],"category_scores_gemma":[0.0038999505,0.00023868663,0.0005849738,0.0017644421,0.000097508855,0.00053718523,0.00053842785,0.00051181426,0.0003422755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055877303,0.000016138494,0.9986634,0.000010918664,0.000044666136,0.000018920713,0.000047271864,0.00003363618,0.00004045537,0.000021006594,0.00021059599,0.00083717104],"study_design_scores_gemma":[0.0000057514303,0.000060342656,0.999065,0.000008262314,0.000030538205,0.00008928185,0.000090409085,0.00017315598,0.000031368327,0.000015043743,0.00042834878,0.0000025330985],"about_ca_topic_score_codex":0.01453196,"about_ca_topic_score_gemma":0.013614143,"teacher_disagreement_score":0.01453196,"about_ca_system_score_codex":0.0005348391,"about_ca_system_score_gemma":0.00070968224,"threshold_uncertainty_score":0.028894782},"labels":[],"label_agreement":null},{"id":"W2809268959","doi":"10.1093/neuonc/noy059.352","title":"LGG-10. EPIGENETIC/GENETIC/MORPHOLOGIC ANALYSES REVEAL CLINICAL/PROGNOSTIC INSIGHT OF PEDIATRIC LOW GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"CDKN2A; Glioma; Methylation; DNA methylation; Epigenetics; CDKN2B; Biology; Pathology; Oncology; Bioinformatics; Cancer research; Gene; Medicine; Genetics; Gene expression","score_opus":0.0958626000334138,"score_gpt":0.3999463705813813,"score_spread":0.30408377054796754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809268959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302167,0.00055430486,0.0014032322,0.0000907966,0.000005893585,0.00002151241,0.0034189573,0.00013371106,0.0013498666],"genre_scores_gemma":[0.9877714,0.00022940384,0.0048956173,0.00006711609,0.0000057777593,0.000030674986,0.005581328,0.000047453566,0.0013712355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998988,0.000018294415,0.000005790897,0.000031788153,0.000022917513,0.000022360598],"domain_scores_gemma":[0.9998184,0.000029271514,0.00005724857,0.00001892315,0.000027871656,0.000048359714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021338585,0.00024318763,0.00019755821,0.00072360004,0.00013573948,0.0003667166,0.00015781546,0.0002167058,0.0017634572],"category_scores_gemma":[0.00042570254,0.000121336576,0.00012885552,0.0006004909,0.00015098938,0.00010726505,0.0001960927,0.00022363887,0.0005754939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014122821,0.00005790452,0.7537238,0.000110517525,0.00006278599,0.00049802125,0.00016439367,0.001053787,0.19701259,0.00019462818,0.0021484236,0.043560863],"study_design_scores_gemma":[0.000016888223,0.00017156015,0.9623581,0.000014769416,0.00005206907,0.0013246406,0.00012337808,0.002234841,0.02939792,0.00025679157,0.0040410818,0.000007985463],"about_ca_topic_score_codex":0.0034124628,"about_ca_topic_score_gemma":0.006495124,"teacher_disagreement_score":0.0034124628,"about_ca_system_score_codex":0.0004436822,"about_ca_system_score_gemma":0.00021520042,"threshold_uncertainty_score":0.006785214},"labels":[],"label_agreement":null},{"id":"W2809271078","doi":"10.1093/neuonc/noy059.198","title":"EMBR-14. RECLASSIFICATION OF CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR (CNS-PNET) INTO ENTITIES REFLECTS OUTCOME: RESULTS FROM THE PROSPECTIVE SJYC07 AND SJMB03 TRIALS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Primitive neuroectodermal tumor; Prospective cohort study; Central nervous system; Oncology; Neuroblastoma; Internal medicine; Metastasis; Ganglioneuroblastoma; Pathology; Progression-free survival; Cancer; Biology; Ganglioneuroma","score_opus":0.06106181632952824,"score_gpt":0.3447251826771337,"score_spread":0.2836633663476055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809271078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97768867,0.011857976,0.0008256697,0.0010889281,0.00020558071,0.00084280287,0.0047673574,0.00008229069,0.0026407244],"genre_scores_gemma":[0.9759656,0.0031593833,0.0024625035,0.0013482813,0.0001786921,0.001748557,0.012471507,0.00007186181,0.0025935308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99795365,0.0013691789,0.00015693827,0.0002734626,0.00014585894,0.0001008589],"domain_scores_gemma":[0.99821305,0.0005677887,0.00053052034,0.0002375618,0.00016560259,0.00028546725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067377132,0.00058830983,0.0011100665,0.0002612481,0.00028706665,0.00085130235,0.00060922484,0.0010404033,0.002004926],"category_scores_gemma":[0.0031150097,0.0003483096,0.002087129,0.00042389994,0.0005391789,0.00064869924,0.0005311749,0.0014833842,0.00058612844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7495838,0.0028071427,0.11632953,0.00256139,0.011453612,0.0000847265,0.00023099968,0.002186837,0.015167545,0.00033559487,0.005662605,0.0935962],"study_design_scores_gemma":[0.37277892,0.19372624,0.36995146,0.0007115104,0.01991741,0.0008614879,0.00027168723,0.0041497825,0.0089015635,0.0018678562,0.026733285,0.00012879053],"about_ca_topic_score_codex":0.00055996893,"about_ca_topic_score_gemma":0.0019270933,"teacher_disagreement_score":0.0067377132,"about_ca_system_score_codex":0.00047268884,"about_ca_system_score_gemma":0.0006499744,"threshold_uncertainty_score":0.03563285},"labels":[],"label_agreement":null},{"id":"W2809290008","doi":"10.1093/neuonc/noy059.272","title":"GERM-26. LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN ADULT SURVIVORS OF PEDIATRIC INTRACRANIAL GERM CELL TUMOR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Survivorship curve; Quality of life (healthcare); Vitality; SF-36; Germ cell tumors; Mental health; Population; Cohort; Radiation therapy; Pediatrics; Internal medicine; Health related quality of life; Cancer; Chemotherapy; Psychiatry","score_opus":0.02872095459368577,"score_gpt":0.32442525097264696,"score_spread":0.2957042963789612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809290008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625623,0.00088458473,0.00011898758,0.00006499309,0.0000101736505,0.00003326732,0.0016981468,0.0000068835734,0.0009266148],"genre_scores_gemma":[0.99715024,0.00030959677,0.00023611107,0.00003746809,0.000006820739,0.000060507205,0.0018298345,0.0000018088886,0.00036761322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999772,0.00006696236,0.0000298173,0.000029450897,0.000057726877,0.00004410104],"domain_scores_gemma":[0.99927753,0.00007096473,0.00038689823,0.000021592596,0.00008502881,0.0001579711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056266354,0.00024720907,0.0002556798,0.00036738304,0.00019558554,0.000296589,0.00017368783,0.0001857027,0.0022988794],"category_scores_gemma":[0.0013824622,0.00007193006,0.00048623778,0.0005887095,0.00014550556,0.00028082557,0.00034872975,0.0003438303,0.0002268244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002330129,0.000090537076,0.9893384,0.00007363737,0.00008176652,0.00010822567,0.00012426726,0.00016334218,0.00026983663,0.000022746512,0.00036907397,0.009125205],"study_design_scores_gemma":[0.00001536138,0.00033771005,0.9985196,0.000012312436,0.000026557656,0.0002304527,0.00007318461,0.00009212338,0.00010928139,0.000015989797,0.0005644213,0.0000029487715],"about_ca_topic_score_codex":0.0021319299,"about_ca_topic_score_gemma":0.0034172875,"teacher_disagreement_score":0.0022988794,"about_ca_system_score_codex":0.00031219705,"about_ca_system_score_gemma":0.00023083617,"threshold_uncertainty_score":0.007690549},"labels":[],"label_agreement":null},{"id":"W2809299590","doi":"10.1093/neuonc/noy059.406","title":"MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Cohort; Sonic hedgehog; Medicine; Oncology; Internal medicine; Pathology; Biology; Genetics; Gene","score_opus":0.01089287699986119,"score_gpt":0.2705299974540069,"score_spread":0.2596371204541457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809299590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215937,0.0005527253,0.00016736994,0.000077503675,0.0000071304503,0.000117409494,0.00571551,0.00003145433,0.0011715945],"genre_scores_gemma":[0.9818657,0.00036447032,0.0012912196,0.00008822832,0.000012642143,0.00024879546,0.014904172,0.000029327894,0.0011953752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983835,0.00003516905,0.000013496463,0.000041376206,0.000042514886,0.000029037681],"domain_scores_gemma":[0.9995946,0.000055183584,0.00014623499,0.000027607517,0.000040865092,0.00013547258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034472352,0.0002818376,0.00046252884,0.00065889995,0.0002944073,0.00034251687,0.00043253353,0.00024282178,0.0017498919],"category_scores_gemma":[0.0005970166,0.00019921371,0.00024518894,0.0005192472,0.00016863635,0.00019502443,0.00024668354,0.00036657485,0.0002773302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068626883,0.00026007963,0.9332496,0.00013156458,0.0001201755,0.0005477737,0.00017807733,0.00041633975,0.02381609,0.0001181305,0.0028176627,0.031481892],"study_design_scores_gemma":[0.0004007705,0.002154289,0.9847125,0.000014843925,0.00006973206,0.0017630741,0.000074344025,0.00043180943,0.005046196,0.000048810893,0.005275115,0.000008545734],"about_ca_topic_score_codex":0.007309335,"about_ca_topic_score_gemma":0.015459357,"teacher_disagreement_score":0.007309335,"about_ca_system_score_codex":0.0009689706,"about_ca_system_score_gemma":0.00073577894,"threshold_uncertainty_score":0.014533579},"labels":[],"label_agreement":null},{"id":"W2809322172","doi":"10.1093/neuonc/noy059.289","title":"HGG-17. TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE REPLICATION REPAIR DEFICIENCY AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Cancer research; DNA mismatch repair; Biology; Exome sequencing; Medicine; Genetics; DNA repair; Gene","score_opus":0.016079143818490918,"score_gpt":0.30489655623109685,"score_spread":0.28881741241260594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809322172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932715,0.0007411754,0.0009107745,0.00006114094,0.0000055413907,0.000026480251,0.003957783,0.00006742566,0.0009581338],"genre_scores_gemma":[0.9918349,0.0003635316,0.002281335,0.000052732335,0.000007505215,0.000035032164,0.0049114525,0.000033456436,0.00048019268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998221,0.000032868968,0.000013363861,0.000050890303,0.000047546437,0.000033247856],"domain_scores_gemma":[0.99954706,0.000081094586,0.00020136002,0.000035270645,0.000049826078,0.00008533489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034652455,0.00024040186,0.00035463646,0.00067861367,0.00013965165,0.00035250883,0.00016435132,0.00018434339,0.0016702731],"category_scores_gemma":[0.00060138234,0.000120746314,0.00021980789,0.0007238597,0.0001641806,0.00015045574,0.00022667415,0.00024556584,0.00031623634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000901403,0.000030089073,0.9255114,0.000060200735,0.00010146796,0.0002764007,0.000061702565,0.00069871085,0.042795125,0.000094788746,0.0010535062,0.028415143],"study_design_scores_gemma":[0.000031804713,0.00032969244,0.9794087,0.000010871662,0.00006856668,0.0013863129,0.000046058216,0.0013343813,0.014609576,0.00012220188,0.002646642,0.0000053154304],"about_ca_topic_score_codex":0.0020086449,"about_ca_topic_score_gemma":0.0034539783,"teacher_disagreement_score":0.0020086449,"about_ca_system_score_codex":0.00031331967,"about_ca_system_score_gemma":0.00029289522,"threshold_uncertainty_score":0.0055876374},"labels":[],"label_agreement":null},{"id":"W2809322634","doi":"10.1093/neuonc/noy059.262","title":"GERM-15. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS (CNS GCT): A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germ cell tumors; Cog; Radiation therapy; Internal medicine; Germinoma; Chemotherapy; Oncology; Germ cell; Progression-free survival; Phases of clinical research; Central nervous system; Biology","score_opus":0.015496295709902708,"score_gpt":0.3042077213853403,"score_spread":0.2887114256754376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809322634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211943,0.0016909342,0.00030491882,0.00030070497,0.0000979781,0.0018946001,0.0016175172,0.000091210924,0.0018827645],"genre_scores_gemma":[0.98340607,0.0015977004,0.0020484244,0.0011452908,0.00011265227,0.0029770238,0.0051856507,0.00003521972,0.0034919987],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996166,0.00021740815,0.000014384368,0.000053075968,0.000040603998,0.000057756664],"domain_scores_gemma":[0.99966013,0.000054108168,0.000070377195,0.00003080454,0.00001715231,0.00016739797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019493771,0.0011504748,0.0011319994,0.00035855317,0.00023588423,0.0005925578,0.0008270642,0.00090249564,0.0030459708],"category_scores_gemma":[0.0006252558,0.00039387413,0.0011105553,0.0002913595,0.00062537054,0.00047652653,0.000391621,0.0015903914,0.00057072245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78910786,0.044140723,0.018141959,0.001088991,0.0017030826,0.00030509089,0.00041572543,0.003831627,0.021291807,0.0006625593,0.007015304,0.11229522],"study_design_scores_gemma":[0.6562836,0.31120652,0.02299878,0.000053477426,0.00056470546,0.00030325036,0.000061102204,0.001418051,0.0022141617,0.00025237,0.0046231872,0.00002078543],"about_ca_topic_score_codex":0.0014982361,"about_ca_topic_score_gemma":0.0035209649,"teacher_disagreement_score":0.0030459708,"about_ca_system_score_codex":0.00080573926,"about_ca_system_score_gemma":0.0010951484,"threshold_uncertainty_score":0.010309398},"labels":[],"label_agreement":null},{"id":"W2809357869","doi":"10.1093/neuonc/noy059.270","title":"GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Children's Hospital of Eastern Ontario; Children's Hospital of Winnipeg; Stollery Children's Hospital; Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Germ cell tumors; Biopsy; Retrospective cohort study; Teratoma; Germinoma; Surgery; Internal medicine","score_opus":0.01380006950805162,"score_gpt":0.3079585571166512,"score_spread":0.2941584876085996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809357869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871945,0.00042392453,0.00005664811,0.000013591397,0.0000032544344,0.000012449755,0.0001734952,0.000002076931,0.00059510925],"genre_scores_gemma":[0.9991722,0.00034447655,0.000047059155,0.000024447543,0.000009792124,0.00001149033,0.00027022217,0.000001998061,0.00011825482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963486,0.00006047043,0.00006874872,0.00010623696,0.00007156204,0.00005804757],"domain_scores_gemma":[0.99905115,0.00010453262,0.0004930213,0.00009386647,0.00008385394,0.00017355847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045802005,0.00026035492,0.00028106663,0.001206411,0.00051334326,0.0006285141,0.00024372106,0.0003158775,0.001602929],"category_scores_gemma":[0.0009802328,0.0003287287,0.00035135922,0.0018438051,0.0004103688,0.0005302335,0.0005151191,0.00033443415,0.00033344945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022269025,0.000011704104,0.99855703,0.000010698906,0.000015749218,0.0004852602,0.00010068773,0.000007915775,0.00009236911,0.00001181584,0.000034956633,0.00064953446],"study_design_scores_gemma":[0.0000042697725,0.00009593407,0.99420977,0.000015331998,0.000041871062,0.0044494513,0.00045249413,0.000074926946,0.00007614753,0.000018293,0.0005569269,0.0000045901907],"about_ca_topic_score_codex":0.0044481475,"about_ca_topic_score_gemma":0.0040294607,"teacher_disagreement_score":0.0044481475,"about_ca_system_score_codex":0.00035813093,"about_ca_system_score_gemma":0.0004077542,"threshold_uncertainty_score":0.008844495},"labels":[],"label_agreement":null},{"id":"W2809379977","doi":"10.1093/neuonc/noy059.591","title":"QOL-09. EMOTION RECOGNITION IN PEDIATRIC BRAIN TUMOR PATIENTS: VIEWING PATTERNS AND WHITE MATTER STRUCTURE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pediatric Oncology Group; Hospital for Sick Children; University of Toronto","funders":"","keywords":"White matter; Psychology; Voxel; Audiology; Fractional anisotropy; Brain activity and meditation; Neuroimaging; Medicine; Neuroscience; Magnetic resonance imaging; Electroencephalography; Radiology","score_opus":0.01574954987454885,"score_gpt":0.26896320228917375,"score_spread":0.2532136524146249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809379977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983783,0.0000635281,0.000059989325,0.000020305944,0.000001660532,0.000012364983,0.00077898236,0.000006597073,0.0006782415],"genre_scores_gemma":[0.99796283,0.00005143013,0.00019949823,0.000013011313,0.000001932475,0.000017702423,0.0013074308,0.0000059053477,0.00044027387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999049,0.000014717781,0.000013454976,0.000025000882,0.000020608239,0.000021328235],"domain_scores_gemma":[0.99948186,0.00006305179,0.00027843853,0.00001952447,0.000068376175,0.00008869842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019502481,0.00031011135,0.00025344884,0.00045259684,0.00018976517,0.0003934797,0.0001888196,0.00020114759,0.0037057456],"category_scores_gemma":[0.0010510155,0.00013736643,0.00020949403,0.0005103124,0.00019470153,0.0002499817,0.00026642048,0.00020776976,0.0003920397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044538986,0.00007624342,0.98754823,0.000030537605,0.00005437835,0.00038710446,0.00014457299,0.00009932586,0.0020291887,0.00003669891,0.0004930682,0.008655337],"study_design_scores_gemma":[0.000014658599,0.00013867137,0.99824893,0.0000036099925,0.000015790387,0.00086684787,0.00006942809,0.000102862316,0.0002552394,0.000017104183,0.00026440885,0.0000024801864],"about_ca_topic_score_codex":0.004343747,"about_ca_topic_score_gemma":0.0039712284,"teacher_disagreement_score":0.004343747,"about_ca_system_score_codex":0.00038457225,"about_ca_system_score_gemma":0.00021059976,"threshold_uncertainty_score":0.012396932},"labels":[],"label_agreement":null},{"id":"W2809384402","doi":"10.1093/neuonc/noy059.163","title":"DIPG-70. CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN &lt;3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Radiological weapon; Pathological; Radiation therapy; Internal medicine; Pediatrics; Oncology; Surgery","score_opus":0.02935779722875415,"score_gpt":0.3418658147109468,"score_spread":0.31250801748219265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809384402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254274,0.0003392259,0.00016437052,0.00003140937,0.0000046326527,0.000020557773,0.005627262,0.000024750367,0.0012450864],"genre_scores_gemma":[0.99248767,0.00020411263,0.0001994924,0.000022789447,0.0000069355774,0.00003616861,0.006805591,0.000011661434,0.00022553574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997671,0.000023034694,0.000025345438,0.000060768023,0.00006111389,0.0000625822],"domain_scores_gemma":[0.9990497,0.000111509224,0.00049988646,0.000050770894,0.00006996687,0.00021821454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036937054,0.00025933274,0.00031933933,0.0010836445,0.00028669578,0.0004209679,0.00023954021,0.00020485584,0.0012685945],"category_scores_gemma":[0.0010817426,0.0001374748,0.00025912662,0.0012527454,0.00027153932,0.00033650515,0.00037002115,0.00031665753,0.00041724736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074508935,0.000008829386,0.9969734,0.000012179687,0.000014774994,0.00036291257,0.00003857798,0.000044218737,0.00024888382,0.00001763739,0.00038163786,0.0018224495],"study_design_scores_gemma":[0.000006537432,0.00005969702,0.99608743,0.0000054590105,0.000013953719,0.00262719,0.00008256939,0.000056343422,0.00013691695,0.000015955826,0.0009049222,0.0000029684884],"about_ca_topic_score_codex":0.005732059,"about_ca_topic_score_gemma":0.005039194,"teacher_disagreement_score":0.005732059,"about_ca_system_score_codex":0.00044667543,"about_ca_system_score_gemma":0.0004468245,"threshold_uncertainty_score":0.011397362},"labels":[],"label_agreement":null},{"id":"W2809386381","doi":"10.1093/neuonc/noy059.116","title":"DIPG-23. BRAINSTEM RADIATION EXPOSURE CONFERS SUBSTANTIAL RISK OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) IN MEDULLOBLASTOMA SURVIVORS: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Oncology; Internal medicine; Cancer research","score_opus":0.014141587043497477,"score_gpt":0.27460925563391814,"score_spread":0.26046766859042064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809386381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953496,0.00033953518,0.0003129404,0.000047018093,0.0000046556975,0.000024916671,0.0017968008,0.000040325896,0.002084246],"genre_scores_gemma":[0.9976803,0.00022322065,0.00013938078,0.00001735296,0.0000060430316,0.000013324303,0.0017110269,0.0000070699134,0.00020236005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976856,0.00003086152,0.00002790641,0.000067269175,0.00006578764,0.00003970195],"domain_scores_gemma":[0.9992176,0.00010319176,0.00032829636,0.00012859017,0.000081932616,0.00014034774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027493786,0.00015890312,0.00024006744,0.0006899222,0.00028575488,0.00039673664,0.00020819373,0.00013389079,0.0013632916],"category_scores_gemma":[0.001245625,0.00011263819,0.00020059998,0.0008960996,0.00016715839,0.00017483333,0.00041931978,0.00023904668,0.0002613181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011087018,0.000013945074,0.9900152,0.000022860882,0.000032979027,0.0012143297,0.00012349157,0.00007004602,0.00061910826,0.00003759347,0.00039750623,0.007342027],"study_design_scores_gemma":[0.0000082722,0.00010079948,0.98998636,0.000008852367,0.00004443511,0.006700844,0.00013194473,0.00016142066,0.00061823556,0.000037583377,0.0021950519,0.0000062080353],"about_ca_topic_score_codex":0.004112604,"about_ca_topic_score_gemma":0.0036557433,"teacher_disagreement_score":0.004112604,"about_ca_system_score_codex":0.00024962134,"about_ca_system_score_gemma":0.000324771,"threshold_uncertainty_score":0.00817734},"labels":[],"label_agreement":null},{"id":"W2809405227","doi":"10.1093/neuonc/noy059.292","title":"HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; University of Manitoba; University of Toronto; Université Laval; Hospital for Sick Children","funders":"","keywords":"Methylation; Biology; DNA methylation; Epigenetics; CpG site; DNA mismatch repair; Mutation; Cancer research; Gene; Histone; Genetics; DNA repair; Gene expression","score_opus":0.017801524156210596,"score_gpt":0.28663133194678186,"score_spread":0.26882980779057125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809405227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927264,0.000100436475,0.00009188152,0.000010882575,0.0000011892722,0.0000044609133,0.00025522063,0.000010652889,0.00025262058],"genre_scores_gemma":[0.99928254,0.000031576576,0.00014515297,0.000007912874,0.0000010721409,0.00000408854,0.00036063578,0.0000023763744,0.00016465469],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999169,0.000014648504,0.00000788784,0.000022379349,0.000018332856,0.000019810863],"domain_scores_gemma":[0.99986863,0.000019798386,0.000038634924,0.000009976591,0.000019678477,0.000043263783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010065053,0.00012231249,0.00016058133,0.00072981836,0.00014128682,0.00018370942,0.00011544479,0.0002005342,0.0010961117],"category_scores_gemma":[0.00033990172,0.00007998162,0.00012560013,0.00041548666,0.000114684204,0.00007763666,0.00014993887,0.00015201925,0.00019745351],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074894645,0.000023287987,0.93748635,0.000030176701,0.00003900127,0.00065781135,0.0001678082,0.00010410758,0.05422088,0.000042425567,0.00021553824,0.0062635303],"study_design_scores_gemma":[0.0000031835748,0.00014412242,0.9940035,0.0000018651234,0.000012573045,0.0012079077,0.00006050009,0.00012843574,0.0041554663,0.000021782027,0.0002590416,0.0000015877386],"about_ca_topic_score_codex":0.0022405272,"about_ca_topic_score_gemma":0.0023821807,"teacher_disagreement_score":0.0022405272,"about_ca_system_score_codex":0.00015530146,"about_ca_system_score_gemma":0.000101047895,"threshold_uncertainty_score":0.0044549704},"labels":[],"label_agreement":null},{"id":"W2809463855","doi":"10.1093/neuonc/noy059.400","title":"LGG-60. THE GENETIC LANDSCAPE OF PEDIATRIC LOW-GRADE GLIOMAS: INCIDENCE, PROGNOSIS AND RESPONSE TO THERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cohort; IDH1; Oncology; Internal medicine; Incidence (geometry); Targeted therapy; Glioma; Cumulative incidence; Pathology; Cancer research; Mutation; Cancer; Gene; Biology; Genetics","score_opus":0.02530242724296016,"score_gpt":0.3326451749118376,"score_spread":0.3073427476688774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809463855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371463,0.0028889824,0.00022905084,0.00015300681,0.000009701781,0.000010062467,0.0010531847,0.000032292854,0.0019091475],"genre_scores_gemma":[0.9975585,0.0006450608,0.00015638336,0.000045558005,0.000007471227,0.000006295119,0.001297147,0.000008196879,0.0002753748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979717,0.000027751075,0.000017869183,0.00004542198,0.00006799932,0.00004378349],"domain_scores_gemma":[0.9996076,0.000035765224,0.00021801474,0.000016318763,0.000040939776,0.00008124503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002802799,0.00014492165,0.00022754226,0.0004626655,0.0001075226,0.0003760015,0.00012789668,0.00015850134,0.0008574484],"category_scores_gemma":[0.0007347143,0.000060866074,0.00018884768,0.0006113272,0.00015952038,0.00017696571,0.00017795066,0.00019215456,0.0003616249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005479476,0.000034341097,0.9431829,0.00007829086,0.000082872655,0.0006242479,0.00006580534,0.0004033817,0.006381586,0.00009043947,0.0010458697,0.047462415],"study_design_scores_gemma":[0.000010113393,0.0001880133,0.99369603,0.00002002975,0.000041170955,0.001994162,0.000075628406,0.00023152865,0.0013372728,0.000085510605,0.00231753,0.0000031263596],"about_ca_topic_score_codex":0.0033996822,"about_ca_topic_score_gemma":0.0052214065,"teacher_disagreement_score":0.0033996822,"about_ca_system_score_codex":0.0006871953,"about_ca_system_score_gemma":0.00034413757,"threshold_uncertainty_score":0.0067597628},"labels":[],"label_agreement":null},{"id":"W2809494470","doi":"10.1093/neuonc/noy059.715","title":"TBIO-27. GABRIELLA MILLER KIDS FIRST DATA RESOURCE CENTER ADVANCING GENETIC RESEARCH IN CHILDHOOD CANCER AND STRUCTURAL BIRTH DEFECTS THROUGH LARGE SCALE INTEGRATED DATA-DRIVEN DISCOVERY AND CLOUD-BASED PLATFORMS FOR COLLABORATIVE ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Context (archaeology); Psychological intervention; Resource (disambiguation); Medicine; Early childhood; Translational research; Data science; Psychology; Biology; Computer science; Pathology; Developmental psychology; Psychiatry","score_opus":0.044692356661876716,"score_gpt":0.35197240418239933,"score_spread":0.3072800475205226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809494470","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022426299,0.0019902317,0.01550861,0.023298303,0.0032294793,0.0010246984,0.79599714,0.04899237,0.10771658],"genre_scores_gemma":[0.009965069,0.0027774714,0.04923317,0.0065887673,0.0016655183,0.0016216428,0.8654757,0.009927772,0.05274481],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948638,0.0009064727,0.00041250934,0.0010408858,0.0021046062,0.0006717834],"domain_scores_gemma":[0.9717703,0.0039193183,0.0013195047,0.0055346675,0.0058929767,0.011563289],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.012265427,0.0014450166,0.0017840721,0.0037640992,0.0021519104,0.008241962,0.00402274,0.0019516114,0.1391322],"category_scores_gemma":[0.023569131,0.0011516282,0.0015269911,0.0057425583,0.0010451722,0.0032944118,0.008258825,0.004050239,0.108351976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024376682,0.00005117579,0.0015730184,0.00012555363,0.000024985842,0.00007137503,0.00008306895,0.00016068698,0.000694372,0.0021935643,0.9758548,0.018923666],"study_design_scores_gemma":[0.0003013578,0.00006833238,0.0051240935,0.00023091672,0.000023478935,0.0000786801,0.00013369534,0.0011269411,0.000724824,0.0038271733,0.988308,0.00005252118],"about_ca_topic_score_codex":0.03581432,"about_ca_topic_score_gemma":0.06297102,"teacher_disagreement_score":0.9959773,"about_ca_system_score_codex":0.0032388098,"about_ca_system_score_gemma":0.010522621,"threshold_uncertainty_score":0.4654436},"labels":[],"label_agreement":null},{"id":"W2809498498","doi":"10.1093/neuonc/noy059.306","title":"HGG-34. EARLY PRECLINICAL OUTCOMES OF INTRATUMORAL MODULATION THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA AND GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; In vivo; Glioma; Oncology; Cancer; Internal medicine; Cancer research; Biology","score_opus":0.04540121480667646,"score_gpt":0.33567413975282284,"score_spread":0.29027292494614637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809498498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288875,0.0016276889,0.0017989617,0.00015935798,0.000078458754,0.0003231694,0.0008130791,0.00014773975,0.002162787],"genre_scores_gemma":[0.9939705,0.0010702378,0.0017173949,0.00009848714,0.00001021894,0.00019938007,0.0011312517,0.000022427927,0.0017802425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998356,0.000024334098,0.000008293224,0.000028830265,0.000046060923,0.00005680268],"domain_scores_gemma":[0.99993324,0.0000071531776,0.0000135396185,0.000008825123,0.000011514082,0.000025631005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024366133,0.0004875222,0.0004200015,0.00036165345,0.00014109173,0.00028365664,0.00032596712,0.00038018578,0.001270542],"category_scores_gemma":[0.00012226422,0.00012817394,0.00032309318,0.00024556328,0.0002803002,0.00019597175,0.00017173555,0.000996602,0.00023193174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015668551,0.0020849416,0.0007691688,0.00021572878,0.000050627754,0.00016054642,0.0001000175,0.0013739442,0.9771367,0.00037402302,0.000979533,0.015187952],"study_design_scores_gemma":[0.00036519254,0.03286724,0.008607822,0.000023109082,0.00013304676,0.00040653645,0.00009675537,0.0029687935,0.9469919,0.00016174003,0.007359595,0.000018125627],"about_ca_topic_score_codex":0.0027802691,"about_ca_topic_score_gemma":0.0043437593,"teacher_disagreement_score":0.0027802691,"about_ca_system_score_codex":0.00041401468,"about_ca_system_score_gemma":0.0004951915,"threshold_uncertainty_score":0.005528152},"labels":[],"label_agreement":null},{"id":"W2809550909","doi":"10.1093/neuonc/noy059.092","title":"DEV-17. WHO ARE THE HIGH RISK MEDULLOBLASTOMA SUBGROUPS IN JORDAN?","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Radiation therapy; Wnt signaling pathway; Oncology; Internal medicine; Craniotomy; Medicine; Cohort; Biology; Surgery; Cancer research; Gene","score_opus":0.008217581750055535,"score_gpt":0.2506050405821834,"score_spread":0.24238745883212787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809550909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968375,0.0006941915,0.000057491714,0.0004147484,0.000013253936,0.000011072631,0.00061641977,0.000007705022,0.001347594],"genre_scores_gemma":[0.99498147,0.0007564804,0.00019781641,0.00034108982,0.00003499214,0.000026665284,0.001435273,0.00001465807,0.0022116315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975854,0.000039305458,0.00002157441,0.000046541787,0.00004432476,0.00008973723],"domain_scores_gemma":[0.9995246,0.00003022388,0.00022339539,0.00001784926,0.00005960873,0.0001443728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035164892,0.00017667505,0.00025825153,0.0006342557,0.00049647846,0.0008164618,0.00030246167,0.00030973254,0.0032531978],"category_scores_gemma":[0.0009983829,0.00019351703,0.0002912909,0.0009078182,0.00026857117,0.0007964836,0.00054423686,0.00030685245,0.001282375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001346147,0.000027339667,0.98634005,0.000017970173,0.000012656106,0.0003612391,0.00048629186,0.000028358081,0.0003473857,0.000071531664,0.0006089842,0.011563572],"study_design_scores_gemma":[0.000024845958,0.00015244211,0.9774615,0.0000754105,0.00003372087,0.004125896,0.0074364636,0.0002505226,0.00050281023,0.00060699857,0.0093135275,0.000015816098],"about_ca_topic_score_codex":0.005636502,"about_ca_topic_score_gemma":0.009777664,"teacher_disagreement_score":0.005636502,"about_ca_system_score_codex":0.0005963328,"about_ca_system_score_gemma":0.000894014,"threshold_uncertainty_score":0.011207402},"labels":[],"label_agreement":null},{"id":"W2809567172","doi":"10.1093/neuonc/noy059.131","title":"DIPG-38. ID1 EXPRESSION CORRELATES WITH H3F3A K27M MUTATION AND EXTRA-PONTINE INVASION IN DIPG","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Biology; Epigenetics; DNA damage; DNA methylation; Gene expression; Gene; DNA; Genetics","score_opus":0.012122006453099726,"score_gpt":0.2841426731399698,"score_spread":0.2720206666868701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809567172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913174,0.00013698211,0.00018603323,0.000011993734,0.0000011060505,0.0000039607758,0.00019627057,0.000014825702,0.00031701138],"genre_scores_gemma":[0.9991873,0.00007453359,0.0002603769,0.000009114597,0.0000013315957,0.0000032394075,0.00027450392,0.0000051848883,0.00018436054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999062,0.0000068411173,0.0000066147913,0.000031470066,0.00002496832,0.00002397697],"domain_scores_gemma":[0.99979764,0.000029130857,0.00007268258,0.000011962613,0.000017298054,0.000071344984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007200946,0.00020062983,0.00017366829,0.0005302014,0.00016103966,0.00022920646,0.00013900678,0.00017958824,0.0012457495],"category_scores_gemma":[0.00024765,0.00013698461,0.000115830066,0.00037216817,0.00026660517,0.00009274673,0.00022824298,0.00023914083,0.00022447115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011729441,0.000058263493,0.5832444,0.00013464649,0.00007352494,0.02463396,0.00044233806,0.00030518457,0.37587425,0.000257342,0.00047163334,0.013331545],"study_design_scores_gemma":[0.000014650173,0.00019321094,0.94704956,0.000005911296,0.000030362378,0.027608812,0.00015616349,0.0004922042,0.023174185,0.0000909,0.0011784708,0.000005601562],"about_ca_topic_score_codex":0.0025326745,"about_ca_topic_score_gemma":0.003007531,"teacher_disagreement_score":0.0025326745,"about_ca_system_score_codex":0.0003392381,"about_ca_system_score_gemma":0.00014761562,"threshold_uncertainty_score":0.0050358176},"labels":[],"label_agreement":null},{"id":"W2809567626","doi":"10.1093/neuonc/noy059.407","title":"MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Cohort; Vincristine; Medulloblastoma; Refractory (planetary science); Retrospective cohort study; Surgery; Etoposide; Internal medicine; Oncology; Chemotherapy; Cyclophosphamide; Pathology","score_opus":0.02681821576154795,"score_gpt":0.3158897007560264,"score_spread":0.28907148499447843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809567626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473036,0.008489913,0.0010228584,0.0006063426,0.00007181808,0.00021017776,0.0005338567,0.00012791449,0.0042067254],"genre_scores_gemma":[0.98733073,0.0068240217,0.0024105178,0.00068655313,0.00014127666,0.00010589359,0.001121614,0.00009114871,0.0012882284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996741,0.000060500435,0.000047472757,0.00007353004,0.00007435537,0.0000700921],"domain_scores_gemma":[0.99940574,0.00005761071,0.00012352386,0.000036242836,0.00002630913,0.000350569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003225475,0.00054491166,0.00045273386,0.00042260537,0.0005953832,0.0007600243,0.0006542375,0.00058330904,0.0014396653],"category_scores_gemma":[0.0009901626,0.00022585198,0.00055780006,0.0006485655,0.0003798326,0.00038365534,0.00065049186,0.0006909098,0.0008173601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027190528,0.0041918834,0.4746384,0.00086473266,0.00047175848,0.09860636,0.0024949478,0.001955019,0.021835217,0.00082759955,0.008470075,0.382925],"study_design_scores_gemma":[0.0017106446,0.020042019,0.5383797,0.00046617963,0.00048240228,0.3798925,0.0016114295,0.0026921818,0.0127655165,0.0004512167,0.041370265,0.00013581217],"about_ca_topic_score_codex":0.004800431,"about_ca_topic_score_gemma":0.0083630355,"teacher_disagreement_score":0.004800431,"about_ca_system_score_codex":0.0014594586,"about_ca_system_score_gemma":0.0011194769,"threshold_uncertainty_score":0.010589182},"labels":[],"label_agreement":null},{"id":"W2809581673","doi":"10.1093/neuonc/noy059.373","title":"LGG-32. EVALUATION OF PEDIATRIC GLIOMA OUTCOME USING INTRAOPERATIVE MRI: A COHORT STUDY USING I-MiND (IMRIS MULTICENTER iMRI NEUROSURGERY DATABASE)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Neurosurgery; Intraoperative MRI; Interventional magnetic resonance imaging; Glioma; Cohort; Resection; Magnetic resonance imaging; Radiology; Surgery; Nuclear medicine; Pathology","score_opus":0.11165254043079617,"score_gpt":0.40890252771754804,"score_spread":0.2972499872867519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809581673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988018,0.00005520774,0.00005279875,0.000007982268,9.693974e-7,0.000011441835,0.0008718119,0.0000031124966,0.00019475464],"genre_scores_gemma":[0.9969091,0.00011190753,0.00013859836,0.000012565812,0.0000044868575,0.000034696048,0.0027024325,0.000005698932,0.000080554026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996989,0.000052800224,0.000037932194,0.00009804469,0.00006344461,0.0000489691],"domain_scores_gemma":[0.99910694,0.000085229585,0.0005055639,0.000082502636,0.00010309418,0.00011662253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038703126,0.00030464667,0.00028285646,0.0010165448,0.00027380206,0.0005028469,0.0002821898,0.00020095413,0.00085811445],"category_scores_gemma":[0.0015368572,0.00020246679,0.00032338253,0.001241014,0.00019241785,0.00052057556,0.00045638834,0.00025923437,0.00035274113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000415632,0.00000958837,0.99882835,0.0000035146647,0.000012192808,0.00010414686,0.00003145096,0.000018445951,0.00011562964,0.0000065055665,0.00008021524,0.00074835494],"study_design_scores_gemma":[0.0000053311965,0.00008152966,0.9983321,0.000004050156,0.000017270557,0.00090103433,0.00016933518,0.00010723251,0.00012270878,0.000010937841,0.00024554663,0.000002919681],"about_ca_topic_score_codex":0.0043681664,"about_ca_topic_score_gemma":0.0048033,"teacher_disagreement_score":0.0043681664,"about_ca_system_score_codex":0.00036261737,"about_ca_system_score_gemma":0.00037137888,"threshold_uncertainty_score":0.00868547},"labels":[],"label_agreement":null},{"id":"W2809594451","doi":"10.1093/neuonc/noy059.199","title":"EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; DNA methylation; Disease; Glioma; Pathology; Cancer research; Biology; Gene; Gene expression","score_opus":0.0650480438436011,"score_gpt":0.3876435477530053,"score_spread":0.32259550390940417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809594451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95373875,0.0031533807,0.003935018,0.00027899278,0.000088046625,0.0006399938,0.033790436,0.00019352339,0.0041819336],"genre_scores_gemma":[0.9383284,0.000439564,0.004378388,0.0002789377,0.00007511,0.00078665424,0.054511726,0.00006746694,0.0011338359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99479324,0.0015103443,0.0011169564,0.0014835574,0.00076129433,0.00033454792],"domain_scores_gemma":[0.98888457,0.0018238975,0.0037711998,0.002183237,0.0026241653,0.0007128195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011786843,0.0004940477,0.0015385111,0.0027385512,0.0004861372,0.0013226281,0.0011690714,0.00056656054,0.0016315154],"category_scores_gemma":[0.013409999,0.00034612275,0.001827267,0.0020941962,0.00031410358,0.00083353004,0.0016663959,0.00056964013,0.00064927206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009758086,0.00011765947,0.9480307,0.00051033497,0.002990324,0.00036573454,0.00030013808,0.00072556676,0.0036322114,0.00016203901,0.0022785175,0.031128718],"study_design_scores_gemma":[0.00036514804,0.0016664038,0.9803658,0.00014123728,0.0017540817,0.0015533265,0.00016846145,0.0013293846,0.002556621,0.00030086975,0.00974325,0.000055544006],"about_ca_topic_score_codex":0.0019549115,"about_ca_topic_score_gemma":0.0024168487,"teacher_disagreement_score":0.011786843,"about_ca_system_score_codex":0.00134559,"about_ca_system_score_gemma":0.0011834708,"threshold_uncertainty_score":0.06233555},"labels":[],"label_agreement":null},{"id":"W2809612791","doi":"10.1093/neuonc/noy059.387","title":"LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Trametinib; Rash; Cohort; Internal medicine; Adverse effect; Oncology; Pediatrics","score_opus":0.023525267255858396,"score_gpt":0.26173528561534565,"score_spread":0.23821001835948724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809612791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961266,0.00093272753,0.00026336324,0.00016139394,0.000009964128,0.00028588955,0.0011785321,0.00004395407,0.0009975296],"genre_scores_gemma":[0.9944999,0.00079127273,0.0011514866,0.0003404231,0.000022315753,0.00024307071,0.0024307526,0.000018736668,0.0005021296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999803,0.00006291543,0.000011842605,0.000042650518,0.000029220051,0.000050463746],"domain_scores_gemma":[0.99975735,0.000021281003,0.00006165119,0.000016562331,0.00002096836,0.00012226545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045597827,0.00040187582,0.00073223293,0.00019018326,0.00028026843,0.0005611457,0.00020562416,0.00030391334,0.0008021895],"category_scores_gemma":[0.0003793779,0.00019048141,0.00052392075,0.00035511956,0.00027815506,0.00028583524,0.00026973337,0.0008110193,0.00027451408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06822077,0.0040769256,0.6449232,0.00045260246,0.0008121888,0.0052843504,0.0007168997,0.0036666412,0.079806425,0.00046137787,0.01333029,0.17824832],"study_design_scores_gemma":[0.019629804,0.10743405,0.7919716,0.00012360353,0.0010259713,0.017754016,0.0005062349,0.0036380154,0.023975072,0.00044194635,0.033439256,0.000060464718],"about_ca_topic_score_codex":0.0015234061,"about_ca_topic_score_gemma":0.0055151186,"teacher_disagreement_score":0.0015234061,"about_ca_system_score_codex":0.00065011723,"about_ca_system_score_gemma":0.0010275068,"threshold_uncertainty_score":0.0047169924},"labels":[],"label_agreement":null},{"id":"W2809620633","doi":"10.1093/neuonc/noy059.104","title":"DIPG-11. TRANSCRIPTIONAL REGULATION OF NEURAL PROGENITOR CELL FATE BY DLX HOMEOBOX GENES - RELEVANCE TO DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Biology; OLIG2; Chromatin immunoprecipitation; Transcription factor; Neurosphere; Cancer research; Genetics; Promoter; Cell biology; Cellular differentiation; Gene expression; Gene; Oligodendrocyte; Myelin; Neuroscience","score_opus":0.008048469591676967,"score_gpt":0.26133311822397404,"score_spread":0.25328464863229705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809620633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98127097,0.0040262556,0.004188942,0.00033814364,0.00006378945,0.000109137596,0.0029193829,0.00042528674,0.0066581224],"genre_scores_gemma":[0.9815974,0.0015389324,0.0024769236,0.00013346551,0.000007397788,0.000059787177,0.0038419194,0.000044455614,0.010299655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999918,0.0000073276165,0.0000048726965,0.000023382096,0.000022515247,0.000023868224],"domain_scores_gemma":[0.9999503,0.000006206194,0.000012935349,0.000005814515,0.0000034166487,0.000021252981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008092765,0.000244237,0.00015794177,0.00017541827,0.00012332658,0.0002347877,0.00020590646,0.00023265311,0.002320834],"category_scores_gemma":[0.000060985698,0.000096911695,0.00016294213,0.00016639412,0.00025066693,0.000087445114,0.00026356982,0.00057104946,0.0006145097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017640072,0.000030914314,0.0007819863,0.00011400567,0.0000046773803,0.0003389849,0.000017977934,0.000060079972,0.9926812,0.00026483182,0.00022556359,0.0053032963],"study_design_scores_gemma":[0.000053900556,0.00067880267,0.021207763,0.000017360122,0.000025517214,0.0031735282,0.0000729328,0.00072495546,0.9539386,0.00013977634,0.019961588,0.000005338975],"about_ca_topic_score_codex":0.000985196,"about_ca_topic_score_gemma":0.0022476998,"teacher_disagreement_score":0.002320834,"about_ca_system_score_codex":0.00040010194,"about_ca_system_score_gemma":0.00023067073,"threshold_uncertainty_score":0.007763922},"labels":[],"label_agreement":null},{"id":"W2809629943","doi":"10.1093/neuonc/noy059.275","title":"HGG-03. PREVALENCE OF BIALLELIC MISMATCH REPAIR DEFICIENCY IN CHILDREN WITH MALIGNANT GLIOMA TREATED AT KING FAHAD MEDICAL CITY (KFMC)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Neurofibromatosis; Pathological; Population; Anaplastic astrocytoma; Glioma; Retrospective cohort study; Pediatrics; Internal medicine; Oncology; Astrocytoma; Pathology; Cancer research","score_opus":0.022955870657520965,"score_gpt":0.29800848588084355,"score_spread":0.2750526152233226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809629943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994295,0.000077336335,0.000011654014,0.000021174965,0.0000014396435,0.000002679687,0.0002517847,0.000002365147,0.0002021174],"genre_scores_gemma":[0.99953246,0.000050444753,0.0000318101,0.000017538916,0.0000021260648,0.000002915641,0.0002738641,7.122866e-7,0.00008816308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981743,0.000021178113,0.000025976242,0.000047061487,0.000040657185,0.00004775453],"domain_scores_gemma":[0.9993911,0.000066109526,0.0003459174,0.000016601547,0.000049862316,0.0001303449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012746907,0.00018432984,0.000120000455,0.0008345422,0.000310203,0.0003190317,0.0002434925,0.00033836532,0.0024870986],"category_scores_gemma":[0.000695967,0.00017485583,0.00016165058,0.0006691049,0.00023879224,0.00024434555,0.00030202372,0.00027632964,0.00026200566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018940153,0.000008059758,0.998425,0.0000071946456,0.0000059372614,0.00055064476,0.00007398452,0.000010286422,0.00017374785,0.000009742546,0.00010014038,0.0006162528],"study_design_scores_gemma":[0.0000028637553,0.000065202206,0.9935015,0.0000092567725,0.000010190104,0.005578754,0.00037889605,0.0000502826,0.00013967523,0.000008870489,0.00025221388,0.0000022219856],"about_ca_topic_score_codex":0.009475437,"about_ca_topic_score_gemma":0.01154474,"teacher_disagreement_score":0.009475437,"about_ca_system_score_codex":0.0004216083,"about_ca_system_score_gemma":0.00033010994,"threshold_uncertainty_score":0.018840551},"labels":[],"label_agreement":null},{"id":"W2809637362","doi":"10.1093/neuonc/noy059.552","title":"NURS-03. DEVELOPMENT OF A NEURO-ONCOLOGY LONG TERM FOLLOW UP NURSE CLINICIAN AT A TERTIARY HEALTH CARE CENTER","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Neurocognitive; Survivorship curve; Pediatrics; Multidisciplinary approach; Family medicine; Psychiatry; Cancer; Internal medicine; Cognition","score_opus":0.04096336180518702,"score_gpt":0.3822045984677057,"score_spread":0.3412412366625187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809637362","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05863743,0.0016797651,0.011909433,0.2005816,0.020584028,0.005229215,0.0031795474,0.0039610653,0.694238],"genre_scores_gemma":[0.121780284,0.0026005325,0.03274996,0.14467219,0.002308521,0.006435797,0.0024201286,0.0011584009,0.6858742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971681,0.0010377034,0.00019531755,0.00029620354,0.00064893794,0.0006537208],"domain_scores_gemma":[0.9585487,0.00087577326,0.000761878,0.0005131029,0.008182345,0.031118123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033653649,0.00037489264,0.00036092964,0.00051780645,0.0047745514,0.0035321717,0.0015488465,0.0025392517,0.19187407],"category_scores_gemma":[0.009082388,0.0007122115,0.0004387052,0.00033889333,0.0008536401,0.0027864312,0.005378401,0.0042045773,0.071866944],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007534577,0.00088650925,0.0066421274,0.00026811575,0.000009021867,0.0010103579,0.0032779223,0.00009214564,0.00068162393,0.0009648316,0.8594901,0.12660196],"study_design_scores_gemma":[0.00012359285,0.0008321696,0.009980119,0.000728235,0.000011509387,0.0016866797,0.0135143595,0.0003941839,0.0003663951,0.0011045608,0.9711988,0.000059356295],"about_ca_topic_score_codex":0.007184065,"about_ca_topic_score_gemma":0.034013946,"teacher_disagreement_score":0.19187407,"about_ca_system_score_codex":0.00391127,"about_ca_system_score_gemma":0.017404206,"threshold_uncertainty_score":0.6418827},"labels":[],"label_agreement":null},{"id":"W2809653498","doi":"10.1093/neuonc/noy059.231","title":"EPEN-31. SUBGROUP SPECIFIC LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN POSTERIOR FOSSA EPENDYMOMA (PFE)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurocognitive; Medicine; Cohort; Ependymoma; Neuropsychology; Proportional hazards model; Subgroup analysis; Radiation therapy; Prospective cohort study; Internal medicine; Oncology; Surgery; Pediatrics; Cognition; Psychiatry; Confidence interval","score_opus":0.034560012226980595,"score_gpt":0.3201784184600376,"score_spread":0.285618406233057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809653498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911386,0.00017652154,0.00009647295,0.000015935404,0.000002435695,0.0000037834855,0.0003862502,0.000003475433,0.00020131323],"genre_scores_gemma":[0.99906605,0.000056595614,0.00005776704,0.0000118330745,0.000003681158,0.0000057507564,0.00068399997,0.0000022182774,0.00011213437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984574,0.000019163395,0.000018884979,0.00005994953,0.00002127836,0.000034947312],"domain_scores_gemma":[0.9993722,0.00011162609,0.00028652247,0.000087782675,0.000047764544,0.00009414977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004856368,0.0001772883,0.00034189378,0.00058480876,0.0002485396,0.00046174892,0.00019889048,0.000297229,0.0010988169],"category_scores_gemma":[0.0016696658,0.00008297614,0.00047160056,0.00053991145,0.00017512497,0.0005133626,0.00045078975,0.00030189962,0.00028875782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028914635,0.000015537398,0.9923062,0.00001144531,0.00007916303,0.00048664375,0.000060872168,0.0001834555,0.00072675274,0.000031614174,0.00017468358,0.005634485],"study_design_scores_gemma":[0.000005542436,0.00011173399,0.99735284,0.0000069421785,0.000032719043,0.0015704064,0.000086220716,0.00026471747,0.00018080384,0.00010928233,0.00027566982,0.0000030627189],"about_ca_topic_score_codex":0.0022823373,"about_ca_topic_score_gemma":0.0034549038,"teacher_disagreement_score":0.0022823373,"about_ca_system_score_codex":0.0002401004,"about_ca_system_score_gemma":0.00022399951,"threshold_uncertainty_score":0.0045380592},"labels":[],"label_agreement":null},{"id":"W2883055139","doi":"10.1093/neuonc/noy099","title":"Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Retrospective cohort study; Oncology; Cohort; Proportional hazards model; Performance status; Nephrectomy; Overall survival; Kidney; Confidence interval","score_opus":0.026716118426693265,"score_gpt":0.30451959854374994,"score_spread":0.2778034801170567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883055139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64999646,0.024513353,0.22945681,0.010522262,0.0013015125,0.0015225183,0.059989262,0.0042550345,0.018442782],"genre_scores_gemma":[0.78522986,0.0069913818,0.17632581,0.0008612838,0.00055288844,0.0008349943,0.02799883,0.0001815013,0.0010234945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775773,0.00075930404,0.00046041078,0.00017279602,0.00076304865,0.00008672595],"domain_scores_gemma":[0.98715067,0.005912727,0.0022856286,0.0006030527,0.0034402255,0.00060774165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061989888,0.0006755505,0.0006609115,0.0053961664,0.00022889154,0.0014162408,0.0012962093,0.00041673236,0.0011761854],"category_scores_gemma":[0.029496998,0.00013528063,0.000747115,0.0036796222,0.00018787014,0.0013426419,0.0011573106,0.00082031696,0.000442828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023549715,0.00006848797,0.5840555,0.00033422757,0.00035277105,0.00013935602,0.00014841404,0.0033307811,0.00024852375,0.00078568433,0.024732651,0.38556805],"study_design_scores_gemma":[0.00018960745,0.0005757885,0.8436271,0.000999355,0.0010032455,0.0026008969,0.0005823274,0.06097832,0.0019070152,0.00806163,0.07923382,0.00024079677],"about_ca_topic_score_codex":0.0034378883,"about_ca_topic_score_gemma":0.0053568697,"teacher_disagreement_score":0.0061989888,"about_ca_system_score_codex":0.00065916247,"about_ca_system_score_gemma":0.0010005049,"threshold_uncertainty_score":0.032783747},"labels":[],"label_agreement":null},{"id":"W2887130720","doi":"10.1093/neuonc/noy134","title":"Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioma; Key (lock); Voxel; Medicine; Computational biology; Pathology; Computer science; Cancer research; Biology; Radiology","score_opus":0.010798399330164533,"score_gpt":0.24855474226089389,"score_spread":0.23775634293072936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887130720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952054,0.000067288216,0.00019865159,0.00000860881,0.0000011668014,0.0000022246138,0.000080066086,0.0000042805577,0.000117135154],"genre_scores_gemma":[0.99972945,0.000016556265,0.00011687239,0.000003059597,0.0000016366039,0.0000014935423,0.00010422501,0.000002094904,0.000024565488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999824,0.000037358048,0.000016536085,0.00006173967,0.000032462343,0.000027987784],"domain_scores_gemma":[0.9993518,0.00018275488,0.00028969697,0.0000643678,0.000058852645,0.000052489046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027140393,0.00017457712,0.00023030833,0.000609253,0.00013619637,0.00034548188,0.00019410448,0.00022616424,0.0011406613],"category_scores_gemma":[0.0013018603,0.00009550805,0.00024115805,0.0004736753,0.00021648874,0.00020884107,0.00024156929,0.00016809277,0.0002008306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005827564,0.000016552327,0.9869348,0.00001970213,0.000086513544,0.0003240101,0.00006499376,0.00029172187,0.0064952704,0.000030114763,0.0000688378,0.0050848606],"study_design_scores_gemma":[0.0000068304153,0.00014534323,0.99655175,0.0000023328048,0.000048201575,0.001339342,0.00009249439,0.00058492157,0.0010155891,0.000065618806,0.00014353544,0.0000039728243],"about_ca_topic_score_codex":0.0013502203,"about_ca_topic_score_gemma":0.0019462801,"teacher_disagreement_score":0.0013502203,"about_ca_system_score_codex":0.00019793643,"about_ca_system_score_gemma":0.00021092911,"threshold_uncertainty_score":0.0038158894},"labels":[],"label_agreement":null},{"id":"W2889789648","doi":"10.1093/neuonc/noy139.187","title":"P01.145 Tumor growth dynamics in serially-imaged low-grade glioma patients","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Natural history; Asymptomatic; Magnetic resonance imaging; Glioma; Cohort; Proportional hazards model; Radiology; Retrospective cohort study; Lesion; Medical record; Nuclear medicine; Internal medicine; Surgery","score_opus":0.011857030226386189,"score_gpt":0.2754583837170686,"score_spread":0.2636013534906824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889789648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962723,0.000048460846,0.000033141918,0.000008812904,9.344591e-7,0.000002699397,0.000106126994,0.0000021332737,0.00017045712],"genre_scores_gemma":[0.99960047,0.000035623834,0.000046581765,0.0000068449112,0.000003405251,0.000004109813,0.00025158364,0.0000015930787,0.000049827788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989367,0.00002031773,0.000012558403,0.000028953315,0.000020499963,0.000024033767],"domain_scores_gemma":[0.99934083,0.00014479323,0.0003150585,0.000032721382,0.00006327394,0.00010331814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016813684,0.00013046627,0.00018103984,0.0005244261,0.00019335895,0.0004215317,0.00015462103,0.00016222808,0.0008317002],"category_scores_gemma":[0.0016862603,0.00009701692,0.00010248987,0.0005118613,0.00018337394,0.0002889324,0.0002000663,0.0002004239,0.00024234281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012602597,0.000019421475,0.9965295,0.0000044638177,0.00000527977,0.0004419201,0.00006752159,0.0000525112,0.00038442222,0.000015098899,0.00008730164,0.0022665495],"study_design_scores_gemma":[0.000009638914,0.00021473017,0.9952312,0.0000042649813,0.000013279444,0.0030880077,0.00015151137,0.0005119279,0.00038350365,0.000040009,0.00034729837,0.0000046184723],"about_ca_topic_score_codex":0.0021208085,"about_ca_topic_score_gemma":0.0020501865,"teacher_disagreement_score":0.0021208085,"about_ca_system_score_codex":0.00028666682,"about_ca_system_score_gemma":0.00022428545,"threshold_uncertainty_score":0.0042169094},"labels":[],"label_agreement":null},{"id":"W2890573151","doi":"10.1093/neuonc/noy139.409","title":"P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; non-small cell lung cancer (NSCLC); Adverse effect; Oncology; Neurocognitive; Internal medicine; Radiology; Clinical trial; Radiation therapy","score_opus":0.13772833863690861,"score_gpt":0.4710848910372112,"score_spread":0.3333565524003026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890573151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666137,0.0047166753,0.0010878313,0.001582666,0.00030108728,0.0054339073,0.007863738,0.00019826058,0.0122021325],"genre_scores_gemma":[0.95209044,0.0052589173,0.0029849794,0.0048196334,0.00027770802,0.007103653,0.015989829,0.00011778651,0.011357112],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997825,0.000078328456,0.000011753713,0.000034375447,0.000039019935,0.000054066764],"domain_scores_gemma":[0.9997607,0.000025542673,0.00004874749,0.000017833665,0.00002550903,0.00012174808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011808415,0.0009770762,0.0010288052,0.00022687328,0.00036213236,0.0010052598,0.00059269636,0.0009925507,0.005060337],"category_scores_gemma":[0.00041995465,0.00031162164,0.001378872,0.0002537806,0.00039357448,0.0005302638,0.00028969286,0.002163845,0.0014126585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5360043,0.073260665,0.024027867,0.0026364592,0.003426157,0.0007157885,0.0004630405,0.0038523339,0.062368765,0.001596955,0.04968313,0.2419645],"study_design_scores_gemma":[0.509861,0.40852097,0.04450315,0.00021326446,0.0015475377,0.0009469869,0.00013688311,0.0022435933,0.0067302,0.0011779958,0.024067864,0.000050630868],"about_ca_topic_score_codex":0.0011455172,"about_ca_topic_score_gemma":0.0046456764,"teacher_disagreement_score":0.005060337,"about_ca_system_score_codex":0.0006616076,"about_ca_system_score_gemma":0.0017425233,"threshold_uncertainty_score":0.016928554},"labels":[],"label_agreement":null},{"id":"W2890668257","doi":"10.1093/neuonc/noy139.090","title":"P01.048 A novel transducer array layout for delivering Tumor Treating Fields to the infratentorial brain at therapeutic levels","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transducer; Computer science; Medicine; Biomedical engineering; Acoustics; Physics","score_opus":0.07982424291848482,"score_gpt":0.3295257589355382,"score_spread":0.24970151601705337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890668257","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12700325,0.0019571395,0.80544573,0.0016479039,0.0022412997,0.00078348356,0.0020415618,0.008281678,0.05059793],"genre_scores_gemma":[0.4623292,0.0014626834,0.49587527,0.00091424637,0.00028483363,0.0008077889,0.0015024205,0.00058139535,0.03624224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997466,0.000044876917,0.00001589759,0.000047083024,0.000120491044,0.000025075717],"domain_scores_gemma":[0.9996032,0.00009148131,0.00008233809,0.000046260837,0.00012235857,0.00005434519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026541445,0.00049217977,0.0002298961,0.00032157786,0.00018748433,0.0005753439,0.00069881754,0.00073156366,0.010886795],"category_scores_gemma":[0.0008635136,0.00036823668,0.00030668927,0.0002180742,0.0002516571,0.0005804927,0.00037978622,0.00041325248,0.003277268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057189557,0.00018787022,0.0018164371,0.0003638023,0.000042862233,0.0009281835,0.00020364724,0.014110237,0.8245274,0.007458345,0.020059643,0.12972975],"study_design_scores_gemma":[0.0003755377,0.0061490573,0.006944421,0.000086967615,0.00025569546,0.007941297,0.00017404801,0.10673233,0.5739019,0.0030308445,0.2941934,0.00021455935],"about_ca_topic_score_codex":0.0005363646,"about_ca_topic_score_gemma":0.0008821969,"teacher_disagreement_score":0.010886795,"about_ca_system_score_codex":0.00031056255,"about_ca_system_score_gemma":0.0007138528,"threshold_uncertainty_score":0.036419928},"labels":[],"label_agreement":null},{"id":"W2891211750","doi":"10.1093/neuonc/noy139.025","title":"OS3.6 Development and validation of a DNA methylome-based predictor of meningioma recurrence and meningioma recurrence score","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nomogram; DNA methylation; Oncology; Internal medicine; Meningioma; Cohort; Medicine; Proportional hazards model; Microarray; Bioinformatics; Computational biology; Biology; Gene; Surgery; Genetics; Gene expression","score_opus":0.027704484369472752,"score_gpt":0.31974196413130257,"score_spread":0.2920374797618298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891211750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627739,0.0002936917,0.02512798,0.00024446385,0.00003889824,0.00020209079,0.009746965,0.00046041224,0.0011115979],"genre_scores_gemma":[0.95485336,0.00014806427,0.025257457,0.000079113765,0.000036199373,0.00034914637,0.017903887,0.000106646585,0.0012661952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991385,0.00024127676,0.000095136624,0.00016365743,0.00026346993,0.00009797225],"domain_scores_gemma":[0.9982243,0.00057469035,0.00037237947,0.00018484714,0.0004664475,0.00017735192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039887736,0.0008315496,0.00070506247,0.0014225588,0.00027999334,0.0009910474,0.000714562,0.00054079684,0.0016758123],"category_scores_gemma":[0.0050955815,0.00030785662,0.00122901,0.0008778258,0.00020312713,0.00032210193,0.0008352689,0.0009077187,0.00079565484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022292226,0.00024617798,0.89702547,0.0001434624,0.0007489271,0.00013940356,0.00010450447,0.02658342,0.0128246015,0.00038870727,0.00329519,0.05627097],"study_design_scores_gemma":[0.0004646275,0.0021858248,0.63393754,0.0000643805,0.00086469715,0.00062221184,0.00014244547,0.32854787,0.024678158,0.001798873,0.006570724,0.00012274578],"about_ca_topic_score_codex":0.0030685645,"about_ca_topic_score_gemma":0.004871944,"teacher_disagreement_score":0.0039887736,"about_ca_system_score_codex":0.0005401225,"about_ca_system_score_gemma":0.0012640251,"threshold_uncertainty_score":0.021094918},"labels":[],"label_agreement":null},{"id":"W2891484912","doi":"10.1093/neuonc/noy132","title":"MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Epigenetics; Biomarker; DNA methylation; Methylation; Glioblastoma; Oncology; Methyltransferase; Medicine; Clinical Practice; Bioinformatics; Internal medicine; Biology; Gene; Cancer research; Genetics; Gene expression; Family medicine","score_opus":0.23212082194676248,"score_gpt":0.43766612720138737,"score_spread":0.2055453052546249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891484912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104441046,0.99701715,0.00022232278,0.0019562335,0.00017021176,0.0000050523445,0.0000245643,0.0000059222602,0.00049406546],"genre_scores_gemma":[0.001150231,0.99728894,0.00052402855,0.0006372627,0.00019845393,0.0000066689345,0.00003948363,0.0000020411073,0.00015297004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937636,0.00017276006,0.00014440964,0.00008869177,0.00018450555,0.00003323611],"domain_scores_gemma":[0.9977557,0.001284447,0.00019144203,0.00003844581,0.00066212576,0.00006781887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022107405,0.0006405163,0.0014468059,0.002846287,0.0002900173,0.00123407,0.0011509527,0.001315307,0.0022136634],"category_scores_gemma":[0.0049809176,0.000225925,0.0008318115,0.0019603083,0.0006166441,0.0018555481,0.000703266,0.0020902269,0.00095051265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053804255,0.000029487246,0.0007471599,0.021221109,0.00017287716,0.00021057524,0.00009227881,0.00035888475,0.0005154523,0.004024541,0.025218185,0.9473557],"study_design_scores_gemma":[0.000027818736,0.00011396928,0.0029223405,0.030977048,0.00065117923,0.0024481867,0.00025618498,0.00040601322,0.00048304803,0.0073385667,0.9543329,0.000042835025],"about_ca_topic_score_codex":0.0024408218,"about_ca_topic_score_gemma":0.0049056523,"teacher_disagreement_score":0.002846287,"about_ca_system_score_codex":0.0010834051,"about_ca_system_score_gemma":0.002723384,"threshold_uncertainty_score":0.01169163},"labels":[],"label_agreement":null},{"id":"W2891665709","doi":"10.1093/neuonc/noy139.032","title":"OS5.1 Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Glioma; Retrospective cohort study; Cohort; Population; Histopathology; Pathology; Cancer research","score_opus":0.013562024839118118,"score_gpt":0.28886048042287177,"score_spread":0.27529845558375365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891665709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692434,0.0004271598,0.000140845,0.000026959688,0.000006836874,0.000016929673,0.0009085494,0.000008298274,0.0015400875],"genre_scores_gemma":[0.9970962,0.00014830202,0.00017953925,0.000019188346,0.0000062637987,0.0000119000415,0.001989096,0.000004160192,0.00054533617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981505,0.000011617932,0.000028712375,0.00004044451,0.000039469844,0.000064731306],"domain_scores_gemma":[0.99969316,0.000018009554,0.00016321943,0.000012859291,0.00004030628,0.000072444906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024042638,0.00024957114,0.00021046706,0.0010093792,0.00023767607,0.0005833733,0.0002566859,0.00022751078,0.0017620785],"category_scores_gemma":[0.0005134952,0.00009558429,0.0002814265,0.00070787536,0.00021034045,0.00024153567,0.0003223683,0.00015405576,0.0003653296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002632421,0.000011758996,0.99181795,0.000022354869,0.000018411003,0.00047651285,0.00006305014,0.00007269994,0.0030900424,0.00008051119,0.00023887778,0.0038446444],"study_design_scores_gemma":[0.000005447155,0.00009499831,0.99584645,0.000012800066,0.000023348706,0.0015684329,0.0002070062,0.00018395435,0.00080461364,0.00012152079,0.0011279461,0.000003579937],"about_ca_topic_score_codex":0.0024070058,"about_ca_topic_score_gemma":0.004434601,"teacher_disagreement_score":0.0024070058,"about_ca_system_score_codex":0.00035631206,"about_ca_system_score_gemma":0.00031330087,"threshold_uncertainty_score":0.00589478},"labels":[],"label_agreement":null},{"id":"W2897975460","doi":"10.1093/neuonc/noy170","title":"Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Amgen","keywords":"Glioblastoma; Medicine; Virology; Oncology; Cancer research","score_opus":0.05805621625914466,"score_gpt":0.3732452274658427,"score_spread":0.31518901120669807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897975460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006522689,0.9993387,0.000023212624,0.0001945984,0.000073471674,0.000001973391,0.0000070683595,0.0000017773386,0.00029391274],"genre_scores_gemma":[0.00086949865,0.9984366,0.000047127593,0.0002886516,0.00014863102,0.000004033915,0.000015146648,0.0000011616467,0.00018907861],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997739,0.0000558574,0.000044573935,0.00003891235,0.000069530106,0.000017270018],"domain_scores_gemma":[0.99953973,0.00027581857,0.000076130644,0.00001037809,0.000072944,0.00002502495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080985035,0.00040221232,0.0013443372,0.0011875989,0.00019743016,0.000799106,0.0007748171,0.0013009061,0.0026600158],"category_scores_gemma":[0.0012138601,0.00018790505,0.00046997966,0.0012915301,0.00048393,0.0011779941,0.00039273023,0.001558858,0.0011055582],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016680826,0.000049361166,0.0001491326,0.019827256,0.00010109552,0.00017960578,0.00006408739,0.00017119202,0.0006944686,0.003185942,0.021443613,0.95396745],"study_design_scores_gemma":[0.00005995433,0.00026935863,0.0010684851,0.0081553245,0.00023666583,0.0028387117,0.00010530344,0.00006498462,0.00035093317,0.0023043968,0.98452306,0.000022868944],"about_ca_topic_score_codex":0.00073153124,"about_ca_topic_score_gemma":0.0017619133,"teacher_disagreement_score":0.0026600158,"about_ca_system_score_codex":0.000435302,"about_ca_system_score_gemma":0.0006466965,"threshold_uncertainty_score":0.008898616},"labels":[],"label_agreement":null},{"id":"W2899525399","doi":"10.1093/neuonc/noy148.1045","title":"SURG-09. AWAKE CRANIOTOMY FOR BRAIN TUMOR IN OCTOGENARIANS AND NONAGENARIANS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Propofol; Remifentanil; Surgery; Craniotomy; Institutional review board; Anesthesia","score_opus":0.030455254860467813,"score_gpt":0.3153718078542733,"score_spread":0.2849165529938055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899525399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593973,0.0002473482,0.000037088488,0.00009844858,0.000016504757,0.00001509523,0.0004112588,0.0000034256702,0.003231071],"genre_scores_gemma":[0.997198,0.00048329317,0.000119513985,0.00018675433,0.00003340924,0.0000149070775,0.0005734076,0.0000035737937,0.0013872],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99987435,0.000015296993,0.000015122629,0.000015713815,0.00002001958,0.00005944205],"domain_scores_gemma":[0.9997676,0.000021667103,0.00008005823,0.000008979861,0.0000160169,0.000105742205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121905876,0.0001286997,0.00010206268,0.0004964825,0.00046423118,0.00037821382,0.00009851131,0.00017195249,0.0029161966],"category_scores_gemma":[0.00037210804,0.000115169794,0.000172034,0.00053377706,0.00016493627,0.00019250078,0.0003019172,0.00019439583,0.0005310628],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014434701,0.00004932568,0.99132794,0.000012239576,0.000013725832,0.0025032777,0.00012176747,0.000015008504,0.0003739268,0.00003137,0.00053914846,0.004867997],"study_design_scores_gemma":[0.0000075496287,0.00013465827,0.9923183,0.000012953412,0.000015143898,0.005200558,0.00081427826,0.00004575116,0.000104760606,0.000033956017,0.0013078309,0.0000042278157],"about_ca_topic_score_codex":0.014533721,"about_ca_topic_score_gemma":0.04297768,"teacher_disagreement_score":0.014533721,"about_ca_system_score_codex":0.0004288314,"about_ca_system_score_gemma":0.0005136423,"threshold_uncertainty_score":0.02889824},"labels":[],"label_agreement":null},{"id":"W2899592545","doi":"10.1093/neuonc/noy148.885","title":"PDTM-46. POLIOVIRUS RECEPTOR (CD155) EXPRESSION IN PEDIATRIC BRAIN TUMORS MEDIATES ONCOLYSIS OF MEDULLOBLASTOMA AND PLEOMORPHIC XANTHOASTROCYTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Oncolytic virus; Glioma; Biology; Pathology; Medicine; Virology; Immunology; Virus","score_opus":0.012056359443080885,"score_gpt":0.2896964221114844,"score_spread":0.2776400626684035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899592545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989003,0.0002628716,0.00031465033,0.00001438104,0.0000026869536,0.000007682032,0.00010846919,0.000012902434,0.00037609128],"genre_scores_gemma":[0.9984541,0.00023129006,0.0005132329,0.000010012376,0.000001967964,0.000013692947,0.00031155374,0.000004343423,0.00045963164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990237,0.00001284786,0.0000081702265,0.000024909788,0.000025934485,0.00002566316],"domain_scores_gemma":[0.9999467,0.000011341683,0.000016456255,0.0000048464476,0.0000043522605,0.000016288317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009046671,0.00015260528,0.00016367574,0.00015750714,0.00010401984,0.00022657865,0.00008168671,0.00012876243,0.0008072885],"category_scores_gemma":[0.00013413602,0.00010599509,0.00014629647,0.00012410709,0.00014124034,0.00012930564,0.000093905874,0.00029690642,0.0002348486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017336769,0.000036663332,0.0035273114,0.000018126384,0.00000600027,0.00014204533,0.000027167389,0.000086550725,0.99405766,0.000047534373,0.000053678028,0.0018239175],"study_design_scores_gemma":[0.000030053154,0.0012668439,0.123362295,0.000006460863,0.00002642953,0.0020590262,0.00009879871,0.0016541971,0.8692589,0.000043202275,0.0021897359,0.000004099723],"about_ca_topic_score_codex":0.0011589415,"about_ca_topic_score_gemma":0.0014618929,"teacher_disagreement_score":0.0011589415,"about_ca_system_score_codex":0.000354142,"about_ca_system_score_gemma":0.00020471703,"threshold_uncertainty_score":0.0027006269},"labels":[],"label_agreement":null},{"id":"W2899594668","doi":"10.1093/neuonc/noy148.716","title":"NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Randomized controlled trial; Clinical endpoint; Radiation therapy; Memantine; Oncology; Surgery; Dementia; Disease; Cognition","score_opus":0.03719127935502972,"score_gpt":0.3496399232182937,"score_spread":0.312448643863264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899594668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942926,0.0012108128,0.00021094225,0.00030585207,0.000089017114,0.0011498827,0.000995101,0.000060229748,0.0016856223],"genre_scores_gemma":[0.9876468,0.0015105387,0.0013537076,0.0007538227,0.00021266215,0.002610242,0.002780859,0.000020199195,0.0031112006],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973303,0.00014473214,0.000013694204,0.000030469664,0.00003010509,0.000047926187],"domain_scores_gemma":[0.9995455,0.000102497856,0.000098660756,0.000046601774,0.000030247467,0.0001763997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010238942,0.0008608925,0.000880264,0.00021247365,0.00021096409,0.00037596526,0.000607446,0.00062313286,0.0036287422],"category_scores_gemma":[0.0008076044,0.00017763366,0.0006386252,0.00026869666,0.0005550756,0.00030105116,0.000182002,0.0013307572,0.0005731657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77551246,0.04602462,0.013535936,0.00087941193,0.000803897,0.00021511523,0.00015786434,0.001393403,0.019068426,0.00027919706,0.006124974,0.13600472],"study_design_scores_gemma":[0.58525467,0.38558733,0.021186493,0.000060890226,0.0004580275,0.00022113895,0.000037609632,0.00086423237,0.0031607726,0.00018080776,0.00296796,0.000020058871],"about_ca_topic_score_codex":0.0021093425,"about_ca_topic_score_gemma":0.007383275,"teacher_disagreement_score":0.0036287422,"about_ca_system_score_codex":0.0006917877,"about_ca_system_score_gemma":0.0015179305,"threshold_uncertainty_score":0.01213932},"labels":[],"label_agreement":null},{"id":"W2899599875","doi":"10.1093/neuonc/noy148.528","title":"IMMU-25. PROGRAMMED CELL DEATH-LIGAND 1 (PD-L1) IS NOT EXPRESSED IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TUMOR CELLS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Cancer research; Ligand (biochemistry); Programmed cell death; Chemistry; Biology; Apoptosis; Receptor; Biochemistry","score_opus":0.020519272324484906,"score_gpt":0.28258021935772065,"score_spread":0.26206094703323574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899599875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491346,0.0012109582,0.00091567985,0.00004185205,0.00001075674,0.000014521884,0.0002246245,0.00003611146,0.0026320175],"genre_scores_gemma":[0.9976126,0.00019523325,0.00065942015,0.00002010674,0.0000024612152,0.000012346266,0.00042679746,0.000005327558,0.0010656386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998274,0.000016341963,0.000013705557,0.000055869015,0.000040321538,0.0000464408],"domain_scores_gemma":[0.9998934,0.000014356526,0.000024855508,0.000017292257,0.0000145193835,0.000035421126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010606809,0.00013787624,0.00017400295,0.00029062736,0.00021652177,0.0003508247,0.00016987791,0.00022996472,0.0015392775],"category_scores_gemma":[0.00017162538,0.00012758376,0.00010818813,0.00020196126,0.0002751311,0.00019211571,0.00018113773,0.00030894863,0.00030598743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004186826,0.00006679458,0.012104837,0.000092140916,0.000025671374,0.0016243007,0.000116209754,0.000117284835,0.98044616,0.00051557313,0.00015031103,0.0043220376],"study_design_scores_gemma":[0.000115287934,0.0017572683,0.21571404,0.0000472738,0.00008096573,0.026805572,0.00073099794,0.004298815,0.7210217,0.0007556154,0.028652128,0.000020407679],"about_ca_topic_score_codex":0.00074205373,"about_ca_topic_score_gemma":0.0010331519,"teacher_disagreement_score":0.0015392775,"about_ca_system_score_codex":0.00033412213,"about_ca_system_score_gemma":0.0001743238,"threshold_uncertainty_score":0.005149424},"labels":[],"label_agreement":null},{"id":"W2899619720","doi":"10.1093/neuonc/noy148.1076","title":"TMIC-17. IMMUNE MICROENVIRONMENT OF NF2-ALTERED RADIATION-INDUCED MENINGIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immunohistochemistry; Immune system; Tumor microenvironment; Radiation therapy; Cancer research; Pathology; Medicine; Exome sequencing; Biology; Gene; Phenotype; Internal medicine; Immunology; Genetics","score_opus":0.027243710967553264,"score_gpt":0.2940254445578332,"score_spread":0.2667817335902799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899619720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713624,0.000663038,0.00028187045,0.000020547612,0.0000052892456,0.000013498591,0.0008300232,0.000029454435,0.0010201747],"genre_scores_gemma":[0.99726105,0.00025930972,0.0004181632,0.000022440992,0.000007278599,0.000017162234,0.0014471725,0.0000117467,0.0005556643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986124,0.000014055934,0.000013782003,0.000035577847,0.000037796362,0.000037503047],"domain_scores_gemma":[0.99978894,0.000016163478,0.00011006815,0.000019690651,0.000020710462,0.000044405777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016957075,0.00020245831,0.0002014933,0.0005099059,0.00024095303,0.00042094343,0.0001310834,0.00016378111,0.0015624468],"category_scores_gemma":[0.00030280853,0.00009735741,0.00023075167,0.00047586314,0.00015985842,0.00012444565,0.0001903832,0.0001808204,0.00034772386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002797594,0.00012188191,0.36494055,0.0002684182,0.00011991771,0.0058465,0.00031223288,0.00032954596,0.60804397,0.00026047102,0.00061073137,0.016348183],"study_design_scores_gemma":[0.000024431954,0.00034712342,0.93403953,0.000023369763,0.000086884036,0.011848678,0.00027533594,0.0005606465,0.049261108,0.00015212153,0.003372985,0.000007743691],"about_ca_topic_score_codex":0.0008125849,"about_ca_topic_score_gemma":0.0009931286,"teacher_disagreement_score":0.0015624468,"about_ca_system_score_codex":0.00032493114,"about_ca_system_score_gemma":0.00024467145,"threshold_uncertainty_score":0.00522691},"labels":[],"label_agreement":null},{"id":"W2899651508","doi":"10.1093/neuonc/noy148.960","title":"RTHP-30. MANAGEMENT OF GLIOBLASTOMA IN THE ELDERLY - A 10-YEAR ANALYSIS OF THE BC CANCER AGENCY POPULATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Internal medicine; Radiation therapy; Univariate analysis; Cancer; Cancer registry; Multivariate analysis; Population; Glioblastoma; Surgery; Oncology","score_opus":0.02058208041906901,"score_gpt":0.32238060223442394,"score_spread":0.30179852181535494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899651508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886544,0.0015861247,0.00007080615,0.00022908639,0.000012139743,0.000029306615,0.008010135,0.000012865928,0.0013950599],"genre_scores_gemma":[0.9904295,0.0011959586,0.00008366867,0.0001479886,0.00001575032,0.000030394647,0.007496079,0.000007707063,0.0005930757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995307,0.000056282548,0.00004505022,0.00007609656,0.00015743157,0.00013450191],"domain_scores_gemma":[0.9985856,0.000058348043,0.0006797968,0.000053682554,0.00032441356,0.0002981413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054981996,0.00021234203,0.00031265605,0.0009198091,0.0005933894,0.0007552585,0.00034724185,0.00024065112,0.0011933674],"category_scores_gemma":[0.0012985213,0.00015724543,0.00047504666,0.002343082,0.00016682879,0.00026845903,0.00054593396,0.0004725179,0.00037172195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012270617,0.000021216705,0.994918,0.000022872067,0.000066436354,0.00005035578,0.000056998735,0.000059692644,0.00006436372,0.000011944564,0.000910568,0.0036949697],"study_design_scores_gemma":[0.0000068255627,0.000026497955,0.9986512,0.00002168907,0.00002997682,0.000073648545,0.00012699675,0.000112444446,0.000023194709,0.000008060906,0.00091689406,0.0000025352122],"about_ca_topic_score_codex":0.4701228,"about_ca_topic_score_gemma":0.5261363,"teacher_disagreement_score":0.4701228,"about_ca_system_score_codex":0.0030408606,"about_ca_system_score_gemma":0.0035073813,"threshold_uncertainty_score":0.9347728},"labels":[],"label_agreement":null},{"id":"W2899668992","doi":"10.1093/neuonc/noy148.124","title":"CBMT-05. ROLE OF THE let7-eEF2K AXIS IN MYC-DRIVEN MEDULLOBLASTOMA ADAPTATION TO NUTRIENT DEPRIVATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"microRNA; Untranslated region; Biology; Three prime untranslated region; Cancer research; Messenger RNA; Molecular biology; Gene; Genetics","score_opus":0.009849345950799797,"score_gpt":0.25543492278454066,"score_spread":0.24558557683374085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899668992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90026027,0.012167128,0.007144228,0.0027707163,0.0014852983,0.0008091276,0.027269443,0.0038388246,0.044254985],"genre_scores_gemma":[0.94890827,0.0019452019,0.0039820415,0.0009066455,0.00008884411,0.0005294699,0.016680202,0.00042451394,0.026534844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961334,0.00003728896,0.000023448763,0.00007959888,0.00014470557,0.00010160193],"domain_scores_gemma":[0.9996061,0.000025336352,0.000058571215,0.000041077805,0.00004632481,0.00022258377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041116608,0.0005136854,0.00057379407,0.00055380806,0.0007141196,0.0010154543,0.00068980217,0.0009845907,0.014309994],"category_scores_gemma":[0.00032947012,0.00025811567,0.00048296506,0.00035301465,0.00046732652,0.00031472978,0.00053727586,0.0016901481,0.0044329674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006196955,0.00056288665,0.00310014,0.00052780565,0.000073005016,0.00047871307,0.00008418917,0.00045978595,0.9547457,0.0020578417,0.006636573,0.02507635],"study_design_scores_gemma":[0.0013028882,0.004419416,0.04533337,0.00017909033,0.00022428732,0.0024350954,0.00023932617,0.0033924477,0.8174885,0.0011187837,0.12380758,0.00005918012],"about_ca_topic_score_codex":0.0030766183,"about_ca_topic_score_gemma":0.0044460995,"teacher_disagreement_score":0.014309994,"about_ca_system_score_codex":0.0012019909,"about_ca_system_score_gemma":0.0014041716,"threshold_uncertainty_score":0.04787171},"labels":[],"label_agreement":null},{"id":"W2899678915","doi":"10.1093/neuonc/noy148.946","title":"RTHP-14. TUMOR-TREATING FIELDS FOR GLIOBLASTOMA: NUMERICAL SIMULATION EXPLORES SUB-CELLULAR MECHANISMS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Photoreceptor and optogenetics research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kinesin; Multiphysics; Microtubule; Electric field; Biophysics; Materials science; Physics; Finite element method; Mechanics; Nanotechnology; Chemistry; Biology","score_opus":0.05480316101704988,"score_gpt":0.350625736378356,"score_spread":0.2958225753613061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899678915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.790482,0.00063423906,0.11926415,0.0012424383,0.0002440395,0.0003623061,0.005757655,0.0034746572,0.07853857],"genre_scores_gemma":[0.9204343,0.00027864665,0.06729023,0.00020250487,0.000022137827,0.0005069374,0.0021946067,0.000427327,0.008643261],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99989367,0.00002228882,0.000003492075,0.000012554199,0.000039254202,0.000028862918],"domain_scores_gemma":[0.99968517,0.00017424427,0.000030570714,0.00002157859,0.000060347997,0.00002806322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025371768,0.00050578284,0.00052067434,0.0002669394,0.0003434704,0.00052360847,0.00088578585,0.0011369078,0.0066764117],"category_scores_gemma":[0.0007767592,0.00028156873,0.0005299551,0.0002917036,0.0003547839,0.000320998,0.00038872202,0.000566167,0.00058341277],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009937844,0.00015464555,0.0028067357,0.00018803975,0.000031128824,0.00018754455,0.00012840745,0.9734799,0.007901513,0.003541407,0.002829452,0.008651903],"study_design_scores_gemma":[0.000020683807,0.000033942066,0.00035438623,0.000008897419,0.0000042819256,0.000020443242,0.00002139085,0.99663454,0.0013593903,0.00047329746,0.0010635095,0.0000053525346],"about_ca_topic_score_codex":0.009938689,"about_ca_topic_score_gemma":0.007909121,"teacher_disagreement_score":0.009938689,"about_ca_system_score_codex":0.00065474905,"about_ca_system_score_gemma":0.0010473267,"threshold_uncertainty_score":0.022334814},"labels":[],"label_agreement":null},{"id":"W2899680932","doi":"10.1093/neuonc/noy148.404","title":"EXTH-56. CLINICALLY DELIVERABLE DEEP BRAIN STIMULATOR GENERATED ELECTRICAL FIELDS HAVE PROFOUND EFFECTS ON GLIOBLASTOMA MULTIFORME CELL LINES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell cycle; Viability assay; Cell growth; Deep brain stimulation; Cell; Cell culture; Glioblastoma; Medicine; Cancer research; U87; Biomedical engineering; Pathology; Biology; Internal medicine; Cancer; Parkinson's disease","score_opus":0.02656223905121688,"score_gpt":0.3171566067505411,"score_spread":0.29059436769932423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899680932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96856624,0.00618256,0.008177306,0.0005883085,0.0001770563,0.00045786894,0.0040738587,0.0005623243,0.011214533],"genre_scores_gemma":[0.95714694,0.004649103,0.011816779,0.00031547082,0.000025339621,0.00050849386,0.005825543,0.00008881113,0.019623581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998431,0.000024010467,0.000016664968,0.00003334563,0.000057988942,0.000024821902],"domain_scores_gemma":[0.9999372,0.000016703787,0.000013721946,0.000012539023,0.000008196961,0.000011688547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001686645,0.0003989105,0.00033539007,0.00027226075,0.0001745723,0.00026043464,0.00024185736,0.0003362303,0.002319314],"category_scores_gemma":[0.00010198282,0.00012507844,0.00024584532,0.00020033697,0.00022063876,0.00014175738,0.00015579551,0.0006534356,0.0006314781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027467284,0.00020461182,0.00030963836,0.00011829235,0.000011097885,0.0000875252,0.000044753237,0.00037142838,0.9856542,0.00015790063,0.0008873031,0.011878632],"study_design_scores_gemma":[0.00012575676,0.0018729815,0.005448658,0.000013647858,0.000031512944,0.00044234394,0.000029000592,0.00069843023,0.9806716,0.00006809978,0.010588903,0.0000090853055],"about_ca_topic_score_codex":0.0010417487,"about_ca_topic_score_gemma":0.003256343,"teacher_disagreement_score":0.002319314,"about_ca_system_score_codex":0.0002803251,"about_ca_system_score_gemma":0.00023114165,"threshold_uncertainty_score":0.007758856},"labels":[],"label_agreement":null},{"id":"W2899685235","doi":"10.1093/neuonc/noy148.358","title":"EXTH-09. DIANHYDROGALACTITOL (VAL-083) HAS THE POTENTIAL TO OVERCOME MAJOR CHALLENGES IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Combination therapy; Medicine; Radiation therapy; Pharmacology; IC50; Cell culture; Biology; Internal medicine; Genetics","score_opus":0.04265341174979834,"score_gpt":0.3047942839018642,"score_spread":0.26214087215206583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899685235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96930224,0.017836021,0.0037008878,0.0005136393,0.000081372375,0.000088895744,0.000826905,0.0002590763,0.007391075],"genre_scores_gemma":[0.98867583,0.004362177,0.0025998857,0.00013331175,0.000014234504,0.00003173651,0.0010962794,0.000023976156,0.003062504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995816,0.0000071898367,0.0000022922795,0.0000072748244,0.000015201012,0.000009903408],"domain_scores_gemma":[0.99997056,0.00000323435,0.000008808677,0.0000031173752,0.0000028686306,0.000011352451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006992076,0.0002607621,0.00016958934,0.0001416763,0.000077362034,0.0002039251,0.0001913959,0.00017856118,0.0012770443],"category_scores_gemma":[0.00004433862,0.00007606177,0.00016465108,0.00016417309,0.00013541176,0.00011756912,0.00019882621,0.0005761865,0.00045416568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042919393,0.0001733447,0.0008029471,0.00024869348,0.00003368648,0.00024338189,0.000030948882,0.0005981579,0.9457886,0.0005316883,0.0007975834,0.050321754],"study_design_scores_gemma":[0.00018808732,0.00416611,0.009261154,0.00002147833,0.000071613555,0.0028780159,0.000049616567,0.00097620394,0.928795,0.0002832147,0.053293936,0.00001549613],"about_ca_topic_score_codex":0.00064712064,"about_ca_topic_score_gemma":0.0016051441,"teacher_disagreement_score":0.0012770443,"about_ca_system_score_codex":0.0002753361,"about_ca_system_score_gemma":0.00021401973,"threshold_uncertainty_score":0.0042721033},"labels":[],"label_agreement":null},{"id":"W2899686888","doi":"10.1093/neuonc/noy148.1021","title":"STEM-14. GROWTH FACTOR RECEPTOR CO-INHERITANCE DURING ASYMMETRIC CELL DIVISION DRIVES THE CANCER STEM CELL PHENOTYPE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Stem cell; Biology; Cancer stem cell; Cell biology; Cell division; Mitosis; Asymmetric cell division; Cancer research; Cell fate determination; Growth factor; Receptor; Cell; Transcription factor; Genetics; Gene","score_opus":0.026355352018920933,"score_gpt":0.2953011207182357,"score_spread":0.2689457686993148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899686888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678624,0.0015829947,0.01476374,0.00037647068,0.000116549236,0.00013902622,0.002218585,0.0006136318,0.012326694],"genre_scores_gemma":[0.9734489,0.0006311627,0.0084476145,0.00015516461,0.000016143485,0.00010529245,0.0027246966,0.00011820331,0.0143528795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975497,0.000027702044,0.000021504367,0.000059145335,0.000095994576,0.00004076926],"domain_scores_gemma":[0.99985194,0.00002311327,0.000039958784,0.000022647077,0.000017052349,0.00004527971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017083205,0.00028212336,0.00023823555,0.00040064813,0.000235681,0.00041428016,0.00028328423,0.00036122536,0.0037820623],"category_scores_gemma":[0.00011184073,0.00019727058,0.00026790675,0.00023336848,0.00030878815,0.00019467053,0.00029083138,0.0006026918,0.0016253213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043054908,0.000016192344,0.00022179291,0.000019184685,0.0000019662398,0.00005765676,0.000011712453,0.000036410096,0.99696296,0.00041775426,0.00010449923,0.0021067322],"study_design_scores_gemma":[0.000017777627,0.00010582317,0.0041140616,0.0000046507607,0.0000068332165,0.00025373994,0.000013969265,0.0016324704,0.98626024,0.00014192531,0.0074447067,0.000003794961],"about_ca_topic_score_codex":0.0007059927,"about_ca_topic_score_gemma":0.0014732687,"teacher_disagreement_score":0.0037820623,"about_ca_system_score_codex":0.0006421054,"about_ca_system_score_gemma":0.00043137485,"threshold_uncertainty_score":0.012652278},"labels":[],"label_agreement":null},{"id":"W2899687079","doi":"10.1093/neuonc/noy148.628","title":"MNGI-12. EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACTIVATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Meningioma; Immunohistochemistry; Univariate analysis; Medicine; Hypoxia (environmental); Internal medicine; Oncology; Tumor hypoxia; Pathology; Cancer research; Multivariate analysis; Chemistry","score_opus":0.03096945953902957,"score_gpt":0.2924236436807877,"score_spread":0.26145418414175814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899687079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903914,0.00090897793,0.0007538747,0.000055864006,0.000010560344,0.000025340583,0.0070672245,0.00007511547,0.000711674],"genre_scores_gemma":[0.98784375,0.00032217437,0.0019680934,0.000042818134,0.000007609002,0.000053391803,0.008777499,0.000016927206,0.0009676875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998715,0.000015540125,0.000013310083,0.000044254455,0.000028766537,0.000026652924],"domain_scores_gemma":[0.9998078,0.000028991995,0.00008191177,0.000015743024,0.000030298079,0.000035345038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030625126,0.00019321428,0.00027216654,0.00086732785,0.00027907867,0.0005235595,0.00019563532,0.00026176768,0.0014966633],"category_scores_gemma":[0.0004465654,0.00015783487,0.0002821691,0.0006764602,0.00017365206,0.00013675948,0.00025872004,0.00036995288,0.0004298454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020831365,0.00008499034,0.8771233,0.0002823237,0.00022697487,0.00031885804,0.00017850393,0.0014493036,0.09420071,0.000088934576,0.0015194846,0.022443434],"study_design_scores_gemma":[0.000016681332,0.00013870964,0.9753387,0.00002425375,0.000091113085,0.00062024646,0.00012114276,0.003363383,0.016814485,0.00015056472,0.003307279,0.0000133683],"about_ca_topic_score_codex":0.004456369,"about_ca_topic_score_gemma":0.008832114,"teacher_disagreement_score":0.004456369,"about_ca_system_score_codex":0.000489306,"about_ca_system_score_gemma":0.00026561975,"threshold_uncertainty_score":0.008860886},"labels":[],"label_agreement":null},{"id":"W2899690379","doi":"10.1093/neuonc/noy148.1121","title":"TMOD-08. GROWTH IMPAIRMENT UNDER CONDITIONS FAVORING MITOCHONDRIAL OXIDATIVE METABOLISM IN A YEAST MODEL OF CANCER-ASSOCIATED ISOCITRATE DEHYDROGENASE MUTATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microbial Metabolic Engineering and Bioproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Biology; IDH2; Mutant; Biochemistry; Saccharomyces cerevisiae; Isocitrate lyase; Wild type; Yeast; Molecular biology; Gene; Metabolism; Enzyme; Glyoxylate cycle","score_opus":0.012818007117168276,"score_gpt":0.27637479913113006,"score_spread":0.26355679201396176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899690379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593726,0.0016113919,0.009548537,0.00065134495,0.00042570615,0.00060804014,0.016639752,0.0014705088,0.009672173],"genre_scores_gemma":[0.9364835,0.0012958539,0.017023992,0.00026086564,0.00003500424,0.0010612591,0.021874985,0.00039390044,0.021570561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996189,0.00006425441,0.00006211878,0.00008687505,0.000096525946,0.00007130381],"domain_scores_gemma":[0.99977,0.000026694759,0.000041787243,0.00003838506,0.000029250115,0.0000939023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021254194,0.0006924622,0.0007227507,0.000467169,0.00030786867,0.0005366627,0.0010111314,0.00077669363,0.0046841786],"category_scores_gemma":[0.00016426767,0.00021341577,0.00064251863,0.0005754119,0.00032793023,0.00021306117,0.00051764754,0.0012761689,0.0021805645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011486049,0.00056022493,0.00029573994,0.000115174924,0.00001315603,0.00025643143,0.000041945405,0.00026057227,0.99143475,0.0004547101,0.0007222773,0.0046964665],"study_design_scores_gemma":[0.00026562312,0.002963281,0.002175179,0.000020944264,0.000029483068,0.0005285781,0.000068836736,0.0019732649,0.97704345,0.00013774078,0.014775342,0.000018217112],"about_ca_topic_score_codex":0.0019235107,"about_ca_topic_score_gemma":0.0018914263,"teacher_disagreement_score":0.0046841786,"about_ca_system_score_codex":0.00061975425,"about_ca_system_score_gemma":0.00070385676,"threshold_uncertainty_score":0.01567012},"labels":[],"label_agreement":null},{"id":"W2899734820","doi":"10.1093/neuonc/noy148.345","title":"EPID-18. MALIGNANT PRIMARY BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMOURS DIAGNOSED AMONG THE CANADIAN POPULATION FROM 2009 TO 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Central nervous system; Medicine; Population; Primary (astronomy); Oncology; Internal medicine; Environmental health","score_opus":0.01805945505709355,"score_gpt":0.2682606130221059,"score_spread":0.25020115796501236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899734820","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08499939,0.0031969137,0.0003470508,0.0007856,0.00010321923,0.00032931456,0.8941661,0.00021652244,0.015855791],"genre_scores_gemma":[0.4856742,0.0066412264,0.0019556822,0.0009717998,0.00008941085,0.000620719,0.49553853,0.00009038986,0.008418057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855906,0.000042923402,0.00014725394,0.00022635845,0.0006596808,0.00036468383],"domain_scores_gemma":[0.99623436,0.000091303875,0.0005280959,0.00006784209,0.0026406858,0.0004377494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062436645,0.00057839655,0.0005814379,0.0050531155,0.0021792878,0.0011247441,0.0015291178,0.0003199299,0.008309289],"category_scores_gemma":[0.0036222052,0.0004363816,0.00085581833,0.009247052,0.00029368544,0.00044446214,0.0009171701,0.0007018449,0.0010189561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039058182,0.000070126705,0.67155504,0.0018225949,0.00038409245,0.0002537745,0.0007523027,0.00069642917,0.0004213867,0.0012528232,0.2838436,0.03855731],"study_design_scores_gemma":[0.000052765325,0.000027933878,0.9565472,0.00043912706,0.00015868495,0.00020217877,0.0005217462,0.00042171762,0.00019113258,0.000102956095,0.041295424,0.000039055038],"about_ca_topic_score_codex":0.9936207,"about_ca_topic_score_gemma":0.99585414,"teacher_disagreement_score":0.030721055,"about_ca_system_score_codex":0.030721055,"about_ca_system_score_gemma":0.053415846,"threshold_uncertainty_score":0.22289789},"labels":[],"label_agreement":null},{"id":"W2899762883","doi":"10.1093/neuonc/noy148.974","title":"RBTT-04. DOES EXERCISE IMPROVE PROGRESSION FREE SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH GLIOBLASTOMA? A TRIAL IN PROGRESS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Toronto Western Hospital; Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Physical therapy; Neurocognitive; Mood; Randomized controlled trial; Progression-free survival; Actigraphy; Clinical trial; Cognition; Internal medicine; Psychiatry; Overall survival","score_opus":0.019157233636498534,"score_gpt":0.3300420864897643,"score_spread":0.3108848528532658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899762883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602451,0.007901868,0.0007002436,0.0040223645,0.0011071102,0.013752067,0.0060291733,0.000500032,0.0057419613],"genre_scores_gemma":[0.9372348,0.0069076414,0.0030658538,0.005564743,0.0011000185,0.026627142,0.0071394886,0.00009017544,0.012270014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993242,0.00041003278,0.00005141097,0.00006603837,0.000044696284,0.00010357884],"domain_scores_gemma":[0.99911207,0.00019885067,0.0002366205,0.00008726392,0.00007054956,0.000294629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026541941,0.0021116592,0.0024491875,0.00063598086,0.00048662262,0.001050014,0.0013595368,0.0027531243,0.010555439],"category_scores_gemma":[0.0018484814,0.00045077942,0.002570033,0.0005513687,0.0008980275,0.0011749084,0.00052421994,0.0030544621,0.002282561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9461648,0.010407116,0.00189246,0.0010765655,0.001157049,0.00007601558,0.000111939175,0.00042116194,0.0014295015,0.00021122812,0.0031060728,0.03394607],"study_design_scores_gemma":[0.833618,0.15705937,0.0053022853,0.00012144936,0.0005805374,0.000048145714,0.000059607348,0.0003647813,0.0003057758,0.00026002168,0.0022571124,0.00002288611],"about_ca_topic_score_codex":0.0021297398,"about_ca_topic_score_gemma":0.004422676,"teacher_disagreement_score":0.010555439,"about_ca_system_score_codex":0.00064400776,"about_ca_system_score_gemma":0.0015471773,"threshold_uncertainty_score":0.03531146},"labels":[],"label_agreement":null},{"id":"W2899768010","doi":"10.1093/neuonc/noz036.198","title":"MEDU-40. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Medulloblastoma; Population; Cerebellum; Lineage markers; Single-cell analysis; Cell sorting; Progenitor cell; Stem cell; Genetics; Cell; Neuroscience","score_opus":0.01767454300854074,"score_gpt":0.26982320938251136,"score_spread":0.2521486663739706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899768010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107745,0.002049052,0.022723183,0.00027060628,0.000104932304,0.000113909686,0.052299764,0.0020882306,0.009575792],"genre_scores_gemma":[0.88743687,0.0009968147,0.034675915,0.00035447231,0.000034899287,0.00031611553,0.061731547,0.0010007867,0.013452533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998023,0.000008514266,0.00000878128,0.000087544766,0.000054013257,0.000038881182],"domain_scores_gemma":[0.9998908,0.00002272004,0.000025847175,0.000017119231,0.000019230845,0.000024338784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017585402,0.0002794634,0.00032579532,0.0005062543,0.0004548407,0.0004862211,0.00022044382,0.00033148206,0.0041446136],"category_scores_gemma":[0.0002474239,0.00019178628,0.00042975156,0.00038268825,0.00020652032,0.00015032139,0.0003413925,0.00029519878,0.001806416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001440205,0.000014931163,0.006012452,0.00011831787,0.000020962463,0.00013092985,0.00012746945,0.0002925682,0.98291713,0.0003100205,0.0009177188,0.008993496],"study_design_scores_gemma":[0.00003712493,0.00024520242,0.22941744,0.000055742177,0.00012015166,0.0012186125,0.0003035438,0.010321159,0.6920331,0.0008647884,0.065352045,0.000031129843],"about_ca_topic_score_codex":0.0025834502,"about_ca_topic_score_gemma":0.011344502,"teacher_disagreement_score":0.0041446136,"about_ca_system_score_codex":0.0004725935,"about_ca_system_score_gemma":0.00040214483,"threshold_uncertainty_score":0.013865113},"labels":[],"label_agreement":null},{"id":"W2899795015","doi":"10.1093/neuonc/noz126.359","title":"P14.124 EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Oncology; Internal medicine; Population; Dacarbazine; Radiation therapy; Randomized controlled trial; Glioma; Phases of clinical research; Quality of life (healthcare); Performance status; Cancer; Clinical trial; Chemotherapy; Surgery; Cancer research","score_opus":0.009241219352810219,"score_gpt":0.2747187578403678,"score_spread":0.2654775384875576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899795015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612885,0.008035731,0.000845822,0.0018668136,0.001080128,0.015406444,0.0039394335,0.00026247965,0.0072746887],"genre_scores_gemma":[0.967303,0.00372953,0.0025061576,0.0023648145,0.00053010666,0.011168565,0.004032891,0.0000694766,0.008295566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993174,0.00040936263,0.000034718887,0.000077618024,0.000056931778,0.00010396608],"domain_scores_gemma":[0.9994105,0.00009482425,0.00011967309,0.000030736934,0.000052308525,0.0002919729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00202864,0.0016623209,0.0022112518,0.00058916473,0.0003637062,0.0008745643,0.0011463363,0.0014477962,0.0064187623],"category_scores_gemma":[0.0012546446,0.0005623268,0.0014394136,0.00054702134,0.0008165972,0.0006103067,0.00030652992,0.002929146,0.0011004637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.939976,0.012564707,0.0012676248,0.0008563039,0.00078822486,0.00007058433,0.000040300823,0.0007717779,0.00816144,0.00024852937,0.0053594667,0.029895037],"study_design_scores_gemma":[0.9137139,0.08081796,0.00243045,0.000040603103,0.00040538027,0.000039013343,0.000014586593,0.0005208538,0.00063972385,0.00011793959,0.0012439993,0.000015641132],"about_ca_topic_score_codex":0.0035074947,"about_ca_topic_score_gemma":0.010955871,"teacher_disagreement_score":0.0064187623,"about_ca_system_score_codex":0.0013196837,"about_ca_system_score_gemma":0.0020837807,"threshold_uncertainty_score":0.02147293},"labels":[],"label_agreement":null},{"id":"W2899817298","doi":"10.1093/neuonc/noy148.681","title":"PATH-25. SURVIVAL STRATIFICATION OF IDH MUTANT GLIOMA USING METHYLATION AND mRNA ANALYSIS OF HOX GENES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Food Quality and Safety Studies","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hox gene; Biology; Methylation; Glioma; Gene; Hazard ratio; Cancer research; Genetics; Molecular biology; Oncology; Gene expression; Internal medicine; Medicine; Confidence interval","score_opus":0.08373638907665247,"score_gpt":0.3234200550005184,"score_spread":0.23968366592386592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899817298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732363,0.00021112229,0.0005964108,0.000024716863,0.0000034371367,0.000009504477,0.0013786447,0.00002472099,0.00042772677],"genre_scores_gemma":[0.9973767,0.00006682914,0.0005748714,0.0000083989,0.0000015185145,0.000015613961,0.001554025,0.0000053321373,0.00039670191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991584,0.000017407821,0.0000070522697,0.000021657755,0.000017877408,0.000020193833],"domain_scores_gemma":[0.9998946,0.000030491101,0.000029956092,0.000008689648,0.00001435876,0.000022015136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018349198,0.0001635414,0.00016514212,0.00045373206,0.000110308254,0.00027722973,0.00009886072,0.00009659137,0.00153352],"category_scores_gemma":[0.00029162574,0.000058371865,0.00021251258,0.00022429785,0.00009244299,0.000068559115,0.00018738389,0.00016210561,0.0002948053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020216792,0.000075020886,0.8279654,0.00011945643,0.00015218476,0.00025589223,0.00011670191,0.002050513,0.12684862,0.0001351248,0.0006796599,0.039579898],"study_design_scores_gemma":[0.000016438056,0.00033116844,0.97472894,0.0000058607616,0.000092204966,0.000505774,0.00008034571,0.004504638,0.018412923,0.00018923814,0.0011250564,0.000007482722],"about_ca_topic_score_codex":0.002362446,"about_ca_topic_score_gemma":0.0036252334,"teacher_disagreement_score":0.002362446,"about_ca_system_score_codex":0.00028968017,"about_ca_system_score_gemma":0.00023861199,"threshold_uncertainty_score":0.005130112},"labels":[],"label_agreement":null},{"id":"W2899848229","doi":"10.1093/neuonc/noy148.447","title":"GENE-21. A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PFA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS?","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Phytoplasmas and Hemiptera pathogens","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; McGill University; Hospital for Sick Children; Montreal Children's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Progenitor cell; Ependymoma; Population; Stem cell; Progenitor; Cerebellum; Neuroscience; Cell biology; Pathology","score_opus":0.035206359652087675,"score_gpt":0.26987416264269637,"score_spread":0.2346678029906087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899848229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92171574,0.0038068518,0.018177476,0.00047575368,0.00024523825,0.00014689917,0.04124334,0.0017549042,0.012433654],"genre_scores_gemma":[0.91740096,0.0013720742,0.014582918,0.0005188936,0.000032924756,0.00021579872,0.051826887,0.0007589206,0.01329055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963653,0.000009329776,0.0000183409,0.00019062398,0.00008764351,0.000057513],"domain_scores_gemma":[0.99979717,0.000030357656,0.000062332474,0.000026965505,0.000039074166,0.00004410367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001163853,0.00030229017,0.00037462305,0.00063353137,0.00054690347,0.00071384496,0.0002576146,0.00050006935,0.003667986],"category_scores_gemma":[0.00035288677,0.0002585711,0.00044908572,0.0005608291,0.00028573716,0.00021790357,0.00052252656,0.0005204575,0.0028240385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022817157,0.000017207098,0.016132949,0.00021801329,0.000040178227,0.0011348602,0.00017938143,0.00022969198,0.9582717,0.0006514618,0.0013644167,0.021532044],"study_design_scores_gemma":[0.00004067527,0.0002703676,0.39894253,0.00013078611,0.00025272608,0.014460506,0.00035876138,0.0044709938,0.4418811,0.0011833623,0.1379375,0.00007063892],"about_ca_topic_score_codex":0.0022847143,"about_ca_topic_score_gemma":0.0047897818,"teacher_disagreement_score":0.003667986,"about_ca_system_score_codex":0.00045709562,"about_ca_system_score_gemma":0.00050439074,"threshold_uncertainty_score":0.012270629},"labels":[],"label_agreement":null},{"id":"W2899858004","doi":"10.1093/neuonc/noy148.444","title":"GENE-18. DIVERGENT CLONAL EVOLUTION OF MELANOMA BRAIN METASTASES DURING TREATMENT WITH IMMUNOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Melanoma; CD8; Cancer research; CDKN2A; Immune checkpoint; Tumor microenvironment; Biology; Exome sequencing; Somatic evolution in cancer; Immune system; Medicine; Immunology; Cancer; Gene; Mutation; Internal medicine; Genetics","score_opus":0.024871509586972984,"score_gpt":0.30064076716428056,"score_spread":0.2757692575773076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899858004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685436,0.00024883178,0.0010770528,0.0000439658,0.0000058707838,0.000018525578,0.0010120971,0.000030989344,0.00070835167],"genre_scores_gemma":[0.9959449,0.00010880249,0.0016209072,0.000052174884,0.0000044971707,0.000024763614,0.0015326149,0.000032513304,0.00067882624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998673,0.000014242093,0.0000074811314,0.000042219624,0.000042702795,0.00002605152],"domain_scores_gemma":[0.99979466,0.000042983567,0.00006833544,0.000019411551,0.00004293424,0.000031747462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013188657,0.00014206345,0.00024658832,0.00032220787,0.00018131694,0.00023677158,0.00011165341,0.00021088246,0.0011465581],"category_scores_gemma":[0.00038944697,0.000077018056,0.00020563063,0.00032577265,0.0001301586,0.00008912605,0.00011431724,0.00023393678,0.00028278472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007173713,0.00006300336,0.09636278,0.00009875127,0.00006682706,0.0012367459,0.00023330585,0.0010641192,0.87149537,0.00022246767,0.0005212578,0.027918056],"study_design_scores_gemma":[0.000041579813,0.00077098963,0.74571306,0.000030355815,0.00011424023,0.008013314,0.00019473361,0.006869873,0.23043972,0.0006626508,0.007130785,0.00001862546],"about_ca_topic_score_codex":0.0006947185,"about_ca_topic_score_gemma":0.0013981075,"teacher_disagreement_score":0.0011465581,"about_ca_system_score_codex":0.00024038854,"about_ca_system_score_gemma":0.00015502035,"threshold_uncertainty_score":0.0038356185},"labels":[],"label_agreement":null},{"id":"W2899864286","doi":"10.1093/neuonc/noy148.869","title":"PDTM-28. THE CONTRIBUTION OF PAX GENES AS NOVEL TUMOR SUPPRESSORS IN GROUP 3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Gene silencing; Biology; H3K4me3; Transcription factor; Psychological repression; Gene; Gene knockdown; Cancer research; Medulloblastoma; Tumor progression; Histone; PAX6; Gene expression; Genetics; Promoter","score_opus":0.007132682933297351,"score_gpt":0.2599134212055321,"score_spread":0.2527807382722348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899864286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925413,0.0024600797,0.0014882368,0.00011471657,0.00002321301,0.000036720274,0.0014522569,0.000113737246,0.0017696837],"genre_scores_gemma":[0.9947472,0.00083665265,0.000885514,0.000048661583,0.000006028812,0.000032608394,0.0016496828,0.000021199838,0.0017723258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995553,0.000004147598,0.0000029516073,0.000010110813,0.00001786968,0.000009327166],"domain_scores_gemma":[0.99996626,0.0000049272885,0.0000110512065,0.0000038802705,0.0000028459363,0.000010976567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007238234,0.00018960421,0.00016818978,0.0002181786,0.00014427182,0.00019393908,0.00012646156,0.00016938087,0.00097445183],"category_scores_gemma":[0.000079382626,0.00008656203,0.0002199089,0.00017953363,0.00014176562,0.00007240691,0.00016447455,0.00030876932,0.00026352482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028026768,0.000026170885,0.003502733,0.00007387855,0.000012878217,0.00033063182,0.00003053818,0.0002080041,0.98772055,0.00017329973,0.00022648873,0.0074146003],"study_design_scores_gemma":[0.000119924545,0.0007116169,0.14040174,0.000025058134,0.000113978625,0.0039254604,0.00012611329,0.0030952762,0.8257,0.00048549115,0.025281388,0.000013953072],"about_ca_topic_score_codex":0.00082133966,"about_ca_topic_score_gemma":0.0015636001,"teacher_disagreement_score":0.00097445183,"about_ca_system_score_codex":0.0003127285,"about_ca_system_score_gemma":0.00020653331,"threshold_uncertainty_score":0.0032598376},"labels":[],"label_agreement":null},{"id":"W2899874060","doi":"10.1093/neuonc/noy148.452","title":"GENE-26. MOLECULAR CHARACTERIZATION OF BENIGN AND MALIGNANT PERIPHERAL NERVE SHEATH TUMORS THAT OCCUR IN SPORADIC AND SYNDROMIC SETTINGS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CDKN2A; Neurofibromatosis; Pathology; Neurofibroma; Malignant peripheral nerve sheath tumor; Biology; Plexiform neurofibroma; Cancer research; Medicine; Gene; Genetics","score_opus":0.013398232685898478,"score_gpt":0.26039333330421094,"score_spread":0.24699510061831245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899874060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978555,0.00031299068,0.0005202405,0.000015744938,0.0000028504405,0.0000063914854,0.0006670767,0.000013565829,0.0006057565],"genre_scores_gemma":[0.99637765,0.00013491159,0.0014727514,0.000015992518,0.0000022053148,0.000011203806,0.0011898393,0.0000060171533,0.0007894449],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992406,0.0000054623547,0.000005284192,0.000032945696,0.000019769295,0.000012538668],"domain_scores_gemma":[0.9999014,0.00001543981,0.000037681773,0.00000732079,0.000012626195,0.000025513787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006222334,0.00013284925,0.000105424544,0.00038930462,0.00010930869,0.00014434656,0.000085151725,0.00011670158,0.0012511077],"category_scores_gemma":[0.00018802551,0.000061004488,0.00011496867,0.00024215385,0.00011798747,0.000050131766,0.00008436136,0.00010390652,0.00033136518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026434445,0.000024814033,0.09485268,0.000055862252,0.000029529956,0.00080830837,0.00008710649,0.00020769225,0.89384353,0.00014595635,0.00013614283,0.009544004],"study_design_scores_gemma":[0.000012352598,0.00022711813,0.8587088,0.000009857116,0.000040243638,0.005831736,0.00010457836,0.0014591442,0.12976731,0.0001532042,0.0036801896,0.0000053604936],"about_ca_topic_score_codex":0.0007674064,"about_ca_topic_score_gemma":0.001861489,"teacher_disagreement_score":0.0012511077,"about_ca_system_score_codex":0.00014285622,"about_ca_system_score_gemma":0.00009533333,"threshold_uncertainty_score":0.0041853786},"labels":[],"label_agreement":null},{"id":"W2899883991","doi":"10.1093/neuonc/noy148.844","title":"PDTM-02. STRESS GRANULES ARE INDUCED BY OXIDATIVE STRESS IN PEDIATRIC BRAIN TUMORS AND PREDICT POOR OUTCOME","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxidative stress; Immunohistochemistry; Stress granule; RNA-binding protein; Tissue microarray; Cancer research; Biology; Medicine; Pediatric cancer; Pathology; Internal medicine; Cancer; Messenger RNA; Translation (biology); Gene","score_opus":0.024155818613867112,"score_gpt":0.321844854003722,"score_spread":0.29768903538985486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899883991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423075,0.0012002097,0.00031004366,0.000090850044,0.000006998618,0.000016195701,0.0033851068,0.0000314046,0.0007284755],"genre_scores_gemma":[0.9920853,0.00084062095,0.0007697697,0.000043705,0.000011220134,0.00003355785,0.0058125667,0.000011245008,0.0003920481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984705,0.000018034018,0.000018558047,0.000039576305,0.000045859433,0.000030865383],"domain_scores_gemma":[0.99932456,0.000059345715,0.00045382525,0.000021585436,0.00005264618,0.00008794038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021307904,0.00019754954,0.00021335778,0.000585049,0.00020373309,0.0003802871,0.0001885438,0.00024783186,0.0018560764],"category_scores_gemma":[0.0006035371,0.0000802285,0.00019025597,0.00078759994,0.00015061737,0.00019355152,0.00027101662,0.000327768,0.00040740296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003936742,0.000033627734,0.9869162,0.00006568292,0.000034637862,0.00040803457,0.000032800413,0.00007685971,0.0042047543,0.00004445898,0.00052743626,0.0072618867],"study_design_scores_gemma":[0.000012557544,0.00015622925,0.9883354,0.000028560009,0.00006812209,0.0039883717,0.00014756095,0.00026225077,0.0040602684,0.0000843835,0.002852408,0.000003930964],"about_ca_topic_score_codex":0.001155335,"about_ca_topic_score_gemma":0.0021653355,"teacher_disagreement_score":0.0018560764,"about_ca_system_score_codex":0.00031746126,"about_ca_system_score_gemma":0.00030985303,"threshold_uncertainty_score":0.0062092543},"labels":[],"label_agreement":null},{"id":"W2899925807","doi":"10.1093/neuonc/noy148.421","title":"EXTH-74. MOLECULAR MECHANISMS OF ANTI-TUMOR ACTION OF TTFIELDS DETERMINED BY MEASUREMENTS AND MODELING OF ELECTRO-CONDUCTIVE PROPERTIES OF MICROTUBULES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Microtubule; Tubulin; Materials science; Mitosis; Electrical conductor; Actin; Biophysics; Chemistry; Biology; Cell biology; Composite material","score_opus":0.08775125009070173,"score_gpt":0.2989265778698019,"score_spread":0.2111753277791002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899925807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9209836,0.0007903844,0.060177006,0.00023450273,0.000038681937,0.00004493123,0.00030653575,0.00028394378,0.017140538],"genre_scores_gemma":[0.98749894,0.00037257132,0.0057022064,0.000022621052,0.0000054476195,0.000028362281,0.0001247656,0.000015671163,0.0062295026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997735,0.0000030051326,8.3498554e-7,0.000003898426,0.0000103717975,0.000004542854],"domain_scores_gemma":[0.9999646,0.000011840488,0.0000074820655,0.000003539543,0.0000073649226,0.000005088433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006582967,0.00013182446,0.00008722957,0.000107568856,0.00014045708,0.00019198662,0.00017045521,0.00017023236,0.001975524],"category_scores_gemma":[0.00009626017,0.00006533323,0.00011549797,0.00008383152,0.00021098705,0.00021785952,0.00009210484,0.00017132077,0.00033015021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011814611,0.00006371596,0.0020749997,0.00010185726,0.000011915062,0.00035192317,0.00006172425,0.1164182,0.84804034,0.02040608,0.0005923124,0.01175879],"study_design_scores_gemma":[0.000025789464,0.00022651971,0.0038366928,0.000008855429,0.000010961619,0.00014121027,0.000043589196,0.59306026,0.39250827,0.00489029,0.0052323723,0.000015184894],"about_ca_topic_score_codex":0.0006496549,"about_ca_topic_score_gemma":0.00047582388,"teacher_disagreement_score":0.001975524,"about_ca_system_score_codex":0.00038987971,"about_ca_system_score_gemma":0.00015853324,"threshold_uncertainty_score":0.006608844},"labels":[],"label_agreement":null},{"id":"W2899929689","doi":"10.1093/neuonc/noy148.854","title":"PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Chromatin immunoprecipitation; OLIG2; Histone H3; Cancer research; Histone; Genetics; Promoter; Molecular biology; Gene expression; Gene; Myelin; Oligodendrocyte","score_opus":0.015535951224219677,"score_gpt":0.26876989937306767,"score_spread":0.253233948148848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899929689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974776,0.0018080319,0.0028459313,0.00016026641,0.00003469083,0.00003696759,0.0026657095,0.00017974184,0.0025208807],"genre_scores_gemma":[0.9896588,0.00058241584,0.0013225431,0.00008927179,0.000006344149,0.000055765373,0.0025365262,0.0000445303,0.005703862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999155,0.0000079124065,0.00000460104,0.00003178335,0.000021387614,0.00001886383],"domain_scores_gemma":[0.999961,0.0000055545142,0.000011199643,0.0000033423,0.000003791825,0.000015106712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063320615,0.0001425059,0.00016020755,0.00013596241,0.00012633645,0.00021647035,0.00011718957,0.00016181343,0.0027280464],"category_scores_gemma":[0.000059315582,0.00009833552,0.00013003183,0.000116639625,0.00017991578,0.00006812305,0.00014833282,0.00038363817,0.00061964936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025324745,0.000025222584,0.001339603,0.000052745094,0.0000030905935,0.00012924551,0.000025824636,0.00008513272,0.99534434,0.000103384285,0.00014616706,0.0024920616],"study_design_scores_gemma":[0.000037656202,0.00030031204,0.057414833,0.000012841529,0.000016214693,0.0011596024,0.000100923644,0.0008312491,0.92835957,0.00007233759,0.011689153,0.000005258997],"about_ca_topic_score_codex":0.0010541431,"about_ca_topic_score_gemma":0.0021500345,"teacher_disagreement_score":0.0027280464,"about_ca_system_score_codex":0.00035874842,"about_ca_system_score_gemma":0.00023545664,"threshold_uncertainty_score":0.009126246},"labels":[],"label_agreement":null},{"id":"W2899933904","doi":"10.1093/neuonc/noy148.261","title":"COMP-06. GLIOBLASTOMA DEVELOPMENT MIRRORS THE DEVELOPING BRAIN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Progenitor cell; Biology; Cancer research; Population; Cell; Progenitor; Lineage (genetic); Cancer stem cell; Glioma; Stem cell; Mesenchymal stem cell; Neuroscience; Cell biology; Genetics; Gene; Medicine","score_opus":0.026337220604852916,"score_gpt":0.3245071122679938,"score_spread":0.29816989166314084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899933904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55559593,0.0037709838,0.016787281,0.0022936347,0.00048372272,0.00053070846,0.15648983,0.014850569,0.24919729],"genre_scores_gemma":[0.6318346,0.0023217462,0.043394707,0.0013469106,0.00012226467,0.0007708008,0.193577,0.0034338033,0.12319817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998499,0.000017335291,0.000008734073,0.00004468254,0.00005535382,0.000024045807],"domain_scores_gemma":[0.99972934,0.000032256896,0.000038479342,0.000031329553,0.00006463761,0.00010400913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021641215,0.00046410196,0.00018806227,0.0007138528,0.0003381061,0.0007927015,0.000399059,0.00044627624,0.03535071],"category_scores_gemma":[0.00027869365,0.00017680498,0.00021091745,0.0006966342,0.0002958784,0.00020393735,0.00038044102,0.00041012146,0.018683298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004883882,0.00065036473,0.06951968,0.0007014206,0.000096563366,0.002455164,0.0003347323,0.0019977165,0.59448105,0.00756831,0.10930901,0.20800205],"study_design_scores_gemma":[0.00039714624,0.0014684291,0.19173963,0.0001223835,0.000089872614,0.010145809,0.00025251397,0.0046968535,0.25963625,0.0033659043,0.5280196,0.00006562892],"about_ca_topic_score_codex":0.0037129212,"about_ca_topic_score_gemma":0.006153024,"teacher_disagreement_score":0.03535071,"about_ca_system_score_codex":0.000531634,"about_ca_system_score_gemma":0.0009277995,"threshold_uncertainty_score":0.11825991},"labels":[],"label_agreement":null},{"id":"W2899936404","doi":"10.1093/neuonc/noy148.1177","title":"CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA <i>IN VITRO</i> AND <i>IN VIVO</i>","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Glioma; Ketoconazole; In vivo; Glycolysis; Apoptosis; Gene knockdown; Chemistry; Cancer research; In vitro; Angiogenesis; Biology; Pharmacology; Biochemistry; Metabolism","score_opus":0.009128024869980739,"score_gpt":0.27746871025280667,"score_spread":0.26834068538282596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899936404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96104115,0.012555962,0.0077035427,0.0003628626,0.00009506456,0.0006987469,0.010768504,0.000384291,0.006389815],"genre_scores_gemma":[0.9594475,0.0078012967,0.0105067715,0.00024043427,0.000028173796,0.00042732662,0.017091027,0.00004859016,0.0044089416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998005,0.00003553764,0.000019873629,0.000042114905,0.000063661995,0.000038301067],"domain_scores_gemma":[0.9999026,0.000014192726,0.00001742392,0.00000946049,0.000037722337,0.00001869378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002666324,0.0005091784,0.0006789151,0.00070620805,0.0002486079,0.00036215238,0.0003780637,0.0002922077,0.0015318036],"category_scores_gemma":[0.00021644392,0.00017058967,0.00042267746,0.0006420696,0.00016660924,0.00018360205,0.0001729727,0.00038054533,0.000505873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006832295,0.00027679448,0.0012446201,0.00022810875,0.00004396565,0.00015053936,0.000021498787,0.00095419725,0.9783518,0.00013842438,0.00062226487,0.017284626],"study_design_scores_gemma":[0.00023062693,0.0025127768,0.009164568,0.000022066542,0.0001331918,0.0003207069,0.000027357435,0.0024252085,0.9769124,0.000042636475,0.008191557,0.000016939735],"about_ca_topic_score_codex":0.0022050815,"about_ca_topic_score_gemma":0.004381398,"teacher_disagreement_score":0.0022050815,"about_ca_system_score_codex":0.00047355832,"about_ca_system_score_gemma":0.00040722065,"threshold_uncertainty_score":0.00512439},"labels":[],"label_agreement":null},{"id":"W2899936890","doi":"10.1093/neuonc/noy148.599","title":"INNV-28. EXTENT OF RESECTION IN NEWLY DIAGNOSED GLIOBLASTOMA: INCORPORATING CLINICAL AND MOLECULAR DATA TO PREDICT OUTCOME","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Shared Health; University of Manitoba","funders":"","keywords":"Glioblastoma; Medicine; Oncology; Proportional hazards model; Internal medicine; Overall survival; IDH1; Retrospective cohort study; Surgical resection; Surgery; Mutant; Cancer research; Gene; Biology","score_opus":0.07195302820360715,"score_gpt":0.38967579637823563,"score_spread":0.31772276817462847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899936890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406826,0.0005174972,0.0035321156,0.00017957416,0.000023813283,0.000019108562,0.0010178908,0.000051673975,0.00058998395],"genre_scores_gemma":[0.99787796,0.00008219959,0.0010435836,0.000013835035,0.0000089849,0.000014403787,0.00059285,0.0000134184065,0.000352658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993062,0.00040777805,0.000040134408,0.00010073569,0.000078278455,0.000066835935],"domain_scores_gemma":[0.9983316,0.00089842035,0.00039744924,0.00009689715,0.00009352768,0.00018207071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022227725,0.00048505247,0.00047391752,0.00047134372,0.00012373934,0.0004804092,0.000442736,0.00025717262,0.0010911438],"category_scores_gemma":[0.0044837636,0.00017196774,0.0007235831,0.00039033993,0.00016103551,0.00031928212,0.0005469655,0.00058271334,0.00024434508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002072548,0.00009057581,0.96468985,0.00004773374,0.0004861764,0.00008562071,0.000038124443,0.01218803,0.00062386965,0.00014331471,0.0004102972,0.019123763],"study_design_scores_gemma":[0.00010261796,0.0016237433,0.84449494,0.00003546483,0.00069003226,0.00032365258,0.00010223222,0.14746477,0.0015690174,0.001282637,0.0022780157,0.00003290563],"about_ca_topic_score_codex":0.0075065196,"about_ca_topic_score_gemma":0.013475386,"teacher_disagreement_score":0.0075065196,"about_ca_system_score_codex":0.0005788802,"about_ca_system_score_gemma":0.00081057765,"threshold_uncertainty_score":0.014925659},"labels":[],"label_agreement":null},{"id":"W2899994584","doi":"10.1093/neuonc/noy148.543","title":"IMMU-40. SINGLE-CELL LEVEL COMPARISON OF HISTOPATHOLOGY AND SINGLE-CELL RNA-SEQ DATABASES BETWEEN IDH-MUT AND –WT GLIOBLASTOMAS REVEALS DISTINCT INNATE IMMUNE MICROENVIRONMENTS THAT CAN BE EXPLOITED FOR THERAPEUTIC GAIN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Flow cytometry; Immune system; CD163; Biology; Glioma; Innate immune system; Cell; Microglia; Immunotherapy; CD68; Cancer research; Inflammation; Molecular biology; Phenotype; Immunology; Immunohistochemistry; Gene; Genetics","score_opus":0.08957499304302995,"score_gpt":0.29645322495828164,"score_spread":0.20687823191525168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899994584","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21937077,0.006012302,0.13103361,0.0009092536,0.0010728125,0.0011228768,0.55655324,0.06627878,0.017646356],"genre_scores_gemma":[0.2610214,0.0021815298,0.28429145,0.0018506601,0.0002608386,0.0072551207,0.4223976,0.013466432,0.007274873],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99721426,0.00028888468,0.00022056409,0.0013456639,0.000678156,0.0002524888],"domain_scores_gemma":[0.9991547,0.0002929143,0.0001908558,0.0001330018,0.00013088624,0.000097662734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038644443,0.0017358433,0.002079183,0.0024150007,0.0015169544,0.0027058406,0.001434676,0.0012512548,0.008875495],"category_scores_gemma":[0.0027897167,0.0012703538,0.0015358033,0.0022785293,0.00096221204,0.0008256508,0.00200616,0.0015681351,0.0065097567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062107835,0.00061624596,0.030396579,0.00863396,0.002300154,0.00066623493,0.0027569174,0.007885683,0.77401936,0.0069830976,0.0887164,0.07081465],"study_design_scores_gemma":[0.0010090307,0.0019255147,0.095618255,0.0007762944,0.0010708474,0.001432836,0.0008782409,0.0972211,0.56220484,0.012216037,0.22513881,0.0005082481],"about_ca_topic_score_codex":0.0023212966,"about_ca_topic_score_gemma":0.006061321,"teacher_disagreement_score":0.008875495,"about_ca_system_score_codex":0.0011905165,"about_ca_system_score_gemma":0.0016450909,"threshold_uncertainty_score":0.029691458},"labels":[],"label_agreement":null},{"id":"W2899995714","doi":"10.1093/neuonc/noy148.039","title":"ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Chemoradiotherapy; Hazard ratio; Regimen; Population; Glioma; Clinical endpoint; Radiation therapy; Phases of clinical research; Chemotherapy; Confidence interval; Clinical trial","score_opus":0.030644769724216588,"score_gpt":0.35519731503702423,"score_spread":0.32455254531280764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899995714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959085,0.0010720358,0.00039889058,0.0001952,0.00006567584,0.00080972526,0.00086107966,0.00005447975,0.00063447515],"genre_scores_gemma":[0.98632973,0.0011122101,0.0020027305,0.00081244716,0.00018173759,0.0017965428,0.004791217,0.00006117558,0.0029121458],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990645,0.00061437936,0.000036787886,0.00010186506,0.00008431792,0.00009815746],"domain_scores_gemma":[0.9987556,0.00016142747,0.00033385606,0.00015975004,0.00009028339,0.00049920654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034545232,0.0013902321,0.0015004642,0.00046272107,0.00036275692,0.00088395044,0.0009927239,0.0009722919,0.0021171474],"category_scores_gemma":[0.0014279227,0.00044718754,0.0011609409,0.00039414046,0.00086257036,0.00054370257,0.00029881243,0.0024093552,0.00097207516],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6024515,0.1424731,0.031229138,0.0006584503,0.0028280336,0.00041258868,0.00034067797,0.003925368,0.080659576,0.00020447306,0.007993814,0.12682322],"study_design_scores_gemma":[0.21578899,0.7255821,0.041493077,0.0000389627,0.0011059062,0.0005396646,0.00006770795,0.0015273954,0.009533222,0.00015286349,0.0041275583,0.00004253124],"about_ca_topic_score_codex":0.0010693789,"about_ca_topic_score_gemma":0.0024424829,"teacher_disagreement_score":0.0034545232,"about_ca_system_score_codex":0.0008772564,"about_ca_system_score_gemma":0.0014159132,"threshold_uncertainty_score":0.01826948},"labels":[],"label_agreement":null},{"id":"W2900003524","doi":"10.1093/neuonc/noy148.311","title":"DRES-04. CHARACTERIZATION OF A MODEL OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; MLH1; MSH2; Cancer research; Methyltransferase; Downregulation and upregulation; DNA repair; Homologous recombination; Biology; DNA mismatch repair; O-6-methylguanine-DNA methyltransferase; Thiostrepton; Glioblastoma; Gene; Genetics; Methylation","score_opus":0.023196527109781984,"score_gpt":0.29343457948954754,"score_spread":0.27023805237976556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900003524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912493,0.0005899568,0.0037569327,0.00018003462,0.00003647603,0.00010687847,0.0017863946,0.00014291763,0.0021511319],"genre_scores_gemma":[0.9779202,0.0007523806,0.0071661253,0.00013394552,0.0000070528718,0.00015320741,0.0051759924,0.00006286156,0.008628316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985135,0.000023177272,0.000016086948,0.00002769056,0.000045202927,0.000036467172],"domain_scores_gemma":[0.9999058,0.000011559106,0.000021740894,0.000015029491,0.00001386479,0.00003205964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018920709,0.0003083704,0.00029516924,0.00039113092,0.00018688338,0.00024308055,0.00047471235,0.00032472517,0.0016799899],"category_scores_gemma":[0.00012830686,0.00014642724,0.00033991438,0.0002589414,0.00015865482,0.00015374612,0.0001887098,0.0005868149,0.00059041014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006639475,0.00007413648,0.00018178626,0.000017004977,0.0000034319478,0.00007601844,0.000013400034,0.00010369355,0.99855024,0.00012508317,0.000078114725,0.00071061717],"study_design_scores_gemma":[0.00004657186,0.0016252657,0.007826097,0.000009317676,0.000021368867,0.0007144233,0.00008372764,0.004273823,0.9783117,0.00011064534,0.006966186,0.000011034938],"about_ca_topic_score_codex":0.00467269,"about_ca_topic_score_gemma":0.0048000757,"teacher_disagreement_score":0.00467269,"about_ca_system_score_codex":0.00065509387,"about_ca_system_score_gemma":0.00032674184,"threshold_uncertainty_score":0.009290934},"labels":[],"label_agreement":null},{"id":"W2900009291","doi":"10.1093/neuonc/noy148.1136","title":"TMOD-24. PATIENT-DERIVED BRAIN TUMOUR IPSCS: MODELS FOR INVESTIGATING GLIOMA STEMNESS AND DRUG DISCOVERY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Induced pluripotent stem cell; Glioma; Biology; SOX2; Cancer research; Neural stem cell; Organoid; Cancer stem cell; Cellular differentiation; Stem cell; Cell biology; Embryonic stem cell; Gene; Genetics","score_opus":0.034616086691377314,"score_gpt":0.29531819122035763,"score_spread":0.2607021045289803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900009291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391037,0.009909215,0.07034677,0.0010296243,0.0005207345,0.001278847,0.05137759,0.0032341133,0.023199374],"genre_scores_gemma":[0.88997895,0.0062173535,0.030425295,0.00046019716,0.000056810106,0.0014173543,0.042806838,0.00060807297,0.028029116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955875,0.000055651002,0.000056427627,0.00009093883,0.00017900199,0.000059227757],"domain_scores_gemma":[0.99977547,0.000039929175,0.00005603751,0.000049287755,0.000035724897,0.00004359954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006509443,0.00050595065,0.00056174025,0.0006678658,0.00030474865,0.00080448284,0.00056170597,0.0008437619,0.0043198736],"category_scores_gemma":[0.00029556543,0.0002627123,0.00055776286,0.0005720232,0.00035352388,0.0003332778,0.00040547075,0.0014930598,0.0024886748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003354212,0.00016289746,0.0007125383,0.00031580936,0.00004048081,0.0005935569,0.00011831337,0.0010027231,0.97898716,0.0011194235,0.002002843,0.014608818],"study_design_scores_gemma":[0.00006682747,0.00077591086,0.0036524793,0.000045637877,0.00010413462,0.0025450906,0.00006878212,0.0025890558,0.9456381,0.0005590201,0.04392372,0.000031190193],"about_ca_topic_score_codex":0.0010762833,"about_ca_topic_score_gemma":0.0014252729,"teacher_disagreement_score":0.0043198736,"about_ca_system_score_codex":0.00043485887,"about_ca_system_score_gemma":0.0004343925,"threshold_uncertainty_score":0.014451444},"labels":[],"label_agreement":null},{"id":"W2900131948","doi":"10.1093/neuonc/noy148.916","title":"QOLP-30. SURVIVAL, LOCAL CONTROL, AND HEALTH RELATED QUALITY OF LIFE IN OLIGOMETASTATIC AND POLYMETASTATIC SPINAL TUMORS: A MULTICENTER, INTERNATIONAL STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Toronto Western Hospital; McGill University; Montreal General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Spinal cord compression; Disease; Internal medicine; Spinal disease; Oncology; Performance status; Physical therapy; Spinal cord; Cancer; Surgery; Lumbar","score_opus":0.06468878878732995,"score_gpt":0.39163280597127836,"score_spread":0.3269440171839484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900131948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983991,0.00037071024,0.00010079948,0.000029744593,0.000006007367,0.00004815567,0.0006600971,0.000003051597,0.00038235547],"genre_scores_gemma":[0.9982686,0.000121409736,0.00017913122,0.000035249992,0.000012707908,0.0000898472,0.0010742268,0.000002814584,0.00021597027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939907,0.00027711273,0.000047508012,0.0001150447,0.0000920003,0.00006923782],"domain_scores_gemma":[0.99813145,0.00023998355,0.000997515,0.00009307173,0.00012582114,0.00041230893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019393684,0.0005156843,0.00038853253,0.0007918476,0.0002808269,0.00046180742,0.0003206958,0.00032019845,0.00096472545],"category_scores_gemma":[0.0019538195,0.00025226513,0.0006097043,0.0011343354,0.00031374773,0.00052294607,0.0006683649,0.00061871135,0.000260922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002634502,0.000435563,0.9929242,0.000038139682,0.00030869772,0.000067345165,0.00010786067,0.00015612457,0.00029170138,0.000033470253,0.00021543876,0.002786899],"study_design_scores_gemma":[0.00022968811,0.0015456278,0.9969699,0.000009804068,0.00009236092,0.00027529182,0.00011306512,0.00025457662,0.000064151514,0.000026222362,0.00041389288,0.000005389243],"about_ca_topic_score_codex":0.0013641482,"about_ca_topic_score_gemma":0.0011670253,"teacher_disagreement_score":0.0019393684,"about_ca_system_score_codex":0.00026219082,"about_ca_system_score_gemma":0.0002771066,"threshold_uncertainty_score":0.010256469},"labels":[],"label_agreement":null},{"id":"W2900133207","doi":"10.1093/neuonc/noy148.1135","title":"TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Chemoradiotherapy; Radiation therapy; Somatic evolution in cancer; Oncology; Glioblastoma; Medicine; Stem cell; Biology; Cancer research; Bioinformatics; Internal medicine; Cancer; Genetics","score_opus":0.013840688834285457,"score_gpt":0.3489778122568107,"score_spread":0.3351371234225252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953022,0.00069577276,0.0015509856,0.000050331284,0.000011103729,0.000024644054,0.0005648544,0.00009601411,0.0017040973],"genre_scores_gemma":[0.99668485,0.0003201269,0.0011545569,0.000049660714,0.0000030274773,0.000034158333,0.0004970902,0.00002002643,0.0012366687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988747,0.000011184838,0.0000062248305,0.000025565067,0.00004125865,0.000028342567],"domain_scores_gemma":[0.9999026,0.000012681479,0.000028120956,0.00000958838,0.00002673012,0.000020316767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011430436,0.00009338891,0.00016543479,0.0002294555,0.00011271201,0.00028601705,0.000107059655,0.00013788097,0.0010036262],"category_scores_gemma":[0.00019989964,0.00007821859,0.00011073349,0.00016486694,0.0001173158,0.00011179371,0.00010827967,0.00023025193,0.00019279284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018301432,0.000033819397,0.003064377,0.00003498624,0.000011107279,0.000049927614,0.000042235435,0.000741974,0.9820448,0.00017105877,0.00025114746,0.013371552],"study_design_scores_gemma":[0.000015433146,0.00086478255,0.05716649,0.000009421308,0.00003642633,0.0004596162,0.00008488871,0.0062314835,0.9284951,0.00014887739,0.006473214,0.00001425227],"about_ca_topic_score_codex":0.0019310077,"about_ca_topic_score_gemma":0.0029947604,"teacher_disagreement_score":0.0019310077,"about_ca_system_score_codex":0.00039864017,"about_ca_system_score_gemma":0.00018196936,"threshold_uncertainty_score":0.0038395524},"labels":[],"label_agreement":null},{"id":"W2900133605","doi":"10.1093/neuonc/noy148.1115","title":"TMOD-02. DIFFUSE GLIOMATOSIS IN MOUSE MODEL OF GFAP TISSUE SPECIFIC KNOCK IN OF EGFRvIII AND KNOCK OUT OF p19 ARF","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pathology; Immunohistochemistry; Biology; NeuN; Synaptophysin; Glioma; Nestin; Glial fibrillary acidic protein; Genetically modified mouse; Parenchyma; Leptomeninges; Cancer research; Transgene; Medicine; Neural stem cell; Stem cell; Central nervous system; Cell biology","score_opus":0.07303066409905097,"score_gpt":0.3795410821435967,"score_spread":0.30651041804454576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97815233,0.0013312876,0.0075635244,0.0005417008,0.00015411462,0.0004657431,0.0035390463,0.00077957025,0.007472705],"genre_scores_gemma":[0.9389736,0.0018116758,0.010928013,0.00030158594,0.000047064572,0.0010663392,0.006028277,0.00017103345,0.04067247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996629,0.000040431027,0.00003645741,0.000087987515,0.000086472515,0.0000856699],"domain_scores_gemma":[0.99981135,0.000014578101,0.000052819913,0.000027084525,0.000015352689,0.00007889096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033945288,0.0011119144,0.00044737768,0.0011956817,0.00044533898,0.0004421333,0.00048535332,0.0010809524,0.003891679],"category_scores_gemma":[0.000100657635,0.00042885653,0.0005334693,0.0004728835,0.0005273231,0.000447821,0.0003366261,0.0016095594,0.0015889866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045063082,0.0006928812,0.00044931637,0.000078521916,0.000015080535,0.00066914177,0.00006484546,0.00013662766,0.99368906,0.0007946543,0.00043820325,0.0025210434],"study_design_scores_gemma":[0.0003627706,0.0050875642,0.005491206,0.000042142106,0.000067743036,0.0052125975,0.00010399927,0.0019824698,0.9617216,0.00040960548,0.019495161,0.000023099677],"about_ca_topic_score_codex":0.00081077195,"about_ca_topic_score_gemma":0.0015233431,"teacher_disagreement_score":0.003891679,"about_ca_system_score_codex":0.00054982444,"about_ca_system_score_gemma":0.00040866635,"threshold_uncertainty_score":0.013018966},"labels":[],"label_agreement":null},{"id":"W2900138717","doi":"10.1093/neuonc/noy148.125","title":"CBMT-06. LOWER GRADE ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS METABOLICALLY MIMICKING GLIOBLASTOMA (GBM) EXPRESS HIGHER R:S 2-HYDROXYGLUTARATE RATIOS RELATIVE TO NON-GBM-MIMICKING IDH MUTANT GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Glioma; Cancer research; Mutant; Wild type; Carcinogenesis; Metabolic pathway; Biology; Chemistry; Metabolism; Internal medicine; Medicine; Enzyme; Cancer; Biochemistry; Gene","score_opus":0.014793151684431263,"score_gpt":0.2784057015416299,"score_spread":0.2636125498571987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900138717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914103,0.000968621,0.0010461052,0.00019849328,0.00005505329,0.00012491956,0.0030640545,0.00026895708,0.002863491],"genre_scores_gemma":[0.9845599,0.0005330297,0.0024315715,0.00018483713,0.000011338607,0.0001599048,0.008357874,0.00004660663,0.0037148765],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982375,0.000017106138,0.000013227553,0.000041615138,0.00006437075,0.00003992155],"domain_scores_gemma":[0.99986684,0.000013033726,0.000025028345,0.000016312011,0.000018477002,0.000060284347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014902068,0.000313516,0.0003867353,0.00039470033,0.0002674841,0.00032602184,0.00029161712,0.0003380595,0.002245313],"category_scores_gemma":[0.00022796394,0.00012794838,0.00018834202,0.00041812213,0.00023711045,0.00016651061,0.00015767604,0.00071430363,0.00062801444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019441792,0.0005316375,0.0057996875,0.00009658322,0.000032293407,0.00023893932,0.00003062959,0.00025742094,0.98006856,0.00018307642,0.0010201265,0.009796829],"study_design_scores_gemma":[0.00031596347,0.005369924,0.07228509,0.000023011045,0.00009235297,0.0030746288,0.00007659683,0.002345928,0.9019566,0.00022532305,0.01421305,0.000021522334],"about_ca_topic_score_codex":0.0039080167,"about_ca_topic_score_gemma":0.005422053,"teacher_disagreement_score":0.0039080167,"about_ca_system_score_codex":0.00044740306,"about_ca_system_score_gemma":0.0005376201,"threshold_uncertainty_score":0.0077705383},"labels":[],"label_agreement":null},{"id":"W2900142401","doi":"10.1093/neuonc/noy148.1067","title":"TMIC-07. HYPOXIC MICROENVIRONMENT CONFERS SPECIFIC ALTERATIONS IN DNA METHYLATION PROFILES IN GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Biology; Laser capture microdissection; Epigenetics; Cancer research; Glioma; Methylation; HIF1A; microRNA; Tumor microenvironment; CpG site; Angiogenesis; Hypoxia (environmental); Wnt signaling pathway; Epigenomics; Microdissection; Pathology; Gene expression; Gene; Medicine; Genetics; Chemistry","score_opus":0.016941690571771587,"score_gpt":0.27359170109626674,"score_spread":0.25665001052449515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900142401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971308,0.00019086033,0.00030883227,0.000027485106,0.0000054496254,0.000012100432,0.0011422884,0.000041603547,0.001140505],"genre_scores_gemma":[0.9951302,0.0001429204,0.00040921557,0.000033634697,0.0000027046592,0.000031828327,0.002866398,0.000014830695,0.0013682628],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991274,0.000008951758,0.0000054909397,0.000017021846,0.00002322237,0.000032601336],"domain_scores_gemma":[0.99993503,0.0000058521387,0.000016433702,0.0000053833564,0.0000074864265,0.0000297753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009245242,0.00012661068,0.0002127242,0.0003023559,0.00014293962,0.0001606311,0.00008471979,0.00011604144,0.002456906],"category_scores_gemma":[0.00012872671,0.000091041176,0.0001240775,0.00024011549,0.00012565967,0.00003967879,0.00011324421,0.00018768858,0.00036950083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009686929,0.00007945648,0.01286171,0.00003920939,0.00001696424,0.0001461845,0.000063007865,0.00015142487,0.979814,0.00007850847,0.00049818214,0.005282756],"study_design_scores_gemma":[0.000056293775,0.001972935,0.6105507,0.000014733113,0.00008614184,0.0016804768,0.00019226132,0.0021817489,0.3788851,0.00014616137,0.004219172,0.000014345859],"about_ca_topic_score_codex":0.0026615986,"about_ca_topic_score_gemma":0.0051523615,"teacher_disagreement_score":0.0026615986,"about_ca_system_score_codex":0.00020391014,"about_ca_system_score_gemma":0.0002625265,"threshold_uncertainty_score":0.0082191825},"labels":[],"label_agreement":null},{"id":"W2900174653","doi":"10.1093/neuonc/noy148.1174","title":"CADD-35. THE DEVELOPMENT OF PERSONALIZED CAM AVATAR MODEL TO PREDICT CHEMOTHERAPEUTIC DRUG SENSITIVITY/RESISTANCE OF GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"In ovo; Medicine; Glioma; Ex vivo; Temozolomide; In vivo; Oncology; Chorioallantoic membrane; Drug; Precision medicine; Personalized medicine; Cancer research; Internal medicine; Pathology; Bioinformatics; Pharmacology; Biology; Embryo; Angiogenesis","score_opus":0.014827514702109407,"score_gpt":0.288236127921865,"score_spread":0.27340861321975557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900174653","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8880635,0.004589399,0.09349365,0.00039723978,0.00017465361,0.0002940504,0.004989762,0.0014918016,0.006505829],"genre_scores_gemma":[0.9543295,0.001633961,0.036086712,0.00011344717,0.000017382878,0.00020504676,0.003880019,0.00010457703,0.0036293366],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999731,0.000034432538,0.000017787666,0.00007714447,0.00009956671,0.00004017518],"domain_scores_gemma":[0.99985766,0.000032528762,0.000038369908,0.000016833877,0.00002513688,0.000029430847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003877834,0.00050684076,0.00037528135,0.00081885926,0.00020613533,0.00047153587,0.00037686166,0.00061165274,0.0018186034],"category_scores_gemma":[0.00028645946,0.00032204817,0.00042282394,0.00035123012,0.00025380068,0.00027902625,0.00024377658,0.00082116126,0.000620663],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027073442,0.00013760487,0.0019033765,0.00014391726,0.000025118208,0.00013015301,0.00006778548,0.003226351,0.9828909,0.0009236825,0.00069919816,0.009581149],"study_design_scores_gemma":[0.000091607544,0.0009619621,0.009567827,0.000036113146,0.00014959591,0.001054129,0.00007393771,0.06971353,0.8984171,0.0006641106,0.019196142,0.00007398716],"about_ca_topic_score_codex":0.002793282,"about_ca_topic_score_gemma":0.0019754432,"teacher_disagreement_score":0.002793282,"about_ca_system_score_codex":0.0005078026,"about_ca_system_score_gemma":0.00029225924,"threshold_uncertainty_score":0.0060837865},"labels":[],"label_agreement":null},{"id":"W2900191363","doi":"10.1093/neuonc/noy148.939","title":"RTHP-07. TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Oncology; Cohort; Medicine; Internal medicine; Transcription factor; Gene signature; Radiation therapy; Adjuvant; Cancer research; Gene; Biology; Gene expression; Genetics","score_opus":0.03312960050686395,"score_gpt":0.2854135150547225,"score_spread":0.2522839145478586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900191363","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40204683,0.0011129928,0.030555546,0.0015056265,0.00027253144,0.00033195125,0.53803045,0.017833872,0.00831017],"genre_scores_gemma":[0.59116155,0.0004949937,0.034213327,0.0004077816,0.00013223803,0.001013427,0.36139217,0.002803409,0.008381175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966085,0.00007663224,0.000016947091,0.00014446356,0.000055287852,0.00004583087],"domain_scores_gemma":[0.99904567,0.00049246545,0.00016500105,0.00011502101,0.00008531495,0.000096549746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088920904,0.00067287206,0.00048147322,0.00071515405,0.0002864996,0.0008385441,0.00087711465,0.0005196052,0.024074808],"category_scores_gemma":[0.0033509969,0.00041215934,0.0012620991,0.00050226133,0.00021694125,0.00048915675,0.0009168809,0.00071620545,0.004093006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046245786,0.00033789175,0.42884892,0.0018852748,0.0021987949,0.00087782386,0.001164044,0.0408959,0.016970742,0.0036551415,0.3425592,0.15598172],"study_design_scores_gemma":[0.0015805797,0.0026538277,0.53004104,0.00032767226,0.0019611488,0.0037928957,0.000674389,0.24762467,0.023623886,0.017467069,0.17000283,0.00024999032],"about_ca_topic_score_codex":0.005727006,"about_ca_topic_score_gemma":0.011248776,"teacher_disagreement_score":0.024074808,"about_ca_system_score_codex":0.00048128713,"about_ca_system_score_gemma":0.000824102,"threshold_uncertainty_score":0.08053833},"labels":[],"label_agreement":null},{"id":"W2900192395","doi":"10.1093/neuonc/noy148.168","title":"CSIG-02. VAL-083 INHIBITS PROLIFERATION OF A PANEL OF EIGHT GLIOBLASTOMA STEM CELL LINES: DOWNREGULATION OF BDR4 AS A NOVEL ANTI-NEOPLASTIC MECHANISM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Neurosphere; Cancer research; Stem cell; OLIG2; Cell growth; Downregulation and upregulation; Biology; Cyclin D1; Stem cell marker; Nestin; Cell cycle; Chemistry; Neural stem cell; Cell biology; Cellular differentiation; Cell; Oligodendrocyte; Biochemistry; Gene","score_opus":0.01570420584508861,"score_gpt":0.2522941678922644,"score_spread":0.23658996204717578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900192395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955388,0.0008996288,0.0005022919,0.00012533189,0.000021408086,0.000045449164,0.00094807707,0.00011231636,0.0018067226],"genre_scores_gemma":[0.9933816,0.0006581018,0.0013961876,0.00011168578,0.000004922209,0.000065257846,0.0026515436,0.000016892596,0.0017137406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992144,0.000011962966,0.000007740136,0.00001287224,0.000025380095,0.000020529567],"domain_scores_gemma":[0.9999639,0.000004515749,0.000006576896,0.0000051585243,0.000005316698,0.000014483177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001030799,0.00030540163,0.00032060195,0.00020657034,0.00012893678,0.00026059707,0.00027548286,0.00023933429,0.0014181081],"category_scores_gemma":[0.00006789852,0.000102361526,0.00027332242,0.00030054414,0.00019263868,0.00008632396,0.00012847067,0.00064701674,0.0004374405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005990182,0.00026820198,0.0005333823,0.00007253726,0.00002095344,0.000063142565,0.000025928512,0.00025088305,0.9907363,0.00008253205,0.00040858495,0.0069386084],"study_design_scores_gemma":[0.00023773624,0.0032049066,0.010765773,0.0000073820543,0.000058985883,0.00049724267,0.000042330797,0.0015324014,0.97813475,0.000045967176,0.0054627997,0.000009696932],"about_ca_topic_score_codex":0.0015847001,"about_ca_topic_score_gemma":0.0032600749,"teacher_disagreement_score":0.0015847001,"about_ca_system_score_codex":0.00033656403,"about_ca_system_score_gemma":0.00039144332,"threshold_uncertainty_score":0.004744053},"labels":[],"label_agreement":null},{"id":"W2900244736","doi":"10.1093/neuonc/noy148.343","title":"EPID-16. CONSIDERATIONS FOR A SURGICAL RCT IN LOW-GRADE GLIOMAS: A SURVEY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Randomized controlled trial; Medicine; Observational study; Randomization; Clinical equipoise; Clinical endpoint; Specialty; Oncology; Internal medicine; Family medicine","score_opus":0.0687747390986135,"score_gpt":0.3640701691860082,"score_spread":0.29529543008739473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900244736","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28716317,0.005543039,0.033560697,0.288527,0.004622912,0.1468776,0.089869924,0.0042759962,0.13955966],"genre_scores_gemma":[0.34359506,0.0048402804,0.1068725,0.12840319,0.0015883447,0.37898546,0.015648788,0.0009652711,0.019101134],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.8939711,0.07346704,0.01941148,0.0017247335,0.007181525,0.004244149],"domain_scores_gemma":[0.6769604,0.23949467,0.028929621,0.0110913105,0.027962202,0.015561773],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17942166,0.0006324391,0.0012484916,0.0019214583,0.0015590072,0.0047610234,0.0011437513,0.0041924044,0.035825986],"category_scores_gemma":[0.24713326,0.0009802287,0.0017294119,0.0021626912,0.0015477659,0.006122331,0.0056150793,0.004246934,0.01043647],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007668556,0.0030145706,0.11143113,0.02190051,0.0003472517,0.0009008849,0.013750577,0.0011544668,0.0023438095,0.011264859,0.43883738,0.387386],"study_design_scores_gemma":[0.0041785385,0.005912309,0.1169272,0.010856712,0.00020370744,0.00054884376,0.010941257,0.0018628886,0.0015269734,0.009460556,0.8373464,0.00023471865],"about_ca_topic_score_codex":0.00061634,"about_ca_topic_score_gemma":0.0010893776,"teacher_disagreement_score":0.82057834,"about_ca_system_score_codex":0.00478127,"about_ca_system_score_gemma":0.012599706,"threshold_uncertainty_score":0.9488838},"labels":[],"label_agreement":null},{"id":"W2900256197","doi":"10.1093/neuonc/noy148.060","title":"ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Internal medicine; Phases of clinical research; Radiation therapy; Clinical trial; Cancer research; Chemotherapy","score_opus":0.015300275342520006,"score_gpt":0.31782206039973687,"score_spread":0.3025217850572169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900256197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990294,0.0012445451,0.0006608305,0.0005379271,0.00015221005,0.002973886,0.0014924945,0.00022978515,0.0024144575],"genre_scores_gemma":[0.9836321,0.0015217139,0.0019304854,0.0012122446,0.00013722031,0.0032215759,0.00409865,0.00008018131,0.0041658436],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997024,0.00011692408,0.0000121719095,0.000052338775,0.000028454608,0.00008761995],"domain_scores_gemma":[0.9996848,0.00002535701,0.000034612018,0.000030674262,0.000028521155,0.0001961778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009401208,0.0016393166,0.0015554093,0.000513659,0.0003200358,0.00078109885,0.00081080716,0.0010442223,0.002710419],"category_scores_gemma":[0.00045139474,0.0005583777,0.0010987954,0.00035213734,0.0008034303,0.0005760888,0.00028857976,0.002835691,0.0010490583],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5354529,0.13700698,0.0059716683,0.00086619565,0.0015937345,0.0007852469,0.0005838633,0.0060099894,0.16921343,0.0008408545,0.012127668,0.12954737],"study_design_scores_gemma":[0.39352977,0.57663786,0.011595211,0.000029093775,0.00041122953,0.00046414768,0.000080354934,0.0021523084,0.009545893,0.00036330943,0.005145043,0.00004583685],"about_ca_topic_score_codex":0.0023460947,"about_ca_topic_score_gemma":0.005821712,"teacher_disagreement_score":0.002710419,"about_ca_system_score_codex":0.00087684894,"about_ca_system_score_gemma":0.0016815492,"threshold_uncertainty_score":0.009067297},"labels":[],"label_agreement":null},{"id":"W2900303949","doi":"10.1093/neuonc/noy148.019","title":"ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Oncolytic virus; Pembrolizumab; Interim; Medicine; Oncolytic adenovirus; Glioblastoma; Oncology; Internal medicine; Phases of clinical research; Virology; Cancer research; Clinical trial; Cancer; Immunotherapy; Geography","score_opus":0.042373530892576235,"score_gpt":0.36793823247529517,"score_spread":0.32556470158271894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900303949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8700786,0.012698957,0.0073425793,0.0043162615,0.0019701063,0.016060604,0.044441063,0.0016618461,0.04143],"genre_scores_gemma":[0.86395043,0.0045538507,0.011654679,0.004955589,0.0010198032,0.01587695,0.06774284,0.00039867207,0.029847076],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993499,0.0002921914,0.000029089808,0.000091404254,0.00008591828,0.00015160105],"domain_scores_gemma":[0.9990238,0.00011666888,0.00018900368,0.000106250016,0.000074941025,0.0004893965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038977284,0.0020148195,0.0014268794,0.0004783381,0.0007021821,0.0015653266,0.0016272019,0.0020151187,0.009125125],"category_scores_gemma":[0.0015462678,0.00081009977,0.0011957916,0.00037107206,0.0005318555,0.0008770295,0.0004913126,0.0033663248,0.0031115308],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45866734,0.054143224,0.014643911,0.0013354943,0.0032321601,0.0012032208,0.00047331967,0.0055777603,0.09841144,0.0019951768,0.10278799,0.25752896],"study_design_scores_gemma":[0.473549,0.39203835,0.033048853,0.00010779727,0.0017450807,0.0013992701,0.000076766555,0.0025291035,0.019906309,0.001322479,0.074189216,0.000087773056],"about_ca_topic_score_codex":0.0010539021,"about_ca_topic_score_gemma":0.0022284873,"teacher_disagreement_score":0.009125125,"about_ca_system_score_codex":0.0011356041,"about_ca_system_score_gemma":0.0018495946,"threshold_uncertainty_score":0.030526519},"labels":[],"label_agreement":null},{"id":"W2900305229","doi":"10.1093/neuonc/noy148.316","title":"DRES-09. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES DRIVERS OF CHEMORESISTANCE IN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Chemotherapy; Biology; Cancer research; Sonic hedgehog; Metastasis; Oncology; Cancer; Medicine; Internal medicine; Gene; Genetics","score_opus":0.02764333757226746,"score_gpt":0.31228911194245046,"score_spread":0.284645774370183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900305229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96551114,0.0019707857,0.0120243635,0.0005016721,0.00013065616,0.00015945037,0.011584833,0.0011446655,0.0069723744],"genre_scores_gemma":[0.95921177,0.0014267827,0.011338869,0.00034991902,0.00001854112,0.00015510009,0.011378108,0.00036407236,0.015756894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997559,0.00002075577,0.000016523089,0.00007235872,0.00008012581,0.000054328568],"domain_scores_gemma":[0.999877,0.000022175165,0.00004270085,0.000012316999,0.000007556774,0.000038289203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020306904,0.00035844295,0.00038575585,0.00046447065,0.00020414103,0.00036228582,0.00040292094,0.00043739006,0.0042876177],"category_scores_gemma":[0.000107595835,0.00028021928,0.0004988068,0.0002924591,0.00032416717,0.0001677418,0.0003241987,0.0010802586,0.0009984463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008332308,0.00003635055,0.00018224027,0.000032614887,0.000005360141,0.0000405977,0.000012527956,0.00017537629,0.997891,0.00018284174,0.0001429606,0.0012149068],"study_design_scores_gemma":[0.00009459948,0.000987143,0.017355211,0.00001980556,0.00005760222,0.0006518087,0.00009032791,0.0045652385,0.9565028,0.00022648806,0.019423326,0.00002557385],"about_ca_topic_score_codex":0.0020667277,"about_ca_topic_score_gemma":0.005735452,"teacher_disagreement_score":0.0042876177,"about_ca_system_score_codex":0.00051701715,"about_ca_system_score_gemma":0.00028634473,"threshold_uncertainty_score":0.01434356},"labels":[],"label_agreement":null},{"id":"W2900310694","doi":"10.1093/neuonc/noy148.096","title":"ACTR-66. BEVACIZUMAB THERAPY FOR THE TREATMENT OF ADULT GLIOBLASTOMA: SYSTEMATIC REVIEW &amp; META-ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Bevacizumab; Medicine; Oncology; Internal medicine; Hazard ratio; Glioblastoma; Meta-analysis; Progression-free survival; Randomized controlled trial; Population; Chemotherapy; Confidence interval; Cancer research","score_opus":0.07408253091990977,"score_gpt":0.36904526070823557,"score_spread":0.29496272978832583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900310694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034118418,0.99330246,0.000526185,0.00028402745,0.0001539487,0.00037887218,0.0014676319,0.000038491467,0.00043647215],"genre_scores_gemma":[0.15108597,0.8390192,0.0027997016,0.001756271,0.00034156302,0.0022239087,0.0019274419,0.00006556071,0.0007803237],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926126,0.0036898495,0.0018812929,0.00066831685,0.0008429863,0.0003049529],"domain_scores_gemma":[0.9859957,0.0095665725,0.0028580548,0.00038490316,0.0009599271,0.00023470703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009535884,0.0020533067,0.011401869,0.0074920813,0.0004847264,0.0025940693,0.0017146261,0.0016923823,0.0059037604],"category_scores_gemma":[0.025137128,0.0009882705,0.027969407,0.008728771,0.0005342581,0.0016459118,0.0012763992,0.0018297291,0.0005325122],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016616022,0.000024717596,0.0038341405,0.5819996,0.3966391,0.00010764045,0.00007182828,0.0004922693,0.00019498567,0.00017463873,0.0019016509,0.012897843],"study_design_scores_gemma":[0.0010059753,0.00022992102,0.0056777415,0.05389896,0.9344233,0.000112775415,0.000051059047,0.00026918945,0.000115203984,0.0002651652,0.003919125,0.000031598873],"about_ca_topic_score_codex":0.010694443,"about_ca_topic_score_gemma":0.028756492,"teacher_disagreement_score":0.011401869,"about_ca_system_score_codex":0.0022444797,"about_ca_system_score_gemma":0.0034316792,"threshold_uncertainty_score":0.050431132},"labels":[],"label_agreement":null},{"id":"W2900342617","doi":"10.1093/neuonc/noy148.313","title":"DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; Cancer research; Biology; PARP inhibitor; DNA repair; Synthetic lethality; MSH2; Methyltransferase; Poly ADP ribose polymerase; MLH1; DNA mismatch repair; Molecular biology; Gene; Genetics; Methylation; Polymerase; Glioblastoma","score_opus":0.01949112033093168,"score_gpt":0.3336514222823488,"score_spread":0.3141603019514171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900342617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793465,0.006647812,0.002557213,0.00044528095,0.00016143304,0.00019152227,0.0022551555,0.0008680546,0.0075270594],"genre_scores_gemma":[0.98327404,0.0034800842,0.0028428119,0.00024790064,0.000020836553,0.000119201235,0.0041875727,0.00004045057,0.005787029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999112,0.000013374922,0.000009224776,0.00001665044,0.000017884606,0.00003177227],"domain_scores_gemma":[0.99994767,0.000004961657,0.0000120636305,0.000006579186,0.000007112032,0.00002157631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016609153,0.00040739172,0.000491828,0.00037190097,0.00013325612,0.0002728704,0.00038726802,0.00032689513,0.0030438025],"category_scores_gemma":[0.00011057817,0.00014711887,0.00034186477,0.0002742237,0.0001560496,0.00013576265,0.00014230939,0.00096118444,0.0010058024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020189998,0.0012263734,0.0007208212,0.00033414265,0.000061615254,0.0002770684,0.000043335705,0.0007053789,0.9532844,0.00060389313,0.002151987,0.038571984],"study_design_scores_gemma":[0.001091736,0.013680333,0.012986942,0.000057815207,0.00012782,0.0016416085,0.00006418961,0.0030408597,0.94318,0.00022890186,0.023866093,0.00003374548],"about_ca_topic_score_codex":0.00075891084,"about_ca_topic_score_gemma":0.0018154512,"teacher_disagreement_score":0.0030438025,"about_ca_system_score_codex":0.0002457532,"about_ca_system_score_gemma":0.00029045145,"threshold_uncertainty_score":0.0101825},"labels":[],"label_agreement":null},{"id":"W2900363699","doi":"10.1093/neuonc/noy148.964","title":"RTHP-34. CRANIOSPINAL IRRADIATION (CSI) AS PART OF RE-IRRADIATION (RT2) FOR CHILDREN WITH RECURRENT INTRACRANIAL EPENDYMOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ependymoma; Medicine; Radiation therapy; Overall survival; Nuclear medicine; Log-rank test; Surgery","score_opus":0.020900944284560557,"score_gpt":0.30734559449112686,"score_spread":0.2864446502065663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900363699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793992,0.016391886,0.00026882702,0.00006822756,0.0000147395485,0.000058949085,0.0013977914,0.000027340113,0.0023729976],"genre_scores_gemma":[0.9930275,0.004667126,0.0004249935,0.000028986793,0.000024350733,0.000052273295,0.0015430583,0.000009856627,0.00022183791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979395,0.000050201972,0.000029534322,0.000037709928,0.000062634266,0.000025946763],"domain_scores_gemma":[0.9994622,0.00013898725,0.00028686028,0.000027320486,0.00003400456,0.000050629114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041692713,0.00016146449,0.0002549493,0.00035469377,0.00012366113,0.00019246759,0.00019848242,0.0001408189,0.0014466577],"category_scores_gemma":[0.00090823177,0.00006500932,0.0002848021,0.00069889444,0.00018674621,0.00020102333,0.0001642755,0.00018754172,0.00028756494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031742991,0.00012737006,0.82694656,0.002165389,0.0005317888,0.0038165061,0.00023143411,0.000558989,0.005583393,0.00012733701,0.0014317713,0.15530513],"study_design_scores_gemma":[0.00022109092,0.00259044,0.97324896,0.00021279146,0.0003896349,0.0149667105,0.000115793715,0.00014455027,0.0028446906,0.00003855429,0.0052198344,0.000006855707],"about_ca_topic_score_codex":0.0012763913,"about_ca_topic_score_gemma":0.0017364622,"teacher_disagreement_score":0.0014466577,"about_ca_system_score_codex":0.00031230302,"about_ca_system_score_gemma":0.00056128285,"threshold_uncertainty_score":0.004839599},"labels":[],"label_agreement":null},{"id":"W2900387472","doi":"10.1093/neuonc/noy148.172","title":"CSIG-06. THE MOLECULAR SUBTYPE OF PRIMARY GLIOBLASTOMA CELLS CORRELATES WITH RESPONSE TO THERAPEUTIC AGENTS THAT INDUCE APOPTOSIS OR SENESCENCE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Senescence; Glioblastoma; Apoptosis; Cancer research; Primary (astronomy); Cellular senescence; Biology; Cell biology; Genetics; Gene; Phenotype; Physics","score_opus":0.022051754566907732,"score_gpt":0.279633525026118,"score_spread":0.25758177045921027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900387472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668414,0.0013371673,0.0005383781,0.00013642285,0.000032558244,0.00006354915,0.0070009353,0.00023572498,0.003971008],"genre_scores_gemma":[0.9717865,0.00065639784,0.0009957475,0.00017528558,0.000012909971,0.00012854068,0.020148516,0.000046077705,0.0060500265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997737,0.000020266913,0.000015658667,0.00005903352,0.000067252266,0.000064247324],"domain_scores_gemma":[0.99976283,0.000024735715,0.000042518644,0.000029034656,0.000049373317,0.00009150605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013632188,0.0002803625,0.00048013084,0.00050765206,0.00022492686,0.00036172383,0.00018528104,0.0003793864,0.0060295574],"category_scores_gemma":[0.00020914736,0.00016890107,0.00028318135,0.00061176927,0.00017627525,0.00011537502,0.00019023765,0.00063538534,0.0025605822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019126361,0.00022625933,0.026633741,0.00012401029,0.000060784892,0.0002099415,0.00005669926,0.0000786108,0.96065915,0.00006458545,0.0017760146,0.008197638],"study_design_scores_gemma":[0.0001110624,0.003153529,0.5950824,0.000026336045,0.00013971084,0.0033555762,0.00017294717,0.00080801506,0.38235044,0.000120195706,0.014661689,0.000018055174],"about_ca_topic_score_codex":0.0019504952,"about_ca_topic_score_gemma":0.0025006558,"teacher_disagreement_score":0.0060295574,"about_ca_system_score_codex":0.00038987823,"about_ca_system_score_gemma":0.00032085544,"threshold_uncertainty_score":0.020170867},"labels":[],"label_agreement":null},{"id":"W2900423557","doi":"10.1093/neuonc/noy148.777","title":"NIMG-51. THE IMPACT OF FUNCTIONAL MAGNETIC RESONANCE IMAGING ON CLINICAL OUTCOMES IN A PROPENSITY-MATCHED LOW GRADE GLIOMA COHORT","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Functional magnetic resonance imaging; Propensity score matching; Magnetic resonance imaging; Cohort; Retrospective cohort study; Glioma; Cohort study; Surgery; Internal medicine; Radiology","score_opus":0.04926363825930713,"score_gpt":0.36658623593270584,"score_spread":0.3173225976733987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900423557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872416,0.00012375978,0.00019541389,0.00005220281,0.000007322987,0.000028999071,0.00038207567,0.000008767419,0.00047717436],"genre_scores_gemma":[0.99858093,0.000052948108,0.00021085591,0.00006827781,0.000011553261,0.000032146796,0.00085129973,0.0000066304124,0.00018536873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999508,0.00019268313,0.000031374635,0.000108648586,0.000089244306,0.00007003876],"domain_scores_gemma":[0.9992023,0.000126902,0.00029968363,0.00013384018,0.00006028624,0.00017697917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021109,0.0002054413,0.0002965367,0.00041790894,0.00025006465,0.0003862412,0.00027236072,0.00030033189,0.0013770098],"category_scores_gemma":[0.0025828,0.000104716986,0.00033314788,0.0004259518,0.00021716392,0.00027707886,0.0004139097,0.0001902266,0.0003915236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016188916,0.00009125922,0.9895201,0.000012147802,0.00012489749,0.00017598964,0.00003401754,0.00009057685,0.0010820255,0.00003747686,0.0003445421,0.0068680495],"study_design_scores_gemma":[0.000105618565,0.0007735736,0.99727964,0.0000047684784,0.000093539944,0.00040379266,0.000046894962,0.0002977494,0.0003029544,0.000044925233,0.000641993,0.000004571008],"about_ca_topic_score_codex":0.0020963806,"about_ca_topic_score_gemma":0.0032368277,"teacher_disagreement_score":0.0020963806,"about_ca_system_score_codex":0.00028892086,"about_ca_system_score_gemma":0.00033196402,"threshold_uncertainty_score":0.005400181},"labels":[],"label_agreement":null},{"id":"W2908578072","doi":"10.1093/neuonc/noy143","title":"Imaging and diagnostic advances for intracranial meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology; Medical imaging; Radiological imaging; Asymptomatic; Radiological weapon; Magnetic resonance imaging; Medical physics; Pathology","score_opus":0.040986541535662974,"score_gpt":0.3667433045078545,"score_spread":0.32575676297219147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908578072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012665211,0.9982899,0.00015450685,0.0005319494,0.00016321977,0.00000221385,0.000009838849,0.000006029834,0.0007156509],"genre_scores_gemma":[0.0013150808,0.99753654,0.00033236912,0.00026504614,0.00034908555,0.0000028028753,0.000024369703,0.0000018542348,0.00017282397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996018,0.000075756645,0.00009306717,0.00006220628,0.00013737669,0.000029768556],"domain_scores_gemma":[0.9986625,0.00076783,0.0001802548,0.000035220208,0.00030545893,0.000048736772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086156995,0.00078570034,0.0008582425,0.0043927305,0.00033157755,0.0009747731,0.0008335814,0.0011842456,0.0021837906],"category_scores_gemma":[0.002452034,0.000301601,0.0007970561,0.0022578258,0.0008461863,0.0018788152,0.0005804238,0.0022019383,0.0010284205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047365877,0.000047504436,0.0010884478,0.015598612,0.000097611104,0.0009626119,0.00011838122,0.0003531658,0.0012076219,0.003174583,0.025350783,0.95195323],"study_design_scores_gemma":[0.000016314623,0.00008954322,0.0044350214,0.012354713,0.00031314962,0.023340492,0.00022744609,0.00025337923,0.0012242596,0.004452996,0.9532355,0.00005713521],"about_ca_topic_score_codex":0.001978096,"about_ca_topic_score_gemma":0.002567326,"teacher_disagreement_score":0.0043927305,"about_ca_system_score_codex":0.0008511786,"about_ca_system_score_gemma":0.0014307356,"threshold_uncertainty_score":0.007305503},"labels":[],"label_agreement":null},{"id":"W2908805387","doi":"10.1093/neuonc/noy136","title":"Advances in multidisciplinary therapy for meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Medicine; Meningioma; Radiation therapy; Adjuvant radiotherapy; Retrospective cohort study; Adjuvant therapy; Systemic therapy; Surgery; Oncology; Internal medicine; Cancer; Chemotherapy; Breast cancer","score_opus":0.08942907686859627,"score_gpt":0.423043469464102,"score_spread":0.33361439259550574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908805387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007242041,0.99838436,0.00008756796,0.0005101225,0.0002110421,0.0000033935978,0.000008251608,0.0000035972294,0.0007192587],"genre_scores_gemma":[0.00097595184,0.99782157,0.00019210008,0.00037836746,0.00032754298,0.0000066568796,0.0000224248,0.0000016042742,0.00027387554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970835,0.00006788559,0.00005520618,0.000049074522,0.00009429881,0.000025190142],"domain_scores_gemma":[0.9992112,0.00042971084,0.00012025023,0.000018076635,0.00016539298,0.000055274948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008344929,0.0006976211,0.0008036122,0.0026116997,0.00037149238,0.000851904,0.00086028734,0.0009110538,0.0038960995],"category_scores_gemma":[0.0015178967,0.00018049397,0.0008076425,0.0016935058,0.00047186835,0.001260939,0.0008216939,0.001850609,0.0009781586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037794613,0.00006153256,0.0003828141,0.018444145,0.000121640616,0.00023378093,0.00010124332,0.0003329674,0.00030060118,0.0037720024,0.032815885,0.9433956],"study_design_scores_gemma":[0.000026374217,0.000073741874,0.002310504,0.013659993,0.00017012331,0.0028562348,0.00015150227,0.00012274647,0.00015689063,0.0035018788,0.9769474,0.000022645672],"about_ca_topic_score_codex":0.001716855,"about_ca_topic_score_gemma":0.0039712363,"teacher_disagreement_score":0.0038960995,"about_ca_system_score_codex":0.000971571,"about_ca_system_score_gemma":0.0015993165,"threshold_uncertainty_score":0.013033688},"labels":[],"label_agreement":null},{"id":"W2909042567","doi":"10.1093/neuonc/noy195","title":"Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health and Social Services; CancerCare Manitoba; Alberta Hospital Edmonton; Alberta Health Services; Cancer Care Ontario; Public Health Agency of Canada; BC Cancer Agency; Brain Tumour Foundation of Canada; University of Alberta","funders":"BC Cancer Agency; Health Canada; University of Alberta; Brain Tumour Foundation of Canada; Fondation Brain Canada; McGill University","keywords":"Medicine; Population; Incidence (geometry); Cancer registry; Brain tumor; Confidence interval; Histology; Cancer; Pediatrics; Internal medicine; Pathology","score_opus":0.011462942562967997,"score_gpt":0.2424730851837808,"score_spread":0.2310101426208128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909042567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6181637,0.018610716,0.0009516405,0.0013724234,0.00021340224,0.0003898021,0.33107334,0.0003274301,0.0288976],"genre_scores_gemma":[0.91189504,0.011812805,0.0012436537,0.000812345,0.000071113056,0.00010802624,0.070349656,0.000035908284,0.0036716065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892884,0.000019925523,0.000067220106,0.00013421815,0.0005345327,0.00031524443],"domain_scores_gemma":[0.998454,0.00003325119,0.00026339616,0.000029307046,0.00096586015,0.00025418284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033921818,0.00047908165,0.0004628896,0.0028921706,0.0018005094,0.0009601434,0.0010698977,0.00024963656,0.002374346],"category_scores_gemma":[0.0013874454,0.0002692786,0.00070594053,0.0060743974,0.00038586676,0.00029602935,0.00075885985,0.0005210869,0.0004132243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014707494,0.000023055787,0.948979,0.00041889685,0.00018914662,0.00040209148,0.00024906,0.00031429445,0.0003796918,0.0002415704,0.027332721,0.021323333],"study_design_scores_gemma":[0.000017845872,0.000026985937,0.9821515,0.0002769483,0.00016486131,0.0008614583,0.00048448524,0.0003233383,0.00033074364,0.00006116885,0.015279102,0.000021572656],"about_ca_topic_score_codex":0.99216557,"about_ca_topic_score_gemma":0.9957081,"teacher_disagreement_score":0.02416517,"about_ca_system_score_codex":0.02416517,"about_ca_system_score_gemma":0.044793654,"threshold_uncertainty_score":0.17533141},"labels":[],"label_agreement":null},{"id":"W2909734970","doi":"10.1093/neuonc/noy152","title":"Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Medicine; Quality of life (healthcare); Meningioma; Confidence interval; Prospective cohort study; Population; Cohort; Cohort study; Cross-sectional study; Health related quality of life; Surgery; Internal medicine; Disease; Pathology","score_opus":0.11215384200841856,"score_gpt":0.44048188621134854,"score_spread":0.32832804420293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909734970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995933,0.000118990465,0.00003738731,0.000023441251,0.0000038655003,0.0000070171677,0.00013108639,0.0000011911114,0.00008376465],"genre_scores_gemma":[0.9995029,0.00007977254,0.00006318422,0.000033702367,0.0000065785925,0.000010630254,0.00025230122,8.268486e-7,0.000050082173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995067,0.00016543052,0.000058850484,0.000088030334,0.00010246827,0.00007851773],"domain_scores_gemma":[0.9979609,0.00037009406,0.0008718662,0.00015175404,0.00020254905,0.00044269397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012376981,0.00024450634,0.0003270566,0.000586774,0.00044642302,0.00060378044,0.00023874147,0.00042925126,0.00082084595],"category_scores_gemma":[0.0028423704,0.00030328002,0.00048025194,0.00055514753,0.0002538164,0.00060415204,0.0004267433,0.0007407015,0.0002470929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006595148,0.000049401686,0.9993531,0.0000033825117,0.000030415502,0.000050367347,0.00005290836,0.000009076396,0.00007418122,0.000002744398,0.000025887657,0.00028260032],"study_design_scores_gemma":[0.000006839006,0.00031957694,0.9990144,0.0000040536697,0.000020046205,0.00029949608,0.0001680021,0.000048303362,0.000027702336,0.0000057735715,0.00008289562,0.000002927888],"about_ca_topic_score_codex":0.0024197153,"about_ca_topic_score_gemma":0.0027652648,"teacher_disagreement_score":0.0024197153,"about_ca_system_score_codex":0.0002224242,"about_ca_system_score_gemma":0.00029624082,"threshold_uncertainty_score":0.006545663},"labels":[],"label_agreement":null},{"id":"W2910801868","doi":"10.1093/neuonc/noy178","title":"Molecular and translational advances in meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Meningioma; Epigenomics; Medicine; Clinical trial; Disease; Bioinformatics; Pathology; Biology","score_opus":0.04450437069654302,"score_gpt":0.3673298499988644,"score_spread":0.3228254793023214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910801868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001324481,0.99763083,0.00014287891,0.0007202243,0.00034153374,0.0000038276144,0.000023735814,0.000010709298,0.0009938024],"genre_scores_gemma":[0.0011272455,0.997358,0.00023537556,0.00042850035,0.00033526076,0.0000048134116,0.000043604923,0.000002122808,0.00046512226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997855,0.000036162335,0.000040192543,0.000036207406,0.00007870023,0.000023287474],"domain_scores_gemma":[0.9993017,0.0003968865,0.00006790847,0.00002243274,0.00016487799,0.000046208792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072483544,0.0006176093,0.000799184,0.0023235604,0.0002890327,0.0010083123,0.00061166816,0.001173872,0.0036299957],"category_scores_gemma":[0.0014640876,0.00018931284,0.00062783755,0.0014104276,0.0004777336,0.0014232574,0.000635866,0.0020719466,0.0014842298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008095659,0.00007542696,0.00035582465,0.018554643,0.00010117875,0.0004201687,0.000096226475,0.00052159803,0.0021849037,0.0069222306,0.040745392,0.9299414],"study_design_scores_gemma":[0.000010055089,0.00007007895,0.00070289895,0.0034810558,0.00009533418,0.0017416396,0.00005730242,0.000085636,0.0006875015,0.0028086463,0.9902445,0.000015376563],"about_ca_topic_score_codex":0.0009001748,"about_ca_topic_score_gemma":0.0015575583,"teacher_disagreement_score":0.0036299957,"about_ca_system_score_codex":0.0006817121,"about_ca_system_score_gemma":0.0013648694,"threshold_uncertainty_score":0.012143493},"labels":[],"label_agreement":null},{"id":"W2910893602","doi":"10.1093/neuonc/noy181","title":"Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas","year":2018,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology","score_opus":0.10621162622252624,"score_gpt":0.3454834786583993,"score_spread":0.23927185243587307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910893602","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003937883,0.030005379,0.00013094669,0.19767243,0.77111566,0.000020067617,0.000043935077,0.000033865705,0.0009384157],"genre_scores_gemma":[0.00033191853,0.017382586,0.00018123744,0.08079654,0.8998581,0.00002403,0.000029549965,0.000019248784,0.0013768508],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98814195,0.003042572,0.002673677,0.0010773125,0.0041216067,0.00094283215],"domain_scores_gemma":[0.9076326,0.04963462,0.005830643,0.001368356,0.026107065,0.00942673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017470242,0.0032813372,0.005340702,0.0048092296,0.003936299,0.01208241,0.0046717986,0.041035216,0.0063662934],"category_scores_gemma":[0.06932832,0.0013092234,0.0044056876,0.0027254908,0.004488519,0.010140597,0.0038577355,0.047676507,0.00545111],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029964474,0.00001665738,0.000071047994,0.0005045946,0.000028886468,0.0001630882,0.000036744208,0.00003271571,0.000024398518,0.00041902214,0.9898134,0.008859464],"study_design_scores_gemma":[0.00011638946,0.0000432324,0.00039586434,0.004171395,0.0001500202,0.00063740223,0.00026279694,0.00013782576,0.00006074976,0.0020498272,0.99192035,0.000054157103],"about_ca_topic_score_codex":0.004653277,"about_ca_topic_score_gemma":0.011730104,"teacher_disagreement_score":0.041035216,"about_ca_system_score_codex":0.0057435194,"about_ca_system_score_gemma":0.011019452,"threshold_uncertainty_score":0.092392564},"labels":[],"label_agreement":null},{"id":"W2911536283","doi":"10.1093/neuonc/noz021","title":"Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; American University of Beirut; Deutsche Forschungsgemeinschaft; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Drosophila melanogaster; Mutant; Histone; Histone H3; Gene; Gene knockdown; Genetics; Chromatin; RNA interference; Chromatin immunoprecipitation; Model organism; Phenotype; Mutation; Epigenetics; Genetic screen; Cell biology; Gene expression; RNA; Promoter","score_opus":0.01451104366238806,"score_gpt":0.28491693362805803,"score_spread":0.27040588996567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911536283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806295,0.0015722603,0.009531822,0.00011778734,0.00002517494,0.000108259504,0.0060855686,0.00033788328,0.0015917405],"genre_scores_gemma":[0.96533126,0.0017722785,0.01679829,0.00014284694,0.000007744992,0.00015747758,0.008648601,0.00017254046,0.006969041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999119,0.0000073376555,0.000009630296,0.000032663924,0.000024939594,0.000013511082],"domain_scores_gemma":[0.9998846,0.00001889418,0.000052513522,0.00001119424,0.000009821691,0.000022968561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083943436,0.00039024747,0.00014281727,0.00042469223,0.0001848258,0.00018007196,0.00027294483,0.0002607064,0.0011987528],"category_scores_gemma":[0.000069333815,0.00018792333,0.000339062,0.00019950986,0.00021175368,0.00009519162,0.00021571625,0.00037490766,0.0006274063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029215693,0.0000046974137,0.00033482528,0.00002873193,0.000002971702,0.000047364625,0.0000072847306,0.00002424629,0.9987753,0.00002578298,0.000025964688,0.00069369376],"study_design_scores_gemma":[0.0000174383,0.000113395676,0.025512699,0.0000114505365,0.000035534493,0.00063119497,0.000047724407,0.0006620869,0.9696474,0.000039961193,0.003273752,0.0000074130157],"about_ca_topic_score_codex":0.0017117831,"about_ca_topic_score_gemma":0.0032298737,"teacher_disagreement_score":0.0017117831,"about_ca_system_score_codex":0.0004482966,"about_ca_system_score_gemma":0.00024000746,"threshold_uncertainty_score":0.0040102005},"labels":[],"label_agreement":null},{"id":"W2939794316","doi":"10.1093/neuonc/noz066","title":"Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute; AOSpine; AO Foundation","keywords":"Telomerase reverse transcriptase; Chordoma; Chondrosarcoma; Medicine; Telomerase; Mutation; Sarcoma; Cancer research; Internal medicine; Oncology; Pathology; Biology; Gene; Genetics","score_opus":0.038795111187250424,"score_gpt":0.32358151874992513,"score_spread":0.2847864075626747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939794316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950767,0.0002674555,0.000043281296,0.000009102455,0.0000025176569,0.0000015285485,0.0000758215,0.0000020470436,0.00009052198],"genre_scores_gemma":[0.99984396,0.000035670422,0.000024604224,0.0000024268702,0.0000029468088,9.335108e-7,0.00007418384,5.2579884e-7,0.0000146777365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979943,0.000037170703,0.000029411174,0.000050834627,0.000041529205,0.000041684667],"domain_scores_gemma":[0.9978479,0.00064645644,0.00085108506,0.0000822226,0.00017550927,0.00039681062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057973276,0.00016274804,0.00015822833,0.0006134608,0.00015733647,0.00036972406,0.00022793547,0.00026088918,0.0010552855],"category_scores_gemma":[0.002189221,0.00008796867,0.00028444093,0.00035792272,0.00025882738,0.00021918296,0.00017764821,0.00020780224,0.0001304807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016278568,0.0000058155692,0.9979868,0.00000344927,0.000018344328,0.00012744858,0.000012383355,0.000056652243,0.00046284805,0.000003657421,0.000026850865,0.0011328877],"study_design_scores_gemma":[0.000007016971,0.00011224135,0.99793565,0.0000044200315,0.00004954208,0.0011581383,0.000052675743,0.00028157848,0.00029050623,0.000016344444,0.00008871675,0.000003142868],"about_ca_topic_score_codex":0.0012660404,"about_ca_topic_score_gemma":0.002065191,"teacher_disagreement_score":0.0012660404,"about_ca_system_score_codex":0.0002275457,"about_ca_system_score_gemma":0.0002071042,"threshold_uncertainty_score":0.0035303235},"labels":[],"label_agreement":null},{"id":"W2940897955","doi":"10.1093/neuonc/noz036.200","title":"MEDU-42. ELUCIDATING THE ROLE OF STRESS GRANULE FORMATION IN MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medulloblastoma; Stress granule; Cancer research; Apoptosis; Vincristine; Malignancy; Kinase; Cell growth; Integrated stress response; Biology; Translation (biology); Medicine; Cell biology; Internal medicine; Gene; Chemotherapy; Genetics","score_opus":0.007395292899446653,"score_gpt":0.2691838098082964,"score_spread":0.2617885169088498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940897955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975938,0.011306813,0.0050890753,0.0002880832,0.00006845409,0.00011445703,0.0025075204,0.00021255949,0.0044749943],"genre_scores_gemma":[0.9782526,0.0055197123,0.0071041654,0.00017525631,0.00001564474,0.00007600212,0.004231002,0.000042973606,0.0045826384],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999905,0.000011561521,0.000010443969,0.000020219282,0.00003448053,0.00001833622],"domain_scores_gemma":[0.9999553,0.000008823491,0.00001419606,0.0000039706997,0.0000067221094,0.000011040172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001296647,0.00028336525,0.0003402728,0.00050076336,0.00024177482,0.00032746064,0.00017703339,0.000293036,0.0011970304],"category_scores_gemma":[0.00008122671,0.00015717377,0.0003774952,0.00031143482,0.00017599779,0.00015392742,0.00016590902,0.00033054609,0.00039602042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010829857,0.00002602827,0.0005431772,0.00010404776,0.000005794425,0.00006777358,0.000014371241,0.0000994179,0.9960563,0.00010095711,0.00007751509,0.002796306],"study_design_scores_gemma":[0.000023962675,0.00043291246,0.020944895,0.000014071114,0.00003549264,0.00048804993,0.00005263653,0.0015034099,0.96701574,0.00006466579,0.0094182165,0.0000059452564],"about_ca_topic_score_codex":0.0016714806,"about_ca_topic_score_gemma":0.0027220931,"teacher_disagreement_score":0.0016714806,"about_ca_system_score_codex":0.0004344884,"about_ca_system_score_gemma":0.00031299458,"threshold_uncertainty_score":0.0040044785},"labels":[],"label_agreement":null},{"id":"W2941020419","doi":"10.1093/neuonc/noz036.008","title":"ATRT-09. INTEGRATIVE ANALYSES OF GENE REGULATORY LANDSCAPES REVEAL RHABDOID TUMOR SUBGROUPS WITH POSSIBLE IMMUNE MODULATION THROUGH EPIGENETIC DYSREGULATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Epigenetics; Immune system; Gene; Immune dysregulation; Biology; Epigenesis; Psychology; DNA methylation; Neuroscience; Genetics; Gene expression","score_opus":0.028439028686886105,"score_gpt":0.31530838113756016,"score_spread":0.2868693524506741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941020419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8474315,0.003498082,0.024369154,0.00041675128,0.00017918389,0.0002558716,0.10896053,0.0034562699,0.011432765],"genre_scores_gemma":[0.7699585,0.0017217966,0.034304623,0.00074441155,0.000050238308,0.0005356592,0.18050942,0.0017825039,0.010392858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955565,0.000030727446,0.000022933604,0.00019942447,0.00012504385,0.00006629998],"domain_scores_gemma":[0.9998165,0.000034106757,0.00005426537,0.00002863014,0.000020319203,0.000046331734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004476902,0.00037452433,0.00073187053,0.0006714554,0.0004184718,0.0007608141,0.00063547556,0.00038703275,0.004818795],"category_scores_gemma":[0.00027992766,0.00029980464,0.0009667063,0.0007583805,0.00022274787,0.00019269362,0.0007113768,0.0009761508,0.0017365069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016656314,0.00016001172,0.03906134,0.000892507,0.0004991941,0.00073057954,0.00039878703,0.00291466,0.8949888,0.0018807525,0.010734851,0.046072803],"study_design_scores_gemma":[0.00061731716,0.0017553635,0.43755695,0.00020180923,0.0015316643,0.0062923944,0.0006605671,0.031445906,0.33633327,0.0031244636,0.18031399,0.00016625281],"about_ca_topic_score_codex":0.0016707671,"about_ca_topic_score_gemma":0.0043836245,"teacher_disagreement_score":0.004818795,"about_ca_system_score_codex":0.000378337,"about_ca_system_score_gemma":0.0004770988,"threshold_uncertainty_score":0.016120493},"labels":[],"label_agreement":null},{"id":"W2941112345","doi":"10.1093/neuonc/noz036.159","title":"LGG-16. PREDICTORS OF OUTCOME IN BRAF-V600E PEDIATRIC GLIOMAS TREATED WITH BRAF INHIBITORS: A REPORT FROM THE PLGG TASKFORCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cohort; Clinical trial; Chemotherapy; V600E; Mutation; Gene","score_opus":0.015121974236586842,"score_gpt":0.27326831815945585,"score_spread":0.258146343922869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941112345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683857,0.0017819331,0.00016921913,0.00014552003,0.0000066253865,0.000010372602,0.0006196181,0.000010536471,0.00041755356],"genre_scores_gemma":[0.99840266,0.00054941187,0.000086255845,0.000027857097,0.0000114263175,0.000010937592,0.000771463,0.000005165464,0.00013475817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967,0.00009768208,0.00003175137,0.000057925627,0.000090008434,0.00005272514],"domain_scores_gemma":[0.9985008,0.0004378817,0.000681751,0.000044826214,0.0001535319,0.00018111228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007523481,0.00022733188,0.00022974031,0.0003729853,0.0001357123,0.0003173036,0.00014731879,0.00020931155,0.00031898334],"category_scores_gemma":[0.002157419,0.0000959119,0.0002587183,0.0005665241,0.00018542279,0.00018158129,0.0001680362,0.00029918275,0.0001178558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004467101,0.000015493972,0.990681,0.000024888746,0.000051465635,0.00024416237,0.00004794783,0.00013755029,0.00036111366,0.000009215576,0.0003185562,0.007661969],"study_design_scores_gemma":[0.000019671907,0.00023267129,0.99756634,0.000010046401,0.00006347583,0.00078555057,0.000051008155,0.00018641184,0.00036514012,0.000013008202,0.00070352067,0.000003114112],"about_ca_topic_score_codex":0.0051321634,"about_ca_topic_score_gemma":0.004960623,"teacher_disagreement_score":0.0051321634,"about_ca_system_score_codex":0.00041258056,"about_ca_system_score_gemma":0.0003292905,"threshold_uncertainty_score":0.010204613},"labels":[],"label_agreement":null},{"id":"W2941193626","doi":"10.1093/neuonc/noz036.170","title":"MEDU-11. MOLECULAR CHARACTERIZATION OF ETMRs REVEALS A ROLE FOR R-LOOP MEDIATED CHROMOSOMAL INSTABILITY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Somatic cell; Biology; Genome instability; Germline; Chromosome instability; Missense mutation; Gene; Genetics; Allele; Chromosome; Cancer research; DNA; Mutation; DNA damage","score_opus":0.00781702785624331,"score_gpt":0.2546241547081392,"score_spread":0.2468071268518959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941193626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769554,0.0021528946,0.0044923383,0.00033252625,0.00006776212,0.000097048185,0.008400547,0.00029264067,0.0072089224],"genre_scores_gemma":[0.9718394,0.0006132597,0.0076917023,0.00017492022,0.000022199452,0.00008762311,0.012129087,0.000050439034,0.007391266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997782,0.000020784835,0.000022725066,0.00007301109,0.00005275579,0.00005244013],"domain_scores_gemma":[0.9996786,0.000075734,0.00007929434,0.000035217803,0.00003799555,0.00009313888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020276605,0.00030162287,0.00024797794,0.0009564917,0.00028635896,0.00050071324,0.00026950974,0.0006734257,0.005918779],"category_scores_gemma":[0.0005079124,0.00015887433,0.00023732147,0.00049578043,0.00025298845,0.00020673784,0.00029453225,0.0004261059,0.0018486618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001671861,0.00009679002,0.11986205,0.00042867466,0.00007671427,0.0058205724,0.0002887038,0.00082654343,0.8290426,0.001128072,0.0025832318,0.03817416],"study_design_scores_gemma":[0.000078439894,0.0007668175,0.50020033,0.00008151924,0.00010466878,0.038564105,0.00031444282,0.0068898434,0.4011233,0.0008695386,0.050971527,0.000035514557],"about_ca_topic_score_codex":0.0005625313,"about_ca_topic_score_gemma":0.0014155154,"teacher_disagreement_score":0.005918779,"about_ca_system_score_codex":0.00037053475,"about_ca_system_score_gemma":0.00015228432,"threshold_uncertainty_score":0.019800246},"labels":[],"label_agreement":null},{"id":"W2941439192","doi":"10.1093/neuonc/noz036.112","title":"HGG-18. ALTERNATIVE SPLICING OF NEUROFIBROMIN 1 IS ASSOCIATED WITH ELEVATED MAPK ACTIVITY AND POOR PROGNOSIS IN HIGH-GRADE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurofibromin 1; MAPK/ERK pathway; Glioma; Cancer research; PI3K/AKT/mTOR pathway; Biology; Alternative splicing; RNA splicing; Carcinogenesis; Mutation; Signal transduction; Neurofibromatosis; Medicine; Genetics; Gene; RNA; Messenger RNA","score_opus":0.016597045529105105,"score_gpt":0.28580200456537247,"score_spread":0.26920495903626734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941439192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842846,0.0002539481,0.00019216102,0.000035583864,0.000007253893,0.0000049645755,0.00083626877,0.00001523918,0.00022615882],"genre_scores_gemma":[0.9980702,0.000106980515,0.0002718018,0.00003176005,0.000010183409,0.0000091244165,0.0011372877,0.000009760246,0.00035291218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998599,0.0000142802055,0.000011082177,0.000054790507,0.000030146608,0.000029696555],"domain_scores_gemma":[0.9996686,0.000032484393,0.00017500276,0.000015937427,0.000025510255,0.00008238306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012686569,0.00022752357,0.00020421755,0.00045258712,0.0003047975,0.00029167774,0.00011002209,0.0003168251,0.0017942172],"category_scores_gemma":[0.00034724583,0.000088931294,0.0002670374,0.00057418115,0.00019573141,0.00010448328,0.0001944012,0.0003696703,0.00036066465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013378727,0.000051073584,0.92532974,0.000075239805,0.00016490166,0.0017596517,0.00015864293,0.0001578958,0.060192443,0.000082887804,0.0008663845,0.009823309],"study_design_scores_gemma":[0.000010818762,0.0001035515,0.9926035,0.00000688812,0.000050273095,0.0028413187,0.00009562227,0.00028244805,0.0027617093,0.000119610406,0.0011188207,0.000005473232],"about_ca_topic_score_codex":0.0011238551,"about_ca_topic_score_gemma":0.0015924831,"teacher_disagreement_score":0.0017942172,"about_ca_system_score_codex":0.00012528972,"about_ca_system_score_gemma":0.00015593566,"threshold_uncertainty_score":0.0060022473},"labels":[],"label_agreement":null},{"id":"W2941510530","doi":"10.1093/neuonc/noz036.057","title":"DIPG-36. CLINICAL, RADIOLOGICAL, AND HISTO-MOLECULAR CHARACTERISTICS OF DIFFUSE INTRINSIC PONTINE GLIOMA IN PATIENTS WHO SURVIVE LESS THAN 3 MONTHS FROM DIAGNOSIS: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Glioma; Stereotactic biopsy; Biopsy; Radiation therapy; Chemotherapy; Radiology; Surgery; Internal medicine","score_opus":0.022778514090043785,"score_gpt":0.29302628062065617,"score_spread":0.2702477665306124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941510530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294394,0.000325606,0.00012403347,0.00003790597,0.000005162574,0.000024654642,0.005289749,0.000017802024,0.001230979],"genre_scores_gemma":[0.99189574,0.00015189676,0.00017021302,0.000024728879,0.000008645705,0.00003457784,0.00751421,0.0000061955648,0.00019374717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996989,0.000034118,0.00005409711,0.000089422036,0.0000653233,0.00005818575],"domain_scores_gemma":[0.9987128,0.00012921588,0.00066306564,0.000119023825,0.0001382445,0.00023776438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044649324,0.00018388763,0.00034875833,0.0010292786,0.00023977463,0.00038964456,0.00026034922,0.00020426564,0.0008987315],"category_scores_gemma":[0.0014330919,0.00012118395,0.00021436304,0.0014161862,0.00021709125,0.00036718868,0.0004082225,0.00024910638,0.0003686385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006150821,0.0000073436986,0.99719137,0.000010993289,0.000010212045,0.00017866542,0.000038180173,0.00003519077,0.00017542741,0.000010975282,0.0002796164,0.0020006204],"study_design_scores_gemma":[0.0000078005505,0.000048279053,0.9971831,0.000005245369,0.000013201679,0.0015750334,0.00007795452,0.00009421755,0.000092350994,0.000014772579,0.00088433974,0.0000036704096],"about_ca_topic_score_codex":0.003031078,"about_ca_topic_score_gemma":0.0027557558,"teacher_disagreement_score":0.003031078,"about_ca_system_score_codex":0.00024988496,"about_ca_system_score_gemma":0.00029008064,"threshold_uncertainty_score":0.006026864},"labels":[],"label_agreement":null},{"id":"W2941757790","doi":"10.1093/neuonc/noz036.059","title":"DIPG-38. DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Wee1; DNA damage; Cell cycle checkpoint; Cancer; IC50; Cell cycle; Chemistry; Medicine; Pharmacology; In vitro; Internal medicine; Biology; DNA; Cyclin-dependent kinase 1; Biochemistry; Genetics","score_opus":0.013355405510796867,"score_gpt":0.29550850844423965,"score_spread":0.28215310293344276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941757790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667114,0.0012666755,0.00041149277,0.0000871874,0.000026506648,0.000025203728,0.0003057784,0.00007820252,0.0011278575],"genre_scores_gemma":[0.9966028,0.0007005127,0.0007187212,0.000034059725,0.000008143257,0.000024451832,0.00050117535,0.0000109667835,0.0013991562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998772,0.000021088641,0.000009156563,0.000022134878,0.00003684911,0.00003353784],"domain_scores_gemma":[0.9999348,0.000007902302,0.000016547132,0.000005870208,0.000004705487,0.000030185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009918573,0.00044676723,0.00034580298,0.0002830553,0.00010551838,0.00017214508,0.00022932405,0.00020339304,0.0010410065],"category_scores_gemma":[0.000070756774,0.00012478989,0.0002266255,0.00023895077,0.00021011957,0.00016888062,0.00014582934,0.000665389,0.00023091058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010845995,0.00035586496,0.0003494865,0.000065725806,0.00002365935,0.00009009951,0.000027418013,0.00022185339,0.992737,0.000076164346,0.00019285327,0.0047752927],"study_design_scores_gemma":[0.00012539559,0.006789086,0.006967,0.000005603651,0.00004303035,0.00038131562,0.00003334232,0.00094234245,0.9820531,0.00003319463,0.002620403,0.0000061427377],"about_ca_topic_score_codex":0.0015123053,"about_ca_topic_score_gemma":0.002571756,"teacher_disagreement_score":0.0015123053,"about_ca_system_score_codex":0.00028304124,"about_ca_system_score_gemma":0.00029595062,"threshold_uncertainty_score":0.003482461},"labels":[],"label_agreement":null},{"id":"W2941875587","doi":"10.1093/neuonc/noz036.247","title":"TMOD-09. TUMOR ASSOCIATED MACROPHAGE DYNAMICS IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Dynamics (music); Macrophage; Glioma; Medicine; Cancer research; Biology; Psychology; Genetics","score_opus":0.010146963247358715,"score_gpt":0.27176422639003867,"score_spread":0.26161726314267997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941875587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389714,0.0010966404,0.00092620845,0.00009485658,0.000020328496,0.00003890898,0.0010683401,0.000090722955,0.002766915],"genre_scores_gemma":[0.9908455,0.00080286065,0.0016977543,0.00007883767,0.000008292204,0.000079064004,0.002591078,0.000023538163,0.003873128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999162,0.000008642867,0.0000062259714,0.000018609151,0.00002202773,0.000028291208],"domain_scores_gemma":[0.9999354,0.0000050553604,0.000014592234,0.00000485036,0.000007936142,0.000032117845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096202624,0.00013842068,0.00018448933,0.000226978,0.00013344253,0.0002934769,0.00010831127,0.00026370154,0.0019274793],"category_scores_gemma":[0.00006817804,0.000094185845,0.00013919645,0.000240469,0.00011634325,0.00012134964,0.00012737018,0.00043602067,0.0004981927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012204058,0.00019488484,0.010662232,0.00012983145,0.000018056391,0.00048930396,0.00005396321,0.000311347,0.96880406,0.00021341235,0.0007783819,0.017124174],"study_design_scores_gemma":[0.0001630681,0.004406901,0.19096598,0.000027373395,0.000074764605,0.0072461683,0.00034154358,0.0038405962,0.76666045,0.00025866347,0.025997577,0.000016909786],"about_ca_topic_score_codex":0.00077355775,"about_ca_topic_score_gemma":0.00127819,"teacher_disagreement_score":0.0019274793,"about_ca_system_score_codex":0.00030190425,"about_ca_system_score_gemma":0.00023853489,"threshold_uncertainty_score":0.0064480305},"labels":[],"label_agreement":null},{"id":"W2941922482","doi":"10.1093/neuonc/noz036.204","title":"MEDU-46. SONIC HEDGEHOG SPEEDS UP DNA REPLICATION AND CAUSES CANCER-INITIATING MUTATIONS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Sonic hedgehog; Biology; DNA damage; Cancer research; Genome instability; DNA repair; DNA replication; PTCH1; Genetics; DNA; Cell biology; Gene","score_opus":0.03350962826161385,"score_gpt":0.329669469553169,"score_spread":0.29615984129155515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941922482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98286384,0.0057537546,0.0032780468,0.00025190864,0.00013642406,0.00005916687,0.0011431827,0.00041899577,0.006094614],"genre_scores_gemma":[0.9895862,0.0015280216,0.0019741396,0.0000615614,0.000018295012,0.000031925632,0.00059255294,0.000023634242,0.0061836066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.000021540052,0.000011812546,0.000027374934,0.00004250398,0.000032618285],"domain_scores_gemma":[0.99992836,0.000008761756,0.000020294983,0.000008102048,0.000005675594,0.00002877262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007851287,0.0003198436,0.00017927036,0.00026047212,0.00015156233,0.00020471447,0.00012185243,0.00023167426,0.0021373893],"category_scores_gemma":[0.0000842219,0.00014626201,0.0002241527,0.00009275787,0.00017111654,0.00012499616,0.00022930505,0.000390805,0.0005930535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007686636,0.000018601144,0.00033685568,0.000035453493,0.000004152705,0.00006965654,0.000008099909,0.000040677372,0.9969357,0.00020144376,0.00007479744,0.0021976698],"study_design_scores_gemma":[0.000011922048,0.00039853927,0.0068820016,0.00000810657,0.000017793012,0.00036729185,0.000013535281,0.00049737375,0.98371744,0.000065679356,0.008017374,0.0000029696168],"about_ca_topic_score_codex":0.00065725454,"about_ca_topic_score_gemma":0.0012957377,"teacher_disagreement_score":0.0021373893,"about_ca_system_score_codex":0.00033708196,"about_ca_system_score_gemma":0.00017315257,"threshold_uncertainty_score":0.0071502924},"labels":[],"label_agreement":null},{"id":"W2942009355","doi":"10.1093/neuonc/noz036.124","title":"IMMU-03. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Evasion (ethics); Mutant; Medulloblastoma; Immune system; Tumor necrosis factor alpha; Cancer research; Biology; Immunology; Gene; Genetics","score_opus":0.010968401386089874,"score_gpt":0.26282367724237293,"score_spread":0.25185527585628303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942009355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948068,0.0011641021,0.0010028782,0.00015788153,0.000100671066,0.00006514427,0.00028351354,0.0001862106,0.0022327858],"genre_scores_gemma":[0.9942569,0.0007819953,0.0011563608,0.000066820336,0.000030606472,0.00006679875,0.0008081042,0.000027764452,0.0028048016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.000023958566,0.000011244456,0.000025609437,0.000034732973,0.00005673088],"domain_scores_gemma":[0.99989974,0.000014539955,0.000019507817,0.00001562983,0.00000779419,0.00004278596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018086746,0.0004302701,0.00036105252,0.00038124938,0.00018095216,0.0002542078,0.00037435052,0.0003868544,0.0010073017],"category_scores_gemma":[0.000088913745,0.00011843079,0.00040807735,0.00017259904,0.00028095758,0.00021504473,0.00016073207,0.0010745483,0.00037444045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011867153,0.001022991,0.00044232066,0.00009908254,0.000029727427,0.00025577974,0.00006859819,0.0003688142,0.9887518,0.0004191576,0.00029031473,0.0070646657],"study_design_scores_gemma":[0.0002412077,0.006176404,0.0023743755,0.000008091131,0.000033351815,0.0005217112,0.000028174782,0.0013087367,0.9848186,0.00007884169,0.004403881,0.0000066045195],"about_ca_topic_score_codex":0.0013606662,"about_ca_topic_score_gemma":0.0020356956,"teacher_disagreement_score":0.0013606662,"about_ca_system_score_codex":0.00044603465,"about_ca_system_score_gemma":0.00038604296,"threshold_uncertainty_score":0.003369689},"labels":[],"label_agreement":null},{"id":"W2942071564","doi":"10.1093/neuonc/noz036.043","title":"DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Carcinogenesis; Biology; Epigenetics; Downregulation and upregulation; Astrocyte; DNA methylation; Transcriptome; Cancer; Gene expression; Gene; Genetics; Neuroscience; Central nervous system","score_opus":0.019812996240092036,"score_gpt":0.3001464937425,"score_spread":0.280333497502408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942071564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92483014,0.003046125,0.041454617,0.00087472884,0.00030496623,0.00047065335,0.009384345,0.0020729615,0.017561411],"genre_scores_gemma":[0.9355766,0.002204967,0.025614152,0.00033846046,0.000020091125,0.00035564243,0.006294782,0.00034618593,0.029249184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.000018238517,0.00001277997,0.000055140412,0.00006896286,0.000043123968],"domain_scores_gemma":[0.99989974,0.00000898648,0.000034361685,0.00001328003,0.000009297517,0.000034366174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001646974,0.0006045486,0.0002781712,0.00058756006,0.00036781232,0.0003880535,0.00064249255,0.0006302981,0.0036899438],"category_scores_gemma":[0.00006617995,0.000353774,0.00044000585,0.00038662434,0.00047030856,0.00022379523,0.0005030087,0.0012120104,0.0012119764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100527584,0.000043562766,0.00036456645,0.00006637729,0.000011576354,0.0001715175,0.000023576044,0.00029197012,0.99388266,0.0009728078,0.00031232217,0.0037586202],"study_design_scores_gemma":[0.00004379258,0.00034616084,0.0026753906,0.000015679369,0.000041976135,0.0007054377,0.000031408974,0.0021663161,0.96932286,0.00023947007,0.02440075,0.000010838327],"about_ca_topic_score_codex":0.0030045344,"about_ca_topic_score_gemma":0.0059410045,"teacher_disagreement_score":0.0036899438,"about_ca_system_score_codex":0.00081851054,"about_ca_system_score_gemma":0.00049362826,"threshold_uncertainty_score":0.012344122},"labels":[],"label_agreement":null},{"id":"W2942081042","doi":"10.1093/neuonc/noz036.017","title":"BIOL-04. DISTAL-LESS/DLX2 HOMEOBOX GENE REGULATION OF CHEMOKINE RECEPTOR CXCR4 - ROLE IN MIGRATION IN FOREBRAIN DEVELOPMENT AND CNS TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Chromatin immunoprecipitation; Homeobox; Chemokine receptor; Promoter; DLX5; Homeobox A1; Transcription factor; Ganglionic eminence; Gene knockdown; Cell biology; Progenitor cell; Genetics; Gene; Gene expression; Receptor; Stem cell; Chemokine","score_opus":0.007720562370815912,"score_gpt":0.2359173302880664,"score_spread":0.2281967679172505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942081042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97680014,0.0039915056,0.004875186,0.00045861662,0.00011486445,0.00006874809,0.003012705,0.00031785187,0.010360437],"genre_scores_gemma":[0.95784134,0.000933333,0.004101155,0.00032729516,0.000025852352,0.00006068838,0.0043978933,0.00007711884,0.03223537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987376,0.000010533667,0.0000054328366,0.00004666031,0.00003112263,0.000032474858],"domain_scores_gemma":[0.99993455,0.000004749896,0.000018735944,0.0000045903153,0.0000053792633,0.000031990465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010581483,0.00042202466,0.00014651453,0.00021481092,0.00023366416,0.00029193953,0.00021584381,0.0002867425,0.00784984],"category_scores_gemma":[0.000045549557,0.00011464222,0.00024314706,0.000086260516,0.00026976474,0.00014470458,0.00024034662,0.00047995194,0.001980676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012754604,0.00003308912,0.00067626295,0.000051972907,0.0000043030695,0.00012806171,0.00001430912,0.00003681999,0.996609,0.00027423384,0.00022132504,0.0018230755],"study_design_scores_gemma":[0.00007540599,0.00035947448,0.07307956,0.000029927365,0.000023403589,0.0015762638,0.00012304871,0.001380854,0.9036397,0.00018162801,0.019521672,0.00000917248],"about_ca_topic_score_codex":0.0012704997,"about_ca_topic_score_gemma":0.0026497925,"teacher_disagreement_score":0.00784984,"about_ca_system_score_codex":0.0005562105,"about_ca_system_score_gemma":0.00025804553,"threshold_uncertainty_score":0.026260316},"labels":[],"label_agreement":null},{"id":"W2942259759","doi":"10.1093/neuonc/noz036.169","title":"MEDU-10. THERAPEUTIC TARGETING OF STEM CELL SELF-RENEWAL IN CHILDHOOD MEDULLOBLASTOMA: STRATEGIES FOR BLOCKING RECURRENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; BMI1; Wnt signaling pathway; Cancer research; Neural stem cell; Stem cell; Carcinogenesis; Biology; Medicine; Signal transduction; Internal medicine; Cancer; Cell biology","score_opus":0.011233738385092562,"score_gpt":0.2671099982123849,"score_spread":0.25587625982729234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942259759","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93055934,0.033781,0.008204719,0.0014117828,0.0003090634,0.0002913148,0.0023277006,0.0008719019,0.022243278],"genre_scores_gemma":[0.96397877,0.012856671,0.0053321496,0.0003046782,0.000035450954,0.0001473496,0.0017628529,0.0000494897,0.015532653],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994314,0.00000623268,0.0000040572686,0.000010756602,0.000018143677,0.000017667622],"domain_scores_gemma":[0.9999678,0.000003455563,0.000009332726,0.0000027972262,0.0000043082273,0.000012400861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010735222,0.00029067587,0.00025799978,0.0003514587,0.0001360261,0.00026602906,0.00030697536,0.00033683077,0.0029165265],"category_scores_gemma":[0.00005516235,0.00010178821,0.00023429036,0.00020293915,0.00018535931,0.00019051446,0.00020700293,0.0006789594,0.00078579807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011856462,0.00066237646,0.0012432737,0.0006519478,0.00005535204,0.0003048381,0.00010542107,0.0009958947,0.9016026,0.002463339,0.0026830253,0.088046335],"study_design_scores_gemma":[0.00030529953,0.0036007727,0.0071607595,0.000052336847,0.000093521,0.0011847789,0.000068569905,0.0027454041,0.9176807,0.00032287353,0.06676588,0.00001910706],"about_ca_topic_score_codex":0.0013046819,"about_ca_topic_score_gemma":0.005830069,"teacher_disagreement_score":0.0029165265,"about_ca_system_score_codex":0.0006849591,"about_ca_system_score_gemma":0.00042444293,"threshold_uncertainty_score":0.009756744},"labels":[],"label_agreement":null},{"id":"W2942259789","doi":"10.1093/neuonc/noz036.164","title":"MEDU-04. AN OTX2-PAX GENE NETWORK REGULATES GROUP 3 MEDULLOBLASTOMA DIFFERENTIATION AND TUMOR GROWTH","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Biology; Gene silencing; Cancer research; SOX2; PAX6; Transcription factor; Gene; Genetics","score_opus":0.004464760759300378,"score_gpt":0.21914764425750355,"score_spread":0.21468288349820316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942259789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97871745,0.003126947,0.0036718687,0.00023533037,0.00006220998,0.00005532807,0.0030405303,0.00048524883,0.010605103],"genre_scores_gemma":[0.9819052,0.0006917785,0.0017400327,0.00015368963,0.0000100776015,0.000059196886,0.0030543634,0.00006493147,0.012320794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992085,0.0000073241445,0.0000032805056,0.000021537371,0.000021587444,0.000025399524],"domain_scores_gemma":[0.9999535,0.000004148606,0.000013623229,0.0000036340234,0.0000049247733,0.000020213629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056295987,0.00024025909,0.00015611747,0.00026168983,0.0003208117,0.00030796084,0.00017083596,0.00020625073,0.003087773],"category_scores_gemma":[0.00006832305,0.00011260533,0.00026958657,0.00017650212,0.00019674649,0.00015130083,0.00035579628,0.00032612286,0.00067810446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034222365,0.000042978143,0.0041300966,0.00009517457,0.000012610632,0.0002922349,0.00006865583,0.0001558708,0.9845062,0.0006804422,0.00074816134,0.008925378],"study_design_scores_gemma":[0.00007469748,0.0004440372,0.19152038,0.000043390435,0.000081807004,0.0017320798,0.00026349162,0.0043330872,0.76390606,0.00059980736,0.03698549,0.000015797168],"about_ca_topic_score_codex":0.0013154072,"about_ca_topic_score_gemma":0.0024310586,"teacher_disagreement_score":0.003087773,"about_ca_system_score_codex":0.000494266,"about_ca_system_score_gemma":0.00027100602,"threshold_uncertainty_score":0.010329604},"labels":[],"label_agreement":null},{"id":"W2942462405","doi":"10.1093/neuonc/noz036.126","title":"IMMU-05. COMBINATIONAL CAR T-CELL AND EPIGENETIC MODIFIER THERAPY TO TARGET POSTERIOR FOSSA TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Internal medicine; Ependymoma; Cancer research; Gastroenterology; Surgery","score_opus":0.02445736219046114,"score_gpt":0.31455335705601534,"score_spread":0.2900959948655542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942462405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90055454,0.026410533,0.009814645,0.002302946,0.0010312089,0.0014542114,0.003832793,0.002193756,0.052405283],"genre_scores_gemma":[0.9540852,0.0078029903,0.009804771,0.0011475227,0.0002478487,0.0011767313,0.005651015,0.00009994978,0.019983929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964094,0.00007291855,0.000016597149,0.000076900644,0.000102016216,0.00009070603],"domain_scores_gemma":[0.9998473,0.000028810593,0.000021692567,0.000022309987,0.000015221331,0.00006465368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072306686,0.00067992357,0.00075954205,0.0006326727,0.00028754713,0.0010105608,0.0007284279,0.0011379849,0.0049061924],"category_scores_gemma":[0.00024239825,0.00024007178,0.0006962217,0.00041217526,0.0005425597,0.0004334042,0.00046030132,0.0026834346,0.0016188287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014412663,0.012959274,0.0042578657,0.0015450673,0.00063521287,0.0008082217,0.00035445567,0.005325963,0.63461566,0.007733541,0.020911988,0.29644006],"study_design_scores_gemma":[0.009270172,0.08537929,0.012994375,0.00018301436,0.00085276423,0.0036227289,0.00017684224,0.01029748,0.7194744,0.0015846747,0.15609048,0.000073813724],"about_ca_topic_score_codex":0.001368377,"about_ca_topic_score_gemma":0.0032949804,"teacher_disagreement_score":0.0049061924,"about_ca_system_score_codex":0.0010988185,"about_ca_system_score_gemma":0.0011188564,"threshold_uncertainty_score":0.016412914},"labels":[],"label_agreement":null},{"id":"W2944107502","doi":"10.1093/neuonc/noz084","title":"Proteomic analysis of meningiomas reveals clinically distinct molecular patterns","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Meningioma; Biology; Proteomics; Tandem mass tag; Pathology; Pathological; Cancer research; Bioinformatics; Computational biology; Quantitative proteomics; Medicine; Genetics; Gene","score_opus":0.023233692775150305,"score_gpt":0.32552197172673886,"score_spread":0.30228827895158855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944107502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751854,0.0006660881,0.00077900063,0.000031009014,0.0000048217953,0.000011685343,0.00059663574,0.00002813101,0.00036413278],"genre_scores_gemma":[0.9948756,0.00070537376,0.0023102877,0.00003317632,0.000009940876,0.000022069782,0.0017003949,0.000009828932,0.0003333367],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987006,0.000009494256,0.000014545628,0.000041534477,0.000042461652,0.000021872149],"domain_scores_gemma":[0.9998159,0.000022581004,0.00006988237,0.000017491564,0.000042956817,0.000031315445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023888357,0.00034754587,0.000219696,0.0011691405,0.00030839923,0.00040584782,0.00012078329,0.00021665619,0.0004261384],"category_scores_gemma":[0.00033035676,0.000091468966,0.00027589157,0.0005843382,0.00024560938,0.00015012026,0.00029795276,0.0001872103,0.00023246308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049721904,0.000042084237,0.1114496,0.00014856477,0.00011788406,0.0006879757,0.00023293501,0.00018105723,0.87854844,0.0000932827,0.00024970743,0.007751199],"study_design_scores_gemma":[0.000010945151,0.00021496326,0.86023825,0.00002100865,0.00010944698,0.0035021412,0.00038371974,0.0010644452,0.1321123,0.00027622632,0.0020513348,0.000015164509],"about_ca_topic_score_codex":0.00069920655,"about_ca_topic_score_gemma":0.0011707972,"teacher_disagreement_score":0.0011691405,"about_ca_system_score_codex":0.0002677788,"about_ca_system_score_gemma":0.00022542343,"threshold_uncertainty_score":0.001942873},"labels":[],"label_agreement":null},{"id":"W2945334907","doi":"10.1093/neuonc/noz088","title":"A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research","funders":"Blood Cancer UK; Cancer Research UK","keywords":"Primary central nervous system lymphoma; Genome-wide association study; Single-nucleotide polymorphism; Biology; Genetic association; Carcinogenesis; Germline; Genetics; Genetic predisposition; Lymphoma; Diffuse large B-cell lymphoma; Gene; Genotype; Immunology","score_opus":0.03826111693814501,"score_gpt":0.32475077663734314,"score_spread":0.28648965969919815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945334907","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956728,0.0010622342,0.0008533626,0.00023227904,0.000021142723,0.00001623239,0.0015805854,0.00003287503,0.00052854413],"genre_scores_gemma":[0.99797624,0.00024219674,0.00044274656,0.00007049148,0.000022483076,0.000020569745,0.0009256505,0.000013799158,0.00028585934],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99888414,0.00029765305,0.00007463537,0.000506104,0.000126006,0.00011148521],"domain_scores_gemma":[0.9979499,0.00067749096,0.0005479388,0.00026101575,0.00017379256,0.00038986036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009524725,0.00057240226,0.0006302999,0.0011311312,0.00075572025,0.00083821977,0.00065560825,0.00068701163,0.0036545524],"category_scores_gemma":[0.0032812953,0.00029769525,0.0013260677,0.002659196,0.0004037043,0.00028105217,0.0008548651,0.0008058494,0.00032895978],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016530035,0.000094482406,0.9768375,0.00013850926,0.003649287,0.0017212894,0.0002901312,0.0004145183,0.00712538,0.00024761818,0.0012900422,0.006538167],"study_design_scores_gemma":[0.00014958033,0.000121136254,0.9938955,0.000024830018,0.0021984996,0.0011240329,0.00011913215,0.00096335495,0.00032291486,0.00026708384,0.00080013287,0.000013807286],"about_ca_topic_score_codex":0.008361153,"about_ca_topic_score_gemma":0.009978919,"teacher_disagreement_score":0.008361153,"about_ca_system_score_codex":0.00035025674,"about_ca_system_score_gemma":0.00037747377,"threshold_uncertainty_score":0.016624987},"labels":[],"label_agreement":null},{"id":"W2947364881","doi":"10.1093/neuonc/noz126.006","title":"PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioma; Isocitrate dehydrogenase; Medicine; Internal medicine; Interim analysis; Hazard ratio; Oncology; IDH1; Univariate analysis; Randomized controlled trial; Confidence interval; Radiation therapy; Cancer research; Biology; Multivariate analysis","score_opus":0.014003937425835864,"score_gpt":0.30957072835750776,"score_spread":0.2955667909316719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947364881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738307,0.003568171,0.003066153,0.0014303607,0.0006139363,0.003896606,0.007528025,0.00020630722,0.0058597713],"genre_scores_gemma":[0.97345364,0.0006995602,0.0033986003,0.0012955536,0.0002028797,0.0062449463,0.009034029,0.000097938035,0.005572864],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803334,0.0013372065,0.00006869365,0.00023344402,0.00015620941,0.00017111494],"domain_scores_gemma":[0.9984585,0.00043856108,0.00040227702,0.00021301722,0.00013366481,0.0003539361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048355074,0.0010295141,0.001569679,0.00029097588,0.00029615103,0.00091476965,0.00053328194,0.00082279596,0.00534923],"category_scores_gemma":[0.0027677394,0.0003651177,0.002125395,0.00031816968,0.0006021119,0.0006595156,0.00048065514,0.0019297445,0.00062935805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9594471,0.0020010164,0.004435777,0.00042417608,0.0020019612,0.000062726205,0.00004359627,0.0015753952,0.007298833,0.00043348622,0.004230871,0.018045094],"study_design_scores_gemma":[0.75844705,0.18220504,0.033858947,0.000101154175,0.0040146643,0.00018744158,0.000053503587,0.003899086,0.0056135193,0.0015823265,0.009973763,0.00006347367],"about_ca_topic_score_codex":0.0005866351,"about_ca_topic_score_gemma":0.0018325538,"teacher_disagreement_score":0.00534923,"about_ca_system_score_codex":0.0010878558,"about_ca_system_score_gemma":0.0015617217,"threshold_uncertainty_score":0.025572896},"labels":[],"label_agreement":null},{"id":"W2948500453","doi":"10.1093/neuonc/noz061","title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Brain Tumour Charity","keywords":"Nomogram; Oncology; DNA methylation; Hazard ratio; Medicine; Internal medicine; Proportional hazards model; Meningioma; Bioinformatics; Surgery; Confidence interval; Biology; Genetics; Gene","score_opus":0.043418339530454805,"score_gpt":0.348758398496677,"score_spread":0.3053400589662222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948500453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8697353,0.0036902702,0.119913995,0.0017504519,0.00009650098,0.00021527814,0.0017912653,0.0008302241,0.001976665],"genre_scores_gemma":[0.9731424,0.00047281635,0.02538663,0.00008220947,0.000034619952,0.00006397066,0.0006040626,0.00003550166,0.00017778411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883336,0.00055866275,0.00009591313,0.00020778734,0.00023810171,0.00006604409],"domain_scores_gemma":[0.9953629,0.002292957,0.0010783463,0.00033439536,0.0006347065,0.0002966994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006253601,0.0010589184,0.00086690445,0.002420109,0.00038192276,0.0012587989,0.0007321973,0.0006068037,0.00050895463],"category_scores_gemma":[0.011500504,0.00022551954,0.0011040132,0.0007852161,0.00032835567,0.0006293086,0.0007856839,0.0010488289,0.00030025432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006791121,0.000109870736,0.8608866,0.00010559334,0.00056706666,0.00013531586,0.00014397019,0.032221437,0.0028168636,0.0004073367,0.0022061034,0.0997207],"study_design_scores_gemma":[0.000111491216,0.0010773075,0.41627124,0.00020255573,0.00085207325,0.0009149706,0.00033404966,0.5646885,0.0076376335,0.0035446046,0.004251725,0.00011373963],"about_ca_topic_score_codex":0.0027655778,"about_ca_topic_score_gemma":0.004648308,"teacher_disagreement_score":0.006253601,"about_ca_system_score_codex":0.0008289863,"about_ca_system_score_gemma":0.00088881596,"threshold_uncertainty_score":0.03307259},"labels":[],"label_agreement":null},{"id":"W2950177304","doi":"10.1093/neuonc/noz014","title":"Updates in the management of intradural spinal cord tumors: a radiation oncology focus","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Radiosurgery; Spinal cord; Radiation therapy; Adjuvant radiotherapy; Radiation treatment planning; Neuroimaging; Radiation oncology; Radiology","score_opus":0.06083292035226089,"score_gpt":0.38982472479798425,"score_spread":0.32899180444572335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950177304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011725642,0.9979614,0.00012121263,0.0005373049,0.00027457954,0.0000039324464,0.00002273167,0.000007725533,0.00095394783],"genre_scores_gemma":[0.00052028213,0.9984341,0.00019345789,0.0002894533,0.00025753005,0.0000030782421,0.00003562923,0.0000016950711,0.00026476852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978656,0.000044728735,0.000045384266,0.000034433335,0.00007222974,0.000016652448],"domain_scores_gemma":[0.9992957,0.0004061883,0.0000923267,0.000013716126,0.00015805248,0.000034012486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006017031,0.0005315289,0.0009162831,0.0021508469,0.00023872872,0.00090640126,0.0007722077,0.000766841,0.0035925307],"category_scores_gemma":[0.0013244698,0.00019450151,0.00054363336,0.0020306797,0.00038884953,0.0012126028,0.0004932755,0.0015480666,0.0012389154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003937428,0.00003511402,0.00024273724,0.021960992,0.00007968295,0.00022231168,0.000105645435,0.00040845526,0.0007035302,0.0024253894,0.036940183,0.93683666],"study_design_scores_gemma":[0.00000854735,0.000073034695,0.0009113492,0.009253226,0.00014752964,0.0017605769,0.00008933834,0.00008450772,0.00019937758,0.0014614825,0.98599446,0.00001656296],"about_ca_topic_score_codex":0.001365039,"about_ca_topic_score_gemma":0.0031181492,"teacher_disagreement_score":0.0035925307,"about_ca_system_score_codex":0.0006686176,"about_ca_system_score_gemma":0.0012164841,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2954113326","doi":"10.1093/neuonc/noz036.185","title":"MEDU-26. LATENT SOX9-POSITIVE CELLS RESPONSIBLE FOR MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; SOX9; Medicine; Biology; Oncology; Internal medicine; Pathology; Transcription factor","score_opus":0.02444233564010413,"score_gpt":0.3118399544628589,"score_spread":0.2873976188227548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954113326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970373,0.00033160963,0.0011935874,0.000052205916,0.000017138987,0.00002822353,0.00038755246,0.00007887408,0.0008735404],"genre_scores_gemma":[0.99737334,0.00008201133,0.00034817838,0.000018256545,0.0000033281678,0.0000164518,0.00027456039,0.000010993765,0.0018728813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988925,0.0000106308535,0.0000115938665,0.000027325854,0.000032467124,0.000028831839],"domain_scores_gemma":[0.9998536,0.00001467967,0.0000507574,0.000017694452,0.000010094665,0.00005304649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008871539,0.00017184201,0.00021857317,0.00027360112,0.00018095388,0.00026245468,0.00012842902,0.00026445082,0.002281444],"category_scores_gemma":[0.00008916583,0.000104318926,0.0002260545,0.00010927357,0.00023367307,0.00010301466,0.00018826104,0.0004224652,0.0006862885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013309844,0.00003408543,0.0016994106,0.000014870145,0.000004105667,0.00044999443,0.00001844801,0.000026604914,0.99637187,0.000120402074,0.00006742624,0.0010595544],"study_design_scores_gemma":[0.00005107633,0.0008027236,0.053488284,0.000009320364,0.000027778275,0.0069198706,0.000118874326,0.0017665597,0.93164706,0.00014298984,0.005016554,0.000008826255],"about_ca_topic_score_codex":0.0005434544,"about_ca_topic_score_gemma":0.0006935625,"teacher_disagreement_score":0.002281444,"about_ca_system_score_codex":0.00028834652,"about_ca_system_score_gemma":0.00014253592,"threshold_uncertainty_score":0.0076322556},"labels":[],"label_agreement":null},{"id":"W2965868302","doi":"10.1093/neuonc/noz104","title":"Barriers to accrual and enrollment in brain tumor trials","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Accrual; Clinical trial; Medicine; Clinical Oncology; Oncology; Internal medicine; Brain tumor; Cancer; Intensive care medicine; Pathology; Finance","score_opus":0.6162676222829154,"score_gpt":0.6451334011564825,"score_spread":0.028865778873567116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965868302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013497152,0.59628075,0.030908434,0.30553725,0.006233759,0.00875528,0.0012429494,0.00026819058,0.037276287],"genre_scores_gemma":[0.24512115,0.46840155,0.058540277,0.16843946,0.012401327,0.03467408,0.0017813562,0.00037588924,0.010264915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6816986,0.23692471,0.035143614,0.006121284,0.036279254,0.0038324664],"domain_scores_gemma":[0.5138753,0.3929424,0.044878867,0.015664486,0.025279645,0.007359424],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27635792,0.00065054244,0.002367609,0.0025427614,0.0015904232,0.00576862,0.0044556796,0.0041574617,0.008641922],"category_scores_gemma":[0.37830767,0.000969516,0.0020214682,0.0035272927,0.005452072,0.0059696985,0.0067941495,0.0072480845,0.0019394553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008046837,0.0003234738,0.010631377,0.02300674,0.0005328659,0.00042479785,0.0031187024,0.0013522287,0.00035190274,0.073308684,0.08566839,0.8004761],"study_design_scores_gemma":[0.0015105624,0.0007717748,0.0193457,0.07847694,0.00055239163,0.0028050917,0.0025314474,0.0013295617,0.001032411,0.1027612,0.78874636,0.0001365144],"about_ca_topic_score_codex":0.0032740016,"about_ca_topic_score_gemma":0.004025324,"teacher_disagreement_score":0.7236421,"about_ca_system_score_codex":0.00603753,"about_ca_system_score_gemma":0.03001663,"threshold_uncertainty_score":0.8923795},"labels":[],"label_agreement":null},{"id":"W2966974286","doi":"10.1093/neuonc/noz144","title":"Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Radiosurgery; Radiation therapy; Stereotactic radiotherapy; Odds ratio; Radiology; Retrospective cohort study; Internal medicine","score_opus":0.020314546432880082,"score_gpt":0.32420640377673066,"score_spread":0.3038918573438506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966974286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995739,0.00021704276,0.000040641546,0.000015304739,0.0000011112418,0.0000029480618,0.000052101983,0.0000015714661,0.00009539982],"genre_scores_gemma":[0.99977785,0.0000616357,0.00002962872,0.000004593616,0.0000035780781,0.0000016146005,0.000100431396,5.5726673e-7,0.000020198539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980885,0.000041634168,0.0000218404,0.000038778788,0.000056211302,0.000032644923],"domain_scores_gemma":[0.99858487,0.00030540404,0.00083196466,0.000042763935,0.00007103962,0.00016396282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030735513,0.00016217069,0.00020714942,0.00032999413,0.0001828484,0.00034184146,0.0002698414,0.00025386093,0.0009980073],"category_scores_gemma":[0.001848485,0.00013448758,0.00023868073,0.000386427,0.00023863476,0.00028062056,0.00026829014,0.00031584344,0.00009904453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007565186,0.000006761018,0.99875426,0.0000042941274,0.0000111841655,0.00011958275,0.000009203942,0.000052086925,0.0001830811,0.0000032261398,0.000018614917,0.000762086],"study_design_scores_gemma":[0.000005138013,0.00008907887,0.99864715,0.0000032757457,0.000018216359,0.000860768,0.00003528846,0.00017823499,0.0000914696,0.000008911179,0.000060658404,0.0000017016368],"about_ca_topic_score_codex":0.0021863573,"about_ca_topic_score_gemma":0.003330926,"teacher_disagreement_score":0.0021863573,"about_ca_system_score_codex":0.00025428412,"about_ca_system_score_gemma":0.0003284906,"threshold_uncertainty_score":0.0043472648},"labels":[],"label_agreement":null},{"id":"W2967570386","doi":"10.1093/neuonc/noz140","title":"Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Garron Family Cancer Centre; National Health and Medical Research Council; Medical Research Council; Canadian Cancer Society Research Institute; Brain Tumour Research","keywords":"Mitochondrial DNA; Cancer research; Metformin; Biology; Glycolysis; Carcinogenesis; Mitochondrion; In vivo; Apoptosis; Pharmacology; Biochemistry; Molecular biology; Cancer; Endocrinology; Metabolism; Genetics; Insulin; Gene","score_opus":0.01721324516394191,"score_gpt":0.27195604361080006,"score_spread":0.25474279844685815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967570386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977405,0.016303843,0.0046630087,0.00018959724,0.000032595897,0.000090582515,0.00020718237,0.000107544685,0.0010005499],"genre_scores_gemma":[0.98970556,0.006624432,0.0030392904,0.000037316713,0.000015131749,0.00005277225,0.00021121628,0.000010040583,0.00030424254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999443,0.000009708733,0.0000043259315,0.000011691282,0.000017143724,0.00001275673],"domain_scores_gemma":[0.9999193,0.000010186722,0.000037366066,0.000007758507,0.000009621525,0.000015758826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013509617,0.00031732058,0.00030371608,0.0002972542,0.000107922184,0.00023299275,0.00022326772,0.00021400893,0.0006554505],"category_scores_gemma":[0.00011177474,0.00006419221,0.00015103359,0.00025154196,0.00018323376,0.00017626045,0.00017704148,0.00035845628,0.00012135416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022484912,0.00049263716,0.009522827,0.0008588025,0.00009494475,0.0007980352,0.000065712455,0.0014091963,0.8722349,0.000565051,0.00057072565,0.11113873],"study_design_scores_gemma":[0.00031735073,0.009924661,0.045574643,0.00011145223,0.00034960054,0.0067859045,0.00015279677,0.002424065,0.9163232,0.00058532256,0.017430512,0.00002055757],"about_ca_topic_score_codex":0.0002870322,"about_ca_topic_score_gemma":0.0008951852,"teacher_disagreement_score":0.0006554505,"about_ca_system_score_codex":0.0003120816,"about_ca_system_score_gemma":0.00031011223,"threshold_uncertainty_score":0.0022642612},"labels":[],"label_agreement":null},{"id":"W2969765955","doi":"10.1093/neuonc/noz158","title":"Molecular correlates of cerebellar mutism syndrome in medulloblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; National Institutes of Health; Brain Tumour Charity; Pediatric Brain Tumor Foundation; American Brain Tumor Association","keywords":"Medulloblastoma; Medicine; Cohort; Odds ratio; Oncology; Subgroup analysis; Internal medicine; Posterior fossa; Pediatrics; Surgery; Pathology; Confidence interval","score_opus":0.008709402895213554,"score_gpt":0.2603287975178987,"score_spread":0.2516193946226852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969765955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994924,0.00015588409,0.00004921247,0.000021234722,0.0000018299896,0.0000028402612,0.00013336499,0.000004167789,0.00013911635],"genre_scores_gemma":[0.9995672,0.000085845466,0.00010521167,0.000005600508,0.0000048215716,0.000003206454,0.00019085595,0.0000019816657,0.0000352468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999782,0.000035893598,0.000030382422,0.000059061258,0.00005285631,0.000039883616],"domain_scores_gemma":[0.9985127,0.00015530814,0.0010139317,0.000050636616,0.00008083008,0.00018659899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031594044,0.00029486744,0.0002532732,0.0013344219,0.00034954437,0.0004768162,0.0003357036,0.00026111936,0.0013426271],"category_scores_gemma":[0.0015893098,0.00014637894,0.0002669282,0.00081965904,0.00033337952,0.0002712296,0.00046627322,0.00030746273,0.00012829156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006272303,0.00000731334,0.99740845,0.000005320989,0.000025017405,0.00025498122,0.000021329046,0.00006890185,0.0013191189,0.000025870246,0.000036744565,0.0007642776],"study_design_scores_gemma":[0.000002491778,0.000039091065,0.99789715,0.0000036222018,0.000025151794,0.0013493712,0.00006683316,0.00014751154,0.00029211686,0.000045344743,0.0001291711,0.0000020636205],"about_ca_topic_score_codex":0.0035974293,"about_ca_topic_score_gemma":0.0035950046,"teacher_disagreement_score":0.0035974293,"about_ca_system_score_codex":0.00033177895,"about_ca_system_score_gemma":0.0004208162,"threshold_uncertainty_score":0.0071529746},"labels":[],"label_agreement":null},{"id":"W2969951593","doi":"10.1093/neuonc/noz137","title":"Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Flinn Foundation","keywords":"Biology; Somatic cell; Cancer research; Metastasis; Nonsynonymous substitution; Phenotype; Pathology; Cancer; Gene; Genome; Genetics; Medicine","score_opus":0.012034795196554841,"score_gpt":0.2756917279217693,"score_spread":0.2636569327252145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969951593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958191,0.00022733974,0.0027331652,0.00002400555,0.0000062084073,0.000050605067,0.00030099327,0.00004652724,0.0007920541],"genre_scores_gemma":[0.9956956,0.00016914394,0.0024492845,0.000022916942,0.0000027894012,0.0000349372,0.00071732706,0.000013511019,0.0008945419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999063,0.00001444185,0.0000121036355,0.00002378612,0.00002675238,0.000016596568],"domain_scores_gemma":[0.99978,0.00006959428,0.00003915851,0.000035960544,0.000022057502,0.00005316144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019640781,0.00022560361,0.00017623928,0.00020649354,0.000106037136,0.00023678398,0.00012533728,0.00018981622,0.0013440524],"category_scores_gemma":[0.00019452932,0.000087808345,0.00014815641,0.00010323612,0.00011770956,0.00010719961,0.00021369634,0.0005453107,0.0002575618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018822358,0.00008691248,0.004397283,0.000022886676,0.000012226429,0.00026393365,0.0000380363,0.00015007051,0.99150664,0.0002125875,0.00010182839,0.0030195077],"study_design_scores_gemma":[0.00006737048,0.0028985026,0.047578447,0.000012856337,0.000059643186,0.007529768,0.0000859501,0.0035710398,0.9328951,0.00022797749,0.005063406,0.000009987843],"about_ca_topic_score_codex":0.0003594408,"about_ca_topic_score_gemma":0.0006617725,"teacher_disagreement_score":0.0013440524,"about_ca_system_score_codex":0.00017913365,"about_ca_system_score_gemma":0.000137447,"threshold_uncertainty_score":0.004496336},"labels":[],"label_agreement":null},{"id":"W2971408290","doi":"10.1093/neuonc/noz126.327","title":"P14.92 Study of Glutaminergic and Glutamatergic Metabolism in 1H-MRS Monovoxel in the Most Aggressive Part of 62 Glioblastoma Before and After 18 months Treatment","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut interdisciplinaire d'innovation technologique; Université de Sherbrooke","funders":"","keywords":"T-cell receptor; Glioblastoma; Radiation therapy; Glutamine; Medicine; Internal medicine; Glutamatergic; Glutamate receptor; Oncology; Gastroenterology; Biology; Cancer research; T cell; Amino acid; Immunology; Receptor; Biochemistry; Immune system","score_opus":0.013594801122954032,"score_gpt":0.3035628431579576,"score_spread":0.2899680420350036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971408290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925905,0.00021200215,0.00012942535,0.000008444342,0.0000024639444,0.0000046375085,0.00013251152,0.000006052029,0.00024533673],"genre_scores_gemma":[0.9993137,0.000081918464,0.000097957105,0.0000066168577,0.0000034225884,0.000008626002,0.00022609333,0.0000033455685,0.00025828497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99995756,0.000005461917,0.000004066178,0.0000098307855,0.000009175157,0.000013869859],"domain_scores_gemma":[0.99989724,0.0000101119585,0.000032795637,0.0000060672014,0.000021085587,0.00003273673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105195984,0.00016214396,0.00028818686,0.00031131876,0.0002113952,0.00025644543,0.00008728024,0.00016283,0.0011710196],"category_scores_gemma":[0.00021688934,0.00007543443,0.00012320388,0.0002466784,0.00012563607,0.00012358003,0.00011957965,0.0001260128,0.000283459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010226749,0.0002801198,0.78432494,0.00012241853,0.00012439235,0.0028937224,0.0004923047,0.00032066574,0.16015133,0.000045591587,0.00038409067,0.04063365],"study_design_scores_gemma":[0.000018965224,0.0010959917,0.9882067,0.0000040512323,0.00005371018,0.0013937673,0.0001699089,0.0003467112,0.008093094,0.000030473539,0.0005803378,0.00000634057],"about_ca_topic_score_codex":0.0019569332,"about_ca_topic_score_gemma":0.0016889258,"teacher_disagreement_score":0.0019569332,"about_ca_system_score_codex":0.00015236261,"about_ca_system_score_gemma":0.00016239926,"threshold_uncertainty_score":0.0039174557},"labels":[],"label_agreement":null},{"id":"W2971458410","doi":"10.1093/neuonc/noz126.271","title":"P14.36 Treatment patterns by O6-methylguanine DNA methyltransferase promoter (MGMT) status in newly-diagnosed glioblastoma multiforme (GBM): a multi-country chart review study","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Procarbazine; Lomustine; Internal medicine; Radiation therapy; Glioblastoma; Oncology; Surgery; Vincristine; Chemotherapy; Cancer research","score_opus":0.01997145928084013,"score_gpt":0.31810502807559654,"score_spread":0.2981335687947564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971458410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942531,0.000781447,0.0001184895,0.00008200212,0.0000054583243,0.00005358704,0.0041098623,0.000008375136,0.00058769615],"genre_scores_gemma":[0.9976846,0.00039189484,0.00017696313,0.000029393274,0.0000049923956,0.000029108518,0.0015586984,0.0000020620616,0.00012227849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999046,0.00026064462,0.00021295829,0.00018692866,0.00017406611,0.00011928789],"domain_scores_gemma":[0.9938876,0.0011109741,0.003622585,0.00014931204,0.0009060739,0.0003235075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092651456,0.000117115276,0.00021592288,0.0021939739,0.00034971288,0.0006101781,0.00029243788,0.00022351781,0.0010800116],"category_scores_gemma":[0.0032660505,0.00015976744,0.00031480813,0.003407836,0.0002357718,0.00039619752,0.00037470754,0.00014883622,0.0001645897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012319716,0.0000041368917,0.9985689,0.000025359572,0.000013598009,0.000075431286,0.000094667266,0.000012589507,0.00005341248,0.0000043166915,0.00013964283,0.000995667],"study_design_scores_gemma":[0.0000015752281,0.000017406821,0.99894994,0.000015981745,0.000010354207,0.00021523079,0.00034986768,0.00004062912,0.00005745355,0.0000018865998,0.0003373895,0.000002343147],"about_ca_topic_score_codex":0.03710436,"about_ca_topic_score_gemma":0.048917033,"teacher_disagreement_score":0.03710436,"about_ca_system_score_codex":0.0009280917,"about_ca_system_score_gemma":0.0009919419,"threshold_uncertainty_score":0.07377678},"labels":[],"label_agreement":null},{"id":"W2971480381","doi":"10.1093/neuonc/noz126.265","title":"P14.30 Treatment outcomes of newly-diagnosed glioblastoma multiforme (GBM) by O6-methylguanine DNA methyltransferase promoter (MGMT) status: a multi-country study","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Life expectancy; Temozolomide; Glioblastoma; Internal medicine; Radiation therapy; Surgery","score_opus":0.018700778715185752,"score_gpt":0.31456889053716497,"score_spread":0.2958681118219792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971480381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985116,0.00023655385,0.000027000164,0.000048461083,0.0000029523328,0.0000073158035,0.0008823366,0.0000012253048,0.00028258568],"genre_scores_gemma":[0.9993868,0.000080930244,0.000021694987,0.000018343855,0.0000034414265,0.000004611915,0.00042541343,7.6167424e-7,0.00005799084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992557,0.00025969214,0.00007726716,0.0001340167,0.00011644328,0.00015675851],"domain_scores_gemma":[0.99723744,0.00035083323,0.0015526274,0.00007119338,0.0003697727,0.00041825918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007726954,0.00019184627,0.00032985542,0.0008145083,0.00040249943,0.00071696553,0.00039249592,0.00028776925,0.001099827],"category_scores_gemma":[0.0023595034,0.0001591295,0.00063890213,0.0015946104,0.00029774237,0.00039498886,0.0005258031,0.0002889236,0.00014808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033249038,0.00000647617,0.9994506,0.000004558767,0.000036391455,0.000012447124,0.000020382206,0.000018393868,0.000017835311,0.0000027578897,0.000040944706,0.00035591348],"study_design_scores_gemma":[0.0000034353277,0.000036645,0.99956316,0.0000062668405,0.000023666242,0.000052988362,0.00014738571,0.000054498192,0.000016732243,0.00000278901,0.00009078724,0.000001626567],"about_ca_topic_score_codex":0.088740304,"about_ca_topic_score_gemma":0.10886756,"teacher_disagreement_score":0.088740304,"about_ca_system_score_codex":0.0011435513,"about_ca_system_score_gemma":0.0009284525,"threshold_uncertainty_score":0.17644751},"labels":[],"label_agreement":null},{"id":"W2971565273","doi":"10.1093/neuonc/noz126.346","title":"P14.111 Successful treatment of extensive metastatic disease with successive use of two different EGF receptor antagonists: case report and review of the literature","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lesion; Progressive disease; Adenocarcinoma; Biopsy; Pathology; Radiology; Oncology; Internal medicine; Cancer; Disease","score_opus":0.019081788891445513,"score_gpt":0.3480427698820698,"score_spread":0.32896098099062426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971565273","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18816145,0.75492907,0.011416047,0.0065759844,0.0037677793,0.0003301856,0.00039369683,0.000433233,0.033992514],"genre_scores_gemma":[0.6107529,0.3625411,0.005574951,0.005531686,0.007333095,0.0001352556,0.00054899853,0.00010201512,0.007479903],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994273,0.000079413934,0.00015110629,0.00012146259,0.00011575008,0.000104928615],"domain_scores_gemma":[0.9994311,0.00022646473,0.00016043201,0.00005110234,0.00005905134,0.000071764975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032547925,0.0014411206,0.0013459668,0.0026544163,0.00084218034,0.001540171,0.0016757628,0.003770105,0.0018155029],"category_scores_gemma":[0.0010299967,0.00050694944,0.001001783,0.002352794,0.0014438885,0.0018356572,0.0007661066,0.0018391659,0.0013046614],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004219174,0.000084113075,0.0030772653,0.001312392,0.00009404939,0.9472163,0.00023243508,0.00021189629,0.0016475084,0.00038484382,0.0040106163,0.041686404],"study_design_scores_gemma":[0.000008778719,0.00004961763,0.0016864975,0.00027078777,0.00006588771,0.9832776,0.00015268271,0.00016028456,0.00061828987,0.00016614968,0.013526153,0.00001713626],"about_ca_topic_score_codex":0.0006555857,"about_ca_topic_score_gemma":0.0008913433,"teacher_disagreement_score":0.003770105,"about_ca_system_score_codex":0.00058984064,"about_ca_system_score_gemma":0.0006791471,"threshold_uncertainty_score":0.006073475},"labels":[],"label_agreement":null},{"id":"W2971939959","doi":"10.1093/neuonc/noz126.115","title":"P05.01 the efficacy of donepezil on cognitive function in postoperative brain tumor patients","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Donepezil; Cognition; Medicine; Montreal Cognitive Assessment; Verbal fluency test; Brain tumor; Verbal memory; Cognitive decline; Dementia; Psychology; Internal medicine; Psychiatry; Neuropsychology; Cognitive impairment; Disease","score_opus":0.015094329918717874,"score_gpt":0.29535394261686615,"score_spread":0.28025961269814825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971939959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997163,0.0013437239,0.000036432128,0.00010700444,0.00009011184,0.00007626629,0.00022900155,0.0000073527817,0.0009469975],"genre_scores_gemma":[0.9986935,0.00039542883,0.000078834026,0.00007113834,0.00003241856,0.000067992114,0.00014359462,9.817492e-7,0.0005162054],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99979335,0.00006567504,0.00002444357,0.00002657782,0.00003311741,0.000056892222],"domain_scores_gemma":[0.99943644,0.00016211347,0.00009836787,0.000030616786,0.000064034466,0.00020843135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044026767,0.00032084656,0.00083013764,0.0001490943,0.00019521032,0.00033804323,0.00023606961,0.0003384997,0.0042077326],"category_scores_gemma":[0.0007840284,0.00010327313,0.00068788294,0.00015130716,0.00020004778,0.00021822375,0.00017955861,0.0006506664,0.00038614843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7442156,0.027538806,0.05815458,0.0017205366,0.0014944916,0.00036034582,0.00024130939,0.00032979465,0.018098943,0.00010447645,0.0027457685,0.14499526],"study_design_scores_gemma":[0.05958673,0.61213404,0.3149882,0.00022496257,0.0015673138,0.00043610026,0.00032286104,0.0010453847,0.006970963,0.00019058453,0.0024976947,0.00003529156],"about_ca_topic_score_codex":0.0005562593,"about_ca_topic_score_gemma":0.0008510607,"teacher_disagreement_score":0.0042077326,"about_ca_system_score_codex":0.00015880981,"about_ca_system_score_gemma":0.00042882832,"threshold_uncertainty_score":0.014076233},"labels":[],"label_agreement":null},{"id":"W2972016058","doi":"10.1093/neuonc/noz126.167","title":"P11.21 Treating numerous secondary tumors in the brain with tumor treating fields: Simulation study to identify optimal transducer array layout","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transducer; Brain tumor; Melanoma; Biomedical engineering; Pathology; Physics; Cancer research; Acoustics","score_opus":0.019306224455466692,"score_gpt":0.32949968572035016,"score_spread":0.31019346126488345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972016058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697836,0.00025531097,0.022481985,0.00013852544,0.000026185038,0.000086071,0.00059430604,0.00020419464,0.0064298273],"genre_scores_gemma":[0.99102074,0.00012669303,0.0073784715,0.000024241528,0.000005499102,0.000056828983,0.00019160239,0.000028196258,0.0011677243],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999256,0.000020894931,0.000002805355,0.000011830251,0.000015825719,0.000022984601],"domain_scores_gemma":[0.99926513,0.0005239417,0.00007331871,0.000027717693,0.00007104187,0.000038917486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020534672,0.0004317128,0.00045287065,0.00038205707,0.00020367597,0.00043210745,0.0006417151,0.0008045093,0.0025570237],"category_scores_gemma":[0.0009474005,0.00027977693,0.00047730622,0.00036260183,0.00043173437,0.000199414,0.00026185982,0.0002991819,0.0001865389],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008276258,0.00003878172,0.0010419016,0.000037693993,0.0000150481565,0.00009451305,0.000022880646,0.9953576,0.0016845352,0.00025728138,0.00015192507,0.0012151281],"study_design_scores_gemma":[0.000044776898,0.00016317422,0.0008739728,0.0000073679416,0.00002542135,0.000049044178,0.000037609534,0.99596137,0.0022892847,0.00021075793,0.00032960775,0.0000076283177],"about_ca_topic_score_codex":0.009976664,"about_ca_topic_score_gemma":0.006193812,"teacher_disagreement_score":0.009976664,"about_ca_system_score_codex":0.00053457974,"about_ca_system_score_gemma":0.0007492055,"threshold_uncertainty_score":0.019837141},"labels":[],"label_agreement":null},{"id":"W2972108419","doi":"10.1093/neuonc/noz126.164","title":"P11.18 Tumor treating fields (TTFields) treatment of spinal cord metastases","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Spinal cord; Cancer; Lung cancer; Radiology; Pathology; Internal medicine","score_opus":0.024096254416006397,"score_gpt":0.3437658164713789,"score_spread":0.3196695620553725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972108419","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.850554,0.0021324873,0.09734182,0.00066241104,0.00019811305,0.0003092709,0.0025223787,0.0011481688,0.04513139],"genre_scores_gemma":[0.9806296,0.00043775668,0.012091963,0.00007562888,0.000012208663,0.00012289929,0.00037486973,0.000077626275,0.006177467],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999747,0.0000043521704,8.881523e-7,0.000004775637,0.000009078664,0.0000061912174],"domain_scores_gemma":[0.99995315,0.000016087084,0.000011533853,0.000002642907,0.000007113869,0.000009374693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057281362,0.00021553226,0.0001600631,0.00014601607,0.000097686985,0.00017836755,0.00024414365,0.00021379926,0.004874791],"category_scores_gemma":[0.00017937517,0.00007425432,0.00016539851,0.00010759942,0.00013677814,0.00010278152,0.00015281714,0.00014484374,0.00043743823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006246085,0.00024065675,0.0039981483,0.0005435249,0.000050560662,0.0013823427,0.000086457236,0.8211614,0.10267241,0.004102489,0.008244699,0.056892723],"study_design_scores_gemma":[0.00022688287,0.0022860486,0.005258938,0.000060334212,0.00006834904,0.0011611268,0.000084260675,0.8872483,0.07791056,0.002842574,0.0228221,0.000030468222],"about_ca_topic_score_codex":0.0021116945,"about_ca_topic_score_gemma":0.0021439693,"teacher_disagreement_score":0.004874791,"about_ca_system_score_codex":0.00024025106,"about_ca_system_score_gemma":0.00038985576,"threshold_uncertainty_score":0.01630783},"labels":[],"label_agreement":null},{"id":"W2972153599","doi":"10.1093/neuonc/noz126.131","title":"P08.05 Cognitive impairment in patients with newly-diagnosed high-grade gliomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dysexecutive syndrome; Cognition; Logistic regression; Montreal Cognitive Assessment; Medicine; Executive dysfunction; Stepwise regression; Internal medicine; Executive functions; Effects of sleep deprivation on cognitive performance; Psychology; Oncology; Audiology; Psychiatry; Cognitive impairment; Neuropsychology","score_opus":0.0107031853448566,"score_gpt":0.27408779660997407,"score_spread":0.2633846112651175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972153599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903,0.00020044044,0.00007051242,0.000044271175,0.00001189449,0.0000032321554,0.00014436111,0.000004684518,0.0004906089],"genre_scores_gemma":[0.99977976,0.000024351264,0.000027677248,0.000006502895,0.000008556622,0.000001603029,0.00006964406,7.6161047e-7,0.00008098894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997776,0.00005733961,0.000023415452,0.000050366307,0.000045622226,0.000045649253],"domain_scores_gemma":[0.998384,0.00044538212,0.00070007425,0.00005887533,0.00014801187,0.00026368332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033624942,0.00037982606,0.00027490433,0.00084033544,0.00026359092,0.0005131632,0.0003202186,0.0003763633,0.0031064984],"category_scores_gemma":[0.002227296,0.00010490759,0.0004896309,0.00061288866,0.00027841958,0.00028270978,0.00030176583,0.00041811474,0.00032284035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018099594,0.000021508633,0.99778134,0.000010884018,0.000036464528,0.00026276952,0.000024939365,0.000040190203,0.0001846191,0.000011130994,0.000083956395,0.0013611934],"study_design_scores_gemma":[0.0000071815275,0.00011656031,0.998135,0.000005019174,0.00003491591,0.0011598243,0.000079535756,0.00022387295,0.00011464011,0.000034768804,0.000086515,0.0000022409702],"about_ca_topic_score_codex":0.0024662192,"about_ca_topic_score_gemma":0.0013759938,"teacher_disagreement_score":0.0031064984,"about_ca_system_score_codex":0.00020013403,"about_ca_system_score_gemma":0.0003025139,"threshold_uncertainty_score":0.010392308},"labels":[],"label_agreement":null},{"id":"W2972232735","doi":"10.1093/neuonc/noz126.171","title":"P11.25 Assessing electrical properties of cells as predictive marker for patient-specific TTFields response and optimal frequency","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microfluidic and Bio-sensing Technologies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dielectrophoresis; Materials science; Capacitance; Permittivity; Electric field; Biomedical engineering; Optoelectronics; Nanotechnology; Dielectric; Chemistry; Medicine; Physics; Microfluidics; Electrode","score_opus":0.013484104507266,"score_gpt":0.2289120334157998,"score_spread":0.2154279289085338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972232735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855971,0.00195967,0.008430032,0.00014296721,0.000048585258,0.00007593366,0.00089016126,0.00013063614,0.0027248936],"genre_scores_gemma":[0.9934557,0.00063529355,0.003219508,0.00007356926,0.000014542514,0.00011538252,0.00060739054,0.000021584237,0.0018570054],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996537,0.00005627874,0.0000305518,0.00008643075,0.000116575124,0.00005652418],"domain_scores_gemma":[0.999551,0.00018781908,0.00008847897,0.000034657594,0.00008665931,0.00005134463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003177053,0.00029114846,0.000350817,0.0003694813,0.00015903241,0.000448691,0.00014328514,0.00044453586,0.0041888584],"category_scores_gemma":[0.0006281856,0.000112935035,0.00017660565,0.00036188628,0.00025334494,0.0002100016,0.00018600129,0.000440377,0.00092647225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007557055,0.000126746,0.016382925,0.00013291281,0.00002581303,0.00020386504,0.00006009859,0.00040672073,0.96976244,0.00010747852,0.00038883492,0.011646529],"study_design_scores_gemma":[0.000022276363,0.0019009045,0.088877946,0.00002105466,0.000056792804,0.0013194142,0.00019640017,0.0027261146,0.9008972,0.00024390305,0.0037218896,0.000016191616],"about_ca_topic_score_codex":0.00015653126,"about_ca_topic_score_gemma":0.00016435447,"teacher_disagreement_score":0.0041888584,"about_ca_system_score_codex":0.00019241875,"about_ca_system_score_gemma":0.00012748939,"threshold_uncertainty_score":0.014013171},"labels":[],"label_agreement":null},{"id":"W2972253681","doi":"10.1093/neuonc/noz126.319","title":"P14.84 Intraarterial chemotherapy and osmotic blood-brain barrier modification in the treatment of primary CNS lymphoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Methotrexate; Central nervous system; Primary central nervous system lymphoma; Mannitol; Blood–brain barrier; Institutional review board; Anesthesia; Internal medicine; Oncology; Surgery","score_opus":0.017407822594991833,"score_gpt":0.27657405770059484,"score_spread":0.259166235105603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972253681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865215,0.009200737,0.001079324,0.00021832145,0.00014244406,0.000534217,0.00013647845,0.00007663629,0.0020903575],"genre_scores_gemma":[0.9925625,0.003530147,0.0015801154,0.00017461875,0.000100913654,0.00045953557,0.00024311738,0.000015891099,0.0013331977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99972874,0.0000995361,0.000018547908,0.000044509226,0.000046194567,0.00006241314],"domain_scores_gemma":[0.9998542,0.000020384194,0.000027898795,0.000016106123,0.000018223076,0.00006321245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045283636,0.00034690186,0.00093857327,0.00043039932,0.00023398652,0.00055753614,0.0004083772,0.00036360256,0.0016344828],"category_scores_gemma":[0.0002953936,0.00015110575,0.00036536824,0.00046845665,0.0004045773,0.0002973143,0.00028531632,0.000906577,0.0004406632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05530978,0.039303187,0.014875756,0.0019044499,0.00070693094,0.001584788,0.00036716004,0.0031388593,0.25630444,0.0008576418,0.0049773986,0.6206697],"study_design_scores_gemma":[0.02888799,0.746471,0.057966318,0.00025402103,0.0011815059,0.005749217,0.0001835216,0.0048101377,0.11236038,0.00052460487,0.041545242,0.00006613428],"about_ca_topic_score_codex":0.0004726327,"about_ca_topic_score_gemma":0.00086401857,"teacher_disagreement_score":0.0016344828,"about_ca_system_score_codex":0.0003709122,"about_ca_system_score_gemma":0.0006987253,"threshold_uncertainty_score":0.0054678917},"labels":[],"label_agreement":null},{"id":"W2972294464","doi":"10.1093/neuonc/noz126.186","title":"P11.40 Development of an implantable multifunctional biodevice (GlioGel) in the treatment of recurrent glioblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"In vivo; Temozolomide; Chemokine; Glioma; In vitro; Doxorubicin; Cancer research; Adjuvant; Brain tumor; Glioblastoma; Chemotherapy; Chemotaxis; Medicine; Pathology; Biology; Immunology; Internal medicine; Inflammation","score_opus":0.025962242766585288,"score_gpt":0.3058512753699586,"score_spread":0.27988903260337333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972294464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845708,0.0035265856,0.009115652,0.00015853919,0.00010689074,0.00011365641,0.0002752137,0.00016747758,0.0019651211],"genre_scores_gemma":[0.9852688,0.0026867473,0.008013902,0.00009283995,0.00002597071,0.00011390838,0.0003606772,0.000035635534,0.003401505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999486,0.000006700489,0.0000029306457,0.00001186236,0.000015614089,0.000014167468],"domain_scores_gemma":[0.9999628,0.000004766584,0.000010965784,0.0000025245317,0.0000060067255,0.000012963161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013492083,0.0002977838,0.00019439601,0.0002453152,0.00006785373,0.00018657092,0.00016962411,0.00027780284,0.00086587336],"category_scores_gemma":[0.0000656567,0.00009796852,0.00030540308,0.00009158888,0.00011828205,0.00015517948,0.00015001424,0.00024503635,0.0002636608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011741122,0.00011176255,0.00012127013,0.00012394073,0.000010991451,0.00010886884,0.000021278629,0.00031577167,0.99056107,0.000092733964,0.00013170466,0.008283147],"study_design_scores_gemma":[0.000067669025,0.004099243,0.0030700974,0.000027488948,0.00007559644,0.000529201,0.00002192053,0.0019736108,0.98264635,0.000047924616,0.007428014,0.000012913752],"about_ca_topic_score_codex":0.0003445277,"about_ca_topic_score_gemma":0.00040882727,"teacher_disagreement_score":0.00086587336,"about_ca_system_score_codex":0.00011758459,"about_ca_system_score_gemma":0.00013393548,"threshold_uncertainty_score":0.0028966665},"labels":[],"label_agreement":null},{"id":"W2977486434","doi":"10.1093/neuonc/noz174","title":"Finding a four-leaf clover—identifying long-term survivors in IDH-wildtype glioblastoma","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Term (time); Glioblastoma; Wild type; Biology; Type (biology); Genetics; Oncology; Medicine; Cancer research; Gene; Ecology; Physics; Astronomy","score_opus":0.0451457835727409,"score_gpt":0.3194752112077933,"score_spread":0.2743294276350524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977486434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6822643,0.0052567814,0.0012629806,0.28709456,0.0034494842,0.00008448122,0.00067699124,0.00011886683,0.019791566],"genre_scores_gemma":[0.946983,0.0026444613,0.0010050577,0.041712184,0.0032524716,0.000019821991,0.00020541722,0.000043304583,0.004134372],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99981016,0.000029439329,0.000022062037,0.000026537387,0.000034121964,0.00007780723],"domain_scores_gemma":[0.9994493,0.00016747665,0.000073285664,0.00002372216,0.000095314455,0.00019094997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019003407,0.00027265845,0.00045825893,0.000540328,0.0011344418,0.00077466056,0.00052552996,0.0037103929,0.0018189065],"category_scores_gemma":[0.0026696764,0.00019484658,0.00043456318,0.00043327798,0.00051070726,0.0009515184,0.00045754964,0.002483988,0.00069955515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048213592,0.00017791771,0.32475182,0.000093952876,0.000050619,0.5529103,0.0008868078,0.00048601953,0.0045184023,0.0013747911,0.06983714,0.044430066],"study_design_scores_gemma":[0.00007191535,0.0008137991,0.12235604,0.00034962714,0.00020712282,0.8080127,0.0076450333,0.0044047907,0.00245739,0.008725126,0.044853877,0.00010258556],"about_ca_topic_score_codex":0.009219687,"about_ca_topic_score_gemma":0.011889456,"teacher_disagreement_score":0.009219687,"about_ca_system_score_codex":0.0010623863,"about_ca_system_score_gemma":0.00090575585,"threshold_uncertainty_score":0.018332005},"labels":[],"label_agreement":null},{"id":"W2978500253","doi":"10.1093/neuonc/noz126.185","title":"P11.39 Chloroquine as an anti-glioblastoma therapeutic: repurposing of an old drug","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Drug; Pharmacology; Cerebrospinal fluid; Blood–brain barrier; Brain tumor; Internal medicine; Pathology; Central nervous system","score_opus":0.015730661209330678,"score_gpt":0.3067880532282295,"score_spread":0.2910573920188988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978500253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.614112,0.31773835,0.009884833,0.008013346,0.0012975418,0.00047044142,0.0018040452,0.0005024602,0.04617698],"genre_scores_gemma":[0.8709404,0.10333303,0.0049116276,0.0016016576,0.0004411722,0.0001549938,0.0008375123,0.000040694555,0.01773893],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995697,0.000008219754,0.0000028948562,0.000008466494,0.000011451868,0.000012036816],"domain_scores_gemma":[0.99996483,0.0000036744618,0.000007695464,0.0000026948546,0.000009136647,0.000011860403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112086615,0.00032160358,0.00026001062,0.00024550638,0.00014213013,0.00032595996,0.00025098593,0.00029167635,0.0027760365],"category_scores_gemma":[0.00006273508,0.00008477506,0.0001434812,0.00013044363,0.0002602671,0.00028142487,0.00023898538,0.00047086008,0.00054477766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022593231,0.00037667577,0.0010113211,0.0016658807,0.000051208335,0.0012947817,0.00008416491,0.00059577933,0.7648497,0.0044442127,0.008065455,0.21530147],"study_design_scores_gemma":[0.000893045,0.012705131,0.013232214,0.0003916194,0.00021560164,0.0065938276,0.00011566724,0.0030404867,0.5813243,0.0024706114,0.37894687,0.00007064982],"about_ca_topic_score_codex":0.00050497934,"about_ca_topic_score_gemma":0.0009992846,"teacher_disagreement_score":0.0027760365,"about_ca_system_score_codex":0.0003145675,"about_ca_system_score_gemma":0.0002533418,"threshold_uncertainty_score":0.009286761},"labels":[],"label_agreement":null},{"id":"W2981017557","doi":"10.1093/neuonc/noz175.323","title":"EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Glioma; Computer science; Electronic data capture; Medical physics; Medicine; Clinical trial; Translational research; Data science; Data mining; Pathology","score_opus":0.07409258431600414,"score_gpt":0.39058704126985927,"score_spread":0.31649445695385514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981017557","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013338762,0.0012113173,0.13453169,0.016702242,0.0013820583,0.021362087,0.7744639,0.00762294,0.029385028],"genre_scores_gemma":[0.063806444,0.0015583,0.37798285,0.008684664,0.000648451,0.08264968,0.45451933,0.0023923563,0.007757957],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.895544,0.057400584,0.033158842,0.004489971,0.007516453,0.0018900795],"domain_scores_gemma":[0.6360221,0.17849934,0.03498543,0.08483356,0.057232045,0.008427498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14246882,0.0008070451,0.0016356596,0.006603655,0.0015144027,0.005266158,0.0028067906,0.0022295786,0.021318758],"category_scores_gemma":[0.2931815,0.0014719462,0.0036658377,0.009786994,0.0017165313,0.0044220276,0.009222536,0.0033636813,0.008601175],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005147709,0.0005812606,0.07508407,0.016505193,0.0016798202,0.00046106728,0.0044368855,0.0035100325,0.0020101713,0.0887872,0.5512413,0.25055534],"study_design_scores_gemma":[0.0017710428,0.00079554995,0.07334815,0.0052200295,0.0006749595,0.0002903687,0.0008364063,0.0016088217,0.00358328,0.023070151,0.8886051,0.00019612735],"about_ca_topic_score_codex":0.005655852,"about_ca_topic_score_gemma":0.005526942,"teacher_disagreement_score":0.14246882,"about_ca_system_score_codex":0.0046401015,"about_ca_system_score_gemma":0.02743626,"threshold_uncertainty_score":0.7534562},"labels":[],"label_agreement":null},{"id":"W2982733458","doi":"10.1093/neuonc/noz175.1132","title":"TMOD-33. AN INTEGRATED APPROACH COMBINING MATHEMATICAL AND GENOMIC METHODS TO REVEAL THE OPTIMAL TIMING OF THERAPEUTIC INTERVENTION IN WHO GRADE II DIFFUSE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; Radiation therapy; Oncology; Somatic cell; Fluid-attenuated inversion recovery; Pathological; Temozolomide; Medicine; Germline mutation; Internal medicine; Proportional hazards model; Mutation; Pathology; Biology; Cancer research; Magnetic resonance imaging; Radiology; Genetics; Gene","score_opus":0.05572562521701402,"score_gpt":0.36968547767997,"score_spread":0.313959852462956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982733458","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14001381,0.0008388922,0.8536288,0.0004391102,0.00005990194,0.00014145435,0.00071657076,0.0010207127,0.0031405878],"genre_scores_gemma":[0.74021405,0.00045397686,0.25615862,0.00009613545,0.000030484158,0.00026352357,0.00056918216,0.0001917418,0.002022274],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99987304,0.00005149791,0.0000073976125,0.000030464225,0.00002311222,0.000014422966],"domain_scores_gemma":[0.99961674,0.00020882333,0.00008479875,0.000023713466,0.000043280983,0.000022590675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008157172,0.0005796573,0.0006331586,0.0007051381,0.0001948696,0.00069653464,0.0004446787,0.0004129778,0.0017538446],"category_scores_gemma":[0.0015326922,0.00033121073,0.00086583913,0.0003888805,0.00026839148,0.00036800277,0.0005197563,0.00036224385,0.0002205174],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024425332,0.000085484935,0.011545955,0.00019749248,0.0001582455,0.0001420797,0.00003637669,0.903193,0.009517223,0.011999586,0.0008268324,0.06205347],"study_design_scores_gemma":[0.000007602061,0.000037500642,0.00067276607,0.000004513721,0.0000130541985,0.000022069175,0.0000071471095,0.99651104,0.00058453914,0.0017487801,0.00038491015,0.000006089338],"about_ca_topic_score_codex":0.0039305054,"about_ca_topic_score_gemma":0.0037304016,"teacher_disagreement_score":0.0039305054,"about_ca_system_score_codex":0.0010367379,"about_ca_system_score_gemma":0.0011235768,"threshold_uncertainty_score":0.007815242},"labels":[],"label_agreement":null},{"id":"W2982734891","doi":"10.1093/neuonc/noz175.442","title":"GENE-40. CHARACTERIZING EPIGENETIC INTRATUMORAL HETEROGENEITY IN GLIOMA USING SINGLE-CELL BISULFITE SEQUENCING","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Epigenetics; Biology; Glioma; Epigenomics; DNA methylation; Genetics; Bisulfite sequencing; Epigenome; Computational biology; Cancer research; Gene; Gene expression","score_opus":0.048467219867310105,"score_gpt":0.297158030611291,"score_spread":0.24869081074398086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982734891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970549,0.0007100426,0.02538703,0.000056377026,0.000009678382,0.000056862023,0.0021074153,0.0001880726,0.00093554304],"genre_scores_gemma":[0.96449065,0.0003695373,0.029503573,0.000044980065,0.0000045395686,0.00007683116,0.003487288,0.000057734454,0.0019649812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999076,0.000011357605,0.000005171109,0.000037221267,0.000026984462,0.00001169353],"domain_scores_gemma":[0.99991095,0.000017089009,0.000024913921,0.000016558244,0.00002004706,0.0000105070485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017605301,0.0001578978,0.00016574426,0.00041322727,0.000115700685,0.00023380054,0.00011549312,0.00015082835,0.00068580307],"category_scores_gemma":[0.00020582874,0.000109138295,0.00016624315,0.00020477969,0.0001521547,0.00008931807,0.00012459098,0.00017097105,0.0002213136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005021281,0.000010634487,0.003130499,0.00003000881,0.000013001235,0.00001853388,0.00003969479,0.00035042796,0.9899025,0.000103549304,0.00004758907,0.006303367],"study_design_scores_gemma":[0.00001248788,0.00030852688,0.09554075,0.000011565472,0.000078269375,0.00047204408,0.00008116666,0.010274569,0.8866851,0.0005261063,0.0059983633,0.000011108815],"about_ca_topic_score_codex":0.0010812655,"about_ca_topic_score_gemma":0.0034348085,"teacher_disagreement_score":0.0010812655,"about_ca_system_score_codex":0.00020658648,"about_ca_system_score_gemma":0.00022444718,"threshold_uncertainty_score":0.0022942424},"labels":[],"label_agreement":null},{"id":"W2982750119","doi":"10.1093/neuonc/noz175.433","title":"GENE-31. IDENTIFICATION OF CORE AND CONTEXT-SPECIFIC FITNESS GENES IN GLIOBLASTOMA STEM CELLS VIA GENOME-WIDE CRISPR-Cas9 SCREENS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Context (archaeology); Stem cell; CRISPR; Computational biology; Gene; Genetics; SOX2; Epigenetics; Embryonic stem cell","score_opus":0.012980330572009778,"score_gpt":0.2735275995119839,"score_spread":0.26054726893997415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982750119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96004176,0.00080157694,0.02703503,0.00019828184,0.00004463569,0.00039325774,0.006839497,0.0009501313,0.0036958493],"genre_scores_gemma":[0.9732915,0.00042785588,0.016508022,0.00012372353,0.000004520938,0.00022479992,0.0040739584,0.0001589895,0.0051865303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996836,0.000029416042,0.000041286363,0.000070888505,0.00012942108,0.000045479585],"domain_scores_gemma":[0.9997868,0.00005048652,0.00007442506,0.000025213989,0.000024149953,0.000038992497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003270245,0.00043918367,0.00043701165,0.0005316224,0.0002202035,0.000437589,0.0003198503,0.00034277953,0.0019181416],"category_scores_gemma":[0.00027237655,0.00016217411,0.00039267543,0.0003458907,0.00031254013,0.00011913578,0.00042266256,0.0004154938,0.00062705594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005437993,0.0000362895,0.00047995406,0.00004456777,0.000009328478,0.00009101524,0.000016252485,0.00042784304,0.9958068,0.00019107501,0.000114023875,0.0027283684],"study_design_scores_gemma":[0.00001550421,0.00027238403,0.0053392216,0.000007193877,0.00003094014,0.00030713345,0.000031988206,0.004843907,0.9849615,0.000120305835,0.0040579243,0.000011954316],"about_ca_topic_score_codex":0.0011958753,"about_ca_topic_score_gemma":0.0035859293,"teacher_disagreement_score":0.0019181416,"about_ca_system_score_codex":0.00046095136,"about_ca_system_score_gemma":0.00035794135,"threshold_uncertainty_score":0.0064167976},"labels":[],"label_agreement":null},{"id":"W2983101271","doi":"10.1093/neuonc/noz175.328","title":"EPID-28. WHAT DO PATTERNS OF “UNCLASSIFIED” BRAIN TUMORS TELL US ABOUT INCIDENCE RATES OF NON-MALIGNANT BRAIN TUMORS IN CANADA?","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Incidence (geometry); Medicine; Population; Demography; Epidemiology; Disease; Pathology; Environmental health","score_opus":0.010641020316094056,"score_gpt":0.29376110912570885,"score_spread":0.2831200888096148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983101271","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43079868,0.0049702884,0.0015199793,0.0057206904,0.00012012193,0.00022327552,0.5117335,0.00026302203,0.044650532],"genre_scores_gemma":[0.87560695,0.0027428002,0.0015401879,0.0007562912,0.00003132394,0.0001233423,0.1103893,0.000056028734,0.008753793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988317,0.00010441303,0.00010913106,0.00019867168,0.0004234531,0.0003325738],"domain_scores_gemma":[0.9959156,0.00025847752,0.0006379973,0.00016231481,0.002599944,0.0004256789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093539123,0.00024510504,0.00034220488,0.002335086,0.0009389002,0.001322591,0.00086960185,0.00026182484,0.005643423],"category_scores_gemma":[0.0053895526,0.00024398074,0.00062318845,0.0059230365,0.00033515325,0.00036823333,0.0004891829,0.00045715118,0.0007842066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012327061,0.000022373419,0.9497915,0.00023277737,0.00013125206,0.000054570122,0.00042968086,0.0003857928,0.00012476987,0.0009228481,0.020908955,0.026872238],"study_design_scores_gemma":[0.0000113928,0.000013674841,0.98808706,0.000091358525,0.00004109295,0.000051257703,0.0004384005,0.0004411105,0.00011751829,0.00012608377,0.0105678905,0.000013175232],"about_ca_topic_score_codex":0.9882317,"about_ca_topic_score_gemma":0.9895064,"teacher_disagreement_score":0.022019455,"about_ca_system_score_codex":0.022019455,"about_ca_system_score_gemma":0.029267775,"threshold_uncertainty_score":0.15976304},"labels":[],"label_agreement":null},{"id":"W2983242644","doi":"10.1093/neuonc/noz175.055","title":"ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Internal medicine; Oncology; Phases of clinical research; Adverse effect; Adjuvant; Methyltransferase; Radiation therapy; Clinical endpoint; Adjuvant therapy; Clinical trial; Cancer; Chemotherapy; Biology; DNA","score_opus":0.010454612080597522,"score_gpt":0.2936011169252499,"score_spread":0.2831465048446524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983242644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996429,0.00089370256,0.00028541673,0.00014599766,0.00006182957,0.00087600405,0.0005041848,0.000076009754,0.0007277806],"genre_scores_gemma":[0.99299496,0.00082478346,0.0009052014,0.00047693486,0.00011010156,0.0012620264,0.0017451976,0.000020294361,0.0016605596],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99964523,0.00017034482,0.000015924094,0.00006315671,0.000034905464,0.00007034388],"domain_scores_gemma":[0.9995888,0.000044562963,0.00006304831,0.000033123928,0.000028415878,0.00024218818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328903,0.0013344618,0.0016188241,0.00034350378,0.0002895805,0.000605406,0.0005709515,0.00084506784,0.0019657773],"category_scores_gemma":[0.0005153615,0.0004847779,0.0010320216,0.00034084602,0.00064828055,0.00042744863,0.00022535509,0.002241541,0.00071299996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7416058,0.08620175,0.012183786,0.0004972563,0.0013850473,0.00036249484,0.00029316306,0.0026747754,0.07180503,0.00023183768,0.0035733122,0.07918575],"study_design_scores_gemma":[0.3067347,0.6634237,0.021697082,0.000020201309,0.00052507885,0.00026385405,0.000051023962,0.0014829687,0.0038617102,0.00011240007,0.0017955693,0.000031762243],"about_ca_topic_score_codex":0.0016622514,"about_ca_topic_score_gemma":0.0034923723,"teacher_disagreement_score":0.0019657773,"about_ca_system_score_codex":0.00075180124,"about_ca_system_score_gemma":0.0011001707,"threshold_uncertainty_score":0.0070279837},"labels":[],"label_agreement":null},{"id":"W2983438087","doi":"10.1093/neuonc/noz175.196","title":"CSIG-26. IS INTRINSIC APOPTOSIS THE SIGNALING PATHWAY ACTIVATED BY TUMOR-TREATING FIELDS FOR GLIOBLASTOMA?","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Microtubule; Dexamethasone; Cell cycle; Chemistry; Glioma; Cancer research; Cell cycle checkpoint; Cell biology; Medicine; Internal medicine; Biology; Biochemistry","score_opus":0.008785879074293387,"score_gpt":0.22723520900923871,"score_spread":0.2184493299349453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983438087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97167003,0.0066559324,0.0020623826,0.0018176318,0.00023223368,0.00011291568,0.00092475204,0.00027954523,0.016244592],"genre_scores_gemma":[0.9928284,0.0015348399,0.0009445599,0.00031049547,0.000023368653,0.00003116015,0.0007094663,0.000017422211,0.0036003855],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999658,0.0000051413936,0.0000017930232,0.0000039792785,0.000009034069,0.000014279348],"domain_scores_gemma":[0.99996233,0.0000024502122,0.0000075313815,0.0000032560833,0.000004445075,0.000020022293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079796264,0.00015128235,0.00023806344,0.00013740783,0.00010664058,0.00022231459,0.00025159545,0.00025287824,0.0033946275],"category_scores_gemma":[0.00008090667,0.00005996547,0.00013985514,0.00018589738,0.00024900166,0.00012988162,0.000119186334,0.00034208872,0.0008839921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007854644,0.0009652408,0.0095114615,0.00064210076,0.00007408617,0.0005905924,0.00006849773,0.0031583386,0.8197653,0.0036186934,0.00895818,0.14479282],"study_design_scores_gemma":[0.0018919383,0.02127591,0.06535091,0.00018928126,0.00026517734,0.0026276056,0.00030899714,0.011321202,0.80517155,0.0036144296,0.08792866,0.00005429058],"about_ca_topic_score_codex":0.0020560727,"about_ca_topic_score_gemma":0.0030637444,"teacher_disagreement_score":0.0033946275,"about_ca_system_score_codex":0.00047186995,"about_ca_system_score_gemma":0.0006685679,"threshold_uncertainty_score":0.011356175},"labels":[],"label_agreement":null},{"id":"W2983439350","doi":"10.1093/neuonc/noz175.231","title":"CMET-30. COMPREHENSIVE METHYLOME ANALYSIS OF EGFR-MUTANT PRIMARY LUNG ADENOCARCINOMA AND MATCHED BRAIN METASTASIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Adenocarcinoma; Methylation; Biology; Cancer research; Lung cancer; Epigenetics; Metastasis; Lung; Brain metastasis; Pathology; Gene; Medicine; Cancer; Genetics; Internal medicine; Gene expression","score_opus":0.01898871956096887,"score_gpt":0.3415605696622252,"score_spread":0.32257185010125633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983439350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965204,0.00030930387,0.0008610727,0.000026202468,0.000003822935,0.000023157096,0.0017793565,0.000034697572,0.0004420792],"genre_scores_gemma":[0.99472964,0.00009543912,0.0011322824,0.000025141562,0.0000024526448,0.000038580973,0.0032823083,0.000010447163,0.0006837823],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998698,0.0000128696865,0.000008382055,0.000043651504,0.000040336556,0.000024965102],"domain_scores_gemma":[0.9999074,0.000011363476,0.00002005192,0.00001060996,0.000022731901,0.000027826647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001349418,0.00014259086,0.00025614072,0.00047346126,0.00020466863,0.00017349186,0.00015141282,0.00019147182,0.001668876],"category_scores_gemma":[0.00024364553,0.000091106216,0.00018535931,0.00027614448,0.00009517184,0.00006537574,0.0002494434,0.00017691881,0.0002709228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013180319,0.000052420888,0.13885114,0.000080168815,0.00007479243,0.00030180582,0.00009158622,0.0002666828,0.8436467,0.000052837066,0.00039568852,0.014867982],"study_design_scores_gemma":[0.000032542346,0.0006659228,0.86366147,0.000008343105,0.000092619346,0.002474424,0.000113374015,0.0021864618,0.12830396,0.00008832323,0.0023639384,0.000008612764],"about_ca_topic_score_codex":0.0019292928,"about_ca_topic_score_gemma":0.0032619268,"teacher_disagreement_score":0.0019292928,"about_ca_system_score_codex":0.00020967808,"about_ca_system_score_gemma":0.00016233933,"threshold_uncertainty_score":0.0055829287},"labels":[],"label_agreement":null},{"id":"W2983703208","doi":"10.1093/neuonc/noz175.012","title":"ATIM-12. AVELUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME-THE SEJ STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Clinique Neuro-Outaouais","funders":"","keywords":"Avelumab; Temozolomide; Medicine; Radiation therapy; Oncology; Internal medicine; Glioblastoma; Interim analysis; Immunotherapy; Clinical trial; Nivolumab; Cancer research; Cancer","score_opus":0.01701592231573077,"score_gpt":0.2967068258603395,"score_spread":0.2796909035446087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983703208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901714,0.0043645343,0.00016712477,0.00056002085,0.00014611219,0.0006526934,0.0015725612,0.00002304698,0.0023426022],"genre_scores_gemma":[0.99018085,0.0025843515,0.00044477062,0.00064872357,0.00023373679,0.0005832024,0.0022521722,0.000011367812,0.0030608878],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949265,0.00026378408,0.000032975484,0.000060241215,0.000053926597,0.00009628998],"domain_scores_gemma":[0.9993538,0.00008698182,0.00013166697,0.00006338783,0.000055474073,0.00030867272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018875172,0.0005358311,0.0011920058,0.00031169236,0.0002533046,0.000851654,0.00047187912,0.00076683884,0.0020870008],"category_scores_gemma":[0.00066756696,0.000249653,0.001406937,0.00043083544,0.00037108763,0.00057227653,0.00029375346,0.0011719972,0.000497141],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6948391,0.022756511,0.10027592,0.0022688792,0.0075590513,0.0011772536,0.0003142049,0.0014669626,0.02320989,0.0007036913,0.009116535,0.13631198],"study_design_scores_gemma":[0.35161385,0.34487492,0.26723376,0.00021567939,0.005206595,0.0012560416,0.00025068756,0.0014399133,0.0057468233,0.00053649995,0.021546388,0.00007878228],"about_ca_topic_score_codex":0.001166244,"about_ca_topic_score_gemma":0.0032408454,"teacher_disagreement_score":0.0020870008,"about_ca_system_score_codex":0.0005567176,"about_ca_system_score_gemma":0.0010716057,"threshold_uncertainty_score":0.009982228},"labels":[],"label_agreement":null},{"id":"W2983720088","doi":"10.1093/neuonc/noz175.479","title":"HOUT-14. PROGNOSTIC IMPACT OF FIRST PSEUDOPROGRESSION ON MRI IN GLIOBLASTOMA, AN 11 YEARS EXPERIENCE FROM A CANADIAN UNIVERSITY CENTER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"École de Technologie Supérieure; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Glioblastoma; Cohort; Incidence (geometry); Radiation therapy; Internal medicine; Tumor progression; Oncology; Nuclear medicine; Cancer","score_opus":0.012044571287049001,"score_gpt":0.28043768035370686,"score_spread":0.26839310906665786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983720088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996372,0.0006874257,0.00004093651,0.00032547617,0.00001502007,0.000017535656,0.0009169357,0.000005980756,0.0016188435],"genre_scores_gemma":[0.99792033,0.00046788328,0.000066713146,0.000070289294,0.00001854346,0.000006797489,0.00091506995,0.000005018147,0.00052939786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995066,0.000036446218,0.000028888086,0.000056978402,0.00015673599,0.00021442953],"domain_scores_gemma":[0.99794656,0.00008201519,0.0005506159,0.000051848274,0.0006833306,0.0006856833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005399127,0.00022341723,0.00019044802,0.0010930778,0.001595331,0.0009627279,0.00056378497,0.00032653104,0.0015316133],"category_scores_gemma":[0.0024629964,0.00015558783,0.00027438847,0.0015185912,0.00047481334,0.00042180668,0.0006183093,0.00046149475,0.00030826105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061063605,0.000017323842,0.9935017,0.000010996194,0.000013175289,0.00030372426,0.00027478536,0.000038532246,0.00012618751,0.00001938571,0.0006691716,0.0049640485],"study_design_scores_gemma":[0.0000023240927,0.00004095103,0.99788,0.000021059548,0.000014289,0.00050920027,0.00052871543,0.000077213335,0.000067355155,0.00001262333,0.0008384295,0.000007901031],"about_ca_topic_score_codex":0.68943673,"about_ca_topic_score_gemma":0.79561025,"teacher_disagreement_score":0.31056327,"about_ca_system_score_codex":0.006603965,"about_ca_system_score_gemma":0.0082926415,"threshold_uncertainty_score":0.62478447},"labels":[],"label_agreement":null},{"id":"W2983746712","doi":"10.1093/neuonc/noz175.804","title":"PDTM-28. AN OTX2-PAX3 SIGNALLING AXIS REGULATES GROUP 3 MEDULLOBLASTOMA CELL FATE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Biology; PAX6; Cancer research; In vivo; Chromatin; Cell fate determination; Transcription factor; Gene; Genetics","score_opus":0.00807951501155157,"score_gpt":0.23966385841881335,"score_spread":0.23158434340726178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983746712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935313,0.0009063345,0.0019390004,0.00009065212,0.00001679083,0.000033074193,0.0014038954,0.00011100015,0.0019680257],"genre_scores_gemma":[0.99516654,0.00028205264,0.00083825825,0.000040326708,0.000003244942,0.00003436016,0.0010213382,0.000022451188,0.0025915878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.0000069647954,0.0000036693946,0.000013966656,0.00002193478,0.000020976695],"domain_scores_gemma":[0.99996936,0.000005139025,0.00000806396,0.0000030767246,0.0000027522512,0.000011528684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050711744,0.00017274606,0.00014865652,0.00016190634,0.00015652186,0.00015659888,0.00010437455,0.00014881096,0.0016073748],"category_scores_gemma":[0.000040540377,0.00007981628,0.00016846198,0.000098312914,0.00014956434,0.0000986716,0.00013006307,0.00039199056,0.00038513175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007525507,0.000009766301,0.00021579815,0.000014865411,0.0000017369823,0.000022783472,0.000006307102,0.00003882002,0.99873894,0.000052560717,0.00005496388,0.00076822244],"study_design_scores_gemma":[0.000020119367,0.00015828067,0.018567823,0.000003933525,0.000010009524,0.00017906597,0.000041476575,0.000985497,0.9764662,0.000056260775,0.0035083748,0.0000029393505],"about_ca_topic_score_codex":0.0009973029,"about_ca_topic_score_gemma":0.002204405,"teacher_disagreement_score":0.0016073748,"about_ca_system_score_codex":0.00031660983,"about_ca_system_score_gemma":0.00019756744,"threshold_uncertainty_score":0.005377233},"labels":[],"label_agreement":null},{"id":"W2983802169","doi":"10.1093/neuonc/noz175.381","title":"EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Temozolomide; Cancer research; DNA damage; Reactive oxygen species; Thioredoxin reductase; Thioredoxin; Cytotoxicity; Cell culture; Chemistry; Oxidative stress; Biology; Glioma; Immunology; Biochemistry; In vitro","score_opus":0.00810914141307381,"score_gpt":0.27170703475949987,"score_spread":0.2635978933464261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983802169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978551,0.00076972664,0.00035107665,0.00007187868,0.00003472692,0.000031019772,0.00021098294,0.000058017762,0.00061740744],"genre_scores_gemma":[0.9969798,0.0004932287,0.0005864974,0.000040151557,0.0000132304685,0.000040887484,0.00061718066,0.00000953323,0.0012195328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998555,0.00003915333,0.000015691341,0.00002009746,0.000027938744,0.00004160622],"domain_scores_gemma":[0.99987984,0.000019389172,0.000021761693,0.000011952341,0.00001079487,0.00005614232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018317558,0.00038463622,0.00046775478,0.00031140336,0.00012983644,0.00023182893,0.00024530868,0.0002887044,0.0016181613],"category_scores_gemma":[0.00013376458,0.00013772763,0.00023734341,0.00020062429,0.0002300454,0.00014812095,0.00018780064,0.0005893821,0.00031554067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018670894,0.0005596593,0.00031199917,0.00006269032,0.000018249579,0.00009014312,0.000029527871,0.00012833028,0.9936837,0.00007793541,0.00013566845,0.0030350261],"study_design_scores_gemma":[0.00019393639,0.008353686,0.0050416496,0.0000071380837,0.00003201341,0.0002658685,0.000027650525,0.0008569938,0.9840487,0.000030567135,0.0011359198,0.000005818216],"about_ca_topic_score_codex":0.00081744697,"about_ca_topic_score_gemma":0.0010905266,"teacher_disagreement_score":0.0016181613,"about_ca_system_score_codex":0.00019512099,"about_ca_system_score_gemma":0.00027281552,"threshold_uncertainty_score":0.0054132342},"labels":[],"label_agreement":null},{"id":"W2983816200","doi":"10.1093/neuonc/noz175.183","title":"CSIG-12. PREX1 LINKS ABERRANT PI 3-KINASE PATHWAY SIGNALING TO MAINTENANCE OF THE NEURAL STEM CELL-LIKE PHENOTYPE OF GLIOBLASTOMA CELLS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital","funders":"","keywords":"Neural stem cell; Biology; Cell biology; Stem cell; Progenitor cell; Cancer research; Signal transduction","score_opus":0.009186315090915359,"score_gpt":0.23520399384489846,"score_spread":0.2260176787539831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983816200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819324,0.0014811138,0.0041044494,0.00043109205,0.00017315536,0.00008832507,0.0066392785,0.0007644434,0.0043858145],"genre_scores_gemma":[0.9855436,0.0004813493,0.0015831016,0.00023304875,0.000007815715,0.00006358669,0.0055953492,0.000121905585,0.006370181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979526,0.000013970522,0.000019206831,0.000047070316,0.00007303455,0.0000514538],"domain_scores_gemma":[0.9998198,0.000015441467,0.000049303864,0.000021752876,0.000017234399,0.000076395365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013670055,0.00042691175,0.00044416988,0.0003430646,0.00027705243,0.0004806318,0.00033482973,0.0004671147,0.0038063957],"category_scores_gemma":[0.00012788326,0.00024140328,0.00030460863,0.0002670229,0.00030817583,0.00014137913,0.0003764304,0.001135165,0.0019983964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013956185,0.00004417614,0.00040282702,0.000051884996,0.0000074549444,0.000101975704,0.000013522663,0.00013391473,0.9973761,0.00011122585,0.0003406864,0.0012767196],"study_design_scores_gemma":[0.00004393422,0.00024663148,0.02145627,0.000014127987,0.000024317058,0.0005102171,0.00006320262,0.0031129753,0.96499425,0.00011959827,0.009401016,0.00001353612],"about_ca_topic_score_codex":0.0026762013,"about_ca_topic_score_gemma":0.004214273,"teacher_disagreement_score":0.0038063957,"about_ca_system_score_codex":0.00060947106,"about_ca_system_score_gemma":0.0005061947,"threshold_uncertainty_score":0.012733638},"labels":[],"label_agreement":null},{"id":"W2983854420","doi":"10.1093/neuonc/noz175.315","title":"EPID-15. GUIDELINES FOR THE OPTIMAL USE OF SOCIAL MEDIA FOR NEURO-ONCOLOGISTS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Theme (computing); Social media; Empowerment; Psychology; Medicine; Computer science; World Wide Web; Political science","score_opus":0.34678932329809453,"score_gpt":0.49278081519979755,"score_spread":0.14599149190170302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983854420","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020245686,0.04753504,0.07978587,0.105439305,0.0066718333,0.2097059,0.30340895,0.013192158,0.21401529],"genre_scores_gemma":[0.034079406,0.031061398,0.5004085,0.017105635,0.0009953295,0.27787754,0.10061406,0.0017312133,0.036127035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9291682,0.031374678,0.0283494,0.0011316463,0.0074453484,0.0025306458],"domain_scores_gemma":[0.8210592,0.086525396,0.02438841,0.0053149704,0.05571662,0.0069953706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.080040894,0.0014628188,0.0029118254,0.014079756,0.0015684456,0.005051567,0.006060454,0.005189708,0.033536676],"category_scores_gemma":[0.13864346,0.0022173391,0.006847895,0.009136971,0.0015102444,0.0055467044,0.008266788,0.004795877,0.023706537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000710378,0.0008438664,0.014519514,0.043114074,0.00025369777,0.00038144726,0.0028504117,0.0008981492,0.00079203886,0.006476482,0.48988846,0.43927148],"study_design_scores_gemma":[0.0012548502,0.00060390786,0.04612343,0.06978171,0.0003540443,0.00042694536,0.002625849,0.0010298282,0.001541851,0.0076300777,0.8683648,0.00026273832],"about_ca_topic_score_codex":0.008478778,"about_ca_topic_score_gemma":0.011605492,"teacher_disagreement_score":0.080040894,"about_ca_system_score_codex":0.0056652618,"about_ca_system_score_gemma":0.022698207,"threshold_uncertainty_score":0.42330176},"labels":[],"label_agreement":null},{"id":"W2983979515","doi":"10.1093/neuonc/noz175.220","title":"CMET-19. QUESTIONING THE PARADIGM: DO CSF CYTOLOGY AND MRI SCANNING IDENTIFY THE SAME DISEASE IN PATIENTS WITH NEOPLASTIC MENINGITIS (NM) – DATA FROM AN INTERNATIONAL NM REGISTRY AND A META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Gold standard (test); Medicine; Cytology; Meta-analysis; Radiology; Internal medicine; Pathology; Nuclear medicine","score_opus":0.042225743716117266,"score_gpt":0.34200391848477646,"score_spread":0.2997781747686592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983979515","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024498895,0.9583763,0.0029132173,0.00391532,0.0013877606,0.0009175643,0.0059965667,0.00007095329,0.001923502],"genre_scores_gemma":[0.8187062,0.15633287,0.00597948,0.0072563123,0.0019210158,0.003727822,0.004758926,0.00013034478,0.0011869584],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95469403,0.027518058,0.008912042,0.004790695,0.003030539,0.0010547356],"domain_scores_gemma":[0.87881386,0.09815238,0.015145636,0.0035314152,0.0033877639,0.00096900127],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.046910793,0.0017854593,0.008597601,0.0042695096,0.0008039136,0.004497481,0.0031847884,0.003477013,0.007847858],"category_scores_gemma":[0.1096462,0.0010913523,0.03929597,0.005536409,0.0014327351,0.003588989,0.001880464,0.0029608463,0.0006877381],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046729683,0.000040852152,0.034785334,0.20043485,0.74256575,0.00018438294,0.0001747035,0.000494128,0.00020278391,0.0005046769,0.0026493059,0.013290247],"study_design_scores_gemma":[0.0028950006,0.0005928373,0.030967453,0.031607516,0.9258391,0.00024776757,0.00016773926,0.00073863013,0.000211297,0.0018526514,0.004810804,0.00006917186],"about_ca_topic_score_codex":0.0045602936,"about_ca_topic_score_gemma":0.007203187,"teacher_disagreement_score":0.9914024,"about_ca_system_score_codex":0.002073505,"about_ca_system_score_gemma":0.0031851816,"threshold_uncertainty_score":0.24809092},"labels":[],"label_agreement":null},{"id":"W2984113977","doi":"10.1093/neuonc/noz175.1000","title":"STEM-27. LEVERAGING FUNCTIONAL GENETIC DEPENDENCIES IN TREATMENT-REFRACTORY GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"CRISPR; Context (archaeology); Genome editing; Biology; Temozolomide; Gene knockout; Stem cell; Cancer research; Gene; Computational biology; Bioinformatics; Genetics; Glioblastoma","score_opus":0.027881022889461534,"score_gpt":0.27395388702221923,"score_spread":0.2460728641327577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984113977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890237,0.002629263,0.0023444656,0.00040609305,0.00011993143,0.00019062399,0.0015764944,0.00033319148,0.0033762706],"genre_scores_gemma":[0.9926883,0.0013910586,0.0017042672,0.00014710458,0.00001107591,0.00009139003,0.0016219582,0.00004921291,0.0022955828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990356,0.000012661238,0.000010130082,0.000014487774,0.000035554793,0.000023648803],"domain_scores_gemma":[0.99993575,0.000009577183,0.000016383965,0.0000070728797,0.0000074466066,0.000023831459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019608373,0.0002777014,0.00036113395,0.00036783755,0.00015442815,0.0003320372,0.00024327157,0.00024941866,0.002419278],"category_scores_gemma":[0.00012297418,0.00010820257,0.00024663183,0.0002507886,0.00024942507,0.0001031449,0.0002218551,0.00053148513,0.00044730137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006490977,0.0003893875,0.0010713718,0.00025517985,0.000034512115,0.0006647023,0.00005991719,0.0021697038,0.9698883,0.0011080866,0.001643966,0.022065775],"study_design_scores_gemma":[0.00027901802,0.0036609464,0.0076156994,0.0000455454,0.00012367555,0.0014656744,0.000097983306,0.0073631927,0.94869757,0.0005459793,0.030074095,0.000030598592],"about_ca_topic_score_codex":0.0012652556,"about_ca_topic_score_gemma":0.002347966,"teacher_disagreement_score":0.002419278,"about_ca_system_score_codex":0.00045413387,"about_ca_system_score_gemma":0.00040073655,"threshold_uncertainty_score":0.008093238},"labels":[],"label_agreement":null},{"id":"W2984194917","doi":"10.1093/neuonc/noz175.447","title":"GENE-45. DISSECTING THE DRIVERS OF ADULT H3K27M-GLIOMAS AT THE SINGLE-CELL LEVEL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Context (archaeology); Glioma; Carcinogenesis; Biology; Transcriptome; Cancer research; Cancer; Gene; Gene expression; Genetics","score_opus":0.03252501835138273,"score_gpt":0.2781104484428717,"score_spread":0.24558543009148898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984194917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929543,0.0006267693,0.0032673685,0.000047014448,0.00001007479,0.000017103996,0.0023607623,0.000038886497,0.0006777477],"genre_scores_gemma":[0.9923685,0.00043420622,0.0035899736,0.000049994676,0.000006412575,0.000028673383,0.002226898,0.000019390542,0.0012759967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994457,0.0000032545602,0.0000036263814,0.000020185036,0.000013852348,0.000014629991],"domain_scores_gemma":[0.999948,0.000008453276,0.000016797789,0.0000041891954,0.000009224782,0.000013357442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074025185,0.000105423744,0.00014618826,0.00017149973,0.00014391541,0.0002630233,0.000083895975,0.00015119828,0.0010069923],"category_scores_gemma":[0.00008170603,0.00008381809,0.00016793128,0.00018538794,0.00011513565,0.00011294041,0.00012714641,0.00016394783,0.00028803304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047450594,0.0000046212695,0.0059274966,0.000021135944,0.0000056111116,0.00005094853,0.00003977544,0.00006532743,0.9921314,0.00005559686,0.000048065955,0.0016025905],"study_design_scores_gemma":[0.000008200508,0.0003698318,0.27857244,0.000009533862,0.000050064704,0.001196694,0.0004503448,0.0026552929,0.7084943,0.000168472,0.008015867,0.000008911182],"about_ca_topic_score_codex":0.001057279,"about_ca_topic_score_gemma":0.0027360064,"teacher_disagreement_score":0.001057279,"about_ca_system_score_codex":0.00019089268,"about_ca_system_score_gemma":0.00014040913,"threshold_uncertainty_score":0.0033687353},"labels":[],"label_agreement":null},{"id":"W2984488881","doi":"10.1093/neuonc/noz175.838","title":"QOLP-18. A TIME-BASED MODEL OF EARLY PALLIATIVE CARE INTERVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA, A SINGLE INSTITUTION FEASIBILITY STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Specialty; Quality of life (healthcare); Intervention (counseling); Palliative care; Physical therapy; Distress; Population; Patient satisfaction; Internal medicine; Family medicine; Surgery; Nursing","score_opus":0.08835455645446269,"score_gpt":0.3811224056015717,"score_spread":0.29276784914710896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984488881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970804,0.00005729584,0.0003622048,0.00008117461,0.000011036161,0.0019300114,0.00018094108,0.000009502294,0.00028736744],"genre_scores_gemma":[0.9925976,0.00008782108,0.0017796427,0.00011186914,0.000028496272,0.0048702983,0.0003522718,0.0000047800686,0.00016720915],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99730396,0.0018701043,0.00017493748,0.00018071207,0.00022694124,0.00024341041],"domain_scores_gemma":[0.997124,0.0005975456,0.0007586669,0.0002320871,0.00045824735,0.00082937215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004874076,0.0005695598,0.00064452045,0.0004687184,0.00065007294,0.0006632076,0.00047007683,0.00034826444,0.0018330311],"category_scores_gemma":[0.0049428963,0.00036634377,0.00093953207,0.00043528396,0.00057855446,0.0010553809,0.0008733901,0.000946625,0.0003018743],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119819984,0.12993413,0.64161,0.00048314198,0.00069788744,0.00037219457,0.0018016339,0.0024920113,0.0027516633,0.00031241163,0.001706428,0.098018534],"study_design_scores_gemma":[0.030889021,0.3691407,0.5880279,0.00008177063,0.00038171103,0.0002614223,0.0017872745,0.006484621,0.00095299847,0.00017315433,0.0017448652,0.00007452163],"about_ca_topic_score_codex":0.004442479,"about_ca_topic_score_gemma":0.0077099996,"teacher_disagreement_score":0.004874076,"about_ca_system_score_codex":0.0020251088,"about_ca_system_score_gemma":0.0033587439,"threshold_uncertainty_score":0.025776923},"labels":[],"label_agreement":null},{"id":"W2984561122","doi":"10.1093/neuonc/noz175.298","title":"DRES-10. TEMOZOLOMIDE-ASSOCIATED HYPERMUTATION DETECTED WITH A GENE PANEL SIGNATURE IMPROVES IMMUNE RESPONSE IN GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Somatic hypermutation; Temozolomide; Microsatellite instability; Cancer research; Gene signature; Biology; Gene; Concordance; Medicine; Glioblastoma; Oncology; Genetics; Gene expression; Antibody","score_opus":0.006310535102696933,"score_gpt":0.23013754111851575,"score_spread":0.2238270060158188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984561122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935783,0.00067843404,0.0006162725,0.000086085885,0.000023062585,0.000025866266,0.004362236,0.00009996619,0.0005297287],"genre_scores_gemma":[0.98573375,0.00036416657,0.0013284098,0.00015647321,0.000007907417,0.000038895178,0.01173665,0.000018999739,0.00061481335],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998789,0.000014802235,0.000010380403,0.000040590996,0.000028883418,0.000026524409],"domain_scores_gemma":[0.9998572,0.000021490372,0.000040987936,0.000013355642,0.000030095336,0.000036886806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028901396,0.00020867724,0.000393437,0.00033662483,0.00010554153,0.0003193695,0.00014510985,0.00012915125,0.0011881317],"category_scores_gemma":[0.0003578141,0.00007061886,0.00023093217,0.0002832845,0.0000947485,0.0001135434,0.00015692595,0.00036102106,0.00021480069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057399166,0.00084557344,0.10868701,0.0004208875,0.00040011443,0.0001912313,0.00007567468,0.0035490682,0.7919175,0.000151864,0.0056295516,0.08239158],"study_design_scores_gemma":[0.00032891418,0.005911505,0.611634,0.00007315107,0.0006184652,0.0010987169,0.00021845603,0.018278252,0.34679705,0.00047787957,0.014515042,0.000048573405],"about_ca_topic_score_codex":0.0014216203,"about_ca_topic_score_gemma":0.0029797023,"teacher_disagreement_score":0.0014216203,"about_ca_system_score_codex":0.00030945244,"about_ca_system_score_gemma":0.0002540108,"threshold_uncertainty_score":0.003974676},"labels":[],"label_agreement":null},{"id":"W2984664109","doi":"10.1093/neuonc/noz175.429","title":"GENE-27. MENINGIOMA RECURRENCE: ROLE OF M1/M2 TUMOUR-ASSOCIATED MACROPHAGE INFILTRATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Meningioma; Immunohistochemistry; Phenotype; Infiltration (HVAC); Pathology; Immune system; Medicine; Cancer research; Biology; Immunology; Gene","score_opus":0.008211731318695712,"score_gpt":0.2320693349143049,"score_spread":0.2238576035956092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984664109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892524,0.005584925,0.0018965098,0.00024920295,0.000057083587,0.00004418412,0.0005684182,0.00012171955,0.002225494],"genre_scores_gemma":[0.9943573,0.001680262,0.00073644344,0.00007802149,0.000010938695,0.00003838578,0.00039538462,0.000020142646,0.0026831503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999892,0.000014632654,0.000007819712,0.000025908112,0.00003068656,0.000028928536],"domain_scores_gemma":[0.9998982,0.000021019992,0.00003390412,0.000007692846,0.000014709081,0.000024601992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001531674,0.00023067251,0.00020807584,0.00019230596,0.000113755596,0.00032290592,0.00012386554,0.00020612196,0.0019381257],"category_scores_gemma":[0.00015232469,0.0000869381,0.00019721924,0.0001606259,0.00027362825,0.00013826569,0.00012501488,0.0003712649,0.00047880612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062110747,0.000072744544,0.0023745787,0.00021298123,0.000018963665,0.00024261227,0.000035208075,0.00015137151,0.9894712,0.0001541896,0.0003128037,0.006332131],"study_design_scores_gemma":[0.00004165105,0.0010912452,0.040159985,0.000031636748,0.000098832934,0.001429748,0.0001568335,0.0017517145,0.947132,0.00017414172,0.007919986,0.000012233901],"about_ca_topic_score_codex":0.00066798157,"about_ca_topic_score_gemma":0.00063042424,"teacher_disagreement_score":0.0019381257,"about_ca_system_score_codex":0.00029656917,"about_ca_system_score_gemma":0.00022168233,"threshold_uncertainty_score":0.0064837337},"labels":[],"label_agreement":null},{"id":"W2984683685","doi":"10.1093/neuonc/noz175.331","title":"EPID-31. EFFICIENT STUDY OF SURGICALLY TREATED MENINGIOMA THROUGH CLINICAL DATA STANDARDIZATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Alberta","funders":"","keywords":"Electronic data capture; Medicine; Medical physics; Standardization; Terminology; Scope (computer science); Consistency (knowledge bases); Data science; Computer science; Clinical trial; Pathology; Artificial intelligence","score_opus":0.10661931371964042,"score_gpt":0.40976584459933685,"score_spread":0.30314653087969645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984683685","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040192313,0.0016701682,0.19190238,0.013719655,0.0013599976,0.04770717,0.5840652,0.020462811,0.09892029],"genre_scores_gemma":[0.1925476,0.001529305,0.35769486,0.004772185,0.0006662678,0.07514711,0.3509831,0.0036040656,0.013055489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8661548,0.07557768,0.037702896,0.006642441,0.012095492,0.0018267471],"domain_scores_gemma":[0.53630817,0.23745945,0.05021848,0.103042364,0.063033335,0.009938254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1715684,0.0008343335,0.0017376058,0.008796986,0.0012688059,0.0052159596,0.0028969215,0.0013762108,0.028402012],"category_scores_gemma":[0.30670923,0.0015556404,0.0020848697,0.008986894,0.0015014268,0.0052947,0.008732064,0.002332529,0.009728375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009579837,0.0011960831,0.14197555,0.010894407,0.0013913234,0.00051250966,0.0029076647,0.0059051868,0.0027855635,0.0406079,0.32166106,0.46058294],"study_design_scores_gemma":[0.0038648807,0.0017714923,0.19339123,0.0050551635,0.00068741,0.0004650648,0.0013223281,0.009094583,0.012572747,0.024445368,0.7469823,0.0003474079],"about_ca_topic_score_codex":0.0038234082,"about_ca_topic_score_gemma":0.0032989162,"teacher_disagreement_score":0.1715684,"about_ca_system_score_codex":0.0046652756,"about_ca_system_score_gemma":0.02185321,"threshold_uncertainty_score":0.90735126},"labels":[],"label_agreement":null},{"id":"W2984737845","doi":"10.1093/neuonc/noz175.436","title":"GENE-34. THERAPEUTICALLY TARGETING EPIGENOMIC AND TRANSCRIPTIONAL DYSFUNCTION IN ATRX-DEFICIENT GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; SIRT2; Epigenomics; Biology; Chromatin; Death-associated protein 6; Epigenetics; Genetics; Histone; Gene; Cancer research; Mutation; DNA methylation; Gene expression; Sirtuin; Nuclear protein; Transcription factor; Acetylation","score_opus":0.019044234620464458,"score_gpt":0.2720036081499647,"score_spread":0.25295937352950026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984737845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853592,0.0021480971,0.0059515755,0.0002515377,0.000078130055,0.00022405984,0.0019211599,0.0008579619,0.0032083048],"genre_scores_gemma":[0.98696995,0.0010070826,0.004381703,0.000085790314,0.000007759839,0.00013783558,0.0015948934,0.00006374909,0.0057512694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990463,0.0000087274575,0.000003751829,0.000023466,0.000024196534,0.000035306144],"domain_scores_gemma":[0.99996626,0.000004776721,0.000010005493,0.0000036354631,0.00000371013,0.000011573041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006960788,0.0004225536,0.0002983442,0.0004936386,0.00011583592,0.00024285282,0.00023530447,0.00025321794,0.0021791167],"category_scores_gemma":[0.000057053647,0.00015609618,0.0002727406,0.00032408777,0.0001897574,0.00010905279,0.00014491018,0.0006622201,0.00046972165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024377895,0.0001080887,0.000100760124,0.00005083913,0.000009587372,0.000040069594,0.000012201496,0.00038974456,0.99370617,0.00020587217,0.00023523945,0.004897729],"study_design_scores_gemma":[0.00008369286,0.0010589171,0.0027238976,0.000006944859,0.000051943283,0.00013679895,0.000023279754,0.0022809384,0.9876216,0.00008076459,0.005924813,0.0000063881853],"about_ca_topic_score_codex":0.000805857,"about_ca_topic_score_gemma":0.0019045232,"teacher_disagreement_score":0.0021791167,"about_ca_system_score_codex":0.00030636953,"about_ca_system_score_gemma":0.00025528984,"threshold_uncertainty_score":0.0072898865},"labels":[],"label_agreement":null},{"id":"W2985015496","doi":"10.1093/neuonc/noz175.663","title":"NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Quality of life (healthcare); Verbal learning; Neurocognitive; Chemoradiotherapy; Oncology; Radiation therapy; Cognition","score_opus":0.03699080372732048,"score_gpt":0.3344651818423563,"score_spread":0.2974743781150358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985015496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970132,0.0004904953,0.000117323565,0.00007437886,0.000011503725,0.00037311515,0.0013442884,0.000018674134,0.00055698404],"genre_scores_gemma":[0.9921346,0.00033693583,0.00063170894,0.00017335734,0.000036022757,0.00064845267,0.005144549,0.0000117390155,0.000882532],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924964,0.0005127787,0.00004085075,0.00005899599,0.00007998022,0.00005779551],"domain_scores_gemma":[0.9989422,0.0002565692,0.0002877086,0.00009897891,0.00009097022,0.00032363375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023176554,0.0005089806,0.0007321726,0.0002549041,0.00023771165,0.00035076163,0.0004871071,0.0002986524,0.0015020302],"category_scores_gemma":[0.0012993693,0.00020059329,0.000519864,0.00035726037,0.0003782818,0.00020494434,0.00016510117,0.0006325081,0.00029184768],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3496397,0.046767246,0.40548903,0.0011179802,0.0041022254,0.00036459012,0.0004226795,0.003665699,0.03267546,0.00016444275,0.008993588,0.14659745],"study_design_scores_gemma":[0.12481638,0.28792202,0.5694229,0.00005253068,0.0019238953,0.0005153587,0.00009791959,0.0023878366,0.006988407,0.00009858016,0.005738645,0.000035595727],"about_ca_topic_score_codex":0.0035044276,"about_ca_topic_score_gemma":0.008543632,"teacher_disagreement_score":0.0035044276,"about_ca_system_score_codex":0.0008301463,"about_ca_system_score_gemma":0.0011631071,"threshold_uncertainty_score":0.01225704},"labels":[],"label_agreement":null},{"id":"W2985130805","doi":"10.1093/neuonc/noz175.994","title":"STEM-21. INVESTIGATING DOT1L AS AN EPIGENETIC VULNERABILITY IN BRAIN TUMOR STEM CELLS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; University of Toronto; SickKids Foundation; Ontario Brain Institute","funders":"","keywords":"Stem cell; Biology; Cancer research; Epigenetics; Neural stem cell; Embryonic stem cell; Methyltransferase; Cancer stem cell; Cell biology; Genetics; Methylation; Gene","score_opus":0.02122578722057692,"score_gpt":0.29567190841531643,"score_spread":0.2744461211947395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985130805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825852,0.0030940208,0.005790439,0.00024463315,0.000066302855,0.00012360218,0.003137534,0.00025599686,0.0047022095],"genre_scores_gemma":[0.9876304,0.0011183139,0.0019811937,0.00011106078,0.0000054078487,0.00006512757,0.0028132848,0.00002624958,0.0062489067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998894,0.000008799416,0.00000968388,0.00003379974,0.000039931365,0.000018468383],"domain_scores_gemma":[0.9999238,0.000009851006,0.000026678452,0.000006581275,0.000013724315,0.000019342631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001429557,0.0002516504,0.00027491167,0.00029232638,0.00017741631,0.000363382,0.00017217825,0.00036217464,0.0022117358],"category_scores_gemma":[0.00008579309,0.000113976654,0.00024453687,0.00020693781,0.00019755369,0.0001682374,0.00021626014,0.000357243,0.0006051118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005613518,0.000016900567,0.0004939734,0.00006340213,0.0000061097935,0.00007094116,0.00001701273,0.0000823508,0.99654764,0.00015779998,0.00007457065,0.0024131588],"study_design_scores_gemma":[0.00000950059,0.00024538988,0.007443028,0.0000073567094,0.000022967159,0.0002996661,0.0000398245,0.0009612846,0.984903,0.000070084665,0.005993919,0.000003906813],"about_ca_topic_score_codex":0.000978036,"about_ca_topic_score_gemma":0.0013305012,"teacher_disagreement_score":0.0022117358,"about_ca_system_score_codex":0.0004144368,"about_ca_system_score_gemma":0.00024110127,"threshold_uncertainty_score":0.0073990226},"labels":[],"label_agreement":null},{"id":"W2985230452","doi":"10.1093/neuonc/noab196.861","title":"TAMI-79. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Cancer research; Epigenetics; Biology; Mutation; Histone; Transcriptome; GATA2; Gene; Gene expression; Genetics","score_opus":0.023194236798508114,"score_gpt":0.30199445227612004,"score_spread":0.2788002154776119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985230452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882004,0.0039151707,0.0019733354,0.00032588083,0.00017312585,0.00018525362,0.00073228957,0.00038359078,0.0041109584],"genre_scores_gemma":[0.99516195,0.0012842935,0.00092878286,0.00014269314,0.000012181325,0.00009442313,0.0005860448,0.000020930445,0.0017687462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999614,0.0000038432395,0.0000018889855,0.000007185624,0.000008025842,0.000017660279],"domain_scores_gemma":[0.9999764,0.000002491951,0.000004678851,0.0000028900738,0.0000017800628,0.000011828844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000668017,0.00031682904,0.0003327216,0.0002356026,0.0001283913,0.0001611501,0.00031789255,0.0002645807,0.0016093112],"category_scores_gemma":[0.000066918125,0.000071220966,0.00020323755,0.00017091792,0.00022105504,0.00012477442,0.00013957218,0.0007241071,0.0002925949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004907786,0.0014806582,0.0010702633,0.0005636912,0.00008666953,0.0015975721,0.000087006265,0.0009005041,0.8904622,0.001443386,0.0025057755,0.09489448],"study_design_scores_gemma":[0.0025970691,0.023399945,0.017910518,0.00005869141,0.00021859704,0.0050659836,0.00015377685,0.0035702686,0.9052085,0.0007984886,0.04098219,0.000036014117],"about_ca_topic_score_codex":0.0007219865,"about_ca_topic_score_gemma":0.0013138251,"teacher_disagreement_score":0.0016093112,"about_ca_system_score_codex":0.00024260959,"about_ca_system_score_gemma":0.00033633324,"threshold_uncertainty_score":0.00538373},"labels":[],"label_agreement":null},{"id":"W2985346758","doi":"10.1093/neuonc/noz175.232","title":"CMET-31. WHOLE BRAIN RADIOTHERAPY VERSUS STEREOTACTIC RADIOSURGERY IN POOR-PROGNOSIS PATIENTS WITH 1 – 10 BRAIN METASTASES: A RANDOMIZED FEASIBILITY STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Positive Living North; Spinal Cord Injury BC; Kelowna General Hospital","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Radiation therapy; Randomized controlled trial; Brain metastasis; Population; Cumulative incidence; Internal medicine; Clinical trial; Surgery; Cancer; Cohort; Metastasis","score_opus":0.026386777972574122,"score_gpt":0.31609834216350036,"score_spread":0.28971156419092625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985346758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499236,0.002614313,0.0014635181,0.0012126588,0.0008585972,0.040515322,0.0011191514,0.00010700401,0.0021858753],"genre_scores_gemma":[0.96209043,0.0014818484,0.0030340166,0.0010601748,0.00076297024,0.028582994,0.00050148834,0.000019649216,0.0024664616],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99626154,0.002712582,0.00019983696,0.00030485392,0.00024082146,0.00028028377],"domain_scores_gemma":[0.996657,0.0013933958,0.00080444274,0.0002224611,0.00025035432,0.0006723614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006921885,0.0017467529,0.0026147708,0.000572006,0.000556411,0.0010338436,0.0011583826,0.0021751493,0.008479853],"category_scores_gemma":[0.004444285,0.00089082075,0.002374878,0.0006872585,0.001847769,0.0011743893,0.00063440594,0.0025537093,0.0015122951],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96957713,0.019348508,0.0007173006,0.00045516173,0.00047288794,0.000046059708,0.000049606224,0.00021839046,0.0015214948,0.00009156198,0.00043503137,0.007066818],"study_design_scores_gemma":[0.8478281,0.14961158,0.0010476664,0.000025085898,0.00031904032,0.000020745238,0.00002315738,0.00034384627,0.0002579969,0.00012173539,0.00038870345,0.000012222043],"about_ca_topic_score_codex":0.0016346929,"about_ca_topic_score_gemma":0.0028839137,"teacher_disagreement_score":0.008479853,"about_ca_system_score_codex":0.0011465128,"about_ca_system_score_gemma":0.003733887,"threshold_uncertainty_score":0.03660685},"labels":[],"label_agreement":null},{"id":"W2985386174","doi":"10.1093/neuonc/noz175.1101","title":"TMOD-02. A MODEL OF THE INITIATION AND GENOMIC LANDSCAPE OF GLIOBLASTOMA (GBM)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Calgary","funders":"Narodowe Centrum Badań i Rozwoju; Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN","keywords":"Subventricular zone; Biology; Comparative genomic hybridization; Cancer research; Gene; Neural stem cell; Stem cell; Cell biology; Genetics; Genome","score_opus":0.009558195283931996,"score_gpt":0.23899709456751525,"score_spread":0.22943889928358324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985386174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299557,0.00058293116,0.006782655,0.00027144686,0.00009612183,0.00013018101,0.0036442755,0.00029499494,0.0052019623],"genre_scores_gemma":[0.97161263,0.0005774216,0.008264209,0.00013465698,0.000009814724,0.00023070876,0.0037826167,0.00011526305,0.015272584],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99981433,0.000018457946,0.000017409942,0.00004584945,0.00006164501,0.000042339478],"domain_scores_gemma":[0.99986196,0.000014328185,0.000036330926,0.000016958198,0.000011736265,0.00005868866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016543416,0.00034374406,0.00020550088,0.0006484595,0.00018312372,0.00034998785,0.00042794604,0.0004806107,0.0026377286],"category_scores_gemma":[0.00006931873,0.00021303151,0.0002558527,0.00040458658,0.00034483892,0.0001969815,0.00028046354,0.00093147135,0.00083259743],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028642995,0.00016049408,0.00027579293,0.000040488416,0.0000051691204,0.00018281741,0.0000492615,0.00033328898,0.9958637,0.0008993364,0.00025541557,0.0016476989],"study_design_scores_gemma":[0.000099821526,0.0019090938,0.005679269,0.000019404897,0.000026496069,0.0010678278,0.00018500704,0.006030153,0.9693812,0.00050200906,0.015084205,0.00001551958],"about_ca_topic_score_codex":0.0022792676,"about_ca_topic_score_gemma":0.0023952366,"teacher_disagreement_score":0.0026377286,"about_ca_system_score_codex":0.00046972747,"about_ca_system_score_gemma":0.0003179377,"threshold_uncertainty_score":0.00882405},"labels":[],"label_agreement":null},{"id":"W2985498522","doi":"10.1093/neuonc/noz175.617","title":"PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Subtyping; Ependymoma; Medical diagnosis; DNA methylation; Glioma; Medulloblastoma; Medicine; Pathology; Brain tumor; Oncology; Internal medicine; Biology; Cancer research; Gene; Gene expression; Genetics","score_opus":0.05041236766600137,"score_gpt":0.3550329904914273,"score_spread":0.3046206228254259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985498522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96152705,0.009578149,0.002690405,0.0021495875,0.0001288239,0.00016391695,0.001144715,0.00019144744,0.022425864],"genre_scores_gemma":[0.9872869,0.0040422776,0.0039404137,0.00039991827,0.00008773944,0.000030475418,0.0007216321,0.000056418412,0.0034342406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943656,0.0001301048,0.0000477925,0.00012167078,0.00017653292,0.00008733915],"domain_scores_gemma":[0.99830025,0.00027872325,0.00019066404,0.00013487613,0.0006720194,0.00042348923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014645716,0.000441826,0.00027388666,0.0007429343,0.00067149504,0.0011898889,0.00049242895,0.00049463013,0.002710923],"category_scores_gemma":[0.0027468146,0.0002301786,0.00021549343,0.00086176,0.0007234066,0.00047677074,0.00073692907,0.00048446748,0.0012600607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065395545,0.00010783174,0.71017796,0.0002494734,0.00005720246,0.009926523,0.002630005,0.0010762558,0.016604504,0.0006528877,0.0072436268,0.2506197],"study_design_scores_gemma":[0.000055730514,0.0011238655,0.9278315,0.00019277804,0.00009265721,0.023953995,0.0018711151,0.0042078397,0.00835254,0.00044778548,0.03177527,0.00009491713],"about_ca_topic_score_codex":0.09887796,"about_ca_topic_score_gemma":0.15367848,"teacher_disagreement_score":0.90112203,"about_ca_system_score_codex":0.003818905,"about_ca_system_score_gemma":0.002651686,"threshold_uncertainty_score":0.19660485},"labels":[],"label_agreement":null},{"id":"W2985655825","doi":"10.1093/neuonc/noz175.696","title":"NIMG-25. LESION-NETWORK ANALYSIS TO IDENTIFY PREFERENTIALLY-ENGAGED NETWORKS IN EPILEPTOGENIC TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Voxel; Parahippocampal gyrus; Lesion; Epilepsy; Neuroscience; Medicine; Psychology; Radiology; Pathology; Temporal lobe","score_opus":0.05170857288066104,"score_gpt":0.3224845097373746,"score_spread":0.27077593685671353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985655825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7193783,0.0014723501,0.19100626,0.00075003866,0.0001874933,0.0016865461,0.04597391,0.015744269,0.023800904],"genre_scores_gemma":[0.82839316,0.00030277178,0.14566395,0.00014207338,0.000044900808,0.0020655917,0.015462493,0.00076292397,0.0071621323],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998617,0.00005130194,0.000006367121,0.00003199439,0.000030632298,0.000017986156],"domain_scores_gemma":[0.999642,0.00014418157,0.00005632254,0.000048275484,0.000053194268,0.00005602629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008605615,0.00047363032,0.00040825753,0.0012434544,0.00029322997,0.0005986893,0.0006020273,0.0003342818,0.013531436],"category_scores_gemma":[0.0023740218,0.00019066021,0.0005022422,0.0007544427,0.00023175556,0.00030679218,0.0005004599,0.00022713472,0.0011399596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003361824,0.00049004576,0.132795,0.0013875237,0.0020366174,0.0013668729,0.000762551,0.06504152,0.03877979,0.012625201,0.09743845,0.6439145],"study_design_scores_gemma":[0.0008385877,0.0011310261,0.41612646,0.00017481785,0.0008078471,0.0019536398,0.0004324003,0.47377458,0.018921228,0.031630013,0.05405818,0.00015120569],"about_ca_topic_score_codex":0.0059318114,"about_ca_topic_score_gemma":0.014978149,"teacher_disagreement_score":0.013531436,"about_ca_system_score_codex":0.00050857005,"about_ca_system_score_gemma":0.0008072778,"threshold_uncertainty_score":0.045267224},"labels":[],"label_agreement":null},{"id":"W2985913611","doi":"10.1093/neuonc/noz175.1151","title":"SCIDOT-15. DISRUPTING THE BLOOD-BRAIN BARRIER IN NEURO-ONCOLOGY: INNOVATIONS, ACHIEVEMENTS, AND LESSONS LEARNED FROM CLINICAL TRIALS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Blood–brain barrier; Clinical trial; Oncology; Internal medicine; Adverse effect","score_opus":0.16020268465407844,"score_gpt":0.42240610877113366,"score_spread":0.2622034241170552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985913611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0100946305,0.9546724,0.0018301052,0.010653922,0.001765412,0.0026223646,0.0042767366,0.00024715526,0.013837295],"genre_scores_gemma":[0.07060068,0.8893751,0.011324633,0.0126003735,0.0019962902,0.004274991,0.005788769,0.00013054712,0.0039086267],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99165314,0.004645597,0.001934097,0.0003906355,0.0011174442,0.00025901114],"domain_scores_gemma":[0.9836572,0.009034511,0.0031211209,0.00065355026,0.0025685788,0.0009650348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01859345,0.0008349029,0.0029368962,0.0026246158,0.0004265088,0.0036007415,0.0013053922,0.0022290684,0.010711106],"category_scores_gemma":[0.017207075,0.00028072036,0.0035298564,0.0029119235,0.0010399583,0.0025259375,0.0013791898,0.0022380159,0.002442321],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016136477,0.00075962726,0.0015491925,0.24217916,0.003640455,0.00026880394,0.00026057172,0.00059255,0.004522299,0.005915156,0.031259123,0.6929165],"study_design_scores_gemma":[0.025800377,0.025806567,0.010532342,0.26232493,0.016033957,0.0012066318,0.00053887727,0.001174767,0.007486905,0.01290752,0.63594866,0.00023842443],"about_ca_topic_score_codex":0.0004490151,"about_ca_topic_score_gemma":0.0011541168,"teacher_disagreement_score":0.01859345,"about_ca_system_score_codex":0.0011970401,"about_ca_system_score_gemma":0.004714141,"threshold_uncertainty_score":0.0983327},"labels":[],"label_agreement":null},{"id":"W2986141571","doi":"10.1093/neuonc/noz175.226","title":"CMET-25. COMPARATIVE EFFICACY OF TREATMENT PARADIGMS FOR BRAIN METASTASES – A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Temozolomide; Oncology; Randomized controlled trial; Lung cancer; Progression-free survival; Incidence (geometry); Meta-analysis; Melanoma; Adverse effect; Brain metastasis; Cancer; Overall survival; Radiation therapy; Metastasis","score_opus":0.18117725682860739,"score_gpt":0.4508045744584285,"score_spread":0.26962731762982106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986141571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025362617,0.9917739,0.00043401678,0.00044120362,0.0002690981,0.0023609533,0.0014422572,0.00003963625,0.00070268253],"genre_scores_gemma":[0.069133945,0.9175563,0.003137949,0.001476444,0.00026372506,0.006839151,0.0011162861,0.000038356753,0.00043781125],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.986381,0.006428972,0.0044042324,0.0007634349,0.0017219341,0.00030048666],"domain_scores_gemma":[0.9653638,0.025173508,0.0062964894,0.00048420302,0.0022684739,0.0004135583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013475183,0.001722454,0.0135964425,0.00935356,0.00068869995,0.003558865,0.0022560766,0.0020526785,0.010990322],"category_scores_gemma":[0.051932678,0.0009990532,0.013662181,0.007204267,0.0010351549,0.002904058,0.0017238705,0.0017363871,0.0005518192],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049072277,0.000012416949,0.0003004366,0.96711206,0.021099787,0.000029329245,0.00007044126,0.000079934514,0.000093817165,0.00017190984,0.00058363203,0.0099557005],"study_design_scores_gemma":[0.0024940122,0.00054144004,0.0032180578,0.7464032,0.23522662,0.0001904459,0.00022241822,0.0002470205,0.00018993567,0.0006246481,0.010593802,0.00004841122],"about_ca_topic_score_codex":0.005303575,"about_ca_topic_score_gemma":0.014219465,"teacher_disagreement_score":0.0135964425,"about_ca_system_score_codex":0.004806574,"about_ca_system_score_gemma":0.009254857,"threshold_uncertainty_score":0.071264386},"labels":[],"label_agreement":null},{"id":"W2986281301","doi":"10.1093/neuonc/noz175.1140","title":"TMOD-41. ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODELS OF BRAIN METASTASIS: PLATFORMS FOR PRECISION ONCOLOGY AND UNDERSTANDING TUMOR BIOLOGY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Princess Margaret Cancer Centre; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Cancer research; Cancer; Targeted therapy; Metastasis; Immunohistochemistry; Breast cancer; Pathology; Oncology; Internal medicine","score_opus":0.0700968200232243,"score_gpt":0.3308375232073462,"score_spread":0.2607407031841219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986281301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91331583,0.0097004585,0.052457575,0.001484926,0.00038988763,0.00067544065,0.0074349614,0.00093187165,0.013609078],"genre_scores_gemma":[0.95431423,0.005409252,0.026711132,0.00019986453,0.00003535464,0.00049312075,0.003815564,0.00007392774,0.008947526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971145,0.00006721608,0.000020905245,0.000054420627,0.00009698252,0.000049046554],"domain_scores_gemma":[0.9998198,0.000030682208,0.00004627669,0.00004060443,0.00002385066,0.00003885221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006333849,0.00056433305,0.00039927324,0.0005673955,0.00026272307,0.00070693425,0.0004684776,0.00051483634,0.0031870948],"category_scores_gemma":[0.00017308802,0.00027878585,0.00035669425,0.00045256683,0.00040234847,0.0005241915,0.00036234388,0.001495701,0.0007604749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003245392,0.00028373458,0.0009087619,0.00023783499,0.00002851594,0.00016306019,0.0000518371,0.00078863284,0.9878471,0.0015207333,0.001185915,0.006659359],"study_design_scores_gemma":[0.00013126382,0.0025621483,0.0052182954,0.000041552823,0.00007379204,0.0010519805,0.00011433846,0.0050029173,0.96499044,0.00061274815,0.020180818,0.00001975901],"about_ca_topic_score_codex":0.0011399824,"about_ca_topic_score_gemma":0.0020155418,"teacher_disagreement_score":0.0031870948,"about_ca_system_score_codex":0.00053942384,"about_ca_system_score_gemma":0.0005040094,"threshold_uncertainty_score":0.0106619},"labels":[],"label_agreement":null},{"id":"W2986352314","doi":"10.1093/neuonc/noz175.914","title":"RBTT-02. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Adverse effect; Oncology; Internal medicine; Radiology; Randomized controlled trial; Radiation therapy","score_opus":0.030637920352280915,"score_gpt":0.33799543508606666,"score_spread":0.30735751473378575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986352314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95791006,0.015666123,0.0007329977,0.0019859343,0.0006581976,0.0036134475,0.007835857,0.00043771756,0.011159728],"genre_scores_gemma":[0.96082693,0.0068323044,0.0013769647,0.0033933679,0.0004711079,0.005886563,0.011978632,0.0001175429,0.009116567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996525,0.00016316798,0.000017621067,0.000055537665,0.0000355065,0.000075613316],"domain_scores_gemma":[0.9996486,0.000053254513,0.00010435561,0.000024155297,0.000021817332,0.00014777594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015016176,0.0014713549,0.001612358,0.00034391947,0.00037976252,0.0014650312,0.0009446271,0.0014430666,0.0074339053],"category_scores_gemma":[0.0007785881,0.000368941,0.0022906263,0.00037223453,0.0005418474,0.00088785065,0.00034667985,0.002945545,0.001593378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8625667,0.012934181,0.0042769243,0.0030587043,0.0025657555,0.00021564914,0.00017629244,0.003120436,0.013599889,0.00082125753,0.019975424,0.07668879],"study_design_scores_gemma":[0.826115,0.15069626,0.011289584,0.00023171084,0.001112699,0.00033055642,0.00007275671,0.0016564738,0.0013480606,0.0008155499,0.0062790173,0.00005226245],"about_ca_topic_score_codex":0.0019883646,"about_ca_topic_score_gemma":0.006866444,"teacher_disagreement_score":0.0074339053,"about_ca_system_score_codex":0.001095919,"about_ca_system_score_gemma":0.0013671975,"threshold_uncertainty_score":0.024868846},"labels":[],"label_agreement":null},{"id":"W2986411077","doi":"10.1093/neuonc/noaa004","title":"SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Immune system; Biology; Cancer research; Immunology; Medicine","score_opus":0.021321787892530735,"score_gpt":0.2893955586368539,"score_spread":0.26807377074432315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986411077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99968517,0.000118064854,0.00007498992,0.0000023164437,3.8076647e-7,0.0000018414939,0.00003893429,0.0000018115167,0.00007647546],"genre_scores_gemma":[0.99977297,0.00003675739,0.000055718378,0.0000015788461,8.0917204e-7,0.0000021256233,0.00006773709,7.728438e-7,0.000061526815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999268,0.000010427297,0.000008309466,0.000025031968,0.000014172145,0.00001523246],"domain_scores_gemma":[0.99976856,0.000034407312,0.0001078104,0.000013993964,0.00002126771,0.00005395856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021577303,0.00012894353,0.00015406164,0.0005535674,0.00012052074,0.00016663435,0.00009917438,0.00013436696,0.0006562236],"category_scores_gemma":[0.00023627903,0.00007697694,0.000100310106,0.00022434768,0.00016219127,0.00012016489,0.0001265279,0.00011601267,0.00010488379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000993262,0.00003560792,0.9183349,0.00002280518,0.00006933315,0.00033421387,0.00008080012,0.00012964498,0.07613096,0.000029784833,0.0000388536,0.0037999046],"study_design_scores_gemma":[0.0000053039084,0.00010769102,0.9939678,0.0000018260515,0.000026446274,0.00077402964,0.0000558626,0.0002514559,0.004649449,0.000024015004,0.00013402889,0.000002194859],"about_ca_topic_score_codex":0.00054791494,"about_ca_topic_score_gemma":0.0007475665,"teacher_disagreement_score":0.0006562236,"about_ca_system_score_codex":0.00016308871,"about_ca_system_score_gemma":0.000096331416,"threshold_uncertainty_score":0.002195239},"labels":[],"label_agreement":null},{"id":"W2986474427","doi":"10.1093/neuonc/noz175.575","title":"INNV-34. PATTERNS OF FAILURE AND DEVELOPMENT OF A NOVEL PROGNOSTIC SCORING SYSTEM IN ELDERLY PATIENTS WITH GLIOBLASTOMA – FOLLOW UP ON 10 YEAR ANALYSIS OF THE BC CANCER AGENCY POPULATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Univariate analysis; Internal medicine; Glioblastoma; Performance status; Cancer; Population; Surgery; Multivariate analysis","score_opus":0.014867253305721957,"score_gpt":0.2604247628973116,"score_spread":0.24555750959158965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986474427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989837,0.000090180256,0.00013389938,0.000020921148,0.0000032147263,0.0000061631486,0.0005383389,0.000004776927,0.00021874037],"genre_scores_gemma":[0.99878424,0.00003009098,0.00012556431,0.0000058510027,0.0000043016753,0.000007702478,0.0009419247,0.0000021019584,0.00009818403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966586,0.000101998514,0.00003954288,0.000056600333,0.00007533088,0.000060675182],"domain_scores_gemma":[0.99875355,0.00017676358,0.0005882749,0.0000654243,0.0002500602,0.00016590524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010672545,0.0002473524,0.00026226483,0.0012233328,0.00023341675,0.00052240805,0.00029241727,0.0002586818,0.0007807807],"category_scores_gemma":[0.0024001193,0.00011550501,0.0003292927,0.00089663896,0.00014316742,0.00032785267,0.0004785887,0.00031318082,0.00029182545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014534043,0.000007244083,0.9974662,0.00000281918,0.000019934885,0.000019418403,0.00002052029,0.000094564806,0.00013597203,0.000008759007,0.0001160428,0.0019631346],"study_design_scores_gemma":[0.000004057725,0.000074898264,0.9985499,0.00000281923,0.000011930229,0.0000946828,0.00005960179,0.00096101506,0.000054576547,0.000018427238,0.0001655337,0.000002481133],"about_ca_topic_score_codex":0.008663896,"about_ca_topic_score_gemma":0.008611871,"teacher_disagreement_score":0.008663896,"about_ca_system_score_codex":0.0004602355,"about_ca_system_score_gemma":0.00034879375,"threshold_uncertainty_score":0.017226934},"labels":[],"label_agreement":null},{"id":"W2986598134","doi":"10.1093/neuonc/noz175.798","title":"PDTM-22. A C19MC-LIN28A-MYCN ONCOGENIC CIRCUIT DRIVEN BY HIJACKED SUPER-ENHANCERS IS A DISTINCT THERAPEUTIC VULNERABILITY IN ETMRS – A LETHAL BRAIN TUMOR","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Biology; Enhancer; Embryonic stem cell; Neural stem cell; Chromatin; Lineage (genetic); Cell; Gene; Cell biology; Stem cell; Transcription factor; Genetics","score_opus":0.015146781668642926,"score_gpt":0.2805255523321021,"score_spread":0.26537877066345916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986598134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960626,0.0005086312,0.0016485945,0.000043397544,0.000013966657,0.000025921814,0.00019975076,0.000060567687,0.0014366065],"genre_scores_gemma":[0.99710304,0.00018486487,0.00080095895,0.000016383563,0.0000022506624,0.000017433096,0.00022757011,0.000009669225,0.0016377729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999373,0.000007726646,0.0000041520098,0.000015197535,0.000017679286,0.000017999098],"domain_scores_gemma":[0.99996436,0.0000070544756,0.0000075261405,0.000005435977,0.0000027142285,0.000012923337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006317206,0.00019846142,0.00014442999,0.00011663828,0.00009923833,0.00013609174,0.00013705385,0.00016884053,0.00137036],"category_scores_gemma":[0.000049068505,0.00006687838,0.000113891365,0.00005745747,0.0001337174,0.00009650381,0.00011638686,0.00040881385,0.00022609458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007419341,0.000029019195,0.00012318799,0.00001157164,0.0000035806202,0.000046044723,0.0000050948365,0.00006992962,0.99847883,0.00015189101,0.000030157267,0.0009765864],"study_design_scores_gemma":[0.000010501245,0.0003408732,0.0013288815,0.0000011833579,0.000006409758,0.0002561585,0.0000068319223,0.0006026523,0.9956923,0.00003403124,0.0017190453,0.0000012250096],"about_ca_topic_score_codex":0.00038315423,"about_ca_topic_score_gemma":0.00065582787,"teacher_disagreement_score":0.00137036,"about_ca_system_score_codex":0.00020244942,"about_ca_system_score_gemma":0.000119710625,"threshold_uncertainty_score":0.004584372},"labels":[],"label_agreement":null},{"id":"W2986682168","doi":"10.1093/neuonc/noz175.488","title":"HOUT-23. ADULT MEDULLOBLASTOMA TREATMENT IMPACT SINCE 2006: A CANADIAN UNIVERSITY CENTER EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Lomustine; Medulloblastoma; Radiation therapy; Etoposide; Chemotherapy; Vincristine; Cohort; Concomitant; Internal medicine; Oncology; Surgery; Cyclophosphamide","score_opus":0.01222054368330804,"score_gpt":0.2754624270305985,"score_spread":0.26324188334729043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986682168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96674556,0.010873533,0.00022651031,0.002175674,0.00009757392,0.000110631125,0.0018610831,0.000049535985,0.017859861],"genre_scores_gemma":[0.9840591,0.009733394,0.00059867586,0.00065748394,0.00009391047,0.000030947307,0.0015489698,0.000039540108,0.0032378144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938846,0.000040863248,0.000034736655,0.000076196695,0.00025009274,0.00020964174],"domain_scores_gemma":[0.9985863,0.000058247897,0.00028533256,0.000038607755,0.00036873363,0.00066271995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046053567,0.00025939778,0.00023842348,0.0011361295,0.0019251013,0.0009962921,0.00056166796,0.00033500855,0.0025297273],"category_scores_gemma":[0.0015280071,0.00018136119,0.00026764686,0.0030172004,0.000703264,0.00040346634,0.0006817764,0.00049153675,0.0004207944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033559726,0.00032683767,0.8434523,0.00023086084,0.000076557706,0.004791533,0.0034074616,0.0003398506,0.001874036,0.0006548581,0.011265844,0.13324435],"study_design_scores_gemma":[0.00004031904,0.00028929525,0.9577176,0.00024787555,0.000060511797,0.0075519374,0.002852534,0.0003092281,0.00048287548,0.00009493495,0.03030795,0.00004491292],"about_ca_topic_score_codex":0.8348814,"about_ca_topic_score_gemma":0.9216448,"teacher_disagreement_score":0.16511858,"about_ca_system_score_codex":0.016349833,"about_ca_system_score_gemma":0.019544661,"threshold_uncertainty_score":0.33218193},"labels":[],"label_agreement":null},{"id":"W2986909789","doi":"10.1093/neuonc/noz175.192","title":"CSIG-22. REGULATION OF GLIOMA STEM CELL SELF-RENEWAL AND TUMORIGENESIS BY CARBOHYDRATE BINDING PROTEINS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene knockdown; Carcinogenesis; Biology; Cancer research; Stem cell; STAT3; Glioma; Molecular biology; Cell biology; Cell culture; Signal transduction; Genetics; Gene","score_opus":0.0071015434597486125,"score_gpt":0.21794300702146824,"score_spread":0.21084146356171962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986909789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9352664,0.010490036,0.008098989,0.0011768736,0.00050623046,0.00020549707,0.02137736,0.0020310131,0.020847624],"genre_scores_gemma":[0.96649253,0.001858149,0.0026455186,0.0004014038,0.00001888933,0.00011895158,0.013553459,0.00024938065,0.014661655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998307,0.000014841906,0.000010721885,0.000046361212,0.000049263883,0.000048078513],"domain_scores_gemma":[0.99989545,0.0000059613017,0.000024651574,0.000010487304,0.000012369374,0.000050968836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011127206,0.00041779305,0.00028590584,0.0003093194,0.00030845715,0.0005842786,0.00032081903,0.0003774655,0.004029028],"category_scores_gemma":[0.00009423364,0.00016199607,0.0003698399,0.00038148207,0.00029481767,0.00014817774,0.0003554786,0.0008450417,0.0023293023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026301556,0.000043172986,0.00045732828,0.0001272179,0.000010426443,0.00008251799,0.000014645185,0.00019709684,0.9931933,0.0003929384,0.0010178218,0.0042005363],"study_design_scores_gemma":[0.00005364806,0.00023287369,0.014657035,0.00002570407,0.00003435542,0.00032117788,0.00005903842,0.002729534,0.9475956,0.00022620411,0.034045964,0.000018895205],"about_ca_topic_score_codex":0.0025221102,"about_ca_topic_score_gemma":0.0031189555,"teacher_disagreement_score":0.004029028,"about_ca_system_score_codex":0.0008080162,"about_ca_system_score_gemma":0.00067676615,"threshold_uncertainty_score":0.013478458},"labels":[],"label_agreement":null},{"id":"W2986952922","doi":"10.1093/neuonc/noz175.092","title":"ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION &amp; PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Oncology; Clinical endpoint; Cumulative incidence; Radiosurgery; Radiation therapy; Randomized controlled trial; Cognition; Cohort","score_opus":0.0244943871227393,"score_gpt":0.3090803672934381,"score_spread":0.28458598017069875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986952922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733293,0.0007254335,0.00014007435,0.00009033717,0.00004188479,0.00016017632,0.0003527134,0.000032152853,0.0011243195],"genre_scores_gemma":[0.9964719,0.0005730428,0.000261807,0.00012972455,0.00005287671,0.00028973588,0.000759481,0.000010111772,0.0014513629],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996487,0.00015691965,0.000020171079,0.000053206495,0.00004668007,0.0000743437],"domain_scores_gemma":[0.9996345,0.00006411708,0.00007601641,0.00006711585,0.000020475778,0.00013767854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068962696,0.0005319516,0.0009114962,0.00027738756,0.00016742414,0.00036907083,0.0005307194,0.00042225159,0.0027987969],"category_scores_gemma":[0.00057745376,0.00014366876,0.0007982848,0.00028712332,0.00050465745,0.00030610734,0.00018104311,0.001186293,0.00057787966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63218087,0.058482658,0.012233206,0.00059938466,0.0015144567,0.00019307443,0.00020206395,0.0028365143,0.04597586,0.00039146564,0.0046790615,0.24071142],"study_design_scores_gemma":[0.11965407,0.78955823,0.07222173,0.00006497813,0.0011493985,0.00028409658,0.000102117265,0.0021839228,0.011212903,0.0002218693,0.0033003998,0.000046293535],"about_ca_topic_score_codex":0.0015308005,"about_ca_topic_score_gemma":0.003940646,"teacher_disagreement_score":0.0027987969,"about_ca_system_score_codex":0.00042906165,"about_ca_system_score_gemma":0.00058744836,"threshold_uncertainty_score":0.009362876},"labels":[],"label_agreement":null},{"id":"W2986955991","doi":"10.1093/neuonc/noz175.1137","title":"TMOD-38. PRODUCTION OF D-2-HYDROXYGLUTARATE IN SACCHAROMYCES CEREVISIAE LEADS TO GROWTH IMPAIRMENT AND DECREASED SURVIVAL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Saccharomyces cerevisiae; Biology; Mitochondrion; Carcinogenesis; Respiratory chain; Genetics; Knockout mouse; Biochemistry; Gene; Cell biology; Molecular biology","score_opus":0.009316071521989282,"score_gpt":0.2594382541529083,"score_spread":0.250122182630919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986955991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95168173,0.0030813129,0.011577138,0.00042658913,0.00023846589,0.00023312077,0.027149424,0.0014850956,0.0041270424],"genre_scores_gemma":[0.94760245,0.0013369791,0.012748799,0.00015534653,0.000015679076,0.00019862643,0.028863667,0.00047919006,0.008599291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999634,0.000041523126,0.0000671664,0.00008940463,0.000115244715,0.000052555017],"domain_scores_gemma":[0.9997838,0.00003891979,0.00005384917,0.00004099005,0.000023881481,0.000058578225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018496842,0.0008764167,0.00057647406,0.00043484438,0.00022335694,0.00052586873,0.0005432128,0.00035194706,0.0022888691],"category_scores_gemma":[0.0002069388,0.0002479616,0.00050386146,0.00057567743,0.00020185209,0.00015669763,0.0005468099,0.0006494224,0.0015096047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012343182,0.000042500273,0.00016756191,0.000058317622,0.00000922199,0.00007348657,0.000012987898,0.000085936954,0.99804026,0.000044593926,0.00012316841,0.0012184978],"study_design_scores_gemma":[0.000020742771,0.00019101254,0.0032542832,0.000017323167,0.000022613718,0.00019896874,0.00004593145,0.0015117349,0.98939556,0.000044630768,0.0052806614,0.000016467056],"about_ca_topic_score_codex":0.0024481623,"about_ca_topic_score_gemma":0.002066586,"teacher_disagreement_score":0.0024481623,"about_ca_system_score_codex":0.00047087713,"about_ca_system_score_gemma":0.00026465158,"threshold_uncertainty_score":0.007657051},"labels":[],"label_agreement":null},{"id":"W2987001203","doi":"10.1093/neuonc/noz175.056","title":"ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal; McGill University; University of Calgary","funders":"","keywords":"Procarbazine; Medicine; Lomustine; Oligodendroglial Tumor; Internal medicine; Hazard ratio; Oncology; Anaplastic astrocytoma; Oligodendroglioma; Vincristine; Progression-free survival; Chemoradiotherapy; Proportional hazards model; Nuclear medicine; Glioma; Radiation therapy; Astrocytoma; Overall survival; Chemotherapy; Confidence interval; Cancer research","score_opus":0.0254265101341337,"score_gpt":0.30211824224713424,"score_spread":0.2766917321130005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987001203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8695128,0.012712041,0.0020345494,0.004129612,0.0010884401,0.010502382,0.03789699,0.0007661719,0.061356958],"genre_scores_gemma":[0.90178114,0.0038638809,0.007463874,0.0037542135,0.00050506974,0.0071331854,0.029524077,0.00037247757,0.0456021],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993703,0.000325427,0.00004139847,0.00009816203,0.000085708234,0.00007917921],"domain_scores_gemma":[0.9993304,0.00011683955,0.000108455475,0.00006939172,0.00006186146,0.00031317185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016797299,0.00045288925,0.0010579117,0.0003337694,0.00025785516,0.00055167987,0.00062127,0.0005631056,0.016756775],"category_scores_gemma":[0.0009439511,0.00022254427,0.0012711448,0.00030858183,0.00023651637,0.00018060776,0.00034787174,0.0012087126,0.0032945732],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57090646,0.011466165,0.01248528,0.0011519511,0.001565879,0.00020984322,0.000084193154,0.002320748,0.01847042,0.00054107746,0.05077214,0.33002597],"study_design_scores_gemma":[0.39796007,0.30184528,0.14903088,0.00061219645,0.00462542,0.00094957295,0.00009115687,0.0037756616,0.014342605,0.0009819114,0.12571523,0.000070064445],"about_ca_topic_score_codex":0.0025183426,"about_ca_topic_score_gemma":0.00752598,"teacher_disagreement_score":0.016756775,"about_ca_system_score_codex":0.00097389676,"about_ca_system_score_gemma":0.0016327337,"threshold_uncertainty_score":0.056056976},"labels":[],"label_agreement":null},{"id":"W2987430440","doi":"10.1093/neuonc/noz175.287","title":"DDIS-36. BTP-7, A NOVEL PEPTIDE FOR THERAPEUTIC TARGETING OF MALIGNANT BRAIN TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Peptide; Cancer research; Peptide library; Gene isoform; Biology; Brain tumor; Molecular biology; Biochemistry; Medicine; Peptide sequence; Pathology; Gene","score_opus":0.020164067049152558,"score_gpt":0.2779066520696116,"score_spread":0.25774258502045905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987430440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636912,0.013582888,0.013126092,0.00036291516,0.00017989049,0.00025356142,0.00144078,0.00032716064,0.0070354217],"genre_scores_gemma":[0.97851175,0.0050300094,0.009220611,0.00020345987,0.000035454617,0.0001365866,0.0015838386,0.000026994994,0.005251277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999198,0.0000097767115,0.0000047655335,0.000017534805,0.000031359916,0.00001673818],"domain_scores_gemma":[0.9999747,0.0000029553426,0.000006912858,0.00000160218,0.0000035360665,0.000010227236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000961399,0.0004621177,0.00024696076,0.0002595712,0.00009607794,0.00022411872,0.00020800285,0.0003408788,0.0009751219],"category_scores_gemma":[0.00006825643,0.00012876121,0.00016898323,0.0001943582,0.00014134085,0.00016972864,0.00015882147,0.00044137138,0.00050895417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011275293,0.00004543759,0.00008896401,0.0001154018,0.000007182185,0.00007905556,0.0000067406645,0.00042281728,0.990905,0.00016769755,0.00027703342,0.0077719702],"study_design_scores_gemma":[0.000056186178,0.00081270945,0.0008312468,0.000008683339,0.00001962371,0.0005096123,0.0000067507153,0.0015462256,0.98825336,0.00010228132,0.007845226,0.000007990774],"about_ca_topic_score_codex":0.0002530198,"about_ca_topic_score_gemma":0.00032820605,"teacher_disagreement_score":0.0009751219,"about_ca_system_score_codex":0.0003101069,"about_ca_system_score_gemma":0.00019930642,"threshold_uncertainty_score":0.0032621622},"labels":[],"label_agreement":null},{"id":"W2987493194","doi":"10.1093/neuonc/noz175.771","title":"PDCT-08. SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; CDKN2A; Glioma; Concomitant; Cohort; Discontinuation; V600E; Mutation; Cancer research; Cancer; Gene","score_opus":0.018998637659840747,"score_gpt":0.2863293868600879,"score_spread":0.2673307492002472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987493194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976464,0.00037866647,0.00016956944,0.00006603667,0.000009655397,0.00001715731,0.0005774442,0.000017256125,0.0011177605],"genre_scores_gemma":[0.9980566,0.00013060929,0.00012569752,0.00003848459,0.000009658003,0.00001657761,0.001385563,0.0000064289434,0.00023037154],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99985015,0.00003170193,0.000012006275,0.00003464407,0.00002522184,0.00004622931],"domain_scores_gemma":[0.99953425,0.000045943518,0.00017016711,0.000026181098,0.000034513403,0.00018889802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002448663,0.00014936537,0.0002952852,0.00022836358,0.00020828685,0.00043256363,0.00013807912,0.00015747335,0.0012733581],"category_scores_gemma":[0.0003957802,0.00004904067,0.00022584424,0.0003010443,0.00017422558,0.00018726582,0.00026778338,0.00031218753,0.00028793502],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010931539,0.00079301884,0.8883437,0.0001098214,0.00016835803,0.002587331,0.00012897665,0.0007570821,0.01101163,0.00017935674,0.0023073202,0.0826818],"study_design_scores_gemma":[0.00041704194,0.009140805,0.97342694,0.000032859058,0.0001429403,0.007477215,0.00019329789,0.0008306202,0.0040139654,0.00016803753,0.0041451734,0.000011180553],"about_ca_topic_score_codex":0.0009938541,"about_ca_topic_score_gemma":0.0015277694,"teacher_disagreement_score":0.0012733581,"about_ca_system_score_codex":0.00046275332,"about_ca_system_score_gemma":0.00047523444,"threshold_uncertainty_score":0.0042598248},"labels":[],"label_agreement":null},{"id":"W2987562677","doi":"10.1093/neuonc/noz175.309","title":"EPID-09. PROGNOSTIC FACTORS IN ADULT PATIENTS WITH PRIMARY INTRACRANIAL EPENDYMOMAS: A POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Ependymoma; Cohort; Proportional hazards model; Radiation therapy; Epidemiology; Cancer registry; Surveillance, Epidemiology, and End Results; Brain tumor; Internal medicine; Cohort study; Chemotherapy; Survival analysis; Population; Relative survival; Oncology; Surgery; Pathology","score_opus":0.010594942822823937,"score_gpt":0.26224893281382433,"score_spread":0.2516539899910004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987562677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786896,0.00046708295,0.00017758402,0.00007027501,0.0000150704045,0.00006203304,0.010350413,0.000016576148,0.0009718685],"genre_scores_gemma":[0.99074125,0.00027224302,0.0001902534,0.00006178019,0.000035348978,0.00008326216,0.00834688,0.00000619023,0.0002627425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951875,0.000081470724,0.00008015679,0.00016741164,0.000080676284,0.00007147169],"domain_scores_gemma":[0.9988876,0.00013582056,0.00051109586,0.000114786744,0.00014035427,0.00021036621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000562356,0.0003267724,0.00043812345,0.0009401104,0.00033372358,0.00069021643,0.0004741141,0.00037007162,0.0018778712],"category_scores_gemma":[0.0017515762,0.0003011522,0.0005096656,0.001981654,0.00019898987,0.0006307323,0.0005778653,0.0005898654,0.0006621883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010671559,0.000036748577,0.9985606,0.000024030262,0.000055551758,0.00006441426,0.000026936883,0.000019452618,0.00005729751,0.000013190371,0.00027900471,0.00075608806],"study_design_scores_gemma":[0.000025304198,0.000099589895,0.99885166,0.000009857811,0.000052263127,0.00027876365,0.000085385785,0.00010136042,0.00003032779,0.000019102123,0.00044268998,0.0000037067723],"about_ca_topic_score_codex":0.0040251496,"about_ca_topic_score_gemma":0.0032519347,"teacher_disagreement_score":0.0040251496,"about_ca_system_score_codex":0.00032333072,"about_ca_system_score_gemma":0.00053384673,"threshold_uncertainty_score":0.008003473},"labels":[],"label_agreement":null},{"id":"W2987705555","doi":"10.1093/neuonc/noz175.233","title":"CMET-32. DNA METHYLATION ALTERATIONS IN LUNG ADENOCARCINOMAS THAT DEVELOP BRAIN METASTASES","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Brain metastasis; DNA methylation; Oncology; Medicine; Methylation; Metastasis; Lung cancer; Cohort; Internal medicine; Proportional hazards model; Adenocarcinoma; Receiver operating characteristic; Bisulfite sequencing; Cancer; Univariate analysis; Multivariate analysis; Biology; DNA; Gene","score_opus":0.02379090645040036,"score_gpt":0.29992634526114065,"score_spread":0.27613543881074026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987705555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982299,0.00022417113,0.0006354526,0.000051393185,0.0000036067715,0.000009966501,0.00058723043,0.000026963888,0.00023135197],"genre_scores_gemma":[0.9990495,0.000032364613,0.00031561073,0.0000067180827,0.0000017373087,0.0000051440506,0.00037898304,0.0000032054138,0.00020675547],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998603,0.0000316102,0.0000073243014,0.00004865239,0.000028268183,0.000023859495],"domain_scores_gemma":[0.99964166,0.00008065943,0.00012656901,0.000022751146,0.000040807507,0.00008758631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035501664,0.00019544069,0.00024177137,0.00029795675,0.00012798305,0.00020906639,0.00019387402,0.0002643661,0.0019475437],"category_scores_gemma":[0.0010427703,0.000102750266,0.00025324643,0.00022937589,0.00016808156,0.0001388674,0.00020749061,0.00029071714,0.0003689748],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015797868,0.00008548643,0.93460405,0.0000634038,0.00010750794,0.00028019925,0.000052733205,0.0017247864,0.04302301,0.000057321435,0.00047943278,0.017942302],"study_design_scores_gemma":[0.000022639948,0.00032939724,0.9855304,0.000005760606,0.00004184115,0.0007358132,0.000040950716,0.0078895325,0.004896805,0.00014923413,0.00035194043,0.0000056191498],"about_ca_topic_score_codex":0.003597725,"about_ca_topic_score_gemma":0.0045430204,"teacher_disagreement_score":0.003597725,"about_ca_system_score_codex":0.00024701635,"about_ca_system_score_gemma":0.00029738888,"threshold_uncertainty_score":0.0071535707},"labels":[],"label_agreement":null},{"id":"W2987742329","doi":"10.1093/neuonc/noz175.774","title":"PDCT-13. ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Internal medicine; Response Evaluation Criteria in Solid Tumors; Refractory (planetary science); Oncology; Population; Phases of clinical research; Gastroenterology; Clinical trial; Cancer; Adenocarcinoma","score_opus":0.019675176996520223,"score_gpt":0.3154177275162873,"score_spread":0.2957425505197671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987742329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867988,0.005903142,0.0003065395,0.00044176367,0.000058029047,0.00019152024,0.0020334302,0.00007423719,0.0041924743],"genre_scores_gemma":[0.9917653,0.0026875813,0.0007092231,0.00031061118,0.000035967612,0.00015752527,0.0026391528,0.000010175596,0.0016845173],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990344,0.00003140034,0.0000075407047,0.000015453867,0.000017935383,0.000024324776],"domain_scores_gemma":[0.9997949,0.00003556782,0.000061301966,0.000007673784,0.00001973745,0.00008087671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029007788,0.0001612142,0.00050136924,0.00012693938,0.00014574468,0.00028070484,0.00016996314,0.00017521683,0.0022775657],"category_scores_gemma":[0.00030483262,0.000083283165,0.00027672376,0.00020334592,0.00012473304,0.00014976555,0.00016592389,0.0006118856,0.00036243265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08925922,0.004578553,0.3269845,0.001990535,0.0011339552,0.0027587006,0.00034466627,0.003114944,0.03254078,0.0011380005,0.037859622,0.49829653],"study_design_scores_gemma":[0.07242923,0.112514794,0.65867764,0.0008704408,0.0017514444,0.01407712,0.0005735469,0.006648066,0.023233913,0.000728247,0.10844098,0.000054693268],"about_ca_topic_score_codex":0.0014713724,"about_ca_topic_score_gemma":0.0066231685,"teacher_disagreement_score":0.0022775657,"about_ca_system_score_codex":0.00048551205,"about_ca_system_score_gemma":0.0007436817,"threshold_uncertainty_score":0.007619202},"labels":[],"label_agreement":null},{"id":"W2987847528","doi":"10.1093/neuonc/noz175.493","title":"HOUT-28. FIRST-LINE TEMOZOLOMIDE VS PCV FOR LOW GRADE GLIOMAS: A 11 YEARS REAL-WORLD DATA FROM CHUM, UNIVERSITY CENTER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Temozolomide; Lomustine; Procarbazine; Medicine; Dacarbazine; Internal medicine; Glioma; Progression-free survival; Vincristine; Regimen; Karnofsky Performance Status; Radiation therapy; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.046498865829104286,"score_gpt":0.3088564711884389,"score_spread":0.2623576053593346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987847528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289423,0.0019748025,0.00006225258,0.00024246011,0.000012456727,0.000031758715,0.0042352937,0.0000051681136,0.00054162345],"genre_scores_gemma":[0.99220467,0.0009928609,0.00007732014,0.00018251974,0.000032981963,0.000033848064,0.006197876,0.0000067405194,0.0002712465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897265,0.0002636016,0.00014444343,0.00019720643,0.00020033415,0.00022176027],"domain_scores_gemma":[0.99663025,0.00056284474,0.0019096958,0.00010501254,0.0003430207,0.00044918788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085155014,0.00025666557,0.00047004054,0.0008931894,0.00036236146,0.00087253633,0.00033391867,0.00041974292,0.001963067],"category_scores_gemma":[0.002084004,0.00019778777,0.0007985952,0.001714201,0.00025070467,0.0007233677,0.00052551547,0.0006415848,0.0003363573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003913052,0.00028665448,0.97900003,0.00017747187,0.0004309091,0.0003184918,0.00015379107,0.00039036834,0.00033991493,0.000052090174,0.0033187068,0.01161849],"study_design_scores_gemma":[0.000247298,0.0011920208,0.99330306,0.00009905378,0.00033411576,0.0006570972,0.00072592625,0.00087099813,0.00027011693,0.000039782633,0.0022321283,0.000028421175],"about_ca_topic_score_codex":0.01330522,"about_ca_topic_score_gemma":0.017486146,"teacher_disagreement_score":0.01330522,"about_ca_system_score_codex":0.0017859549,"about_ca_system_score_gemma":0.0010442984,"threshold_uncertainty_score":0.026455522},"labels":[],"label_agreement":null},{"id":"W2987946496","doi":"10.1093/neuonc/noz175.073","title":"ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Trametinib; Medicine; Dabrafenib; Internal medicine; Oncology; Glioma; Progression-free survival; Discontinuation; Interim analysis; Clinical endpoint; MEK inhibitor; Clinical trial; Chemotherapy; Cancer; Cancer research; MAPK/ERK pathway; Vemurafenib; Metastatic melanoma","score_opus":0.011397720992406346,"score_gpt":0.2691038434296475,"score_spread":0.25770612243724117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987946496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845695,0.005219059,0.0005477882,0.0003812174,0.00008152345,0.00057607365,0.003445031,0.00018292433,0.004996764],"genre_scores_gemma":[0.99213433,0.0009978118,0.0007887603,0.00034796624,0.00006246043,0.00026552912,0.0043879254,0.000017435003,0.0009978659],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940217,0.00028115633,0.00004842822,0.000093906085,0.00010676734,0.00006760364],"domain_scores_gemma":[0.9995012,0.00007669523,0.00016676717,0.000045466946,0.00006043433,0.00014932342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014844927,0.0003896104,0.0010943167,0.0003553863,0.00018958107,0.00059112976,0.00036015495,0.00034706428,0.0023599837],"category_scores_gemma":[0.00083262636,0.00018242453,0.001041699,0.00034549818,0.00022196745,0.00046381517,0.00017737504,0.0008708805,0.0006939347],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37152645,0.008804747,0.07040617,0.001535376,0.0036392044,0.0006696995,0.0002577862,0.006101985,0.05375874,0.0006014216,0.018673735,0.46402475],"study_design_scores_gemma":[0.2771899,0.2818467,0.3644373,0.00028325414,0.006607444,0.003909215,0.00020563517,0.012234841,0.019534819,0.0010760346,0.0325206,0.00015426513],"about_ca_topic_score_codex":0.0009693635,"about_ca_topic_score_gemma":0.003938369,"teacher_disagreement_score":0.0023599837,"about_ca_system_score_codex":0.00066704967,"about_ca_system_score_gemma":0.000882096,"threshold_uncertainty_score":0.007894933},"labels":[],"label_agreement":null},{"id":"W2987989330","doi":"10.1093/neuonc/noz175.968","title":"RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Cancer; Neurotrophin; Gastroenterology; Surgery; Receptor","score_opus":0.009831218568027171,"score_gpt":0.25399045314443164,"score_spread":0.24415923457640445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987989330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831965,0.00517002,0.00038333415,0.00028116212,0.00003260152,0.00019754891,0.0026885273,0.00010099891,0.007949235],"genre_scores_gemma":[0.9955374,0.0007706349,0.0004942165,0.00019794468,0.000029705649,0.00006863565,0.002110235,0.000007126066,0.0007841099],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996369,0.000077848075,0.000051087034,0.000076857075,0.000074756455,0.00008254915],"domain_scores_gemma":[0.99961555,0.00007984082,0.00011627522,0.000024371542,0.000062036284,0.00010177311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046774987,0.00020769073,0.00066511735,0.00029193005,0.00025675245,0.00046203882,0.0001664019,0.00016776516,0.0031695114],"category_scores_gemma":[0.00061416306,0.00007830934,0.0004578162,0.0004068059,0.00019125815,0.0002076632,0.00023522397,0.00036516905,0.00056319765],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02185702,0.0015745618,0.55334115,0.0011209651,0.000963987,0.0040505696,0.0002916499,0.0017629499,0.09162529,0.0003913217,0.0141599085,0.3088607],"study_design_scores_gemma":[0.0051932577,0.033633847,0.85812825,0.0002248363,0.0016185498,0.018635085,0.0002974522,0.003198973,0.042523533,0.0006370468,0.035850674,0.000058456666],"about_ca_topic_score_codex":0.0012477861,"about_ca_topic_score_gemma":0.0040574525,"teacher_disagreement_score":0.0031695114,"about_ca_system_score_codex":0.00074324943,"about_ca_system_score_gemma":0.0005468576,"threshold_uncertainty_score":0.01060307},"labels":[],"label_agreement":null},{"id":"W2988060405","doi":"10.1093/neuonc/noz175.383","title":"EXTH-52. CO-TARGETING ONCOSTATIN M RECEPTOR USING MONOCLONAL ANTIBODIES IN COMBINATION WITH PRESENT STANDARDS OF CARE FOR GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncostatin M; Monoclonal antibody; Cancer research; Temozolomide; Signal transduction; Medicine; STAT3; Biology; Cytokine; Immunology; Antibody; Pharmacology; Glioma; Interleukin 6; Cell biology","score_opus":0.010732321429492837,"score_gpt":0.3069892383573241,"score_spread":0.2962569169278313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988060405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735386,0.012886236,0.0049055847,0.0007035448,0.0004047524,0.000516944,0.00059059827,0.00043273982,0.00602105],"genre_scores_gemma":[0.984863,0.0046554958,0.005072142,0.00028327107,0.000073298106,0.00029791804,0.001362036,0.000027605767,0.0033652575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981874,0.00003256142,0.000018990373,0.000028685687,0.000052371885,0.000048747435],"domain_scores_gemma":[0.99995303,0.0000052685546,0.000009978375,0.0000068189133,0.000007674011,0.000017277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002125225,0.00035442185,0.00038183844,0.00037427468,0.00015286043,0.00024625892,0.00032840983,0.00033208402,0.0014551046],"category_scores_gemma":[0.00010059335,0.00012269271,0.00031629513,0.00023274275,0.0001511141,0.00016408169,0.00021539092,0.0006990447,0.000469691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008600687,0.00095661887,0.0009810769,0.00027976237,0.000060691313,0.00024598298,0.000029565976,0.00035066978,0.95037526,0.0004116826,0.0019955095,0.04345301],"study_design_scores_gemma":[0.0007103962,0.009597697,0.010552254,0.000038690945,0.00021856978,0.001895439,0.00003120049,0.0024817407,0.943219,0.000109032495,0.031121058,0.000024871784],"about_ca_topic_score_codex":0.00055159023,"about_ca_topic_score_gemma":0.0015002341,"teacher_disagreement_score":0.0014551046,"about_ca_system_score_codex":0.0003425603,"about_ca_system_score_gemma":0.00033086422,"threshold_uncertainty_score":0.004867792},"labels":[],"label_agreement":null},{"id":"W2988067761","doi":"10.1093/neuonc/noz217","title":"Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood–brain barrier deficiencies","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Blood–brain barrier; Medicine; Cancer research; Neuroscience; Psychology; Central nervous system","score_opus":0.018329565370066844,"score_gpt":0.25998527766261487,"score_spread":0.241655712292548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988067761","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038511334,0.006615428,0.000595364,0.94910556,0.032521203,0.000044285363,0.00012151115,0.00007374783,0.007071792],"genre_scores_gemma":[0.06844146,0.0136214,0.0016932805,0.77785057,0.09881044,0.0002455186,0.00014146761,0.000058536876,0.039137367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960583,0.00009421984,0.00004642006,0.000049791386,0.00012360528,0.00008018907],"domain_scores_gemma":[0.9991247,0.00048635638,0.000074515345,0.00003542138,0.00011688916,0.00016207527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007194997,0.00044379407,0.0006224301,0.00033036873,0.0010867118,0.0013341671,0.0005174998,0.015680391,0.002895723],"category_scores_gemma":[0.0035967662,0.00028383167,0.0005996064,0.00022477184,0.0010257957,0.0008642302,0.00049396715,0.010723718,0.0018582483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004943315,0.00014594466,0.0013160397,0.00017991882,0.00004753069,0.014769052,0.00007972641,0.0004612629,0.0033079716,0.007753473,0.9296355,0.041809376],"study_design_scores_gemma":[0.0007116098,0.00035358724,0.0020349724,0.00019369606,0.00008119046,0.013062284,0.0001204301,0.0025345369,0.004726938,0.015858972,0.9602535,0.00006838056],"about_ca_topic_score_codex":0.0013897854,"about_ca_topic_score_gemma":0.0025267247,"teacher_disagreement_score":0.015680391,"about_ca_system_score_codex":0.0023769531,"about_ca_system_score_gemma":0.0011027913,"threshold_uncertainty_score":0.017246127},"labels":[],"label_agreement":null},{"id":"W2988133706","doi":"10.1093/neuonc/noz175.862","title":"RDNA-01. TUBULIN AND MICROTUBULES AS MOLECULAR TARGETS FOR TTFIELD THERAPY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microtubule; Tubulin; Biophysics; Cytoskeleton; Dipole; Intracellular; Materials science; Chemistry; Cell; Cell biology; Biology; Biochemistry; Organic chemistry","score_opus":0.00797132998518724,"score_gpt":0.26395436614406814,"score_spread":0.2559830361588809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988133706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615189,0.0023051922,0.021446077,0.00017627886,0.00007615602,0.000058062556,0.00036419858,0.0002449339,0.01381027],"genre_scores_gemma":[0.99152386,0.00043853422,0.004342044,0.00004669007,0.000008626711,0.000021923472,0.00020381641,0.00002209959,0.0033924843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999291,0.000007584482,0.0000031548093,0.000017029804,0.000029593099,0.000013656976],"domain_scores_gemma":[0.999931,0.000018813711,0.000022466804,0.0000039836273,0.000010973971,0.000012851488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112257854,0.00016194463,0.00013617676,0.0001582333,0.00014350706,0.00034264688,0.00021562661,0.00025336572,0.002483675],"category_scores_gemma":[0.00017983773,0.00007651383,0.00011144163,0.00017287527,0.00029273526,0.00017561977,0.00015288025,0.00021526834,0.0003729981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012904711,0.000036473248,0.0019233428,0.00010068292,0.00000870121,0.000102368365,0.000025758494,0.002037631,0.98767763,0.0025653841,0.0002170723,0.005175921],"study_design_scores_gemma":[0.000025484103,0.0003229572,0.00532224,0.000013508688,0.000021297763,0.00016917188,0.000042813754,0.016066073,0.97032446,0.0007288524,0.006953383,0.000009810597],"about_ca_topic_score_codex":0.00087778864,"about_ca_topic_score_gemma":0.0007919786,"teacher_disagreement_score":0.002483675,"about_ca_system_score_codex":0.00033334582,"about_ca_system_score_gemma":0.00023471742,"threshold_uncertainty_score":0.008308709},"labels":[],"label_agreement":null},{"id":"W2988677670","doi":"10.1093/neuonc/noz175.644","title":"PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; DNA methylation; Methylation; Epigenetics; DNA; Biology; Brain tumor; Pathology; Molecular biology; Cancer research; Gene; Genetics; Medicine; Gene expression","score_opus":0.01777987691746194,"score_gpt":0.28961814237103917,"score_spread":0.27183826545357725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988677670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643445,0.00030034292,0.002256922,0.000013792879,0.0000013176018,0.000006067226,0.00031237662,0.00003498901,0.00063972373],"genre_scores_gemma":[0.99875045,0.00006169544,0.00056155253,0.0000072176385,0.0000010525179,0.0000069434523,0.00032398722,0.000012000551,0.00027508114],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998479,0.000019296871,0.000010504082,0.00006755025,0.000028450364,0.000026247199],"domain_scores_gemma":[0.9998591,0.000029833494,0.000043278884,0.000019599254,0.000028607943,0.000019529585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621585,0.00017501178,0.00018091645,0.0003773121,0.00015528442,0.00032829057,0.00010814243,0.00013877473,0.0018113685],"category_scores_gemma":[0.00035620423,0.00015431143,0.00015559346,0.00029810393,0.00021458778,0.00015271547,0.00024262255,0.0001754698,0.00036919312],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013376429,0.000026198506,0.36921266,0.000112392954,0.00016299968,0.00021087914,0.00030826865,0.00097259745,0.59604996,0.00016612028,0.0001697758,0.03127053],"study_design_scores_gemma":[0.000008901378,0.00021987915,0.92303413,0.000006083658,0.000083465864,0.0015509807,0.0001630412,0.003232452,0.070621185,0.00020529027,0.0008675246,0.0000070707065],"about_ca_topic_score_codex":0.0012556871,"about_ca_topic_score_gemma":0.0016067956,"teacher_disagreement_score":0.0018113685,"about_ca_system_score_codex":0.00016951562,"about_ca_system_score_gemma":0.00010786848,"threshold_uncertainty_score":0.006059587},"labels":[],"label_agreement":null},{"id":"W2988779892","doi":"10.1093/neuonc/noz213","title":"Less treatment for Wing less medulloblastoma: germline data re-emphasize this","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Germline; Wing; Biology; Genetics; Engineering; Aerospace engineering","score_opus":0.10624419864360987,"score_gpt":0.3604692555815921,"score_spread":0.25422505693798225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988779892","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005177288,0.0056107384,0.0006579309,0.95686364,0.0133269895,0.000013732111,0.00013755594,0.000067992856,0.018144177],"genre_scores_gemma":[0.10124977,0.009644579,0.001805165,0.7590349,0.11425192,0.000030627616,0.00026624813,0.000120785735,0.0135960635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944884,0.00013680726,0.00008855316,0.00008175346,0.000125153,0.00011899233],"domain_scores_gemma":[0.99726284,0.0014594257,0.0002001565,0.00013973816,0.00036300562,0.00057480193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057518075,0.00029801414,0.00048721465,0.00057993416,0.0013813496,0.0016800994,0.0007759757,0.011843495,0.0053708134],"category_scores_gemma":[0.0058067203,0.00022473841,0.00061634474,0.00046143887,0.0012078551,0.0019727703,0.0007445496,0.013918731,0.0031210347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001482884,0.0000909111,0.0140432585,0.00023580814,0.00006537336,0.087020345,0.00021319384,0.00067106914,0.0013933216,0.014124801,0.817656,0.06433763],"study_design_scores_gemma":[0.000117845746,0.00018444331,0.0074971216,0.00069658185,0.00008600378,0.22825137,0.0006661664,0.0012694516,0.0010401353,0.042634204,0.7174711,0.00008547116],"about_ca_topic_score_codex":0.0026118984,"about_ca_topic_score_gemma":0.0068692346,"teacher_disagreement_score":0.011843495,"about_ca_system_score_codex":0.0020977198,"about_ca_system_score_gemma":0.0014279485,"threshold_uncertainty_score":0.017967224},"labels":[],"label_agreement":null},{"id":"W2988963154","doi":"10.1093/neuonc/noz175.809","title":"PDTM-33. EUROPEAN GENETIC ANCESTRY ASSOCIATED WITH RISK OF CHILDHOOD EPENDYMOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ependymoma; Genome-wide association study; Demography; Incidence (geometry); Odds ratio; Ethnic group; Medicine; Genetics; Biology; Genotype; Pathology; Single-nucleotide polymorphism","score_opus":0.013697712664484746,"score_gpt":0.25801340542607026,"score_spread":0.24431569276158552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988963154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973098,0.0004751128,0.00029194215,0.0000789055,0.000007884611,0.0000042994966,0.0010227815,0.000018572544,0.00079083705],"genre_scores_gemma":[0.998495,0.000110203124,0.00033626292,0.000018992923,0.0000068778622,0.000005592356,0.00057810853,0.000008182398,0.00044078412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998086,0.00004132769,0.0000148942245,0.000075986594,0.000026333542,0.00003284387],"domain_scores_gemma":[0.9993174,0.00014862897,0.0003248223,0.000039878734,0.000047144567,0.0001220103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511008,0.00029966576,0.00018509121,0.000635177,0.00034076898,0.00039041697,0.000234449,0.00033553192,0.0049909004],"category_scores_gemma":[0.0010254557,0.00011383643,0.00040642856,0.0009003746,0.00020171184,0.00013794357,0.00034791435,0.0004358187,0.00034584798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002702235,0.000018968596,0.99182326,0.000019294283,0.00009961741,0.000453529,0.000056028544,0.00016121354,0.002187138,0.00010450543,0.00029478702,0.0045114374],"study_design_scores_gemma":[0.000009410781,0.000032136973,0.99759537,0.00001621631,0.00005554593,0.0007845373,0.000048715025,0.00035450805,0.0003542919,0.000078098245,0.00066845136,0.000002714715],"about_ca_topic_score_codex":0.005953704,"about_ca_topic_score_gemma":0.004997737,"teacher_disagreement_score":0.005953704,"about_ca_system_score_codex":0.00023702024,"about_ca_system_score_gemma":0.00022833767,"threshold_uncertainty_score":0.016696215},"labels":[],"label_agreement":null},{"id":"W2989038942","doi":"10.1093/neuonc/noz175.070","title":"ACTR-27. EVOLUTION OF THE NEUROSURGEON’S ROLE IN CLINICAL TRIALS FOR GBM: A SYSTEMATIC OVERVIEW OF THE CLINICALTRIALS.GOV DATABASE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Tolerability; Neurosurgery; Demographics; Psychological intervention; Randomized controlled trial; Internal medicine; Oncology; Surgery; Adverse effect; Demography","score_opus":0.19921297757867987,"score_gpt":0.4562506505405482,"score_spread":0.2570376729618683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989038942","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043912907,0.94434136,0.003346807,0.007723459,0.000846485,0.006837543,0.025781736,0.00019058013,0.006540746],"genre_scores_gemma":[0.1292696,0.7325275,0.03419559,0.017261831,0.0014822141,0.05200428,0.030898388,0.0006332067,0.0017274058],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7930019,0.11875867,0.06215479,0.007439154,0.017444534,0.0012009937],"domain_scores_gemma":[0.61902744,0.25615385,0.079963565,0.011224284,0.030012215,0.0036186555],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13042249,0.0010910279,0.007980117,0.015816936,0.00079240854,0.0073928772,0.0029332081,0.002667453,0.009512268],"category_scores_gemma":[0.26753417,0.0011260883,0.0066667744,0.027767818,0.0018516338,0.005631042,0.0042420784,0.0033184828,0.0015694159],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005826796,0.00007246352,0.005293638,0.68876535,0.021200446,0.0000888287,0.00038955154,0.00053805194,0.0004673791,0.006613792,0.032609325,0.23813444],"study_design_scores_gemma":[0.0066838553,0.0007738784,0.019287745,0.76994133,0.03601684,0.00043945154,0.00048397353,0.0008450357,0.00045297807,0.006513386,0.15839683,0.00016461589],"about_ca_topic_score_codex":0.0021452887,"about_ca_topic_score_gemma":0.0068349,"teacher_disagreement_score":0.8695775,"about_ca_system_score_codex":0.005274805,"about_ca_system_score_gemma":0.012335305,"threshold_uncertainty_score":0.6897483},"labels":[],"label_agreement":null},{"id":"W2989078280","doi":"10.1093/neuonc/noz175.1023","title":"SURG-23. INTRAPARENCHYMAL MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA: A NOVEL DISEASE PRESENTATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphatic system; MALT lymphoma; Lymphoma; Lesion; Pathology; Presentation (obstetrics); Mucosa-associated lymphoid tissue; Meningioma; Parenchyma; Radiology","score_opus":0.019532676623506544,"score_gpt":0.30165019316692226,"score_spread":0.2821175165434157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989078280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92145556,0.02181397,0.0048335334,0.005644682,0.00046094132,0.00017076785,0.0014031958,0.00038258536,0.04383485],"genre_scores_gemma":[0.9907608,0.00350651,0.0015542551,0.00052223937,0.00042957373,0.00002356836,0.00027555873,0.00001875215,0.0029087404],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997944,0.000018003066,0.000033896853,0.00004328517,0.000028495138,0.000081966784],"domain_scores_gemma":[0.99961627,0.00006832077,0.00013776151,0.000023213624,0.00003971733,0.00011469992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017989604,0.00096062146,0.00045841798,0.0021169812,0.00078940956,0.0018016935,0.0005681309,0.0020019428,0.0059423256],"category_scores_gemma":[0.00087865593,0.00031617846,0.0004904849,0.0012429281,0.00097480003,0.0013469389,0.0006957743,0.0010656914,0.0025683444],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051693965,0.000023253011,0.0120342495,0.0001077705,0.000016144508,0.97634625,0.00009889247,0.00005716306,0.004056065,0.00056532555,0.0006976476,0.005945481],"study_design_scores_gemma":[0.00000909235,0.000027403446,0.00503246,0.00003065425,0.000020198482,0.99114275,0.00013129765,0.00016161613,0.0011196281,0.0003629543,0.0019565106,0.000005409434],"about_ca_topic_score_codex":0.0010604509,"about_ca_topic_score_gemma":0.0017767695,"teacher_disagreement_score":0.0059423256,"about_ca_system_score_codex":0.00092771376,"about_ca_system_score_gemma":0.00065944524,"threshold_uncertainty_score":0.019879043},"labels":[],"label_agreement":null},{"id":"W2989460017","doi":"10.1093/neuonc/noz175.071","title":"ACTR-28. A CALL FOR INCREASED ROLE OF NEUROSURGEONS IN SURGICAL TRIALS FOR NON-GLIOMATOUS PRIMARY CNS TUMORS: A SYSTEMATIC REVIEW OF THE CLINICALTRIALS.GOV DATABASE","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Surgery; Oncology; Internal medicine","score_opus":0.1255841497779495,"score_gpt":0.4245200108524419,"score_spread":0.29893586107449244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989460017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034278396,0.96444285,0.0015897847,0.008451634,0.0012836604,0.006460076,0.011003982,0.00013989666,0.0032003066],"genre_scores_gemma":[0.10298782,0.802165,0.020427452,0.022606095,0.0013733347,0.03761369,0.010756153,0.000282958,0.0017875022],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.91398853,0.047127943,0.026836213,0.0030945332,0.008124461,0.000828409],"domain_scores_gemma":[0.7230719,0.1984148,0.05028511,0.0062886984,0.019198654,0.0027408993],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07319363,0.0011073621,0.01023386,0.01078065,0.00064585573,0.0058609163,0.0027821127,0.0033088936,0.014516992],"category_scores_gemma":[0.1777426,0.0009957507,0.009184299,0.011314666,0.001423521,0.0058620223,0.002618382,0.0027546238,0.001384246],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012455016,0.00002799563,0.0010304308,0.92784125,0.009631579,0.00004835403,0.000117359916,0.00011484842,0.00019588911,0.0010339322,0.0088508455,0.049862143],"study_design_scores_gemma":[0.0040429253,0.0004559091,0.0064510205,0.88795924,0.037733972,0.00019673798,0.00031714508,0.00027541828,0.00018703479,0.002503788,0.059807613,0.00006918954],"about_ca_topic_score_codex":0.0025307874,"about_ca_topic_score_gemma":0.008094083,"teacher_disagreement_score":0.9268064,"about_ca_system_score_codex":0.0047177733,"about_ca_system_score_gemma":0.013653657,"threshold_uncertainty_score":0.38708955},"labels":[],"label_agreement":null},{"id":"W2989513644","doi":"10.1093/neuonc/noz175.050","title":"ACTR-06. CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM: HALF-WAY REPORT","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Radiation therapy; O-6-methylguanine-DNA methyltransferase; Oncology; Internal medicine; Methyltransferase; Guanine; Stage (stratigraphy); Phases of clinical research; Clinical trial; Nuclear medicine; Cancer research; Biology; DNA; Gene; Adverse effect","score_opus":0.05515892660588789,"score_gpt":0.3857798892029587,"score_spread":0.3306209625970708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989513644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036283,0.0047655264,0.0010368725,0.0012481774,0.00036636603,0.0022723607,0.0030310845,0.00033583425,0.0065809335],"genre_scores_gemma":[0.9751153,0.0025271163,0.0017929443,0.0026552323,0.00038768075,0.002382489,0.004635186,0.0000644014,0.010439691],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994448,0.0003088952,0.000027873572,0.000053563494,0.000055901935,0.0001090116],"domain_scores_gemma":[0.99914443,0.00014131101,0.00011130549,0.00008949082,0.000049829618,0.00046366983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022047237,0.0011370861,0.0014182667,0.00041999086,0.0003815768,0.0010023172,0.0010226868,0.0017425474,0.0047447807],"category_scores_gemma":[0.00077330234,0.00041398845,0.0013209381,0.00032269882,0.00074979186,0.000886015,0.0003805611,0.0036249924,0.0018714472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7123053,0.05174854,0.006138801,0.0009205049,0.0015250198,0.00052968966,0.0003206202,0.0025333543,0.036699776,0.0009250282,0.015521092,0.17083228],"study_design_scores_gemma":[0.41895005,0.55092275,0.013810398,0.00006695638,0.00034263282,0.0004886465,0.000047450896,0.0018514431,0.0062633962,0.00031912926,0.0068906653,0.000046446832],"about_ca_topic_score_codex":0.00060858123,"about_ca_topic_score_gemma":0.0012431908,"teacher_disagreement_score":0.0047447807,"about_ca_system_score_codex":0.0004941275,"about_ca_system_score_gemma":0.0010099723,"threshold_uncertainty_score":0.015872836},"labels":[],"label_agreement":null},{"id":"W2989904783","doi":"10.1093/neuonc/noz219.1199","title":"LTBK-08. TOCA 511 &amp; TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Alberta; Montreal Neurological Institute and Hospital; University Health Network; CancerCare Manitoba; Sunnybrook Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Clinical endpoint; Internal medicine; Interim analysis; Oncology; Adverse effect; Bevacizumab; Progression-free survival; Glioma; Lomustine; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Cancer research; Vincristine","score_opus":0.016201114525663706,"score_gpt":0.28850317837808576,"score_spread":0.27230206385242206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989904783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325037,0.0038654967,0.00018895984,0.00034121168,0.00011680266,0.00029998107,0.00035714562,0.000046405003,0.0015337241],"genre_scores_gemma":[0.99757034,0.00077511225,0.00024403032,0.00024181418,0.00006778759,0.00024384304,0.0003071045,0.0000049714517,0.00054484495],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952126,0.00021579197,0.000030171192,0.00008086513,0.000040528055,0.00011144244],"domain_scores_gemma":[0.9995455,0.00010407572,0.00010220834,0.000032306434,0.000021786702,0.00019407965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092552946,0.00059118046,0.0016418674,0.00030827397,0.00021097194,0.0006240761,0.000498935,0.00068925245,0.0035497048],"category_scores_gemma":[0.00088446314,0.0002157971,0.0012637832,0.0003973718,0.0005166543,0.00055094156,0.00022546685,0.0014081777,0.00048310615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84585416,0.009422196,0.0041469526,0.0007364043,0.0013600985,0.0001563015,0.00011283362,0.0014924901,0.0052942317,0.00030306235,0.0025330225,0.1285882],"study_design_scores_gemma":[0.34427348,0.61174357,0.030942865,0.00012130588,0.0022675053,0.00041000795,0.00015888465,0.0033154667,0.0025195451,0.00058417773,0.0036066906,0.00005648052],"about_ca_topic_score_codex":0.0015989046,"about_ca_topic_score_gemma":0.00482639,"teacher_disagreement_score":0.0035497048,"about_ca_system_score_codex":0.0013599084,"about_ca_system_score_gemma":0.0011511331,"threshold_uncertainty_score":0.011874914},"labels":[],"label_agreement":null},{"id":"W2992048139","doi":"10.1093/neuonc/noz203","title":"Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brain Tumour Foundation of Canada; University of Alberta","funders":"Uncle Kory Foundation; Fondation Brain Canada; Musella Foundation For Brain Tumor Research and Information; Children's Brain Tumor Foundation; National Brain Tumor Society","keywords":"Glioblastoma; Incidence (geometry); Demography; New england; Medicine; Geography; History; Gerontology; Political science; Sociology; Cancer research; Law; Physics","score_opus":0.014309428696533363,"score_gpt":0.26034038086706407,"score_spread":0.2460309521705307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992048139","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75054526,0.02060961,0.00030121146,0.047428988,0.0012567061,0.00008256445,0.15634148,0.00014529479,0.023288848],"genre_scores_gemma":[0.92082953,0.016685199,0.00045827692,0.008631089,0.00051369856,0.00005751532,0.041102998,0.000039377806,0.01168234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993747,0.000022504793,0.00010817889,0.00005991991,0.00021087787,0.00022386388],"domain_scores_gemma":[0.99785006,0.00008163809,0.00044703303,0.000021071895,0.0013025963,0.0002975906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030017615,0.0002072486,0.0003722924,0.0017413889,0.000764551,0.0012144343,0.000700375,0.0009525742,0.0016985888],"category_scores_gemma":[0.002615936,0.000227104,0.00062028517,0.005207597,0.0003905454,0.0004994798,0.0005975859,0.0010082321,0.00039972088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055906514,0.000050569914,0.8489278,0.00035183382,0.00018777627,0.0008174205,0.00073239254,0.0007610312,0.0002517802,0.0006015141,0.124202475,0.022556325],"study_design_scores_gemma":[0.000025566045,0.000029451689,0.9714867,0.00020907522,0.000098964076,0.0005476029,0.0015460624,0.00044399765,0.00016781491,0.00007482614,0.025344795,0.000025104067],"about_ca_topic_score_codex":0.9797616,"about_ca_topic_score_gemma":0.9902982,"teacher_disagreement_score":0.022308148,"about_ca_system_score_codex":0.022308148,"about_ca_system_score_gemma":0.022220533,"threshold_uncertainty_score":0.16185772},"labels":[],"label_agreement":null},{"id":"W2994157979","doi":"10.1093/neuonc/noz225","title":"Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Pituitary adenoma; Stereotactic radiotherapy; Hypopituitarism; Randomized controlled trial; MEDLINE; Radiation therapy; Nuclear medicine; Radiology; Adenoma; Surgery; Internal medicine","score_opus":0.12615381411686147,"score_gpt":0.39132124303505517,"score_spread":0.26516742891819367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994157979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025508176,0.9945972,0.0006371755,0.00084107736,0.00021337283,0.0001601668,0.0005009253,0.000017231348,0.00048204628],"genre_scores_gemma":[0.14231178,0.849755,0.002734191,0.0023944515,0.0006811215,0.0007653251,0.0009853066,0.000042730353,0.00033007792],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97921413,0.010125475,0.0056975055,0.0020607698,0.0023986408,0.0005035368],"domain_scores_gemma":[0.9413962,0.04242838,0.0096155675,0.0014352795,0.0046829563,0.00044160924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03140594,0.002465226,0.010123342,0.008520527,0.00047684324,0.003644598,0.0022679241,0.0023415836,0.0045079244],"category_scores_gemma":[0.08664803,0.0013112274,0.033430785,0.008303798,0.0008357414,0.0020963706,0.0013249455,0.0019294232,0.0003820507],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010871511,0.000022440805,0.009246982,0.40812618,0.55366594,0.00015693578,0.00020841157,0.00060536806,0.0001861433,0.0003223908,0.0020297219,0.02434239],"study_design_scores_gemma":[0.00049470493,0.00015127329,0.008321038,0.07901171,0.90668,0.00017637719,0.00011311266,0.00023880518,0.00012387609,0.0005678992,0.0040856022,0.000035618075],"about_ca_topic_score_codex":0.00976097,"about_ca_topic_score_gemma":0.017142836,"teacher_disagreement_score":0.03140594,"about_ca_system_score_codex":0.0038092684,"about_ca_system_score_gemma":0.0059963665,"threshold_uncertainty_score":0.16609246},"labels":[],"label_agreement":null},{"id":"W2995532498","doi":"10.1093/neuonc/noz232","title":"A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; London Health Sciences Centre","funders":"National Cancer Institute; Deciphera Pharmaceuticals; Five Prime Therapeutics; American Society of Clinical Oncology; Sanofi; Celldex Therapeutics; AstraZeneca; Eli Lilly and Company","keywords":"Bevacizumab; Medicine; Concomitant; Clinical endpoint; Combination therapy; Internal medicine; Phases of clinical research; Hazard ratio; Adverse effect; Oncology; Randomized controlled trial; Progression-free survival; Surgery; Overall survival; Clinical trial; Chemotherapy; Confidence interval","score_opus":0.008743713209318665,"score_gpt":0.280442104597949,"score_spread":0.27169839138863033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995532498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835686,0.0027430279,0.0008878604,0.0007767163,0.00082336995,0.008309697,0.001059749,0.000119898774,0.0017109935],"genre_scores_gemma":[0.980162,0.0021184632,0.0022695411,0.0016804067,0.0006407142,0.009131841,0.0015338892,0.000038609105,0.002424623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989365,0.00062745996,0.00006069594,0.0001634609,0.00007102757,0.00014084305],"domain_scores_gemma":[0.99839467,0.00037718218,0.0004123048,0.00014770885,0.00011985385,0.00054830115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002898361,0.0018890469,0.0031315382,0.00052314723,0.0003969911,0.0011048396,0.00095468987,0.0016694686,0.005896279],"category_scores_gemma":[0.0024067676,0.00076643116,0.0018593876,0.0005411168,0.0013853065,0.0009443378,0.0004904383,0.0030115242,0.0010489743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9765785,0.01074355,0.00062483666,0.00027420046,0.00063364825,0.000032680564,0.000038839415,0.00019626129,0.002275782,0.00006699205,0.0005808944,0.007953849],"study_design_scores_gemma":[0.9095393,0.08862255,0.000800845,0.000013132878,0.00024292801,0.000021036012,0.000012036703,0.00019031233,0.0001853516,0.00006657955,0.0002980558,0.000007919062],"about_ca_topic_score_codex":0.0009247749,"about_ca_topic_score_gemma":0.0024461043,"teacher_disagreement_score":0.005896279,"about_ca_system_score_codex":0.0009449828,"about_ca_system_score_gemma":0.0019402584,"threshold_uncertainty_score":0.019724965},"labels":[],"label_agreement":null},{"id":"W2996978679","doi":"10.1093/neuonc/noz175.159","title":"CBMT-37. OSMR CONTROLS CELLULAR RESPIRATION AND RESISTANCE TO THERAPY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cell biology; Signal transduction; Cancer research; Cell growth; Receptor; Biochemistry","score_opus":0.014294468822460346,"score_gpt":0.26118228914964847,"score_spread":0.24688782032718812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996978679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925092,0.0020503656,0.0012843659,0.00025294116,0.000038773396,0.000030377912,0.000832699,0.00024987344,0.0027514957],"genre_scores_gemma":[0.99680686,0.00023882839,0.00044884908,0.000031267835,0.0000038644603,0.00001894881,0.00030538143,0.000030901134,0.002115061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999742,0.000030925752,0.00001869723,0.000047540314,0.00008613136,0.000074703305],"domain_scores_gemma":[0.9998111,0.000019332376,0.000059950424,0.000021684647,0.000015983707,0.00007201457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013978862,0.00022212135,0.000318052,0.00033085977,0.00024109117,0.00047095952,0.00028549018,0.00029754118,0.00267248],"category_scores_gemma":[0.00014988528,0.00010703821,0.00015889674,0.00021838694,0.00049748895,0.00017674733,0.00028951754,0.0005442773,0.0007758995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021686089,0.000031965883,0.00019737634,0.000014826919,0.00000238181,0.000037783913,0.000007951679,0.000069592286,0.9981184,0.00016390732,0.0000962096,0.0010427062],"study_design_scores_gemma":[0.000033705448,0.0003114815,0.0056217443,0.000008868502,0.000011857446,0.00022435216,0.000043612516,0.0017401316,0.98713696,0.00012936426,0.004729099,0.000008886807],"about_ca_topic_score_codex":0.0017421353,"about_ca_topic_score_gemma":0.002057726,"teacher_disagreement_score":0.00267248,"about_ca_system_score_codex":0.0010365245,"about_ca_system_score_gemma":0.00039745023,"threshold_uncertainty_score":0.008940399},"labels":[],"label_agreement":null},{"id":"W2997037042","doi":"10.1093/neuonc/noz175.664","title":"NCOG-03. COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cognition; Neuropsychology; Effects of sleep deprivation on cognitive performance; Boston Naming Test; Internal medicine; Depression (economics); Lung cancer; Multivariate analysis; Oncology; Clinical psychology; Psychiatry","score_opus":0.014832760062012474,"score_gpt":0.28134491353216967,"score_spread":0.2665121534701572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997037042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624926,0.00029954003,0.000019135552,0.00018436376,0.000014435817,0.000021474665,0.0014638146,0.000007313428,0.0017405972],"genre_scores_gemma":[0.99772316,0.00008761209,0.00006338932,0.000092554634,0.000017605349,0.000025182448,0.0014802248,0.0000023200118,0.0005079841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996797,0.00007676791,0.00004371393,0.000045527748,0.000079167636,0.00007520049],"domain_scores_gemma":[0.997959,0.00025267908,0.0008170313,0.000047813777,0.00028853907,0.0006349731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005608783,0.00018693169,0.00028548937,0.00042706498,0.00045455288,0.0007223719,0.0003336059,0.00038457225,0.0028641827],"category_scores_gemma":[0.0022135568,0.00009678508,0.00024831318,0.0009867484,0.0002143898,0.00028623885,0.00037692595,0.00042437034,0.0004924712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017386454,0.0000533432,0.9976388,0.00001193008,0.000015840278,0.000040555715,0.000022579565,0.000020179728,0.000056050103,0.000004372421,0.00035786693,0.0016046187],"study_design_scores_gemma":[0.000020963234,0.00013714365,0.99922407,0.0000054595976,0.000012432452,0.00012480858,0.00006366086,0.00006231409,0.000021947522,0.000007646115,0.00031783324,0.0000017408767],"about_ca_topic_score_codex":0.014019852,"about_ca_topic_score_gemma":0.027888084,"teacher_disagreement_score":0.014019852,"about_ca_system_score_codex":0.0006486112,"about_ca_system_score_gemma":0.00078943634,"threshold_uncertainty_score":0.027876496},"labels":[],"label_agreement":null},{"id":"W2997049714","doi":"10.1093/neuonc/noz243","title":"Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Junta de Castilla y León; Ministerio de Economía y Competitividad; Canada Research Chairs; Fundación Ramón Areces","keywords":"Glioma; SOX2; Cancer research; In vivo; Stem cell; Nestin; Biology; Cell culture; Pathology; Neural stem cell; Transcription factor; Medicine; Cell biology; Gene","score_opus":0.00992218349736684,"score_gpt":0.24099141525660725,"score_spread":0.2310692317592404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997049714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951925,0.0010503054,0.0018831848,0.000116010946,0.000047232897,0.000039714352,0.0004967034,0.00015674859,0.0010176933],"genre_scores_gemma":[0.9913112,0.0014543715,0.0023739382,0.000049853046,0.000016489754,0.00007670375,0.00080460426,0.000046512087,0.0038662609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997943,0.0000290204,0.000023062752,0.0000491088,0.00005699796,0.000047540263],"domain_scores_gemma":[0.9998431,0.00001954526,0.0000592563,0.000018824852,0.000011122849,0.000048221547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019418407,0.0006267429,0.00034458272,0.00039280043,0.00017056709,0.0002206966,0.00021646087,0.00046253877,0.0011417081],"category_scores_gemma":[0.00007705957,0.00019316011,0.0002895998,0.00021592925,0.0003484443,0.00031688373,0.00013540764,0.0008352614,0.00037231937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012664587,0.00006216871,0.000052297153,0.000031826272,0.000004231783,0.000035187844,0.000014312907,0.000052217616,0.9991074,0.000061793355,0.00004866994,0.0004032366],"study_design_scores_gemma":[0.00002032314,0.00097169506,0.0012415706,0.000005192554,0.000017105165,0.00021298112,0.000018595802,0.0005629704,0.9959709,0.000030020074,0.0009450074,0.000003642105],"about_ca_topic_score_codex":0.00048345095,"about_ca_topic_score_gemma":0.0005865943,"teacher_disagreement_score":0.0011417081,"about_ca_system_score_codex":0.0002345881,"about_ca_system_score_gemma":0.00021680807,"threshold_uncertainty_score":0.0038193464},"labels":[],"label_agreement":null},{"id":"W2997503641","doi":"10.1093/neuonc/noz175.767","title":"PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medulloblastoma; Medicine; Chemotherapy; Methotrexate; Oncology; Internal medicine; Clinical trial; Radiation therapy; Surgery; Pathology","score_opus":0.015548650979009218,"score_gpt":0.31137848314307853,"score_spread":0.29582983216406933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997503641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90398926,0.080987096,0.00088394596,0.00043877427,0.00015761446,0.0015189736,0.0057713734,0.000034998033,0.0062179845],"genre_scores_gemma":[0.97666377,0.016649153,0.0011696186,0.000381161,0.00010749613,0.0009830567,0.0035494452,0.000010310188,0.00048603106],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99850416,0.0006851167,0.00025068963,0.000197933,0.00024750404,0.00011462739],"domain_scores_gemma":[0.997283,0.00081440463,0.0011956346,0.00012357152,0.00024146734,0.00034192918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026445275,0.00031958148,0.0010129465,0.0011238953,0.00019179341,0.00080301124,0.0004805113,0.00046392306,0.0022981633],"category_scores_gemma":[0.0032865861,0.00015042821,0.0022091842,0.0016329701,0.00034002343,0.0006047183,0.0003674643,0.0007202262,0.0002599645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45097056,0.005112551,0.11830038,0.009196087,0.01777064,0.00045054403,0.00025594918,0.0030454707,0.003840743,0.0009266317,0.0026998324,0.3874306],"study_design_scores_gemma":[0.12045538,0.40316278,0.37919936,0.004341915,0.039312214,0.003563362,0.00076507166,0.0022432753,0.0057743643,0.00080570934,0.04026305,0.00011350204],"about_ca_topic_score_codex":0.001623791,"about_ca_topic_score_gemma":0.0031953736,"teacher_disagreement_score":0.0026445275,"about_ca_system_score_codex":0.0015581449,"about_ca_system_score_gemma":0.001438625,"threshold_uncertainty_score":0.013985753},"labels":[],"label_agreement":null},{"id":"W2998197281","doi":"10.1093/neuonc/noz235","title":"Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Brain Tumour Charity; Deutsche Forschungsgemeinschaft; Cancer Research UK","keywords":"Consensus conference; Atypical teratoid rhabdoid tumor; Current (fluid); Medicine; Pathology; Internal medicine; Immunohistochemistry; Geology","score_opus":0.04495351810615278,"score_gpt":0.3486779024792435,"score_spread":0.30372438437309074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998197281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02547401,0.92653716,0.014859206,0.028838733,0.0012880135,0.00008588439,0.00087940914,0.00019768931,0.001839802],"genre_scores_gemma":[0.22557174,0.7059152,0.042604886,0.013698571,0.0052611814,0.00030232858,0.0055660643,0.00027078908,0.00080922415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916359,0.0019896482,0.0020928134,0.0029008116,0.0010249178,0.0003559075],"domain_scores_gemma":[0.9737878,0.014504987,0.002668781,0.0026612887,0.0055133034,0.0008638366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02882869,0.0011492403,0.0046436265,0.0072844764,0.0008518196,0.004453998,0.0053332625,0.0018607457,0.0013236551],"category_scores_gemma":[0.021362437,0.00061399746,0.00482757,0.005087714,0.0031170852,0.006040638,0.0027074239,0.003283679,0.00060614647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010202394,0.000096162745,0.07008491,0.018713055,0.0040589734,0.00049334095,0.0021460506,0.0019545415,0.0067608543,0.014993289,0.01823332,0.86144525],"study_design_scores_gemma":[0.00041750714,0.0014095355,0.1527374,0.052716494,0.026924983,0.00738341,0.0105384365,0.007801805,0.008669015,0.11994883,0.6108822,0.0005704211],"about_ca_topic_score_codex":0.0038642776,"about_ca_topic_score_gemma":0.0027965368,"teacher_disagreement_score":0.02882869,"about_ca_system_score_codex":0.002222895,"about_ca_system_score_gemma":0.005543363,"threshold_uncertainty_score":0.15246254},"labels":[],"label_agreement":null},{"id":"W2998325113","doi":"10.1093/neuonc/noz175.032","title":"ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pembrolizumab; Medicine; Adverse effect; Oncology; Internal medicine; Oncolytic adenovirus; Oncolytic virus; Phases of clinical research; Cohort; Toxicity; Surgery; Immunotherapy; Cancer","score_opus":0.04000655458309873,"score_gpt":0.37554350045798796,"score_spread":0.33553694587488925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998325113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472861,0.005776295,0.003754803,0.0019184112,0.00042372863,0.011646967,0.012565566,0.0006811411,0.015946927],"genre_scores_gemma":[0.9466427,0.002387834,0.0074652135,0.002598962,0.0003894348,0.011571864,0.018518088,0.00012427784,0.010301621],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992982,0.00035519092,0.000027223681,0.000093854585,0.000073751806,0.00015168317],"domain_scores_gemma":[0.9992404,0.00009102073,0.00012870389,0.00007638488,0.00005553892,0.00040807098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003883722,0.0016180845,0.0011234157,0.0004039272,0.0006187907,0.0011728443,0.0012262996,0.0014258071,0.0052694385],"category_scores_gemma":[0.0010110254,0.0006273916,0.00086774037,0.0003379269,0.0005689478,0.0006822951,0.0003575026,0.0027336434,0.0016754862],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4922304,0.05629941,0.022516096,0.0011945055,0.002288265,0.0012377312,0.00044441683,0.0032821957,0.1330978,0.0011269978,0.042432677,0.24384953],"study_design_scores_gemma":[0.42767575,0.4699472,0.04968983,0.00008813668,0.0011200866,0.0011277376,0.00007316152,0.0022042242,0.015799208,0.00060621655,0.03160789,0.000060483093],"about_ca_topic_score_codex":0.0013908639,"about_ca_topic_score_gemma":0.0029618205,"teacher_disagreement_score":0.0052694385,"about_ca_system_score_codex":0.0010824832,"about_ca_system_score_gemma":0.0018581263,"threshold_uncertainty_score":0.020539343},"labels":[],"label_agreement":null},{"id":"W2998443374","doi":"10.1093/neuonc/noz237","title":"How should we manage incidental meningiomas?","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Brain Tumour Charity","keywords":"Meningioma; Computer science; Business; Medicine; Radiology","score_opus":0.055227328889227115,"score_gpt":0.30446917191344736,"score_spread":0.24924184302422026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998443374","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021940283,0.0038589572,0.00024102903,0.97507125,0.0115665095,0.000015837193,0.000023699946,0.00002118079,0.0070075253],"genre_scores_gemma":[0.044666205,0.010252251,0.0016936054,0.7624719,0.17196408,0.00006365601,0.00006614798,0.00005496373,0.008767105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980994,0.00043704786,0.0003715238,0.000225723,0.0004223945,0.00044383298],"domain_scores_gemma":[0.9923922,0.0024638055,0.0010796498,0.00019113666,0.0010648218,0.002808371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457732,0.0007144313,0.0010802868,0.001615342,0.0058311275,0.004446511,0.0012851353,0.03748003,0.0072968663],"category_scores_gemma":[0.02692527,0.000705332,0.0012534007,0.0009020143,0.0033544227,0.0056116437,0.0025552656,0.029975662,0.0048756306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011145607,0.00020960528,0.014404861,0.0003733348,0.00008791561,0.1966828,0.00093141774,0.0006988849,0.0008799685,0.007462784,0.7289587,0.049198188],"study_design_scores_gemma":[0.00023002803,0.00023499192,0.007456766,0.0028088223,0.0001396322,0.35712817,0.003954292,0.0016122219,0.0005909302,0.05712771,0.568481,0.00023540396],"about_ca_topic_score_codex":0.004370614,"about_ca_topic_score_gemma":0.008608635,"teacher_disagreement_score":0.03748003,"about_ca_system_score_codex":0.003936753,"about_ca_system_score_gemma":0.004987064,"threshold_uncertainty_score":0.028563261},"labels":[],"label_agreement":null},{"id":"W3000663133","doi":"10.1093/neuonc/noaa003","title":"Modeling DIPG in the mouse brainstem","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Brainstem; Neuroscience; Biology; Medicine; Computer science","score_opus":0.034001795677342864,"score_gpt":0.25877142649666307,"score_spread":0.22476963081932022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000663133","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18884173,0.0123127205,0.5227314,0.23314261,0.010270711,0.00016177709,0.0029751149,0.0055165566,0.024047349],"genre_scores_gemma":[0.77354044,0.010910145,0.15383555,0.03050091,0.001581506,0.0002831474,0.00068088726,0.00092557166,0.027741881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991405,0.00001622156,0.0000043764458,0.000019843857,0.000033740933,0.000011782532],"domain_scores_gemma":[0.9997645,0.00012664507,0.000021926728,0.000024152892,0.000027110722,0.000035728288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047856427,0.0003650636,0.00033127517,0.00016138676,0.00028818494,0.0007242316,0.0011381436,0.0021348943,0.0015359299],"category_scores_gemma":[0.0007128814,0.00024777066,0.000535127,0.000100630095,0.00046008587,0.00054436293,0.00042804886,0.0019195682,0.0006575239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006371107,0.00012592529,0.0050086067,0.00064390217,0.00016072104,0.0066738063,0.00018997278,0.15569325,0.575429,0.09732455,0.08899278,0.069120325],"study_design_scores_gemma":[0.0002483669,0.00032706143,0.0027110376,0.000113590446,0.00021956084,0.0044038193,0.00018060513,0.56230825,0.16881353,0.076387696,0.18419392,0.000092532806],"about_ca_topic_score_codex":0.0058577196,"about_ca_topic_score_gemma":0.009794928,"teacher_disagreement_score":0.0058577196,"about_ca_system_score_codex":0.00123777,"about_ca_system_score_gemma":0.00052283396,"threshold_uncertainty_score":0.011647224},"labels":[],"label_agreement":null},{"id":"W3001828378","doi":"10.1093/neuonc/noaa007","title":"Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Sunnybrook Research Institute","keywords":"Radiosurgery; Radiomics; Medicine; Stereotactic radiotherapy; Medical physics; Radiology; Radiation therapy","score_opus":0.032448662517219236,"score_gpt":0.29534824347099187,"score_spread":0.26289958095377264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001828378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991979,0.0009544354,0.0058261817,0.00006481448,0.000020431595,0.000042421856,0.00039408513,0.00010531179,0.0006132747],"genre_scores_gemma":[0.9982223,0.00007816045,0.0013739351,0.0000078765615,0.000012550234,0.000016241349,0.00023409557,0.000005556883,0.000049360042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939203,0.00017986685,0.000073410934,0.00011122069,0.000201464,0.00004202702],"domain_scores_gemma":[0.9971065,0.001289871,0.000885536,0.00011869557,0.00045921333,0.0001402778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015502586,0.0005444911,0.00050852355,0.0015815023,0.00019218278,0.0005886366,0.0002779072,0.00029867233,0.00048458594],"category_scores_gemma":[0.005383337,0.00010485628,0.000474604,0.00045247714,0.00024596183,0.00032159654,0.00027229087,0.00043827156,0.00020749179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024295298,0.00021272596,0.86071867,0.00014347996,0.000462003,0.00012162409,0.00007377915,0.016295372,0.010325589,0.00007800187,0.0006816845,0.10845748],"study_design_scores_gemma":[0.000069047885,0.0016312365,0.8916853,0.000045405042,0.00047004168,0.00086563296,0.00007323003,0.094545215,0.009129001,0.00037944713,0.0010546236,0.00005193649],"about_ca_topic_score_codex":0.0008232676,"about_ca_topic_score_gemma":0.001022847,"teacher_disagreement_score":0.0015815023,"about_ca_system_score_codex":0.0003583464,"about_ca_system_score_gemma":0.00023589276,"threshold_uncertainty_score":0.008198619},"labels":[],"label_agreement":null},{"id":"W3003700434","doi":"10.1093/neuonc/noaa019","title":"A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Temozolomide; Radiosurgery; Glioblastoma; Medicine; Oncology; Recursive partitioning; Internal medicine; Nuclear medicine; Radiation therapy; Cancer research","score_opus":0.026057030864722736,"score_gpt":0.30346848838304247,"score_spread":0.27741145751831975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003700434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965198,0.0014417097,0.00022108143,0.00013018676,0.0000579367,0.00086045446,0.00023180648,0.000028219967,0.00050876616],"genre_scores_gemma":[0.9948665,0.0013135473,0.0005966722,0.00040598572,0.00010360275,0.0012338659,0.0007351656,0.000011019283,0.00073351106],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996859,0.00012591208,0.000024883811,0.00006546277,0.000035278903,0.00006263562],"domain_scores_gemma":[0.9994741,0.000054472246,0.00016706382,0.000030484296,0.00003164679,0.00024220682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013423983,0.0012124024,0.0012758146,0.0004099569,0.00028083602,0.0006117483,0.00072249066,0.00077814714,0.0017730397],"category_scores_gemma":[0.0006018586,0.00038051954,0.00090990914,0.00032795363,0.0006862705,0.00062853174,0.000283422,0.0014352459,0.00037695238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.822288,0.04805221,0.011735836,0.0012205887,0.002038527,0.00026789718,0.00034505117,0.0026572752,0.027370716,0.00022482983,0.0022645718,0.081534445],"study_design_scores_gemma":[0.5562811,0.41747767,0.02014017,0.000051817275,0.00067916315,0.00023916531,0.00006669542,0.0012270934,0.0024216168,0.00015240668,0.0012376662,0.000025429275],"about_ca_topic_score_codex":0.00092769874,"about_ca_topic_score_gemma":0.0030518307,"teacher_disagreement_score":0.0017730397,"about_ca_system_score_codex":0.00080822106,"about_ca_system_score_gemma":0.0011856778,"threshold_uncertainty_score":0.00709939},"labels":[],"label_agreement":null},{"id":"W3005433336","doi":"10.1093/neuonc/noaa025","title":"Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Masonic Cancer Center, University of Minnesota; National Institutes of Health; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Breast cancer; Estrogen; Oncology; Internal medicine; Medicine; Progesterone receptor; Estrogen receptor; Cancer; Primary tumor; Metastasis","score_opus":0.02705868606800896,"score_gpt":0.3086234255814649,"score_spread":0.2815647395134559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005433336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826354,0.001231545,0.000031867366,0.000041044827,0.0000048440797,0.0000033841384,0.00019815328,0.0000013236511,0.00022430571],"genre_scores_gemma":[0.99953544,0.00019312462,0.00002995276,0.000008923249,0.000007284444,0.000002569153,0.00018918095,6.655172e-7,0.00003283298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992705,0.00021305955,0.00010809841,0.0001219777,0.0001902916,0.00009613161],"domain_scores_gemma":[0.9968541,0.00093419506,0.0016146724,0.00014268655,0.00020675435,0.00024755736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088644703,0.00010349516,0.0002867991,0.0004895019,0.00016481553,0.0003255615,0.0002450174,0.00018269556,0.00090588105],"category_scores_gemma":[0.0050794203,0.0000786512,0.00037698634,0.00059003796,0.00019527676,0.00018572215,0.00024308216,0.00033465837,0.000110799934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005364987,0.000015308015,0.99568117,0.00001957199,0.000057938145,0.00009537274,0.000018213652,0.000044604665,0.00011329878,0.000008719858,0.000055765035,0.0033534619],"study_design_scores_gemma":[0.000008662075,0.00011404421,0.9984743,0.000010391893,0.00007203772,0.0007420231,0.000048132668,0.0001570651,0.00014881916,0.000027041984,0.0001953866,0.0000021644967],"about_ca_topic_score_codex":0.001518649,"about_ca_topic_score_gemma":0.0018696808,"teacher_disagreement_score":0.001518649,"about_ca_system_score_codex":0.00045657286,"about_ca_system_score_gemma":0.00027700435,"threshold_uncertainty_score":0.0046880245},"labels":[],"label_agreement":null},{"id":"W3006409908","doi":"10.1093/neuonc/noaa036","title":"Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Gilbert Family Foundation","keywords":"Neurofibromatosis; Glioma; Medicine; Consensus conference; Oncology; Internal medicine; Pathology; Cancer research","score_opus":0.04169166591255971,"score_gpt":0.2939665582084656,"score_spread":0.25227489229590594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006409908","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013755496,0.09277222,0.002049423,0.8480208,0.051458213,0.00036202904,0.00030406113,0.000052537824,0.0036051946],"genre_scores_gemma":[0.03993412,0.23703614,0.025161473,0.6265606,0.05841455,0.0020635584,0.0023370895,0.00019496884,0.008297571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95641106,0.015730564,0.01120536,0.0031021289,0.01029714,0.0032538178],"domain_scores_gemma":[0.83077437,0.05757046,0.007981821,0.00269957,0.076483876,0.02448991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.103345945,0.0016538808,0.003210323,0.0041724015,0.004317317,0.0064262263,0.0076493807,0.020741675,0.0036539778],"category_scores_gemma":[0.106792346,0.0015093847,0.005295142,0.002694533,0.003203252,0.010310174,0.011367173,0.03322069,0.001537576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018626256,0.00016914173,0.0025900265,0.00841363,0.00027457267,0.0011091391,0.0027304522,0.000731358,0.0010870801,0.009137095,0.75234646,0.22122481],"study_design_scores_gemma":[0.0001185711,0.00009195826,0.0021619399,0.0172194,0.00027054598,0.0010356557,0.0031403166,0.00027930844,0.00034318995,0.0069950754,0.9682119,0.00013206578],"about_ca_topic_score_codex":0.010099483,"about_ca_topic_score_gemma":0.013267244,"teacher_disagreement_score":0.103345945,"about_ca_system_score_codex":0.013469499,"about_ca_system_score_gemma":0.046706166,"threshold_uncertainty_score":0.5465521},"labels":[],"label_agreement":null},{"id":"W3007390653","doi":"10.1093/neuonc/noaa043","title":"The Society for Neuro-Oncology: 20/20 vision for the future","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02130765648942999,"score_gpt":0.3771883343025872,"score_spread":0.3558806778131572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007390653","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079247524,0.06583175,0.001446204,0.57037526,0.2737431,0.0000612895,0.0003688735,0.00048605446,0.08689504],"genre_scores_gemma":[0.021014176,0.13301422,0.006611025,0.32285306,0.2015176,0.00040290426,0.0018502302,0.0007767124,0.31196013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945939,0.0011509416,0.00029623532,0.00046302401,0.002160876,0.0013350354],"domain_scores_gemma":[0.98423946,0.0008173712,0.00039425574,0.00039366697,0.0035111574,0.01064421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008817991,0.0015238611,0.00096776616,0.0016826487,0.0029418839,0.011157279,0.0017729974,0.011257881,0.046478204],"category_scores_gemma":[0.010046524,0.00043398445,0.00093342486,0.0010608258,0.0031765276,0.0073638074,0.006926026,0.013926828,0.04212685],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023007045,0.00003410181,0.00017085658,0.00010912527,0.0000058498094,0.000055271677,0.00008739017,0.000030392916,0.00010862418,0.007452925,0.9442521,0.04767045],"study_design_scores_gemma":[0.0000051277857,0.00001534449,0.00014798885,0.00013519035,0.0000024144224,0.00009048585,0.00009995089,0.000018980963,0.000024357098,0.0023470707,0.99710804,0.0000051118977],"about_ca_topic_score_codex":0.0018398796,"about_ca_topic_score_gemma":0.0036493472,"teacher_disagreement_score":0.046478204,"about_ca_system_score_codex":0.003418377,"about_ca_system_score_gemma":0.0193949,"threshold_uncertainty_score":0.1554851},"labels":[],"label_agreement":null},{"id":"W3008330096","doi":"10.1093/neuonc/noaa044","title":"Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute on Deafness and Other Communication Disorders; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Beijing Municipal Science and Technology Commission; National Institute on Drug Abuse; National Natural Science Foundation of China","keywords":"Glioma; Resting state fMRI; Neuroscience; Functional connectivity; Biology; Psychology; Cancer research","score_opus":0.03703399342944552,"score_gpt":0.30116702731075506,"score_spread":0.26413303388130954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008330096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988543,0.000056659053,0.00065195584,0.000028325678,0.0000023175644,0.000006620385,0.0001549678,0.000016019036,0.00022883434],"genre_scores_gemma":[0.9991804,0.00003181376,0.0005175358,0.000010333381,0.0000049810865,0.000010612058,0.00018558014,0.0000025956115,0.00005606491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993825,0.000017901215,0.0000040318528,0.000021035676,0.000008415807,0.0000102467],"domain_scores_gemma":[0.9997366,0.0000798994,0.00009839666,0.00001727901,0.000029305203,0.000038485825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018158788,0.00024728946,0.0001712427,0.00044239996,0.000106512736,0.00021342593,0.00016217519,0.00032858175,0.00086422765],"category_scores_gemma":[0.00083603215,0.00008609198,0.00015272041,0.00021863694,0.00012692582,0.00018799143,0.000111331385,0.00018527874,0.00015601121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017085437,0.00032263165,0.88167876,0.00008525448,0.00027740747,0.0005880198,0.0002716699,0.0011338092,0.08276127,0.00013007916,0.0007345994,0.03030805],"study_design_scores_gemma":[0.000014660452,0.00040482666,0.99248934,0.0000036506253,0.000060177365,0.0008489169,0.00006834685,0.002459227,0.003393429,0.00009792887,0.00015032459,0.000009080044],"about_ca_topic_score_codex":0.0006140762,"about_ca_topic_score_gemma":0.0017700098,"teacher_disagreement_score":0.00086422765,"about_ca_system_score_codex":0.00012253475,"about_ca_system_score_gemma":0.00010278534,"threshold_uncertainty_score":0.002891183},"labels":[],"label_agreement":null},{"id":"W3009065698","doi":"10.1093/neuonc/noaa046","title":"Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Calgary; Alberta Children's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute","keywords":"Atypical teratoid rhabdoid tumor; SMARCB1; Epigenomics; Transcriptome; Epigenetics; Carcinogenesis; Biology; DNA methylation; Cancer; Bioinformatics; Cancer research; Medicine; Genetics; Gene; Gene expression","score_opus":0.03959391944520126,"score_gpt":0.2977486473901111,"score_spread":0.25815472794490985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009065698","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.073484436,0.74994385,0.051248122,0.07701801,0.0034159524,0.00032767974,0.0006539619,0.0007430854,0.043164946],"genre_scores_gemma":[0.33799732,0.5877891,0.040824223,0.019715872,0.0032286188,0.00032502192,0.00083480775,0.00014141937,0.009143588],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967265,0.00008492991,0.000026595602,0.000051161212,0.00009823061,0.00006651378],"domain_scores_gemma":[0.9994986,0.0001523158,0.000088739085,0.000042365522,0.00011907613,0.000098856915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014969206,0.0004697877,0.0005116184,0.0009477252,0.00041230375,0.002010702,0.00073265244,0.0009994131,0.0038398507],"category_scores_gemma":[0.0010455372,0.00022665663,0.0005753952,0.0003434671,0.0008941896,0.0017519448,0.0012197695,0.0028757737,0.0015613878],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005710418,0.0010305346,0.0042778514,0.002651572,0.00019587272,0.0010990938,0.00045650956,0.0042606415,0.13819067,0.08783971,0.03417862,0.7252478],"study_design_scores_gemma":[0.00034610825,0.0018155792,0.005763693,0.0015636003,0.0002619283,0.0032217596,0.00070915825,0.004785844,0.056090202,0.058955014,0.8664079,0.00007932866],"about_ca_topic_score_codex":0.00050156284,"about_ca_topic_score_gemma":0.001809409,"teacher_disagreement_score":0.0038398507,"about_ca_system_score_codex":0.0009847409,"about_ca_system_score_gemma":0.0014360223,"threshold_uncertainty_score":0.012845576},"labels":[],"label_agreement":null},{"id":"W3010939994","doi":"10.1093/neuonc/noaa045","title":"AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Cancer Institute; Abramson Cancer Center; Penn Center for Precision Medicine, University of Pennsylvania; Wellcome Trust","keywords":"Precision oncology; Medicine; Medical physics; Precision medicine; Neuroimaging; Oncology; Internal medicine; Pathology","score_opus":0.030748780861377518,"score_gpt":0.3208276696118267,"score_spread":0.2900788887504492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010939994","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01924382,0.019835304,0.0062070345,0.8552339,0.011213664,0.0007903907,0.007803481,0.00064833206,0.079024136],"genre_scores_gemma":[0.4313236,0.034247104,0.05540401,0.3515496,0.03806208,0.0061099967,0.02013638,0.0007230508,0.0624442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942386,0.0030978704,0.0005674351,0.00034639274,0.0013187941,0.00043088148],"domain_scores_gemma":[0.9631665,0.018637441,0.0017314001,0.0026190714,0.011078229,0.0027674083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017994989,0.0005509744,0.0013101633,0.0013886264,0.00092707435,0.003453663,0.0016771101,0.0034917784,0.011877311],"category_scores_gemma":[0.05029156,0.00023860588,0.0009103089,0.0017338993,0.0011154185,0.0023624855,0.002311677,0.0038971396,0.0062601385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016432737,0.0002127526,0.03396077,0.00043422513,0.00016501537,0.00076315907,0.0001566797,0.00056149304,0.00062081893,0.009510186,0.6339163,0.31805542],"study_design_scores_gemma":[0.0019855953,0.0022012505,0.048939828,0.0043472745,0.0006622752,0.0051598707,0.0009871047,0.0081234705,0.003701839,0.07166225,0.852027,0.00020219616],"about_ca_topic_score_codex":0.0034001218,"about_ca_topic_score_gemma":0.0045377705,"teacher_disagreement_score":0.017994989,"about_ca_system_score_codex":0.0021612253,"about_ca_system_score_gemma":0.0063017122,"threshold_uncertainty_score":0.0951677},"labels":[],"label_agreement":null},{"id":"W3012355718","doi":"10.1093/neuonc/noaa059","title":"MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; University of California, San Francisco; National Institutes of Health; National Institute of General Medical Sciences; University of Oklahoma","keywords":"Somatic hypermutation; Methyltransferase; Biology; Temozolomide; Methylation; Cancer research; Glioma; O-6-methylguanine-DNA methyltransferase; DNA methylation; Bisulfite sequencing; Oncology; Medicine; Genetics; Gene; Gene expression","score_opus":0.0566727774134514,"score_gpt":0.3176718136678781,"score_spread":0.2609990362544267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012355718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994124,0.0002078614,0.00010875647,0.00003145348,0.000002271689,0.0000033669742,0.00008645423,0.0000078008,0.00013958097],"genre_scores_gemma":[0.9996264,0.000061495215,0.00008363133,0.000008078957,0.0000031349202,0.0000023484754,0.0001492779,0.0000016678423,0.000063874875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998777,0.000021861035,0.000015675285,0.000030079542,0.000032594908,0.000022106218],"domain_scores_gemma":[0.9988452,0.0002323975,0.0005203673,0.000052804062,0.00010772398,0.00024141607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029277097,0.00017929617,0.00026675928,0.00041533736,0.0001287644,0.00023455566,0.00020261221,0.0002846422,0.0010399241],"category_scores_gemma":[0.0018215508,0.00009032293,0.00028432786,0.00030169706,0.0001520858,0.00015601538,0.00018114137,0.00039755384,0.0001837229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017454172,0.000012646642,0.9958662,0.000006285974,0.000027394542,0.00004217848,0.0000162736,0.00010186134,0.0014100804,0.000004091602,0.000047153844,0.0022912587],"study_design_scores_gemma":[0.0000042027423,0.00010721497,0.9982363,0.0000022354425,0.000028744153,0.00031216707,0.000029559797,0.00050577556,0.0006709905,0.000016512708,0.000084498344,0.00000193386],"about_ca_topic_score_codex":0.003075823,"about_ca_topic_score_gemma":0.0049224216,"teacher_disagreement_score":0.003075823,"about_ca_system_score_codex":0.00028549833,"about_ca_system_score_gemma":0.0002155859,"threshold_uncertainty_score":0.006115794},"labels":[],"label_agreement":null},{"id":"W3014007830","doi":"10.1093/neuonc/noaa079","title":"Neuro-oncology in adolescents and young adults—an unmet need","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Psychology; Internal medicine","score_opus":0.020852614834897733,"score_gpt":0.28715578511135176,"score_spread":0.266303170276454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014007830","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012358293,0.002112909,0.0000369896,0.9845673,0.007765101,0.000007117164,0.000031073334,0.000010754512,0.004232806],"genre_scores_gemma":[0.022317758,0.008185202,0.00042491083,0.90508455,0.052975252,0.000056950983,0.00008686887,0.000033157023,0.010835329],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981462,0.00057389017,0.00026460204,0.00014498417,0.0003844412,0.00048590807],"domain_scores_gemma":[0.9907184,0.0023419356,0.0008571928,0.00012074985,0.0011275315,0.004834194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014293825,0.00040659864,0.000830559,0.000748398,0.004450982,0.0034114898,0.0009140839,0.029481707,0.0130425375],"category_scores_gemma":[0.01045705,0.0005265624,0.00073973153,0.0006677531,0.0019649046,0.0032777074,0.0025738275,0.020883543,0.0040467917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029477887,0.000086014144,0.0068706605,0.00014208966,0.000013476811,0.01367513,0.0004476402,0.00009728163,0.0001681498,0.003285313,0.95405513,0.021129657],"study_design_scores_gemma":[0.00015408474,0.00018595422,0.011170654,0.0024042944,0.000051640825,0.042774227,0.00500318,0.00052337506,0.00017807822,0.013338644,0.92414945,0.000066514986],"about_ca_topic_score_codex":0.0099127805,"about_ca_topic_score_gemma":0.033213966,"teacher_disagreement_score":0.029481707,"about_ca_system_score_codex":0.0039443593,"about_ca_system_score_gemma":0.009761362,"threshold_uncertainty_score":0.043631613},"labels":[],"label_agreement":null},{"id":"W3015188401","doi":"10.1093/neuonc/noaa077","title":"Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; SickKids Foundation; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Methylation; Epigenetics; DNA methylation; Glioma; Pathological; Oncology; Pathology; Univariate analysis; Multivariate analysis; Medicine; Biology; Internal medicine; Cancer research; Gene; Genetics; Gene expression","score_opus":0.03388530004287449,"score_gpt":0.3629684025690152,"score_spread":0.3290831025261407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015188401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854136,0.00035309192,0.00043025202,0.000022399217,0.0000017900729,0.00000815265,0.0003154538,0.000018427098,0.00030904537],"genre_scores_gemma":[0.9985746,0.00013373481,0.000666064,0.000009790506,0.000004160516,0.000007931278,0.0005308548,0.000007892832,0.00006482102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966574,0.000064988955,0.000031868243,0.00011236487,0.00007784749,0.000047304693],"domain_scores_gemma":[0.99901426,0.00020621512,0.00037181113,0.000076003584,0.00019103565,0.00014073464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005666326,0.00031050981,0.00027021446,0.001507862,0.00018629077,0.00039810015,0.00029212495,0.00021115568,0.0006460475],"category_scores_gemma":[0.0017605242,0.00011221056,0.00021375871,0.000845967,0.00019928685,0.00030054615,0.00050685304,0.00023538347,0.00018162337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027724032,0.00001623339,0.9783094,0.000036734767,0.00004587867,0.00023998482,0.00005540166,0.00026204568,0.0068608513,0.000014631603,0.00010828813,0.01377315],"study_design_scores_gemma":[0.000004613218,0.00014195037,0.9934697,0.00000925427,0.00007795898,0.001513178,0.00010773668,0.00082193635,0.0034054383,0.000060287435,0.00038300327,0.0000048697048],"about_ca_topic_score_codex":0.0013933211,"about_ca_topic_score_gemma":0.0026261192,"teacher_disagreement_score":0.001507862,"about_ca_system_score_codex":0.00032381536,"about_ca_system_score_gemma":0.00030521824,"threshold_uncertainty_score":0.0029966831},"labels":[],"label_agreement":null},{"id":"W3016851479","doi":"10.1093/neuonc/noaa102","title":"Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on “Head Start” III: a multi-institutional, prospective clinical trial","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medulloblastoma; Medicine; Internal medicine; ThioTEPA; Regimen; Carboplatin; Induction chemotherapy; Prospective cohort study; Chemotherapy; Oncology; Clinical trial; Surgery; Pathology","score_opus":0.0810362073673501,"score_gpt":0.36345624048938907,"score_spread":0.282420033122039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016851479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980153,0.0009160376,0.00007689935,0.00008815872,0.00002602629,0.00033196688,0.00025577878,0.000006847966,0.00028301682],"genre_scores_gemma":[0.996837,0.0008187598,0.00030599616,0.0002622241,0.00008121464,0.0005443243,0.0008964095,0.0000043266186,0.00024965298],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992685,0.00044325204,0.000054377273,0.000076536366,0.00006080077,0.00009662655],"domain_scores_gemma":[0.9986291,0.00019143974,0.00044361394,0.00008831724,0.00005811994,0.00058951456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021451171,0.00071101653,0.0010675361,0.00023204542,0.00035229116,0.00074738776,0.00052727637,0.0006007153,0.0012615223],"category_scores_gemma":[0.00082670065,0.00022518067,0.001074684,0.0002956463,0.0005888843,0.00046869493,0.00039017215,0.001174895,0.00022344533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7859216,0.023256112,0.13766344,0.00062859774,0.0034259937,0.000344298,0.00019812403,0.001503641,0.0076506254,0.00015041178,0.0018350978,0.03742195],"study_design_scores_gemma":[0.2615695,0.5402797,0.18755731,0.00015404758,0.0020811069,0.0005571815,0.00019400888,0.0012534772,0.0035179975,0.00016646543,0.0026236675,0.000045576096],"about_ca_topic_score_codex":0.00087820645,"about_ca_topic_score_gemma":0.0027203357,"teacher_disagreement_score":0.0021451171,"about_ca_system_score_codex":0.0007811859,"about_ca_system_score_gemma":0.0014978967,"threshold_uncertainty_score":0.011344552},"labels":[],"label_agreement":null},{"id":"W3016855810","doi":"10.1093/neuonc/noaa093","title":"In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children; University of British Columbia; Hotchkiss Brain Institute; University of Calgary","funders":"Alberta Innovates; Alberta Cancer Foundation; Genome Canada","keywords":"Glioblastoma; Platelet-derived growth factor receptor; Neural stem cell; In vitro; Null (SQL); Progenitor cell; Progenitor; Cancer research; Biology; Neuroscience; Cell biology; Computer science; Data mining; Stem cell; Growth factor; Genetics; Receptor","score_opus":0.045737084991053854,"score_gpt":0.31404902323501815,"score_spread":0.2683119382439643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016855810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726963,0.0008176223,0.020857412,0.00008779016,0.00003929815,0.00008164625,0.00080701965,0.0001543645,0.0044583944],"genre_scores_gemma":[0.9825784,0.0009293105,0.013704534,0.000016127333,0.000004525229,0.00010192419,0.00059063983,0.00003204848,0.0020424165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998994,0.000009675153,0.000009746332,0.000017242299,0.0000444601,0.000019416419],"domain_scores_gemma":[0.9998976,0.000019663345,0.00003738646,0.000011158985,0.000012689667,0.000021486874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011436858,0.00046612328,0.00023545572,0.00028812914,0.00018834615,0.00046229613,0.00046132543,0.0003367089,0.00063856],"category_scores_gemma":[0.0001018153,0.00024218432,0.0003040765,0.00024331658,0.00016568312,0.00013156878,0.00033143407,0.00036983832,0.000316949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000134868,0.00009436589,0.0016653576,0.00012720257,0.00001912937,0.00066318916,0.000110510024,0.07098289,0.92305547,0.0011099806,0.00012633814,0.0019106796],"study_design_scores_gemma":[0.00003523774,0.0004460102,0.0033966657,0.000028312023,0.00005129594,0.00047894017,0.00008182244,0.17275691,0.8187304,0.00034427518,0.0036296966,0.0000203142],"about_ca_topic_score_codex":0.004125273,"about_ca_topic_score_gemma":0.0029756776,"teacher_disagreement_score":0.004125273,"about_ca_system_score_codex":0.0005087783,"about_ca_system_score_gemma":0.00046085665,"threshold_uncertainty_score":0.008202493},"labels":[],"label_agreement":null},{"id":"W3019927786","doi":"10.1093/neuonc/nou206.58","title":"EPIGENOME ALTERATIONS DEFINE LETHAL CIMP POSITIVE EPENDYMOMAS OF INFANCY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Epigenome; Atypical teratoid rhabdoid tumor; DNA methylation; CpG site; Genetics; Cancer research; Exome sequencing; Mutation; Medulloblastoma; Gene; Gene expression","score_opus":0.012154956617595492,"score_gpt":0.28100684654907465,"score_spread":0.2688518899314792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019927786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983804,0.00024452448,0.000519773,0.000009071766,0.0000013000126,0.000007525163,0.00017940022,0.000011718349,0.0006462163],"genre_scores_gemma":[0.9984964,0.0002142404,0.00069710496,0.000009378139,0.000002307211,0.00001156977,0.00032173624,0.000006758422,0.00024049591],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992883,0.000008049542,0.0000065345153,0.00001852277,0.000020655465,0.00001739474],"domain_scores_gemma":[0.9998729,0.000037323625,0.00004834681,0.000007763862,0.0000115532375,0.000021968792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010325541,0.00018999602,0.00016936084,0.0006000546,0.00012818334,0.00016318935,0.0001454663,0.00017430169,0.0011803451],"category_scores_gemma":[0.00038017,0.00009291511,0.000094981806,0.00029806868,0.00022397815,0.00010328299,0.00031360658,0.00013574997,0.00016606857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007779943,0.00004885172,0.39689115,0.000114894494,0.000053559153,0.012916559,0.00056746136,0.00042274923,0.5668965,0.0004581138,0.00026441514,0.020587694],"study_design_scores_gemma":[0.000005913877,0.00015880368,0.94104236,0.0000071295253,0.000034842542,0.0192337,0.0001961044,0.0003169772,0.037506573,0.00017638384,0.001316176,0.0000049690434],"about_ca_topic_score_codex":0.00057004805,"about_ca_topic_score_gemma":0.00093612756,"teacher_disagreement_score":0.0011803451,"about_ca_system_score_codex":0.00017518127,"about_ca_system_score_gemma":0.000092717026,"threshold_uncertainty_score":0.0039486885},"labels":[],"label_agreement":null},{"id":"W3020099303","doi":"10.1093/neuonc/noaa106","title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Glioblastoma; Medicine; Oncology; Current (fluid); Internal medicine; Clinical Oncology; Cancer research; Cancer; Engineering","score_opus":0.034191579583664235,"score_gpt":0.34282959343282104,"score_spread":0.3086380138491568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020099303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008911631,0.99585634,0.00009563246,0.0017134979,0.0006080668,0.00001107137,0.00007283637,0.000010986793,0.0015424644],"genre_scores_gemma":[0.00048535163,0.9977831,0.00019581862,0.00062192196,0.00024007283,0.000011490891,0.00010238887,0.0000020908592,0.00055775023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975175,0.000047988233,0.00005550114,0.000031364994,0.00008559422,0.000027769669],"domain_scores_gemma":[0.99958915,0.00012559757,0.00007770706,0.0000064823507,0.00016177403,0.00003929992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007022249,0.0006932334,0.0010208816,0.0021918726,0.00028254732,0.0009087568,0.0006007522,0.0009963898,0.0042367424],"category_scores_gemma":[0.0011318631,0.0001736789,0.00057358056,0.0023891407,0.00024941558,0.0011000517,0.0007539123,0.0012545132,0.0019848542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005173013,0.00002692455,0.00019539046,0.018807724,0.000063300315,0.00015070997,0.000067042216,0.00016859347,0.00044128523,0.0023611647,0.12589228,0.85177386],"study_design_scores_gemma":[0.000012427108,0.0000456592,0.00062063494,0.010593297,0.00012600984,0.0008374263,0.00006725185,0.00003956104,0.000119941535,0.0010969411,0.9864298,0.000011034593],"about_ca_topic_score_codex":0.002648617,"about_ca_topic_score_gemma":0.0050462666,"teacher_disagreement_score":0.0042367424,"about_ca_system_score_codex":0.0007918838,"about_ca_system_score_gemma":0.0030034874,"threshold_uncertainty_score":0.014173269},"labels":[],"label_agreement":null},{"id":"W3021575924","doi":"10.1093/neuonc/noaa113","title":"Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Radiation oncology; Intensive care medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Disease; Medical physicist; Radiation therapy; Internal medicine; Medical physics; Infectious disease (medical specialty)","score_opus":0.07763169866407814,"score_gpt":0.37186556768401996,"score_spread":0.2942338690199418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021575924","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0650329,0.068197116,0.019278163,0.7732103,0.008356577,0.0008416903,0.0011697409,0.0003206342,0.06359288],"genre_scores_gemma":[0.6753096,0.10883962,0.042784195,0.15646502,0.0064131333,0.0010840653,0.0019993642,0.00015509152,0.0069500008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971758,0.0014336793,0.00038870462,0.00017685688,0.00042912332,0.0003957794],"domain_scores_gemma":[0.99505156,0.0010692353,0.0009127366,0.00016454887,0.0017478133,0.0010539712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047388105,0.00034210845,0.0004349789,0.0006265168,0.0013664373,0.0012793385,0.0010482785,0.00270904,0.0017880575],"category_scores_gemma":[0.018144596,0.00014298542,0.00066518446,0.0003602013,0.0006573291,0.0015241774,0.0027935517,0.0037964352,0.0005739696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029741463,0.00026535607,0.036971066,0.004018329,0.00030224925,0.0037761366,0.0032990242,0.0068780296,0.0021512955,0.013568692,0.4319726,0.49649972],"study_design_scores_gemma":[0.0002537108,0.0008388965,0.045329154,0.019763015,0.0006163377,0.0074598957,0.011280559,0.0042430763,0.00396344,0.06481744,0.8412028,0.00023164897],"about_ca_topic_score_codex":0.005771213,"about_ca_topic_score_gemma":0.017224696,"teacher_disagreement_score":0.005771213,"about_ca_system_score_codex":0.0028362048,"about_ca_system_score_gemma":0.009852158,"threshold_uncertainty_score":0.025061488},"labels":[],"label_agreement":null},{"id":"W3027128667","doi":"10.1093/neuonc/noaa122","title":"Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Garron Family Cancer Centre; C.R. Younger Foundation; Canadian Institutes of Health Research; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Medulloblastoma; Medicine; Neurocognitive; Regimen; Cohort; Hazard ratio; Oncology; Pediatrics; Sonic hedgehog; Internal medicine; Retrospective cohort study; Pathology; Psychiatry; Confidence interval","score_opus":0.03309177039895234,"score_gpt":0.3156633087290038,"score_spread":0.28257153833005144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027128667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617562,0.022555912,0.0029624158,0.005529942,0.00004849665,0.00004018643,0.00082581706,0.00004064362,0.006240306],"genre_scores_gemma":[0.9948172,0.0029569985,0.0011752687,0.00032174392,0.0000382683,0.000025253623,0.0003643021,0.000014704496,0.00028631047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973005,0.000114342176,0.000015409056,0.000037253074,0.0000646527,0.00003832895],"domain_scores_gemma":[0.9995351,0.00013792081,0.00019337649,0.000027642966,0.000040742536,0.00006528284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006672989,0.000085568,0.00029165216,0.00016769895,0.00013809097,0.0004242795,0.00013581834,0.00017026678,0.0013449686],"category_scores_gemma":[0.0015693682,0.000034848512,0.00013771687,0.00020997638,0.00019369017,0.00028856352,0.0003143034,0.0003482548,0.00015839242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003239303,0.00021954955,0.51861733,0.00028765958,0.00022879409,0.0005079947,0.00036804678,0.0055421693,0.011996903,0.003369881,0.004774001,0.4508484],"study_design_scores_gemma":[0.00014515102,0.0030760386,0.9420914,0.0003751079,0.00037486848,0.00205439,0.00083557557,0.004907449,0.0062510176,0.00458556,0.035286024,0.000017499615],"about_ca_topic_score_codex":0.001142831,"about_ca_topic_score_gemma":0.0027559667,"teacher_disagreement_score":0.0013449686,"about_ca_system_score_codex":0.00074452325,"about_ca_system_score_gemma":0.00066220027,"threshold_uncertainty_score":0.0054019094},"labels":[],"label_agreement":null},{"id":"W3030232989","doi":"10.1093/neuonc/noaa129","title":"SNO 25th anniversary history series: Investing in the membership of the Society for Neuro-Oncology","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Series (stratigraphy); Oncology; Medicine; Internal medicine; Biology","score_opus":0.0753301635316908,"score_gpt":0.2959662792448666,"score_spread":0.22063611571317582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030232989","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014887269,0.010964999,0.000658279,0.094475366,0.7449537,0.00020921868,0.0011726075,0.00039014444,0.14568697],"genre_scores_gemma":[0.006597182,0.019561248,0.00088439777,0.028982515,0.29959106,0.0002978095,0.0022638023,0.0006745017,0.64114743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997227,0.0002769343,0.00013439619,0.00027154526,0.0015435206,0.000546473],"domain_scores_gemma":[0.98776996,0.00066416804,0.00048852124,0.00041585133,0.0037656506,0.006895718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004771129,0.0012878617,0.0006560536,0.002255761,0.002792642,0.007680274,0.0018481796,0.0043267766,0.13329327],"category_scores_gemma":[0.008738851,0.0005494077,0.00075792754,0.0013293574,0.0010225533,0.0042128186,0.0050215456,0.0053348946,0.0801167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010055066,0.000014347268,0.00009705205,0.000062856874,0.0000014544554,0.000029007664,0.000024559038,0.000012208321,0.00009088262,0.00049318455,0.98464566,0.014518765],"study_design_scores_gemma":[0.0000051088255,0.000028226788,0.00083355006,0.00017149786,0.0000028165116,0.00004741238,0.000092391834,0.000020473222,0.00008314532,0.00036990092,0.99833894,0.00000662166],"about_ca_topic_score_codex":0.0021546215,"about_ca_topic_score_gemma":0.007568404,"teacher_disagreement_score":0.13329327,"about_ca_system_score_codex":0.0026222277,"about_ca_system_score_gemma":0.005798927,"threshold_uncertainty_score":0.4459104},"labels":[],"label_agreement":null},{"id":"W3033204265","doi":"10.1093/neuonc/noaa130","title":"European genetic ancestry associated with risk of childhood ependymoma","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Centers for Disease Control and Prevention; University of Southern California; Cancer Registry of Greater California; National Institutes of Health; National Center for Chronic Disease Prevention and Health Promotion; Novocure; Pediatric Brain Tumor Foundation; California Department of Public Health; Musella Foundation For Brain Tumor Research and Information; Cancer Prevention and Research Institute of Texas; Sontag Foundation; American Brain Tumor Association; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Ependymoma; Incidence (geometry); Demography; Population; Odds ratio; Genetic genealogy; Ethnic group; Medicine; Odds; Pathology; Logistic regression; Internal medicine","score_opus":0.02370578433672586,"score_gpt":0.26475672654973204,"score_spread":0.2410509422130062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033204265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989286,0.00018501338,0.00013511105,0.000028587781,0.0000026216626,0.0000025391712,0.00017161552,0.0000037168707,0.00054212863],"genre_scores_gemma":[0.9994979,0.000087333014,0.000135023,0.000007633999,0.000003073597,0.0000023182681,0.00017074856,0.0000028662957,0.00009310134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997389,0.0000631854,0.00002212443,0.00009380755,0.000039019273,0.000042972562],"domain_scores_gemma":[0.99896646,0.00023756997,0.00048814763,0.000074766904,0.00009550055,0.00013754152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039390608,0.00018272639,0.00015327128,0.00048726177,0.0003052651,0.0003819178,0.00016894618,0.00019659985,0.0022361916],"category_scores_gemma":[0.0018175219,0.000107815926,0.00024253882,0.0006159028,0.00025436198,0.00015558812,0.00029966378,0.00028153544,0.000117069496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006482853,0.000007536672,0.99811625,0.0000040406244,0.000039774128,0.00011505185,0.0000430764,0.00007099829,0.00038914505,0.00004949149,0.0000491494,0.001050692],"study_design_scores_gemma":[0.0000027763292,0.000018160383,0.9989718,0.000006460406,0.000031697014,0.00042941925,0.00005269439,0.0001546606,0.00011501954,0.000051306706,0.0001646834,0.0000013805134],"about_ca_topic_score_codex":0.005894932,"about_ca_topic_score_gemma":0.005604062,"teacher_disagreement_score":0.005894932,"about_ca_system_score_codex":0.00018071818,"about_ca_system_score_gemma":0.00020703056,"threshold_uncertainty_score":0.011721253},"labels":[],"label_agreement":null},{"id":"W3043701315","doi":"10.1093/neuonc/noaa168","title":"CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; ECOG-ACRIN Cancer Research Group; National Institutes of Health; American College of Radiology Imaging Network; Alliance for Clinical Trials in Oncology Foundation","keywords":"Oligodendroglioma; Medicine; Oncology; Phases of clinical research; Internal medicine; Nuclear medicine; Glioma; Cancer research; Chemotherapy; Astrocytoma","score_opus":0.10551957367800514,"score_gpt":0.3849784594191705,"score_spread":0.2794588857411654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043701315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734763,0.0039697336,0.0022776832,0.0007565135,0.0002514501,0.011522061,0.004699528,0.00021628015,0.0028303429],"genre_scores_gemma":[0.96124244,0.002975306,0.0050769397,0.0014927698,0.00033068506,0.01798719,0.0047357543,0.00007778789,0.0060811215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991703,0.00055850216,0.00002352914,0.0000863476,0.00008172764,0.00007959365],"domain_scores_gemma":[0.999193,0.00014919454,0.0002136453,0.00006113765,0.000046726163,0.00033633006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019428104,0.001261866,0.0019068288,0.00040875733,0.00028735033,0.0007953297,0.0009701345,0.00093379855,0.0048029306],"category_scores_gemma":[0.0012885169,0.0004947287,0.0012050018,0.00040074668,0.0007022046,0.0003876237,0.0004560022,0.0014100994,0.0008208887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9059044,0.013537382,0.0037594177,0.0014546853,0.0016104665,0.00012795294,0.00010711217,0.0014157664,0.022616569,0.00028026602,0.0035869263,0.04559903],"study_design_scores_gemma":[0.89712554,0.09267044,0.005307307,0.000030444717,0.0004759381,0.000110190456,0.000013772486,0.0005743316,0.0010914975,0.00012970193,0.0024527905,0.000018077575],"about_ca_topic_score_codex":0.0012171187,"about_ca_topic_score_gemma":0.0037088734,"teacher_disagreement_score":0.0048029306,"about_ca_system_score_codex":0.0010866936,"about_ca_system_score_gemma":0.0018007212,"threshold_uncertainty_score":0.016067445},"labels":[],"label_agreement":null},{"id":"W3048948367","doi":"10.1093/neuonc/noaa192","title":"Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Radiosurgery; Medicine; Neurocognitive; Appropriate Use Criteria; Asymptomatic; Stereotactic biopsy; Whole brain radiotherapy; Appropriateness criteria; Radiation therapy; Medical physics; Oncology; Brain metastasis; Internal medicine; Radiology; Cancer; Cognition; Biopsy; Metastasis; Psychiatry","score_opus":0.05265641195152338,"score_gpt":0.31557431487638454,"score_spread":0.26291790292486117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048948367","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014970558,0.44497055,0.007987812,0.2539332,0.08067225,0.032854285,0.11076966,0.0005748088,0.06674034],"genre_scores_gemma":[0.018049056,0.52458966,0.045362692,0.14281237,0.041542027,0.09499659,0.09899869,0.0010137456,0.032635286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93199515,0.022811636,0.030044071,0.0020730465,0.01141744,0.001658543],"domain_scores_gemma":[0.751778,0.08594656,0.059992373,0.0039985897,0.09096001,0.0073245666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0779189,0.00275427,0.0075334096,0.012445363,0.0018442728,0.0074459864,0.007425543,0.008500529,0.03780485],"category_scores_gemma":[0.20905259,0.0018387608,0.007397137,0.013487208,0.0012338908,0.004447915,0.0044647967,0.0059765214,0.017478101],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042212688,0.00004258133,0.0008165081,0.09270714,0.00063857174,0.00007472073,0.000135063,0.0003246685,0.00017629402,0.0015333038,0.79554087,0.10758804],"study_design_scores_gemma":[0.000886244,0.0001830872,0.0048840838,0.26623604,0.0019029119,0.00014167487,0.0001927368,0.00023909859,0.00029427896,0.0029947972,0.7219283,0.00011666711],"about_ca_topic_score_codex":0.008544816,"about_ca_topic_score_gemma":0.01092309,"teacher_disagreement_score":0.0779189,"about_ca_system_score_codex":0.006719774,"about_ca_system_score_gemma":0.031666998,"threshold_uncertainty_score":0.41207945},"labels":[],"label_agreement":null},{"id":"W3094720086","doi":"10.1093/neuonc/noaa251","title":"A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Brain Tumour Charity; Cancer Research UK","keywords":"Missense mutation; Epidermal growth factor receptor; Biology; Cancer research; Glioma; DNA methylation; Methylation; Mutation; Pathology; Gene; Genetics; Medicine; Cancer; Gene expression","score_opus":0.032568848816974416,"score_gpt":0.29872848756955706,"score_spread":0.26615963875258264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094720086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980331,0.0002839037,0.0008599107,0.000013817907,0.000001714517,0.00001088854,0.0003369616,0.000025843428,0.00043387667],"genre_scores_gemma":[0.9977241,0.00032751472,0.00080748886,0.000015885173,0.000006387549,0.000017626298,0.0009557724,0.000012526841,0.00013261811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998665,0.000010468834,0.000014094721,0.000037383874,0.00003823677,0.000033273758],"domain_scores_gemma":[0.9996001,0.00003578348,0.0002380049,0.00003163394,0.000042467396,0.000052050556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011491813,0.00032654536,0.00027377543,0.0005798211,0.00019441845,0.00032967216,0.00021158153,0.00015143925,0.0010190672],"category_scores_gemma":[0.00041585276,0.00011045677,0.00018277553,0.0004856965,0.00020317148,0.00015493525,0.0002744149,0.00015729372,0.0002838471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038184278,0.000030622865,0.81738514,0.00015279093,0.00009013213,0.0060545737,0.00037647106,0.00023544561,0.15310957,0.00024944518,0.00037668133,0.021557178],"study_design_scores_gemma":[0.000010299062,0.00020210935,0.91236514,0.000012398811,0.00007243017,0.062483076,0.00034905065,0.00037616273,0.022132454,0.0001856431,0.0018026647,0.000008653066],"about_ca_topic_score_codex":0.0008683702,"about_ca_topic_score_gemma":0.0019793191,"teacher_disagreement_score":0.0010190672,"about_ca_system_score_codex":0.00021603015,"about_ca_system_score_gemma":0.0002485889,"threshold_uncertainty_score":0.0034090877},"labels":[],"label_agreement":null},{"id":"W3095696354","doi":"10.1093/neuonc/noaa248","title":"Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Brain Tumor Society","keywords":"Genome-wide association study; Biology; Single-nucleotide polymorphism; Genetics; Computational biology; Linkage disequilibrium; Epigenomics; 1000 Genomes Project; Genetic association; Gene; DNA methylation; Gene expression; Genotype","score_opus":0.03183574458150139,"score_gpt":0.2637381451802909,"score_spread":0.23190240059878947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095696354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879671,0.00018887939,0.009432511,0.000056364366,0.0000041429985,0.000011472967,0.0015716527,0.00024290463,0.0005250093],"genre_scores_gemma":[0.9949425,0.00006129007,0.0034665798,0.000013372926,0.0000023016535,0.000009658879,0.0013605651,0.000022814334,0.00012100845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985945,0.000026048483,0.0000119740935,0.000049226317,0.000032176136,0.000021133003],"domain_scores_gemma":[0.9995716,0.00023885944,0.00008304412,0.000032741646,0.000041689484,0.000031967546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033923064,0.00033138506,0.00023896898,0.00060700846,0.00020276297,0.000290929,0.00031447364,0.00025606502,0.0026659602],"category_scores_gemma":[0.0010632018,0.00012361245,0.000498925,0.00059378176,0.0001853572,0.000117900534,0.00019328264,0.00026380713,0.00033252625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022817291,0.00018406141,0.5712893,0.0005764415,0.0006190924,0.0008831115,0.00023408876,0.064332224,0.29679367,0.0022294277,0.0012600119,0.059316862],"study_design_scores_gemma":[0.00013162791,0.0003902339,0.621761,0.00003527916,0.00062616164,0.00093363586,0.00013452185,0.27626428,0.09199257,0.0043434626,0.003343673,0.00004360206],"about_ca_topic_score_codex":0.0042160405,"about_ca_topic_score_gemma":0.0055087227,"teacher_disagreement_score":0.0042160405,"about_ca_system_score_codex":0.00038779725,"about_ca_system_score_gemma":0.00035352484,"threshold_uncertainty_score":0.008918524},"labels":[],"label_agreement":null},{"id":"W3096194200","doi":"10.1093/neuonc/noaa217","title":"Intellectual changes after radiation for children with brain tumors: which brain structures are most important?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Neurocognitive; Neuropsychology; Intelligence quotient; Temporal lobe; Medicine; Cognition; Nuclear medicine; Pediatrics; Psychology; Audiology; Psychiatry; Epilepsy","score_opus":0.01621154194445419,"score_gpt":0.27352011426073003,"score_spread":0.25730857231627585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096194200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998026,0.0012235529,0.00006999451,0.000097729986,0.00000391462,0.000005491524,0.00025680076,0.0000042185648,0.00031234368],"genre_scores_gemma":[0.999062,0.0004567567,0.0001299333,0.000022645247,0.000012124827,0.0000047745593,0.00024809406,0.0000020592056,0.000061571904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995993,0.00008926087,0.00004603919,0.0000683477,0.00011398537,0.0000830682],"domain_scores_gemma":[0.9972492,0.00045297065,0.0019440739,0.000047302758,0.00016569262,0.00014075513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006297661,0.00040674114,0.0003457557,0.00078829814,0.00020455506,0.0005174557,0.0003796666,0.00025657163,0.00089751463],"category_scores_gemma":[0.0032431276,0.00009210387,0.0004862255,0.0009468438,0.000504642,0.00037378582,0.00038435255,0.00045901595,0.00012975685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005817011,0.000008752507,0.9969199,0.000017679064,0.000026189035,0.00012987945,0.0000388056,0.00005037796,0.00007722774,0.000007589182,0.000035600544,0.0026297115],"study_design_scores_gemma":[0.000002641815,0.00008299453,0.9986242,0.000013242007,0.00003396322,0.00076825573,0.00011165461,0.000059636306,0.0001562706,0.000015972271,0.00012933362,0.000001933263],"about_ca_topic_score_codex":0.007821052,"about_ca_topic_score_gemma":0.009272782,"teacher_disagreement_score":0.007821052,"about_ca_system_score_codex":0.00075636513,"about_ca_system_score_gemma":0.0008267644,"threshold_uncertainty_score":0.015551031},"labels":[],"label_agreement":null},{"id":"W3110384303","doi":"10.1093/neuonc/noaa267","title":"The genetic landscape of choroid plexus tumors in children and adults","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"Deutsche Forschungsgemeinschaft; Canada Foundation for Innovation","keywords":"Choroid plexus; Medicine; Anatomy; Biology; Neuroscience; Central nervous system","score_opus":0.009779667837681867,"score_gpt":0.25099615971349176,"score_spread":0.2412164918758099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110384303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801636,0.000712389,0.000086444605,0.000058476176,0.0000017786098,0.000004991637,0.00038004824,0.0000067049623,0.00073275744],"genre_scores_gemma":[0.9983234,0.00071011233,0.00027464848,0.000030047795,0.000005576484,0.000008628194,0.00050301204,0.000006571688,0.00013805676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979705,0.000027725413,0.000014965627,0.000061829225,0.000048643098,0.00004974376],"domain_scores_gemma":[0.99963593,0.00007869529,0.0001587124,0.000010322536,0.000042738702,0.000073509356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016881927,0.00021029092,0.00020243977,0.00083751685,0.00035547928,0.00040613575,0.00015227837,0.0002602713,0.0012525968],"category_scores_gemma":[0.0008890307,0.00012034744,0.000120682664,0.0007658059,0.00032474406,0.00024022175,0.00033149158,0.000203211,0.00018357091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002501952,0.000011810278,0.97611064,0.000041251886,0.000031769396,0.0029668943,0.00050221715,0.0001722902,0.008442676,0.000113980626,0.00036569964,0.010990572],"study_design_scores_gemma":[0.000005546463,0.000103745624,0.9846394,0.000024652018,0.000033692613,0.011116926,0.00084411347,0.00014306919,0.0011250329,0.00014415005,0.0018137665,0.000005994858],"about_ca_topic_score_codex":0.0045800903,"about_ca_topic_score_gemma":0.0044363756,"teacher_disagreement_score":0.0045800903,"about_ca_system_score_codex":0.0004400346,"about_ca_system_score_gemma":0.00031725946,"threshold_uncertainty_score":0.009106815},"labels":[],"label_agreement":null},{"id":"W3110657713","doi":"10.1093/neuonc/noaa222.260","title":"GCT-42. CLINICAL CHARACTERISTICS OF LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) PATIENTS ENROLLED ON ACNS1123 WITH RELAPSE: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germ cell tumors; Cog; Internal medicine; Radiation therapy; Oncology; Cohort; Chemotherapy; Gastroenterology; Surgery","score_opus":0.018251379089733247,"score_gpt":0.28532887929849005,"score_spread":0.2670775002087568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110657713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892384,0.00014238205,0.000016352891,0.00003257931,0.00000469839,0.000027019067,0.00044157734,0.0000030383842,0.00040850465],"genre_scores_gemma":[0.99869484,0.00003552106,0.000039567054,0.000051045365,0.00000742291,0.000028979366,0.00096635486,0.0000021885905,0.00017413756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997937,0.00004924947,0.000016319125,0.000052319403,0.000037437556,0.00005100819],"domain_scores_gemma":[0.9993673,0.0000888281,0.00018664724,0.000044872297,0.000044794826,0.00026755163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005626563,0.0001947123,0.00046152668,0.00024222313,0.00031655518,0.000437515,0.0002806433,0.0004164508,0.0017311976],"category_scores_gemma":[0.00085536134,0.00014982812,0.0004011195,0.0005110333,0.00021871286,0.00034991716,0.00020784128,0.0004934488,0.000291752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010992284,0.00053687603,0.975759,0.000037464048,0.00012373805,0.00018904073,0.00012292541,0.00026842262,0.0022845457,0.000039322123,0.0009434637,0.008702871],"study_design_scores_gemma":[0.00078969,0.004980747,0.9920536,0.00000729537,0.00006563022,0.00047203992,0.00008713692,0.0002516461,0.00020272465,0.00003651768,0.0010464641,0.000006354372],"about_ca_topic_score_codex":0.0027923656,"about_ca_topic_score_gemma":0.005803949,"teacher_disagreement_score":0.0027923656,"about_ca_system_score_codex":0.0005628483,"about_ca_system_score_gemma":0.0004271246,"threshold_uncertainty_score":0.0057914257},"labels":[],"label_agreement":null},{"id":"W3110717943","doi":"10.1093/neuonc/noaa222.720","title":"RARE-09. PRESERVATION OF ENDOCRINE FUNCTION AFTER OMMAYA RESERVOIR INSERTION IN CHILDREN WITH CYSTIC CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Endocrine system; Medicine; Craniopharyngioma; Surgery; Neurocognitive; Ommaya reservoir; Hormone; Internal medicine; Chemotherapy; Cognition","score_opus":0.016895088617275105,"score_gpt":0.2588533310370583,"score_spread":0.24195824241978323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110717943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988104,0.00025963088,0.000069927235,0.0000310992,0.000004138946,0.0000037563682,0.0001618595,0.0000068521604,0.0006523072],"genre_scores_gemma":[0.9996444,0.00008608501,0.0000765813,0.000011372139,0.0000059481936,0.0000029885584,0.00010724627,0.0000014608892,0.00006388626],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997595,0.000028648063,0.000030023886,0.000045267883,0.0000476206,0.00008887914],"domain_scores_gemma":[0.99896514,0.00022794401,0.0005501438,0.000034440898,0.00005242967,0.00016985805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002192967,0.0001481307,0.00015678549,0.00051374343,0.00038782737,0.00038348694,0.00018569455,0.000246491,0.0018092428],"category_scores_gemma":[0.0012600962,0.000096687945,0.00020201209,0.0003928452,0.0003891911,0.00028901233,0.0002354737,0.0002970831,0.00021746935],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007025094,0.000014809405,0.9853566,0.000018368239,0.000007656898,0.010079259,0.00007284572,0.0000431437,0.00084739993,0.000056149376,0.00013322111,0.0033003483],"study_design_scores_gemma":[0.000009755629,0.00024839977,0.8801471,0.00002147132,0.000028527464,0.11642399,0.00041799142,0.00019701096,0.0016093159,0.00007756078,0.000812728,0.0000060984457],"about_ca_topic_score_codex":0.002329607,"about_ca_topic_score_gemma":0.0026708015,"teacher_disagreement_score":0.002329607,"about_ca_system_score_codex":0.0004547366,"about_ca_system_score_gemma":0.00046390935,"threshold_uncertainty_score":0.006052494},"labels":[],"label_agreement":null},{"id":"W3110733681","doi":"10.1093/neuonc/noaa222.220","title":"ETMR-17. SINGLE-CELL TRANSCRIPTOME ANALYSIS OF ETMR PATIENT SAMPLES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University; University of Toronto; Montreal Children's Hospital","funders":"","keywords":"Biology; Phenotype; Transcriptome; Genetic heterogeneity; Cell; Computational biology; Single-cell analysis; Brain tumor; Cell type; Population; Bioinformatics; Cancer research; Neuroscience; Genetics; Gene; Pathology; Gene expression; Medicine","score_opus":0.034501752884138565,"score_gpt":0.25017401069717216,"score_spread":0.2156722578130336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110733681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559425,0.00045352985,0.006174165,0.00017441732,0.00002758733,0.00004535301,0.036089372,0.00036622095,0.0007267756],"genre_scores_gemma":[0.8838253,0.000354547,0.018076794,0.00018803614,0.000024436718,0.00018945616,0.096192434,0.00014832316,0.0010005737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997781,0.000031241034,0.000022034708,0.000100521305,0.000038793092,0.000029395545],"domain_scores_gemma":[0.9996517,0.00013133581,0.00005239705,0.000057199297,0.00006953235,0.00003786138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040216075,0.00028484364,0.00036058592,0.00042450466,0.0002724537,0.00048481653,0.00026555214,0.0004502913,0.0014735346],"category_scores_gemma":[0.00081439497,0.00013577507,0.000530641,0.0005238426,0.00020554477,0.00013651037,0.0003171624,0.00038195623,0.0010095369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023176468,0.00035370866,0.4147143,0.0007854774,0.00056191615,0.0049862126,0.0010996959,0.025195647,0.43788615,0.0009736589,0.01687985,0.09424573],"study_design_scores_gemma":[0.00013134438,0.0007007235,0.76070994,0.000094231924,0.00030377012,0.010291623,0.0014487254,0.08475249,0.10867617,0.0016355267,0.031153986,0.00010140548],"about_ca_topic_score_codex":0.0015745958,"about_ca_topic_score_gemma":0.002052322,"teacher_disagreement_score":0.0015745958,"about_ca_system_score_codex":0.00024570824,"about_ca_system_score_gemma":0.00026495152,"threshold_uncertainty_score":0.004929483},"labels":[],"label_agreement":null},{"id":"W3110760136","doi":"10.1093/neuonc/noaa222.225","title":"ETMR-22. TITLE: DEFINING THE CLINICAL AND PROGNOSTIC LANDSCAPE OF EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRs), A RARE BRAIN TUMOR REGISTRY (RBTC) STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Disease; Internal medicine; Cohort; Oncology; Multivariate analysis; Cerebrum; Radiation therapy; Pediatrics; Pathology; Gastroenterology; Central nervous system","score_opus":0.04325438688759634,"score_gpt":0.3404604411401131,"score_spread":0.2972060542525167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110760136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773645,0.00018284167,0.0001589459,0.00004151155,0.0000031532397,0.000013551811,0.0013956109,0.000006481737,0.00046140532],"genre_scores_gemma":[0.9977677,0.000073365685,0.00015137144,0.000024482844,0.000008119992,0.000009538517,0.001730278,0.0000051652123,0.00022998112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953675,0.00013672511,0.00006966951,0.00013228266,0.000074628304,0.000050008126],"domain_scores_gemma":[0.9981086,0.00033461713,0.0007416686,0.0002770063,0.00021765978,0.0003204393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370881,0.0001409027,0.00019514778,0.00044667438,0.0002520406,0.00065470254,0.00037704184,0.0002404947,0.0018413679],"category_scores_gemma":[0.002518979,0.00015121818,0.00022413002,0.00064749515,0.00019973083,0.0005008987,0.00062203425,0.00030470567,0.00041984458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000426874,0.000024098228,0.99377877,0.000019435383,0.00005594164,0.000462312,0.00010772159,0.00008906576,0.0012648517,0.000053857948,0.00033961935,0.0033775151],"study_design_scores_gemma":[0.000028235021,0.00023057009,0.9942123,0.000011224498,0.00006186823,0.0029287196,0.00022065976,0.0003060748,0.0006090392,0.00004589369,0.0013393906,0.0000059056283],"about_ca_topic_score_codex":0.0018030145,"about_ca_topic_score_gemma":0.0034476472,"teacher_disagreement_score":0.0018413679,"about_ca_system_score_codex":0.00026019636,"about_ca_system_score_gemma":0.00034543592,"threshold_uncertainty_score":0.006159961},"labels":[],"label_agreement":null},{"id":"W3110770353","doi":"10.1093/neuonc/noaa222.374","title":"IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; CancerCare Manitoba; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Immune system; Oncology; Internal medicine; Immunotherapy; Brain tumor; Immune checkpoint; Cancer research; Immunology; Pathology","score_opus":0.05623190931796352,"score_gpt":0.3499459876646465,"score_spread":0.293714078346683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110770353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717987,0.00007128255,0.00011731677,0.00003098294,0.0000029466862,0.000024672278,0.002012849,0.0000125622255,0.00054737926],"genre_scores_gemma":[0.99640346,0.000058079237,0.00012766306,0.000029142979,0.00000605274,0.0000377789,0.0031991096,0.000010958172,0.0001276683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907994,0.00024424976,0.000077829034,0.00032523915,0.00014049567,0.00013222624],"domain_scores_gemma":[0.9975024,0.00020694622,0.0009579103,0.0005699209,0.00027791705,0.0004849345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011321154,0.00037648084,0.00045784152,0.0009525402,0.00068191026,0.0010646608,0.00057281024,0.00034546736,0.0015762878],"category_scores_gemma":[0.0021923,0.0002660821,0.00038470628,0.0014249635,0.00032872276,0.0004933839,0.00086488633,0.0004739223,0.00064848445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024534474,0.0000541623,0.9970214,0.000009599673,0.00006029215,0.00037885754,0.00009293153,0.00005084216,0.00042104736,0.00003142081,0.0004346901,0.0011994712],"study_design_scores_gemma":[0.000061986204,0.00032708686,0.99428576,0.000010485551,0.00010947493,0.0028804964,0.00043744704,0.0003730607,0.0006457094,0.00004476615,0.00080926437,0.000014418004],"about_ca_topic_score_codex":0.0040089316,"about_ca_topic_score_gemma":0.0048183375,"teacher_disagreement_score":0.0040089316,"about_ca_system_score_codex":0.0004427181,"about_ca_system_score_gemma":0.0007257468,"threshold_uncertainty_score":0.007971168},"labels":[],"label_agreement":null},{"id":"W3110825381","doi":"10.1093/neuonc/noaa222.842","title":"TBIO-15. MODELING DEVELOPMENTAL GENE EXPRESSION DYNAMICS AT CELLULAR RESOLUTION TO INTERPRET PEDIATRIC BRAIN TUMOR TRANSCRIPTIONAL PROGRAMS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University; Jewish General Hospital","funders":"","keywords":"Carcinogenesis; Biology; Gene; Transcriptome; Gene expression; Forebrain; Transcription factor; Gene regulatory network; Computational biology; Developmental biology; PAX6; Neuroscience; Genetics; Central nervous system","score_opus":0.02414728527735468,"score_gpt":0.24033658465005223,"score_spread":0.21618929937269754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110825381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6028845,0.0013275594,0.31753612,0.00053991954,0.00015296596,0.00014011213,0.05378541,0.0142107345,0.009422738],"genre_scores_gemma":[0.7950823,0.0013174573,0.16171426,0.00020763942,0.000058154248,0.0004065142,0.03544573,0.0010142789,0.004753651],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99993396,0.000009246689,0.000002785674,0.000024252551,0.000017116641,0.000012587915],"domain_scores_gemma":[0.9998703,0.00005724368,0.000021449086,0.000015053915,0.000017509941,0.000018464472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028213867,0.0005049124,0.0004253162,0.000520153,0.00021533095,0.0005712841,0.00063052133,0.0005689456,0.0033433947],"category_scores_gemma":[0.00041200063,0.00027038067,0.000729053,0.0005341692,0.0002954271,0.00016752553,0.00029523481,0.00045204,0.00059837836],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003673392,0.00015008736,0.023102993,0.00048614162,0.00016570323,0.00018775239,0.00019826104,0.8476768,0.08614891,0.0064506233,0.007796409,0.027268933],"study_design_scores_gemma":[0.0000147349365,0.00004746427,0.006204528,0.000011865163,0.000016761933,0.00005238756,0.000040631265,0.97688234,0.009385674,0.0022942037,0.005034535,0.000014777294],"about_ca_topic_score_codex":0.0115051875,"about_ca_topic_score_gemma":0.01923195,"teacher_disagreement_score":0.0115051875,"about_ca_system_score_codex":0.00068372063,"about_ca_system_score_gemma":0.0007793568,"threshold_uncertainty_score":0.022876441},"labels":[],"label_agreement":null},{"id":"W3110829851","doi":"10.1093/neuonc/noaa215.893","title":"TAMI-04. TUMOR TREATING FIELDS (TTFIELDS) HINDER GLIOMA CELL MOTILITY THROUGH REGULATION OF MICROTUBULE AND ACTIN DYNAMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Motility; Glioma; Microtubule; Cancer research; Medicine; Biology; Cell biology","score_opus":0.032807958249309786,"score_gpt":0.27625128274327443,"score_spread":0.24344332449396464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110829851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343635,0.0038324618,0.003614447,0.0004849125,0.00014426089,0.0001373822,0.0016130767,0.00042061543,0.0063164895],"genre_scores_gemma":[0.98903066,0.0017698187,0.0031137227,0.00017400653,0.000014523746,0.00015993555,0.0017370726,0.000030813408,0.003969368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995077,0.0000055190685,0.0000031080103,0.000008988566,0.000014352215,0.000017365386],"domain_scores_gemma":[0.9999696,0.0000042564907,0.000008348012,0.0000022505683,0.00000459214,0.000010900785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082648105,0.0003149546,0.00025227666,0.00018449425,0.00016912023,0.00020897052,0.00020104383,0.00024803585,0.0033844975],"category_scores_gemma":[0.00007474145,0.00009742307,0.00027411184,0.00018196138,0.00012536836,0.00013992118,0.000099839446,0.0005074104,0.00051924743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012191723,0.000275527,0.0005601321,0.00032152128,0.00002771101,0.0001034225,0.000029813018,0.00071958714,0.97613406,0.000560674,0.0018436975,0.018204685],"study_design_scores_gemma":[0.00041981234,0.0036880053,0.005651391,0.000019546364,0.0000883968,0.00034853938,0.00005302562,0.0050822785,0.96684843,0.00023890959,0.017546555,0.000015184388],"about_ca_topic_score_codex":0.0010782516,"about_ca_topic_score_gemma":0.002076061,"teacher_disagreement_score":0.0033844975,"about_ca_system_score_codex":0.00029894494,"about_ca_system_score_gemma":0.00047367119,"threshold_uncertainty_score":0.01132226},"labels":[],"label_agreement":null},{"id":"W3110837854","doi":"10.1093/neuonc/noaa222.698","title":"QOL-40. THE IMPACT OF TASK COMPLEXITY ON INFORMATION PROCESSING SPEED AND NEURAL COMMUNICATION IN PAEDIATRIC BRAIN TUMOUR SURVIVORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Magnetoencephalography; Cognition; Audiology; Task (project management); Neuroimaging; Neuroscience; Medicine; Electroencephalography; Psychology","score_opus":0.03996061775644011,"score_gpt":0.3214333546548075,"score_spread":0.2814727368983674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110837854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985586,0.00015366105,0.000063734624,0.000025753649,0.0000038255625,0.000012875505,0.00044529667,0.0000070717183,0.00072923873],"genre_scores_gemma":[0.9986706,0.000088314504,0.00015358701,0.000010475407,0.0000018590675,0.000028464872,0.00051057804,0.000003729956,0.0005324416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995339,0.00008276664,0.00006616287,0.000070237904,0.00016070825,0.00008629142],"domain_scores_gemma":[0.9980421,0.00040449697,0.00091851124,0.000079001475,0.00020141226,0.00035440124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005729585,0.00038362975,0.00032931182,0.00048629876,0.00022830829,0.00067617337,0.0002901235,0.00023090397,0.0047014705],"category_scores_gemma":[0.003948746,0.00013455185,0.00058878044,0.0004336381,0.0002572018,0.0003403573,0.0006700155,0.00058420375,0.00035019664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035749885,0.00020858808,0.97526574,0.000106487816,0.00021353299,0.00019257257,0.0005763117,0.0004818786,0.0012751708,0.000082355866,0.00067220844,0.020567577],"study_design_scores_gemma":[0.000005134229,0.00022139463,0.9986085,0.000009972069,0.000021849595,0.00014480723,0.0001738194,0.00022396186,0.00015303768,0.000042278658,0.0003886833,0.0000066351377],"about_ca_topic_score_codex":0.002757608,"about_ca_topic_score_gemma":0.0022962212,"teacher_disagreement_score":0.0047014705,"about_ca_system_score_codex":0.00040623895,"about_ca_system_score_gemma":0.00030362056,"threshold_uncertainty_score":0.015727997},"labels":[],"label_agreement":null},{"id":"W3110859485","doi":"10.1093/neuonc/noaa215.897","title":"TAMI-08. A TALE OF TWO TELOMERE MAINTENANCE MECHANISMS: TERT EXPRESSION AND THE ALT PATHWAY INDUCE UNIQUE MRS-DETECTABLE METABOLIC REPROGRAMMING IN LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Telomere; Biology; Cancer research; Glutaminase; Alanine; Enzyme; Glutamine; Cell biology; Biochemistry; Amino acid; DNA","score_opus":0.015243252125043946,"score_gpt":0.2864258164013784,"score_spread":0.2711825642763344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110859485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862155,0.001884638,0.005112913,0.0006171919,0.00031957185,0.00009848599,0.0008233605,0.00045690214,0.004471471],"genre_scores_gemma":[0.985076,0.0009877403,0.003997679,0.00039221428,0.000028571212,0.00012909021,0.001250997,0.000114648035,0.008023031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998915,0.0000134001175,0.0000081651215,0.000024665303,0.00002080766,0.000041269086],"domain_scores_gemma":[0.9999083,0.000009284128,0.00002322415,0.00001140598,0.000009208251,0.000038548904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013491465,0.00034512748,0.00030744923,0.0001558884,0.000141439,0.0003385152,0.00024002006,0.00040056012,0.0033140713],"category_scores_gemma":[0.00013375108,0.00015065903,0.00034261943,0.00013216819,0.00020389477,0.00023129245,0.00023009961,0.0008461831,0.0008302412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000526534,0.000088618166,0.00022188593,0.00007933202,0.000017235358,0.00013674807,0.00002321592,0.0000359203,0.99409544,0.00027927003,0.00037630583,0.004119544],"study_design_scores_gemma":[0.00010890227,0.0020914192,0.0036342188,0.000015680856,0.00006894796,0.000773533,0.00008269164,0.0008118026,0.98054093,0.00024581933,0.011614321,0.000011703833],"about_ca_topic_score_codex":0.000287378,"about_ca_topic_score_gemma":0.00045858053,"teacher_disagreement_score":0.0033140713,"about_ca_system_score_codex":0.00018058073,"about_ca_system_score_gemma":0.0002429575,"threshold_uncertainty_score":0.011086702},"labels":[],"label_agreement":null},{"id":"W3110870249","doi":"10.1093/neuonc/noaa215.556","title":"NCOG-17. PREDICTORS OF SURVIVAL IN ELDERLY PATIENTS UNDERGOING SURGERY FOR GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Survival analysis; Pathological; Surgery; Complication; Internal medicine","score_opus":0.04135882310759069,"score_gpt":0.29462501824749154,"score_spread":0.25326619513990084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110870249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763615,0.0022498125,0.00015068456,0.00038890887,0.00007185876,0.00001535914,0.007568461,0.000026721526,0.0018921613],"genre_scores_gemma":[0.99427515,0.0005625937,0.00020570934,0.00010521886,0.000055124878,0.00002120805,0.0042282203,0.000009100563,0.00053764606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997254,0.000043588083,0.00005667176,0.000048148602,0.000058315123,0.00006783122],"domain_scores_gemma":[0.9964528,0.0004549673,0.0021345546,0.000079586986,0.00032344542,0.00055454357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004745726,0.00015614634,0.00025947893,0.00077225297,0.00023983317,0.00058247626,0.0002614467,0.00023957377,0.004821272],"category_scores_gemma":[0.0028659047,0.000087886256,0.0003444742,0.0017736178,0.00017297584,0.0003282699,0.00042897533,0.00050600735,0.0005041134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007711719,0.0000069122166,0.9977986,0.000026397076,0.000024280402,0.00003435609,0.000011491617,0.00002563421,0.000032134936,0.000010696462,0.0005309511,0.0014212695],"study_design_scores_gemma":[0.000008345075,0.000037178477,0.9981907,0.00002617662,0.000043844488,0.00023038292,0.000078288744,0.00012988437,0.00004188357,0.000051769886,0.0011588034,0.0000026723815],"about_ca_topic_score_codex":0.0035915305,"about_ca_topic_score_gemma":0.004910154,"teacher_disagreement_score":0.004821272,"about_ca_system_score_codex":0.00030294422,"about_ca_system_score_gemma":0.00076148653,"threshold_uncertainty_score":0.016128778},"labels":[],"label_agreement":null},{"id":"W3110871843","doi":"10.1093/neuonc/noaa215.933","title":"TAMI-46. TNFα SECRETED BY GLIOMA ASSOCIATED MACROPHAGES PROMOTES ENDOTHELIAL ACTIVATION AND RESISTANCE AGAINST ANTI-ANGIOGENIC THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Glioma; Tumor necrosis factor alpha; Cancer research; In vivo; Bone marrow; Downregulation and upregulation; Tumor microenvironment; Secretion; Immunology; Population; Medicine; Angiogenesis; Macrophage; Biology; In vitro; Internal medicine; Tumor cells","score_opus":0.015041356225327323,"score_gpt":0.24827636085161295,"score_spread":0.23323500462628563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110871843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943098,0.0021641788,0.0013307141,0.00019123095,0.00009929431,0.000059837406,0.00022201973,0.00007460448,0.0015482052],"genre_scores_gemma":[0.99599874,0.0007018376,0.0008387213,0.00009452542,0.000023609076,0.000056900506,0.00026968133,0.000008048611,0.002008019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.00002644211,0.00001458332,0.000018932462,0.000022567214,0.000053445106],"domain_scores_gemma":[0.9999349,0.0000068856,0.000015393045,0.00000816937,0.000006771742,0.000027828102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015439886,0.00022399395,0.00031332416,0.00012107537,0.000104764425,0.00028034218,0.00011583713,0.0002332953,0.0014238905],"category_scores_gemma":[0.000068653586,0.00008392174,0.0002577099,0.00010485368,0.00014440714,0.00013818727,0.00012893236,0.00077678764,0.00045576753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010476717,0.00043162276,0.0004990334,0.00007326454,0.0000122998745,0.00012192458,0.000029671617,0.0000793691,0.9933656,0.00011507646,0.00020315543,0.0040213997],"study_design_scores_gemma":[0.00025049128,0.005436281,0.0062762043,0.000018026121,0.000047160996,0.0008363884,0.000067519904,0.0013723049,0.97907275,0.00010293828,0.0065137376,0.000006215099],"about_ca_topic_score_codex":0.00017672627,"about_ca_topic_score_gemma":0.00020897492,"teacher_disagreement_score":0.0014238905,"about_ca_system_score_codex":0.000119163604,"about_ca_system_score_gemma":0.00018399007,"threshold_uncertainty_score":0.0047634244},"labels":[],"label_agreement":null},{"id":"W3110887690","doi":"10.1093/neuonc/noaa222.659","title":"PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Brain tumor; CDKN2A; Atypical teratoid rhabdoid tumor; Germline; PTCH1; Oncology; Internal medicine; Glioma; Astrocytoma; Medicine; Biology; Cancer research; Pathology; Bioinformatics; Cancer; Sonic hedgehog; Genetics; Gene","score_opus":0.02333542339404392,"score_gpt":0.29091927068363543,"score_spread":0.2675838472895915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110887690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987347,0.0020561195,0.00047088007,0.00056704425,0.000075546726,0.00050901703,0.007073579,0.00003632201,0.0018644094],"genre_scores_gemma":[0.9830566,0.00070441683,0.0014481703,0.0005176992,0.00006333231,0.0012929034,0.011633002,0.000035040124,0.0012489324],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990336,0.00047448493,0.00006581203,0.00018587362,0.0001404476,0.000099769655],"domain_scores_gemma":[0.99887735,0.00032140655,0.00031079625,0.00014564031,0.000089539455,0.00025527418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027146318,0.00040608775,0.0009588109,0.00023479798,0.00026200764,0.0011382592,0.00037687816,0.0004953083,0.0019734616],"category_scores_gemma":[0.0022205873,0.00017111066,0.00093205634,0.00045206066,0.00033862962,0.00052505505,0.00030194683,0.0012147236,0.0003001255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4825028,0.0030516507,0.29004663,0.0012633569,0.0066799014,0.00035325895,0.00038473695,0.0058461777,0.021410694,0.0010615202,0.024636595,0.1627627],"study_design_scores_gemma":[0.17712879,0.071849585,0.6877468,0.0003259269,0.0065493546,0.001220061,0.00036594726,0.010738498,0.013165467,0.002176497,0.028591562,0.0001414363],"about_ca_topic_score_codex":0.0011672304,"about_ca_topic_score_gemma":0.0037056066,"teacher_disagreement_score":0.0027146318,"about_ca_system_score_codex":0.0007082272,"about_ca_system_score_gemma":0.0010854304,"threshold_uncertainty_score":0.014356554},"labels":[],"label_agreement":null},{"id":"W3110910606","doi":"10.1093/neuonc/noaa222.222","title":"ETMR-19. SINGLE CELL ANALYSES OF ETMRs REVEAL THAT C19MC+ POPULATION DRIVES CELL CYCLE PROGRESSION AND STEM CELL MAINTENANCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Stem cell; Population; Wnt signaling pathway; Biology; Cell; Cell cycle; Cell biology; Cancer research; Cell growth; Signal transduction; Genetics; Medicine","score_opus":0.028804015157162677,"score_gpt":0.30006083684240664,"score_spread":0.27125682168524395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110910606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507101,0.00087592105,0.021967355,0.00014455552,0.00005948279,0.00012239472,0.01980747,0.0006831286,0.00562951],"genre_scores_gemma":[0.94072527,0.000492086,0.022349428,0.00019059578,0.000014851026,0.00021616,0.02174179,0.00035338255,0.013916473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997985,0.000010321626,0.0000148639065,0.00008422912,0.00006016215,0.000031880652],"domain_scores_gemma":[0.99980253,0.000036417052,0.000037385398,0.000035427332,0.000039082537,0.00004917777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002167988,0.00021728427,0.00021210751,0.0003008876,0.00036158937,0.0003579804,0.00021109589,0.00025970713,0.0039299214],"category_scores_gemma":[0.00018610612,0.00014626466,0.0002809311,0.00026867594,0.00020192083,0.00016429603,0.00027320127,0.0005672105,0.0014396653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054084656,0.000008504804,0.0010319398,0.00002105423,0.0000060654916,0.000048233338,0.000028256334,0.00006314398,0.99710196,0.00014567375,0.0001814186,0.0013095548],"study_design_scores_gemma":[0.000009164753,0.00011552692,0.03118098,0.000006371493,0.000014674774,0.00038078666,0.00004943761,0.0020363806,0.956694,0.00012377539,0.009379106,0.000009679567],"about_ca_topic_score_codex":0.002280426,"about_ca_topic_score_gemma":0.0041714385,"teacher_disagreement_score":0.0039299214,"about_ca_system_score_codex":0.00035634008,"about_ca_system_score_gemma":0.00019513103,"threshold_uncertainty_score":0.013146877},"labels":[],"label_agreement":null},{"id":"W3110913480","doi":"10.1093/neuonc/noaa215.242","title":"CTNI-76. PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Methyltransferase; Phases of clinical research; O-6-methylguanine-DNA methyltransferase; Internal medicine; Radiation therapy; In vivo; Oncology; Nuclear medicine; Gastroenterology; Clinical trial; Adverse effect; Biology; DNA; Methylation","score_opus":0.09570379679146818,"score_gpt":0.41866782647270745,"score_spread":0.3229640296812393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110913480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97411704,0.004972627,0.0006541181,0.0010186954,0.00045264128,0.005892837,0.0036122764,0.00040341035,0.008876357],"genre_scores_gemma":[0.9634103,0.004355941,0.0029781891,0.0013863497,0.00021075667,0.005501371,0.0064801746,0.00007321441,0.015603741],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997254,0.000096811425,0.000010615962,0.000047105736,0.00003645646,0.000083589446],"domain_scores_gemma":[0.9996007,0.00002568254,0.00005581221,0.000027111375,0.000019932004,0.00027090506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011744184,0.0026294559,0.0015444644,0.000658667,0.0004956061,0.0012419885,0.0016090262,0.0012563027,0.0047633625],"category_scores_gemma":[0.0006592344,0.00070349796,0.0008246951,0.00053166266,0.0011801858,0.0006936088,0.0004322071,0.0036386289,0.0018556702],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62516034,0.07706021,0.004196783,0.0019849378,0.0012250973,0.0008335827,0.00041333277,0.01047199,0.117169544,0.0014725465,0.01958508,0.1404265],"study_design_scores_gemma":[0.58981323,0.36994734,0.009364155,0.00013537986,0.00041712815,0.0008355506,0.000082873405,0.002997724,0.014265851,0.00047007145,0.011579825,0.00009083376],"about_ca_topic_score_codex":0.004253581,"about_ca_topic_score_gemma":0.013806625,"teacher_disagreement_score":0.0047633625,"about_ca_system_score_codex":0.0018565588,"about_ca_system_score_gemma":0.003405856,"threshold_uncertainty_score":0.015935063},"labels":[],"label_agreement":null},{"id":"W3110925972","doi":"10.1093/neuonc/noaa222.370","title":"IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Medicine; Cancer; Oncology; Germline; Internal medicine; Cancer research; Biology; Colorectal cancer; Gene; Allele; Microsatellite; Genetics","score_opus":0.01901834200951528,"score_gpt":0.27254156985053835,"score_spread":0.25352322784102305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110925972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133606,0.012239122,0.0022666736,0.0005994505,0.00007699641,0.00008490446,0.00022896391,0.000085387524,0.003082476],"genre_scores_gemma":[0.9944213,0.0023891428,0.0022233312,0.00021861696,0.000031755157,0.000037109647,0.00024771626,0.000009057601,0.0004219429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999249,0.000015642572,0.000009250503,0.000013950471,0.000015907266,0.000020298823],"domain_scores_gemma":[0.9998348,0.000024074398,0.000060551953,0.000008084295,0.000012599133,0.00005982898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015620248,0.00022905113,0.000453758,0.000272261,0.00023223311,0.00017507172,0.00017839902,0.00028089868,0.0005463358],"category_scores_gemma":[0.0003338429,0.000090682464,0.0002992418,0.00022494722,0.00021909062,0.00012891133,0.00026558278,0.0006006125,0.00017245839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048968694,0.0010979598,0.4144768,0.0015012957,0.00037623793,0.095663995,0.0009466662,0.0029451423,0.119798206,0.0022632715,0.007522413,0.34851107],"study_design_scores_gemma":[0.0009460935,0.01620746,0.59617424,0.0003569997,0.00036282834,0.25863725,0.0004592342,0.004480178,0.075308494,0.0010654796,0.045940023,0.0000616741],"about_ca_topic_score_codex":0.0005889182,"about_ca_topic_score_gemma":0.0018587329,"teacher_disagreement_score":0.0005889182,"about_ca_system_score_codex":0.0004326387,"about_ca_system_score_gemma":0.0005651766,"threshold_uncertainty_score":0.003139019},"labels":[],"label_agreement":null},{"id":"W3110928912","doi":"10.1093/neuonc/noaa222.536","title":"MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Copy-number variation; Oncology; Biomarker; Cell-free fetal DNA; Internal medicine; Prospective cohort study; Pathology; Genome; Biology; Gene; Genetics","score_opus":0.015135786449551557,"score_gpt":0.28604767331919306,"score_spread":0.2709118868696415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110928912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987998,0.0004395888,0.00022850456,0.00001546634,0.0000029236714,0.000009229861,0.00034793874,0.000010835183,0.0001457264],"genre_scores_gemma":[0.9992642,0.00007343901,0.00027813084,0.000007678875,0.000003601519,0.000009712841,0.0002786159,0.0000032902315,0.000081326405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963987,0.000058889993,0.000038565202,0.000114426315,0.000085187094,0.00006301739],"domain_scores_gemma":[0.99871516,0.0002796372,0.00061223883,0.00006391349,0.00014178311,0.00018737321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075938035,0.00024267018,0.0003778711,0.0008729168,0.00028512132,0.00064788247,0.00032816353,0.00029137006,0.00090926],"category_scores_gemma":[0.0021983406,0.000115927076,0.000260416,0.0005595674,0.0002716245,0.0003380044,0.00037747217,0.00025635376,0.0001508672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066138495,0.000028344155,0.98614997,0.000019243049,0.000044645443,0.0001435261,0.00006318199,0.00018311315,0.0080250595,0.000025374966,0.00008145864,0.0045747417],"study_design_scores_gemma":[0.000014150219,0.0004470669,0.9924845,0.000009321184,0.00005882361,0.0009771043,0.000098170945,0.000807719,0.0044975695,0.00005346862,0.0005466781,0.00000532017],"about_ca_topic_score_codex":0.004154099,"about_ca_topic_score_gemma":0.0032994556,"teacher_disagreement_score":0.004154099,"about_ca_system_score_codex":0.0006449085,"about_ca_system_score_gemma":0.0004248028,"threshold_uncertainty_score":0.008259833},"labels":[],"label_agreement":null},{"id":"W3110935379","doi":"10.1093/neuonc/noaa222.649","title":"PATH-14. GENETIC SUSCEPTIBILITY AND OUTCOMES OF PEDIATRIC, ADOLESCENT AND YOUNG ADULT IDH-MUTANT ASTROCYTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"ATRX; Medicine; Oncology; Internal medicine; Germline; IDH1; Mutation; Cancer; Young adult; Cancer research; Gene; Biology; Genetics","score_opus":0.019508112615464698,"score_gpt":0.2788905089600257,"score_spread":0.259382396344561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110935379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996233,0.000056370278,0.000026809415,0.000006223892,8.3528715e-7,0.000002190408,0.00013364526,0.0000021841877,0.00014844765],"genre_scores_gemma":[0.99962795,0.000029847084,0.000048222213,0.0000052304617,0.000002055942,0.000003359892,0.00021544159,0.0000015312918,0.00006639622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998252,0.000027349548,0.000022840353,0.000044485085,0.000036079306,0.000044045213],"domain_scores_gemma":[0.99917006,0.00009772153,0.00044181698,0.000032725966,0.00008018455,0.00017753552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025924004,0.00014473453,0.00018074781,0.00066169456,0.00025123396,0.00034597036,0.00013582104,0.0001683104,0.0015809933],"category_scores_gemma":[0.00099219,0.00009803665,0.00012714726,0.0004373288,0.00021144701,0.00022647064,0.00027940745,0.00015929664,0.00031906454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004722124,0.000008588595,0.99786794,0.0000032927514,0.00000837668,0.0003349933,0.0000262706,0.000024430863,0.00044093226,0.000009532773,0.00003871281,0.001189713],"study_design_scores_gemma":[0.0000027585834,0.00009300162,0.99644864,0.0000032637809,0.000007547501,0.0028056696,0.00012574719,0.00007546498,0.00027895547,0.000021904165,0.0001359689,0.0000010450709],"about_ca_topic_score_codex":0.0017860366,"about_ca_topic_score_gemma":0.0025809803,"teacher_disagreement_score":0.0017860366,"about_ca_system_score_codex":0.00028825473,"about_ca_system_score_gemma":0.00028844635,"threshold_uncertainty_score":0.005288899},"labels":[],"label_agreement":null},{"id":"W3110936563","doi":"10.1093/neuonc/noaa222.133","title":"EPCT-09. CLR 131 IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC MALIGNANCIES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Medulloblastoma; Adverse effect; Population; Internal medicine; Oncology; Nuclear medicine; Pathology","score_opus":0.02203706713411252,"score_gpt":0.26577358251702043,"score_spread":0.24373651538290791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110936563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548777,0.021505045,0.00085181114,0.0019593504,0.00011333179,0.00046052752,0.0032818438,0.00030793677,0.016642476],"genre_scores_gemma":[0.983824,0.006908793,0.0016545728,0.0013138972,0.00012846026,0.00020972053,0.0039411937,0.000050114515,0.0019692255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998634,0.00004626035,0.000010767897,0.000027070439,0.000026877378,0.000025754538],"domain_scores_gemma":[0.9996797,0.0000701593,0.00009726138,0.000014101633,0.000023840583,0.00011502027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037282903,0.00020689242,0.0005514496,0.00019472491,0.0001613043,0.00037795305,0.00025556135,0.00031262357,0.0035665773],"category_scores_gemma":[0.00049379654,0.00009696568,0.0002964759,0.0003993926,0.00022884418,0.00030918466,0.00018111891,0.00067847135,0.0007020098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022115605,0.0018136117,0.44775695,0.0014345249,0.00039721318,0.009916436,0.00045619393,0.0025707316,0.025533017,0.0009013718,0.04224742,0.4448569],"study_design_scores_gemma":[0.014360677,0.04293763,0.74264264,0.00080813095,0.0009461858,0.041007053,0.0005288424,0.005452115,0.018412702,0.0011307985,0.13170105,0.00007217563],"about_ca_topic_score_codex":0.0015635681,"about_ca_topic_score_gemma":0.004188375,"teacher_disagreement_score":0.0035665773,"about_ca_system_score_codex":0.0006389962,"about_ca_system_score_gemma":0.00074903126,"threshold_uncertainty_score":0.01193136},"labels":[],"label_agreement":null},{"id":"W3110946424","doi":"10.1093/neuonc/noaa222.433","title":"LGG-55. OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; Glioma; CDKN2A; Discontinuation; V600E; Concomitant; Cancer; Cancer research; Mutation","score_opus":0.0283945740418875,"score_gpt":0.2858317490018318,"score_spread":0.2574371749599443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110946424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939,0.00015356578,0.00003919415,0.000017316315,0.0000015078423,0.0000036411311,0.0001663509,0.0000033525314,0.00022500234],"genre_scores_gemma":[0.99953365,0.000047709385,0.000024693938,0.000011882636,0.0000022696972,0.000003999926,0.0003328288,0.0000013216976,0.000041632553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997985,0.000051582738,0.000015649846,0.000038004342,0.000035635378,0.000060759732],"domain_scores_gemma":[0.9994715,0.00007370411,0.00026070094,0.000019457295,0.00004153883,0.00013312101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023243074,0.00012849382,0.00024384703,0.00023789596,0.00017771717,0.0002906944,0.00010435524,0.00013269669,0.00044896113],"category_scores_gemma":[0.0007022952,0.00007047066,0.00021022177,0.00030283537,0.00022793852,0.0001706118,0.00022807112,0.0002528305,0.00013088468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008615935,0.00006310407,0.9884803,0.000016235037,0.0000728756,0.000789223,0.000109829394,0.00028409928,0.0014744649,0.00003181007,0.00031697738,0.0074994173],"study_design_scores_gemma":[0.00003557045,0.0013088047,0.99456316,0.000008484694,0.00005706395,0.0020246531,0.00016573892,0.0002553449,0.0009419063,0.000030147741,0.0006046403,0.0000045069437],"about_ca_topic_score_codex":0.002645178,"about_ca_topic_score_gemma":0.0031678125,"teacher_disagreement_score":0.002645178,"about_ca_system_score_codex":0.0005875312,"about_ca_system_score_gemma":0.00025359774,"threshold_uncertainty_score":0.0052595735},"labels":[],"label_agreement":null},{"id":"W3110951180","doi":"10.1093/neuonc/noaa222.736","title":"RARE-25. RETINAL ASTROCYTOMA mTOR INHIBITOR THERAPY IN TUBEROUS SCLEROSIS MOSAICISM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Tuberous sclerosis; Medicine; Retinal; Everolimus; Retina; mTORC1; Enucleation; Ophthalmology; Pathology; PI3K/AKT/mTOR pathway; Internal medicine; Surgery; Neuroscience; Psychology; Biology","score_opus":0.08722362094705445,"score_gpt":0.3218538980837035,"score_spread":0.23463027713664908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110951180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8955869,0.025771312,0.0044501107,0.0050752745,0.0003333114,0.00019381903,0.00095177506,0.0011992548,0.06643828],"genre_scores_gemma":[0.9918389,0.0017602772,0.0011657324,0.0005644301,0.00011018291,0.000021368793,0.00021244794,0.000027894199,0.0042988453],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9999063,0.000011734872,0.0000120122395,0.00001799636,0.000020124853,0.00003174301],"domain_scores_gemma":[0.99982834,0.000028148728,0.00005910147,0.000011500111,0.0000145951535,0.000058307498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104238476,0.00030361244,0.00028289773,0.00045593808,0.00042951363,0.00028771302,0.00023790028,0.0006779501,0.002671189],"category_scores_gemma":[0.0003390782,0.00008431889,0.0002975783,0.00023250718,0.00037314088,0.00019857727,0.00021952597,0.0005519823,0.00087355037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041958436,0.0001227274,0.029369172,0.00030456946,0.000048726743,0.8813234,0.00012871007,0.00046216208,0.024692502,0.0018158121,0.0036009667,0.05771169],"study_design_scores_gemma":[0.000030805044,0.00032282746,0.014654265,0.00005046063,0.00002425752,0.97246414,0.00004369882,0.00032308555,0.0038577926,0.00042919605,0.0077904994,0.000008964976],"about_ca_topic_score_codex":0.0012877684,"about_ca_topic_score_gemma":0.0023177841,"teacher_disagreement_score":0.002671189,"about_ca_system_score_codex":0.0004384531,"about_ca_system_score_gemma":0.00031830955,"threshold_uncertainty_score":0.008935988},"labels":[],"label_agreement":null},{"id":"W3110951411","doi":"10.1093/neuonc/noaa215.344","title":"EPID-26. CLINICAL AND HISTOLOGICAL CHARACTERIZATION OF PRIMARY CENTRAL NERVOUS SYSTEM SARCOMA IN PEDIATRICS. A SINGLE INSTITUTION EXPERIENCE IN A MIDDLE-INCOME COUNTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Sarcoma; Vomiting; Radiation therapy; Central nervous system; Surgery; Pathology; Internal medicine","score_opus":0.07430441565403519,"score_gpt":0.3303386264161332,"score_spread":0.25603421076209804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110951411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825805,0.00043238583,0.00016166666,0.000024198862,0.0000047870244,0.000029961247,0.0002692085,0.000011437505,0.0008083102],"genre_scores_gemma":[0.99892175,0.00031201553,0.00028271604,0.000017280001,0.0000052420664,0.000012303319,0.00029927705,0.000004881835,0.00014456437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995431,0.000087734414,0.00007809834,0.000105555046,0.0000819057,0.00010376863],"domain_scores_gemma":[0.99904877,0.000110668574,0.00035161112,0.00005360102,0.00009815619,0.00033723452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042210086,0.00035691552,0.00024886188,0.0015248909,0.0004740287,0.0006871458,0.00031668137,0.0002527312,0.0014982881],"category_scores_gemma":[0.0013766559,0.00026083447,0.00020779869,0.0010998123,0.00040511685,0.00035580783,0.0006664606,0.000247679,0.00050420663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032430773,0.00003757747,0.98828006,0.000026506486,0.000007149155,0.0053226477,0.0002063655,0.000032501954,0.00076305674,0.000015735592,0.00012055965,0.005155417],"study_design_scores_gemma":[0.000007852812,0.00025009684,0.95095426,0.000037047303,0.000015955455,0.04518776,0.001249614,0.00016598904,0.00093035883,0.000022289016,0.001170258,0.000008540013],"about_ca_topic_score_codex":0.004240836,"about_ca_topic_score_gemma":0.006749013,"teacher_disagreement_score":0.004240836,"about_ca_system_score_codex":0.0007629069,"about_ca_system_score_gemma":0.00084647984,"threshold_uncertainty_score":0.008432329},"labels":[],"label_agreement":null},{"id":"W3111018425","doi":"10.1093/neuonc/noaa215.240","title":"CTNI-74. PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE +/- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Oncology; Internal medicine; Clinical endpoint; Radiation therapy; Clinical trial; Surgery","score_opus":0.030551676510782676,"score_gpt":0.32373109012069323,"score_spread":0.29317941360991057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111018425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96813524,0.009934079,0.00073615706,0.0014497804,0.00065686245,0.0042698076,0.0038936927,0.00036837682,0.010556006],"genre_scores_gemma":[0.9616314,0.0053871577,0.003412177,0.0021841691,0.0005032956,0.0059215347,0.008342281,0.00013334831,0.012484606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99961096,0.00017316289,0.000016930642,0.000069504655,0.00004078684,0.00008866911],"domain_scores_gemma":[0.9995253,0.0000412642,0.00010294787,0.000035982524,0.000028991462,0.00026560752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012364998,0.0015109061,0.001738885,0.00059346884,0.0005155221,0.0012482634,0.0012375672,0.0010086318,0.0052253157],"category_scores_gemma":[0.0007348655,0.00036320812,0.0015109106,0.0005178973,0.00093806814,0.0007147183,0.0003397739,0.0025804008,0.0011371667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8867316,0.014256523,0.001899892,0.0011898504,0.001306648,0.00014350981,0.00009876697,0.0024250213,0.011342447,0.0007466195,0.012531881,0.06732725],"study_design_scores_gemma":[0.75797766,0.21830723,0.007430331,0.00018008877,0.0012632741,0.00027773963,0.000066699155,0.0022588915,0.0026799545,0.000788743,0.008698692,0.00007067074],"about_ca_topic_score_codex":0.0057901284,"about_ca_topic_score_gemma":0.016499097,"teacher_disagreement_score":0.0057901284,"about_ca_system_score_codex":0.0021539459,"about_ca_system_score_gemma":0.0026548353,"threshold_uncertainty_score":0.017480493},"labels":[],"label_agreement":null},{"id":"W3111018487","doi":"10.1093/neuonc/noaa215.283","title":"EPCO-04. GENOMIC AND EPIGENOMIC HALLMARKS OF SCHWANNOMATOSIS SCHWANNOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenomics; Biology; Epigenetics; Genetics; Loss of heterozygosity; SMARCB1; DNA methylation; Germline mutation; Germline; Gene; Mutation; Computational biology; Allele; Gene expression","score_opus":0.031506055309047154,"score_gpt":0.2780110550293171,"score_spread":0.24650499972026996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111018487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890788,0.0010246199,0.0015658737,0.00014689451,0.000020650677,0.000036313853,0.0013655984,0.00008482303,0.006676533],"genre_scores_gemma":[0.9947798,0.00030303164,0.0012172062,0.00007271635,0.000012738145,0.00002310607,0.0014368418,0.000017879387,0.0021366768],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998543,0.000010884715,0.000014523607,0.000040001545,0.000046066092,0.000034190834],"domain_scores_gemma":[0.99966884,0.000057023863,0.00010916151,0.000028236129,0.000054554606,0.000082196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011603071,0.00026646364,0.0001487793,0.00086060626,0.00023324792,0.00034347826,0.00020394726,0.0003339696,0.0043263803],"category_scores_gemma":[0.00039742122,0.00008764062,0.00012131657,0.0005319321,0.00025345897,0.00019162304,0.00025930654,0.00024482078,0.0006718609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089732354,0.00012558645,0.18430068,0.0002458922,0.00007920865,0.033869676,0.00017100782,0.00041665178,0.7440682,0.0009086524,0.0012579635,0.033659168],"study_design_scores_gemma":[0.000040776886,0.00033694986,0.77023786,0.00005164251,0.00011302838,0.09211756,0.00029062148,0.0015582574,0.120132275,0.0010633472,0.014039183,0.00001850569],"about_ca_topic_score_codex":0.00058374647,"about_ca_topic_score_gemma":0.0009920629,"teacher_disagreement_score":0.0043263803,"about_ca_system_score_codex":0.00019776664,"about_ca_system_score_gemma":0.00019627789,"threshold_uncertainty_score":0.01447314},"labels":[],"label_agreement":null},{"id":"W3111041338","doi":"10.1093/neuonc/noaa222.528","title":"MBRS-10. QUIESCENT SOX9-POSITIVE CELLS BEHIND MYC DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Retinoblastoma; Cancer research; Medicine; Doxycycline; Primary tumor; Oncology; Metastasis; Biology; Cancer; Internal medicine; Gene","score_opus":0.017397230178970286,"score_gpt":0.26104375845985306,"score_spread":0.24364652828088276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111041338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962627,0.00050412107,0.0012043396,0.000043363354,0.000013828035,0.000021559645,0.00048663918,0.000100714125,0.0013628643],"genre_scores_gemma":[0.996725,0.00011596222,0.0005129156,0.000015115723,0.000004336083,0.0000130260205,0.00033496192,0.000012422382,0.002266392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989486,0.000011833069,0.000007852452,0.000026109645,0.000027200944,0.000032139065],"domain_scores_gemma":[0.9998596,0.000021421301,0.000039579518,0.000017754921,0.000014675684,0.00004703493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077808305,0.0001406187,0.00018982436,0.00018624583,0.00014757621,0.00026642505,0.00013103292,0.00021179568,0.0020830361],"category_scores_gemma":[0.00008457481,0.00010346131,0.00013577366,0.00009251125,0.0001891169,0.00012895129,0.00013813522,0.00043064044,0.00061427284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091224276,0.000019341995,0.000829065,0.000010472354,0.0000017367879,0.00010279673,0.000014902737,0.000024745652,0.9981311,0.00010255966,0.000042025662,0.0006299905],"study_design_scores_gemma":[0.00001750395,0.00056626304,0.031514578,0.000007289874,0.00001272938,0.0010430438,0.00008526103,0.0015410676,0.961842,0.00010438225,0.0032611212,0.000004714922],"about_ca_topic_score_codex":0.001505471,"about_ca_topic_score_gemma":0.0014635196,"teacher_disagreement_score":0.0020830361,"about_ca_system_score_codex":0.00033721147,"about_ca_system_score_gemma":0.00014711959,"threshold_uncertainty_score":0.0069684386},"labels":[],"label_agreement":null},{"id":"W3111049071","doi":"10.1093/neuonc/noaa215.585","title":"NCOG-47. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université Laval; University of Alberta; University of British Columbia; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Neurocognitive; Surgery; Radiation therapy; Retrospective cohort study; Pathology","score_opus":0.03528585428673552,"score_gpt":0.2649763907668616,"score_spread":0.22969053648012605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111049071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94736564,0.023032006,0.00042439593,0.004595583,0.00024031026,0.000073316,0.0023995403,0.0001225961,0.021746585],"genre_scores_gemma":[0.98820996,0.0070440136,0.0005293419,0.00062495656,0.00015426619,0.00004501792,0.0020290571,0.000020792733,0.0013426208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990284,0.000016350476,0.000008884667,0.00001337328,0.000017231263,0.00004116472],"domain_scores_gemma":[0.9995597,0.00005221724,0.00018310697,0.000009160091,0.000040603434,0.00015510326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016274402,0.00010134763,0.00023014261,0.00020863269,0.00019008481,0.00035667606,0.00027472823,0.00028913384,0.0024976018],"category_scores_gemma":[0.0008512853,0.000047486614,0.00020992813,0.00033930794,0.00018012724,0.00024948857,0.00014567841,0.00028376296,0.0004392626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011428188,0.00014828301,0.799227,0.0003771993,0.00006755849,0.003878115,0.00021954847,0.00033761305,0.0023473129,0.0003750662,0.0139805265,0.17789912],"study_design_scores_gemma":[0.00013882095,0.0009193263,0.95330584,0.0005965367,0.0001516088,0.010454655,0.00078878965,0.00038748607,0.0016371986,0.00050327816,0.031101156,0.000015351818],"about_ca_topic_score_codex":0.0063125216,"about_ca_topic_score_gemma":0.01476233,"teacher_disagreement_score":0.0063125216,"about_ca_system_score_codex":0.00075421017,"about_ca_system_score_gemma":0.00089970784,"threshold_uncertainty_score":0.012551546},"labels":[],"label_agreement":null},{"id":"W3111053470","doi":"10.1093/neuonc/noaa215.852","title":"SURG-05. IDEAL TREATMENT REGIMEN FOR PATIENTS WITH ≥1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Meta-analysis; Randomized controlled trial; Oncology; Brain metastasis; non-small cell lung cancer (NSCLC); Regimen; Cancer; Metastasis","score_opus":0.061050671977176375,"score_gpt":0.34625990714207094,"score_spread":0.28520923516489455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111053470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009938806,0.9842301,0.0011821797,0.000599171,0.00043135267,0.0008843982,0.0017510433,0.00007967473,0.0009031849],"genre_scores_gemma":[0.44885707,0.53675467,0.005261026,0.0023546934,0.00058488216,0.002753601,0.0023844203,0.00009179877,0.0009578463],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99398583,0.0031923992,0.0014445486,0.00065290387,0.0005649305,0.00015940494],"domain_scores_gemma":[0.9935703,0.0042505194,0.001322162,0.00020083919,0.00046840752,0.00018767497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00905318,0.0020023983,0.014993923,0.0053688213,0.00047546707,0.0026428995,0.001933336,0.0021914407,0.0075177248],"category_scores_gemma":[0.016837649,0.0010789427,0.034001186,0.004475957,0.0005898747,0.0018341813,0.0011735499,0.0018631393,0.0005522936],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053498135,0.000052719653,0.002775828,0.3797492,0.5928076,0.00007021057,0.0000661503,0.000682449,0.00016831141,0.00025315836,0.00093141495,0.017093142],"study_design_scores_gemma":[0.003957402,0.0004600365,0.003051593,0.021446215,0.9675339,0.000075869975,0.000049557046,0.00047169233,0.00008493065,0.00053678383,0.0023002087,0.000031833963],"about_ca_topic_score_codex":0.0043706223,"about_ca_topic_score_gemma":0.008540251,"teacher_disagreement_score":0.014993923,"about_ca_system_score_codex":0.0022914296,"about_ca_system_score_gemma":0.0019628634,"threshold_uncertainty_score":0.047878385},"labels":[],"label_agreement":null},{"id":"W3111053964","doi":"10.1093/neuonc/noaa222.722","title":"RARE-11. QUANTITATIVE MR IMAGING FEATURES ASSOCIATED WITH UNIQUE TRANSCRIPTIONAL CHARACTERISTICS IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA: A POTENTIAL GUIDE FOR THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Craniopharyngioma; Wnt signaling pathway; Cyst; Biology; Computational biology; Medicine; Bioinformatics; Gene; Pathology; Genetics; Endocrinology","score_opus":0.021370407560067087,"score_gpt":0.2878212856003791,"score_spread":0.26645087804031203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111053964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336611,0.0041484805,0.048154615,0.0023043046,0.00005534486,0.00012978047,0.006269726,0.0006542607,0.0046224175],"genre_scores_gemma":[0.9505464,0.000816924,0.044848118,0.00014042456,0.000042576703,0.00009809489,0.0024339228,0.0000809298,0.0009925078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979824,0.00005131571,0.0000216318,0.000059099297,0.000042893716,0.000026934718],"domain_scores_gemma":[0.9995505,0.00013262744,0.0001647898,0.000030040406,0.000068354464,0.000053601456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000800999,0.00038857013,0.0003145477,0.0010900326,0.0002470698,0.0006034822,0.00033456233,0.00023240835,0.0019640923],"category_scores_gemma":[0.0013411075,0.00014022984,0.0003324746,0.00060800405,0.0002834574,0.0002330143,0.00024353986,0.00041958672,0.0004034458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000713515,0.00014595466,0.64504844,0.00031040993,0.00019064837,0.0010367157,0.00025784888,0.0048131384,0.17127219,0.0020810068,0.0043072486,0.16982286],"study_design_scores_gemma":[0.000069531074,0.0005069374,0.91026074,0.00016089495,0.00023389656,0.0065506115,0.0006794057,0.026619662,0.032543156,0.0054101255,0.016897757,0.00006739099],"about_ca_topic_score_codex":0.0012718962,"about_ca_topic_score_gemma":0.0029212711,"teacher_disagreement_score":0.0019640923,"about_ca_system_score_codex":0.00051543664,"about_ca_system_score_gemma":0.00041858834,"threshold_uncertainty_score":0.006570518},"labels":[],"label_agreement":null},{"id":"W3111083929","doi":"10.1093/neuonc/noaa215.225","title":"CTNI-59. FIRST SAFETY ANALYSIS OF ANAPLASTIC MENINGIOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meningioma; Adverse effect; Oncology; Internal medicine; Lung cancer; Cancer; Surgery","score_opus":0.015087921792601372,"score_gpt":0.2582071799256962,"score_spread":0.24311925813309482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111083929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96193564,0.008822911,0.00084604684,0.00048768907,0.00010370337,0.00067070394,0.013334534,0.00014501027,0.013653814],"genre_scores_gemma":[0.98126054,0.001985715,0.0008129858,0.0006452873,0.00011390713,0.00035751204,0.012590624,0.00003226784,0.0022010894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999199,0.00016675411,0.000112384725,0.000155582,0.00029196957,0.00007426406],"domain_scores_gemma":[0.9978637,0.00031871453,0.0011013383,0.00012578523,0.00025779393,0.00033277186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010358123,0.00024474005,0.000621561,0.0004305444,0.00033699858,0.0007227507,0.00025200742,0.00033640282,0.0031052746],"category_scores_gemma":[0.0020031559,0.00011410823,0.0008476413,0.00052013685,0.00028310035,0.00031368254,0.00027092593,0.00090946746,0.0006723647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09384182,0.0031486584,0.5658815,0.0027233495,0.002127561,0.0016311486,0.00042498132,0.0014056648,0.045315064,0.0007556492,0.019990256,0.26275432],"study_design_scores_gemma":[0.006358549,0.06488662,0.836823,0.00058163237,0.0022421263,0.005759218,0.0002100008,0.0018563292,0.023953676,0.0006459208,0.056596745,0.000086182336],"about_ca_topic_score_codex":0.0012712472,"about_ca_topic_score_gemma":0.0025895687,"teacher_disagreement_score":0.0031052746,"about_ca_system_score_codex":0.0010723217,"about_ca_system_score_gemma":0.0010753246,"threshold_uncertainty_score":0.0103881955},"labels":[],"label_agreement":null},{"id":"W3111092241","doi":"10.1093/neuonc/noaa222.192","title":"EPID-06. DIAGNOSTIC INTERVAL TIME OF PEDIATRIC CNS TUMORS: A REPORT OF THE CANCER IN YOUNG PEOPLE IN CANADA (CYP-C) DATABASE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; C17 Council; BC Children's Hospital; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Demographics; Cohort; Atypical teratoid rhabdoid tumor; Pediatrics; Confidence interval; Cancer; Database; Internal medicine; Pathology; Demography","score_opus":0.019209281843366066,"score_gpt":0.2803934093081584,"score_spread":0.26118412746479236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111092241","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03544928,0.00094075256,0.00026819375,0.00028147368,0.000022441413,0.00018398369,0.9587043,0.00013096048,0.0040185754],"genre_scores_gemma":[0.19949782,0.0023682334,0.0016275665,0.00036394174,0.000046850208,0.0005012909,0.79342574,0.000094566756,0.0020739255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981331,0.00010656121,0.00028212508,0.0003796933,0.00072090037,0.00037761274],"domain_scores_gemma":[0.99015754,0.00062504277,0.0019615113,0.0003856607,0.0060219476,0.0008482776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011118593,0.0006303774,0.0010034316,0.005142784,0.0015870814,0.0018657207,0.0014175511,0.0004343155,0.006639471],"category_scores_gemma":[0.008443044,0.00046479638,0.000808099,0.016112842,0.00038089335,0.00048232003,0.00085510133,0.00077417644,0.0011535886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006626558,0.000055496344,0.7350923,0.001599967,0.0005111566,0.00023767815,0.00049869105,0.0010309662,0.00020868935,0.0010122271,0.24249938,0.016590703],"study_design_scores_gemma":[0.00016099097,0.000033921515,0.9374702,0.00053465966,0.00021591409,0.00028111698,0.0005143324,0.0011218593,0.00026380105,0.00016785222,0.059179895,0.00005545175],"about_ca_topic_score_codex":0.98035586,"about_ca_topic_score_gemma":0.98204803,"teacher_disagreement_score":0.024584517,"about_ca_system_score_codex":0.024584517,"about_ca_system_score_gemma":0.034617707,"threshold_uncertainty_score":0.17837399},"labels":[],"label_agreement":null},{"id":"W3111131691","doi":"10.1093/neuonc/noaa215.543","title":"NCOG-04. PRETREATMENT VOLUME OF MR-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS NEUROCOGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT+MEMANTINE FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGYCC001","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; University of Saskatchewan","funders":"","keywords":"Memantine; Medicine; Neurocognitive; Boston Naming Test; Cohort; Post-hoc analysis; Trail Making Test; Internal medicine; Oncology; Nuclear medicine; Dementia; Cognition; Psychiatry; Cognitive impairment","score_opus":0.01886071845245987,"score_gpt":0.308536920879403,"score_spread":0.28967620242694314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111131691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918132,0.00021027541,0.00016050824,0.000045952136,0.00001355621,0.00035695307,0.0060775676,0.000028615636,0.0012933188],"genre_scores_gemma":[0.99084306,0.000044226177,0.00025265937,0.000073491894,0.0000149372645,0.00041712463,0.007262385,0.000012995295,0.0010792457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999438,0.00020444216,0.00005376236,0.000119768854,0.00011230371,0.00007174713],"domain_scores_gemma":[0.99900275,0.00015129121,0.00037037974,0.00014498325,0.00012883253,0.00020180637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010676867,0.0004023801,0.00058737275,0.00036382413,0.0002702536,0.00032379964,0.00058564515,0.00022967768,0.0035115634],"category_scores_gemma":[0.0015561138,0.00012574848,0.00058304786,0.0005435308,0.00023065996,0.00024172619,0.00029875204,0.00045165172,0.00061809685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057270054,0.0014274936,0.9079391,0.00018952817,0.0010387531,0.00015624591,0.00006813579,0.00057845534,0.006311798,0.00008907277,0.0045902357,0.020341072],"study_design_scores_gemma":[0.0021785123,0.009547283,0.9832122,0.000013622955,0.00036984976,0.00024934913,0.00003959785,0.00060790457,0.0016600796,0.00007477614,0.0020380758,0.000008708678],"about_ca_topic_score_codex":0.0054655666,"about_ca_topic_score_gemma":0.011019582,"teacher_disagreement_score":0.0054655666,"about_ca_system_score_codex":0.00066223403,"about_ca_system_score_gemma":0.00071094406,"threshold_uncertainty_score":0.01174742},"labels":[],"label_agreement":null},{"id":"W3111132783","doi":"10.1093/neuonc/noaa215.816","title":"RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Clinical trial; Medicine; Clinical endpoint; Agile software development; Glioblastoma; Medical physics; Oncology; Internal medicine; Computer science; Cancer research","score_opus":0.4516531105571223,"score_gpt":0.5440306338959288,"score_spread":0.09237752333880644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111132783","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195323,0.011199407,0.0076691583,0.009843728,0.0019146928,0.010473122,0.009997775,0.0012595885,0.028110217],"genre_scores_gemma":[0.9442723,0.004119051,0.011222876,0.00850262,0.00054431526,0.009991171,0.007954238,0.00024549424,0.01314799],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990087,0.0006616618,0.000033165983,0.00011320886,0.000083270716,0.00010003241],"domain_scores_gemma":[0.9991316,0.00021848232,0.00015085255,0.000084761064,0.00008604003,0.00032826216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034530463,0.0009891315,0.0009276753,0.00041307267,0.000398839,0.0010836672,0.0005037325,0.0009485404,0.006222678],"category_scores_gemma":[0.0020658397,0.0002546988,0.0014774265,0.00038171577,0.0008121146,0.00090039603,0.00078695134,0.0036583252,0.0009658668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5304109,0.02558044,0.005968095,0.002340781,0.0024199085,0.00032903344,0.00035972142,0.0075570205,0.0154409325,0.005457052,0.070405036,0.33373109],"study_design_scores_gemma":[0.7186317,0.21395433,0.01044627,0.0006021345,0.001257545,0.00044156358,0.00021247215,0.00754567,0.005089683,0.005015771,0.036694616,0.00010820672],"about_ca_topic_score_codex":0.000880032,"about_ca_topic_score_gemma":0.0019466607,"teacher_disagreement_score":0.006222678,"about_ca_system_score_codex":0.0008625786,"about_ca_system_score_gemma":0.0016343218,"threshold_uncertainty_score":0.020816863},"labels":[],"label_agreement":null},{"id":"W3111168043","doi":"10.1093/neuonc/noaa215.649","title":"NIMG-36. AUTOMATIC STRATIFICATION OF ENHANCING AND NON-ENHANCING GLIOMAS INTO GENETIC SUBTYPES USING DEEP NEURAL NETWORKS AND DIFFUSION-WEIGHTED IMAGING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fluid-attenuated inversion recovery; Nuclear medicine; Medicine; Wild type; Magnetic resonance imaging; Mutant; Radiology; Biology; Genetics; Gene","score_opus":0.008937830575716326,"score_gpt":0.2789556554477138,"score_spread":0.27001782487199744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111168043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32665914,0.0076722917,0.2503817,0.0028620868,0.0017086111,0.0032986822,0.13694333,0.24807529,0.022398878],"genre_scores_gemma":[0.45090735,0.0013571436,0.31175932,0.0013808483,0.00021844631,0.0023284813,0.1940214,0.003572291,0.034454692],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99972993,0.000051451763,0.000014357517,0.00009806288,0.000055644454,0.000050536244],"domain_scores_gemma":[0.9998099,0.00002786366,0.000018743187,0.00004110072,0.000070146096,0.00003222097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074916903,0.0018016556,0.00073472725,0.0012070857,0.00039754628,0.00070242875,0.0014712317,0.0014629804,0.00804595],"category_scores_gemma":[0.0011916431,0.00057729497,0.0013299172,0.00079230004,0.00026647304,0.00043067322,0.00087635574,0.00062627567,0.0054208855],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014014952,0.0004358305,0.007568364,0.00060093775,0.0007080055,0.00048832275,0.00010110522,0.12360841,0.014399892,0.0019694034,0.23837432,0.61034393],"study_design_scores_gemma":[0.00043500582,0.0003383846,0.0070806732,0.00009455409,0.00013724384,0.00023291612,0.000051932166,0.9259271,0.01821945,0.0064909235,0.040898137,0.00009362278],"about_ca_topic_score_codex":0.039631043,"about_ca_topic_score_gemma":0.03696292,"teacher_disagreement_score":0.039631043,"about_ca_system_score_codex":0.0012107942,"about_ca_system_score_gemma":0.0014916529,"threshold_uncertainty_score":0.07880074},"labels":[],"label_agreement":null},{"id":"W3111212852","doi":"10.1093/neuonc/noaa222.445","title":"LINC-10. SIOP PODC ADAPTED TREATMENT GUIDELINES FOR CRANIOPHARYNGIOMA IN LOW- AND MIDDLE-INCOME SETTINGS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Guideline; Medicine; Radiation therapy; Multidisciplinary approach; Intensive care medicine; Pediatrics; Family medicine; Internal medicine; Surgery; Pathology","score_opus":0.07080230233917652,"score_gpt":0.33857971891781224,"score_spread":0.26777741657863574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111212852","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020458402,0.034354214,0.028706895,0.21400775,0.011114107,0.010284772,0.059729043,0.0068676067,0.6144772],"genre_scores_gemma":[0.13037857,0.09002404,0.24208325,0.122025646,0.006179772,0.019845322,0.16855994,0.00362413,0.21727937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763286,0.00080581184,0.0006211642,0.00011306211,0.000530851,0.00029622656],"domain_scores_gemma":[0.99259937,0.0012384774,0.0009410731,0.00017380167,0.0035742074,0.0014731196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002860382,0.0005379602,0.0004861305,0.0020548394,0.00072710257,0.0014465208,0.0015841374,0.0026403076,0.03165395],"category_scores_gemma":[0.010116297,0.0003046688,0.00105609,0.0014806617,0.00041046905,0.0010889687,0.0022779158,0.0028933575,0.016045738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000651199,0.00014121759,0.00453002,0.0014197461,0.000018340465,0.0011269993,0.00035571898,0.0007489699,0.00086917914,0.0029220001,0.83656144,0.1512412],"study_design_scores_gemma":[0.00006972878,0.00006088985,0.010067631,0.0048086783,0.000021595633,0.0013471404,0.00040102119,0.0003965102,0.00037908985,0.0015305334,0.9808881,0.000029056777],"about_ca_topic_score_codex":0.018066818,"about_ca_topic_score_gemma":0.027754785,"teacher_disagreement_score":0.03165395,"about_ca_system_score_codex":0.0028183267,"about_ca_system_score_gemma":0.010005986,"threshold_uncertainty_score":0.105892956},"labels":[],"label_agreement":null},{"id":"W3111229185","doi":"10.1093/neuonc/noaa222.405","title":"LGG-23. EXCELLENT CLINICAL / RADIOLOGICAL RESPONSE TO BRAF INHIBITION IN A YOUNG CHILD WITH IN-OPERABLE SUPRA-SELLAR PILOCYTIC ASTROCYTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trametinib; Pilocytic astrocytoma; Temozolomide; Oncology; Regimen; Internal medicine; Population; Lomustine; Vincristine; Dabrafenib; Chemotherapy; Vemurafenib; Glioma; Radiology; Astrocytoma; Cancer research; Cancer; Cyclophosphamide","score_opus":0.036983869973123945,"score_gpt":0.31999092182742633,"score_spread":0.2830070518543024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111229185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98467976,0.0035227237,0.0007304886,0.0034394288,0.00015520255,0.00011430546,0.0006287859,0.00013341695,0.0065958854],"genre_scores_gemma":[0.9970047,0.00085189025,0.00039588418,0.00059175945,0.00006378213,0.000013745553,0.00017291444,0.000017812528,0.00088747666],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99990284,0.000008145646,0.000009088962,0.00002666304,0.000015348605,0.00003795137],"domain_scores_gemma":[0.99971217,0.000036759677,0.000053591622,0.000008496635,0.000026609034,0.00016229125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087236804,0.0005868509,0.00050630956,0.00052979623,0.00086718326,0.00044013045,0.00033994805,0.0011600666,0.0010943],"category_scores_gemma":[0.0005442366,0.00022358769,0.0004126834,0.000310953,0.0004860061,0.00046426323,0.00032865602,0.0013786934,0.00036575733],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000720742,0.000058577756,0.024381641,0.000048250873,0.000009762791,0.969799,0.00014038237,0.000083483326,0.0024102153,0.00010345718,0.00053606863,0.0023571472],"study_design_scores_gemma":[0.000010773924,0.00043720205,0.044358898,0.000033936838,0.000022481678,0.9514955,0.00022414298,0.00026515606,0.0011736639,0.00014609317,0.0018171007,0.0000151131735],"about_ca_topic_score_codex":0.004568462,"about_ca_topic_score_gemma":0.00869934,"teacher_disagreement_score":0.004568462,"about_ca_system_score_codex":0.0010394368,"about_ca_system_score_gemma":0.00058597175,"threshold_uncertainty_score":0.009083748},"labels":[],"label_agreement":null},{"id":"W3111237371","doi":"10.1093/neuonc/noaa222.200","title":"EPID-14. GABRIELLA MILLER KIDS FIRST DATA RESOURCE CENTER: COLLABORATIVE PLATFORMS FOR ACCELERATING RESEARCH IN PEDIATRIC CANCERS &amp; STRUCTURAL BIRTH DEFECTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Interoperability; Computer science; Workflow; Cloud computing; Download; Data science; Resource (disambiguation); World Wide Web; Database","score_opus":0.5799484253499697,"score_gpt":0.5626859255386454,"score_spread":0.017262499811324328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111237371","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028323336,0.0010923253,0.009145827,0.010347527,0.00068725675,0.000947565,0.9063365,0.022807725,0.045803055],"genre_scores_gemma":[0.021641074,0.0017907136,0.052079108,0.0070831324,0.0009635213,0.0038552769,0.88137573,0.008737064,0.022474369],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940766,0.0019859246,0.0007823059,0.0011309063,0.0014368007,0.00058728276],"domain_scores_gemma":[0.95136696,0.015071525,0.0045426856,0.008854827,0.008035778,0.012128174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014224371,0.0008815011,0.0014923868,0.0052051023,0.0015013831,0.004777396,0.0036671686,0.0021207419,0.15541461],"category_scores_gemma":[0.056192163,0.001294328,0.001504271,0.0054705767,0.0007254011,0.0035767811,0.009397094,0.0030151745,0.06573758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007128525,0.00008493908,0.007840009,0.0006014255,0.000092896786,0.00011030746,0.0001915525,0.00024778052,0.00033445188,0.0047793183,0.9463747,0.038629696],"study_design_scores_gemma":[0.0012617208,0.00012887985,0.01766199,0.0009822825,0.00012993615,0.00018965606,0.00018032314,0.0008640435,0.0012417125,0.006814111,0.97044665,0.00009864275],"about_ca_topic_score_codex":0.0120803835,"about_ca_topic_score_gemma":0.01611833,"teacher_disagreement_score":0.15541461,"about_ca_system_score_codex":0.0026305828,"about_ca_system_score_gemma":0.011346582,"threshold_uncertainty_score":0.5199137},"labels":[],"label_agreement":null},{"id":"W3111276509","doi":"10.1093/neuonc/noaa215.845","title":"STEM-28. NANOPARTICLES ENCAPSULATING A CONNEXIN43 MIMETIC PEPTIDE LIMIT GLIOMA STEM CELL SURVIVAL AND GLIOBLASTOMA PROGRESSION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Glioma; Cancer research; Stem cell; Microtubule; Neurosphere; Population; Brain tumor; In vivo; In vitro; Peptide; Biology; Chemistry; Medicine; Cell biology; Pathology; Biochemistry; Adult stem cell","score_opus":0.022188707121968018,"score_gpt":0.24620447627864195,"score_spread":0.22401576915667393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111276509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477637,0.0010490386,0.002468904,0.0000688092,0.000038729027,0.000029673884,0.00011652382,0.00006034831,0.0013914538],"genre_scores_gemma":[0.9959657,0.00033259823,0.0016843897,0.000051783172,0.000007653849,0.00003489752,0.00012474133,0.000011187048,0.0017869378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991643,0.000010279363,0.000006684331,0.000021352396,0.000025841577,0.000019430809],"domain_scores_gemma":[0.99994063,0.00001375042,0.00001644384,0.000004184964,0.0000099936415,0.000014998413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011910907,0.00023889563,0.00018443551,0.0001227126,0.00008552761,0.0001902694,0.00009446063,0.0002634364,0.00087067304],"category_scores_gemma":[0.000089287074,0.000090254216,0.00013862687,0.000062122315,0.00015815395,0.00019159785,0.000118188014,0.0002614402,0.00015250433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099318844,0.00003875926,0.00013516033,0.000044085165,0.0000042445945,0.000031421,0.000015878788,0.00017254132,0.9975629,0.00008743735,0.000070929906,0.0017372178],"study_design_scores_gemma":[0.000011226759,0.0004505082,0.0011592944,0.0000034430184,0.000008701269,0.00004720178,0.000012884131,0.0015357108,0.99528164,0.000026694552,0.0014604124,0.000002309134],"about_ca_topic_score_codex":0.00053616904,"about_ca_topic_score_gemma":0.00073181256,"teacher_disagreement_score":0.00087067304,"about_ca_system_score_codex":0.00022043983,"about_ca_system_score_gemma":0.00018346313,"threshold_uncertainty_score":0.0029127002},"labels":[],"label_agreement":null},{"id":"W3111280014","doi":"10.1093/neuonc/noaa215.566","title":"NCOG-28. SURGERY FOR RECURRENT GBM IMPROVES SURVIVAL INDEPENDENT OF PROGNOSTIC FACTORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Proportional hazards model; Internal medicine; Overall survival; Oncology; Surgery; Survival analysis","score_opus":0.060201753995783744,"score_gpt":0.3158303975689967,"score_spread":0.25562864357321297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111280014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97976375,0.0048255576,0.00030790328,0.00125486,0.00018345917,0.000039145583,0.009036676,0.00016050959,0.0044280984],"genre_scores_gemma":[0.98781115,0.0011593256,0.0005217605,0.00038940163,0.00006682601,0.00004326726,0.008018892,0.000036607227,0.0019528549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973696,0.000045023095,0.000025602303,0.00006331569,0.00006872001,0.000060271865],"domain_scores_gemma":[0.9989141,0.0001441526,0.00047687386,0.000045048542,0.00012183679,0.00029799575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032700767,0.00015021465,0.00040133926,0.00030530876,0.00020392587,0.00047665447,0.00030094298,0.00019453396,0.006152785],"category_scores_gemma":[0.0015136861,0.00006945836,0.00035151216,0.000580977,0.00016287396,0.00022215102,0.000364879,0.00037685427,0.0009777863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036670365,0.0003851618,0.86206454,0.0004611102,0.00050462305,0.00021626274,0.000081894075,0.000394981,0.004907077,0.00014140921,0.020374686,0.10680114],"study_design_scores_gemma":[0.00014002048,0.0005518415,0.9898893,0.000045231525,0.00018468747,0.0003433007,0.00007346164,0.00048617108,0.00082230696,0.00022329886,0.007230521,0.000009720764],"about_ca_topic_score_codex":0.0040425216,"about_ca_topic_score_gemma":0.01064913,"teacher_disagreement_score":0.006152785,"about_ca_system_score_codex":0.00055188156,"about_ca_system_score_gemma":0.0010175019,"threshold_uncertainty_score":0.020583093},"labels":[],"label_agreement":null},{"id":"W3111311155","doi":"10.1093/neuonc/noaa222.090","title":"DIPG-43. CAN WE REPROGRAM DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)? EXPLORING THE ROLE OF DISTALLESS/DLX HOMEOBOX GENE REGULATION OF OLIGODENDROGLIAL PROGENITOR CELLS (OPC) IN THE DEVELOPING VERTEBRATE NERVOUS SYSTEM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; OLIG2; Progenitor cell; Cellular differentiation; Neurosphere; Cell biology; Neural stem cell; Cancer research; Stem cell; Oligodendrocyte; Genetics; Gene; Myelin; Adult stem cell; Neuroscience; Central nervous system","score_opus":0.03152641859133665,"score_gpt":0.2560911470825856,"score_spread":0.22456472849124898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111311155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97439843,0.010451609,0.005220455,0.0017588473,0.00017247448,0.000121647594,0.000757324,0.00060938933,0.0065098433],"genre_scores_gemma":[0.98793274,0.0039281673,0.0034009547,0.00044425266,0.000020395386,0.00004279317,0.00060141814,0.000076196906,0.0035531179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991417,0.000012477993,0.0000051203033,0.00001595363,0.000022576094,0.000029712786],"domain_scores_gemma":[0.99994814,0.0000060035677,0.000011582184,0.000008352165,0.000004730283,0.000021134332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019341188,0.00026082178,0.00019553164,0.00013015537,0.0001044293,0.00025633638,0.00022147446,0.0002953249,0.0014584791],"category_scores_gemma":[0.000091979506,0.00008637798,0.00016487543,0.00010828143,0.00021421777,0.00021658618,0.00021143391,0.0006626564,0.00067472726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014707679,0.000056737663,0.00053852424,0.00012392149,0.00001152269,0.0002451412,0.000029042008,0.00015574739,0.9849629,0.00053310726,0.0004999621,0.0126963025],"study_design_scores_gemma":[0.00008576618,0.0017481422,0.011921402,0.00004168707,0.00006564667,0.003207395,0.00017114829,0.0009432638,0.94534653,0.0006493322,0.035805948,0.000013721488],"about_ca_topic_score_codex":0.00049725024,"about_ca_topic_score_gemma":0.0011408329,"teacher_disagreement_score":0.0014584791,"about_ca_system_score_codex":0.00024095994,"about_ca_system_score_gemma":0.00014284329,"threshold_uncertainty_score":0.0048790574},"labels":[],"label_agreement":null},{"id":"W3111313584","doi":"10.1093/neuonc/noaa222.212","title":"ETMR-08. INTERNATIONAL CONSENSUS PROTOCOL FOR EMBRYONAL TUMOR WITH MULTILAYER ROSETTES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Chemotherapy; Clinical trial; Radiation therapy; Oncology; Topotecan; Protocol (science); Induction chemotherapy; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.049436311953836465,"score_gpt":0.3539403094111172,"score_spread":0.30450399745728074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111313584","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015382471,0.014308688,0.15453327,0.03408591,0.009396525,0.5948307,0.039531127,0.0038991123,0.13403232],"genre_scores_gemma":[0.03314236,0.00918865,0.27656406,0.012603144,0.0014710836,0.5924692,0.04576542,0.00085672917,0.027939327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96176857,0.022000846,0.010130727,0.00119196,0.003329668,0.0015781922],"domain_scores_gemma":[0.9319199,0.0136549845,0.008379734,0.0054526567,0.03710771,0.003485014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07975032,0.0015085873,0.0022690143,0.0051846663,0.0024450123,0.0031898983,0.007306526,0.005464761,0.025017971],"category_scores_gemma":[0.066342495,0.0016382851,0.005260014,0.0036785875,0.0019209133,0.0028868814,0.004692008,0.00607457,0.014017973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005971695,0.0011875142,0.0070814355,0.030500483,0.0006416969,0.0026620487,0.0030989428,0.0066395677,0.0073265326,0.029720431,0.6603644,0.24480532],"study_design_scores_gemma":[0.0028682726,0.0007345106,0.012130839,0.01934226,0.00032516837,0.0013718081,0.0011177041,0.0038180605,0.0043273806,0.010621682,0.943094,0.00024830678],"about_ca_topic_score_codex":0.005340165,"about_ca_topic_score_gemma":0.0056324117,"teacher_disagreement_score":0.07975032,"about_ca_system_score_codex":0.006207846,"about_ca_system_score_gemma":0.029718067,"threshold_uncertainty_score":0.42176503},"labels":[],"label_agreement":null},{"id":"W3111326672","doi":"10.1093/neuonc/noaa215.092","title":"COVD-08. THE DIVIDED PRINCIPLE OF JUSTICE: ETHICAL DECISION-MAKING IN CANCER CARE DURING THE COVID-19 PANDEMIC","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Economic Justice; 2019-20 coronavirus outbreak; Ethical decision; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Political science; Sociology; Psychology; Medicine; Virology; Law; Pathology; Infectious disease (medical specialty); Outbreak","score_opus":0.14059576891632775,"score_gpt":0.4900574272838087,"score_spread":0.34946165836748094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111326672","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029035212,0.010595625,0.034302127,0.5725435,0.0041961316,0.00026336656,0.0001750598,0.000087343746,0.3488016],"genre_scores_gemma":[0.8805845,0.0034569902,0.022927266,0.06973574,0.0016663203,0.0003805142,0.00012784598,0.00011726872,0.021003557],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.967451,0.023188846,0.0013445085,0.0016171212,0.0040694023,0.0023291318],"domain_scores_gemma":[0.97007847,0.01996214,0.0018086128,0.0020068896,0.0034517206,0.002692187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03436437,0.0003784324,0.0005732936,0.0012235502,0.0099367,0.017820923,0.0017511044,0.011534319,0.005418572],"category_scores_gemma":[0.03167094,0.00044426243,0.0008883139,0.0012879383,0.05544665,0.00710743,0.014526667,0.016668214,0.0007936561],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015325299,0.000017756594,0.000399297,0.000055564476,0.0000037903444,0.00013960678,0.0072244722,0.00026943447,0.000062697,0.9710518,0.0134486,0.0073116645],"study_design_scores_gemma":[0.000023357283,0.00003168291,0.0009153418,0.0007016557,0.000007315402,0.00035032164,0.009025609,0.0008442949,0.0002386761,0.8478449,0.1399635,0.00005336825],"about_ca_topic_score_codex":0.011658943,"about_ca_topic_score_gemma":0.015677668,"teacher_disagreement_score":0.03436437,"about_ca_system_score_codex":0.015398706,"about_ca_system_score_gemma":0.02519907,"threshold_uncertainty_score":0.18173832},"labels":[],"label_agreement":null},{"id":"W3111343982","doi":"10.1093/neuonc/noab195.011","title":"Chemotherapy strategies for young children newly diagnosed with desmoplastic/extensive nodular medulloblastoma up to the era of molecular profiling – a comparative outcomes analysis of prospective multi-center European and North American trials.","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Induction chemotherapy; Chemotherapy; Internal medicine; Clinical trial; Surgery; Pathology","score_opus":0.027636611289669263,"score_gpt":0.32327387925239115,"score_spread":0.2956372679627219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111343982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85939634,0.13636956,0.000425476,0.00033734806,0.00010319227,0.00083891005,0.0008619744,0.000018254375,0.0016490173],"genre_scores_gemma":[0.97493964,0.021812076,0.0008096391,0.00042633506,0.000104103136,0.0005879259,0.0010365718,0.0000064765627,0.00027713538],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972138,0.0018445648,0.00035079528,0.0002601073,0.00019521515,0.00013551049],"domain_scores_gemma":[0.99682295,0.0012212204,0.0013510744,0.00014695294,0.00016103184,0.000296743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00446376,0.00040645857,0.0011102839,0.0008274569,0.00019514294,0.0007220453,0.00037864115,0.00055476086,0.00086259673],"category_scores_gemma":[0.0038077738,0.00020977308,0.0019396454,0.0009915361,0.00041471602,0.0006869579,0.00033854265,0.00073609146,0.00010293433],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55257404,0.0038384357,0.07627466,0.0057205264,0.024588166,0.00025846914,0.000273309,0.003207032,0.0049340995,0.00061952986,0.0016376527,0.32607415],"study_design_scores_gemma":[0.23074755,0.38009915,0.3032055,0.0039557423,0.049525667,0.0018362941,0.00074628915,0.0019051792,0.0060395575,0.0009052561,0.02088888,0.00014499188],"about_ca_topic_score_codex":0.0010949381,"about_ca_topic_score_gemma":0.004957922,"teacher_disagreement_score":0.00446376,"about_ca_system_score_codex":0.001090366,"about_ca_system_score_gemma":0.0008591858,"threshold_uncertainty_score":0.023606896},"labels":[],"label_agreement":null},{"id":"W3111351219","doi":"10.1093/neuonc/noaa222.241","title":"GCT-21. CENTRAL NERVOUS SYSTEM GERMINOMA - PONDERING THE NEXT STEPS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Clinical trial; Intensive care medicine; Germ cell tumors; Radiation therapy; Neuroscience; Pathology; Chemotherapy; Surgery; Psychology","score_opus":0.047953098766740296,"score_gpt":0.2819145050478508,"score_spread":0.2339614062811105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111351219","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007894026,0.9035347,0.0013135285,0.05368926,0.003856958,0.00012325097,0.00067762926,0.00012985189,0.028780822],"genre_scores_gemma":[0.116773464,0.827591,0.0065544853,0.028899483,0.0040867613,0.00017050416,0.0017983936,0.00007731287,0.014048585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968004,0.00012560205,0.000042913438,0.000034061373,0.00007210704,0.00004536619],"domain_scores_gemma":[0.99878806,0.0005057213,0.00017592593,0.00004186134,0.00027488143,0.00021350452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011687058,0.00021338728,0.0005294104,0.0004746579,0.00039121724,0.0012207598,0.000463411,0.0011536792,0.011356579],"category_scores_gemma":[0.0023440244,0.00008079634,0.00054956955,0.0006006769,0.00039491785,0.0009613787,0.000427158,0.0016602696,0.0027345053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007522574,0.00018825618,0.0066093053,0.009149434,0.00015845882,0.0021333818,0.0002052703,0.00053293334,0.0026119526,0.011055174,0.102456145,0.8641475],"study_design_scores_gemma":[0.00019034075,0.0009674205,0.01225363,0.0092968745,0.00045445768,0.00953595,0.0005848409,0.00040745325,0.0025419353,0.020548906,0.94316334,0.000054849723],"about_ca_topic_score_codex":0.0018937719,"about_ca_topic_score_gemma":0.0050308164,"teacher_disagreement_score":0.011356579,"about_ca_system_score_codex":0.000654506,"about_ca_system_score_gemma":0.0021165754,"threshold_uncertainty_score":0.037991583},"labels":[],"label_agreement":null},{"id":"W3111413047","doi":"10.1093/neuonc/noaa222.453","title":"LINC-18. FOLLOW-UP EVALUATION OF A WEB-BASED PEDIATRIC BRAIN TUMOR BOARD IN LATIN AMERICA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Latin Americans; Psychological intervention; Family medicine; Institutional review board; Presentation (obstetrics); Modalities; MEDLINE; Medical physics; Medical education; Nursing; Surgery; Political science","score_opus":0.043407517764554086,"score_gpt":0.3839605859701843,"score_spread":0.3405530682056302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111413047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96576345,0.00085333997,0.0010812132,0.0057026274,0.00017713639,0.0010513117,0.005034106,0.0003768078,0.019959806],"genre_scores_gemma":[0.981888,0.00095873955,0.0048097116,0.0018546734,0.00009958258,0.0014775497,0.004558562,0.00010831277,0.0042448672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527466,0.0025689725,0.00047850917,0.00040876048,0.0006953535,0.0005737238],"domain_scores_gemma":[0.9525699,0.011433399,0.01468389,0.0016490462,0.013031277,0.0066324645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010721312,0.00023140889,0.0002569197,0.0013613041,0.0009353047,0.001889874,0.00077734893,0.0006146849,0.0064290436],"category_scores_gemma":[0.044328034,0.00025024306,0.00036965183,0.0010703477,0.00042067183,0.0015079834,0.0013967562,0.0007819273,0.0021658414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031252665,0.0006046343,0.91659164,0.00028085546,0.000031327967,0.0014000544,0.0073193978,0.00021986377,0.00052140036,0.00019491337,0.017307475,0.055215966],"study_design_scores_gemma":[0.00010999708,0.0011052944,0.878197,0.0007575138,0.00006836769,0.0017525562,0.030259922,0.00141396,0.0012238811,0.00019829464,0.08485184,0.00006137541],"about_ca_topic_score_codex":0.011478711,"about_ca_topic_score_gemma":0.012967866,"teacher_disagreement_score":0.011478711,"about_ca_system_score_codex":0.0032090673,"about_ca_system_score_gemma":0.004085186,"threshold_uncertainty_score":0.05670041},"labels":[],"label_agreement":null},{"id":"W3111419497","doi":"10.1093/neuonc/noaa222.522","title":"MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Cancer research; Oncogene; Biology; Context (archaeology); Mediator; Gene; Computational biology; Genetics; Cell biology; Cell cycle","score_opus":0.015873070933057943,"score_gpt":0.2675625135859207,"score_spread":0.25168944265286275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111419497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95344704,0.0029169754,0.013423854,0.00061078963,0.00015819691,0.00029001784,0.014597751,0.0020167336,0.012538765],"genre_scores_gemma":[0.9520578,0.0016279198,0.013150724,0.00036765682,0.000035965364,0.00016752866,0.015927225,0.0006114185,0.016053721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997229,0.000025757676,0.000017517566,0.00006686636,0.000120849414,0.00004608671],"domain_scores_gemma":[0.9998222,0.000026839976,0.000055768967,0.000022436123,0.000016425107,0.00005627803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041241542,0.00040237186,0.0003764261,0.00046508983,0.00036669755,0.00074419455,0.0004514511,0.00044808275,0.005214775],"category_scores_gemma":[0.00016767815,0.00026552938,0.00037291416,0.0002702294,0.00035561773,0.00022378284,0.00038094187,0.0008653723,0.0020050148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046731794,0.00006418059,0.001670075,0.00009151622,0.000017181996,0.0000982026,0.000036007914,0.00043804126,0.9913362,0.00059034844,0.00070019753,0.0044906996],"study_design_scores_gemma":[0.00016060322,0.0011394314,0.026858069,0.000042146956,0.000084374704,0.0010048114,0.00013546995,0.0074813757,0.9166392,0.00048264276,0.045946,0.000025886471],"about_ca_topic_score_codex":0.0020173476,"about_ca_topic_score_gemma":0.0043943655,"teacher_disagreement_score":0.005214775,"about_ca_system_score_codex":0.0006965681,"about_ca_system_score_gemma":0.0005362427,"threshold_uncertainty_score":0.017445207},"labels":[],"label_agreement":null},{"id":"W3111439303","doi":"10.1093/neuonc/noaa215.739","title":"QOLP-14. FROM SYMPTOMS TO RADIOTHERAPY: A QUALITATIVE ASSESSMENT OF PATIENT EXPERIENCE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thematic analysis; Empathy; Anxiety; Grounded theory; Medicine; Qualitative research; Perception; Patient experience; Focus group; Health care; Psychology; Psychiatry","score_opus":0.11904557650495172,"score_gpt":0.46804479647526936,"score_spread":0.34899921997031763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111439303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939275,0.00042840617,0.001466082,0.0013095483,0.000054302618,0.00033883576,0.00043285752,0.0000148729305,0.0020276492],"genre_scores_gemma":[0.9959131,0.00051905104,0.0012917183,0.000430848,0.000014083754,0.00057796773,0.00018312296,0.000015067069,0.0010549382],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99461323,0.003982155,0.00022942637,0.00020610866,0.00033022312,0.0006388246],"domain_scores_gemma":[0.98933893,0.0076979864,0.0009406559,0.00017389502,0.00074337464,0.0011051001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00973598,0.0005428024,0.0006566754,0.001458402,0.0036546877,0.0028957275,0.0013970454,0.0010999993,0.0024424386],"category_scores_gemma":[0.011991791,0.00044257904,0.00054572406,0.0013651685,0.0045275013,0.0022732571,0.004417472,0.0020553372,0.00030056018],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039181512,0.00004134779,0.004798514,0.00030167215,0.000005785775,0.00047771927,0.987805,0.000059773964,0.00062935275,0.00044140895,0.00053821714,0.0048621246],"study_design_scores_gemma":[0.000004943198,0.0000651671,0.0038067703,0.00013856965,0.0000036438498,0.00021377478,0.9921468,0.00007831164,0.00017547443,0.00015279834,0.003199628,0.000014132513],"about_ca_topic_score_codex":0.0043456405,"about_ca_topic_score_gemma":0.0072982856,"teacher_disagreement_score":0.00973598,"about_ca_system_score_codex":0.0042299964,"about_ca_system_score_gemma":0.00390367,"threshold_uncertainty_score":0.051489413},"labels":[],"label_agreement":null},{"id":"W3111439742","doi":"10.1093/neuonc/noaa222.560","title":"MBRS-54. POOR SURVIVAL IN REPLICATION REPAIR DEFICIENT HYPERMUTANT MEDULLOBLASTOMA AND CNS EMBRYONAL TUMORS: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Germline mutation; Atypical teratoid rhabdoid tumor; Biology; Medicine; Mutation; Internal medicine; Oncology; Genetics; Gene","score_opus":0.03209832332616528,"score_gpt":0.29668872118507766,"score_spread":0.26459039785891236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111439742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691534,0.0009814309,0.0001860661,0.00008708568,0.000011421402,0.000018981766,0.00056922546,0.00002046012,0.0012099941],"genre_scores_gemma":[0.99869365,0.00020321106,0.00007925626,0.000035966095,0.000012082065,0.000008801691,0.00074830616,0.000006877696,0.00021194325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996061,0.00005662513,0.000045443885,0.00011757496,0.000087519904,0.00008687311],"domain_scores_gemma":[0.99910957,0.00013772307,0.0002594831,0.00015415812,0.0001328357,0.00020622773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005709567,0.00034426473,0.0003027101,0.0010940086,0.0005620661,0.0006611147,0.00035592046,0.00033583373,0.0011063626],"category_scores_gemma":[0.001396383,0.0001399029,0.00026308652,0.0007163699,0.00036431887,0.00016617263,0.00046462097,0.0002717325,0.00029389607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057316315,0.00006748976,0.97205484,0.000039802293,0.00013586633,0.00913568,0.00036197915,0.00007070283,0.0057120034,0.00009946167,0.0008890965,0.010859774],"study_design_scores_gemma":[0.000042585107,0.0002940629,0.9633088,0.000025696474,0.00017657736,0.028860392,0.00042963354,0.00022199699,0.0026982094,0.000050707495,0.003872991,0.000018368733],"about_ca_topic_score_codex":0.0074780006,"about_ca_topic_score_gemma":0.0049678423,"teacher_disagreement_score":0.0074780006,"about_ca_system_score_codex":0.00046151716,"about_ca_system_score_gemma":0.00041551772,"threshold_uncertainty_score":0.014868915},"labels":[],"label_agreement":null},{"id":"W3111444730","doi":"10.1093/neuonc/noaa222.348","title":"IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Medicine; Concordance; Radiomics; Magnetic resonance imaging; Radiology; Artificial intelligence; Internal medicine; Computer science","score_opus":0.016532222824277673,"score_gpt":0.29395882249949284,"score_spread":0.27742659967521516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111444730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97067666,0.0014195178,0.020434124,0.0003757393,0.000063916086,0.000112455025,0.0044383546,0.00070051197,0.0017788457],"genre_scores_gemma":[0.98324525,0.0001806234,0.011304504,0.00006644123,0.000030277517,0.0000729502,0.004107394,0.0000374752,0.0009551976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994906,0.00017769159,0.00003536005,0.0001306683,0.00010514863,0.00006042856],"domain_scores_gemma":[0.9991775,0.00029183106,0.00021771321,0.00006055094,0.00015780366,0.000094511466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020965151,0.0010011856,0.0006683363,0.0011857998,0.0001957206,0.0009011836,0.00040628368,0.0005136044,0.0019286262],"category_scores_gemma":[0.0024245128,0.00018385643,0.0006682382,0.00061569683,0.00028377565,0.00029993674,0.00045626916,0.00049768673,0.0011355056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014574714,0.0003229404,0.82989645,0.00014758256,0.00045946735,0.00034977408,0.00006135463,0.034568217,0.013360768,0.00023211753,0.0035150442,0.115628876],"study_design_scores_gemma":[0.00010547106,0.0010372312,0.507972,0.00010073299,0.00035086847,0.0012096233,0.00011978686,0.47057864,0.013850272,0.0009806792,0.0036351443,0.000059610305],"about_ca_topic_score_codex":0.0024368092,"about_ca_topic_score_gemma":0.0024127995,"teacher_disagreement_score":0.0024368092,"about_ca_system_score_codex":0.00045686256,"about_ca_system_score_gemma":0.00057426596,"threshold_uncertainty_score":0.011087596},"labels":[],"label_agreement":null},{"id":"W3111452451","doi":"10.1093/neuonc/noaa215.428","title":"EXTH-74. IND-ENABLING CHARACTERIZATION OF DUAL DRD2- AND ClpP-TARGETING AGENT ONC206 AS THE NEXT IMIPRIDONE FOR CLINICAL NEURO-ONCOLOGY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Agonist; Pharmacology; Cell culture; Antagonist; Endocrinology; Internal medicine; Receptor; Chemistry; Medicine; Biology","score_opus":0.08203127632265171,"score_gpt":0.3619152169515216,"score_spread":0.2798839406288699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111452451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875238,0.0020174196,0.0031184752,0.00010713335,0.00002735515,0.00016225368,0.001222482,0.00011118475,0.0057098484],"genre_scores_gemma":[0.98791236,0.0009223872,0.0039252345,0.00006878071,0.0000072458943,0.00005896775,0.0019387165,0.000023873206,0.0051423274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999959,0.0000066044245,0.0000023328228,0.0000057856587,0.000015952153,0.000010292661],"domain_scores_gemma":[0.99997926,0.0000020089838,0.0000040059704,0.000002047863,0.0000048478164,0.000007719693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007513864,0.000189676,0.0001441258,0.00012865565,0.00007884969,0.00014856411,0.00013922618,0.00014486736,0.0015552391],"category_scores_gemma":[0.00006295982,0.0000670957,0.00011846084,0.00010782786,0.000065462016,0.000082542094,0.00007819211,0.00020078656,0.00050417637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036423103,0.0001139803,0.00023766412,0.000054822496,0.0000072227836,0.0001288139,0.000013346142,0.00031028743,0.9900101,0.00016020189,0.00029957556,0.008299836],"study_design_scores_gemma":[0.00014628816,0.0027089005,0.003555667,0.00000956398,0.00003134784,0.00105048,0.000019113073,0.0031808843,0.97575414,0.000065201435,0.013467369,0.000011056313],"about_ca_topic_score_codex":0.00059581635,"about_ca_topic_score_gemma":0.00092623295,"teacher_disagreement_score":0.0015552391,"about_ca_system_score_codex":0.00017971225,"about_ca_system_score_gemma":0.00020519091,"threshold_uncertainty_score":0.0052027702},"labels":[],"label_agreement":null},{"id":"W3111457091","doi":"10.1093/neuonc/noaa215.363","title":"EXTH-09. NEO-ADJUVANT TEMOZOLOMIDE INCREASES THE EFFICACY OF SUBSEQUENT CONCURRENT CHEMORADIATION IN A TRANSGLUTAMINASE-2 DEPENDENT MANNER","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Radioresistance; In vivo; Cancer research; Dacarbazine; Downregulation and upregulation; Oncology; Medicine; Radiation therapy; Glioma; Internal medicine; Biology; Melanoma","score_opus":0.03405436361435305,"score_gpt":0.30221516278141913,"score_spread":0.2681607991670661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111457091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712235,0.0006848236,0.0003311032,0.000089744964,0.000066800436,0.00003680679,0.00032446935,0.000097142176,0.0012468343],"genre_scores_gemma":[0.99497813,0.0004094626,0.00085235055,0.00008764945,0.00001852262,0.00005071523,0.00088339846,0.000016321666,0.002703528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991393,0.000015234181,0.0000076119168,0.000017706205,0.000019323672,0.000026228388],"domain_scores_gemma":[0.99988914,0.0000173119,0.000018363546,0.000012581614,0.000007892242,0.000054739987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010909637,0.00024164692,0.00031868243,0.00014770587,0.000063771404,0.00020908636,0.00020404646,0.0002112447,0.0038066239],"category_scores_gemma":[0.00011470662,0.00010111402,0.00019384443,0.0001064915,0.00019449074,0.00017038648,0.00015334043,0.00091308646,0.0004817588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006354154,0.0028796445,0.0010298968,0.00016872305,0.0000436826,0.00007847061,0.0000402128,0.00029778024,0.96849245,0.00019019787,0.0010443992,0.01938031],"study_design_scores_gemma":[0.00069827243,0.02729795,0.01335457,0.000023089076,0.00008204271,0.00041652375,0.000056094337,0.0016976122,0.9502051,0.00008899913,0.0060682646,0.000011582634],"about_ca_topic_score_codex":0.00039092515,"about_ca_topic_score_gemma":0.0009962408,"teacher_disagreement_score":0.0038066239,"about_ca_system_score_codex":0.00015216412,"about_ca_system_score_gemma":0.0002583535,"threshold_uncertainty_score":0.012734413},"labels":[],"label_agreement":null},{"id":"W3111517195","doi":"10.1093/neuonc/noaa222.345","title":"IMG-09. RESPONSE ASSESSMENT IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY COMMITTEE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Drug response; Clinical trial; Medical physics; Oncology; Internal medicine; Drug","score_opus":0.0321352473590854,"score_gpt":0.34132871324827635,"score_spread":0.30919346588919094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111517195","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006410625,0.048304178,0.039896008,0.76692116,0.019006843,0.025714876,0.0073392275,0.0030852158,0.08332193],"genre_scores_gemma":[0.028823454,0.044499267,0.37540606,0.42476994,0.015459653,0.046875767,0.016930176,0.0017513286,0.045484405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9010323,0.05693401,0.019887056,0.0024592709,0.01554904,0.004138284],"domain_scores_gemma":[0.7726643,0.062131487,0.03162259,0.008808606,0.10392651,0.02084646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14181374,0.002000701,0.0038720919,0.0047441144,0.0024928427,0.005259627,0.01056993,0.022119125,0.0042969026],"category_scores_gemma":[0.14652392,0.0016622253,0.007137931,0.004296013,0.002863475,0.0039007324,0.0054009412,0.021190636,0.011037447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066489517,0.00077009876,0.0032242676,0.0033030435,0.0002207219,0.00040083652,0.00049036636,0.0021065902,0.0019666108,0.0052355775,0.76018316,0.2214339],"study_design_scores_gemma":[0.0008036048,0.0008343212,0.010249196,0.015504771,0.0003208066,0.00045731114,0.00032369848,0.0020582702,0.001770724,0.0036604241,0.9638409,0.00017600624],"about_ca_topic_score_codex":0.0100787,"about_ca_topic_score_gemma":0.011919727,"teacher_disagreement_score":0.14181374,"about_ca_system_score_codex":0.0070257336,"about_ca_system_score_gemma":0.028963873,"threshold_uncertainty_score":0.7499917},"labels":[],"label_agreement":null},{"id":"W3111542780","doi":"10.1093/neuonc/noaa222.070","title":"DIPG-20. DETERMINATION AND MANAGEMENT OF HYDROCEPHALUS IN PATIENTS WITH DIPG, AN INSTITUTIONAL EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hydrocephalus; Univariate analysis; External ventricular drain; Cerebrospinal fluid; Surgery; Hazard ratio; Population; Multivariate analysis; Internal medicine","score_opus":0.01954453598674619,"score_gpt":0.28644167671736576,"score_spread":0.26689714073061954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111542780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702054,0.0010332597,0.00043960448,0.00013013522,0.000009086925,0.000022134327,0.000073744864,0.000019016765,0.0012525347],"genre_scores_gemma":[0.9984653,0.00048490713,0.00072663196,0.0000988135,0.000017968987,0.000008135951,0.00008402773,0.0000062902027,0.00010792842],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995938,0.0001469498,0.00004653146,0.00008757426,0.000053800333,0.00007151735],"domain_scores_gemma":[0.9990356,0.00016913241,0.0002222839,0.00008975832,0.00009279534,0.00039056342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063227967,0.00027877046,0.00013890886,0.00054274,0.00044120688,0.0005227378,0.00038320958,0.0002516768,0.00066883076],"category_scores_gemma":[0.0021636433,0.0001273431,0.00019266992,0.00059000903,0.000577666,0.00033489676,0.00071544375,0.00036671574,0.00024456324],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029257816,0.0003592804,0.90425664,0.00010132119,0.000058063797,0.010424299,0.0016608578,0.00030522788,0.002758829,0.00012858132,0.0009908389,0.078663535],"study_design_scores_gemma":[0.00009264079,0.0028237442,0.8689886,0.00013850948,0.00009860498,0.11071054,0.003769693,0.00095394166,0.0047116335,0.00029543252,0.0073482436,0.00006848247],"about_ca_topic_score_codex":0.0017196237,"about_ca_topic_score_gemma":0.002523753,"teacher_disagreement_score":0.0017196237,"about_ca_system_score_codex":0.00058829214,"about_ca_system_score_gemma":0.00054699887,"threshold_uncertainty_score":0.004268408},"labels":[],"label_agreement":null},{"id":"W3111544385","doi":"10.1093/neuonc/noaa215.112","title":"COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pandemic; Salary; Psychosocial; Medicine; Coronavirus disease 2019 (COVID-19); Family medicine; Telemedicine; Clinical trial; Nursing; Psychology; Health care; Internal medicine; Political science; Psychiatry","score_opus":0.11191427915913023,"score_gpt":0.4299457917972057,"score_spread":0.3180315126380755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111544385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95486486,0.0044493843,0.00064455793,0.014518026,0.00025730327,0.00018714464,0.0058417935,0.000046476245,0.019190673],"genre_scores_gemma":[0.99419713,0.0016989202,0.00038097383,0.0012485451,0.00014047914,0.000078092366,0.0016672768,0.000012625627,0.00057597674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956767,0.0014576805,0.00080297265,0.00037343852,0.0010092378,0.00068001985],"domain_scores_gemma":[0.9648927,0.0042153397,0.019065762,0.001043005,0.0056302357,0.0051530423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007134995,0.00023322034,0.00022645315,0.0023327244,0.0009782886,0.0022621255,0.0007326646,0.0010217373,0.0034051295],"category_scores_gemma":[0.019194724,0.00021917358,0.00041418147,0.0029838998,0.0010007151,0.0028635047,0.0033595532,0.0016635426,0.0005744119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045336918,0.000048605612,0.9810116,0.0001378613,0.000025764835,0.00012524218,0.000994265,0.00010836089,0.00012078517,0.00018456344,0.0029582141,0.014239269],"study_design_scores_gemma":[0.0000023433454,0.00007717245,0.98910517,0.00020432282,0.0000080024065,0.00017574112,0.005529123,0.00022882764,0.00006614824,0.00008048309,0.0045063864,0.000016090602],"about_ca_topic_score_codex":0.00984312,"about_ca_topic_score_gemma":0.014028212,"teacher_disagreement_score":0.00984312,"about_ca_system_score_codex":0.0015293501,"about_ca_system_score_gemma":0.0020143585,"threshold_uncertainty_score":0.037733853},"labels":[],"label_agreement":null},{"id":"W3111581706","doi":"10.1093/neuonc/noaa222.171","title":"EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Medicine; Internal medicine; Cohort; Oncology; Chemotherapy; Radiation therapy; Progression-free survival; Surgery","score_opus":0.03088575724016148,"score_gpt":0.291910606719114,"score_spread":0.26102484947895255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111581706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956499,0.0023338213,0.00010325086,0.00004627287,0.0000072780754,0.000011544666,0.0005209657,0.000005693911,0.00132133],"genre_scores_gemma":[0.9983595,0.00058029906,0.000056539146,0.000021733746,0.000008631436,0.0000063907028,0.0006669205,0.0000025954187,0.00029734013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997341,0.000035274345,0.000033523505,0.000060780854,0.00008467899,0.00005163449],"domain_scores_gemma":[0.9993204,0.00014288671,0.0002928182,0.000046140744,0.00007906623,0.00011870027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033588754,0.00017666291,0.00022317833,0.0005935995,0.0002399823,0.00033568518,0.00020956254,0.00019901057,0.0009230602],"category_scores_gemma":[0.0009678321,0.000093404946,0.00024912087,0.0007302344,0.00026757465,0.00026473435,0.00026613814,0.0002529115,0.00024691413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004044813,0.000038417933,0.9560233,0.000103563354,0.000102850456,0.011873836,0.0002718303,0.00030910553,0.002459435,0.00008216987,0.0006659859,0.02766499],"study_design_scores_gemma":[0.00001290129,0.00015350826,0.98013866,0.000023469029,0.000049288872,0.01710775,0.00010989075,0.00014093965,0.00061471446,0.000037859485,0.00160409,0.0000068645836],"about_ca_topic_score_codex":0.0032825214,"about_ca_topic_score_gemma":0.003864885,"teacher_disagreement_score":0.0032825214,"about_ca_system_score_codex":0.00046510994,"about_ca_system_score_gemma":0.00027181645,"threshold_uncertainty_score":0.006526828},"labels":[],"label_agreement":null},{"id":"W3111586173","doi":"10.1093/neuonc/noaa222.714","title":"RARE-02.RE-IRRADIATION FOR RECURRENT CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Neurocognitive; Cumulative dose; Surgery; Optic chiasm; Nuclear medicine; Ophthalmology; Optic nerve; Cognition","score_opus":0.04199124678458554,"score_gpt":0.31875104485479694,"score_spread":0.2767597980702114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111586173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772764,0.0031894224,0.0005621146,0.00016637893,0.000025197774,0.00005051202,0.0006037376,0.00013302789,0.0075420043],"genre_scores_gemma":[0.9965497,0.0005544167,0.00048589165,0.0000916913,0.000049485352,0.000023951861,0.00071876514,0.000022502578,0.0015035191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998615,0.00001836584,0.000017723656,0.000029650053,0.000033378346,0.000039388084],"domain_scores_gemma":[0.9996668,0.00005005791,0.00013966388,0.000028869305,0.000016061938,0.0000984601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002312898,0.00018942225,0.00024333513,0.00038740836,0.00032602865,0.00038043957,0.00024786472,0.00034132597,0.0051323236],"category_scores_gemma":[0.0005301372,0.000082353006,0.0003409001,0.0002763644,0.00021797484,0.0001382529,0.00022720687,0.00024697583,0.0014216948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020528683,0.00033168035,0.7985543,0.0003727696,0.00012610758,0.04519082,0.000272965,0.0004421723,0.02348148,0.000556468,0.0030674774,0.12555084],"study_design_scores_gemma":[0.00021742958,0.002000257,0.5976117,0.000083797015,0.00018443633,0.3709638,0.00021480856,0.00067590777,0.009076985,0.0003104133,0.018636178,0.000024241906],"about_ca_topic_score_codex":0.0011959905,"about_ca_topic_score_gemma":0.0016769057,"teacher_disagreement_score":0.0051323236,"about_ca_system_score_codex":0.00040076883,"about_ca_system_score_gemma":0.00031675355,"threshold_uncertainty_score":0.017169297},"labels":[],"label_agreement":null},{"id":"W3111592258","doi":"10.1093/neuonc/noaa222.015","title":"ATRT-16. MODELLING ATRT THROUGH SWI/SNF COMPLEX DEFICIENCY IN GENETICALLY-ENGINEERED MOUSE MODELS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"SMARCB1; Atypical teratoid rhabdoid tumor; Biology; Embryonic stem cell; Stem cell; Cancer research; Progenitor cell; Neural stem cell; Cell biology; Genetics; Medulloblastoma; Gene; Gene expression","score_opus":0.058963389022737185,"score_gpt":0.2888073450202462,"score_spread":0.229843955997509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111592258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608822,0.0017318762,0.02365629,0.00043348546,0.0001874174,0.0010692531,0.005973144,0.000920347,0.0051460913],"genre_scores_gemma":[0.9453137,0.002448083,0.024954392,0.00018683572,0.000039121383,0.002034222,0.0047350293,0.00047606134,0.019812524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992932,0.00010742741,0.000121780315,0.00018542171,0.00018516865,0.000107051055],"domain_scores_gemma":[0.9993881,0.000069062306,0.00028174155,0.00006284801,0.00003836952,0.00015983214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008490292,0.0012481172,0.0005570618,0.002504877,0.00043130477,0.0007661343,0.00088066666,0.0014505439,0.0047851354],"category_scores_gemma":[0.00032221433,0.00058710045,0.00094135944,0.0006689108,0.00095334597,0.00055091083,0.0006076206,0.0016963094,0.0017396815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031674336,0.00025477685,0.00038729163,0.00009703847,0.00002443066,0.000520421,0.000056098183,0.0006400143,0.9946255,0.00087425334,0.00021422324,0.0019892335],"study_design_scores_gemma":[0.00025621394,0.0021808308,0.0028953943,0.00006151574,0.00010901394,0.00252301,0.000093463124,0.005788649,0.9719149,0.00032875093,0.013822971,0.000025376938],"about_ca_topic_score_codex":0.0008012246,"about_ca_topic_score_gemma":0.0014627283,"teacher_disagreement_score":0.0047851354,"about_ca_system_score_codex":0.0007468029,"about_ca_system_score_gemma":0.00045768206,"threshold_uncertainty_score":0.0160079},"labels":[],"label_agreement":null},{"id":"W3111604562","doi":"10.1093/neuonc/noaa222.276","title":"GCT-59. EPIDEMIOLOGY OF PEDIATRIC INTRA-CRANIAL GERM CELL TUMORS: COMPARING THE INCIDENCE OF INTRA-CRANIAL GERM CELL TUMORS IN THE NATIVE JAPANESE POPULATION AND IMMIGRANT JAPANESE POPULATIONS ABROAD","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Incidence (geometry); Medulloblastoma; Demography; Population; Epidemiology; Medicine; Immigration; Germ cell tumors; Pediatrics; Pathology; Internal medicine; Geography; Environmental health","score_opus":0.040109853985057835,"score_gpt":0.3211728424116079,"score_spread":0.28106298842655003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111604562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986872,0.0003821838,0.000046289908,0.0000150777605,0.0000032611085,0.000005006032,0.00045841964,0.0000025395018,0.00040009472],"genre_scores_gemma":[0.998941,0.00028948317,0.000053495358,0.000007734577,0.0000040434265,0.000005581557,0.0005996075,0.0000017780195,0.000097304786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971503,0.000046070876,0.000041908585,0.000072445386,0.000063195694,0.000061366096],"domain_scores_gemma":[0.99926573,0.000046223176,0.00035886676,0.00003590446,0.00013324842,0.00015989262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029664155,0.00012968757,0.00018079608,0.0012230729,0.00026671958,0.00045048108,0.00025006873,0.00016581129,0.0010867268],"category_scores_gemma":[0.00079273625,0.00015422699,0.0003426129,0.0015899832,0.00022108626,0.0003014452,0.00034645502,0.0002087696,0.00019038572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015112047,0.0000026630985,0.998987,0.000006477099,0.00001667689,0.000043650118,0.000047812202,0.000011737967,0.000102592705,0.000006235973,0.0000364171,0.0007236278],"study_design_scores_gemma":[6.6971063e-7,0.000014759807,0.9994367,0.0000033396361,0.000009867075,0.00014367145,0.00021531983,0.000030400357,0.000027707782,0.0000036979625,0.00011313462,7.3635584e-7],"about_ca_topic_score_codex":0.033365294,"about_ca_topic_score_gemma":0.02939657,"teacher_disagreement_score":0.033365294,"about_ca_system_score_codex":0.00040027627,"about_ca_system_score_gemma":0.00043681613,"threshold_uncertainty_score":0.066342175},"labels":[],"label_agreement":null},{"id":"W3111626448","doi":"10.1093/neuonc/noaa222.183","title":"EPEN-50. THE MANAGEMENT AND TREATMENT OF PEDIATRIC SPINAL CORD EPENDYMOMA: RESULTS FROM A COLLABORATIVE INTERNATIONAL MULTI-INSTITUTIONAL REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ependymoma; Cohort; Spinal cord; Hazard ratio; Radiation therapy; Internal medicine; Oncology; Surgery; Confidence interval","score_opus":0.057383780453172085,"score_gpt":0.344314526923004,"score_spread":0.2869307464698319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111626448","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40304032,0.5573119,0.0037735521,0.0029691139,0.00040355753,0.0023149583,0.011386518,0.00011019084,0.018690016],"genre_scores_gemma":[0.64167273,0.3268263,0.009335551,0.0018312458,0.00037733014,0.001475982,0.016818222,0.00008683858,0.0015758041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957884,0.0016406323,0.0010970162,0.00029343722,0.0010221971,0.00015837466],"domain_scores_gemma":[0.9848652,0.0052451803,0.004507966,0.00097617577,0.0035604925,0.00084487407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011889915,0.0003772128,0.00049184775,0.0032248835,0.0002140822,0.0009865838,0.0009875181,0.0004059877,0.00065299636],"category_scores_gemma":[0.014581523,0.00016716062,0.000789419,0.0046962094,0.00033855846,0.00053992536,0.0006520666,0.00028638187,0.00024722697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011052507,0.000354792,0.18286113,0.008026455,0.0016382276,0.0011287741,0.0007727019,0.0013865732,0.0032088845,0.0005455241,0.016790211,0.7821815],"study_design_scores_gemma":[0.0006292542,0.0017726104,0.8313769,0.01404342,0.0035547896,0.0045118006,0.0010911198,0.0007919458,0.00361109,0.00012458277,0.13843,0.00006253546],"about_ca_topic_score_codex":0.002804112,"about_ca_topic_score_gemma":0.0054315086,"teacher_disagreement_score":0.011889915,"about_ca_system_score_codex":0.0009954063,"about_ca_system_score_gemma":0.0029691432,"threshold_uncertainty_score":0.062880635},"labels":[],"label_agreement":null},{"id":"W3111628160","doi":"10.1093/neuonc/noaa215.223","title":"CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Meningioma; Gastroenterology; Surgery; Confidence interval","score_opus":0.04227633261742913,"score_gpt":0.3063355793747301,"score_spread":0.26405924675730097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111628160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356724,0.0047011487,0.00029777133,0.0007300364,0.00011001067,0.0006661075,0.0025327234,0.00006747791,0.007327445],"genre_scores_gemma":[0.9900281,0.0013994391,0.00066610484,0.00062438374,0.00012067975,0.0006254967,0.004336281,0.000029807701,0.0021695814],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996797,0.00012377744,0.000024049072,0.00005745737,0.00005727082,0.000057659156],"domain_scores_gemma":[0.99950397,0.00004257787,0.00014222269,0.0000414564,0.000021022566,0.00024878918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014319229,0.00047927027,0.0007021537,0.00027201246,0.00025249275,0.0005219322,0.00045749664,0.00038980818,0.0027860154],"category_scores_gemma":[0.00076788815,0.00015880451,0.00047443534,0.00030170713,0.00031341318,0.00028419748,0.0003134843,0.0008381452,0.0007259494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46979105,0.014487237,0.1327094,0.0017837309,0.0014752864,0.0005792506,0.00036924655,0.0031205064,0.033896156,0.00066744053,0.031275097,0.30984554],"study_design_scores_gemma":[0.17049077,0.32118118,0.45537546,0.00046508835,0.0028539689,0.0017821629,0.00024568342,0.003177314,0.012236729,0.0009809134,0.031135187,0.00007545483],"about_ca_topic_score_codex":0.001613814,"about_ca_topic_score_gemma":0.006091049,"teacher_disagreement_score":0.0027860154,"about_ca_system_score_codex":0.0008427387,"about_ca_system_score_gemma":0.0010634323,"threshold_uncertainty_score":0.00932014},"labels":[],"label_agreement":null},{"id":"W3111632648","doi":"10.1093/neuonc/noaa215.280","title":"EPCO-01. LUNG ADENOCARCINOMA BRAIN METASTASIS PREDICTION, PREVENTION, AND NON-INVASIVE DIAGNOSIS USING METHYLATION SIGNATURES WITHIN TISSUE AND CIRCULATING TUMOUR DNA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"DNA methylation; Methylation; Adenocarcinoma; Brain metastasis; Lung cancer; Oncology; Metastasis; Differentially methylated regions; Cancer research; Biology; Stage (stratigraphy); Cohort; Cancer; Pathology; Internal medicine; Medicine; DNA; Gene; Genetics; Gene expression","score_opus":0.02521400779802102,"score_gpt":0.29755169153881117,"score_spread":0.27233768374079015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111632648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97191834,0.0016479765,0.0058104056,0.00083061284,0.000085093285,0.00021582204,0.01533784,0.00047908517,0.0036749362],"genre_scores_gemma":[0.97633183,0.00030869673,0.0036079742,0.00019017291,0.00004855043,0.0001323616,0.015023172,0.00008158894,0.004275663],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999458,0.00022748671,0.000023542338,0.000163135,0.00007529166,0.00005252071],"domain_scores_gemma":[0.99745125,0.0011739252,0.0004572752,0.00016128446,0.00031651955,0.00043974994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002290345,0.0004979655,0.0005323498,0.0004382323,0.00018556816,0.0007151987,0.0006052289,0.00051047,0.0052431775],"category_scores_gemma":[0.0035888383,0.0002269715,0.00052262744,0.00036012096,0.0001708697,0.0003085598,0.00050198636,0.0006160376,0.0020220312],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007621838,0.00044362515,0.9176936,0.00023890715,0.0003307632,0.00010740635,0.00003324575,0.0066200327,0.00629209,0.00018345949,0.0048091514,0.055625953],"study_design_scores_gemma":[0.0005832959,0.0038521143,0.8424921,0.00009886092,0.00049317617,0.0005663959,0.00008343236,0.13681924,0.007028524,0.00048282687,0.007466664,0.000033293043],"about_ca_topic_score_codex":0.006821102,"about_ca_topic_score_gemma":0.0087276185,"teacher_disagreement_score":0.006821102,"about_ca_system_score_codex":0.0005811725,"about_ca_system_score_gemma":0.00096998527,"threshold_uncertainty_score":0.017540216},"labels":[],"label_agreement":null},{"id":"W3111637277","doi":"10.1093/neuonc/noaa222.728","title":"RARE-17. SURVIVAL BENEFIT FOR INDIVIDUALS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME AND BRAIN TUMORS WHO UNDERGO SURVEILLANCE PROTOCOL. A REPORT FROM THE INTERNATIONAL REPLICATION REPAIR CONSORTIUM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; University of Manitoba; Research Institute in Oncology and Hematology; Centre hospitalier universitaire de Québec; University of Ottawa; McGill University Health Centre; McGill University; Children's Hospital of Eastern Ontario; London Health Sciences Centre; SickKids Foundation; University of Toronto; Western University; CancerCare Manitoba; Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Asymptomatic; Oncology; Cancer; Internal medicine","score_opus":0.03344212194068255,"score_gpt":0.31196797052240743,"score_spread":0.2785258485817249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111637277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566585,0.001437024,0.00018718845,0.00026168578,0.00002170514,0.00004852135,0.00088761165,0.000021978069,0.0014684137],"genre_scores_gemma":[0.9968142,0.00038160238,0.00034265663,0.00022599954,0.000029478526,0.00008057371,0.0018315158,0.0000031745035,0.00029074872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996371,0.00017736747,0.00003144855,0.000061347615,0.00004081359,0.00005191343],"domain_scores_gemma":[0.9985507,0.00040734527,0.00048503923,0.00011259064,0.00012972087,0.0003145429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011201019,0.0001240433,0.0001927618,0.00040165082,0.00019013176,0.00027050186,0.0001299199,0.00025726826,0.0010371918],"category_scores_gemma":[0.0023350015,0.000054514163,0.0002428725,0.0003944295,0.00014284138,0.00015622764,0.00019224786,0.00015956786,0.00013856502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004933815,0.0003158078,0.94148713,0.00009834841,0.00013433445,0.0006939286,0.00012051038,0.0002637277,0.0012247693,0.00013190114,0.0022202241,0.04837548],"study_design_scores_gemma":[0.00089683145,0.005874498,0.98213047,0.00007455353,0.0003164103,0.003207716,0.00021822703,0.00094168534,0.0016080391,0.00019595987,0.0045164963,0.000019188206],"about_ca_topic_score_codex":0.0013146043,"about_ca_topic_score_gemma":0.0014907293,"teacher_disagreement_score":0.0013146043,"about_ca_system_score_codex":0.00025565762,"about_ca_system_score_gemma":0.0004982169,"threshold_uncertainty_score":0.005923748},"labels":[],"label_agreement":null},{"id":"W3111646813","doi":"10.1093/neuonc/noaa222.416","title":"LGG-34. CLINICAL AND MOLECULAR CHARACTERIZATION OF A MULTI-INSTITUTIONAL COHORT OF PEDIATRIC SPINAL CORD LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CDKN2A; Medicine; Cohort; Oncology; Fusion gene; STK11; Internal medicine; IDH1; KRAS; Pathology; Cancer; Mutation; Gene; Biology; Genetics; Colorectal cancer","score_opus":0.046681860737357674,"score_gpt":0.3480639976226735,"score_spread":0.3013821368853158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111646813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994537,0.000050174793,0.000024880525,0.0000117169275,0.0000010727193,0.0000072456396,0.00032086598,0.0000032047697,0.00012711299],"genre_scores_gemma":[0.99926084,0.000038292626,0.00005390576,0.000011418952,0.000002987728,0.000010404465,0.0005555889,0.0000027552028,0.00006377982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995709,0.000051621388,0.000037109225,0.00017196235,0.00006962633,0.000098867466],"domain_scores_gemma":[0.9989473,0.000104562045,0.00049518317,0.0000732256,0.00012892667,0.00025079108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033136518,0.00032181063,0.0003372319,0.0015808677,0.0007253585,0.0006192862,0.0004133094,0.00033946632,0.0013319497],"category_scores_gemma":[0.0012281986,0.00020540801,0.00023562416,0.0012276132,0.00043209756,0.00031587054,0.0005532,0.00033153675,0.0002949754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032861986,0.000010341568,0.9985311,0.0000036043864,0.000008398419,0.00030882185,0.00005438116,0.000019047011,0.0004449686,0.0000059391837,0.000060674898,0.0005197375],"study_design_scores_gemma":[0.0000023029293,0.000059375034,0.9973308,0.0000027063163,0.000009498927,0.0020019668,0.00022525123,0.00005950144,0.00014645584,0.000007548631,0.00015241871,0.0000022104157],"about_ca_topic_score_codex":0.010664026,"about_ca_topic_score_gemma":0.013420709,"teacher_disagreement_score":0.010664026,"about_ca_system_score_codex":0.00070845947,"about_ca_system_score_gemma":0.0005370995,"threshold_uncertainty_score":0.021203876},"labels":[],"label_agreement":null},{"id":"W3111654317","doi":"10.1093/neuonc/noaa222.765","title":"RARE-55. CHALLENGES AND SPECIFIC STRATEGIES FOR CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME IN LOW RESOURCE SETTINGS. ON BEHALF OF THE INTERNATIONAL RRD CONSORTIUM IN LOW RESOURCE SETTINGS PANEL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PMS2; MSH6; Medicine; MSH2; Lynch syndrome; Oncology; Intensive care medicine; DNA mismatch repair; Colorectal cancer; Internal medicine; Cancer","score_opus":0.04496372023528123,"score_gpt":0.27933028000355986,"score_spread":0.23436655976827864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111654317","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03036549,0.050908852,0.019111468,0.72993344,0.018726842,0.0014548672,0.00228055,0.001426612,0.14579196],"genre_scores_gemma":[0.3756438,0.065701574,0.084804505,0.29747525,0.036300424,0.0049697887,0.009627066,0.00083766185,0.124639966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969868,0.001176493,0.00038877365,0.0002643711,0.0004660339,0.00071751897],"domain_scores_gemma":[0.98833466,0.0015329836,0.00094234035,0.00035560993,0.0023209609,0.0065134815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071219075,0.0005374267,0.00046736837,0.001420426,0.001941754,0.0018865652,0.0012540293,0.0026972021,0.019465992],"category_scores_gemma":[0.008541613,0.00022616769,0.00062570826,0.0006905477,0.00083046115,0.0010936143,0.004138871,0.0029424601,0.0036119353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085352396,0.0001326924,0.033234537,0.000877436,0.000030447822,0.014445743,0.00069504825,0.000536591,0.0020637661,0.006301383,0.73105353,0.21054354],"study_design_scores_gemma":[0.00006240347,0.00016657072,0.04319566,0.005406159,0.000037048474,0.028942224,0.0030830242,0.001003347,0.00050687644,0.004927958,0.91260624,0.000062550636],"about_ca_topic_score_codex":0.0049078176,"about_ca_topic_score_gemma":0.009703366,"teacher_disagreement_score":0.019465992,"about_ca_system_score_codex":0.0013781473,"about_ca_system_score_gemma":0.0065552164,"threshold_uncertainty_score":0.06512022},"labels":[],"label_agreement":null},{"id":"W3111693169","doi":"10.1093/neuonc/noaa215.859","title":"SURG-12. PREDICTORS OF SURVIVAL AND UTILITY OF INTRAOPERATIVE MRI FOR RESECTION OF GRADE II ASTROCYTOMAS AND OLIGODENDROGLIOMAS: A MULTICENTER ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Astrocytoma; Progression-free survival; Glioma; Internal medicine; Retrospective cohort study; Overall survival; Resection; Magnetic resonance imaging; Gastroenterology; Surgery; Oncology; Radiology","score_opus":0.0341941944633523,"score_gpt":0.3098234883462424,"score_spread":0.2756292938828901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111693169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987281,0.00029480827,0.00010468615,0.000018124967,0.0000040804152,0.0000061663272,0.00070499885,0.0000040544373,0.00013504825],"genre_scores_gemma":[0.9990356,0.00005296327,0.00007895954,0.000008511705,0.0000072978814,0.000007568071,0.00074484054,0.0000024096312,0.000061927254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994642,0.00017950918,0.00008909293,0.00014646376,0.000065247215,0.00005535257],"domain_scores_gemma":[0.9974184,0.00031828808,0.0015271009,0.00022254104,0.00019759637,0.0003161218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013311501,0.00030669742,0.00024375196,0.0008470337,0.00017277178,0.00053903577,0.00029175283,0.00018953734,0.0012109765],"category_scores_gemma":[0.0020720689,0.00014688101,0.00083785405,0.0007256582,0.00016967766,0.00024313292,0.0003696786,0.00019042802,0.00023555926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027389385,0.000007750912,0.99845946,0.000007633432,0.00015723241,0.000024978031,0.0000100751695,0.000043158045,0.00016752776,0.0000047216413,0.000054995737,0.00078848033],"study_design_scores_gemma":[0.000018154384,0.00015540453,0.9986104,0.0000051200877,0.00017142216,0.00020072174,0.000062568826,0.00034105222,0.0001628217,0.000012696122,0.0002564918,0.0000030633564],"about_ca_topic_score_codex":0.0019384596,"about_ca_topic_score_gemma":0.0022465663,"teacher_disagreement_score":0.0019384596,"about_ca_system_score_codex":0.00027161805,"about_ca_system_score_gemma":0.00027874095,"threshold_uncertainty_score":0.0070399046},"labels":[],"label_agreement":null},{"id":"W3111695551","doi":"10.1093/neuonc/noaa222.825","title":"SWK-08. DELAYED DIAGNOSIS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN CHILDREN: PERSPECTIVE FROM THE FRONTLINE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Infectious Diseases Centre; University of British Columbia","funders":"","keywords":"Medicine; Medical diagnosis; Vomiting; Family medicine; Pediatrics; Clinical Practice; Brain tumor; Psychiatry; Pathology; Internal medicine","score_opus":0.015062690241028395,"score_gpt":0.26126742577581,"score_spread":0.24620473553478162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111695551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56786287,0.011912925,0.00028630102,0.31366697,0.0028701418,0.00009768998,0.010199635,0.000102388374,0.09300107],"genre_scores_gemma":[0.9021806,0.016060567,0.0011886243,0.055626977,0.0018710165,0.00012469386,0.0046901335,0.00013540556,0.018121919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986563,0.0002034542,0.000086951695,0.00007569899,0.00035015045,0.0006275209],"domain_scores_gemma":[0.9894533,0.00073716923,0.0016154305,0.000065359265,0.002787548,0.0053410884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012655986,0.00016839613,0.00021315912,0.00066483434,0.002012245,0.0014314853,0.0005374403,0.00094761094,0.011018122],"category_scores_gemma":[0.004878553,0.00014443329,0.0002943478,0.0012958588,0.0007725062,0.0009973319,0.00081173715,0.0016453674,0.0014955101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089899404,0.000120486526,0.67564404,0.00036372367,0.000023143275,0.0015284216,0.0066703637,0.00006701406,0.0002803459,0.0007602452,0.25509214,0.059360195],"study_design_scores_gemma":[0.000027797358,0.00013053002,0.80987686,0.0011602155,0.000025633755,0.0021421136,0.036073826,0.00006288538,0.000108819324,0.00013315896,0.15021047,0.000047702273],"about_ca_topic_score_codex":0.3731441,"about_ca_topic_score_gemma":0.5324072,"teacher_disagreement_score":0.3731441,"about_ca_system_score_codex":0.006868594,"about_ca_system_score_gemma":0.015014897,"threshold_uncertainty_score":0.7419443},"labels":[],"label_agreement":null},{"id":"W3111710464","doi":"10.1093/neuonc/noaa222.259","title":"GCT-41. RESPONSE-BASED RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LOCALIZED GERMINOMA: A CHILDREN’S ONCOLOGY GROUP (COG) PROSPECTIVE PHASE 2 CLINICAL TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cog; Carboplatin; Etoposide; Germinoma; Chemotherapy; Radiation therapy; Phases of clinical research; Internal medicine; Central nervous system; Surgery; Oncology; Gastroenterology; Cisplatin","score_opus":0.029779315413367126,"score_gpt":0.3299005253535205,"score_spread":0.30012120994015334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111710464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568295,0.0014237803,0.00010626669,0.0002639614,0.000073002186,0.0010625893,0.0006215841,0.000036229005,0.0007296005],"genre_scores_gemma":[0.99193245,0.0014307124,0.0006888461,0.0007065562,0.00015399711,0.0015960681,0.0019896976,0.000014223027,0.0014875607],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996062,0.00020381597,0.000019271538,0.00006579333,0.00003723106,0.00006779533],"domain_scores_gemma":[0.99955803,0.00006027033,0.000082255574,0.00003908028,0.000025751857,0.00023461883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018458404,0.0009986536,0.0013769699,0.0002879894,0.00034829366,0.00094557804,0.00062954496,0.0009900829,0.002395125],"category_scores_gemma":[0.00056173914,0.00035115643,0.0011292342,0.0004104428,0.0007483028,0.00046139027,0.0003253598,0.001873652,0.0004509438],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86099833,0.036937196,0.022723934,0.000787117,0.0013672389,0.00026619862,0.00020895666,0.0022650978,0.010634352,0.00023755539,0.0034426155,0.06013136],"study_design_scores_gemma":[0.6313123,0.32515973,0.036251165,0.000054407254,0.0007049459,0.00029659763,0.00006696522,0.0012840534,0.0016208298,0.00019320013,0.0030253292,0.000030462883],"about_ca_topic_score_codex":0.0014842072,"about_ca_topic_score_gemma":0.004016919,"teacher_disagreement_score":0.002395125,"about_ca_system_score_codex":0.0008647137,"about_ca_system_score_gemma":0.0018006593,"threshold_uncertainty_score":0.00976181},"labels":[],"label_agreement":null},{"id":"W3111753833","doi":"10.1093/neuonc/noaa222.088","title":"DIPG-41. DISSECTING THE MECHANISTIC BASIS FOR <i>ACVR1</i> AND <i>PIK3CA</i> MUTATION CO-OCCURRENCE IN DIFFUSE MIDLINE GLIOMAS USING GENETICALLY ENGINEERED MOUSE MODELS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"OLIG2; Biology; Forebrain; Gene; Carcinogenesis; Epigenetics; Transcription factor; Cancer research; Histone; Transcriptome; Mutation; Oligodendrocyte; Genetics; Neuroscience; Gene expression; Myelin; Central nervous system","score_opus":0.0500216919919357,"score_gpt":0.3121620055092161,"score_spread":0.2621403135172804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111753833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95305187,0.0027082693,0.016327837,0.0019212356,0.00032484156,0.0004068916,0.008753012,0.0011073442,0.015398764],"genre_scores_gemma":[0.9762314,0.0010211777,0.0062140734,0.00055314065,0.000022351769,0.00037322685,0.0033154497,0.00020108213,0.012068086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995958,0.000058895264,0.000030828953,0.00010589537,0.00009641129,0.00011211778],"domain_scores_gemma":[0.99978465,0.000022944023,0.00005679881,0.000021612124,0.000013867262,0.000100121186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030004655,0.0006433434,0.00032911848,0.0006684379,0.00034981623,0.0006150936,0.0007246041,0.000974976,0.005596996],"category_scores_gemma":[0.00013142986,0.00035700042,0.0005593962,0.000294039,0.0006763319,0.00046105197,0.00049554,0.0018966177,0.0016646294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003139769,0.00009207614,0.0003519221,0.00009326772,0.000014564072,0.00023781229,0.00001887647,0.00016512726,0.99535275,0.0011591372,0.00033337544,0.0018669999],"study_design_scores_gemma":[0.00022127255,0.0008476689,0.0064726993,0.00004155515,0.000060180104,0.0013838416,0.0001247269,0.0035862606,0.9696739,0.000452606,0.01711278,0.000022459652],"about_ca_topic_score_codex":0.001636257,"about_ca_topic_score_gemma":0.0025559755,"teacher_disagreement_score":0.005596996,"about_ca_system_score_codex":0.0008709664,"about_ca_system_score_gemma":0.00049999024,"threshold_uncertainty_score":0.018723786},"labels":[],"label_agreement":null},{"id":"W3111755010","doi":"10.1093/neuonc/noaa222.036","title":"DDEL-01. ENHANCING DRUG DELIVERY WITH MRgFUS FOR DIFFUSE INTRINSIC PONTINE GLIOMA MODEL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Doxorubicin; Brainstem; In vivo; Glioma; Microbubbles; Drug; Blood–brain barrier; Pharmacology; Pathology; Cancer research; Chemotherapy; Central nervous system; Internal medicine; Ultrasound; Biology; Radiology","score_opus":0.021727403911953814,"score_gpt":0.2687987008879853,"score_spread":0.24707129697603147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111755010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016774,0.0014686892,0.005280831,0.00022096837,0.000056055014,0.0001394739,0.00071302056,0.00023104763,0.0017221184],"genre_scores_gemma":[0.9843833,0.001469676,0.0074483817,0.00009072523,0.000011976982,0.00020816806,0.0010749315,0.00003724642,0.0052755876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987423,0.000014474643,0.000007811971,0.00003283992,0.000037023896,0.00003349778],"domain_scores_gemma":[0.99992216,0.0000111649015,0.0000191421,0.000008746974,0.000010511787,0.000028226805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019040352,0.00037671096,0.0002821298,0.0003233896,0.00012802918,0.00017249506,0.0002722353,0.0004055154,0.0013585952],"category_scores_gemma":[0.0000867052,0.00011754536,0.00020615713,0.00022206652,0.00028324506,0.00023540904,0.00013336277,0.00067561556,0.0003737641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023210427,0.00014439279,0.00009676035,0.00006740848,0.0000053092017,0.000086838954,0.000022099764,0.00010363263,0.99665016,0.00012364097,0.0001560435,0.0023114558],"study_design_scores_gemma":[0.000045331548,0.0016694615,0.0008602495,0.0000038879084,0.000015992377,0.00023132135,0.000014951924,0.0007821837,0.99401325,0.000023946348,0.00233548,0.000003932526],"about_ca_topic_score_codex":0.0016437303,"about_ca_topic_score_gemma":0.0020920378,"teacher_disagreement_score":0.0016437303,"about_ca_system_score_codex":0.00035157282,"about_ca_system_score_gemma":0.00033012094,"threshold_uncertainty_score":0.0045449734},"labels":[],"label_agreement":null},{"id":"W3111760764","doi":"10.1093/neuonc/noaa215.059","title":"BIOM-62 SENSITIVE DETECTION AND DISCRIMINATION OF INTRACRANIAL TUMORS BY BLOOD","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biomarker; DNA methylation; Methylation; Glioma; Brain tumor; Medicine; Oncology; Internal medicine; Differential diagnosis; Cancer; Pathology; Cancer research; Biology; DNA; Gene; Gene expression","score_opus":0.010071678059508772,"score_gpt":0.2656741941715288,"score_spread":0.25560251611202006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111760764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8376775,0.0016566323,0.14700589,0.0004144676,0.00014266097,0.00012748288,0.0052845352,0.0031062893,0.004584539],"genre_scores_gemma":[0.9675175,0.00025547657,0.025029564,0.00012653125,0.000030782332,0.00010010839,0.0042060516,0.00007222905,0.0026617819],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996387,0.000074272226,0.000023426177,0.00015739934,0.00006894819,0.00003714977],"domain_scores_gemma":[0.9993369,0.00033820266,0.00010216781,0.00005921184,0.00012605505,0.000037405858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008418883,0.0008670334,0.00062736205,0.0008582085,0.00017040258,0.00082374905,0.00042948962,0.000649515,0.0018161744],"category_scores_gemma":[0.0019203403,0.00031767925,0.00087367196,0.00037565466,0.00023006012,0.00031588078,0.00042227775,0.0006614078,0.0012916175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027283789,0.0005573433,0.26247853,0.0004270109,0.0006759687,0.0003571067,0.00011879963,0.23056448,0.24648616,0.0014978853,0.0063404087,0.24776797],"study_design_scores_gemma":[0.000036656336,0.0002893461,0.035814803,0.000021577154,0.000087931294,0.00022395594,0.000023448913,0.91530764,0.044368885,0.0017817036,0.002010261,0.000033702992],"about_ca_topic_score_codex":0.0038111145,"about_ca_topic_score_gemma":0.0028695082,"teacher_disagreement_score":0.0038111145,"about_ca_system_score_codex":0.00053971185,"about_ca_system_score_gemma":0.00052471063,"threshold_uncertainty_score":0.007577896},"labels":[],"label_agreement":null},{"id":"W3111796351","doi":"10.1093/neuonc/noaa222.501","title":"MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Regimen; Vincristine; Radiation therapy; Chemotherapy regimen; Surgery; Cyclophosphamide; Oncology","score_opus":0.028819902447269136,"score_gpt":0.2799672016497182,"score_spread":0.2511472992024491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111796351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720806,0.0010705756,0.00011976473,0.00008082716,0.000013076754,0.00044522167,0.00044243174,0.000022249696,0.00059782417],"genre_scores_gemma":[0.9957495,0.0010601991,0.0007418777,0.00015335712,0.0000361718,0.0004453243,0.001179353,0.000009069025,0.00062507234],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995389,0.0002117802,0.000033709297,0.0000687936,0.00005829279,0.000088544424],"domain_scores_gemma":[0.9994479,0.000097746655,0.000117619486,0.00003996702,0.00004151797,0.00025529994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011949759,0.0005041021,0.00092410913,0.00037007756,0.0003048248,0.0005300122,0.0005874321,0.00044638535,0.0013705128],"category_scores_gemma":[0.0006972526,0.00019331895,0.00067609124,0.00030377283,0.00044317983,0.0003753137,0.00030244066,0.00074435625,0.0003257425],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34846228,0.09234543,0.17116483,0.000937889,0.0017255964,0.0019510791,0.0008897179,0.0028624875,0.035688024,0.00030102197,0.0032779044,0.34039372],"study_design_scores_gemma":[0.054643124,0.7517865,0.17946339,0.00009296496,0.001075556,0.0009584425,0.00029186165,0.0010501635,0.0061868536,0.000075852564,0.0043439493,0.000031346946],"about_ca_topic_score_codex":0.005712341,"about_ca_topic_score_gemma":0.011839133,"teacher_disagreement_score":0.005712341,"about_ca_system_score_codex":0.00093681633,"about_ca_system_score_gemma":0.0014669654,"threshold_uncertainty_score":0.011358142},"labels":[],"label_agreement":null},{"id":"W3111800309","doi":"10.1093/neuonc/noaa222.828","title":"SWK-11. ASSESSMENT OF THE INDIRECT COSTS ASSOCIATED WITH PROTON THERAPY TREATMENT FOR ALBERTA PATIENTS REFERRED OUT OF COUNTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Stollery Children's Hospital","funders":"","keywords":"Guardian; Medicine; Referral; Proton therapy; Family medicine; Indirect costs; Demography; Business; Political science; Surgery; Radiation therapy","score_opus":0.04210654748746865,"score_gpt":0.3365403763682218,"score_spread":0.29443382888075315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111800309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258524,0.00031086738,0.00009585316,0.00022914185,0.000008828145,0.00006897634,0.0035468682,0.000013251175,0.003140805],"genre_scores_gemma":[0.9938345,0.0002846301,0.0005287686,0.00009725654,0.00001198229,0.000068731206,0.0031883246,0.000006349687,0.00197949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999255,0.00021148253,0.000101245016,0.000052305775,0.00025985175,0.00012017445],"domain_scores_gemma":[0.99648166,0.00049242127,0.0016709176,0.00006556221,0.00079809374,0.000491269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008943906,0.00025778217,0.00019978151,0.0015249404,0.0005914904,0.0007898426,0.00060466875,0.00029045285,0.0036865214],"category_scores_gemma":[0.004392626,0.00017662469,0.0005101096,0.0016499668,0.00022698038,0.00028009826,0.00064629724,0.0004142709,0.00042535184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001154701,0.000039655504,0.9934488,0.000031645355,0.00003081287,0.00005150538,0.000108594504,0.00018355327,0.000039616458,0.00002254496,0.0007311865,0.005196646],"study_design_scores_gemma":[0.000008394612,0.00008798549,0.99818903,0.000016521644,0.000020512438,0.00008941684,0.00041251228,0.00038797536,0.000046765297,0.0000119700035,0.00072332565,0.0000055081787],"about_ca_topic_score_codex":0.30636635,"about_ca_topic_score_gemma":0.4221025,"teacher_disagreement_score":0.6936337,"about_ca_system_score_codex":0.0055033104,"about_ca_system_score_gemma":0.0026780053,"threshold_uncertainty_score":0.6091662},"labels":[],"label_agreement":null},{"id":"W3111804892","doi":"10.1093/neuonc/noaa222.346","title":"IMG-10. MRI-BASED RADIOMIC PROGNOSTIC MARKERS OF DIFFUSE MIDLINE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Radiomics; Gray level; Proportional hazards model; Concordance; Artificial intelligence; Radiology; Nuclear medicine; Internal medicine; Computer science; Image (mathematics)","score_opus":0.016125506266176086,"score_gpt":0.2940524861700402,"score_spread":0.2779269799038641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111804892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913511,0.0017603447,0.0021615585,0.00013237963,0.000022173908,0.000060805804,0.0030491033,0.00012102486,0.0013414973],"genre_scores_gemma":[0.99449134,0.00022864254,0.0022242782,0.0000355251,0.00002117301,0.000042402535,0.0024784913,0.0000116797955,0.00046652535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975246,0.000052363564,0.000020709393,0.00007331405,0.000060836137,0.00004032398],"domain_scores_gemma":[0.99933964,0.000111893925,0.00027722074,0.00004449852,0.00011031444,0.00011646528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006896375,0.00057467417,0.0003520853,0.0012911261,0.00015252426,0.0006208816,0.0003293194,0.00035239477,0.0018351873],"category_scores_gemma":[0.0014035612,0.00011686293,0.0002333727,0.00081410975,0.00023169746,0.00023759065,0.00036381773,0.0002757225,0.0005686382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010597765,0.00008900095,0.94919384,0.00012157449,0.00012083702,0.00020986165,0.00004266307,0.0019298849,0.010464552,0.000090624875,0.0011349776,0.03554255],"study_design_scores_gemma":[0.000035938374,0.00044193887,0.9749008,0.000035152225,0.0001533472,0.0011753594,0.000113402355,0.01134136,0.008437963,0.00035577427,0.0029893941,0.00001963666],"about_ca_topic_score_codex":0.0017612106,"about_ca_topic_score_gemma":0.0019011254,"teacher_disagreement_score":0.0018351873,"about_ca_system_score_codex":0.00031784285,"about_ca_system_score_gemma":0.00028566824,"threshold_uncertainty_score":0.006139338},"labels":[],"label_agreement":null},{"id":"W3111829628","doi":"10.1093/neuonc/noaa215.281","title":"EPCO-02. MOLECULAR CHARACTERIZATION OF TWO NOVEL MPNST SUBGROUPS IDENTIFIES THERAPEUTIC OPPORTUNITIES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cancer research; Wnt signaling pathway; Biology; Targeted therapy; Transcriptome; Medicine; Internal medicine; Signal transduction; Cancer; Genetics; Gene expression; Gene","score_opus":0.07732098688833675,"score_gpt":0.30785285782687166,"score_spread":0.23053187093853492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111829628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98686975,0.0011381272,0.0021717115,0.00027428655,0.00003275114,0.00015066401,0.004979313,0.00014176565,0.004241657],"genre_scores_gemma":[0.97900873,0.0004099251,0.0033914652,0.00023921805,0.000020538637,0.00017987087,0.013281131,0.00006606285,0.003403051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998307,0.000015180156,0.000010647684,0.000058162852,0.000047295267,0.00003799832],"domain_scores_gemma":[0.99970526,0.00003900773,0.00005310933,0.00003280679,0.000069975074,0.00009975384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028497292,0.0002369572,0.00027294562,0.0005564619,0.00031121433,0.00060550525,0.000300877,0.00045763797,0.0031706654],"category_scores_gemma":[0.00043240678,0.00012492455,0.00020496194,0.0004153308,0.00018931355,0.0002449541,0.00031138823,0.000581028,0.0009583246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002998491,0.00025397906,0.10735732,0.00027344082,0.00009058527,0.00064562634,0.00013887761,0.000758776,0.8275714,0.00067955325,0.0037145861,0.055517398],"study_design_scores_gemma":[0.00026565912,0.0016526707,0.60062027,0.0000756155,0.00023393694,0.0050139637,0.00037293194,0.009032816,0.3431528,0.0011963324,0.03834913,0.000033852386],"about_ca_topic_score_codex":0.0009768552,"about_ca_topic_score_gemma":0.0014612206,"teacher_disagreement_score":0.0031706654,"about_ca_system_score_codex":0.0004429893,"about_ca_system_score_gemma":0.0004326917,"threshold_uncertainty_score":0.010606945},"labels":[],"label_agreement":null},{"id":"W3111832741","doi":"10.1093/neuonc/noaa222.115","title":"DIPG-73. SENESCENCE ASSOCIATED SECRETORY PHENOTYPE AS A MECHANISM OF RESISTANCE AND THERAPEUTIC VULNERABILITY IN BMI1 INHIBITOR TREATED DIPG","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"BMI1; Cancer research; In vivo; Senescence; Apoptosis; Phenotype; Biology; Histone H3; Synthetic lethality; Cell culture; Epigenetics; Cell biology; Gene; Genetics; DNA repair","score_opus":0.027446583687917404,"score_gpt":0.29119980426584985,"score_spread":0.26375322057793243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111832741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349433,0.0016878499,0.0012769474,0.00014012438,0.000039015773,0.00007731793,0.0015008261,0.0002550352,0.0015285886],"genre_scores_gemma":[0.9933697,0.0007246759,0.0011010981,0.00010785063,0.000005906839,0.000065201086,0.0019375391,0.00003155132,0.002656546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991655,0.000004925841,0.000004828457,0.000019277119,0.000030616135,0.000023713363],"domain_scores_gemma":[0.99993277,0.000007094625,0.000012685079,0.000006178689,0.000008267448,0.000033103017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008647383,0.0002498835,0.0004090481,0.00028064303,0.000111797664,0.0002199905,0.0001831293,0.0002322918,0.0020554955],"category_scores_gemma":[0.00007553118,0.00009439238,0.00025791343,0.00023130854,0.00016978351,0.00010768236,0.00013385786,0.00067616143,0.0004093733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032046664,0.00011255855,0.00090995093,0.00006686195,0.0000143543075,0.00023959261,0.000015332995,0.000115788265,0.9916922,0.000069846945,0.00027858163,0.0061645242],"study_design_scores_gemma":[0.00008888532,0.0037945546,0.036472306,0.000010759427,0.00006663268,0.0021238418,0.00006766353,0.0017043047,0.94843256,0.00010941498,0.0071147764,0.000014434357],"about_ca_topic_score_codex":0.0013144217,"about_ca_topic_score_gemma":0.0018382268,"teacher_disagreement_score":0.0020554955,"about_ca_system_score_codex":0.00033423112,"about_ca_system_score_gemma":0.0001883562,"threshold_uncertainty_score":0.00687629},"labels":[],"label_agreement":null},{"id":"W3111879451","doi":"10.1093/neuonc/noaa215.772","title":"RADT-19. EFFECTS OF RADIATION DOSE-RATE AND TUMOR CHARACTERISTICS ON LOCAL CONTROL AND TOXICITY AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Acoustic neuroma; Nuclear medicine; Hazard ratio; Schwannoma; Cumulative incidence; Lesion; Radiation therapy; Radiology; Surgery; Confidence interval; Internal medicine; Cohort","score_opus":0.01328803839082017,"score_gpt":0.2524608727621117,"score_spread":0.23917283437129155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111879451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966029,0.0011340475,0.00024617367,0.00005031878,0.000010868063,0.000018963603,0.00092708704,0.00001425102,0.0009953561],"genre_scores_gemma":[0.99843484,0.00011177673,0.000109730034,0.000018943716,0.000014974955,0.000017632663,0.0005926967,0.00001273072,0.00068660587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991222,0.0002482541,0.00011309103,0.00015318912,0.00024884217,0.00011445839],"domain_scores_gemma":[0.9974101,0.0005829092,0.0014638867,0.00011037247,0.00014298713,0.0002896659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012793588,0.00015419391,0.00032749248,0.00045305872,0.00013304586,0.0005256595,0.0003214816,0.00016369695,0.0030794542],"category_scores_gemma":[0.002706179,0.00009553026,0.0007129241,0.0005951554,0.0001848487,0.0002357037,0.00020214138,0.00021146657,0.0004505464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030654767,0.000060072998,0.97794116,0.00007354067,0.00033843794,0.00019140873,0.000044045257,0.0004019978,0.0011060154,0.00004130726,0.0003439092,0.016392719],"study_design_scores_gemma":[0.00004630044,0.0015373781,0.9957377,0.000010406691,0.00014269212,0.0004152461,0.000028054154,0.00031873686,0.00074241037,0.00002176811,0.0009945408,0.00000469393],"about_ca_topic_score_codex":0.0044864933,"about_ca_topic_score_gemma":0.006548289,"teacher_disagreement_score":0.0044864933,"about_ca_system_score_codex":0.0009763309,"about_ca_system_score_gemma":0.0005185708,"threshold_uncertainty_score":0.010301769},"labels":[],"label_agreement":null},{"id":"W3111884990","doi":"10.1093/neuonc/noaa215.306","title":"EPCO-27. GLIOMA SINGLE CELL MULTI-OMIC ANALYSES REVEALS REGULATORS OF PLASTICITY AND ADAPTIVE STRESS RESPONSE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Transcriptome; Glioma; Stem cell; Histone; Carcinogenesis; Transcription factor; Genetics; Cancer research; Gene; Gene expression","score_opus":0.053678361106581786,"score_gpt":0.318715153809698,"score_spread":0.2650367927031162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111884990","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45664167,0.0026607711,0.03478766,0.00058162573,0.00017965266,0.00031095775,0.47914127,0.010119067,0.015577208],"genre_scores_gemma":[0.40777788,0.0010303495,0.04547476,0.00049702247,0.00004208238,0.0005177374,0.5332289,0.0023210628,0.009110206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994198,0.00003796666,0.0000374683,0.00019021278,0.00020543754,0.00010927128],"domain_scores_gemma":[0.99947387,0.000088491564,0.0000860467,0.00010953625,0.0001573836,0.00008467745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008237703,0.00071128935,0.0008966783,0.0018379487,0.0007510959,0.0011680824,0.0006874966,0.000539859,0.0059820227],"category_scores_gemma":[0.0007087617,0.000322097,0.0007249494,0.0017717447,0.00026479823,0.0003473897,0.00086553063,0.00062951073,0.0048380964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014638177,0.00008540107,0.020107312,0.0007444195,0.00020183391,0.00031405932,0.00013376855,0.0015716541,0.9338766,0.0013755138,0.015887529,0.02423802],"study_design_scores_gemma":[0.00025711293,0.0007322252,0.31389785,0.00017939467,0.00044817908,0.001966839,0.0002735948,0.037061278,0.47508037,0.0024960139,0.1674406,0.0001665307],"about_ca_topic_score_codex":0.0054672416,"about_ca_topic_score_gemma":0.009500765,"teacher_disagreement_score":0.0059820227,"about_ca_system_score_codex":0.000756404,"about_ca_system_score_gemma":0.00097052514,"threshold_uncertainty_score":0.020011842},"labels":[],"label_agreement":null},{"id":"W3111907072","doi":"10.1093/neuonc/noaa222.831","title":"TBIO-02. IMMUNE PROFILING OF RARE EMBRYONAL BRAIN TUMORS REVEAL EVIDENCE OF DYSREGULATED INTERFERON SIGNALLING AS A POTENTIAL DETERMINANT OF IMMUNOLOGICAL HETEROGENEITY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; In silico; Immune system; Glioma; Epigenomics; Transcriptome; Immunotherapy; Tumor microenvironment; Computational biology; Cancer research; Immunology; DNA methylation; Genetics; Gene; Gene expression","score_opus":0.033377809654690664,"score_gpt":0.2987804849533806,"score_spread":0.26540267529868994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111907072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197525,0.000653638,0.0025435896,0.000065267835,0.000014121273,0.000027169568,0.0034705615,0.00010029505,0.0011502899],"genre_scores_gemma":[0.9860763,0.00037222818,0.0024335766,0.00015272353,0.0000065299173,0.00008295725,0.008922595,0.000062712534,0.0018902577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99979395,0.000020297613,0.000011635493,0.00005029024,0.00007003074,0.00005374044],"domain_scores_gemma":[0.9998437,0.000027399865,0.000043957738,0.000014870391,0.000019791152,0.00005019983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017131113,0.00017812602,0.00022388785,0.00033476207,0.0002358903,0.00037015486,0.00019733868,0.00023352628,0.0014598916],"category_scores_gemma":[0.00015428363,0.00010399058,0.00017625758,0.0002754101,0.00016877147,0.00008093221,0.00016631624,0.00053171563,0.00041796733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002760067,0.000025984486,0.0050663133,0.000031773947,0.000014031314,0.000089553374,0.0000301117,0.000101986625,0.9922002,0.000049839113,0.00016032756,0.0019537942],"study_design_scores_gemma":[0.000035602316,0.0007540687,0.22159241,0.000018767078,0.000080190206,0.0021261598,0.00030031492,0.00337744,0.76279867,0.00026021662,0.008637575,0.00001859851],"about_ca_topic_score_codex":0.0009184136,"about_ca_topic_score_gemma":0.0017409059,"teacher_disagreement_score":0.0014598916,"about_ca_system_score_codex":0.00022687457,"about_ca_system_score_gemma":0.0001712912,"threshold_uncertainty_score":0.004883826},"labels":[],"label_agreement":null},{"id":"W3111914727","doi":"10.1093/neuonc/noaa222.668","title":"QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Worry; Quality of life (healthcare); Medulloblastoma; Radiation therapy; Cancer; Pediatric cancer; Family medicine; Physical therapy; Anxiety; Internal medicine; Psychiatry; Nursing","score_opus":0.019186850732725517,"score_gpt":0.3054117004378184,"score_spread":0.2862248497050929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111914727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986737,0.00012011749,0.000026174306,0.00009299228,0.0000032003877,0.000010565747,0.00043514563,0.000002815546,0.000635399],"genre_scores_gemma":[0.99914503,0.00010483837,0.00008462763,0.000039550443,0.000003104067,0.000017516142,0.00040439944,0.0000012650806,0.00019967704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994881,0.00013384693,0.000062694104,0.000042108895,0.00012928736,0.00014394053],"domain_scores_gemma":[0.99781394,0.00037299393,0.0010928798,0.000038398077,0.000267445,0.00041432647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093882735,0.00017836447,0.0002023402,0.00048033247,0.00031534818,0.0006028889,0.00024596488,0.00018968106,0.003064684],"category_scores_gemma":[0.0030370872,0.00012473042,0.00040194133,0.0005704163,0.00030869633,0.000427291,0.0006718411,0.00051261496,0.00018078108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030520565,0.00002889844,0.99428314,0.000029106988,0.00002766055,0.000063326625,0.00094578246,0.000044628137,0.00010798358,0.000021478938,0.00045393207,0.003963487],"study_design_scores_gemma":[0.0000025511179,0.00009711009,0.99704117,0.0000134498005,0.000009396649,0.00017839728,0.0019436647,0.00007039943,0.00005895757,0.000012405246,0.000568622,0.0000037860425],"about_ca_topic_score_codex":0.008517651,"about_ca_topic_score_gemma":0.012228615,"teacher_disagreement_score":0.008517651,"about_ca_system_score_codex":0.0006637827,"about_ca_system_score_gemma":0.00049065414,"threshold_uncertainty_score":0.016936123},"labels":[],"label_agreement":null},{"id":"W3111923710","doi":"10.1093/neuonc/noaa222.613","title":"NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Natural history; Natural history study; Pediatrics; Internal medicine; Radiology","score_opus":0.05540380640046057,"score_gpt":0.3285610388089389,"score_spread":0.27315723240847833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111923710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989755,0.000080282705,0.000047969726,0.000024277831,0.0000019388629,0.000021800979,0.0005890507,0.0000026243974,0.00025661694],"genre_scores_gemma":[0.99925524,0.000029032457,0.00007490701,0.000021918255,0.000005372795,0.000020447173,0.0004886377,0.0000019285164,0.00010248978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993048,0.00025013954,0.000063379404,0.00018776188,0.000104079234,0.00008983904],"domain_scores_gemma":[0.99768174,0.0005593309,0.0009793513,0.00013668406,0.00014021584,0.00050268805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013415011,0.00023693733,0.0002175125,0.0006337629,0.00044818933,0.00069609104,0.00045163513,0.0004190255,0.0022761489],"category_scores_gemma":[0.0024718978,0.0002587632,0.00032107637,0.000740434,0.00031358478,0.0007889749,0.0004900801,0.00041262226,0.0004439648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023028458,0.00004999407,0.9989299,0.000004454639,0.000016071052,0.00004339432,0.000059385224,0.000012358514,0.00013923524,0.000007718876,0.0000517133,0.000455488],"study_design_scores_gemma":[0.000021392952,0.0002227603,0.9991041,0.0000034403188,0.000018628647,0.00022223132,0.0001299322,0.000086410495,0.00006639947,0.000007341537,0.000114827606,0.000002521272],"about_ca_topic_score_codex":0.003050856,"about_ca_topic_score_gemma":0.004320967,"teacher_disagreement_score":0.003050856,"about_ca_system_score_codex":0.00035141717,"about_ca_system_score_gemma":0.00037397223,"threshold_uncertainty_score":0.0076144934},"labels":[],"label_agreement":null},{"id":"W3111926312","doi":"10.1093/neuonc/noaa222.132","title":"EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Adverse effect; Tropomyosin receptor kinase A; Fusion gene; Oncology; Cancer; Gastroenterology; Receptor; Neurotrophin; Gene; Biology","score_opus":0.013157519264743537,"score_gpt":0.2512920259977259,"score_spread":0.23813450673298234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111926312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97038305,0.010960215,0.000716426,0.0006470043,0.00006181402,0.0003331827,0.0043611005,0.00014274222,0.012394589],"genre_scores_gemma":[0.989493,0.0024725953,0.0010754993,0.00041784102,0.000049216727,0.00014823055,0.0048804744,0.00001671509,0.0014463995],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99977785,0.00006566915,0.000027408409,0.000040729894,0.00004433957,0.00004404905],"domain_scores_gemma":[0.9996524,0.00007408599,0.00009225155,0.000018639921,0.00006008536,0.00010253902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005641994,0.00024383357,0.0005843583,0.00020097733,0.00015103315,0.00052359473,0.00021992298,0.000273477,0.0032132096],"category_scores_gemma":[0.0005810036,0.00007873322,0.00038652262,0.0003911915,0.00018451025,0.00029033408,0.00018411485,0.0006063701,0.0006302236],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050099123,0.002598628,0.31563592,0.0020430954,0.0010825933,0.0071990066,0.0003051196,0.0049054166,0.10089278,0.0011972255,0.03653659,0.4775046],"study_design_scores_gemma":[0.02664236,0.073433876,0.651089,0.00051710726,0.0020895444,0.033299085,0.00031285099,0.008707814,0.09582717,0.00082755316,0.107167415,0.000086230095],"about_ca_topic_score_codex":0.0010743641,"about_ca_topic_score_gemma":0.0028179595,"teacher_disagreement_score":0.0032132096,"about_ca_system_score_codex":0.0007465005,"about_ca_system_score_gemma":0.0007687221,"threshold_uncertainty_score":0.010749221},"labels":[],"label_agreement":null},{"id":"W3111979438","doi":"10.1093/neuonc/noaa222.776","title":"RONC-03. NEUROCOGNITIVE CHANGES AFTER RADIATION FOR PEDIATRIC BRAIN TUMOURS: WHICH BRAIN SUBSTRUCTURES ARE MOST IMPORTANT?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Neurocognitive; Medicine; Hippocampus; Intelligence quotient; Neuropsychology; Pediatrics; Cognition; Wechsler Adult Intelligence Scale; Nuclear medicine; Psychology; Internal medicine; Audiology; Psychiatry","score_opus":0.019224484503398254,"score_gpt":0.2890138421141553,"score_spread":0.26978935761075706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111979438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404825,0.0032952824,0.0003286852,0.0004806084,0.00003531613,0.000048295464,0.007958664,0.00004321703,0.0037617087],"genre_scores_gemma":[0.9905578,0.0007392883,0.00083829317,0.00016451761,0.000038363298,0.00010316941,0.0064794556,0.000029618099,0.0010494946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989453,0.0003177591,0.000120677476,0.00019315054,0.0002809868,0.0001421123],"domain_scores_gemma":[0.9958574,0.0006373835,0.0023477848,0.00015713659,0.0006315904,0.0003686674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016406032,0.00027324556,0.00049167546,0.0005037817,0.00023880157,0.00080090517,0.00069127337,0.00035614343,0.0036104596],"category_scores_gemma":[0.0041420325,0.00012312178,0.0007728265,0.0014048711,0.0004069054,0.00042036298,0.00042145295,0.00038805482,0.0006701554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037806696,0.000019005822,0.9889452,0.00009583849,0.00011179146,0.00007681519,0.000044640332,0.00023898772,0.00017424856,0.00006425069,0.0009525478,0.008898618],"study_design_scores_gemma":[0.000027322209,0.00028641088,0.99478936,0.0000955906,0.00014792067,0.00047379098,0.00012593987,0.00035022805,0.00042221442,0.000062491374,0.0032101655,0.0000085370175],"about_ca_topic_score_codex":0.013961539,"about_ca_topic_score_gemma":0.022633309,"teacher_disagreement_score":0.013961539,"about_ca_system_score_codex":0.0014043861,"about_ca_system_score_gemma":0.0022069467,"threshold_uncertainty_score":0.027760565},"labels":[],"label_agreement":null},{"id":"W3111985146","doi":"10.1093/neuonc/noaa222.484","title":"MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Copy-number variation; Exome; Cohort; Biology; Exome sequencing; Gene; Medicine; Bioinformatics; Cancer research; Genome; Genetics; Mutation","score_opus":0.007042168819649711,"score_gpt":0.24567298345416375,"score_spread":0.23863081463451402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111985146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674857,0.0002031405,0.0004840203,0.00003139682,0.0000033583615,0.000037335314,0.001953966,0.00006188284,0.0004763063],"genre_scores_gemma":[0.9944813,0.00004522065,0.0010870105,0.000021793601,0.000005243024,0.000040068015,0.0040417006,0.000016023561,0.0002617027],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951947,0.00007588221,0.000049310114,0.00016330443,0.000108926215,0.00008315311],"domain_scores_gemma":[0.9994791,0.00009093037,0.00014498089,0.00010312078,0.00007922621,0.00010264216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081052014,0.000196769,0.00048049368,0.0012346527,0.00031986984,0.00047745137,0.0005032648,0.00025594493,0.0019864154],"category_scores_gemma":[0.001241853,0.00014213187,0.00029753408,0.0007152839,0.0001786574,0.00014628294,0.00050763605,0.00019872122,0.0005189286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037138609,0.00021211602,0.7644974,0.00012371781,0.00025318327,0.00082160404,0.00037219236,0.000859647,0.17167202,0.00017016685,0.0010904453,0.056213606],"study_design_scores_gemma":[0.00011285067,0.0007427471,0.9654417,0.000010179775,0.00017910716,0.0029832823,0.00020775347,0.0021037257,0.024333391,0.00013104932,0.0037425845,0.000011583226],"about_ca_topic_score_codex":0.0046567298,"about_ca_topic_score_gemma":0.005625526,"teacher_disagreement_score":0.0046567298,"about_ca_system_score_codex":0.0005993173,"about_ca_system_score_gemma":0.00046322533,"threshold_uncertainty_score":0.009259284},"labels":[],"label_agreement":null},{"id":"W3111988047","doi":"10.1093/neuonc/noaa215.494","title":"INNV-11. GLIOBLASTOMA IN THE OLDER PERSON – HOW DO WE DECIDE ON TREATMENT?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glioblastoma; Population; Cohort; Incidence (geometry); Test (biology); Gerontology; Family medicine; Internal medicine; Environmental health","score_opus":0.03826035598309131,"score_gpt":0.2994631702256527,"score_spread":0.2612028142425614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111988047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8243993,0.02439233,0.0005486361,0.11033281,0.0012612651,0.00012210466,0.004232032,0.00003865156,0.034672976],"genre_scores_gemma":[0.9816321,0.006060234,0.00059198966,0.007634062,0.00039376534,0.00007757731,0.0013083078,0.000013886062,0.002288139],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974591,0.00135424,0.00027157555,0.00013252247,0.00035789429,0.00042464735],"domain_scores_gemma":[0.99126124,0.0028479015,0.0029377448,0.0001510052,0.0010610452,0.0017410625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032721784,0.00009657497,0.00037010404,0.00054070563,0.0006913745,0.0015622377,0.00043335216,0.00066867116,0.005805842],"category_scores_gemma":[0.017800655,0.000108151406,0.00034674,0.000980521,0.00033653146,0.0010470165,0.0008835058,0.0016322698,0.0008678772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032163147,0.00027673718,0.86765885,0.00028038296,0.00007227069,0.0001685303,0.0009021712,0.00013858562,0.000042593136,0.0006993019,0.026151983,0.10328704],"study_design_scores_gemma":[0.00006269834,0.0004931832,0.94481915,0.002344606,0.00014399571,0.00070758106,0.008684484,0.0008397189,0.00013078364,0.0027237996,0.03898688,0.00006319467],"about_ca_topic_score_codex":0.013922286,"about_ca_topic_score_gemma":0.026523327,"teacher_disagreement_score":0.013922286,"about_ca_system_score_codex":0.0013172708,"about_ca_system_score_gemma":0.0017808651,"threshold_uncertainty_score":0.027682483},"labels":[],"label_agreement":null},{"id":"W3111988545","doi":"10.1093/neuonc/noaa222.357","title":"IMG-22. A DEEP LEARNING MODEL FOR AUTOMATIC POSTERIOR FOSSA PEDIATRIC BRAIN TUMOR SEGMENTATION: A MULTI-INSTITUTIONAL STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Segmentation; Deep learning; Computer science; Ground truth; Artificial intelligence; Medulloblastoma; Ependymoma; Pilocytic astrocytoma; Convolutional neural network; Neuroradiologist; Medicine; Magnetic resonance imaging; Radiology; Astrocytoma; Glioma; Pathology","score_opus":0.04452866306211238,"score_gpt":0.33331009159362346,"score_spread":0.28878142853151106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111988545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745335,0.00048341893,0.021158613,0.00017904659,0.000034121622,0.00014301576,0.002175769,0.00068792456,0.0006046138],"genre_scores_gemma":[0.97677284,0.00018877318,0.017044855,0.000090143505,0.000023585453,0.00015014343,0.005012461,0.0001463165,0.00057093246],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991736,0.00033388878,0.00005433271,0.00021899593,0.00013201685,0.00008724076],"domain_scores_gemma":[0.9971733,0.0011188991,0.0003584912,0.0005855053,0.00056118355,0.00020253516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028704216,0.0011516431,0.00055887556,0.0010245987,0.00028609505,0.000735807,0.0013072442,0.0009852706,0.0011142127],"category_scores_gemma":[0.0059597525,0.0003855904,0.0008190466,0.000769356,0.0005096613,0.0007466542,0.00081607525,0.0009504058,0.00051947095],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002666425,0.0022977297,0.37554047,0.0004379332,0.0018350616,0.0016395479,0.00040596945,0.33717102,0.010360492,0.0011722539,0.014772201,0.251701],"study_design_scores_gemma":[0.00016398833,0.0016149505,0.06851865,0.00005266284,0.00036338816,0.0010532347,0.00025624593,0.91077805,0.012915226,0.0007860443,0.0034263853,0.000071249546],"about_ca_topic_score_codex":0.011189823,"about_ca_topic_score_gemma":0.00956978,"teacher_disagreement_score":0.011189823,"about_ca_system_score_codex":0.0010930601,"about_ca_system_score_gemma":0.0007513851,"threshold_uncertainty_score":0.0222494},"labels":[],"label_agreement":null},{"id":"W3111996078","doi":"10.1093/neuonc/noaa222.667","title":"QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Neurocognitive; Medicine; Medulloblastoma; Radiation therapy; Pediatrics; Cognition; Internal medicine; Psychiatry; Pathology","score_opus":0.034038019124207126,"score_gpt":0.3137440631071398,"score_spread":0.2797060439829327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111996078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995096,0.000054170752,0.000024008343,0.00001437312,0.0000015061901,0.0000043405944,0.00026742747,0.0000014442227,0.00012310072],"genre_scores_gemma":[0.9991641,0.000033455162,0.00003653659,0.000009118654,0.0000018738272,0.000007921767,0.000654738,0.0000011231491,0.00009116738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974746,0.000060998147,0.000027254264,0.000048567355,0.000057629306,0.00005801598],"domain_scores_gemma":[0.9986615,0.000114642186,0.00075056194,0.000045836954,0.00019238047,0.00023504213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065617147,0.00014840341,0.00021865821,0.0005346954,0.0003253837,0.00045049097,0.000200035,0.00021382821,0.0008821847],"category_scores_gemma":[0.0018903788,0.0001286808,0.0004053154,0.000625153,0.00015287864,0.00040346116,0.00033282538,0.00050200545,0.00021489103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018087978,0.000036376197,0.9983333,0.0000028846923,0.000028422033,0.000018112687,0.000043757045,0.00003140427,0.0001159207,0.0000045026704,0.000042821062,0.0011615803],"study_design_scores_gemma":[0.00000579639,0.00018835449,0.9994832,0.0000014011807,0.000012244327,0.00005081739,0.000067526445,0.00006204162,0.000050641094,0.0000033028912,0.00007336424,0.0000012923704],"about_ca_topic_score_codex":0.0052559734,"about_ca_topic_score_gemma":0.005056677,"teacher_disagreement_score":0.0052559734,"about_ca_system_score_codex":0.00046205774,"about_ca_system_score_gemma":0.00037520117,"threshold_uncertainty_score":0.010450721},"labels":[],"label_agreement":null},{"id":"W3112001372","doi":"10.1093/neuonc/noaa215.233","title":"CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Surgery; Receptor; Neurotrophin","score_opus":0.014923764730465115,"score_gpt":0.25709316747128363,"score_spread":0.24216940274081852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112001372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66370225,0.015096053,0.0011195692,0.00063216547,0.00007743748,0.00085215265,0.30779335,0.00016237187,0.010564602],"genre_scores_gemma":[0.6614166,0.0031104549,0.0010571632,0.0006026502,0.00011613923,0.00078306894,0.3302201,0.000052012005,0.0026417316],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99895346,0.00027217495,0.0001590348,0.00024413315,0.00022632479,0.00014479426],"domain_scores_gemma":[0.998223,0.00046702646,0.0006596745,0.00019975663,0.0002790799,0.00017145766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013953972,0.0006146814,0.0013668219,0.00069202646,0.00026596847,0.0007901852,0.0008720688,0.00046358645,0.0043962165],"category_scores_gemma":[0.002201488,0.00023206204,0.001801142,0.0014170321,0.00019293997,0.0004341605,0.0005299718,0.00071623205,0.0013718813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08499182,0.00081916776,0.5711767,0.0102627035,0.012498108,0.0014308294,0.000281883,0.006557021,0.012073631,0.0006382381,0.103427194,0.19584274],"study_design_scores_gemma":[0.018545883,0.0059013907,0.8594461,0.0015724716,0.010514267,0.003892621,0.00023080409,0.006522495,0.003974134,0.0009306955,0.08833706,0.0001320233],"about_ca_topic_score_codex":0.003588276,"about_ca_topic_score_gemma":0.010998945,"teacher_disagreement_score":0.0043962165,"about_ca_system_score_codex":0.0007410647,"about_ca_system_score_gemma":0.0011112039,"threshold_uncertainty_score":0.01470685},"labels":[],"label_agreement":null},{"id":"W3112008511","doi":"10.1093/neuonc/noaa222.092","title":"DIPG-46. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Histopathology; Medicine; Medical diagnosis; Neuroimaging; Biopsy; Pilocytic astrocytoma; Radiology; Pathology; Astrocytoma; Glioma","score_opus":0.044146907517437176,"score_gpt":0.3297210212274241,"score_spread":0.2855741137099869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112008511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916468,0.0010795774,0.00018907516,0.0000762757,0.000010112008,0.00006933222,0.0035962602,0.000023932049,0.0033086003],"genre_scores_gemma":[0.996714,0.00030635812,0.0002031443,0.000038464612,0.000012641858,0.000047262365,0.002478334,0.0000065413633,0.0001932722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993734,0.00009582195,0.00011200905,0.00016901946,0.000104954575,0.00014490819],"domain_scores_gemma":[0.9980039,0.000243829,0.0010358646,0.00018353279,0.0002489812,0.0002838226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000730994,0.00016128384,0.00028216964,0.0019965228,0.000351314,0.0007750487,0.00033890578,0.00021618241,0.002823418],"category_scores_gemma":[0.0027312213,0.00014401316,0.00017466304,0.00221581,0.0003342751,0.00056992174,0.00065122166,0.00017135411,0.00065304246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007342204,0.000011169816,0.9953577,0.00003526132,0.000009732959,0.0009954259,0.000071556846,0.00001979383,0.00023638443,0.000026787027,0.00034913936,0.0028136314],"study_design_scores_gemma":[0.000008524802,0.00005324055,0.99080664,0.000023424469,0.00001892275,0.00696819,0.00038813252,0.00010045347,0.00037417863,0.00002982141,0.0012235615,0.0000050389763],"about_ca_topic_score_codex":0.0030666732,"about_ca_topic_score_gemma":0.0028006113,"teacher_disagreement_score":0.0030666732,"about_ca_system_score_codex":0.0004615733,"about_ca_system_score_gemma":0.00074186205,"threshold_uncertainty_score":0.00944525},"labels":[],"label_agreement":null},{"id":"W3112019368","doi":"10.1093/neuonc/noaa215.047","title":"BIOM-50. GENETIC PREDISPOSITION TO LONGER TELOMERE LENGTH AND RISK OF CHILDHOOD, ADOLESCENT AND ADULT-ONSET EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ependymoma; Telomere; Medicine; Population; Oncology; Genome-wide association study; Internal medicine; Pediatrics; Single-nucleotide polymorphism; Biology; Pathology; Genetics; Genotype","score_opus":0.011171728224493091,"score_gpt":0.25612428980165475,"score_spread":0.24495256157716166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112019368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945602,0.0005693655,0.000954896,0.00011444018,0.000017044327,0.000016509392,0.0026313474,0.000044182772,0.0010920528],"genre_scores_gemma":[0.9974037,0.00010755959,0.00072199595,0.00003965982,0.000014364685,0.000018011115,0.0011372416,0.000010410512,0.0005470055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951136,0.000120199096,0.000052428684,0.00020327042,0.000057585814,0.00005522689],"domain_scores_gemma":[0.9984485,0.00039095993,0.0007164312,0.00016073458,0.00009892829,0.00018446615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005409172,0.00039711312,0.00022715163,0.0008338999,0.00035671412,0.00050798606,0.00036130304,0.0004215719,0.0072968523],"category_scores_gemma":[0.0022381693,0.00014880528,0.0006589379,0.0010166164,0.00028205558,0.00020299316,0.00034426342,0.00041758458,0.00038927697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005254776,0.000029903325,0.9910772,0.00003493833,0.00029484605,0.00035697437,0.0000588661,0.00013791601,0.002675946,0.00013991121,0.0003151216,0.0043529277],"study_design_scores_gemma":[0.00002306212,0.000094885305,0.99753356,0.0000122274605,0.00014243835,0.00068288954,0.00003531768,0.0002992918,0.0004756502,0.00010460213,0.00059265184,0.0000032844046],"about_ca_topic_score_codex":0.0060223537,"about_ca_topic_score_gemma":0.0039407643,"teacher_disagreement_score":0.0072968523,"about_ca_system_score_codex":0.00023796834,"about_ca_system_score_gemma":0.00028290125,"threshold_uncertainty_score":0.024410427},"labels":[],"label_agreement":null},{"id":"W3112027773","doi":"10.1093/neuonc/noaa215.989","title":"LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Pembrolizumab; Temozolomide; Medicine; Phases of clinical research; Regimen; Internal medicine; Adverse effect; Surgery; Oncology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.03219008510426249,"score_gpt":0.34872699407953633,"score_spread":0.31653690897527387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112027773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906651,0.0023056967,0.0007373453,0.0003339079,0.00011131888,0.0025805025,0.0013478233,0.00016669113,0.0017515599],"genre_scores_gemma":[0.9855467,0.0014045181,0.0023793373,0.00062619615,0.0001476212,0.0033916924,0.0032749982,0.00003972455,0.003189117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99932194,0.0003982584,0.000024597382,0.000095154996,0.00005808903,0.00010203726],"domain_scores_gemma":[0.99949884,0.000052618867,0.00011274055,0.000051022627,0.00004511706,0.00023959285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002378358,0.0017689401,0.0013245852,0.00045243985,0.00049161364,0.00093379506,0.0014357939,0.001114003,0.0035673822],"category_scores_gemma":[0.00060130184,0.00075610814,0.0007451327,0.0003948904,0.0007555691,0.0006052194,0.0003013116,0.0022206192,0.0012946251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56770873,0.12345178,0.012656697,0.00096063036,0.0014813364,0.0005717191,0.00037337502,0.0023029055,0.17678103,0.00037040512,0.007788111,0.10555325],"study_design_scores_gemma":[0.40255463,0.5620084,0.014919567,0.00004034308,0.0005463283,0.00055154343,0.00007819115,0.0011655331,0.01366614,0.00011201754,0.004324402,0.00003293878],"about_ca_topic_score_codex":0.002255715,"about_ca_topic_score_gemma":0.0053331666,"teacher_disagreement_score":0.0035673822,"about_ca_system_score_codex":0.00119821,"about_ca_system_score_gemma":0.0017662194,"threshold_uncertainty_score":0.01257813},"labels":[],"label_agreement":null},{"id":"W3112033076","doi":"10.1093/neuonc/noaa222.428","title":"LGG-50. INTEGRATED MOLECULAR AND CLINICAL ANALYSIS OF 1,000 PEDIATRIC LOW-GRADE GLIOMAS UNCOVERS NOVEL SUBGROUPS FOR CLINICAL RISK STRATIFICATION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"IDH1; Risk stratification; Medicine; Internal medicine; Cohort; Oncology; Histology; Gastroenterology; Pathology; Mutation; Biology; Gene; Genetics","score_opus":0.06929710980612228,"score_gpt":0.40745634062080505,"score_spread":0.3381592308146828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112033076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695385,0.0002463778,0.00042846007,0.000056531466,0.00000358238,0.000021730544,0.0014840633,0.00006155459,0.0007439107],"genre_scores_gemma":[0.9955894,0.000083090876,0.00076929905,0.00003116098,0.0000067839205,0.000025682042,0.0031973985,0.000014967636,0.00028232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997286,0.0000541989,0.000019520818,0.00008217599,0.00005674246,0.00005872136],"domain_scores_gemma":[0.9996165,0.00005824208,0.00011868541,0.00004331396,0.000045212484,0.00011801453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047859413,0.0003153401,0.00029494503,0.00093986647,0.0002580266,0.0006999129,0.0002935978,0.00031722468,0.0012813513],"category_scores_gemma":[0.0011527017,0.000113213646,0.00022153191,0.00075746473,0.00019918219,0.00029306673,0.000528907,0.00029240054,0.0005617633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034380943,0.00002138909,0.9736476,0.00001650515,0.000041324365,0.00034251282,0.00006556513,0.00023231383,0.007071152,0.00006763336,0.00081913173,0.017331092],"study_design_scores_gemma":[0.000014613722,0.00014251766,0.99289775,0.000007906762,0.00003923686,0.0017869165,0.00010909797,0.0009895988,0.0017187697,0.00012400464,0.002165601,0.0000039750075],"about_ca_topic_score_codex":0.0022492337,"about_ca_topic_score_gemma":0.0031781574,"teacher_disagreement_score":0.0022492337,"about_ca_system_score_codex":0.00050889933,"about_ca_system_score_gemma":0.00026657648,"threshold_uncertainty_score":0.0044723153},"labels":[],"label_agreement":null},{"id":"W3112040438","doi":"10.1093/neuonc/noaa222.270","title":"GCT-52. TRANSCRIPTOME OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR REVEALS ITS PATHOGENESIS AND CONTRASTS WITH TESTICULAR COUNTERPARTS IN INTEGRATED OMICS ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Transcriptome; Atypical teratoid rhabdoid tumor; Germinoma; Germ cell tumors; DNA methylation; Germ cell; Embryonic stem cell; Epigenetics; Cancer research; Genetics; Gene; Gene expression","score_opus":0.012245279618759831,"score_gpt":0.24196034727371973,"score_spread":0.22971506765495991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112040438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459884,0.005656649,0.0040130396,0.00025900942,0.00005608623,0.000045296732,0.040490683,0.00041725786,0.0030736385],"genre_scores_gemma":[0.93114054,0.002217807,0.0048527825,0.0002344792,0.000017341948,0.00007399694,0.058224257,0.00013773717,0.0031011782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982303,0.000010734817,0.0000101991545,0.00007405548,0.00004676361,0.000035209425],"domain_scores_gemma":[0.9998759,0.000021102074,0.000039761122,0.000012396624,0.000029454462,0.00002132113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001438471,0.00025005132,0.0003669095,0.0007622659,0.00040268054,0.000584258,0.00012985154,0.00021488077,0.0016293383],"category_scores_gemma":[0.00020887752,0.00013782959,0.00040805247,0.001227629,0.00013217387,0.00014787428,0.00033807367,0.00029901823,0.00043552803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064138765,0.00004265001,0.14636405,0.0008248966,0.000372258,0.0010499678,0.00040245062,0.000782157,0.8183022,0.00041277983,0.0032043492,0.02760082],"study_design_scores_gemma":[0.000027025677,0.00018267203,0.891439,0.00015567947,0.0006233186,0.0027839073,0.00076835474,0.0042443005,0.070118256,0.0006339308,0.028991835,0.00003166442],"about_ca_topic_score_codex":0.0027741694,"about_ca_topic_score_gemma":0.006634344,"teacher_disagreement_score":0.0027741694,"about_ca_system_score_codex":0.00030531923,"about_ca_system_score_gemma":0.00040192355,"threshold_uncertainty_score":0.0055160522},"labels":[],"label_agreement":null},{"id":"W3112051513","doi":"10.1093/neuonc/noaa222.243","title":"GCT-23. MULTI-INSTITUTIONAL ANALYSIS OF TREATMENT MODALITIES IN BASAL GANGLIA AND THALAMIC GERMINOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Basal ganglia; Nuclear medicine; Germinoma; Basal (medicine); Radiation therapy; Central nervous system; Radiology; Internal medicine","score_opus":0.046845077412024906,"score_gpt":0.3140051202842474,"score_spread":0.26716004287222245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112051513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799335,0.0005579869,0.000111929934,0.000016756083,0.0000027717588,0.000022595003,0.0008184566,0.000006534486,0.00046965774],"genre_scores_gemma":[0.9993255,0.00005802413,0.00008202684,0.000008176226,0.0000036420076,0.000010921819,0.00047369208,0.0000026308883,0.00003544002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992149,0.00027206165,0.000108767534,0.00014617287,0.0001438013,0.00011436448],"domain_scores_gemma":[0.99720085,0.0005295128,0.0016252515,0.00015149347,0.00021688211,0.00027607687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011091633,0.0002436086,0.00032722222,0.0018843065,0.00030300548,0.00060415803,0.00029814997,0.00022399996,0.001327712],"category_scores_gemma":[0.0027200123,0.000108291235,0.00064285647,0.0026229038,0.0003059145,0.0003307989,0.00044486334,0.0002259321,0.00017700723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002142416,0.000015504595,0.9967981,0.000015391613,0.00012309363,0.0001601008,0.00002747216,0.00014183766,0.00020433136,0.000010958583,0.000070428134,0.00221861],"study_design_scores_gemma":[0.00000804689,0.0001113463,0.99839324,0.0000062632203,0.000101797,0.0006673786,0.0001255809,0.00020932495,0.00013822808,0.000022451752,0.00021229149,0.0000040011428],"about_ca_topic_score_codex":0.0048795585,"about_ca_topic_score_gemma":0.0054841954,"teacher_disagreement_score":0.0048795585,"about_ca_system_score_codex":0.0007960947,"about_ca_system_score_gemma":0.00038947145,"threshold_uncertainty_score":0.009702325},"labels":[],"label_agreement":null},{"id":"W3112056129","doi":"10.1093/neuonc/noaa222.570","title":"MBRS-66. COST-EFFECTIVE METHOD TO INCORPORATE MOLECULAR CLASSIFICATION OF MEDULLOBLASTOMA INTO A LATIN-AMERICAN CLINICAL TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Monosomy; Immunohistochemistry; Internal medicine; Fluorescence in situ hybridization; Oncology; Cancer research; Histogenesis; Medicine; Biology; Pathology; Bioinformatics; Gene; Genetics; Karyotype","score_opus":0.04892589931349365,"score_gpt":0.3908982649223801,"score_spread":0.34197236560888644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112056129","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66002184,0.031594813,0.079312734,0.025156569,0.00402347,0.09129511,0.017974809,0.003273058,0.08734758],"genre_scores_gemma":[0.8693063,0.0038692874,0.06263805,0.005670364,0.0007033853,0.04175719,0.005137268,0.00025613102,0.010661994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930948,0.0055283904,0.00036709898,0.00037528286,0.00037248703,0.00026199187],"domain_scores_gemma":[0.9970806,0.00073400483,0.0009731655,0.00030275361,0.00042818752,0.00048129083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0123107545,0.0007136012,0.0012261342,0.0009248111,0.00031416886,0.0013103393,0.0005229588,0.0009061965,0.016244045],"category_scores_gemma":[0.01064253,0.00034583744,0.0013513069,0.0008500152,0.00040809682,0.0008024987,0.00090977905,0.0009996297,0.0024813474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26139215,0.007939298,0.033278268,0.0020965654,0.0032345967,0.0003292496,0.00016061637,0.0074139754,0.008686406,0.005742365,0.022614269,0.64711225],"study_design_scores_gemma":[0.4016865,0.14759283,0.11363102,0.002098176,0.007147578,0.00095891993,0.00037184745,0.031234222,0.00759855,0.0143706165,0.2731023,0.00020740429],"about_ca_topic_score_codex":0.00080677675,"about_ca_topic_score_gemma":0.0014385332,"teacher_disagreement_score":0.016244045,"about_ca_system_score_codex":0.0013866388,"about_ca_system_score_gemma":0.002610643,"threshold_uncertainty_score":0.06510627},"labels":[],"label_agreement":null},{"id":"W3112068339","doi":"10.1093/neuonc/noaa222.733","title":"RARE-22. GERMLINE PATHOGENIC VARIANT c.1552G&amp;gt;A;p.E518K IN DGCR8 CONFERS SUSCEPTIBILITY FOR SCHWANNOMATOSIS AND THYROID TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Jewish General Hospital; University Health Network; McGill University","funders":"","keywords":"Germline; Germline mutation; Schwannoma; Biology; Cancer research; Thyroid cancer; Somatic cell; Wilms' tumor; SMARCB1; Thyroid; Pathology; Medicine; Mutation; Genetics; Gene","score_opus":0.04108704870604132,"score_gpt":0.32339168569279486,"score_spread":0.28230463698675357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112068339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641514,0.00024413041,0.0006579726,0.00013108723,0.000036686066,0.000036640606,0.00042661763,0.00005942516,0.0019922685],"genre_scores_gemma":[0.99828124,0.000045604233,0.00033668522,0.00005344417,0.000030629555,0.000009393991,0.00020806937,0.00001560855,0.0010193649],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997316,0.000046720375,0.000039785533,0.00008149444,0.000055269727,0.000045111905],"domain_scores_gemma":[0.99946386,0.00015591724,0.00015107161,0.00002616428,0.000039240957,0.00016375772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017956205,0.0011620097,0.00031876992,0.0010435391,0.000673635,0.00028286106,0.00033005484,0.0010346337,0.007854381],"category_scores_gemma":[0.00058373174,0.00020252164,0.0004519314,0.00044867428,0.00044253984,0.0001452023,0.0003991642,0.00047594728,0.0008382757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012892537,0.00035394952,0.13413928,0.00012761896,0.00023137542,0.39845228,0.0006873587,0.00047402046,0.45029435,0.0010171424,0.0015070619,0.011426279],"study_design_scores_gemma":[0.00019176774,0.0007831981,0.31446224,0.0001146224,0.00021478484,0.6376737,0.00039154702,0.0015618297,0.0372401,0.0003951994,0.0069121085,0.00005890226],"about_ca_topic_score_codex":0.0018980986,"about_ca_topic_score_gemma":0.0016712879,"teacher_disagreement_score":0.007854381,"about_ca_system_score_codex":0.0002861286,"about_ca_system_score_gemma":0.00018534128,"threshold_uncertainty_score":0.026275516},"labels":[],"label_agreement":null},{"id":"W3112100083","doi":"10.1093/neuonc/noaa215.007","title":"BIOM-07. EXPRESSION OF ANDROGEN RECEPTOR AND PROGRAMMED DEATH-LIGAND 1 IN BREAST-TO-BRAIN-METASTASES.","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Immunohistochemistry; Androgen receptor; Breast cancer; Tissue microarray; Programmed cell death; Cancer research; Cancer; Medicine; Oncology; Apoptosis; Internal medicine; Pathology; Biology; Prostate cancer","score_opus":0.03126967492989289,"score_gpt":0.30773491660322516,"score_spread":0.27646524167333225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112100083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985201,0.0026052473,0.00067695166,0.00017392688,0.000025914622,0.000067531095,0.0036505347,0.00010027752,0.0074985838],"genre_scores_gemma":[0.99033433,0.0005318308,0.0014659051,0.00006226796,0.000014497998,0.0000695153,0.0034388932,0.000013207036,0.0040695593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987745,0.00002002682,0.000010774376,0.000023124181,0.00004074421,0.000027929022],"domain_scores_gemma":[0.99987316,0.000017660726,0.000040829647,0.0000058645646,0.000023376411,0.00003908358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019222952,0.00014950018,0.00013449552,0.0007626779,0.00019541403,0.00040260574,0.00017510325,0.00020049252,0.005205705],"category_scores_gemma":[0.00029640866,0.000108926,0.000112226495,0.0004885172,0.0001295882,0.00013216719,0.00021443234,0.00026472326,0.0010839212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028187584,0.00028314075,0.5630302,0.00047283492,0.000111425536,0.0038056741,0.00018239842,0.0002643167,0.3423285,0.0008857837,0.0055288463,0.080288135],"study_design_scores_gemma":[0.00007885904,0.0006290834,0.9180103,0.00003422302,0.00005440472,0.015641604,0.00022334905,0.0009800124,0.049409647,0.0002879698,0.014642401,0.000008162331],"about_ca_topic_score_codex":0.0012362242,"about_ca_topic_score_gemma":0.002146474,"teacher_disagreement_score":0.005205705,"about_ca_system_score_codex":0.00035884607,"about_ca_system_score_gemma":0.00033848503,"threshold_uncertainty_score":0.017414749},"labels":[],"label_agreement":null},{"id":"W3112144762","doi":"10.1093/neuonc/noaa215.211","title":"CTNI-45. A PHASE 1B/2 CLINICAL STUDY OF NAPABUCASIN IN COMBINATION WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH RECURRENT OR PROGRESSED GLIOBLASTOMA MULTIFORME (GBM)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Tolerability; Phases of clinical research; Adverse effect; Oncology; Surgery; Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.1544762611913571,"score_gpt":0.4754712240521156,"score_spread":0.3209949628607585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112144762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781615,0.003105997,0.00078416726,0.00043502552,0.00015287181,0.0035331508,0.0012914679,0.00017980109,0.002701511],"genre_scores_gemma":[0.9859731,0.002632892,0.0026246952,0.000685646,0.00012304627,0.0024039901,0.0026020317,0.000035317047,0.0029193235],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997043,0.00013832316,0.00001545406,0.000048213707,0.000026728974,0.00006690313],"domain_scores_gemma":[0.9997247,0.000022810462,0.000047438592,0.00001964126,0.000019195386,0.00016622928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010813983,0.0013254181,0.0012598293,0.0004266158,0.00032988342,0.0006321917,0.0006910313,0.00074199366,0.0028432314],"category_scores_gemma":[0.00053252256,0.0005685079,0.00087063864,0.00034589713,0.00062602473,0.00051920116,0.00027421012,0.0022120776,0.00063307415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5141149,0.101997845,0.0064255684,0.0012565843,0.0015632109,0.00041831596,0.00048508006,0.003551395,0.19618589,0.00074919884,0.009434664,0.16381739],"study_design_scores_gemma":[0.44407386,0.5203029,0.014455641,0.000058436206,0.00058182137,0.000372276,0.000058805403,0.0021106696,0.012231217,0.00019057294,0.00551485,0.000048964983],"about_ca_topic_score_codex":0.002522103,"about_ca_topic_score_gemma":0.007882861,"teacher_disagreement_score":0.0028432314,"about_ca_system_score_codex":0.0008777965,"about_ca_system_score_gemma":0.0017971017,"threshold_uncertainty_score":0.00951153},"labels":[],"label_agreement":null},{"id":"W3112159644","doi":"10.1093/neuonc/noaa222.702","title":"QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Health care; Family medicine","score_opus":0.03513154014876986,"score_gpt":0.3554632314070621,"score_spread":0.32033169125829225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112159644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92417336,0.0015612625,0.005331745,0.01035999,0.0002823165,0.01592118,0.024563573,0.00076897955,0.01703762],"genre_scores_gemma":[0.93511856,0.0012119111,0.035707835,0.0017405928,0.00006729536,0.010380849,0.013524946,0.000113255126,0.0021347199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9820409,0.009726117,0.002311512,0.0007813105,0.0035070549,0.0016331094],"domain_scores_gemma":[0.9772987,0.0025597492,0.0063533895,0.0012637216,0.0047078733,0.007816542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022209885,0.00059184403,0.00080865866,0.0016508311,0.0010965415,0.0018868105,0.0011426858,0.00045001158,0.002670296],"category_scores_gemma":[0.020823732,0.00040605792,0.0014276664,0.002439856,0.00089616666,0.0010368801,0.0035727187,0.0016791703,0.0003793325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019856193,0.005674333,0.6408186,0.0015919136,0.00097327464,0.00020268484,0.0042346874,0.0036230942,0.0008788855,0.0012654123,0.041923057,0.29682836],"study_design_scores_gemma":[0.0011368389,0.003876685,0.9646797,0.0007798457,0.00024931322,0.00014741329,0.0019581823,0.0019737661,0.00074328884,0.00026192988,0.024117295,0.00007563398],"about_ca_topic_score_codex":0.01272882,"about_ca_topic_score_gemma":0.014226137,"teacher_disagreement_score":0.022209885,"about_ca_system_score_codex":0.005880104,"about_ca_system_score_gemma":0.014240319,"threshold_uncertainty_score":0.11745846},"labels":[],"label_agreement":null},{"id":"W3112164247","doi":"10.1093/neuonc/noaa215.251","title":"DDRE-06. CELLULAR STRESS RESPONSE IN DIPG THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cancer research; Bystander effect; Integrated stress response; Glioma; Oncology; Biology; Immunology; Genetics; Gene","score_opus":0.03885441262013729,"score_gpt":0.31000083798625916,"score_spread":0.2711464253661219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112164247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8174727,0.0784197,0.008814054,0.005958679,0.0022884523,0.0014732367,0.006623748,0.001946993,0.07700248],"genre_scores_gemma":[0.95179206,0.015743714,0.00522745,0.0025157111,0.00017025229,0.0004798819,0.0049643535,0.00010232575,0.019004155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982077,0.000035765006,0.000010335035,0.000033909906,0.00005350409,0.0000456507],"domain_scores_gemma":[0.9999081,0.000011879675,0.00001599099,0.000013974018,0.000016411175,0.00003360768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037422008,0.0004098975,0.0005173523,0.00032283238,0.00019419297,0.0007257668,0.00044616734,0.0006248623,0.0052023972],"category_scores_gemma":[0.00015908216,0.00011179691,0.00035109217,0.00028810886,0.00027470783,0.00025325487,0.0003620752,0.0015547725,0.0014690841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007828522,0.0037751344,0.003467899,0.0024448144,0.00017043586,0.0009372539,0.00017083179,0.0028525153,0.55233425,0.006538249,0.03203113,0.3874491],"study_design_scores_gemma":[0.0037245764,0.036686804,0.021598453,0.000430023,0.00029983706,0.007685464,0.00024734638,0.0060446966,0.4970924,0.0027037205,0.42339355,0.00009312804],"about_ca_topic_score_codex":0.00041443956,"about_ca_topic_score_gemma":0.0009600103,"teacher_disagreement_score":0.0052023972,"about_ca_system_score_codex":0.0007032161,"about_ca_system_score_gemma":0.00056316896,"threshold_uncertainty_score":0.017403722},"labels":[],"label_agreement":null},{"id":"W3112175108","doi":"10.1093/neuonc/noaa215.168","title":"CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Internal medicine; Nuclear medicine; Radiation therapy; Urology","score_opus":0.14483321113072276,"score_gpt":0.44853757322026333,"score_spread":0.30370436208954055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112175108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54637253,0.43108532,0.0025617147,0.0021211966,0.0025844423,0.0045075323,0.005742019,0.00036986457,0.0046553975],"genre_scores_gemma":[0.93544537,0.05030762,0.0030453743,0.0014457272,0.0014197316,0.0037154087,0.0026301409,0.00008237956,0.0019083247],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99433064,0.0038165087,0.0007154504,0.0006261264,0.000341586,0.00016964985],"domain_scores_gemma":[0.99420255,0.0028217852,0.002007625,0.00027188213,0.0002774733,0.00041876768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00764417,0.00235457,0.008382442,0.0011555424,0.00034192525,0.0026825645,0.0013463964,0.0016891678,0.0047512073],"category_scores_gemma":[0.011377574,0.00081763783,0.010744393,0.002062661,0.0010377577,0.0012768316,0.0006332844,0.002477615,0.0004931594],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8264787,0.0005323975,0.0026076636,0.018224299,0.12577774,0.00005869655,0.000037972663,0.00075555587,0.0012156722,0.00014842475,0.0010863632,0.023076437],"study_design_scores_gemma":[0.6970087,0.041343577,0.016227143,0.0018178117,0.23864761,0.0001436688,0.00009053528,0.0014659257,0.00059949246,0.0004068803,0.002160344,0.000088311455],"about_ca_topic_score_codex":0.0026813503,"about_ca_topic_score_gemma":0.005508143,"teacher_disagreement_score":0.008382442,"about_ca_system_score_codex":0.001335449,"about_ca_system_score_gemma":0.0014450027,"threshold_uncertainty_score":0.04042673},"labels":[],"label_agreement":null},{"id":"W3112196266","doi":"10.1093/neuonc/noaa222.624","title":"NURS-04. COMBINATION OF NEURO-ONCOLOGY AND DERMATOLOGY CLINICS IMPROVE THE MANAGEMENT AND KNOWLEDGE OF SKIN-RELATED TOXICITIES WITH MEK AND BRAF TARGETED THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dermatology; Oncology nursing; Oncology; Internal medicine; Nursing; Nurse education","score_opus":0.012253833091315423,"score_gpt":0.2562277906902607,"score_spread":0.24397395759894527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112196266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44318488,0.0030418786,0.010059211,0.20165733,0.014719171,0.007922557,0.0028924854,0.0018792263,0.31464317],"genre_scores_gemma":[0.6926308,0.00505989,0.05411222,0.084259875,0.0013176478,0.010295101,0.0021590728,0.0005242986,0.14964108],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99709296,0.0015229194,0.0001353133,0.00019447131,0.00054186775,0.0005125049],"domain_scores_gemma":[0.9785169,0.0008080127,0.0007319814,0.00031270518,0.0032255459,0.016404849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038150807,0.0002588893,0.00029189556,0.00040504406,0.003639018,0.0018999134,0.0010425404,0.00089407456,0.038122308],"category_scores_gemma":[0.008850262,0.00040589503,0.0005423837,0.00025333505,0.0007547418,0.0014277657,0.004173311,0.0032843158,0.007971047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016884506,0.007338731,0.038920682,0.0008728783,0.00003975283,0.000502329,0.010580695,0.0002486529,0.0008241763,0.0016179265,0.5080636,0.43082175],"study_design_scores_gemma":[0.00077057345,0.0044605155,0.09391895,0.002534287,0.000091750124,0.001787951,0.06287166,0.0015603629,0.0022016766,0.004860634,0.8247499,0.00019175584],"about_ca_topic_score_codex":0.004051474,"about_ca_topic_score_gemma":0.014439056,"teacher_disagreement_score":0.038122308,"about_ca_system_score_codex":0.0034776868,"about_ca_system_score_gemma":0.017920475,"threshold_uncertainty_score":0.12753177},"labels":[],"label_agreement":null},{"id":"W3112205496","doi":"10.1093/neuonc/noaa222.340","title":"IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Clinical trial; Disease; Progressive disease; Oncology; Internal medicine; Medical physics","score_opus":0.041003994562401946,"score_gpt":0.3428109529851919,"score_spread":0.30180695842278993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112205496","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011664687,0.13496055,0.07099235,0.6501634,0.014479758,0.020531274,0.016278328,0.004864613,0.07606504],"genre_scores_gemma":[0.05416694,0.13149022,0.4952927,0.18117756,0.008897918,0.052657496,0.049356237,0.0023556435,0.024605399],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9405699,0.029775392,0.016784947,0.0015830119,0.008887226,0.0023995405],"domain_scores_gemma":[0.85109496,0.045738477,0.025331743,0.0043339403,0.06439575,0.009105193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09048898,0.0020314308,0.0037897665,0.006926866,0.0014206675,0.0039121564,0.008358719,0.008870236,0.0038441925],"category_scores_gemma":[0.1182532,0.0011589063,0.0065874527,0.00502425,0.0019776302,0.0039024763,0.005481666,0.012998339,0.008147909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006602137,0.00043341826,0.0074864146,0.008692775,0.00037831994,0.0003258446,0.0009529084,0.0032108915,0.0012153905,0.0055537173,0.52680975,0.44428042],"study_design_scores_gemma":[0.000817293,0.0010003013,0.021433229,0.06111118,0.00093948183,0.0008756083,0.0010055312,0.003554487,0.0022766578,0.008587532,0.89815485,0.00024382636],"about_ca_topic_score_codex":0.009347364,"about_ca_topic_score_gemma":0.0068838624,"teacher_disagreement_score":0.09048898,"about_ca_system_score_codex":0.007005447,"about_ca_system_score_gemma":0.019623788,"threshold_uncertainty_score":0.47855717},"labels":[],"label_agreement":null},{"id":"W3112223097","doi":"10.1093/neuonc/noaa215.119","title":"CSIG-07. c-Src PHOSPHORYLATES AND INACTIVATES THE CIC TUMOR SUPPRESSOR PROTEIN IN GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; Dasatinib; Phosphorylation; Cancer research; MAPK/ERK pathway; Tyrosine kinase; Tyrosine phosphorylation; Receptor tyrosine kinase; Tyrosine; Chemistry; Cell biology; Signal transduction; Molecular biology; Biology; Biochemistry","score_opus":0.011188640438070925,"score_gpt":0.259227402604683,"score_spread":0.2480387621666121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112223097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297935,0.002024783,0.00048633388,0.00017751553,0.000063569576,0.0000647433,0.0007332198,0.000108730506,0.0033617243],"genre_scores_gemma":[0.99453706,0.0006764211,0.00053001335,0.00011409926,0.000010476854,0.000051033214,0.001675699,0.000014061451,0.0023912129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986887,0.000012299103,0.000011635256,0.000016605241,0.00004009329,0.000050433297],"domain_scores_gemma":[0.99993944,0.0000048934776,0.000008684471,0.000008363474,0.0000068561976,0.00003167569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011575134,0.0003119513,0.00045515748,0.0002214166,0.00016114303,0.00026538764,0.00026807308,0.00034040955,0.0015210985],"category_scores_gemma":[0.00008801323,0.00012079929,0.00023419745,0.0002626632,0.00023555948,0.000084147316,0.00016164548,0.0005906446,0.0006563866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032389053,0.00013086811,0.00054736127,0.000073865274,0.00001885204,0.00026817556,0.0000133172525,0.00007941769,0.9935737,0.00016778623,0.0004397427,0.0043630083],"study_design_scores_gemma":[0.00025698234,0.0027699608,0.029139383,0.000014793911,0.00007673097,0.0027215905,0.00005699638,0.001785101,0.9511406,0.00012777443,0.011899255,0.000010833599],"about_ca_topic_score_codex":0.001802255,"about_ca_topic_score_gemma":0.0021363066,"teacher_disagreement_score":0.001802255,"about_ca_system_score_codex":0.00040958583,"about_ca_system_score_gemma":0.00046584828,"threshold_uncertainty_score":0.0050886273},"labels":[],"label_agreement":null},{"id":"W3112252398","doi":"10.1093/neuonc/noaa215.976","title":"TMOD-26. ESTABLISHING A PATIENT-DERIVED, IN-VITRO ORGANOTYPIC SLICE CULTURE MODEL OF GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Flow cytometry; Cell culture; Viral vector; Western blot; Transduction (biophysics); Glioblastoma; Cancer research; Lentivirus; U87; Confocal microscopy; Confocal; In vitro; Biology; Cell biology; Pathology; Molecular biology; Medicine; Immunology; Human immunodeficiency virus (HIV); Biophysics; Genetics; Gene; Physics","score_opus":0.015090551830159631,"score_gpt":0.2481827822920996,"score_spread":0.23309223046193997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112252398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243578,0.0028789728,0.05010098,0.00041222098,0.00042154803,0.0006781289,0.009437498,0.0006292421,0.01108352],"genre_scores_gemma":[0.91746646,0.0024969247,0.0602302,0.00022220892,0.000032669992,0.0007092176,0.006897262,0.00017889777,0.011766028],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99958557,0.00007301958,0.00005672158,0.00009807098,0.00011415384,0.0000725139],"domain_scores_gemma":[0.99975306,0.000036778714,0.00004672574,0.000058471775,0.00004913652,0.00005586316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072592346,0.0006878377,0.000467404,0.0003479283,0.0002970423,0.0004996503,0.00052123645,0.00054692745,0.0020082623],"category_scores_gemma":[0.00015705288,0.0002733313,0.0006437681,0.0002890892,0.00023070857,0.00026136794,0.00028078567,0.0009887565,0.0014925877],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015363834,0.00013776294,0.0003694432,0.00012552901,0.000017631099,0.00032082788,0.00008924596,0.00043044257,0.99582833,0.00041760365,0.0004191186,0.0016903757],"study_design_scores_gemma":[0.000033784716,0.001070083,0.0033342254,0.00003302363,0.00005035454,0.00144262,0.000100808684,0.0035711555,0.97775376,0.0001109581,0.012480133,0.00001905628],"about_ca_topic_score_codex":0.002486655,"about_ca_topic_score_gemma":0.0050361063,"teacher_disagreement_score":0.002486655,"about_ca_system_score_codex":0.0004275171,"about_ca_system_score_gemma":0.0004935114,"threshold_uncertainty_score":0.006718278},"labels":[],"label_agreement":null},{"id":"W3112261995","doi":"10.1093/neuonc/noaa222.502","title":"MBCL-26. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Internal medicine; Oncology; Radiation therapy; Anaplasia; Survival analysis; Pathology","score_opus":0.02388990840599439,"score_gpt":0.2766337158713896,"score_spread":0.2527438074653952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112261995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948776,0.0001827923,0.000057179066,0.000020244603,0.000001907869,0.000005741225,0.00008376468,0.0000050340254,0.00015551303],"genre_scores_gemma":[0.9996493,0.000021939783,0.0000384158,0.000006410876,0.0000022371855,0.0000041697785,0.00010853137,0.0000016339776,0.0001672554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985397,0.000028236242,0.00001555677,0.000028655853,0.000038124144,0.000035378373],"domain_scores_gemma":[0.99939775,0.00008483605,0.00032687865,0.000019180181,0.00003544238,0.00013596278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023094207,0.0001007213,0.00024194157,0.00023588401,0.00014372864,0.00019673485,0.00014208826,0.00016103167,0.0014135534],"category_scores_gemma":[0.00083931116,0.00005921825,0.00025775807,0.00018640858,0.00009157421,0.000110145746,0.00012619268,0.00021444788,0.0001412534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020811064,0.00007744425,0.9773492,0.000020175083,0.0000878373,0.00016361022,0.000042478223,0.00015260438,0.010193024,0.00002027376,0.00017676773,0.009635392],"study_design_scores_gemma":[0.000034974753,0.0006864984,0.9968573,0.0000036736888,0.00006135487,0.0004233892,0.00004787417,0.00034337887,0.0011999132,0.000026126125,0.00031317808,0.0000023935602],"about_ca_topic_score_codex":0.0018231049,"about_ca_topic_score_gemma":0.0026343875,"teacher_disagreement_score":0.0018231049,"about_ca_system_score_codex":0.00028473503,"about_ca_system_score_gemma":0.00021164629,"threshold_uncertainty_score":0.004728794},"labels":[],"label_agreement":null},{"id":"W3112266738","doi":"10.1093/neuonc/noaa222.293","title":"HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Internal medicine; Refractory (planetary science); Response Evaluation Criteria in Solid Tumors; Oncology; Adverse effect; Fusion gene; Progressive disease; Disease; Cancer; Adenocarcinoma; Biology; Gene","score_opus":0.05858310600731239,"score_gpt":0.35919888882075207,"score_spread":0.3006157828134397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112266738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5998864,0.06834531,0.0019904058,0.0025304195,0.0004774963,0.00042459174,0.31180358,0.00033918003,0.014202572],"genre_scores_gemma":[0.68232447,0.03288671,0.0025552951,0.0019760097,0.00037939873,0.0005038118,0.274647,0.00013788734,0.004589471],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941325,0.00014918046,0.00009152938,0.000091792324,0.00018389242,0.000070396396],"domain_scores_gemma":[0.9974886,0.00054595136,0.0010621444,0.000116045085,0.0004690329,0.0003182898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012917762,0.0003482548,0.0008094689,0.00081918,0.00012919288,0.0008491675,0.0003863134,0.00035490838,0.0023111932],"category_scores_gemma":[0.0017216081,0.00015428245,0.0007355735,0.0019809853,0.00016326034,0.0004835595,0.000389441,0.00076640304,0.00091329485],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013785217,0.0003344115,0.6622899,0.0029051085,0.0034359407,0.0004139473,0.0002295577,0.0017078381,0.0036403073,0.00039241428,0.09626878,0.21459644],"study_design_scores_gemma":[0.002630559,0.0022633139,0.8513135,0.0010213563,0.0028984153,0.0013601218,0.00019971408,0.00046247928,0.0018351463,0.00015034234,0.13582581,0.000039296345],"about_ca_topic_score_codex":0.0055381604,"about_ca_topic_score_gemma":0.008244339,"teacher_disagreement_score":0.0055381604,"about_ca_system_score_codex":0.00052009075,"about_ca_system_score_gemma":0.00084798626,"threshold_uncertainty_score":0.011011839},"labels":[],"label_agreement":null},{"id":"W3112270188","doi":"10.1093/neuonc/noaa222.224","title":"ETMR-21. META-ANALYSIS OF PINEAL REGION TUMOURS DEMONSTRATES MOLECULAR SUBGROUPS WITH DISTINCT CLINICO-PATHOLOGICAL FEATURES: A CONSENSUS STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Drosha; microRNA; Pinealoma; Pathological; Internal medicine; Metastasis; Oncology; Medicine; Biology; Cancer; Pathology; Gene; Genetics","score_opus":0.09120658281862033,"score_gpt":0.34775629893601884,"score_spread":0.2565497161173985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112270188","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26443732,0.70531976,0.011381871,0.0019927628,0.0007894687,0.0003482734,0.013062347,0.00029134934,0.0023768686],"genre_scores_gemma":[0.95898104,0.031458497,0.002680217,0.0010111966,0.0003061282,0.00027746992,0.0046506952,0.00014324998,0.0004914247],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894348,0.004890493,0.0014983686,0.0029026836,0.0009258323,0.00034800937],"domain_scores_gemma":[0.983392,0.010036179,0.0022163116,0.0025033373,0.0013955407,0.00045663895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013222648,0.0013452715,0.0052142036,0.0024709054,0.00057133636,0.0024383802,0.0018663913,0.001547659,0.002989713],"category_scores_gemma":[0.01866966,0.0007686232,0.020995686,0.003460622,0.00047801377,0.0009308011,0.0013329891,0.0013611148,0.00044352125],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006564972,0.000030994543,0.17635433,0.015721537,0.7732453,0.00035544776,0.00011851603,0.0016373972,0.002501653,0.00025706252,0.0028090102,0.020403786],"study_design_scores_gemma":[0.0012364044,0.0005201638,0.17037116,0.0019501707,0.8154813,0.0006432848,0.000116280105,0.0016788602,0.00084857334,0.0008841157,0.0062088845,0.000060818642],"about_ca_topic_score_codex":0.0031924646,"about_ca_topic_score_gemma":0.0052194647,"teacher_disagreement_score":0.013222648,"about_ca_system_score_codex":0.00067124807,"about_ca_system_score_gemma":0.0008384487,"threshold_uncertainty_score":0.069928885},"labels":[],"label_agreement":null},{"id":"W3112275523","doi":"10.1093/neuonc/noaa215.763","title":"RADT-09. TYPE AND TIMING OF SYSTEMIC THERAPY USE PREDICT SURVIVAL IN PATIENTS WITH BRAIN METASTASES TREATED WITH RADIATION THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Systemic therapy; Radiation therapy; Cohort; Nomogram; Multivariate analysis; Oncology; Survival analysis; Population; Pharmacy; Chemotherapy; Cancer; Surgery; Breast cancer","score_opus":0.03976402430096057,"score_gpt":0.27926717526547296,"score_spread":0.23950315096451238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112275523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944825,0.00039908788,0.00011655985,0.00010016916,0.000009601124,0.000009407576,0.0036870847,0.000007726809,0.0011879205],"genre_scores_gemma":[0.99805105,0.00007712523,0.000092699825,0.00002417795,0.000008209879,0.000005359278,0.0015491467,0.0000025214842,0.00018966518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976724,0.000040249117,0.000037384725,0.000056366942,0.00005566495,0.0000430234],"domain_scores_gemma":[0.99860305,0.0001975025,0.0007658671,0.00005813034,0.00016423388,0.00021112437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002906814,0.00011242862,0.00021359164,0.0005667074,0.00019741378,0.00044526937,0.0002966113,0.00019144555,0.0022245508],"category_scores_gemma":[0.0018105892,0.000080850594,0.0003189797,0.0011229647,0.0001635238,0.00016617849,0.0002335528,0.00029940245,0.00027352106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005152747,0.0000040807113,0.9987872,0.0000061577007,0.000015652113,0.000014905951,0.0000051226652,0.000047140635,0.000068097135,0.0000059925906,0.00015339955,0.0008407996],"study_design_scores_gemma":[0.000005141911,0.00002553913,0.99915123,0.0000056000463,0.000019183315,0.0001271407,0.000029540537,0.00024985577,0.000056377572,0.000011884458,0.00031702756,0.0000014008275],"about_ca_topic_score_codex":0.039417904,"about_ca_topic_score_gemma":0.0675342,"teacher_disagreement_score":0.039417904,"about_ca_system_score_codex":0.00073783274,"about_ca_system_score_gemma":0.00091019523,"threshold_uncertainty_score":0.07837689},"labels":[],"label_agreement":null},{"id":"W3112280284","doi":"10.1093/neuonc/noaa222.665","title":"PATH-30. EXOSOMES AS A SOURCE OF PLASMA ctDNA TO IDENTIFY POINT MUTATIONS IN PEDIATRIC GLIOMA PATIENTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Liquid biopsy; Glioma; Microvesicles; Exosome; DNA sequencing; Point mutation; DNA; Cell-free fetal DNA; Medicine; Biopsy; Mutation; Cancer research; Internal medicine; Oncology; Pathology; Cancer; Gene; Biology; microRNA; Genetics","score_opus":0.011419155511925018,"score_gpt":0.2820337321736703,"score_spread":0.27061457666174527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112280284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241674,0.0029081916,0.0018637407,0.00015926277,0.000029267649,0.00007846319,0.0013062281,0.000118874275,0.0011192304],"genre_scores_gemma":[0.9936466,0.0008527203,0.0034630918,0.0000962471,0.0000131018,0.000062992534,0.0011525642,0.000029337783,0.0006834014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998073,0.00003004331,0.000019326235,0.000050254814,0.00006529321,0.000027854343],"domain_scores_gemma":[0.9997831,0.000054236396,0.00006440927,0.000012893334,0.000054008357,0.000031392734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026522978,0.00029277123,0.00026814645,0.0006784106,0.00021910836,0.00054720195,0.00017061392,0.00038179694,0.0015881563],"category_scores_gemma":[0.0007072152,0.00016169976,0.00022203941,0.00035885154,0.00019700499,0.00026682642,0.0003717838,0.00033401768,0.00050627894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003515628,0.00018628778,0.50839794,0.0008852463,0.00014487699,0.007181675,0.0011759981,0.0009639833,0.36878446,0.00043484516,0.0025944985,0.105734624],"study_design_scores_gemma":[0.00015053198,0.0022327506,0.60652333,0.00023813311,0.00022034218,0.029950073,0.0010419436,0.005107876,0.3265178,0.00056170754,0.02740553,0.000049947128],"about_ca_topic_score_codex":0.0006522105,"about_ca_topic_score_gemma":0.0005914901,"teacher_disagreement_score":0.0015881563,"about_ca_system_score_codex":0.00033366345,"about_ca_system_score_gemma":0.0002560699,"threshold_uncertainty_score":0.0053129196},"labels":[],"label_agreement":null},{"id":"W3112290402","doi":"10.1093/neuonc/noaa215.389","title":"EXTH-35. SYNERGISTIC EFFECT OF TARGETING THIOREDOXIN REDUCTASE (TRX1) AND DEPLETION OF GLUTATHIONE SYSTEM (GSH) IN GLIOBLASTOMA STEM CELLS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Gene knockdown; Cancer research; Reactive oxygen species; Glutathione; Thioredoxin; Stem cell; Cytotoxic T cell; Apoptosis; Chemistry; Temozolomide; Thioredoxin reductase; Biology; Pharmacology; Oxidative stress; Glioma; Immunology; In vitro; Cell biology; Biochemistry; Enzyme","score_opus":0.007555543761766764,"score_gpt":0.24497172367207287,"score_spread":0.2374161799103061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112290402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218434,0.0029063297,0.000840652,0.00022192304,0.000144174,0.00011320546,0.00064150064,0.00020529242,0.0027426349],"genre_scores_gemma":[0.9954364,0.0009793013,0.0009259167,0.000102993305,0.000013512332,0.000061408275,0.0006254743,0.000010423802,0.0018445452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999843,0.000025010639,0.000015980939,0.000029446417,0.00004407953,0.0000424994],"domain_scores_gemma":[0.9999261,0.000009949029,0.000010336538,0.0000064421038,0.0000073386273,0.00003979517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001365657,0.00044075726,0.0005414263,0.00042918578,0.00015790608,0.0002718634,0.00024127052,0.0003558129,0.0014603151],"category_scores_gemma":[0.0000766577,0.00014510167,0.0003807046,0.00026975267,0.0002438703,0.00017025559,0.0002957509,0.0006170936,0.00021616532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021033124,0.0007189583,0.0004635134,0.00029853216,0.00007990152,0.0002641755,0.000115231356,0.00062406843,0.9801717,0.00046140567,0.000911183,0.013788022],"study_design_scores_gemma":[0.00034467896,0.006904284,0.0068072104,0.000021727645,0.00014551243,0.0004037655,0.00010190658,0.0018989199,0.9747654,0.00016065873,0.008426688,0.0000193619],"about_ca_topic_score_codex":0.0013323176,"about_ca_topic_score_gemma":0.0024749658,"teacher_disagreement_score":0.0014603151,"about_ca_system_score_codex":0.00029957635,"about_ca_system_score_gemma":0.00040187658,"threshold_uncertainty_score":0.0048852563},"labels":[],"label_agreement":null},{"id":"W3112295718","doi":"10.1093/neuonc/noaa222.322","title":"HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; PDGFRA; Genetics; HRAS; Computational biology; Amplicon; Genome; Glioma; Breakpoint; KRAS; Cancer research; Gene; Polymerase chain reaction; Mutation","score_opus":0.020007901364057588,"score_gpt":0.27824953311632783,"score_spread":0.2582416317522702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112295718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853077,0.0012232934,0.0017562903,0.00010363096,0.000013909798,0.000041005158,0.009814755,0.00031951407,0.001420101],"genre_scores_gemma":[0.97912395,0.00053781236,0.0023701498,0.000098137105,0.000017521637,0.000037895967,0.01699084,0.00012739869,0.00069625047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996847,0.000026955968,0.000016546242,0.00012287233,0.000086052125,0.00006292184],"domain_scores_gemma":[0.999694,0.00006277678,0.00011271901,0.000031359294,0.000024647028,0.00007449128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002402914,0.00030043672,0.00033348918,0.0008251176,0.00034334778,0.00055231625,0.0002518609,0.0003880698,0.0025515205],"category_scores_gemma":[0.0005240334,0.00015306272,0.0003920263,0.0017266077,0.00020349701,0.00015543791,0.0004833655,0.0003204562,0.00073388475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013726011,0.000050607956,0.876319,0.00035164147,0.00025770126,0.0015090802,0.00022650996,0.0025576742,0.061992202,0.0007205598,0.003761926,0.050880548],"study_design_scores_gemma":[0.00004400151,0.00016468254,0.96835995,0.000039869905,0.0002499626,0.0028606267,0.00012844916,0.0031728214,0.010704898,0.0008552977,0.013402918,0.000016475457],"about_ca_topic_score_codex":0.0028972712,"about_ca_topic_score_gemma":0.004494015,"teacher_disagreement_score":0.0028972712,"about_ca_system_score_codex":0.00040387423,"about_ca_system_score_gemma":0.000508566,"threshold_uncertainty_score":0.008535683},"labels":[],"label_agreement":null},{"id":"W3112296607","doi":"10.1093/neuonc/noaa215.962","title":"TMOD-11. APPLICATION OF A NOVEL TRANSGENIC AND SYNGENEIC MOUSE MODELS OF HUMAN CLASSICAL GLIOBLASTOMA FOR DRUG SCREENING AND PRE-CLINICAL TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer research; CDKN2A; Biology; Genetically modified mouse; Epigenetics; Transgene; Pathology; Medicine; Cancer; Gene; Genetics","score_opus":0.1445148284966045,"score_gpt":0.41371513791106423,"score_spread":0.2692003094144597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112296607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457924,0.010580129,0.015683169,0.0012707893,0.00078258733,0.0047209943,0.011728007,0.0008938655,0.008548053],"genre_scores_gemma":[0.92149556,0.012636683,0.021461772,0.00077046116,0.000106184,0.0068753813,0.014717368,0.00012703302,0.021809569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964213,0.0000756496,0.000031685995,0.000072253744,0.00008169662,0.0000965501],"domain_scores_gemma":[0.99982435,0.00001341323,0.00004454767,0.000021405967,0.000031796942,0.000064505126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008757047,0.001030355,0.00087939634,0.0007192591,0.00025365167,0.00075273856,0.0006169519,0.00090595905,0.003079252],"category_scores_gemma":[0.00015674379,0.00038769655,0.0006254826,0.0005499578,0.0004431023,0.00046407589,0.00024872334,0.0018609742,0.0008887779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061044386,0.0040614195,0.0005591684,0.0006424736,0.00015147569,0.00021354572,0.000062026986,0.0012416559,0.95658714,0.00096666237,0.0026326773,0.026777413],"study_design_scores_gemma":[0.006399998,0.08308768,0.0037420287,0.00009150165,0.0005492357,0.000749047,0.00008763081,0.002493046,0.8569169,0.0003460024,0.04547786,0.00005906337],"about_ca_topic_score_codex":0.0011142206,"about_ca_topic_score_gemma":0.003125621,"teacher_disagreement_score":0.003079252,"about_ca_system_score_codex":0.00070494186,"about_ca_system_score_gemma":0.0010569018,"threshold_uncertainty_score":0.010301173},"labels":[],"label_agreement":null},{"id":"W3112297166","doi":"10.1093/neuonc/noaa222.510","title":"MBCL-34. EFFICACY OF METHOTREXATE (MTX) ACCORDING TO MOLECULAR SUB-TYPE IN YOUNG CHILDREN WITH MEDULLOBLASTOMA (MB): A REPORT FROM CHILDREN’S ONCOLOGY GROUP PHASE III TRIAL ACNS0334","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Medulloblastoma; Oncology; ThioTEPA; Vincristine; Etoposide; Cyclophosphamide; Chemotherapy; Cancer research","score_opus":0.021962437252536503,"score_gpt":0.3248733294773049,"score_spread":0.3029108922247684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112297166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990647,0.0067640697,0.00013094085,0.00028248367,0.000039710707,0.00027549977,0.00086857966,0.000032485077,0.00095915335],"genre_scores_gemma":[0.99464226,0.0021374496,0.00047226934,0.0002696744,0.000064092084,0.0003124485,0.0014570516,0.000012221052,0.0006325511],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995572,0.00023053821,0.000037081016,0.000061674604,0.00004829293,0.000065305576],"domain_scores_gemma":[0.99918693,0.00021466946,0.00020598207,0.000051042614,0.00003426016,0.0003071323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012588552,0.00056018995,0.001122122,0.00046329753,0.00021145305,0.0005174512,0.0005061253,0.0005390856,0.0015761835],"category_scores_gemma":[0.001046032,0.00025108838,0.0008809793,0.0004450107,0.0004056061,0.0003316294,0.00022225673,0.001403028,0.00027734338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72026294,0.0067237085,0.055247568,0.001135357,0.0030175773,0.0003092969,0.00034775602,0.0021741148,0.024504546,0.00031854236,0.0038748174,0.18208383],"study_design_scores_gemma":[0.46035808,0.31833833,0.20070015,0.00028524408,0.0034216254,0.000904994,0.00013338507,0.0017622065,0.006581721,0.000422549,0.0070364047,0.00005523558],"about_ca_topic_score_codex":0.002723582,"about_ca_topic_score_gemma":0.012313452,"teacher_disagreement_score":0.002723582,"about_ca_system_score_codex":0.0010588377,"about_ca_system_score_gemma":0.0008319062,"threshold_uncertainty_score":0.007682383},"labels":[],"label_agreement":null},{"id":"W3112302730","doi":"10.1093/neuonc/noaa215.711","title":"PATH-30. CLINICAL AND GENETIC CHARACTERISTICS OF HISTONE H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IN ADULTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"ATRX; Histone H3; Glioma; Astrocytoma; Biology; Histone; Pathology; Epigenetics; Mutation; Medicine; Cancer research; Gene; Genetics","score_opus":0.030555003995752877,"score_gpt":0.3364346872338789,"score_spread":0.30587968323812603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112302730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775654,0.00021186515,0.00007982583,0.00002904268,0.0000037313432,0.000012815521,0.00053178315,0.000008293076,0.0013661156],"genre_scores_gemma":[0.9991584,0.000086426575,0.00009947238,0.000018475095,0.000005244854,0.000007460955,0.00041595715,0.0000021364256,0.00020653599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999008,0.000007781231,0.000013213215,0.000031414034,0.000014901054,0.000031790278],"domain_scores_gemma":[0.9996793,0.000029434857,0.00012236241,0.000011180078,0.00003712776,0.00012050821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010956321,0.0002477631,0.00015188276,0.0005885288,0.00026665095,0.00027479426,0.00012956682,0.00026286513,0.0021024984],"category_scores_gemma":[0.0006014821,0.000105694926,0.00012382964,0.00041514065,0.00019301688,0.00024462712,0.00020386152,0.0001873369,0.00052507484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015348052,0.000027637045,0.9865997,0.00001133638,0.0000056794693,0.0076243556,0.00007878131,0.00006351403,0.0016424651,0.00004797561,0.00031061357,0.0034344746],"study_design_scores_gemma":[0.000008243215,0.00022233208,0.9631697,0.000011080088,0.000009011262,0.03464928,0.0002340628,0.00014929844,0.0005083264,0.000059126756,0.0009755161,0.00000400347],"about_ca_topic_score_codex":0.0020491632,"about_ca_topic_score_gemma":0.002285398,"teacher_disagreement_score":0.0021024984,"about_ca_system_score_codex":0.00024834537,"about_ca_system_score_gemma":0.00026313143,"threshold_uncertainty_score":0.007033527},"labels":[],"label_agreement":null},{"id":"W3112303343","doi":"10.1093/neuonc/noaa215.172","title":"CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Lapatinib; Radiosurgery; Internal medicine; Clinical endpoint; Breast cancer; Oncology; Pertuzumab; Adjuvant; Radiation therapy; Cancer; Trastuzumab; Randomized controlled trial","score_opus":0.01945880982942613,"score_gpt":0.31803899461758994,"score_spread":0.29858018478816384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112303343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931676,0.0020437636,0.0004226338,0.00044902743,0.00022923943,0.0045733517,0.0008078984,0.000091755646,0.0020655163],"genre_scores_gemma":[0.98269296,0.0027521693,0.0017069989,0.0011722542,0.00031383763,0.0055440553,0.0017709662,0.000029440856,0.0040173302],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994733,0.0003015581,0.000028611688,0.000078901525,0.000038730148,0.000079002115],"domain_scores_gemma":[0.99938405,0.00009468358,0.00015130968,0.000040038594,0.000032661817,0.0002972272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018982975,0.0016394024,0.001888946,0.00045849947,0.00040747388,0.0009619078,0.0010771342,0.0011262031,0.0052637155],"category_scores_gemma":[0.0011120961,0.0007833708,0.0012321122,0.00051636336,0.0012365862,0.0007122851,0.00038282364,0.0029327201,0.0010317527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93242925,0.028930975,0.0013940269,0.00057184184,0.0005585256,0.000052341555,0.00008086858,0.00066200044,0.007088823,0.00014171914,0.0011634934,0.026926149],"study_design_scores_gemma":[0.78608626,0.2090221,0.0023104795,0.00002601003,0.0003236882,0.00005065725,0.00002599178,0.0004746157,0.0007668453,0.00007740037,0.0008210437,0.000014900507],"about_ca_topic_score_codex":0.002333952,"about_ca_topic_score_gemma":0.006643098,"teacher_disagreement_score":0.0052637155,"about_ca_system_score_codex":0.0014202745,"about_ca_system_score_gemma":0.0020334008,"threshold_uncertainty_score":0.017608881},"labels":[],"label_agreement":null},{"id":"W3112353403","doi":"10.1093/neuonc/noaa215.587","title":"NCOG-49. COMBINED NECROSIS AND BRAIN INVASION PREDICT RADIO-RESISTANCE AND TUMOR RECURRENCE IN ATYPICAL MENINGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Necrosis; Meningioma; Grading (engineering); Univariate analysis; Cohort; Proportional hazards model; Radiation therapy; Internal medicine; Concomitant; Adjuvant therapy; Surgery; Gastroenterology; Cancer; Multivariate analysis","score_opus":0.02975072618798996,"score_gpt":0.2769766309139448,"score_spread":0.24722590472595485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112353403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842995,0.0002229342,0.000054105734,0.000027263526,0.000004897072,0.000005368552,0.0007096415,0.0000050399517,0.0005406651],"genre_scores_gemma":[0.9993237,0.000043249485,0.00006639266,0.000005572333,0.00000500065,0.000004392388,0.00040555754,0.000001558374,0.0001445048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997961,0.000030266765,0.00003901749,0.000045160657,0.000048412396,0.000041115913],"domain_scores_gemma":[0.99896896,0.00011909728,0.00055214483,0.000055368375,0.0001143553,0.00019002492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025498186,0.00013872697,0.0001973178,0.00053774106,0.00023735833,0.00041737466,0.00022421895,0.00019339804,0.002316219],"category_scores_gemma":[0.0011981832,0.0001016216,0.0002697861,0.000666899,0.00015004186,0.00017604546,0.00026821395,0.00020578929,0.00024775555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009882731,0.0000051792326,0.99872005,0.0000073106203,0.000012358263,0.000089077046,0.000008487661,0.000023663246,0.00027458658,0.0000040122054,0.0000664488,0.00069007126],"study_design_scores_gemma":[0.000004478785,0.000028806962,0.99868447,0.0000040613227,0.000022621907,0.0005676639,0.000040169576,0.00016542658,0.00021759603,0.000014991032,0.00024840792,0.0000013360176],"about_ca_topic_score_codex":0.00404693,"about_ca_topic_score_gemma":0.0073667425,"teacher_disagreement_score":0.00404693,"about_ca_system_score_codex":0.00032430413,"about_ca_system_score_gemma":0.00035141298,"threshold_uncertainty_score":0.008046746},"labels":[],"label_agreement":null},{"id":"W3112381783","doi":"10.1093/neuonc/noaa215.640","title":"NIMG-27. THRESHOLD VALUES OF EARLY METABOLIC CHANGES IN 1H MRSI METABOLIC METRICS PREDICTIVE FOR SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Choline; Medicine; Creatine; Glioma; Internal medicine; Magnetic resonance imaging; Proportional hazards model; Gastroenterology; Nuclear medicine; Urology; Radiology","score_opus":0.028935673253662003,"score_gpt":0.27893070911435985,"score_spread":0.24999503586069785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112381783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99943036,0.00010581011,0.00003911239,0.000026797596,0.0000033442557,0.0000029861496,0.00012392868,0.0000028822083,0.00026488313],"genre_scores_gemma":[0.9996767,0.00002065654,0.000031048672,0.000011922366,0.0000036546598,0.0000028346417,0.00017086643,0.0000010689151,0.00008131281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989295,0.000023253335,0.000009171817,0.000023655748,0.000022381504,0.000028600181],"domain_scores_gemma":[0.99927145,0.0001462983,0.00031263955,0.000028543369,0.000068264715,0.00017279186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002345928,0.00015224497,0.00021494369,0.00021780012,0.00014653396,0.00030489892,0.00013780461,0.00023570957,0.00092211296],"category_scores_gemma":[0.0010640864,0.00006515877,0.00017250674,0.00022659873,0.00014086776,0.00014312606,0.0001400942,0.00024292577,0.00024193001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007625021,0.000033694498,0.99441165,0.000006348838,0.0000223799,0.00012790275,0.000014182995,0.00008525662,0.0015126957,0.000009427598,0.00010455008,0.0029093905],"study_design_scores_gemma":[0.00001082995,0.00022352707,0.9988574,0.0000013324859,0.000014250195,0.00026008964,0.000030730764,0.00017507015,0.00027632774,0.000019681966,0.00012901702,0.0000017844498],"about_ca_topic_score_codex":0.001298807,"about_ca_topic_score_gemma":0.0022978047,"teacher_disagreement_score":0.001298807,"about_ca_system_score_codex":0.00027021626,"about_ca_system_score_gemma":0.00018967962,"threshold_uncertainty_score":0.0030847788},"labels":[],"label_agreement":null},{"id":"W3112395311","doi":"10.1093/neuonc/noaa215.892","title":"TAMI-03. IDENTIFICATION OF NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS THROUGH IN VIVO FUNCTIONAL GENOMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CRISPR; Brain metastasis; Metastasis; Primary tumor; Lung cancer; In vivo; Cancer research; Functional genomics; Cancer; Medicine; Cas9; Biology; Genome; Computational biology; Gene; Genomics; Oncology; Internal medicine; Genetics","score_opus":0.02125884097446389,"score_gpt":0.3050911775633286,"score_spread":0.2838323365888647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112395311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8256444,0.0025566146,0.1282622,0.0018893643,0.0005648653,0.0010979458,0.015748568,0.0048132725,0.019422838],"genre_scores_gemma":[0.9112352,0.0013990038,0.049254514,0.00065714936,0.00003463936,0.00069279585,0.01237763,0.0010257369,0.02332335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997315,0.00003616266,0.000024852265,0.00006437267,0.00008573234,0.000057316516],"domain_scores_gemma":[0.9998098,0.00003472576,0.00005915067,0.000020138268,0.000019895584,0.000056348217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045687822,0.00047783743,0.00036998463,0.00048086344,0.00030162086,0.00072367035,0.00088329497,0.00064889714,0.0039405227],"category_scores_gemma":[0.00019209356,0.0002537489,0.0005318956,0.00031326592,0.00037301355,0.00024130526,0.00038067682,0.0014805137,0.0018523803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100595265,0.000066512424,0.0002066801,0.000055146895,0.000011527458,0.0000980276,0.00002295633,0.00026025722,0.9944389,0.00095271115,0.00056229264,0.0032244388],"study_design_scores_gemma":[0.00008812227,0.00046922168,0.003433965,0.000023648405,0.000054330856,0.00078841666,0.000072107636,0.009101484,0.94762397,0.00047260514,0.037847675,0.000024488974],"about_ca_topic_score_codex":0.0011543108,"about_ca_topic_score_gemma":0.0018713679,"teacher_disagreement_score":0.0039405227,"about_ca_system_score_codex":0.0006668272,"about_ca_system_score_gemma":0.0004876658,"threshold_uncertainty_score":0.013182342},"labels":[],"label_agreement":null},{"id":"W3112397639","doi":"10.1093/neuonc/noaa215.196","title":"CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Temozolomide; Concomitant; Internal medicine; Clinical endpoint; Progression-free survival; Oligodendroglioma; Oncology; Glioma; Surgery; Gastroenterology; Randomized controlled trial; Radiation therapy; Chemotherapy; Astrocytoma","score_opus":0.08930946883976972,"score_gpt":0.3700152749557415,"score_spread":0.2807058061159718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112397639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97402126,0.006766278,0.00091663655,0.0010572616,0.00039599944,0.0062839626,0.0044159493,0.0002458385,0.0058969264],"genre_scores_gemma":[0.971923,0.0041237054,0.0028935208,0.0016501074,0.00029783382,0.0065788557,0.0054411064,0.000062901,0.0070288987],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995763,0.00025438896,0.000013306255,0.00005552157,0.00004339607,0.000057116056],"domain_scores_gemma":[0.99942243,0.00009606254,0.00012601333,0.0000347441,0.000028745228,0.00029196937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014991316,0.0014063651,0.0016762648,0.00044271955,0.00034255933,0.0009537293,0.0011543323,0.00086225034,0.0039890716],"category_scores_gemma":[0.00094863534,0.00045650624,0.0013361317,0.00042324277,0.0008906344,0.0005131857,0.00037982967,0.0020359347,0.0007952592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9101731,0.011002301,0.0020220347,0.0014564724,0.0012191029,0.0001310789,0.00011810265,0.0019506583,0.013924576,0.00041277386,0.0059125293,0.051677253],"study_design_scores_gemma":[0.8848154,0.105690256,0.0042204503,0.000051670257,0.0005469229,0.0001224228,0.000026699454,0.0010541482,0.000983678,0.00021053947,0.0022504616,0.000027483851],"about_ca_topic_score_codex":0.0032323538,"about_ca_topic_score_gemma":0.013591582,"teacher_disagreement_score":0.0039890716,"about_ca_system_score_codex":0.0015925037,"about_ca_system_score_gemma":0.0019832614,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3112416841","doi":"10.1093/neuonc/noaa222.307","title":"HGG-20. DIAGNOSTIC AND BIOLOGICAL ROLE OF METHYLATION PATTERNS IN REPLICATION REPAIR DEFICIENT HIGH GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; Dalhousie University; Université Laval; Hospital for Sick Children","funders":"","keywords":"Epigenetics; DNA methylation; Methylation; Biology; Genetics; Context (archaeology); Gene; Cancer research; Gene expression","score_opus":0.024799563310060214,"score_gpt":0.2849263233552051,"score_spread":0.2601267600451449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112416841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726486,0.00032352353,0.0013193669,0.000015274103,0.000002014993,0.000009038118,0.00047658145,0.00006336649,0.0005258808],"genre_scores_gemma":[0.99784553,0.00008058726,0.0012441229,0.000010338785,0.000001202969,0.000005979842,0.00046560023,0.000010083264,0.00033663795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984586,0.000021636051,0.000011730851,0.00004458837,0.000039444567,0.000036754354],"domain_scores_gemma":[0.9998523,0.000019148247,0.000052063293,0.000016693117,0.000021024684,0.000038781323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012729526,0.00016333259,0.00014764447,0.00052942976,0.00008812711,0.00025066693,0.00013288143,0.00019949445,0.000932791],"category_scores_gemma":[0.00020116637,0.00011043486,0.00009472257,0.0002475853,0.00013896343,0.00007695191,0.0001822491,0.0001410226,0.0002210599],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002517014,0.000007378778,0.02831506,0.000027184995,0.00001592119,0.00008329706,0.000025319514,0.000076355645,0.968298,0.000036964117,0.00003465401,0.0028280544],"study_design_scores_gemma":[0.0000067078586,0.00029915464,0.6019327,0.000005031453,0.000046269353,0.0017135562,0.00010927213,0.0013660907,0.39329812,0.000103514016,0.0011125574,0.0000069200955],"about_ca_topic_score_codex":0.0014098334,"about_ca_topic_score_gemma":0.0019880552,"teacher_disagreement_score":0.0014098334,"about_ca_system_score_codex":0.00022061351,"about_ca_system_score_gemma":0.000082428276,"threshold_uncertainty_score":0.003120482},"labels":[],"label_agreement":null},{"id":"W3112428041","doi":"10.1093/neuonc/noaa215.094","title":"COVD-11. THE BRAIN TUMOR AND NOT FOR PROFIT AND CHARITY EXPERIENCE OF COVID 19: REACTING AND ADJUSTING TO AN UNPRECEDENTED GLOBAL PANDEMIC IN THE 21ST CENTURY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Alliance; Pandemic; Coronavirus disease 2019 (COVID-19); Descriptive statistics; Business; Public relations; Profit (economics); Health care; Political science; Marketing; Economic growth; Economics; Disease; Medicine; Infectious disease (medical specialty); Pathology","score_opus":0.13912187874939436,"score_gpt":0.4404631463481133,"score_spread":0.30134126759871893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112428041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7837696,0.001657927,0.00033589822,0.15836631,0.0013524228,0.0000878745,0.0004611475,0.000047930334,0.05392081],"genre_scores_gemma":[0.9773412,0.0013101306,0.00027360817,0.01502194,0.00021966298,0.00006435148,0.00015956107,0.000030204052,0.0055794595],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99164444,0.0049033123,0.0002240321,0.00022194,0.001101974,0.0019042584],"domain_scores_gemma":[0.98027533,0.0045078704,0.003178305,0.00040467232,0.0019033736,0.009730483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007586042,0.00023780686,0.00027002592,0.0007634287,0.010768459,0.005913852,0.00095798186,0.0015945733,0.0077269124],"category_scores_gemma":[0.01644122,0.00029041825,0.00027815346,0.0010779825,0.005537848,0.0033638058,0.011552589,0.0053861667,0.00062828173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017175244,0.00051551266,0.16140975,0.00048415462,0.00004164074,0.003933928,0.5357589,0.00027052502,0.00070508773,0.023017263,0.2146708,0.059020653],"study_design_scores_gemma":[0.0000130986355,0.00017998324,0.03998592,0.000377317,0.000009776186,0.0010386579,0.81176513,0.00013593909,0.00016317265,0.0011633537,0.14511451,0.00005316206],"about_ca_topic_score_codex":0.02325865,"about_ca_topic_score_gemma":0.04788849,"teacher_disagreement_score":0.02325865,"about_ca_system_score_codex":0.009100689,"about_ca_system_score_gemma":0.009047771,"threshold_uncertainty_score":0.06603044},"labels":[],"label_agreement":null},{"id":"W3112457373","doi":"10.1093/neuonc/noaa215.611","title":"NCOG-73. EFFECT OF TIME TO DIAGNOSIS IN CHILDREN WITH MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS ON SURVIVAL OUTCOMES AND DISEASE-ASSOCIATED MORBIDITY: AN INSTITUTIONAL COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Ependymoma; Cohort; Pediatrics; Proportional hazards model; Retrospective cohort study; Disease; Glioma; Internal medicine; Surgery; Pathology","score_opus":0.01413229069521295,"score_gpt":0.26788582985182974,"score_spread":0.2537535391566168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112457373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972057,0.00040848687,0.000050802453,0.000035397235,0.0000093744875,0.000013835646,0.0017741586,0.000003660865,0.00049856806],"genre_scores_gemma":[0.99832624,0.00017673564,0.00006441241,0.00002074165,0.000008342268,0.00001710063,0.0012762777,0.000003873452,0.00010625899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988913,0.00023632355,0.00012153182,0.00027379364,0.000220611,0.00025636857],"domain_scores_gemma":[0.99504304,0.0006758319,0.0030216316,0.0003120359,0.00040550905,0.0005418827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012274267,0.00029186188,0.0003116882,0.0012023002,0.0005648481,0.0007801299,0.0006259009,0.00026564483,0.0019252389],"category_scores_gemma":[0.004258091,0.00028360798,0.0006524412,0.0020413082,0.00033600873,0.00056639366,0.00063137914,0.000569893,0.00023301807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050767485,0.000007934126,0.99945444,0.0000037503432,0.0000289639,0.000037253358,0.000014965736,0.000010036086,0.000020155334,0.0000059309036,0.00006973683,0.0002960966],"study_design_scores_gemma":[0.0000069056,0.000049030536,0.9993936,0.000009763705,0.000029766048,0.00018454234,0.000101687365,0.000047679277,0.000028367172,0.000006021408,0.00014038853,0.0000022851505],"about_ca_topic_score_codex":0.03648219,"about_ca_topic_score_gemma":0.04324757,"teacher_disagreement_score":0.03648219,"about_ca_system_score_codex":0.0011623047,"about_ca_system_score_gemma":0.0010606343,"threshold_uncertainty_score":0.07253969},"labels":[],"label_agreement":null},{"id":"W3112465741","doi":"10.1093/neuonc/noaa222.111","title":"DIPG-68. ALPHA-THALASSEMIA X-LINKED MENTAL RETARDATION PROTEIN (ATRX) LOSS-OF-FUNCTION IN A MOUSE MODEL OF DIFFUSE INTRINSIC PONTINE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"ATRX; Biology; Cancer research; Nestin; Glioma; Carcinogenesis; Mutation; Genetics; Gene; Stem cell; Neural stem cell","score_opus":0.029422406604801207,"score_gpt":0.2812602307276711,"score_spread":0.25183782412286987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112465741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303186,0.0006664595,0.002643966,0.00018713747,0.00005820926,0.00014646135,0.0014063179,0.00029398434,0.0015655976],"genre_scores_gemma":[0.9824995,0.000835459,0.0036791917,0.00009698441,0.000014988491,0.00033266205,0.0015050205,0.000066054985,0.010970224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960643,0.00005080577,0.000045312085,0.00010099714,0.00010940982,0.00008707369],"domain_scores_gemma":[0.9997117,0.00002234256,0.00010644675,0.000029080114,0.000016823957,0.000113666974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026714435,0.00080071855,0.00033265757,0.0011767773,0.00024977323,0.00035372478,0.000457847,0.00082657696,0.0024046586],"category_scores_gemma":[0.000099761986,0.00035660702,0.00048143332,0.00028571644,0.00044479402,0.00035351224,0.00031095423,0.001427612,0.0006599535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039426622,0.0003129526,0.00039044156,0.000051680603,0.00001388804,0.0002865011,0.000048722814,0.00013892564,0.99669254,0.0003009093,0.00012242443,0.001246732],"study_design_scores_gemma":[0.00020162587,0.0044576386,0.007085957,0.000034106106,0.00006124176,0.0016551535,0.00014228155,0.0020845323,0.97949505,0.00015440525,0.0046111248,0.000016897664],"about_ca_topic_score_codex":0.0008289397,"about_ca_topic_score_gemma":0.0014131072,"teacher_disagreement_score":0.0024046586,"about_ca_system_score_codex":0.00043846315,"about_ca_system_score_gemma":0.00028592517,"threshold_uncertainty_score":0.008044362},"labels":[],"label_agreement":null},{"id":"W3112468799","doi":"10.1093/neuonc/noaa222.833","title":"TBIO-05. GENOME-SCALE NUCLEOTIDE-SPECIFIC CHARACTERIZATION OF 5-HYDROXYMETHYLCYTOSINE IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"CpG site; DNA methylation; Biology; 5-Hydroxymethylcytosine; Cancer research; Genome; Gene; Glioma; Genetics; Molecular biology; Gene expression","score_opus":0.013092659836523583,"score_gpt":0.23005758969776058,"score_spread":0.216964929861237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112468799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.706321,0.0016130098,0.010481207,0.00037460562,0.00011726461,0.0002858756,0.26909855,0.0025891827,0.009119253],"genre_scores_gemma":[0.68174803,0.00062283623,0.018463304,0.00040248552,0.000045360266,0.0010570533,0.2896532,0.0013496601,0.0066580633],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991177,0.00018782057,0.000044004224,0.000287447,0.00020379081,0.00015937556],"domain_scores_gemma":[0.9985921,0.00027067945,0.0004624334,0.00018030622,0.00015344961,0.00034099622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013224813,0.00047082483,0.0007020266,0.0011454528,0.00060701364,0.0012209319,0.0011321564,0.00049267214,0.008610165],"category_scores_gemma":[0.0018662454,0.00043931056,0.00060582045,0.0017534666,0.00031231227,0.00023028924,0.0008814247,0.0009017998,0.0016201532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008010298,0.00028270454,0.7823323,0.0012677601,0.0011001577,0.00027958685,0.0008348155,0.0044632414,0.10232066,0.0015209059,0.040240634,0.05734696],"study_design_scores_gemma":[0.0002624769,0.0011673236,0.90799105,0.00011489316,0.0008663725,0.0009223394,0.00029326856,0.005755404,0.027038136,0.0008914909,0.054641042,0.00005627454],"about_ca_topic_score_codex":0.014166525,"about_ca_topic_score_gemma":0.017290823,"teacher_disagreement_score":0.014166525,"about_ca_system_score_codex":0.0010090758,"about_ca_system_score_gemma":0.0012468885,"threshold_uncertainty_score":0.028803825},"labels":[],"label_agreement":null},{"id":"W3112476639","doi":"10.1093/neuonc/noaa215.917","title":"TAMI-29. MULTIFACTORIAL UPREGULATION OF ID1 DRIVES DIPG INVASIVENESS AND IS THERAPEUTICALLY TARGETABLE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gene knockdown; Cancer research; Downregulation and upregulation; Small hairpin RNA; Biology; Carcinogenesis; Cancer; Cell culture; Gene; Genetics","score_opus":0.02301430700370621,"score_gpt":0.2961122783630555,"score_spread":0.27309797135934927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112476639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97344726,0.0025211843,0.0056712483,0.0004787569,0.0002366863,0.00017276175,0.008996463,0.0009778561,0.0074977577],"genre_scores_gemma":[0.98472035,0.0006079925,0.0020998071,0.00020052325,0.000008496362,0.00011795452,0.004173556,0.00010143676,0.0079699755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983084,0.000009911141,0.000010175286,0.00005393615,0.000044281576,0.000050759147],"domain_scores_gemma":[0.9998896,0.000011191797,0.000026146186,0.000014670038,0.000007938306,0.000050380597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012907725,0.00024191779,0.00029619253,0.00021770979,0.00020981528,0.00030387106,0.00024344074,0.000321799,0.0049159704],"category_scores_gemma":[0.00010770804,0.00016077163,0.00034162024,0.000202467,0.00027625824,0.00010679536,0.00028319942,0.0010140196,0.0015162453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001967168,0.000063135725,0.0003527209,0.000098009004,0.000009419238,0.00012096739,0.000022867203,0.000126638,0.99483067,0.00029743888,0.0009255219,0.002955997],"study_design_scores_gemma":[0.000093268,0.00068224425,0.015487692,0.000019444347,0.00003908376,0.0006184333,0.000104276754,0.002802608,0.96279705,0.00020579761,0.017135717,0.000014361722],"about_ca_topic_score_codex":0.0016470294,"about_ca_topic_score_gemma":0.0036498432,"teacher_disagreement_score":0.0049159704,"about_ca_system_score_codex":0.00040961237,"about_ca_system_score_gemma":0.00036266804,"threshold_uncertainty_score":0.016445577},"labels":[],"label_agreement":null},{"id":"W3112477812","doi":"10.1093/neuonc/noaa222.100","title":"DIPG-55. PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hydrocephalus; Cohort; Surgery; Survival analysis; Glioma; Medical record; Incidence (geometry); Cohort study; Internal medicine","score_opus":0.015168859743813176,"score_gpt":0.25422076407299565,"score_spread":0.23905190432918247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112477812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616575,0.00033786008,0.00008642464,0.00003539453,0.0000033918805,0.0000074281807,0.0026734986,0.000012429343,0.00067779317],"genre_scores_gemma":[0.9977362,0.00016339439,0.0000811491,0.000010133335,0.0000037141906,0.000010326184,0.0019450057,0.0000034024547,0.000046705896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942917,0.000097419856,0.000093055794,0.00014883881,0.00013430585,0.00009724776],"domain_scores_gemma":[0.9979151,0.00029858763,0.001219554,0.00016107642,0.0002091481,0.00019650233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059870334,0.0001403398,0.0002864204,0.0011674361,0.0002188238,0.00053615676,0.00022774083,0.00016774995,0.00081986253],"category_scores_gemma":[0.0023925116,0.00012753972,0.0002902494,0.0021264015,0.00023145987,0.00039733792,0.0004261238,0.00032699958,0.00019362442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018437608,0.0000029662299,0.99884605,0.0000049981695,0.00000964486,0.000055937377,0.000029051997,0.000023675802,0.000041189858,0.000009133355,0.000101134785,0.00085774],"study_design_scores_gemma":[0.0000020838843,0.000027679176,0.99900395,0.0000047988315,0.000011339769,0.00049040857,0.00009306936,0.000062987274,0.000051353883,0.00000594787,0.00024435561,0.000001911762],"about_ca_topic_score_codex":0.0061719976,"about_ca_topic_score_gemma":0.004505543,"teacher_disagreement_score":0.0061719976,"about_ca_system_score_codex":0.00042916756,"about_ca_system_score_gemma":0.000445253,"threshold_uncertainty_score":0.012272179},"labels":[],"label_agreement":null},{"id":"W3112499229","doi":"10.1093/neuonc/noaa222.291","title":"GCT-75. ISOLATED PITUITARY STALK THICKENING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pituitary stalk; Diabetes insipidus; Cohort; Malignancy; Germinoma; Germ cell tumors; Magnetic resonance imaging; Internal medicine; Radiology; Pediatrics; Gastroenterology; Pathology; Pituitary gland; Hormone","score_opus":0.02896208801568675,"score_gpt":0.29191436498490303,"score_spread":0.2629522769692163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112499229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698,0.0011459567,0.00004182495,0.00007488735,0.0000120359055,0.00000792539,0.0005592534,0.000009680523,0.0011685637],"genre_scores_gemma":[0.9991928,0.00027121423,0.00004783829,0.000025411597,0.000021704825,0.0000043863124,0.00028285614,0.000002198235,0.00015164373],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998349,0.000019893598,0.000014875849,0.000043033124,0.000035351422,0.000051800544],"domain_scores_gemma":[0.9986534,0.000360251,0.0005839713,0.000047220296,0.00006526034,0.0002899507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019984132,0.00023000769,0.00024618357,0.00061758485,0.00038519508,0.0004543798,0.00024804863,0.00022262344,0.0034228277],"category_scores_gemma":[0.0015358602,0.000112226604,0.0002529086,0.00078764424,0.00041177802,0.00033164615,0.00024972062,0.00033889382,0.00035726532],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015121866,0.000018609944,0.9950577,0.000019915427,0.0000150420165,0.0019519747,0.000019782883,0.000039934403,0.00028866352,0.000019543791,0.00016314046,0.0022544614],"study_design_scores_gemma":[0.000014856951,0.0002383191,0.9845189,0.000025980216,0.000034997494,0.014104396,0.00015870099,0.00010989605,0.00026070024,0.000045792494,0.00048313977,0.000004297589],"about_ca_topic_score_codex":0.0034820128,"about_ca_topic_score_gemma":0.0031721443,"teacher_disagreement_score":0.0034820128,"about_ca_system_score_codex":0.00034182076,"about_ca_system_score_gemma":0.00046280865,"threshold_uncertainty_score":0.0114504695},"labels":[],"label_agreement":null},{"id":"W3112505324","doi":"10.1093/neuonc/noaa222.427","title":"LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH <i>BRAF</i> V600-MUTANT LOW-GRADE GLIOMA (LGG)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Trametinib; Combination therapy; Dabrafenib; Internal medicine; Adverse effect; Interim analysis; Refractory (planetary science); Oncology; Phases of clinical research; Clinical trial; Gastroenterology; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.014611663211555761,"score_gpt":0.26312724526150627,"score_spread":0.2485155820499505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112505324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486476,0.0018608794,0.00016289324,0.00015452498,0.00001832617,0.00026400445,0.0012782301,0.000055945176,0.0013404709],"genre_scores_gemma":[0.9964953,0.00063212245,0.0004537156,0.00019539158,0.000017421973,0.00019138571,0.0017026745,0.000011150603,0.00030077746],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996526,0.00015858478,0.000020662663,0.000056341723,0.00005070898,0.00006106651],"domain_scores_gemma":[0.9996939,0.000047406917,0.00008674049,0.000024205603,0.000022920245,0.00012484772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059433235,0.0003572287,0.00074984366,0.00025065424,0.00017380364,0.00048581153,0.0003408419,0.00034311562,0.0016559158],"category_scores_gemma":[0.00056061347,0.00019279047,0.00058956776,0.00035197524,0.00036667433,0.00030217087,0.00020032629,0.00082733145,0.0004173072],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32976606,0.0152893765,0.20459945,0.0013877929,0.0024782259,0.0017045937,0.00046525375,0.00597378,0.10089618,0.00046746508,0.014768292,0.32220346],"study_design_scores_gemma":[0.11574712,0.42881265,0.3938385,0.00019863372,0.0025625771,0.003591955,0.00032693555,0.0051606465,0.030682636,0.00034839267,0.018665353,0.000064712214],"about_ca_topic_score_codex":0.0017910635,"about_ca_topic_score_gemma":0.0051579126,"teacher_disagreement_score":0.0017910635,"about_ca_system_score_codex":0.00086072925,"about_ca_system_score_gemma":0.0011353267,"threshold_uncertainty_score":0.0062450767},"labels":[],"label_agreement":null},{"id":"W3112565522","doi":"10.1093/neuonc/noaa215.090","title":"COVD-06. BRAIN TUMOURS AND COVID-19: THE PATIENT AND CAREGIVER EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Anxiety; Telehealth; Population; Isolation (microbiology); Quality of life (healthcare); Health care; Family medicine; Telemedicine; Psychiatry; Internal medicine; Nursing; Disease; Environmental health; Bioinformatics","score_opus":0.07347576339368843,"score_gpt":0.39013368972249934,"score_spread":0.3166579263288109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112565522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051894,0.0023139922,0.00014175326,0.007283887,0.0001381709,0.00002809142,0.00039072946,0.000015416967,0.009168909],"genre_scores_gemma":[0.9972873,0.001052199,0.00008714784,0.00080931856,0.000035080924,0.000016175089,0.00012009564,0.0000048279094,0.0005879086],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9975299,0.0014835309,0.00020782236,0.000087937544,0.00030233274,0.00038843404],"domain_scores_gemma":[0.99101186,0.0023094388,0.0025856867,0.0001693079,0.0007438612,0.0031798077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028135024,0.00016962492,0.00032985385,0.0005378636,0.0019416079,0.0019170073,0.00034965703,0.00047272892,0.0050460054],"category_scores_gemma":[0.012552288,0.00017239033,0.00024908193,0.00083468296,0.0009909591,0.0013084188,0.0029814309,0.0011516332,0.00045235895],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016983085,0.00015413524,0.8712905,0.00029220205,0.00005417668,0.001944449,0.06874105,0.00008362991,0.00018355511,0.00061561796,0.021301033,0.035169825],"study_design_scores_gemma":[0.00003056793,0.00049332826,0.5919017,0.0010342828,0.000058254886,0.008659325,0.35406753,0.0003760083,0.00026822355,0.0005736264,0.042448934,0.000088216046],"about_ca_topic_score_codex":0.008131682,"about_ca_topic_score_gemma":0.0082266815,"teacher_disagreement_score":0.008131682,"about_ca_system_score_codex":0.0013554844,"about_ca_system_score_gemma":0.0017847032,"threshold_uncertainty_score":0.016880572},"labels":[],"label_agreement":null},{"id":"W3112598367","doi":"10.1093/neuonc/noaa222.446","title":"LINC-11. NEUROPATHOLOGY REVIEW OF LATIN AMERICAN CHILDHOOD AND ADOLESCENT BRAIN TUMOR PATIENTS: A MULTI-NATIONAL, MULTI-DISCIPLINARY PEDIATRIC NEURO-ONCOLOGY TELECONFERENCE EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Subspecialty; Medicine; Neuropathology; Atypical teratoid rhabdoid tumor; Medulloblastoma; Latin Americans; Family medicine; Pediatrics; Pathology; Disease; Political science","score_opus":0.038639359100607076,"score_gpt":0.3747304223493535,"score_spread":0.33609106324874644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112598367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868998,0.0018670722,0.00077845587,0.00094776525,0.000055075794,0.000117982556,0.0006207163,0.00009855245,0.008614503],"genre_scores_gemma":[0.9908942,0.0022598144,0.0033878377,0.00071136875,0.00006983541,0.00010719658,0.000751943,0.00006533552,0.0017525099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993316,0.0002385913,0.00009588504,0.00012365825,0.0000982965,0.00011199134],"domain_scores_gemma":[0.997439,0.00043625294,0.00078367523,0.00014351016,0.0005311231,0.0006663269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015044392,0.00029896718,0.00014023078,0.0010725602,0.0008472368,0.00083475176,0.0005519528,0.00035254145,0.0037063898],"category_scores_gemma":[0.0027469702,0.00021002963,0.00013401112,0.0011567463,0.00052213523,0.0006156631,0.001071769,0.0003395257,0.00083985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012608709,0.00020049734,0.8761964,0.00021232855,0.00003072812,0.036703587,0.0051440494,0.00026848962,0.003613388,0.0002448583,0.0084907655,0.06876873],"study_design_scores_gemma":[0.000033921682,0.00043492505,0.7858948,0.00047614175,0.000057702666,0.13317776,0.023721991,0.00080968987,0.0031761786,0.00032886944,0.051831227,0.000056804012],"about_ca_topic_score_codex":0.0059415535,"about_ca_topic_score_gemma":0.016997185,"teacher_disagreement_score":0.0059415535,"about_ca_system_score_codex":0.0015185522,"about_ca_system_score_gemma":0.002314994,"threshold_uncertainty_score":0.012399137},"labels":[],"label_agreement":null},{"id":"W3112623271","doi":"10.1093/neuonc/noaa215.818","title":"STEM-01. TARGETING BRAIN METASTASIS-INITIATING CELLS: A PREVENTATIVE APPROACH","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Medicine; Melanoma; Metastasis; Primary tumor; Breast cancer; In vivo; Cancer research; Population; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.06523996043810575,"score_gpt":0.3271838431786136,"score_spread":0.26194388274050784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112623271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8957772,0.025274592,0.041125186,0.003430529,0.00059149397,0.0018143189,0.0052872826,0.0022666974,0.02443265],"genre_scores_gemma":[0.9241161,0.019625451,0.028537218,0.001682717,0.00010777489,0.0007134905,0.0058366084,0.00012154981,0.019259192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999083,0.000012388942,0.000005271691,0.000019016941,0.000037392678,0.000017540226],"domain_scores_gemma":[0.9999088,0.000018345963,0.000019239189,0.000007951856,0.00002158667,0.000024175091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019086794,0.00066136074,0.0004196573,0.0006744048,0.00015463062,0.00056205457,0.0004896559,0.00040125835,0.0035523016],"category_scores_gemma":[0.000111925976,0.0001567985,0.00042027063,0.00027500658,0.00028631935,0.0002579887,0.00022307772,0.0011569296,0.0006750562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040481106,0.0005710518,0.00066866045,0.00053621543,0.000057952922,0.00020323486,0.000038940456,0.00081594294,0.94983864,0.0013733347,0.002118584,0.04337264],"study_design_scores_gemma":[0.00020478487,0.0028755255,0.0023110257,0.00005155816,0.00009877745,0.0004753324,0.000043417436,0.0021606884,0.96835995,0.0004536237,0.022952877,0.00001234694],"about_ca_topic_score_codex":0.00057404133,"about_ca_topic_score_gemma":0.0015234612,"teacher_disagreement_score":0.0035523016,"about_ca_system_score_codex":0.00038722908,"about_ca_system_score_gemma":0.00045865818,"threshold_uncertainty_score":0.011883557},"labels":[],"label_agreement":null},{"id":"W3112642730","doi":"10.1093/neuonc/noaa215.349","title":"EPID-31. CONTEMPORARY MANAGEMENT OF GRADE 2 AND 3 GLIOMA IN ALBERTA AND MANITOBA, 2012–2016: COMPARISON OF TOLERABILITY AND OUTCOMES ACROSS CHEMOTHERAPY REGIMENS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba; University of Alberta","funders":"","keywords":"Temozolomide; Medicine; Tolerability; Internal medicine; Procarbazine; Adverse effect; Rash; Nausea; Glioma; Oncology; Lomustine; Clinical trial; Vincristine; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.05325933579988171,"score_gpt":0.34830389388112576,"score_spread":0.2950445580812441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112642730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815701,0.0034373738,0.00023094025,0.00053227996,0.000022294349,0.00029529535,0.011082489,0.000047774345,0.0027813548],"genre_scores_gemma":[0.9835534,0.0016796263,0.0005376339,0.00037323261,0.000028042065,0.0001389479,0.012310636,0.000012466171,0.0013660123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994072,0.00009433111,0.000039931714,0.00009721103,0.00024092956,0.000120475175],"domain_scores_gemma":[0.99795234,0.00011752897,0.0006824599,0.00006407301,0.00063395087,0.00054951163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013026958,0.00029030003,0.0003428351,0.0011600018,0.00066890696,0.00080251397,0.0009474037,0.00022462082,0.0008530002],"category_scores_gemma":[0.0020145148,0.00020141127,0.00038341054,0.0030638347,0.00047398734,0.00020561239,0.00061430305,0.00044145214,0.00016754151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031303132,0.00033059466,0.93786395,0.00030262631,0.00024771213,0.00015231105,0.0005451109,0.0012938207,0.0011278287,0.00013230792,0.004063296,0.050809987],"study_design_scores_gemma":[0.00014753084,0.00047271635,0.99579924,0.000042856733,0.00008743089,0.00007760751,0.00032544642,0.0003278973,0.00017755592,0.000026219263,0.0025056575,0.000009767057],"about_ca_topic_score_codex":0.9067985,"about_ca_topic_score_gemma":0.9532639,"teacher_disagreement_score":0.09320152,"about_ca_system_score_codex":0.020522818,"about_ca_system_score_gemma":0.016162416,"threshold_uncertainty_score":0.18750077},"labels":[],"label_agreement":null},{"id":"W3112650211","doi":"10.1093/neuonc/noaa215.593","title":"NCOG-55. HARMONIZING LANGUAGE TO MAXIMIZE IMPACT: AN UPDATE ON COMMON DATA ELEMENTS FOR MENINGIOMA AND REVIEW OF CLINICAL TRIALS IN MENINGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Meningioma; Clinical trial; Medical physics; Oncology; Internal medicine; Surgery","score_opus":0.4427761434981502,"score_gpt":0.535081993609911,"score_spread":0.09230585011176085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112650211","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035950537,0.4721799,0.07121146,0.13671498,0.020992942,0.05747312,0.17520136,0.010460416,0.052170828],"genre_scores_gemma":[0.018720368,0.31228295,0.33224493,0.06431337,0.006638076,0.11862093,0.12928702,0.0070043085,0.010888068],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.6816846,0.13228588,0.13412622,0.008680642,0.03949594,0.0037267283],"domain_scores_gemma":[0.40392455,0.33696365,0.10317467,0.04569009,0.101626806,0.0086202],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.285543,0.002310075,0.012227313,0.027789412,0.0018118066,0.013517663,0.011712351,0.005820746,0.017693184],"category_scores_gemma":[0.4768993,0.0027455143,0.013374823,0.03740376,0.0036531358,0.009645738,0.013855626,0.00851755,0.008152103],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018306694,0.00009962977,0.0014153083,0.19492644,0.004695841,0.00018169149,0.001185728,0.001237187,0.00075137895,0.009986107,0.38324252,0.40044746],"study_design_scores_gemma":[0.0016332779,0.00017182599,0.0034361333,0.15739423,0.0037137184,0.0002229507,0.00020324437,0.0003754238,0.00058745965,0.0072275554,0.8248463,0.00018782626],"about_ca_topic_score_codex":0.011639975,"about_ca_topic_score_gemma":0.017846348,"teacher_disagreement_score":0.71445704,"about_ca_system_score_codex":0.015065933,"about_ca_system_score_gemma":0.06968796,"threshold_uncertainty_score":0.8810527},"labels":[],"label_agreement":null},{"id":"W3112653889","doi":"10.1093/neuonc/noaa222.598","title":"MODL-25. REPLICATION REPAIR DEFICIENT MOUSE MODELS PROVIDE INSIGHT ON HYPERMUTANT BRAIN TUMOURS, MECHANISMS OF IMMUNE EVASION, AND COMBINATORIAL IMMUNOTHERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Immunoediting; Cancer research; Biology; Nestin; OLIG2; Immune system; Immunotherapy; Conditional gene knockout; Medulloblastoma; Immunology; Gene; Central nervous system; Oligodendrocyte; Phenotype; Stem cell; Neuroscience; Neural stem cell; Myelin; Genetics","score_opus":0.021103152419640638,"score_gpt":0.26502564869597356,"score_spread":0.24392249627633292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112653889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94825417,0.005256997,0.020941282,0.0017790237,0.00023860484,0.0003099045,0.009225639,0.0019705615,0.0120237665],"genre_scores_gemma":[0.9363927,0.003463262,0.018603085,0.00057753903,0.0000738429,0.00057234877,0.0055161086,0.0004421866,0.03435883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996692,0.00004281911,0.000033180946,0.000074221956,0.00009222776,0.00008842752],"domain_scores_gemma":[0.999689,0.00002375325,0.0001262972,0.000029970677,0.000016735099,0.00011428242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040563758,0.0009276779,0.00041310556,0.0018090309,0.00039299804,0.0007202259,0.0006530462,0.00093749765,0.005112041],"category_scores_gemma":[0.000118241565,0.0004245178,0.00048520626,0.00037218042,0.00061578373,0.0007648621,0.0004121959,0.0017811125,0.0016768186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000446393,0.00022315618,0.00065068674,0.00013463886,0.000023270644,0.0004070036,0.000052223255,0.00032205266,0.98936427,0.0024519444,0.0010307792,0.004893548],"study_design_scores_gemma":[0.00020214636,0.001454334,0.006051473,0.000102727194,0.00008635446,0.0023964585,0.00012946759,0.003067413,0.9477782,0.0012030574,0.03749918,0.000029109422],"about_ca_topic_score_codex":0.00053200865,"about_ca_topic_score_gemma":0.0016317173,"teacher_disagreement_score":0.005112041,"about_ca_system_score_codex":0.0007707873,"about_ca_system_score_gemma":0.00039671548,"threshold_uncertainty_score":0.017101526},"labels":[],"label_agreement":null},{"id":"W3112666175","doi":"10.1093/neuonc/noaa222.615","title":"NFB-12. TRAMETINIB THERAPY FOR PEDIATRIC PATIENTS WITH REFRACTORY LOW GRADE GLIOMA OR EXTENSIVE SYMPTOMATIC PLEXIFORM NEUROFIBROMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Trametinib; Clinical trial; Refractory (planetary science); Internal medicine; Oncology","score_opus":0.03686654401893162,"score_gpt":0.314632845416433,"score_spread":0.27776630139750136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112666175","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92662394,0.043499164,0.0014972474,0.0031170112,0.00018238014,0.00018599695,0.0010229151,0.00026067288,0.023610583],"genre_scores_gemma":[0.9875144,0.006447506,0.0016485425,0.00084438536,0.000064621716,0.00005476926,0.0007140082,0.000016830389,0.0026950086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999567,0.0000058771884,0.000004343319,0.000008651999,0.000008390285,0.000016150381],"domain_scores_gemma":[0.99988186,0.0000142906,0.000038309994,0.000003496869,0.0000100668785,0.00005201029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083507344,0.0002022,0.00028565,0.00015760961,0.0003081309,0.00021047346,0.00016550548,0.00028267124,0.00183408],"category_scores_gemma":[0.00016757779,0.00005851393,0.00022449918,0.00018516854,0.00016141309,0.00018566249,0.00012921987,0.0006342893,0.00050911016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050971764,0.00134084,0.17734075,0.002015275,0.0003280484,0.09766432,0.0007395732,0.002370187,0.060176123,0.001790847,0.03791343,0.61322343],"study_design_scores_gemma":[0.0020764514,0.0121873915,0.32921845,0.0009798374,0.00047448312,0.42170855,0.00069327187,0.003617878,0.035006665,0.0011433829,0.19281673,0.000076898745],"about_ca_topic_score_codex":0.0018696132,"about_ca_topic_score_gemma":0.009616829,"teacher_disagreement_score":0.0018696132,"about_ca_system_score_codex":0.00056917313,"about_ca_system_score_gemma":0.0005147598,"threshold_uncertainty_score":0.0061356425},"labels":[],"label_agreement":null},{"id":"W3112670293","doi":"10.1093/neuonc/noaa215.191","title":"CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University; University of Toronto; University of British Columbia; Hospital for Sick Children; McGill University Health Centre; Centre hospitalier universitaire de Québec; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Tolerability; Internal medicine; Adverse effect; MAPK/ERK pathway; Progressive disease; Oncology; Gastroenterology; Progression-free survival; Surgery; Disease; Overall survival; Kinase; Biology","score_opus":0.026646744472562996,"score_gpt":0.2899561925069944,"score_spread":0.2633094480344314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112670293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843699,0.0043072617,0.00061880046,0.000666817,0.00015935683,0.004411027,0.0025631292,0.00017969213,0.002724104],"genre_scores_gemma":[0.97563404,0.0049578724,0.0029522078,0.0009599316,0.00018878466,0.0051696915,0.005660905,0.000061653576,0.0044149063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996208,0.00018881676,0.0000150680535,0.00004905038,0.000035133846,0.00009111445],"domain_scores_gemma":[0.99945444,0.000054793156,0.00010590362,0.000031271215,0.000036609297,0.0003169747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001566026,0.001810454,0.0014698579,0.0004902177,0.00038194036,0.00084635476,0.0012173714,0.0011275397,0.0037613413],"category_scores_gemma":[0.00072574883,0.0006560726,0.0010735972,0.00055340043,0.00072834047,0.00065428123,0.00028290285,0.0028810946,0.0011113918],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5645112,0.107608885,0.014197987,0.0022712955,0.001986686,0.0014603423,0.0005761979,0.006328975,0.09249189,0.0008296426,0.014188975,0.193548],"study_design_scores_gemma":[0.53738964,0.42654103,0.0177641,0.000076484,0.00056057115,0.00136889,0.00009686165,0.0019794973,0.0070747198,0.00015745727,0.0069414075,0.00004940519],"about_ca_topic_score_codex":0.0023890475,"about_ca_topic_score_gemma":0.0071463506,"teacher_disagreement_score":0.0037613413,"about_ca_system_score_codex":0.0013976536,"about_ca_system_score_gemma":0.0023073107,"threshold_uncertainty_score":0.012582958},"labels":[],"label_agreement":null},{"id":"W3112694400","doi":"10.1093/neuonc/noaa222.316","title":"HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital","funders":"","keywords":"Anaplasia; Pleomorphic xanthoastrocytoma; Medicine; Lomustine; Oncology; Chemotherapy; Radiation therapy; Internal medicine; Pathology; Astrocytoma; Vincristine; Glioma; Cancer research","score_opus":0.022055614471710335,"score_gpt":0.25420221221721734,"score_spread":0.232146597745507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112694400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792445,0.00044845673,0.00030438552,0.00018138601,0.000024488885,0.000035930618,0.00009086836,0.000022060323,0.0009679245],"genre_scores_gemma":[0.9991411,0.00018715052,0.00018329335,0.00010715261,0.000038450726,0.000012323273,0.00008839497,0.0000075246435,0.00023453953],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997317,0.00002672178,0.000030042414,0.000074003605,0.00004295255,0.00009455686],"domain_scores_gemma":[0.999305,0.00010638782,0.00021937635,0.000045132623,0.00003200538,0.00029195068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016087452,0.0008022426,0.00055246445,0.0007048136,0.0014529506,0.00066195923,0.0004201843,0.0011466908,0.0011185032],"category_scores_gemma":[0.00092215824,0.00045466772,0.00069301575,0.00078719435,0.0007100232,0.0005762884,0.0007391671,0.001015496,0.00034715116],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062492305,0.00011159875,0.20740153,0.000024044886,0.000032476528,0.78737456,0.0004460607,0.00012274482,0.001257007,0.00014767579,0.00029307284,0.0027267835],"study_design_scores_gemma":[0.000015016913,0.00030731666,0.11423297,0.0000133878175,0.000028797445,0.88366026,0.0003792327,0.00021128434,0.00041084626,0.00009201466,0.0006379395,0.000010838416],"about_ca_topic_score_codex":0.001725543,"about_ca_topic_score_gemma":0.0023759278,"teacher_disagreement_score":0.001725543,"about_ca_system_score_codex":0.0006579028,"about_ca_system_score_gemma":0.0005818268,"threshold_uncertainty_score":0.004773438},"labels":[],"label_agreement":null},{"id":"W3112706733","doi":"10.1093/neuonc/noaa222.031","title":"ATRT-33. ENABLING RAPID CLASSIFICATION OF ATRT WITH NANOSTRING NCOUNTER PLATFORM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Subtyping; DNA methylation; Transcriptome; Epigenetics; Computational biology; Workflow; Gene expression; Gene; Bioinformatics; Biology; Computer science; Database; Genetics","score_opus":0.0325335385647089,"score_gpt":0.274933744672727,"score_spread":0.24240020610801813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112706733","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.326376,0.0014949453,0.5872862,0.0007392453,0.00031536876,0.0011782537,0.035599086,0.03500694,0.012003978],"genre_scores_gemma":[0.3671103,0.0005929819,0.57659316,0.00078775943,0.00007566995,0.0035125173,0.03191116,0.0023932063,0.017023234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773514,0.00022422719,0.00018808944,0.0009210883,0.00076699915,0.00016440614],"domain_scores_gemma":[0.9992704,0.00020858024,0.00013413157,0.0001791626,0.00015302129,0.00005467294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019549672,0.0008451718,0.00057246827,0.0016844599,0.00046503902,0.0008236525,0.0008047888,0.0008007845,0.0066480436],"category_scores_gemma":[0.0018289464,0.00067487,0.00058068504,0.00066761754,0.0005308694,0.0005313488,0.0008944179,0.0008230923,0.0038907418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033220247,0.000074140764,0.01311052,0.0002765057,0.00010980193,0.00021584476,0.00012649591,0.002411672,0.93208146,0.0010185954,0.006762595,0.043480176],"study_design_scores_gemma":[0.000028237933,0.00014722499,0.02368407,0.000027995484,0.00005417226,0.0006021804,0.000032751333,0.046535462,0.9050475,0.0009124594,0.022870313,0.000057685542],"about_ca_topic_score_codex":0.0015289373,"about_ca_topic_score_gemma":0.004067678,"teacher_disagreement_score":0.0066480436,"about_ca_system_score_codex":0.0005859344,"about_ca_system_score_gemma":0.0006870283,"threshold_uncertainty_score":0.022239864},"labels":[],"label_agreement":null},{"id":"W3112725910","doi":"10.1093/neuonc/noaa215.002","title":"BIOM-02. IDENTIFYING MGMT ALTERATIONS AS BIOMARKERS OF SURVIVAL IN LUNG ADENOCARCINOMA WITH BRAIN METASTASES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Oncology; Adenocarcinoma; Lung cancer; Methylation; Medicine; DNA methylation; Internal medicine; Proportional hazards model; Cohort; Survival analysis; Cancer; Confounding; Cancer research; Biology; Gene; Genetics; Gene expression","score_opus":0.030526273214919783,"score_gpt":0.3125680782667459,"score_spread":0.2820418050518261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112725910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808337,0.0018213001,0.0024985482,0.0002689908,0.00004248478,0.00006365616,0.011880254,0.00021557265,0.0023755026],"genre_scores_gemma":[0.98221016,0.00032571008,0.002927273,0.00009837698,0.00003085569,0.00013557653,0.011238997,0.000034324585,0.0029985954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964,0.000110907284,0.000029660367,0.000094199604,0.00007938366,0.00004588055],"domain_scores_gemma":[0.99925214,0.00018907106,0.00024752205,0.0000614119,0.00010367869,0.00014617776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078740256,0.0003511014,0.0003999658,0.00077779684,0.00021817445,0.0006418374,0.0004312764,0.00036368525,0.0035493441],"category_scores_gemma":[0.0015532684,0.000257837,0.000462973,0.0008968465,0.00012610044,0.00016992149,0.00057166186,0.0004178687,0.001120014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027203765,0.00011769074,0.95474184,0.00018055976,0.00034743513,0.000083127336,0.000055570374,0.00089030626,0.0135854455,0.00013810674,0.0018573297,0.02528223],"study_design_scores_gemma":[0.00010046764,0.0005800003,0.9803696,0.000021216438,0.00028320166,0.00038497118,0.00006407347,0.0061254394,0.006525452,0.00028869422,0.005245093,0.000011840605],"about_ca_topic_score_codex":0.0022623064,"about_ca_topic_score_gemma":0.0032647,"teacher_disagreement_score":0.0035493441,"about_ca_system_score_codex":0.0003697445,"about_ca_system_score_gemma":0.00050190766,"threshold_uncertainty_score":0.011873722},"labels":[],"label_agreement":null},{"id":"W3112734515","doi":"10.1093/neuonc/noaa222.395","title":"LGG-13. THE CLINICAL AND MOLECULAR LANDSCAPE OF GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Cohort; Young adult; Oncology; Internal medicine; Cancer research","score_opus":0.023505155555610148,"score_gpt":0.31369301472764355,"score_spread":0.2901878591720334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112734515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815804,0.00053107017,0.00004622926,0.000047777405,0.000003228469,0.0000065172785,0.00046625288,0.000005998132,0.0007348277],"genre_scores_gemma":[0.99884206,0.0002335227,0.00006831573,0.000028681943,0.000005704175,0.0000065219997,0.0005532118,0.0000027394392,0.00025925707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989307,0.000017266033,0.000009907061,0.00002971397,0.000019387651,0.000030599243],"domain_scores_gemma":[0.9996685,0.000030631254,0.00018026646,0.000006492808,0.000033987744,0.00008018806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013489935,0.00014170885,0.00016955928,0.0005237999,0.0002237581,0.00036373275,0.000109988636,0.00018753204,0.0016006503],"category_scores_gemma":[0.0005232769,0.00008004449,0.00011658868,0.0006041448,0.00013933296,0.0002302686,0.00021944205,0.00017906673,0.00036286033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054417276,0.000010074309,0.99545926,0.000010169565,0.0000076134706,0.0005321684,0.000034565986,0.000014616324,0.0005288296,0.000020530902,0.0001768239,0.0031509434],"study_design_scores_gemma":[0.000002232739,0.00006828635,0.9958507,0.0000102926315,0.000009639947,0.0031457813,0.00020580651,0.000039992916,0.00013169971,0.00003429425,0.0005000481,0.0000012208643],"about_ca_topic_score_codex":0.0023056888,"about_ca_topic_score_gemma":0.0034107459,"teacher_disagreement_score":0.0023056888,"about_ca_system_score_codex":0.0002031897,"about_ca_system_score_gemma":0.00024609908,"threshold_uncertainty_score":0.0053547025},"labels":[],"label_agreement":null},{"id":"W3112753901","doi":"10.1093/neuonc/noaa222.417","title":"LGG-35. FUNCTIONAL GENOMIC APPROACHES TO IDENTIFY THERAPEUTIC TARGETS IN <i>MYB</i> AND <i>MYBL1</i> EXPRESSING PEDIATRIC LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"MYB; Biology; Cell cycle; Long non-coding RNA; Neural stem cell; Glioma; Gene; Transcription factor; Cancer research; Genetics; Computational biology; RNA; Stem cell","score_opus":0.09870630516554331,"score_gpt":0.2981041554665014,"score_spread":0.19939785030095808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112753901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92553484,0.0038431168,0.04955313,0.0007690582,0.0001458995,0.0007488967,0.00768405,0.002827757,0.008893229],"genre_scores_gemma":[0.9536946,0.0013137464,0.030815184,0.000324888,0.000014151021,0.00036477626,0.0046459124,0.00032293095,0.008503916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980694,0.00003034021,0.000014588857,0.000047815684,0.000060832255,0.000039613686],"domain_scores_gemma":[0.99991953,0.0000138065,0.000031847227,0.000008010978,0.0000059940653,0.000020827283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023315675,0.00048801178,0.00028263108,0.00040742513,0.00017049782,0.0004226112,0.0003987449,0.0004221059,0.0031989978],"category_scores_gemma":[0.00009376772,0.0002291527,0.00035026408,0.00024288733,0.00033606496,0.0001332311,0.0002706409,0.0009499028,0.0011320297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049919538,0.000024811308,0.00009553974,0.000041176492,0.000005662537,0.00002895606,0.000012121589,0.00020700881,0.9971011,0.00020793163,0.00013446204,0.0020911645],"study_design_scores_gemma":[0.00005352946,0.00038933728,0.0023089622,0.000014553473,0.0000393724,0.0002674067,0.00003076933,0.0014852175,0.9849333,0.000116580835,0.01035271,0.000008195023],"about_ca_topic_score_codex":0.0010771593,"about_ca_topic_score_gemma":0.001968925,"teacher_disagreement_score":0.0031989978,"about_ca_system_score_codex":0.00052976445,"about_ca_system_score_gemma":0.00037723168,"threshold_uncertainty_score":0.010701776},"labels":[],"label_agreement":null},{"id":"W3112757605","doi":"10.1093/neuonc/noaa222.223","title":"ETMR-20. IMPACT OF HIGH DOSE CHEMOTHERAPY WITH AND WITHOUT METHOTREXATE (MTX) ON OUTCOME OF PATIENTS WITH EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRs): A REPORT FROM CHILDREN’S ONCOLOGY GROUP PHASE III TRIAL ACNS0334","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Methotrexate; Regimen; Oncology; Internal medicine; Radiation therapy; Surgery; Pathology","score_opus":0.030537965874463335,"score_gpt":0.3423896198946818,"score_spread":0.31185165402021847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112757605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774736,0.00083137746,0.000088024426,0.00011744199,0.000027204409,0.00007250546,0.0004237048,0.000012866358,0.0006795352],"genre_scores_gemma":[0.99738985,0.00033707806,0.00020848555,0.00017359701,0.000042959502,0.0001111468,0.0012738056,0.000007428738,0.00045570533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950314,0.00026354924,0.000041260493,0.000077484816,0.000051271367,0.00006335584],"domain_scores_gemma":[0.9985985,0.0003549468,0.00031925598,0.00014071378,0.000056254197,0.0005302522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013624389,0.00034103615,0.00082720333,0.00024576095,0.00023785856,0.0005810781,0.0005260219,0.00055319845,0.0014595719],"category_scores_gemma":[0.0012533487,0.00013305742,0.0008661588,0.00025389748,0.0003240677,0.0005216656,0.0002546143,0.0015375043,0.0002687059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71645707,0.01658356,0.074051924,0.0003691662,0.0019713666,0.00034648058,0.0002884231,0.0039345347,0.029398106,0.0003477199,0.0038237793,0.15242797],"study_design_scores_gemma":[0.12320736,0.6146761,0.24145024,0.00008436213,0.0013223032,0.0010787941,0.00012756865,0.0039761798,0.00890102,0.00038554482,0.0047359145,0.000054498163],"about_ca_topic_score_codex":0.0006642865,"about_ca_topic_score_gemma":0.0016705197,"teacher_disagreement_score":0.0014595719,"about_ca_system_score_codex":0.0007253803,"about_ca_system_score_gemma":0.00057699496,"threshold_uncertainty_score":0.007205367},"labels":[],"label_agreement":null},{"id":"W3112819026","doi":"10.1093/neuonc/noaa215.285","title":"EPCO-06. MOLECULAR DETERMINANTS OF EVOLUTION AND PROGNOSIS AMONG DIFFUSE LOWER GRADE ASTROCYTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Glioma; Isocitrate dehydrogenase; Oligodendroglioma; Cancer research; Mutant; Methylation; Reprogramming; Gene; Astrocytoma; Genetics; Enzyme","score_opus":0.020592227490768028,"score_gpt":0.2814678186736482,"score_spread":0.2608755911828802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112819026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972167,0.00014661404,0.00009878325,0.000035478704,0.000005909639,0.0000074537884,0.0012704298,0.000011732026,0.0012068213],"genre_scores_gemma":[0.9964258,0.000061567116,0.00011856286,0.000019409625,0.000008268694,0.000011212397,0.0023844244,0.000008265492,0.0009624409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998745,0.000016460686,0.000014632063,0.000029704748,0.00002580001,0.000038934864],"domain_scores_gemma":[0.9992601,0.00006115919,0.00023556798,0.00004330315,0.00013061636,0.00026910662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016565784,0.00013557017,0.0001636492,0.0007482311,0.00023331486,0.0004851852,0.00018688999,0.00026650887,0.0046375166],"category_scores_gemma":[0.0005766118,0.00007088895,0.0001325477,0.00081125536,0.0001412083,0.00017900988,0.00023390734,0.00028057428,0.00095277117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011504475,0.00005048817,0.97171056,0.000029220615,0.00003722359,0.00031223844,0.00003126844,0.00009219801,0.019802107,0.00006883385,0.00055253564,0.006162949],"study_design_scores_gemma":[0.000008183763,0.00008281437,0.99751747,0.0000037192951,0.000015232829,0.00045623613,0.000042949556,0.00017636779,0.0009538877,0.00004232128,0.0006990452,0.0000017406867],"about_ca_topic_score_codex":0.0016322557,"about_ca_topic_score_gemma":0.0018718338,"teacher_disagreement_score":0.0046375166,"about_ca_system_score_codex":0.00027642606,"about_ca_system_score_gemma":0.00021964363,"threshold_uncertainty_score":0.015514016},"labels":[],"label_agreement":null},{"id":"W3112835023","doi":"10.1093/neuonc/noaa222.655","title":"PATH-20. METHYLATION ARRAY PROFILING OF PEDIATRIC BRAIN TUMORS; SINGLE CENTRE EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methylation; DNA methylation; Medulloblastoma; Glioma; Medicine; Histopathology; Ependymoma; Oncology; Pathology; Internal medicine; Bioinformatics; Biology; Cancer research; Gene; Genetics; Gene expression","score_opus":0.1507867397177991,"score_gpt":0.4039198196266042,"score_spread":0.2531330799088051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112835023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279445,0.0009992921,0.0034059237,0.00018333008,0.000015675902,0.00011372622,0.00049514044,0.00016820394,0.0018243075],"genre_scores_gemma":[0.99215674,0.0010398579,0.005292897,0.000121397745,0.000036381938,0.00007101492,0.00066257257,0.00007914553,0.0005399375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933463,0.00017798251,0.00004182621,0.000246908,0.00011667993,0.000082042294],"domain_scores_gemma":[0.9992692,0.00011675866,0.00013633232,0.00008605993,0.00010654169,0.0002852438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081390975,0.0004326187,0.00029728058,0.0005284658,0.00028594345,0.00045828253,0.00038500325,0.00032548516,0.0016256185],"category_scores_gemma":[0.0014382642,0.00023593282,0.00024259296,0.0006196559,0.00037404336,0.00039956186,0.00063265767,0.00042584745,0.00089627766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007750959,0.0003563279,0.78981715,0.00017906367,0.00010129812,0.013173997,0.0013403438,0.0012622925,0.024444656,0.00022280245,0.0018648154,0.1664621],"study_design_scores_gemma":[0.00022773366,0.0057435716,0.8015244,0.00010710513,0.00016413492,0.14181797,0.0013348232,0.00417624,0.028965397,0.00055386353,0.015295973,0.00008869069],"about_ca_topic_score_codex":0.0019548072,"about_ca_topic_score_gemma":0.0019569546,"teacher_disagreement_score":0.0019548072,"about_ca_system_score_codex":0.00048284675,"about_ca_system_score_gemma":0.0008344607,"threshold_uncertainty_score":0.005438268},"labels":[],"label_agreement":null},{"id":"W3112840818","doi":"10.1093/neuonc/noaa222.210","title":"ETMR-06. DISSECTING THE MOLECULAR AND DEVELOPMENTAL BASIS OF PINEOBLASTOMA THROUGH GENOMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pinealocyte; Biology; Genomics; microRNA; Cancer research; Gene; Computational biology; Pineal gland; Genetics; Genome; Neuroscience","score_opus":0.021361198202763644,"score_gpt":0.24734882591578292,"score_spread":0.22598762771301928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112840818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62677,0.00478878,0.09376789,0.004545661,0.00074334117,0.0005434377,0.21977423,0.013575032,0.03549156],"genre_scores_gemma":[0.55695766,0.0022738338,0.105717316,0.0027075873,0.00022589804,0.0007892012,0.30004618,0.0031951843,0.028087212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999572,0.0000730243,0.000020903424,0.00012931005,0.00013589094,0.00006903557],"domain_scores_gemma":[0.99946016,0.00008976154,0.000094803465,0.000083107116,0.00009856045,0.00017359309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014208569,0.00035685784,0.0004890612,0.00047967842,0.00038596976,0.0009149052,0.000656431,0.00059953355,0.006878984],"category_scores_gemma":[0.00052054157,0.00023341276,0.0006678792,0.00041084268,0.00024966657,0.00039331304,0.00083325134,0.0010785973,0.0031903258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024417972,0.00041408278,0.028691538,0.00063014607,0.00018157711,0.00066934025,0.00027044333,0.010451208,0.8131683,0.011277428,0.048704807,0.0830995],"study_design_scores_gemma":[0.000787182,0.0025344403,0.17498362,0.000251794,0.00036152988,0.003852031,0.00030436117,0.052237418,0.31992295,0.009681729,0.4348993,0.00018360117],"about_ca_topic_score_codex":0.0016907807,"about_ca_topic_score_gemma":0.0029004111,"teacher_disagreement_score":0.006878984,"about_ca_system_score_codex":0.0007196883,"about_ca_system_score_gemma":0.0011052496,"threshold_uncertainty_score":0.02301246},"labels":[],"label_agreement":null},{"id":"W3112851454","doi":"10.1093/neuonc/noaa222.401","title":"LGG-19. SPINAL LOW-GRADE GLIOMAS IN CANADIAN CHILDREN: A MULTI-CENTRE RETROSPECTIVE REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Stollery Children's Hospital; Hospital for Sick Children; Agricultural Research Institute of Ontario","funders":"","keywords":"Medicine; Retrospective cohort study; Pathological; Pilocytic astrocytoma; Surgery; Radiation therapy; Chemotherapy; Pediatrics; Astrocytoma; Internal medicine; Glioma","score_opus":0.026844336057462788,"score_gpt":0.30989366830199216,"score_spread":0.2830493322445294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112851454","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47877443,0.48607454,0.00024097496,0.0008744573,0.00013054443,0.00042285628,0.025498752,0.000049611397,0.007933915],"genre_scores_gemma":[0.77834547,0.21227849,0.0005989215,0.00066798535,0.00009005753,0.00017960553,0.0070783976,0.00001953112,0.0007415034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841535,0.00008978964,0.00036376182,0.00027421076,0.0006039456,0.00025294555],"domain_scores_gemma":[0.99622154,0.0003929628,0.0019277487,0.00008761473,0.0010991052,0.00027101545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010459692,0.0007191553,0.0009905079,0.0069608088,0.0017177109,0.0012105809,0.0011504128,0.00067742565,0.0027860976],"category_scores_gemma":[0.003036641,0.00046186513,0.0007744506,0.015743183,0.0008009891,0.0004818132,0.0005716379,0.00039335073,0.00038399344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026569562,0.00003460976,0.9276109,0.01686561,0.00060581247,0.0047918274,0.001195551,0.0000984636,0.00083649135,0.00035689154,0.0059844577,0.041353624],"study_design_scores_gemma":[0.000030813047,0.00007536217,0.96269727,0.004890441,0.0009287629,0.010930161,0.0016511135,0.00007776517,0.00022007686,0.000030379284,0.01842668,0.000041131167],"about_ca_topic_score_codex":0.8045127,"about_ca_topic_score_gemma":0.83865815,"teacher_disagreement_score":0.19548732,"about_ca_system_score_codex":0.011723676,"about_ca_system_score_gemma":0.023284927,"threshold_uncertainty_score":0.3932771},"labels":[],"label_agreement":null},{"id":"W3112871129","doi":"10.1093/neuonc/noaa222.456","title":"LINC-21. SURVEY ON THE RESOURCES AVAILABLE FOR PEDIATRIC NEURO-ONCOLOGY IN CHILE, SOUTH AMERICA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Medicine; Pediatric cancer; Gemcitabine; Childhood cancer; Topotecan; Radiation oncology; Radiation therapy; Oncology; Cancer; Pediatrics; Internal medicine; Chemotherapy","score_opus":0.052167992404418995,"score_gpt":0.29528332948063585,"score_spread":0.24311533707621685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112871129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701675,0.0004600145,0.00008780485,0.00060925167,0.000008015774,0.00013352008,0.020108178,0.00003016482,0.008395527],"genre_scores_gemma":[0.98712534,0.000696774,0.000298291,0.00024747854,0.000013906027,0.00035261438,0.008131048,0.000010222193,0.0031242853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994536,0.00013347267,0.00007593455,0.00006262668,0.00012577123,0.00014861763],"domain_scores_gemma":[0.99625623,0.0005846896,0.0018300893,0.000089224304,0.0005760573,0.0006637525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075685966,0.00022375361,0.00014315965,0.0018721509,0.00036636542,0.00076039374,0.00053488195,0.00019757931,0.0078981845],"category_scores_gemma":[0.0027060825,0.00017866575,0.00016031085,0.0026465948,0.00029010497,0.00047321155,0.0008396995,0.00027192844,0.0008636765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002659708,0.000034739784,0.9907872,0.00014266095,0.000017428458,0.0001919008,0.00081785396,0.00006440402,0.00025396628,0.0000762223,0.0026495485,0.0049374346],"study_design_scores_gemma":[0.0000045208567,0.000023568284,0.993708,0.000044986326,0.0000041068333,0.00010473049,0.0020790403,0.00004529931,0.00008916208,0.000014282772,0.0038774332,0.0000047120516],"about_ca_topic_score_codex":0.050775338,"about_ca_topic_score_gemma":0.046272516,"teacher_disagreement_score":0.050775338,"about_ca_system_score_codex":0.0021793686,"about_ca_system_score_gemma":0.0033551161,"threshold_uncertainty_score":0.1009596},"labels":[],"label_agreement":null},{"id":"W3112899297","doi":"10.1093/neuonc/noaa222.194","title":"EPID-08. FINDING THE NEEDLE IN THE HAY STACK – POPULATION-BASED STUDY OF PREDIAGNOSTIC SYMPTOMATIC INTERVAL IN CHILDREN WITH CNS TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Pediatrics; Medical record; Population; Paresis; Confidence interval; Diagnosis code; Ataxia; Health care; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.026589189848266106,"score_gpt":0.29513332224347677,"score_spread":0.2685441323952107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112899297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935348,0.00017909789,0.000040511088,0.00005381464,0.0000051919505,0.00003172567,0.0050286516,0.000008895201,0.0011173674],"genre_scores_gemma":[0.9968045,0.00022209439,0.000104034894,0.000041106963,0.0000049657506,0.000024210034,0.0025254323,0.0000049975956,0.0002686671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995061,0.000039923252,0.00004732755,0.00009346659,0.00015313317,0.0001600417],"domain_scores_gemma":[0.9983846,0.000109827735,0.0007152706,0.000044548007,0.00042189294,0.00032387907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003296957,0.00023801171,0.00027895602,0.0013252307,0.0008759871,0.00078287494,0.0006085621,0.00027821524,0.002368286],"category_scores_gemma":[0.0015936518,0.00029713212,0.00030637597,0.0024343925,0.00039263425,0.00035761713,0.00045344952,0.0005430831,0.00034172498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009683686,0.0000065726244,0.9994469,0.0000057983516,0.000005174976,0.000028639979,0.000046748646,0.000008904658,0.00002048371,0.0000050053513,0.00013787037,0.0002781565],"study_design_scores_gemma":[0.000001343015,0.000014596536,0.99940157,0.0000073282754,0.0000035439998,0.00010099512,0.00027314882,0.000026451791,0.000014514609,0.0000020052262,0.00015306138,0.0000013408779],"about_ca_topic_score_codex":0.68265307,"about_ca_topic_score_gemma":0.7276073,"teacher_disagreement_score":0.68265307,"about_ca_system_score_codex":0.004636808,"about_ca_system_score_gemma":0.0050574085,"threshold_uncertainty_score":0.63843167},"labels":[],"label_agreement":null},{"id":"W3112901064","doi":"10.1093/neuonc/noaa222.673","title":"QOL-09. WHOLE-BRAIN WHITE MATTER NETWORK CONNECTIVITY IS DISRUPTED BY PEDIATRIC BRAIN TUMOR TREATMENT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"White matter; Magnetic resonance imaging; Medicine; Psychology; Neuroscience; Nuclear medicine; Audiology; Radiology","score_opus":0.04164659635995809,"score_gpt":0.3417017554282418,"score_spread":0.3000551590682837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112901064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953713,0.00011371355,0.00039802332,0.00012262636,0.0000073934257,0.000018699937,0.0024439574,0.000053946103,0.0014703983],"genre_scores_gemma":[0.99678016,0.00008938871,0.0006604096,0.000029366909,0.000003840326,0.000040917053,0.001816803,0.000022244349,0.00055697944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983156,0.00003165693,0.000011531878,0.000044782526,0.00003728622,0.000043134463],"domain_scores_gemma":[0.9989961,0.00014725223,0.00056254567,0.000046341953,0.00009159821,0.00015616637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034093455,0.00019614074,0.00017135982,0.00036892376,0.00022413775,0.0004587231,0.00022223151,0.00016588956,0.006518879],"category_scores_gemma":[0.0022293206,0.00010283525,0.00030093495,0.0004448818,0.00024125143,0.00037185734,0.00047492873,0.00030846772,0.00040148714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029205976,0.000114471106,0.9534404,0.00010396266,0.0002094607,0.00020085153,0.0003662036,0.0013146305,0.0031190095,0.0004661266,0.0035748524,0.03679804],"study_design_scores_gemma":[0.000007139704,0.00007982965,0.99714595,0.000010151127,0.00003253169,0.0002501699,0.00010572261,0.0005605256,0.0005720594,0.00016996785,0.0010607573,0.000005241363],"about_ca_topic_score_codex":0.0039022518,"about_ca_topic_score_gemma":0.004059879,"teacher_disagreement_score":0.006518879,"about_ca_system_score_codex":0.0004996951,"about_ca_system_score_gemma":0.0005415342,"threshold_uncertainty_score":0.02180779},"labels":[],"label_agreement":null},{"id":"W3112979975","doi":"10.1093/neuonc/noaa215.654","title":"NIMG-41. VARIATION IN PERFUSION AND PERMEABILITY MRI DEPENDING ON VASCULAR INPUT FUNCTION SELECTION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"SSS*; Medicine; Nuclear medicine; Perfusion; Dynamic contrast-enhanced MRI; Radiology; Magnetic resonance imaging; Internal medicine","score_opus":0.02509115661679715,"score_gpt":0.29041493022263565,"score_spread":0.2653237736058385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112979975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486995,0.00043247556,0.0021589687,0.000032336477,0.0000062722884,0.000017373644,0.0003739619,0.00015012904,0.0019585215],"genre_scores_gemma":[0.99769825,0.000054097287,0.0012072072,0.000020907024,0.000002586719,0.000024354855,0.0004734442,0.00005690863,0.0004621246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998785,0.000041353058,0.0000054947013,0.000027122507,0.000023037612,0.000024539857],"domain_scores_gemma":[0.99979883,0.00007630267,0.000026282656,0.000028542288,0.00003531898,0.000034691384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051059487,0.00023754129,0.0002291527,0.00023958381,0.00014352828,0.00027200233,0.00016820982,0.00024515364,0.0017269982],"category_scores_gemma":[0.0009923228,0.00012354528,0.00014248348,0.00017732076,0.0002058256,0.0001386623,0.00015603309,0.00015722084,0.00051212875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064158915,0.00021635066,0.14993271,0.00021392597,0.00017160967,0.002105424,0.0003503733,0.0050865207,0.71231425,0.00061951845,0.0028292465,0.11974417],"study_design_scores_gemma":[0.00014010156,0.0017879446,0.77549106,0.000026865682,0.00020369848,0.00761296,0.00011940593,0.019602865,0.18724702,0.0006680424,0.0070536667,0.000046317673],"about_ca_topic_score_codex":0.0014766094,"about_ca_topic_score_gemma":0.0015596717,"teacher_disagreement_score":0.0017269982,"about_ca_system_score_codex":0.00026125732,"about_ca_system_score_gemma":0.0001654679,"threshold_uncertainty_score":0.005777359},"labels":[],"label_agreement":null},{"id":"W3112995881","doi":"10.1093/neuonc/noaa222.684","title":"QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Craniopharyngioma; Medicine; Quality of life (healthcare); Categorical variable; Artificial intelligence; Machine learning; Pediatrics; Surgery; Computer science","score_opus":0.04000410185333333,"score_gpt":0.31708878211197117,"score_spread":0.27708468025863786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112995881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98760337,0.00022948429,0.009206795,0.0002401184,0.000019909297,0.000045768043,0.0017666228,0.00024099476,0.0006470887],"genre_scores_gemma":[0.9949249,0.000035427525,0.003531537,0.000028150334,0.000009100469,0.000030643485,0.0012597452,0.000007672035,0.00017286142],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972886,0.00008986045,0.000032858195,0.000074779455,0.00003538984,0.000038185848],"domain_scores_gemma":[0.9987509,0.0005981291,0.00029535985,0.00009034172,0.00016863702,0.00009661612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113961,0.00051164423,0.00028656927,0.0008109555,0.00015257152,0.000674177,0.0002623959,0.0003711039,0.0014653696],"category_scores_gemma":[0.005363459,0.0001207956,0.00057445455,0.00037735578,0.00015881874,0.0003207912,0.00037789054,0.0005548875,0.00042811234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065293023,0.0002765237,0.8742229,0.00006414881,0.00024333507,0.0001441542,0.00009384175,0.0341715,0.002557891,0.00018984417,0.0018167921,0.085566275],"study_design_scores_gemma":[0.000045884066,0.0004356376,0.4211043,0.000049057046,0.00011355018,0.00031422582,0.00017952331,0.57108337,0.0037359628,0.0019010184,0.0010069428,0.000030445808],"about_ca_topic_score_codex":0.004437922,"about_ca_topic_score_gemma":0.0049448195,"teacher_disagreement_score":0.004437922,"about_ca_system_score_codex":0.0005896664,"about_ca_system_score_gemma":0.00045491505,"threshold_uncertainty_score":0.00882417},"labels":[],"label_agreement":null},{"id":"W3113000665","doi":"10.1093/neuonc/noaa215.846","title":"STEM-29. THE HISTONE VARIANT macroH2A2 ORCHESTRATES AN ACTIONABLE CHROMATIN PROGRAM OF STEMNESS IN GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Chromatin; Epigenetics; Biology; Histone; Epigenomics; Reprogramming; Cancer research; Transcription factor; Glioblastoma; Transcriptome; Stem cell; Computational biology; Cell biology; Cell; Genetics; DNA methylation; Gene expression; Gene","score_opus":0.01906152914665282,"score_gpt":0.2949411824889666,"score_spread":0.2758796533423138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113000665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833566,0.002229078,0.0063565024,0.00013155512,0.00004090609,0.000055131106,0.0057492987,0.00029104896,0.0017898263],"genre_scores_gemma":[0.99213725,0.0004909938,0.0015924609,0.0000954542,0.000008232822,0.000029785835,0.0036399078,0.00003477253,0.001971131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993145,0.000006593878,0.0000050065696,0.000022059981,0.000021464335,0.000013430488],"domain_scores_gemma":[0.9999342,0.0000069972766,0.000020066997,0.00000823423,0.000009146201,0.000021313022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011263486,0.00021806361,0.0002580374,0.00026757413,0.00015874092,0.0003140979,0.00011203971,0.00015784166,0.001669983],"category_scores_gemma":[0.000083013576,0.00011189289,0.00019301818,0.00020439443,0.00017003527,0.000107348125,0.00016269389,0.00020245677,0.00032684996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011073309,0.000006784887,0.0011365277,0.00002823396,0.000012662354,0.00004401719,0.000007924185,0.00012510818,0.9964484,0.00006500804,0.000087164175,0.0019273806],"study_design_scores_gemma":[0.000016827418,0.0003309476,0.034601577,0.0000067661163,0.00003719658,0.0002949753,0.000046267833,0.0014579446,0.9573946,0.0001461503,0.005657461,0.000009345464],"about_ca_topic_score_codex":0.00096207595,"about_ca_topic_score_gemma":0.0028321217,"teacher_disagreement_score":0.001669983,"about_ca_system_score_codex":0.00027908344,"about_ca_system_score_gemma":0.00019926955,"threshold_uncertainty_score":0.005586624},"labels":[],"label_agreement":null},{"id":"W3113002109","doi":"10.1093/neuonc/noaa215.190","title":"CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"IDH1; Anaplastic astrocytoma; Internal medicine; Glioma; Medicine; Oncology; Astrocytoma; Adjuvant therapy; Isocitrate dehydrogenase; Methylation; Cancer research; Biology; Chemotherapy; Mutation; Genetics; Gene","score_opus":0.015174105669922675,"score_gpt":0.3051012183696928,"score_spread":0.2899271126997701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113002109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882698,0.0058087846,0.00033344972,0.0007073707,0.0003113852,0.000883727,0.0014056803,0.000042182135,0.0022376103],"genre_scores_gemma":[0.99008465,0.0018158588,0.00056273205,0.00071291724,0.00021402902,0.001478382,0.0026447715,0.000021943568,0.0024647126],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994684,0.00035094138,0.000023241333,0.00007425547,0.000033358607,0.00004988572],"domain_scores_gemma":[0.99945086,0.00010221942,0.00013578146,0.000048712074,0.00003320902,0.00022914447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013842935,0.000882569,0.001465835,0.00019745501,0.00026272307,0.0009389522,0.00053571234,0.0006835776,0.002035333],"category_scores_gemma":[0.0009816716,0.00023701144,0.0009536967,0.00031317244,0.0005626678,0.000443954,0.00024090665,0.0015202615,0.00024408197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96486634,0.0018154237,0.0063576796,0.000477476,0.0018979621,0.00006818092,0.000037820286,0.001019109,0.0040234113,0.0002682518,0.0024338842,0.01673444],"study_design_scores_gemma":[0.8311023,0.122404195,0.031630024,0.00015374408,0.0037557187,0.00024504354,0.00008768825,0.0026478046,0.0020190836,0.0010868615,0.0048103556,0.000057116507],"about_ca_topic_score_codex":0.0015109292,"about_ca_topic_score_gemma":0.004930711,"teacher_disagreement_score":0.002035333,"about_ca_system_score_codex":0.0009175836,"about_ca_system_score_gemma":0.0009979174,"threshold_uncertainty_score":0.007320881},"labels":[],"label_agreement":null},{"id":"W3113025753","doi":"10.1093/neuonc/noaa222.116","title":"DIPG-74. RE-IRRADIATION OF DIPG: DATA FROM THE INTERNATIONAL DIPG REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Clinical trial; Internal medicine; Surgery","score_opus":0.10722863328306377,"score_gpt":0.3827924553330714,"score_spread":0.2755638220500076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113025753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62951136,0.15276806,0.0028827367,0.0016686005,0.00028029285,0.0013790696,0.190267,0.0003074335,0.02093552],"genre_scores_gemma":[0.8370446,0.046893038,0.0024826734,0.0011572505,0.00024812447,0.00069020485,0.110425726,0.000103810584,0.00095451367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970395,0.00073128,0.0010059805,0.00043171618,0.0005904331,0.0002009405],"domain_scores_gemma":[0.98015296,0.0050672623,0.010803616,0.0015472409,0.0019230298,0.00050596974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028148405,0.00024052772,0.00064662314,0.0038603444,0.00019021516,0.0009424422,0.00064742053,0.00029310837,0.001987133],"category_scores_gemma":[0.012707103,0.00018469279,0.0006131454,0.0088494,0.00025837222,0.0006199548,0.00057178986,0.0003421662,0.0008439682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071155984,0.000034269375,0.9100635,0.005606219,0.00045405887,0.0005321853,0.00022097051,0.00015365267,0.0003227932,0.00019107106,0.0128568765,0.06885271],"study_design_scores_gemma":[0.00008951489,0.00017954111,0.95785964,0.0016250829,0.00045852456,0.002948422,0.00027456865,0.0001000359,0.00034502166,0.00006251996,0.0360422,0.000014950812],"about_ca_topic_score_codex":0.0048407945,"about_ca_topic_score_gemma":0.0047872933,"teacher_disagreement_score":0.0048407945,"about_ca_system_score_codex":0.00073843595,"about_ca_system_score_gemma":0.0017059516,"threshold_uncertainty_score":0.014886498},"labels":[],"label_agreement":null},{"id":"W3113039004","doi":"10.1093/neuonc/noaa222.252","title":"GCT-33. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Contouring; Radiation therapy; Cog; Germ cell tumors; Clinical trial; Central nervous system; Internal medicine; Chemotherapy; Oncology; Nuclear medicine","score_opus":0.02208761623045421,"score_gpt":0.32952917548143207,"score_spread":0.3074415592509779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113039004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942008,0.0012088084,0.00021036873,0.00029878446,0.000042077754,0.0018218749,0.0009276775,0.00009510526,0.0011945146],"genre_scores_gemma":[0.9885421,0.0012786296,0.002209786,0.00066323497,0.000094421106,0.002528602,0.002956489,0.000058995214,0.0016678702],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994684,0.00032055535,0.000014797851,0.00006440252,0.000050554067,0.000081408994],"domain_scores_gemma":[0.99942267,0.000120761055,0.00011903075,0.000060341186,0.000028340743,0.0002489303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020046665,0.0011646531,0.0011963055,0.0005061682,0.00026525988,0.0005514249,0.00070336286,0.0007822448,0.0038672192],"category_scores_gemma":[0.0009824341,0.00041377026,0.001118921,0.0005373716,0.0008605796,0.0003729154,0.00032048154,0.0017874254,0.0006439946],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73300165,0.038199455,0.02169378,0.0013043889,0.0015290729,0.00044516765,0.0005541353,0.0062933424,0.02714365,0.00041278332,0.008899941,0.16052262],"study_design_scores_gemma":[0.61155033,0.33794826,0.041242797,0.000065291926,0.0006275786,0.00046130747,0.0000852448,0.0020436123,0.0022070918,0.0002234235,0.0035092847,0.00003576993],"about_ca_topic_score_codex":0.0029087882,"about_ca_topic_score_gemma":0.007533175,"teacher_disagreement_score":0.0038672192,"about_ca_system_score_codex":0.0010130086,"about_ca_system_score_gemma":0.0014612484,"threshold_uncertainty_score":0.012937129},"labels":[],"label_agreement":null},{"id":"W3113041355","doi":"10.1093/neuonc/noaa215.581","title":"NCOG-43. NEUROCOGNITIVE IMPAIRMENT AND FRAILTY IN GERIATRIC PATIENTS WITH HIGH GRADE GLIOMA AND THORACIC MALIGNANCY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Malignancy; Glioma; Internal medicine; Cohort; Geriatric oncology; Incidence (geometry); Cancer; Physical therapy; Oncology; Cognition","score_opus":0.02019640096826152,"score_gpt":0.2865715662885672,"score_spread":0.2663751653203057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113041355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845845,0.00084658136,0.000059836155,0.00018544377,0.000019225616,0.000035156612,0.0061242105,0.000020335348,0.004250795],"genre_scores_gemma":[0.99566734,0.00022098437,0.00013122018,0.00011081293,0.000017014763,0.00003432589,0.003455925,0.0000038883773,0.00035859097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997507,0.000032584427,0.00005092944,0.000035881378,0.000064743625,0.00006528901],"domain_scores_gemma":[0.9984785,0.00013276572,0.000781052,0.00004139432,0.00025431905,0.00031193774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003754638,0.00013755387,0.00024233956,0.0010300992,0.00033848165,0.000479611,0.00018832603,0.00020868998,0.0026314487],"category_scores_gemma":[0.0018782844,0.000063846186,0.00024209359,0.0020002364,0.00014188477,0.00023168532,0.0004582572,0.00025473183,0.00041414532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007155966,0.000010032022,0.99635327,0.000019469664,0.000009926641,0.000052847725,0.000028905906,0.000016568692,0.000046575507,0.000007615703,0.0006194266,0.0027638401],"study_design_scores_gemma":[0.0000024451724,0.000020051915,0.99941707,0.000008790864,0.000006436473,0.00010097965,0.00004611639,0.000026180127,0.000017967837,0.000010193643,0.00034293547,9.1908026e-7],"about_ca_topic_score_codex":0.018190973,"about_ca_topic_score_gemma":0.026895626,"teacher_disagreement_score":0.018190973,"about_ca_system_score_codex":0.0006145856,"about_ca_system_score_gemma":0.0006029492,"threshold_uncertainty_score":0.036170185},"labels":[],"label_agreement":null},{"id":"W3113060413","doi":"10.1093/neuonc/noaa222.732","title":"RARE-21. CANCER SPECTRUM IN GERMLINE SUFU MUTATION CARRIERS: A COLLABORATIVE PROJECT OF THE SIOPE HOST GENOME WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Germline; Medicine; Cohort; Cancer; Germline mutation; Medulloblastoma; Internal medicine; Oncology; Gastroenterology; Mutation; Pathology; Biology; Genetics","score_opus":0.026693588313672197,"score_gpt":0.2919195217558639,"score_spread":0.2652259334421917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113060413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776959,0.0009648811,0.0011024532,0.00024393386,0.000017219214,0.00028346627,0.015917724,0.00007614375,0.0036983052],"genre_scores_gemma":[0.9591414,0.0018841114,0.0051797405,0.00015504507,0.00006487924,0.00047814666,0.030384043,0.00006402395,0.0026487573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990828,0.00034999047,0.0000835715,0.00020661196,0.00018652367,0.00009043045],"domain_scores_gemma":[0.99787486,0.00058383244,0.000399242,0.00022828816,0.00043929982,0.00047453228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033659646,0.00051485404,0.00043227407,0.0037883737,0.0009628774,0.0006041425,0.0004528614,0.00034506645,0.0033122965],"category_scores_gemma":[0.0021875936,0.00018191038,0.00035303802,0.0022885054,0.00034351167,0.0002255232,0.0011008553,0.00020649827,0.00058411993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012716842,0.0001844342,0.94372433,0.00021670772,0.00020216165,0.0016843312,0.0011215465,0.00041785452,0.004905123,0.00038509944,0.0040962263,0.041790474],"study_design_scores_gemma":[0.0001730949,0.00033410892,0.9848779,0.00010611598,0.00012867578,0.0022672405,0.000841433,0.0006585501,0.0013948794,0.0001546979,0.009050481,0.000012773464],"about_ca_topic_score_codex":0.023155902,"about_ca_topic_score_gemma":0.0114775365,"teacher_disagreement_score":0.023155902,"about_ca_system_score_codex":0.00081787235,"about_ca_system_score_gemma":0.001557106,"threshold_uncertainty_score":0.046042204},"labels":[],"label_agreement":null},{"id":"W3113076192","doi":"10.1093/neuonc/noaa222.114","title":"DIPG-72. LONG-TERM SURVIVAL OF A CLASSIC DIFFUSE INTRINSIC PONTINE GLIOMA TREATED WITH NIMOTUZUMAB","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nimotuzumab; Medicine; Radiation therapy; Concomitant; Glioma; Oncology; Biopsy; Neuroimaging; Dysarthria; Brain biopsy; Neurooncology; Internal medicine; Surgery; Radiology; Cancer; Cancer research","score_opus":0.02626182079625786,"score_gpt":0.2798786969207702,"score_spread":0.25361687612451234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113076192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757,0.0063982783,0.00057186006,0.0008866324,0.000051429673,0.000043901367,0.00025653577,0.000074774944,0.004146657],"genre_scores_gemma":[0.99740833,0.0007440323,0.00017943111,0.00022535362,0.000027463877,0.000008841684,0.0002795812,0.0000048266265,0.001122187],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9999527,0.0000038565486,0.0000033513493,0.000011042606,0.000009315325,0.000019805451],"domain_scores_gemma":[0.999913,0.0000058071946,0.000014759731,0.0000056834574,0.000007795319,0.0000529487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074412754,0.00019578647,0.00037355424,0.0001294674,0.00033277078,0.00025453276,0.00018705185,0.00046925692,0.0005692247],"category_scores_gemma":[0.00016676166,0.00006786739,0.00018000364,0.0001565017,0.00021960594,0.00016748848,0.00019783738,0.0005397232,0.0003304273],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038114735,0.0011026451,0.08953074,0.0005029517,0.00019787878,0.6925695,0.0006160809,0.0012524514,0.05803222,0.00068493234,0.004387272,0.14731187],"study_design_scores_gemma":[0.00026133086,0.010964684,0.1635781,0.000095849966,0.00020579241,0.7914252,0.0002383903,0.0024311834,0.013592991,0.0006586362,0.016506227,0.00004160665],"about_ca_topic_score_codex":0.0013018232,"about_ca_topic_score_gemma":0.0028266178,"teacher_disagreement_score":0.0013018232,"about_ca_system_score_codex":0.00052076316,"about_ca_system_score_gemma":0.00029229323,"threshold_uncertainty_score":0.0037784576},"labels":[],"label_agreement":null},{"id":"W3113085829","doi":"10.1093/neuonc/noaa215.550","title":"NCOG-11. POST-RADIOSURGICAL OUTCOMES OF CYSTIC VESTIBULAR SCHWANNOMAS, A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Radiosurgery; Systematic review; Cochrane Library; Vestibular Schwannomas; Observational study; MEDLINE; Surgery; Radiology; Internal medicine; Vestibular system","score_opus":0.08059136450558868,"score_gpt":0.3652479284145198,"score_spread":0.2846565639089311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113085829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040556313,0.9939394,0.00026733824,0.00017529428,0.000118980955,0.00027223327,0.00095098163,0.000015945714,0.00020410573],"genre_scores_gemma":[0.1814048,0.8103629,0.002024326,0.0010556192,0.00027130358,0.0026529978,0.0017318621,0.000036589572,0.00045969491],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98961455,0.0039561875,0.0035095734,0.00124227,0.0012791224,0.00039834098],"domain_scores_gemma":[0.9833099,0.011621777,0.0031561225,0.00042549302,0.0012432511,0.00024340677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012129719,0.002127638,0.013864158,0.008148067,0.0006821514,0.0036657003,0.0020146547,0.0024002518,0.0048469617],"category_scores_gemma":[0.032827877,0.001127892,0.033530474,0.008505635,0.00074985327,0.0018561136,0.0017285766,0.0017277588,0.0003154778],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013727662,0.00003053987,0.0055017136,0.6362508,0.34460396,0.00012249664,0.00008920476,0.00032655193,0.00012105103,0.0001667421,0.00076878996,0.010645362],"study_design_scores_gemma":[0.00076754973,0.00022720468,0.009144189,0.056806147,0.9297239,0.00014248227,0.00008437168,0.00018220788,0.000093505354,0.00024587614,0.0025484415,0.00003411916],"about_ca_topic_score_codex":0.008386209,"about_ca_topic_score_gemma":0.017633846,"teacher_disagreement_score":0.013864158,"about_ca_system_score_codex":0.0027957095,"about_ca_system_score_gemma":0.004260852,"threshold_uncertainty_score":0.0641489},"labels":[],"label_agreement":null},{"id":"W3113133978","doi":"10.1093/neuonc/noaa215.946","title":"TAMI-59. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Biology; Epigenome; Epigenetics; Hypoxia (environmental); Ependymoma; Medulloblastoma; Histone methylation; Histone; Cancer research; Cell biology; Genetics; DNA methylation; Chemistry; Pathology; Medicine; Gene expression; Oxygen","score_opus":0.01314354954261283,"score_gpt":0.2558142341550323,"score_spread":0.24267068461241947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113133978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879539,0.0011211142,0.0042224526,0.00033919202,0.00014707558,0.00006401952,0.0014773341,0.0002850558,0.004389836],"genre_scores_gemma":[0.994313,0.00042343675,0.0010351238,0.00014938664,0.0000139294725,0.000044498454,0.0007033735,0.000054635468,0.0032626258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999913,0.000010532794,0.000007996147,0.00002561575,0.000016905211,0.00002594191],"domain_scores_gemma":[0.99990547,0.000014947523,0.000028568316,0.000008090174,0.0000054261063,0.0000374073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008134026,0.00028567016,0.00021491745,0.00018550889,0.00020860325,0.0002056869,0.00021759981,0.00034606896,0.0038405128],"category_scores_gemma":[0.00016286618,0.00012076406,0.00029382212,0.00014216482,0.00020823344,0.00008961035,0.00028559635,0.00057421887,0.0009700935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000353268,0.00010177078,0.0024316101,0.00008887431,0.00001893987,0.004307387,0.000054776014,0.00024063987,0.9849338,0.0006937061,0.0005177421,0.0062575717],"study_design_scores_gemma":[0.00014067181,0.0018157116,0.08940025,0.000071177456,0.00014465881,0.017112797,0.00036039398,0.007537361,0.8486927,0.0009989553,0.03368634,0.0000389995],"about_ca_topic_score_codex":0.000614982,"about_ca_topic_score_gemma":0.0010552026,"teacher_disagreement_score":0.0038405128,"about_ca_system_score_codex":0.00026884812,"about_ca_system_score_gemma":0.00016381718,"threshold_uncertainty_score":0.012847781},"labels":[],"label_agreement":null},{"id":"W3113153326","doi":"10.1093/neuonc/noaa222.608","title":"NFB-04. EXAMINING DIFFUSION, ARTERIAL SPIN-LABELED PERFUSION, AND VOLUMETRIC CHANGES IN THE NEUROFIBROMATOSIS TYPE 1 BRAIN USING AN ATLAS-BASED, MULTI-PARAMETRIC APPROACH","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Brain atlas; Cerebral blood flow; Putamen; White matter; Magnetic resonance imaging; Diffusion MRI; Effective diffusion coefficient; Globus pallidus; Thalamus; Caudate nucleus; Cardiology; Nuclear medicine; Basal ganglia; Neuroscience; Internal medicine; Psychology; Radiology; Central nervous system","score_opus":0.0896814171976663,"score_gpt":0.3218216275368122,"score_spread":0.2321402103391459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113153326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967566,0.000072117495,0.0023103429,0.0000066978278,0.0000013355562,0.000019369054,0.00047759333,0.000032878284,0.00032302886],"genre_scores_gemma":[0.99725986,0.000015612579,0.0023268666,0.0000021116696,7.217841e-7,0.000019884834,0.00028400804,0.000006997536,0.000083954146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968314,0.00011072354,0.000027319284,0.00008019872,0.000073237126,0.000025409669],"domain_scores_gemma":[0.99918276,0.00019263,0.0003783779,0.00008779961,0.000103880324,0.000054561686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010564895,0.00027071626,0.00018217978,0.0012060474,0.00027616395,0.000561077,0.0003111965,0.00017229338,0.00091884343],"category_scores_gemma":[0.0017164963,0.00013284988,0.00027594,0.0006369608,0.00026507684,0.00028662744,0.00040046312,0.00015822999,0.00011425664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006416465,0.000060306353,0.95296526,0.00007198306,0.00022824608,0.0003719367,0.00048485873,0.003442227,0.018958196,0.00030094452,0.00023614852,0.02223833],"study_design_scores_gemma":[0.000011716861,0.00018797947,0.97888774,0.000008260029,0.000059421924,0.0015123285,0.00024512448,0.012686389,0.005565732,0.0002208698,0.0006020276,0.000012391994],"about_ca_topic_score_codex":0.006000045,"about_ca_topic_score_gemma":0.005633598,"teacher_disagreement_score":0.006000045,"about_ca_system_score_codex":0.00047011516,"about_ca_system_score_gemma":0.00030005287,"threshold_uncertainty_score":0.011930227},"labels":[],"label_agreement":null},{"id":"W3113178349","doi":"10.1093/neuonc/noaa215.463","title":"IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chimeric antigen receptor; Antigen; Epidermal growth factor receptor; Cancer research; Glioma; Tumor antigen; Brain tumor; Immunotherapy; Receptor; Priming (agriculture); Biology; Immunology; Medicine; Immune system; Pathology; Internal medicine","score_opus":0.12878803851665777,"score_gpt":0.35772822192127884,"score_spread":0.22894018340462108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113178349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750543,0.0030057062,0.017974429,0.00019438333,0.000054406224,0.00015580338,0.00013990254,0.00021230827,0.003208694],"genre_scores_gemma":[0.99204016,0.000593755,0.0051337997,0.00006904643,0.000010346574,0.000055142616,0.00009275888,0.0000135726905,0.0019915234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990594,0.000012531315,0.0000045818915,0.000018974939,0.000024269224,0.000033665674],"domain_scores_gemma":[0.9999728,0.0000032667515,0.000008419645,0.0000029749674,0.0000058939477,0.000006627009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011144109,0.00028515828,0.00019906562,0.00012952444,0.000092116614,0.00029317543,0.00021405137,0.00022449705,0.00097116426],"category_scores_gemma":[0.000053701548,0.00008413625,0.00013747768,0.000075713404,0.00012418603,0.00018593,0.00018613417,0.00040106673,0.00027462823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010322651,0.00007103524,0.00012353454,0.000060168957,0.0000061412848,0.000041446146,0.000017571809,0.0007004527,0.98918355,0.00070623093,0.00014902289,0.008837739],"study_design_scores_gemma":[0.00003730436,0.0011124212,0.00066791347,0.0000060184307,0.000030875923,0.00021951056,0.000012586734,0.005969495,0.98553574,0.00012564735,0.006277187,0.0000052098044],"about_ca_topic_score_codex":0.00059924764,"about_ca_topic_score_gemma":0.0009613444,"teacher_disagreement_score":0.00097116426,"about_ca_system_score_codex":0.00045102657,"about_ca_system_score_gemma":0.00024105461,"threshold_uncertainty_score":0.0032724738},"labels":[],"label_agreement":null},{"id":"W3113204569","doi":"10.1093/neuonc/noaa215.003","title":"BIOM-03. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Brain metastasis; Metastasis; Immunohistochemistry; Histopathology; Cancer; Cell; Cancer research; Pathology; Oncology; Internal medicine; Biology","score_opus":0.04225631736646311,"score_gpt":0.3231833320711179,"score_spread":0.28092701470465475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113204569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986568,0.0006287115,0.00090245844,0.00040602902,0.000055336794,0.0000270151,0.008705571,0.00014862219,0.0025582653],"genre_scores_gemma":[0.98859125,0.00034307002,0.0015356133,0.00021338747,0.000022575865,0.0000742469,0.0070033846,0.00004937205,0.0021670463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966824,0.000038719314,0.000031711126,0.00010205929,0.00008561221,0.00007373959],"domain_scores_gemma":[0.9989813,0.00009077092,0.00054028514,0.000059797356,0.0001266033,0.00020125775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035958816,0.00028933375,0.00033953445,0.0007205764,0.00053063117,0.00089593016,0.00032643796,0.00047212775,0.008933259],"category_scores_gemma":[0.0009004389,0.00018911184,0.00037603086,0.0010837447,0.00039561215,0.00028769052,0.0007595797,0.00075615244,0.0020142472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019693584,0.00022603302,0.85660523,0.00044429366,0.00029388754,0.00057315204,0.0002559617,0.00052281516,0.116765454,0.0003839572,0.0051097837,0.016850142],"study_design_scores_gemma":[0.000023486518,0.00021898096,0.98298544,0.000037476235,0.00010504176,0.0013579506,0.000492777,0.0011950306,0.0083643,0.00058862515,0.004613838,0.00001710433],"about_ca_topic_score_codex":0.001128831,"about_ca_topic_score_gemma":0.0017144547,"teacher_disagreement_score":0.008933259,"about_ca_system_score_codex":0.00033969115,"about_ca_system_score_gemma":0.00051694,"threshold_uncertainty_score":0.029884696},"labels":[],"label_agreement":null},{"id":"W3113212222","doi":"10.1093/neuonc/noaa222.748","title":"RARE-38. CLINICAL PRESENTATION OF MGA-NUTM1 FUSION TRANSCRIPT SARCOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; CD99; Solitary fibrous tumor; Sarcoma; Magnetic resonance imaging; Ewing's sarcoma; Desmin; Ifosfamide; Cerebellar hemisphere; Etoposide; Radiology; Pathology; CD34; Chemotherapy; Surgery; Biology; Immunohistochemistry; Vimentin","score_opus":0.08564949981405803,"score_gpt":0.3791303695257698,"score_spread":0.2934808697117117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113212222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97284514,0.003267619,0.0030016417,0.0010941183,0.00012837072,0.00021022873,0.0010068153,0.0003489408,0.018097106],"genre_scores_gemma":[0.9961169,0.0004869571,0.000903172,0.0002242524,0.000113964015,0.00002657688,0.0003538249,0.000025445452,0.0017488796],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996569,0.000025266025,0.00003583404,0.00012064131,0.000053618158,0.00010765597],"domain_scores_gemma":[0.9994968,0.00007536233,0.00017039425,0.000036744463,0.00004081459,0.00017982139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013907332,0.0010163434,0.00051723374,0.0008242045,0.00089404086,0.0006027001,0.00052071427,0.0019110807,0.005051817],"category_scores_gemma":[0.00087011163,0.000420094,0.0004548654,0.0005856195,0.0006684185,0.0008030109,0.00067296345,0.0008136515,0.0016032654],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006686742,0.000026286845,0.023357073,0.000048094225,0.000008448592,0.9678091,0.00008958556,0.000168442,0.0053557055,0.0003827906,0.0005010898,0.0021865943],"study_design_scores_gemma":[0.000008365085,0.00006055638,0.010238425,0.000011795029,0.000006716171,0.98725444,0.00006255054,0.00021210927,0.0008622206,0.0002038359,0.0010726027,0.000006353676],"about_ca_topic_score_codex":0.0007715542,"about_ca_topic_score_gemma":0.00095821195,"teacher_disagreement_score":0.005051817,"about_ca_system_score_codex":0.0006256456,"about_ca_system_score_gemma":0.00035046198,"threshold_uncertainty_score":0.016900003},"labels":[],"label_agreement":null},{"id":"W3113231955","doi":"10.1093/neuonc/noaa222.356","title":"IMG-21. PROSPECTIVE PREOPERATIVE DETERMINATION OF ISOCITRATE DEHYDROGENASE MUTATION IN GLIOMAS USING SPECTRAL EDITING MAGNETIC RESONANCE SPECTROSCOPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; Magnetic resonance imaging; IDH1; Proton magnetic resonance; In vivo magnetic resonance spectroscopy; Medicine; Brain tumor; Magnetic resonance spectroscopic imaging; Nuclear medicine; Radiology; Oncology; Pathology; Mutant; Nuclear magnetic resonance; Cancer research; Biology; Genetics; Enzyme; Gene","score_opus":0.024658556178598107,"score_gpt":0.3421544068164735,"score_spread":0.31749585063787544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113231955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999453,0.000066421206,0.00005914552,0.000013913667,0.0000026087594,0.000010842798,0.000108958244,0.0000044481694,0.00028064157],"genre_scores_gemma":[0.99953175,0.000019630372,0.000089990746,0.000019443218,0.0000038491535,0.000010142494,0.00018101544,0.0000017542808,0.00014248594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983406,0.000038977912,0.000015313952,0.000054353543,0.000023609777,0.000033716682],"domain_scores_gemma":[0.9993979,0.00015272982,0.00013374847,0.00004315739,0.000085454645,0.00018696865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036645134,0.00023690096,0.00020761152,0.00035130428,0.0002426408,0.00029754514,0.0001389262,0.0003315194,0.0010922421],"category_scores_gemma":[0.0011312595,0.00014239491,0.00012470044,0.00024079157,0.00020574908,0.0002543889,0.00020921457,0.0003210678,0.0005151002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006748195,0.00007079497,0.9958352,0.000005146631,0.0000068093927,0.0002572674,0.000033460543,0.0000393767,0.0010766701,0.000008133889,0.00006720431,0.0019251844],"study_design_scores_gemma":[0.000024391718,0.0019111331,0.994585,0.0000048428456,0.000017678176,0.0012825744,0.00008949381,0.00037034202,0.0012888849,0.000020101006,0.0003991819,0.0000063470807],"about_ca_topic_score_codex":0.0010980541,"about_ca_topic_score_gemma":0.0011653968,"teacher_disagreement_score":0.0010980541,"about_ca_system_score_codex":0.00018187483,"about_ca_system_score_gemma":0.0001684342,"threshold_uncertainty_score":0.0036539435},"labels":[],"label_agreement":null},{"id":"W3113238513","doi":"10.1093/neuonc/noaa222.035","title":"COVD-04. CHARACTERISTICS OF SARS-COV-2 IN 64 CHILDREN WITH CNS TUMORS: A REPORT FROM THE SIOP/ST. JUDE CHILDREN’S RESEARCH HOSPITAL (SJCRH) GLOBAL COVID-19 CHILDHOOD CANCER REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Asymptomatic; Cancer; Radiation therapy; Cancer registry; Internal medicine; Pediatrics; Chemotherapy; Pediatric cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.09024475866289997,"score_gpt":0.42864073413368947,"score_spread":0.3383959754707895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113238513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878614,0.00021416454,0.00007159896,0.000054614324,0.0000078538005,0.000026083864,0.011056786,0.000008758807,0.0006987237],"genre_scores_gemma":[0.9858688,0.00033402993,0.00020969837,0.000069905946,0.00001023603,0.000056450423,0.01324361,0.000009092504,0.00019817334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934167,0.00009521307,0.00011571401,0.00015168716,0.00018266733,0.00011315796],"domain_scores_gemma":[0.9980756,0.00020134124,0.0011025695,0.000089884845,0.00026717578,0.00026337698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006426733,0.00025486568,0.00032362647,0.0016048553,0.00040797837,0.00056339655,0.00031855333,0.00029820285,0.0012710812],"category_scores_gemma":[0.0017707826,0.00028596554,0.00031606937,0.0028632283,0.00032155975,0.00045322656,0.0004595411,0.00039061523,0.0003046011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000101553305,0.000004166833,0.99932134,0.000004695515,0.0000053654594,0.000051376708,0.00003053998,0.000020476666,0.000040957726,0.0000067689093,0.00022070744,0.000283438],"study_design_scores_gemma":[0.0000037246007,0.000029380612,0.9987557,0.0000091759875,0.0000062021736,0.00043052665,0.00022996856,0.0000627196,0.000053355267,0.00000491819,0.00041197625,0.0000023146317],"about_ca_topic_score_codex":0.030497843,"about_ca_topic_score_gemma":0.036169812,"teacher_disagreement_score":0.030497843,"about_ca_system_score_codex":0.0009907382,"about_ca_system_score_gemma":0.0011333881,"threshold_uncertainty_score":0.060640693},"labels":[],"label_agreement":null},{"id":"W3113245969","doi":"10.1093/neuonc/noaa222.760","title":"RARE-50. TREATMENT RESPONSE OF CNS HIGH-GRADE NEUROEPITHELIAL TUMORS WITH MN1 ALTERATION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Ependymoma; Radiological weapon; Chemotherapy; Radiology; Oncology; Surgery","score_opus":0.02757787070712044,"score_gpt":0.2874370897305876,"score_spread":0.2598592190234672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113245969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658763,0.00071017793,0.00024716873,0.00006500794,0.000010905719,0.000024752007,0.0002155914,0.000024303374,0.0021144317],"genre_scores_gemma":[0.99903417,0.0001088017,0.00019539328,0.000036841575,0.000007046576,0.000012683523,0.00034434328,0.0000043412406,0.00025646342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998091,0.000040908566,0.000021204896,0.00004020116,0.000039867427,0.000048818427],"domain_scores_gemma":[0.99971074,0.000089167275,0.0000890534,0.000020885522,0.000028893655,0.00006132674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759505,0.00009419456,0.00023192068,0.00017487601,0.000118572054,0.00020595556,0.00012775626,0.00012778646,0.0010612782],"category_scores_gemma":[0.00075563096,0.000026268935,0.00014300493,0.0001449287,0.00010843569,0.00010902939,0.0001328272,0.00015612475,0.0002473713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036591627,0.0005800192,0.7365842,0.00016335878,0.00024516042,0.0017825845,0.00014361746,0.002248644,0.070430316,0.00014911013,0.0016272044,0.1823866],"study_design_scores_gemma":[0.00007266051,0.0034445825,0.97227377,0.000018936795,0.00012770804,0.0046805413,0.00009683611,0.0012696297,0.014363881,0.0001250062,0.0035182803,0.000008157526],"about_ca_topic_score_codex":0.0007894908,"about_ca_topic_score_gemma":0.0017576865,"teacher_disagreement_score":0.0010612782,"about_ca_system_score_codex":0.000456629,"about_ca_system_score_gemma":0.0001806472,"threshold_uncertainty_score":0.0035503507},"labels":[],"label_agreement":null},{"id":"W3113287358","doi":"10.1093/neuonc/noaa215.693","title":"PATH-11. PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Epigenetics; IDH1; Glioma; Oncology; Medicine; Internal medicine; Methylation; Bioinformatics; Cancer research; Biology; Genetics","score_opus":0.016621812179875826,"score_gpt":0.30101493431987436,"score_spread":0.2843931221399985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113287358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486744,0.0008328234,0.0006122198,0.00033476247,0.00009555171,0.00081364234,0.0015462558,0.000031923904,0.0008653264],"genre_scores_gemma":[0.99237084,0.00020590477,0.0010652184,0.00045052875,0.00005733211,0.0018388656,0.002639845,0.000019301255,0.0013521619],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981585,0.0013651381,0.00007734708,0.00021382055,0.00010189874,0.0000832713],"domain_scores_gemma":[0.9977775,0.0008490826,0.00055483455,0.00032988176,0.00013293406,0.0003556723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055846823,0.00048828003,0.00068838923,0.00014742123,0.00020766261,0.00070210616,0.00052258983,0.00079640886,0.0025142112],"category_scores_gemma":[0.0026112911,0.00026121124,0.0010876962,0.00023598972,0.0006750372,0.0004501512,0.00040146534,0.0009936516,0.00024308078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9073106,0.0025157537,0.059390195,0.00049059215,0.0020098335,0.0000616963,0.000078916804,0.0015113853,0.008612961,0.00032640176,0.0020850583,0.01560654],"study_design_scores_gemma":[0.5620632,0.22012217,0.18717021,0.00014626043,0.0050169337,0.0002653096,0.00015912649,0.009646016,0.007936133,0.001814208,0.005591835,0.00006858653],"about_ca_topic_score_codex":0.0005393904,"about_ca_topic_score_gemma":0.0015498298,"teacher_disagreement_score":0.0055846823,"about_ca_system_score_codex":0.0005756513,"about_ca_system_score_gemma":0.0010383837,"threshold_uncertainty_score":0.029534996},"labels":[],"label_agreement":null},{"id":"W3113354958","doi":"10.1093/neuonc/noaa222.104","title":"DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene knockdown; Cancer research; Chromatin immunoprecipitation; Biology; Downregulation and upregulation; Medicine; Gene expression; Gene; Genetics; Promoter","score_opus":0.0262905072779288,"score_gpt":0.29283221384761327,"score_spread":0.26654170656968446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113354958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981155,0.0028849777,0.0029012205,0.00032632163,0.00014027023,0.000120200864,0.0076364265,0.0005631347,0.004272517],"genre_scores_gemma":[0.98755556,0.0012279343,0.0018684322,0.00023721126,0.000008418969,0.0000886808,0.00438812,0.000066719644,0.0045589237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998399,0.0000079761885,0.00000846267,0.000051059902,0.000047288035,0.000045284607],"domain_scores_gemma":[0.9999075,0.000009971376,0.000018651273,0.000011485919,0.000007692653,0.000044720924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007751667,0.00025174543,0.00027086627,0.00026682287,0.00017523371,0.0002265648,0.00022696653,0.0003271957,0.0040515605],"category_scores_gemma":[0.00012760164,0.00015224556,0.00036294232,0.00016653363,0.00030144033,0.00012930059,0.00030853832,0.0008680827,0.00080152816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035509595,0.000040947372,0.0006711543,0.00015863324,0.000010458725,0.00046360752,0.000021068214,0.00006777239,0.99362224,0.00013291313,0.00036898616,0.00408713],"study_design_scores_gemma":[0.000063131905,0.0009084499,0.030760683,0.00003084483,0.00004821165,0.0019975563,0.00011328511,0.00060285453,0.9538228,0.00017056185,0.011468544,0.000013098818],"about_ca_topic_score_codex":0.0026302377,"about_ca_topic_score_gemma":0.00431256,"teacher_disagreement_score":0.0040515605,"about_ca_system_score_codex":0.00048735001,"about_ca_system_score_gemma":0.00037127905,"threshold_uncertainty_score":0.013553858},"labels":[],"label_agreement":null},{"id":"W3115366055","doi":"10.1093/neuonc/noaa300","title":"Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Oncology; Radiation therapy; Internal medicine; Adjuvant; Oligodendroglioma; Adjuvant therapy; Gene signature; Overall survival; Transcription factor; Adjuvant radiotherapy; Glioma; Cancer; Cancer research; Gene expression; Gene; Biology; Astrocytoma; Genetics","score_opus":0.05016786983759589,"score_gpt":0.2905154291076138,"score_spread":0.2403475592700179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115366055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961836,0.0006806218,0.0013210173,0.00012714918,0.000004493078,0.000006264861,0.0012095177,0.00002319404,0.0004441395],"genre_scores_gemma":[0.9985852,0.0001645495,0.00041723996,0.000014753,0.0000039525207,0.0000062488625,0.00071231194,0.000004185122,0.00009158743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986136,0.000024890363,0.000010128862,0.000054370114,0.000023582494,0.000025670697],"domain_scores_gemma":[0.9996339,0.00010795307,0.00016969383,0.000021779135,0.000029623465,0.000036965117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020788467,0.00014705086,0.00020610604,0.0005109899,0.000107609485,0.0002755317,0.00013528902,0.00013596515,0.0012895414],"category_scores_gemma":[0.0012014667,0.00006624479,0.00027131315,0.0005359465,0.00016579547,0.00017986791,0.00020908435,0.00016992247,0.00020264101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005210619,0.000021067053,0.9734725,0.000053810152,0.0001012418,0.00008028945,0.0001312774,0.0024024528,0.007107538,0.00016837456,0.0004080889,0.015532215],"study_design_scores_gemma":[0.000017346405,0.00013838039,0.9788574,0.000023853947,0.0001761444,0.00045314978,0.00025817478,0.0139446575,0.0030755848,0.0013884214,0.0016546849,0.000012267221],"about_ca_topic_score_codex":0.003567777,"about_ca_topic_score_gemma":0.004241861,"teacher_disagreement_score":0.003567777,"about_ca_system_score_codex":0.00041949592,"about_ca_system_score_gemma":0.00033054894,"threshold_uncertainty_score":0.0070940256},"labels":[],"label_agreement":null},{"id":"W3115713778","doi":"10.1093/neuonc/noaa306","title":"Modeling human brain tumors in flies, worms, and zebrafish: From proof of principle to novel therapeutic targets","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Zebrafish; Biology; Danio; Model organism; Caenorhabditis elegans; Computational biology; Drosophila melanogaster; Genome; RNA interference; Neuroscience; Genetics; RNA; Gene","score_opus":0.03541518766050802,"score_gpt":0.3599964333821772,"score_spread":0.3245812457216692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115713778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035579695,0.99626416,0.0008426288,0.00042087285,0.00021283567,0.000013097983,0.000045317796,0.000029410045,0.0018159726],"genre_scores_gemma":[0.0017349649,0.99622834,0.0007095898,0.00029679824,0.00006999855,0.00001658973,0.00006639095,0.0000047986696,0.0008725241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998621,0.000022475095,0.0000138127925,0.000023560524,0.00006124175,0.000016742068],"domain_scores_gemma":[0.99984276,0.0000751848,0.000020700045,0.000006133727,0.000038025166,0.000017140334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005432019,0.00078995025,0.00084900414,0.0012672957,0.00015185222,0.0006367053,0.00079224614,0.0008637728,0.0018523592],"category_scores_gemma":[0.0004523648,0.00025462935,0.0005198955,0.000602645,0.0004389349,0.00078083837,0.0004799455,0.0019115538,0.0010327853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008752216,0.00008887916,0.00014934779,0.01289852,0.000107813044,0.00033028377,0.00006264652,0.0008952198,0.014157068,0.010733125,0.035960827,0.9245287],"study_design_scores_gemma":[0.000025991543,0.00016463436,0.00048654087,0.0017876372,0.00012189282,0.0012885879,0.000034103647,0.00019911851,0.003501244,0.0024609275,0.989907,0.000022315819],"about_ca_topic_score_codex":0.00085022533,"about_ca_topic_score_gemma":0.0016616904,"teacher_disagreement_score":0.0018523592,"about_ca_system_score_codex":0.0005524336,"about_ca_system_score_gemma":0.0005745307,"threshold_uncertainty_score":0.006196797},"labels":[],"label_agreement":null},{"id":"W3116476506","doi":"10.1093/neuonc/noaa285","title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; McMaster University Medical Centre; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Queen's University","funders":"","keywords":"Incidence (geometry); Medicine; Breast cancer; Oncology; Meta-analysis; Metastatic breast cancer; Internal medicine; Cancer","score_opus":0.05164096575749747,"score_gpt":0.35873308155939376,"score_spread":0.30709211580189627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116476506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063262735,0.99158585,0.000385233,0.00019535788,0.00010333658,0.00016592638,0.0009601896,0.000019224268,0.0002585844],"genre_scores_gemma":[0.1941767,0.800627,0.0018163765,0.00070928194,0.00021348543,0.00083524233,0.0013221579,0.000027252428,0.00027248048],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99123704,0.00419839,0.0024045412,0.000993666,0.00085307914,0.00031340588],"domain_scores_gemma":[0.9803105,0.014523947,0.0029300298,0.0005371911,0.0014783051,0.00021994722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010094741,0.0024824785,0.0151800355,0.007974423,0.0005835137,0.0027802163,0.0018095855,0.0019063734,0.0026269497],"category_scores_gemma":[0.030133527,0.0016130275,0.032414623,0.009748511,0.0006048437,0.0014907278,0.0013573213,0.0014734196,0.00028445257],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012051852,0.000017232402,0.007958537,0.33689153,0.64433366,0.00021493869,0.00008454158,0.00072067237,0.00024248924,0.000108156324,0.00075359613,0.007469473],"study_design_scores_gemma":[0.00029185863,0.000114683266,0.005567747,0.023518998,0.96853215,0.0001545484,0.000041517902,0.00017085964,0.0001044447,0.00013753858,0.0013437703,0.000021926438],"about_ca_topic_score_codex":0.010194451,"about_ca_topic_score_gemma":0.022358641,"teacher_disagreement_score":0.0151800355,"about_ca_system_score_codex":0.0024819036,"about_ca_system_score_gemma":0.0030886421,"threshold_uncertainty_score":0.053386748},"labels":[],"label_agreement":null},{"id":"W3118298499","doi":"10.1093/neuonc/noab002","title":"Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Neurological Institute and Hospital; McGill Genome Centre; Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"Terry Fox Foundation","keywords":"RNA-binding protein; RNA; Protein expression; Cancer research; Medicine; Pathology; Biology; Gene; Biochemistry","score_opus":0.032851372766128005,"score_gpt":0.29790296445135717,"score_spread":0.2650515916852292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118298499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971957,0.0006201671,0.0010760236,0.00006137669,0.000009441621,0.00002042489,0.0003973504,0.000055827866,0.00056370755],"genre_scores_gemma":[0.99800557,0.00020268818,0.00072338304,0.000047057987,0.000004291563,0.00002296001,0.000663857,0.00001382496,0.00031642884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984396,0.000021098884,0.000010702647,0.000031788528,0.000059119924,0.000033227916],"domain_scores_gemma":[0.9997043,0.000054348406,0.00012668189,0.000028415585,0.000032767737,0.000053439875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024598153,0.00020067766,0.00023529909,0.00019901931,0.00011087719,0.00031401287,0.00015576967,0.000155488,0.0010172989],"category_scores_gemma":[0.0003798708,0.000121004734,0.00017274707,0.00013610303,0.00021940209,0.00012024237,0.0001846384,0.0005780929,0.00028520913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019581078,0.00006322003,0.010157856,0.000055333243,0.000020682539,0.00010201188,0.000025622594,0.000215473,0.98630154,0.000051784442,0.00018260728,0.002628061],"study_design_scores_gemma":[0.00006153028,0.0031141122,0.38587922,0.000034101824,0.00011853215,0.003399409,0.00019941457,0.006976548,0.59699,0.00016857487,0.0030334855,0.000024997034],"about_ca_topic_score_codex":0.0006745536,"about_ca_topic_score_gemma":0.0013813627,"teacher_disagreement_score":0.0010172989,"about_ca_system_score_codex":0.00033922613,"about_ca_system_score_gemma":0.00019932276,"threshold_uncertainty_score":0.0034031868},"labels":[],"label_agreement":null},{"id":"W3121286955","doi":"10.1093/neuonc/noab010","title":"De-coding Group 3 medulloblastoma biology with noncoding RNA","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medulloblastoma; Long non-coding RNA; Non-coding RNA; Computational biology; Biology; Coding (social sciences); RNA; Genetics; Mathematics; Gene; Statistics","score_opus":0.017175688637500994,"score_gpt":0.2881248394257934,"score_spread":0.2709491507882924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121286955","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004250203,0.0061141145,0.0010980135,0.95364386,0.024297955,0.000035240933,0.00008190512,0.00006509452,0.010413624],"genre_scores_gemma":[0.06999172,0.007871636,0.0016910123,0.7955882,0.09467852,0.0001420994,0.00009290073,0.000060756876,0.02988309],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926215,0.00017228459,0.000063571555,0.00010793917,0.00026565915,0.00012841292],"domain_scores_gemma":[0.9977704,0.0015535268,0.00014737048,0.00012198616,0.00015033774,0.00025640152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015386312,0.0004906939,0.000540301,0.00026341455,0.0013855103,0.0016477071,0.0007306398,0.01410702,0.0033045074],"category_scores_gemma":[0.0046989764,0.00030141187,0.0006427345,0.00021922226,0.0019386341,0.0012756366,0.00071520824,0.011813266,0.001980757],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036847004,0.00011415301,0.0019531904,0.00013128134,0.000049124414,0.011391919,0.0001888244,0.00035543926,0.007252759,0.028996665,0.9031953,0.046002787],"study_design_scores_gemma":[0.0003352994,0.00022651629,0.0019870505,0.00011149261,0.00007373718,0.009129943,0.00021956782,0.0019332226,0.0075550196,0.063230954,0.91515106,0.000046073583],"about_ca_topic_score_codex":0.0010623322,"about_ca_topic_score_gemma":0.0022681875,"teacher_disagreement_score":0.01410702,"about_ca_system_score_codex":0.0023127836,"about_ca_system_score_gemma":0.000984443,"threshold_uncertainty_score":0.016780496},"labels":[],"label_agreement":null},{"id":"W3121678103","doi":"10.1093/neuonc/noaa305","title":"Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Medicine; Psychology; Psychoanalysis; Cancer research","score_opus":0.025224053839641797,"score_gpt":0.27770968523758177,"score_spread":0.25248563139794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121678103","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040929535,0.0016242077,0.000027314656,0.9851784,0.0108544305,0.0000058761034,0.00003069213,0.000016169066,0.0018535117],"genre_scores_gemma":[0.0075438013,0.00286696,0.00017207928,0.94437474,0.03868928,0.000025103267,0.000050955437,0.000026587539,0.0062505184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986413,0.00045268878,0.00014969634,0.00014611013,0.00037941357,0.00023084242],"domain_scores_gemma":[0.9948571,0.002284353,0.00029673986,0.00010615516,0.0011822159,0.0012735503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017986739,0.00065033353,0.0010482146,0.00065112644,0.0029268768,0.002254185,0.0014842121,0.029013334,0.0049346383],"category_scores_gemma":[0.014603794,0.00047996378,0.000892909,0.0006888821,0.001816618,0.0024289237,0.0010626302,0.024602192,0.0038596345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005407154,0.00002282387,0.00059705944,0.00004421536,0.000011571075,0.003213785,0.000079839054,0.00008203607,0.0000801682,0.00075955637,0.9900067,0.0050483397],"study_design_scores_gemma":[0.00014553142,0.000116553434,0.0021422526,0.0005183441,0.000051603558,0.012252116,0.00086271105,0.0006171539,0.00033417664,0.0059308,0.9769354,0.00009330999],"about_ca_topic_score_codex":0.007572033,"about_ca_topic_score_gemma":0.014645223,"teacher_disagreement_score":0.029013334,"about_ca_system_score_codex":0.0041702227,"about_ca_system_score_gemma":0.004126258,"threshold_uncertainty_score":0.030257225},"labels":[],"label_agreement":null},{"id":"W3127159106","doi":"10.1093/neuonc/noab034","title":"Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Loss function; Internal medicine; Ependymoma; Cytogenetics; Biology; Weight loss; Oncology; Risk stratification; Chromosome; Methylation; Gastroenterology; Medicine; Genetics; Pathology; Gene; Phenotype","score_opus":0.013728333183979573,"score_gpt":0.27480754030278215,"score_spread":0.26107920711880256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127159106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772793,0.00042505295,0.00062208244,0.00003203359,0.000004976821,0.000012117844,0.00028685972,0.000015234997,0.00087367336],"genre_scores_gemma":[0.9991059,0.00011904467,0.00032633313,0.00001381022,0.0000051346065,0.0000055094433,0.00025523402,0.0000029618561,0.00016601884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999795,0.000018296843,0.00001768407,0.000074310774,0.00005919556,0.0000354608],"domain_scores_gemma":[0.9995927,0.00011420627,0.00014763161,0.00004965521,0.00003106164,0.00006468717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030346398,0.00023917413,0.00035604025,0.00034014985,0.00034801438,0.000414127,0.0002121415,0.00024153844,0.0016736502],"category_scores_gemma":[0.0011435525,0.00009669449,0.00021696028,0.00047958604,0.00039534993,0.00026883325,0.00054874434,0.00031466948,0.00019608559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010722334,0.00004756759,0.9219752,0.000087128654,0.00014454384,0.0050352146,0.0001012072,0.00052076316,0.04218244,0.0001888248,0.00037782287,0.028266931],"study_design_scores_gemma":[0.000015991578,0.00017106766,0.97434074,0.000010344453,0.000052271847,0.020622537,0.000058168545,0.00031897923,0.0032281792,0.0002741198,0.0009021835,0.0000054671164],"about_ca_topic_score_codex":0.00083251524,"about_ca_topic_score_gemma":0.0014688239,"teacher_disagreement_score":0.0016736502,"about_ca_system_score_codex":0.00022327476,"about_ca_system_score_gemma":0.00018363394,"threshold_uncertainty_score":0.0055989027},"labels":[],"label_agreement":null},{"id":"W3127414577","doi":"10.1093/neuonc/noab017","title":"Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; University of California, San Diego; National Cancer Institute; National Institutes of Health; Centre Technologique des Résidus Industriels; American Cancer Society; U.S. Department of Veterans Affairs; Moores Cancer Center, UC San Diego Health; Georgia Clinical and Translational Science Alliance","keywords":"Fractional anisotropy; Diffusion MRI; White matter; Medicine; Nuclear medicine; Motor cortex; Precentral gyrus; Magnetic resonance imaging; Internal medicine; Radiology","score_opus":0.03285513162950509,"score_gpt":0.3542082188403241,"score_spread":0.321353087210819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127414577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908495,0.000278363,0.00011714843,0.00001945938,0.0000019619326,0.0000137151155,0.00027855713,0.0000073248502,0.00019866046],"genre_scores_gemma":[0.9992113,0.00007065131,0.00011646565,0.000012556369,0.00000360351,0.00001583619,0.00038260015,0.000001970766,0.00018496551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998406,0.000037441132,0.0000148269,0.000050341197,0.00003004987,0.000026802],"domain_scores_gemma":[0.9990615,0.00013070976,0.00051569723,0.00007642266,0.000115014285,0.00010062165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006833063,0.000257895,0.00034543723,0.00030558804,0.00016688749,0.00034043452,0.00020906281,0.00029001676,0.00088606746],"category_scores_gemma":[0.0016489397,0.000105878804,0.00026376641,0.00030978952,0.00017575864,0.00026141055,0.00020623322,0.00037598802,0.00018433688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002010359,0.0001913457,0.9847558,0.000033490214,0.00019287805,0.000050543887,0.00005841666,0.00042677732,0.0032641585,0.0000126701925,0.00010445844,0.008899038],"study_design_scores_gemma":[0.000017107675,0.00086340244,0.9980205,0.0000031508212,0.000040883195,0.00011129581,0.000015764297,0.00016013213,0.00064143346,0.00001847073,0.00010565158,0.0000021539133],"about_ca_topic_score_codex":0.0019225085,"about_ca_topic_score_gemma":0.002313498,"teacher_disagreement_score":0.0019225085,"about_ca_system_score_codex":0.00029629646,"about_ca_system_score_gemma":0.00023224995,"threshold_uncertainty_score":0.0038226247},"labels":[],"label_agreement":null},{"id":"W3128294753","doi":"10.1093/neuonc/noab004","title":"In the beginning: PDGFA and the genesis of GBM","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Cancer Foundation; Genome Canada","keywords":"Computer science; Psychology","score_opus":0.02962222994486428,"score_gpt":0.2972527079075465,"score_spread":0.2676304779626822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128294753","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005097447,0.006343191,0.00006762254,0.9733358,0.017939355,0.0000069301886,0.000026132968,0.000010107628,0.0017611457],"genre_scores_gemma":[0.00738955,0.0052479114,0.00021754115,0.8275474,0.1544175,0.00002409361,0.000026874288,0.000017025235,0.0051120664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977423,0.00093948137,0.00032360927,0.00022083393,0.00048528548,0.0002885375],"domain_scores_gemma":[0.99444324,0.0036583901,0.00034901593,0.00012625002,0.0006148257,0.0008083574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002505108,0.00087759405,0.0015949429,0.0007616865,0.0032653178,0.0038673424,0.001277688,0.04799265,0.0035444836],"category_scores_gemma":[0.013549097,0.0006440038,0.0010481592,0.0006600976,0.0026607127,0.0041950447,0.0016673639,0.041711584,0.0025296586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002708535,0.000075228425,0.001937822,0.00016255076,0.000050908075,0.008951042,0.0003462135,0.00014792301,0.00053851824,0.005716136,0.96354365,0.018259125],"study_design_scores_gemma":[0.000333371,0.00014096747,0.0023234747,0.0006331367,0.000094793206,0.010148637,0.0009305313,0.0007464202,0.00043805165,0.02520019,0.9589031,0.000107390086],"about_ca_topic_score_codex":0.0049072797,"about_ca_topic_score_gemma":0.008758589,"teacher_disagreement_score":0.04799265,"about_ca_system_score_codex":0.0033639274,"about_ca_system_score_gemma":0.0028845556,"threshold_uncertainty_score":0.024407089},"labels":[],"label_agreement":null},{"id":"W3134763185","doi":"10.1093/neuonc/noab057","title":"MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"Focused Ultrasound Foundation","keywords":"Medicine; Liquid biopsy; Biomarker; Temozolomide; Biopsy; Brain biopsy; Pathology; Brain tumor; Oncology; Cancer; Glioma; Internal medicine; Cancer research; Biology","score_opus":0.012342447963754749,"score_gpt":0.233070411040181,"score_spread":0.22072796307642625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134763185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900514,0.0004693864,0.00022135988,0.000028429853,0.000005542593,0.000052497664,0.00005119912,0.000010012707,0.00015637821],"genre_scores_gemma":[0.99874747,0.00023264727,0.00054319773,0.00007511117,0.000016635504,0.00006907032,0.00019473178,0.000002581325,0.000118408316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998318,0.000052395346,0.000013964319,0.00004590949,0.000029386558,0.000026543757],"domain_scores_gemma":[0.9997241,0.00006471473,0.0000943065,0.000016840087,0.000033993914,0.000066045206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037567434,0.0003502626,0.0006643976,0.00020362104,0.00018126854,0.00029716777,0.0001692422,0.0002738462,0.00072811666],"category_scores_gemma":[0.0005773261,0.00013932338,0.00020831604,0.00016747315,0.00022773498,0.00020237645,0.0001581698,0.00038386625,0.00018632719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08702248,0.005643882,0.41421348,0.00042846275,0.00044142455,0.001272492,0.00039258788,0.0012147549,0.34404206,0.000087127475,0.0014892683,0.14375189],"study_design_scores_gemma":[0.006207819,0.1484455,0.7807688,0.000053890377,0.0008689259,0.0042864927,0.00031484757,0.0034387207,0.052627582,0.00020897081,0.0027331458,0.000045323894],"about_ca_topic_score_codex":0.00047913988,"about_ca_topic_score_gemma":0.0008087206,"teacher_disagreement_score":0.00072811666,"about_ca_system_score_codex":0.00028888616,"about_ca_system_score_gemma":0.00037472238,"threshold_uncertainty_score":0.002435863},"labels":[],"label_agreement":null},{"id":"W3135188269","doi":"10.1093/neuonc/noab064","title":"Brainstem gliomas … the devil is in the details","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Brainstem; Medicine; Internal medicine","score_opus":0.041073676061902265,"score_gpt":0.30537390633386935,"score_spread":0.2643002302719671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135188269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010740653,0.0019650995,0.000093665345,0.96364367,0.019681865,0.000018337952,0.000051642335,0.000023127994,0.013448532],"genre_scores_gemma":[0.015678786,0.003783787,0.0004501827,0.8709374,0.04738608,0.000055540997,0.00005837145,0.0000477634,0.061602086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989324,0.00025114446,0.000107018524,0.00013183466,0.0003266426,0.0002509091],"domain_scores_gemma":[0.9983543,0.00055273576,0.00011827527,0.000053819374,0.0003468455,0.00057407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010826492,0.0006040867,0.0008125366,0.0005743002,0.004055692,0.0032892944,0.0010286674,0.029281931,0.009107124],"category_scores_gemma":[0.008730669,0.00050802215,0.0008701435,0.00044935013,0.0018557381,0.0031585689,0.0012362354,0.028566353,0.004226738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004467617,0.000036018955,0.001543385,0.000052042444,0.00001912693,0.018176807,0.00021209464,0.00014254973,0.00030418552,0.005851139,0.9633035,0.010314413],"study_design_scores_gemma":[0.00005562735,0.000054923352,0.001237403,0.00024578415,0.000024853663,0.012894901,0.00075297186,0.00045610618,0.00019882922,0.012416457,0.9716158,0.00004640217],"about_ca_topic_score_codex":0.012712212,"about_ca_topic_score_gemma":0.028052567,"teacher_disagreement_score":0.029281931,"about_ca_system_score_codex":0.0034093168,"about_ca_system_score_gemma":0.0050350646,"threshold_uncertainty_score":0.030466318},"labels":[],"label_agreement":null},{"id":"W3137367749","doi":"10.1093/neuonc/noab027","title":"Medulloblastoma (cross)talk through extracellular vesicles","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Extracellular vesicles; Vesicle; Chemistry; Medicine; Cell biology; Biology; Cancer research; Biochemistry; Membrane","score_opus":0.019007131321207345,"score_gpt":0.2877132220485177,"score_spread":0.26870609072731033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137367749","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010838076,0.017483434,0.00090391486,0.9212137,0.037128985,0.000041163636,0.0001322268,0.00007863731,0.01217986],"genre_scores_gemma":[0.20006576,0.020160962,0.0017219789,0.57421863,0.16030224,0.00017553348,0.00010715902,0.00008363232,0.04316419],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949515,0.00015066942,0.000051256924,0.000066244844,0.00014755935,0.000089152556],"domain_scores_gemma":[0.9986903,0.00084656547,0.00014227914,0.00006213788,0.000105318446,0.00015339242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008519255,0.00037967818,0.00046727058,0.0002963914,0.0009726871,0.0017419643,0.00049170636,0.011620101,0.002813152],"category_scores_gemma":[0.0039047548,0.00024068622,0.0005234977,0.00020846348,0.0010012047,0.001207704,0.00079377677,0.0076385587,0.0016391979],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009007672,0.00006313693,0.002529808,0.00028811616,0.00010509089,0.05229307,0.00023672005,0.00045066074,0.0068678837,0.029655594,0.8504436,0.05616554],"study_design_scores_gemma":[0.00054162415,0.00017745924,0.0022350852,0.00024396364,0.00010204932,0.030800944,0.00037615444,0.0023789546,0.0065637045,0.0410141,0.91550803,0.000057827536],"about_ca_topic_score_codex":0.0007569469,"about_ca_topic_score_gemma":0.0012255833,"teacher_disagreement_score":0.011620101,"about_ca_system_score_codex":0.0018806378,"about_ca_system_score_gemma":0.0004478786,"threshold_uncertainty_score":0.013644993},"labels":[],"label_agreement":null},{"id":"W3139439448","doi":"10.1093/neuonc/noab067","title":"The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Instituto Nacional do Câncer, Ministério da Saúde; CHILDREN with CANCER UK; Saskatchewan Cancer Agency; Susan G. Komen","keywords":"Histology; Medicine; Population; Brain tumor; Pediatrics; Pathology; Environmental health","score_opus":0.009281192311493845,"score_gpt":0.2858275920494354,"score_spread":0.2765463997379416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139439448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880013,0.0006802673,0.00007246067,0.000042610187,0.000007394781,0.00005191605,0.010461952,0.0000091197,0.0006730129],"genre_scores_gemma":[0.9860167,0.0010462228,0.00021750915,0.000103434,0.000024492496,0.00009644365,0.012195371,0.00001114289,0.00028877618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900585,0.00011369943,0.00020526003,0.000285136,0.00021416131,0.00017595573],"domain_scores_gemma":[0.99802077,0.00018956377,0.0011954698,0.000118421165,0.00027555495,0.00020025628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008797232,0.00045035421,0.00053538976,0.003299404,0.00059820677,0.0010260561,0.00070339773,0.0005193502,0.0014474426],"category_scores_gemma":[0.0020775413,0.000689108,0.0006598837,0.004151439,0.00059688435,0.0009920038,0.001097587,0.0005697463,0.0005502273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037825623,0.000010495415,0.9986438,0.00003325685,0.000038349684,0.00010640425,0.00011522677,0.000013611173,0.000055291577,0.000009998676,0.00030941478,0.0006264111],"study_design_scores_gemma":[0.0000076009433,0.0000366092,0.99837434,0.000029172343,0.00003717589,0.00042539812,0.00050740683,0.000039517334,0.00004069561,0.000005918926,0.0004917435,0.0000044060916],"about_ca_topic_score_codex":0.037366785,"about_ca_topic_score_gemma":0.055736255,"teacher_disagreement_score":0.037366785,"about_ca_system_score_codex":0.0014239969,"about_ca_system_score_gemma":0.0012010256,"threshold_uncertainty_score":0.07429856},"labels":[],"label_agreement":null},{"id":"W3141953003","doi":"10.1093/neuonc/noab035","title":"The relevance of surgical status in nodular leptomeningeal metastasis patient outcomes","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Relevance (law); Metastasis; Clinical significance; Radiology; Pathology; Internal medicine; Cancer","score_opus":0.026879895231642456,"score_gpt":0.3114301502874609,"score_spread":0.28455025505581844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141953003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48975885,0.0106011545,0.0005202818,0.43134558,0.0032464645,0.000042174168,0.0019355016,0.000034096436,0.062515855],"genre_scores_gemma":[0.9697205,0.0025569384,0.00025144618,0.02027104,0.004646896,0.0000263821,0.00044342762,0.0000118859925,0.0020715066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921274,0.00025663382,0.00010439599,0.00007718261,0.00015271697,0.0001964142],"domain_scores_gemma":[0.99562055,0.0020451415,0.0006730672,0.0001292867,0.00068243063,0.0008494299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009435199,0.000108998625,0.00039525196,0.00058821036,0.00072601484,0.0012574723,0.00047547414,0.0018174769,0.003722446],"category_scores_gemma":[0.011499593,0.00010313044,0.0003453429,0.0011736372,0.00052105635,0.0010888256,0.0006448415,0.002083399,0.0005629194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037416248,0.000087230284,0.8981083,0.000103857376,0.000071007176,0.005651609,0.00046632736,0.0004476821,0.00033110206,0.0022032692,0.04044429,0.051711164],"study_design_scores_gemma":[0.00009968366,0.00030261665,0.91612744,0.00060928136,0.0001743362,0.016316114,0.0042445553,0.0020408938,0.00034084643,0.018689668,0.040976953,0.00007764712],"about_ca_topic_score_codex":0.0057461453,"about_ca_topic_score_gemma":0.014537464,"teacher_disagreement_score":0.0057461453,"about_ca_system_score_codex":0.0014147196,"about_ca_system_score_gemma":0.0012569418,"threshold_uncertainty_score":0.012452841},"labels":[],"label_agreement":null},{"id":"W3143439380","doi":"10.1093/neuonc/noab082","title":"Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Brain Tumor Society","keywords":"Clinical trial; Coronavirus disease 2019 (COVID-19); Food and drug administration; Brain tumor; Medicine; Medical education; Internal medicine; Psychiatry; Pharmacology","score_opus":0.5043035813782832,"score_gpt":0.5875728022539016,"score_spread":0.08326922087561839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143439380","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0078627085,0.013743148,0.012027621,0.90063405,0.03304598,0.0017033962,0.0012297785,0.0002396291,0.029513652],"genre_scores_gemma":[0.13828725,0.031165026,0.053985573,0.67400473,0.01684916,0.005663334,0.0047121993,0.0008602135,0.07447246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.92254585,0.04797275,0.0035926383,0.0029559901,0.016462302,0.0064704563],"domain_scores_gemma":[0.86362314,0.059229862,0.006086154,0.0042349524,0.030955385,0.03587064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18091851,0.0014900756,0.00083983474,0.001269905,0.0047228746,0.013401,0.004459776,0.015853655,0.01523342],"category_scores_gemma":[0.11458706,0.0011376949,0.0025993364,0.0011616246,0.0036757472,0.008197042,0.015739828,0.024409277,0.0038511008],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004032899,0.0007122445,0.0017498528,0.0008897734,0.000110579116,0.0008527858,0.002135053,0.0017026974,0.0009168683,0.020636963,0.8969425,0.072947435],"study_design_scores_gemma":[0.00022169815,0.00044728257,0.0017025046,0.0011376353,0.000035065168,0.00025286776,0.0020787383,0.0004957477,0.0010104745,0.00749217,0.9850256,0.00010021168],"about_ca_topic_score_codex":0.009164386,"about_ca_topic_score_gemma":0.018476108,"teacher_disagreement_score":0.18091851,"about_ca_system_score_codex":0.016500436,"about_ca_system_score_gemma":0.07257615,"threshold_uncertainty_score":0.9568},"labels":[],"label_agreement":null},{"id":"W3153000652","doi":"10.1093/neuonc/noab093","title":"Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; American Cancer Society; U.S. Department of Defense","keywords":"Pentose phosphate pathway; Flux (metallurgy); Glycolysis; Glioma; Chemistry; Phosphate; Biochemistry; Carbohydrate metabolism; Metabolism; Cell biology; Cancer research; Biology","score_opus":0.017358623992627366,"score_gpt":0.27437140621611095,"score_spread":0.25701278222348356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153000652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809193,0.0020369466,0.014483842,0.00017526944,0.00002695388,0.000021515263,0.00042642152,0.0001654732,0.0017442645],"genre_scores_gemma":[0.98411787,0.001815187,0.011898851,0.00012584632,0.000013399331,0.000054392523,0.00072006765,0.00004739,0.0012069339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999329,0.000012925234,0.0000037076295,0.000017669498,0.000014925213,0.000017894052],"domain_scores_gemma":[0.9999443,0.0000067061947,0.000019823596,0.0000044357803,0.000012274605,0.0000124102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010160309,0.0002959159,0.000166367,0.0002477931,0.00010871151,0.00025487808,0.00016333399,0.00034491552,0.00080406904],"category_scores_gemma":[0.00011701583,0.000129363,0.00016819651,0.0002927484,0.00016659162,0.00021933726,0.00013603413,0.00040055896,0.0001700706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018076853,0.000014212907,0.0013190822,0.000050651808,0.000010384858,0.00010424285,0.000019245914,0.000077152035,0.9959929,0.00006968391,0.000066408,0.0020954337],"study_design_scores_gemma":[0.000014258675,0.00023958112,0.013994422,0.000009089861,0.000050751958,0.0006385376,0.000075676464,0.0015795459,0.98198247,0.00012933394,0.0012773457,0.000008853598],"about_ca_topic_score_codex":0.0007954566,"about_ca_topic_score_gemma":0.0012708047,"teacher_disagreement_score":0.00080406904,"about_ca_system_score_codex":0.00023247417,"about_ca_system_score_gemma":0.0001520378,"threshold_uncertainty_score":0.002689898},"labels":[],"label_agreement":null},{"id":"W3155618875","doi":"10.1093/neuonc/noab189","title":"COVID-19 in pediatric cancer: Where are the brain tumors?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital","funders":"","keywords":"Medicine; Pediatric oncology; Pediatric cancer; Pandemic; Immunosuppression; Cancer; Coronavirus disease 2019 (COVID-19); Disease; Pediatrics; Oncology; Internal medicine; Intensive care medicine; Infectious disease (medical specialty)","score_opus":0.0711742864164797,"score_gpt":0.39886004312712403,"score_spread":0.3276857567106443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155618875","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003230108,0.0010460995,0.00003694245,0.9911075,0.004578793,0.000005250708,0.000032873435,0.0000075677926,0.002861986],"genre_scores_gemma":[0.004408726,0.0019504811,0.0001730528,0.96995,0.01926674,0.0000189988,0.0000348095,0.000021207554,0.004175993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944149,0.0014468187,0.0007363148,0.00046314293,0.0014149876,0.0015239362],"domain_scores_gemma":[0.98422354,0.005742373,0.0011435057,0.00029926578,0.0030202328,0.0055710752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042334143,0.00069512543,0.0014359943,0.0008069059,0.0067753065,0.005052351,0.0017431645,0.058921322,0.011330237],"category_scores_gemma":[0.025631256,0.0007613135,0.0015277663,0.0010017043,0.0041660047,0.006418678,0.0045039565,0.050234962,0.003937266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019650231,0.000037761034,0.0026830214,0.00006921876,0.000011645118,0.0030629858,0.00026838877,0.000099016266,0.00016113042,0.008190213,0.975128,0.010268988],"study_design_scores_gemma":[0.000066690554,0.00009037201,0.0028212625,0.00091685925,0.00003742182,0.006007597,0.0018469597,0.00040776588,0.00023436065,0.017164353,0.9703143,0.000091986374],"about_ca_topic_score_codex":0.029724564,"about_ca_topic_score_gemma":0.058786634,"teacher_disagreement_score":0.058921322,"about_ca_system_score_codex":0.00825936,"about_ca_system_score_gemma":0.022719398,"threshold_uncertainty_score":0.059926093},"labels":[],"label_agreement":null},{"id":"W3158444240","doi":"10.1093/neuonc/noab088","title":"Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Medical Research Council; Brain Tumour Charity; National Cancer Institute; Cancer Research UK; Cancer Australia; KWF Kankerbestrijding; NRG Oncology; U.S. Department of Defense","keywords":"Temozolomide; Anaplastic astrocytoma; Glioma; Oncology; IDH1; Internal medicine; Medicine; Hazard ratio; CDKN2A; DNA methylation; Cancer research; Biology; Astrocytoma; Cancer; Genetics; Mutation","score_opus":0.024297912445691607,"score_gpt":0.30847900653563326,"score_spread":0.28418109408994163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158444240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865603,0.0004916095,0.00008503673,0.00009568416,0.000015329306,0.00006607148,0.00027489726,0.00000837014,0.0003069158],"genre_scores_gemma":[0.9983569,0.0001143561,0.00015496332,0.00013395338,0.000014616753,0.00012140796,0.00089555123,0.0000051642614,0.00020305133],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999148,0.00054531044,0.000039809624,0.00014087003,0.000065020686,0.0000610333],"domain_scores_gemma":[0.99906725,0.00031218122,0.00029146593,0.00009478427,0.00006527842,0.00016914844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021604039,0.00037268386,0.0006343237,0.00012848573,0.00020427832,0.0005603808,0.0003116056,0.00053445774,0.0010057967],"category_scores_gemma":[0.001797212,0.00014226639,0.00062908675,0.00020553182,0.00037605327,0.000362362,0.00023957125,0.00068597426,0.00011656734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76579535,0.0022103733,0.16905837,0.00035936196,0.0028512622,0.00013512789,0.00018248279,0.003075192,0.016041921,0.0002655404,0.0026387577,0.03738635],"study_design_scores_gemma":[0.19785714,0.13040274,0.6425566,0.00009678554,0.0055997814,0.0006098546,0.00018015306,0.009513774,0.0077194045,0.0013120334,0.004072304,0.00007937541],"about_ca_topic_score_codex":0.0007075368,"about_ca_topic_score_gemma":0.002709335,"teacher_disagreement_score":0.0021604039,"about_ca_system_score_codex":0.0005385541,"about_ca_system_score_gemma":0.00061904814,"threshold_uncertainty_score":0.011425436},"labels":[],"label_agreement":null},{"id":"W3161379071","doi":"10.1093/neuonc/noab078","title":"Reply to letter by Schwartz et al.","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Philosophy; Psychology; Psychoanalysis","score_opus":0.030072708552614888,"score_gpt":0.31823177536103386,"score_spread":0.28815906680841896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161379071","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022120078,0.00092357135,0.000033864544,0.9818264,0.0144374175,0.000009403036,0.000055510493,0.00001984737,0.0024727627],"genre_scores_gemma":[0.0016446827,0.0006878449,0.000072841096,0.9759142,0.016441144,0.000025122987,0.00003419409,0.000019490099,0.0051604486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979144,0.000610715,0.00023447105,0.00025215792,0.00060034427,0.00038786326],"domain_scores_gemma":[0.99424654,0.0029018295,0.0002938562,0.00013712542,0.0012631976,0.0011575083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029421705,0.0008877512,0.0014225737,0.0008586768,0.004316946,0.0034808181,0.0019590892,0.057310432,0.009593297],"category_scores_gemma":[0.018203262,0.00086710183,0.0011796228,0.0008138275,0.0025347641,0.0038834785,0.0016628861,0.037848953,0.010027425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030508858,0.000011325739,0.00026904198,0.000021587053,0.00000562513,0.00082533865,0.000049935494,0.000024804238,0.0000380954,0.0006196283,0.9962676,0.0018365853],"study_design_scores_gemma":[0.00012685786,0.0000605327,0.0013110845,0.00031325154,0.000036300076,0.00347824,0.0005180205,0.0003749144,0.0002729275,0.0065622902,0.9868571,0.00008843631],"about_ca_topic_score_codex":0.0098985825,"about_ca_topic_score_gemma":0.016851755,"teacher_disagreement_score":0.057310432,"about_ca_system_score_codex":0.0038672576,"about_ca_system_score_gemma":0.005997936,"threshold_uncertainty_score":0.03209281},"labels":[],"label_agreement":null},{"id":"W3162066709","doi":"10.1093/neuonc/noab036","title":"Loss of H3K27me3 in meningiomas","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology","score_opus":0.03115777824416481,"score_gpt":0.31288817980757083,"score_spread":0.281730401563406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162066709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999114,0.00043552747,0.00019844223,0.000018756202,0.0000016909358,0.0000039147185,0.00009692806,0.000007188551,0.00012366362],"genre_scores_gemma":[0.99963,0.00011495884,0.00013247339,0.0000047811936,0.0000031869001,0.0000024263254,0.0000842134,0.0000018485534,0.000026116595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961984,0.000057190002,0.000056626282,0.000092182505,0.000113611015,0.00006055499],"domain_scores_gemma":[0.99833494,0.00014607758,0.0010378936,0.00017561653,0.00014522333,0.00016028387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011099302,0.0002821672,0.00023282463,0.0011589266,0.00036741595,0.00044574137,0.0002536224,0.00022910071,0.00037003262],"category_scores_gemma":[0.0019138666,0.00015622469,0.00024818914,0.00062528084,0.0004594942,0.00027166543,0.00043810447,0.00027073483,0.00013037423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004995341,0.000017557259,0.9787426,0.000038302376,0.000084021485,0.00043462924,0.00009367278,0.00019583615,0.014571236,0.00002589055,0.00006392463,0.0052327514],"study_design_scores_gemma":[0.000005135535,0.00015219128,0.9941849,0.000006077888,0.000042609303,0.0015399902,0.00006237203,0.00018588753,0.0035249547,0.000065971304,0.00022682363,0.0000031323666],"about_ca_topic_score_codex":0.0031537544,"about_ca_topic_score_gemma":0.0033436746,"teacher_disagreement_score":0.0031537544,"about_ca_system_score_codex":0.0005788529,"about_ca_system_score_gemma":0.0003906761,"threshold_uncertainty_score":0.0062707663},"labels":[],"label_agreement":null},{"id":"W3163074318","doi":"","title":"The Canadian paediatric brain tumour consortium (CPBTC): A model of cooperation using teleconferencing services","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Teleconference; Telecommunications; Computer science","score_opus":0.03294521497880057,"score_gpt":0.2784333733223388,"score_spread":0.24548815834353824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163074318","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17427498,0.0010483059,0.052305438,0.057989843,0.00067143835,0.0008705921,0.000590648,0.0005174679,0.7117313],"genre_scores_gemma":[0.9103467,0.0006712177,0.02962177,0.0029602454,0.00007966548,0.00021078745,0.00026136907,0.00007180517,0.05577648],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949327,0.0016598363,0.000088748224,0.00033742274,0.0016463932,0.0013349605],"domain_scores_gemma":[0.99535686,0.00074725115,0.00020209067,0.00024470422,0.0013704983,0.0020786503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003892973,0.0003457112,0.00011244439,0.0015369926,0.007299723,0.006278929,0.001918746,0.0029799573,0.008782558],"category_scores_gemma":[0.007896305,0.0002721022,0.00034639408,0.0027396127,0.0037091395,0.0026924617,0.0042374483,0.0018098562,0.0009470459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001739556,0.00023600183,0.02827166,0.00012537812,0.000040430867,0.00545885,0.012732208,0.012590546,0.0012976561,0.67266303,0.122854136,0.14355616],"study_design_scores_gemma":[0.0002292999,0.00041972494,0.038251273,0.0005185255,0.000081063896,0.0056265667,0.03630325,0.034477737,0.0015104149,0.07503165,0.80718005,0.00037046373],"about_ca_topic_score_codex":0.7947921,"about_ca_topic_score_gemma":0.8910421,"teacher_disagreement_score":0.97047645,"about_ca_system_score_codex":0.02952356,"about_ca_system_score_gemma":0.084781334,"threshold_uncertainty_score":0.41283274},"labels":[],"label_agreement":null},{"id":"W3164180016","doi":"10.1093/neuonc/noab131","title":"Metformin effects on brain development following cranial irradiation in a mouse model","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Metformin; Medicine; Neuroscience; Biology; Endocrinology; Diabetes mellitus","score_opus":0.012720500676021233,"score_gpt":0.2740832325343112,"score_spread":0.26136273185829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164180016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97816396,0.0066916035,0.007265482,0.0007140705,0.00029976602,0.0003054135,0.0027573307,0.00047150732,0.0033308004],"genre_scores_gemma":[0.962321,0.010269484,0.011385711,0.00048390104,0.00006124038,0.0012855832,0.0031199183,0.00015170535,0.010921493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967086,0.00004544449,0.000035774716,0.00007857812,0.00010870432,0.000060643444],"domain_scores_gemma":[0.9997181,0.000021517035,0.00012055335,0.00003148892,0.000031208307,0.000077046934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047263113,0.001002182,0.00065897405,0.0013657231,0.00042246943,0.0004720895,0.00073266984,0.00095848716,0.0021110172],"category_scores_gemma":[0.000184029,0.00035731844,0.0008494338,0.00042381484,0.0005674382,0.0005198975,0.00035695737,0.0020847209,0.0005157868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021381318,0.00091526425,0.0012925008,0.00029669201,0.00006849997,0.00034224696,0.00008751008,0.00047115472,0.9854557,0.0005223824,0.000582603,0.007827207],"study_design_scores_gemma":[0.0003770611,0.009355999,0.011800823,0.00012065006,0.00037358096,0.0007177383,0.00018223835,0.002722165,0.96337885,0.0005093226,0.0104042515,0.00005737004],"about_ca_topic_score_codex":0.00092871796,"about_ca_topic_score_gemma":0.0021848984,"teacher_disagreement_score":0.0021110172,"about_ca_system_score_codex":0.0006082594,"about_ca_system_score_gemma":0.0006913985,"threshold_uncertainty_score":0.0070620775},"labels":[],"label_agreement":null},{"id":"W3164773505","doi":"10.1093/neuonc/noab136","title":"Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Deutsche Kinderkrebsstiftung; Brain Tumour Charity","keywords":"DNA methylation; Atypical teratoid rhabdoid tumor; Methylation; Medicine; Glioma; Neuroblastoma; Retrospective cohort study; Oncology; Pathology; Internal medicine; Biology; Immunohistochemistry; Cancer research; DNA; Gene; Genetics; Cell culture; Gene expression","score_opus":0.029479160069184145,"score_gpt":0.3651712102795587,"score_spread":0.3356920502103745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164773505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941942,0.00216294,0.0014886751,0.00004565459,0.000010806245,0.000033674343,0.0006603609,0.000011201858,0.0013924303],"genre_scores_gemma":[0.9977798,0.00071406184,0.00047724176,0.000032682237,0.000016692247,0.000025072444,0.0008545798,0.000009988416,0.000089899084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841607,0.00061838026,0.00024115935,0.00045142754,0.00017950844,0.00009347255],"domain_scores_gemma":[0.9962225,0.0011393736,0.0011683758,0.0007398175,0.00052422803,0.00020576539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034119745,0.00039379962,0.00032225857,0.001185176,0.00029504063,0.0006112235,0.00023316251,0.00020841857,0.00087035995],"category_scores_gemma":[0.005026742,0.00017831872,0.00046322704,0.0013952,0.0005421048,0.00050314463,0.00048201572,0.0002696629,0.0002840374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038128797,0.000032471366,0.98970395,0.00003339287,0.00014241679,0.0001779935,0.00017593743,0.000118136595,0.001026767,0.000045090885,0.00010994082,0.008052606],"study_design_scores_gemma":[0.000025415842,0.00045956904,0.9929766,0.00003838794,0.0005705032,0.0019635374,0.0004133125,0.00030319457,0.00097417226,0.00004564384,0.002215311,0.000014230317],"about_ca_topic_score_codex":0.0012276886,"about_ca_topic_score_gemma":0.0012151322,"teacher_disagreement_score":0.0034119745,"about_ca_system_score_codex":0.00029905155,"about_ca_system_score_gemma":0.00033506379,"threshold_uncertainty_score":0.018044472},"labels":[],"label_agreement":null},{"id":"W3165056209","doi":"10.1093/neuonc/noab134","title":"Spatial concordance of DNA methylation classification in diffuse glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; U.S. Department of Defense","keywords":"Concordance; DNA methylation; Glioma; Biology; Methylation; Computational biology; DNA; Genetics; Gene","score_opus":0.03552386051443346,"score_gpt":0.319901244927632,"score_spread":0.28437738441319854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165056209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980981,0.0001177701,0.0014217125,0.0000071294617,4.1181235e-7,0.000003218972,0.00009537559,0.000014796093,0.00024152553],"genre_scores_gemma":[0.99939656,0.000022095204,0.00042765142,0.0000020595396,6.0320906e-7,0.0000022668335,0.000100797275,0.0000035651958,0.000044294095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997756,0.000044915643,0.000020342879,0.000078492056,0.000054419346,0.000026198388],"domain_scores_gemma":[0.999411,0.00019902932,0.00019000116,0.00006462128,0.00009738362,0.000038011538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003625446,0.00012988683,0.00015436839,0.0005865909,0.00012630151,0.00029182294,0.0001416967,0.00016326143,0.00065592444],"category_scores_gemma":[0.0012379015,0.0001232879,0.00007995302,0.00024386724,0.00025219226,0.00014956761,0.0004070183,0.00013038295,0.0001301931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001226981,0.000020253672,0.83954763,0.00007178332,0.00010783776,0.000218512,0.0006195618,0.002610579,0.12512186,0.000175856,0.000086897184,0.030192237],"study_design_scores_gemma":[0.000008920125,0.00012472355,0.96567607,0.0000055566356,0.00005109129,0.0013763702,0.00022404766,0.0042756577,0.027634578,0.00025992884,0.0003516961,0.000011357134],"about_ca_topic_score_codex":0.0015591407,"about_ca_topic_score_gemma":0.0028600881,"teacher_disagreement_score":0.0015591407,"about_ca_system_score_codex":0.00019396406,"about_ca_system_score_gemma":0.00013398608,"threshold_uncertainty_score":0.0031000972},"labels":[],"label_agreement":null},{"id":"W3166172363","doi":"10.1093/neuonc/noab090.198","title":"EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Calgary; University of Alberta; McMaster University","funders":"","keywords":"Medicine; Ependymoma; Medulloblastoma; Astrocytoma; Surgery; Pilocytic astrocytoma; Retrospective cohort study; Hydrocephalus; Glioma","score_opus":0.014250421261590885,"score_gpt":0.2784480752848482,"score_spread":0.26419765402325734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166172363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913864,0.002040663,0.00009896537,0.000029009016,0.000008348766,0.00004870891,0.005396436,0.000007742206,0.0009837495],"genre_scores_gemma":[0.9951669,0.0011801786,0.00012123294,0.00002697064,0.0000080138525,0.00004955487,0.0032749102,0.0000036457407,0.00016858017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943084,0.00007285318,0.00011529867,0.0001082887,0.0001765336,0.00009613484],"domain_scores_gemma":[0.99735105,0.00038640838,0.0014627604,0.000104802544,0.0004707081,0.00022431408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005928583,0.00016700673,0.0002520413,0.0018759767,0.00040342924,0.0003970435,0.00038059754,0.00020980087,0.0018442834],"category_scores_gemma":[0.0023360003,0.00020725827,0.00023697143,0.0028637075,0.0002862323,0.0003751075,0.0003227936,0.00019161428,0.0002231262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038911687,0.000006069821,0.99692625,0.000085705244,0.00002234212,0.0008555748,0.000068738744,0.000011478373,0.00018913372,0.000009848046,0.00026553756,0.0015204577],"study_design_scores_gemma":[0.0000017887306,0.00003318774,0.99687,0.000037795795,0.00002002123,0.0021798539,0.00021616725,0.000018527016,0.00008447884,0.0000025926342,0.000533858,0.0000018369194],"about_ca_topic_score_codex":0.036686786,"about_ca_topic_score_gemma":0.04259283,"teacher_disagreement_score":0.036686786,"about_ca_system_score_codex":0.0007229683,"about_ca_system_score_gemma":0.0014862049,"threshold_uncertainty_score":0.07294649},"labels":[],"label_agreement":null},{"id":"W3166680572","doi":"10.1093/neuonc/noab090.103","title":"HGG-39. ALTERNATIVE SPLICING OF <i>NEUROFIBROMIN 1</i> IS ASSOCIATED WITH ELEVATED MAPK ACTIVITY AND POOR PROGNOSIS IN HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Neurofibromin 1; RNA splicing; MAPK/ERK pathway; Biology; Cancer research; Spliceosome; Carcinogenesis; Alternative splicing; Genetics; Gene; Signal transduction; RNA; Messenger RNA","score_opus":0.020466211873663907,"score_gpt":0.2823634488948709,"score_spread":0.261897237021207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166680572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992835,0.000112407746,0.00013484196,0.00001700356,0.0000018980342,0.0000032400098,0.00026276137,0.000007767178,0.00017653887],"genre_scores_gemma":[0.99933785,0.000053575743,0.00014727507,0.00001314624,0.0000031283416,0.0000030466379,0.00032118388,0.0000046680307,0.00011611772],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999907,0.00001209183,0.0000075604403,0.00003205873,0.000022148588,0.000019158357],"domain_scores_gemma":[0.9997559,0.00002744775,0.00012689472,0.000014179064,0.000017559005,0.000058040983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011864455,0.00017707408,0.00014640922,0.00031779497,0.00020895121,0.00025951554,0.00010903438,0.00018327935,0.0012395049],"category_scores_gemma":[0.0002560511,0.0000798484,0.00014023707,0.0003244464,0.00018203826,0.00008610429,0.00017082147,0.00021699296,0.00023051289],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000808625,0.0000440356,0.87606674,0.00004747296,0.000094895455,0.001450466,0.000112756396,0.00011677295,0.112112336,0.00008959058,0.00043349955,0.00862278],"study_design_scores_gemma":[0.0000065465765,0.00011504342,0.9892021,0.000005826378,0.000032853626,0.0034549516,0.000096644464,0.00024818472,0.00611555,0.000088268614,0.0006303841,0.0000035408364],"about_ca_topic_score_codex":0.00091306126,"about_ca_topic_score_gemma":0.0014507938,"teacher_disagreement_score":0.0012395049,"about_ca_system_score_codex":0.00014186515,"about_ca_system_score_gemma":0.00012576708,"threshold_uncertainty_score":0.004146576},"labels":[],"label_agreement":null},{"id":"W3166940707","doi":"10.1093/neuonc/noab090.168","title":"RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Glioma; Oncology; Neuroblastoma; Gastroenterology; Cancer research; Receptor; Neurotrophin; Biology","score_opus":0.006823661440236482,"score_gpt":0.23211809392366775,"score_spread":0.22529443248343126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166940707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96869814,0.01322262,0.0008840563,0.00065018836,0.00009304183,0.0004280912,0.006172464,0.00027098096,0.009580356],"genre_scores_gemma":[0.9829044,0.0048481673,0.0022620189,0.00068963337,0.000102872786,0.00046727035,0.007271723,0.000040029507,0.0014138507],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975413,0.000080340295,0.000025164305,0.000042556003,0.000054613505,0.000043272114],"domain_scores_gemma":[0.99953103,0.00009491296,0.00016335443,0.000021545366,0.000057275247,0.00013189303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054407737,0.0002460151,0.00079921266,0.00023357928,0.00013386642,0.00047472754,0.0002363507,0.0003047228,0.003054944],"category_scores_gemma":[0.0006724967,0.00013812337,0.00062328164,0.00034498997,0.00023226546,0.00027482572,0.00022707648,0.00071840006,0.000815331],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11026258,0.0044224486,0.1636105,0.0032720864,0.0016596199,0.0035589635,0.0003866047,0.0063589467,0.06870095,0.001552969,0.035581544,0.6006328],"study_design_scores_gemma":[0.0963834,0.21330608,0.46701553,0.0010980979,0.0043586623,0.02367927,0.0005245123,0.013217172,0.05457067,0.0012607512,0.12444459,0.00014121406],"about_ca_topic_score_codex":0.0009235739,"about_ca_topic_score_gemma":0.0024481986,"teacher_disagreement_score":0.003054944,"about_ca_system_score_codex":0.0007414398,"about_ca_system_score_gemma":0.0008842435,"threshold_uncertainty_score":0.010219812},"labels":[],"label_agreement":null},{"id":"W3167505290","doi":"10.1093/neuonc/noab090.176","title":"RARE-15. THE MOLECULAR PROFILE OF SECONDARY MENINGIOMAS IN SURVIVORS OF CHILDHOOD NON-CENTRAL NERVOUS SYSTEM CANCERS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Cohort; Meningioma; Radiation therapy; Exome sequencing; Oncology; Cancer; Internal medicine; Surgery; Biology; Mutation; Genetics; Gene","score_opus":0.01019744195147335,"score_gpt":0.24849548749599237,"score_spread":0.23829804554451903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167505290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977717,0.00032988266,0.000106853295,0.000034660065,0.0000042858296,0.000009487488,0.0010664293,0.000014529587,0.00066221086],"genre_scores_gemma":[0.998075,0.00019726182,0.00025561632,0.00002196728,0.0000068760055,0.000010944466,0.0010704289,0.0000066515636,0.00035532107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998053,0.000016133374,0.000026207137,0.00005402362,0.000043026594,0.000055310928],"domain_scores_gemma":[0.99939275,0.000056565874,0.00032829688,0.000028619179,0.00006531059,0.00012840216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014253089,0.00018374901,0.0002258085,0.0009854166,0.00034219035,0.00037944384,0.00023262737,0.00025946012,0.0025294202],"category_scores_gemma":[0.00064540806,0.00010279858,0.00022726558,0.0006947221,0.00023309718,0.00014820925,0.00026640802,0.00021279685,0.00041276135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016562162,0.000020186677,0.98249406,0.00003189049,0.000021611857,0.0015892003,0.00008349649,0.00007781392,0.009731363,0.00005569512,0.00024505783,0.0054840487],"study_design_scores_gemma":[0.000005741705,0.00012830565,0.9816244,0.000012356301,0.000033160555,0.012056419,0.00019825781,0.00014846375,0.0044392208,0.00007665184,0.0012717308,0.000005324383],"about_ca_topic_score_codex":0.0025360074,"about_ca_topic_score_gemma":0.0027715757,"teacher_disagreement_score":0.0025360074,"about_ca_system_score_codex":0.00037259754,"about_ca_system_score_gemma":0.00027157736,"threshold_uncertainty_score":0.008461714},"labels":[],"label_agreement":null},{"id":"W3168486234","doi":"10.1093/neuonc/noab090.197","title":"EPCT-11. RURALITY INDEX SCORE AND PEDIATRIC NEURO-ONCOLOGICAL OUTCOME IN ONTARIO","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rurality; Medicine; Index (typography); Demography; Cohort; Rural area; Pediatrics; Population; Environmental health; Internal medicine; Pathology","score_opus":0.10717405221317859,"score_gpt":0.43370736578740066,"score_spread":0.32653331357422205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168486234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927039,0.00028403502,0.000054374203,0.00024536264,0.0000066727835,0.000020017082,0.0044470215,0.00000661674,0.0022319707],"genre_scores_gemma":[0.9980118,0.0001392809,0.000049043596,0.000020774565,0.0000036708088,0.000013546427,0.0014475723,0.0000020268014,0.0003121356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961084,0.000024783545,0.00003176954,0.000058453756,0.00013279896,0.00014135634],"domain_scores_gemma":[0.99835986,0.00006977415,0.00076878554,0.000032202788,0.00039541814,0.0003739656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026761877,0.00015708762,0.00017309563,0.000785819,0.00075521274,0.00057670654,0.00056495494,0.0001768999,0.0024589251],"category_scores_gemma":[0.001827208,0.00013553939,0.0002752442,0.0018489637,0.0004877448,0.00025929022,0.00065291487,0.000305519,0.00016215818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015879144,0.0000045010897,0.99854076,0.0000134424,0.000009185078,0.00006302216,0.00014796283,0.00003507792,0.00004158632,0.000023538076,0.00042477087,0.00068038754],"study_design_scores_gemma":[0.0000014321716,0.000007813477,0.99919575,0.000011777077,0.0000046749137,0.00006911813,0.00023717691,0.0000669578,0.000017857788,0.000007723692,0.00037804685,0.0000016707081],"about_ca_topic_score_codex":0.8950941,"about_ca_topic_score_gemma":0.93617207,"teacher_disagreement_score":0.1049059,"about_ca_system_score_codex":0.008579716,"about_ca_system_score_gemma":0.008768157,"threshold_uncertainty_score":0.21104741},"labels":[],"label_agreement":null},{"id":"W3168961686","doi":"10.1093/neuonc/noab090.038","title":"EMBR-20. ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"microRNA; Biology; Untranslated region; Messenger RNA; Three prime untranslated region; Translation (biology); Medulloblastoma; Translational regulation; Cancer research; Molecular biology; Genetics; Gene","score_opus":0.011302065578731415,"score_gpt":0.28199158325182067,"score_spread":0.27068951767308924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168961686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532466,0.006481618,0.018434329,0.0007402872,0.00057273736,0.00020836687,0.007309279,0.0013053344,0.011701377],"genre_scores_gemma":[0.9753592,0.0011048951,0.005869386,0.0002996734,0.000033266097,0.00012457198,0.0037675917,0.00038302358,0.013058345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966633,0.000033758864,0.000031962132,0.000112197245,0.000090620306,0.00006523104],"domain_scores_gemma":[0.99979264,0.000024034432,0.00007255327,0.000024166015,0.000019050427,0.00006750588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023990794,0.0005028563,0.0003047196,0.0003610276,0.0003724944,0.000568273,0.00033527595,0.00043436934,0.004977169],"category_scores_gemma":[0.00018992466,0.00031153878,0.00058505405,0.00017110512,0.00039248247,0.00020419378,0.0005369495,0.00092790334,0.0026501957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107832464,0.000021971686,0.00020612625,0.000046116005,0.0000041035496,0.00007436705,0.000017544775,0.000047267054,0.99800485,0.0002685326,0.00015756195,0.001043899],"study_design_scores_gemma":[0.000037904472,0.00019480434,0.008152126,0.000032870317,0.000022086615,0.00040277338,0.000060292405,0.0018411773,0.9676303,0.0002668565,0.021343315,0.000015500267],"about_ca_topic_score_codex":0.001873784,"about_ca_topic_score_gemma":0.0029363197,"teacher_disagreement_score":0.004977169,"about_ca_system_score_codex":0.0009711767,"about_ca_system_score_gemma":0.00054428563,"threshold_uncertainty_score":0.01665026},"labels":[],"label_agreement":null},{"id":"W3169246075","doi":"10.1093/neuonc/noab090.008","title":"ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Biology; Transfection; RNA interference; Cancer research; Small hairpin RNA; Gene; Blot; Cell culture; Molecular biology; Genetics; RNA","score_opus":0.01721175098722627,"score_gpt":0.2911656772268459,"score_spread":0.2739539262396196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169246075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625115,0.0019496925,0.013887439,0.00024842995,0.00006833459,0.0006107318,0.013676242,0.0010533084,0.0059942664],"genre_scores_gemma":[0.9363118,0.0022976692,0.022063727,0.000254338,0.000017448692,0.0004902531,0.025416953,0.00032476053,0.012823146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997328,0.000026614125,0.000027515807,0.000054706274,0.000125933,0.000032421205],"domain_scores_gemma":[0.99982506,0.000041036015,0.000055501292,0.000018852757,0.000019693447,0.000039891307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003175772,0.0003891803,0.00049933436,0.00044539353,0.00022798612,0.00035356803,0.00041395408,0.0003960123,0.0025765281],"category_scores_gemma":[0.00018224945,0.00021423779,0.00043074533,0.0003423326,0.00020076703,0.00011208746,0.00018282572,0.0006809667,0.001160565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008451357,0.00005471562,0.00043769594,0.00006036239,0.000017908482,0.00015933506,0.000013199372,0.00020009161,0.9961934,0.00009506858,0.00029632714,0.0023873604],"study_design_scores_gemma":[0.00009179417,0.0009315853,0.013922521,0.000022177212,0.0001649845,0.0019182577,0.00005421954,0.006515501,0.9629605,0.00006604917,0.013334338,0.00001812535],"about_ca_topic_score_codex":0.000949152,"about_ca_topic_score_gemma":0.0033155521,"teacher_disagreement_score":0.0025765281,"about_ca_system_score_codex":0.00034385454,"about_ca_system_score_gemma":0.0002750889,"threshold_uncertainty_score":0.008619368},"labels":[],"label_agreement":null},{"id":"W3169764605","doi":"10.1093/neuonc/noab090.193","title":"EPCT-07. ID1 IS A KEY TRANSCRIPTIONAL REGULATOR OF DIPG INVASION AND IS TARGETABLE WITH CANNABIDIOL","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene knockdown; Cancer research; Biology; Carcinogenesis; Small hairpin RNA; Exome sequencing; Cancer; Mutation; Gene; Genetics","score_opus":0.01345260532825223,"score_gpt":0.265789012475972,"score_spread":0.25233640714771977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169764605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8288167,0.01804174,0.015591891,0.0027034853,0.0015739105,0.000353022,0.08986609,0.0037142078,0.03933892],"genre_scores_gemma":[0.8959551,0.0034920028,0.0041478844,0.0017354473,0.00005983734,0.00032843175,0.060224127,0.00061887957,0.033438332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996049,0.000019931136,0.000017595372,0.000115064984,0.00013917475,0.00010327508],"domain_scores_gemma":[0.9998031,0.000023805427,0.000042162435,0.00002402366,0.000031374922,0.00007553742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024232548,0.00041140232,0.00052050385,0.00046793316,0.0006779297,0.0009671615,0.0004497105,0.00074202335,0.015685484],"category_scores_gemma":[0.0002794666,0.00030035392,0.0006314905,0.00045924637,0.0005215398,0.00023687273,0.0005474537,0.0020813756,0.0046709757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026756998,0.00026383062,0.008452395,0.0009060883,0.00012352668,0.000939198,0.00012136409,0.00088605436,0.9424898,0.002710185,0.017113026,0.023318807],"study_design_scores_gemma":[0.0006852174,0.00083717617,0.15534735,0.0002689981,0.00031147298,0.003274128,0.0003114308,0.005817883,0.7211905,0.0015853408,0.1102946,0.00007595259],"about_ca_topic_score_codex":0.0040221475,"about_ca_topic_score_gemma":0.0065447874,"teacher_disagreement_score":0.015685484,"about_ca_system_score_codex":0.00086633925,"about_ca_system_score_gemma":0.0011061829,"threshold_uncertainty_score":0.052473128},"labels":[],"label_agreement":null},{"id":"W3170014096","doi":"10.1093/neuonc/noab090.147","title":"TMOD-06. LOSS OF DICER COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE METASTATIC MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dicer; Biology; PTEN; Medulloblastoma; Cancer research; Carcinogenesis; Glioma; microRNA; Tumor progression; Tumor initiation; Cancer; Genetics; Small interfering RNA; PI3K/AKT/mTOR pathway; Gene; RNA","score_opus":0.014979936731803605,"score_gpt":0.30108288245367376,"score_spread":0.28610294572187017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170014096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929598,0.00062709,0.003852949,0.00008511924,0.000030307998,0.00006205936,0.0009125167,0.00022706452,0.0012431613],"genre_scores_gemma":[0.9926957,0.00024269015,0.002787872,0.000038930015,0.00000586425,0.000058680238,0.000833335,0.00006974713,0.0032672512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996811,0.00003922438,0.000050296458,0.000079901976,0.00008750294,0.00006206201],"domain_scores_gemma":[0.9996358,0.00005172157,0.00012398488,0.000051998384,0.000018944196,0.00011752095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021850878,0.00033192005,0.00033879804,0.0003827103,0.00015474552,0.0003296646,0.0002830901,0.00037013442,0.0013323379],"category_scores_gemma":[0.00017588388,0.00023301096,0.00032433693,0.00015257981,0.00026081182,0.00016772437,0.0002664888,0.0007300987,0.00068496104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037673344,0.00001801718,0.00013122556,0.000010487522,0.0000023704863,0.000057150355,0.0000053520853,0.000032048327,0.99929655,0.000044670116,0.000019726578,0.00034477023],"study_design_scores_gemma":[0.000011590599,0.00021264434,0.0025473011,0.0000021809308,0.000006398947,0.0003638001,0.000014578562,0.000797319,0.9945411,0.000017525233,0.0014825719,0.0000029543162],"about_ca_topic_score_codex":0.00046649622,"about_ca_topic_score_gemma":0.0008115631,"teacher_disagreement_score":0.0013323379,"about_ca_system_score_codex":0.00034652077,"about_ca_system_score_gemma":0.00020467036,"threshold_uncertainty_score":0.004457116},"labels":[],"label_agreement":null},{"id":"W3170458266","doi":"10.1093/neuonc/noab090.040","title":"EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Context (archaeology); BMI1; Biology; CRISPR; Cancer research; PI3K/AKT/mTOR pathway; Cancer; Gene; Signal transduction; Genetics","score_opus":0.022094467575562583,"score_gpt":0.2825927927255436,"score_spread":0.260498325149981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170458266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.929224,0.017453782,0.021560134,0.0008733976,0.00022850001,0.00087891065,0.0040119737,0.0010869117,0.024682317],"genre_scores_gemma":[0.9729398,0.0065970654,0.013306126,0.00022620228,0.000017550272,0.00025666592,0.0013865016,0.000068463596,0.0052016107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991906,0.000009658656,0.0000047297794,0.000018016905,0.000030554547,0.000017986331],"domain_scores_gemma":[0.9999608,0.000004079074,0.0000119632305,0.0000034608684,0.000006530837,0.000013177438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017970282,0.00033923532,0.00032075142,0.0003705473,0.00014811545,0.00029740814,0.00031149335,0.00025595835,0.0025157784],"category_scores_gemma":[0.00011639119,0.00017253832,0.00037655927,0.00021650092,0.00017725247,0.00019724069,0.00027918458,0.00062751665,0.00062104734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048147613,0.00023490126,0.0004368186,0.00039166008,0.000042331434,0.00021608401,0.00004673626,0.002870698,0.9651351,0.0010643237,0.0011001767,0.027979618],"study_design_scores_gemma":[0.00025137156,0.003627905,0.0031696158,0.00006720912,0.00014931784,0.0006951899,0.00005002142,0.0060217897,0.936045,0.0004590239,0.04942422,0.00003939676],"about_ca_topic_score_codex":0.00085445633,"about_ca_topic_score_gemma":0.0030508095,"teacher_disagreement_score":0.0025157784,"about_ca_system_score_codex":0.00040324082,"about_ca_system_score_gemma":0.0003842131,"threshold_uncertainty_score":0.008416176},"labels":[],"label_agreement":null},{"id":"W3170650872","doi":"10.1093/neuonc/noab132","title":"An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"National Institute for Health and Care Research","keywords":"Medicine; Asymptomatic; Radiosurgery; Meningioma; Cohort; Propensity score matching; Watchful waiting; Surgery; Radiology; Internal medicine; Radiation therapy; Cancer","score_opus":0.018594191007778794,"score_gpt":0.34521713418771127,"score_spread":0.32662294317993246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170650872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916303,0.00019625631,0.0001249125,0.000017630184,0.000006725687,0.000015157466,0.00029447235,0.0000026689402,0.00017928368],"genre_scores_gemma":[0.9991725,0.00007329458,0.00009234085,0.00002178549,0.000014999202,0.000016722961,0.0005460462,0.0000039460224,0.000058256086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851495,0.0005166237,0.0001367849,0.00045612847,0.00018969779,0.00018578226],"domain_scores_gemma":[0.99630934,0.0004676907,0.0016122471,0.0009185913,0.00026336155,0.00042878193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002308458,0.00052490697,0.0005845833,0.0010003204,0.0006412944,0.0009907556,0.0007450926,0.0005151073,0.0012179913],"category_scores_gemma":[0.0043683467,0.0005147122,0.0013266166,0.0014516236,0.000427575,0.00064318214,0.00088288897,0.00071042427,0.00026804395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012274196,0.0000716192,0.9962327,0.000011610091,0.0006108475,0.00012357374,0.00012342913,0.00003864657,0.00021577641,0.000039356597,0.00015531435,0.0011496568],"study_design_scores_gemma":[0.00013913712,0.00050369755,0.9972525,0.000008019382,0.0004659541,0.0004634042,0.00028156504,0.000320993,0.00009369855,0.000034185123,0.00042613185,0.000010682881],"about_ca_topic_score_codex":0.0044528586,"about_ca_topic_score_gemma":0.0042221686,"teacher_disagreement_score":0.0044528586,"about_ca_system_score_codex":0.0004189009,"about_ca_system_score_gemma":0.0004812858,"threshold_uncertainty_score":0.012208462},"labels":[],"label_agreement":null},{"id":"W3170737052","doi":"10.1093/neuonc/noab090.054","title":"EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Radiation therapy; Oncology; Internal medicine; Context (archaeology); Hazard ratio; Cohort; Lomustine; Population; Surgery; Vincristine; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.0323953465718085,"score_gpt":0.3235388786236317,"score_spread":0.2911435320518232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170737052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861377,0.002376998,0.0006590829,0.000325496,0.00006606555,0.00092131074,0.006420978,0.00003564693,0.0030567097],"genre_scores_gemma":[0.9806455,0.00072582776,0.0009412924,0.0002837418,0.00014749925,0.0015059954,0.011978769,0.000046371864,0.003725132],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99844366,0.00088917173,0.00008932151,0.0002285547,0.00018529658,0.00016404693],"domain_scores_gemma":[0.9975568,0.00059960806,0.0006812545,0.0005077713,0.00022137417,0.00043306578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045266654,0.0006852644,0.0010880412,0.00030866158,0.00038191545,0.0012569543,0.00070276787,0.00064709136,0.0030209278],"category_scores_gemma":[0.0030449776,0.00029500606,0.0011908835,0.0006361661,0.000494823,0.00064488023,0.0006186421,0.0008206535,0.00077334436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52011573,0.0042172545,0.39590898,0.0010319004,0.007666397,0.001214026,0.00029475536,0.0013903527,0.006428092,0.00074489234,0.010838134,0.050149526],"study_design_scores_gemma":[0.13305077,0.086553305,0.73988014,0.00030739792,0.008888654,0.0017672295,0.00027769312,0.0018739612,0.0062561184,0.00088852725,0.020162782,0.00009348322],"about_ca_topic_score_codex":0.00077262364,"about_ca_topic_score_gemma":0.0013169553,"teacher_disagreement_score":0.0045266654,"about_ca_system_score_codex":0.00048968487,"about_ca_system_score_gemma":0.0008203795,"threshold_uncertainty_score":0.02393955},"labels":[],"label_agreement":null},{"id":"W3170891449","doi":"10.1093/neuonc/noab090.121","title":"IMMU-14. COMPUTATIONAL DECONVOLUTION OF TUMOR-INFILTRATING IMMUNE COMPONENTS IN PEDIATRIC NERVOUS SYSTEM TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Cancer research; CD8; Medicine; T cell; Immune checkpoint; Immunology; Biology","score_opus":0.033518168114641644,"score_gpt":0.3120968245030121,"score_spread":0.2785786563883705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170891449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8156189,0.002765528,0.13463597,0.0012651038,0.00034740556,0.00020712648,0.027808918,0.009001064,0.008350092],"genre_scores_gemma":[0.8682836,0.0006429512,0.096609406,0.00056175096,0.00009208419,0.000449685,0.029082203,0.0009241035,0.0033541843],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998796,0.00003640458,0.0000046879563,0.000038485825,0.000018253146,0.00002260317],"domain_scores_gemma":[0.9996542,0.00024304997,0.000027767808,0.00001563446,0.00003339613,0.000025951053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050834107,0.00079174276,0.00053846557,0.0005986163,0.00038333106,0.0006804733,0.00076605624,0.0010237371,0.0029741628],"category_scores_gemma":[0.0013585867,0.00045121426,0.0014320395,0.000475725,0.00035235597,0.00020985269,0.00047020367,0.0007778736,0.0005923384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004554166,0.00013053286,0.020119656,0.00038187607,0.00034682814,0.00021708399,0.0001062145,0.94374156,0.005214122,0.0022330564,0.007772398,0.019281277],"study_design_scores_gemma":[0.00003197307,0.000037368623,0.0020893214,0.000011698739,0.000023730456,0.000033011107,0.00003203619,0.9939266,0.001040978,0.0010909725,0.001673039,0.00000923196],"about_ca_topic_score_codex":0.017380046,"about_ca_topic_score_gemma":0.016481781,"teacher_disagreement_score":0.017380046,"about_ca_system_score_codex":0.0006832399,"about_ca_system_score_gemma":0.0012158094,"threshold_uncertainty_score":0.03455782},"labels":[],"label_agreement":null},{"id":"W3171058716","doi":"10.1093/neuonc/noab090.049","title":"EMBR-32. INTEGRATED STRESS RESPONSE PLAYS A PRO-SURVIVAL ROLE IN MYC-DRIVEN MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Integrated stress response; Unfolded protein response; Gene knockdown; Apoptosis; Translation (biology); Cancer research; Programmed cell death; Initiation factor; Cell biology; Endoplasmic reticulum; Messenger RNA; Biology; Chemistry; Biochemistry; Gene","score_opus":0.015271436749753153,"score_gpt":0.31087881378433646,"score_spread":0.2956073770345833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171058716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889698,0.0030278836,0.002467941,0.00023993546,0.00008059996,0.000071233895,0.001689281,0.00020359253,0.0032497204],"genre_scores_gemma":[0.9939029,0.00068519375,0.00070683693,0.000047790407,0.000005094582,0.000041826894,0.0011049685,0.000022603997,0.0034828065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.0000109894845,0.000006433075,0.000017664344,0.00002981221,0.000024865101],"domain_scores_gemma":[0.99994385,0.000005011686,0.000013647647,0.0000049484065,0.0000054273137,0.000027060563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010936843,0.00024036563,0.00015555785,0.00021872619,0.00018175348,0.00022090187,0.00014653409,0.00020078638,0.00320145],"category_scores_gemma":[0.000073049894,0.00011337883,0.0002262216,0.000114125876,0.0001674928,0.00014222502,0.00017224197,0.00049780076,0.000700436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020331374,0.000045801753,0.0005961738,0.000053773812,0.000005739638,0.00015950581,0.000015093461,0.00009070668,0.9968359,0.00017535199,0.00019111621,0.0016276349],"study_design_scores_gemma":[0.00008703726,0.0009070936,0.027334685,0.000027859613,0.00004387064,0.0016862247,0.00012024678,0.0030928026,0.9479179,0.0003114232,0.018460575,0.000010284501],"about_ca_topic_score_codex":0.0011162843,"about_ca_topic_score_gemma":0.0017240207,"teacher_disagreement_score":0.00320145,"about_ca_system_score_codex":0.0004446912,"about_ca_system_score_gemma":0.00023947831,"threshold_uncertainty_score":0.010709941},"labels":[],"label_agreement":null},{"id":"W3171192879","doi":"10.1093/neuonc/noab090.021","title":"EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; Proportional hazards model; Oncology; Cohort; Clinical trial; Survival analysis; Log-rank test; Wilcoxon signed-rank test; Internal medicine; Pediatrics; Mann–Whitney U test; Pathology","score_opus":0.031917764932091065,"score_gpt":0.322704676709906,"score_spread":0.2907869117778149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171192879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.922127,0.057687398,0.002195011,0.00039061604,0.000097805365,0.0004558699,0.013288742,0.00005958066,0.0036979413],"genre_scores_gemma":[0.9853247,0.005557421,0.0009532145,0.00027359763,0.00010442493,0.0005051165,0.00674076,0.000033660097,0.0005070862],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98352134,0.008604791,0.0024402852,0.0024032344,0.0026328538,0.00039743286],"domain_scores_gemma":[0.97390884,0.00899637,0.011350672,0.0023759764,0.0026122532,0.0007558921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018663011,0.0007251757,0.0023383186,0.005692753,0.00050404255,0.0021231389,0.0012948212,0.0008467025,0.002224407],"category_scores_gemma":[0.02309566,0.0004913239,0.0048253164,0.007470519,0.00065149204,0.0011470633,0.0022208137,0.0007012041,0.0003824749],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042647882,0.00009980951,0.9093866,0.005050978,0.060160205,0.00024194652,0.0007038206,0.00048262827,0.0005409385,0.0001928589,0.001664753,0.017210804],"study_design_scores_gemma":[0.00037711265,0.00093681476,0.9623378,0.00085780234,0.03002322,0.00064212614,0.0004934749,0.00052270095,0.00016037407,0.000146116,0.0034599614,0.00004242452],"about_ca_topic_score_codex":0.0062965755,"about_ca_topic_score_gemma":0.009305448,"teacher_disagreement_score":0.018663011,"about_ca_system_score_codex":0.0010307668,"about_ca_system_score_gemma":0.00127102,"threshold_uncertainty_score":0.09870058},"labels":[],"label_agreement":null},{"id":"W3171268121","doi":"10.1093/neuonc/noab090.039","title":"EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Biomarker; Immunohistochemistry; Risk stratification; Receiver operating characteristic; Multivariate analysis; Medicine; Bioinformatics; Biology; Pathology; Genetics","score_opus":0.02222417297214018,"score_gpt":0.3545420029800312,"score_spread":0.332317830007891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171268121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988084,0.00023882279,0.0005222913,0.000015032565,0.000004637694,0.000022393011,0.00030731293,0.000008969578,0.00007215948],"genre_scores_gemma":[0.99853265,0.00006138073,0.0005000319,0.000017384804,0.0000057494403,0.0000267503,0.00073333265,0.000010315992,0.000112537615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999243,0.00021825885,0.000055052755,0.00029280447,0.00010741484,0.00008343829],"domain_scores_gemma":[0.9983949,0.00037026507,0.0004601787,0.0003301092,0.00020477954,0.0002397433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023676057,0.00041250544,0.000517058,0.0009824262,0.0004410513,0.00070048013,0.00039574038,0.0004240371,0.0012142163],"category_scores_gemma":[0.002592,0.00021372325,0.0008375887,0.00044435877,0.00048714565,0.0003238765,0.0007280331,0.0004542895,0.00031977196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028244534,0.00030190015,0.9593705,0.0000907356,0.00080567837,0.0005093535,0.0003512817,0.00079703424,0.023645993,0.000105814324,0.00035894717,0.0108382385],"study_design_scores_gemma":[0.00010541136,0.001704102,0.9789225,0.00002486573,0.0007637743,0.0021377266,0.0004884488,0.005868257,0.0074193818,0.0005291222,0.0020014131,0.000034930257],"about_ca_topic_score_codex":0.0014111479,"about_ca_topic_score_gemma":0.0012784055,"teacher_disagreement_score":0.0023676057,"about_ca_system_score_codex":0.00052912533,"about_ca_system_score_gemma":0.00039100306,"threshold_uncertainty_score":0.012521207},"labels":[],"label_agreement":null},{"id":"W3171734833","doi":"10.1093/neuonc/noab090.003","title":"ATRT-04. CORRELATION OF CLINICOPATHOLOGIC FEATURES AND CUMULATIVE INCIDENCE OF RELAPSE FOR PATIENTS WITH ATYPICAL TERATOID RHABDOID TUMOR ON ACNS0333: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Cumulative incidence; Internal medicine; Incidence (geometry); Relapse prevention; Chemotherapy; Cohort; Oncology; Radiation therapy; Immunohistochemistry","score_opus":0.0104755144788739,"score_gpt":0.2859926181670484,"score_spread":0.2755171036881745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171734833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989083,0.00028496215,0.00006002844,0.00003809382,0.0000028727165,0.0000052862188,0.00027161214,0.0000059909507,0.00042282738],"genre_scores_gemma":[0.99946827,0.000079959194,0.00004548848,0.000013751306,0.0000058089195,0.000004450639,0.00029878924,0.0000025895936,0.00008079825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972934,0.000061755854,0.000031880147,0.000059395807,0.00007845423,0.0000391835],"domain_scores_gemma":[0.99877626,0.00034852832,0.00046515997,0.000080466656,0.00012141809,0.00020811099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047281678,0.00012995473,0.00018706433,0.0004109504,0.00016895117,0.00024634064,0.00018492046,0.00019517085,0.0007999467],"category_scores_gemma":[0.0014420211,0.00009825462,0.00024487684,0.00032830556,0.00018702813,0.0001305138,0.00013269098,0.00027050727,0.00016619528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019785325,0.000015739668,0.99420494,0.000008250861,0.00003794043,0.00030019807,0.00003698993,0.00009193409,0.00057637173,0.000011721921,0.00025564784,0.0042624553],"study_design_scores_gemma":[0.000018018503,0.00018073156,0.9964141,0.000004903529,0.000037432965,0.0021832325,0.000056703662,0.00027266005,0.00033662101,0.000012803381,0.0004791082,0.0000036635172],"about_ca_topic_score_codex":0.0019536503,"about_ca_topic_score_gemma":0.0026407118,"teacher_disagreement_score":0.0019536503,"about_ca_system_score_codex":0.00034092774,"about_ca_system_score_gemma":0.00022958987,"threshold_uncertainty_score":0.003884554},"labels":[],"label_agreement":null},{"id":"W3171770674","doi":"10.1093/neuonc/noab090.162","title":"RARE-01. ASSESSING THE SYMPTOM DIAGNOSTIC INTERVAL FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMOURS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Ependymoma; Vomiting; Nausea; Glioma; Retrospective cohort study; Pediatrics; Internal medicine; Surgery; Pathology","score_opus":0.015588288604384312,"score_gpt":0.28959555575805573,"score_spread":0.2740072671536714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171770674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858118,0.0015815417,0.00028135648,0.00031396773,0.000032454253,0.000054568518,0.00856138,0.000041780044,0.0033211277],"genre_scores_gemma":[0.9939931,0.00053275866,0.0010254473,0.00010240513,0.000025848081,0.00006276082,0.003851768,0.000017559749,0.0003884374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902654,0.00017140467,0.00021889605,0.000169452,0.00020802858,0.00020564166],"domain_scores_gemma":[0.99013525,0.0017160068,0.0058675394,0.00017726218,0.0012470643,0.00085695053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011888332,0.00022505643,0.0002276807,0.0016781833,0.00038968484,0.0006859694,0.00066418963,0.00028919452,0.0037158998],"category_scores_gemma":[0.00588021,0.0001711247,0.00031390064,0.0017774277,0.00044753787,0.00046612593,0.00056922226,0.0005108361,0.00062518456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027317932,0.0000064014225,0.9971029,0.000032075222,0.0000067021356,0.00010230766,0.000078166595,0.000026189198,0.00003773086,0.00002407674,0.00049963157,0.0020563942],"study_design_scores_gemma":[0.0000061520614,0.000044293454,0.9956007,0.000081372775,0.000014956548,0.0016546638,0.00062929466,0.00015160578,0.00012569796,0.00003030442,0.0016546332,0.0000063683524],"about_ca_topic_score_codex":0.04138801,"about_ca_topic_score_gemma":0.053091615,"teacher_disagreement_score":0.04138801,"about_ca_system_score_codex":0.0017850235,"about_ca_system_score_gemma":0.0020804757,"threshold_uncertainty_score":0.082294226},"labels":[],"label_agreement":null},{"id":"W3174246647","doi":"10.1093/neuonc/noab106","title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11779,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Brain Tumour Charity; World Health Organization","keywords":"Grading (engineering); Nomenclature; Central nervous system; Medical diagnosis; Brain tumor; Classification scheme; Pathology; Biology; Taxonomy (biology); Computer science; Medicine; Neuroscience; Bioinformatics; Information retrieval; Zoology","score_opus":0.04515445518274325,"score_gpt":0.3309438238166508,"score_spread":0.2857893686339075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174246647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005887636,0.97076786,0.002327031,0.0062612207,0.005433567,0.0001716671,0.0024447714,0.00011738115,0.011887767],"genre_scores_gemma":[0.0019717347,0.9820727,0.0036147109,0.0019977929,0.0014371849,0.000108219356,0.004824533,0.00002823356,0.0039448966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999116,0.00014863772,0.00018699758,0.00009434824,0.0003594977,0.00009458302],"domain_scores_gemma":[0.99822956,0.000344266,0.000248691,0.000044128556,0.0010124558,0.00012093883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001648782,0.0013176234,0.0012349719,0.00756226,0.00048577847,0.0014389436,0.0013370787,0.0010438642,0.005127308],"category_scores_gemma":[0.0027738567,0.0003166684,0.0012258097,0.005558105,0.0007112337,0.0016516808,0.00082677626,0.0021308416,0.0048953122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008145533,0.000029773548,0.0011026462,0.013544419,0.00011161498,0.0003090739,0.00013223207,0.00041286284,0.001098514,0.006338689,0.29092965,0.68590903],"study_design_scores_gemma":[0.000007278722,0.00003823705,0.0013249656,0.0039304164,0.00006564502,0.0009830799,0.000055899116,0.00005715606,0.00017246735,0.0014268561,0.99191684,0.000021130467],"about_ca_topic_score_codex":0.009703637,"about_ca_topic_score_gemma":0.010977326,"teacher_disagreement_score":0.009703637,"about_ca_system_score_codex":0.0023945884,"about_ca_system_score_gemma":0.007089729,"threshold_uncertainty_score":0.019294322},"labels":[],"label_agreement":null},{"id":"W3176243936","doi":"10.1093/neuonc/noab159","title":"The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Deutsche Forschungsgemeinschaft; Wellcome Trust; Francis Crick Institute; Fonds de recherche du Québec; Deutsche Krebshilfe; Cancer Research UK","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Brain metastasis; Melanoma; Metastasis; Cancer research; Medicine; Neuroscience; Internal medicine; Psychology; Cancer; Biology; Signal transduction; Cell biology","score_opus":0.019167413576155305,"score_gpt":0.30761217040208505,"score_spread":0.28844475682592974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176243936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573372,0.031902734,0.0047792164,0.0006049258,0.0000836635,0.00012717597,0.0003294135,0.00032100815,0.0045145648],"genre_scores_gemma":[0.98732066,0.008682382,0.0025727244,0.000087542845,0.000025291256,0.00005697369,0.00017157377,0.000011709796,0.0010711213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999616,0.0000057428506,0.000002801833,0.000006846666,0.000009856229,0.000013044784],"domain_scores_gemma":[0.99997115,0.0000036864046,0.000008540664,0.0000023218665,0.000005511155,0.000008784203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114682894,0.00039246862,0.00021051742,0.00023587636,0.00012957683,0.00020829757,0.00017341082,0.00025177927,0.00097184785],"category_scores_gemma":[0.00005719959,0.00008183352,0.00020668737,0.0001234977,0.00016563003,0.00016855163,0.00012712422,0.00052847055,0.00022819448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008045464,0.00022117663,0.0012227478,0.0004807498,0.000027437254,0.00016986624,0.000017957103,0.00039809328,0.97050405,0.00040936752,0.0003920063,0.025352117],"study_design_scores_gemma":[0.00016582264,0.0034397282,0.014810929,0.000055062003,0.00014140815,0.0011705725,0.000040767864,0.0025116797,0.9669317,0.00041068593,0.010308842,0.000012803038],"about_ca_topic_score_codex":0.00029346655,"about_ca_topic_score_gemma":0.00061788724,"teacher_disagreement_score":0.00097184785,"about_ca_system_score_codex":0.00023546649,"about_ca_system_score_gemma":0.0003214914,"threshold_uncertainty_score":0.003251195},"labels":[],"label_agreement":null},{"id":"W31786602","doi":"10.1093/neuonc/noz203","title":"Salvation in the Tribulation: Revisited","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Historical and Linguistic Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uncle Kory Foundation; Fondation Brain Canada; Musella Foundation For Brain Tumor Research and Information; National Brain Tumor Society","keywords":"Computer science","score_opus":0.04593678078568604,"score_gpt":0.3614538914035087,"score_spread":0.31551711061782267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31786602","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22286579,0.07331077,0.0032012414,0.45992056,0.007060846,0.000025127261,0.00008710801,0.00005858958,0.23346996],"genre_scores_gemma":[0.968715,0.010001531,0.00028691892,0.014030532,0.0014888061,0.000015505866,0.000018008679,0.000035188936,0.005408507],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930443,0.0047764657,0.00020180967,0.00054776,0.0005802213,0.0008494098],"domain_scores_gemma":[0.99210525,0.0055146315,0.0007750532,0.0003598084,0.0007070363,0.0005382858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006430558,0.00045704507,0.00060774514,0.0017412704,0.012591314,0.00810123,0.0017942803,0.0056798905,0.0054487656],"category_scores_gemma":[0.011373804,0.00024150066,0.00036660425,0.002259512,0.055591997,0.012638122,0.007208815,0.012476926,0.00042808295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021568898,0.000012360183,0.00080811745,0.00020011296,0.00001125564,0.0005252642,0.32370406,0.000050607337,0.00012139479,0.6520927,0.011329245,0.011123194],"study_design_scores_gemma":[0.000012209409,0.000041585234,0.00282428,0.0009424723,0.000018049464,0.0013615211,0.48292384,0.00016977222,0.00037659885,0.09775964,0.41353074,0.000039457507],"about_ca_topic_score_codex":0.020490522,"about_ca_topic_score_gemma":0.029401343,"teacher_disagreement_score":0.020490522,"about_ca_system_score_codex":0.008505132,"about_ca_system_score_gemma":0.0050493367,"threshold_uncertainty_score":0.061709344},"labels":[],"label_agreement":null},{"id":"W3182039670","doi":"10.1093/neuonc/noab178","title":"Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Brain Tumour Charity; CHILDREN with CANCER UK; Canadian Institutes of Health Research; National Institute for Health and Care Research; Action Medical Research; Cancer Research UK; C.R. Younger Foundation; Academy of Medical Sciences; JGW Patterson Foundation","keywords":"Medulloblastoma; Biology; Oncology; Wnt signaling pathway; Disease; Mutation; Genetic divergence; Internal medicine; Gene; Cohort; Genetics; Bioinformatics; Medicine; Genetic diversity","score_opus":0.013510534655763868,"score_gpt":0.2713937264407502,"score_spread":0.25788319178498637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182039670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930716,0.00019314037,0.0001181122,0.000012125535,7.014473e-7,0.0000034048587,0.00017333328,0.000014230287,0.0001777715],"genre_scores_gemma":[0.99941754,0.00008535533,0.000098378485,0.0000067457872,0.0000019588606,0.0000036634399,0.00029877608,0.00000457084,0.00008309437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998153,0.000020577643,0.00001245201,0.000055622884,0.000048812628,0.000047279926],"domain_scores_gemma":[0.9996112,0.00003690348,0.00019638836,0.000032467848,0.00004023393,0.00008277967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023411015,0.00015762012,0.00028915066,0.0004808552,0.00020783275,0.0004657564,0.00023210628,0.00020828744,0.00092024956],"category_scores_gemma":[0.000599763,0.0001147273,0.00019469726,0.00038376474,0.00023846007,0.0002818255,0.00045542352,0.00026351,0.00022620476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006963691,0.00003833105,0.8966219,0.000043297918,0.00006973965,0.00056269433,0.00028900383,0.00025404658,0.08734645,0.00015840062,0.00016122469,0.013758502],"study_design_scores_gemma":[0.0000041732915,0.0001228211,0.99342996,0.0000048596658,0.0000307801,0.0013282249,0.00014112025,0.00027709774,0.004189833,0.00009120651,0.00037598435,0.000003981594],"about_ca_topic_score_codex":0.0017472384,"about_ca_topic_score_gemma":0.002124578,"teacher_disagreement_score":0.0017472384,"about_ca_system_score_codex":0.0004484043,"about_ca_system_score_gemma":0.00024623825,"threshold_uncertainty_score":0.003474176},"labels":[],"label_agreement":null},{"id":"W3182741432","doi":"10.1093/neuonc/noab164","title":"Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Selumetinib; Medicine; Internal medicine; Cancer research; Cancer","score_opus":0.041005595553394725,"score_gpt":0.2994889941255563,"score_spread":0.25848339857216157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182741432","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002696893,0.013954239,0.00038937927,0.94769055,0.024770172,0.00003862349,0.000096612566,0.00008732472,0.0102761835],"genre_scores_gemma":[0.026221631,0.020954942,0.001071395,0.82418185,0.10331938,0.000069779824,0.000119818964,0.00007149669,0.02398966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994697,0.0001295344,0.00006165556,0.00006267047,0.00018871765,0.00008780908],"domain_scores_gemma":[0.99927574,0.00030641028,0.000059340782,0.000022477685,0.00013228608,0.00020375151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006095367,0.0005480886,0.0006555923,0.0005320563,0.0011565385,0.001360628,0.00085959287,0.010708604,0.0041250847],"category_scores_gemma":[0.0032668079,0.0002462986,0.00074938004,0.00037566572,0.0010591046,0.0025629995,0.00040188024,0.009350098,0.00469837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014478542,0.00007995063,0.001475082,0.00016092448,0.000030008236,0.02534182,0.00010361043,0.00025564784,0.0006701549,0.0028188797,0.92142063,0.04749864],"study_design_scores_gemma":[0.00024822555,0.000322536,0.0022667309,0.0005757343,0.000059157777,0.080334604,0.0003269208,0.0013158476,0.0010533534,0.0124977995,0.90092915,0.00006985755],"about_ca_topic_score_codex":0.0021466848,"about_ca_topic_score_gemma":0.004383745,"teacher_disagreement_score":0.010708604,"about_ca_system_score_codex":0.0021794557,"about_ca_system_score_gemma":0.0010108097,"threshold_uncertainty_score":0.015813172},"labels":[],"label_agreement":null},{"id":"W3186420077","doi":"10.1093/neuonc/noab172","title":"SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Mentorship; Diversity (politics); Ethnic group; Oncology; Clinical Oncology; Medicine; Internal medicine; Medical education; Psychology; Political science; Cancer","score_opus":0.062953334179413,"score_gpt":0.34059270574443024,"score_spread":0.2776393715650172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186420077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686882,0.0003485912,0.00064310496,0.0020821872,0.00005558104,0.0006190658,0.016642224,0.000040588333,0.010880549],"genre_scores_gemma":[0.97293705,0.0006197225,0.0036183014,0.0010515803,0.000058295234,0.0017343127,0.017040297,0.000029878085,0.002910505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985227,0.00044546885,0.00024342355,0.000099567165,0.00045953106,0.00022932695],"domain_scores_gemma":[0.9933863,0.0006774547,0.0025078645,0.0001884713,0.0018862422,0.0013536289],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046877232,0.00020839869,0.00022753465,0.0021955005,0.00095632585,0.00091216434,0.00069267175,0.00051200774,0.0024537249],"category_scores_gemma":[0.0072360234,0.00017969667,0.00030224348,0.0018540449,0.00035913955,0.0012137191,0.0021879256,0.00066142535,0.0010597258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058948357,0.00009619399,0.98244804,0.00007072737,0.0000152001685,0.00003006406,0.0009806183,0.000064876345,0.000112776754,0.00013239206,0.0081145,0.007875722],"study_design_scores_gemma":[0.000011406411,0.00013725072,0.98475504,0.000108886576,0.0000071707404,0.00009896571,0.0034942736,0.00025148827,0.00011839563,0.00014851116,0.01085698,0.000011582789],"about_ca_topic_score_codex":0.013457655,"about_ca_topic_score_gemma":0.0334934,"teacher_disagreement_score":0.9953123,"about_ca_system_score_codex":0.0012084,"about_ca_system_score_gemma":0.0025341553,"threshold_uncertainty_score":0.02675867},"labels":[],"label_agreement":null},{"id":"W3197841440","doi":"10.1093/neuonc/noab205","title":"Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Transcriptome; Computational biology; Genome; Pituitary tumors; Biology; Bioinformatics; Genetics; Gene; Endocrinology; Gene expression","score_opus":0.04060059740498982,"score_gpt":0.296075306838956,"score_spread":0.25547470943396616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197841440","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00200386,0.04734311,0.012289263,0.89780504,0.03460577,0.00005353231,0.0010563852,0.00047853822,0.0043645115],"genre_scores_gemma":[0.027216028,0.06335961,0.02847458,0.7613327,0.10726873,0.0002612621,0.0016343183,0.00043064114,0.010022184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748236,0.0008542131,0.00022680678,0.00031976646,0.0008695487,0.00024737674],"domain_scores_gemma":[0.97597516,0.015272272,0.0006460183,0.0021620793,0.0034093198,0.002535114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065086093,0.0006487967,0.0022930773,0.0007440864,0.001167915,0.003656164,0.0016687623,0.010378907,0.004921109],"category_scores_gemma":[0.015729578,0.00042791976,0.001186701,0.0006210032,0.002326373,0.004115341,0.0022184344,0.020684103,0.0042286813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004975406,0.00012599198,0.0035295703,0.0007740832,0.00020718672,0.0028014444,0.00036198297,0.00038904123,0.016910993,0.014445738,0.7802085,0.1797479],"study_design_scores_gemma":[0.00012064646,0.00012580327,0.0030085705,0.0003407301,0.000078488934,0.0022663937,0.00065154873,0.0009174313,0.0026760935,0.07216028,0.9175632,0.00009072831],"about_ca_topic_score_codex":0.0014601084,"about_ca_topic_score_gemma":0.0032996864,"teacher_disagreement_score":0.010378907,"about_ca_system_score_codex":0.0013782812,"about_ca_system_score_gemma":0.0020108875,"threshold_uncertainty_score":0.034421206},"labels":[],"label_agreement":null},{"id":"W3198752233","doi":"10.1093/neuonc/noab210","title":"The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Glioma; Multivariate analysis; Univariate analysis; Surgery; Surgical resection; Radiological weapon; Multicenter study; Radiology; Internal medicine; Randomized controlled trial","score_opus":0.02317050830082183,"score_gpt":0.2951102802211432,"score_spread":0.27193977192032137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198752233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99975413,0.00010809174,0.000020646106,0.0000130599765,0.0000016229232,0.0000019169013,0.000049373266,9.67555e-7,0.00005010064],"genre_scores_gemma":[0.9997327,0.000053263564,0.000033631954,0.0000093278895,0.00000838559,0.0000030109486,0.00014404525,9.728702e-7,0.000014702719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996736,0.00010630047,0.00003479983,0.00007958554,0.000039150236,0.000066511486],"domain_scores_gemma":[0.99871063,0.00024126317,0.00055730535,0.00009581943,0.00009006254,0.00030494915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006432701,0.00025814495,0.0003562063,0.00051802763,0.000297146,0.00043909266,0.00023052718,0.00027254486,0.00084664475],"category_scores_gemma":[0.0017415375,0.00013907239,0.00046261106,0.00044762337,0.0002504001,0.00030922415,0.0003317584,0.00023795542,0.00016254488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000356851,0.000024865667,0.99825794,0.000004828214,0.000038044236,0.0000916619,0.000020454916,0.000024114886,0.00015730417,0.000004032147,0.000028923763,0.0009910221],"study_design_scores_gemma":[0.000037370904,0.0005006981,0.9979814,0.00000618045,0.000084889856,0.0007838072,0.000116319854,0.00018795618,0.00010028527,0.000022292215,0.0001736511,0.0000049836326],"about_ca_topic_score_codex":0.00083594176,"about_ca_topic_score_gemma":0.0012154435,"teacher_disagreement_score":0.00084664475,"about_ca_system_score_codex":0.00021305121,"about_ca_system_score_gemma":0.00028181393,"threshold_uncertainty_score":0.0034019947},"labels":[],"label_agreement":null},{"id":"W3199027842","doi":"10.1093/neuonc/noab180.043","title":"OS10.5.A BrainWear: Longitudinal, objective assessment of physical activity in 42 HGG patients","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biobank; Medicine; Accelerometer; Physical activity; Longitudinal study; Quality of life (healthcare); Physical therapy; Physical medicine and rehabilitation; Computer science; Pathology; Bioinformatics","score_opus":0.023590876452461048,"score_gpt":0.36074223704773156,"score_spread":0.3371513605952705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199027842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865484,0.00011697746,0.00009191845,0.000020641804,0.0000032974954,0.00004673401,0.00079365686,0.000006345768,0.00026552656],"genre_scores_gemma":[0.9966904,0.00009557273,0.00021663429,0.00009568764,0.000009504794,0.00010595859,0.0023094472,0.0000057775364,0.00047095446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959177,0.00006962512,0.000045113167,0.00013539274,0.00006615112,0.000091878086],"domain_scores_gemma":[0.9996182,0.00004741608,0.000115777926,0.000035878475,0.00006922434,0.00011348434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005628475,0.00030688843,0.00034682662,0.0005006257,0.00054240465,0.00068334216,0.00017492354,0.00034790224,0.001019413],"category_scores_gemma":[0.0009629453,0.00021195851,0.00032963033,0.00066084345,0.00026805032,0.00029063455,0.0006213952,0.00038564773,0.00054216536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011017002,0.000372221,0.9876704,0.000036193673,0.000043119155,0.00033275175,0.00045965638,0.000104042854,0.00076091546,0.00001195101,0.00036189976,0.008745093],"study_design_scores_gemma":[0.0000769397,0.0020070856,0.9955657,0.000012024827,0.0000433017,0.00044254676,0.0003844583,0.00017190399,0.00019085377,0.000024912672,0.0010680049,0.000012319689],"about_ca_topic_score_codex":0.0055807563,"about_ca_topic_score_gemma":0.0053593754,"teacher_disagreement_score":0.0055807563,"about_ca_system_score_codex":0.00039197525,"about_ca_system_score_gemma":0.00038799137,"threshold_uncertainty_score":0.011096537},"labels":[],"label_agreement":null},{"id":"W3199163722","doi":"10.1093/neuonc/noab214","title":"Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Toronto Western Hospital; St. Michael's Hospital; Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pipeline (software); Computer science","score_opus":0.21680980812596296,"score_gpt":0.48633851246172133,"score_spread":0.2695287043357584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199163722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031005303,0.99795806,0.0001360343,0.00067367166,0.00020848577,0.00010275431,0.00013039778,0.0000046678,0.00047582082],"genre_scores_gemma":[0.0019201738,0.99630666,0.0005127277,0.00069006206,0.00013064491,0.0001810291,0.00016229031,0.000004377352,0.00009207169],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9826885,0.005893783,0.007291627,0.0009964395,0.0027895644,0.00034014977],"domain_scores_gemma":[0.8953543,0.08008812,0.0116398055,0.0015392826,0.010805102,0.00057347026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026009727,0.00126653,0.004435902,0.019728627,0.0009905442,0.004687472,0.0018980617,0.0027257344,0.003938966],"category_scores_gemma":[0.078227706,0.0011304106,0.0051966575,0.023490299,0.0017821972,0.0045995535,0.002107321,0.0025559987,0.00067914126],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002671018,0.000048507845,0.00083788345,0.7198105,0.0020841358,0.00022834896,0.0009970872,0.000277847,0.00058248814,0.0017987256,0.007223665,0.26584366],"study_design_scores_gemma":[0.000059133876,0.00015156691,0.0022931069,0.86703867,0.007570227,0.00041400717,0.0006605212,0.00007856854,0.0002843753,0.0007889613,0.12062319,0.000037700505],"about_ca_topic_score_codex":0.006910848,"about_ca_topic_score_gemma":0.018815497,"teacher_disagreement_score":0.026009727,"about_ca_system_score_codex":0.0045228614,"about_ca_system_score_gemma":0.022472776,"threshold_uncertainty_score":0.13755423},"labels":[],"label_agreement":null},{"id":"W3200062275","doi":"10.1093/neuonc/noab180.013","title":"JS01.4.A The neurocognitive function changes with awake craniotomy for low-grade glioma in the left hemispheric eloquent regions","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Medicine; Perioperative; Cognition; Craniotomy; Glioma; Awake craniotomy; Effects of sleep deprivation on cognitive performance; Brain tumor; Anesthesia; Psychiatry","score_opus":0.02718965427623115,"score_gpt":0.2911649513503074,"score_spread":0.26397529707407624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200062275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998635,0.00010930017,0.00007470853,0.000042155083,0.000010660792,0.000011029928,0.00030040366,0.0000056770486,0.00081099215],"genre_scores_gemma":[0.9986859,0.000063985404,0.00010303343,0.00003882777,0.000014768903,0.000013453576,0.0005331863,0.0000028403251,0.0005440515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991643,0.000008707359,0.000011816804,0.000016141845,0.000018861258,0.000028074102],"domain_scores_gemma":[0.9997725,0.000016134121,0.00008812826,0.000012457344,0.00004104008,0.000069858615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019206242,0.00014802381,0.00015572793,0.00025822938,0.00025601423,0.00022997502,0.00010999408,0.00012817381,0.0037472432],"category_scores_gemma":[0.00039782966,0.000066866836,0.00020507844,0.00033106582,0.000152164,0.00013749395,0.0001637797,0.0001537363,0.00050057704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004102206,0.0000846358,0.9780919,0.0000641414,0.000037248792,0.0025111784,0.0001443688,0.000099389435,0.0052758106,0.000042872074,0.00059741497,0.01264074],"study_design_scores_gemma":[0.000015820886,0.00031500202,0.99496835,0.0000075386683,0.0000288218,0.0028829994,0.00013202133,0.00020414623,0.0005477081,0.00003213799,0.0008614958,0.0000040751147],"about_ca_topic_score_codex":0.003519214,"about_ca_topic_score_gemma":0.0040215384,"teacher_disagreement_score":0.0037472432,"about_ca_system_score_codex":0.00025639872,"about_ca_system_score_gemma":0.00052762625,"threshold_uncertainty_score":0.0125358105},"labels":[],"label_agreement":null},{"id":"W3200402883","doi":"10.1093/neuonc/noab227","title":"Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Center for Cancer Research","keywords":"Classifier (UML); Confidence interval; Medicine; Methylation; Oncology; DNA methylation; Brain tumor; Artificial intelligence; Internal medicine; Pathology; Computer science; Biology","score_opus":0.04601508791301511,"score_gpt":0.3890986404856309,"score_spread":0.3430835525726158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200402883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599853,0.0031304983,0.030018212,0.00092438527,0.00010565861,0.00039633238,0.0008782714,0.0004947896,0.004066457],"genre_scores_gemma":[0.95130765,0.0003720412,0.046697788,0.00019550562,0.0000677792,0.00013808324,0.0006249477,0.00006272354,0.00053345505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9782405,0.010872147,0.0018115587,0.0029462804,0.005283044,0.00084655324],"domain_scores_gemma":[0.94853735,0.034260552,0.00568463,0.0027895772,0.0069475067,0.001780447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027155172,0.00093363936,0.0010203919,0.0028841756,0.0008465536,0.002191103,0.0011410486,0.0011510206,0.001470301],"category_scores_gemma":[0.057342645,0.0003698413,0.00064300897,0.0016012928,0.0005701668,0.00096220843,0.0018931237,0.0010640296,0.00061567023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018813356,0.00027940446,0.8128089,0.00026839663,0.00042178683,0.00035404615,0.000675901,0.002583824,0.012021864,0.00023213711,0.0009735002,0.16749892],"study_design_scores_gemma":[0.00009847278,0.0026962224,0.8644336,0.00036123185,0.0007712065,0.0032171535,0.00088763464,0.080140404,0.041412987,0.0010496263,0.0047882083,0.00014320438],"about_ca_topic_score_codex":0.0048834006,"about_ca_topic_score_gemma":0.011793526,"teacher_disagreement_score":0.027155172,"about_ca_system_score_codex":0.0012982362,"about_ca_system_score_gemma":0.0020356101,"threshold_uncertainty_score":0.14361203},"labels":[],"label_agreement":null},{"id":"W3200623012","doi":"10.1093/neuonc/noab180.181","title":"P14.76 Bevacizumab (BEV) alone or in combination with chemotherapy in recurrent Glioblastoma Multiforme (GBM): A real world experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Chemotherapy; Internal medicine; Cohort; Glioblastoma; Oncology; Retrospective cohort study; Surgery; Population","score_opus":0.022970938212678243,"score_gpt":0.3236547406914029,"score_spread":0.3006838024787246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200623012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997962,0.0012933899,0.000093007046,0.00006301742,0.000007426268,0.000028402172,0.00005583428,0.000004666866,0.0004922602],"genre_scores_gemma":[0.99755293,0.001697979,0.00022471172,0.00008543301,0.000024564895,0.000021821337,0.0001763993,0.000002833663,0.00021331538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968076,0.00013580272,0.000025732748,0.000048368598,0.00005287919,0.00005640546],"domain_scores_gemma":[0.99968827,0.00006609608,0.00007878164,0.000021090971,0.00002805421,0.00011777542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006757099,0.00021816528,0.0002854227,0.00020517546,0.0002822802,0.00047588834,0.00020317496,0.0002424609,0.0004821557],"category_scores_gemma":[0.00090540556,0.000102255675,0.00027228697,0.00032168638,0.00028833802,0.00023706206,0.00034121162,0.00031275177,0.0001946735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015542109,0.008664029,0.66750216,0.00040080535,0.0006628671,0.010714684,0.0013397161,0.0015033778,0.018633272,0.00029729347,0.002854732,0.27188495],"study_design_scores_gemma":[0.0035532156,0.08738416,0.84050417,0.00017521785,0.0007327309,0.035804965,0.001308814,0.002724067,0.009049503,0.00028601495,0.018395117,0.000081948805],"about_ca_topic_score_codex":0.0027652504,"about_ca_topic_score_gemma":0.0032989571,"teacher_disagreement_score":0.0027652504,"about_ca_system_score_codex":0.0007415946,"about_ca_system_score_gemma":0.0005046454,"threshold_uncertainty_score":0.00549829},"labels":[],"label_agreement":null},{"id":"W3200626583","doi":"10.1093/neuonc/noab213","title":"A molecularly integrated grade for meningioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; Brain Tumour Charity; Brain Science Foundation","keywords":"Meningioma; Grading (engineering); Medicine; CDKN2A; Cohort; Proportional hazards model; Oncology; Radiosurgery; Radiology; Internal medicine; Radiation therapy; Cancer; Biology","score_opus":0.039975119889256755,"score_gpt":0.32312395743146904,"score_spread":0.2831488375422123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200626583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80928516,0.0020496713,0.17463644,0.00139495,0.0003019206,0.00063911435,0.0049021244,0.0013288344,0.0054616793],"genre_scores_gemma":[0.9233448,0.00028050004,0.073297516,0.00015162452,0.000053178483,0.000099676006,0.0017567555,0.0000660382,0.00094995607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993912,0.00012456745,0.000066300905,0.00014286891,0.00019299457,0.00008201901],"domain_scores_gemma":[0.99823207,0.00030378473,0.0005641745,0.00021650658,0.0005016097,0.0001819571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018117463,0.0009193487,0.00044036462,0.0015608543,0.0003388263,0.0012164413,0.0007582389,0.00039743297,0.0012109447],"category_scores_gemma":[0.004766655,0.0001724061,0.0010662666,0.0006873331,0.00028961085,0.00067159714,0.00079918257,0.0007907972,0.00047298605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075598125,0.00015751141,0.7665923,0.00019622232,0.00050168444,0.00011686248,0.00013738795,0.02079945,0.009886576,0.0017667708,0.005586163,0.19350313],"study_design_scores_gemma":[0.00023139436,0.0022203382,0.6078407,0.00026813775,0.0014600867,0.0015384792,0.00025364617,0.32984334,0.02141159,0.013946338,0.020816121,0.00016982533],"about_ca_topic_score_codex":0.005660021,"about_ca_topic_score_gemma":0.012723026,"teacher_disagreement_score":0.005660021,"about_ca_system_score_codex":0.0012510928,"about_ca_system_score_gemma":0.0012620252,"threshold_uncertainty_score":0.011254191},"labels":[],"label_agreement":null},{"id":"W3202924187","doi":"10.1093/neuonc/noab235","title":"DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Beijing Municipal Science and Technology Commission; Canada Research Chairs; Terry Fox Research Institute; Canadian Cancer Society; National Institutes of Health; Ontario Institute for Cancer Research; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"DNA methylation; Chordoma; Methylation; Cancer research; DNA; Biology; Pathology; Medicine; Genetics; Gene; Gene expression","score_opus":0.01921135623655127,"score_gpt":0.30150047928464474,"score_spread":0.28228912304809345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202924187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967405,0.00032977032,0.0020849588,0.000035981066,0.000004340503,0.000011286391,0.0004227576,0.00003469726,0.0003356932],"genre_scores_gemma":[0.9990652,0.000035681987,0.000506037,0.000006516592,0.000003033617,0.000004692553,0.00030301587,0.0000052888095,0.00007060885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961936,0.000073320436,0.000030328329,0.00014365278,0.00008045658,0.0000528647],"domain_scores_gemma":[0.9987866,0.0004037564,0.0004255756,0.000109774555,0.00017260741,0.00010165993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086679705,0.00023409342,0.00026634402,0.00062416535,0.0001640432,0.00045190944,0.00024679812,0.00023488801,0.0009119827],"category_scores_gemma":[0.0027545767,0.00009731666,0.0002891642,0.0003811885,0.00020920378,0.00020599444,0.00047501657,0.00033655664,0.0002187072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006375082,0.000011069122,0.9759971,0.000027715922,0.00012700273,0.0000619384,0.000107423984,0.0007556596,0.010405006,0.00004614224,0.00013699307,0.011686496],"study_design_scores_gemma":[0.000013280663,0.00013149173,0.9883448,0.000010073223,0.000098618664,0.00054974185,0.00017126022,0.005200492,0.0047427034,0.0003810479,0.0003473609,0.000009035747],"about_ca_topic_score_codex":0.001647358,"about_ca_topic_score_gemma":0.0023359205,"teacher_disagreement_score":0.001647358,"about_ca_system_score_codex":0.0003071542,"about_ca_system_score_gemma":0.00020575654,"threshold_uncertainty_score":0.0045841336},"labels":[],"label_agreement":null},{"id":"W3206367283","doi":"10.1093/neuonc/noab245","title":"Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of British Columbia; Hospital for Sick Children","funders":"National Cancer Institute; Agency for Healthcare Research and Quality; Isabella and Marcus Foundation; Robert Connor Dawes Foundation; Cure Brain Cancer Foundation; Brooke Healey Foundation; Reflections of Grace Foundation; Jeffrey Thomas Hayden Foundation; Cure Starts Now Foundation; Musella Foundation For Brain Tumor Research and Information","keywords":"Medical diagnosis; Histopathology; Medicine; Radiology; Biopsy; Stereotactic biopsy; Medical imaging; Magnetic resonance imaging; Pathology","score_opus":0.02741761961563569,"score_gpt":0.31952144682370054,"score_spread":0.2921038272080648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206367283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487466,0.0006597798,0.00043074266,0.000097922806,0.000027257478,0.000037727983,0.0008913503,0.000048522572,0.0029319522],"genre_scores_gemma":[0.99866784,0.00018421095,0.00033324718,0.000021898646,0.000017318032,0.000018727544,0.0006834604,0.000009745678,0.00006364345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367505,0.0019318901,0.0012273225,0.0012738083,0.0012212995,0.0006706471],"domain_scores_gemma":[0.96760803,0.007385883,0.014236364,0.0039520287,0.005548112,0.001269637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060079396,0.00029986183,0.00045241156,0.0050967564,0.00036292363,0.0016649084,0.00095897366,0.0004014397,0.001389573],"category_scores_gemma":[0.03625701,0.000342183,0.00035370773,0.002710398,0.0006429468,0.0012141793,0.0018136649,0.000333418,0.00063358934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000840243,0.0000069604566,0.9962218,0.000019541276,0.000018359955,0.00024038598,0.000099251374,0.00007023935,0.00018373909,0.000021912172,0.0002004929,0.0028333429],"study_design_scores_gemma":[0.000010820697,0.00007438208,0.9926702,0.00006386912,0.000051569416,0.0037956377,0.0005341493,0.0011179867,0.0008038848,0.000042075044,0.0008233284,0.000012098952],"about_ca_topic_score_codex":0.0042458004,"about_ca_topic_score_gemma":0.0041041644,"teacher_disagreement_score":0.0060079396,"about_ca_system_score_codex":0.00066281995,"about_ca_system_score_gemma":0.0007252445,"threshold_uncertainty_score":0.03177339},"labels":[],"label_agreement":null},{"id":"W3207478520","doi":"10.1093/neuonc/noab238","title":"Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Convolutional neural network; Radiogenomics; Diffusion MRI; Glioma; Magnetic resonance imaging; Artificial intelligence; Medicine; Computer science; Machine learning; Radiology; Nuclear medicine; Radiomics; Cancer research","score_opus":0.011456615099725105,"score_gpt":0.2578165132133335,"score_spread":0.2463598981136084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207478520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9056788,0.0021857477,0.08604819,0.0009474876,0.00010691702,0.0001248307,0.0013280944,0.0010821613,0.0024978928],"genre_scores_gemma":[0.97623706,0.00036338906,0.020700904,0.00016198365,0.000038816393,0.00004720845,0.0017002346,0.00004052945,0.00070986955],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955636,0.00012445942,0.000039258848,0.00013021239,0.000080361024,0.000069407535],"domain_scores_gemma":[0.99870527,0.0006099942,0.00018322564,0.0001355091,0.000276462,0.00008950286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015729713,0.0013808913,0.00064276083,0.001081436,0.00024716737,0.00082377257,0.000675396,0.00070412847,0.00067119877],"category_scores_gemma":[0.0036584886,0.00025695353,0.00091078825,0.00044585884,0.00033194,0.00085122726,0.0008939642,0.0010752195,0.00048949866],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001374938,0.0008798968,0.20156719,0.00027483064,0.000747955,0.00027292292,0.00012907319,0.27332065,0.016453078,0.00081266055,0.0061582895,0.49800852],"study_design_scores_gemma":[0.000040465,0.0003063124,0.013829309,0.000059065478,0.00014533396,0.00015164867,0.00004851403,0.97546583,0.007364996,0.0018194896,0.00073960924,0.00002937517],"about_ca_topic_score_codex":0.0071387216,"about_ca_topic_score_gemma":0.009444428,"teacher_disagreement_score":0.0071387216,"about_ca_system_score_codex":0.0008217397,"about_ca_system_score_gemma":0.0008920629,"threshold_uncertainty_score":0.014194369},"labels":[],"label_agreement":null},{"id":"W3208793479","doi":"10.1093/neuonc/noab249","title":"The data behind the image—Deep learning and its potential impact in neuro-oncological imaging","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deep learning; Artificial intelligence; Computer science; Data science","score_opus":0.02253871348312259,"score_gpt":0.34445580765706363,"score_spread":0.32191709417394104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208793479","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043752062,0.0028093625,0.0009751783,0.9892623,0.0047145505,0.000004696678,0.000050151535,0.000023098995,0.0017231167],"genre_scores_gemma":[0.029155988,0.008160636,0.0035728794,0.8557381,0.09357917,0.00005688605,0.00008457304,0.00008261879,0.009569089],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979961,0.00096485164,0.00014377446,0.00015616277,0.0005921087,0.00014705406],"domain_scores_gemma":[0.97536474,0.01987103,0.00082389876,0.0006698374,0.002220578,0.0010498579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043019624,0.0003750653,0.0009042934,0.0005371609,0.0011290836,0.003249883,0.0011818768,0.020282425,0.0038207213],"category_scores_gemma":[0.034556948,0.00038752783,0.0005897611,0.00050479453,0.0042405524,0.0046869493,0.0011166837,0.029264625,0.0026028014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016996793,0.000036840298,0.0011041065,0.00012762684,0.000041679374,0.0014373694,0.00009847079,0.000581341,0.00041794346,0.027376886,0.90448546,0.06412234],"study_design_scores_gemma":[0.00017004396,0.00009530599,0.0011399403,0.0004758055,0.000044779663,0.003216621,0.00024189265,0.007927638,0.0011897305,0.26747584,0.71794087,0.00008158565],"about_ca_topic_score_codex":0.0035730752,"about_ca_topic_score_gemma":0.006101178,"teacher_disagreement_score":0.020282425,"about_ca_system_score_codex":0.0027956418,"about_ca_system_score_gemma":0.0017927677,"threshold_uncertainty_score":0.022751212},"labels":[],"label_agreement":null},{"id":"W3211085456","doi":"10.1093/neuonc/noab252","title":"EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Germ cell tumors; Germinoma; Chemotherapy; Biopsy; Population; Chemoradiotherapy; Disease; Surgery; Incidence (geometry); Oncology; Internal medicine","score_opus":0.014894473166292426,"score_gpt":0.2745480269951017,"score_spread":0.2596535538288093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211085456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043938265,0.9840641,0.0005491644,0.0059547513,0.0035355997,0.00007470509,0.0005027931,0.000028441898,0.004851083],"genre_scores_gemma":[0.0028377457,0.9872464,0.0013092434,0.0032151376,0.0019374014,0.00013062272,0.0013106401,0.000012496986,0.002000318],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99910116,0.00018409992,0.00031084986,0.00008341737,0.00024355041,0.00007691044],"domain_scores_gemma":[0.99830806,0.0004913,0.0004128923,0.00002787556,0.0006155757,0.00014434237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002127876,0.0006841077,0.0014149992,0.0037806705,0.0003422047,0.0011934699,0.0015258015,0.0017243639,0.0050961855],"category_scores_gemma":[0.0038602324,0.00028307174,0.001209649,0.002372404,0.00034192554,0.0011727833,0.0010147421,0.0011146863,0.002251675],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001496273,0.00004193951,0.0014927463,0.03798279,0.00024319834,0.0005433236,0.00011248626,0.00041003944,0.00046670152,0.0019628387,0.2602799,0.6963144],"study_design_scores_gemma":[0.00005247483,0.0000794765,0.004349275,0.05141877,0.00064463477,0.0035229668,0.00016771139,0.00013713894,0.00022211921,0.0015786379,0.9378001,0.000026742286],"about_ca_topic_score_codex":0.0030599455,"about_ca_topic_score_gemma":0.005000405,"teacher_disagreement_score":0.0050961855,"about_ca_system_score_codex":0.001249193,"about_ca_system_score_gemma":0.00487816,"threshold_uncertainty_score":0.017048478},"labels":[],"label_agreement":null},{"id":"W3211524163","doi":"10.1093/neuonc/noab196.080","title":"STEM-04. PD-1 INDEPENDENT OF PD-L1 LIGATION PROMOTES GLIOBLASTOMA GROWTH THROUGH THE NFkB PATHWAY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioblastoma; Cancer research; PD-L1; Immune system; Stem cell; Biology; Cell biology; Immunology; Immunotherapy","score_opus":0.017812823253044455,"score_gpt":0.2927611497394863,"score_spread":0.27494832648644185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211524163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009156,0.0013407764,0.0022916312,0.0003237042,0.00005747575,0.000053445463,0.00079446746,0.00030737589,0.004739686],"genre_scores_gemma":[0.9931914,0.00046773572,0.0015886755,0.000109654575,0.000015374946,0.00005064174,0.0009225924,0.000020814725,0.0036332093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999882,0.000019091887,0.000010734733,0.000022095228,0.000035259516,0.000030778865],"domain_scores_gemma":[0.99988747,0.000018982822,0.00002181826,0.000011606458,0.000010567638,0.00004956863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011626517,0.00024773335,0.00022552254,0.00034559716,0.00012815633,0.0003819333,0.0001240672,0.00018517788,0.0019710914],"category_scores_gemma":[0.000073959774,0.000104446226,0.00016821109,0.00017344835,0.00023230532,0.0001511719,0.00015597061,0.0007302629,0.0004760367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042791624,0.00021726334,0.00037628075,0.000062195126,0.000008921475,0.000048030884,0.000032972726,0.00012529003,0.9927804,0.0005679226,0.00048693994,0.004865939],"study_design_scores_gemma":[0.000077490695,0.0010186324,0.003599927,0.000011733414,0.000021866304,0.00021587628,0.00003670213,0.0017744143,0.9838446,0.00019154821,0.009204272,0.0000029564305],"about_ca_topic_score_codex":0.00048984704,"about_ca_topic_score_gemma":0.0009129077,"teacher_disagreement_score":0.0019710914,"about_ca_system_score_codex":0.00032691789,"about_ca_system_score_gemma":0.00033000764,"threshold_uncertainty_score":0.0065939426},"labels":[],"label_agreement":null},{"id":"W3212593103","doi":"10.1093/neuonc/noab259","title":"Consensus core clinical data elements for meningiomas (v2021.1)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Medicine; Data sharing; Medical physics; Core (optical fiber); Meningioma; Process (computing); Computer science; Pathology; Alternative medicine","score_opus":0.2623891071117285,"score_gpt":0.45603660722943723,"score_spread":0.1936475001177087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212593103","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01400793,0.009193247,0.31335086,0.027345499,0.003931442,0.04465068,0.49650577,0.015500149,0.07551445],"genre_scores_gemma":[0.03433488,0.0027926145,0.41646293,0.0097758025,0.0006296168,0.048283122,0.47508466,0.003885749,0.008750606],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9009742,0.042752076,0.037633732,0.0050321473,0.010584205,0.003023582],"domain_scores_gemma":[0.72981906,0.13030165,0.028646084,0.03905117,0.06131884,0.010863216],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10874029,0.0014270092,0.0033588475,0.015300024,0.002773999,0.006103402,0.006715555,0.0052469163,0.037750784],"category_scores_gemma":[0.22818246,0.0023323603,0.0051319874,0.012598477,0.0020006332,0.0033272693,0.007628585,0.0065882895,0.018833483],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003694623,0.00031576242,0.015416283,0.03015351,0.0017957086,0.0009638511,0.0023635544,0.0057583004,0.0071611046,0.050254088,0.65910447,0.22301878],"study_design_scores_gemma":[0.0015247049,0.00023161723,0.017690001,0.013789978,0.0007060582,0.0009276287,0.0005109048,0.0018124959,0.0046926383,0.025421541,0.9324714,0.0002209696],"about_ca_topic_score_codex":0.013648733,"about_ca_topic_score_gemma":0.011594269,"teacher_disagreement_score":0.89125973,"about_ca_system_score_codex":0.0056327246,"about_ca_system_score_gemma":0.04703499,"threshold_uncertainty_score":0.5750805},"labels":[],"label_agreement":null},{"id":"W3213185511","doi":"10.1093/neuonc/noab196.005","title":"EPCO-06. AGE- AND REGION-SPECIFIC MULTI-OMIC CHARACTERIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Histone H3; Glioma; Cell; Chromatin; Pathology; Cancer research; Genetics; Medicine; Gene","score_opus":0.03576736390376401,"score_gpt":0.2876001096597463,"score_spread":0.2518327457559823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213185511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.742911,0.0033498553,0.010503804,0.0005649052,0.00027523327,0.0007220784,0.2177875,0.0038503355,0.0200354],"genre_scores_gemma":[0.46885666,0.0012902903,0.017846372,0.0005559923,0.000084913394,0.0009019308,0.49853268,0.0015220997,0.010409071],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99938536,0.000043183034,0.000062182495,0.0001873211,0.0001843934,0.00013751445],"domain_scores_gemma":[0.998572,0.000108248074,0.00016813971,0.00023791978,0.00049038354,0.00042328166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092238135,0.00059356244,0.00053336687,0.0023930238,0.0006792966,0.00090337405,0.0008586379,0.0008146049,0.008940333],"category_scores_gemma":[0.0011772942,0.00034162693,0.00041965413,0.0015686526,0.0002787864,0.0004067146,0.0010487834,0.0006489132,0.008145744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006564076,0.00053388445,0.21130176,0.0012055655,0.0002619955,0.0036360514,0.0004256441,0.0011581345,0.6384952,0.001227895,0.05877702,0.07641283],"study_design_scores_gemma":[0.00043635772,0.0014163496,0.522566,0.0002588472,0.00026981282,0.015112604,0.00035231933,0.00436401,0.28582442,0.0006525667,0.16864361,0.000103020255],"about_ca_topic_score_codex":0.0034538484,"about_ca_topic_score_gemma":0.0062798867,"teacher_disagreement_score":0.008940333,"about_ca_system_score_codex":0.0007324709,"about_ca_system_score_gemma":0.0010375951,"threshold_uncertainty_score":0.029908419},"labels":[],"label_agreement":null},{"id":"W3213465860","doi":"10.1093/neuonc/noab196.468","title":"PATH-16. EVALUATION OF SEX-BASED DIFFERENCES IN CLINICAL OUTCOMES AND TUMOR GENOMICS IN PATIENTS WITH NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA RECEIVING CHEMORADIATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"CDKN2A; Hazard ratio; CDKN2B; Medicine; Internal medicine; Oncology; Cancer; Exome sequencing; Confidence interval; Biology; Gene; Mutation; Genetics","score_opus":0.037335554312836715,"score_gpt":0.3130729328709455,"score_spread":0.2757373785581088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213465860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885213,0.00013481859,0.00007273618,0.0000199595,0.0000040602145,0.000003945374,0.0006308975,0.000003502829,0.00027803183],"genre_scores_gemma":[0.99929845,0.000030624793,0.000057676534,0.000013605815,0.0000047033623,0.0000053066633,0.00046847403,0.000002247094,0.00011882939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976605,0.00005884791,0.000026493784,0.000064878,0.000039686405,0.000044126697],"domain_scores_gemma":[0.9989911,0.00014661685,0.00058408186,0.000046385052,0.000080433856,0.00015140937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005100758,0.00017516372,0.00023076839,0.00049585255,0.00014504607,0.00040143722,0.00018254077,0.00014934814,0.0018145371],"category_scores_gemma":[0.0012045526,0.00007583349,0.00033801646,0.00048686573,0.00015369746,0.00025230672,0.0002964397,0.00019609286,0.00030274788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032842116,0.000009068751,0.9972409,0.0000054821935,0.000032681786,0.000031241703,0.00001206762,0.000031409632,0.00023371849,0.000007900067,0.000053974083,0.0020130335],"study_design_scores_gemma":[0.000014160441,0.00018387898,0.99879324,0.000002420275,0.000031564367,0.0002919601,0.000045260116,0.00018795073,0.0002072332,0.000027627508,0.00021251796,0.0000020757616],"about_ca_topic_score_codex":0.0009074619,"about_ca_topic_score_gemma":0.0012392027,"teacher_disagreement_score":0.0018145371,"about_ca_system_score_codex":0.00026518706,"about_ca_system_score_gemma":0.00023935115,"threshold_uncertainty_score":0.0060702562},"labels":[],"label_agreement":null},{"id":"W3214849846","doi":"10.1093/neuonc/noab196.548","title":"NIMG-50. DEUTERIUM METABOLIC IMAGING OF THE ALTERNATIVE LENGTHENING OF TELOMERES PATHWAY REPORTS ON TUMOR BURDEN AND PSEUDOPROGRESSION IN LOW-GRADE GLIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"Telomere; Glioma; Glycolysis; Cancer research; Neurosphere; Flux (metallurgy); In vivo; Magnetic resonance imaging; Chemistry; Biology; Medicine; Enzyme; Biochemistry; In vitro; DNA; Endothelial stem cell; Radiology","score_opus":0.011982725583524596,"score_gpt":0.2696421688163785,"score_spread":0.2576594432328539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214849846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98406154,0.0037311008,0.0062079458,0.00016954188,0.00003022467,0.000032635,0.0007051769,0.00016782508,0.004893874],"genre_scores_gemma":[0.98434675,0.0017423425,0.0071803913,0.0001297287,0.0000086634755,0.000057091216,0.0011815409,0.000054309272,0.0052992473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999528,0.0000106288935,0.000002290722,0.000009388917,0.000012177374,0.000012709878],"domain_scores_gemma":[0.9999689,0.000005489782,0.0000073431706,0.0000028987113,0.0000042864986,0.000011028652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013637336,0.00020575673,0.00013191815,0.0002469099,0.00010099415,0.00018756765,0.00020513868,0.00029544372,0.0015564814],"category_scores_gemma":[0.000080965474,0.00012691396,0.00009177965,0.000183457,0.00015123303,0.00015987855,0.00014527238,0.00024379634,0.00023797539],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017530238,0.000015743366,0.00040476056,0.000035456305,0.000008064877,0.000065294524,0.0000127131,0.000046443725,0.99710137,0.00005651767,0.00011444388,0.001963874],"study_design_scores_gemma":[0.00003144574,0.00045397592,0.016492661,0.000009267495,0.000048990416,0.0005907443,0.000052831725,0.0019453176,0.97633547,0.00008702524,0.0039449283,0.0000074406507],"about_ca_topic_score_codex":0.0018884509,"about_ca_topic_score_gemma":0.0030448837,"teacher_disagreement_score":0.0018884509,"about_ca_system_score_codex":0.00022575424,"about_ca_system_score_gemma":0.00015575229,"threshold_uncertainty_score":0.0052069426},"labels":[],"label_agreement":null},{"id":"W3214977940","doi":"10.1093/neuonc/noab270","title":"Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Germinoma; Radiation oncology; Medicine; Radiation therapy; Oncology; Internal medicine","score_opus":0.02193581011029141,"score_gpt":0.33252448757492686,"score_spread":0.3105886774646355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214977940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942883,0.0010018328,0.00024872817,0.00044351167,0.000066263055,0.0021394293,0.0010565766,0.000030897812,0.00072436855],"genre_scores_gemma":[0.9834329,0.0018439285,0.002340221,0.0009540538,0.0002465949,0.005207037,0.0039360765,0.00003832536,0.0020009794],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937683,0.00039727346,0.00002074236,0.00007428904,0.000053227446,0.00007759592],"domain_scores_gemma":[0.9990048,0.00018476228,0.0002501789,0.0001078553,0.00004820033,0.0004041792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020702484,0.001025229,0.0017320127,0.00031661225,0.0003599543,0.0004933061,0.0008324938,0.000872459,0.0037319704],"category_scores_gemma":[0.0010480528,0.00035960088,0.0011750808,0.0004544664,0.00083109766,0.00041194976,0.00037190254,0.002424522,0.00052781415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85219157,0.03787808,0.030602021,0.00072640204,0.0024710638,0.00028037175,0.00035539974,0.003030011,0.014017552,0.0003037891,0.0051646684,0.052979086],"study_design_scores_gemma":[0.7466196,0.20777737,0.038979013,0.00002962831,0.000535623,0.00021025304,0.00004432619,0.0006478143,0.0013400378,0.00010150954,0.0036949085,0.000019855459],"about_ca_topic_score_codex":0.0025595059,"about_ca_topic_score_gemma":0.004944902,"teacher_disagreement_score":0.0037319704,"about_ca_system_score_codex":0.0011630356,"about_ca_system_score_gemma":0.0025966577,"threshold_uncertainty_score":0.01248467},"labels":[],"label_agreement":null},{"id":"W3215083260","doi":"10.1093/neuonc/noab196.911","title":"IOTG-02. Glioma Supra Marginal Incision Trial (G-SUMIT): a phase II pilot randomized control trial to assess the feasibility of “supra-marginal” surgical resection of malignant glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Glioma; Surgery; Resection; Radiation therapy","score_opus":0.07907108385133853,"score_gpt":0.38999143415155435,"score_spread":0.3109203503002158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215083260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98602456,0.001888653,0.0008713996,0.0010921954,0.00041832944,0.0060944464,0.00090464135,0.00011716735,0.0025885864],"genre_scores_gemma":[0.97848666,0.001273599,0.0024853381,0.0017646474,0.00044725998,0.011496724,0.0011369834,0.000028294266,0.0028806461],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992084,0.00053507095,0.00003439295,0.00007000122,0.000049575563,0.00010258168],"domain_scores_gemma":[0.9988423,0.00032922282,0.00031021354,0.00011285447,0.000057470595,0.00034796385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022858689,0.0013894235,0.001395493,0.00031326473,0.00027974145,0.0009619412,0.0007551332,0.0014523255,0.0052211313],"category_scores_gemma":[0.0020662104,0.00034925676,0.001548357,0.00031303486,0.0011273506,0.00091566925,0.0004883612,0.0026365558,0.0008447124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9651091,0.013179574,0.0009922123,0.0008373836,0.0005704571,0.000059711216,0.00006557826,0.00041292593,0.0022905373,0.00024123042,0.0011001517,0.015141152],"study_design_scores_gemma":[0.85166603,0.14403395,0.0020066756,0.000051160976,0.0003559878,0.00003630511,0.00003622864,0.00046360673,0.0004761059,0.00019257343,0.000668705,0.00001278255],"about_ca_topic_score_codex":0.0007815403,"about_ca_topic_score_gemma":0.0014258268,"teacher_disagreement_score":0.0052211313,"about_ca_system_score_codex":0.00062870793,"about_ca_system_score_gemma":0.0010853317,"threshold_uncertainty_score":0.017466426},"labels":[],"label_agreement":null},{"id":"W3215114010","doi":"10.1093/neuonc/noab196.231","title":"CTNI-06. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University; Hospital for Sick Children; Centre Hospitalier Universitaire de Sherbrooke; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Tolerability; Internal medicine; MAPK/ERK pathway; Progressive disease; Oncology; Progression-free survival; Adverse effect; Gastroenterology; Surgery; Disease; Overall survival; Biology; Kinase","score_opus":0.019691603867848895,"score_gpt":0.29284752650206736,"score_spread":0.27315592263421845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215114010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901405,0.0032453642,0.00044800356,0.0006417746,0.00010458195,0.0019748332,0.0014321771,0.00013410402,0.0018785746],"genre_scores_gemma":[0.98316944,0.0039721173,0.0025302728,0.00087324507,0.00016828779,0.0026308692,0.003520195,0.000042909516,0.0030926086],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968266,0.0001491386,0.000014846149,0.000044964694,0.000032465894,0.00007595963],"domain_scores_gemma":[0.9994641,0.000052990792,0.000088630135,0.000028982113,0.00003411568,0.00033118582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014617356,0.0015978728,0.0016387252,0.0004281676,0.00039308402,0.0010292836,0.0011691739,0.0011026888,0.0028410354],"category_scores_gemma":[0.000703068,0.0005220979,0.0009781902,0.00051932345,0.0007486916,0.0007601467,0.00033587133,0.0033546903,0.0008194615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5055586,0.105674125,0.019064065,0.0022340906,0.0020126065,0.0015926366,0.0008352036,0.0069233025,0.08892825,0.0010304133,0.014162334,0.25198433],"study_design_scores_gemma":[0.5206526,0.43793637,0.021895636,0.0000889556,0.0006120268,0.001624209,0.00011597474,0.0028897237,0.0074450052,0.00018047291,0.0064953123,0.00006378024],"about_ca_topic_score_codex":0.0021270874,"about_ca_topic_score_gemma":0.0067036985,"teacher_disagreement_score":0.0028410354,"about_ca_system_score_codex":0.0014076367,"about_ca_system_score_gemma":0.002396228,"threshold_uncertainty_score":0.010213196},"labels":[],"label_agreement":null},{"id":"W3215163439","doi":"10.1093/neuonc/noab196.001","title":"EPCO-02. GERMLINE SINGLE NUCLEOTIDE POLYMORPHISM rs55705857 AT 8q24 INTERACTS WITH SOMATIC IDH1 MUTATION TO ENHANCE HUMAN GLIOMA FORMATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Isocitrate dehydrogenase; Single-nucleotide polymorphism; Glioma; Biology; IDH1; Germline; Locus (genetics); Genetics; Molecular biology; Germline mutation; Cancer research; Genotype; Mutant; Gene; Mutation","score_opus":0.01959444430569937,"score_gpt":0.31207794412746254,"score_spread":0.29248349982176314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215163439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593496,0.00024453294,0.00062244385,0.00009099388,0.000027864513,0.00001759808,0.001671297,0.000045842386,0.0013444946],"genre_scores_gemma":[0.9965443,0.00007333815,0.00043967995,0.00011465493,0.000012452138,0.000020459254,0.0011843913,0.000030119454,0.0015806349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999864,0.000020214056,0.000008682423,0.000061013983,0.000023218005,0.000022835122],"domain_scores_gemma":[0.999734,0.00006980731,0.00007666423,0.000028060764,0.000016083233,0.00007542869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001479252,0.00025640216,0.0002324591,0.0004198532,0.00019335306,0.0002480418,0.000241835,0.00028958297,0.008758063],"category_scores_gemma":[0.00037544718,0.00011095525,0.00028340012,0.00037753588,0.00017493404,0.00006721507,0.00021877125,0.00032939692,0.0009014119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045650587,0.00047631966,0.20519789,0.00026498403,0.00042235374,0.0031214382,0.00015480051,0.00063640304,0.7545959,0.00080653606,0.0040337173,0.025724567],"study_design_scores_gemma":[0.0003447821,0.00070096954,0.93682504,0.000046776626,0.00039941905,0.0044240193,0.00013227448,0.0027881805,0.046763394,0.0004975641,0.0070556817,0.000021867905],"about_ca_topic_score_codex":0.0016332187,"about_ca_topic_score_gemma":0.0018288872,"teacher_disagreement_score":0.008758063,"about_ca_system_score_codex":0.00016800624,"about_ca_system_score_gemma":0.00016469976,"threshold_uncertainty_score":0.029298663},"labels":[],"label_agreement":null},{"id":"W3215197047","doi":"10.1093/neuonc/noab274","title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Trk receptor; Central nervous system; Medicine; Fusion; Primary (astronomy); Neuroscience; Cancer research; Internal medicine; Biology; Neurotrophin; Receptor","score_opus":0.011731057816536357,"score_gpt":0.2667124807461399,"score_spread":0.2549814229296035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215197047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990413,0.006958543,0.00021601928,0.00015695248,0.00002023831,0.00013211834,0.00047391612,0.000030518193,0.0015987913],"genre_scores_gemma":[0.9970227,0.0016127191,0.00016889648,0.00013016045,0.000032157757,0.00007016856,0.0007005473,0.000005361333,0.0002573206],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995957,0.00014217838,0.00003997674,0.000058238864,0.000102038255,0.000061978695],"domain_scores_gemma":[0.99934775,0.00016522339,0.00021320756,0.000024946785,0.00010738267,0.00014148244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012045945,0.0002252185,0.0009327733,0.00021481216,0.00014560563,0.00040205783,0.00019724427,0.00021958753,0.0011445137],"category_scores_gemma":[0.00091045286,0.000076114164,0.00050543586,0.00023443827,0.00024830608,0.0002577023,0.00015670001,0.0006719022,0.0002700414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12313119,0.0075959335,0.21927309,0.0028071953,0.0024341955,0.0015696785,0.000320422,0.0063431635,0.12502125,0.00025323496,0.010383692,0.50086695],"study_design_scores_gemma":[0.033469256,0.28354844,0.5971291,0.0003482227,0.0028328402,0.008297327,0.0002404716,0.0068809534,0.05579763,0.00029710453,0.0110932365,0.000065463624],"about_ca_topic_score_codex":0.0008506642,"about_ca_topic_score_gemma":0.0019725545,"teacher_disagreement_score":0.0012045945,"about_ca_system_score_codex":0.0010654487,"about_ca_system_score_gemma":0.0005960597,"threshold_uncertainty_score":0.0077304244},"labels":[],"label_agreement":null},{"id":"W3215248537","doi":"10.1093/neuonc/noab196.879","title":"TMOD-18. DIRECT IN VIVO CRISPR SCREEN IDENTIFIES COOPERATING TUMOR SUPPRESSORS THAT DRIVE PROGRESSION OF IDH1-MUTANT LOW-GRADE GLIOMA TO AGGRESSIVE GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; McGill University; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"ATRX; IDH1; Cancer research; Glioma; Mutant; Biology; PTEN; CRISPR; Mutation; PI3K/AKT/mTOR pathway; Gene; Genetics; Signal transduction","score_opus":0.021574559586447196,"score_gpt":0.3262766865455839,"score_spread":0.3047021269591367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215248537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654659,0.00072387495,0.021799231,0.00014643586,0.000065690525,0.00031721254,0.006162541,0.0013329166,0.0039861826],"genre_scores_gemma":[0.971273,0.00047678,0.015097394,0.000078458135,0.0000071431728,0.00016147153,0.0043376097,0.00020554749,0.008362513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980205,0.000017308741,0.000022371125,0.000054375134,0.00006660491,0.00003726806],"domain_scores_gemma":[0.9998702,0.000019381885,0.000046454876,0.00001467118,0.00001167895,0.00003757341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017679486,0.00037427663,0.00042526817,0.00039241902,0.00014851156,0.00032077316,0.00030310082,0.00029871447,0.0018168334],"category_scores_gemma":[0.00009336158,0.00017283522,0.00027478248,0.0002260185,0.00019791945,0.00006445893,0.0002198148,0.00043573565,0.0006818706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037014233,0.000019031862,0.00019789091,0.000023910925,0.000004354989,0.000078722696,0.000008281896,0.000069692054,0.99842036,0.000073844814,0.00007011618,0.0009968181],"study_design_scores_gemma":[0.000018154375,0.00022085782,0.003048751,0.0000048640436,0.000026064978,0.00058435416,0.000016308044,0.0016264757,0.9896818,0.000029774208,0.0047372407,0.0000053610515],"about_ca_topic_score_codex":0.00090113847,"about_ca_topic_score_gemma":0.002151556,"teacher_disagreement_score":0.0018168334,"about_ca_system_score_codex":0.0003308289,"about_ca_system_score_gemma":0.00023847645,"threshold_uncertainty_score":0.006077945},"labels":[],"label_agreement":null},{"id":"W3215364878","doi":"10.1093/neuonc/noab196.594","title":"NCOG-01. RADIATION THERAPY MANAGEMENT FOR METASTATIC DISEASE TO THE BRAIN IN NSCLC PATIENTS – SURVIVAL OUTCOMES OF THE BRITISH COLUMBIA POPULATION 1996-2016","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Radiosurgery; Lung cancer; Radiation therapy; Proportional hazards model; Oncology; Performance status; Brain metastasis; Cancer; Population; Surgery; Metastasis","score_opus":0.021310284801281002,"score_gpt":0.303587966725419,"score_spread":0.282277681924138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215364878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072996,0.0041070054,0.00013748133,0.0017801522,0.000110007306,0.00011112458,0.06999537,0.00006973929,0.016389541],"genre_scores_gemma":[0.94503427,0.0018356952,0.00020042848,0.00036107138,0.00004997631,0.00007533276,0.045351323,0.00002613246,0.007065751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.00003847106,0.000045211644,0.00006593763,0.00013486111,0.00010896095],"domain_scores_gemma":[0.99785596,0.0000925764,0.0007144999,0.000060416554,0.00075536297,0.0005211206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047064852,0.0002019547,0.00021491417,0.0012612874,0.0006060543,0.00078517565,0.0006160402,0.0002887036,0.0042711697],"category_scores_gemma":[0.0017678292,0.00015757998,0.00021803388,0.004040013,0.0002606833,0.000258354,0.00045021492,0.00043992052,0.0008452788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108373046,0.000021292857,0.9822105,0.00007026211,0.000034503722,0.00008332199,0.00007553222,0.000101463935,0.00011148321,0.00003332201,0.008124759,0.0090252515],"study_design_scores_gemma":[0.000007140669,0.000010505167,0.99698406,0.000038787377,0.000010981322,0.000061844126,0.00011546282,0.000057069352,0.000026925843,0.000009428443,0.0026753428,0.000002481581],"about_ca_topic_score_codex":0.7921063,"about_ca_topic_score_gemma":0.86450315,"teacher_disagreement_score":0.20789373,"about_ca_system_score_codex":0.005757341,"about_ca_system_score_gemma":0.006407563,"threshold_uncertainty_score":0.41823608},"labels":[],"label_agreement":null},{"id":"W3215366287","doi":"10.1093/neuonc/noab196.061","title":"BIOM-30. BLOOD COUNTS THROUGH TREATMENT COURSE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neutropenia; Temozolomide; Internal medicine; Gastroenterology; Glioblastoma; Lymphocyte; Radiation therapy; Proportional hazards model; Chemotherapy; Oncology; Cancer research","score_opus":0.01769910270985805,"score_gpt":0.29522945524976657,"score_spread":0.27753035253990854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215366287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792564,0.00021036695,0.000060135528,0.000040053936,0.000004048812,0.000009609369,0.001275153,0.0000062605313,0.0004687967],"genre_scores_gemma":[0.9989517,0.000059231766,0.00006505144,0.000022430359,0.0000040227465,0.000011151684,0.0007415599,0.0000014231894,0.00014350508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997528,0.00004921675,0.000041080544,0.00006342742,0.00004713763,0.000046166562],"domain_scores_gemma":[0.99897444,0.000116809075,0.00068458455,0.000023692308,0.000086612046,0.00011389054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022009372,0.0001302383,0.00023687049,0.00057058106,0.00019871401,0.000363426,0.0001868497,0.00016861015,0.0010300467],"category_scores_gemma":[0.0013088476,0.00008903948,0.00018955811,0.0009800008,0.00008521452,0.0002091972,0.00019609867,0.00029499707,0.0002576038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006262748,0.000012020885,0.99887735,0.0000034455327,0.000007175863,0.000027030412,0.000019279538,0.00002528092,0.00006885706,0.0000033774531,0.00007474469,0.00081884133],"study_design_scores_gemma":[0.0000027899005,0.00004956104,0.9994074,0.0000024264907,0.0000068129702,0.00010518622,0.000036418594,0.00015570146,0.000066982706,0.0000069464036,0.0001581899,0.0000014577124],"about_ca_topic_score_codex":0.008044739,"about_ca_topic_score_gemma":0.009557048,"teacher_disagreement_score":0.008044739,"about_ca_system_score_codex":0.00049466855,"about_ca_system_score_gemma":0.00036582863,"threshold_uncertainty_score":0.01599586},"labels":[],"label_agreement":null},{"id":"W3215398375","doi":"10.1093/neuonc/noab196.021","title":"EPCO-22. INHERITED POLYMORPHISM IN CHROMOSOME 8Q24 COOPERATES WITH MUTANT IDH1, Trp53 AND ATRX LOSS TO INDUCE LOW-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"ATRX; Biology; Allele; Genetics; CDKN2A; Locus (genetics); Glioma; Cancer research; Penetrance; Gene; Single-nucleotide polymorphism; Genotype; Mutant; IDH1; Carcinogenesis; Mutation; Phenotype","score_opus":0.018053797502934458,"score_gpt":0.2826563719139711,"score_spread":0.26460257441103663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215398375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948319,0.00039549224,0.0017317334,0.00015751523,0.000053688287,0.00006829916,0.0009751491,0.0002124983,0.0015736546],"genre_scores_gemma":[0.9964455,0.00015838533,0.00056236406,0.00006831795,0.0000099712925,0.000043782482,0.0005816356,0.000042753218,0.0020873307],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998492,0.000029619985,0.0000144142905,0.000037091384,0.000035207926,0.000034462006],"domain_scores_gemma":[0.9998093,0.000031269672,0.00006067475,0.00002017132,0.0000072752678,0.000071287395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013877949,0.000570435,0.0003151658,0.0005875525,0.00016557192,0.00019793135,0.00024670048,0.000400562,0.0036691467],"category_scores_gemma":[0.0001397445,0.00014619187,0.00038662195,0.0002449658,0.00026632322,0.000054968794,0.00029289938,0.0006657975,0.0006560964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029068018,0.00017786995,0.0014942939,0.00003241171,0.000038639108,0.0019121537,0.000016778484,0.00013883221,0.99315685,0.00020489756,0.00026437515,0.0022723428],"study_design_scores_gemma":[0.00045416955,0.0030198698,0.103912994,0.000046966714,0.00018678495,0.023703387,0.00013904674,0.005039514,0.8515344,0.00044121224,0.011485873,0.000035737103],"about_ca_topic_score_codex":0.0008778856,"about_ca_topic_score_gemma":0.0012311203,"teacher_disagreement_score":0.0036691467,"about_ca_system_score_codex":0.00023573832,"about_ca_system_score_gemma":0.00015714095,"threshold_uncertainty_score":0.012274504},"labels":[],"label_agreement":null},{"id":"W3215432528","doi":"10.1093/neuonc/noab196.453","title":"INNV-43. MORE THAN WHAT MEETS THE EYE: ETMR AN UNDER RECOGNISED ATYPICAL BRAINSTEM PRIMARY. A RARE BRAIN TUMOR CONSORTIUM (RBTC) STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Brainstem; Radiation therapy; Chemotherapy; Biopsy; Brain tumor; Pediatrics; Radiology; Surgery; Pathology; Internal medicine","score_opus":0.03640527548951738,"score_gpt":0.332351303696803,"score_spread":0.2959460282072856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215432528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929362,0.0022025553,0.000119217446,0.00031784133,0.000032111646,0.00001458324,0.0003680388,0.000012711107,0.0039968067],"genre_scores_gemma":[0.9987765,0.00036719406,0.000049853803,0.00013743945,0.000030541938,0.0000024637316,0.00017196669,0.00000712415,0.00045690127],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99962234,0.00005212857,0.000038806695,0.000117847085,0.000086152024,0.00008262979],"domain_scores_gemma":[0.9993,0.000110342895,0.000251663,0.000056621826,0.00006398434,0.00021728643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033211822,0.0002453957,0.0002559891,0.00073910895,0.0006780428,0.0009825821,0.00030812822,0.00063031854,0.0043362486],"category_scores_gemma":[0.0010351075,0.00025920765,0.00027253787,0.0008003574,0.00034873042,0.00081589643,0.00049906434,0.00052413205,0.00063398527],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016147016,0.000041589446,0.95078623,0.00007628743,0.000046938134,0.037087698,0.00031935528,0.000054352793,0.00259037,0.00020360394,0.0011446581,0.007487385],"study_design_scores_gemma":[0.000017815102,0.0002387306,0.6926837,0.00015645515,0.00011411711,0.29420522,0.0024785285,0.0003637573,0.00079975184,0.00042893144,0.00849211,0.000020836766],"about_ca_topic_score_codex":0.0039008954,"about_ca_topic_score_gemma":0.005834421,"teacher_disagreement_score":0.0043362486,"about_ca_system_score_codex":0.00035176578,"about_ca_system_score_gemma":0.00035000505,"threshold_uncertainty_score":0.014506161},"labels":[],"label_agreement":null},{"id":"W3215441874","doi":"10.1093/neuonc/noab196.031","title":"EPCO-32. IDENTIFICATION OF PROGNOSTIC CHORDOMA SUBGROUPS USING DNA METHYLATION SIGNATURES IN TISSUE AND PLASMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chordoma; DNA methylation; Differentially methylated regions; Proportional hazards model; Biology; Epigenetics; Methylation; Cancer research; Oncology; Bioinformatics; Internal medicine; Pathology; Medicine; Gene; Genetics; Gene expression","score_opus":0.026749080330018046,"score_gpt":0.3248480902901534,"score_spread":0.29809900996013533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215441874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935354,0.00043653764,0.0038648772,0.000035178375,0.0000063240054,0.000040517367,0.0014832184,0.00007442491,0.0005235593],"genre_scores_gemma":[0.9961267,0.0000687605,0.0018046227,0.0000139196845,0.0000032942487,0.000027269589,0.0015477051,0.000012188065,0.00039545502],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996629,0.000062810526,0.00002259301,0.00014080627,0.00006570319,0.000045215616],"domain_scores_gemma":[0.9994135,0.00015393773,0.00018293358,0.00006166962,0.00009667652,0.00009143762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006033884,0.00027777924,0.0003128436,0.00073853234,0.00020798916,0.0005179121,0.0002673049,0.00024291257,0.0018816288],"category_scores_gemma":[0.0013154623,0.00015437545,0.00034737942,0.00048051085,0.00020923313,0.00018510093,0.0004401057,0.0002592744,0.00059330766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021427332,0.00005479386,0.80575204,0.0001450976,0.00020949141,0.00020786512,0.0002017782,0.0017481367,0.15647623,0.00015359408,0.00048211776,0.032426074],"study_design_scores_gemma":[0.000052336312,0.0005869413,0.93586177,0.000024237377,0.00015153694,0.0013734847,0.00026070166,0.017207593,0.04197552,0.0006059594,0.0018770196,0.000022969472],"about_ca_topic_score_codex":0.002425447,"about_ca_topic_score_gemma":0.00313362,"teacher_disagreement_score":0.002425447,"about_ca_system_score_codex":0.00035052848,"about_ca_system_score_gemma":0.00032735732,"threshold_uncertainty_score":0.0062946677},"labels":[],"label_agreement":null},{"id":"W3215445514","doi":"10.1093/neuonc/noab196.915","title":"ITVT-03. Use of Functional MRI and DTI for Surgical Planning of Maximal Extent of Resection of CNS Tumors - A Single Neurosurgical Center’s Experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Magnetic resonance imaging; Diffusion MRI; Neuronavigation; Surgical planning; Functional imaging; Functional magnetic resonance imaging; Neuroimaging; Radiology; Nuclear medicine","score_opus":0.1644279284472633,"score_gpt":0.3897089641072013,"score_spread":0.22528103565993798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215445514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96056473,0.0026670129,0.021740599,0.00073406106,0.00013533632,0.00025919368,0.0003665422,0.00046499041,0.013067428],"genre_scores_gemma":[0.96447253,0.0014903555,0.030498054,0.00025543413,0.00010416137,0.00007832928,0.0004950443,0.00020107179,0.002405016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996499,0.00007238114,0.000056364035,0.000074906005,0.00006226935,0.00008408426],"domain_scores_gemma":[0.9990458,0.000112158086,0.00012660738,0.00012365932,0.00013044184,0.0004613979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086602673,0.0005231348,0.00022105842,0.00084965647,0.00043168233,0.00073890574,0.00066374004,0.0004433433,0.0026845632],"category_scores_gemma":[0.001567826,0.00026371362,0.00043171755,0.00054414093,0.00041967048,0.00046392108,0.0008540233,0.0006704355,0.0011027656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005823585,0.0012478308,0.22890179,0.00032162957,0.00018384421,0.096655615,0.0032380598,0.0042779236,0.047236618,0.0006425985,0.0055501345,0.6111616],"study_design_scores_gemma":[0.00012805371,0.003883538,0.37018624,0.00046443683,0.00022455209,0.5306665,0.0042289454,0.009293899,0.04071172,0.001550339,0.038448576,0.00021329496],"about_ca_topic_score_codex":0.0028408545,"about_ca_topic_score_gemma":0.006296892,"teacher_disagreement_score":0.0028408545,"about_ca_system_score_codex":0.00053494517,"about_ca_system_score_gemma":0.0013960833,"threshold_uncertainty_score":0.008980751},"labels":[],"label_agreement":null},{"id":"W3215503905","doi":"10.1093/neuonc/noab196.612","title":"NCOG-21. PREDICTORS OF SURVIVAL IN ELDERLY PATIENTS UNDERGOING SURGERY FOR GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Complication; Medical record; Retrospective cohort study; Surgery; Comorbidity; Survival analysis; Proportional hazards model; Internal medicine","score_opus":0.02611137550732264,"score_gpt":0.28274584972044947,"score_spread":0.25663447421312685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215503905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975585,0.00062469346,0.00005136508,0.00009057475,0.000016728332,0.0000045023526,0.0009135019,0.0000053103217,0.0007347811],"genre_scores_gemma":[0.9990551,0.00014778133,0.00006278718,0.00002648525,0.000013501294,0.0000037189368,0.0005655993,0.0000013520319,0.00012370046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998692,0.000021294592,0.000022724469,0.000019746449,0.000029373366,0.00003762576],"domain_scores_gemma":[0.9984693,0.00021523127,0.00082739495,0.000026314498,0.00016380318,0.00029800963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025995585,0.00010566871,0.00014137683,0.00049638026,0.00023301563,0.0003740366,0.0001287224,0.0001634848,0.0021540874],"category_scores_gemma":[0.0015164115,0.0000546792,0.00018444817,0.0007330522,0.0001323897,0.00021270962,0.00024116336,0.00028728708,0.00021899621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019524257,0.0000034923605,0.9992461,0.0000045222264,0.000005543512,0.00002505645,0.000005341617,0.000010309304,0.000024197137,0.0000035227501,0.00009549413,0.00055681134],"study_design_scores_gemma":[0.0000015177236,0.00002624364,0.9993339,0.000006117161,0.000010945362,0.00020123088,0.00004581365,0.000061943676,0.00002913318,0.000013839308,0.00026816345,0.0000010876223],"about_ca_topic_score_codex":0.0025763162,"about_ca_topic_score_gemma":0.0043146797,"teacher_disagreement_score":0.0025763162,"about_ca_system_score_codex":0.0001642741,"about_ca_system_score_gemma":0.0003539302,"threshold_uncertainty_score":0.007206142},"labels":[],"label_agreement":null},{"id":"W3215508843","doi":"10.1093/neuonc/noab196.242","title":"CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Clinical endpoint; Medicine; Oncology; Bevacizumab; Phases of clinical research; Internal medicine; Radiation therapy; Clinical trial; Cancer research; Chemotherapy","score_opus":0.01334965007866061,"score_gpt":0.3127865269656032,"score_spread":0.2994368768869426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215508843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97351086,0.0060289605,0.0013941206,0.001645254,0.00044877213,0.010470554,0.0028591985,0.00035712725,0.0032852055],"genre_scores_gemma":[0.9455624,0.008406726,0.007612101,0.0031534361,0.00040893248,0.017796444,0.0066699157,0.00017762717,0.010212321],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994098,0.0002749555,0.000024935987,0.00008810511,0.00007391341,0.0001283845],"domain_scores_gemma":[0.9994025,0.000053619748,0.0001269657,0.00005102783,0.00005526893,0.00031051482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023427845,0.0019842507,0.0018788715,0.00086691306,0.00041443462,0.0013098645,0.0015664682,0.001679076,0.005012957],"category_scores_gemma":[0.00094581634,0.00075351907,0.001636268,0.00055035035,0.0012391892,0.0010810292,0.0004721394,0.0039244057,0.0012363837],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.624213,0.13817064,0.0045831283,0.0022873457,0.002395653,0.00043388957,0.00045869674,0.0044454555,0.06274849,0.0011512472,0.013250632,0.1458618],"study_design_scores_gemma":[0.56086916,0.41836086,0.004647576,0.000097717064,0.00058906095,0.00033524702,0.00007642126,0.0012427289,0.006868691,0.0004518387,0.0064129354,0.000047826714],"about_ca_topic_score_codex":0.0016445653,"about_ca_topic_score_gemma":0.004551006,"teacher_disagreement_score":0.005012957,"about_ca_system_score_codex":0.001376867,"about_ca_system_score_gemma":0.0028332488,"threshold_uncertainty_score":0.016770005},"labels":[],"label_agreement":null},{"id":"W3215519365","doi":"10.1093/neuonc/noab196.669","title":"EXTH-30. HARNESSING CELLULAR STRESS FOR IMMUNE TARGETING OF DIPGS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Context (archaeology); Immune system; Cancer research; In vivo; Ex vivo; Glioma; Pharmacology; Immunology; Biology; Genetics","score_opus":0.01776142761993329,"score_gpt":0.3139705883554132,"score_spread":0.2962091607354799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215519365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97250754,0.004549224,0.005221648,0.0006736474,0.00017252767,0.0004105016,0.003271414,0.0005714625,0.012622057],"genre_scores_gemma":[0.9840248,0.0017753801,0.0027945717,0.00041404378,0.00002128407,0.00014087802,0.0030968082,0.00003657781,0.0076956414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999943,0.000006162569,0.0000026123291,0.000008755511,0.000020848936,0.00001853807],"domain_scores_gemma":[0.99996865,0.0000034956188,0.000004830975,0.0000032356827,0.0000038254043,0.000015926982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010329845,0.00021752909,0.00016607456,0.00013821572,0.00008941889,0.00020738204,0.00014387151,0.0002267286,0.0030404415],"category_scores_gemma":[0.000051511775,0.00006801121,0.00018206515,0.00008729331,0.00011989798,0.00011370223,0.00020075901,0.00047806592,0.00067886466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000654089,0.00028537586,0.0003647464,0.00020008949,0.000016860195,0.00015643124,0.000026134705,0.00056519103,0.9749976,0.00046523265,0.0015214719,0.020746866],"study_design_scores_gemma":[0.000415379,0.004403959,0.0055126636,0.00002705841,0.0000403987,0.0008388191,0.000044469223,0.002543018,0.95227915,0.00037066048,0.033507787,0.00001661432],"about_ca_topic_score_codex":0.00036235337,"about_ca_topic_score_gemma":0.0008215311,"teacher_disagreement_score":0.0030404415,"about_ca_system_score_codex":0.00022783793,"about_ca_system_score_gemma":0.00024700598,"threshold_uncertainty_score":0.010171235},"labels":[],"label_agreement":null},{"id":"W3215530196","doi":"10.1093/neuonc/noab196.353","title":"EPID-20. THE RISING INCIDENCE AND PREVALENCE OF BRAIN TUMOURS: A CANADIAN EPIDEMIOLOGICAL STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Incidence (geometry); Medicine; Epidemiology; Demography; Cancer registry; Standardized rate; Pediatrics; Pathology","score_opus":0.048383281597215534,"score_gpt":0.3541804403768442,"score_spread":0.30579715877962865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215530196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.784667,0.010933343,0.001166698,0.0038515492,0.00016350838,0.0006319152,0.1669875,0.00014295576,0.03145556],"genre_scores_gemma":[0.9637615,0.0047123693,0.0014711121,0.0006226639,0.00004075078,0.00020823102,0.02561937,0.000024907198,0.0035390176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853027,0.000098657874,0.00012939598,0.00020135843,0.0006851196,0.00035519715],"domain_scores_gemma":[0.99670273,0.00010779267,0.0005327782,0.00008447102,0.0020956355,0.00047660156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011770698,0.00035807272,0.0003635797,0.0035906467,0.002256053,0.0014138328,0.0010072298,0.00043663607,0.003830414],"category_scores_gemma":[0.0032211521,0.000366753,0.00090013875,0.00810543,0.0003734003,0.00050491217,0.0008274521,0.0007424573,0.00044547653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036733803,0.000024723937,0.98367983,0.0002483869,0.000089877445,0.00008243144,0.00042964623,0.00010956652,0.00009770844,0.00030248822,0.006309467,0.0085891355],"study_design_scores_gemma":[0.000005434192,0.000011695919,0.99536574,0.000082071114,0.000039877035,0.00006299618,0.0003346348,0.0001474153,0.000028320312,0.000028508292,0.003885571,0.000007797599],"about_ca_topic_score_codex":0.99445254,"about_ca_topic_score_gemma":0.99516886,"teacher_disagreement_score":0.97523344,"about_ca_system_score_codex":0.024766594,"about_ca_system_score_gemma":0.04370212,"threshold_uncertainty_score":0.17969507},"labels":[],"label_agreement":null},{"id":"W3215679919","doi":"10.1093/neuonc/noaa222.407","title":"LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; BC Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; McGill University; University of British Columbia; Hospital for Sick Children; Université de Montréal; Montreal Children's Hospital; Centre hospitalier universitaire de Québec; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trametinib; Medicine; Tolerability; Adverse effect; Internal medicine; MAPK/ERK pathway; Oncology; Refractory (planetary science); Gastroenterology; Surgery; Biology","score_opus":0.025199194936663446,"score_gpt":0.2910351558811074,"score_spread":0.26583596094444395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215679919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994935,0.0025327958,0.0003451402,0.00048708674,0.000065511806,0.0027740747,0.0018282528,0.00015189307,0.0018658851],"genre_scores_gemma":[0.9856053,0.0023442323,0.0019795597,0.0010693558,0.0000773305,0.0025647543,0.0039638057,0.000034200264,0.0023614785],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995759,0.00019004174,0.000013650721,0.000053346812,0.000042558728,0.00012441736],"domain_scores_gemma":[0.9996088,0.00003779965,0.000064795764,0.000021127866,0.000024411525,0.00024298539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014476817,0.0015904398,0.001343943,0.00050685304,0.00033512161,0.0008624776,0.0011200849,0.0010900934,0.0027360807],"category_scores_gemma":[0.0005168575,0.0005128671,0.0010853553,0.0004884497,0.0007542673,0.00048262542,0.00027589788,0.0021798874,0.0008261533],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44730255,0.11273813,0.032591503,0.0018855849,0.0028414452,0.0018145273,0.0007837697,0.006758686,0.10170216,0.00083875575,0.02023647,0.27050644],"study_design_scores_gemma":[0.45256418,0.48813,0.03937403,0.00008127887,0.000788291,0.001148115,0.00014470579,0.0022311867,0.007624278,0.000200026,0.007664893,0.000048888833],"about_ca_topic_score_codex":0.0053348993,"about_ca_topic_score_gemma":0.017554222,"teacher_disagreement_score":0.0053348993,"about_ca_system_score_codex":0.001924559,"about_ca_system_score_gemma":0.0026804158,"threshold_uncertainty_score":0.013963699},"labels":[],"label_agreement":null},{"id":"W3215696868","doi":"10.1093/neuonc/noab196.498","title":"PATH-46. DIAGNOSTIC IMPACT OF THE CNS TUMOR METHYLATION PROFILING IN A NEUROPATHOLOGY CONSULT PRACTICE","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropathology; Classifier (UML); Brain tumor; Medulloblastoma; Methylation; Medicine; DNA methylation; Profiling (computer programming); Oncology; Pathology; Internal medicine; Artificial intelligence; Computer science; Biology; Disease","score_opus":0.015847717853677324,"score_gpt":0.35420435867283906,"score_spread":0.3383566408191617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215696868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161875,0.0005854973,0.0037988618,0.00081179873,0.000025745256,0.00005258116,0.0007278589,0.00014325108,0.0022355337],"genre_scores_gemma":[0.9958924,0.000102455306,0.0034436404,0.00006288614,0.000010215875,0.00001056245,0.00025847717,0.000012492829,0.00020684171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957908,0.0019158165,0.0002923352,0.0007769242,0.00092382915,0.00030038372],"domain_scores_gemma":[0.9886077,0.005582666,0.0024404125,0.00066902325,0.0018378088,0.0008624063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004543137,0.00030089048,0.00033746284,0.0011381935,0.0005948237,0.0013095564,0.00051711494,0.00048878504,0.0030590857],"category_scores_gemma":[0.022825398,0.00021011857,0.00038019285,0.0009814295,0.0005173087,0.00056947867,0.001110825,0.00048654425,0.0009744127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048772362,0.000097351935,0.92638385,0.00010433744,0.00009896868,0.0006373138,0.00029826304,0.0015529683,0.0043826886,0.00013974229,0.0010317909,0.064784996],"study_design_scores_gemma":[0.000024277353,0.0008214305,0.9679959,0.00008130658,0.00014738186,0.0025083977,0.00076786836,0.018247202,0.0069673364,0.00050193886,0.0019032737,0.000033662975],"about_ca_topic_score_codex":0.007614602,"about_ca_topic_score_gemma":0.015574828,"teacher_disagreement_score":0.007614602,"about_ca_system_score_codex":0.0012420304,"about_ca_system_score_gemma":0.0017299332,"threshold_uncertainty_score":0.024026692},"labels":[],"label_agreement":null},{"id":"W3215705432","doi":"10.1093/neuonc/noab196.100","title":"STEM-26. BLOOD-TUMOR BARRIER IS COMPOSED OF MECHANOSENSING TUMOR CELLS THAT MASK THERAPEUTIC VULNERABILITY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Cell biology; Biology; Wnt signaling pathway; Stem cell; Signal transduction; Cancer research; Neuroscience","score_opus":0.04135974310705605,"score_gpt":0.2928577645974006,"score_spread":0.25149802149034456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215705432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96741086,0.0024697774,0.01655275,0.00036111198,0.00008754926,0.000072434435,0.0015817378,0.0005262769,0.010937513],"genre_scores_gemma":[0.98659235,0.00053622056,0.003977106,0.00012079786,0.000011297691,0.000045128145,0.001000659,0.000049494418,0.0076668914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.0000033735535,0.000003839756,0.000015601563,0.00003128971,0.000012012572],"domain_scores_gemma":[0.99991167,0.0000052351106,0.00002518503,0.000007121495,0.000012256167,0.00003854215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000627738,0.00016932694,0.0001787404,0.00018722049,0.00023832844,0.0004204237,0.00013143086,0.00025872892,0.0033124257],"category_scores_gemma":[0.00006547126,0.00011663627,0.00015988752,0.00013507543,0.00021841317,0.00026527405,0.00024069128,0.0004052188,0.00067066203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004249902,0.00001057499,0.00075779395,0.00004071588,0.000004380434,0.000113870025,0.000027242855,0.00010577527,0.9943921,0.0013402244,0.00020750497,0.0029572942],"study_design_scores_gemma":[0.00003205621,0.00019120611,0.02657306,0.00002383056,0.000026351376,0.0009349063,0.00016799009,0.0045641325,0.93282914,0.0010766875,0.033568043,0.00001257357],"about_ca_topic_score_codex":0.0006275615,"about_ca_topic_score_gemma":0.0011086436,"teacher_disagreement_score":0.0033124257,"about_ca_system_score_codex":0.00033308406,"about_ca_system_score_gemma":0.00024435626,"threshold_uncertainty_score":0.011081219},"labels":[],"label_agreement":null},{"id":"W3215705870","doi":"10.1093/neuonc/noab196.123","title":"CBIO-24. NF2 LOSS-OF-FUNCTION COOPERATES WITH HYPOXIA TO DRIVE RADIATION RESISTANCE IN GRADE 2 MENINGIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Radioresistance; Necrosis; Cancer research; Downregulation and upregulation; Gene knockdown; Biology; Clonogenic assay; DNA damage; Programmed cell death; Radiation therapy; Hypoxia (environmental); Pathology; In vitro; Cell culture; Medicine; Apoptosis; Internal medicine; Gene; Chemistry; Genetics; DNA","score_opus":0.02078153122316179,"score_gpt":0.3060761352444582,"score_spread":0.2852946040212964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215705870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946556,0.0010132856,0.0009928278,0.00015904495,0.00003246669,0.000028619777,0.0019225867,0.00013436243,0.0010611059],"genre_scores_gemma":[0.994753,0.00036886046,0.0007152988,0.00009357616,0.000006708894,0.00003324343,0.0024077324,0.000026173911,0.0015952911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998369,0.000016713919,0.000016671558,0.00003359718,0.000046446647,0.000049518498],"domain_scores_gemma":[0.9998473,0.000016389267,0.000043518423,0.00001875231,0.000012811303,0.00006124107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015838214,0.00029960633,0.00033110403,0.0003411402,0.00024106931,0.0004069853,0.00017742712,0.00027518414,0.0017291881],"category_scores_gemma":[0.00013864855,0.00012531086,0.0003478082,0.00022159104,0.00018512917,0.00009984078,0.00014966163,0.00047228322,0.00061141286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023179539,0.00004792377,0.0010963591,0.000034435605,0.000012432774,0.0001346981,0.000010503488,0.00005925137,0.9973801,0.000031263055,0.00015819754,0.000802981],"study_design_scores_gemma":[0.00006532918,0.00079365534,0.068484105,0.000022625312,0.00005635252,0.0016524777,0.00013543351,0.0024696132,0.9192006,0.00011960586,0.006985866,0.000014356885],"about_ca_topic_score_codex":0.0016962119,"about_ca_topic_score_gemma":0.0022585003,"teacher_disagreement_score":0.0017291881,"about_ca_system_score_codex":0.00045727214,"about_ca_system_score_gemma":0.00024808364,"threshold_uncertainty_score":0.0057846904},"labels":[],"label_agreement":null},{"id":"W3215884701","doi":"10.1093/neuonc/noab196.863","title":"TMOD-01. AN IN VIVO FUNCTIONAL GENOMICS SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"In vivo; Lung cancer; Brain metastasis; Metastasis; CRISPR; Lung; Cancer; Primary tumor; Medicine; Brain tumor; Cancer research; Biology; Computational biology; Bioinformatics; Neuroscience; Pathology; Gene; Internal medicine; Genetics","score_opus":0.12586533757090496,"score_gpt":0.4465192405110154,"score_spread":0.3206539029401104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215884701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88343525,0.0024019512,0.08194074,0.0009418231,0.00022597676,0.0009409532,0.015876973,0.0029465493,0.011289801],"genre_scores_gemma":[0.922081,0.0016803177,0.04444363,0.0005824757,0.000022629925,0.00043938024,0.016336652,0.00054499175,0.013868897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951327,0.00006856443,0.00004842871,0.00011614564,0.0001749035,0.00007873525],"domain_scores_gemma":[0.99968374,0.0000872352,0.00008472706,0.000031761498,0.000036180387,0.0000763511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061492575,0.00074043294,0.00063730025,0.0005973433,0.00026970715,0.0007360679,0.0007334642,0.0007449761,0.0030826998],"category_scores_gemma":[0.00028825336,0.00026532845,0.00061325356,0.00039570263,0.00038793831,0.00017722577,0.00038589083,0.0009956501,0.0011072309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067067536,0.00007650244,0.00033824786,0.00006805429,0.000015557967,0.00010613504,0.000010691255,0.0003787078,0.9959329,0.00024816874,0.00025167473,0.0025063355],"study_design_scores_gemma":[0.00006224217,0.00070238044,0.0027045344,0.000016264286,0.00007475417,0.0006902981,0.000045569715,0.004838295,0.98013294,0.00016384559,0.0105455285,0.000023249177],"about_ca_topic_score_codex":0.001392144,"about_ca_topic_score_gemma":0.0024605584,"teacher_disagreement_score":0.0030826998,"about_ca_system_score_codex":0.00064950535,"about_ca_system_score_gemma":0.00064720825,"threshold_uncertainty_score":0.010312617},"labels":[],"label_agreement":null},{"id":"W3215896415","doi":"10.1093/neuonc/noab196.015","title":"EPCO-16. ONCOHISTONE INTERACTOME PROFILING UNCOVERS MECHANISMS OF CHROMATIN DISRUPTION AND IDENTIFIES POTENTIAL THERAPEUTIC TARGETS IN PEDIATRIC HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Methyltransferase; Chromatin; Epigenetics; Histone; Methylation; PRC2; DNA methylation; Biology; Mutant; EZH2; Transcription factor; Histone methylation; Histone H3; Genetics; Cell biology; DNA; Gene; Gene expression","score_opus":0.011220755896348404,"score_gpt":0.28270145925320606,"score_spread":0.27148070335685764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215896415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926237,0.0013452161,0.0017871185,0.000066149725,0.000007365293,0.000026494292,0.002530519,0.00013148483,0.0014821407],"genre_scores_gemma":[0.99082774,0.00059173506,0.0021746485,0.000055096025,0.0000023972345,0.00003987907,0.0036792422,0.000023634486,0.002605659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999137,0.000005262522,0.0000037041725,0.000018793624,0.000037650014,0.000020854211],"domain_scores_gemma":[0.999943,0.000007800618,0.000018574347,0.0000046563805,0.00000791242,0.000018094877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008102742,0.0002038382,0.00019018035,0.0004216774,0.00012699132,0.00022707648,0.00014330604,0.00020266883,0.0018084128],"category_scores_gemma":[0.00008326236,0.00010218597,0.00013959054,0.0003182343,0.00011509623,0.00010446744,0.0001736991,0.00018455248,0.00037799162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003571508,0.00002155626,0.008433511,0.00006764003,0.00002038972,0.000103805694,0.000015511947,0.00032048865,0.98340815,0.000079214085,0.0002494512,0.0069231195],"study_design_scores_gemma":[0.000029306078,0.00049041695,0.15083057,0.000013379975,0.00006483503,0.0014320518,0.00009220771,0.004276397,0.8322921,0.00013430146,0.0103339115,0.0000105620065],"about_ca_topic_score_codex":0.000979249,"about_ca_topic_score_gemma":0.001848646,"teacher_disagreement_score":0.0018084128,"about_ca_system_score_codex":0.00031486753,"about_ca_system_score_gemma":0.00015371988,"threshold_uncertainty_score":0.0060496926},"labels":[],"label_agreement":null},{"id":"W3215935280","doi":"10.1093/neuonc/noab196.876","title":"TMOD-15. CHARACTERIZATION OF THE MINIMAL RESIDUAL DISEASE STATE REVEALS DISTINCT EVOLUTIONARY TRAJECTORIES OF HUMAN GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Minimal residual disease; Glioblastoma; Disease; Brain tumor; Transcriptome; Cancer research; Oncology; Biology; Cancer; Medicine; Gene; Internal medicine; Pathology; Genetics; Gene expression","score_opus":0.009684409550831444,"score_gpt":0.2567727922615968,"score_spread":0.2470883827107654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215935280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695444,0.00027994104,0.0011702628,0.000021490523,0.0000044586272,0.000010460189,0.0011609609,0.000020034313,0.0003779033],"genre_scores_gemma":[0.9948954,0.00018813631,0.0016171675,0.000029114137,0.000001913828,0.000021433132,0.0024564562,0.000016627127,0.0007738057],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999491,0.000003952593,0.000004073211,0.000015768737,0.0000124666285,0.000014639507],"domain_scores_gemma":[0.999925,0.0000101184805,0.000023761055,0.0000073437027,0.000016810127,0.000017026001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011540483,0.00008719098,0.00016485027,0.000282083,0.00013451619,0.00034066098,0.00008614232,0.00012834038,0.00063453027],"category_scores_gemma":[0.00019139917,0.00006585604,0.00011456527,0.00024119807,0.00013096047,0.00008090026,0.00017529888,0.0001492418,0.00024103024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019047954,0.000013991663,0.014990972,0.00003413078,0.000010568746,0.0000688946,0.000085997446,0.00024417642,0.9786224,0.00017512705,0.00009166926,0.005471651],"study_design_scores_gemma":[0.000014091798,0.0007741178,0.5587359,0.000030037225,0.000052393298,0.0015379221,0.00045716448,0.00803874,0.41885912,0.0007650834,0.010709488,0.000026029635],"about_ca_topic_score_codex":0.0013312674,"about_ca_topic_score_gemma":0.0020941205,"teacher_disagreement_score":0.0013312674,"about_ca_system_score_codex":0.00024766487,"about_ca_system_score_gemma":0.00014483406,"threshold_uncertainty_score":0.0026470423},"labels":[],"label_agreement":null},{"id":"W3215974396","doi":"10.1093/neuonc/noab196.615","title":"NCOG-24. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Demographics; Chemotherapy; Internal medicine; Glioblastoma; Oncology; Proportional hazards model; Retrospective cohort study; Overall survival; Surgery","score_opus":0.019325454212087124,"score_gpt":0.30946887311374577,"score_spread":0.2901434189016586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215974396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431663,0.001085704,0.00015187237,0.00029715154,0.000018587318,0.00017218672,0.05141167,0.00006545843,0.0036310472],"genre_scores_gemma":[0.96656066,0.00037422654,0.00037486485,0.00016552096,0.000013355953,0.00021869384,0.030969666,0.00002799006,0.0012949666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906653,0.00018236745,0.00013216319,0.00017253513,0.0002410954,0.00020534867],"domain_scores_gemma":[0.994909,0.00046995963,0.0019392872,0.00020115543,0.0016320565,0.00084849744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000998831,0.00032664562,0.00056936766,0.00190728,0.0007300868,0.0011663258,0.000948643,0.0003302289,0.0025237869],"category_scores_gemma":[0.0042534317,0.00024475192,0.00036618544,0.0050610644,0.00033041975,0.00031396377,0.0006962346,0.00038209843,0.00063681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007615394,0.00004742408,0.9872075,0.000114682196,0.00012561296,0.00007259078,0.0000917161,0.00029560053,0.00011282876,0.000037246915,0.004467263,0.0066659977],"study_design_scores_gemma":[0.000061556435,0.000066684865,0.9966625,0.000049209837,0.000059825317,0.00010456313,0.00018431731,0.0005367356,0.000058754922,0.000022024818,0.002183003,0.000010847795],"about_ca_topic_score_codex":0.7796849,"about_ca_topic_score_gemma":0.8341436,"teacher_disagreement_score":0.2203151,"about_ca_system_score_codex":0.008217454,"about_ca_system_score_gemma":0.0065085907,"threshold_uncertainty_score":0.44322515},"labels":[],"label_agreement":null},{"id":"W3216064554","doi":"10.1093/neuonc/noab196.886","title":"TMOD-25. LATENT SOX9-POSITIVE CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RELAPSE","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Metastasis; Medicine; SOX9; Doxycycline; Immune system; Biology; Gene; Transcription factor; Cancer; Internal medicine; Immunology; Genetics","score_opus":0.016248565749370232,"score_gpt":0.2784242439363501,"score_spread":0.2621756781869799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216064554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540687,0.0001641447,0.0032044768,0.000038635015,0.000014410247,0.000014280376,0.00034475842,0.00009094901,0.0007214334],"genre_scores_gemma":[0.9974045,0.00006430987,0.0009719951,0.000007703452,8.950852e-7,0.000009107571,0.00018777588,0.000008751476,0.0013448301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999528,0.000003995757,0.0000028118732,0.000015452566,0.0000135759055,0.000011315349],"domain_scores_gemma":[0.99995613,0.0000067434516,0.000012533713,0.0000050209233,0.000004246549,0.000015316815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052323725,0.00015832476,0.00019599288,0.00010113254,0.000096708514,0.00023357794,0.00015553116,0.00017044968,0.0017080691],"category_scores_gemma":[0.000056194396,0.00008707225,0.00020185884,0.00006995237,0.00013389463,0.0001008849,0.000121444806,0.00033005266,0.00024469596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019287197,0.00008598649,0.0014375102,0.00003121488,0.000008095863,0.00015175888,0.000020553498,0.0022072722,0.99288636,0.00041950433,0.00010501319,0.0024537975],"study_design_scores_gemma":[0.000029654864,0.0007082528,0.007605998,0.00000607439,0.000021979693,0.00033893058,0.00006139804,0.05035496,0.9382544,0.00024491386,0.0023645153,0.000008833155],"about_ca_topic_score_codex":0.0032560874,"about_ca_topic_score_gemma":0.0026407398,"teacher_disagreement_score":0.0032560874,"about_ca_system_score_codex":0.0004719671,"about_ca_system_score_gemma":0.00018464649,"threshold_uncertainty_score":0.0064742565},"labels":[],"label_agreement":null},{"id":"W3216078554","doi":"10.1093/neuonc/noab196.373","title":"IMMU-14. REVEALING THE MANY MYELOID STATES IN HUMAN BRAIN TUMORS AND WAYS TO PERTURB THEM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Tumor microenvironment; Reprogramming; Immunotherapy; Myeloid; Immune system; Brain tumor; Cancer research; Biology; Myeloid cells; Cancer immunotherapy; Medicine; Cell; Immunology; Pathology","score_opus":0.022148403595210354,"score_gpt":0.27306192061723394,"score_spread":0.2509135170220236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216078554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9434417,0.002473806,0.04393546,0.00042137824,0.00010992595,0.00013899295,0.0034031998,0.00054901897,0.005526552],"genre_scores_gemma":[0.9515117,0.0015160247,0.03681327,0.00017511491,0.000014998204,0.000109274384,0.0033888998,0.000119350385,0.00635134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988604,0.0000148323825,0.000009222433,0.00003562701,0.000031028947,0.000023286862],"domain_scores_gemma":[0.9999299,0.000013086262,0.000017639106,0.000013688857,0.000010829758,0.000014875191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023803281,0.0002416073,0.0001563424,0.00034221009,0.00018932257,0.00033024148,0.00017158022,0.0001936826,0.0017946041],"category_scores_gemma":[0.00008590589,0.00015476321,0.00017337709,0.0002217646,0.00024420858,0.00014070266,0.00023249522,0.0004861187,0.00063026836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046789955,0.000012936265,0.00044661982,0.000026553924,0.000004264703,0.000033762313,0.000021842496,0.00010382222,0.9962364,0.00020075624,0.00006386074,0.002802469],"study_design_scores_gemma":[0.0000044406374,0.0001283842,0.0026024096,0.0000039885645,0.00001175938,0.00027226357,0.00003946176,0.0009091543,0.99066764,0.00017708639,0.0051801405,0.0000031736595],"about_ca_topic_score_codex":0.0005621267,"about_ca_topic_score_gemma":0.0013849317,"teacher_disagreement_score":0.0017946041,"about_ca_system_score_codex":0.00024216909,"about_ca_system_score_gemma":0.00020912083,"threshold_uncertainty_score":0.0060035586},"labels":[],"label_agreement":null},{"id":"W3216104460","doi":"10.1093/neuonc/noab196.603","title":"NCOG-12. COGNITIVE FUNCTION (CF) &amp; QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, &amp; VINCRISTINE (PCV) + RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; University of Calgary; Victoria Hospital; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Procarbazine; Quality of life (healthcare); Internal medicine; Oncology; Vincristine; Physical therapy; Chemotherapy","score_opus":0.04271951688715805,"score_gpt":0.32815808853094314,"score_spread":0.2854385716437851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216104460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068147,0.0051323036,0.00018884713,0.00038061826,0.00011798225,0.00024393278,0.0020622076,0.000035708734,0.0011568698],"genre_scores_gemma":[0.99625117,0.00075227045,0.00024434645,0.00023337301,0.000086119144,0.0004156132,0.0014137601,0.000007513684,0.00059577834],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978478,0.001598693,0.00010798322,0.00021479739,0.000117403746,0.00011331491],"domain_scores_gemma":[0.99836737,0.0005679071,0.00053381134,0.000111184454,0.000101263955,0.0003185022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032023417,0.0005891566,0.0019260662,0.00028424303,0.00021642867,0.0008481552,0.0008798573,0.0006402596,0.002495391],"category_scores_gemma":[0.0032776915,0.00026886733,0.0024458405,0.0005702942,0.00035789443,0.00052245037,0.00033426296,0.0014888871,0.0002858118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8530581,0.002266472,0.07447919,0.0016781801,0.013538454,0.000055335222,0.00009379504,0.002458322,0.0018154574,0.00020322484,0.0036738217,0.046679694],"study_design_scores_gemma":[0.52997917,0.15548727,0.2754182,0.00044450632,0.024540292,0.00024142671,0.00017529645,0.0065333117,0.0013368838,0.00087143685,0.004885729,0.00008653787],"about_ca_topic_score_codex":0.004490435,"about_ca_topic_score_gemma":0.0085809445,"teacher_disagreement_score":0.004490435,"about_ca_system_score_codex":0.0009075194,"about_ca_system_score_gemma":0.0010947562,"threshold_uncertainty_score":0.016935825},"labels":[],"label_agreement":null},{"id":"W3216145966","doi":"10.1093/neuonc/noab267","title":"Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Race (biology); Melanoma; Medicine; Internal medicine; Oncology; Cancer research; Sociology; Gender studies","score_opus":0.03220070741561534,"score_gpt":0.3175659699784853,"score_spread":0.28536526256287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216145966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052548316,0.0009995069,0.000031176114,0.9916958,0.0039418107,0.0000047928957,0.000019787321,0.000006296358,0.0027754512],"genre_scores_gemma":[0.006130808,0.0013364941,0.00012931137,0.9662946,0.017724559,0.000022238783,0.000019267953,0.000015727426,0.008327016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980568,0.00074289826,0.00015519474,0.00019313599,0.00042403795,0.00042792122],"domain_scores_gemma":[0.9954129,0.0024212797,0.00025446768,0.00009486544,0.00050846545,0.0013081552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027958385,0.00053827825,0.001315126,0.0004252475,0.0054606185,0.0031293214,0.0013747836,0.04955126,0.010335993],"category_scores_gemma":[0.015074936,0.0004149442,0.00090406724,0.00050437247,0.0025788269,0.00421757,0.0014504236,0.043156143,0.004222317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012642618,0.00006164858,0.0014855453,0.000059861253,0.00002022896,0.0021387457,0.00024942905,0.00005890184,0.00021783572,0.006042853,0.9743352,0.015203369],"study_design_scores_gemma":[0.00024756882,0.00018660707,0.0027886177,0.0005311152,0.00006088421,0.005360371,0.001629806,0.00057759986,0.00026647103,0.026394386,0.9618783,0.00007824624],"about_ca_topic_score_codex":0.015795322,"about_ca_topic_score_gemma":0.035168905,"teacher_disagreement_score":0.04955126,"about_ca_system_score_codex":0.004534362,"about_ca_system_score_gemma":0.0072606974,"threshold_uncertainty_score":0.03457731},"labels":[],"label_agreement":null},{"id":"W3216151293","doi":"10.1093/neuonc/noab196.692","title":"EXTH-53. ANTI-ROBO1 CAR T CELLS EFFECTIVELY TARGET MALIGNANT BRAIN CANCER","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McMaster University","funders":"","keywords":"Downregulation and upregulation; Cancer research; Chimeric antigen receptor; Glioma; Cancer; Degranulation; Medicine; Antigen; Antibody; Brain tumor; Cancer cell; Immunology; Immunotherapy; Biology; Receptor; Pathology; Internal medicine; Gene","score_opus":0.02928900314783732,"score_gpt":0.3489784364317776,"score_spread":0.3196894332839403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216151293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817615,0.0034607651,0.00461399,0.000453951,0.00011339298,0.00015448102,0.00068575615,0.00046539915,0.008290784],"genre_scores_gemma":[0.9919247,0.0010055293,0.0014159877,0.000114720104,0.00002025645,0.000086292064,0.00043385642,0.000025008461,0.0049736574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999211,0.000006533393,0.0000040046148,0.000015127561,0.000013089404,0.000040103187],"domain_scores_gemma":[0.9999714,0.0000049726127,0.000004691902,0.0000036136323,0.0000033728693,0.000011996524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006845948,0.0003620999,0.00029185074,0.00019471286,0.000118907985,0.00033437228,0.00013752567,0.0002694974,0.002241125],"category_scores_gemma":[0.000054059783,0.00007895435,0.00018674837,0.00010152609,0.00017408609,0.00017845651,0.00013079686,0.0006354628,0.0005762436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003652396,0.00033184365,0.00046773918,0.00010230935,0.000020128506,0.00015677375,0.00004104281,0.00053150766,0.9793985,0.00055514823,0.0014040236,0.0166259],"study_design_scores_gemma":[0.00015543272,0.0024099294,0.004480383,0.000016019661,0.00006123186,0.0007236007,0.00004572416,0.0026387312,0.97332,0.00016522262,0.015975237,0.000008441446],"about_ca_topic_score_codex":0.0010253545,"about_ca_topic_score_gemma":0.0016037128,"teacher_disagreement_score":0.002241125,"about_ca_system_score_codex":0.00027332007,"about_ca_system_score_gemma":0.00028500255,"threshold_uncertainty_score":0.0074973702},"labels":[],"label_agreement":null},{"id":"W3216334861","doi":"10.1093/neuonc/noab196.032","title":"EPCO-33. CELL-TYPE PROPORTION DECONVOLUTION OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS FROM SINGLE NUCLEI RNA-seq UNCOVERS UNDERLYING TRANSCRIPTOMIC CHANGES FROM BULK TUMOR RNA-seq COMPARED TO NORMAL BRAIN","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Transcriptome; Gene; RNA; Cell type; RNA-Seq; Gene expression; Brain tumor; Cell; Molecular biology; Cancer research; Genetics; Pathology; Medicine","score_opus":0.037818530060769,"score_gpt":0.27279361741492497,"score_spread":0.23497508735415598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216334861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90075666,0.00083862426,0.038754754,0.0002284784,0.00007271822,0.00015823792,0.051048297,0.0028595396,0.0052827247],"genre_scores_gemma":[0.85485184,0.00055885396,0.048294727,0.00028983632,0.000019541409,0.00055899203,0.087497585,0.0013943603,0.006534379],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.000017804272,0.000012713782,0.000115679904,0.000093476876,0.000039366212],"domain_scores_gemma":[0.9997042,0.00008616253,0.000050354924,0.000033228593,0.00008423603,0.000041728505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038985928,0.0003376358,0.0003220663,0.0005205736,0.0003817764,0.0005256863,0.00033460476,0.00030952384,0.005040062],"category_scores_gemma":[0.00059440144,0.0002918772,0.0003177838,0.00042748085,0.00019665854,0.00019367984,0.00039213896,0.00042481214,0.0015894786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049598323,0.000033781515,0.022181824,0.00019489034,0.00006124268,0.00015506186,0.000114114424,0.0015060741,0.95094013,0.00035874787,0.0044401935,0.019517962],"study_design_scores_gemma":[0.00008017412,0.00028446212,0.26659632,0.00006075564,0.00012604237,0.000986939,0.00021441205,0.033191074,0.66883117,0.0005181056,0.0290633,0.00004723394],"about_ca_topic_score_codex":0.0046505104,"about_ca_topic_score_gemma":0.010078239,"teacher_disagreement_score":0.005040062,"about_ca_system_score_codex":0.0005010952,"about_ca_system_score_gemma":0.00047559539,"threshold_uncertainty_score":0.016860664},"labels":[],"label_agreement":null},{"id":"W3216361204","doi":"10.1093/neuonc/noab196.741","title":"QOLP-20. DIETARY, ACTIVITY, AND QUALITY OF LIFE METRICS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA IMPLEMENTING A KETOGENIC DIET: RESULTS OF A PHASE 1 CLINICAL TRIAL","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketogenic diet; Medicine; Ketosis; Ketone bodies; Quality of life (healthcare); Internal medicine; Clinical trial; Endocrinology; Diabetes mellitus; Metabolism; Epilepsy","score_opus":0.10290699529354985,"score_gpt":0.41716605604836166,"score_spread":0.3142590607548118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216361204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238515,0.0021000868,0.00029632536,0.00051448104,0.000092787064,0.0022412955,0.0015123949,0.00006157546,0.0007959791],"genre_scores_gemma":[0.98514396,0.0014881847,0.0014080507,0.00069172867,0.00014060352,0.0079251705,0.0022985379,0.00001665407,0.00088717754],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99905795,0.0005566794,0.00005846456,0.000119754826,0.00008193921,0.00012519631],"domain_scores_gemma":[0.9988275,0.00020696044,0.00037520254,0.00007936083,0.00012134155,0.00038967442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028217311,0.0017097603,0.0021540124,0.00042875682,0.00036912045,0.0009418897,0.0007272038,0.0009451448,0.0028678076],"category_scores_gemma":[0.0018831446,0.0003919807,0.0018780723,0.0005688483,0.0007979334,0.00090105814,0.0005388819,0.0024927077,0.0004911775],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87583554,0.033818044,0.012539776,0.0010684028,0.00246183,0.00008140802,0.00013464029,0.0012930837,0.0046500205,0.0001187383,0.0026079877,0.065390594],"study_design_scores_gemma":[0.6649031,0.30045363,0.030151144,0.00007097931,0.0010331098,0.000091216534,0.00006338102,0.001101533,0.00092551217,0.00020788575,0.0009631112,0.000035349593],"about_ca_topic_score_codex":0.0009742072,"about_ca_topic_score_gemma":0.0016270323,"teacher_disagreement_score":0.0028678076,"about_ca_system_score_codex":0.00092253654,"about_ca_system_score_gemma":0.0015344992,"threshold_uncertainty_score":0.014922917},"labels":[],"label_agreement":null},{"id":"W3216384050","doi":"10.1093/neuonc/noab196.855","title":"TAMI-73. GLIOBLASTOMA CELL POPULATIONS WITH DISTINCT ONCOGENIC PROGRAMS RELEASE PODOPLANIN AS PROCOAGULANT EXTRACELLULAR VESICLES","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Podoplanin; Cancer research; Microvesicles; Biology; Chemistry; Immunology; microRNA; Gene; Biochemistry","score_opus":0.015314858277603633,"score_gpt":0.266599253932278,"score_spread":0.25128439565467436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216384050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847306,0.0009052295,0.00400561,0.00013545068,0.000045556513,0.000101551246,0.0059849513,0.00022996198,0.0038611763],"genre_scores_gemma":[0.9750381,0.00060052273,0.0040506865,0.00019813754,0.000010831635,0.00025150215,0.012545235,0.000042034597,0.0072628614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986434,0.000006252024,0.000011436195,0.00003223542,0.000032656077,0.000053039017],"domain_scores_gemma":[0.9999503,0.0000062649883,0.000010933631,0.0000065098247,0.000010301733,0.000015736938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008859222,0.00017308786,0.0002609434,0.00027775596,0.0002239613,0.0003765535,0.00011466507,0.00016389374,0.0021545598],"category_scores_gemma":[0.000084852785,0.00011093165,0.00029655165,0.0004130605,0.000088459004,0.00012236534,0.0001791721,0.0003231132,0.00070167304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003433359,0.000090660826,0.0045743366,0.00007343275,0.000033231667,0.00020133097,0.000089838104,0.00014854335,0.9851245,0.00033917252,0.0010521896,0.0079294285],"study_design_scores_gemma":[0.000059456932,0.0005087566,0.064460896,0.00001189985,0.00009442386,0.0010268834,0.00026980558,0.002931706,0.91140586,0.0002568122,0.018957395,0.000016113736],"about_ca_topic_score_codex":0.0028470505,"about_ca_topic_score_gemma":0.0037371542,"teacher_disagreement_score":0.0028470505,"about_ca_system_score_codex":0.00025475782,"about_ca_system_score_gemma":0.0002335637,"threshold_uncertainty_score":0.0072076917},"labels":[],"label_agreement":null},{"id":"W3216564407","doi":"10.1093/neuonc/noab196.092","title":"STEM-18. STROMAL EXTRACELLULAR VESICLES DRIVE GLIOMA STEM CELL REPROGRAMMING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Reprogramming; Stromal cell; Cell biology; Biology; Stem cell; Mesenchymal stem cell; Glioma; Cancer stem cell; Phenotype; Extracellular vesicle; Microvesicles; Cell; Cancer research; microRNA; Genetics; Gene","score_opus":0.018250900688940707,"score_gpt":0.2700543197270724,"score_spread":0.2518034190381317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216564407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624474,0.0033580505,0.018861722,0.000440271,0.00017920928,0.00018418647,0.0019364316,0.00040812884,0.012184593],"genre_scores_gemma":[0.99008894,0.0008644949,0.0033230747,0.00006283827,0.000010843929,0.000051481748,0.000571472,0.00003794875,0.004988852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988806,0.000018307657,0.000010435159,0.000021867496,0.000034331508,0.000026892169],"domain_scores_gemma":[0.9999356,0.000012126869,0.000025388928,0.000006341357,0.0000075499274,0.000013053156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015061308,0.00022834551,0.00017600987,0.00022192682,0.00011138108,0.00044527277,0.00015510418,0.0003017195,0.0022902742],"category_scores_gemma":[0.00007594979,0.000105908504,0.00022689255,0.00016187747,0.00022285024,0.00019048723,0.00032681972,0.00042991486,0.00054485997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011445937,0.000039504528,0.00026165828,0.00012203662,0.0000073436095,0.00010839503,0.000052648367,0.00028712008,0.99122685,0.0023826323,0.00020052375,0.0051967804],"study_design_scores_gemma":[0.000022208256,0.00020817266,0.0011789337,0.0000119286515,0.000015282796,0.00020485846,0.000046275698,0.0015528923,0.9774646,0.0004209147,0.018869312,0.000004683129],"about_ca_topic_score_codex":0.00039024488,"about_ca_topic_score_gemma":0.00055020896,"teacher_disagreement_score":0.0022902742,"about_ca_system_score_codex":0.00029686026,"about_ca_system_score_gemma":0.00017916186,"threshold_uncertainty_score":0.00766176},"labels":[],"label_agreement":null},{"id":"W3216894132","doi":"10.1093/neuonc/noab196.081","title":"STEM-05. FUNCTIONAL MAPPING REVEALS WIDESPREAD REMODELLING AND UNRECOGNIZED PATHWAY DEPENDENCIES IN RECURRENT GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"PTEN; Cancer research; Biology; Signal transduction; Synthetic lethality; Genetics; PI3K/AKT/mTOR pathway; DNA repair; Gene","score_opus":0.04605082114340747,"score_gpt":0.2971969502306166,"score_spread":0.2511461290872091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216894132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939837,0.00028329273,0.003358989,0.00005811627,0.0000081141225,0.000016371856,0.0010356914,0.0002400203,0.0010158637],"genre_scores_gemma":[0.99448943,0.00016537141,0.0020015237,0.000030425519,0.0000019462186,0.000017546212,0.00121532,0.000030801257,0.0020478046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999113,0.0000059408626,0.000006955037,0.000022338882,0.000035327805,0.000018212999],"domain_scores_gemma":[0.99992836,0.000009381186,0.000027042473,0.000009064384,0.000007423252,0.000018711418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009985839,0.00019836873,0.00018708038,0.0003497127,0.00012168058,0.00033844163,0.0001781471,0.00018929278,0.001886532],"category_scores_gemma":[0.00009186958,0.00012528435,0.00015527659,0.00021161884,0.00017315439,0.00008538989,0.00016485766,0.00024484226,0.0003547132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051784817,0.000010409038,0.00069048634,0.000019004443,0.0000056023578,0.000072683666,0.0000126297455,0.00011387766,0.9968117,0.00014117778,0.00005483878,0.0020157485],"study_design_scores_gemma":[0.000013033052,0.00019971418,0.026190607,0.000004805376,0.00003165252,0.0008409604,0.000041606603,0.0030052373,0.96551913,0.0001820669,0.0039657727,0.0000053697236],"about_ca_topic_score_codex":0.0011435645,"about_ca_topic_score_gemma":0.0017634052,"teacher_disagreement_score":0.001886532,"about_ca_system_score_codex":0.00028463543,"about_ca_system_score_gemma":0.00018960565,"threshold_uncertainty_score":0.0063111186},"labels":[],"label_agreement":null},{"id":"W3216935060","doi":"10.1093/neuonc/noab196.524","title":"NIMG-24. RANO CRITERIA DETECTS EARLY PROGRESSION SOONER THAN MODIFIED RANO CRITERIA IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Medicine; Progression-free survival; Tumor progression; Retrospective cohort study; Radiation therapy; Oncology; Surgery; Internal medicine; Overall survival; Radiology; Medical physics; Cancer; Cancer research","score_opus":0.01651467078057148,"score_gpt":0.2938790076198118,"score_spread":0.2773643368392403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216935060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550146,0.0018209593,0.00027854575,0.00006654579,0.000015073141,0.00004157266,0.00061391504,0.000019544397,0.0016424817],"genre_scores_gemma":[0.99866533,0.00021200335,0.00037403684,0.000035594512,0.000010855807,0.00002450216,0.00049896986,0.0000040261675,0.00017482112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931014,0.00019846093,0.00014445557,0.00013630632,0.00012345998,0.00008715995],"domain_scores_gemma":[0.9977418,0.00046213882,0.0012142595,0.00008634635,0.00031547726,0.00018006458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010732419,0.00023654975,0.0004485195,0.001348858,0.00020825388,0.0005505804,0.00039230438,0.00036219246,0.00089450524],"category_scores_gemma":[0.0036165027,0.00012592043,0.0003065802,0.0009828213,0.00024570356,0.00043957887,0.00033796026,0.00019969085,0.00026728908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024703896,0.000010439802,0.9938896,0.000028456405,0.00002864974,0.00024900096,0.00001787876,0.00006336419,0.0004459733,0.000012403899,0.0001868545,0.0048203417],"study_design_scores_gemma":[0.000011209084,0.00013284087,0.9968432,0.0000156548,0.000043472,0.001607915,0.000048415557,0.0003062772,0.00046584947,0.000034892608,0.00048489514,0.000005523177],"about_ca_topic_score_codex":0.0036881124,"about_ca_topic_score_gemma":0.008143194,"teacher_disagreement_score":0.0036881124,"about_ca_system_score_codex":0.0005218999,"about_ca_system_score_gemma":0.00035438398,"threshold_uncertainty_score":0.0073333383},"labels":[],"label_agreement":null},{"id":"W3216971193","doi":"10.1093/neuonc/noab272","title":"Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Western University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Magnetic resonance imaging; Ependymoma; Radiology; Proportional hazards model; Oncology; Internal medicine","score_opus":0.010521962687975893,"score_gpt":0.27227363370569285,"score_spread":0.26175167101771696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216971193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778974,0.0003381468,0.0013764126,0.0000371856,0.0000034976088,0.000009319985,0.00015388078,0.000013700797,0.00027818116],"genre_scores_gemma":[0.9987525,0.00008222362,0.0008100652,0.000009332529,0.000008006482,0.000006872777,0.0002593399,0.000003761556,0.0000679818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982685,0.00003289308,0.000023006607,0.000052673447,0.00004067239,0.000023978499],"domain_scores_gemma":[0.9990396,0.00033614747,0.00036061002,0.00007062717,0.000117035255,0.00007589397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008341379,0.00036712975,0.00032828993,0.0012321854,0.00015142914,0.0005949649,0.0002742313,0.00035327286,0.00064452295],"category_scores_gemma":[0.0026362552,0.00009766054,0.0002899703,0.0005804039,0.00025952174,0.0004168949,0.00035877444,0.00027742036,0.00022999039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007571775,0.000056417462,0.93833345,0.00006906007,0.00016454195,0.0004662562,0.00012260566,0.0028294397,0.024233745,0.000117010226,0.00024250263,0.03260786],"study_design_scores_gemma":[0.000029671024,0.0002812642,0.97216415,0.00002732036,0.00019586348,0.0024419464,0.00018626062,0.01676931,0.0063774316,0.00082013634,0.00068403373,0.00002259753],"about_ca_topic_score_codex":0.00081657,"about_ca_topic_score_gemma":0.0007831111,"teacher_disagreement_score":0.0012321854,"about_ca_system_score_codex":0.00021231752,"about_ca_system_score_gemma":0.00016870005,"threshold_uncertainty_score":0.0044113994},"labels":[],"label_agreement":null},{"id":"W3216975602","doi":"10.1093/neuonc/noab196.078","title":"STEM-02. THERAPEUTIC INTERVENTION OF LUNG-, BREAST-, AND MELANOMA-BRAIN METASTASIS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Population; Medicine; Breast cancer; Context (archaeology); Cancer research; Metastasis; Melanoma; In vivo; Lung cancer; Cancer stem cell; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.026815285374729915,"score_gpt":0.3221159003478448,"score_spread":0.2953006149731149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216975602","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7146676,0.15910341,0.02578862,0.006255001,0.0012734478,0.0015022857,0.0066327173,0.002463236,0.08231376],"genre_scores_gemma":[0.8865479,0.06475433,0.009165428,0.0020788622,0.00016147428,0.0004541726,0.0047545987,0.00009704792,0.031986147],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999362,0.000009152798,0.000004128796,0.000012836659,0.000025798648,0.000011873904],"domain_scores_gemma":[0.9999411,0.000008684668,0.000016990945,0.000003290599,0.0000128937,0.00001694457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016704637,0.0005114975,0.00027509575,0.0005710002,0.00014121059,0.00044953093,0.00024208831,0.00035669698,0.0052356073],"category_scores_gemma":[0.00010223792,0.00010372219,0.00029072713,0.00033344468,0.00022750317,0.00020225611,0.00021503572,0.0007865221,0.00095379975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075077254,0.00055193267,0.00118068,0.0014855441,0.000076440454,0.0004571565,0.00007688952,0.0010662269,0.8119248,0.0050840913,0.0049948865,0.17235056],"study_design_scores_gemma":[0.00053649396,0.0059728594,0.007193804,0.00026330317,0.00020791685,0.0011646856,0.00010934121,0.002731344,0.8472821,0.0023772356,0.13213398,0.000026922517],"about_ca_topic_score_codex":0.0007114924,"about_ca_topic_score_gemma":0.0019589541,"teacher_disagreement_score":0.0052356073,"about_ca_system_score_codex":0.0003494008,"about_ca_system_score_gemma":0.00033961682,"threshold_uncertainty_score":0.017514884},"labels":[],"label_agreement":null},{"id":"W3216996692","doi":"10.1093/neuonc/noab196.233","title":"CTNI-08. DB102-01 ENGAGE STUDY: A BIOMARKER-GUIDED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF DB102 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Placebo; Internal medicine; Biomarker; Clinical endpoint; Oncology; Surrogate endpoint; Clinical trial; Phases of clinical research; Progression-free survival; Randomized controlled trial; Radiation therapy; Chemotherapy; Pathology","score_opus":0.0727596786582985,"score_gpt":0.3900084116739805,"score_spread":0.317248733015682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216996692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96164995,0.0053059985,0.0013748362,0.0019289573,0.0011050901,0.018227667,0.004108239,0.00046882042,0.0058303652],"genre_scores_gemma":[0.94428897,0.0033602484,0.00502241,0.0042622103,0.0010880099,0.028658733,0.0050088977,0.00009595425,0.008214646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907315,0.0005460596,0.0000466169,0.00013375194,0.000078955054,0.00012142858],"domain_scores_gemma":[0.99895835,0.0001634177,0.00029861176,0.000090530404,0.00009256774,0.0003964625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024939158,0.0026149522,0.0026334117,0.00055179634,0.00070317223,0.0014058937,0.0012084144,0.002841788,0.0071495827],"category_scores_gemma":[0.0015505916,0.0007311218,0.0016791959,0.00054293405,0.0013206286,0.0011435493,0.0004622657,0.003852656,0.0014782668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9719595,0.010628797,0.00051531586,0.0004926841,0.0005714996,0.000029779629,0.00003180172,0.00022250788,0.005555328,0.00016348834,0.0016803514,0.008149047],"study_design_scores_gemma":[0.9263945,0.07071487,0.00091473444,0.000023446362,0.00026681644,0.00002240859,0.000011049861,0.00023748261,0.00050565234,0.000113619324,0.00078140676,0.000014005844],"about_ca_topic_score_codex":0.000981056,"about_ca_topic_score_gemma":0.0034626352,"teacher_disagreement_score":0.0071495827,"about_ca_system_score_codex":0.000896039,"about_ca_system_score_gemma":0.0019924717,"threshold_uncertainty_score":0.023917735},"labels":[],"label_agreement":null},{"id":"W3217006037","doi":"10.1093/neuonc/noab196.466","title":"PATH-14. ALPHA CARDIAC ACTIN EXPRESSION IS OBSERVED IN AGGRESSIVE GLIOMA SUBTYPES AND GLIOBLASTOMA STEM CELLS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glioma; Biology; Cancer research; Actin; Western blot; Pathology; Protein subunit; Molecular biology; Cell biology; Medicine; Gene; Genetics","score_opus":0.02383724390006087,"score_gpt":0.27874561897179145,"score_spread":0.2549083750717306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217006037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965867,0.00047378574,0.00044205444,0.00003514499,0.0000041722874,0.000011520054,0.0010517116,0.000049303282,0.001345581],"genre_scores_gemma":[0.9955289,0.00030002132,0.0006774658,0.00003685519,0.000005708959,0.000023741573,0.0020374733,0.00001705816,0.0013728348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989045,0.0000067523456,0.000007572264,0.00002998072,0.000039875616,0.00002519814],"domain_scores_gemma":[0.9998528,0.000011754718,0.000070165566,0.000008602691,0.00001701784,0.000039625364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007733799,0.0001386352,0.00014056882,0.00055249315,0.00016392782,0.00032493763,0.000086439286,0.00014649959,0.0016101426],"category_scores_gemma":[0.000101894744,0.00013215534,0.000110962435,0.00044462146,0.00015037687,0.000079336016,0.00012514822,0.00020004093,0.00051332713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003611559,0.000022387445,0.043059584,0.00007966697,0.00002611944,0.00032101688,0.00007782424,0.0001114804,0.9490392,0.00010007822,0.00037612888,0.0064253854],"study_design_scores_gemma":[0.000022876326,0.00025939176,0.8196721,0.000017821012,0.00005280604,0.0023623577,0.00024414193,0.0013163356,0.16961543,0.00022365019,0.0062033767,0.000009670552],"about_ca_topic_score_codex":0.0010145492,"about_ca_topic_score_gemma":0.001501752,"teacher_disagreement_score":0.0016101426,"about_ca_system_score_codex":0.00019073476,"about_ca_system_score_gemma":0.00015273382,"threshold_uncertainty_score":0.005386412},"labels":[],"label_agreement":null},{"id":"W3217052936","doi":"10.1093/neuonc/noab196.634","title":"NCOG-44. FEASIBILITY AND UTILITY OF THE MONTREAL COGNITIVE ASSESSMENT IN ROUTINE CLINICAL EXAMS AND TELEHEALTH VISITS IN NEURO-ONCOLOGY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telehealth; Montreal Cognitive Assessment; Medicine; Telemedicine; Cognition; Physical therapy; Descriptive statistics; Reliability (semiconductor); Test (biology); Family medicine; Cognitive impairment; Health care; Psychiatry","score_opus":0.06249526940776881,"score_gpt":0.41118645046855257,"score_spread":0.3486911810607838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217052936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946673,0.00018177423,0.0004666223,0.0003394387,0.000027426197,0.0003191911,0.00075131335,0.000036484886,0.0032104864],"genre_scores_gemma":[0.9974369,0.00006722323,0.0011286879,0.00013243537,0.000016905567,0.00023301011,0.0004745801,0.000010127088,0.000500157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960393,0.002338375,0.00028613178,0.00022643978,0.0007637763,0.0003460191],"domain_scores_gemma":[0.9903222,0.0039414857,0.0026421547,0.00034451336,0.0017605238,0.0009890666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056611667,0.00020287262,0.00021328454,0.0004903902,0.0003767147,0.0006475347,0.00035509383,0.00035223423,0.0027523534],"category_scores_gemma":[0.019840999,0.00013636948,0.00048699367,0.00054798153,0.00023331217,0.00045014886,0.00067382696,0.00039532562,0.0005890785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054907013,0.0004125546,0.9628491,0.00003136914,0.000033234763,0.00004367627,0.00027912948,0.00014666718,0.00026029916,0.000023068915,0.0016050244,0.033766825],"study_design_scores_gemma":[0.000071303104,0.0011567292,0.9957262,0.000022618291,0.000025326017,0.00011490197,0.0003910717,0.00088838703,0.00027119945,0.000023609417,0.0013003688,0.000008200103],"about_ca_topic_score_codex":0.0112004215,"about_ca_topic_score_gemma":0.019762445,"teacher_disagreement_score":0.0112004215,"about_ca_system_score_codex":0.00087750005,"about_ca_system_score_gemma":0.0010242298,"threshold_uncertainty_score":0.029939413},"labels":[],"label_agreement":null},{"id":"W3217065735","doi":"10.1093/neuonc/noab196.728","title":"QOLP-07. EXPLORING CALM IN PATIENTS WITH HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Distress; Randomized controlled trial; Anxiety; Depression (economics); Quality of life (healthcare); Clinical trial; Adverse effect; Cancer; Clinical psychology; Internal medicine; Physical therapy; Psychiatry; Nursing","score_opus":0.034265807147396146,"score_gpt":0.2869844000601862,"score_spread":0.2527185929127901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217065735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048257,0.0009029159,0.00026454357,0.00087618537,0.000028479191,0.00088261534,0.0017214902,0.00005853925,0.004782734],"genre_scores_gemma":[0.9913762,0.00086480076,0.0021180632,0.00054349896,0.000032406562,0.0021140098,0.0018896193,0.000008232865,0.0010532376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996321,0.0002007262,0.000026056074,0.000029567555,0.00005038415,0.00006106491],"domain_scores_gemma":[0.99920565,0.00023421894,0.0002089157,0.000028387654,0.00008177848,0.00024100275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000973273,0.0002281405,0.00037167536,0.00026968116,0.0002804539,0.0004909081,0.00022829152,0.00023012966,0.005879307],"category_scores_gemma":[0.0016844182,0.00009499358,0.0005108699,0.00049647986,0.0001985144,0.0002934825,0.00049796526,0.0006154748,0.0005711994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026766783,0.011012216,0.32172632,0.0018741013,0.0004468117,0.0003319588,0.001474291,0.00072079815,0.0025118866,0.00059169595,0.013990262,0.618553],"study_design_scores_gemma":[0.013743887,0.053968757,0.90404594,0.0003823388,0.00059220137,0.0005691252,0.0018195984,0.0014359422,0.0018155198,0.00093226525,0.020642243,0.000052161922],"about_ca_topic_score_codex":0.0015747194,"about_ca_topic_score_gemma":0.0032711583,"teacher_disagreement_score":0.005879307,"about_ca_system_score_codex":0.0005891187,"about_ca_system_score_gemma":0.0011707586,"threshold_uncertainty_score":0.019668281},"labels":[],"label_agreement":null},{"id":"W3217106497","doi":"10.1093/neuonc/noab196.288","title":"DDRE-04. EFFECTIVENESS AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH LEPTOMENINGEAL METASTASES FORM NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Medicine; Common Terminology Criteria for Adverse Events; Internal medicine; Oncology; Lung cancer; Adverse effect; Meta-analysis; Hazard ratio; Epidermal growth factor receptor; Cancer; Confidence interval; Erlotinib","score_opus":0.03459315506263771,"score_gpt":0.3857840444814286,"score_spread":0.3511908894187909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217106497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007013389,0.9893106,0.00046409125,0.00030675874,0.00014878697,0.00048009446,0.001666517,0.00003345318,0.00057628093],"genre_scores_gemma":[0.2589776,0.73158914,0.0023719224,0.0016376381,0.00033304287,0.001917043,0.0023108167,0.000050092942,0.0008127434],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993105,0.0031069042,0.0020467576,0.0007107103,0.00079825346,0.00023234134],"domain_scores_gemma":[0.9911963,0.005674546,0.0018604948,0.00024107678,0.0008409016,0.00018663112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009406376,0.0018812517,0.014026939,0.0060536503,0.00048431905,0.0027713743,0.0018085764,0.0021286428,0.0058970926],"category_scores_gemma":[0.01794018,0.0009974056,0.031452246,0.0063813115,0.00057843624,0.0016405773,0.0012406666,0.0016461916,0.00051087694],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002260272,0.00003430124,0.00359929,0.5202418,0.4602399,0.00011021565,0.000066005865,0.00041450452,0.00025168655,0.00016975304,0.0009728719,0.011639428],"study_design_scores_gemma":[0.0014925484,0.0002799931,0.004488734,0.032764375,0.9575994,0.00013536934,0.000047925343,0.0002107684,0.0001232424,0.00023206798,0.0025972829,0.000028355294],"about_ca_topic_score_codex":0.0046056686,"about_ca_topic_score_gemma":0.011766215,"teacher_disagreement_score":0.014026939,"about_ca_system_score_codex":0.0024525588,"about_ca_system_score_gemma":0.0028082712,"threshold_uncertainty_score":0.049746275},"labels":[],"label_agreement":null},{"id":"W3217143832","doi":"10.1093/neuonc/noab196.217","title":"CTIM-25. A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Medicine; Nivolumab; Internal medicine; Placebo; Oncology; Radiation therapy; Phases of clinical research; Progression-free survival; Randomized controlled trial; Gastroenterology; Cancer; Clinical trial; Overall survival; Immunotherapy; Pathology","score_opus":0.011643069760755319,"score_gpt":0.28607589327143335,"score_spread":0.27443282351067805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217143832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861843,0.0035643945,0.00052393903,0.00048096088,0.00050377933,0.0048301443,0.0016264506,0.00015675671,0.002129337],"genre_scores_gemma":[0.99090624,0.0011442503,0.0008550531,0.0006654862,0.00017752053,0.0030827948,0.0010230772,0.000018049042,0.002127596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999521,0.0002535754,0.000024871359,0.000078894234,0.000028898092,0.00009269773],"domain_scores_gemma":[0.9994412,0.00010563573,0.00012701954,0.000040625106,0.000039308234,0.00024625327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013492157,0.001226799,0.001841992,0.00043574232,0.0003611897,0.0010481916,0.00092939695,0.0013215931,0.004909001],"category_scores_gemma":[0.0009778556,0.00059697963,0.0014512554,0.00036065897,0.000901817,0.0006542619,0.0002919682,0.0022269492,0.00080648356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9690982,0.008413169,0.00090716104,0.00036450077,0.00072018587,0.0000384556,0.000036532852,0.00038936795,0.0057122232,0.00007989354,0.0009556339,0.013284649],"study_design_scores_gemma":[0.8849698,0.109910354,0.0022700704,0.000024033507,0.0005367412,0.000027454664,0.000019447765,0.00040926354,0.0009416828,0.00009181084,0.0007833741,0.000016031094],"about_ca_topic_score_codex":0.001710397,"about_ca_topic_score_gemma":0.0054929354,"teacher_disagreement_score":0.004909001,"about_ca_system_score_codex":0.0010570498,"about_ca_system_score_gemma":0.0017214769,"threshold_uncertainty_score":0.016422272},"labels":[],"label_agreement":null},{"id":"W3217210659","doi":"10.1093/neuonc/noab196.026","title":"EPCO-27. SINGLE-CELL ANALYSIS OF ETMR PATIENT SAMPLES LINKS TRANSCRIPTIONAL PHENOTYPES TO GENETIC DRIVER ALTERATIONS AND INFORMS NOVEL THERAPEUTIC STRATEGIES","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; SOX2; Embryonic stem cell; Stem cell; Phenotype; Neural stem cell; microRNA; Population; Progenitor cell; Cell; Gene silencing; KLF4; Cancer research; Genetics; Cell biology; Gene; Medicine","score_opus":0.021333463713070627,"score_gpt":0.2644507298644257,"score_spread":0.24311726615135507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217210659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96957076,0.0015887329,0.009777101,0.00038190145,0.00005870981,0.00021711853,0.010995179,0.00042231055,0.006988172],"genre_scores_gemma":[0.9665259,0.000708746,0.010517544,0.0002410035,0.00002039977,0.00025558667,0.016082844,0.0001544754,0.0054935254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977213,0.000019877216,0.000026365098,0.000075204436,0.00006774602,0.000038751303],"domain_scores_gemma":[0.9997571,0.000051696385,0.00002917616,0.00004022131,0.000067758374,0.000053978172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038648912,0.00019674351,0.00028097501,0.0004854889,0.00026122792,0.0003643451,0.00028487298,0.0003441079,0.004607232],"category_scores_gemma":[0.00034959186,0.00010295632,0.00015694195,0.00034870583,0.00020496544,0.0001238744,0.00020744669,0.0004125035,0.00169075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674433,0.00007931426,0.023037544,0.00009845933,0.000030314868,0.0014298866,0.00007596254,0.00026307628,0.9586609,0.00021646587,0.0017828809,0.013757794],"study_design_scores_gemma":[0.00006106207,0.0005643978,0.2328979,0.000037443155,0.0000706492,0.009784781,0.00018190034,0.0036682887,0.7267904,0.00026249915,0.02566307,0.000017586613],"about_ca_topic_score_codex":0.0010415412,"about_ca_topic_score_gemma":0.0018935528,"teacher_disagreement_score":0.004607232,"about_ca_system_score_codex":0.00025539743,"about_ca_system_score_gemma":0.00019727924,"threshold_uncertainty_score":0.015412748},"labels":[],"label_agreement":null},{"id":"W3217222663","doi":"10.1093/neuonc/noab196.463","title":"PATH-11. PDGFA INITIATES ABERRANT MITOSIS AND MALIGNANT TRANSFORMATION OF NEURAL PROGENITOR CELLS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Biology; Mitosis; Progenitor cell; Cell biology; Platelet-derived growth factor receptor; Growth factor; Cell cycle; Subventricular zone; Stem cell; Cancer research; Immunology; Cell; Genetics; Receptor","score_opus":0.022924073194300815,"score_gpt":0.27875670326381685,"score_spread":0.25583263006951606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217222663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910234,0.0015071541,0.0020204808,0.000086988344,0.000033608518,0.000045777426,0.0009276624,0.00008738662,0.004267497],"genre_scores_gemma":[0.99169135,0.00095157285,0.0015046415,0.00005663228,0.0000061454857,0.00005854165,0.0010022065,0.000015168431,0.0047137863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999201,0.000010377833,0.000011946567,0.00001320508,0.000025125724,0.000019263256],"domain_scores_gemma":[0.9999293,0.000016064194,0.000017716915,0.000008817819,0.000007838117,0.00002017068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006603117,0.00023089166,0.00015287398,0.0002340133,0.0001648465,0.00028447915,0.000110821165,0.00022766965,0.0015652776],"category_scores_gemma":[0.00006820268,0.00013393025,0.00016067385,0.000121346755,0.00012450368,0.00010190407,0.00022264976,0.0004384485,0.00074091466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013607356,0.00003915437,0.0007003001,0.000044080247,0.000003968562,0.00024721716,0.000027849197,0.00006587823,0.9965444,0.00025649852,0.000084912856,0.0018497445],"study_design_scores_gemma":[0.000019014837,0.00043198682,0.013852916,0.000013044387,0.000011659829,0.0009898165,0.000056432284,0.0011371333,0.9771115,0.00013854692,0.0062344633,0.000003486788],"about_ca_topic_score_codex":0.001075023,"about_ca_topic_score_gemma":0.0012790839,"teacher_disagreement_score":0.0015652776,"about_ca_system_score_codex":0.00025205573,"about_ca_system_score_gemma":0.00031581544,"threshold_uncertainty_score":0.0052363873},"labels":[],"label_agreement":null},{"id":"W3217321524","doi":"10.1093/neuonc/noab196.246","title":"CTNI-21. PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Medicine; Methyltransferase; Radiation therapy; O-6-methylguanine-DNA methyltransferase; In vivo; Internal medicine; Phases of clinical research; Oncology; Stage (stratigraphy); Gastroenterology; Cancer research; Chemotherapy; Biology; DNA; Methylation","score_opus":0.025632566711072675,"score_gpt":0.34625628651452445,"score_spread":0.3206237198034518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217321524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906356,0.0015505826,0.0005394784,0.0003308324,0.0001528111,0.0036374638,0.001245705,0.00012720712,0.0017802975],"genre_scores_gemma":[0.9787396,0.0021085953,0.0032719837,0.0007736691,0.00017120352,0.0047502047,0.0044517484,0.00007832029,0.0056546056],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995517,0.00020958584,0.000020245454,0.000073608746,0.000056216624,0.0000886161],"domain_scores_gemma":[0.9993825,0.000044373803,0.000095241296,0.00006661227,0.000048533977,0.00036281886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015413858,0.0019291524,0.0019081325,0.0006504206,0.0005618026,0.0010066939,0.0017274193,0.0014340552,0.0024785944],"category_scores_gemma":[0.0006928606,0.0010055437,0.0010528684,0.00057050784,0.0010751407,0.00063525635,0.00050888455,0.0038447788,0.0009419004],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44396046,0.21202517,0.008282368,0.001012992,0.0014226519,0.0007672875,0.0006773685,0.007515522,0.22113423,0.0006437971,0.006887445,0.09567066],"study_design_scores_gemma":[0.260052,0.69345057,0.012328356,0.000040669158,0.0004458915,0.0007640332,0.000083987245,0.002286068,0.024804633,0.00023675294,0.0054490627,0.00005801852],"about_ca_topic_score_codex":0.0030872854,"about_ca_topic_score_gemma":0.006953357,"teacher_disagreement_score":0.0030872854,"about_ca_system_score_codex":0.0012841668,"about_ca_system_score_gemma":0.0029664808,"threshold_uncertainty_score":0.0093173385},"labels":[],"label_agreement":null},{"id":"W3217334326","doi":"10.1093/neuonc/noab196.588","title":"NCMP-17. BEWARE: ALL POSTERIOR FOSSA MASSES IN CHILDREN ARE NOT BRAIN TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lumbar puncture; Papilledema; Headaches; Bone marrow; Radiology; Pathology; Surgery; Cerebrospinal fluid","score_opus":0.022379855995034646,"score_gpt":0.30217476056253645,"score_spread":0.2797949045675018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217334326","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34075528,0.020987963,0.0049303067,0.049270675,0.009473724,0.00052264176,0.01227642,0.0031101892,0.5586728],"genre_scores_gemma":[0.8685245,0.012542117,0.00798615,0.009160838,0.006283034,0.000395762,0.008680656,0.00081948674,0.0856075],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9995432,0.00006967196,0.000055351404,0.00006627564,0.00014976482,0.000115665185],"domain_scores_gemma":[0.9982551,0.0004655435,0.0004038936,0.00013850068,0.000335475,0.00040150678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039377206,0.0004478579,0.00035526752,0.0007628691,0.00069915893,0.0010118359,0.0005564025,0.0017570307,0.038441807],"category_scores_gemma":[0.0042254757,0.00023476665,0.00016923284,0.000693891,0.00062677846,0.0011130119,0.0007520452,0.0010759486,0.015412819],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057478226,0.00013770541,0.23714006,0.00081738306,0.000033188415,0.1851839,0.0005020947,0.00052724715,0.0044640177,0.004877925,0.3414059,0.22433583],"study_design_scores_gemma":[0.000060487037,0.0001595023,0.096936524,0.0014020262,0.000037073776,0.45420763,0.000582083,0.0005807625,0.002849287,0.0030611316,0.44008452,0.000038952523],"about_ca_topic_score_codex":0.0012606521,"about_ca_topic_score_gemma":0.0018848771,"teacher_disagreement_score":0.038441807,"about_ca_system_score_codex":0.00045442118,"about_ca_system_score_gemma":0.00083183136,"threshold_uncertainty_score":0.12860066},"labels":[],"label_agreement":null},{"id":"W3217336123","doi":"10.1093/neuonc/noab196.234","title":"CTNI-09. TRIDENT PHASE 3 TRIAL (EF-32): FIRST-LINE TUMOR TREATING FIELDS (TTFields; 200 KHZ) CONCOMITANT WITH CHEMO-RADIATION, FOLLOWED BY MAINTENANCE TTFIELDS/TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Radiation therapy; Clinical endpoint; Oncology; Internal medicine; Phases of clinical research; Surgery; Clinical trial","score_opus":0.013821871884512433,"score_gpt":0.29384194120033774,"score_spread":0.2800200693158253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217336123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403526,0.006973191,0.00069026795,0.0016712771,0.00058879243,0.0040579936,0.0039305924,0.0003025544,0.0077500823],"genre_scores_gemma":[0.9650465,0.004631942,0.0035170154,0.0026446052,0.00035789103,0.00601767,0.0073544043,0.00009040767,0.010339572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99970824,0.00011809551,0.0000142874105,0.00006020895,0.00003278884,0.000066330846],"domain_scores_gemma":[0.9995807,0.000037745383,0.00010259887,0.000028797363,0.000027115228,0.00022296839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013094853,0.00132046,0.0015871018,0.00045590743,0.00040272434,0.0009943268,0.0007963652,0.0011738713,0.0060417545],"category_scores_gemma":[0.0007294158,0.00038481044,0.0012318862,0.0004352404,0.0008691906,0.0007904823,0.00029730695,0.0030399212,0.0010337805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85372317,0.018968537,0.0022067206,0.001580248,0.0010635332,0.00018129472,0.00013523179,0.0017980026,0.019778661,0.0009124921,0.01636686,0.08328532],"study_design_scores_gemma":[0.77804637,0.20292802,0.0059997602,0.00019164327,0.0006078092,0.00033475528,0.000056103934,0.0014745402,0.0027742875,0.00071821804,0.0068171425,0.000051345836],"about_ca_topic_score_codex":0.0024485434,"about_ca_topic_score_gemma":0.00938412,"teacher_disagreement_score":0.0060417545,"about_ca_system_score_codex":0.0015896799,"about_ca_system_score_gemma":0.0020219975,"threshold_uncertainty_score":0.020211697},"labels":[],"label_agreement":null},{"id":"W3217378019","doi":"10.1093/neuonc/noab196.020","title":"EPCO-21. CORE REGULATORY CIRCUIT TRANSCRIPTION FACTORS DRIVE EXPRESSION FROM HIGH LEVEL AMPLICONS IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncogene; Enhancer; Amplicon; Biology; Transcription factor; Cancer research; Oncogene Proteins; Genetics; Gene; Regulation of gene expression; Cell cycle; Polymerase chain reaction","score_opus":0.04037904642475229,"score_gpt":0.27600996968007707,"score_spread":0.23563092325532478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217378019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803883,0.0016054644,0.005565969,0.00012091327,0.000038035912,0.000055068365,0.008130909,0.00041421407,0.0036811568],"genre_scores_gemma":[0.9799968,0.0005861666,0.0052545667,0.00017193801,0.000011815058,0.00008681874,0.009726624,0.00017991441,0.0039854464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997125,0.000016118343,0.000013961135,0.0001050583,0.000083494044,0.00006876179],"domain_scores_gemma":[0.99963224,0.000059842194,0.00010527482,0.000036555448,0.00008079864,0.00008528643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019945833,0.00025198123,0.00032574905,0.00038434647,0.00027517418,0.0005099961,0.00026306545,0.00026417588,0.0046412577],"category_scores_gemma":[0.00034233084,0.0002151836,0.00028286348,0.00039928372,0.0002601356,0.00022226691,0.00041105537,0.00043385767,0.0013883369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047470018,0.000047586596,0.022530042,0.00024555932,0.000024223333,0.00014558957,0.000085619366,0.00047576576,0.96039623,0.00031341746,0.0010528311,0.014208368],"study_design_scores_gemma":[0.00004530189,0.00032364178,0.2924918,0.0000483319,0.00007264617,0.0010455099,0.0002158003,0.0036474243,0.68568355,0.00036302654,0.016042301,0.00002068375],"about_ca_topic_score_codex":0.0021210418,"about_ca_topic_score_gemma":0.0042362856,"teacher_disagreement_score":0.0046412577,"about_ca_system_score_codex":0.0005616433,"about_ca_system_score_gemma":0.0004925151,"threshold_uncertainty_score":0.015526593},"labels":[],"label_agreement":null},{"id":"W3217659434","doi":"10.1093/neuonc/noab196.571","title":"NIMG-74. RESPONSE ASSESSMENT AFTER DOSE-ESCALATED RADIOTHERAPY: IMAGING PROTOCOL OF A MULTICENTER PHASE III TRIAL ON INTRAOPERATIVE RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (INTRAGO-II;ARO2016-1;AG-NRO-03)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Neuroradiology; Radiation therapy; Radiology; Radiological weapon; Nuclear medicine; Glioblastoma; Neurology","score_opus":0.015423539568487252,"score_gpt":0.3625809745348222,"score_spread":0.34715743496633494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217659434","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13718642,0.0014729346,0.010482285,0.0017538466,0.000599493,0.8238343,0.012911149,0.00072309974,0.011036479],"genre_scores_gemma":[0.073632404,0.00041410542,0.018482497,0.0012789111,0.00012442394,0.89672405,0.0071152905,0.00009803155,0.0021302176],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897231,0.007828894,0.0006105606,0.00069628895,0.000574482,0.00056667905],"domain_scores_gemma":[0.9946662,0.0005647303,0.0015720546,0.00076160335,0.0009430448,0.0014923583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018512752,0.0023309207,0.002235433,0.0008693003,0.0014618594,0.0014226144,0.0027879954,0.0022684895,0.008377613],"category_scores_gemma":[0.009020706,0.0010442341,0.0016621351,0.0012332951,0.0016653023,0.00091114186,0.0013725988,0.0040922556,0.0039330004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8546658,0.02617904,0.004494313,0.002558595,0.0008826451,0.00022193002,0.00047964326,0.00491594,0.015562972,0.0017627993,0.024344038,0.06393237],"study_design_scores_gemma":[0.7658805,0.1379213,0.022547765,0.0005612703,0.0011906736,0.00023040734,0.00017214504,0.0034921411,0.006520692,0.0014376235,0.059908684,0.00013688064],"about_ca_topic_score_codex":0.0023506258,"about_ca_topic_score_gemma":0.0055772774,"teacher_disagreement_score":0.018512752,"about_ca_system_score_codex":0.003888739,"about_ca_system_score_gemma":0.009353292,"threshold_uncertainty_score":0.09790599},"labels":[],"label_agreement":null},{"id":"W3217762824","doi":"10.1093/neuonc/noab196.450","title":"INNV-40. REAL WORLD INTEGRATION OF THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE IN PATIENTS WITH IDH-WT GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Physical therapy","score_opus":0.030635473931922053,"score_gpt":0.3790991979070396,"score_spread":0.34846372397511755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217762824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94025475,0.000964719,0.0021458277,0.0020044472,0.00017645299,0.0014442081,0.025216846,0.0006841205,0.02710859],"genre_scores_gemma":[0.97426355,0.0003481478,0.00832581,0.00062200305,0.00006562469,0.0025225682,0.010937397,0.000113244496,0.0028017177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974964,0.0012934012,0.00028535404,0.0002968288,0.00045573968,0.00017214588],"domain_scores_gemma":[0.99405175,0.0015856739,0.0019078729,0.0004434924,0.0009924105,0.0010187227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005332939,0.0002471737,0.00048702193,0.0007976472,0.00039876217,0.0013178507,0.0005285479,0.00032040518,0.004406859],"category_scores_gemma":[0.010239861,0.00015083584,0.0003719447,0.0012723635,0.0003102784,0.0007481884,0.001326384,0.00051330583,0.0017210509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031696872,0.000606342,0.8658146,0.00020578521,0.0001209825,0.00010289432,0.0004092235,0.0008869812,0.00043033416,0.00042160245,0.020047434,0.10778406],"study_design_scores_gemma":[0.0004029259,0.0016312283,0.9680216,0.00017769999,0.00006789901,0.0002382392,0.00057832315,0.004005427,0.00060736283,0.0010975444,0.023104887,0.00006683887],"about_ca_topic_score_codex":0.004207777,"about_ca_topic_score_gemma":0.011806521,"teacher_disagreement_score":0.005332939,"about_ca_system_score_codex":0.0015678103,"about_ca_system_score_gemma":0.0015689333,"threshold_uncertainty_score":0.028203547},"labels":[],"label_agreement":null},{"id":"W3217776441","doi":"10.1093/neuonc/noab196.072","title":"BIOM-41. LIVE-CELL IMAGING SHOWS UNEVEN SEGREGATION OF EXTRACHROMOSOMAL DNA ELEMENTS AND TRANSCRIPTIONALLY ACTIVE EXTRACHROMOSOMAL DNA CLUSTERS IN CANCER","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extrachromosomal DNA; Biology; Mitosis; DNA; Carcinogenesis; Cell biology; Genetics; Cell; Cancer","score_opus":0.012188513807999044,"score_gpt":0.27023144227397505,"score_spread":0.258042928465976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217776441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535231,0.0034466535,0.03480761,0.00032041266,0.000053580963,0.0000326065,0.00082549104,0.0005056143,0.0064848927],"genre_scores_gemma":[0.9720605,0.0012547836,0.018717723,0.00010418266,0.000006878476,0.0000432486,0.00070016715,0.00009251408,0.0070200013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990916,0.00000795981,0.0000053219674,0.000036635804,0.00002205707,0.000018854],"domain_scores_gemma":[0.9999318,0.000020357744,0.000013306419,0.000010022185,0.000008707815,0.000015795797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013406211,0.0001955764,0.00014627053,0.00032293427,0.00022823451,0.00036923378,0.00017621105,0.00038237227,0.0015079431],"category_scores_gemma":[0.00010090761,0.00021019593,0.00012645528,0.0002957072,0.0002216443,0.00022220671,0.00026471392,0.00043882316,0.00047324065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019961146,0.000006308975,0.00022595045,0.000025515506,0.000002824806,0.000044978377,0.000024240308,0.00010505306,0.99810994,0.0001744372,0.000046591504,0.0012142037],"study_design_scores_gemma":[0.000005609728,0.00004875459,0.00787277,0.0000074035556,0.000009169352,0.00031911547,0.00004258153,0.0035861707,0.98427194,0.00017566548,0.0036538565,0.000007034135],"about_ca_topic_score_codex":0.0017728801,"about_ca_topic_score_gemma":0.0028184808,"teacher_disagreement_score":0.0017728801,"about_ca_system_score_codex":0.00032091048,"about_ca_system_score_gemma":0.00021372242,"threshold_uncertainty_score":0.0050445795},"labels":[],"label_agreement":null},{"id":"W3217784408","doi":"10.1093/neuonc/noab196.798","title":"TAMI-14. REDUCTION IN S. CEREVISIAE GROWTH AND CELL VIABILITY IN RESPONSE TO D-2-HYDROXYGLUTARATE ACCUMULATION IS DAMPENED BY GROWTH CONDITIONS PERMISSIVE OF OXIDATIVE PHOSPHORYLATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Viability assay; Biology; Yeast; Biochemistry; Oxidative phosphorylation; Cell growth; Saccharomyces cerevisiae; Mitochondrion; Isocitrate dehydrogenase; Glycolysis; Cell; Cell biology; Metabolism","score_opus":0.012715252238251517,"score_gpt":0.29339647857306966,"score_spread":0.2806812263348181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217784408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818087,0.001307213,0.006141675,0.00034915272,0.00025841442,0.00012226778,0.0042498936,0.00044370827,0.0053189546],"genre_scores_gemma":[0.9713415,0.0008401197,0.010000688,0.00018970117,0.000025961031,0.00023394651,0.0064520487,0.0002564648,0.010659606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972683,0.00004189581,0.000044565164,0.0000669725,0.000069981055,0.000049798648],"domain_scores_gemma":[0.9998098,0.00003337503,0.00004152623,0.000037928883,0.00001862766,0.000058803078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013451619,0.0005107891,0.0003826795,0.0002127376,0.00019512713,0.00045550385,0.000512785,0.000294911,0.003754593],"category_scores_gemma":[0.00011484507,0.00021753447,0.00035990166,0.00029270875,0.00023464604,0.00012751028,0.00043642466,0.0006911999,0.0011621226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022998359,0.00007044383,0.00011558997,0.000037710393,0.0000068530035,0.000051680046,0.000016826125,0.000032098054,0.99829143,0.00010161611,0.00008320902,0.0009624404],"study_design_scores_gemma":[0.000030353238,0.00037210406,0.0041727964,0.000012934804,0.000014743678,0.00017119193,0.000058475936,0.0008038176,0.9883022,0.000054131964,0.0059985467,0.0000086588925],"about_ca_topic_score_codex":0.0009110928,"about_ca_topic_score_gemma":0.001378673,"teacher_disagreement_score":0.003754593,"about_ca_system_score_codex":0.0003366648,"about_ca_system_score_gemma":0.0003328533,"threshold_uncertainty_score":0.012560368},"labels":[],"label_agreement":null},{"id":"W3217795007","doi":"10.1093/neuonc/noab196.719","title":"EXTH-80. PBI-200: IN VIVO EFFICACY OF A NOVEL, HIGHLY CNS-PENETRANT NEXT GENERATION TRK INHIBITOR","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Trk receptor; In vivo; Pharmacology; Medicine; Potency; Cancer research; In vitro; Biology; Internal medicine; Receptor; Neurotrophin; Biochemistry; Genetics","score_opus":0.05111894012264943,"score_gpt":0.31172980431160974,"score_spread":0.2606108641889603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217795007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869925,0.00187383,0.0022139351,0.00027449208,0.00011563608,0.00025058206,0.0020087708,0.00060246204,0.0056678876],"genre_scores_gemma":[0.9858088,0.0014235359,0.0025579077,0.00018151362,0.00003302807,0.00027370465,0.0032517354,0.00007422959,0.0063955896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998609,0.000025748088,0.000007052925,0.000030660125,0.000028866649,0.00004683706],"domain_scores_gemma":[0.9999273,0.000011166418,0.000012157233,0.000008172472,0.00000793903,0.000033266613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024818582,0.00063114753,0.0005132295,0.00032478743,0.00013425169,0.00032815352,0.0004141639,0.00050060183,0.002337788],"category_scores_gemma":[0.00010698463,0.0001909495,0.00024307612,0.00020892013,0.00024573377,0.0003920887,0.000121754856,0.0015337404,0.000849722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067828787,0.0045583346,0.0003367591,0.00016644636,0.00005769137,0.00011493635,0.00005177446,0.0013236501,0.9642664,0.00025489315,0.00236403,0.019722123],"study_design_scores_gemma":[0.001979315,0.034104344,0.004768405,0.000014734502,0.00009023024,0.00046691103,0.000030280156,0.004625972,0.9494373,0.00009833232,0.0043571745,0.000027082448],"about_ca_topic_score_codex":0.0017750645,"about_ca_topic_score_gemma":0.002479434,"teacher_disagreement_score":0.002337788,"about_ca_system_score_codex":0.0005075751,"about_ca_system_score_gemma":0.00064403476,"threshold_uncertainty_score":0.007820666},"labels":[],"label_agreement":null},{"id":"W3612970","doi":"10.1093/neuonc/nor150","title":"IMMUNOLOGY RESEARCH","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brucella: diagnosis, epidemiology, treatment","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Engineering ethics; Engineering","score_opus":0.34669180482299566,"score_gpt":0.4549594897990909,"score_spread":0.10826768497609524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3612970","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015765427,0.08586873,0.016993549,0.021872643,0.029534068,0.00077138504,0.0053537665,0.0024866406,0.8213538],"genre_scores_gemma":[0.072026886,0.040566403,0.0102570085,0.0122852195,0.006297078,0.00056903,0.014117179,0.00053299806,0.84334815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985232,0.00024734501,0.0001053836,0.0004078265,0.00046442787,0.00025187925],"domain_scores_gemma":[0.998869,0.0000931725,0.00008215726,0.00021408561,0.0004347607,0.00030684457],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012863667,0.0011678253,0.0007631425,0.0013045501,0.0011640138,0.0037765384,0.0013620951,0.0021879517,0.21661736],"category_scores_gemma":[0.0014976542,0.00044680448,0.0009705501,0.0010478717,0.00069665944,0.0017099411,0.0019433211,0.003089495,0.1852052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006213056,0.0005072668,0.002180208,0.0015749583,0.00010333317,0.00064411585,0.000335989,0.000251231,0.067731395,0.03091555,0.31460896,0.5805257],"study_design_scores_gemma":[0.00004286624,0.00012822234,0.0010673192,0.00010075753,0.00001822439,0.000505621,0.00006399025,0.000107450556,0.0039669448,0.0023576363,0.9916319,0.000009092849],"about_ca_topic_score_codex":0.0009253594,"about_ca_topic_score_gemma":0.0009998202,"teacher_disagreement_score":0.78338265,"about_ca_system_score_codex":0.0016451275,"about_ca_system_score_gemma":0.0023488486,"threshold_uncertainty_score":0.7246573},"labels":[],"label_agreement":null},{"id":"W4200001411","doi":"10.1093/neuonc/noab279","title":"Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lomustine; Procarbazine; Medicine; Temozolomide; Oncology; Internal medicine; Oligodendroglioma; Oligodendroglial Tumor; Bevacizumab; Glioma; Vincristine; Astrocytoma; Radiation therapy; Chemotherapy; Cancer research; Cyclophosphamide","score_opus":0.01947085525348784,"score_gpt":0.31188992917641567,"score_spread":0.2924190739229278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200001411","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005299489,0.76338786,0.010392018,0.12458096,0.010151423,0.0041333754,0.028790254,0.000782334,0.052482378],"genre_scores_gemma":[0.030498078,0.7332612,0.055575635,0.10001798,0.0048061204,0.007836567,0.043734692,0.0002902825,0.02397946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739444,0.0007054555,0.0010110099,0.00017048967,0.00054791174,0.0001707028],"domain_scores_gemma":[0.99536407,0.001021483,0.0010815639,0.000090964015,0.0021053355,0.00033657378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026734027,0.0011616871,0.002009095,0.0027831635,0.00066028413,0.0014216007,0.003293507,0.0034726174,0.00521669],"category_scores_gemma":[0.008622833,0.00044618925,0.0035814338,0.0027148137,0.0004477083,0.0015494352,0.0012707538,0.0024238739,0.0032824697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017073138,0.00007363226,0.0019260274,0.039746277,0.000692275,0.00029010331,0.00017875609,0.0010964313,0.0007025581,0.0030130392,0.72308916,0.22902094],"study_design_scores_gemma":[0.00053865835,0.00015785462,0.0062695066,0.17360988,0.002114222,0.0013872144,0.00019713584,0.0008671794,0.00044490545,0.006537529,0.8077943,0.00008174798],"about_ca_topic_score_codex":0.018670121,"about_ca_topic_score_gemma":0.036641866,"teacher_disagreement_score":0.018670121,"about_ca_system_score_codex":0.0029961017,"about_ca_system_score_gemma":0.008797007,"threshold_uncertainty_score":0.037122905},"labels":[],"label_agreement":null},{"id":"W4200003507","doi":"10.1093/neuonc/noab196.283","title":"CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Gastroenterology; Receptor; Neurotrophin","score_opus":0.005435077052758422,"score_gpt":0.22623551095783923,"score_spread":0.2208004339050808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200003507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844281,0.010152399,0.00026361796,0.00026197438,0.000042321146,0.00016701057,0.0011015522,0.000072160605,0.0035107958],"genre_scores_gemma":[0.99323046,0.0034196272,0.00040525242,0.00025302067,0.00004069396,0.00014188547,0.0016792113,0.000012271114,0.00081753347],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99985445,0.000041353163,0.000014103412,0.000029846333,0.000029506577,0.000030760853],"domain_scores_gemma":[0.99969625,0.00004220592,0.00008749199,0.000011835775,0.000029329885,0.00013289774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003540188,0.00028158296,0.0006552637,0.00017738165,0.00013109141,0.00033890252,0.00021339826,0.00024539683,0.001511502],"category_scores_gemma":[0.00048046347,0.00012467595,0.00039315244,0.0002223661,0.00022657993,0.00030090337,0.00013247228,0.0008684914,0.0003636095],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16308072,0.008018801,0.15286191,0.002052887,0.0012417209,0.0026112453,0.00044277436,0.0048550544,0.08959462,0.00069163245,0.020717075,0.5538316],"study_design_scores_gemma":[0.058913168,0.25991148,0.5743252,0.0005577832,0.0022083519,0.010602122,0.00041616533,0.0091137225,0.041263293,0.00046528742,0.042125713,0.00009774687],"about_ca_topic_score_codex":0.0012082251,"about_ca_topic_score_gemma":0.003621429,"teacher_disagreement_score":0.001511502,"about_ca_system_score_codex":0.00076491275,"about_ca_system_score_gemma":0.00072524237,"threshold_uncertainty_score":0.0055497885},"labels":[],"label_agreement":null},{"id":"W4200005408","doi":"10.1093/neuonc/noab196.251","title":"CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Internal medicine; Adjuvant; Radiation therapy; Methyltransferase; Chemoradiotherapy; O-6-methylguanine-DNA methyltransferase; Chemotherapy; DNA; Biology; Methylation","score_opus":0.012645587143556502,"score_gpt":0.30346787384469015,"score_spread":0.29082228670113364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200005408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554056,0.00092446373,0.00023146035,0.00022404295,0.00009161985,0.0013102833,0.0006027749,0.00007048567,0.0010043187],"genre_scores_gemma":[0.99168783,0.0011419716,0.00095653994,0.0004661815,0.00010815728,0.0015009058,0.0017501597,0.00002464192,0.0023635055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997286,0.000115741925,0.000011578017,0.000051024625,0.00002171866,0.000071337214],"domain_scores_gemma":[0.9995647,0.00003454761,0.00006459905,0.000030482204,0.00002597307,0.00027966668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010103221,0.0016601778,0.0015639353,0.00040928312,0.00033682288,0.00084332784,0.00080444076,0.001015895,0.00227939],"category_scores_gemma":[0.00052296853,0.0005933707,0.0009980031,0.00037794784,0.00088399375,0.0005701467,0.00027403582,0.0027283863,0.0007035194],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7866386,0.083166644,0.005271587,0.0004619069,0.00082574534,0.0002812686,0.00022957298,0.0021082477,0.063681714,0.00028034084,0.0028227903,0.05423158],"study_design_scores_gemma":[0.42573306,0.55769706,0.008189691,0.000022387234,0.00034492614,0.0002028157,0.00005129442,0.0009252462,0.004971165,0.00012756111,0.0017028647,0.000032004955],"about_ca_topic_score_codex":0.0019193498,"about_ca_topic_score_gemma":0.0059503755,"teacher_disagreement_score":0.00227939,"about_ca_system_score_codex":0.0010220327,"about_ca_system_score_gemma":0.0019211668,"threshold_uncertainty_score":0.0076253414},"labels":[],"label_agreement":null},{"id":"W4200240386","doi":"10.1093/neuonc/noab196.525","title":"NIMG-25. IMPROVING THE NONINVASIVE CLASSIFICATION OF GLIOMA GENETIC SUBTYPE WITH DEEP LEARNING AND DIFFUSION-WEIGHTED IMAGING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Glioma; Fluid-attenuated inversion recovery; Nuclear medicine; Artificial intelligence; Radiology; Computer science; Magnetic resonance imaging; Cancer research","score_opus":0.008333367874437536,"score_gpt":0.2677057116391958,"score_spread":0.25937234376475826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200240386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5367289,0.0221318,0.15181208,0.012959219,0.004676722,0.003971856,0.122178584,0.09102685,0.054514002],"genre_scores_gemma":[0.6212263,0.0021439581,0.17063962,0.0047154576,0.0004990386,0.002142369,0.1715794,0.0025631082,0.024490694],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992119,0.00032743212,0.00003788401,0.00015103236,0.00016831662,0.00010347094],"domain_scores_gemma":[0.99926406,0.0001880883,0.00004748914,0.00012797941,0.00023891739,0.0001333976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030286224,0.0013965513,0.0008207846,0.0011091258,0.00040866146,0.0011011667,0.0018190328,0.0015745469,0.005794808],"category_scores_gemma":[0.004865616,0.00039829014,0.0012637579,0.0006577025,0.00037990828,0.00061934674,0.0013752661,0.0010705986,0.006260515],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020144996,0.0008161042,0.028370822,0.0007261725,0.001133135,0.00034632368,0.000097998236,0.068011776,0.0097433925,0.0019960653,0.28189337,0.6048505],"study_design_scores_gemma":[0.0016564218,0.00158203,0.02351766,0.0005015485,0.00060829346,0.00048034595,0.00014178122,0.8293389,0.027552728,0.009571145,0.104837604,0.00021146181],"about_ca_topic_score_codex":0.022028467,"about_ca_topic_score_gemma":0.02515204,"teacher_disagreement_score":0.022028467,"about_ca_system_score_codex":0.0013715802,"about_ca_system_score_gemma":0.0027542582,"threshold_uncertainty_score":0.043800533},"labels":[],"label_agreement":null},{"id":"W4200335423","doi":"10.1093/neuonc/noab262","title":"Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Asymptomatic; Guideline; Systemic therapy; Radiation therapy; Lung cancer; Brain metastasis; Cancer; Oncology; Surgery; Radiology; Breast cancer; Internal medicine; Metastasis; Pathology","score_opus":0.048119475896673536,"score_gpt":0.37346465163376297,"score_spread":0.32534517573708943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200335423","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051504914,0.37665728,0.018993117,0.35854268,0.01759505,0.010992248,0.050760556,0.0015414031,0.15976721],"genre_scores_gemma":[0.02460922,0.41022226,0.094049975,0.29057282,0.010742237,0.01773978,0.09754548,0.0006607462,0.05385746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692553,0.0010659802,0.0008875547,0.00018554243,0.0007093886,0.0002260705],"domain_scores_gemma":[0.99435353,0.0010834212,0.0010922434,0.00012838273,0.002709577,0.00063284347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003997771,0.0013971638,0.0019097287,0.0030053887,0.000848533,0.0019872151,0.0046434104,0.006317136,0.0087136],"category_scores_gemma":[0.010929923,0.00055214885,0.0029692026,0.0030630964,0.00060474453,0.0018113366,0.001817464,0.004065984,0.006890157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006614487,0.00006588656,0.0007892808,0.007198645,0.00014256463,0.00018950815,0.000078402896,0.00079339906,0.00028192747,0.0022208856,0.892512,0.09566144],"study_design_scores_gemma":[0.00034857457,0.000112101545,0.0036556527,0.05592963,0.00046719625,0.0008408759,0.00010387858,0.00082102855,0.00021506762,0.0068061114,0.9306424,0.00005746368],"about_ca_topic_score_codex":0.020014914,"about_ca_topic_score_gemma":0.033944882,"teacher_disagreement_score":0.020014914,"about_ca_system_score_codex":0.004013189,"about_ca_system_score_gemma":0.012045497,"threshold_uncertainty_score":0.03979683},"labels":[],"label_agreement":null},{"id":"W4200411804","doi":"10.1093/neuonc/noab196.066","title":"BIOM-35. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Children's Hospital","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Immunohistochemistry; Biomarker; Risk stratification; Receiver operating characteristic; Multivariate analysis; Medicine; Bioinformatics; Biology; Pathology; Genetics","score_opus":0.03312051520766966,"score_gpt":0.34972324853284326,"score_spread":0.3166027333251736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200411804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985318,0.00024170954,0.000640527,0.000019451,0.0000053153612,0.000027778377,0.00043572765,0.000013404067,0.000084202184],"genre_scores_gemma":[0.9981273,0.000055871973,0.00069118896,0.000016527289,0.000005519932,0.00003074892,0.00096452853,0.00000872588,0.00009968885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991811,0.00027225853,0.000056120105,0.0002962904,0.00010709489,0.00008714495],"domain_scores_gemma":[0.9984843,0.00036227866,0.00043869202,0.0003310998,0.00017368478,0.00020991401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027832256,0.00045199043,0.0005022158,0.0011171215,0.00045124892,0.00067820016,0.00042990336,0.0004204718,0.0013727164],"category_scores_gemma":[0.003053022,0.0002154513,0.00093454437,0.00056151696,0.00047747686,0.00029180152,0.00077731523,0.00039508528,0.00033533096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029284782,0.000295395,0.9670922,0.00009472388,0.0008607933,0.00028474553,0.00024648642,0.0009939506,0.01421896,0.00013537523,0.0004413006,0.012407616],"study_design_scores_gemma":[0.00013483819,0.001483627,0.9802611,0.000023936225,0.0008283981,0.001128967,0.0003445479,0.008494,0.004895881,0.0006322015,0.0017451899,0.000027193928],"about_ca_topic_score_codex":0.002093164,"about_ca_topic_score_gemma":0.0017590139,"teacher_disagreement_score":0.0027832256,"about_ca_system_score_codex":0.0006368069,"about_ca_system_score_gemma":0.00049144565,"threshold_uncertainty_score":0.014719248},"labels":[],"label_agreement":null},{"id":"W4200508878","doi":"10.1093/neuonc/noab282","title":"Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"Medicine; Clinical trial; Oncology; Targeted therapy; Internal medicine; Clinical research; Precision medicine; Bioinformatics; Cancer; Pathology","score_opus":0.1129376079302941,"score_gpt":0.39541470149860886,"score_spread":0.28247709356831474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200508878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523926,0.0009634002,0.0014109865,0.0001901001,0.000014312804,0.00005633605,0.00068675715,0.000016733427,0.0014222004],"genre_scores_gemma":[0.9984742,0.00012711356,0.0010055486,0.000067750465,0.0000102148315,0.000015559783,0.00023926483,0.0000032507382,0.000057098478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986468,0.00060676236,0.00021794377,0.00023247235,0.00020581123,0.00009021675],"domain_scores_gemma":[0.9958656,0.0017033512,0.0013465253,0.00022309484,0.0006075305,0.00025403695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004237364,0.0001734143,0.00029725506,0.0007875804,0.00020085627,0.00091781357,0.0003192675,0.00026484596,0.0011681024],"category_scores_gemma":[0.0067346254,0.000092310765,0.00022355531,0.0005482474,0.000285687,0.00043975323,0.00038480622,0.0002844317,0.00025595762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061136467,0.000045459587,0.97572714,0.000038666323,0.00004239745,0.00027449048,0.00006870427,0.00050173217,0.0017284695,0.00011162211,0.0003693976,0.02048047],"study_design_scores_gemma":[0.000091949725,0.0017179888,0.9615137,0.00019013818,0.00032014985,0.004166557,0.0006692009,0.013655337,0.0114730345,0.0011363976,0.0050283656,0.00003733962],"about_ca_topic_score_codex":0.0007573983,"about_ca_topic_score_gemma":0.0014535873,"teacher_disagreement_score":0.004237364,"about_ca_system_score_codex":0.0006136724,"about_ca_system_score_gemma":0.0005885434,"threshold_uncertainty_score":0.022409618},"labels":[],"label_agreement":null},{"id":"W4205312646","doi":"10.1093/neuonc/noac013","title":"Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Neurofibromatosis; Optic nerve; Glioma; Neurofibromatoses; Radiation therapy","score_opus":0.019629401950657453,"score_gpt":0.26554555802627605,"score_spread":0.2459161560756186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205312646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999371,0.00026815676,0.000024929028,0.000039967148,0.0000029726948,0.000003736465,0.00014402883,0.0000036646215,0.00014170856],"genre_scores_gemma":[0.9995739,0.00010419925,0.000052218384,0.000013841496,0.000006803209,0.0000058828714,0.00020481383,0.0000022585475,0.000036089714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961793,0.00007963608,0.000037355836,0.00009388776,0.00009292721,0.000078270015],"domain_scores_gemma":[0.99787486,0.00027961945,0.0014273332,0.00006104238,0.00007868479,0.00027850247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004273144,0.00030025086,0.00032062366,0.0006378152,0.00040259038,0.00042206887,0.00044540857,0.0005020162,0.001388348],"category_scores_gemma":[0.0020399021,0.00024027993,0.00041837033,0.0008261273,0.0003059425,0.00039726327,0.00028216964,0.0006533851,0.00014084239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019038724,0.0000085228,0.999433,0.0000027381336,0.000008082703,0.00013343542,0.000019262283,0.000020208467,0.000052944084,0.0000051122347,0.000040482028,0.00025707157],"study_design_scores_gemma":[0.0000033136023,0.000051075862,0.9983419,0.000006040042,0.0000138747855,0.0012955485,0.00008543554,0.000089191206,0.000037301175,0.000008641588,0.00006537464,0.0000022677134],"about_ca_topic_score_codex":0.0069524976,"about_ca_topic_score_gemma":0.007114543,"teacher_disagreement_score":0.0069524976,"about_ca_system_score_codex":0.00043059548,"about_ca_system_score_gemma":0.00059223536,"threshold_uncertainty_score":0.013824046},"labels":[],"label_agreement":null},{"id":"W4206467252","doi":"10.1093/neuonc/noac012","title":"SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"NIHR Great Ormond Street Hospital Biomedical Research Centre; Associazione Bianca Garavaglia; Brain Tumour Charity; CHILDREN with CANCER UK; James Tudor Foundation; National Institute for Health and Care Research; Cancer Research UK","keywords":"Ependymoma; Cohort; Medicine; Term (time); Oncology; Internal medicine; Surgery; Physics","score_opus":0.03388866853965134,"score_gpt":0.32307463042945755,"score_spread":0.2891859618898062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206467252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248016,0.0012744011,0.00031934903,0.00015754592,0.00003361891,0.00042832957,0.0042488244,0.000016087222,0.0010417525],"genre_scores_gemma":[0.9844444,0.0006607724,0.0007170609,0.00020971854,0.00010744963,0.0011326805,0.011253144,0.00004164767,0.0014331714],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983443,0.0008312369,0.000101588164,0.00030923527,0.00022736783,0.00018632428],"domain_scores_gemma":[0.9958994,0.0007850345,0.0014762711,0.0009038605,0.0003667933,0.000568531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004353839,0.00072988647,0.0011883056,0.00032946037,0.000496087,0.0012163457,0.0007417536,0.0006348777,0.002308614],"category_scores_gemma":[0.0050256453,0.00030607,0.0014173128,0.00079218915,0.00048647728,0.0005087078,0.0007407671,0.00079886965,0.00057258067],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29788026,0.0016099064,0.65384734,0.0009064798,0.00750509,0.0010074753,0.00041419917,0.0007851665,0.0045819585,0.00045083673,0.0071954243,0.023815762],"study_design_scores_gemma":[0.06310059,0.03294829,0.8817211,0.00031670125,0.008056277,0.0015959259,0.0003067246,0.0010152849,0.0018957691,0.00040724486,0.008552336,0.000083803265],"about_ca_topic_score_codex":0.0018997352,"about_ca_topic_score_gemma":0.0031410437,"teacher_disagreement_score":0.004353839,"about_ca_system_score_codex":0.00068247557,"about_ca_system_score_gemma":0.0012413965,"threshold_uncertainty_score":0.023025572},"labels":[],"label_agreement":null},{"id":"W4206962479","doi":"10.1093/neuonc/noac021","title":"Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Thompson Rivers University; University Health Network","funders":"Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development","keywords":"Biology; Transcriptome; Seminoma; Germ cell tumors; Phenotype; Tumor microenvironment; Germ cell; Atypical teratoid rhabdoid tumor; Embryonic stem cell; Germinoma; Cancer research; Pathology; Immune system; Immunology; Genetics; Gene expression; Immunohistochemistry; Gene; Medicine; Chemotherapy","score_opus":0.021433863403657823,"score_gpt":0.27887818517481566,"score_spread":0.25744432177115784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206962479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944535,0.0009639624,0.002023735,0.000028297163,0.0000052954992,0.000012872048,0.0018437725,0.00003092285,0.0006376028],"genre_scores_gemma":[0.9928745,0.00072394346,0.0027554145,0.000030899875,0.00000576448,0.000032221735,0.0028882194,0.000015469597,0.0006736379],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989116,0.000008870585,0.0000064797346,0.000042754833,0.000028977938,0.000021781603],"domain_scores_gemma":[0.9998956,0.000015773263,0.000037307705,0.000010419199,0.000024843122,0.000016109076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011475564,0.00015655246,0.0001984705,0.0005961523,0.00018156033,0.00018956298,0.00011388832,0.00012806166,0.0008336163],"category_scores_gemma":[0.00020119995,0.00007288172,0.00021091806,0.0005678548,0.00012211123,0.00011661048,0.00019581673,0.00014774024,0.0001586872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025638746,0.000016708122,0.15059589,0.0001266975,0.000093287075,0.00034077937,0.0002019828,0.0002283798,0.83348125,0.00008724999,0.00016316309,0.014408241],"study_design_scores_gemma":[0.0000065340464,0.00020437989,0.87437934,0.000019089774,0.00018456508,0.002257317,0.00031921023,0.0014780909,0.117831625,0.0002035167,0.003104489,0.000011827727],"about_ca_topic_score_codex":0.0011249684,"about_ca_topic_score_gemma":0.002492856,"teacher_disagreement_score":0.0011249684,"about_ca_system_score_codex":0.00015184295,"about_ca_system_score_gemma":0.00019075368,"threshold_uncertainty_score":0.0027887821},"labels":[],"label_agreement":null},{"id":"W4206992752","doi":"10.1093/neuonc/noac022","title":"Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"In vivo; Glycolysis; Astrocytoma; Cancer research; In vivo magnetic resonance spectroscopy; Phosphofructokinase; Ex vivo; Glioma; Chemistry; Magnetic resonance spectroscopic imaging; Magnetic resonance imaging; Pathology; Biology; Medicine; Enzyme; Biochemistry","score_opus":0.012451803179203974,"score_gpt":0.2827565351614721,"score_spread":0.2703047319822681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206992752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96335983,0.0059688515,0.026067493,0.0004277042,0.000044138174,0.0000473208,0.0006970054,0.0003312536,0.0030564219],"genre_scores_gemma":[0.97889405,0.0038823371,0.01503652,0.000117596945,0.000032581862,0.000057957623,0.0005001415,0.000054816683,0.0014240303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994135,0.000014397031,0.0000029704681,0.000012312413,0.000018289227,0.000010688634],"domain_scores_gemma":[0.9999213,0.000020758887,0.00002695371,0.0000063115103,0.0000129230875,0.0000118291855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017887713,0.0002664761,0.00019420852,0.0003143681,0.00009552599,0.00025546394,0.00023583452,0.0004228675,0.0006970924],"category_scores_gemma":[0.00022137881,0.0001588619,0.00011197508,0.00021424782,0.00017693163,0.00030278743,0.00015922831,0.00037002942,0.00017280718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026807672,0.000019103654,0.0010128343,0.000088623994,0.000011798122,0.000047586345,0.00001381117,0.00022621348,0.99218035,0.00010756197,0.00013535137,0.005888702],"study_design_scores_gemma":[0.000047362126,0.00051274395,0.019099893,0.000018355982,0.000083850755,0.000760748,0.000059063197,0.0053776964,0.9703447,0.00036908273,0.003308523,0.000017952341],"about_ca_topic_score_codex":0.00066263176,"about_ca_topic_score_gemma":0.0013336608,"teacher_disagreement_score":0.0006970924,"about_ca_system_score_codex":0.00031418263,"about_ca_system_score_gemma":0.00019712072,"threshold_uncertainty_score":0.0023320317},"labels":[],"label_agreement":null},{"id":"W4210724732","doi":"10.1093/neuonc/noac032","title":"The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Incidence (geometry); Distribution (mathematics); Meningioma; Medicine; Mathematics; Surgery; Mathematical analysis","score_opus":0.034708535235699375,"score_gpt":0.3300618490305295,"score_spread":0.2953533137948301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210724732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995852,0.00093185785,0.0004005395,0.000108965636,0.00004038914,0.000017903061,0.00053521054,0.000011437292,0.0021017813],"genre_scores_gemma":[0.99891484,0.00019043694,0.0002641712,0.000015009384,0.000012653931,0.0000066500916,0.0004800862,0.000007813635,0.00010833368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962947,0.0009140834,0.0005803384,0.0005644376,0.0012344087,0.0004120859],"domain_scores_gemma":[0.986102,0.0031858694,0.005573054,0.0009683647,0.0033905401,0.0007801634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044998215,0.00024627653,0.0002396567,0.002041618,0.00029997647,0.00091823516,0.0005425331,0.00022688562,0.00077635364],"category_scores_gemma":[0.017125273,0.00018664174,0.00059710885,0.0009014875,0.0004516102,0.0005970476,0.00086122315,0.00041986635,0.00021841485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010284915,0.000004462407,0.9961366,0.000015172898,0.00003767356,0.000043981432,0.00012426166,0.00006645933,0.00014520124,0.000038042144,0.00016865693,0.003116723],"study_design_scores_gemma":[0.0000021449791,0.00004680677,0.99795157,0.000037591224,0.00003902894,0.00033937467,0.0003219028,0.00036008417,0.0003322833,0.000044745488,0.00051783654,0.0000065982795],"about_ca_topic_score_codex":0.015533056,"about_ca_topic_score_gemma":0.030267335,"teacher_disagreement_score":0.015533056,"about_ca_system_score_codex":0.0009153896,"about_ca_system_score_gemma":0.0009953267,"threshold_uncertainty_score":0.03088528},"labels":[],"label_agreement":null},{"id":"W4212899626","doi":"10.1093/neuonc/nou174.292","title":"P15.13 * THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Metric (unit); Clinical trial; Intensive care medicine; Psychological intervention; Medical physics; Physical therapy; Internal medicine","score_opus":0.04391201782448898,"score_gpt":0.3599111750061347,"score_spread":0.3159991571816457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212899626","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041725487,0.006682626,0.03360267,0.04994105,0.018322038,0.0039351876,0.029837145,0.004064156,0.81188965],"genre_scores_gemma":[0.24741487,0.008733437,0.08967456,0.028132815,0.0045210086,0.006879037,0.05408134,0.0035085613,0.5570544],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990392,0.0003011148,0.00011074521,0.00008449464,0.0003717236,0.00009279638],"domain_scores_gemma":[0.9958496,0.00070849154,0.00044650031,0.00017457012,0.002190796,0.00063003035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016887642,0.00050694874,0.00047207213,0.0008654585,0.0006983944,0.0014907873,0.001032715,0.0012033009,0.09344435],"category_scores_gemma":[0.0067372825,0.00018218048,0.00036945278,0.0012234406,0.0006253264,0.00084716524,0.0010969171,0.0017350245,0.038827185],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035457665,0.00013898047,0.011024052,0.00029179783,0.000015471682,0.0004971209,0.000080997655,0.00018887052,0.0008765,0.003413643,0.7859283,0.19718972],"study_design_scores_gemma":[0.00015405215,0.00033515014,0.028149854,0.0006381028,0.000016568958,0.0024269756,0.00016709958,0.0008092419,0.0020644525,0.004291437,0.96091485,0.00003219029],"about_ca_topic_score_codex":0.0026195555,"about_ca_topic_score_gemma":0.0043439944,"teacher_disagreement_score":0.09344435,"about_ca_system_score_codex":0.0008046723,"about_ca_system_score_gemma":0.0026754362,"threshold_uncertainty_score":0.31260246},"labels":[],"label_agreement":null},{"id":"W4212979581","doi":"10.1093/neuonc/nov061.111","title":"MB-35 * VERY ENCOURAGING LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOME OF YOUNG CHILDREN TREATED FOR MEDULLOBLASTOMA WITH SEQUENTIAL HIGH DOSE CHEMOTHERAPY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Neurocognitive; Term (time); Chemotherapy; Outcome (game theory); Medicine; Pediatrics; Oncology; Internal medicine; Cognition; Mathematics; Physics; Psychiatry; Pathology","score_opus":0.031007402473552003,"score_gpt":0.312244952060734,"score_spread":0.281237549587182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212979581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919766,0.0003565979,0.00008712055,0.00001538227,0.0000027774201,0.000006463173,0.00010647271,0.0000051598786,0.00022251045],"genre_scores_gemma":[0.99950945,0.000108782166,0.00010853999,0.000013106132,0.0000041628145,0.000004106453,0.00017736072,0.0000015925219,0.000072874405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989474,0.000022387048,0.000011475217,0.000018669758,0.000022172728,0.000030525905],"domain_scores_gemma":[0.99966156,0.000046225523,0.00015803346,0.000016785676,0.000027982223,0.000089459885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018018566,0.00011179031,0.00022722008,0.00018872887,0.00016459927,0.00018982399,0.000077720804,0.000098224366,0.00036495953],"category_scores_gemma":[0.0005365412,0.000052932388,0.00017546612,0.00019604035,0.00015003426,0.000117819494,0.00016804581,0.0001341684,0.00009400711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061648246,0.00008762935,0.97286654,0.00004149317,0.0000705978,0.0017797169,0.00017008645,0.000163095,0.0053683273,0.000029493689,0.00027147643,0.018534975],"study_design_scores_gemma":[0.00003893107,0.0019353465,0.9877081,0.000015693553,0.00007246086,0.0066776173,0.00014238466,0.00015708985,0.0018072646,0.000026424406,0.001414406,0.0000042827833],"about_ca_topic_score_codex":0.0024855186,"about_ca_topic_score_gemma":0.005467034,"teacher_disagreement_score":0.0024855186,"about_ca_system_score_codex":0.00036213183,"about_ca_system_score_gemma":0.0003056737,"threshold_uncertainty_score":0.004942119},"labels":[],"label_agreement":null},{"id":"W4213298430","doi":"10.1093/neuonc/nox036.312","title":"P09.57 Clinical trials of VAL-083 in patients with chemoresistant glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Clinical trial; Oncology; Internal medicine; Glioma; Phases of clinical research; Chemotherapy; Cancer research","score_opus":0.07139444316969258,"score_gpt":0.4071667440077629,"score_spread":0.33577230083807036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213298430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771211,0.00681302,0.000542085,0.0015703696,0.00046899254,0.0042464095,0.0016876077,0.00021970947,0.0073308293],"genre_scores_gemma":[0.97703004,0.005591856,0.0016361242,0.0033506735,0.00021031634,0.004583262,0.002911696,0.000040879415,0.004645138],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996278,0.000191283,0.000031119303,0.000046983867,0.000031535536,0.00007121874],"domain_scores_gemma":[0.9996166,0.0000473452,0.000051752206,0.000026634012,0.000034923178,0.00022279254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012624213,0.0009859533,0.0015470505,0.00046711604,0.00041002882,0.0008518054,0.0008181862,0.0010853,0.004332806],"category_scores_gemma":[0.0007109627,0.0004685853,0.0009739459,0.00051210314,0.0008246464,0.0005902824,0.0005123197,0.002658498,0.0009315938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69198024,0.039044082,0.0060869604,0.0015711364,0.0015715921,0.00044125915,0.00036460374,0.0017803869,0.036951724,0.0011496029,0.011416344,0.20764211],"study_design_scores_gemma":[0.44154975,0.53192645,0.012151569,0.00013971902,0.00045811865,0.0002556805,0.00010748538,0.00092653866,0.0028611235,0.0005993073,0.008983259,0.000041023093],"about_ca_topic_score_codex":0.0016886411,"about_ca_topic_score_gemma":0.0050729034,"teacher_disagreement_score":0.004332806,"about_ca_system_score_codex":0.0008592764,"about_ca_system_score_gemma":0.0015893317,"threshold_uncertainty_score":0.014494717},"labels":[],"label_agreement":null},{"id":"W4213432989","doi":"10.1093/neuonc/noac057","title":"Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Cohort; Germ cell tumors; Cog; Clinical trial; Central nervous system; Disease; Oncology; Cohort study; Chemotherapy; Surgery","score_opus":0.03128564086027897,"score_gpt":0.3422894081930291,"score_spread":0.31100376733275015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213432989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.651948,0.32714728,0.0071815797,0.00059305556,0.00028301126,0.001054686,0.009300336,0.00015710332,0.0023348841],"genre_scores_gemma":[0.9810791,0.012671985,0.0012604147,0.00030240347,0.00012184366,0.0006079403,0.0037267932,0.000045593482,0.000183859],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96175414,0.023832407,0.007341031,0.0038274908,0.0026843452,0.0005606192],"domain_scores_gemma":[0.95736605,0.024429716,0.01289491,0.0029609543,0.0017110511,0.00063725706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033536058,0.001280543,0.006672363,0.0037704434,0.00033474003,0.0025768897,0.0008218509,0.0010120561,0.0012540707],"category_scores_gemma":[0.037566133,0.00063475315,0.013175497,0.004108419,0.00044296737,0.0010578119,0.0012299733,0.00068096083,0.00017338223],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039454054,0.0001274647,0.33785048,0.008917819,0.5769851,0.00023099284,0.00016047932,0.0028472594,0.0012844322,0.00015543232,0.0012456039,0.030740898],"study_design_scores_gemma":[0.0065053334,0.0053506,0.397699,0.0015599888,0.5790932,0.00088934024,0.00028548742,0.0028202904,0.00088511384,0.00064517633,0.0041508474,0.00011562907],"about_ca_topic_score_codex":0.0006368761,"about_ca_topic_score_gemma":0.0009451277,"teacher_disagreement_score":0.033536058,"about_ca_system_score_codex":0.00066637265,"about_ca_system_score_gemma":0.00075896434,"threshold_uncertainty_score":0.1773578},"labels":[],"label_agreement":null},{"id":"W4214581307","doi":"10.1093/neuonc/noy059.587","title":"QOL-05. E-SURVEY OF CURRENT INTERNATIONAL PHYSIOTHERAPY PRACTICE FOR CHILDREN WITH ATAXIA FOLLOWING SURGICAL RESECTION OF POSTERIOR FOSSA TUMOUR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychological intervention; Physical therapy; Intervention (counseling); Psychosocial; Rehabilitation; Gait training; Physical medicine and rehabilitation; Nursing","score_opus":0.035935525871608025,"score_gpt":0.38884707824862325,"score_spread":0.3529115523770152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214581307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9178683,0.0013453494,0.00066049583,0.0013064854,0.00007007281,0.0018991231,0.06690542,0.00012575489,0.009818987],"genre_scores_gemma":[0.9347952,0.0032582032,0.007249284,0.0014066244,0.00006755929,0.006475346,0.040610313,0.00006126111,0.006076186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740463,0.0006734496,0.00091196195,0.00018799183,0.00043125055,0.00039074698],"domain_scores_gemma":[0.9873261,0.0034481788,0.0051827505,0.00023488056,0.0027095603,0.0010985023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043083522,0.000355828,0.0007108153,0.0025714966,0.00042628648,0.0009521741,0.00051785534,0.0007915429,0.007833673],"category_scores_gemma":[0.009788913,0.00036197994,0.00079496216,0.0025084824,0.0003413785,0.0012198015,0.0014936329,0.00096794637,0.001999866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036581367,0.0005290294,0.9087498,0.003260891,0.00017733706,0.00042049258,0.0067412597,0.00046831204,0.00039561265,0.00025784504,0.021893319,0.056740243],"study_design_scores_gemma":[0.0000430274,0.0004989841,0.97296405,0.00063943095,0.000027578246,0.0005164985,0.006787866,0.00019474007,0.00014828176,0.00004977021,0.018094035,0.000035853605],"about_ca_topic_score_codex":0.0072428915,"about_ca_topic_score_gemma":0.011762474,"teacher_disagreement_score":0.007833673,"about_ca_system_score_codex":0.0020183222,"about_ca_system_score_gemma":0.0014340564,"threshold_uncertainty_score":0.026206195},"labels":[],"label_agreement":null},{"id":"W4214703099","doi":"10.1093/neuonc/noaa215.807","title":"RTID-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1-10) FROM NSCLC IN THE PHASE 3 METIS TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Oncology; Adverse effect; Neurocognitive; Internal medicine; Randomized controlled trial; Radiation therapy","score_opus":0.048985329043387336,"score_gpt":0.3436906354942629,"score_spread":0.29470530645087556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214703099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95742124,0.017084945,0.0006136509,0.0023122067,0.0008195284,0.0040156124,0.006968516,0.00036983384,0.010394625],"genre_scores_gemma":[0.9561946,0.008556163,0.0015938702,0.004634556,0.0004968021,0.007013988,0.010582962,0.000098752906,0.01082845],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959165,0.00019687637,0.000020530078,0.000066376015,0.00003586439,0.00008870453],"domain_scores_gemma":[0.9995974,0.000063808606,0.000107283675,0.000023459192,0.000022356926,0.00018576349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521092,0.0013811226,0.0018173081,0.0003675428,0.00041368723,0.0017280089,0.00095790793,0.0015908366,0.0074424],"category_scores_gemma":[0.0008169432,0.00043542858,0.002262163,0.000360616,0.00065572915,0.0009186355,0.00041277826,0.0037204216,0.0013880797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85448325,0.015432724,0.004120905,0.0034295383,0.0022514497,0.0002016838,0.00018799157,0.0029859466,0.012714816,0.000980387,0.017546838,0.08566447],"study_design_scores_gemma":[0.8181768,0.16293955,0.008304289,0.0002450319,0.00091690046,0.00027696276,0.00007259962,0.0015059548,0.0013109302,0.0008263346,0.005378806,0.0000459082],"about_ca_topic_score_codex":0.0018308565,"about_ca_topic_score_gemma":0.007391079,"teacher_disagreement_score":0.0074424,"about_ca_system_score_codex":0.0013001616,"about_ca_system_score_gemma":0.001770234,"threshold_uncertainty_score":0.024897277},"labels":[],"label_agreement":null},{"id":"W4214740171","doi":"10.1093/neuonc/nou265.2","title":"NT-02 * EARLY TREATMENT OF HER2-AMPLIFIED BRAIN TUMOURS WITH TARGETED NK-92 CELLS AND FOCUSED ULTRASOUND IMPROVES SURVIVAL","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Brain metastasis; Cancer research; Microbubbles; Breast cancer; Radiation therapy; Metastasis; Pathology; Cancer; Internal medicine; Ultrasound","score_opus":0.01303862848947757,"score_gpt":0.23979880754532307,"score_spread":0.2267601790558455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214740171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826945,0.0041759806,0.002044588,0.00026725393,0.00019049515,0.00016766068,0.00029405643,0.00020551818,0.004384942],"genre_scores_gemma":[0.9900485,0.0016648258,0.0022744504,0.00022896047,0.000059372738,0.0001707537,0.0007937108,0.000025738509,0.0047336714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992776,0.000010995936,0.0000059557437,0.000013426263,0.00001524711,0.000026544963],"domain_scores_gemma":[0.9999448,0.000009344748,0.0000086163745,0.000005780591,0.000008566289,0.000022877468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009780414,0.00038450462,0.00065206224,0.000171663,0.00009594135,0.00020970845,0.00027465046,0.00032469424,0.0021047927],"category_scores_gemma":[0.000116303425,0.000079329584,0.00025026835,0.0001298628,0.00018207644,0.0001982462,0.0001654302,0.00080855534,0.00046937563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005942396,0.0018232672,0.0006643236,0.0002037771,0.00006879593,0.0002897088,0.000052223957,0.00069605047,0.94066006,0.00019270372,0.0014443073,0.047962297],"study_design_scores_gemma":[0.0015232586,0.043172438,0.0120441895,0.00005618045,0.0002167275,0.0020667596,0.00009259808,0.0040755617,0.9126028,0.00020819515,0.023906741,0.000034544006],"about_ca_topic_score_codex":0.0012227386,"about_ca_topic_score_gemma":0.0017278896,"teacher_disagreement_score":0.0021047927,"about_ca_system_score_codex":0.00020027872,"about_ca_system_score_gemma":0.00025715522,"threshold_uncertainty_score":0.007041216},"labels":[],"label_agreement":null},{"id":"W4220732082","doi":"10.1093/neuonc/noac072","title":"Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Temozolomide; Chemoradiotherapy; Internal medicine; Population; Cohort; Retrospective cohort study; Neutropenia; Oncology; Surgery; Cancer; Radiation therapy; Chemotherapy","score_opus":0.014494316526808593,"score_gpt":0.32554737051981536,"score_spread":0.31105305399300676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220732082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966779,0.0018614568,0.000117867734,0.00035598746,0.000010921935,0.000029157622,0.0002471006,0.000005286149,0.0006943812],"genre_scores_gemma":[0.9994923,0.00024053016,0.000054501972,0.000041288502,0.000010391898,0.000004909703,0.00012986672,7.431725e-7,0.000025460335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.0004362431,0.00014530976,0.00013820366,0.00050615805,0.00013346676],"domain_scores_gemma":[0.99258065,0.0016842621,0.0043763034,0.00021309259,0.0004930211,0.00065257965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001499233,0.0001320022,0.00038775362,0.0002745664,0.00024593255,0.00054094195,0.0002715186,0.00030920087,0.00058761466],"category_scores_gemma":[0.014020847,0.00010428311,0.0006867052,0.0004965558,0.00023455209,0.00025911527,0.00022846855,0.00035556013,0.000062788764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030223895,0.00012566669,0.9636478,0.00011725146,0.0004504,0.00007254644,0.000069091606,0.0006694177,0.0002202549,0.00004383649,0.00036277788,0.031198686],"study_design_scores_gemma":[0.00015537573,0.001398327,0.99601644,0.00004499761,0.00030852776,0.00013897143,0.000049947517,0.0013271013,0.00013486923,0.00005013206,0.0003687818,0.0000064164137],"about_ca_topic_score_codex":0.026756577,"about_ca_topic_score_gemma":0.03626979,"teacher_disagreement_score":0.026756577,"about_ca_system_score_codex":0.002206341,"about_ca_system_score_gemma":0.002493075,"threshold_uncertainty_score":0.053201675},"labels":[],"label_agreement":null},{"id":"W4220994793","doi":"10.1093/neuonc/noac062","title":"Opportunities and challenges for the development of “core outcome sets” in neuro-oncology","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Marie Curie; National Institute for Health and Care Research","keywords":"Delphi method; Intervention (counseling); Scope (computer science); Medicine; Brain tumor; Glioma; Oncology; Clinical trial; Precision oncology; Delphi; Medical physics; Internal medicine; Psychology; Intensive care medicine; Pathology; Cancer research; Computer science; Psychiatry; Cancer; Artificial intelligence","score_opus":0.7326601777933447,"score_gpt":0.5548178042793237,"score_spread":0.177842373514021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220994793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012074963,0.9020703,0.02849464,0.056886584,0.0031787213,0.0018286704,0.0002271397,0.00007228077,0.0060341638],"genre_scores_gemma":[0.029965999,0.7481277,0.17845686,0.026216207,0.0028803102,0.012916017,0.0005598372,0.000108606066,0.0007684614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7175458,0.2406939,0.019604266,0.0042600594,0.016000787,0.0018952133],"domain_scores_gemma":[0.3853958,0.5645318,0.0119724525,0.008961245,0.026382005,0.0027567735],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.37268105,0.0015953074,0.006601873,0.0071250442,0.0014672442,0.0087886285,0.0050735385,0.00550407,0.0035077278],"category_scores_gemma":[0.33735362,0.0010758754,0.0055685258,0.008018488,0.0076135034,0.01390767,0.009413785,0.012521633,0.00095422694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022809078,0.00018415632,0.00085534656,0.11907072,0.00065754924,0.00007410046,0.0026193655,0.0013719135,0.00021825559,0.13974737,0.012872642,0.72210056],"study_design_scores_gemma":[0.0003380707,0.0007109849,0.0030452167,0.47127345,0.0009174958,0.00032282106,0.004178605,0.0017910205,0.00062655675,0.164231,0.3523585,0.00020627036],"about_ca_topic_score_codex":0.0040411013,"about_ca_topic_score_gemma":0.0043561338,"teacher_disagreement_score":0.627319,"about_ca_system_score_codex":0.009712438,"about_ca_system_score_gemma":0.04875088,"threshold_uncertainty_score":0.7735959},"labels":[],"label_agreement":null},{"id":"W4221089132","doi":"10.1093/neuonc/noac081","title":"Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back","year":2022,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; National Cancer Center","keywords":"Medicine; Internal medicine; Oncology; Radiology","score_opus":0.03636947294559108,"score_gpt":0.2981983915010021,"score_spread":0.261828918555411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221089132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865762,0.010646022,0.00041039492,0.0012771414,0.000047746475,0.000021350981,0.0002516587,0.000020833526,0.000748708],"genre_scores_gemma":[0.99551636,0.0028169206,0.0006264195,0.0002597847,0.00018960072,0.000013668108,0.00040801428,0.000008756462,0.00016044146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993641,0.00015645172,0.000118026815,0.000101953345,0.00015015154,0.00010934513],"domain_scores_gemma":[0.9966274,0.00090766005,0.0014184903,0.00017555356,0.0004863493,0.0003844849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001584535,0.00024011526,0.000514262,0.0015876135,0.00038949616,0.00079153606,0.0008782864,0.0006810792,0.0009652776],"category_scores_gemma":[0.006336994,0.00019710664,0.0006883046,0.0013300754,0.0003455079,0.0014425156,0.0004817923,0.0010492126,0.0002376031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061220235,0.00003463053,0.991102,0.000028637334,0.000026706248,0.00012979607,0.00007360742,0.00003275996,0.00007244751,0.000017524642,0.00027777694,0.008142938],"study_design_scores_gemma":[0.00000445367,0.00015382314,0.99631613,0.000118633725,0.00007778854,0.0011782293,0.0008187757,0.00047789657,0.00015040278,0.00008842684,0.00060256827,0.000012835935],"about_ca_topic_score_codex":0.006349394,"about_ca_topic_score_gemma":0.008606397,"teacher_disagreement_score":0.006349394,"about_ca_system_score_codex":0.00045169215,"about_ca_system_score_gemma":0.0005962776,"threshold_uncertainty_score":0.01262486},"labels":[],"label_agreement":null},{"id":"W4223537410","doi":"10.1093/neuonc/noac087","title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; F. Hoffmann-La Roche; Cancer Research Foundation","keywords":"ROS1; Medicine; Internal medicine; Oncology; Cancer; Adenocarcinoma","score_opus":0.009531803600998194,"score_gpt":0.2932586197177411,"score_spread":0.2837268161167429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223537410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977496,0.013869559,0.00014880346,0.0010234904,0.000069782305,0.00025372815,0.0031180196,0.000024832196,0.0039956714],"genre_scores_gemma":[0.9892868,0.006359534,0.00034326734,0.00079876045,0.000057168705,0.00017443778,0.00240354,0.0000065981903,0.00056994724],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997739,0.000057388308,0.000025173447,0.000040007748,0.000049628885,0.000054007967],"domain_scores_gemma":[0.9994803,0.000101020036,0.00020375203,0.000010977449,0.000046087825,0.00015781175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046529222,0.00020967367,0.00055556674,0.00016296093,0.00024127329,0.00039518866,0.00018994456,0.00036204277,0.0015288644],"category_scores_gemma":[0.0008168373,0.0001224168,0.00048042386,0.00032359688,0.00018223884,0.00030043357,0.00026105862,0.00067146495,0.00027469473],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030003544,0.0010957166,0.8161961,0.0014960995,0.0006932665,0.0023541485,0.00039157047,0.00069838774,0.004249478,0.00031671082,0.016204812,0.12630022],"study_design_scores_gemma":[0.0113347545,0.024290409,0.8993601,0.0009883251,0.0016091638,0.010041399,0.0009030422,0.0009937795,0.004350539,0.00032263758,0.04577128,0.00003450314],"about_ca_topic_score_codex":0.0029575329,"about_ca_topic_score_gemma":0.011128067,"teacher_disagreement_score":0.0029575329,"about_ca_system_score_codex":0.0007663899,"about_ca_system_score_gemma":0.001701363,"threshold_uncertainty_score":0.0058805943},"labels":[],"label_agreement":null},{"id":"W4223566665","doi":"10.1093/neuonc/noac085","title":"Glioblastoma scRNA-seq shows treatment-induced, immune-dependent increase in mesenchymal cancer cells and structural variants in distal neural stem cells","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University; McGill Genome Centre; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; Cancer Research Society; Canadian Institutes of Health Research; KWF Kankerbestrijding; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Brain Tumour Foundation of Canada","keywords":"Subventricular zone; Biology; Mesenchymal stem cell; Neural stem cell; Cancer research; Progenitor cell; Immune system; Cancer; Tumor microenvironment; Cancer stem cell; Cancer cell; Stem cell; Immunology; Cell biology; Genetics","score_opus":0.018218892729097155,"score_gpt":0.2827486938397232,"score_spread":0.264529801110626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223566665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599807,0.0022992517,0.017239125,0.00026947158,0.00019026747,0.00009222732,0.014209496,0.0008412491,0.0048781787],"genre_scores_gemma":[0.9584085,0.0010617798,0.017347533,0.00064195547,0.00003283488,0.00018381469,0.016613673,0.00032471766,0.0053853896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976367,0.000009724937,0.000016941125,0.000089381276,0.00007792836,0.00004232829],"domain_scores_gemma":[0.9998574,0.000026364656,0.00003508798,0.000015598793,0.00004178261,0.000023756573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001554597,0.00019799608,0.0002806947,0.0003267266,0.00027397674,0.0004019082,0.0001409101,0.00024736254,0.0016348695],"category_scores_gemma":[0.00025738234,0.00012657134,0.00036466325,0.00027546866,0.00018943616,0.000094654584,0.00017786991,0.0003835778,0.0006742435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012507643,0.000016772316,0.002405551,0.00009806667,0.000021130654,0.00007396215,0.000054948592,0.00013994223,0.99267995,0.00007681486,0.0004491643,0.0038585858],"study_design_scores_gemma":[0.000025040796,0.00019223272,0.08888809,0.00002846205,0.00012880762,0.00058498624,0.00017176452,0.0036690217,0.8913094,0.00019761908,0.0147856735,0.000018900597],"about_ca_topic_score_codex":0.0019734004,"about_ca_topic_score_gemma":0.0051188213,"teacher_disagreement_score":0.0019734004,"about_ca_system_score_codex":0.0002635555,"about_ca_system_score_gemma":0.00034337252,"threshold_uncertainty_score":0.0054691434},"labels":[],"label_agreement":null},{"id":"W4224981127","doi":"10.1093/neuonc/noac106","title":"Factors correlating with survival following adjuvant or definitive radiosurgery for large brain metastases","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiosurgery; Internal medicine; Adjuvant; Propensity score matching; Multivariate analysis; Urology; Incidence (geometry); Univariate analysis; Cumulative incidence; Oncology; Prospective cohort study; Gastroenterology; Nuclear medicine; Surgery; Cohort; Radiation therapy","score_opus":0.07140361507150825,"score_gpt":0.3339277149654085,"score_spread":0.26252409989390024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224981127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994654,0.00018092057,0.000111092515,0.000025995914,0.0000017566688,0.000002401558,0.00008125385,0.0000025959507,0.00012850435],"genre_scores_gemma":[0.99978477,0.000031631276,0.000035455498,0.0000072412895,0.000005107771,0.0000020363534,0.0001075389,8.0632515e-7,0.000025426796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997625,0.00006549264,0.000030809166,0.00006283295,0.000037430353,0.000040950963],"domain_scores_gemma":[0.9982918,0.00046583533,0.00091553404,0.000081517435,0.0000555269,0.00018982694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005220785,0.0001227016,0.00021239874,0.00028870167,0.00013185815,0.00021576337,0.00019748606,0.00020107854,0.0012512399],"category_scores_gemma":[0.0021406962,0.000071111834,0.00029659946,0.00032107267,0.00026832623,0.00016541965,0.00024813166,0.00026902324,0.00012414235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028026156,0.000017325488,0.99666154,0.000007631802,0.000037154074,0.00005414843,0.000011258966,0.00017267813,0.00041038383,0.0000146812245,0.000048264432,0.0022846833],"study_design_scores_gemma":[0.0000102447075,0.0002717442,0.99856025,0.000002790943,0.00004567967,0.00041396567,0.000034657463,0.0002985964,0.00019938762,0.0000416562,0.00011850924,0.0000024281387],"about_ca_topic_score_codex":0.0007242879,"about_ca_topic_score_gemma":0.0014122698,"teacher_disagreement_score":0.0012512399,"about_ca_system_score_codex":0.00020947606,"about_ca_system_score_gemma":0.00030698528,"threshold_uncertainty_score":0.0041858554},"labels":[],"label_agreement":null},{"id":"W4225630787","doi":"10.1093/neuonc/noac116","title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Temozolomide; Medicine; Internal medicine; Nivolumab; Placebo; Regimen; Dacarbazine; Chemoradiotherapy; Gastroenterology; Radiation therapy; Progression-free survival; Randomized controlled trial; Clinical endpoint; Chemotherapy; Oncology; Cancer; Immunotherapy; Pathology","score_opus":0.02156685144926639,"score_gpt":0.3125214745721496,"score_spread":0.2909546231228832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225630787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764055,0.006955995,0.001006821,0.0015778579,0.0011977992,0.006337884,0.002587594,0.00027458888,0.0036559445],"genre_scores_gemma":[0.98035645,0.0036220022,0.0017204509,0.0019431623,0.0003981107,0.005503411,0.0021940966,0.000042245618,0.00422001],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958485,0.00024334552,0.000018088085,0.000072761984,0.0000247907,0.000056191097],"domain_scores_gemma":[0.99925727,0.00015427326,0.0001908796,0.00006056086,0.00004758429,0.00028951548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017097968,0.001420541,0.0024688495,0.00036238463,0.00040699035,0.0010336643,0.0011650487,0.0013663624,0.006431273],"category_scores_gemma":[0.0012517023,0.0006314947,0.0015621084,0.00038943085,0.0009298132,0.00072545157,0.00034391996,0.0027761818,0.0013263533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9728397,0.0061861807,0.00058879505,0.00051270396,0.00095445995,0.000029574134,0.00004530341,0.00039815652,0.003059795,0.00011893874,0.0015700752,0.013696399],"study_design_scores_gemma":[0.951445,0.04546693,0.0011421951,0.00002952919,0.0003954645,0.000027253682,0.000015573572,0.00032930291,0.00037691393,0.00011169162,0.0006518752,0.000008299484],"about_ca_topic_score_codex":0.0018765508,"about_ca_topic_score_gemma":0.004754771,"teacher_disagreement_score":0.006431273,"about_ca_system_score_codex":0.0011035973,"about_ca_system_score_gemma":0.0016188987,"threshold_uncertainty_score":0.021514773},"labels":[],"label_agreement":null},{"id":"W4226297738","doi":"10.1093/neuonc/noac088","title":"Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fördergemeinschaft Kinderkrebs-Zentrum Hamburg; Friedberg Charitable Foundation; Deutsche Forschungsgemeinschaft; Making Headway Foundation; Gert und Susanna Mayer Stiftung","keywords":"DNA methylation; Ependymoma; Histopathology; Biology; Methylation; Pathological; Pathology; Disease; Oncology; Medicine; Gene; Genetics; Gene expression","score_opus":0.02063884002091162,"score_gpt":0.2846931370558588,"score_spread":0.2640542970349472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226297738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994067,0.00011011173,0.00020778827,0.000007238433,7.716078e-7,0.00000561773,0.00014882085,0.0000051985057,0.000107861444],"genre_scores_gemma":[0.99900764,0.00006028898,0.00032623977,0.000008785671,0.0000026284995,0.000009009787,0.0004964451,0.0000031081065,0.000085876156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997887,0.000022870516,0.000023274428,0.00007571916,0.000045031433,0.000044391923],"domain_scores_gemma":[0.9995468,0.000080973776,0.00018987553,0.000054443382,0.000052038205,0.000075699616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031978448,0.00017952832,0.00024918024,0.0005238014,0.00025374262,0.0003707503,0.00022746522,0.00021296713,0.0005176764],"category_scores_gemma":[0.0008146457,0.00012983532,0.00019969599,0.0003925474,0.0001653539,0.00018745643,0.00038236845,0.00026404418,0.0001845231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027254177,0.000028318504,0.94061196,0.000023134988,0.000060452807,0.00079444697,0.00013994986,0.00012966659,0.0502975,0.000037240377,0.00011535734,0.007489391],"study_design_scores_gemma":[0.000004718708,0.00008374813,0.99401903,0.0000029432765,0.000023015786,0.0030635665,0.00007962569,0.0002762694,0.0020939123,0.000043644515,0.0003061706,0.000003318639],"about_ca_topic_score_codex":0.00070109015,"about_ca_topic_score_gemma":0.0012477582,"teacher_disagreement_score":0.00070109015,"about_ca_system_score_codex":0.00016385327,"about_ca_system_score_gemma":0.00014868556,"threshold_uncertainty_score":0.0017317533},"labels":[],"label_agreement":null},{"id":"W4229781797","doi":"10.1093/neuonc/nov237.13","title":"TMOD-13GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Anatomy; Pathology; Biology; Medicine; Neuroscience","score_opus":0.07750652243336452,"score_gpt":0.3173663730650181,"score_spread":0.23985985063165355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229781797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8598732,0.0068040243,0.0699674,0.0020048493,0.0010612289,0.0027728546,0.02664913,0.0042313896,0.026636025],"genre_scores_gemma":[0.788019,0.007941915,0.06474605,0.00087289105,0.00014937535,0.006347118,0.023342473,0.0010672119,0.10751401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834585,0.00018087051,0.00025058514,0.00046940622,0.00043198737,0.00032126185],"domain_scores_gemma":[0.9989998,0.00017034118,0.00028820493,0.00014120461,0.00009774402,0.0003027635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001243426,0.0019432277,0.00095396023,0.0032215868,0.0007227868,0.0010386652,0.0014695995,0.0027430593,0.0089674555],"category_scores_gemma":[0.00039324947,0.0010668564,0.0012790437,0.0011588197,0.0011457059,0.0011000695,0.00066373846,0.004128651,0.00330806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072437275,0.0008284815,0.00044455894,0.0002319271,0.00005100416,0.00047972772,0.00011763349,0.0007070838,0.9886389,0.0023145746,0.0013552355,0.004106521],"study_design_scores_gemma":[0.00037089025,0.0025684068,0.002309073,0.00008129837,0.00011892727,0.0013376003,0.00013986904,0.005107042,0.9565159,0.0006224781,0.030784106,0.00004431034],"about_ca_topic_score_codex":0.0017512903,"about_ca_topic_score_gemma":0.0028732056,"teacher_disagreement_score":0.0089674555,"about_ca_system_score_codex":0.0012993928,"about_ca_system_score_gemma":0.0010393269,"threshold_uncertainty_score":0.029999137},"labels":[],"label_agreement":null},{"id":"W4230245164","doi":"10.1093/neuonc/nov061.79","title":"MB-03 * FUNCTIONAL CHARACTERIZATION OF NOVEL BIOMARKERS IN SELECTING FOR SUBTYPE SPECIFIC MEDULLOBLASTOMA PHENOTYPES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Medulloblastoma; Phenotype; Computational biology; Cancer research; Biology; Medicine; Genetics; Gene","score_opus":0.055424394973749826,"score_gpt":0.2966071030809768,"score_spread":0.241182708107227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230245164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98421407,0.00084808783,0.0037305886,0.000107652784,0.00001886113,0.00008913706,0.008063556,0.0003662026,0.002561867],"genre_scores_gemma":[0.962653,0.00047435108,0.009842989,0.00014591163,0.0000119937995,0.00017010485,0.0219981,0.00013352802,0.0045700306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997545,0.000017776909,0.000016510921,0.00006792661,0.000100037134,0.000043246717],"domain_scores_gemma":[0.99982506,0.000030580242,0.000036367965,0.00002479247,0.000043529075,0.000039784096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027502858,0.00029109212,0.00042034136,0.00059037725,0.00024558738,0.00079621,0.00028983268,0.00029025963,0.0022090867],"category_scores_gemma":[0.00040394548,0.00017304445,0.00029075012,0.0004144595,0.0001356308,0.00017148732,0.0002587156,0.0005320901,0.0010541044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039571943,0.00006537907,0.024234625,0.00010953122,0.000044093475,0.00007760144,0.00004608058,0.00044457917,0.96119,0.00020961724,0.0010572654,0.0121255],"study_design_scores_gemma":[0.00006054633,0.0006319857,0.23004761,0.000035859444,0.0001555057,0.0011699371,0.00016671316,0.012672491,0.730501,0.00030783052,0.02422618,0.000024310639],"about_ca_topic_score_codex":0.0050374274,"about_ca_topic_score_gemma":0.0055942046,"teacher_disagreement_score":0.0050374274,"about_ca_system_score_codex":0.0005282472,"about_ca_system_score_gemma":0.00034153607,"threshold_uncertainty_score":0.010016203},"labels":[],"label_agreement":null},{"id":"W4230473682","doi":"10.1093/neuonc/noy059.162","title":"DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Radiological weapon; Pathological; Population; Pediatrics; Overall survival; Retrospective cohort study; Internal medicine; Surgery","score_opus":0.011178961558542713,"score_gpt":0.2636494803249901,"score_spread":0.2524705187664474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230473682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424237,0.0003870911,0.0001170791,0.000033236913,0.0000057286484,0.000011785425,0.004233796,0.000009394493,0.00095960725],"genre_scores_gemma":[0.9945011,0.00019636023,0.000093547125,0.000026835998,0.000009833867,0.000019405452,0.004958895,0.0000038601975,0.00019020564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980277,0.000020734346,0.00002900847,0.00006620201,0.000038516755,0.000042854612],"domain_scores_gemma":[0.99922407,0.000114125396,0.0003995813,0.000053583237,0.000066919856,0.0001416561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028257802,0.00017394737,0.00024433574,0.0009535636,0.00023215853,0.00037353378,0.00019402454,0.00020742396,0.0014255552],"category_scores_gemma":[0.0010765576,0.00013173009,0.00024214578,0.001119662,0.00013630577,0.00045563566,0.0003033428,0.00026821982,0.00045574707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047899,0.0000068768095,0.9983735,0.000006853207,0.000010964969,0.00012372421,0.000020432364,0.000019562314,0.00012482202,0.000006299289,0.00014158344,0.0011174604],"study_design_scores_gemma":[0.000002655175,0.00004234402,0.99864465,0.0000031716006,0.000008614235,0.00077253906,0.00005802022,0.000035458594,0.000043861415,0.0000062797035,0.0003804036,0.0000020931716],"about_ca_topic_score_codex":0.0034352085,"about_ca_topic_score_gemma":0.003174449,"teacher_disagreement_score":0.0034352085,"about_ca_system_score_codex":0.00024076703,"about_ca_system_score_gemma":0.00023864521,"threshold_uncertainty_score":0.0068303943},"labels":[],"label_agreement":null},{"id":"W4232086884","doi":"10.1093/neuonc/now212.452","title":"MPTH-14. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF MEDULLOBLASTOMAS IN JAPAN","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cytogenetics; Immunohistochemistry; Molecular genetics; Oncology; Biology; Phenotype; Internal medicine; Molecular cytogenetics; Gene; Cancer research; Pathology; Bioinformatics; Medicine; Genetics; Chromosome","score_opus":0.0338789855703825,"score_gpt":0.3417916033240748,"score_spread":0.30791261775369233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232086884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806184,0.00053007517,0.00017557469,0.000034174223,0.000007720506,0.000022720174,0.0005853766,0.000010178907,0.0005723029],"genre_scores_gemma":[0.9967969,0.00029936785,0.0003939596,0.000020547533,0.00001961357,0.00004304064,0.002055277,0.000008778786,0.00036253824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995877,0.000042284126,0.000083722334,0.00009909737,0.0000962816,0.00009091284],"domain_scores_gemma":[0.9991793,0.00006306012,0.0002934925,0.00003521922,0.0001773632,0.0002515666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045674347,0.0003006364,0.00034462524,0.0033833892,0.00049988396,0.0005250318,0.00038567276,0.00023015185,0.0011154573],"category_scores_gemma":[0.0011188943,0.00024193508,0.00045109814,0.0016743683,0.00032803306,0.00037865737,0.00056289684,0.00023983202,0.00041204583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001338653,0.000016585318,0.99110186,0.000024036985,0.000023306731,0.00028771232,0.0001315601,0.00007093758,0.0021284637,0.000026003961,0.00018493221,0.0058707395],"study_design_scores_gemma":[0.000011162751,0.000057794932,0.9970541,0.000006685287,0.000024538798,0.0011616207,0.0001809582,0.0002882296,0.00028276638,0.000028359422,0.0008992058,0.000004693148],"about_ca_topic_score_codex":0.009503848,"about_ca_topic_score_gemma":0.0070260633,"teacher_disagreement_score":0.009503848,"about_ca_system_score_codex":0.000672069,"about_ca_system_score_gemma":0.0006890325,"threshold_uncertainty_score":0.018897057},"labels":[],"label_agreement":null},{"id":"W4232542154","doi":"10.1093/neuonc/noaa087","title":"Erratum to ‘Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo’","year":2020,"lang":"en","type":"erratum","venue":"Neuro-Oncology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Junta de Castilla y León; Ministerio de Economía y Competitividad; Fundación Ramón Areces","keywords":"In vivo; Glioma; Cancer research; Peptide; Biology; Chemistry; Cell biology; Biochemistry; Genetics","score_opus":0.013340792271496548,"score_gpt":0.2509124046445097,"score_spread":0.23757161237301316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232542154","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022868832,0.0018326001,0.00054614025,0.055948738,0.9356004,0.00003519466,0.0005282465,0.00027293203,0.005007036],"genre_scores_gemma":[0.0073737674,0.013912923,0.005637175,0.22531065,0.36430722,0.00023737604,0.0036521198,0.0011881826,0.37838054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700195,0.00032727173,0.00060348125,0.00032862692,0.0014930721,0.00024560283],"domain_scores_gemma":[0.9889986,0.0032685369,0.00093897287,0.00056534045,0.0052965046,0.0009319866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031899165,0.0021224935,0.0018528114,0.00348459,0.003253442,0.0028998002,0.0029002263,0.009267111,0.023573201],"category_scores_gemma":[0.016575314,0.0016021637,0.0020292317,0.0012595677,0.0017520182,0.0016040632,0.0011919605,0.009082994,0.020109212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053678228,0.000015411135,0.00004686955,0.0000618553,0.000009253751,0.00029392223,0.000008316506,0.00003748788,0.00021490054,0.00026446657,0.99578345,0.0032104678],"study_design_scores_gemma":[0.000056691762,0.000056428322,0.00077721215,0.00014465916,0.000044964945,0.0006398184,0.000031851676,0.00022310067,0.0010699461,0.000527261,0.99639124,0.00003686935],"about_ca_topic_score_codex":0.015455402,"about_ca_topic_score_gemma":0.026901238,"teacher_disagreement_score":0.023573201,"about_ca_system_score_codex":0.00423379,"about_ca_system_score_gemma":0.0044713104,"threshold_uncertainty_score":0.07886016},"labels":[],"label_agreement":null},{"id":"W4232613062","doi":"10.1093/neuonc/nox168.810","title":"PDTM-48. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Gene silencing; Apoptosis; Radiation therapy; Chemotherapy; Medicine; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.01978901821219837,"score_gpt":0.2912706027479169,"score_spread":0.2714815845357185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232613062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869263,0.004913527,0.0035672311,0.0004080938,0.00007214242,0.000115917166,0.00091176084,0.000213389,0.0028717082],"genre_scores_gemma":[0.992455,0.0016279471,0.002132441,0.000058515034,0.000007338068,0.00006183202,0.0009903761,0.000017973665,0.0026486013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999534,0.000005081208,0.0000029121047,0.000012055682,0.000014905021,0.00001172028],"domain_scores_gemma":[0.9999765,0.0000022398651,0.0000075811386,0.0000030623385,0.0000026170549,0.000007983047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008385711,0.00020079614,0.0001957092,0.00017104346,0.0001749966,0.00016263216,0.00013273592,0.0002071838,0.0014897755],"category_scores_gemma":[0.000058375434,0.00006926515,0.00021763281,0.00014908478,0.00015438825,0.0001236642,0.00012588176,0.0004955064,0.00023784245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025701485,0.000066398265,0.0006470856,0.00009612925,0.000009074868,0.00006654901,0.00001905683,0.00013584623,0.99212146,0.00015930287,0.000306903,0.0061152675],"study_design_scores_gemma":[0.00005957101,0.0009449529,0.008924641,0.00000972087,0.000025848018,0.00047671286,0.00002754253,0.0006131964,0.9791515,0.00008953394,0.009672508,0.0000043387854],"about_ca_topic_score_codex":0.0009581873,"about_ca_topic_score_gemma":0.001788032,"teacher_disagreement_score":0.0014897755,"about_ca_system_score_codex":0.00039607062,"about_ca_system_score_gemma":0.00021990431,"threshold_uncertainty_score":0.0049838424},"labels":[],"label_agreement":null},{"id":"W4232645866","doi":"10.1093/neuonc/noaa222.495","title":"MBCL-19. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH DESMOPLASTIC/EXTENSIVE NODULAR MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS OF PROSPECTIVE MULTI-CENTER EUROPEAN AND NORTH AMERICAN TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Induction chemotherapy; Chemotherapy; Oncology; Clinical trial; Internal medicine; Methotrexate; Cytarabine; Surgery; Pathology","score_opus":0.03707217594381081,"score_gpt":0.32851647301048736,"score_spread":0.29144429706667657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232645866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8010064,0.19149244,0.0005655659,0.0005049258,0.00014592118,0.0012628781,0.001597626,0.00003266684,0.0033917192],"genre_scores_gemma":[0.9752864,0.020713856,0.0009992751,0.00045861545,0.00011340902,0.00062426145,0.0013124887,0.000009183289,0.00048260673],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970982,0.001876732,0.0003353103,0.00029651626,0.0002427228,0.00015054725],"domain_scores_gemma":[0.99662423,0.0011171739,0.0015596158,0.00014184376,0.00020550589,0.00035169453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005247489,0.00040246316,0.001089677,0.0012006533,0.000187346,0.0008691769,0.00043276098,0.00049750693,0.0013647882],"category_scores_gemma":[0.0037471948,0.00020544289,0.0019411028,0.0010942119,0.00041942895,0.00063951104,0.00034584815,0.00060031464,0.00016219962],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5150717,0.0025077846,0.07596968,0.006764673,0.025017811,0.00024262936,0.00019310231,0.0020394824,0.0052493983,0.0005615366,0.0015321273,0.36485013],"study_design_scores_gemma":[0.27929923,0.30217886,0.30941078,0.0044404347,0.060527176,0.0020204717,0.0006029216,0.0020105361,0.006736329,0.0009328909,0.03169857,0.00014173592],"about_ca_topic_score_codex":0.00092752196,"about_ca_topic_score_gemma":0.004123164,"teacher_disagreement_score":0.005247489,"about_ca_system_score_codex":0.0010762191,"about_ca_system_score_gemma":0.0008064812,"threshold_uncertainty_score":0.027751684},"labels":[],"label_agreement":null},{"id":"W4233683996","doi":"10.1093/neuonc/noaa222.339","title":"IMG-03. RESPONSE ASSESSMENT IN PEDIATRIC LOW-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medical physics; Clinical trial; MEDLINE; Consensus conference; Pathology; Internal medicine","score_opus":0.04050351392236156,"score_gpt":0.3450257419854616,"score_spread":0.30452222806310003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233683996","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01569332,0.13893478,0.086973466,0.6421211,0.015863566,0.024469135,0.0097845765,0.0028752284,0.0632849],"genre_scores_gemma":[0.081480525,0.09778186,0.5577562,0.16224255,0.008283196,0.04842825,0.025449751,0.0022363574,0.016341353],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.892431,0.060171615,0.026225086,0.0028974952,0.01512713,0.0031475897],"domain_scores_gemma":[0.7412331,0.08878956,0.03499616,0.0093529355,0.111984886,0.013643284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17812754,0.001829784,0.0038078588,0.00692278,0.0018462867,0.005245302,0.010171472,0.010600039,0.0031465103],"category_scores_gemma":[0.19918154,0.0011873405,0.006978931,0.0047953627,0.002526643,0.004270436,0.006744473,0.013299225,0.0065850383],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008137833,0.00046384207,0.010212869,0.01279653,0.00057756394,0.00037268165,0.0016842221,0.0037218952,0.001907232,0.0065056086,0.44411597,0.5168277],"study_design_scores_gemma":[0.001005909,0.0012325242,0.027692739,0.08182122,0.0017358377,0.000978437,0.00180423,0.0048910473,0.0036858877,0.012299265,0.86250865,0.00034426848],"about_ca_topic_score_codex":0.0072766664,"about_ca_topic_score_gemma":0.0063194316,"teacher_disagreement_score":0.17812754,"about_ca_system_score_codex":0.0073281773,"about_ca_system_score_gemma":0.024167677,"threshold_uncertainty_score":0.9420397},"labels":[],"label_agreement":null},{"id":"W4234183193","doi":"10.1093/neuonc/noaa215.644","title":"NIMG-31. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Histopathology; Medicine; Pilocytic astrocytoma; Medical diagnosis; Biopsy; Pathology; Radiology; Astrocytoma; Stereotactic biopsy; Glioma; Medulloblastoma; Ganglioglioma; Epilepsy","score_opus":0.044511088822360594,"score_gpt":0.32953472570027104,"score_spread":0.28502363687791044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234183193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853006,0.0018739658,0.00020860838,0.00013159653,0.000017322393,0.00012471149,0.0059467447,0.000040846986,0.0063556833],"genre_scores_gemma":[0.9936401,0.0005717496,0.00036603922,0.000067274595,0.000023209184,0.000097154836,0.0048298803,0.000011321731,0.0003931397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993906,0.00012104058,0.0001022466,0.00014071612,0.000116983734,0.00012843395],"domain_scores_gemma":[0.9980761,0.00022111837,0.0009909072,0.00015772415,0.00028811782,0.00026606928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093899283,0.00014865438,0.000307216,0.0021094598,0.00033208815,0.00071774004,0.00039176902,0.00021422758,0.002807853],"category_scores_gemma":[0.003037457,0.000111613495,0.0001466648,0.0023969966,0.00025996153,0.0004677621,0.0005990201,0.00013592158,0.0007691126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100868136,0.000015710666,0.9922747,0.00006283446,0.000013712394,0.0010704384,0.0000835633,0.000023814542,0.0003151728,0.00004096311,0.0008625607,0.005135682],"study_design_scores_gemma":[0.000010994031,0.000059523696,0.9905365,0.000041110558,0.000021934078,0.005847671,0.0003850164,0.00012261365,0.00040566,0.00003946557,0.0025241326,0.000005430888],"about_ca_topic_score_codex":0.003286755,"about_ca_topic_score_gemma":0.0037663402,"teacher_disagreement_score":0.003286755,"about_ca_system_score_codex":0.000477412,"about_ca_system_score_gemma":0.00093266036,"threshold_uncertainty_score":0.009393215},"labels":[],"label_agreement":null},{"id":"W4236152653","doi":"10.1093/neuonc/noy148.863","title":"PDTM-21. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; McGill University; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Medulloblastoma; Population; Cerebellum; Lineage markers; Single-cell analysis; Progenitor cell; Stem cell; Genetics; Cell; Neuroscience","score_opus":0.041318687902551686,"score_gpt":0.3141205460476487,"score_spread":0.27280185814509705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236152653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8290625,0.0021406387,0.043499064,0.0004436443,0.00018063145,0.0003384428,0.1070178,0.004845522,0.012471621],"genre_scores_gemma":[0.74336547,0.001252658,0.06718682,0.0006359981,0.000045341447,0.00094190944,0.1666036,0.0021786666,0.017789599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996369,0.000016800572,0.000020151978,0.00015837644,0.00011642351,0.00005136466],"domain_scores_gemma":[0.9998215,0.000038941453,0.00003870634,0.000032986205,0.0000328504,0.000035018624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029029782,0.00034756112,0.00052462664,0.0004315186,0.0005941571,0.0007181752,0.0003999145,0.0004912433,0.0031413245],"category_scores_gemma":[0.00041546486,0.00034419957,0.0004638773,0.00044021013,0.00024121141,0.00017507955,0.00058053865,0.0007615312,0.0020991806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001575501,0.000020607426,0.004687541,0.0001493492,0.000023300508,0.00011704556,0.000098740995,0.00059404597,0.98295677,0.0003326314,0.0017178654,0.009144495],"study_design_scores_gemma":[0.00006242793,0.00033325818,0.10753611,0.000054280546,0.00013543342,0.001082302,0.00017271227,0.0130883055,0.78414416,0.0006955507,0.0926503,0.00004519903],"about_ca_topic_score_codex":0.0028104233,"about_ca_topic_score_gemma":0.010478184,"teacher_disagreement_score":0.0031413245,"about_ca_system_score_codex":0.0006470556,"about_ca_system_score_gemma":0.00065809506,"threshold_uncertainty_score":0.010508716},"labels":[],"label_agreement":null},{"id":"W4236267368","doi":"10.1093/neuonc/noz175.452","title":"GENE-50. SWI/SNF COMPLEX HETEROGENEITY RELATES WITH POLYPHENOTYPIC DIFFERENTIATION, PROGNOSIS AND IMMUNE RESPONSE IN RHABDOID TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"SMARCB1; Biology; DNA methylation; SWI/SNF; SMARCA4; Epigenetics; Cancer research; Immunohistochemistry; Methylation; Cellular differentiation; Gene; Gene expression; Immunology; Genetics; Chromatin remodeling","score_opus":0.012317014728936607,"score_gpt":0.25798695469413613,"score_spread":0.24566993996519954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236267368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967456,0.00009564538,0.00008446804,0.0000023772748,3.3017895e-7,0.0000017596993,0.00004854413,0.0000020970056,0.000090223],"genre_scores_gemma":[0.99975914,0.000025066589,0.000058355476,0.0000016768456,5.3422013e-7,0.0000021526403,0.000058817877,6.7548757e-7,0.000093712435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999362,0.0000099238005,0.0000065448976,0.000021214471,0.000013215851,0.0000128935135],"domain_scores_gemma":[0.9998504,0.00002083512,0.0000699478,0.000009241879,0.000012270794,0.000037274265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001570445,0.000099451485,0.000115170784,0.0003970465,0.000077171855,0.00014203652,0.000064112806,0.00010368808,0.0006653893],"category_scores_gemma":[0.00014423497,0.000055117598,0.00009139432,0.00014760028,0.0001460272,0.00007919753,0.000080239675,0.000092336384,0.00011310057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012092975,0.000056030145,0.569542,0.000034749915,0.000067640576,0.00042852474,0.00009064474,0.00019422246,0.42349797,0.00006875242,0.000062049534,0.0047480795],"study_design_scores_gemma":[0.000007059806,0.00017685439,0.9766475,0.0000020562436,0.00002461714,0.0008880517,0.00005572001,0.00038990038,0.021556528,0.000031752847,0.00021787635,0.0000021303822],"about_ca_topic_score_codex":0.00044940048,"about_ca_topic_score_gemma":0.0006069561,"teacher_disagreement_score":0.0006653893,"about_ca_system_score_codex":0.0001386389,"about_ca_system_score_gemma":0.000071660106,"threshold_uncertainty_score":0.002225995},"labels":[],"label_agreement":null},{"id":"W4236954344","doi":"10.1093/neuonc/now075.26","title":"LG-26GERMLINE AND SOMATIC FGFR1 ABNORMALITIES IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Somatic cell; Psychology; Biology; Genetics","score_opus":0.01605979703592154,"score_gpt":0.2763636554146519,"score_spread":0.2603038583787304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236954344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860424,0.0002759386,0.0002894786,0.000016595835,0.0000022748993,0.000003250554,0.00015164261,0.000012410008,0.0006440847],"genre_scores_gemma":[0.999158,0.000088703775,0.0002817151,0.000009909243,0.0000016398027,0.0000019188374,0.000109664674,0.000004623872,0.00034378972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998783,0.000013179844,0.000013402956,0.000042514068,0.000031997606,0.00002065511],"domain_scores_gemma":[0.9997863,0.000055013912,0.000079578036,0.000017643233,0.000013291319,0.00004810688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012598529,0.0003081917,0.00014338136,0.00062556664,0.00016170254,0.00019740926,0.00014766742,0.00022614955,0.0022133305],"category_scores_gemma":[0.0004248206,0.00011125496,0.00015212482,0.00030479342,0.00027554747,0.00011641382,0.00022313175,0.00013191777,0.00038430383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006508231,0.00007059152,0.49381325,0.00016777219,0.00007923719,0.13754989,0.00066721067,0.00064004475,0.34893396,0.00041350845,0.0003900359,0.01662371],"study_design_scores_gemma":[0.000020263318,0.00021676275,0.72711635,0.000027472252,0.00006959019,0.22889358,0.00035817313,0.00079176767,0.038946338,0.00025602765,0.0032890737,0.000014729454],"about_ca_topic_score_codex":0.00092962093,"about_ca_topic_score_gemma":0.0014427409,"teacher_disagreement_score":0.0022133305,"about_ca_system_score_codex":0.00021034025,"about_ca_system_score_gemma":0.00009332517,"threshold_uncertainty_score":0.0074043274},"labels":[],"label_agreement":null},{"id":"W4237365222","doi":"10.1093/neuonc/nox168.1130","title":"SCDT-51. INITIAL EXPERIENCE OF BLOOD-BRAIN BARRIER OPENING FOR CHEMOTHERAPEUTIC-DRUG DELIVERY TO BRAIN TUMOURS BY MR-GUIDED FOCUSED ULTRASOUND","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Scottish Cot Death Trust","keywords":"Medicine; Microbubbles; Blood–brain barrier; Extravasation; Magnetic resonance imaging; Glioma; Focused ultrasound; Drug delivery; Ultrasound; Radiology; Pathology; Internal medicine; Central nervous system; Cancer research","score_opus":0.027136394705324644,"score_gpt":0.3085902262507642,"score_spread":0.28145383154543957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237365222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96307313,0.01191584,0.0072680484,0.0018374313,0.00020129021,0.0010153697,0.0007187823,0.00031274348,0.013657365],"genre_scores_gemma":[0.9837689,0.0048348824,0.0051305117,0.0014228857,0.00014477021,0.0003259477,0.0013365346,0.000074246,0.0029612668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99940443,0.00024341766,0.000052764844,0.00009864523,0.00009251479,0.00010818015],"domain_scores_gemma":[0.9995852,0.00016450332,0.00003699329,0.000057973044,0.000048970443,0.000106384985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012832505,0.00048579098,0.00075356284,0.000421514,0.00047591238,0.0006089946,0.00033939397,0.00064945646,0.0017705552],"category_scores_gemma":[0.0013536853,0.00017947167,0.00032515457,0.00036686068,0.0004509434,0.00036866378,0.00044363507,0.00087336765,0.0009869721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015927223,0.009177777,0.025894178,0.0009849662,0.00027319562,0.004401264,0.0020825341,0.0032448645,0.5213528,0.002651601,0.009306863,0.40470263],"study_design_scores_gemma":[0.009788859,0.17727256,0.066041015,0.00020588981,0.0006025553,0.027216045,0.0002845116,0.005352868,0.54660684,0.0009926179,0.16546665,0.00016952727],"about_ca_topic_score_codex":0.0009207955,"about_ca_topic_score_gemma":0.0012668697,"teacher_disagreement_score":0.0017705552,"about_ca_system_score_codex":0.00055343076,"about_ca_system_score_gemma":0.0007397752,"threshold_uncertainty_score":0.0067865252},"labels":[],"label_agreement":null},{"id":"W4237835182","doi":"10.1093/neuonc/now212.640","title":"PDTB-21. CD271 (p75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Gene knockdown; Flow cytometry; Immunohistochemistry; Low-affinity nerve growth factor receptor; Wnt signaling pathway; Progenitor cell; Biology; Sonic hedgehog; Phenotype; Stem cell; Cell culture; Molecular biology; Cell biology; Immunology; Signal transduction; Gene; Receptor; Genetics; Neurotrophin","score_opus":0.011433614078062175,"score_gpt":0.26667647280408446,"score_spread":0.2552428587260223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237835182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634666,0.01920032,0.0057429466,0.0010746707,0.00014357442,0.00022178913,0.00091068575,0.000297656,0.008941708],"genre_scores_gemma":[0.98054415,0.007994965,0.003640667,0.00020536693,0.000025009533,0.000104129605,0.001173397,0.000020535685,0.0062916847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999372,0.0000074879777,0.000002922942,0.00001105875,0.000021283107,0.000019971332],"domain_scores_gemma":[0.9999851,0.0000016131344,0.000003277817,0.0000015185417,0.0000024772555,0.000006063696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092440605,0.00023054496,0.00023644514,0.00028657637,0.000180651,0.0002747982,0.00021072206,0.00024229658,0.0009988205],"category_scores_gemma":[0.000052040177,0.00012141747,0.00018977984,0.00019543993,0.00015614828,0.00012283272,0.00016767975,0.0005295524,0.00036901468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024519445,0.00011205304,0.00038592936,0.000108660766,0.000013279607,0.00017882272,0.000023492054,0.0003283268,0.98336434,0.00035562125,0.00078610744,0.014098191],"study_design_scores_gemma":[0.00017092866,0.0013000313,0.007301168,0.00001794712,0.0000796937,0.0012611287,0.00004201546,0.0026302799,0.9552071,0.00014078162,0.031836852,0.000012011061],"about_ca_topic_score_codex":0.0017599461,"about_ca_topic_score_gemma":0.0036096242,"teacher_disagreement_score":0.0017599461,"about_ca_system_score_codex":0.0005843666,"about_ca_system_score_gemma":0.00029938648,"threshold_uncertainty_score":0.004239857},"labels":[],"label_agreement":null},{"id":"W4237937188","doi":"10.1093/neuonc/5.1.23","title":"Tenth International Symposium on Pediatric Neuro-Oncology","year":2003,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Pediatric oncology; Medicine; Medical physics; Internal medicine; Cancer","score_opus":0.020291391596054375,"score_gpt":0.30031013466099443,"score_spread":0.28001874306494007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237937188","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019332947,0.36805812,0.023644827,0.06455447,0.15172896,0.0003249082,0.0011287756,0.0010284983,0.37019852],"genre_scores_gemma":[0.050679095,0.26900864,0.019586315,0.005602774,0.04713805,0.00028407885,0.0016344562,0.0002974747,0.60576916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999801,0.000039760907,0.000019453799,0.00003872475,0.000054434848,0.000046661633],"domain_scores_gemma":[0.99958843,0.00005165839,0.000021954625,0.000028340577,0.00015326194,0.00015640598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071825524,0.0007033525,0.00033983839,0.001183113,0.00038048765,0.0007476538,0.0004202576,0.0010519936,0.054599978],"category_scores_gemma":[0.00044564618,0.00018904694,0.0004305134,0.0004000148,0.0003440265,0.0007217106,0.0007236894,0.0015418504,0.0140986405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012524107,0.00009332885,0.0022215988,0.00052835624,0.000048026635,0.0014343795,0.00008741285,0.00034373737,0.0035586741,0.005064158,0.44832042,0.5381746],"study_design_scores_gemma":[0.000009251939,0.000049348644,0.0015639713,0.00015946338,0.000015766322,0.003685828,0.000036146615,0.00008459019,0.0005026299,0.00092383666,0.9929639,0.0000051840707],"about_ca_topic_score_codex":0.00079541566,"about_ca_topic_score_gemma":0.0040167263,"teacher_disagreement_score":0.054599978,"about_ca_system_score_codex":0.0007911801,"about_ca_system_score_gemma":0.0011358719,"threshold_uncertainty_score":0.1826551},"labels":[],"label_agreement":null},{"id":"W4239674161","doi":"10.1093/neuonc/noq116.s8","title":"-Omics and Prognostic Markers","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Computational biology; Omics; Biology; Medicine; Data science; Computer science; Bioinformatics","score_opus":0.0072056197055349646,"score_gpt":0.2531591448037866,"score_spread":0.24595352509825164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239674161","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22976762,0.32146245,0.086632654,0.15942265,0.009141094,0.0004264108,0.09956321,0.001379927,0.092204034],"genre_scores_gemma":[0.8270919,0.073773004,0.034547996,0.017845403,0.008776757,0.00047605397,0.028295986,0.00025689843,0.00893619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797875,0.0008779917,0.00019175875,0.0004309284,0.0003573312,0.00016322866],"domain_scores_gemma":[0.9945964,0.0020993527,0.0014765488,0.0006989445,0.000840208,0.0002886376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002910311,0.0009494102,0.0011644929,0.0028983129,0.0005115411,0.003119169,0.00062739284,0.0008942219,0.008812633],"category_scores_gemma":[0.009121586,0.0001932513,0.00082798844,0.004828748,0.000895966,0.0013076027,0.0015310841,0.0013631306,0.0024415057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078715483,0.000105675404,0.48514062,0.0022072725,0.001960805,0.00079722464,0.00039011965,0.0026419207,0.0026003611,0.036954064,0.056839485,0.40957528],"study_design_scores_gemma":[0.00013820501,0.00040006507,0.27556628,0.00341482,0.0016765827,0.004826164,0.00089923094,0.008377024,0.0030483757,0.22641186,0.4750821,0.00015937517],"about_ca_topic_score_codex":0.0011678715,"about_ca_topic_score_gemma":0.0007926479,"teacher_disagreement_score":0.008812633,"about_ca_system_score_codex":0.0010051113,"about_ca_system_score_gemma":0.0009911767,"threshold_uncertainty_score":0.029481232},"labels":[],"label_agreement":null},{"id":"W4239860724","doi":"10.1093/neuonc/nox168.1042","title":"TMOD-03. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Stem cell; Population; Downregulation and upregulation; Medulloblastoma; Gene; Cancer research; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.02712140931057723,"score_gpt":0.32212241250258006,"score_spread":0.29500100319200284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239860724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892677,0.001056619,0.00091561646,0.00021431374,0.000047082747,0.00013843656,0.0035627035,0.00022958525,0.0049089477],"genre_scores_gemma":[0.9808164,0.0006631464,0.00158053,0.00037154026,0.000017239414,0.00030545008,0.00845487,0.00009290911,0.0076979715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986315,0.00001330482,0.000008208049,0.000024726214,0.000042798143,0.00004775566],"domain_scores_gemma":[0.9999162,0.000012885045,0.000016070051,0.000011757829,0.000008867195,0.000034260385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015318494,0.00019724386,0.00038529647,0.00026392238,0.0002131642,0.00042047136,0.000191845,0.00032827648,0.0042424374],"category_scores_gemma":[0.00013869326,0.00007534335,0.00029307455,0.0002600277,0.00023362628,0.0001354837,0.0001804642,0.000876033,0.0009263063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001759033,0.00057727424,0.0039375224,0.00014070432,0.000025993722,0.00025873684,0.00012001655,0.0002773449,0.9655447,0.00047595095,0.001839824,0.025042899],"study_design_scores_gemma":[0.00045902093,0.013094254,0.07273364,0.00005222251,0.00016705468,0.0031439965,0.00035907244,0.0024298723,0.8553111,0.00057546125,0.05165529,0.00001910059],"about_ca_topic_score_codex":0.00082581094,"about_ca_topic_score_gemma":0.0014150073,"teacher_disagreement_score":0.0042424374,"about_ca_system_score_codex":0.00035116298,"about_ca_system_score_gemma":0.00042081423,"threshold_uncertainty_score":0.014192402},"labels":[],"label_agreement":null},{"id":"W4240082975","doi":"10.1093/neuonc/noy148.977","title":"RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Oncology; Dacarbazine; Internal medicine; Radiation therapy; Population; Chemotherapy; Quality of life (healthcare); Phases of clinical research; Randomized controlled trial; Clinical trial","score_opus":0.011390608306242824,"score_gpt":0.28608055039673225,"score_spread":0.2746899420904894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240082975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681768,0.0048149866,0.00092851353,0.001628701,0.0006971709,0.012080282,0.0044386555,0.00044477632,0.00678998],"genre_scores_gemma":[0.95659953,0.0044945343,0.0041900114,0.0028436498,0.0006230323,0.013290843,0.0071090055,0.00013101526,0.010718454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994331,0.00031601597,0.00002466832,0.00006302034,0.00004850321,0.00011471708],"domain_scores_gemma":[0.99940574,0.00007914956,0.00014452616,0.000036553647,0.00003513728,0.00029886462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022114937,0.0021984368,0.002166865,0.0007647546,0.00040306363,0.00082986784,0.001398087,0.0017728026,0.007246753],"category_scores_gemma":[0.0011307267,0.00067525153,0.0014790377,0.00062253216,0.00091784546,0.0008464496,0.0003561808,0.00317481,0.0017791054],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9088687,0.023803774,0.0015973715,0.00070637197,0.0005951216,0.000083364845,0.000071496936,0.0009697768,0.012597319,0.00043869042,0.006430253,0.0438377],"study_design_scores_gemma":[0.87050766,0.12279321,0.0029216078,0.000035914152,0.00028078762,0.000066768,0.000021176,0.00059971545,0.0008483165,0.00014894738,0.0017560286,0.000019779656],"about_ca_topic_score_codex":0.00400992,"about_ca_topic_score_gemma":0.01262209,"teacher_disagreement_score":0.007246753,"about_ca_system_score_codex":0.0013309828,"about_ca_system_score_gemma":0.0022275755,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4240141338","doi":"10.1093/neuonc/nox036.229","title":"P08.40 The prognostic and predictive value of an explant assay of gliomas in response to temozolomide","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Glioma; Explant culture; Cancer research; Medicine; Apoptosis; Methylation; In vivo; Pathological; Pathology; Oncology; Biology; In vitro","score_opus":0.02449150331396757,"score_gpt":0.3203009703170735,"score_spread":0.29580946700310595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240141338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972728,0.0008188041,0.00046169123,0.000058239002,0.00003007692,0.0000119642755,0.00064839947,0.000033067015,0.00066495396],"genre_scores_gemma":[0.99834657,0.00017785929,0.00038602334,0.000013469941,0.000015116062,0.000012245061,0.00069606764,0.000004196318,0.0003484691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983263,0.000039064707,0.000014074833,0.00003409274,0.00005815032,0.00002199176],"domain_scores_gemma":[0.99898785,0.0002816228,0.00036168878,0.00006580375,0.00016697888,0.00013601672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032069458,0.00027768684,0.0002503963,0.00037879785,0.00013542765,0.0005272316,0.00020999358,0.00026419302,0.0024224264],"category_scores_gemma":[0.0011187147,0.0000883153,0.00017063587,0.00035954738,0.00019823825,0.00014227549,0.00020453363,0.0004668434,0.00072055677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003131786,0.0001440175,0.9239211,0.000086340275,0.000087312794,0.0006162161,0.00008183152,0.0004076981,0.05350503,0.000034537115,0.0007467697,0.017237306],"study_design_scores_gemma":[0.00005313323,0.0026885606,0.95092416,0.000020100815,0.00013832406,0.004785447,0.00015375957,0.0028796222,0.036194533,0.00009495773,0.0020522925,0.000015228397],"about_ca_topic_score_codex":0.00050073257,"about_ca_topic_score_gemma":0.0004275063,"teacher_disagreement_score":0.0024224264,"about_ca_system_score_codex":0.00020694885,"about_ca_system_score_gemma":0.00013754574,"threshold_uncertainty_score":0.008103788},"labels":[],"label_agreement":null},{"id":"W4240277013","doi":"10.1093/neuonc/now212.887","title":"TMOD-17. CONVERGENCE OF BMI1 AND CHD7 ON ERK SIGNALLING IN MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"BMI1; Medulloblastoma; Biology; Cancer research; Polycomb-group proteins; Wnt signaling pathway; Gene knockdown; Cell biology; Stem cell; Signal transduction; Genetics; Repressor; Transcription factor; Cell culture","score_opus":0.01459587306335238,"score_gpt":0.277045863754923,"score_spread":0.26244999069157066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240277013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831261,0.0046565356,0.0014654773,0.0003678516,0.00012574202,0.00004063133,0.0022103465,0.00018419272,0.007823198],"genre_scores_gemma":[0.985635,0.0019306547,0.0012096576,0.0001572397,0.00001742638,0.00004117877,0.0032851046,0.000042517986,0.0076813786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998759,0.000010201757,0.000008576562,0.000022366825,0.00004006632,0.000042850188],"domain_scores_gemma":[0.99991655,0.000005489694,0.000019556353,0.000005321656,0.000008460673,0.00004465165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008741877,0.00027691037,0.00022157667,0.00032878638,0.00020526098,0.000431549,0.0002173941,0.0002442214,0.003605194],"category_scores_gemma":[0.000096679,0.00014815062,0.0003307201,0.00019174186,0.00022696177,0.00017818871,0.00036138762,0.0005371868,0.0009248812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042793312,0.000032532465,0.0011742713,0.000109083085,0.000010144498,0.00017418948,0.000013961902,0.00009398986,0.9941455,0.00032517442,0.00022974666,0.0032633317],"study_design_scores_gemma":[0.00009047029,0.0005220704,0.054762635,0.000029710198,0.000048472248,0.0013127534,0.00014798823,0.001312381,0.9228055,0.00025212183,0.01870344,0.000012521118],"about_ca_topic_score_codex":0.0013488606,"about_ca_topic_score_gemma":0.0027661696,"teacher_disagreement_score":0.003605194,"about_ca_system_score_codex":0.0005386929,"about_ca_system_score_gemma":0.0004148455,"threshold_uncertainty_score":0.012060523},"labels":[],"label_agreement":null},{"id":"W4240779700","doi":"10.1215/s152285170100031x","title":"Immunotherapy Task Force For Malignant Brain Tumors April 21, 2001, Toronto, Ontario","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Task force; Immunotherapy; Task (project management); Conjunction (astronomy); Medicine; Internal medicine; Management; Political science; Cancer","score_opus":0.025623962175538063,"score_gpt":0.3056082259843714,"score_spread":0.2799842638088333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240779700","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011567893,0.09370524,0.004544231,0.36190167,0.14585392,0.005132697,0.049734343,0.0007322025,0.32682776],"genre_scores_gemma":[0.016853357,0.050857097,0.002758899,0.01920166,0.017320797,0.0012586387,0.021710193,0.00031710687,0.8697223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979734,0.00012357876,0.00012669506,0.000116982505,0.0011366315,0.00052276417],"domain_scores_gemma":[0.99344975,0.00037518254,0.00047191192,0.00015028118,0.0036271948,0.0019257034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034834524,0.0012639192,0.0012430216,0.0015896396,0.003526073,0.002500293,0.0014291505,0.0035160582,0.027193505],"category_scores_gemma":[0.003938431,0.0008495519,0.0008051183,0.0018883691,0.00087331154,0.00071519363,0.0012426322,0.0031912208,0.0133762825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000598433,0.000014131528,0.00089848205,0.00010038319,0.0000059268996,0.000053711683,0.000038819235,0.00009506447,0.00023671103,0.0001990108,0.9871558,0.011142202],"study_design_scores_gemma":[0.00004945306,0.000022376478,0.010018148,0.00019183008,0.000017573284,0.00005058382,0.00008173946,0.000090419286,0.00010593156,0.00011690049,0.989244,0.0000110016435],"about_ca_topic_score_codex":0.5663004,"about_ca_topic_score_gemma":0.86288244,"teacher_disagreement_score":0.5663004,"about_ca_system_score_codex":0.012638746,"about_ca_system_score_gemma":0.042933468,"threshold_uncertainty_score":0.8725075},"labels":[],"label_agreement":null},{"id":"W4240905434","doi":"10.1215/s1522851799000541","title":"Myeloablative chemotherapy for recurrent aggressive oligodendroglioma","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"York University; Memorial Sloan-Kettering Cancer Center; Massachusetts General Hospital","keywords":"Oligodendroglioma; Chemotherapy; Medicine; Oncology; Internal medicine; Glioma; Cancer research; Astrocytoma","score_opus":0.023512595755182723,"score_gpt":0.3268441634979715,"score_spread":0.3033315677427888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240905434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967108,0.0023848598,0.00025058305,0.000053691845,0.000009899595,0.00004443237,0.000036985963,0.000011399788,0.000497533],"genre_scores_gemma":[0.9978613,0.0010935651,0.0004075892,0.00012099283,0.000048605252,0.000059331884,0.00013387232,0.000004116155,0.0002704881],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.000075123804,0.000020983278,0.000016229302,0.000033514876,0.000039967566],"domain_scores_gemma":[0.9997422,0.00005783597,0.00008260778,0.000020669757,0.000014506186,0.00008217515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038405767,0.00023216693,0.0005812074,0.00017307748,0.00022622118,0.0002153359,0.00016473194,0.00020003482,0.0004904019],"category_scores_gemma":[0.0006124746,0.0000837422,0.00021762929,0.00018532203,0.0001693489,0.0001508134,0.00015106412,0.00028722954,0.00016068519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034103055,0.0048446604,0.2332593,0.00085515215,0.00046165776,0.007339061,0.00157544,0.0030493424,0.19506992,0.0007554619,0.0026143834,0.51607263],"study_design_scores_gemma":[0.010184473,0.1974567,0.68440634,0.0002599263,0.0010706343,0.029610489,0.00035100075,0.00494392,0.03258992,0.00076068775,0.03828956,0.00007638147],"about_ca_topic_score_codex":0.00049220864,"about_ca_topic_score_gemma":0.0018403034,"teacher_disagreement_score":0.0005812074,"about_ca_system_score_codex":0.0003474182,"about_ca_system_score_gemma":0.00033777746,"threshold_uncertainty_score":0.00252074},"labels":[],"label_agreement":null},{"id":"W4240962932","doi":"10.1093/neuonc/nox036.076","title":"OS11.5 ACT IV: An international, double-blind, phase 3 trial of rindopepimut in newly diagnosed, EGFRvIII-expressing glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temozolomide; Interim analysis; Hazard ratio; Internal medicine; Oncology; Cohort; Clinical endpoint; Confidence interval; Randomized controlled trial; Chemotherapy","score_opus":0.0690954306968465,"score_gpt":0.4028926386686069,"score_spread":0.33379720797176043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240962932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865215,0.003238616,0.00094247935,0.00075295335,0.00035842825,0.0021566264,0.0016529988,0.00040539508,0.0039709196],"genre_scores_gemma":[0.98036283,0.002842402,0.001978069,0.0014797474,0.00023476713,0.0033685844,0.0033664715,0.000070867674,0.0062962533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997166,0.00012518186,0.000012266379,0.00004932162,0.000019431687,0.00007722462],"domain_scores_gemma":[0.9996105,0.00005379005,0.00007612063,0.000038898794,0.000027644788,0.00019302126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011189034,0.0019522021,0.001457603,0.0005546195,0.00035249928,0.0009865612,0.0010099222,0.0011153527,0.005045536],"category_scores_gemma":[0.00063267513,0.00045957594,0.0011131819,0.00034458912,0.0010018336,0.00084733637,0.0003423432,0.002952912,0.0011759194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88866305,0.021786222,0.0011650802,0.000715569,0.0007090213,0.00009024284,0.00014781987,0.001518574,0.015245866,0.0004609907,0.005108255,0.064389214],"study_design_scores_gemma":[0.8132412,0.1779001,0.0026886796,0.000054505497,0.00036726432,0.000116405994,0.000038956816,0.00091376086,0.0022361814,0.0003253251,0.0020879873,0.000029754141],"about_ca_topic_score_codex":0.0010228626,"about_ca_topic_score_gemma":0.0030596168,"teacher_disagreement_score":0.005045536,"about_ca_system_score_codex":0.0008408092,"about_ca_system_score_gemma":0.001432032,"threshold_uncertainty_score":0.016878963},"labels":[],"label_agreement":null},{"id":"W4241427629","doi":"10.1093/neuonc/nov061.132","title":"PM-10 * GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Genetically engineered; Genetically modified organism; Biology; Computational biology; Genetics; Neuroscience; Gene","score_opus":0.0719459831229457,"score_gpt":0.312822113114756,"score_spread":0.2408761299918103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241427629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.872426,0.0056907022,0.056251258,0.0034672732,0.001755596,0.0021566846,0.02238405,0.004345191,0.03152321],"genre_scores_gemma":[0.79936343,0.0062524127,0.052344184,0.0011913955,0.00024152957,0.005811353,0.017097639,0.0015576663,0.116140336],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983911,0.00019207048,0.00021186953,0.00050993916,0.0004125291,0.00028252194],"domain_scores_gemma":[0.99853706,0.00024364445,0.00041227494,0.00017076965,0.00012733683,0.0005089282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010867884,0.0018380493,0.00082059024,0.0026865911,0.0006940237,0.0011331679,0.0016044237,0.0034984031,0.012008347],"category_scores_gemma":[0.0005246341,0.0012613697,0.0011209575,0.00081673224,0.0012308006,0.0013241494,0.0008509451,0.0052290075,0.004953271],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095225975,0.0010597705,0.0005382397,0.00024358802,0.000051655315,0.00087300636,0.00015172947,0.00056665245,0.98622084,0.003249416,0.0019615695,0.004131332],"study_design_scores_gemma":[0.00077040296,0.0037151913,0.0044738646,0.0002049066,0.00014904614,0.0046697254,0.00030520777,0.008669356,0.9107778,0.0014716724,0.06471785,0.00007491387],"about_ca_topic_score_codex":0.0013897602,"about_ca_topic_score_gemma":0.0020117126,"teacher_disagreement_score":0.012008347,"about_ca_system_score_codex":0.0012882634,"about_ca_system_score_gemma":0.00090350537,"threshold_uncertainty_score":0.04017192},"labels":[],"label_agreement":null},{"id":"W4242213985","doi":"10.1093/neuonc/noy059.223","title":"EPEN-23. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Histogenesis; Biology; Genetic heterogeneity; Oncology; Gene; Pathology; Genetics; Bioinformatics; Internal medicine; Immunohistochemistry; Medicine; Immunology; Phenotype","score_opus":0.018585694410918754,"score_gpt":0.29883193160052446,"score_spread":0.28024623718960573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242213985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678814,0.00079368125,0.0012606746,0.000027443188,0.0000030479607,0.00001714832,0.00047823173,0.000019438248,0.00061219174],"genre_scores_gemma":[0.9972868,0.0003432072,0.0011909987,0.00001397869,0.0000046413993,0.000018553526,0.00095198606,0.00000921066,0.00018053378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999793,0.00001596244,0.000023021543,0.00007925253,0.00005278274,0.000036055237],"domain_scores_gemma":[0.99970067,0.000060942268,0.00011545525,0.000027780543,0.00005129583,0.000043893433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020926543,0.00024126962,0.00029480585,0.0007864108,0.00022409287,0.00034559454,0.0002252174,0.00018952468,0.00054757844],"category_scores_gemma":[0.00065750047,0.00011710724,0.000216322,0.0007136434,0.00026070618,0.0002602723,0.00028293603,0.00026098022,0.00016817069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004027411,0.000028795745,0.7690182,0.00012672701,0.00012685882,0.0045272545,0.00031593998,0.0015009281,0.17978983,0.00042202979,0.00035948542,0.04338134],"study_design_scores_gemma":[0.000010121052,0.000094277915,0.972328,0.000009775461,0.00006686746,0.011190486,0.00020354458,0.0013453577,0.01210534,0.00038877685,0.0022480206,0.000009574335],"about_ca_topic_score_codex":0.0020626022,"about_ca_topic_score_gemma":0.003914394,"teacher_disagreement_score":0.0020626022,"about_ca_system_score_codex":0.00028491835,"about_ca_system_score_gemma":0.0002382912,"threshold_uncertainty_score":0.004101217},"labels":[],"label_agreement":null},{"id":"W4242737299","doi":"10.1093/neuonc/noy059.495","title":"MBRS-50. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto; University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Gene knockdown; Cancer research; Apoptosis; Gene silencing; DNA damage; Biology; RNA interference; Sensitization; Immunology; Gene; DNA; RNA; Biochemistry","score_opus":0.018185790717808764,"score_gpt":0.30778094548731333,"score_spread":0.2895951547695046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242737299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853871,0.004901412,0.004795594,0.00035709096,0.000048692298,0.00010978097,0.0016499371,0.0003831016,0.0023671703],"genre_scores_gemma":[0.98996043,0.001590929,0.0035322434,0.000093257135,0.000008603216,0.00004962674,0.0023459804,0.000038988153,0.0023799457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998785,0.000014131311,0.0000089043,0.000027019005,0.000051762654,0.000019679293],"domain_scores_gemma":[0.99993014,0.000008244782,0.000028293598,0.000008160298,0.000009444867,0.000015742082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022738044,0.00027165687,0.00026691065,0.00021240805,0.00016667343,0.00023847281,0.00014912416,0.0002375354,0.001564633],"category_scores_gemma":[0.0001346096,0.000096962256,0.00034512978,0.00016963236,0.00020241256,0.00016760943,0.00013214337,0.0005053667,0.00037905484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012531505,0.000028066617,0.001489833,0.00007892638,0.000009554578,0.00007494902,0.000017991986,0.000117612515,0.993658,0.00006620426,0.00017403418,0.0041594254],"study_design_scores_gemma":[0.000027973701,0.00058377057,0.021918714,0.000013434825,0.0000446388,0.00079446496,0.00003071147,0.00071242213,0.96701425,0.00006999634,0.008784005,0.000005575634],"about_ca_topic_score_codex":0.0013042253,"about_ca_topic_score_gemma":0.0022601278,"teacher_disagreement_score":0.001564633,"about_ca_system_score_codex":0.00045077,"about_ca_system_score_gemma":0.00022623324,"threshold_uncertainty_score":0.005234182},"labels":[],"label_agreement":null},{"id":"W4243036438","doi":"10.1093/neuonc/noaa222.500","title":"MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Izaak Walton Killam Health Centre; Stollery Children's Hospital; Alberta Children's Hospital; University of Calgary; University of British Columbia; University of Alberta; BC Children's Hospital; Université Laval; Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Chemotherapy; Neurocognitive; Retrospective cohort study; Young adult; Salvage therapy; Surgery; Oncology; Internal medicine; Pathology","score_opus":0.037378132802897916,"score_gpt":0.26372608050898283,"score_spread":0.2263479477060849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243036438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905912,0.0062295967,0.00020068223,0.0005528791,0.00002675426,0.000022317001,0.00039139832,0.00003575632,0.0019492293],"genre_scores_gemma":[0.99681467,0.0019973896,0.0002380821,0.00012686006,0.000037617174,0.000015822454,0.00049219205,0.0000059910763,0.0002712614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993634,0.000011216426,0.000005341663,0.000010390093,0.000009064362,0.000027608055],"domain_scores_gemma":[0.9997482,0.000034012894,0.00011345809,0.0000067921746,0.00001477531,0.00008276236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016098823,0.00012915963,0.00028613926,0.00017949358,0.00016304254,0.0003056058,0.00024028613,0.00026585363,0.0010701118],"category_scores_gemma":[0.0005746484,0.000056680332,0.0002430898,0.00021514912,0.00016247405,0.00025143934,0.000146903,0.00025274206,0.00025618222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017783262,0.00016654114,0.8710132,0.00026893645,0.00007524587,0.007103282,0.00024727054,0.0003220724,0.0042616217,0.00020534942,0.0023174037,0.112240694],"study_design_scores_gemma":[0.000139299,0.002636264,0.96189904,0.0002578504,0.00014852884,0.02342818,0.0006915976,0.00047328984,0.0031840699,0.00040413075,0.006723887,0.000013894599],"about_ca_topic_score_codex":0.002225728,"about_ca_topic_score_gemma":0.005607882,"teacher_disagreement_score":0.002225728,"about_ca_system_score_codex":0.0004902988,"about_ca_system_score_gemma":0.00047652924,"threshold_uncertainty_score":0.0044255853},"labels":[],"label_agreement":null},{"id":"W4243210036","doi":"10.1093/neuonc/nox083.123","title":"IMMU-13. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Exome sequencing; Cancer research; Cancer; DNA mismatch repair; Biology; Deep sequencing; Genetics; Medicine; Gene; DNA repair; Genome; Antibody","score_opus":0.011569161597073947,"score_gpt":0.2890082230358321,"score_spread":0.2774390614387582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243210036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89235026,0.0028362912,0.045198306,0.00040104106,0.00006070564,0.00024265776,0.04549315,0.004238782,0.00917885],"genre_scores_gemma":[0.86182284,0.0009937953,0.08800038,0.00027714053,0.000032311047,0.00034719997,0.044678837,0.0005681107,0.0032792434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973255,0.00003175451,0.000016891445,0.00010189818,0.00007574734,0.000041071213],"domain_scores_gemma":[0.9996159,0.00010628267,0.00010933983,0.00004442965,0.000056209137,0.00006765621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078691123,0.00051626196,0.00047744226,0.0011596263,0.00029203529,0.00053525454,0.00034793903,0.00044363525,0.003453],"category_scores_gemma":[0.00086330593,0.00031487475,0.00032840075,0.00082850887,0.0002278301,0.00020278711,0.0005394853,0.00039971786,0.0012958995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022079553,0.00016618098,0.47611704,0.00056943565,0.00038804076,0.0012521481,0.00025698342,0.0065858057,0.33775815,0.0016551085,0.013682026,0.15936115],"study_design_scores_gemma":[0.00017917732,0.0010372843,0.62556314,0.00015297375,0.0003953763,0.0065021343,0.0001580559,0.055534843,0.25584248,0.00238439,0.052192934,0.0000572184],"about_ca_topic_score_codex":0.001223084,"about_ca_topic_score_gemma":0.0034101931,"teacher_disagreement_score":0.003453,"about_ca_system_score_codex":0.0004959026,"about_ca_system_score_gemma":0.000480224,"threshold_uncertainty_score":0.01155138},"labels":[],"label_agreement":null},{"id":"W4243655222","doi":"10.1093/neuonc/noz175.800","title":"PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Social Innovation; Hospital for Sick Children","funders":"","keywords":"Drosha; Medulloblastoma; Germline; Oncology; Epigenetics; Brain tumor; Internal medicine; DNA methylation; Methylation; Medicine; Biology; Bioinformatics; Pathology; Genetics; Gene","score_opus":0.012099061686657244,"score_gpt":0.283983785275169,"score_spread":0.27188472358851173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243655222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833506,0.00020813852,0.00019670316,0.000050032722,0.0000038704143,0.000021506989,0.0006584908,0.000015677124,0.0005104104],"genre_scores_gemma":[0.9984314,0.00009271376,0.00016738269,0.000026458416,0.000007680331,0.000014418951,0.0010493463,0.0000093008075,0.00020120681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995739,0.000058730868,0.000039883074,0.00013253417,0.00011294671,0.00008191651],"domain_scores_gemma":[0.9992908,0.00011509368,0.000171628,0.00008590549,0.00013761637,0.00019894639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005071418,0.00027899514,0.00027667521,0.0011351369,0.0008892869,0.00073663774,0.00039513496,0.0003412617,0.001251567],"category_scores_gemma":[0.0012357221,0.00020101834,0.00021535704,0.0008553532,0.00037568723,0.00014110438,0.00067495526,0.0003209359,0.00034138357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005274037,0.00011706081,0.96071744,0.000042435284,0.00008937396,0.010615806,0.000778981,0.0001009031,0.012875259,0.00012669222,0.0013545171,0.012654171],"study_design_scores_gemma":[0.000043712702,0.00016841381,0.96158755,0.000014676885,0.0000679454,0.032272954,0.0006476413,0.0003468881,0.0020888639,0.000077702796,0.0026679588,0.000015662163],"about_ca_topic_score_codex":0.0090811625,"about_ca_topic_score_gemma":0.008034077,"teacher_disagreement_score":0.0090811625,"about_ca_system_score_codex":0.0005107635,"about_ca_system_score_gemma":0.00042586937,"threshold_uncertainty_score":0.018056571},"labels":[],"label_agreement":null},{"id":"W4243908687","doi":"10.1093/neuonc/noy148.988","title":"RARE-11. EFFICACY AND SAFETY OF DABRAFENIB + TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED LOW-GRADE GLIOMA (LGG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Internal medicine; Adverse effect; Progression-free survival; Oncology; Clinical endpoint; Refractory (planetary science); Nausea; Melanoma; Glioma; MEK inhibitor; Gastroenterology; Surgery; Clinical trial; Cancer; Vemurafenib; Chemotherapy; Cancer research; Metastatic melanoma","score_opus":0.015409064341804737,"score_gpt":0.288089727165392,"score_spread":0.27268066282358727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243908687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921393,0.0038753403,0.00027929284,0.00032394895,0.00005174164,0.00026995718,0.00080461084,0.00012525676,0.002130722],"genre_scores_gemma":[0.99632263,0.001055522,0.0005171454,0.0002842479,0.000041767726,0.00015045039,0.00096519926,0.0000070444603,0.00065598],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975497,0.00009777995,0.000025795402,0.0000382441,0.000033535114,0.000049818384],"domain_scores_gemma":[0.9996165,0.00007824819,0.000118206124,0.000024471363,0.000024846755,0.00013762288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065187336,0.00036452612,0.00092934334,0.0002814222,0.00016166706,0.00042675508,0.00031623605,0.00043741823,0.0024162694],"category_scores_gemma":[0.0006943677,0.00019107333,0.0006627075,0.00025068605,0.000345611,0.00039576134,0.00023160735,0.0009851453,0.0005179222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.408448,0.012672567,0.04794082,0.0020773243,0.0016784713,0.0014444607,0.00038116454,0.0034519504,0.05955879,0.0007957352,0.008711229,0.45283955],"study_design_scores_gemma":[0.33278215,0.49675417,0.1152565,0.00030449647,0.0021232723,0.006441544,0.00031946425,0.0061758724,0.019775458,0.0006640715,0.019284729,0.00011831468],"about_ca_topic_score_codex":0.00071022625,"about_ca_topic_score_gemma":0.0038255244,"teacher_disagreement_score":0.0024162694,"about_ca_system_score_codex":0.000502089,"about_ca_system_score_gemma":0.00053226884,"threshold_uncertainty_score":0.008083284},"labels":[],"label_agreement":null},{"id":"W4244695146","doi":"10.1093/neuonc/nox074","title":"Highlights from the Literature","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.07111079299926222,"score_gpt":0.3750462248450668,"score_spread":0.30393543184580457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244695146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018117396,0.55880183,0.002393751,0.12684754,0.13088787,0.00035671596,0.005001348,0.00064850174,0.17325073],"genre_scores_gemma":[0.012303398,0.66304487,0.0029334542,0.10168061,0.13588522,0.00039033557,0.009347426,0.00039110778,0.07402365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893135,0.00017249912,0.00021120747,0.00015526704,0.00039091724,0.00013869922],"domain_scores_gemma":[0.9950782,0.0011623189,0.0005015369,0.00023767256,0.0022236397,0.0007965982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001296542,0.0008001423,0.00091704255,0.006105451,0.0010756945,0.004655718,0.0016996348,0.002863494,0.1205307],"category_scores_gemma":[0.00935531,0.00034540743,0.0009523288,0.0045206742,0.0008035114,0.0034123783,0.0022256381,0.0033635919,0.059194874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008861124,0.000041748033,0.00037556177,0.004080763,0.00003778468,0.0007018988,0.0001004662,0.00006863475,0.00020974792,0.0041989065,0.68805814,0.30203772],"study_design_scores_gemma":[0.000013920721,0.00001502679,0.00026938363,0.0041892827,0.000031252253,0.0013626459,0.00008071342,0.000016846596,0.00006890426,0.0015159928,0.9924269,0.000009299786],"about_ca_topic_score_codex":0.0015507768,"about_ca_topic_score_gemma":0.0023304096,"teacher_disagreement_score":0.1205307,"about_ca_system_score_codex":0.001618025,"about_ca_system_score_gemma":0.0044785794,"threshold_uncertainty_score":0.40321535},"labels":[],"label_agreement":null},{"id":"W4244728752","doi":"10.1093/neuonc/noaa215.238","title":"CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Internal medicine; Oncology; Adjuvant; Radiation therapy; Adjuvant therapy; Cancer; Chemotherapy","score_opus":0.016191380885355787,"score_gpt":0.2998533169003955,"score_spread":0.28366193601503975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244728752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954471,0.0010795179,0.00022056265,0.0002272288,0.00008760091,0.0011511832,0.0006079642,0.0000837175,0.0010951547],"genre_scores_gemma":[0.9926036,0.0010823769,0.00081392657,0.00040685677,0.000104072664,0.0013104695,0.0014561558,0.000023257144,0.0021992624],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997639,0.00009487407,0.000009256885,0.00004569436,0.000020454538,0.00006568502],"domain_scores_gemma":[0.99966025,0.000026899173,0.00005140982,0.00002280936,0.000020618729,0.00021801915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008348484,0.0015982753,0.0014509859,0.00040866595,0.00034958238,0.0007860089,0.0007176214,0.00094408955,0.0025751267],"category_scores_gemma":[0.00046131705,0.00053458865,0.000882894,0.00039373018,0.0008114456,0.00054991664,0.0002495628,0.0026514337,0.0007295662],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7818021,0.071705006,0.005016715,0.00047741833,0.0008015491,0.00024455242,0.00022962796,0.0021655846,0.066931255,0.00028675998,0.003348672,0.06699084],"study_design_scores_gemma":[0.40151072,0.58017826,0.009010914,0.000024989444,0.00039661405,0.00021667447,0.000058754355,0.0010509457,0.005341392,0.00013909324,0.002035645,0.000036023874],"about_ca_topic_score_codex":0.0023059489,"about_ca_topic_score_gemma":0.006953291,"teacher_disagreement_score":0.0025751267,"about_ca_system_score_codex":0.001057489,"about_ca_system_score_gemma":0.0017066215,"threshold_uncertainty_score":0.008614659},"labels":[],"label_agreement":null},{"id":"W4244757840","doi":"10.1093/neuonc/noz036.192","title":"MEDU-34. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Radiation therapy; Oncology; Vincristine; Chemotherapy; Internal medicine; Surgery; Adjuvant therapy; Cyclophosphamide; Pathology","score_opus":0.01923915387060987,"score_gpt":0.269810175691131,"score_spread":0.25057102182052116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244757840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989818,0.00007201682,0.00009454966,0.00005015727,0.0000101274045,0.0003774432,0.00014237265,0.000009467729,0.00026213622],"genre_scores_gemma":[0.99705625,0.00018135925,0.00091178075,0.00012441611,0.000050625,0.0007552241,0.00046602613,0.000007018347,0.00044725862],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994512,0.00026148572,0.000038195598,0.000103346494,0.000040886476,0.00010479122],"domain_scores_gemma":[0.9989767,0.00026217193,0.00011351886,0.00009317205,0.00006574988,0.0004887391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085783284,0.0006857952,0.0008253602,0.00036198396,0.0006993718,0.00029844546,0.00053174404,0.0007224993,0.0020098495],"category_scores_gemma":[0.0011989755,0.00028035234,0.0007917797,0.00028280847,0.0007208844,0.00035175067,0.00037832416,0.0011394834,0.00039717014],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37466624,0.2859307,0.15827076,0.00055390055,0.0007015066,0.0054955394,0.0023705377,0.0035269174,0.04133026,0.00046473375,0.0016767202,0.1250122],"study_design_scores_gemma":[0.024246877,0.88431567,0.08364158,0.000020661128,0.00020050764,0.0010086014,0.00025001745,0.00079579174,0.0037533261,0.00006563482,0.0016810952,0.00002018569],"about_ca_topic_score_codex":0.004179054,"about_ca_topic_score_gemma":0.005998382,"teacher_disagreement_score":0.004179054,"about_ca_system_score_codex":0.0010174308,"about_ca_system_score_gemma":0.0020057342,"threshold_uncertainty_score":0.0083094835},"labels":[],"label_agreement":null},{"id":"W4244793041","doi":"10.1093/neuonc/noy148.975","title":"RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Adverse effect; Oncology; Internal medicine; Clinical trial; Radiology; Radiation therapy","score_opus":0.04607792567418675,"score_gpt":0.36039493658699506,"score_spread":0.31431701091280834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244793041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92019916,0.013396282,0.002093846,0.0030750171,0.00060234393,0.0071136025,0.024583114,0.0008255099,0.02811124],"genre_scores_gemma":[0.90117365,0.009824844,0.007008053,0.008188291,0.0005061307,0.008869804,0.03964073,0.00038703842,0.024401508],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959654,0.00016643702,0.000022497085,0.00005810499,0.00008032396,0.00007609149],"domain_scores_gemma":[0.9996449,0.000033149714,0.00010049152,0.000032049316,0.000030389845,0.00015910511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019478895,0.0013113674,0.0013816982,0.00033947633,0.0003303939,0.0010401203,0.0011210061,0.0013531427,0.008060497],"category_scores_gemma":[0.00054331246,0.00035443736,0.0016338114,0.00030278743,0.00038829312,0.0006326257,0.00032684216,0.002238836,0.0036051872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43332067,0.06657829,0.016571501,0.003517336,0.0034577507,0.00051761256,0.00045198065,0.0054263882,0.106335185,0.002390396,0.08195426,0.27947864],"study_design_scores_gemma":[0.5102624,0.37903202,0.036750387,0.00031999062,0.0019955176,0.0013253045,0.0001336322,0.0023351123,0.009686194,0.0013890628,0.056674764,0.0000955891],"about_ca_topic_score_codex":0.0020233344,"about_ca_topic_score_gemma":0.0071229427,"teacher_disagreement_score":0.008060497,"about_ca_system_score_codex":0.0008300866,"about_ca_system_score_gemma":0.0017829881,"threshold_uncertainty_score":0.026965022},"labels":[],"label_agreement":null},{"id":"W4244948088","doi":"10.1093/neuonc/noz036.184","title":"MEDU-25. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICs CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Population; Gene knockdown; Biology; Medulloblastoma; Cancer research; Stem cell; Small hairpin RNA; Internal medicine; Oncology; Gene; Medicine; Genetics","score_opus":0.02205771830723043,"score_gpt":0.285522454845309,"score_spread":0.2634647365380786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244948088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927706,0.0015855405,0.0013220476,0.00010759344,0.000025776044,0.000042504158,0.0013690938,0.00013064488,0.0026461459],"genre_scores_gemma":[0.99156344,0.00050092925,0.00094332313,0.000084349726,0.0000062497725,0.00005770085,0.0015071034,0.000029822197,0.005306985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999075,0.0000088103225,0.000006044278,0.00001827553,0.000030100986,0.000029149567],"domain_scores_gemma":[0.99993443,0.000007624475,0.000019517463,0.0000071654486,0.0000074951163,0.000023771456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011161562,0.00017773463,0.00024675834,0.0002904592,0.0002036424,0.00038678065,0.00012976328,0.00023880706,0.0022524516],"category_scores_gemma":[0.00009116358,0.00006940261,0.00022412362,0.00016085581,0.0001760975,0.00011111311,0.00016691709,0.00040236497,0.00051720714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015437015,0.000036406364,0.0014532385,0.00003685438,0.000006921247,0.00010949866,0.00005653153,0.000070337584,0.99185103,0.00021346113,0.00018358712,0.005827625],"study_design_scores_gemma":[0.000029428815,0.0010225626,0.06636024,0.00002064877,0.000055423694,0.00096766575,0.00017840485,0.001364181,0.90943813,0.00021923486,0.020335814,0.000008359614],"about_ca_topic_score_codex":0.00093008124,"about_ca_topic_score_gemma":0.001566401,"teacher_disagreement_score":0.0022524516,"about_ca_system_score_codex":0.00033652873,"about_ca_system_score_gemma":0.00021478799,"threshold_uncertainty_score":0.007535219},"labels":[],"label_agreement":null},{"id":"W4245632703","doi":"10.1093/neuonc/noz175.054","title":"ACTR-11. SECOND INTERIM AND 1ST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CODELETION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Glioma; Interim analysis; Isocitrate dehydrogenase; Hazard ratio; Oncology; IDH1; Randomized controlled trial; Confidence interval; Radiation therapy; Cancer research; Biology","score_opus":0.014905637133393239,"score_gpt":0.31729356504368544,"score_spread":0.30238792791029223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245632703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749443,0.004172177,0.0019442469,0.0012117308,0.000616136,0.0027540822,0.006866134,0.00017823701,0.00731312],"genre_scores_gemma":[0.97446865,0.0008225643,0.002419353,0.0010855208,0.00024185951,0.004771978,0.009569274,0.000076080374,0.006544668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968988,0.002274928,0.000090058325,0.0002823311,0.00023601414,0.00021790156],"domain_scores_gemma":[0.9978078,0.00066855,0.0005939134,0.00030686107,0.00015725166,0.0004655842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006149733,0.0010306971,0.0018113565,0.0003643291,0.00030769056,0.0010232286,0.00054207933,0.00095514156,0.0054648155],"category_scores_gemma":[0.0031377473,0.00040088882,0.0021864802,0.00034504524,0.0006321498,0.0006704879,0.00044227942,0.0021317068,0.00076768623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96464247,0.0021880032,0.0044433787,0.00037757226,0.0018965076,0.000062572515,0.000036136742,0.0016490427,0.005200615,0.00039504076,0.0036239761,0.015484669],"study_design_scores_gemma":[0.7419478,0.18190701,0.04913963,0.000116710726,0.0046491977,0.00023628413,0.000053862914,0.004268448,0.005623057,0.0014300407,0.010545852,0.000082098086],"about_ca_topic_score_codex":0.00057944213,"about_ca_topic_score_gemma":0.002002688,"teacher_disagreement_score":0.006149733,"about_ca_system_score_codex":0.000996658,"about_ca_system_score_gemma":0.0013835859,"threshold_uncertainty_score":0.032523334},"labels":[],"label_agreement":null},{"id":"W4246785612","doi":"10.1093/neuonc/nov228.28","title":"PTPS-28INHIBITION OF LACTATE DEHYDROGENASE-A USING SODIUM OXAMATE LEADS TO METABOLIC CHANGES, DECREASED GROWTH AND MIGRATION IN MEDULLOBLASTOMA CELL LINES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Supramolecular Self-Assembly in Materials","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Lactate dehydrogenase; Sodium; Sodium lactate; Cell biology; Chemistry; Biology; Cancer research; Biochemistry; Enzyme","score_opus":0.030627539628955407,"score_gpt":0.2874013955255016,"score_spread":0.25677385589654617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246785612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956813,0.0010950639,0.0012640757,0.000090853224,0.0000408838,0.000034971064,0.00059550337,0.00007574302,0.001121694],"genre_scores_gemma":[0.99312806,0.00093912304,0.0015049323,0.000033216034,0.0000075464495,0.00005107418,0.0010470935,0.000017600438,0.0032713127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981993,0.000019330757,0.000028394219,0.00003812299,0.000055009154,0.00003922279],"domain_scores_gemma":[0.99990356,0.000012418029,0.00002913111,0.00001240496,0.000010705501,0.000031852884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015176927,0.0002584947,0.00032437802,0.00015011597,0.00012243292,0.00021340475,0.0001860912,0.00013556253,0.0013894334],"category_scores_gemma":[0.00010992466,0.00013500372,0.0002838517,0.00016977168,0.00016559735,0.00014872967,0.00016495766,0.00047261448,0.00030637128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020251247,0.000067616624,0.0002481855,0.000036655292,0.0000056088634,0.000044391792,0.000013886492,0.00008680184,0.9980995,0.000036877973,0.00008113267,0.0010768628],"study_design_scores_gemma":[0.000025700498,0.0009502803,0.0074832314,0.0000047037843,0.00001520726,0.00016747949,0.00004077237,0.00092402706,0.988214,0.000019417039,0.0021512997,0.0000038562566],"about_ca_topic_score_codex":0.0026149312,"about_ca_topic_score_gemma":0.003495233,"teacher_disagreement_score":0.0026149312,"about_ca_system_score_codex":0.00026212807,"about_ca_system_score_gemma":0.00032163947,"threshold_uncertainty_score":0.005199373},"labels":[],"label_agreement":null},{"id":"W4247033514","doi":"10.1093/neuonc/noq116.s12","title":"Pediatrics Laboratory Research","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine","score_opus":0.06282275067363098,"score_gpt":0.41497756922211493,"score_spread":0.35215481854848396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247033514","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030787947,0.042400643,0.01006036,0.018968284,0.009229141,0.0016750868,0.032972578,0.003222353,0.8506835],"genre_scores_gemma":[0.16525145,0.031657666,0.0158722,0.006320212,0.0031437161,0.0018995674,0.035281125,0.001106712,0.73946744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961702,0.001063998,0.0003122819,0.0010179424,0.0010026699,0.0004328292],"domain_scores_gemma":[0.9939825,0.0009672456,0.0006529711,0.0012409864,0.002008751,0.0011475042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029586495,0.0015453014,0.000949393,0.0027924639,0.001608585,0.0028042612,0.0020383368,0.0013240908,0.39495698],"category_scores_gemma":[0.008093818,0.00060735253,0.0009983311,0.002739928,0.0009908075,0.001151166,0.0018103315,0.0020874816,0.17575207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008386778,0.001095714,0.034134485,0.00167023,0.00017096689,0.002727898,0.00047988325,0.0004223347,0.0036452608,0.011455656,0.36501527,0.5783435],"study_design_scores_gemma":[0.0002733174,0.0003863354,0.028810445,0.0008937083,0.000067318775,0.0038182517,0.00036239298,0.00025423363,0.0022375868,0.0036916346,0.95917284,0.000031973075],"about_ca_topic_score_codex":0.0055546323,"about_ca_topic_score_gemma":0.0053915153,"teacher_disagreement_score":0.39495698,"about_ca_system_score_codex":0.0030096495,"about_ca_system_score_gemma":0.004864695,"threshold_uncertainty_score":0.8630204},"labels":[],"label_agreement":null},{"id":"W4248153717","doi":"10.1093/neuonc/nox083.163","title":"MEDU-12. CD271 (P75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Low-affinity nerve growth factor receptor; Biology; Cancer research; Wnt signaling pathway; Cell biology; Signal transduction; Neurotrophin; Receptor; Genetics","score_opus":0.03483821565849053,"score_gpt":0.33102675158198475,"score_spread":0.2961885359234942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248153717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93850684,0.03945816,0.007978231,0.001172389,0.00020180295,0.00026834576,0.00089233497,0.0005027257,0.011019123],"genre_scores_gemma":[0.97651255,0.010659015,0.004872168,0.00023393323,0.00005292387,0.000112726295,0.0010073076,0.000023712826,0.0065256036],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999348,0.0000070471256,0.0000029490532,0.000011718699,0.000023325361,0.000020041954],"domain_scores_gemma":[0.999982,0.000001785006,0.0000045639576,0.0000014326795,0.000003445871,0.000006816575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117437914,0.00027265484,0.00031680005,0.00041626766,0.00015696215,0.0004008376,0.00022562018,0.00026086456,0.001160906],"category_scores_gemma":[0.00005770836,0.00011180683,0.00022410888,0.00022797633,0.0001761697,0.00015180472,0.0001661498,0.00049068476,0.00043107558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067579886,0.00024284345,0.0018443387,0.0003284237,0.0000326554,0.0004282227,0.000045758923,0.0005517414,0.9328085,0.0006268578,0.0013901335,0.061024632],"study_design_scores_gemma":[0.00025272893,0.0022755,0.018969143,0.000050135404,0.0002070751,0.002476216,0.00010438848,0.004874017,0.9179961,0.00034323242,0.052430928,0.000020562367],"about_ca_topic_score_codex":0.0010509053,"about_ca_topic_score_gemma":0.002897063,"teacher_disagreement_score":0.001160906,"about_ca_system_score_codex":0.0005731614,"about_ca_system_score_gemma":0.0003201951,"threshold_uncertainty_score":0.0041585565},"labels":[],"label_agreement":null},{"id":"W4248583111","doi":"10.1093/neuonc/noz175.379","title":"EXTH-47. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Chromatin immunoprecipitation; Biology; Gene knockdown; Enhancer; Pathology; Medicine; Gene expression; Gene; Genetics; Promoter","score_opus":0.012404726114331825,"score_gpt":0.27704638113302754,"score_spread":0.26464165501869574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248583111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782384,0.003404089,0.0021676938,0.00027705284,0.00015233409,0.00014913331,0.0016822182,0.0004542065,0.003889442],"genre_scores_gemma":[0.9922287,0.0014082541,0.0011736765,0.00017331875,0.000012264784,0.00010365376,0.0013067697,0.000038691895,0.0035546303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993837,0.0000060274256,0.0000036115525,0.000014669215,0.000016054095,0.000021285912],"domain_scores_gemma":[0.9999472,0.000007754035,0.000009705799,0.000008828141,0.0000034164718,0.000023087297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099316334,0.00027498612,0.00033026197,0.0002423137,0.0001114715,0.00018742391,0.00026395483,0.00033257323,0.0031078425],"category_scores_gemma":[0.00011129518,0.000103573344,0.00024540155,0.00014003462,0.00027990446,0.00012155453,0.00015724408,0.00091495016,0.0004201913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005322175,0.0009898735,0.0013109255,0.0005028323,0.00009089885,0.0019258029,0.000088158245,0.00061324786,0.9230012,0.0011512502,0.001610895,0.06339271],"study_design_scores_gemma":[0.0013053734,0.013047455,0.017984023,0.000064163294,0.00018242982,0.0045176,0.0001362278,0.0020282336,0.9321312,0.0006421224,0.027928984,0.000032192733],"about_ca_topic_score_codex":0.0008321528,"about_ca_topic_score_gemma":0.0016302065,"teacher_disagreement_score":0.0031078425,"about_ca_system_score_codex":0.00024018993,"about_ca_system_score_gemma":0.00034671044,"threshold_uncertainty_score":0.010396779},"labels":[],"label_agreement":null},{"id":"W4249757522","doi":"10.1093/neuonc/nov206.08","title":"ATCT-08THE IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA: A SECONDARY ANALYSIS OF EORTC AND NRG ONCOLOGY/RTOG","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioblastoma; Medicine; Oncology; Adjuvant; Internal medicine; Cancer research","score_opus":0.023883929749458632,"score_gpt":0.335393357412885,"score_spread":0.3115094276634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249757522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437575,0.012615579,0.0012043468,0.00052432687,0.0002944808,0.0016232312,0.035918448,0.00008970825,0.003972391],"genre_scores_gemma":[0.971484,0.0019816095,0.0006128752,0.00048236235,0.0004299062,0.0012725503,0.02187723,0.0000578403,0.0018017029],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.994334,0.0033038598,0.0006610272,0.0006974538,0.0007113326,0.00029236075],"domain_scores_gemma":[0.9880861,0.0039166952,0.0045371987,0.0012631111,0.0011424947,0.0010543754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008375981,0.0012783684,0.0025995565,0.0014120599,0.0002971012,0.0012522176,0.0007768887,0.0008393148,0.005951388],"category_scores_gemma":[0.010871657,0.0002855411,0.010891401,0.0021601666,0.0003610508,0.00065994315,0.00081986334,0.0012780932,0.0007227076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7098208,0.0016089934,0.12080882,0.0052052503,0.11497064,0.00035318866,0.00010296791,0.0034367088,0.0032790257,0.00027325668,0.009837658,0.030302765],"study_design_scores_gemma":[0.19721243,0.06699842,0.55858546,0.0005815017,0.15474747,0.0010873252,0.00015712371,0.0041905832,0.0021540006,0.00096571475,0.0132014435,0.000118528464],"about_ca_topic_score_codex":0.0025901909,"about_ca_topic_score_gemma":0.0040445263,"teacher_disagreement_score":0.008375981,"about_ca_system_score_codex":0.0009169024,"about_ca_system_score_gemma":0.0013866739,"threshold_uncertainty_score":0.04429698},"labels":[],"label_agreement":null},{"id":"W4249946082","doi":"10.1093/neuonc/now070.30","title":"EPN-31MOLECULAR REFINEMENT OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2016,"lang":"es","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Anatomy; Radiology","score_opus":0.019718702800600736,"score_gpt":0.29749768332231424,"score_spread":0.2777789805217135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249946082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915623,0.0020528056,0.0034880592,0.00011922326,0.000018344608,0.00004508986,0.0010646419,0.000040331845,0.0016092148],"genre_scores_gemma":[0.9935249,0.00086925895,0.0032290327,0.000028663902,0.000011988854,0.00002900618,0.0018290619,0.000010226541,0.000467812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997769,0.000022269263,0.000023435943,0.000064638094,0.0000767114,0.000035981528],"domain_scores_gemma":[0.99968684,0.000044589906,0.000114847906,0.000026843818,0.00008510827,0.000041794847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002588123,0.00037017584,0.00028383383,0.0009016989,0.0003061272,0.00033119242,0.00026315977,0.00019861003,0.0007606047],"category_scores_gemma":[0.0007291162,0.00013220853,0.0002854507,0.00087267184,0.0002674114,0.00027543373,0.00041719028,0.0004150512,0.00021717159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005135532,0.000057045443,0.8174315,0.00022888204,0.00015691352,0.009979525,0.00027924933,0.002176728,0.117282666,0.0010702944,0.0011060705,0.04971758],"study_design_scores_gemma":[0.000015153492,0.000112337824,0.9557304,0.00002346477,0.00008718785,0.015717307,0.00021521738,0.0039056446,0.01733974,0.000999352,0.005839393,0.000014869853],"about_ca_topic_score_codex":0.0029417858,"about_ca_topic_score_gemma":0.0043528327,"teacher_disagreement_score":0.0029417858,"about_ca_system_score_codex":0.00038404617,"about_ca_system_score_gemma":0.0004491709,"threshold_uncertainty_score":0.005849302},"labels":[],"label_agreement":null},{"id":"W4250206320","doi":"10.1093/neuonc/nor156","title":"PEDIATRICS CLINICAL RESEARCH","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Computer science","score_opus":0.458000253747527,"score_gpt":0.585007938015258,"score_spread":0.12700768426773096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250206320","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030692362,0.010531551,0.0017036375,0.019543111,0.008224209,0.0003116354,0.0049275937,0.0011049757,0.950584],"genre_scores_gemma":[0.034004893,0.021089943,0.003972894,0.012959927,0.0048153005,0.0004036087,0.009994991,0.00060551154,0.9121528],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990095,0.00020563658,0.00008867765,0.00017668332,0.00034836243,0.0001710779],"domain_scores_gemma":[0.9974438,0.00025531265,0.00017709666,0.00024130735,0.000967432,0.0009150862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008932098,0.000678365,0.00044806313,0.0016448019,0.0013435455,0.0022616326,0.0011622926,0.0015432193,0.49022692],"category_scores_gemma":[0.0035850278,0.00028306336,0.0003583912,0.0017303836,0.0005605732,0.0013993244,0.0020423674,0.002452937,0.31708458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051679937,0.000115748124,0.0023774789,0.00028922228,0.000008395385,0.0010025112,0.0001273453,0.000045074194,0.00041489178,0.0063261227,0.73452646,0.2547151],"study_design_scores_gemma":[0.00001597794,0.000019115721,0.0013961489,0.00019601922,0.0000032063238,0.0012700428,0.000081710554,0.00001918816,0.000104624276,0.00085194426,0.9960382,0.0000037716693],"about_ca_topic_score_codex":0.0023688166,"about_ca_topic_score_gemma":0.0032429115,"teacher_disagreement_score":0.49022692,"about_ca_system_score_codex":0.001596761,"about_ca_system_score_gemma":0.0034842256,"threshold_uncertainty_score":0.7271294},"labels":[],"label_agreement":null},{"id":"W4250453028","doi":"10.1093/neuonc/not047","title":"Abstracts","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science","score_opus":0.013816929759044626,"score_gpt":0.27775749798613386,"score_spread":0.2639405682270892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250453028","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002979839,0.01030784,0.008246118,0.015379368,0.030265411,0.00064938137,0.020067824,0.005637687,0.90646654],"genre_scores_gemma":[0.014224036,0.0073386314,0.003971574,0.005211214,0.005996475,0.00036550642,0.019059703,0.0016897026,0.94214314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845076,0.0002074585,0.00013784283,0.00034712523,0.00066615985,0.00019057408],"domain_scores_gemma":[0.99782157,0.00021506764,0.000114707545,0.00029323742,0.0009510982,0.00060438015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012918487,0.0012790889,0.00093595765,0.0022391723,0.0018091154,0.0052508027,0.0020747446,0.0024849558,0.6687413],"category_scores_gemma":[0.0042710886,0.00038533044,0.0010300586,0.0021460464,0.0005674054,0.0032705239,0.004208206,0.001706365,0.52477163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016061845,0.000068191854,0.0005241476,0.0007131521,0.000016161803,0.0002349566,0.00014120048,0.000090050504,0.0008701274,0.007589789,0.8114249,0.17816664],"study_design_scores_gemma":[0.000010476075,0.00001879867,0.00031335928,0.00013202894,0.000005142413,0.00015526336,0.000058271202,0.00003194634,0.00021111406,0.0011838875,0.99787366,0.0000060942116],"about_ca_topic_score_codex":0.0017775961,"about_ca_topic_score_gemma":0.0019250271,"teacher_disagreement_score":0.3312587,"about_ca_system_score_codex":0.0016453828,"about_ca_system_score_gemma":0.003005616,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4250934049","doi":"10.1093/neuonc/nou243.11","title":"CN-11 * ORTERONEL (TAK-700) AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Posterior reversible encephalopathy syndrome; Headaches; Internal medicine; Endocrinology; Urology; Surgery; Magnetic resonance imaging; Radiology","score_opus":0.02507679741692753,"score_gpt":0.2819334388349893,"score_spread":0.25685664141806175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250934049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515849,0.0047538253,0.0016044399,0.0045829657,0.0001791044,0.00026229784,0.00044214222,0.00020304926,0.036387358],"genre_scores_gemma":[0.99484456,0.00089220575,0.00028487237,0.0010200052,0.00009550678,0.000021209555,0.0002129414,0.000007203454,0.0026215096],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99984753,0.000026285814,0.0000144816295,0.00003514564,0.000017660946,0.000058934987],"domain_scores_gemma":[0.9997887,0.00006812596,0.000040331208,0.000012688285,0.000017477016,0.00007267743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017051617,0.00082924584,0.00041285795,0.00051269267,0.00060183794,0.0002584466,0.00044361412,0.0013330671,0.0026057295],"category_scores_gemma":[0.0005109568,0.00029090597,0.00034993782,0.00035977556,0.0005843427,0.0005298543,0.00023607862,0.0011416678,0.00039259435],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002080416,0.000547858,0.039651006,0.00027104025,0.00015520953,0.9152467,0.00016502522,0.00036876716,0.008443289,0.0013756005,0.0025234872,0.029171487],"study_design_scores_gemma":[0.0005273983,0.0032521256,0.14197263,0.00011913537,0.00015398013,0.84026474,0.00024963284,0.00135929,0.0040006232,0.0010807485,0.006972233,0.00004754241],"about_ca_topic_score_codex":0.005606098,"about_ca_topic_score_gemma":0.0065201386,"teacher_disagreement_score":0.005606098,"about_ca_system_score_codex":0.0007316139,"about_ca_system_score_gemma":0.0006991043,"threshold_uncertainty_score":0.011146903},"labels":[],"label_agreement":null},{"id":"W4251009049","doi":"10.1093/neuonc/noaa222.185","title":"EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Epigenome; Ependymoma; Epigenetics; Biology; Cancer research; Tumor microenvironment; Acetylation; Cell biology; DNA methylation; Biochemistry; Medicine; Pathology","score_opus":0.01368834798923768,"score_gpt":0.2578224894722051,"score_spread":0.24413414148296742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251009049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041486,0.0011083052,0.0038438584,0.00020572483,0.000037716793,0.00003206647,0.00083497254,0.00014248649,0.0033800334],"genre_scores_gemma":[0.99664634,0.00035283394,0.0007361212,0.00004252288,0.000003779768,0.000018539136,0.00032880149,0.000019462339,0.0018515725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999157,0.000013113861,0.0000069788143,0.000022372984,0.000018923549,0.000022806007],"domain_scores_gemma":[0.9999112,0.000026167902,0.000022930279,0.000009872137,0.0000057194366,0.000024146579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081848426,0.00019965887,0.00015487526,0.0001576398,0.00013924742,0.00018435832,0.00015404665,0.00027755898,0.0017195548],"category_scores_gemma":[0.0001307743,0.00008245556,0.00012977194,0.00008664726,0.00021187749,0.00009026327,0.00021565086,0.00041068977,0.00038401503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015640305,0.00005521069,0.0011287659,0.00003085915,0.000006728476,0.0014942933,0.000022680191,0.00023953058,0.99188566,0.00042570077,0.00017808909,0.0043761185],"study_design_scores_gemma":[0.000017219283,0.00048282428,0.02204049,0.000012923031,0.00001909944,0.004104036,0.00007979128,0.0024591347,0.96281284,0.00026503205,0.0076978537,0.000008739192],"about_ca_topic_score_codex":0.00065564696,"about_ca_topic_score_gemma":0.0010546051,"teacher_disagreement_score":0.0017195548,"about_ca_system_score_codex":0.00030081818,"about_ca_system_score_gemma":0.0001468684,"threshold_uncertainty_score":0.005752504},"labels":[],"label_agreement":null},{"id":"W4251295856","doi":"10.1093/neuonc/noy059.033","title":"ATRT-36. META-ANALYSIS OF TREATMENT MODALITIES IN METASTATIC ATYPICAL TERATOID/RHABDOID TUMORS IN CHILDREN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Atypical teratoid rhabdoid tumor; Chemotherapy; Confidence interval; Univariate analysis; Oncology; Radiation therapy; Internal medicine; Multivariate analysis; Central nervous system","score_opus":0.03839222590954251,"score_gpt":0.32430352863761513,"score_spread":0.28591130272807264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251295856","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06963999,0.9223104,0.0014178909,0.0003859049,0.0003289519,0.00013254822,0.004717156,0.000078100966,0.0009889808],"genre_scores_gemma":[0.85948414,0.13215774,0.0020781094,0.0007615198,0.00035707752,0.00040546854,0.0037942089,0.00011659467,0.00084522786],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929188,0.002827691,0.0015975349,0.0014980482,0.00086366077,0.00029418757],"domain_scores_gemma":[0.98928565,0.007302848,0.0019787692,0.00062665105,0.00052475574,0.00028134213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078031123,0.0015713838,0.007812366,0.0040465016,0.00058516645,0.002183298,0.001342991,0.0013736698,0.0030000415],"category_scores_gemma":[0.012868841,0.0007775575,0.035567258,0.0054792147,0.00041465712,0.0010643248,0.0010138935,0.0017084723,0.00032544578],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057967356,0.000031516876,0.067754336,0.044812474,0.86656845,0.00021067342,0.000077876204,0.0012709294,0.0007200315,0.00012541193,0.0010821314,0.011549391],"study_design_scores_gemma":[0.00067389884,0.00043419795,0.052925017,0.0022727565,0.93920004,0.00026849378,0.00006039621,0.000521469,0.0003133991,0.00023253734,0.0030658331,0.000032043747],"about_ca_topic_score_codex":0.0047463328,"about_ca_topic_score_gemma":0.007928571,"teacher_disagreement_score":0.007812366,"about_ca_system_score_codex":0.0011307036,"about_ca_system_score_gemma":0.0010221165,"threshold_uncertainty_score":0.041267276},"labels":[],"label_agreement":null},{"id":"W4251454374","doi":"10.1093/neuonc/nou239.21","title":"BI-21 * BRAF MUTATION AND CDKN2A DELETIONS DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"ATRX; CDKN2A; Glioma; Biology; IDH1; Cancer research; Oncology; Mutation; Somatic cell; Medicine; Genetics; Gene","score_opus":0.014558264774087393,"score_gpt":0.2870590009820569,"score_spread":0.2725007362079695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251454374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997285,0.000020589656,0.000028362232,0.000003601691,3.2342749e-7,0.0000030482968,0.000047826798,0.000002480241,0.00016525292],"genre_scores_gemma":[0.999724,0.000016740696,0.00004141008,0.0000036852723,8.541725e-7,0.0000029054788,0.0001507485,0.0000014879895,0.00005828885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998147,0.000017138167,0.000015089616,0.000052915584,0.000046319015,0.000053749245],"domain_scores_gemma":[0.99962604,0.00003342112,0.00016115114,0.000033211047,0.000046443492,0.000099670055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001232209,0.00023915703,0.00022728594,0.0004895878,0.00038999255,0.00033288437,0.00025559915,0.00023805027,0.00095165893],"category_scores_gemma":[0.00059324544,0.00013989942,0.00014469078,0.000507653,0.00042443405,0.00013916525,0.0003563678,0.00018205163,0.00019505904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010570164,0.0000130510725,0.99305385,0.000007706877,0.000013908038,0.0009385009,0.00012323032,0.00004212693,0.0041658855,0.000019547282,0.000050924365,0.0014654878],"study_design_scores_gemma":[0.0000037173722,0.00008400337,0.99562126,0.0000010975209,0.000007972929,0.0035204021,0.00015757873,0.00009294699,0.000353858,0.000018345618,0.00013734998,0.0000014237844],"about_ca_topic_score_codex":0.017286595,"about_ca_topic_score_gemma":0.04461989,"teacher_disagreement_score":0.017286595,"about_ca_system_score_codex":0.00060106465,"about_ca_system_score_gemma":0.000741111,"threshold_uncertainty_score":0.034371972},"labels":[],"label_agreement":null},{"id":"W4251991087","doi":"10.1093/neuonc/nox168.936","title":"STEM-21. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL Wnt PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cancer research; Biology; In vivo; SOX2; Beta-catenin; Context (archaeology); Signal transduction; Cell biology; Transcription factor; Gene; Genetics","score_opus":0.03219366632729257,"score_gpt":0.2797318604996017,"score_spread":0.24753819417230913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251991087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874549,0.0052944846,0.0034930538,0.00029488106,0.000038565206,0.00006436444,0.00043783616,0.00017634923,0.0027454384],"genre_scores_gemma":[0.99303,0.00276867,0.0016314671,0.000059655675,0.000016797057,0.000045143377,0.0005727922,0.000021458272,0.0018540681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995446,0.0000066851076,0.0000049170867,0.000008200605,0.000015162659,0.000010607818],"domain_scores_gemma":[0.9999653,0.000004373966,0.000011375258,0.0000043069754,0.0000030720419,0.000011572567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012061513,0.00019909085,0.0002112759,0.0002175828,0.00011583979,0.0002512287,0.00013952999,0.00011204857,0.0013159008],"category_scores_gemma":[0.0000769368,0.00007853204,0.00016461058,0.00013181126,0.00013056833,0.00012762901,0.00014420995,0.00032005348,0.0002732711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028622834,0.00006957983,0.003014987,0.00010247303,0.000014743885,0.00038287544,0.0000620842,0.00041911774,0.96976155,0.0009348379,0.0004068967,0.024544518],"study_design_scores_gemma":[0.00008219838,0.0015179209,0.025189923,0.000029112342,0.00012742952,0.0031264692,0.00012222108,0.002170028,0.93716973,0.0003496452,0.030109307,0.0000060166612],"about_ca_topic_score_codex":0.0007233173,"about_ca_topic_score_gemma":0.0023208794,"teacher_disagreement_score":0.0013159008,"about_ca_system_score_codex":0.00029749068,"about_ca_system_score_gemma":0.00029083274,"threshold_uncertainty_score":0.004402101},"labels":[],"label_agreement":null},{"id":"W4252705843","doi":"10.1215/s1522851701000461","title":"Metastatic papillary craniopharyngioma: Case study and study of tumor angiogenesis","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Craniopharyngioma; Medicine; Angiogenesis; Pathology; Cancer research; Radiology","score_opus":0.04011557964673074,"score_gpt":0.30816557748066736,"score_spread":0.2680499978339366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252705843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915638,0.002404461,0.0013640496,0.0006234004,0.00007769063,0.00005837691,0.000097357086,0.00006708711,0.0037438676],"genre_scores_gemma":[0.99726546,0.0007680278,0.0008183562,0.00013315554,0.00020883422,0.00001786648,0.000058299254,0.000010954294,0.0007190294],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99968445,0.000028975179,0.000027344524,0.00008080279,0.000057659865,0.00012086771],"domain_scores_gemma":[0.99898416,0.0002940033,0.00018871865,0.00015192645,0.00007432063,0.00030688025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038586106,0.0012157311,0.00075399707,0.001434247,0.0021736398,0.0011026794,0.00076243444,0.003570353,0.0014622667],"category_scores_gemma":[0.001980498,0.00088328024,0.0008647281,0.00075048057,0.0013002321,0.0011503055,0.0010347151,0.0018064668,0.00076883053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043699667,0.000040017978,0.008023324,0.000021374146,0.000009535672,0.98819214,0.0003156369,0.00006048017,0.0019208455,0.0001455557,0.00010880701,0.0011186292],"study_design_scores_gemma":[0.00000891897,0.000071110306,0.0039619594,0.000004017432,0.000009469724,0.99478453,0.000092336355,0.00012327604,0.00045276995,0.000079808706,0.0004047437,0.0000070948845],"about_ca_topic_score_codex":0.0026691798,"about_ca_topic_score_gemma":0.0029126464,"teacher_disagreement_score":0.003570353,"about_ca_system_score_codex":0.00085815456,"about_ca_system_score_gemma":0.0006361851,"threshold_uncertainty_score":0.0062264204},"labels":[],"label_agreement":null},{"id":"W4252970161","doi":"10.1215/15228517-4-3-214","title":"Canadian Neuro-oncology 10th Biennial Meeting","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Manitoba; Montreal Neurological Institute and Hospital; CancerCare Manitoba","funders":"","keywords":"Medicine; Oncology; Internal medicine; Medical physics","score_opus":0.02704887058149659,"score_gpt":0.282291522257822,"score_spread":0.2552426516763254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252970161","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013799242,0.057634577,0.0023117291,0.23199409,0.24080451,0.0006079421,0.007852211,0.00055169576,0.44444403],"genre_scores_gemma":[0.024666997,0.02176981,0.001772003,0.008457145,0.009994022,0.00011479661,0.0024137099,0.00014698514,0.93066454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897575,0.00007502481,0.00003120233,0.00008031757,0.0004672708,0.00037040596],"domain_scores_gemma":[0.9975197,0.000047016063,0.00004160787,0.000029168725,0.00140766,0.0009547576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012430571,0.0013932927,0.00067460217,0.0019576605,0.0037815233,0.002239327,0.0013702111,0.0043277917,0.09748813],"category_scores_gemma":[0.0012632904,0.00038985853,0.000906453,0.0012417305,0.00082371687,0.0006609295,0.0014140751,0.0027932501,0.024403272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008553035,0.000034329754,0.00083712634,0.000091766626,0.000013020478,0.00018601352,0.000032331423,0.00013490004,0.00031991786,0.00044215887,0.9749281,0.022894738],"study_design_scores_gemma":[0.000019457979,0.000021608632,0.003142152,0.00007362564,0.000013884921,0.00019006702,0.00008776395,0.00010772431,0.0001458586,0.00022291298,0.99596137,0.000013636427],"about_ca_topic_score_codex":0.5451471,"about_ca_topic_score_gemma":0.91211313,"teacher_disagreement_score":0.5451471,"about_ca_system_score_codex":0.01565252,"about_ca_system_score_gemma":0.02555158,"threshold_uncertainty_score":0.9150632},"labels":[],"label_agreement":null},{"id":"W4253125386","doi":"10.1093/neuonc/now188.181","title":"P08.48 Combined alterations in MAPK pathway genes, CDKN2A/B and ATRX characterize anaplastic pilocytic astrocytoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"ATRX; Pilocytic astrocytoma; CDKN2A; Cancer research; Anaplastic astrocytoma; Astrocytoma; Gene; Biology; Medicine; Glioma; Genetics; Mutation","score_opus":0.021650308722584177,"score_gpt":0.26793796724899366,"score_spread":0.2462876585264095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253125386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044013,0.0015017746,0.0006537371,0.00020551731,0.000035864072,0.000038892416,0.0006127328,0.00014598871,0.006365352],"genre_scores_gemma":[0.99785197,0.00032682528,0.00023808994,0.000066190645,0.000013484199,0.00003217585,0.00032660997,0.0000137556335,0.0011310459],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991155,0.000014813889,0.000008162046,0.000022818485,0.000019116063,0.000023608613],"domain_scores_gemma":[0.9999337,0.000010053833,0.00002531777,0.000007870713,0.0000067533015,0.000016341006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073858784,0.0003968454,0.00031649123,0.00046693574,0.0001942176,0.00022995201,0.00020502409,0.00037273415,0.0038852054],"category_scores_gemma":[0.00020665898,0.00011557344,0.0002177179,0.00044279406,0.00027615184,0.00012622915,0.00014986198,0.00022410334,0.0012042205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038889425,0.00065493485,0.18013448,0.0003651975,0.00035434205,0.06415694,0.00017326667,0.0005524677,0.5917324,0.0012324675,0.007672091,0.14908256],"study_design_scores_gemma":[0.00060163427,0.004925977,0.4957102,0.000058136226,0.00035616866,0.38867915,0.00024500507,0.0019564214,0.07843829,0.0017115484,0.027281612,0.00003592897],"about_ca_topic_score_codex":0.0003734195,"about_ca_topic_score_gemma":0.000723102,"teacher_disagreement_score":0.0038852054,"about_ca_system_score_codex":0.00022886996,"about_ca_system_score_gemma":0.00012417337,"threshold_uncertainty_score":0.012997329},"labels":[],"label_agreement":null},{"id":"W4253312121","doi":"10.1093/neuonc/now073.105","title":"HG-109CONTEMPORARY SURVIVAL ENDPOINTS: AN INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA REGISTRY STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Oncology; Cancer research","score_opus":0.023863114997970326,"score_gpt":0.3341269492117,"score_spread":0.31026383421372966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253312121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900243,0.0002772897,0.00032018774,0.000080554586,0.0000084645035,0.0001551697,0.007022492,0.000015481399,0.00209589],"genre_scores_gemma":[0.9856954,0.00018102533,0.00034178188,0.00008100564,0.000018334209,0.00020344609,0.013281543,0.000010182378,0.00018730592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884284,0.00036358266,0.00016055917,0.000300144,0.00020614632,0.000126818],"domain_scores_gemma":[0.99767643,0.00028982814,0.0009757662,0.0005004491,0.00021720542,0.00034036677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022144585,0.00031536684,0.00048265603,0.0008822381,0.0002992886,0.0009155243,0.0005857102,0.000331465,0.0010777983],"category_scores_gemma":[0.0028226639,0.00017100759,0.00034712796,0.002533278,0.00033754922,0.00074386486,0.0009883713,0.00048800875,0.0005533329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092782587,0.00012325298,0.9921599,0.00006222939,0.00011968061,0.0003100282,0.00018498368,0.00014761342,0.00025485447,0.00012848798,0.0011425496,0.004438618],"study_design_scores_gemma":[0.00018874324,0.000397087,0.9959655,0.000024790896,0.00014715608,0.0006843005,0.0003080542,0.0002654826,0.00018876033,0.0000769731,0.001739417,0.000013716226],"about_ca_topic_score_codex":0.003929509,"about_ca_topic_score_gemma":0.0064430484,"teacher_disagreement_score":0.003929509,"about_ca_system_score_codex":0.0008266538,"about_ca_system_score_gemma":0.0011789202,"threshold_uncertainty_score":0.011711359},"labels":[],"label_agreement":null},{"id":"W4253468179","doi":"10.1093/neuonc/nox168.722","title":"PATH-32. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Genetic heterogeneity; Medulloblastoma; Gene; Genetics; Oncology; Bioinformatics; Pathology; Medicine","score_opus":0.023139083481306187,"score_gpt":0.31204627730103107,"score_spread":0.2889071938197249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253468179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974025,0.00044438112,0.00089360576,0.00002159796,0.0000024645176,0.000016508264,0.00047729546,0.000017106719,0.0007244163],"genre_scores_gemma":[0.99825686,0.000189692,0.00069672905,0.000011338358,0.000002956369,0.000019105082,0.0006777226,0.0000067045057,0.00013885285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997949,0.000015454047,0.00002281526,0.000079202735,0.000049554917,0.00003815786],"domain_scores_gemma":[0.9996985,0.000061766325,0.0001358558,0.000021528476,0.000042930642,0.0000394579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001727581,0.00022267671,0.0002263668,0.00077285856,0.00023715974,0.00032282007,0.00019852104,0.00018604545,0.0010079354],"category_scores_gemma":[0.00058520964,0.00011946111,0.00022000121,0.0005924236,0.00027716102,0.00024635214,0.000255751,0.00025080677,0.0002249084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043325213,0.00004035049,0.8162911,0.00010380257,0.000103143975,0.0046734973,0.00032992632,0.0010023859,0.14379883,0.00054901605,0.00036594403,0.032308742],"study_design_scores_gemma":[0.00001506204,0.00012323607,0.97308403,0.00000922007,0.00006405712,0.012307493,0.00026485565,0.0012078817,0.010693797,0.00047070812,0.001751298,0.000008533289],"about_ca_topic_score_codex":0.0017934341,"about_ca_topic_score_gemma":0.003589935,"teacher_disagreement_score":0.0017934341,"about_ca_system_score_codex":0.0002800785,"about_ca_system_score_gemma":0.00025830473,"threshold_uncertainty_score":0.0035660267},"labels":[],"label_agreement":null},{"id":"W4253874867","doi":"10.1093/neuonc/now076.77","title":"MB-81THE GD3 ACETYLATION PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR PAEDIATRIC MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Acetylation; Cancer research; Medicine; Chemistry; Biochemistry","score_opus":0.016139275131488908,"score_gpt":0.2848312842288182,"score_spread":0.2686920090973293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253874867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649979,0.02624768,0.0018674848,0.00067236956,0.00013195843,0.0001139905,0.0007906383,0.00032907407,0.0048489273],"genre_scores_gemma":[0.9812283,0.010766245,0.0018088944,0.00016409428,0.000025260415,0.00006999058,0.0019077203,0.000030237605,0.0039992947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995816,0.000005237976,0.0000027447136,0.000005522932,0.000011542019,0.00001680283],"domain_scores_gemma":[0.99998057,0.0000017414536,0.0000047831763,0.0000019445672,0.0000029532664,0.000007994294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008015264,0.0002528917,0.0003686919,0.00015300946,0.00010601884,0.00025850208,0.00019451095,0.00018748433,0.0015032908],"category_scores_gemma":[0.000062435654,0.00008777804,0.000179953,0.00019424352,0.0001239037,0.0000983642,0.00015048831,0.0005985228,0.00054501137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009748982,0.00021417796,0.0010263736,0.00021060943,0.000034943823,0.00020486138,0.00003283013,0.00031643276,0.97221375,0.00033924077,0.00095789874,0.023473978],"study_design_scores_gemma":[0.0007960821,0.0054515484,0.030901158,0.000075095275,0.00026167015,0.0019339502,0.00012810821,0.0015418017,0.87937236,0.00031097702,0.07920302,0.000024299365],"about_ca_topic_score_codex":0.0016419995,"about_ca_topic_score_gemma":0.00364847,"teacher_disagreement_score":0.0016419995,"about_ca_system_score_codex":0.00034721653,"about_ca_system_score_gemma":0.0003638035,"threshold_uncertainty_score":0.0050290227},"labels":[],"label_agreement":null},{"id":"W4254437594","doi":"10.1215/s1152851705200406","title":"Abstracts for the Second International Symposium on Central Nervous System Germ Cell Tumors","year":2005,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Germ cell tumors; Germ cell; Central nervous system; Neuroscience; Biology; Genetics","score_opus":0.014987666798865939,"score_gpt":0.2729815386472019,"score_spread":0.257993871848336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254437594","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019166322,0.14536709,0.00399854,0.044188675,0.5755348,0.00046784262,0.00283285,0.0004507848,0.20799297],"genre_scores_gemma":[0.035165727,0.07869222,0.0025930353,0.0074234772,0.19394447,0.00036365777,0.0035666854,0.00043721325,0.6778135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966323,0.00005013886,0.000040617164,0.00007388338,0.00010694586,0.00006519278],"domain_scores_gemma":[0.99934036,0.00005335245,0.00005107821,0.000028813758,0.0002652162,0.0002611283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068324874,0.0012526965,0.0007652299,0.0017660571,0.0006024256,0.0016716779,0.00085988647,0.0014896217,0.077002175],"category_scores_gemma":[0.0006232603,0.00023329974,0.00084653223,0.0006420295,0.0003347627,0.0010109561,0.0012304655,0.0017850746,0.035262898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004167067,0.00019826561,0.0024517023,0.0010305754,0.00008541916,0.0021232085,0.00015944222,0.00015350513,0.005576418,0.0014449719,0.8013392,0.18502057],"study_design_scores_gemma":[0.000031006843,0.00010386214,0.0029362612,0.00028193023,0.000041100076,0.002014073,0.00007000079,0.00007155305,0.00068262074,0.00054296956,0.9932132,0.000011566108],"about_ca_topic_score_codex":0.000641954,"about_ca_topic_score_gemma":0.0020042285,"teacher_disagreement_score":0.92299783,"about_ca_system_score_codex":0.00077014195,"about_ca_system_score_gemma":0.00084466697,"threshold_uncertainty_score":0.25759792},"labels":[],"label_agreement":null},{"id":"W4254888685","doi":"10.1093/neuonc/now212.284","title":"EXTH-40. M011L-DEFICIENT ONCOLYTIC MYXOMA VIRUS INDUCES APOPTOSIS IN BRAIN TUMOR INITIATING CELLS AND ENHANCES SURVIVAL IN A NOVEL IMMUNOCOMPETENT MOUSE MODEL OF GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Myxoma virus; Apoptosis; Temozolomide; Glioma; Biology; Cancer research; Programmed cell death; Virus; Cell culture; Virology; Genetics","score_opus":0.028132409752156827,"score_gpt":0.30027926414700884,"score_spread":0.27214685439485203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254888685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968585,0.00042417194,0.0010454307,0.000099314806,0.000026803888,0.000062665385,0.00053572666,0.00008310092,0.00086414826],"genre_scores_gemma":[0.9942719,0.0003766344,0.001889135,0.000043880013,0.000010370275,0.00009554106,0.0006899774,0.000022663748,0.0025999758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997451,0.000034188924,0.00003403336,0.00005561044,0.00006001499,0.00007095854],"domain_scores_gemma":[0.9998368,0.000019765439,0.00005342703,0.00001977266,0.000009484511,0.000060687875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002472812,0.0005649606,0.00035451594,0.00047696533,0.00018424305,0.00036395786,0.0004008533,0.0005630852,0.001111521],"category_scores_gemma":[0.00010348311,0.00021658784,0.00034339543,0.00019450781,0.00042036016,0.00035515055,0.0001639497,0.001253901,0.000344576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025465107,0.00019145853,0.00013967346,0.00002295751,0.000005138841,0.000065913366,0.000026685177,0.00008444892,0.99837095,0.00018743426,0.000042338957,0.00060826074],"study_design_scores_gemma":[0.000104370694,0.002229257,0.0027964923,0.000008694693,0.000016977288,0.00040019563,0.00003434796,0.0015328884,0.99159735,0.00007482983,0.0011989004,0.0000056556723],"about_ca_topic_score_codex":0.0010025607,"about_ca_topic_score_gemma":0.001302408,"teacher_disagreement_score":0.001111521,"about_ca_system_score_codex":0.0005109456,"about_ca_system_score_gemma":0.00031423778,"threshold_uncertainty_score":0.0037183762},"labels":[],"label_agreement":null},{"id":"W4280638952","doi":"10.1093/neuonc/noac123","title":"Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Isabella and Marcus Foundation; Robert Connor Dawes Foundation; Cure Brain Cancer Foundation; Brooke Healey Foundation; Cure Starts Now Foundation; Strong; Reflections of Grace Foundation; Jeffrey Thomas Hayden Foundation; Musella Foundation For Brain Tumor Research and Information","keywords":"Medicine; Pediatrics; Population; Internal medicine","score_opus":0.014572547709080312,"score_gpt":0.2707352956366816,"score_spread":0.2561627479276013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280638952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502414,0.00037535018,0.00007989975,0.00006426263,0.0000056298823,0.000017573502,0.0038211106,0.000011526611,0.0006004517],"genre_scores_gemma":[0.9955989,0.00037563042,0.00012934234,0.000047149017,0.000011296268,0.000037457852,0.0037084674,0.000006618226,0.00008506829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994307,0.000069940244,0.00009020788,0.00013995501,0.00015454141,0.00011464134],"domain_scores_gemma":[0.9977825,0.00030876725,0.0013600318,0.00010603282,0.000147346,0.000295315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072713825,0.00023480783,0.00046372984,0.0013204734,0.00031588742,0.0004717514,0.00037272155,0.00030139837,0.0011249996],"category_scores_gemma":[0.0021464557,0.00016486253,0.00033505773,0.0019394683,0.0002997852,0.000554607,0.00048977823,0.0003985484,0.00028494332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025346337,0.0000046868126,0.9989477,0.0000061847463,0.000007950117,0.00010768624,0.00004390599,0.000021384505,0.000043706463,0.000007685152,0.0001829301,0.00060085824],"study_design_scores_gemma":[0.000002903637,0.000042585296,0.9982426,0.0000069576554,0.000009671141,0.0010763984,0.00016450687,0.000037225578,0.00003750685,0.0000073121582,0.00036934973,0.0000029293983],"about_ca_topic_score_codex":0.006138115,"about_ca_topic_score_gemma":0.0042920187,"teacher_disagreement_score":0.006138115,"about_ca_system_score_codex":0.00047569672,"about_ca_system_score_gemma":0.0005562757,"threshold_uncertainty_score":0.012204766},"labels":[],"label_agreement":null},{"id":"W4281382214","doi":"10.1093/neuonc/noac141","title":"Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; Helse Sør-Øst RHF; National Cancer Institute; National Institutes of Health; Norges Forskningsråd; Universitetet i Oslo; National Human Genome Research Institute; Pediatric Brain Tumor Foundation","keywords":"Gene knockdown; Cancer research; Downregulation and upregulation; Glioma; Medicine; Biology; Cell culture; Gene; Genetics","score_opus":0.012145755985862986,"score_gpt":0.26907731042382643,"score_spread":0.25693155443796345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281382214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339527,0.0019580745,0.0023928701,0.00013610096,0.000018910592,0.00006358516,0.0004973685,0.00020379081,0.0013340573],"genre_scores_gemma":[0.9963104,0.0009167116,0.0014876944,0.000041700787,0.000004141719,0.000033727418,0.0003291951,0.000010713478,0.0008655379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996257,0.0000033806775,0.0000017741912,0.0000070357246,0.000013795472,0.000011427855],"domain_scores_gemma":[0.99997675,0.0000033757224,0.000007799863,0.0000029321538,0.0000021070266,0.0000070612537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006644427,0.00026070964,0.0001923839,0.00020079692,0.000066702276,0.00013135868,0.0001896212,0.00014464291,0.0008891544],"category_scores_gemma":[0.00006242875,0.000059054204,0.000113229406,0.00014196704,0.00014029378,0.00008498924,0.00015603294,0.0003891126,0.00012917588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007813144,0.00015301791,0.001322431,0.00024185209,0.00003059617,0.00041742844,0.000036665297,0.00039510176,0.9672761,0.0003015466,0.00035061073,0.028693413],"study_design_scores_gemma":[0.00021052016,0.0030014047,0.01758826,0.00002656889,0.000099925615,0.0020149248,0.00008092185,0.0017881615,0.96370214,0.0002721186,0.01120429,0.000010820678],"about_ca_topic_score_codex":0.00065499183,"about_ca_topic_score_gemma":0.0020945389,"teacher_disagreement_score":0.0008891544,"about_ca_system_score_codex":0.00033687154,"about_ca_system_score_gemma":0.00027803308,"threshold_uncertainty_score":0.0029745102},"labels":[],"label_agreement":null},{"id":"W4281609813","doi":"10.1093/neuonc/noac079.353","title":"LGG-41. The clinical and molecular landscape of gliomas in adolescents and young adults","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"CDKN2A; ATRX; Medicine; Glioma; Cohort; Oncology; Young adult; Internal medicine; Melanoma; Cancer research; Mutation; Cancer; Biology; Gene; Genetics","score_opus":0.018243485969278883,"score_gpt":0.3127269763470132,"score_spread":0.2944834903777343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281609813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747545,0.0007235227,0.000042190994,0.000055939683,0.000003892672,0.000007287332,0.0007774315,0.0000055901314,0.00090871536],"genre_scores_gemma":[0.9985545,0.0002639178,0.00006907515,0.000027239974,0.0000058963183,0.000007371347,0.0008318946,0.0000028535203,0.00023708484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986947,0.000023255074,0.000012960765,0.000035851197,0.000023768054,0.00003474804],"domain_scores_gemma":[0.9996593,0.000033821434,0.00017684292,0.0000072608896,0.00003902934,0.00008362842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017099518,0.0001195516,0.00015359753,0.00056623283,0.00021130049,0.0003512398,0.0001011281,0.00017128354,0.0013120925],"category_scores_gemma":[0.0006109978,0.00006884712,0.00013058713,0.00072143076,0.00013127354,0.00020280105,0.0002548086,0.00015821279,0.00032429112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081850885,0.0000093925,0.9945852,0.000017282999,0.000011173502,0.00045564136,0.000047739508,0.000023894478,0.0004027674,0.000031486285,0.00020601579,0.0041274033],"study_design_scores_gemma":[0.0000023761988,0.00007231658,0.9968579,0.000015114422,0.000011555257,0.0018927357,0.00017548953,0.00003486498,0.000103326456,0.00003572832,0.00079732266,0.0000011162134],"about_ca_topic_score_codex":0.0029222087,"about_ca_topic_score_gemma":0.0045320443,"teacher_disagreement_score":0.0029222087,"about_ca_system_score_codex":0.00024903656,"about_ca_system_score_gemma":0.0002696056,"threshold_uncertainty_score":0.0058104396},"labels":[],"label_agreement":null},{"id":"W4281609890","doi":"10.1093/neuonc/noac137","title":"Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Meningioma; Oncology; Internal medicine; Medicine; Surgery","score_opus":0.03686795975668634,"score_gpt":0.32402441550872996,"score_spread":0.2871564557520436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281609890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856021,0.005356387,0.00030733176,0.00051278487,0.0000454686,0.000695387,0.0035490163,0.000032783988,0.0038987224],"genre_scores_gemma":[0.9881853,0.0019148514,0.0006476209,0.0006654057,0.00010262709,0.0005642356,0.0071094627,0.000016447839,0.0007940612],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940777,0.000250473,0.0000632313,0.00007719163,0.00012663659,0.00007468702],"domain_scores_gemma":[0.9989862,0.00015941521,0.0003984281,0.00007465225,0.00008531288,0.0002960352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002144046,0.00044987947,0.00077581225,0.00020785198,0.00029745692,0.0004076306,0.00027672906,0.00040750398,0.0014764231],"category_scores_gemma":[0.0013611128,0.00009753192,0.0006412624,0.00038302297,0.0002332199,0.00026587973,0.00036884134,0.0008036462,0.0003849073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42000866,0.01166714,0.25326687,0.002078969,0.003633982,0.00054722925,0.00042058315,0.003550128,0.019367915,0.00033927773,0.020632764,0.26448643],"study_design_scores_gemma":[0.10622808,0.28975922,0.55966395,0.00058902433,0.0044644275,0.001893137,0.00020904248,0.0019697454,0.00817294,0.00081878254,0.026165234,0.000066405846],"about_ca_topic_score_codex":0.0010206116,"about_ca_topic_score_gemma":0.0026106702,"teacher_disagreement_score":0.002144046,"about_ca_system_score_codex":0.00073803106,"about_ca_system_score_gemma":0.00090718956,"threshold_uncertainty_score":0.01133889},"labels":[],"label_agreement":null},{"id":"W4281616881","doi":"10.1093/neuonc/noac079.203","title":"GCT-09. Transcriptome and methylome profiles of CNS germ cell tumors and their comparison with testicular counterpart","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thompson Rivers University","funders":"","keywords":"Transcriptome; Biology; Germinoma; Seminoma; Germ cell tumors; Germ cell; Atypical teratoid rhabdoid tumor; Methylation; DNA methylation; Pathology; Immunohistochemistry; Gene expression; Genetics; Immunology; Gene; Medicine; Chemotherapy","score_opus":0.018765382108171573,"score_gpt":0.2736661221622107,"score_spread":0.2549007400540391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281616881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262035,0.0015177438,0.00069274346,0.000043427684,0.000013944458,0.000023099401,0.00388177,0.000062473686,0.001144335],"genre_scores_gemma":[0.9891651,0.00066562044,0.0012335113,0.000053416486,0.000009983811,0.00005616614,0.007471218,0.000033936652,0.0013110532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983525,0.00001391871,0.000010020186,0.000063514126,0.000041966057,0.000035282963],"domain_scores_gemma":[0.99985945,0.000013745843,0.000046864512,0.000014445111,0.000028745158,0.00003674886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012716072,0.00017524858,0.00031474538,0.0005503776,0.00028096937,0.00039543642,0.00016065393,0.0002323627,0.0022297143],"category_scores_gemma":[0.00024871054,0.000095568445,0.00024034939,0.0007153664,0.00016024911,0.00012552972,0.0002795423,0.0002474647,0.0004104643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025424825,0.0001082858,0.48437932,0.00042478085,0.00034365783,0.0014002972,0.00063313474,0.00049679296,0.46149158,0.0002170748,0.0015277921,0.046434723],"study_design_scores_gemma":[0.000030055555,0.00042513883,0.9489733,0.00003295559,0.0002549589,0.0060322676,0.00055262604,0.0010713603,0.03603928,0.00024840428,0.006321853,0.000017736294],"about_ca_topic_score_codex":0.0019339629,"about_ca_topic_score_gemma":0.003002754,"teacher_disagreement_score":0.0022297143,"about_ca_system_score_codex":0.0002394687,"about_ca_system_score_gemma":0.0002495721,"threshold_uncertainty_score":0.0074591637},"labels":[],"label_agreement":null},{"id":"W4281625178","doi":"10.1093/neuonc/noac079.251","title":"HGG-36. Elucidating the role of long non-coding RNAs in pediatric high grade gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"CRISPR; Biology; Computational biology; Genome; Cas9; Histone; RNA interference; Long non-coding RNA; Genetics; RNA; Gene","score_opus":0.010242314031833037,"score_gpt":0.27637667873465094,"score_spread":0.2661343647028179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281625178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98582315,0.0037368212,0.005664521,0.00014155023,0.000011459518,0.00009192833,0.0026575457,0.00018835936,0.0016845856],"genre_scores_gemma":[0.98655057,0.0018980835,0.007014847,0.00009974953,0.000007055996,0.000044861827,0.003437249,0.000040199386,0.0009073628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999052,0.0000086094215,0.0000063532107,0.0000270171,0.000028525732,0.000024336885],"domain_scores_gemma":[0.99988055,0.00001650414,0.000047616195,0.000008343448,0.00001322075,0.00003373864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001526239,0.00028713318,0.00018267307,0.00039264507,0.00010363648,0.00024279772,0.00017413142,0.00027959372,0.0010230151],"category_scores_gemma":[0.00013521782,0.0001079717,0.00022458825,0.0003769166,0.00017638419,0.00012118903,0.00019740363,0.00031535,0.0003369173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008043007,0.0000670208,0.04263026,0.0004519288,0.00004836465,0.0013810967,0.00009616433,0.00067621324,0.92467827,0.0003405745,0.00039449413,0.028431235],"study_design_scores_gemma":[0.000068970716,0.0012329419,0.3766501,0.000057697638,0.00018982268,0.010345121,0.00030443992,0.0024630926,0.59094477,0.00061333796,0.017108392,0.000021265872],"about_ca_topic_score_codex":0.0016584757,"about_ca_topic_score_gemma":0.0019385527,"teacher_disagreement_score":0.0016584757,"about_ca_system_score_codex":0.0003902404,"about_ca_system_score_gemma":0.00042667883,"threshold_uncertainty_score":0.0034223795},"labels":[],"label_agreement":null},{"id":"W4281627759","doi":"10.1093/neuonc/noac079.063","title":"DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenome; Chromatin; Epigenetics; Histone; Biology; Transcription (linguistics); Transcriptome; Genetics; Cell biology; Cancer research; DNA methylation; Gene; Gene expression","score_opus":0.015527463166217744,"score_gpt":0.2911000665546894,"score_spread":0.27557260338847167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281627759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91428065,0.017075777,0.002883003,0.0051365932,0.0006007036,0.0012475423,0.035238117,0.001147043,0.0223905],"genre_scores_gemma":[0.9401374,0.0064226747,0.004918369,0.0036224613,0.0000844725,0.0006834085,0.035845496,0.00012366631,0.008161933],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981946,0.00003656707,0.000011771153,0.000035495363,0.000052850173,0.000043876007],"domain_scores_gemma":[0.9997832,0.00001748349,0.00003144814,0.000026786765,0.000024216679,0.00011687109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057485164,0.0003051656,0.0005858908,0.00025456698,0.00023578487,0.0005302939,0.0003981176,0.0006515131,0.0045708604],"category_scores_gemma":[0.00027573932,0.00020405288,0.00038638743,0.00036428936,0.00029897233,0.00022667824,0.00043877654,0.0013445229,0.0013652907],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03969849,0.0033339735,0.07775724,0.003845696,0.0006843225,0.0042464565,0.000279579,0.0030651356,0.3597105,0.0037134665,0.07587236,0.42779282],"study_design_scores_gemma":[0.0113320295,0.06604671,0.30312344,0.0006736314,0.001471805,0.023060173,0.0005905042,0.0056330888,0.17620443,0.0039492883,0.40779433,0.00012063074],"about_ca_topic_score_codex":0.0014426475,"about_ca_topic_score_gemma":0.0045801536,"teacher_disagreement_score":0.0045708604,"about_ca_system_score_codex":0.00064093486,"about_ca_system_score_gemma":0.00092669914,"threshold_uncertainty_score":0.015291095},"labels":[],"label_agreement":null},{"id":"W4281630031","doi":"10.1093/neuonc/noac079.196","title":"GCT-02. Imaging response assessment for Central Nervous System Germ Cell Tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group (SIOPE-BTG) and North American Children’s Oncology Group (COG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Clinical trial; Internal medicine; Germ cell tumors; Disease; Radiological weapon; Chemotherapy; Surgery","score_opus":0.016431813384265824,"score_gpt":0.28999091683955425,"score_spread":0.27355910345528844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281630031","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027092071,0.34892565,0.108945765,0.39408928,0.022362271,0.014316631,0.014898274,0.0036217328,0.06574839],"genre_scores_gemma":[0.116942525,0.22842306,0.4477782,0.09935695,0.006563509,0.023572242,0.054815125,0.0020655172,0.020482916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97143775,0.011993857,0.008376868,0.0013616462,0.005363739,0.0014661313],"domain_scores_gemma":[0.9276515,0.022307064,0.009009431,0.0020823455,0.033665404,0.0052842726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.072963625,0.0014253312,0.0037407472,0.005792195,0.001422401,0.0040204767,0.010289815,0.006982716,0.002746368],"category_scores_gemma":[0.059666503,0.0008831847,0.00821231,0.0040318174,0.0020446875,0.0030413002,0.0055986233,0.009243788,0.0039420896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009011365,0.00045378326,0.01159257,0.024042059,0.0009970592,0.0007121791,0.0020242957,0.0045693163,0.003952749,0.011219483,0.32055664,0.6189787],"study_design_scores_gemma":[0.00074672536,0.00079762936,0.0211304,0.06870093,0.0021095022,0.0019223667,0.002267295,0.0042468077,0.003633913,0.016868588,0.87731594,0.00025985183],"about_ca_topic_score_codex":0.008471742,"about_ca_topic_score_gemma":0.005862273,"teacher_disagreement_score":0.072963625,"about_ca_system_score_codex":0.005519436,"about_ca_system_score_gemma":0.01617358,"threshold_uncertainty_score":0.38587314},"labels":[],"label_agreement":null},{"id":"W4281631742","doi":"10.1093/neuonc/noac079.417","title":"MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"DNA methylation; Cohort; Epigenetics; Oncology; Biology; Methylation; Differentially methylated regions; Internal medicine; Medulloblastoma; Bioinformatics; Genetics; Medicine; Gene; Gene expression","score_opus":0.015471338879330842,"score_gpt":0.28890613709084517,"score_spread":0.27343479821151434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281631742","genre_codex":"software","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061075475,0.0016339937,0.33029073,0.0011271342,0.00039363178,0.0012029777,0.15983865,0.437541,0.00689639],"genre_scores_gemma":[0.19897035,0.00069349655,0.5410766,0.0016869196,0.00012338573,0.0044955057,0.21693112,0.026492786,0.00952991],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989543,0.00019848507,0.00007146165,0.0004743663,0.00019077605,0.000110565066],"domain_scores_gemma":[0.999025,0.0004807556,0.00011903958,0.0000975153,0.00015720284,0.000120427605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029972827,0.0015899999,0.0015966919,0.0018495489,0.0008073882,0.0014704235,0.0017042073,0.00073749106,0.019077942],"category_scores_gemma":[0.004738235,0.0011437917,0.0021931431,0.0010630292,0.00044893398,0.00078324956,0.0016222084,0.0018374475,0.012773244],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008448694,0.0009353281,0.07636119,0.0051368796,0.0031816217,0.0018086189,0.0022173508,0.035791658,0.14140733,0.010806397,0.40308863,0.31081635],"study_design_scores_gemma":[0.0015256542,0.0009908318,0.0658553,0.00031137772,0.0008010417,0.00093139784,0.00038657346,0.64115834,0.09034033,0.022038018,0.17534512,0.00031598905],"about_ca_topic_score_codex":0.0043054367,"about_ca_topic_score_gemma":0.008607255,"teacher_disagreement_score":0.019077942,"about_ca_system_score_codex":0.0010289007,"about_ca_system_score_gemma":0.002413673,"threshold_uncertainty_score":0.06382203},"labels":[],"label_agreement":null},{"id":"W4281632416","doi":"10.1093/neuonc/noac079.212","title":"GCT-18. Endoscopic third ventriculostomy (ETV) and tumor biopsy are not associated with relapse rate or patterns in primary central nervous system (CNS) germ cell tumor (GCT)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Biopsy; Internal medicine; Surgery; Radiology; Chemotherapy","score_opus":0.014933443125683411,"score_gpt":0.24143273873422172,"score_spread":0.22649929560853832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869484,0.00061164657,0.000041939544,0.000021564121,0.0000047481353,0.0000034471775,0.00028472283,0.0000039273573,0.00033308653],"genre_scores_gemma":[0.99963474,0.00006665006,0.000029566392,0.0000066678563,0.0000037227346,0.0000019460836,0.0002075,0.0000016161703,0.000047707428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995733,0.00007227345,0.00006371586,0.000109264394,0.00011341152,0.000067931076],"domain_scores_gemma":[0.9971826,0.0005979906,0.0015367726,0.00014167711,0.00019274426,0.00034828592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004756586,0.00011540824,0.00026284409,0.000523724,0.0001894495,0.00040304943,0.00028144984,0.0002869873,0.0020221293],"category_scores_gemma":[0.0024907046,0.00011819163,0.00041014512,0.00088467466,0.00021015904,0.00032323183,0.00021776337,0.00032156098,0.00016060691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008638794,0.0000042162605,0.9989575,0.000007634902,0.000021208083,0.00008614154,0.000007931421,0.000008974981,0.000082130384,0.0000024646176,0.00002572988,0.00070957607],"study_design_scores_gemma":[0.000004220122,0.00005755406,0.9984707,0.00000722545,0.000033907516,0.0011143467,0.000053027004,0.00006606854,0.000080406906,0.0000070418428,0.00010427322,0.0000011035557],"about_ca_topic_score_codex":0.0021167165,"about_ca_topic_score_gemma":0.003198227,"teacher_disagreement_score":0.0021167165,"about_ca_system_score_codex":0.00024386843,"about_ca_system_score_gemma":0.0002670649,"threshold_uncertainty_score":0.0067646503},"labels":[],"label_agreement":null},{"id":"W4281632793","doi":"10.1093/neuonc/noac079.226","title":"HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; BC Children's Hospital; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Radiation therapy; Pathology; Gastroenterology; Neurotrophin; Receptor","score_opus":0.012495681392844935,"score_gpt":0.2829487737865249,"score_spread":0.27045309239367993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911624,0.000088552326,0.000023005565,0.000014542938,0.0000018196251,0.0000068197273,0.0005416802,0.0000034534041,0.00020389412],"genre_scores_gemma":[0.9986972,0.00006817937,0.000056818684,0.000019061592,0.000005177954,0.000010770919,0.0010707151,0.0000024130961,0.000069609334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978226,0.000028257113,0.000020166772,0.00007358929,0.000033913384,0.00006183326],"domain_scores_gemma":[0.99921227,0.00011932151,0.00033741357,0.00003542617,0.000058040958,0.00023746601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002618331,0.0003001547,0.00031906,0.0007032459,0.00038451105,0.00045491458,0.00023034171,0.00033670216,0.0013034287],"category_scores_gemma":[0.0009685396,0.00018895972,0.0002293409,0.0009726783,0.00031294505,0.00041136311,0.00041967048,0.00037444226,0.00034680185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043908658,0.000011800411,0.9985159,0.0000041282187,0.000008426619,0.00046284133,0.00003550183,0.000026750464,0.00017855145,0.000006100379,0.000091463065,0.0006147217],"study_design_scores_gemma":[0.0000048435363,0.00009684035,0.9965385,0.0000031544978,0.000009263647,0.0028821868,0.0001579485,0.0000619462,0.000046513713,0.000010087598,0.0001866657,0.0000021024669],"about_ca_topic_score_codex":0.0028164713,"about_ca_topic_score_gemma":0.0028230585,"teacher_disagreement_score":0.0028164713,"about_ca_system_score_codex":0.00042232047,"about_ca_system_score_gemma":0.0004139979,"threshold_uncertainty_score":0.005600214},"labels":[],"label_agreement":null},{"id":"W4281638651","doi":"10.1093/neuonc/noac079.049","title":"RARE-24. The use of novel<i>in vitro</i> models to study adamantinomatous craniopharyngioma disease biology and drug response","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Cell culture; Biology; Population; Immunofluorescence; Cell; Molecular biology; Vimentin; Cell biology; In vitro; Transfection; Immunology; Genetics; Antibody; Immunohistochemistry; Medicine","score_opus":0.04786275865996559,"score_gpt":0.3022018912081063,"score_spread":0.2543391325481407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281638651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85505164,0.018629676,0.07077999,0.002675713,0.0010972719,0.00092824386,0.015381698,0.002644863,0.03281091],"genre_scores_gemma":[0.9352825,0.008336681,0.024139585,0.00069137145,0.00015879842,0.00066261046,0.01267202,0.0003923608,0.017664013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952054,0.00012417044,0.000068997455,0.000093248564,0.00013943507,0.000053606596],"domain_scores_gemma":[0.99943537,0.00008989141,0.00015710402,0.00014660515,0.000078760655,0.00009222326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008796926,0.00055446906,0.00038720528,0.00047744726,0.00038030394,0.0011810878,0.00064633327,0.00066982204,0.0045465906],"category_scores_gemma":[0.00046431238,0.00023730178,0.00061240076,0.0003192194,0.00037132011,0.00047350596,0.0004403873,0.0012117611,0.002600646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020344245,0.00008538102,0.00088575186,0.00017759566,0.00002412192,0.00026260034,0.00003773046,0.0002957796,0.9904751,0.00064434286,0.0009347997,0.0059734276],"study_design_scores_gemma":[0.000051210016,0.0010679036,0.0051410724,0.000046740828,0.00008122962,0.0020986088,0.00008943834,0.0015159815,0.949696,0.00045845305,0.039735682,0.000017694048],"about_ca_topic_score_codex":0.0010238171,"about_ca_topic_score_gemma":0.0014123202,"teacher_disagreement_score":0.0045465906,"about_ca_system_score_codex":0.00063149555,"about_ca_system_score_gemma":0.00048493757,"threshold_uncertainty_score":0.015209854},"labels":[],"label_agreement":null},{"id":"W4281640097","doi":"10.1093/neuonc/noac079.462","title":"MEDB-88. BAF60C/SMARCD3-mediated novel neurodevelopmental epigenomic program promotes metastatic dissemination in medulloblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; Epigenomics; Cerebellum; Reelin; Chromatin; Transcription factor; Neuroscience; EZH2; Cancer research; Enhancer; Genetics; Gene expression; Gene; DNA methylation","score_opus":0.01391385690840411,"score_gpt":0.2983467163557028,"score_spread":0.2844328594472987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281640097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95300126,0.0023017959,0.007338181,0.00012186349,0.000025368696,0.000033328462,0.03348011,0.0012110089,0.0024870217],"genre_scores_gemma":[0.9551629,0.00070089265,0.003108391,0.0000936689,0.0000055003516,0.000040649848,0.038796354,0.0001140411,0.0019775508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999785,0.000012699931,0.00001355151,0.00007871431,0.000071539216,0.000038480237],"domain_scores_gemma":[0.99986875,0.000012449826,0.00005981624,0.000016393184,0.000017986593,0.000024581708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016570934,0.00026559495,0.00039097868,0.00056814577,0.00025034163,0.00037923106,0.0001804205,0.00016859359,0.0017633253],"category_scores_gemma":[0.00017941179,0.00017970488,0.00035840433,0.00065689755,0.00014392284,0.00017440674,0.0003300838,0.0003245658,0.0008197262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004685622,0.000037022215,0.030933985,0.00022390818,0.00009158718,0.00031281394,0.000056089957,0.00080087164,0.9516952,0.00043311907,0.0014891103,0.013457797],"study_design_scores_gemma":[0.00006651892,0.00019081587,0.49398276,0.000047794907,0.00016961938,0.001359388,0.00012691117,0.012403602,0.46258464,0.0007307267,0.028303407,0.000033817054],"about_ca_topic_score_codex":0.0035190564,"about_ca_topic_score_gemma":0.0049877544,"teacher_disagreement_score":0.0035190564,"about_ca_system_score_codex":0.00044765795,"about_ca_system_score_gemma":0.00034811307,"threshold_uncertainty_score":0.006997168},"labels":[],"label_agreement":null},{"id":"W4281642484","doi":"10.1093/neuonc/noac079.199","title":"GCT-05. Multi-institutional analysis of treatment modalities in metastatic germinoma in children","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germinoma; Chemotherapy; Germ cell tumors; Radiation therapy; Biopsy; Primary tumor; Radiology; Progressive disease; Surgery; Metastasis; Internal medicine; Cancer","score_opus":0.03782648099807337,"score_gpt":0.3229005641374541,"score_spread":0.28507408313938076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281642484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985292,0.00022198274,0.000054657976,0.00001607294,0.0000018811529,0.000012565173,0.000983377,0.0000047948865,0.00017548545],"genre_scores_gemma":[0.9989134,0.00006246933,0.00013172245,0.000010518592,0.0000044078906,0.000015917278,0.000830895,0.0000035821922,0.000027025457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993187,0.00017393555,0.00010161112,0.00013584847,0.00014305992,0.00012687904],"domain_scores_gemma":[0.996779,0.0006377283,0.0018982954,0.00012796062,0.0001850817,0.000371832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000840814,0.00027017065,0.00037668296,0.0016391706,0.00045875655,0.00056254904,0.00040156965,0.00028246327,0.0015497287],"category_scores_gemma":[0.0024716659,0.00015686743,0.00071181724,0.0024153742,0.0003243375,0.0003242664,0.0006042654,0.00040961197,0.00014208473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009434257,0.000009424773,0.99890924,0.000013055039,0.000044061937,0.00008948938,0.000031236275,0.000052151718,0.00008533113,0.0000073572196,0.000053608306,0.00061069836],"study_design_scores_gemma":[0.0000075695657,0.00013294046,0.9984195,0.0000070412734,0.00004721901,0.00076321774,0.00015869427,0.00011580011,0.00012510283,0.000006100558,0.00021399255,0.000002880007],"about_ca_topic_score_codex":0.005052512,"about_ca_topic_score_gemma":0.0049265507,"teacher_disagreement_score":0.005052512,"about_ca_system_score_codex":0.001097344,"about_ca_system_score_gemma":0.0007274169,"threshold_uncertainty_score":0.010046184},"labels":[],"label_agreement":null},{"id":"W4281646138","doi":"10.1093/neuonc/noac079.393","title":"MEDB-18. Elongation control of mRNA translation supports Group 3 medulloblastoma adaptation to nutrient deprivation","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Gene knockdown; Translation (biology); Biology; Cell biology; Messenger RNA; Apoptosis; Biochemistry; Gene","score_opus":0.017733089707436606,"score_gpt":0.26077433357502705,"score_spread":0.24304124386759043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281646138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155104,0.0016065009,0.0021912723,0.0001706671,0.00006374591,0.000027863214,0.0026578167,0.00013141704,0.0015996732],"genre_scores_gemma":[0.9898122,0.000601285,0.0021699555,0.00009252601,0.000011010146,0.000040320057,0.0032974877,0.000070501876,0.0039048363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998752,0.000009888648,0.000009787414,0.00003732677,0.00003556861,0.000032242442],"domain_scores_gemma":[0.99986386,0.000015036802,0.00004748091,0.000013506258,0.000015399746,0.00004476732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117967225,0.00027199328,0.00021780429,0.000234974,0.0001833283,0.00034886942,0.0001550656,0.00020416519,0.0021565014],"category_scores_gemma":[0.000121269026,0.00013109778,0.00021218376,0.0001314341,0.0001802788,0.00013121535,0.00020083424,0.00037359504,0.00074345205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012409885,0.000008582735,0.00031015876,0.00001970913,0.0000019048866,0.000031045514,0.0000058056075,0.000012060825,0.9990004,0.000032537253,0.000045692916,0.00040799397],"study_design_scores_gemma":[0.000015401876,0.00012728514,0.027826753,0.000010658318,0.000009106723,0.00026624103,0.000041039802,0.00073771144,0.96646905,0.000049011713,0.004443023,0.0000047649314],"about_ca_topic_score_codex":0.0011615792,"about_ca_topic_score_gemma":0.0026753803,"teacher_disagreement_score":0.0021565014,"about_ca_system_score_codex":0.00047224946,"about_ca_system_score_gemma":0.00025402728,"threshold_uncertainty_score":0.0072141886},"labels":[],"label_agreement":null},{"id":"W4281648883","doi":"10.1093/neuonc/noac079.297","title":"IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Medulloblastoma; Tumor microenvironment; Biology; Cell type; Cancer research; Myeloid; Immunotherapy; Transcriptome; Cell; Immunology; Gene; Genetics; Gene expression","score_opus":0.014127060509964354,"score_gpt":0.2691264567533607,"score_spread":0.25499939624339635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281648883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9224016,0.0029259643,0.0055561387,0.00022861855,0.000039458577,0.0000525056,0.06499696,0.00059914653,0.003199634],"genre_scores_gemma":[0.89079106,0.00092295907,0.011404125,0.00024167511,0.00003307148,0.00020321878,0.09477728,0.00017325887,0.0014532869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927455,0.00008484857,0.00003879323,0.0003097162,0.00015188557,0.00014022342],"domain_scores_gemma":[0.99948597,0.00012777974,0.0001760645,0.0000468795,0.00008775877,0.00007540083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061746215,0.0003188976,0.00047189603,0.0009511563,0.00047937332,0.00079625746,0.00029689254,0.00030477453,0.0018594807],"category_scores_gemma":[0.0007599696,0.00018989749,0.00051498483,0.0015697746,0.00027602076,0.0002447307,0.0006932886,0.00046178894,0.00094552356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016322061,0.00016298892,0.6934228,0.0008874185,0.0003645362,0.00029864337,0.0006639181,0.003915515,0.22687839,0.00089801784,0.009202145,0.06167343],"study_design_scores_gemma":[0.0000490925,0.00046560232,0.90960014,0.00011423833,0.0002987462,0.0009128245,0.00065310596,0.010310196,0.050560303,0.0008766851,0.02612124,0.000037863567],"about_ca_topic_score_codex":0.0016142374,"about_ca_topic_score_gemma":0.0027993014,"teacher_disagreement_score":0.0018594807,"about_ca_system_score_codex":0.00046787297,"about_ca_system_score_gemma":0.0006435727,"threshold_uncertainty_score":0.006220579},"labels":[],"label_agreement":null},{"id":"W4281654265","doi":"10.1093/neuonc/noac079.082","title":"DIPG-25. Patterns of cerebrospinal fluid diversion and survival in children with diffuse intrinsic pontine glioma: a report from the International Diffuse Intrinsic Pontine Glioma Registry","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hydrocephalus; Glioma; Vomiting; Incidence (geometry); Cerebrospinal fluid; Surgery; Radiation therapy; Internal medicine","score_opus":0.01135986040156675,"score_gpt":0.24773150296573,"score_spread":0.23637164256416324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281654265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971488,0.00031982694,0.000057953814,0.000033715267,0.0000024586752,0.0000060557195,0.001967658,0.000007962704,0.00045549852],"genre_scores_gemma":[0.9980507,0.00013740861,0.000057247227,0.000008657525,0.0000028202187,0.000009474605,0.0016864783,0.0000028663467,0.000044337496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942374,0.00009647544,0.000090093075,0.00015577559,0.00013787427,0.00009608136],"domain_scores_gemma":[0.9977944,0.00031362855,0.0013215013,0.00014855355,0.00019004366,0.00023190341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006502663,0.00015331032,0.0002608342,0.0010380088,0.00020524864,0.000565733,0.00028227456,0.00020235292,0.0007634585],"category_scores_gemma":[0.002499186,0.00014184364,0.00028792594,0.0020147352,0.00027327944,0.00043207384,0.00046483762,0.000314551,0.00019871401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025537343,0.0000030026692,0.9989699,0.000005404351,0.00001043243,0.000076384895,0.00003135254,0.000024610019,0.00004330713,0.00000838318,0.00008454859,0.00071709836],"study_design_scores_gemma":[0.0000025393642,0.000029603798,0.99896455,0.0000047352614,0.000010010286,0.00059331243,0.00010107417,0.000059319926,0.00004411954,0.000007042665,0.00018170393,0.0000018798709],"about_ca_topic_score_codex":0.0050595207,"about_ca_topic_score_gemma":0.004351762,"teacher_disagreement_score":0.0050595207,"about_ca_system_score_codex":0.00045311698,"about_ca_system_score_gemma":0.0004449424,"threshold_uncertainty_score":0.010060132},"labels":[],"label_agreement":null},{"id":"W4281661953","doi":"10.1093/neuonc/noac079.511","title":"QOL-28. Clinico-molecular correlates of quality of survival and neurocognitive outcomes in medulloblastoma; a meta-analysis of the SIOP-UKCCSG-PNET3 and HIT-SIOP-PNET4 trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurocognitive; Survivorship curve; Quality of life (healthcare); Wechsler Adult Intelligence Scale; Internal medicine; Oncology; Randomized controlled trial; Clinical trial; Cancer; Cognition; Psychiatry","score_opus":0.13076726378010523,"score_gpt":0.4100935557205783,"score_spread":0.2793262919404731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281661953","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35617965,0.6316283,0.0027566713,0.0010131603,0.00043326773,0.00022834261,0.006448265,0.0001146905,0.0011976776],"genre_scores_gemma":[0.9771308,0.019333482,0.00065943354,0.00029458682,0.0001459919,0.00019846926,0.0018928312,0.000035385983,0.00030916627],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99367505,0.003681232,0.00075782434,0.0011075169,0.0005519192,0.000226364],"domain_scores_gemma":[0.9919159,0.0050651906,0.0017320042,0.00056756637,0.00039794025,0.0003214202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009961787,0.0013355656,0.0056803697,0.0020402845,0.00042657103,0.0024712957,0.0011525748,0.0010630576,0.0019027259],"category_scores_gemma":[0.009516887,0.00066767994,0.023045229,0.0027869388,0.00046181868,0.0007553585,0.000998179,0.0015747336,0.00017414968],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013061799,0.0000324854,0.09634816,0.010357478,0.87128514,0.00009215224,0.00003641771,0.0011157766,0.0005810082,0.00009187021,0.0006407366,0.0063569187],"study_design_scores_gemma":[0.002439142,0.0008289539,0.13861111,0.0010602998,0.85291845,0.00015293929,0.000059010777,0.0012698178,0.0003602397,0.00036872836,0.0018963413,0.000034980836],"about_ca_topic_score_codex":0.0043984316,"about_ca_topic_score_gemma":0.006169641,"teacher_disagreement_score":0.009961787,"about_ca_system_score_codex":0.00089798303,"about_ca_system_score_gemma":0.00069340685,"threshold_uncertainty_score":0.05268359},"labels":[],"label_agreement":null},{"id":"W4281671975","doi":"10.1093/neuonc/noac079.094","title":"DIPG-37. Exploring the role of the epigenetic factor H2A.Z acetylation in DIPG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Histone H3; Histone; Epigenetics; Carcinogenesis; Cancer research; Biology; Acetylation; Nucleosome; Genetics; Enhancer; Cancer; Gene; Molecular biology; Transcription factor","score_opus":0.026823172876355272,"score_gpt":0.26632675998467614,"score_spread":0.23950358710832087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281671975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97124743,0.0038559432,0.0012840213,0.0002400465,0.000036993075,0.000041016032,0.021196276,0.00020681463,0.0018913558],"genre_scores_gemma":[0.97163177,0.000907497,0.0017026493,0.00012908095,0.000012406627,0.000023255196,0.024137838,0.00004859722,0.0014068229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998473,0.000008062314,0.000007826166,0.000056835856,0.000035438952,0.00004453803],"domain_scores_gemma":[0.99984884,0.000014361308,0.00004898756,0.000013815956,0.000025402831,0.0000485576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021735534,0.0002958798,0.00039992825,0.0007058097,0.00036271106,0.00047214463,0.0002670196,0.00030399332,0.0026924338],"category_scores_gemma":[0.0002490121,0.00016205136,0.0004969818,0.0008963161,0.00017479032,0.00018975993,0.0004059345,0.0004346423,0.0010418727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020537258,0.0001523498,0.38074857,0.0009404243,0.0005046762,0.0010270231,0.00018483461,0.00092574325,0.5692491,0.00051508914,0.003984233,0.039714377],"study_design_scores_gemma":[0.000036715173,0.00028279403,0.9189845,0.000046394936,0.00021805726,0.0014644775,0.00024970554,0.003193367,0.059268985,0.0004900429,0.01573976,0.000025265394],"about_ca_topic_score_codex":0.0061934977,"about_ca_topic_score_gemma":0.008988613,"teacher_disagreement_score":0.0061934977,"about_ca_system_score_codex":0.00043514164,"about_ca_system_score_gemma":0.00033063907,"threshold_uncertainty_score":0.012314856},"labels":[],"label_agreement":null},{"id":"W4281673082","doi":"10.1093/neuonc/noac079.330","title":"LGG-15. Late mortality and morbidity of adult survivors of childhood glioma treated across three decades: a report from the Childhood Cancer Survivor Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cumulative incidence; Incidence (geometry); Late effect; Glioma; Radiation therapy; Pediatrics; Cancer; Internal medicine; Surgery; Cohort","score_opus":0.03519455248854827,"score_gpt":0.3401039937371175,"score_spread":0.3049094412485693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281673082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617416,0.00048967486,0.00007281869,0.00010434757,0.0000045025276,0.0000049908786,0.0028218294,0.00000786619,0.0003199095],"genre_scores_gemma":[0.9976331,0.00019916527,0.000038186667,0.000026682957,0.0000044947437,0.00000759906,0.0019584063,0.0000022766872,0.00013011064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998092,0.00004965933,0.000021960459,0.000047493075,0.00003377734,0.000038047943],"domain_scores_gemma":[0.99898356,0.000105614345,0.0005928975,0.00005785025,0.000107640415,0.00015234842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006394108,0.0001890089,0.00023036654,0.0005471986,0.00021975633,0.00034866293,0.00026729162,0.00022167242,0.0007984587],"category_scores_gemma":[0.0017392634,0.00011158327,0.00054443686,0.0008325117,0.00011788277,0.00022427004,0.00041677372,0.00030789626,0.00012628827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033956927,0.0000045163906,0.99908686,0.0000057394686,0.00004489921,0.000016678416,0.00002789108,0.000033487973,0.000021202575,0.000006756004,0.000105759726,0.0006122956],"study_design_scores_gemma":[0.0000027814283,0.00002158805,0.9995952,0.000004075215,0.00003323955,0.000056280067,0.000065482745,0.0000701857,0.000020233963,0.0000060461484,0.00012348473,0.0000014080251],"about_ca_topic_score_codex":0.029133035,"about_ca_topic_score_gemma":0.028481616,"teacher_disagreement_score":0.029133035,"about_ca_system_score_codex":0.00045110137,"about_ca_system_score_gemma":0.00043395467,"threshold_uncertainty_score":0.057926893},"labels":[],"label_agreement":null},{"id":"W4281675166","doi":"10.1093/neuonc/noac079.006","title":"ATRT-07. Low-grade diffusely infiltrative tumor, SMARCB1-mutant: a clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atypical teratoid rhabdoid tumor; SMARCB1; DNA methylation; Pathology; Lesion; Methylation; Epigenetics; Medicine; Immunohistochemistry; Cancer research; Biology; DNA; Gene; Genetics; Gene expression","score_opus":0.030702632775183147,"score_gpt":0.3043249687461088,"score_spread":0.27362233597092567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281675166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978108,0.00018385811,0.0003782084,0.000041069427,0.000007028764,0.00004151892,0.00019690947,0.000023098888,0.0013176257],"genre_scores_gemma":[0.9985268,0.00006811587,0.00046289866,0.000029834684,0.000008466481,0.000014430869,0.0004008565,0.000009583976,0.00047893293],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997962,0.000017228422,0.00003276581,0.0000694163,0.000038164355,0.000046249832],"domain_scores_gemma":[0.999456,0.00008223541,0.00013530428,0.000053290634,0.00004228783,0.00023078389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026263692,0.00033204572,0.00034505595,0.0008042614,0.0004455279,0.00044059302,0.0003543595,0.0004740176,0.00178753],"category_scores_gemma":[0.00057393877,0.00016326812,0.0002715005,0.0004084837,0.00044216576,0.0002354012,0.00044103048,0.0005491917,0.0005748221],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012764675,0.000561983,0.65426075,0.00010328531,0.00007597942,0.21214621,0.0005112228,0.00025463017,0.11665137,0.0004088776,0.00054408173,0.013205092],"study_design_scores_gemma":[0.000065408974,0.0013585114,0.44119456,0.000017526674,0.000061391394,0.5411442,0.0003599647,0.0010186038,0.012805149,0.0001791906,0.0017725597,0.000023035871],"about_ca_topic_score_codex":0.00058488065,"about_ca_topic_score_gemma":0.00084149133,"teacher_disagreement_score":0.00178753,"about_ca_system_score_codex":0.000284477,"about_ca_system_score_gemma":0.0002039529,"threshold_uncertainty_score":0.005979955},"labels":[],"label_agreement":null},{"id":"W4281678078","doi":"10.1093/neuonc/noac079.448","title":"MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Minimal residual disease; Oncology; Biomarker; Liquid biopsy; Internal medicine; Cerebrospinal fluid; Prospective cohort study; Surrogate endpoint; Pathology; Cancer; Biology; Bone marrow","score_opus":0.013219359947624285,"score_gpt":0.2857020498579654,"score_spread":0.2724826899103411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281678078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887116,0.0043520555,0.0019730248,0.00013234335,0.000028308641,0.00014969303,0.002235907,0.00013162501,0.002125846],"genre_scores_gemma":[0.9953359,0.0004946099,0.001947318,0.000076080745,0.00000865201,0.00008986502,0.0014013036,0.000016501528,0.0006298672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951386,0.00013638988,0.000037877104,0.00010222635,0.00015401236,0.000055578177],"domain_scores_gemma":[0.99934536,0.00016866466,0.00019946373,0.00003972297,0.00012789905,0.00011886433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009450314,0.00021714198,0.00042766996,0.0007691365,0.00023448186,0.0005471853,0.00024413434,0.00026120202,0.0014712359],"category_scores_gemma":[0.0014135089,0.00013141595,0.00014943804,0.0004105334,0.00025753994,0.00025757827,0.00027193959,0.00029043845,0.00043625495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007994494,0.00022741509,0.81328225,0.00026595863,0.00014050995,0.0010803691,0.00022002363,0.00064435694,0.11961607,0.00021452378,0.0015744182,0.05473963],"study_design_scores_gemma":[0.00021959184,0.003383043,0.90058386,0.00006356152,0.0001189079,0.0046998453,0.00023278059,0.0026353977,0.08032296,0.00020054505,0.0075188517,0.000020769481],"about_ca_topic_score_codex":0.0028434168,"about_ca_topic_score_gemma":0.0034532496,"teacher_disagreement_score":0.0028434168,"about_ca_system_score_codex":0.0005807755,"about_ca_system_score_gemma":0.00029211826,"threshold_uncertainty_score":0.0056537986},"labels":[],"label_agreement":null},{"id":"W4281679010","doi":"10.1093/neuonc/noac079.474","title":"NFB-12. Effect of trametinib on leg length discrepancy in a child with NF1 related plexiform neurofibroma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Plexiform neurofibroma; Bone age; Neurofibroma; Trametinib; Neurofibromatosis; Radiology; Anatomy; Biology","score_opus":0.01129989077058915,"score_gpt":0.29624410415454494,"score_spread":0.2849442133839558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281679010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913378,0.003046012,0.0003519947,0.0013472423,0.00005024362,0.000038703893,0.00023125272,0.000048421316,0.0035484002],"genre_scores_gemma":[0.998226,0.0004959084,0.00025740592,0.00030830028,0.000024712015,0.000006593262,0.00011857729,0.0000051444836,0.00055724056],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998983,0.000017027998,0.000012469218,0.000026139633,0.000020143412,0.00002587176],"domain_scores_gemma":[0.99965465,0.000078556615,0.000084747466,0.00001231668,0.000029337,0.00014038089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012338646,0.00034513144,0.00029934853,0.0003456891,0.0005023482,0.00020179071,0.0002805494,0.0007764324,0.000928204],"category_scores_gemma":[0.000666032,0.00014257318,0.0003039023,0.00024041766,0.00028042158,0.0002525344,0.00017944977,0.0010385242,0.00022218406],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080008915,0.00037181267,0.098741665,0.00015205434,0.000046832614,0.8682275,0.000329952,0.0003497937,0.008867298,0.00022189892,0.0011341495,0.020756993],"study_design_scores_gemma":[0.000082555656,0.001767847,0.123940505,0.00008393564,0.00006211336,0.8669849,0.0001800511,0.0009414589,0.002827107,0.00012963636,0.0029822974,0.000017678822],"about_ca_topic_score_codex":0.0031380083,"about_ca_topic_score_gemma":0.005739997,"teacher_disagreement_score":0.0031380083,"about_ca_system_score_codex":0.00062144466,"about_ca_system_score_gemma":0.00031222266,"threshold_uncertainty_score":0.006239474},"labels":[],"label_agreement":null},{"id":"W4281685066","doi":"10.1093/neuonc/noac079.382","title":"MEDB-07. Long-term medical and functional outcomes of medulloblastoma survivors: a population-based, matched cohort study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Interquartile range; Medulloblastoma; Hazard ratio; Cancer registry; National Death Index; Population; Cohort; Pediatrics; Medical record; Proportional hazards model; Cancer; Internal medicine; Confidence interval","score_opus":0.020368692093338286,"score_gpt":0.3065351404884014,"score_spread":0.2861664483950631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281685066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005,0.00046166178,0.00014112971,0.00013809797,0.000019191692,0.00010303582,0.017542278,0.000018730068,0.0015258432],"genre_scores_gemma":[0.98919415,0.00022360517,0.0002285553,0.000095674746,0.00001487813,0.00011993654,0.008712694,0.000010417699,0.0014001069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993856,0.00007434213,0.000051409523,0.00017005,0.00015238182,0.00016612267],"domain_scores_gemma":[0.99889636,0.000047283433,0.000348065,0.00014296878,0.00024034412,0.0003249952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000626941,0.0003744442,0.00040084546,0.00094593136,0.0013915865,0.0009957806,0.0009722738,0.00053044787,0.0037053018],"category_scores_gemma":[0.001581116,0.00045945548,0.0006807178,0.0019202039,0.00033082007,0.0003493004,0.00074934,0.0005856647,0.0008605287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028551498,0.00004511054,0.9974625,0.000021463,0.00011552131,0.000085355394,0.00010300688,0.000015530444,0.00016256692,0.000031208085,0.0008439937,0.0008281561],"study_design_scores_gemma":[0.000046514084,0.000054922675,0.9986004,0.000013434937,0.00006583051,0.000099267905,0.00015294815,0.0000651221,0.000027114846,0.000014078162,0.00085623097,0.0000039389292],"about_ca_topic_score_codex":0.4616349,"about_ca_topic_score_gemma":0.4979296,"teacher_disagreement_score":0.4616349,"about_ca_system_score_codex":0.0032239305,"about_ca_system_score_gemma":0.0037182271,"threshold_uncertainty_score":0.9178958},"labels":[],"label_agreement":null},{"id":"W4281685884","doi":"10.1093/neuonc/noac079.222","title":"HGG-06. Phase 2 Study of Veliparib and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma without H3 K27M or BRAF Mutations: A Report from the Children's Oncology Group ACNS1721 Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; Oncology; Radiation therapy; PARP inhibitor; Chemotherapy; Glioma; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.01189601658187891,"score_gpt":0.2865408807553826,"score_spread":0.2746448641735037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281685884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926565,0.0012478039,0.0002310358,0.00021724701,0.000058056834,0.0028039454,0.0018178284,0.00005498168,0.00091258995],"genre_scores_gemma":[0.98360056,0.0015772961,0.0022175768,0.00085385155,0.00014646548,0.004530704,0.0052342745,0.00003538723,0.0018038291],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999353,0.000340434,0.000033439985,0.000112856396,0.000054157048,0.00010609373],"domain_scores_gemma":[0.9992568,0.00009135869,0.00013658061,0.00008604441,0.000042841464,0.00038628723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019790921,0.0015313303,0.0019869239,0.00046139577,0.00041889813,0.0008730162,0.0010950582,0.0012219895,0.0027192675],"category_scores_gemma":[0.0008108794,0.00075981,0.0015090541,0.0005948228,0.0009858622,0.0006851929,0.00045115492,0.0025451754,0.00072880945],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8735358,0.047118932,0.018071475,0.00058418076,0.0018096784,0.00024971628,0.00023547254,0.0018956622,0.014589187,0.00016172668,0.002538995,0.0392091],"study_design_scores_gemma":[0.68739486,0.28781685,0.0200657,0.0000290877,0.00061553676,0.0002550464,0.00004358152,0.0004090132,0.001668415,0.0001090575,0.0015709896,0.000021874659],"about_ca_topic_score_codex":0.0018939286,"about_ca_topic_score_gemma":0.00468527,"teacher_disagreement_score":0.0027192675,"about_ca_system_score_codex":0.0013783848,"about_ca_system_score_gemma":0.0026123147,"threshold_uncertainty_score":0.010466576},"labels":[],"label_agreement":null},{"id":"W4281687841","doi":"10.1093/neuonc/noac079.324","title":"LGG-08. MR Imaging of pediatric low-grade gliomas: Pretherapeutic differentiation of<i>BRAF</i> V600E mutation,<i>BRAF</i>-Fused and Wild-Type tumors in patients without Neurofibromatosis-1","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Public Health Ontario; BC Children's Hospital; Dalhousie University; University of Toronto; Izaak Walton Killam Health Centre","funders":"","keywords":"V600E; Medicine; Wild type; Mutation; Magnetic resonance imaging; Cancer research; Mutant; Pathology; Nuclear medicine; Radiology; Biology; Gene; Genetics","score_opus":0.011587093337299693,"score_gpt":0.2622167037895961,"score_spread":0.2506296104522964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281687841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991704,0.00014879006,0.00009084075,0.000026603366,0.0000027668889,0.0000108787435,0.0002327842,0.000008890088,0.00030814492],"genre_scores_gemma":[0.99892503,0.000045422195,0.00039716015,0.000016792275,0.0000041843946,0.000014902819,0.00050095626,0.000004602874,0.00009092296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999571,0.00016075592,0.00006145645,0.000077079545,0.00007576898,0.000053851007],"domain_scores_gemma":[0.9982889,0.00037706742,0.0006853771,0.00007546403,0.0002979308,0.00027517672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097259774,0.00019519449,0.00022175994,0.0009612944,0.00014587175,0.0003536081,0.00031589976,0.00037552253,0.0010383223],"category_scores_gemma":[0.0031751418,0.00016008738,0.00014890009,0.0007173896,0.00027363034,0.00035305927,0.00033952345,0.00016112153,0.00045339335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014419438,0.000010193216,0.9978611,0.000010719853,0.00000756526,0.00013733639,0.000021307083,0.000028512082,0.00025273813,0.0000037668751,0.000101129335,0.0014215632],"study_design_scores_gemma":[0.000014866449,0.00018663473,0.9969453,0.00000886388,0.000021541542,0.0018411741,0.000107548,0.00021219214,0.00041632465,0.000014180592,0.00022853208,0.0000028113302],"about_ca_topic_score_codex":0.0019501036,"about_ca_topic_score_gemma":0.002699453,"teacher_disagreement_score":0.0019501036,"about_ca_system_score_codex":0.00041621368,"about_ca_system_score_gemma":0.00036033936,"threshold_uncertainty_score":0.0051436424},"labels":[],"label_agreement":null},{"id":"W4281689332","doi":"10.1093/neuonc/noac079.170","title":"EPID-02. Survival Experience in Pediatric Patients of Central Nervous System (CNS) Tumour in Canada","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Choroid plexus; Astrocytoma; Central nervous system; Internal medicine; Oncology; Cancer; Pathology; Glioma","score_opus":0.018065750585793985,"score_gpt":0.2603503529750069,"score_spread":0.24228460238921293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281689332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671044,0.0012904251,0.00014361052,0.00068918854,0.000025749865,0.000031197713,0.0249415,0.00003633616,0.00573764],"genre_scores_gemma":[0.9897508,0.0007715551,0.00009340489,0.00012235224,0.000008509102,0.000014869645,0.0083095515,0.000009915205,0.00091909035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994947,0.000025494852,0.000024712906,0.00007445384,0.0001536541,0.00022696998],"domain_scores_gemma":[0.99842465,0.00006914935,0.00040053274,0.000034202887,0.0006398722,0.0004316047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030721686,0.00019417019,0.00026057198,0.00072027394,0.0010519561,0.0009298743,0.0005568893,0.00022827389,0.0028833093],"category_scores_gemma":[0.002138706,0.00014553915,0.00036036185,0.0028625668,0.000439687,0.00028443223,0.00069479557,0.0005633764,0.00026971666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005644594,0.0000085631145,0.990373,0.00003191225,0.000028791657,0.00012700833,0.00047886302,0.00017745902,0.000068118694,0.00017940931,0.0032008188,0.0052696913],"study_design_scores_gemma":[0.0000057173406,0.000024968629,0.99572104,0.000036699406,0.000018062625,0.00021019347,0.0008326036,0.00017239727,0.000056519097,0.000028211656,0.0028851263,0.000008626055],"about_ca_topic_score_codex":0.96660274,"about_ca_topic_score_gemma":0.9775354,"teacher_disagreement_score":0.033397257,"about_ca_system_score_codex":0.019953098,"about_ca_system_score_gemma":0.025619294,"threshold_uncertainty_score":0.14477056},"labels":[],"label_agreement":null},{"id":"W4281690021","doi":"10.1093/neuonc/noac079.074","title":"DIPG-17. CD155 regulates cell growth and immune evasion in diffuse intrinsic pontine glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer research; Immune checkpoint; Biology; Immune system; CD137; IL-2 receptor; Immunotherapy; Glioma; T cell; CD86; CD44; Immunology; Cell","score_opus":0.00853908833374474,"score_gpt":0.22943345955700156,"score_spread":0.22089437122325684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281690021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770737,0.0010425275,0.00022250172,0.000029105073,0.000007719729,0.0000122126685,0.00017395128,0.000026314712,0.0007782948],"genre_scores_gemma":[0.9982582,0.00034275005,0.00021157644,0.000023654962,0.0000023464759,0.000011246382,0.00025564784,0.0000039288316,0.0008906358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999454,0.0000064905266,0.0000031387722,0.000009814423,0.000012678249,0.000022609442],"domain_scores_gemma":[0.9999727,0.0000033464628,0.000006963482,0.0000020905334,0.0000025313698,0.000012441886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050100607,0.00017247647,0.00016542786,0.00012914067,0.00007729979,0.00018920834,0.00011378434,0.00017415483,0.0013102806],"category_scores_gemma":[0.00004895974,0.000070424976,0.00010600196,0.00009568644,0.00013632643,0.00008569882,0.0001289797,0.00030649133,0.00030381454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018987081,0.000041212264,0.0007678607,0.000054889533,0.0000045193524,0.00017981372,0.000018838378,0.00006386917,0.99651235,0.00006654282,0.00008284334,0.0020174687],"study_design_scores_gemma":[0.00008990175,0.0017713986,0.05271291,0.000015083236,0.000027786804,0.0017142544,0.00012148971,0.0010290457,0.93548685,0.00006506393,0.0069604213,0.0000058451915],"about_ca_topic_score_codex":0.0007799545,"about_ca_topic_score_gemma":0.001099673,"teacher_disagreement_score":0.0013102806,"about_ca_system_score_codex":0.00027341128,"about_ca_system_score_gemma":0.00017254293,"threshold_uncertainty_score":0.0043833256},"labels":[],"label_agreement":null},{"id":"W4281692082","doi":"10.1093/neuonc/noac079.155","title":"EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"CTCF; Biology; Carcinogenesis; Genome; Chromosome conformation capture; DNA methylation; Enhancer; Gene; Chromatin; Genetics; Cancer research; Computational biology; Gene expression","score_opus":0.04432274116930166,"score_gpt":0.33169151334022573,"score_spread":0.28736877217092405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281692082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700899,0.012845151,0.009985108,0.00026882513,0.00010815467,0.00016614833,0.002105868,0.0004576163,0.0039731837],"genre_scores_gemma":[0.98624855,0.0030961728,0.004658414,0.00013560567,0.000010979121,0.000121589976,0.002440987,0.00004564158,0.0032421106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999281,0.0000064489773,0.0000037369546,0.000020157271,0.000023389202,0.000018170766],"domain_scores_gemma":[0.9999641,0.00000543082,0.000011334636,0.0000050299445,0.0000057193847,0.000008326887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009430169,0.00026546785,0.00030423715,0.00022417834,0.00010051645,0.00036114253,0.00021377603,0.00024138649,0.0019940103],"category_scores_gemma":[0.00009294851,0.0001219024,0.00025081442,0.00018339456,0.0001166523,0.00016044664,0.0001617983,0.00058625865,0.00044114253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034759086,0.00013631677,0.0014186354,0.000212301,0.0000349705,0.0001299468,0.000026592943,0.0012988893,0.96848744,0.00038694683,0.00062302995,0.026897378],"study_design_scores_gemma":[0.00012982808,0.0010844491,0.013578431,0.000024036239,0.00011185083,0.0007217381,0.000049515784,0.0058599887,0.9464257,0.0003398587,0.031660005,0.000014613043],"about_ca_topic_score_codex":0.0003838668,"about_ca_topic_score_gemma":0.0007730813,"teacher_disagreement_score":0.0019940103,"about_ca_system_score_codex":0.00027707277,"about_ca_system_score_gemma":0.00013481306,"threshold_uncertainty_score":0.006670654},"labels":[],"label_agreement":null},{"id":"W4281702701","doi":"10.1093/neuonc/noac079.583","title":"OTHR-45. Kids First Variant WorkBench: application to germline genomic discoveries in the Children's Brain Tumor Network","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Python (programming language); Computer science; Genomics; Ensembl; Database; Genome; Biology; Gene; Genetics; Programming language","score_opus":0.005433572827895831,"score_gpt":0.23454205331168054,"score_spread":0.2291084804837847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281702701","genre_codex":"software","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020068768,0.0009852883,0.15051973,0.00096532475,0.00044850432,0.0008205709,0.21475591,0.5960205,0.015415441],"genre_scores_gemma":[0.12971164,0.0015963818,0.3361572,0.0010410814,0.00022964449,0.0031175155,0.4223266,0.091717854,0.014102155],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983152,0.00035427633,0.00016661918,0.0005299987,0.0005005874,0.0001333523],"domain_scores_gemma":[0.9961486,0.0022937132,0.00026013123,0.0006961055,0.00027620274,0.00032518574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004839038,0.0019631577,0.0010046681,0.0033638137,0.00086790574,0.0024463953,0.0032363755,0.00076247373,0.064570576],"category_scores_gemma":[0.008193605,0.0013753932,0.0021905496,0.002619026,0.0005736719,0.0015149104,0.0043997117,0.0012531643,0.016550243],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004470763,0.00048683264,0.029744953,0.0042561633,0.0014343606,0.002824095,0.0024363452,0.03161531,0.021483913,0.012593613,0.71255785,0.17609589],"study_design_scores_gemma":[0.004834284,0.0007014419,0.04077855,0.0012094982,0.0007249017,0.0020618057,0.0013274682,0.22414485,0.046520796,0.04222925,0.63476247,0.000704718],"about_ca_topic_score_codex":0.012850191,"about_ca_topic_score_gemma":0.016215516,"teacher_disagreement_score":0.064570576,"about_ca_system_score_codex":0.0011985964,"about_ca_system_score_gemma":0.0014687162,"threshold_uncertainty_score":0.2160101},"labels":[],"label_agreement":null},{"id":"W4281707601","doi":"10.1093/neuonc/noac079.076","title":"DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Carcinogenesis; Epigenetics; Transcriptome; Cancer research; Epigenomics; Transcription factor; Oncogene; Cancer; Pediatric cancer; DNA methylation; Genetics; Gene; Gene expression; Cell cycle","score_opus":0.027099990667278882,"score_gpt":0.3557544753334464,"score_spread":0.32865448466616753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281707601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263836,0.002489985,0.005861619,0.00011237748,0.000013400282,0.00005831529,0.005018262,0.00026758426,0.003540054],"genre_scores_gemma":[0.98904735,0.0012365042,0.0040976144,0.00011885352,0.000009040842,0.000044053544,0.0041867355,0.00008675886,0.0011729717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997199,0.000018088907,0.000013019511,0.00011052378,0.00009712856,0.000041275976],"domain_scores_gemma":[0.99979526,0.000027803526,0.000097763936,0.000018739927,0.0000227136,0.000037779235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002763541,0.00024279194,0.00029561645,0.0005837512,0.0001793408,0.00029603697,0.00016556056,0.00018998298,0.001690961],"category_scores_gemma":[0.00017634619,0.00016367964,0.00022148437,0.0006633236,0.00021751705,0.00012798146,0.00031717084,0.00034101907,0.00035700042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003207985,0.000023003864,0.060588118,0.00014466998,0.00009166476,0.00061114656,0.000065891116,0.00039647057,0.92371655,0.0003408599,0.00046262765,0.013238227],"study_design_scores_gemma":[0.000027928301,0.00046686814,0.58840114,0.000029357312,0.0003260854,0.010515996,0.00022589255,0.0021098305,0.37299344,0.00030695673,0.024578644,0.000017951617],"about_ca_topic_score_codex":0.0013351726,"about_ca_topic_score_gemma":0.0028612006,"teacher_disagreement_score":0.001690961,"about_ca_system_score_codex":0.00040771437,"about_ca_system_score_gemma":0.0003345553,"threshold_uncertainty_score":0.005656779},"labels":[],"label_agreement":null},{"id":"W4281711757","doi":"10.1093/neuonc/noac079.587","title":"PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Immunohistochemistry; Biomarker; Multivariate analysis; Receiver operating characteristic; Biology; Medicine; Bioinformatics; Pathology; Genetics","score_opus":0.020240693518660563,"score_gpt":0.34173489698509263,"score_spread":0.3214942034664321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281711757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972314,0.00013962426,0.0008883759,0.00004387522,0.0000121142975,0.000060916518,0.0014205794,0.000029556944,0.00017345227],"genre_scores_gemma":[0.9950074,0.00006219711,0.0012743254,0.000042058513,0.000015681742,0.00011363686,0.0031529795,0.00003917653,0.0002926492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990466,0.00029785992,0.000056762132,0.0003707436,0.000117510834,0.000110371424],"domain_scores_gemma":[0.9973706,0.0006201147,0.000686169,0.0006325211,0.00029052925,0.00040006562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002929742,0.0004433877,0.00050573464,0.0008163183,0.000567765,0.00088268204,0.00064847805,0.00053382077,0.0028046505],"category_scores_gemma":[0.0038314548,0.00031762203,0.0009816781,0.0005574918,0.0005545552,0.00053463475,0.00092205143,0.0006802298,0.0007651373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004857314,0.00036381086,0.97699,0.00008194098,0.0006051992,0.0003398441,0.00020801283,0.0004624033,0.0048673274,0.00013131973,0.0009666847,0.010126142],"study_design_scores_gemma":[0.00036431273,0.0027018937,0.98188776,0.000030188232,0.0008723682,0.0019513773,0.00041889612,0.005815223,0.0023797806,0.0006823296,0.0028648546,0.00003098262],"about_ca_topic_score_codex":0.0013615025,"about_ca_topic_score_gemma":0.0013442463,"teacher_disagreement_score":0.002929742,"about_ca_system_score_codex":0.00060094864,"about_ca_system_score_gemma":0.0008944613,"threshold_uncertainty_score":0.015494168},"labels":[],"label_agreement":null},{"id":"W4281722844","doi":"10.1093/neuonc/noac079.369","title":"LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Biology; Cell; Microglia; Single-cell analysis; Progenitor cell; Cell type; Genetic heterogeneity; Population; Cell cycle; Cancer research; Gene; Bioinformatics; Neuroscience; Phenotype; Medicine; Immunology; Cell biology; Genetics; Stem cell; Inflammation","score_opus":0.05608979461747214,"score_gpt":0.3139350522948154,"score_spread":0.25784525767734323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281722844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567154,0.005938372,0.022867886,0.00039978093,0.00004540678,0.00005766257,0.011396076,0.0004656239,0.0021138468],"genre_scores_gemma":[0.9657032,0.002385976,0.01760375,0.00021681971,0.00003527939,0.00009193543,0.012650868,0.00016274999,0.0011493473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999785,0.000016934495,0.000011974253,0.00009653204,0.000048575854,0.000040967818],"domain_scores_gemma":[0.99975544,0.000056142082,0.00010209623,0.000020487163,0.000042058746,0.000023723544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032619032,0.000269675,0.00036032355,0.0006327547,0.00020239557,0.00066598627,0.00023236958,0.0003102178,0.0011270441],"category_scores_gemma":[0.00045268488,0.00014947537,0.00027616316,0.0009267008,0.00021224123,0.00031142385,0.00024240266,0.000411171,0.0006613851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025555404,0.000025278408,0.078741215,0.0004202943,0.00003930134,0.00015300995,0.0002019743,0.001198845,0.88702285,0.00038535285,0.0007684236,0.030787785],"study_design_scores_gemma":[0.000018110599,0.00014730448,0.6747058,0.00010399967,0.00014418807,0.0008414327,0.00056829274,0.0129926,0.28938338,0.0015491046,0.019518778,0.00002688138],"about_ca_topic_score_codex":0.0023956914,"about_ca_topic_score_gemma":0.004111378,"teacher_disagreement_score":0.0023956914,"about_ca_system_score_codex":0.0003955869,"about_ca_system_score_gemma":0.00033212677,"threshold_uncertainty_score":0.004763484},"labels":[],"label_agreement":null},{"id":"W4281724068","doi":"10.1093/neuonc/noac079.423","title":"MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; London Health Sciences Centre; BC Children's Hospital; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Salvage therapy; Chemotherapy; Neurocognitive; Surgery; Population; Cohort; Internal medicine; Pathology","score_opus":0.01458668472295697,"score_gpt":0.29203563345011685,"score_spread":0.27744894872715986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281724068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981499,0.0010957503,0.00007179187,0.000059143258,0.000003877783,0.000007272855,0.00013908486,0.000009293416,0.00046397536],"genre_scores_gemma":[0.9989686,0.0005135363,0.00014138616,0.00004668142,0.0000069616663,0.0000071219606,0.00017014463,0.0000035302623,0.00014210017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987245,0.000029242041,0.000011543011,0.000021880316,0.000025470943,0.0000393789],"domain_scores_gemma":[0.9996234,0.00007049276,0.00018614785,0.000016603666,0.000014681022,0.00008867301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020819313,0.00012383756,0.00025746555,0.00020076627,0.00015272494,0.0002006417,0.0001753952,0.00021905031,0.0010706648],"category_scores_gemma":[0.000725938,0.00009075651,0.00020096297,0.00029181765,0.00023473038,0.00018200927,0.00013917973,0.0001545065,0.00024568668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005575268,0.000049985454,0.9677182,0.00008068386,0.000032003536,0.0038076227,0.00019133973,0.00013581263,0.003698439,0.00006919043,0.00032063888,0.02333853],"study_design_scores_gemma":[0.000031006814,0.0009777141,0.9801573,0.00004943716,0.000047326117,0.0150505975,0.00046290274,0.00015952288,0.0014154249,0.00008943193,0.0015554433,0.000003890422],"about_ca_topic_score_codex":0.002208912,"about_ca_topic_score_gemma":0.0073330733,"teacher_disagreement_score":0.002208912,"about_ca_system_score_codex":0.0004505322,"about_ca_system_score_gemma":0.00039122193,"threshold_uncertainty_score":0.0043920875},"labels":[],"label_agreement":null},{"id":"W4281728046","doi":"10.1093/neuonc/noac079.217","title":"HGG-01. A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes and promotion of the NOTCH pathway","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"ATRX; Context (archaeology); Cancer research; Biology; Mutation; Gene; Genetics","score_opus":0.019860776948453594,"score_gpt":0.2544088677058148,"score_spread":0.2345480907573612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281728046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890837,0.0004814989,0.0050518,0.00032593426,0.000095063726,0.0001525633,0.002120044,0.0005021079,0.0021873428],"genre_scores_gemma":[0.9820586,0.00039360276,0.006964554,0.00016870181,0.000022875574,0.00019312785,0.0020491977,0.00018992688,0.007959495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996402,0.00004986019,0.000034917877,0.00008789251,0.0000999071,0.00008729207],"domain_scores_gemma":[0.9996958,0.00002894049,0.00011062614,0.000035016525,0.000013612678,0.00011613228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029111266,0.00059502467,0.00034418283,0.0007171332,0.00027411053,0.00035878998,0.0005974458,0.00075137865,0.00285307],"category_scores_gemma":[0.00010795409,0.00023787149,0.00040324946,0.0003302733,0.00056099467,0.00026542458,0.00037549247,0.0014243949,0.0009076383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035449804,0.00014358178,0.00022045318,0.000021807055,0.000008899815,0.00015378903,0.00002386803,0.000112216556,0.99758387,0.00028734613,0.00018245404,0.0009071974],"study_design_scores_gemma":[0.00012215256,0.0011749573,0.0031900385,0.000009734584,0.000025788217,0.00071038865,0.00006103579,0.0015540025,0.988557,0.00008773877,0.0044960873,0.000011052074],"about_ca_topic_score_codex":0.0016832566,"about_ca_topic_score_gemma":0.002071987,"teacher_disagreement_score":0.00285307,"about_ca_system_score_codex":0.0005983091,"about_ca_system_score_gemma":0.00038649203,"threshold_uncertainty_score":0.009544432},"labels":[],"label_agreement":null},{"id":"W4281728172","doi":"10.1093/neuonc/noac079.221","title":"HGG-05. Systematic review of diffuse hemispheric glioma, H3 G34-mutant and clinical factors influencing outcomes","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"ATRX; Medicine; PDGFRA; Internal medicine; Oncology; IDH1; Glioma; Pediatrics; Mutation; Cancer research; Stromal cell","score_opus":0.034325994089038636,"score_gpt":0.3453557440419695,"score_spread":0.31102974995293087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281728172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042336644,0.9829313,0.00035063704,0.00084607623,0.00032954838,0.0021365052,0.008135771,0.000049709164,0.0009866907],"genre_scores_gemma":[0.042114004,0.94366044,0.0017827183,0.0020413476,0.00021131878,0.0061304565,0.0034505315,0.000035445457,0.0005737465],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9887637,0.0036224646,0.00491377,0.0008584666,0.001417074,0.00042459852],"domain_scores_gemma":[0.96578735,0.020845853,0.008953594,0.0006743204,0.0031429648,0.00059584493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01123032,0.0016680531,0.010611316,0.018862184,0.00084541703,0.0034550647,0.002449122,0.0020474468,0.010472347],"category_scores_gemma":[0.046268485,0.001195458,0.007881101,0.018185291,0.0011155731,0.0029928614,0.0027558985,0.0010287801,0.00079419214],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016832053,0.0000060026064,0.0008249634,0.9840352,0.0064687035,0.00005444748,0.00012814337,0.000034034074,0.00009325226,0.00010730106,0.0011593318,0.006920237],"study_design_scores_gemma":[0.00043751154,0.000170668,0.006044123,0.9147224,0.06506651,0.00027126266,0.00029183645,0.00004961765,0.00010058039,0.0002599256,0.012555189,0.00003042705],"about_ca_topic_score_codex":0.011689109,"about_ca_topic_score_gemma":0.028697101,"teacher_disagreement_score":0.018862184,"about_ca_system_score_codex":0.004537247,"about_ca_system_score_gemma":0.017292598,"threshold_uncertainty_score":0.059392333},"labels":[],"label_agreement":null},{"id":"W4281731883","doi":"10.1093/neuonc/noac079.116","title":"DIPG-59. Blood Brain Barrier (BBB) modulation using Cadherin peptides in the treatment of Diffuse Midline Glioma of the Pons (DMG-P)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Manitoba","funders":"","keywords":"In vitro; Blood–brain barrier; Glioma; Chemistry; Tight junction; Cancer research; Permeability (electromagnetism); Brainstem; In vivo; Biophysics; Pathology; Pharmacology; Medicine; Central nervous system; Biochemistry; Biology; Internal medicine; Membrane","score_opus":0.032572868630529384,"score_gpt":0.30683182144574206,"score_spread":0.2742589528152127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281731883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893646,0.0073934267,0.0012390153,0.000100328514,0.00006943968,0.000102344005,0.00026417116,0.00008586194,0.0013807155],"genre_scores_gemma":[0.9943764,0.002705059,0.0014348222,0.000051659736,0.00001037369,0.000049528917,0.00032918525,0.0000067000833,0.0010362681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999554,0.0000063771918,0.0000028345642,0.000007828073,0.000014033897,0.000013460135],"domain_scores_gemma":[0.9999796,0.000002330954,0.000005015714,0.0000015917433,0.0000032850562,0.000008132229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075427815,0.00024386332,0.00022040178,0.00015005888,0.00007617799,0.00014259669,0.00015744813,0.00020389048,0.00081862556],"category_scores_gemma":[0.000055772856,0.00005220889,0.00014300342,0.00012318707,0.000109355395,0.0001160171,0.00010160212,0.00042149454,0.00016531588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007591749,0.00033129822,0.00031405568,0.00039555368,0.000019972544,0.00028595314,0.000023926263,0.00020671109,0.9806692,0.000121139994,0.00029868254,0.01657426],"study_design_scores_gemma":[0.0002464551,0.008995137,0.007287079,0.000024108956,0.000080889746,0.0012330033,0.000037025973,0.0008010652,0.97235876,0.000052465315,0.008875981,0.000008087312],"about_ca_topic_score_codex":0.0006400302,"about_ca_topic_score_gemma":0.00092603266,"teacher_disagreement_score":0.00081862556,"about_ca_system_score_codex":0.00017867667,"about_ca_system_score_gemma":0.00016876536,"threshold_uncertainty_score":0.002738595},"labels":[],"label_agreement":null},{"id":"W4281738783","doi":"10.1093/neuonc/noac079.216","title":"GCT-22. OUTCOMES OF CHILDREN WITH LOCALIZED AND METASTATIC GERMINOMA TREATED WITH CHEMOTHERAPY FOLLOWED BY RADIATION THERAPY WITHOUT PRIMARY TUMOR BOOST","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Germinoma; Retrospective cohort study; Primary tumor; Radiology; Surgery; Internal medicine; Metastasis; Cancer","score_opus":0.010812067301997238,"score_gpt":0.26733861349501886,"score_spread":0.2565265461930216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281738783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995327,0.00012304136,0.000017563325,0.000015440404,0.0000021182452,0.00000453025,0.00014908538,0.0000018972352,0.0001536006],"genre_scores_gemma":[0.99951303,0.000059800146,0.00003190196,0.000011564243,0.0000041422213,0.000008027073,0.00030800613,0.0000014971516,0.00006190706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983025,0.00002618131,0.000015763617,0.000041974294,0.00002870892,0.00005711166],"domain_scores_gemma":[0.99904245,0.00010600989,0.00053934776,0.000024034476,0.000046105437,0.00024205488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019768917,0.00017770634,0.00030675213,0.00031863077,0.0004075609,0.00039718015,0.00020487559,0.0002848472,0.00088364934],"category_scores_gemma":[0.00092046795,0.00011056541,0.00038099271,0.00043566048,0.00030432534,0.0002665564,0.0002965087,0.0004555232,0.00016686473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015646704,0.000047312646,0.99656194,0.000011473872,0.000023747225,0.0011348902,0.000078023746,0.00009019909,0.00030222465,0.000013772744,0.00010553079,0.0014744643],"study_design_scores_gemma":[0.000027889791,0.001090885,0.99119425,0.000014872002,0.000040377472,0.006634703,0.0002550183,0.00014539668,0.00025403645,0.000018298739,0.00031902533,0.000005178598],"about_ca_topic_score_codex":0.0034521306,"about_ca_topic_score_gemma":0.0045343298,"teacher_disagreement_score":0.0034521306,"about_ca_system_score_codex":0.00078338094,"about_ca_system_score_gemma":0.0004883133,"threshold_uncertainty_score":0.006864071},"labels":[],"label_agreement":null},{"id":"W4281749964","doi":"10.1093/neuonc/noac079.310","title":"IMMU-17. Comprehensive immunological gene expression profiling of pediatric brain tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Immune system; Immunotherapy; Glioma; Immune privilege; Cancer research; Brain tumor; Tumor microenvironment; Immune checkpoint; Gene expression profiling; Medicine; Biology; Immunology; Gene expression; Pathology; Gene","score_opus":0.03296625932492335,"score_gpt":0.3054882796986671,"score_spread":0.27252202037374373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281749964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331665,0.0007054973,0.0019844156,0.000017611606,0.0000047050194,0.00003439062,0.0031322516,0.000045471443,0.0007588482],"genre_scores_gemma":[0.98660266,0.0007359566,0.0057677296,0.000056833473,0.000007730837,0.000102851394,0.0056008277,0.000025606036,0.00109981],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999876,0.000010741029,0.000008933469,0.00003782642,0.000035954497,0.000030459465],"domain_scores_gemma":[0.99991703,0.000013351577,0.000033397075,0.0000054808033,0.0000145395425,0.000016184324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011876634,0.00018874866,0.00017040045,0.0007690507,0.000104179446,0.00020004227,0.00008620847,0.00011332739,0.0006523178],"category_scores_gemma":[0.00011180501,0.00007771436,0.00010793176,0.0005657293,0.00012122185,0.00007419897,0.00011598844,0.00015637193,0.0002166281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040869907,0.00004734389,0.08988901,0.00008662038,0.000030299827,0.00027985463,0.00010044441,0.00037497506,0.89512813,0.00006243437,0.00025397647,0.013338189],"study_design_scores_gemma":[0.000011451082,0.00065581175,0.57305133,0.000015056556,0.00007237252,0.0022500744,0.0002537957,0.0019055629,0.41592994,0.00007925071,0.005767364,0.000007943158],"about_ca_topic_score_codex":0.00056210253,"about_ca_topic_score_gemma":0.0010376549,"teacher_disagreement_score":0.0007690507,"about_ca_system_score_codex":0.00014285214,"about_ca_system_score_gemma":0.0001344654,"threshold_uncertainty_score":0.0021821856},"labels":[],"label_agreement":null},{"id":"W4281753564","doi":"10.1093/neuonc/noac079.340","title":"LGG-26. Predicting MAPK inhibitor sensitivity in pediatric low-grade gliomas with novel gene expression-derived signatures","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"MAPK/ERK pathway; Gene signature; Biology; Cancer research; Gene expression; Gene; Gene expression profiling; Medicine; Bioinformatics; Pathology; Genetics; Signal transduction","score_opus":0.014743019385586031,"score_gpt":0.25972111797201575,"score_spread":0.24497809858642972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281753564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88376576,0.0032352463,0.0031911752,0.00025561487,0.00003943205,0.000094556315,0.106246166,0.0011454487,0.0020266853],"genre_scores_gemma":[0.75119364,0.0008839215,0.009238737,0.00025835272,0.000032474654,0.00015593067,0.23674539,0.000101375575,0.0013901939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958485,0.000060016242,0.000029312076,0.00016296194,0.000105868865,0.00005700776],"domain_scores_gemma":[0.9995819,0.00012333538,0.0001056508,0.000044036347,0.00008408279,0.00006095124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047899873,0.0007236235,0.0005625461,0.0013852991,0.00019229094,0.0006042116,0.0003705556,0.00042457585,0.0010044881],"category_scores_gemma":[0.0009095671,0.00014154289,0.00062144554,0.0011013304,0.00019541888,0.0001739618,0.0004752967,0.00034650657,0.00081185007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023219648,0.00032379635,0.7736884,0.0010855595,0.00092654227,0.0005784859,0.000117877324,0.023646658,0.074900955,0.0003711579,0.0302924,0.09174618],"study_design_scores_gemma":[0.00024818996,0.0011923016,0.8088538,0.00017047681,0.00083301944,0.0023315188,0.00033666033,0.09201498,0.054839566,0.0013872474,0.037697427,0.000094936404],"about_ca_topic_score_codex":0.0036494667,"about_ca_topic_score_gemma":0.006878088,"teacher_disagreement_score":0.0036494667,"about_ca_system_score_codex":0.0005180807,"about_ca_system_score_gemma":0.00049788837,"threshold_uncertainty_score":0.0072564483},"labels":[],"label_agreement":null},{"id":"W4281755113","doi":"10.1093/neuonc/noac079.530","title":"SURG-12. Endoscopic evaluation of ventricular dissemination in primary central nervous system (CNS) germ cell tumors (GCTs)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Neurosurgery; Germ cell tumors; Endoscopic third ventriculostomy; Exact test; Internal medicine; Primary tumor; Surgery; Oncology; Pathology; Cancer; Endoscopy; Metastasis; Chemotherapy","score_opus":0.01647057869221559,"score_gpt":0.2844507484136681,"score_spread":0.2679801697214525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281755113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974788,0.0005173245,0.00014760939,0.00003799569,0.0000081856715,0.000007037558,0.00020047821,0.000015201748,0.0015874401],"genre_scores_gemma":[0.9992675,0.00012127617,0.00017711989,0.00001673034,0.000008579612,0.000003381161,0.00017099011,0.0000018846025,0.00023249353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986243,0.000026622121,0.00002199315,0.000022828663,0.000034170705,0.00003188117],"domain_scores_gemma":[0.99944824,0.00011999485,0.00017667007,0.00002609619,0.00007306318,0.00015591495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036405068,0.0001767404,0.00015538708,0.0006158113,0.00016245517,0.00029723128,0.00013702824,0.00022008092,0.0030954794],"category_scores_gemma":[0.00097587844,0.00007787534,0.00018712267,0.0002740251,0.0002014443,0.0002705279,0.0002109124,0.00020567905,0.00049372803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029236684,0.000028087363,0.9864094,0.0000336763,0.00002848612,0.0027774302,0.00003925188,0.000079278354,0.0015955517,0.000017786626,0.00029541395,0.008403311],"study_design_scores_gemma":[0.000025941454,0.0004701032,0.9697337,0.000020532263,0.00003982812,0.025798332,0.00014102545,0.00059122883,0.0023573572,0.000039955758,0.0007773116,0.0000047068497],"about_ca_topic_score_codex":0.0010172616,"about_ca_topic_score_gemma":0.0019498763,"teacher_disagreement_score":0.0030954794,"about_ca_system_score_codex":0.00026863033,"about_ca_system_score_gemma":0.00026580977,"threshold_uncertainty_score":0.010355413},"labels":[],"label_agreement":null},{"id":"W4281777545","doi":"10.1093/neuonc/noac079.389","title":"MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Retrospective cohort study; Chemotherapy; Radiation therapy; Internal medicine; Oncology; Missense mutation; Incidence (geometry); Pathology; Mutation; Biology","score_opus":0.02551840645439419,"score_gpt":0.3166582305985973,"score_spread":0.29113982414420314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281777545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993405,0.00017474123,0.000033702512,0.000013931658,0.0000014159411,0.00000322372,0.00020725658,0.000003906859,0.00022121615],"genre_scores_gemma":[0.9996055,0.000050131992,0.000038713188,0.0000048231727,0.0000025728345,0.000004026938,0.00025259872,0.0000014035844,0.000040167295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998671,0.000023560104,0.00001593793,0.000036261365,0.000028678209,0.000028406312],"domain_scores_gemma":[0.9994898,0.000058813584,0.0002907032,0.000016810101,0.000029179435,0.00011466725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019642766,0.00023275428,0.000276795,0.0006194111,0.0002706845,0.00028817146,0.00017944668,0.00020498422,0.0011700785],"category_scores_gemma":[0.00074596144,0.00011085404,0.00018074954,0.00046815263,0.00022743226,0.00024267344,0.00025961277,0.00018954978,0.00023749667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015389256,0.0000101796,0.99576145,0.000008044951,0.000015428086,0.0012077178,0.000038524544,0.00004808501,0.0010131485,0.000011541072,0.00006557509,0.0016664346],"study_design_scores_gemma":[0.000008225956,0.0001328315,0.9909525,0.0000055327987,0.000020038307,0.008053902,0.00009005461,0.00013847442,0.00036123124,0.000018994393,0.00021557268,0.0000026754765],"about_ca_topic_score_codex":0.0014628335,"about_ca_topic_score_gemma":0.0016082504,"teacher_disagreement_score":0.0014628335,"about_ca_system_score_codex":0.00029649993,"about_ca_system_score_gemma":0.0002653388,"threshold_uncertainty_score":0.0039142966},"labels":[],"label_agreement":null},{"id":"W4281779592","doi":"10.1093/neuonc/noac079.372","title":"LGG-61. Cerebrospinal fluid as a source for liquid biopsy in pediatric gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Liquid biopsy; Biopsy; Medicine; Cerebrospinal fluid; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.019711849833012062,"score_gpt":0.3019914259427216,"score_spread":0.28227957610970955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281779592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768067,0.002706073,0.017179454,0.00013421026,0.00004467287,0.0002715684,0.0009045419,0.0004982447,0.0014545168],"genre_scores_gemma":[0.96442276,0.0012835445,0.031474277,0.00019297624,0.000022208216,0.00012879973,0.0014497809,0.000098034834,0.00092764734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990422,0.00027465812,0.000059580583,0.0001972228,0.00035267923,0.00007374451],"domain_scores_gemma":[0.99933004,0.00023841692,0.00015843763,0.00006285335,0.00015275355,0.00005754759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008664734,0.0006140513,0.00035313514,0.0008144749,0.0002603398,0.0006568819,0.00031227386,0.00041006066,0.00095638045],"category_scores_gemma":[0.0011739811,0.00020322263,0.00019640687,0.00052341085,0.0004765788,0.00024143023,0.00031407812,0.00035449635,0.00050124404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013782682,0.00021587228,0.13700055,0.00037629518,0.00007674844,0.0026360047,0.00039523293,0.0009080064,0.80747646,0.000139413,0.0005730287,0.048824143],"study_design_scores_gemma":[0.00003245056,0.0016123776,0.14668638,0.00009175111,0.00011779684,0.006331745,0.00028085694,0.0041383994,0.8340296,0.00015229105,0.006496599,0.000029775127],"about_ca_topic_score_codex":0.0021927343,"about_ca_topic_score_gemma":0.0025565566,"teacher_disagreement_score":0.0021927343,"about_ca_system_score_codex":0.00034730855,"about_ca_system_score_gemma":0.000440872,"threshold_uncertainty_score":0.004582405},"labels":[],"label_agreement":null},{"id":"W4281781457","doi":"10.1093/neuonc/noac079.048","title":"RARE-23. Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Endocrine system; Medicine; Surgery; Craniopharyngioma; Ommaya reservoir; Radiation therapy; Debulking; Retrospective cohort study; Hormone; Internal medicine; Chemotherapy; Cancer","score_opus":0.012611462153198279,"score_gpt":0.2563043907920206,"score_spread":0.24369292863882233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281781457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989685,0.00023426632,0.000060192284,0.000028617618,0.0000036678123,0.0000039579236,0.00016433206,0.000005332515,0.00053115806],"genre_scores_gemma":[0.99964,0.00009340568,0.000061920175,0.000010808358,0.0000051139714,0.00000326136,0.00011724325,0.0000016071305,0.00006675371],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99971145,0.00003112601,0.000038956776,0.000049309754,0.00006115601,0.000107965774],"domain_scores_gemma":[0.998955,0.00021732891,0.000557939,0.00003670018,0.000070330236,0.00016263606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026246143,0.00018444008,0.00017902625,0.00073146366,0.00046473838,0.0003748796,0.00019842414,0.00025900188,0.0016198184],"category_scores_gemma":[0.001239571,0.00011169547,0.00025987282,0.00051826175,0.0004005572,0.00031305544,0.00027822534,0.00035500192,0.00020692617],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054684297,0.000013249196,0.98748803,0.000019554524,0.000007720865,0.009367755,0.00008045149,0.000031970558,0.0006711975,0.000032237902,0.000089904075,0.0021432578],"study_design_scores_gemma":[0.00000708086,0.00022300772,0.9125299,0.000018239474,0.000030249304,0.08449974,0.0004172723,0.00012289445,0.0014801497,0.000044187902,0.0006222387,0.0000049626888],"about_ca_topic_score_codex":0.0025207803,"about_ca_topic_score_gemma":0.002709799,"teacher_disagreement_score":0.0025207803,"about_ca_system_score_codex":0.00048722184,"about_ca_system_score_gemma":0.0005246881,"threshold_uncertainty_score":0.005418837},"labels":[],"label_agreement":null},{"id":"W4281784147","doi":"10.1093/neuonc/noac079.038","title":"RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Quality of life (healthcare); Pediatrics; Neurocognitive; Chemotherapy; Biopsy; Surgery; Internal medicine; Psychiatry; Cognition","score_opus":0.027259042182802503,"score_gpt":0.3087836467949135,"score_spread":0.281524604612111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281784147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303377,0.00096410624,0.0000669996,0.00082730356,0.00001180863,0.000009603809,0.0010376845,0.000008427087,0.004040254],"genre_scores_gemma":[0.99838877,0.00065471086,0.00009426914,0.00010650966,0.00001271926,0.000008747432,0.00043683845,0.000002299608,0.00029513787],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99980074,0.000049638267,0.000022611563,0.00002702118,0.000041824333,0.000058186626],"domain_scores_gemma":[0.99924576,0.000091250855,0.0003632657,0.00001070254,0.00007813277,0.00021079576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032593636,0.00012327709,0.00017475233,0.0004929082,0.0006203008,0.000535192,0.00014455467,0.00022901727,0.0024320486],"category_scores_gemma":[0.0012608803,0.00006237323,0.00027909863,0.00059088663,0.00019957188,0.00047162865,0.0004177938,0.0003313456,0.00022757456],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040432922,0.000060010356,0.9819194,0.0000518874,0.000024400677,0.0028225966,0.0013525967,0.0000871583,0.00020421244,0.00013298195,0.0014084458,0.011896065],"study_design_scores_gemma":[0.000005788385,0.00013981495,0.9774239,0.00008644914,0.00003202458,0.013265443,0.0054209763,0.00011744855,0.00018316666,0.00012280444,0.003187978,0.000014108895],"about_ca_topic_score_codex":0.0051768194,"about_ca_topic_score_gemma":0.007713412,"teacher_disagreement_score":0.0051768194,"about_ca_system_score_codex":0.00053904246,"about_ca_system_score_gemma":0.00048237955,"threshold_uncertainty_score":0.0102933645},"labels":[],"label_agreement":null},{"id":"W4281829220","doi":"10.1093/neuonc/noac079.301","title":"IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.01715287258485537,"score_gpt":0.27390931060693846,"score_spread":0.2567564380220831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281829220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937809,0.0033811736,0.00023553171,0.00015414246,0.000027002026,0.00013669256,0.0008767659,0.00006191421,0.0013459728],"genre_scores_gemma":[0.9960061,0.0008247794,0.00065246073,0.00022375239,0.00002714981,0.00010156658,0.0015882051,0.000011252527,0.00056476076],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974316,0.000094577066,0.000017342933,0.000058971393,0.000051444105,0.000034428558],"domain_scores_gemma":[0.99954504,0.00008147395,0.00015113015,0.000039572315,0.00003678523,0.00014592917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081257755,0.00030624162,0.00055817823,0.00022064526,0.00014047703,0.00066266616,0.00044909428,0.00033687698,0.0019872028],"category_scores_gemma":[0.0006752383,0.00016602312,0.00056177715,0.00026074867,0.00028228157,0.00038601906,0.00023036654,0.0010387864,0.00037731152],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31037396,0.013670161,0.1403121,0.0017478416,0.002065913,0.0004287331,0.00030597564,0.0061997194,0.10345036,0.0006192248,0.009874355,0.41095173],"study_design_scores_gemma":[0.10848912,0.44046146,0.34305388,0.0003079133,0.00294707,0.0025706936,0.00019995678,0.011409213,0.06469782,0.00036446247,0.025411777,0.00008657601],"about_ca_topic_score_codex":0.0011047344,"about_ca_topic_score_gemma":0.0028251333,"teacher_disagreement_score":0.0019872028,"about_ca_system_score_codex":0.0010040097,"about_ca_system_score_gemma":0.0009722683,"threshold_uncertainty_score":0.0072846413},"labels":[],"label_agreement":null},{"id":"W4281836521","doi":"10.1093/neuonc/noac079.275","title":"HGG-60. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Amplicon; CDKN2A; Genetics; Glioma; Cancer research; Computational biology; Gene","score_opus":0.01134033711379088,"score_gpt":0.28941597157509813,"score_spread":0.27807563446130723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281836521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467576,0.00033257916,0.0006428021,0.000060581035,0.000011042236,0.000009532047,0.003727404,0.0000660113,0.00047432593],"genre_scores_gemma":[0.9924716,0.00015165281,0.00060219486,0.000042434745,0.00000882445,0.000009131732,0.006455998,0.000053126914,0.00020485697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964404,0.00003928233,0.000027049793,0.00016755259,0.000056698285,0.00006532558],"domain_scores_gemma":[0.9994029,0.00012565024,0.0001960215,0.00008059542,0.00006568898,0.00012920448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042763125,0.00031722133,0.00033248,0.0006796696,0.00032155518,0.0007089954,0.00028179836,0.00043723668,0.0022509582],"category_scores_gemma":[0.0015895034,0.00013823537,0.00054113794,0.0011990846,0.00030235996,0.00025873928,0.0006999396,0.0004097043,0.0005984754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005133045,0.000019162035,0.9786551,0.000040698713,0.00021146386,0.00029674964,0.00010566756,0.00082260213,0.005598126,0.00011365616,0.0012264312,0.012397093],"study_design_scores_gemma":[0.000024219526,0.00008431345,0.99009293,0.000025826288,0.00022949916,0.0012695658,0.00019857653,0.0026101198,0.0019960303,0.00046066623,0.002995982,0.000012305151],"about_ca_topic_score_codex":0.0037179622,"about_ca_topic_score_gemma":0.0045374297,"teacher_disagreement_score":0.0037179622,"about_ca_system_score_codex":0.00031125348,"about_ca_system_score_gemma":0.0003556513,"threshold_uncertainty_score":0.007530272},"labels":[],"label_agreement":null},{"id":"W4281863432","doi":"10.1093/neuonc/noac079.183","title":"ETMR-05. Single-cell transcriptomics of ETMR reveals developmental cellular programs and tumor-pericyte communications in the microenvironment","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Tumor microenvironment; Wnt signaling pathway; Cell biology; Embryonic stem cell; Transcriptome; Neural stem cell; Stem cell; Progenitor cell; Neuroblast; Pericyte; Cell; Extracellular matrix; Cancer research; Signal transduction; Neurogenesis; Genetics; Endothelial stem cell","score_opus":0.04709514991579847,"score_gpt":0.27447280051935175,"score_spread":0.22737765060355328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281863432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8057444,0.002019275,0.051528197,0.0003860648,0.00012231653,0.0001891621,0.12876806,0.0039457893,0.0072967666],"genre_scores_gemma":[0.7280458,0.0012533835,0.084869586,0.00056218036,0.000047667276,0.0006459395,0.17096138,0.001384796,0.012229317],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997261,0.000022762488,0.000015948042,0.00011735314,0.00008229734,0.000035487312],"domain_scores_gemma":[0.9998012,0.000058343685,0.00003841281,0.00003368202,0.000035307847,0.000033129672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003675913,0.0003244773,0.00038785735,0.0003055799,0.0003315143,0.00064038043,0.00033986542,0.000630842,0.0028543128],"category_scores_gemma":[0.0002566054,0.00021966331,0.000532414,0.00035120468,0.00020458316,0.00021748678,0.00040157748,0.0007002134,0.0015095946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024315515,0.00003747068,0.002398829,0.00015499453,0.000032682972,0.00015078735,0.000065390544,0.0011089443,0.98857296,0.0004207796,0.0015398157,0.0052741785],"study_design_scores_gemma":[0.00008742425,0.0006915666,0.08813666,0.000060496746,0.00012655611,0.0017887127,0.00017044757,0.030373372,0.8293583,0.00087717344,0.048256923,0.00007249798],"about_ca_topic_score_codex":0.0010498667,"about_ca_topic_score_gemma":0.002181538,"teacher_disagreement_score":0.0028543128,"about_ca_system_score_codex":0.00028286886,"about_ca_system_score_gemma":0.00037661614,"threshold_uncertainty_score":0.009548664},"labels":[],"label_agreement":null},{"id":"W4281863931","doi":"10.1093/neuonc/noac079.472","title":"NFB-08. TRAM-01: A Phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IWK Foundation; BC Children's Hospital; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Neurofibromatosis; Trametinib; Adverse effect; Dysgeusia; Surgery; Internal medicine; Radiology","score_opus":0.02761007312132264,"score_gpt":0.32906746521333063,"score_spread":0.301457392092008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281863931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943117,0.0023276024,0.0004222019,0.00027736457,0.00003715875,0.00092070753,0.00072658446,0.000074722826,0.0009019794],"genre_scores_gemma":[0.9888709,0.0022309904,0.002353636,0.0005497345,0.00007213671,0.0018377776,0.0024061834,0.00002925143,0.0016492727],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979097,0.000086005726,0.0000117022055,0.000035808713,0.00003185227,0.000043772572],"domain_scores_gemma":[0.99964404,0.00004051657,0.00007902797,0.000019832487,0.00002529239,0.00019132404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011664912,0.00097312743,0.0010616817,0.00027356722,0.0002421167,0.0005917958,0.0005964109,0.0007301039,0.002160953],"category_scores_gemma":[0.0005093463,0.0003773279,0.0006603436,0.00029966034,0.00041112927,0.00054083526,0.00027459968,0.0019982469,0.000540017],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43462065,0.10766927,0.035148114,0.0016637059,0.0024751315,0.0014371506,0.0007611482,0.0049583823,0.082409084,0.00063238636,0.011410856,0.31681406],"study_design_scores_gemma":[0.4695518,0.4500517,0.056423225,0.000093768445,0.0007199532,0.0030086122,0.00012909835,0.0037602235,0.007988049,0.00021753261,0.008006009,0.00004991302],"about_ca_topic_score_codex":0.0011467421,"about_ca_topic_score_gemma":0.0026615786,"teacher_disagreement_score":0.002160953,"about_ca_system_score_codex":0.0007808581,"about_ca_system_score_gemma":0.001389927,"threshold_uncertainty_score":0.0072291493},"labels":[],"label_agreement":null},{"id":"W4281875960","doi":"10.1093/neuonc/noac079.547","title":"OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Physical medicine and rehabilitation; Physical therapy","score_opus":0.039775396692827286,"score_gpt":0.35168583339705556,"score_spread":0.31191043670422824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281875960","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80249166,0.0032233333,0.01925101,0.0028561302,0.0007354022,0.010591323,0.060200617,0.0019798267,0.098670736],"genre_scores_gemma":[0.86669534,0.0027273076,0.07362526,0.0012114063,0.00014336179,0.010841814,0.03106331,0.00030801696,0.0133840935],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978167,0.0005899485,0.0004985539,0.00016750873,0.0007669741,0.00016040752],"domain_scores_gemma":[0.9946602,0.00086904183,0.0019361102,0.00017581983,0.001854175,0.0005047766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003266437,0.00047900993,0.00066135766,0.0014846263,0.00028619627,0.0006668577,0.0009321163,0.00044908933,0.005577256],"category_scores_gemma":[0.007975116,0.00015503484,0.00076306105,0.0007677484,0.00030386727,0.0007751191,0.0011023738,0.0009542715,0.0017132602],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010036083,0.00079779193,0.6659969,0.00087582076,0.00026094328,0.0005255779,0.00068378553,0.0017435144,0.0026522996,0.0012962692,0.08681544,0.23734799],"study_design_scores_gemma":[0.00022198638,0.000976226,0.96109533,0.00029618386,0.00009962995,0.0010940472,0.00052902394,0.0020490843,0.0018057032,0.0004624639,0.031297583,0.00007279676],"about_ca_topic_score_codex":0.004137401,"about_ca_topic_score_gemma":0.0074017146,"teacher_disagreement_score":0.005577256,"about_ca_system_score_codex":0.0010891042,"about_ca_system_score_gemma":0.0015965778,"threshold_uncertainty_score":0.018657804},"labels":[],"label_agreement":null},{"id":"W4281885836","doi":"10.1093/neuonc/noac079.042","title":"RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Craniopharyngioma; Medicine; Cohort; Radiation therapy; Quality of life (healthcare); Surgery; Cohort study; Chemotherapy; Retrospective cohort study; Comorbidity; Internal medicine; Pediatrics","score_opus":0.09912414256084784,"score_gpt":0.35376999917756696,"score_spread":0.2546458566167191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281885836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88241976,0.0076732542,0.0024824243,0.0027049063,0.00021630079,0.0006435514,0.09831463,0.0000824104,0.005462769],"genre_scores_gemma":[0.9238304,0.003649689,0.005601166,0.0014532143,0.00014301059,0.0018103169,0.06265876,0.00007524387,0.000778218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681085,0.0010060712,0.0007948265,0.00056730275,0.000555684,0.0002652555],"domain_scores_gemma":[0.9884865,0.0020419122,0.0050716554,0.0011408326,0.0023986888,0.0008603456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049732523,0.0002699451,0.0005773566,0.001620481,0.00067336444,0.0011060244,0.00075274176,0.00029385713,0.0023788544],"category_scores_gemma":[0.011222702,0.00020246312,0.0008204975,0.0027990218,0.00019720702,0.000895079,0.0009145514,0.00056565675,0.0005327996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010517471,0.000021475487,0.9866571,0.0002964495,0.00020789292,0.00019823534,0.00020797127,0.000068319096,0.00024918787,0.00014587032,0.0042418754,0.0076005217],"study_design_scores_gemma":[0.000021476637,0.000055290733,0.99135524,0.0003008145,0.00010588393,0.0005335753,0.00050783425,0.00009983893,0.00013247566,0.00013037765,0.0067454614,0.000011770875],"about_ca_topic_score_codex":0.028021615,"about_ca_topic_score_gemma":0.051897228,"teacher_disagreement_score":0.028021615,"about_ca_system_score_codex":0.0011691215,"about_ca_system_score_gemma":0.002472483,"threshold_uncertainty_score":0.05571699},"labels":[],"label_agreement":null},{"id":"W4281887121","doi":"10.1093/neuonc/noac079.233","title":"HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Tropomyosin receptor kinase A; Confidence interval; Clinical endpoint; Oncology; Gastroenterology; Neurotrophin; Surgery; Clinical trial; Receptor","score_opus":0.008306892474957191,"score_gpt":0.24107876995063443,"score_spread":0.23277187747567724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281887121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884976,0.008360616,0.00023026232,0.00022241022,0.000032561766,0.00020007044,0.00089957676,0.000050541174,0.0015065005],"genre_scores_gemma":[0.99422014,0.002603503,0.00043936836,0.00028281583,0.000041503394,0.00017280948,0.0015571798,0.000010915678,0.0006717574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999711,0.0001189643,0.000023040693,0.000041684238,0.000053903714,0.00005146345],"domain_scores_gemma":[0.9995876,0.000076749784,0.00014906867,0.000021354414,0.0000435473,0.000121710174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006966315,0.00027883556,0.0008818985,0.00017277837,0.00012938224,0.00036225785,0.00025766325,0.00037084433,0.001410247],"category_scores_gemma":[0.0007713788,0.00014080707,0.00048817068,0.0003133651,0.00026040708,0.00029464456,0.0001715632,0.0009028749,0.00042886595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17942119,0.0066962354,0.16225564,0.0027714458,0.0018646806,0.0022325043,0.00069238484,0.0039635613,0.06609896,0.00036884355,0.015128587,0.5585061],"study_design_scores_gemma":[0.06569717,0.32095253,0.54879314,0.00041463212,0.0018795177,0.006601561,0.000277559,0.0034115687,0.021489149,0.0002565403,0.030157495,0.00006907922],"about_ca_topic_score_codex":0.001042519,"about_ca_topic_score_gemma":0.002566315,"teacher_disagreement_score":0.001410247,"about_ca_system_score_codex":0.00066434726,"about_ca_system_score_gemma":0.0006163691,"threshold_uncertainty_score":0.0048202276},"labels":[],"label_agreement":null},{"id":"W4281901111","doi":"10.1093/neuonc/noac079.198","title":"GCT-04. Pattern of Treatment Failures in Central Nervous System Non-Germinomatous Germ Cell Tumors (CNS-NGGCT): A Pooled Analysis of Clinical Trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Cohort; Cog; Central nervous system; Germ cell tumors; Clinical trial; Oncology; Disease; Chemotherapy","score_opus":0.05428292682633083,"score_gpt":0.3703771646224035,"score_spread":0.31609423779607265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281901111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72192067,0.26052707,0.0040252954,0.0005534631,0.00024203955,0.0008570533,0.009091371,0.00016512134,0.0026178965],"genre_scores_gemma":[0.9881356,0.0073173754,0.000777645,0.00022596307,0.00009121222,0.0004628414,0.0026782698,0.000035415575,0.00027580687],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.978924,0.014666511,0.0026681884,0.002051159,0.001354633,0.00033562595],"domain_scores_gemma":[0.9803185,0.011585085,0.005643745,0.0012930437,0.0006975002,0.00046199816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019997068,0.00089035736,0.0041817017,0.002472194,0.00021932596,0.0019448847,0.0006616769,0.00091282075,0.0018346633],"category_scores_gemma":[0.019541629,0.00037061214,0.011054511,0.003031028,0.00035813215,0.0008144609,0.00080452935,0.0006022092,0.00021106069],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08611013,0.0001717357,0.22860143,0.010792954,0.62479997,0.00020568972,0.00011312164,0.0027747785,0.0019504487,0.00017615939,0.0017300383,0.042573564],"study_design_scores_gemma":[0.014343787,0.010533648,0.398114,0.0014560365,0.5632274,0.0007981675,0.00022888566,0.00374734,0.0012018398,0.0007122532,0.0055426,0.000094044204],"about_ca_topic_score_codex":0.00050059083,"about_ca_topic_score_gemma":0.00076799834,"teacher_disagreement_score":0.019997068,"about_ca_system_score_codex":0.00056786777,"about_ca_system_score_gemma":0.0005946202,"threshold_uncertainty_score":0.105755925},"labels":[],"label_agreement":null},{"id":"W4281904723","doi":"10.1093/neuonc/noac079.702","title":"INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuropsychology; Medicine; Medulloblastoma; Radiation therapy; Cognition; Pediatrics; Psychiatry; Surgery; Pathology","score_opus":0.029520625663199684,"score_gpt":0.3227030704319748,"score_spread":0.29318244476877514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281904723","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12576939,0.62042457,0.004014504,0.10484959,0.0056750174,0.00035231138,0.013933977,0.0012983896,0.123682186],"genre_scores_gemma":[0.38891834,0.51595134,0.026258739,0.02226722,0.005241668,0.00066509313,0.018264253,0.0005181127,0.021915218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994035,0.00019476085,0.00007665666,0.000059491504,0.00017876216,0.00008696806],"domain_scores_gemma":[0.9956601,0.00077675073,0.0008171487,0.00014017988,0.0013415247,0.0012642049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026521096,0.00030514578,0.00047072343,0.0005242999,0.0003033104,0.0012768905,0.00085293147,0.0007496139,0.014085833],"category_scores_gemma":[0.006113668,0.000116286465,0.0006762401,0.00090753764,0.00041027067,0.0008912418,0.0014274163,0.0016955957,0.0034218698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088608684,0.00020625009,0.019244187,0.0023202095,0.00013493665,0.00014083584,0.00015620328,0.00035008483,0.0006402902,0.0023443466,0.0767014,0.89687526],"study_design_scores_gemma":[0.0007088915,0.005065229,0.18404858,0.010296714,0.00050233933,0.0021054,0.0005883641,0.00054391514,0.0033090573,0.0036421472,0.78910697,0.0000823291],"about_ca_topic_score_codex":0.0033552991,"about_ca_topic_score_gemma":0.008721981,"teacher_disagreement_score":0.014085833,"about_ca_system_score_codex":0.0015691678,"about_ca_system_score_gemma":0.0039882245,"threshold_uncertainty_score":0.047121823},"labels":[],"label_agreement":null},{"id":"W4281909587","doi":"10.1093/neuonc/noac079.413","title":"MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"GLI2; Cancer research; Carcinogenesis; Medulloblastoma; Biology; Embryonic stem cell; MAPK/ERK pathway; Population; Cell biology; Medicine; Sonic hedgehog; Genetics; Signal transduction; Cancer","score_opus":0.04233833967915349,"score_gpt":0.30549004933970997,"score_spread":0.26315170966055645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281909587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492724,0.015776372,0.0051363125,0.0014935752,0.0002507323,0.00020710453,0.005453081,0.00071852695,0.021691877],"genre_scores_gemma":[0.98706114,0.0025787926,0.0010238973,0.00027555562,0.00002135581,0.00006533888,0.0026238756,0.000036536272,0.006313513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986446,0.0000131047,0.000009482631,0.000028458895,0.00004401226,0.000040424682],"domain_scores_gemma":[0.9999305,0.00000421468,0.000020805019,0.0000063200728,0.0000065966265,0.0000315772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014295611,0.000364197,0.00023425954,0.00042403367,0.00030330577,0.0003755757,0.00024790323,0.0003297215,0.004657961],"category_scores_gemma":[0.000088338296,0.00018277587,0.00027568228,0.0001951647,0.00026350198,0.0001482296,0.0003603505,0.0006398256,0.002136409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041395743,0.00009281942,0.0028700915,0.00025459935,0.000023743863,0.001177954,0.000033946093,0.0002617048,0.9836916,0.0019622475,0.0011249251,0.008092477],"study_design_scores_gemma":[0.00020148703,0.0008807603,0.07136142,0.00010912742,0.00009448281,0.007478174,0.00019413886,0.0040547056,0.83095986,0.0016685968,0.08296868,0.000028516662],"about_ca_topic_score_codex":0.0014547491,"about_ca_topic_score_gemma":0.00163524,"teacher_disagreement_score":0.004657961,"about_ca_system_score_codex":0.0007616204,"about_ca_system_score_gemma":0.00033177802,"threshold_uncertainty_score":0.015582383},"labels":[],"label_agreement":null},{"id":"W4281927392","doi":"10.1093/neuonc/noac079.306","title":"IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Centre hospitalier de l'Université Laval; CancerCare Manitoba; London Health Sciences Centre; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Pembrolizumab; Blockade; Ipilimumab; Nivolumab; Internal medicine; Oncology; Progression-free survival; Gastroenterology; Surgery; Immunotherapy; Overall survival; Cancer","score_opus":0.04748209181420845,"score_gpt":0.3231993565652041,"score_spread":0.27571726475099567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281927392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767786,0.0014818256,0.00016141808,0.00007502157,0.000018383618,0.00008695163,0.00015000744,0.000022190889,0.00032625385],"genre_scores_gemma":[0.9976712,0.0009181974,0.00031326286,0.00010188153,0.00003912954,0.00006851238,0.00045001783,0.0000071525583,0.00043061402],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973136,0.000118134056,0.000019270514,0.00005555858,0.000023867024,0.000051846426],"domain_scores_gemma":[0.9995042,0.00008123198,0.00008422802,0.000076367825,0.000036095873,0.00021779686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013108342,0.0008068575,0.0010905457,0.0002633254,0.00019378049,0.00071032875,0.0005763851,0.00053635024,0.0014756185],"category_scores_gemma":[0.0004140074,0.00021502035,0.00076763396,0.00026950383,0.0004569843,0.00037374912,0.000190285,0.001661276,0.00043796396],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4944749,0.0972165,0.038248744,0.0013610643,0.0024770575,0.00091545965,0.00045279678,0.0037854535,0.12256978,0.00024845125,0.0032060521,0.23504381],"study_design_scores_gemma":[0.069011286,0.8516499,0.04948898,0.000080137186,0.0015154849,0.0014307466,0.00014077828,0.0027033023,0.02091473,0.00009653732,0.0029269333,0.00004113928],"about_ca_topic_score_codex":0.0008647092,"about_ca_topic_score_gemma":0.001159529,"teacher_disagreement_score":0.0014756185,"about_ca_system_score_codex":0.00063872465,"about_ca_system_score_gemma":0.0006231353,"threshold_uncertainty_score":0.006932497},"labels":[],"label_agreement":null},{"id":"W4281953957","doi":"10.1093/neuonc/noac079.371","title":"LGG-60. Development and implementation of a complementary diagnostic tool to detect targetable pathways in pediatric glioma patients","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Glioma; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Cancer research; Concordance; Medicine; Transcriptome; Biology; Signal transduction; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.019309938076444183,"score_gpt":0.28638215054632143,"score_spread":0.2670722124698772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281953957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587559,0.005717923,0.014299738,0.001978059,0.00024695657,0.00094336644,0.006439195,0.002462631,0.009156162],"genre_scores_gemma":[0.9395373,0.0018794346,0.045104943,0.0016885947,0.0000746166,0.00077610195,0.008279273,0.00020831644,0.002451453],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999298,0.00015089479,0.00004494345,0.00019339201,0.00022301357,0.00008984186],"domain_scores_gemma":[0.9993782,0.00009239175,0.00011524687,0.000047068275,0.00021204665,0.00015509492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014335376,0.00063200045,0.0005815806,0.00094551546,0.00022175611,0.0009126354,0.0004990046,0.0007498769,0.0015208182],"category_scores_gemma":[0.0014265269,0.00021533712,0.00037955336,0.00052882987,0.00033257162,0.00038072673,0.0005509991,0.000562423,0.0012208422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040253806,0.0007265267,0.4820446,0.0005110301,0.00016736108,0.0010513428,0.00039158095,0.0018234648,0.20642385,0.0007041422,0.00979382,0.29233697],"study_design_scores_gemma":[0.0006030281,0.0074775587,0.6585598,0.00041301217,0.000482973,0.0046232087,0.00071029144,0.01664825,0.24033186,0.0014731362,0.06856843,0.000108434084],"about_ca_topic_score_codex":0.0019439602,"about_ca_topic_score_gemma":0.0026278233,"teacher_disagreement_score":0.0019439602,"about_ca_system_score_codex":0.00084731425,"about_ca_system_score_gemma":0.0009100209,"threshold_uncertainty_score":0.007581353},"labels":[],"label_agreement":null},{"id":"W4281954110","doi":"10.1093/neuonc/noac079.621","title":"LINC-22. Primary central nervous system (CNS) germ cell tumors (GCT) in Central America and the Caribbean region: an AHOPCA 20-year experience","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Headaches; Germ cell tumors; Pediatrics; Epidemiology; Germinoma; Internal medicine; Surgery; Chemotherapy","score_opus":0.012671837209737856,"score_gpt":0.2488739161612729,"score_spread":0.23620207895153505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281954110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583757,0.0020524638,0.000053813743,0.00007704825,0.0000065637882,0.000025481706,0.00008543507,0.000006334091,0.0018553635],"genre_scores_gemma":[0.9969278,0.0020758654,0.00014912002,0.000114246985,0.000015508773,0.000026494288,0.0002276647,0.000005106862,0.0004582328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982077,0.000046023353,0.000018125824,0.000024037607,0.000027811397,0.0000633161],"domain_scores_gemma":[0.99973303,0.000040564253,0.000075582844,0.000014951845,0.000032485434,0.00010328832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002857652,0.00029730695,0.00013038544,0.0005308879,0.0005889586,0.00054969057,0.00024960705,0.00025237675,0.0008385578],"category_scores_gemma":[0.00065956026,0.00011462702,0.0001509354,0.00081249623,0.00030349087,0.00026794657,0.00053653866,0.00016507725,0.00019878508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019815634,0.00032226092,0.9160461,0.0001255851,0.000053685115,0.03201725,0.002012976,0.00014085844,0.0020917598,0.000090905756,0.0010680618,0.045832362],"study_design_scores_gemma":[0.000066479006,0.0011960056,0.9099404,0.0001747861,0.00009683178,0.07191179,0.0047208588,0.0003659258,0.00078959815,0.000072189745,0.010643221,0.00002186801],"about_ca_topic_score_codex":0.014812495,"about_ca_topic_score_gemma":0.02522516,"teacher_disagreement_score":0.014812495,"about_ca_system_score_codex":0.0007562779,"about_ca_system_score_gemma":0.0007203955,"threshold_uncertainty_score":0.029452562},"labels":[],"label_agreement":null},{"id":"W4281996388","doi":"10.1093/neuonc/noac079.339","title":"LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Berlin Institute of Health; Deutschen Konsortium für Translationale Krebsforschung; Freie Universität Berlin; McGill University Health Centre; Deutsches Krebsforschungszentrum; Humboldt-Universität zu Berlin; McGill University","keywords":"MEK inhibitor; In vivo; MAPK/ERK pathway; Trametinib; Cancer research; Pharmacology; Melanoma; Biology; Kinase; Cell biology","score_opus":0.026960471800129882,"score_gpt":0.27030121092381715,"score_spread":0.24334073912368726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281996388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98406094,0.005740099,0.0017818605,0.0002492509,0.000056613582,0.00010844518,0.003028556,0.0006373072,0.0043369182],"genre_scores_gemma":[0.9893854,0.0022889369,0.0016686867,0.000084079256,0.000006182773,0.00008475082,0.0034593951,0.000033314027,0.0029893464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992716,0.000012173834,0.0000049351893,0.000013599115,0.000015669812,0.000026553049],"domain_scores_gemma":[0.9999666,0.0000033991673,0.000006882083,0.000003845005,0.000003212793,0.000016012986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001110341,0.00052719895,0.0002996489,0.00032698148,0.000102472564,0.00026557746,0.0002502168,0.00030910067,0.0015920943],"category_scores_gemma":[0.000054763008,0.00011040053,0.00027824336,0.00021404363,0.00014734674,0.00016012262,0.00010524936,0.0005722986,0.0005622633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015322607,0.00054145046,0.00049936323,0.0001663005,0.000034828834,0.000117196425,0.00001947879,0.00064489397,0.97573584,0.00012062707,0.0014461376,0.019141713],"study_design_scores_gemma":[0.0002522606,0.004969419,0.0061307247,0.000014866657,0.00007644278,0.0005371089,0.000024294495,0.0010706172,0.9788014,0.000042859992,0.008066614,0.000013464403],"about_ca_topic_score_codex":0.0019558792,"about_ca_topic_score_gemma":0.003946265,"teacher_disagreement_score":0.0019558792,"about_ca_system_score_codex":0.00043055625,"about_ca_system_score_gemma":0.00036203398,"threshold_uncertainty_score":0.0053260922},"labels":[],"label_agreement":null},{"id":"W4281998879","doi":"10.1093/neuonc/noac079.569","title":"OTHR-31. The molecular profile of secondary meningiomas in survivors of childhood non-central nervous system (CNS) cancers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Meningioma; Cohort; Medicine; Exome sequencing; Exome; Radiation therapy; Germline mutation; Oncology; Internal medicine; Pathology; Gene; Biology; Mutation; Genetics","score_opus":0.01018043689883057,"score_gpt":0.2464159697532678,"score_spread":0.2362355328544372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281998879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982369,0.00022347513,0.000053647997,0.00002391433,0.0000020323225,0.0000071951085,0.0007753473,0.000009146503,0.0006683743],"genre_scores_gemma":[0.9984297,0.00012310148,0.00010204411,0.000013594428,0.0000024315145,0.0000055139326,0.0008084723,0.000005007649,0.000510158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991393,0.0000058321584,0.00000673417,0.00001932872,0.000025741698,0.000028495691],"domain_scores_gemma":[0.9997019,0.000023729513,0.00012805466,0.000014687328,0.000054081025,0.00007746764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094928386,0.00014690048,0.00015283056,0.00051451207,0.0002743291,0.00021837758,0.00016025125,0.00014954337,0.0023446733],"category_scores_gemma":[0.00038028747,0.000085373686,0.000113157526,0.00046066495,0.00016126478,0.00008560978,0.00017085648,0.00016787142,0.00039874166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031712317,0.00002300275,0.9748274,0.00004261492,0.00002083867,0.0012036482,0.00015148842,0.00009422587,0.016620083,0.000035856967,0.00033153847,0.0063321344],"study_design_scores_gemma":[0.0000043529953,0.00008579678,0.99426794,0.0000056095796,0.000014732906,0.0024720645,0.00009530389,0.0000717766,0.0022695956,0.000018062256,0.00069261075,0.0000020650687],"about_ca_topic_score_codex":0.014304548,"about_ca_topic_score_gemma":0.017739573,"teacher_disagreement_score":0.014304548,"about_ca_system_score_codex":0.0005340554,"about_ca_system_score_gemma":0.00045856964,"threshold_uncertainty_score":0.028442562},"labels":[],"label_agreement":null},{"id":"W4282002300","doi":"10.1093/neuonc/noac079.284","title":"IMG-08. Response assessment for pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Clinical trial; Radiation therapy; Radiological weapon; Magnetic resonance imaging; Prospective cohort study; Natural history study; Radiology; Internal medicine; Oncology; Disease","score_opus":0.03229251964687891,"score_gpt":0.34545194753579966,"score_spread":0.31315942788892076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282002300","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016154988,0.19115098,0.061508585,0.5759717,0.0151256705,0.027411027,0.016510062,0.0042772666,0.09188975],"genre_scores_gemma":[0.06727365,0.12881686,0.4702876,0.1772317,0.01117812,0.06724246,0.051864758,0.0025959115,0.02350904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9444747,0.029110113,0.0134317065,0.00180941,0.008812031,0.00236212],"domain_scores_gemma":[0.88837737,0.02871337,0.020150559,0.0034618394,0.049462218,0.009834627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.102964535,0.0024089795,0.0050425734,0.0066719614,0.0014348426,0.0043943054,0.010292147,0.010935234,0.0040627704],"category_scores_gemma":[0.0940833,0.0010616386,0.00675357,0.004739987,0.0019132784,0.0035015463,0.006467086,0.0091163935,0.00865271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010508602,0.0006623535,0.010597349,0.008502946,0.00061341893,0.00029061412,0.00062623405,0.003326775,0.001384318,0.004635627,0.48393872,0.48437083],"study_design_scores_gemma":[0.0013347572,0.0014339833,0.032094553,0.0531201,0.0015929085,0.00080022105,0.0008885021,0.0046512047,0.0021919648,0.007295207,0.89436054,0.00023609953],"about_ca_topic_score_codex":0.0058598467,"about_ca_topic_score_gemma":0.0043193717,"teacher_disagreement_score":0.102964535,"about_ca_system_score_codex":0.0067128013,"about_ca_system_score_gemma":0.01679989,"threshold_uncertainty_score":0.54453504},"labels":[],"label_agreement":null},{"id":"W4282023526","doi":"10.1093/neuonc/noac079.044","title":"RARE-19. Molecular characterization and treatment response of metastatic DIA/DIG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Vincristine; Carboplatin; Adjuvant therapy; Adjuvant; Surgery; Chemotherapy; Oncology; Internal medicine; Cisplatin; Cyclophosphamide","score_opus":0.02463289840132039,"score_gpt":0.30055116228849293,"score_spread":0.27591826388717255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282023526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917675,0.0019710138,0.00083956996,0.00018332429,0.000019710476,0.000042159958,0.0005567783,0.000059233556,0.0045605656],"genre_scores_gemma":[0.9972715,0.00031859466,0.000875243,0.00006306288,0.000018351364,0.000017004868,0.0007180446,0.000011762101,0.00070656283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997875,0.000019100027,0.000030415002,0.000053542528,0.000053335618,0.00005602076],"domain_scores_gemma":[0.99964786,0.0000632591,0.000118951124,0.000025253124,0.00006141536,0.00008333774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017406368,0.00025671208,0.00026955444,0.00053731276,0.0002588138,0.0003935311,0.0002817841,0.00048433268,0.0014421495],"category_scores_gemma":[0.0005864696,0.00011335213,0.00020984127,0.00029955778,0.00026228934,0.00017944019,0.00017744473,0.00030200183,0.00047471488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012081097,0.00018954184,0.48878226,0.00037289792,0.00009055104,0.2071154,0.00047522722,0.0011494677,0.24538282,0.0009800062,0.0016827225,0.05257114],"study_design_scores_gemma":[0.000057824807,0.0012778029,0.32062995,0.000046077166,0.0001232045,0.58815247,0.00033617445,0.0023503904,0.07488723,0.00035939715,0.011755413,0.000024088558],"about_ca_topic_score_codex":0.0013504506,"about_ca_topic_score_gemma":0.0014271847,"teacher_disagreement_score":0.0014421495,"about_ca_system_score_codex":0.0005885647,"about_ca_system_score_gemma":0.00022712392,"threshold_uncertainty_score":0.004824519},"labels":[],"label_agreement":null},{"id":"W4286615423","doi":"10.1093/neuonc/noac180","title":"Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Centre Léon Bérard","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Concomitant; Oncology; Metastatic breast cancer; Clinical endpoint; Brain metastasis; Cancer; Quality of life (healthcare); Metastasis; Radiation therapy; Population; Phases of clinical research; Chemotherapy; Clinical trial","score_opus":0.015089337099935058,"score_gpt":0.31592942794437523,"score_spread":0.3008400908444402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286615423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957443,0.0006072208,0.00051561836,0.00016825061,0.000039046365,0.0018154007,0.00027096158,0.000024806553,0.0008142426],"genre_scores_gemma":[0.9927834,0.00075562554,0.0012527583,0.0004264916,0.00007154829,0.0025694638,0.0010303862,0.000012317943,0.0010978754],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997738,0.000111028385,0.000010298382,0.000034844797,0.000022584294,0.000047525325],"domain_scores_gemma":[0.9996481,0.000053130505,0.00006721054,0.000041342853,0.000032774708,0.00015742425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008669875,0.0008362899,0.00109952,0.00022166733,0.00025834586,0.00049938913,0.0005469465,0.00059368636,0.0017196956],"category_scores_gemma":[0.0006166656,0.0003043062,0.0004638302,0.00028573224,0.0004553328,0.00034358355,0.00021294298,0.0017958243,0.0003973917],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43666303,0.20970984,0.022923877,0.00090210664,0.0011161772,0.0008242872,0.0006725038,0.003943277,0.183924,0.00039041424,0.0035997322,0.13533074],"study_design_scores_gemma":[0.3243806,0.63385755,0.022792356,0.000040958726,0.00041396564,0.00065400405,0.000091756,0.0019311106,0.011801565,0.00015852852,0.0038573367,0.000020300145],"about_ca_topic_score_codex":0.00064210605,"about_ca_topic_score_gemma":0.0010444989,"teacher_disagreement_score":0.0017196956,"about_ca_system_score_codex":0.0005419145,"about_ca_system_score_gemma":0.0012524442,"threshold_uncertainty_score":0.005752921},"labels":[],"label_agreement":null},{"id":"W4289100902","doi":"10.1093/neuonc/noac188","title":"EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; LEO Pharma; Servier; Associazione Italiana per la Ricerca sul Cancro; Sanofi; Brain Tumour Charity; Agios Pharmaceuticals; Novocure; Genentech; Y-mAbs Therapeutics; BeiGene; National Cancer Institute; Medac; European Federation of Pharmaceutical Industries and Associations; Fondazione Italiana per la Ricerca sul Cancro; Pfizer; BioClinica; AstraZeneca; American Society of Clinical Oncology","keywords":"Glioma; Medicine; Oligodendroglioma; Pathology; Astrocytoma; Cancer research","score_opus":0.04568042957002215,"score_gpt":0.3217638257064698,"score_spread":0.2760833961364476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289100902","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075578946,0.4793229,0.026368989,0.1426993,0.07127336,0.0020755609,0.013207388,0.0013921694,0.25610247],"genre_scores_gemma":[0.032020394,0.5101866,0.08351635,0.1326562,0.028953377,0.0048457156,0.046884056,0.0014615221,0.15947573],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996911,0.0006638186,0.00087262504,0.00018992611,0.0010388376,0.0003238161],"domain_scores_gemma":[0.99398357,0.0012050626,0.00096920505,0.00022158779,0.0030619355,0.00055868365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004072632,0.0013441625,0.0012628464,0.005238491,0.0007469709,0.0018165611,0.002654756,0.003695496,0.006238982],"category_scores_gemma":[0.007630892,0.00041240934,0.0019356507,0.0035341645,0.0015542974,0.0017711653,0.0022509722,0.0036937215,0.007362664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001129257,0.00007215385,0.0018539712,0.0026724453,0.000045673474,0.00092068216,0.00019772747,0.0006187092,0.0017136032,0.0082729105,0.7863408,0.19717851],"study_design_scores_gemma":[0.00002052285,0.000026107371,0.0018451296,0.0032821707,0.000031429932,0.001477329,0.000095015865,0.00011676624,0.00019080307,0.0027995568,0.99009913,0.000015981002],"about_ca_topic_score_codex":0.012642847,"about_ca_topic_score_gemma":0.018150736,"teacher_disagreement_score":0.012642847,"about_ca_system_score_codex":0.0023735214,"about_ca_system_score_gemma":0.008856647,"threshold_uncertainty_score":0.025138557},"labels":[],"label_agreement":null},{"id":"W4294679016","doi":"10.1093/neuonc/noac174.281","title":"P13.01.A Challenges and Solutions for Establishing a CNS Tumor Registry in Africa","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Pathological; Developing country; Incidence (geometry); Pathology; Economic growth","score_opus":0.06946607252400029,"score_gpt":0.30330116276196983,"score_spread":0.23383509023796956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294679016","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011557307,0.080262415,0.019802114,0.8042889,0.01413489,0.0011993387,0.022087395,0.0009450012,0.045722675],"genre_scores_gemma":[0.25898555,0.28277004,0.2067881,0.15413508,0.017660877,0.0057076127,0.047298826,0.001394494,0.0252595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98254323,0.010114789,0.0030144441,0.0013065228,0.0018440569,0.0011770625],"domain_scores_gemma":[0.828231,0.0976012,0.01648245,0.008036519,0.037301257,0.012347602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03439481,0.00056256645,0.0011093393,0.0073185787,0.002265181,0.007836101,0.003456262,0.004077259,0.03907679],"category_scores_gemma":[0.108016945,0.0006136897,0.0016067437,0.009857281,0.0018532304,0.020780541,0.0052859676,0.004977492,0.010313886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021132291,0.00015711435,0.021020547,0.016730232,0.00016759624,0.0020545165,0.0022829364,0.00059690984,0.0006850282,0.04365887,0.42677304,0.48566192],"study_design_scores_gemma":[0.00006701371,0.00009960769,0.01057018,0.023522567,0.00012489053,0.001989699,0.0074510225,0.00080269604,0.0005350098,0.021382766,0.93336076,0.000093813935],"about_ca_topic_score_codex":0.010654707,"about_ca_topic_score_gemma":0.0086782295,"teacher_disagreement_score":0.03907679,"about_ca_system_score_codex":0.0028616795,"about_ca_system_score_gemma":0.032675136,"threshold_uncertainty_score":0.18189937},"labels":[],"label_agreement":null},{"id":"W4294680146","doi":"10.1093/neuonc/noac174.233","title":"P11.44.A The impact of heme biosynthesis regulation on glioma aggressiveness: correlations with most recent diagnostic molecular markers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Biology; Heme; Biosynthesis; Cancer research; Gene; Genetics; Biochemistry; Enzyme","score_opus":0.014628132194430687,"score_gpt":0.28485870768444616,"score_spread":0.27023057549001545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294680146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481505,0.0009495329,0.0006602574,0.00008327636,0.000012812222,0.000012699503,0.00211206,0.00003090563,0.0013233419],"genre_scores_gemma":[0.99738485,0.00022209086,0.00033491716,0.000020070544,0.00001765837,0.000012454789,0.0016297438,0.000010586737,0.00036749005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997758,0.00003792723,0.000025321355,0.00007236112,0.000044945777,0.00004364965],"domain_scores_gemma":[0.99915993,0.00020300139,0.00038898565,0.000044101456,0.00008438487,0.000119672295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023068393,0.00026007433,0.00027817572,0.0008767174,0.00021768427,0.00060051464,0.00016862879,0.00023150558,0.0028035867],"category_scores_gemma":[0.00084646366,0.00008953579,0.00024198284,0.0011567804,0.00020465886,0.00016929788,0.00023967611,0.00030481347,0.0006267871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008131454,0.00003160558,0.9752611,0.0000628181,0.00012183776,0.00086976297,0.000037871938,0.00023310618,0.0095686205,0.0000806522,0.000504352,0.012415049],"study_design_scores_gemma":[0.000008840417,0.000085073305,0.993082,0.000008792961,0.000108190914,0.0024556145,0.000063325446,0.00063149916,0.0018725538,0.00017630524,0.0015019656,0.0000059546446],"about_ca_topic_score_codex":0.0010189736,"about_ca_topic_score_gemma":0.0008655231,"teacher_disagreement_score":0.0028035867,"about_ca_system_score_codex":0.000184848,"about_ca_system_score_gemma":0.00022414266,"threshold_uncertainty_score":0.00937897},"labels":[],"label_agreement":null},{"id":"W4294682852","doi":"10.1093/neuonc/noac174.138","title":"P07.06.B The Impact of Using Intraoperative Ultrasound on Surgical Resection of High-Grade Glioma: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Systematic review; MEDLINE; Study heterogeneity; Resection; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.13871388304492588,"score_gpt":0.42595199513707,"score_spread":0.2872381120921441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294682852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053329263,0.9868123,0.0015095483,0.0007824412,0.0004961229,0.0009930548,0.0031105469,0.0000729331,0.00089010404],"genre_scores_gemma":[0.2378199,0.739022,0.0077580083,0.0024530268,0.0009451692,0.007238497,0.0032951836,0.000106843094,0.0013612716],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9858063,0.0071506286,0.0033350012,0.0013061253,0.0018815767,0.0005203984],"domain_scores_gemma":[0.9724033,0.020960206,0.0037764187,0.0006792972,0.0018788383,0.00030192913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01595975,0.0023692788,0.011554636,0.0082984865,0.0006922243,0.0046250443,0.002446955,0.003129269,0.01306193],"category_scores_gemma":[0.03736925,0.0014474909,0.039761785,0.010634329,0.0009868245,0.0028533547,0.0015766758,0.0022431156,0.0009961468],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014419918,0.000029124729,0.004381893,0.6129364,0.36719546,0.00014868075,0.00008447049,0.00035816364,0.00018084724,0.0002444934,0.0017369492,0.011261508],"study_design_scores_gemma":[0.0012847253,0.00025286517,0.0071361586,0.07366324,0.9115509,0.00020588908,0.000097388765,0.00038483823,0.00014740156,0.0005493848,0.0046843025,0.00004296086],"about_ca_topic_score_codex":0.005147351,"about_ca_topic_score_gemma":0.007841233,"teacher_disagreement_score":0.01595975,"about_ca_system_score_codex":0.0020395236,"about_ca_system_score_gemma":0.004635591,"threshold_uncertainty_score":0.08440423},"labels":[],"label_agreement":null},{"id":"W4294683598","doi":"10.1093/neuonc/noac174.222","title":"P11.33.B Tumour Treating Fields (TTFields; 200 kHz) with chemo-radiation and maintenance TTFields/temozolomide as first-line treatment for newly-diagnosed glioblastoma: The phase 3 TRIDENT Trial (EF-32)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Clinical endpoint; Clinical trial; Concomitant; Phases of clinical research; Cancer; Adverse effect; Progression-free survival; Radiation therapy; Surgery; Chemotherapy","score_opus":0.02202927441482746,"score_gpt":0.3144258127881759,"score_spread":0.29239653837334845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294683598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96970505,0.0071092164,0.0010846864,0.0018512481,0.00054487697,0.0047579594,0.0057804384,0.00037894002,0.00878751],"genre_scores_gemma":[0.9626697,0.0043408833,0.002949261,0.0024892697,0.00025264418,0.0067049437,0.00767876,0.000101326776,0.012813212],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999824,0.00006491858,0.000008625939,0.00003514803,0.000020575193,0.00004683042],"domain_scores_gemma":[0.9997464,0.000025062755,0.000053054308,0.000017686496,0.000018122817,0.0001396569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009807766,0.0008465338,0.0009996092,0.0003408307,0.00031958148,0.00067308435,0.0005142672,0.000918401,0.010365779],"category_scores_gemma":[0.00041522054,0.00031971373,0.0007508823,0.00033888008,0.0006058753,0.0005629607,0.00026993224,0.002415588,0.0016909424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7871776,0.02254838,0.0030075186,0.001420618,0.0009663836,0.00026050824,0.0001272019,0.0015447024,0.04245086,0.0010567694,0.020183397,0.119256094],"study_design_scores_gemma":[0.7077652,0.25977948,0.008956508,0.0001664885,0.0006361994,0.00050903956,0.00006105484,0.00121493,0.004725558,0.0010208403,0.015126383,0.000038407925],"about_ca_topic_score_codex":0.0011262199,"about_ca_topic_score_gemma":0.0031378816,"teacher_disagreement_score":0.010365779,"about_ca_system_score_codex":0.0006210941,"about_ca_system_score_gemma":0.0011894006,"threshold_uncertainty_score":0.03467703},"labels":[],"label_agreement":null},{"id":"W4294684310","doi":"10.1093/neuonc/noac174.050","title":"OS07.5.A Report from the pooled analysis of the randomized trials NORDIC, NOA-8 and CE.6 on elderly patients with glioblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; University of Toronto; Queen's University","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Internal medicine; Randomized controlled trial; Glioblastoma; Radiation therapy; Clinical trial; Oncology; Quality of life (healthcare); Pooled analysis; Overall survival; Confidence interval","score_opus":0.01790241735507129,"score_gpt":0.2887873855189513,"score_spread":0.27088496816387997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294684310","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17845759,0.6374819,0.0100503005,0.0032808213,0.0030247336,0.007063027,0.15120843,0.0004813386,0.008951855],"genre_scores_gemma":[0.7702304,0.09588839,0.010479223,0.00506622,0.0016316766,0.01639546,0.0959832,0.00046002003,0.0038653968],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.953137,0.035092466,0.005528533,0.0026784104,0.002808159,0.0007554641],"domain_scores_gemma":[0.96281683,0.021952061,0.009436888,0.002755303,0.0024378528,0.00060099165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051535286,0.002208723,0.009201007,0.0026636058,0.00038130028,0.0024788387,0.0012841626,0.0018130454,0.004310982],"category_scores_gemma":[0.054793358,0.0009502093,0.02344181,0.003522762,0.0004921943,0.0010910939,0.0015760117,0.0016787298,0.0005150165],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23940364,0.00018707021,0.020751623,0.08240989,0.59036636,0.00019826174,0.00012725512,0.0031469073,0.0008273785,0.00092265016,0.022968818,0.03869014],"study_design_scores_gemma":[0.11360696,0.0056850384,0.0497742,0.008040447,0.7926905,0.0003436981,0.00013535007,0.0014194262,0.00093291845,0.0013348124,0.025857085,0.00017945495],"about_ca_topic_score_codex":0.0033869108,"about_ca_topic_score_gemma":0.0060319323,"teacher_disagreement_score":0.051535286,"about_ca_system_score_codex":0.0016426546,"about_ca_system_score_gemma":0.0024700097,"threshold_uncertainty_score":0.27254796},"labels":[],"label_agreement":null},{"id":"W4294685605","doi":"10.1093/neuonc/noac174.033","title":"OS02.5.A Alzheimer-type neuropathological changes in glioblastoma-adjacent cortex","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropathology; Pathology; Neuropil; Medicine; Neurology; Cerebral amyloid angiopathy; Amyloid (mycology); Neurochemistry; Internal medicine; Dementia; Central nervous system; Disease; Psychiatry","score_opus":0.042155248664756555,"score_gpt":0.3241784885956057,"score_spread":0.28202323993084916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294685605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990368,0.00018249894,0.00008083781,0.000006677928,0.0000029209898,0.0000053917656,0.00026876616,0.000008330693,0.00040771943],"genre_scores_gemma":[0.9992524,0.00006684356,0.00010159692,0.000007941771,0.0000024246087,0.000004337226,0.00033993743,0.0000024081046,0.00022216766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999928,0.00000789163,0.00000844608,0.000019516852,0.0000147985575,0.000021384474],"domain_scores_gemma":[0.9997869,0.000012895105,0.0000930852,0.000014301826,0.0000363033,0.00005644352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020104864,0.00020289853,0.00017154815,0.0008510931,0.00028768065,0.00033852423,0.00012820144,0.00013338376,0.0019206731],"category_scores_gemma":[0.0003467812,0.00010448997,0.0001624324,0.0003624456,0.00015417245,0.00010097248,0.00022524792,0.00008937805,0.0003272266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014789996,0.00009883916,0.9231276,0.00006550537,0.00007384483,0.0033428965,0.00014536259,0.00009421266,0.062693544,0.00007755673,0.00036596466,0.0084356535],"study_design_scores_gemma":[0.000007885065,0.00015145274,0.9934382,0.000005970715,0.000025662845,0.0032572132,0.00007538962,0.00014622869,0.0025210467,0.000044619734,0.00032377563,0.000002535645],"about_ca_topic_score_codex":0.0036785454,"about_ca_topic_score_gemma":0.0033438301,"teacher_disagreement_score":0.0036785454,"about_ca_system_score_codex":0.00021913325,"about_ca_system_score_gemma":0.00021188859,"threshold_uncertainty_score":0.0073143244},"labels":[],"label_agreement":null},{"id":"W4294686035","doi":"10.1093/neuonc/noac174.254","title":"P11.65.B GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Agile software development; Medicine; Randomization; Protocol (science); Clinical trial; Biomarker; Medical physics; Oncology; Computer science; Internal medicine; Software engineering; Pathology; Alternative medicine","score_opus":0.4195986878733863,"score_gpt":0.5471289144013946,"score_spread":0.12753022652800827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294686035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96107924,0.0031286785,0.009177602,0.0035673275,0.00064210326,0.007589331,0.0045086727,0.0009825001,0.009324578],"genre_scores_gemma":[0.9605651,0.0013521613,0.0159065,0.003299498,0.00025823648,0.008816245,0.0037314633,0.00020748281,0.005863397],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989266,0.0007056537,0.000038960214,0.0001412763,0.00007694923,0.000110586465],"domain_scores_gemma":[0.99884737,0.00024848725,0.00020543602,0.000115418006,0.000089523965,0.0004937949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035648695,0.00097464485,0.000989238,0.00035202006,0.00032572635,0.0008949123,0.00051007606,0.0007839033,0.0050586616],"category_scores_gemma":[0.0023193373,0.00021173593,0.0012971653,0.0003420196,0.0008029049,0.0006700637,0.0008998742,0.0024972577,0.00080577604],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62175727,0.025146794,0.0065777516,0.0014226341,0.0022637432,0.00031231833,0.00032084284,0.01200129,0.020630362,0.0036294647,0.03319913,0.2727384],"study_design_scores_gemma":[0.60887426,0.32894382,0.015487755,0.0003461804,0.0014391587,0.00038504074,0.00015634728,0.011618443,0.0074236104,0.005840266,0.019380154,0.00010500175],"about_ca_topic_score_codex":0.000949959,"about_ca_topic_score_gemma":0.0016457222,"teacher_disagreement_score":0.0050586616,"about_ca_system_score_codex":0.00071845006,"about_ca_system_score_gemma":0.00210339,"threshold_uncertainty_score":0.018853009},"labels":[],"label_agreement":null},{"id":"W4296781687","doi":"10.1093/neuonc/noac221","title":"Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Clinical trial; Magnetic resonance imaging; Progressive disease; Prospective cohort study; Oncology; Radiology; Internal medicine; Disease","score_opus":0.029395434214440536,"score_gpt":0.33596266804512376,"score_spread":0.30656723383068324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296781687","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018852323,0.21455458,0.08945201,0.5593478,0.0174467,0.022615554,0.008530848,0.002467013,0.06673317],"genre_scores_gemma":[0.08623337,0.1520267,0.54720944,0.13207598,0.009246028,0.037346683,0.020215724,0.0015174572,0.014128651],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9372554,0.03104245,0.01872337,0.0017449412,0.009316596,0.0019173159],"domain_scores_gemma":[0.8346242,0.05291539,0.021493776,0.0052129417,0.07801416,0.00773955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.104826495,0.0017929127,0.0036067069,0.0055931043,0.0019306871,0.0034949156,0.007988902,0.007076626,0.0018797125],"category_scores_gemma":[0.1061195,0.0008929639,0.0069813635,0.0038449646,0.0022284756,0.0035125162,0.004902211,0.01087057,0.0028103187],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007139476,0.0005951223,0.01651023,0.009081091,0.0006894789,0.00047839584,0.0011924949,0.0032997997,0.0021447043,0.0071648364,0.41843832,0.5396916],"study_design_scores_gemma":[0.0008766743,0.0011545892,0.038080316,0.04799603,0.001791524,0.001613416,0.0017161635,0.00441527,0.0036298523,0.010226212,0.88818717,0.0003127477],"about_ca_topic_score_codex":0.007926676,"about_ca_topic_score_gemma":0.0076917405,"teacher_disagreement_score":0.104826495,"about_ca_system_score_codex":0.0052026235,"about_ca_system_score_gemma":0.021989733,"threshold_uncertainty_score":0.5543821},"labels":[],"label_agreement":null},{"id":"W4298395292","doi":"10.1093/neuonc/noac200.023","title":"Health-Related Quality of Life in Patients With High-Grade Glioma: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Checklist; Quality of life (healthcare); Life expectancy; Anxiety; Depression (economics); Physical therapy; Population; Health related quality of life; Mental health; Social support; Gerontology; Psychiatry; Psychology; Internal medicine; Environmental health; Disease","score_opus":0.06730882957820372,"score_gpt":0.365950299012285,"score_spread":0.29864146943408126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298395292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016511315,0.9974788,0.000056972236,0.00015100813,0.000043303276,0.00014822936,0.00032881732,0.0000039025613,0.00013774843],"genre_scores_gemma":[0.036238406,0.96204066,0.00032758212,0.00048506208,0.00007534669,0.00049256446,0.00026322392,0.0000032313485,0.00007384004],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99452245,0.0018633809,0.0020570264,0.0004514948,0.00091437297,0.00019113583],"domain_scores_gemma":[0.9824097,0.011650803,0.004406532,0.00017394795,0.0011648496,0.0001941755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004977844,0.0011443725,0.0069877002,0.007316451,0.00042855126,0.0024400463,0.0013108435,0.0015055235,0.003560289],"category_scores_gemma":[0.023752116,0.00073207135,0.006686359,0.008467814,0.00070046145,0.0017675388,0.0012729586,0.0010321804,0.00018425043],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017871095,0.000017525195,0.0016232891,0.96480376,0.01061121,0.00007867381,0.00012412494,0.0000800279,0.00008753935,0.000089954716,0.0007951561,0.021509994],"study_design_scores_gemma":[0.00047697278,0.00039394997,0.016077306,0.86498046,0.103648,0.0007686613,0.00042636466,0.00013665597,0.00017656403,0.00028937793,0.012569808,0.00005598031],"about_ca_topic_score_codex":0.006639449,"about_ca_topic_score_gemma":0.015472847,"teacher_disagreement_score":0.007316451,"about_ca_system_score_codex":0.00285595,"about_ca_system_score_gemma":0.0055573853,"threshold_uncertainty_score":0.026325643},"labels":[],"label_agreement":null},{"id":"W4300547400","doi":"10.1215/15228517-2008-024","title":"Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Calgary","funders":"US-UK Fulbright Commission; Fulbright Australia; Dana-Farber Cancer Institute","keywords":"Medicine; Pediatric oncology; Medical physics; Oncology; Internal medicine; Cancer","score_opus":0.02651239030925449,"score_gpt":0.290919689644171,"score_spread":0.26440729933491647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300547400","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029001604,0.33598158,0.0043963976,0.045294303,0.3565888,0.0004004678,0.0022299862,0.0007188615,0.2514894],"genre_scores_gemma":[0.0094208475,0.2875361,0.0030939535,0.010855315,0.15849355,0.0003396295,0.003338243,0.00040550798,0.5265169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954754,0.000059542657,0.000050173905,0.00009938063,0.00017943257,0.00006386551],"domain_scores_gemma":[0.99855167,0.00009919681,0.000084963,0.00004805205,0.00066700595,0.00054909853],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088728446,0.0014685848,0.00090644474,0.0018748848,0.0005066265,0.001995514,0.0009793652,0.0016860008,0.11661835],"category_scores_gemma":[0.0013058081,0.00035839784,0.00069984957,0.0008560463,0.00031825824,0.001483411,0.0013079036,0.002849576,0.07910157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008638794,0.00004495377,0.0004325795,0.0004958674,0.000022832204,0.00022601146,0.000029264755,0.00007745545,0.0008553586,0.00078102964,0.79486394,0.20208423],"study_design_scores_gemma":[0.00000937845,0.000025959438,0.0006265181,0.0002936395,0.000015273317,0.000586305,0.00001814092,0.000032377335,0.00014243163,0.00027686954,0.9979679,0.000005357503],"about_ca_topic_score_codex":0.0008019502,"about_ca_topic_score_gemma":0.0023349994,"teacher_disagreement_score":0.88338166,"about_ca_system_score_codex":0.0010148117,"about_ca_system_score_gemma":0.001421902,"threshold_uncertainty_score":0.39012724},"labels":[],"label_agreement":null},{"id":"W4304109093","doi":"10.1093/neuonc/noac232","title":"Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000–2014 (CONCORD-3)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Centers for Disease Control and Prevention; Susan G. Komen; Swiss Re; Maine Cancer Foundation; CHILDREN with CANCER UK; Institut National Du Cancer; Instituto Nacional do Câncer, Ministério da Saúde; American Cancer Society; Cancer Research UK; Cancer Registry of Greater California; Swiss Cancer Research Foundation; Ligue Contre le Cancer; Saskatchewan Cancer Agency","keywords":"Medicine; Medulloblastoma; Population; Cancer; Survival analysis; Demography; Oncology; Internal medicine; Pathology; Environmental health","score_opus":0.015604013290088614,"score_gpt":0.3016568838066956,"score_spread":0.286052870516607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304109093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596139,0.001054127,0.0003111177,0.0001221165,0.000010463436,0.000029557828,0.038298987,0.000026780446,0.0005329162],"genre_scores_gemma":[0.96314335,0.00080243446,0.00065106474,0.00005840622,0.000012523232,0.00006215164,0.03504559,0.000013871979,0.00021054121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896204,0.00017932044,0.0002181047,0.00028737617,0.00017667323,0.00017648446],"domain_scores_gemma":[0.99637765,0.00056469144,0.0019886428,0.00031838863,0.0005447483,0.000205906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017670424,0.0002775214,0.00039431485,0.0027460586,0.0003355465,0.00070576766,0.0005753875,0.0002988683,0.0009476515],"category_scores_gemma":[0.0042027407,0.00031795376,0.00080664415,0.0050923694,0.00040097634,0.0006533338,0.0010154886,0.0004611276,0.000228191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043134707,0.000005215138,0.9972888,0.000047329595,0.00009653514,0.000027781369,0.0001232628,0.0001463535,0.000032576092,0.000031555166,0.0006690931,0.0014883264],"study_design_scores_gemma":[0.0000045206843,0.000021205195,0.9983006,0.00003910594,0.000054127984,0.000113595,0.0002954847,0.00021053913,0.00004911916,0.0000137102315,0.00089332013,0.0000047406784],"about_ca_topic_score_codex":0.09437316,"about_ca_topic_score_gemma":0.113031425,"teacher_disagreement_score":0.09437316,"about_ca_system_score_codex":0.0014675565,"about_ca_system_score_gemma":0.0015618964,"threshold_uncertainty_score":0.1876477},"labels":[],"label_agreement":null},{"id":"W4308684155","doi":"10.1093/neuonc/noac217","title":"Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Centers for Disease Control and Prevention; Swiss Cancer Research Foundation; Susan G. Komen; Ligue Contre le Cancer; Swiss Re; CHILDREN with CANCER UK; National Cancer Institute; Institut National Du Cancer; Cancer Research UK; American Cancer Society","keywords":"Medicine; Oligodendroglioma; Population; Glioma; Brain tumor; Histology; Survival analysis; Astrocytoma; Oncology; Glioblastoma; Demography; Gerontology; Internal medicine; Pathology; Environmental health; Cancer research","score_opus":0.01656716708719176,"score_gpt":0.3036107421851673,"score_spread":0.28704357509797557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308684155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94898117,0.0011464567,0.00042384246,0.000101344456,0.000011182512,0.000040858784,0.048634235,0.000029595592,0.0006313657],"genre_scores_gemma":[0.93834454,0.00091661065,0.00068901456,0.00007617374,0.000021060954,0.00007285538,0.05957218,0.000013247959,0.00029431056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990687,0.00014104073,0.00022795155,0.00026153898,0.0001704867,0.00013034149],"domain_scores_gemma":[0.9972531,0.00034004796,0.0014972959,0.00026060402,0.00046891725,0.0001799982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015339208,0.00023156583,0.0004170209,0.002278695,0.00024730832,0.0005852651,0.0004275118,0.0002584656,0.0007682845],"category_scores_gemma":[0.0029469738,0.00022260453,0.00066923694,0.004229123,0.0002726465,0.0004880804,0.0009908896,0.00030948519,0.000260344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007652655,0.0000061945047,0.9960198,0.0000690174,0.00011771389,0.000040937495,0.00010567776,0.00013994676,0.0000742437,0.000032261752,0.0009851538,0.0023326518],"study_design_scores_gemma":[0.000005341462,0.000029231041,0.99826556,0.000032422657,0.000054690256,0.000102396865,0.00019377697,0.00017218845,0.00006714979,0.000011456236,0.001061628,0.000004165127],"about_ca_topic_score_codex":0.06798367,"about_ca_topic_score_gemma":0.07352515,"teacher_disagreement_score":0.06798367,"about_ca_system_score_codex":0.00097130914,"about_ca_system_score_gemma":0.00112222,"threshold_uncertainty_score":0.13517594},"labels":[],"label_agreement":null},{"id":"W4308976535","doi":"10.1093/neuonc/noac209.183","title":"CSIG-34. LIN28B-LET-7-PBK PATHWAY IS AN IMPORTANT REGULATOR OF GROUP 3 MEDULLOBLASTOMA PROLIFERATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene knockdown; Cell growth; Apoptosis; Small hairpin RNA; Cancer research; Downregulation and upregulation; Medulloblastoma; Metastasis; Biology; Cell cycle; Stem cell; Cell biology; Cancer; Genetics","score_opus":0.019880294588353466,"score_gpt":0.28090917801063015,"score_spread":0.2610288834222767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500097,0.0031089543,0.0022809536,0.00045601104,0.00006748005,0.00006531103,0.0021740315,0.00038737693,0.0064588813],"genre_scores_gemma":[0.9885217,0.001036911,0.0018396417,0.00015531617,0.000009031497,0.00005832149,0.002416795,0.00004266883,0.005919602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999136,0.00000918123,0.000003587999,0.000014709728,0.000029978783,0.00002890674],"domain_scores_gemma":[0.99994624,0.000005143338,0.00001191844,0.0000041340218,0.0000041941603,0.000028410022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006116001,0.00029151567,0.00021465778,0.00026761674,0.00025455363,0.0002618246,0.00016955603,0.00026356202,0.0039400044],"category_scores_gemma":[0.00006403173,0.00013273199,0.00026065818,0.00014912985,0.00019224142,0.00013601688,0.00021283519,0.00089644326,0.0009692942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025165212,0.000053542593,0.000642026,0.00004742634,0.000007776094,0.000105378596,0.00000990258,0.0000779298,0.9957646,0.00014462112,0.00038428616,0.002510804],"study_design_scores_gemma":[0.00008490491,0.00067280675,0.046385553,0.000022835877,0.00003750482,0.0009471366,0.00008794075,0.0017519547,0.9367373,0.00022278917,0.013040853,0.00000840945],"about_ca_topic_score_codex":0.0015549273,"about_ca_topic_score_gemma":0.0024387015,"teacher_disagreement_score":0.0039400044,"about_ca_system_score_codex":0.00048330493,"about_ca_system_score_gemma":0.0004237522,"threshold_uncertainty_score":0.013180673},"labels":[],"label_agreement":null},{"id":"W4308976543","doi":"10.1093/neuonc/noac209.442","title":"EPCO-07. NON-GENOMIC DETERMINANTS OF TUMOR CELL PHENOTYPES IN ADULT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Phenotype; Biology; Epigenetics; Cancer research; Genetics; Somatic evolution in cancer; Mesenchymal stem cell; DNA methylation; Cancer; Tumor progression; Gene; Gene expression","score_opus":0.0061046569588486125,"score_gpt":0.24327205798355153,"score_spread":0.2371674010247029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94127554,0.00085573137,0.01893095,0.00027642306,0.000077190314,0.000065277265,0.026656562,0.0012476521,0.010614696],"genre_scores_gemma":[0.934238,0.00061435066,0.015886506,0.00025719233,0.000022821696,0.00016982261,0.04056554,0.00037706955,0.007868756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998344,0.000012696769,0.000010393721,0.000053413758,0.000058499514,0.000030611285],"domain_scores_gemma":[0.9995852,0.00006299207,0.00009345919,0.000051510102,0.00011885703,0.00008801315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003414374,0.00019432836,0.00020508745,0.00049779273,0.00024943886,0.0004583035,0.00017928507,0.00026538916,0.0052530174],"category_scores_gemma":[0.00041293117,0.00012002575,0.00018101999,0.0005400803,0.00018572518,0.0001944544,0.00029957693,0.00030530585,0.001453222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017136199,0.00019877573,0.11051992,0.0006058569,0.000092961236,0.0006119343,0.0001955481,0.0049943742,0.76609015,0.0041613956,0.010757819,0.10005769],"study_design_scores_gemma":[0.00010495805,0.0007110221,0.55835074,0.00009300525,0.00012095286,0.0017563906,0.00022048304,0.029102456,0.34879535,0.0041211913,0.056571014,0.000052346044],"about_ca_topic_score_codex":0.0031494442,"about_ca_topic_score_gemma":0.005776671,"teacher_disagreement_score":0.0052530174,"about_ca_system_score_codex":0.00051902945,"about_ca_system_score_gemma":0.00066229684,"threshold_uncertainty_score":0.017573118},"labels":[],"label_agreement":null},{"id":"W4308976590","doi":"10.1093/neuonc/noac209.303","title":"CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Agile software development; Randomization; Biomarker; Clinical trial; Oncology; Glioblastoma; Protocol (science); Internal medicine; Computer science; Pathology; Cancer research; Alternative medicine; Biology; Software engineering","score_opus":0.3613912606678735,"score_gpt":0.5353546190290961,"score_spread":0.17396335836122256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38335815,0.239512,0.038843025,0.10152852,0.011253078,0.030100022,0.07074309,0.0049459953,0.11971606],"genre_scores_gemma":[0.5391704,0.1386989,0.08344584,0.077931285,0.0055652256,0.04888921,0.068297975,0.0022348126,0.035766445],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980552,0.001184269,0.0001376637,0.00015919271,0.00032392633,0.00013973947],"domain_scores_gemma":[0.9960211,0.0013592605,0.0006014198,0.00028686947,0.00072920986,0.0010022921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008350118,0.0013150558,0.002151508,0.0008762375,0.0004278755,0.0017662393,0.0014664284,0.0015530547,0.006267048],"category_scores_gemma":[0.007903971,0.0003319245,0.0025490774,0.0011529607,0.000609109,0.0015116222,0.00088899635,0.00448585,0.0016309189],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070795275,0.0028011329,0.003099256,0.003950093,0.00286385,0.00027895512,0.0002197869,0.0047122077,0.006802529,0.003212671,0.17044799,0.7308162],"study_design_scores_gemma":[0.38735732,0.08844666,0.026999494,0.0059163994,0.0057613077,0.0012284619,0.00021081654,0.0064532356,0.0061675613,0.0130858505,0.45804417,0.00032863996],"about_ca_topic_score_codex":0.0020855435,"about_ca_topic_score_gemma":0.0073055304,"teacher_disagreement_score":0.008350118,"about_ca_system_score_codex":0.0016020401,"about_ca_system_score_gemma":0.002846214,"threshold_uncertainty_score":0.044160187},"labels":[],"label_agreement":null},{"id":"W4308976659","doi":"10.1093/neuonc/noac209.010","title":"ANGI-11. RAB27 IS REQUIRED FOR REGULATING INTACT VASCULATURE IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Angiogenesis; Pathology; Vascular permeability; Glioma; Cancer research; Medicine; Endocrinology","score_opus":0.012085935201713752,"score_gpt":0.25685195754691365,"score_spread":0.2447660223451999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493575,0.00075432047,0.0016243876,0.00016176495,0.00002098326,0.000014950422,0.00097272097,0.00019075446,0.0013243856],"genre_scores_gemma":[0.9963972,0.00026629135,0.000570843,0.00003760139,0.000003266097,0.000016913944,0.0007197701,0.000043183118,0.0019449646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999006,0.000012754773,0.000010319215,0.000019418554,0.000027460363,0.000029413477],"domain_scores_gemma":[0.99977475,0.000019440417,0.000075428805,0.00002073946,0.00001990876,0.00008977532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008580635,0.00018752168,0.00020956235,0.00034804438,0.00019988553,0.0003287588,0.00018777951,0.00024414086,0.0020805162],"category_scores_gemma":[0.00013507994,0.00014069017,0.00019248683,0.0001382239,0.00028384195,0.000113742135,0.00026526672,0.0004445111,0.00081751717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010201085,0.000014569125,0.00047790896,0.000019790628,0.0000027519902,0.00017518408,0.000007904615,0.000050490024,0.998447,0.00012892268,0.00008253388,0.0004909857],"study_design_scores_gemma":[0.00003530243,0.00015633742,0.040808003,0.000012896607,0.00003284541,0.0018946881,0.0001452416,0.0035309116,0.9470967,0.00022566262,0.006046802,0.000014523281],"about_ca_topic_score_codex":0.0015908274,"about_ca_topic_score_gemma":0.0018522578,"teacher_disagreement_score":0.0020805162,"about_ca_system_score_codex":0.0003919291,"about_ca_system_score_gemma":0.00034092774,"threshold_uncertainty_score":0.006960094},"labels":[],"label_agreement":null},{"id":"W4308976783","doi":"10.1093/neuonc/noac209.327","title":"CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Confidence interval; Clinical endpoint; Glioma; Oncology; Gastroenterology; Surgery; Clinical trial; Receptor; Neurotrophin; Cancer research","score_opus":0.008525808754963329,"score_gpt":0.23888200652768363,"score_spread":0.2303561977727203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96370935,0.023728918,0.00045100067,0.00058254274,0.00009686129,0.00044630846,0.004299338,0.00011583251,0.00656998],"genre_scores_gemma":[0.98438925,0.004736098,0.00061054534,0.00060694676,0.00009165536,0.0003100924,0.0079681855,0.000018586195,0.0012686814],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995565,0.0001395393,0.00004695794,0.000100904195,0.00009548808,0.00006061453],"domain_scores_gemma":[0.99943537,0.000083211795,0.00020400398,0.000033965236,0.000069955975,0.00017358117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010188426,0.00037833193,0.0009817643,0.00024313896,0.00021100353,0.00058079406,0.0002838352,0.00029865638,0.0018800335],"category_scores_gemma":[0.0009862399,0.00014079257,0.0005592936,0.000466247,0.0002968835,0.00043782702,0.00021478388,0.0007429364,0.00058110495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16756758,0.0044155405,0.19588655,0.0043460065,0.0029995206,0.0012485541,0.0002894624,0.0060248678,0.07940513,0.000687324,0.029397404,0.50773203],"study_design_scores_gemma":[0.098473005,0.14166737,0.6435521,0.0010272199,0.005358498,0.0066534686,0.0002786086,0.010788699,0.027943337,0.000987667,0.06309963,0.00017039174],"about_ca_topic_score_codex":0.0013422072,"about_ca_topic_score_gemma":0.0048642266,"teacher_disagreement_score":0.0018800335,"about_ca_system_score_codex":0.0010353817,"about_ca_system_score_gemma":0.0010923024,"threshold_uncertainty_score":0.007512212},"labels":[],"label_agreement":null},{"id":"W4308976790","doi":"10.1093/neuonc/noac209.276","title":"CTNI-10. RANDOMIZED PIVOTAL STUDY OF BLOOD-BRAIN BARRIER (BBB) DISRUPTION USING EXABLATE MODEL 4000 WITH STANDARD OF CARE (SOC) THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAIN METASTASES: LIMITLESS TRIAL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Lung cancer; Internal medicine; Randomized controlled trial; Clinical endpoint; non-small cell lung cancer (NSCLC); Pembrolizumab; Progression-free survival; Randomization; Immunotherapy; Cancer; Overall survival","score_opus":0.02676823639182252,"score_gpt":0.3253090690855392,"score_spread":0.2985408326937167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554813,0.011087126,0.0016926926,0.0025148224,0.0017052975,0.012864997,0.005139243,0.00048044606,0.009033982],"genre_scores_gemma":[0.9451082,0.0059131957,0.005604682,0.0044840765,0.0013467217,0.01617139,0.0070250677,0.00012109541,0.014225716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99902415,0.0005944642,0.000047559035,0.00015216308,0.0000750542,0.00010662136],"domain_scores_gemma":[0.9985619,0.00032696457,0.00040671922,0.00011679214,0.00012712473,0.00046047723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034517467,0.0024891307,0.002402622,0.00051738956,0.00045928927,0.0016257649,0.0014999106,0.0028064356,0.0063771345],"category_scores_gemma":[0.0023754328,0.0006901208,0.0019851113,0.00048665467,0.0014372009,0.0014957351,0.00054155436,0.0039278055,0.0013708711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9764642,0.004962714,0.0004158321,0.000918117,0.0007480244,0.00004547467,0.000033964305,0.00053960265,0.0045727906,0.0003234121,0.0022337975,0.008742073],"study_design_scores_gemma":[0.9192297,0.07697324,0.00074919226,0.000052691346,0.00042294397,0.00004480129,0.000014380965,0.0005614285,0.00062511687,0.00019505052,0.0011122386,0.000019147235],"about_ca_topic_score_codex":0.0011827664,"about_ca_topic_score_gemma":0.0026685887,"teacher_disagreement_score":0.0063771345,"about_ca_system_score_codex":0.001311844,"about_ca_system_score_gemma":0.0016785349,"threshold_uncertainty_score":0.021333635},"labels":[],"label_agreement":null},{"id":"W4308976883","doi":"10.1093/neuonc/noac209.135","title":"STEM-18. EPIGENETIC AND MOLECULAR COORDINATION BETWEEN HDAC2 AND SMAD3-SKI IS REQUIRED FOR GROWTH AND STEM CELL CHARACTERISTICS OF BRAIN TUMOUR STEM CELLS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; Biology; Stem cell; Chromatin; Cancer stem cell; Neural stem cell; Cancer research; Cell growth; Cell biology; Genetics","score_opus":0.019614621106355354,"score_gpt":0.27745685641914053,"score_spread":0.25784223531278516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97899663,0.0026324491,0.009878235,0.00025551912,0.00012236885,0.000057884146,0.0028302306,0.0004775643,0.0047491393],"genre_scores_gemma":[0.9892998,0.0005522808,0.0018558189,0.00008534381,0.000013659085,0.00003884393,0.0025542006,0.000053856886,0.0055461875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998628,0.000010299654,0.0000149671405,0.00003629747,0.00004949339,0.00002609636],"domain_scores_gemma":[0.9998925,0.0000058694336,0.000040667877,0.000009691412,0.000012192675,0.000039186045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101145175,0.00031178122,0.0002603713,0.00019748136,0.00018788931,0.00034750445,0.00020955896,0.00020793166,0.002880358],"category_scores_gemma":[0.000069367015,0.00018626821,0.00036855976,0.00013101693,0.000218439,0.00014383119,0.0002427477,0.00037275316,0.0009653961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056705165,0.0000102981685,0.0004379473,0.000037178084,0.0000058214846,0.00005811741,0.000010029543,0.000034944867,0.9981458,0.00012813022,0.00007229622,0.0010027118],"study_design_scores_gemma":[0.000015441854,0.0001003244,0.011340433,0.0000067361784,0.000020311043,0.00034359162,0.000029357896,0.00092357094,0.9805726,0.00005061659,0.006593182,0.0000038282883],"about_ca_topic_score_codex":0.0008405517,"about_ca_topic_score_gemma":0.0020061887,"teacher_disagreement_score":0.002880358,"about_ca_system_score_codex":0.0003528252,"about_ca_system_score_gemma":0.00034683855,"threshold_uncertainty_score":0.009635806},"labels":[],"label_agreement":null},{"id":"W4308976884","doi":"10.1093/neuonc/noac209.400","title":"DDDR-35. TARGETING GBM INVASION BY INHIBITING KCNA1 WITH 4-AMINOPYRIDINE: AN FDA APPROVED DRUG THAT EASILY PASS THROUGH THE BBB","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medicine; Drug; Glioblastoma; Cancer research; 4-Aminopyridine; Oncology; Pharmacology; Pathology; Internal medicine","score_opus":0.026420053005179685,"score_gpt":0.2749201693302587,"score_spread":0.248500116325079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870568,0.004972568,0.0026493832,0.00025622037,0.000105686464,0.00007511666,0.0013971924,0.0002705945,0.0032165532],"genre_scores_gemma":[0.9875425,0.0026128578,0.0038755601,0.00011188016,0.000012270879,0.00006141019,0.0017231907,0.000019145295,0.004041241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999131,0.000011676143,0.000007306117,0.000020135585,0.000021591557,0.000026228818],"domain_scores_gemma":[0.9999654,0.0000052145733,0.000009745786,0.0000040172545,0.000005458685,0.000010066068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009568926,0.00034854727,0.00024843868,0.00031583442,0.00012231016,0.00018883581,0.0001545945,0.0002327716,0.0016845785],"category_scores_gemma":[0.00005740785,0.000115390634,0.00022377878,0.00018769359,0.00016202,0.00015402095,0.000099057186,0.00048956304,0.0003983317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003339757,0.00012409294,0.00018787183,0.00008107554,0.00000906637,0.000032979908,0.000013789091,0.00015968563,0.9937459,0.00013344818,0.00031948718,0.004858558],"study_design_scores_gemma":[0.0000817083,0.0021886814,0.0032900025,0.000009719405,0.000031460313,0.00024300926,0.000019290304,0.0008913475,0.98733366,0.000042528227,0.0058606598,0.000008003172],"about_ca_topic_score_codex":0.0011518071,"about_ca_topic_score_gemma":0.0021950942,"teacher_disagreement_score":0.0016845785,"about_ca_system_score_codex":0.00030864452,"about_ca_system_score_gemma":0.0002840718,"threshold_uncertainty_score":0.0056354403},"labels":[],"label_agreement":null},{"id":"W4308976889","doi":"10.1093/neuonc/noac209.057","title":"BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Univariate analysis; Exome sequencing; Multivariate analysis; Internal medicine; Oncology; Logistic regression; Exome; Univariate; Medicine; Biology; Bioinformatics; Gene; Genetics; Multivariate statistics; Mutation","score_opus":0.04077867267202619,"score_gpt":0.26582499817758987,"score_spread":0.2250463255055637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973469,0.00027918722,0.0011249733,0.000054310087,0.000005758511,0.0000068718145,0.000880262,0.00002869103,0.00027312434],"genre_scores_gemma":[0.9981793,0.00005732323,0.0008136259,0.00002056418,0.0000045531765,0.000005766138,0.0008345927,0.0000047032054,0.000079568425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968266,0.00009612843,0.00003922216,0.000094833886,0.00005086419,0.00003631392],"domain_scores_gemma":[0.99946374,0.00019645621,0.000189688,0.000034715464,0.000046048575,0.00006945711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068003056,0.00028440403,0.00030313808,0.0008690332,0.0001726382,0.00048665813,0.00019659029,0.0002563447,0.0012258342],"category_scores_gemma":[0.00136839,0.00008932787,0.000540406,0.0007248206,0.00014207159,0.00018963295,0.00032493423,0.00023611714,0.00020648527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045384924,0.000027866856,0.9837034,0.000024743022,0.00016228517,0.0001963164,0.00002003749,0.0012981434,0.0042051226,0.000062340354,0.00022317066,0.009622729],"study_design_scores_gemma":[0.000022133474,0.00020282624,0.9798885,0.000014352396,0.00023281635,0.0010782196,0.000056993846,0.015105158,0.0023903514,0.00034782392,0.00064809725,0.000012671188],"about_ca_topic_score_codex":0.0019295122,"about_ca_topic_score_gemma":0.0029430354,"teacher_disagreement_score":0.0019295122,"about_ca_system_score_codex":0.0002196231,"about_ca_system_score_gemma":0.00030291392,"threshold_uncertainty_score":0.0041007996},"labels":[],"label_agreement":null},{"id":"W4308977007","doi":"10.1093/neuonc/noac209.646","title":"NIMG-28. USE OF NEUROIMAGING TECHNIQUES IN GLIOMA PATIENTS – RESULTS OF AN INTERNATIONAL SURVEY ON BEHALF OF THE EORTC BRAIN TUMOR GROUP","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Neuroimaging; Medicine; Glioma; Nuclear medicine; Magnetic resonance imaging; Diffusion MRI; Radiology; Medical physics; Psychiatry","score_opus":0.035672399757505614,"score_gpt":0.3169352618992086,"score_spread":0.281262862141703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954267,0.00034050355,0.00006331378,0.00018709603,0.000010940438,0.000031837142,0.0018376717,0.000007645543,0.0020943345],"genre_scores_gemma":[0.9979613,0.00029460722,0.00011917224,0.0000897411,0.000013420001,0.000044067623,0.0011351346,0.0000045746947,0.00033792687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924904,0.00026806805,0.00013134604,0.00008842703,0.00015379765,0.0001092178],"domain_scores_gemma":[0.9967008,0.0004603325,0.0020554021,0.000078598816,0.0003298874,0.0003749625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010434972,0.00017283075,0.00019928819,0.0014763409,0.00016360864,0.00037387118,0.00023357774,0.000307257,0.0012593055],"category_scores_gemma":[0.0026287532,0.00008693958,0.00026379383,0.0014407323,0.00021797048,0.0004604097,0.0005118842,0.00024844863,0.00042069232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003402116,0.000026105534,0.9971656,0.000021982414,0.0000129188265,0.000030938325,0.00016337197,0.0000294114,0.000113862814,0.000010131133,0.000294367,0.0020973678],"study_design_scores_gemma":[0.0000020350717,0.000051959923,0.9985582,0.000008387056,0.000004889823,0.00010215676,0.0006089019,0.000073719966,0.00004671942,0.000005412401,0.00053521874,0.0000024094766],"about_ca_topic_score_codex":0.0031678244,"about_ca_topic_score_gemma":0.0022969556,"teacher_disagreement_score":0.0031678244,"about_ca_system_score_codex":0.00029880163,"about_ca_system_score_gemma":0.00025188515,"threshold_uncertainty_score":0.0062987804},"labels":[],"label_agreement":null},{"id":"W4308977070","doi":"10.1093/neuonc/noac209.333","title":"CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHIBITOR TOVORAFENIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RAF-ALTERED RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA OR ADVANCED SOLID TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McGill University Health Centre; Université de Montréal; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Vomiting; Anemia; Oncology; Glioma; Surgery; Clinical trial; Cancer research","score_opus":0.016804126077242278,"score_gpt":0.3232962237666636,"score_spread":0.3064920976894213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898094,0.004420706,0.00057051243,0.00039922647,0.00009948609,0.0014251472,0.0012926768,0.00014665253,0.0018362632],"genre_scores_gemma":[0.9836029,0.0052477648,0.001866493,0.0006594669,0.0001129217,0.0016262849,0.0032334935,0.000030120824,0.003620564],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984646,0.000054083015,0.0000075620874,0.000027837745,0.000017518043,0.000046623187],"domain_scores_gemma":[0.9997762,0.000019849525,0.000038068494,0.000008916354,0.000016764257,0.00014018669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006913066,0.00097434415,0.0010734121,0.00029242368,0.00020915353,0.0005969828,0.0005160853,0.0004926376,0.0022586037],"category_scores_gemma":[0.0003386348,0.00034730145,0.0007531303,0.00025528643,0.0003522307,0.0003599205,0.00024144264,0.0017132628,0.0004726654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4500164,0.07930185,0.018000709,0.002670595,0.002153906,0.0014999707,0.00062681886,0.0047673066,0.1608418,0.00089702365,0.017179731,0.26204398],"study_design_scores_gemma":[0.43242478,0.5047088,0.028813675,0.00013340796,0.0009780112,0.0018267941,0.0001328108,0.0027188307,0.015004478,0.000284245,0.012907403,0.000066849396],"about_ca_topic_score_codex":0.001591313,"about_ca_topic_score_gemma":0.006098573,"teacher_disagreement_score":0.0022586037,"about_ca_system_score_codex":0.00077625964,"about_ca_system_score_gemma":0.0014171947,"threshold_uncertainty_score":0.007555783},"labels":[],"label_agreement":null},{"id":"W4308977071","doi":"10.1093/neuonc/noac209.368","title":"DDDR-03. DEVELOPMENT OF NOVEL ANTI-BRAIN METASTASIS INHIBITORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Cancer research; Medicine; Metastasis; Cell; Population; Cell culture; Transcriptome; Pathology; Cancer; Biology; Gene; Internal medicine; Gene expression","score_opus":0.04471516655315932,"score_gpt":0.3191582260845011,"score_spread":0.2744430595313418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8611403,0.03692628,0.017842492,0.0021954475,0.0009092109,0.0019910268,0.014877154,0.0020835816,0.062034506],"genre_scores_gemma":[0.9105623,0.016669435,0.013103026,0.0017312315,0.00010131555,0.0008249234,0.0167748,0.00011140321,0.040121686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998858,0.00001689068,0.000008470633,0.000026328595,0.00003108785,0.000031405838],"domain_scores_gemma":[0.9999099,0.000009685889,0.000016371077,0.000006578209,0.000019004425,0.000038625098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022767483,0.0005851491,0.0005065307,0.00055345026,0.00016810463,0.0006429958,0.00059581525,0.00049294316,0.0062638833],"category_scores_gemma":[0.00017737334,0.00021568601,0.0004170905,0.00037725488,0.0001604231,0.00023751702,0.00020523278,0.0011035175,0.0023395114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001817889,0.0019001198,0.0011085884,0.00079546287,0.00014629566,0.00053772016,0.000054643187,0.0030028787,0.85139567,0.0018735918,0.0112172365,0.12615003],"study_design_scores_gemma":[0.004823197,0.029190818,0.013423951,0.00023539731,0.00035360717,0.0041998625,0.00009194007,0.010319853,0.7639625,0.0010376722,0.17227188,0.00008929342],"about_ca_topic_score_codex":0.0009864301,"about_ca_topic_score_gemma":0.0019814002,"teacher_disagreement_score":0.0062638833,"about_ca_system_score_codex":0.00049496756,"about_ca_system_score_gemma":0.0005515098,"threshold_uncertainty_score":0.020954788},"labels":[],"label_agreement":null},{"id":"W4308977216","doi":"10.1093/neuonc/noac209.808","title":"EXTH-09. HSP90 INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hsp90; Hsp90 inhibitor; Cancer research; Glioma; Medicine; Cancer; Cell culture; Viability assay; Biology; Heat shock protein; Internal medicine; Biochemistry; Genetics; Gene","score_opus":0.024749196199097635,"score_gpt":0.3183052436406788,"score_spread":0.29355604744158115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879089,0.0038707748,0.0012326027,0.0003565918,0.000088869274,0.00026433068,0.0012377669,0.00027620947,0.0047637913],"genre_scores_gemma":[0.9886579,0.0022342247,0.0016124586,0.0003219274,0.000016727634,0.00010243518,0.0018949949,0.000022799186,0.005136544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999534,0.0000057048387,0.000002391515,0.000009015875,0.000012774473,0.000016757782],"domain_scores_gemma":[0.9999769,0.0000019212566,0.0000035554704,0.0000026773243,0.0000025034856,0.00001246669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009056123,0.00023466101,0.00031413892,0.00018115122,0.00009757071,0.00022053611,0.00025015694,0.0002493901,0.0020971468],"category_scores_gemma":[0.000042287924,0.00007284287,0.00020679658,0.00016724112,0.00017034131,0.00015346945,0.00017485967,0.0007971913,0.0003992631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005412893,0.0034908208,0.0022061593,0.0007541191,0.00012891408,0.0013454374,0.000098784556,0.0014575407,0.7716055,0.0012928756,0.004910119,0.2072968],"study_design_scores_gemma":[0.004412311,0.081705295,0.046549387,0.00010079997,0.00030159418,0.007150263,0.00014697124,0.0041969535,0.7983256,0.00061573664,0.0564427,0.000052452466],"about_ca_topic_score_codex":0.0005562675,"about_ca_topic_score_gemma":0.0020394332,"teacher_disagreement_score":0.0020971468,"about_ca_system_score_codex":0.000221279,"about_ca_system_score_gemma":0.00023354522,"threshold_uncertainty_score":0.007015705},"labels":[],"label_agreement":null},{"id":"W4308977228","doi":"10.1093/neuonc/noac209.462","title":"EPCO-28. DOT1L AND PRC2 REGULATE A SHARED EPIGENETIC MECHANISM IN GLIOBLASTOMA AND MIXED LINEAGE LEUKEMIA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; PRC2; Biology; DNA methylation; Chromatin; Cancer research; Histone; Genetics; EZH2; Gene; Gene expression","score_opus":0.010823839808588141,"score_gpt":0.2540997245746737,"score_spread":0.24327588476608558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941758,0.002212176,0.0014384363,0.00008852809,0.000008585721,0.000022847791,0.0005315892,0.000058156005,0.0014638674],"genre_scores_gemma":[0.99550503,0.0004946911,0.0006707234,0.00005523235,0.0000022963407,0.000020449967,0.00085944583,0.000008701861,0.0023834642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998864,0.000011274592,0.00001037963,0.00002224576,0.000042601594,0.000027171289],"domain_scores_gemma":[0.99992967,0.000006457061,0.000025819008,0.0000058222745,0.00000921183,0.000022989012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103768885,0.00021038961,0.00024602024,0.00025281048,0.00010118559,0.0002859857,0.00015542397,0.00015385097,0.0012484596],"category_scores_gemma":[0.00008816442,0.000112416725,0.00013888726,0.00014714232,0.0001752003,0.00010265086,0.00025350202,0.0002357435,0.00032195885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017572627,0.000017424347,0.00085558754,0.000021799095,0.000005482814,0.000047992762,0.0000058301052,0.00007334462,0.99675,0.00008825292,0.00003606231,0.0019224989],"study_design_scores_gemma":[0.000041743362,0.00053570763,0.059855644,0.0000069077273,0.000027684164,0.00059884967,0.000049949398,0.001492519,0.93383926,0.00008974521,0.0034561984,0.000005771479],"about_ca_topic_score_codex":0.0008756867,"about_ca_topic_score_gemma":0.0016712563,"teacher_disagreement_score":0.0012484596,"about_ca_system_score_codex":0.00032014167,"about_ca_system_score_gemma":0.00019518555,"threshold_uncertainty_score":0.0041764975},"labels":[],"label_agreement":null},{"id":"W4308977249","doi":"10.1093/neuonc/noac209.594","title":"PATH-21. INVESTIGATING CHANGES IN IDH MUTATION STATUS AT GLIOMA RECURRENCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"IDH2; Isocitrate dehydrogenase; IDH1; Glioma; Sanger sequencing; Immunohistochemistry; Carcinogenesis; Biology; Pathology; Mutation; Methylation; Biopsy; Cancer research; PTEN; Oncology; Medicine; Cancer; Gene; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.03756683201148126,"score_gpt":0.31348693781309633,"score_spread":0.2759201058016151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954417,0.0005024302,0.00068861956,0.00008911717,0.000011925781,0.0000393243,0.0006617465,0.00006232017,0.0025027352],"genre_scores_gemma":[0.99717295,0.00015537675,0.0010589516,0.000036609254,0.0000069404828,0.000026949261,0.00063170015,0.000014979668,0.00089562667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998301,0.000026250886,0.000021861682,0.000039940463,0.000043940756,0.000037805134],"domain_scores_gemma":[0.99960643,0.00007805839,0.0001357003,0.000028016088,0.00008035832,0.000071534625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034555403,0.0002110961,0.0002603291,0.0010485782,0.00025444105,0.0004772043,0.00032586613,0.0002999856,0.0032645077],"category_scores_gemma":[0.00093737355,0.000101652804,0.00015036712,0.0005914191,0.000245918,0.00027403972,0.00029857722,0.0002159486,0.00089150685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084314914,0.000050579056,0.92519253,0.0001024455,0.000035055175,0.004229966,0.00025037766,0.00029528158,0.033778932,0.00016831346,0.0007034953,0.034349766],"study_design_scores_gemma":[0.000022306565,0.0007092031,0.9332713,0.000018985776,0.000082389015,0.020378083,0.00037929317,0.001691086,0.038432766,0.00026563962,0.0047342223,0.000014731218],"about_ca_topic_score_codex":0.0020652018,"about_ca_topic_score_gemma":0.0020642655,"teacher_disagreement_score":0.0032645077,"about_ca_system_score_codex":0.00050576497,"about_ca_system_score_gemma":0.00030740583,"threshold_uncertainty_score":0.010920882},"labels":[],"label_agreement":null},{"id":"W4308977251","doi":"10.1093/neuonc/noac209.271","title":"CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Centre hospitalier universitaire de Québec; BC Children's Hospital; SickKids Foundation; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Neurofibromatosis; Adverse effect; Dysgeusia; Internal medicine; Surgery; Radiology","score_opus":0.02775016837810763,"score_gpt":0.3290209320926506,"score_spread":0.301270763714543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846775,0.004931789,0.0006231114,0.0006023107,0.000120361845,0.0020203246,0.0013431093,0.00013779827,0.0017535458],"genre_scores_gemma":[0.9816294,0.0043031876,0.0031042784,0.0011170793,0.00018067118,0.0029115505,0.003299406,0.000038374998,0.0034161],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997681,0.000091400216,0.000013157018,0.000040393617,0.000028275392,0.000058754154],"domain_scores_gemma":[0.9995358,0.000041804637,0.000076117496,0.000022485465,0.000030994655,0.00029279166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013037137,0.0011755986,0.0013637091,0.00033498587,0.00031647703,0.0008386209,0.00083095394,0.0008603578,0.0027094807],"category_scores_gemma":[0.0005332428,0.00040786268,0.0008353008,0.00036831287,0.00055218016,0.00059136865,0.00030365674,0.002764339,0.0005929382],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44284523,0.12125375,0.02061376,0.0019941684,0.0021388468,0.0015863387,0.00055571663,0.0054592784,0.080914415,0.00086957717,0.015809773,0.30595917],"study_design_scores_gemma":[0.47548595,0.46690807,0.031338867,0.00009651918,0.000811855,0.0023648024,0.000112598005,0.00327196,0.010230449,0.000254725,0.0090626655,0.000061541774],"about_ca_topic_score_codex":0.0012223974,"about_ca_topic_score_gemma":0.0038320266,"teacher_disagreement_score":0.0027094807,"about_ca_system_score_codex":0.00086717296,"about_ca_system_score_gemma":0.0019546796,"threshold_uncertainty_score":0.009064078},"labels":[],"label_agreement":null},{"id":"W4308977252","doi":"10.1093/neuonc/noac209.571","title":"INNV-31. PROTECT: PROCARBAZINE, LOMUSTINE, AND VINCRISTINE VERSUS TEMOZOLAMIDE IN HIGH-RISK, LOW-GRADE GLIOMAS: A RETROSPECTIVE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Procarbazine; Medicine; Lomustine; Oligodendroglioma; Temozolomide; Vincristine; Internal medicine; Retrospective cohort study; Glioma; Surgery; Oncology; Chemotherapy; Astrocytoma; Cyclophosphamide","score_opus":0.013487882927569972,"score_gpt":0.28114174097646943,"score_spread":0.26765385804889946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911517,0.00033777743,0.00004216148,0.000012284326,0.0000051551096,0.000025728688,0.00034256652,0.0000012516671,0.00011789046],"genre_scores_gemma":[0.99898213,0.00015047683,0.000068918875,0.000027282245,0.000008799281,0.000025329331,0.00058803114,0.0000015829321,0.0001473058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992167,0.00022515866,0.00007559476,0.0002261751,0.0001225511,0.00013375763],"domain_scores_gemma":[0.9988238,0.00019206542,0.0004423379,0.000119697994,0.000108000844,0.00031403836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010087,0.00033346756,0.00051434856,0.00042062253,0.0004231637,0.0006080559,0.0005689209,0.00045359606,0.0013214231],"category_scores_gemma":[0.0013381151,0.00033440767,0.000837544,0.00080174353,0.0003741707,0.00036432585,0.00037659032,0.00041978632,0.0002574005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008818033,0.00023397671,0.9873574,0.000037114703,0.00047501992,0.00015722167,0.00007758574,0.00007226126,0.00043200082,0.000020145993,0.00016997641,0.002149402],"study_design_scores_gemma":[0.0007748846,0.006119775,0.9897383,0.000025524145,0.00060179026,0.0007129506,0.00032681096,0.0004372697,0.00036654132,0.000037966798,0.0008363967,0.000021713913],"about_ca_topic_score_codex":0.01238488,"about_ca_topic_score_gemma":0.015464336,"teacher_disagreement_score":0.01238488,"about_ca_system_score_codex":0.0010945377,"about_ca_system_score_gemma":0.0008841838,"threshold_uncertainty_score":0.0246256},"labels":[],"label_agreement":null},{"id":"W4308977416","doi":"10.1093/neuonc/noac209.952","title":"QOL-25. IMPACTS OF IMPLEMENTING A PROSPECTIVE TREATMENT AND SURVEILLANCE PROTOCOL FOR THE MANAGEMENT OF NF2-ASSOCIATED VESTIBULAR SCHWANNOMAS ON TUMOR GROWTH, HEARING OUTCOMES, AND QUALITY OF LIFE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Neurofibromatosis type 2; Quality of life (healthcare); Prospective cohort study; Hearing loss; Cohort; Pediatrics; Surgery; Internal medicine; Audiology; Schwannoma; Chemotherapy","score_opus":0.06412302229070513,"score_gpt":0.3670834514717785,"score_spread":0.30296042918107335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95231277,0.0004215308,0.002157295,0.00079335587,0.00017758418,0.029800164,0.008268874,0.00016641445,0.0059020435],"genre_scores_gemma":[0.9458297,0.00020158307,0.008427534,0.0003650445,0.000046688452,0.038559243,0.0053894417,0.000015072404,0.001165744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931993,0.004135739,0.00075225823,0.00043554703,0.00088400545,0.0005931005],"domain_scores_gemma":[0.98782814,0.0021779728,0.0040641027,0.0013163869,0.001991229,0.0026222959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0129596535,0.0005061723,0.0005714725,0.00047495725,0.0011003724,0.0008680575,0.00076086994,0.00053255254,0.0029852334],"category_scores_gemma":[0.015365687,0.00028533154,0.0019397562,0.0006441474,0.0005147063,0.00047530327,0.00089488673,0.00089494983,0.00051275006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10678568,0.054082338,0.48270896,0.0011788972,0.0021265598,0.0002064853,0.0011470558,0.0069305347,0.0032347778,0.0009491387,0.017639877,0.3230097],"study_design_scores_gemma":[0.024606377,0.10465072,0.8503378,0.0003549865,0.00080038805,0.00008902925,0.00053356576,0.0032223277,0.002360807,0.0002657091,0.012649675,0.00012860978],"about_ca_topic_score_codex":0.015717948,"about_ca_topic_score_gemma":0.026043808,"teacher_disagreement_score":0.015717948,"about_ca_system_score_codex":0.004267312,"about_ca_system_score_gemma":0.010412367,"threshold_uncertainty_score":0.06853807},"labels":[],"label_agreement":null},{"id":"W4308977430","doi":"10.1093/neuonc/noac209.177","title":"CSIG-28. THE HEDGEHOG GENE EXPRESSION PROGRAM REGULATES LIPID FEEDBACK MECHANISMS UNDERLYING HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Smoothened; Hedgehog signaling pathway; Hedgehog; GLI1; Biology; Cilium; Sonic hedgehog; Cell biology; Genetics; Gene","score_opus":0.030108250192044134,"score_gpt":0.2916004519560762,"score_spread":0.2614922017640321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98730856,0.0011138883,0.0026524127,0.00020975199,0.000048990292,0.000060726146,0.0030293819,0.00024449918,0.0053318185],"genre_scores_gemma":[0.9897445,0.00037047107,0.0016274679,0.000111968264,0.0000043574214,0.000039638788,0.0020639198,0.000060181894,0.0059775123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998814,0.0000094922,0.0000065670024,0.000029925659,0.00003918852,0.00003345859],"domain_scores_gemma":[0.99992263,0.0000049695163,0.000018853103,0.0000062595836,0.000009276898,0.000038039416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071497925,0.00025305524,0.00021645159,0.00026002177,0.00023134185,0.00024140929,0.00018878646,0.00020274748,0.0020881789],"category_scores_gemma":[0.0000692248,0.00014378772,0.0002305454,0.00014728057,0.00027103134,0.00009898344,0.00026385218,0.00042449252,0.0010064293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006530743,0.000008716914,0.0002235352,0.000018557106,0.0000018663586,0.000042357096,0.0000074892587,0.000042567586,0.99882144,0.0000878072,0.00007586726,0.0006045947],"study_design_scores_gemma":[0.000028575505,0.00015963783,0.027763138,0.000014849849,0.000017045972,0.000213495,0.00010385673,0.0019133909,0.9633177,0.00014576057,0.0063135973,0.0000089561645],"about_ca_topic_score_codex":0.0028212764,"about_ca_topic_score_gemma":0.0056440034,"teacher_disagreement_score":0.0028212764,"about_ca_system_score_codex":0.00066218514,"about_ca_system_score_gemma":0.00041206274,"threshold_uncertainty_score":0.0069856644},"labels":[],"label_agreement":null},{"id":"W4308977441","doi":"10.1093/neuonc/noac209.318","title":"CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dosing; Body surface area; MAPK/ERK pathway; Toxicity; MEK inhibitor; Adverse effect; Internal medicine; Oncology; Nuclear medicine; Kinase; Chemistry","score_opus":0.024339299112671783,"score_gpt":0.31004749124828296,"score_spread":0.28570819213561116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908449,0.0021485284,0.0006865479,0.00036286964,0.000061798855,0.0009815493,0.0017201616,0.00012840104,0.0030653311],"genre_scores_gemma":[0.98772544,0.0016876744,0.002250837,0.00028147496,0.00003694991,0.0007973325,0.004279011,0.00005915755,0.0028820382],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970967,0.00013324343,0.000016354335,0.00003672479,0.000038283273,0.00006573384],"domain_scores_gemma":[0.9996132,0.000052544754,0.00005936535,0.000027125421,0.000025071751,0.00022277354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089561776,0.0007440151,0.0009703532,0.00021021816,0.00023515106,0.0007314329,0.00061094534,0.00045636963,0.001992178],"category_scores_gemma":[0.00048848323,0.00022678073,0.00055734726,0.0002772625,0.00050066144,0.00033676333,0.0002077957,0.001689828,0.00057803333],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2409606,0.0342326,0.023215992,0.0021874807,0.0014160716,0.0014927412,0.0005948239,0.012604239,0.3725018,0.0012985484,0.013038523,0.29645658],"study_design_scores_gemma":[0.17766699,0.60632795,0.07765235,0.00020830291,0.001205402,0.0037118515,0.0001791091,0.00542817,0.0993968,0.00045207623,0.02764949,0.00012141779],"about_ca_topic_score_codex":0.003188748,"about_ca_topic_score_gemma":0.0128205195,"teacher_disagreement_score":0.003188748,"about_ca_system_score_codex":0.0011946389,"about_ca_system_score_gemma":0.0020119213,"threshold_uncertainty_score":0.008667767},"labels":[],"label_agreement":null},{"id":"W4308977714","doi":"10.1093/neuonc/noac209.144","title":"STEM-27. MECHANOSENSITIVE BRAIN TUMOR CELLS CONSTRUCT BLOOD-TUMOR BARRIER TO MASK CHEMOSENSITIVITY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Mechanosensitive channels; SOX2; Biology; Cancer cell; Cell biology; Wnt signaling pathway; Brain tumor; Cancer research; Cancer; Ion channel; Pathology; Medicine; Signal transduction","score_opus":0.01639442208434566,"score_gpt":0.26171038339733105,"score_spread":0.2453159613129854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714775,0.0010887913,0.018183874,0.0004974208,0.00012703192,0.00012230343,0.00060910813,0.00039444916,0.0074995887],"genre_scores_gemma":[0.98527586,0.00044325466,0.006491391,0.000100366364,0.000010423088,0.00006358785,0.00035836335,0.000043078497,0.007213513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999254,0.0000072207285,0.000005474549,0.000015317191,0.000031552325,0.000014962125],"domain_scores_gemma":[0.99993384,0.000010171338,0.00001755615,0.000007903682,0.000007621366,0.0000229134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109325265,0.0002269334,0.00015738253,0.00016730605,0.00013393587,0.00027434845,0.00017919806,0.00027538385,0.0028804454],"category_scores_gemma":[0.000059478938,0.00013952906,0.00016605083,0.00009391572,0.00025197642,0.00016807817,0.00022114631,0.0006031248,0.0006016885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025996149,0.000025704217,0.00016409044,0.000026263158,0.0000032861758,0.000044999986,0.000017358887,0.00010869313,0.99696606,0.0006985974,0.00015756105,0.0017614109],"study_design_scores_gemma":[0.000015681384,0.00011237487,0.0008952218,0.0000048985266,0.0000067774918,0.00013755543,0.000020605243,0.0014521144,0.9899531,0.00014036521,0.007258686,0.0000026349219],"about_ca_topic_score_codex":0.000560838,"about_ca_topic_score_gemma":0.0012204854,"teacher_disagreement_score":0.0028804454,"about_ca_system_score_codex":0.00027262024,"about_ca_system_score_gemma":0.00021271082,"threshold_uncertainty_score":0.009636104},"labels":[],"label_agreement":null},{"id":"W4308977734","doi":"10.1093/neuonc/noac209.296","title":"CTNI-31. COG ACNS1721: PHASE 2 STUDY OF VELIPARIB AND LOCAL IRRADIATION, FOLLOWED BY MAINTENANCE VELIPARIB AND TEMOZOLOMIDE, IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA WITHOUT H3 K27M OR BRAF MUTATIONS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; PARP inhibitor; Oncology; Radiation therapy; Glioma; Interim analysis; Clinical trial; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.012898713778758715,"score_gpt":0.2864777575381292,"score_spread":0.2735790437593705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105257,0.0013664189,0.00028729552,0.0002465599,0.00010079127,0.0042844038,0.0011507876,0.000069888025,0.0014413601],"genre_scores_gemma":[0.98283523,0.0018440166,0.002243175,0.0005526194,0.0001438774,0.0062012295,0.0029836367,0.000031880423,0.0031642935],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951124,0.00022050152,0.000025254829,0.000100000114,0.000042092684,0.000100980775],"domain_scores_gemma":[0.9992879,0.00006333652,0.00010404979,0.000055474226,0.00004238815,0.00044692893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015614652,0.0019360165,0.002025557,0.0006791331,0.0005447961,0.00098862,0.0012546871,0.0009676974,0.004453212],"category_scores_gemma":[0.00068786,0.0007930623,0.0013559117,0.0006794627,0.0013269149,0.000757847,0.0004689765,0.0027910222,0.0009561272],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8658379,0.060588002,0.0043515866,0.00069810584,0.0007662653,0.00018180031,0.00019169883,0.0021380573,0.01923147,0.00028339602,0.0018234215,0.043908283],"study_design_scores_gemma":[0.6093206,0.37837666,0.006999692,0.00003264295,0.00036949982,0.00022030306,0.000044586744,0.00066786556,0.0020951885,0.0001624921,0.0016835426,0.00002697111],"about_ca_topic_score_codex":0.0022055474,"about_ca_topic_score_gemma":0.006856634,"teacher_disagreement_score":0.004453212,"about_ca_system_score_codex":0.0017027241,"about_ca_system_score_gemma":0.0035754,"threshold_uncertainty_score":0.014897466},"labels":[],"label_agreement":null},{"id":"W4308977735","doi":"10.1093/neuonc/noac209.019","title":"BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Cancer research; Protein kinase B; Medicine; Signal transduction; Biology; Genetics","score_opus":0.08886516930571865,"score_gpt":0.35031463791012984,"score_spread":0.2614494686044112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6125916,0.015151212,0.22667128,0.004904945,0.0010333703,0.0008835092,0.04335454,0.02351867,0.07189074],"genre_scores_gemma":[0.7745122,0.00379795,0.18079022,0.0013977208,0.00013287384,0.0007165337,0.019971492,0.0010710362,0.017610077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945086,0.00011675638,0.000030091314,0.00012350197,0.00022544629,0.000053265616],"domain_scores_gemma":[0.9996153,0.00010038424,0.00010886625,0.000056303314,0.000073550975,0.000045514742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012810309,0.00073884666,0.0005350393,0.00074461557,0.00020181322,0.00089522783,0.0005178117,0.0006880613,0.0056320354],"category_scores_gemma":[0.0007707021,0.00039062955,0.0003644676,0.0004925233,0.0004133299,0.00036842434,0.0007547458,0.0005915708,0.0036490266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001710019,0.00032293814,0.013823521,0.00082320167,0.00013174505,0.00019042796,0.00008855705,0.013082095,0.8167859,0.00426256,0.017591383,0.13118769],"study_design_scores_gemma":[0.00016718521,0.0012308893,0.014271438,0.000082889295,0.00010649766,0.00077242655,0.00007381142,0.05875742,0.8553462,0.0038810943,0.06523879,0.00007130059],"about_ca_topic_score_codex":0.00065768627,"about_ca_topic_score_gemma":0.0012715716,"teacher_disagreement_score":0.0056320354,"about_ca_system_score_codex":0.00068435166,"about_ca_system_score_gemma":0.00077826326,"threshold_uncertainty_score":0.018841088},"labels":[],"label_agreement":null},{"id":"W4308977915","doi":"10.1093/neuonc/noac209.200","title":"RADT-10. THE LOST METASTASES: DEEP LEARNING’S POTENTIAL IN RADIOSURGERY QUALITY ASSURANCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Centre Hospitalier de l’Université de Montréal; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Radiosurgery; False positive paradox; Radiology; Quality assurance; Medical physics; Radiation therapy; Nuclear medicine; Artificial intelligence; Computer science; Pathology","score_opus":0.017400297816076417,"score_gpt":0.32343560148428885,"score_spread":0.3060353036682124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47621882,0.009589912,0.45992458,0.008976243,0.0008219463,0.00034034337,0.0029158276,0.015861068,0.025351187],"genre_scores_gemma":[0.86744314,0.00083025964,0.12208132,0.00054163893,0.000074171425,0.00012384613,0.0020242697,0.00026767328,0.006613763],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99946815,0.00020119958,0.00002747871,0.00009465913,0.00014599493,0.0000625571],"domain_scores_gemma":[0.9986669,0.0006883263,0.00012533997,0.0001114599,0.00029838146,0.00010959655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025290211,0.0006067291,0.0003234004,0.0004768262,0.00020566964,0.000856764,0.0010885473,0.0010884621,0.0029833792],"category_scores_gemma":[0.003964932,0.0002341336,0.0003535633,0.00034133327,0.0003792739,0.0006468034,0.0008392395,0.0009961891,0.00064234197],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062618265,0.00037942667,0.016972413,0.0003506754,0.00016063107,0.00025419396,0.000070521906,0.430847,0.007852161,0.0070484965,0.02632935,0.50910896],"study_design_scores_gemma":[0.00001995285,0.000126466,0.0011376363,0.000028415165,0.000012826529,0.000060440754,0.000012084693,0.9880983,0.006216934,0.0018701224,0.0024060619,0.000010761948],"about_ca_topic_score_codex":0.005936138,"about_ca_topic_score_gemma":0.0060421354,"teacher_disagreement_score":0.005936138,"about_ca_system_score_codex":0.0010592191,"about_ca_system_score_gemma":0.0010309903,"threshold_uncertainty_score":0.013374925},"labels":[],"label_agreement":null},{"id":"W4308977924","doi":"10.1093/neuonc/noac209.120","title":"STEM-03. MOLECULAR PROFILING OF PRIMARY VERSUS RECURRENT GLIOBLASTOMA BRAIN TUMOR STEM CELLS UNCOVERS SIGNALING MECHANISMS THAT PROMOTE THE AGGRESSIVENESS OF RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Stem cell; Temozolomide; Cancer research; Brain tumor; Population; Cancer stem cell; Primary tumor; Medicine; Biology; Oncology; Cancer; Pathology; Internal medicine; Glioblastoma; Metastasis; Genetics","score_opus":0.024638354563905875,"score_gpt":0.2747157493756938,"score_spread":0.2500773948117879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722837,0.0017989298,0.0036259915,0.00017891663,0.000048740374,0.00014551506,0.01846965,0.00056034623,0.0028882811],"genre_scores_gemma":[0.9347682,0.0018817785,0.008510422,0.00031271522,0.000031410727,0.00040706966,0.046543103,0.000116587646,0.00742864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978024,0.000009918421,0.000017919052,0.00005761405,0.000089351735,0.000044984954],"domain_scores_gemma":[0.9998516,0.000020927424,0.00004455942,0.000010061219,0.000034241482,0.000038610033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019455771,0.00025061675,0.00042582655,0.0010317316,0.0003174843,0.0006607591,0.00020311687,0.0002964985,0.0032629503],"category_scores_gemma":[0.00021745774,0.00016909752,0.00032405532,0.0009478719,0.00021554212,0.00017343892,0.00022616594,0.00038636365,0.0008053738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060455897,0.00007754607,0.014292045,0.00022286407,0.00004221011,0.00018886398,0.00012785735,0.0002676433,0.96616423,0.0002412145,0.0010079909,0.01676304],"study_design_scores_gemma":[0.000052840864,0.0011789144,0.2391086,0.000045591834,0.00018852828,0.0010932955,0.0003495724,0.0040951865,0.7342991,0.0004121844,0.01915122,0.000024893317],"about_ca_topic_score_codex":0.0010075792,"about_ca_topic_score_gemma":0.002148345,"teacher_disagreement_score":0.0032629503,"about_ca_system_score_codex":0.00033830566,"about_ca_system_score_gemma":0.00037373288,"threshold_uncertainty_score":0.010915637},"labels":[],"label_agreement":null},{"id":"W4308977947","doi":"10.1093/neuonc/noac209.109","title":"CNSC-28. IDENTIFICATION OF EAG2-KVß2 POTASSIUM CHANNEL COMPLEX IN NEURON-GBM COMMUNICATIONS REVEALS GBM VULNERABILITY TO DESIGNER INTERFERENCE PEPTIDE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Cell growth; RNA interference; Biology; Potassium channel; Regulator; Cell; Neuroscience; Cell biology; Endocrinology; Gene; RNA; Biochemistry","score_opus":0.052973766892466204,"score_gpt":0.32683669675710086,"score_spread":0.2738629298646347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873447,0.00094452995,0.0049738362,0.00015856158,0.000080901336,0.00009645444,0.002654151,0.00014754159,0.0035993652],"genre_scores_gemma":[0.98026544,0.0005726041,0.0053003104,0.00018873496,0.000008011568,0.00011428679,0.007401276,0.00007723067,0.006072016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984074,0.000014753894,0.000014022175,0.00004102273,0.00005150283,0.00003792029],"domain_scores_gemma":[0.9999231,0.000010124813,0.000016113654,0.000010726404,0.00001716129,0.000022827762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011723293,0.0002759447,0.00026670282,0.00018879007,0.00023482821,0.00020137074,0.0002941949,0.00028267072,0.002584609],"category_scores_gemma":[0.00012257052,0.00012228462,0.00026644155,0.00016265867,0.00018467166,0.00009616365,0.00015899086,0.0004406403,0.0008315361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006938849,0.000020086696,0.000100709236,0.000017115663,0.0000045474344,0.000037727088,0.0000058595215,0.000050535768,0.99891806,0.00006881857,0.000111388144,0.00059585884],"study_design_scores_gemma":[0.000030402927,0.00021730675,0.0036683392,0.000006648305,0.000017612232,0.000336003,0.00001900849,0.0016717528,0.9890698,0.00005475988,0.004902586,0.000005794476],"about_ca_topic_score_codex":0.0022369237,"about_ca_topic_score_gemma":0.0029993725,"teacher_disagreement_score":0.002584609,"about_ca_system_score_codex":0.00047491584,"about_ca_system_score_gemma":0.00028313193,"threshold_uncertainty_score":0.008646369},"labels":[],"label_agreement":null},{"id":"W4308977979","doi":"10.1093/neuonc/noac209.1140","title":"MODL-12. A NOVEL GENETICALLY ENGINEERED H3.3G34R MODEL REVEALS COOPERATION WITH ATRX LOSS IN UPREGULATION OF HOXA CLUSTER GENES AND PROMOTION OF NEURONAL LINEAGE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Context (archaeology); Biology; Gene; Cancer research; Genetics; Mutation","score_opus":0.0237888244673174,"score_gpt":0.26931468147261517,"score_spread":0.24552585700529778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839244,0.00076438865,0.008310884,0.00047926803,0.00015129622,0.00019502426,0.0029129519,0.0006241684,0.0026375575],"genre_scores_gemma":[0.9758614,0.0005429013,0.009195799,0.0001601972,0.000028452585,0.00031649458,0.0023170712,0.0002086096,0.011368993],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999655,0.00004211733,0.000037827325,0.00008554114,0.0000955456,0.00008401969],"domain_scores_gemma":[0.99968433,0.00002513703,0.00013148146,0.000027026075,0.000015576501,0.00011646357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003428006,0.0005755342,0.0004042007,0.00082556385,0.0003002672,0.00042066263,0.00062982703,0.0007576091,0.002705062],"category_scores_gemma":[0.00009734544,0.00029707263,0.00039560476,0.0002994339,0.00047918645,0.00027948257,0.00033243943,0.0014513957,0.0010342618],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003024992,0.00013036859,0.00017356148,0.000026269694,0.000006255818,0.0001184378,0.000019788467,0.00009907634,0.99780315,0.00036631792,0.00012931372,0.0008249345],"study_design_scores_gemma":[0.00013607786,0.0011253774,0.0022852125,0.000012594237,0.000024234761,0.0006296882,0.00005451298,0.0018941581,0.98617595,0.00010730041,0.0075454675,0.000009403655],"about_ca_topic_score_codex":0.0008625141,"about_ca_topic_score_gemma":0.0014692527,"teacher_disagreement_score":0.002705062,"about_ca_system_score_codex":0.0006540917,"about_ca_system_score_gemma":0.00041626743,"threshold_uncertainty_score":0.009049356},"labels":[],"label_agreement":null},{"id":"W4308978003","doi":"10.1093/neuonc/noac209.916","title":"QLTI-14. PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR SURVIVOR AND CAREGIVER EXPERIENCES WITH MULTIDISCIPLINARY TELEMEDICINE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Telemedicine; Telehealth; Medicine; Pediatric oncology; Survivorship curve; Pediatric cancer; Multidisciplinary approach; Demographics; Family medicine; Medical emergency; Health care; Cancer; Internal medicine","score_opus":0.020120244840176594,"score_gpt":0.30895029268460766,"score_spread":0.28883004784443106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308978003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955734,0.00014727685,0.00008138622,0.0005636021,0.00002194156,0.00007799408,0.00047467792,0.000010681913,0.0030490132],"genre_scores_gemma":[0.99817526,0.00023503882,0.00022436546,0.00014492507,0.000011833974,0.00013910378,0.0003763536,0.0000042530737,0.0006889444],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99869543,0.00052222644,0.00014995351,0.00006421257,0.00023834324,0.00032976232],"domain_scores_gemma":[0.9905538,0.0019865902,0.0035321047,0.00019112475,0.00123938,0.0024970197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025384077,0.00018224024,0.0002831511,0.00067089376,0.0011047417,0.0012135671,0.00043294317,0.0003158877,0.0060140444],"category_scores_gemma":[0.009068255,0.00019558123,0.00049177086,0.00062276627,0.00040410087,0.0007085594,0.001755876,0.00083446666,0.00041446605],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011021158,0.0003528713,0.9515215,0.00016521414,0.000044257573,0.00039195194,0.021693332,0.0001099228,0.00023266576,0.00010623981,0.004747545,0.020524343],"study_design_scores_gemma":[0.000020911542,0.00036099667,0.9241234,0.00015750088,0.000025225121,0.0005660579,0.06843732,0.00030042414,0.00021202206,0.000051834657,0.0057218038,0.000022500117],"about_ca_topic_score_codex":0.010638972,"about_ca_topic_score_gemma":0.012764035,"teacher_disagreement_score":0.010638972,"about_ca_system_score_codex":0.001515616,"about_ca_system_score_gemma":0.0015947684,"threshold_uncertainty_score":0.021154106},"labels":[],"label_agreement":null},{"id":"W4309013902","doi":"10.1093/neuonc/noac209.397","title":"DDDR-32. A NEW IMMUNOMODULATORY FUNCTION OF PYRIDO-PYRIMIDINE DERIVATIVES TO IMPAIR METASTATIC GROUP 3 MEDULLOBLASTOMA IN VIVO","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medulloblastoma; In vivo; Cancer research; Epithelial–mesenchymal transition; Vincristine; Medicine; Pharmacology; Biology; Oncology; Metastasis; Chemotherapy; Internal medicine; Chemistry; Cancer; Cyclophosphamide","score_opus":0.022728537731646185,"score_gpt":0.28986979557692005,"score_spread":0.26714125784527387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309013902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871996,0.005179651,0.0028463502,0.00021392331,0.00009803711,0.00012714585,0.0008660962,0.0001636596,0.0033056352],"genre_scores_gemma":[0.99186885,0.002165329,0.0020737846,0.00007399819,0.000012307852,0.00007373874,0.0008189248,0.000011741692,0.0029012356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999951,0.000010638894,0.0000046069163,0.000010398304,0.000010604292,0.000012755344],"domain_scores_gemma":[0.99997115,0.0000047359667,0.000005937457,0.00000393201,0.0000035366104,0.000010662725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082721905,0.00028452012,0.00019239435,0.00018602557,0.000090956564,0.00011228452,0.00013659382,0.00018995852,0.001840814],"category_scores_gemma":[0.000058713307,0.00006866629,0.00017246629,0.000101000405,0.00011588221,0.0001280199,0.00008764054,0.0004364715,0.00028106503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046384544,0.00018603074,0.00010176936,0.0001242549,0.000010258892,0.00007185124,0.000017110737,0.00020565427,0.9930662,0.00016391404,0.00019667132,0.0053924136],"study_design_scores_gemma":[0.00024229339,0.003589841,0.0020410933,0.000014844477,0.000036340418,0.000328162,0.000015902639,0.00071935717,0.9845632,0.000074273936,0.008365921,0.000008748558],"about_ca_topic_score_codex":0.0004448502,"about_ca_topic_score_gemma":0.00060908403,"teacher_disagreement_score":0.001840814,"about_ca_system_score_codex":0.0001330696,"about_ca_system_score_gemma":0.00017618215,"threshold_uncertainty_score":0.0061581135},"labels":[],"label_agreement":null},{"id":"W4309014060","doi":"10.1093/neuonc/noac209.507","title":"IMMU-09. IMMUNOLOGICAL CHARACTERIZATION OF PEDIATRIC BRAIN TUMORS HAS CLINICAL IMPLICATIONS FOR PATIENT MANAGEMENT AND PROGNOSIS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Inflammation; Immunotherapy; Immune system; Glioma; Medicine; Brain tumor; Tumor microenvironment; Cancer research; Biomarker; Immunology; Pathology; Biology","score_opus":0.052818894544610306,"score_gpt":0.33387839038335715,"score_spread":0.28105949583874684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843919,0.0047596125,0.0017208806,0.00038340042,0.000071358794,0.000067598005,0.002864287,0.000114535425,0.005626371],"genre_scores_gemma":[0.99153274,0.0010120693,0.0032822806,0.00014350284,0.0000530636,0.00006911861,0.0028839218,0.000025645153,0.0009976563],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996797,0.00006900779,0.000026121756,0.000058919028,0.00009190896,0.00007440516],"domain_scores_gemma":[0.9994536,0.00007108183,0.00025416084,0.00002945396,0.00009005883,0.00010162832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006798364,0.00032413873,0.0003357124,0.00066055224,0.00020981627,0.0006099505,0.00023149961,0.0002461725,0.0020371848],"category_scores_gemma":[0.00071629684,0.00011245703,0.00019217655,0.0005806233,0.00019114059,0.00023935597,0.0003425533,0.00047694624,0.00070529565],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014201729,0.00014545108,0.90395886,0.00015456718,0.00008845254,0.0004250292,0.0000826509,0.0005305007,0.035497285,0.00037388285,0.002862672,0.054460462],"study_design_scores_gemma":[0.000043610384,0.00091702136,0.93176234,0.000073290204,0.00013387007,0.0044729467,0.00025838806,0.002720611,0.03979954,0.00048364289,0.019318381,0.000016457247],"about_ca_topic_score_codex":0.0006668072,"about_ca_topic_score_gemma":0.0010536124,"teacher_disagreement_score":0.0020371848,"about_ca_system_score_codex":0.00053958583,"about_ca_system_score_gemma":0.00033618193,"threshold_uncertainty_score":0.006815076},"labels":[],"label_agreement":null},{"id":"W4309014071","doi":"10.1093/neuonc/noac209.469","title":"EPCO-35. THE ZINC FINGER IN THE CEREBELLUM (ZIC1/4) LOCUS IS A CONTEXT DEPENDENT DRIVER GENE IN MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Chromatin; Medulloblastoma; Genetics; Cancer research; Gene; Phenotype; High-mobility group; Context (archaeology); Histone","score_opus":0.01804259810641576,"score_gpt":0.26511078014504835,"score_spread":0.2470681820386326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668,0.0003162739,0.0011546785,0.000016409193,0.000005962556,0.000021804799,0.0010704114,0.00007408391,0.0006603251],"genre_scores_gemma":[0.99686915,0.00017028033,0.000641622,0.00001250866,0.0000013227556,0.000014235318,0.0012209113,0.000013772274,0.0010562403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999879,0.000007132103,0.000006814352,0.00004076915,0.000043640703,0.000022667396],"domain_scores_gemma":[0.9999409,0.000008169224,0.000021396785,0.0000079133615,0.000005835626,0.000015867476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008037652,0.00017598135,0.00015423626,0.00036983247,0.00013402836,0.00019663585,0.00017496459,0.00014320442,0.0012085675],"category_scores_gemma":[0.00016948492,0.00013095136,0.00017119356,0.00019794267,0.00015960254,0.000059984122,0.00019633365,0.0002153833,0.00028010146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097911834,0.000010716302,0.006572418,0.000023373697,0.000014578534,0.00019994272,0.000017762079,0.00013588928,0.9907479,0.000072589246,0.00007294754,0.002034042],"study_design_scores_gemma":[0.000038392584,0.00021636019,0.42070353,0.000013729423,0.00008854991,0.0021513002,0.00006637593,0.0027582792,0.56803596,0.0001632593,0.0057525723,0.000011659713],"about_ca_topic_score_codex":0.00572595,"about_ca_topic_score_gemma":0.008477519,"teacher_disagreement_score":0.00572595,"about_ca_system_score_codex":0.00046254383,"about_ca_system_score_gemma":0.00024361463,"threshold_uncertainty_score":0.011385262},"labels":[],"label_agreement":null},{"id":"W4309014292","doi":"10.1093/neuonc/noac209.472","title":"EPCO-38. TYPE B ULTRA LONG-RANGE INTERACTIONS IN PFAS (TULIPS) ARE RECURRENT EPIGENOMIC FEATURES OF PFA EPENDYMOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; Université de Montréal; University of Calgary; McGill University; Centre Hospitalier Universitaire Sainte-Justine; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Epigenomics; Epigenetics; Ependymoma; Genome; Genetics; Bisulfite sequencing; Computational biology; DNA methylation; Gene; Pathology; Medicine; Gene expression","score_opus":0.03514456935066453,"score_gpt":0.3296389742227801,"score_spread":0.2944944048721156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685174,0.00033169653,0.0013553838,0.000021245742,0.0000044397284,0.000012043358,0.0007025324,0.000047133264,0.000673734],"genre_scores_gemma":[0.9979393,0.00010064271,0.0007403779,0.000018305429,0.000002570619,0.000010223486,0.0008123845,0.000016466316,0.0003597981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998797,0.0000053239883,0.000009543843,0.00004374862,0.00003280516,0.00002886466],"domain_scores_gemma":[0.9998,0.000031623433,0.000069530004,0.000021722884,0.000023023591,0.000054101652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072195246,0.00018892945,0.0001551974,0.0005310202,0.00027263013,0.00029906156,0.00015153775,0.00017534602,0.0021673227],"category_scores_gemma":[0.00026045027,0.00009489888,0.00019533487,0.00038265984,0.00019030969,0.00013271668,0.0003029835,0.0002988854,0.00040093908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032746102,0.0000243501,0.09024431,0.00006965123,0.00006622693,0.003251937,0.00014641277,0.00015715258,0.8956336,0.00013800284,0.0002888968,0.009651988],"study_design_scores_gemma":[0.000012710767,0.00016871686,0.8238531,0.000016175445,0.00008007338,0.01923583,0.00036994374,0.0011764454,0.150161,0.00025947363,0.004653609,0.000012861824],"about_ca_topic_score_codex":0.0012801681,"about_ca_topic_score_gemma":0.0019214409,"teacher_disagreement_score":0.0021673227,"about_ca_system_score_codex":0.00018171586,"about_ca_system_score_gemma":0.000106772146,"threshold_uncertainty_score":0.0072503686},"labels":[],"label_agreement":null},{"id":"W4309014302","doi":"10.1093/neuonc/noac209.435","title":"EPID-25. THE CLINICAL AND MOLECULAR LANDSCAPE OF GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Cohort; Young adult; Internal medicine; Oncology; Cancer research","score_opus":0.0197734005871599,"score_gpt":0.3174353657158528,"score_spread":0.2976619651286929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944537,0.000928106,0.00007428867,0.00008624008,0.0000093491335,0.00001649565,0.0024607377,0.000009910333,0.0019611893],"genre_scores_gemma":[0.99713,0.00041007056,0.00010743587,0.000035728874,0.000011439559,0.000020166168,0.0016269672,0.000003876689,0.00065439567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985826,0.00002444348,0.000017145045,0.000033881046,0.000026305983,0.000039924827],"domain_scores_gemma":[0.99953663,0.000039182894,0.00023264666,0.00000823354,0.000060992672,0.00012232756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019000273,0.00013226426,0.00017657585,0.0006889225,0.00023548897,0.00041000012,0.00010702893,0.00014488089,0.0027598788],"category_scores_gemma":[0.00074037927,0.00008047968,0.00014856453,0.00080906367,0.00011633416,0.00023398252,0.0003069212,0.00017449791,0.00049530243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055273405,0.000011925917,0.994672,0.000023356737,0.000010492245,0.00029200758,0.0000539617,0.00002170673,0.0001894195,0.000034623798,0.00031325806,0.00432204],"study_design_scores_gemma":[0.0000024999686,0.00007011553,0.9972187,0.000016671504,0.000010410736,0.0011704045,0.0001829037,0.000029255803,0.00008286444,0.000031201827,0.0011836273,0.0000011838638],"about_ca_topic_score_codex":0.0027870596,"about_ca_topic_score_gemma":0.0038547758,"teacher_disagreement_score":0.0027870596,"about_ca_system_score_codex":0.00022359003,"about_ca_system_score_gemma":0.00030019134,"threshold_uncertainty_score":0.0092327},"labels":[],"label_agreement":null},{"id":"W4309014408","doi":"10.1093/neuonc/noac209.452","title":"EPCO-17. UNMASKING CLONAL EVOLUTION OF DIFFUSE INTRINSIC GLIOMA USING MULTI-MODAL GENOMIC DATA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Somatic evolution in cancer; Epigenome; DNA methylation; Transcriptome; Genetics; Glioma; Exome sequencing; Epigenomics; Exome; Genome; Phenotype; Computational biology; Gene; Gene expression","score_opus":0.06440820373949774,"score_gpt":0.3327576589872273,"score_spread":0.2683494552477296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726273,0.0010516009,0.011215643,0.00024881685,0.000050348383,0.00010163303,0.012114991,0.00054559304,0.0020440384],"genre_scores_gemma":[0.95868284,0.00038390042,0.019446582,0.00013172324,0.000034999244,0.00014997156,0.019622777,0.00016292415,0.0013843124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997259,0.00002920267,0.000021663409,0.000106489686,0.000068644375,0.000048068887],"domain_scores_gemma":[0.9992353,0.00019132847,0.00019226588,0.000088752175,0.00017235636,0.000120000186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048946805,0.00019298303,0.00031755512,0.00094526773,0.00024390026,0.00052840606,0.00024907693,0.00031552653,0.002249041],"category_scores_gemma":[0.0011618211,0.00016531274,0.00025810336,0.00067096954,0.00017311212,0.00020706293,0.0004068862,0.00034912443,0.0006789083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016004544,0.00013090606,0.361663,0.00061580125,0.00028265655,0.0015770039,0.00038829452,0.0040041003,0.51439375,0.0008599029,0.0048257187,0.10965844],"study_design_scores_gemma":[0.00013970213,0.0007166087,0.6582205,0.00013273257,0.0004005286,0.007410081,0.00047598052,0.04875201,0.23997852,0.0016918384,0.04200382,0.00007772866],"about_ca_topic_score_codex":0.0014823469,"about_ca_topic_score_gemma":0.0048348648,"teacher_disagreement_score":0.002249041,"about_ca_system_score_codex":0.0003081353,"about_ca_system_score_gemma":0.00042798131,"threshold_uncertainty_score":0.007523775},"labels":[],"label_agreement":null},{"id":"W4309014415","doi":"10.1093/neuonc/noac209.398","title":"DDDR-33. TARGETING TGFΒ PATHWAY DEPENDENCIES IN GROUP 3 MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medulloblastoma; Cancer research; Effector; Biology; Transforming growth factor; Cell biology","score_opus":0.01805968335924277,"score_gpt":0.27305550557854463,"score_spread":0.25499582221930184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925296,0.0015545313,0.0022809028,0.00018137925,0.00006537903,0.00020744902,0.0007653963,0.00016709056,0.002248163],"genre_scores_gemma":[0.99274105,0.0012356887,0.0019107681,0.00007839563,0.000006965762,0.00011191978,0.0007685399,0.000024144108,0.0031225572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.000013672371,0.000008805073,0.000015826174,0.00003089493,0.00003375387],"domain_scores_gemma":[0.99995565,0.0000049744935,0.000013167396,0.0000057487346,0.000003726786,0.000016845386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015835572,0.0003270401,0.00026426357,0.0002951304,0.00012204104,0.00024606293,0.00021608226,0.00024769388,0.0016939177],"category_scores_gemma":[0.00006349851,0.00013932778,0.00029324,0.00016353892,0.0002138329,0.00012762086,0.0001700536,0.0007257333,0.00042297877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005078026,0.0003531115,0.00040073742,0.00010827606,0.000017519573,0.00021436145,0.000046441044,0.00048358974,0.98950547,0.0004100091,0.00034769584,0.0076048165],"study_design_scores_gemma":[0.00036245768,0.005061333,0.0050171064,0.000021642913,0.00007358523,0.0008350838,0.00007881725,0.0017356521,0.969676,0.00013427278,0.016990919,0.000012982249],"about_ca_topic_score_codex":0.0012091738,"about_ca_topic_score_gemma":0.0030167387,"teacher_disagreement_score":0.0016939177,"about_ca_system_score_codex":0.000345571,"about_ca_system_score_gemma":0.00033931652,"threshold_uncertainty_score":0.005666673},"labels":[],"label_agreement":null},{"id":"W4309014483","doi":"10.1093/neuonc/noac209.399","title":"DDDR-34. RECURRENT RELA FUSION-POSITIVE EPENDYMOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: A CASE REPORT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Ependymoma; Medicine; Carboplatin; Internal medicine; Oncology; Neutropenia; Temozolomide; Chemotherapy; Gastroenterology; Surgery; Cisplatin","score_opus":0.03688535145602527,"score_gpt":0.33629641486761613,"score_spread":0.29941106341159085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827011,0.0041406075,0.0022689835,0.0019857646,0.00025633612,0.00021688695,0.0002964852,0.0002841658,0.00784955],"genre_scores_gemma":[0.9956864,0.0008152998,0.00065882015,0.0006757545,0.00023616546,0.000022216635,0.00014881791,0.000028682873,0.0017278992],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963963,0.000027362445,0.000034536402,0.00011551473,0.000059807662,0.00012309947],"domain_scores_gemma":[0.99949026,0.00006731167,0.00009743417,0.000055474717,0.000029862134,0.00025956664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021476751,0.001246848,0.0012557923,0.0009642986,0.00163128,0.00087600795,0.00090326555,0.0034035973,0.0015438711],"category_scores_gemma":[0.0007610669,0.00072944735,0.0014012293,0.00074830244,0.00083677453,0.0009764448,0.00083601585,0.0027093156,0.0009084811],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007412196,0.000060601044,0.0023834573,0.000019579737,0.0000122210595,0.9945205,0.00005642533,0.000058795224,0.001344695,0.00005494798,0.00012994054,0.0012846872],"study_design_scores_gemma":[0.00004218278,0.00028966003,0.004910749,0.000009175978,0.00003692084,0.992153,0.000049181497,0.00045854895,0.001245054,0.0000826552,0.000710393,0.00001242012],"about_ca_topic_score_codex":0.0022444532,"about_ca_topic_score_gemma":0.0030092988,"teacher_disagreement_score":0.0034035973,"about_ca_system_score_codex":0.0011619582,"about_ca_system_score_gemma":0.0006185362,"threshold_uncertainty_score":0.00843066},"labels":[],"label_agreement":null},{"id":"W4309014865","doi":"10.1093/neuonc/noac209.401","title":"DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Texas MD Anderson Cancer Center","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Clinical trial; Dexamethasone; Oncology; Refractory (planetary science); Adverse effect; Radiosurgery; PTEN; Gastroenterology; Surgery; Radiation therapy; Chemotherapy","score_opus":0.024971132027790763,"score_gpt":0.32462487955634184,"score_spread":0.29965374752855106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991769,0.00029590854,0.000027788768,0.00006163098,0.0000068832355,0.000020425457,0.00008855271,0.000007984365,0.00031385804],"genre_scores_gemma":[0.9993476,0.000096995405,0.00006599912,0.000095831645,0.000012425573,0.000018846109,0.00025282174,0.0000020879895,0.00010749659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973375,0.00008916669,0.00002670143,0.00005289107,0.000030754443,0.00006671371],"domain_scores_gemma":[0.9995716,0.000046654575,0.00012159999,0.000019471254,0.000022214317,0.00021851456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422495,0.0001973767,0.0005877833,0.000242954,0.00027210815,0.00040364295,0.0002468346,0.00038116964,0.00079774414],"category_scores_gemma":[0.00054964,0.00011233099,0.00039705881,0.00047773955,0.00026164093,0.00023000705,0.0003325025,0.0005327881,0.00016514857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04153117,0.0036449253,0.8755847,0.00011614665,0.00041406826,0.002887954,0.00032474165,0.00075118965,0.016369201,0.0001283541,0.0017791634,0.056468446],"study_design_scores_gemma":[0.0052518086,0.05605531,0.9251889,0.000043523392,0.000425504,0.0045912513,0.00025117883,0.0017105883,0.0024219623,0.0002257349,0.003796348,0.000037992162],"about_ca_topic_score_codex":0.002925,"about_ca_topic_score_gemma":0.0040076734,"teacher_disagreement_score":0.002925,"about_ca_system_score_codex":0.00063787116,"about_ca_system_score_gemma":0.0006449786,"threshold_uncertainty_score":0.005815923},"labels":[],"label_agreement":null},{"id":"W4309014874","doi":"10.1093/neuonc/noac209.410","title":"EOLP-05. POSTMORTEM TISSUE DONATION: GIVING FAMILIES THE ABILITY TO CHOOSE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Conversation; Donation; Organ donation; Medicine; Health care; Health professionals; Psychology; Family medicine; Social psychology; Transplantation; Public relations; Political science; Surgery; Law; Communication","score_opus":0.08955006624669676,"score_gpt":0.41093308561708813,"score_spread":0.3213830193703914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014874","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3183122,0.0028555733,0.012357337,0.27955955,0.0071385223,0.0026983183,0.012768036,0.0032696284,0.36104086],"genre_scores_gemma":[0.6304145,0.005632594,0.0661229,0.11408975,0.002339897,0.011891485,0.012656996,0.0012602133,0.15559168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972029,0.0017516338,0.000116277006,0.00010306623,0.00031629953,0.0005098887],"domain_scores_gemma":[0.97913367,0.004562926,0.00088032056,0.0011200872,0.0028646449,0.011438435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010694126,0.00021171915,0.00019452488,0.00038557185,0.0029131891,0.0018336044,0.0012836929,0.001451037,0.06591911],"category_scores_gemma":[0.0259408,0.00022999343,0.00041207173,0.00034065061,0.0008164358,0.001766563,0.0063892193,0.002944996,0.013159206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064051634,0.001579633,0.010880722,0.00028058887,0.000013335287,0.000512288,0.0039297557,0.00013419366,0.00028508893,0.0029950922,0.6593359,0.31941292],"study_design_scores_gemma":[0.0006336962,0.0016865896,0.027181203,0.0017013317,0.00003708051,0.0017113166,0.012772522,0.000345953,0.0011263571,0.006118947,0.94659346,0.00009150387],"about_ca_topic_score_codex":0.002267843,"about_ca_topic_score_gemma":0.006447146,"teacher_disagreement_score":0.06591911,"about_ca_system_score_codex":0.0021156974,"about_ca_system_score_gemma":0.007830353,"threshold_uncertainty_score":0.22052139},"labels":[],"label_agreement":null},{"id":"W4309014881","doi":"10.1093/neuonc/noac209.396","title":"DDDR-31. THE THERAPEUTIC POTENTIAL OF THE LONG NON-CODING RNA LNC-HLX-2-7 IN GROUP 3 MEDULLOBLASTOMAS IN CHILDREN","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Biology; Chromatin immunoprecipitation; Cancer research; Medulloblastoma; RNA; Enhancer; Long non-coding RNA; Promoter; Gene; Gene expression; Genetics","score_opus":0.007836248946568576,"score_gpt":0.26234683628395244,"score_spread":0.25451058733738385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349,0.0028788485,0.0010738488,0.000108016655,0.00004752531,0.000090969035,0.00032304268,0.00009221496,0.0018955037],"genre_scores_gemma":[0.99563795,0.00088292995,0.0013806126,0.000052979583,0.000008925584,0.0000575134,0.0004170701,0.000012461416,0.0015496574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999145,0.000014842598,0.0000042439347,0.000019433384,0.00002321176,0.000023602468],"domain_scores_gemma":[0.9999653,0.0000053934887,0.000008841926,0.000003358482,0.0000031810873,0.000013952765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011844468,0.00022317622,0.0002547153,0.00014863652,0.000100748,0.00018700658,0.00015291625,0.00023978033,0.0012860586],"category_scores_gemma":[0.00006884823,0.00007928239,0.00019351259,0.000092665396,0.00019563161,0.000104176965,0.00017476082,0.00039396578,0.00024328573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090769,0.00021336382,0.0013604901,0.00012905699,0.000029041077,0.00020553662,0.00004997747,0.00040715744,0.9828876,0.00023780626,0.00029604923,0.013276069],"study_design_scores_gemma":[0.000475327,0.009416686,0.013638155,0.000019663032,0.000092676,0.0010169207,0.000083923886,0.0016466238,0.9589567,0.00008850023,0.0145522,0.000012570653],"about_ca_topic_score_codex":0.0012973333,"about_ca_topic_score_gemma":0.0024062674,"teacher_disagreement_score":0.0012973333,"about_ca_system_score_codex":0.00032650863,"about_ca_system_score_gemma":0.0004196911,"threshold_uncertainty_score":0.004302323},"labels":[],"label_agreement":null},{"id":"W4309015204","doi":"10.1093/neuonc/noac209.677","title":"NIMG-59. EVALUATION OF THE RESPONSE ASSESSMENT CRITERIA IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fluid-attenuated inversion recovery; Glioblastoma; Correlation; Population; Nuclear medicine; Oncology; Internal medicine; Surgery; Radiology; Magnetic resonance imaging; Cancer research","score_opus":0.03871838840867693,"score_gpt":0.37675921570429155,"score_spread":0.33804082729561463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956728,0.00088782527,0.00061265583,0.00010258249,0.000025652225,0.00009780595,0.00060459087,0.00003061588,0.001965601],"genre_scores_gemma":[0.99776685,0.00010614993,0.00097367744,0.000054524444,0.00001678178,0.000104019804,0.00076615287,0.00001230637,0.00019961814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970624,0.0014140635,0.000373587,0.00035447735,0.0006204101,0.00017505912],"domain_scores_gemma":[0.99484503,0.001614898,0.002004596,0.00027212917,0.0008828841,0.0003803721],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006055455,0.0002855925,0.0008193404,0.00167713,0.00021116858,0.0005154423,0.0005080633,0.00032926787,0.0006440618],"category_scores_gemma":[0.011351713,0.00010567879,0.0005220437,0.0010706822,0.00028892196,0.0003432828,0.0006440937,0.00029141284,0.00033759087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002613005,0.00007369703,0.9640697,0.00008968249,0.00019021393,0.00015851147,0.00012363183,0.00047329505,0.0017286348,0.00007241324,0.00066233653,0.029744767],"study_design_scores_gemma":[0.00009014979,0.0005808777,0.994344,0.000023745608,0.000107961554,0.00047507707,0.00008996779,0.0021551198,0.00089857954,0.00008532182,0.0011372209,0.000011988786],"about_ca_topic_score_codex":0.0026098893,"about_ca_topic_score_gemma":0.003911757,"teacher_disagreement_score":0.9939445,"about_ca_system_score_codex":0.000773609,"about_ca_system_score_gemma":0.0005193227,"threshold_uncertainty_score":0.03202474},"labels":[],"label_agreement":null},{"id":"W4309015237","doi":"10.1093/neuonc/noac209.133","title":"STEM-16. MACROH2A2 REPRESSES AN EPIGENETIC SELF-RENEWAL NETWORK IN GLIOBLASTOMA STEM CELLS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; McGill University; University of Calgary","funders":"","keywords":"Epigenetics; Psychological repression; Biology; Gene knockdown; Stem cell; Chromatin; Cancer research; Phenotype; Downregulation and upregulation; Histone; Repressor; Glioblastoma; IRF4; Enhancer; Cell biology; Gene expression; Gene; Genetics; Transcription factor","score_opus":0.01014786125436833,"score_gpt":0.24897101861208995,"score_spread":0.2388231573577216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932749,0.0016095148,0.001968586,0.0001252302,0.00003412839,0.0000260041,0.00069358456,0.00010317752,0.0021648302],"genre_scores_gemma":[0.9961175,0.00028839445,0.0006757841,0.000055510525,0.0000067944616,0.000022365952,0.0005396932,0.000010502284,0.00228352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999403,0.000009458466,0.00000491062,0.000013082629,0.00002172587,0.00001054454],"domain_scores_gemma":[0.99993694,0.000009172413,0.000017750843,0.000006452694,0.0000065349423,0.000023060213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008698046,0.0001431191,0.00020313468,0.00016259665,0.00011604177,0.00024579704,0.00009757945,0.00012796596,0.0014942253],"category_scores_gemma":[0.00006279769,0.00007993236,0.00012897661,0.00010875962,0.00016161281,0.00008158387,0.00012714593,0.0002103158,0.00028238707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052366337,0.0000070316332,0.00028431293,0.000014732071,0.0000040506516,0.00003179482,0.000004172968,0.000042332515,0.9987437,0.00005922079,0.000039451206,0.00071688974],"study_design_scores_gemma":[0.000014795776,0.00021459644,0.010369767,0.000003201026,0.000010990036,0.00017540995,0.000022619679,0.0008221052,0.9850819,0.00005321004,0.0032280942,0.0000032933715],"about_ca_topic_score_codex":0.0004771108,"about_ca_topic_score_gemma":0.0011086124,"teacher_disagreement_score":0.0014942253,"about_ca_system_score_codex":0.0002161851,"about_ca_system_score_gemma":0.00012889817,"threshold_uncertainty_score":0.004998684},"labels":[],"label_agreement":null},{"id":"W4309015243","doi":"10.1093/neuonc/noac209.910","title":"QLTI-08. SURVEY OF CANADIAN NEURO-ONCOLOGY CLINICIANS ABOUT THE TREATMENT OF ADULT MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Lomustine; Medicine; Medulloblastoma; Vincristine; Regimen; Population; Oncology; Chemotherapy; Internal medicine; Chemotherapy regimen; Carboplatin; Cyclophosphamide; Cisplatin; Pathology","score_opus":0.04468450738810469,"score_gpt":0.32469772969155547,"score_spread":0.28001322230345077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91495353,0.0018361071,0.00017124318,0.014931583,0.00008773053,0.0004813164,0.037858505,0.00007732527,0.029602615],"genre_scores_gemma":[0.9844061,0.0016106401,0.0007049753,0.0035639887,0.0000519177,0.00024365351,0.005977982,0.000014841585,0.0034259446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997347,0.00034609728,0.00035272827,0.0002486399,0.0011863807,0.0005190409],"domain_scores_gemma":[0.9829584,0.0016904201,0.0051923045,0.00015333857,0.006441801,0.0035637023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019261965,0.00014809171,0.00020079882,0.0014978303,0.0019032756,0.00096131326,0.000847779,0.00054275506,0.0044038827],"category_scores_gemma":[0.010666043,0.00025754658,0.00024120173,0.0039352616,0.0005706063,0.00041284258,0.00063817855,0.0006391509,0.00068959343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078487574,0.00004846111,0.95747894,0.00029414755,0.000015861327,0.00015325978,0.003473597,0.00008292581,0.00026467815,0.00009912499,0.026283056,0.011727428],"study_design_scores_gemma":[0.00000993824,0.0000324848,0.98773205,0.000098806064,0.0000048150305,0.000082210645,0.0040479745,0.000110721194,0.000047051482,0.000012732628,0.007810511,0.000010630943],"about_ca_topic_score_codex":0.96418554,"about_ca_topic_score_gemma":0.97379774,"teacher_disagreement_score":0.96418554,"about_ca_system_score_codex":0.025199424,"about_ca_system_score_gemma":0.028047336,"threshold_uncertainty_score":0.18283552},"labels":[],"label_agreement":null},{"id":"W4309015489","doi":"10.1093/neuonc/noac209.110","title":"CNSC-29. INVESTIGATING THE INFLUENCE OF DOPAMINERGIC ACTIVITY ON THE GLIOBLASTOMA NICHE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroscience; Dopamine; Biology; Dopaminergic; Neurotransmitter; Neurotransmitter receptor; Context (archaeology); Neural stem cell; Stem cell; Central nervous system; Receptor; Cell biology; Genetics","score_opus":0.03546660014543478,"score_gpt":0.3122072322256023,"score_spread":0.2767406320801675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648313,0.0045943186,0.0075142235,0.0005407012,0.00043396122,0.00038487243,0.007194105,0.00032758378,0.014178935],"genre_scores_gemma":[0.9753263,0.0018266528,0.006827526,0.00041505013,0.000030567757,0.00047211166,0.0065865293,0.00010387492,0.008411394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995652,0.000043007112,0.00003252818,0.00008172353,0.00018968066,0.000087815206],"domain_scores_gemma":[0.9997806,0.000024837633,0.000030013927,0.000026060045,0.00006198219,0.00007651187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041856695,0.0002631643,0.00047417716,0.0004160086,0.00037882582,0.00043224913,0.0003264666,0.00039844602,0.003824996],"category_scores_gemma":[0.00020600544,0.00015815426,0.00042484127,0.00038266784,0.00025570783,0.00019460019,0.00030130186,0.0011362182,0.001170748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005185425,0.00039614763,0.0019659088,0.00023673923,0.000021116984,0.00018501541,0.000072129806,0.00040419062,0.98565996,0.00070356426,0.0019057951,0.007930856],"study_design_scores_gemma":[0.00014885521,0.0021175856,0.016727354,0.000036022513,0.00007933366,0.00051971676,0.00022273071,0.005733546,0.94371945,0.00025054946,0.030422203,0.000022705966],"about_ca_topic_score_codex":0.0058420426,"about_ca_topic_score_gemma":0.0073131244,"teacher_disagreement_score":0.0058420426,"about_ca_system_score_codex":0.00066066184,"about_ca_system_score_gemma":0.00086007785,"threshold_uncertainty_score":0.012795925},"labels":[],"label_agreement":null},{"id":"W4309015989","doi":"10.1093/neuonc/noac209.078","title":"BIOS-02. CLINICAL OUTCOMES OF OVER 600 PATIENTS WITH GLIOBLASTOMA TREATED AT A CANADIAN TERTIARY CENTER IN THE PAST 15 YEARS: A COMPARATIVE ANALYSIS WITH THE PIVOTAL STUPP TRIAL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Cohort; Glioblastoma; Internal medicine; Confidence interval; Radiation therapy; Regimen; Clinical trial; Concomitant; Retrospective cohort study; Medical record; Subgroup analysis; Cohort study; Pediatrics; Surgery","score_opus":0.02343917120064924,"score_gpt":0.3187141365418633,"score_spread":0.29527496534121406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865914,0.0017205972,0.00006382286,0.00028236472,0.000018864472,0.00013156474,0.009303528,0.000008200204,0.0018796779],"genre_scores_gemma":[0.98855513,0.0007884507,0.00013298122,0.0001944694,0.00003998071,0.00008648138,0.0099208625,0.0000067767373,0.00027488812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983164,0.00034017267,0.00015369193,0.00028920258,0.000643536,0.0002571299],"domain_scores_gemma":[0.99582434,0.00039076648,0.0018023682,0.0002468438,0.0010239957,0.0007116179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023347149,0.00046198023,0.00092130894,0.0013658524,0.0009643321,0.00079666387,0.0009855683,0.00047566995,0.0015445035],"category_scores_gemma":[0.0046615214,0.00022671111,0.0011271896,0.0039132936,0.00055242784,0.00046273612,0.0007093637,0.0005472155,0.0002284043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010896047,0.00021642611,0.96593684,0.0002989176,0.0017398753,0.00012547265,0.0002089121,0.00048302708,0.00055475585,0.00020695764,0.0045003695,0.014832451],"study_design_scores_gemma":[0.0005221549,0.0006080578,0.9964933,0.000031613185,0.00035997486,0.000096906246,0.00014128769,0.00025712044,0.00007053388,0.00003775104,0.0013611661,0.000020219053],"about_ca_topic_score_codex":0.51303023,"about_ca_topic_score_gemma":0.61569697,"teacher_disagreement_score":0.51303023,"about_ca_system_score_codex":0.007315763,"about_ca_system_score_gemma":0.007143739,"threshold_uncertainty_score":0.9796753},"labels":[],"label_agreement":null},{"id":"W4309016097","doi":"10.1093/neuonc/noac209.756","title":"NCOG-03. IMPACT OF THE RATE OF RADIOGRAPHIC RESPONSE (RR) OF BRAIN METASTASES (BM) TO WHOLE BRAIN RADIATION THERAPY (WBRT) ON NEUROCOGNITIVE FUNCTION (NCF) ON NRG-CC001","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Neurocognitive; Randomized controlled trial; Logistic regression; Whole brain radiotherapy; Clinical trial; Oncology; Cancer; Cognition; Brain metastasis","score_opus":0.0316856420480753,"score_gpt":0.35668463174787735,"score_spread":0.32499898969980207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766639,0.0020831847,0.00027523233,0.0008822163,0.00010046629,0.00070607866,0.011205063,0.00013464726,0.007949243],"genre_scores_gemma":[0.98840314,0.0002982445,0.0007495679,0.000476787,0.00005793418,0.0011020913,0.0069663515,0.000055372624,0.0018905019],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9962748,0.0022624873,0.0002554755,0.0003540761,0.0006105122,0.0002427371],"domain_scores_gemma":[0.9899042,0.004468473,0.0023890703,0.0006840383,0.0008121986,0.001741987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058942167,0.00027682536,0.0010077702,0.00033236275,0.00021510893,0.0007407452,0.0010287483,0.00048904185,0.0048657316],"category_scores_gemma":[0.009554958,0.00011189814,0.0009159436,0.0009683896,0.00042132643,0.0004577261,0.00034903173,0.0009642077,0.0008837782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47555378,0.00410763,0.3191595,0.0010351635,0.0024766617,0.00007925052,0.00014395374,0.0033167005,0.0032811202,0.00036923165,0.017667228,0.17280976],"study_design_scores_gemma":[0.038758054,0.055464953,0.88575846,0.00013792592,0.0015560351,0.00016452845,0.00010473895,0.0033553003,0.0028522715,0.00039932897,0.011400227,0.00004820388],"about_ca_topic_score_codex":0.006734214,"about_ca_topic_score_gemma":0.014695139,"teacher_disagreement_score":0.006734214,"about_ca_system_score_codex":0.0015391888,"about_ca_system_score_gemma":0.0025390582,"threshold_uncertainty_score":0.031171978},"labels":[],"label_agreement":null},{"id":"W4309016107","doi":"10.1093/neuonc/noac209.1156","title":"MODL-29. IN SILICO MODELING TO PREDICT ONCOGENICITY AND POTENTIAL TARGETABILITY OF NOVEL FGFR VARIANTS IN PEDIATRIC LOW GRADE GLIOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Fibroblast growth factor receptor 1; Missense mutation; Mutation; In silico; Wild type; Fibroblast growth factor receptor; Cancer research; Gene; Biology; Genetics; Receptor; Fibroblast growth factor","score_opus":0.01853663400268998,"score_gpt":0.28392536243993577,"score_spread":0.2653887284372458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8996987,0.0013010527,0.06696481,0.0005311807,0.00013282994,0.00032566264,0.011423858,0.008679258,0.0109427385],"genre_scores_gemma":[0.9202814,0.0006670419,0.065349855,0.00016395714,0.000025256762,0.00053993025,0.009658244,0.0008133859,0.0025008111],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99988353,0.00003356339,0.000008592772,0.000023771654,0.000029187033,0.000021392172],"domain_scores_gemma":[0.9995758,0.0002634611,0.00004861063,0.00001841353,0.000054226388,0.000039506034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068706623,0.0009399828,0.00077228976,0.0007698412,0.00039363487,0.00067081803,0.00097564043,0.00092715304,0.0044045183],"category_scores_gemma":[0.00095371215,0.00054970576,0.0010905748,0.0003980645,0.00024063897,0.00031945872,0.00039453557,0.0006217186,0.0007510454],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004369363,0.000182001,0.012492621,0.00033934202,0.00019611047,0.0004088496,0.00007485678,0.9656392,0.006033811,0.0022544865,0.0029724378,0.008969243],"study_design_scores_gemma":[0.000041337986,0.00007212147,0.00068145455,0.000009757871,0.000023462784,0.000048418544,0.000010482135,0.9955917,0.0016978113,0.000451219,0.0013655808,0.0000067286464],"about_ca_topic_score_codex":0.0076861675,"about_ca_topic_score_gemma":0.0069482327,"teacher_disagreement_score":0.0076861675,"about_ca_system_score_codex":0.0010607126,"about_ca_system_score_gemma":0.0011428768,"threshold_uncertainty_score":0.015282869},"labels":[],"label_agreement":null},{"id":"W4309016113","doi":"10.1093/neuonc/noac209.311","title":"CTNI-46. PIVOTAL STUDY TO EVALUATE SAFETY AND EFFICACY OF EXABLATE MODEL 4000 USING MICROBUBBLE RESONATORS TO TEMPORARILY MEDIATE BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Liquid biopsy; Oncology; Biomarker; Surrogate endpoint; Biopsy; Internal medicine; Cancer; Chemistry","score_opus":0.016929066958419378,"score_gpt":0.30241226127756804,"score_spread":0.28548319431914865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873087,0.002744961,0.001806384,0.00046926478,0.00021400409,0.0030268682,0.0018131591,0.00013269721,0.0024840198],"genre_scores_gemma":[0.98522365,0.0015970952,0.00273769,0.00075157173,0.00020800192,0.0028650498,0.0031396258,0.000051197312,0.0034260703],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993093,0.0003504289,0.000039853163,0.0001116902,0.00008540112,0.00010319847],"domain_scores_gemma":[0.9989795,0.00012519197,0.00028320975,0.00012297105,0.00013589316,0.0003531763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028866301,0.00095341675,0.0012666495,0.00020439793,0.00031534248,0.0008162911,0.0006050054,0.00097133266,0.0030180772],"category_scores_gemma":[0.0010673312,0.00036978276,0.00082308415,0.00034051327,0.0006336026,0.00051696657,0.00023371051,0.0018838242,0.0009322788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7391612,0.029246511,0.008635984,0.0007634574,0.00078202673,0.00025468427,0.00013024596,0.00096994656,0.16398036,0.0003069986,0.0037288917,0.052039646],"study_design_scores_gemma":[0.120526426,0.82303846,0.014814798,0.000037395654,0.0006050145,0.0004129248,0.000044843426,0.00091328815,0.035271633,0.00011485807,0.0041910433,0.00002927151],"about_ca_topic_score_codex":0.0006513362,"about_ca_topic_score_gemma":0.0012254186,"teacher_disagreement_score":0.0030180772,"about_ca_system_score_codex":0.0006010821,"about_ca_system_score_gemma":0.0013769607,"threshold_uncertainty_score":0.01526612},"labels":[],"label_agreement":null},{"id":"W4309016122","doi":"10.1093/neuonc/noac209.128","title":"STEM-11. POLYAMINE METABOLISM AND INFLAMMATORY STATE CONTROL A VIRAL MIMICRY-DRIVEN QUIESCENT PHENOTYPE IN GLIOMA STEM CELLS (GSCS)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Stem cell; Cell biology; Downregulation and upregulation; Polycomb-group proteins; Cancer research; Genetics; Gene expression; Gene; Repressor","score_opus":0.011021320147083924,"score_gpt":0.26215465227140156,"score_spread":0.25113333212431765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971132,0.0006833006,0.0006127901,0.000029479608,0.000008834281,0.000036779118,0.00083777367,0.000051248673,0.000626658],"genre_scores_gemma":[0.99679714,0.00020998523,0.00038960934,0.000037785685,0.0000041097624,0.000038048278,0.0012250487,0.000008664266,0.0012896269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987614,0.000019683319,0.000017617343,0.00002491163,0.00003722205,0.000024433335],"domain_scores_gemma":[0.99987733,0.000016152457,0.000032089865,0.000019610603,0.000018059796,0.000036739282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010387709,0.00024044035,0.00028436826,0.0003479545,0.00010895145,0.0003000231,0.00012450559,0.00020915215,0.001358962],"category_scores_gemma":[0.0001221754,0.000095437936,0.00023188243,0.00024925417,0.0001813285,0.00011363795,0.0001773703,0.00028003097,0.00035737225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025268577,0.000037101705,0.0028040502,0.00003963413,0.000009675771,0.00009487725,0.00004888914,0.00007406919,0.99396014,0.000060938746,0.000056507564,0.0025612535],"study_design_scores_gemma":[0.000024948822,0.0015089686,0.09057845,0.0000102764825,0.000039786177,0.00076287537,0.00019245935,0.0013073975,0.90199435,0.00009205847,0.003479906,0.000008509426],"about_ca_topic_score_codex":0.0007668019,"about_ca_topic_score_gemma":0.0010416866,"teacher_disagreement_score":0.001358962,"about_ca_system_score_codex":0.00023622297,"about_ca_system_score_gemma":0.00013251827,"threshold_uncertainty_score":0.0045461655},"labels":[],"label_agreement":null},{"id":"W4309016124","doi":"10.1093/neuonc/noac209.877","title":"EXTH-79. HIJACKING A NEURODEVELOPMENTAL EPIGENOMIC PROGRAM IN METASTATIC DISSEMINATION OF MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebellum; Biology; Reelin; Epigenomics; Chromatin; Neuroscience; Transcription factor; DAB1; EZH2; Cancer research; Gene expression; Genetics; Gene; DNA methylation; Receptor","score_opus":0.013343170313016975,"score_gpt":0.30915709065271274,"score_spread":0.2958139203396958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442735,0.0015141866,0.006811462,0.00012953667,0.000041170966,0.000042906227,0.043027233,0.0012347209,0.0029253394],"genre_scores_gemma":[0.94187444,0.0006041684,0.004006456,0.0001879491,0.0000126438745,0.00006637691,0.050454773,0.00018216461,0.0026109894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997789,0.0000126969,0.000013285289,0.00008140804,0.00006989998,0.000043894233],"domain_scores_gemma":[0.9998367,0.000024251023,0.000060353053,0.000022997092,0.000015898751,0.000039851086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019470246,0.00027036958,0.0003916221,0.0005210983,0.00025308688,0.0003504668,0.0002197201,0.00020112589,0.0028706123],"category_scores_gemma":[0.00020490684,0.00016243194,0.00032264285,0.0005484941,0.00017884796,0.00018649852,0.00043136207,0.0004177614,0.0009731863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064278266,0.00005747567,0.040932577,0.00032897762,0.00013717987,0.00058398745,0.000074564414,0.0013744505,0.9318732,0.0006900802,0.0027933286,0.020511486],"study_design_scores_gemma":[0.00011937438,0.0003252901,0.5030691,0.000054794014,0.0002012061,0.0019255129,0.0001455169,0.014864326,0.440908,0.0012703035,0.037063442,0.000053114865],"about_ca_topic_score_codex":0.002419097,"about_ca_topic_score_gemma":0.00420844,"teacher_disagreement_score":0.0028706123,"about_ca_system_score_codex":0.00039553447,"about_ca_system_score_gemma":0.00032701733,"threshold_uncertainty_score":0.009603202},"labels":[],"label_agreement":null},{"id":"W4309016321","doi":"10.1093/neuonc/noac209.341","title":"DNAR-09. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON HIGH GRADE GLIOMAS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS; A REPORT FROM THE IRRDC AND THE GLIOMA TASKFORCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Lynch syndrome; Medicine; Glioma; Germline mutation; Germline; Cancer; Internal medicine; Oncology; Cancer research; Mutation; Genetics; Biology; Gene; Allele; Microsatellite; Colorectal cancer","score_opus":0.011191222141052884,"score_gpt":0.2773429234042501,"score_spread":0.2661517012631972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8075057,0.038732186,0.00067568425,0.003606106,0.00037494098,0.0003732116,0.12859,0.000272725,0.019869348],"genre_scores_gemma":[0.9243965,0.015133556,0.0013246513,0.0012782883,0.00018892677,0.00027038003,0.053505227,0.00006638617,0.0038361126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995111,0.00010182627,0.000052245392,0.00007810322,0.00018733145,0.00006942452],"domain_scores_gemma":[0.99843067,0.00021251132,0.00052173756,0.00005206091,0.00041567243,0.00036725952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091620453,0.00025061314,0.00021737088,0.0007978821,0.00021125456,0.00037421225,0.00023658473,0.00030050403,0.0011795003],"category_scores_gemma":[0.0011755874,0.00013493704,0.00024542352,0.0009771163,0.00010518626,0.00013829535,0.0003243103,0.00039183442,0.0005761577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005022976,0.00010047384,0.93703216,0.00038328592,0.0001563415,0.00068828976,0.00014213433,0.00012090575,0.0013660201,0.00007828613,0.018178338,0.04125157],"study_design_scores_gemma":[0.00004668903,0.00026036086,0.9776038,0.00013248576,0.000113640555,0.0008669595,0.00017257711,0.000060397047,0.00059984537,0.000012567021,0.020122679,0.000008007611],"about_ca_topic_score_codex":0.02244338,"about_ca_topic_score_gemma":0.020553388,"teacher_disagreement_score":0.02244338,"about_ca_system_score_codex":0.0004412479,"about_ca_system_score_gemma":0.00097283116,"threshold_uncertainty_score":0.04462552},"labels":[],"label_agreement":null},{"id":"W4309016324","doi":"10.1093/neuonc/noac209.142","title":"STEM-25. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES ESSENTIALITY OF POTASSIUM HOMEOSTASIS IN MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; Functional genomics; Homeostasis; Transposable element; Cell biology; Gene; Cancer research; Genomics; Genetics; Genome","score_opus":0.01375607269982954,"score_gpt":0.24859400984256114,"score_spread":0.2348379371427316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98411393,0.0003777656,0.011757387,0.00016108656,0.000023945593,0.00003479023,0.0010583368,0.00027703843,0.0021958034],"genre_scores_gemma":[0.9916825,0.00020489372,0.0039747064,0.00005501974,0.0000038054498,0.00002083323,0.00091935997,0.00006325708,0.0030755035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999137,0.000010918133,0.0000059510267,0.000022773967,0.000028570132,0.00001800944],"domain_scores_gemma":[0.99990535,0.000016080332,0.000034599758,0.000009271979,0.0000063710977,0.000028453735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000126463,0.00021281917,0.00014288742,0.00028625768,0.00016589162,0.00024313662,0.0002131831,0.00019345651,0.0018548392],"category_scores_gemma":[0.00008090975,0.00014562576,0.00017750717,0.0001063399,0.00030827694,0.00012768648,0.00020318253,0.00034170298,0.00030964398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017334463,0.000004030708,0.00010849778,0.0000063205457,9.1913546e-7,0.00001416041,0.0000047364215,0.000043588192,0.99928457,0.0001234639,0.000011727261,0.000380556],"study_design_scores_gemma":[0.000008830157,0.000095519616,0.0065720873,0.0000033265653,0.000010342627,0.00019171537,0.000019225117,0.0013412543,0.988494,0.00012088581,0.0031394006,0.000003426344],"about_ca_topic_score_codex":0.0011798711,"about_ca_topic_score_gemma":0.0027108237,"teacher_disagreement_score":0.0018548392,"about_ca_system_score_codex":0.00047158683,"about_ca_system_score_gemma":0.0002467113,"threshold_uncertainty_score":0.0062050223},"labels":[],"label_agreement":null},{"id":"W4309016325","doi":"10.1093/neuonc/noac209.264","title":"CTIM-32. FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Temozolomide; Medulloblastoma; Regimen; Glioma; Ependymoma; Tolerability; Chemotherapy; Internal medicine; Radiation therapy; Surgery; Oncology; Adverse effect; Pathology","score_opus":0.01425346185207096,"score_gpt":0.3017858235590598,"score_spread":0.28753236170698887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230766,0.0025561445,0.00034292167,0.00024624058,0.000074691154,0.002221515,0.0013094294,0.000050886003,0.0008905754],"genre_scores_gemma":[0.9885061,0.0021771763,0.0017006311,0.00046795016,0.00013730748,0.0028484475,0.0022220532,0.000024792787,0.0019156027],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995634,0.00023669623,0.00001554135,0.000067744404,0.000037437963,0.000079241276],"domain_scores_gemma":[0.99943537,0.00007702837,0.0001734721,0.00005005267,0.00003630272,0.00022776246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015509473,0.0012501482,0.0016261543,0.00032206046,0.00032718948,0.00076033105,0.0006570231,0.00070193555,0.0022548747],"category_scores_gemma":[0.0006335435,0.00044564152,0.0010777577,0.00035122776,0.0009144629,0.0005070879,0.00026070367,0.0023963796,0.00043090098],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80107695,0.04757,0.015532419,0.001205392,0.0018683777,0.00029521485,0.00025684573,0.0033691777,0.045911163,0.000446599,0.004549906,0.07791795],"study_design_scores_gemma":[0.4963242,0.46918553,0.021223066,0.000058221452,0.0010218802,0.00039569067,0.00006154192,0.0013913483,0.0063392436,0.00023284183,0.0037316708,0.000034607656],"about_ca_topic_score_codex":0.0009777644,"about_ca_topic_score_gemma":0.0036954451,"teacher_disagreement_score":0.0022548747,"about_ca_system_score_codex":0.0011233414,"about_ca_system_score_gemma":0.0020747858,"threshold_uncertainty_score":0.008202255},"labels":[],"label_agreement":null},{"id":"W4309016784","doi":"10.1093/neuonc/noac209.775","title":"NCOG-22. TIGER PRO-ACTIVE STUDY: INVESTIGATING DAILY ACTIVITY, SLEEP AND NEUROCOGNITIVE FUNCTIONING IN GLIOBLASTOMA PATIENTS APPLYING TTFIELDS THERAPY IN GERMANY IN ROUTINE CLINICAL CARE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Medicine; Quality of life (healthcare); Adverse effect; Clinical trial; Oncology; Internal medicine; Cognition; Psychiatry","score_opus":0.039854096848771774,"score_gpt":0.341000527857423,"score_spread":0.30114643100865124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91971457,0.041825112,0.0013314901,0.0014228096,0.00045638694,0.0018470789,0.028079849,0.00008675537,0.0052360413],"genre_scores_gemma":[0.97060704,0.003727473,0.0014913896,0.0010858882,0.00018366032,0.0021257063,0.019282263,0.000030238001,0.001466492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972588,0.0015386322,0.0003422463,0.00043336934,0.0002536465,0.0001732157],"domain_scores_gemma":[0.9974172,0.00061825314,0.0010161706,0.00035296948,0.00031410588,0.0002812782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003983957,0.0007256655,0.0015035764,0.00062994135,0.0004102906,0.0010553735,0.0005945264,0.00085278845,0.0022356033],"category_scores_gemma":[0.00507915,0.00026967656,0.001972274,0.0014712695,0.0004050657,0.00062427897,0.0007143963,0.00078340294,0.00052945275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20960952,0.0030732718,0.5642084,0.014168948,0.041371856,0.00045389638,0.00065154367,0.0028640337,0.0035091224,0.0015905198,0.030582907,0.12791601],"study_design_scores_gemma":[0.033288565,0.020160606,0.87697136,0.0017776153,0.03244211,0.0003606475,0.00038767545,0.0019545548,0.0017417411,0.0009706682,0.029771928,0.00017255705],"about_ca_topic_score_codex":0.005920244,"about_ca_topic_score_gemma":0.01131728,"teacher_disagreement_score":0.005920244,"about_ca_system_score_codex":0.0012639981,"about_ca_system_score_gemma":0.0015994962,"threshold_uncertainty_score":0.021069467},"labels":[],"label_agreement":null},{"id":"W4309016792","doi":"10.1093/neuonc/noac209.830","title":"EXTH-32. SEQUENTIAL SUNITINIB AND AURANOFIN TREATMENT INDUCEDCYTOTOXICITY THROUGH ROS-MEDIATED MECHANISM IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Sunitinib; Cancer research; Temozolomide; Pharmacology; Reactive oxygen species; Angiogenesis; DNA damage; Cytotoxic T cell; Medicine; Chemistry; Cancer; Immunology; Glioma; Internal medicine; Biochemistry; Rheumatoid arthritis","score_opus":0.03953968774424947,"score_gpt":0.31145081082842535,"score_spread":0.27191112308417587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927827,0.003509376,0.0009779742,0.00012380347,0.00011097175,0.00013398264,0.0006790043,0.00013421667,0.0015478669],"genre_scores_gemma":[0.9961184,0.0008281033,0.00063198945,0.000046290148,0.000012914247,0.000100640595,0.0008269443,0.000009021092,0.0014256935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984705,0.000021320922,0.000016414118,0.000028772856,0.000029120214,0.000057262278],"domain_scores_gemma":[0.9999598,0.0000032033236,0.00000973154,0.0000048504967,0.000006893394,0.00001538882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012714932,0.0003809431,0.0005943859,0.0002998521,0.000196971,0.00017247697,0.00020572457,0.00026300125,0.001786188],"category_scores_gemma":[0.000073369076,0.00014931269,0.00035209086,0.0002128967,0.00013474328,0.00016027523,0.00017844206,0.00036627325,0.00035307254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023911698,0.00033275282,0.00076881296,0.0001700529,0.000032499578,0.00020032313,0.000039939423,0.00020174454,0.9862693,0.0000973092,0.0004041247,0.009091996],"study_design_scores_gemma":[0.00031363076,0.0057852566,0.017308673,0.00001552473,0.00007307076,0.0006891549,0.000051551237,0.0019283555,0.9698361,0.00011090216,0.0038693142,0.000018479852],"about_ca_topic_score_codex":0.0010014041,"about_ca_topic_score_gemma":0.0017665959,"teacher_disagreement_score":0.001786188,"about_ca_system_score_codex":0.0002840033,"about_ca_system_score_gemma":0.0003641319,"threshold_uncertainty_score":0.0059754252},"labels":[],"label_agreement":null},{"id":"W4309016801","doi":"10.1093/neuonc/noac209.757","title":"NCOG-04. RANO-BM RESPONSE CRITERIA VERIFICATION STUDY IN A SRS-TREATED COHORT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiosurgery; Cohort; False positive paradox; Predictive value; Retrospective cohort study; Oncology; Demographics; Internal medicine; Radiology; Nuclear medicine; Surgery; Radiation therapy; Machine learning","score_opus":0.03607026819700404,"score_gpt":0.3542618700671986,"score_spread":0.3181916018701946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983475,0.00017900909,0.00012741797,0.000027187305,0.0000045694833,0.000041531825,0.0006771297,0.000005390924,0.00059028517],"genre_scores_gemma":[0.99805164,0.000052875148,0.00015972211,0.000034329492,0.000008989945,0.000072066374,0.001319646,0.000007011953,0.00029360136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990037,0.00037548383,0.0000939651,0.00020279667,0.0002179379,0.00010613152],"domain_scores_gemma":[0.99830425,0.00037326617,0.0006702523,0.00018514264,0.0002868511,0.00018032752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014512934,0.00016678171,0.0003859111,0.00048270778,0.00030546714,0.0004576637,0.00038282986,0.00025828427,0.0013850003],"category_scores_gemma":[0.0033503664,0.00013451297,0.00041221397,0.000578531,0.00023242296,0.00027930838,0.00036869632,0.0003518657,0.0005465371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012076998,0.00013619398,0.9939936,0.000022790662,0.0000714814,0.00015859448,0.00011305272,0.00006203232,0.0007644115,0.000024544192,0.00031152554,0.0031342097],"study_design_scores_gemma":[0.000095233125,0.0011549334,0.9962119,0.000011454144,0.0000727263,0.0005918674,0.00016098654,0.0002874848,0.0003950495,0.000021291577,0.0009903845,0.0000065614604],"about_ca_topic_score_codex":0.0062583266,"about_ca_topic_score_gemma":0.008074871,"teacher_disagreement_score":0.0062583266,"about_ca_system_score_codex":0.0006967281,"about_ca_system_score_gemma":0.00066096254,"threshold_uncertainty_score":0.0124438405},"labels":[],"label_agreement":null},{"id":"W4309016939","doi":"10.1093/neuonc/noac209.583","title":"PATH-10. A CASE OF ADULT THALAMIC DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED WITH AN IMPRESSIVE RESPONSE TO RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Concomitant; Regimen; Radiation therapy; Magnetic resonance imaging; Fluid-attenuated inversion recovery; Internal medicine; Surgery; Oncology; Radiology","score_opus":0.014590420221369789,"score_gpt":0.2947048100645221,"score_spread":0.2801143898431523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792997,0.0017761164,0.0013246826,0.0013362409,0.0001229953,0.00014528674,0.00047782832,0.0001237226,0.015393343],"genre_scores_gemma":[0.996671,0.0004229931,0.0007182007,0.0003601057,0.00009391983,0.000016642989,0.00015358647,0.000010795008,0.0015527455],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998777,0.000009805582,0.0000111013505,0.000028943496,0.000016993368,0.00005546543],"domain_scores_gemma":[0.999848,0.00002529984,0.000030980664,0.000011175259,0.000015815725,0.00006867326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008315722,0.00056962494,0.0002406417,0.00050033064,0.0006130937,0.0004871074,0.00047881203,0.001191495,0.0016355234],"category_scores_gemma":[0.0004851463,0.00024567475,0.00037859476,0.00036815752,0.00050850684,0.00034721685,0.0003307964,0.0007169317,0.0005384645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000714381,0.000027280688,0.0064605884,0.000031667467,0.000005946159,0.9877592,0.000111163965,0.0000834166,0.0026638915,0.0001227249,0.000289217,0.0023734549],"study_design_scores_gemma":[0.000029119166,0.00018551017,0.020313762,0.000009061376,0.00001686317,0.9757297,0.0001429645,0.00043173335,0.00132098,0.00008816251,0.0017242568,0.000007833566],"about_ca_topic_score_codex":0.008978188,"about_ca_topic_score_gemma":0.009659395,"teacher_disagreement_score":0.008978188,"about_ca_system_score_codex":0.0010041054,"about_ca_system_score_gemma":0.0005886677,"threshold_uncertainty_score":0.01785183},"labels":[],"label_agreement":null},{"id":"W4309017078","doi":"10.1093/neuonc/noac209.113","title":"CNSC-32. ACTIN SUBUNIT STRUCTURAL DIVERSITY IN SHH MEDULLOBLASTOMA: IMPLICATIONS FOR CANCER BIOLOGY AND NEURODEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University","funders":"","keywords":"Biology; Actin; Cell biology; Sonic hedgehog; Molecular biology; Signal transduction","score_opus":0.04385490861652398,"score_gpt":0.3440628560121906,"score_spread":0.30020794739566664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278814,0.0021953885,0.0012823876,0.00013883653,0.000017381044,0.000023833181,0.0016636688,0.00006178992,0.0018284953],"genre_scores_gemma":[0.9940586,0.000760944,0.0011667124,0.00003740874,0.0000074785316,0.000022999871,0.002003494,0.000021170013,0.0019210911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991727,0.000008618076,0.0000065760314,0.000023662144,0.00002796094,0.000015919772],"domain_scores_gemma":[0.999879,0.000009625167,0.000045153938,0.000008744362,0.000018818744,0.000038627182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014308949,0.00018379369,0.00012701954,0.00041437635,0.00021631768,0.00019613326,0.00014185366,0.00015767317,0.0014788862],"category_scores_gemma":[0.00010807275,0.000093672985,0.000114418326,0.00021992737,0.00021088446,0.00010397491,0.00013436095,0.00020317148,0.0004270131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015397707,0.00001107142,0.003579658,0.000035868114,0.0000053074664,0.0001604739,0.000016615415,0.00009446332,0.9936429,0.00018213684,0.00014180841,0.0019756327],"study_design_scores_gemma":[0.000036570334,0.00027393663,0.32974628,0.00004817534,0.00005256208,0.0032783325,0.00017746726,0.0035112796,0.64755964,0.00062403636,0.014675933,0.00001574814],"about_ca_topic_score_codex":0.0023293376,"about_ca_topic_score_gemma":0.0039365026,"teacher_disagreement_score":0.0023293376,"about_ca_system_score_codex":0.00053930713,"about_ca_system_score_gemma":0.00027844292,"threshold_uncertainty_score":0.0049473643},"labels":[],"label_agreement":null},{"id":"W4309017087","doi":"10.1093/neuonc/noac209.769","title":"NCOG-16. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bevacizumab; Medicine; Temozolomide; Demographics; Glioblastoma; Oncology; Internal medicine; Progression-free survival; Overall survival; Surgery; Chemotherapy; Cancer research","score_opus":0.023660969356367856,"score_gpt":0.3273901123684455,"score_spread":0.30372914301207765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97839534,0.00058912067,0.00014995485,0.00012850366,0.000020434558,0.00006824641,0.019444251,0.000025982561,0.0011780888],"genre_scores_gemma":[0.9774695,0.00016749096,0.00032481048,0.000059553186,0.000021303345,0.00015455233,0.021445598,0.000013979632,0.00034314443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984333,0.00045621363,0.00032076985,0.00026935773,0.0003171837,0.00020318483],"domain_scores_gemma":[0.9909931,0.0008824027,0.0058427337,0.00029661294,0.0009735874,0.0010116025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018030986,0.00030160043,0.00063072116,0.0019581816,0.00036227357,0.0010478836,0.0006196567,0.00033093645,0.0016716588],"category_scores_gemma":[0.006334469,0.00018924604,0.0005568537,0.004117546,0.00030412665,0.0005420855,0.0006486038,0.000431947,0.00039181404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007194583,0.000028223212,0.996259,0.00003886199,0.000113260794,0.000022704302,0.000022924223,0.00014012061,0.000048397702,0.000016791759,0.00078850705,0.0018018946],"study_design_scores_gemma":[0.000055328976,0.00016072109,0.9976452,0.000020417401,0.000075689524,0.00012306425,0.000091396905,0.0006964413,0.00005529015,0.000031884792,0.0010346667,0.000009784808],"about_ca_topic_score_codex":0.043019533,"about_ca_topic_score_gemma":0.058225226,"teacher_disagreement_score":0.043019533,"about_ca_system_score_codex":0.0024041655,"about_ca_system_score_gemma":0.0015303436,"threshold_uncertainty_score":0.08553827},"labels":[],"label_agreement":null},{"id":"W4309017207","doi":"10.1093/neuonc/noac209.763","title":"NCOG-10. SURGERY FOR RECURRENT GBM: A RETROSPECTIVE CASE-CONTROL STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cohort; Surgery; Retrospective cohort study; Multivariate analysis; Disease; Internal medicine","score_opus":0.03528777109535199,"score_gpt":0.3236461614410002,"score_spread":0.28835839034564825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983864,0.0006556956,0.00011776705,0.000020104802,0.000008426225,0.000028679604,0.0003383103,0.0000050122762,0.00043959252],"genre_scores_gemma":[0.9992662,0.00014586272,0.0000969764,0.000022645037,0.000013950258,0.00002280648,0.00033424346,0.0000021937262,0.0000951791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991991,0.00018468458,0.00009701641,0.0002708143,0.00015805408,0.00009035106],"domain_scores_gemma":[0.998423,0.0002561438,0.00087791646,0.00014132874,0.00014161546,0.00016005774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090030814,0.00030191545,0.0003864079,0.0010022474,0.00046752745,0.0005884834,0.00040622323,0.00037550318,0.00151033],"category_scores_gemma":[0.0019075851,0.00032390706,0.00032475704,0.0013931878,0.00031142743,0.00033255198,0.00030053698,0.0003626447,0.00028407777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000927536,0.00003346286,0.9987196,0.000012882728,0.000043125012,0.00024983668,0.000024885567,0.000007649473,0.000120665856,0.000012844991,0.00007324578,0.00060916727],"study_design_scores_gemma":[0.000021839289,0.00022027176,0.9967943,0.000009907829,0.00007736124,0.0021714007,0.00011242165,0.00012732788,0.000075028074,0.00001825606,0.00036723568,0.0000046018067],"about_ca_topic_score_codex":0.0043119113,"about_ca_topic_score_gemma":0.004267661,"teacher_disagreement_score":0.0043119113,"about_ca_system_score_codex":0.0003361888,"about_ca_system_score_gemma":0.0003823637,"threshold_uncertainty_score":0.008573651},"labels":[],"label_agreement":null},{"id":"W4309017246","doi":"10.1093/neuonc/noac209.958","title":"RBIO-06. CLINICAL AND MOLECULAR PREDICTORS OF RADIATION RESPONSIVENESS IN MENINGIOMAS: A MULTICENTER RETROSPECTIVE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Meningioma; Medicine; Oncology; Cohort; DNA methylation; Internal medicine; Propensity score matching; Malignant meningioma; Pathology; Biology; Gene expression; Gene; Genetics","score_opus":0.020174283903825002,"score_gpt":0.331057886604955,"score_spread":0.31088360270113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977635,0.00032869042,0.00012574525,0.000027427895,0.0000064538044,0.00001786712,0.0014623029,0.000008386938,0.00025967925],"genre_scores_gemma":[0.99809486,0.0001155606,0.00014431884,0.00002392199,0.000012265439,0.000036268382,0.0014032193,0.000008684023,0.00016095278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993693,0.00010742114,0.00007477352,0.00026627968,0.000085452935,0.00009671292],"domain_scores_gemma":[0.9985164,0.0001093344,0.0006670854,0.00029841045,0.00013471582,0.00027406204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010249517,0.00039228756,0.000513538,0.0007464279,0.00064128527,0.00086451473,0.0006020241,0.00044963186,0.0016771356],"category_scores_gemma":[0.0015618778,0.00044043743,0.0007866818,0.0012421417,0.00024990615,0.0004614774,0.00055798196,0.00060134224,0.00064071256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004793988,0.000030144409,0.99764013,0.000014644154,0.00013511113,0.00012678241,0.000053165564,0.000029207102,0.0006725505,0.000013865681,0.00015034793,0.0006547501],"study_design_scores_gemma":[0.000033317487,0.0001708888,0.998147,0.0000074629056,0.00014837182,0.0005355328,0.00012019987,0.00014535018,0.00016398676,0.000020705971,0.000499995,0.0000072589887],"about_ca_topic_score_codex":0.0034174153,"about_ca_topic_score_gemma":0.003015808,"teacher_disagreement_score":0.0034174153,"about_ca_system_score_codex":0.00037817453,"about_ca_system_score_gemma":0.00045687953,"threshold_uncertainty_score":0.0067950487},"labels":[],"label_agreement":null},{"id":"W4309017257","doi":"10.1093/neuonc/noac209.059","title":"BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM “HEAD START” 4 PROTOCOL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebrospinal fluid; RNA; Biology; RNA extraction; Non-coding RNA; Oncology; Bioinformatics; Medicine; Internal medicine; Gene; Cancer research; Genetics","score_opus":0.04850376539374591,"score_gpt":0.29431981969933146,"score_spread":0.24581605430558556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62279457,0.0017123141,0.008541488,0.0022179922,0.00073893,0.3237312,0.026454885,0.0005195037,0.013289042],"genre_scores_gemma":[0.36792994,0.0006744026,0.013025331,0.0032206918,0.00037277152,0.58919215,0.019397723,0.00015912192,0.006027825],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971486,0.0017455978,0.00020549954,0.00040838032,0.00017678543,0.0003152136],"domain_scores_gemma":[0.9965474,0.0006099293,0.00042822413,0.00072462996,0.00052941643,0.0011604305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050826794,0.0010941979,0.0012719454,0.00035982288,0.0014448129,0.0010696938,0.0011948107,0.0018356843,0.0164996],"category_scores_gemma":[0.0054029115,0.00053875713,0.0015392973,0.0004517729,0.0010995232,0.00074638706,0.0011898668,0.0017234718,0.004028391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8190502,0.028195582,0.022583049,0.0023806593,0.0009851962,0.0005745744,0.000518429,0.001791511,0.024416693,0.0015099949,0.026499609,0.07149448],"study_design_scores_gemma":[0.42942792,0.41213012,0.08852895,0.00067727594,0.0014152124,0.00045483472,0.00029162352,0.0014648705,0.012544797,0.0019100466,0.051031638,0.00012280543],"about_ca_topic_score_codex":0.002193065,"about_ca_topic_score_gemma":0.0031322888,"teacher_disagreement_score":0.0164996,"about_ca_system_score_codex":0.0017768583,"about_ca_system_score_gemma":0.007697486,"threshold_uncertainty_score":0.055196702},"labels":[],"label_agreement":null},{"id":"W4309017261","doi":"10.1093/neuonc/noac209.1133","title":"MODL-05. DISCOVERY OF DYNAMIC MINIMAL RESIDUAL DISEASE STATES IN ADULT GLIOBLASTOMA USING SINGLE CELL TECHNOLOGY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Multidrug tolerance; Minimal residual disease; Disease; Residual; Computational biology; Rapid cycling; Chemoradiotherapy; Biology; Cancer research; Cancer; Medicine; Genetics; Computer science; Pathology; Neuroscience; Bacteria; Algorithm","score_opus":0.0097194999590045,"score_gpt":0.24090129072359287,"score_spread":0.23118179076458836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93531036,0.00190949,0.028497221,0.00046288737,0.00008616432,0.00020531044,0.028072916,0.0019687568,0.0034868824],"genre_scores_gemma":[0.9160636,0.0008898835,0.045047127,0.0004819024,0.000028136274,0.00045144887,0.03223395,0.00036745207,0.004436384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996623,0.000023834395,0.000024176346,0.00010967148,0.00012926586,0.00005074043],"domain_scores_gemma":[0.99960035,0.00010612252,0.00008712434,0.000059085854,0.00008258779,0.000064746295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007904491,0.00021741586,0.0005425675,0.00056288665,0.0002944713,0.00083932595,0.00038511743,0.00039136552,0.0015016483],"category_scores_gemma":[0.0005980426,0.00020028789,0.0002594752,0.00043901624,0.00027265924,0.00027416463,0.00039124672,0.0005354331,0.0007620317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034693818,0.0000758689,0.012256174,0.00022890659,0.000033548993,0.0001130092,0.00011687303,0.0011773284,0.9576417,0.0008208632,0.0025626654,0.02462605],"study_design_scores_gemma":[0.00007039478,0.00073332345,0.06795296,0.000044099346,0.00008716537,0.00056565175,0.00016057749,0.026365273,0.8725504,0.0011742539,0.030254442,0.000041486965],"about_ca_topic_score_codex":0.0017910942,"about_ca_topic_score_gemma":0.004152594,"teacher_disagreement_score":0.0017910942,"about_ca_system_score_codex":0.00077090744,"about_ca_system_score_gemma":0.0006319685,"threshold_uncertainty_score":0.0055933595},"labels":[],"label_agreement":null},{"id":"W4309017263","doi":"10.1093/neuonc/noac209.611","title":"PATH-38. DISSEMINATED “MYXOID GLIONEURONAL TUMOR, PDGFRA P. K385-MUTANT” IN AN ADOLESCENT MANAGED WITH OBSERVATION AND WITHOUT ANY ADJUVANT THERAPY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Hospital for Sick Children; Children's Hospital of Winnipeg; CancerCare Manitoba","funders":"","keywords":"Medicine; PDGFRA; Septum pellucidum; Pilocytic astrocytoma; Pathology; Radiology; Glioma; Cancer research; Astrocytoma; GiST","score_opus":0.02351185612717296,"score_gpt":0.2864063054543172,"score_spread":0.2628944493271443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806834,0.0032054754,0.0011191057,0.005866531,0.0002810598,0.00014624628,0.0003136753,0.000076545584,0.008307975],"genre_scores_gemma":[0.9950925,0.001171048,0.00057935325,0.0008880155,0.0002082582,0.000026017768,0.00014152894,0.000013381667,0.001879893],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999811,0.000016007181,0.000016526554,0.00006537787,0.00003082006,0.000060226048],"domain_scores_gemma":[0.9997079,0.00003272547,0.00006232405,0.000009939803,0.000030127369,0.00015699407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001067807,0.0006961517,0.00049736496,0.0007287453,0.0013276626,0.0004622822,0.0005080255,0.0018483654,0.0018033914],"category_scores_gemma":[0.0006742098,0.0003293388,0.00048067715,0.00036833584,0.0005461783,0.0011035616,0.00052256766,0.0021704517,0.0003568143],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025647738,0.00007847212,0.018364988,0.000031094703,0.000007001778,0.9779986,0.00018387029,0.000101075784,0.0009171512,0.00021992817,0.0003993915,0.0016728414],"study_design_scores_gemma":[0.000019472855,0.00022603701,0.02140035,0.000057690773,0.000014007459,0.9753772,0.00020099452,0.000454668,0.00034893653,0.00022173928,0.0016670867,0.000011777523],"about_ca_topic_score_codex":0.0034865658,"about_ca_topic_score_gemma":0.0042244666,"teacher_disagreement_score":0.0034865658,"about_ca_system_score_codex":0.00091018796,"about_ca_system_score_gemma":0.000896416,"threshold_uncertainty_score":0.0069325566},"labels":[],"label_agreement":null},{"id":"W4309017265","doi":"10.1093/neuonc/noac209.197","title":"RADT-07. RADIOGRAPHIC “NECROSIS\" FOLLOWING SINGLE-FRACTION SRS AND IMMUNE CHECKPOINT INHIBITION IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH BRAIN METASTASES: AN INTERNATIONAL MULTICENTER STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiosurgery; Hazard ratio; Internal medicine; Lung cancer; Necrosis; Renal cell carcinoma; Melanoma; Urology; Histology; Radiation therapy; Oncology; Nuclear medicine; Confidence interval; Cancer research","score_opus":0.016438307310203903,"score_gpt":0.27549046062668386,"score_spread":0.25905215331647996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989768,0.00041922973,0.000052744483,0.000037809703,0.000009770008,0.000013370813,0.00024309084,0.000003726271,0.00024355331],"genre_scores_gemma":[0.9989586,0.0001129559,0.000060842347,0.000041340863,0.000028906852,0.000015955387,0.00063547486,0.0000023499233,0.00014365945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947435,0.00021561851,0.000047118883,0.0001254669,0.00007575153,0.000061698905],"domain_scores_gemma":[0.9987332,0.0001614237,0.00066514645,0.00007793986,0.000091827365,0.00027041684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012979883,0.0004911017,0.00054415467,0.0004412241,0.00028223125,0.00064263283,0.00048490014,0.00052122027,0.0012360216],"category_scores_gemma":[0.0016164498,0.00021776897,0.0010799376,0.0006629195,0.00036940153,0.00040424307,0.00043831166,0.00064813904,0.00031853173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065798676,0.00036553407,0.9872995,0.000046626265,0.0007349616,0.00015360651,0.00006005081,0.00016463565,0.0007634928,0.000022320637,0.00032169826,0.0034877162],"study_design_scores_gemma":[0.0005027816,0.003113325,0.99417615,0.000012845308,0.00046061026,0.00055826566,0.00008938309,0.00046023921,0.00019363908,0.000026734364,0.00039706368,0.000009024213],"about_ca_topic_score_codex":0.0010102695,"about_ca_topic_score_gemma":0.0011391432,"teacher_disagreement_score":0.0012979883,"about_ca_system_score_codex":0.00027807895,"about_ca_system_score_gemma":0.00032430008,"threshold_uncertainty_score":0.0068645477},"labels":[],"label_agreement":null},{"id":"W4309017270","doi":"10.1093/neuonc/noac209.295","title":"CTNI-30. LOGGIC/FIREFLY-2: A PHASE 3, RANDOMIZED TRIAL OF TOVORAFENIB VS. CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED LOW-GRADE GLIOMA HARBORING AN ACTIVATING RAF ALTERATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Regimen; Internal medicine; Chemotherapy regimen; Clinical endpoint; Oncology; Chemotherapy; Randomized controlled trial; Phases of clinical research; Glioma; Adverse effect; Cancer research","score_opus":0.016577567645459448,"score_gpt":0.30397161738416234,"score_spread":0.2873940497387029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831751,0.004590959,0.00058098807,0.001217084,0.0005768014,0.0046553044,0.0020890045,0.00029462003,0.0028201547],"genre_scores_gemma":[0.97899574,0.0033045467,0.0021091138,0.0015488423,0.0003810775,0.006337968,0.0024337983,0.00006047452,0.004828551],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996381,0.0001649876,0.000014713517,0.00006467678,0.00003005966,0.00008754833],"domain_scores_gemma":[0.99932003,0.00010291653,0.00013149396,0.00004070732,0.00003512827,0.00036966638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001347114,0.0020458894,0.0023180235,0.00045696145,0.00044077158,0.0012423416,0.0011324335,0.0011858491,0.0064918115],"category_scores_gemma":[0.00092201674,0.00067332236,0.0016118799,0.00042113647,0.001093818,0.0010553116,0.00036231658,0.0042028963,0.0009998669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94619197,0.017931685,0.00091010734,0.0006510726,0.00076175324,0.000100132864,0.00008237529,0.00080917677,0.006439116,0.00024205259,0.0034231937,0.022457372],"study_design_scores_gemma":[0.8841859,0.11111396,0.0016176461,0.000033179775,0.00027477174,0.00008399996,0.000031936102,0.0007741259,0.0007058216,0.00016892604,0.0009878146,0.00002189323],"about_ca_topic_score_codex":0.0021530287,"about_ca_topic_score_gemma":0.0070807324,"teacher_disagreement_score":0.0064918115,"about_ca_system_score_codex":0.0014517219,"about_ca_system_score_gemma":0.002133517,"threshold_uncertainty_score":0.02171725},"labels":[],"label_agreement":null},{"id":"W4309017517","doi":"10.1093/neuonc/noac209.601","title":"PATH-28. DIFFERENCES IN METHYLATION PROFILES BETWEEN LONG-TERM SURVIVORS AND SHORT-TERM SURVIVORS OF IDH WILD-TYPE GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"Isocitrate dehydrogenase; CDKN2A; Methylation; DNA methylation; CDKN2B; Biology; IDH1; Oncology; Cancer research; Internal medicine; Medicine; Genetics; Gene; Gene expression; Enzyme","score_opus":0.032745849954341134,"score_gpt":0.30335962577374065,"score_spread":0.2706137758193995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984452,0.0001465004,0.00012280965,0.000014762739,0.000002069714,0.0000034638815,0.0008994776,0.00000793569,0.00035773715],"genre_scores_gemma":[0.99854505,0.000043947475,0.00009935342,0.0000094268025,0.0000014879253,0.0000050595368,0.000945159,0.0000040126197,0.00034648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990404,0.000010640322,0.000010620979,0.00002913757,0.000019322395,0.000026199828],"domain_scores_gemma":[0.9997942,0.00002314317,0.00009115546,0.0000138539635,0.0000271557,0.000050482122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013670055,0.00011647745,0.0001459423,0.00037490943,0.00016719871,0.00026941544,0.00012918068,0.00012441598,0.0032245927],"category_scores_gemma":[0.00036891497,0.00006534993,0.00014055864,0.00032517966,0.00014122513,0.0001283164,0.00025165998,0.00011723507,0.00046017978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071643374,0.000017829832,0.9590616,0.00002796143,0.00004788285,0.00020125933,0.000102635306,0.00009501243,0.028822357,0.00003997982,0.000289416,0.010577663],"study_design_scores_gemma":[0.0000031223235,0.000086592736,0.9972765,0.0000018186525,0.000015921625,0.00047100606,0.000057607063,0.000107998,0.001587402,0.000026533144,0.00036393403,0.0000015542281],"about_ca_topic_score_codex":0.0020421932,"about_ca_topic_score_gemma":0.0024616765,"teacher_disagreement_score":0.0032245927,"about_ca_system_score_codex":0.00022516867,"about_ca_system_score_gemma":0.00012163603,"threshold_uncertainty_score":0.010787308},"labels":[],"label_agreement":null},{"id":"W4309017638","doi":"10.1093/neuonc/noac209.879","title":"EXTH-81. ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; In vivo; Radiation therapy; Cytotoxic T cell; Oncology; Chemotherapy; Wnt signaling pathway; Primitive neuroectodermal tumor; Cancer research; Internal medicine; In vitro; Biology; Signal transduction","score_opus":0.029741173404336116,"score_gpt":0.30260519332213504,"score_spread":0.2728640199177989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905618,0.003012282,0.0015743715,0.00019727324,0.000073598596,0.00008564572,0.0004111557,0.000116247786,0.0039676595],"genre_scores_gemma":[0.99391794,0.0014012925,0.00097171124,0.00012908234,0.00001165074,0.00004721093,0.0008746339,0.000009405051,0.0026370743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999597,0.000003321844,0.0000019688782,0.000007275016,0.000010944479,0.000016740541],"domain_scores_gemma":[0.9999883,0.0000011405083,0.0000024781095,0.000001429435,0.0000017866012,0.000004765629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004892058,0.00019739101,0.00020893828,0.00015878225,0.00012059869,0.00018921195,0.00016373504,0.000185759,0.0014403956],"category_scores_gemma":[0.000038219816,0.000068214256,0.0002096215,0.000114035574,0.000092356735,0.00010102699,0.00011303425,0.00037251532,0.00037331486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040676017,0.00029740867,0.0006977726,0.00014467942,0.00002710134,0.00015389755,0.00003143304,0.0012272432,0.9682484,0.00035795715,0.0011505033,0.02725678],"study_design_scores_gemma":[0.00045964224,0.0070544407,0.025931608,0.000050160455,0.00019838144,0.0017760672,0.00011060013,0.010720468,0.91714007,0.0002579129,0.036276318,0.000024453879],"about_ca_topic_score_codex":0.0012577915,"about_ca_topic_score_gemma":0.0023063614,"teacher_disagreement_score":0.0014403956,"about_ca_system_score_codex":0.00031890642,"about_ca_system_score_gemma":0.00017114868,"threshold_uncertainty_score":0.0048186183},"labels":[],"label_agreement":null},{"id":"W4309017650","doi":"10.1093/neuonc/noac209.069","title":"BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Proteomics; Cerebrospinal fluid; Brain tumor; Biomarker; Biomarker discovery; Medicine; Malignancy; Brain biopsy; Liquid biopsy; Pathology; Receiver operating characteristic; Oncology; Cancer; Biopsy; Biology; Internal medicine; Gene","score_opus":0.040537385572249986,"score_gpt":0.3157343512396935,"score_spread":0.2751969656674435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8977531,0.029584289,0.04958668,0.002512748,0.00036319558,0.000369667,0.010427365,0.0017898016,0.007613109],"genre_scores_gemma":[0.90554434,0.006981163,0.069747895,0.00070289214,0.00016592408,0.00032689888,0.009664744,0.00009186901,0.0067743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996178,0.000049062965,0.000044826313,0.00010842554,0.00013461616,0.000045259563],"domain_scores_gemma":[0.9996637,0.000060519887,0.0001079775,0.000020400905,0.000098708755,0.00004871464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079148135,0.00067040254,0.0004999652,0.0017231127,0.0003726132,0.0011502748,0.00036555048,0.00077597867,0.0016730576],"category_scores_gemma":[0.0008484425,0.0002625235,0.0004165866,0.0007712124,0.00037399132,0.00047975092,0.00060552434,0.00044710163,0.0016533904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006244113,0.00015571134,0.04439622,0.00069978455,0.00013496503,0.00046625038,0.00008383286,0.0011100941,0.8463669,0.00069291325,0.0032734307,0.10199544],"study_design_scores_gemma":[0.00008650276,0.0007372191,0.14876726,0.00019321332,0.0002552484,0.00394835,0.00015241942,0.020283114,0.79047555,0.0020019303,0.03303752,0.000061622784],"about_ca_topic_score_codex":0.0012828729,"about_ca_topic_score_gemma":0.0015666538,"teacher_disagreement_score":0.0017231127,"about_ca_system_score_codex":0.0006032889,"about_ca_system_score_gemma":0.0006544817,"threshold_uncertainty_score":0.005596876},"labels":[],"label_agreement":null},{"id":"W4309017983","doi":"10.1093/neuonc/noac209.169","title":"CSIG-20. PROTEOGENOMICS PROFILING REVEALS ENRICHED PROTEIN TRANSLATION REGULATORS AS NEW THERAPEUTIC TARGETS IN DIPG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Biology; Proteome; Histone; Epigenetics; Transcriptome; Histone H3; Proteomics; Gene knockdown; DNA methylation; Metabolome; Methylation; Translation (biology); Cell biology; Molecular biology; Cancer research; Genetics; Messenger RNA; Gene expression; Bioinformatics; Apoptosis; Metabolomics; DNA; Gene","score_opus":0.023574319208424045,"score_gpt":0.285881132570665,"score_spread":0.26230681336224093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818366,0.006559856,0.0026073952,0.00023432627,0.000054465014,0.00011832652,0.0066499254,0.00034078865,0.0015982874],"genre_scores_gemma":[0.9784241,0.0028051261,0.005319436,0.00023012387,0.000017106875,0.00012490542,0.010753866,0.000071407245,0.002253862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999126,0.000007663068,0.000004698553,0.000020922576,0.000031239695,0.00002286709],"domain_scores_gemma":[0.9999509,0.0000052802534,0.000012242605,0.0000046994587,0.000011182411,0.000015599077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012959634,0.00039739072,0.0004985164,0.00045547716,0.00019020283,0.00034013006,0.00020304736,0.0002628749,0.0009886826],"category_scores_gemma":[0.00013186684,0.00013817541,0.00034963555,0.0006034623,0.00016892297,0.00012954656,0.00017811787,0.00037512934,0.00044131436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066522474,0.00003824898,0.0020223544,0.00014044797,0.000030922638,0.00015456631,0.000013516407,0.0001830369,0.990721,0.00004138948,0.00035664588,0.0056325835],"study_design_scores_gemma":[0.000085951724,0.0010333637,0.08081114,0.000022513554,0.0001732716,0.0015764423,0.00006327453,0.0043074405,0.90083355,0.00020504543,0.010866793,0.000021209355],"about_ca_topic_score_codex":0.0011469895,"about_ca_topic_score_gemma":0.0015147128,"teacher_disagreement_score":0.0011469895,"about_ca_system_score_codex":0.00037186514,"about_ca_system_score_gemma":0.00028479315,"threshold_uncertainty_score":0.0033075213},"labels":[],"label_agreement":null},{"id":"W4309017992","doi":"10.1093/neuonc/noac209.618","title":"PATH-45. INTRAEPIGLIOM - RAPID SEQUENCING-BASED DIAGNOSIS OF BRAIN TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nanopore sequencing; Minion; Medical diagnosis; Computer science; Brain biopsy; Classifier (UML); DNA sequencing; Medicine; Artificial intelligence; Pathology; Biopsy; Biology; Gene","score_opus":0.013739696045676588,"score_gpt":0.2567201268820625,"score_spread":0.24298043083638593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017992","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.575119,0.003212239,0.36187717,0.0008976717,0.00031902164,0.0008729435,0.026470536,0.024796197,0.0064353044],"genre_scores_gemma":[0.49610955,0.00051113206,0.47744238,0.0008286612,0.00006541435,0.0008640836,0.019191382,0.0009158554,0.0040716077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985967,0.00025923146,0.00009278156,0.00062798004,0.00030989572,0.00011340861],"domain_scores_gemma":[0.9992663,0.00032178784,0.000127672,0.00008927779,0.00013837074,0.0000564992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014463864,0.0007892212,0.00040154933,0.0009975216,0.00030015843,0.0006265112,0.00048472363,0.00075769285,0.0028795705],"category_scores_gemma":[0.0021616234,0.00039622906,0.0005199064,0.0003545337,0.00034259234,0.0002962425,0.000664854,0.00063637376,0.002044211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025496092,0.0002270898,0.051284246,0.0005871706,0.00031636277,0.000490777,0.00031056404,0.013823071,0.7196533,0.0013832027,0.010892502,0.19848207],"study_design_scores_gemma":[0.0001841168,0.0012318745,0.059505176,0.000097065946,0.00018417982,0.0016430673,0.0000956809,0.21317387,0.6958805,0.0024444524,0.025430698,0.0001294633],"about_ca_topic_score_codex":0.0013969204,"about_ca_topic_score_gemma":0.003105862,"teacher_disagreement_score":0.0028795705,"about_ca_system_score_codex":0.00052262796,"about_ca_system_score_gemma":0.00082613283,"threshold_uncertainty_score":0.009633064},"labels":[],"label_agreement":null},{"id":"W4309018298","doi":"10.1093/neuonc/noac209.217","title":"RADT-27. FRACTIONATED RADIOTHERAPY AS FIRST-LINE TREATMENT FOR INTRACRANIAL MENINGIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Cohort; Meningioma; Cavernous sinus; Adverse effect; Surgery; Logistic regression; Proportional hazards model; Stage (stratigraphy); Radiology; Internal medicine","score_opus":0.036167948901926913,"score_gpt":0.3304965788096187,"score_spread":0.29432862990769176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845977,0.010215796,0.0007993351,0.0003836391,0.000057403573,0.000047309266,0.0012070129,0.00010198785,0.0025898397],"genre_scores_gemma":[0.9957659,0.0017323828,0.00061381934,0.00008852893,0.000040696574,0.00002092967,0.0010417458,0.00001732941,0.00067858386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997744,0.000044374487,0.000022958935,0.000048048165,0.000064719905,0.000045471872],"domain_scores_gemma":[0.99910885,0.00016603089,0.00045116813,0.000045044435,0.0000621647,0.00016674305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041450534,0.00013399834,0.00036849934,0.00036712657,0.00019742807,0.0003119239,0.00024970016,0.00014152142,0.0016586217],"category_scores_gemma":[0.0013059884,0.000057828565,0.0005642844,0.00043373028,0.00015912419,0.00010982482,0.00018848196,0.00030339282,0.0003816121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033017567,0.0002888721,0.8243109,0.00066265586,0.000457257,0.0027615244,0.00013686783,0.0013024622,0.008537709,0.00023489326,0.0037490332,0.15425608],"study_design_scores_gemma":[0.0001585286,0.0028999427,0.97527224,0.000121446006,0.00025679023,0.0074851234,0.000090560614,0.0015145489,0.004597574,0.00022663885,0.007357518,0.000019214978],"about_ca_topic_score_codex":0.0024477642,"about_ca_topic_score_gemma":0.0045431326,"teacher_disagreement_score":0.0024477642,"about_ca_system_score_codex":0.00071137334,"about_ca_system_score_gemma":0.00075417024,"threshold_uncertainty_score":0.005548656},"labels":[],"label_agreement":null},{"id":"W4309018309","doi":"10.1093/neuonc/noac209.804","title":"EXTH-05. TOWARD 100% CLINICAL EFFICACY FOR TUMOR-TREATING FIELDS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"In vivo; Radiation therapy; Intracellular; Cancer; Medicine; Biology; Internal medicine; Cell biology","score_opus":0.05895194278720524,"score_gpt":0.38844839722916424,"score_spread":0.329496454441959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9106818,0.0037280712,0.03892733,0.00094697083,0.00020377466,0.0009508653,0.003405272,0.002054443,0.039101537],"genre_scores_gemma":[0.97746736,0.0005521123,0.010170246,0.0003257472,0.000026127349,0.00026875516,0.0015187063,0.00023500873,0.009436043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993942,0.00019112688,0.000033044696,0.000095363015,0.0002158485,0.00007050194],"domain_scores_gemma":[0.9992162,0.0003637961,0.00010056891,0.00009113978,0.00013555851,0.00009276309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018947283,0.00039815193,0.00036115493,0.00045977614,0.0001278757,0.00037461967,0.0003951796,0.0005204538,0.014134003],"category_scores_gemma":[0.0014008965,0.00018048089,0.00033848698,0.00028134868,0.00046813616,0.0003782856,0.00034955255,0.0006801562,0.002418981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006384923,0.0022861122,0.008315902,0.0011716402,0.00009774298,0.000182555,0.00019611683,0.020662123,0.78967106,0.0050764787,0.008020976,0.15793438],"study_design_scores_gemma":[0.000734409,0.036833853,0.023383105,0.00015253057,0.00010549486,0.00081964256,0.00014400732,0.031672627,0.87223685,0.0021246492,0.03174484,0.00004788012],"about_ca_topic_score_codex":0.00055173534,"about_ca_topic_score_gemma":0.00050622126,"teacher_disagreement_score":0.014134003,"about_ca_system_score_codex":0.00039327104,"about_ca_system_score_gemma":0.000549711,"threshold_uncertainty_score":0.047282934},"labels":[],"label_agreement":null},{"id":"W4309018312","doi":"10.1093/neuonc/noac209.572","title":"INNV-32. COMPARING THE MONTREAL COGNITIVE ASSESSMENT (MOCA) FULL AND 5-MINUTE PROTOCOLS IN MILD COGNITIVE IMPAIRMENT SCREENING OF ADULT CNS TUMOR PATIENTS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Cognition; Internal medicine; Physical therapy; Psychiatry","score_opus":0.032577586381566784,"score_gpt":0.33349237071671156,"score_spread":0.3009147843351448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950948,0.0004080413,0.00042238415,0.00008180438,0.0000324013,0.0005036733,0.0014013891,0.000034970904,0.0020206086],"genre_scores_gemma":[0.99495125,0.00009813622,0.0016173641,0.0000801299,0.0000102310705,0.0006396558,0.002190746,0.000009192307,0.00040325025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974502,0.0016199315,0.00023076836,0.00022793697,0.00029917664,0.00017201681],"domain_scores_gemma":[0.99659234,0.0009445309,0.00091578026,0.00018425864,0.00079912157,0.0005640186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043444275,0.00036580078,0.00046102935,0.0007949769,0.00028935587,0.00061568804,0.0006346436,0.00040433806,0.0010855859],"category_scores_gemma":[0.011742575,0.00019867782,0.00046372143,0.00066389126,0.00019872084,0.0005828625,0.0008577045,0.0003307639,0.0003871623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019560426,0.0009745155,0.9134351,0.00017870632,0.00040949535,0.000116715615,0.0004433836,0.0011714232,0.0006834858,0.0002320406,0.0026603471,0.06013436],"study_design_scores_gemma":[0.0007374547,0.0067322436,0.98359054,0.000067126544,0.00012263063,0.00022660743,0.0003646683,0.0049140016,0.0006283684,0.00024780715,0.002338444,0.000030123634],"about_ca_topic_score_codex":0.010954513,"about_ca_topic_score_gemma":0.01660054,"teacher_disagreement_score":0.010954513,"about_ca_system_score_codex":0.0008979466,"about_ca_system_score_gemma":0.00093317596,"threshold_uncertainty_score":0.022975862},"labels":[],"label_agreement":null},{"id":"W4309018548","doi":"10.1093/neuonc/noac209.588","title":"PATH-15. THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Oligodendroglioma; CDKN2A; Astrocytoma; Glioma; Oncology; Medicine; Methylation; IDH1; Internal medicine; Univariate analysis; Cancer research; Biology; Multivariate analysis; Mutant; Cancer; Gene","score_opus":0.023086148226408986,"score_gpt":0.3059110953441583,"score_spread":0.2828249471177493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970215,0.0012435336,0.00023920901,0.000099956604,0.000009363303,0.0000054598527,0.000602581,0.000014507453,0.00076378766],"genre_scores_gemma":[0.999148,0.00018300851,0.00012729957,0.000007895618,0.000008182629,0.0000024765984,0.00028438002,0.0000023905736,0.00023626348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999274,0.000015760232,0.000008088823,0.000012251101,0.000016904762,0.000019605695],"domain_scores_gemma":[0.9995658,0.000089569294,0.00022014121,0.00001392271,0.000036251822,0.000074434865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001733452,0.00014710877,0.00011667989,0.0002478127,0.000103894425,0.00024374311,0.00012085679,0.00013140617,0.0025706172],"category_scores_gemma":[0.00065162836,0.00006895422,0.00011608836,0.00025656648,0.00013985542,0.00015405356,0.0001278446,0.00012505625,0.00038923428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011021171,0.00001598648,0.9729542,0.000053230775,0.000038623268,0.0006943466,0.000023102191,0.00030338037,0.007120976,0.00005319494,0.0003909993,0.017249847],"study_design_scores_gemma":[0.000022240903,0.00024644737,0.989136,0.000010937594,0.000070596296,0.0034180458,0.00004070663,0.00097321114,0.004612228,0.00016975967,0.0012959107,0.0000040466784],"about_ca_topic_score_codex":0.0013316718,"about_ca_topic_score_gemma":0.0014469093,"teacher_disagreement_score":0.0025706172,"about_ca_system_score_codex":0.00027168484,"about_ca_system_score_gemma":0.00025819542,"threshold_uncertainty_score":0.008599639},"labels":[],"label_agreement":null},{"id":"W4309018553","doi":"10.1093/neuonc/noac209.1144","title":"MODL-16. SOMATICALLY ENGINEERED MOUSE MODELS RECAPITULATING CELLULAR AND MOLECULAR FEATURES OF HUMAN GBM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"PTEN; Biology; CDKN2A; Cancer research; PDGFRA; Context (archaeology); Phenotype; Mesenchymal stem cell; Pathology; Stromal cell; PI3K/AKT/mTOR pathway; Gene; Genetics; Medicine; Signal transduction","score_opus":0.009580931457660003,"score_gpt":0.2737601221694131,"score_spread":0.2641791907117531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8943261,0.002752626,0.052374173,0.0012350734,0.00057310186,0.001436467,0.03126858,0.0035489607,0.012484939],"genre_scores_gemma":[0.8515196,0.0036019997,0.06320519,0.00061125204,0.00010281379,0.0032902563,0.018990947,0.0011961526,0.05748181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993449,0.000075791286,0.00012330966,0.00015831446,0.0001597003,0.00013793744],"domain_scores_gemma":[0.999438,0.000042652642,0.0002764575,0.00007318447,0.000041284176,0.00012845144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009192514,0.0013424846,0.0005786485,0.0016505176,0.0005099754,0.00071344647,0.0010521018,0.0011112595,0.007348577],"category_scores_gemma":[0.0001819494,0.00058679,0.00061959267,0.00073111727,0.0008884392,0.0006720168,0.000533817,0.001965129,0.0035616036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004918756,0.0002625302,0.0005988183,0.00021207552,0.000020144837,0.00021876348,0.00008480824,0.00033063217,0.9923765,0.0015377665,0.0007007779,0.0031654085],"study_design_scores_gemma":[0.00022589562,0.0011635937,0.00326236,0.000074826414,0.00006632642,0.0015751637,0.00008023912,0.0018395765,0.96251625,0.0005195166,0.028654236,0.000021958742],"about_ca_topic_score_codex":0.00060068176,"about_ca_topic_score_gemma":0.0011898063,"teacher_disagreement_score":0.007348577,"about_ca_system_score_codex":0.00069354236,"about_ca_system_score_gemma":0.0007183258,"threshold_uncertainty_score":0.0245834},"labels":[],"label_agreement":null},{"id":"W4309018697","doi":"10.1093/neuonc/noac209.1165","title":"MODL-38. DEVELOPMENTAL EFFECTS OF MYBL1 ACTIVATION ON MURINE BRAIN AND GLIAL DEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"OLIG2; Biology; Progenitor cell; Neural stem cell; Cell biology; Stem cell; Neuroscience; Central nervous system","score_opus":0.015198184312156466,"score_gpt":0.2746167002708395,"score_spread":0.25941851595868304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057395,0.0020567053,0.0039265933,0.0005273039,0.0001159562,0.00024123918,0.006074816,0.00056742626,0.0059160194],"genre_scores_gemma":[0.96630025,0.0010883687,0.0069599384,0.00021105952,0.000025774427,0.0005236303,0.004087327,0.00028761558,0.020516088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994148,0.00008040967,0.000057833626,0.00013666724,0.00012762815,0.00018274046],"domain_scores_gemma":[0.9994931,0.000052289608,0.00015948532,0.000044695058,0.00003678444,0.0002134807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003478558,0.00087402615,0.00035945777,0.001232354,0.00039266306,0.0003915299,0.00062460214,0.000868108,0.006173557],"category_scores_gemma":[0.00015654543,0.000352723,0.000452376,0.00025148346,0.0005557868,0.00038364233,0.0003978672,0.0015380475,0.002125644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003687543,0.00016884774,0.00021729287,0.000070795446,0.0000071590384,0.000109504246,0.00004343835,0.0001560562,0.9957982,0.0005728843,0.00019021539,0.00229695],"study_design_scores_gemma":[0.00007628471,0.0010385645,0.0022896677,0.000026822185,0.000014236815,0.0002455484,0.00005409587,0.00079691334,0.987922,0.00016262809,0.007364676,0.000008527402],"about_ca_topic_score_codex":0.0010113554,"about_ca_topic_score_gemma":0.0020567137,"teacher_disagreement_score":0.006173557,"about_ca_system_score_codex":0.0009557283,"about_ca_system_score_gemma":0.00049434707,"threshold_uncertainty_score":0.020652592},"labels":[],"label_agreement":null},{"id":"W4309018743","doi":"10.1093/neuonc/noac209.1116","title":"TMIC-73. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hamilton Health Sciences; Occupational Cancer Research Centre; University Health Network","funders":"","keywords":"Hypoxia (environmental); Pathology; Biology; Immunohistochemistry; Angiogenesis; Cell type; Cell; Mass cytometry; Tumor microenvironment; Cancer research; Phenotype; Medicine; Chemistry; Tumor cells","score_opus":0.023595048954478802,"score_gpt":0.2781064633221459,"score_spread":0.2545114143676671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902604,0.0011512197,0.0057625417,0.00006660211,0.000020070103,0.000061645595,0.0010559955,0.00019678863,0.0014245585],"genre_scores_gemma":[0.9887079,0.00058039074,0.008779236,0.000036047026,0.000007718278,0.00005238113,0.0009390318,0.00001953884,0.00087778916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999285,0.000008871678,0.0000060477896,0.0000122588735,0.000024317776,0.000019972871],"domain_scores_gemma":[0.9999211,0.000006618708,0.000018294193,0.0000049269815,0.000022791324,0.000026364098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017185447,0.00019163275,0.00018945982,0.00094350957,0.00020813101,0.00027357557,0.00010149695,0.00017746132,0.00091384625],"category_scores_gemma":[0.000119300836,0.00012224754,0.00012240082,0.00047576812,0.00013686436,0.00013238906,0.00014907598,0.00016985994,0.00022210591],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025908512,0.000030098814,0.008131812,0.00005115032,0.000013881833,0.00021831493,0.000032307275,0.00023203275,0.9861102,0.000055755983,0.00015978448,0.004705547],"study_design_scores_gemma":[0.000016973938,0.00047566812,0.3018912,0.000010655278,0.0000923953,0.0030404474,0.00029722808,0.01037611,0.68140775,0.0001242633,0.0022414043,0.000025922332],"about_ca_topic_score_codex":0.0017979334,"about_ca_topic_score_gemma":0.002381187,"teacher_disagreement_score":0.0017979334,"about_ca_system_score_codex":0.00023992671,"about_ca_system_score_gemma":0.00017838132,"threshold_uncertainty_score":0.0035749078},"labels":[],"label_agreement":null},{"id":"W4309019018","doi":"10.1093/neuonc/noac209.1131","title":"MODL-03. IDH-MUTANT GLIOMA GWAS ALLELE RS55705857 ON 8Q24 IS CHANGING THE DYNAMICS OF UNPATTERNED CEREBRAL ORGANOID DEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Organoid; Allele; Biology; Induced pluripotent stem cell; Embryoid body; Genetics; Molecular biology; Cancer research; Cell biology; Embryonic stem cell; Gene","score_opus":0.022057185326070924,"score_gpt":0.28007110375935945,"score_spread":0.2580139184332885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997468,0.000110029105,0.000376012,0.000058794503,0.000009613135,0.000007355171,0.0012674549,0.00004460233,0.0006581909],"genre_scores_gemma":[0.997607,0.00007177513,0.00050308486,0.000045269564,0.0000066727857,0.000015709224,0.00079251983,0.00002923818,0.00092879357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987197,0.000012264776,0.000011575349,0.00005775781,0.000028530496,0.00001795395],"domain_scores_gemma":[0.99983275,0.000023616027,0.00008621332,0.000015499856,0.000008910143,0.000032939453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008678668,0.00030084228,0.00021537345,0.00057623815,0.00016891814,0.0002865075,0.00021344831,0.00030895098,0.0043625375],"category_scores_gemma":[0.00023706793,0.00012370065,0.00024584064,0.00039602854,0.00016027174,0.000087075154,0.00017811636,0.00040659634,0.00041370027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003010303,0.0001775598,0.19671711,0.00011295907,0.0002190489,0.0053807665,0.000277657,0.00056974887,0.7715654,0.00083806855,0.0016317641,0.019499492],"study_design_scores_gemma":[0.00009321016,0.0003370619,0.9297704,0.000026353086,0.00024230426,0.011193649,0.00021232355,0.0015615595,0.050882097,0.00045009895,0.0052008787,0.000030001831],"about_ca_topic_score_codex":0.0014627702,"about_ca_topic_score_gemma":0.001815033,"teacher_disagreement_score":0.0043625375,"about_ca_system_score_codex":0.00017699575,"about_ca_system_score_gemma":0.00013420421,"threshold_uncertainty_score":0.014594078},"labels":[],"label_agreement":null},{"id":"W4309019023","doi":"10.1093/neuonc/noac209.1014","title":"TMET-09. LOSS OF MAT2A COMPROMISES METHIONINE METABOLISM AND REPRESENTS A VULNERABILITY IN H3K27M MUTANT GLIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University","funders":"","keywords":"Epigenetics; Methionine Adenosyltransferase; Methionine; Methylation; Biology; Mutant; Methyltransferase; DNA methylation; Cancer research; Cell biology; Genetics; Chemistry; Gene; Gene expression; Amino acid","score_opus":0.02042787843049634,"score_gpt":0.3095081475939314,"score_spread":0.2890802691634351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927053,0.0005152918,0.001979887,0.00024466243,0.000090551526,0.00010872766,0.001976498,0.0001839209,0.002195222],"genre_scores_gemma":[0.9917613,0.0003842308,0.0014740968,0.00010104282,0.000010178021,0.0001391381,0.0017565677,0.0000418332,0.004331556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998354,0.000020546091,0.000015596752,0.00003794794,0.00004229408,0.000048189733],"domain_scores_gemma":[0.99990785,0.00001165291,0.000023157525,0.000009225325,0.000005336608,0.000042832846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013834838,0.00034318122,0.0002844675,0.00037940446,0.00019846541,0.00031313454,0.00032877634,0.0004376153,0.003066564],"category_scores_gemma":[0.00008268508,0.00016051046,0.0003151285,0.00027615842,0.00032294195,0.00025110538,0.00017081054,0.0011962114,0.0006383294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006865169,0.00025291299,0.0003821944,0.00003510246,0.000013630076,0.00014820027,0.000013610526,0.00017050038,0.99600273,0.00027760695,0.0001963258,0.0018206786],"study_design_scores_gemma":[0.000106092586,0.0028721993,0.0043044877,0.0000060349244,0.000029951883,0.0010375036,0.000033948025,0.0014271847,0.9856727,0.00011620398,0.004386695,0.0000069262383],"about_ca_topic_score_codex":0.00081553723,"about_ca_topic_score_gemma":0.0011065118,"teacher_disagreement_score":0.003066564,"about_ca_system_score_codex":0.0003781718,"about_ca_system_score_gemma":0.00032479857,"threshold_uncertainty_score":0.010258675},"labels":[],"label_agreement":null},{"id":"W4309019064","doi":"10.1093/neuonc/noac209.1104","title":"TMIC-60. THE ROLE OF ICAM1 IN GLIOBLASTOMA TUMORIGENESIS UNDER HYPOXIC CONDITIONS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Carcinogenesis; Tumor microenvironment; Cancer research; ICAM-1; Biology; Cell growth; Cell adhesion molecule; Tumor progression; Cell adhesion; Intracellular; Cell; Cell biology; Cancer; Tumor cells; Biochemistry","score_opus":0.00865200405683501,"score_gpt":0.2583086582321263,"score_spread":0.2496566541752913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889416,0.00516193,0.0006697202,0.00037748096,0.0000826627,0.00003732262,0.00045388975,0.000072152514,0.004250816],"genre_scores_gemma":[0.9946045,0.0018599685,0.00033834644,0.0001784904,0.000027424805,0.000033204247,0.00063193013,0.000009122298,0.0023170654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993956,0.000004938843,0.000002665536,0.0000070277233,0.000010176266,0.000035699188],"domain_scores_gemma":[0.9999578,0.0000024713074,0.0000090290705,0.0000023061586,0.000003959102,0.000024480349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006769036,0.00022910246,0.00017166237,0.00019739909,0.00016646109,0.00019899274,0.00010893939,0.00023006035,0.00225365],"category_scores_gemma":[0.000047873968,0.00007225303,0.00017330305,0.0001039525,0.00011339992,0.000105130006,0.00014119658,0.000361694,0.00061361806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049674936,0.00014679234,0.0011381875,0.00009075262,0.000008159599,0.00012599428,0.000015991816,0.000058232083,0.99151117,0.0002968685,0.0004445458,0.0056664753],"study_design_scores_gemma":[0.00018426876,0.003576232,0.07870703,0.000087243854,0.000106470165,0.001549881,0.00015415713,0.0017641889,0.89611924,0.0005810388,0.017159034,0.000011170695],"about_ca_topic_score_codex":0.0006862891,"about_ca_topic_score_gemma":0.0006012282,"teacher_disagreement_score":0.00225365,"about_ca_system_score_codex":0.00022555911,"about_ca_system_score_gemma":0.00024440006,"threshold_uncertainty_score":0.0075392127},"labels":[],"label_agreement":null},{"id":"W4310516388","doi":"10.1093/neuonc/noac264","title":"Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Cerebrospinal fluid; Pathology; Liquid biopsy; Neoplasm; Medicine; Computational biology; Biology; Cancer; Internal medicine","score_opus":0.04875382338574128,"score_gpt":0.33314255775091794,"score_spread":0.28438873436517664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310516388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86612165,0.0036332335,0.12318879,0.00049921864,0.00008112316,0.00034213977,0.003148654,0.0010849274,0.0019002953],"genre_scores_gemma":[0.9530997,0.0006369021,0.04234565,0.0001432499,0.000039486476,0.00018117431,0.0028060735,0.00005884175,0.00068888924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991203,0.00032305124,0.00006334268,0.00022575399,0.00019927109,0.00006827938],"domain_scores_gemma":[0.9981244,0.00094726984,0.00037261253,0.00015485928,0.00030268144,0.00009812825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025361208,0.0009876861,0.00067104306,0.0012920536,0.0003528945,0.0010690353,0.0007086759,0.0006864023,0.0012024444],"category_scores_gemma":[0.0059498507,0.00036295026,0.0006467871,0.00051614235,0.0003736627,0.0006923091,0.00094322773,0.0010025922,0.0007644952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004214055,0.00056087394,0.4861472,0.0006858873,0.00073344406,0.0006955907,0.00041797437,0.080890805,0.13375394,0.00089191174,0.0038676132,0.2871406],"study_design_scores_gemma":[0.00011182187,0.0011312106,0.11504122,0.00022306743,0.00033092016,0.00094680325,0.00031388176,0.7770321,0.095451586,0.004021257,0.005320413,0.000075730175],"about_ca_topic_score_codex":0.0024539744,"about_ca_topic_score_gemma":0.005220517,"teacher_disagreement_score":0.0025361208,"about_ca_system_score_codex":0.00073041534,"about_ca_system_score_gemma":0.00092153414,"threshold_uncertainty_score":0.013412416},"labels":[],"label_agreement":null},{"id":"W4310786023","doi":"10.1093/neuonc/noac262","title":"Association of circulating markers with cognitive decline after radiation therapy for brain metastasis","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McMaster University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Neurocognitive; Medicine; Internal medicine; Cognitive decline; Brain metastasis; Oncology; Radiosurgery; Radiation therapy; Apolipoprotein E; Clinical endpoint; Gastroenterology; Randomized controlled trial; Dementia; Cognition; Metastasis; Cancer; Psychiatry; Disease","score_opus":0.020128949864012893,"score_gpt":0.311917193401129,"score_spread":0.29178824353711613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310786023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729997,0.0015275575,0.00014734524,0.00010413128,0.00001655127,0.00008611079,0.00030474996,0.000008851682,0.0005048236],"genre_scores_gemma":[0.9988745,0.0002626463,0.00016926925,0.00008268585,0.000027370459,0.00008122727,0.00032552285,0.0000022588188,0.00017457116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996216,0.00017720378,0.00003752708,0.000050931754,0.00007027234,0.000042360312],"domain_scores_gemma":[0.9982967,0.00058031455,0.00069165375,0.00008312698,0.00013499585,0.0002132225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013439397,0.00030742108,0.00066182954,0.00017938082,0.00018326713,0.0003889904,0.00023466235,0.00036597587,0.0013156716],"category_scores_gemma":[0.002428824,0.00010365526,0.00048506891,0.00037216215,0.00017101622,0.00015566914,0.0001076141,0.00064465747,0.00015474949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18938084,0.006100989,0.70663565,0.00073494134,0.0040837727,0.00017556373,0.000108538225,0.0011802512,0.013444223,0.000090613765,0.0016745216,0.07639008],"study_design_scores_gemma":[0.009942064,0.05864068,0.92232704,0.00006862065,0.0014579197,0.00039887632,0.00003178279,0.00089201797,0.004951657,0.00014403279,0.0011271712,0.000018067438],"about_ca_topic_score_codex":0.0006021807,"about_ca_topic_score_gemma":0.0014976356,"teacher_disagreement_score":0.0013439397,"about_ca_system_score_codex":0.0002996849,"about_ca_system_score_gemma":0.00055905245,"threshold_uncertainty_score":0.0071074963},"labels":[],"label_agreement":null},{"id":"W4311662637","doi":"10.1093/neuonc/noac271","title":"BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Mdm2; Cancer research; Temozolomide; Apoptosis; Glioma; In vivo; Stem cell; In vitro; Biology; Medicine; Cell biology","score_opus":0.01770364078331007,"score_gpt":0.24633740342756605,"score_spread":0.22863376264425597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311662637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858964,0.0068381364,0.002824232,0.00018770536,0.000053467615,0.00011649402,0.0010131078,0.00040012714,0.0026703333],"genre_scores_gemma":[0.98876977,0.0043514264,0.0026804886,0.00007675887,0.000018711467,0.0001339986,0.0018601337,0.000033866556,0.0020748787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999149,0.000011380946,0.000009007303,0.000014481253,0.000033458276,0.00001668512],"domain_scores_gemma":[0.9999579,0.000003474341,0.000012843721,0.000004226251,0.0000067775895,0.000014662102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010231253,0.0005730983,0.00044949003,0.00034416185,0.00009834545,0.0001833727,0.0003032115,0.00023012418,0.0008278133],"category_scores_gemma":[0.000052124564,0.00012826857,0.00020205506,0.00025864333,0.000119052864,0.00014147218,0.00013769678,0.00056351715,0.0006514178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004079942,0.00022598861,0.00019192816,0.00011142963,0.000020391159,0.000047038146,0.000011964297,0.00027269387,0.98961383,0.00005855008,0.00043343223,0.008604795],"study_design_scores_gemma":[0.000213551,0.0031893984,0.0040052864,0.00000917662,0.00005657405,0.00070884987,0.000016944106,0.0013526566,0.98469794,0.000043567037,0.0056947446,0.000011310624],"about_ca_topic_score_codex":0.0004343329,"about_ca_topic_score_gemma":0.0010535371,"teacher_disagreement_score":0.0008278133,"about_ca_system_score_codex":0.00019122516,"about_ca_system_score_gemma":0.00020304212,"threshold_uncertainty_score":0.002769351},"labels":[],"label_agreement":null},{"id":"W4313446900","doi":"10.1093/neuonc/noac209","title":"Author Index","year":2022,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Mathematics; Computer science; World Wide Web","score_opus":0.04315502769267362,"score_gpt":0.34890001309538643,"score_spread":0.30574498540271283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313446900","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028741697,0.0014012014,0.0008261973,0.0027700616,0.006774514,0.00028428636,0.022707291,0.002162051,0.9627871],"genre_scores_gemma":[0.00076026557,0.0010704855,0.0006164858,0.0011081849,0.001515358,0.0001355305,0.009272399,0.0008190588,0.98470217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994373,0.0000859394,0.0000521576,0.00006209091,0.0003013144,0.00006122998],"domain_scores_gemma":[0.9954483,0.0009596554,0.0001907903,0.00022984378,0.0019046826,0.001266683],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00058047083,0.0014623731,0.0012451267,0.0058909175,0.0010805319,0.0042401175,0.0012614123,0.001698935,0.898253],"category_scores_gemma":[0.0069763903,0.00055763155,0.0006027555,0.0041575506,0.0004203231,0.0020254778,0.0019908964,0.0014604282,0.8524729],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015701022,0.000016170716,0.00005213996,0.00010120588,0.0000011183544,0.000018179611,0.000004612158,0.000044426644,0.000045042376,0.0003451609,0.9668229,0.03253339],"study_design_scores_gemma":[0.000029907016,0.000018732297,0.00027931345,0.00022462416,0.000003770974,0.00007732134,0.000019972877,0.00010654878,0.00010666244,0.0012743003,0.997851,0.000007804093],"about_ca_topic_score_codex":0.0027414437,"about_ca_topic_score_gemma":0.0058201333,"teacher_disagreement_score":0.10174698,"about_ca_system_score_codex":0.0014969513,"about_ca_system_score_gemma":0.0022446464,"threshold_uncertainty_score":0.14512974},"labels":[],"label_agreement":null},{"id":"W4321372568","doi":"10.1093/neuonc/noad031","title":"Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Sidney Kimmel Comprehensive Cancer Center; National Institutes of Health; Hospital for Sick Children; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Centre de Recherche en Cancérologie de Marseille; Brain Tumour Charity; Murdoch Children's Research Institute; Children’s Hospital of Wisconsin Research Institute; Alder Hey Children's NHS Foundation Trust; Morgan Adams Foundation; Children's Hospital Colorado; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Clinical endpoint; Adverse effect; Cancer; Clinical trial; Immunotherapy","score_opus":0.021348993129385572,"score_gpt":0.29249290710806514,"score_spread":0.27114391397867954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321372568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268086,0.013435855,0.0003976905,0.00042442392,0.00004050084,0.00022247525,0.0007117972,0.000065837296,0.002020556],"genre_scores_gemma":[0.993912,0.003234289,0.0009096477,0.00041131862,0.000043854845,0.00014761793,0.0009389581,0.000011161648,0.0003911971],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979585,0.0000784661,0.000017615965,0.00003558034,0.00004483323,0.000027713748],"domain_scores_gemma":[0.99956256,0.00009586157,0.00018123418,0.000024667725,0.000036903657,0.000098696786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079407863,0.00021470361,0.0005138948,0.00016424246,0.00013829785,0.0004506415,0.00032437433,0.00025212663,0.0013398833],"category_scores_gemma":[0.0008487287,0.000116063246,0.0004803698,0.00026054814,0.00021040124,0.00032449525,0.00019330587,0.00096575497,0.0002222118],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1572619,0.004957242,0.14088905,0.002179451,0.0020808787,0.000492181,0.00031812646,0.005297983,0.053546593,0.00062370667,0.012546976,0.619806],"study_design_scores_gemma":[0.09981777,0.237326,0.554725,0.0007432258,0.0039384724,0.003819323,0.0002445214,0.008335034,0.034498997,0.00056089886,0.055901755,0.000088993766],"about_ca_topic_score_codex":0.0010729632,"about_ca_topic_score_gemma":0.005081529,"teacher_disagreement_score":0.0013398833,"about_ca_system_score_codex":0.00094787235,"about_ca_system_score_gemma":0.00098458,"threshold_uncertainty_score":0.0068773627},"labels":[],"label_agreement":null},{"id":"W4321611743","doi":"10.1093/neuonc/noad047","title":"The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Temozolomide; Carboplatin; Medicine; Glioma; Drug; Oncology; Drug resistance; Cancer research; Internal medicine; Pharmacology; Cisplatin; Chemotherapy; Biology","score_opus":0.025114773436739412,"score_gpt":0.27943862448361007,"score_spread":0.25432385104687066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347914,0.0010574977,0.013339067,0.00009817369,0.000028425722,0.00020722946,0.00067189685,0.00016379196,0.00095480174],"genre_scores_gemma":[0.9848956,0.0005847529,0.012924784,0.000035275218,0.000006581482,0.00011872144,0.0010474733,0.00002249709,0.00036435033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973184,0.00008125211,0.00002647242,0.000051606854,0.000074216914,0.00003455685],"domain_scores_gemma":[0.99961865,0.00010102988,0.00009966818,0.00007227279,0.000063975516,0.000044366006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007221723,0.00052781764,0.00031774954,0.00043959793,0.00015438929,0.00037549713,0.000297942,0.00037923778,0.0007865663],"category_scores_gemma":[0.00052675843,0.0001922726,0.00028823328,0.00021369025,0.00025400062,0.0002922949,0.00029569425,0.0007372346,0.0003186481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063996244,0.0003232958,0.015368154,0.000093051836,0.000043604865,0.0002121342,0.00008784609,0.002164128,0.9732185,0.00028711007,0.00033751415,0.0072247996],"study_design_scores_gemma":[0.00013449564,0.006699223,0.043454748,0.00003079374,0.0001451774,0.0033389241,0.00013338651,0.024797944,0.9166946,0.00022145335,0.004311342,0.00003778679],"about_ca_topic_score_codex":0.0012696765,"about_ca_topic_score_gemma":0.0012458664,"teacher_disagreement_score":0.0012696765,"about_ca_system_score_codex":0.00037967617,"about_ca_system_score_gemma":0.0003519843,"threshold_uncertainty_score":0.0038192272},"labels":[],"label_agreement":null},{"id":"W4323037649","doi":"10.1093/neuonc/noad053","title":"Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Friedberg Charitable Foundation; Deutsche Krebshilfe","keywords":"Malignant peripheral nerve sheath tumor; Epigenetics; CDKN2A; Pathology; Neurofibromatosis; Malignant transformation; Neurofibroma; Biology; DNA methylation; Cancer research; Medicine; Internal medicine; Cancer; Gene; Gene expression","score_opus":0.02322527932694977,"score_gpt":0.2864650449770008,"score_spread":0.263239765650051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323037649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986745,0.00017671286,0.00069344015,0.0000088937295,0.0000013764208,0.0000065797763,0.000068774425,0.0000115656985,0.00035825963],"genre_scores_gemma":[0.9990262,0.00006808401,0.0006643363,0.0000056198132,0.0000030092342,0.000006348515,0.00009874152,0.000002932517,0.00012483729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984133,0.000017027709,0.000021425121,0.00005234226,0.00004009563,0.000027725742],"domain_scores_gemma":[0.9995857,0.00009104828,0.00016549203,0.0000406758,0.00006049451,0.000056543515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018143124,0.00013681165,0.00017599073,0.0007802693,0.00016343883,0.00028285995,0.00012442144,0.0001746309,0.0011216791],"category_scores_gemma":[0.0006027406,0.000092796894,0.00010777297,0.0004427677,0.00029734918,0.00022709618,0.00027328517,0.00012209866,0.0001881647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073902356,0.000037655725,0.6763426,0.00012431254,0.000097963035,0.002666281,0.00060249737,0.00036722637,0.30177534,0.00028589557,0.00009723971,0.016863955],"study_design_scores_gemma":[0.0000061605997,0.00010430383,0.967188,0.000008238566,0.000058726266,0.010667718,0.00033676336,0.0009812844,0.019282304,0.00038169313,0.00097472203,0.000010078587],"about_ca_topic_score_codex":0.0005721383,"about_ca_topic_score_gemma":0.0014008471,"teacher_disagreement_score":0.0011216791,"about_ca_system_score_codex":0.0001578111,"about_ca_system_score_gemma":0.00011440459,"threshold_uncertainty_score":0.0037523508},"labels":[],"label_agreement":null},{"id":"W4365442816","doi":"10.1093/neuonc/noad019","title":"Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Royal University Hospital; Saskatoon City Hospital","funders":"Economic and Social Research Council; Vascular Society; Engineering and Physical Sciences Research Council; Association of Upper Gastrointestinal Surgery of Great Britain and Ireland; British Gynaecological Cancer Society; Prince Sultan Military Medical City; Urology Foundation; Medizinische Universität Innsbruck; University of Cape Town; King Saud University; Università di Bologna; Sapienza Università di Roma; Universität Innsbruck; King Faisal Specialist Hospital and Research Centre; NIH Clinical Center; Bowel Disease Research Foundation; Wellcome Trust; University College London; Cancer Research UK; George Washington University; University of the Philippines; National Institute for Health and Care Research; European Society of Coloproctology; Humanitas Research Hospital; Government of the United Kingdom; Yorkshire Cancer Research; Tishreen University; Queen Elizabeth Hospital Birmingham Charity; Bowel and Cancer Research; Humanitas University; Sarcoma UK; Massachusetts General Hospital","keywords":"Medicine; Pandemic; Incidence (geometry); Logistic regression; Odds ratio; Confounding; Prospective cohort study; Cohort; Cohort study; Pediatrics; Internal medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.033303256343916746,"score_gpt":0.3649152209356489,"score_spread":0.33161196459173214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365442816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877554,0.000103433646,0.00012448075,0.00006740081,0.0000072641355,0.000009435131,0.000639069,0.0000019020839,0.00027141866],"genre_scores_gemma":[0.9990337,0.000080742095,0.0000874481,0.00003437287,0.000007980907,0.00001053093,0.0007020564,0.000002512528,0.000040681145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990274,0.00031667613,0.00012585772,0.00024814438,0.00010665679,0.00017519132],"domain_scores_gemma":[0.9959766,0.00042465355,0.002468534,0.00042940097,0.00027292292,0.00042789662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015218057,0.00029169914,0.0002636887,0.0007934705,0.00043472953,0.00077277346,0.00051346095,0.00038760633,0.00085370307],"category_scores_gemma":[0.0041096504,0.0002408428,0.00061484484,0.0014438529,0.0003553072,0.00053301646,0.0009263037,0.0006663421,0.00013314601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035969697,0.000009203058,0.99930334,0.0000026097916,0.000039920636,0.000026682044,0.00009289548,0.000033834807,0.000036467805,0.000014323813,0.000070510396,0.000334267],"study_design_scores_gemma":[0.0000024779235,0.000025187715,0.9993824,0.0000045793663,0.000013082876,0.00007603921,0.00024303094,0.00012609542,0.0000124539565,0.000015802572,0.00009519961,0.0000037313548],"about_ca_topic_score_codex":0.013733314,"about_ca_topic_score_gemma":0.013898941,"teacher_disagreement_score":0.013733314,"about_ca_system_score_codex":0.00046329395,"about_ca_system_score_gemma":0.00044353312,"threshold_uncertainty_score":0.027306795},"labels":[],"label_agreement":null},{"id":"W4366365187","doi":"10.1093/neuonc/noad078","title":"LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"Norgine; Deutschen Konsortium für Translationale Krebsforschung; Universität Heidelberg; Servier; Medizinische Universität Wien; National and Kapodistrian University of Athens; PharmaMar; Alexion Pharmaceuticals; University of New South Wales; Jazz Pharmaceuticals; Deutsche Kinderkrebsstiftung; McMaster University; Deutsches Krebsforschungszentrum; Univerzita Karlova v Praze; Universitätsklinikum Heidelberg; Freie Universität Berlin; Brain Tumour Charity; Sanofi; Universität Wien; Semmelweis Egyetem; Pfizer; Rigshospitalet; Amgen; Humboldt-Universität zu Berlin; Eli Lilly and Company; Pediatric Brain Tumor Foundation","keywords":"RNA; Medicine; Fusion gene; DNA methylation; RNA-Seq; Gene; Oncology; Bioinformatics; Internal medicine; Cancer research; Biology; Genetics; Transcriptome; Gene expression","score_opus":0.10939937354189294,"score_gpt":0.4281708339732458,"score_spread":0.31877146043135285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366365187","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47471678,0.0026666422,0.010524245,0.0059224926,0.00031569847,0.00092717307,0.4846268,0.0018362737,0.018463876],"genre_scores_gemma":[0.5368072,0.0010444411,0.024873259,0.0022947954,0.00041184283,0.0021149216,0.42967305,0.00052511337,0.0022553904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996243,0.0013436918,0.00057426095,0.0009864962,0.0005675189,0.0002850982],"domain_scores_gemma":[0.9759137,0.005208199,0.00719424,0.0033673288,0.0060545886,0.0022619383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071747317,0.00035693884,0.00065963727,0.0029848632,0.00038298315,0.0018913938,0.0012265671,0.0006193358,0.006245268],"category_scores_gemma":[0.017950542,0.00025738677,0.0003144113,0.0040112496,0.00024176628,0.000876456,0.001463404,0.00053176534,0.0027471713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028410894,0.00019340697,0.82911193,0.0005331726,0.00022669043,0.00035702751,0.00042296658,0.0013465392,0.003482066,0.0009647284,0.09322435,0.067296065],"study_design_scores_gemma":[0.0007024744,0.0004263226,0.8943226,0.0005020365,0.00034015666,0.001024145,0.00064889464,0.0056481557,0.0051051467,0.00078118726,0.090403296,0.00009562123],"about_ca_topic_score_codex":0.0072836555,"about_ca_topic_score_gemma":0.010985958,"teacher_disagreement_score":0.0072836555,"about_ca_system_score_codex":0.0015209602,"about_ca_system_score_gemma":0.0031537798,"threshold_uncertainty_score":0.03794408},"labels":[],"label_agreement":null},{"id":"W4367060277","doi":"10.1093/neuonc/noad059","title":"Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; Northwestern University","keywords":"Medicine; Glioma; Internal medicine; Low molecular weight heparin; Oncology; Risk factor; Intensive care medicine; Thrombosis; Cancer research","score_opus":0.06284997916318107,"score_gpt":0.4287012859428215,"score_spread":0.3658513067796404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367060277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042457753,0.9986437,0.000094460804,0.00047743384,0.00007827476,0.0000039342412,0.000020411113,0.000002501629,0.00025482874],"genre_scores_gemma":[0.0028063706,0.9965622,0.00013695241,0.00016973767,0.00022395396,0.0000059225795,0.000040685867,0.0000010676978,0.000053042873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940574,0.00013062666,0.00021407506,0.0001016791,0.00011386444,0.000033986264],"domain_scores_gemma":[0.998123,0.00096288294,0.0005469267,0.000021105394,0.00026257714,0.00008337417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007870072,0.0005887459,0.0009946617,0.0035169104,0.00025895177,0.0011122698,0.00066931,0.00084954314,0.0014794891],"category_scores_gemma":[0.0027844857,0.00027701596,0.0006321941,0.0034560699,0.00043942907,0.001450604,0.00055710983,0.000990458,0.00032912884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012456263,0.00007649151,0.01140868,0.037724193,0.00056907424,0.0007992977,0.00025166522,0.000646893,0.00040299277,0.0021171235,0.02325547,0.92262346],"study_design_scores_gemma":[0.00008526554,0.00041337294,0.081466824,0.11012151,0.0033283168,0.040797643,0.0016843316,0.0011732384,0.0007241001,0.0062243147,0.7537961,0.00018498716],"about_ca_topic_score_codex":0.0021831787,"about_ca_topic_score_gemma":0.002931708,"teacher_disagreement_score":0.0035169104,"about_ca_system_score_codex":0.0007279679,"about_ca_system_score_gemma":0.0016254367,"threshold_uncertainty_score":0.005281806},"labels":[],"label_agreement":null},{"id":"W4367184303","doi":"10.1093/neuonc/noad082","title":"Mitogen-induced defective mitosis transforms neural progenitor cells","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Calgary","funders":"Alberta Children's Hospital Foundation; Alberta Cancer Foundation; Canadian Institutes of Health Research; Alberta Innovates; Cancer Research Society","keywords":"Mitosis; Biology; Progenitor cell; Cell biology; Neural stem cell; Population; Cell division; Cancer research; Genetics; Stem cell; Cell","score_opus":0.01619326943506174,"score_gpt":0.27376029121176787,"score_spread":0.25756702177670615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367184303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951552,0.0005054503,0.0023220226,0.000030988464,0.000018750354,0.000040841896,0.00044051488,0.00007169856,0.0014144733],"genre_scores_gemma":[0.99381906,0.00045457904,0.0026256205,0.000023663802,0.000007151859,0.00006100626,0.0012020698,0.000019578525,0.0017872591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991643,0.000009757629,0.000011621924,0.000013171564,0.000035716243,0.000013254895],"domain_scores_gemma":[0.9998765,0.00003435161,0.000035788184,0.00001993676,0.000010892455,0.000022532979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105536295,0.00030803337,0.00014978612,0.00025226056,0.00011388659,0.00018898549,0.00019936952,0.00016877212,0.00093013264],"category_scores_gemma":[0.00010331726,0.00010267455,0.00016648046,0.00015354717,0.00013732033,0.00008697217,0.00019821122,0.00038410327,0.00035161304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007239331,0.000034875327,0.00021979689,0.000027793052,0.0000033516683,0.000075290765,0.000018919352,0.00008941615,0.9986021,0.00013824565,0.00001894118,0.0006989382],"study_design_scores_gemma":[0.000020345251,0.0003537394,0.0029968508,0.0000065801883,0.000012032065,0.00042837055,0.000017478525,0.0012796194,0.9920447,0.00007268627,0.0027646988,0.0000028711645],"about_ca_topic_score_codex":0.0006394641,"about_ca_topic_score_gemma":0.0008054813,"teacher_disagreement_score":0.00093013264,"about_ca_system_score_codex":0.00027779225,"about_ca_system_score_gemma":0.00021290644,"threshold_uncertainty_score":0.0031116009},"labels":[],"label_agreement":null},{"id":"W4380302352","doi":"10.1093/neuonc/noad073.245","title":"MDB-12. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE-CHECKPOINT INHIBITION: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Sonic hedgehog; Transcriptome; Microsatellite instability; Immune checkpoint; Chromosome instability; Immune system; Immunotherapy; Genetics; Gene; Gene expression; Chromosome","score_opus":0.03871376592034477,"score_gpt":0.3327544107041853,"score_spread":0.29404064478384057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957515,0.0009998059,0.00084899005,0.00004333751,0.000008686725,0.000026458812,0.0018208616,0.000057194273,0.00044307028],"genre_scores_gemma":[0.9967327,0.00026376083,0.00058681256,0.00002892861,0.0000037195637,0.000025243702,0.0016303582,0.00002247233,0.0007059761],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998685,0.000015325553,0.0000115701105,0.00004623007,0.000029428189,0.000028923085],"domain_scores_gemma":[0.99981934,0.000019747817,0.0000562944,0.000028255574,0.000019070567,0.00005732801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018931915,0.00022255487,0.0002995038,0.00057835877,0.00017837962,0.00027043946,0.0001629875,0.00024093305,0.0016448419],"category_scores_gemma":[0.00015051932,0.00011600227,0.00028622738,0.00028031785,0.00021180617,0.00008719514,0.00025387038,0.00027337714,0.0004114959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009326753,0.00007217504,0.026947541,0.00006447438,0.00003158219,0.00036019064,0.0000473335,0.000063852865,0.9681864,0.000029042592,0.00009640952,0.0031682572],"study_design_scores_gemma":[0.000045812532,0.0017640026,0.44910347,0.000015829428,0.00015642421,0.005584021,0.0002339486,0.0011229903,0.53735006,0.00009845672,0.0045118243,0.000013211876],"about_ca_topic_score_codex":0.0008061819,"about_ca_topic_score_gemma":0.00086918235,"teacher_disagreement_score":0.0016448419,"about_ca_system_score_codex":0.0002834628,"about_ca_system_score_gemma":0.00013923322,"threshold_uncertainty_score":0.0055025816},"labels":[],"label_agreement":null},{"id":"W4380302375","doi":"10.1093/neuonc/noad073.313","title":"TRLS-10. ROVER: A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"PDGFRA; Cancer research; Glioma; Medicine; Stromal cell; GiST","score_opus":0.036139378281458495,"score_gpt":0.34302528398990506,"score_spread":0.30688590570844654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97936743,0.0058029136,0.0016634918,0.0011660515,0.00024496595,0.0035587838,0.0038234743,0.000774508,0.0035983308],"genre_scores_gemma":[0.9728439,0.005262618,0.004554338,0.0013571492,0.00013632837,0.0033512285,0.0073080277,0.00020039814,0.004985983],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947935,0.00021125947,0.00002604474,0.000099409874,0.000057726378,0.0001262824],"domain_scores_gemma":[0.9995541,0.00005105173,0.00007361313,0.00003639613,0.000046218353,0.0002385905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017746245,0.0020179045,0.00244469,0.00049681053,0.00040774935,0.0012434829,0.0010898156,0.0014829582,0.0037799843],"category_scores_gemma":[0.0005710519,0.0008539435,0.0014950488,0.00044085836,0.0009162277,0.0011045124,0.00036828758,0.0038451145,0.0015147517],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2673212,0.12319322,0.014070728,0.003063024,0.003626164,0.002503963,0.0012728262,0.014729416,0.25597844,0.0023940434,0.039617255,0.27222976],"study_design_scores_gemma":[0.35832015,0.56739515,0.02006536,0.000121640805,0.0010183967,0.0035408647,0.00024977542,0.006843987,0.022661548,0.0005380256,0.019125793,0.000119255084],"about_ca_topic_score_codex":0.002107252,"about_ca_topic_score_gemma":0.0049191928,"teacher_disagreement_score":0.0037799843,"about_ca_system_score_codex":0.0015341786,"about_ca_system_score_gemma":0.0022726073,"threshold_uncertainty_score":0.012645304},"labels":[],"label_agreement":null},{"id":"W4380302463","doi":"10.1093/neuonc/noad073.212","title":"LGG-02. DRUG-CLASS SPECIFIC GENE-BASED MAPK SENSITIVITY SCORES (MSS) PREDICT SENSITIVITY TO MAPK INHIBITORS AND IDENTIFY IMMUNE INFILTRATION AS PUTATIVE TARGET IN PEDIATRIC LOW-GRADE GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"MAPK/ERK pathway; Biology; Immune system; Cancer research; Gene; Gene expression; Gene expression profiling; Gene signature; Medicine; Bioinformatics; Immunology; Genetics; Signal transduction","score_opus":0.01617576121760463,"score_gpt":0.2890989774877802,"score_spread":0.2729232162701756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302463","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4528144,0.0054554073,0.0028331405,0.0007030702,0.00011283236,0.00019820512,0.52957106,0.003701884,0.0046099504],"genre_scores_gemma":[0.27172205,0.0010066279,0.006613161,0.0006769226,0.000044444758,0.00025287142,0.71746397,0.00019402734,0.002026013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936205,0.00009795764,0.000040064715,0.00026916718,0.00014471708,0.00008605988],"domain_scores_gemma":[0.9994838,0.00014820373,0.00012130045,0.000075994365,0.00009498091,0.00007574308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065977086,0.0007958361,0.0007534174,0.0013654141,0.0002777128,0.0009767932,0.0006894748,0.00066069106,0.0026770057],"category_scores_gemma":[0.0014236368,0.0001831293,0.0009792821,0.0013150026,0.00027377883,0.00025893844,0.0007547871,0.00047813338,0.0016602736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039591477,0.00039790996,0.6664753,0.0029696047,0.0019361548,0.0005296013,0.0001475521,0.02048521,0.039911963,0.0009938936,0.1587308,0.10346293],"study_design_scores_gemma":[0.0008597613,0.0021203635,0.7156355,0.00046983,0.0016679716,0.0023587754,0.00033102164,0.052791845,0.037458733,0.0030806698,0.18308803,0.00013759678],"about_ca_topic_score_codex":0.0049445527,"about_ca_topic_score_gemma":0.009997399,"teacher_disagreement_score":0.0049445527,"about_ca_system_score_codex":0.0007271982,"about_ca_system_score_gemma":0.00082622847,"threshold_uncertainty_score":0.009831548},"labels":[],"label_agreement":null},{"id":"W4380302510","doi":"10.1093/neuonc/noad073.254","title":"MDB-21. THE OTX2-REGULATED ALTERNATIVE SPLICING LANDSCAPE CONTROLS DIFFERENTIATION AND RECONSTITUTES THE DEVELOPMENTAL ORIGINS OF GROUP 3 MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Exon; RNA splicing; Exon skipping; Medulloblastoma; Biology; Alternative splicing; Morpholino; Transcriptome; Gene knockdown; Genetics; RNA; Cancer research; Gene; Molecular biology; Gene expression","score_opus":0.014854754473857519,"score_gpt":0.27505033023836506,"score_spread":0.2601955757645075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700814,0.00044890586,0.0007640109,0.000039481514,0.000008487743,0.000011299267,0.0006859603,0.000033041408,0.0010007088],"genre_scores_gemma":[0.9954287,0.00018310391,0.00056418555,0.000030845054,0.0000021188991,0.000016067363,0.0012001545,0.000020102867,0.0025547524],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999342,0.0000054783836,0.0000038540356,0.000017654193,0.00002165361,0.000017166767],"domain_scores_gemma":[0.9999479,0.0000058838605,0.000015680302,0.000005015436,0.0000050066137,0.000020490364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061068924,0.00013241747,0.00011104426,0.00015772686,0.00016047158,0.0002664083,0.00010061848,0.00012916049,0.0014251921],"category_scores_gemma":[0.000070279464,0.00007356685,0.00011389692,0.0000933622,0.00015438428,0.00007888376,0.00017859523,0.0002571312,0.0003446596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007167802,0.0000077389595,0.0012660347,0.000010350659,0.0000019980578,0.000057361445,0.000011795711,0.00004241306,0.9977309,0.00006450562,0.000039140876,0.00069601537],"study_design_scores_gemma":[0.000015393898,0.00015333014,0.07305346,0.0000071654185,0.000016588041,0.0006743638,0.000106446874,0.0016152527,0.9176051,0.00009009679,0.006657859,0.0000049336236],"about_ca_topic_score_codex":0.0011768636,"about_ca_topic_score_gemma":0.0028717702,"teacher_disagreement_score":0.0014251921,"about_ca_system_score_codex":0.0003402543,"about_ca_system_score_gemma":0.00016108743,"threshold_uncertainty_score":0.0047677755},"labels":[],"label_agreement":null},{"id":"W4380354323","doi":"10.1093/neuonc/noad073.117","title":"EPEN-13. PATTERN OF RELAPSE IN POSTERIOR FOSSA EPENDYMOMA GROUP A","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Neurosurgery; Radiation therapy; Surgery","score_opus":0.02625450403093505,"score_gpt":0.3063737258674627,"score_spread":0.28011922183652765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883395,0.00030742984,0.00004524858,0.000015914418,0.0000028667175,0.0000053304034,0.000118473916,0.000004318594,0.0006663825],"genre_scores_gemma":[0.9995691,0.000066484434,0.00003767615,0.000008058857,0.000003208311,0.000003346312,0.00015798194,0.0000013587655,0.00015275963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985147,0.000016243113,0.000017896007,0.000035891942,0.000032539516,0.000045937504],"domain_scores_gemma":[0.9995828,0.000058832633,0.00018253113,0.000019282008,0.00004990985,0.00010656709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015723,0.0001766151,0.00017265139,0.00059716945,0.00027080427,0.00026531526,0.00020413403,0.00022860062,0.001231654],"category_scores_gemma":[0.00071678514,0.00007807178,0.00015590846,0.00038163646,0.00029425212,0.00015189697,0.00018599509,0.00018411556,0.0003225469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020597983,0.000017716085,0.98815805,0.000018798091,0.000012777428,0.004422368,0.00012902592,0.000050103197,0.0025710333,0.000011966309,0.00017443429,0.004227754],"study_design_scores_gemma":[0.000006947058,0.00011066732,0.9872091,0.000006841467,0.000010828103,0.0115761,0.00017170627,0.000097510565,0.00053632015,0.000011084027,0.00025906085,0.0000038855533],"about_ca_topic_score_codex":0.008997343,"about_ca_topic_score_gemma":0.0119586475,"teacher_disagreement_score":0.008997343,"about_ca_system_score_codex":0.00047328576,"about_ca_system_score_gemma":0.00029206424,"threshold_uncertainty_score":0.017889977},"labels":[],"label_agreement":null},{"id":"W4380354470","doi":"10.1093/neuonc/noad073.141","title":"OUTC-04. SUBSEQUENT CNS MALIGNANCY AMONG SURVIVORS OF CHILDHOOD CANCER: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY (CCSS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Confidence interval; Cancer; Internal medicine; Radiation therapy; Childhood cancer; Malignancy; Oncology; Pediatrics; Cohort","score_opus":0.028509285726435223,"score_gpt":0.31735768605780246,"score_spread":0.2888484003313672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364496,0.0003869916,0.00007861814,0.00007833912,0.000009501692,0.000014662687,0.014623253,0.000010455312,0.0011531612],"genre_scores_gemma":[0.99117154,0.0003177931,0.00006453594,0.000039079358,0.000011081146,0.000028398888,0.007881914,0.0000048986003,0.00048083905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980193,0.000036651025,0.00002419234,0.000038785365,0.00006294015,0.000035528472],"domain_scores_gemma":[0.9987412,0.0001336277,0.0006567921,0.00006753799,0.00021956771,0.00018122155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041807792,0.00016239942,0.00022814574,0.00062078284,0.00027523295,0.00039021941,0.0002210791,0.00016864504,0.0014443878],"category_scores_gemma":[0.0013702537,0.00013754966,0.0003259528,0.0012605295,0.00010048502,0.00019126674,0.00028913055,0.00027050622,0.00021732673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016719243,0.000004826364,0.99918956,0.000006392991,0.000017131553,0.000018723646,0.00002105839,0.000016769303,0.000029006997,0.0000049883006,0.00026097437,0.00041377425],"study_design_scores_gemma":[0.0000020174052,0.000012077634,0.99954295,0.0000034259926,0.000012729022,0.00005484851,0.00005402691,0.00003944883,0.000025376612,0.0000029779908,0.0002489885,0.0000011291713],"about_ca_topic_score_codex":0.049957007,"about_ca_topic_score_gemma":0.047767453,"teacher_disagreement_score":0.049957007,"about_ca_system_score_codex":0.00036783755,"about_ca_system_score_gemma":0.00048254742,"threshold_uncertainty_score":0.09933245},"labels":[],"label_agreement":null},{"id":"W4380354507","doi":"10.1093/neuonc/noad073.037","title":"BIOL-18. NEWLY DEVELOPED REPLICATION REPAIR DEFICIENT (RRD) MOUSE MODELS PROVIDE INSIGHTS INTO MEDULLOBLASTOMA/GLIOMAGENESIS AND RESPONSE TO IMMUNOTHERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"OLIG2; Medulloblastoma; Cancer research; Nestin; Glioma; Biology; Germline; MLH1; Germline mutation; DNA mismatch repair; Mutation; Genetics; Stem cell; Gene; DNA repair; Neural stem cell; Neuroscience; Oligodendrocyte; Myelin; Central nervous system","score_opus":0.044175812476814014,"score_gpt":0.3301377840276562,"score_spread":0.2859619715508422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88195527,0.009356395,0.06450562,0.0026188483,0.00064631604,0.0006501145,0.016652616,0.0035302066,0.020084538],"genre_scores_gemma":[0.87859166,0.007505022,0.04337001,0.0006364465,0.00013099641,0.0012188065,0.009664705,0.0006617116,0.058220565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996624,0.000043416287,0.00003993037,0.000095252806,0.00009605391,0.00006299928],"domain_scores_gemma":[0.99973744,0.000016114165,0.00010118943,0.000024471827,0.00002078734,0.000100102036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004932031,0.0008998454,0.00032413812,0.0014478933,0.0003754189,0.0006592944,0.00064251863,0.0009752793,0.0056554126],"category_scores_gemma":[0.00011742034,0.0005041737,0.0006157514,0.0003084251,0.0005919235,0.0006460075,0.0005456257,0.0017871215,0.0019601646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026612534,0.00011401134,0.00063624996,0.000136527,0.00001809364,0.00016590656,0.00005673479,0.000131693,0.9904185,0.0019853737,0.00068013574,0.0053907097],"study_design_scores_gemma":[0.00021477099,0.0011839931,0.009396544,0.000125317,0.00010996222,0.0020309663,0.00013448295,0.0021045804,0.9182749,0.0008937521,0.06550335,0.000027316684],"about_ca_topic_score_codex":0.00072331907,"about_ca_topic_score_gemma":0.0023028639,"teacher_disagreement_score":0.0056554126,"about_ca_system_score_codex":0.0006608992,"about_ca_system_score_gemma":0.00040531327,"threshold_uncertainty_score":0.01891923},"labels":[],"label_agreement":null},{"id":"W4380355153","doi":"10.1093/neuonc/noad073.082","title":"DIPG-35. IDENTIFYING DRIVER-SPECIFIC VULNERABILITIES IN PAEDIATRIC HIGH GRADE GLIOMA SUBTYPES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Biology; Glioma; Cancer research; Transcriptome; Phenotype; Genetics; Gene; Gene expression","score_opus":0.03810334214116783,"score_gpt":0.3066112993186172,"score_spread":0.26850795717744935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638809,0.00381902,0.0125538055,0.00033591606,0.00006762011,0.00045313325,0.012490369,0.00078504544,0.005614345],"genre_scores_gemma":[0.974707,0.0022405528,0.009565204,0.00022607652,0.000008404521,0.00017029175,0.010122109,0.00012642572,0.0028339413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998103,0.000016840238,0.000015389396,0.000054483236,0.000054232078,0.00004882919],"domain_scores_gemma":[0.99989426,0.00002449327,0.000030416451,0.000012506384,0.000010051462,0.000028365555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023571428,0.00032420026,0.0004442258,0.000622752,0.00018555259,0.00038598373,0.00026318085,0.00046257867,0.003197388],"category_scores_gemma":[0.00020680111,0.00020738381,0.00034627342,0.00050861784,0.00026874407,0.00013720829,0.00042349013,0.0007096839,0.00073818304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004428333,0.00007891598,0.007475272,0.000280007,0.00005317003,0.00042484028,0.000060371935,0.00060776365,0.9715808,0.0003331358,0.0007425673,0.017920429],"study_design_scores_gemma":[0.00014553331,0.0019106738,0.08866447,0.00007539218,0.00033093468,0.0077538565,0.00021627771,0.004495592,0.8532942,0.0005604499,0.042517666,0.00003502266],"about_ca_topic_score_codex":0.001775624,"about_ca_topic_score_gemma":0.0033757444,"teacher_disagreement_score":0.003197388,"about_ca_system_score_codex":0.00052201503,"about_ca_system_score_gemma":0.00037827494,"threshold_uncertainty_score":0.0106963515},"labels":[],"label_agreement":null},{"id":"W4380355317","doi":"10.1093/neuonc/noad073.027","title":"BIOL-08. RADIATION DRIVES METASTASIS IN MEDULLOBLASTOMA THROUGH AN INFLAMMATORY PROCESS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Inflammation; Metastasis; Cancer research; Chemokine; Radiation therapy; Intravital microscopy; Brain metastasis; Pathology; Immunology; Internal medicine; Cancer","score_opus":0.0324658596702496,"score_gpt":0.3463694103499357,"score_spread":0.31390355067968606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985031,0.0035942404,0.004701298,0.00031821514,0.00009522231,0.00010485759,0.003177248,0.00031005495,0.0026678622],"genre_scores_gemma":[0.9884952,0.001886475,0.003301093,0.00020438325,0.000020854985,0.00011683028,0.002505643,0.000053156426,0.0034165252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997693,0.000026220741,0.000013800977,0.000053779717,0.00008521811,0.00005172123],"domain_scores_gemma":[0.99986756,0.000012209872,0.000058613532,0.000008642585,0.000017740202,0.000035209177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016714867,0.0003441712,0.00028799457,0.0003821948,0.00029710238,0.0005061817,0.00012903874,0.00030675562,0.002580595],"category_scores_gemma":[0.00013161058,0.00016498913,0.00049831474,0.00024649594,0.0002957481,0.00023319833,0.00027009315,0.0008059914,0.00065545866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016311325,0.00004513872,0.0017100212,0.00012525592,0.000013723041,0.000109685905,0.000028931598,0.000075272445,0.99596244,0.00009934067,0.00012964747,0.0015374589],"study_design_scores_gemma":[0.000047367514,0.0015914437,0.10638622,0.00006420962,0.00008774189,0.0015553245,0.00032214317,0.0020227323,0.87654257,0.00030635766,0.011052214,0.000021605467],"about_ca_topic_score_codex":0.001243763,"about_ca_topic_score_gemma":0.0018754936,"teacher_disagreement_score":0.002580595,"about_ca_system_score_codex":0.00048604733,"about_ca_system_score_gemma":0.00039609725,"threshold_uncertainty_score":0.008632898},"labels":[],"label_agreement":null},{"id":"W4380355976","doi":"10.1093/neuonc/noad073.175","title":"HGG-26. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Microsatellite instability; Glioma; Genome instability; ATRX; Cancer research; Genetics; Somatic hypermutation; Mutation; Transcriptome; Chromothripsis; DNA mismatch repair; Gene; Allele; Microsatellite; DNA repair; Gene expression; Antibody","score_opus":0.023053933566318657,"score_gpt":0.30159566507537555,"score_spread":0.2785417315090569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986545,0.00022245503,0.00017631575,0.00001909409,0.0000022515817,0.000009856683,0.000596957,0.000014009573,0.00030466082],"genre_scores_gemma":[0.9979146,0.00007364604,0.00024811513,0.000026195621,0.0000039604656,0.000008582389,0.0015220776,0.000008366175,0.00019446161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998728,0.000013953203,0.000008751216,0.000054076703,0.000017327275,0.000033195425],"domain_scores_gemma":[0.9997713,0.000030260298,0.000052477837,0.000041111285,0.00002907023,0.00007586602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016229383,0.0002098981,0.00027023995,0.00049344555,0.00021833072,0.00040118798,0.00015878756,0.00021178194,0.0015879892],"category_scores_gemma":[0.00028589874,0.00010022807,0.00021790667,0.00041208233,0.00020835815,0.00010024384,0.00034092367,0.00019675739,0.00039479122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001385898,0.00010687529,0.845205,0.00007686406,0.00011965172,0.0013868208,0.00018004196,0.00013554622,0.13480242,0.000077091056,0.0005148992,0.016008988],"study_design_scores_gemma":[0.00002762036,0.0004530953,0.98172176,0.0000067204455,0.00008436329,0.0053286934,0.00020261394,0.00030271037,0.010111239,0.00006885327,0.0016868256,0.00000550829],"about_ca_topic_score_codex":0.0009769873,"about_ca_topic_score_gemma":0.0015079834,"teacher_disagreement_score":0.0015879892,"about_ca_system_score_codex":0.00021917379,"about_ca_system_score_gemma":0.00013894092,"threshold_uncertainty_score":0.0053123236},"labels":[],"label_agreement":null},{"id":"W4380356855","doi":"10.1093/neuonc/noad073.248","title":"MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Retrospective cohort study; Internal medicine; Missense mutation; Chemotherapy; Oncology; Radiation therapy; Cohort; Pediatrics; Mutation; Pathology; Biology; Genetics","score_opus":0.027585985185095294,"score_gpt":0.33046548048890756,"score_spread":0.30287949530381225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380356855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992901,0.0001486785,0.000021824386,0.000012430097,0.0000016583722,0.000002640782,0.00027807493,0.0000021889805,0.00024226548],"genre_scores_gemma":[0.9995672,0.000039436167,0.000018299985,0.0000054244,0.000002202999,0.000003910374,0.0002897992,0.0000010990194,0.000072587565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998603,0.00001883852,0.000017736455,0.000035888188,0.000026721773,0.00004050424],"domain_scores_gemma":[0.9994357,0.00007390997,0.00027793436,0.000017736142,0.00003442007,0.00016023385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016723285,0.00018960203,0.00023443068,0.0007277781,0.00031253148,0.00033082196,0.00018121254,0.0002351468,0.0015403918],"category_scores_gemma":[0.000805342,0.00011813078,0.00020430793,0.0005160135,0.00018967564,0.0002622388,0.0002359155,0.00023377579,0.00021526199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010089427,0.0000120877385,0.998374,0.0000033684512,0.000010133644,0.00031152193,0.00002725126,0.000045817116,0.00038544202,0.000008907926,0.00004415544,0.00067645736],"study_design_scores_gemma":[0.000004342219,0.000102745245,0.99761117,0.0000031891232,0.000010717659,0.0017946581,0.00007895652,0.00010238421,0.00011731379,0.000014858967,0.00015723942,0.0000024647181],"about_ca_topic_score_codex":0.0033052487,"about_ca_topic_score_gemma":0.002923764,"teacher_disagreement_score":0.0033052487,"about_ca_system_score_codex":0.0003036437,"about_ca_system_score_gemma":0.0002502013,"threshold_uncertainty_score":0.006572008},"labels":[],"label_agreement":null},{"id":"W4380358406","doi":"10.1093/neuonc/noad073.010","title":"ATRT-10. SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CELLULAR HIERARCHIES AND THERAPEUTIC VULNERABILITIES OF ETMR","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Transcriptome; SOX2; Neurogenesis; Neural stem cell; Cell cycle; Gene silencing; Population; microRNA; Cell; Cancer research; Stem cell; Progenitor cell; Cell biology; Gene; Genetics; Embryonic stem cell; Gene expression; Medicine","score_opus":0.026753731136171983,"score_gpt":0.26090613472528146,"score_spread":0.23415240358910946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818848,0.0013183797,0.007974307,0.00015193576,0.00003473772,0.000049521695,0.006430878,0.00032367834,0.0018317404],"genre_scores_gemma":[0.98321426,0.0006920028,0.0060580303,0.00012413165,0.000009613226,0.00008398766,0.0073474934,0.00010669319,0.0023637612],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981683,0.000015572163,0.000010338395,0.000064272404,0.00006115295,0.000031858504],"domain_scores_gemma":[0.99984396,0.00003375076,0.00004347982,0.0000205214,0.000026510914,0.00003178574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022177133,0.00018801782,0.0003170587,0.0002481111,0.00018142034,0.0005045011,0.00017376304,0.00023589685,0.0010982989],"category_scores_gemma":[0.00021346683,0.00013338732,0.0002997295,0.00023327173,0.00016358288,0.00015498829,0.00018415523,0.00053248985,0.00057417754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010092755,0.000014234199,0.0019398808,0.000043450975,0.000011217221,0.000067711495,0.000024786963,0.00034493723,0.9941269,0.00008961371,0.00016335839,0.0030728693],"study_design_scores_gemma":[0.000020227113,0.00042766664,0.074640185,0.00001746339,0.00006953903,0.0010035268,0.00018634972,0.012859454,0.9006551,0.0003001848,0.009800639,0.000019668576],"about_ca_topic_score_codex":0.0006035187,"about_ca_topic_score_gemma":0.00080762943,"teacher_disagreement_score":0.0010982989,"about_ca_system_score_codex":0.00028660885,"about_ca_system_score_gemma":0.00021667477,"threshold_uncertainty_score":0.0036742091},"labels":[],"label_agreement":null},{"id":"W4380358639","doi":"10.1093/neuonc/noad073.219","title":"LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Adverse effect; Medicine; Glioma; Clinical endpoint; Internal medicine; Phases of clinical research; Clinical trial; Oncology; Surgery; Gastroenterology; Cancer research","score_opus":0.07688933433642507,"score_gpt":0.40788209386077073,"score_spread":0.33099275952434565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799105,0.00462271,0.00046531975,0.0010430916,0.00018234196,0.0012877773,0.00539697,0.00021940295,0.006871857],"genre_scores_gemma":[0.98031336,0.0028861298,0.0014064626,0.0015825143,0.000165136,0.0012058375,0.007540284,0.000054270473,0.0048460294],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951327,0.00026992182,0.000016579368,0.00005427525,0.000060176655,0.00008580441],"domain_scores_gemma":[0.99960035,0.000059894017,0.00008384245,0.000035407298,0.000024950592,0.00019559148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014811575,0.00086466054,0.0010865885,0.00024456813,0.00017505969,0.0008882745,0.0006172295,0.00087843236,0.003756809],"category_scores_gemma":[0.00063135894,0.0002778553,0.0008566252,0.0002557832,0.00042202283,0.00037885003,0.0002721725,0.0017470373,0.0010496941],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5929267,0.025323655,0.032012824,0.0017357706,0.0022277175,0.00081000995,0.00026944475,0.0024276127,0.056877732,0.001065614,0.039631493,0.24469149],"study_design_scores_gemma":[0.5243314,0.36887395,0.0692633,0.00019287608,0.0012019112,0.0011155761,0.00010167967,0.002005027,0.008805421,0.00061392185,0.023439448,0.00005556171],"about_ca_topic_score_codex":0.00094593136,"about_ca_topic_score_gemma":0.004452085,"teacher_disagreement_score":0.003756809,"about_ca_system_score_codex":0.0008047064,"about_ca_system_score_gemma":0.0011565721,"threshold_uncertainty_score":0.012567818},"labels":[],"label_agreement":null},{"id":"W4380358945","doi":"10.1093/neuonc/noad073.229","title":"LGG-20. LANDSCAPE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Fibroblast growth factor receptor; Fibroblast growth factor receptor 1; Glioma; Cohort; Young adult; Oncology; Pediatric cancer; Internal medicine; Cancer; Fibroblast growth factor; Cancer research; Pediatrics; Receptor","score_opus":0.012426141081313003,"score_gpt":0.2752612076046285,"score_spread":0.2628350665233155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971431,0.0005559206,0.000100168254,0.000032761647,0.000001725095,0.000007691106,0.0013185937,0.000013107288,0.00082688243],"genre_scores_gemma":[0.99687445,0.0003290669,0.00021634577,0.00002958886,0.0000048377447,0.000009189694,0.0022946908,0.000012418687,0.00022931158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969435,0.000037400398,0.000029941126,0.00008813406,0.000071363334,0.00007880309],"domain_scores_gemma":[0.9994491,0.000066366294,0.00025152875,0.000025234574,0.000096867036,0.000110953486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000274585,0.00018297973,0.00025164272,0.0013402017,0.00031903657,0.0006069593,0.00021708237,0.00025228845,0.002037975],"category_scores_gemma":[0.000835503,0.00010249798,0.0002562863,0.0014393871,0.00025418232,0.0002852347,0.000501057,0.00020069546,0.00048815485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002586328,0.000013371876,0.98187387,0.00003633283,0.00005392475,0.00070893025,0.00013688582,0.00011934351,0.00738717,0.000101133315,0.00036096506,0.00894948],"study_design_scores_gemma":[0.0000027971691,0.00006058188,0.99521244,0.000008774558,0.000027030894,0.0024929391,0.00020548092,0.00013080832,0.00048104007,0.00009434835,0.0012807217,0.0000029996054],"about_ca_topic_score_codex":0.0031520084,"about_ca_topic_score_gemma":0.0049413578,"teacher_disagreement_score":0.0031520084,"about_ca_system_score_codex":0.00034557213,"about_ca_system_score_gemma":0.00026864698,"threshold_uncertainty_score":0.0068176985},"labels":[],"label_agreement":null},{"id":"W4380359043","doi":"10.1093/neuonc/noad073.195","title":"IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Ipilimumab; Medicine; Nivolumab; Immunotherapy; Internal medicine; Progressive disease; Immune checkpoint; Salvage therapy; Oncology; Expanded access; Progression-free survival; Blockade; Surgery; Chemotherapy; Cancer","score_opus":0.037875624931700096,"score_gpt":0.34134928180455,"score_spread":0.3034736568728499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380359043","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9235962,0.039690997,0.005812689,0.0018886864,0.00038292396,0.0011963813,0.0034732595,0.00034954483,0.023609387],"genre_scores_gemma":[0.96771073,0.013246988,0.0061788373,0.0021630733,0.00042482486,0.00053201575,0.0057312213,0.00006435359,0.0039480105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990146,0.00041084268,0.00014386466,0.00012882744,0.00013551668,0.00016631569],"domain_scores_gemma":[0.9990884,0.00022335284,0.00020110836,0.00016731115,0.0001138892,0.00020595644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029605548,0.00060352415,0.000582345,0.0006275926,0.00025363546,0.0009962355,0.00047520295,0.00066223403,0.001287197],"category_scores_gemma":[0.0012140018,0.00015544753,0.00078895275,0.00047034063,0.00038032173,0.00027660534,0.00032585338,0.0007933306,0.0008099492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03962078,0.014282334,0.12938495,0.0017583583,0.0013519817,0.011820049,0.0006439182,0.0024620816,0.061473552,0.002161393,0.015023569,0.72001696],"study_design_scores_gemma":[0.022182211,0.24597391,0.2325416,0.0012341714,0.0040977374,0.04723942,0.000759853,0.0061202436,0.18849184,0.0010215952,0.250155,0.0001824409],"about_ca_topic_score_codex":0.00085301034,"about_ca_topic_score_gemma":0.00090068736,"teacher_disagreement_score":0.0029605548,"about_ca_system_score_codex":0.0007308414,"about_ca_system_score_gemma":0.0011877064,"threshold_uncertainty_score":0.015657067},"labels":[],"label_agreement":null},{"id":"W4380359389","doi":"10.1093/neuonc/noad073.061","title":"DIPG-14. PROTEOGENOMICS PROFILING REVEALS ENRICHED NON-HISTONE PROTEIN METHYLTRANSFERASES AS NEW THERAPEUTIC TARGETS IN DIPG","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Histone; Proteome; Histone H3; Transcriptome; Proteomics; Proteogenomics; Methyltransferase; DNA methylation; Methylation; Genetics; Cancer research; Gene expression; DNA; Gene","score_opus":0.03884201523732462,"score_gpt":0.34493542876432387,"score_spread":0.30609341352699926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380359389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976233,0.009613572,0.0055105495,0.0003500513,0.00005620948,0.00013956922,0.006224113,0.00037449232,0.0014984986],"genre_scores_gemma":[0.9818491,0.0027967244,0.0057377513,0.00027868402,0.000012559684,0.00009338413,0.0073840814,0.000057119207,0.0017906803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999306,0.000005046063,0.000003329524,0.000019508643,0.000022978511,0.000018422508],"domain_scores_gemma":[0.99996054,0.0000038121932,0.000011664923,0.00000408316,0.000008019592,0.000011874364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012626611,0.00033525485,0.00039769165,0.00034550708,0.00014214788,0.00027823515,0.00020817785,0.00026418446,0.0009639835],"category_scores_gemma":[0.000106657666,0.00012161284,0.0003090285,0.0003720119,0.00016498112,0.00014141445,0.00021227563,0.00044689412,0.00031463677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051669945,0.000037880596,0.0031642835,0.00022907603,0.00005177659,0.00020368557,0.00001645972,0.00026275194,0.9830168,0.00008545932,0.0005611499,0.011854024],"study_design_scores_gemma":[0.00010357647,0.0010824283,0.089488074,0.000027479551,0.00020215029,0.0022241909,0.00007250753,0.004232569,0.8863373,0.0004270517,0.015777629,0.000025159292],"about_ca_topic_score_codex":0.0007586497,"about_ca_topic_score_gemma":0.0011600732,"teacher_disagreement_score":0.0009639835,"about_ca_system_score_codex":0.00031693932,"about_ca_system_score_gemma":0.00023104755,"threshold_uncertainty_score":0.0032248497},"labels":[],"label_agreement":null},{"id":"W4380361287","doi":"10.1093/neuonc/noad073.015","title":"ATRT-15. ATRTS HIJACK EPIGENETIC MECHANISMS TO PROMOTE IMMUNOSUPPRESSION AND ESCAPE FROM NK CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Chromatin; Biology; Enhancer; Chromatin remodeling; Cancer research; Epigenetics; Cell biology; Gene silencing; Histone; Transcription factor; Genetics; Gene","score_opus":0.014510554393316194,"score_gpt":0.27493065728412613,"score_spread":0.26042010289080997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380361287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870007,0.0027967454,0.0035134992,0.00023356185,0.00008704303,0.0000773469,0.000649756,0.00032911845,0.005312266],"genre_scores_gemma":[0.9940157,0.0005031503,0.0012090928,0.00008171014,0.000013736244,0.000042558968,0.00054103066,0.00002101502,0.003572003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986625,0.000020538891,0.000013367066,0.000027468457,0.00003541381,0.000036963203],"domain_scores_gemma":[0.99992776,0.0000072933935,0.00002078965,0.0000135536,0.000005708148,0.000024982364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014092984,0.0002066726,0.00025991892,0.0001372855,0.00010596224,0.00032197052,0.00019829534,0.00020505636,0.003095028],"category_scores_gemma":[0.00008741593,0.00008652259,0.00020890162,0.00010533411,0.00019275535,0.00017448327,0.00021091221,0.00068951293,0.0009417924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027997248,0.00012690165,0.0007759403,0.00006600451,0.000017889663,0.00012090969,0.000018318076,0.0002633441,0.9880531,0.00055348285,0.00034795285,0.009376221],"study_design_scores_gemma":[0.00015913339,0.0024624837,0.007613219,0.000018727613,0.000056122084,0.0016946101,0.00005087659,0.0018862259,0.9629901,0.00030536353,0.022754692,0.0000083993755],"about_ca_topic_score_codex":0.00014306465,"about_ca_topic_score_gemma":0.0003239049,"teacher_disagreement_score":0.003095028,"about_ca_system_score_codex":0.00019383022,"about_ca_system_score_gemma":0.00017189527,"threshold_uncertainty_score":0.010353923},"labels":[],"label_agreement":null},{"id":"W4380362243","doi":"10.1093/neuonc/noad073.198","title":"IMMU-11. PRECLINICAL HIGH-RISK PEDIATRIC BRAIN TUMOR MODELS FOR IMMUNOTHERAPY: HURDLES AND THE WAY FORWARD","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Immunotherapy; Medicine; Brain tumor; Cancer; Cancer immunotherapy; Epigenetics; Immunology; Oncology; Bioinformatics; Immune system; Cancer research; Internal medicine; Biology; Pathology","score_opus":0.030122104084715332,"score_gpt":0.3238255471242193,"score_spread":0.29370344303950396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4024231,0.21848765,0.21888974,0.052706763,0.007759026,0.004827684,0.020839976,0.007867865,0.06619818],"genre_scores_gemma":[0.60345787,0.15842512,0.16648364,0.008708516,0.0010439267,0.0049927505,0.024518546,0.0015479813,0.030821638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998514,0.0005799003,0.00011444524,0.00011842693,0.00041685047,0.0002563844],"domain_scores_gemma":[0.99827445,0.0003746813,0.00028889548,0.00022056056,0.0004289237,0.000412536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056047374,0.0010403607,0.0012754052,0.00081208564,0.00042577175,0.0025059544,0.002027143,0.0016957928,0.0043317983],"category_scores_gemma":[0.0015009406,0.0005623582,0.0009852161,0.0005430145,0.0008894348,0.002094857,0.0009635846,0.0071054623,0.0028913717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00216734,0.002907811,0.0030107559,0.005148765,0.00035248176,0.0006960286,0.0004969896,0.0035733227,0.8339128,0.016582467,0.039838783,0.09131249],"study_design_scores_gemma":[0.00046858395,0.013225738,0.0046617994,0.0014777689,0.0005360568,0.0022582032,0.00050088076,0.0051373653,0.6108458,0.004834727,0.35594505,0.00010799927],"about_ca_topic_score_codex":0.0014323648,"about_ca_topic_score_gemma":0.0027068509,"teacher_disagreement_score":0.0056047374,"about_ca_system_score_codex":0.0011476721,"about_ca_system_score_gemma":0.0018750117,"threshold_uncertainty_score":0.029641092},"labels":[],"label_agreement":null},{"id":"W4380362967","doi":"10.1093/neuonc/noad073.067","title":"DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Carcinogenesis; Epigenetics; Biology; Transcription factor; Cancer research; Histone; Glioma; Cell biology; Genetics; Cancer; Gene","score_opus":0.01834662421488841,"score_gpt":0.30521042662217124,"score_spread":0.2868638024072828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98998135,0.0024090775,0.004585723,0.00007846392,0.000009362924,0.000041516258,0.00074586796,0.000082603605,0.0020660732],"genre_scores_gemma":[0.991601,0.0007114099,0.0037676084,0.000050835217,0.000007605031,0.000038143236,0.0012757621,0.00002801589,0.0025196706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998996,0.000010863555,0.0000057207617,0.000031184372,0.00002721628,0.000025450412],"domain_scores_gemma":[0.999936,0.000008205812,0.000022548464,0.000004421961,0.0000059972863,0.000022887829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015878679,0.0002877059,0.00016054613,0.00036353464,0.000107892345,0.00028264106,0.00015461631,0.00023973236,0.0013027027],"category_scores_gemma":[0.00007648239,0.00011353625,0.00014998934,0.00018139872,0.00021284433,0.00017694934,0.00021818734,0.0002150548,0.00044576987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004614536,0.0000060373995,0.00048548597,0.000022412589,0.0000020257733,0.000110708475,0.0000073962174,0.00002331723,0.9985753,0.00010832662,0.000015312973,0.0005974932],"study_design_scores_gemma":[0.000015374011,0.0002141906,0.022958066,0.000006059373,0.00001656271,0.0012921079,0.00007794176,0.0011283656,0.97015285,0.00013149307,0.0040022847,0.0000046977875],"about_ca_topic_score_codex":0.00043448264,"about_ca_topic_score_gemma":0.0007023866,"teacher_disagreement_score":0.0013027027,"about_ca_system_score_codex":0.00030732967,"about_ca_system_score_gemma":0.00016015807,"threshold_uncertainty_score":0.004357934},"labels":[],"label_agreement":null},{"id":"W4380363071","doi":"10.1093/neuonc/noad073.114","title":"EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia","funders":"","keywords":"Ependymoma; Medicine; Cohort; Epidemiology; Copy-number variation; Metastasis; Population; Oncology; Pathology; Internal medicine; Pediatrics; Biology; Cancer; Genetics; Genome","score_opus":0.016508631324363077,"score_gpt":0.2791648079999841,"score_spread":0.262656176675621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380363071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696213,0.00055396225,0.0001392932,0.000036760503,0.000010973607,0.0000133888825,0.00042764717,0.000009107995,0.0018467761],"genre_scores_gemma":[0.9987356,0.00020150206,0.00013339624,0.000020497555,0.000009951866,0.0000053407775,0.00038262937,0.000002012119,0.0005091188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998895,0.000009532801,0.0000112789285,0.000031656196,0.000019850697,0.000038046244],"domain_scores_gemma":[0.9998004,0.0000342589,0.000062375955,0.0000123579985,0.000026338197,0.000064364955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012049248,0.00024472908,0.00020181842,0.0005741576,0.00036126137,0.0002779072,0.00012575315,0.000236633,0.0016435245],"category_scores_gemma":[0.00047297977,0.00008670644,0.000105401115,0.00044719095,0.00021048792,0.00018308304,0.00030592325,0.00021623993,0.0004172806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002026236,0.000056368914,0.93616265,0.00003589853,0.000019949544,0.044016566,0.00014683207,0.00007049697,0.00728029,0.0001092644,0.0004352304,0.011463792],"study_design_scores_gemma":[0.000005499096,0.0001865073,0.8882189,0.000013699883,0.000020997786,0.107906595,0.00022281228,0.0001463551,0.001346212,0.00008225859,0.0018433768,0.0000069446833],"about_ca_topic_score_codex":0.0021100452,"about_ca_topic_score_gemma":0.0026529976,"teacher_disagreement_score":0.0021100452,"about_ca_system_score_codex":0.00018206013,"about_ca_system_score_gemma":0.00024209684,"threshold_uncertainty_score":0.005498171},"labels":[],"label_agreement":null},{"id":"W4380365659","doi":"10.1093/neuonc/noad073.214","title":"LGG-04. CLINICALLY RELEVANT MODELING OF FUSION-DRIVEN PEDIATRIC LOW GRADE GLIOMAS USING DROSOPHILA MELANOGASTER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Drosophila melanogaster; Biology; Model organism; Zebrafish; Phenotype; Melanogaster; Glioma; Fusion protein; Fusion gene; Mdm2; Signal transduction; Cancer research; Gene; Computational biology; Genetics","score_opus":0.059989039324182356,"score_gpt":0.34442734460077057,"score_spread":0.2844383052765882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380365659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8563908,0.0021166704,0.08478437,0.0006421797,0.00021395426,0.00077210524,0.028010853,0.00351138,0.023557663],"genre_scores_gemma":[0.8851547,0.001435726,0.07759217,0.00018157411,0.0000131413235,0.0010956599,0.013288593,0.0007526799,0.020485576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999143,0.00001442088,0.000007808827,0.000021373051,0.00002871087,0.000013288661],"domain_scores_gemma":[0.9999162,0.000021055019,0.000022092234,0.000010386435,0.000011158779,0.000019156778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001536891,0.0005070176,0.00019777137,0.00039333067,0.00023780028,0.000344375,0.0006194356,0.0006886074,0.003942964],"category_scores_gemma":[0.000119341465,0.00021720245,0.00043598888,0.0001405053,0.0002203022,0.00014914278,0.0003263757,0.0007021955,0.00092506094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018031578,0.00012857102,0.0014251488,0.00026570784,0.000024490004,0.0005492887,0.00007140308,0.018235682,0.9684231,0.0032173505,0.0018091289,0.005669853],"study_design_scores_gemma":[0.00022365834,0.0010074598,0.008582645,0.00012083356,0.0001182156,0.0011019405,0.00017546774,0.17452882,0.72978556,0.0015966697,0.08269708,0.000061515835],"about_ca_topic_score_codex":0.0037160902,"about_ca_topic_score_gemma":0.0033473247,"teacher_disagreement_score":0.003942964,"about_ca_system_score_codex":0.00060872507,"about_ca_system_score_gemma":0.0002979633,"threshold_uncertainty_score":0.013190508},"labels":[],"label_agreement":null},{"id":"W4380366399","doi":"10.1093/neuonc/noad073.042","title":"BIOL-23. LOSS OF MICRORNAS COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE MYC-DEPENDENT METASTATIC MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Dicer; Biology; Cancer research; Medulloblastoma; PTEN; Gene silencing; microRNA; Glioma; Tumor progression; Tumor initiation; Carcinogenesis; Cancer; PI3K/AKT/mTOR pathway; Small interfering RNA; Genetics; Cell culture; Transfection; Signal transduction","score_opus":0.02381797646764164,"score_gpt":0.29444827492564724,"score_spread":0.27063029845800557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380366399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901844,0.0009633227,0.0043427357,0.00012060629,0.000060190963,0.000059663238,0.0010681321,0.00033546923,0.0028654253],"genre_scores_gemma":[0.9925844,0.00027130503,0.0016936767,0.0000375113,0.0000068802274,0.000050695515,0.0007377438,0.00006808874,0.004549646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977237,0.000027299842,0.000029677762,0.00005394652,0.00007310507,0.00004367781],"domain_scores_gemma":[0.9998349,0.000022248432,0.000051327384,0.000021911319,0.000009353832,0.000060289723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017192528,0.00037445794,0.00024892142,0.00030350074,0.00018230264,0.0003689959,0.00022964066,0.0003279249,0.0016988711],"category_scores_gemma":[0.00011677194,0.00024161261,0.00031435554,0.000080757054,0.0002163014,0.00014350226,0.00030906618,0.0005756343,0.0009070595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003594791,0.00001870045,0.00013710557,0.0000102932,0.0000035011067,0.00009185873,0.0000066844805,0.000041295174,0.9989686,0.000121034136,0.00003245406,0.00053256727],"study_design_scores_gemma":[0.000009648115,0.00017000339,0.0035323414,0.000003627292,0.000008942685,0.00047515696,0.000016379317,0.00094930344,0.991243,0.000038052087,0.0035500342,0.0000033581987],"about_ca_topic_score_codex":0.0006051801,"about_ca_topic_score_gemma":0.0012993984,"teacher_disagreement_score":0.0016988711,"about_ca_system_score_codex":0.00045274227,"about_ca_system_score_gemma":0.00020084018,"threshold_uncertainty_score":0.005683303},"labels":[],"label_agreement":null},{"id":"W4380368215","doi":"10.1093/neuonc/noad073.222","title":"LGG-12. CLINICAL AND MOLECULAR FEATURES OF DISSEMINATED PEDIATRIC LOW-GRADE GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"KRAS; Medicine; Glioma; Population; Oncology; Metastasis; Internal medicine; Cancer research; Cancer; Colorectal cancer","score_opus":0.022943631839554487,"score_gpt":0.3506606101613883,"score_spread":0.3277169783218338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977622,0.00023395041,0.0001440549,0.000038624115,0.0000024888338,0.000017455004,0.00037428408,0.000021287708,0.0014056067],"genre_scores_gemma":[0.9992187,0.000068007954,0.00016721987,0.000013402318,0.0000039399997,0.000010829375,0.00037874677,0.0000042222887,0.0001350118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984443,0.000020180822,0.000016174461,0.000044648557,0.00003220783,0.0000422722],"domain_scores_gemma":[0.99947613,0.00006357007,0.0002176591,0.000022019905,0.000045132045,0.00017549866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020421151,0.00036459407,0.000229431,0.0009628939,0.0002825608,0.00035882008,0.00026975805,0.00035208077,0.001981765],"category_scores_gemma":[0.0010007094,0.0001383786,0.00013524659,0.0007561377,0.00041410883,0.00034279653,0.00036532522,0.0003183074,0.00041458497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017700801,0.000019208297,0.9803892,0.000025178038,0.000008651337,0.010119402,0.00006784373,0.00022536896,0.0040293564,0.000084020256,0.00028112854,0.0045737512],"study_design_scores_gemma":[0.000013863724,0.00016814197,0.95125794,0.00001088635,0.00001938249,0.046199895,0.00019466973,0.0005158033,0.000800201,0.00011458983,0.00069707,0.000007547063],"about_ca_topic_score_codex":0.003075551,"about_ca_topic_score_gemma":0.0029330144,"teacher_disagreement_score":0.003075551,"about_ca_system_score_codex":0.00041697995,"about_ca_system_score_gemma":0.00034213506,"threshold_uncertainty_score":0.006629646},"labels":[],"label_agreement":null},{"id":"W4380368915","doi":"10.1093/neuonc/noad073.060","title":"DIPG-13. NEW IMMUNOCOMPETENT GENETICALLY-ENGINEERED MOUSE MODELS OF PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMAS REVEAL MECHANISMS OF TUMOR INITIATION AND PROGRESSION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Lineage markers; OLIG2; Cancer research; KRAS; Cell of origin; Glioma; Tumor initiation; IDH1; Pathology; Mutation; Progenitor cell; Oligodendrocyte; Gene; Stem cell; Carcinogenesis; Medicine; Myelin; Genetics","score_opus":0.029249437841759048,"score_gpt":0.2896653529142814,"score_spread":0.2604159150725224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532156,0.0030980187,0.020876812,0.0011608311,0.0003289349,0.00065100763,0.011205159,0.0015009211,0.007962636],"genre_scores_gemma":[0.9263905,0.0031976625,0.024004448,0.00057573704,0.00008493402,0.0019457218,0.009657289,0.000649639,0.033494085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992908,0.00009453535,0.000086391214,0.00020242865,0.0001515016,0.0001742995],"domain_scores_gemma":[0.99940693,0.000064784785,0.00020160251,0.00006697316,0.000042772783,0.00021692725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006754858,0.001495048,0.00057767535,0.0018427883,0.00050379976,0.00090092776,0.0009733323,0.0016981418,0.005457934],"category_scores_gemma":[0.0002037865,0.0006579364,0.00075974263,0.00052973593,0.0010729787,0.0010249707,0.00047569783,0.0031400167,0.0023049682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006867422,0.0005296286,0.00035302885,0.00016815832,0.000020294145,0.0004210109,0.00007740858,0.00034146593,0.99264824,0.0012501079,0.00051472936,0.0029892146],"study_design_scores_gemma":[0.00039329383,0.0024772757,0.005033585,0.000103692226,0.00008257972,0.0017377001,0.0001842115,0.0033285292,0.96842974,0.0004947997,0.01770343,0.000031206648],"about_ca_topic_score_codex":0.0008690382,"about_ca_topic_score_gemma":0.0017726785,"teacher_disagreement_score":0.005457934,"about_ca_system_score_codex":0.0009133479,"about_ca_system_score_gemma":0.0005962728,"threshold_uncertainty_score":0.018258631},"labels":[],"label_agreement":null},{"id":"W4380368985","doi":"10.1093/neuonc/noad073.240","title":"MDB-07. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF KDM2B TARGETS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Demethylase; Cancer research; Medulloblastoma; Biology; Effector; Epigenetics; Downregulation and upregulation; Carcinogenesis; Cancer; Gene; Cell biology; Genetics","score_opus":0.019951217120714956,"score_gpt":0.2950622195076874,"score_spread":0.27511100238697245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946121,0.00094465783,0.0010762716,0.0001930779,0.000037224887,0.00004549437,0.00085027306,0.000098525714,0.0021423455],"genre_scores_gemma":[0.99471825,0.0004183261,0.0008860433,0.0000956444,0.000005979959,0.000047824367,0.00076667493,0.000023181756,0.0030381458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987555,0.000013579131,0.00001290806,0.000019323004,0.000041690826,0.00003696714],"domain_scores_gemma":[0.9999312,0.000009687704,0.00001848184,0.0000069773255,0.0000059546055,0.000027717422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001014418,0.00020399045,0.00019184481,0.00020723617,0.00012620521,0.0002740839,0.00015315018,0.00023074442,0.0023411645],"category_scores_gemma":[0.00005985892,0.00010413188,0.00023476462,0.00012786253,0.00017931925,0.00011336813,0.0001559935,0.0007112005,0.00060444174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016399017,0.00009765918,0.00051441154,0.000033430377,0.0000061071455,0.00004824232,0.000016634665,0.000093153176,0.99675614,0.00012603072,0.00014432374,0.0019999568],"study_design_scores_gemma":[0.000056341054,0.00074516196,0.010561959,0.000008127332,0.000021525095,0.00030299503,0.000063269814,0.0012109381,0.9808193,0.000060954186,0.0061447406,0.000004623322],"about_ca_topic_score_codex":0.00059718086,"about_ca_topic_score_gemma":0.0012311231,"teacher_disagreement_score":0.0023411645,"about_ca_system_score_codex":0.00026667587,"about_ca_system_score_gemma":0.00020040633,"threshold_uncertainty_score":0.007831931},"labels":[],"label_agreement":null},{"id":"W4380369756","doi":"10.1093/neuonc/noad073.271","title":"MDB-39. ASSESSMENT OF MEDULLOBLASTOMA PATIENTS THROUGH MONITORING EXTRACELLULAR VESICLES VIA SURFACE-ENHANCED RAMAN SPECTROSCOPY COMBINED WITH MACHINE LEARNING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Extracellular vesicles; Liquid biopsy; Medulloblastoma; Machine learning; Computer science; Raman spectroscopy; Extracellular vesicle; Artificial intelligence; Medicine; Bioinformatics; Biomedical engineering; Pathology; Cancer; Chemistry; Internal medicine; Biology","score_opus":0.010944685083116162,"score_gpt":0.287793572053417,"score_spread":0.27684888697030086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380369756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813462,0.0011763609,0.014495666,0.00009974561,0.00002119217,0.000059451068,0.0017488705,0.00027467438,0.0007780099],"genre_scores_gemma":[0.982114,0.00032053914,0.015303549,0.000040634855,0.0000064192345,0.00006261095,0.0014029405,0.000026876345,0.0007224309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997434,0.0000421962,0.000017649058,0.00009113067,0.00008260496,0.000022978069],"domain_scores_gemma":[0.99985886,0.000036386715,0.000046078647,0.000010286508,0.000035016026,0.0000132698515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035211115,0.0003500184,0.0003030127,0.0005945196,0.00016001001,0.0003217508,0.00021505417,0.00029564212,0.0006144696],"category_scores_gemma":[0.0005303907,0.00014498744,0.0003498409,0.00029693954,0.00011394861,0.00016854698,0.00021855171,0.00023318986,0.00023238218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016041317,0.00029687522,0.13787216,0.00031827381,0.00021087976,0.00045614145,0.0001307518,0.018107016,0.7547529,0.0002844099,0.000973053,0.08499342],"study_design_scores_gemma":[0.000039071452,0.0009200024,0.18726468,0.000042756204,0.00016388705,0.001105247,0.00015174113,0.14721183,0.6584873,0.0005065983,0.0040426985,0.000064146785],"about_ca_topic_score_codex":0.0018783726,"about_ca_topic_score_gemma":0.0020889202,"teacher_disagreement_score":0.0018783726,"about_ca_system_score_codex":0.00029508257,"about_ca_system_score_gemma":0.00021466248,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4380371135","doi":"10.1093/neuonc/noad073.006","title":"ATRT-06. ETMR TUMORIGENESIS MIRRORS RADIAL GLIAL DEVELOPMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Wnt signaling pathway; Embryonic stem cell; Carcinogenesis; microRNA; Embryogenesis; Context (archaeology); Gene; Cancer research; Genetics; Cell biology","score_opus":0.027583391616586926,"score_gpt":0.30340009055339573,"score_spread":0.2758166989368088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97013265,0.0007496842,0.008056099,0.00013597994,0.00003390701,0.0000506819,0.016360193,0.0006202542,0.003860545],"genre_scores_gemma":[0.9460237,0.000692741,0.013069476,0.00021783527,0.000010845277,0.00014230087,0.034011252,0.00036498118,0.005466853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995784,0.000036611185,0.000029396992,0.00017014786,0.00012983444,0.00005545332],"domain_scores_gemma":[0.9995339,0.0000880617,0.00015065515,0.0000661005,0.000065091655,0.000096325086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040478757,0.00026611506,0.00031485254,0.0005446985,0.00034434398,0.00061817555,0.0002355552,0.00028623777,0.002717353],"category_scores_gemma":[0.00043044344,0.00018457291,0.0004195729,0.0004840059,0.00028500854,0.000206541,0.00037661722,0.0007641762,0.0013099656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000499761,0.00006517581,0.026612857,0.00014992389,0.000114827795,0.00036719727,0.00008333554,0.0014926016,0.9563475,0.00067776843,0.0014179158,0.0121711455],"study_design_scores_gemma":[0.000065641005,0.00079614297,0.30280408,0.00006374631,0.0002314054,0.004255546,0.0002644727,0.014393796,0.6345948,0.0013202914,0.04116276,0.000047285484],"about_ca_topic_score_codex":0.0014197459,"about_ca_topic_score_gemma":0.0032672286,"teacher_disagreement_score":0.002717353,"about_ca_system_score_codex":0.00037474593,"about_ca_system_score_gemma":0.00043367076,"threshold_uncertainty_score":0.009090424},"labels":[],"label_agreement":null},{"id":"W4380372174","doi":"10.1093/neuonc/noad073.083","title":"DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Methionine Adenosyltransferase; Methionine; Epigenetics; Methyltransferase; Methylation; Histone; Biology; Regulator; Cell biology; Cancer research; Biochemistry; Amino acid; Gene","score_opus":0.02888501305955689,"score_gpt":0.3151405217067985,"score_spread":0.28625550864724164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380372174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223995,0.00076037407,0.0047824997,0.00012601909,0.000040430827,0.00003662108,0.0006419414,0.00023974209,0.0011325063],"genre_scores_gemma":[0.99480325,0.00026113214,0.0022176174,0.00004282779,0.000004326724,0.000037791895,0.0003898546,0.000024471079,0.0022188665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985504,0.000013994653,0.000013047276,0.000038147242,0.00005077447,0.000029006116],"domain_scores_gemma":[0.9998975,0.000010406061,0.000042549,0.00001304559,0.000007631301,0.000028880786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012730231,0.00032619655,0.00021066058,0.00025951528,0.0001258663,0.00023737056,0.0003142893,0.00023354811,0.0010442332],"category_scores_gemma":[0.00006430991,0.00016739221,0.00028789605,0.00012191553,0.00025611286,0.00013119057,0.0002450326,0.00046728706,0.00029027817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000451304,0.000011596946,0.00008444956,0.00000875415,0.0000020730008,0.000025696287,0.00000287923,0.000029723704,0.99940157,0.000059084075,0.000014430183,0.00031468848],"study_design_scores_gemma":[0.000009232272,0.00019660598,0.0019557439,0.0000019004598,0.0000061514675,0.00011609625,0.000009718432,0.00078599504,0.995968,0.000036361445,0.00091119646,0.000002909233],"about_ca_topic_score_codex":0.00086787145,"about_ca_topic_score_gemma":0.0011831846,"teacher_disagreement_score":0.0010442332,"about_ca_system_score_codex":0.00031641728,"about_ca_system_score_gemma":0.00019746498,"threshold_uncertainty_score":0.0034933686},"labels":[],"label_agreement":null},{"id":"W4380372553","doi":"10.1093/neuonc/noad073.176","title":"HGG-27. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A REPORT FROM THE IRRDC AND THE GLIOMA TASK FORCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Structural Genomics Consortium; Hospital for Sick Children","funders":"","keywords":"Medicine; Germline; Oncology; Glioma; DNA mismatch repair; Internal medicine; Cancer research; Germline mutation; Cancer; Mutation; Genetics; Biology; Gene","score_opus":0.01177961469797215,"score_gpt":0.28856862690539814,"score_spread":0.27678901220742597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380372553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578159,0.0068893414,0.00015230557,0.00053729536,0.000040110244,0.000051407813,0.031050516,0.00002369517,0.0034395154],"genre_scores_gemma":[0.9852359,0.002362875,0.0001266817,0.00015067618,0.00002497946,0.000037877107,0.011554562,0.000008298696,0.0004981534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999605,0.00005384539,0.00003741775,0.00008322576,0.00015502793,0.00006554968],"domain_scores_gemma":[0.9988549,0.00010323677,0.00047360107,0.000042613447,0.00029350776,0.0002322194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006409633,0.00023551367,0.00020382421,0.00093491806,0.00030766972,0.00041731083,0.00029412704,0.00021430397,0.0008544535],"category_scores_gemma":[0.001233395,0.0001321856,0.00028646164,0.0015967785,0.00017518176,0.00016016784,0.00033430473,0.0002499057,0.00019537957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038529663,0.0000039585716,0.9959337,0.000035696085,0.000046440153,0.00006331034,0.00005269616,0.000017924896,0.00009644333,0.000014033071,0.00115458,0.0025426368],"study_design_scores_gemma":[0.0000034278148,0.000011593207,0.9986659,0.000020082547,0.000038573293,0.000097818396,0.000081631944,0.00001887945,0.000049725597,0.0000035672404,0.001007513,0.0000012198844],"about_ca_topic_score_codex":0.18212934,"about_ca_topic_score_gemma":0.19995946,"teacher_disagreement_score":0.18212934,"about_ca_system_score_codex":0.0009003883,"about_ca_system_score_gemma":0.0014726138,"threshold_uncertainty_score":0.36213845},"labels":[],"label_agreement":null},{"id":"W4381250167","doi":"10.1093/neuonc/noad073.320","title":"Author Index","year":2023,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.0589635921977023,"score_gpt":0.3666350457616977,"score_spread":0.3076714535639954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381250167","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002863175,0.0014563,0.0007882119,0.0027880997,0.00709477,0.00027864476,0.021034196,0.0019570596,0.9643162],"genre_scores_gemma":[0.0007646101,0.0011148255,0.0005721359,0.0010964469,0.0015828077,0.0001313023,0.008610992,0.00074548327,0.9853814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994466,0.000084100844,0.000051883046,0.00006130271,0.00029466525,0.00006155754],"domain_scores_gemma":[0.995542,0.00089818507,0.00018754449,0.00022177144,0.0018871041,0.0012634643],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005709036,0.0014514958,0.0012494541,0.005823583,0.0010800358,0.0042708395,0.001254503,0.0017235071,0.893722],"category_scores_gemma":[0.0067301444,0.00054685236,0.00061453495,0.0041241623,0.00042790952,0.0019470342,0.001963267,0.0014971222,0.84923434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016363156,0.000016419459,0.00005265238,0.0001014221,0.0000011692786,0.000018311364,0.0000043500268,0.000045819095,0.00004393665,0.00034847728,0.9659067,0.03344431],"study_design_scores_gemma":[0.000031342934,0.00001938161,0.00028958922,0.00023740834,0.000003984165,0.000078063356,0.00001926382,0.000110387446,0.000106640146,0.001333663,0.9977623,0.000007876454],"about_ca_topic_score_codex":0.0028230532,"about_ca_topic_score_gemma":0.0060787383,"teacher_disagreement_score":0.106278,"about_ca_system_score_codex":0.0015251689,"about_ca_system_score_gemma":0.0023186698,"threshold_uncertainty_score":0.15159267},"labels":[],"label_agreement":null},{"id":"W4382395320","doi":"10.1093/neuonc/noad114","title":"Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute of Neurological Disorders and Stroke; Helse Sør-Øst RHF; University of California, San Francisco; Deutschen Konsortium für Translationale Krebsforschung; Université de Recherche Paris Sciences et Lettres; Norges Forskningsråd; Institut Gustave-Roussy; Deutsche Kinderkrebsstiftung; Universitätsklinikum Hamburg-Eppendorf; Making Headway Foundation; Universitätsklinikum Heidelberg; Université Paris-Saclay; Universitetet i Oslo; Bundesministerium für Bildung und Forschung; Hospital for Sick Children; State Government of Victoria; Brain Tumour Research; Institut National de la Santé et de la Recherche Médicale; Bundesamt für Gesundheit; Brain Tumour Charity; Deutsches Krebsforschungszentrum; Centre National de la Recherche Scientifique; Robert Connor Dawes Foundation; Cancer Australia; National Institutes of Health; Friedberg Charitable Foundation; Cancer Research UK; Eli Lilly and Company; Y-mAbs Therapeutics","keywords":"Li–Fraumeni syndrome; Medulloblastoma; Outcome (game theory); Medicine; Pediatrics; Oncology; Cancer research; Mutation; Genetics; Germline mutation; Biology","score_opus":0.03179412279404297,"score_gpt":0.33670182763302103,"score_spread":0.30490770483897806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382395320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956447,0.00013220422,0.000028851626,0.00000859584,0.0000010363259,0.0000031947154,0.00014176544,0.000002409886,0.00011734916],"genre_scores_gemma":[0.999577,0.00007908253,0.000038673446,0.00000395553,0.0000030144472,0.0000048104303,0.00027033783,0.0000012995094,0.00002197748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998211,0.000030631727,0.00002191277,0.000049089325,0.00003340419,0.00004389688],"domain_scores_gemma":[0.9993262,0.00008699004,0.00039140068,0.00002813749,0.000039475155,0.00012781892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025525576,0.00028043226,0.0003185017,0.0007085641,0.00032223092,0.00033388872,0.00023063642,0.00021437327,0.0008029664],"category_scores_gemma":[0.00093590724,0.0001340216,0.00022491849,0.0005061315,0.00026095807,0.00027933397,0.00032093283,0.0002250313,0.00015003055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013939344,0.000011206927,0.9971097,0.000005249977,0.00001594303,0.00088114606,0.000049898357,0.000059477927,0.0006136552,0.000008452192,0.000042525284,0.0010633619],"study_design_scores_gemma":[0.0000073440774,0.00016356952,0.99299884,0.0000041284798,0.000028907665,0.0061442386,0.0001224369,0.00013353543,0.00020991672,0.0000180295,0.00016569125,0.0000032764347],"about_ca_topic_score_codex":0.0020446875,"about_ca_topic_score_gemma":0.0018850536,"teacher_disagreement_score":0.0020446875,"about_ca_system_score_codex":0.00036705888,"about_ca_system_score_gemma":0.00032291148,"threshold_uncertainty_score":0.004065573},"labels":[],"label_agreement":null},{"id":"W4383481395","doi":"10.1093/neuonc/noad110","title":"Increasing growth and impact of <i>Neuro-Oncology</i>","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Web site; Gerontology; Oncology; General surgery; Internal medicine; Computer science; The Internet","score_opus":0.025357579235806855,"score_gpt":0.3266095411650331,"score_spread":0.30125196192922626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383481395","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080946204,0.076442294,0.0009966299,0.48108408,0.41406626,0.0000401599,0.00044254723,0.00052975974,0.025588842],"genre_scores_gemma":[0.01694072,0.10897357,0.004509677,0.17941946,0.65989625,0.00010236854,0.0009933361,0.0010080732,0.028156588],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9628584,0.008571114,0.0034948988,0.0030782283,0.019803047,0.0021943224],"domain_scores_gemma":[0.7406466,0.064325936,0.02290869,0.0080995215,0.11775048,0.046268735],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.027829804,0.0012136052,0.0020763741,0.008919802,0.0029566626,0.021207418,0.0038465105,0.009673828,0.043950196],"category_scores_gemma":[0.15689269,0.00083569245,0.002010411,0.0074424953,0.0060837846,0.015016638,0.005212547,0.011076207,0.03571039],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027819768,0.000014118339,0.0006311873,0.0010362052,0.00002454683,0.00013639126,0.00016143659,0.00003381198,0.00023987572,0.0023117193,0.95493823,0.0404447],"study_design_scores_gemma":[0.000015228666,0.000041347357,0.0021215696,0.0018387054,0.000028128045,0.0009848241,0.00046565005,0.0001229431,0.00024936817,0.0049914503,0.9890956,0.00004520659],"about_ca_topic_score_codex":0.0012999183,"about_ca_topic_score_gemma":0.0029121325,"teacher_disagreement_score":0.9910802,"about_ca_system_score_codex":0.005478664,"about_ca_system_score_gemma":0.012610674,"threshold_uncertainty_score":0.14717984},"labels":[],"label_agreement":null},{"id":"W4384926001","doi":"10.1093/neuonc/noad126","title":"Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; Thompson Rivers University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Isocitrate dehydrogenase; Hox gene; Biology; DNA methylation; Glioma; Methylation; Oncology; Cancer research; IDH2; Gene; Genetics; IDH1; Mutant; Gene expression; Medicine","score_opus":0.024133731369126384,"score_gpt":0.31293716154411855,"score_spread":0.28880343017499216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384926001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945813,0.00008282984,0.00021726321,0.00000820884,5.278424e-7,0.0000031918084,0.00013846594,0.000008923453,0.00008239385],"genre_scores_gemma":[0.99945277,0.000026517328,0.00024921002,0.0000040662885,8.508858e-7,0.00000269714,0.0002154145,0.00000189107,0.000046615714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989736,0.000014654686,0.000007592578,0.00003037718,0.000028869576,0.000021174132],"domain_scores_gemma":[0.9997409,0.0000546232,0.00011730889,0.00002228248,0.000030192217,0.000034809837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306769,0.00018204797,0.00017241828,0.00069356477,0.00010946871,0.00022528914,0.00017074705,0.00013458675,0.0005120614],"category_scores_gemma":[0.00049126183,0.00007517914,0.0001397237,0.00039829165,0.00013971918,0.000071289054,0.00021165377,0.00017570738,0.00008005456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009366286,0.000044389857,0.8712907,0.00003934239,0.00012024543,0.00020444042,0.00011062969,0.0010270004,0.111372754,0.00006745562,0.00014074655,0.01464574],"study_design_scores_gemma":[0.000010099644,0.000113471135,0.98596174,0.0000030384294,0.000071657414,0.0005078469,0.00004579588,0.0024837614,0.01055949,0.000073089126,0.00016579898,0.0000041080516],"about_ca_topic_score_codex":0.0025219042,"about_ca_topic_score_gemma":0.004038881,"teacher_disagreement_score":0.0025219042,"about_ca_system_score_codex":0.00027169028,"about_ca_system_score_gemma":0.00018811123,"threshold_uncertainty_score":0.005014479},"labels":[],"label_agreement":null},{"id":"W4385330942","doi":"10.1093/neuonc/noad134","title":"Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXR<b>α</b> neurogenic pathway","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Biology; SOX2; Stem cell; Cancer research; Cell migration; Cancer stem cell; Epithelial–mesenchymal transition; Stem cell marker; Cell; Transcription factor; Cell biology; Transition (genetics); Biochemistry; Gene","score_opus":0.01022647543154151,"score_gpt":0.24481000452448196,"score_spread":0.23458352909294045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385330942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960271,0.00047447937,0.0017791695,0.000051106752,0.000012234498,0.000027332004,0.00050593226,0.00005284645,0.0010697515],"genre_scores_gemma":[0.99428636,0.00039554972,0.0018083612,0.00006899295,0.00000420396,0.00006692672,0.0012688633,0.000016572745,0.0020842536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991095,0.000008583082,0.0000080268765,0.000017545824,0.000027396536,0.00002751221],"domain_scores_gemma":[0.99994516,0.0000050020763,0.000011521523,0.00000591859,0.000013666669,0.000018603514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008631187,0.00015835649,0.00018285727,0.00026339723,0.00018299052,0.00025531635,0.000102383485,0.0001539493,0.0010941947],"category_scores_gemma":[0.000048009064,0.000084799234,0.00022011451,0.00018389046,0.00016209448,0.00009352919,0.00013323071,0.00032942236,0.0004776717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001492681,0.000041196734,0.0014051945,0.000025374547,0.0000054481825,0.00015114795,0.000047148314,0.00004155958,0.9963839,0.00015488616,0.0000962859,0.0014985312],"study_design_scores_gemma":[0.000027654667,0.0005391692,0.03574753,0.000011732403,0.00003240699,0.0006641337,0.0002686128,0.0017685666,0.95578146,0.00013915157,0.005009073,0.00001054707],"about_ca_topic_score_codex":0.0012828283,"about_ca_topic_score_gemma":0.0019074387,"teacher_disagreement_score":0.0012828283,"about_ca_system_score_codex":0.00028518902,"about_ca_system_score_gemma":0.00028812696,"threshold_uncertainty_score":0.0036604404},"labels":[],"label_agreement":null},{"id":"W4385441608","doi":"10.1093/neuonc/noad141","title":"Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Panobinostat; Neutropenia; Tolerability; Glioma; Population; Nausea; Toxicity; Internal medicine; Oncology; Adverse effect","score_opus":0.01781532449310919,"score_gpt":0.29939279666851515,"score_spread":0.28157747217540596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385441608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922604,0.0032572977,0.00065716,0.0007634328,0.000058994385,0.0022659255,0.0017106371,0.00008666165,0.0019738548],"genre_scores_gemma":[0.9766335,0.0048627215,0.004554775,0.0011689304,0.00012814594,0.003357446,0.0071878154,0.000053038806,0.0020536326],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965096,0.00016484913,0.000027501173,0.000051803363,0.00004424153,0.000060709124],"domain_scores_gemma":[0.99941385,0.00010540058,0.00010316982,0.000045764522,0.000060057217,0.00027178877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012735145,0.0010640449,0.0013389545,0.00026413333,0.0003695789,0.00051479565,0.0007119712,0.0009158157,0.001550396],"category_scores_gemma":[0.00067958503,0.00034775634,0.0008650676,0.00042512506,0.0004018172,0.00041712727,0.00034546916,0.0022445559,0.0003950455],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43078792,0.050202392,0.05302206,0.002520364,0.0034340653,0.0022309988,0.0015493801,0.006539079,0.11138422,0.0007111142,0.019616438,0.318002],"study_design_scores_gemma":[0.42980817,0.48639965,0.056631763,0.00011071896,0.0010174498,0.0017242709,0.00013177966,0.0014972135,0.010168672,0.00020310115,0.012267686,0.000039438775],"about_ca_topic_score_codex":0.0029320645,"about_ca_topic_score_gemma":0.008425537,"teacher_disagreement_score":0.0029320645,"about_ca_system_score_codex":0.0009688774,"about_ca_system_score_gemma":0.0023149336,"threshold_uncertainty_score":0.007029712},"labels":[],"label_agreement":null},{"id":"W4385483101","doi":"10.1093/neuonc/noad140","title":"<i>Isocitrate dehydrogenase</i> wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Direction Générale de l’offre de Soins; Advanced Remanufacturing and Technology Centre; Institut National de la Santé et de la Recherche Médicale; Brigham and Women's Hospital","keywords":"Isocitrate dehydrogenase; Ribosome biogenesis; Ribosomal RNA; Biology; Ribosome; RNA; Methylation; Glioma; Molecular biology; Cancer research; Genetics; Biochemistry; Gene; Enzyme","score_opus":0.019624136466634662,"score_gpt":0.2943896365440803,"score_spread":0.2747655000774456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353373,0.0005132529,0.0024666172,0.00003298909,0.000010413924,0.0000124303015,0.0026822707,0.00017731964,0.0005709975],"genre_scores_gemma":[0.99095386,0.00037151604,0.002549634,0.000066428416,0.000006896895,0.000027457549,0.004997288,0.00009006968,0.0009368986],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998258,0.0000109824805,0.00001530874,0.00006788839,0.000043602566,0.000036487843],"domain_scores_gemma":[0.99978167,0.00002471602,0.00010923101,0.000024430074,0.00002283738,0.00003718195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017931293,0.00025488733,0.00024614015,0.00042499357,0.00014671682,0.00047770565,0.00013138211,0.00017622263,0.0013035533],"category_scores_gemma":[0.00027151988,0.00014169223,0.0002498392,0.0004225216,0.0002459658,0.00010968542,0.00024004845,0.00030323866,0.00036401738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016480406,0.00004709072,0.14992855,0.00025947986,0.000245954,0.0006313842,0.00030529473,0.0004374215,0.816975,0.00030182846,0.0009792962,0.028240709],"study_design_scores_gemma":[0.00003365342,0.00033363243,0.82057625,0.000031662526,0.0001774792,0.0029229776,0.0003366629,0.0014751077,0.16729064,0.00042185353,0.0063771745,0.000022871352],"about_ca_topic_score_codex":0.0014512511,"about_ca_topic_score_gemma":0.003020177,"teacher_disagreement_score":0.0014512511,"about_ca_system_score_codex":0.00020449773,"about_ca_system_score_gemma":0.00013984181,"threshold_uncertainty_score":0.004360795},"labels":[],"label_agreement":null},{"id":"W4385909599","doi":"10.1093/neuonc/noad151","title":"Prognostic value of integrative genomic approaches for IDH-mutant gliomas","year":2023,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology; Library science; Internal medicine; Medicine; Gerontology; Family medicine; Computer science","score_opus":0.0617632911076632,"score_gpt":0.3083971603640845,"score_spread":0.24663386925642128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385909599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94084764,0.024181526,0.015027052,0.0023105987,0.00031175118,0.0001235279,0.004946295,0.00032656072,0.0119249895],"genre_scores_gemma":[0.9890821,0.0019117625,0.004596911,0.00019384018,0.0002156529,0.000039808623,0.003241198,0.00004722551,0.0006714874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994991,0.00013227716,0.00003294206,0.00014506774,0.00012286802,0.00006782596],"domain_scores_gemma":[0.9986947,0.00036581085,0.00031151474,0.00013566541,0.00028823703,0.00020408428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018083215,0.0008295769,0.00074892706,0.0015682962,0.00033963576,0.0016710701,0.0007684613,0.00047701123,0.002406043],"category_scores_gemma":[0.003899304,0.00016249715,0.0005370283,0.001769961,0.00039247127,0.00087311305,0.00091230153,0.000790471,0.0006715149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021650286,0.00016861389,0.76257694,0.00029589128,0.0014428205,0.00043688316,0.00024900702,0.0039131045,0.007528499,0.0016363555,0.003311579,0.21627516],"study_design_scores_gemma":[0.00021278395,0.0011374499,0.92640907,0.00026181608,0.002941907,0.002293807,0.0007153154,0.030186841,0.006128035,0.014194469,0.0154023515,0.0001161915],"about_ca_topic_score_codex":0.0015293042,"about_ca_topic_score_gemma":0.003467847,"teacher_disagreement_score":0.002406043,"about_ca_system_score_codex":0.00068415934,"about_ca_system_score_gemma":0.0005789106,"threshold_uncertainty_score":0.009563386},"labels":[],"label_agreement":null},{"id":"W4386537414","doi":"10.1093/neuonc/noad137.450","title":"P22.01.A PERSON-CENTRED PRACTICE: EXPLORING FAMILY STRENGTH BY USING GENOGRAMS AND ECOMAPS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Family and Patient Care in Intensive Care Units","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genogram; Conversation; Intervention (counseling); Nursing; Distress; Psychology; Kinship; Presentation (obstetrics); Medicine; Developmental psychology; Psychotherapist; Sociology; Communication","score_opus":0.3113215594542156,"score_gpt":0.42121983656914835,"score_spread":0.10989827711493277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5351529,0.0013086123,0.1483612,0.016911443,0.0016222575,0.0023282506,0.002349864,0.0033010521,0.2886644],"genre_scores_gemma":[0.8197538,0.0012131719,0.14351404,0.0011758661,0.00009612001,0.002518037,0.00048327132,0.0006196353,0.030626101],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9971296,0.0025158876,0.000040470008,0.000087918015,0.00013575956,0.00009044097],"domain_scores_gemma":[0.9937842,0.004505682,0.00029108132,0.00044129335,0.00046942808,0.0005084277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049543474,0.0004233747,0.0001822001,0.0008762685,0.0011920336,0.0029102336,0.0009021677,0.0007983673,0.019372595],"category_scores_gemma":[0.013339958,0.00021025765,0.00030976857,0.0009785211,0.0021330542,0.002395826,0.002510434,0.0009241601,0.002560738],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002117941,0.00020112812,0.010739577,0.00092367554,0.000019950488,0.003098343,0.47294134,0.0009069874,0.0017516693,0.034107428,0.08493009,0.39016795],"study_design_scores_gemma":[0.00009764386,0.00051860115,0.020329585,0.0017733935,0.00003902029,0.0038979086,0.44528294,0.0032989,0.0025089108,0.032466605,0.48966512,0.00012134105],"about_ca_topic_score_codex":0.0011908193,"about_ca_topic_score_gemma":0.0020164282,"teacher_disagreement_score":0.019372595,"about_ca_system_score_codex":0.00076573,"about_ca_system_score_gemma":0.0013878497,"threshold_uncertainty_score":0.06480777},"labels":[],"label_agreement":null},{"id":"W4386537420","doi":"10.1093/neuonc/noad137.391","title":"P17.01.A THE VALUE OF ETOPOSIDE FOR RECURRENT GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Etoposide; Medicine; Glioma; Internal medicine; Bevacizumab; Chemotherapy; Retrospective cohort study; Oligodendroglioma; Carboplatin; Surgery; Oncology; Astrocytoma; Cisplatin; Cancer research","score_opus":0.03986563303474235,"score_gpt":0.34630953173963214,"score_spread":0.3064438987048898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94567776,0.005384795,0.0029448164,0.0042006974,0.0011559263,0.000092957176,0.007303126,0.00030257987,0.032937318],"genre_scores_gemma":[0.99498737,0.00028047257,0.00056726247,0.00013864631,0.00024142418,0.000037556707,0.00067648676,0.000045712153,0.0030250594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992982,0.000168549,0.000069022455,0.00015158483,0.00016578783,0.00014688869],"domain_scores_gemma":[0.99841917,0.00039629804,0.0005517288,0.0001053467,0.00018405376,0.0003433907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006299402,0.00029638433,0.00032925032,0.000447986,0.00021765543,0.0006517044,0.00056964095,0.0005690527,0.032170113],"category_scores_gemma":[0.0024477353,0.00007802951,0.00047044776,0.0007826746,0.0003113912,0.00045187218,0.00016146156,0.00062509254,0.0033353043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020922279,0.00044713967,0.7621065,0.0012138699,0.0014704148,0.011537478,0.00032781553,0.00085367204,0.018356765,0.0042470754,0.025731707,0.1527854],"study_design_scores_gemma":[0.0007123036,0.00369018,0.9214921,0.00034137745,0.00062424055,0.025896382,0.00043849202,0.0036677055,0.0051523307,0.0040703774,0.033881187,0.000033284967],"about_ca_topic_score_codex":0.00031637689,"about_ca_topic_score_gemma":0.00018484853,"teacher_disagreement_score":0.032170113,"about_ca_system_score_codex":0.00022115286,"about_ca_system_score_gemma":0.0005141596,"threshold_uncertainty_score":0.10761976},"labels":[],"label_agreement":null},{"id":"W4386537550","doi":"10.1093/neuonc/noad137.155","title":"P06.15.B IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibroblast activation protein, alpha; Chimeric antigen receptor; Cancer research; Stromal cell; Medicine; Glioma; Antigen; U87; Immunology; Immunotherapy; Cancer; Internal medicine; Immune system","score_opus":0.05777059559807561,"score_gpt":0.3468138788377503,"score_spread":0.28904328323967465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96973455,0.009038177,0.01102782,0.00052977196,0.00026498435,0.00032634658,0.0006843046,0.0003705716,0.008023568],"genre_scores_gemma":[0.9848363,0.0024734726,0.0058017126,0.00016278878,0.000042383534,0.0002151127,0.0007234667,0.000027635997,0.0057171197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.000008577503,0.0000039055762,0.000011976929,0.00001582368,0.00002173846],"domain_scores_gemma":[0.9999776,0.0000022498589,0.000004929676,0.0000023053049,0.0000038687267,0.000009117319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001423421,0.0002654567,0.00033052752,0.00022939949,0.00014025111,0.00029261332,0.00027307443,0.0004910635,0.0019660587],"category_scores_gemma":[0.00005491629,0.00007743414,0.00023127878,0.00014834032,0.0001625421,0.00013701506,0.00013533587,0.00045781993,0.0006214248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00102387,0.0006154059,0.000537818,0.00029114747,0.000026917225,0.0007361396,0.0000658666,0.0011509352,0.955191,0.0011405697,0.0021640246,0.037056334],"study_design_scores_gemma":[0.0004284528,0.006277317,0.0040758387,0.000052532116,0.00011585708,0.004133146,0.000056323435,0.009589239,0.9326175,0.0004258546,0.042207655,0.000020369253],"about_ca_topic_score_codex":0.00064990664,"about_ca_topic_score_gemma":0.0005199956,"teacher_disagreement_score":0.0019660587,"about_ca_system_score_codex":0.00022197275,"about_ca_system_score_gemma":0.00031809567,"threshold_uncertainty_score":0.006577134},"labels":[],"label_agreement":null},{"id":"W4386537575","doi":"10.1093/neuonc/noad137.004","title":"PL02.2.A RAPID, COMPREHENSIVE REPORTING OF MOLECULAR DIAGNOSTICS WITH RAPID-CNS2: A PROSPECTIVE VALIDATION COHORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Indel; Turnaround time; Concordance; DNA sequencing; Nanopore sequencing; Computational biology; Subtyping; Molecular diagnostics; Copy-number variation; Medical diagnosis; Whole genome sequencing; Biology; Medicine; Bioinformatics; Genetics; Computer science; Genome; Gene; Single-nucleotide polymorphism; Pathology; Genotype","score_opus":0.030956044199625266,"score_gpt":0.31722814736600796,"score_spread":0.2862721031663827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554342,0.00036514623,0.013808852,0.0002784756,0.00006901673,0.0018982771,0.024395533,0.0005098631,0.0032407476],"genre_scores_gemma":[0.9049156,0.00019731646,0.013847927,0.0007464036,0.00009129439,0.0028442538,0.07272996,0.00066420453,0.0039631277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981754,0.0005016429,0.000143051,0.00068436255,0.00032275033,0.00017293992],"domain_scores_gemma":[0.9965252,0.00055088033,0.00036121273,0.0012598261,0.00084629696,0.00045650857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045216917,0.0009554546,0.00043986892,0.0007195107,0.0008831165,0.0012192549,0.0010635514,0.0008117209,0.0048473733],"category_scores_gemma":[0.00593831,0.00060347066,0.00057471904,0.0005376414,0.0006969071,0.00056569715,0.001472376,0.00078479305,0.003564258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010574565,0.0026261094,0.8658563,0.000437543,0.0005272154,0.0027277481,0.0013228725,0.0016910762,0.046558283,0.00123739,0.022343032,0.044097915],"study_design_scores_gemma":[0.002597395,0.015387829,0.82754374,0.0002460091,0.00084777153,0.01624897,0.0010498646,0.010443866,0.044565316,0.0016818589,0.0791868,0.00020063229],"about_ca_topic_score_codex":0.002978497,"about_ca_topic_score_gemma":0.0016136487,"teacher_disagreement_score":0.0048473733,"about_ca_system_score_codex":0.00062146125,"about_ca_system_score_gemma":0.0011330384,"threshold_uncertainty_score":0.023913324},"labels":[],"label_agreement":null},{"id":"W4386537608","doi":"10.1093/neuonc/noad137.101","title":"P02.16.B COMPENSATORY CROSS-TALK BETWEEN AUTOPHAGY AND GLYCOLYSIS REGULATES SENESCENCE AND STEMNESS IN HETEROGENEOUS GLIOBLASTOMA TUMOR SUBPOPULATIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Biology; Glycolysis; Cancer research; Autophagy; Stem cell; Senescence; Cancer stem cell; Downregulation and upregulation; Cell biology; Apoptosis; Biochemistry; Metabolism","score_opus":0.014845394026434023,"score_gpt":0.2903988259796543,"score_spread":0.27555343195322024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96826553,0.0017582558,0.011702327,0.0004894062,0.00019376105,0.00011216553,0.009114607,0.001055575,0.0073084394],"genre_scores_gemma":[0.983745,0.0005856446,0.002716288,0.00012790647,0.000027242679,0.0001393306,0.0048695765,0.00019341557,0.0075957184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998385,0.00001858667,0.000013114199,0.00004935785,0.000040945095,0.00003940367],"domain_scores_gemma":[0.9997856,0.00002126927,0.000072450915,0.000021861564,0.000030680105,0.00006817411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027653994,0.00027509624,0.00029525254,0.00054818235,0.00037118155,0.0007930797,0.00021592861,0.00037318768,0.009460093],"category_scores_gemma":[0.00020772994,0.00015563544,0.00022665468,0.00046314718,0.00032620368,0.00022148374,0.0003086295,0.0005634441,0.0029978403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009411245,0.00010103626,0.0052848314,0.0001603028,0.00002498239,0.0004844286,0.00009756722,0.0001523193,0.97964245,0.0014212155,0.001380879,0.0103088105],"study_design_scores_gemma":[0.00023681579,0.0011023997,0.14783178,0.000084690335,0.00011250514,0.0066969185,0.0005732536,0.0075140465,0.7767118,0.002237608,0.056858536,0.00003958499],"about_ca_topic_score_codex":0.0005087548,"about_ca_topic_score_gemma":0.0004447486,"teacher_disagreement_score":0.009460093,"about_ca_system_score_codex":0.000293405,"about_ca_system_score_gemma":0.0004888936,"threshold_uncertainty_score":0.031647146},"labels":[],"label_agreement":null},{"id":"W4386537623","doi":"10.1093/neuonc/noad137.220","title":"P10.22.B COMBINATION OF ARTS MIMETICS WITH AUTOPHAGY INHIBITORS AS A NOVEL THERAPEUTIC STRATEGY TO OVERCOME APOPTOSIS RESISTANCE IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"Institut National Du Cancer; European Commission","keywords":"Apoptosis; Autophagy; Programmed cell death; In vivo; Cancer research; Medicine; Downregulation and upregulation; Radiation therapy; Chemistry; Biology; Internal medicine; Biochemistry; Biotechnology","score_opus":0.016721277247648207,"score_gpt":0.26192059412356977,"score_spread":0.24519931687592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98188424,0.0062755267,0.004429714,0.00036424198,0.0002496365,0.00020995559,0.0006461083,0.00028143162,0.0056591267],"genre_scores_gemma":[0.9866384,0.0031451613,0.004204595,0.00016838688,0.0000468195,0.00015756632,0.00074288936,0.000033352895,0.0048627737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999423,0.000007272919,0.0000057145603,0.000011804978,0.000015567613,0.0000172458],"domain_scores_gemma":[0.9999715,0.000003293047,0.0000061916226,0.0000027568992,0.00000460441,0.000011640701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009320013,0.0003451619,0.00032670135,0.00028037693,0.00011669591,0.00023592067,0.00021315645,0.00027412645,0.0017582129],"category_scores_gemma":[0.000056997254,0.000095677955,0.0002291575,0.00013228168,0.00015886826,0.00015721364,0.00013130384,0.0004662472,0.0005005918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005487649,0.00029213793,0.00014952284,0.00014762927,0.000017946411,0.00018082121,0.000013052556,0.00041704037,0.98543036,0.00026399986,0.0005045169,0.01203421],"study_design_scores_gemma":[0.000142718,0.0036894525,0.0015340763,0.000017758348,0.000051061215,0.00054799585,0.000020806328,0.0022162136,0.9807772,0.0000993194,0.010890806,0.000012572204],"about_ca_topic_score_codex":0.00038687044,"about_ca_topic_score_gemma":0.0004959033,"teacher_disagreement_score":0.0017582129,"about_ca_system_score_codex":0.00019333074,"about_ca_system_score_gemma":0.00022747672,"threshold_uncertainty_score":0.005881846},"labels":[],"label_agreement":null},{"id":"W4386537642","doi":"10.1093/neuonc/noad137.071","title":"OS12.7.A IMPLEMENTATION OF A NATIONAL AYA MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interim; Population; Survivorship curve; Neurosurgery; Oncology; Young adult; Pediatrics; Family medicine; Internal medicine; Cancer; Surgery","score_opus":0.02576346696352007,"score_gpt":0.3355378453889705,"score_spread":0.30977437842545047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7407152,0.002882369,0.0027977272,0.10855083,0.0025727076,0.0040205284,0.0077661225,0.00057566125,0.13011882],"genre_scores_gemma":[0.88978374,0.0029331346,0.007843762,0.02623413,0.00039096767,0.0009986218,0.0077683134,0.00025765214,0.06378965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99196553,0.0010250155,0.0002206115,0.0003225341,0.003508697,0.0029576863],"domain_scores_gemma":[0.9700537,0.0016030334,0.0013481319,0.0005604976,0.0112140905,0.015220539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008034184,0.00038177255,0.00021295698,0.00073415437,0.0064106933,0.0020644306,0.0018504595,0.0011568796,0.0027809686],"category_scores_gemma":[0.016790748,0.00037128862,0.00033846972,0.00090847845,0.0010292003,0.00043455904,0.0021077301,0.0018843549,0.0005168681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483886,0.0007329354,0.33846536,0.00034295802,0.00007945053,0.0056930287,0.008937526,0.0015020332,0.0035562653,0.005488943,0.4744413,0.16021174],"study_design_scores_gemma":[0.00008427891,0.00039636221,0.52905536,0.0003195429,0.000067891946,0.0012503882,0.012086436,0.0015990194,0.001644905,0.00047569224,0.45288864,0.0001315086],"about_ca_topic_score_codex":0.94361997,"about_ca_topic_score_gemma":0.96332556,"teacher_disagreement_score":0.9554377,"about_ca_system_score_codex":0.044562273,"about_ca_system_score_gemma":0.16274312,"threshold_uncertainty_score":0.32332343},"labels":[],"label_agreement":null},{"id":"W4386537711","doi":"10.1093/neuonc/noad137.173","title":"P07.13.B A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Lung cancer; Brain metastasis; Internal medicine; Microbubbles; Oncology; Randomized controlled trial; Cancer; Metastasis; Immunotherapy; Ultrasound; Radiology","score_opus":0.017863501952171585,"score_gpt":0.276954727855032,"score_spread":0.25909122590286043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522354,0.009760164,0.0023975896,0.0022518996,0.0025153544,0.021782264,0.0032283454,0.00040241945,0.005426651],"genre_scores_gemma":[0.9584264,0.0020011954,0.0043618875,0.002372905,0.0009818067,0.023511954,0.001490047,0.000051784045,0.0068021216],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99837047,0.0009853679,0.00011356624,0.00026963043,0.000092799826,0.00016821979],"domain_scores_gemma":[0.9982901,0.00058840076,0.00038735248,0.00015019199,0.0001673563,0.00041657063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030242198,0.0015301701,0.0026906556,0.0004992392,0.00043545951,0.0014247741,0.000791251,0.002530814,0.015362298],"category_scores_gemma":[0.0030653572,0.0007033314,0.0023559849,0.00037472614,0.0011412275,0.0012539302,0.00062112696,0.0026788053,0.0013604881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9867737,0.0032285615,0.00029862276,0.000586077,0.0009811156,0.000015687216,0.000014226968,0.00011360001,0.0013600044,0.00017949424,0.00077552337,0.005673361],"study_design_scores_gemma":[0.9416271,0.05531674,0.0007355012,0.000051989777,0.00069865276,0.000012907,0.0000114033555,0.00029969137,0.00024101946,0.00021815032,0.0007774577,0.00000946916],"about_ca_topic_score_codex":0.00060479844,"about_ca_topic_score_gemma":0.00076773704,"teacher_disagreement_score":0.015362298,"about_ca_system_score_codex":0.000656958,"about_ca_system_score_gemma":0.0013023347,"threshold_uncertainty_score":0.05139196},"labels":[],"label_agreement":null},{"id":"W4386537716","doi":"10.1093/neuonc/noad137.019","title":"JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurotoxicity; Lymphoma; Encephalopathy; Internal medicine; Toxicity; Gastroenterology; Pediatrics; Oncology","score_opus":0.026686438841491265,"score_gpt":0.3005137498712934,"score_spread":0.2738273110298022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976815,0.00077714276,0.000057541376,0.00004127077,0.0000070912865,0.00005100685,0.00050395005,0.0000032688445,0.0008771411],"genre_scores_gemma":[0.9977538,0.0003979635,0.00006258382,0.00007728211,0.0000324767,0.00006274799,0.0011260324,0.0000035329506,0.00048359873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996631,0.000105987274,0.000045896755,0.00007002919,0.000060110935,0.000054906453],"domain_scores_gemma":[0.99935955,0.00006332958,0.00025376928,0.000038124846,0.00008033548,0.00020498248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053121493,0.00035759126,0.00035304844,0.0007775219,0.00043869996,0.0006284261,0.00038667463,0.00038945978,0.0018973923],"category_scores_gemma":[0.0006341258,0.0002098733,0.0006025754,0.0009595242,0.00023494176,0.00042223852,0.0003862353,0.0003381109,0.00046801925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00472248,0.0006190011,0.9845579,0.00012754957,0.00036838476,0.0007529766,0.00012996212,0.00010895484,0.0008679867,0.00004354722,0.00036406482,0.007337225],"study_design_scores_gemma":[0.00082966965,0.0051719993,0.98798394,0.000042143718,0.000550447,0.002500294,0.00030905794,0.0003582715,0.0003405035,0.000073529045,0.0018246118,0.000015573665],"about_ca_topic_score_codex":0.0033904377,"about_ca_topic_score_gemma":0.0041469582,"teacher_disagreement_score":0.0033904377,"about_ca_system_score_codex":0.0006400671,"about_ca_system_score_gemma":0.0005246916,"threshold_uncertainty_score":0.0067414045},"labels":[],"label_agreement":null},{"id":"W4386537729","doi":"10.1093/neuonc/noad137.449","title":"P21.07.B THE LHSC/WESTERN BRAIN TUMOUR TISSUE BANK: A GLOBAL RESOURCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tissue bank; Brain tissue; Medicine; Pathology; Tumour tissue; Internal medicine","score_opus":0.02734096135030423,"score_gpt":0.33230360508125195,"score_spread":0.3049626437309477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537729","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02702391,0.003137206,0.020750869,0.011264463,0.0014275599,0.007752044,0.32876104,0.024291823,0.575591],"genre_scores_gemma":[0.04375893,0.0028056495,0.07436979,0.002699061,0.0010664106,0.007348359,0.5486714,0.012595889,0.3066845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966967,0.0010094821,0.00043758686,0.00041050126,0.0010668176,0.00037891732],"domain_scores_gemma":[0.97525126,0.004444819,0.0019896524,0.0040273145,0.009754664,0.0045322822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009157552,0.0006096799,0.00063158973,0.005218913,0.0010676617,0.004017394,0.0022991628,0.001294439,0.27424726],"category_scores_gemma":[0.011506403,0.00076517527,0.0003744965,0.0056282952,0.0009569114,0.0019721368,0.0030876407,0.0007911394,0.22979172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006444469,0.00020661601,0.0088440245,0.0007195378,0.000019332825,0.00042630796,0.00027899654,0.00021851927,0.0057572057,0.0024232522,0.79897624,0.18148564],"study_design_scores_gemma":[0.00014743507,0.00017680468,0.018255688,0.00037928592,0.0000143007555,0.0004966855,0.00020058914,0.00046729887,0.0035574322,0.0005001349,0.9757764,0.00002798441],"about_ca_topic_score_codex":0.013241231,"about_ca_topic_score_gemma":0.01132377,"teacher_disagreement_score":0.98675877,"about_ca_system_score_codex":0.0016893704,"about_ca_system_score_gemma":0.007669771,"threshold_uncertainty_score":0.91744846},"labels":[],"label_agreement":null},{"id":"W4386537738","doi":"10.1093/neuonc/noad137.263","title":"P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Agile software development; Medicine; Biomarker; Glioblastoma; Randomization; Clinical trial; Oncology; Internal medicine; Medical physics; Computer science; Cancer research; Biology; Software engineering","score_opus":0.05586208752735044,"score_gpt":0.3697767566920936,"score_spread":0.31391466916474314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56743634,0.081279665,0.041812185,0.07491204,0.008136044,0.030094512,0.071441114,0.0046527926,0.12023524],"genre_scores_gemma":[0.7241029,0.0379872,0.056971528,0.058172587,0.003406027,0.033194434,0.042290833,0.0015944976,0.042280007],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987149,0.0008228011,0.000065718676,0.00010514763,0.00018019966,0.00011115106],"domain_scores_gemma":[0.9969753,0.0010695613,0.00042809598,0.00021267685,0.0004311344,0.0008831787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058708433,0.00086858793,0.0014784265,0.00056473876,0.0003997333,0.0014033386,0.00079981185,0.0013807459,0.008498062],"category_scores_gemma":[0.00439183,0.00025516134,0.0017268477,0.00067347445,0.00051146775,0.0010011614,0.00073928654,0.0035840655,0.0018272531],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10177038,0.005568142,0.004933239,0.0031312243,0.0020311251,0.00043579133,0.00025136635,0.004458791,0.014564633,0.0037167242,0.198807,0.66033155],"study_design_scores_gemma":[0.41294685,0.13641807,0.035267685,0.0028358137,0.002935347,0.0013650546,0.00019883896,0.007087168,0.010238488,0.012866849,0.377625,0.00021486325],"about_ca_topic_score_codex":0.00093013974,"about_ca_topic_score_gemma":0.0030226777,"teacher_disagreement_score":0.008498062,"about_ca_system_score_codex":0.0007785154,"about_ca_system_score_gemma":0.0017772407,"threshold_uncertainty_score":0.031048417},"labels":[],"label_agreement":null},{"id":"W4386537774","doi":"10.1093/neuonc/noad137.297","title":"P11.63.B VALIDATING THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE: A MULTI-CENTER PROSPECTIVE STUDY IN PATIENTS WITH GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Prospective cohort study; Demographics; Performance status; Oncology; Physical therapy; Cancer","score_opus":0.03686687034144451,"score_gpt":0.3955371347037637,"score_spread":0.3586702643623192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986077,0.00006955413,0.00015839742,0.000069394446,0.000010617552,0.00011142376,0.0005401573,0.0000053439553,0.00042749662],"genre_scores_gemma":[0.99809414,0.000058916194,0.00033296875,0.00011698483,0.000016910692,0.00021771912,0.00094687985,0.0000056042986,0.00020988302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987012,0.000498748,0.00018010133,0.00026938377,0.00020398306,0.00014653686],"domain_scores_gemma":[0.99565625,0.00063783297,0.001846167,0.00030243932,0.00088205445,0.00067531725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002524895,0.0003786202,0.0003713918,0.0008789247,0.00071997405,0.000965272,0.0005011012,0.0005160725,0.001637387],"category_scores_gemma":[0.0056656944,0.00023287859,0.0003894078,0.0012935423,0.0005161291,0.0007809165,0.0008654658,0.00060241006,0.00088131725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001711764,0.00015291054,0.99789125,0.000011120072,0.000020306514,0.000037919763,0.00007164026,0.000022451039,0.00011908105,0.0000101725,0.00022595761,0.0012660425],"study_design_scores_gemma":[0.000036149373,0.00062865904,0.9979984,0.000014555817,0.000029537903,0.00022905576,0.00030765732,0.00022603164,0.00009296335,0.000027230828,0.00040272504,0.0000069522525],"about_ca_topic_score_codex":0.004198285,"about_ca_topic_score_gemma":0.0056397906,"teacher_disagreement_score":0.004198285,"about_ca_system_score_codex":0.00060336996,"about_ca_system_score_gemma":0.0007940128,"threshold_uncertainty_score":0.013353109},"labels":[],"label_agreement":null},{"id":"W4386537972","doi":"10.1093/neuonc/noad137.061","title":"OS09.4.A RANO 2.0: UPDATE TO THE RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR HIGH- AND LOW-GRADE GLIOMAS IN ADULTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Glioma; Cohort; Glioblastoma; Radiation therapy; Tumor progression; Medical physics; Radiology; Oncology; Surgery; Internal medicine; Cancer; Cancer research","score_opus":0.025056878561897655,"score_gpt":0.3532995330266157,"score_spread":0.32824265446471806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537972","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20232534,0.14733623,0.24345736,0.0809498,0.008157482,0.02987166,0.08135316,0.01621049,0.19033848],"genre_scores_gemma":[0.29788843,0.042235717,0.44047248,0.021666301,0.0029931578,0.03228228,0.12601233,0.0063207624,0.030128634],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9843286,0.006358497,0.0056753713,0.0005555749,0.0023217096,0.000760282],"domain_scores_gemma":[0.94356596,0.017486187,0.013363167,0.0023459385,0.020698788,0.002539912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035467304,0.0012532873,0.0028713946,0.00509128,0.0005862268,0.0032516303,0.0027680378,0.001804395,0.0031385603],"category_scores_gemma":[0.04749904,0.0006949817,0.0031524024,0.003634301,0.0007976385,0.002545519,0.0034372609,0.0030264377,0.003547228],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005195898,0.00042058504,0.06341349,0.008144153,0.00087093405,0.0005132874,0.0008966168,0.004270969,0.0036458096,0.010372701,0.22816771,0.6740878],"study_design_scores_gemma":[0.0014571749,0.002132007,0.13657369,0.007817743,0.0015722908,0.0027051573,0.00050506805,0.008612782,0.0062790983,0.011506817,0.82045215,0.00038611182],"about_ca_topic_score_codex":0.0037943115,"about_ca_topic_score_gemma":0.004796232,"teacher_disagreement_score":0.035467304,"about_ca_system_score_codex":0.0024613836,"about_ca_system_score_gemma":0.004670912,"threshold_uncertainty_score":0.18757129},"labels":[],"label_agreement":null},{"id":"W4386537973","doi":"10.1093/neuonc/noad137.006","title":"PL02.4.A SHARED DECISION-MAKING IN NEUROSURGICAL CONSULTATIONS WITH NEWLY DIAGNOSED BRAIN TUMOR PATIENTS: A THEMATIC ANALYSIS OF PATIENT INVOLVEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Thematic analysis; Coding (social sciences); Medicine; Psychology; Qualitative research; Medical education; Nursing","score_opus":0.09808959879734741,"score_gpt":0.4129529608637065,"score_spread":0.31486336206635906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350274,0.00084946677,0.02259545,0.010942027,0.0002949016,0.004916034,0.0018790924,0.00011813744,0.02337737],"genre_scores_gemma":[0.9672693,0.00072778156,0.018854314,0.0008312755,0.0000501804,0.0057013775,0.00062726095,0.00012594242,0.0058127046],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9770747,0.018020479,0.0010031573,0.0008197408,0.0018636949,0.0012181913],"domain_scores_gemma":[0.9407906,0.049398817,0.0023331277,0.0011125206,0.004520566,0.001844482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03284906,0.00053984177,0.0006781494,0.0033874998,0.0073534595,0.006321672,0.002524698,0.0019949821,0.0053820503],"category_scores_gemma":[0.045625504,0.00053526164,0.0008743298,0.0045755603,0.007705135,0.005522661,0.007854071,0.0029019255,0.00066562585],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003757921,0.00002700564,0.0014013096,0.0005438758,0.000005568955,0.00025448753,0.9846052,0.00007859348,0.00046204447,0.0033998997,0.0008827626,0.008301682],"study_design_scores_gemma":[0.000009311495,0.00003247955,0.0021832446,0.00046901067,0.000006878882,0.00014438956,0.9845697,0.00036388868,0.0003908907,0.0017163625,0.010097445,0.000016459473],"about_ca_topic_score_codex":0.0055089816,"about_ca_topic_score_gemma":0.0048527704,"teacher_disagreement_score":0.03284906,"about_ca_system_score_codex":0.009886836,"about_ca_system_score_gemma":0.01040445,"threshold_uncertainty_score":0.17372447},"labels":[],"label_agreement":null},{"id":"W4386538594","doi":"10.1093/neuonc/noad137.403","title":"P17.13.A OUTCOME ANALYSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH ORAL ETOPOSIDE (VP16) IN ALBERTA, CANADA: A POPULATION-BASED RETROSPECTIVE STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Proportional hazards model; Glioma; Retrospective cohort study; Population; Survival analysis; Log-rank test; Progression-free survival; Oligodendroglioma; Surgery; Overall survival; Chemotherapy; Astrocytoma","score_opus":0.01726419991707103,"score_gpt":0.2886614279773033,"score_spread":0.2713972280602323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386538594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702305,0.0004855537,0.00004414177,0.000059746537,0.0000045788447,0.00003872558,0.0013056616,0.0000051385196,0.0010333052],"genre_scores_gemma":[0.9983,0.00024325,0.000058238475,0.00006331483,0.0000075436405,0.000015628058,0.0009685229,0.0000029278071,0.00034063324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994148,0.000039404105,0.00004116708,0.0001223081,0.00020896202,0.00017328284],"domain_scores_gemma":[0.9988612,0.000060938495,0.00038854312,0.0000452587,0.00033231286,0.00031173576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033312725,0.00041087792,0.00041542805,0.0011224679,0.0013683542,0.00093789253,0.00086403376,0.0004032245,0.001384012],"category_scores_gemma":[0.000929818,0.00032294812,0.00047550493,0.0033135153,0.00061194395,0.00024398144,0.00038797787,0.00047977146,0.00031596934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012995252,0.000031857926,0.9978327,0.000019309915,0.00003442814,0.0002695893,0.000111555906,0.00003004483,0.0001818326,0.000019198513,0.00023134614,0.0011080924],"study_design_scores_gemma":[0.000016764485,0.000078233774,0.99841297,0.0000130341,0.000042284086,0.00041493037,0.00042071362,0.0001193438,0.00005933695,0.000011951344,0.00040352027,0.000006828074],"about_ca_topic_score_codex":0.86034447,"about_ca_topic_score_gemma":0.8636923,"teacher_disagreement_score":0.13965553,"about_ca_system_score_codex":0.00949649,"about_ca_system_score_gemma":0.010014379,"threshold_uncertainty_score":0.2809559},"labels":[],"label_agreement":null},{"id":"W4386538802","doi":"10.1093/neuonc/noad137.005","title":"PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Temozolomide; Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Nivolumab; Oncology; Progression-free survival; Randomized controlled trial; Phases of clinical research; Dacarbazine; Surrogate endpoint; Cancer; Chemotherapy; Confidence interval; Immunotherapy","score_opus":0.027444133392864743,"score_gpt":0.3433068402133076,"score_spread":0.3158627068204429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386538802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593598,0.0037274763,0.0012077979,0.0023203292,0.00043708636,0.012568625,0.009731013,0.0004677093,0.0101800235],"genre_scores_gemma":[0.9466284,0.0031093021,0.004845909,0.00405357,0.00032172468,0.016789736,0.011881455,0.00011068957,0.012259232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996252,0.00022605986,0.0000141033925,0.000044928074,0.00003312504,0.000056635552],"domain_scores_gemma":[0.9996007,0.000074700445,0.00008396514,0.000022361692,0.000023806486,0.0001943645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015523406,0.0010632672,0.0011460535,0.00035621048,0.0003011944,0.0007780548,0.00093106576,0.0010669271,0.010746675],"category_scores_gemma":[0.001051375,0.00050755555,0.0010096827,0.0003889131,0.0007247681,0.0005712495,0.0003724805,0.0024105865,0.0019725647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92356807,0.011502042,0.002374868,0.00063534064,0.0005299926,0.000097247634,0.00008027771,0.00071035104,0.0076278253,0.00043227992,0.007943368,0.044498287],"study_design_scores_gemma":[0.9289343,0.06330112,0.003097348,0.000050740866,0.00032183895,0.00007552591,0.000029550236,0.00053349615,0.00067272194,0.00035937486,0.0026120532,0.00001200908],"about_ca_topic_score_codex":0.001807831,"about_ca_topic_score_gemma":0.0073705576,"teacher_disagreement_score":0.010746675,"about_ca_system_score_codex":0.0010398865,"about_ca_system_score_gemma":0.0024525754,"threshold_uncertainty_score":0.035951257},"labels":[],"label_agreement":null},{"id":"W4386557984","doi":"10.1093/neuonc/noad137.011","title":"KS02.6.A INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE III STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Glioma; Interim analysis; Randomized controlled trial; Clinical endpoint; Placebo; Randomization; Hazard ratio; Surgery; Oncology; Confidence interval; Pathology","score_opus":0.0548570023581767,"score_gpt":0.3746291240748868,"score_spread":0.3197721217167101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386557984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717809,0.0066680494,0.0012471969,0.001171917,0.0007799446,0.009061423,0.003243733,0.0006042841,0.005442513],"genre_scores_gemma":[0.97348595,0.0039060833,0.0020160025,0.001872929,0.0003535636,0.008831832,0.002124451,0.0000625696,0.0073465956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995315,0.00023860308,0.00002177898,0.00008266341,0.00003242859,0.00009297909],"domain_scores_gemma":[0.99959165,0.000069345144,0.0000856059,0.000029710794,0.000030181578,0.00019356217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015038169,0.0022230272,0.0028021513,0.00085336197,0.0004113735,0.0013091698,0.0012251437,0.0017845401,0.008829172],"category_scores_gemma":[0.0009405549,0.00087432395,0.0015618622,0.00064945704,0.0015009086,0.0011096103,0.00043304017,0.0030483261,0.0018148284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9554925,0.01291127,0.0004390878,0.0010186981,0.0007090611,0.000048791346,0.000069636095,0.0004192505,0.008255969,0.00018021211,0.0016765367,0.018779002],"study_design_scores_gemma":[0.940987,0.056401867,0.0008581615,0.00002486969,0.00025249203,0.000030067427,0.000021221598,0.00027953202,0.00046454614,0.0001069702,0.00055980537,0.0000134763595],"about_ca_topic_score_codex":0.00090650265,"about_ca_topic_score_gemma":0.002865777,"teacher_disagreement_score":0.008829172,"about_ca_system_score_codex":0.0006988275,"about_ca_system_score_gemma":0.0018819253,"threshold_uncertainty_score":0.029536545},"labels":[],"label_agreement":null},{"id":"W4386558863","doi":"10.1093/neuonc/noad137.003","title":"PL02.1.A DELINEATING AND TARGETING A NOVEL METABOLISM-BASED POST-TRANSLATIONAL MECHANISM REGULATING THE ABUNDANCE OF THE ‘UNDRUGGABLE’ ONCOPROTEIN C-MYC IN MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Epigenetics; Biology; Mechanism (biology); Cancer; Oncogene; Regulator; Bioinformatics; Genetics; Gene","score_opus":0.01824140100343512,"score_gpt":0.28064705153394437,"score_spread":0.26240565053050924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386558863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535683,0.004936085,0.025791215,0.0009950427,0.00023569119,0.0004548451,0.0044469777,0.00085557665,0.008716335],"genre_scores_gemma":[0.9671733,0.0022205121,0.015763842,0.00032874115,0.000031525593,0.00024722161,0.006459995,0.00015784038,0.007617086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999186,0.000011147924,0.000009733041,0.000022453783,0.000019848945,0.000018163002],"domain_scores_gemma":[0.99994326,0.00000854626,0.000015507498,0.0000068235695,0.0000069576413,0.000018938892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024467518,0.00040089435,0.0002949408,0.00020133484,0.0002154815,0.00046358534,0.000518302,0.0004345135,0.0025506516],"category_scores_gemma":[0.00011671049,0.00018175885,0.0003660294,0.0002018321,0.00023842778,0.00026445434,0.00020008862,0.0007767854,0.0010189095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003643031,0.000089337336,0.00023067214,0.000094786,0.00000926344,0.0001096975,0.000012786241,0.00018428569,0.9939877,0.000412242,0.0002645895,0.004240324],"study_design_scores_gemma":[0.0001501363,0.0009562407,0.002582452,0.000018159468,0.00003801072,0.00045956823,0.000026124259,0.00268328,0.9793092,0.00020276608,0.013562921,0.0000111335685],"about_ca_topic_score_codex":0.00068881415,"about_ca_topic_score_gemma":0.00081146456,"teacher_disagreement_score":0.0025506516,"about_ca_system_score_codex":0.00037584253,"about_ca_system_score_gemma":0.0005097667,"threshold_uncertainty_score":0.008532822},"labels":[],"label_agreement":null},{"id":"W4386561105","doi":"10.1093/neuonc/noad137.362","title":"P14.11.B A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Microbubbles; Liquid biopsy; Biopsy; Brain tumor; Radiology; Ultrasound; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.018799516868296146,"score_gpt":0.30101907223871116,"score_spread":0.282219555370415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386561105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908627,0.002250436,0.0015659716,0.0004859574,0.00017144147,0.002936393,0.00069800974,0.000095740215,0.000933388],"genre_scores_gemma":[0.98524785,0.0011843144,0.0030327078,0.000680234,0.00034830335,0.005453156,0.001392884,0.000058781687,0.002601793],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988655,0.0005635933,0.00007055011,0.00023458307,0.00008322798,0.00018264401],"domain_scores_gemma":[0.9987664,0.0001881548,0.00026533625,0.00013086022,0.00015820577,0.00049095915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038740344,0.0014101403,0.001684576,0.0003442255,0.00044998905,0.00095256424,0.0006855024,0.0012007727,0.0037256605],"category_scores_gemma":[0.001164047,0.00041876055,0.001241604,0.0004116073,0.0011460852,0.0006706233,0.0005689703,0.0017939705,0.0010178685],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.823653,0.040003397,0.008508874,0.00073377497,0.0013597409,0.00017543967,0.00015568416,0.00057885895,0.06872461,0.00034414371,0.0023561239,0.053406466],"study_design_scores_gemma":[0.19553314,0.7759786,0.0128486175,0.000038125832,0.0009934362,0.00017367117,0.00004086472,0.0006606916,0.010842458,0.00013910492,0.0027247865,0.00002653183],"about_ca_topic_score_codex":0.0004149806,"about_ca_topic_score_gemma":0.00041029608,"teacher_disagreement_score":0.0038740344,"about_ca_system_score_codex":0.00058250705,"about_ca_system_score_gemma":0.0019641304,"threshold_uncertainty_score":0.020488083},"labels":[],"label_agreement":null},{"id":"W4386757632","doi":"10.1093/neuonc/noad170","title":"Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Children’s Hospital of Wisconsin Research Institute; Stand Up To Cancer; Seattle Children's Research Institute; Nationwide Children's Hospital; Hospital for Sick Children; Ohio State University","keywords":"Medicine; Immunotherapy; Intensive care medicine; Brain tumor; Clinical trial; Cancer; Oncology; Internal medicine; Pathology","score_opus":0.11407454973622747,"score_gpt":0.4144428150837515,"score_spread":0.30036826534752403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386757632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007877922,0.9921124,0.0015395903,0.0026236912,0.0005422548,0.000056740893,0.00013652699,0.000047144677,0.0021537885],"genre_scores_gemma":[0.003448981,0.99209726,0.0020391173,0.001057164,0.00019934187,0.00006276609,0.00019914025,0.0000144172545,0.0008817194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999481,0.00018724153,0.000057833488,0.000049195343,0.00016801021,0.000056748428],"domain_scores_gemma":[0.9987509,0.00057731033,0.00013329451,0.000053580243,0.00038084318,0.00010389366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032861973,0.00074896024,0.0017862796,0.0010915841,0.00024468987,0.0019258657,0.0013037074,0.0015175518,0.00265845],"category_scores_gemma":[0.0018380973,0.0003491304,0.0009935205,0.00080313254,0.00071560737,0.0027017747,0.000775874,0.0038785657,0.0016678609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035715764,0.00034496584,0.0006298747,0.035385344,0.00023585594,0.00048920594,0.00020560031,0.0016970723,0.027136086,0.025709243,0.07422443,0.8335852],"study_design_scores_gemma":[0.000049463255,0.00047896858,0.0004915466,0.0045732292,0.00018270324,0.00076047104,0.00011537154,0.00029501165,0.005299391,0.0047041522,0.98301744,0.000032141266],"about_ca_topic_score_codex":0.0013181387,"about_ca_topic_score_gemma":0.0027770041,"teacher_disagreement_score":0.0032861973,"about_ca_system_score_codex":0.0008642491,"about_ca_system_score_gemma":0.002081033,"threshold_uncertainty_score":0.017379284},"labels":[],"label_agreement":null},{"id":"W4386800568","doi":"10.1093/neuonc/noad147.094","title":"WHAT ROLE CAN A PERSONAL TRAINER PLAY IN IMPROVING QUALITY OF LIFE THROUGHOUT ONCOLOGY TREATMENT FOR PEOPLE WITH A BRAIN TUMOUR","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Trainer; Medicine; Quality of life (healthcare); Oncology; Psychology; Medical education; Nursing","score_opus":0.053694379902390635,"score_gpt":0.3754868771917523,"score_spread":0.32179249728936166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800568","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028094057,0.9337033,0.00088665885,0.019388838,0.0019379787,0.0003600479,0.00011455385,0.000042723346,0.015471771],"genre_scores_gemma":[0.15420637,0.8338928,0.0030779103,0.0043747327,0.00057813723,0.0005539193,0.0001201244,0.000026759424,0.00316928],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971764,0.00175459,0.00028796904,0.00014520207,0.00042190432,0.00021398737],"domain_scores_gemma":[0.9966229,0.0023167278,0.0003640913,0.000058064892,0.00039131037,0.00024682016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031514738,0.00030367437,0.0007150713,0.0011603815,0.0009755605,0.0021889722,0.0011249192,0.001603941,0.0041277143],"category_scores_gemma":[0.010037556,0.00018443832,0.000792373,0.0012087126,0.0009356741,0.002326569,0.0011272078,0.0013341118,0.00050740386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019430397,0.0002343465,0.003909597,0.0658705,0.00024872366,0.0010520455,0.013938302,0.00022974263,0.000293477,0.002997422,0.023612157,0.8874194],"study_design_scores_gemma":[0.00020017146,0.0012379627,0.03219994,0.2268884,0.0011361919,0.0077531156,0.049023516,0.0002826555,0.0007283787,0.002621297,0.67780423,0.00012408356],"about_ca_topic_score_codex":0.005011057,"about_ca_topic_score_gemma":0.012026486,"teacher_disagreement_score":0.005011057,"about_ca_system_score_codex":0.001927262,"about_ca_system_score_gemma":0.0038633547,"threshold_uncertainty_score":0.01666677},"labels":[],"label_agreement":null},{"id":"W4386800574","doi":"10.1093/neuonc/noad147.025","title":"INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Glioma; Gastroenterology; Randomization; Clinical endpoint; Randomized controlled trial; Hazard ratio; Surgery; Confidence interval; Pathology","score_opus":0.057691041798597194,"score_gpt":0.3784737549682509,"score_spread":0.32078271316965373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773802,0.0054267594,0.0009397091,0.0012523045,0.000578683,0.0074054957,0.002095479,0.00041532906,0.0045060595],"genre_scores_gemma":[0.9789007,0.0027191034,0.0019735626,0.002351449,0.00036290736,0.0075432356,0.0016206078,0.00005521412,0.004473189],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994418,0.0003461772,0.000020970641,0.000070757094,0.000034201832,0.00008610345],"domain_scores_gemma":[0.99948454,0.00011629702,0.00012937273,0.000032490618,0.000031435236,0.00020581973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018806825,0.0019388479,0.002663484,0.0007758152,0.00048162675,0.0013875299,0.0010775385,0.0018485122,0.0066045662],"category_scores_gemma":[0.0011374847,0.0007351944,0.0016517106,0.0005843084,0.0013745944,0.0010620842,0.00046461966,0.002926341,0.0011017711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970959,0.009116044,0.00059998635,0.0005653316,0.000545992,0.000046492576,0.00006115817,0.00033045592,0.0048309374,0.00013699089,0.0011986146,0.011609015],"study_design_scores_gemma":[0.9338509,0.06296802,0.0014701969,0.00002656742,0.00025116868,0.000033901048,0.000022984688,0.00030740214,0.0003797885,0.00012171964,0.00055338873,0.000013956056],"about_ca_topic_score_codex":0.00087445934,"about_ca_topic_score_gemma":0.0028813535,"teacher_disagreement_score":0.0066045662,"about_ca_system_score_codex":0.00082556903,"about_ca_system_score_gemma":0.0015645243,"threshold_uncertainty_score":0.022094429},"labels":[],"label_agreement":null},{"id":"W4386800579","doi":"10.1093/neuonc/noad174","title":"Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Cannonball Kids' cancer Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Temozolomide; Internal medicine; Immunotherapy; Oncology; Gastroenterology; Radiation therapy; Chemotherapy; Glioma; Cancer; Cancer research","score_opus":0.033341433046735265,"score_gpt":0.32507363542328427,"score_spread":0.291732202376549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98033625,0.011364124,0.00078597636,0.0008436623,0.00015185407,0.0019652043,0.0022528695,0.00012233965,0.0021778299],"genre_scores_gemma":[0.9742804,0.010314984,0.0037614221,0.0011832352,0.00023280094,0.0037608233,0.003754441,0.000050301576,0.0026616042],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997271,0.0001219756,0.00001577507,0.0000433787,0.00003142401,0.00006031606],"domain_scores_gemma":[0.9994122,0.00009386851,0.00015961574,0.000040211115,0.000043854874,0.00025027545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010273302,0.0012693264,0.0017817264,0.00025247663,0.00029391653,0.00070521876,0.00067278807,0.0010045652,0.0019250701],"category_scores_gemma":[0.00053814973,0.00031474387,0.0010354848,0.00033063244,0.00063096976,0.00043059792,0.0002801853,0.002588335,0.0004114982],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5189874,0.044127557,0.029958447,0.0054040384,0.005827102,0.0015897437,0.0009274994,0.0072440095,0.07736658,0.0015370144,0.023720117,0.2833105],"study_design_scores_gemma":[0.6071817,0.3237928,0.026159087,0.00029719996,0.001936886,0.0021693874,0.000121217694,0.0019293606,0.016191155,0.00037756102,0.019798823,0.000044821685],"about_ca_topic_score_codex":0.0014164952,"about_ca_topic_score_gemma":0.0040885084,"teacher_disagreement_score":0.0019250701,"about_ca_system_score_codex":0.0013007809,"about_ca_system_score_gemma":0.0020285859,"threshold_uncertainty_score":0.009437859},"labels":[],"label_agreement":null},{"id":"W4386800582","doi":"10.1093/neuonc/noad147.086","title":"TITLE THE TEENAGE AND YOUNG ADULT (TYA) POPULATION (16-24YO) BENEfiT FROM HAVING SPECIALIST NURSE INPUT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Attendance; Medicine; Nursing; Family medicine; Nurse practitioners; Population; Outpatient clinic; Clinical nurse specialist; Health care; Internal medicine","score_opus":0.025226945666145542,"score_gpt":0.3240391236161963,"score_spread":0.2988121779500508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800582","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4139039,0.5331212,0.00078366906,0.011448229,0.00212718,0.00035617466,0.0031962965,0.000056907396,0.035006367],"genre_scores_gemma":[0.70958406,0.27902293,0.0012969052,0.0027105229,0.00049646286,0.00031354444,0.0011741474,0.000017964547,0.0053835935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99962306,0.00016171475,0.00005195217,0.00003042578,0.00007420254,0.00005857288],"domain_scores_gemma":[0.99855465,0.0007866563,0.00033250186,0.000019235831,0.00016635806,0.00014054491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058079953,0.00010739482,0.00032779048,0.00034859646,0.00023630474,0.00062867947,0.00020153324,0.00033913396,0.011190139],"category_scores_gemma":[0.00437034,0.00007437444,0.0004733981,0.00074295094,0.00015293872,0.0006341596,0.00039727183,0.00029524296,0.00056534924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004929888,0.00017295586,0.29352662,0.026404846,0.00062266394,0.0025436834,0.004743804,0.00030660667,0.001405418,0.0028355755,0.034190115,0.6327547],"study_design_scores_gemma":[0.00012364013,0.0012235788,0.64152664,0.034814153,0.0008747642,0.008807087,0.01771288,0.0001703772,0.0009314228,0.0020925212,0.2916819,0.000041088755],"about_ca_topic_score_codex":0.0037350636,"about_ca_topic_score_gemma":0.012336686,"teacher_disagreement_score":0.011190139,"about_ca_system_score_codex":0.00041882062,"about_ca_system_score_gemma":0.0016260295,"threshold_uncertainty_score":0.037434757},"labels":[],"label_agreement":null},{"id":"W4386800593","doi":"10.1093/neuonc/noad147.085","title":"SHOULD CALCIUM SUPPLEMENTS BE PRESCRIBED PROPHYLACTICALLY FOR PATIENTS DIAGNOSED WITH A HIGH-GRADE GLIOMA (HGG) ON PROLONGED STEROID USE?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Osteoporosis; Dexamethasone; Debulking; Quality of life (healthcare); Glioma; Surgery; Internal medicine; Cancer","score_opus":0.07053719159932792,"score_gpt":0.3372964755544658,"score_spread":0.26675928395513787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800593","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66005236,0.23194161,0.0018407379,0.06974121,0.0017788629,0.0002443892,0.00061857776,0.00011479492,0.03366747],"genre_scores_gemma":[0.9387385,0.04725561,0.0021225354,0.007992287,0.0011394675,0.000052112006,0.0002259566,0.000012142194,0.0024614187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999892,0.00002797357,0.000024950137,0.000011584415,0.000022553817,0.00002100996],"domain_scores_gemma":[0.9996136,0.00013786604,0.00012356839,0.000009309867,0.00005653177,0.000059216436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013481229,0.00009560527,0.00029912544,0.0002892742,0.0004513775,0.00040223455,0.00019225958,0.00097552565,0.002178078],"category_scores_gemma":[0.001642334,0.000067915884,0.00025995262,0.00031872344,0.00027235656,0.0005005923,0.00014249109,0.0007060875,0.0003746679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024499549,0.00043224107,0.3332861,0.0045312135,0.00021647688,0.15059346,0.0007228201,0.00036242668,0.00632169,0.0017244244,0.03697215,0.46238703],"study_design_scores_gemma":[0.00048638266,0.0021410515,0.27771696,0.009291496,0.0007613774,0.49112,0.0075836605,0.00082409754,0.007248923,0.006353604,0.19634248,0.00012989755],"about_ca_topic_score_codex":0.0025285413,"about_ca_topic_score_gemma":0.0057182023,"teacher_disagreement_score":0.0025285413,"about_ca_system_score_codex":0.00044047568,"about_ca_system_score_gemma":0.0009142616,"threshold_uncertainty_score":0.00728637},"labels":[],"label_agreement":null},{"id":"W4386800630","doi":"10.1093/neuonc/noad147.087","title":"THE ROLE OF A GENOMICS CLINICAL NURSE SPECIALIST IN HELPING TO BUILD A PATHWAY FOR WHOLE GENOME SEQUENCING TO BE OFFERED TO NEURO-ONCOLOGY PATIENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical nurse specialist; Medicine; Test (biology); Oncology nursing; Informed consent; Nursing; Whole genome sequencing; Genome; Nurse education; Pathology; Genetics; Gene; Alternative medicine; Biology","score_opus":0.030042483578097346,"score_gpt":0.31953381712593026,"score_spread":0.2894913335478329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800630","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.097801216,0.008713574,0.08987837,0.6552212,0.029083788,0.0054003033,0.0011459911,0.006587046,0.10616849],"genre_scores_gemma":[0.40033376,0.00918204,0.25283885,0.23815453,0.009443603,0.004534883,0.0010283949,0.0017015494,0.08278234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913223,0.004596695,0.0007729158,0.00074667495,0.001180727,0.0013807956],"domain_scores_gemma":[0.9303333,0.01026694,0.0026154958,0.0015106207,0.013677986,0.041595686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01190399,0.00051240076,0.00063429377,0.0014630996,0.00529629,0.0044089328,0.0017313443,0.003964036,0.045399982],"category_scores_gemma":[0.034476444,0.00094322645,0.00076716044,0.00047664714,0.0019454419,0.005241218,0.007875481,0.00901935,0.016506195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037302452,0.0010464375,0.024286635,0.001271657,0.00006423591,0.022652162,0.026488004,0.0008380311,0.004910262,0.005891291,0.63413966,0.27803853],"study_design_scores_gemma":[0.00031247718,0.0014400083,0.018458134,0.0041375784,0.000056822864,0.030919421,0.070637025,0.0027467317,0.0025511237,0.018074252,0.85016185,0.0005045662],"about_ca_topic_score_codex":0.0037820498,"about_ca_topic_score_gemma":0.0061297836,"teacher_disagreement_score":0.045399982,"about_ca_system_score_codex":0.0026676725,"about_ca_system_score_gemma":0.015572796,"threshold_uncertainty_score":0.15187812},"labels":[],"label_agreement":null},{"id":"W4386800653","doi":"10.1093/neuonc/noad147.048","title":"AN ANALYSIS OF THE EFFECTIVENESS OF CURRENT PROVISION OF FATIGUE MANAGEMENT STRATEGIES WITHIN A NEURO-ONCOLOGY MDT CLINIC","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Cancer-related fatigue; Psychological intervention; Rehabilitation; Quality of life (healthcare); Physical therapy; Intervention (counseling); Cancer; Internal medicine; Nursing","score_opus":0.04810793204400959,"score_gpt":0.3929343795516356,"score_spread":0.34482644750762603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953876,0.00065096916,0.00014608534,0.000784865,0.000024502062,0.00027666768,0.0009448846,0.000014524843,0.0017699995],"genre_scores_gemma":[0.99773836,0.00035583135,0.00042581,0.00024879156,0.000031587133,0.0002736707,0.00054160843,0.0000062476015,0.0003779935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935347,0.0029581978,0.00082516205,0.00063368276,0.001306524,0.00074180996],"domain_scores_gemma":[0.967843,0.0132264905,0.0089317355,0.00083303393,0.0041444227,0.005021313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006293608,0.00013900665,0.0005556523,0.001202795,0.0010711632,0.0014335171,0.0008842469,0.00058266585,0.0038282077],"category_scores_gemma":[0.035407588,0.00021226167,0.00069683074,0.0013055986,0.00042989478,0.0011138254,0.0011427194,0.0008458284,0.0005191428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060831825,0.0047804145,0.77354306,0.0010621123,0.0005248937,0.00022710812,0.00575873,0.00086074637,0.00051282987,0.00024869008,0.005194842,0.20120335],"study_design_scores_gemma":[0.00030419452,0.005906209,0.9843763,0.00034559218,0.00018839061,0.00011778799,0.004499615,0.001249255,0.000193632,0.00007251097,0.0027109603,0.0000355076],"about_ca_topic_score_codex":0.017144235,"about_ca_topic_score_gemma":0.036515996,"teacher_disagreement_score":0.017144235,"about_ca_system_score_codex":0.0037632661,"about_ca_system_score_gemma":0.0035427206,"threshold_uncertainty_score":0.03408891},"labels":[],"label_agreement":null},{"id":"W4386800655","doi":"10.1093/neuonc/noad147.047","title":"PSYCHOLOGY EDUCATION WORKSHOPS ARE AN INNOVATIVE METHOD OF OFFERING PSYCHOLOGICAL INPUT TO A WIDER POPULATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Psychology; Set (abstract data type); Service (business); Medical education; Population; Medicine; Computer science","score_opus":0.10146406825778896,"score_gpt":0.47826145585896435,"score_spread":0.37679738760117537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800655","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29693392,0.004117414,0.17995663,0.03540882,0.010328221,0.021282408,0.0012471294,0.007875347,0.44285017],"genre_scores_gemma":[0.5444909,0.006088823,0.26739466,0.015875703,0.0045440076,0.024254361,0.0007923741,0.0011101373,0.135449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515533,0.0031760905,0.0001875235,0.00036483334,0.0005461075,0.0005701019],"domain_scores_gemma":[0.98701084,0.007535751,0.0008548507,0.000982374,0.000642685,0.0029735921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067082783,0.00088392553,0.0005762571,0.0012998836,0.0025705942,0.0027720963,0.0018491924,0.0016537666,0.054014042],"category_scores_gemma":[0.0102347005,0.0005727341,0.0011016012,0.00070997584,0.0011637848,0.0019887253,0.0065861857,0.0034537646,0.012000444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089783693,0.012850234,0.003139996,0.002718158,0.00010002134,0.0019251213,0.032186285,0.0005920214,0.00999049,0.005286158,0.14779794,0.78251576],"study_design_scores_gemma":[0.0027093992,0.0076524066,0.02642747,0.0028585496,0.0001544775,0.0028228173,0.038731046,0.0012899319,0.007053295,0.018725393,0.8912959,0.00027936834],"about_ca_topic_score_codex":0.00032348058,"about_ca_topic_score_gemma":0.001139726,"teacher_disagreement_score":0.054014042,"about_ca_system_score_codex":0.0007044469,"about_ca_system_score_gemma":0.002222213,"threshold_uncertainty_score":0.180695},"labels":[],"label_agreement":null},{"id":"W4386800658","doi":"10.1093/neuonc/noad147.089","title":"STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM GASTROINTESTINAL PRIMARIES: ANALYSIS OF OUTCOMES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rectum; Malignancy; Radiosurgery; Gastrointestinal cancer; Colorectal cancer; Cohort; Retrospective cohort study; Cancer; Internal medicine; Radiology; Surgery; Radiation therapy","score_opus":0.04920836028553705,"score_gpt":0.3489789069499843,"score_spread":0.29977054666444725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830735,0.0005903447,0.00010409342,0.000030984444,0.000004242548,0.000007092921,0.00056343846,0.0000036253432,0.00038876233],"genre_scores_gemma":[0.9991806,0.00015166125,0.00003827451,0.0000069836465,0.000006663035,0.000004950858,0.00057361723,0.0000014532928,0.000035736786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995633,0.00010050018,0.00007798218,0.00007794753,0.00010672163,0.0000735853],"domain_scores_gemma":[0.9972644,0.00045828894,0.0016550224,0.00006633189,0.00029531567,0.00026067728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061653217,0.00015723538,0.00031516908,0.0013863603,0.00020325732,0.000507385,0.00020173166,0.00017531494,0.0007805716],"category_scores_gemma":[0.0026653376,0.000067994486,0.0005518521,0.0011128224,0.00023563091,0.0002945269,0.0004279789,0.00018475408,0.0001449591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010559801,0.0000060573097,0.99763143,0.00001599814,0.000057154513,0.00007430236,0.000020438882,0.00005320781,0.0001027389,0.0000070117953,0.000054485958,0.0018716435],"study_design_scores_gemma":[0.0000039930633,0.00011679951,0.99889743,0.00000885632,0.000046270517,0.0004783054,0.000089327084,0.00016287675,0.00008436881,0.00001702652,0.00009202596,0.0000026062921],"about_ca_topic_score_codex":0.0019263477,"about_ca_topic_score_gemma":0.0031364544,"teacher_disagreement_score":0.0019263477,"about_ca_system_score_codex":0.0004234381,"about_ca_system_score_gemma":0.0003093008,"threshold_uncertainty_score":0.0038303137},"labels":[],"label_agreement":null},{"id":"W4386808336","doi":"10.1093/neuonc/noad171","title":"Unraveling schwannomas","year":2023,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric oncology; Medicine; Library science; Family medicine; Internal medicine","score_opus":0.05028158929375985,"score_gpt":0.31394747561683156,"score_spread":0.2636658863230717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386808336","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004508537,0.14807263,0.0018016906,0.6948287,0.13728534,0.000042398704,0.00007634547,0.00012239921,0.013261941],"genre_scores_gemma":[0.027921226,0.084678076,0.0015122953,0.29868087,0.5770398,0.000038316008,0.00010004145,0.000049674996,0.009979646],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99888605,0.000258123,0.00016550085,0.00012693119,0.0004354574,0.00012794661],"domain_scores_gemma":[0.9968431,0.0014624484,0.00025499545,0.00016296004,0.0007856697,0.00049080036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015480496,0.0007204298,0.0006730638,0.0014858001,0.0016736392,0.0022385132,0.0012546936,0.010983539,0.0022727856],"category_scores_gemma":[0.006498168,0.00047031147,0.000401109,0.00065822963,0.0023757354,0.0049981615,0.0013217259,0.011588511,0.0028799525],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009581221,0.00006660419,0.0025990591,0.0005631325,0.00003093775,0.050932053,0.000773491,0.00022678544,0.0020549793,0.015168096,0.7566646,0.17082456],"study_design_scores_gemma":[0.000030185645,0.000051387487,0.0006780701,0.00054354296,0.000017730814,0.05654618,0.00044437166,0.00023661363,0.00033100083,0.014603934,0.92649615,0.000020903364],"about_ca_topic_score_codex":0.0009877858,"about_ca_topic_score_gemma":0.0022858982,"teacher_disagreement_score":0.010983539,"about_ca_system_score_codex":0.0020897256,"about_ca_system_score_gemma":0.0017454156,"threshold_uncertainty_score":0.015162051},"labels":[],"label_agreement":null},{"id":"W4386949028","doi":"10.1093/neuonc/noad125","title":"Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; Pediatric Brain Tumor Foundation; School of Medicine, Emory University; Array BioPharma; University of California, Los Angeles; Universitätsklinikum Heidelberg; Perelman School of Medicine, University of Pennsylvania; U.S. Department of Defense; Ian's Friends Foundation; Springworks Therapeutics; Deutsches Krebsforschungszentrum; National Cancer Institute; Alexion Pharmaceuticals; University of Toronto; Emory University; Deutschen Konsortium für Translationale Krebsforschung; Children's National Hospital; University of Pennsylvania; Hospital for Sick Children; Pfizer; Exelixis; Children's Hospital of Philadelphia; AstraZeneca; Brain Tumour Charity","keywords":"Medicine; MAPK/ERK pathway; Glioma; Microglia; Central nervous system; Stromal cell; Oncology; Brain tumor; Bioinformatics; Cancer research; Neuroscience; Internal medicine; Pathology; Signal transduction; Psychology; Biology; Inflammation","score_opus":0.14984592951819511,"score_gpt":0.4152956796911838,"score_spread":0.26544975017298866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386949028","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.371,0.06882486,0.48721135,0.0077897916,0.0030185196,0.0043806694,0.015598323,0.003977504,0.038199004],"genre_scores_gemma":[0.742712,0.06932841,0.15613708,0.0021801325,0.00033011666,0.004551333,0.013832533,0.00085984817,0.010068384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956197,0.00013304269,0.00002784639,0.00006492089,0.00014599318,0.00006618208],"domain_scores_gemma":[0.99943846,0.00016665527,0.00009653982,0.00006685855,0.00013364603,0.00009784739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016200128,0.0010266453,0.0006723823,0.0006470272,0.0002650776,0.0013274843,0.001167083,0.0010705037,0.0037740846],"category_scores_gemma":[0.0015671401,0.0003762202,0.00071185146,0.00037486013,0.00043532875,0.0010240044,0.0007097986,0.0024345187,0.0012595113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018787419,0.0024839537,0.004546796,0.0047033117,0.00038866207,0.0013547101,0.00042102716,0.04913936,0.7299668,0.021070074,0.03289257,0.15115403],"study_design_scores_gemma":[0.0006160675,0.01141882,0.0039349045,0.00096943544,0.0009821218,0.002164893,0.00039416645,0.060454775,0.6154722,0.012097404,0.29134235,0.00015277773],"about_ca_topic_score_codex":0.0017561512,"about_ca_topic_score_gemma":0.002385739,"teacher_disagreement_score":0.0037740846,"about_ca_system_score_codex":0.00086873805,"about_ca_system_score_gemma":0.0014032231,"threshold_uncertainty_score":0.012625515},"labels":[],"label_agreement":null},{"id":"W4387946694","doi":"10.1093/neuonc/noad208","title":"Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Deutsche Forschungsgemeinschaft","keywords":"Proteome; Tumor microenvironment; Metabolome; Lipidomics; Immune system; Omics; Proteomics; Tumor progression; Metabolomics; Reprogramming; Cancer research; Computational biology; Basigin; Cell; Biology; Bioinformatics; Cancer; Immunology; Biochemistry; Gene; Genetics","score_opus":0.01131400021762956,"score_gpt":0.2692886709685247,"score_spread":0.25797467075089514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387946694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983367,0.00030484863,0.00040797886,0.00002126319,0.0000036545464,0.000009976573,0.000616141,0.000022031856,0.00027741332],"genre_scores_gemma":[0.9973386,0.00021151824,0.00080151076,0.000029808392,0.000006727115,0.000020192905,0.0013785226,0.00000933377,0.00020381706],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991107,0.0000068768263,0.000010639445,0.000024083973,0.000023420787,0.000024010587],"domain_scores_gemma":[0.99987066,0.000011446021,0.0000509103,0.000012532331,0.00002216084,0.000032311553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015580398,0.00024679035,0.00023312897,0.00094467355,0.00016089324,0.00034274,0.000106483385,0.00018688588,0.0009591884],"category_scores_gemma":[0.00022620521,0.000076978264,0.00021948118,0.00047163724,0.00017305816,0.0001463908,0.00030675798,0.0001987288,0.00024239965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011135676,0.000044283865,0.14890802,0.00010079148,0.00006933384,0.00067310955,0.00017513789,0.00008006164,0.83743376,0.000074309486,0.00018559831,0.011142044],"study_design_scores_gemma":[0.000009977941,0.000372815,0.92270285,0.000008775632,0.000064795604,0.0027616834,0.00022128406,0.00049153797,0.07219849,0.00011735317,0.0010427401,0.000007688158],"about_ca_topic_score_codex":0.0007075995,"about_ca_topic_score_gemma":0.0007153337,"teacher_disagreement_score":0.0009591884,"about_ca_system_score_codex":0.00020676464,"about_ca_system_score_gemma":0.00012815572,"threshold_uncertainty_score":0.003208816},"labels":[],"label_agreement":null},{"id":"W4387949117","doi":"10.1093/neuonc/noad196","title":"Time to treat the climate and nature crisis as one indivisible global health emergency","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.03938171483665656,"score_gpt":0.37404322914137833,"score_spread":0.3346615143047218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949117","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031230325,0.015498661,0.0006440855,0.9144613,0.06565165,0.000016250304,0.000058804235,0.00010794609,0.0032489297],"genre_scores_gemma":[0.006213118,0.01314077,0.0016049076,0.90651226,0.060761232,0.00007359468,0.0001632908,0.00021919743,0.011311616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916141,0.00279766,0.0005040628,0.0008400531,0.0026065982,0.0016375501],"domain_scores_gemma":[0.9606127,0.01472197,0.0015606928,0.0015528626,0.005712646,0.015839176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014682082,0.0021794548,0.0025389728,0.0019333023,0.011842631,0.021857878,0.0041375854,0.038659494,0.048706215],"category_scores_gemma":[0.032561433,0.0010777648,0.0021140934,0.0015050124,0.013199313,0.035010163,0.014746054,0.068752386,0.017506858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005037801,0.00006057261,0.00019087513,0.00026192248,0.000027654805,0.00027242693,0.0016553212,0.000048614816,0.0002285727,0.0137264915,0.9627343,0.020742843],"study_design_scores_gemma":[0.00003141506,0.00005470285,0.00030205105,0.00071490364,0.000015149809,0.0003353414,0.004554973,0.000074409276,0.00006722626,0.019736355,0.97406673,0.00004681268],"about_ca_topic_score_codex":0.004630639,"about_ca_topic_score_gemma":0.008037407,"teacher_disagreement_score":0.048706215,"about_ca_system_score_codex":0.0056196554,"about_ca_system_score_gemma":0.016000692,"threshold_uncertainty_score":0.16293848},"labels":[],"label_agreement":null},{"id":"W4388486354","doi":"10.1093/neuonc/noad210","title":"Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"Medical Research Council; Deutschen Konsortium für Translationale Krebsforschung; National Centre for the Replacement Refinement and Reduction of Animals in Research; Brain Tumour Charity; University of Glasgow; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Cancer Research UK; University of Sheffield; Deutsches Krebsforschungszentrum","keywords":"Internalization; Intravital microscopy; Cytoskeleton; In vivo; Cancer research; Integrin; Motility; Biology; Pathology; Cell biology; Cell; Medicine","score_opus":0.025797958188337845,"score_gpt":0.3085467064945886,"score_spread":0.28274874830625074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917864,0.0026655954,0.0032073623,0.00019637612,0.000027468197,0.000032444994,0.00032631194,0.00019056855,0.001567495],"genre_scores_gemma":[0.9952539,0.0014753776,0.0018181216,0.000044069282,0.000007068597,0.00002792809,0.000351042,0.000017163287,0.0010053058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999151,0.000010856867,0.000008622974,0.000016211834,0.000028786235,0.000020454725],"domain_scores_gemma":[0.99992263,0.000012933363,0.000032834458,0.0000071460786,0.000008971769,0.000015603826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012620736,0.00025572517,0.00023281865,0.0001824287,0.000095888485,0.00031007885,0.00017755102,0.00018359978,0.00092355005],"category_scores_gemma":[0.00007667387,0.000084176456,0.00019097097,0.0000971556,0.00018874329,0.00014001339,0.00011496307,0.00055873283,0.00027661116],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007752829,0.00003721434,0.0001828818,0.000049879138,0.000007121078,0.000020681002,0.0000054483103,0.000081522,0.99800116,0.000057541976,0.000063843436,0.0014150973],"study_design_scores_gemma":[0.000023097444,0.00044086913,0.0052225674,0.000007436216,0.000025773796,0.0002038987,0.000020174595,0.0013510564,0.9904447,0.000033419008,0.0022239292,0.0000030856975],"about_ca_topic_score_codex":0.00036739215,"about_ca_topic_score_gemma":0.0009213857,"teacher_disagreement_score":0.00092355005,"about_ca_system_score_codex":0.00025329107,"about_ca_system_score_gemma":0.00022165697,"threshold_uncertainty_score":0.0030895472},"labels":[],"label_agreement":null},{"id":"W4388551842","doi":"10.1093/neuonc/noad195","title":"Pediatric low-grade glioma: State-of-the-art and ongoing challenges","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Deutsches Krebsforschungszentrum; Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Medicine; Glioma; Clinical trial; Quality of life (healthcare); Disease; Natural history; Epidemiology; Intensive care medicine; Pathology; Internal medicine; Cancer research","score_opus":0.0757305325320381,"score_gpt":0.3544998617690252,"score_spread":0.2787693292369871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388551842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009728205,0.99823344,0.00008124561,0.0008654339,0.00013706465,0.0000023045125,0.000022101334,0.000007007802,0.0005540499],"genre_scores_gemma":[0.0006768875,0.9983479,0.00013973525,0.00042389715,0.0002161836,0.0000040340874,0.000035207468,0.0000019193963,0.00015424461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956757,0.000086698354,0.00007935543,0.00007313744,0.00015018483,0.000043123076],"domain_scores_gemma":[0.99836415,0.0009865309,0.00016890322,0.000034998575,0.00036807338,0.000077377255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013724294,0.00059591996,0.0013762487,0.0017346522,0.00027470075,0.0014557954,0.0007969957,0.0010667462,0.002835861],"category_scores_gemma":[0.0022622966,0.00025032135,0.0007099035,0.0021068377,0.00060705387,0.002252681,0.00070191245,0.0020747632,0.0011255575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007555792,0.000035887628,0.00029557868,0.019065216,0.0000715074,0.00014205735,0.000078169665,0.00043404326,0.0005056577,0.0053572,0.033126567,0.94081265],"study_design_scores_gemma":[0.000011554908,0.00009393873,0.0009927449,0.009390484,0.00015533972,0.0011222085,0.00012434741,0.00014214143,0.00027926156,0.0034813366,0.9841852,0.000021394226],"about_ca_topic_score_codex":0.0021879445,"about_ca_topic_score_gemma":0.004234896,"teacher_disagreement_score":0.002835861,"about_ca_system_score_codex":0.0011977404,"about_ca_system_score_gemma":0.0023737948,"threshold_uncertainty_score":0.009486914},"labels":[],"label_agreement":null},{"id":"W4388588341","doi":"10.1093/neuonc/noad179.0959","title":"QOL-07. RESISTING DECLINES IN FUNCTIONAL FITNESS: PRELIMINARY FINDINGS FROM THE RESIST TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acadia University; Dalhousie University","funders":"","keywords":"Medicine; Physical therapy; Attrition; Grip strength; Circuit training; Adverse effect; Randomized controlled trial; Internal medicine","score_opus":0.06705979609911875,"score_gpt":0.3419399845171719,"score_spread":0.2748801884180532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144686,0.004338783,0.00049728167,0.0024276692,0.0002053352,0.0012296952,0.003275699,0.00014699997,0.006431745],"genre_scores_gemma":[0.9792027,0.0034494088,0.0018114184,0.0027791497,0.0005520293,0.005024415,0.0036563196,0.00003596103,0.0034886235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992453,0.0005174263,0.000049650826,0.00003794313,0.00007715392,0.00007254696],"domain_scores_gemma":[0.99921227,0.00028960127,0.00020874401,0.000070310794,0.00004119844,0.00017784108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021396778,0.0004417984,0.0006231828,0.00019117958,0.00017795558,0.00063483475,0.00027305778,0.000534883,0.0056380043],"category_scores_gemma":[0.0021660393,0.00012557869,0.0009476412,0.00024003585,0.00043320595,0.0005818016,0.00041805778,0.0012830745,0.0007130685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6773827,0.019810062,0.028286375,0.0029665132,0.0035786203,0.0003209568,0.00044350495,0.0013692543,0.008331082,0.001551934,0.013188263,0.24277075],"study_design_scores_gemma":[0.55294937,0.28747675,0.1274591,0.0005249685,0.002328905,0.000508328,0.0004022661,0.001365023,0.0023889835,0.0019833362,0.022541957,0.000071022034],"about_ca_topic_score_codex":0.00023351784,"about_ca_topic_score_gemma":0.0005937588,"teacher_disagreement_score":0.0056380043,"about_ca_system_score_codex":0.00022987419,"about_ca_system_score_gemma":0.00048708904,"threshold_uncertainty_score":0.018860996},"labels":[],"label_agreement":null},{"id":"W4388588352","doi":"10.1093/neuonc/noad179.1142","title":"TMIC-77. UNVEILING THE DEPTHS: EXPLORING DIFFUSE MIDLINE GLIOMA, TUMORIGENESIS, AND RADIATION RESISTANCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroscience; Carcinogenesis; Glioma; Resistance (ecology); Cancer; Biology; Bioinformatics; Psychology; Cancer research; Genetics; Ecology","score_opus":0.048697231723253694,"score_gpt":0.3045791695223482,"score_spread":0.2558819377990945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588352","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13400745,0.016020777,0.0047454555,0.0025389306,0.00046233126,0.00015918455,0.82557416,0.0024579028,0.014033768],"genre_scores_gemma":[0.09685957,0.0038352238,0.0067817266,0.0013260723,0.00010367435,0.00024542096,0.88855255,0.00031718667,0.0019784977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989784,0.00013586595,0.000096300755,0.00029781117,0.00023878121,0.00025284258],"domain_scores_gemma":[0.9982147,0.00036144248,0.00031018423,0.00039321245,0.00041262343,0.00030769643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012149474,0.0010722567,0.0015716365,0.0034003528,0.0013345109,0.002314777,0.0014298442,0.0016910777,0.005667419],"category_scores_gemma":[0.0037329297,0.0003572612,0.0013783788,0.0042996146,0.00056950987,0.0009874448,0.0020651852,0.0015177007,0.004931352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020919407,0.00041749747,0.30856857,0.008316033,0.0014913116,0.0016814698,0.0007323687,0.016034901,0.06939695,0.008297499,0.45814627,0.12482519],"study_design_scores_gemma":[0.00038108623,0.0005269331,0.26263258,0.0017741576,0.0014086985,0.003581215,0.001439081,0.018172162,0.030519601,0.009393653,0.6699294,0.0002413952],"about_ca_topic_score_codex":0.016530424,"about_ca_topic_score_gemma":0.029181136,"teacher_disagreement_score":0.016530424,"about_ca_system_score_codex":0.0016310805,"about_ca_system_score_gemma":0.0028807675,"threshold_uncertainty_score":0.032868385},"labels":[],"label_agreement":null},{"id":"W4388588359","doi":"10.1093/neuonc/noad179.0628","title":"INNV-39. INVESTIGATING MULTI-AGENT INTRATHECAL CHEMOTHERAPY AS A TREATMENT FOR PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: SAFETY AND EFFICACY RESULTS FROM AN INSTITUTIONAL COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rituximab; Etoposide; Ommaya reservoir; Internal medicine; Primary central nervous system lymphoma; Cytarabine; Oncology; ThioTEPA; Lymphoma; Topotecan; Diffuse large B-cell lymphoma; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.03249400732168699,"score_gpt":0.3152593963784103,"score_spread":0.28276538905672327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985493,0.0005399138,0.000114699724,0.000013517733,0.0000048774464,0.0001162005,0.00026390282,0.000003976546,0.00039350294],"genre_scores_gemma":[0.99859005,0.00026393175,0.00014373907,0.000046430814,0.000014376012,0.00007725406,0.00066592434,0.0000043451,0.00019380945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985843,0.000650141,0.00014423806,0.00027258106,0.00020169951,0.00014705937],"domain_scores_gemma":[0.99747354,0.00057428936,0.000985398,0.0003674106,0.00022806408,0.000371234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024010113,0.0003309866,0.00047087285,0.00059207587,0.0003061546,0.00071145507,0.00046912624,0.00034738024,0.0016542801],"category_scores_gemma":[0.0022118085,0.00020326488,0.0007539719,0.0006905846,0.00046073107,0.00040990944,0.00046443832,0.00037927425,0.0004695533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026268672,0.004240254,0.9381918,0.0002058968,0.00069245696,0.0005726992,0.0004017192,0.00026215753,0.003972839,0.000081741615,0.00033101437,0.024778834],"study_design_scores_gemma":[0.004351431,0.082294315,0.8973447,0.00012787634,0.0014294325,0.0029864612,0.0007417308,0.0011316965,0.0052296543,0.00013202116,0.004185824,0.000044881243],"about_ca_topic_score_codex":0.001057816,"about_ca_topic_score_gemma":0.0010091898,"teacher_disagreement_score":0.0024010113,"about_ca_system_score_codex":0.0005728869,"about_ca_system_score_gemma":0.0005763884,"threshold_uncertainty_score":0.0126978755},"labels":[],"label_agreement":null},{"id":"W4388588361","doi":"10.1093/neuonc/noad179.1177","title":"MODL-26. A PROTOCOL TO ADAPT GLIOBLASTOMA IN VITRO CULTURE SYSTEMS INTO ORGANOID MODELS USING NEUROCULT™ NS-A PROLIFERATION MEDIUM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; In vitro; In vivo; Spheroid; Cell culture; Cell biology; Chemistry; Biology; Biochemistry","score_opus":0.03608982723777983,"score_gpt":0.3341194128589796,"score_spread":0.2980295856211998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588361","genre_codex":"methods","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17122817,0.013991795,0.6350171,0.0011603582,0.0033117738,0.023622777,0.056772735,0.018081095,0.07681418],"genre_scores_gemma":[0.14289778,0.008921983,0.6249341,0.0010279123,0.0003440521,0.05934888,0.093609825,0.0034153739,0.065500125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975783,0.00038720382,0.00045931348,0.0004791819,0.0007859306,0.00031004322],"domain_scores_gemma":[0.9989955,0.00019945913,0.0001653732,0.00024351581,0.00024568875,0.00015049562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019200862,0.0018405487,0.0012342322,0.0024013666,0.0011614193,0.00092166057,0.0018356913,0.0010333178,0.011217868],"category_scores_gemma":[0.0006787381,0.0012300096,0.0013218983,0.0010846184,0.0007317833,0.00057241047,0.0011790785,0.0032168848,0.013557417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004022164,0.0003366755,0.00040903458,0.0006509564,0.000030056102,0.0005072749,0.00027670886,0.0005086597,0.9732702,0.0015467448,0.0064524915,0.015608956],"study_design_scores_gemma":[0.0001535643,0.0009507407,0.0032598262,0.00023240781,0.00009713077,0.0011029541,0.00006551383,0.0020368977,0.7384699,0.0004247598,0.25311238,0.00009398592],"about_ca_topic_score_codex":0.0007763762,"about_ca_topic_score_gemma":0.0021526632,"teacher_disagreement_score":0.011217868,"about_ca_system_score_codex":0.0006661675,"about_ca_system_score_gemma":0.0010234246,"threshold_uncertainty_score":0.0375275},"labels":[],"label_agreement":null},{"id":"W4388588373","doi":"10.1093/neuonc/noad179.0660","title":"PATH-30. GLIOMAS WITH FGFR ONCOGENIC ALTERATIONS: CLINICO-PATHOLOGICAL FEATURES, MANAGEMENT AND OUTCOMES IN PEDIATRIC, ADOLESCENT AND YOUNG ADULT PATIENTS.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Winnipeg; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Fibroblast growth factor receptor; Pathological; Astrocytoma; Pilocytic astrocytoma; Fibroblast growth factor receptor 1; Glioma; PTPN11; Internal medicine; Oncology; Pathology; Fibroblast growth factor; Cancer; Cancer research; Receptor; KRAS; Colorectal cancer","score_opus":0.01431956166184641,"score_gpt":0.2966408297902794,"score_spread":0.282321268128433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685043,0.0011063303,0.00009147411,0.00006776251,0.0000065969107,0.000014962332,0.00070448226,0.000010308263,0.0011476106],"genre_scores_gemma":[0.9982393,0.0006206823,0.0001816763,0.00002973246,0.000011988417,0.000014578142,0.00072425586,0.000003381514,0.0001743118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998983,0.000012901364,0.000013564839,0.000022632994,0.000023157281,0.000029374782],"domain_scores_gemma":[0.99970394,0.000024387182,0.00016754601,0.000005245601,0.000021754877,0.000077015946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012999005,0.00020806474,0.00017265287,0.00043439856,0.0002763262,0.0003358062,0.00012260582,0.00018289704,0.0013121333],"category_scores_gemma":[0.00046266,0.000087846536,0.00013766252,0.00054456975,0.00017206845,0.00029083443,0.0002363464,0.00021499021,0.0003690112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009334597,0.00003826635,0.986997,0.000030114908,0.000012900905,0.0047590085,0.00007716286,0.000071604976,0.00055326155,0.00003103917,0.00037804886,0.006958196],"study_design_scores_gemma":[0.000009689703,0.00019811146,0.9595426,0.000039409893,0.000018475062,0.038326494,0.00041432036,0.00016850902,0.00032642117,0.00006644046,0.00088477356,0.000004777225],"about_ca_topic_score_codex":0.0017002433,"about_ca_topic_score_gemma":0.0019061682,"teacher_disagreement_score":0.0017002433,"about_ca_system_score_codex":0.00030065046,"about_ca_system_score_gemma":0.00030339253,"threshold_uncertainty_score":0.0043895245},"labels":[],"label_agreement":null},{"id":"W4388588374","doi":"10.1093/neuonc/noad179.0337","title":"CTNI-55. A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Concordance; Biopsy; Liquid biopsy; Microbubbles; Blood sampling; Radiology; Ultrasound; Internal medicine; Oncology; Cancer","score_opus":0.011266891437333922,"score_gpt":0.24814163151063656,"score_spread":0.23687474007330264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887382,0.0045750397,0.0008433783,0.000512207,0.0002688058,0.0028485553,0.0008408145,0.00009347463,0.0012794165],"genre_scores_gemma":[0.9843151,0.0030840812,0.0023262543,0.0011244323,0.00052604015,0.004197037,0.0026099866,0.000053461692,0.0017636673],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981981,0.0008621642,0.00012760742,0.00038052423,0.00012165974,0.00031010632],"domain_scores_gemma":[0.998109,0.00021786442,0.00043738022,0.00024575787,0.0001638742,0.0008261693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048315898,0.0022866616,0.0026111396,0.0005493305,0.0006422887,0.0016857923,0.0011357117,0.0014593863,0.002786434],"category_scores_gemma":[0.00230237,0.00074269116,0.0022027285,0.0007277154,0.001648768,0.0010257775,0.0006259609,0.002360241,0.0010869255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92046183,0.025131496,0.0058647767,0.0005887941,0.002172648,0.0000935442,0.00015429157,0.000520927,0.01831345,0.00018173888,0.0010914976,0.025424998],"study_design_scores_gemma":[0.42933494,0.5489948,0.013259875,0.00005550567,0.0023335477,0.0001411678,0.000054740845,0.0004167261,0.0033041951,0.0001068884,0.0019500534,0.000047643567],"about_ca_topic_score_codex":0.0019541876,"about_ca_topic_score_gemma":0.0027393054,"teacher_disagreement_score":0.0048315898,"about_ca_system_score_codex":0.0012848643,"about_ca_system_score_gemma":0.002999264,"threshold_uncertainty_score":0.025552213},"labels":[],"label_agreement":null},{"id":"W4388588379","doi":"10.1093/neuonc/noad179.1183","title":"MODL-32. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO GLIOMAGENESIS IN A NOVEL MOUSE MODEL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Pathology; NeuN; OLIG2; Immunohistochemistry; Glioma; Biology; Cancer research; Glial fibrillary acidic protein; Medicine; Oligodendrocyte; Central nervous system","score_opus":0.0371716245391149,"score_gpt":0.30388335912019804,"score_spread":0.26671173458108316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96208924,0.0024033014,0.017484289,0.0009636777,0.00026590948,0.0009071616,0.006768468,0.0015914321,0.0075264596],"genre_scores_gemma":[0.9294198,0.0030693556,0.020390645,0.00032684446,0.000065066066,0.0017086469,0.0060640434,0.0004096613,0.03854601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952435,0.00005590612,0.000054621887,0.00011909453,0.00014137526,0.00010465377],"domain_scores_gemma":[0.9996656,0.000033501718,0.000117476375,0.00004495338,0.00002725536,0.00011109814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004646604,0.0015452794,0.0005724121,0.0025546958,0.0006252856,0.0006349776,0.0007723233,0.0012204039,0.004301066],"category_scores_gemma":[0.00013651856,0.0006544948,0.0007552008,0.00059270684,0.0008347112,0.00056630734,0.0005067738,0.0020639994,0.0021411607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041066788,0.00048318593,0.00028558393,0.000072872564,0.000019113382,0.00041991813,0.00006109857,0.00020398399,0.99388665,0.0014680539,0.00044211085,0.00224672],"study_design_scores_gemma":[0.000372451,0.001864495,0.0026469608,0.000050618175,0.000059209407,0.0022154893,0.00008925411,0.001995172,0.9752855,0.00042329406,0.014976896,0.000020609677],"about_ca_topic_score_codex":0.0013204846,"about_ca_topic_score_gemma":0.0025475249,"teacher_disagreement_score":0.004301066,"about_ca_system_score_codex":0.0008979218,"about_ca_system_score_gemma":0.0006131779,"threshold_uncertainty_score":0.014388502},"labels":[],"label_agreement":null},{"id":"W4388588383","doi":"10.1093/neuonc/noad179.0051","title":"BIOM-40. THERABIOME-GBM: THERAPEUTIC OUTCOMES RELATED TO GUT MICROBIOME IN GLIOBLASTOMA (GBM) PATIENTS RECEIVING CHEMO-RADIATION: A PROSPECTIVE OBSERVATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Adjuvant; Observational study; Clinical endpoint; Prospective cohort study; Radiation therapy; Colorectal cancer; Randomized controlled trial; Cancer","score_opus":0.04321680355414979,"score_gpt":0.3412842826837754,"score_spread":0.2980674791296256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98469615,0.001972354,0.0003185599,0.00024900254,0.000035756977,0.00020560832,0.011214485,0.000011041904,0.0012970263],"genre_scores_gemma":[0.99231863,0.00057716033,0.00042954422,0.00026803074,0.00003980443,0.00038827595,0.005324984,0.000008558142,0.00064509845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993229,0.00014845993,0.00012931986,0.00018561262,0.00009231195,0.00012136028],"domain_scores_gemma":[0.9988864,0.00011128045,0.0005711478,0.000081961094,0.00014625977,0.00020304784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086903985,0.00038117796,0.0006469764,0.00058221235,0.0008333876,0.0008435811,0.00046389233,0.0006598501,0.0029298826],"category_scores_gemma":[0.0017798025,0.0003659867,0.0013270773,0.0014581437,0.00023385248,0.0007153517,0.0009544447,0.0011328727,0.000932043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015750782,0.0002554524,0.9926675,0.00036770065,0.0004701575,0.00006273608,0.00013494378,0.00004784864,0.00034666926,0.00007257538,0.0012418996,0.0027574224],"study_design_scores_gemma":[0.00019632788,0.0010973425,0.99423766,0.00013130419,0.00055869966,0.00027362022,0.00043120765,0.00019504374,0.00012610831,0.00011505891,0.0026193457,0.000018317676],"about_ca_topic_score_codex":0.0050322395,"about_ca_topic_score_gemma":0.006395247,"teacher_disagreement_score":0.0050322395,"about_ca_system_score_codex":0.0004979994,"about_ca_system_score_gemma":0.0008491914,"threshold_uncertainty_score":0.010005891},"labels":[],"label_agreement":null},{"id":"W4388588426","doi":"10.1093/neuonc/noad179.0992","title":"RTID-01. A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pembrolizumab; Lung cancer; Clinical endpoint; Brain metastasis; Randomized controlled trial; Internal medicine; Oncology; Surgery; Cancer; Metastasis; Immunotherapy","score_opus":0.018234762465045854,"score_gpt":0.27840953344250785,"score_spread":0.260174770977462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675915,0.007452755,0.0015589781,0.0013083866,0.0018707521,0.014308518,0.0024340954,0.00023548206,0.0032395374],"genre_scores_gemma":[0.96684974,0.0023950178,0.0035260143,0.0018220649,0.0010872507,0.016776903,0.0016735992,0.000045402838,0.005824016],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99810284,0.0011392632,0.00016608341,0.0003056137,0.00010250357,0.00018371928],"domain_scores_gemma":[0.99831283,0.0005095365,0.0004326521,0.00016687083,0.00012796736,0.00045029155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003251499,0.0017910396,0.0032415248,0.00057257933,0.00044313542,0.0016147846,0.0010692811,0.0022753358,0.010360282],"category_scores_gemma":[0.003480198,0.00084411784,0.0023690285,0.00043201848,0.0012099474,0.0012626078,0.0006650438,0.0027231497,0.0014012061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9890187,0.0031162605,0.000245671,0.00049335614,0.00060516584,0.000015437205,0.000015613887,0.00009430938,0.001145245,0.000110642766,0.0002918236,0.0048478297],"study_design_scores_gemma":[0.95083797,0.047275458,0.00043835753,0.000027218068,0.00047093525,0.000013443206,0.000011358347,0.00018235977,0.00021278296,0.0000991995,0.00042227044,0.000008644255],"about_ca_topic_score_codex":0.000684203,"about_ca_topic_score_gemma":0.0010877795,"teacher_disagreement_score":0.010360282,"about_ca_system_score_codex":0.000851336,"about_ca_system_score_gemma":0.0013349043,"threshold_uncertainty_score":0.03465855},"labels":[],"label_agreement":null},{"id":"W4388588427","doi":"10.1093/neuonc/noad179.0976","title":"QOL-24. FINANCIAL AID REQUESTS BY BRAIN TUMOR PATIENTS IN ONTARIO THROUGH GOFUNDME","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Thematic analysis; Finance; Psychosocial; Distress; Indirect costs; Medicine; Qualitative research; Psychology; Business; Psychiatry; Clinical psychology; Accounting","score_opus":0.034898855266942516,"score_gpt":0.2582457067067476,"score_spread":0.2233468514398051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684002,0.00042657988,0.00019690223,0.004664571,0.0000528853,0.00032278182,0.009558886,0.000033962733,0.016343217],"genre_scores_gemma":[0.9906996,0.000498524,0.00049955054,0.00056473794,0.000015470934,0.00041561932,0.0016007791,0.000020260046,0.0056854524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980579,0.0003820477,0.0001642053,0.00011869195,0.0006707953,0.0006063062],"domain_scores_gemma":[0.9909053,0.0015550201,0.0021874532,0.00020880638,0.00317356,0.0019698902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018865013,0.00022879773,0.00032620746,0.0013456772,0.0038733904,0.0021890241,0.000885162,0.00044593797,0.00832969],"category_scores_gemma":[0.011367517,0.0002559813,0.0005232834,0.0032625424,0.0015254631,0.001092575,0.0027556077,0.00072576443,0.0004059991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029327962,0.00013108746,0.5864105,0.0010944003,0.0000702832,0.0010164061,0.31576246,0.00028578148,0.0006845719,0.0013647428,0.04343576,0.049450625],"study_design_scores_gemma":[0.000020541944,0.00007379133,0.66246444,0.00047963866,0.000022026963,0.0001447583,0.2816941,0.00022788519,0.00011766881,0.00014685377,0.05453844,0.00006989355],"about_ca_topic_score_codex":0.9078092,"about_ca_topic_score_gemma":0.959064,"teacher_disagreement_score":0.0921908,"about_ca_system_score_codex":0.03645914,"about_ca_system_score_gemma":0.04409083,"threshold_uncertainty_score":0.26453084},"labels":[],"label_agreement":null},{"id":"W4388588432","doi":"10.1093/neuonc/noad179.0990","title":"RBIO-10. NEUROMODULATORY EFFECT AND DOSE RESPONSE OF FUNCTIONAL RADIOSURGERY ON CORTICAL NEURONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Radiosurgery; Prefrontal cortex; Neuroscience; Premovement neuronal activity; Medicine; Nuclear medicine; Chemistry; Radiation therapy; Biology; Cognition; Internal medicine","score_opus":0.049419818128794195,"score_gpt":0.29943393993182027,"score_spread":0.25001412180302607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962359,0.0007099635,0.001476577,0.000065494125,0.000025188301,0.000030902112,0.000236609,0.00009434671,0.0011250575],"genre_scores_gemma":[0.99593544,0.0004022958,0.0016587852,0.000051284056,0.0000070062074,0.00005754287,0.00026291775,0.000037691425,0.0015870183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998387,0.000019778996,0.000015772861,0.000035774927,0.000041532145,0.000048440044],"domain_scores_gemma":[0.99980265,0.00005968977,0.000052191393,0.000024322231,0.00002337815,0.000037821083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016714341,0.0004399979,0.00037695884,0.00021799417,0.00009646462,0.00024800393,0.00043703476,0.00041671388,0.0022896565],"category_scores_gemma":[0.00030321814,0.00018146499,0.00030166254,0.00012552842,0.000244353,0.00018356777,0.0001977889,0.0006079256,0.00035031117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021216867,0.000037916492,0.00011103244,0.00004329935,0.000009995664,0.000028894574,0.000009029762,0.000107019034,0.9985267,0.000028461312,0.000027384058,0.00085810304],"study_design_scores_gemma":[0.00001879075,0.0012913183,0.0043584285,0.000007521279,0.000022066877,0.000117131785,0.000028960425,0.0007655016,0.9930368,0.000029208979,0.00031996085,0.0000043423097],"about_ca_topic_score_codex":0.00083906815,"about_ca_topic_score_gemma":0.0009808153,"teacher_disagreement_score":0.0022896565,"about_ca_system_score_codex":0.00031798866,"about_ca_system_score_gemma":0.00023577876,"threshold_uncertainty_score":0.0076596737},"labels":[],"label_agreement":null},{"id":"W4388588439","doi":"10.1093/neuonc/noad179.0111","title":"CNSC-27. LOSS OF CAPICUA IMPAIRS OLIGODENDROGENESIS IN THE DEVELOPING MOUSE BRAIN","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; PDGFRA; Oligodendrocyte; Molecular biology; Transcriptome; Cell biology; Lineage markers; Cancer research; Myelin; Gene expression; Neuroscience; Gene; Genetics; Stem cell; Central nervous system; Progenitor cell","score_opus":0.03412638087190769,"score_gpt":0.3197003617921852,"score_spread":0.2855739809202775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616807,0.0034508293,0.0077242334,0.00041952575,0.0002999275,0.0004000954,0.014044414,0.0012975804,0.010682741],"genre_scores_gemma":[0.9370888,0.002755954,0.009345835,0.00033773287,0.00006626215,0.0011276029,0.011816518,0.00077686564,0.036684487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920374,0.00006164986,0.00008233392,0.00018005383,0.00026603608,0.00020632586],"domain_scores_gemma":[0.9991985,0.000044093318,0.00023909727,0.000070300506,0.00007377962,0.0003743206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050288887,0.001343364,0.00063682697,0.0015613233,0.00049430656,0.00056121097,0.0008354162,0.0008531734,0.0060158554],"category_scores_gemma":[0.00018359488,0.0005266219,0.00082821294,0.00054105336,0.0008440555,0.00033434198,0.0005435191,0.0017591906,0.0027998632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026564166,0.00014452674,0.00023014484,0.0001379472,0.000012880066,0.00019909647,0.000042603708,0.00017098329,0.9963321,0.0003284055,0.00044380222,0.0016919383],"study_design_scores_gemma":[0.000044877273,0.00047824054,0.004897856,0.000046270226,0.000042276748,0.00036663937,0.000066747416,0.0010142869,0.98536867,0.000084581676,0.007574088,0.00001545242],"about_ca_topic_score_codex":0.0023111382,"about_ca_topic_score_gemma":0.004017081,"teacher_disagreement_score":0.0060158554,"about_ca_system_score_codex":0.0006692053,"about_ca_system_score_gemma":0.00088831305,"threshold_uncertainty_score":0.020125091},"labels":[],"label_agreement":null},{"id":"W4388588461","doi":"10.1093/neuonc/noad179.0296","title":"CTNI-14. NEOADJUVANT STEREOTACTIC RADIOSURGERY (NASRS) FOR LARGE BRAIN METASTASES (BRM): RESULTS OF AN INTERNATIONAL MULTICENTER PHASE II TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Radiation therapy; Surgery; Lesion; Nuclear medicine; Randomized controlled trial","score_opus":0.05529110521120137,"score_gpt":0.3893552114297121,"score_spread":0.3340641062185107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813998,0.008916051,0.000729316,0.0013016151,0.00034562795,0.0022654461,0.0012743124,0.00014052202,0.003627344],"genre_scores_gemma":[0.9810394,0.0060964413,0.0023213204,0.0014974928,0.00036358443,0.002752097,0.0030022375,0.000044945667,0.0028825367],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992198,0.0005313297,0.000043239084,0.00008011531,0.000054059426,0.00007147934],"domain_scores_gemma":[0.9991227,0.00014032237,0.00022665085,0.000066475215,0.000061043684,0.0003828023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024679643,0.0012036562,0.0015574701,0.00035112398,0.00034842786,0.0009740244,0.00082990865,0.00096893415,0.0026573339],"category_scores_gemma":[0.0013090239,0.0003964771,0.0010116675,0.00049754156,0.00096692564,0.0006730141,0.00029890533,0.0024825342,0.00074143836],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84565556,0.025381027,0.0062174564,0.0011385665,0.001519272,0.00011981763,0.00013874416,0.0021806057,0.018025463,0.00032855666,0.004897754,0.09439717],"study_design_scores_gemma":[0.6537543,0.32214788,0.0137574505,0.00014260075,0.0010687526,0.000245637,0.00008280431,0.0015153525,0.0027803716,0.00029882204,0.0041601993,0.000045890614],"about_ca_topic_score_codex":0.001464177,"about_ca_topic_score_gemma":0.005694632,"teacher_disagreement_score":0.0026573339,"about_ca_system_score_codex":0.0009703296,"about_ca_system_score_gemma":0.0018034041,"threshold_uncertainty_score":0.013051987},"labels":[],"label_agreement":null},{"id":"W4388588466","doi":"10.1093/neuonc/noad179.0227","title":"RADT-38. DOSE ESCALATED RADIOTHERAPY IS ASSOCIATED WITH IMPROVED OUTCOMES FOR HIGH GRADE MENINGIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Nuclear medicine; Cumulative dose; Internal medicine; Concomitant; Gastroenterology; Surgery; Urology","score_opus":0.03261581152657773,"score_gpt":0.31418200231484666,"score_spread":0.28156619078826894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983412,0.0007591582,0.00022357245,0.00007002361,0.000006911346,0.00001384769,0.000120294804,0.000016582653,0.0004484004],"genre_scores_gemma":[0.9992798,0.0001319969,0.00022018593,0.000044512923,0.0000074188765,0.0000068199006,0.00018519638,0.000004508978,0.00011956299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999665,0.00010753853,0.000033518794,0.000058336518,0.00009290633,0.000042688866],"domain_scores_gemma":[0.99935037,0.00012822039,0.00028852065,0.00008766489,0.00004085487,0.00010433622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006479992,0.00014208526,0.0003751486,0.0002346185,0.00013047784,0.00036062664,0.00023278224,0.0001834339,0.0010401827],"category_scores_gemma":[0.0010839599,0.00006684943,0.0004684897,0.00023551231,0.0001855779,0.00019470634,0.00027244876,0.00033538433,0.00015918823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018337648,0.0012682034,0.69263923,0.0003614245,0.0009262845,0.00094203855,0.00024671984,0.004116777,0.070287965,0.0002036632,0.0013960538,0.20927395],"study_design_scores_gemma":[0.0005530443,0.012335988,0.97134507,0.000041167077,0.00031913022,0.0018451767,0.000080833015,0.0015165696,0.0082834745,0.00045720965,0.003208269,0.000013990666],"about_ca_topic_score_codex":0.0005796114,"about_ca_topic_score_gemma":0.00083348085,"teacher_disagreement_score":0.0010401827,"about_ca_system_score_codex":0.00049639307,"about_ca_system_score_gemma":0.0002846718,"threshold_uncertainty_score":0.003601551},"labels":[],"label_agreement":null},{"id":"W4388588487","doi":"10.1093/neuonc/noad179.0967","title":"QOL-15. THE PIVOTAL TRIDENT STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Oncology; Concomitant; Internal medicine; Clinical endpoint; Radiation therapy; Chemoradiotherapy; Hazard ratio; Progression-free survival; Clinical trial; Chemotherapy; Confidence interval","score_opus":0.016422238184064988,"score_gpt":0.28520466473494865,"score_spread":0.2687824265508837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96578115,0.0056375023,0.000990638,0.0018953115,0.0006596177,0.008717328,0.010308076,0.000085982014,0.0059243436],"genre_scores_gemma":[0.9502154,0.0030261907,0.0044060135,0.00246144,0.00041310594,0.022398727,0.0107983695,0.000053532913,0.0062272204],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99871457,0.0008562366,0.00007602929,0.00013959127,0.00009121243,0.00012233284],"domain_scores_gemma":[0.9982493,0.00020785881,0.0005526581,0.00011400514,0.00019488596,0.00068132905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033684,0.0013334595,0.0015756447,0.00025188804,0.00045693357,0.00090174354,0.00065969443,0.00092924235,0.0061407625],"category_scores_gemma":[0.0019165357,0.0004609373,0.0022633516,0.00049023057,0.0007647575,0.0007562995,0.00059113087,0.0020985403,0.00090392894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95345116,0.0074410653,0.004764003,0.00066170027,0.0017091428,0.0000223556,0.00007430563,0.0004832306,0.0029203438,0.00026006816,0.004136495,0.024076127],"study_design_scores_gemma":[0.7523326,0.20708926,0.030216794,0.00016902202,0.0014620937,0.0000789284,0.000069865295,0.00055359094,0.0010880928,0.00033745702,0.006569036,0.000033213386],"about_ca_topic_score_codex":0.0013700807,"about_ca_topic_score_gemma":0.0031618103,"teacher_disagreement_score":0.0061407625,"about_ca_system_score_codex":0.000925858,"about_ca_system_score_gemma":0.0022393323,"threshold_uncertainty_score":0.02054292},"labels":[],"label_agreement":null},{"id":"W4388588489","doi":"10.1093/neuonc/noad179.0615","title":"INNV-26. THE CHALLENGE OF TREATING ADULTS WITH MEDULLOBLASTOMA – THE CANON EXPERIENCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Dalhousie University; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Population; Young adult; Pediatrics; Brain tumor; Radiation therapy; Internal medicine; Pathology","score_opus":0.023368114692024877,"score_gpt":0.30004251576857444,"score_spread":0.27667440107654956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4765597,0.025823439,0.0009739462,0.2904543,0.0046551903,0.00022991278,0.000930167,0.00015450739,0.20021875],"genre_scores_gemma":[0.89226747,0.020354584,0.0035409024,0.047929194,0.0014328968,0.00010545722,0.0006972205,0.00017727111,0.033495042],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99808216,0.00043255667,0.00009146092,0.00014424311,0.0005393312,0.00071019464],"domain_scores_gemma":[0.993097,0.0006085011,0.0005385533,0.00009082281,0.00087396894,0.004791223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001742204,0.00020635773,0.00015388428,0.00039125342,0.00497988,0.0021481856,0.0010080568,0.0012754769,0.009267912],"category_scores_gemma":[0.005371753,0.0002127654,0.00022111427,0.00078940776,0.0016138048,0.0012894424,0.0024335077,0.001958092,0.0011289981],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001831744,0.0002618117,0.22424056,0.000738158,0.00003856809,0.02126994,0.055002894,0.00031269563,0.0013755157,0.0059515033,0.46891358,0.22171162],"study_design_scores_gemma":[0.000033352528,0.00027688968,0.11274474,0.0018640961,0.000034869383,0.029082928,0.15068403,0.00035724198,0.00035057528,0.001661988,0.7028136,0.00009560049],"about_ca_topic_score_codex":0.39038813,"about_ca_topic_score_gemma":0.7505182,"teacher_disagreement_score":0.39038813,"about_ca_system_score_codex":0.013507055,"about_ca_system_score_gemma":0.021617724,"threshold_uncertainty_score":0.77623165},"labels":[],"label_agreement":null},{"id":"W4388588499","doi":"10.1093/neuonc/noad179.0556","title":"IMMU-24. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Ipilimumab; Medicine; Internal medicine; Oncology; Expanded access; Nivolumab; Immune checkpoint; Progression-free survival; Progressive disease; Salvage therapy; Immunotherapy; Surgery; Chemotherapy; Cancer","score_opus":0.037144638281678174,"score_gpt":0.325559275956624,"score_spread":0.2884146376749458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82487553,0.15217382,0.0026891315,0.0034541714,0.00022494445,0.0008280584,0.0020942008,0.00015508936,0.01350501],"genre_scores_gemma":[0.95517665,0.0325895,0.0031351768,0.0025669346,0.00023787301,0.0005018182,0.0035053531,0.000042207004,0.0022444145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987526,0.000613639,0.00013510928,0.00014984014,0.00020008784,0.00014866443],"domain_scores_gemma":[0.99844754,0.00047316105,0.00029401606,0.0001414931,0.0003808539,0.00026289508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046671643,0.00053180056,0.0005193041,0.0005816596,0.00022356959,0.0007051848,0.0004119922,0.00054252404,0.0006169195],"category_scores_gemma":[0.0021283065,0.00010903178,0.0006258762,0.0005838811,0.0003271218,0.00019534903,0.00032673622,0.0005527844,0.00026513447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01879403,0.0032129653,0.08964891,0.0020556066,0.0010088653,0.0028118708,0.0007652199,0.0011657155,0.059994347,0.0008698874,0.014663532,0.8050091],"study_design_scores_gemma":[0.011931347,0.08074369,0.48877206,0.0015864418,0.0054765614,0.015625916,0.0012341909,0.0036315694,0.17138262,0.00069189194,0.21871023,0.00021353844],"about_ca_topic_score_codex":0.0016202219,"about_ca_topic_score_gemma":0.0017816663,"teacher_disagreement_score":0.0046671643,"about_ca_system_score_codex":0.00081271346,"about_ca_system_score_gemma":0.0013882787,"threshold_uncertainty_score":0.024682641},"labels":[],"label_agreement":null},{"id":"W4388588513","doi":"10.1093/neuonc/noad179.0843","title":"NCOG-30. ENVIRONMENTAL ENRICHMENT AND HEALTH OUTCOMES AFTER RADIATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Socioeconomic status; Montreal Cognitive Assessment; Glioma; Cohort; Physical therapy; Cognition; Gerontology; Psychology; Internal medicine; Cognitive impairment; Psychiatry; Population","score_opus":0.022718172714691176,"score_gpt":0.3295687331466246,"score_spread":0.30685056043193343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95579135,0.0008813003,0.00012167599,0.0007415711,0.00008981739,0.0002844578,0.02746358,0.000047499823,0.014578711],"genre_scores_gemma":[0.96698207,0.00045379245,0.0005527907,0.00045598194,0.00004805056,0.00038018354,0.02658962,0.000033818244,0.0045035575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967265,0.00007743442,0.000036615962,0.000047004527,0.00008084253,0.00008550545],"domain_scores_gemma":[0.9982376,0.0001326503,0.00060042593,0.00006830109,0.0003955111,0.00056542567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050664437,0.00020412743,0.00027438454,0.00042719426,0.0006226386,0.0005501479,0.00036449693,0.00031725553,0.0042234175],"category_scores_gemma":[0.0017726228,0.00008944823,0.00026393193,0.0010078792,0.00016346422,0.0002248713,0.00067822536,0.0004075974,0.00083154766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005029782,0.0002304385,0.9874122,0.00007831979,0.00005003431,0.000038064638,0.00006033235,0.00012191493,0.0002619791,0.00004227515,0.003961164,0.0072401934],"study_design_scores_gemma":[0.000022041226,0.00008702789,0.9977513,0.000012120809,0.000014436392,0.000024537138,0.00004599003,0.00003813227,0.000046894147,0.000025119616,0.0019297332,0.0000026036591],"about_ca_topic_score_codex":0.027395528,"about_ca_topic_score_gemma":0.059624948,"teacher_disagreement_score":0.027395528,"about_ca_system_score_codex":0.00078212516,"about_ca_system_score_gemma":0.0012309449,"threshold_uncertainty_score":0.05447209},"labels":[],"label_agreement":null},{"id":"W4388588518","doi":"10.1093/neuonc/noad179.0978","title":"QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT <i>IDH1/2</i>DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Quality of life (healthcare); Randomized controlled trial; Neurocognitive; Internal medicine; Physical therapy; Cognition; Psychiatry; Pathology","score_opus":0.04818460316316055,"score_gpt":0.3572831364768596,"score_spread":0.3090985333136991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689047,0.007348072,0.0011619576,0.00078196474,0.0007297772,0.013478001,0.0038471303,0.00029303425,0.0034553516],"genre_scores_gemma":[0.971838,0.0029227682,0.0022372936,0.001018,0.00028340804,0.016650511,0.0018696603,0.000035959303,0.0031444242],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99933714,0.0003641571,0.000035217123,0.00010105673,0.0000522102,0.00011018189],"domain_scores_gemma":[0.9993981,0.00013986825,0.00018474198,0.00003875687,0.00004078667,0.00019777533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018278578,0.001891221,0.0027761513,0.0006311917,0.00040940705,0.0009290201,0.0007555021,0.0012445042,0.008398582],"category_scores_gemma":[0.0012155812,0.00078513374,0.0025414121,0.00049950054,0.0013384484,0.00076784356,0.00036145563,0.0024931072,0.00095297635],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9761958,0.00654277,0.00043811178,0.0006584138,0.00072893186,0.000027237933,0.000029369801,0.00041127444,0.0033262486,0.000108970955,0.00080338,0.010729425],"study_design_scores_gemma":[0.9475246,0.050085194,0.0011317418,0.000018321938,0.00022993893,0.000016756283,0.000009320585,0.00022710451,0.0002773069,0.00008848887,0.00038121815,0.0000099095305],"about_ca_topic_score_codex":0.0006682004,"about_ca_topic_score_gemma":0.0015736925,"teacher_disagreement_score":0.008398582,"about_ca_system_score_codex":0.0007581504,"about_ca_system_score_gemma":0.001453714,"threshold_uncertainty_score":0.02809608},"labels":[],"label_agreement":null},{"id":"W4388588526","doi":"10.1093/neuonc/noad179.0151","title":"CCRG-02. DEVELOPMENTALLY PARTITIONED PROLIFERATIVE COMPARTMENTS IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Transcriptome; Progenitor cell; Cell growth; Compartment (ship); Cancer research; Neural stem cell; Cell; Pathology; Stem cell; Gene; Cell biology; Gene expression; Genetics; Medicine","score_opus":0.02535767786171686,"score_gpt":0.28661878104856214,"score_spread":0.26126110318684526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96323097,0.0021148983,0.0073041376,0.0002506186,0.00006343185,0.00007589779,0.023656754,0.0006235194,0.002679837],"genre_scores_gemma":[0.96967155,0.00047808164,0.0050976435,0.0002253917,0.000006917604,0.00010843701,0.022518273,0.00015573067,0.0017379234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980325,0.000013277254,0.000010595185,0.000070818605,0.000057410678,0.000044645185],"domain_scores_gemma":[0.9997837,0.000030028621,0.00006274782,0.000029224142,0.00004452636,0.000049848426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019707788,0.00025508276,0.00034096412,0.00045799869,0.0003787327,0.000715556,0.00021392631,0.000371255,0.0014269256],"category_scores_gemma":[0.00030388086,0.00014835954,0.00024496135,0.00065832026,0.00019764525,0.000120563265,0.00024168771,0.00038758715,0.0007085267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009549255,0.00008869186,0.038836483,0.00032435404,0.00008406414,0.00067400694,0.00017173108,0.003917051,0.92655957,0.0013105057,0.005248903,0.021829773],"study_design_scores_gemma":[0.00017500916,0.0005030786,0.3575461,0.0001459268,0.00027460375,0.0029637557,0.00062746,0.05199912,0.5149875,0.0020583384,0.06862589,0.000093180344],"about_ca_topic_score_codex":0.0072722593,"about_ca_topic_score_gemma":0.0106894355,"teacher_disagreement_score":0.0072722593,"about_ca_system_score_codex":0.0005980688,"about_ca_system_score_gemma":0.00073306344,"threshold_uncertainty_score":0.014459908},"labels":[],"label_agreement":null},{"id":"W4388588533","doi":"10.1093/neuonc/noad179.0970","title":"QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; McGill University Health Centre; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"","keywords":"Lomustine; Procarbazine; Medicine; Vincristine; Internal medicine; Oncology; Randomization; Post-hoc analysis; Survival analysis; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.06165610226933519,"score_gpt":0.3420842834167095,"score_spread":0.2804281811473743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905306,0.00011520717,0.0001077539,0.000034348177,0.000024651557,0.00009877789,0.0003555833,0.000006816526,0.0002038371],"genre_scores_gemma":[0.9984546,0.000033033593,0.00015601801,0.000049575683,0.00002526039,0.00025916687,0.00037528586,0.000005493641,0.00064156007],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987355,0.0006321481,0.000064289896,0.00022864592,0.00010093148,0.0002384674],"domain_scores_gemma":[0.99850285,0.0006408543,0.00030291578,0.00015447276,0.00010041176,0.00029848897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015382606,0.00049912144,0.0013268137,0.0002118569,0.00016492873,0.00058697537,0.0004890493,0.00059774483,0.0040260637],"category_scores_gemma":[0.0021563875,0.00019962099,0.0019898063,0.00026033036,0.00030822845,0.00043034495,0.00036128805,0.0013670842,0.00027284957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82874006,0.009264649,0.112080954,0.00038302422,0.0048773102,0.00013794619,0.00028854437,0.001428213,0.015274058,0.00012735424,0.001858002,0.025539814],"study_design_scores_gemma":[0.035515893,0.38104147,0.5630141,0.000046039637,0.004277466,0.00015423693,0.00036884064,0.0048189573,0.007054511,0.0002212338,0.0034395223,0.000047779093],"about_ca_topic_score_codex":0.0006759926,"about_ca_topic_score_gemma":0.0006746221,"teacher_disagreement_score":0.0040260637,"about_ca_system_score_codex":0.00034886858,"about_ca_system_score_gemma":0.0006516603,"threshold_uncertainty_score":0.013468504},"labels":[],"label_agreement":null},{"id":"W4388588541","doi":"10.1093/neuonc/noad179.0470","title":"EPCO-05. SPATIOTEMPORAL MODELLING OF GLIOBLASTOMA FOR DRUG PREDICTION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tumor microenvironment; Cancer research; Downregulation and upregulation; Tumor progression; Microglia; Glioblastoma; Biology; Brain tumor; Computational biology; Neuroscience; Medicine; Immunology; Gene; Inflammation; Pathology; Tumor cells; Genetics","score_opus":0.04295914583397537,"score_gpt":0.30626219704702073,"score_spread":0.26330305121304537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588541","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18899214,0.0030722842,0.68034357,0.0033433444,0.000695177,0.00062093633,0.031815704,0.015893666,0.07522319],"genre_scores_gemma":[0.8063074,0.0011540167,0.16082227,0.00041061253,0.000098419936,0.00076938485,0.009589442,0.0008153182,0.0200332],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998913,0.000032549313,0.000007050705,0.000022120166,0.000028706978,0.000018232913],"domain_scores_gemma":[0.9996636,0.0001563041,0.00004095363,0.000026020838,0.00008363021,0.000029387273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044519402,0.00069542264,0.00054052426,0.0005100206,0.00023314274,0.0007892151,0.0006128401,0.001251303,0.010910244],"category_scores_gemma":[0.0010293047,0.00027410086,0.0010223283,0.00039197004,0.0002589656,0.00030133314,0.00047202333,0.0006099691,0.0014565809],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009051703,0.00004381783,0.0011429616,0.00010092936,0.000034358258,0.00006939599,0.000011071964,0.9748633,0.0016212421,0.0048555923,0.005777275,0.011389622],"study_design_scores_gemma":[0.0000057389366,0.000011385321,0.00009250381,0.0000050790754,0.000002610321,0.000008552011,0.0000019160273,0.99717146,0.00031707447,0.00064123265,0.0017405594,0.0000019494269],"about_ca_topic_score_codex":0.02823915,"about_ca_topic_score_gemma":0.0174529,"teacher_disagreement_score":0.02823915,"about_ca_system_score_codex":0.0011127064,"about_ca_system_score_gemma":0.0015605087,"threshold_uncertainty_score":0.056149602},"labels":[],"label_agreement":null},{"id":"W4388588548","doi":"10.1093/neuonc/noad179.0044","title":"BIOM-33. TRNA FRAGMENTS IN PLASMA EXTRACELLULAR VESICLES FROM HIGH GRADE GLIOMA PATIENTS, POTENTIAL BIOMARKERS?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Transfer RNA; Biology; RNA; Translation (biology); Small RNA; Epigenetics; Extracellular vesicles; Computational biology; Cell biology; Molecular biology; Cancer research; Biochemistry; Gene; Messenger RNA","score_opus":0.013681023995712872,"score_gpt":0.25648016628450165,"score_spread":0.2427991422887888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995089,0.0020273963,0.00062540936,0.00014518596,0.000029757528,0.000012855239,0.0011101601,0.00003586647,0.00092434714],"genre_scores_gemma":[0.9982297,0.0002889178,0.0003455515,0.0000462496,0.000011075446,0.000007665754,0.0006557315,0.000007041996,0.00040811353],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998667,0.000017672508,0.00001418,0.000031282205,0.000035047105,0.000035130295],"domain_scores_gemma":[0.99983823,0.000033639804,0.000058161568,0.000010691395,0.00003283792,0.0000264031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001963814,0.00025911772,0.00030672728,0.0008125919,0.0002528541,0.00083150563,0.00019231421,0.00047168558,0.0022515494],"category_scores_gemma":[0.0006443476,0.00009324778,0.00018496173,0.0005368579,0.00018838063,0.00017852474,0.00031686106,0.00033851506,0.0006413128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051752636,0.00011486593,0.72781396,0.00056195277,0.00023792492,0.004976409,0.000733859,0.0003527302,0.20121129,0.00040773157,0.0017267388,0.056687325],"study_design_scores_gemma":[0.00004456259,0.0006430101,0.93428636,0.000118624775,0.00018011138,0.014744188,0.0018720505,0.001467941,0.03785832,0.0011832501,0.007564692,0.00003684105],"about_ca_topic_score_codex":0.0008361628,"about_ca_topic_score_gemma":0.0006979626,"teacher_disagreement_score":0.0022515494,"about_ca_system_score_codex":0.00021091424,"about_ca_system_score_gemma":0.000115141025,"threshold_uncertainty_score":0.0075321198},"labels":[],"label_agreement":null},{"id":"W4388588556","doi":"10.1093/neuonc/noad179.0479","title":"EPCO-16. DISRUPTING DOT1L EPIGENETIC ACTIVITY REPROGRAMS GLIOBLASTOMA STEM CELLS TOWARDS A DOPAMINERGIC NEURONAL-LIKE STATE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; Biology; Chromatin; Neural stem cell; Transcription factor; Stem cell; Epigenetic regulation of neurogenesis; Epigenomics; Embryonic stem cell; Gene silencing; Regulation of gene expression; Neuroscience; Gene expression; Genetics; Cancer research; Cell biology; DNA methylation; Chromatin remodeling; Gene","score_opus":0.021296636547715606,"score_gpt":0.29542410880173037,"score_spread":0.27412747225401474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908126,0.0013550952,0.0019423609,0.00018232591,0.00007079558,0.00007002172,0.0025442054,0.00020537688,0.0028172384],"genre_scores_gemma":[0.9850642,0.0007664136,0.0015896574,0.00013513857,0.0000074781688,0.000109238565,0.0040085902,0.00004019053,0.008278909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988186,0.000010644248,0.000016415974,0.000028647633,0.00003218444,0.000030226613],"domain_scores_gemma":[0.9999118,0.000011246388,0.000022080867,0.000012228498,0.000011261811,0.00003149153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086832704,0.0002666146,0.00026576137,0.00021449204,0.0001340101,0.00026460591,0.00020145986,0.00028069867,0.0024769832],"category_scores_gemma":[0.00007607403,0.00010885829,0.00019497481,0.00019455417,0.00018820057,0.00011069074,0.0001641903,0.0005728356,0.0007422988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016793981,0.000087283704,0.00028124842,0.000049333124,0.0000061844,0.00004818922,0.000014541764,0.0000930652,0.9966537,0.000106640065,0.00019321848,0.0022985442],"study_design_scores_gemma":[0.000034683973,0.00056252,0.0048965053,0.00000765092,0.000014725765,0.00013793458,0.000022932469,0.000689715,0.9888672,0.000032711287,0.004729432,0.000004013223],"about_ca_topic_score_codex":0.0011576926,"about_ca_topic_score_gemma":0.0021459034,"teacher_disagreement_score":0.0024769832,"about_ca_system_score_codex":0.0002903745,"about_ca_system_score_gemma":0.00030725848,"threshold_uncertainty_score":0.008286357},"labels":[],"label_agreement":null},{"id":"W4388588565","doi":"10.1093/neuonc/noad179.0473","title":"EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Biology; Computational biology; Exome sequencing; RNA; Deep sequencing; Exome; Cell type; Tumor microenvironment; Genome; Cell; Gene; Genetics; Phenotype; Cancer","score_opus":0.02119131351393815,"score_gpt":0.24084192963388285,"score_spread":0.21965061611994469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588565","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062151585,0.0045258077,0.0631838,0.0017571864,0.0011276712,0.0008128228,0.7636803,0.057529107,0.04523178],"genre_scores_gemma":[0.0606938,0.00162235,0.051992815,0.0012334833,0.00024086937,0.0012129757,0.86389095,0.0075016627,0.011611193],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988128,0.00015857234,0.000066322464,0.0004155148,0.0003577312,0.00018910493],"domain_scores_gemma":[0.9983664,0.00026982767,0.00015849405,0.00038973658,0.00050290854,0.00031260075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002523208,0.0014053007,0.00096919585,0.0015365134,0.000794219,0.0018230261,0.0014007732,0.0013232523,0.020610683],"category_scores_gemma":[0.0023108148,0.0005696917,0.00087815034,0.0013450896,0.00042844244,0.00083033333,0.002060191,0.0010094037,0.028798118],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024009945,0.0003383211,0.020765638,0.0030918273,0.0004703993,0.0005749882,0.00030194892,0.008803463,0.15075453,0.009751991,0.68390673,0.11883916],"study_design_scores_gemma":[0.00079826283,0.00091145444,0.048996437,0.00063226966,0.00026517172,0.0012278705,0.00020270956,0.053428426,0.12023817,0.014880703,0.75814044,0.00027797578],"about_ca_topic_score_codex":0.0036535505,"about_ca_topic_score_gemma":0.0059741084,"teacher_disagreement_score":0.020610683,"about_ca_system_score_codex":0.0007787406,"about_ca_system_score_gemma":0.0021742128,"threshold_uncertainty_score":0.06894964},"labels":[],"label_agreement":null},{"id":"W4388588572","doi":"10.1093/neuonc/noad179.0183","title":"CSIG-27. FLUID SHEAR STRESS ACTIVATES A MECHANO-METASTATIC CASCADE TO PROMOTE MEDULLOBLASTOMA METASTASIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Metastasis; Cancer research; Cerebrospinal fluid; Cancer cell; Cell; Cell migration; Medulloblastoma; Chemistry; Medicine; Pathology; Cancer; Internal medicine","score_opus":0.018680038004465705,"score_gpt":0.2958610730525301,"score_spread":0.2771810350480644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758245,0.0006300308,0.0059704874,0.00022132431,0.00007607682,0.00006071728,0.00072071963,0.00031408115,0.0044240896],"genre_scores_gemma":[0.99612314,0.0003130361,0.0017544366,0.000053927368,0.0000037778266,0.000036229576,0.0003193612,0.000025694095,0.0013703505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999536,0.0000039594056,0.0000016578094,0.000008056124,0.000014983525,0.000017684952],"domain_scores_gemma":[0.9999678,0.0000037512646,0.000007091687,0.0000017755698,0.0000033220863,0.000016275724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006158826,0.0002653421,0.00020317828,0.00012879202,0.00015903817,0.0002461934,0.00018645976,0.00023171116,0.0028725401],"category_scores_gemma":[0.00008851267,0.00015306915,0.00035602867,0.00009633749,0.00019359987,0.00012349215,0.00020273357,0.0003762702,0.00030271616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035216735,0.00012958527,0.0018938462,0.00014866068,0.000019709249,0.00021222486,0.000020293546,0.01852471,0.9715493,0.0012107255,0.00085717323,0.0050816936],"study_design_scores_gemma":[0.00025902607,0.0012016762,0.016164435,0.00003904225,0.0000632597,0.00026330128,0.00011671647,0.22395392,0.743859,0.0011786625,0.0128521165,0.000048903727],"about_ca_topic_score_codex":0.003470656,"about_ca_topic_score_gemma":0.0038264298,"teacher_disagreement_score":0.003470656,"about_ca_system_score_codex":0.0005464751,"about_ca_system_score_gemma":0.0005535244,"threshold_uncertainty_score":0.00960958},"labels":[],"label_agreement":null},{"id":"W4388588586","doi":"10.1093/neuonc/noad179.0682","title":"PATH-52. MENINGIOMA MOLECULAR GROUPS PREDICT RESPONSE TO SURGERY AND RADIOTHERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Toronto Western Hospital; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Adjuvant; Meningioma; Medicine; Methylation; Oncology; Proportional hazards model; Internal medicine; Adjuvant therapy; Radiation therapy; Surgery; Cancer; Biology; Genetics; Gene","score_opus":0.024543917635204814,"score_gpt":0.2979852114148522,"score_spread":0.2734412937796474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91007715,0.0019534386,0.0019226666,0.0006617583,0.00004306129,0.000037310998,0.08363503,0.0001431023,0.0015265046],"genre_scores_gemma":[0.9407687,0.00040532494,0.002104956,0.0001090185,0.000026359694,0.00005885428,0.055958424,0.000026038782,0.0005423084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941266,0.00010327748,0.00007796396,0.0002387067,0.0000870173,0.000080522375],"domain_scores_gemma":[0.99854636,0.00038868448,0.00062986376,0.00017480363,0.00012818848,0.00013214214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079838675,0.00031896995,0.0004248131,0.00088252773,0.00028170674,0.0007731483,0.00042703017,0.00032977902,0.003144145],"category_scores_gemma":[0.0032205475,0.00016208722,0.0007358852,0.0011860653,0.0002018908,0.00036956038,0.0006197046,0.00053477386,0.00089757197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065520953,0.000026036609,0.9802483,0.00021133212,0.00043338354,0.00008604796,0.000056948094,0.0009356577,0.003122094,0.00012269647,0.002947539,0.011154805],"study_design_scores_gemma":[0.000048708676,0.00009112458,0.986611,0.000054109983,0.00032558112,0.0004093647,0.000099568875,0.002945473,0.0021497456,0.0006725827,0.006577713,0.000014981215],"about_ca_topic_score_codex":0.0045956736,"about_ca_topic_score_gemma":0.0064518396,"teacher_disagreement_score":0.0045956736,"about_ca_system_score_codex":0.00049964146,"about_ca_system_score_gemma":0.00081531005,"threshold_uncertainty_score":0.010518193},"labels":[],"label_agreement":null},{"id":"W4388588599","doi":"10.1093/neuonc/noad179.0518","title":"DISP-02. PATTERNS IN THE INCIDENCE OF BRAIN METASTASIS BY RACE AND ETHNICITY: A SYSTEMATIC REVIEW","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Incidence (geometry); Medicine; Pacific islanders; Ethnic group; Cancer; Lung cancer; Demography; Internal medicine; Oncology; Population","score_opus":0.08173283595690423,"score_gpt":0.4092282875138548,"score_spread":0.3274954515569506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027244857,0.9874392,0.0002719022,0.000701737,0.00019347615,0.0008866583,0.006773001,0.000030488578,0.0009791924],"genre_scores_gemma":[0.03337443,0.9589068,0.0013470912,0.0012783569,0.00013917628,0.0022901432,0.002267297,0.000023077451,0.00037369537],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9897159,0.002632648,0.0048754695,0.00085867895,0.0016105867,0.00030673927],"domain_scores_gemma":[0.9577251,0.02950033,0.008262683,0.0005505319,0.0035219798,0.00043936208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076115974,0.0012003406,0.007986654,0.014252199,0.0006649062,0.0031802487,0.0019283647,0.0016985759,0.011799729],"category_scores_gemma":[0.049726028,0.000997387,0.007971865,0.016099958,0.0010056128,0.0032187493,0.0017231683,0.0011230048,0.00081413775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010812055,0.0000061199744,0.0016694318,0.9788432,0.0070686885,0.000052529977,0.00011696529,0.00003210836,0.0000701938,0.00014783724,0.0013642636,0.010520529],"study_design_scores_gemma":[0.00029695735,0.00013783484,0.012298931,0.91300553,0.057841327,0.00041719645,0.0003292889,0.00006728016,0.00010295381,0.00033129976,0.015140161,0.00003121388],"about_ca_topic_score_codex":0.010142832,"about_ca_topic_score_gemma":0.025562024,"teacher_disagreement_score":0.014252199,"about_ca_system_score_codex":0.0035136566,"about_ca_system_score_gemma":0.010368925,"threshold_uncertainty_score":0.040254474},"labels":[],"label_agreement":null},{"id":"W4388588613","doi":"10.1093/neuonc/noad179.0030","title":"BIOM-19. PLASMA EXTRACELLULAR VESICLE SAMPLING FROM HIGH GRADE GLIOMA PATIENTS DEMONSTRATES A SMALL RNA SIGNATURE INDICATIVE OF DISEASE AND IDENTIFIES LNCRNA RPPH1 AS A HIGH GRADE GLIOMA BIOMARKER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Glioma; Paracrine signalling; microRNA; RNA; Biomarker; Cancer research; Biology; Extracellular vesicle; Messenger RNA; Transfer RNA; Small RNA; Microvesicles; Cell biology; Gene; Biochemistry; Receptor","score_opus":0.020356099455629804,"score_gpt":0.2751730821211275,"score_spread":0.2548169826654977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971892,0.00042209245,0.0008235881,0.000036440037,0.000008526429,0.000017393035,0.0007869633,0.000041119343,0.0006745852],"genre_scores_gemma":[0.9975165,0.000120458,0.00084929535,0.000033985943,0.000004144985,0.000014396071,0.0009992669,0.000007602528,0.00045441516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.0000115281,0.00000976851,0.0000372925,0.000023835828,0.000019682393],"domain_scores_gemma":[0.99992394,0.0000138385285,0.00002552556,0.000006559633,0.000014313326,0.000015880469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010376571,0.00020138822,0.00016826949,0.00046241135,0.0001917733,0.00035882965,0.00011035569,0.00024196022,0.001564782],"category_scores_gemma":[0.00024381379,0.000086558066,0.00014595134,0.0002537235,0.00012915494,0.000100080135,0.00022197994,0.00018666932,0.0003848798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001945288,0.000083558814,0.39005077,0.000201378,0.00010575788,0.0015520632,0.00029532248,0.00029687013,0.57292336,0.00014271997,0.0006757185,0.031727333],"study_design_scores_gemma":[0.000025285513,0.0007387798,0.87807494,0.000021576177,0.00007791666,0.008088175,0.00037906863,0.001778238,0.10746034,0.00016270074,0.0031779357,0.000015204355],"about_ca_topic_score_codex":0.000932151,"about_ca_topic_score_gemma":0.0010972944,"teacher_disagreement_score":0.001564782,"about_ca_system_score_codex":0.00016454891,"about_ca_system_score_gemma":0.00011137747,"threshold_uncertainty_score":0.0052346587},"labels":[],"label_agreement":null},{"id":"W4388588618","doi":"10.1093/neuonc/noad179.0190","title":"RADT-01. BASELINE HIPPOCAMPAL VOLUME AS A PREDICTOR OF NEUROCOGNITIVE CHANGES AFTER WBRT OR HA-WBRT: SECONDARY ANALYSIS OF NRG ONCOLOGY CC001","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Correlation; Baseline (sea); Oncology; Nuclear medicine; Cognition","score_opus":0.02596337875086452,"score_gpt":0.31816516016348984,"score_spread":0.2922017814126253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974868,0.00020693846,0.000097611904,0.000017184268,0.000009607296,0.00007703195,0.0015359321,0.00000895911,0.0005598222],"genre_scores_gemma":[0.99725986,0.000035981415,0.0000812332,0.000016515949,0.00001459067,0.00009378364,0.0018316244,0.0000060748293,0.00066032214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993217,0.00024538932,0.00004550233,0.00014585567,0.00014968951,0.00009181297],"domain_scores_gemma":[0.998264,0.0005661202,0.0005426589,0.00016462072,0.00015796478,0.0003046486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013912652,0.00039859876,0.0007986561,0.00046644016,0.00015642606,0.00048559532,0.000544814,0.00026951564,0.0035025117],"category_scores_gemma":[0.002237954,0.00009407033,0.001262835,0.0005641163,0.00027254332,0.00030209598,0.00035604314,0.0005967123,0.00038502878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1048314,0.0012761885,0.8603511,0.00036030708,0.0020219772,0.000236807,0.000112303416,0.0015846913,0.0041054506,0.0001282149,0.0016082564,0.02338334],"study_design_scores_gemma":[0.0013434766,0.01788663,0.9752079,0.000017356653,0.0007980061,0.00017521459,0.00007475352,0.0019658478,0.0013407943,0.00006696351,0.0011088107,0.000014176439],"about_ca_topic_score_codex":0.0025254162,"about_ca_topic_score_gemma":0.003336652,"teacher_disagreement_score":0.0035025117,"about_ca_system_score_codex":0.00059936673,"about_ca_system_score_gemma":0.0006665041,"threshold_uncertainty_score":0.011717081},"labels":[],"label_agreement":null},{"id":"W4388588619","doi":"10.1093/neuonc/noad179.0507","title":"EPCO-45. CELLULAR HIERARCHIES OF ETMR ARE SHAPED BY ONCOGENIC MICRORNAS AND RECEPTOR-LIGAND INTERACTIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; microRNA; Population; Cell; Stem cell; Neural stem cell; Cancer research; Neuroscience; Genetics; Cell biology; Gene; Medicine","score_opus":0.013759409685136649,"score_gpt":0.2791785041914618,"score_spread":0.2654190945063251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917624,0.0007188503,0.0040990748,0.000029624578,0.0000057382235,0.000019880486,0.0011234002,0.000086019325,0.0021549533],"genre_scores_gemma":[0.9929686,0.00021679573,0.003524556,0.000036765316,0.000002578029,0.00003783998,0.0012318122,0.000032322205,0.0019486216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999856,0.000012655433,0.00001023861,0.000048820526,0.000043420387,0.000028884959],"domain_scores_gemma":[0.99983764,0.000028602255,0.00005029973,0.00001600315,0.0000316201,0.00003581373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012171354,0.000118042044,0.0001432021,0.00034745163,0.00021318595,0.00037746606,0.000113642076,0.00016362454,0.0012809492],"category_scores_gemma":[0.00016548354,0.00012468034,0.00013436556,0.00019637766,0.00015112954,0.00014825942,0.0002115549,0.00022198881,0.00040617216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008086136,0.0000101421665,0.011274792,0.000028819471,0.000010460162,0.0002006186,0.000059507092,0.0001915326,0.98382723,0.00034274027,0.00010539051,0.0038678604],"study_design_scores_gemma":[0.000008785532,0.00019211131,0.31032225,0.00001097711,0.000037112073,0.0027820189,0.00020586626,0.0043002097,0.66780025,0.0003250015,0.013998072,0.000017386781],"about_ca_topic_score_codex":0.0010827143,"about_ca_topic_score_gemma":0.001571588,"teacher_disagreement_score":0.0012809492,"about_ca_system_score_codex":0.0002916741,"about_ca_system_score_gemma":0.00017131816,"threshold_uncertainty_score":0.004285276},"labels":[],"label_agreement":null},{"id":"W4388588622","doi":"10.1093/neuonc/noad179.0599","title":"INNV-10. GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS – EXPERIENCE OF CASES PRESENTED AT NATIONAL AYA MULTI-DISCIPLINARY ROUNDS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Health Sciences Centre; CancerCare Manitoba; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; PDGFRA; Oncology; Internal medicine; KRAS; Population; CDKN2A; Young adult; Cancer; Cancer research; Colorectal cancer; GiST","score_opus":0.04863606249864656,"score_gpt":0.3583593643765998,"score_spread":0.30972330187795327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453635,0.0025770066,0.00029097908,0.0007909104,0.000094729236,0.00012475684,0.00029662534,0.000034764427,0.011253867],"genre_scores_gemma":[0.9921766,0.0027823157,0.00095822196,0.0004860022,0.00006989966,0.00004467707,0.00049574295,0.000026307865,0.002960215],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995546,0.00008665648,0.0000374073,0.000045235476,0.00009112284,0.00018497735],"domain_scores_gemma":[0.99925834,0.000059980623,0.00019874895,0.000013725059,0.000095105395,0.00037417244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035554435,0.00028828223,0.0001340768,0.00048923417,0.0012872878,0.00064423395,0.0003351446,0.00032106106,0.0026391514],"category_scores_gemma":[0.0013622475,0.00016249281,0.0001521315,0.00070199306,0.00035035823,0.00040630286,0.00088574877,0.00047145336,0.0006950062],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019382079,0.00016035119,0.7864531,0.00028917383,0.00002398267,0.11984333,0.010744004,0.00024693055,0.0023031335,0.00057813065,0.013447076,0.06571692],"study_design_scores_gemma":[0.000018377441,0.0005359859,0.49859455,0.0006458415,0.000033412045,0.39526352,0.04074784,0.00038433712,0.0019530846,0.00051803334,0.061253153,0.00005187866],"about_ca_topic_score_codex":0.020670883,"about_ca_topic_score_gemma":0.06229039,"teacher_disagreement_score":0.020670883,"about_ca_system_score_codex":0.0018971476,"about_ca_system_score_gemma":0.0017487104,"threshold_uncertainty_score":0.041101158},"labels":[],"label_agreement":null},{"id":"W4388588647","doi":"10.1093/neuonc/noad179.0619","title":"INNV-30. DEVELOPMENT AND IMPLEMENTATION OF A NOVEL, BRIEF NEUROCOGNITIVE SCREENING AND REHABILITATION SERVICE IN A CLINICAL NEURO-ONCOLOGY SETTING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Neurorehabilitation; Rehabilitation; Neuropsychology; Medicine; Mood; Quality of life (healthcare); Cognition; Psychology; Psychiatry; Physical medicine and rehabilitation; Physical therapy; Nursing","score_opus":0.10972876307335845,"score_gpt":0.4507277966976187,"score_spread":0.34099903362426026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74922526,0.001155488,0.05544997,0.023348635,0.0023008052,0.065965354,0.0069636744,0.009965376,0.08562538],"genre_scores_gemma":[0.5701398,0.000910619,0.34423858,0.01308281,0.00039245284,0.037787147,0.011587672,0.00063688745,0.021224078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957878,0.0019483537,0.00027826635,0.00039428094,0.000738701,0.00085254724],"domain_scores_gemma":[0.9926904,0.0006180432,0.00030215704,0.00026904792,0.0012444423,0.004876009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00824994,0.0004754435,0.00042598305,0.00045345403,0.0013612353,0.0015557879,0.003125771,0.00078438374,0.009850214],"category_scores_gemma":[0.008295818,0.00037074994,0.0005098612,0.0002768227,0.000599124,0.0009029184,0.0033353963,0.0014579277,0.0030200263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033577206,0.024088169,0.074396916,0.0006194707,0.000092305534,0.00076588115,0.001854,0.0029214462,0.0075205355,0.0023383452,0.12365064,0.7583946],"study_design_scores_gemma":[0.011863603,0.05314209,0.36028054,0.0019245466,0.00032135757,0.0031024565,0.012266937,0.053912032,0.014472199,0.0073134443,0.4808159,0.00058499095],"about_ca_topic_score_codex":0.021416368,"about_ca_topic_score_gemma":0.05967558,"teacher_disagreement_score":0.021416368,"about_ca_system_score_codex":0.0049107247,"about_ca_system_score_gemma":0.026516741,"threshold_uncertainty_score":0.04363036},"labels":[],"label_agreement":null},{"id":"W4388588697","doi":"10.1093/neuonc/noad179.0624","title":"INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Dalhousie University; Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; BC Cancer Agency; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Medulloblastoma; Population; Atypical teratoid rhabdoid tumor; Young adult; Neurosurgery; Pediatrics; Ependymoma; Oncology; Multidisciplinary approach; Family medicine; Internal medicine; Pathology; Psychiatry","score_opus":0.019401270188600363,"score_gpt":0.3170526776971318,"score_spread":0.2976514075085314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75467235,0.0037596305,0.002424908,0.07173696,0.0019504755,0.0041997787,0.009401367,0.00045412878,0.15140037],"genre_scores_gemma":[0.9071481,0.0024193253,0.0071678003,0.020972,0.00027705487,0.00096151,0.008535889,0.00013355656,0.052384805],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99380845,0.0006793377,0.00018763797,0.0002680157,0.0028581105,0.002198392],"domain_scores_gemma":[0.98148674,0.0008181563,0.0009327212,0.00033297282,0.0059831026,0.010446306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005138882,0.0003063567,0.00016061732,0.0006871599,0.0051250467,0.0016614358,0.001733343,0.001197862,0.0023607318],"category_scores_gemma":[0.010859327,0.00031078648,0.00026343716,0.0007457628,0.0007409624,0.00031992962,0.0017643824,0.001504584,0.00037202256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003163768,0.00052561704,0.5200618,0.0002762768,0.00006190657,0.0052068057,0.0067165988,0.0012210972,0.0030670504,0.0046580504,0.31532723,0.14256117],"study_design_scores_gemma":[0.00004760179,0.0002125286,0.70876026,0.00024310515,0.000037582497,0.00084717333,0.00704391,0.00090497086,0.0010733025,0.00025013206,0.28051484,0.00006468146],"about_ca_topic_score_codex":0.95560247,"about_ca_topic_score_gemma":0.97075874,"teacher_disagreement_score":0.9635741,"about_ca_system_score_codex":0.03642589,"about_ca_system_score_gemma":0.14115871,"threshold_uncertainty_score":0.26428956},"labels":[],"label_agreement":null},{"id":"W4388588709","doi":"10.1093/neuonc/noad179.0513","title":"EPCO-51. FUNCTIONAL ANALYSIS OF REGULATORY MUTATIONS IN PEDIATRIC BRAIN TUMORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gene; Biology; Transcription factor; Genetics; Chromatin; Enhancer; Genome; Regulatory sequence; Somatic cell; Computational biology","score_opus":0.013997817955015176,"score_gpt":0.2635607364601688,"score_spread":0.24956291850515364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805374,0.0010975264,0.0014124829,0.00003345771,0.000010290934,0.000022715003,0.00811373,0.00008313091,0.0011729415],"genre_scores_gemma":[0.9894112,0.00025068232,0.0016770781,0.000031731353,0.000005045796,0.000031057338,0.00800714,0.00003215629,0.00055391015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998067,0.000020018242,0.000015069909,0.000074211144,0.000048006434,0.000036015008],"domain_scores_gemma":[0.9995983,0.00011427478,0.0001527756,0.000025125759,0.000039088307,0.00007044543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018218446,0.00024131309,0.00027688395,0.0011523295,0.0002250431,0.00029655563,0.00023881572,0.00025054076,0.0024154808],"category_scores_gemma":[0.00048592433,0.00009302778,0.00026662706,0.001202937,0.00014146867,0.00009590503,0.00021788382,0.00017313028,0.0004952276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017413822,0.00009331775,0.41444287,0.0004212546,0.00024464028,0.0016568209,0.00011059069,0.002166899,0.5512143,0.00044237945,0.0014069271,0.02605863],"study_design_scores_gemma":[0.00003792164,0.00021517885,0.92016524,0.000034676443,0.0001606418,0.0027723464,0.0000824189,0.005479,0.06551693,0.0002100119,0.0053138766,0.000011764954],"about_ca_topic_score_codex":0.0019262157,"about_ca_topic_score_gemma":0.0021474867,"teacher_disagreement_score":0.0024154808,"about_ca_system_score_codex":0.00032769179,"about_ca_system_score_gemma":0.00024675083,"threshold_uncertainty_score":0.008080602},"labels":[],"label_agreement":null},{"id":"W4388588713","doi":"10.1093/neuonc/noad179.0074","title":"BIOM-63. PROTEOMIC BASED PROFILING OF CSF FOR CNSL MANAGEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cerebrospinal fluid; Primary central nervous system lymphoma; Proteomics; Medicine; Lymphoma; Shotgun proteomics; Oncology; Clinical endpoint; Bioinformatics; Internal medicine; Biology; Clinical trial","score_opus":0.020812268447916886,"score_gpt":0.2987394049311476,"score_spread":0.2779271364832307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823172,0.006213825,0.0043935184,0.0003633601,0.00010468065,0.00018345308,0.0042807385,0.00021175435,0.0019313828],"genre_scores_gemma":[0.9810557,0.0019750104,0.010337129,0.00021574403,0.000049344635,0.00015288405,0.0044918223,0.000026566759,0.0016958121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997968,0.000032197233,0.000027080796,0.000045150744,0.000070107795,0.000028736147],"domain_scores_gemma":[0.9998406,0.00002029928,0.000049328923,0.0000079134215,0.00006305422,0.000018780138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003271215,0.00046401724,0.00035374702,0.0011380212,0.00036756028,0.0006370974,0.00021419632,0.0003658787,0.0010382392],"category_scores_gemma":[0.00050919,0.00013694374,0.00024622487,0.0007868602,0.00019061114,0.00019230157,0.00035010598,0.00031701635,0.000650164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008797331,0.0001394664,0.04875969,0.00035049545,0.000060177816,0.0006271117,0.00013669416,0.00024923417,0.9201515,0.00008273992,0.00088695687,0.027676173],"study_design_scores_gemma":[0.00006156952,0.0012849236,0.34994188,0.00011339995,0.00021979056,0.0041310797,0.0004719454,0.0052841394,0.6254412,0.00031631684,0.012690876,0.000042947213],"about_ca_topic_score_codex":0.0011684513,"about_ca_topic_score_gemma":0.0011372935,"teacher_disagreement_score":0.0011684513,"about_ca_system_score_codex":0.0003091923,"about_ca_system_score_gemma":0.00031741802,"threshold_uncertainty_score":0.0034732819},"labels":[],"label_agreement":null},{"id":"W4388588716","doi":"10.1093/neuonc/noad179.0374","title":"DNAR-08. BASE EXCISION REPAIR AS A THERAPEUTIC TARGET FOR DIFFUSE HEMISPHERIC GLIOMA, H3.3G34-MUTANT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Hospital for Sick Children","funders":"","keywords":"XRCC1; Base excision repair; DNA repair; Biology; Cancer research; Glioma; Nucleotide excision repair; Homologous recombination; ERCC1; Gene knockdown; Wild type; Mutant; Mutation; DNA mismatch repair; Molecular biology; Genetics; Apoptosis; DNA; Single-nucleotide polymorphism; Gene","score_opus":0.031622645338935725,"score_gpt":0.322488166151862,"score_spread":0.29086552081292627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899165,0.0035331545,0.0013267082,0.00022290648,0.000054895,0.00012705989,0.0013065245,0.00033412705,0.0031781746],"genre_scores_gemma":[0.99148035,0.0010209975,0.001736305,0.00012264565,0.0000081485205,0.00006052762,0.0017029443,0.000029214,0.003838907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999336,0.0000063040197,0.00000446707,0.000017188184,0.000019060835,0.000019446361],"domain_scores_gemma":[0.9999589,0.0000029278094,0.000012598556,0.000006054425,0.0000045580587,0.000015000875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011550259,0.0002838295,0.00035515695,0.0001670104,0.00010858346,0.00020469927,0.00022698082,0.00040340231,0.0025272376],"category_scores_gemma":[0.000053090724,0.00009740087,0.00023148327,0.0001702504,0.00015226427,0.00010128078,0.00014148487,0.00051284366,0.0006767829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008560196,0.00023544153,0.0014541075,0.00023619067,0.000042840675,0.00035785694,0.000029166138,0.0002316634,0.9785534,0.00020098532,0.00076279714,0.0170396],"study_design_scores_gemma":[0.0004557444,0.008848779,0.031627603,0.000027183456,0.00015531422,0.003666302,0.00007036316,0.001226785,0.9376394,0.00016555534,0.016102081,0.000014852793],"about_ca_topic_score_codex":0.00052961323,"about_ca_topic_score_gemma":0.0014821,"teacher_disagreement_score":0.0025272376,"about_ca_system_score_codex":0.0002459072,"about_ca_system_score_gemma":0.00020206797,"threshold_uncertainty_score":0.008454442},"labels":[],"label_agreement":null},{"id":"W4388588719","doi":"10.1093/neuonc/noad179.0400","title":"DDDR-06. THE SMOKING CESSATION AGENT LOBELINE DELAYS HYPOXIC STRESS RECOVERY RESULTING IN GLIOBLASTOMA CELL DEATH","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Hypoxia (environmental); Programmed cell death; Cell biology; Stress granule; Chemistry; Cell; Gene silencing; Cancer research; Pharmacology; Apoptosis; Biology; Translation (biology); Messenger RNA; Biochemistry","score_opus":0.02131458777356622,"score_gpt":0.2777015387823962,"score_spread":0.25638695100882997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766774,0.010252928,0.0017430392,0.0004489612,0.000287644,0.00019897344,0.0029180313,0.00043146068,0.007041478],"genre_scores_gemma":[0.9807742,0.0045329276,0.0021054195,0.0004893541,0.0000412988,0.00016377856,0.0043659145,0.00003200828,0.0074951546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998951,0.00001616131,0.000013231726,0.000024917328,0.000022313181,0.00002827192],"domain_scores_gemma":[0.99993515,0.00000791346,0.000013271182,0.000007571577,0.000011397545,0.000024699759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008686856,0.00034491715,0.00043058602,0.00024009513,0.0001178649,0.00021777126,0.0002788978,0.0004358773,0.0036662926],"category_scores_gemma":[0.00009789513,0.00010839962,0.00035320787,0.00020369519,0.00012622097,0.00015864604,0.00021170524,0.0008132364,0.0008673766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003021127,0.0010335285,0.0008378425,0.00044611312,0.000056673285,0.00021507646,0.0000543248,0.00027396227,0.9646449,0.00026483732,0.0021939494,0.026957627],"study_design_scores_gemma":[0.00054196146,0.019332012,0.01720014,0.00005551623,0.000108727014,0.0009446488,0.000079225385,0.0010896187,0.93529445,0.00010968098,0.025212856,0.00003112919],"about_ca_topic_score_codex":0.0009857086,"about_ca_topic_score_gemma":0.0025889322,"teacher_disagreement_score":0.0036662926,"about_ca_system_score_codex":0.00020098366,"about_ca_system_score_gemma":0.00034053792,"threshold_uncertainty_score":0.012264907},"labels":[],"label_agreement":null},{"id":"W4388588751","doi":"10.1093/neuonc/noad179.0508","title":"EPCO-46. CHARACTERIZING ATYPICAL TERATOID RHABDOID TUMOR SUBTYPE ENHANCER INTERACTION LANDSCAPE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Enhancer; SMARCB1; Biology; PDGFRB; DNA methylation; Epigenetics; Genetics; Histone; Epigenomics; Chromatin immunoprecipitation; Gene; Genome; Computational biology; Cancer research; Promoter; Chromatin remodeling; Transcription factor; Gene expression","score_opus":0.01740175606500304,"score_gpt":0.30063517374927407,"score_spread":0.283233417684271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060786,0.0009173343,0.002450993,0.00003795003,0.000005936944,0.00002649736,0.0023455878,0.00013775226,0.0034702374],"genre_scores_gemma":[0.99391794,0.00019150849,0.0015072564,0.000032886204,0.000003881501,0.000026867852,0.002925474,0.000032499964,0.0013616484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998636,0.000008704923,0.000009935334,0.00004477486,0.000041578238,0.000031350144],"domain_scores_gemma":[0.9998486,0.00001801098,0.000050286417,0.000018187437,0.000024158378,0.000040705247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010448548,0.00017631525,0.00017385386,0.0008394524,0.00019005942,0.00032713302,0.00018264748,0.00024082419,0.0040336503],"category_scores_gemma":[0.00020362413,0.00010901921,0.00014765517,0.000558686,0.00011531068,0.00012667433,0.00019000417,0.00016695178,0.0011479892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045572608,0.000050493727,0.22792098,0.0001674217,0.00005441538,0.0022295776,0.00010373949,0.0005891086,0.7528383,0.0005092423,0.0007665223,0.014314462],"study_design_scores_gemma":[0.00002859435,0.00016758427,0.74224436,0.000039438793,0.00015488548,0.017060615,0.00028559155,0.006516609,0.21442616,0.00074293505,0.018316377,0.000016778311],"about_ca_topic_score_codex":0.00094196637,"about_ca_topic_score_gemma":0.0016287147,"teacher_disagreement_score":0.0040336503,"about_ca_system_score_codex":0.00018528722,"about_ca_system_score_gemma":0.00014072117,"threshold_uncertainty_score":0.0134938955},"labels":[],"label_agreement":null},{"id":"W4388588782","doi":"10.1093/neuonc/noad179.0520","title":"DISP-05. UNDERSTANDING THE INDIVIDUAL CHALLENGES AND EXPERIENCES OF YOUNG ADULTS WITH A DIAGNOSIS OF GLIOBLASTOMA AND HIGH-GRADE ASTROCYTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; The Scarborough Hospital; University of Toronto","funders":"","keywords":"Thematic analysis; Glioma; Qualitative research; Young adult; Population; Medicine; Axial coding; Glioblastoma; Psychology; Gerontology; Grounded theory; Sociology","score_opus":0.05866666519521551,"score_gpt":0.30979447899514356,"score_spread":0.25112781379992805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545995,0.0015719355,0.0005739527,0.018302988,0.00064990204,0.00014911505,0.00046569775,0.00003485935,0.023652034],"genre_scores_gemma":[0.9860903,0.0012244027,0.00063026673,0.0042966935,0.00005851156,0.00016948812,0.0001642862,0.00002047745,0.0073455237],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9976107,0.0011766889,0.000119526165,0.00011559898,0.00030812496,0.00066938146],"domain_scores_gemma":[0.9932488,0.0017231061,0.0006687589,0.00011137263,0.0009828474,0.0032650745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043449495,0.00023044542,0.000395141,0.0005630264,0.006357615,0.0046114693,0.000964634,0.0013194041,0.008194751],"category_scores_gemma":[0.009279299,0.00038220335,0.00047015972,0.00064640504,0.0026983107,0.002794693,0.005708361,0.0029075935,0.0012192864],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006092702,0.00011197316,0.037238102,0.00031572804,0.000010923655,0.002539637,0.9290139,0.000032563894,0.00040029365,0.0019384607,0.011069799,0.017267732],"study_design_scores_gemma":[0.00000334841,0.000052135347,0.006900208,0.00014513024,0.0000037961493,0.00066336314,0.9760084,0.000027815808,0.000072595125,0.00024068661,0.01587163,0.000010851735],"about_ca_topic_score_codex":0.019839678,"about_ca_topic_score_gemma":0.031698745,"teacher_disagreement_score":0.019839678,"about_ca_system_score_codex":0.004188383,"about_ca_system_score_gemma":0.008086857,"threshold_uncertainty_score":0.03944838},"labels":[],"label_agreement":null},{"id":"W4388588799","doi":"10.1093/neuonc/noad179.0424","title":"DDDR-31. TARGETING CANCER STEM CELLS WITH A CDK2 INHIBITOR IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cancer research; Stem cell; CDK inhibitor; Cyclin-dependent kinase; Cancer stem cell; Biology; Cancer; Cell cycle; Cell biology; Genetics","score_opus":0.008996403821320255,"score_gpt":0.25389812578119003,"score_spread":0.24490172195986978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733387,0.015124403,0.002806205,0.00038594267,0.00009995842,0.00030346436,0.0014245664,0.0002860135,0.006230855],"genre_scores_gemma":[0.9859218,0.006429789,0.0028955014,0.00017063715,0.0000130206145,0.00010288377,0.001330307,0.00002006298,0.0031159262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999366,0.000008311607,0.000006105273,0.000012406234,0.000016785554,0.000019786537],"domain_scores_gemma":[0.9999758,0.0000030552683,0.0000046038813,0.000002434862,0.000004202857,0.000009903847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107414584,0.00034500347,0.00043348127,0.00049038575,0.0001366939,0.00031728606,0.00022599481,0.0002265808,0.001297358],"category_scores_gemma":[0.000060541955,0.00011875264,0.00022506222,0.00032583973,0.00013490218,0.00014752444,0.00018646901,0.0004259546,0.0003608058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008179704,0.0005432536,0.0007252149,0.00033226167,0.000044685654,0.00028690262,0.000035280722,0.0021787013,0.96365774,0.0004463584,0.001218483,0.029713133],"study_design_scores_gemma":[0.0004129116,0.0054506,0.0043195067,0.000030671396,0.000078779114,0.0007748922,0.000038301387,0.0040250714,0.96966267,0.00016792527,0.015019966,0.00001867727],"about_ca_topic_score_codex":0.0020424635,"about_ca_topic_score_gemma":0.0046571186,"teacher_disagreement_score":0.0020424635,"about_ca_system_score_codex":0.00044862746,"about_ca_system_score_gemma":0.00041105304,"threshold_uncertainty_score":0.004340112},"labels":[],"label_agreement":null},{"id":"W4388588801","doi":"10.1093/neuonc/noad179.0333","title":"CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT <i>IDH1</i>/<i>2</i> DIFFUSE GLIOMA (INDIGO): EXPLORATORY ANALYSIS OF VARIANT ALLELE FREQUENCY AND PROGRESSION-FREE SURVIVAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Medicine; IDH1; Internal medicine; Glioma; Placebo; Hazard ratio; Gastroenterology; Isocitrate dehydrogenase; Mucositis; Oligodendroglioma; Oncology; Interim analysis; Progression-free survival; Randomized controlled trial; Confidence interval; Astrocytoma; Pathology; Chemotherapy; Mutant; Biology; Genetics; Cancer research","score_opus":0.02803217890194327,"score_gpt":0.32091978870986276,"score_spread":0.2928876098079195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94683665,0.010894643,0.0018170906,0.0015571692,0.0020432835,0.019576581,0.0059561497,0.0006487905,0.010669601],"genre_scores_gemma":[0.9699499,0.0033438778,0.0022685868,0.0017096043,0.00042415265,0.013632266,0.0026085796,0.00005253361,0.006010543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99933535,0.00031802236,0.00003757821,0.00013025661,0.00005136484,0.000127527],"domain_scores_gemma":[0.9993303,0.00013773867,0.00016537136,0.000052663203,0.00004424932,0.0002697576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016580864,0.0020309165,0.0028985129,0.00067657366,0.00056243804,0.0012279318,0.0011572393,0.002112824,0.010970629],"category_scores_gemma":[0.001625309,0.000968631,0.002019353,0.0006422012,0.0015715971,0.0011140418,0.0003401437,0.0037747729,0.0017734744],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97866195,0.005255049,0.00024718913,0.0005805569,0.00051384856,0.000029016775,0.000029230527,0.0003597481,0.0033634154,0.00015516498,0.001260144,0.009544579],"study_design_scores_gemma":[0.9614336,0.036613226,0.0005822478,0.000022115139,0.0002272749,0.000018691566,0.000008450876,0.00026482003,0.00028637395,0.00011706419,0.00041312462,0.000013066848],"about_ca_topic_score_codex":0.0013030253,"about_ca_topic_score_gemma":0.004485032,"teacher_disagreement_score":0.010970629,"about_ca_system_score_codex":0.0010911297,"about_ca_system_score_gemma":0.0020891987,"threshold_uncertainty_score":0.036700368},"labels":[],"label_agreement":null},{"id":"W4388588806","doi":"10.1093/neuonc/noad179.0014","title":"BIOM-03. LACK OF CORRELATION OF MR-DETERMINED WHITE MATTER INJURY(WMI)WITH NEUROCOGNITIVE FUNCTION (NCF)6 MONTHS FOLLOWING WBRT+/-HIPPOCAMPAL AVOIDANCE(HA)+MEMANTINE:SECONDARY ANALYSIS OF NRG ONCOLOGY NRGCC001","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Memantine; Medicine; Neurocognitive; Post-hoc analysis; Oncology; Internal medicine; Trail Making Test; Fluid-attenuated inversion recovery; Nuclear medicine; Magnetic resonance imaging; Radiology; NMDA receptor; Cognition; Cognitive impairment; Psychiatry","score_opus":0.023750770192931453,"score_gpt":0.3130954493925948,"score_spread":0.28934467919966333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159616,0.00016499017,0.00019689796,0.00006715965,0.000016239746,0.00020249402,0.0052153417,0.000027895274,0.0025128624],"genre_scores_gemma":[0.9931852,0.000037744678,0.0003253511,0.000062034684,0.000012172802,0.00032903306,0.0044425656,0.000011720645,0.0015941081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941564,0.00016792984,0.000060280137,0.00013698444,0.0001371231,0.00008203877],"domain_scores_gemma":[0.9988049,0.0002340674,0.00045934063,0.00013584133,0.00015022431,0.00021555692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097445736,0.0002834374,0.000552188,0.00031251807,0.00021472614,0.00035918746,0.00046143803,0.0002885858,0.006796875],"category_scores_gemma":[0.0019153502,0.00011185706,0.0006129801,0.00046208833,0.0003007121,0.00027002027,0.00033085063,0.0003921898,0.0008888422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12224831,0.0028040437,0.79227096,0.00030624724,0.001328583,0.00017116165,0.00013152162,0.0010923024,0.012819741,0.0002269884,0.004870651,0.061729364],"study_design_scores_gemma":[0.0019557222,0.015515804,0.9756512,0.00001627509,0.0003343229,0.00018392346,0.000059076872,0.00075459975,0.0025249328,0.00010596754,0.0028880183,0.000010116698],"about_ca_topic_score_codex":0.0033547287,"about_ca_topic_score_gemma":0.005286595,"teacher_disagreement_score":0.006796875,"about_ca_system_score_codex":0.0005945298,"about_ca_system_score_gemma":0.000869671,"threshold_uncertainty_score":0.022737801},"labels":[],"label_agreement":null},{"id":"W4388588881","doi":"10.1093/neuonc/noad179.0815","title":"NCOG-02. MANAGEMENT OF PATIENTS WITH MELANOMA BRAIN METASTASES AND PRIOR SYSTEMIC TREATMENT EXPOSURE: A SINGLE-CENTER EXPERIENCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Melanoma; Single Center; Internal medicine; Oncology; Progression-free survival; Proportional hazards model; Retrospective cohort study; Adverse effect; Expanded access; Systemic therapy; Overall survival; Cancer; Cancer research","score_opus":0.027698674775487948,"score_gpt":0.2859832643915798,"score_spread":0.25828458961609185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949516,0.0010527875,0.00030580504,0.00019289972,0.000015308358,0.000075501004,0.00031765623,0.00002240861,0.0030660094],"genre_scores_gemma":[0.99535286,0.0010014732,0.0011874123,0.00027174305,0.000046405326,0.00007329981,0.0010605892,0.000020172507,0.0009860529],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99977356,0.0000764005,0.000018361194,0.000046303594,0.000040492076,0.000044887885],"domain_scores_gemma":[0.99945253,0.00009750624,0.00011330637,0.00004873869,0.00005021365,0.0002378114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005868154,0.00018136794,0.00018839087,0.00019224876,0.00025027027,0.00044973538,0.00027810386,0.00021701718,0.00126026],"category_scores_gemma":[0.0009503442,0.00008176519,0.00019206043,0.0003984257,0.00017161097,0.00020949783,0.00037858897,0.0003093271,0.00037301428],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007437541,0.0012801951,0.8775396,0.00009341554,0.0000683186,0.004579224,0.0005128112,0.00033601897,0.002672773,0.00012846831,0.0039782147,0.10806721],"study_design_scores_gemma":[0.0003692367,0.0038880925,0.955571,0.00009685032,0.00007735762,0.022497501,0.0009421842,0.0015027456,0.001164892,0.000111019115,0.013757411,0.000021746055],"about_ca_topic_score_codex":0.004669021,"about_ca_topic_score_gemma":0.009205707,"teacher_disagreement_score":0.004669021,"about_ca_system_score_codex":0.00052382785,"about_ca_system_score_gemma":0.0008331351,"threshold_uncertainty_score":0.009283662},"labels":[],"label_agreement":null},{"id":"W4388588920","doi":"10.1093/neuonc/noad179.1198","title":"MODL-47. A NEW MOUSE MODEL OF IDH MUTATED GLIOMAS IDENTIFIES TUMOR CELLS OF ORIGIN AND DETERMINANTS OF SENSITIVITY TO IDH INHIBITORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; IDH1; Mutant; Cancer research; IDH2; Glioma; Tumor progression; Genetics; Gene","score_opus":0.035271072152317055,"score_gpt":0.3161033457505929,"score_spread":0.28083227359827584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96631426,0.0015795855,0.016246682,0.000774543,0.00019256379,0.00024342738,0.008268891,0.0011980642,0.0051819244],"genre_scores_gemma":[0.94641787,0.0015948175,0.017757269,0.0003124202,0.000038890867,0.0006015874,0.0065208133,0.00042382826,0.026332371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993374,0.000051795905,0.00007645906,0.00017633487,0.00019147321,0.00016657042],"domain_scores_gemma":[0.99951994,0.00004023655,0.00018286027,0.00004647746,0.000031367832,0.00017905975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031694354,0.0011109969,0.00052628544,0.0020940716,0.00041528846,0.00063764106,0.0007791552,0.0012456474,0.0041935192],"category_scores_gemma":[0.00013402799,0.00058794324,0.0007708839,0.0005230617,0.00081525726,0.0006283224,0.00045354397,0.002594796,0.0014648318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030662108,0.00019117426,0.0004613501,0.000067792185,0.00001526537,0.00023332464,0.000050176866,0.00019625132,0.99534297,0.0008982397,0.0003133047,0.0019234658],"study_design_scores_gemma":[0.000084614476,0.0005408284,0.0038809706,0.000029075967,0.00004489232,0.00072592037,0.00007520171,0.0019702811,0.9845078,0.00023254265,0.007892894,0.000014975792],"about_ca_topic_score_codex":0.0011883276,"about_ca_topic_score_gemma":0.0023948196,"teacher_disagreement_score":0.0041935192,"about_ca_system_score_codex":0.0009862798,"about_ca_system_score_gemma":0.00053337426,"threshold_uncertainty_score":0.014028728},"labels":[],"label_agreement":null},{"id":"W4388588953","doi":"10.1093/neuonc/noad179.0677","title":"PATH-47. MOLECULAR MARKERS ASSOCIATED WITH SURVIVAL IN GRADE 3 MENINGIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"CDKN2A; BAP1; Immunohistochemistry; Meningioma; Grading (engineering); Pathology; Medicine; Oncology; Biology; Internal medicine; Cancer research; Cancer","score_opus":0.028321900888070153,"score_gpt":0.29011775765510134,"score_spread":0.2617958567670312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940276,0.00008875825,0.00008612193,0.000015944437,0.0000025072507,0.0000020212044,0.00016785276,0.0000045600787,0.00022945684],"genre_scores_gemma":[0.999703,0.000024614978,0.00004188067,0.0000035873152,0.0000024702467,0.0000019546312,0.00014112018,0.0000012267259,0.000080070466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989486,0.00001543176,0.000014668268,0.000024242678,0.000021073816,0.000029689269],"domain_scores_gemma":[0.99942756,0.00009212127,0.000268859,0.000040338713,0.00006131066,0.00010972198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020364608,0.00016707154,0.0001536472,0.00052701076,0.0003355993,0.00047541637,0.0001606665,0.00020715376,0.002047136],"category_scores_gemma":[0.00087811815,0.000093317874,0.00026085586,0.00037096912,0.00018722762,0.00020290317,0.00022372247,0.00025995483,0.0003093271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013676868,0.000009384678,0.99686855,0.0000036958584,0.000014022888,0.00037804738,0.000017525366,0.000059386468,0.0010984299,0.0000112401995,0.000057118978,0.0013458737],"study_design_scores_gemma":[0.000003620817,0.00008652442,0.9968072,0.0000030222895,0.000023626462,0.0015819478,0.000076562006,0.00046154062,0.00062199903,0.000060676815,0.00027046868,0.0000028739692],"about_ca_topic_score_codex":0.0016806776,"about_ca_topic_score_gemma":0.00195588,"teacher_disagreement_score":0.002047136,"about_ca_system_score_codex":0.0002602455,"about_ca_system_score_gemma":0.00023545326,"threshold_uncertainty_score":0.0068482757},"labels":[],"label_agreement":null},{"id":"W4388588958","doi":"10.1093/neuonc/noad179.1159","title":"MODL-08. A COMPENDIUM OF SYNGENEIC, TRANSPLANTABLE PEDIATRIC HIGH-GRADE GLIOMA MODELS REVEALS SUBTYPE-SPECIFIC THERAPEUTIC VULNERABILITIES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Montreal Children's Hospital; Jewish General Hospital","funders":"","keywords":"Biology; Cancer research; Histone H3; KRAS; Phenotype; Glioma; Mutation; Gene; Histone; Genetics","score_opus":0.049477504449376576,"score_gpt":0.2942189613114304,"score_spread":0.2447414568620538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6892474,0.012588301,0.13667674,0.0031037761,0.0008970015,0.004798771,0.094851196,0.01084546,0.046991337],"genre_scores_gemma":[0.5884461,0.014440335,0.1399123,0.0013655245,0.00013740751,0.00887768,0.1741744,0.003076497,0.06956981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948007,0.00007325389,0.000070693764,0.000065693675,0.00020936923,0.000101038706],"domain_scores_gemma":[0.9996617,0.00006113419,0.00006821768,0.0000873629,0.00005196354,0.00006975235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012537714,0.0010865352,0.000606277,0.0020496636,0.00053605024,0.00064323883,0.0014558675,0.00079238013,0.0041818367],"category_scores_gemma":[0.00027015572,0.0004942771,0.0005947911,0.00062682026,0.00031515706,0.00045450783,0.0006614642,0.0019547811,0.0030937158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006149666,0.0006069765,0.00095340086,0.00032500658,0.00006231517,0.00027237082,0.000110734676,0.0010943003,0.9562265,0.0023522088,0.011697168,0.025684038],"study_design_scores_gemma":[0.00035447688,0.002601269,0.004859838,0.0001168876,0.00020809725,0.0021964372,0.000084206236,0.0056397906,0.8056294,0.0005690465,0.17769718,0.000043315697],"about_ca_topic_score_codex":0.0009162569,"about_ca_topic_score_gemma":0.0022419272,"teacher_disagreement_score":0.0041818367,"about_ca_system_score_codex":0.0006242587,"about_ca_system_score_gemma":0.00058010744,"threshold_uncertainty_score":0.013989627},"labels":[],"label_agreement":null},{"id":"W4388588967","doi":"10.1093/neuonc/noad179.0900","title":"EXTH-47. TUMOUR-TARGETED PAN-RAS INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Chimera (genetics); Cancer research; Viability assay; Downregulation and upregulation; Glioma; Cell; Targeted therapy; Cell culture; Biology; Cancer; Biochemistry","score_opus":0.025646377028864065,"score_gpt":0.3257621961385854,"score_spread":0.30011581910972135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851708,0.008209916,0.002270921,0.0001946726,0.000053854754,0.00010310075,0.0005239574,0.00021050591,0.0032622719],"genre_scores_gemma":[0.99236685,0.002946944,0.0012781819,0.000058199523,0.000008091936,0.00003981768,0.0005206254,0.000012031978,0.0027692865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994755,0.0000054729585,0.0000022346112,0.000009992128,0.000016298089,0.00001838861],"domain_scores_gemma":[0.9999831,0.0000017997596,0.0000041015633,0.0000021828366,0.000001757624,0.0000071591444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007398228,0.00025901943,0.00028857507,0.00014403251,0.000069444315,0.00022255127,0.00019455288,0.00021669958,0.0014150538],"category_scores_gemma":[0.000031011965,0.00006944094,0.00021243397,0.00014646452,0.00015765076,0.00012092675,0.00012479929,0.00051878707,0.00031672363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043503297,0.00019489696,0.0003403965,0.00021255485,0.00002300984,0.0002394632,0.000021460666,0.0003217846,0.9783545,0.00028710932,0.00029929788,0.019270485],"study_design_scores_gemma":[0.00016176811,0.005737052,0.005556944,0.000019308105,0.00005979749,0.0014413712,0.000028230499,0.0008566854,0.9765879,0.00008333655,0.009458844,0.000008605145],"about_ca_topic_score_codex":0.00060116115,"about_ca_topic_score_gemma":0.001118206,"teacher_disagreement_score":0.0014150538,"about_ca_system_score_codex":0.00022586987,"about_ca_system_score_gemma":0.0002101334,"threshold_uncertainty_score":0.004733801},"labels":[],"label_agreement":null},{"id":"W4388588971","doi":"10.1093/neuonc/noad179.0259","title":"CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clinical endpoint; Medicine; Pembrolizumab; Oncolytic virus; Oncology; Internal medicine; Hazard ratio; Confidence interval; Phases of clinical research; Clinical trial; Immunotherapy; Cancer","score_opus":0.03965479245783439,"score_gpt":0.38643010450204035,"score_spread":0.346775312044206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931859,0.0033263543,0.00053123257,0.00033109187,0.00015212248,0.0011719395,0.00040391585,0.000075457705,0.00082203315],"genre_scores_gemma":[0.99156463,0.0024011508,0.0013055104,0.00053107704,0.00018250171,0.0013470905,0.00094598415,0.000028632237,0.0016933434],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999648,0.00017313364,0.000019549943,0.000060851944,0.000034498178,0.0000640867],"domain_scores_gemma":[0.9997675,0.00002655443,0.000055247154,0.000021402668,0.00001980626,0.00010943789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015515323,0.0013876976,0.0014593697,0.0003842549,0.0002970004,0.000684489,0.0005652981,0.00083048735,0.0017286671],"category_scores_gemma":[0.00040290694,0.00040010043,0.0009097709,0.00031712095,0.0006253634,0.0005457836,0.00028753342,0.0019971507,0.00044977912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6633105,0.054836243,0.0044275913,0.001583576,0.0025953397,0.0004354398,0.00031748664,0.0046684807,0.09618391,0.0005466409,0.0060231686,0.16507162],"study_design_scores_gemma":[0.44971702,0.5233904,0.008162804,0.00006647061,0.00083093025,0.00036634746,0.00006304267,0.0031792945,0.010143555,0.00028738054,0.0037513298,0.000041444782],"about_ca_topic_score_codex":0.0008561837,"about_ca_topic_score_gemma":0.00173827,"teacher_disagreement_score":0.0017286671,"about_ca_system_score_codex":0.00071662426,"about_ca_system_score_gemma":0.0008943016,"threshold_uncertainty_score":0.008205414},"labels":[],"label_agreement":null},{"id":"W4388588988","doi":"10.1093/neuonc/noad179.0679","title":"PATH-49. COMPREHENSIVE RNA-SEQ ANALYSIS REVEALS NOVEL SUBTYPES OF MENINGIOMAS AND PREDICTS PATIENT OUTCOME.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Meningioma; Computational biology; Biology; Grading (engineering); DNA sequencing; Gene; Bioinformatics; Medicine; Genetics; Pathology","score_opus":0.053970420198538115,"score_gpt":0.3192611067677274,"score_spread":0.2652906865691893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88828176,0.0011154087,0.02220673,0.00041316537,0.00010085573,0.00016667198,0.082187645,0.0016598585,0.0038679955],"genre_scores_gemma":[0.88578874,0.00041221388,0.02650563,0.00034257528,0.000042494194,0.0003109655,0.08422767,0.0002978654,0.0020718938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957913,0.000050964813,0.000028583,0.00020127412,0.00008617336,0.00005384056],"domain_scores_gemma":[0.99963856,0.00012894183,0.0000706097,0.00005039625,0.00006761292,0.000043870456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059912517,0.0003679668,0.00036601038,0.00064738933,0.00056746334,0.0007064948,0.00031144105,0.0003093303,0.0015362296],"category_scores_gemma":[0.0011995558,0.00020261474,0.00050524465,0.0005682625,0.0002273436,0.0001839648,0.00049353467,0.00042008198,0.0008765311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019040252,0.00021622499,0.4475075,0.0008657698,0.0007975282,0.00074365037,0.00040206668,0.018423352,0.39656946,0.0015928956,0.024632288,0.10634519],"study_design_scores_gemma":[0.00017187883,0.0005542499,0.7138296,0.00014714382,0.00051271345,0.001720196,0.00046019227,0.13070536,0.10783794,0.0041424753,0.039806787,0.00011157883],"about_ca_topic_score_codex":0.0030480232,"about_ca_topic_score_gemma":0.00809409,"teacher_disagreement_score":0.0030480232,"about_ca_system_score_codex":0.00052851386,"about_ca_system_score_gemma":0.00066055823,"threshold_uncertainty_score":0.0060606003},"labels":[],"label_agreement":null},{"id":"W4388588992","doi":"10.1093/neuonc/noad179.0672","title":"PATH-42. UNCOVERING AN ASSOCIATION BETWEEN OLIGODENDROGLIOMA AND THE HUMAN PAPILLOMAVIRUS (HPV) THROUGH MOLECULAR SUBPOPULATION ANALYSIS USING NETRAAI","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Biology; Glioma; Cancer research; HDAC1; Copy-number variation; Gene; Molecular biology; Histone; Genetics; Histone deacetylase; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.04053056462054656,"score_gpt":0.34510781130023604,"score_spread":0.3045772466796895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967124,0.0010117682,0.008143048,0.00026574952,0.000047199163,0.000070060654,0.021183126,0.00065763347,0.001497545],"genre_scores_gemma":[0.94043756,0.00033330845,0.015598711,0.0001894357,0.000040994997,0.00014856803,0.04168705,0.00009787174,0.0014664732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996965,0.000039362883,0.000023659155,0.00015026036,0.000044583234,0.00004558947],"domain_scores_gemma":[0.9996793,0.000104581,0.000091925926,0.000031220196,0.000043367774,0.000049625894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048027709,0.0003965701,0.00043242922,0.0009317895,0.00032172198,0.0006681319,0.0002784087,0.0002437501,0.0025480941],"category_scores_gemma":[0.0007457401,0.00020283353,0.0007415532,0.00046080176,0.00013599613,0.0001950025,0.0005953696,0.00045774947,0.00090139266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016508577,0.00034078571,0.74404293,0.00046345635,0.00091918255,0.00045033701,0.00023724281,0.0050159995,0.14746168,0.00053521444,0.0054674507,0.093414836],"study_design_scores_gemma":[0.00012768712,0.001028721,0.83728254,0.000075910626,0.0010137188,0.0015894459,0.0004143143,0.09592386,0.0407194,0.0023680902,0.019379048,0.00007723343],"about_ca_topic_score_codex":0.0011168678,"about_ca_topic_score_gemma":0.0020218792,"teacher_disagreement_score":0.0025480941,"about_ca_system_score_codex":0.00024918452,"about_ca_system_score_gemma":0.00039233323,"threshold_uncertainty_score":0.008524239},"labels":[],"label_agreement":null},{"id":"W4388589009","doi":"10.1093/neuonc/noad179.1201","title":"MODL-50. CLONAL EXPANSION OF SPONTANEOUS AND INJECTED TUMORS IN SYNGENEIC MOUSE MODELS OF GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Somatic cell; Transcriptome; Electroporation; Cancer research; Population; Gene; Genetics; Gene expression; Medicine","score_opus":0.02123646328589057,"score_gpt":0.28106860178831355,"score_spread":0.259832138502423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.921202,0.0033531024,0.035953555,0.00082371815,0.0003867682,0.00080779527,0.024221,0.003979626,0.0092724385],"genre_scores_gemma":[0.90441734,0.0022867487,0.0382072,0.000634388,0.000078591285,0.0030002755,0.018930105,0.0011303812,0.031315107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886996,0.00012315095,0.00010950087,0.00030320292,0.00038518693,0.00020888117],"domain_scores_gemma":[0.99941444,0.0000746465,0.00021603021,0.000091564936,0.000051781233,0.00015150895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078820053,0.00085921655,0.0006037042,0.0024677073,0.00045655327,0.0006231721,0.0006529724,0.0010388518,0.004354939],"category_scores_gemma":[0.0002181501,0.00046433386,0.00065203494,0.0008570011,0.0006372401,0.00046089134,0.000420865,0.002135716,0.0017898005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035109476,0.0003153716,0.00063533353,0.00010883869,0.000023491753,0.00013497508,0.000079267884,0.00026308425,0.9922247,0.00070555357,0.0009873506,0.004170851],"study_design_scores_gemma":[0.000107491986,0.0011912703,0.006117269,0.000040832518,0.000055920496,0.000465758,0.00005716794,0.0027330436,0.97973067,0.00029220435,0.009186318,0.000022077038],"about_ca_topic_score_codex":0.0011348018,"about_ca_topic_score_gemma":0.0024270606,"teacher_disagreement_score":0.004354939,"about_ca_system_score_codex":0.00068236043,"about_ca_system_score_gemma":0.0003916699,"threshold_uncertainty_score":0.0145686865},"labels":[],"label_agreement":null},{"id":"W4388589012","doi":"10.1093/neuonc/noad179.1204","title":"Author Index","year":2023,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Psychology; Computer science; World Wide Web","score_opus":0.0589635921977023,"score_gpt":0.3666350457616977,"score_spread":0.3076714535639954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589012","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002863175,0.0014563,0.0007882119,0.0027880997,0.00709477,0.00027864476,0.021034196,0.0019570596,0.9643162],"genre_scores_gemma":[0.0007646101,0.0011148255,0.0005721359,0.0010964469,0.0015828077,0.0001313023,0.008610992,0.00074548327,0.9853814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994466,0.000084100844,0.000051883046,0.00006130271,0.00029466525,0.00006155754],"domain_scores_gemma":[0.995542,0.00089818507,0.00018754449,0.00022177144,0.0018871041,0.0012634643],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005709036,0.0014514958,0.0012494541,0.005823583,0.0010800358,0.0042708395,0.001254503,0.0017235071,0.893722],"category_scores_gemma":[0.0067301444,0.00054685236,0.00061453495,0.0041241623,0.00042790952,0.0019470342,0.001963267,0.0014971222,0.84923434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016363156,0.000016419459,0.00005265238,0.0001014221,0.0000011692786,0.000018311364,0.0000043500268,0.000045819095,0.00004393665,0.00034847728,0.9659067,0.03344431],"study_design_scores_gemma":[0.000031342934,0.00001938161,0.00028958922,0.00023740834,0.000003984165,0.000078063356,0.00001926382,0.000110387446,0.000106640146,0.001333663,0.9977623,0.000007876454],"about_ca_topic_score_codex":0.0028230532,"about_ca_topic_score_gemma":0.0060787383,"teacher_disagreement_score":0.106278,"about_ca_system_score_codex":0.0015251689,"about_ca_system_score_gemma":0.0023186698,"threshold_uncertainty_score":0.15159267},"labels":[],"label_agreement":null},{"id":"W4388589017","doi":"10.1093/neuonc/noad179.1097","title":"TMIC-31. MULTI-PLATFORM GENOMIC LANDSCAPE OF INTRA-TUMORAL HYPOXIA IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thompson Rivers University; University Health Network; University of Toronto; The Scarborough Hospital; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Transcriptome; Biology; Laser capture microdissection; Epigenomics; Hypoxia (environmental); Chromatin; DNA methylation; Gene expression profiling; Cancer research; Gene expression; Computational biology; Gene; Genetics; Chemistry","score_opus":0.017071761693759208,"score_gpt":0.2731218528501231,"score_spread":0.2560500911563639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98487204,0.001724859,0.00379562,0.00014091152,0.000025138828,0.00005071064,0.0074441317,0.00025326657,0.0016932928],"genre_scores_gemma":[0.987074,0.0005739621,0.0029829189,0.00009090419,0.000007863212,0.00006744103,0.0077914596,0.000032835862,0.0013784303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989223,0.00000953843,0.0000052003365,0.00002881711,0.000036634414,0.00002751521],"domain_scores_gemma":[0.99990547,0.000011490629,0.000030463501,0.000008870179,0.000021516142,0.000022040858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012471198,0.00019236685,0.00027987137,0.0004099356,0.0002280694,0.00029400733,0.00011265678,0.00018518689,0.0015971512],"category_scores_gemma":[0.0001808566,0.00011684913,0.0001941689,0.0005351703,0.00013984194,0.00008530614,0.00019778966,0.00022627768,0.00035104985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005606081,0.000021030604,0.011282893,0.00011618397,0.000026758446,0.0001405952,0.00004185619,0.0006165081,0.9779027,0.000090297704,0.00054978515,0.0086506335],"study_design_scores_gemma":[0.000049511364,0.0011162439,0.39100775,0.00003492824,0.00018644809,0.0019699803,0.00029667435,0.009829047,0.5838452,0.00049930415,0.011131382,0.000033531367],"about_ca_topic_score_codex":0.0017814975,"about_ca_topic_score_gemma":0.0025847221,"teacher_disagreement_score":0.0017814975,"about_ca_system_score_codex":0.00027976517,"about_ca_system_score_gemma":0.00028569138,"threshold_uncertainty_score":0.0053429604},"labels":[],"label_agreement":null},{"id":"W4388589038","doi":"10.1093/neuonc/noad179.0792","title":"NCMP-08. TREATMENT OF PITUITARY METASTASIS: A SINGLE CENTER EXPERIENCE AND SYSTEMATIC LITERATURE REVIEW","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Diabetes insipidus; Retrospective cohort study; Hypopituitarism; Radiation therapy; Surgery; Radiosurgery; Internal medicine","score_opus":0.03463046874427136,"score_gpt":0.3221712558658526,"score_spread":0.28754078712158126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00631647,0.9894861,0.00014188878,0.00043799038,0.000094433344,0.00044538206,0.002212947,0.000017594157,0.0008472518],"genre_scores_gemma":[0.043238316,0.9519853,0.0011490812,0.0008151338,0.00011956407,0.0007683845,0.0016754228,0.000018657343,0.00023017057],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947371,0.0010294741,0.0027404146,0.00042328014,0.00093030516,0.00013943663],"domain_scores_gemma":[0.9798125,0.0120541565,0.005397066,0.00032937166,0.0020427073,0.0003641269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004333596,0.0009304836,0.00324112,0.02157731,0.0007300246,0.00209249,0.0013397621,0.0013594506,0.0030925074],"category_scores_gemma":[0.02232439,0.0005728061,0.002487514,0.02257783,0.00076465774,0.0017018676,0.0011586596,0.0005940939,0.00040992134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030299553,0.000049971786,0.012536152,0.8509671,0.004863499,0.0020720516,0.0012050312,0.00013547037,0.00076091534,0.00033334913,0.0072669643,0.11950652],"study_design_scores_gemma":[0.00016521067,0.00027590062,0.035528082,0.8919898,0.025581177,0.0069582104,0.0014565012,0.00013303122,0.00044062317,0.00017394265,0.037235066,0.00006239622],"about_ca_topic_score_codex":0.010332657,"about_ca_topic_score_gemma":0.02627126,"teacher_disagreement_score":0.02157731,"about_ca_system_score_codex":0.0031422894,"about_ca_system_score_gemma":0.00975664,"threshold_uncertainty_score":0.022918522},"labels":[],"label_agreement":null},{"id":"W4388589044","doi":"10.1093/neuonc/noad179.0639","title":"PATH-09. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A MULTI-CENTRIC, COLLABORATIVE STUDY LED BY THE IRRDC AND GLIOMA TASKFORCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; Germline; DNA mismatch repair; Glioma; Germline mutation; Medicine; Somatic hypermutation; Oncology; Internal medicine; Cancer; Mutation; Cancer research; Genetics; Biology; Immunology; Allele; Microsatellite; Gene; Antibody","score_opus":0.012914611588804494,"score_gpt":0.30634772352351586,"score_spread":0.2934331119347114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589044","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40129748,0.0026736176,0.00047037972,0.00085329567,0.00007624273,0.00032290607,0.5909229,0.00008068857,0.003302488],"genre_scores_gemma":[0.55290836,0.0023197827,0.0016306898,0.00058027124,0.0000870651,0.0009745697,0.43920445,0.00013118434,0.0021637045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886024,0.0002714127,0.00014276686,0.0003542327,0.0001941783,0.0001771139],"domain_scores_gemma":[0.99453706,0.00070185034,0.001384893,0.00054727343,0.0014481753,0.0013807744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023964595,0.00039044005,0.00078090566,0.0014871001,0.0007581768,0.0012227719,0.0010854696,0.0005578256,0.002922912],"category_scores_gemma":[0.0059946105,0.0003899643,0.0008303314,0.0040330295,0.0002726655,0.0004733295,0.0015800302,0.0007084831,0.0010449677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084159843,0.000034702334,0.96233445,0.00060989754,0.00067347387,0.00011242708,0.00043853026,0.00013770176,0.0002781427,0.00019909455,0.028656783,0.005683168],"study_design_scores_gemma":[0.00015061126,0.00008772092,0.98703706,0.00023536691,0.0005522129,0.00017810857,0.00051776896,0.00013779002,0.0000883452,0.00004776427,0.010955239,0.00001202371],"about_ca_topic_score_codex":0.25922537,"about_ca_topic_score_gemma":0.31102008,"teacher_disagreement_score":0.25922537,"about_ca_system_score_codex":0.00269013,"about_ca_system_score_gemma":0.004921009,"threshold_uncertainty_score":0.515433},"labels":[],"label_agreement":null},{"id":"W4388589064","doi":"10.1093/neuonc/noad179.0692","title":"PATH-63. NEXT GENERATION SEQUENCING FOR CNS TUMORS IN CHILDREN; DOES IT ADD VALUE IN A MIDDLE-INCOME COUNTRY SETUP?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Trametinib; Oncology; Internal medicine; Targeted therapy; Dabrafenib; Glioma; Sarcoma; Cancer; Pathology; Cancer research; MAPK/ERK pathway; Metastatic melanoma; Kinase","score_opus":0.05613365512920913,"score_gpt":0.3043581957851118,"score_spread":0.2482245406559027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46966818,0.1292275,0.020640412,0.26093236,0.0044246023,0.00080296426,0.025693988,0.0033215515,0.085288435],"genre_scores_gemma":[0.7320068,0.07262207,0.1165721,0.044233922,0.0024251426,0.00072919665,0.014592948,0.0013877393,0.015430109],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99874216,0.00049664744,0.000103432656,0.00017215619,0.00030649267,0.00017914563],"domain_scores_gemma":[0.9935696,0.0018022147,0.0010198853,0.00019415483,0.00206666,0.0013473701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004218914,0.00038362498,0.00041849277,0.0008211714,0.0003004619,0.0012467359,0.00069968245,0.0008604549,0.014358367],"category_scores_gemma":[0.006793168,0.00014635605,0.00032181677,0.0011525424,0.0007375459,0.00156331,0.0009645738,0.001179928,0.0028614185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001245422,0.00013060271,0.23156615,0.0017937822,0.000112159294,0.0026801846,0.0006077096,0.00090852496,0.0047421632,0.0027086956,0.08095573,0.67254883],"study_design_scores_gemma":[0.0003079102,0.0018686128,0.34013107,0.007463411,0.00027437598,0.011420464,0.004611765,0.003125195,0.009389835,0.0069832653,0.6142755,0.00014860256],"about_ca_topic_score_codex":0.004715553,"about_ca_topic_score_gemma":0.008522791,"teacher_disagreement_score":0.014358367,"about_ca_system_score_codex":0.0016608704,"about_ca_system_score_gemma":0.0036419895,"threshold_uncertainty_score":0.048033535},"labels":[],"label_agreement":null},{"id":"W4388589072","doi":"10.1093/neuonc/noad179.1050","title":"TMET-06. METABOLOGENOMIC CHARACTERIZATION UNCOVERS HETEROGENEITY AMONGST IDH MUTANT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; Thompson Rivers University; University Health Network","funders":"","keywords":"Isocitrate dehydrogenase; Biology; Epigenetics; Glioma; IDH1; DNA methylation; Mutant; Cancer research; Genetics; Gene; Enzyme; Gene expression; Biochemistry","score_opus":0.028457859274519548,"score_gpt":0.29776820204228954,"score_spread":0.26931034276777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524456,0.00056576426,0.0010748291,0.00009311602,0.000016543267,0.000034235876,0.0021273845,0.00008790282,0.00075578684],"genre_scores_gemma":[0.9909276,0.0002449747,0.0015040219,0.000063531705,0.000007872897,0.000051641007,0.006250249,0.000024111889,0.0009260357],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999851,0.000022409267,0.000011050849,0.000044971148,0.000037986298,0.000032524484],"domain_scores_gemma":[0.99987066,0.000021363192,0.000034838304,0.000013905855,0.000014264079,0.000044981258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027090192,0.00029359612,0.0005112852,0.00047721202,0.00015119338,0.00048335677,0.00029824808,0.00029455835,0.00149859],"category_scores_gemma":[0.00029674682,0.00012664426,0.0002368811,0.0006084017,0.000190174,0.00016361533,0.00018911526,0.00049068476,0.00037341277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008426538,0.00049080263,0.13620508,0.00017941996,0.0001853984,0.0006223889,0.0000725409,0.002224924,0.8081249,0.00033791468,0.001596018,0.041534144],"study_design_scores_gemma":[0.00046815642,0.010109228,0.54387724,0.00003209533,0.00038698284,0.007367632,0.0002628362,0.016026756,0.40800166,0.0007849085,0.012642833,0.000039746566],"about_ca_topic_score_codex":0.0008294311,"about_ca_topic_score_gemma":0.0010835846,"teacher_disagreement_score":0.00149859,"about_ca_system_score_codex":0.00036691225,"about_ca_system_score_gemma":0.00030307192,"threshold_uncertainty_score":0.0050132275},"labels":[],"label_agreement":null},{"id":"W4388589074","doi":"10.1093/neuonc/noad179.0671","title":"PATH-41. INTEGRATED MOLECULAR ANALYSIS REVEALS HYPERMETHYLATION AND OVEREXPRESSION OF HOX GENES TO BE POOR PROGNOSTICATORS IN IDH MUTANT GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Thompson Rivers University","funders":"","keywords":"Hox gene; Biology; DNA methylation; Glioma; Methylation; Oncology; Copy-number variation; Cancer research; Proportional hazards model; Gene; Genetics; Internal medicine; Gene expression; Genome; Medicine","score_opus":0.02175187963742699,"score_gpt":0.31188484975283143,"score_spread":0.29013297011540445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983486,0.000095936906,0.00051350275,0.000018527107,0.000001636168,0.000007465281,0.0007401368,0.000030218709,0.00024402115],"genre_scores_gemma":[0.99834096,0.000026034188,0.0007038357,0.0000073629844,0.0000012518486,0.0000070189644,0.0007287652,0.000005599327,0.00017908664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989283,0.000015679947,0.0000068358086,0.000035603716,0.000025614941,0.000023426885],"domain_scores_gemma":[0.99981815,0.000039286664,0.00007024923,0.000018012219,0.000017788843,0.000036589176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020918265,0.00021094519,0.00018967275,0.00060376263,0.00015207927,0.0002506932,0.00017431383,0.00011670537,0.0012865044],"category_scores_gemma":[0.00038530672,0.00008315207,0.00017222701,0.00033996103,0.00015491957,0.00006914313,0.00025001031,0.00017955947,0.00018596723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016838292,0.00007319318,0.72861964,0.00007873613,0.00012818756,0.00045523132,0.00009680609,0.0015315488,0.23836745,0.00021316818,0.000524609,0.028227564],"study_design_scores_gemma":[0.000020542364,0.00024999536,0.97210395,0.0000045036854,0.000081351376,0.0009722433,0.000048684862,0.005083446,0.020603288,0.00015516464,0.00067053153,0.0000063013317],"about_ca_topic_score_codex":0.0030428981,"about_ca_topic_score_gemma":0.0043949396,"teacher_disagreement_score":0.0030428981,"about_ca_system_score_codex":0.00032667394,"about_ca_system_score_gemma":0.00028097662,"threshold_uncertainty_score":0.006050408},"labels":[],"label_agreement":null},{"id":"W4388589080","doi":"10.1093/neuonc/noad179.1121","title":"TMIC-55. TURNING ENEMY INTO ALLY: HIJACK BRAIN TUMOR CELLS TO BREAK DOWN THE BLOOD-TUMOR BARRIER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Wnt signaling pathway; Blood–brain barrier; Gene knockdown; Medulloblastoma; Brain tumor; Mesenchymal stem cell; Cancer stem cell; Medicine; Cancer; Signal transduction; Cell biology; Internal medicine; Biology; Pathology; Cell culture; Central nervous system","score_opus":0.007864318550274883,"score_gpt":0.2561955975863183,"score_spread":0.24833127903604343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559212,0.009433094,0.0081654815,0.0026429428,0.0010357862,0.00024001113,0.0031570042,0.0015519969,0.01785243],"genre_scores_gemma":[0.9815407,0.0034567562,0.0037707528,0.0006882439,0.000052161893,0.0001304048,0.0018907242,0.000069260306,0.008400947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985015,0.000012611347,0.000012300869,0.000031573967,0.000035225927,0.000058131598],"domain_scores_gemma":[0.9999378,0.0000056036097,0.000012579802,0.000008478509,0.0000071221157,0.000028376124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014385862,0.0004505891,0.00041445773,0.00025282978,0.00026137815,0.0004298085,0.0003530976,0.00054120884,0.0035303247],"category_scores_gemma":[0.000116966294,0.00017021532,0.00044473424,0.00019242152,0.00034320855,0.0002885528,0.00019280921,0.0015049938,0.0014059432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000550065,0.00025200786,0.000273762,0.0001686184,0.000028536044,0.00012067669,0.000025840176,0.00045651663,0.9856328,0.00091421907,0.0024774713,0.00909953],"study_design_scores_gemma":[0.0001961607,0.0015182409,0.0020202084,0.000027504455,0.00007936848,0.00044827998,0.000044171382,0.0020381222,0.97275305,0.00018009132,0.020675806,0.00001900409],"about_ca_topic_score_codex":0.0016096691,"about_ca_topic_score_gemma":0.0019654424,"teacher_disagreement_score":0.0035303247,"about_ca_system_score_codex":0.00054819306,"about_ca_system_score_gemma":0.0005895908,"threshold_uncertainty_score":0.011810124},"labels":[],"label_agreement":null},{"id":"W4388589102","doi":"10.1093/neuonc/noad179.0637","title":"PATH-07. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Microsatellite instability; Glioma; Cancer research; Genome instability; ATRX; PTEN; Mutation; DNA mismatch repair; Immune system; Somatic hypermutation; Genetics; Gene; DNA repair; Allele; Microsatellite; Antibody; B cell; DNA damage","score_opus":0.021332969871373814,"score_gpt":0.2952102071822529,"score_spread":0.2738772373108791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956654,0.00051284995,0.00052520935,0.0000519035,0.000008589913,0.00004795005,0.002053124,0.00004748026,0.001087634],"genre_scores_gemma":[0.99389184,0.00027503248,0.0009292883,0.000053939537,0.000009653999,0.00005479241,0.0040484914,0.00001657287,0.0007205157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998703,0.000014701322,0.000012678615,0.000046231697,0.000020048537,0.000036146543],"domain_scores_gemma":[0.99980515,0.000025412333,0.000050432966,0.000032468975,0.000020976886,0.00006555618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017932814,0.00021629829,0.00019112891,0.0005836252,0.00017592245,0.00033616397,0.00017809852,0.00021044117,0.0034995535],"category_scores_gemma":[0.00018133006,0.0001420258,0.00020401203,0.00034393554,0.00021214249,0.00011230037,0.00034250514,0.00026646213,0.00082540617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002853085,0.000334723,0.2364961,0.00032476627,0.00011433653,0.0025490115,0.00015049176,0.00014800904,0.73153484,0.00030896164,0.0010321932,0.024153486],"study_design_scores_gemma":[0.0001720629,0.0033219077,0.8434281,0.000029390992,0.00019495942,0.030566432,0.0002600355,0.0008625861,0.11101705,0.00025274727,0.009882183,0.000012625823],"about_ca_topic_score_codex":0.00036285893,"about_ca_topic_score_gemma":0.00048727152,"teacher_disagreement_score":0.0034995535,"about_ca_system_score_codex":0.00026142623,"about_ca_system_score_gemma":0.00022979618,"threshold_uncertainty_score":0.011707246},"labels":[],"label_agreement":null},{"id":"W4388589111","doi":"10.1093/neuonc/noad179.0181","title":"CSIG-25. OVERCOMING RESISTANCE TO THERAPIES TARGETING THE MAPK PATHWAY IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Cancer research; Psychological repression; Repressor; Transcription factor; Receptor tyrosine kinase; Context (archaeology); Signal transduction; Carcinogenesis; Kinase; Biology; Cell biology; Cancer; Gene; Gene expression; Genetics","score_opus":0.013445097062256247,"score_gpt":0.28246637455434126,"score_spread":0.269021277492085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835565,0.009090837,0.0006049165,0.00045529194,0.00011585832,0.00021599428,0.00065724377,0.00029319554,0.0050101946],"genre_scores_gemma":[0.9934464,0.002635366,0.0007306334,0.00017711731,0.00001362553,0.00006649321,0.001041734,0.00001761955,0.0018709823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999037,0.000010502354,0.000005907056,0.000013207332,0.000020383435,0.000046250745],"domain_scores_gemma":[0.99994934,0.0000039374618,0.00000594259,0.0000064333876,0.000006300916,0.000027974587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018943362,0.00031084806,0.0006430421,0.0005605379,0.00020834901,0.00039189888,0.00043613042,0.00031279676,0.0015190844],"category_scores_gemma":[0.00010803174,0.00013381294,0.00030913338,0.00040699364,0.000264901,0.00013524039,0.0002529496,0.0007118603,0.00051782967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004859658,0.0023311358,0.0043211547,0.00075154344,0.00024137693,0.0014401686,0.00013739752,0.003391909,0.76815337,0.0016024086,0.0073818173,0.20538804],"study_design_scores_gemma":[0.0023109016,0.032429423,0.056894094,0.0001789425,0.00054936437,0.0044258526,0.0002662508,0.008795129,0.81998557,0.001018892,0.07303972,0.0001058713],"about_ca_topic_score_codex":0.0024683904,"about_ca_topic_score_gemma":0.005686435,"teacher_disagreement_score":0.0024683904,"about_ca_system_score_codex":0.0006821667,"about_ca_system_score_gemma":0.00070417474,"threshold_uncertainty_score":0.0050818324},"labels":[],"label_agreement":null},{"id":"W4388589113","doi":"10.1093/neuonc/noad179.0794","title":"NCMP-10. DEXAMETHASONE: A TOOL AND A PROBLEM IN GLIOBLASTOMA MANAGEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Metformin; Dexamethasone; Leukocytosis; Glycemic; Internal medicine; Diabetes mellitus; Univariate analysis; Gastroenterology; Complication; Proportional hazards model; Hazard ratio; Surgery; Multivariate analysis; Endocrinology","score_opus":0.01926542897391518,"score_gpt":0.2984501386200385,"score_spread":0.2791847096461233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589113","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48675144,0.2761176,0.006690135,0.20353608,0.0029711174,0.00017391027,0.0025307958,0.0002821665,0.020946836],"genre_scores_gemma":[0.9297205,0.044711243,0.010361894,0.0101656355,0.0018279148,0.000096356496,0.0009835423,0.000060005845,0.002072865],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981419,0.0006548209,0.0003005321,0.00015342637,0.00062173576,0.00012763237],"domain_scores_gemma":[0.99356717,0.0018842464,0.0024818184,0.00017106273,0.001069238,0.0008264661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027140793,0.00025169837,0.00049109303,0.0007940094,0.0005060517,0.0015582913,0.0007636561,0.0005530118,0.001651287],"category_scores_gemma":[0.0098806815,0.000112732436,0.0002773667,0.001822122,0.00052810926,0.0015068293,0.00062204764,0.0014620911,0.00034449188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007215337,0.00020416915,0.52614015,0.0008830237,0.00014119326,0.0012960695,0.0002749567,0.00033176877,0.0006969861,0.0019531543,0.020903155,0.44645387],"study_design_scores_gemma":[0.00016524429,0.0015199612,0.79682827,0.005169058,0.0006146419,0.01413683,0.0039783507,0.0050947657,0.002460953,0.010195491,0.15968786,0.00014854729],"about_ca_topic_score_codex":0.004629307,"about_ca_topic_score_gemma":0.008230946,"teacher_disagreement_score":0.004629307,"about_ca_system_score_codex":0.0010916273,"about_ca_system_score_gemma":0.0023903945,"threshold_uncertainty_score":0.014353633},"labels":[],"label_agreement":null},{"id":"W4388589123","doi":"10.1093/neuonc/noad179.0793","title":"NCMP-09. THE CURRENT LANDSCAPE OF SPINE ONCOLOGY SURGICAL TRIALS AND FUTURE OPPORTUNITIES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Population; Internal medicine; Observational study; Oncology","score_opus":0.12787348597349069,"score_gpt":0.3933893854923453,"score_spread":0.2655158995188546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051494236,0.42832348,0.007894608,0.391863,0.013038343,0.008481134,0.069432214,0.0014248237,0.074393034],"genre_scores_gemma":[0.05780687,0.35406664,0.1586755,0.2254786,0.021417107,0.056992937,0.0996109,0.0029734115,0.022977948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.80594844,0.12121335,0.037365686,0.006517681,0.02585425,0.0031005237],"domain_scores_gemma":[0.40259126,0.41655827,0.061457176,0.019512532,0.077183545,0.022697203],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21610655,0.0010578074,0.0042693187,0.010166053,0.0018829834,0.016017675,0.0059779496,0.0064338883,0.05042142],"category_scores_gemma":[0.37937844,0.0015774628,0.0034600464,0.018266784,0.0037448176,0.011656302,0.0077649327,0.005723632,0.015367918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034171818,0.00017409543,0.0033763044,0.08173595,0.0009588367,0.00017834165,0.00038386806,0.000529605,0.00040837334,0.0171395,0.42435494,0.467343],"study_design_scores_gemma":[0.002019976,0.00054555194,0.0055475645,0.13416693,0.0009705287,0.00045892783,0.0003368714,0.00075121777,0.00029734013,0.020805594,0.8339768,0.00012276035],"about_ca_topic_score_codex":0.0051807943,"about_ca_topic_score_gemma":0.013635546,"teacher_disagreement_score":0.21610655,"about_ca_system_score_codex":0.0117387185,"about_ca_system_score_gemma":0.04458226,"threshold_uncertainty_score":0.96668017},"labels":[],"label_agreement":null},{"id":"W4388589141","doi":"10.1093/neuonc/noad179.1060","title":"TMET-16. ELUCIDATING MECHANISMS OF ENHANCED OXIDATIVE PHOSPHORYLATION IN MYC-AMPLIFIED MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Gene knockdown; Oxidative phosphorylation; Cell biology; Biology; Elongation factor; Chemistry; Molecular biology; Biochemistry; Apoptosis; Gene; RNA","score_opus":0.018151320542822653,"score_gpt":0.2953032925489374,"score_spread":0.27715197200611474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153334,0.002505607,0.0022646582,0.00015944152,0.000048751263,0.00009637932,0.0017500491,0.0001005447,0.0015412876],"genre_scores_gemma":[0.9933431,0.0013061145,0.0014140342,0.000053358475,0.0000062789586,0.000066237386,0.0017811883,0.0000125648585,0.002017125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991906,0.000009904909,0.000007693292,0.000017141117,0.000025428877,0.000020730668],"domain_scores_gemma":[0.9999628,0.000004424442,0.000014353414,0.0000030575723,0.000004349442,0.000011173473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015278946,0.00028701383,0.00021073493,0.00030770025,0.00012975969,0.00023633448,0.00024166376,0.00024502652,0.0014579354],"category_scores_gemma":[0.00007940799,0.00014013734,0.00026238413,0.00027541432,0.00015550609,0.00019110322,0.00012388823,0.00042511613,0.0003049399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060864456,0.000100615835,0.0009706894,0.00011722922,0.00001775042,0.00010566715,0.0000115763,0.00025337428,0.99504167,0.00019146007,0.00013797995,0.0024434053],"study_design_scores_gemma":[0.00009393373,0.000953584,0.009618924,0.000012545549,0.000028916344,0.0004998283,0.000027498938,0.0022730133,0.98165166,0.00010117234,0.0047339206,0.000004928036],"about_ca_topic_score_codex":0.0011064374,"about_ca_topic_score_gemma":0.0015891327,"teacher_disagreement_score":0.0014579354,"about_ca_system_score_codex":0.0005271419,"about_ca_system_score_gemma":0.00030048398,"threshold_uncertainty_score":0.0048772693},"labels":[],"label_agreement":null},{"id":"W4388589166","doi":"10.1093/neuonc/noad179.0138","title":"STEM-12. TARGETING GLIOBLASTOMA WITH A BRAIN PENETRANT DRUG THAT IMPAIRS BRAIN TUMOUR STEM CELLS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Stem cell; Cancer research; Biology; DNA repair; Neural stem cell; Cell cycle; Cancer stem cell; Notch signaling pathway; Transcriptome; Cell; Signal transduction; Gene; Cell biology; Gene expression; Genetics","score_opus":0.014192328949022637,"score_gpt":0.256676528824476,"score_spread":0.24248419987545336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920589,0.0014615112,0.0023870694,0.00018083012,0.00006746786,0.00011318218,0.001065779,0.00020225646,0.0024630732],"genre_scores_gemma":[0.9938916,0.0009563435,0.0015809599,0.00007516881,0.00000854854,0.00006322054,0.00084374286,0.000016287198,0.0025641732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990094,0.000011167827,0.00001381188,0.000021200514,0.000031039766,0.000021839536],"domain_scores_gemma":[0.9999448,0.0000058446885,0.000020386644,0.000006688116,0.00000670614,0.000015603579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001043642,0.00042085597,0.0002887149,0.0003651132,0.00013307987,0.00023966856,0.00020309693,0.00032887948,0.0014651715],"category_scores_gemma":[0.000060237428,0.00011248697,0.00020764538,0.00021824999,0.00019900354,0.0001320955,0.00014643981,0.00046179138,0.00033398395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020123334,0.00013680209,0.00016962038,0.00005781074,0.000009213867,0.000065317756,0.000011148472,0.00013518764,0.9953884,0.00020810011,0.00012828883,0.0034887372],"study_design_scores_gemma":[0.00003786482,0.00090656785,0.0015394121,0.0000053982662,0.00001789266,0.00019419288,0.000012246172,0.0005294897,0.99363834,0.000048364396,0.0030668152,0.0000032974715],"about_ca_topic_score_codex":0.0008669172,"about_ca_topic_score_gemma":0.001503759,"teacher_disagreement_score":0.0014651715,"about_ca_system_score_codex":0.00024210839,"about_ca_system_score_gemma":0.00027687155,"threshold_uncertainty_score":0.0049014688},"labels":[],"label_agreement":null},{"id":"W4388589183","doi":"10.1093/neuonc/noad179.1119","title":"TMIC-53. TRANSGLUTAMINASE 2 EXPRESSION IN GLIOBLASTOMA: EVIDENCE FOR A ROLE IN EFFEROCYTOSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; St. Michael's Hospital; Ottawa Hospital","funders":"","keywords":"Efferocytosis; Phagocytosis; Biology; CD68; Cancer research; Glioma; Cancer cell; Immunohistochemistry; Macrophage; Microglia; Cancer; Apoptosis; Immunology; Inflammation; In vitro","score_opus":0.05354532237780473,"score_gpt":0.3367665591048757,"score_spread":0.28322123672707095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919208,0.005620535,0.00066040974,0.000098834185,0.000021475818,0.000016379641,0.00032904005,0.000028437464,0.0013039651],"genre_scores_gemma":[0.9977701,0.0010206721,0.00034329234,0.000042916003,0.000010861031,0.0000133357735,0.00036879026,0.0000035174091,0.0004264811],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991906,0.000010987906,0.000008682836,0.000015033818,0.000017659313,0.000028527922],"domain_scores_gemma":[0.9999012,0.000009031324,0.000041063566,0.000007147963,0.00001846712,0.000023061128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015578615,0.00016977363,0.00018132194,0.00055082527,0.00013249477,0.0002133954,0.00010847086,0.00025718685,0.0010095105],"category_scores_gemma":[0.0001739993,0.000082403516,0.00013709058,0.00033469664,0.0002430437,0.00008888382,0.0001236879,0.00018381717,0.00024550522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007667292,0.000039112358,0.022150105,0.00013952068,0.000032090946,0.0011795433,0.000042603213,0.00006246079,0.9704011,0.00010693667,0.000221661,0.0048581976],"study_design_scores_gemma":[0.00008586421,0.0011404816,0.5773846,0.000070138034,0.00020429044,0.0108332895,0.00030130814,0.0013681588,0.40134466,0.00043788392,0.0068140505,0.0000152193315],"about_ca_topic_score_codex":0.001089281,"about_ca_topic_score_gemma":0.0006858243,"teacher_disagreement_score":0.001089281,"about_ca_system_score_codex":0.0002882289,"about_ca_system_score_gemma":0.00014836776,"threshold_uncertainty_score":0.0033771992},"labels":[],"label_agreement":null},{"id":"W4388589198","doi":"10.1093/neuonc/noad179.1057","title":"TMET-13. DNA DAMAGE SIGNALING ACTIVATES GTP SYNTHESIS TO PROMOTE GLIOBLASTOMA TREATMENT RESISTANCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"DNA damage; Cancer research; DNA repair; Pharmacology; Signal transduction; DNA synthesis; Medicine; Biology; In vitro; DNA; Biochemistry","score_opus":0.015232352303123552,"score_gpt":0.2747155993197101,"score_spread":0.2594832470165866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930059,0.0014940505,0.001141257,0.00046160578,0.000102660444,0.000090531365,0.00081792445,0.00017659579,0.0027095252],"genre_scores_gemma":[0.99675995,0.000528417,0.00044095286,0.000093165174,0.000006863855,0.000042868585,0.0003963772,0.000010418081,0.0017208592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999082,0.000016291884,0.0000051446777,0.0000121089015,0.000019109257,0.000039195744],"domain_scores_gemma":[0.99994576,0.000010011789,0.000011578897,0.0000053989306,0.0000062085096,0.000021093245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012622892,0.00026746062,0.0003180238,0.0002909512,0.0001612022,0.00038402365,0.00014243783,0.0003039945,0.0031996015],"category_scores_gemma":[0.00009630883,0.000116079726,0.00023629772,0.00020148078,0.00017612505,0.00016278669,0.0001448012,0.00094078964,0.00046271557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00176312,0.00074981316,0.0012385475,0.00011225722,0.000035635807,0.00013673362,0.000038984464,0.0008298685,0.9801051,0.00057764514,0.001157332,0.013254901],"study_design_scores_gemma":[0.00037729563,0.0055843038,0.013537239,0.000030006893,0.000058519756,0.00046830205,0.000073742754,0.004097883,0.96392107,0.00027706052,0.011561967,0.000012615152],"about_ca_topic_score_codex":0.0011373926,"about_ca_topic_score_gemma":0.0024428256,"teacher_disagreement_score":0.0031996015,"about_ca_system_score_codex":0.0004713397,"about_ca_system_score_gemma":0.0003605165,"threshold_uncertainty_score":0.0107037425},"labels":[],"label_agreement":null},{"id":"W4388589200","doi":"10.1093/neuonc/noad179.1070","title":"TMIC-04. IMMUNE PROFILING OF PEDIATRIC ONCOHISTONE GLIOMAS REVEALS DIVERSE MYELOID POPULATIONS AND TUMOR-PROMOTING BEHAVIORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Jewish General Hospital; Centre Hospitalier Universitaire Sainte-Justine; Université Laval; McGill University","funders":"","keywords":"Myeloid; Immune system; Cancer research; Mass cytometry; Biology; Tumor microenvironment; Glioma; Histone H3; Epigenome; Immunology; Epigenetics; Phenotype; DNA methylation; Genetics","score_opus":0.04512539116291482,"score_gpt":0.3351938413008249,"score_spread":0.2900684501379101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964663,0.00019354063,0.001402837,0.000014106718,0.0000019872223,0.000022532195,0.0009191904,0.00005354043,0.00092597125],"genre_scores_gemma":[0.9931942,0.00021479932,0.00281934,0.000029678327,0.0000025259435,0.000035987025,0.0025454166,0.000023729237,0.0011344055],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999217,0.000007256094,0.000004920467,0.00002273934,0.000018961526,0.000024465646],"domain_scores_gemma":[0.9999267,0.000007958483,0.000021521564,0.0000064463115,0.00001314245,0.000024158007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009792286,0.00015481398,0.000108684864,0.00030312134,0.000114588554,0.00018259246,0.00009747744,0.00017562481,0.0010687873],"category_scores_gemma":[0.00006296157,0.000080595644,0.0000877029,0.0002273835,0.00010840789,0.00007291564,0.00009600963,0.00022084608,0.00025830176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034827768,0.000044470682,0.013630851,0.000030463745,0.000006188058,0.00018621038,0.000045251105,0.00011395227,0.9816559,0.000060620165,0.00012521811,0.0037526188],"study_design_scores_gemma":[0.000016795415,0.0010240248,0.2766706,0.000009374339,0.000036115613,0.0033672443,0.00019927471,0.0021687313,0.7130062,0.00007025238,0.0034246738,0.0000066495954],"about_ca_topic_score_codex":0.00072235265,"about_ca_topic_score_gemma":0.0010644236,"teacher_disagreement_score":0.0010687873,"about_ca_system_score_codex":0.00015657618,"about_ca_system_score_gemma":0.00009734247,"threshold_uncertainty_score":0.0035755038},"labels":[],"label_agreement":null},{"id":"W4388589205","doi":"10.1093/neuonc/noad179.1083","title":"TMIC-17. THE ROLE OF ICAM1 IN GLIOBLASTOMA TUMORIGENESIS UNDER HYPOXIC CONDITIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; The Scarborough Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Tumor microenvironment; Biology; Carcinogenesis; Cancer","score_opus":0.013335124329389958,"score_gpt":0.27282350821881635,"score_spread":0.2594883838894264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832508,0.00844874,0.0012208783,0.00046149493,0.00011059022,0.000057828456,0.001711533,0.00013617742,0.0046018837],"genre_scores_gemma":[0.9899914,0.003415276,0.00066544686,0.00020924723,0.000031485793,0.000056034507,0.0021933932,0.000018498002,0.0034192062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999254,0.000006214461,0.0000035487665,0.00001134169,0.000015845017,0.000037616748],"domain_scores_gemma":[0.99993956,0.0000027907843,0.000021864555,0.0000031381642,0.000005962918,0.000026687321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008357387,0.00030416407,0.00020497094,0.00028513628,0.00020192831,0.00032566892,0.0001182322,0.00019457367,0.0025285508],"category_scores_gemma":[0.000052111445,0.00009321675,0.00019653575,0.0002555538,0.00016526389,0.00010142672,0.00016209093,0.00049571216,0.0005776368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005685468,0.00012227542,0.0032533724,0.00020577629,0.000017120286,0.0002233067,0.000027075195,0.00014680358,0.9849914,0.0004186951,0.0006426092,0.009383135],"study_design_scores_gemma":[0.0001295658,0.0023509436,0.13622916,0.00011128187,0.00016203265,0.001906392,0.0002667999,0.00214147,0.82878804,0.0007877063,0.027111776,0.000014897999],"about_ca_topic_score_codex":0.00052989676,"about_ca_topic_score_gemma":0.0005626329,"teacher_disagreement_score":0.0025285508,"about_ca_system_score_codex":0.0003003379,"about_ca_system_score_gemma":0.0003810986,"threshold_uncertainty_score":0.008458853},"labels":[],"label_agreement":null},{"id":"W4388589206","doi":"10.1093/neuonc/noad179.1190","title":"MODL-39. ELUCIDATING THE TRANSCRIPTOMIC LANDSCAPE OF METASTATIC PEDIATRIC MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medulloblastoma; Transcriptome; Biology; Wnt signaling pathway; Epigenetics; Gene; Disease; Cancer research; Bioinformatics; Computational biology; Genetics; Gene expression; Medicine; Internal medicine","score_opus":0.028529829108366857,"score_gpt":0.303704263540375,"score_spread":0.2751744344320081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96836364,0.004485084,0.004581595,0.0002492475,0.000055829274,0.000084825006,0.02000649,0.0001899087,0.0019833522],"genre_scores_gemma":[0.96034247,0.0027568848,0.0077423486,0.00021533563,0.00003098239,0.00015806226,0.02507373,0.00010580199,0.003574383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998716,0.000007146055,0.000005449502,0.000042677984,0.000040644616,0.000032367872],"domain_scores_gemma":[0.99993193,0.000011001468,0.000024015486,0.0000061154365,0.000010982472,0.000016044516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013972638,0.00024245073,0.00029634844,0.00045763885,0.00023996581,0.00040072968,0.00013418208,0.00016194726,0.0016366395],"category_scores_gemma":[0.000116330375,0.00012000698,0.00023724588,0.00045445774,0.00017156941,0.00014563202,0.00019030551,0.00038063675,0.0005714311],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039328114,0.000033579454,0.0070548356,0.00016201063,0.000020297432,0.00017779409,0.000057121335,0.00026186506,0.98388404,0.00017380707,0.00041357137,0.007367818],"study_design_scores_gemma":[0.000083135965,0.0011608654,0.29546288,0.00008979186,0.00020076998,0.0023338874,0.00068202213,0.0077855885,0.637244,0.00079479255,0.05413198,0.000030341089],"about_ca_topic_score_codex":0.0008538797,"about_ca_topic_score_gemma":0.0016375427,"teacher_disagreement_score":0.0016366395,"about_ca_system_score_codex":0.00040019196,"about_ca_system_score_gemma":0.00035445884,"threshold_uncertainty_score":0.0054751635},"labels":[],"label_agreement":null},{"id":"W4388589215","doi":"10.1093/neuonc/noad179.0267","title":"CTIM-27. PERIPHERAL BIOMARKER ANALYSIS OF T CELL-MEDIATED COLLAGEN REMODELING CORRELATES WITH TUMOR RESPONSES IN A PHASE IIA TRIAL OF VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Variation Biotechnologies (Canada)","funders":"","keywords":"Medicine; CD8; Biomarker; Immune system; Antigen; T cell; Granzyme B; Immunotherapy; Immunology; ELISPOT; Nivolumab; Internal medicine; Chemistry","score_opus":0.0409655345464307,"score_gpt":0.3630091074634387,"score_spread":0.32204357291700797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983498,0.00046117717,0.0001529544,0.000053632117,0.00002649054,0.00017843665,0.00023388022,0.00001870509,0.0005249824],"genre_scores_gemma":[0.9980433,0.00012233936,0.00023526653,0.000096166594,0.000017812423,0.00017879726,0.00063161243,0.000005052849,0.00066954154],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99979883,0.000067448185,0.000011133618,0.000040315386,0.000024077688,0.000058219768],"domain_scores_gemma":[0.99974614,0.00003804166,0.000053339918,0.00002151706,0.000020742546,0.00012011765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072163536,0.0004373638,0.0005729164,0.00015899207,0.00016691152,0.00047099002,0.00021779991,0.0003874763,0.0011768725],"category_scores_gemma":[0.00039810114,0.00020438252,0.00023801829,0.00013321076,0.0002717548,0.00020700648,0.0001237122,0.0009758794,0.00038614072],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32621643,0.02365375,0.068448894,0.0004441732,0.00051629473,0.00038990407,0.00027626503,0.0028916756,0.46606195,0.00026956567,0.0042623547,0.10656872],"study_design_scores_gemma":[0.046172358,0.63135237,0.21643206,0.000054669734,0.00049036817,0.0012763881,0.00011957286,0.0052590063,0.0920227,0.00019197664,0.0065832315,0.00004530629],"about_ca_topic_score_codex":0.00033372708,"about_ca_topic_score_gemma":0.0006012279,"teacher_disagreement_score":0.0011768725,"about_ca_system_score_codex":0.0003936512,"about_ca_system_score_gemma":0.00040866673,"threshold_uncertainty_score":0.003937006},"labels":[],"label_agreement":null},{"id":"W4388589244","doi":"10.1093/neuonc/noad179.0780","title":"NIMG-85. EVALUATING THE PERFORMANCE OF A DEEP LEARNING GLIOMA SEGMENTATION MODEL USING COMBINED PRE- AND POST-TREATMENT MRI TRAINING DATA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Computer science; Segmentation; Convolutional neural network; Workflow; Magnetic resonance imaging; Artificial intelligence; Glioma; Dice; Deep learning; Pattern recognition (psychology); Machine learning; Medicine; Radiology","score_opus":0.07624121402978769,"score_gpt":0.3977261482719263,"score_spread":0.32148493424213864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082156,0.0062677055,0.035877343,0.0021358537,0.0009492123,0.00084351125,0.016346646,0.02074362,0.008620545],"genre_scores_gemma":[0.9159527,0.0007126445,0.03984056,0.0010723689,0.00010892787,0.00047157783,0.036195867,0.0005705129,0.0050747455],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991124,0.0002942845,0.000053411546,0.00027772473,0.00014168135,0.000120408295],"domain_scores_gemma":[0.9985228,0.0006425727,0.00012414165,0.00019010424,0.00036356135,0.00015689683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004455817,0.0024199926,0.0010349262,0.001227612,0.00053046853,0.001011898,0.0020846564,0.002948151,0.0019529131],"category_scores_gemma":[0.005637197,0.0007633905,0.0018205695,0.00084379496,0.0006786987,0.0007725091,0.0009189091,0.0015009214,0.001541984],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002142003,0.0011921378,0.021093335,0.00061225094,0.0013871903,0.00039193357,0.00011949287,0.77790076,0.0069039217,0.00061903795,0.029482178,0.15815571],"study_design_scores_gemma":[0.00013027732,0.0005816522,0.0044934256,0.000050099465,0.00012722425,0.00006922322,0.000032498527,0.9872951,0.005031757,0.0004178889,0.0017409914,0.000029756728],"about_ca_topic_score_codex":0.047687482,"about_ca_topic_score_gemma":0.03377549,"teacher_disagreement_score":0.047687482,"about_ca_system_score_codex":0.002498908,"about_ca_system_score_gemma":0.0024011768,"threshold_uncertainty_score":0.094819784},"labels":[],"label_agreement":null},{"id":"W4388589279","doi":"10.1093/neuonc/noad179.0997","title":"RTID-06. THE PIVOTAL METIS (EF-25) STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) FOLLOWING RADIOSURGERY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Oncology; Clinical endpoint; Lung cancer; Neurocognitive; Internal medicine; Radiation therapy; Clinical trial; Cognition","score_opus":0.031133857206822626,"score_gpt":0.3257966754217294,"score_spread":0.2946628182149068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91168827,0.014956111,0.0019463799,0.005539134,0.0016911144,0.019806422,0.01931692,0.00029873953,0.024756942],"genre_scores_gemma":[0.92674905,0.0068872757,0.0047572786,0.0063929455,0.0010815503,0.018989393,0.015635675,0.00011748298,0.019389238],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924684,0.0004471056,0.000043176224,0.00010378874,0.000056687106,0.00010243371],"domain_scores_gemma":[0.9990043,0.00018003334,0.00026893048,0.000056976332,0.00008549973,0.00040426422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00310138,0.0019354259,0.0016657051,0.0002581469,0.00043027478,0.0013385824,0.0009916967,0.002095835,0.008994788],"category_scores_gemma":[0.002080926,0.00049790594,0.0017775326,0.00036694322,0.0006644153,0.0007317851,0.00034550903,0.003353479,0.0022263306],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8872681,0.014332226,0.0033459112,0.0022899369,0.0012941111,0.00015864304,0.0001444442,0.0014737244,0.0170214,0.0011749432,0.02087291,0.050623544],"study_design_scores_gemma":[0.7602382,0.21347709,0.006504599,0.00020680118,0.00080307404,0.00025474562,0.000044863325,0.0007671266,0.0023828677,0.00060508226,0.014671524,0.000044054075],"about_ca_topic_score_codex":0.0008784462,"about_ca_topic_score_gemma":0.0032724722,"teacher_disagreement_score":0.008994788,"about_ca_system_score_codex":0.001075261,"about_ca_system_score_gemma":0.0019772658,"threshold_uncertainty_score":0.03009057},"labels":[],"label_agreement":null},{"id":"W4388589457","doi":"10.1093/neuonc/noad179.0158","title":"CSIG-02. SHH PATHWAY ACTIVATION DRIVES NEURAL CREST CELL SIGNATURE IN A SUBGROUP OF MPNSTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McMaster University; University of Toronto","funders":"","keywords":"Neural crest; Cancer research; Biology; Neurofibroma; Neural stem cell; Neurofibromatosis; Cell biology; Pathology; Medicine; Stem cell; Genetics","score_opus":0.02427417512274905,"score_gpt":0.31639231195074036,"score_spread":0.2921181368279913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970772,0.00016953898,0.0003602837,0.000043809196,0.000008411646,0.000024717781,0.00090278574,0.00005675249,0.0013565245],"genre_scores_gemma":[0.99434,0.0001327666,0.0006266661,0.00004406477,0.0000042645734,0.00003790479,0.0021150212,0.00001787946,0.0026815291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998778,0.000010011385,0.000011241727,0.00003200162,0.00004200953,0.000026956908],"domain_scores_gemma":[0.99989593,0.000011640876,0.000020782229,0.000015335097,0.0000092816335,0.00004701054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007014776,0.00019182617,0.00021888077,0.0002856293,0.00018671186,0.0002325766,0.0001223951,0.00024929884,0.001829602],"category_scores_gemma":[0.00009875161,0.00012047605,0.0002009645,0.00023649474,0.00021090014,0.000068468944,0.0001324335,0.00042174937,0.0007223568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107981905,0.000032619235,0.0023927414,0.000012292169,0.000004364763,0.00024696146,0.000013669452,0.000048126887,0.9958839,0.000039155628,0.000104371094,0.001113741],"study_design_scores_gemma":[0.00005768347,0.0011983435,0.1333538,0.0000074996924,0.00003471257,0.0063509154,0.00012708864,0.0018667687,0.85098195,0.000117426076,0.00589167,0.000012164545],"about_ca_topic_score_codex":0.0013673062,"about_ca_topic_score_gemma":0.0020807944,"teacher_disagreement_score":0.001829602,"about_ca_system_score_codex":0.00023469793,"about_ca_system_score_gemma":0.00020225532,"threshold_uncertainty_score":0.006120622},"labels":[],"label_agreement":null},{"id":"W4388589461","doi":"10.1093/neuonc/noad179.0319","title":"CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACCORDING TO PRIOR MAPK INHIBITOR TREATMENT IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Phases of clinical research; Glioma; Internal medicine; Surgery; Oncology; Cancer research; Clinical trial","score_opus":0.07453843266915541,"score_gpt":0.40596120970024585,"score_spread":0.33142277703109047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609006,0.0063882084,0.00028841262,0.0004135672,0.00015435128,0.00077253545,0.0026975414,0.0000662972,0.0031291267],"genre_scores_gemma":[0.9900358,0.0020812624,0.0005577992,0.00039131317,0.00013557849,0.00065815094,0.0038678118,0.000019989533,0.002252361],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99919707,0.00041724704,0.000044059794,0.00011815619,0.00008449365,0.00013903147],"domain_scores_gemma":[0.9994167,0.00007678593,0.00013651105,0.000051060877,0.00003018001,0.00028875066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016748866,0.0010108275,0.001280415,0.00033980937,0.0002479647,0.0009347377,0.000745398,0.000757482,0.0033693577],"category_scores_gemma":[0.00096451136,0.00034497882,0.001259789,0.00041061032,0.00048450168,0.00043532773,0.0003205399,0.0014859133,0.00070265634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8188851,0.01368917,0.037178826,0.00096005923,0.002566689,0.00028581553,0.00015755814,0.0019827762,0.023852047,0.00032855716,0.007002264,0.09311117],"study_design_scores_gemma":[0.48808366,0.3574777,0.12695065,0.00017691727,0.0032242655,0.0006790372,0.0001194334,0.0023644646,0.007739377,0.00041358752,0.012675878,0.000095078234],"about_ca_topic_score_codex":0.0015478712,"about_ca_topic_score_gemma":0.00753223,"teacher_disagreement_score":0.0033693577,"about_ca_system_score_codex":0.0011480155,"about_ca_system_score_gemma":0.0016889184,"threshold_uncertainty_score":0.011271656},"labels":[],"label_agreement":null},{"id":"W4388589463","doi":"10.1093/neuonc/noad179.0133","title":"STEM-06. OSMR INTERACTOME MAPPING REVEALS THE SIGNIFICANCE OF A CHLORIDE CHANNEL IN CYTOKINE REGULATION AND BRAIN TUMOUR STEM CELL SELF-RENEWAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; University of Ottawa","funders":"","keywords":"Biology; Cell biology; Signal transduction; Interactome; Cancer research; Biochemistry; Gene","score_opus":0.036617784045119,"score_gpt":0.29122844744130055,"score_spread":0.25461066339618155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826947,0.00094108854,0.008854886,0.0001566173,0.000018271283,0.000043686683,0.004684747,0.00041719992,0.0021887915],"genre_scores_gemma":[0.97360027,0.0005746358,0.011388424,0.000105491454,0.0000061142423,0.00005535748,0.009979705,0.00005823764,0.0042317323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000008222207,0.0000064860897,0.000025208827,0.000044245317,0.000022959948],"domain_scores_gemma":[0.99991846,0.00001602109,0.000025261672,0.0000074515574,0.000011847351,0.000020946056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011260609,0.00020607223,0.00031809023,0.00065242936,0.00024039429,0.0003768742,0.00016451252,0.00020903052,0.0027491695],"category_scores_gemma":[0.00011089305,0.000093910974,0.00032195088,0.00041983576,0.00013202397,0.00013994252,0.00027030928,0.0002138598,0.0008668904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006267545,0.000008529303,0.00096712285,0.000037916274,0.0000066105436,0.000077953475,0.000011578643,0.000060447943,0.99710315,0.00008345444,0.000077660385,0.0015028369],"study_design_scores_gemma":[0.000015719688,0.00018617854,0.05063203,0.00001217061,0.000049839524,0.0011896471,0.00011577609,0.0048172,0.93467313,0.0002101749,0.008088026,0.0000102268405],"about_ca_topic_score_codex":0.0006694637,"about_ca_topic_score_gemma":0.0013596779,"teacher_disagreement_score":0.0027491695,"about_ca_system_score_codex":0.00022405441,"about_ca_system_score_gemma":0.00016403523,"threshold_uncertainty_score":0.0091968775},"labels":[],"label_agreement":null},{"id":"W4388589468","doi":"10.1093/neuonc/noad179.0377","title":"DNAR-11. NUCLEAR POTASSIUM GOVERNS NUCLEAR ENVELOPE INTEGRITY AND GENOMIC STRUCTURE IN MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Potassium channel; Cell biology; Nuclear pore; Cytosol; Nuclear localization sequence; Biology; Potassium; Cell nucleus; Chemistry; Biophysics; Nucleus; Biochemistry","score_opus":0.011813585789159382,"score_gpt":0.24613790240063863,"score_spread":0.23432431661147923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482745,0.0010562517,0.0028021322,0.00008610867,0.000012752333,0.000010921075,0.0002550406,0.00009972333,0.000849442],"genre_scores_gemma":[0.9985813,0.00017402515,0.00048468044,0.000014205636,0.0000012248939,0.0000039293764,0.00009536546,0.000008297193,0.0006370081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999913,0.000010421327,0.000007566241,0.000022182036,0.000028432334,0.000018392253],"domain_scores_gemma":[0.99989116,0.0000069444386,0.000057706395,0.000007983903,0.000010103607,0.000026051594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010402905,0.0001537385,0.00014558842,0.00016231442,0.00013222505,0.00022472406,0.00012729563,0.00017600064,0.00087868643],"category_scores_gemma":[0.00010438957,0.00008732911,0.00012724381,0.00007625256,0.00025877086,0.00017933533,0.0001681673,0.00027650673,0.00026759377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005120625,0.00000457105,0.00059786526,0.000020152691,0.0000020401205,0.00003984814,0.000010004803,0.000051518364,0.99857557,0.000096839336,0.000016500402,0.0005338911],"study_design_scores_gemma":[0.000012315308,0.00018197192,0.027356114,0.000008904218,0.00001784263,0.0005863555,0.00008836286,0.0016663502,0.96756905,0.00016014934,0.0023459916,0.0000064342544],"about_ca_topic_score_codex":0.0011506749,"about_ca_topic_score_gemma":0.0018919333,"teacher_disagreement_score":0.0011506749,"about_ca_system_score_codex":0.0005046086,"about_ca_system_score_gemma":0.00018397077,"threshold_uncertainty_score":0.0036612153},"labels":[],"label_agreement":null},{"id":"W4388589481","doi":"10.1093/neuonc/noad179.0105","title":"CNSC-21. INVESTIGATING THE EVOLUTION OF NEURON-GLIOMA CIRCUIT DYNAMICS USING AN IN VIVO IMAGING METHOD","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Neuroscience; Neuron; Biological neural network; Calcium imaging; Premovement neuronal activity; Biology; Synaptogenesis; In vivo; Calcium; Medicine; Cancer research; Internal medicine","score_opus":0.0497082504688876,"score_gpt":0.3465323853873724,"score_spread":0.2968241349184848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8602008,0.0021089183,0.12313303,0.00031673865,0.00019272589,0.0002502619,0.002268021,0.0011139337,0.010415593],"genre_scores_gemma":[0.78483313,0.0015960177,0.19807664,0.00024805707,0.00003408546,0.00077168626,0.002063722,0.00032730485,0.012049299],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986696,0.000012108218,0.000007240124,0.000050030707,0.00004128929,0.000022375712],"domain_scores_gemma":[0.9998091,0.000026154352,0.000051893792,0.00002045316,0.00005669034,0.000035746103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027802805,0.00043802473,0.00024329132,0.00048002377,0.00028839684,0.00034165362,0.00046858753,0.0006070336,0.0020120698],"category_scores_gemma":[0.00022802808,0.00022782314,0.00025154004,0.00034976722,0.00026002573,0.00028743665,0.0002714293,0.0005055681,0.0005254078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030098761,0.000014504414,0.0003350053,0.00003569343,0.000004179084,0.000048398007,0.000019528212,0.00016560857,0.9963755,0.00018319646,0.00014256596,0.0026457398],"study_design_scores_gemma":[0.000016415761,0.00017405175,0.009085019,0.000013320234,0.000030156685,0.0004291359,0.000038865648,0.015227252,0.9687921,0.00014625098,0.006027839,0.000019688134],"about_ca_topic_score_codex":0.0038831998,"about_ca_topic_score_gemma":0.006588152,"teacher_disagreement_score":0.0038831998,"about_ca_system_score_codex":0.0006189939,"about_ca_system_score_gemma":0.0004827381,"threshold_uncertainty_score":0.0077212453},"labels":[],"label_agreement":null},{"id":"W4388589483","doi":"10.1093/neuonc/noad179.0187","title":"CSIG-31. JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TO DRIVE CIC- REARRANGED SARCOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Barrie Urology Group; University of Toronto","funders":"","keywords":"STAT1; Cancer research; STAT protein; Transcription factor; JAK-STAT signaling pathway; Janus kinase 1; Fusion protein; Effector; STAT3; Janus kinase; Signal transduction; STAT4; PIM1; Biology; stat; Gene; Cell biology; Phosphorylation; Receptor tyrosine kinase; Genetics","score_opus":0.017080852392914566,"score_gpt":0.28663714626804526,"score_spread":0.2695562938751307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946331,0.0006904081,0.0008209777,0.0001403776,0.00004156477,0.00008184327,0.0012360264,0.00013852584,0.002217167],"genre_scores_gemma":[0.9960598,0.00017482291,0.00079235656,0.000040410978,0.0000037029633,0.00004153002,0.0012126472,0.000010798495,0.0016640304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997973,0.000030944044,0.00002248976,0.000033562992,0.000064369415,0.000051282786],"domain_scores_gemma":[0.99991226,0.000018387786,0.000018026492,0.000016803548,0.000006753942,0.000027720333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014794916,0.0002273835,0.00022997678,0.00023028572,0.00017311492,0.00030330953,0.00018956914,0.0002715634,0.002136698],"category_scores_gemma":[0.000098293145,0.00011563319,0.0002066984,0.00023290701,0.0002044147,0.00009420894,0.00015378394,0.00054901955,0.0007711282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014450512,0.00010153155,0.0005096204,0.000032359494,0.000005708593,0.00010258525,0.000014515892,0.00017828165,0.9974227,0.00014791447,0.00020028176,0.0011400311],"study_design_scores_gemma":[0.00005511177,0.00048755758,0.0059039583,0.000004885941,0.000015700862,0.00064395694,0.000030145211,0.002134625,0.9862635,0.000041297284,0.004415152,0.0000040598698],"about_ca_topic_score_codex":0.0010544795,"about_ca_topic_score_gemma":0.0019928813,"teacher_disagreement_score":0.002136698,"about_ca_system_score_codex":0.00041886675,"about_ca_system_score_gemma":0.00029539867,"threshold_uncertainty_score":0.0071480274},"labels":[],"label_agreement":null},{"id":"W4388589484","doi":"10.1093/neuonc/noad179.0965","title":"QOL-13. MEASURING FEAR OF CANCER RECURRENCE IN PATIENTS WITH PRIMARY BRAIN TUMORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Discriminant validity; Exploratory factor analysis; Clinical psychology; Distress; Coping (psychology); Anxiety; Psychology; Medicine; Cronbach's alpha; Brain tumor; Internal medicine; Psychiatry; Psychometrics","score_opus":0.02496247449658845,"score_gpt":0.3009778744280461,"score_spread":0.27601539993145763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042106,0.00082584244,0.0005353572,0.00026554725,0.00003032846,0.0003517433,0.0030193632,0.00003364317,0.0045170384],"genre_scores_gemma":[0.9941863,0.00044370515,0.0018653162,0.000110015724,0.000016837397,0.0003735285,0.0022632726,0.0000067820843,0.00073415093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999012,0.00030119478,0.000205924,0.00007751761,0.00024535443,0.00015801907],"domain_scores_gemma":[0.9965622,0.0008825611,0.0015840088,0.00010061853,0.00054177357,0.00032899267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020038625,0.0005260532,0.0005894905,0.0011907314,0.00032443585,0.00065453816,0.00048177136,0.00034662633,0.0035960348],"category_scores_gemma":[0.0056028324,0.0001531458,0.0015553131,0.0009925038,0.0003804316,0.0004802528,0.0010037548,0.0008001507,0.00042086336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000472434,0.00045854112,0.9311141,0.00048499447,0.0007535743,0.00014593595,0.00076316355,0.00083772925,0.00050328724,0.00028884242,0.0031974672,0.060979776],"study_design_scores_gemma":[0.000043903387,0.00055017974,0.9948708,0.00007774558,0.00010477287,0.00035195187,0.000558713,0.0006932099,0.00022589132,0.00023160416,0.0022680452,0.000023241386],"about_ca_topic_score_codex":0.0016893181,"about_ca_topic_score_gemma":0.0030588575,"teacher_disagreement_score":0.0035960348,"about_ca_system_score_codex":0.0008816948,"about_ca_system_score_gemma":0.0007104997,"threshold_uncertainty_score":0.012029946},"labels":[],"label_agreement":null},{"id":"W4388589496","doi":"10.1093/neuonc/noad179.0306","title":"CTNI-24. CLINICAL ACTIVITY AND SAFETY OF THE RAF INHIBITOR TOVORAFENIB IN PATIENTS WITH OPTIC PATHWAY GLIOMAS IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Glioma; Internal medicine; Progressive disease; Phases of clinical research; Oncology; Gastroenterology; Surgery; Disease; Cancer research; Chemotherapy","score_opus":0.031141463253088645,"score_gpt":0.34197814888971584,"score_spread":0.3108366856366272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908517,0.004778784,0.00019672462,0.0002844421,0.00007385255,0.00041219703,0.0014892726,0.00005733646,0.001855628],"genre_scores_gemma":[0.99397874,0.0016420695,0.0003676816,0.00019159766,0.00004524981,0.0003082153,0.0020907365,0.00001200953,0.0013636474],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997017,0.00014570045,0.0000143411025,0.00004101108,0.00003762272,0.000059586375],"domain_scores_gemma":[0.99964404,0.000038040314,0.00009561419,0.0000208497,0.000024468,0.00017701754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007930388,0.0006584727,0.0007597289,0.00021519078,0.00018550642,0.0007294769,0.00049188593,0.00046073718,0.0020513057],"category_scores_gemma":[0.00055662927,0.00020659456,0.0007394531,0.0002516288,0.00030691858,0.00032367586,0.00017816781,0.0011776777,0.000449493],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6380365,0.017277287,0.04580101,0.002019388,0.0029024633,0.00078210834,0.00031142373,0.004093828,0.07547766,0.00054532755,0.013305,0.19944805],"study_design_scores_gemma":[0.40824115,0.40132976,0.1405927,0.00019980993,0.002174919,0.0020079801,0.00022538604,0.0041809524,0.022624316,0.00047706396,0.017840505,0.00010534868],"about_ca_topic_score_codex":0.0012977837,"about_ca_topic_score_gemma":0.0063976985,"teacher_disagreement_score":0.0020513057,"about_ca_system_score_codex":0.00085193326,"about_ca_system_score_gemma":0.0011535321,"threshold_uncertainty_score":0.0068622828},"labels":[],"label_agreement":null},{"id":"W4388589521","doi":"10.1093/neuonc/noad179.0127","title":"CNSC-44. BIOLOGICAL PATTERN DISCOVERY IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; Ontario Brain Institute; SickKids Foundation; Centre for Global Health Research; University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Phenotype; Pixel; Computational biology; Biology; Computer science; Gene; Pattern recognition (psychology); Neuroscience; Artificial intelligence; Genetics; Cancer research","score_opus":0.015157873181392308,"score_gpt":0.295798267752786,"score_spread":0.28064039457139367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5526719,0.01001231,0.043829672,0.0021067273,0.0011914223,0.001388747,0.3006725,0.05878878,0.02933795],"genre_scores_gemma":[0.38376188,0.0017949289,0.10789211,0.0006335814,0.00016590623,0.0008740076,0.49006778,0.0015675692,0.013242205],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990357,0.00012093692,0.000054455828,0.00023464052,0.00041965485,0.00013463329],"domain_scores_gemma":[0.99941313,0.0000926673,0.00006568953,0.00008882624,0.00024916307,0.0000906627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085847225,0.0010162053,0.00080983003,0.0026036534,0.0005099132,0.0008958209,0.0010685775,0.0008176784,0.0050250585],"category_scores_gemma":[0.0017763189,0.00025134467,0.0010794979,0.0015487353,0.00029269952,0.0003152502,0.00084288366,0.0004238856,0.0036738124],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020407422,0.00093298795,0.040711887,0.0028122254,0.0006894442,0.0009778758,0.00017375183,0.042876106,0.0924813,0.003926067,0.42748132,0.38489628],"study_design_scores_gemma":[0.00066959916,0.0010629903,0.0950724,0.00026953698,0.0003402177,0.0011836673,0.00031187682,0.5869756,0.094131924,0.005765486,0.21407147,0.00014528558],"about_ca_topic_score_codex":0.0291304,"about_ca_topic_score_gemma":0.03584201,"teacher_disagreement_score":0.0291304,"about_ca_system_score_codex":0.001363428,"about_ca_system_score_gemma":0.002259556,"threshold_uncertainty_score":0.057921708},"labels":[],"label_agreement":null},{"id":"W4388589533","doi":"10.1093/neuonc/noad179.0527","title":"DISP-12. BRAIN CANCER CANADA FUNDS CRITICALLY NEEDED RESEARCH AND ADVOCATES FOR PATIENTS, WITH THE AIM TO IMPROVE OUTCOMES FOR CANADIANS DIAGNOSED WITH PRIMARY MALIGNANT BRAIN TUMOURS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Temozolomide; Medicine; Brain cancer; Cancer; Family medicine; Glioblastoma; Political science; Internal medicine; Cancer research","score_opus":0.16511492376747897,"score_gpt":0.4173282999642205,"score_spread":0.25221337619674156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589533","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068114097,0.006727928,0.0033214719,0.22444953,0.022553224,0.003952984,0.07038621,0.004101298,0.65769607],"genre_scores_gemma":[0.06344422,0.0057741534,0.014290717,0.07013883,0.003919598,0.001416549,0.040716738,0.0019210832,0.79837817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873217,0.0014636739,0.00037042444,0.0008808129,0.006795592,0.0031677603],"domain_scores_gemma":[0.88822865,0.00578292,0.0017121289,0.0028558036,0.05027815,0.05114234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009524244,0.00093604776,0.0009638737,0.0021679902,0.007864613,0.008533532,0.002486318,0.0038379233,0.22179584],"category_scores_gemma":[0.03042581,0.0009729452,0.001342365,0.0018510143,0.0022438979,0.001744672,0.004523821,0.004043282,0.044429883],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001866798,0.000046278547,0.0014278062,0.00015346549,0.000020558611,0.00009067089,0.00007800993,0.0000647381,0.00023582314,0.0027929412,0.9685579,0.026345177],"study_design_scores_gemma":[0.00015652846,0.00006474675,0.004663196,0.0002319141,0.000019708114,0.00010439112,0.0002729582,0.00019715115,0.00020016018,0.0005643616,0.9934907,0.00003423651],"about_ca_topic_score_codex":0.8287214,"about_ca_topic_score_gemma":0.92663974,"teacher_disagreement_score":0.9356545,"about_ca_system_score_codex":0.0643455,"about_ca_system_score_gemma":0.34119734,"threshold_uncertainty_score":0.741981},"labels":[],"label_agreement":null},{"id":"W4388589549","doi":"10.1093/neuonc/noad179.0499","title":"EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transcriptome; Phenotype; Temozolomide; Biology; Exome sequencing; RNA; Cohort; microRNA; Cancer research; Medicine; Glioblastoma; Internal medicine; Genetics; Gene; Gene expression","score_opus":0.02749759633724188,"score_gpt":0.3110289152744299,"score_spread":0.283531318937188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.711956,0.002471896,0.08520338,0.0007091981,0.0002866021,0.00061466603,0.17946312,0.007977605,0.011317607],"genre_scores_gemma":[0.63404864,0.0012315845,0.09025643,0.00097177067,0.00009477896,0.0018750877,0.26044047,0.0028384707,0.008242836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993813,0.000062866166,0.000034554916,0.0002443724,0.00018899399,0.000087889275],"domain_scores_gemma":[0.99931467,0.00011220304,0.00008099752,0.000118716234,0.00026027203,0.00011315793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001166308,0.00044477536,0.00051889196,0.0006301825,0.0005585268,0.00067815103,0.00059910514,0.00044506352,0.0047261147],"category_scores_gemma":[0.0010466638,0.0003711453,0.00043983624,0.0006792179,0.00034316993,0.0002603502,0.0007328259,0.00055782346,0.00335079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001442392,0.00018976879,0.067225516,0.0007936255,0.00028948896,0.00038000787,0.0006241422,0.0056676194,0.8278851,0.00166448,0.036413644,0.05742425],"study_design_scores_gemma":[0.00018212874,0.0011839375,0.30399597,0.00019883714,0.00031419034,0.0013730838,0.0005297795,0.046050485,0.505559,0.002676203,0.13774422,0.00019224909],"about_ca_topic_score_codex":0.0046594334,"about_ca_topic_score_gemma":0.010593159,"teacher_disagreement_score":0.0047261147,"about_ca_system_score_codex":0.00053782767,"about_ca_system_score_gemma":0.00093461166,"threshold_uncertainty_score":0.01581043},"labels":[],"label_agreement":null},{"id":"W4388589565","doi":"10.1093/neuonc/noad179.0037","title":"BIOM-26. RAPID IDENTIFICATION OF <i>IDH1</i>-R132 VARIANTS IN GLIOMA WITH LOCKED NUCLEIC ACID LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LNA-LAMP)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Isocitrate dehydrogenase; Chemistry; Wild type; Mutant; Molecular biology; Loop-mediated isothermal amplification; IDH1; Locked nucleic acid; DNA; Oligonucleotide; Biology; Gene; Biochemistry; Enzyme","score_opus":0.02212467388148024,"score_gpt":0.2841468640563205,"score_spread":0.26202219017484024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8487313,0.0032986961,0.12003423,0.0005717388,0.00025185547,0.00061831094,0.004623162,0.0031508785,0.018719804],"genre_scores_gemma":[0.7882009,0.0022980154,0.16399881,0.00034607586,0.000035160876,0.00065951573,0.011308349,0.00061228714,0.032540914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996475,0.000074014795,0.00003236935,0.00009597264,0.000098890785,0.000051127932],"domain_scores_gemma":[0.9998204,0.0000312906,0.000051399475,0.00002224811,0.00003918677,0.00003554289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038036617,0.00067353196,0.0002588027,0.00058505347,0.00021379477,0.00044501433,0.00028548663,0.00040979296,0.004647995],"category_scores_gemma":[0.00039633727,0.00036363205,0.00032653537,0.000316079,0.00031692119,0.00022273045,0.0003480658,0.00039610273,0.0039290944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008123162,0.000024110646,0.00043501952,0.000046223595,0.0000032692135,0.000040384322,0.00001550031,0.000060358678,0.99473,0.000044400265,0.00022290806,0.0042965403],"study_design_scores_gemma":[0.000010820367,0.000133063,0.003583608,0.000010071263,0.000008766704,0.000305658,0.000012807686,0.00086539076,0.9915073,0.000043173248,0.0035091839,0.00001002518],"about_ca_topic_score_codex":0.00090401387,"about_ca_topic_score_gemma":0.0018979452,"teacher_disagreement_score":0.004647995,"about_ca_system_score_codex":0.0003947506,"about_ca_system_score_gemma":0.0003264003,"threshold_uncertainty_score":0.015549123},"labels":[],"label_agreement":null},{"id":"W4388589580","doi":"10.1093/neuonc/noad179.0366","title":"CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Regorafenib; Medicine; Clinical endpoint; Randomization; Randomized controlled trial; Internal medicine; Oncology; Hazard ratio; Confidence interval; Cancer; Colorectal cancer","score_opus":0.38453446809192626,"score_gpt":0.455586521230215,"score_spread":0.07105205313828872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89862156,0.028446272,0.0040781405,0.0049217106,0.0013912646,0.0047717984,0.01734055,0.0009612541,0.039467473],"genre_scores_gemma":[0.9538503,0.005382427,0.0042112684,0.0031891,0.0005246494,0.0037471156,0.014637102,0.00015595586,0.014302147],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994168,0.00031377055,0.000021636793,0.00009943721,0.00008344181,0.000064957414],"domain_scores_gemma":[0.99941766,0.00011882555,0.0001450028,0.00007175299,0.0000548293,0.00019192796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001591366,0.0010615881,0.0012224178,0.00030130844,0.0003085498,0.0010219767,0.0005208811,0.0007884616,0.0071827075],"category_scores_gemma":[0.002249789,0.0002946842,0.0014478153,0.00029267304,0.00058354094,0.0008164894,0.0003364907,0.0025148331,0.0012833929],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77551913,0.0053713894,0.0029982284,0.002605275,0.0035515958,0.00009999523,0.0001498596,0.004143164,0.0071456023,0.0020252976,0.04158663,0.15480383],"study_design_scores_gemma":[0.8343775,0.10379601,0.014623217,0.00064872985,0.0036521675,0.00036313312,0.0000843865,0.005222785,0.0033103558,0.0028768827,0.030959517,0.00008532205],"about_ca_topic_score_codex":0.0018923773,"about_ca_topic_score_gemma":0.0053882054,"teacher_disagreement_score":0.0071827075,"about_ca_system_score_codex":0.0013542642,"about_ca_system_score_gemma":0.0014616284,"threshold_uncertainty_score":0.0240286},"labels":[],"label_agreement":null},{"id":"W4388589709","doi":"10.1093/neuonc/noad179.0442","title":"EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Retrospective cohort study; Oncology; Central nervous system; Glioma; Gastroenterology; Pathology; Neurotrophin; Cancer research","score_opus":0.07178946823431683,"score_gpt":0.3735676617704192,"score_spread":0.3017781935361024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748284,0.00009606886,0.000048366805,0.000011462635,0.000003510981,0.000016485741,0.0018973481,0.0000027359984,0.00044121145],"genre_scores_gemma":[0.9953341,0.00006475587,0.00007260681,0.00001544307,0.000011221196,0.000030006773,0.004221325,0.0000036835943,0.0002467437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969363,0.0000593532,0.000048212365,0.000099797406,0.00004719759,0.000051828403],"domain_scores_gemma":[0.9989042,0.000117553485,0.00052865763,0.00007367986,0.00010326226,0.0002726255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006553168,0.00028915674,0.00037777852,0.00068702176,0.00022828109,0.00046417542,0.0004175175,0.00026979973,0.001745851],"category_scores_gemma":[0.0010025038,0.00014338136,0.0003294745,0.0007288762,0.0002307926,0.00044786005,0.0004736834,0.00027645373,0.00046922176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005976899,0.000039197475,0.99790144,0.000011110062,0.000043514287,0.00012118651,0.000017163167,0.000041770087,0.0002535479,0.000008477348,0.0001328356,0.00083196],"study_design_scores_gemma":[0.00006347357,0.00032018937,0.998254,0.000005209726,0.000041826228,0.00068691734,0.000048184873,0.00012162015,0.00015582416,0.000014870215,0.00028394136,0.0000039273987],"about_ca_topic_score_codex":0.0015844081,"about_ca_topic_score_gemma":0.0018212161,"teacher_disagreement_score":0.001745851,"about_ca_system_score_codex":0.00036488197,"about_ca_system_score_gemma":0.0003738692,"threshold_uncertainty_score":0.0058404207},"labels":[],"label_agreement":null},{"id":"W4388589743","doi":"10.1093/neuonc/noad179.0467","title":"EPCO-02. DNA METHYLATION PROFILING OF BRAIN METASTASIS REVEALS UNDERLING TUMOR RECURRENCE SIGNAL AND ASSOCIATED PATHWAYS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"DNA methylation; CpG site; Methylation; Epigenetics; Biology; Differentially methylated regions; Cancer research; Metastasis; Molecular biology; Computational biology; Oncology; DNA; Cancer; Medicine; Genetics; Gene expression; Gene","score_opus":0.04339248786605172,"score_gpt":0.3123219602283687,"score_spread":0.268929472362317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920875,0.0046598404,0.018616557,0.00061841065,0.000096883276,0.00030981886,0.038013026,0.0017895235,0.015020898],"genre_scores_gemma":[0.92093426,0.0014189214,0.015769847,0.00034877678,0.000042895103,0.00046521606,0.043397274,0.00032605173,0.017296638],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998029,0.000018465376,0.000009633251,0.00007053044,0.000059586386,0.00003889159],"domain_scores_gemma":[0.9998122,0.000028282195,0.0000328736,0.000021841472,0.000055026725,0.0000497016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029145312,0.00029039773,0.00031218425,0.00068433053,0.0002895951,0.00052575395,0.00036795015,0.000361578,0.0070053744],"category_scores_gemma":[0.00034006574,0.00018508134,0.00020781752,0.000544337,0.00015977674,0.00018523069,0.0003117824,0.00042174413,0.0021299203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001649095,0.00012000023,0.033863705,0.00037119625,0.000070049886,0.000283856,0.00006273305,0.0006236155,0.9080722,0.00049396214,0.00587371,0.04851588],"study_design_scores_gemma":[0.00026478726,0.0010502082,0.34112105,0.00005867761,0.00021039731,0.0027370374,0.00009570889,0.009788462,0.6040167,0.0007371697,0.039877724,0.000042153562],"about_ca_topic_score_codex":0.0028648637,"about_ca_topic_score_gemma":0.004969219,"teacher_disagreement_score":0.0070053744,"about_ca_system_score_codex":0.00035929485,"about_ca_system_score_gemma":0.0005274691,"threshold_uncertainty_score":0.023435295},"labels":[],"label_agreement":null},{"id":"W4388590013","doi":"10.1093/neuonc/noad179.0587","title":"IMMU-55. THERAPEUTIC WINDOW ENABLING ERADICATION OF RESIDUAL GLIOMA STEM CELLS BY INTRACRANIAL NK CELL AND EXTRACELLULAR VESICLE-MEDIATED THERAPY FOLLOWING TEMOZOLOMIDE-INDUCED TUMOUR DEPOPULATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Glioma; Cancer research; Stem cell; Adjuvant; Immunology; Biology; Medicine; Cell biology","score_opus":0.023373059182646913,"score_gpt":0.2933260544799681,"score_spread":0.2699529952973212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970605,0.00075479894,0.00083878986,0.00004029802,0.000031455747,0.00003269174,0.00018776662,0.00007934057,0.000974238],"genre_scores_gemma":[0.99790525,0.0003037959,0.0006783593,0.000018590012,0.0000068410623,0.000022000397,0.00021604613,0.000006819918,0.0008422776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992406,0.000007076784,0.0000051717566,0.000015967913,0.000013636267,0.00003422317],"domain_scores_gemma":[0.99996495,0.000005196867,0.000009379974,0.00000488153,0.0000027166516,0.00001285668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009207007,0.00032796428,0.00031944257,0.00014447943,0.00008672008,0.00025005965,0.00016616343,0.00021353849,0.0010153459],"category_scores_gemma":[0.000055313685,0.00008094918,0.0001978302,0.00009317151,0.00025990428,0.00018118575,0.00014456335,0.00051075034,0.00023595465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003963332,0.00011756282,0.0001732611,0.00005326991,0.00000651788,0.00006536857,0.000021773913,0.00017603322,0.99637175,0.00018133018,0.00007532362,0.00236154],"study_design_scores_gemma":[0.000052864667,0.0028755357,0.0021376496,0.0000047687945,0.000029030058,0.00020709337,0.000019035037,0.0011163148,0.9920184,0.000029370462,0.0015061272,0.0000038221915],"about_ca_topic_score_codex":0.00076763757,"about_ca_topic_score_gemma":0.00091061246,"teacher_disagreement_score":0.0010153459,"about_ca_system_score_codex":0.00024553423,"about_ca_system_score_gemma":0.00017726666,"threshold_uncertainty_score":0.0033966303},"labels":[],"label_agreement":null},{"id":"W4388590014","doi":"10.1093/neuonc/noad179.0159","title":"CSIG-03. SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOUR PROGRESSION IN MPNST","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; McMaster University","funders":"","keywords":"Cancer research; Biology; Neural crest; Wnt signaling pathway; Transcription factor; Cell biology; Signal transduction; Biochemistry","score_opus":0.014827794039939602,"score_gpt":0.284706817355861,"score_spread":0.2698790233159214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712534,0.0021163914,0.00082682905,0.00039028752,0.0001342476,0.0001430827,0.003871548,0.00061031233,0.004781884],"genre_scores_gemma":[0.98713374,0.0008502326,0.001290231,0.00032566104,0.000020556949,0.00017789021,0.0059093568,0.00005979199,0.004232603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998198,0.000017189735,0.000012367542,0.000031848635,0.00006189979,0.000056894707],"domain_scores_gemma":[0.9998085,0.00001711678,0.000027008562,0.000019726014,0.000020554986,0.00010717818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026160004,0.00034290063,0.00065735413,0.0003714642,0.0003205937,0.0005205306,0.00037658203,0.00045043085,0.0053415936],"category_scores_gemma":[0.00019296151,0.000174779,0.000413579,0.00030964753,0.0003087431,0.00016941043,0.0002739125,0.0010616746,0.0015330316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068367654,0.0011050508,0.01729354,0.000423417,0.00010103091,0.00056473986,0.00008612556,0.0010027892,0.9277205,0.0003973839,0.004967003,0.03950166],"study_design_scores_gemma":[0.0010948707,0.01183359,0.16823535,0.000085139705,0.00029029482,0.0035952106,0.00027305755,0.0069150566,0.7786031,0.00063054415,0.02839335,0.000050402108],"about_ca_topic_score_codex":0.0016391674,"about_ca_topic_score_gemma":0.0033564637,"teacher_disagreement_score":0.0053415936,"about_ca_system_score_codex":0.00049141987,"about_ca_system_score_gemma":0.00093738205,"threshold_uncertainty_score":0.017869413},"labels":[],"label_agreement":null},{"id":"W4388590026","doi":"10.1093/neuonc/noad179.0157","title":"CSIG-01. DEFINING THE INVOLVEMENT OF THE PERIVASCULAR NICHE IN BRAIN TUMOR METASTASES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Intravasation; Pathology; Wnt signaling pathway; Metastasis; Cancer research; Medicine; Cancer; Signal transduction; Cell biology","score_opus":0.03762858983162251,"score_gpt":0.31109616535680085,"score_spread":0.2734675755251783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9111539,0.008032507,0.014394744,0.002067751,0.0007938014,0.0009785228,0.0261473,0.0022465023,0.034185063],"genre_scores_gemma":[0.94883096,0.0026777734,0.01168738,0.0011169169,0.00006367664,0.0006374077,0.022394609,0.00036350935,0.012227681],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994979,0.000053515483,0.00003520042,0.00010584623,0.00014887558,0.00015881583],"domain_scores_gemma":[0.99958473,0.000043084518,0.00006862088,0.00005006617,0.000054590815,0.00019886052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051715143,0.00044844212,0.0005922305,0.0009418399,0.00057358656,0.00093647867,0.00046727725,0.00093274796,0.007980675],"category_scores_gemma":[0.0003490562,0.00028254814,0.00053069816,0.00061686075,0.00057982386,0.00028350228,0.00068742386,0.0015411965,0.002799333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001011833,0.00026123552,0.003859244,0.0003803859,0.000029436484,0.00053385436,0.000082724924,0.0002962615,0.97417676,0.0011257957,0.003558323,0.014684098],"study_design_scores_gemma":[0.00058037933,0.003015815,0.08298793,0.00017971967,0.00021893367,0.0072773527,0.00046445732,0.0065155705,0.795559,0.0009807781,0.102145575,0.000074440635],"about_ca_topic_score_codex":0.0025997802,"about_ca_topic_score_gemma":0.003994664,"teacher_disagreement_score":0.007980675,"about_ca_system_score_codex":0.00092977245,"about_ca_system_score_gemma":0.0014189875,"threshold_uncertainty_score":0.026697993},"labels":[],"label_agreement":null},{"id":"W4388590054","doi":"10.1093/neuonc/noad179.0340","title":"CTNI-58. UPDATED RESULTS AND MOLECULAR SUBGROUP ANALYSES FROM THE RANDOMIZED PHASE 3 MIRAGE TRIAL ON MARIZOMIB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; Queen's University; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Internal medicine; Oncology; Interim analysis; Randomized controlled trial; Chemotherapy; Isocitrate dehydrogenase; O-6-methylguanine-DNA methyltransferase; Radiation therapy; Methyltransferase; Biology","score_opus":0.022321352402795216,"score_gpt":0.32043109964655014,"score_spread":0.29810974724375494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89113516,0.08612662,0.0018018092,0.0020477828,0.0011492668,0.0016363945,0.010856837,0.00024767139,0.004998423],"genre_scores_gemma":[0.9735371,0.009165917,0.0015518246,0.0012569684,0.0007842735,0.0017435971,0.0100509375,0.00007115596,0.0018382235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99749446,0.0015119575,0.00023570428,0.00033310207,0.00021724783,0.00020759727],"domain_scores_gemma":[0.9981852,0.0006740972,0.0005672847,0.00021600207,0.00010790679,0.00024954494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047777314,0.0016145755,0.003867662,0.0008720459,0.00030138314,0.0011927804,0.00090145966,0.0008161814,0.004281307],"category_scores_gemma":[0.0043769972,0.0004319291,0.0061790273,0.0011390998,0.00037327252,0.000896144,0.0006091261,0.0015544735,0.00047368882],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8762433,0.00043545355,0.027594456,0.0030205403,0.032717187,0.00020730855,0.000065439206,0.0017111195,0.003573901,0.00024340807,0.0050236946,0.049164336],"study_design_scores_gemma":[0.64419585,0.033907026,0.17007475,0.0007242421,0.12843698,0.0005713534,0.00017397248,0.004349584,0.002106673,0.0025405379,0.012725064,0.00019394195],"about_ca_topic_score_codex":0.0012064655,"about_ca_topic_score_gemma":0.0056234696,"teacher_disagreement_score":0.0047777314,"about_ca_system_score_codex":0.00071022654,"about_ca_system_score_gemma":0.0011007619,"threshold_uncertainty_score":0.025267363},"labels":[],"label_agreement":null},{"id":"W4388590067","doi":"10.1093/neuonc/noad179.0613","title":"INNV-24. MACHINE LEARNING-BASED SPECTROSCOPIC TISSUE DIFFERENTIATION IN FLUORESCENCE-GUIDED NEUROSURGERY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Artificial intelligence; Principal component analysis; Computer science; Pattern recognition (psychology); Hyperspectral imaging; Dimensionality reduction; Random forest; Fluorophore; Glioma; Fluorescence; Physics; Biology; Optics; Cancer research","score_opus":0.03009660723060128,"score_gpt":0.3440383126285565,"score_spread":0.31394170539795524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590067","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28126442,0.012961526,0.55250555,0.0036993134,0.00316906,0.0013206067,0.013653182,0.034969978,0.096456386],"genre_scores_gemma":[0.6647169,0.0023407573,0.24970262,0.00052163843,0.00042678145,0.0007768337,0.023496946,0.0024810894,0.055536482],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992893,0.00018361308,0.000029306595,0.0001351762,0.00028715003,0.00007534157],"domain_scores_gemma":[0.9994455,0.00010887038,0.000042302552,0.000070789145,0.00026608093,0.000066440596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015187936,0.0006808618,0.00044688414,0.00073554064,0.0004039775,0.0009541638,0.000984405,0.0009132304,0.006242445],"category_scores_gemma":[0.0015549421,0.00023485576,0.0004162617,0.00057230215,0.00031025033,0.00041060813,0.000629431,0.0004655436,0.003393676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011229289,0.00026622458,0.008622025,0.0004936276,0.00014003759,0.00029240976,0.00006940911,0.13223714,0.053339276,0.005689761,0.09365909,0.7040681],"study_design_scores_gemma":[0.00010155936,0.000372948,0.010401008,0.00009889313,0.0000344972,0.00028305285,0.00006074643,0.8432152,0.07508959,0.007024903,0.0632402,0.00007740965],"about_ca_topic_score_codex":0.00646791,"about_ca_topic_score_gemma":0.008319692,"teacher_disagreement_score":0.00646791,"about_ca_system_score_codex":0.0010451708,"about_ca_system_score_gemma":0.0012644713,"threshold_uncertainty_score":0.020883083},"labels":[],"label_agreement":null},{"id":"W4388590430","doi":"10.1093/neuonc/noad179.0569","title":"IMMU-37. TARGETING NON-CATALYTIC ACTIVATORS OF THE PROTEASOME DECREASES TUMOR GROWTH AND ENHANCES ANTIGEN PRESENTATION IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Proteasome; Proteostasis; Biology; Cancer research; Cell biology; Neural stem cell; Stem cell; Activator (genetics); Downregulation and upregulation; In vivo; Biochemistry; Receptor","score_opus":0.01052500384115085,"score_gpt":0.2665183434337563,"score_spread":0.25599333959260545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902498,0.004756152,0.0016840466,0.00020009487,0.00013008867,0.0000481,0.00082899857,0.00030618004,0.0017964643],"genre_scores_gemma":[0.99311274,0.0019115481,0.0014571939,0.000092554146,0.0000140113225,0.0000405479,0.0011159668,0.000032282995,0.0022232514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998536,0.000015711154,0.000014616472,0.000022895156,0.000044480326,0.000048672857],"domain_scores_gemma":[0.99993587,0.0000070966903,0.000013420048,0.000006806218,0.000007875641,0.000028881537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013059334,0.00048659043,0.00042886595,0.00035060602,0.000120621335,0.00030446725,0.0002367806,0.00021190211,0.0015117862],"category_scores_gemma":[0.000084976105,0.00012965988,0.0002603177,0.0002713734,0.000255301,0.00014200008,0.00013744438,0.0006484715,0.00045873775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047965845,0.00017169442,0.00024940897,0.00009255861,0.000013122958,0.00004239942,0.00001206671,0.00014045293,0.99518967,0.00008250678,0.00021740646,0.0033089174],"study_design_scores_gemma":[0.00003787353,0.0011955207,0.0019165992,0.000007500866,0.00003146691,0.00010875623,0.00001893228,0.0006740243,0.9933989,0.000044219734,0.002561888,0.000004276584],"about_ca_topic_score_codex":0.0014514923,"about_ca_topic_score_gemma":0.002370767,"teacher_disagreement_score":0.0015117862,"about_ca_system_score_codex":0.0004772773,"about_ca_system_score_gemma":0.000543893,"threshold_uncertainty_score":0.0050573945},"labels":[],"label_agreement":null},{"id":"W4388590481","doi":"10.1093/neuonc/noad179.1001","title":"SURG-02. SURGICAL OUTCOME OF SUPRATENTORIAL MENINGIOMA PATIENTS AGED ≥80 YEARS – RETROSPECTIVE INTERNATIONAL MULTICENTER STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Neurosurgery; Meningioma; Population; Surgery; Radiology","score_opus":0.03787618942484005,"score_gpt":0.34054426142688743,"score_spread":0.3026680720020474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985116,0.0001865061,0.000032725144,0.000014095637,0.000004508533,0.000008642677,0.00080641557,0.0000027584326,0.00043263572],"genre_scores_gemma":[0.99857557,0.000111780864,0.000036468988,0.000022128695,0.00001545927,0.000019056144,0.0010797319,0.000002687146,0.0001370434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997234,0.000044315508,0.000043239925,0.000085876076,0.00004276568,0.000060406215],"domain_scores_gemma":[0.9989557,0.000078199075,0.0005523745,0.00007859541,0.000101956975,0.00023315584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004726352,0.00036136727,0.00024479092,0.0010856981,0.00042900536,0.0005081282,0.00028241184,0.00029825233,0.0021842946],"category_scores_gemma":[0.00083416846,0.0002411737,0.00049061206,0.0010798861,0.00023360824,0.0005700467,0.00042816944,0.0003097742,0.0006646807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006367416,0.000013518163,0.9993042,0.0000051468096,0.000025751651,0.000065137545,0.000021405913,0.000012405354,0.000058446913,0.0000045288166,0.00005731022,0.00036844434],"study_design_scores_gemma":[0.00000738741,0.0000864374,0.99899405,0.0000052205487,0.000021902893,0.00041859035,0.00014406323,0.000044658984,0.000031290005,0.000009802954,0.00023389081,0.0000026364921],"about_ca_topic_score_codex":0.002700204,"about_ca_topic_score_gemma":0.0028021112,"teacher_disagreement_score":0.002700204,"about_ca_system_score_codex":0.00027899857,"about_ca_system_score_gemma":0.00027343316,"threshold_uncertainty_score":0.0073072314},"labels":[],"label_agreement":null},{"id":"W4388590565","doi":"10.1093/neuonc/noad179.0472","title":"EPCO-08. CONVERGENCE OF NON-CODING SOMATIC MUTATIONS ON CANCER DRIVER PLEXUSES IN PEDIATRIC HIGH-GRADE GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epigenetics; Biology; Pediatric cancer; Somatic cell; Genetics; Gene; Germline mutation; Glioma; Cancer; Mutation","score_opus":0.03378009687224769,"score_gpt":0.3344156060484884,"score_spread":0.3006355091762407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91442823,0.0019582345,0.009397479,0.00078008947,0.00012661188,0.0000963297,0.06364388,0.00096234574,0.008606867],"genre_scores_gemma":[0.92835206,0.0011089814,0.0075386246,0.00023101333,0.000051907187,0.000094395735,0.060184475,0.000248922,0.0021896623],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955803,0.00004439277,0.000038246162,0.0001482949,0.00013536081,0.00007569765],"domain_scores_gemma":[0.99821943,0.0004893568,0.0005151923,0.00013846799,0.00032848705,0.00030911405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004748425,0.00034682234,0.00028124705,0.0019463634,0.00042334304,0.00087080663,0.00042791833,0.0004596519,0.010070341],"category_scores_gemma":[0.0023280226,0.00013885483,0.0004618805,0.0022459603,0.00019683133,0.00039977118,0.00076864514,0.00041656717,0.001368525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012574872,0.00015023987,0.87845856,0.00069177925,0.00050285866,0.0012752073,0.00020590892,0.0054300264,0.028024971,0.0024390072,0.014757077,0.06680692],"study_design_scores_gemma":[0.00006852754,0.00025681275,0.936506,0.0001272515,0.0003618005,0.0040177484,0.00032197195,0.019414546,0.010325027,0.0035757981,0.024992216,0.000032329233],"about_ca_topic_score_codex":0.0045482656,"about_ca_topic_score_gemma":0.0062931427,"teacher_disagreement_score":0.010070341,"about_ca_system_score_codex":0.00061423366,"about_ca_system_score_gemma":0.00091943494,"threshold_uncertainty_score":0.033688664},"labels":[],"label_agreement":null},{"id":"W4388590604","doi":"10.1093/neuonc/noad179.1078","title":"TMIC-12. RAB27 REGULATION OF VASCULAR WALL INTEGRITY MEDIATES T-CELL INFILTERATION IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Angiogenesis; Cell biology; Tumor microenvironment; Microvesicles; Cell type; Exosome; Vascular permeability; Cancer research; Pathology; Cell; Immune system; Immunology; microRNA; Medicine; Endocrinology; Gene","score_opus":0.012215200247837609,"score_gpt":0.2658197568793628,"score_spread":0.2536045566315252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958513,0.00093348045,0.00082816026,0.00013578868,0.00002209686,0.000022472657,0.00051572063,0.00009339563,0.0015976815],"genre_scores_gemma":[0.99658763,0.0003474162,0.0003340129,0.000047876838,0.0000059711415,0.00002716118,0.00049991993,0.000019972771,0.0021301243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998683,0.000016394191,0.000009960929,0.000018674462,0.000021394477,0.0000652625],"domain_scores_gemma":[0.99988866,0.0000076263077,0.000028505623,0.00001001031,0.000010186254,0.00005509941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100987985,0.00028886218,0.00028678437,0.00025128116,0.0001763571,0.0003321087,0.00019987945,0.00030071812,0.0023211385],"category_scores_gemma":[0.000073549876,0.0001348389,0.0002341356,0.00015191695,0.00026020454,0.00012920964,0.00021599204,0.0006147654,0.0009941482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015731294,0.000035571433,0.0001831503,0.000026533702,0.000002728856,0.000094789866,0.000010130956,0.000032950287,0.99882513,0.000091860085,0.00008485191,0.00045502585],"study_design_scores_gemma":[0.0000490382,0.00044048013,0.015720803,0.000009478516,0.000022422737,0.00076555944,0.00010479866,0.0016353872,0.977421,0.00010471723,0.0037199857,0.000006352436],"about_ca_topic_score_codex":0.0012183912,"about_ca_topic_score_gemma":0.0014754414,"teacher_disagreement_score":0.0023211385,"about_ca_system_score_codex":0.00035411937,"about_ca_system_score_gemma":0.00024143115,"threshold_uncertainty_score":0.0077649355},"labels":[],"label_agreement":null},{"id":"W4388590609","doi":"10.1093/neuonc/noad179.0135","title":"STEM-09. EXPLORING THE ROLE OF <i>TP53</i> IN REDOX REGULATION AND RESPONSE OF GLIOBLASTOMA STEM CELLS TO ROS-INDUCING AGENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene knockdown; Auranofin; Thioredoxin; Cancer research; Stem cell; Neurosphere; Reactive oxygen species; Radioresistance; Glutathione; Biology; Chemistry; Molecular biology; Cell culture; Oxidative stress; Cell biology; Immunology; Biochemistry; Cellular differentiation; Gene; Enzyme; Genetics","score_opus":0.030610390358254237,"score_gpt":0.298693212859479,"score_spread":0.2680828225012247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808148,0.004996407,0.004574483,0.000525746,0.00011863218,0.00016174231,0.0025999316,0.00047254664,0.0057356195],"genre_scores_gemma":[0.98687416,0.0018269249,0.0031646036,0.00027302542,0.000019027018,0.0001122234,0.003398456,0.00004069993,0.004290799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989676,0.000010288565,0.000011072961,0.00002204422,0.0000401631,0.00001962983],"domain_scores_gemma":[0.99990964,0.000012009679,0.000025147683,0.000006489341,0.00002139828,0.000025301593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019372712,0.00023742646,0.00027017193,0.00037379688,0.00019381709,0.00041716942,0.00017720583,0.00034921832,0.0029893692],"category_scores_gemma":[0.00011916281,0.00011837604,0.00024699068,0.00026590354,0.00020956036,0.00021180557,0.00014301037,0.0003832222,0.00063525327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026066558,0.00006686171,0.0014912179,0.00015910692,0.0000123136215,0.00014986377,0.0000413028,0.000105853804,0.98804003,0.00028877164,0.00037755095,0.0090063475],"study_design_scores_gemma":[0.000025631796,0.0006545552,0.011636438,0.000016133643,0.00003590962,0.00044731327,0.000070213275,0.0011128302,0.9763837,0.00017000017,0.009442042,0.00000531074],"about_ca_topic_score_codex":0.00067986135,"about_ca_topic_score_gemma":0.0007614861,"teacher_disagreement_score":0.0029893692,"about_ca_system_score_codex":0.0003138318,"about_ca_system_score_gemma":0.00025765144,"threshold_uncertainty_score":0.010000467},"labels":[],"label_agreement":null},{"id":"W4388590642","doi":"10.1093/neuonc/noad179.0134","title":"STEM-08. OVERCOMING GLIOBLASTOMA STEM CELL RESISTANCE TO RADIATION THROUGH TARGETING THIOREDOXIN REDUCTASE 1","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Radioresistance; Cancer research; Stem cell; RAD51; Viability assay; Thioredoxin reductase; Reactive oxygen species; DNA damage; Thioredoxin; Biology; Auranofin; Chemistry; Molecular biology; Immunology; Oxidative stress; Cell; Cell culture; Cell biology; Biochemistry; DNA; Genetics","score_opus":0.013996015384087592,"score_gpt":0.2814658345402434,"score_spread":0.2674698191561558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92621636,0.03718569,0.015302986,0.0026616426,0.0009612382,0.0005907599,0.0020957168,0.0016864176,0.013299085],"genre_scores_gemma":[0.9719344,0.009765562,0.0067890068,0.0007874563,0.000096131465,0.00021786253,0.0025078885,0.000041551924,0.00786016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998914,0.000009569163,0.000009812498,0.000021375925,0.000043967466,0.000023833902],"domain_scores_gemma":[0.99994636,0.000005737026,0.000014323286,0.0000038754893,0.000014617047,0.000015034386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020044686,0.00036224577,0.00041834402,0.0005107338,0.00019139043,0.0004162147,0.00025796902,0.00041880205,0.0026510174],"category_scores_gemma":[0.00010548237,0.00012329307,0.00038572185,0.0003115073,0.00022438556,0.00021775735,0.00022781079,0.00069159124,0.0006317896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006200854,0.00044086637,0.0024768552,0.0013167405,0.00008884165,0.00048210463,0.0001865869,0.00079038535,0.86652154,0.0022089889,0.005021368,0.119845584],"study_design_scores_gemma":[0.00032525472,0.0038354024,0.011845595,0.000104172614,0.0003379467,0.0017980894,0.00014980685,0.0039970046,0.8861859,0.00091716636,0.0904766,0.000027070835],"about_ca_topic_score_codex":0.00064255076,"about_ca_topic_score_gemma":0.00121515,"teacher_disagreement_score":0.0026510174,"about_ca_system_score_codex":0.00031205808,"about_ca_system_score_gemma":0.00036489154,"threshold_uncertainty_score":0.0088685155},"labels":[],"label_agreement":null},{"id":"W4388590663","doi":"10.1093/neuonc/noad179.0357","title":"CTNI-75. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trk receptor; Internal medicine; Glioma; Oncology; Clinical endpoint; Gastroenterology; Clinical trial; Surgery; Receptor; Neurotrophin; Cancer research","score_opus":0.009833608865202266,"score_gpt":0.25464255903679917,"score_spread":0.2448089501715969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5286356,0.40828723,0.0018398162,0.0017196361,0.00023861932,0.0014818917,0.033826467,0.00026914518,0.02370163],"genre_scores_gemma":[0.8928819,0.06994778,0.0020986486,0.0022550884,0.00035222637,0.0005648554,0.029464174,0.000068005356,0.0023674315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984092,0.00038233236,0.00022712472,0.00027926828,0.0005905257,0.00011152023],"domain_scores_gemma":[0.9963883,0.0009724106,0.0017815845,0.00010699496,0.00053567317,0.00021501303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037865997,0.00052597746,0.0015367328,0.0016755244,0.00019407284,0.0012960155,0.00077685615,0.000367991,0.0022063681],"category_scores_gemma":[0.0028587705,0.00023023457,0.002473075,0.00246657,0.00031395152,0.0006947536,0.00027655918,0.00081520446,0.00056789455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04249519,0.0005369982,0.24966453,0.019100206,0.03209551,0.0007189087,0.00025354585,0.004732255,0.01699234,0.00072779926,0.03281312,0.5998696],"study_design_scores_gemma":[0.012983357,0.011946339,0.816362,0.0029847538,0.05138924,0.0033654028,0.00014640337,0.0032671387,0.005854837,0.0005962612,0.090916134,0.00018812412],"about_ca_topic_score_codex":0.0030311302,"about_ca_topic_score_gemma":0.010318492,"teacher_disagreement_score":0.0037865997,"about_ca_system_score_codex":0.002297408,"about_ca_system_score_gemma":0.0013645991,"threshold_uncertainty_score":0.02002567},"labels":[],"label_agreement":null},{"id":"W4388590676","doi":"10.1093/neuonc/noad179.0476","title":"EPCO-13. CNMF-SNS, A FRAMEWORK FOR UNSUPERVISED INTEGRATION OF MULTIOMICS DATA, IDENTIFIES INVASION AND RECURRENCE ASSOCIATED PROGRAMS IN GBM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Metadata; Computational biology; Computer science; Data integration; Biology; Data mining; World Wide Web","score_opus":0.06679155015222803,"score_gpt":0.32222876892496793,"score_spread":0.2554372187727399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590676","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009610642,0.00015754664,0.98694706,0.00015917877,0.00001984808,0.000066080946,0.00073064904,0.0017985848,0.0005103793],"genre_scores_gemma":[0.19443993,0.00019022926,0.7969443,0.00023913535,0.00007728927,0.00042683043,0.0052615125,0.0006313291,0.0017894381],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99898106,0.00039841386,0.00004858106,0.000273443,0.00020552016,0.00009291389],"domain_scores_gemma":[0.9981034,0.00078731903,0.00023659134,0.00022146781,0.0004806817,0.0001705767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028420773,0.0008540062,0.0006958877,0.0017912426,0.0006003003,0.0011036352,0.0012871338,0.0011655516,0.0021614742],"category_scores_gemma":[0.007166282,0.0004952944,0.0016677737,0.0010505109,0.0008075194,0.0009951541,0.0018203069,0.0013450109,0.0006477692],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041126786,0.00027783672,0.012424945,0.00053096033,0.00041547912,0.0003443198,0.00050140894,0.6774188,0.012954039,0.06921984,0.014762214,0.21073888],"study_design_scores_gemma":[0.000008019472,0.000021397907,0.0007057446,0.000014995512,0.000008744511,0.000028291122,0.000018502635,0.9821998,0.00052001333,0.014738982,0.0017253271,0.000010138704],"about_ca_topic_score_codex":0.012774898,"about_ca_topic_score_gemma":0.022424389,"teacher_disagreement_score":0.012774898,"about_ca_system_score_codex":0.0010969677,"about_ca_system_score_gemma":0.0019679544,"threshold_uncertainty_score":0.025401056},"labels":[],"label_agreement":null},{"id":"W4388590696","doi":"10.1093/neuonc/noad179.0862","title":"EXTH-08. IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibroblast activation protein, alpha; Chimeric antigen receptor; Cancer research; U87; Medicine; Stromal cell; Glioma; Antigen; Immunotherapy; Immunology; Cancer; Internal medicine; Immune system","score_opus":0.05985623119210558,"score_gpt":0.3477529791566311,"score_spread":0.2878967479645255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820067,0.005247014,0.0059199138,0.00047352625,0.00018697925,0.00039136264,0.00067032943,0.00026358775,0.004840663],"genre_scores_gemma":[0.9872765,0.002077461,0.0040759672,0.0002568029,0.000036857637,0.00027066274,0.001079768,0.000028791448,0.004897233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992883,0.000010746862,0.0000043985115,0.00001316084,0.000014948699,0.000027912136],"domain_scores_gemma":[0.9999734,0.0000031233774,0.000004391242,0.0000033248875,0.000004384371,0.000011307976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001628106,0.0002888294,0.00036290634,0.0002214284,0.00012820461,0.00023184154,0.0002858682,0.00043921047,0.0016583124],"category_scores_gemma":[0.00006177872,0.0000810163,0.00027613368,0.00014316605,0.00015967607,0.000151067,0.00015927355,0.00049660413,0.000508066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015175502,0.0012896513,0.0012358581,0.00048242477,0.000060986506,0.00096821727,0.0001350411,0.0017311987,0.9179544,0.0011335952,0.0032035594,0.070287555],"study_design_scores_gemma":[0.0011408399,0.014140079,0.0073677297,0.000053084063,0.00021168319,0.0037443708,0.00007637393,0.009254313,0.9264969,0.00039460693,0.03708878,0.000031177864],"about_ca_topic_score_codex":0.0010526588,"about_ca_topic_score_gemma":0.0012386846,"teacher_disagreement_score":0.0016583124,"about_ca_system_score_codex":0.00025777135,"about_ca_system_score_gemma":0.00034427192,"threshold_uncertainty_score":0.0055476427},"labels":[],"label_agreement":null},{"id":"W4388590720","doi":"10.1093/neuonc/noad179.0675","title":"PATH-45. OUTCOMES OF AN IRRADIATION SPARING APPROACH IN MEDULLOBLASTOMA BY SUBGROUP IN YOUNG CHILDREN: AN INSTITUTIONAL REVIEW","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medulloblastoma; Medicine; Neurocognitive; Radiation therapy; Subgroup analysis; Salvage therapy; Pediatrics; Internal medicine; Surgery; Chemotherapy; Confidence interval; Cognition; Pathology","score_opus":0.022755631577075493,"score_gpt":0.30447300663911453,"score_spread":0.28171737506203903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7559707,0.12815963,0.0016151252,0.0027444155,0.00033246182,0.0054767863,0.07016333,0.00013004514,0.03540747],"genre_scores_gemma":[0.88120496,0.07884732,0.0034531027,0.0013714198,0.00021701392,0.0029958219,0.027103353,0.00008764151,0.004719337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976369,0.00072227983,0.0008346771,0.00018249977,0.00045602318,0.0001676767],"domain_scores_gemma":[0.9858424,0.0027637228,0.0060189813,0.0007476779,0.0039589936,0.0006682382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004345696,0.00015823073,0.00031531692,0.003267887,0.00049895706,0.001014109,0.00050732144,0.0002849072,0.0027711608],"category_scores_gemma":[0.010765929,0.0002096447,0.00030333467,0.004455449,0.00044430053,0.00039966588,0.0006597592,0.00016886178,0.0008890392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007588722,0.00007515787,0.8545655,0.0060679675,0.0002717249,0.0017014983,0.0015264734,0.0001276007,0.0019550696,0.00074757804,0.016689776,0.11551281],"study_design_scores_gemma":[0.00011186648,0.00033763683,0.8834022,0.006438979,0.00043462132,0.003537791,0.0023562983,0.00013631865,0.001520571,0.000064276894,0.10163364,0.000025866522],"about_ca_topic_score_codex":0.013420765,"about_ca_topic_score_gemma":0.01660459,"teacher_disagreement_score":0.013420765,"about_ca_system_score_codex":0.0018777552,"about_ca_system_score_gemma":0.006335366,"threshold_uncertainty_score":0.026685297},"labels":[],"label_agreement":null},{"id":"W4388590859","doi":"10.1093/neuonc/noad179.0796","title":"NCMP-12. PREVALENCE OF RADIONECROSIS IN RECURRENT GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Radiological weapon; Temozolomide; Radiation therapy; Surgery; Glioblastoma; Retrospective cohort study; Demographics; Chemotherapy","score_opus":0.028426229317967334,"score_gpt":0.3184327131447918,"score_spread":0.2900064838268245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987293,0.0006169918,0.000035539604,0.00002564995,0.0000044659514,0.000004119551,0.00026162073,0.0000049030828,0.0003172656],"genre_scores_gemma":[0.9992347,0.0001627182,0.000073696494,0.000008456242,0.000008947393,0.0000073752426,0.00033636927,0.000002135774,0.0001656041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955124,0.00007677211,0.000067071865,0.000099908015,0.00013258882,0.00007236295],"domain_scores_gemma":[0.9972556,0.0002761276,0.0018331764,0.00006896392,0.00023520105,0.00033100505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037109063,0.00021231044,0.00023701279,0.0013735835,0.0002588908,0.00042327706,0.00040953193,0.00033208088,0.002232828],"category_scores_gemma":[0.0020466177,0.00013259916,0.00018639346,0.0010529341,0.00023813607,0.00024322612,0.00027981878,0.0002920534,0.000384161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052009163,0.000011619253,0.9983271,0.000010520803,0.000007860337,0.00016870425,0.00002184679,0.0000055401306,0.00018361847,0.00000421229,0.000050382143,0.0011566363],"study_design_scores_gemma":[0.000001608543,0.000059573566,0.99774015,0.000006436081,0.000011338369,0.0018190915,0.0000763796,0.00003707193,0.00011292265,0.0000071123077,0.00012636477,0.0000020098948],"about_ca_topic_score_codex":0.002749436,"about_ca_topic_score_gemma":0.0024442389,"teacher_disagreement_score":0.002749436,"about_ca_system_score_codex":0.0002671161,"about_ca_system_score_gemma":0.00027127797,"threshold_uncertainty_score":0.007469535},"labels":[],"label_agreement":null},{"id":"W4388591133","doi":"10.1093/neuonc/noad179.1147","title":"TMIC-82. SPATIAL AND SINGLE-CELL PROTEOMIC LANDSCAPING OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; The Scarborough Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Mass cytometry; Biology; Immune system; Hypoxia (environmental); Tumor microenvironment; Pathology; Cancer research; Angiogenesis; Cell; Immunohistochemistry; Tumor hypoxia; Immunology; Medicine; Radiation therapy; Phenotype; Internal medicine; Chemistry","score_opus":0.009624555154845863,"score_gpt":0.2251201950069586,"score_spread":0.21549563985211273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388591133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934815,0.0014931269,0.0017258323,0.000082197475,0.000022035325,0.00004007223,0.0015089959,0.00006167483,0.0015844665],"genre_scores_gemma":[0.99286264,0.00080959947,0.0022382825,0.00006173471,0.000008876307,0.000044794855,0.0023703484,0.000010007846,0.0015937476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999959,0.0000042136908,0.0000028546765,0.000009882753,0.000011423172,0.00001257316],"domain_scores_gemma":[0.99997807,0.0000019178135,0.0000049447262,0.0000026021316,0.000004767098,0.000007798058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007440622,0.00014854583,0.00014412828,0.00017949099,0.000116636395,0.00018409168,0.00007351608,0.00012030098,0.00060952565],"category_scores_gemma":[0.00007028074,0.00006742975,0.00009347961,0.00019785567,0.00009124342,0.000071957365,0.00008632009,0.00014910041,0.00027945754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014268556,0.000021244572,0.0010094314,0.000027477525,0.0000035536268,0.00005252138,0.00000959074,0.00007676255,0.9961934,0.0000279403,0.00010658329,0.0023287472],"study_design_scores_gemma":[0.000027085853,0.0008913161,0.10995592,0.000010228661,0.000045959478,0.0012245849,0.00011453793,0.0038115575,0.8782985,0.00008804528,0.005522145,0.000010107817],"about_ca_topic_score_codex":0.0008316899,"about_ca_topic_score_gemma":0.0013875881,"teacher_disagreement_score":0.0008316899,"about_ca_system_score_codex":0.00015857497,"about_ca_system_score_gemma":0.00015535345,"threshold_uncertainty_score":0.0020390153},"labels":[],"label_agreement":null},{"id":"W4388794664","doi":"10.1093/neuonc/noad179.1202","title":"LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT <i>IDH1</i> OR <i>IDH2</i> DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 INDIGO STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Medicine; Magnetic resonance imaging; Glioma; Isocitrate dehydrogenase; Nuclear medicine; IDH1; IDH2; Randomized controlled trial; Internal medicine; Urology; Radiology; Pathology; Nuclear magnetic resonance; Mutant","score_opus":0.05801742463777383,"score_gpt":0.36938723975326787,"score_spread":0.31136981511549405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388794664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782236,0.010947474,0.00043718517,0.000832161,0.0003619598,0.0006716928,0.0031219746,0.00029249175,0.0051113563],"genre_scores_gemma":[0.9901896,0.0028804026,0.00056501327,0.0006116732,0.00012807723,0.0005371384,0.002337557,0.000032033815,0.002718435],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995803,0.00022860986,0.000026723823,0.000055290042,0.000045058474,0.00006408407],"domain_scores_gemma":[0.99960095,0.00009599462,0.00010742043,0.000031184958,0.000024224275,0.00014032677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011774583,0.0006112066,0.0015530303,0.0002442137,0.00018312859,0.0009092149,0.00056289847,0.0008058632,0.0072710887],"category_scores_gemma":[0.0008264297,0.00026793077,0.0009913836,0.00025994668,0.0006311715,0.0005796203,0.00016906156,0.0016837567,0.001743856],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8758858,0.00936246,0.002190253,0.0011987755,0.0009792359,0.00006823863,0.000053891603,0.0009966824,0.020184953,0.00030263173,0.0038986024,0.08487851],"study_design_scores_gemma":[0.64458215,0.32063848,0.019406257,0.00017042797,0.0013509743,0.00025852467,0.00008576556,0.0014566707,0.006753198,0.00042449325,0.004819621,0.000053445623],"about_ca_topic_score_codex":0.00053794304,"about_ca_topic_score_gemma":0.0015933918,"teacher_disagreement_score":0.0072710887,"about_ca_system_score_codex":0.0005048102,"about_ca_system_score_gemma":0.00088097254,"threshold_uncertainty_score":0.024324179},"labels":[],"label_agreement":null},{"id":"W4389776001","doi":"10.1093/neuonc/noad215","title":"Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Institut Servier; Servier; Hospices Civils de Lyon","keywords":"Medicine; Interquartile range; Radiosurgery; Hazard ratio; Hypopituitarism; Confidence interval; Internal medicine; Pituitary tumors; Nuclear medicine; Urology; Radiation therapy","score_opus":0.03862930551718622,"score_gpt":0.3120743884343426,"score_spread":0.27344508291715636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389776001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958366,0.00021834887,0.000049842918,0.000015121102,0.0000017361931,0.000013767828,0.00006127341,0.0000011305686,0.000055152093],"genre_scores_gemma":[0.99960107,0.00010220456,0.00006447332,0.000010983959,0.0000095394,0.000011915394,0.00016453135,0.0000019282352,0.00003337904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992386,0.00035270638,0.00005805982,0.00017554582,0.000117158525,0.000057883954],"domain_scores_gemma":[0.9979825,0.0002991351,0.0010871356,0.0001853856,0.00015778819,0.0002881219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018729619,0.00045991622,0.0004440175,0.00045406132,0.00037736585,0.00039031278,0.00032584596,0.000231221,0.00070993387],"category_scores_gemma":[0.001580955,0.0002966894,0.00072814064,0.00054195785,0.00037925513,0.00033621286,0.0003823983,0.00039596413,0.0001539976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029661946,0.00028717256,0.9904772,0.000031399566,0.00041238285,0.00030939438,0.00022704527,0.000111252026,0.001865894,0.000022283511,0.0001068272,0.003182842],"study_design_scores_gemma":[0.00033651094,0.00263002,0.9938319,0.000008240077,0.00024482427,0.0016403166,0.00018452868,0.0003021349,0.00038947392,0.000020316736,0.00040091065,0.000010796787],"about_ca_topic_score_codex":0.0015305978,"about_ca_topic_score_gemma":0.0012065219,"teacher_disagreement_score":0.0018729619,"about_ca_system_score_codex":0.00039386514,"about_ca_system_score_gemma":0.00042812582,"threshold_uncertainty_score":0.009905279},"labels":[],"label_agreement":null},{"id":"W4389800287","doi":"10.1093/neuonc/noad230","title":"Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fetal and Pediatric Neurological Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Brain Institute; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Autism; Lesion; Connectome; Neuroscience; Prefrontal cortex; Psychology; Autism spectrum disorder; Medicine; Functional connectivity; Psychiatry; Cognition","score_opus":0.027043237060381572,"score_gpt":0.2876712719687268,"score_spread":0.26062803490834524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389800287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986929,0.00009008491,0.00061990204,0.000016647862,0.0000026668504,0.000010173646,0.00017443325,0.000021511087,0.00037163662],"genre_scores_gemma":[0.9992939,0.00007087216,0.00036161434,0.0000073990063,0.000002527508,0.0000074412164,0.0002018442,0.0000036308852,0.000050758415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997471,0.000019889954,0.00002951306,0.00009677799,0.00006812943,0.000038465678],"domain_scores_gemma":[0.9992298,0.00009590573,0.0005302252,0.000038275954,0.000040484258,0.00006529975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014089237,0.00038931926,0.00022093685,0.00070549705,0.00034596407,0.0003028622,0.0002528406,0.00020979306,0.0011066155],"category_scores_gemma":[0.0010561554,0.00012084803,0.00016972766,0.0005961384,0.0006717905,0.00027404938,0.00052966626,0.00018318414,0.00011979123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019355699,0.000036081958,0.94474953,0.00010337925,0.00009710277,0.023761068,0.00035561863,0.0004349,0.016676534,0.00050419726,0.00042249289,0.012665465],"study_design_scores_gemma":[0.000008671471,0.00010089235,0.92545825,0.000018159784,0.00004466883,0.07054021,0.0003285734,0.00070197636,0.0019173587,0.00026862964,0.000604575,0.000008043582],"about_ca_topic_score_codex":0.0031463471,"about_ca_topic_score_gemma":0.007016688,"teacher_disagreement_score":0.0031463471,"about_ca_system_score_codex":0.00036946332,"about_ca_system_score_gemma":0.0005057421,"threshold_uncertainty_score":0.006256044},"labels":[],"label_agreement":null},{"id":"W4390132029","doi":"10.1093/neuonc/noad253","title":"Management of sporadic intracanalicular vestibular schwannomas: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Schwannoma; Guideline; Meta-analysis; Acoustic neuroma; Facial nerve; Radiology; Surgery; Internal medicine; Radiation therapy; Pathology","score_opus":0.15592663211883456,"score_gpt":0.44663820355659334,"score_spread":0.2907115714377588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390132029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008878033,0.99742496,0.00018973429,0.0009548809,0.00013036304,0.00015113037,0.00010252357,0.000007037192,0.00015163161],"genre_scores_gemma":[0.021569304,0.9745272,0.0018306725,0.0011801138,0.00017301759,0.00044082553,0.00020476454,0.0000065102213,0.000067624125],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873399,0.0042682905,0.0057051196,0.00077230943,0.0016865717,0.00022777471],"domain_scores_gemma":[0.94685376,0.03179283,0.012986154,0.0007405263,0.0072096055,0.00041716325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02482181,0.0015159466,0.0059831054,0.011639235,0.0005659479,0.002314777,0.0027261076,0.0019109679,0.0013563643],"category_scores_gemma":[0.061117046,0.0009998283,0.007555886,0.008450224,0.0010713459,0.00229836,0.0011777501,0.0009672503,0.00020175609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046175133,0.000028251592,0.0034685873,0.86049396,0.023669224,0.00018142207,0.0004141035,0.0003916733,0.00036545758,0.00049695314,0.0052346014,0.10479395],"study_design_scores_gemma":[0.0004287168,0.00038973434,0.009598585,0.8076713,0.14587003,0.00064624014,0.0005819718,0.00034942923,0.00038154685,0.0010276871,0.03297756,0.00007723303],"about_ca_topic_score_codex":0.00467132,"about_ca_topic_score_gemma":0.0138696935,"teacher_disagreement_score":0.02482181,"about_ca_system_score_codex":0.0038969803,"about_ca_system_score_gemma":0.01038117,"threshold_uncertainty_score":0.13127184},"labels":[],"label_agreement":null},{"id":"W4390237156","doi":"10.1093/neuonc/noad227","title":"Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Clinical trial; Medicine; Clinical endpoint; Pace; Quality of life (healthcare); Glioma; Dosing; Clinical study design; Intensive care medicine; Pediatrics; Internal medicine; Nursing","score_opus":0.20088572179948258,"score_gpt":0.4618926606091563,"score_spread":0.26100693880967374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390237156","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033938608,0.15605278,0.28025144,0.29717118,0.030575715,0.16530898,0.010542242,0.003143715,0.053560097],"genre_scores_gemma":[0.019836036,0.04328687,0.6152374,0.10872913,0.0084368335,0.18479188,0.008838746,0.001317167,0.009525993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6146458,0.2800999,0.06603734,0.0076180995,0.024170497,0.0074284202],"domain_scores_gemma":[0.65462184,0.13562143,0.04420958,0.02763721,0.11508538,0.022824625],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41487506,0.003984495,0.011159926,0.0066298135,0.00551412,0.017044606,0.021660805,0.024021234,0.0049148086],"category_scores_gemma":[0.27146795,0.003944028,0.02103119,0.009638662,0.008234263,0.006700102,0.0083885295,0.03319068,0.010515776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00706015,0.00077807915,0.0025803144,0.04317535,0.004090519,0.00095669826,0.0028336777,0.0064917,0.003929185,0.051691413,0.5592253,0.31718755],"study_design_scores_gemma":[0.01126767,0.0016984906,0.0049661133,0.07145317,0.004120959,0.0009983764,0.0009197071,0.0047999644,0.0030207185,0.06049578,0.8357806,0.00047842402],"about_ca_topic_score_codex":0.007238662,"about_ca_topic_score_gemma":0.010261142,"teacher_disagreement_score":0.58512497,"about_ca_system_score_codex":0.009064579,"about_ca_system_score_gemma":0.06901133,"threshold_uncertainty_score":0.7215632},"labels":[],"label_agreement":null},{"id":"W4391048911","doi":"10.1093/neuonc/noad239","title":"Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Glioblastoma; Library science; Medicine; Oncology; Internal medicine; Cancer research; Computer science","score_opus":0.01550966452913645,"score_gpt":0.2800069366418131,"score_spread":0.26449727211267665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391048911","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014514393,0.013921506,0.0001240438,0.9023977,0.08267232,0.0000072174826,0.00011179994,0.00006559631,0.0005546474],"genre_scores_gemma":[0.0029438229,0.030934624,0.00037099977,0.7965256,0.16175212,0.000041632644,0.00012942849,0.00007390045,0.0072278865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960626,0.00074037915,0.0007279454,0.0006288839,0.0013968804,0.00044331394],"domain_scores_gemma":[0.9723963,0.010781238,0.0015020481,0.0010052366,0.0111022545,0.0032129127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00695341,0.0013843193,0.0028265198,0.0020318378,0.002603434,0.0043805293,0.0038873595,0.026684292,0.010985576],"category_scores_gemma":[0.03728031,0.0008687981,0.0019997281,0.0017127475,0.0061654556,0.010355423,0.0034763154,0.038773462,0.009238078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043747234,0.000009982858,0.00013446122,0.00014711326,0.000013040853,0.00016816008,0.0000651323,0.000030061357,0.00007636911,0.0006379883,0.9904516,0.008222258],"study_design_scores_gemma":[0.00012906146,0.00008671067,0.00087174465,0.0007260311,0.00008005131,0.0017357782,0.00083529094,0.00022313566,0.00046306863,0.01017353,0.98452884,0.00014680588],"about_ca_topic_score_codex":0.00532644,"about_ca_topic_score_gemma":0.006078441,"teacher_disagreement_score":0.026684292,"about_ca_system_score_codex":0.003701829,"about_ca_system_score_gemma":0.005499102,"threshold_uncertainty_score":0.036773562},"labels":[],"label_agreement":null},{"id":"W4391050603","doi":"10.1093/neuonc/noae009","title":"Prognostic value of DNA methylation subclassification, aneuploidy, and <i>CDKN2A/B</i> homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gray Family Foundation; National Institute of Neurological Disorders and Stroke; NYU Grossman School of Medicine; National Cancer Institute; National Institutes of Health; Friedberg Charitable Foundation; Saitama Medical University; Making Headway Foundation; Deutsches Krebsforschungszentrum","keywords":"CDKN2A; Aneuploidy; Cancer research; DNA methylation; Biology; Mutant; Methylation; Molecular biology; DNA; Genetics; Gene; Chromosome; Gene expression","score_opus":0.045960270906536475,"score_gpt":0.36291175620368443,"score_spread":0.31695148529714795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391050603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962175,0.00009067548,0.00005373672,0.000010361693,0.0000013621662,0.0000024154845,0.00010575441,0.0000019971458,0.00011204522],"genre_scores_gemma":[0.99966943,0.000029125233,0.000061984276,0.0000025953739,0.000002360473,0.0000019174738,0.00018751647,0.0000010665553,0.00004394522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988043,0.000024697842,0.000018401794,0.000031621516,0.000024756137,0.000020069327],"domain_scores_gemma":[0.9989549,0.0002935671,0.00039334263,0.00006188187,0.00010684481,0.00018945533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053004833,0.00018562391,0.00015290504,0.0008527097,0.0001755334,0.00036469818,0.0001997655,0.00023798969,0.00085861667],"category_scores_gemma":[0.0015062396,0.000108390515,0.00019493113,0.0003786796,0.00020659556,0.00023285327,0.00023543261,0.00023329418,0.00016192209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013747507,0.000005588594,0.9983925,0.0000018501603,0.000013770083,0.00001827386,0.0000101764845,0.00006140396,0.000452431,0.0000034547618,0.000018033992,0.0008849101],"study_design_scores_gemma":[0.000005543937,0.00007723557,0.99839574,0.000003604035,0.000031358348,0.00020894912,0.000049074068,0.0006984813,0.00043416244,0.000022749005,0.00007098851,0.00000218392],"about_ca_topic_score_codex":0.002698684,"about_ca_topic_score_gemma":0.005540827,"teacher_disagreement_score":0.002698684,"about_ca_system_score_codex":0.0002823954,"about_ca_system_score_gemma":0.0002785664,"threshold_uncertainty_score":0.005365908},"labels":[],"label_agreement":null},{"id":"W4391212727","doi":"10.1093/neuonc/noae013","title":"Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Toronto; Université de Montréal; McGill University Health Centre; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Fondation du cancer du sein du Québec","keywords":"Cancer research; Astrocyte; Brain cancer; Neuroscience; Medicine; Chemistry; Biology; Internal medicine; Cancer; Central nervous system","score_opus":0.021984281394992415,"score_gpt":0.30962978465020535,"score_spread":0.28764550325521293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391212727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951656,0.00074060814,0.0024224033,0.000065533226,0.000008576338,0.000027956388,0.0006290839,0.00009638403,0.0008439305],"genre_scores_gemma":[0.99617445,0.00030976257,0.0011815081,0.00003264715,0.000004266346,0.00004508594,0.00079377147,0.000016444348,0.0014419641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999027,0.000008010521,0.000007459055,0.000020213818,0.00003691752,0.000024597739],"domain_scores_gemma":[0.9998411,0.000015230834,0.000057598987,0.000011959928,0.000022767668,0.000051349783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000948787,0.00023239173,0.00016059267,0.00027457403,0.000116940646,0.00020821697,0.000084957144,0.00016723285,0.0014563965],"category_scores_gemma":[0.00009543183,0.00013652116,0.00018238001,0.00015555593,0.0002015665,0.00009881067,0.00016437734,0.00064294494,0.0004911478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009478827,0.000014616282,0.0007116736,0.00001635997,0.0000030164185,0.000050681134,0.000010105379,0.0000131625775,0.998657,0.000015689284,0.000023076911,0.00038985506],"study_design_scores_gemma":[0.000017937553,0.00035385435,0.07220785,0.000005846631,0.000016759037,0.0011364057,0.000083909385,0.0010776382,0.923914,0.00007521251,0.0011042757,0.000006249496],"about_ca_topic_score_codex":0.0011408151,"about_ca_topic_score_gemma":0.0016333417,"teacher_disagreement_score":0.0014563965,"about_ca_system_score_codex":0.00025340702,"about_ca_system_score_gemma":0.00015325812,"threshold_uncertainty_score":0.004872203},"labels":[],"label_agreement":null},{"id":"W4391680089","doi":"10.1093/neuonc/noae015","title":"Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research UK; National Institutes of Health; National Center for Advancing Translational Sciences; Brain Tumour Charity; National Institute for Health and Care Research; U.S. National Library of Medicine","keywords":"Senescence; Biology; Wnt signaling pathway; Phenotype; Cell biology; PI3K/AKT/mTOR pathway; Gene expression; Signal transduction; Cancer research; Cytokine; Gene; Immunology; Genetics","score_opus":0.04077302181136114,"score_gpt":0.3044155289531641,"score_spread":0.26364250714180293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391680089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77228594,0.0019936308,0.22159296,0.00060400774,0.000049879545,0.00007548463,0.0013958907,0.0006536505,0.0013484667],"genre_scores_gemma":[0.93758464,0.00059256307,0.058774482,0.00012414901,0.00007224206,0.00010154802,0.0019396174,0.00006184102,0.0007489857],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99972874,0.000066961824,0.000020311956,0.00009048555,0.000044535125,0.000048938582],"domain_scores_gemma":[0.99970394,0.00013002062,0.00006545491,0.000023174716,0.000048619277,0.000028766848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077580754,0.0007645389,0.000502392,0.0012989881,0.0002543884,0.0007059752,0.00033431174,0.00042497372,0.0004955879],"category_scores_gemma":[0.0008059369,0.00014789373,0.0008048445,0.0005405253,0.00031502248,0.0003266646,0.0004531907,0.0006124122,0.00017378127],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010111057,0.00057119195,0.16480173,0.00055575906,0.00054944697,0.0016967445,0.00056564965,0.22191258,0.27628967,0.0029390862,0.0048883087,0.32421875],"study_design_scores_gemma":[0.000011028139,0.00013775851,0.02828088,0.000029361176,0.00007969772,0.00027872098,0.00017376931,0.9474545,0.018102404,0.003599322,0.0018203201,0.000032195447],"about_ca_topic_score_codex":0.0011495758,"about_ca_topic_score_gemma":0.0013060624,"teacher_disagreement_score":0.0012989881,"about_ca_system_score_codex":0.00030814734,"about_ca_system_score_gemma":0.00037740418,"threshold_uncertainty_score":0.0041029453},"labels":[],"label_agreement":null},{"id":"W4391727359","doi":"10.1093/neuonc/noae004","title":"The greatest challenge for pediatric low-grade glioma","year":2024,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"American Lebanese Syrian Associated Charities","keywords":"Glioma; Medicine; Psychology; Cancer research","score_opus":0.021680342177018194,"score_gpt":0.31999787418122827,"score_spread":0.2983175320042101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391727359","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030097019,0.010779997,0.00008479784,0.10361291,0.8838655,0.00001271443,0.000034731234,0.00003542905,0.0015439219],"genre_scores_gemma":[0.00028230567,0.004740629,0.00006952922,0.047827225,0.9426425,0.000016077478,0.000020033449,0.000020302368,0.0043813116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99570066,0.0010806891,0.0005564317,0.00046967893,0.0018523029,0.00034020917],"domain_scores_gemma":[0.9782883,0.009974995,0.0013458591,0.00045549517,0.0060226456,0.0039127534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006712035,0.0031457567,0.00354382,0.002919873,0.0032352174,0.0070738024,0.0030403852,0.025162222,0.0092952605],"category_scores_gemma":[0.028098473,0.0013226363,0.0026658957,0.0012640998,0.0025221354,0.0053360583,0.0023373622,0.034541465,0.0068822126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014496147,0.0000049912505,0.00002274669,0.00012146599,0.0000120650175,0.00008027019,0.000007925617,0.000017295795,0.000018653298,0.0001912936,0.9953329,0.0041758204],"study_design_scores_gemma":[0.00007808135,0.00003430205,0.0003235629,0.00067308627,0.00008073012,0.00039584556,0.0000527864,0.00014734043,0.00006061429,0.0013593936,0.9967691,0.000025202433],"about_ca_topic_score_codex":0.003989037,"about_ca_topic_score_gemma":0.012144441,"teacher_disagreement_score":0.025162222,"about_ca_system_score_codex":0.005165682,"about_ca_system_score_gemma":0.004437962,"threshold_uncertainty_score":0.037479818},"labels":[],"label_agreement":null},{"id":"W4392091868","doi":"10.1093/neuonc/noae011","title":"Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Cancer stem cell; Biology; Phenotype; Stem cell; Tumor initiation; Glioblastoma; Cancer; Computational biology; Neuroscience; Population; Cancer research; Carcinogenesis; Genetics; Gene; Medicine","score_opus":0.056584379339052374,"score_gpt":0.336925615272217,"score_spread":0.2803412359331646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392091868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008655416,0.9968644,0.00018023424,0.001219826,0.00032208615,0.000003833628,0.00001866168,0.0000072192493,0.0012971794],"genre_scores_gemma":[0.0006794032,0.99795413,0.00013273385,0.00053991337,0.0002299629,0.000005135309,0.000023757075,0.0000015832845,0.00043338808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998363,0.000033966036,0.000022460415,0.000027447497,0.000059579626,0.000020289495],"domain_scores_gemma":[0.9996972,0.00015193356,0.0000283184,0.000006661955,0.00008572597,0.00003015375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007178943,0.0006274811,0.0010180363,0.0017672165,0.00036569408,0.0010015917,0.00076659257,0.0014324896,0.0026454863],"category_scores_gemma":[0.000884608,0.0001974616,0.0005116079,0.001749533,0.0009787384,0.0019857225,0.00070580473,0.002134822,0.0013874897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000715217,0.0000347071,0.00029026132,0.016231984,0.000057292986,0.0002997235,0.00014052688,0.00046168,0.0013374985,0.023325022,0.05102629,0.9067235],"study_design_scores_gemma":[0.000007634114,0.000051795312,0.0005740982,0.0036925776,0.00005463272,0.0010121055,0.00008799528,0.00008360762,0.00029530082,0.008428198,0.9856942,0.000017739572],"about_ca_topic_score_codex":0.0020849928,"about_ca_topic_score_gemma":0.002577858,"teacher_disagreement_score":0.0026454863,"about_ca_system_score_codex":0.0012300501,"about_ca_system_score_gemma":0.0021389013,"threshold_uncertainty_score":0.008924663},"labels":[],"label_agreement":null},{"id":"W4392383461","doi":"10.1093/neuonc/noad260","title":"Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Varian Medical Systems","keywords":"Medicine; Neuroscience; Intensive care medicine; Medical physics; Psychology","score_opus":0.09528532878963727,"score_gpt":0.4073076194701921,"score_spread":0.31202229068055487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101667094,0.9981134,0.00018938891,0.0007556104,0.00014188403,0.0000034253567,0.0000075103903,0.0000045172123,0.00068267906],"genre_scores_gemma":[0.00074263645,0.99816954,0.00028521565,0.0003380161,0.00019885511,0.0000061358087,0.00001268529,0.0000016307841,0.00024520973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997948,0.000055945304,0.000030130448,0.000033526725,0.00006596414,0.000019653506],"domain_scores_gemma":[0.99948597,0.0003170881,0.000051281535,0.000017902676,0.00010174672,0.00002608548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009073992,0.0005835871,0.0013970243,0.0015590354,0.0002475598,0.0011265208,0.00095846574,0.0012985996,0.0025796585],"category_scores_gemma":[0.00096678094,0.00019116043,0.0006306502,0.0012895402,0.0007869352,0.0016762305,0.00064332713,0.0028834515,0.0012985324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005402371,0.000071348644,0.0001253234,0.013665915,0.00009456199,0.00021001956,0.00007800461,0.0005777995,0.001247515,0.0092886565,0.017934944,0.9566518],"study_design_scores_gemma":[0.000024635052,0.00017500207,0.00075298006,0.009533963,0.00014417386,0.002156455,0.00012462294,0.0002504698,0.00049180107,0.008613534,0.9777068,0.000025668121],"about_ca_topic_score_codex":0.00085447216,"about_ca_topic_score_gemma":0.0022307234,"teacher_disagreement_score":0.0025796585,"about_ca_system_score_codex":0.0006100586,"about_ca_system_score_gemma":0.0010594573,"threshold_uncertainty_score":0.008629799},"labels":[],"label_agreement":null},{"id":"W4392383663","doi":"10.1093/neuonc/noad258","title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Margin (machine learning); Horizon; Glioblastoma; Computer science; Data science; Biology; Machine learning; Cancer research; Physics; Astronomy","score_opus":0.046336094332469165,"score_gpt":0.3727056468891048,"score_spread":0.32636955255663563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083231724,0.99837047,0.00020101426,0.0006400721,0.00020024815,0.0000027963054,0.000007801991,0.000006712742,0.0004877343],"genre_scores_gemma":[0.0006420886,0.9980889,0.0003007234,0.0004479535,0.00021969524,0.00000502511,0.000015213572,0.0000025796153,0.0002777645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997873,0.00004950296,0.000030190395,0.000035953428,0.000075212316,0.0000219502],"domain_scores_gemma":[0.9994368,0.00031470973,0.000060467388,0.000018124982,0.0001375753,0.000032176897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009860924,0.00071609486,0.0013107731,0.0013678819,0.0002252477,0.0011410698,0.00085720327,0.0014087041,0.0027958783],"category_scores_gemma":[0.0010957187,0.00025251275,0.0007480151,0.0014722632,0.00070927787,0.0024494822,0.00061655685,0.0024925678,0.0014048283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076869444,0.00006488408,0.00012133208,0.018546607,0.00008482858,0.00012611461,0.00010043091,0.0005705725,0.0013559402,0.009689668,0.019847173,0.9494157],"study_design_scores_gemma":[0.000018306844,0.00017187906,0.0005538763,0.005015336,0.00011079115,0.00073501567,0.000086471155,0.00017010211,0.00040690892,0.005814067,0.98689157,0.000025677635],"about_ca_topic_score_codex":0.0011260686,"about_ca_topic_score_gemma":0.0019310482,"teacher_disagreement_score":0.0027958783,"about_ca_system_score_codex":0.0007035948,"about_ca_system_score_gemma":0.0013528186,"threshold_uncertainty_score":0.009353161},"labels":[],"label_agreement":null},{"id":"W4392383680","doi":"10.1093/neuonc/noae002","title":"Pushing the boundaries of radiation technology for the management of central nervous system tumors","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Varian Medical Systems","keywords":"Central nervous system; Neuroscience; Medicine; Biology","score_opus":0.014237464976619069,"score_gpt":0.28129883759956553,"score_spread":0.2670613726229465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383680","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018436035,0.54937434,0.0215706,0.3668794,0.00565608,0.00005520796,0.00017938389,0.00018775996,0.037661172],"genre_scores_gemma":[0.37060148,0.46035513,0.047248024,0.09461192,0.0196555,0.00015443392,0.00020918016,0.00044014462,0.006724137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930676,0.0036592432,0.0006028462,0.00043641828,0.001761596,0.0004723647],"domain_scores_gemma":[0.9776234,0.016138924,0.001967018,0.0007642786,0.002178786,0.0013276878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01831628,0.0005830031,0.0010560061,0.0020760628,0.0014776052,0.007869425,0.0019232642,0.0038972783,0.0064675235],"category_scores_gemma":[0.025826761,0.00031056697,0.0010557657,0.0009144617,0.006044055,0.01194538,0.0046025896,0.009061471,0.0016920972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009097667,0.000283824,0.007852031,0.0026395288,0.0002470651,0.0012111416,0.0013872458,0.005301645,0.0052560675,0.15015967,0.055872604,0.76887935],"study_design_scores_gemma":[0.00015464578,0.0011702083,0.01088468,0.0104612075,0.0002891116,0.0050467066,0.004842325,0.0042042555,0.004814253,0.2291373,0.72877216,0.00022311506],"about_ca_topic_score_codex":0.0032208702,"about_ca_topic_score_gemma":0.008597845,"teacher_disagreement_score":0.01831628,"about_ca_system_score_codex":0.0038814445,"about_ca_system_score_gemma":0.00885838,"threshold_uncertainty_score":0.096866906},"labels":[],"label_agreement":null},{"id":"W4392383953","doi":"10.1093/neuonc/noad225","title":"Stereotactic body radiation therapy for spinal metastases: A new standard of care","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Standard of care; Radiology; Surgery","score_opus":0.06956092265825706,"score_gpt":0.42341474750623,"score_spread":0.3538538248479729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009534646,0.9974631,0.00016497975,0.0007640633,0.00023256379,0.0000041771036,0.000016370592,0.0000073889237,0.001252034],"genre_scores_gemma":[0.00054468605,0.9982843,0.00019393644,0.00036771694,0.00022061406,0.000004080053,0.000024975507,0.0000016367774,0.00035801032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974936,0.000047972877,0.000036864538,0.00003912118,0.00010938895,0.000017254943],"domain_scores_gemma":[0.9996438,0.00015929654,0.000052635234,0.000010748359,0.00010880053,0.000024616571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055385794,0.0005626968,0.00095580786,0.0018486001,0.00023583857,0.00089390244,0.0006375812,0.0008997554,0.0034184288],"category_scores_gemma":[0.0008145696,0.00014808225,0.0004972308,0.0018096588,0.0005166991,0.0013115823,0.0004915396,0.0018478322,0.0016291095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037284717,0.00003521163,0.00017206867,0.014651239,0.00006620048,0.00019154027,0.00006341103,0.0002520815,0.0012337915,0.0040512555,0.029450707,0.94979525],"study_design_scores_gemma":[0.000008883763,0.00007435575,0.00061432656,0.004904525,0.000084229185,0.0015647088,0.0000555783,0.00006811388,0.00024544873,0.0019653435,0.9904004,0.000014020295],"about_ca_topic_score_codex":0.0011496525,"about_ca_topic_score_gemma":0.0022154313,"teacher_disagreement_score":0.0034184288,"about_ca_system_score_codex":0.0006183158,"about_ca_system_score_gemma":0.0013052617,"threshold_uncertainty_score":0.011435747},"labels":[],"label_agreement":null},{"id":"W4392617890","doi":"10.1093/neuonc/noae041","title":"Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Lung cancer; Oncology; Radiation therapy; Anaplastic lymphoma kinase; Internal medicine; Epidermal growth factor receptor; Precision medicine; Cancer; Pathology","score_opus":0.02122577001766642,"score_gpt":0.3476098907851175,"score_spread":0.3263841207674511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392617890","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004256204,0.16524844,0.01684998,0.27863893,0.046839524,0.06952351,0.24025108,0.00095742574,0.17743485],"genre_scores_gemma":[0.037604067,0.22285804,0.10043183,0.13237943,0.026781766,0.14761531,0.26769754,0.0014579495,0.063173965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9693587,0.009042949,0.014352597,0.0010814285,0.0050308364,0.001133437],"domain_scores_gemma":[0.8464541,0.037048567,0.026966184,0.0030409868,0.08140204,0.0050881337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041290388,0.0016202349,0.0042192624,0.008716854,0.0018706218,0.0047415756,0.0047415392,0.0052876226,0.03252207],"category_scores_gemma":[0.11405785,0.0012731222,0.0039372058,0.008375545,0.0010971825,0.0029683372,0.0028498878,0.0038481199,0.01971863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019942378,0.00004188809,0.0019316404,0.019911535,0.00015647087,0.00012966634,0.00016561501,0.00024800946,0.00027369877,0.0019856573,0.90562123,0.069335185],"study_design_scores_gemma":[0.0003205273,0.00013358622,0.008889346,0.061459795,0.00045970766,0.00026735812,0.00032146744,0.00026318803,0.00031468674,0.0023200063,0.9251608,0.000089501424],"about_ca_topic_score_codex":0.008629198,"about_ca_topic_score_gemma":0.013047658,"teacher_disagreement_score":0.041290388,"about_ca_system_score_codex":0.0044732573,"about_ca_system_score_gemma":0.028069114,"threshold_uncertainty_score":0.21836704},"labels":[],"label_agreement":null},{"id":"W4392951258","doi":"10.1093/neuonc/noae053","title":"Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Ottawa; Université Laval; Centre Hospitalier de l’Université de Montréal; Queen's University; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Institut National de la Santé et de la Recherche Médicale; European Organisation for Research and Treatment of Cancer; Centre National de la Recherche Scientifique; University of Ottawa","keywords":"Glioblastoma; Randomized controlled trial; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.0115263114028471,"score_gpt":0.28380151986380736,"score_spread":0.27227520846096026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392951258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696824,0.012698308,0.0006597424,0.002612733,0.0011072487,0.007556071,0.0024830506,0.00017317657,0.0030271865],"genre_scores_gemma":[0.9676943,0.007586335,0.0020688633,0.0030879523,0.00075755693,0.012044779,0.0028756405,0.000044877965,0.0038397454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99949515,0.00027839205,0.000026424943,0.00008181122,0.000040527266,0.00007763176],"domain_scores_gemma":[0.99917287,0.00015190443,0.00023854613,0.00006749917,0.000059738708,0.00030933286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00197364,0.0016015291,0.0024772885,0.0004416885,0.0004738062,0.0010017701,0.00079942856,0.0012744556,0.0053386176],"category_scores_gemma":[0.0017331237,0.00053057226,0.0021417262,0.0005295754,0.00071267446,0.00078762503,0.0004230282,0.0021161123,0.00078997394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97808915,0.0027280196,0.0009308861,0.0005881659,0.0010279869,0.0000646951,0.000038068974,0.00037983243,0.001551084,0.00010645016,0.0018935,0.012602079],"study_design_scores_gemma":[0.97553885,0.020661576,0.0017514665,0.000036386635,0.00047478123,0.00004029112,0.000011418713,0.00031423394,0.00012751896,0.00019387844,0.00083953096,0.000009967009],"about_ca_topic_score_codex":0.0018760953,"about_ca_topic_score_gemma":0.0052507627,"teacher_disagreement_score":0.0053386176,"about_ca_system_score_codex":0.0012751252,"about_ca_system_score_gemma":0.002151066,"threshold_uncertainty_score":0.0178594},"labels":[],"label_agreement":null},{"id":"W4396592399","doi":"10.1093/neuonc/noae082","title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"National Cancer Institute","keywords":"Meningioma; Consensus conference; Medicine; Medical physics; Library science; Computer science; Pathology; Internal medicine","score_opus":0.1883482153606337,"score_gpt":0.4648894672680111,"score_spread":0.27654125190737744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396592399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064529036,0.8214643,0.002988986,0.1283447,0.028357992,0.0005005325,0.0012782734,0.00015533133,0.016264595],"genre_scores_gemma":[0.006456182,0.9160286,0.008307153,0.047073536,0.010549156,0.0008756252,0.0038012257,0.00011953999,0.006788895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921434,0.002270694,0.0021656465,0.00044600206,0.0024105497,0.00056372257],"domain_scores_gemma":[0.9751517,0.006865041,0.0032901214,0.0006441231,0.012296631,0.0017523508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016694508,0.0011295924,0.001690969,0.006417084,0.0014227959,0.0036471945,0.003157123,0.004587549,0.0048975865],"category_scores_gemma":[0.036660016,0.00043394516,0.002436844,0.0048433244,0.0012515825,0.0031225143,0.0036285836,0.004191371,0.0035876776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010094786,0.000031173742,0.0006967813,0.016967276,0.000156978,0.0003001334,0.00036794442,0.0003328332,0.00047012515,0.008988753,0.6674398,0.30414736],"study_design_scores_gemma":[0.000024545996,0.000032964883,0.0006559062,0.025145262,0.0002033721,0.000679234,0.00026112024,0.000060597424,0.00017264065,0.0031670565,0.96957237,0.000024874564],"about_ca_topic_score_codex":0.007072587,"about_ca_topic_score_gemma":0.01123113,"teacher_disagreement_score":0.016694508,"about_ca_system_score_codex":0.00486268,"about_ca_system_score_gemma":0.030003738,"threshold_uncertainty_score":0.088290036},"labels":[],"label_agreement":null},{"id":"W4396903194","doi":"10.1093/neuonc/noae074","title":"Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Rigshospitalet; Novartis Pharmaceuticals Corporation; University College London; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Pediatric Brain Tumor Foundation","keywords":"Medicine; Glioma; Oncology; Natural history; Internal medicine; Targeted therapy; Clinical trial; Cancer research; Cancer","score_opus":0.03238611905169145,"score_gpt":0.29302353762105454,"score_spread":0.26063741856936307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396903194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6308933,0.006983711,0.14002791,0.06350749,0.0013038302,0.09953288,0.003055169,0.00023937282,0.054456443],"genre_scores_gemma":[0.6946353,0.003534146,0.21172713,0.008168193,0.00021545085,0.07775406,0.0016737507,0.00010005131,0.002192011],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.8389921,0.13157974,0.015431671,0.0024700463,0.006615194,0.0049111755],"domain_scores_gemma":[0.9350256,0.036624078,0.0052334457,0.0022855143,0.018003562,0.0028279207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16107273,0.0008882521,0.0013248489,0.005353519,0.0026274095,0.003328024,0.002737908,0.0019313166,0.0023341253],"category_scores_gemma":[0.109095715,0.0007781695,0.0031689268,0.0030469715,0.0034132395,0.0033335057,0.012530445,0.0039325315,0.00040105986],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012232249,0.00084361195,0.063569054,0.012732907,0.00093060266,0.0018385841,0.45667952,0.0068658297,0.0037361565,0.037795465,0.03369511,0.38009003],"study_design_scores_gemma":[0.0007751009,0.002522919,0.07336887,0.023163058,0.0008651202,0.00237862,0.609273,0.021503396,0.0037515992,0.05705428,0.20458505,0.00075893744],"about_ca_topic_score_codex":0.0060307463,"about_ca_topic_score_gemma":0.0065602455,"teacher_disagreement_score":0.16107273,"about_ca_system_score_codex":0.010762228,"about_ca_system_score_gemma":0.023324424,"threshold_uncertainty_score":0.8518442},"labels":[],"label_agreement":null},{"id":"W4399760403","doi":"10.1093/neuonc/noae064.406","title":"LGG-13. UNRAVELING THE SPATIAL TUMOR MICROENVIRONMENT OF PEDIATRIC LOW-GRADE GLIOMAS USING IMAGING MASS CYTOMETRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Mass cytometry; Tumor microenvironment; Cancer research; Flow cytometry; Medicine; Pathology; Chemistry; Tumor cells; Immunology; Phenotype","score_opus":0.018915989341028092,"score_gpt":0.29306601255437925,"score_spread":0.27415002321335113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97890365,0.0032964633,0.009796081,0.00017151952,0.000012018776,0.000070706345,0.0051553454,0.0005249223,0.002069171],"genre_scores_gemma":[0.97324693,0.0012193386,0.015213966,0.00013022288,0.000011989585,0.00010039417,0.00854958,0.00010494503,0.001422581],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998387,0.00001783091,0.000011768079,0.000048831138,0.000046754445,0.00003609239],"domain_scores_gemma":[0.9998615,0.000021920783,0.000050863437,0.000014116537,0.000033078944,0.000018384782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028369718,0.00025514577,0.00022666484,0.0014397805,0.00024090527,0.00054563093,0.00025530663,0.00032660045,0.0011918894],"category_scores_gemma":[0.00031605488,0.00015437309,0.00016483612,0.00091915426,0.00019507021,0.00019168846,0.00025414163,0.0002508601,0.0006112118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045742837,0.000031435484,0.12025644,0.00030139022,0.000041166506,0.00040028483,0.00020945512,0.00076601247,0.8414243,0.00029673259,0.0012813653,0.034534045],"study_design_scores_gemma":[0.000027502536,0.00020998818,0.5048222,0.00006553913,0.00010646119,0.003036438,0.0004806338,0.008126037,0.45643783,0.0006862546,0.025975486,0.000025557727],"about_ca_topic_score_codex":0.0029056477,"about_ca_topic_score_gemma":0.004218269,"teacher_disagreement_score":0.0029056477,"about_ca_system_score_codex":0.00048573423,"about_ca_system_score_gemma":0.00025848998,"threshold_uncertainty_score":0.005777478},"labels":[],"label_agreement":null},{"id":"W4399760496","doi":"10.1093/neuonc/noae064.680","title":"OTHR-09. HEALTHCARE PROVIDERS’ PERSPECTIVES ON MALAYSIA-SINGAPORE VIRTUAL PEDIATRIC NEURO-ONCOLOGY TUMOR BOARD MEETING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Health care; Medicine; Internal medicine; Political science; Cancer","score_opus":0.03170460768437626,"score_gpt":0.33953480912128253,"score_spread":0.30783020143690626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9233169,0.001350794,0.00064950495,0.03769328,0.0008691888,0.00013688422,0.00081019854,0.00009586665,0.03507733],"genre_scores_gemma":[0.9867545,0.0011496015,0.0006255671,0.0042830207,0.0001656864,0.000084653875,0.00023545127,0.00003567161,0.0066657807],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9958205,0.0025538553,0.0001949952,0.0001596238,0.00036544766,0.0009054893],"domain_scores_gemma":[0.9866642,0.0026874729,0.0023108306,0.00018223803,0.0008814443,0.0072737955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045835655,0.00017048985,0.00012951827,0.00025466067,0.0016904168,0.0025270467,0.0004681502,0.0007282894,0.015238127],"category_scores_gemma":[0.009454126,0.00016666231,0.00024412107,0.00038503905,0.0005756928,0.0016388772,0.0027309735,0.0011931583,0.0012513102],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008403197,0.0008358044,0.3610352,0.002002389,0.000086819935,0.00858162,0.21913016,0.0006672284,0.003704872,0.006400654,0.17504899,0.22166596],"study_design_scores_gemma":[0.00004822861,0.0007552956,0.19154535,0.0010555335,0.000040114992,0.0041546016,0.5322881,0.00086374604,0.001221811,0.0005605129,0.26735282,0.000113978436],"about_ca_topic_score_codex":0.006912658,"about_ca_topic_score_gemma":0.009682558,"teacher_disagreement_score":0.015238127,"about_ca_system_score_codex":0.0025485987,"about_ca_system_score_gemma":0.0048012696,"threshold_uncertainty_score":0.050976634},"labels":[],"label_agreement":null},{"id":"W4399760686","doi":"10.1093/neuonc/noae064.129","title":"DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Germline; Homologous recombination; Recombination; Gene; Genetics; Homologous chromosome; Biology","score_opus":0.013922105843938893,"score_gpt":0.2785072447483076,"score_spread":0.26458513890436874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877125,0.00015247082,0.0001246262,0.000023229553,0.0000026352106,0.000007916704,0.00029815861,0.00001148769,0.00060820905],"genre_scores_gemma":[0.9991424,0.000090250775,0.00017394598,0.0000189489,0.000004790278,0.000005230554,0.00044730172,0.000005432415,0.000111720234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997323,0.00002279989,0.00002124219,0.00012373838,0.000051512277,0.00004837654],"domain_scores_gemma":[0.99967957,0.000050436975,0.00013365252,0.000029016295,0.000020642714,0.000086648804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014678735,0.0003461353,0.00024981325,0.0007275219,0.00038237483,0.0005198301,0.00026846083,0.00035563213,0.0023585383],"category_scores_gemma":[0.0007384314,0.00021076607,0.0001796701,0.00079967163,0.00028884457,0.0002522466,0.00039400073,0.00030472365,0.0004088567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001959853,0.000023103317,0.97588253,0.000032733915,0.000034035904,0.0077348026,0.00016088919,0.00011032167,0.009214535,0.00013347765,0.00032929704,0.006148234],"study_design_scores_gemma":[0.000011551785,0.000117483054,0.95811397,0.00001224713,0.000034074874,0.03836607,0.00022171855,0.00029060012,0.0015869852,0.000115449846,0.0011235416,0.000006343598],"about_ca_topic_score_codex":0.0014638437,"about_ca_topic_score_gemma":0.0017415814,"teacher_disagreement_score":0.0023585383,"about_ca_system_score_codex":0.00020007565,"about_ca_system_score_gemma":0.0002044223,"threshold_uncertainty_score":0.007890046},"labels":[],"label_agreement":null},{"id":"W4399783279","doi":"10.1093/neuonc/noae064.742","title":"LMIC-25. EXPANDING THE PEDIATRIC NEURO-ONCOLOGY TELECONFERENCE EXPERIENCES, A LUXURY, OR A NECESSITY?","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Teleconference; Pediatric oncology; Medicine; Oncology; Internal medicine; Computer science; Multimedia; Cancer","score_opus":0.030467687468952266,"score_gpt":0.38827274808532236,"score_spread":0.3578050606163701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7502301,0.009388675,0.0014803113,0.11526054,0.0037267406,0.0005039227,0.0018705098,0.0003556123,0.11718362],"genre_scores_gemma":[0.9559479,0.0048542977,0.0036216546,0.013908168,0.001127531,0.00072748004,0.0015492897,0.0002019727,0.018061742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960561,0.0020594823,0.00016124622,0.00019398508,0.00060433574,0.00092480436],"domain_scores_gemma":[0.98683965,0.0027751515,0.0016704659,0.00039796642,0.0020386036,0.0062780716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069052936,0.00021159442,0.00013482835,0.00045351157,0.0016403729,0.003207236,0.00087557244,0.0009970849,0.0224534],"category_scores_gemma":[0.016639913,0.00015314682,0.00022295162,0.0007520982,0.0009022261,0.0024508226,0.0024659014,0.0012329139,0.003230621],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005968581,0.00035854563,0.19614704,0.001219722,0.000033878805,0.0057425266,0.04566082,0.0002422871,0.0015329286,0.0065269335,0.43017337,0.31176502],"study_design_scores_gemma":[0.000068827605,0.0005840666,0.16588427,0.0033629406,0.000030342615,0.008226729,0.15092541,0.0003783573,0.0013167606,0.0010428624,0.66808766,0.00009171357],"about_ca_topic_score_codex":0.0052497797,"about_ca_topic_score_gemma":0.012282793,"teacher_disagreement_score":0.0224534,"about_ca_system_score_codex":0.0039144144,"about_ca_system_score_gemma":0.006204361,"threshold_uncertainty_score":0.07511407},"labels":[],"label_agreement":null},{"id":"W4399783330","doi":"10.1093/neuonc/noae064.737","title":"LMIC-20. REAL-WORLD EXPERIENCE IN DEALING WITH CHILDREN WITH SUSPECTED CENTRAL NERVOUS SYSTEM (CNS) TUMORS AT THE CHILDREN’S HOSPITAL LAHORE (UCHS), PAKISTAN","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Central nervous system; Medicine; Pediatrics; Internal medicine","score_opus":0.008549059024879003,"score_gpt":0.3198964566380918,"score_spread":0.3113473976132128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976961,0.00024090709,0.00004478406,0.00036675925,0.000015573447,0.000025275358,0.0003869699,0.000006637185,0.0012168841],"genre_scores_gemma":[0.9984573,0.00043530887,0.00019796562,0.00021443375,0.000019737643,0.000021657866,0.00027807435,0.000003483934,0.000372067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995247,0.00007935642,0.000043650834,0.00006408155,0.00006246668,0.00022582492],"domain_scores_gemma":[0.9979297,0.00021074894,0.00084040384,0.00003502708,0.00015492892,0.00082923606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004442213,0.00031599103,0.000194967,0.0006152226,0.0013326907,0.0008017657,0.00044725425,0.00044216076,0.0036761155],"category_scores_gemma":[0.0016851288,0.000318072,0.00025902633,0.000854046,0.0007482437,0.0007485571,0.0008257196,0.0007551825,0.0004197901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018618819,0.000040046412,0.9913976,0.000027414126,0.000005470546,0.004191736,0.0013760779,0.000037051042,0.00015846867,0.00003058147,0.0007334484,0.001983365],"study_design_scores_gemma":[0.000008579022,0.00031725163,0.95943207,0.00008694535,0.0000115011935,0.019688837,0.017376887,0.00013493563,0.00023374404,0.000045079476,0.00264548,0.000018790812],"about_ca_topic_score_codex":0.02857914,"about_ca_topic_score_gemma":0.038847934,"teacher_disagreement_score":0.02857914,"about_ca_system_score_codex":0.002019137,"about_ca_system_score_gemma":0.0027694057,"threshold_uncertainty_score":0.05682558},"labels":[],"label_agreement":null},{"id":"W4399783502","doi":"10.1093/neuonc/noae064.743","title":"LMIC-26. DEVELOPMENT OF THE ST. JUDE GLOBAL VIRTUAL PEDIATRIC NEURO-ONCOLOGY FELLOWSHIP (VPNOF): INCREASING PEDIATRIC NEURO-ONCOLOGY CAPACITY IN LOW- AND MIDDLE- INCOME COUNTRIES (LMIC)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Medicine; Low and middle income countries; Oncology; Internal medicine; Developing country; Cancer; Biology","score_opus":0.03429775718912896,"score_gpt":0.2978717037872885,"score_spread":0.2635739465981595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8920333,0.0008251543,0.0026246693,0.020002,0.0007696552,0.002950822,0.0014607155,0.00021370618,0.079119876],"genre_scores_gemma":[0.9439982,0.0006093889,0.014947235,0.0027105543,0.00012093566,0.002256458,0.0011747915,0.000035168483,0.034147263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915147,0.00033371427,0.000019990326,0.000048633807,0.000067681365,0.00037852343],"domain_scores_gemma":[0.99657935,0.0001212658,0.00015112874,0.00003394679,0.00030554127,0.0028087902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028561973,0.000294956,0.00008645677,0.0002319928,0.0012367753,0.0008738293,0.00082047685,0.00070244115,0.008273589],"category_scores_gemma":[0.0021037313,0.00016927511,0.0001368281,0.00022213002,0.00045910894,0.00051438017,0.002144656,0.0007471079,0.0012245593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008361851,0.002339191,0.23448656,0.0020166414,0.0000397369,0.0061106673,0.015238029,0.003922769,0.016192446,0.012389848,0.21789011,0.4885379],"study_design_scores_gemma":[0.0003107896,0.002907159,0.5447134,0.00094838056,0.000021209731,0.001819475,0.023054766,0.0023156253,0.0060407906,0.0007000159,0.41711047,0.000057929265],"about_ca_topic_score_codex":0.00904404,"about_ca_topic_score_gemma":0.02263653,"teacher_disagreement_score":0.00904404,"about_ca_system_score_codex":0.0033014272,"about_ca_system_score_gemma":0.022556853,"threshold_uncertainty_score":0.027677953},"labels":[],"label_agreement":null},{"id":"W4399783760","doi":"10.1093/neuonc/noae064.457","title":"MDB-08. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF POLYCOMB TARGETS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medulloblastoma; Deregulation; Polycomb-group proteins; Cancer research; Transforming growth factor; Cell biology; Medicine; Biology; Gene; Repressor; Genetics; Market economy; Transcription factor; Economics","score_opus":0.01444555046815065,"score_gpt":0.28894290607598183,"score_spread":0.2744973556078312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341303,0.0013545292,0.0013956421,0.00020424897,0.000038653867,0.00004822439,0.0012784018,0.00014312883,0.002124153],"genre_scores_gemma":[0.9939329,0.00048714734,0.0008401213,0.00010917069,0.000005593519,0.00004513946,0.0011774354,0.000025653058,0.0033768069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998934,0.000009983986,0.00000842235,0.000017722768,0.00003915205,0.000031320324],"domain_scores_gemma":[0.99992967,0.0000093273875,0.000020747344,0.0000068963946,0.000006083981,0.000027284146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008373533,0.00018675087,0.00018488309,0.00021314857,0.00011090299,0.000251488,0.00012817675,0.00018526179,0.0025874858],"category_scores_gemma":[0.000063579035,0.000100481564,0.00024346093,0.00012957263,0.00015439164,0.00009034946,0.0001735966,0.0006567007,0.0005631448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016190755,0.00006365929,0.0007442827,0.00003159256,0.000007290285,0.00003651259,0.000013686711,0.00006665998,0.9968047,0.00008044096,0.0001528577,0.001836386],"study_design_scores_gemma":[0.00005637192,0.00075729855,0.023115223,0.0000097823595,0.000030480429,0.00032822564,0.00009253615,0.0016278864,0.96590716,0.00008740693,0.007981781,0.0000057183106],"about_ca_topic_score_codex":0.00066490466,"about_ca_topic_score_gemma":0.0012891766,"teacher_disagreement_score":0.0025874858,"about_ca_system_score_codex":0.00020915375,"about_ca_system_score_gemma":0.00015901208,"threshold_uncertainty_score":0.008656025},"labels":[],"label_agreement":null},{"id":"W4399784033","doi":"10.1093/neuonc/noae064.540","title":"MDB-92. EFFECT OF REDUCED-DOSE CRANIOSPINAL IRRADIATION AND REDUCED-DOSE ADJUVANT CHEMOTHERAPY ON CHILDREN AND ADOLESCENTS WITH WNT MEDULLOBLASTOMA WITHOUT RESIDUAL OR METASTATIC DISEASE: RESULTS FROM THE SJMB12 CLINICAL TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Adjuvant; Chemotherapy; Oncology; Adjuvant chemotherapy; Clinical trial; Disease; Internal medicine; Cancer research; Cancer","score_opus":0.0278449845270876,"score_gpt":0.3569852122955307,"score_spread":0.3291402277684431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122167,0.0058803144,0.000115186966,0.0003277049,0.00006633545,0.00034560025,0.0010461577,0.000031988584,0.00096517924],"genre_scores_gemma":[0.99253696,0.0034593993,0.00046891204,0.00040259084,0.00008335788,0.00058115786,0.001632318,0.000012566665,0.000822703],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996182,0.00021655284,0.000024984372,0.00004591474,0.000036853096,0.000057435864],"domain_scores_gemma":[0.999501,0.00010108968,0.00012716446,0.000030169314,0.000025387044,0.00021526101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009791828,0.000643314,0.0016340493,0.00028208192,0.00019840068,0.0006519358,0.0005460669,0.00060722406,0.001947654],"category_scores_gemma":[0.00069361436,0.00021816987,0.0010930264,0.00039080685,0.0004208654,0.00033143975,0.00024169369,0.0019273685,0.00033886248],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84701854,0.009172013,0.018788995,0.0013351566,0.0029282474,0.00017018424,0.00015106461,0.0016363407,0.010914704,0.00026025562,0.0030502114,0.10457434],"study_design_scores_gemma":[0.62319314,0.2888405,0.07343753,0.00024855506,0.0030043991,0.00042567254,0.00011949175,0.0012999531,0.0032364624,0.0002804172,0.0058751297,0.00003872594],"about_ca_topic_score_codex":0.0020115718,"about_ca_topic_score_gemma":0.0060315323,"teacher_disagreement_score":0.0020115718,"about_ca_system_score_codex":0.0007220213,"about_ca_system_score_gemma":0.0010422942,"threshold_uncertainty_score":0.006515503},"labels":[],"label_agreement":null},{"id":"W4399784911","doi":"10.1093/neuonc/noae064.594","title":"QOL-06. RECURRENCE PATTERNS AND SURVEILLANCE IMAGING IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Brain tumor; Neuroimaging; Medicine; Pathology; Psychiatry","score_opus":0.014480491537026536,"score_gpt":0.29580501014737265,"score_spread":0.28132451861034613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970829,0.00036370137,0.000046427234,0.0000764656,0.0000048857846,0.00000868598,0.0017577406,0.000009071596,0.00065003545],"genre_scores_gemma":[0.9982103,0.00015425881,0.000090102796,0.000019019984,0.000005504284,0.0000141074115,0.0013650468,0.0000036705273,0.00013786483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996306,0.00007593293,0.000057046916,0.000054829317,0.000090953254,0.000090649744],"domain_scores_gemma":[0.99739313,0.00023366435,0.0017652677,0.000044006178,0.00023430209,0.0003295849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005170164,0.0001685997,0.00023219947,0.00093993894,0.00023296032,0.0005502501,0.000287455,0.00018080728,0.0021643157],"category_scores_gemma":[0.0029628205,0.0000996418,0.00042579733,0.0013271815,0.00016533292,0.00037747648,0.0004635491,0.00043940917,0.0002347738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023235822,0.000009394776,0.9978677,0.0000080018235,0.000015625403,0.00003466746,0.000031409567,0.000022304324,0.000019022706,0.000006136363,0.00015315766,0.001809166],"study_design_scores_gemma":[0.0000028525988,0.000060493414,0.9991026,0.000009372875,0.0000145918775,0.00029224085,0.00010780262,0.00007492864,0.000038241054,0.0000069009557,0.00028800243,0.0000020358045],"about_ca_topic_score_codex":0.0048456946,"about_ca_topic_score_gemma":0.004367032,"teacher_disagreement_score":0.0048456946,"about_ca_system_score_codex":0.0005073867,"about_ca_system_score_gemma":0.00049334817,"threshold_uncertainty_score":0.009635031},"labels":[],"label_agreement":null},{"id":"W4399784988","doi":"10.1093/neuonc/noae064.480","title":"MDB-31. THE CLINICAL SIGNIFICANCE OF SUB-TOTAL SURGICAL RESECTION IN CHILDHOOD MEDULLOBLASTOMA: A MULTI-COHORT ANALYSIS OF 1100 PATIENTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cohort; Surgical resection; Resection; Medicine; Clinical significance; Pediatrics; Surgery; Internal medicine; Pathology","score_opus":0.024510492161660288,"score_gpt":0.3455398177984323,"score_spread":0.321029325636772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971723,0.0003445305,0.00007607936,0.000027305296,0.0000043711266,0.0000086687005,0.0021662754,0.0000052524,0.00019519213],"genre_scores_gemma":[0.9968727,0.00012349994,0.000100150544,0.000016476806,0.0000051841976,0.000013240433,0.0027350057,0.000006850349,0.00012675535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927884,0.000103684826,0.000079032405,0.00030021835,0.00011832328,0.00012004547],"domain_scores_gemma":[0.9985897,0.00018465682,0.00061048986,0.00018572212,0.00010935589,0.0003200998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007002555,0.0002809,0.00053412514,0.0010477384,0.00060036354,0.0009283782,0.00050193944,0.00037239247,0.0017030354],"category_scores_gemma":[0.0016349296,0.0003580248,0.000568668,0.0013914893,0.0003538226,0.00044057393,0.0009269552,0.0005579492,0.00040506778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022762797,0.000010476549,0.9979036,0.000015214213,0.00012074597,0.00010498858,0.000059075348,0.000057811747,0.0003760428,0.000018686373,0.00018705604,0.00091867323],"study_design_scores_gemma":[0.00001166853,0.000058067166,0.9983505,0.000008576686,0.00007227175,0.00050058647,0.00010813194,0.00023447086,0.00012966356,0.000023833443,0.00049647497,0.0000057065736],"about_ca_topic_score_codex":0.009520525,"about_ca_topic_score_gemma":0.016021876,"teacher_disagreement_score":0.009520525,"about_ca_system_score_codex":0.00076296425,"about_ca_system_score_gemma":0.00054878485,"threshold_uncertainty_score":0.018930256},"labels":[],"label_agreement":null},{"id":"W4399785207","doi":"10.1093/neuonc/noae064.599","title":"QOL-11. LATE MORBIDITY AND MORTALITY IN SURVIVORS OF CHILDHOOD EPENDYMOMA: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY (CCSS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Childhood cancer; Ependymoma; Medicine; Late childhood; Pediatrics; Cancer; Psychology; Developmental psychology; Internal medicine; Surgery","score_opus":0.04004659183636042,"score_gpt":0.3575714754479581,"score_spread":0.3175248836115977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140364,0.00064015406,0.00010557582,0.00009605448,0.000009160692,0.000012653044,0.0070423232,0.00000740855,0.0006829869],"genre_scores_gemma":[0.995252,0.00023992374,0.00006415071,0.000022892165,0.0000088637835,0.00002018655,0.0041448288,0.0000021769292,0.0002449126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997477,0.00007332825,0.000034449535,0.000042691256,0.00005679915,0.000044985118],"domain_scores_gemma":[0.99848527,0.00023662817,0.00076970604,0.00007460285,0.0002316507,0.00020216133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010893584,0.00024035234,0.00024261816,0.00094031467,0.00022368642,0.00046857414,0.0002576124,0.00019760849,0.001002918],"category_scores_gemma":[0.002288094,0.00013045818,0.0007160833,0.0012161961,0.00017776141,0.00030840922,0.0005772215,0.00039589358,0.00014120103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003278759,0.0000071039985,0.9985077,0.000014630969,0.00007593463,0.000018188784,0.000037240756,0.000047458263,0.000019391278,0.000008759903,0.00021806163,0.0010127021],"study_design_scores_gemma":[0.0000032394357,0.000026036638,0.9995449,0.000005504258,0.000029637498,0.000044094893,0.00007489507,0.000043339907,0.000020674785,0.0000057252205,0.0001999548,0.0000019900226],"about_ca_topic_score_codex":0.011483327,"about_ca_topic_score_gemma":0.011984242,"teacher_disagreement_score":0.011483327,"about_ca_system_score_codex":0.00035166115,"about_ca_system_score_gemma":0.00036677608,"threshold_uncertainty_score":0.02283293},"labels":[],"label_agreement":null},{"id":"W4399785372","doi":"10.1093/neuonc/noae064.516","title":"MDB-67. MEDULLOBLASTOMA MOLECULAR SUBGROUPING AND OUTCOMES DATA OF A SINGLE CENTER FROM A LOW-MIDDLE-INCOME COUNTRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Center (category theory); Medulloblastoma; Middle income country; Low and middle income countries; Single Center; Low income; Geography; Political science; Demographic economics; Economic growth; Medicine; Economics; Developing country; Internal medicine","score_opus":0.031074163528177233,"score_gpt":0.30538341735320534,"score_spread":0.27430925382502813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812216,0.00018900985,0.00006623547,0.000042698528,0.000004029008,0.000016502177,0.0009828433,0.0000065260374,0.0005699578],"genre_scores_gemma":[0.9985024,0.00010470861,0.00010304928,0.000032060594,0.0000070693045,0.000016139355,0.0011527251,0.000004769915,0.000077099576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922085,0.00012525651,0.00013567127,0.0001711283,0.0001786206,0.00016842475],"domain_scores_gemma":[0.9973333,0.00026955587,0.0012280369,0.0001573333,0.00044199638,0.00056975475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005102569,0.0002607099,0.00047526186,0.0016549046,0.0008198934,0.0006672461,0.00036782282,0.00024677624,0.0019982487],"category_scores_gemma":[0.0016475917,0.00020756779,0.00039863278,0.0018926861,0.00037177705,0.00036784494,0.00090239116,0.0002882572,0.00043222585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004169223,0.000010685691,0.998696,0.000012035253,0.000023542185,0.00013907088,0.000082679115,0.0000186654,0.00012959135,0.000009018262,0.00013768773,0.0006993583],"study_design_scores_gemma":[0.00001117848,0.00009582407,0.99716383,0.00002275472,0.000047040234,0.0013058236,0.0005941117,0.0000898705,0.00021863007,0.000013541734,0.0004312846,0.0000060452744],"about_ca_topic_score_codex":0.016237652,"about_ca_topic_score_gemma":0.018410685,"teacher_disagreement_score":0.016237652,"about_ca_system_score_codex":0.0008505681,"about_ca_system_score_gemma":0.0009232312,"threshold_uncertainty_score":0.032286286},"labels":[],"label_agreement":null},{"id":"W4399785410","doi":"10.1093/neuonc/noae064.524","title":"MDB-75. MOLECULAR PATHOLOGY, TREATMENT AND PROGNOSIS OF INFANT SONIC HEDGEHOG MEDULLOBLASTOMA: A GLOBAL MULTI-COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Cohort; Medicine; Pathology; Pediatrics; Oncology; Biology; Genetics","score_opus":0.017728028246070605,"score_gpt":0.31267845243534237,"score_spread":0.29495042418927175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996431,0.0010688608,0.000085888525,0.000039388426,0.0000037483164,0.000014706286,0.0020223777,0.0000075387643,0.00032638758],"genre_scores_gemma":[0.9976617,0.0002850879,0.00008916529,0.00002949526,0.000007053457,0.000019600655,0.0017426462,0.0000063936277,0.00015888641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999553,0.00009184982,0.00003671021,0.00017391297,0.000056552723,0.00008784639],"domain_scores_gemma":[0.99931633,0.000062056526,0.00029036353,0.00008365212,0.000056759967,0.00019099121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008533286,0.0004361084,0.00055820344,0.0010697386,0.00038038607,0.00065542856,0.00043862956,0.00032777767,0.0012570836],"category_scores_gemma":[0.0007661252,0.00027176412,0.0006433964,0.0013339072,0.00028266828,0.00037721262,0.00074135925,0.0004061092,0.00034583444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007444085,0.000032312404,0.99551255,0.00003069134,0.0004064827,0.000079957266,0.00006425243,0.000058892783,0.00040886013,0.000020326324,0.00020711092,0.0024341976],"study_design_scores_gemma":[0.000030778476,0.00015688648,0.9986761,0.000010477133,0.00023875563,0.00018627569,0.00009357476,0.00006753584,0.00008871266,0.000016199778,0.00043006765,0.0000046280984],"about_ca_topic_score_codex":0.009848856,"about_ca_topic_score_gemma":0.01287399,"teacher_disagreement_score":0.009848856,"about_ca_system_score_codex":0.0005833524,"about_ca_system_score_gemma":0.00050330727,"threshold_uncertainty_score":0.019583046},"labels":[],"label_agreement":null},{"id":"W4399785510","doi":"10.1093/neuonc/noae064.520","title":"MDB-71. IDENTIFICATION AND DESCRIPTION OF A NOVEL TYPE OF MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Identification (biology); Type (biology); Computer science; Medicine; Biology; Pathology","score_opus":0.04954582884353479,"score_gpt":0.3300709417756912,"score_spread":0.2805251129321564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813851,0.0023315384,0.0044502793,0.00033450976,0.00008741997,0.00020911486,0.004533991,0.000425393,0.0062427493],"genre_scores_gemma":[0.9905318,0.0006851747,0.003727098,0.00008546909,0.00003775468,0.000041847456,0.003399387,0.00006412507,0.0014272424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997137,0.000007590416,0.00002421511,0.00009872752,0.00008208344,0.00007360551],"domain_scores_gemma":[0.99968064,0.000024540592,0.00007630086,0.000030940788,0.000047711528,0.00013991886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011894132,0.0005038538,0.0003897781,0.002462193,0.00052692235,0.00066862046,0.00047642872,0.0005852152,0.0016664753],"category_scores_gemma":[0.0005994744,0.000314749,0.00038272858,0.0010541435,0.00043712335,0.00024664355,0.00065623055,0.00043251188,0.0011343651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009187967,0.00012906716,0.24087796,0.000492294,0.00011951184,0.24951279,0.00051256455,0.00066758227,0.45327204,0.0015658775,0.0038367514,0.04809478],"study_design_scores_gemma":[0.000054283337,0.00024312126,0.43935356,0.00009112597,0.00026645695,0.433947,0.00046567986,0.0042816447,0.08986457,0.0009881717,0.030389491,0.000054959164],"about_ca_topic_score_codex":0.0048383307,"about_ca_topic_score_gemma":0.005680106,"teacher_disagreement_score":0.0048383307,"about_ca_system_score_codex":0.0007433638,"about_ca_system_score_gemma":0.00036367224,"threshold_uncertainty_score":0.009620309},"labels":[],"label_agreement":null},{"id":"W4399785658","doi":"10.1093/neuonc/noae064.402","title":"LGG-09. REBOUND GROWTH AFTER MAPKI WITHDRAWAL INVOLVES RAPID MAPK REACTIVATION AND CYTOKINE-MEDIATED MICROGLIA RECRUITMENT IN PEDIATRIC LOW-GRADE GLIOMA MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Brain Tumour Research; Universitätsklinikum Heidelberg; Hospital for Sick Children; Murdoch Children's Research Institute; McGill University Health Centre; Deutsches Krebsforschungszentrum; Broad Institute; Brigham and Women's Hospital; McGill University; Deutschen Konsortium für Translationale Krebsforschung; Children’s Hospital of Wisconsin Research Institute","keywords":"Microglia; MAPK/ERK pathway; Glioma; Cytokine; Medicine; Cancer research; Immunology; Biology; Signal transduction; Cell biology; Inflammation","score_opus":0.028960789535693962,"score_gpt":0.2913320260027335,"score_spread":0.2623712364670395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809584,0.002564083,0.0034816018,0.0003276844,0.00011465785,0.00026225028,0.008726891,0.0005312767,0.003033198],"genre_scores_gemma":[0.9687167,0.0019797685,0.0059769666,0.0004844553,0.000014772873,0.00067341205,0.01716122,0.000099204175,0.0048935595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997594,0.000024353392,0.000015615333,0.00005010936,0.00008453645,0.00006608257],"domain_scores_gemma":[0.99987733,0.000014093045,0.000027212092,0.000017551325,0.000020875063,0.000042937503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024106265,0.0005086202,0.00049540395,0.00032944715,0.00019153647,0.0004210917,0.0003026094,0.00046969525,0.0018907278],"category_scores_gemma":[0.00015862245,0.00016395142,0.0004529583,0.0002815279,0.00021052205,0.00020602648,0.00020155477,0.0012826639,0.0009129155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016202369,0.00072682294,0.002663211,0.00036412696,0.000060122882,0.00048219296,0.00009863325,0.0012968412,0.978392,0.0002080969,0.003408905,0.010678838],"study_design_scores_gemma":[0.00018372189,0.00532705,0.018597461,0.000057220135,0.00013061994,0.00129106,0.00020002916,0.0055308943,0.95081896,0.00025605087,0.01757283,0.000034148223],"about_ca_topic_score_codex":0.0023767462,"about_ca_topic_score_gemma":0.0036557643,"teacher_disagreement_score":0.0023767462,"about_ca_system_score_codex":0.0004691037,"about_ca_system_score_gemma":0.0005186143,"threshold_uncertainty_score":0.006325066},"labels":[],"label_agreement":null},{"id":"W4399785672","doi":"10.1093/neuonc/noae064.405","title":"LGG-12. INTEGRATED CLINICAL AND MOLECULAR CHARACTERIZATION OF 200 DISSEMINATED PEDIATRIC LOW-GRADE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen Elizabeth II Health Sciences Centre; University of Alberta; Izaak Walton Killam Health Centre; Western University; McMaster Children's Hospital; BC Children's Hospital; Dalhousie University; Hamilton Health Sciences; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Characterization (materials science); Medicine; Materials science; Nanotechnology","score_opus":0.018311074113078595,"score_gpt":0.329719354058822,"score_spread":0.31140827994574344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780697,0.00024096327,0.00017364774,0.000008966312,0.0000015610146,0.000021324995,0.0013476848,0.00002122412,0.00037760095],"genre_scores_gemma":[0.995539,0.000120673954,0.000521184,0.000011768887,0.0000032524658,0.000032886353,0.0035744812,0.000011405763,0.00018537187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997601,0.00003283388,0.00002518496,0.000077669734,0.000055290813,0.000048923783],"domain_scores_gemma":[0.9996165,0.000053514894,0.0001034628,0.00003564602,0.00008219593,0.00010865519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045415893,0.00030320746,0.00029973147,0.0016514867,0.00025848654,0.00045252673,0.0002841742,0.0002553317,0.0009581663],"category_scores_gemma":[0.00092999486,0.00013525368,0.00016752188,0.0013165465,0.0002536734,0.00023467018,0.0005528693,0.00018612636,0.00039427125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023799657,0.000021359048,0.9857853,0.00002962699,0.000020289197,0.00046997276,0.00013243573,0.00013186243,0.0042605824,0.000017796168,0.00028072792,0.00861204],"study_design_scores_gemma":[0.000010865751,0.00015027226,0.99362296,0.000007930011,0.000030699965,0.002631429,0.00020908013,0.00035515585,0.0017670672,0.000026484364,0.001184344,0.0000037712064],"about_ca_topic_score_codex":0.003257973,"about_ca_topic_score_gemma":0.0035409736,"teacher_disagreement_score":0.003257973,"about_ca_system_score_codex":0.0003758859,"about_ca_system_score_gemma":0.00024420233,"threshold_uncertainty_score":0.0064780116},"labels":[],"label_agreement":null},{"id":"W4399785764","doi":"10.1093/neuonc/noae064.404","title":"LGG-11. UNDERSTANDING THE TRANSCRIPTIONAL HETEROGENEITY OF PEDIATRIC LOW-GRADE GLIOMAS AND ITS IMPLICATION FOR TUMOR PATHOPHYSIOLOGY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pathophysiology; Glioma; Neuroscience; Medicine; Bioinformatics; Biology; Internal medicine; Cancer research","score_opus":0.04970402409740556,"score_gpt":0.3416704531739886,"score_spread":0.29196642907658304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615258,0.009347692,0.008919183,0.00032530582,0.000027552453,0.00004584171,0.016989732,0.00026553357,0.002553496],"genre_scores_gemma":[0.97251725,0.0031835632,0.007440192,0.00020140935,0.000028132758,0.0000676633,0.015460104,0.000081603815,0.0010201455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999819,0.000015067104,0.000008813558,0.00008339638,0.00003057714,0.00004317405],"domain_scores_gemma":[0.9997371,0.000050193376,0.00012329807,0.000018509363,0.000036897713,0.00003395703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022091197,0.00027659794,0.0003522015,0.00083339785,0.00021806962,0.000723938,0.00021506853,0.00030054126,0.0012778486],"category_scores_gemma":[0.0003406665,0.00013180725,0.00028584833,0.0011478328,0.00024886685,0.000333507,0.00029260523,0.00031256635,0.00066747377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046739617,0.000041348132,0.3564679,0.0008389855,0.00013017724,0.00032905783,0.00038972567,0.0020044846,0.581646,0.0008406033,0.0018410751,0.055003244],"study_design_scores_gemma":[0.000012046356,0.00009972223,0.91462123,0.00009168042,0.00014277876,0.0008764897,0.000709934,0.0060740644,0.055181835,0.0015720171,0.020599691,0.000018478715],"about_ca_topic_score_codex":0.0022763915,"about_ca_topic_score_gemma":0.0046259025,"teacher_disagreement_score":0.0022763915,"about_ca_system_score_codex":0.0003859076,"about_ca_system_score_gemma":0.00032215414,"threshold_uncertainty_score":0.004526317},"labels":[],"label_agreement":null},{"id":"W4399785848","doi":"10.1093/neuonc/noae064.279","title":"GCT-24. ISOLATED PITUITARY STALK THICKENING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Thickening; Pituitary stalk; Stalk; Anatomy; Medicine; Internal medicine; Pituitary gland; Biology; Chemistry; Polymer science; Hormone","score_opus":0.02164818797106968,"score_gpt":0.3038675953850749,"score_spread":0.28221940741400525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964462,0.0015167277,0.00005085505,0.00008271769,0.000012676123,0.000006738141,0.00082307484,0.000010223759,0.0010507358],"genre_scores_gemma":[0.9987,0.00042992047,0.000075846765,0.000027430244,0.000026024307,0.000005191244,0.0005931375,0.0000035198345,0.00013883198],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997433,0.000038320286,0.000028382294,0.000066322165,0.00006231485,0.00006139861],"domain_scores_gemma":[0.99684083,0.00085109455,0.0015887815,0.000097104836,0.00015127554,0.00047084343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033014896,0.00022840124,0.00030020621,0.00079447404,0.00037572574,0.0006220894,0.00031659202,0.00024453874,0.0039873268],"category_scores_gemma":[0.0023986653,0.00012594252,0.00025456116,0.0011137663,0.00048315543,0.00038447033,0.00029994844,0.00044987022,0.00047063862],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008258649,0.00000882803,0.9972957,0.000022065016,0.000011443097,0.00085261604,0.000012548777,0.000022183087,0.0001371004,0.000012723643,0.00008639223,0.0014557635],"study_design_scores_gemma":[0.000008493591,0.0001868018,0.9855356,0.000034675777,0.000029993878,0.013160689,0.00014502535,0.00008600503,0.0002944025,0.000042114567,0.00047278614,0.0000035808607],"about_ca_topic_score_codex":0.0019107251,"about_ca_topic_score_gemma":0.0016750132,"teacher_disagreement_score":0.0039873268,"about_ca_system_score_codex":0.00028742515,"about_ca_system_score_gemma":0.00049487484,"threshold_uncertainty_score":0.013338864},"labels":[],"label_agreement":null},{"id":"W4399785874","doi":"10.1093/neuonc/noae064.278","title":"GCT-23. LONG-TERM FOLLOW-UP AND SURVIVALS OF PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) ENROLLED ON ACNS1123: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Cog; Medicine; Central nervous system; Oncology; Germ cell tumors; Internal medicine; Term (time); Germ cell; Pediatrics; Biology; Chemotherapy; Genetics","score_opus":0.010139871985898325,"score_gpt":0.2608826823328361,"score_spread":0.2507428103469378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986451,0.00026159643,0.000022558928,0.000035322188,0.000006757463,0.00001917967,0.0006260847,0.0000047000276,0.0003785801],"genre_scores_gemma":[0.998072,0.00006408833,0.000029742396,0.000047697853,0.0000106498555,0.000025525027,0.0014799129,0.000002121137,0.00026817396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998087,0.00005045586,0.000012093974,0.000046878766,0.000032048276,0.00004983351],"domain_scores_gemma":[0.9993031,0.00006848519,0.00018842042,0.000047024452,0.00004740059,0.0003455141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005734854,0.0002370033,0.00038607424,0.0002676438,0.00033504784,0.00064088934,0.00031813933,0.0005132124,0.0015661535],"category_scores_gemma":[0.0006757321,0.00011053474,0.00040541354,0.00039371217,0.00022057566,0.00034342194,0.00023288658,0.0005114183,0.0003514321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0150888655,0.000623486,0.9659721,0.0000450157,0.00037839028,0.00046215495,0.000117872034,0.00039429058,0.0021884874,0.000036863723,0.0012772859,0.013415146],"study_design_scores_gemma":[0.0009954838,0.0063781366,0.9893016,0.000013319395,0.00021106104,0.0007301006,0.00007478971,0.0003552721,0.00039593497,0.00004351293,0.0014909314,0.000009811304],"about_ca_topic_score_codex":0.002382899,"about_ca_topic_score_gemma":0.0044434387,"teacher_disagreement_score":0.002382899,"about_ca_system_score_codex":0.0006788562,"about_ca_system_score_gemma":0.00034905737,"threshold_uncertainty_score":0.0052392483},"labels":[],"label_agreement":null},{"id":"W4399785926","doi":"10.1093/neuonc/noae064.426","title":"LGG-34. THE LANDSCAPE OF GLIOMAS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS REVEALS INSIGHTS ON GLIOMAGENESIS: A CANADIAN ADOLESCENTS AND YOUNG ADULTS NEURO-ONCOLOGY NETWORK (CANON) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children; Stollery Children's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Young adult; Glioma; Pediatrics; Oncology; Internal medicine; Cancer research","score_opus":0.010137694195403434,"score_gpt":0.2572078656732736,"score_spread":0.24707017147787014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670304,0.0015910702,0.000107763764,0.00048674512,0.0000153941,0.00008111219,0.0066452525,0.000009176777,0.004360443],"genre_scores_gemma":[0.9936086,0.0013038354,0.00021458237,0.00016254194,0.000016735255,0.00003593549,0.0035097625,0.0000101852565,0.0011379258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956137,0.00003963131,0.000015017808,0.00007211924,0.000115254144,0.00019660774],"domain_scores_gemma":[0.9990121,0.000044653865,0.00018072974,0.000027948794,0.00042002092,0.00031445213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005894554,0.0003934113,0.00030178856,0.0015440256,0.0016048928,0.0009036392,0.00055429625,0.00033780903,0.0024062982],"category_scores_gemma":[0.0010987164,0.0002116705,0.00047626047,0.0034807618,0.00038044393,0.00030457496,0.0005732611,0.00055179634,0.00030218903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114852315,0.000033459393,0.9909685,0.000037902457,0.000043439097,0.0001952992,0.00043698537,0.000061280676,0.00020026455,0.0001691159,0.0018388283,0.005900037],"study_design_scores_gemma":[0.0000076052156,0.000027748481,0.99685043,0.000033381097,0.00003514075,0.00017358636,0.0008625971,0.00009155607,0.00003439484,0.000025138857,0.0018534376,0.0000049478263],"about_ca_topic_score_codex":0.9485308,"about_ca_topic_score_gemma":0.96651846,"teacher_disagreement_score":0.99054414,"about_ca_system_score_codex":0.009455867,"about_ca_system_score_gemma":0.014860431,"threshold_uncertainty_score":0.10354459},"labels":[],"label_agreement":null},{"id":"W4399786010","doi":"10.1093/neuonc/noae064.431","title":"LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Université Laval","funders":"University of California, San Francisco; Medical School, University of Michigan; Université de Montréal; Rigshospitalet; Humboldt-Universität zu Berlin; Centre Hospitalier Universitaire de Québec; Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children; Tel Aviv University; Seoul National University; College of Medicine, Seoul National University; Gentofte Hospital; Yonsei University; Newcastle University; Cancer Research Institute; Texas Children's Hospital; McGill University; McGill University Health Centre; Deutsches Krebsforschungszentrum; Freie Universität Berlin; Université Laval","keywords":"Refractory (planetary science); Glioma; Internal medicine; Medicine; Firefly protocol; Gastroenterology; Oncology; Cancer research; Biology","score_opus":0.02920981703444509,"score_gpt":0.3246425832411657,"score_spread":0.2954327662067206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98716426,0.0060400036,0.00028012958,0.0006194967,0.00011328237,0.00039337552,0.0011649103,0.00012862233,0.004095941],"genre_scores_gemma":[0.99282056,0.0023399536,0.0005372372,0.00046085863,0.000055634897,0.00038134516,0.0013571036,0.000017575132,0.002029708],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998265,0.00007184507,0.000009768307,0.000025737116,0.00002573233,0.000040467814],"domain_scores_gemma":[0.9998443,0.000025659294,0.000033985554,0.000011647793,0.000009892397,0.00007453596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005464481,0.00050857884,0.0006665673,0.0001748425,0.00015225935,0.00057363167,0.00032491563,0.0003741218,0.0031623468],"category_scores_gemma":[0.00045062022,0.00014844714,0.000763156,0.00018878358,0.00025461407,0.00031466948,0.00020116502,0.0012393083,0.0004892964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4842274,0.008654389,0.011605338,0.0037755023,0.0033858798,0.00073803426,0.0004577095,0.0047620004,0.037183493,0.0013546568,0.020617727,0.4232379],"study_design_scores_gemma":[0.66028893,0.2606508,0.037152905,0.00048350717,0.0020151292,0.0020815087,0.00024990673,0.0036330991,0.01210858,0.0013240025,0.019950595,0.00006089889],"about_ca_topic_score_codex":0.0010017634,"about_ca_topic_score_gemma":0.004717243,"teacher_disagreement_score":0.0031623468,"about_ca_system_score_codex":0.00071152113,"about_ca_system_score_gemma":0.00076447334,"threshold_uncertainty_score":0.010579109},"labels":[],"label_agreement":null},{"id":"W4399786324","doi":"10.1093/neuonc/noae064.286","title":"HGG-02. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Central nervous system; Term (time); Oncology; Neuroscience; Internal medicine; Psychology; Neurotrophin","score_opus":0.008770957790696442,"score_gpt":0.2604579846732377,"score_spread":0.2516870268825413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8475526,0.087693155,0.0014045959,0.00092555676,0.00008037669,0.00083963166,0.051289193,0.00025670673,0.009958153],"genre_scores_gemma":[0.935699,0.016793732,0.0017924557,0.0012627856,0.00018776697,0.0005058752,0.042208347,0.00007948196,0.0014705461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985214,0.0005433872,0.00015649086,0.00023216446,0.00042367534,0.00012287058],"domain_scores_gemma":[0.99634016,0.0011655762,0.0016044818,0.00017466643,0.00046010906,0.00025494164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037642138,0.00049344293,0.0012733653,0.0011871266,0.0001464574,0.0010928124,0.00065008656,0.00042759534,0.0019639751],"category_scores_gemma":[0.0029019006,0.00021973916,0.0018620702,0.0021096126,0.00029068915,0.00067315844,0.00041685672,0.0007035449,0.0005205284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02726777,0.00032887424,0.6758692,0.0047976347,0.013389476,0.0005785995,0.0002444044,0.002649027,0.0055837557,0.0003094518,0.021171398,0.24781036],"study_design_scores_gemma":[0.0048148897,0.005519319,0.94450915,0.0005447408,0.011444713,0.0015385239,0.00010254239,0.0012079054,0.0021369308,0.00019017894,0.027937837,0.00005327409],"about_ca_topic_score_codex":0.0024200007,"about_ca_topic_score_gemma":0.00498939,"teacher_disagreement_score":0.0037642138,"about_ca_system_score_codex":0.0009839634,"about_ca_system_score_gemma":0.0009230724,"threshold_uncertainty_score":0.019907296},"labels":[],"label_agreement":null},{"id":"W4399786782","doi":"10.1093/neuonc/noae064.512","title":"MDB-63. AN INTERNATIONAL META-ANALYSIS OF SHH MEDULLOBLASTOMA SUBTYPES DEFINES A CLINICALLY SIGNIFICANT HIGH-RISK VARIANT OF SHH-SUBTYPE 3","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Montreal Clinical Research Institute","funders":"","keywords":"Medulloblastoma; Meta-analysis; Oncology; Internal medicine; Medicine; Cancer research; Biology","score_opus":0.054452805042927245,"score_gpt":0.35286293143572417,"score_spread":0.2984101263927969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6996299,0.27601567,0.0064714653,0.0012540933,0.00047766493,0.000114548755,0.011433092,0.00028520633,0.004318371],"genre_scores_gemma":[0.9908283,0.0050471495,0.00074149173,0.00018246552,0.000105319115,0.000039626866,0.0026538654,0.000061910134,0.000339766],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963186,0.0012347939,0.00038142776,0.0013322979,0.00045660196,0.0002763679],"domain_scores_gemma":[0.9965366,0.0013871506,0.00067136274,0.00073440303,0.00034881363,0.00032175827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005587082,0.0012399879,0.0032045112,0.0027408677,0.0007488843,0.0021072428,0.0011089309,0.00088021235,0.00247311],"category_scores_gemma":[0.006366704,0.00056027883,0.009355864,0.0034116148,0.00035249456,0.0005544942,0.0013143496,0.0011743339,0.0004011853],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007500582,0.000031893676,0.7289489,0.002878124,0.23131688,0.00027725106,0.00012448973,0.000934743,0.0037797084,0.00024468382,0.0025712522,0.021391548],"study_design_scores_gemma":[0.00046225623,0.00039683215,0.71843773,0.0005688111,0.27067947,0.00046435415,0.00015031299,0.0023498829,0.0012208122,0.00069709204,0.0045372676,0.000035194666],"about_ca_topic_score_codex":0.008435124,"about_ca_topic_score_gemma":0.013043293,"teacher_disagreement_score":0.008435124,"about_ca_system_score_codex":0.00059319683,"about_ca_system_score_gemma":0.00072765956,"threshold_uncertainty_score":0.029547691},"labels":[],"label_agreement":null},{"id":"W4399786829","doi":"10.1093/neuonc/noae064.666","title":"NURS-18. GERMINOMA PATIENTS – MORE PRONE TO PSYCHIATRIC DISORDERS, ALLERGIES, AND WEIGHT PROBLEMS? AN INSTITUTIONAL REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychiatry; Medicine; Allergy; Pediatrics; Psychology; Immunology","score_opus":0.01508636337774292,"score_gpt":0.31023694844692534,"score_spread":0.2951505850691824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786829","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39213485,0.5104942,0.0009966647,0.032814994,0.0031022856,0.0042875563,0.008468803,0.00015647046,0.04754416],"genre_scores_gemma":[0.6376795,0.32797924,0.002730534,0.014956142,0.0011193078,0.0028457576,0.0044622505,0.00005259418,0.00817478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956648,0.0020561519,0.0012187092,0.0002144882,0.0005585335,0.00028733953],"domain_scores_gemma":[0.97857213,0.004335427,0.008619057,0.0006924382,0.00595978,0.0018211368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047770967,0.00020645969,0.00042378315,0.003515263,0.001144903,0.0014300593,0.00080944184,0.0008425897,0.006502911],"category_scores_gemma":[0.01871213,0.00026500004,0.0004548383,0.0039422656,0.0004620908,0.0011835413,0.0014056186,0.0004315622,0.0013363633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041420708,0.00035966898,0.58792245,0.024169315,0.00022469602,0.007850853,0.006674354,0.00006841985,0.0006771496,0.0009813865,0.06423429,0.30642316],"study_design_scores_gemma":[0.00015329389,0.00060110755,0.6615663,0.032140326,0.0003353836,0.014749338,0.03010536,0.00012317134,0.00034911808,0.00022406976,0.25958538,0.000067137],"about_ca_topic_score_codex":0.006022922,"about_ca_topic_score_gemma":0.009090563,"teacher_disagreement_score":0.006502911,"about_ca_system_score_codex":0.0018617122,"about_ca_system_score_gemma":0.0066226884,"threshold_uncertainty_score":0.025264025},"labels":[],"label_agreement":null},{"id":"W4399786833","doi":"10.1093/neuonc/noae064.511","title":"MDB-62. SUBGROUP AND SUBTYPE-SPECIFIC OUTCOMES IN METASTATIC INFANT MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Pediatrics; Internal medicine; Cancer research","score_opus":0.025812783386054815,"score_gpt":0.311856198046107,"score_spread":0.2860434146600522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767894,0.0010927225,0.00007385192,0.000038950686,0.0000051569077,0.0000047596177,0.0007016541,0.000005362969,0.00039872018],"genre_scores_gemma":[0.99906534,0.00012957981,0.000029022509,0.000011009118,0.000006410877,0.000003974376,0.00061738037,0.0000033954914,0.00013393241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999749,0.00005035776,0.000019777619,0.0000758474,0.000049550752,0.0000554059],"domain_scores_gemma":[0.99943537,0.00008380095,0.00025399245,0.000049026974,0.00003692261,0.00014080148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046651263,0.0001860066,0.00046690818,0.00048629806,0.00024103507,0.0005416602,0.00029435763,0.00028343766,0.0021201093],"category_scores_gemma":[0.00096402486,0.00009632205,0.0005646249,0.00064268307,0.00015025819,0.00019588153,0.00049373746,0.00032311227,0.00027481577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001115643,0.000015618753,0.9919892,0.000028247752,0.00019732291,0.00021513634,0.000045840832,0.00016095584,0.0011053843,0.00004045852,0.0002397917,0.004846312],"study_design_scores_gemma":[0.00001854535,0.00015051468,0.9980306,0.000013736438,0.00013333972,0.0004584469,0.00011073717,0.0002802363,0.00019288114,0.00012753614,0.00047980217,0.000003491457],"about_ca_topic_score_codex":0.0042280285,"about_ca_topic_score_gemma":0.0062598507,"teacher_disagreement_score":0.0042280285,"about_ca_system_score_codex":0.00036533186,"about_ca_system_score_gemma":0.0003294365,"threshold_uncertainty_score":0.008406818},"labels":[],"label_agreement":null},{"id":"W4399786848","doi":"10.1093/neuonc/noae064.576","title":"NFS-18. LOWER BODY SURFACE AREA IS ASSOCIATED WITH INCREASED LIKELIHOOD OF PLEXIFORM NEUROFIBROMA RESPONSE TO MEK INHIBITION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Plexiform neurofibroma; Chemistry; Medicine; Neurofibroma; Pathology; Neurofibromatosis","score_opus":0.022692542437214247,"score_gpt":0.2870040665296568,"score_spread":0.2643115240924426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849284,0.00026278844,0.0001863625,0.000056451703,0.000010124013,0.000010193456,0.00044093851,0.000008855527,0.00053143175],"genre_scores_gemma":[0.9993864,0.00003740978,0.00010960096,0.000016997434,0.000012439526,0.000010576919,0.00018951132,0.0000024463316,0.00023459733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994765,0.00012195771,0.000061655985,0.00015429768,0.000114619266,0.00007105418],"domain_scores_gemma":[0.9947524,0.00086179527,0.0034020345,0.00019586628,0.00026670477,0.0005212027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009770073,0.00024890457,0.0003062831,0.00044319293,0.00027155122,0.00051875075,0.00028626778,0.00034107466,0.0051920027],"category_scores_gemma":[0.0030169582,0.0001268312,0.00056619215,0.00047692985,0.00024396795,0.00033469312,0.0002284372,0.00068536727,0.0003443658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005494093,0.00004246719,0.9966462,0.000015920077,0.00008504148,0.000102240614,0.000019319315,0.00005005433,0.00068809575,0.00001833388,0.000105507606,0.0016773049],"study_design_scores_gemma":[0.000021964503,0.0002689432,0.9975102,0.000009244204,0.00007314781,0.0010368343,0.0000483477,0.0003236272,0.00028999272,0.000061380015,0.0003521913,0.0000039972383],"about_ca_topic_score_codex":0.00088404265,"about_ca_topic_score_gemma":0.0009630884,"teacher_disagreement_score":0.0051920027,"about_ca_system_score_codex":0.00019655975,"about_ca_system_score_gemma":0.00029443004,"threshold_uncertainty_score":0.017369032},"labels":[],"label_agreement":null},{"id":"W4399786851","doi":"10.1093/neuonc/noae064.498","title":"MDB-49. OUTCOMES OF SONIC HEDGEHOG (SHH) MEDULLOBLASTOMA (MB) IN CHILDREN AND ADULTS TREATED WITH RISK-ADAPTED THERAPY ON A PROSPECTIVE INTERNATIONAL PROTOCOL (SJMB12)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Medicine; Protocol (science); Oncology; Internal medicine; Pediatrics; Pathology; Biology; Genetics; Gene; Alternative medicine","score_opus":0.008117846420133063,"score_gpt":0.2833669149260139,"score_spread":0.2752490685058808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810968,0.0016186852,0.00030547593,0.0002759074,0.000035977915,0.002508847,0.010065115,0.00003529126,0.0040578796],"genre_scores_gemma":[0.98497653,0.0007062517,0.0007082948,0.0002806469,0.000029853247,0.0033575168,0.008682804,0.0000131346205,0.0012449475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947864,0.00020830918,0.00006365055,0.00008344538,0.000063052255,0.0001030069],"domain_scores_gemma":[0.99941695,0.000041535255,0.00020670077,0.000036281912,0.000039846323,0.0002587017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010254116,0.00032591086,0.00049323717,0.00031885656,0.00037701416,0.00056544086,0.000408568,0.00036296187,0.00313101],"category_scores_gemma":[0.0008963204,0.00018032402,0.0005337857,0.0005617825,0.0002391901,0.00026857835,0.00052771,0.0005300839,0.0004700262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33831227,0.008896265,0.46364447,0.0011332476,0.0016630836,0.0006108925,0.00057868595,0.003903142,0.009409813,0.00088797824,0.01971641,0.15124379],"study_design_scores_gemma":[0.057949282,0.083129205,0.8332645,0.0002943394,0.00079336093,0.00080180884,0.00030854624,0.0010046961,0.0022661677,0.00027132346,0.019885289,0.000031525484],"about_ca_topic_score_codex":0.0038416055,"about_ca_topic_score_gemma":0.010740683,"teacher_disagreement_score":0.0038416055,"about_ca_system_score_codex":0.0014930413,"about_ca_system_score_gemma":0.0018594603,"threshold_uncertainty_score":0.010832787},"labels":[],"label_agreement":null},{"id":"W4399786914","doi":"10.1093/neuonc/noae064.260","title":"GCT-05. UPDATED REPORT ON TREATMENT MODALITIES IN METASTATIC GERMINOMA IN CHILDREN: A MULTI-INSTITUTIONAL ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Germinoma; Modalities; Medicine; Treatment modality; Oncology; Pediatrics; Radiology; Internal medicine; Radiation therapy; Sociology; Social science","score_opus":0.035750149504011806,"score_gpt":0.33929040188067017,"score_spread":0.3035402523766584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91501117,0.015267232,0.0005346695,0.00026674103,0.00007387068,0.0001233595,0.06420888,0.00011636216,0.004397711],"genre_scores_gemma":[0.9442662,0.008461844,0.0012691143,0.00019011679,0.00012595444,0.00012715555,0.044993952,0.00005427844,0.0005112478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889404,0.0002280726,0.00025964665,0.00018393874,0.00030546798,0.00012899381],"domain_scores_gemma":[0.99571216,0.00077235553,0.0024206166,0.00018509266,0.00052433345,0.00038549848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010333109,0.00043016183,0.00055209803,0.0046938946,0.0003323919,0.00079926255,0.00045456694,0.0002768895,0.0023039388],"category_scores_gemma":[0.0029595261,0.00019846464,0.0009757841,0.008598113,0.0001988067,0.0005853226,0.0005681899,0.00037535772,0.00043640885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014339513,0.000021701686,0.9871726,0.00012915998,0.00023829764,0.0004045176,0.000060211383,0.00014985692,0.0001427209,0.00003067938,0.0018435396,0.009663286],"study_design_scores_gemma":[0.000018622002,0.00006620118,0.99303013,0.000077552024,0.0002091099,0.0021387108,0.0002043777,0.00011420988,0.0001320108,0.000018591658,0.0039828834,0.000007672029],"about_ca_topic_score_codex":0.0077328268,"about_ca_topic_score_gemma":0.007380438,"teacher_disagreement_score":0.0077328268,"about_ca_system_score_codex":0.00076722295,"about_ca_system_score_gemma":0.0007659883,"threshold_uncertainty_score":0.015375674},"labels":[],"label_agreement":null},{"id":"W4399786936","doi":"10.1093/neuonc/noae064.323","title":"HGG-39. CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT: INTERIM RESULTS OF A MULTICENTRE INTERNATIONAL STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Children's Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Quadrise Canada Corporation (Canada); Izaak Walton Killam Health Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Interim; Medicine; Glioma; Oncology; Internal medicine; Cancer research; Political science","score_opus":0.046199313113795486,"score_gpt":0.3845902446688563,"score_spread":0.3383909315550608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885917,0.00016288992,0.00007607779,0.000013784273,0.0000031777442,0.000022277312,0.0006290806,0.0000047893677,0.00022873029],"genre_scores_gemma":[0.99823534,0.00005045372,0.00008362963,0.000019608186,0.00001236188,0.000025732768,0.0014231709,0.0000035981197,0.00014614353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936193,0.00021882738,0.00004468169,0.00018496833,0.00008514993,0.0001044099],"domain_scores_gemma":[0.9988642,0.00015121642,0.00038216638,0.00015052666,0.0001029317,0.00034906314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014518595,0.00062231143,0.00045859587,0.0007476823,0.00037939704,0.00054879324,0.00045584506,0.0005177391,0.001220301],"category_scores_gemma":[0.0015563774,0.00025281674,0.0005480468,0.0009782405,0.00044253896,0.00054308,0.00059627503,0.00039724266,0.00055901514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061714696,0.00023969151,0.98738307,0.000018445042,0.00017912508,0.00023903293,0.00016144713,0.00016156018,0.0011603293,0.000014426078,0.00021743617,0.004053953],"study_design_scores_gemma":[0.00012673478,0.001488067,0.99760675,0.000002821748,0.00006385509,0.00022894578,0.000066922956,0.000095024756,0.00011384671,0.000014890165,0.00018469703,0.0000073818314],"about_ca_topic_score_codex":0.0023572687,"about_ca_topic_score_gemma":0.0016804625,"teacher_disagreement_score":0.0023572687,"about_ca_system_score_codex":0.0004236797,"about_ca_system_score_gemma":0.00027855474,"threshold_uncertainty_score":0.0076782703},"labels":[],"label_agreement":null},{"id":"W4399787104","doi":"10.1093/neuonc/noae064.191","title":"ETMR-21. PRIMARY DIFFUSE LEPTOMENINGEAL MELANOMATOSIS (PDLM) ASSOCIATED WITH INTRACRANIAL BLEEDING AND RAPID PROGRESSION IN A CHILD","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Intracranial bleeding; Medicine; Intracranial Hemorrhages; Radiology; Surgery; Subarachnoid hemorrhage","score_opus":0.01343723688936166,"score_gpt":0.28390391634341383,"score_spread":0.2704666794540522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900592,0.0013513422,0.00077920227,0.00095572026,0.00007613768,0.0000831245,0.0008117124,0.00012776126,0.0057558315],"genre_scores_gemma":[0.9964604,0.0006696546,0.0009114809,0.00027570303,0.00006314791,0.000021332644,0.00032257178,0.000019438381,0.0012561918],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99982387,0.000021982154,0.000018611445,0.00004865187,0.000028663326,0.000058337107],"domain_scores_gemma":[0.9995902,0.00008989608,0.00012070818,0.00002169274,0.000030227366,0.00014728558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016535088,0.00083032425,0.000389488,0.00074631197,0.00075055857,0.0005138573,0.0003868009,0.0013078002,0.0018188882],"category_scores_gemma":[0.00073932455,0.00031498974,0.0003830463,0.00048674326,0.00062950025,0.0006211089,0.0005334718,0.0011513217,0.0005978833],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050921153,0.000037701193,0.021292565,0.00004190558,0.0000069729954,0.97319275,0.000112462265,0.000081128615,0.0026615516,0.00019819435,0.00040340595,0.0019204948],"study_design_scores_gemma":[0.000008632089,0.00010726475,0.024889484,0.000015959682,0.000007793216,0.9730896,0.00007631102,0.00017329119,0.00057337753,0.00007255549,0.0009786705,0.0000071791183],"about_ca_topic_score_codex":0.002034759,"about_ca_topic_score_gemma":0.0026448646,"teacher_disagreement_score":0.002034759,"about_ca_system_score_codex":0.00053528696,"about_ca_system_score_gemma":0.0004705124,"threshold_uncertainty_score":0.0060847998},"labels":[],"label_agreement":null},{"id":"W4399787125","doi":"10.1093/neuonc/noae064.109","title":"DIPG-56. BRAINSTEM TUMOR BIOPSY: A SINGLE INSTITUTE EXPERIENCE OF SAFETY AND FEASIBILITY IN A LOW-MIDDLE INCOME COUNTRY (LMIC)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Brainstem; Low and middle income countries; Medicine; Biopsy; Pathology; Economic growth; Developing country; Internal medicine; Economics","score_opus":0.035673579392464565,"score_gpt":0.31156417013293825,"score_spread":0.2758905907404737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928133,0.0010123448,0.001043376,0.0005381519,0.000033916825,0.0002041862,0.00030375386,0.00010243058,0.0039485805],"genre_scores_gemma":[0.9930693,0.0010852425,0.003176209,0.0006971645,0.000044250024,0.000108490196,0.0006039693,0.00006473151,0.0011506731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994319,0.0001588161,0.000041998166,0.00012420892,0.000104176004,0.0001388132],"domain_scores_gemma":[0.99859387,0.00019092193,0.00021210182,0.00019931525,0.00019741312,0.00060637965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011589449,0.00057508016,0.00028788342,0.0005090119,0.00080900086,0.001044668,0.0006997259,0.000517897,0.0020510987],"category_scores_gemma":[0.0024298355,0.00031108913,0.00022912365,0.0005759345,0.00078133296,0.0005402139,0.0012108699,0.00064823456,0.0015189918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009409384,0.0013186226,0.7783181,0.00030555594,0.00008800408,0.06895614,0.004112497,0.0006741243,0.012528491,0.00028081227,0.0050691855,0.12740763],"study_design_scores_gemma":[0.00025483718,0.0050734365,0.78013325,0.00037697674,0.00014039838,0.17274718,0.009949372,0.00125115,0.009330304,0.0004427555,0.020182576,0.00011785333],"about_ca_topic_score_codex":0.0037243618,"about_ca_topic_score_gemma":0.0073130624,"teacher_disagreement_score":0.0037243618,"about_ca_system_score_codex":0.00117164,"about_ca_system_score_gemma":0.0020441895,"threshold_uncertainty_score":0.008500814},"labels":[],"label_agreement":null},{"id":"W4399787129","doi":"10.1093/neuonc/noae064.312","title":"HGG-28. THE IMPACT OF CMMRD IN HIGH-GRADE GLIOMA PATIENTS, A RETROSPECTIVE ANALYSIS OF 7 YEARS IN LMIC; AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.01784094156722224,"score_gpt":0.3405402765137991,"score_spread":0.3226993349465769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987657,0.00022771102,0.000025371612,0.000021676957,0.0000029527887,0.00000749959,0.0004565383,0.0000030470433,0.00048942387],"genre_scores_gemma":[0.9993507,0.00009516709,0.000025374658,0.000021601303,0.000006170678,0.0000072351017,0.00040185318,0.000001805148,0.00009010643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958223,0.000073586845,0.000047942955,0.000110360066,0.00008126901,0.00010465375],"domain_scores_gemma":[0.9991528,0.00007768032,0.00040487913,0.00005186433,0.00010895106,0.000203803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003396418,0.00030786838,0.00023764526,0.001479406,0.0005976534,0.00058737246,0.00032578167,0.00033546987,0.0016607567],"category_scores_gemma":[0.000954633,0.00024195678,0.00031855877,0.0014818897,0.00033812947,0.00043840753,0.00042787814,0.00036751016,0.0004970753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021886595,0.0000072721878,0.99921834,0.0000032988369,0.0000073535257,0.00024309882,0.000029939887,0.0000070107435,0.0000527834,0.0000037984373,0.000054941775,0.00035024548],"study_design_scores_gemma":[0.0000037933116,0.000072480005,0.99781287,0.000007523008,0.000016553751,0.0013310895,0.0003559085,0.000045818713,0.00005199323,0.000007000802,0.00029255025,0.000002523485],"about_ca_topic_score_codex":0.009649684,"about_ca_topic_score_gemma":0.010307941,"teacher_disagreement_score":0.009649684,"about_ca_system_score_codex":0.0005378779,"about_ca_system_score_gemma":0.0005369142,"threshold_uncertainty_score":0.019187033},"labels":[],"label_agreement":null},{"id":"W4399787164","doi":"10.1093/neuonc/noae064.632","title":"QOL-44. EARLY SEVERE HEARING LOSS IN CANADIAN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS: A POPULATION-BASED COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cohort; Medicine; Hearing loss; Audiology; Central nervous system; Cohort study; Pediatrics; Internal medicine","score_opus":0.01797742612512392,"score_gpt":0.2694619551868979,"score_spread":0.251484529061774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887014,0.00040552288,0.000079028,0.00018408237,0.000009916763,0.000058925318,0.008565566,0.000009922191,0.0018168781],"genre_scores_gemma":[0.9953667,0.00032214585,0.00015530962,0.000077660545,0.00000661975,0.00004400594,0.0035387042,0.000004538156,0.0004841822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999405,0.00003298964,0.000032815304,0.00011829625,0.00020388149,0.00020703487],"domain_scores_gemma":[0.9990289,0.000038337887,0.00029269676,0.00004287878,0.00038172927,0.00021542913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059099,0.0004216161,0.00040704312,0.0011315293,0.0019741687,0.0009873939,0.0008663871,0.0003905562,0.0025164916],"category_scores_gemma":[0.0013949317,0.00028944938,0.0007943291,0.0028216213,0.00037954192,0.00042264262,0.00064801803,0.000721351,0.00029347747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001957567,0.000015014383,0.9985045,0.000011127987,0.000024014389,0.00003379609,0.00011677372,0.000021147984,0.000039508202,0.000018571945,0.00042936392,0.00076668896],"study_design_scores_gemma":[0.00000473771,0.000014351698,0.99915314,0.000010145529,0.000015684971,0.00006297025,0.00022966134,0.000070772425,0.000014127835,0.0000069871253,0.00041307375,0.0000043298983],"about_ca_topic_score_codex":0.953329,"about_ca_topic_score_gemma":0.95963126,"teacher_disagreement_score":0.046670973,"about_ca_system_score_codex":0.009330367,"about_ca_system_score_gemma":0.012001134,"threshold_uncertainty_score":0.09389162},"labels":[],"label_agreement":null},{"id":"W4399787174","doi":"10.1093/neuonc/noae064.145","title":"DIPG-92. IMMUNE ACTIVATION STUDIES WITH THE NEOANTIGEN-BASED PEPTIDE VACCINE RHSC-DIPGVAX DEMONSTRATE ANTIBODY-MEDIATED RESPONSES AND EPITOPE SPREADING IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epitope; Medicine; Antibody; Immune escape; Immune system; Peptide; Cancer research; Immunology; Biology","score_opus":0.010677600450379772,"score_gpt":0.26603344979007026,"score_spread":0.25535584933969047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886847,0.00031239248,0.00020104663,0.00002074051,0.000005457103,0.00002824036,0.000115896386,0.00001160619,0.0004361837],"genre_scores_gemma":[0.99895275,0.00012436658,0.00019316394,0.00002449087,0.0000034461675,0.000016987044,0.00038042606,0.0000019220363,0.00030234677],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999267,0.000015277688,0.000004095564,0.000019259709,0.000011667041,0.00002300287],"domain_scores_gemma":[0.9999374,0.000016369047,0.000011331653,0.000005366781,0.000006785949,0.000022744036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001529835,0.0001802061,0.00018498534,0.00010206268,0.000062480205,0.00010488957,0.000074670206,0.00016040014,0.0010790012],"category_scores_gemma":[0.00012661768,0.000059041256,0.0001322171,0.00008031767,0.0001157849,0.00010896152,0.000092466,0.00034756574,0.00018090886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004265453,0.00092700456,0.016939405,0.00018767788,0.000057155936,0.0008445171,0.000118842465,0.000534371,0.95128685,0.000109101966,0.00050441164,0.024225391],"study_design_scores_gemma":[0.0011259541,0.08273427,0.3167213,0.000027351303,0.0001820582,0.009679034,0.00023921675,0.0033811803,0.5769228,0.00014350534,0.008830053,0.000013169136],"about_ca_topic_score_codex":0.00039237508,"about_ca_topic_score_gemma":0.0004672561,"teacher_disagreement_score":0.0010790012,"about_ca_system_score_codex":0.00016251203,"about_ca_system_score_gemma":0.000099254416,"threshold_uncertainty_score":0.0036095977},"labels":[],"label_agreement":null},{"id":"W4399787182","doi":"10.1093/neuonc/noae064.144","title":"DIPG-91. CLINICAL, RADIOGRAPHIC, HISTOPATHOLOGIC, AND MOLECULAR CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA-AN UPDATE FROM THE INTERNATIONAL AND EUROPEAN SOCIETY FOR PEDIATRIC ONCOLOGY DIPG REGISTRIES (IDIPGR/SIOPE-DIPGR)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatric oncology; Radiography; Oncology; Radiology; Pathology; Pediatrics; Internal medicine; Cancer","score_opus":0.02751790419075425,"score_gpt":0.3174674727999535,"score_spread":0.2899495686091993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9126844,0.0043967706,0.00089161465,0.0002306858,0.000018970402,0.00017967302,0.07870856,0.000108572836,0.0027807928],"genre_scores_gemma":[0.86884165,0.0024760435,0.0016159025,0.00014159452,0.000026888514,0.00025155416,0.12621747,0.000037585924,0.00039118752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902046,0.00022646607,0.0001624156,0.00022699863,0.0002489018,0.00011467333],"domain_scores_gemma":[0.9967428,0.00053945044,0.0016602589,0.0003427929,0.00038039003,0.00033432784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021303857,0.00026909608,0.00054463174,0.0024011324,0.00013956486,0.0007098662,0.0005958811,0.0002649783,0.0007399984],"category_scores_gemma":[0.002975034,0.00017542412,0.00029767083,0.0055362512,0.00018590836,0.00053105515,0.000791248,0.0002885613,0.00046804224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011888764,0.0000094432935,0.98912185,0.00006546011,0.000040053066,0.00007038018,0.00004271119,0.000103677645,0.0001642724,0.000034773664,0.0015540387,0.008674389],"study_design_scores_gemma":[0.000016529995,0.000042503358,0.9965899,0.00002621172,0.000029425217,0.00047415067,0.000074720745,0.00011306267,0.00010167284,0.000019107078,0.0025094938,0.000003181538],"about_ca_topic_score_codex":0.0065263966,"about_ca_topic_score_gemma":0.0083144065,"teacher_disagreement_score":0.0065263966,"about_ca_system_score_codex":0.00055632344,"about_ca_system_score_gemma":0.0006918975,"threshold_uncertainty_score":0.012976825},"labels":[],"label_agreement":null},{"id":"W4399787188","doi":"10.1093/neuonc/noae064.771","title":"RADT-11. PROTON BEAM THERAPY (PBT) FOR CENTRAL NERVOUS SYSTEM (CNS) TUMOURS IN CHILDREN: A CANADIAN PEDIATRIC BRAIN TUMOUR CONSORTIUM STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; Centre Hospitalier de l’Université de Montréal; Université Laval; McGill University Health Centre; Université du Québec à Montréal; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; Western University; CancerCare Manitoba; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Alberta; University of Saskatchewan; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia","funders":"","keywords":"Central nervous system; Medicine; Proton therapy; Pediatrics; Oncology; Internal medicine; Radiation therapy","score_opus":0.014696614127688561,"score_gpt":0.2931227222297732,"score_spread":0.2784261081020846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711822,0.0023008361,0.00018133015,0.00049715076,0.000031487238,0.00025635722,0.019126417,0.000015725529,0.0064084297],"genre_scores_gemma":[0.9850916,0.002029112,0.0004991712,0.00022800236,0.000026859723,0.00015794452,0.010813471,0.000012634399,0.0011412024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989029,0.00007497263,0.000057332298,0.00016973267,0.0004078534,0.00038721637],"domain_scores_gemma":[0.99799794,0.00009870783,0.00051068276,0.00006562078,0.0008019478,0.0005249826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008813773,0.00055457896,0.0005393099,0.0013636285,0.0021495281,0.0011483222,0.0010535015,0.00041767376,0.002529798],"category_scores_gemma":[0.0019178852,0.00033364436,0.0008893476,0.006343293,0.0005413582,0.00034967437,0.0008301012,0.000754106,0.0002905999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012238718,0.000043429955,0.9922255,0.000119893026,0.000097884265,0.00022860555,0.00035316433,0.00011078462,0.00010023572,0.00014435568,0.0026035951,0.0038500575],"study_design_scores_gemma":[0.000029191287,0.000050176164,0.99543923,0.00010616907,0.000115482195,0.00028383717,0.0009188671,0.00015238521,0.000061489736,0.000020308822,0.0028107855,0.000012082415],"about_ca_topic_score_codex":0.97405666,"about_ca_topic_score_gemma":0.9857209,"teacher_disagreement_score":0.025943339,"about_ca_system_score_codex":0.017891511,"about_ca_system_score_gemma":0.031848803,"threshold_uncertainty_score":0.1298126},"labels":[],"label_agreement":null},{"id":"W4399787197","doi":"10.1093/neuonc/noae064.634","title":"QOL-46. EFFECTIVENESS OF A TELEREHABILITATION PROGRAM TO IMPROVE VISUAL PERCEPTION IN CHILDREN AND ADOLESCENTS WITH HEMIANOPIA CONSECUTIVE TO A BRAIN TUMOUR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ophthalmology and Visual Impairment Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Hospital for Sick Children","funders":"","keywords":"Telerehabilitation; Medicine; Visual field; Visual impairment; Physical medicine and rehabilitation; Audiology; Intervention (counseling); Population; Physical therapy; Telemedicine; Health care; Ophthalmology","score_opus":0.008795789715740935,"score_gpt":0.35925771076009033,"score_spread":0.3504619210443494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878806,0.00028394864,0.000065562475,0.000019132682,0.000010174527,0.00035184584,0.00015299513,0.000009637156,0.00031866375],"genre_scores_gemma":[0.9981365,0.00020164947,0.0004959202,0.000026293716,0.00000879913,0.0007086576,0.00020956251,0.0000020107796,0.00021059411],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995845,0.00018813947,0.0000411258,0.000058178815,0.0000526013,0.000075567004],"domain_scores_gemma":[0.99960345,0.00007885659,0.00011508787,0.000022768118,0.000034243465,0.00014561128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064938096,0.0004399509,0.000786807,0.00028512158,0.00023720201,0.00024207629,0.00020225918,0.00026168884,0.0019188977],"category_scores_gemma":[0.00088515185,0.00013441758,0.0012490186,0.00019163493,0.00018947861,0.00018487075,0.00027563682,0.0005127948,0.00014352691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14816423,0.19977193,0.23678549,0.003406868,0.0030720427,0.00048445122,0.0011798409,0.002809459,0.013468638,0.00022998279,0.002804829,0.38782227],"study_design_scores_gemma":[0.02828006,0.2869645,0.6770804,0.00015883498,0.0007789398,0.00031162004,0.0003018826,0.0012372647,0.0029240747,0.00004886421,0.0018824994,0.000031094925],"about_ca_topic_score_codex":0.0010880718,"about_ca_topic_score_gemma":0.0013700722,"teacher_disagreement_score":0.0019188977,"about_ca_system_score_codex":0.00036905953,"about_ca_system_score_gemma":0.00051558454,"threshold_uncertainty_score":0.0064194202},"labels":[],"label_agreement":null},{"id":"W4399787272","doi":"10.1093/neuonc/noae064.412","title":"LGG-19. SLIPPED CAPITAL FEMORAL EPIPHYSIS (SCFE): A RARE ADVERSE EVENT ASSOCIATED WITH FGFR TYROSINE KINASE INHIBITOR THERAPY IN A CHILD","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Slipped capital femoral epiphysis; Medicine; Surgery; Adverse effect; Shunt (medical); Fibroblast growth factor receptor 1; Tyrosine-kinase inhibitor; Internal medicine; Cancer; Fibroblast growth factor; Femoral head","score_opus":0.011924171234979785,"score_gpt":0.28162160052856083,"score_spread":0.26969742929358104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280406,0.0063806153,0.001562402,0.0019317265,0.00011235731,0.000111463916,0.0011068223,0.00013483367,0.0058557764],"genre_scores_gemma":[0.9960061,0.0011921596,0.0009361126,0.0007439059,0.00006259956,0.00001594322,0.0003433883,0.000024262381,0.00067555514],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99958974,0.0000657173,0.000062364605,0.000088047214,0.00009335254,0.00010090255],"domain_scores_gemma":[0.9983535,0.0005374145,0.00057348737,0.00007261117,0.00012225177,0.00034073772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026536765,0.000572641,0.0005680884,0.0008875203,0.00069076795,0.00060371426,0.00033470048,0.0013155218,0.0016663634],"category_scores_gemma":[0.0020747543,0.00033599514,0.0005972383,0.0007597665,0.00075783505,0.000636583,0.0005798717,0.0012459868,0.00045367453],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008121584,0.000036137502,0.0875096,0.00010433593,0.000035887275,0.9047358,0.00022194613,0.00011083698,0.0012219332,0.00023882756,0.0010203818,0.004683228],"study_design_scores_gemma":[0.0000071222876,0.00012440856,0.03326993,0.000047053967,0.000022153816,0.96402574,0.00014601609,0.0001021551,0.0005981077,0.000093189876,0.0015565499,0.00000769818],"about_ca_topic_score_codex":0.0024786403,"about_ca_topic_score_gemma":0.0036042882,"teacher_disagreement_score":0.0024786403,"about_ca_system_score_codex":0.00073185965,"about_ca_system_score_gemma":0.00063599146,"threshold_uncertainty_score":0.0055745244},"labels":[],"label_agreement":null},{"id":"W4399787325","doi":"10.1093/neuonc/noae064.291","title":"HGG-07. INVESTIGATING THE ROLE OF SENESCENCE IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Senescence; Neuroscience; Medicine; Psychology; Internal medicine","score_opus":0.01940519275454203,"score_gpt":0.2896968689154964,"score_spread":0.27029167616095434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808961,0.0038521835,0.0011953382,0.0006446749,0.00007925777,0.00028437868,0.006832946,0.00013712459,0.0060778954],"genre_scores_gemma":[0.97847646,0.0030283753,0.003721461,0.0005433245,0.00006483685,0.00033453148,0.011627227,0.00004828524,0.0021554488],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975616,0.00007732871,0.00001681909,0.000033501365,0.000050663424,0.00006550022],"domain_scores_gemma":[0.99952614,0.00007309369,0.00010322845,0.000037521277,0.00009114198,0.0001688869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007948523,0.00020751197,0.0002553989,0.00041048604,0.0002532778,0.00044795228,0.0002146375,0.00050809357,0.0021044381],"category_scores_gemma":[0.00043055753,0.000120516255,0.00024014025,0.00062059885,0.00017000317,0.00023450087,0.000245538,0.00044054957,0.0007180007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016047893,0.0015069272,0.60030335,0.0012451924,0.00027525605,0.0035870299,0.0006414853,0.0014395026,0.24157064,0.0019285963,0.015972031,0.115482144],"study_design_scores_gemma":[0.00075147004,0.010945018,0.7942343,0.00016386485,0.00034253518,0.0075756186,0.00096953526,0.0020956628,0.10188277,0.0008575679,0.08014807,0.000033677745],"about_ca_topic_score_codex":0.0019465153,"about_ca_topic_score_gemma":0.0017168893,"teacher_disagreement_score":0.0021044381,"about_ca_system_score_codex":0.0006036823,"about_ca_system_score_gemma":0.00090416544,"threshold_uncertainty_score":0.007040024},"labels":[],"label_agreement":null},{"id":"W4399787335","doi":"10.1093/neuonc/noae064.294","title":"HGG-10. YAP1-MAML2 FUSION IN YOUNG CHILDREN WITH PEDIATRIC HIGH-GRADE GLIOMA: A CASE REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; B.C. Women's Hospital & Health Centre; BC Children's Hospital","funders":"","keywords":"Medicine; Neurooncology; Oncology; Lomustine; Dabrafenib; Chemotherapy; Debulking; Internal medicine; Pediatrics; Pathology; Cancer; Vincristine; Cyclophosphamide","score_opus":0.005524020834230137,"score_gpt":0.24881238843044562,"score_spread":0.24328836759621547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212366,0.0021378477,0.0017089454,0.00094083877,0.00010422859,0.000108849614,0.000360841,0.00011650261,0.0023984525],"genre_scores_gemma":[0.9971324,0.0006724378,0.0012554773,0.00027664565,0.00013596207,0.000023178149,0.00012774988,0.000020440993,0.00035568036],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999315,0.000047332087,0.00007127546,0.0002010903,0.000119772405,0.00024565787],"domain_scores_gemma":[0.9984144,0.00034897434,0.00040211008,0.00007455254,0.000109696186,0.0006502058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031080452,0.0016251442,0.0011500902,0.002267416,0.0017612199,0.0012383384,0.0009930743,0.003561573,0.0014730337],"category_scores_gemma":[0.0017431122,0.0010821677,0.0009898263,0.001724899,0.0014659369,0.0012875979,0.0016296671,0.002353815,0.0005060881],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022831848,0.00001772045,0.017539568,0.00003337775,0.000011487584,0.9800608,0.00018591012,0.00007143548,0.0007024031,0.00013181669,0.000212298,0.0010103538],"study_design_scores_gemma":[0.0000062346985,0.000039705574,0.010938503,0.00001325681,0.000016279304,0.98802537,0.00014564542,0.00014173365,0.00030872712,0.000073763265,0.00028197048,0.000008879007],"about_ca_topic_score_codex":0.005362632,"about_ca_topic_score_gemma":0.006810947,"teacher_disagreement_score":0.005362632,"about_ca_system_score_codex":0.0017782984,"about_ca_system_score_gemma":0.0009972693,"threshold_uncertainty_score":0.012902558},"labels":[],"label_agreement":null},{"id":"W4399787342","doi":"10.1093/neuonc/noae064.295","title":"HGG-11. TRANS-SPECIES STUDY OF IDH-MUTANT REPLICATION-REPAIR DEFICIENT HIGH-GRADE GLIOMAS (RRD-HGG) AND RESPONSE TO COMBINED TARGETED AND IMMUNOTHERAPY: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Immunotherapy; Replication (statistics); Cancer research; Biology; Virology; Genetics; Gene; Immune system","score_opus":0.027479780797774703,"score_gpt":0.3212379657217738,"score_spread":0.29375818492399913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739146,0.0005565697,0.00036969298,0.000024016552,0.000007065177,0.00009060209,0.0009159056,0.000028402072,0.0006162702],"genre_scores_gemma":[0.99470794,0.00044305273,0.0007440705,0.000054510634,0.000008911159,0.000073267416,0.002523082,0.000024704614,0.0014204092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969983,0.00007165698,0.000019357822,0.00009054421,0.000050399725,0.00006824326],"domain_scores_gemma":[0.9996823,0.000035436176,0.00006894495,0.00006935752,0.000027493645,0.000116386385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004889395,0.00049310393,0.00047232222,0.0006466192,0.00021335736,0.0003126933,0.0003869802,0.00042051103,0.0016360335],"category_scores_gemma":[0.000170517,0.00020444159,0.00046832405,0.00040879496,0.00039565572,0.00020992993,0.00028146512,0.0006570785,0.00056161603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008490373,0.0030657756,0.03369768,0.00020018878,0.00015975638,0.0015601004,0.00018604776,0.00038857677,0.94114554,0.00020753405,0.00035346087,0.010544973],"study_design_scores_gemma":[0.0011007072,0.08051585,0.46195018,0.000035545974,0.00059583987,0.016013406,0.0007111107,0.002326456,0.42687482,0.00021738041,0.009609181,0.000049555285],"about_ca_topic_score_codex":0.0011112627,"about_ca_topic_score_gemma":0.0010036946,"teacher_disagreement_score":0.0016360335,"about_ca_system_score_codex":0.00041814087,"about_ca_system_score_gemma":0.00021348598,"threshold_uncertainty_score":0.0054730773},"labels":[],"label_agreement":null},{"id":"W4399787348","doi":"10.1093/neuonc/noae064.297","title":"HGG-13. INFANT-TYPE HEMISPHERIC GLIOMA (IHG): AN INDIVIDUAL PATIENT DATA META-ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Multivariate analysis; Glioma; Cohort; Radiation therapy; Fusion gene; Chemotherapy; Gene; Cancer research; Biology","score_opus":0.11487717057612667,"score_gpt":0.3663949881683763,"score_spread":0.2515178175922496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787348","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12450838,0.8521156,0.0060487394,0.001239972,0.0008569717,0.00041492702,0.012386872,0.00029118801,0.00213741],"genre_scores_gemma":[0.9402554,0.050003894,0.0026179284,0.0012167789,0.0003225761,0.0006712927,0.0039336057,0.00015731886,0.0008212357],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894287,0.006022783,0.0015367479,0.001881636,0.0007107076,0.00041933593],"domain_scores_gemma":[0.98518384,0.01099089,0.0014895953,0.0012502781,0.00072361436,0.0003617123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011568303,0.0018589735,0.008302808,0.003289402,0.000637945,0.002565817,0.0017947888,0.0020866543,0.0045427377],"category_scores_gemma":[0.02046746,0.00094350055,0.03361284,0.0058866437,0.00056865776,0.0014533638,0.0013613935,0.0021368272,0.00051073503],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066364906,0.00003194657,0.04192633,0.027680269,0.91355246,0.00025213094,0.000056575558,0.0010018087,0.00042693032,0.0001470117,0.0016726966,0.0066154194],"study_design_scores_gemma":[0.0011514339,0.0003430028,0.025140917,0.0015079146,0.96817666,0.00020731533,0.000048642498,0.00081715145,0.00016522566,0.00038844277,0.0020233518,0.000029891622],"about_ca_topic_score_codex":0.0052845664,"about_ca_topic_score_gemma":0.007560253,"teacher_disagreement_score":0.011568303,"about_ca_system_score_codex":0.00094090524,"about_ca_system_score_gemma":0.001277318,"threshold_uncertainty_score":0.061179817},"labels":[],"label_agreement":null},{"id":"W4399787357","doi":"10.1093/neuonc/noae064.203","title":"EPEN-01. DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"thermodynamics and calorimetric analyses","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Psychology; Medicine; Evolutionary biology; Pathology","score_opus":0.013917177201926863,"score_gpt":0.2991686772891252,"score_spread":0.28525150008719835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680007,0.00023996488,0.00022279134,0.0000114194045,0.0000033059457,0.000012474973,0.001945431,0.000014193516,0.00075028336],"genre_scores_gemma":[0.99407,0.0000925358,0.00025146498,0.000018758348,0.000004319636,0.000017371316,0.0050087324,0.000014357143,0.00052245543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996476,0.00003903194,0.000041673968,0.00014742473,0.00006004589,0.00006409322],"domain_scores_gemma":[0.99950016,0.00010996282,0.00017251537,0.0000717236,0.00006960434,0.00007603011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040411478,0.00020877697,0.0003072734,0.00087590533,0.00025736075,0.00052227534,0.00039213744,0.0002412549,0.00278904],"category_scores_gemma":[0.0009003498,0.00012781195,0.00040480608,0.0008103568,0.00017488317,0.0002588908,0.00055435224,0.0002541804,0.0005272954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041975352,0.000020995141,0.9851237,0.000038743165,0.00013828768,0.00047879558,0.00009944704,0.00013646469,0.0049532927,0.00005836981,0.0003831415,0.008148888],"study_design_scores_gemma":[0.0000058519845,0.000040399224,0.9964684,0.000008355827,0.00004862882,0.0012982762,0.00007596725,0.00017801837,0.0009648191,0.000057790352,0.0008503041,0.0000031119312],"about_ca_topic_score_codex":0.001858486,"about_ca_topic_score_gemma":0.0032612896,"teacher_disagreement_score":0.00278904,"about_ca_system_score_codex":0.00026925933,"about_ca_system_score_gemma":0.00016524403,"threshold_uncertainty_score":0.009330332},"labels":[],"label_agreement":null},{"id":"W4399787377","doi":"10.1093/neuonc/noae064.442","title":"LGG-51. SYSTEMIC IMMUNE TOXICITY OF BRAF AND MEK-INHIBITORS IN CHILDREN: A PAN-CANADIAN SERIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Princess Margaret Cancer Centre; Université Laval; Hospital for Sick Children","funders":"","keywords":"Medicine; Concomitant; Discontinuation; Adverse effect; MAPK/ERK pathway; Internal medicine; Pediatrics; Kinase","score_opus":0.008781556336678464,"score_gpt":0.25566027662338725,"score_spread":0.2468787202867088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764539,0.007661116,0.0004174598,0.0009581306,0.00008953182,0.00016631308,0.0022066834,0.00005194757,0.011994904],"genre_scores_gemma":[0.99328655,0.003742401,0.0003563001,0.000586392,0.00004792951,0.000021150083,0.0008554232,0.000029524626,0.0010742783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993406,0.000037141104,0.00006026549,0.00013819638,0.00019968602,0.00022407583],"domain_scores_gemma":[0.9988695,0.000087685235,0.00033676636,0.000041285333,0.00027938822,0.00038545168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002495452,0.0006290666,0.00041036648,0.0015855891,0.0014971237,0.00069505925,0.0004891782,0.0006715709,0.003234999],"category_scores_gemma":[0.0011746786,0.000327167,0.0005437459,0.0027523101,0.00084485376,0.0003654325,0.000581773,0.00086537394,0.0004543798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014354124,0.00009002538,0.8926163,0.00027883096,0.000094789146,0.07604151,0.0010293406,0.00016921973,0.0015106552,0.0005530212,0.005625629,0.021847043],"study_design_scores_gemma":[0.000046775593,0.0002272121,0.76295346,0.00031915057,0.00013580984,0.21840057,0.0018819158,0.00021256665,0.00052174606,0.00015225742,0.015098365,0.000050061764],"about_ca_topic_score_codex":0.4626964,"about_ca_topic_score_gemma":0.561918,"teacher_disagreement_score":0.53730357,"about_ca_system_score_codex":0.006381928,"about_ca_system_score_gemma":0.0066738576,"threshold_uncertainty_score":0.9200064},"labels":[],"label_agreement":null},{"id":"W4399787378","doi":"10.1093/neuonc/noae064.250","title":"METB-09. VARIANT WORKBENCH IN THE KIDS FIRST PROGRAM FACILITATES GENOMIC DISCOVERIES IN PEDIATRIC NEURO-ONCOLOGY RESEARCH","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Workbench; Pediatric oncology; Computational biology; Oncology; Medicine; Computer science; Internal medicine; Biology; Artificial intelligence; Cancer","score_opus":0.07026701302173444,"score_gpt":0.40057277913916634,"score_spread":0.3303057661174319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787378","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007474439,0.0010346099,0.11097721,0.0016233083,0.00083248154,0.0006126579,0.32211977,0.52391696,0.031408675],"genre_scores_gemma":[0.03195098,0.0008585954,0.23500134,0.0012368963,0.0003079818,0.0018194797,0.5561357,0.15389396,0.018795092],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728477,0.0005389064,0.00026270788,0.00083514437,0.00083039986,0.0002480049],"domain_scores_gemma":[0.9919878,0.0033154655,0.00058661913,0.0019325885,0.0011483765,0.0010291354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00688709,0.0021929333,0.0018625932,0.0044437787,0.0010881315,0.005364517,0.005096002,0.0012687288,0.1428281],"category_scores_gemma":[0.015109709,0.0020391354,0.0022346484,0.0043850066,0.00073806907,0.0036373327,0.006478929,0.002985705,0.09916619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025953478,0.00021870427,0.0056311213,0.0012159946,0.0002801761,0.0006764209,0.00059607555,0.0022942435,0.008229557,0.011769908,0.86683345,0.09965915],"study_design_scores_gemma":[0.0018543566,0.00030133472,0.00855978,0.00062397827,0.00018433297,0.00088079413,0.0002555064,0.01966366,0.018512085,0.020066362,0.9288384,0.00025932345],"about_ca_topic_score_codex":0.0064243358,"about_ca_topic_score_gemma":0.007179342,"teacher_disagreement_score":0.1428281,"about_ca_system_score_codex":0.0011269066,"about_ca_system_score_gemma":0.0026523443,"threshold_uncertainty_score":0.47780764},"labels":[],"label_agreement":null},{"id":"W4399787410","doi":"10.1093/neuonc/noae064.112","title":"DIPG-59. RADIATION-INDUCED DIPG IN A CHILD PREVIOUSLY IRRADIATED FOR CRANIOPHARYNGIOMA: CASE REPORT AND LITERATURE REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Craniopharyngioma; Medicine; Headaches; Radiation therapy; Vomiting; Glioma; Surgery; Nuclear medicine","score_opus":0.017562463598306426,"score_gpt":0.32611490147488,"score_spread":0.30855243787657355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787410","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12591769,0.857154,0.0016910504,0.0019220102,0.0010934955,0.00018801761,0.000602659,0.0001608631,0.011270267],"genre_scores_gemma":[0.42065233,0.56848377,0.0021549321,0.002074854,0.0031681221,0.000081789694,0.0009491504,0.000046660483,0.0023883698],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995227,0.000037273847,0.00017565,0.00010514991,0.000083018276,0.00007626814],"domain_scores_gemma":[0.9993273,0.0001796524,0.00030784495,0.00003210882,0.00006565251,0.00008748356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002501133,0.0009808976,0.0009581731,0.0038845062,0.000879838,0.0011883926,0.0011741404,0.0020208259,0.0023853136],"category_scores_gemma":[0.0008479951,0.0005350439,0.0006507328,0.00405414,0.0010198468,0.0017031822,0.0008695832,0.001079322,0.0012472788],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005049538,0.00008717517,0.01774284,0.0044619683,0.00009838791,0.9209906,0.0005110527,0.00014082804,0.0020687652,0.00040232867,0.0054971436,0.047948427],"study_design_scores_gemma":[0.0000075866374,0.000036250683,0.0076368824,0.0007372865,0.000117766715,0.9734904,0.00035963434,0.00007768827,0.00047344665,0.00016118215,0.016884595,0.00001735059],"about_ca_topic_score_codex":0.0017595005,"about_ca_topic_score_gemma":0.002174636,"teacher_disagreement_score":0.0038845062,"about_ca_system_score_codex":0.0005641712,"about_ca_system_score_gemma":0.0008967804,"threshold_uncertainty_score":0.007979691},"labels":[],"label_agreement":null},{"id":"W4399787415","doi":"10.1093/neuonc/noae064.455","title":"MDB-06. ALTERNATIVE SPLICING MEDIATED BY OTX2 DRIVES THE DEVELOPMENT OF GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Group (periodic table); RNA splicing; Alternative splicing; Computer science; Biology; Chemistry; Genetics; Gene","score_opus":0.012632861009094722,"score_gpt":0.28346698657588854,"score_spread":0.2708341255667938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942987,0.00037685636,0.0016967816,0.00011782705,0.00002639805,0.00003788984,0.0011389968,0.00012626935,0.0021802622],"genre_scores_gemma":[0.9894276,0.00020697904,0.0012468115,0.00008516311,0.000007706663,0.000052511674,0.0013549365,0.00008349162,0.007534841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998442,0.000016791848,0.000010822997,0.000037799175,0.00005557386,0.00003485699],"domain_scores_gemma":[0.9998418,0.0000220813,0.000040149713,0.0000133501135,0.000008325369,0.000074218704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010883069,0.00019535665,0.00016934291,0.00030775715,0.00018795721,0.00027783567,0.00017655513,0.00026010757,0.002707505],"category_scores_gemma":[0.00009799347,0.00014138506,0.00019296094,0.00013971065,0.00025005106,0.00008834655,0.00027137238,0.00064814126,0.00063182553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068230605,0.000021201418,0.0007245514,0.000015483549,0.0000031242673,0.00014407576,0.000015950829,0.000023449042,0.9981667,0.000105644795,0.000069000664,0.0006426101],"study_design_scores_gemma":[0.00003781457,0.0002993435,0.039428636,0.000012331414,0.000022857936,0.0014508412,0.00011625289,0.0017759184,0.94858986,0.00011013271,0.008148756,0.0000072935136],"about_ca_topic_score_codex":0.0011414726,"about_ca_topic_score_gemma":0.0032720866,"teacher_disagreement_score":0.002707505,"about_ca_system_score_codex":0.00038918052,"about_ca_system_score_gemma":0.00024134,"threshold_uncertainty_score":0.009057522},"labels":[],"label_agreement":null},{"id":"W4399787448","doi":"10.1093/neuonc/noae064.449","title":"LGG-60. DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; CancerCare Manitoba; Agricultural Research Institute of Ontario; University of Toronto; Université Laval; University of Alberta","funders":"","keywords":"Medicine; Cohort; Fibroblast growth factor receptor; Young adult; Oncology; Glioma; Internal medicine; Adjuvant therapy; Population; Chemotherapy; Cancer research; Fibroblast growth factor; Receptor","score_opus":0.01645547678036938,"score_gpt":0.3184839624679051,"score_spread":0.3020284856875357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982924,0.00016169534,0.000071992865,0.000012187847,0.0000017337916,0.000010354646,0.00076750375,0.000008492389,0.00067361305],"genre_scores_gemma":[0.998923,0.00006486621,0.000074764,0.000006984037,0.0000020735224,0.000005657556,0.0008235677,0.000003562049,0.000095469346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997009,0.000016177723,0.000023375547,0.00007823233,0.00007762145,0.00010374613],"domain_scores_gemma":[0.99939036,0.000042755597,0.00021358317,0.0000312501,0.00010798382,0.00021409994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026764354,0.00021308515,0.00022364377,0.0013033448,0.0004969846,0.00054894073,0.0002932604,0.00022261534,0.0014240667],"category_scores_gemma":[0.0008074859,0.000116317846,0.00020566004,0.0009834499,0.00039124506,0.0002019547,0.0004281711,0.00023636354,0.0002535073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013750837,0.000010709126,0.99326307,0.000009443923,0.000019964318,0.00031984705,0.00007885018,0.000043404194,0.002836854,0.000025311623,0.00013135675,0.003123688],"study_design_scores_gemma":[0.0000025055572,0.00003492358,0.99824774,0.0000024585368,0.000013174599,0.0008756775,0.00014767809,0.000067393215,0.00026623183,0.000015450025,0.00032474514,0.0000020053346],"about_ca_topic_score_codex":0.05979232,"about_ca_topic_score_gemma":0.077912025,"teacher_disagreement_score":0.05979232,"about_ca_system_score_codex":0.0010133509,"about_ca_system_score_gemma":0.00091204874,"threshold_uncertainty_score":0.11888856},"labels":[],"label_agreement":null},{"id":"W4399787498","doi":"10.1093/neuonc/noae064.726","title":"LMIC-09. CRADLE TO CRAYON: THE IMPACT OF COLLABORATION ON PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS IN GHANA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Central nervous system; Medicine; Internal medicine","score_opus":0.008381989423736746,"score_gpt":0.2600119523311023,"score_spread":0.25162996290736556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332155,0.005723038,0.00010645398,0.0053603905,0.00011465556,0.000034211436,0.00030671485,0.000017322323,0.005015625],"genre_scores_gemma":[0.9960802,0.0023120563,0.00018164453,0.00038233024,0.000039671686,0.00002925112,0.00013337262,0.000010840818,0.0008305462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877733,0.0005133012,0.000056227953,0.00011250466,0.00014650554,0.00039420283],"domain_scores_gemma":[0.99284244,0.0011333355,0.0023301176,0.000089199435,0.00032395136,0.0032810261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010319198,0.00015679252,0.00015012443,0.0005550097,0.0010114107,0.0008772948,0.0005098296,0.00047989975,0.0065892413],"category_scores_gemma":[0.0050729564,0.00014136982,0.00017228055,0.0013372176,0.0006266109,0.0009291689,0.0020162323,0.00067460985,0.00039463467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034933738,0.00019305752,0.9228756,0.00048616139,0.00003119135,0.01157581,0.005759644,0.0001922075,0.000677983,0.0004191465,0.0070202034,0.050419737],"study_design_scores_gemma":[0.000035497524,0.0003820695,0.91896564,0.0011126107,0.00003493849,0.014791764,0.043709937,0.00017223817,0.0003858561,0.00027395785,0.020114362,0.000021217493],"about_ca_topic_score_codex":0.013293969,"about_ca_topic_score_gemma":0.022122247,"teacher_disagreement_score":0.013293969,"about_ca_system_score_codex":0.0018064196,"about_ca_system_score_gemma":0.004475105,"threshold_uncertainty_score":0.02643323},"labels":[],"label_agreement":null},{"id":"W4399787504","doi":"10.1093/neuonc/noae064.378","title":"IMMU-07. COMBINED PD1 AND LAG3 INHIBITION IN PRECLINICAL MODELS AND PATIENTS WITH DNA REPLICATION REPAIR DEFICIENT GLIOBLASTOMA (RRD-GBM): AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Cancer research; Immune checkpoint; Immune system; CD8; Immunotherapy; Medicine; Nestin; Biology; Immunology; Stem cell; Neural stem cell; Cell biology","score_opus":0.030716375058360914,"score_gpt":0.3307876099051599,"score_spread":0.300071234846799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910432,0.0041817743,0.00088710967,0.00033946507,0.000094564995,0.0004389397,0.0010303983,0.0001471499,0.0018373111],"genre_scores_gemma":[0.9910493,0.0028894253,0.0013377779,0.00033462077,0.00006976546,0.0004613193,0.0019367073,0.000035817335,0.0018853021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999716,0.00008797071,0.000016164333,0.000054295164,0.000043561744,0.00008191674],"domain_scores_gemma":[0.99976176,0.00001696821,0.000041265735,0.000039822113,0.000019089775,0.00012114906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011249942,0.0010098756,0.0011322205,0.0004694318,0.00022770524,0.0008369372,0.00070249,0.00058945204,0.0014492191],"category_scores_gemma":[0.00018722743,0.0003127479,0.00083596486,0.00042208057,0.0006484283,0.0004771199,0.00029788632,0.002395835,0.00066626375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09541887,0.092860304,0.012636985,0.0018381914,0.0016296697,0.0008132372,0.000491157,0.0046724854,0.61834306,0.0011776503,0.0075923633,0.16252597],"study_design_scores_gemma":[0.025924254,0.713167,0.023250438,0.00013950537,0.0016063076,0.0016211059,0.00034770952,0.0036447446,0.210245,0.00045802662,0.01952601,0.000069873364],"about_ca_topic_score_codex":0.00068817404,"about_ca_topic_score_gemma":0.0020573882,"teacher_disagreement_score":0.0014492191,"about_ca_system_score_codex":0.00062459975,"about_ca_system_score_gemma":0.0011860586,"threshold_uncertainty_score":0.0059496164},"labels":[],"label_agreement":null},{"id":"W4399787533","doi":"10.1093/neuonc/noae064.582","title":"NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Natural history; Medicine; Volume (thermodynamics); Multicenter study; Oncology; Internal medicine; Physics","score_opus":0.02273708099177605,"score_gpt":0.2661632712251791,"score_spread":0.24342619023340303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993869,0.00011425867,0.000039747396,0.000011958908,0.0000014280985,0.0000092993,0.0003395145,0.0000028355987,0.000094094605],"genre_scores_gemma":[0.99926287,0.000036016674,0.00009985844,0.0000060052525,0.0000045642787,0.000010075048,0.00049477944,0.0000019065686,0.00008401101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995771,0.00016332038,0.000031024803,0.00013222115,0.000061915336,0.000034413224],"domain_scores_gemma":[0.9972409,0.0005943333,0.001495354,0.00015937045,0.00014134502,0.0003686768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012572943,0.0003652608,0.00022821492,0.00054712064,0.00031443677,0.0004632834,0.00041113576,0.00031483453,0.0009727631],"category_scores_gemma":[0.0030478886,0.00019062331,0.00033134906,0.00048803224,0.0003299504,0.00045417107,0.00043022312,0.00032399938,0.00017382253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088183366,0.00007174978,0.99636203,0.0000110257915,0.00005198734,0.00006546376,0.000062050334,0.00008398438,0.00041441838,0.0000102256445,0.00007164011,0.0019136679],"study_design_scores_gemma":[0.000033146996,0.0004068665,0.9985378,0.000003317829,0.000034773715,0.00030797097,0.000076491924,0.00024313072,0.00019398329,0.000014570476,0.00014449102,0.000003443711],"about_ca_topic_score_codex":0.0039181462,"about_ca_topic_score_gemma":0.0049805185,"teacher_disagreement_score":0.0039181462,"about_ca_system_score_codex":0.00036745574,"about_ca_system_score_gemma":0.0002179156,"threshold_uncertainty_score":0.0077906847},"labels":[],"label_agreement":null},{"id":"W4399787571","doi":"10.1093/neuonc/noae064.023","title":"BIOM-03. IMMUNO-ONCOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS REVEALS MAJOR CLINICAL SIGNIFICANCE OF THE TUMOR IMMUNE MICROENVIRONMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Hospital for Sick Children","funders":"","keywords":"Profiling (computer programming); Tumor microenvironment; Immune system; Medicine; Cancer research; Biology; Immunology; Computer science","score_opus":0.028606927554040353,"score_gpt":0.32830821660162207,"score_spread":0.2997012890475817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94491076,0.00093991135,0.00471593,0.00032272836,0.00003349799,0.00010776912,0.043043144,0.0006849422,0.005241402],"genre_scores_gemma":[0.9128749,0.0007684709,0.01863647,0.0002314385,0.00003353206,0.0003643347,0.06311484,0.00026327936,0.0037126697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999647,0.00007079646,0.000029487937,0.00008654523,0.000101473255,0.00006467773],"domain_scores_gemma":[0.9993268,0.00011867456,0.00025407822,0.00005028017,0.0001335237,0.00011653978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004970097,0.00032051976,0.0003342738,0.0008813802,0.00019858769,0.00063261663,0.00026702316,0.00029533898,0.0028345317],"category_scores_gemma":[0.0009350454,0.00018546822,0.00020670096,0.0009698429,0.00016026745,0.00016892121,0.00047931002,0.00035052796,0.0014348148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025297229,0.00024257203,0.74625206,0.00038453523,0.00018120602,0.00042732517,0.0002455391,0.0023716188,0.1754104,0.0006631042,0.012846828,0.05844513],"study_design_scores_gemma":[0.00007690634,0.0005715172,0.87683356,0.000040516436,0.0001168336,0.0018315178,0.00021305152,0.0051430073,0.082654916,0.0004988685,0.031999376,0.000019837904],"about_ca_topic_score_codex":0.0018384211,"about_ca_topic_score_gemma":0.0032173968,"teacher_disagreement_score":0.0028345317,"about_ca_system_score_codex":0.00043286415,"about_ca_system_score_gemma":0.000546483,"threshold_uncertainty_score":0.009482443},"labels":[],"label_agreement":null},{"id":"W4399787597","doi":"10.1093/neuonc/noae064.458","title":"MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; CancerCare Manitoba; BC Children's Hospital; London Health Sciences Centre; Alberta Children's Hospital; University of Alberta Hospital; Izaak Walton Killam Health Centre","funders":"","keywords":"Medulloblastoma; Chemotherapy; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.010728644035745626,"score_gpt":0.24696240476272938,"score_spread":0.23623376072698374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792576,0.00048068003,0.00010984135,0.00002400999,0.0000031644126,0.000017911418,0.00029458548,0.000006937944,0.0011370021],"genre_scores_gemma":[0.9984492,0.00021113775,0.00023838926,0.00002441313,0.0000059718413,0.000013382932,0.0006156606,0.000003607206,0.00043825383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987876,0.000018988037,0.000010567486,0.000022579277,0.00002235128,0.000046629582],"domain_scores_gemma":[0.99979097,0.00002502284,0.0000864493,0.000012410309,0.000013631332,0.000071588096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013910265,0.00013541577,0.00026817073,0.0002646574,0.00025135378,0.00024628566,0.000119023476,0.0001257889,0.0013424271],"category_scores_gemma":[0.00038203417,0.00008913106,0.00018653926,0.00031743373,0.00016314285,0.00011657757,0.00023595891,0.00014642766,0.00019724236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012945998,0.00012819142,0.9668004,0.000046973782,0.000054933214,0.0046018935,0.00008685801,0.00018813291,0.0060293283,0.00009769025,0.00035124246,0.020319711],"study_design_scores_gemma":[0.00009512131,0.0015735063,0.9657994,0.000026908661,0.00009849418,0.025034687,0.00016505718,0.00030686244,0.0031861241,0.0000667063,0.0036415458,0.0000055950327],"about_ca_topic_score_codex":0.004141218,"about_ca_topic_score_gemma":0.006376606,"teacher_disagreement_score":0.004141218,"about_ca_system_score_codex":0.0004564634,"about_ca_system_score_gemma":0.0005469684,"threshold_uncertainty_score":0.008234203},"labels":[],"label_agreement":null},{"id":"W4399787615","doi":"10.1093/neuonc/noae064.441","title":"LGG-50. POOR RESPONSE TO MEKI RE-INITIATION IN PEDIATRIC LOW-GRADE GLIOMA AFTER TREATMENT DISCONTINUATION. A PLGG TASKFORCE STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; University of Calgary; University of Alberta; Hospital for Sick Children","funders":"","keywords":"Discontinuation; Medicine; Glioma; Internal medicine; Cancer research","score_opus":0.02396260610034954,"score_gpt":0.3312306650524043,"score_spread":0.3072680589520547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997241,0.00063972035,0.00006396874,0.00011488958,0.0000072315156,0.00009349806,0.0011890125,0.000009153958,0.00064153003],"genre_scores_gemma":[0.9964754,0.00024163724,0.00008282716,0.0001463594,0.000019958508,0.00011367478,0.0025264304,0.000008812865,0.0003849575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900925,0.0004405162,0.0000709739,0.00017085661,0.00015406459,0.0001542157],"domain_scores_gemma":[0.99784625,0.00044751583,0.0008705531,0.0001401634,0.00018717734,0.0005083356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022292677,0.0004805713,0.00052825833,0.00049361674,0.0003247385,0.00065491255,0.000508509,0.0006632898,0.0010053521],"category_scores_gemma":[0.0019135245,0.00018586991,0.0005618412,0.0006490991,0.00027628615,0.00035166685,0.0003614572,0.00045088472,0.00045425183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008947539,0.00035434533,0.9762121,0.00008777536,0.00023531678,0.0004770091,0.00017043226,0.00017493112,0.0011635779,0.000028592527,0.0012988122,0.010849546],"study_design_scores_gemma":[0.00078842026,0.0045074834,0.991067,0.000023860008,0.00017150673,0.0006031461,0.00015055029,0.00026009406,0.00035536478,0.000023569146,0.0020389569,0.000010105092],"about_ca_topic_score_codex":0.0044717113,"about_ca_topic_score_gemma":0.006438862,"teacher_disagreement_score":0.0044717113,"about_ca_system_score_codex":0.0009950413,"about_ca_system_score_gemma":0.00088295207,"threshold_uncertainty_score":0.0117896795},"labels":[],"label_agreement":null},{"id":"W4399787616","doi":"10.1093/neuonc/noae064.200","title":"ETMR-30. CLINICAL AND MOLECULAR CHARACTERIZATION OF<i>DICER</i>-MUTANT CENTRAL NERVOUS SYSTEM SARCOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Dicer; Mutant; Central nervous system; Cancer research; Biology; Neuroscience; Genetics; Gene; RNA interference; RNA","score_opus":0.020045079287449124,"score_gpt":0.31177580615531464,"score_spread":0.2917307268678655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961338,0.0003723238,0.00039594862,0.000052327912,0.0000058665178,0.000043747714,0.0010032611,0.0000231167,0.001969657],"genre_scores_gemma":[0.99612135,0.00010452679,0.0006768076,0.00005068753,0.000008094789,0.00002088045,0.001802023,0.0000080935315,0.0012075738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977213,0.000034405923,0.00003327214,0.00007941876,0.000040220188,0.000040608964],"domain_scores_gemma":[0.9995964,0.00006046015,0.00010450762,0.000040052677,0.00006197147,0.00013658352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039558008,0.00017530007,0.0002461967,0.00040645682,0.00019265263,0.00027490198,0.00021504905,0.0003098749,0.0018828219],"category_scores_gemma":[0.00058639556,0.00008312273,0.00019254447,0.00024849104,0.00018483373,0.00013090529,0.00020637503,0.0001920465,0.0006889333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035216017,0.00033550506,0.7126615,0.00013898886,0.00007245437,0.020911613,0.00021217497,0.00087880535,0.22238643,0.0003973898,0.0013636214,0.03711994],"study_design_scores_gemma":[0.00013859944,0.001905082,0.88563,0.00002181227,0.000057554113,0.07397727,0.00011789488,0.0016806326,0.029912386,0.00019389998,0.0063488656,0.00001591807],"about_ca_topic_score_codex":0.00078242185,"about_ca_topic_score_gemma":0.00086265424,"teacher_disagreement_score":0.0018828219,"about_ca_system_score_codex":0.00026444276,"about_ca_system_score_gemma":0.00019049158,"threshold_uncertainty_score":0.006298661},"labels":[],"label_agreement":null},{"id":"W4399787623","doi":"10.1093/neuonc/noae064.272","title":"GCT-17. EXPLORING NEW THRESHOLDS FOR BETA-HCG IN CENTRAL NERVOUS SYSTEM GERMINOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Central nervous system; BETA (programming language); Medicine; Neuroscience; Internal medicine; Psychology; Computer science; Radiation therapy","score_opus":0.07287621574597153,"score_gpt":0.3185463476945076,"score_spread":0.2456701319485361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787623","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11841236,0.87396866,0.0019633702,0.0016388904,0.00045432977,0.00027800156,0.0016091467,0.00005087808,0.001624419],"genre_scores_gemma":[0.90684897,0.087516405,0.0021365646,0.0011161693,0.0005428037,0.00028148526,0.0010718127,0.00003915532,0.000446686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99327916,0.003691565,0.0013375797,0.00081885525,0.00064867997,0.00022430364],"domain_scores_gemma":[0.97042793,0.021820573,0.0050883284,0.0007360775,0.0013338166,0.0005931792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018764598,0.0011017103,0.003786409,0.0029035292,0.0002270018,0.0026842377,0.001497888,0.0012570142,0.003521862],"category_scores_gemma":[0.0216915,0.0005696893,0.013272057,0.0047803894,0.00067037414,0.0013691612,0.00076477794,0.0010119823,0.000334741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02825692,0.0001948921,0.40185064,0.09750076,0.30080095,0.00074517867,0.00035713747,0.0021110948,0.0022784737,0.0008330326,0.0021565575,0.16291434],"study_design_scores_gemma":[0.0063415905,0.00625061,0.2415185,0.020034926,0.6978825,0.0012244497,0.00059814507,0.0026133738,0.0021938502,0.0042945864,0.016950548,0.00009693119],"about_ca_topic_score_codex":0.0021714154,"about_ca_topic_score_gemma":0.003168011,"teacher_disagreement_score":0.018764598,"about_ca_system_score_codex":0.0009691632,"about_ca_system_score_gemma":0.001733793,"threshold_uncertainty_score":0.09923786},"labels":[],"label_agreement":null},{"id":"W4399787624","doi":"10.1093/neuonc/noae064.198","title":"ETMR-28. EVALUATING THERAPEUTIC APPROACHES IN EMBRYONAL TUMORS WITH PLAGL1 AND PLAGL2 AMPLIFICATION AND UNRAVELING MOLECULAR PARALLELS IN EPIGENETICALLY RELATED TUMORS WITH PLAG1-ALTERATIONS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Parallels; Biology; Cancer research","score_opus":0.04808041833156861,"score_gpt":0.33018004007067625,"score_spread":0.28209962173910763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953022,0.0022362047,0.00079772447,0.00007713957,0.000009217174,0.0000704172,0.00021735682,0.000017271524,0.0012725086],"genre_scores_gemma":[0.9964749,0.00060466945,0.0017166181,0.000053142678,0.00000887597,0.000070037706,0.000423649,0.0000062140366,0.00064180576],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998411,0.0000611675,0.00001299427,0.00003362976,0.000022895481,0.000028184355],"domain_scores_gemma":[0.99985135,0.000041336083,0.000032357802,0.000017715096,0.000015079307,0.000042121024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005604909,0.0001771043,0.000317487,0.0002585664,0.000106648105,0.00022623279,0.00024419182,0.00027086807,0.0014536482],"category_scores_gemma":[0.00031339555,0.000075180935,0.00029029808,0.00016668344,0.00019343989,0.00027886455,0.0001903665,0.0002935147,0.00019601829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018707054,0.0014137608,0.1575123,0.00065602455,0.0003624671,0.0022266877,0.00019987451,0.005063717,0.6352985,0.0006695836,0.00075047754,0.17713946],"study_design_scores_gemma":[0.0017954471,0.054701675,0.47038907,0.00012066259,0.0007851358,0.010933963,0.00044540016,0.010743756,0.4331361,0.0009506837,0.015958393,0.000039763745],"about_ca_topic_score_codex":0.00034729764,"about_ca_topic_score_gemma":0.00071540906,"teacher_disagreement_score":0.0014536482,"about_ca_system_score_codex":0.000380211,"about_ca_system_score_gemma":0.00031927117,"threshold_uncertainty_score":0.0048629045},"labels":[],"label_agreement":null},{"id":"W4399787675","doi":"10.1093/neuonc/noae064.161","title":"TRLS-08. ROVER: A PHASE 1/2 TRIAL IN PROGRESS OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"PDGFRA; Cancer research; Medicine; Internal medicine; Oncology","score_opus":0.03006075930259937,"score_gpt":0.37202751995279526,"score_spread":0.3419667606501959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96675915,0.00995453,0.0016543643,0.002258432,0.00037990656,0.004048271,0.006268094,0.0011482885,0.007529066],"genre_scores_gemma":[0.9670504,0.005122056,0.0045092003,0.0018718201,0.00018599538,0.0036470783,0.010700561,0.00017904647,0.006733898],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949276,0.00021424689,0.000027062933,0.00008917862,0.00005039851,0.00012636096],"domain_scores_gemma":[0.9995271,0.00005948502,0.00007886515,0.00003181397,0.000040870436,0.0002618325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016701365,0.00182694,0.0021673867,0.00045761836,0.0003508879,0.0012440076,0.0011494401,0.0017170232,0.005141174],"category_scores_gemma":[0.0005956506,0.00046807993,0.0015178865,0.00035969258,0.00093101215,0.001191701,0.00042007276,0.003320559,0.0016041028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35137215,0.04942851,0.01398161,0.004189502,0.004227016,0.0026231888,0.0009890973,0.01417067,0.11627308,0.0033870174,0.06281664,0.37654155],"study_design_scores_gemma":[0.54146385,0.39476648,0.015447593,0.00020396993,0.0008913659,0.0030211876,0.00015443854,0.0054957373,0.012052661,0.00086095004,0.025536856,0.00010499792],"about_ca_topic_score_codex":0.0013762638,"about_ca_topic_score_gemma":0.0033058408,"teacher_disagreement_score":0.005141174,"about_ca_system_score_codex":0.0013330417,"about_ca_system_score_gemma":0.0018260116,"threshold_uncertainty_score":0.01719892},"labels":[],"label_agreement":null},{"id":"W4399787683","doi":"10.1093/neuonc/noae064.700","title":"OTHR-30. THE CLINICAL AND BIOLOGICAL LANDSCAPE OF CNS CANCERS IN CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY: AN IRRDC COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Princess Margaret Cancer Centre; Sinai Health System; Occupational Cancer Research Centre","funders":"","keywords":"Cohort; Medicine; Oncology; Internal medicine","score_opus":0.06269165643510391,"score_gpt":0.3841950514050217,"score_spread":0.32150339496991776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967154,0.000103416874,0.00008954338,0.000028492686,0.000005405325,0.000027927175,0.0023426348,0.000004464161,0.00068277336],"genre_scores_gemma":[0.9966348,0.00007632977,0.00010681056,0.000040284613,0.000008953097,0.000033041888,0.002503694,0.0000072961357,0.0005889149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994671,0.00008304145,0.00004700392,0.00018466929,0.000073469964,0.00014467681],"domain_scores_gemma":[0.9991818,0.000049371363,0.0002614175,0.00017927714,0.0000974526,0.0002306825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006375815,0.00033666188,0.00036210511,0.00062927714,0.00067598687,0.0008160912,0.00048443492,0.00032087287,0.003513777],"category_scores_gemma":[0.0009673836,0.00034103452,0.00046168285,0.000989485,0.0002331294,0.00039775134,0.00067630195,0.00050176296,0.0010001151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035845605,0.000059590264,0.99753064,0.0000085535485,0.000048155925,0.00024136153,0.00008414295,0.000024872135,0.0004507232,0.000023281265,0.0002891329,0.0008810508],"study_design_scores_gemma":[0.00006060197,0.00021259573,0.99770856,0.000009487294,0.00006638233,0.0006358371,0.00025262864,0.0001230838,0.00012321676,0.000022717766,0.000776972,0.000007878832],"about_ca_topic_score_codex":0.012422556,"about_ca_topic_score_gemma":0.018457828,"teacher_disagreement_score":0.012422556,"about_ca_system_score_codex":0.0005021893,"about_ca_system_score_gemma":0.00053533283,"threshold_uncertainty_score":0.024700522},"labels":[],"label_agreement":null},{"id":"W4399787702","doi":"10.1093/neuonc/noae064.031","title":"BIOM-12. LIQUID BIOPSIES IN CNS TUMORS: A COMBINED APPROACH TO PROFILING CSF","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Sunnybrook Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; McMaster University; London Health Sciences Centre; BC Children's Hospital; University of Toronto; University of Alberta","funders":"","keywords":"Profiling (computer programming); Liquid biopsy; Pathology; Medicine; Cancer research; Computer science; Internal medicine; Cancer","score_opus":0.039325480299829935,"score_gpt":0.3195016982892759,"score_spread":0.2801762179894459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6904241,0.014009739,0.2697319,0.0018385135,0.00047559311,0.0009482955,0.008563955,0.0043934593,0.009614463],"genre_scores_gemma":[0.6781432,0.003060142,0.30631417,0.00086373446,0.00017927229,0.0006203597,0.0041029244,0.00038798337,0.006328157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981681,0.00046473468,0.00013157535,0.00046574543,0.0006456166,0.0001241675],"domain_scores_gemma":[0.9992914,0.00020179366,0.0001230215,0.00007738165,0.00023581024,0.000070446375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014303699,0.0009999932,0.0007324336,0.0028499193,0.00039883348,0.0015457518,0.00055898534,0.0010978915,0.0023741515],"category_scores_gemma":[0.0014528005,0.00060352497,0.00051668484,0.0014885269,0.0004328483,0.00050632213,0.00094881427,0.0007827425,0.0015476915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080846203,0.00014211058,0.03009592,0.00039053644,0.0001400963,0.0003129613,0.00012512424,0.00082577905,0.8824236,0.00024094603,0.001122461,0.08337197],"study_design_scores_gemma":[0.000059350717,0.0009024966,0.062376767,0.00010767832,0.0002689037,0.0031204263,0.00016082106,0.022570223,0.89826995,0.0005860338,0.011493385,0.00008397977],"about_ca_topic_score_codex":0.0008686598,"about_ca_topic_score_gemma":0.0018957133,"teacher_disagreement_score":0.0028499193,"about_ca_system_score_codex":0.00033791596,"about_ca_system_score_gemma":0.00044824425,"threshold_uncertainty_score":0.007942319},"labels":[],"label_agreement":null},{"id":"W4399787706","doi":"10.1093/neuonc/noae064.691","title":"OTHR-21. DEVELOPING A NEURO-ONCOLOGY PROGRAM FOR ADOLESCENTS AND YOUNG ADULTS IN CANADA – THE CANON EXPERIENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; London Health Sciences Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Canon; Medicine; Oncology; Internal medicine; Psychology; Art; Literature","score_opus":0.027241688650517695,"score_gpt":0.3375838640222208,"score_spread":0.3103421753717031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787706","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5923138,0.008546779,0.0030842542,0.126791,0.0024710577,0.0020892576,0.007815362,0.00065669,0.25623178],"genre_scores_gemma":[0.828792,0.008357758,0.017603008,0.028038463,0.00055924803,0.0007390992,0.0042621233,0.00033417004,0.11131421],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982664,0.00023404007,0.00005014435,0.00013427196,0.0004643715,0.0008508681],"domain_scores_gemma":[0.9857539,0.00022076814,0.00035550067,0.00008625721,0.0023890464,0.011194581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017488169,0.00035341855,0.00013187375,0.00085165125,0.005703327,0.0018459089,0.001293679,0.00075549737,0.014708104],"category_scores_gemma":[0.0021023564,0.0003003127,0.00030254852,0.001054002,0.0013594357,0.00061672495,0.0029097383,0.0012838641,0.0013288948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000301696,0.0010601354,0.34730393,0.00044897693,0.000053453798,0.0049579083,0.016856195,0.0007847465,0.0028149362,0.00848612,0.35697132,0.2599606],"study_design_scores_gemma":[0.00011538834,0.00040427063,0.32361278,0.0008409613,0.000037136597,0.0016175593,0.032256275,0.00084752915,0.00075300795,0.00076991064,0.63866115,0.00008391222],"about_ca_topic_score_codex":0.96849704,"about_ca_topic_score_gemma":0.9913167,"teacher_disagreement_score":0.94395137,"about_ca_system_score_codex":0.056048658,"about_ca_system_score_gemma":0.18661465,"threshold_uncertainty_score":0.40666342},"labels":[],"label_agreement":null},{"id":"W4399787756","doi":"10.1093/neuonc/noae064.579","title":"NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Natural history; Medicine; Natural history study; Neuroimaging; Multicenter study; Internal medicine; Psychiatry","score_opus":0.028352382888624877,"score_gpt":0.29930930877971246,"score_spread":0.27095692589108755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989392,0.000090847796,0.000023212286,0.000010219081,0.0000014091154,0.000012481636,0.0006398327,0.0000021146914,0.0002807282],"genre_scores_gemma":[0.9989255,0.000036218826,0.00004889143,0.000009185744,0.0000044042336,0.00001516916,0.00087931927,0.0000013660657,0.00007994291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955195,0.00009507602,0.00007372313,0.00011369261,0.00009847197,0.00006705983],"domain_scores_gemma":[0.99764854,0.00030993644,0.0014320224,0.000098010765,0.00015862225,0.00035284905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077775866,0.00030217867,0.00023355123,0.0012281763,0.0003459451,0.00045194413,0.0003680238,0.0003371771,0.0016266056],"category_scores_gemma":[0.0021016551,0.00018564462,0.00033772513,0.0008181803,0.00026337942,0.0006263571,0.00048285612,0.0002643321,0.00035099694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042514097,0.000012072536,0.9995004,0.0000023827524,0.00000766759,0.000039673025,0.000024777568,0.000011227543,0.00006585541,0.0000032354078,0.000031007752,0.00025923777],"study_design_scores_gemma":[0.0000034865857,0.000055351138,0.99921346,0.000002576819,0.0000063597954,0.0004659289,0.000090551715,0.000039884133,0.00003973796,0.000004468457,0.00007682942,0.0000014298538],"about_ca_topic_score_codex":0.003218905,"about_ca_topic_score_gemma":0.0041859015,"teacher_disagreement_score":0.003218905,"about_ca_system_score_codex":0.0003664288,"about_ca_system_score_gemma":0.00025114082,"threshold_uncertainty_score":0.0064003468},"labels":[],"label_agreement":null},{"id":"W4399787812","doi":"10.1093/neuonc/noae064.085","title":"DIPG-32. NEOANTIGEN HEAT SHOCK PROTEIN VACCINE, RHSC-DIPGVAX, IS ASSOCIATED WITH INCREASED VACCINE-INDUCED B CELLS AND BCR/TCR REPERTOIRE DIVERSITY IN PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"breakpoint cluster region; Repertoire; T-cell receptor; Heat shock protein; Immunology; Medicine; Virology; Biology; Immune system; Receptor; Genetics; T cell; Gene","score_opus":0.009175616349071639,"score_gpt":0.22077338426460397,"score_spread":0.21159776791553234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987974,0.0003366663,0.00014861766,0.000044803965,0.000003028217,0.00001026878,0.00021211672,0.000017404214,0.00042968735],"genre_scores_gemma":[0.99934894,0.00010434204,0.000114276234,0.000024015819,0.000003970033,0.0000061787046,0.00025383657,0.0000033601652,0.00014109818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989295,0.0000212575,0.0000072584944,0.000031076543,0.00001933167,0.000028128756],"domain_scores_gemma":[0.99972206,0.000056122757,0.0001145341,0.00001304793,0.00002183817,0.000072373114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001679364,0.00018930036,0.00029002145,0.00023368842,0.00013279213,0.0002925567,0.0001220081,0.00021555423,0.0010828071],"category_scores_gemma":[0.0003605488,0.000112502305,0.00011903266,0.0002332468,0.00019249713,0.00017867888,0.000121823854,0.00035065316,0.00016040672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012952604,0.0007146035,0.6549037,0.00027563018,0.00016751452,0.008850145,0.00037399857,0.0009351437,0.26235065,0.00029008588,0.002358287,0.055827655],"study_design_scores_gemma":[0.00032223514,0.007698385,0.93318033,0.0000315261,0.00013217215,0.023613727,0.0003389231,0.0013146107,0.028972212,0.00017408349,0.0042073927,0.000014420297],"about_ca_topic_score_codex":0.00054452976,"about_ca_topic_score_gemma":0.00056538644,"teacher_disagreement_score":0.0010828071,"about_ca_system_score_codex":0.0003050498,"about_ca_system_score_gemma":0.00019662835,"threshold_uncertainty_score":0.003622353},"labels":[],"label_agreement":null},{"id":"W4399787813","doi":"10.1093/neuonc/noae064.003","title":"ATRT-03. PRIMARY DIFFUSE LEPTOMENINGEAL ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF CHILDHOOD DEMONSTRATING UNEXPECTED IMPROVEMENT UPON CESSATION OF CONVENTIONAL THERAPY FOR PRESUMED PROGRESSION; A MOLECULARLY CHARACTERIZED CASE REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Pathology; Oncology; Immunohistochemistry","score_opus":0.01137535861243506,"score_gpt":0.2981042778859546,"score_spread":0.28672891927351957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899725,0.0014002442,0.0020693783,0.00051958713,0.000048714828,0.00008936032,0.00040081053,0.00012033315,0.0053790896],"genre_scores_gemma":[0.996707,0.0005542142,0.0016088595,0.00013850287,0.000052777734,0.0000136693,0.00023742563,0.000024025307,0.00066362927],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965227,0.000027027012,0.000038844144,0.000114824885,0.00006372295,0.000103332],"domain_scores_gemma":[0.9992912,0.00014015356,0.00019737583,0.00006572587,0.00005919948,0.00024628468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018867507,0.0006158518,0.00047163517,0.00086439983,0.00076172926,0.0007944509,0.00064318767,0.0013708331,0.0013428311],"category_scores_gemma":[0.00093627564,0.0003918129,0.0005289352,0.0004861036,0.00085204287,0.0007505156,0.0005996956,0.0012412865,0.00057793385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048445418,0.00003421363,0.025002368,0.00005321571,0.000012374682,0.96525586,0.0001675378,0.00017459397,0.0052222502,0.00023190041,0.0002258203,0.0035713373],"study_design_scores_gemma":[0.0000044863955,0.000067316694,0.0115085,0.0000093584085,0.000013361587,0.98544693,0.00007898181,0.0002462117,0.0019405709,0.0000694831,0.0006079844,0.000006716507],"about_ca_topic_score_codex":0.0022319856,"about_ca_topic_score_gemma":0.003314755,"teacher_disagreement_score":0.0022319856,"about_ca_system_score_codex":0.0008304145,"about_ca_system_score_gemma":0.0006935083,"threshold_uncertainty_score":0.006025076},"labels":[],"label_agreement":null},{"id":"W4399787827","doi":"10.1093/neuonc/noae064.139","title":"DIPG-86. INVESTIGATING THE TUMOR ENVIRONMENT AND SIGNALING DEPENDENCIES DRIVING DIFFUSE MIDLINE GLIOMA TUMOR INITIATION, PROGRESSION, AND RESISTANCE: A COMPREHENSIVE APPROACH LEVERAGING BULK MULTIOMICS DECONVOLUTION AND SINGLE-CELL OMICS VALIDATION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Deconvolution; Omics; Glioma; Cell; Computational biology; Cancer research; Medicine; Biology; Computer science; Bioinformatics; Genetics","score_opus":0.021655528524746264,"score_gpt":0.25115165998225814,"score_spread":0.22949613145751188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90488756,0.003672703,0.0451128,0.00050402817,0.000096288844,0.00029857396,0.038307644,0.0022522043,0.0048682564],"genre_scores_gemma":[0.8846524,0.0016126654,0.048987042,0.00068088854,0.000023591252,0.00034092966,0.059875734,0.00050516834,0.0033216707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966884,0.000034253873,0.00001719806,0.00013291666,0.00009529521,0.000051559626],"domain_scores_gemma":[0.9997894,0.000035222783,0.00003464074,0.00004411489,0.000053167823,0.000043456224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000714544,0.00063523784,0.00074105524,0.0005660947,0.00034211678,0.000712355,0.0004206965,0.000651774,0.0014590104],"category_scores_gemma":[0.00043962308,0.000328407,0.0006886031,0.00073907804,0.0003053434,0.00024234627,0.0007065817,0.0008247049,0.0009550615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055467384,0.00011092947,0.022318874,0.0005103415,0.00019832164,0.00034786537,0.0001020921,0.005970188,0.9275279,0.0007221909,0.0030981377,0.03853851],"study_design_scores_gemma":[0.00016988677,0.0012845998,0.17745185,0.00010746583,0.0005939342,0.002910464,0.00033926775,0.056736067,0.7077776,0.0022583625,0.050255734,0.00011477412],"about_ca_topic_score_codex":0.0019756837,"about_ca_topic_score_gemma":0.0033269944,"teacher_disagreement_score":0.0019756837,"about_ca_system_score_codex":0.00040452663,"about_ca_system_score_gemma":0.0006842542,"threshold_uncertainty_score":0.0048808455},"labels":[],"label_agreement":null},{"id":"W4399787842","doi":"10.1093/neuonc/noae064.183","title":"ETMR-13. MARROW-ABLATIVE CONSOLIDATION CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (HDCT) DECREASES THE DEVELOPMENT OF CHOROID PLEXUS CARCINOMA (CPC)-SPECIFIC RELAPSE IN HIGH-RISK TP53-MUTATED (GERMLINE OR SOMATIC) YOUNG CHILDREN WITH NEWLY DIAGNOSED CPC","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Ablative case; Somatic cell; Progenitor cell; Oncology; Bone marrow; Internal medicine; Stem cell; Radiation therapy; Biology; Gene","score_opus":0.013433519201668012,"score_gpt":0.25818499136866385,"score_spread":0.24475147216699583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990264,0.00033815272,0.00012702023,0.000026280364,0.000005413333,0.000012090125,0.000045674766,0.000024254236,0.00039482157],"genre_scores_gemma":[0.99868315,0.00014180777,0.0004010493,0.000045797315,0.000008071481,0.000012280467,0.00029908546,0.000004055202,0.00040462788],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999043,0.000032631728,0.000007232961,0.000016142865,0.000014852725,0.000024719922],"domain_scores_gemma":[0.99975866,0.00007594759,0.00006003069,0.000019320265,0.000014604217,0.00007129949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018137347,0.00013292755,0.00027954706,0.00014144763,0.000077039724,0.00017534937,0.00017935157,0.00017748737,0.0017253853],"category_scores_gemma":[0.00048026702,0.00006771676,0.00011418639,0.00013274212,0.00013488572,0.000115203846,0.00012756903,0.00035226895,0.00021670516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054313518,0.006886847,0.21772446,0.00035739172,0.00039620558,0.001284109,0.00030987101,0.005213737,0.21540721,0.00059514696,0.0043849624,0.4931266],"study_design_scores_gemma":[0.0062822155,0.08654393,0.76103795,0.00015942889,0.00039160246,0.007521991,0.00024951898,0.011540156,0.11627607,0.00021738105,0.009754689,0.000025114845],"about_ca_topic_score_codex":0.0007081297,"about_ca_topic_score_gemma":0.0015960991,"teacher_disagreement_score":0.0017253853,"about_ca_system_score_codex":0.00018072093,"about_ca_system_score_gemma":0.0003148207,"threshold_uncertainty_score":0.005771935},"labels":[],"label_agreement":null},{"id":"W4399787848","doi":"10.1093/neuonc/noae064.068","title":"DIPG-15. NOVEL CNS SENSING SYNNOTCH-CAR T CELLS FOR TARGETING DIFFUSE MIDLINE GLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Glioma; Medicine; Neuroscience; Cancer research; Biology","score_opus":0.04177343121070988,"score_gpt":0.34884445503677874,"score_spread":0.3070710238260689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268086,0.0020429627,0.010383246,0.00012988156,0.000049478964,0.0001998095,0.0003682504,0.00023759916,0.0039079576],"genre_scores_gemma":[0.99298155,0.00045247958,0.00423089,0.00006067936,0.000006849898,0.000055557855,0.0002434811,0.000008915465,0.0019595197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999429,0.0000064079964,0.0000032767882,0.000014708925,0.000013412364,0.000019235533],"domain_scores_gemma":[0.9999833,0.0000016570367,0.0000036464871,0.000002206185,0.000002575494,0.000006461547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006386184,0.0002967092,0.0001420426,0.00016289926,0.000067753,0.00018561399,0.00020045199,0.00030713194,0.0008801105],"category_scores_gemma":[0.00003634738,0.000074687094,0.00014466581,0.00009606989,0.000109437184,0.000114231814,0.00014395591,0.00033197924,0.000266279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010440441,0.00005064808,0.00021001538,0.000057674857,0.0000059445333,0.00008600137,0.000014041949,0.00034145568,0.9936522,0.0003357483,0.00015219304,0.0049897255],"study_design_scores_gemma":[0.00008446414,0.0013006626,0.0017140951,0.0000061958713,0.000032510707,0.00062331377,0.000019321675,0.0037792288,0.98644316,0.00008621181,0.005905062,0.000005849742],"about_ca_topic_score_codex":0.00071296486,"about_ca_topic_score_gemma":0.0008018635,"teacher_disagreement_score":0.0008801105,"about_ca_system_score_codex":0.0002603033,"about_ca_system_score_gemma":0.00017435987,"threshold_uncertainty_score":0.0029442906},"labels":[],"label_agreement":null},{"id":"W4399787930","doi":"10.1093/neuonc/noae064.120","title":"DIPG-67. RE-IRRADIATION PRACTICES AND OUTCOMES IN PATIENTS WITH DIPG/DMG: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine","score_opus":0.0337108376477026,"score_gpt":0.37432074616300565,"score_spread":0.34060990851530304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988461,0.0006540761,0.00013067284,0.0001067187,0.000007686406,0.000030972293,0.008557276,0.000021806467,0.0020297545],"genre_scores_gemma":[0.99103737,0.00039156975,0.00015697295,0.00004995343,0.00001214445,0.000042826323,0.008105108,0.00001060855,0.00019337985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992618,0.0001329098,0.000121739096,0.00017901266,0.00017382167,0.00013076227],"domain_scores_gemma":[0.99621105,0.0004041274,0.0025534234,0.00024756073,0.00026413944,0.00031974533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008163825,0.00014843624,0.00032111708,0.001480353,0.00027763072,0.00072991394,0.00036733382,0.00020495588,0.0012917719],"category_scores_gemma":[0.0032490196,0.00014427748,0.00028828633,0.0032685457,0.00025407836,0.00048360444,0.0005695058,0.00040499232,0.0003514706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003961724,0.000010036601,0.9979723,0.00001361496,0.000010104877,0.00006988842,0.000046834582,0.000024133196,0.000023765415,0.000019102332,0.00033953952,0.0014309864],"study_design_scores_gemma":[0.0000074932677,0.0000456999,0.99804175,0.000016268454,0.000016821468,0.00064725574,0.00023719689,0.000069616486,0.00007910572,0.0000147382225,0.00082070316,0.0000033643516],"about_ca_topic_score_codex":0.0063214954,"about_ca_topic_score_gemma":0.004878352,"teacher_disagreement_score":0.0063214954,"about_ca_system_score_codex":0.0008031475,"about_ca_system_score_gemma":0.0007681421,"threshold_uncertainty_score":0.012569368},"labels":[],"label_agreement":null},{"id":"W4399787937","doi":"10.1093/neuonc/noae064.045","title":"CP-07. FEASIBILITY, TOLERABILITY AND FIRST EXPERIENCE OF INTRACYSTIC TREATMENT WITH PEGINTERFERON ALFA-2A IN PATIENTS WITH CYSTIC CRANIOPHARYNGIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Tolerability; Craniopharyngioma; Medicine; Peginterferon alfa-2a; Internal medicine; Surgery; Ribavirin; Adverse effect; Virology","score_opus":0.015902674095488286,"score_gpt":0.28322842089823497,"score_spread":0.2673257468027467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334174,0.0031803166,0.00085935113,0.0001563998,0.00002882354,0.00017091451,0.0002538842,0.00003452323,0.001974151],"genre_scores_gemma":[0.9958448,0.0013019129,0.0010825054,0.00025473814,0.000048992115,0.0001368122,0.0005673372,0.000014774632,0.0007480268],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999762,0.000077263554,0.000026504746,0.000059844944,0.00003820201,0.00003612426],"domain_scores_gemma":[0.999689,0.00006843262,0.00005081283,0.000045594436,0.000031432974,0.00011482242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004683745,0.0003329923,0.00060524733,0.00020747796,0.0004304044,0.0004088187,0.0002919373,0.0004477582,0.0011316254],"category_scores_gemma":[0.00075039297,0.00012394541,0.00056805374,0.00019136906,0.00026297692,0.00032055977,0.00034486747,0.0008122327,0.00054074865],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051822755,0.027564446,0.13088484,0.0016458614,0.0008590089,0.029769985,0.0022106464,0.0019919104,0.15001105,0.000681566,0.005067691,0.5974903],"study_design_scores_gemma":[0.009513448,0.47757545,0.28585476,0.00028343557,0.0015096172,0.09255771,0.0009167125,0.0039065816,0.09453052,0.00061149296,0.03255857,0.00018170096],"about_ca_topic_score_codex":0.0006209704,"about_ca_topic_score_gemma":0.00060397066,"teacher_disagreement_score":0.0011316254,"about_ca_system_score_codex":0.00037199297,"about_ca_system_score_gemma":0.0004675381,"threshold_uncertainty_score":0.0037856698},"labels":[],"label_agreement":null},{"id":"W4399787963","doi":"10.1093/neuonc/noae064.041","title":"CP-03. EXTRACELLULAR MATRIX REMODELING REVEALS NON-CELL AUTONOMOUS TUMOR FORMATION MECHANISM IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Mechanism (biology); Extracellular matrix; Cell biology; Chemistry; Matrix (chemical analysis); Biology; Physics","score_opus":0.015858918191849907,"score_gpt":0.28345932259239526,"score_spread":0.26760040440054533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92520225,0.0014559664,0.0047398494,0.00018894904,0.000061951905,0.000043464534,0.06449609,0.0010487067,0.0027627586],"genre_scores_gemma":[0.81084985,0.0004982637,0.00806769,0.00012208568,0.00003154892,0.00011072415,0.1781808,0.00016975736,0.0019692874],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995503,0.00003408919,0.00004271536,0.00017243718,0.000110033696,0.00009051772],"domain_scores_gemma":[0.9991885,0.00022891157,0.0001691499,0.00010550492,0.00016961675,0.00013834413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039487836,0.0003874715,0.00041345484,0.0013443693,0.00060432364,0.0009092366,0.00043529767,0.0006218508,0.0031462514],"category_scores_gemma":[0.0009696411,0.0001582324,0.000580014,0.0011702529,0.00025347614,0.00024064035,0.0004358023,0.00047078356,0.0020261507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00213673,0.0003590883,0.45895636,0.0014095325,0.00054637063,0.004239611,0.00045675627,0.008286372,0.4051415,0.0008069865,0.025288943,0.09237177],"study_design_scores_gemma":[0.000065204615,0.00041744125,0.8194693,0.00008841699,0.0003157457,0.008797147,0.0006262751,0.031503122,0.099390216,0.0011107656,0.038145345,0.00007106504],"about_ca_topic_score_codex":0.0043744873,"about_ca_topic_score_gemma":0.0059999316,"teacher_disagreement_score":0.0043744873,"about_ca_system_score_codex":0.00038697262,"about_ca_system_score_gemma":0.0005552338,"threshold_uncertainty_score":0.010525286},"labels":[],"label_agreement":null},{"id":"W4399787981","doi":"10.1093/neuonc/noae064.228","title":"EPEN-26. DRUG SCREENING IN PATIENT-DERIVED MODELS OF POSTERIOR FOSSA A EPENDYMOMA REVEALS NOVEL PHARMACOLOGICAL VULNERABILITIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Drug; Medicine; Computational biology; Computer science; Biology; Pharmacology; Radiology","score_opus":0.04859920495729063,"score_gpt":0.32903128993282044,"score_spread":0.2804320849755298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98569727,0.0026045206,0.0031845847,0.0002962515,0.00008829145,0.0001973037,0.004785764,0.00016736118,0.002978761],"genre_scores_gemma":[0.9848862,0.0018532871,0.0029079642,0.00011127509,0.00001087855,0.00013109008,0.006037579,0.000024636573,0.004037039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984944,0.00002673775,0.000016083113,0.000033022316,0.000049870723,0.00002483257],"domain_scores_gemma":[0.99988365,0.000028913208,0.00002101618,0.000019395144,0.000017431203,0.000029682198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002535407,0.00049319066,0.00042887003,0.00033352256,0.00015919293,0.00037815503,0.00036450007,0.00040113786,0.0017453433],"category_scores_gemma":[0.00018284158,0.0001351535,0.00036099987,0.00023684677,0.00020985428,0.00016720845,0.00014977655,0.0008779345,0.00054324773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057434954,0.00058840675,0.0007527237,0.00011211524,0.000035958208,0.00045917075,0.000023770008,0.0011938686,0.9900093,0.00017716663,0.00052252744,0.0055505256],"study_design_scores_gemma":[0.00020711943,0.0051214667,0.0082895225,0.000018300105,0.00007646949,0.001245313,0.000063177315,0.004905795,0.9702617,0.00012281642,0.009667337,0.000020960577],"about_ca_topic_score_codex":0.0013931817,"about_ca_topic_score_gemma":0.0023679696,"teacher_disagreement_score":0.0017453433,"about_ca_system_score_codex":0.00035107677,"about_ca_system_score_gemma":0.00030639436,"threshold_uncertainty_score":0.005838752},"labels":[],"label_agreement":null},{"id":"W4399788046","doi":"10.1093/neuonc/noae064.229","title":"EPEN-27. GAINING A CLUE FROM 1Q: A HIGH-RISK CHROMOSOMAL GAIN IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Radiology","score_opus":0.017279964879323657,"score_gpt":0.2906174167592925,"score_spread":0.27333745187996883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005646,0.002917672,0.0022776637,0.0005943817,0.000050640916,0.000043825847,0.0017677877,0.00011126025,0.0021802022],"genre_scores_gemma":[0.9927463,0.0014289458,0.0026937528,0.00024041979,0.000025074401,0.000016184495,0.0017768836,0.000041457446,0.0010310505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989855,0.000004566864,0.000006592403,0.000033833367,0.00003186852,0.00002464596],"domain_scores_gemma":[0.9998828,0.000026855867,0.00003325933,0.0000065614654,0.000015845022,0.00003465984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009785714,0.0003756156,0.00034471843,0.00057834055,0.00030697678,0.00038026736,0.00020645752,0.0005549243,0.0017250428],"category_scores_gemma":[0.00032613653,0.00012564349,0.00021590701,0.00045304166,0.0002970426,0.00023078865,0.00030356552,0.0005616479,0.00054974924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094017206,0.00006877451,0.06555708,0.0003397827,0.00007252303,0.093172304,0.00022918433,0.000799363,0.8080653,0.0008043465,0.002066725,0.02788445],"study_design_scores_gemma":[0.000052660052,0.00053028023,0.4629514,0.00011387812,0.00021176634,0.20766385,0.0007182704,0.003238448,0.29281265,0.0020723802,0.029573051,0.000061324004],"about_ca_topic_score_codex":0.00096718915,"about_ca_topic_score_gemma":0.0017449396,"teacher_disagreement_score":0.0017250428,"about_ca_system_score_codex":0.00041771858,"about_ca_system_score_gemma":0.00025772615,"threshold_uncertainty_score":0.005770862},"labels":[],"label_agreement":null},{"id":"W4399788059","doi":"10.1093/neuonc/noae064.230","title":"EPEN-28. NOVEL TARGET IDENTIFICATION IN RECURRENT POSTERIOR FOSSA EPENDYMOMA GROUP A","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Identification (biology); Group (periodic table); Medicine; Surgery; Biology; Chemistry; Botany","score_opus":0.029043228449110312,"score_gpt":0.32400332458535563,"score_spread":0.2949600961362453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94404477,0.020775218,0.012231609,0.0008817503,0.00032498315,0.00032232006,0.015490868,0.0009845011,0.004943938],"genre_scores_gemma":[0.94027066,0.008224377,0.018662281,0.000900356,0.00011069377,0.00030920442,0.025702043,0.00015701012,0.0056633013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983954,0.000009482675,0.00001105457,0.00005978672,0.000052804633,0.000027296523],"domain_scores_gemma":[0.9998729,0.00002519609,0.000039159833,0.000010880476,0.00002106662,0.00003066342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021061621,0.00046267037,0.0007953952,0.000629359,0.00032942047,0.00060779,0.0003424333,0.0005861899,0.0018374404],"category_scores_gemma":[0.00028870278,0.00015078924,0.000490667,0.00054262805,0.00019957114,0.00021120964,0.00035599666,0.0006139878,0.0009972246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075842463,0.00010053992,0.008480637,0.00066932966,0.00010773929,0.0020369824,0.00005612805,0.0006751978,0.9557125,0.00022343526,0.0022685626,0.028910508],"study_design_scores_gemma":[0.00023131707,0.0014958965,0.123800315,0.00018038579,0.00073982787,0.013728368,0.00025919653,0.010455636,0.77513015,0.0012977005,0.0725953,0.0000859305],"about_ca_topic_score_codex":0.0005843747,"about_ca_topic_score_gemma":0.0009519627,"teacher_disagreement_score":0.0018374404,"about_ca_system_score_codex":0.00035156292,"about_ca_system_score_gemma":0.0003695037,"threshold_uncertainty_score":0.006146848},"labels":[],"label_agreement":null},{"id":"W4399788453","doi":"10.1093/neuonc/noae064.611","title":"QOL-23. POTENTIAL MYELIN REPAIR AFTER IRRADIATED PEDIATRIC BRAIN TUMOR: A MAGNETIZATION TRANSFER IMAGING ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Magnetization transfer; Myelin; Medicine; Magnetic resonance imaging; Nuclear magnetic resonance; Neuroscience; Psychology; Radiology; Internal medicine; Physics; Central nervous system","score_opus":0.007680952033568629,"score_gpt":0.2979096014245667,"score_spread":0.2902286493909981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725854,0.00024495207,0.00036250695,0.000035426707,0.000005416239,0.000025792531,0.0014606626,0.000009913984,0.0005966461],"genre_scores_gemma":[0.99806887,0.000081338425,0.00043531737,0.000009113698,0.000004101055,0.000042959076,0.0009656575,0.000006648504,0.00038606688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996953,0.000082712686,0.0000399149,0.00005622293,0.00007083176,0.000055037977],"domain_scores_gemma":[0.9988863,0.00021794657,0.0005823621,0.00004922364,0.0001477672,0.00011635184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075364363,0.0003335318,0.00034699877,0.0009405104,0.00019609474,0.00057818653,0.000269161,0.00022350436,0.0026879637],"category_scores_gemma":[0.0021220674,0.000083634295,0.0007663932,0.000995956,0.00022297796,0.00028370478,0.00049182336,0.0004030973,0.00026169058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092345546,0.00015310064,0.9800648,0.000099748075,0.0002938536,0.00019890165,0.00016343518,0.0006813664,0.0011167797,0.00009743175,0.0004546376,0.015752537],"study_design_scores_gemma":[0.000008708516,0.00029316262,0.99756324,0.000010831248,0.00008020178,0.00021610911,0.00013704084,0.00074421003,0.00037924043,0.000066973786,0.0004935435,0.0000068026034],"about_ca_topic_score_codex":0.0019655668,"about_ca_topic_score_gemma":0.0016832462,"teacher_disagreement_score":0.0026879637,"about_ca_system_score_codex":0.00037252792,"about_ca_system_score_gemma":0.000308641,"threshold_uncertainty_score":0.0089921355},"labels":[],"label_agreement":null},{"id":"W4399812090","doi":"10.1093/neuonc/noae064.780","title":"Author Index","year":2024,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.04177445664300288,"score_gpt":0.3591699679761732,"score_spread":0.3173955113331703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399812090","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028971076,0.0014223068,0.00081033254,0.002842555,0.006760849,0.0002837666,0.022731962,0.0021053774,0.9627533],"genre_scores_gemma":[0.00074762554,0.0010644684,0.0005934873,0.0011074952,0.0015198708,0.00013412998,0.008993754,0.00077426597,0.9850648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994442,0.0000850709,0.00005125255,0.00006160591,0.00029641902,0.000061506464],"domain_scores_gemma":[0.9954841,0.0009371566,0.00018998861,0.00022224209,0.0018852999,0.0012812014],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005742008,0.001455817,0.0012495231,0.0058605745,0.0010784186,0.0041626277,0.0012797138,0.0016935944,0.90214896],"category_scores_gemma":[0.006939158,0.0005566236,0.00061583304,0.0040896134,0.00042635272,0.001963206,0.0020032255,0.0014681275,0.8553268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016369268,0.00001653757,0.000052172763,0.00010176775,0.0000011656463,0.000017542143,0.000004404082,0.000044404544,0.00004375833,0.00033995372,0.96594685,0.033415094],"study_design_scores_gemma":[0.000032421358,0.000019820895,0.00028585386,0.00023237096,0.0000040361865,0.00007444417,0.000019835115,0.00010819835,0.00010688661,0.0013356528,0.9977725,0.000007966515],"about_ca_topic_score_codex":0.0028310851,"about_ca_topic_score_gemma":0.0062203757,"teacher_disagreement_score":0.09785104,"about_ca_system_score_codex":0.0015330557,"about_ca_system_score_gemma":0.0023290573,"threshold_uncertainty_score":0.13957256},"labels":[],"label_agreement":null},{"id":"W4399899541","doi":"10.1093/neuonc/noae103","title":"Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"Clinical Oncology; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.15340276550253168,"score_gpt":0.493052051049666,"score_spread":0.3396492855471343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399899541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006378709,0.99432194,0.00016777204,0.0034696602,0.0008837181,0.000019096675,0.00004563586,0.000009330439,0.0010189585],"genre_scores_gemma":[0.00061194226,0.9969337,0.0004509112,0.0011449187,0.00036351106,0.00002374102,0.0000860914,0.0000029135122,0.00038225407],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99886847,0.00027800875,0.00027143923,0.00010831141,0.0003863596,0.000087359454],"domain_scores_gemma":[0.9972453,0.0010585432,0.0003558238,0.000051522504,0.0011445249,0.00014437117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003636367,0.0009463306,0.0019267191,0.0047252937,0.000498272,0.0017026529,0.0017496779,0.002160622,0.0032319806],"category_scores_gemma":[0.005482893,0.00037690907,0.0013879039,0.004399624,0.0007682834,0.0020064933,0.0011371472,0.0026625062,0.0014298442],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009540628,0.00004272362,0.0003402106,0.04171009,0.00019642634,0.00024207857,0.00012780097,0.00040531292,0.0004617479,0.004908484,0.17363976,0.77782995],"study_design_scores_gemma":[0.000029461926,0.00006524474,0.00087459455,0.035346318,0.00036387786,0.0010976618,0.0001152786,0.000107725115,0.00015814857,0.0025722967,0.9592453,0.000024114765],"about_ca_topic_score_codex":0.0032083916,"about_ca_topic_score_gemma":0.006694633,"teacher_disagreement_score":0.0047252937,"about_ca_system_score_codex":0.0020231516,"about_ca_system_score_gemma":0.0075995736,"threshold_uncertainty_score":0.01923114},"labels":[],"label_agreement":null},{"id":"W4399973113","doi":"10.1093/neuonc/noae108","title":"No benefit from TMZ treatment in glioblastoma with truly unmethylated <i>MGMT</i> promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Deutschen Konsortium für Translationale Krebsforschung; Universität Zürich; Centre Hospitalier Universitaire Vaudois; Umeå Universitet; Linköpings Universitet; Université de Lausanne; European Organisation for Research and Treatment of Cancer; Deutsches Krebsforschungszentrum","keywords":"Temozolomide; Methyltransferase; Oncology; Medicine; Internal medicine; Clinical trial; O-6-methylguanine-DNA methyltransferase; Population; Radiation therapy; DNA methylation; Glioblastoma; Chemotherapy; Methylation; Cancer research; Biology; Gene; Genetics; Gene expression","score_opus":0.01213492661300165,"score_gpt":0.27164213802023135,"score_spread":0.2595072114072297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399973113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6252955,0.2597686,0.03260397,0.002561294,0.00189969,0.0051999628,0.06624295,0.0006211658,0.0058069145],"genre_scores_gemma":[0.9511065,0.008224455,0.013405569,0.0013091095,0.00039134038,0.00323823,0.020195987,0.0002876028,0.0018411839],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.94840586,0.03331672,0.006671783,0.005444719,0.0048236805,0.001337226],"domain_scores_gemma":[0.9701465,0.01859762,0.0052477084,0.0032605196,0.00224882,0.00049882446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04818769,0.0024970663,0.008662983,0.0039281747,0.0003692628,0.0024088155,0.001325391,0.0010719631,0.0018210417],"category_scores_gemma":[0.05276281,0.00081298343,0.02813255,0.003128173,0.00067873555,0.00086340506,0.0018655175,0.0016032723,0.0003050911],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06496483,0.00012788003,0.1150455,0.017827233,0.7282052,0.00059174624,0.00039944818,0.012371412,0.00509892,0.00079465064,0.0086951675,0.045877974],"study_design_scores_gemma":[0.010918405,0.005616555,0.31213263,0.0026691344,0.6133916,0.00078567886,0.00033765985,0.008158875,0.003495536,0.0016870052,0.040585063,0.00022183693],"about_ca_topic_score_codex":0.007586534,"about_ca_topic_score_gemma":0.010214472,"teacher_disagreement_score":0.04818769,"about_ca_system_score_codex":0.0012537983,"about_ca_system_score_gemma":0.0022650429,"threshold_uncertainty_score":0.2548439},"labels":[],"label_agreement":null},{"id":"W4400448150","doi":"10.1093/neuonc/noae120","title":"A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; University of Toronto; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Biology; PI3K/AKT/mTOR pathway; Kinase; MAPK/ERK pathway; Signal transduction; Cell biology","score_opus":0.01707681928460649,"score_gpt":0.3037402657138452,"score_spread":0.28666344642923874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400448150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899777,0.0019659712,0.001983232,0.00014591834,0.000019400375,0.000119464086,0.0034244617,0.00024324347,0.0021205517],"genre_scores_gemma":[0.99047333,0.0014455677,0.002421973,0.00011431282,0.0000056017716,0.00008193014,0.003925986,0.000026100854,0.0015052032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.0000122720585,0.000010351016,0.000034781824,0.00004748792,0.000022778284],"domain_scores_gemma":[0.9999157,0.000019701487,0.000022404905,0.000009832118,0.000014449604,0.00001785088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017380016,0.00047700419,0.0005513424,0.00064729125,0.0001957023,0.00033565352,0.00022765616,0.00026875304,0.002056013],"category_scores_gemma":[0.0001434998,0.00016272755,0.00044792215,0.00040800014,0.00010861017,0.00017926525,0.00024548577,0.00032122945,0.00044409177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042536054,0.00019634803,0.005587112,0.00013270605,0.00009719784,0.00025600847,0.0000185954,0.0007438177,0.97802997,0.00007598715,0.0004474803,0.013989457],"study_design_scores_gemma":[0.00020627816,0.0038878003,0.089640684,0.00002910816,0.00060068944,0.004213747,0.00011175752,0.0069280504,0.88484085,0.00021591311,0.009282315,0.00004275726],"about_ca_topic_score_codex":0.0004850298,"about_ca_topic_score_gemma":0.0023929738,"teacher_disagreement_score":0.002056013,"about_ca_system_score_codex":0.00038151623,"about_ca_system_score_gemma":0.00024523196,"threshold_uncertainty_score":0.0068780184},"labels":[],"label_agreement":null},{"id":"W4400811773","doi":"10.1093/neuonc/noae133","title":"Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"Institut Servier; Servier; Hospices Civils de Lyon","keywords":"Radiosurgery; Medicine; Stenosis; Internal medicine; Stroke (engine); Radiology; Cardiology; Radiation therapy","score_opus":0.010106235952071455,"score_gpt":0.259128630144173,"score_spread":0.24902239419210154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400811773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995814,0.00013597388,0.000044148597,0.000008181551,0.0000016236676,0.0000041203384,0.00013977867,0.0000020599086,0.00008258323],"genre_scores_gemma":[0.9995683,0.00006679037,0.000035008725,0.000010484113,0.000006192196,0.0000058381597,0.00026331944,0.0000014824226,0.000042547854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993549,0.00017267844,0.000073500545,0.00023377566,0.000097410106,0.000067712004],"domain_scores_gemma":[0.99870956,0.00018898226,0.00065209676,0.00015752923,0.000101846636,0.0001901097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074157194,0.00037596474,0.00060228,0.0008252394,0.00043914138,0.00060119614,0.00041695056,0.00042547658,0.0007991026],"category_scores_gemma":[0.0013859827,0.00045755485,0.0007971259,0.0011491746,0.00033875927,0.00037740506,0.00035221258,0.00033961216,0.000183694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018302705,0.000021147756,0.99900526,0.000004479856,0.000121163765,0.000073726806,0.00004648136,0.000032342818,0.00013068483,0.0000045229435,0.0000281496,0.00034907047],"study_design_scores_gemma":[0.000028799976,0.000249624,0.99880517,0.0000032781957,0.00011300234,0.0004072525,0.00009139207,0.00013919051,0.000057718367,0.0000076213205,0.000092525835,0.000004346065],"about_ca_topic_score_codex":0.00582616,"about_ca_topic_score_gemma":0.003932044,"teacher_disagreement_score":0.00582616,"about_ca_system_score_codex":0.00040014772,"about_ca_system_score_gemma":0.0002541896,"threshold_uncertainty_score":0.011584461},"labels":[],"label_agreement":null},{"id":"W4401103260","doi":"10.1093/neuonc/noae128","title":"SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Mental Health Research Canada; Hospital for Sick Children","funders":"Health and Medical Research Fund","keywords":"Medicine; Parenchyma; Papillary tumor; Pathology","score_opus":0.06826265927675501,"score_gpt":0.3813802784144904,"score_spread":0.3131176191377354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401103260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005153954,0.9663754,0.001798334,0.0125784585,0.0057915533,0.00009153576,0.000522371,0.00007040077,0.0122565385],"genre_scores_gemma":[0.002561931,0.9836258,0.0026353493,0.0054697096,0.0013519573,0.0001078895,0.0009940688,0.000026793196,0.0032264441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990821,0.00017174063,0.0002560832,0.00009161657,0.00031163526,0.00008676234],"domain_scores_gemma":[0.9985617,0.00042842483,0.00018499198,0.000036183163,0.0006542169,0.00013453256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025067506,0.0006976966,0.0013393627,0.0034943114,0.0005263629,0.0014385806,0.002345693,0.0025158715,0.0051168646],"category_scores_gemma":[0.0042067515,0.00024180365,0.0014359643,0.0021233067,0.0005707146,0.0014254228,0.0013539309,0.0022317455,0.0034809937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011296968,0.00005105747,0.000534333,0.021896727,0.00016891546,0.00052692107,0.00015290512,0.0006105912,0.0009235581,0.0054693157,0.2038453,0.76570743],"study_design_scores_gemma":[0.000024772946,0.0000418518,0.0009645335,0.021051409,0.0001766374,0.0012694282,0.00009749812,0.00007754748,0.00025306796,0.0023135121,0.97371215,0.000017598473],"about_ca_topic_score_codex":0.0029652412,"about_ca_topic_score_gemma":0.0049028713,"teacher_disagreement_score":0.0051168646,"about_ca_system_score_codex":0.001315674,"about_ca_system_score_gemma":0.0059794993,"threshold_uncertainty_score":0.01711756},"labels":[],"label_agreement":null},{"id":"W4401200548","doi":"10.1093/neuonc/noae142","title":"A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institutes of Health; National Cancer Institute; Dana-Farber Cancer Institute; Pediatric Low Grade Astrocytoma Foundation; Pediatric Brain Tumor Foundation","keywords":"Glioma; Mutant; Medicine; Gerontology; Oncology; Biology; Genetics; Gene","score_opus":0.014357171846603017,"score_gpt":0.3071908395523446,"score_spread":0.2928336677057416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401200548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995183,0.00010790621,0.00003127005,0.0000059955587,8.7402356e-7,0.0000022777633,0.0002191093,0.0000013290689,0.00011308754],"genre_scores_gemma":[0.9993499,0.00009016137,0.000060355895,0.000008967904,0.000003601821,0.0000039510383,0.00045553027,0.0000014630433,0.000026071708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997913,0.00002617672,0.00002947625,0.00006613814,0.00004139293,0.000045614193],"domain_scores_gemma":[0.99912006,0.00014412952,0.00043061472,0.00004694961,0.00009054023,0.00016783712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003168342,0.00016255667,0.0002976697,0.0008382034,0.00024982565,0.0003616733,0.00018843201,0.00019327307,0.0008241118],"category_scores_gemma":[0.0012595131,0.00010097498,0.0002502934,0.0008663413,0.00015542797,0.00031267037,0.0002842216,0.00016569543,0.00016378282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012673181,0.000005755507,0.9981193,0.000005144361,0.000018423947,0.00015939237,0.00004691663,0.000027556467,0.00034524794,0.000010699236,0.000036335707,0.001098561],"study_design_scores_gemma":[0.0000038350663,0.000106044434,0.9984754,0.0000024344752,0.0000150929745,0.00091933284,0.00013321835,0.000081024096,0.00009935246,0.000011770384,0.00015079846,0.0000016771219],"about_ca_topic_score_codex":0.0025572742,"about_ca_topic_score_gemma":0.0029345052,"teacher_disagreement_score":0.0025572742,"about_ca_system_score_codex":0.00029821083,"about_ca_system_score_gemma":0.00030429137,"threshold_uncertainty_score":0.0050848126},"labels":[],"label_agreement":null},{"id":"W4401200574","doi":"10.1093/neuonc/noae143","title":"Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse?","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Glioblastoma; Horse; Oncology; Medicine; Cancer research; Biology","score_opus":0.016065409108778447,"score_gpt":0.270192571550423,"score_spread":0.2541271624416445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401200574","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80627984,0.186616,0.00037447765,0.0047086403,0.00021780204,0.000056313267,0.00021008654,0.000018343893,0.0015185456],"genre_scores_gemma":[0.95080507,0.044990674,0.00046335944,0.002469023,0.0005605719,0.00003449135,0.00029144756,0.000004294555,0.0003810724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986196,0.000049595877,0.000022403916,0.000012647461,0.00003478571,0.000018593384],"domain_scores_gemma":[0.9996697,0.00006265575,0.00015119181,0.000009011649,0.00003725886,0.000070160946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051911385,0.00012296374,0.00055993424,0.00016669807,0.00015713734,0.00030125558,0.00020052407,0.0002559425,0.0003696846],"category_scores_gemma":[0.00088391383,0.000065690016,0.00035726395,0.00038635498,0.00015810903,0.00041192974,0.0001259955,0.00044055417,0.000103677696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023366444,0.00067690253,0.25722897,0.0019466286,0.0010404901,0.0012470267,0.00036345943,0.000866672,0.009003449,0.0004036648,0.008084313,0.69577193],"study_design_scores_gemma":[0.0031298667,0.026826309,0.8955337,0.0015759526,0.0027712928,0.004278941,0.0007921788,0.0020231926,0.0047231326,0.00135219,0.05690139,0.00009200523],"about_ca_topic_score_codex":0.0012032109,"about_ca_topic_score_gemma":0.005367281,"teacher_disagreement_score":0.0012032109,"about_ca_system_score_codex":0.00053209387,"about_ca_system_score_gemma":0.0004924144,"threshold_uncertainty_score":0.0038605928},"labels":[],"label_agreement":null},{"id":"W4401793465","doi":"10.1093/neuonc/noae166","title":"Distinct relapse pattern across molecular ependymoma types","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Universitätsklinikum Hamburg-Eppendorf; National Institutes of Health; Universitätsklinikum Heidelberg; Aarhus Universitetshospital; Medizinische Universität Wien; Hospital for Sick Children; CERN; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum; Rheinische Friedrich-Wilhelms-Universität Bonn; Universität Wien; Universitätsklinikum Essen; Deutschen Konsortium für Translationale Krebsforschung; Aarhus Universitet","keywords":"Ependymoma; Medicine; Internal medicine; Cohort; Gastroenterology; Pathology; Oncology","score_opus":0.017766836948739862,"score_gpt":0.3247350209039006,"score_spread":0.30696818395516073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401793465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998461,0.0002819103,0.00023033151,0.000011460162,0.0000028225948,0.000010801574,0.00055583974,0.000014672511,0.00043106225],"genre_scores_gemma":[0.9982079,0.000117736345,0.0001882046,0.000014891808,0.0000033168533,0.000011060321,0.0013075081,0.000009184031,0.000140186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964464,0.00003741888,0.00004444839,0.0001427447,0.00006211387,0.00006861681],"domain_scores_gemma":[0.9994186,0.00013597483,0.00019873437,0.00006677687,0.00010331051,0.00007657555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038531906,0.00018905397,0.0003489193,0.000883907,0.00021441128,0.0003716725,0.00032747813,0.00019979903,0.0013116753],"category_scores_gemma":[0.0011601527,0.00010674893,0.00037928548,0.00050199183,0.00020400657,0.00022934964,0.0004814126,0.00024005782,0.0002506583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038740775,0.000013921078,0.98300064,0.000030578438,0.00013422422,0.00036423292,0.00014924181,0.00010133399,0.0076618018,0.00004779335,0.0002040639,0.007904697],"study_design_scores_gemma":[0.000005494176,0.00005536019,0.9967146,0.000008837203,0.000053257198,0.001596359,0.000118737655,0.00015028668,0.00086353056,0.000070356575,0.0003584478,0.0000047940803],"about_ca_topic_score_codex":0.0017242334,"about_ca_topic_score_gemma":0.0036046715,"teacher_disagreement_score":0.0017242334,"about_ca_system_score_codex":0.00028133448,"about_ca_system_score_gemma":0.0001899319,"threshold_uncertainty_score":0.0043880343},"labels":[],"label_agreement":null},{"id":"W4401984414","doi":"10.1093/neuonc/noae171","title":"NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Robert H. Lurie Comprehensive Cancer Center; Università degli Studi di Torino; Universität Zürich; Medizinische Universität Wien; Memorial Sloan-Kettering Cancer Center; University of Toronto; Universität Wien; University of Texas MD Anderson Cancer Center; Northwestern University","keywords":"Balanced scorecard; Medicine; Nano-; Medical physics; Radiology; Internal medicine; Business; Engineering","score_opus":0.05619876028713701,"score_gpt":0.41040174623150216,"score_spread":0.35420298594436517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401984414","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6051299,0.0081868945,0.11043948,0.0569615,0.0035285063,0.057688188,0.05221302,0.002481011,0.103371605],"genre_scores_gemma":[0.6718229,0.004022471,0.22856674,0.005803954,0.0005153784,0.036547683,0.045692794,0.0002532849,0.0067748595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97587025,0.009848671,0.007597776,0.00088594813,0.004593434,0.0012039297],"domain_scores_gemma":[0.9700823,0.006933995,0.006045709,0.0009871048,0.0136543615,0.0022964876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023687148,0.0007874116,0.0018069836,0.0043238956,0.0008071066,0.001617858,0.0019959072,0.0015220895,0.0033570093],"category_scores_gemma":[0.04818149,0.00031686862,0.002235348,0.002663764,0.00054597115,0.0022775647,0.0042094775,0.0019484403,0.0016682755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013168672,0.0012557463,0.22938587,0.002907134,0.00092357455,0.00036864818,0.0014744246,0.0067045,0.0015460446,0.0048985467,0.25184074,0.49737787],"study_design_scores_gemma":[0.001787182,0.0021189277,0.75846994,0.003088695,0.0004575703,0.0018314186,0.0033055304,0.028743703,0.0020469576,0.011296243,0.18636593,0.00048784204],"about_ca_topic_score_codex":0.003966825,"about_ca_topic_score_gemma":0.004448994,"teacher_disagreement_score":0.023687148,"about_ca_system_score_codex":0.0046167164,"about_ca_system_score_gemma":0.006537992,"threshold_uncertainty_score":0.12527114},"labels":[],"label_agreement":null},{"id":"W4402118551","doi":"10.1093/neuonc/noae170","title":"cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Grading (engineering); Medicine; Medical physics; Psychology; Engineering","score_opus":0.0883324755852867,"score_gpt":0.3992109467485592,"score_spread":0.3108784711632725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402118551","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009538354,0.056802347,0.050330218,0.6015874,0.09791732,0.0055578095,0.03089964,0.0058271326,0.14153986],"genre_scores_gemma":[0.045589812,0.09231251,0.2881667,0.25325897,0.05489622,0.0100070825,0.15705724,0.005877722,0.092833705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9792964,0.007726975,0.0050943275,0.0008089062,0.0055111055,0.0015622358],"domain_scores_gemma":[0.8664546,0.026638735,0.009964892,0.0057311156,0.083289035,0.007921709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0552419,0.0014521284,0.0018727881,0.007379945,0.001376022,0.004678582,0.008687115,0.008594188,0.006856248],"category_scores_gemma":[0.107970886,0.0010015863,0.0035295545,0.0045829937,0.0018266897,0.0037721992,0.0055642175,0.009798152,0.011335697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001161571,0.00007385528,0.0025655862,0.0010182046,0.00005526907,0.00019153094,0.00030128803,0.0007177583,0.0006249954,0.002347621,0.89123285,0.100754865],"study_design_scores_gemma":[0.00008329035,0.00008593771,0.005906404,0.0049197488,0.00014861028,0.0004373904,0.00028629872,0.00054989825,0.0007278885,0.0031105615,0.9836623,0.00008172736],"about_ca_topic_score_codex":0.027357655,"about_ca_topic_score_gemma":0.025457362,"teacher_disagreement_score":0.0552419,"about_ca_system_score_codex":0.005346691,"about_ca_system_score_gemma":0.019939711,"threshold_uncertainty_score":0.29215056},"labels":[],"label_agreement":null},{"id":"W4402553041","doi":"10.1093/neuonc/noae157","title":"<i>MGMT</i> promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Methylation; Astrocytoma; Mutant; Cancer research; Biology; Chemotherapy; Oncology; Medicine; Genetics; Glioblastoma; Gene","score_opus":0.026463147145407376,"score_gpt":0.32856589179060314,"score_spread":0.30210274464519576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402553041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634224,0.0009849861,0.00006219941,0.00023966738,0.000022453138,0.000010524729,0.0014675584,0.00001039515,0.0008599103],"genre_scores_gemma":[0.9973605,0.00038006864,0.000063872096,0.00009915883,0.000036851652,0.000012504399,0.0017869181,0.0000049121813,0.000255203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984944,0.000021693815,0.000018529177,0.000033421264,0.00003337059,0.000043596567],"domain_scores_gemma":[0.9990682,0.00010014738,0.00055122474,0.00004377306,0.00007676574,0.00015994733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002488429,0.00012322808,0.00024202622,0.0004812082,0.00025375374,0.00031909344,0.00026191672,0.00024303395,0.0013963884],"category_scores_gemma":[0.0013500538,0.000089877016,0.00037545382,0.00070977287,0.0001347389,0.00034458618,0.00026640244,0.0004182443,0.00025580171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006283821,0.00004041997,0.99161595,0.000017709903,0.000079712765,0.000098969605,0.000031008036,0.00013540343,0.00018251933,0.000020809075,0.00094569306,0.006203471],"study_design_scores_gemma":[0.0000142474155,0.00016823738,0.9984511,0.000015852269,0.00008352886,0.00019395148,0.000044950262,0.00030855395,0.00009665189,0.00008564435,0.00053299207,0.000004213987],"about_ca_topic_score_codex":0.008594907,"about_ca_topic_score_gemma":0.014991993,"teacher_disagreement_score":0.008594907,"about_ca_system_score_codex":0.0005634481,"about_ca_system_score_gemma":0.00046582764,"threshold_uncertainty_score":0.017089725},"labels":[],"label_agreement":null},{"id":"W4402574381","doi":"10.1093/neuonc/noae194","title":"“Splice of Life”: How RNA is Rewriting the Meningioma Story","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rewriting; Meningioma; splice; Computational biology; RNA; Biology; Medicine; Computer science; Genetics; Programming language; Gene; Pathology","score_opus":0.030859038646492826,"score_gpt":0.2928308399295469,"score_spread":0.2619718012830541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402574381","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030295027,0.0037197445,0.00009628359,0.98215044,0.011955384,0.0000025052566,0.000007384956,0.000008988969,0.0017563063],"genre_scores_gemma":[0.009307096,0.0036092852,0.0002224129,0.9197101,0.06238562,0.000014375478,0.00000833822,0.000029692377,0.004713097],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676394,0.0015937303,0.00024483688,0.00030696922,0.00069409853,0.00039644685],"domain_scores_gemma":[0.9915992,0.0061382465,0.00033957782,0.00022861642,0.00063235086,0.0010619749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003955163,0.000695844,0.0010547894,0.0005510836,0.005162617,0.0052275197,0.0014752251,0.045785666,0.004273247],"category_scores_gemma":[0.024252508,0.00045979215,0.0008836178,0.0004452443,0.007575058,0.0072075836,0.002659716,0.05670493,0.0023846976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009439636,0.000039771603,0.0003780928,0.00010743425,0.000033098124,0.0061750133,0.0015939076,0.00013672866,0.00043472587,0.031260308,0.93847674,0.021269858],"study_design_scores_gemma":[0.00007387652,0.000056598437,0.00026440437,0.00029233977,0.000024557346,0.004933084,0.0016088828,0.00028483666,0.00030100186,0.07155794,0.9205376,0.000064966785],"about_ca_topic_score_codex":0.0045534587,"about_ca_topic_score_gemma":0.006641789,"teacher_disagreement_score":0.045785666,"about_ca_system_score_codex":0.0043752706,"about_ca_system_score_gemma":0.0034097102,"threshold_uncertainty_score":0.031744897},"labels":[],"label_agreement":null},{"id":"W4403194748","doi":"10.1093/neuonc/noae206","title":"EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Research Foundation Singapore","keywords":"RELB; EZH2; Reactive oxygen species; Biology; Cancer research; Phenotype; Methylation; Cell biology; Genetics; NFKB1; Transcription factor; Gene","score_opus":0.02789442078578806,"score_gpt":0.2959887971987281,"score_spread":0.26809437641294004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403194748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790823,0.0005328306,0.0007618243,0.0000351375,0.000004926235,0.000012052305,0.00025287713,0.00002028253,0.00047186844],"genre_scores_gemma":[0.9987575,0.00020736456,0.00033072766,0.000024576175,0.0000029618793,0.000015564865,0.00029012666,0.0000039041065,0.00036719895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.0000070437077,0.00000647425,0.00002225166,0.000025818754,0.0000281643],"domain_scores_gemma":[0.9999505,0.0000040783243,0.000019260058,0.000003508762,0.0000058442033,0.000016740978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102387006,0.0001622482,0.00012486083,0.00033347585,0.00011608194,0.00025390452,0.00008954279,0.00016150606,0.00093756476],"category_scores_gemma":[0.00007518466,0.00007477068,0.00010224758,0.0001682772,0.00020650693,0.00015783307,0.00020098711,0.00023875126,0.00015866525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048178772,0.000028717392,0.00829113,0.000051230283,0.000017170523,0.00015130745,0.000045015713,0.00008082693,0.9880823,0.0002476332,0.00008205765,0.0024408796],"study_design_scores_gemma":[0.000036567246,0.0004626549,0.22875653,0.000013642723,0.000079339174,0.00198763,0.00028132153,0.0014491413,0.7618647,0.00059589854,0.004461863,0.000010660823],"about_ca_topic_score_codex":0.00029664952,"about_ca_topic_score_gemma":0.0006383066,"teacher_disagreement_score":0.00093756476,"about_ca_system_score_codex":0.0002998098,"about_ca_system_score_gemma":0.00011642382,"threshold_uncertainty_score":0.0031363964},"labels":[],"label_agreement":null},{"id":"W4403341017","doi":"10.1093/neuonc/noae204","title":"Pediatric cranial stereotactic radiosurgery: Meta-analysis and international stereotactic radiosurgery society practice guidelines","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; MEDLINE; Medical literature; Medical record; Craniopharyngioma; Radiology; Medical physics; Radiation therapy; Pathology","score_opus":0.1760418275465362,"score_gpt":0.4361398566304072,"score_spread":0.26009802908387103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403341017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054854904,0.98771566,0.00240383,0.0010533883,0.00023055769,0.000328893,0.0020816333,0.00004896247,0.0006516157],"genre_scores_gemma":[0.318807,0.6604347,0.010217215,0.0031462368,0.0006291195,0.0025616002,0.0036717732,0.000119159835,0.00041313595],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9661547,0.01650651,0.009952791,0.0035661643,0.0032969927,0.0005228027],"domain_scores_gemma":[0.9255903,0.05254151,0.013592986,0.0027661584,0.0050913403,0.00041770513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042272534,0.0020776244,0.007963732,0.00907363,0.00039906526,0.0025928703,0.0026504693,0.0019783624,0.0030380215],"category_scores_gemma":[0.09123113,0.0012887954,0.025995126,0.011263258,0.0007301776,0.0019014992,0.0013742475,0.0016620076,0.0003138372],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012329674,0.000019983714,0.039263424,0.29925096,0.6205092,0.0002107162,0.0002853924,0.0015457512,0.00020558739,0.000653902,0.0060564564,0.03076559],"study_design_scores_gemma":[0.0009339166,0.00017464455,0.034817673,0.077423155,0.8734416,0.00034131223,0.00020522616,0.0010399116,0.00025771168,0.0014675583,0.009833023,0.00006437847],"about_ca_topic_score_codex":0.009693442,"about_ca_topic_score_gemma":0.014982251,"teacher_disagreement_score":0.042272534,"about_ca_system_score_codex":0.002544811,"about_ca_system_score_gemma":0.004310261,"threshold_uncertainty_score":0.22356123},"labels":[],"label_agreement":null},{"id":"W4403438489","doi":"10.1093/neuonc/noae158.084","title":"USING CCA-MRI TO PREDICT RESPONSE TO STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Royal Ottawa Mental Health Centre","funders":"","keywords":"Radiosurgery; Medicine; Stereotactic radiotherapy; Medical physics; Radiology; Nuclear medicine; Radiation therapy","score_opus":0.04691854705204666,"score_gpt":0.31659494103873714,"score_spread":0.26967639398669047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403438489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986375,0.00030644363,0.00019897944,0.000034548997,0.000010111786,0.0000113933975,0.0001448584,0.000010286472,0.0006459735],"genre_scores_gemma":[0.9994361,0.000058434394,0.00013078858,0.000012691155,0.000008744558,0.000009516528,0.00018035901,0.0000024369988,0.00016090921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998549,0.000030811658,0.000015000975,0.000038797298,0.0000369893,0.000023491792],"domain_scores_gemma":[0.9994485,0.00017843313,0.00013663743,0.000021930167,0.00010856899,0.00010595815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003346006,0.0003408299,0.00029091872,0.0005865074,0.00015088072,0.00037799665,0.0001731052,0.0003590668,0.0011892323],"category_scores_gemma":[0.0015435015,0.0001383799,0.00026612522,0.0002174507,0.00018229551,0.00022379585,0.00021411791,0.00031027192,0.0005087354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011827727,0.00004612996,0.98919934,0.000015286767,0.00004499832,0.00014701724,0.000027720891,0.0002767993,0.003872055,0.000013041394,0.00016494932,0.0050098677],"study_design_scores_gemma":[0.000030063433,0.00069188175,0.99427915,0.0000064304263,0.000078692574,0.00087024743,0.00009718431,0.0020345196,0.0015629871,0.000045100867,0.00029573712,0.000008016545],"about_ca_topic_score_codex":0.0013372399,"about_ca_topic_score_gemma":0.0016389912,"teacher_disagreement_score":0.0013372399,"about_ca_system_score_codex":0.0002073498,"about_ca_system_score_gemma":0.000174753,"threshold_uncertainty_score":0.0039783716},"labels":[],"label_agreement":null},{"id":"W4403483237","doi":"10.1093/neuonc/noae144.300","title":"P17.13.B NANO-LM: AN UPDATED SCORECARD FOR THE CLINICAL ASSESSMENT OF PATIENTS WITH LEPTOMENINGEAL METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Balanced scorecard; Nano-; Medicine; Medical physics; Radiology; Internal medicine; Engineering; Process management; Chemical engineering","score_opus":0.055074635300159845,"score_gpt":0.4087459070068606,"score_spread":0.35367127170670076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403483237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74004716,0.0048928354,0.047770217,0.02231488,0.0018382479,0.036800258,0.047254607,0.0016900029,0.09739171],"genre_scores_gemma":[0.80177724,0.002115182,0.12681708,0.0028269978,0.00040582652,0.028172053,0.031346936,0.00016643353,0.0063721933],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9876079,0.0057704165,0.003739335,0.00041882216,0.0018133039,0.0006503086],"domain_scores_gemma":[0.977205,0.0076752463,0.0054090964,0.0008488641,0.006913644,0.0019481122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014350074,0.0006235196,0.0012093874,0.0028842895,0.00049165013,0.0014149493,0.0012269001,0.0010108467,0.0054899696],"category_scores_gemma":[0.0323974,0.00021798586,0.001554083,0.0019589672,0.0004652891,0.0014880543,0.0025824867,0.0012753912,0.0022197624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00205213,0.0014825047,0.32339394,0.0029034903,0.00083443674,0.00028301124,0.0009821383,0.0052332873,0.0015335511,0.005419615,0.17553133,0.48035058],"study_design_scores_gemma":[0.0015190137,0.0019403074,0.8480709,0.0018607874,0.00033703103,0.0008950414,0.0017544444,0.017084854,0.0014424698,0.007056636,0.117747344,0.00029108886],"about_ca_topic_score_codex":0.0017989288,"about_ca_topic_score_gemma":0.0018677001,"teacher_disagreement_score":0.014350074,"about_ca_system_score_codex":0.0024033422,"about_ca_system_score_gemma":0.0029456418,"threshold_uncertainty_score":0.075891316},"labels":[],"label_agreement":null},{"id":"W4403509708","doi":"10.1093/neuonc/noae144.492","title":"P27.30.B VALIDATING THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY SCALE FOR VIRTUAL VISITS: A PILOT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Scale (ratio); Medicine; Medical physics; Oncology; Geography; Cartography","score_opus":0.04977349197660855,"score_gpt":0.37233928372797476,"score_spread":0.32256579175136624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403509708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561436,0.000112608555,0.001849206,0.00024027648,0.0001194477,0.008351978,0.00093388854,0.000052784202,0.002725365],"genre_scores_gemma":[0.97277945,0.00013952823,0.006349988,0.00038135512,0.00010020661,0.017188653,0.001456355,0.00004726447,0.0015571417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495846,0.003387074,0.00032992495,0.00033699314,0.0006494641,0.0003380186],"domain_scores_gemma":[0.9834922,0.007357001,0.0020497178,0.0014804894,0.0034344452,0.0021861496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0107226465,0.00081901415,0.0006469696,0.0005519768,0.00083455973,0.0010764735,0.0009576,0.0010146666,0.0067858556],"category_scores_gemma":[0.017900981,0.000406746,0.0010258064,0.00050914974,0.0010363,0.0010832342,0.0010585069,0.0017971668,0.0029284009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05597241,0.14507772,0.62179595,0.001418921,0.00070776005,0.0012238458,0.0064810505,0.0024850508,0.0094404,0.0011739617,0.013408983,0.14081399],"study_design_scores_gemma":[0.011963408,0.27683416,0.68880534,0.00028116963,0.00030555535,0.00073622796,0.003362839,0.00545365,0.0024044933,0.0005411,0.009200283,0.00011175871],"about_ca_topic_score_codex":0.0018308512,"about_ca_topic_score_gemma":0.0018088322,"teacher_disagreement_score":0.0107226465,"about_ca_system_score_codex":0.0007113368,"about_ca_system_score_gemma":0.002072822,"threshold_uncertainty_score":0.0567075},"labels":[],"label_agreement":null},{"id":"W4403510173","doi":"10.1093/neuonc/noae144.265","title":"P14.14.A INTRA-ARTERIAL CHEMOTHERAPY TREATMENT FOR RELAPSING GLIOBLASTOMA: RESULTS FROM A FIVE-YEAR SERIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Glioblastoma; Series (stratigraphy); Chemotherapy; Medicine; Oncology; Internal medicine; Cancer research; Geology","score_opus":0.020377283237840178,"score_gpt":0.3025474898477629,"score_spread":0.28217020660992276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975296,0.019044882,0.0014529267,0.00018037246,0.00013005277,0.00018620069,0.0010387016,0.000035419787,0.0026353337],"genre_scores_gemma":[0.9770512,0.016238838,0.0010840439,0.0004938567,0.00017441523,0.00016310069,0.0027963019,0.000042517135,0.0019557932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996092,0.00006576234,0.00008819087,0.00006591957,0.000105561434,0.00006544426],"domain_scores_gemma":[0.9995047,0.00007142611,0.00015161833,0.000054578326,0.000081848055,0.00013593324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004502499,0.00044162787,0.0005157922,0.00079933787,0.00048945454,0.0007677045,0.000342528,0.00047339156,0.0012538992],"category_scores_gemma":[0.0009310281,0.0001654668,0.0010512843,0.0012075227,0.0003513376,0.00037282816,0.00035987952,0.0004892085,0.00091029756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040521757,0.0068809567,0.45147878,0.0014123297,0.0019399432,0.024466552,0.0016642573,0.0013459782,0.008355353,0.00043463527,0.008013252,0.48995575],"study_design_scores_gemma":[0.00078813976,0.02785809,0.8716508,0.00070713676,0.002498243,0.05260184,0.0013890674,0.0011705144,0.005422155,0.00030624983,0.035464466,0.00014324868],"about_ca_topic_score_codex":0.0013157467,"about_ca_topic_score_gemma":0.0012929529,"teacher_disagreement_score":0.0013157467,"about_ca_system_score_codex":0.0004537935,"about_ca_system_score_gemma":0.00063493644,"threshold_uncertainty_score":0.0041947365},"labels":[],"label_agreement":null},{"id":"W4403510301","doi":"10.1093/neuonc/noae144.081","title":"OS10.5.A MINIMALLY INVASIVE BRAIN METASTASES ARE CHARACTERIZED BY AN ACTIVE, ANTI-CANCER IMMUNE INFILTRATE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Immune system; Brain cancer; Medicine; Cancer; Pathology; Immunology; Internal medicine","score_opus":0.040304973291413936,"score_gpt":0.36759510682662466,"score_spread":0.32729013353521075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452907,0.0007125919,0.0011135763,0.00007403042,0.000015267835,0.000030922514,0.0010410001,0.00009362776,0.0023898967],"genre_scores_gemma":[0.99311286,0.0002702396,0.0013323402,0.000104539475,0.000007881423,0.000037542082,0.0022133943,0.000022759048,0.0028983648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991703,0.0000055914456,0.000005767645,0.00002210317,0.000023026463,0.000026568232],"domain_scores_gemma":[0.9998841,0.000011692977,0.000031869884,0.000008862042,0.000010728329,0.000052796313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089365356,0.00031897545,0.0001934539,0.00036358385,0.0001779639,0.0003574295,0.0001289921,0.00025574223,0.0029575035],"category_scores_gemma":[0.00009182964,0.00013969601,0.00013471578,0.00019025343,0.00019883057,0.00014420884,0.00018183218,0.00043259314,0.00069098355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034769197,0.00010276157,0.0066365073,0.000048483296,0.000009286571,0.0003791983,0.000037238937,0.000086173866,0.9881892,0.00021446783,0.00032900015,0.0036199011],"study_design_scores_gemma":[0.00016870102,0.0040329434,0.35775983,0.00003530949,0.000085786225,0.011198976,0.0004779454,0.0027261884,0.60088515,0.0008054649,0.021798477,0.000025189856],"about_ca_topic_score_codex":0.0008181066,"about_ca_topic_score_gemma":0.001308519,"teacher_disagreement_score":0.0029575035,"about_ca_system_score_codex":0.00027892305,"about_ca_system_score_gemma":0.00013005141,"threshold_uncertainty_score":0.009893775},"labels":[],"label_agreement":null},{"id":"W4403510351","doi":"10.1093/neuonc/noae144.454","title":"P26.06.B EVALUATION OF THE ANTITUMOR EFFECT OF A CHEMOTHERAPY-LOADED DEVICE FOR THE TREATMENT OF PRIMARY BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"Chemotherapy; Medicine; Primary (astronomy); Oncology; Internal medicine; Physics","score_opus":0.028062297360796733,"score_gpt":0.3183576420683153,"score_spread":0.29029534470751855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114424,0.0020088418,0.0037529394,0.00006387052,0.00013411175,0.000117532785,0.00041910866,0.0001369469,0.0022224279],"genre_scores_gemma":[0.98666394,0.0012669063,0.005754484,0.0000414353,0.00002582516,0.000110725254,0.0005022985,0.000035803158,0.005598564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.000012436395,0.0000057953866,0.000019554973,0.000032181717,0.00001725164],"domain_scores_gemma":[0.9998939,0.000029048655,0.000021865142,0.0000088043225,0.00002212653,0.000024236366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001802788,0.0003633825,0.00017205795,0.0003216192,0.00011543807,0.00017907133,0.00017233723,0.00033791643,0.0027737499],"category_scores_gemma":[0.00015268111,0.00008815257,0.0002546716,0.000150543,0.00014167602,0.00012500856,0.0000720627,0.00022125452,0.00048992573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037494715,0.0002553915,0.00017431023,0.00011006671,0.000006448357,0.00011391268,0.0000128019965,0.00022243649,0.9934127,0.0000615598,0.00014658013,0.005108911],"study_design_scores_gemma":[0.00003168929,0.0053964294,0.0022697423,0.000012785463,0.000023052515,0.0002120614,0.000013295055,0.0013881996,0.98842853,0.000012865651,0.0022050894,0.0000061853107],"about_ca_topic_score_codex":0.00021318147,"about_ca_topic_score_gemma":0.00011704216,"teacher_disagreement_score":0.0027737499,"about_ca_system_score_codex":0.00007168034,"about_ca_system_score_gemma":0.00011593338,"threshold_uncertainty_score":0.009279132},"labels":[],"label_agreement":null},{"id":"W4403510885","doi":"10.1093/neuonc/noae144.156","title":"P08.03.A CSF-BASED PROTEOMIC BIOMARKERS OF RESPONSE TO MULTI-AGENT INTRAVENTRICULAR CHEMOTHERAPY IN CNS LYMPHOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Chemotherapy; Oncology; Pathology; Internal medicine","score_opus":0.015716096674965742,"score_gpt":0.3112791570470995,"score_spread":0.29556306037213376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963569,0.0007782883,0.00043807892,0.000118482654,0.000023645016,0.000038489175,0.0013057196,0.000039580358,0.00090082415],"genre_scores_gemma":[0.9972983,0.00012449142,0.0008341746,0.00007733933,0.000016344835,0.000043804284,0.0012025789,0.0000075552557,0.00039543054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997718,0.00004601579,0.000037097852,0.000047448517,0.0000625471,0.000035120323],"domain_scores_gemma":[0.99933404,0.00013058742,0.0002488529,0.00003296572,0.00015585759,0.000097674485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040909782,0.00021889205,0.00032742004,0.0006631296,0.00021065757,0.0007028784,0.0002626199,0.00037636637,0.0018064136],"category_scores_gemma":[0.001109815,0.000090034344,0.00019350741,0.00053921645,0.00019757176,0.00023645032,0.0002587215,0.00034718358,0.0005789141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043602586,0.00034236436,0.8387925,0.00021811962,0.00013767395,0.0013627161,0.00013649212,0.00071441504,0.1068486,0.00011863957,0.0019103464,0.045057822],"study_design_scores_gemma":[0.000099786615,0.0023789185,0.9543526,0.00003918332,0.00015364184,0.004910274,0.0002434511,0.002906561,0.031185152,0.0002813053,0.003432307,0.00001685821],"about_ca_topic_score_codex":0.0005524873,"about_ca_topic_score_gemma":0.0004892675,"teacher_disagreement_score":0.0018064136,"about_ca_system_score_codex":0.00031619988,"about_ca_system_score_gemma":0.0003054657,"threshold_uncertainty_score":0.006043017},"labels":[],"label_agreement":null},{"id":"W4403511081","doi":"10.1093/neuonc/noae144.458","title":"P26.10.B OPTIMIZING DELIVERY OF CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Glioblastoma; Medicine; Pharmacology; Oncology; Cancer research","score_opus":0.015655462176887965,"score_gpt":0.2705744865291922,"score_spread":0.25491902435230424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724773,0.0061909393,0.014555405,0.00035732574,0.00018920134,0.00023694437,0.00046049184,0.0003988955,0.0051335217],"genre_scores_gemma":[0.9776359,0.005036812,0.011533854,0.00010752681,0.00005229345,0.00020613462,0.0004268545,0.00006573897,0.0049347533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999273,0.000011519384,0.0000053076333,0.000014046812,0.000018543315,0.000023224435],"domain_scores_gemma":[0.99995697,0.0000035946314,0.000013284437,0.000003709848,0.000007819952,0.000014585009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015717962,0.0003669182,0.0002509292,0.00029344583,0.00014851779,0.00031903535,0.00024818938,0.0002745591,0.0014301457],"category_scores_gemma":[0.00008158527,0.00010160163,0.0001968696,0.00019838744,0.000200375,0.00017629204,0.00015721544,0.0004453513,0.0004751993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009486521,0.0003735593,0.00034012995,0.00013192766,0.000010659987,0.00014565967,0.000021293812,0.00047395733,0.9769985,0.00042601072,0.00065861375,0.01947101],"study_design_scores_gemma":[0.00012303847,0.004721504,0.0026819652,0.000023201068,0.000059030677,0.00061043224,0.000025546868,0.0037646233,0.97786796,0.000149595,0.009959442,0.000013796176],"about_ca_topic_score_codex":0.0011579881,"about_ca_topic_score_gemma":0.0008268921,"teacher_disagreement_score":0.0014301457,"about_ca_system_score_codex":0.00023648774,"about_ca_system_score_gemma":0.00039904244,"threshold_uncertainty_score":0.0047843456},"labels":[],"label_agreement":null},{"id":"W4403511284","doi":"10.1093/neuonc/noae144.079","title":"OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Regorafenib; Agile software development; Medicine; Oncology; Computer science; Internal medicine; Software engineering","score_opus":0.07117241439050807,"score_gpt":0.39326491584887086,"score_spread":0.32209250145836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90944016,0.018412113,0.0042517255,0.005112669,0.0012857993,0.006289491,0.023294229,0.0011949815,0.030718843],"genre_scores_gemma":[0.94895816,0.0041568563,0.006422012,0.0033201901,0.00056743633,0.0057637827,0.017038342,0.00020421883,0.013569014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999258,0.0004501335,0.000031057814,0.00010796395,0.000076665165,0.000076084514],"domain_scores_gemma":[0.99926263,0.0001810411,0.00015927468,0.00009484169,0.000058881415,0.00024333739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019316677,0.0009930194,0.0012338109,0.00032766457,0.00025710446,0.0009865994,0.00053804304,0.0008682171,0.010907327],"category_scores_gemma":[0.002140632,0.0002881374,0.0015182009,0.0002519971,0.000648541,0.00079497206,0.00037585633,0.002207727,0.0016715021],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80418235,0.0060319216,0.0027771222,0.002282087,0.0024080686,0.00010338675,0.00011267619,0.0033490628,0.010480949,0.0023610615,0.029615194,0.13629618],"study_design_scores_gemma":[0.8241495,0.13298659,0.0074503957,0.0003612445,0.002301171,0.00023476798,0.00005993527,0.003691079,0.0034727694,0.0032768298,0.021954326,0.00006140928],"about_ca_topic_score_codex":0.00077533635,"about_ca_topic_score_gemma":0.0027709445,"teacher_disagreement_score":0.010907327,"about_ca_system_score_codex":0.00093434984,"about_ca_system_score_gemma":0.0015892431,"threshold_uncertainty_score":0.036488652},"labels":[],"label_agreement":null},{"id":"W4403511401","doi":"10.1093/neuonc/noae144.085","title":"OS11.7.A DELETION OF MONOCARBOXYLATE TRANSPORTER 1 IN MYELOID CELLS FAVOURS GLIOBLASTOMA DEVELOPMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Immune system; Microglia; Myeloid; Transporter; Tumor microenvironment; Cancer research; Biology; Haematopoiesis; Phenotype; Immunology; Inflammation; Chemistry; Cell biology; Stem cell; Biochemistry; Gene","score_opus":0.015043837969478127,"score_gpt":0.27479423660356317,"score_spread":0.25975039863408506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129444,0.0006444461,0.0034323945,0.0001667156,0.00010796312,0.00007500364,0.0024559747,0.00012854434,0.0016945109],"genre_scores_gemma":[0.9851393,0.00091004226,0.0023445413,0.0001236135,0.000020300104,0.00012931429,0.0028086305,0.00016296301,0.008361262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997229,0.000028315155,0.000038521062,0.00006328685,0.000066480454,0.00008047374],"domain_scores_gemma":[0.99972874,0.000029510182,0.00010569484,0.000015126007,0.000016114547,0.00010483821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012241844,0.00045913694,0.00029315142,0.0004932955,0.00019555532,0.0003781266,0.0002465789,0.00056397927,0.0043378877],"category_scores_gemma":[0.00012510193,0.00022384578,0.00036610043,0.0002646546,0.00052554224,0.00017052691,0.00033046387,0.00066883746,0.0013254788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038489848,0.00004990542,0.0004927365,0.000053055996,0.000008604896,0.00014483975,0.000027813234,0.00006647798,0.99762756,0.00017652086,0.00008329409,0.0008844066],"study_design_scores_gemma":[0.000120207114,0.00103006,0.019160366,0.000043567197,0.000103081125,0.0012812814,0.00026639015,0.0012042299,0.96558017,0.00024824045,0.010936938,0.000025396725],"about_ca_topic_score_codex":0.00087716733,"about_ca_topic_score_gemma":0.0013851759,"teacher_disagreement_score":0.0043378877,"about_ca_system_score_codex":0.0002786312,"about_ca_system_score_gemma":0.00028628306,"threshold_uncertainty_score":0.014511645},"labels":[],"label_agreement":null},{"id":"W4403511685","doi":"10.1093/neuonc/noae144.013","title":"KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Phase (matter); Oncology; Cancer research; Medical physics; Internal medicine; Computer science; Software engineering; Chemistry","score_opus":0.07161932857619517,"score_gpt":0.400097296983522,"score_spread":0.3284779684073268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630422,0.0069157286,0.0021324789,0.0024926949,0.0004098725,0.0031898187,0.00815779,0.0008038322,0.012855534],"genre_scores_gemma":[0.97670573,0.0027972106,0.0029750902,0.0020817388,0.00016328295,0.0027917738,0.0058145924,0.000112396025,0.0065582073],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995427,0.0002678123,0.000020216099,0.000054676,0.000044902008,0.000069681424],"domain_scores_gemma":[0.9994585,0.00007948453,0.00013779836,0.00004417938,0.00004755685,0.00023248275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015566925,0.00077723566,0.00091000705,0.0003202021,0.00026847568,0.0008186178,0.0006760081,0.00064547727,0.008071],"category_scores_gemma":[0.0010890533,0.00022868214,0.0012172033,0.00034907102,0.0004720445,0.000575121,0.0003546273,0.002119137,0.0011590482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6762084,0.013546143,0.0046529304,0.0020794235,0.0020665673,0.00019837788,0.00021074362,0.0050857435,0.02099009,0.002285579,0.029618252,0.24305767],"study_design_scores_gemma":[0.6865289,0.26305786,0.015840834,0.00030956246,0.0014819317,0.00040682312,0.00015178004,0.0054254965,0.0050029103,0.0026670014,0.01904437,0.000082541446],"about_ca_topic_score_codex":0.0015159133,"about_ca_topic_score_gemma":0.005036491,"teacher_disagreement_score":0.008071,"about_ca_system_score_codex":0.0008191511,"about_ca_system_score_gemma":0.0016745677,"threshold_uncertainty_score":0.027000189},"labels":[],"label_agreement":null},{"id":"W4403511868","doi":"10.1093/neuonc/noae144.174","title":"P09.15.A SATURATION TRANSFER MRI ENABLES EARLY DETECTION OF CANCER LESIONS IN THE CNS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Saturation (graph theory); Medicine; Biomedical engineering; Nuclear magnetic resonance; Pathology; Mathematics; Physics","score_opus":0.019387561248837365,"score_gpt":0.3114161613789614,"score_spread":0.292028600130124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88359547,0.006100309,0.059744205,0.0013837173,0.0005940565,0.00062148337,0.004189509,0.0031066625,0.04066452],"genre_scores_gemma":[0.9152559,0.0027864296,0.041229047,0.00032465335,0.00014083386,0.00041734998,0.0041433363,0.00036696112,0.03533541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999223,0.000013948519,0.0000053834315,0.000021259037,0.000020843254,0.00001625908],"domain_scores_gemma":[0.9998902,0.000013839183,0.000021044316,0.0000111433565,0.000030197734,0.000033514327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033455342,0.00036364727,0.00024135565,0.00043604439,0.00016241954,0.0003187447,0.00034413557,0.0005164069,0.011470868],"category_scores_gemma":[0.00023929299,0.00014731598,0.00018005015,0.00019040897,0.0003003797,0.00032810282,0.00020200651,0.0004990175,0.003465819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093022897,0.0001615789,0.0004948444,0.00010429143,0.000008136657,0.00017932669,0.00001522298,0.00010593157,0.9762357,0.0004975184,0.0016544092,0.019612838],"study_design_scores_gemma":[0.00014491862,0.0018657113,0.0088116145,0.000039721333,0.000042237116,0.0017099272,0.00002652879,0.0037105656,0.95591825,0.0006975305,0.02702012,0.00001279037],"about_ca_topic_score_codex":0.0005863791,"about_ca_topic_score_gemma":0.0005259018,"teacher_disagreement_score":0.011470868,"about_ca_system_score_codex":0.00021476422,"about_ca_system_score_gemma":0.00037443955,"threshold_uncertainty_score":0.038373828},"labels":[],"label_agreement":null},{"id":"W4403511991","doi":"10.1093/neuonc/noae144.216","title":"P12.03.B CAN COGNITIVE PERFORMANCE PREDICT NEUROTOXICITY INCIDENCE FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR LYMPHOMA?","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Neurotoxicity; Lymphoma; Incidence (geometry); Cognition; Antigen; B-cell lymphoma; Medicine; Immunology; Cancer research; Oncology; Internal medicine; T cell; Mathematics; Immune system; Toxicity; Psychiatry","score_opus":0.02217804031714789,"score_gpt":0.3119823217989977,"score_spread":0.28980428148184983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979214,0.00023117241,0.00016976571,0.00004692102,0.000007714879,0.0000146576185,0.00066538836,0.0000073409146,0.00093564176],"genre_scores_gemma":[0.9991043,0.000054097894,0.000078058845,0.000024765177,0.000017553253,0.000014392362,0.0004604089,0.0000032371036,0.00024317125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997161,0.00007815343,0.000042205993,0.00005380605,0.000053012493,0.000056717516],"domain_scores_gemma":[0.9981394,0.00039288777,0.0009006238,0.000071006914,0.00020933161,0.00028682424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005793913,0.00022812745,0.00029692624,0.0007511925,0.00023458271,0.00064060936,0.00034064168,0.0003676416,0.0038988837],"category_scores_gemma":[0.0018725395,0.0000813567,0.00032708532,0.0008741657,0.00030649133,0.00040837057,0.00029028894,0.0003931822,0.0008316403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039172173,0.000049138343,0.9966934,0.000010082625,0.000021035468,0.00020817034,0.000016385797,0.000046397327,0.00030867913,0.000012532244,0.00012868154,0.0021137637],"study_design_scores_gemma":[0.000014285982,0.00050772686,0.9965339,0.0000065192767,0.000029485163,0.0018748149,0.000060012044,0.00033232238,0.00027400977,0.000036436864,0.00032688733,0.0000036357217],"about_ca_topic_score_codex":0.00093236455,"about_ca_topic_score_gemma":0.0005990201,"teacher_disagreement_score":0.0038988837,"about_ca_system_score_codex":0.00020753413,"about_ca_system_score_gemma":0.00025268493,"threshold_uncertainty_score":0.013043106},"labels":[],"label_agreement":null},{"id":"W4403512422","doi":"10.1093/neuonc/noae144.473","title":"P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Phase (matter); Oncology; Internal medicine; Computer science; Cancer research; Software engineering; Physics","score_opus":0.35388210331361186,"score_gpt":0.5455905287246768,"score_spread":0.19170842541106498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967633,0.004475036,0.0048847836,0.0034401522,0.00038057702,0.0060713873,0.0035513707,0.0005669121,0.008996749],"genre_scores_gemma":[0.971329,0.0024046707,0.0071711754,0.0033600896,0.00020874944,0.006930493,0.003699812,0.00016431561,0.0047316602],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993579,0.00035244063,0.00002722837,0.00011138704,0.000058928545,0.0000920554],"domain_scores_gemma":[0.99917275,0.00015796734,0.00011907546,0.000081201164,0.00007003371,0.0003988572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024754086,0.0009922964,0.0009796526,0.00034102006,0.0003231449,0.000868779,0.0005496581,0.0007599468,0.0043237433],"category_scores_gemma":[0.0016101779,0.00021729193,0.0011757773,0.00034070795,0.0010186101,0.000862125,0.0008982924,0.0030430094,0.00071202073],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5261253,0.02909078,0.0072981333,0.002359269,0.0025457118,0.0005538335,0.00047575147,0.012808479,0.032806206,0.0042978083,0.037920617,0.34371814],"study_design_scores_gemma":[0.62354416,0.31620848,0.01353665,0.00034941794,0.0011623418,0.0004915961,0.00020079262,0.006835757,0.0088763675,0.0054873265,0.02320499,0.000102143706],"about_ca_topic_score_codex":0.00069580646,"about_ca_topic_score_gemma":0.0016801745,"teacher_disagreement_score":0.0043237433,"about_ca_system_score_codex":0.0007385774,"about_ca_system_score_gemma":0.0017272597,"threshold_uncertainty_score":0.014464378},"labels":[],"label_agreement":null},{"id":"W4403512568","doi":"10.1093/neuonc/noae144.188","title":"P10.12.B DEEP LEARNING-BASED NORMALIZATION AND UNMIXING OF HYPERSPECTRAL IMAGES FOR BRAIN TUMOR SURGERY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hyperspectral imaging; Normalization (sociology); Artificial intelligence; Spatial normalization; Computer science; Deep learning; Computer vision; Pattern recognition (psychology); Medicine; Sociology","score_opus":0.03192292005977731,"score_gpt":0.29285854920819937,"score_spread":0.26093562914842205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512568","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019338679,0.00041280966,0.9620589,0.000505633,0.00015718638,0.00010049659,0.000586692,0.011646291,0.005193257],"genre_scores_gemma":[0.36727655,0.0008707091,0.6026897,0.00045214308,0.00010318756,0.00048746492,0.0037410357,0.0015747284,0.02280453],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99983597,0.000024991341,0.000006526093,0.000041490184,0.00006322685,0.000027738606],"domain_scores_gemma":[0.9996581,0.00007201886,0.00003497933,0.000049377002,0.00015572832,0.000029697867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000660664,0.00081899314,0.00026300753,0.000367954,0.00022192702,0.00054575107,0.0010890928,0.00078270416,0.007986929],"category_scores_gemma":[0.001261401,0.00030148056,0.00040411478,0.0003312685,0.00039656667,0.00081739365,0.00084073114,0.0015315709,0.0029466404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043641316,0.00038002717,0.0020289863,0.000258415,0.00011481657,0.00015916335,0.000097312324,0.36208835,0.041674323,0.010896252,0.039184812,0.5426811],"study_design_scores_gemma":[0.000009150654,0.00002988795,0.00027233656,0.000010133266,0.0000053292088,0.0000307093,0.000004798641,0.98006034,0.012781297,0.0019190686,0.0048693637,0.0000074604595],"about_ca_topic_score_codex":0.0052173827,"about_ca_topic_score_gemma":0.0056534153,"teacher_disagreement_score":0.007986929,"about_ca_system_score_codex":0.00055380014,"about_ca_system_score_gemma":0.0012396508,"threshold_uncertainty_score":0.026718974},"labels":[],"label_agreement":null},{"id":"W4403512673","doi":"10.1093/neuonc/noae144.253","title":"P14.02.B A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.01179688764908209,"score_gpt":0.28621758925858,"score_spread":0.2744207016094979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96634656,0.007079991,0.0016013451,0.0017496537,0.0018215091,0.014126956,0.002943387,0.0002903016,0.0040403316],"genre_scores_gemma":[0.97038233,0.0015662235,0.0036444208,0.001500891,0.00080865837,0.014434962,0.0016587008,0.000036985934,0.005966666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99883515,0.0006599564,0.00008118349,0.0002226549,0.000057222762,0.0001437653],"domain_scores_gemma":[0.99886036,0.00033544414,0.00030296558,0.00009373406,0.000105280444,0.00030230812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022872484,0.0017214885,0.0027054083,0.0005045449,0.00037421027,0.0012750857,0.0008094685,0.0019766055,0.013419325],"category_scores_gemma":[0.0022478644,0.00080459524,0.0021240483,0.0003945649,0.0011868643,0.0013688405,0.00053329696,0.002444519,0.0013498077],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98815906,0.0030448383,0.00036116387,0.00056921504,0.00097114587,0.000014561867,0.000014772378,0.000120508565,0.0016012426,0.00013560893,0.000551755,0.0044561992],"study_design_scores_gemma":[0.9473853,0.04970637,0.00089119497,0.00003307568,0.0006056347,0.000013154262,0.000011835365,0.00030763706,0.00024431807,0.00017362609,0.00061971997,0.000008164513],"about_ca_topic_score_codex":0.0005209831,"about_ca_topic_score_gemma":0.00068862084,"teacher_disagreement_score":0.013419325,"about_ca_system_score_codex":0.000534636,"about_ca_system_score_gemma":0.001020637,"threshold_uncertainty_score":0.044892132},"labels":[],"label_agreement":null},{"id":"W4403512977","doi":"10.1093/neuonc/noae144.256","title":"P14.05.A A PROSPECTIVE, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Focused ultrasound; Medicine; Blood–brain barrier; Multicenter study; Multicenter trial; Ultrasound; Biopsy; Radiology; Internal medicine; Randomized controlled trial; Cancer research; Central nervous system","score_opus":0.01171061866547595,"score_gpt":0.2741897330267077,"score_spread":0.2624791143612317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512977","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805269,0.0037615006,0.002059183,0.0013556269,0.00071503554,0.003777644,0.0031337903,0.00024171048,0.004428696],"genre_scores_gemma":[0.983533,0.00068168243,0.0029897157,0.000872521,0.00031929585,0.004452784,0.002263116,0.000049184637,0.0048387507],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979272,0.0012704182,0.00009722003,0.00035982224,0.00010870146,0.00023659966],"domain_scores_gemma":[0.9979735,0.0007261338,0.000415869,0.00021922575,0.00014466312,0.00052056456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044068755,0.0011628872,0.0015869432,0.00026291853,0.00030756238,0.0011113008,0.0005433505,0.0012025057,0.0116388835],"category_scores_gemma":[0.0027990935,0.00026654216,0.001508871,0.00032449834,0.0007235866,0.0009607624,0.0004329597,0.0018441904,0.0010157146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97720057,0.0022968252,0.0030077265,0.00036411354,0.0011416309,0.00005144477,0.00003507372,0.000241909,0.0041317707,0.00022948897,0.0017269506,0.009572602],"study_design_scores_gemma":[0.5680903,0.37686685,0.035213742,0.00012484303,0.0032595592,0.00016151975,0.00007734881,0.002884014,0.0053945356,0.0011896031,0.0066962163,0.000041521558],"about_ca_topic_score_codex":0.0001832397,"about_ca_topic_score_gemma":0.00021705485,"teacher_disagreement_score":0.0116388835,"about_ca_system_score_codex":0.0002854379,"about_ca_system_score_gemma":0.0011450028,"threshold_uncertainty_score":0.03893596},"labels":[],"label_agreement":null},{"id":"W4403513063","doi":"10.1093/neuonc/noae144.005","title":"PL02.3.A MOLECULAR CLASSIFICATION TO REFINE SURGICAL AND RADIOTHERAPEUTIC DECISION MAKING IN MENINGIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Meningioma; Medicine; Medical physics; Computer science; Radiology","score_opus":0.03670693701165599,"score_gpt":0.36549188449885317,"score_spread":0.32878494748719717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403513063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627709,0.0024061224,0.012846844,0.0017069344,0.00015132807,0.0003126197,0.013349346,0.00031399983,0.00614182],"genre_scores_gemma":[0.9812646,0.00027914168,0.011614948,0.00020506773,0.00009014753,0.00015519203,0.0054869233,0.000055535897,0.00084845664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897885,0.00042564046,0.00014291666,0.00015798579,0.00020070028,0.000093973154],"domain_scores_gemma":[0.99635553,0.0011624952,0.0015360349,0.0002557114,0.00037611095,0.0003141557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038748314,0.00046093133,0.00045299673,0.0019020023,0.00034878144,0.001844853,0.00073715387,0.0005105277,0.0043390207],"category_scores_gemma":[0.0060661207,0.00018113395,0.00073795335,0.0016413236,0.00034026368,0.0007156347,0.00077797775,0.00078584073,0.001141433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004563757,0.000115907504,0.8954658,0.00021312371,0.0003010951,0.00032927937,0.00008864928,0.0034002014,0.004856885,0.00082407624,0.005780687,0.08406059],"study_design_scores_gemma":[0.0004711784,0.0012092246,0.92560714,0.00019174357,0.00067272934,0.0024037284,0.0003604269,0.039579142,0.006537153,0.0065131886,0.01639041,0.0000639997],"about_ca_topic_score_codex":0.0021238592,"about_ca_topic_score_gemma":0.0026934594,"teacher_disagreement_score":0.0043390207,"about_ca_system_score_codex":0.00096847134,"about_ca_system_score_gemma":0.0011430231,"threshold_uncertainty_score":0.020492375},"labels":[],"label_agreement":null},{"id":"W4403518724","doi":"10.1093/neuonc/noae144.401","title":"P20.14.A METASTATIC EPITHELIOD SOLITARY FIBROUS TUMOR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Solitary fibrous tumor; Metastatic tumor; Medicine; Metastasis; Internal medicine; Biology; Cancer; Cell biology","score_opus":0.03246371963430006,"score_gpt":0.33713715722534193,"score_spread":0.3046734375910419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403518724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95744115,0.003093708,0.0033748075,0.0012309031,0.00026458793,0.00017637698,0.0006638172,0.00035075014,0.03340405],"genre_scores_gemma":[0.9953951,0.00042442098,0.00090038555,0.00016397644,0.00026308504,0.000020956624,0.00014896618,0.000019918267,0.0026632703],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997892,0.000014591492,0.000022237977,0.000054695796,0.00004535353,0.00007385091],"domain_scores_gemma":[0.9994419,0.00008333726,0.00015102321,0.000056106655,0.000050902883,0.00021666792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016676723,0.0013738432,0.00042066022,0.0011063584,0.0010472244,0.00074126216,0.00054674246,0.0020453648,0.005639277],"category_scores_gemma":[0.0009983011,0.00035406352,0.00042067707,0.00077960786,0.0006988725,0.00061205274,0.0005846769,0.0008135387,0.0022689148],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033514305,0.000012291256,0.0028149218,0.00002771891,0.000004229776,0.9926393,0.00002937265,0.000051023202,0.0023909968,0.00017175115,0.00020606992,0.0016188943],"study_design_scores_gemma":[0.00001376742,0.00005282874,0.0051968456,0.000010907411,0.000010671204,0.9912412,0.000046938927,0.00038439408,0.0012564523,0.0003064714,0.0014736505,0.000005783421],"about_ca_topic_score_codex":0.0011844639,"about_ca_topic_score_gemma":0.0011055892,"teacher_disagreement_score":0.005639277,"about_ca_system_score_codex":0.0006098886,"about_ca_system_score_gemma":0.0003423478,"threshold_uncertainty_score":0.018865287},"labels":[],"label_agreement":null},{"id":"W4403713387","doi":"10.1093/neuonc/noae186","title":"Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Research UK","keywords":"Medicine; Medulloblastoma; Germ cell tumors; Population; Oncology; Brain tumor; Ependymoma; Clinical trial; Cancer; Multidisciplinary approach; Internal medicine; Pathology; Chemotherapy","score_opus":0.025426289152954605,"score_gpt":0.32491509859269035,"score_spread":0.29948880943973577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403713387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007098671,0.99839044,0.00007813515,0.0006805395,0.00021804767,0.0000072093003,0.00003477777,0.0000052884243,0.0005146367],"genre_scores_gemma":[0.00049265835,0.9988096,0.00017253567,0.00026076692,0.00009593435,0.000007679473,0.000047060345,0.0000010517454,0.000112850124],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995246,0.000098235076,0.00014157135,0.000062013656,0.00013831782,0.000035325054],"domain_scores_gemma":[0.99869424,0.00070738234,0.00020883008,0.000017186765,0.00032022427,0.000052144176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012495213,0.0007484476,0.0014042318,0.003260972,0.00032398177,0.00096131774,0.0010089071,0.0011597903,0.0024965557],"category_scores_gemma":[0.0030485783,0.00027120218,0.0010394234,0.0027965885,0.0003736214,0.0011907383,0.00070385705,0.0013749171,0.0007571818],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054768498,0.000034488963,0.0005008603,0.05385466,0.00022306126,0.00024036101,0.00012554234,0.00039754406,0.00030138393,0.0021187775,0.05800404,0.8841445],"study_design_scores_gemma":[0.000027586557,0.00008658094,0.002234523,0.068408996,0.0007767593,0.0024658334,0.0002215464,0.0001368077,0.00021165563,0.002008213,0.92338973,0.00003163629],"about_ca_topic_score_codex":0.0034633114,"about_ca_topic_score_gemma":0.0068205367,"teacher_disagreement_score":0.0034633114,"about_ca_system_score_codex":0.00093546556,"about_ca_system_score_gemma":0.003554162,"threshold_uncertainty_score":0.008351862},"labels":[],"label_agreement":null},{"id":"W4404110331","doi":"10.1093/neuonc/noae236","title":"Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Center for Biomedical Informatics and Information Technology, National Cancer Institute; Canadian Institutes of Health Research; University of Pennsylvania; Deutschen Konsortium für Translationale Krebsforschung; Freie Universität Berlin; National Cancer Institute; Humboldt-Universität zu Berlin; Deutsches Krebsforschungszentrum; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Pennsylvania State University; Vanderbilt University; Vanderbilt University Medical Center","keywords":"Meningioma; DNA methylation; Methylation; Medicine; Oncology; Internal medicine; Computational biology; DNA; Biology; Genetics; Surgery; Gene","score_opus":0.06262276848569368,"score_gpt":0.3403999430935071,"score_spread":0.27777717460781337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404110331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838464,0.0005081206,0.012977696,0.00020504332,0.0000308247,0.00008730696,0.0019178427,0.0000871351,0.00033968617],"genre_scores_gemma":[0.986864,0.00018340029,0.008690351,0.00010050782,0.000035972145,0.00008908007,0.0037768767,0.000032844815,0.0002269082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984932,0.0007896474,0.00007286241,0.0003716438,0.00019533125,0.000077275094],"domain_scores_gemma":[0.99563414,0.0013200312,0.0006604375,0.0012572071,0.0008541017,0.00027415037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080716945,0.0007914527,0.00047424133,0.00045550498,0.00039869698,0.00074383826,0.00090161175,0.00054409733,0.00069617893],"category_scores_gemma":[0.008740033,0.00038846012,0.0009953841,0.00049696234,0.00022771716,0.00047174873,0.00069276744,0.0007737074,0.0004129524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010814634,0.00020654939,0.9766516,0.000035087032,0.0005182756,0.00009586513,0.000105189996,0.0032532315,0.0020363163,0.00009657114,0.0007271207,0.015192781],"study_design_scores_gemma":[0.00045922247,0.0032997334,0.86787546,0.00005837718,0.0019864263,0.001348388,0.00019848402,0.10756015,0.009685026,0.0007029197,0.0067329677,0.00009293786],"about_ca_topic_score_codex":0.0032657213,"about_ca_topic_score_gemma":0.004060155,"teacher_disagreement_score":0.0080716945,"about_ca_system_score_codex":0.0005257682,"about_ca_system_score_gemma":0.0009794761,"threshold_uncertainty_score":0.042687714},"labels":[],"label_agreement":null},{"id":"W4404230670","doi":"10.1093/neuonc/noae165.0733","title":"PATH-34. IT NEVER RAINS BUT IT POURS - DIAGNOSING ANAPLASTIC PLEOMORPHIC XANTHASTROCYTOMA TWICE IN A FORTNIGHT - OUR EXPERIENCE IN A RESOURCE CONSTRAINED SETTING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Path (computing); Resource (disambiguation); Medicine; Computer science; Computer network","score_opus":0.03072457366236028,"score_gpt":0.3389251647075505,"score_spread":0.30820059104519026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9016025,0.015120397,0.0049223145,0.010197483,0.00095351646,0.0002614816,0.00071803964,0.00057802483,0.06564622],"genre_scores_gemma":[0.9773308,0.004024778,0.0032691066,0.0025146503,0.00021498537,0.000042640906,0.00042890696,0.00013052137,0.012043646],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99977344,0.000044203847,0.00002488998,0.000046246878,0.000028649665,0.00008257358],"domain_scores_gemma":[0.9994727,0.00007380873,0.00007657099,0.000035825386,0.00006926294,0.00027187268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029157905,0.00059349375,0.00022446645,0.00048547037,0.0012106339,0.0009397571,0.00036456212,0.0007329387,0.012162812],"category_scores_gemma":[0.0012334937,0.00028335257,0.00026234286,0.00046207936,0.0006130049,0.0009424574,0.00096577796,0.0012859335,0.0045479895],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035896018,0.00028409684,0.2328987,0.00039298422,0.00005082677,0.62593895,0.0017370409,0.00034254702,0.009430821,0.00051519147,0.016248122,0.11180171],"study_design_scores_gemma":[0.00003250378,0.00048244052,0.059408613,0.00035256724,0.000054309345,0.87927777,0.0031593526,0.00057150377,0.0030455664,0.00082102447,0.05275085,0.000043529057],"about_ca_topic_score_codex":0.003047735,"about_ca_topic_score_gemma":0.0062480145,"teacher_disagreement_score":0.012162812,"about_ca_system_score_codex":0.00052418275,"about_ca_system_score_gemma":0.000787389,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4404230690","doi":"10.1093/neuonc/noae165.0970","title":"EXTH-39. A BENCH-TOP MODEL FOR THE OPTIMIZATION OF ULTRASOUND PARAMETERS FOR SONODYNAMIC THERAPY OF GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sonodynamic therapy; Glioblastoma; Ultrasound; Medicine; Cancer research; Radiology","score_opus":0.018690383364374886,"score_gpt":0.26797522763803067,"score_spread":0.24928484427365577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91302353,0.0038468672,0.07565022,0.00025889912,0.00015756022,0.0004502381,0.002402865,0.0008372331,0.003372494],"genre_scores_gemma":[0.91945314,0.0029890435,0.068647236,0.000121742465,0.000023606503,0.0007421764,0.002053042,0.00011563338,0.0058544655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998363,0.000021108262,0.000010245715,0.000033271423,0.00007264756,0.000026268732],"domain_scores_gemma":[0.99991405,0.000021241289,0.000022275077,0.000009484367,0.000015851381,0.00001709105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036948675,0.00045041923,0.0003266188,0.00022939556,0.00019121093,0.00023640275,0.00050504843,0.00041830054,0.0021702058],"category_scores_gemma":[0.00013504234,0.00018731599,0.00036235544,0.0002026957,0.00018031335,0.00019538219,0.0002373941,0.00039500016,0.00053947576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065913344,0.000047085487,0.00007174182,0.00007548258,0.0000045657603,0.000057666577,0.000018064806,0.0008907073,0.9960796,0.00009172709,0.00010560845,0.0024919054],"study_design_scores_gemma":[0.000032122654,0.0012675574,0.0016323456,0.000018289416,0.000036194437,0.0001942826,0.000032531327,0.011442639,0.9793408,0.000114519884,0.0058688666,0.000019892792],"about_ca_topic_score_codex":0.002321766,"about_ca_topic_score_gemma":0.0030288915,"teacher_disagreement_score":0.002321766,"about_ca_system_score_codex":0.0003814546,"about_ca_system_score_gemma":0.00038669124,"threshold_uncertainty_score":0.007260084},"labels":[],"label_agreement":null},{"id":"W4404230706","doi":"10.1093/neuonc/noae165.0967","title":"EXTH-36. SHIFTING FROM EPIGENETICS TO THE EPICHAPEROME: HSP90 AS A THERAPEUTIC TARGET FOR H3K27M DIFFUSE MIDLINE GLIOMA (DMG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Epigenetics; Hsp90; Glioma; Medicine; Cancer research; Biology; Heat shock protein; Genetics","score_opus":0.02822209775957269,"score_gpt":0.3418564886060926,"score_spread":0.3136343908465199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103945,0.002187962,0.0026260703,0.00022042193,0.000029724657,0.00007162478,0.0016464078,0.00017069199,0.0020075678],"genre_scores_gemma":[0.992462,0.0011505059,0.0023397196,0.00013688215,0.000006176765,0.000030434463,0.0012289642,0.000022565135,0.0026228067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993646,0.00000601317,0.0000042402617,0.000014245034,0.000020981883,0.000018037746],"domain_scores_gemma":[0.9999728,0.0000025506474,0.000007534794,0.0000032877106,0.0000031788911,0.0000106571215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007778894,0.00029802977,0.00024491418,0.00014334008,0.00009713856,0.00018617907,0.00015234532,0.00017903393,0.0013777693],"category_scores_gemma":[0.000044397435,0.00009164637,0.0001587105,0.00017437134,0.00017004515,0.00011506803,0.00013990996,0.0004176981,0.00040915323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015468919,0.000032188305,0.00014538331,0.000044017557,0.0000069865955,0.00005639787,0.0000093424305,0.000123138,0.99626863,0.00008567453,0.0001348459,0.0029387847],"study_design_scores_gemma":[0.000036311823,0.0004860088,0.0031133946,0.000003592321,0.0000120710365,0.00020861009,0.000011573483,0.00038613525,0.99266726,0.0000391008,0.0030317758,0.0000042070324],"about_ca_topic_score_codex":0.00045133644,"about_ca_topic_score_gemma":0.0011064284,"teacher_disagreement_score":0.0013777693,"about_ca_system_score_codex":0.00023556306,"about_ca_system_score_gemma":0.00014257344,"threshold_uncertainty_score":0.0046090484},"labels":[],"label_agreement":null},{"id":"W4404230715","doi":"10.1093/neuonc/noae165.0531","title":"DDDR-46. TARGETING TRANSGLUTAMINASE 2 (TGM2) ENHANCES SENSITIVITY OF GLIOBLASTOMA CELL LINES TO RADIOTHERAPY AND TEMOZOLOMIDE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Glioblastoma; Tissue transglutaminase; Radiation therapy; Sensitivity (control systems); Cancer research; Medicine; Chemistry; Internal medicine; Enzyme","score_opus":0.01276079973339035,"score_gpt":0.27864743829705646,"score_spread":0.2658866385636661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920672,0.002109356,0.002250161,0.00016918055,0.00008400843,0.000045486027,0.0010251426,0.00030315298,0.0019463188],"genre_scores_gemma":[0.9935535,0.00079669553,0.0016776442,0.0000732891,0.0000070519995,0.000043536133,0.0013308024,0.00002294018,0.0024944504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.000017933307,0.000018135393,0.00003448787,0.00003657265,0.000028706472],"domain_scores_gemma":[0.999956,0.000004001166,0.000012070186,0.000007651569,0.000005673629,0.000014538029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010326151,0.0003389279,0.00041301205,0.00017505084,0.00012501726,0.0002685796,0.00017746977,0.0002849618,0.0014239651],"category_scores_gemma":[0.000061840496,0.00012325827,0.00024220604,0.00019641474,0.00016560461,0.00015297723,0.00014462347,0.0005889188,0.0005195259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102151316,0.000061698935,0.00011898215,0.000035126508,0.000005286842,0.000018233839,0.000009038172,0.00008911734,0.9982089,0.000040151976,0.00010915125,0.0012022565],"study_design_scores_gemma":[0.000018008486,0.0005294993,0.0016262201,0.0000032309738,0.000011624126,0.00009614639,0.000012044867,0.00059221,0.99499434,0.000013271814,0.0020999592,0.0000034477346],"about_ca_topic_score_codex":0.00097323494,"about_ca_topic_score_gemma":0.0012937548,"teacher_disagreement_score":0.0014239651,"about_ca_system_score_codex":0.00023426826,"about_ca_system_score_gemma":0.0001705939,"threshold_uncertainty_score":0.004763603},"labels":[],"label_agreement":null},{"id":"W4404230722","doi":"10.1093/neuonc/noae165.1257","title":"TMIC-80. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC TUMOR MICROENVIRONMENT IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Tumor microenvironment; Pathology; Medicine; Cancer research; Tumor cells","score_opus":0.012878047212027259,"score_gpt":0.26305098526134585,"score_spread":0.2501729380493186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913942,0.00085630757,0.0054940158,0.000039923598,0.00001427506,0.00007459892,0.00077387725,0.00012926615,0.0012235319],"genre_scores_gemma":[0.98534924,0.0006975702,0.011374173,0.00004791206,0.0000071799204,0.00010280972,0.0012681861,0.00002901804,0.0011239338],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994624,0.00000648896,0.000004484624,0.000012220688,0.00001688729,0.000013556928],"domain_scores_gemma":[0.9999573,0.0000042178085,0.00000909354,0.0000038008623,0.000011791136,0.00001378108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013632383,0.00025190486,0.00016017166,0.0006289953,0.00017331842,0.00017582737,0.000093905874,0.00016916638,0.0007743366],"category_scores_gemma":[0.000097247925,0.00009024011,0.00010544043,0.0002653555,0.000116984695,0.00012137616,0.00012906877,0.00017272531,0.00021287883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013654552,0.000023541203,0.0023996937,0.00002335085,0.0000055193877,0.00008373473,0.000017690241,0.000073379495,0.9950275,0.000027115997,0.000055993616,0.0021259226],"study_design_scores_gemma":[0.00001973647,0.00048958,0.1293046,0.000007928498,0.000050979215,0.0017603915,0.00009589153,0.003842889,0.86244684,0.000091219015,0.001878899,0.000011046256],"about_ca_topic_score_codex":0.0012943915,"about_ca_topic_score_gemma":0.00156508,"teacher_disagreement_score":0.0012943915,"about_ca_system_score_codex":0.00022171362,"about_ca_system_score_gemma":0.00013762024,"threshold_uncertainty_score":0.0025903583},"labels":[],"label_agreement":null},{"id":"W4404230724","doi":"10.1093/neuonc/noae165.0960","title":"EXTH-29. EVALUATION OF THE ANTITUMOR EFFECT OF A CHEMOTHERAPY-LOADED DEVICE FOR THE TREATMENT OF PRIMARY BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"Primary (astronomy); Chemotherapy; Medicine; Brain tumor; Oncology; Internal medicine; Cancer research; Pathology; Physics","score_opus":0.02879134635896587,"score_gpt":0.3189839866964344,"score_spread":0.29019264033746855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484813,0.0020858943,0.0013864787,0.000037575774,0.000075293196,0.00009717022,0.00031798056,0.000050343508,0.0011011475],"genre_scores_gemma":[0.99308467,0.0012086234,0.002403292,0.000035122397,0.00001553527,0.00007620912,0.000488115,0.000015883716,0.0026725424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999099,0.000015686916,0.000006067914,0.0000197798,0.000031868516,0.000016742357],"domain_scores_gemma":[0.99992204,0.000022941926,0.000013136262,0.000005843708,0.000014441058,0.00002158714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015530827,0.0002576313,0.00022576457,0.0002483011,0.00009281318,0.00012894969,0.00016259155,0.0002532324,0.0018222132],"category_scores_gemma":[0.00010347581,0.00007826216,0.0002900618,0.000117940566,0.00011895119,0.000105184154,0.00008057989,0.0002303169,0.00031592385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040324382,0.00037441173,0.00020268775,0.0001137588,0.000008992923,0.00008753731,0.000013562861,0.0002194162,0.993471,0.000033979875,0.00008342861,0.004987935],"study_design_scores_gemma":[0.00006712186,0.009661032,0.0037533178,0.000008474626,0.000034855024,0.00013812234,0.000013357377,0.001376185,0.9834871,0.000011037522,0.0014431796,0.000006198407],"about_ca_topic_score_codex":0.0004070881,"about_ca_topic_score_gemma":0.00038861527,"teacher_disagreement_score":0.0018222132,"about_ca_system_score_codex":0.00010207301,"about_ca_system_score_gemma":0.00013993798,"threshold_uncertainty_score":0.006095886},"labels":[],"label_agreement":null},{"id":"W4404230727","doi":"10.1093/neuonc/noae165.0607","title":"IMMU-14. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE CHECKPOINT INHIBITION: AN IRRDC REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Immune checkpoint; Replication (statistics); Immune system; Cancer research; Biology; Immunotherapy; Immunology; Virology","score_opus":0.0242567763184399,"score_gpt":0.3205111076496576,"score_spread":0.2962543313312177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993898,0.0013882761,0.0014108646,0.000058153615,0.00001875909,0.00003844306,0.0022254952,0.00011143437,0.0008506615],"genre_scores_gemma":[0.9949024,0.00037569692,0.0011151922,0.000046313202,0.000008851285,0.00003884036,0.002331545,0.0000350345,0.0011461682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997831,0.000025985955,0.000020487125,0.00007301598,0.00004990338,0.000047493602],"domain_scores_gemma":[0.99977094,0.000024124523,0.00006973749,0.000047034442,0.000026585234,0.00006159661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003089015,0.00028899522,0.0003099402,0.0007833462,0.00023210849,0.00032748937,0.00020345685,0.00032907457,0.0019612107],"category_scores_gemma":[0.0001831113,0.0001375068,0.00038326584,0.00035855916,0.00027582765,0.00010850261,0.00032591863,0.00032574314,0.000550831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000827191,0.00009226838,0.023190822,0.00006783574,0.000034939832,0.00037664335,0.00005292619,0.00006322775,0.97138727,0.000035650064,0.00013390309,0.0037373796],"study_design_scores_gemma":[0.000038563667,0.0020676467,0.34258783,0.000013569601,0.00015838313,0.005202257,0.00021156644,0.0010106948,0.6436483,0.00009034249,0.004957544,0.000013281468],"about_ca_topic_score_codex":0.000840903,"about_ca_topic_score_gemma":0.00090428,"teacher_disagreement_score":0.0019612107,"about_ca_system_score_codex":0.00036050926,"about_ca_system_score_gemma":0.00016082314,"threshold_uncertainty_score":0.006560862},"labels":[],"label_agreement":null},{"id":"W4404230728","doi":"10.1093/neuonc/noae165.0955","title":"EXTH-24. THERAPEUTIC TARGETING OF MISLOCALIZED NUCLEAR ENVELOPE PROTEINS IN<i>MYC</i>-DRIVEN GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; National Research Council Canada; University of Toronto; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medulloblastoma; Envelope (radar); Group (periodic table); Cancer research; Neuroscience; Biology; Chemistry; Computer science; Telecommunications","score_opus":0.00980264798282271,"score_gpt":0.2538272993630138,"score_spread":0.24402465138019108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907404,0.0016295546,0.0017281693,0.00016272507,0.00010973777,0.00014123971,0.0027033978,0.00036651292,0.0024183497],"genre_scores_gemma":[0.9904784,0.000773561,0.0014956067,0.00010872539,0.000009200274,0.00011017132,0.0026094767,0.000048504447,0.004366368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999169,0.000007702636,0.0000046877644,0.000018783865,0.000026991405,0.000025005],"domain_scores_gemma":[0.99996305,0.0000044191806,0.0000096486865,0.0000046954706,0.0000034197697,0.000014713571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011180384,0.00022423861,0.00030638822,0.00019123008,0.00012398312,0.00030858305,0.00020115965,0.0002919615,0.00205708],"category_scores_gemma":[0.00006439166,0.00009547189,0.00028365015,0.00014220686,0.00018945945,0.00011445227,0.00012214325,0.0007310135,0.0005978348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008383346,0.00028442658,0.00031307578,0.00011343873,0.000025820455,0.00016529826,0.000029312254,0.00045580222,0.9898636,0.0002356473,0.00070626877,0.006969017],"study_design_scores_gemma":[0.00019208965,0.0023786405,0.005133394,0.000014098261,0.000055024168,0.0004779046,0.00004718488,0.0023546712,0.9765885,0.00010993656,0.012635642,0.000012879297],"about_ca_topic_score_codex":0.0007963216,"about_ca_topic_score_gemma":0.0015347988,"teacher_disagreement_score":0.00205708,"about_ca_system_score_codex":0.00034465763,"about_ca_system_score_gemma":0.00026825973,"threshold_uncertainty_score":0.0068815947},"labels":[],"label_agreement":null},{"id":"W4404230732","doi":"10.1093/neuonc/noae165.0956","title":"EXTH-25. OPTIMIZATION OF NEW CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pharmacology; Chemotherapeutic drugs; Cancer research; Internal medicine; Chemotherapy","score_opus":0.025620880079863576,"score_gpt":0.3435177750892911,"score_spread":0.3178968950094275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827654,0.005526322,0.0031922844,0.00021096822,0.00007642622,0.0002069582,0.00026642522,0.00013292143,0.0021111115],"genre_scores_gemma":[0.9908579,0.002933384,0.004051165,0.000085316235,0.0000216089,0.000116412244,0.00040520902,0.00002520217,0.0015037499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.00001831045,0.000006683783,0.000015241109,0.000022570206,0.000024516625],"domain_scores_gemma":[0.9999573,0.0000042310794,0.000009808645,0.0000030459864,0.000006382388,0.000019164125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022545095,0.00033251615,0.00029390672,0.00035077802,0.000112548325,0.00037553345,0.00025951207,0.0001963258,0.00062802335],"category_scores_gemma":[0.00011175887,0.00013155436,0.00025336863,0.00019425168,0.00016091701,0.00015608857,0.000156987,0.00045324836,0.00020710024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037807792,0.0017457423,0.0018483087,0.00028528087,0.00007575934,0.00038838174,0.00009815297,0.0046213125,0.8814023,0.0006210639,0.0014341219,0.10369881],"study_design_scores_gemma":[0.0008957039,0.03416529,0.013485064,0.000049292383,0.00022999392,0.0006813841,0.00008113799,0.010440235,0.92022717,0.00020593528,0.019485386,0.00005326444],"about_ca_topic_score_codex":0.002234324,"about_ca_topic_score_gemma":0.0044953804,"teacher_disagreement_score":0.002234324,"about_ca_system_score_codex":0.0004007029,"about_ca_system_score_gemma":0.00051162817,"threshold_uncertainty_score":0.004442692},"labels":[],"label_agreement":null},{"id":"W4404230737","doi":"10.1093/neuonc/noae165.0037","title":"EPCO-38. IDENTIFYING THE MOLECULAR SIGNATURE OF INFILTRATING EDGE IN GLIOBLASTOMA AS DRIVERS OF TUMOUR INVASION AND RECURRENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioblastoma; Signature (topology); Pathology; Biology; Medicine; Oncology; Cancer research; Mathematics","score_opus":0.018283488072068584,"score_gpt":0.3235120622537771,"score_spread":0.3052285741817085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957623,0.0009207331,0.0008441672,0.000049121107,0.000007513149,0.00001898371,0.0014887674,0.000039788283,0.0008687995],"genre_scores_gemma":[0.9941286,0.00032942824,0.0010178912,0.00003873021,0.0000034942195,0.000036194502,0.0025346975,0.000014418943,0.0018965657],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991167,0.0000056231534,0.0000047862454,0.000021136684,0.000025528774,0.000031261035],"domain_scores_gemma":[0.9999367,0.0000060801144,0.000018109713,0.000005387268,0.000010434085,0.00002322459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000687514,0.00020624719,0.00022340954,0.00035820555,0.00012880222,0.00024085243,0.00012701337,0.00015691936,0.0021691166],"category_scores_gemma":[0.000091298425,0.0000940671,0.00014189031,0.00026577074,0.00015033672,0.00011992153,0.00019090525,0.00026693812,0.00042262732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033602625,0.000022919416,0.011600725,0.00005521596,0.000009638871,0.00007742691,0.00003365747,0.00010074536,0.9825501,0.00007213541,0.00013406499,0.005007362],"study_design_scores_gemma":[0.000025145488,0.0008264919,0.4743823,0.000024653675,0.000079561934,0.00092080934,0.00026882978,0.0020125995,0.5148608,0.00024761498,0.0063371365,0.00001400668],"about_ca_topic_score_codex":0.0013955495,"about_ca_topic_score_gemma":0.0020195358,"teacher_disagreement_score":0.0021691166,"about_ca_system_score_codex":0.00019877806,"about_ca_system_score_gemma":0.00016073667,"threshold_uncertainty_score":0.0072563887},"labels":[],"label_agreement":null},{"id":"W4404230748","doi":"10.1093/neuonc/noae165.1252","title":"TMIC-75. ICAM-1 PROMOTES AN IMMUNOSUPPRESSIVE LANDSCAPE IN GLIOBLASTOMAS BY REGULATING THE PHENOTYPIC POLARIZATION STATE OF TUMOR ASSOCIATED MACROPHAGES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Phenotype; ICAM-1; Glioblastoma; Cancer research; Polarization (electrochemistry); Biology; Immunology; Chemistry; Genetics; Gene; Cell adhesion molecule","score_opus":0.007259614208771409,"score_gpt":0.25993952079567284,"score_spread":0.2526799065869014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966383,0.00091671164,0.00030496516,0.00011390065,0.000038032784,0.00001881955,0.00030636904,0.000052399417,0.0016104372],"genre_scores_gemma":[0.9973115,0.00038923477,0.00024429458,0.00009763832,0.000010629812,0.000022101927,0.00032958685,0.000006938052,0.0015882739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.0000060473453,0.0000047724384,0.0000117272,0.000018024533,0.00006244646],"domain_scores_gemma":[0.9999615,0.0000021342191,0.0000062732734,0.0000028075247,0.000003417365,0.00002374636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051575185,0.00025943067,0.00019977636,0.00021683642,0.00016922169,0.00024025542,0.000109342574,0.00016605256,0.0013292832],"category_scores_gemma":[0.000035664176,0.00006935206,0.00014569702,0.00012314304,0.0001914753,0.000086149295,0.00011464386,0.00047283032,0.00042182635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015058606,0.00007577982,0.00027311072,0.000033520242,0.000003557435,0.000049011327,0.000013344206,0.000050871797,0.9976035,0.00009504501,0.00018145256,0.0014702249],"study_design_scores_gemma":[0.000098147015,0.0022130103,0.043652523,0.00002294625,0.000053193682,0.00041749072,0.00020393301,0.0011026056,0.94508135,0.00016599476,0.006976951,0.000011932682],"about_ca_topic_score_codex":0.0012963451,"about_ca_topic_score_gemma":0.002170934,"teacher_disagreement_score":0.0013292832,"about_ca_system_score_codex":0.0002558083,"about_ca_system_score_gemma":0.00024323333,"threshold_uncertainty_score":0.004446864},"labels":[],"label_agreement":null},{"id":"W4404230811","doi":"10.1093/neuonc/noae165.0789","title":"NIMG-23. A NOVEL APPROACH TO PERFUSION MRI STUDIES IN BRAIN TUMOR PATIENTS USING ENDOGENOUS DEOXYHEMOGLOBIN AS A CONTRAST AGENT: A PROOF-OF-CONCEPT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Proof of concept; Contrast (vision); Endogeny; Medicine; Perfusion; Magnetic resonance imaging; Neuroscience; Internal medicine; Computer science; Radiology; Artificial intelligence; Psychology","score_opus":0.09303234986110322,"score_gpt":0.3537981192688025,"score_spread":0.2607657694076993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92212147,0.012502874,0.05122022,0.0016232686,0.00063394447,0.00403372,0.0014024358,0.0009525451,0.0055095865],"genre_scores_gemma":[0.92756015,0.0038449392,0.058560595,0.0016955163,0.00017817465,0.0030952094,0.0015672934,0.00021480635,0.0032834138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996892,0.000119737284,0.000008012784,0.000054530024,0.00008668485,0.0000419703],"domain_scores_gemma":[0.9998196,0.000020596954,0.000026656293,0.00001671406,0.00003126716,0.000085211104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012531702,0.00072056573,0.000555243,0.00021479206,0.00017139838,0.0005552925,0.0008063018,0.0008039519,0.0013334716],"category_scores_gemma":[0.00044225113,0.00021649945,0.00037928837,0.0001121652,0.00036306237,0.00030963836,0.000321714,0.0010182497,0.00062070676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002482675,0.0040993094,0.0008980858,0.0005317505,0.00020277113,0.0009264687,0.00011636829,0.0006559311,0.9312217,0.00043216566,0.0051268376,0.053305876],"study_design_scores_gemma":[0.0051473714,0.06394709,0.013648168,0.00014928506,0.0005898117,0.007829501,0.00016506646,0.011274944,0.82973504,0.0005090712,0.066870995,0.00013368153],"about_ca_topic_score_codex":0.00044915162,"about_ca_topic_score_gemma":0.00049989374,"teacher_disagreement_score":0.0013334716,"about_ca_system_score_codex":0.0002532235,"about_ca_system_score_gemma":0.0005444296,"threshold_uncertainty_score":0.0066275},"labels":[],"label_agreement":null},{"id":"W4404230824","doi":"10.1093/neuonc/noae165.0657","title":"IMMU-65. TARGETING AXONAL GUIDANCE DEPENDENCIES IN GLIOBLASTOMA WITH ROBO1 CAR T CELLS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; National Research Council Canada; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Neuroscience; Computer science; Computational biology; Biology","score_opus":0.012816616305450066,"score_gpt":0.2739697940066686,"score_spread":0.26115317770121854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218035,0.00088419276,0.003946447,0.00015132505,0.00003143113,0.00006420234,0.00044954152,0.0002930451,0.0019994662],"genre_scores_gemma":[0.99494463,0.0004212159,0.0017049274,0.00005553386,0.0000058836035,0.00004434002,0.00046553795,0.00001893409,0.0023389682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999093,0.000007795067,0.000006295306,0.000019303874,0.00002177475,0.00003546668],"domain_scores_gemma":[0.9999708,0.000002288752,0.000008644566,0.0000034241234,0.0000033111555,0.00001145468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010590466,0.0003416385,0.00019897433,0.00020886278,0.00011197465,0.0003144137,0.0001702655,0.0002335254,0.0010119939],"category_scores_gemma":[0.000042834676,0.0001310529,0.00021598299,0.000109315784,0.00016139583,0.00010562721,0.0001879891,0.0004621183,0.0004203688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007315758,0.00005853494,0.00021819668,0.000034326647,0.00000808157,0.000055913217,0.00001505982,0.00024713512,0.9966536,0.00017656326,0.00014891347,0.0023104555],"study_design_scores_gemma":[0.00004039051,0.000802584,0.0023155038,0.0000056362196,0.000034804256,0.0003475502,0.000023605704,0.002282198,0.98868257,0.0000633428,0.005396574,0.0000052285086],"about_ca_topic_score_codex":0.0014716632,"about_ca_topic_score_gemma":0.0018899732,"teacher_disagreement_score":0.0014716632,"about_ca_system_score_codex":0.0003174283,"about_ca_system_score_gemma":0.00026399133,"threshold_uncertainty_score":0.0033854842},"labels":[],"label_agreement":null},{"id":"W4404230831","doi":"10.1093/neuonc/noae165.0411","title":"CTNI-44. NCT03643549 PHASE IB/II TRIAL: EFFICACY, SAFETY, AND BIOLOGICAL MECHANISMS OF OBJECTIVE RESPONSES IN RECURRENT GBM PATIENTS WITH UNMETHYLATED MGMT PROMOTER TREATED WITH SEQUENTIAL BORTEZOMIB AND TEMOZOLOMIDE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Temozolomide; Bortezomib; Medicine; Oncology; Phases of clinical research; Internal medicine; Glioblastoma; Cancer research; Pharmacology; Clinical trial; Multiple myeloma","score_opus":0.025475230966699052,"score_gpt":0.3209164149299225,"score_spread":0.29544118396322344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748171,0.007072634,0.000499708,0.0008134549,0.0003774009,0.005720969,0.004334342,0.00024312655,0.0061212424],"genre_scores_gemma":[0.9746991,0.0025763852,0.0014358839,0.0011462105,0.00042900414,0.005831269,0.007158567,0.000056766778,0.0066668666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993642,0.00031599175,0.0000401786,0.000089072135,0.00006576629,0.00012488225],"domain_scores_gemma":[0.99947196,0.00004863317,0.00013325509,0.000042170745,0.000038674956,0.00026534495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017461393,0.0016328208,0.002461516,0.0006989221,0.00052627415,0.001215021,0.00093288743,0.0014401602,0.0071973237],"category_scores_gemma":[0.00090505887,0.0005298314,0.0011385032,0.0007302987,0.0009062734,0.00063545373,0.00047995767,0.0023441224,0.0014566372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90124565,0.013716154,0.004143354,0.00093213725,0.0010577599,0.00015895121,0.00010342098,0.0010121695,0.019512538,0.0003223985,0.00532345,0.05247199],"study_design_scores_gemma":[0.7358649,0.23966868,0.013296361,0.00010024084,0.00085915904,0.0003533259,0.000044831202,0.0010489678,0.0033057923,0.0002979222,0.0051221233,0.000037748527],"about_ca_topic_score_codex":0.0023321495,"about_ca_topic_score_gemma":0.0058194436,"teacher_disagreement_score":0.0071973237,"about_ca_system_score_codex":0.0016529685,"about_ca_system_score_gemma":0.0026952866,"threshold_uncertainty_score":0.024077415},"labels":[],"label_agreement":null},{"id":"W4404230846","doi":"10.1093/neuonc/noae165.1282","title":"TMOD-18. FUNCTIONAL DISSECTION OF RECURRENT COPY-NUMBER-ALTERATIONS INFORMS MECHANISMS OF LOW-GRADE-GLIOMA PROGRESSION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Glioma; Dissection (medical); Medicine; Cancer research; Biology; Neuroscience; Surgery","score_opus":0.029448219150672625,"score_gpt":0.3430704509514019,"score_spread":0.31362223180072923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655587,0.0018722027,0.013755149,0.0003209584,0.00010724208,0.00007578995,0.013905541,0.0008340835,0.0035703173],"genre_scores_gemma":[0.97871894,0.00064142776,0.008198847,0.0001751059,0.000013797335,0.00008362935,0.007639167,0.0001552486,0.004373838],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981064,0.000009517933,0.000013826975,0.00008188451,0.000048722126,0.000035373665],"domain_scores_gemma":[0.9997521,0.000026912165,0.00012069642,0.000020650928,0.000020483149,0.00005907955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002770273,0.00029655395,0.00033777938,0.00054802303,0.00022723763,0.0007206969,0.00039102917,0.0003579688,0.004226142],"category_scores_gemma":[0.00025317905,0.0001994992,0.00028040822,0.00035977145,0.00031105056,0.00023442485,0.00029958892,0.0005731772,0.0010425871],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085763173,0.00006684698,0.020617243,0.00026769203,0.000056911766,0.000183205,0.00006038049,0.0006443658,0.9551111,0.0009812525,0.0013316924,0.019821681],"study_design_scores_gemma":[0.0001863719,0.0010178516,0.16729595,0.000069994916,0.00023626666,0.0024822454,0.00013720672,0.016501341,0.76756084,0.0012474803,0.04321857,0.000045913202],"about_ca_topic_score_codex":0.0012465061,"about_ca_topic_score_gemma":0.0025819514,"teacher_disagreement_score":0.004226142,"about_ca_system_score_codex":0.0005451249,"about_ca_system_score_gemma":0.00036941635,"threshold_uncertainty_score":0.014137864},"labels":[],"label_agreement":null},{"id":"W4404230872","doi":"10.1093/neuonc/noae165.1285","title":"TMOD-21. MOUSE MODEL TO CONDITIONALLY EXPRESS A DIFFUSE MIDLINE GLIOMA DERIVED MUTATION IN THE ONCOGENIC PHOSPHATASE PPM1D","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mutation; Glioma; Biology; Cancer research; Genetics; Gene","score_opus":0.014511212398814154,"score_gpt":0.2831384317947988,"score_spread":0.26862721939598466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92405516,0.004406526,0.031132573,0.0016420885,0.00093952566,0.0010789772,0.017403904,0.0024591777,0.01688211],"genre_scores_gemma":[0.84776425,0.0043149837,0.035437223,0.0007394087,0.00014633039,0.002580546,0.015461239,0.0008282742,0.09272773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907494,0.000095966796,0.00012959231,0.00028993064,0.00023214877,0.00017746224],"domain_scores_gemma":[0.99946386,0.00004825574,0.00019760206,0.000052787007,0.000040547497,0.00019700652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058563484,0.0013560454,0.0006096448,0.0019589532,0.0007130927,0.0007574196,0.001108198,0.0022053407,0.009383335],"category_scores_gemma":[0.00023643047,0.00080473634,0.0009465326,0.00077175425,0.0010863836,0.00075604225,0.0007891437,0.0026457414,0.004128226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003208458,0.0002848224,0.0003721756,0.00017591735,0.000022345594,0.00061939855,0.00007756454,0.00016420601,0.9931411,0.0015514935,0.0006160572,0.0026540407],"study_design_scores_gemma":[0.0004019504,0.0017833007,0.005278726,0.00009207824,0.00012939177,0.0046584085,0.00016700906,0.002888005,0.9337268,0.0006029118,0.050228164,0.000043307595],"about_ca_topic_score_codex":0.00095681427,"about_ca_topic_score_gemma":0.0016611969,"teacher_disagreement_score":0.009383335,"about_ca_system_score_codex":0.0010532687,"about_ca_system_score_gemma":0.0005521907,"threshold_uncertainty_score":0.03139031},"labels":[],"label_agreement":null},{"id":"W4404230874","doi":"10.1093/neuonc/noae165.0629","title":"IMMU-36. MULTI-OMIC CHARACTERIZATION OF A SYNGENEIC MOUSE CANCER STEM CELL MODEL OF GBM FOR PRECLINICAL APPLICATIONS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association; University of Calgary","funders":"","keywords":"Cancer; Cancer research; Computational biology; Cancer stem cell; Biology; Genetics","score_opus":0.07576980243174139,"score_gpt":0.3765004190004864,"score_spread":0.300730616568745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8936529,0.0020197025,0.07102867,0.0005893,0.00027794664,0.0010902385,0.01814044,0.001983062,0.011217782],"genre_scores_gemma":[0.8595042,0.0015571901,0.078955345,0.0002723949,0.000049275706,0.0021118326,0.019072352,0.0007310754,0.03774627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912125,0.0001002999,0.000109132525,0.00018087709,0.00035465148,0.00013382218],"domain_scores_gemma":[0.999516,0.00005554756,0.00013927788,0.00008429338,0.00008254987,0.00012230614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008109242,0.0012033392,0.00049107336,0.0022795636,0.00041017565,0.00066477223,0.0005570873,0.0008900588,0.0047910297],"category_scores_gemma":[0.00015380816,0.00047518802,0.000709162,0.0007459156,0.00059193117,0.0003598315,0.00034442,0.0014828397,0.0023253309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007414286,0.00006727556,0.00013020818,0.000029954193,0.00000554221,0.00003986063,0.00003047559,0.00009543156,0.9985819,0.00023900784,0.00008731633,0.00061893545],"study_design_scores_gemma":[0.000023285933,0.00034016246,0.0020214478,0.000009033368,0.000022346758,0.00017515673,0.00003250857,0.0016247748,0.9903052,0.00008231766,0.0053565437,0.0000072673392],"about_ca_topic_score_codex":0.0015634358,"about_ca_topic_score_gemma":0.0027464242,"teacher_disagreement_score":0.0047910297,"about_ca_system_score_codex":0.0007081024,"about_ca_system_score_gemma":0.00034223782,"threshold_uncertainty_score":0.01602757},"labels":[],"label_agreement":null},{"id":"W4404230928","doi":"10.1093/neuonc/noae165.0511","title":"DDDR-26. IDENTIFICATION OF MODULATORS OF IDH INHIBITOR SENSITIVITY IN<i>IDH</i>-MUTATED DIFFUSE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Identification (biology); Sensitivity (control systems); Biology; Botany; Engineering","score_opus":0.016454271741290286,"score_gpt":0.2981942380691827,"score_spread":0.28173996632789244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345864,0.005766471,0.002648258,0.00036079937,0.00009940609,0.00024363147,0.0019048201,0.00031464515,0.005203341],"genre_scores_gemma":[0.98799545,0.0023722153,0.0030081363,0.00020607501,0.000016488257,0.00010100735,0.0022893227,0.000032295342,0.0039790287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999193,0.000009857315,0.000008378441,0.000019730589,0.000020548914,0.000022318638],"domain_scores_gemma":[0.99994135,0.000005334929,0.000014683675,0.000006611852,0.0000068806166,0.000025101494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014762899,0.00034211695,0.0004151228,0.00025832863,0.000113224225,0.00036425013,0.00027969983,0.000215706,0.0018074397],"category_scores_gemma":[0.000085260195,0.00015347076,0.00023535787,0.00021327133,0.00016813476,0.000143418,0.00012426754,0.00066620624,0.0005465408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006177001,0.00026816243,0.00052095467,0.00010344303,0.000024950916,0.000114317045,0.000015398135,0.00051824644,0.9868205,0.0002499258,0.0004933786,0.010253091],"study_design_scores_gemma":[0.00052247493,0.0056545595,0.00650431,0.000019695031,0.00008353829,0.00084064837,0.000034979643,0.0020752533,0.965939,0.00014082542,0.018161174,0.00002365176],"about_ca_topic_score_codex":0.0005306767,"about_ca_topic_score_gemma":0.0015809897,"teacher_disagreement_score":0.0018074397,"about_ca_system_score_codex":0.00033826663,"about_ca_system_score_gemma":0.0003003362,"threshold_uncertainty_score":0.0060465336},"labels":[],"label_agreement":null},{"id":"W4404236532","doi":"10.1093/neuonc/noae165.0526","title":"DDDR-41. A GENOME-WIDE CRISPR/CAS9 SCREEN IN GLIOBLASTOMA STEM CELLS UNVEILS SYNTHETIC LETHAL INTERACTIONS AND RESISTANCE MECHANISMS OF JIN001, A BLOOD-BRAIN BARRIER-PENETRANT HSP90 INHIBITOR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Penetrant (biochemical); Blood–brain barrier; Glioblastoma; Biology; Cancer research; Neuroscience; Genetics; Gene; Central nervous system; Biotechnology","score_opus":0.016338885421779872,"score_gpt":0.28882862749890476,"score_spread":0.2724897420771249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95539063,0.0012459625,0.023608247,0.0002601001,0.00009891323,0.0003351215,0.011198732,0.0017766805,0.0060856496],"genre_scores_gemma":[0.9544001,0.00082553626,0.019601298,0.00020665723,0.000007265731,0.00021246885,0.014079845,0.00027835678,0.010388571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999589,0.000034976343,0.00005483347,0.00010129527,0.00015818953,0.00006168462],"domain_scores_gemma":[0.9998493,0.000032323962,0.00004278772,0.00002327242,0.000017136472,0.000035157304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022141176,0.00047167024,0.0005759394,0.00039562795,0.00020622792,0.00037474398,0.00037794153,0.00041798622,0.0020452167],"category_scores_gemma":[0.00018009015,0.00020654436,0.00042373547,0.00037096578,0.00024954972,0.00012818372,0.00027089208,0.000636435,0.0007978829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005419137,0.00004009529,0.00020465716,0.000033163156,0.000005669285,0.000058073078,0.000007773034,0.000116317686,0.9977449,0.00007517429,0.00012983997,0.0015299825],"study_design_scores_gemma":[0.000014446383,0.00019875214,0.0035335028,0.000005689326,0.000021740472,0.00023632131,0.000019392497,0.0014058365,0.99076825,0.000027064916,0.003760189,0.000008845461],"about_ca_topic_score_codex":0.002168673,"about_ca_topic_score_gemma":0.0036629185,"teacher_disagreement_score":0.002168673,"about_ca_system_score_codex":0.00046427103,"about_ca_system_score_gemma":0.00045751475,"threshold_uncertainty_score":0.006841898},"labels":[],"label_agreement":null},{"id":"W4404236533","doi":"10.1093/neuonc/noae165.0377","title":"CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université Laval; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Refractory (planetary science); Medicine; Internal medicine; Glioma; Firefly protocol; Drug; Oncology; Pharmacology; Cancer research; Biology","score_opus":0.024914131407601892,"score_gpt":0.31721692825927367,"score_spread":0.29230279685167176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934189,0.0029751759,0.00011433034,0.0003117932,0.000059639548,0.00016981838,0.0009298639,0.000037968504,0.0019825897],"genre_scores_gemma":[0.99378985,0.0015632695,0.000419485,0.00042597577,0.00007083145,0.0001603957,0.0022746737,0.00001640589,0.0012790917],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968505,0.00015016968,0.000016387497,0.0000453942,0.00003508056,0.00006787087],"domain_scores_gemma":[0.99949944,0.00006211076,0.000095451775,0.00004001325,0.000027318638,0.00027564706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008216356,0.00044707034,0.0008923443,0.0001663624,0.00019169871,0.0006474531,0.00039042052,0.00036557205,0.0019490005],"category_scores_gemma":[0.00064258295,0.00015719955,0.0006630648,0.00023496238,0.00039819692,0.0003557356,0.0002133472,0.0012953953,0.0004840853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55211806,0.01634025,0.041099086,0.0011413065,0.0019094812,0.0005985504,0.0005099966,0.0026360305,0.061739594,0.00051526795,0.016161308,0.30523103],"study_design_scores_gemma":[0.32009238,0.4958315,0.14644039,0.0002184498,0.0018871254,0.0021490755,0.00039319388,0.0026455012,0.012918854,0.00048951653,0.016849982,0.00008405965],"about_ca_topic_score_codex":0.0016957669,"about_ca_topic_score_gemma":0.0071557625,"teacher_disagreement_score":0.0019490005,"about_ca_system_score_codex":0.0008913577,"about_ca_system_score_gemma":0.0008900304,"threshold_uncertainty_score":0.0065200925},"labels":[],"label_agreement":null},{"id":"W4404236611","doi":"10.1093/neuonc/noae165.0905","title":"NCOG-23. CLINICIAN AND PATIENT REPORTED OUTCOMES IN YOUNG ADULTS WITH GLIOBLASTOMA: RESULTS FROM A MULTIMODAL PROSPECTIVE STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Multimodal therapy; Medicine; Prospective cohort study; Pediatrics; Internal medicine; Cancer research","score_opus":0.015290227991696576,"score_gpt":0.30961974280847127,"score_spread":0.2943295148167747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976404,0.00030331934,0.000038550184,0.000040379255,0.0000075610915,0.000030305835,0.0015431144,0.000002414896,0.00039404433],"genre_scores_gemma":[0.9979558,0.0001542929,0.000067611654,0.000059928494,0.00001199853,0.00006022016,0.0015316344,0.0000022073377,0.00015633155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925977,0.00024313951,0.00012266055,0.00013420115,0.00014074465,0.00009935135],"domain_scores_gemma":[0.9967534,0.00035964994,0.0019080548,0.00011359572,0.00042506302,0.00044022035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014974124,0.0002758553,0.0004811397,0.00080916274,0.0004106575,0.0007684449,0.00034118278,0.00039805422,0.0011301565],"category_scores_gemma":[0.0035452822,0.0001796845,0.00058243435,0.0013549189,0.00020472835,0.0006475658,0.0006465233,0.00044942705,0.00039711694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000895812,0.000026933447,0.99933165,0.000007943303,0.00003243092,0.000015147305,0.00003644457,0.000006325342,0.000020712288,0.0000034010868,0.000065654734,0.00036378158],"study_design_scores_gemma":[0.000009803952,0.00010160687,0.9995285,0.000006387876,0.00002584419,0.00004426996,0.0001293408,0.00003622483,0.00001091655,0.000005069758,0.00010012208,0.0000019107986],"about_ca_topic_score_codex":0.006142343,"about_ca_topic_score_gemma":0.008834256,"teacher_disagreement_score":0.006142343,"about_ca_system_score_codex":0.00042597574,"about_ca_system_score_gemma":0.00041969548,"threshold_uncertainty_score":0.0122131705},"labels":[],"label_agreement":null},{"id":"W4404236652","doi":"10.1093/neuonc/noae165.1045","title":"QOL-10. AN ASSESSMENT TOOL FOR MEASURING CAREGIVERS’ DEATH ANXIETY IN PRIMARY BRAIN TUMOR: A CONFIRMATORY FACTOR ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Confirmatory factor analysis; Death anxiety; Clinical psychology; Anxiety; Psychology; Medicine; Psychiatry; Structural equation modeling; Statistics","score_opus":0.1193444174506611,"score_gpt":0.43382880282938596,"score_spread":0.31448438537872486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642616,0.0002904709,0.021994617,0.00040416827,0.000085994965,0.0035466752,0.005114389,0.00022216528,0.004080046],"genre_scores_gemma":[0.96430755,0.00016570746,0.02467953,0.00008887429,0.000016999507,0.005685476,0.0041430704,0.00004764771,0.0008650737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634016,0.0018239636,0.0004951101,0.00022496398,0.0009413992,0.00017438631],"domain_scores_gemma":[0.99041486,0.00376035,0.0013474668,0.0005031866,0.0037240572,0.0002500582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011950768,0.0007605721,0.0006173451,0.0022089563,0.00056359824,0.00067356916,0.00048051385,0.00020084075,0.002641526],"category_scores_gemma":[0.018484477,0.00036609173,0.0015116589,0.0017579752,0.00038467365,0.0004113988,0.0009058607,0.0009193815,0.00052335975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048608016,0.0006526573,0.8690571,0.00033407146,0.00041927994,0.00024699562,0.0023134043,0.0010906598,0.0018069973,0.0005932354,0.006579983,0.11641948],"study_design_scores_gemma":[0.0002716958,0.0006425623,0.98256654,0.00013851993,0.0001458821,0.00032836123,0.0020097708,0.007189761,0.0010836908,0.00063380564,0.004940414,0.00004898046],"about_ca_topic_score_codex":0.00291049,"about_ca_topic_score_gemma":0.004817727,"teacher_disagreement_score":0.011950768,"about_ca_system_score_codex":0.0006126711,"about_ca_system_score_gemma":0.0020078584,"threshold_uncertainty_score":0.06320244},"labels":[],"label_agreement":null},{"id":"W4404236710","doi":"10.1093/neuonc/noae165.0885","title":"NCOG-03. DESCRIPTIVE ANALYSIS AND OUTCOME COMPARISON BETWEEN PATIENTS WITH GLIOBLASTOMA MULTIFORME WHO RECEIVE 15 VERSUS 30 FRACTIONS OF RADIOTHERAPY: A RETROSPECTIVE CHART REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Glioblastoma; Radiation therapy; Medicine; Chart; Descriptive statistics; Oncology; Internal medicine; Statistics; Mathematics; Cancer research","score_opus":0.031224744082871677,"score_gpt":0.3401410186669304,"score_spread":0.30891627458405874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807242,0.00072161667,0.00016063738,0.00005087357,0.0000107814385,0.00018166268,0.016266838,0.000020911668,0.0018625743],"genre_scores_gemma":[0.9872376,0.0003819624,0.00030692422,0.000052292657,0.000010745543,0.00023704783,0.011463278,0.0000091171705,0.00030099638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992586,0.00011202695,0.00022643126,0.00015383198,0.00016934064,0.000079738515],"domain_scores_gemma":[0.9955859,0.0007076925,0.0024641817,0.00014327673,0.0007786222,0.0003201514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079587696,0.0001407217,0.00035344515,0.002253472,0.00036992715,0.00047341935,0.00031713035,0.00017187002,0.0019853124],"category_scores_gemma":[0.0026035877,0.00015065414,0.00024634908,0.0032661778,0.00022509955,0.0003976162,0.00029138368,0.0001942439,0.00040144945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012706015,0.000018794583,0.99767953,0.00004285992,0.00001486316,0.0001379151,0.00007133303,0.00001520533,0.00010081976,0.0000144872365,0.0003743948,0.0014027477],"study_design_scores_gemma":[0.000012320197,0.00012415281,0.997755,0.00002487474,0.000016325253,0.00057535357,0.00032824406,0.00007112587,0.00013126137,0.000009757257,0.00094752765,0.0000041184217],"about_ca_topic_score_codex":0.012462716,"about_ca_topic_score_gemma":0.012519918,"teacher_disagreement_score":0.012462716,"about_ca_system_score_codex":0.0011157804,"about_ca_system_score_gemma":0.0011263159,"threshold_uncertainty_score":0.024780333},"labels":[],"label_agreement":null},{"id":"W4404236764","doi":"10.1093/neuonc/noae165.0064","title":"ANGI-05. UNSUPERVISED DECONVOLUTION OF SPATIOTEMPORAL HETEROGENEITY REVEALS HIGH-RESOLUTION INVASION STATES IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Glioblastoma; Deconvolution; Tumour heterogeneity; High resolution; Tumor heterogeneity; Biology; Computer science; Geography; Cancer research; Remote sensing; Cancer; Genetics; Algorithm","score_opus":0.01976993667904103,"score_gpt":0.3105037646722247,"score_spread":0.29073382799318365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8911522,0.00021465041,0.091348894,0.0001640878,0.00003736605,0.000047962218,0.007879005,0.007106083,0.002049723],"genre_scores_gemma":[0.908395,0.00014649784,0.07420742,0.00006701873,0.000014114252,0.00007476101,0.014559776,0.0006799519,0.0018555614],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99986136,0.000020932779,0.0000076491815,0.00004748242,0.00003620252,0.000026381536],"domain_scores_gemma":[0.99975866,0.0000764891,0.000034905665,0.000037351263,0.00005802448,0.00003454987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005132552,0.00040197276,0.00040675432,0.00081293884,0.00028686668,0.0006600146,0.00044303932,0.0003036877,0.0014599492],"category_scores_gemma":[0.00083535886,0.00020032437,0.0007062191,0.00060953613,0.00022863787,0.0002400402,0.00043625827,0.00040809932,0.00048387906],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019338648,0.00058261753,0.12641343,0.0005524072,0.0006407803,0.0005119686,0.00047072774,0.255077,0.4478651,0.006195589,0.016127981,0.14362854],"study_design_scores_gemma":[0.000024831787,0.00011189847,0.06115591,0.00001095436,0.00005609967,0.00014751313,0.00009816097,0.8902611,0.043066654,0.0025600716,0.0024521668,0.000054612352],"about_ca_topic_score_codex":0.010703508,"about_ca_topic_score_gemma":0.01364811,"teacher_disagreement_score":0.010703508,"about_ca_system_score_codex":0.00047238547,"about_ca_system_score_gemma":0.0009082205,"threshold_uncertainty_score":0.021282434},"labels":[],"label_agreement":null},{"id":"W4404236800","doi":"10.1093/neuonc/noae165.1053","title":"QOL-18. MANAGING CANCER AND LIVING MEANINGFULLY (CALM) IN PRIMARY AND SECONDARY MALIGNANT BRAIN TUMOR PATIENTS: INTERIM ANALYSIS OF A PHASE IIC RANDOMIZED CONTROL PILOT TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Interim analysis; Interim; Medicine; Randomized controlled trial; Oncology; Brain cancer; Cancer; Internal medicine; History","score_opus":0.14298452950604917,"score_gpt":0.4139463736709291,"score_spread":0.27096184416487995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90987206,0.001187339,0.0027423059,0.0008980097,0.0005725611,0.07697176,0.0044714813,0.00028776302,0.0029966258],"genre_scores_gemma":[0.83424383,0.0006613971,0.010528042,0.0009836939,0.0004171075,0.14801218,0.0024589298,0.000044462835,0.0026504106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99560827,0.0028692933,0.00029500356,0.00035151158,0.0003025615,0.00057332753],"domain_scores_gemma":[0.9930647,0.0024645866,0.001566739,0.0009090812,0.0006824162,0.001312328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0116437,0.0017043168,0.0026969265,0.0008742715,0.00084278325,0.0014946288,0.0012832737,0.002162926,0.009367206],"category_scores_gemma":[0.009540492,0.0007538139,0.0026804847,0.0008115175,0.0017904404,0.0013594752,0.00088208937,0.0029073528,0.001298018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.948727,0.031110302,0.0015590057,0.00040808143,0.0006514562,0.000041970896,0.000109195804,0.00035589916,0.0012163244,0.00015793991,0.0011866863,0.01447606],"study_design_scores_gemma":[0.8037173,0.19176593,0.0025652994,0.000037111102,0.0003868532,0.000019393628,0.00003821395,0.00029411117,0.00046831075,0.00017135845,0.0005235437,0.000012480064],"about_ca_topic_score_codex":0.0008669643,"about_ca_topic_score_gemma":0.0011810675,"teacher_disagreement_score":0.0116437,"about_ca_system_score_codex":0.00090738665,"about_ca_system_score_gemma":0.0036613056,"threshold_uncertainty_score":0.061578453},"labels":[],"label_agreement":null},{"id":"W4404236843","doi":"10.1093/neuonc/noae165.0982","title":"EXTH-51. ENHANCING GLIOBLASTOMA TREATMENT: ALLOGENEIC CAR-T CELLS OVERCOMES FUNCTIONAL DEFICITS OF PATIENT-DERIVED AUTOLOGOUS PRODUCTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Medicine","score_opus":0.02533520469584187,"score_gpt":0.29759105269736946,"score_spread":0.2722558480015276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537754,0.0007790081,0.0019022799,0.00009990767,0.000048146754,0.000057062323,0.00025012568,0.00011895646,0.0013668576],"genre_scores_gemma":[0.9971982,0.00030786186,0.00076254155,0.00006110381,0.000009554781,0.000038038546,0.0003502932,0.00001568438,0.001256722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998803,0.000014398376,0.000009517316,0.000027085618,0.000026109365,0.0000424917],"domain_scores_gemma":[0.999959,0.0000048581496,0.000008735301,0.0000060757866,0.000004845019,0.00001646745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011903233,0.000319679,0.00039987257,0.00016938927,0.00010101591,0.00033516058,0.0001973959,0.0002875345,0.0017953919],"category_scores_gemma":[0.00007256465,0.00007510827,0.0001965097,0.000121751735,0.00019999,0.00016728882,0.00018218099,0.0008035881,0.0003970435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095913844,0.00070473657,0.0006751423,0.00013238004,0.000029079423,0.00016765553,0.00006136261,0.000535969,0.9776708,0.0004328772,0.0005685388,0.018062176],"study_design_scores_gemma":[0.000188039,0.0062615713,0.0042736195,0.000011830478,0.00012624126,0.00079593813,0.000044705197,0.0019612473,0.97858626,0.00011440939,0.0076256674,0.00001038712],"about_ca_topic_score_codex":0.00045536342,"about_ca_topic_score_gemma":0.0006051092,"teacher_disagreement_score":0.0017953919,"about_ca_system_score_codex":0.00015862941,"about_ca_system_score_gemma":0.00026440443,"threshold_uncertainty_score":0.0060061216},"labels":[],"label_agreement":null},{"id":"W4404236871","doi":"10.1093/neuonc/noae165.1304","title":"Author Index","year":2024,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.04177445664300288,"score_gpt":0.3591699679761732,"score_spread":0.3173955113331703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236871","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028971076,0.0014223068,0.00081033254,0.002842555,0.006760849,0.0002837666,0.022731962,0.0021053774,0.9627533],"genre_scores_gemma":[0.00074762554,0.0010644684,0.0005934873,0.0011074952,0.0015198708,0.00013412998,0.008993754,0.00077426597,0.9850648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994442,0.0000850709,0.00005125255,0.00006160591,0.00029641902,0.000061506464],"domain_scores_gemma":[0.9954841,0.0009371566,0.00018998861,0.00022224209,0.0018852999,0.0012812014],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005742008,0.001455817,0.0012495231,0.0058605745,0.0010784186,0.0041626277,0.0012797138,0.0016935944,0.90214896],"category_scores_gemma":[0.006939158,0.0005566236,0.00061583304,0.0040896134,0.00042635272,0.001963206,0.0020032255,0.0014681275,0.8553268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016369268,0.00001653757,0.000052172763,0.00010176775,0.0000011656463,0.000017542143,0.000004404082,0.000044404544,0.00004375833,0.00033995372,0.96594685,0.033415094],"study_design_scores_gemma":[0.000032421358,0.000019820895,0.00028585386,0.00023237096,0.0000040361865,0.00007444417,0.000019835115,0.00010819835,0.00010688661,0.0013356528,0.9977725,0.000007966515],"about_ca_topic_score_codex":0.0028310851,"about_ca_topic_score_gemma":0.0062203757,"teacher_disagreement_score":0.09785104,"about_ca_system_score_codex":0.0015330557,"about_ca_system_score_gemma":0.0023290573,"threshold_uncertainty_score":0.13957256},"labels":[],"label_agreement":null},{"id":"W4404236916","doi":"10.1093/neuonc/noae165.1195","title":"TMIC-17. TARGETING THE FLUIDIC FORCE-SENSING MECHANISM TO TREAT BRAIN TUMOR METASTASIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mechanism (biology); Fluidics; Neuroscience; Metastasis; Nanotechnology; Medicine; Engineering; Biology; Materials science; Cancer; Physics; Aerospace engineering; Internal medicine","score_opus":0.023364234611637193,"score_gpt":0.3053918151395524,"score_spread":0.2820275805279152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8625356,0.076510005,0.02229654,0.003472567,0.0021200692,0.00068860804,0.00210564,0.0014162872,0.028854685],"genre_scores_gemma":[0.94491535,0.029655404,0.009009499,0.000908078,0.0001495196,0.00044426543,0.0013347946,0.000065026856,0.013518032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994123,0.000005286631,0.000003219419,0.00000884917,0.000016047588,0.00002537012],"domain_scores_gemma":[0.9999665,0.000002725731,0.000008837653,0.0000024087067,0.0000056774124,0.000013765944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012532854,0.00041052105,0.00030418928,0.0004345263,0.00014737835,0.00037473632,0.0002592277,0.00041721654,0.0023617854],"category_scores_gemma":[0.00007067444,0.00015699911,0.0003864139,0.0002815129,0.0002679461,0.00019513698,0.00019590731,0.00088017463,0.00069646694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007715647,0.0006868498,0.0007468348,0.0009267841,0.00008031363,0.0005282452,0.00006341448,0.0021278937,0.9064859,0.0032403364,0.0060712923,0.078270525],"study_design_scores_gemma":[0.00036498,0.0028877112,0.0022097332,0.00009522215,0.00014797437,0.0012962489,0.00005340557,0.004403803,0.9235149,0.0005614083,0.06443859,0.000026088832],"about_ca_topic_score_codex":0.0007228102,"about_ca_topic_score_gemma":0.0013092702,"teacher_disagreement_score":0.0023617854,"about_ca_system_score_codex":0.00037936738,"about_ca_system_score_gemma":0.0006525397,"threshold_uncertainty_score":0.007900894},"labels":[],"label_agreement":null},{"id":"W4404236986","doi":"10.1093/neuonc/noae165.1056","title":"QOL-21. PSYCHOMETRIC VALIDATION OF THE FEAR OF CANCER RECURRENCE INVENTORY FOR PRIMARY BRAIN TUMOR PATIENTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Brain tumor; Cancer recurrence; Clinical psychology; Psychology; Medicine; Cancer; Oncology; Internal medicine; Psychiatry","score_opus":0.03047491309852898,"score_gpt":0.34415229642449047,"score_spread":0.3136773833259615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066937,0.000480518,0.000902951,0.00015880658,0.00004184425,0.0009742658,0.0032891305,0.000056269477,0.0034268526],"genre_scores_gemma":[0.9909801,0.00021958358,0.0026068087,0.00010833725,0.000025586458,0.0015810598,0.0037532446,0.000016611364,0.0007085197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831957,0.0005315154,0.0003452685,0.00015931357,0.0004763642,0.00016789293],"domain_scores_gemma":[0.9943125,0.0015834941,0.0024027766,0.00024937457,0.0010337644,0.0004181814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004029132,0.00056608143,0.0007025801,0.0015080896,0.0004181261,0.00065211946,0.00074937294,0.0004165312,0.0030200963],"category_scores_gemma":[0.0096580265,0.00027003494,0.0017751686,0.0012263107,0.000417507,0.0005420431,0.001165797,0.0009712578,0.0006503316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000816127,0.00077529444,0.94301385,0.00027791777,0.0005252179,0.00016043588,0.000809491,0.0011860748,0.0008330035,0.00021719378,0.003319894,0.048065465],"study_design_scores_gemma":[0.000118118915,0.00083034113,0.9956216,0.000043951062,0.00006498383,0.00024471775,0.00025164525,0.00095455634,0.00024237421,0.00013616579,0.0014702816,0.000021212281],"about_ca_topic_score_codex":0.0013832769,"about_ca_topic_score_gemma":0.0019597923,"teacher_disagreement_score":0.004029132,"about_ca_system_score_codex":0.00064575387,"about_ca_system_score_gemma":0.0007689089,"threshold_uncertainty_score":0.021308303},"labels":[],"label_agreement":null},{"id":"W4404236989","doi":"10.1093/neuonc/noae165.1068","title":"RBIO-02. DEVELOPMENT OF FLASH-CAR RADIOIMMUNOTHERAPY FOR PEDIATRIC BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radioimmunotherapy; Flash (photography); Medicine; Physics; Immunology","score_opus":0.013585652492482973,"score_gpt":0.31251624213741663,"score_spread":0.2989305896449337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90409935,0.02936983,0.03626103,0.00082110096,0.00041642177,0.00096095854,0.0020359622,0.0022735577,0.023761827],"genre_scores_gemma":[0.95756006,0.012709093,0.017020764,0.0004126007,0.0000753837,0.00063355133,0.0026563487,0.00023643216,0.008695829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999012,0.000014011525,0.0000047451736,0.00002990805,0.000025562882,0.000024601266],"domain_scores_gemma":[0.9999416,0.000006205767,0.000014052051,0.000009534172,0.000007161934,0.00002146779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031554158,0.00047888258,0.00035578563,0.00042750753,0.00012851146,0.0003343656,0.0005782072,0.00036883942,0.0030005178],"category_scores_gemma":[0.000097212316,0.0001988899,0.00041700836,0.0002473286,0.00024814112,0.00037189526,0.00027404338,0.00070744,0.0010400306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022097602,0.0014143813,0.0011835508,0.00062641344,0.00013474688,0.00029401996,0.000094704796,0.0021259934,0.8770181,0.0019983626,0.0024503171,0.110449694],"study_design_scores_gemma":[0.00097364094,0.018117102,0.008306168,0.00010154961,0.0004018472,0.0024457974,0.00006309377,0.0044913297,0.8957451,0.0005003271,0.06881836,0.00003577798],"about_ca_topic_score_codex":0.0007106009,"about_ca_topic_score_gemma":0.00086823,"teacher_disagreement_score":0.0030005178,"about_ca_system_score_codex":0.00037641337,"about_ca_system_score_gemma":0.00046895616,"threshold_uncertainty_score":0.01003778},"labels":[],"label_agreement":null},{"id":"W4404237010","doi":"10.1093/neuonc/noae165.0256","title":"CSIG-07. JAK1/STAT1/3 COOPERATES WITH THE CIC-FUSIONS TO DRIVE CIC-REARRANGED SARCOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer research; Medicine","score_opus":0.01905711853716609,"score_gpt":0.31082484847666025,"score_spread":0.2917677299394942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949921,0.0006532931,0.0005431448,0.00017664656,0.00004437166,0.000069564376,0.001244317,0.00014787675,0.00212874],"genre_scores_gemma":[0.9959025,0.00017066396,0.00070434104,0.0000685477,0.0000055589835,0.00003947449,0.0016175522,0.000013232316,0.0014781113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979013,0.0000351746,0.00002207599,0.000027431915,0.000060762934,0.00006450193],"domain_scores_gemma":[0.9998864,0.000026134536,0.000019663763,0.0000203283,0.0000072388625,0.000040224517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020053553,0.00028282544,0.0003279771,0.00026168185,0.00019606801,0.00032027537,0.00022809395,0.0003636504,0.0019014277],"category_scores_gemma":[0.00011307975,0.00013985754,0.00028319645,0.00023114761,0.00021931257,0.0000937097,0.00014150226,0.00073468697,0.0006844583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029710072,0.00028463165,0.0007911922,0.000043840162,0.000012599708,0.00014992025,0.000021718604,0.00029926503,0.99503386,0.00019657037,0.00046818887,0.002401102],"study_design_scores_gemma":[0.00015558451,0.0017028761,0.0149361,0.000007927763,0.000032037005,0.0013134514,0.000055362165,0.004290039,0.9712992,0.00007767257,0.0061216783,0.000008078629],"about_ca_topic_score_codex":0.0012863795,"about_ca_topic_score_gemma":0.0028182743,"teacher_disagreement_score":0.0019014277,"about_ca_system_score_codex":0.0004576408,"about_ca_system_score_gemma":0.0003283685,"threshold_uncertainty_score":0.0063608885},"labels":[],"label_agreement":null},{"id":"W4404237017","doi":"10.1093/neuonc/noae165.0946","title":"EXTH-15. AN EGFRVIII RNA-LNP VACCINE PROTOTYPE ACHIEVES TUMOUR CLEARANCE IN A GBM MOUSE MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Cancer research; Virology; RNA; Immunology; Medicine; Biology; Genetics","score_opus":0.025147403641010424,"score_gpt":0.3374182770290223,"score_spread":0.31227087338801185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849904,0.0012317123,0.008738064,0.00036483485,0.0001949126,0.00026270014,0.0015219738,0.00048794344,0.0022073763],"genre_scores_gemma":[0.98469734,0.0011177314,0.0059721684,0.00016192744,0.000029244042,0.0003474275,0.001895651,0.000092231894,0.0056863027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972004,0.000030418983,0.000021930164,0.000069631074,0.000072339775,0.000085584485],"domain_scores_gemma":[0.99984646,0.000017442324,0.000044350647,0.000014265597,0.000020941292,0.00005643553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034756275,0.000689489,0.0005084167,0.0005460685,0.00017059148,0.0003624603,0.00039180863,0.00085183827,0.0015537906],"category_scores_gemma":[0.00012617103,0.00022143983,0.00044658792,0.00018499877,0.0003936157,0.00038633714,0.00015725788,0.0014401061,0.0005784156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042435774,0.0005639977,0.00010548638,0.00007293447,0.000017011556,0.000048166487,0.000031748423,0.0004787269,0.9951874,0.00025767935,0.00029642822,0.0025161423],"study_design_scores_gemma":[0.00014573394,0.006203145,0.0008375184,0.000015131397,0.00003823021,0.00017406775,0.000027588256,0.0020302024,0.98694533,0.00008754712,0.0034868277,0.000008560948],"about_ca_topic_score_codex":0.0009909472,"about_ca_topic_score_gemma":0.0011159924,"teacher_disagreement_score":0.0015537906,"about_ca_system_score_codex":0.00049209606,"about_ca_system_score_gemma":0.0003672237,"threshold_uncertainty_score":0.005198002},"labels":[],"label_agreement":null},{"id":"W4404237029","doi":"10.1093/neuonc/noae165.0050","title":"EPCO-51. A MULTI-OMIC ANALYSIS OF REGIONAL HETEROGENEITY IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"","keywords":"Glioblastoma; Computational biology; Biology; Cancer research","score_opus":0.03463462110902515,"score_gpt":0.36445497332715104,"score_spread":0.3298203522181259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89849097,0.0040295706,0.013942853,0.00039830973,0.00011600486,0.00017570569,0.074611895,0.0011783027,0.007056406],"genre_scores_gemma":[0.9200833,0.0007806444,0.016075982,0.00041332116,0.00007563685,0.00030497034,0.059705004,0.00035765974,0.0022035756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993537,0.00006206228,0.000050590465,0.00025967156,0.00016160998,0.00011222347],"domain_scores_gemma":[0.9992084,0.00020313016,0.00021307822,0.0001108833,0.00017841408,0.00008609344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008045749,0.00040056926,0.0007642789,0.0024485898,0.00051949796,0.0013486679,0.00035184473,0.0005217417,0.0027220233],"category_scores_gemma":[0.0014345545,0.00018910572,0.0006242677,0.0021114976,0.00025524138,0.0003924703,0.0009089252,0.00039884335,0.0011795565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016846006,0.00014662952,0.39960992,0.001154132,0.0011583159,0.001009235,0.00045915946,0.004716973,0.49322587,0.0015321227,0.010727555,0.084575586],"study_design_scores_gemma":[0.00006509461,0.00036408764,0.91314757,0.00017692034,0.0007171495,0.0016081498,0.0005205176,0.020456152,0.038060594,0.002101385,0.022699319,0.0000830001],"about_ca_topic_score_codex":0.0026524728,"about_ca_topic_score_gemma":0.0053136894,"teacher_disagreement_score":0.0027220233,"about_ca_system_score_codex":0.0005344371,"about_ca_system_score_gemma":0.00053523283,"threshold_uncertainty_score":0.0091061},"labels":[],"label_agreement":null},{"id":"W4404237036","doi":"10.1093/neuonc/noae165.0062","title":"ANGI-03. GLIOMA STEM CELLS INDUCE VASECTASIA – A NON-ANGIOGENIC BRAIN TUMOUR NEOVASCULARIZATION PROCESS DRIVEN BY INTERCELLULAR EGFR TRANSFER THROUGH EXTRACELLULAR VESICLES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University","funders":"","keywords":"Extracellular vesicles; Glioma; Intracellular; Angiogenesis; Extracellular; Neovascularization; Vesicle; Cell biology; Chemistry; Cancer research; Biology; Biochemistry","score_opus":0.016196066025127447,"score_gpt":0.27475513739553614,"score_spread":0.2585590713704087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955367,0.00034239507,0.0014871028,0.000061175386,0.000027032274,0.00005290654,0.000599984,0.00012934202,0.0017634572],"genre_scores_gemma":[0.9944437,0.00018602745,0.0010357458,0.000052944808,0.000006785976,0.000054744047,0.00091330835,0.000015841975,0.0032910397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998791,0.000017164642,0.00001176768,0.00002315719,0.000035839512,0.00003288445],"domain_scores_gemma":[0.999933,0.0000099603,0.000017695198,0.000007934595,0.000006436597,0.000025070398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010464482,0.00023501323,0.00017899572,0.00017391288,0.00008593949,0.00021196861,0.00011973084,0.00018494904,0.0010720453],"category_scores_gemma":[0.000051365063,0.000092108436,0.00022629689,0.00010367888,0.00019549864,0.00008850432,0.00015128336,0.0006126673,0.0003599284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005637217,0.000029864006,0.00007188497,0.000014659464,0.00000257046,0.000026519278,0.000010623418,0.000028830555,0.9992642,0.000097461845,0.000037490987,0.00035952753],"study_design_scores_gemma":[0.000011704721,0.00037428914,0.0028944197,0.000002545,0.000008801145,0.000100795645,0.000023973254,0.00068233657,0.9941712,0.000037890437,0.0016896371,0.0000022957383],"about_ca_topic_score_codex":0.00083716214,"about_ca_topic_score_gemma":0.0009482232,"teacher_disagreement_score":0.0010720453,"about_ca_system_score_codex":0.00022190607,"about_ca_system_score_gemma":0.00017884267,"threshold_uncertainty_score":0.0035863519},"labels":[],"label_agreement":null},{"id":"W4404237050","doi":"10.1093/neuonc/noae165.0660","title":"IMMU-69. THERAPEUTIC WINDOW ENABLING ERADICATION OF RESIDUAL GLIOMA STEM CELLS BY INTRACRANIAL NK CELL THERAPY FOLLOWING TEMOZOLOMIDE-INDUCED TUMOUR DEPOPULATION – A POSSIBLE ROLE OF CYTOTOXIC EXTRACELLULAR VESICLES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Extracellular vesicles; Cytotoxic T cell; Glioma; Cancer research; Glioblastoma; Stem cell; Cell; Chemistry; Medicine; Cell biology; Biology; In vitro","score_opus":0.01328378312796306,"score_gpt":0.26588070287668286,"score_spread":0.2525969197487198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970157,0.00082174985,0.0009147881,0.000040883227,0.000026238604,0.000031439515,0.00018033589,0.000054404423,0.00091443094],"genre_scores_gemma":[0.99795014,0.00028280518,0.0006934892,0.00001654498,0.000005339336,0.000018889446,0.0001809665,0.0000051811658,0.00084659545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994266,0.0000070198143,0.0000033471858,0.000011189147,0.000011433447,0.000024345827],"domain_scores_gemma":[0.9999769,0.0000033086785,0.0000067964434,0.0000028320067,0.0000024199953,0.000007865883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000708853,0.00027942983,0.00027076324,0.00011583469,0.000071045484,0.00020945208,0.00012573853,0.00020134829,0.0010051434],"category_scores_gemma":[0.000044055305,0.000069234644,0.00016461324,0.000072002054,0.00018105381,0.0001552791,0.00012220348,0.0003914534,0.00023829551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040259972,0.00009158077,0.00014120803,0.000045059303,0.000005020675,0.000062453495,0.000016699187,0.00013816406,0.9962782,0.00014162464,0.000053886357,0.0026235504],"study_design_scores_gemma":[0.000047763653,0.0025157281,0.002027098,0.0000040220816,0.000020462938,0.00024500804,0.000020650217,0.0010548005,0.9921923,0.000034496272,0.0018340123,0.00000356576],"about_ca_topic_score_codex":0.0005326967,"about_ca_topic_score_gemma":0.0006908492,"teacher_disagreement_score":0.0010051434,"about_ca_system_score_codex":0.00017397043,"about_ca_system_score_gemma":0.00014152048,"threshold_uncertainty_score":0.0033625364},"labels":[],"label_agreement":null},{"id":"W4404237082","doi":"10.1093/neuonc/noae165.0122","title":"BIOM-50. SERIAL INTRACRANIAL CEREBROSPINAL CELL-FREE DNA FOR DISEASE MONITORING IN PATIENTS WITH GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cerebrospinal fluid; Brain Cell; Medicine; Brain disease; Pathology; Disease; Biology; Neuroscience","score_opus":0.012699836978594694,"score_gpt":0.27613591978354546,"score_spread":0.2634360828049508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930187,0.0020251956,0.0007969249,0.00018566506,0.000026768512,0.00007029941,0.0012915924,0.00015297637,0.002431854],"genre_scores_gemma":[0.9960998,0.00034514256,0.0018804631,0.00008959089,0.000016642478,0.00006588175,0.00087192457,0.000010583397,0.0006200172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984574,0.00003704848,0.000019731,0.000039127488,0.000038259608,0.000019959529],"domain_scores_gemma":[0.9996538,0.00010164674,0.00009848145,0.000020482463,0.00006496928,0.000060647326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031673873,0.0003171911,0.000322597,0.0007893013,0.00017784041,0.00036475834,0.00016896728,0.00023211536,0.0015609732],"category_scores_gemma":[0.000976563,0.00009706514,0.000112221365,0.000427881,0.00013984313,0.00023974218,0.00015926095,0.00020906539,0.0005347765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035147308,0.00015604928,0.8376482,0.00017334537,0.0000700239,0.00079198804,0.00015230988,0.00037153912,0.0445474,0.00009108839,0.0020147737,0.11046863],"study_design_scores_gemma":[0.00011383312,0.0021012498,0.94977367,0.00005680813,0.00010235786,0.0040312167,0.00014428415,0.0028980384,0.03453753,0.00019555443,0.0060258196,0.000019817824],"about_ca_topic_score_codex":0.0006852301,"about_ca_topic_score_gemma":0.0010570432,"teacher_disagreement_score":0.0015609732,"about_ca_system_score_codex":0.00029499677,"about_ca_system_score_gemma":0.0001932972,"threshold_uncertainty_score":0.0052220225},"labels":[],"label_agreement":null},{"id":"W4404237084","doi":"10.1093/neuonc/noae165.0234","title":"STEM-08. LIPID SATURATION HOMEOSTASIS PRESENTS A TARGETABLE VULNERABILITY IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Homeostasis; Saturation (graph theory); Vulnerability (computing); Biology; Internal medicine; Cancer research; Medicine; Cell biology; Computer science; Mathematics; Computer security; Combinatorics","score_opus":0.016299259136220132,"score_gpt":0.2873422987769701,"score_spread":0.27104303964074994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310184,0.0013213011,0.0023699994,0.00014998576,0.000023054383,0.000033368284,0.001606456,0.00022654432,0.0011674316],"genre_scores_gemma":[0.9945568,0.00085584924,0.0012500103,0.00011763888,0.0000043209066,0.000030645588,0.0015160029,0.000039235794,0.0016295855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999281,0.0000049305695,0.0000047269186,0.000019486133,0.00002893317,0.0000137458555],"domain_scores_gemma":[0.9999435,0.000007654801,0.00002108984,0.0000049662945,0.0000077261775,0.000015009745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008488426,0.00021151113,0.00015914421,0.0003016056,0.0001335943,0.00025933448,0.00011991615,0.00024765093,0.0017212845],"category_scores_gemma":[0.00011092848,0.000094289906,0.00021700062,0.00018141446,0.0001945093,0.0001456916,0.00018125953,0.00038431608,0.0003319055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018609015,0.000017789722,0.002257221,0.000054318152,0.000011643365,0.0002580442,0.00003057419,0.00006951785,0.9924508,0.00009937689,0.0001301357,0.0044346293],"study_design_scores_gemma":[0.00002421075,0.00047705998,0.06364587,0.000020124799,0.000058998074,0.0023981738,0.00015958249,0.0015671969,0.92153573,0.00032702726,0.009774927,0.000011096727],"about_ca_topic_score_codex":0.0013985084,"about_ca_topic_score_gemma":0.002075332,"teacher_disagreement_score":0.0017212845,"about_ca_system_score_codex":0.00035662335,"about_ca_system_score_gemma":0.00017129921,"threshold_uncertainty_score":0.0057582855},"labels":[],"label_agreement":null},{"id":"W4404237093","doi":"10.1093/neuonc/noae165.0439","title":"CTNI-72. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Texas MD Anderson Cancer Center","keywords":"Glioblastoma; Medicine; Computer science; Cancer research","score_opus":0.02444994315947624,"score_gpt":0.3381895540139563,"score_spread":0.31373961085448004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979018,0.0009913462,0.000063985244,0.00007823512,0.000011940761,0.00006843952,0.0001989734,0.000021662048,0.00066364836],"genre_scores_gemma":[0.9988686,0.00029956806,0.00009061849,0.00010806442,0.000019538576,0.000055575463,0.00037709053,0.0000037662362,0.00017715423],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998074,0.000075256314,0.000016204014,0.000032085354,0.000025555952,0.00004355983],"domain_scores_gemma":[0.9997496,0.00003689599,0.00007470046,0.000013837502,0.000018404742,0.00010656719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041608096,0.00027192145,0.0007063322,0.00022562254,0.00018850084,0.00028155182,0.0002482424,0.0002965986,0.0010657756],"category_scores_gemma":[0.00039736816,0.000078685414,0.00029728285,0.00040093946,0.0002555828,0.00016626154,0.00017761282,0.00049864256,0.00021171007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19336666,0.013689644,0.44991773,0.00080313993,0.0013261026,0.0035966355,0.00051156734,0.002233467,0.07241451,0.00025257198,0.0062954836,0.25559253],"study_design_scores_gemma":[0.038918212,0.27002358,0.65822285,0.00012119958,0.0012390914,0.0050273975,0.000256986,0.0037885942,0.013427494,0.0003328246,0.008576787,0.0000650006],"about_ca_topic_score_codex":0.0022369323,"about_ca_topic_score_gemma":0.0032295117,"teacher_disagreement_score":0.0022369323,"about_ca_system_score_codex":0.00044074512,"about_ca_system_score_gemma":0.0005802175,"threshold_uncertainty_score":0.004447758},"labels":[],"label_agreement":null},{"id":"W4404237122","doi":"10.1093/neuonc/noae165.0527","title":"DDDR-42. LEVERAGING GENOME-WIDE CRISPR/CAS9 KNOCKOUT DRUG SCREENS TO IDENTIFY SENSITIZERS FOR PROTEOSOME INHIBITORS IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CRISPR; Glioblastoma; Drug discovery; Computational biology; Drug; Genome; Drug target; Cancer research; Biology; Genetics; Pharmacology; Bioinformatics; Gene","score_opus":0.014976858419600407,"score_gpt":0.3048440016401705,"score_spread":0.2898671432205701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517682,0.004397772,0.02816826,0.00052774616,0.0001524739,0.0004938713,0.00666939,0.0016746342,0.006147553],"genre_scores_gemma":[0.9701779,0.002193998,0.018423336,0.0002450432,0.000010286043,0.00018793168,0.0031308166,0.00014711393,0.0054836143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997501,0.000023600118,0.000033325963,0.00006162106,0.00009530314,0.000036013],"domain_scores_gemma":[0.9999194,0.000012225723,0.000028333421,0.0000098752125,0.000012425831,0.000017685037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024602047,0.0004589256,0.0005876477,0.00040126697,0.0002066659,0.00047284746,0.0003273408,0.00040520474,0.0014142737],"category_scores_gemma":[0.00014543287,0.00022465207,0.00037350904,0.0002521158,0.00021679919,0.00013836408,0.0002565951,0.00053088943,0.00045109904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005705199,0.000039771356,0.00019848677,0.00005930285,0.000010984487,0.00007955444,0.000009187883,0.0003222382,0.9961592,0.000100152385,0.00014551783,0.0028186415],"study_design_scores_gemma":[0.000025145582,0.00036584603,0.0019182593,0.000010314029,0.000034891043,0.0004451435,0.000020255688,0.0022867569,0.98849547,0.00005959874,0.0063260286,0.00001234576],"about_ca_topic_score_codex":0.0015453346,"about_ca_topic_score_gemma":0.0035940225,"teacher_disagreement_score":0.0015453346,"about_ca_system_score_codex":0.00043139685,"about_ca_system_score_gemma":0.00032686023,"threshold_uncertainty_score":0.0047311783},"labels":[],"label_agreement":null},{"id":"W4404237137","doi":"10.1093/neuonc/noae165.1265","title":"TMOD-01. EGFR AMPLIFICATION ACCOMPANIES ADAPTATION TO MITOGEN-INDUCED DEFECTIVE MITOSIS IN PDGFA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mitosis; Adaptation (eye); Cell biology; Computer science; Cancer research; Biology; Neuroscience","score_opus":0.024785124473883608,"score_gpt":0.29833751854341223,"score_spread":0.27355239406952864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953525,0.00064895995,0.00087762624,0.00013423213,0.00006406956,0.000059367616,0.0012600067,0.000085201726,0.0015180632],"genre_scores_gemma":[0.9923138,0.00039306845,0.0007398597,0.00007987719,0.000013260191,0.00009734165,0.0015245934,0.000029807277,0.004808373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982125,0.000029124545,0.000021266986,0.000038066617,0.000040999483,0.00004932547],"domain_scores_gemma":[0.999811,0.00002492871,0.000050542953,0.000021113487,0.000010777638,0.00008168651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117899304,0.00031885473,0.00030886795,0.00030969386,0.00014875917,0.00026143872,0.0002686101,0.0005118596,0.0021013343],"category_scores_gemma":[0.0001237699,0.00019243949,0.00028852254,0.00017958891,0.00027313983,0.00014493894,0.00016289786,0.0008858918,0.0006953626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004955834,0.00014342608,0.00020420017,0.000023841872,0.000004881751,0.0002584613,0.000012225503,0.000034785193,0.9978363,0.00010798919,0.00007323672,0.00080514577],"study_design_scores_gemma":[0.00009927725,0.0029233492,0.0074601336,0.000009075969,0.000022002536,0.0017971841,0.000047666912,0.00126705,0.9820753,0.00008024504,0.004211978,0.0000067540136],"about_ca_topic_score_codex":0.0009577076,"about_ca_topic_score_gemma":0.0011907677,"teacher_disagreement_score":0.0021013343,"about_ca_system_score_codex":0.0002923944,"about_ca_system_score_gemma":0.00024253833,"threshold_uncertainty_score":0.0070296526},"labels":[],"label_agreement":null},{"id":"W4404237190","doi":"10.1093/neuonc/noae165.0375","title":"CTNI-07. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Central nervous system; Medicine; Term (time); Neuroscience; Internal medicine; Biology; Neurotrophin","score_opus":0.009264451921468471,"score_gpt":0.26307294993444813,"score_spread":0.25380849801297967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65965277,0.22347489,0.0031082218,0.0020976446,0.0003147258,0.0025394554,0.08288973,0.00043429923,0.025488364],"genre_scores_gemma":[0.8481945,0.05009496,0.0042828782,0.0025639487,0.00058743963,0.0016324266,0.08879234,0.00015183339,0.003699622],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9975228,0.0007734944,0.00035450896,0.000350244,0.0008371332,0.00016181094],"domain_scores_gemma":[0.99278355,0.0020380472,0.0034044331,0.00029988555,0.0010119632,0.00046204106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055718143,0.000684628,0.0020609382,0.0015779051,0.00024225385,0.0016606736,0.0012715535,0.00057172315,0.0033431593],"category_scores_gemma":[0.0052761156,0.00031749276,0.0032468475,0.003129858,0.00039207746,0.0010717512,0.0005139619,0.0014055227,0.00090789044],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.094841994,0.00092012447,0.34330145,0.01991365,0.040869217,0.0005973542,0.00029431473,0.006663523,0.01160959,0.0010677408,0.04110985,0.4388112],"study_design_scores_gemma":[0.02727848,0.02606823,0.7699639,0.0037652042,0.06758595,0.0039873035,0.00019604062,0.0063318945,0.005443323,0.0009943179,0.08808958,0.00029583444],"about_ca_topic_score_codex":0.002404249,"about_ca_topic_score_gemma":0.00742915,"teacher_disagreement_score":0.0055718143,"about_ca_system_score_codex":0.001983051,"about_ca_system_score_gemma":0.0017942965,"threshold_uncertainty_score":0.029466927},"labels":[],"label_agreement":null},{"id":"W4404237224","doi":"10.1093/neuonc/noae165.0307","title":"RADT-23. MOLECULAR PROFILING OF GLIOMAS: INSIGHTS INTO RADIONECROSIS AND PSEUDOPROGRESSION THROUGH NEXT-GENERATION SEQUENCING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Profiling (computer programming); Medicine; Computer science","score_opus":0.05263591488240864,"score_gpt":0.3246426146994567,"score_spread":0.27200669981704806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93121094,0.030809356,0.010758566,0.0008873181,0.0001352972,0.00024526814,0.019484628,0.00063945656,0.00582918],"genre_scores_gemma":[0.9590478,0.0067841155,0.018584237,0.00046524938,0.000059148468,0.00017474627,0.011316633,0.000098060045,0.0034700402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943453,0.000118219665,0.00007462124,0.00015979294,0.00015993381,0.00005298695],"domain_scores_gemma":[0.9992112,0.00018725275,0.0003118774,0.000055895536,0.00017119781,0.000062653606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009528779,0.00031877906,0.00045314812,0.0018634178,0.00023161682,0.0010022593,0.0003609918,0.00044532432,0.0015448183],"category_scores_gemma":[0.0013970442,0.00016492305,0.0005015831,0.0014332564,0.000230856,0.0002195017,0.00027366634,0.00032634803,0.0008809705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010883441,0.00014720198,0.6193197,0.0013926799,0.0004891203,0.004081001,0.0004230114,0.0027944366,0.16438106,0.0007866995,0.0048374585,0.20025921],"study_design_scores_gemma":[0.00007697327,0.0007358306,0.7703762,0.00037681585,0.00079925806,0.016123405,0.0005277502,0.015112817,0.14333983,0.0013153839,0.05111117,0.000104563806],"about_ca_topic_score_codex":0.0027204459,"about_ca_topic_score_gemma":0.0037496132,"teacher_disagreement_score":0.0027204459,"about_ca_system_score_codex":0.0005867796,"about_ca_system_score_gemma":0.00054342824,"threshold_uncertainty_score":0.0054093003},"labels":[],"label_agreement":null},{"id":"W4404237229","doi":"10.1093/neuonc/noae165.0235","title":"STEM-09. A GROUP 3 MEDULLOBLASTOMA STEM CELL PROGRAM IS MAINTAINED BY OTX2-MEDIATED ALTERNATIVE SPLICING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Toronto; University of Manitoba","funders":"","keywords":"Medulloblastoma; Stem cell; RNA splicing; Group (periodic table); Biology; Alternative splicing; Cell biology; Genetics; Chemistry; Gene; Exon; RNA","score_opus":0.01256463644469216,"score_gpt":0.2906526383074274,"score_spread":0.27808800186273525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584139,0.0019945437,0.01736333,0.00028148614,0.00013432674,0.00009534362,0.011266045,0.0015952417,0.008855826],"genre_scores_gemma":[0.9702965,0.0006330814,0.006109768,0.00032468373,0.000025693134,0.00008076378,0.012765263,0.0003366459,0.009427653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980694,0.00000774897,0.0000077390005,0.00006562197,0.00007859001,0.00003341372],"domain_scores_gemma":[0.999856,0.000017910876,0.000052014355,0.000012382246,0.000020425934,0.00004130991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013906803,0.0002476724,0.00026644,0.00030071268,0.000325718,0.0006474032,0.00019491458,0.0002775397,0.0033226048],"category_scores_gemma":[0.00014523166,0.00018139387,0.00029100137,0.00029524634,0.0003108869,0.00019609625,0.00040050872,0.0005756552,0.0010757615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009917032,0.000012417191,0.0024353846,0.00007452866,0.000010556389,0.00012028161,0.00006950937,0.00014314396,0.989423,0.00074941077,0.00054825295,0.0063143536],"study_design_scores_gemma":[0.00004597839,0.00022856283,0.10753548,0.000045453824,0.00007041825,0.0009369145,0.00027766812,0.007377638,0.83969796,0.0011241885,0.042635098,0.000024731771],"about_ca_topic_score_codex":0.0010065784,"about_ca_topic_score_gemma":0.0019803331,"teacher_disagreement_score":0.0033226048,"about_ca_system_score_codex":0.0004087141,"about_ca_system_score_gemma":0.0003876025,"threshold_uncertainty_score":0.011115193},"labels":[],"label_agreement":null},{"id":"W4404237231","doi":"10.1093/neuonc/noae165.0909","title":"NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wild type; Mutant; Glioma; Biology; Cancer research; Genetics; Gene","score_opus":0.01978293145703199,"score_gpt":0.24633273726975163,"score_spread":0.22654980581271963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882406,0.00017327773,0.00008839018,0.000026932968,0.000009000926,0.0000075733624,0.0003443196,0.000009366189,0.00051701633],"genre_scores_gemma":[0.9990557,0.000043883734,0.00008556514,0.000017777702,0.0000048352626,0.000006121468,0.00042743928,0.0000023727916,0.00035632018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999043,0.000008397882,0.000009984551,0.000026546011,0.000022462307,0.000028391469],"domain_scores_gemma":[0.999622,0.000025383773,0.0001713381,0.00001636432,0.000039511247,0.0001252965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012697207,0.00034127175,0.00026255604,0.0005058496,0.0002534092,0.000384937,0.00020243398,0.0002596212,0.001940699],"category_scores_gemma":[0.0004279842,0.000097623386,0.0002227247,0.00034027148,0.00019594446,0.00011916417,0.0002112326,0.0003484793,0.00031526343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015312902,0.00011789667,0.97572154,0.000028392345,0.0000687204,0.0010177994,0.00005889391,0.000051691688,0.01716974,0.00005036354,0.00035868693,0.0038249388],"study_design_scores_gemma":[0.00001772046,0.00020344788,0.9951049,0.000005025942,0.000030686406,0.0023621828,0.0000880184,0.0001519075,0.0015621013,0.00005672553,0.0004135887,0.0000036127933],"about_ca_topic_score_codex":0.0027353235,"about_ca_topic_score_gemma":0.0023180742,"teacher_disagreement_score":0.0027353235,"about_ca_system_score_codex":0.0002875057,"about_ca_system_score_gemma":0.00019506777,"threshold_uncertainty_score":0.006492257},"labels":[],"label_agreement":null},{"id":"W4404237248","doi":"10.1093/neuonc/noae165.0684","title":"INNV-22. CEREBELLOPONTINE EPIDERMOID CYST TO SQUAMOUS CELL CARCINOMA: MALIGNANT TRANSFORMATION, LEPTOMENINGEAL CARCINOMATOSIS, AND MANAGEMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cerebellopontine angle; Basal cell; Epidermoid cyst; Epidermoid carcinoma; Malignant transformation; Pathology; Radiology; Magnetic resonance imaging","score_opus":0.014177353836299183,"score_gpt":0.27130949722804276,"score_spread":0.25713214339174356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8340542,0.09711325,0.0044875075,0.010245982,0.0008543107,0.00020850147,0.00021899938,0.00032890443,0.05248847],"genre_scores_gemma":[0.9851664,0.0094932625,0.0013894945,0.0010430262,0.00067528564,0.000022030381,0.00015003006,0.000019989417,0.0020405059],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99985397,0.00002315047,0.000022131704,0.000018069864,0.000039024806,0.000043618726],"domain_scores_gemma":[0.9997392,0.00005415442,0.00007297205,0.000014405902,0.000034792087,0.00008450999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018078937,0.00032534276,0.00030739355,0.00063758245,0.0007425592,0.0007726965,0.00046788275,0.0009789733,0.0008753613],"category_scores_gemma":[0.0010488959,0.00013107379,0.00025501128,0.0003823577,0.00045169733,0.00052325276,0.00034983756,0.0009573979,0.00043670184],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006150908,0.00007316578,0.053615205,0.00025779492,0.000020618194,0.8867223,0.00019059087,0.0003066732,0.0028122023,0.00068154477,0.0034713282,0.05178704],"study_design_scores_gemma":[0.000009805622,0.000065228916,0.012479054,0.00012672904,0.000017050745,0.97912943,0.00023345165,0.0004572887,0.0007575008,0.00062771846,0.006086252,0.000010457689],"about_ca_topic_score_codex":0.00093228504,"about_ca_topic_score_gemma":0.0017265584,"teacher_disagreement_score":0.0009789733,"about_ca_system_score_codex":0.0005525263,"about_ca_system_score_gemma":0.00064511015,"threshold_uncertainty_score":0.0040088296},"labels":[],"label_agreement":null},{"id":"W4404237266","doi":"10.1093/neuonc/noae165.0209","title":"CNSC-53. SHH ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cancer research; Medicine; Chemistry","score_opus":0.01016793389450418,"score_gpt":0.28793598823608246,"score_spread":0.2777680543415783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497956,0.0014787384,0.000723574,0.00008933502,0.000023912773,0.000044330114,0.0010983351,0.000082312625,0.0014798621],"genre_scores_gemma":[0.9949921,0.0006580225,0.0008406397,0.000048141334,0.000006491733,0.000058094287,0.001737374,0.0000105739055,0.001648549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987507,0.000011124553,0.000009973145,0.000025735715,0.00004529276,0.0000327341],"domain_scores_gemma":[0.9999044,0.000011589334,0.000021055774,0.000009810876,0.000014210766,0.000038864393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011861004,0.00023763935,0.00025847767,0.00029285278,0.00019128899,0.00025803718,0.00015223945,0.00018716887,0.00188706],"category_scores_gemma":[0.00009834367,0.00009122542,0.00021002244,0.00016672049,0.00020909651,0.00010463464,0.00014904456,0.00037769118,0.0004511214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000228802,0.000042294174,0.0018929013,0.00004577244,0.000005034909,0.000106515916,0.0000120431305,0.00007187377,0.9953975,0.00005100542,0.00012410362,0.0020221912],"study_design_scores_gemma":[0.000028142893,0.00045362685,0.04664546,0.000011341321,0.000019905585,0.00050128216,0.00005235788,0.0009732177,0.9486107,0.00004322989,0.0026564358,0.0000043160085],"about_ca_topic_score_codex":0.002338233,"about_ca_topic_score_gemma":0.0036358067,"teacher_disagreement_score":0.002338233,"about_ca_system_score_codex":0.0004217379,"about_ca_system_score_gemma":0.00039205168,"threshold_uncertainty_score":0.006312847},"labels":[],"label_agreement":null},{"id":"W4404237278","doi":"10.1093/neuonc/noae165.0144","title":"BIOM-72. INTEGRATION OF ULTRASENSITIVE ELECTROLUMINESCENT IMMUNOASSAY AND CELL-FREE DNAMETHYLATION ANALYSIS FOR NON-INVASIVE MONITORING OF ADULT DIFFUSE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Electroluminescence; Immunoassay; Medicine; Materials science; Nanotechnology; Immunology; Antibody","score_opus":0.008749751292167129,"score_gpt":0.28253661744148817,"score_spread":0.273786866149321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93088835,0.0016478073,0.064600185,0.00011099552,0.000037016627,0.00007637207,0.0010654985,0.0007423379,0.0008314119],"genre_scores_gemma":[0.9570061,0.0004511465,0.03988047,0.000048395526,0.000012843207,0.00010133226,0.00060625805,0.000020605046,0.0018727566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975854,0.00005197596,0.000013730044,0.00007791727,0.00008029056,0.000017586737],"domain_scores_gemma":[0.99987006,0.000034678273,0.000042609514,0.000010460908,0.000029789442,0.000012448418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047727936,0.000454492,0.00025758095,0.00053603493,0.00009736085,0.00033051206,0.00018099825,0.00031563305,0.00045776714],"category_scores_gemma":[0.00051107735,0.0001999042,0.0002754193,0.00029760838,0.00012628597,0.00012790337,0.00018954978,0.00024985019,0.0003294588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044042605,0.00011182678,0.01887161,0.00009035262,0.00006961212,0.00010702251,0.000058651665,0.0016636777,0.93550885,0.00010596073,0.0001970374,0.04277509],"study_design_scores_gemma":[0.000026039532,0.00074500387,0.06815847,0.000012738064,0.00011149169,0.00054633984,0.000045157045,0.05529082,0.87307787,0.00015744276,0.0017948207,0.00003385485],"about_ca_topic_score_codex":0.00103315,"about_ca_topic_score_gemma":0.0018790737,"teacher_disagreement_score":0.00103315,"about_ca_system_score_codex":0.00022850973,"about_ca_system_score_gemma":0.00022312388,"threshold_uncertainty_score":0.0025241375},"labels":[],"label_agreement":null},{"id":"W4404237283","doi":"10.1093/neuonc/noae165.1191","title":"TMIC-13. INTEGRATING SNRNASEQ AND SPATIAL TRANSCRIPTOME (ST) SHOWS DIVERSE TRANSCRIPTOMIC LANDSCAPE FOR TUMOR MICROENVIRONMENT (TME) IN INTRACRANIAL GERMINOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Transcriptome; Tumor microenvironment; Biology; Computational biology; Evolutionary biology; Cancer research; Gene; Genetics; Tumor cells; Gene expression","score_opus":0.01602132791858902,"score_gpt":0.2706089686518943,"score_spread":0.2545876407333053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90383655,0.0009457678,0.025442824,0.0002277247,0.00013505784,0.00019237484,0.062104985,0.0025916297,0.0045231767],"genre_scores_gemma":[0.7616624,0.0005892716,0.0633237,0.0004695274,0.000049475886,0.00059787574,0.16724345,0.0011703016,0.0048939902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995859,0.00003439463,0.000036548387,0.00015964014,0.00010239159,0.000081087295],"domain_scores_gemma":[0.9997366,0.00007517459,0.000035602534,0.000041634772,0.000076846554,0.00003408816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005509085,0.0004302334,0.00045444455,0.00057518354,0.00052244763,0.0006755618,0.00030136935,0.0004014332,0.0032592057],"category_scores_gemma":[0.00066014536,0.00033179478,0.0005753074,0.000786957,0.00024736396,0.00019680579,0.0004950131,0.00041155572,0.0010492272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015025516,0.00010057899,0.057207245,0.0006186572,0.0002069948,0.0006992881,0.0007192157,0.002720666,0.8948814,0.0005468305,0.0081677325,0.03262888],"study_design_scores_gemma":[0.0001585397,0.00080674235,0.37682906,0.00016131732,0.00053777924,0.0025355418,0.000999853,0.035645947,0.52303994,0.0007249839,0.058436938,0.00012325261],"about_ca_topic_score_codex":0.0023143587,"about_ca_topic_score_gemma":0.005734794,"teacher_disagreement_score":0.0032592057,"about_ca_system_score_codex":0.0003642447,"about_ca_system_score_gemma":0.00061624136,"threshold_uncertainty_score":0.01090312},"labels":[],"label_agreement":null},{"id":"W4404237303","doi":"10.1093/neuonc/noae165.1033","title":"QLTI-19. PEDIATRIC NEURO-ONCOLOGISTS NAVIGATING AN ADULT WORLD: A TALE OF TWO CENTERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.03230364447811652,"score_gpt":0.3779923748733064,"score_spread":0.3456887303951899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237303","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1887625,0.009913541,0.0060509853,0.62112135,0.013065907,0.00096779485,0.0026883432,0.001852276,0.15557729],"genre_scores_gemma":[0.5768196,0.014685035,0.06813876,0.22443894,0.0068087294,0.0028710677,0.006299385,0.0017085822,0.09822992],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9938233,0.0022325371,0.000366957,0.00051985227,0.0013535735,0.0017037987],"domain_scores_gemma":[0.96897763,0.0017004064,0.001648169,0.00061815005,0.0035223665,0.023533313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080041075,0.00045471214,0.00033592372,0.0012332445,0.006915005,0.0063751377,0.0020861123,0.0018062914,0.021816332],"category_scores_gemma":[0.010568244,0.0005938502,0.0005070959,0.0016338269,0.002412673,0.0040034805,0.008922938,0.00640434,0.0042908597],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014380508,0.00067799434,0.09615446,0.00030712812,0.000043038046,0.0011987671,0.014112035,0.00020147198,0.00081788906,0.0055117584,0.60336965,0.27746195],"study_design_scores_gemma":[0.00015781344,0.00070988596,0.11581511,0.0017579668,0.00005155168,0.0025681132,0.068577036,0.0005645979,0.00056721916,0.004003948,0.8050813,0.00014545016],"about_ca_topic_score_codex":0.014979697,"about_ca_topic_score_gemma":0.05771382,"teacher_disagreement_score":0.021816332,"about_ca_system_score_codex":0.0067859073,"about_ca_system_score_gemma":0.020348448,"threshold_uncertainty_score":0.07298297},"labels":[],"label_agreement":null},{"id":"W4404237307","doi":"10.1093/neuonc/noae165.0406","title":"CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Computer science; Oncology; Internal medicine; Cancer research; Software engineering","score_opus":0.044634207610980435,"score_gpt":0.36553796943474026,"score_spread":0.32090376182375985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43965718,0.25402677,0.032124832,0.080984786,0.010085709,0.028479353,0.049951416,0.0036897147,0.101000324],"genre_scores_gemma":[0.6080949,0.12849888,0.06917911,0.067897335,0.0046824003,0.04513201,0.043430485,0.0017423677,0.03134256],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979582,0.0012946345,0.000141813,0.00016994464,0.00029765404,0.00013771439],"domain_scores_gemma":[0.9963702,0.0013552363,0.0005954187,0.0002618357,0.0005636047,0.0008537311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008167558,0.0011750562,0.0022152027,0.0007203295,0.00040413073,0.0017389836,0.0012316621,0.0015179494,0.0056967866],"category_scores_gemma":[0.0076669627,0.00030072097,0.0026662138,0.0010095764,0.00059238094,0.0014193497,0.00084581546,0.0047239214,0.0014583174],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11123262,0.0031987466,0.0029281615,0.0055236286,0.003487191,0.00026371895,0.00025858686,0.0049295435,0.008243144,0.0037362217,0.116244055,0.7399544],"study_design_scores_gemma":[0.48917815,0.118848026,0.023839768,0.006545557,0.006325848,0.0010697034,0.00020661874,0.005384611,0.006140611,0.011548323,0.33062086,0.00029194605],"about_ca_topic_score_codex":0.0013763903,"about_ca_topic_score_gemma":0.0052611344,"teacher_disagreement_score":0.008167558,"about_ca_system_score_codex":0.0014055556,"about_ca_system_score_gemma":0.0024331862,"threshold_uncertainty_score":0.04319471},"labels":[],"label_agreement":null},{"id":"W4404237320","doi":"10.1093/neuonc/noae165.0027","title":"EPCO-28. UNVEILING INVASIVE MECHANISMS OF GLIOBLASTOMA CELLS THROUGH MULTIMODAL SINGLE-CELL SEQUENCING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Neuroscience; Biology; Cancer research","score_opus":0.016842466162759882,"score_gpt":0.257278388518656,"score_spread":0.2404359223558961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212125,0.0013272018,0.06459771,0.00018343939,0.00009554623,0.0002072787,0.006525932,0.0008528385,0.0049976804],"genre_scores_gemma":[0.91672426,0.00081012683,0.06374849,0.00026112748,0.000020466508,0.00041816567,0.010936755,0.00037881415,0.006701849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978226,0.000016559854,0.000016215712,0.00007474794,0.00007216808,0.00003796522],"domain_scores_gemma":[0.9997526,0.000040566287,0.00004295553,0.0000289025,0.00009925126,0.000035805155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039242787,0.00030025086,0.00034979757,0.0003623957,0.00032117218,0.00043234703,0.0002458411,0.0003828477,0.0013590786],"category_scores_gemma":[0.00038951883,0.00017965109,0.00028616682,0.0002807945,0.0002734822,0.00020868938,0.00035740054,0.000438778,0.00073288113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080330705,0.000019886145,0.0016602793,0.00007136603,0.000009303691,0.000054989938,0.00004923328,0.0005855896,0.9893869,0.00028192208,0.00031363344,0.0074865953],"study_design_scores_gemma":[0.000018760606,0.00027286305,0.023126408,0.000024007288,0.00004889287,0.00030772996,0.00009480508,0.026242768,0.93747336,0.0004897438,0.011877757,0.0000230218],"about_ca_topic_score_codex":0.001489221,"about_ca_topic_score_gemma":0.0031043917,"teacher_disagreement_score":0.001489221,"about_ca_system_score_codex":0.0003204024,"about_ca_system_score_gemma":0.00036828863,"threshold_uncertainty_score":0.0045465827},"labels":[],"label_agreement":null},{"id":"W4404237342","doi":"10.1093/neuonc/noae165.0308","title":"RADT-24. WALLERIAN DEGENERATION OF THE CORTICOSPINAL TRACT IN GLIOMAS: A RETROSPECTIVE ANALYSIS AND A SYSTEMATIC REVIEW OF MOTOR FUNCTION IN ELOQUENT AREAS POST-RADIATION THERAPY. HOW IMPORTANT IS MOTOR FUNCTION FOR PATIENTS WITH GLIOMAS IN RADIATION THERAPY?","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Corticospinal tract; Wallerian degeneration; Motor function; Medicine; Physical medicine and rehabilitation; Neuroscience; Magnetic resonance imaging; Anatomy; Psychology; Radiology","score_opus":0.017728065537044223,"score_gpt":0.28856885068861193,"score_spread":0.27084078515156773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007924191,0.987211,0.00020158506,0.00022673293,0.00009872183,0.0006586024,0.0032557787,0.000013639726,0.00040975315],"genre_scores_gemma":[0.067649856,0.9253985,0.0012495344,0.0006074333,0.00013334965,0.002156153,0.002487298,0.000018330866,0.00029956526],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99072707,0.0015815307,0.005570754,0.0007317625,0.0011677385,0.00022124485],"domain_scores_gemma":[0.97482353,0.013118889,0.008898786,0.00048739006,0.002330195,0.00034118793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066405563,0.0013158189,0.007257622,0.023868645,0.0006851439,0.0024053578,0.0015797745,0.0013282956,0.0036852676],"category_scores_gemma":[0.023932153,0.000806071,0.0072377953,0.022707053,0.00095892843,0.0019230063,0.0013592959,0.00062765565,0.0003979063],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029459363,0.000016715876,0.0060949572,0.9649112,0.010297701,0.00033963964,0.00021848809,0.00006466496,0.00036935063,0.00013295012,0.00095388055,0.016305959],"study_design_scores_gemma":[0.0004572708,0.00053190434,0.037551925,0.7832837,0.15769035,0.002149946,0.0007251059,0.00012982784,0.00055978616,0.00026219315,0.016579235,0.00007892327],"about_ca_topic_score_codex":0.005392966,"about_ca_topic_score_gemma":0.015084348,"teacher_disagreement_score":0.023868645,"about_ca_system_score_codex":0.0023682783,"about_ca_system_score_gemma":0.00695503,"threshold_uncertainty_score":0.035118997},"labels":[],"label_agreement":null},{"id":"W4404237353","doi":"10.1093/neuonc/noae165.1299","title":"TMOD-35. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO SPONTANEOUS GLIOMAGENESIS IN A NOVEL MOUSE MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"CDKN2A; Cancer research; Cell biology; Biology; Chemistry; Genetics; Gene","score_opus":0.018662322432263994,"score_gpt":0.300250370571499,"score_spread":0.281588048139235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610191,0.002323027,0.020205915,0.00067549804,0.00019380706,0.0005356587,0.0065240436,0.0017403489,0.0067824987],"genre_scores_gemma":[0.94534314,0.0026950599,0.017626345,0.00019932796,0.00003555661,0.0008606752,0.0052548037,0.0003359676,0.027649123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995009,0.00006575327,0.00005820869,0.00012310024,0.00015278855,0.000099232886],"domain_scores_gemma":[0.9997148,0.00002942737,0.00009150942,0.000047998907,0.000021261658,0.00009507791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041724855,0.0011996021,0.000432114,0.0018114892,0.00045689003,0.0006211459,0.0007683881,0.00097418635,0.00341544],"category_scores_gemma":[0.000110506815,0.0005663902,0.000720713,0.00054900046,0.00074231444,0.0004292981,0.00041118453,0.0015994848,0.0017891737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015538101,0.00018298863,0.00013474644,0.000040491683,0.00001145705,0.00018659153,0.000032066644,0.00012235712,0.99716526,0.0006777865,0.00020176762,0.001089153],"study_design_scores_gemma":[0.00013152549,0.0008814732,0.0019974343,0.00002486952,0.000037174086,0.0011143722,0.00005020414,0.0014836079,0.98499715,0.0002822119,0.0089872675,0.000012702557],"about_ca_topic_score_codex":0.0013865636,"about_ca_topic_score_gemma":0.0024453646,"teacher_disagreement_score":0.00341544,"about_ca_system_score_codex":0.0008154844,"about_ca_system_score_gemma":0.00046778156,"threshold_uncertainty_score":0.011425793},"labels":[],"label_agreement":null},{"id":"W4404237401","doi":"10.1093/neuonc/noae165.0381","title":"CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Glioma; Oncology","score_opus":0.029446798593411656,"score_gpt":0.3416222584285629,"score_spread":0.31217545983515127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97567093,0.01702148,0.00039831988,0.0007808314,0.00043371023,0.0008497669,0.0014534935,0.000090618974,0.0033008642],"genre_scores_gemma":[0.9903938,0.0034528826,0.0005257942,0.0006863159,0.00018821453,0.00046247724,0.0016599906,0.000028417498,0.0026020387],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99935263,0.0003877962,0.000037557293,0.000082086044,0.000049861395,0.00009009475],"domain_scores_gemma":[0.9992873,0.00016424191,0.00023547308,0.000052489362,0.000032956068,0.00022752793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023592487,0.00086844177,0.0018732589,0.00044119803,0.0002496499,0.0008811337,0.0007589228,0.00082524144,0.0028531947],"category_scores_gemma":[0.001369977,0.00034924046,0.0023250708,0.00045240618,0.0005418724,0.00054324203,0.00033064064,0.0018940568,0.00060863345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91958296,0.003273133,0.0049751517,0.00091673486,0.0033247136,0.00005851939,0.00007348998,0.0014878897,0.0027423748,0.00019073159,0.0019603355,0.061414],"study_design_scores_gemma":[0.53347105,0.3875465,0.058775425,0.00036521212,0.007947276,0.00029113347,0.00014767116,0.002858576,0.0025454056,0.001051485,0.004940038,0.000060160208],"about_ca_topic_score_codex":0.0019290724,"about_ca_topic_score_gemma":0.008546395,"teacher_disagreement_score":0.0028531947,"about_ca_system_score_codex":0.0015830819,"about_ca_system_score_gemma":0.0011218837,"threshold_uncertainty_score":0.0124771},"labels":[],"label_agreement":null},{"id":"W4404237411","doi":"10.1093/neuonc/noae165.0678","title":"INNV-15. A PIVOTAL, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR PLASMA-BASED LIQUID BIOPSY IN PATIENTS WITH GLIOBLASTOMA (LIBERATE)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Focused ultrasound; Blood–brain barrier; Liquid biopsy; Medicine; Biopsy; Ultrasound; Brain biopsy; Multicenter trial; Multicenter study; Radiology; Pathology; Internal medicine; Cancer research; Randomized controlled trial; Central nervous system; Cancer","score_opus":0.007935530442875571,"score_gpt":0.2828799126506333,"score_spread":0.2749443822077577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754937,0.0130711915,0.0010032214,0.001621443,0.0005055745,0.0032937138,0.0021277315,0.00013314965,0.0027501667],"genre_scores_gemma":[0.9810358,0.0036924956,0.002550213,0.0022881879,0.00034806697,0.004198155,0.0032814418,0.000033849923,0.0025718028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99921954,0.00043632786,0.00004536164,0.00013426093,0.00004543342,0.00011913181],"domain_scores_gemma":[0.9990711,0.00017184163,0.00024007048,0.00006310045,0.00007445318,0.00037937675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026323525,0.0012500463,0.0017064956,0.00028914018,0.0003341594,0.0011556756,0.0006726005,0.0010905509,0.003578041],"category_scores_gemma":[0.0013774139,0.00036818226,0.0014556859,0.00031947333,0.00071662467,0.0007181519,0.0005097963,0.001987655,0.0006981605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9228818,0.0073537077,0.0038610273,0.0012321993,0.0017764638,0.000071099836,0.00010387523,0.0005416666,0.007848025,0.0004089301,0.0027210123,0.051200267],"study_design_scores_gemma":[0.73043954,0.25124425,0.008889947,0.00015876946,0.0013055318,0.00015132746,0.00005430091,0.0006803339,0.002316399,0.000550087,0.004177698,0.00003178752],"about_ca_topic_score_codex":0.00065685785,"about_ca_topic_score_gemma":0.0018402473,"teacher_disagreement_score":0.003578041,"about_ca_system_score_codex":0.00083901646,"about_ca_system_score_gemma":0.0015233562,"threshold_uncertainty_score":0.01392138},"labels":[],"label_agreement":null},{"id":"W4404237499","doi":"10.1093/neuonc/noae165.1079","title":"RTID-03. A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Internal medicine; Oncology; Blood–brain barrier; Cancer; Immunotherapy; Central nervous system","score_opus":0.011956561376987723,"score_gpt":0.286510960461027,"score_spread":0.2745543990840392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509463,0.014390224,0.0017783268,0.0021698056,0.0022116327,0.016285814,0.00629764,0.0005301008,0.005390149],"genre_scores_gemma":[0.9610196,0.0033251543,0.00397613,0.002480657,0.00090673874,0.020070413,0.002829647,0.00005484195,0.0053367293],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987374,0.00071614387,0.0001084905,0.000220925,0.00007439956,0.0001426784],"domain_scores_gemma":[0.99888223,0.00026189294,0.00032807505,0.000092252594,0.00011510907,0.0003204034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025137379,0.0019600808,0.00314056,0.00047901794,0.0005330962,0.0014674028,0.0012768972,0.0018349121,0.010706529],"category_scores_gemma":[0.0028955552,0.0007697429,0.0023741259,0.00053107616,0.0009863277,0.001198669,0.0005105574,0.0031526948,0.0013446516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.983124,0.0033281527,0.0003631387,0.0010933186,0.0014753089,0.000021766245,0.000026050586,0.00016420789,0.0015660522,0.00016223801,0.001093142,0.0075826137],"study_design_scores_gemma":[0.97746074,0.020637192,0.00044146154,0.000030278175,0.00053943775,0.000013765164,0.000010231206,0.00018710832,0.00016546743,0.00008542931,0.00042177876,0.000007235161],"about_ca_topic_score_codex":0.0014082206,"about_ca_topic_score_gemma":0.002920492,"teacher_disagreement_score":0.010706529,"about_ca_system_score_codex":0.0010898177,"about_ca_system_score_gemma":0.0016785781,"threshold_uncertainty_score":0.03581685},"labels":[],"label_agreement":null},{"id":"W4404237571","doi":"10.1093/neuonc/noae165.0563","title":"EPID-27. THE INCIDENCE OF BRAIN METASTASIS IN GASTROINTESTINAL CANCER ACCORDING TO PRIMARY SITE AND STAGE: A 15-YEAR SINGLE INSTITUTIONAL ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Princess Margaret Cancer Centre","funders":"","keywords":"Stage (stratigraphy); Incidence (geometry); Brain metastasis; Cancer; Medicine; Metastasis; Gastrointestinal cancer; Oncology; Internal medicine; Colorectal cancer; Biology","score_opus":0.03285760923445909,"score_gpt":0.3376853058823464,"score_spread":0.30482769664788734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825654,0.00032764045,0.00028726694,0.00003694602,0.000009932892,0.000044662796,0.01581055,0.000025311101,0.0008922526],"genre_scores_gemma":[0.98793155,0.00011860978,0.00019033489,0.00002400609,0.000010864473,0.000062595245,0.011333513,0.000009041234,0.0003194579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910825,0.00019714181,0.00019849124,0.0002358057,0.00014169021,0.000118506905],"domain_scores_gemma":[0.99709153,0.00033660437,0.0016405053,0.00024845178,0.0003682842,0.00031461898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012022549,0.00028993769,0.00038671834,0.002311312,0.00026726615,0.00069666276,0.00062469946,0.00029329397,0.0023914876],"category_scores_gemma":[0.0025895995,0.00030139807,0.0012480399,0.0026750495,0.00017207518,0.0005295032,0.0008767692,0.00048893,0.0005774931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017967314,0.000015536822,0.9982652,0.000021652831,0.00015713047,0.000032821947,0.00002031825,0.000095375464,0.00004868158,0.000013585786,0.00041168008,0.00073836895],"study_design_scores_gemma":[0.000013316052,0.00008018867,0.9989452,0.000006071578,0.000067115776,0.00011006802,0.00006735982,0.00036672878,0.000043814365,0.000014528416,0.0002819631,0.0000037135167],"about_ca_topic_score_codex":0.008568042,"about_ca_topic_score_gemma":0.0063329446,"teacher_disagreement_score":0.008568042,"about_ca_system_score_codex":0.0005659398,"about_ca_system_score_gemma":0.00039968584,"threshold_uncertainty_score":0.017036378},"labels":[],"label_agreement":null},{"id":"W4404237574","doi":"10.1093/neuonc/noae165.0566","title":"EPID-30. THE COST OF HOSPITAL-BASED CARE AMONG CANADIAN PATIENTS WITH MALIGNANT CENTRAL NERVOUS SYSTEM TUMOURS IN COMPARISON TO THOSE WITH LUNG AND COLORECTAL CANCERS IN THE YEAR PRECEDING THEIR CANCER DIAGNOSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; Lung; Lung cancer; Central nervous system; Internal medicine; Cancer","score_opus":0.013385779181110757,"score_gpt":0.23594317967590042,"score_spread":0.22255740049478967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237574","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4761574,0.0027932308,0.00049958105,0.0018071433,0.00008408698,0.00014269358,0.50343317,0.0001409033,0.014941772],"genre_scores_gemma":[0.8604036,0.0012123194,0.00072475517,0.00030570172,0.000032607433,0.00007308767,0.13365741,0.000025545687,0.0035649897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999052,0.000052847445,0.0000903076,0.00013577777,0.0003717507,0.00029745506],"domain_scores_gemma":[0.9974216,0.00012462976,0.00068626826,0.000060977374,0.0012798812,0.00042660933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047462934,0.00035821972,0.00041390755,0.0020705587,0.00090809545,0.0010965745,0.0011680317,0.00030211644,0.0070394394],"category_scores_gemma":[0.0043914667,0.0002496323,0.0010787299,0.0059894156,0.00029199352,0.0004000783,0.0006943545,0.0007249695,0.00060457224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001810429,0.00002712761,0.96667707,0.0002983441,0.0002825134,0.00006580794,0.00015357879,0.0010601595,0.00008478838,0.0005230612,0.022250315,0.008396256],"study_design_scores_gemma":[0.000017139286,0.000013780921,0.9928048,0.00006960476,0.000055719607,0.000072253286,0.00022569907,0.00092661835,0.000056262277,0.00006464173,0.005677606,0.00001592554],"about_ca_topic_score_codex":0.9892396,"about_ca_topic_score_gemma":0.9908202,"teacher_disagreement_score":0.032969844,"about_ca_system_score_codex":0.032969844,"about_ca_system_score_gemma":0.024712177,"threshold_uncertainty_score":0.23921412},"labels":[],"label_agreement":null},{"id":"W4404237580","doi":"10.1093/neuonc/noae165.0324","title":"RADT-40. EVALUATION OF SMALLER CLINICAL TARGET VOLUMES AND PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TO INFORM FUTURE DIRECTIONS IN RADIATION TREATMENT PLANNING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Glioblastoma; Radiation treatment planning; Medicine; Radiation therapy; Radiation oncology; Medical physics; Oncology; Internal medicine; Cancer research","score_opus":0.027465133829638645,"score_gpt":0.36281263169263633,"score_spread":0.33534749786299767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977502,0.0004914344,0.00032197812,0.000043753604,0.0000037681382,0.000022720946,0.0004888824,0.00001725233,0.0008599539],"genre_scores_gemma":[0.99829596,0.00014604903,0.0007513627,0.000019080611,0.0000037581553,0.000024851846,0.00045908926,0.000005293741,0.0002945189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988663,0.000026687538,0.000018334047,0.000025470039,0.000022279162,0.000020545147],"domain_scores_gemma":[0.99966383,0.000044676435,0.00016123209,0.000012868212,0.000045099725,0.000072334675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042855207,0.00018452962,0.00026754683,0.00060097873,0.00014890022,0.00031751455,0.00023386006,0.00017923328,0.0014992094],"category_scores_gemma":[0.0006702534,0.000094943774,0.00018744018,0.00041850755,0.00015658635,0.00022750364,0.00017696994,0.00014436033,0.00031998512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029929905,0.000017480776,0.98930955,0.000026092646,0.000011710859,0.0004589215,0.00004242786,0.00021306223,0.0017886687,0.00002296361,0.00021572015,0.0075940997],"study_design_scores_gemma":[0.000016183827,0.00030269113,0.9941729,0.000009826947,0.000019280802,0.0025482147,0.000101072656,0.00074248883,0.0013476046,0.000060017468,0.000674912,0.0000047609637],"about_ca_topic_score_codex":0.0027939302,"about_ca_topic_score_gemma":0.0073202,"teacher_disagreement_score":0.0027939302,"about_ca_system_score_codex":0.00043891894,"about_ca_system_score_gemma":0.0003134712,"threshold_uncertainty_score":0.005555272},"labels":[],"label_agreement":null},{"id":"W4404237582","doi":"10.1093/neuonc/noae165.0033","title":"EPCO-34. DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA BY INTEGRATIVE SINGLE-CELL GENOMICS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Glioblastoma; Biology; Computational biology; Neuroscience; Evolutionary biology; Cancer research","score_opus":0.016061784743276332,"score_gpt":0.2519497478516496,"score_spread":0.23588796310837326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415667,0.0009054512,0.03467502,0.00019843326,0.00003480904,0.00007098951,0.02026779,0.0005330843,0.0017476464],"genre_scores_gemma":[0.9541116,0.00044588436,0.02240309,0.00013662975,0.00001868454,0.0001781405,0.021166181,0.00024665205,0.0012932231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980325,0.000024618337,0.000011187309,0.00007887437,0.000042779666,0.00003926907],"domain_scores_gemma":[0.9997476,0.00006273502,0.00004785997,0.000042862262,0.00006498858,0.000033953307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620423,0.00022833027,0.00049158244,0.0005218464,0.0002794269,0.000673713,0.00022508431,0.00026050615,0.0013017216],"category_scores_gemma":[0.00059241714,0.00018000226,0.00035414522,0.00065801665,0.00023436431,0.00024129881,0.00040584026,0.00038744972,0.000730715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043062805,0.000052791118,0.0788808,0.00025307958,0.00013400904,0.0001827086,0.00028219307,0.004811947,0.8763672,0.0012413946,0.0017926092,0.035570584],"study_design_scores_gemma":[0.0000392697,0.00038651167,0.6409409,0.00006823378,0.00023855243,0.00086351624,0.0005009609,0.050791536,0.2763574,0.0033699244,0.026357431,0.00008567579],"about_ca_topic_score_codex":0.0023249316,"about_ca_topic_score_gemma":0.0053206757,"teacher_disagreement_score":0.0023249316,"about_ca_system_score_codex":0.0003583847,"about_ca_system_score_gemma":0.0004888659,"threshold_uncertainty_score":0.004622817},"labels":[],"label_agreement":null},{"id":"W4404237602","doi":"10.1093/neuonc/noae165.0081","title":"BIOM-08. LEVERAGING CSF PROTEOMICS TO OPTIMIZE CNS LYMPHOMA MANAGEMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteomics; Lymphoma; Computational biology; Computer science; Medicine; Immunology; Biology; Gene; Genetics","score_opus":0.026041957325661006,"score_gpt":0.30502791185521955,"score_spread":0.27898595452955854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9347558,0.021799337,0.018733684,0.0057751806,0.00031942752,0.00047791615,0.0037535047,0.0014282393,0.012956786],"genre_scores_gemma":[0.95136225,0.006948912,0.030943234,0.0013429221,0.0001732175,0.00034156934,0.0040099686,0.0001168547,0.0047611315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998204,0.00004809118,0.00001586399,0.00004118104,0.0000448816,0.000029574761],"domain_scores_gemma":[0.99971944,0.00003648007,0.00010251618,0.000015806816,0.00006183557,0.00006387338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064350467,0.00035557285,0.0003598234,0.00050444703,0.0002431524,0.0011088485,0.00041214304,0.0004294835,0.002816072],"category_scores_gemma":[0.0006403936,0.00015337742,0.0002740899,0.0004328262,0.00022004756,0.00044039966,0.000672998,0.00044706865,0.0017185892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00355559,0.0008004695,0.11964355,0.0012356624,0.00022398321,0.0010235573,0.00026349546,0.0032791966,0.3375946,0.001254063,0.017655034,0.51347077],"study_design_scores_gemma":[0.0007995392,0.0073601822,0.33659932,0.0008981925,0.0006380072,0.010163998,0.000973228,0.025738358,0.4478878,0.0045235255,0.16429475,0.0001231255],"about_ca_topic_score_codex":0.0008839159,"about_ca_topic_score_gemma":0.0014280906,"teacher_disagreement_score":0.002816072,"about_ca_system_score_codex":0.0007006317,"about_ca_system_score_gemma":0.00093650405,"threshold_uncertainty_score":0.0094207525},"labels":[],"label_agreement":null},{"id":"W4404237684","doi":"10.1093/neuonc/noae165.0848","title":"NIMG-84. BELZUTIFAN REDUCTION OF CEREBRAL BLOOD FLOW IN VHL-ASSOCIATED HEMANGIOBLASTOMA PREDICTS RESPONSE TO TREATMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cerebral blood flow; Reduction (mathematics); Medicine; Cardiology; Internal medicine; Mathematics","score_opus":0.010186188364043485,"score_gpt":0.2693476324826886,"score_spread":0.2591614441186451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844414,0.00024804397,0.00011330524,0.00002945265,0.000004289062,0.0000110506535,0.0002897211,0.000012474748,0.0008475211],"genre_scores_gemma":[0.9994024,0.000042446365,0.00007576696,0.000014043268,0.000004419787,0.000008198861,0.0002781335,0.0000025284357,0.0001720152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998425,0.00003305306,0.000011653583,0.000041647723,0.000042571297,0.000028508388],"domain_scores_gemma":[0.9995943,0.000069434136,0.00017585618,0.000020078322,0.00004690341,0.00009335029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026522702,0.00015075359,0.0002809809,0.0004088053,0.00016670284,0.00023889221,0.00015317355,0.0001817514,0.0015470035],"category_scores_gemma":[0.0008843965,0.000071751325,0.0001773485,0.00032400253,0.00014322026,0.00018002765,0.00012261177,0.00021960634,0.00024500315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015966836,0.00011287622,0.9844678,0.00001632113,0.000054629203,0.00026300707,0.000021982389,0.00012605167,0.005754632,0.000020136404,0.000288637,0.0072772596],"study_design_scores_gemma":[0.000019045849,0.00024545882,0.99777895,0.0000024287344,0.00002694803,0.00055270916,0.000017966468,0.00038902188,0.00072704646,0.00001698847,0.00022123435,0.0000022490049],"about_ca_topic_score_codex":0.0020343764,"about_ca_topic_score_gemma":0.002188316,"teacher_disagreement_score":0.0020343764,"about_ca_system_score_codex":0.00035436335,"about_ca_system_score_gemma":0.00015409352,"threshold_uncertainty_score":0.005175233},"labels":[],"label_agreement":null},{"id":"W4404237690","doi":"10.1093/neuonc/noae165.0420","title":"CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Glioma; Double blinded; Medicine; Internal medicine; IDH1; Troponin I; Oncology; Mutation; Pathology; Biology; Genetics; Cancer research; Myocardial infarction","score_opus":0.027410436379942817,"score_gpt":0.3456325533764556,"score_spread":0.31822211699651276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.914808,0.03303641,0.0026985547,0.0025747258,0.0011967063,0.020904863,0.011773101,0.0008370534,0.012170649],"genre_scores_gemma":[0.9591837,0.008212794,0.003999301,0.0031056227,0.00042948674,0.013606069,0.00559211,0.000089920155,0.005781065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99909127,0.00046964025,0.000058431953,0.00015087696,0.000088677465,0.00014101864],"domain_scores_gemma":[0.999331,0.000109431116,0.00021002891,0.000049946746,0.000064419895,0.00023512254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025949639,0.0016191925,0.0025387954,0.0006846299,0.00045509398,0.0013704286,0.0011728292,0.0014248203,0.0066418992],"category_scores_gemma":[0.0015243115,0.00066965166,0.002002283,0.00081640464,0.0011111108,0.00089263136,0.00034029843,0.002909557,0.0011277695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9259834,0.006555368,0.0013681935,0.0017535973,0.0020901253,0.000077848104,0.00009361491,0.0006525419,0.011397634,0.00034001033,0.0043168883,0.04537072],"study_design_scores_gemma":[0.9493582,0.0430241,0.002913538,0.000070388465,0.0010171817,0.000060411377,0.000018666959,0.00031770003,0.00090782664,0.00019025088,0.0020958516,0.000025871219],"about_ca_topic_score_codex":0.0013131178,"about_ca_topic_score_gemma":0.0063683963,"teacher_disagreement_score":0.0066418992,"about_ca_system_score_codex":0.001120555,"about_ca_system_score_gemma":0.0022323849,"threshold_uncertainty_score":0.02221936},"labels":[],"label_agreement":null},{"id":"W4404237702","doi":"10.1093/neuonc/noae165.0606","title":"IMMU-13. TRANS-SPECIES STUDY OF IDH-MUTANT REPLICATION-REPAIR DEFICIENT HIGH-GRADE GLIOMAS (RRD-HGG) AND RESPONSE TO COMBINED TARGETED AND IMMUNOTHERAPY: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Immunotherapy; Replication (statistics); Cancer research; Biology; Medicine; Immune system; Virology; Immunology; Genetics; Gene","score_opus":0.026173590907149172,"score_gpt":0.31945960694186926,"score_spread":0.2932860160347201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969999,0.0009502693,0.00029438233,0.00003072608,0.000009414146,0.000086356566,0.0007931953,0.000025831403,0.00080984225],"genre_scores_gemma":[0.995402,0.0004816022,0.00045506324,0.00004492789,0.000015092865,0.00006085465,0.0018679944,0.000016520858,0.001655983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996823,0.000071898736,0.000016401556,0.00009114179,0.000060310944,0.00007792143],"domain_scores_gemma":[0.9996289,0.000034158747,0.000086529464,0.000074747375,0.00003613785,0.000139565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007500727,0.00059642,0.0005730906,0.00070186297,0.00023640433,0.0003905415,0.00046859312,0.00046274648,0.0016708521],"category_scores_gemma":[0.00020258594,0.00023023391,0.0005138049,0.0003775751,0.000475125,0.00021639814,0.0002276119,0.0006681466,0.0005504789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019704418,0.00388451,0.050823294,0.0002691581,0.00027068693,0.0013430059,0.00028473913,0.00044616495,0.90782905,0.00016934535,0.00038364943,0.0145920655],"study_design_scores_gemma":[0.001607066,0.104716964,0.5673595,0.00003556707,0.0008456271,0.008249947,0.00065845856,0.0020960753,0.3061563,0.000132375,0.008087678,0.000054460317],"about_ca_topic_score_codex":0.0023693002,"about_ca_topic_score_gemma":0.0018589621,"teacher_disagreement_score":0.0023693002,"about_ca_system_score_codex":0.0007175988,"about_ca_system_score_gemma":0.00028371965,"threshold_uncertainty_score":0.005589485},"labels":[],"label_agreement":null},{"id":"W4404237720","doi":"10.1093/neuonc/noae165.1041","title":"QOL-06. OPTIMIZING NEUROFIBROMATOSIS CARE: A COMPREHENSIVE ECONOMIC EVALUATION OF A SPECIALIZED EXPERTISE CENTER’S IMPACT ON PATIENT OUTCOMES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Université de Montréal","funders":"","keywords":"Center (category theory); Neurofibromatosis; Medicine; Quality of life (healthcare); Gerontology; Nursing; Pathology","score_opus":0.05008768357515468,"score_gpt":0.3594361160678967,"score_spread":0.309348432492742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97499055,0.0021819533,0.0030246167,0.0016627548,0.000073708376,0.002680977,0.009446408,0.000056534227,0.005882477],"genre_scores_gemma":[0.99124604,0.00045269873,0.004237671,0.0001853787,0.000020491869,0.00090172834,0.002681568,0.000009287304,0.0002653364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958235,0.002785348,0.0002721745,0.00019190456,0.00052042335,0.00040659413],"domain_scores_gemma":[0.9938828,0.0024157567,0.0015608041,0.00023353314,0.00071575446,0.0011913786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0091584865,0.00055717997,0.0007395814,0.0010199657,0.00038043756,0.0015445299,0.0007767984,0.00056814525,0.0034320005],"category_scores_gemma":[0.018610993,0.00020948783,0.002609512,0.0017226032,0.0005031464,0.000662204,0.0013654344,0.0008167167,0.00021238171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04550654,0.01291004,0.4362507,0.003787207,0.010304827,0.00034045338,0.0004981447,0.16040127,0.0014187066,0.008713516,0.023937065,0.2959315],"study_design_scores_gemma":[0.011683936,0.048060037,0.67463374,0.0017227281,0.0053320527,0.00054032257,0.0014480862,0.23460075,0.0014894283,0.0029819862,0.017242903,0.00026397273],"about_ca_topic_score_codex":0.019552717,"about_ca_topic_score_gemma":0.019108688,"teacher_disagreement_score":0.019552717,"about_ca_system_score_codex":0.007954203,"about_ca_system_score_gemma":0.006301324,"threshold_uncertainty_score":0.05771202},"labels":[],"label_agreement":null},{"id":"W4404237730","doi":"10.1093/neuonc/noae165.0685","title":"INNV-23. UNDERSTANDING THE BURDEN OF MIDH1/2 DIFFUSE GLIOMA AND THE COMPLEXITY OF NAVIGATING THE PATIENT PATHWAY: INSIGHTS FROM PATIENTS AND CAREGIVERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brain Tumour Foundation of Canada","funders":"","keywords":"Glioma; Medicine; Psychology; Cancer research","score_opus":0.04093549528277272,"score_gpt":0.2766028338466548,"score_spread":0.23566733856388208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97435826,0.0018509695,0.0009554882,0.012101251,0.00017471952,0.000082289116,0.00020708346,0.000018350507,0.0102516],"genre_scores_gemma":[0.99554366,0.00072680746,0.00038598245,0.0017083072,0.00001961946,0.000067400266,0.000068354144,0.0000113291935,0.0014686522],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9948933,0.0039785267,0.00010134239,0.00014751432,0.00024697641,0.0006324682],"domain_scores_gemma":[0.9943558,0.002898388,0.0006754222,0.00014580537,0.000579338,0.0013453664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056246407,0.00037599576,0.0003979776,0.0004603726,0.0063460227,0.0034703952,0.0009561245,0.0008891624,0.0029080233],"category_scores_gemma":[0.009082003,0.00027051294,0.00034187746,0.00047636215,0.0031057734,0.002659912,0.004401713,0.0022369875,0.00031585852],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043276585,0.000051716015,0.021949401,0.00013803714,0.0000096549475,0.0010393191,0.959831,0.000057164,0.00025754765,0.0014038123,0.0046304762,0.010588714],"study_design_scores_gemma":[0.0000037066618,0.000035214343,0.003141768,0.00011359223,0.000004716563,0.00038196638,0.9840036,0.000064328335,0.00006166639,0.00040066207,0.0117767425,0.000011947349],"about_ca_topic_score_codex":0.019283473,"about_ca_topic_score_gemma":0.032166198,"teacher_disagreement_score":0.019283473,"about_ca_system_score_codex":0.0049269362,"about_ca_system_score_gemma":0.0047048074,"threshold_uncertainty_score":0.038342476},"labels":[],"label_agreement":null},{"id":"W4404237739","doi":"10.1093/neuonc/noae165.0444","title":"CTNI-77. PHASE 1 DOSE FINDING STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF IOPOFOSINE I 131 IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH INOPERABLE RELAPSED OR REFRACTORY HIGH-GRADE GLIOMAS: A TRIAL-IN-PROGRESS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Tolerability; Medicine; Refractory (planetary science); Oncology; Internal medicine; Adverse effect; Materials science","score_opus":0.03368687855500614,"score_gpt":0.36609094977179135,"score_spread":0.3324040712167852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794958,0.0047642183,0.000753669,0.000968297,0.00019583944,0.00459605,0.003176612,0.00025430255,0.0057951403],"genre_scores_gemma":[0.96480143,0.0067764786,0.0036037122,0.0019699258,0.00020883695,0.0063837105,0.0077571184,0.00011408636,0.008384745],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996561,0.00015224874,0.000012392504,0.000046520156,0.000041077546,0.00009161091],"domain_scores_gemma":[0.99939966,0.00007842311,0.00011344461,0.00003540448,0.000045073062,0.0003280732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012990916,0.0017670316,0.0017309389,0.000383497,0.00042652222,0.0012618575,0.0011597063,0.0014008938,0.0045900187],"category_scores_gemma":[0.0009712138,0.0006024052,0.0010541355,0.00041178547,0.0010114325,0.0007802266,0.0002957123,0.0035269193,0.0012831155],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6803008,0.059207693,0.0075441585,0.002001977,0.0021408405,0.000971628,0.0006620684,0.0046557263,0.08338025,0.0014071839,0.019194175,0.1385335],"study_design_scores_gemma":[0.58521616,0.3867561,0.007897099,0.00012891715,0.0006248087,0.0008594525,0.00013641566,0.0013373423,0.006506442,0.00035250932,0.010127063,0.00005771616],"about_ca_topic_score_codex":0.0048201215,"about_ca_topic_score_gemma":0.016515346,"teacher_disagreement_score":0.0048201215,"about_ca_system_score_codex":0.0018365347,"about_ca_system_score_gemma":0.0032456254,"threshold_uncertainty_score":0.01535511},"labels":[],"label_agreement":null},{"id":"W4404237749","doi":"10.1093/neuonc/noae165.0098","title":"BIOM-25. MOLECULAR PROFILING PREDICTS EARLY AND LATE PROGRESSION IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; St. Michael's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Glioblastoma; Profiling (computer programming); Cancer research; Computational biology; Oncology; Medicine; Biology; Computer science; Programming language","score_opus":0.013040131393637109,"score_gpt":0.30873377450495776,"score_spread":0.2956936431113206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969907,0.0007757578,0.00034333722,0.000055197946,0.000008982451,0.000016811062,0.0010080397,0.000031130174,0.0007700509],"genre_scores_gemma":[0.9972082,0.00020658334,0.00055865844,0.00002860364,0.0000059529966,0.000017342747,0.001239042,0.000006817325,0.00072879024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990654,0.000014511782,0.000011136908,0.00002212736,0.000021904487,0.000023809454],"domain_scores_gemma":[0.9997582,0.000033296943,0.00009319266,0.000013325516,0.000043701773,0.00005825472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029458277,0.0002586749,0.00033499353,0.000965496,0.00020349275,0.0005164197,0.0001535119,0.0002765133,0.0019969305],"category_scores_gemma":[0.0004996081,0.00012511946,0.00022779968,0.0004655793,0.00017180221,0.00018167534,0.0002313895,0.00026623992,0.00049160095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00248997,0.00013618683,0.8953679,0.00011585472,0.000100461555,0.0003009838,0.00007309479,0.00067341444,0.07677589,0.00009885717,0.0011292837,0.02273804],"study_design_scores_gemma":[0.000015520829,0.0003968924,0.98585737,0.000010139396,0.00006317951,0.0004354616,0.00008824837,0.0014918743,0.01055512,0.00012868182,0.0009473647,0.000010056864],"about_ca_topic_score_codex":0.0016703798,"about_ca_topic_score_gemma":0.0020717839,"teacher_disagreement_score":0.0019969305,"about_ca_system_score_codex":0.00037469005,"about_ca_system_score_gemma":0.0001748982,"threshold_uncertainty_score":0.006680429},"labels":[],"label_agreement":null},{"id":"W4404237753","doi":"10.1093/neuonc/noae165.1172","title":"TMET-34. PYROPTOSIS IS AN ACQUIRED VULNERABILITY OF BRAIN METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Discovery Centre","funders":"","keywords":"Pyroptosis; Vulnerability (computing); Neuroscience; Medicine; Computer science; Biology; Internal medicine; Computer security; Inflammation","score_opus":0.031098934585338245,"score_gpt":0.3408959726596121,"score_spread":0.30979703807427383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889733,0.002177683,0.0030174723,0.00039884628,0.00008493814,0.000064960834,0.0020861363,0.0002172238,0.0029793938],"genre_scores_gemma":[0.99416625,0.00070944324,0.0008592482,0.00012593278,0.00000821416,0.000046148038,0.0012181202,0.00002124038,0.0028455276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990296,0.000011362103,0.000005484219,0.000023850778,0.000030463336,0.000025872298],"domain_scores_gemma":[0.9999416,0.0000065885893,0.00001986154,0.0000035996018,0.000007507919,0.000020790194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000672876,0.0002559664,0.00020426973,0.00027351585,0.00014119832,0.00019514852,0.00012522415,0.0003057273,0.0029256039],"category_scores_gemma":[0.00009796899,0.00010412989,0.00023012966,0.0001949564,0.00018668962,0.00013704563,0.00015262856,0.0007704958,0.0004993561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031494175,0.000042722193,0.0004453521,0.000054779583,0.0000103297625,0.00027758203,0.000007768997,0.000101371144,0.9964824,0.00009682897,0.00022548155,0.00194041],"study_design_scores_gemma":[0.00006285613,0.0012749287,0.023086667,0.000015509038,0.00003458319,0.0038957645,0.00006637436,0.0015879642,0.96171963,0.00046030342,0.007781174,0.000014280689],"about_ca_topic_score_codex":0.0005596144,"about_ca_topic_score_gemma":0.0006005994,"teacher_disagreement_score":0.0029256039,"about_ca_system_score_codex":0.00028808028,"about_ca_system_score_gemma":0.00016861063,"threshold_uncertainty_score":0.009787142},"labels":[],"label_agreement":null},{"id":"W4404237783","doi":"10.1093/neuonc/noae165.0562","title":"EPID-26. STEREOTACTIC RADIOSURGERY FOR CRANIAL NERVE METASTASES: A SINGLE INSTITUTION EXPERIENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Radiosurgery; Medicine; Radiology; Medical physics; Radiation therapy","score_opus":0.05668305401001557,"score_gpt":0.3472880838732518,"score_spread":0.2906050298632362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996911,0.00056563225,0.00044774092,0.00010783617,0.0000114919,0.00006836512,0.00014487629,0.000029832405,0.0017131774],"genre_scores_gemma":[0.99684477,0.00087675446,0.00088671636,0.00012055081,0.000028659555,0.000048861293,0.00032448242,0.000026356078,0.0008430571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993498,0.0001656298,0.00007836328,0.00012089802,0.0001668795,0.000118368705],"domain_scores_gemma":[0.9991968,0.00014741278,0.00018219757,0.00007969163,0.00008189896,0.00031187054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008084841,0.00045739525,0.0003052683,0.0004928401,0.00053167867,0.0006545993,0.0004899248,0.00034093292,0.0022975784],"category_scores_gemma":[0.0018598966,0.000240469,0.00043483108,0.0007585222,0.0002666029,0.00036561757,0.00060677854,0.00041343647,0.0009883968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001151648,0.0065197563,0.79956925,0.00024331783,0.00021248581,0.015044987,0.0018649147,0.0012296475,0.011727036,0.0002075426,0.0021679301,0.16006142],"study_design_scores_gemma":[0.0006225788,0.020310001,0.89041156,0.00015007397,0.00021350897,0.063357614,0.0019727426,0.002597595,0.008358637,0.00016389735,0.011754535,0.00008731626],"about_ca_topic_score_codex":0.002338967,"about_ca_topic_score_gemma":0.004542954,"teacher_disagreement_score":0.002338967,"about_ca_system_score_codex":0.00067130884,"about_ca_system_score_gemma":0.000772423,"threshold_uncertainty_score":0.0076861978},"labels":[],"label_agreement":null},{"id":"W4404237802","doi":"10.1093/neuonc/noae165.0569","title":"EPID-33. EPITHELOID SARCOMA IN A LONG-TERM SURVIVOR OF AN ATYPICAL TERATOID / RHABDOID TUMOR WITH RHABDOID TUMOR PREDISPOSITION SYNDROME","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Sarcoma; Pathology; Medicine; Term (time); Immunohistochemistry; Astronomy","score_opus":0.008175095435983533,"score_gpt":0.27334286161396504,"score_spread":0.2651677661779815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592507,0.0005393246,0.00020819405,0.00078810524,0.00003762883,0.000029111547,0.0003440602,0.000022910488,0.0021055127],"genre_scores_gemma":[0.9980652,0.00023305418,0.00016705997,0.00024645965,0.000035118737,0.0000069417133,0.00019312894,0.0000054369293,0.0010477181],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997764,0.000020519661,0.000025431264,0.000068578294,0.000033178272,0.00007592308],"domain_scores_gemma":[0.9993051,0.000079188554,0.00016832478,0.00002906424,0.000059744336,0.0003585433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016871082,0.00045473574,0.000445834,0.0011025991,0.0015743544,0.00055732654,0.0003873594,0.0012085411,0.0021225095],"category_scores_gemma":[0.0007699567,0.00028776514,0.00048506542,0.0006505675,0.00047911677,0.0006273094,0.0005904484,0.001478585,0.0004851387],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093414346,0.00019332013,0.16056773,0.000027844455,0.000016560789,0.8327262,0.000830301,0.00011699097,0.0017369516,0.00019143705,0.00040447683,0.0030948438],"study_design_scores_gemma":[0.0000119052465,0.0005792645,0.15243739,0.00003992509,0.000021183641,0.8437905,0.00090076163,0.00029805725,0.0005354445,0.00015964403,0.0012090104,0.00001689197],"about_ca_topic_score_codex":0.0041043456,"about_ca_topic_score_gemma":0.0049729478,"teacher_disagreement_score":0.0041043456,"about_ca_system_score_codex":0.00085662276,"about_ca_system_score_gemma":0.0006362825,"threshold_uncertainty_score":0.008160889},"labels":[],"label_agreement":null},{"id":"W4404237883","doi":"10.1093/neuonc/noae165.1162","title":"TMET-24. MULTI-OMIC CHARACTERIZATION OF THE TEMPORAL METABOLIC ADAPTATIONS UNDERPINNING THERAPY RESISTANCE AND TUMOR RECURRENCE IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Glioblastoma; Underpinning; Resistance (ecology); Neuroscience; Medicine; Biology; Cancer research; Ecology; Engineering","score_opus":0.021073900754398835,"score_gpt":0.2835700286311456,"score_spread":0.26249612787674675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87883365,0.006734216,0.014947922,0.0004979477,0.00021581142,0.00015512266,0.09470505,0.0007358867,0.0031744286],"genre_scores_gemma":[0.89560115,0.0032402293,0.013756109,0.00042053024,0.00005219572,0.0003093959,0.08299735,0.00026027596,0.003362781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997451,0.000016901164,0.000020455986,0.00008811475,0.00007810712,0.000051326977],"domain_scores_gemma":[0.9997861,0.000032310698,0.00007103213,0.000018623203,0.00006271028,0.000029272886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029333815,0.0003917244,0.0008639523,0.0009458385,0.00044566597,0.000990819,0.00026577048,0.00044865182,0.0015545572],"category_scores_gemma":[0.00040263683,0.00020499811,0.0006417594,0.0018654614,0.000230309,0.00033824018,0.00040572404,0.00068558287,0.00075520296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015359321,0.00009317938,0.02873456,0.00072408654,0.00020736545,0.00033413302,0.00012947216,0.0023662928,0.9396683,0.0005175842,0.0031458046,0.022543231],"study_design_scores_gemma":[0.00008464646,0.0009449522,0.4846683,0.0001815776,0.0004753245,0.0018813554,0.00062425487,0.025473954,0.44578192,0.0019625237,0.037749518,0.0001716385],"about_ca_topic_score_codex":0.0026210544,"about_ca_topic_score_gemma":0.0041944175,"teacher_disagreement_score":0.0026210544,"about_ca_system_score_codex":0.00055945816,"about_ca_system_score_gemma":0.00053452776,"threshold_uncertainty_score":0.0052115917},"labels":[],"label_agreement":null},{"id":"W4404237915","doi":"10.1093/neuonc/noae165.0654","title":"IMMU-62. INVIGORATING EFFECTOR IMMUNE CELLS WITH HIGHLY SELECTIVE IL-2R AGONISTS AND POTENTIAL SYNERGY WITH TUMOR TARGETING THERAPEUTICS FOR TREATMENT OF GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Effector; Immune system; Cancer research; Medicine; Immunology","score_opus":0.006984292440468937,"score_gpt":0.2409440363658122,"score_spread":0.23395974392534324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97791654,0.011652683,0.0038710167,0.00038691875,0.00018486529,0.00023153427,0.00036116628,0.00021886756,0.0051764078],"genre_scores_gemma":[0.9883592,0.004458517,0.0029831403,0.00021351283,0.00005833126,0.00015177668,0.0004845429,0.000015589465,0.0032753514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999474,0.0000097945085,0.000004467273,0.0000073491774,0.0000121072735,0.000018817753],"domain_scores_gemma":[0.99998045,0.000002194478,0.000004565305,0.0000016185326,0.0000019969918,0.00000920062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012315008,0.00038923763,0.00029090763,0.00023391492,0.00006743457,0.00025774556,0.00014003129,0.00022347922,0.001010827],"category_scores_gemma":[0.00004031911,0.000079494515,0.00023522148,0.000102139216,0.00012527884,0.000116451585,0.0001745237,0.00043139356,0.00033658906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011123648,0.00061038666,0.00025167657,0.00021836469,0.000024735644,0.00016263244,0.000041414773,0.0007791928,0.95922875,0.00047268294,0.0006360517,0.03646169],"study_design_scores_gemma":[0.0014249877,0.018466098,0.0050505553,0.0000629644,0.0001550209,0.0008658559,0.00005780969,0.0044884705,0.9402181,0.00028891012,0.028895974,0.000025212013],"about_ca_topic_score_codex":0.00024615094,"about_ca_topic_score_gemma":0.0006693626,"teacher_disagreement_score":0.001010827,"about_ca_system_score_codex":0.0001500038,"about_ca_system_score_gemma":0.0002094325,"threshold_uncertainty_score":0.00338161},"labels":[],"label_agreement":null},{"id":"W4404238060","doi":"10.1093/neuonc/noae165.0243","title":"STEM-17. THE UROKINASE RECEPTOR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN BRAIN CANCERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Urokinase receptor; Receptor; Cancer research; Medicine; Oncology; Internal medicine; Biology","score_opus":0.01951022704912398,"score_gpt":0.28925094475637886,"score_spread":0.2697407177072549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87857467,0.07873815,0.024820438,0.0023348187,0.0013626127,0.0004902642,0.001483156,0.00063293235,0.011562993],"genre_scores_gemma":[0.951036,0.027338037,0.012041979,0.000880813,0.00019863997,0.00027623915,0.0016915923,0.000049550432,0.006487128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992394,0.000009880325,0.0000064668343,0.000013085834,0.000026878648,0.000019770838],"domain_scores_gemma":[0.99995124,0.0000070616793,0.00001335723,0.0000034191912,0.000009818375,0.000015206126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016216174,0.00026230235,0.00031535572,0.00037876426,0.00012168778,0.00037029496,0.00022198078,0.0002993822,0.0018726314],"category_scores_gemma":[0.00007462081,0.000098943616,0.000339289,0.00023830369,0.00018874597,0.00021415159,0.00023103766,0.0006638485,0.0005243649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027090032,0.00024815722,0.0012584645,0.00058829517,0.000050112376,0.00031987706,0.000056170426,0.001134041,0.9315647,0.0021625168,0.0020724863,0.060274318],"study_design_scores_gemma":[0.00014154895,0.0015714192,0.0032474769,0.00008007132,0.00016092703,0.0011808369,0.00005432378,0.0034026548,0.9052234,0.0008232124,0.08409992,0.000014184875],"about_ca_topic_score_codex":0.00020825172,"about_ca_topic_score_gemma":0.0003368338,"teacher_disagreement_score":0.0018726314,"about_ca_system_score_codex":0.00028152176,"about_ca_system_score_gemma":0.0002816101,"threshold_uncertainty_score":0.0062645674},"labels":[],"label_agreement":null},{"id":"W4404238107","doi":"10.1093/neuonc/noae165.0019","title":"EPCO-20. MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Princess Margaret Cancer Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Oligodendroglioma; Mutant; Lineage (genetic); Biology; Genetics; Gene; Glioma; Astrocytoma","score_opus":0.02048866232450902,"score_gpt":0.3009695805885792,"score_spread":0.2804809182640702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434483,0.00071625964,0.0012029134,0.00008435305,0.000031466247,0.000039849056,0.0009965256,0.00009837569,0.0024855735],"genre_scores_gemma":[0.992967,0.00035064947,0.0016342412,0.00012240847,0.0000075615567,0.00005145277,0.0016323059,0.000035882094,0.0031984656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999094,0.00001157097,0.000007780979,0.000020702848,0.000027175773,0.000023401079],"domain_scores_gemma":[0.99992204,0.000017356759,0.000013030194,0.000009489175,0.000011362461,0.00002678696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011795755,0.00015510226,0.0001803663,0.00017600316,0.00011061782,0.00026223456,0.00013115267,0.00015906396,0.0016973685],"category_scores_gemma":[0.00012281643,0.00007476191,0.00011619458,0.000104812694,0.00013960332,0.00008240682,0.00011323653,0.00039311344,0.00041863002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029928412,0.000088995155,0.00081335317,0.00003942442,0.000012835746,0.00005616495,0.000029834215,0.00022114618,0.9923453,0.00009825702,0.00043745188,0.005557868],"study_design_scores_gemma":[0.000034495042,0.0007243809,0.01069148,0.000005903489,0.000023625602,0.00018991772,0.00004014261,0.0014639228,0.98161227,0.000051327028,0.005158756,0.0000038092135],"about_ca_topic_score_codex":0.0012636622,"about_ca_topic_score_gemma":0.0028957494,"teacher_disagreement_score":0.0016973685,"about_ca_system_score_codex":0.00022783793,"about_ca_system_score_gemma":0.000223335,"threshold_uncertainty_score":0.0056782365},"labels":[],"label_agreement":null},{"id":"W4404238114","doi":"10.1093/neuonc/noae165.1159","title":"TMET-21. METABOLIC PROFILING OF MENINGIOMA REVEALS NOVEL SUBGROUP-SPECIFIC BIOLOGIC INSIGHTS AND OUTCOME DEPENDENCIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Profiling (computer programming); Computational biology; Medicine; Biology; Computer science; Programming language","score_opus":0.08379690202335066,"score_gpt":0.353893869957009,"score_spread":0.27009696793365834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561274,0.00097311096,0.0009830041,0.000084269435,0.00000964466,0.000014740751,0.001724128,0.000046411864,0.0005519801],"genre_scores_gemma":[0.9970182,0.00023275244,0.0005245627,0.000033961613,0.000007415468,0.000014888592,0.001664478,0.00001035658,0.0004935228],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998691,0.000019876528,0.000008886621,0.000043490327,0.000028855931,0.000029722556],"domain_scores_gemma":[0.99981064,0.000028519007,0.00007762738,0.000021654403,0.000019386349,0.000042142536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027356358,0.00030474053,0.00034430524,0.00039345288,0.00017031486,0.00041679357,0.00014402016,0.00018658729,0.00096023624],"category_scores_gemma":[0.0003562307,0.00008681465,0.00031350646,0.00043367158,0.00015500395,0.00015929755,0.00021186941,0.00034493537,0.00024200014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008514214,0.00020888094,0.46303305,0.00027741934,0.0005160019,0.0006366546,0.0001079638,0.002538544,0.4671712,0.0002320544,0.0010501036,0.05571407],"study_design_scores_gemma":[0.00008565543,0.0015188596,0.87751627,0.000018299168,0.00042579355,0.0017566499,0.0001491106,0.005784654,0.10788995,0.0009553973,0.0038740598,0.000025328536],"about_ca_topic_score_codex":0.00103782,"about_ca_topic_score_gemma":0.0019596228,"teacher_disagreement_score":0.00103782,"about_ca_system_score_codex":0.0003851828,"about_ca_system_score_gemma":0.00026263067,"threshold_uncertainty_score":0.0032122731},"labels":[],"label_agreement":null},{"id":"W4404239768","doi":"10.1093/neuonc/noae209","title":"Point/Counterpoint: The role of reirradiation in recurrent glioblastoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Counterpoint; Glioblastoma; Point (geometry); Medicine; Psychology; Cancer research; Mathematics","score_opus":0.010952364814358953,"score_gpt":0.2908120409110211,"score_spread":0.2798596760966621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404239768","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03850577,0.3364152,0.006836475,0.54867077,0.036480527,0.0001086168,0.0004012635,0.00021158344,0.032369696],"genre_scores_gemma":[0.49355122,0.20726894,0.0066862507,0.1291083,0.14815459,0.0001599818,0.0003502585,0.00019482385,0.014525572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989048,0.0004926764,0.00015458006,0.00018821874,0.00016035489,0.00009927364],"domain_scores_gemma":[0.9948112,0.003374449,0.0005148373,0.00026668058,0.00069412746,0.00033880115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036008032,0.00048389935,0.0011595334,0.00071368075,0.00045938385,0.0021136336,0.001396576,0.0040808464,0.00814314],"category_scores_gemma":[0.011633926,0.00011628248,0.00095970806,0.00057582284,0.0016427884,0.002846961,0.00084812037,0.0051612533,0.0020523923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041158935,0.00025327245,0.0076613748,0.0030196118,0.00056386826,0.0037714166,0.00036043578,0.003348522,0.0034391514,0.036076464,0.12068498,0.81670505],"study_design_scores_gemma":[0.0015982272,0.004842623,0.022905456,0.009472746,0.0021094005,0.019616239,0.0023014308,0.0037591795,0.0060798205,0.124564394,0.8024193,0.00033121597],"about_ca_topic_score_codex":0.0012313256,"about_ca_topic_score_gemma":0.002254629,"teacher_disagreement_score":0.00814314,"about_ca_system_score_codex":0.001335736,"about_ca_system_score_gemma":0.0015930162,"threshold_uncertainty_score":0.027241468},"labels":[],"label_agreement":null},{"id":"W4404256899","doi":"10.1093/neuonc/noae165.0500","title":"DDDR-15. UTILIZING DEEP DOCKING AND ARTIFICIAL INTELLIGENCE FOR THE DISCOVERY OF NOVEL PARP1-SELECTIVE INHIBITORS FOR USE AGAINST BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Biotech (Canada)","funders":"","keywords":"Docking (animal); Computer science; Artificial intelligence; PARP1; Drug discovery; Computational biology; Neuroscience; Bioinformatics; Biology; Medicine; Poly ADP ribose polymerase","score_opus":0.08396599421269625,"score_gpt":0.36564170173414756,"score_spread":0.2816757075214513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5134629,0.022446916,0.3295692,0.0061473497,0.0014146093,0.0012569515,0.010126887,0.019888135,0.095687024],"genre_scores_gemma":[0.8038531,0.006556979,0.15257643,0.0022502823,0.00006805751,0.00045058643,0.00957797,0.00059697666,0.024069672],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99974054,0.00004345597,0.00001431373,0.000049293136,0.00009141224,0.000061022747],"domain_scores_gemma":[0.99984443,0.000026533615,0.000024795034,0.00001871413,0.00003953237,0.000045947916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005970058,0.00095008936,0.00096322474,0.00048715103,0.0002641167,0.0010109373,0.0010378872,0.00086691685,0.004713419],"category_scores_gemma":[0.0006016805,0.00034093342,0.00082201266,0.0005441886,0.0003637827,0.00064689905,0.00093135063,0.0014230215,0.0018187384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011620627,0.0014596538,0.0042437958,0.0012613243,0.0004885268,0.0007221305,0.00008986866,0.47236133,0.15061784,0.015146914,0.033603717,0.3188428],"study_design_scores_gemma":[0.00045707487,0.0017113889,0.0007799011,0.000055287524,0.0001159602,0.00038495145,0.00002811986,0.8719694,0.081613086,0.004372905,0.03842871,0.00008326412],"about_ca_topic_score_codex":0.0027087217,"about_ca_topic_score_gemma":0.004162766,"teacher_disagreement_score":0.004713419,"about_ca_system_score_codex":0.0009819055,"about_ca_system_score_gemma":0.00093763747,"threshold_uncertainty_score":0.015767932},"labels":[],"label_agreement":null},{"id":"W4404256900","doi":"10.1093/neuonc/noae165.0279","title":"CSIG-30. EXPLORING THE ROLE OF CAPICUA (CIC) IN RESISTANCE MECHANISMS OF MEK INHIBITORS IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fungal Biology and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Resistance (ecology); Cancer research; Chemistry; Medicine; Biology; Ecology","score_opus":0.019683876283176607,"score_gpt":0.2775548213384806,"score_spread":0.257870945055304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95477235,0.024110036,0.0017486388,0.00096875854,0.00023311381,0.0003729149,0.0019920978,0.0003171778,0.015484867],"genre_scores_gemma":[0.9851291,0.0062317313,0.001237709,0.00044990383,0.000042786152,0.0001294693,0.0025932721,0.000022848371,0.004163074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990237,0.000010254652,0.0000051245424,0.000012234856,0.000031364274,0.000038705966],"domain_scores_gemma":[0.999943,0.000003383921,0.0000084495105,0.0000053819876,0.000009374473,0.000030384621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019305259,0.00033836177,0.00048221753,0.00041232698,0.00018106366,0.00029622501,0.0003800805,0.00036274584,0.002615945],"category_scores_gemma":[0.00009413045,0.0001461785,0.00033841436,0.0003308437,0.00017251002,0.00016832567,0.00021492093,0.00062019704,0.00078694493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002631917,0.00083586725,0.0037365102,0.0010997957,0.00011341967,0.0007498005,0.000055225588,0.0011928114,0.90004146,0.001244633,0.0051048687,0.083193675],"study_design_scores_gemma":[0.0014854501,0.016703494,0.07742987,0.00016939985,0.0004555367,0.0039733415,0.00015589497,0.00833425,0.79506904,0.0010356198,0.0951139,0.00007419145],"about_ca_topic_score_codex":0.0014214105,"about_ca_topic_score_gemma":0.0023915046,"teacher_disagreement_score":0.002615945,"about_ca_system_score_codex":0.0005904982,"about_ca_system_score_gemma":0.00063803804,"threshold_uncertainty_score":0.008751273},"labels":[],"label_agreement":null},{"id":"W4404256912","doi":"10.1093/neuonc/noae165.0887","title":"NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre; Montreal Children's Hospital; Université Laval","funders":"","keywords":"Refractory (planetary science); Medicine; Quality of life (healthcare); Firefly protocol; Glioma; Health related quality of life; Phases of clinical research; Internal medicine; Oncology; Clinical trial; Cancer research; Biology; Disease","score_opus":0.05657136340757306,"score_gpt":0.39200850832082756,"score_spread":0.3354371449132545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857231,0.0030250968,0.00025585364,0.0007350726,0.00019885847,0.00089031196,0.004836406,0.00008094019,0.0042543123],"genre_scores_gemma":[0.98155975,0.001236408,0.0013777931,0.0009816498,0.000114445545,0.002484882,0.0083966,0.000019183859,0.0038293134],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994247,0.00036147377,0.00001736683,0.000050620165,0.00006316,0.000082707884],"domain_scores_gemma":[0.9996189,0.000063525265,0.000084421124,0.000024948056,0.000031297004,0.00017684995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013357513,0.0005959748,0.0007156504,0.0001718543,0.00025630806,0.0005091473,0.00043129406,0.0004716388,0.0039969757],"category_scores_gemma":[0.0007356387,0.00019541329,0.0007149612,0.00021758466,0.00037676268,0.00030845864,0.00023956074,0.001548621,0.0005081863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.825082,0.022522109,0.018812906,0.000751663,0.0014467165,0.00011047872,0.000108570035,0.0018386544,0.015057805,0.00035257937,0.02118177,0.092734635],"study_design_scores_gemma":[0.6606825,0.23939928,0.081210844,0.00012176646,0.0010748603,0.00025308048,0.000086651795,0.00277728,0.004323951,0.00040364792,0.009618787,0.000047359797],"about_ca_topic_score_codex":0.00202563,"about_ca_topic_score_gemma":0.008954844,"teacher_disagreement_score":0.0039969757,"about_ca_system_score_codex":0.00084729405,"about_ca_system_score_gemma":0.0010689807,"threshold_uncertainty_score":0.01337117},"labels":[],"label_agreement":null},{"id":"W4404256951","doi":"10.1093/neuonc/noae165.0605","title":"IMMU-12. TRANSLATING COMBINED PD1 AND LAG3 INHIBITION FROM PRECLINICAL MODELS TO PATIENTS WITH REFRACTORY, DNA REPLICATION REPAIR DEFICIENT (RRD) GLIOBLASTOMA: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Glioblastoma; Refractory (planetary science); Replication (statistics); Cancer research; DNA repair; Chemistry; Medicine; DNA; Biology; Virology; Biochemistry; Astrobiology","score_opus":0.03824706815394288,"score_gpt":0.3245622237392192,"score_spread":0.2863151555852763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163556,0.0019177485,0.0015529653,0.0003497586,0.0001494302,0.0005312055,0.001353683,0.00016529566,0.0023443308],"genre_scores_gemma":[0.99215627,0.0012096225,0.0016986866,0.00024151333,0.000050301704,0.00043699687,0.002112533,0.000043328917,0.0020508107],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970883,0.000083041654,0.000019847736,0.00006465595,0.000048075217,0.00007551711],"domain_scores_gemma":[0.9997805,0.000018815419,0.000040715477,0.000043587035,0.00002338644,0.00009306862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011594655,0.0007890351,0.0007315584,0.00036301723,0.00020282599,0.00080339244,0.0005014992,0.00053667574,0.0020100053],"category_scores_gemma":[0.00022180137,0.00030886944,0.0005007996,0.00031146096,0.00054811785,0.00034026807,0.0002935127,0.0017923096,0.0008193889],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033914432,0.022298988,0.005531318,0.0008160215,0.00034561587,0.00034689993,0.00023139246,0.0022674184,0.8702554,0.0006450803,0.0042622383,0.059085183],"study_design_scores_gemma":[0.01744585,0.35730052,0.026031042,0.000115377996,0.0010284549,0.0015743435,0.00036696016,0.0068747676,0.5620443,0.000429105,0.026729597,0.0000596334],"about_ca_topic_score_codex":0.0010267093,"about_ca_topic_score_gemma":0.0022702948,"teacher_disagreement_score":0.0020100053,"about_ca_system_score_codex":0.00080174353,"about_ca_system_score_gemma":0.0010942703,"threshold_uncertainty_score":0.006724179},"labels":[],"label_agreement":null},{"id":"W4404498282","doi":"10.1093/neuonc/noae247","title":"Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Sidney Kimmel Comprehensive Cancer Center; School of Medicine and Public Health, University of Wisconsin-Madison; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; Texas Children's Hospital; McGill University; Johns Hopkins University; Department of Laboratory Medicine and Pathology, University of Washington; University of Washington; St. Jude Children's Research Hospital; Massachusetts General Hospital; Memorial Sloan-Kettering Cancer Center; Syracuse University; Nationwide Children's Hospital; St. Baldrick's Foundation","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; Oncology; Radiation therapy; Interim analysis; Glioma; Chemotherapy; Clinical trial; Surgery; Poly ADP ribose polymerase; Cancer research; Biology","score_opus":0.012553696643349103,"score_gpt":0.29570241881858506,"score_spread":0.28314872217523596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404498282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413437,0.000956563,0.00019022093,0.00044666362,0.00007709728,0.0022412755,0.0012318119,0.00002120693,0.00070071325],"genre_scores_gemma":[0.98480713,0.0017815679,0.002192638,0.0010204501,0.00026100103,0.0048769778,0.0036996163,0.000026270347,0.0013343963],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989017,0.00067132665,0.000043207438,0.0001602246,0.00007797442,0.00014547992],"domain_scores_gemma":[0.9986156,0.00022263484,0.0003296498,0.0001368873,0.000077385754,0.00061787944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027453874,0.0016023696,0.002387231,0.00039418085,0.0003984115,0.00079185364,0.00095891656,0.0010769372,0.0026129966],"category_scores_gemma":[0.0015637112,0.0006342312,0.0018736912,0.0005453655,0.0009234687,0.0006426549,0.0004606445,0.0025293664,0.00043063407],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91548306,0.022318177,0.026359687,0.00040817878,0.0026175773,0.0003165368,0.0002744073,0.0016826493,0.006134819,0.00019773807,0.0027414504,0.02146574],"study_design_scores_gemma":[0.8593317,0.1095217,0.026839437,0.00002689766,0.0007701878,0.00023901208,0.00005073234,0.0005368055,0.00077763846,0.00010302728,0.0017776726,0.00002525339],"about_ca_topic_score_codex":0.0027481397,"about_ca_topic_score_gemma":0.0059152874,"teacher_disagreement_score":0.0027481397,"about_ca_system_score_codex":0.0016986899,"about_ca_system_score_gemma":0.0037267278,"threshold_uncertainty_score":0.014519155},"labels":[],"label_agreement":null},{"id":"W4404610971","doi":"10.1093/neuonc/noae165.1302","title":"LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Computer science; Oncology; Internal medicine; Cancer research; Software engineering","score_opus":0.043452400168828856,"score_gpt":0.3679641266827876,"score_spread":0.32451172651395876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404610971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330889,0.0079948045,0.003008304,0.0045326753,0.00080440845,0.005511354,0.012135276,0.0011225393,0.031801708],"genre_scores_gemma":[0.96496457,0.0023923265,0.0028254553,0.0026190395,0.00023925386,0.0046687513,0.009471834,0.00011406072,0.012704562],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963236,0.00021046103,0.000013450154,0.0000424382,0.000041618525,0.000059680402],"domain_scores_gemma":[0.99966276,0.000046597863,0.00007289288,0.0000320194,0.00003726336,0.00014837849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013429826,0.0006370941,0.00071290135,0.00026791848,0.00027845727,0.00078876707,0.00049825467,0.0006025209,0.011888751],"category_scores_gemma":[0.0010620594,0.00018785958,0.0008095356,0.00029255,0.00038328007,0.00061271054,0.0003975531,0.0019665135,0.0015331119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5721639,0.010827051,0.0045786286,0.0018812127,0.0013486387,0.00019359226,0.00022425868,0.003747746,0.01863676,0.0037111326,0.06012344,0.32256368],"study_design_scores_gemma":[0.7625518,0.16543292,0.01698691,0.00046385356,0.0010229104,0.00042212626,0.00018944583,0.007541364,0.005705973,0.0043890085,0.035219613,0.00007398887],"about_ca_topic_score_codex":0.0014015416,"about_ca_topic_score_gemma":0.004814756,"teacher_disagreement_score":0.011888751,"about_ca_system_score_codex":0.00086596695,"about_ca_system_score_gemma":0.001361682,"threshold_uncertainty_score":0.039771795},"labels":[],"label_agreement":null},{"id":"W4404611180","doi":"10.1093/neuonc/noae165.1301","title":"LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Eflornithine; Astrocytoma; Mutant; Oncology; Progression-free survival; Overall survival; Internal medicine; Medicine; Cancer research; Biology; Glioblastoma; Genetics; Gene; Biochemistry; Enzyme","score_opus":0.012283294393354871,"score_gpt":0.29378386261228306,"score_spread":0.2815005682189282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404611180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881286,0.0035685273,0.00037448952,0.0007496118,0.00017276558,0.00097217446,0.0018669256,0.00016944435,0.0033131284],"genre_scores_gemma":[0.9875125,0.0018822278,0.0010175228,0.001182194,0.00010905182,0.0011023948,0.0036082554,0.00003697345,0.0035488303],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997739,0.00010485675,0.000014844417,0.000033527722,0.000024210589,0.000048567203],"domain_scores_gemma":[0.99964046,0.000046323752,0.0000812818,0.00002657601,0.000030124447,0.00017515027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010277594,0.00077720307,0.0012418572,0.0002449588,0.0002785659,0.0008041637,0.0005395133,0.00075896183,0.0044146315],"category_scores_gemma":[0.0005010269,0.00027745686,0.0013122751,0.00024298416,0.0004929103,0.0004948218,0.00024162041,0.0019481186,0.0011049676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7999379,0.022647569,0.007957727,0.0013079683,0.0018334442,0.00018093633,0.00016553974,0.0019060695,0.04497237,0.000389454,0.008827544,0.10987337],"study_design_scores_gemma":[0.6014617,0.3607306,0.022811236,0.0001302442,0.0013820021,0.0003636449,0.0001030288,0.0015135956,0.0058144964,0.00039861715,0.005248073,0.000042770254],"about_ca_topic_score_codex":0.0009645393,"about_ca_topic_score_gemma":0.0042395657,"teacher_disagreement_score":0.0044146315,"about_ca_system_score_codex":0.00067134853,"about_ca_system_score_gemma":0.0011340221,"threshold_uncertainty_score":0.014768362},"labels":[],"label_agreement":null},{"id":"W4405495024","doi":"10.1093/neuonc/noae230","title":"Molecular classification predicts response to surgery and radiotherapy","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Neurosurgery; Medicine; Library science; Family medicine; Gerontology; General surgery; Surgery","score_opus":0.036492437577884354,"score_gpt":0.3216921471036243,"score_spread":0.28519970952574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405495024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677826,0.012382329,0.00088382745,0.0028536613,0.00064020004,0.00007592387,0.002786671,0.000059000184,0.012535841],"genre_scores_gemma":[0.99170774,0.0023098928,0.00044247048,0.00039430155,0.000528039,0.000027782995,0.0027808312,0.00002349925,0.0017853264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996105,0.00007690856,0.00005050641,0.00007607086,0.00010111716,0.00008490292],"domain_scores_gemma":[0.9970919,0.00088431203,0.0010176563,0.00015408275,0.00033420484,0.00051773223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009843877,0.00030346515,0.00043136868,0.0010174026,0.00025966007,0.0010167472,0.00044471747,0.0007476143,0.0060380935],"category_scores_gemma":[0.0061718286,0.000109212946,0.0006036602,0.00085151324,0.00027548548,0.00081654434,0.00034736766,0.0008232962,0.0016744097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081242435,0.00009346966,0.97232956,0.00007405082,0.00015907505,0.00019158292,0.00004921918,0.00044987717,0.00062241394,0.00014019875,0.0031930108,0.021885108],"study_design_scores_gemma":[0.000034162425,0.00028706164,0.990275,0.0001380273,0.00024878752,0.0009184536,0.00021511635,0.0016464399,0.00034724342,0.0007261126,0.0051439204,0.000019680532],"about_ca_topic_score_codex":0.0015796016,"about_ca_topic_score_gemma":0.001675917,"teacher_disagreement_score":0.0060380935,"about_ca_system_score_codex":0.00037281108,"about_ca_system_score_gemma":0.00035708654,"threshold_uncertainty_score":0.020199478},"labels":[],"label_agreement":null},{"id":"W4405595687","doi":"10.1093/neuonc/noae274","title":"Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Health and Medical Research Council; Perelman School of Medicine, University of Pennsylvania; Universitätsklinikum Heidelberg; Freie Universität Berlin; Humboldt-Universität zu Berlin; University of Pennsylvania; Region Hovedstaden; Deutsches Krebsforschungszentrum; Université de Montréal; Children's National Hospital; Rigshospitalet; Deutschen Konsortium für Translationale Krebsforschung; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Gentofte Hospital; Yonsei University; University of New South Wales; Cancer Institute NSW; Medical Research Council; Department of Health and Social Care; Seattle Children's Research Institute; Great Ormond Street Institute of Child Health; Newcastle University; Texas Children's Hospital; Medical School, University of Michigan; McGill University; McGill University Health Centre; Children's Hospital of Philadelphia","keywords":"Medicine; Glioma; Refractory (planetary science); Tolerability; Internal medicine; Oncology; Subgroup analysis; Surgery; Adverse effect; Cancer research; Confidence interval","score_opus":0.014594908283033897,"score_gpt":0.29364954422103867,"score_spread":0.2790546359380048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405595687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937634,0.004334608,0.000084291096,0.00026857,0.000040559808,0.00013485347,0.0006153588,0.000015941707,0.0007425293],"genre_scores_gemma":[0.9957917,0.0014691863,0.00039440847,0.00024127854,0.000061844374,0.00032616325,0.0012476369,0.000010202692,0.00045747668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994916,0.00027743905,0.000027510743,0.00007494809,0.000057972367,0.00007042139],"domain_scores_gemma":[0.9992472,0.00016024549,0.00029481357,0.00005125799,0.000039067276,0.00020747911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134197,0.00047871735,0.0012802527,0.00014417982,0.00016020832,0.00054134405,0.00040465235,0.00033786328,0.0012376662],"category_scores_gemma":[0.0011647225,0.00017053308,0.0014486664,0.00021942073,0.00030209485,0.00032409458,0.00025832787,0.0013464116,0.00014050798],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7732618,0.004140803,0.061173752,0.0021448224,0.006050673,0.00043905288,0.00039227284,0.0037435913,0.015827082,0.0006604083,0.008777989,0.12338773],"study_design_scores_gemma":[0.46832612,0.24932614,0.24724953,0.00061445334,0.005993759,0.0018851476,0.0002975797,0.003791253,0.008690186,0.0007665392,0.012977771,0.00008149785],"about_ca_topic_score_codex":0.0011120748,"about_ca_topic_score_gemma":0.0039440314,"teacher_disagreement_score":0.00134197,"about_ca_system_score_codex":0.0010801217,"about_ca_system_score_gemma":0.0010747925,"threshold_uncertainty_score":0.007836878},"labels":[],"label_agreement":null},{"id":"W4405724778","doi":"10.1093/neuonc/noae269","title":"VGLL fusions define a new class of intraparenchymal central nervous system schwannoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; SickKids Foundation","funders":"Brain Tumour Charity","keywords":"Schwannoma; Pathology; Medicine; Biology","score_opus":0.025656764633169776,"score_gpt":0.2852317805831701,"score_spread":0.2595750159500003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405724778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924234,0.0012705453,0.0034718115,0.00006356913,0.000023358407,0.000058272268,0.0002861584,0.00012271374,0.0022801377],"genre_scores_gemma":[0.996702,0.00027671538,0.001854554,0.000059342186,0.00003712303,0.000025780131,0.00069896417,0.000029889963,0.0003157294],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995352,0.000021452473,0.0000518683,0.00011604345,0.00014197764,0.0001334137],"domain_scores_gemma":[0.9989366,0.00017760375,0.00038754012,0.00013512695,0.00014140845,0.00022177934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003541322,0.00054449996,0.000398398,0.0017726127,0.00041573052,0.0010739511,0.00061259844,0.0005909269,0.0011029241],"category_scores_gemma":[0.0008953392,0.00017577523,0.00035068707,0.0012389277,0.0011666963,0.00055022206,0.0009850782,0.00061767054,0.00063741015],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013430323,0.00017183798,0.65657896,0.00023648392,0.00021244082,0.067959644,0.0010867415,0.00095834833,0.22135735,0.0015801404,0.0012590826,0.047256052],"study_design_scores_gemma":[0.000091498216,0.0006092855,0.64325005,0.000057274883,0.00031371435,0.3007581,0.0009602882,0.0030408239,0.034925558,0.003320312,0.012618793,0.000054282755],"about_ca_topic_score_codex":0.0008405549,"about_ca_topic_score_gemma":0.0016571371,"teacher_disagreement_score":0.0017726127,"about_ca_system_score_codex":0.0006127534,"about_ca_system_score_gemma":0.0003718593,"threshold_uncertainty_score":0.004445851},"labels":[],"label_agreement":null},{"id":"W4405740627","doi":"10.1093/neuonc/noae271","title":"Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small-cell lung cancer better preserves white matter networks compared to conventional PCI","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; Vlaamse regering; Vlaamse Liga Tegen Kanker; Fonds NutsOhra","keywords":"Conventional PCI; Prophylactic cranial irradiation; Hippocampal formation; Neurocognitive; White matter; Hippocampus; Medicine; Neuropsychology; Neuroscience; Cardiology; Internal medicine; Cognition; Psychology; Radiology; Magnetic resonance imaging","score_opus":0.029815567915925222,"score_gpt":0.35491882690403387,"score_spread":0.32510325898810866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405740627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979133,0.0012618063,0.00026180915,0.0000456529,0.00001664112,0.000061492305,0.000052634743,0.000015648277,0.00037106717],"genre_scores_gemma":[0.99899095,0.00041932322,0.00031242243,0.00003431981,0.000014247684,0.000044285916,0.00008118066,0.000002524812,0.00010078711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999312,0.000016057638,0.000004996656,0.00001811934,0.000013820811,0.00001578305],"domain_scores_gemma":[0.99985445,0.00002489057,0.00005883229,0.0000170959,0.000008654449,0.00003602404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001781211,0.00024164279,0.00041585576,0.00016971746,0.00015441167,0.00021990913,0.00023473374,0.00018106814,0.0010669988],"category_scores_gemma":[0.00033608754,0.00007381477,0.000339355,0.00019457052,0.00024640665,0.00023384155,0.0001535804,0.00040279882,0.000079474354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15603788,0.020703359,0.07191047,0.0025235729,0.0030346722,0.00030430753,0.00025407897,0.011168819,0.18289775,0.0009107008,0.0028350286,0.5474194],"study_design_scores_gemma":[0.025702238,0.5288672,0.3658905,0.00023534059,0.0028583864,0.0014451944,0.00024710663,0.008471135,0.05585267,0.001189264,0.0091654435,0.00007564409],"about_ca_topic_score_codex":0.0007673596,"about_ca_topic_score_gemma":0.0021673434,"teacher_disagreement_score":0.0010669988,"about_ca_system_score_codex":0.00025874816,"about_ca_system_score_gemma":0.00045964753,"threshold_uncertainty_score":0.0035694838},"labels":[],"label_agreement":null},{"id":"W4405815401","doi":"10.1093/neuonc/noae259","title":"The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Sapienza Università di Roma; University of California, San Francisco; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Brigham and Women's Hospital","keywords":"Isocitrate dehydrogenase; Neurocognitive; IDH1; Glioma; Medicine; Mutant; Oncology; Radiation therapy; Chemotherapy; Internal medicine; Cancer research; Cognition; Biology; Psychiatry; Enzyme; Genetics; Gene","score_opus":0.041258751362526346,"score_gpt":0.36264464731136686,"score_spread":0.32138589594884054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405815401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023385635,0.9985821,0.000059536676,0.000185039,0.00011101837,0.0000040895766,0.000017929558,0.0000056191043,0.0008008087],"genre_scores_gemma":[0.0013685983,0.9977926,0.00011462766,0.000180254,0.00008639539,0.0000055657006,0.000036665726,0.0000011815292,0.0004141031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989295,0.000020896541,0.000018621075,0.000016127897,0.000039769915,0.000011664578],"domain_scores_gemma":[0.9998802,0.000054717784,0.000021299436,0.0000024230615,0.000030321953,0.000011054556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000351548,0.00045994797,0.0007525915,0.0013750481,0.00015166265,0.00062365574,0.00042892317,0.0005447148,0.0025835852],"category_scores_gemma":[0.00041970934,0.00013396768,0.0005103248,0.001109946,0.00020384793,0.0006366009,0.00033009954,0.0011599245,0.0009164727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001143049,0.00006046512,0.00012845335,0.015357529,0.0001320807,0.00017810117,0.00004653141,0.00045634748,0.0017276915,0.002095634,0.021599734,0.95810306],"study_design_scores_gemma":[0.000075714896,0.00023844991,0.0011341524,0.004661944,0.00027600012,0.0017888587,0.0000469443,0.00023832213,0.00087745296,0.0015395388,0.98910236,0.000020144025],"about_ca_topic_score_codex":0.00071385386,"about_ca_topic_score_gemma":0.0018555367,"teacher_disagreement_score":0.0025835852,"about_ca_system_score_codex":0.00038538408,"about_ca_system_score_gemma":0.00066313334,"threshold_uncertainty_score":0.0086429715},"labels":[],"label_agreement":null},{"id":"W4405923527","doi":"10.1093/neuonc/noae276","title":"A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"School of Medicine, Duke University; National Institutes of Health; Center for Clinical and Translational Science, Mayo Clinic; University of California, Los Angeles; Universitätsklinikum Heidelberg; University of Pennsylvania; Deutschen Konsortium für Translationale Krebsforschung; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Massachusetts General Hospital; National Cancer Institute; Center for Individualized Medicine, Mayo Clinic; University of Toronto; Deutsches Krebsforschungszentrum; David Geffen School of Medicine, University of California, Los Angeles; Pennsylvania State University","keywords":"Medicine; Internal medicine; Oncology; Clinical Oncology; Cancer","score_opus":0.05875035359369118,"score_gpt":0.4047582591843036,"score_spread":0.3460079055906124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405923527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013547458,0.94412595,0.002585442,0.027221499,0.01217032,0.0001353164,0.0007219632,0.0003024059,0.012601701],"genre_scores_gemma":[0.0008301189,0.9538588,0.004824443,0.015033613,0.004450849,0.0001909054,0.0010062857,0.000071539835,0.019733362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988857,0.00024874246,0.00021579198,0.00013571775,0.00044232397,0.00007177816],"domain_scores_gemma":[0.996476,0.001564872,0.0002854435,0.00016028002,0.0012963036,0.00021709723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001827041,0.0012165102,0.0013639261,0.0041689435,0.00047556433,0.0018538611,0.0017850872,0.002625301,0.01736523],"category_scores_gemma":[0.005824754,0.0005145423,0.0010665196,0.0032567978,0.0010713317,0.003637343,0.0015199214,0.0048509655,0.018973509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027379603,0.000027308204,0.00008528538,0.0045428183,0.00002953191,0.00014863088,0.000062677434,0.00008272538,0.0005259682,0.0040260963,0.69571346,0.29472816],"study_design_scores_gemma":[0.000004449217,0.000015762418,0.000106504696,0.0019526327,0.000008997829,0.00028677558,0.000014829268,0.000020476024,0.000054435055,0.0015023494,0.9960257,0.000007064707],"about_ca_topic_score_codex":0.0024332984,"about_ca_topic_score_gemma":0.005515462,"teacher_disagreement_score":0.01736523,"about_ca_system_score_codex":0.0012204476,"about_ca_system_score_gemma":0.0040959474,"threshold_uncertainty_score":0.058092415},"labels":[],"label_agreement":null},{"id":"W4406169707","doi":"10.1093/neuonc/noae242","title":"Development and validation of a molecular classifier of meningiomas","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Moonshot Research and Development Program; National Cancer Institute; Canadian Institutes of Health Research; Cancer Moonshot; School of Medicine, University of North Carolina at Chapel Hill; Broad Institute; University of Oklahoma Health Sciences Center; NRG Oncology; University Health Network Foundation; Leidos; Vanderbilt University Medical Center; Princess Margaret Hospital Foundation; Deutsches Krebsforschungszentrum; National Institutes of Health; School of Medicine, Case Western Reserve University; Brain Tumour Charity; University of Oklahoma; Case Comprehensive Cancer Center, Case Western Reserve University; Center for Biomedical Informatics and Information Technology, National Cancer Institute; Deutschen Konsortium für Translationale Krebsforschung; University of Pennsylvania; Vanderbilt University; Congress of Neurological Surgeons; Pennsylvania State University; V Foundation for Cancer Research; University of Toronto; Case Western Reserve University; Faculty of Medicine, University of British Columbia; U.S. Department of Health and Human Services","keywords":"DNA methylation; Biology; Methylation; Exome; Exome sequencing; Cell cycle; Computational biology; Bioinformatics; Oncology; Cancer research; DNA; Cell; Genetics; Medicine; Gene; Mutation; Gene expression","score_opus":0.03588568600568398,"score_gpt":0.30792197312331504,"score_spread":0.27203628711763106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406169707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90668285,0.0006464292,0.08493195,0.0005315313,0.00016543733,0.0005235952,0.0034881106,0.0013213251,0.001708722],"genre_scores_gemma":[0.9248221,0.00014903957,0.06767395,0.00014257034,0.00008229114,0.00031654708,0.0062368684,0.00003847173,0.0005382624],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847263,0.00027720936,0.0001961959,0.0004530809,0.00043056434,0.00017035104],"domain_scores_gemma":[0.99483335,0.0021396957,0.0006400272,0.00036141215,0.0017226535,0.00030285324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004258344,0.0008218165,0.0008762564,0.00239347,0.00057684537,0.0014482526,0.0010067717,0.0011102183,0.00075049384],"category_scores_gemma":[0.0076506548,0.00016831924,0.00084877276,0.0006473125,0.00030007574,0.0005884195,0.00087014935,0.0010562037,0.00072125753],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012147666,0.0012552415,0.6007711,0.00030084435,0.0007118555,0.000559436,0.0001426089,0.05352539,0.040999617,0.0008606349,0.0070449165,0.2926135],"study_design_scores_gemma":[0.00015617437,0.0010604706,0.084830254,0.00009998763,0.00044094108,0.0008987952,0.000158162,0.8592071,0.046827476,0.0017559894,0.004515068,0.00004953567],"about_ca_topic_score_codex":0.0021880902,"about_ca_topic_score_gemma":0.0014093388,"teacher_disagreement_score":0.004258344,"about_ca_system_score_codex":0.0010995703,"about_ca_system_score_gemma":0.0017484665,"threshold_uncertainty_score":0.022520602},"labels":[],"label_agreement":null},{"id":"W4406278654","doi":"10.1093/neuonc/noaf008","title":"Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; CancerCare Manitoba; Manitoba Beekeepers' Association; Research Institute in Oncology and Hematology; University of Manitoba","funders":"Genome British Columbia; University of Victoria; Natural Sciences and Engineering Research Council of Canada; Ottawa Hospital Research Institute; Manitoba Medical Service Foundation; Canadian Institutes of Health Research; Cancer Research Society; University of Ottawa; Health Sciences Centre Foundation","keywords":"Temozolomide; Glycolysis; Cancer research; Gene silencing; Mitochondrion; Warburg effect; In vivo; Medicine; Biology; Internal medicine; Glioblastoma; Cell biology; Metabolism; Biochemistry; Gene; Genetics","score_opus":0.007786239043487632,"score_gpt":0.2577072860093345,"score_spread":0.24992104696584688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406278654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974511,0.0010394688,0.00064639194,0.000032227,0.000012322179,0.000015227488,0.00036314828,0.00003671906,0.0004032896],"genre_scores_gemma":[0.99703896,0.0008073866,0.00055440114,0.000027467744,0.000003307397,0.000024104234,0.00072620244,0.000010963636,0.00080722716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999936,0.0000059354707,0.0000060229413,0.000013437519,0.000020424022,0.000018128292],"domain_scores_gemma":[0.9999502,0.000004416587,0.000016473194,0.000004025615,0.000009388408,0.000015488924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010738735,0.00015171386,0.00024614367,0.0002147151,0.0000817425,0.00025818136,0.00009823242,0.00011397198,0.0008120524],"category_scores_gemma":[0.0000932653,0.00008046448,0.00015161942,0.00018265218,0.00011617297,0.0001205574,0.00011210275,0.00035004428,0.00017076544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062821916,0.000092226284,0.0016832706,0.00006127971,0.000012584667,0.000032936896,0.000035772853,0.0001435597,0.99112105,0.00007864862,0.00014576371,0.005964625],"study_design_scores_gemma":[0.00004706767,0.0019781864,0.066954434,0.00001316551,0.00006383305,0.00028255823,0.000102642916,0.0022680678,0.9244179,0.00007436595,0.0037881015,0.00000974779],"about_ca_topic_score_codex":0.00122554,"about_ca_topic_score_gemma":0.002566099,"teacher_disagreement_score":0.00122554,"about_ca_system_score_codex":0.0003037181,"about_ca_system_score_gemma":0.0002555728,"threshold_uncertainty_score":0.002716601},"labels":[],"label_agreement":null},{"id":"W4406784536","doi":"10.1093/neuonc/noae281","title":"Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependencies","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Toronto","keywords":"Metabolite; Internal medicine; Oncology; Subgroup analysis; High-performance liquid chromatography; Cohort; Metabolomics; Bioinformatics; Cancer research; Biology; Chemistry; Medicine; Meta-analysis; Chromatography","score_opus":0.056162312556043405,"score_gpt":0.32373493145011356,"score_spread":0.26757261889407014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406784536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975883,0.00057633535,0.00085419096,0.00004749186,0.0000030948918,0.0000069509133,0.0006152395,0.000022549739,0.00028584144],"genre_scores_gemma":[0.9982174,0.00027583432,0.00058281526,0.000023142793,0.0000053568756,0.0000074116324,0.0007337401,0.0000068854847,0.00014732167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989283,0.000014084369,0.000008920917,0.000031530122,0.000028494218,0.00002416961],"domain_scores_gemma":[0.9996903,0.00004221799,0.00014998984,0.00003812626,0.00003697637,0.00004242047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025390158,0.00035074278,0.00033819006,0.00054489216,0.00013616403,0.00042892195,0.00010027673,0.00016522844,0.00048422022],"category_scores_gemma":[0.00045647426,0.000073608746,0.00033184,0.00043648164,0.00016190433,0.00015829233,0.00031146157,0.00022981853,0.00014963024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002554294,0.00008389768,0.58806,0.00015819426,0.00033224197,0.0005468941,0.00013936173,0.0010463899,0.37923306,0.0001619893,0.00027434088,0.027409405],"study_design_scores_gemma":[0.00001423008,0.00043883576,0.9424371,0.000012326483,0.0002150116,0.0010589128,0.00016076956,0.001667572,0.052096236,0.00068717875,0.0011961174,0.000015682914],"about_ca_topic_score_codex":0.0007470043,"about_ca_topic_score_gemma":0.0014052967,"teacher_disagreement_score":0.0007470043,"about_ca_system_score_codex":0.00031772017,"about_ca_system_score_gemma":0.00021597948,"threshold_uncertainty_score":0.0023052692},"labels":[],"label_agreement":null},{"id":"W4406923721","doi":"10.1093/neuonc/noaf011","title":"Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; SNC-Lavalin (Canada); McGill University","funders":"","keywords":"Glioma; In vivo; Drug delivery; Cancer research; Medicine; U87; Pharmacology; Systemic administration; Chemistry; Biology","score_opus":0.014598613550200243,"score_gpt":0.27288309391589965,"score_spread":0.2582844803656994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406923721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788319,0.0014701881,0.017311111,0.00010404814,0.000032972668,0.000057099103,0.00020712799,0.00020433511,0.0017810446],"genre_scores_gemma":[0.9881644,0.00080249045,0.008929142,0.00003660276,0.000008826557,0.000048062648,0.0001755929,0.000034020668,0.0018007542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999397,0.000004417307,0.0000034998875,0.000016620548,0.000020786627,0.000015117084],"domain_scores_gemma":[0.9999542,0.000008581776,0.000018140348,0.0000034835914,0.000009106087,0.00000657874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075983844,0.0002857472,0.00015705812,0.00011326699,0.0000775719,0.00015949285,0.00014501359,0.00030220256,0.0005219136],"category_scores_gemma":[0.00007697004,0.000083934705,0.00018754888,0.00007000229,0.00014540598,0.0001494054,0.00013079948,0.00027152998,0.00018649196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026694419,0.000009763375,0.00004189761,0.000032334185,0.0000026816579,0.000024132849,0.0000066900134,0.00012220087,0.99851483,0.000039905804,0.000043355525,0.0011354795],"study_design_scores_gemma":[0.000006277665,0.00014103875,0.00047762127,0.00000334788,0.000012676419,0.00010344224,0.0000039221695,0.0013204548,0.9968144,0.000008246044,0.0011044809,0.0000040652467],"about_ca_topic_score_codex":0.0009404339,"about_ca_topic_score_gemma":0.0011258814,"teacher_disagreement_score":0.0009404339,"about_ca_system_score_codex":0.0002598535,"about_ca_system_score_gemma":0.00018243706,"threshold_uncertainty_score":0.0018853545},"labels":[],"label_agreement":null},{"id":"W4407594521","doi":"10.1093/neuonc/noaf033","title":"The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; University of New Brunswick; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Methyltransferase; Methylation; Gene knockdown; Histone; Phosphorylation; Kinase; Epigenetics; Biology; Cancer research; DNA methylation; Cell biology; Protein kinase A; Proteomics; Chemistry; Biochemistry; DNA; Apoptosis; Gene expression; Gene","score_opus":0.011196170626314053,"score_gpt":0.29554985226223884,"score_spread":0.2843536816359248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407594521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888602,0.0075136228,0.0018286002,0.00023660042,0.000010167661,0.000016061522,0.0006821423,0.000062634535,0.00078990933],"genre_scores_gemma":[0.9935163,0.0031625938,0.002050874,0.00008511076,0.000009139514,0.000014228089,0.000724514,0.000013773565,0.00042339537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.0000070246383,0.000003974117,0.000014996074,0.000019645233,0.000016182521],"domain_scores_gemma":[0.99994755,0.000006209865,0.000020460697,0.0000036545694,0.000010167743,0.000011958225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001131831,0.00031988358,0.0002061878,0.00041636807,0.00012221724,0.0002982367,0.00012604574,0.00021453336,0.0006585048],"category_scores_gemma":[0.000114304916,0.00009095301,0.00020905444,0.0003155599,0.0001535217,0.00018952323,0.00020147176,0.00024797273,0.0001766838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045075756,0.000020391348,0.015957879,0.00020312227,0.000065501445,0.00033470013,0.00003628743,0.00027209736,0.9651581,0.00009413464,0.00024238833,0.017164648],"study_design_scores_gemma":[0.00003560708,0.00077126175,0.3679232,0.000038114613,0.00019934816,0.005476672,0.00022849279,0.0026678164,0.6120354,0.00066543976,0.009933943,0.000024631652],"about_ca_topic_score_codex":0.0006466672,"about_ca_topic_score_gemma":0.0012358369,"teacher_disagreement_score":0.0006585048,"about_ca_system_score_codex":0.0002952455,"about_ca_system_score_gemma":0.0001628623,"threshold_uncertainty_score":0.002202928},"labels":[],"label_agreement":null},{"id":"W4407676040","doi":"10.1093/neuonc/noaf020","title":"Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Key Research and Development Program of China; Natural Science Foundation of Beijing Municipality; National Natural Science Foundation of China","keywords":"Biology; Transcriptome; Spatial organization; Stem cell; Progenitor cell; Computational biology; Progenitor; Evolutionary biology; Chromatin; Medulloblastoma; Cell type; Cellular differentiation; Genetics; Cell; Neuroscience; Gene; Gene expression","score_opus":0.011812771542231476,"score_gpt":0.2859893608720139,"score_spread":0.2741765893297824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407676040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86435986,0.01611147,0.058151465,0.0010816688,0.000056717236,0.00009554833,0.05471483,0.0007545046,0.004674026],"genre_scores_gemma":[0.9269788,0.004650273,0.038033534,0.000281183,0.00006076573,0.00013759432,0.028886648,0.00015733544,0.00081378355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967337,0.00004242606,0.00003508654,0.00012891888,0.00006823293,0.000051954932],"domain_scores_gemma":[0.9993748,0.0001728892,0.0002238699,0.000092611794,0.000093810144,0.00004209023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049057254,0.00038333965,0.0007597737,0.0037906652,0.00044512295,0.0012003473,0.00033605966,0.00034568697,0.0010677045],"category_scores_gemma":[0.0009507005,0.00018724635,0.0007663443,0.0038161832,0.00025924918,0.0006392801,0.001076595,0.00040545105,0.00029462297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058714225,0.00009522977,0.4793211,0.0019375965,0.0012011572,0.0011486153,0.0009736831,0.011611235,0.34556672,0.0032362763,0.005473992,0.14884737],"study_design_scores_gemma":[0.00002122532,0.0001104873,0.8952103,0.00026435917,0.00076467794,0.0015715766,0.0014892237,0.027758436,0.029845057,0.009994761,0.03288864,0.000081173064],"about_ca_topic_score_codex":0.0041458835,"about_ca_topic_score_gemma":0.007484703,"teacher_disagreement_score":0.0041458835,"about_ca_system_score_codex":0.0007019279,"about_ca_system_score_gemma":0.0005766999,"threshold_uncertainty_score":0.008243501},"labels":[],"label_agreement":null},{"id":"W4407743909","doi":"10.1093/neuonc/noaf043","title":"End-of-life care in glioblastoma: A population-based study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research; Ministry of Health, Ontario","keywords":"Medicine; Palliative care; End-of-life care; Cohort; Retrospective cohort study; Socioeconomic status; Population; Emergency medicine; Health care; Ambulatory care; Cohort study; Internal medicine; Environmental health; Nursing","score_opus":0.06266760885602997,"score_gpt":0.41663574266437003,"score_spread":0.3539681338083401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407743909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774444,0.00034050766,0.000070646085,0.00007057484,0.000004829248,0.000033522134,0.0014059476,0.000003028971,0.00032642786],"genre_scores_gemma":[0.9984297,0.00027485067,0.000072352035,0.000045172932,0.000010006729,0.000032594296,0.001074124,0.0000017684839,0.00005955701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991345,0.0001319446,0.000101047604,0.00019596286,0.00024063674,0.00019598773],"domain_scores_gemma":[0.9983448,0.00009632654,0.0009299309,0.000087218286,0.00028906798,0.00025258178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009270913,0.00029333256,0.0004787336,0.0015766046,0.0006620826,0.00084661366,0.0006654439,0.00041863965,0.0007039108],"category_scores_gemma":[0.0019176716,0.00031481532,0.00060184195,0.00373388,0.0003816154,0.00067045976,0.00066586636,0.0005119201,0.00016867334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022371814,0.000017325725,0.99935335,0.000008531701,0.000035519883,0.000025106287,0.0000808258,0.000010946483,0.00002433394,0.0000066710677,0.000073116615,0.00034195412],"study_design_scores_gemma":[0.0000030730391,0.00003172362,0.99954706,0.000006949368,0.00002009193,0.000044231703,0.00016680297,0.000036368634,0.000005036581,0.0000060489256,0.00013046635,0.000002029532],"about_ca_topic_score_codex":0.17665406,"about_ca_topic_score_gemma":0.24418104,"teacher_disagreement_score":0.17665406,"about_ca_system_score_codex":0.0026975523,"about_ca_system_score_gemma":0.0025179498,"threshold_uncertainty_score":0.3512516},"labels":[],"label_agreement":null},{"id":"W4407814863","doi":"10.1093/neuonc/noaf047","title":"A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Drug Policy Research Network; Ontario Institute for Cancer Research; St. Michael's Hospital; Canada Research Chairs; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Schwannoma; Meningioma; Medicine; Differential diagnosis; Paraganglioma; Radiology; Pathology","score_opus":0.011726473160360148,"score_gpt":0.2870683786378405,"score_spread":0.2753419054774804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407814863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93466145,0.0010934277,0.05921106,0.00019168787,0.0000488046,0.00024311358,0.0012200399,0.00059980864,0.0027306224],"genre_scores_gemma":[0.9123685,0.000379517,0.08433539,0.00018946927,0.000028959314,0.0002819086,0.0010709814,0.00003065824,0.0013146225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991592,0.00016671616,0.000070258124,0.00023625983,0.0003183474,0.000049138533],"domain_scores_gemma":[0.99896955,0.00031887245,0.00021503332,0.00014137765,0.00030207488,0.00005297124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013539032,0.0003487151,0.00028726077,0.0013919021,0.0002763162,0.0004596322,0.00036990986,0.0003726361,0.00155688],"category_scores_gemma":[0.002283128,0.00023904443,0.00024998764,0.0006594267,0.00032383297,0.0003147199,0.00045849712,0.00035189991,0.00073246186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825304,0.00013874318,0.24933076,0.00018963618,0.00013931013,0.00031456715,0.00015749065,0.0017016793,0.6898089,0.00032654923,0.000544722,0.056265116],"study_design_scores_gemma":[0.000050758175,0.0015933751,0.37493277,0.000052248786,0.00030872654,0.0057321577,0.00023946998,0.057002265,0.5542286,0.0006218981,0.005168382,0.000069344336],"about_ca_topic_score_codex":0.00050401373,"about_ca_topic_score_gemma":0.0012117167,"teacher_disagreement_score":0.00155688,"about_ca_system_score_codex":0.00034866374,"about_ca_system_score_gemma":0.00035582442,"threshold_uncertainty_score":0.0071602464},"labels":[],"label_agreement":null},{"id":"W4408129593","doi":"10.1093/neuonc/noaf058","title":"Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Glioma; Medicine; Artificial intelligence; Medical physics; Computer science; Cancer research","score_opus":0.01590989652841043,"score_gpt":0.3218934579429215,"score_spread":0.3059835614145111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408129593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007980049,0.9469493,0.015840441,0.013155942,0.0006089494,0.000048138063,0.00012242892,0.000061164996,0.01523359],"genre_scores_gemma":[0.102527395,0.8673445,0.024641698,0.0026676266,0.0013085173,0.00007403593,0.00015394695,0.000019317276,0.0012630019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991468,0.00044167947,0.00008763467,0.00007603687,0.00020965723,0.000038170754],"domain_scores_gemma":[0.99642015,0.0028756002,0.00023728487,0.00006348955,0.00033148783,0.0000719179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020574206,0.00042275226,0.0004481906,0.0023331873,0.00022102491,0.0016949737,0.00038156498,0.0007880642,0.0014183153],"category_scores_gemma":[0.0058840355,0.00015250417,0.0007038168,0.0016908797,0.0008265273,0.001057164,0.00077475695,0.0013261297,0.00023384088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011408373,0.00007942332,0.010410996,0.0075482884,0.00040605158,0.0011459782,0.0005956601,0.007808735,0.0013573442,0.06317546,0.011788185,0.8955698],"study_design_scores_gemma":[0.00003714799,0.00059667707,0.02626624,0.020291654,0.0006287878,0.0063075745,0.001683087,0.020797461,0.0052861776,0.20204222,0.7158853,0.00017768616],"about_ca_topic_score_codex":0.0017412921,"about_ca_topic_score_gemma":0.0026478448,"teacher_disagreement_score":0.0023331873,"about_ca_system_score_codex":0.0011141866,"about_ca_system_score_gemma":0.0013642957,"threshold_uncertainty_score":0.010880768},"labels":[],"label_agreement":null},{"id":"W4408245823","doi":"10.1093/neuonc/noaf046","title":"High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université de Montréal; Children's & Women's Health Centre of British Columbia; BC Children's Hospital; University of Manitoba; Juravinski Cancer Centre; University of British Columbia; McMaster University Medical Centre; Dalhousie University; Hamilton Health Sciences; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Spinal Cord Injury BC; SickKids Foundation; BC Cancer Agency","funders":"Terry Fox Research Institute","keywords":"Medulloblastoma; Immunohistochemistry; Oncology; Biology; Internal medicine; Medicine; Cancer research","score_opus":0.024680752986722742,"score_gpt":0.3502271976136253,"score_spread":0.3255464446269026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408245823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228513,0.0010473643,0.0043358877,0.00023938653,0.0000151736485,0.000035865556,0.0013053288,0.000090969515,0.0006448709],"genre_scores_gemma":[0.99409616,0.00037550545,0.0038299416,0.00007593854,0.000017023041,0.00002103194,0.00133504,0.000018843004,0.00023053172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958867,0.000068696914,0.000041744737,0.00012302585,0.0001246787,0.00005330447],"domain_scores_gemma":[0.99941695,0.00011429862,0.00023521924,0.00006652397,0.00010513297,0.00006203999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357945,0.0004814301,0.00037504957,0.0009907089,0.00031542068,0.0008487041,0.00027650487,0.00038457883,0.001049674],"category_scores_gemma":[0.0014076353,0.00016210454,0.00048524624,0.00057102984,0.00036928887,0.00037801737,0.0006492841,0.0004937113,0.0004613061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011612191,0.00015684363,0.50617075,0.0002431339,0.0005941261,0.00041525014,0.00017040319,0.0014868324,0.4650156,0.00022857115,0.0010670392,0.023290208],"study_design_scores_gemma":[0.000040536503,0.0004229555,0.8663679,0.000044096938,0.00037248136,0.0022687104,0.00028343347,0.012304553,0.11384656,0.0007273428,0.0032907955,0.00003061163],"about_ca_topic_score_codex":0.00093294034,"about_ca_topic_score_gemma":0.0019941689,"teacher_disagreement_score":0.001049674,"about_ca_system_score_codex":0.0003791895,"about_ca_system_score_gemma":0.00034635628,"threshold_uncertainty_score":0.0049490333},"labels":[],"label_agreement":null},{"id":"W4408344009","doi":"10.1093/neuonc/noaf061","title":"Germline analysis of an international cohort of pediatric diffuse midline glioma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill Genome Centre; Université de Montréal; McGill University Health Centre","funders":"Medical Research Future Fund; Australian Lions Childhood Cancer Research Foundation","keywords":"Germline; PALB2; Germline mutation; Carcinogenesis; Genetics; Cancer research; Medicine; Glioma; Exome sequencing; Biology; Cancer; Oncology; Gene; Mutation","score_opus":0.012607284383609597,"score_gpt":0.31591087409045465,"score_spread":0.30330358970684507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408344009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990872,0.000078774305,0.00013489624,0.000012056042,0.0000016748528,0.0000064469837,0.00042860614,0.0000034824334,0.00024687842],"genre_scores_gemma":[0.9984659,0.00010721724,0.0002150674,0.000020668229,0.00000519021,0.000012648894,0.0011021952,0.000005534236,0.00006562795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964094,0.00004554613,0.000034793116,0.00017751809,0.000054790053,0.00004634609],"domain_scores_gemma":[0.99949706,0.0000700183,0.0002213688,0.000068977286,0.000055534594,0.00008707247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035569048,0.00031288865,0.0002691056,0.0009847638,0.0003723678,0.00046590625,0.00032290284,0.00022774932,0.0016809897],"category_scores_gemma":[0.0012995197,0.00020934548,0.00023534712,0.0009187515,0.00025095028,0.0002563755,0.0005601689,0.0002942426,0.0002945853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080764825,0.000016104896,0.99536574,0.000010547656,0.00004105938,0.0005483375,0.00013313151,0.00006783713,0.0014193328,0.00004001448,0.00015504633,0.002122092],"study_design_scores_gemma":[0.000010665656,0.00010785449,0.99293923,0.000011012588,0.000046131892,0.0050517903,0.00030669055,0.0002051166,0.0005006168,0.000044951525,0.00077051984,0.000005384076],"about_ca_topic_score_codex":0.0018156869,"about_ca_topic_score_gemma":0.0020008464,"teacher_disagreement_score":0.0018156869,"about_ca_system_score_codex":0.0002074554,"about_ca_system_score_gemma":0.00021074859,"threshold_uncertainty_score":0.0056235194},"labels":[],"label_agreement":null},{"id":"W4408762849","doi":"10.1093/neuonc/noaf079","title":"A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; ECOG-ACRIN Cancer Research Group; Mallinckrodt Pharmaceuticals; Society for Immunotherapy of Cancer; Regeneron Pharmaceuticals; Genentech; University of Pittsburgh; American College of Radiology Imaging Network; EMD Serono; International Association for the Study of Lung Cancer; Gilead Sciences; National Cancer Institute; Brigham and Women's Hospital; Daiichi Sankyo Europe; Sanofi; G1 Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Bill and Melinda Gates Foundation; Amgen; University of Texas MD Anderson Cancer Center; Pfizer","keywords":"Medicine; Nivolumab; Regimen; Immunotherapy; Immune system; Oncology; Clinical trial; Internal medicine; Temozolomide; Adjuvant; Immunology; Chemotherapy","score_opus":0.06658925152181847,"score_gpt":0.39503148754060874,"score_spread":0.3284422360187903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408762849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966709,0.0006815699,0.0002687331,0.00016879599,0.00004176177,0.0014020823,0.00029688564,0.0000310456,0.00043834298],"genre_scores_gemma":[0.991381,0.00082948734,0.0022489873,0.0004838447,0.00014235043,0.0026950182,0.0012795933,0.000014699936,0.0009249674],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992945,0.00035252367,0.000036333797,0.0001251789,0.000068686386,0.00012264107],"domain_scores_gemma":[0.9990963,0.00010529968,0.00021456648,0.00009974718,0.00006788234,0.00041615628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020600792,0.0014856056,0.0012801089,0.0007015768,0.00045202512,0.0008225823,0.0010857746,0.0011385542,0.0028879768],"category_scores_gemma":[0.00089415506,0.00046719372,0.00081587426,0.0005074343,0.0008040963,0.00090786186,0.0005592659,0.002727704,0.0005074373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73463696,0.10675858,0.013313818,0.00057661976,0.0011522204,0.00016655412,0.00020701207,0.0024350623,0.04313402,0.00015792233,0.0018279495,0.095633246],"study_design_scores_gemma":[0.3218737,0.653755,0.016711416,0.00003300445,0.00036161684,0.0002170364,0.00004910918,0.0010815747,0.004680953,0.00012826586,0.0010786195,0.000029612122],"about_ca_topic_score_codex":0.0006997305,"about_ca_topic_score_gemma":0.0025172038,"teacher_disagreement_score":0.0028879768,"about_ca_system_score_codex":0.0009078701,"about_ca_system_score_gemma":0.0014817839,"threshold_uncertainty_score":0.010894895},"labels":[],"label_agreement":null},{"id":"W4409212271","doi":"10.1093/neuonc/noaf092","title":"Salvage therapies for first relapse of SHH medulloblastoma in early childhood","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Université de Montréal; Hospital for Sick Children; BC Children's Hospital; Université Laval; University of British Columbia; London Health Sciences Centre; University of Toronto; Western University; Nova Scotia Health Authority; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; Children's Hospital of Western Ontario; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Hazard ratio; Vismodegib; Radiation therapy; Oncology; Proportional hazards model; Internal medicine; Chemotherapy; Salvage therapy; Cohort; Surgery; Pathology; Confidence interval","score_opus":0.011501372273330717,"score_gpt":0.28328866239599615,"score_spread":0.27178729012266545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409212271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993418,0.004793384,0.0003627857,0.00016878133,0.000019087396,0.000019943112,0.00035273362,0.000027251232,0.00083807437],"genre_scores_gemma":[0.99706036,0.0018435661,0.0002017258,0.00008531756,0.000025784357,0.000011715362,0.0005362945,0.000005828968,0.0002294042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981433,0.0000294794,0.000014264881,0.000034345085,0.000056542915,0.000051075494],"domain_scores_gemma":[0.9994332,0.000074384334,0.00035109356,0.000023329252,0.000025719217,0.00009225754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277105,0.00016777572,0.0005064937,0.00031731027,0.00015527998,0.0002683994,0.0003453286,0.0001822484,0.001033661],"category_scores_gemma":[0.000795072,0.00007981064,0.0005333295,0.00035877837,0.00018270827,0.00015522388,0.00025000577,0.00048290446,0.00015591277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001231924,0.00023002742,0.9264782,0.00029699368,0.00033923594,0.0032213924,0.00020194864,0.00094258186,0.0024999108,0.00021143518,0.00176687,0.0625794],"study_design_scores_gemma":[0.00009332195,0.0015051593,0.9772898,0.00020846259,0.00026925144,0.012320631,0.00026951992,0.0015493324,0.002691267,0.00044351644,0.0033479817,0.00001168041],"about_ca_topic_score_codex":0.0017751609,"about_ca_topic_score_gemma":0.0039599203,"teacher_disagreement_score":0.0017751609,"about_ca_system_score_codex":0.00076585583,"about_ca_system_score_gemma":0.0004964257,"threshold_uncertainty_score":0.0055567026},"labels":[],"label_agreement":null},{"id":"W4410050820","doi":"10.1093/neuonc/noaf118","title":"Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Cancer Institute; Faculty of Medicine and Health, University of Sydney; Faculty of Medicine and Health, University of Leeds; Advanced Accelerator Applications; University of California, San Francisco; Leids Universitair Medisch Centrum; University of Texas MD Anderson Cancer Center; National Institutes of Health; Eli Lilly and Company; Parker Institute for Cancer Immunotherapy; Aptitude Health; EMD Serono; Deutschen Konsortium für Translationale Krebsforschung; LEO Pharma; Universität zu Köln; Massachusetts General Hospital; Universitätsklinikum Köln; Alexion Pharmaceuticals; Cure Brain Cancer Foundation; Children's Hospital Colorado; Moffitt Cancer Center; Universiteit Leiden; Seagen; Agios Pharmaceuticals; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Department of Radiology and Biomedical Imaging, University of California, San Francisco; Amgen; Elekta; Universitätsspital Zürich; Erasmus Universiteit Rotterdam; Memorial Sloan-Kettering Cancer Center; University of Toronto; School of Medicine, Indiana University; Children's Healthcare of Atlanta; National Institute of Neurological Disorders and Stroke; Break Through Cancer; Aflac; U.S. Department of Defense; Bristol-Myers Squibb; University of Leeds; Dana-Farber Cancer Institute; Florida International University; Servier; Incyte; Pfizer; Università degli Studi di Torino; Virginia Commonwealth University; Gilead Sciences; Emory University; Brigham and Women's Hospital","keywords":"Scope (computer science); Variety (cybernetics); Medical physics; Clinical trial; Medicine; Engineering; Psychology; Computer science; Artificial intelligence; Pathology","score_opus":0.023350228916086173,"score_gpt":0.40557643795815995,"score_spread":0.3822262090420738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050820","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049337927,0.27628517,0.14925683,0.2800785,0.022011114,0.062405024,0.04596613,0.0054485444,0.10921074],"genre_scores_gemma":[0.15175271,0.12410485,0.44959885,0.077232674,0.004895377,0.06786692,0.10384458,0.0025515875,0.018152457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9196932,0.040411845,0.012691062,0.003456231,0.018069118,0.005678585],"domain_scores_gemma":[0.84175324,0.047490273,0.018799488,0.0057531693,0.058568772,0.027635125],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.33247468,0.001816612,0.003052655,0.003821734,0.001352146,0.009035889,0.0062667746,0.0059371986,0.007352693],"category_scores_gemma":[0.12082186,0.0011091818,0.004191176,0.0043841656,0.0019531194,0.005630791,0.01003521,0.005926255,0.0049381023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041417647,0.0018093468,0.013819768,0.014703306,0.00068119256,0.00022809717,0.0009527263,0.0038268894,0.0017173205,0.015428253,0.2007443,0.74194694],"study_design_scores_gemma":[0.0021599976,0.0055181645,0.0668005,0.035674967,0.00083352794,0.0004169554,0.0012614796,0.005512177,0.0043395343,0.005554069,0.8716655,0.00026307508],"about_ca_topic_score_codex":0.014501003,"about_ca_topic_score_gemma":0.006937432,"teacher_disagreement_score":0.33247468,"about_ca_system_score_codex":0.010852159,"about_ca_system_score_gemma":0.081624806,"threshold_uncertainty_score":0.8231776},"labels":[],"label_agreement":null},{"id":"W4410050909","doi":"10.1093/neuonc/noaf094","title":"Mind over microbes: targeting the gut–brain axis to improve treatment of pediatric low-grade glioma","year":2025,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Medicine; Neuroscience; Psychology; Cancer research","score_opus":0.016342993199156,"score_gpt":0.29809387383277824,"score_spread":0.28175088063362225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050909","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004812267,0.017010206,0.00020277477,0.9594193,0.014260806,0.000017179404,0.00012929259,0.000035630514,0.0041124206],"genre_scores_gemma":[0.03894102,0.02033497,0.00082996994,0.88055617,0.052932918,0.00007181346,0.00010303837,0.00003514126,0.0061948774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994703,0.00019419038,0.00006611956,0.00006211026,0.00013960968,0.000067627916],"domain_scores_gemma":[0.99718213,0.0017904465,0.00016805016,0.00006263947,0.00035252032,0.00044413572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010568686,0.00040664265,0.001078075,0.00032751434,0.0008859653,0.0011233573,0.0005723845,0.008386918,0.0025433311],"category_scores_gemma":[0.0065279803,0.0001858102,0.0006616423,0.00032949177,0.0009196917,0.0013465579,0.0004837831,0.010671967,0.0013946142],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008402782,0.00022714357,0.008087873,0.00043737935,0.00018363308,0.008622434,0.00016508807,0.0003539772,0.0017174697,0.005985361,0.8480261,0.12535316],"study_design_scores_gemma":[0.0013246147,0.0012047604,0.010656966,0.0008129767,0.00035311823,0.015224407,0.0006499504,0.001056084,0.0026074406,0.025269356,0.9407364,0.00010383885],"about_ca_topic_score_codex":0.0033241084,"about_ca_topic_score_gemma":0.0073913448,"teacher_disagreement_score":0.008386918,"about_ca_system_score_codex":0.0017398206,"about_ca_system_score_gemma":0.001659842,"threshold_uncertainty_score":0.01262331},"labels":[],"label_agreement":null},{"id":"W4410217009","doi":"10.1093/neuonc/noaf119","title":"Consortium trial demonstrates efficacy of selumetinib in pediatric low-grade glioma","year":2025,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Selumetinib; Medicine; Glioma; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.02496946037831344,"score_gpt":0.31313543801832894,"score_spread":0.2881659776400155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410217009","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15722996,0.025605645,0.0009088138,0.7086498,0.014031014,0.00020718777,0.003746087,0.00031748723,0.08930407],"genre_scores_gemma":[0.58424205,0.013386727,0.0017096489,0.35169625,0.014190238,0.0003099347,0.0032890136,0.0001457062,0.031030506],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995827,0.00016649425,0.00002993233,0.000046294623,0.00008203246,0.00009267224],"domain_scores_gemma":[0.99894303,0.0004907943,0.00009830327,0.000033240616,0.000121645724,0.00031286333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006158204,0.00028994514,0.00068572105,0.00016519455,0.00045046027,0.0010457375,0.0004602243,0.0029752066,0.004142886],"category_scores_gemma":[0.0030995111,0.00009603041,0.0005831226,0.00023314184,0.00042390393,0.0006162458,0.0003032569,0.0033368214,0.0014884121],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013573098,0.00066451123,0.015592317,0.00053354056,0.00051175454,0.008925962,0.00016588606,0.0018632262,0.0036008735,0.0065099476,0.74171305,0.20634574],"study_design_scores_gemma":[0.038009237,0.010278583,0.038144443,0.0010730162,0.0009808078,0.01946384,0.0005346359,0.0060101044,0.0080663515,0.020300554,0.85700333,0.00013519943],"about_ca_topic_score_codex":0.0028381757,"about_ca_topic_score_gemma":0.010427024,"teacher_disagreement_score":0.004142886,"about_ca_system_score_codex":0.0020661985,"about_ca_system_score_gemma":0.0012810836,"threshold_uncertainty_score":0.014991343},"labels":[],"label_agreement":null},{"id":"W4410761938","doi":"10.1093/neuonc/noaf125","title":"Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Medizinischen Fakultät Heidelberg, Universität Heidelberg","keywords":"Medicine; Progression-free survival; Radiation therapy; Meningioma; Proportional hazards model; Internal medicine; Clinical endpoint; Retrospective cohort study; Grading (engineering); Oncology; Tumor progression; Surgery; Overall survival; Cancer; Clinical trial; Biology","score_opus":0.011924677539155184,"score_gpt":0.29274558824570135,"score_spread":0.2808209107065462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410761938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942267,0.000296044,0.000059194397,0.000007898467,0.0000018545333,0.0000034133254,0.000060955193,0.000002591961,0.0001453649],"genre_scores_gemma":[0.9997111,0.00009435215,0.000043404285,0.0000058001447,0.000002617618,0.0000023238674,0.0000989133,8.7567076e-7,0.000040680363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998982,0.000019716159,0.000012888352,0.000018131272,0.000022645554,0.000028393897],"domain_scores_gemma":[0.999681,0.000042214415,0.00017611714,0.000028030257,0.000019976957,0.000052662297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023336135,0.00015830724,0.00020337188,0.00027011684,0.00015955644,0.00023241808,0.00016503979,0.0001549048,0.00038549816],"category_scores_gemma":[0.0006367126,0.00008622138,0.00030150844,0.00022617608,0.00012172015,0.00012295389,0.00017166401,0.00017175797,0.00011592818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016934467,0.000059948004,0.98063743,0.00003679719,0.00007484317,0.0017380968,0.000093164526,0.000198486,0.003134154,0.00001945852,0.00012856864,0.012185497],"study_design_scores_gemma":[0.000025114574,0.0009956418,0.9897983,0.000012973906,0.0001552906,0.0064520515,0.00016437218,0.00036239508,0.0014509378,0.000048732138,0.0005277574,0.0000063609173],"about_ca_topic_score_codex":0.0018951568,"about_ca_topic_score_gemma":0.0038894946,"teacher_disagreement_score":0.0018951568,"about_ca_system_score_codex":0.00027889168,"about_ca_system_score_gemma":0.0002966987,"threshold_uncertainty_score":0.0037682056},"labels":[],"label_agreement":null},{"id":"W4411163591","doi":"10.1093/neuonc/noaf132","title":"Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Methotrexate; Medicine; Internal medicine; Chemotherapy; Clinical endpoint; Phases of clinical research; Gastroenterology; Oncology; Surgery; Randomized controlled trial","score_opus":0.013146549451630617,"score_gpt":0.3143747379784106,"score_spread":0.30122818852677996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411163591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867574,0.0062732575,0.00071523007,0.00088036363,0.00024177592,0.002836512,0.0010621212,0.00006653736,0.0011667489],"genre_scores_gemma":[0.98238844,0.0041002585,0.0031469644,0.0014848262,0.0002637802,0.0052058096,0.0016557546,0.00002545594,0.0017287362],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994087,0.00040570807,0.000026201214,0.00005986163,0.000047781778,0.000051731673],"domain_scores_gemma":[0.99900025,0.00032958656,0.0002849528,0.00006905072,0.000054968194,0.00026108694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017627011,0.00074997405,0.0015733233,0.00025631685,0.00027179212,0.00058259646,0.00050795235,0.00090618053,0.0025420503],"category_scores_gemma":[0.001507244,0.00026862446,0.0013502031,0.0002955336,0.0005193204,0.0004135488,0.0002532213,0.0017209353,0.0002995615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9476771,0.00541708,0.0043391036,0.000641148,0.002194541,0.00017146354,0.00010204896,0.0009061067,0.0059740227,0.00025729297,0.0023141634,0.030005876],"study_design_scores_gemma":[0.9488631,0.04354578,0.004763583,0.000041219453,0.00056372,0.00012945902,0.000016778353,0.0005016654,0.0005685009,0.0001042815,0.0008914269,0.000010368871],"about_ca_topic_score_codex":0.0012167669,"about_ca_topic_score_gemma":0.003998861,"teacher_disagreement_score":0.0025420503,"about_ca_system_score_codex":0.00078669563,"about_ca_system_score_gemma":0.0015054216,"threshold_uncertainty_score":0.009322166},"labels":[],"label_agreement":null},{"id":"W4411321230","doi":"10.1093/neuonc/noaf145","title":"Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Research Foundation Singapore","keywords":"Mesenchymal stem cell; Biology; Cancer research; Transcriptome; Computational biology; Phenotype; Gene knockdown; Cell biology; Gene; Gene expression; Genetics","score_opus":0.014917777567835062,"score_gpt":0.28987392668638795,"score_spread":0.2749561491185529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411321230","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3138704,0.014709941,0.041483525,0.000671165,0.00017072723,0.00039503668,0.6104659,0.010272817,0.007960491],"genre_scores_gemma":[0.20388615,0.0067133782,0.067552276,0.0005609965,0.00009750303,0.0008396318,0.7150599,0.0023605602,0.002929601],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953485,0.000044545348,0.000036950594,0.0001552055,0.00015870285,0.000069757865],"domain_scores_gemma":[0.9995228,0.00011820644,0.000107004395,0.000069641705,0.00010248623,0.00007991461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007845112,0.00080686284,0.0010644206,0.0024695178,0.00065247726,0.0012199257,0.00052890065,0.00051688997,0.0024947762],"category_scores_gemma":[0.0010388914,0.00031541797,0.00072251854,0.0022407454,0.0003956495,0.0006556754,0.0013376061,0.00071035925,0.0020049403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018655448,0.000101041536,0.015540234,0.003850357,0.00044108534,0.00120828,0.0006137308,0.0034475822,0.8801226,0.0023042327,0.031206382,0.059298854],"study_design_scores_gemma":[0.0004075405,0.0013818298,0.13663803,0.0011207231,0.0017538875,0.005049766,0.0010309005,0.021204533,0.39553618,0.008458678,0.42698136,0.0004366679],"about_ca_topic_score_codex":0.0010670302,"about_ca_topic_score_gemma":0.0028077532,"teacher_disagreement_score":0.0024947762,"about_ca_system_score_codex":0.0004072692,"about_ca_system_score_gemma":0.0013986556,"threshold_uncertainty_score":0.008345902},"labels":[],"label_agreement":null},{"id":"W4411358292","doi":"10.1093/neuonc/noaf146","title":"Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescence","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; ZonMw","keywords":"Senescence; Radiation therapy; Immunohistochemistry; Pathology; Biology; Medicine; Internal medicine","score_opus":0.01720059588350463,"score_gpt":0.31279402011934593,"score_spread":0.2955934242358413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411358292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900676,0.006057424,0.001894445,0.00007980613,0.0000598399,0.000027456574,0.00028907435,0.000118761986,0.0014057135],"genre_scores_gemma":[0.9940812,0.003063475,0.0010457168,0.000066001034,0.000016988566,0.000025547355,0.0003042291,0.000019518617,0.0013772451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999944,0.000007547939,0.0000056098634,0.000014378681,0.000014419851,0.000014017083],"domain_scores_gemma":[0.99991024,0.000011631366,0.000034743924,0.000015111507,0.000010194365,0.00001802357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009860031,0.00033090837,0.00022951415,0.00022884594,0.00011677805,0.00016891652,0.00012693538,0.00021784082,0.0019399049],"category_scores_gemma":[0.00010521585,0.000091062706,0.00030930171,0.00012124289,0.00019393892,0.0001243389,0.00014339462,0.00037980522,0.0002782699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036976975,0.00004943847,0.0008115833,0.000090429414,0.000021079506,0.00011076707,0.000024698722,0.00008007126,0.9926409,0.00005633867,0.00009909438,0.0056458083],"study_design_scores_gemma":[0.000056378794,0.0063489876,0.047997296,0.000078546094,0.00021096964,0.002001171,0.00012422993,0.0005332055,0.93604285,0.00014950575,0.0064426195,0.000014235203],"about_ca_topic_score_codex":0.00049496075,"about_ca_topic_score_gemma":0.0007452612,"teacher_disagreement_score":0.0019399049,"about_ca_system_score_codex":0.00011485055,"about_ca_system_score_gemma":0.0001539609,"threshold_uncertainty_score":0.006489575},"labels":[],"label_agreement":null},{"id":"W4412356022","doi":"10.1093/neuonc/noaf165","title":"RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; Cleveland Clinic; Medac; Eisai; Les Laboratories Pierre Fabre; LEO Pharma; Incyte; Novocure; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Servier; Pfizer","keywords":"Cohort; Medicine; Glioma; Epilepsy; Post-hoc analysis; Clinical trial; Cohort study; Physical therapy; Internal medicine; Psychiatry","score_opus":0.07208005475233031,"score_gpt":0.4388090640026441,"score_spread":0.36672900925031376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412356022","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25822955,0.14188819,0.27868256,0.038106497,0.0045879306,0.08075076,0.0711846,0.00692085,0.119649105],"genre_scores_gemma":[0.51573086,0.021067636,0.27253208,0.009127809,0.0011957583,0.13969909,0.03297628,0.0014622338,0.0062082973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8740547,0.09094913,0.01831151,0.00287113,0.012685259,0.0011282341],"domain_scores_gemma":[0.73122185,0.14937483,0.081101015,0.010176421,0.024485119,0.00364082],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14362244,0.0013712196,0.0037586852,0.0045154435,0.00062553654,0.0035740498,0.003111621,0.001199625,0.0048391502],"category_scores_gemma":[0.23693308,0.0005161404,0.003872053,0.004873581,0.0010394205,0.0023769317,0.0036890146,0.0023007123,0.0016816357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014499875,0.00071327895,0.19288447,0.014238741,0.01076901,0.00018724828,0.001211828,0.005405064,0.0008062985,0.012975364,0.12835638,0.61795247],"study_design_scores_gemma":[0.027034821,0.00887302,0.5694276,0.019028468,0.012475669,0.0013232903,0.0010776038,0.020251298,0.0030708627,0.03929755,0.2973871,0.0007526633],"about_ca_topic_score_codex":0.001596802,"about_ca_topic_score_gemma":0.0028719818,"teacher_disagreement_score":0.85637754,"about_ca_system_score_codex":0.0024492154,"about_ca_system_score_gemma":0.0070179165,"threshold_uncertainty_score":0.7595571},"labels":[],"label_agreement":null},{"id":"W4412654330","doi":"10.1093/neuonc/noaf150","title":"Erratum to: High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor","year":2025,"lang":"en","type":"erratum","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Research Institute","keywords":"Medulloblastoma; Immunohistochemistry; High resolution; Oncology; Internal medicine; Medicine; Biology; Pathology; History","score_opus":0.025443729800560703,"score_gpt":0.3476445139960351,"score_spread":0.3222007841954744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412654330","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006949231,0.0028450235,0.0008542269,0.10828594,0.88192075,0.00004956514,0.0011949267,0.00026143156,0.0038931982],"genre_scores_gemma":[0.020033207,0.018668609,0.010928402,0.25181666,0.4762263,0.00024360396,0.004897809,0.0015037454,0.21568169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829453,0.00025472362,0.0004070532,0.00019767642,0.0006928432,0.00015327112],"domain_scores_gemma":[0.9848547,0.004611615,0.0009243271,0.0008841293,0.007717181,0.0010081053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026691481,0.0015939706,0.0013267518,0.0031861614,0.0018653647,0.0019925486,0.0016443649,0.0055521675,0.019350875],"category_scores_gemma":[0.031611957,0.0009070742,0.0011397586,0.001445254,0.0014211804,0.0011493433,0.0009650445,0.0063800416,0.017400667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072563664,0.000015023665,0.00026992185,0.00010469097,0.000014337198,0.0008342514,0.000019646684,0.000041953877,0.00013507843,0.0002519459,0.9915782,0.0066624307],"study_design_scores_gemma":[0.00008663608,0.00005834054,0.0028201665,0.00047418382,0.000109684464,0.0033753987,0.00013645193,0.0004101686,0.0010244407,0.0010992353,0.9903499,0.00005539244],"about_ca_topic_score_codex":0.009924928,"about_ca_topic_score_gemma":0.014530061,"teacher_disagreement_score":0.019350875,"about_ca_system_score_codex":0.0021782822,"about_ca_system_score_gemma":0.0031732544,"threshold_uncertainty_score":0.064735174},"labels":[],"label_agreement":null},{"id":"W4412690588","doi":"10.1093/neuonc/noaf164","title":"Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Université de Montréal; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medac; Servier; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Erasmus Universiteit Rotterdam; Springworks Therapeutics; Novocure; Alexion Pharmaceuticals; Eisai; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Counterpoint; Mutant; Oncology; Medicine; Internal medicine; Cancer research; Biology; Psychology; Genetics; Gene","score_opus":0.012304426537141373,"score_gpt":0.29382266277975,"score_spread":0.28151823624260863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412690588","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53157127,0.21458325,0.047937635,0.04404372,0.015099323,0.00667738,0.0042499807,0.005665425,0.13017207],"genre_scores_gemma":[0.875141,0.038833402,0.025180727,0.023253962,0.0038664523,0.001427427,0.0028946572,0.0003581093,0.029044155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999813,0.00003176906,0.000021964837,0.000031430216,0.00005948082,0.000042371496],"domain_scores_gemma":[0.99971837,0.000058078116,0.000057110938,0.000020785772,0.00005581223,0.00008983638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004051437,0.000583361,0.00082723727,0.0007501277,0.00023098986,0.00078090944,0.0005652084,0.0009534241,0.014761893],"category_scores_gemma":[0.001127624,0.00011933156,0.0008848854,0.0002228989,0.00020695674,0.00081075693,0.00044952877,0.0020529227,0.0034171136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013374139,0.0023558403,0.0029116198,0.0016603284,0.00046835642,0.0021056433,0.00010868909,0.0023257397,0.013360881,0.0024774189,0.04436686,0.91448456],"study_design_scores_gemma":[0.022626135,0.040683005,0.04504796,0.007621581,0.0028637554,0.015844299,0.00049916474,0.012426712,0.061780192,0.0269897,0.7632256,0.00039188372],"about_ca_topic_score_codex":0.0006591612,"about_ca_topic_score_gemma":0.0025660696,"teacher_disagreement_score":0.014761893,"about_ca_system_score_codex":0.00055391894,"about_ca_system_score_gemma":0.00041261065,"threshold_uncertainty_score":0.04938346},"labels":[],"label_agreement":null},{"id":"W4413859329","doi":"10.1093/neuonc/noaf140","title":"Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; Medac; Daiichi Sankyo Europe; National Cancer Institute; Servier; Universitat Autònoma de Barcelona; Università degli Studi di Torino; Universität Zürich; Umeå Universitet; Bar-Ilan University; McGill University; University of Leeds; ViewRay; Moffitt Cancer Center; Apollomics; Sidney Kimmel Comprehensive Cancer Center; Pfizer; Incyte; AstraZeneca; Novocure; Cancer Research UK; Boston Scientific Corporation; Karyopharm Therapeutics; Wayne State University; University of Illinois at Urbana-Champaign; Michigan State University; Amgen; College of Engineering, Michigan State University; Johns Hopkins University; Henry Ford Health System; Vrije Universiteit Amsterdam; Focused Ultrasound Foundation; University of Sussex; Alexion Pharmaceuticals; Eli Lilly and Company","keywords":"Liquid biopsy; Biopsy; Brain biopsy; Analyte; Medicine; Brain tumor; Medical physics; Pathology; Internal medicine; Chemistry; Chromatography; Cancer","score_opus":0.026180657650948704,"score_gpt":0.3238853874818349,"score_spread":0.2977047298308862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413859329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104481776,0.998131,0.0004027991,0.00065894955,0.00016808996,0.000013507303,0.000036293673,0.000010651439,0.00047412066],"genre_scores_gemma":[0.0006624474,0.99743253,0.0009086108,0.0004620925,0.00013829947,0.000024101268,0.000079249534,0.000005176592,0.00028749497],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989078,0.000300256,0.00024841772,0.00015085975,0.0003354524,0.000057176687],"domain_scores_gemma":[0.9968099,0.0021105339,0.0002769584,0.000064522836,0.0006724626,0.00006554704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038719003,0.0010075028,0.002005992,0.0038840042,0.00033041186,0.0016321136,0.001468319,0.0015873655,0.0024525018],"category_scores_gemma":[0.0049329177,0.00041108025,0.0015700011,0.002447513,0.0007275757,0.0016446358,0.0009864785,0.0020161585,0.001552561],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011405567,0.000057645528,0.0005027935,0.03078337,0.00023361406,0.00024219061,0.000093369505,0.0003174198,0.0011085847,0.0025785973,0.02009096,0.94387734],"study_design_scores_gemma":[0.00003188092,0.000165278,0.0017125896,0.023991993,0.00080140104,0.0017534692,0.00013978155,0.00019672995,0.0017333786,0.0026240468,0.96678823,0.00006119535],"about_ca_topic_score_codex":0.002097535,"about_ca_topic_score_gemma":0.0034211185,"teacher_disagreement_score":0.0038840042,"about_ca_system_score_codex":0.0010141351,"about_ca_system_score_gemma":0.003354797,"threshold_uncertainty_score":0.020476818},"labels":[],"label_agreement":null},{"id":"W4413927588","doi":"10.1093/neuonc/noaf185.063","title":"DEVELOPING A NOVEL HUMAN MODEL OF MINIMAL RESIDUAL DISEASE IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Glioblastoma; Minimal residual disease; Residual; Cancer research; Computer science; Computational biology; Biology; Medicine; Internal medicine; Leukemia; Algorithm","score_opus":0.05322905011578462,"score_gpt":0.3661837462940857,"score_spread":0.3129546961783011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7666998,0.011963374,0.18349963,0.0021662726,0.001993313,0.0020314937,0.01230013,0.0016373355,0.017708734],"genre_scores_gemma":[0.89830744,0.007490604,0.058248535,0.00070523436,0.00010673219,0.002855502,0.00947524,0.00025278318,0.022557743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995647,0.000059937418,0.000046364836,0.00009833847,0.00016206966,0.00006859138],"domain_scores_gemma":[0.9998447,0.0000197284,0.00002925498,0.000032434204,0.00003382654,0.000040061746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006150051,0.00060694653,0.00064999645,0.00059367926,0.00039745343,0.00086285395,0.0007980011,0.0010033905,0.003762385],"category_scores_gemma":[0.00022156232,0.00033174985,0.00058053946,0.00033737597,0.00048381218,0.00046613437,0.0005022874,0.0015093036,0.0015591207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004995881,0.00031176486,0.00042239105,0.00038900392,0.000037047066,0.00052081683,0.00018652582,0.001079763,0.985261,0.0020379256,0.001762684,0.007491421],"study_design_scores_gemma":[0.00023665444,0.0036986603,0.0046023,0.00019139946,0.00020658893,0.002690218,0.0002998656,0.011699942,0.8729127,0.0018962865,0.1014896,0.00007583561],"about_ca_topic_score_codex":0.0019607048,"about_ca_topic_score_gemma":0.0027901982,"teacher_disagreement_score":0.003762385,"about_ca_system_score_codex":0.00066530786,"about_ca_system_score_gemma":0.000730281,"threshold_uncertainty_score":0.012586474},"labels":[],"label_agreement":null},{"id":"W4413945759","doi":"10.1093/neuonc/noaf185.085","title":"CHILDHOOD CENTRAL NERVOUS SYSTEM TUMOURS IN A MAJOR CENTER IN GHANA: PRESENTATION AND OUTCOMES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Presentation (obstetrics); Central nervous system; Center (category theory); Medicine; Pediatrics; Surgery; Internal medicine","score_opus":0.00993748609862119,"score_gpt":0.28807498670040543,"score_spread":0.2781375006017842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413945759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954385,0.000119009885,0.0000092918945,0.000044545406,0.0000020445696,0.0000061329456,0.00013090725,9.2128124e-7,0.00014318089],"genre_scores_gemma":[0.9995945,0.00015235365,0.00003207874,0.000017895505,0.000004199697,0.000007234024,0.00014264513,6.9539703e-7,0.000048464342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974734,0.0000509818,0.00002640435,0.000046812358,0.000030028848,0.000098410295],"domain_scores_gemma":[0.99899155,0.000093464274,0.00060552463,0.000014782331,0.00007142615,0.00022323325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020488945,0.00028129772,0.0003008489,0.0006428129,0.00057926186,0.0005728078,0.00027480893,0.00032341058,0.0014960606],"category_scores_gemma":[0.0011981576,0.00024719868,0.00017917468,0.0011171035,0.00049961504,0.0006225268,0.00054836186,0.0004328889,0.00015949758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027370133,0.000021854006,0.9982493,0.000013963547,0.0000053302106,0.0006629735,0.00030209465,0.000015103134,0.00006891983,0.000008868858,0.00007360276,0.00055050245],"study_design_scores_gemma":[0.0000069225734,0.00012209028,0.99394363,0.000030464438,0.0000078358025,0.002499423,0.0031325878,0.000049977803,0.00003798276,0.000016304946,0.00014916547,0.0000036124648],"about_ca_topic_score_codex":0.017635796,"about_ca_topic_score_gemma":0.022640351,"teacher_disagreement_score":0.017635796,"about_ca_system_score_codex":0.000968451,"about_ca_system_score_gemma":0.00074621633,"threshold_uncertainty_score":0.035066307},"labels":[],"label_agreement":null},{"id":"W4413970429","doi":"10.1093/neuonc/noaf200","title":"Glioblastoma tumor microtubes and brain fatty acid-binding protein: Path to directional infiltration","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Neurosphere; Cancer research; Protein kinase C; Cell migration; Cell biology; Phosphorylation; Chemistry; Cell; Biology; Cellular differentiation; Gene; Biochemistry","score_opus":0.006785381770277491,"score_gpt":0.2610406630873003,"score_spread":0.2542552813170228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413970429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652745,0.014025544,0.0055204188,0.0007114259,0.000033387547,0.000042042717,0.00030013765,0.00015124519,0.0026883148],"genre_scores_gemma":[0.9902773,0.0051106913,0.0023448712,0.0000872971,0.000012698849,0.000030094961,0.00020505619,0.000009703453,0.0019223201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999653,0.000004857828,0.0000020953241,0.0000056148647,0.000009565709,0.00001249274],"domain_scores_gemma":[0.99994266,0.0000043506075,0.00002698039,0.0000025221275,0.00000953469,0.000013999577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007175509,0.00023715498,0.00008991765,0.0002481752,0.00019945567,0.00025425237,0.00011030625,0.0002588022,0.00079929986],"category_scores_gemma":[0.00006243673,0.00007199854,0.000111547946,0.00013443579,0.00021382618,0.00027029536,0.0002299908,0.00031026127,0.00019165249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017968862,0.00003416204,0.0040604053,0.00024210969,0.000019317113,0.00045094796,0.00006913305,0.00026926704,0.97907317,0.0019261016,0.00038109146,0.013294405],"study_design_scores_gemma":[0.000047434376,0.000723369,0.0889796,0.00007723113,0.00011684173,0.0034276568,0.0004380406,0.0038257204,0.87177825,0.0026670864,0.027896341,0.000022469347],"about_ca_topic_score_codex":0.001497406,"about_ca_topic_score_gemma":0.0020992225,"teacher_disagreement_score":0.001497406,"about_ca_system_score_codex":0.0004959681,"about_ca_system_score_gemma":0.00041969493,"threshold_uncertainty_score":0.0035985112},"labels":[],"label_agreement":null},{"id":"W4414786598","doi":"10.1093/neuonc/noaf193.335","title":"P10.24.A TARGETING NON-GENETIC KINASE-DEPENDENT SIGNALING TO PREVENT GROUP 3 MEDULLOBLASTOMA RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Medulloblastoma; Hedgehog signaling pathway; Downregulation and upregulation; Signal transduction; Kinase; Sonic hedgehog; In vivo; Hedgehog","score_opus":0.017074041001101076,"score_gpt":0.3307893227200309,"score_spread":0.3137152817189298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846526,0.004278899,0.0026676564,0.00044400047,0.00033171795,0.00044345987,0.0016338687,0.00068596436,0.0048618685],"genre_scores_gemma":[0.9861069,0.0027519185,0.0023611598,0.00020504146,0.0000524158,0.0003135434,0.001942162,0.00006767046,0.0061992817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991107,0.000009302465,0.000005910819,0.000018269464,0.000016865451,0.000038561982],"domain_scores_gemma":[0.999928,0.0000061307637,0.000018320998,0.0000067352667,0.000005671241,0.00003503051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012619222,0.00062746427,0.0005022309,0.00034228447,0.00015681075,0.00030580835,0.00053160364,0.00035118024,0.0036693246],"category_scores_gemma":[0.000102919716,0.00016017242,0.00039204347,0.00016658765,0.00034331458,0.00016998276,0.00013104467,0.0010776822,0.001013364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008901252,0.004670056,0.0007592744,0.0004678428,0.0001411585,0.00050371885,0.000039112678,0.0009640781,0.93400604,0.00074472936,0.0038007011,0.045001987],"study_design_scores_gemma":[0.0046423883,0.04891881,0.015279225,0.00008140919,0.0003230943,0.0021035029,0.00010727786,0.0036686843,0.8986427,0.0006097229,0.025571775,0.00005132401],"about_ca_topic_score_codex":0.0010547724,"about_ca_topic_score_gemma":0.0018711184,"teacher_disagreement_score":0.0036693246,"about_ca_system_score_codex":0.00030804423,"about_ca_system_score_gemma":0.0006159713,"threshold_uncertainty_score":0.0122751},"labels":[],"label_agreement":null},{"id":"W4414786640","doi":"10.1093/neuonc/noaf193.347","title":"P11.08.A CLINICAL OUTCOMES AND BIOMARKER SHIFTING OF BREAST CANCER BRAIN METASTASES - A SINGLE INSTITUTION EXPERIENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Breast cancer; Univariate analysis; Medical diagnosis; Multivariate analysis; Retrospective cohort study; Disease; Stage (stratigraphy); Biomarker; Cancer; Biopsy","score_opus":0.06649048133591225,"score_gpt":0.41339939881573173,"score_spread":0.3469089174798195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985127,0.00014058873,0.0001332373,0.000096694734,0.000007117828,0.000021883134,0.00011024176,0.000008927603,0.0009687352],"genre_scores_gemma":[0.9990921,0.00014528954,0.00014732145,0.000044967113,0.000015254502,0.000015319642,0.00012690252,0.0000065290474,0.00040636046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995203,0.00010160748,0.00004196108,0.00010177196,0.00009789367,0.00013647418],"domain_scores_gemma":[0.9986507,0.00017773555,0.0003219938,0.00007056643,0.00013365842,0.0006452847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043745886,0.00027712193,0.00021004365,0.0006403762,0.0006766839,0.0007858943,0.00034102215,0.00027128184,0.0029082834],"category_scores_gemma":[0.0015903367,0.00022780577,0.00020375464,0.00078539684,0.00042612132,0.0003877041,0.000855877,0.00042424048,0.000899863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025893396,0.00034961037,0.95792985,0.000042718708,0.000025381787,0.013649443,0.0007423459,0.000097756405,0.0013753925,0.00007940744,0.0010131923,0.024435926],"study_design_scores_gemma":[0.000042943226,0.0017577227,0.93747103,0.000052953063,0.000035832294,0.052441966,0.0031170438,0.00051003665,0.0015517863,0.0001392133,0.0028490892,0.00003040969],"about_ca_topic_score_codex":0.0033506623,"about_ca_topic_score_gemma":0.0051383604,"teacher_disagreement_score":0.0033506623,"about_ca_system_score_codex":0.00073500245,"about_ca_system_score_gemma":0.000861831,"threshold_uncertainty_score":0.009729207},"labels":[],"label_agreement":null},{"id":"W4414786745","doi":"10.1093/neuonc/noaf193.353","title":"P11.14.A STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"","keywords":"Radiosurgery; Retrospective cohort study; Radiation therapy; Proportional hazards model; Ovarian cancer; Cancer; Brain metastasis; Stage (stratigraphy)","score_opus":0.07695695061213587,"score_gpt":0.4343764193359165,"score_spread":0.3574194687237806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969156,0.0008070503,0.00026462637,0.000036241803,0.0000065436034,0.000078502315,0.0006298963,0.0000071153468,0.001254509],"genre_scores_gemma":[0.9985262,0.00029086616,0.00010702419,0.000038165563,0.00001900127,0.000060358165,0.00074674824,0.000006752001,0.00020475707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903655,0.00016736997,0.00013525395,0.00037425334,0.00015506083,0.00013150896],"domain_scores_gemma":[0.9980381,0.00034322497,0.0008860777,0.0002458342,0.00019937062,0.00028729773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085945893,0.00042805827,0.000470093,0.0017379002,0.0007780971,0.000678385,0.00047424494,0.0004686018,0.003079671],"category_scores_gemma":[0.0019771727,0.00041749462,0.000538121,0.0025935364,0.00056822266,0.00047182717,0.00056742656,0.000540345,0.0008021371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118821925,0.000049883907,0.9960284,0.000034104538,0.000048951773,0.0012405316,0.00010551876,0.000023660541,0.00021191836,0.000036257723,0.00018278403,0.0019191598],"study_design_scores_gemma":[0.00003338335,0.00047505467,0.98691225,0.000042470816,0.00016115146,0.009587317,0.0005577261,0.00015529846,0.00020568032,0.00007765133,0.0017746747,0.000017375798],"about_ca_topic_score_codex":0.0036624784,"about_ca_topic_score_gemma":0.0024794152,"teacher_disagreement_score":0.0036624784,"about_ca_system_score_codex":0.0004349484,"about_ca_system_score_gemma":0.00069635944,"threshold_uncertainty_score":0.010302544},"labels":[],"label_agreement":null},{"id":"W4414792234","doi":"10.1093/neuonc/noaf193.071","title":"OS09.5.A RECURRENT COPY NUMBER ALTERATIONS DRIVE IDH-MUTANT ASTROCYTOMA DEVELOPMENT AND PROGRESSION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Glioma; Astrocytoma; Tumor progression; Gene; Somatic cell; Anaplastic astrocytoma; PDGFRA; Disease","score_opus":0.01893816173263653,"score_gpt":0.3463564281134819,"score_spread":0.32741826638084537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060893,0.00038341375,0.002074977,0.00007971045,0.00003419563,0.000045533834,0.0048099854,0.00020823888,0.001754966],"genre_scores_gemma":[0.98818713,0.00027390328,0.0026980229,0.000102097205,0.0000057944967,0.000049306895,0.006853835,0.0000666616,0.0017632397],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998547,0.00001033376,0.000016641148,0.000043763135,0.000042555577,0.000031913107],"domain_scores_gemma":[0.9998839,0.000015659063,0.00004188941,0.000013134696,0.000008744097,0.00003674955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018137156,0.00029174643,0.000253694,0.00050934096,0.00023382326,0.0003921808,0.00023704444,0.00021332847,0.002567232],"category_scores_gemma":[0.00015814582,0.00016929465,0.00032063376,0.00039948398,0.00024911232,0.00007714081,0.00024144747,0.00043896586,0.0006371174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071996334,0.0002170693,0.018191006,0.00012507789,0.00007224863,0.00021330467,0.000048037946,0.0010299647,0.96811765,0.000521592,0.000953365,0.009790727],"study_design_scores_gemma":[0.00025359416,0.0024061904,0.24677297,0.000038583858,0.00038808153,0.0022993907,0.00022003075,0.018036706,0.7021985,0.00077186263,0.026577085,0.000037058275],"about_ca_topic_score_codex":0.0029167747,"about_ca_topic_score_gemma":0.008444369,"teacher_disagreement_score":0.0029167747,"about_ca_system_score_codex":0.0003933406,"about_ca_system_score_gemma":0.00049360713,"threshold_uncertainty_score":0.008588254},"labels":[],"label_agreement":null},{"id":"W4414792320","doi":"10.1093/neuonc/noaf193.050","title":"OS05.2.A DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA ECOSYSTEMS BY INTEGRATIVE SINGLE-CELL GENOMICS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Glioblastoma; Transcriptome; Genomics; Tumor progression; Tumor microenvironment; Cell; Genome; Disease; Gene","score_opus":0.012389790786707575,"score_gpt":0.24498699842656246,"score_spread":0.2325972076398549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8692849,0.0011476873,0.09170228,0.00037912387,0.00014629455,0.00016112319,0.028287522,0.0034841115,0.005406907],"genre_scores_gemma":[0.8785473,0.00088484643,0.09137822,0.00020297349,0.000028729726,0.000295403,0.02454396,0.0007681654,0.003350451],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983025,0.000016962285,0.00001383491,0.000052711115,0.000058199723,0.000028107203],"domain_scores_gemma":[0.99986863,0.000030645864,0.000030744635,0.000022696126,0.000024660623,0.000022541313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006494227,0.00031264144,0.00059485313,0.0005168171,0.00031619504,0.0010048753,0.00043035092,0.00033461273,0.001287262],"category_scores_gemma":[0.00032187783,0.00019981942,0.00038370895,0.00054496154,0.00027085101,0.0003525981,0.00036343362,0.00057145295,0.0005168752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068696047,0.00014747767,0.02044905,0.00029653832,0.00006862857,0.0001291599,0.00024758658,0.008828414,0.91640437,0.005841286,0.0035295521,0.04337105],"study_design_scores_gemma":[0.00015260869,0.00077347644,0.102008484,0.0000899159,0.00023145704,0.00049043354,0.00065574766,0.28448933,0.54943955,0.007120766,0.054388028,0.00016020714],"about_ca_topic_score_codex":0.003697479,"about_ca_topic_score_gemma":0.006521517,"teacher_disagreement_score":0.003697479,"about_ca_system_score_codex":0.0005491318,"about_ca_system_score_gemma":0.00071997195,"threshold_uncertainty_score":0.007351935},"labels":[],"label_agreement":null},{"id":"W4414792344","doi":"10.1093/neuonc/noaf193.531","title":"P17.15.A ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temozolomide; Adverse effect; Radiation therapy; Clinical trial; O-6-methylguanine-DNA methyltransferase; Proton-pump inhibitor; Aldehyde dehydrogenase; Drug; Meta-analysis","score_opus":0.01038101766363703,"score_gpt":0.28790605452536744,"score_spread":0.2775250368617304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987311,0.00043532174,0.00005756287,0.000046610097,0.000011772275,0.000005879307,0.00043164086,0.0000033030756,0.0002767683],"genre_scores_gemma":[0.99950933,0.00006225258,0.000030414021,0.000013425792,0.0000090382,0.000006056316,0.00027182564,0.0000015553358,0.00009598206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997937,0.000046470734,0.000030886615,0.000049968774,0.00003574559,0.00004323068],"domain_scores_gemma":[0.9974757,0.00046797685,0.0013546565,0.00006746959,0.00013886161,0.0004953986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002961002,0.00016022375,0.00038460875,0.0002999553,0.00016994386,0.0003421543,0.00023853603,0.00028775499,0.0017081365],"category_scores_gemma":[0.0015560426,0.00009364556,0.00041658166,0.00054913596,0.00015977962,0.00022166163,0.00018744053,0.00043413797,0.00016379329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018122218,0.000037720485,0.99521196,0.0000190742,0.00009549232,0.00011730576,0.000011564619,0.00007951003,0.00049976504,0.000012180263,0.000109858796,0.0019932806],"study_design_scores_gemma":[0.000035864075,0.00044600462,0.9986512,0.0000060333286,0.00006360058,0.00024177396,0.000030660787,0.00021018992,0.00013735224,0.000032663676,0.00014054804,0.00000407165],"about_ca_topic_score_codex":0.0013136069,"about_ca_topic_score_gemma":0.0016643474,"teacher_disagreement_score":0.0017081365,"about_ca_system_score_codex":0.00025135136,"about_ca_system_score_gemma":0.0004032343,"threshold_uncertainty_score":0.005714357},"labels":[],"label_agreement":null},{"id":"W4414792352","doi":"10.1093/neuonc/noaf193.562","title":"P17.46.B CLINICAL FEATURES AND MOLECULAR PROFILING USING NEXT GENERATION SEQUENCING AMONG GLIOMA PATIENTS: RETROSPECTIVE REVIEW FROM A QUATERNARY BRAIN TUMOUR CENTER IN CANADA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Oligodendroglioma; Glioma; Astrocytoma; DNA sequencing; Molecular diagnostics; Methylation; Ependymoma; Glioblastoma","score_opus":0.040926911083442936,"score_gpt":0.32980325569837243,"score_spread":0.2888763446149295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782274,0.0056446274,0.00021007164,0.0005412099,0.00003241783,0.00018447154,0.010410922,0.000025555184,0.004723318],"genre_scores_gemma":[0.99263144,0.0029399,0.00021752305,0.0003578081,0.000020237117,0.000045682526,0.003126041,0.000012228421,0.00064921373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981008,0.00008003018,0.0002071794,0.00031587112,0.0008083409,0.00048783096],"domain_scores_gemma":[0.9947941,0.00031817408,0.0014670314,0.000103287326,0.002480847,0.0008365544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049282034,0.00035348782,0.0005441829,0.003158923,0.0023623023,0.0012939237,0.0011449892,0.00047056552,0.0023999277],"category_scores_gemma":[0.0019959556,0.00039120528,0.00036918942,0.008832949,0.00080347434,0.00031220837,0.00076463656,0.00046489056,0.0003974231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046908266,0.000017369637,0.9905861,0.00019001128,0.00003659918,0.002012934,0.00051596586,0.000040039933,0.0003508449,0.000044915872,0.0018652815,0.0042930697],"study_design_scores_gemma":[0.000005540591,0.000030231695,0.99307704,0.00014398259,0.00004245047,0.002320059,0.0019822954,0.00010306492,0.00012065112,0.0000131426805,0.0021484795,0.000012979484],"about_ca_topic_score_codex":0.92983633,"about_ca_topic_score_gemma":0.9466838,"teacher_disagreement_score":0.07016367,"about_ca_system_score_codex":0.015481182,"about_ca_system_score_gemma":0.030570326,"threshold_uncertainty_score":0.1411537},"labels":[],"label_agreement":null},{"id":"W4414792375","doi":"10.1093/neuonc/noaf193.512","title":"P15.22.B UNMASKING SOCIOECONOMIC INEQUITIES IN GLIOBLASTOMA CARE: A SYSTEMATIC REVIEW OF BARRIERS TO PALLIATIVE AND SUPPORTIVE SERVICES IN ASIA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Palliative care; Socioeconomic status; Quality of life (healthcare); Thematic analysis; Distress; MEDLINE; Checklist; Health equity","score_opus":0.03139480794895311,"score_gpt":0.3881658198020412,"score_spread":0.35677101185308807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032976093,0.9901598,0.00041513782,0.0010314629,0.00018826518,0.0013584178,0.0026210647,0.00002314179,0.0009050787],"genre_scores_gemma":[0.036760516,0.9560016,0.0016721615,0.0011483023,0.00010010127,0.0030577767,0.00093787507,0.0000135012015,0.00030821926],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936702,0.0020770517,0.0026265571,0.0004083534,0.0009600302,0.0002576239],"domain_scores_gemma":[0.9765471,0.016314648,0.00478506,0.00029060149,0.0017897387,0.00027283764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085936515,0.001246435,0.0066953115,0.012433729,0.00066411117,0.0030373184,0.0016595917,0.0016207055,0.009102933],"category_scores_gemma":[0.035785425,0.0008497524,0.0068517225,0.014125322,0.001042824,0.0029986924,0.002023944,0.0009892733,0.00038423605],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082663246,0.0000093501885,0.00079787127,0.97398335,0.0041985926,0.000055786302,0.00020063705,0.00004712211,0.00007210807,0.00018872245,0.0010869397,0.019276911],"study_design_scores_gemma":[0.00018280078,0.000116903495,0.004012557,0.954186,0.027555602,0.00021476738,0.00046564214,0.00007259831,0.00009290391,0.0003495523,0.012725857,0.00002474421],"about_ca_topic_score_codex":0.010518461,"about_ca_topic_score_gemma":0.025407009,"teacher_disagreement_score":0.012433729,"about_ca_system_score_codex":0.0034111235,"about_ca_system_score_gemma":0.016989458,"threshold_uncertainty_score":0.045448124},"labels":[],"label_agreement":null},{"id":"W4414792402","doi":"10.1093/neuonc/noaf193.231","title":"P05.26.B FLUOROPHORE ABUNDANCE VERSUS HISTOLOGICAL CELLULARITY IN FLUORESCENCE-GUIDED GLIOMA SURGERY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Fluorophore; Cell; Protoporphyrin IX; Anaplastic astrocytoma; Fluorescence; Astrocytoma; Gliosarcoma","score_opus":0.050919830117507406,"score_gpt":0.326479383981415,"score_spread":0.2755595538639076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134326,0.00043458905,0.0072380546,0.000045390974,0.0000065311747,0.000017412714,0.00022859228,0.00009659768,0.0005896288],"genre_scores_gemma":[0.9966151,0.00007387505,0.002788328,0.000010280424,0.0000030672177,0.000013895917,0.00017721872,0.000010688033,0.00030760438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995722,0.00011912807,0.00002699224,0.00008858302,0.000152557,0.000040542265],"domain_scores_gemma":[0.99868995,0.00051600067,0.00046409227,0.0000589981,0.00014429228,0.00012672413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011730521,0.0002668081,0.00021392039,0.00073818024,0.00012471982,0.00044351726,0.00021163559,0.0003467511,0.001847798],"category_scores_gemma":[0.00214737,0.00016820643,0.00021962059,0.00047122492,0.00044425754,0.0002579169,0.00027669105,0.00027968758,0.0004473103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006309791,0.00047273203,0.45142156,0.00035854743,0.00026668716,0.0004392326,0.00019958282,0.01346872,0.4339246,0.0005297032,0.00075426936,0.09185453],"study_design_scores_gemma":[0.000034890396,0.0023042182,0.73801583,0.000028989607,0.0001222069,0.0014885213,0.000158974,0.106767595,0.14951305,0.00045680994,0.0010778154,0.000031131283],"about_ca_topic_score_codex":0.001712507,"about_ca_topic_score_gemma":0.0013779603,"teacher_disagreement_score":0.001847798,"about_ca_system_score_codex":0.0005359062,"about_ca_system_score_gemma":0.00028957496,"threshold_uncertainty_score":0.0062037706},"labels":[],"label_agreement":null},{"id":"W4414792411","doi":"10.1093/neuonc/noaf193.112","title":"P01.32.B A RECURRENT SINGLE NUCLEOTIDE MUTATION IN TBR1 PROMOTES STEMNESS IN GROUP 4 MEDULLOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"European Commission","keywords":"Medulloblastoma; Transcriptome; Transcription factor; Mutant; Cerebellum; Phenotype; Downregulation and upregulation; Mutation; Gene","score_opus":0.009770740140287885,"score_gpt":0.2683114939061042,"score_spread":0.2585407537658163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792411","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17172448,0.0047287196,0.04120092,0.036621373,0.024481196,0.0016855254,0.21563369,0.02046061,0.4834635],"genre_scores_gemma":[0.37108698,0.0019524207,0.0128989015,0.005860508,0.0023256056,0.001644491,0.091205515,0.006532696,0.50649285],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993482,0.00008767407,0.000022880397,0.00016111111,0.00018615928,0.00019386303],"domain_scores_gemma":[0.9988587,0.0001833202,0.00013882834,0.00013471807,0.00014539751,0.0005390604],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008861105,0.00047585706,0.00054900406,0.00074998336,0.0011358487,0.0018364814,0.000988871,0.002284058,0.40350294],"category_scores_gemma":[0.0012691541,0.00029674254,0.00051677396,0.00077807374,0.0007494822,0.00052988814,0.0009251702,0.0023054476,0.13188468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047228886,0.0010405512,0.012808679,0.0013398003,0.00020615532,0.0049298536,0.0005296595,0.00083081715,0.15829411,0.023975117,0.64757663,0.14374569],"study_design_scores_gemma":[0.00065175846,0.00090541213,0.05457877,0.00055632606,0.00006603524,0.006958027,0.00041046448,0.0023523797,0.021220574,0.008307531,0.90392065,0.00007202079],"about_ca_topic_score_codex":0.0013709291,"about_ca_topic_score_gemma":0.0013709521,"teacher_disagreement_score":0.40350294,"about_ca_system_score_codex":0.00055052474,"about_ca_system_score_gemma":0.0011595909,"threshold_uncertainty_score":0.8508307},"labels":[],"label_agreement":null},{"id":"W4414792454","doi":"10.1093/neuonc/noaf193.186","title":"P03.27.B FLUID-SUPPRESSED APTW IMAGING BEFORE AND AFTER SURGERY IN GLIOBLASTOMA: A PROOF-OF-CONCEPT FOR DETECTING INFILTRATIVE AND RESIDUAL TUMOR BEYOND CONTRAST ENHANCEMENT","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Glioblastoma; Brain tumor; Magnetic resonance imaging; Contrast enhancement; Neuroimaging; Resection; Medical imaging","score_opus":0.011502625635285197,"score_gpt":0.3061267638836265,"score_spread":0.29462413824834127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231435,0.0019900184,0.069085345,0.0004393608,0.0001819311,0.00036784596,0.0006415375,0.0008309075,0.0033195592],"genre_scores_gemma":[0.9366829,0.0008775365,0.05878865,0.0002493893,0.000059132934,0.00032774196,0.00072383304,0.00018091676,0.002109858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991715,0.000018681789,0.0000047538556,0.00001700902,0.00002680671,0.000015606272],"domain_scores_gemma":[0.9998017,0.000034582776,0.000041620493,0.000018686153,0.000059977534,0.00004354778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070476823,0.00030776742,0.00019495361,0.00024075486,0.00013870568,0.00024975705,0.00037928965,0.0004689003,0.0017278913],"category_scores_gemma":[0.00042582632,0.00016212139,0.0001985924,0.00012142604,0.00028978486,0.00026230782,0.00020373931,0.00037537634,0.00058621704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008384213,0.00019300872,0.00077314675,0.00009059449,0.000012330624,0.00044694182,0.000031179658,0.00018688627,0.9822881,0.00013964415,0.00047905522,0.014520675],"study_design_scores_gemma":[0.00028568556,0.0044739502,0.009878331,0.000024449044,0.00007151517,0.0034789785,0.000037561196,0.008192974,0.9686714,0.00019533948,0.0046669897,0.000022901784],"about_ca_topic_score_codex":0.00040835113,"about_ca_topic_score_gemma":0.00023818809,"teacher_disagreement_score":0.0017278913,"about_ca_system_score_codex":0.00013501671,"about_ca_system_score_gemma":0.00039227298,"threshold_uncertainty_score":0.0057803392},"labels":[],"label_agreement":null},{"id":"W4414792521","doi":"10.1093/neuonc/noaf193.426","title":"P12.47.B MOLECULAR PROFILING OF GLIOMAS: INSIGHTS INTO RADIONECROSIS AND PSEUDOPROGRESSION THROUGH NEXT-GENERATION SEQUENCING","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University","funders":"","keywords":"Cancer; PTEN; Radiation therapy; Gene duplication; Proportional hazards model; Disease","score_opus":0.04435703932988823,"score_gpt":0.32481505474238676,"score_spread":0.28045801541249854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454848,0.0085639525,0.013483761,0.002024793,0.0002979519,0.00023043774,0.015927598,0.00056453026,0.013422057],"genre_scores_gemma":[0.9822204,0.0021716831,0.0068693995,0.00035218478,0.0001291853,0.00011185409,0.004073382,0.00010495581,0.00396696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997063,0.00007622136,0.0000385549,0.00006027214,0.000069059526,0.00004952795],"domain_scores_gemma":[0.99903893,0.00029848493,0.00037743908,0.000069901624,0.00012935846,0.000085914646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054232427,0.00029941645,0.0004065111,0.0013460456,0.00030071984,0.00073427084,0.00027079755,0.00057594903,0.0076529537],"category_scores_gemma":[0.001589691,0.00013725068,0.00033586525,0.0013933191,0.00029382407,0.00021920074,0.00021972846,0.0004248528,0.0023733284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031424596,0.0002470546,0.6075573,0.0011453136,0.00033865593,0.02386741,0.00054804864,0.0017778518,0.1383128,0.0023552934,0.013609976,0.20709783],"study_design_scores_gemma":[0.0001315643,0.00060430303,0.8248694,0.00039343283,0.00034942554,0.058293335,0.00045629372,0.008494589,0.046358008,0.002407848,0.057589702,0.000052176736],"about_ca_topic_score_codex":0.0017246701,"about_ca_topic_score_gemma":0.0013847953,"teacher_disagreement_score":0.0076529537,"about_ca_system_score_codex":0.0002938557,"about_ca_system_score_gemma":0.00044596303,"threshold_uncertainty_score":0.025601745},"labels":[],"label_agreement":null},{"id":"W4414792538","doi":"10.1093/neuonc/noaf193.423","title":"P12.44.A ADJUVANT CHEMORADIOTHERAPY WITH PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV) OR TEMOZOLOMIDE FOR 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA: A NETWORK META-ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Temozolomide; Vincristine; Anaplastic astrocytoma; Hazard ratio; Dacarbazine; Radiation therapy; Oligodendroglioma; Progression-free survival; Lomustine","score_opus":0.04225360596508551,"score_gpt":0.33984166414267825,"score_spread":0.2975880581775927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792538","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039643276,0.95149,0.0026096515,0.0006832197,0.00057780906,0.0006471941,0.0027972576,0.00012400729,0.0014275042],"genre_scores_gemma":[0.8120588,0.17773817,0.0030732485,0.0013547657,0.00040840526,0.0014542716,0.002416556,0.000098617995,0.0013970928],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949622,0.00258875,0.00084965874,0.00090474816,0.000443996,0.0002506217],"domain_scores_gemma":[0.9945109,0.0037541285,0.0009418474,0.0002190551,0.0003769183,0.00019718015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006422337,0.0024355992,0.011833913,0.0039033268,0.00046597706,0.002385688,0.0019530272,0.0021471125,0.0051347907],"category_scores_gemma":[0.011048486,0.001100047,0.043951,0.004902141,0.00046922493,0.0015422798,0.001254086,0.0020446808,0.00053825],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006942594,0.000036826186,0.00590356,0.07169902,0.9067839,0.00011143275,0.000037185982,0.00095428264,0.00033681528,0.00010228725,0.0005689691,0.0065231356],"study_design_scores_gemma":[0.0013622175,0.00023577717,0.0036012137,0.0023029146,0.9910062,0.000047630452,0.00001688956,0.00040192046,0.00008097346,0.00016761827,0.0007627369,0.000013874703],"about_ca_topic_score_codex":0.006603765,"about_ca_topic_score_gemma":0.009904734,"teacher_disagreement_score":0.011833913,"about_ca_system_score_codex":0.0015275591,"about_ca_system_score_gemma":0.0014464966,"threshold_uncertainty_score":0.03396499},"labels":[],"label_agreement":null},{"id":"W4414792733","doi":"10.1093/neuonc/noaf193.444","title":"P13.03.B MCM2 HIGHLIGHTS A SUBSET OF AGGRESSIVE MENINGIOMAS WITH ENHANCED PROLIFERATION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Transcriptome; Meningioma; Cell cycle; Cell; Gene; Intracellular","score_opus":0.014750046057824635,"score_gpt":0.2922900020745486,"score_spread":0.27753995601672393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423466,0.0019681342,0.003195435,0.0014724872,0.0001734851,0.000045172077,0.040717732,0.0009123414,0.009168819],"genre_scores_gemma":[0.9744099,0.00046745577,0.0013679069,0.00038235748,0.00010779223,0.00005194161,0.019102054,0.00015624573,0.0039543444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997017,0.000022534927,0.000020191588,0.00009407407,0.00009201832,0.00006954578],"domain_scores_gemma":[0.9995732,0.000100695164,0.00013447787,0.000049985105,0.000048758473,0.00009286334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024461944,0.00045750252,0.00032539613,0.0009608356,0.0005814651,0.0009391288,0.00029285418,0.00052632653,0.011853422],"category_scores_gemma":[0.0007255283,0.00017174424,0.00027229218,0.0010547065,0.00036469,0.00023289591,0.00042180865,0.0004971123,0.002140515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004756805,0.00014997019,0.5222451,0.00068202126,0.00036242968,0.007987107,0.00037141814,0.0012307253,0.33310136,0.0015124888,0.042762518,0.084838025],"study_design_scores_gemma":[0.00012065984,0.00018287434,0.89398515,0.00007908282,0.00021215434,0.013083769,0.00043921595,0.0039980435,0.03674097,0.0019315996,0.049198005,0.00002838163],"about_ca_topic_score_codex":0.0037322803,"about_ca_topic_score_gemma":0.0045261364,"teacher_disagreement_score":0.011853422,"about_ca_system_score_codex":0.00035382848,"about_ca_system_score_gemma":0.0004452547,"threshold_uncertainty_score":0.03965366},"labels":[],"label_agreement":null},{"id":"W4414792770","doi":"10.1093/neuonc/noaf193.041","title":"OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioma; Isocitrate dehydrogenase; Anaplastic astrocytoma; Hazard ratio; Interim analysis; Population; IDH1","score_opus":0.02905064331493146,"score_gpt":0.3800105721582071,"score_spread":0.35095992884327565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310528,0.004571657,0.0035758165,0.0026383938,0.00082533783,0.012165611,0.028189994,0.0003742645,0.016606174],"genre_scores_gemma":[0.91829747,0.0011930178,0.0070085726,0.0038942306,0.00032462465,0.01563824,0.0371675,0.00016730638,0.016309025],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99839157,0.0011997807,0.000054520504,0.00013612455,0.000106629566,0.000111337606],"domain_scores_gemma":[0.9990969,0.00022634304,0.0002373299,0.0000958831,0.000070960494,0.00027254497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004075135,0.00087641255,0.000881791,0.0003293385,0.00025143527,0.00079155905,0.00059668295,0.0009715317,0.0077566374],"category_scores_gemma":[0.0018452649,0.00039503517,0.0015649794,0.00037832235,0.0005171115,0.000615266,0.00044055062,0.0015795225,0.0008515019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.946951,0.002301964,0.004710211,0.00058793783,0.0014119062,0.00005499122,0.000057701905,0.0011754726,0.010279555,0.0009168281,0.010205152,0.021347284],"study_design_scores_gemma":[0.8638182,0.09448624,0.02049234,0.00007293875,0.0016531221,0.00011501729,0.000044450957,0.001639477,0.002554322,0.0010456326,0.01403789,0.000040407183],"about_ca_topic_score_codex":0.00079101726,"about_ca_topic_score_gemma":0.00343082,"teacher_disagreement_score":0.0077566374,"about_ca_system_score_codex":0.00083980314,"about_ca_system_score_gemma":0.0011859862,"threshold_uncertainty_score":0.025948584},"labels":[],"label_agreement":null},{"id":"W4414799604","doi":"10.1093/neuonc/noaf193.251","title":"P07.05.A AWAKE CRANIOTOMY FOR ELOQUENT GLIOMA: A SINGLE CENTER COHORT REVIEW","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Single Center; Perioperative; Craniotomy; Awake craniotomy; Resection; Cohort","score_opus":0.02501823637289909,"score_gpt":0.3330505212646943,"score_spread":0.30803228489179524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799604","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10133706,0.8915456,0.00031222776,0.00063126354,0.00020969739,0.00018484476,0.0029390154,0.000017346525,0.0028229414],"genre_scores_gemma":[0.594379,0.40142527,0.00072647486,0.00058225665,0.00027429234,0.00021634152,0.0018670154,0.000016863474,0.00051243283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992988,0.000104936145,0.00021680865,0.00014421277,0.00017506453,0.00006014401],"domain_scores_gemma":[0.9961229,0.00157827,0.0015564158,0.0000870773,0.0005080073,0.0001473039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012258388,0.00031217773,0.0008455249,0.0038015782,0.0003542627,0.00093435793,0.0008053427,0.00067381345,0.004124742],"category_scores_gemma":[0.0036324456,0.00021093372,0.001036696,0.005213583,0.0003282211,0.00078169705,0.00026837588,0.0002770284,0.00041261598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009553753,0.00013559792,0.64099354,0.09623278,0.008311708,0.0061691664,0.0006673352,0.00019704539,0.00155345,0.00072197703,0.011004454,0.23305762],"study_design_scores_gemma":[0.00017666754,0.00060577254,0.8617516,0.047937814,0.01435142,0.027583838,0.0022717295,0.00034265112,0.00050904835,0.00043806565,0.04392802,0.00010332293],"about_ca_topic_score_codex":0.010220822,"about_ca_topic_score_gemma":0.016685141,"teacher_disagreement_score":0.010220822,"about_ca_system_score_codex":0.0005542189,"about_ca_system_score_gemma":0.0023177874,"threshold_uncertainty_score":0.02032268},"labels":[],"label_agreement":null},{"id":"W4414799658","doi":"10.1093/neuonc/noaf193.014","title":"JS07.6.A AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Jewish General Hospital","funders":"","keywords":"Immune system; CD8; Tumor microenvironment; Juvenile; Immunotherapy; Cytotoxic T cell; Major histocompatibility complex; Cancer; Genetically modified mouse","score_opus":0.01980280638120635,"score_gpt":0.30412466016659784,"score_spread":0.2843218537853915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98073065,0.0020059566,0.008016899,0.00038979895,0.00024943837,0.00029584786,0.004300769,0.0002741191,0.0037364804],"genre_scores_gemma":[0.9583038,0.0026485252,0.011206707,0.00041566353,0.00006564427,0.0009167472,0.006182764,0.00026721615,0.019992955],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99930847,0.00012396852,0.000082577375,0.00013823583,0.0001842017,0.00016258673],"domain_scores_gemma":[0.99928385,0.00008360116,0.00026788472,0.00007690102,0.00007250826,0.00021524563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062001206,0.0006548017,0.00050656905,0.0009147104,0.0003436032,0.0004741525,0.00056220434,0.0009636901,0.0052509103],"category_scores_gemma":[0.00024158451,0.00035563437,0.00070144504,0.00046300195,0.00060338894,0.00067350623,0.00034415346,0.0019219292,0.0019588992],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083851453,0.00037337534,0.00069821725,0.00011873751,0.00001883445,0.00022246495,0.000095626434,0.00015737172,0.9946765,0.0003921353,0.00038661415,0.0020216652],"study_design_scores_gemma":[0.00019514583,0.0069604954,0.0169153,0.000063596955,0.00008479291,0.0023000455,0.00033095252,0.0016378558,0.9538372,0.00028203856,0.01735764,0.00003494114],"about_ca_topic_score_codex":0.0010831882,"about_ca_topic_score_gemma":0.0019396178,"teacher_disagreement_score":0.0052509103,"about_ca_system_score_codex":0.00043545908,"about_ca_system_score_gemma":0.00051881577,"threshold_uncertainty_score":0.017566025},"labels":[],"label_agreement":null},{"id":"W4414799802","doi":"10.1093/neuonc/noaf193.274","title":"P08.06.B THE EGFL7-INTEGRIN Β2 AXIS: A NOVEL REGULATOR OF IMMUNE EVASION IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IONICS Mass Spectrometry (Canada)","funders":"","keywords":"Immune system; Glioma; Tumor microenvironment; Mass cytometry; Flow cytometry; Immunotherapy; Acquired immune system; Glioblastoma","score_opus":0.011449052611020425,"score_gpt":0.27236964154308785,"score_spread":0.26092058893206743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7592836,0.05169744,0.049071908,0.010672645,0.0044147978,0.0004330878,0.03190774,0.0058251605,0.08669351],"genre_scores_gemma":[0.9189012,0.009442766,0.0069345357,0.0020844091,0.00042872166,0.00028476503,0.014510654,0.0005206261,0.046892297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997956,0.000022971575,0.000008428854,0.00004658899,0.00007747216,0.000048930797],"domain_scores_gemma":[0.999835,0.000013394965,0.0000478454,0.000008000146,0.000031414485,0.00006424888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020902613,0.00045090666,0.00031563843,0.00036505732,0.00040312897,0.0009899791,0.0003409162,0.00094498857,0.014334388],"category_scores_gemma":[0.0001831527,0.00017759012,0.00036428485,0.0002759792,0.00030302597,0.0003126182,0.00042460317,0.0012617325,0.006347887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016638169,0.00016359868,0.00847309,0.000997069,0.00010292831,0.002458696,0.0001503008,0.0006666273,0.8844708,0.0065822746,0.028780935,0.065489896],"study_design_scores_gemma":[0.00049761083,0.0015501986,0.14335789,0.00062386465,0.00028399663,0.012169221,0.0010500608,0.017171586,0.3976013,0.008201959,0.41738063,0.00011162505],"about_ca_topic_score_codex":0.0006162775,"about_ca_topic_score_gemma":0.0005322772,"teacher_disagreement_score":0.014334388,"about_ca_system_score_codex":0.0002795956,"about_ca_system_score_gemma":0.00058341,"threshold_uncertainty_score":0.047953308},"labels":[],"label_agreement":null},{"id":"W4414799819","doi":"10.1093/neuonc/noaf193.070","title":"OS09.4.A EARLY TUMOR VOLUME CHANGES PREDICT CLINICAL OUTCOMES IN MIDH1/2 GLIOMA: POST-HOC RESULTS FROM THE PHASE 3 INDIGO TRIAL","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Confidence interval; Magnetic resonance imaging; Hazard ratio; Proportional hazards model; Placebo; Volume (thermodynamics); Isocitrate dehydrogenase; Clinical trial","score_opus":0.043440440036110334,"score_gpt":0.37701988069536574,"score_spread":0.3335794406592554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157035,0.0022298163,0.0005994722,0.00044276728,0.00015840713,0.0005621674,0.002886264,0.00013246346,0.001418327],"genre_scores_gemma":[0.9889026,0.0007570116,0.0012915025,0.0005910373,0.0002267851,0.001093516,0.0050394046,0.000075215234,0.0020229614],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9986879,0.00088445714,0.000043962482,0.00017562821,0.00008342788,0.0001246089],"domain_scores_gemma":[0.99803716,0.00078333984,0.00043173973,0.00024814112,0.00011621281,0.00038332384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056022187,0.0014182228,0.0017050772,0.00029765352,0.000278615,0.0012837481,0.0008124932,0.000766872,0.0032510462],"category_scores_gemma":[0.00320536,0.00037181372,0.0026605383,0.0003462513,0.00085480814,0.00083548826,0.0005535231,0.002330119,0.00072563306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94994986,0.0045900065,0.0131027065,0.00041991525,0.0031671743,0.000046907226,0.000080061174,0.0019242242,0.004918764,0.00012788664,0.0029436545,0.018728718],"study_design_scores_gemma":[0.4234895,0.36303043,0.17158523,0.00012662969,0.013023116,0.0002919293,0.00022247952,0.0126954,0.00786533,0.0013642554,0.0061381226,0.00016752462],"about_ca_topic_score_codex":0.00070154766,"about_ca_topic_score_gemma":0.0014811045,"teacher_disagreement_score":0.0056022187,"about_ca_system_score_codex":0.0005626037,"about_ca_system_score_gemma":0.0011402441,"threshold_uncertainty_score":0.02962774},"labels":[],"label_agreement":null},{"id":"W4414799864","doi":"10.1093/neuonc/noaf193.209","title":"P05.04.B ENRICHMENT AND ANALYTICAL METHODS IN CSF PROTEOMICS: EACH NAIL NEEDS A DIFFERENT HAMMER","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cohort; Coefficient of variation; Reproducibility; Peptide; Nanoparticle tracking analysis; Cohort study","score_opus":0.02322882610921426,"score_gpt":0.3779779979675576,"score_spread":0.3547491718583433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799864","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033154033,0.075278044,0.53361386,0.16473417,0.036474574,0.0021211423,0.0077257524,0.023027757,0.123870656],"genre_scores_gemma":[0.12954639,0.055111673,0.63631916,0.030403458,0.013740993,0.0031513886,0.013852457,0.01587065,0.10200391],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9915754,0.0029222122,0.000472907,0.0010129405,0.0032785332,0.00073799957],"domain_scores_gemma":[0.98133725,0.00498583,0.0010549593,0.003062166,0.007442711,0.0021171656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024183106,0.0013176599,0.0014346138,0.0021264832,0.0020722582,0.009395062,0.0030264275,0.00438448,0.035317093],"category_scores_gemma":[0.014837858,0.0010637647,0.0010394274,0.002412764,0.0029311015,0.0038086404,0.0031562888,0.006193753,0.0370014],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016970146,0.0007926502,0.00511308,0.0031033717,0.00020925386,0.0006765783,0.000529878,0.00083296146,0.0806325,0.024336243,0.32528734,0.5567891],"study_design_scores_gemma":[0.00014000354,0.0010555316,0.008102073,0.001463106,0.000077880024,0.0025302419,0.00051506195,0.0034329637,0.06667998,0.026764555,0.88907874,0.00015982869],"about_ca_topic_score_codex":0.0011149485,"about_ca_topic_score_gemma":0.00097571156,"teacher_disagreement_score":0.035317093,"about_ca_system_score_codex":0.0015393632,"about_ca_system_score_gemma":0.006056675,"threshold_uncertainty_score":0.12789404},"labels":[],"label_agreement":null},{"id":"W4414800130","doi":"10.1093/neuonc/noaf193.466","title":"P14.05.B CAR T-CELL THERAPY DOES NOT LEAD TO MEDIUM-TERM NEUROCOGNITIVE DETERIORATION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS. A LOC NETWORK STUDY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Gene Regulatory Network Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Neuropsychology; Neurotoxicity; Central nervous system; Lymphoma; Primary central nervous system lymphoma","score_opus":0.005836706736002294,"score_gpt":0.23210302602825794,"score_spread":0.22626631929225566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771935,0.0003475834,0.000050779785,0.000044285935,0.0000073135407,0.000019904453,0.00047701513,0.0000051713987,0.0013284812],"genre_scores_gemma":[0.99937576,0.000038247097,0.000023985605,0.000022458937,0.000011967799,0.00001818357,0.00033401494,0.0000021841445,0.00017323313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995809,0.00018143206,0.000025275045,0.00008639965,0.000058877482,0.00006713587],"domain_scores_gemma":[0.99902976,0.00020400854,0.00039336988,0.000068967,0.00008424169,0.00021973548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005077094,0.00024507605,0.000297263,0.00037558805,0.00026137714,0.00045496816,0.00030506987,0.00028862598,0.004216729],"category_scores_gemma":[0.001378272,0.00009463157,0.00032717636,0.00038644782,0.00021830323,0.0003655508,0.00029698483,0.00019553797,0.00032565245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006859358,0.00026748434,0.9823868,0.00006918508,0.0003007155,0.0010983936,0.000081956714,0.00011700704,0.0008931856,0.00004859096,0.00084443146,0.0070327693],"study_design_scores_gemma":[0.00041342317,0.0025132676,0.99235874,0.000022495924,0.00022717955,0.002264234,0.00013407647,0.0005429608,0.00019116358,0.000042301595,0.0012830449,0.0000071707022],"about_ca_topic_score_codex":0.0029962172,"about_ca_topic_score_gemma":0.002359444,"teacher_disagreement_score":0.004216729,"about_ca_system_score_codex":0.00035249203,"about_ca_system_score_gemma":0.0003376928,"threshold_uncertainty_score":0.014106393},"labels":[],"label_agreement":null},{"id":"W4414800137","doi":"10.1093/neuonc/noaf193.011","title":"JS05.6.A EXPLORATORY ANALYSES FROM PHASE 3 INDIGO STUDY SUGGEST POTENTIAL MECHANISM OF SEIZURE CONTROL THROUGH TUMOR VOLUME REDUCTION UNDER TREATMENT WITH VORASIDENIB","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Placebo; Confidence interval; Glioma; Exploratory analysis; Astrocytoma; Brain tumor; Phases of clinical research","score_opus":0.032921942262096396,"score_gpt":0.39499049717856516,"score_spread":0.3620685549164688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804088,0.002412608,0.0025964708,0.00035784647,0.00007963266,0.0012899948,0.008649452,0.0001457829,0.004059399],"genre_scores_gemma":[0.98898447,0.00033963347,0.0019665102,0.00038013302,0.000039641338,0.0012223407,0.0051750424,0.000036632922,0.0018555636],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965688,0.0021673588,0.00018155866,0.00043609596,0.00036112775,0.0002850082],"domain_scores_gemma":[0.9960103,0.0022472239,0.00071398,0.00045061772,0.00022754261,0.00035040034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064108362,0.0007469983,0.0016192618,0.0004798872,0.00030941496,0.00088197034,0.0007262065,0.0005283542,0.00826533],"category_scores_gemma":[0.0052004624,0.00026554608,0.0043869456,0.0005336822,0.0004955858,0.000632566,0.00040746355,0.0013045005,0.00064336386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6713727,0.005874419,0.17151986,0.0021091404,0.019828312,0.0009972232,0.00027579744,0.0065976805,0.031602696,0.001435451,0.011413231,0.07697345],"study_design_scores_gemma":[0.11038604,0.21207444,0.57749456,0.00023606069,0.025836352,0.00205419,0.00041469472,0.023065103,0.02149999,0.0039304295,0.022847332,0.00016082489],"about_ca_topic_score_codex":0.0005470706,"about_ca_topic_score_gemma":0.0017057259,"teacher_disagreement_score":0.00826533,"about_ca_system_score_codex":0.00057959073,"about_ca_system_score_gemma":0.001266711,"threshold_uncertainty_score":0.033904135},"labels":[],"label_agreement":null},{"id":"W4414800233","doi":"10.1093/neuonc/noaf193.286","title":"P08.18.B PROSPECTIVE EVALUATION OF NEUROLOGICAL SAFETY AFTER ANTI-BCMA CAR T-CELL THERAPY IN A SINGLE-CENTRE COHORT","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Cohort; Prospective cohort study; Neurotoxicity; Cognition; Post-concussion syndrome; Neurological examination; Cohort study","score_opus":0.04003583211486778,"score_gpt":0.350929074696149,"score_spread":0.3108932425812812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793625,0.00026804494,0.00016591053,0.000019422554,0.000007346872,0.00011847891,0.0010794038,0.000010287968,0.0003947945],"genre_scores_gemma":[0.9972108,0.00010980108,0.0002425845,0.00005443578,0.000022491107,0.00020147358,0.001858055,0.000007964194,0.00029241582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992919,0.000191805,0.00007700586,0.00026677377,0.00008982752,0.0000827376],"domain_scores_gemma":[0.9982869,0.00015998619,0.00073345995,0.00015865685,0.00030182383,0.00035925268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010190804,0.00044312532,0.0005698438,0.00067233294,0.0006112372,0.00062397565,0.00043527773,0.0003700871,0.0019530635],"category_scores_gemma":[0.0015403595,0.0002757564,0.00062704517,0.00066688407,0.00030927456,0.0004338709,0.000504316,0.00044858942,0.0009990927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037840253,0.0004109656,0.98687416,0.0000878093,0.00027607495,0.0005361901,0.00014216949,0.00010546757,0.0017481077,0.000020402034,0.0006011078,0.005413555],"study_design_scores_gemma":[0.0004302739,0.006576681,0.98846626,0.00002731501,0.00023604176,0.0019498646,0.00013428683,0.00029605845,0.00060148677,0.000030550134,0.001232763,0.000018332641],"about_ca_topic_score_codex":0.0017490983,"about_ca_topic_score_gemma":0.0014358289,"teacher_disagreement_score":0.0019530635,"about_ca_system_score_codex":0.00040237283,"about_ca_system_score_gemma":0.00062440627,"threshold_uncertainty_score":0.0065336823},"labels":[],"label_agreement":null},{"id":"W4414800255","doi":"10.1093/neuonc/noaf193.522","title":"P17.06.A VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Randomized controlled trial; Clinical endpoint; Discontinuation; Quality of life (healthcare); Radiation therapy; Placebo; Chemoradiotherapy; Maintenance therapy","score_opus":0.04164772387309838,"score_gpt":0.42070722184840514,"score_spread":0.37905949797530675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800255","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023092257,0.0012748895,0.002912472,0.00083170936,0.0009127696,0.957148,0.00812004,0.00033798866,0.005369937],"genre_scores_gemma":[0.024462203,0.00078161724,0.0052529327,0.0010909239,0.00025699622,0.96168226,0.0023888785,0.000040824933,0.0040433784],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99517584,0.0027464961,0.00034994987,0.00065542874,0.00041527703,0.0006570728],"domain_scores_gemma":[0.9961075,0.00055727095,0.0008052323,0.0005210546,0.0006380217,0.0013708766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01211465,0.0036829084,0.0042364425,0.0011173908,0.00213695,0.002037437,0.0033225794,0.004998873,0.05371204],"category_scores_gemma":[0.0075114984,0.0020965582,0.002432575,0.0013129496,0.0023035873,0.0019987987,0.001061535,0.0061610974,0.01358293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94426036,0.012898766,0.00046400784,0.00352633,0.00039374316,0.000115646835,0.00013587416,0.00059573655,0.004309713,0.0016125834,0.01583543,0.015851673],"study_design_scores_gemma":[0.9534031,0.026901836,0.0007220535,0.00034401286,0.0001830229,0.000050227387,0.000026185522,0.00042704924,0.00067772326,0.00064436597,0.016591907,0.000028478109],"about_ca_topic_score_codex":0.0016165745,"about_ca_topic_score_gemma":0.0042723785,"teacher_disagreement_score":0.05371204,"about_ca_system_score_codex":0.0024458112,"about_ca_system_score_gemma":0.010349253,"threshold_uncertainty_score":0.1796847},"labels":[],"label_agreement":null},{"id":"W4414800269","doi":"10.1093/neuonc/noaf193.404","title":"P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Phases of clinical research; Methyltransferase; Progressive disease; Standard of care; PARP inhibitor; Radiation therapy; Biomarker","score_opus":0.027819427787130615,"score_gpt":0.38072159493650665,"score_spread":0.35290216714937606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162239,0.010986106,0.002221806,0.00265496,0.0019246198,0.03982391,0.014458665,0.0010927039,0.010613365],"genre_scores_gemma":[0.93561417,0.0029532833,0.005413287,0.0041210162,0.0006156618,0.032193083,0.0058034044,0.00012001427,0.013166004],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99942386,0.00030551956,0.000024329393,0.00010480135,0.000036147325,0.000105416715],"domain_scores_gemma":[0.9993148,0.00014856354,0.00012718722,0.000041375097,0.000054032298,0.00031397078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018168205,0.0020492238,0.0024620127,0.0005699745,0.000391837,0.0009944598,0.00091274676,0.0021144382,0.020267937],"category_scores_gemma":[0.0012758025,0.0006616486,0.0016270586,0.00043375348,0.0011301365,0.0010042604,0.00033054166,0.0031047328,0.0027613253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9769866,0.0063860533,0.00031190808,0.00069370115,0.00060058566,0.00003713226,0.000017335458,0.00015559417,0.0030142013,0.00011090213,0.0021465742,0.009539315],"study_design_scores_gemma":[0.942604,0.05430278,0.0011708413,0.000031739408,0.00021220947,0.000024731362,0.0000073608417,0.00020367894,0.00028125365,0.00012601673,0.0010256165,0.000009644616],"about_ca_topic_score_codex":0.0008810154,"about_ca_topic_score_gemma":0.0019938366,"teacher_disagreement_score":0.020267937,"about_ca_system_score_codex":0.00062559196,"about_ca_system_score_gemma":0.0014945307,"threshold_uncertainty_score":0.067802966},"labels":[],"label_agreement":null},{"id":"W4414874442","doi":"10.1093/neuonc/noaf226","title":"Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Apollomics; Incyte; Novocure; Regeneron Pharmaceuticals; American Society of Clinical Oncology; Servier; EpicentRx; Pfizer","keywords":"Translational research; Call to action; Clinical Oncology; Clinical research; Clinical trial; Alternative medicine; Patient advocacy; Population","score_opus":0.06291692731623424,"score_gpt":0.4209590622161835,"score_spread":0.3580421348999493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414874442","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005146083,0.025638623,0.0013765856,0.95069784,0.02031057,0.000055328925,0.00007831884,0.000044747336,0.0012833598],"genre_scores_gemma":[0.038836934,0.11920043,0.03552093,0.75400364,0.044371683,0.0006166617,0.0014515452,0.00030127756,0.0056968527],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9056367,0.03821974,0.016791804,0.006704003,0.026082084,0.0065655354],"domain_scores_gemma":[0.6918231,0.1340865,0.009884993,0.010270933,0.10567522,0.048259217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17978661,0.0014101738,0.0042527085,0.005291238,0.00733707,0.017790377,0.009780162,0.032755096,0.005771101],"category_scores_gemma":[0.16299024,0.001114452,0.0045194253,0.0043950104,0.0108448975,0.02115552,0.020995995,0.060132165,0.0029454762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000170102,0.0002077945,0.0015311976,0.003430371,0.00019138583,0.0004693163,0.0042635365,0.00048734227,0.0006575555,0.020599972,0.78392315,0.18406822],"study_design_scores_gemma":[0.00012121644,0.00014515957,0.0020230927,0.011606654,0.00019433445,0.00047637854,0.010539691,0.0004929966,0.00050982315,0.052331496,0.9213162,0.00024300219],"about_ca_topic_score_codex":0.00981035,"about_ca_topic_score_gemma":0.016707703,"teacher_disagreement_score":0.17978661,"about_ca_system_score_codex":0.012016416,"about_ca_system_score_gemma":0.08279444,"threshold_uncertainty_score":0.95081383},"labels":[],"label_agreement":null},{"id":"W4415402114","doi":"10.1093/neuonc/noaf245","title":"Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; McMaster Children's Hospital; London Health Sciences Centre; University of Toronto; Western University; Université Laval; BC Children's Hospital; Queen Elizabeth II Health Sciences Centre; Children's Hospital of Western Ontario; SickKids Foundation; Dalhousie University; Princess Margaret Cancer Centre; Stollery Children's Hospital; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Sick Kids Foundation; Pediatric Brain Tumor Foundation","keywords":"Clinical trial; Glioma; Cohort; MEDLINE; Disease","score_opus":0.01502408833485379,"score_gpt":0.33541743817531294,"score_spread":0.32039334984045914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415402114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969471,0.0006906437,0.0004509134,0.00010411936,0.000002450136,0.000013985634,0.0008173631,0.000011723397,0.00096157345],"genre_scores_gemma":[0.99838305,0.00032156354,0.0004027272,0.000026449718,0.0000052913056,0.000007628387,0.0007614857,0.000006285649,0.000085604785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997782,0.000046102094,0.000016569755,0.00006383342,0.00004362894,0.000051637457],"domain_scores_gemma":[0.9995407,0.00006989359,0.00022802553,0.00002422859,0.000060942042,0.00007623606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030200125,0.00020360705,0.000239353,0.000640606,0.00025879848,0.00057194143,0.00023381347,0.00017420581,0.0015772802],"category_scores_gemma":[0.001005014,0.000087294815,0.00012915938,0.00091448077,0.00026371964,0.00030538792,0.00047642709,0.0003079256,0.00018168139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002192422,0.000022230739,0.97985476,0.000045488054,0.00003691173,0.0008722495,0.00012802792,0.0004975137,0.0062691495,0.00025483937,0.00037267117,0.011426927],"study_design_scores_gemma":[0.000008460413,0.00011353684,0.9895516,0.000017453267,0.000046799836,0.0055873813,0.00046224287,0.00059840863,0.0014664972,0.0005297786,0.0016113417,0.0000064775263],"about_ca_topic_score_codex":0.0018090345,"about_ca_topic_score_gemma":0.0028660886,"teacher_disagreement_score":0.0018090345,"about_ca_system_score_codex":0.00046930026,"about_ca_system_score_gemma":0.00047652205,"threshold_uncertainty_score":0.005276561},"labels":[],"label_agreement":null},{"id":"W4415648353","doi":"10.1093/neuonc/noaf247","title":"International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Clinical Practice; Glioma; Gamma knife; MEDLINE","score_opus":0.059861271810178404,"score_gpt":0.39197572893148275,"score_spread":0.33211445712130433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415648353","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013486537,0.80469507,0.041655425,0.07710311,0.004084879,0.010922965,0.020249968,0.00077245664,0.027029617],"genre_scores_gemma":[0.1541101,0.4853746,0.2751252,0.023710834,0.0020103175,0.024712492,0.029622287,0.00041499833,0.004919163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9634811,0.01614001,0.013787501,0.0011859927,0.004999699,0.0004056437],"domain_scores_gemma":[0.9308311,0.02303274,0.019766258,0.0021470091,0.02334022,0.0008826396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04119954,0.0014542214,0.002288228,0.008338601,0.00074874115,0.0017456749,0.0052548293,0.0024833668,0.0030206174],"category_scores_gemma":[0.06925103,0.0007845131,0.004999997,0.007765524,0.0012631166,0.0015190172,0.0016928191,0.0020354677,0.0011920376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078206876,0.00018339555,0.01702474,0.22136284,0.006299096,0.00041555087,0.0019627577,0.004178321,0.002686251,0.008064915,0.2552639,0.48177615],"study_design_scores_gemma":[0.0020409704,0.0007096509,0.051897146,0.3118535,0.01623543,0.0018031308,0.0015256474,0.004533676,0.0028241118,0.018181914,0.5880732,0.0003215678],"about_ca_topic_score_codex":0.013661866,"about_ca_topic_score_gemma":0.017445909,"teacher_disagreement_score":0.04119954,"about_ca_system_score_codex":0.0039620916,"about_ca_system_score_gemma":0.014993417,"threshold_uncertainty_score":0.21788657},"labels":[],"label_agreement":null},{"id":"W4415938647","doi":"10.1093/neuonc/noaf255","title":"Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Subspecialty; Profiling (computer programming); Data sharing; Patient care; Neuroimaging; Scientific progress; Emerging technologies; Scientific discovery","score_opus":0.05714682114220617,"score_gpt":0.3854376150473039,"score_spread":0.32829079390509774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415938647","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017572647,0.039944515,0.002393803,0.5564168,0.32711598,0.00012297196,0.0004071944,0.0005983173,0.071243115],"genre_scores_gemma":[0.036850248,0.08624791,0.012669163,0.35878584,0.2889341,0.0003143235,0.0015436504,0.0011489764,0.21350582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.981791,0.0036325606,0.0013595944,0.0015510397,0.008557609,0.0031081222],"domain_scores_gemma":[0.9423594,0.0062891385,0.0036666244,0.0030201788,0.016308686,0.028355997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019876927,0.0019325248,0.0014545802,0.0048186416,0.0033465219,0.022592781,0.0022827554,0.014149275,0.037439626],"category_scores_gemma":[0.03687916,0.0006707841,0.0014835148,0.0032164718,0.0069469986,0.014653792,0.013096787,0.016756961,0.032432493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045894325,0.000036454516,0.00039061529,0.00019999378,0.000019559291,0.00012804315,0.00035261482,0.00007685413,0.0004780069,0.019202163,0.9084193,0.07065062],"study_design_scores_gemma":[0.0000098236,0.000023512186,0.00034168898,0.00014060932,0.0000043122986,0.000090084584,0.00033510313,0.00004036385,0.00007065428,0.0069621406,0.9919708,0.00001093874],"about_ca_topic_score_codex":0.0017443632,"about_ca_topic_score_gemma":0.0026246796,"teacher_disagreement_score":0.037439626,"about_ca_system_score_codex":0.004975719,"about_ca_system_score_gemma":0.016830405,"threshold_uncertainty_score":0.12524801},"labels":[],"label_agreement":null},{"id":"W4416084780","doi":"10.1093/neuonc/noaf201.0201","title":"BIOM-113. TERT EXPRESSION IN MENINGIOMAS PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENT OF TERT PROMOTER MUTATION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children; University of British Columbia; University Health Network","funders":"","keywords":"Sanger sequencing; Meningioma; Gene expression; Proportional hazards model; Gene; Mutation; Survival analysis","score_opus":0.02132271782543062,"score_gpt":0.32050051350574615,"score_spread":0.29917779568031555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789304,0.0002010801,0.0001663844,0.00003087845,0.000004795425,0.00000625486,0.0012391991,0.000014001907,0.00044437457],"genre_scores_gemma":[0.99834836,0.000058073518,0.00014512753,0.000006024738,0.0000039215197,0.0000059180156,0.0010652875,0.0000029674277,0.0003644018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998192,0.00003449507,0.000020115385,0.000052013133,0.00004468206,0.000029520763],"domain_scores_gemma":[0.99931014,0.00012834,0.00028711604,0.0000666539,0.00007693372,0.0001308588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049572566,0.00021331567,0.00020337422,0.00043158603,0.00020587939,0.00046465444,0.00022485178,0.0001814567,0.0023756926],"category_scores_gemma":[0.0010868313,0.00011987831,0.00025683938,0.00040023107,0.0001968236,0.00014380581,0.00022205719,0.00020955557,0.00050289725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005918458,0.00001584118,0.9902119,0.000020879474,0.000057845187,0.00011603386,0.000031175277,0.00011784482,0.005252396,0.000013101564,0.00020121832,0.0033698194],"study_design_scores_gemma":[0.0000099569215,0.000114543975,0.9971506,0.0000040735695,0.000046200177,0.00039278893,0.00003156512,0.00036634013,0.0015179041,0.000022358465,0.0003413614,0.0000022216134],"about_ca_topic_score_codex":0.006872267,"about_ca_topic_score_gemma":0.008833387,"teacher_disagreement_score":0.006872267,"about_ca_system_score_codex":0.00042190176,"about_ca_system_score_gemma":0.00036555793,"threshold_uncertainty_score":0.013664544},"labels":[],"label_agreement":null},{"id":"W4416084782","doi":"10.1093/neuonc/noaf201.0127","title":"BIOM-39. PLASMA PROTEOMICS REVEAL KEY PRELIMINARY BIOMARKERS FOR GLIOBLASTOMA PROGRESSION AND DIFFERENTIAL DIAGNOSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Hospital for Sick Children; University Health Network; University of Toronto","funders":"","keywords":"Glioblastoma; Receiver operating characteristic; Proteomics; Differential diagnosis; Disease; Brain tumor; Random forest","score_opus":0.014782224832700877,"score_gpt":0.3087694840929666,"score_spread":0.29398725926026575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803351,0.0045054485,0.008865199,0.0005635883,0.00007170409,0.00009000281,0.0025671737,0.00030033974,0.002701475],"genre_scores_gemma":[0.98789006,0.0007098722,0.008229418,0.00013437877,0.000028162513,0.000054351847,0.0015818257,0.000019012688,0.0013529464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997385,0.00006816089,0.0000243635,0.000070663715,0.00006320092,0.000035172518],"domain_scores_gemma":[0.9997857,0.000046548652,0.00007889624,0.0000176836,0.000047036305,0.00002408633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009088182,0.00047503173,0.00032292132,0.0007404005,0.00023730766,0.00080157927,0.0001697568,0.000414702,0.001910354],"category_scores_gemma":[0.00088729797,0.00019032566,0.00038242643,0.00055724796,0.00021073112,0.00027181336,0.00047025186,0.00030616895,0.0008171324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024694751,0.00023009535,0.22615033,0.00042985933,0.00029470678,0.00045222967,0.00019140267,0.0013784132,0.6634873,0.000709226,0.0022182039,0.1019887],"study_design_scores_gemma":[0.000082911465,0.0013054434,0.7339662,0.0000991746,0.00031870266,0.0023236903,0.0002686229,0.016488856,0.2329587,0.0022719174,0.009851899,0.00006384091],"about_ca_topic_score_codex":0.0010362046,"about_ca_topic_score_gemma":0.0010828896,"teacher_disagreement_score":0.001910354,"about_ca_system_score_codex":0.00036085246,"about_ca_system_score_gemma":0.00037926505,"threshold_uncertainty_score":0.00639081},"labels":[],"label_agreement":null},{"id":"W4416084814","doi":"10.1093/neuonc/noaf201.0077","title":"ANGI-11. MESENCHYMAL STEM CELLS AND PERIVASCULAR STROMA ARE ASSOCIATED WITH MICROVASCULAR PROLIFERATION, IMMUNOSUPPRESSION, AND POOR OUTCOME IN GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mesenchymal stem cell; PDGFRB; Stromal cell; Glioma; Transcriptome; Immune system; CD34; Stem cell; Single-cell analysis; Gene signature","score_opus":0.01031928836619211,"score_gpt":0.23751077976274843,"score_spread":0.2271914913965563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807966,0.00062694214,0.00023406457,0.00003732874,0.0000073801625,0.0000046320797,0.0006085671,0.000025194377,0.00037616852],"genre_scores_gemma":[0.99850345,0.00019097203,0.00021364735,0.000024840823,0.000006822639,0.0000061300866,0.0006982696,0.000004316013,0.00035163874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999,0.000013567502,0.000008467635,0.000030659397,0.000025875972,0.00002150761],"domain_scores_gemma":[0.99971575,0.000028621742,0.00014307185,0.000013539824,0.000026149866,0.00007287186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015618552,0.00016987679,0.00021406323,0.00055970956,0.0001583213,0.00040539712,0.00014198912,0.00023257615,0.001593979],"category_scores_gemma":[0.00023557137,0.00009191147,0.00021585659,0.0005158856,0.00019776796,0.000091096495,0.00021564469,0.00028877158,0.00030003168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020055945,0.00008995362,0.8819249,0.00021931468,0.00024219452,0.0005461692,0.000118114556,0.00038489106,0.09671961,0.0001307101,0.0006053882,0.01701317],"study_design_scores_gemma":[0.0000070162528,0.00014007249,0.99228585,0.000013507,0.000089144414,0.00084573636,0.000126279,0.0006094722,0.0051001776,0.00013839755,0.0006372933,0.0000069621233],"about_ca_topic_score_codex":0.0011427249,"about_ca_topic_score_gemma":0.0017514528,"teacher_disagreement_score":0.001593979,"about_ca_system_score_codex":0.00016531415,"about_ca_system_score_gemma":0.00021574834,"threshold_uncertainty_score":0.0053324103},"labels":[],"label_agreement":null},{"id":"W4416084826","doi":"10.1093/neuonc/noaf201.0005","title":"EPCO-05. AN ONCOGENIC PHOTORECEPTOR PROGRAM UNIFIES DISTINCT CENTRAL NERVOUS SYSTEM TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Transcriptome; Transcription factor; Central nervous system; Medulloblastoma; Retinoblastoma; Transcription (linguistics); Phenotype; Reprogramming","score_opus":0.016908538348562766,"score_gpt":0.30849067851333123,"score_spread":0.29158214016476847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96749264,0.0016400828,0.008405087,0.0003005081,0.00009717572,0.00014034359,0.008620054,0.000941164,0.012362887],"genre_scores_gemma":[0.98317254,0.00055657706,0.002989666,0.00029010058,0.000007982268,0.0001178099,0.0072644283,0.00022510276,0.0053758183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997454,0.000016871183,0.00001596007,0.00008695518,0.00008013048,0.000054664462],"domain_scores_gemma":[0.9997602,0.000028634371,0.00006267637,0.000037860074,0.000029293713,0.000081246355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021906449,0.00029223305,0.00028216746,0.00055620604,0.00038928326,0.00071214634,0.00025937083,0.00041885558,0.0036598325],"category_scores_gemma":[0.00021718383,0.00016622571,0.00032875128,0.00035394236,0.00037246596,0.00019110559,0.00050124136,0.00079711305,0.0012275436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007703986,0.00014079473,0.013462521,0.00020402107,0.000047404184,0.0008099559,0.00008482992,0.00073872716,0.9651991,0.0023549108,0.001531997,0.014655263],"study_design_scores_gemma":[0.00017691373,0.0012795237,0.16515286,0.00016635332,0.00029964597,0.008697007,0.0003538101,0.0114244195,0.7267357,0.0022810432,0.08337536,0.00005730925],"about_ca_topic_score_codex":0.0014854466,"about_ca_topic_score_gemma":0.0025746357,"teacher_disagreement_score":0.0036598325,"about_ca_system_score_codex":0.0005914896,"about_ca_system_score_gemma":0.00076451706,"threshold_uncertainty_score":0.01224339},"labels":[],"label_agreement":null},{"id":"W4416084848","doi":"10.1093/neuonc/noaf201.0115","title":"BIOM-27. PREDICTIVE BIOMARKERS OF BRAIN METASTASIS IN TRIPLE-NEGATIVE BREAST CANCER: CLINICOPATHOLOGICAL CORRELATES AND EMERGING EVIDENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Breast cancer; Metastasis; STAT3; Disease; Estrogen receptor; Transcription factor; Carcinogenesis","score_opus":0.035446838863150365,"score_gpt":0.37253579089007793,"score_spread":0.33708895202692757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084848","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066596526,0.9824095,0.00026899192,0.0012244117,0.00022446798,0.000107976324,0.006538106,0.000024002371,0.0025428822],"genre_scores_gemma":[0.076317996,0.91355807,0.0016958001,0.00094187085,0.0004127736,0.00031080478,0.0059791836,0.000020466648,0.0007629972],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99809176,0.00036149498,0.00072606857,0.00024095459,0.00048162526,0.00009809621],"domain_scores_gemma":[0.9865161,0.007595947,0.0035194336,0.00018198839,0.0018993653,0.0002870565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035293098,0.00079748116,0.0028706656,0.015173878,0.00036784913,0.0027651505,0.0011163673,0.001085977,0.0060983943],"category_scores_gemma":[0.012715703,0.00037586835,0.0032667958,0.019278105,0.0005580792,0.0014613257,0.0009386118,0.0008045791,0.0015409199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001602458,0.0001051304,0.06794786,0.58354956,0.010490706,0.0006746693,0.00032939448,0.00046925864,0.001989971,0.0019197932,0.014698194,0.3162229],"study_design_scores_gemma":[0.00064765767,0.00074076577,0.29102162,0.39512768,0.07301227,0.0040103495,0.0012156038,0.001205458,0.0023169834,0.004729408,0.22573645,0.00023580549],"about_ca_topic_score_codex":0.0036897908,"about_ca_topic_score_gemma":0.005170762,"teacher_disagreement_score":0.015173878,"about_ca_system_score_codex":0.0011049985,"about_ca_system_score_gemma":0.004022201,"threshold_uncertainty_score":0.02040112},"labels":[],"label_agreement":null},{"id":"W4416084863","doi":"10.1093/neuonc/noaf201.0097","title":"BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Anaplastic astrocytoma; Grading (engineering); Astrocytoma; Glioma; Radiation therapy; CDKN2A; PTEN; Adjuvant","score_opus":0.018923936981932708,"score_gpt":0.3035092186765667,"score_spread":0.284585281694634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433017,0.0015951811,0.00017677735,0.00040498094,0.00007677931,0.00008318855,0.0021648426,0.000020830028,0.0011472004],"genre_scores_gemma":[0.9919843,0.00041925308,0.0005110847,0.00028484844,0.0000780222,0.00019494162,0.005220748,0.000007712105,0.0012990042],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99965787,0.00020263513,0.000020504709,0.000052009353,0.000034868444,0.000032030915],"domain_scores_gemma":[0.9995802,0.00009897452,0.00012842526,0.000033560056,0.000026858059,0.00013200496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008181678,0.00029813548,0.0006749276,0.00018067683,0.00011057458,0.00049893255,0.00033471198,0.00031919233,0.0020038176],"category_scores_gemma":[0.001001647,0.00015536412,0.0005384543,0.00027243135,0.00021850712,0.00024229383,0.00029630496,0.00056541525,0.00021110797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6216077,0.0021234867,0.27694643,0.00085257797,0.0050110677,0.00009867715,0.000083417006,0.0032222632,0.013192578,0.00063759665,0.0074158898,0.06880832],"study_design_scores_gemma":[0.11212104,0.059347343,0.79995394,0.00013988199,0.006476321,0.0002535057,0.00012208104,0.0077596614,0.0044387495,0.0011748119,0.008155557,0.000057117908],"about_ca_topic_score_codex":0.0008439916,"about_ca_topic_score_gemma":0.0029464823,"teacher_disagreement_score":0.0020038176,"about_ca_system_score_codex":0.00039636297,"about_ca_system_score_gemma":0.00046855002,"threshold_uncertainty_score":0.0067034364},"labels":[],"label_agreement":null},{"id":"W4416084867","doi":"10.1093/neuonc/noaf201.0602","title":"DNAR-11. Differential DNA Damage and Repair burden in proliferating neural progenitor cells","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"DNA damage; DNA repair; Chromatin; Homologous recombination; RAD51; Neural stem cell; DNA; Progenitor cell","score_opus":0.018330492004844823,"score_gpt":0.3216161726590021,"score_spread":0.3032856806541573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97734433,0.004109537,0.004560752,0.00021726465,0.00010770715,0.000073350915,0.009241561,0.00039703192,0.0039484454],"genre_scores_gemma":[0.9608321,0.0024588243,0.004407471,0.00032093623,0.000019596062,0.00018941576,0.016751917,0.00014321241,0.014876542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995765,0.000022942528,0.00003128049,0.00015895531,0.00013561257,0.000074671],"domain_scores_gemma":[0.999689,0.000055782442,0.00007177541,0.000040015417,0.000053318865,0.000090198584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026619853,0.00031594886,0.00040270458,0.00045489488,0.00027057924,0.00066244387,0.00025998062,0.00041439512,0.0039867493],"category_scores_gemma":[0.00026362963,0.00024067225,0.0004140423,0.00040938085,0.00031441997,0.0002268828,0.00036685896,0.001021345,0.0012822639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021915094,0.00005225629,0.0016493077,0.00015482023,0.000020082372,0.000077547586,0.000056353834,0.00015345626,0.9926363,0.000113211565,0.00020738487,0.004659994],"study_design_scores_gemma":[0.00002497247,0.0006469979,0.054488003,0.000039952654,0.00007368938,0.0004972186,0.00026356586,0.0015097667,0.93073803,0.00015514612,0.011541066,0.000021613252],"about_ca_topic_score_codex":0.0017721015,"about_ca_topic_score_gemma":0.002005888,"teacher_disagreement_score":0.0039867493,"about_ca_system_score_codex":0.00032319114,"about_ca_system_score_gemma":0.0004120262,"threshold_uncertainty_score":0.013337016},"labels":[],"label_agreement":null},{"id":"W4416084900","doi":"10.1093/neuonc/noaf201.0060","title":"EPCO-61. INTEGRATIVE MULTI-OMICS ANALYSIS OF GLIOBLASTOMA IDENTIFIES DRIVERS OF TUMOR AGGRESSION AND RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Glioma; Glioblastoma; Brain tumor; Precision medicine; Reprogramming; Cancer; Gene","score_opus":0.016273148387245612,"score_gpt":0.3281350211774062,"score_spread":0.31186187279016064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6106088,0.0026105314,0.03846837,0.001152821,0.00025458826,0.00044963238,0.33223888,0.0073218243,0.006894561],"genre_scores_gemma":[0.36657768,0.0011925371,0.05782949,0.00087406486,0.00008913297,0.0008251975,0.56848514,0.0009698162,0.0031569465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993309,0.000076765726,0.000052925552,0.00026187545,0.0001650019,0.000112670125],"domain_scores_gemma":[0.99909365,0.00015219573,0.00017206836,0.00017336864,0.00027158073,0.00013719822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013198089,0.00091075175,0.0008858395,0.001383244,0.000749078,0.0010469187,0.00061908766,0.0006877879,0.0022647788],"category_scores_gemma":[0.0015588203,0.0003427805,0.0010808702,0.0013177013,0.00029562687,0.0004727075,0.0013540733,0.00074511167,0.001194227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041769566,0.0004775268,0.15868339,0.0022327073,0.0013519111,0.0010324381,0.00041149353,0.017252108,0.6424059,0.0045088036,0.07083103,0.09663578],"study_design_scores_gemma":[0.00088073313,0.0017027789,0.4733146,0.00048522462,0.0013399341,0.0015482083,0.00044493368,0.17840317,0.20590568,0.01089661,0.1247459,0.00033223943],"about_ca_topic_score_codex":0.0061036306,"about_ca_topic_score_gemma":0.011473382,"teacher_disagreement_score":0.0061036306,"about_ca_system_score_codex":0.000719818,"about_ca_system_score_gemma":0.0016857282,"threshold_uncertainty_score":0.012136221},"labels":[],"label_agreement":null},{"id":"W4416084925","doi":"10.1093/neuonc/noaf201.0166","title":"BIOM-78. DNA-METHYLATION PROFILING OF PAN-CANCER BRAIN METASTASES REVEALS EPIGENETIC SIGNATURE ASSOCIATED WITH IMPROVED PATIENT OUTCOMES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Epigenetics; DNA methylation; Concordance; Gene expression profiling; Methylation; Genotyping; Survival analysis; Gene signature","score_opus":0.018158547686560448,"score_gpt":0.32018162722143945,"score_spread":0.302023079534879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982284,0.0006688852,0.002200628,0.00011242044,0.000013568016,0.0000359006,0.013174969,0.00018340613,0.0013262203],"genre_scores_gemma":[0.9780195,0.0002551845,0.0026758222,0.00006298016,0.000011791782,0.000069836584,0.01771264,0.000037332236,0.0011549843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.000038588423,0.000020017844,0.00011138692,0.00006912011,0.000039821098],"domain_scores_gemma":[0.9996184,0.000068454945,0.0001196852,0.000045619963,0.00008156748,0.000066288216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035444633,0.00028410458,0.0004195543,0.00052893016,0.00020381586,0.0004181608,0.0003139099,0.00026643544,0.0037976403],"category_scores_gemma":[0.0007354813,0.00015293054,0.0002259444,0.0006482818,0.0001226326,0.00013858973,0.00044120412,0.00038186117,0.0009924888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004846918,0.0003625057,0.48802283,0.0005807206,0.000574321,0.00028444148,0.00023237565,0.0033363425,0.39884323,0.00036079795,0.0070400983,0.095515415],"study_design_scores_gemma":[0.00013347241,0.0008859781,0.8753979,0.00003935632,0.00031129437,0.0010839682,0.00014472909,0.013490731,0.09934181,0.0006097078,0.008515767,0.000045312157],"about_ca_topic_score_codex":0.0016802235,"about_ca_topic_score_gemma":0.0030771494,"teacher_disagreement_score":0.0037976403,"about_ca_system_score_codex":0.00028488002,"about_ca_system_score_gemma":0.0002902184,"threshold_uncertainty_score":0.012704432},"labels":[],"label_agreement":null},{"id":"W4416084933","doi":"10.1093/neuonc/noaf201.0463","title":"CTIM-06. NIACIN MODULATES IMMUNE RESPONSES IN A PHASE I DOSE-ESCALATION CLINICAL TRIAL OF NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Niacin; Immune system; Clinical trial; Cytokine; Immunosuppression; Immunotherapy; Leukapheresis; Immunosenescence; Myeloid","score_opus":0.02979607474415171,"score_gpt":0.3701827246806268,"score_spread":0.3403866499364751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960532,0.0012184546,0.00020252448,0.0002195962,0.000083400206,0.0010217165,0.00032118845,0.00005525944,0.0008246155],"genre_scores_gemma":[0.99436885,0.0010148732,0.00075898546,0.00031712945,0.000073068084,0.0011650419,0.00065808557,0.000011005245,0.0016329986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996846,0.00015697152,0.000018418345,0.00004048662,0.000025409996,0.000074177166],"domain_scores_gemma":[0.9996489,0.00004509802,0.000075926,0.000029342933,0.000028860972,0.00017187101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009785752,0.00097043364,0.0014103572,0.00041030152,0.00027819985,0.0007421806,0.00078146026,0.00079206534,0.0025023252],"category_scores_gemma":[0.0004969598,0.00037301463,0.000696464,0.0003508021,0.000628238,0.00046077033,0.00028697745,0.002379064,0.00050976087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6772942,0.092188425,0.0053361347,0.0011277081,0.0010509086,0.00019252549,0.00028985747,0.002627022,0.076796845,0.00033361468,0.0036897452,0.13907309],"study_design_scores_gemma":[0.3637887,0.6143421,0.008464682,0.0000517773,0.0003590025,0.00015653115,0.00007099737,0.0014180825,0.009367553,0.00013834485,0.001812741,0.000029551065],"about_ca_topic_score_codex":0.00101167,"about_ca_topic_score_gemma":0.0031111343,"teacher_disagreement_score":0.0025023252,"about_ca_system_score_codex":0.000664283,"about_ca_system_score_gemma":0.0012076446,"threshold_uncertainty_score":0.008371115},"labels":[],"label_agreement":null},{"id":"W4416084950","doi":"10.1093/neuonc/noaf201.0096","title":"BIOM-08. CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Toronto","funders":"","keywords":"CDKN2B; CDKN2A; Grading (engineering); Meningioma; Cohort; Chromosome; Chromosome 22; Proportional hazards model","score_opus":0.01804516890103231,"score_gpt":0.2830084576079969,"score_spread":0.2649632887069646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95724744,0.0014462986,0.0015392464,0.0022101016,0.00016940571,0.00009467105,0.019242242,0.0001641667,0.01788642],"genre_scores_gemma":[0.9851549,0.00036370358,0.0018063342,0.00017333374,0.00006632554,0.000061595696,0.009287808,0.000028651706,0.003057329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996544,0.00010738613,0.000043215256,0.000040960673,0.00009373952,0.00006017287],"domain_scores_gemma":[0.9981458,0.000360937,0.0006580565,0.000119497025,0.0003942426,0.0003216061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011067794,0.0002799199,0.00029565478,0.0011399509,0.00023502755,0.00079469895,0.0003277711,0.00032277388,0.005930962],"category_scores_gemma":[0.004625224,0.0001499007,0.000246161,0.00079652347,0.00015679536,0.00032919788,0.00073808484,0.0003999065,0.001429746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006794047,0.000036229725,0.9606606,0.000038566603,0.00006105152,0.00008329552,0.00005079328,0.00024277593,0.0011627993,0.000090296475,0.005633999,0.031260207],"study_design_scores_gemma":[0.000049726168,0.00015095186,0.9915844,0.000034551238,0.00006006696,0.0003064217,0.000092187416,0.00090849906,0.00079926837,0.0002760012,0.0057296813,0.000008219405],"about_ca_topic_score_codex":0.0070029767,"about_ca_topic_score_gemma":0.011939466,"teacher_disagreement_score":0.0070029767,"about_ca_system_score_codex":0.000492536,"about_ca_system_score_gemma":0.00046306595,"threshold_uncertainty_score":0.019841015},"labels":[],"label_agreement":null},{"id":"W4416084963","doi":"10.1093/neuonc/noaf201.0422","title":"RADT-53. IMPACT OF SMALLER CLINICAL TARGET VOLUME EXPANSIONS FOR THE RADIATION TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Radiation therapy; Cohort; Retrospective cohort study; Glioblastoma; Radiation treatment planning; Abnormality; Cohort study; Disease","score_opus":0.03473264108856151,"score_gpt":0.38082863405487455,"score_spread":0.34609599296631305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931497,0.0040579666,0.00037183522,0.0003528498,0.000038121794,0.000019375499,0.00043960827,0.00003425379,0.001536309],"genre_scores_gemma":[0.99858046,0.00040893868,0.00027498056,0.00010793665,0.00002549846,0.000010399006,0.00040588304,0.000012582774,0.00017327645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959654,0.00013603302,0.00005128472,0.000086097316,0.00007244343,0.000057676465],"domain_scores_gemma":[0.99895775,0.00032675682,0.00037036094,0.00006440731,0.00008390922,0.00019672171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039675,0.00017195447,0.00034099256,0.00024176351,0.000118006705,0.00062515895,0.000269333,0.00017029211,0.0019067517],"category_scores_gemma":[0.0025485088,0.000081700106,0.0005941585,0.00027549284,0.00021966666,0.00029833138,0.00027186208,0.0003445768,0.0002335158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012871283,0.0003761558,0.7765655,0.0002981391,0.0007350252,0.00046154184,0.00008003928,0.006638636,0.012585866,0.00032434915,0.0029159135,0.18614757],"study_design_scores_gemma":[0.00036381968,0.00541086,0.9778946,0.000102411526,0.000694787,0.0011645517,0.000121014156,0.0042520235,0.0050815274,0.0002677547,0.0046269,0.00001958781],"about_ca_topic_score_codex":0.0032100924,"about_ca_topic_score_gemma":0.007466185,"teacher_disagreement_score":0.0032100924,"about_ca_system_score_codex":0.0007093722,"about_ca_system_score_gemma":0.0004532905,"threshold_uncertainty_score":0.006382823},"labels":[],"label_agreement":null},{"id":"W4416084970","doi":"10.1093/neuonc/noaf201.0591","title":"CTP-19. Molecular characterization of the SJMB12 clinical trial for children and young adults with newly diagnosed medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Germline; PTCH1; Medulloblastoma; Germline mutation; Exome sequencing; Exon; Gene; Clinical trial; Exome","score_opus":0.01346328353725241,"score_gpt":0.3111997749173576,"score_spread":0.2977364913801052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723292,0.0095865,0.000595914,0.0011720784,0.0001338052,0.0011469166,0.009323914,0.00009085083,0.005620863],"genre_scores_gemma":[0.9805414,0.0025731877,0.0017659751,0.0008347208,0.00011813133,0.0019232744,0.009682174,0.00004438632,0.0025167698],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994616,0.00021596087,0.000050496288,0.00008447766,0.00009938232,0.00008809279],"domain_scores_gemma":[0.9992756,0.00012528164,0.0002577513,0.000039979957,0.00006138125,0.00024000375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013966729,0.00036113136,0.00086207694,0.0004968058,0.00024507,0.0008095256,0.0003904931,0.00046013304,0.003911378],"category_scores_gemma":[0.001626192,0.00022937173,0.00060079026,0.00075944583,0.00030317335,0.00033624537,0.00025761215,0.0008719945,0.0006822769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32932746,0.0031775874,0.26138675,0.0027349398,0.0025427064,0.00082286954,0.00043348,0.0028728284,0.05770307,0.0023225655,0.020491702,0.31618404],"study_design_scores_gemma":[0.11332991,0.08050738,0.7229577,0.0004913955,0.0027161217,0.0020760465,0.00028381846,0.0039217668,0.011218699,0.0020111909,0.060386173,0.00009972941],"about_ca_topic_score_codex":0.0023294883,"about_ca_topic_score_gemma":0.01062635,"teacher_disagreement_score":0.003911378,"about_ca_system_score_codex":0.0008200883,"about_ca_system_score_gemma":0.0013564896,"threshold_uncertainty_score":0.013084829},"labels":[],"label_agreement":null},{"id":"W4416085230","doi":"10.1093/neuonc/noaf201.1135","title":"IMG-56. Primary tumor type influences anatomical destination in large metastases to the brain and shows a preference for the posterior fossa","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiosurgery; Melanoma; Primary tumor; Lung; Posterior fossa; Brain metastasis; Lesion; Posterior cranial fossa","score_opus":0.03588076848827815,"score_gpt":0.34060595360510065,"score_spread":0.3047251851168225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987042,0.00018299055,0.00009203529,0.00002586009,0.0000055016744,0.0000032690543,0.00028258006,0.0000067421033,0.00069682056],"genre_scores_gemma":[0.9993718,0.000035774763,0.00005338289,0.000010760602,0.0000026017794,0.0000033554709,0.0001542658,0.0000070708998,0.00036100336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998628,0.000020932051,0.000009883208,0.00005424667,0.000023507486,0.000028671495],"domain_scores_gemma":[0.99942964,0.00009377182,0.00025414315,0.000042851658,0.00003297702,0.00014661618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019303952,0.00017684358,0.00027986523,0.0004793249,0.00015788169,0.00035382964,0.00014792575,0.00025391055,0.0046953605],"category_scores_gemma":[0.000879561,0.00009836074,0.00017225379,0.0004263944,0.00027181726,0.00016102538,0.00016531258,0.00021991732,0.0012285262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00165443,0.000049741244,0.9611259,0.000028357874,0.000060202583,0.00066386454,0.00008713283,0.00020322131,0.029318426,0.00005127803,0.0004359331,0.006321605],"study_design_scores_gemma":[0.000006116672,0.00012328457,0.9978703,0.0000039644124,0.000013589118,0.0006798841,0.00006279459,0.00015669712,0.0007624873,0.000050639814,0.00026740553,0.0000027024505],"about_ca_topic_score_codex":0.0013663865,"about_ca_topic_score_gemma":0.0019069023,"teacher_disagreement_score":0.0046953605,"about_ca_system_score_codex":0.00021986323,"about_ca_system_score_gemma":0.00012476419,"threshold_uncertainty_score":0.015707552},"labels":[],"label_agreement":null},{"id":"W4416085232","doi":"10.1093/neuonc/noaf201.1737","title":"TMET-46. Investigating metabolic dependencies during the evolution of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Phenotype; Glioblastoma; Reprogramming; Mitochondrion; Disease; Cancer; Stem cell; Gene deletion; Metabolic stability","score_opus":0.008222305155592906,"score_gpt":0.25902600891243377,"score_spread":0.25080370375684086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929837,0.0016636506,0.0013117943,0.00008435382,0.000038575712,0.000062195875,0.002514239,0.0000777777,0.001263739],"genre_scores_gemma":[0.9911413,0.0009999141,0.0016175322,0.0000746267,0.0000057810294,0.00008507143,0.004632129,0.000022804159,0.0014208141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998915,0.000011881791,0.000009238664,0.000026390082,0.00002923613,0.0000316511],"domain_scores_gemma":[0.99994826,0.0000063200528,0.000016228736,0.0000044037506,0.0000102287795,0.000014606596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014046096,0.00024357795,0.00032595996,0.0003728573,0.00013346926,0.00030463684,0.00016189476,0.00024387795,0.000976108],"category_scores_gemma":[0.00012211251,0.00012570353,0.00025221295,0.00046103177,0.00013368795,0.00018821421,0.00013153417,0.00047049395,0.000225351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015811804,0.00029264882,0.0070207627,0.00014260579,0.000035771875,0.000113315196,0.000033638138,0.001536955,0.97868735,0.00013118956,0.00043074432,0.0099937925],"study_design_scores_gemma":[0.00009461925,0.004263015,0.084091395,0.000023942393,0.000110357054,0.000904142,0.00010900927,0.012362564,0.89000416,0.00016197367,0.007852273,0.000022612281],"about_ca_topic_score_codex":0.0023315095,"about_ca_topic_score_gemma":0.0028095534,"teacher_disagreement_score":0.0023315095,"about_ca_system_score_codex":0.0005211863,"about_ca_system_score_gemma":0.0002768792,"threshold_uncertainty_score":0.0046358705},"labels":[],"label_agreement":null},{"id":"W4416085259","doi":"10.1093/neuonc/noaf201.1278","title":"NCOG-11. Factors influencing social competence in adolescents and young adults surviving pediatric brain tumors treated with radiation therapy: A scoping review","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Social competence; Social skills; Cognition; Formative assessment; Population; Competence (human resources); Checklist; Young adult","score_opus":0.036964899492369745,"score_gpt":0.3592557865811217,"score_spread":0.322290887088752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085096067,0.9955693,0.00011696789,0.00044362736,0.00019329746,0.0004982087,0.0011931806,0.000008993423,0.0011254743],"genre_scores_gemma":[0.0057864767,0.9916065,0.00052488944,0.00033449288,0.000056469642,0.00087160215,0.0006247074,0.00000587498,0.00018912967],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99520564,0.001181537,0.0021568865,0.00036973952,0.0008916698,0.0001945747],"domain_scores_gemma":[0.9794844,0.014748993,0.0033022948,0.00019975398,0.002022353,0.0002421527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007407921,0.0012752181,0.0042751706,0.01531921,0.0010909194,0.0035763087,0.0018690723,0.0022077404,0.0070153954],"category_scores_gemma":[0.032073747,0.000818901,0.0046514194,0.0150297275,0.00090982026,0.0021160014,0.0021187004,0.0013212255,0.00067890313],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093065195,0.000036855257,0.0019517249,0.87034273,0.0016545688,0.00009088447,0.00046889286,0.00012584,0.000095177085,0.000634944,0.004491952,0.12001327],"study_design_scores_gemma":[0.000034085173,0.00004910971,0.0047005117,0.95877105,0.0056556966,0.00018094448,0.00033418642,0.000040875344,0.00005964714,0.00016955112,0.029983807,0.00002056547],"about_ca_topic_score_codex":0.024335295,"about_ca_topic_score_gemma":0.04306517,"teacher_disagreement_score":0.024335295,"about_ca_system_score_codex":0.0037415917,"about_ca_system_score_gemma":0.016785104,"threshold_uncertainty_score":0.04838729},"labels":[],"label_agreement":null},{"id":"W4416085285","doi":"10.1093/neuonc/noaf201.1114","title":"IMG-35. Targeted blood-nerve-barrier opening for the delivery of MEK inhibitor selumetinib in peripheral nerve sheath tumours using focused ultrasound","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Sciatic nerve; Selumetinib; Neurofibromatosis; Adverse effect; Malignant peripheral nerve sheath tumor; Nerve sheath neoplasm; Peripheral; Ultrasound","score_opus":0.016410562931266987,"score_gpt":0.26292544764626946,"score_spread":0.24651488471500246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97459465,0.0062237675,0.014292363,0.00030345022,0.000120945566,0.00015281634,0.00039759738,0.0002850942,0.0036292132],"genre_scores_gemma":[0.986865,0.0015530834,0.008895173,0.0001626947,0.00001563985,0.0001064098,0.00031998212,0.000017215962,0.0020648204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991584,0.00001231177,0.0000036252536,0.000020433896,0.000022509723,0.000025362966],"domain_scores_gemma":[0.9999714,0.000005620261,0.0000074755053,0.00000227675,0.0000036092413,0.000009636335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016243162,0.0003313361,0.00019947108,0.00025712824,0.00012079238,0.00015389457,0.00018967112,0.0003904944,0.0007638839],"category_scores_gemma":[0.00006989676,0.00013181026,0.00025036762,0.00012250076,0.00021951132,0.0001817526,0.00013167245,0.00038357562,0.00022499911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011703063,0.000038781654,0.00005748866,0.000060685452,0.0000057617012,0.00003960075,0.000022399787,0.00024475183,0.99557143,0.00012379418,0.00016974141,0.0035485325],"study_design_scores_gemma":[0.00004236474,0.0016316731,0.0015216359,0.000013155386,0.000027011125,0.0001906118,0.000023860022,0.0033354068,0.98925936,0.00005881105,0.0038863448,0.000009855542],"about_ca_topic_score_codex":0.0013105876,"about_ca_topic_score_gemma":0.0019622413,"teacher_disagreement_score":0.0013105876,"about_ca_system_score_codex":0.000282843,"about_ca_system_score_gemma":0.0001727497,"threshold_uncertainty_score":0.002605915},"labels":[],"label_agreement":null},{"id":"W4416085315","doi":"10.1093/neuonc/noaf201.1333","title":"NCOG-66. ‘Core outcome set’ for leptomeningeal disease (LeptoCOS): a multi-disciplinary, international, consensus effort","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Randomized controlled trial; Outcome (game theory); Clinical trial; Systematic review; Disease; Meta-analysis","score_opus":0.12044128569535015,"score_gpt":0.44523600348808906,"score_spread":0.32479471779273894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085315","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013598279,0.38111818,0.1329627,0.13811618,0.024804803,0.13647413,0.11328611,0.0024500114,0.057189576],"genre_scores_gemma":[0.0567946,0.12114156,0.40577453,0.03184423,0.0028755928,0.28115848,0.09387943,0.0016435027,0.004888039],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7898195,0.0931293,0.07332284,0.006436778,0.033878993,0.0034125762],"domain_scores_gemma":[0.66375697,0.16381189,0.042502437,0.017209854,0.10332939,0.009389468],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27138543,0.0020990446,0.011596525,0.014896313,0.0025029178,0.008465008,0.009643448,0.005281394,0.007549274],"category_scores_gemma":[0.36701217,0.0013685192,0.014321278,0.014606518,0.0033197936,0.0050831977,0.0119995065,0.009976607,0.004457311],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019999482,0.00030451655,0.008457337,0.31854272,0.0078091244,0.00016196167,0.0019536184,0.0027446127,0.00078532216,0.03030454,0.25250247,0.37443376],"study_design_scores_gemma":[0.0037726944,0.0006012112,0.02806036,0.5018518,0.010570223,0.00039241917,0.0013361344,0.0021300088,0.0013699094,0.028306957,0.42124295,0.0003654341],"about_ca_topic_score_codex":0.012915323,"about_ca_topic_score_gemma":0.015645213,"teacher_disagreement_score":0.72861457,"about_ca_system_score_codex":0.013953388,"about_ca_system_score_gemma":0.06049587,"threshold_uncertainty_score":0.89851147},"labels":[],"label_agreement":null},{"id":"W4416085317","doi":"10.1093/neuonc/noaf201.1152","title":"IMG-73. Functional connectivity alterations in disorders of consciousness: a systematic review and exploratory coordinate-based meta-analysis","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minimally conscious state; Persistent vegetative state; Functional connectivity; Default mode network; Functional magnetic resonance imaging; Wakefulness; Precuneus; Brain mapping; Neuroimaging; Prefrontal cortex","score_opus":0.155851679966577,"score_gpt":0.4102132863960282,"score_spread":0.2543616064294512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064868336,0.989613,0.000890756,0.00024096432,0.00011657496,0.00059756724,0.0015428747,0.00006109458,0.0004504735],"genre_scores_gemma":[0.293353,0.69253397,0.0055397535,0.001157827,0.00033761174,0.00409484,0.0022156993,0.00008133836,0.0006859767],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99367106,0.0028079625,0.0017000111,0.00083953916,0.0006872276,0.0002941346],"domain_scores_gemma":[0.99028546,0.0069786,0.0015479105,0.0003339164,0.0007020035,0.00015208349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009000327,0.0023497494,0.013971357,0.007196977,0.00070496876,0.003031371,0.002081542,0.0018245182,0.0065100463],"category_scores_gemma":[0.020651259,0.00096768694,0.027241178,0.0083326455,0.0006456176,0.0016562578,0.0016721931,0.0012846373,0.0005272942],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014555122,0.00003053679,0.0049538435,0.5309894,0.4448335,0.0001825362,0.00011133352,0.00048624774,0.00038320004,0.0002579341,0.000966341,0.015349648],"study_design_scores_gemma":[0.0007479585,0.00022125061,0.0066758874,0.036436968,0.9528686,0.000119138196,0.00006253641,0.00023122628,0.00011775379,0.0003037711,0.002187614,0.000027293368],"about_ca_topic_score_codex":0.006133983,"about_ca_topic_score_gemma":0.015435737,"teacher_disagreement_score":0.013971357,"about_ca_system_score_codex":0.0020963775,"about_ca_system_score_gemma":0.0029490804,"threshold_uncertainty_score":0.0475989},"labels":[],"label_agreement":null},{"id":"W4416085335","doi":"10.1093/neuonc/noaf201.1397","title":"EXTH-64. Allogeneic CAR-DNT cell therapy to overcome spatial heterogeneity in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fonds Wetenschappelijk Onderzoek","keywords":"Chimeric antigen receptor; Cytotoxicity; Cytotoxic T cell; Cell therapy; In vitro; Glioblastoma; Immunotherapy; CD19; Antigen; Cell","score_opus":0.02928261303002896,"score_gpt":0.35076667718269267,"score_spread":0.32148406415266373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456453,0.0014875546,0.0017853321,0.000050381495,0.000033493976,0.00007597077,0.00012728777,0.00007010793,0.0018052524],"genre_scores_gemma":[0.9967225,0.00070699165,0.00072018744,0.000023626639,0.000006851525,0.000032866596,0.00016828939,0.000007788103,0.0016108666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999522,0.000004425796,0.0000027341166,0.000009930066,0.000011846676,0.0000188599],"domain_scores_gemma":[0.9999833,0.0000018911359,0.000003701178,0.0000026944624,0.000002176765,0.0000062537097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000661105,0.00025251275,0.00026256256,0.00024037824,0.000077244455,0.0001826973,0.00012574345,0.00016007059,0.00088362244],"category_scores_gemma":[0.000030785784,0.000069707385,0.00011364338,0.00015200881,0.00011417354,0.00009056632,0.00016044879,0.000309698,0.00021240966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034151398,0.00028029724,0.00036719785,0.00008603414,0.000011870893,0.00012582453,0.000033502954,0.0006042585,0.9854058,0.00033712617,0.0001993783,0.012207306],"study_design_scores_gemma":[0.00021021802,0.005354339,0.0053479853,0.000018223562,0.00007761144,0.0010813051,0.00004579817,0.0031486608,0.9736495,0.00015398239,0.010905525,0.000006768895],"about_ca_topic_score_codex":0.0011075283,"about_ca_topic_score_gemma":0.0014935924,"teacher_disagreement_score":0.0011075283,"about_ca_system_score_codex":0.0001986746,"about_ca_system_score_gemma":0.00023249321,"threshold_uncertainty_score":0.0029559731},"labels":[],"label_agreement":null},{"id":"W4416085345","doi":"10.1093/neuonc/noaf201.1068","title":"PTHP-11. Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights Unique Biology and Underscores the Need for Lifespan Precision in Neuro-Oncology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Meningioma; Young adult; DNA methylation; Cohort; Brain tumor; Precision medicine; Methylation; Clinical Practice","score_opus":0.02481008278023731,"score_gpt":0.3387759911833526,"score_spread":0.3139659084031153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760434,0.006131279,0.00654943,0.001416184,0.00010791888,0.00006242507,0.0050151544,0.0003063377,0.0043677776],"genre_scores_gemma":[0.9924912,0.0010194698,0.0042815446,0.0001580375,0.000034248318,0.000032574862,0.001120449,0.000026047739,0.0008365044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947804,0.00013040709,0.00004899018,0.00016393648,0.00012350475,0.00005506287],"domain_scores_gemma":[0.9977034,0.0007409554,0.000785986,0.00015339174,0.00035348246,0.0002628302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017126472,0.00042906508,0.00040163475,0.0009024703,0.000298491,0.001387586,0.0004828863,0.000505446,0.0014297467],"category_scores_gemma":[0.0048398143,0.00021712418,0.00044967237,0.00059053727,0.00027360034,0.0007760888,0.0006678512,0.0010250058,0.0006125397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041225867,0.000050073333,0.93517387,0.00012631643,0.00016981855,0.000404577,0.00015658821,0.0016279587,0.0066533117,0.0002470911,0.0015635365,0.05341454],"study_design_scores_gemma":[0.000024879544,0.00046120558,0.95953935,0.00016222542,0.00018644966,0.002627904,0.00048823806,0.01326224,0.011673177,0.0014210956,0.010122042,0.00003123962],"about_ca_topic_score_codex":0.0042682565,"about_ca_topic_score_gemma":0.008670528,"teacher_disagreement_score":0.0042682565,"about_ca_system_score_codex":0.00064969173,"about_ca_system_score_gemma":0.0006097304,"threshold_uncertainty_score":0.009057462},"labels":[],"label_agreement":null},{"id":"W4416085364","doi":"10.1093/neuonc/noaf201.1178","title":"IMG-99. Volumetric tumor growth rate (TGR) modeling predicts clinical outcomes in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Glioma; Placebo; Isocitrate dehydrogenase; Confidence interval; Proportional hazards model; Multivariate analysis; Clinical trial; Astrocytoma; Oligodendroglioma","score_opus":0.04054604603426565,"score_gpt":0.3550506624591637,"score_spread":0.3145046164248981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297523,0.0006479968,0.003996083,0.00016600474,0.000012799386,0.000051945,0.0011894662,0.0001259877,0.0008345361],"genre_scores_gemma":[0.9969988,0.00010009379,0.0014705043,0.000044938715,0.000005596974,0.00004068623,0.0010408495,0.000017141592,0.00028147057],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99959606,0.00024785672,0.000013893368,0.00006721242,0.00004748064,0.000027531467],"domain_scores_gemma":[0.99930227,0.0003531664,0.0001650354,0.00007993539,0.000035620986,0.00006396234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025692557,0.00050510257,0.00057046843,0.00037882995,0.000075004486,0.000715721,0.0005377021,0.00037907113,0.0008111205],"category_scores_gemma":[0.0023869197,0.00021026927,0.000802579,0.00030697123,0.00020379506,0.00034732313,0.0002826826,0.0007705017,0.00031517298],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049783267,0.0017466856,0.49418545,0.0003306582,0.0016851672,0.00018498144,0.0002883579,0.31296822,0.028090948,0.0016136824,0.004557319,0.10456531],"study_design_scores_gemma":[0.0010739455,0.008416357,0.16496205,0.00003098636,0.0005194913,0.00030923498,0.000100143065,0.8079065,0.012279567,0.0015233262,0.0028129164,0.000065512344],"about_ca_topic_score_codex":0.001968272,"about_ca_topic_score_gemma":0.0018584589,"teacher_disagreement_score":0.0025692557,"about_ca_system_score_codex":0.0008648629,"about_ca_system_score_gemma":0.000440769,"threshold_uncertainty_score":0.013587713},"labels":[],"label_agreement":null},{"id":"W4416085425","doi":"10.1093/neuonc/noaf201.1402","title":"EXTH-69. CD155 regulates tumor growth and immune evasion in diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"TIGIT; Gene silencing; Immune system; Glioma; Small hairpin RNA; Immune checkpoint; Apoptosis; Flow cytometry","score_opus":0.00881963845761368,"score_gpt":0.2583106986159113,"score_spread":0.24949106015829764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945469,0.002160907,0.0007511217,0.00009425567,0.000022727816,0.000018626928,0.0004786221,0.0000866576,0.0018403337],"genre_scores_gemma":[0.99735224,0.0004585173,0.00027093806,0.0000503545,0.0000038684443,0.000011012083,0.00037639186,0.000008139649,0.0014684759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999941,0.0000063976527,0.0000037271582,0.000014359673,0.000015533631,0.000019016474],"domain_scores_gemma":[0.9999646,0.0000033104182,0.000012658763,0.0000023025482,0.000002558532,0.000014629572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050460894,0.00023003118,0.00015640055,0.00016181359,0.00009898288,0.000197261,0.000095032636,0.00020109062,0.0014390108],"category_scores_gemma":[0.000048453785,0.00007917873,0.00012350475,0.00009509173,0.00015104136,0.000067857036,0.00011698302,0.0003592551,0.00049533905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008739348,0.000018014138,0.00042957606,0.000025317446,0.0000036040306,0.00011839571,0.0000070420697,0.0000533638,0.99774337,0.000079368256,0.00009637443,0.0013382767],"study_design_scores_gemma":[0.000085938045,0.0008300039,0.04038979,0.000017862334,0.000034338274,0.0014311334,0.000099484736,0.001707646,0.9468201,0.00009989697,0.008475604,0.000008276621],"about_ca_topic_score_codex":0.0006981469,"about_ca_topic_score_gemma":0.0009902267,"teacher_disagreement_score":0.0014390108,"about_ca_system_score_codex":0.000319022,"about_ca_system_score_gemma":0.00016344506,"threshold_uncertainty_score":0.004813969},"labels":[],"label_agreement":null},{"id":"W4416085461","doi":"10.1093/neuonc/noaf201.1436","title":"EXTH-103. A prototype mRNA LNP neoantigen vaccine remodels the tumour microenvironment of a syngeneic model of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of Calgary","funders":"","keywords":"Immune system; Tumor microenvironment; CD8; Temozolomide; Chemokine; Immunotherapy; Cytotoxic T cell; T cell; Adoptive cell transfer","score_opus":0.017035598104492858,"score_gpt":0.28097348341996087,"score_spread":0.263937885315468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677473,0.00030762283,0.0015147649,0.000071687835,0.00007368788,0.000060145052,0.00037253957,0.0000714236,0.0007534583],"genre_scores_gemma":[0.99526286,0.00027654335,0.0013343698,0.00005919008,0.000013075115,0.000094343595,0.00060559215,0.000019985066,0.0023341302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998534,0.000017431272,0.0000128676575,0.0000353265,0.000040890605,0.000040114242],"domain_scores_gemma":[0.9999219,0.000009413388,0.00002476824,0.00001005969,0.000007275997,0.00002652302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013369764,0.0004657517,0.00027568176,0.00023217048,0.00008817889,0.00020620726,0.00018166321,0.00031389197,0.0012314628],"category_scores_gemma":[0.000061517705,0.00011311491,0.00017644273,0.000113628965,0.00023321078,0.00020275387,0.000110987625,0.00094124785,0.0002603815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022329418,0.0001722442,0.00007866671,0.000024629411,0.0000035101878,0.000030712923,0.000011003206,0.00008879225,0.9984812,0.000070788185,0.00005467928,0.00076046505],"study_design_scores_gemma":[0.000071822506,0.004568317,0.0022482793,0.000006774828,0.000020916614,0.00021938756,0.000038335045,0.0015543946,0.989664,0.000051935913,0.0015511982,0.0000046366986],"about_ca_topic_score_codex":0.00050284166,"about_ca_topic_score_gemma":0.0006078149,"teacher_disagreement_score":0.0012314628,"about_ca_system_score_codex":0.00022827431,"about_ca_system_score_gemma":0.00020383898,"threshold_uncertainty_score":0.0041196346},"labels":[],"label_agreement":null},{"id":"W4416085464","doi":"10.1093/neuonc/noaf201.1022","title":"PATH-70. Neuropath-IHC: a deep neural network for virtual immunohistochemistry from digital whole slide images of CNS tumors","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunohistochemistry; Interpretability; OLIG2; Glioblastoma; Sensitivity (control systems); Gene expression; Lineage markers","score_opus":0.008345121883805378,"score_gpt":0.2592310332279975,"score_spread":0.25088591134419214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085464","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30650222,0.00092622335,0.6034359,0.0007941948,0.00025638964,0.0004948609,0.008865585,0.07014452,0.0085800905],"genre_scores_gemma":[0.67362565,0.00046795435,0.29729053,0.00048562247,0.000042710824,0.00078989856,0.013361298,0.0012790709,0.0126572875],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998318,0.000030022735,0.000009010935,0.000060958282,0.00004324379,0.000024857318],"domain_scores_gemma":[0.9997234,0.00010199281,0.000047250876,0.000038699887,0.00006566939,0.000023008153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818112,0.000830735,0.000223505,0.0006573366,0.00024142147,0.00045320278,0.0009860402,0.00060666347,0.0074070585],"category_scores_gemma":[0.0011922278,0.00042815862,0.00048074016,0.00033486678,0.000279774,0.00040281823,0.0008463778,0.00063283794,0.0016823498],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009415883,0.00044586835,0.015539621,0.000545246,0.0003474076,0.00063033984,0.00014128869,0.44586185,0.049513243,0.0036619026,0.046701256,0.43567044],"study_design_scores_gemma":[0.000040624887,0.00009921289,0.0016243517,0.000013360609,0.000017437755,0.000094216746,0.0000114621635,0.98639685,0.007935208,0.0013122362,0.0024421667,0.000012877957],"about_ca_topic_score_codex":0.0065365084,"about_ca_topic_score_gemma":0.011159473,"teacher_disagreement_score":0.0074070585,"about_ca_system_score_codex":0.00083364645,"about_ca_system_score_gemma":0.0011140126,"threshold_uncertainty_score":0.024779141},"labels":[],"label_agreement":null},{"id":"W4416085530","doi":"10.1093/neuonc/noaf201.1066","title":"PTHP-09. High-resolution proteomic analysis of medulloblastoma clinical samples identifies MYC immunohistochemistry as a powerful outcome predictor outperforming genetic amplification detection","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Dalhousie University; University of Toronto; BC Children's Hospital; BC Cancer Agency; University of Manitoba; BC Cancer Foundation; Spinal Cord Injury BC; McMaster University","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Biomarker; Targeted therapy; Wnt signaling pathway; Confidence interval","score_opus":0.025580828199294987,"score_gpt":0.35324615708224105,"score_spread":0.3276653288829461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478657,0.00078611827,0.00448519,0.00035536714,0.00004515505,0.000067059445,0.008008681,0.0003653583,0.0011004357],"genre_scores_gemma":[0.98378927,0.0002503404,0.0059933653,0.000082546976,0.000022696306,0.000049645438,0.009100072,0.000051168525,0.0006608675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952126,0.00009740235,0.000043979577,0.00016804806,0.00012277739,0.000046612644],"domain_scores_gemma":[0.99930537,0.00016395081,0.00021472192,0.00009002452,0.00012399923,0.00010202408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011160834,0.00038927546,0.000495736,0.000631498,0.0002468221,0.0010286219,0.00042749348,0.00032425649,0.0019127886],"category_scores_gemma":[0.0018916766,0.00020555496,0.00041671173,0.00050548837,0.00027623164,0.00041203856,0.0008708801,0.0005567444,0.00080591964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039346507,0.00033100013,0.7063072,0.00040164162,0.0010668982,0.00067733246,0.00013467109,0.004332671,0.20424186,0.0003401228,0.007544813,0.07068721],"study_design_scores_gemma":[0.00015401491,0.0010437527,0.8661705,0.000058030157,0.0004368334,0.0022585904,0.00020075821,0.04172461,0.078037605,0.0009098166,0.008955328,0.00005007314],"about_ca_topic_score_codex":0.0019063088,"about_ca_topic_score_gemma":0.0029005588,"teacher_disagreement_score":0.0019127886,"about_ca_system_score_codex":0.00044950735,"about_ca_system_score_gemma":0.0004815331,"threshold_uncertainty_score":0.006398976},"labels":[],"label_agreement":null},{"id":"W4416085532","doi":"10.1093/neuonc/noaf201.1061","title":"PTHP-04. Integrated clinical and molecular landscape of 269 disseminated pediatric low-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Malignancy; Cohort; Glioma; Chemotherapy; Central nervous system; Precision medicine","score_opus":0.014579578834798797,"score_gpt":0.33574457712214506,"score_spread":0.32116499828734624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589086,0.0004028433,0.00035214727,0.000055660195,0.0000046709515,0.000015457337,0.0026210765,0.000020104568,0.0006371178],"genre_scores_gemma":[0.9959239,0.00023797098,0.00028998833,0.000032025622,0.0000062038634,0.000016945229,0.0033034226,0.000018670498,0.00017097927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971336,0.0000333358,0.000025332114,0.00010724354,0.000060811366,0.000059825084],"domain_scores_gemma":[0.9994618,0.00007285085,0.00021768213,0.00004392662,0.00009492187,0.00010880988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025312428,0.0002604371,0.00034090824,0.0007126517,0.00036203276,0.000649445,0.000316897,0.00024872238,0.0015854714],"category_scores_gemma":[0.001151958,0.00015124846,0.0002648005,0.0014032773,0.00024215435,0.00027522846,0.0005982091,0.00043456545,0.0003754663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037732814,0.000022513408,0.98186684,0.00007003232,0.00007296418,0.0010666373,0.00018758394,0.0003773508,0.005146787,0.000095566946,0.0008113462,0.009904966],"study_design_scores_gemma":[0.000015160891,0.00012307493,0.9909045,0.00002073393,0.00008357041,0.0039999555,0.000420705,0.00056406506,0.0011883143,0.0002070351,0.0024631063,0.000009670527],"about_ca_topic_score_codex":0.003660281,"about_ca_topic_score_gemma":0.0034147678,"teacher_disagreement_score":0.003660281,"about_ca_system_score_codex":0.00041785178,"about_ca_system_score_gemma":0.00040569194,"threshold_uncertainty_score":0.0072779655},"labels":[],"label_agreement":null},{"id":"W4416085626","doi":"10.1093/neuonc/noaf201.1491","title":"QLTI-14. Enhancing Awareness and Use of Support Services for Adolescents and Young Adults with High-Grade Glioma: Evaluating 1-Minute Videos and Centralized Resource Navigator","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Resource (disambiguation); Focus group; Psychological intervention; Young adult; Perception; Standardization","score_opus":0.02789915426306975,"score_gpt":0.34236100862684726,"score_spread":0.3144618543637775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960493,0.0005669922,0.0008583985,0.0013356818,0.00015984528,0.02348297,0.003335463,0.00030959793,0.009457962],"genre_scores_gemma":[0.89579886,0.0018770372,0.02612725,0.001055476,0.00010309694,0.062013336,0.0049022003,0.00006466704,0.00805811],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99796295,0.00066670263,0.00016845288,0.0001774591,0.0005507498,0.0004737191],"domain_scores_gemma":[0.9955546,0.0011597467,0.00061859516,0.00015698952,0.00078434823,0.0017257859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036306388,0.00055527186,0.00090267067,0.0005846987,0.0010485861,0.0011282337,0.0015996842,0.00073546387,0.009230854],"category_scores_gemma":[0.009453617,0.00040659093,0.0014673936,0.0005540797,0.00055487745,0.00078458857,0.0018280918,0.0015776791,0.0006934918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011600723,0.07680139,0.0680241,0.008053028,0.0006006303,0.00034878805,0.015235753,0.0018411514,0.004329057,0.0006523848,0.023074012,0.7894389],"study_design_scores_gemma":[0.024827026,0.114170894,0.75785077,0.004363942,0.002151348,0.00033363688,0.015503428,0.005186828,0.005245317,0.00081000844,0.0692675,0.00028922423],"about_ca_topic_score_codex":0.052655715,"about_ca_topic_score_gemma":0.11794536,"teacher_disagreement_score":0.052655715,"about_ca_system_score_codex":0.005664123,"about_ca_system_score_gemma":0.014613918,"threshold_uncertainty_score":0.10469848},"labels":[],"label_agreement":null},{"id":"W4416085639","doi":"10.1093/neuonc/noaf201.1375","title":"EXTH-41. A bench-top model for the sonodynamic therapy of medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sonodynamic therapy; Intracellular; Apoptosis; Ultrasound; Viability assay; Programmed cell death","score_opus":0.01475132279999933,"score_gpt":0.27103054795066545,"score_spread":0.2562792251506661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95063835,0.005688882,0.03271719,0.00038327582,0.00029561206,0.00036802253,0.0027070034,0.00058913906,0.00661235],"genre_scores_gemma":[0.95749635,0.0030010361,0.02557535,0.00014992744,0.000032674896,0.00048609395,0.002175862,0.00006235635,0.011020487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967206,0.000047085214,0.000024996682,0.00006791136,0.00013574495,0.000052216637],"domain_scores_gemma":[0.9998671,0.000024566247,0.000035437115,0.00001816044,0.00001814434,0.000036614772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033347457,0.00051580794,0.00033670748,0.00042279353,0.00032752432,0.00028635812,0.00034412622,0.0005004072,0.0018134839],"category_scores_gemma":[0.00009451659,0.00020678277,0.0004931991,0.00021732593,0.00027782266,0.00029203502,0.00029399613,0.0010249487,0.00054898474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082262544,0.00009859642,0.000118878044,0.00007089906,0.000005574367,0.00010422611,0.000033810327,0.00016591695,0.99793965,0.00013639813,0.00012699512,0.0011168635],"study_design_scores_gemma":[0.00001628556,0.00090607535,0.001526933,0.000012951171,0.000020795507,0.00025041378,0.000051326984,0.0018335449,0.9907832,0.000062563515,0.004527088,0.000008730776],"about_ca_topic_score_codex":0.0027292012,"about_ca_topic_score_gemma":0.0037442357,"teacher_disagreement_score":0.0027292012,"about_ca_system_score_codex":0.0004103113,"about_ca_system_score_gemma":0.00034625723,"threshold_uncertainty_score":0.00606668},"labels":[],"label_agreement":null},{"id":"W4416085660","doi":"10.1093/neuonc/noaf201.1392","title":"EXTH-59. Supporting development of novel brain tumour therapies through global collaboration: early insights from a novel therapeutics accelerator","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cooke Aquaculture (Canada)","funders":"","keywords":"Multidisciplinary approach; Clinical trial; Process (computing); Drug development; Brain cancer","score_opus":0.028491215492830436,"score_gpt":0.32341595017229774,"score_spread":0.2949247346794673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085660","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0561079,0.01328485,0.02272293,0.5036003,0.017146114,0.0062333457,0.004972359,0.003650384,0.37228194],"genre_scores_gemma":[0.31142756,0.014801275,0.0977086,0.20550035,0.007989947,0.0070967465,0.01147688,0.0020758496,0.34192273],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9809488,0.009461518,0.00079218775,0.00080064224,0.0045438595,0.0034530526],"domain_scores_gemma":[0.9280568,0.015276463,0.0023463133,0.0024774955,0.011498434,0.040344525],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055417523,0.00062452175,0.0003784284,0.00063973083,0.0026068203,0.0063524786,0.0018616291,0.004231517,0.06756862],"category_scores_gemma":[0.031986054,0.00041269994,0.0009203145,0.0004706499,0.0016443431,0.0043311585,0.011948651,0.0052371076,0.018730119],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011011543,0.0009813685,0.005003512,0.0015458209,0.000060261067,0.00065990444,0.0027577032,0.0005315848,0.0064936574,0.025475904,0.66884226,0.2865469],"study_design_scores_gemma":[0.0006977099,0.0015443608,0.0066009862,0.0012845763,0.000049974908,0.00033219662,0.001791436,0.0006575292,0.002546677,0.0060564354,0.9783765,0.00006155196],"about_ca_topic_score_codex":0.0024062914,"about_ca_topic_score_gemma":0.0061377836,"teacher_disagreement_score":0.94458246,"about_ca_system_score_codex":0.0036431176,"about_ca_system_score_gemma":0.041112736,"threshold_uncertainty_score":0.29307938},"labels":[],"label_agreement":null},{"id":"W4416085666","doi":"10.1093/neuonc/noaf201.1053","title":"PATH-101. Neuropath-AI, a histopathology-based deep learning classifier for CNS tumors, achieves and improves human neuropathologist-level performance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Classifier (UML); Deep learning; Limiting; Pattern recognition (psychology); Artificial neural network; Probabilistic classification","score_opus":0.043727238303425627,"score_gpt":0.3035716370540142,"score_spread":0.25984439875058857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085666","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80480886,0.00284759,0.1447329,0.0014037037,0.0005559541,0.0004906346,0.0074874116,0.024032611,0.013640369],"genre_scores_gemma":[0.85902554,0.0005577875,0.111753,0.0007209652,0.0000986135,0.00030651715,0.01627864,0.00037921066,0.010879711],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994703,0.00010375612,0.000033669396,0.00018544572,0.00014726706,0.00005950394],"domain_scores_gemma":[0.9990533,0.00040151813,0.0001012464,0.00012432087,0.0002241798,0.00009551104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001752743,0.0009411827,0.00039497094,0.00085725717,0.0003255345,0.00058092026,0.00085612043,0.0009183738,0.0035231875],"category_scores_gemma":[0.0026740003,0.00027051268,0.0005077149,0.0004075428,0.00033239982,0.0005937727,0.00080629374,0.0010622831,0.0015511187],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002073164,0.0013258822,0.0854204,0.0005020291,0.000705289,0.0004959092,0.000131182,0.11028487,0.06317837,0.002424911,0.06545176,0.66800624],"study_design_scores_gemma":[0.00019374365,0.0012164977,0.022434961,0.000053702093,0.00012621382,0.0005657353,0.000056209148,0.9382164,0.025917232,0.0026959083,0.008471399,0.000052035557],"about_ca_topic_score_codex":0.0061836997,"about_ca_topic_score_gemma":0.009480042,"teacher_disagreement_score":0.0061836997,"about_ca_system_score_codex":0.0007556871,"about_ca_system_score_gemma":0.0015159582,"threshold_uncertainty_score":0.012295425},"labels":[],"label_agreement":null},{"id":"W4416085702","doi":"10.1093/neuonc/noaf201.1479","title":"QLTI-02. Management of adverse events occurring with MAPK-directed therapies in patients with pediatric low-grade glioma: Recommendations from an expert Delphi consensus initiative","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Delphi method; Adverse effect; Pharmacovigilance; Tolerability; Health professionals; Health care; MEDLINE; Alternative medicine","score_opus":0.02160847441616567,"score_gpt":0.3100461480209018,"score_spread":0.28843767360473616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085702","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0742536,0.03741988,0.08594935,0.5451954,0.010176235,0.1368619,0.0064963414,0.0012045399,0.102442615],"genre_scores_gemma":[0.3279156,0.032706242,0.33617297,0.09982988,0.0023695142,0.18381822,0.0090791015,0.0003969495,0.0077115307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.78039277,0.16381961,0.03567422,0.0027433576,0.010451386,0.0069186874],"domain_scores_gemma":[0.7469007,0.13797878,0.019994682,0.0050006066,0.07699571,0.013129513],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26642442,0.0016067337,0.0016695563,0.004192794,0.003063714,0.0046387604,0.004836533,0.0058071115,0.005423151],"category_scores_gemma":[0.21310489,0.0011299558,0.006109911,0.0030117834,0.002576218,0.0037714897,0.0119084045,0.0074533694,0.0024783246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017832668,0.00092224666,0.026570877,0.061534707,0.0010693878,0.001562019,0.0605768,0.0071449,0.004962351,0.012275292,0.25620878,0.56538934],"study_design_scores_gemma":[0.0024730058,0.0031191013,0.031103838,0.17622577,0.0015781621,0.0019357855,0.08958399,0.01244941,0.003875496,0.024116885,0.6525945,0.0009440948],"about_ca_topic_score_codex":0.004898414,"about_ca_topic_score_gemma":0.0050159763,"teacher_disagreement_score":0.26642442,"about_ca_system_score_codex":0.010912601,"about_ca_system_score_gemma":0.052043885,"threshold_uncertainty_score":0.9046293},"labels":[],"label_agreement":null},{"id":"W4416085714","doi":"10.1093/neuonc/noaf201.1149","title":"IMG-70. Cerebrovascular disease in pediatric and adult patients with neurofibromatosis type 1: prevalence and characterization","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Moyamoya disease diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ectasia; Moyamoya disease; Magnetic resonance angiography; Neurofibromatosis; Stenosis; Magnetic resonance imaging; Retrospective cohort study; Stroke (engine); Arterial dissection","score_opus":0.005161079378469327,"score_gpt":0.23742101306058128,"score_spread":0.23225993368211195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990922,0.00027478114,0.000033098037,0.000020578515,0.0000020501618,0.0000046441514,0.00016632704,0.0000030041654,0.00040345336],"genre_scores_gemma":[0.99943,0.00015533002,0.000077051765,0.00001874434,0.000010645486,0.0000068756162,0.00023337333,0.0000014885384,0.000066476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999723,0.000053508702,0.00002771765,0.000059155576,0.00006322936,0.0000732654],"domain_scores_gemma":[0.99911827,0.00014009097,0.0004328187,0.000027793129,0.00010909328,0.00017195057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032965955,0.00024533673,0.0002119189,0.001529626,0.0003712442,0.0004712808,0.00031606996,0.00041628748,0.0015864893],"category_scores_gemma":[0.0014470029,0.00015589492,0.00014651802,0.00119019,0.00028090135,0.00034340474,0.00023012221,0.00026391455,0.0003309371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023232808,0.00001194427,0.9986331,0.0000031857812,0.0000051581287,0.00037483877,0.000033460128,0.0000064063624,0.00014709924,0.0000073920332,0.000047642632,0.0007065188],"study_design_scores_gemma":[0.0000023500186,0.00004822111,0.9954413,0.000004164028,0.000006509211,0.004077342,0.00014342953,0.00005055819,0.0000652258,0.00000767642,0.00015166307,0.0000015798327],"about_ca_topic_score_codex":0.0037969437,"about_ca_topic_score_gemma":0.002966825,"teacher_disagreement_score":0.0037969437,"about_ca_system_score_codex":0.00026921107,"about_ca_system_score_gemma":0.00026216134,"threshold_uncertainty_score":0.0075496435},"labels":[],"label_agreement":null},{"id":"W4416085772","doi":"10.1093/neuonc/noaf201.1146","title":"IMG-67. Confirmatory clinical trial evaluating diagnostic performance of confocal laser endomicroscopy (cCeLL - Ex vivo) for intraoperative brain tumor diagnosis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Brain tumor; Glioma; Diagnostic accuracy; Clinical trial; Clinical endpoint; Medical imaging; Prospective cohort study","score_opus":0.07703608728317805,"score_gpt":0.4650945993323546,"score_spread":0.3880585120491765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380434,0.0021317173,0.00096674304,0.00029279306,0.0001204213,0.0014807145,0.0004378002,0.000060488954,0.00070504035],"genre_scores_gemma":[0.9962088,0.00035646558,0.0016416834,0.00022890093,0.00008528275,0.0005982487,0.0005263406,0.0000092419405,0.00034515775],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983752,0.001124472,0.00006970791,0.0002185346,0.00009460513,0.00011741909],"domain_scores_gemma":[0.99640876,0.0013195417,0.0009950502,0.00039882085,0.0003866754,0.00049119507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007580222,0.0013394419,0.0011679378,0.00039541646,0.0002494284,0.0007942088,0.00063751196,0.0010971816,0.0017134902],"category_scores_gemma":[0.005959492,0.00046187657,0.0010850742,0.00027069094,0.0006393913,0.0006916585,0.000286955,0.0016467088,0.0005652781],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9066603,0.008891505,0.017845936,0.00057554396,0.001044874,0.000075922515,0.00009998832,0.001622136,0.010058848,0.0002327034,0.0013278509,0.051564306],"study_design_scores_gemma":[0.2961612,0.64436525,0.03219051,0.00014040738,0.0023007954,0.00023758599,0.00011150632,0.013951432,0.008207449,0.00036550077,0.0018880758,0.00008027195],"about_ca_topic_score_codex":0.00081476953,"about_ca_topic_score_gemma":0.0012607438,"teacher_disagreement_score":0.007580222,"about_ca_system_score_codex":0.0009163216,"about_ca_system_score_gemma":0.0012201442,"threshold_uncertainty_score":0.040088534},"labels":[],"label_agreement":null},{"id":"W4416085782","doi":"10.1093/neuonc/noaf201.1072","title":"PTHP-15. Enhancing Medulloblastoma Classification: Integrating IHC and DNA Methylation Data from the SJMB12 Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Concordance; Wnt signaling pathway; DNA methylation; Methylation","score_opus":0.12773643792734002,"score_gpt":0.4261634033892406,"score_spread":0.29842696546190056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977518,0.015174004,0.0014019667,0.001160503,0.00015691239,0.00035339055,0.0016626244,0.00015567361,0.0024168685],"genre_scores_gemma":[0.9945445,0.0014025959,0.0016877337,0.0003356744,0.00013056952,0.00021136807,0.0012373792,0.000024489902,0.00042571683],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966509,0.0021707376,0.00022950734,0.00039508508,0.0004272243,0.00012651534],"domain_scores_gemma":[0.99660444,0.0013739832,0.0010586506,0.00029601972,0.00038274564,0.00028405077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069711725,0.00052008405,0.001361094,0.00037831572,0.00016367948,0.00096470345,0.00054490776,0.0006512375,0.001463278],"category_scores_gemma":[0.007869727,0.0002574226,0.0013871078,0.00061437977,0.0003938272,0.0006176299,0.00040489217,0.0012581564,0.0002842048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37386185,0.0015650638,0.19104443,0.0041354606,0.017491749,0.00014200673,0.0002337364,0.0074702157,0.011729869,0.0006819372,0.00682668,0.38481703],"study_design_scores_gemma":[0.1802765,0.10328302,0.62208414,0.0015525382,0.033951182,0.0008624332,0.00024847317,0.02500646,0.012107415,0.0039212317,0.016488532,0.00021800716],"about_ca_topic_score_codex":0.0013164857,"about_ca_topic_score_gemma":0.0027657067,"teacher_disagreement_score":0.0069711725,"about_ca_system_score_codex":0.00069490186,"about_ca_system_score_gemma":0.00071861164,"threshold_uncertainty_score":0.0368675},"labels":[],"label_agreement":null},{"id":"W4416085830","doi":"10.1093/neuonc/noaf201.1850","title":"TMIC-96. Integrated multi-omics reveals distinct hypoxic sub-niches and associated epigenomic and genomic alterations in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Epigenomics; Transcriptome; Hypoxia (environmental); Tumor microenvironment; Glioblastoma; Immune system; Gene; Phylogenetic tree; Cell","score_opus":0.01926231134976417,"score_gpt":0.29202998911878514,"score_spread":0.27276767776902094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9128115,0.0022250097,0.025011377,0.00036648154,0.00007892991,0.00008248105,0.053261172,0.0017958353,0.004367229],"genre_scores_gemma":[0.901284,0.0014547779,0.041626066,0.00024119283,0.0000288915,0.00013641933,0.051619887,0.00031129303,0.003297473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997439,0.000024954696,0.000016503176,0.00009466945,0.000077599114,0.00004248578],"domain_scores_gemma":[0.9998752,0.000025074973,0.000034852215,0.00002736965,0.00001953873,0.00001798453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041875776,0.0003975425,0.0004933446,0.00077568734,0.0003151375,0.0010671533,0.00029958948,0.00029475725,0.0015289532],"category_scores_gemma":[0.00030108533,0.00018611854,0.0004067619,0.00096628605,0.0001884304,0.00025481562,0.0003722464,0.000442667,0.0006049368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005899634,0.0000441817,0.01105577,0.00014799899,0.000091753674,0.00012217168,0.000078011486,0.0023687347,0.9670884,0.0003830568,0.001507015,0.016523035],"study_design_scores_gemma":[0.000069243375,0.00050622085,0.21789151,0.000066328495,0.00029582944,0.0011653694,0.00037995417,0.06386389,0.6827,0.0018007968,0.031179922,0.00008094159],"about_ca_topic_score_codex":0.001595827,"about_ca_topic_score_gemma":0.0032704135,"teacher_disagreement_score":0.001595827,"about_ca_system_score_codex":0.00039559274,"about_ca_system_score_gemma":0.000408436,"threshold_uncertainty_score":0.0051148534},"labels":[],"label_agreement":null},{"id":"W4416085853","doi":"10.1093/neuonc/noaf201.1281","title":"NCOG-14. Deficits in Gait Quantified by Large Language Model-derived NANO Scores Predict Survival in High-grade Glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Proportional hazards model; Gait; Survival analysis; Clinical endpoint; Repeated measures design; Cohort","score_opus":0.0190088820304761,"score_gpt":0.3001738062878479,"score_spread":0.28116492425737183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712664,0.000080210884,0.0005705596,0.000056865723,0.000007925692,0.000028658309,0.0012165253,0.000038470374,0.00087415497],"genre_scores_gemma":[0.9977441,0.000025608791,0.00050438964,0.000015553045,0.0000029825758,0.000023044231,0.0014624844,0.000008301613,0.00021353374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996389,0.000115609975,0.000054316613,0.00008113685,0.00006818478,0.00004183312],"domain_scores_gemma":[0.99795616,0.0007106084,0.00064920494,0.0001261603,0.00033422702,0.00022366362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010704966,0.00033918265,0.00024965373,0.0008361309,0.00015293785,0.0006020032,0.00027047968,0.00026581532,0.0018702558],"category_scores_gemma":[0.0059131766,0.00010063528,0.0002931908,0.00042746472,0.0002279092,0.00035949907,0.00057087454,0.00026920077,0.00052431115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047876596,0.000051044335,0.98985845,0.000017874112,0.000042815536,0.000037026348,0.000032697113,0.0010188627,0.00042292898,0.000016204409,0.0007611288,0.007262278],"study_design_scores_gemma":[0.000043776763,0.00035837648,0.9854876,0.000015364085,0.000052572606,0.00024430852,0.00011987428,0.012261736,0.0007233689,0.0001729538,0.0005074683,0.0000125764],"about_ca_topic_score_codex":0.005878287,"about_ca_topic_score_gemma":0.010265763,"teacher_disagreement_score":0.005878287,"about_ca_system_score_codex":0.00052789133,"about_ca_system_score_gemma":0.000434587,"threshold_uncertainty_score":0.011688173},"labels":[],"label_agreement":null},{"id":"W4416098832","doi":"10.1093/neuonc/noaf252","title":"Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Thompson Rivers University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Young adult; Precision medicine; MEDLINE; Divergence (linguistics); Disease","score_opus":0.022098865427625587,"score_gpt":0.32783157276396185,"score_spread":0.3057327073363363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416098832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95588326,0.021240054,0.013432829,0.003862196,0.00014822707,0.00006887574,0.0018520004,0.00019154589,0.0033210001],"genre_scores_gemma":[0.9858235,0.0027872666,0.010208006,0.00024784094,0.000067062225,0.000035672976,0.00053376367,0.000021629907,0.000275213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988555,0.000497761,0.00013031019,0.00021439225,0.00022250255,0.00007952185],"domain_scores_gemma":[0.9902056,0.004433776,0.0028624043,0.00066822616,0.0012786237,0.000551387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005169229,0.00049349654,0.0006913346,0.0013324744,0.00034787421,0.00163709,0.0005679755,0.0004545544,0.0009752032],"category_scores_gemma":[0.012552211,0.00017471968,0.00044504934,0.00091597025,0.00040323546,0.0011909714,0.0010087063,0.0010955172,0.00037653232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018429564,0.000042973712,0.93074185,0.000112786336,0.00015674012,0.000113502596,0.00018107626,0.0013749575,0.0013421073,0.00033679602,0.0009892903,0.06442359],"study_design_scores_gemma":[0.000016583535,0.00045544526,0.9722447,0.00032437863,0.00016065045,0.0010639557,0.0006208512,0.010052684,0.0027040283,0.003667507,0.0086575905,0.00003163295],"about_ca_topic_score_codex":0.004375854,"about_ca_topic_score_gemma":0.010450489,"teacher_disagreement_score":0.005169229,"about_ca_system_score_codex":0.0007453617,"about_ca_system_score_gemma":0.0011568079,"threshold_uncertainty_score":0.02733779},"labels":[],"label_agreement":null},{"id":"W4416098852","doi":"10.1093/neuonc/noaf264","title":"A systematic study of molecular diagnosis, treatment, and prognosis in infant-type hemispheric glioma: An individual patient data meta-analysis of 164 patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; NIHR Great Ormond Street Hospital Biomedical Research Centre; Nationales Centrum für Tumorerkrankungen Heidelberg; Great Ormond Street Institute of Child Health; Université de Genève; CRIS Cancer Foundation; Cancer Research UK; Deutsches Krebsforschungszentrum; St. Jude Children's Research Hospital; New York State Department of Health; American Lebanese Syrian Associated Charities; National Institute on Handicapped Research","keywords":"Patient data; Focus (optics); Patient care; Primary care; MEDLINE; Disease","score_opus":0.06564283970459622,"score_gpt":0.35073784239529965,"score_spread":0.2850950026907034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416098852","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19346628,0.79213226,0.0031683445,0.0007093263,0.00043412112,0.00018716796,0.008827888,0.000111603,0.0009628972],"genre_scores_gemma":[0.94141954,0.051365726,0.0015533064,0.0007305806,0.00018925808,0.0002629649,0.004103444,0.00007161271,0.00030365342],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931999,0.0031962,0.0013760424,0.0014252085,0.00052781217,0.00027483547],"domain_scores_gemma":[0.9902866,0.0061345687,0.0016598662,0.0009907353,0.0006424554,0.00028570922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075116404,0.0014036862,0.007424679,0.0027412404,0.0006638255,0.0018223918,0.001404603,0.0013696769,0.0016694121],"category_scores_gemma":[0.011547161,0.000895669,0.021428362,0.0050594653,0.0004458181,0.00095744996,0.0010634825,0.0011427723,0.00026872946],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006035308,0.000039247632,0.10232523,0.025688283,0.85380423,0.00023565204,0.00008570901,0.00090158475,0.0007801632,0.000098209464,0.0012281665,0.008778156],"study_design_scores_gemma":[0.0007563397,0.0003675797,0.053022105,0.0015172507,0.94075334,0.00021569735,0.000059311227,0.00056959013,0.0002276029,0.00025554624,0.0022237767,0.0000319133],"about_ca_topic_score_codex":0.004432877,"about_ca_topic_score_gemma":0.009051333,"teacher_disagreement_score":0.0075116404,"about_ca_system_score_codex":0.0008428431,"about_ca_system_score_gemma":0.0013322415,"threshold_uncertainty_score":0.03972584},"labels":[],"label_agreement":null},{"id":"W4416139653","doi":"10.1093/neuonc/noaf201.1686","title":"TIP-26. A phase II study evaluating the safety, efficacy, and intracranial activity of tarlatamab in recurrent/refractory <i>IDH</i> -mutant gliomas (TARGID)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clinical endpoint; Cohort; Refractory (planetary science); Phases of clinical research; Population; Glioma; Progressive disease; Cytotoxic T cell; Astrocytoma","score_opus":0.03478204104979758,"score_gpt":0.3822289957258793,"score_spread":0.3474469546760817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992964,0.0013000058,0.0004276863,0.00025208946,0.000086696346,0.0014848217,0.0016130941,0.00010819365,0.0017634173],"genre_scores_gemma":[0.9898117,0.001228337,0.0012855292,0.00051107904,0.00009824619,0.0015728215,0.0032308556,0.00003591827,0.0022254984],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99983406,0.000058636728,0.0000090572385,0.000033231612,0.00001997729,0.000044945693],"domain_scores_gemma":[0.9996227,0.000045630168,0.00006266499,0.000029399978,0.000020568265,0.00021898135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006999689,0.0009486298,0.0011748598,0.00031324202,0.00022651319,0.00078932795,0.0006142459,0.0007972935,0.0031907188],"category_scores_gemma":[0.0004148202,0.00035970198,0.00068064325,0.0002427026,0.00062163564,0.00057913706,0.00022354338,0.0023028322,0.00088394195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5822772,0.07670581,0.009144357,0.0012277706,0.0009974524,0.00084310275,0.00024977128,0.0041214977,0.17976305,0.00068446505,0.010650604,0.1333349],"study_design_scores_gemma":[0.31718674,0.64583355,0.0107292645,0.00004319873,0.00041617293,0.0007733717,0.00008626346,0.0023370548,0.01781445,0.00030598574,0.0044331136,0.000040920728],"about_ca_topic_score_codex":0.0006521204,"about_ca_topic_score_gemma":0.0016140115,"teacher_disagreement_score":0.0031907188,"about_ca_system_score_codex":0.0005485344,"about_ca_system_score_gemma":0.0010790459,"threshold_uncertainty_score":0.010674059},"labels":[],"label_agreement":null},{"id":"W4416139683","doi":"10.1093/neuonc/noaf201.1806","title":"TMIC-51. D-serine facilitates aggressive migration and stemness of recurrent glioblastoma cells by interacting with host endothelial cells","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Gene silencing; Angiogenesis; Endothelial stem cell; Endothelium; Stem cell; Tumor microenvironment; Endogeny; Receptor","score_opus":0.00496196013001678,"score_gpt":0.24776453154945785,"score_spread":0.24280257141944106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915365,0.0014701487,0.0027950914,0.00014467661,0.000060638682,0.000039734157,0.0015239252,0.0001850816,0.0022441174],"genre_scores_gemma":[0.9932597,0.0005825425,0.0019734788,0.00006818205,0.0000066802518,0.000039630948,0.0016561542,0.000017302222,0.0023963365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998093,0.000022731712,0.00002335139,0.00005306028,0.000042175565,0.000049306727],"domain_scores_gemma":[0.9999281,0.00000964295,0.000019576135,0.000010670496,0.000009735519,0.000022300263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001322132,0.00020551457,0.0003111992,0.00014761435,0.00014774447,0.000374637,0.00017739297,0.00018749112,0.0018888948],"category_scores_gemma":[0.00010515456,0.00010388512,0.0002682147,0.00020207374,0.00016423932,0.00010331066,0.00014321944,0.00038469452,0.0005340865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015773161,0.000031007494,0.0004324611,0.000062652274,0.000010250532,0.00003797303,0.000013442369,0.0001008979,0.996977,0.00007961064,0.00017578389,0.0019212181],"study_design_scores_gemma":[0.0000256533,0.00035126155,0.0044366377,0.00000679203,0.000024562174,0.00017146989,0.00002880265,0.0013129793,0.98966134,0.000024180656,0.00395168,0.000004654026],"about_ca_topic_score_codex":0.0017444645,"about_ca_topic_score_gemma":0.0019375972,"teacher_disagreement_score":0.0018888948,"about_ca_system_score_codex":0.00034219815,"about_ca_system_score_gemma":0.00028963297,"threshold_uncertainty_score":0.0063189864},"labels":[],"label_agreement":null},{"id":"W4416139690","doi":"10.1093/neuonc/noaf201.1523","title":"QOL-22. Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Clinical trial; Brain tumor; Temozolomide; Randomized controlled trial; Karnofsky Performance Status","score_opus":0.03033635684256785,"score_gpt":0.3248015901651453,"score_spread":0.29446523332257746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907171,0.005915032,0.00015649763,0.00027663875,0.0000631267,0.000074019765,0.0016771317,0.0000069706934,0.0011133635],"genre_scores_gemma":[0.99724174,0.0005025655,0.00015416543,0.00016928176,0.000054988308,0.00010584254,0.0015945695,0.0000041932576,0.00017263093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962218,0.0026805731,0.00033085747,0.00024336136,0.00031334636,0.00021004182],"domain_scores_gemma":[0.9932728,0.0023806337,0.0031517406,0.00023835895,0.00040857293,0.0005478312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005922248,0.0004051918,0.00097430556,0.0005950389,0.00021162954,0.00089145754,0.00031832836,0.00041018034,0.0011294193],"category_scores_gemma":[0.0092956945,0.00012266745,0.0013830746,0.0010380845,0.00032117617,0.0005746021,0.0006937912,0.0006815851,0.00013869656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05446927,0.00028875604,0.90658253,0.0010935871,0.0049751406,0.0001115943,0.00010232522,0.0007740748,0.0007252738,0.0002742034,0.003073524,0.027529761],"study_design_scores_gemma":[0.003495245,0.005163638,0.98356116,0.00026323716,0.0024971054,0.00017204444,0.0001283465,0.001147394,0.00025839594,0.0005831945,0.002694718,0.000035567427],"about_ca_topic_score_codex":0.00090729457,"about_ca_topic_score_gemma":0.0016052831,"teacher_disagreement_score":0.005922248,"about_ca_system_score_codex":0.000373301,"about_ca_system_score_gemma":0.0004769769,"threshold_uncertainty_score":0.031320214},"labels":[],"label_agreement":null},{"id":"W4416139698","doi":"10.1093/neuonc/noaf201.1707","title":"TMET-16. 3D spectroscopic imaging detects hidden peritumoral activity in gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Magnetic resonance spectroscopic imaging; Metabolite; Fluid-attenuated inversion recovery; Astrocytoma; Radiation therapy; Metabolic activity","score_opus":0.014688137707619129,"score_gpt":0.31222160082128064,"score_spread":0.2975334631136615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615511,0.00091239106,0.032844428,0.00011486678,0.000030842824,0.000062316096,0.0019359884,0.0010729337,0.0014751642],"genre_scores_gemma":[0.9432964,0.0005182581,0.050014988,0.00006153959,0.000011451418,0.00017267666,0.0032530872,0.00025965433,0.0024119164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999212,0.000018773022,0.0000062781737,0.000021236865,0.000018303655,0.000014118524],"domain_scores_gemma":[0.9999008,0.000017446819,0.000037409976,0.00001184102,0.000015466536,0.000016910955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032845177,0.00037266203,0.00028306228,0.00046272003,0.00012104225,0.0004673305,0.0002930114,0.00042171575,0.0023132348],"category_scores_gemma":[0.00038816596,0.0003262653,0.00025488806,0.00035853285,0.00017650095,0.00028134868,0.00023476395,0.0003095941,0.00060536445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017229983,0.00008734267,0.012822469,0.00019259447,0.000089778965,0.00036669293,0.00007315982,0.0044768755,0.9420626,0.00036417498,0.0007708923,0.036970437],"study_design_scores_gemma":[0.00014733103,0.0011171915,0.07781995,0.00003027042,0.00016938883,0.0038090583,0.00009822846,0.07249734,0.8327373,0.0010476809,0.010462381,0.00006385395],"about_ca_topic_score_codex":0.00078459416,"about_ca_topic_score_gemma":0.0010665023,"teacher_disagreement_score":0.0023132348,"about_ca_system_score_codex":0.0002330523,"about_ca_system_score_gemma":0.0003068036,"threshold_uncertainty_score":0.0077385306},"labels":[],"label_agreement":null},{"id":"W4416139719","doi":"10.1093/neuonc/noaf201.1913","title":"TMOD-40. Genetic drivers shape tumor phenotype and composition of the tumor microenvironment in syngeneic mouse models of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Calgary Laboratory Services; Institute of Cancer Research; McGill University Health Centre; University of Calgary","funders":"","keywords":"Nestin; Tumor microenvironment; Phenotype; Mesenchymal stem cell; Transcriptome; Glioblastoma; Electroporation; Infiltration (HVAC); Microglia; Glioma","score_opus":0.009516309209264478,"score_gpt":0.24198111032530098,"score_spread":0.2324648011160365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97496754,0.0017368982,0.01111996,0.0004543971,0.00013820404,0.00016312128,0.005746671,0.00074653066,0.0049266634],"genre_scores_gemma":[0.9667012,0.0016072183,0.007838053,0.00020835387,0.00001823403,0.0004353651,0.0033258884,0.00037241346,0.01949321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993862,0.000059849095,0.00006153011,0.00016091467,0.00017074382,0.00016082308],"domain_scores_gemma":[0.9996673,0.000026694104,0.00012636073,0.000038178143,0.00002791141,0.00011367341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003693274,0.0008998356,0.0003464058,0.00136529,0.00028928273,0.00063294865,0.0004507876,0.0008504834,0.003208619],"category_scores_gemma":[0.00014268211,0.00042450527,0.00048238694,0.00047909032,0.0006835034,0.0004749464,0.00040812444,0.0012438069,0.001230598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018556924,0.0000963121,0.0003051841,0.000046662713,0.000009117659,0.00010323679,0.00004934599,0.00018294246,0.9967919,0.00044144035,0.00019004545,0.0015981424],"study_design_scores_gemma":[0.000054713088,0.00053372997,0.004226739,0.0000315707,0.00004053372,0.00070175354,0.00012159983,0.0019374142,0.98386604,0.0003317151,0.008138632,0.000015585914],"about_ca_topic_score_codex":0.0013244565,"about_ca_topic_score_gemma":0.002563497,"teacher_disagreement_score":0.003208619,"about_ca_system_score_codex":0.0007781005,"about_ca_system_score_gemma":0.00048760278,"threshold_uncertainty_score":0.010733843},"labels":[],"label_agreement":null},{"id":"W4416139731","doi":"10.1093/neuonc/noaf201.1708","title":"TMET-17. Elongation control of mRNA translation drives Group 3 medulloblastoma adaptation to nutrient deprivation","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Translation (biology); Messenger RNA; Mitochondrion; Oxidative phosphorylation; Protein biosynthesis","score_opus":0.010340248302348585,"score_gpt":0.2642208441382736,"score_spread":0.25388059583592504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859612,0.0011829055,0.0037924324,0.00032026644,0.00020224394,0.00012989934,0.0052352985,0.0003824561,0.0027933829],"genre_scores_gemma":[0.98474437,0.0006623133,0.0031078095,0.00012959781,0.000016036889,0.00016081065,0.0040471847,0.00014735496,0.006984537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997471,0.000031287473,0.000033066455,0.00006840019,0.000058238853,0.00006185993],"domain_scores_gemma":[0.9997985,0.000034882527,0.00007244293,0.000020274454,0.000010112879,0.00006376535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020194953,0.00035085226,0.00035296447,0.00025766398,0.00022142504,0.00044069786,0.00032347935,0.00034791217,0.0030803182],"category_scores_gemma":[0.00013579761,0.00018405973,0.0003435544,0.00029747962,0.00035499633,0.00013651844,0.00025612165,0.00077408017,0.0012186301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040287492,0.000066187335,0.00021745145,0.00004983267,0.0000053636,0.00006487943,0.000015413345,0.000112705864,0.9976203,0.00016628436,0.00016793428,0.0011107186],"study_design_scores_gemma":[0.000043902914,0.00030469403,0.00346895,0.000012588308,0.000011361065,0.00015651192,0.000030239627,0.001524907,0.98781675,0.0000421959,0.006581752,0.000006184626],"about_ca_topic_score_codex":0.0013767332,"about_ca_topic_score_gemma":0.002368855,"teacher_disagreement_score":0.0030803182,"about_ca_system_score_codex":0.0007292232,"about_ca_system_score_gemma":0.00049421727,"threshold_uncertainty_score":0.01030463},"labels":[],"label_agreement":null},{"id":"W4416139776","doi":"10.1093/neuonc/noaf201.1568","title":"SURG-11. Efficacy of Radiosurgery with and without Angioembolization:A Subgroup Analysis of Effectiveness in Ruptured versusUnruptured Arteriovenous Malformations.An Updated Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiosurgery; Embolization; Percutaneous; Arteriovenous malformation; Subgroup analysis; Intracranial Arteriovenous Malformations","score_opus":0.021905808510599367,"score_gpt":0.31402274195693275,"score_spread":0.2921169334463334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01441532,0.981676,0.00067549385,0.00028821648,0.0002520754,0.00044856974,0.0018588887,0.000042425705,0.00034307322],"genre_scores_gemma":[0.4837214,0.5049089,0.0029708482,0.0014355634,0.0005060626,0.0026134315,0.0029323862,0.00007550778,0.00083585834],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99289703,0.0027146244,0.002334148,0.00091429823,0.00085797167,0.0002818569],"domain_scores_gemma":[0.98729336,0.00855,0.0026082792,0.00045504924,0.00085172796,0.00024157828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010306987,0.0021046456,0.014353475,0.0066785286,0.000554736,0.00283987,0.0017158035,0.002200804,0.004834966],"category_scores_gemma":[0.020411856,0.0011400768,0.049391225,0.005666358,0.0005943176,0.001705582,0.0013043588,0.001757045,0.00037311064],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034047202,0.000026207177,0.007860976,0.24522309,0.7343078,0.00009024613,0.000063689185,0.000261722,0.00019044876,0.00008250015,0.0005006586,0.00798793],"study_design_scores_gemma":[0.0010897985,0.00018726145,0.0077780853,0.010524646,0.9790036,0.000077866636,0.00004095027,0.00015751291,0.000081370556,0.00013511084,0.0009027931,0.000021088501],"about_ca_topic_score_codex":0.005070998,"about_ca_topic_score_gemma":0.009948139,"teacher_disagreement_score":0.014353475,"about_ca_system_score_codex":0.0019685305,"about_ca_system_score_gemma":0.0019827217,"threshold_uncertainty_score":0.054509223},"labels":[],"label_agreement":null},{"id":"W4416139836","doi":"10.1093/neuonc/noaf201.1630","title":"SURG-76. Glowing Tumours: Implementation and utilization of 5-ALA at a Toronto academic neurosurgical center","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Presentation (obstetrics); Class (philosophy); Process (computing); Resection; Center (category theory)","score_opus":0.03456363198173339,"score_gpt":0.3809601138570502,"score_spread":0.3463964818753168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967293,0.0019280196,0.00018914722,0.012249268,0.00010213259,0.00026511573,0.00076183304,0.00003632049,0.017175093],"genre_scores_gemma":[0.98409003,0.003310086,0.0009010322,0.003125411,0.000047047688,0.000090089765,0.0005462285,0.00001274804,0.007877337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916756,0.00012313691,0.000048067384,0.000053664684,0.0002983563,0.00030920352],"domain_scores_gemma":[0.99659216,0.00023590153,0.00056418957,0.000052738545,0.00077042205,0.0017845575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006752998,0.0001415229,0.000094565905,0.00032574157,0.0020739825,0.0010963723,0.00056052214,0.0003606555,0.0046120454],"category_scores_gemma":[0.003114493,0.00019483654,0.00019818175,0.00068863924,0.0005725894,0.00036662555,0.0010093166,0.00076501194,0.00045159788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028644182,0.0008655578,0.77284634,0.000695097,0.00005479511,0.0043045697,0.015290182,0.0004974767,0.0023324662,0.001154387,0.04095529,0.1607174],"study_design_scores_gemma":[0.000021840957,0.0006778698,0.9533628,0.00036444858,0.000033886572,0.00083911716,0.016996905,0.00025505084,0.0006937346,0.00007344035,0.026643937,0.00003700018],"about_ca_topic_score_codex":0.7138865,"about_ca_topic_score_gemma":0.90891397,"teacher_disagreement_score":0.7138865,"about_ca_system_score_codex":0.024319958,"about_ca_system_score_gemma":0.04704774,"threshold_uncertainty_score":0.5755969},"labels":[],"label_agreement":null},{"id":"W4416139854","doi":"10.1093/neuonc/noaf201.1873","title":"TMIC-120. Investigating EGFRvIII mRNA LNP vaccine-induced re-programming of the GBM TME using the 10x Genomics Visium HD platform","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of Calgary","funders":"","keywords":"Tumor microenvironment; Immune system; Transcriptome; Cytotoxic T cell; Immunotherapy; Messenger RNA; Cancer; Cancer immunotherapy; Cancer vaccine","score_opus":0.05131430558547638,"score_gpt":0.3314214146380487,"score_spread":0.2801071090525723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862698,0.00045641014,0.010448488,0.000069871116,0.000027255926,0.000043134536,0.00086932257,0.0003672521,0.0014485442],"genre_scores_gemma":[0.97735244,0.0005646858,0.015664525,0.0001048174,0.000007743657,0.00013509112,0.0014223782,0.00015930472,0.004589105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999342,0.000005286892,0.000001941864,0.000020516305,0.000020982356,0.00001709247],"domain_scores_gemma":[0.9999634,0.000005663432,0.0000135048085,0.0000028690094,0.0000071947584,0.000007482792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014308211,0.00026533526,0.00017199495,0.00017843337,0.00007560014,0.00021301284,0.00013512555,0.0002340809,0.001117724],"category_scores_gemma":[0.000068092406,0.00013372926,0.00019989604,0.000111905705,0.00020084305,0.00016715137,0.00016796683,0.00033881725,0.0002642731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005349881,0.000011075221,0.00011045164,0.000017438148,0.0000018988547,0.0000086296695,0.000009938704,0.0001863956,0.9984102,0.000051080093,0.000043995722,0.0010954561],"study_design_scores_gemma":[0.000004175234,0.00022965731,0.0014495782,0.0000025990269,0.000006982447,0.00003127671,0.000015280766,0.0029379444,0.99413425,0.00003070147,0.0011534131,0.0000042400993],"about_ca_topic_score_codex":0.0006640191,"about_ca_topic_score_gemma":0.0007760729,"teacher_disagreement_score":0.001117724,"about_ca_system_score_codex":0.00028074527,"about_ca_system_score_gemma":0.0001698857,"threshold_uncertainty_score":0.0037391782},"labels":[],"label_agreement":null},{"id":"W4416139856","doi":"10.1093/neuonc/noaf201.1900","title":"TMOD-26. EGFRvIII overexpression and loss of mouse specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Immunohistochemistry; Glioma; Downregulation and upregulation; Neurosphere; Immune system; Genetically modified mouse; Tumor microenvironment; Microglia; Infiltration (HVAC)","score_opus":0.020069842241522903,"score_gpt":0.2880632902448911,"score_spread":0.26799344800336816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696507,0.0020166857,0.014453022,0.0005653063,0.00017741267,0.0004698442,0.00522791,0.0011991122,0.006240011],"genre_scores_gemma":[0.9496311,0.0026750367,0.014142478,0.00019353743,0.00003830516,0.00076186535,0.004627483,0.00029646815,0.02763377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995509,0.000059963917,0.00005161041,0.00011774531,0.0001297211,0.000090048874],"domain_scores_gemma":[0.9996922,0.000030193452,0.000100368896,0.000050196002,0.000019687373,0.00010743628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004132131,0.0013089229,0.0004726352,0.0016495035,0.0004440122,0.0006174786,0.0007677429,0.0009916513,0.0035595957],"category_scores_gemma":[0.00011770675,0.00053027016,0.00070470176,0.00050853495,0.000751165,0.00042779636,0.0004176075,0.0015677902,0.0017829312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023590281,0.00028863037,0.00021631397,0.00005112413,0.000015070612,0.00037247638,0.000036105106,0.00018198551,0.9959193,0.0008474953,0.0002849072,0.0015506949],"study_design_scores_gemma":[0.00020488686,0.0014830409,0.0027995007,0.000033708155,0.000044190336,0.002137063,0.00006321377,0.0019638455,0.98011774,0.00030203196,0.010834955,0.000015850701],"about_ca_topic_score_codex":0.0011066594,"about_ca_topic_score_gemma":0.0021579713,"teacher_disagreement_score":0.0035595957,"about_ca_system_score_codex":0.00074397435,"about_ca_system_score_gemma":0.00045413428,"threshold_uncertainty_score":0.011907995},"labels":[],"label_agreement":null},{"id":"W4416139866","doi":"10.1093/neuonc/noaf201.1721","title":"TMET-30. Uncovering the metabolic programs underlying malignant cell state heterogeneity in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glycolysis; Transcriptome; Metabolomics; Cell; Oxidative phosphorylation; Cancer cell; Anaerobic glycolysis; Tumor microenvironment; Regulator; microRNA; Bioenergetics","score_opus":0.023675922068753342,"score_gpt":0.28060594652652726,"score_spread":0.2569300244577739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758671,0.0052722655,0.006059483,0.00033383493,0.00009125813,0.00024328123,0.007516156,0.00073081773,0.00388586],"genre_scores_gemma":[0.98470485,0.0030930224,0.003864479,0.000182924,0.000010127311,0.000131532,0.005081393,0.000054212527,0.0028775064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999012,0.000007893736,0.000006914723,0.000028575769,0.00003656145,0.000018885072],"domain_scores_gemma":[0.99994063,0.000008968663,0.000019274346,0.0000050314816,0.000012525488,0.000013541049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000138878,0.0003987401,0.00051192596,0.00035084243,0.00014407057,0.0003490081,0.00021409873,0.0002820849,0.0016252153],"category_scores_gemma":[0.00013355073,0.00015719612,0.00033395368,0.00030863538,0.00016200733,0.00019936704,0.00019883171,0.00044914777,0.00035075197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003233587,0.00007455614,0.00055302295,0.00020006485,0.000026558091,0.000047888112,0.00000959318,0.00085001247,0.99084365,0.00014118198,0.00029642571,0.0066335737],"study_design_scores_gemma":[0.000069788184,0.0013004993,0.0049979743,0.0000155522,0.00007251676,0.00024231595,0.000027277265,0.0036688566,0.98447555,0.00011441862,0.00499924,0.000015901072],"about_ca_topic_score_codex":0.0012251157,"about_ca_topic_score_gemma":0.0035211823,"teacher_disagreement_score":0.0016252153,"about_ca_system_score_codex":0.0005408633,"about_ca_system_score_gemma":0.00038679707,"threshold_uncertainty_score":0.0054368973},"labels":[],"label_agreement":null},{"id":"W4416139869","doi":"10.1093/neuonc/noaf201.1789","title":"TMIC-34. Targeting mechanically regulated cell state in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mesenchymal stem cell; Focal adhesion; Cell; Gene knockdown; Cell adhesion; Cell growth; Lipid raft; Regulator; Kinase","score_opus":0.005803517068367627,"score_gpt":0.25599007105091554,"score_spread":0.2501865539825479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907195,0.0019302639,0.0024925964,0.0002927512,0.000086516135,0.000091071444,0.00046898815,0.00028389526,0.0036344135],"genre_scores_gemma":[0.9952945,0.000719123,0.001285917,0.00008950668,0.000006358051,0.000057174024,0.00034616108,0.000016406773,0.00218473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998872,0.000012663918,0.0000059788113,0.000016521164,0.000027826087,0.000049871327],"domain_scores_gemma":[0.99996865,0.0000031077457,0.000008035244,0.0000034078698,0.000004347697,0.000012598896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010546023,0.00030503207,0.0002474109,0.00029498187,0.00023991482,0.00029107824,0.00024900617,0.0002679034,0.001328238],"category_scores_gemma":[0.00007225151,0.00014440878,0.00017233427,0.00023634461,0.00026251952,0.00016667916,0.00018110994,0.00060839794,0.00033793962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002497686,0.00015696444,0.00012798033,0.00006553774,0.000007481615,0.000043103064,0.000017328102,0.00038360854,0.9937423,0.00043837805,0.00038474795,0.0043828697],"study_design_scores_gemma":[0.0000746957,0.0011706442,0.0029493459,0.0000094731,0.0000328009,0.00016514584,0.000031693762,0.0035491523,0.9860822,0.00014788775,0.005777483,0.000009544214],"about_ca_topic_score_codex":0.0018327432,"about_ca_topic_score_gemma":0.0033131107,"teacher_disagreement_score":0.0018327432,"about_ca_system_score_codex":0.0005881576,"about_ca_system_score_gemma":0.0005517306,"threshold_uncertainty_score":0.0044433475},"labels":[],"label_agreement":null},{"id":"W4416139878","doi":"10.1093/neuonc/noaf201.1670","title":"TIP-10. Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Agile software development; Clinical trial; Glioblastoma; Randomization; Phases of clinical research; Drug development; Disease; Clinical endpoint; Biomarker","score_opus":0.03798152204161998,"score_gpt":0.36510367710203295,"score_spread":0.327122155060413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6916921,0.09198955,0.033994712,0.0630596,0.0063834055,0.015429089,0.04367332,0.0043678004,0.04941034],"genre_scores_gemma":[0.7892399,0.044672284,0.04679141,0.04481521,0.0023372194,0.02385521,0.029293627,0.0010690584,0.017926186],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987256,0.00081779226,0.0000673246,0.00012196468,0.00015979324,0.00010761498],"domain_scores_gemma":[0.9974298,0.0010104399,0.00038686054,0.0001958318,0.00033405644,0.00064304844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055742,0.0008994507,0.0017508526,0.0004317288,0.00027904913,0.0012348391,0.00089010416,0.0011144382,0.0058160545],"category_scores_gemma":[0.005630279,0.00022596399,0.002334174,0.00056395587,0.00045703747,0.0013082754,0.00078482484,0.0039506084,0.0011287137],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11943377,0.0045442884,0.0042122873,0.003725655,0.003217847,0.00020937092,0.0002077721,0.007548975,0.0063695903,0.0031779914,0.11313815,0.7342144],"study_design_scores_gemma":[0.597705,0.1648469,0.027067376,0.0037495112,0.004872588,0.0007997042,0.0002291604,0.013672736,0.0056703174,0.015942058,0.16521503,0.00022967784],"about_ca_topic_score_codex":0.0007870961,"about_ca_topic_score_gemma":0.0027271877,"teacher_disagreement_score":0.0058160545,"about_ca_system_score_codex":0.00085059484,"about_ca_system_score_gemma":0.0015870717,"threshold_uncertainty_score":0.029479504},"labels":[],"label_agreement":null},{"id":"W4416139896","doi":"10.1093/neuonc/noaf201.1666","title":"TIP-06. A global, open-label, randomized Phase 3 trial evaluating niraparib compared to standard temozolomide therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Clinical endpoint; Radiation therapy; Clinical trial; Phases of clinical research; Randomized controlled trial; Quality of life (healthcare); Progression-free survival","score_opus":0.04044565151742892,"score_gpt":0.39377617492435807,"score_spread":0.35333052340692916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702243,0.005187365,0.0011799746,0.0014766031,0.00096582004,0.009486085,0.0054593487,0.00039953372,0.0056208763],"genre_scores_gemma":[0.964149,0.0033643597,0.0036289252,0.003277662,0.00072781486,0.011546314,0.00628609,0.00008201578,0.0069378973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993783,0.000366725,0.000028180475,0.000098104894,0.00004032311,0.00008826801],"domain_scores_gemma":[0.99921477,0.00019348197,0.00015098786,0.000051829964,0.000055276465,0.0003336476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019911646,0.0020945529,0.002517926,0.0005387358,0.00041587796,0.0012293801,0.001190093,0.0018824771,0.012664467],"category_scores_gemma":[0.0016013599,0.0006867753,0.002103319,0.00046510994,0.0011914723,0.0015245092,0.0005177902,0.0041088504,0.0022569816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9651473,0.009616848,0.0006829329,0.00064333266,0.0006712198,0.000041681273,0.00004138571,0.00048270542,0.0032170299,0.00013789555,0.0024135627,0.016904052],"study_design_scores_gemma":[0.8998068,0.09668489,0.0014391991,0.000030072906,0.00022180726,0.000041049592,0.000017202336,0.0004792597,0.00031255293,0.00018051799,0.0007719517,0.000014677877],"about_ca_topic_score_codex":0.00045966048,"about_ca_topic_score_gemma":0.0014555937,"teacher_disagreement_score":0.012664467,"about_ca_system_score_codex":0.0006323309,"about_ca_system_score_gemma":0.0011183919,"threshold_uncertainty_score":0.042366862},"labels":[],"label_agreement":null},{"id":"W4416139905","doi":"10.1093/neuonc/noaf201.1650","title":"SURG-98. Clinical outcomes, operational metrics, and translational insights derived from trials of MR-guided, transcranial, microbubble-enhanced focused ultrasound for brain tumors: a 2010-2025 evidence analysis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Clinical trial; Profiling (computer programming); Focused ultrasound; Translational research; Leverage (statistics); Sonodynamic therapy; Brain disease; Biomarker discovery","score_opus":0.08247454757040577,"score_gpt":0.3645137889073145,"score_spread":0.2820392413369087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07324245,0.8335939,0.004825869,0.00386736,0.00047075507,0.008857335,0.06140657,0.00017362057,0.013562123],"genre_scores_gemma":[0.6519616,0.27847877,0.015276532,0.004048866,0.0005172495,0.016024431,0.0313683,0.00013849346,0.0021857393],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96480846,0.0122257015,0.014750942,0.0017306105,0.0058439947,0.0006403717],"domain_scores_gemma":[0.925888,0.042251546,0.023385338,0.0012653865,0.0060432963,0.0011663899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031698115,0.001124004,0.0041345633,0.011936092,0.0005092026,0.0036238148,0.0011482189,0.0010218405,0.0067004887],"category_scores_gemma":[0.06606437,0.0005303988,0.013922076,0.013666931,0.0010409446,0.001832232,0.0018516983,0.0011954438,0.001221624],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023233537,0.000204509,0.056046624,0.50554985,0.15788656,0.0001914406,0.00045538854,0.0016281393,0.0009792383,0.0019904843,0.009520834,0.24231343],"study_design_scores_gemma":[0.015277168,0.008851214,0.19361432,0.2954713,0.40013894,0.0010538908,0.0011496469,0.0015934703,0.0018508515,0.0040698918,0.076698475,0.00023083236],"about_ca_topic_score_codex":0.0023350215,"about_ca_topic_score_gemma":0.007960967,"teacher_disagreement_score":0.031698115,"about_ca_system_score_codex":0.0040509813,"about_ca_system_score_gemma":0.006929192,"threshold_uncertainty_score":0.1676377},"labels":[],"label_agreement":null},{"id":"W4416139917","doi":"10.1093/neuonc/noaf201.1269","title":"NCOG-02. Conquering Infant Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Radiation therapy; Chemotherapy; Disease; Karnofsky Performance Status; Clinical trial","score_opus":0.04901578176062894,"score_gpt":0.3103657034203307,"score_spread":0.2613499216597018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761139,0.005015526,0.00026915173,0.0028428265,0.00006430641,0.000120875615,0.004053601,0.000038412265,0.011481359],"genre_scores_gemma":[0.98535746,0.0041248705,0.001173199,0.000737023,0.00009575024,0.00013794913,0.0062147784,0.000033418284,0.0021256364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996319,0.000073167685,0.000049084054,0.000039128518,0.00007420602,0.00013247023],"domain_scores_gemma":[0.9980514,0.00014280289,0.00086173665,0.000043875552,0.00025331724,0.00064685283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049625494,0.000100611775,0.00017368086,0.0004594686,0.00051279576,0.00069196476,0.00031380818,0.00020625563,0.003180377],"category_scores_gemma":[0.0017899222,0.00005469652,0.00011496505,0.0013170155,0.00019439583,0.00040720805,0.0005927088,0.0002934492,0.0004982178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017003062,0.00008144259,0.9510588,0.0001446702,0.000016121428,0.0012853786,0.00019500167,0.00007820569,0.00037038958,0.00015563639,0.0054571875,0.040987026],"study_design_scores_gemma":[0.00003260752,0.00022824577,0.96497726,0.0004260666,0.00005065498,0.006855509,0.0039959936,0.0003203329,0.000579269,0.00027850785,0.02224497,0.000010728053],"about_ca_topic_score_codex":0.011883295,"about_ca_topic_score_gemma":0.03437601,"teacher_disagreement_score":0.011883295,"about_ca_system_score_codex":0.0012460146,"about_ca_system_score_gemma":0.0023164183,"threshold_uncertainty_score":0.023628235},"labels":[],"label_agreement":null},{"id":"W4416139920","doi":"10.1093/neuonc/noaf201.1690","title":"TIP-30. Molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG): CONNECT TarGeT (Targeted pediatric HGG therapy) trial in progress","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Young adult; Temozolomide; Clinical trial; Glioma; Everolimus; Immunotherapy; Brain tumor; Precision medicine","score_opus":0.019165966009403828,"score_gpt":0.31466261587175115,"score_spread":0.2954966498623473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9497638,0.008232196,0.0020810196,0.0048081465,0.00048564983,0.004636755,0.0121049825,0.00064439495,0.017243208],"genre_scores_gemma":[0.94495475,0.004288883,0.0076906807,0.006394761,0.00025838165,0.006465912,0.018850114,0.0001475906,0.010948845],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961627,0.00018486586,0.000012786423,0.00006577485,0.000047319318,0.00007300874],"domain_scores_gemma":[0.99956673,0.000047380283,0.00009374364,0.000037188995,0.000025933148,0.00022889712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012522258,0.0008678648,0.00082039286,0.00028674226,0.00035732985,0.0009601168,0.00072484306,0.001046174,0.0044155996],"category_scores_gemma":[0.00082490296,0.0002673974,0.00071723067,0.00029681585,0.00054161885,0.00083351374,0.00053922256,0.0026303416,0.001168733],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30759516,0.019898606,0.025657682,0.0025843268,0.0030699766,0.0010760427,0.0006024904,0.013039035,0.061431397,0.006943993,0.1107798,0.44732147],"study_design_scores_gemma":[0.6316803,0.20599256,0.05358751,0.00062055304,0.0014564157,0.0024150386,0.0002634879,0.011156514,0.01441389,0.0068668392,0.07140412,0.00014276312],"about_ca_topic_score_codex":0.00087740814,"about_ca_topic_score_gemma":0.0055011157,"teacher_disagreement_score":0.0044155996,"about_ca_system_score_codex":0.001072363,"about_ca_system_score_gemma":0.0013857636,"threshold_uncertainty_score":0.01477164},"labels":[],"label_agreement":null},{"id":"W4416139928","doi":"10.1093/neuonc/noaf201.1673","title":"TIP-13. Advancing Patient-Centered Neurological Trials in Canada through Scientific Innovation and Operational Excellence at The Clinical Research Unit at The Montreal Neurological Institute and Hospital","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Excellence; Unit (ring theory); Center of excellence; Clinical trial; Timeline; Cru; Research ethics; Patient recruitment; Certification","score_opus":0.07025444855511315,"score_gpt":0.36733944811234004,"score_spread":0.2970849995572269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139928","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.073707126,0.035367012,0.08876787,0.42439893,0.009790882,0.026189031,0.07281354,0.010494921,0.25847068],"genre_scores_gemma":[0.40445957,0.019300703,0.36466953,0.07945697,0.0020503206,0.018570334,0.039008696,0.0032544592,0.06922946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9486063,0.022874625,0.0025566244,0.0030800463,0.012979877,0.0099025685],"domain_scores_gemma":[0.75946546,0.020557148,0.010101806,0.013822822,0.113870054,0.082182676],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08180884,0.0013183013,0.001352468,0.002415527,0.008441435,0.0124242585,0.006636981,0.0033044459,0.0237688],"category_scores_gemma":[0.07961527,0.0009626174,0.00194122,0.003963356,0.006613109,0.003430846,0.012177069,0.004957369,0.00541885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005767941,0.0006584067,0.026723046,0.0024944548,0.0005559762,0.000558009,0.0022253154,0.0045431494,0.0032557459,0.055381313,0.62391007,0.27392662],"study_design_scores_gemma":[0.0060494896,0.0027452179,0.09752705,0.005797168,0.0005863134,0.00056061224,0.003133825,0.00912059,0.004731833,0.025198534,0.84405035,0.00049898104],"about_ca_topic_score_codex":0.865737,"about_ca_topic_score_gemma":0.92455596,"teacher_disagreement_score":0.91819113,"about_ca_system_score_codex":0.09923315,"about_ca_system_score_gemma":0.5710566,"threshold_uncertainty_score":0.71999025},"labels":[],"label_agreement":null},{"id":"W4416139954","doi":"10.1093/neuonc/noaf201.1653","title":"SURG-101. A pilot study of laser interstitial thermal therapy (LITT) followed by hypofractionated radiation therapy (hypoRT) for patients with recurrent gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Regimen; Radiation therapy; Clinical endpoint; Salvage therapy; Glioma; Biopsy; Radiography","score_opus":0.022240299469711965,"score_gpt":0.3055888615957714,"score_spread":0.28334856212605947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313813,0.0013984436,0.00029942614,0.00015216449,0.00011723852,0.0031761401,0.0006252857,0.000053123673,0.0010399597],"genre_scores_gemma":[0.9904088,0.0012655443,0.0011107966,0.00041190785,0.00019516768,0.004034348,0.0010193418,0.00001598327,0.0015382093],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992415,0.00031121212,0.000056378736,0.00017467843,0.00005680548,0.00015948516],"domain_scores_gemma":[0.99899155,0.00015341221,0.00018990385,0.00011073233,0.000075159405,0.00047917987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001835486,0.0012793203,0.0016755419,0.00047737604,0.000388876,0.00074343395,0.00060362706,0.0008213021,0.0050922753],"category_scores_gemma":[0.0010399742,0.0004908543,0.0022034654,0.00045086342,0.00078307936,0.0007628476,0.0004376397,0.00202196,0.0013860335],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.745731,0.15414494,0.010887023,0.0012358504,0.0017360214,0.00027980018,0.00029627344,0.0009813415,0.013133747,0.00013758182,0.0015376637,0.06989878],"study_design_scores_gemma":[0.08099525,0.9074656,0.008901197,0.000024715868,0.0004913751,0.00008563275,0.00005446872,0.00023408113,0.0007508412,0.000051073515,0.00092889497,0.000016838354],"about_ca_topic_score_codex":0.0015408517,"about_ca_topic_score_gemma":0.0048118574,"teacher_disagreement_score":0.0050922753,"about_ca_system_score_codex":0.0009871649,"about_ca_system_score_gemma":0.0023822722,"threshold_uncertainty_score":0.017035306},"labels":[],"label_agreement":null},{"id":"W4416139978","doi":"10.1093/neuonc/noaf201.1530","title":"QOL-29. Evaluating the effectiveness of a tailored exercise intervention on neuro-oncology patient outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Patient Safety Institute; Alberta Health Services; Kelowna General Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Intervention (counseling); Quality of life (healthcare); Aerobic exercise; Coaching; Health coaching; Physical activity; Randomized controlled trial; Minimal clinically important difference; Psychological intervention","score_opus":0.02859414818323603,"score_gpt":0.3691638314954812,"score_spread":0.3405696833122452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913145,0.0013996758,0.00042243078,0.00026130612,0.000101569625,0.0031348981,0.0013555189,0.000032187232,0.0041610454],"genre_scores_gemma":[0.99283046,0.00045346512,0.0020784424,0.00017537008,0.000034448345,0.0025930677,0.00068604207,0.0000051658008,0.0011435904],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984719,0.0007718105,0.00010576249,0.000115795585,0.0003824348,0.00015219257],"domain_scores_gemma":[0.9985544,0.0004987719,0.00042049243,0.000071667695,0.00017486939,0.00027989259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027119066,0.0004435414,0.0006977558,0.0003112965,0.00029721795,0.0003986413,0.0005300609,0.00033536807,0.0038565248],"category_scores_gemma":[0.0037720627,0.00018482245,0.0017210641,0.00046125945,0.00038269372,0.00021710554,0.00042962292,0.0007484565,0.00027547262],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15760097,0.0683492,0.15861034,0.004262881,0.008081927,0.00011397332,0.0005328489,0.008856638,0.005655608,0.0009181336,0.0076954667,0.5793221],"study_design_scores_gemma":[0.036908966,0.13771293,0.8090774,0.0005675708,0.0028386728,0.00005496703,0.00026133828,0.0041891094,0.0026609718,0.00039784677,0.005269493,0.000060791448],"about_ca_topic_score_codex":0.015072806,"about_ca_topic_score_gemma":0.0317044,"teacher_disagreement_score":0.015072806,"about_ca_system_score_codex":0.0019804924,"about_ca_system_score_gemma":0.0028876252,"threshold_uncertainty_score":0.02997011},"labels":[],"label_agreement":null},{"id":"W4416140053","doi":"10.1093/neuonc/noaf201.1317","title":"NCOG-50. Correlation of tract-based diffusion metrics with visuospatial function following glioma surgery","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Diffusion MRI; White matter; Arcuate fasciculus; Fractional anisotropy; Superior longitudinal fasciculus; Tractography; Fasciculus; Inferior longitudinal fasciculus; Human Connectome Project; Glioma","score_opus":0.03657880437120672,"score_gpt":0.3415430757264585,"score_spread":0.3049642713552518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774396,0.00013681296,0.00011852015,0.000039134222,0.0000060516763,0.000010901445,0.00061541767,0.000017285538,0.0013119404],"genre_scores_gemma":[0.99888164,0.000036019934,0.00007611608,0.0000071410627,0.000001804929,0.000008121186,0.0006042366,0.00000344225,0.0003814496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999143,0.000010053763,0.000013265932,0.000014960261,0.000024093793,0.000023342996],"domain_scores_gemma":[0.99879164,0.00014191223,0.0005376324,0.00004918172,0.00022633627,0.00025339396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018946326,0.00011642648,0.00012537038,0.0004384916,0.00015767918,0.00029598165,0.00015584275,0.00024603854,0.0032560301],"category_scores_gemma":[0.0020724551,0.00005181902,0.00010127208,0.00040977917,0.00020018937,0.00023534754,0.0002642663,0.00022948397,0.0005335258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043416303,0.000036692527,0.9866817,0.000021498214,0.000030814866,0.0001807341,0.000053172582,0.0002497794,0.0031259323,0.000028886665,0.0004797088,0.008676954],"study_design_scores_gemma":[0.0000025534844,0.00012575879,0.99868494,0.0000039982906,0.0000055071428,0.0002153562,0.000046266017,0.00021912025,0.0004283819,0.000024275216,0.00024146482,0.0000023725627],"about_ca_topic_score_codex":0.006725728,"about_ca_topic_score_gemma":0.011121463,"teacher_disagreement_score":0.006725728,"about_ca_system_score_codex":0.0005758694,"about_ca_system_score_gemma":0.00035489045,"threshold_uncertainty_score":0.0133731365},"labels":[],"label_agreement":null},{"id":"W4416140055","doi":"10.1093/neuonc/noaf201.1825","title":"TMIC-70. Integrative spatiotemporal proteomic and metabolomic characterization of immune infiltration following intracranial injection of oncolytic immunotherapy in glioblastoma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncolytic virus; Immune system; Cytotoxic T cell; Immunotherapy; Tumor microenvironment; CD8; Proteomics; Metabolomics","score_opus":0.005301657349595734,"score_gpt":0.27805255078400554,"score_spread":0.2727508934344098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963463,0.0005607313,0.0013313551,0.00004680409,0.0000115960775,0.000039207145,0.0010720119,0.000072388386,0.000519549],"genre_scores_gemma":[0.9948996,0.0003291198,0.0015910406,0.000088381064,0.000006249415,0.00006500028,0.002275157,0.000021420125,0.00072402356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999262,0.000007170598,0.0000034465463,0.000019368668,0.00002185409,0.000021998645],"domain_scores_gemma":[0.99993956,0.0000051559105,0.000017435237,0.0000036785202,0.000018438086,0.000015717465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117576856,0.0002387021,0.0002868155,0.00036498858,0.00015273163,0.0002570584,0.00011479525,0.00019732062,0.00066057936],"category_scores_gemma":[0.00014191061,0.000103267426,0.00017534352,0.00027548784,0.0001382119,0.000093835064,0.0001490852,0.00022369304,0.00019669792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001126767,0.000078035206,0.012502881,0.000051821487,0.000031743373,0.00020221961,0.00009262783,0.00024736283,0.9745969,0.00005145883,0.00034744767,0.010670817],"study_design_scores_gemma":[0.00004826885,0.0022722739,0.2867164,0.000020440402,0.00016507843,0.0017284743,0.00027365837,0.007857593,0.6958482,0.00013123473,0.004911429,0.000026914897],"about_ca_topic_score_codex":0.002026764,"about_ca_topic_score_gemma":0.0018942152,"teacher_disagreement_score":0.002026764,"about_ca_system_score_codex":0.00025273048,"about_ca_system_score_gemma":0.00023384513,"threshold_uncertainty_score":0.00402987},"labels":[],"label_agreement":null},{"id":"W4416140056","doi":"10.1093/neuonc/noaf201.1921","title":"Author Index","year":2025,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission; Santen","keywords":"","score_opus":0.03510670332541381,"score_gpt":0.35557166706374466,"score_spread":0.32046496373833083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140056","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002858626,0.0014666156,0.0007761871,0.0028840401,0.0072177816,0.00027925923,0.021885969,0.0019582652,0.9632461],"genre_scores_gemma":[0.00076183287,0.0010755708,0.00056358404,0.0011626638,0.0015552805,0.00012986017,0.00883833,0.00071523973,0.9851976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942976,0.00008938091,0.00005286652,0.00006434269,0.00029891226,0.00006466484],"domain_scores_gemma":[0.99545586,0.00089147565,0.00018804117,0.00022187366,0.0018881217,0.0013546016],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005874862,0.0014322789,0.0012144286,0.005737891,0.0010934867,0.0043004313,0.0012793409,0.0017516778,0.90118164],"category_scores_gemma":[0.006854261,0.0005458637,0.0006269293,0.0039158873,0.00044688905,0.0019400083,0.0020130742,0.0014989997,0.8542731],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017090744,0.000016411792,0.00004997437,0.00010491589,0.000001185775,0.000017372538,0.0000042193087,0.000044833065,0.0000422382,0.0003644009,0.9656784,0.03365886],"study_design_scores_gemma":[0.000033185872,0.000020224517,0.00027287222,0.0002435053,0.000003954758,0.00007271019,0.000019480618,0.00010797766,0.0001031386,0.0013854423,0.99772984,0.000007773998],"about_ca_topic_score_codex":0.00281993,"about_ca_topic_score_gemma":0.0062380335,"teacher_disagreement_score":0.09881836,"about_ca_system_score_codex":0.0015636211,"about_ca_system_score_gemma":0.002412803,"threshold_uncertainty_score":0.14095241},"labels":[],"label_agreement":null},{"id":"W4416140086","doi":"10.1093/neuonc/noaf201.1647","title":"SURG-95. Spectral Imaging and AI for Brain Tumor Characterization: Toward Data-Driven Surgical Guidance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hyperspectral imaging; Normalization (sociology); Deep learning; Pattern recognition (psychology); Brain tumor; Spatial normalization; Ground truth; Workflow; Margin (machine learning)","score_opus":0.025355784364852536,"score_gpt":0.3689936778659026,"score_spread":0.34363789350105006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140086","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09223265,0.009837011,0.73853093,0.0091510415,0.001605194,0.0010444017,0.039037265,0.05537913,0.053182397],"genre_scores_gemma":[0.34084755,0.005032574,0.5390475,0.0038940303,0.000501655,0.0013704516,0.08027037,0.0051235566,0.023912465],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994698,0.00014204014,0.000038774142,0.000095888885,0.00021686808,0.000036666814],"domain_scores_gemma":[0.99917454,0.00022606638,0.00007546308,0.00014435142,0.00026378542,0.000115615025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017851688,0.0008925611,0.00037887352,0.0007953755,0.00016787446,0.0011642006,0.000820258,0.00086199766,0.0076300185],"category_scores_gemma":[0.0028770566,0.0004170889,0.00054314005,0.00034343897,0.00024752982,0.0005494059,0.0012606964,0.0011917362,0.0074051376],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012293693,0.00029389246,0.013059988,0.00084208697,0.00025049146,0.0003737159,0.00006851589,0.0592225,0.034358397,0.0069756936,0.16210929,0.721216],"study_design_scores_gemma":[0.0004485887,0.00089952775,0.017780643,0.00042411656,0.00014182612,0.0019459528,0.00009806982,0.5880591,0.06588478,0.021086294,0.30305898,0.00017210277],"about_ca_topic_score_codex":0.0025200357,"about_ca_topic_score_gemma":0.0035225211,"teacher_disagreement_score":0.0076300185,"about_ca_system_score_codex":0.00073173275,"about_ca_system_score_gemma":0.0014672065,"threshold_uncertainty_score":0.025524974},"labels":[],"label_agreement":null},{"id":"W4416140091","doi":"10.1093/neuonc/noaf201.1794","title":"TMIC-39. Investigating the role of PDGF-AA in invasive melanoma brain metastases","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Melanoma; Autocrine signalling; Crosstalk; Paracrine signalling; Cancer; Cancer cell; Signal transduction; Cell","score_opus":0.021126449497303707,"score_gpt":0.30625345175927376,"score_spread":0.2851270022619701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901722,0.003345104,0.0013391176,0.00015308495,0.000052811793,0.00014150984,0.00087153714,0.000040212857,0.003884498],"genre_scores_gemma":[0.99217844,0.0016179065,0.0013700778,0.000102809056,0.000024515733,0.000084721156,0.0015155346,0.000008294036,0.0030977153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998901,0.000021542646,0.000005832447,0.0000132816995,0.000034215478,0.000035014982],"domain_scores_gemma":[0.99993515,0.000012197941,0.000007969193,0.0000054719717,0.000010397504,0.000028780389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016385844,0.00024000839,0.00019725064,0.0002782829,0.00012822002,0.00019041222,0.0001307152,0.00025738063,0.0018660361],"category_scores_gemma":[0.00012224859,0.0000929494,0.00019913622,0.00021070197,0.00008991045,0.00009385851,0.00009341358,0.00041407545,0.0006290738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003277843,0.00013628996,0.0007711032,0.000056338715,0.0000064474452,0.00015986849,0.00001049377,0.000065442735,0.99548846,0.00006241517,0.00013690171,0.0027785315],"study_design_scores_gemma":[0.00014764164,0.0067912247,0.054165114,0.000024837262,0.00006619241,0.0023708902,0.00011384755,0.0026720304,0.92332083,0.000192182,0.010127424,0.000007857264],"about_ca_topic_score_codex":0.0010736361,"about_ca_topic_score_gemma":0.0010991399,"teacher_disagreement_score":0.0018660361,"about_ca_system_score_codex":0.00018863354,"about_ca_system_score_gemma":0.00022633118,"threshold_uncertainty_score":0.0062425137},"labels":[],"label_agreement":null},{"id":"W4416140097","doi":"10.1093/neuonc/noaf201.1676","title":"TIP-16. Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; BC Cancer Foundation; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University of British Columbia; Hospital for Sick Children; University of Toronto; CancerCare Manitoba; Queen's University","funders":"","keywords":"Clinical trial; Randomization; Glioma; Precision medicine; Randomized controlled trial; Profiling (computer programming)","score_opus":0.023251069622055733,"score_gpt":0.33389264270034047,"score_spread":0.3106415730782847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7543146,0.069537096,0.0026586214,0.011549886,0.0017030146,0.0065367944,0.06858874,0.00041808697,0.08469319],"genre_scores_gemma":[0.87578034,0.0121326465,0.0042189923,0.0088647,0.0010667568,0.010422224,0.049517132,0.00015438879,0.03784278],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993862,0.00029408597,0.000033565575,0.00011965386,0.00007960023,0.00008683876],"domain_scores_gemma":[0.9992968,0.000079570105,0.0001651893,0.000056107176,0.000061292,0.00034090018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015109191,0.0007240653,0.0012201599,0.00018407429,0.000343539,0.0012236026,0.0006547684,0.00093060685,0.006994629],"category_scores_gemma":[0.0012870842,0.0002349785,0.0009687837,0.00052464363,0.0003235682,0.0005725701,0.00050778396,0.0015315346,0.0018560684],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68947786,0.0022533888,0.047473423,0.0055785975,0.0046997857,0.0004409277,0.00013219875,0.0015972322,0.008296786,0.0027844196,0.06965649,0.1676089],"study_design_scores_gemma":[0.59336704,0.047414564,0.19306943,0.0026274275,0.007090155,0.00086322444,0.00020316083,0.0030709947,0.0045016157,0.0074622324,0.140163,0.00016708304],"about_ca_topic_score_codex":0.0013452081,"about_ca_topic_score_gemma":0.0044463337,"teacher_disagreement_score":0.006994629,"about_ca_system_score_codex":0.0009486597,"about_ca_system_score_gemma":0.0012442927,"threshold_uncertainty_score":0.023399413},"labels":[],"label_agreement":null},{"id":"W4416140109","doi":"10.1093/neuonc/noaf201.1426","title":"EXTH-93. Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cholesterol; Metabolomics; In vivo; Enzyme; Genome editing; Proteomics; CRISPR; Metabolic pathway","score_opus":0.02225998556977041,"score_gpt":0.29938744611548274,"score_spread":0.2771274605457123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253654,0.0015015593,0.000760918,0.00018258707,0.000030741652,0.000096536845,0.0015009616,0.00021471462,0.003175506],"genre_scores_gemma":[0.9931473,0.00097353075,0.0009954633,0.0001078665,0.0000056707013,0.00005520152,0.0015507353,0.000034717224,0.0031294124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.000014742915,0.000010278069,0.000022373279,0.00005961646,0.000039513652],"domain_scores_gemma":[0.9999455,0.000007548116,0.000009765082,0.000007811119,0.0000067206015,0.000022644987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013451515,0.00040990394,0.00047124378,0.0003395511,0.00013348834,0.00041809166,0.00026628713,0.00027570856,0.0024263149],"category_scores_gemma":[0.000096907715,0.00015502005,0.0003065875,0.0003078857,0.00019135083,0.00013097184,0.0002517274,0.0006279342,0.000573133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091047847,0.0004348435,0.001015043,0.00012670885,0.00005714223,0.00047614914,0.000035265093,0.00087136106,0.9765044,0.00019687587,0.0006801441,0.018691672],"study_design_scores_gemma":[0.00036239106,0.008822221,0.013903322,0.000015773716,0.0001532693,0.0024211025,0.00011964866,0.002226467,0.9604145,0.00014067866,0.011398211,0.000022383316],"about_ca_topic_score_codex":0.0025838825,"about_ca_topic_score_gemma":0.0070342245,"teacher_disagreement_score":0.0025838825,"about_ca_system_score_codex":0.00042109695,"about_ca_system_score_gemma":0.00034317418,"threshold_uncertainty_score":0.008116841},"labels":[],"label_agreement":null},{"id":"W4416140125","doi":"10.1093/neuonc/noaf201.0942","title":"INNV-53. Precision Medicine in Pediatric Neuro-Oncology-Experience from a tertiary care center in Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Dabrafenib; Adverse effect; Cohort; Precision medicine; Cancer; Radiation therapy; Retrospective cohort study; Tertiary care","score_opus":0.01146706880917872,"score_gpt":0.2928871973995187,"score_spread":0.28142012859034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718347,0.004308408,0.00038114158,0.0045914096,0.00006703807,0.00015281026,0.0021289247,0.00006596628,0.016469652],"genre_scores_gemma":[0.98667777,0.0046170927,0.0013039059,0.0020679373,0.000053275915,0.00005067176,0.0013492465,0.000052412644,0.0038276364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990496,0.00007647117,0.000039368486,0.000110705616,0.00028175037,0.00044206128],"domain_scores_gemma":[0.9964646,0.00017225933,0.00054366863,0.00006863121,0.0008302314,0.0019205753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045284413,0.0003245302,0.00027916912,0.00068263727,0.0027834254,0.0013609637,0.0009620778,0.00040365022,0.003891853],"category_scores_gemma":[0.0015917184,0.0003019673,0.00026958837,0.003010687,0.0010503383,0.00033695454,0.001347907,0.0008230853,0.0005464658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001657601,0.00020585136,0.9212041,0.00018356388,0.00005234205,0.005079578,0.002764251,0.00063256355,0.0014946378,0.0010479968,0.011527003,0.055642374],"study_design_scores_gemma":[0.00006902111,0.00036987,0.95332676,0.0003349714,0.000045725843,0.0071957507,0.008367928,0.00089391676,0.0009282945,0.00025576557,0.028160643,0.000051385607],"about_ca_topic_score_codex":0.93684787,"about_ca_topic_score_gemma":0.97648627,"teacher_disagreement_score":0.063152134,"about_ca_system_score_codex":0.0386765,"about_ca_system_score_gemma":0.071119756,"threshold_uncertainty_score":0.28061897},"labels":[],"label_agreement":null},{"id":"W4416140129","doi":"10.1093/neuonc/noaf201.1796","title":"TMIC-41. Anti-Robo1/2 monoclonal antibodies as a novel macrophage-based immunotherapy for glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Immune system; Monoclonal antibody; Immunotherapy; Tumor microenvironment; Glioma; Melanoma; Microglia; Lymphatic system; Antigen; Radioimmunotherapy","score_opus":0.018050214931597003,"score_gpt":0.3275249651756882,"score_spread":0.3094747502440912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968691,0.017513096,0.005291276,0.0006061198,0.00022601853,0.00032113542,0.00036225008,0.00025677873,0.006732376],"genre_scores_gemma":[0.9812609,0.007904222,0.004523569,0.00041665952,0.000104025996,0.00020746284,0.0006830444,0.000015781368,0.004884466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992645,0.000011626254,0.000003958147,0.000010328265,0.000015667618,0.00003205382],"domain_scores_gemma":[0.99998224,0.0000015452129,0.0000030104252,0.0000014480646,0.000003725883,0.0000081072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016941689,0.00033320286,0.000278704,0.00036181227,0.00013216531,0.00023019724,0.0002131014,0.00032285022,0.0008942113],"category_scores_gemma":[0.00003917826,0.000088080145,0.00025003962,0.00018083538,0.00012760905,0.00013975249,0.00015054258,0.00046006794,0.00025313706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058401044,0.0008105967,0.0003663841,0.00029439313,0.00003816754,0.00021536084,0.00003619521,0.0006485942,0.9572544,0.00077089196,0.0012639505,0.037717074],"study_design_scores_gemma":[0.00074574014,0.01417511,0.008482991,0.00008134333,0.0002406217,0.0017927913,0.000042666103,0.0049878284,0.9086215,0.00050775724,0.060292322,0.00002930872],"about_ca_topic_score_codex":0.00046107397,"about_ca_topic_score_gemma":0.0008503765,"teacher_disagreement_score":0.0008942113,"about_ca_system_score_codex":0.00021733296,"about_ca_system_score_gemma":0.0003357215,"threshold_uncertainty_score":0.002991438},"labels":[],"label_agreement":null},{"id":"W4416140204","doi":"10.1093/neuonc/noaf201.0554","title":"CTNI-58. UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Manitoba","funders":"","keywords":"Lomustine; Eflornithine; Progression-free survival; Astrocytoma; Clinical endpoint; Overall survival; Anaplastic astrocytoma; Log-rank test","score_opus":0.022739871299676917,"score_gpt":0.3294818697341074,"score_spread":0.3067419984344305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130568,0.039090827,0.0014857725,0.0028692351,0.0010185887,0.009483998,0.018244456,0.00034095193,0.014409387],"genre_scores_gemma":[0.9452562,0.0077395504,0.005037357,0.0029956135,0.00067077734,0.006484514,0.026570905,0.00013860733,0.0051064813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970289,0.0017224129,0.0003190942,0.00037920577,0.00040530786,0.00014505396],"domain_scores_gemma":[0.99477863,0.0007806929,0.0020272636,0.00057300547,0.0011969677,0.00064340374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006524242,0.0006964201,0.0021121358,0.0005777401,0.0006359699,0.0016015817,0.0011349596,0.0011608391,0.0026805268],"category_scores_gemma":[0.006517381,0.00037797232,0.0022986368,0.0006481984,0.00056225766,0.0007883027,0.0005245563,0.0014160324,0.0007943802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7400261,0.002929229,0.02221118,0.0060082464,0.010363242,0.00021042932,0.00039652767,0.0013845098,0.023306632,0.00047189568,0.022519005,0.170173],"study_design_scores_gemma":[0.716153,0.0910868,0.10962041,0.001780335,0.02307252,0.000918728,0.00026663404,0.0030758085,0.009616991,0.0010423864,0.043123923,0.00024255169],"about_ca_topic_score_codex":0.0023620506,"about_ca_topic_score_gemma":0.009417753,"teacher_disagreement_score":0.006524242,"about_ca_system_score_codex":0.0015664846,"about_ca_system_score_gemma":0.0027378935,"threshold_uncertainty_score":0.034503877},"labels":[],"label_agreement":null},{"id":"W4416140212","doi":"10.1093/neuonc/noaf201.0977","title":"PATH-25. Identifying the molecular signature of infiltrating edge cells in glioblastoma as drivers of tumour invasion and recurrence","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; St. Michael's Hospital; Structural Genomics Consortium; Hospital for Sick Children","funders":"","keywords":"Gene signature; Context (archaeology); Glioblastoma; Gene; Gene expression; Cell; Tumour heterogeneity; Population","score_opus":0.013567383767596223,"score_gpt":0.2887506073867453,"score_spread":0.2751832236191491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971712,0.0004854434,0.0010231442,0.000025059255,0.0000035911046,0.000010694181,0.00066916295,0.000036451333,0.0005753913],"genre_scores_gemma":[0.9973374,0.00018307034,0.0011137205,0.000018147362,0.0000028493328,0.00001564751,0.0007379726,0.000009974432,0.00058109267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993503,0.000005249681,0.0000040148457,0.000018200477,0.000015696842,0.000021752106],"domain_scores_gemma":[0.9999244,0.000007773345,0.000028728826,0.0000051806737,0.000013663686,0.000020176047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007719608,0.00014750686,0.00018992537,0.0005196497,0.00015435882,0.00035914485,0.00010241591,0.00014428257,0.0013749001],"category_scores_gemma":[0.00009764368,0.00010130657,0.00015089526,0.00041727858,0.0001696838,0.0001249908,0.00020681611,0.00018468223,0.0002991736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003845582,0.000025671085,0.09326656,0.00011080156,0.00002458513,0.0002553931,0.00015213422,0.00028739191,0.89242905,0.00017104519,0.00019565035,0.012697164],"study_design_scores_gemma":[0.000007728618,0.00026160557,0.8632121,0.000013595746,0.000054585373,0.0008968424,0.00035600585,0.0024924886,0.12958176,0.00022692842,0.002884767,0.00001154096],"about_ca_topic_score_codex":0.0010433279,"about_ca_topic_score_gemma":0.0019671659,"teacher_disagreement_score":0.0013749001,"about_ca_system_score_codex":0.000190845,"about_ca_system_score_gemma":0.00015345759,"threshold_uncertainty_score":0.0045995116},"labels":[],"label_agreement":null},{"id":"W4416140227","doi":"10.1093/neuonc/noaf201.1168","title":"IMG-89. Volumetric (3D) compared with traditional bidirectional (2D) assessment in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Concordance; Glioma; Kappa; Correlation","score_opus":0.03688663681545817,"score_gpt":0.3277187121549753,"score_spread":0.2908320753395171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992191,0.004366377,0.00063356815,0.00028136466,0.000096323565,0.0002148463,0.00076149695,0.00009498181,0.0013600828],"genre_scores_gemma":[0.99739647,0.0005021488,0.00072614074,0.00018869367,0.000045090906,0.00022165375,0.0005108649,0.000013304134,0.00039570962],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890864,0.00072001084,0.000040690215,0.00015332167,0.00010229041,0.000075026204],"domain_scores_gemma":[0.99940383,0.00017275344,0.00023423569,0.00006449337,0.000034787914,0.00008987375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002152785,0.00077673997,0.0014631588,0.00031040268,0.0001275306,0.0009811653,0.0005271713,0.00050594535,0.0014188078],"category_scores_gemma":[0.0018170167,0.00035500483,0.0014426709,0.00032032057,0.0004679586,0.0005976913,0.00034705817,0.0012405815,0.0003151949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7725915,0.0031383445,0.046647716,0.0010701515,0.0049408413,0.000080505364,0.00020535015,0.0069324286,0.017616231,0.00052019773,0.00280977,0.143447],"study_design_scores_gemma":[0.22871509,0.3224051,0.36378005,0.00037380177,0.01320347,0.0006329596,0.00040333092,0.04088309,0.016068358,0.002679455,0.010558164,0.00029706815],"about_ca_topic_score_codex":0.0005853664,"about_ca_topic_score_gemma":0.0019047455,"teacher_disagreement_score":0.002152785,"about_ca_system_score_codex":0.0008251592,"about_ca_system_score_gemma":0.0004597987,"threshold_uncertainty_score":0.011385143},"labels":[],"label_agreement":null},{"id":"W4416140239","doi":"10.1093/neuonc/noaf201.1770","title":"TMIC-15. Reactive Oligodendrocytes Promote Glioblastoma Progression via CCL5/CCR5-Mediated Glioma Stem Cell Maintenance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Paracrine signalling; Glioma; Phenotype; Tumor microenvironment; Tumor progression; Stem cell; Cell culture; Gene knockdown; Cytokine","score_opus":0.010080827340512665,"score_gpt":0.2869629500960002,"score_spread":0.2768821227554875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379635,0.0020555411,0.0013560939,0.000078117184,0.000021308342,0.000039403112,0.0011488387,0.00016273817,0.0013416818],"genre_scores_gemma":[0.9967338,0.0005114874,0.0007909967,0.00005168841,0.000005555024,0.000026218479,0.00096857233,0.000008391588,0.0009032876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987364,0.00001617956,0.000010641216,0.000021031447,0.000029076673,0.000049404607],"domain_scores_gemma":[0.999923,0.000004289806,0.000022979346,0.000007058235,0.000011774067,0.00003080295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015234285,0.00018631812,0.00020187482,0.0002617929,0.00012663605,0.00041879964,0.00013003084,0.00012351382,0.0013108217],"category_scores_gemma":[0.000088464236,0.00006590768,0.00017397209,0.00021252413,0.00015557106,0.0001243211,0.000166543,0.00030993132,0.00030221813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029819942,0.00006148747,0.0020118663,0.00014987517,0.000017064005,0.000059834947,0.000041309486,0.0001920642,0.99116933,0.00025406183,0.00038376497,0.0053611207],"study_design_scores_gemma":[0.000066941255,0.0010283682,0.03916754,0.000036859343,0.00009900026,0.00035544863,0.00020284939,0.0028226618,0.94495463,0.00016920116,0.011085775,0.0000108182985],"about_ca_topic_score_codex":0.0018767205,"about_ca_topic_score_gemma":0.003278949,"teacher_disagreement_score":0.0018767205,"about_ca_system_score_codex":0.00037995915,"about_ca_system_score_gemma":0.00047128982,"threshold_uncertainty_score":0.0043851733},"labels":[],"label_agreement":null},{"id":"W4416140285","doi":"10.1093/neuonc/noaf201.1031","title":"PATH-79. High-grade astrocytoma with piloid features (HGAP) comprehensive update: histological grading, molecular markers and clinical outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"ATRX; Histopathology; Cohort; Immunohistochemistry; Progression-free survival; Astrocytoma; Neurofibromatosis; CDKN2A","score_opus":0.0190740232175289,"score_gpt":0.3251838339024767,"score_spread":0.3061098106849478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6677269,0.07110562,0.012478095,0.0050395643,0.0005002726,0.00077705627,0.2014608,0.0023475073,0.038564175],"genre_scores_gemma":[0.60274166,0.038010962,0.017179592,0.0012753146,0.0006166948,0.0010279046,0.33095697,0.0005316216,0.007659343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999742,0.000038323265,0.000035555153,0.00005335384,0.000084460924,0.000046276353],"domain_scores_gemma":[0.9987728,0.00013419281,0.00029368384,0.00006655957,0.0005201355,0.00021246882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010720151,0.00042888022,0.0005091313,0.0023040944,0.00021227846,0.0007354078,0.00066075474,0.0003267568,0.002021247],"category_scores_gemma":[0.0013646517,0.0002103491,0.00034755978,0.002340404,0.00011899873,0.0006317996,0.0009271743,0.00039814852,0.001776428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007893782,0.000116910844,0.4707814,0.000993438,0.00047202435,0.0005961415,0.00012078465,0.0011903613,0.0029613245,0.0003261786,0.116878115,0.40477392],"study_design_scores_gemma":[0.000077619334,0.00023127945,0.93146324,0.0005100488,0.00040154846,0.0029835354,0.00010836997,0.0012726414,0.0008145191,0.00040048396,0.06170868,0.000028072234],"about_ca_topic_score_codex":0.005628992,"about_ca_topic_score_gemma":0.009111889,"teacher_disagreement_score":0.005628992,"about_ca_system_score_codex":0.0006485744,"about_ca_system_score_gemma":0.0007493118,"threshold_uncertainty_score":0.011192501},"labels":[],"label_agreement":null},{"id":"W4416140351","doi":"10.1093/neuonc/noaf201.0557","title":"CTNI-61. A PHASE 2 STUDY OF ERDAFITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH-WILD TYPE GLIOMA WITH FGFR-TACC GENE FUSIONS: SAFETY RUN-IN COHORT RESULTS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cohort; Tolerability; Adverse effect; Glioma; Performance status; Phases of clinical research","score_opus":0.014434922151624108,"score_gpt":0.3330471567387479,"score_spread":0.3186122345871238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929512,0.00089546235,0.0005486649,0.00024140185,0.00007003827,0.0019275007,0.001993917,0.00008112125,0.0012906101],"genre_scores_gemma":[0.9853157,0.0011616206,0.0019936378,0.00068323454,0.00014200725,0.002092878,0.00681014,0.000052146777,0.0017487202],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992939,0.00031311173,0.000039301354,0.00013979712,0.00008047167,0.00013329528],"domain_scores_gemma":[0.9990043,0.00010676901,0.00019784941,0.00012443744,0.00008630946,0.00048032292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024995285,0.001736864,0.0021109318,0.00040718846,0.00052942877,0.0010621273,0.0007498808,0.001075903,0.002019184],"category_scores_gemma":[0.0013048962,0.00061643845,0.0017858759,0.00039608215,0.00086908834,0.0009876338,0.00046923562,0.0029403626,0.00085730414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6589232,0.076063104,0.04058444,0.00094734377,0.003292767,0.0010948944,0.00072635605,0.004895851,0.084536284,0.0004753594,0.008302034,0.1201584],"study_design_scores_gemma":[0.32307377,0.61347866,0.045066647,0.000046260648,0.0012470534,0.0013970713,0.00013807295,0.0023926522,0.007935142,0.00024883336,0.004891796,0.00008391625],"about_ca_topic_score_codex":0.00119708,"about_ca_topic_score_gemma":0.0033164269,"teacher_disagreement_score":0.0024995285,"about_ca_system_score_codex":0.0011111229,"about_ca_system_score_gemma":0.0021026735,"threshold_uncertainty_score":0.013218939},"labels":[],"label_agreement":null},{"id":"W4416140366","doi":"10.1093/neuonc/noaf201.1473","title":"EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Children's Hospital; BC Cancer Agency; McMaster University","funders":"","keywords":"Medulloblastoma; Antigen; Potency; Disease; Tumor antigen; Immunotherapy; Cell","score_opus":0.034950985266482486,"score_gpt":0.3582756843886205,"score_spread":0.323324699122138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921108,0.00025019894,0.004416051,0.000044528977,0.000006128439,0.00003944808,0.0020616273,0.00008469857,0.0009864616],"genre_scores_gemma":[0.9908249,0.00019424545,0.0042601777,0.00005372265,0.000003921049,0.00006563558,0.0027266175,0.000032076292,0.0018386714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991035,0.000009900763,0.000004081989,0.000021301501,0.000035537614,0.00001880629],"domain_scores_gemma":[0.9999405,0.000011497871,0.000013686991,0.00000591775,0.000013926788,0.000014464481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014583212,0.0001762092,0.00018020747,0.00028656214,0.00015865044,0.0003598164,0.00009206278,0.00016633829,0.0016096092],"category_scores_gemma":[0.00015434645,0.00008873198,0.00014585492,0.00022237754,0.00014537145,0.00014850193,0.0001750874,0.00024844933,0.00032407913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010990527,0.000017160835,0.003336692,0.000018499015,0.0000054330126,0.000015653175,0.000017620632,0.0002556817,0.9934088,0.000062102634,0.00011809761,0.0026343965],"study_design_scores_gemma":[0.000017970053,0.00051546184,0.10487822,0.000007029151,0.000033620476,0.00027664797,0.00013363414,0.009460861,0.88036156,0.00017012673,0.004133755,0.000011203197],"about_ca_topic_score_codex":0.0013759546,"about_ca_topic_score_gemma":0.0024322418,"teacher_disagreement_score":0.0016096092,"about_ca_system_score_codex":0.00026038173,"about_ca_system_score_gemma":0.00016817341,"threshold_uncertainty_score":0.005384743},"labels":[],"label_agreement":null},{"id":"W4416140407","doi":"10.1093/neuonc/noaf201.0988","title":"PATH-36. DNA copy number clustering reveals alterations that influence survival in primary IDH-mutant astrocytoma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Copy-number variation; Copy number analysis; Loss of heterozygosity; Astrocytoma; Glioma; Chromosome; Gene dosage; Germline","score_opus":0.015906125555648194,"score_gpt":0.30068785266664916,"score_spread":0.28478172711100097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893945,0.000075009564,0.00017354137,0.00002814651,0.0000019776903,0.0000039658485,0.00057422684,0.000011580556,0.0001921144],"genre_scores_gemma":[0.9991671,0.000016085354,0.00013639421,0.0000070044625,0.0000015582634,0.000003820403,0.00046094105,0.00000494378,0.00020227891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986017,0.000018146671,0.000012418697,0.00005404179,0.000030118166,0.000025110754],"domain_scores_gemma":[0.99964714,0.000064595195,0.00015142518,0.000029418195,0.000044393004,0.00006292716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014845833,0.00018613914,0.00020355717,0.00052471436,0.00023278869,0.00036820368,0.00020673014,0.00020536983,0.002305235],"category_scores_gemma":[0.00092953193,0.00010888134,0.00023857468,0.00067420275,0.00015816181,0.00013763022,0.0002462277,0.0002002963,0.00044904352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008185733,0.000025111243,0.9780149,0.000018058494,0.00010398668,0.00020190243,0.0000976924,0.0007122211,0.010451839,0.0000484789,0.000377189,0.009130103],"study_design_scores_gemma":[0.00000985136,0.000069250236,0.99646217,0.000002128526,0.000034709345,0.00041649883,0.0000503052,0.0016437469,0.00092203426,0.00013089617,0.00025404352,0.000004364766],"about_ca_topic_score_codex":0.0035998297,"about_ca_topic_score_gemma":0.0038693966,"teacher_disagreement_score":0.0035998297,"about_ca_system_score_codex":0.00031829346,"about_ca_system_score_gemma":0.00023492047,"threshold_uncertainty_score":0.007711768},"labels":[],"label_agreement":null},{"id":"W4416140417","doi":"10.1093/neuonc/noaf201.0702","title":"DDDR-65. Dynamic and multi-omic profiling of glioblastoma to guide personalized medicine","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Personalized medicine; Glioblastoma; Chemoradiotherapy; Precision medicine; Tumor microenvironment; Regimen; Profiling (computer programming)","score_opus":0.018691193942410724,"score_gpt":0.35068278174986006,"score_spread":0.33199158780744936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68901205,0.03844621,0.14505288,0.0063097575,0.00063613255,0.0006316084,0.096509956,0.0062416457,0.017159829],"genre_scores_gemma":[0.8293944,0.0095961625,0.108455256,0.0019853222,0.00018661015,0.00028889158,0.045339417,0.00043130928,0.0043226485],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99953926,0.00007168593,0.000041837728,0.0001358655,0.00014530217,0.0000661879],"domain_scores_gemma":[0.99962735,0.00005468079,0.00011781711,0.000049990485,0.00009641866,0.000053683645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010255524,0.00055577786,0.00070747244,0.0014568571,0.00032723034,0.0015695572,0.0003662413,0.0005125143,0.0012796998],"category_scores_gemma":[0.0007759997,0.00023400794,0.0005944456,0.0012001107,0.00021574178,0.00040752493,0.0008423907,0.00062391226,0.00072915404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069125876,0.00016259677,0.05386668,0.0011457854,0.00033075575,0.00047411796,0.00018905819,0.006099461,0.77119356,0.0037174767,0.012532356,0.14959684],"study_design_scores_gemma":[0.00016501168,0.0011966045,0.19539358,0.00081066514,0.0009044503,0.0026379444,0.00090259855,0.104633726,0.45101798,0.019883528,0.22224039,0.00021352449],"about_ca_topic_score_codex":0.0017131199,"about_ca_topic_score_gemma":0.0031506978,"teacher_disagreement_score":0.0017131199,"about_ca_system_score_codex":0.0007718053,"about_ca_system_score_gemma":0.00092142436,"threshold_uncertainty_score":0.0055998564},"labels":[],"label_agreement":null},{"id":"W4416140500","doi":"10.1093/neuonc/noaf201.0960","title":"PATH-08. Establishing the utility of deep-learning for H&amp;E-based meningioma molecular classification and outcome prediction","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Machine Learning in Bioinformatics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Deep learning; Classifier (UML); Leverage (statistics); Precision medicine; Correlation; Predictive modelling; Neuroimaging; Genomics","score_opus":0.01880609155948536,"score_gpt":0.30846736329931845,"score_spread":0.2896612717398331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7869902,0.0018269307,0.13600817,0.008314373,0.0008751409,0.0006627576,0.034630504,0.012628177,0.018063702],"genre_scores_gemma":[0.8914557,0.0005177297,0.07503663,0.0010285166,0.00010256198,0.0004953705,0.023951245,0.00048479592,0.0069273985],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995485,0.0001607569,0.000018958897,0.00012214668,0.00007451923,0.0000751312],"domain_scores_gemma":[0.9984157,0.0007987141,0.0001370208,0.00016981288,0.00029579565,0.0001830391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025233184,0.00075797376,0.00032403678,0.0005317126,0.00029885807,0.00091655256,0.0008246805,0.0009553801,0.0067488407],"category_scores_gemma":[0.006037321,0.00035615396,0.00064478285,0.00030520078,0.0004519258,0.00069466355,0.0014482201,0.0017705348,0.0027847665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033696878,0.0014468626,0.22103252,0.00069645286,0.0006993328,0.00059132,0.00024170715,0.2510251,0.012880271,0.010499135,0.10067914,0.39683852],"study_design_scores_gemma":[0.00029468085,0.0007567597,0.0118272705,0.000120877965,0.00010419179,0.00019523,0.00006325413,0.95718896,0.00916741,0.009207039,0.011042331,0.000031909654],"about_ca_topic_score_codex":0.0040620663,"about_ca_topic_score_gemma":0.0032888253,"teacher_disagreement_score":0.0067488407,"about_ca_system_score_codex":0.0008325093,"about_ca_system_score_gemma":0.0025594023,"threshold_uncertainty_score":0.022577167},"labels":[],"label_agreement":null},{"id":"W4416140576","doi":"10.1093/neuonc/noaf201.0771","title":"DISP-10. The global landscape of glioblastoma clinical trials: A missing map for low- and middle-income countries","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Glioblastoma; Missing data; Life expectancy; Protocol (science); MEDLINE","score_opus":0.31193223258731584,"score_gpt":0.5823887126944874,"score_spread":0.2704564801071716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140576","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08715678,0.115654536,0.026365843,0.18486528,0.002858495,0.0041796505,0.50940454,0.0031822675,0.0663326],"genre_scores_gemma":[0.60767657,0.049852952,0.067752115,0.025292872,0.00237215,0.01118667,0.23032121,0.0017092132,0.0038362774],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.90643656,0.051323574,0.020902626,0.0050485246,0.012705547,0.0035832874],"domain_scores_gemma":[0.545327,0.28525457,0.08060214,0.018356286,0.053993702,0.016466308],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09117295,0.0008773684,0.002976855,0.015555342,0.0011996529,0.01196223,0.0024296206,0.0017902198,0.020465534],"category_scores_gemma":[0.30193803,0.0011674972,0.0026240004,0.036514293,0.002066827,0.007644474,0.0067409785,0.0026228738,0.0044205035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033943926,0.00021127769,0.22631426,0.044275258,0.003320095,0.0004450139,0.0015319976,0.0037447116,0.00040616744,0.036397956,0.30163252,0.37832645],"study_design_scores_gemma":[0.0015937906,0.0008933809,0.3986589,0.047982294,0.0028467216,0.0014265972,0.00445423,0.008029873,0.00082663517,0.034907106,0.49802402,0.00035641636],"about_ca_topic_score_codex":0.0058527286,"about_ca_topic_score_gemma":0.0058444836,"teacher_disagreement_score":0.90882707,"about_ca_system_score_codex":0.0042604087,"about_ca_system_score_gemma":0.01630888,"threshold_uncertainty_score":0.4821744},"labels":[],"label_agreement":null},{"id":"W4416140708","doi":"10.1093/neuonc/noaf201.0865","title":"IMMU-67. On-Treatment Spatiotemporal Profiling of Glioblastoma During Oncolytic ImmunoTherapy","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncolytic virus; Immune system; Immunotherapy; Glioblastoma; Tumor microenvironment; Transcriptome; Myeloid; Herpes simplex virus; Proteomics","score_opus":0.015345016377177457,"score_gpt":0.327979117982267,"score_spread":0.31263410160508953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903867,0.0010072313,0.005565322,0.000069089365,0.000017739792,0.000035752248,0.0012199495,0.00012898463,0.0015693537],"genre_scores_gemma":[0.99312544,0.00038225253,0.003638311,0.000109955356,0.000008500902,0.000055958793,0.0016536351,0.000055857166,0.0009700719],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986625,0.000013452018,0.000005048848,0.000031178188,0.00004529029,0.00003874756],"domain_scores_gemma":[0.9999225,0.0000097934335,0.000017155387,0.000006478739,0.000030069015,0.000014045927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014820021,0.0002203564,0.00030836687,0.00044555936,0.00020483085,0.00044054224,0.00015699373,0.00023230778,0.0007830006],"category_scores_gemma":[0.00017932695,0.00013781224,0.00015308156,0.00033091722,0.00017939176,0.00015972464,0.00023245155,0.00028085528,0.00029322685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044109495,0.000056800665,0.022527315,0.00008538613,0.000030061721,0.00016086009,0.00020783517,0.0010690228,0.96167994,0.00017834702,0.00043767903,0.013125613],"study_design_scores_gemma":[0.00001756477,0.00054384896,0.17412013,0.000026459986,0.000098919736,0.000905269,0.0006151909,0.01927774,0.7948676,0.0004153741,0.009083508,0.000028425786],"about_ca_topic_score_codex":0.0017843584,"about_ca_topic_score_gemma":0.0026581516,"teacher_disagreement_score":0.0017843584,"about_ca_system_score_codex":0.00032511022,"about_ca_system_score_gemma":0.00019041078,"threshold_uncertainty_score":0.0035479665},"labels":[],"label_agreement":null},{"id":"W4416140781","doi":"10.1093/neuonc/noaf201.0924","title":"INNV-35. Artificial intelligence in Neuro-Oncology: Mapping the field","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Google (Canada)","funders":"","keywords":"Metadata; Field (mathematics); Deep learning; Python (programming language); Precision medicine; Key (lock); Generative grammar","score_opus":0.03112628055538892,"score_gpt":0.35447840790261126,"score_spread":0.32335212734722235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140781","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004140607,0.25937763,0.019756114,0.03975578,0.0071965386,0.002871778,0.46789804,0.02050192,0.17850162],"genre_scores_gemma":[0.030836647,0.31079298,0.08963551,0.02796538,0.0059086457,0.007264432,0.47468367,0.009638785,0.04327403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99412525,0.0016631999,0.0013661466,0.00056923315,0.0017948216,0.00048135163],"domain_scores_gemma":[0.96809846,0.018773546,0.003255424,0.002123124,0.0052809413,0.0024684856],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.010932893,0.0011290347,0.002688442,0.017936956,0.0012861057,0.0095455395,0.0033698701,0.0029248402,0.08880559],"category_scores_gemma":[0.04340837,0.0006591213,0.0021202143,0.016670745,0.0011713114,0.004230595,0.008002483,0.0019651626,0.03882628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036703335,0.00004242409,0.0022029153,0.08117124,0.00035348843,0.0002463848,0.00055557676,0.00077358953,0.001218784,0.024380468,0.5796077,0.30908036],"study_design_scores_gemma":[0.00008404311,0.000059887137,0.0025994394,0.038754757,0.00020232255,0.00022974871,0.00016558851,0.0003231866,0.00035215454,0.015278504,0.941902,0.00004835777],"about_ca_topic_score_codex":0.004467557,"about_ca_topic_score_gemma":0.008520515,"teacher_disagreement_score":0.98206306,"about_ca_system_score_codex":0.0034095352,"about_ca_system_score_gemma":0.013997413,"threshold_uncertainty_score":0.29708427},"labels":[],"label_agreement":null},{"id":"W4416140904","doi":"10.1093/neuonc/noaf201.0359","title":"CSIG-25. EXPLORING THE ROLE OF THE CIC/YY1 COMPLEX IN MODULATING SENSITIVITY OF MEK INHIBITORS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Effector; Transcription factor; Suppressor; Kinase; Transcription (linguistics); Downregulation and upregulation; Cell growth; Signal transduction","score_opus":0.019920383563121712,"score_gpt":0.25587932083091514,"score_spread":0.23595893726779343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98423475,0.009331517,0.0011363274,0.00026814116,0.00008987182,0.00019550782,0.0018883,0.00015597591,0.0026996783],"genre_scores_gemma":[0.992152,0.0028509514,0.0011048006,0.00010411741,0.000014679359,0.000102485435,0.0016441075,0.000019096988,0.0020077697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000012309649,0.000007545649,0.000016488917,0.00002275477,0.000042816417],"domain_scores_gemma":[0.99994886,0.0000044562244,0.000008589319,0.0000048320408,0.000006533861,0.000026734184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023108348,0.0003773502,0.00047264193,0.0003405871,0.00018678949,0.00037825314,0.000390675,0.00027760823,0.0024539419],"category_scores_gemma":[0.000106821535,0.00017335908,0.00034258742,0.0002833531,0.00021081751,0.00021029574,0.00019580833,0.00054180244,0.0005911024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021564455,0.0004509361,0.001635603,0.00037450073,0.0000674528,0.00013432628,0.000028787901,0.00096490135,0.97253937,0.00025689104,0.001083631,0.020307226],"study_design_scores_gemma":[0.00051580195,0.008190958,0.029953212,0.000044793156,0.00019498424,0.00041162275,0.00009289753,0.00512448,0.9415678,0.00017340505,0.013691832,0.000038290753],"about_ca_topic_score_codex":0.0024966362,"about_ca_topic_score_gemma":0.0047527202,"teacher_disagreement_score":0.0024966362,"about_ca_system_score_codex":0.00066281494,"about_ca_system_score_gemma":0.00062329444,"threshold_uncertainty_score":0.008209288},"labels":[],"label_agreement":null},{"id":"W4416140911","doi":"10.1093/neuonc/noaf201.0852","title":"IMMU-54. Leveraging deep immunopeptidomics to identify tumor antigens from glioblastoma tissue samples","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Major histocompatibility complex; Antigen; Human leukocyte antigen; Glioblastoma; Immunotherapy; MHC class I; Proteomics; Genome; Cancer immunotherapy; Gene expression profiling","score_opus":0.015128322723410114,"score_gpt":0.29169795155872513,"score_spread":0.276569628835315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78595203,0.0025663709,0.17587715,0.0007473884,0.00017792826,0.00037239067,0.018052146,0.009196406,0.00705825],"genre_scores_gemma":[0.5884695,0.00091277796,0.3855202,0.0006213961,0.000063973705,0.00047976073,0.019714661,0.0011452426,0.0030725072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995586,0.000051207317,0.000037803016,0.00015740446,0.00013816143,0.000056905345],"domain_scores_gemma":[0.99964595,0.00008283056,0.00006560859,0.00005662971,0.00010121326,0.00004778551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012067253,0.0006402142,0.00041847443,0.001297858,0.00044128302,0.00092978217,0.00046115174,0.0006875592,0.0019916499],"category_scores_gemma":[0.0012657058,0.000431344,0.0004732587,0.00063476764,0.0003238132,0.0004274672,0.00068827247,0.00069234375,0.0011361694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067458954,0.0001024083,0.018636648,0.0003348642,0.00015359283,0.0006254106,0.00024337736,0.0041885395,0.9163353,0.0010491386,0.005317212,0.05233888],"study_design_scores_gemma":[0.00008970096,0.00033899405,0.044161037,0.00006842486,0.00012098991,0.0020267458,0.00021359746,0.09863073,0.8255882,0.0025338407,0.026122222,0.000105565014],"about_ca_topic_score_codex":0.0011654506,"about_ca_topic_score_gemma":0.0025634752,"teacher_disagreement_score":0.0019916499,"about_ca_system_score_codex":0.00044908508,"about_ca_system_score_gemma":0.0005267589,"threshold_uncertainty_score":0.006662786},"labels":[],"label_agreement":null},{"id":"W4416140935","doi":"10.1093/neuonc/noaf201.0790","title":"DISP-30. Impact of distance traveled for clinical trial participation on clinical outcomes in patients with glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Clinical trial; Cohort; Proportional hazards model; Residence; Retrospective cohort study; Karnofsky Performance Status; Cohort study","score_opus":0.3575693211475629,"score_gpt":0.6375715611309188,"score_spread":0.28000223998335594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940534,0.0011344891,0.000116541116,0.000532931,0.00003146687,0.000029931805,0.0020150754,0.000010954255,0.0020751336],"genre_scores_gemma":[0.99848866,0.0001686376,0.00008971484,0.000116091534,0.000023063561,0.000036767386,0.00075345754,0.0000040037357,0.0003194237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979188,0.0008447232,0.00039351595,0.0002809423,0.0002444037,0.00031764063],"domain_scores_gemma":[0.98853755,0.0016816958,0.006346708,0.00037500024,0.00078515767,0.002273947],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00195607,0.00011745113,0.00034525272,0.00058652915,0.00053572946,0.0010496171,0.00039420003,0.00036099955,0.0051062577],"category_scores_gemma":[0.009570259,0.00011221505,0.0006331822,0.0013392472,0.00025138733,0.00071170094,0.0008625424,0.0007052675,0.0006047849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013611251,0.00010823582,0.98661673,0.000088705725,0.00017374862,0.00008991251,0.000098480785,0.00014852396,0.00009702419,0.000077148296,0.0010874067,0.01005301],"study_design_scores_gemma":[0.00005859954,0.00035927532,0.99726933,0.00003936743,0.00006511976,0.0001509295,0.00019734257,0.00031307453,0.000053370095,0.000112372836,0.0013714943,0.000009670663],"about_ca_topic_score_codex":0.005022058,"about_ca_topic_score_gemma":0.009250852,"teacher_disagreement_score":0.99804395,"about_ca_system_score_codex":0.00082219404,"about_ca_system_score_gemma":0.0011534183,"threshold_uncertainty_score":0.017082155},"labels":[],"label_agreement":null},{"id":"W4416140939","doi":"10.1093/neuonc/noaf201.0046","title":"EPCO-47. DISSECTING MYC-DRIVEN EPIGENETIC MECHANISMS THAT PROMOTE GROUP 3 MEDULLOBLASTOMA UTILIZING HUMANIZED IPSC MODELS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"H3K4me3; Epigenetics; Medulloblastoma; Neural stem cell; Chromatin; Histone; Polycomb-group proteins; Induced pluripotent stem cell; Effector; PRC2","score_opus":0.0376564264573605,"score_gpt":0.3122048493021556,"score_spread":0.2745484228447951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94013846,0.001753576,0.030029554,0.0004653487,0.00022271107,0.00048646703,0.009086031,0.0007118253,0.017106127],"genre_scores_gemma":[0.96199876,0.0011477827,0.011616607,0.00020452745,0.000017040045,0.0004750546,0.00596859,0.00014241356,0.01842914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999796,0.00002333861,0.000024188712,0.000041916373,0.0000794912,0.00003513002],"domain_scores_gemma":[0.999884,0.000017422732,0.000029602912,0.00002503849,0.000013593679,0.000030379611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031846768,0.00034434185,0.00019586658,0.00039993873,0.00020949684,0.0004177042,0.00034996268,0.0005611591,0.0032545463],"category_scores_gemma":[0.00010051338,0.00017913281,0.000423625,0.00014353101,0.0002581762,0.0002017032,0.00025568006,0.0009682296,0.0010022484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008264975,0.000072179064,0.00021829078,0.000034568737,0.000007942207,0.000094360985,0.000025925054,0.00027895515,0.9964864,0.00066806405,0.00023656132,0.001794043],"study_design_scores_gemma":[0.000033952474,0.00032012127,0.002103808,0.000014738517,0.000023326314,0.00029120425,0.000027637408,0.0026356792,0.98127717,0.00014827117,0.013118533,0.0000055715195],"about_ca_topic_score_codex":0.001020778,"about_ca_topic_score_gemma":0.0015092611,"teacher_disagreement_score":0.0032545463,"about_ca_system_score_codex":0.00034034674,"about_ca_system_score_gemma":0.00024809263,"threshold_uncertainty_score":0.010887504},"labels":[],"label_agreement":null},{"id":"W4416140966","doi":"10.1093/neuonc/noaf201.0506","title":"CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Randomized controlled trial; Clinical endpoint; Radiation therapy; Placebo; Chemoradiotherapy; Clinical trial; Quality of life (healthcare); Intention-to-treat analysis; Maintenance therapy","score_opus":0.03381051816741617,"score_gpt":0.3980270223201019,"score_spread":0.36421650415268575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140966","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037538145,0.0016876876,0.0033229117,0.0010014143,0.0008968354,0.94234604,0.008283879,0.00034836156,0.00457475],"genre_scores_gemma":[0.040643394,0.0013392438,0.0069624116,0.0015287747,0.00029209402,0.9419426,0.003258754,0.00005011968,0.003982639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961052,0.002212694,0.00031878307,0.00050157076,0.0003609479,0.00050078734],"domain_scores_gemma":[0.9969471,0.00040636407,0.0006864578,0.0003926442,0.0004151142,0.001152332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011039799,0.0032843486,0.0044370415,0.0009959385,0.002005719,0.0019379717,0.0035745266,0.0041223806,0.03375927],"category_scores_gemma":[0.006352855,0.0018094676,0.002168508,0.0013714083,0.0023297688,0.0017793722,0.00085037405,0.0059658005,0.008225417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9415771,0.014255362,0.00062800024,0.004097176,0.00042576186,0.000136748,0.0001484782,0.0008053185,0.005750488,0.0013786319,0.0142652895,0.016531581],"study_design_scores_gemma":[0.9504862,0.033466365,0.00083173934,0.00032923266,0.00024532943,0.00006393212,0.000031163316,0.0004657628,0.0008724155,0.00053619634,0.012637344,0.000034246223],"about_ca_topic_score_codex":0.0019318893,"about_ca_topic_score_gemma":0.0060302974,"teacher_disagreement_score":0.03375927,"about_ca_system_score_codex":0.002637455,"about_ca_system_score_gemma":0.01186429,"threshold_uncertainty_score":0.11293602},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4416140972","doi":"10.1093/neuonc/noaf201.0589","title":"CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Clinical trial; Radiography; Drug; Retrospective cohort study; Phases of clinical research; Drug holiday","score_opus":0.041871743802711574,"score_gpt":0.35258401359150787,"score_spread":0.3107122697887963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709302,0.016289439,0.0005261558,0.00076008047,0.00014373494,0.00038496804,0.0072024213,0.00008899649,0.0036739584],"genre_scores_gemma":[0.97833383,0.005181185,0.0009182407,0.0006312559,0.0001921073,0.00046070263,0.01312337,0.000042356496,0.0011169496],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993168,0.00034154777,0.000048233553,0.000085207415,0.000118959135,0.00008915986],"domain_scores_gemma":[0.9980476,0.00044770434,0.0009025933,0.00011870193,0.00013982173,0.00034365038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023103226,0.0004941162,0.001221175,0.00034817847,0.00019126345,0.001128324,0.00046789725,0.0004442696,0.0021862835],"category_scores_gemma":[0.0022180174,0.00018324633,0.00091505685,0.00069488405,0.00033543597,0.0006189289,0.00029231998,0.0011122709,0.0004883456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3206243,0.004518607,0.1571376,0.0026560482,0.0057184948,0.0006522553,0.00043344658,0.0048031867,0.01832509,0.0005222503,0.025122019,0.4594868],"study_design_scores_gemma":[0.18511926,0.1642792,0.5782834,0.0006670683,0.0075002615,0.0033977276,0.00042103036,0.0042220266,0.010098876,0.0011243672,0.044722576,0.00016422699],"about_ca_topic_score_codex":0.001166229,"about_ca_topic_score_gemma":0.003386465,"teacher_disagreement_score":0.0023103226,"about_ca_system_score_codex":0.00075191306,"about_ca_system_score_gemma":0.0009825475,"threshold_uncertainty_score":0.0122182965},"labels":[],"label_agreement":null},{"id":"W4416141003","doi":"10.1093/neuonc/noaf201.0122","title":"BIOM-34. GENOMIC ANALYSIS OF CSF CTDNA IN LUNG CANCER-RELATED LEPTOMENINGEAL METASTASES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aneuploidy; Lung cancer; Chemotherapy; Allele; Mutation; Lung","score_opus":0.013977656757288275,"score_gpt":0.3812545465734455,"score_spread":0.3672768898161572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935454,0.0011829812,0.0016211588,0.00011863439,0.000013076524,0.000054542706,0.000976906,0.00009435745,0.0023929283],"genre_scores_gemma":[0.99594754,0.0001727779,0.002413505,0.00004277605,0.00000574156,0.000028544275,0.00073865254,0.000009974011,0.0006405729],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986243,0.000021172364,0.000017435521,0.00003310713,0.000036937476,0.000028882803],"domain_scores_gemma":[0.99981636,0.000046326604,0.000045465717,0.000014088907,0.000046965488,0.000030892148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021644477,0.00020443926,0.00014672116,0.0009268002,0.00023560823,0.00034947408,0.00015640295,0.00032514526,0.0021611894],"category_scores_gemma":[0.000559652,0.00011525867,0.00010626225,0.0003758843,0.00023477516,0.00011334056,0.00021949541,0.0001726723,0.0004893006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008235201,0.00006601541,0.42352107,0.0001896171,0.00003500132,0.0051373993,0.00017672151,0.00044080574,0.5154567,0.00025141778,0.00078616414,0.0531156],"study_design_scores_gemma":[0.000044214943,0.0006760933,0.7366759,0.0000364521,0.00006091632,0.023620062,0.00025292207,0.0029154592,0.22784743,0.0003045077,0.0075545097,0.000011596474],"about_ca_topic_score_codex":0.0018018521,"about_ca_topic_score_gemma":0.0022085516,"teacher_disagreement_score":0.0021611894,"about_ca_system_score_codex":0.00035820898,"about_ca_system_score_gemma":0.0002493219,"threshold_uncertainty_score":0.0072298646},"labels":[],"label_agreement":null},{"id":"W4416141004","doi":"10.1093/neuonc/noaf201.0150","title":"BIOM-62. BASELINE NEUROLOGICAL FUNCTION ASSESSED BY NANO PREDICTS PROGRESSION-FREE SURVIVAL IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Cohort; Overall survival; Proportional hazards model; Glioma; Progression-free survival; Survival analysis; Karnofsky Performance Status","score_opus":0.01523134519484571,"score_gpt":0.30476237852017724,"score_spread":0.28953103332533153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974172,0.00018043621,0.00009129432,0.00006460082,0.0000063311795,0.0000093557,0.001430267,0.000012180111,0.00078834716],"genre_scores_gemma":[0.99865806,0.000041007825,0.000067080924,0.000015471373,0.0000044960498,0.000007566524,0.0010290153,0.0000019731642,0.00017526021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997136,0.00003679417,0.000037629485,0.00007191292,0.000079480335,0.00006050398],"domain_scores_gemma":[0.99846953,0.00019353432,0.0006428842,0.00007175673,0.00029376886,0.00032859037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005782697,0.000226432,0.00028144068,0.0008667942,0.00032223706,0.00057772873,0.00036719238,0.00033645207,0.0023790086],"category_scores_gemma":[0.0027423266,0.000085929576,0.0003993785,0.00085319165,0.00029745948,0.000367981,0.0005076172,0.00036397018,0.0004646243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021111974,0.000024912368,0.99611676,0.00001020719,0.000031315423,0.000020755853,0.00001819146,0.00013891928,0.00020590941,0.000011530841,0.00021552591,0.0029948403],"study_design_scores_gemma":[0.0000034142988,0.000056230492,0.99933785,0.000003299587,0.000014437218,0.00004473732,0.000027517348,0.0003122056,0.000057998288,0.000023545432,0.000115941555,0.000002783193],"about_ca_topic_score_codex":0.034225397,"about_ca_topic_score_gemma":0.03935866,"teacher_disagreement_score":0.034225397,"about_ca_system_score_codex":0.0010308665,"about_ca_system_score_gemma":0.0010585226,"threshold_uncertainty_score":0.06805235},"labels":[],"label_agreement":null},{"id":"W4416141005","doi":"10.1093/neuonc/noaf201.0588","title":"CTP-16. ONC201 (Dordaviprone) in the treatment of Diffuse Midline Glioma of the Pons in children: single center experience from Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Single Center; Radiation therapy; Glioma; Chemotherapy; Progression-free survival; Biopsy; Clinical trial","score_opus":0.016292870814488897,"score_gpt":0.277693541229457,"score_spread":0.2614006704149681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324423,0.0032920158,0.0002444535,0.00022764697,0.0000128175125,0.000113693255,0.00030504394,0.00001233222,0.002547819],"genre_scores_gemma":[0.9934001,0.0043639,0.0008154471,0.00014030938,0.000030228497,0.000047508147,0.00049668644,0.000012865477,0.00069296936],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997228,0.000056385725,0.000024349622,0.000039651095,0.00007954582,0.00007737452],"domain_scores_gemma":[0.9995092,0.00007043942,0.00009271643,0.000016477317,0.00009558433,0.00021556168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028310844,0.00039619036,0.0004395866,0.00028469376,0.0005965465,0.0004280901,0.00042089247,0.00027458527,0.0008030303],"category_scores_gemma":[0.00059526064,0.000114797986,0.00036796907,0.0008372567,0.00047121412,0.00014374549,0.00028555605,0.0004455377,0.00021106147],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008812713,0.0044239108,0.5399845,0.0016865167,0.00079057436,0.026122415,0.0037817147,0.003993898,0.028874157,0.00069361494,0.0059008147,0.37493518],"study_design_scores_gemma":[0.0023134823,0.02529004,0.9015418,0.00027490422,0.0004270518,0.034543358,0.0022309741,0.0016884259,0.012538554,0.00012627894,0.018936863,0.00008817062],"about_ca_topic_score_codex":0.2246528,"about_ca_topic_score_gemma":0.37810907,"teacher_disagreement_score":0.2246528,"about_ca_system_score_codex":0.0037057241,"about_ca_system_score_gemma":0.004590132,"threshold_uncertainty_score":0.44669032},"labels":[],"label_agreement":null},{"id":"W4416141008","doi":"10.1093/neuonc/noaf201.0596","title":"DNAR-05. Discovery and development of a novel CNS-penetrating ATR inhibitor","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Variation Biotechnologies (Canada)","funders":"","keywords":"Drug discovery; Adept; In vivo; Kinase; Cancer therapy; Mechanism (biology); Cancer","score_opus":0.03693012742183182,"score_gpt":0.3397739218535768,"score_spread":0.302843794431745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8145164,0.02607494,0.08773759,0.001814259,0.0005753775,0.0018969857,0.0059637194,0.0033257722,0.058094896],"genre_scores_gemma":[0.8897671,0.010967809,0.061621632,0.0010941342,0.00005078435,0.00054937607,0.00577407,0.0001858658,0.029989189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998543,0.00001574167,0.000007858126,0.0000431771,0.00005498377,0.000023976094],"domain_scores_gemma":[0.999908,0.000007731475,0.000023654839,0.000006890302,0.00002021564,0.000033553428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002906883,0.0005832718,0.00055606157,0.0004491069,0.00015321794,0.0005890493,0.0006389192,0.0006306268,0.0027318187],"category_scores_gemma":[0.000253473,0.00024501132,0.0005187525,0.0003301222,0.00021314101,0.0003271767,0.00045557966,0.0010840844,0.001705893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053550274,0.00073536794,0.00051127694,0.0008621178,0.00011672526,0.000683717,0.00007798347,0.015020346,0.8470842,0.004101168,0.004546134,0.12572546],"study_design_scores_gemma":[0.0007210003,0.006089524,0.0010608793,0.00009388621,0.00015777747,0.0013628217,0.000024042101,0.029576015,0.8915849,0.00080148363,0.068449385,0.00007830823],"about_ca_topic_score_codex":0.001002916,"about_ca_topic_score_gemma":0.0013665747,"teacher_disagreement_score":0.0027318187,"about_ca_system_score_codex":0.0006704208,"about_ca_system_score_gemma":0.00060630887,"threshold_uncertainty_score":0.009138882},"labels":[],"label_agreement":null},{"id":"W4416141026","doi":"10.1093/neuonc/noaf201.0119","title":"BIOM-31. PLASMA CELL-FREE DNA METHYLOME PREDICTS RESPONSE TO COMBINED PARP AND IMMUNE CHECKPOINT INHIBITION IN IDH-MUTANT GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Olaparib; Immune checkpoint; DNA methylation; PARP inhibitor; Durvalumab; Glioma; Immune system; Biomarker; Epigenetics","score_opus":0.016935772640992556,"score_gpt":0.3065460026243378,"score_spread":0.28961022998334524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461865,0.00041991175,0.00059769716,0.00012520698,0.000011590551,0.000025902684,0.0035348262,0.000047254667,0.0006188506],"genre_scores_gemma":[0.9952225,0.00009032785,0.0007610402,0.00006810167,0.000008676018,0.000030958123,0.0032438207,0.000007468553,0.0005672115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998945,0.000021127333,0.000010628213,0.000036928937,0.000020016088,0.000016858885],"domain_scores_gemma":[0.9997464,0.000061339924,0.000086562664,0.000018302304,0.000033683515,0.000053738244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025259148,0.00021969558,0.0003286817,0.0003160796,0.0001372283,0.0003889539,0.00017968603,0.0003496649,0.002999059],"category_scores_gemma":[0.0006031435,0.00010306024,0.00018035909,0.00027042063,0.00010742084,0.00018259088,0.00021562065,0.00027966918,0.0006484891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008308966,0.00023374496,0.8573221,0.00018188146,0.00020350864,0.0002680065,0.00008480024,0.0020625815,0.079744205,0.00012346824,0.0024743592,0.048992336],"study_design_scores_gemma":[0.00016997504,0.0012979648,0.9673949,0.000024470583,0.00015329933,0.0014977752,0.000111971305,0.00797837,0.017702222,0.000461501,0.0031872052,0.000020465288],"about_ca_topic_score_codex":0.00077954953,"about_ca_topic_score_gemma":0.001284852,"teacher_disagreement_score":0.002999059,"about_ca_system_score_codex":0.00025525893,"about_ca_system_score_gemma":0.00016373536,"threshold_uncertainty_score":0.010032892},"labels":[],"label_agreement":null},{"id":"W4416141066","doi":"10.1093/neuonc/noaf201.0597","title":"DNAR-06. Discovery and development of novel CNS-penetrating PARP1-selective inhibitors","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"EMD Serono","keywords":"Drug discovery; PARP1; Poly ADP ribose polymerase; Drug development; Drug; Docking (animal); In vivo; Decoy","score_opus":0.03169128465356363,"score_gpt":0.33538403359929386,"score_spread":0.30369274894573023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7562709,0.048207242,0.105556086,0.0034975691,0.0008166556,0.0018393493,0.011825288,0.0053302706,0.06665673],"genre_scores_gemma":[0.85182333,0.018205015,0.08052577,0.0018996706,0.00008370204,0.00053833437,0.010926075,0.00026480152,0.03573322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975115,0.000031125073,0.000015313555,0.00006584913,0.000096356045,0.000040332074],"domain_scores_gemma":[0.99981385,0.000015655565,0.000051474883,0.000013468321,0.0000453061,0.00006026391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047823205,0.00078796135,0.0005998396,0.0005548241,0.00017464322,0.0007733967,0.00073100586,0.00077502645,0.0026190632],"category_scores_gemma":[0.00035955475,0.00030677434,0.0004929444,0.0004109778,0.00025879158,0.00042087058,0.00055171194,0.001490402,0.0019548063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006279583,0.00095649436,0.00094660214,0.00089673785,0.00014506595,0.00054144464,0.00007513372,0.02165884,0.7883092,0.0044982512,0.007057945,0.17428632],"study_design_scores_gemma":[0.0009903939,0.006164295,0.0019321969,0.00011871909,0.00011675452,0.0016305447,0.00002586909,0.03685098,0.874146,0.0012213368,0.07670458,0.00009845593],"about_ca_topic_score_codex":0.0008105673,"about_ca_topic_score_gemma":0.0012469438,"teacher_disagreement_score":0.0026190632,"about_ca_system_score_codex":0.00076860597,"about_ca_system_score_gemma":0.0006103497,"threshold_uncertainty_score":0.008761644},"labels":[],"label_agreement":null},{"id":"W4416141088","doi":"10.1093/neuonc/noaf201.0207","title":"BIOS-06. INCIDENCE RATE OF BRAIN METASTASES AMONG WOMEN WITH GYNECOLOGICAL CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Kingston Health Sciences Centre","funders":"","keywords":"Incidence (geometry); Meta-analysis; Ovarian cancer; Systematic review; Cancer","score_opus":0.03481340492711157,"score_gpt":0.3324645522201437,"score_spread":0.29765114729303216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141088","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005604377,0.9885289,0.0017749646,0.00040292388,0.0002881663,0.00080875104,0.0019753228,0.000077817116,0.0005387297],"genre_scores_gemma":[0.2754282,0.7016665,0.009134618,0.0019065676,0.0006118038,0.0064772996,0.0033386636,0.00014879882,0.0012875887],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97712666,0.011937527,0.0056863413,0.0022855902,0.002406823,0.0005569562],"domain_scores_gemma":[0.9753023,0.018451251,0.0036208145,0.0007187309,0.0016148607,0.00029212292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02324227,0.0037075682,0.019140698,0.010710458,0.00074867054,0.0052498267,0.0027105503,0.0033168066,0.0074492325],"category_scores_gemma":[0.050845675,0.0021240595,0.079148255,0.008846201,0.00095534633,0.0029711088,0.0023293209,0.0029186737,0.00074647024],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012509659,0.000019094572,0.0032851915,0.2574669,0.7314214,0.00008966288,0.000052676067,0.00052389374,0.00012087526,0.00014782924,0.00055530336,0.0050661727],"study_design_scores_gemma":[0.0005337249,0.00012516134,0.002543536,0.015696244,0.9791255,0.000094017094,0.000029856108,0.000230998,0.00007059851,0.00022491004,0.0013036566,0.000021819296],"about_ca_topic_score_codex":0.0062147514,"about_ca_topic_score_gemma":0.009257349,"teacher_disagreement_score":0.02324227,"about_ca_system_score_codex":0.003106782,"about_ca_system_score_gemma":0.0041698585,"threshold_uncertainty_score":0.12291831},"labels":[],"label_agreement":null},{"id":"W4416141092","doi":"10.1093/neuonc/noaf201.0154","title":"BIOM-66. MODERN MOLECULAR PROFILING RECONTEXTUALIZES THE RTOG-0539 TRIAL AND REVEALS HIDDEN HIGH-RISK AND RADIOTHERAPY RESISTANT MENINGIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Grading (engineering); Meningioma; Epigenetics; Radiation therapy; Molecular biomarkers; Gene expression profiling; DNA methylation; Adjuvant; Cohort; Histone deacetylase","score_opus":0.02086159222899891,"score_gpt":0.3046712411534526,"score_spread":0.2838096489244537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700539,0.007809303,0.0029772467,0.002935731,0.00034761496,0.00070227147,0.005893934,0.00034303407,0.008937006],"genre_scores_gemma":[0.98620075,0.0009576335,0.0032440764,0.0011775307,0.00016064568,0.00069204456,0.004313864,0.00006697653,0.0031864697],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986482,0.0008657613,0.00009686154,0.00016264411,0.00012734516,0.0000990629],"domain_scores_gemma":[0.99924695,0.00019020056,0.00024693675,0.00016697713,0.00004310682,0.0001058985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003168704,0.000445037,0.0007956056,0.00036032888,0.00023191959,0.00083092897,0.0003419617,0.00057166105,0.0039090244],"category_scores_gemma":[0.0020980092,0.00020742811,0.001055206,0.0005685759,0.00027365697,0.00047271108,0.0003771177,0.0009797324,0.0007772564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3758593,0.0023228612,0.09052191,0.0022058848,0.006989813,0.00034599344,0.00030585498,0.010152829,0.069605924,0.0033103453,0.018566463,0.4198128],"study_design_scores_gemma":[0.12943403,0.12596768,0.5195772,0.0007210154,0.011168475,0.0012441638,0.0003144848,0.025047235,0.03288049,0.013480333,0.13996905,0.00019589158],"about_ca_topic_score_codex":0.0005645106,"about_ca_topic_score_gemma":0.0015019194,"teacher_disagreement_score":0.0039090244,"about_ca_system_score_codex":0.0004766908,"about_ca_system_score_gemma":0.00068784493,"threshold_uncertainty_score":0.016757905},"labels":[],"label_agreement":null},{"id":"W4416141099","doi":"10.1093/neuonc/noaf201.0686","title":"DDDR-49. IGF1R inhibition arrests meningioma growth","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Ceritinib; Insulin-like growth factor 1 receptor; Ex vivo; Regulator; In vivo; Cell growth; Cell; Receptor","score_opus":0.019656819798956112,"score_gpt":0.30648237286723223,"score_spread":0.2868255530682761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844654,0.004847018,0.0017881104,0.00036073278,0.00021844899,0.00008643958,0.0014579498,0.0005431062,0.006232815],"genre_scores_gemma":[0.9951828,0.00087408733,0.00096110784,0.00008992406,0.00001891929,0.000025123121,0.00086491456,0.000022714257,0.0019604506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.000007766662,0.0000064138153,0.000020871528,0.000020874475,0.000033877255],"domain_scores_gemma":[0.99995184,0.000009934079,0.000008472105,0.000007860692,0.000005753512,0.000016157788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088887464,0.00027327944,0.0004144344,0.00023567202,0.00017754204,0.00028726543,0.00015437619,0.00022398584,0.0021593578],"category_scores_gemma":[0.00010119235,0.00007625597,0.00024803774,0.000115947645,0.00016899144,0.000092487346,0.000117248936,0.00051595,0.00086005655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008793395,0.0003117409,0.00082581135,0.000093991766,0.000021668324,0.0003294666,0.00002398259,0.0007387599,0.9738728,0.00016109944,0.0015016376,0.021239817],"study_design_scores_gemma":[0.00018851372,0.0036431144,0.011131516,0.00000929111,0.00003771896,0.001489616,0.000037999605,0.0026909946,0.9629323,0.00011426903,0.01770436,0.000020361284],"about_ca_topic_score_codex":0.0015920276,"about_ca_topic_score_gemma":0.003007461,"teacher_disagreement_score":0.0021593578,"about_ca_system_score_codex":0.00043145873,"about_ca_system_score_gemma":0.00026064576,"threshold_uncertainty_score":0.007223785},"labels":[],"label_agreement":null},{"id":"W4416141128","doi":"10.1093/neuonc/noaf201.0209","title":"BIOS-08. TREATMENT STRATEGIES FOR PATIENTS WITH LEPTOMENINGEAL METASTATIC DISEASE (LMD): A NETWORK META-ANALYSIS (NMA) OF RANDOMIZED CONTROLLED TRIALS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Randomized controlled trial; Confidence interval; ThioTEPA; Hazard ratio; Radiation therapy; Meta-analysis; Frequentist inference; Survival analysis","score_opus":0.07223634040234676,"score_gpt":0.3764491733524966,"score_spread":0.30421283295014984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141128","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0670465,0.80568385,0.04031451,0.006367153,0.002400903,0.018756144,0.05024669,0.0021197696,0.0070644165],"genre_scores_gemma":[0.7254748,0.13525483,0.0667631,0.0036235405,0.00082700513,0.0457327,0.017424768,0.0008451641,0.004054121],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9670652,0.02568256,0.0029896516,0.0022316726,0.001567152,0.0004637704],"domain_scores_gemma":[0.9694743,0.0248586,0.0031247397,0.0011967133,0.0010133405,0.00033233446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030034186,0.0029655597,0.010983612,0.0057817674,0.0005478429,0.0033818427,0.0024026278,0.0022220733,0.014616406],"category_scores_gemma":[0.061846517,0.0012186024,0.043863863,0.005578629,0.0008527584,0.0020687259,0.0025197915,0.0026383132,0.0010556369],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008605547,0.000044646054,0.004920004,0.17597596,0.7940432,0.00008747594,0.00008551527,0.0019526817,0.0003178878,0.0007895602,0.0029213664,0.0102561535],"study_design_scores_gemma":[0.0065546506,0.0005377525,0.0052104387,0.009959135,0.96715283,0.00009406679,0.00006488606,0.002185666,0.00021658326,0.0018712374,0.006111136,0.000041593383],"about_ca_topic_score_codex":0.0034692874,"about_ca_topic_score_gemma":0.005300904,"teacher_disagreement_score":0.030034186,"about_ca_system_score_codex":0.002101469,"about_ca_system_score_gemma":0.0029931106,"threshold_uncertainty_score":0.15883785},"labels":[],"label_agreement":null},{"id":"W4416141169","doi":"10.1093/neuonc/noaf201.0051","title":"EPCO-52. MACHINE LEARNING AND MULTI-OMIC ANALYSIS IDENTIFY A MICROENVIRONMENT-DRIVEN MENINGIOMA RISK CONTINUUM UNDERLYING MOLECULAR CLASSIFICATIONS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA methylation; Epigenetics; Meningioma; Random forest; Epigenomics; Clinical Practice; Brain tumor; Methylation","score_opus":0.030959269597705872,"score_gpt":0.3384206186877567,"score_spread":0.3074613490900508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72900426,0.0014867408,0.1960402,0.0013483267,0.00019021536,0.00090633624,0.05047056,0.005038634,0.01551485],"genre_scores_gemma":[0.83285177,0.0004293497,0.12070315,0.00041986562,0.000064464846,0.00095475576,0.039348226,0.0005125643,0.004715963],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990644,0.00015829463,0.000077180055,0.00033556065,0.00022828973,0.00013628736],"domain_scores_gemma":[0.9987741,0.00040363218,0.00021479903,0.00023957832,0.00024755066,0.00012031186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017099108,0.00064687774,0.00064795685,0.0020371838,0.0005218071,0.0015819804,0.0006014414,0.0006361455,0.0053469217],"category_scores_gemma":[0.0025821566,0.00023265378,0.00097343203,0.0014248955,0.00037492233,0.0005646736,0.0008474943,0.00065102434,0.0016570819],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00222083,0.0007391458,0.37223753,0.0011566033,0.0009002736,0.0010926283,0.00022242698,0.040274158,0.33107895,0.011446875,0.023387069,0.21524349],"study_design_scores_gemma":[0.00022329255,0.0006718514,0.45098555,0.00013753893,0.00049598794,0.0012914962,0.00021870018,0.39002398,0.10675435,0.012032985,0.037025753,0.00013854972],"about_ca_topic_score_codex":0.0037773384,"about_ca_topic_score_gemma":0.0041389987,"teacher_disagreement_score":0.0053469217,"about_ca_system_score_codex":0.0008027228,"about_ca_system_score_gemma":0.001326616,"threshold_uncertainty_score":0.017887235},"labels":[],"label_agreement":null},{"id":"W4416141195","doi":"10.1093/neuonc/noaf201.0189","title":"BIOM-101. STRATIFICATION OF GLIOBLASTOMA PROGRESSORS USING MULTI-OMIC PROFILING AND GRAPH NEURAL NETWORKS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Orthopaedic Innovation Centre; University of Toronto","funders":"","keywords":"Interpretability; Glioblastoma; Concordance; CDKN2A; Gene expression profiling; Proportional hazards model; Gene; Cohort; PTEN","score_opus":0.029176490203311107,"score_gpt":0.3341762339109622,"score_spread":0.3049997437076511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7762465,0.0013605579,0.20202935,0.0019086028,0.00011050935,0.00026685442,0.011887396,0.0026197867,0.0035705392],"genre_scores_gemma":[0.960729,0.00019497564,0.029515617,0.0001455331,0.000033090946,0.00014452166,0.0076604574,0.00005554537,0.0015213105],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997855,0.00008794269,0.000011501726,0.00007014452,0.000023596407,0.00002132933],"domain_scores_gemma":[0.99957997,0.00021716891,0.00007986608,0.00003110494,0.00006159442,0.000030353927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007598339,0.000676515,0.00043261438,0.0013818075,0.00022695506,0.0005495659,0.00047167318,0.0005558862,0.0012999703],"category_scores_gemma":[0.0019330978,0.00021832802,0.0009742336,0.00058182457,0.00019518964,0.00029177315,0.0004530097,0.00045863455,0.0003699374],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010679626,0.00035542206,0.08899012,0.00022669556,0.00071867823,0.00020850223,0.00007080103,0.76876825,0.0058216825,0.0022063293,0.005013753,0.12655172],"study_design_scores_gemma":[0.000009672259,0.00004166794,0.004496487,0.000007395524,0.000025948493,0.00001853891,0.0000069845346,0.99327904,0.00034829762,0.0014833265,0.00027748485,0.000005138524],"about_ca_topic_score_codex":0.01272435,"about_ca_topic_score_gemma":0.011461253,"teacher_disagreement_score":0.01272435,"about_ca_system_score_codex":0.0010164517,"about_ca_system_score_gemma":0.00071990676,"threshold_uncertainty_score":0.025300562},"labels":[],"label_agreement":null},{"id":"W4416141247","doi":"10.1093/neuonc/noaf201.0260","title":"CNSC-52. SPEECH-DERIVED LINGUISTIC AND SPECTRAL FEATURES PREDICT MOLECULAR SUBTYPES OF ADULT-TYPE DIFFUSE GLIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Correlation; Glioma; Classifier (UML); Spectral density; Boosting (machine learning); Spectral analysis","score_opus":0.008765657759795565,"score_gpt":0.28065856036420267,"score_spread":0.2718929026044071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871254,0.00006013338,0.00019503664,0.000010361178,0.0000028933362,0.00001257688,0.0005238374,0.000009059512,0.0004735932],"genre_scores_gemma":[0.9981111,0.000030807478,0.00024339957,0.0000053398,0.0000034447814,0.000014518903,0.0012342398,0.000005232516,0.00035183513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983144,0.000016393493,0.00002921879,0.00005009424,0.000043000728,0.000029762903],"domain_scores_gemma":[0.9990822,0.0001230095,0.00029597926,0.00006770811,0.0002392494,0.00019184212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004224086,0.00031484594,0.00028377702,0.0008613889,0.0002711029,0.0005707064,0.00022140036,0.00028444064,0.0030792258],"category_scores_gemma":[0.0013538464,0.00009369361,0.00023567808,0.00048475852,0.000265114,0.00023990725,0.00036183247,0.00018491852,0.0008513372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006906284,0.00004158271,0.9781194,0.000026179807,0.00004140255,0.00021212552,0.00006493,0.00033770464,0.009173971,0.000034575543,0.00032466734,0.010932958],"study_design_scores_gemma":[0.000011610837,0.00019045839,0.9962083,0.0000069533235,0.000028123817,0.00086267554,0.00010737465,0.0008003567,0.0013625969,0.00004600148,0.00036962648,0.000006076538],"about_ca_topic_score_codex":0.0029362051,"about_ca_topic_score_gemma":0.0043038237,"teacher_disagreement_score":0.0030792258,"about_ca_system_score_codex":0.00026600016,"about_ca_system_score_gemma":0.00029330378,"threshold_uncertainty_score":0.0103010535},"labels":[],"label_agreement":null},{"id":"W4416141248","doi":"10.1093/neuonc/noaf201.0003","title":"EPCO-03. COMPARATIVE ANALYSIS OF CSF PROTEOMIC TECHNIQUES FOR BRAIN TUMOR RESEARCH","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteomics; Peptide; Extracellular vesicles; Biomarker; Brain tumor; Biomarker discovery; Quantitative proteomics; Microvesicles","score_opus":0.0407274363080798,"score_gpt":0.4109815912301637,"score_spread":0.3702541549220839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86288244,0.013607961,0.07162895,0.00061853684,0.00029646125,0.0015592604,0.025095675,0.002845325,0.021465503],"genre_scores_gemma":[0.7452263,0.006085687,0.19770874,0.00034599882,0.00014813342,0.0023430279,0.037727375,0.0012202054,0.009194552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972299,0.00066776277,0.0003182364,0.00046745164,0.0011037458,0.00021289231],"domain_scores_gemma":[0.9954261,0.001311134,0.0005215669,0.0004064466,0.0020883966,0.00024643374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052957875,0.0008520733,0.00055717863,0.0034690266,0.0005610716,0.0015752563,0.00077739824,0.00075067114,0.004902448],"category_scores_gemma":[0.0053893426,0.0002841035,0.00077968324,0.0024196922,0.00037755637,0.00087704364,0.0011832094,0.0004472291,0.0025468161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006350951,0.00056878844,0.043521196,0.0016294773,0.00033951682,0.0005393306,0.00021593283,0.00092356093,0.7976453,0.0012648829,0.004035765,0.1429653],"study_design_scores_gemma":[0.00018047508,0.0027867088,0.24685848,0.0003038379,0.0005036858,0.0037078697,0.00027119584,0.008781367,0.70197403,0.000631382,0.033898924,0.00010201219],"about_ca_topic_score_codex":0.0013873351,"about_ca_topic_score_gemma":0.0013854805,"teacher_disagreement_score":0.0052957875,"about_ca_system_score_codex":0.00072143873,"about_ca_system_score_gemma":0.0012866926,"threshold_uncertainty_score":0.02800709},"labels":[],"label_agreement":null},{"id":"W4416141251","doi":"10.1093/neuonc/noaf201.0179","title":"BIOM-91. RELATIONSHIPS BETWEEN LYMPHOCYTE COUNTS AND CLINICAL OUTCOMES IN PATIENTS WITH GLIOMAS TREATED WITH PEMBROLIZUMAB","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pembrolizumab; Dexamethasone; Lymphocyte; Oligodendroglioma; Glioma; Astrocytoma; Retrospective cohort study; Survival analysis; Immunotherapy","score_opus":0.029703320931364432,"score_gpt":0.3256042706365583,"score_spread":0.29590094970519387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987853,0.00023057073,0.000039573057,0.000033661017,0.000004401684,0.0000047938393,0.0004142918,0.0000043711466,0.00048301203],"genre_scores_gemma":[0.99940145,0.000041335694,0.000036039743,0.000014409209,0.0000055653677,0.0000067033916,0.0003917291,0.000001045586,0.00010161391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998068,0.000040795137,0.00003162835,0.000038252794,0.0000404986,0.00004203364],"domain_scores_gemma":[0.99897146,0.00011989164,0.00057552155,0.000024965399,0.00012475226,0.00018332043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027125908,0.00013046639,0.00018523705,0.0004772018,0.0001871241,0.0004324791,0.00013839733,0.00017857601,0.0014685756],"category_scores_gemma":[0.0011247987,0.00007998985,0.00016943419,0.0005740837,0.00012569035,0.00024266697,0.00020728634,0.00038284992,0.00030749643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034930464,0.000025520332,0.9973557,0.000008230679,0.000024073706,0.000040974854,0.0000128651345,0.00004454923,0.00031044832,0.0000069123116,0.00011598238,0.0017053819],"study_design_scores_gemma":[0.000013184027,0.00019193013,0.9987564,0.0000044438016,0.000021565533,0.0003056392,0.00004800501,0.0002027776,0.00017280065,0.000017039903,0.0002639863,0.0000023547009],"about_ca_topic_score_codex":0.0010459492,"about_ca_topic_score_gemma":0.0011079087,"teacher_disagreement_score":0.0014685756,"about_ca_system_score_codex":0.00026233683,"about_ca_system_score_gemma":0.00017730842,"threshold_uncertainty_score":0.0049128532},"labels":[],"label_agreement":null},{"id":"W4416141254","doi":"10.1093/neuonc/noaf201.0893","title":"INNV-04. Association of proton pump inhibitor use with outcome of patients with newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Radiation therapy; Drug; Proton-pump inhibitor; Multivariate analysis; Glioblastoma; Methyltransferase; Clinical trial","score_opus":0.0116556074457168,"score_gpt":0.27359647713406204,"score_spread":0.26194086968834523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639326,0.0011844699,0.00007085748,0.000098768905,0.000028726185,0.000018515842,0.0013310623,0.0000056555878,0.0008686213],"genre_scores_gemma":[0.99800783,0.00018006211,0.00006178018,0.000054848373,0.000014791734,0.000020012147,0.0013422612,0.0000029434345,0.00031567155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996339,0.00010421484,0.00005359673,0.000072505994,0.000061309394,0.00007452077],"domain_scores_gemma":[0.9985306,0.0002603085,0.0006692845,0.00005761881,0.00009026788,0.00039188055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004986219,0.00013767065,0.00046542133,0.0002120618,0.00015670764,0.00040282778,0.00028590148,0.00026010358,0.0012969917],"category_scores_gemma":[0.001352407,0.00008410906,0.00049586786,0.00042257534,0.00011857227,0.00021236896,0.00024360651,0.00046075805,0.0001274698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014281953,0.00017746026,0.9702458,0.00010265109,0.00046229595,0.000108782006,0.000021190343,0.0003222471,0.001327149,0.00006240073,0.0006125518,0.012275556],"study_design_scores_gemma":[0.0004105653,0.0019335301,0.99552214,0.00002105277,0.0002566233,0.00018817963,0.000043671847,0.0003710652,0.00029031787,0.00009777809,0.0008567674,0.000008363646],"about_ca_topic_score_codex":0.0018273985,"about_ca_topic_score_gemma":0.0045624566,"teacher_disagreement_score":0.0018273985,"about_ca_system_score_codex":0.00053813483,"about_ca_system_score_gemma":0.00051293144,"threshold_uncertainty_score":0.0043388605},"labels":[],"label_agreement":null},{"id":"W4416141268","doi":"10.1093/neuonc/noaf201.0738","title":"EPID-06. The Key LARGO study: Building an international resource for glioblastoma epidemiology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Epidemiology; Observational study; Generalizability theory; Key (lock); Quality of life (healthcare)","score_opus":0.04506775287228802,"score_gpt":0.3889975794355337,"score_spread":0.34392982656324567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141268","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021729678,0.0024251665,0.020284757,0.011596317,0.00095504307,0.011482544,0.9014817,0.0030882782,0.026956487],"genre_scores_gemma":[0.074690744,0.0034314047,0.09184571,0.0071663307,0.0011475701,0.059779853,0.74955827,0.0023120374,0.010068062],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9893672,0.0058904025,0.0018301083,0.0011640595,0.001109985,0.0006382837],"domain_scores_gemma":[0.93947667,0.015459199,0.00675594,0.012138909,0.014236034,0.011933202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027524732,0.0009386905,0.0021843526,0.00751733,0.0014328251,0.003003339,0.0033569739,0.0015539401,0.041518785],"category_scores_gemma":[0.07994176,0.0015935025,0.0011833125,0.011450312,0.0005032473,0.003903744,0.009645156,0.0025976852,0.015884463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018231763,0.0004642004,0.14384203,0.001822879,0.00033052286,0.0002845771,0.0008959583,0.0005978281,0.00037946997,0.005163654,0.75642043,0.08797529],"study_design_scores_gemma":[0.005174737,0.0006247662,0.33682084,0.004025499,0.0004933516,0.00043975192,0.0012426192,0.0026869772,0.00047216984,0.008150675,0.63960695,0.00026172807],"about_ca_topic_score_codex":0.023684768,"about_ca_topic_score_gemma":0.024066497,"teacher_disagreement_score":0.041518785,"about_ca_system_score_codex":0.002404734,"about_ca_system_score_gemma":0.015261029,"threshold_uncertainty_score":0.1455664},"labels":[],"label_agreement":null},{"id":"W4416141274","doi":"10.1093/neuonc/noaf201.0761","title":"EPID-31. Days alive and at home in glioblastoma patients across age groups: a population-based study in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Glioblastoma; Retrospective cohort study; Cohort; Cohort study; Logistic regression; Frailty Index; Complication; Overall survival; Young adult","score_opus":0.012881039061514936,"score_gpt":0.2847675831838275,"score_spread":0.27188654412231256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738448,0.0013216792,0.00018028966,0.00049527036,0.000025855747,0.00013418541,0.021274583,0.00001719948,0.0027061058],"genre_scores_gemma":[0.99420494,0.00052505627,0.00014137615,0.00019756044,0.000011205527,0.000059244172,0.0040525985,0.0000058035903,0.0008020932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998865,0.00006335647,0.00012391232,0.00026678442,0.0003476125,0.00033334986],"domain_scores_gemma":[0.9972229,0.00008821752,0.00086497096,0.000100037934,0.0011047396,0.0006191303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064039143,0.00045099648,0.00065590855,0.0014282124,0.0027230773,0.0013536536,0.0012736649,0.00048137407,0.0020697007],"category_scores_gemma":[0.0019084786,0.00051150384,0.00086929,0.0057690027,0.0006778622,0.0005396401,0.0010116878,0.0007124555,0.00035668607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005107136,0.00001807598,0.99703705,0.000047176567,0.000052313906,0.00005340144,0.00044186466,0.000040480725,0.00008876638,0.000049781218,0.0011089086,0.0010109976],"study_design_scores_gemma":[0.000009638083,0.000017371016,0.99834883,0.000034658588,0.000027152646,0.000037501573,0.00063531805,0.00013378596,0.000018860086,0.000015890299,0.0007127212,0.000008231179],"about_ca_topic_score_codex":0.99207336,"about_ca_topic_score_gemma":0.99500424,"teacher_disagreement_score":0.02585868,"about_ca_system_score_codex":0.02585868,"about_ca_system_score_gemma":0.029501798,"threshold_uncertainty_score":0.18761873},"labels":[],"label_agreement":null},{"id":"W4416141275","doi":"10.1093/neuonc/noaf201.0172","title":"BIOM-84. MGMT METHYLATION STATUS REMAINS LARGELY UNCHANGED IN RECURRENT GLIOMA AND INFLUENCES RE-TREATMENT WITH TEMOZOLOMIDE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"Temozolomide; Methylation; DNA methylation; Cohort; Biomarker; Glioma; Methyltransferase; O-6-methylguanine-DNA methyltransferase","score_opus":0.028938293878342753,"score_gpt":0.3345602313429151,"score_spread":0.3056219374645724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919087,0.00014732883,0.0000388627,0.000035271525,0.0000020116925,0.000002622041,0.00016306588,0.0000051444204,0.0004148608],"genre_scores_gemma":[0.9996449,0.000029529918,0.00003167566,0.000009874479,0.0000015685754,0.0000019177396,0.00016134593,0.0000020047719,0.00011710862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997619,0.00004889514,0.000021910053,0.00006073735,0.00006083996,0.000045798886],"domain_scores_gemma":[0.9994192,0.00008525931,0.0003296732,0.00003199646,0.000057307196,0.000076620214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029005713,0.00010464162,0.0002673222,0.00034542935,0.00011384729,0.0003432203,0.0001613837,0.00015767889,0.001107857],"category_scores_gemma":[0.0018478666,0.000071008704,0.00020841061,0.00045279166,0.00015245286,0.00014618714,0.00017837978,0.00022304346,0.00024208207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014997801,0.000053663185,0.9681777,0.000024245537,0.00011601322,0.00014870956,0.00010248544,0.00028879862,0.0059883995,0.000032871416,0.00028568864,0.023281727],"study_design_scores_gemma":[0.0000067942183,0.00014289506,0.99841666,0.000001770121,0.000024098787,0.00019761237,0.000039921637,0.0002894554,0.00063559006,0.00002199862,0.00022158866,0.0000015381924],"about_ca_topic_score_codex":0.005024598,"about_ca_topic_score_gemma":0.0055209254,"teacher_disagreement_score":0.005024598,"about_ca_system_score_codex":0.0004481874,"about_ca_system_score_gemma":0.0003172068,"threshold_uncertainty_score":0.009990752},"labels":[],"label_agreement":null},{"id":"W4416141311","doi":"10.1093/neuonc/noaf201.0246","title":"CNSC-38. TARGETING UNC5B INDUCES BLOOD-BRAIN BARRIER PERMEABILITY AND IMPROVES CHEMOTHERAPY DELIVERY AND EFFICACY IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Blood–brain barrier; Glioblastoma; Doxorubicin; Drug delivery; Ubiquitin ligase; Central nervous system; Regulator; Stem cell; Targeted drug delivery","score_opus":0.012921244383024087,"score_gpt":0.27453452701741915,"score_spread":0.26161328263439504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480623,0.0022304028,0.0011891801,0.00009992178,0.000047978945,0.000066792956,0.00039898072,0.000093708084,0.0010667227],"genre_scores_gemma":[0.99527824,0.0011183389,0.0013474494,0.000056063465,0.0000058271735,0.00005534466,0.0005692986,0.000018340937,0.0015512056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998927,0.000010611018,0.000008375886,0.000019429477,0.00003168798,0.00003722639],"domain_scores_gemma":[0.9999653,0.0000026906007,0.0000074119253,0.0000044822887,0.000007130345,0.000013004142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001252017,0.00038744046,0.00041881404,0.00026307625,0.00020147831,0.00018109819,0.00022079574,0.00022254745,0.0010828644],"category_scores_gemma":[0.00008235325,0.00011301087,0.0002312208,0.00019899388,0.00021485865,0.00011883805,0.00014832916,0.00043154965,0.00025924674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037968458,0.00016841461,0.00015471832,0.000104814426,0.000011024521,0.000052048617,0.000027090864,0.0002511338,0.9927798,0.000105891486,0.0002765158,0.0056888177],"study_design_scores_gemma":[0.00008642777,0.002285571,0.0038798011,0.000017042545,0.000047689406,0.00019725224,0.00003990646,0.0021380614,0.9871126,0.000060226906,0.0041252244,0.000010338729],"about_ca_topic_score_codex":0.004717955,"about_ca_topic_score_gemma":0.0057871044,"teacher_disagreement_score":0.004717955,"about_ca_system_score_codex":0.000568992,"about_ca_system_score_gemma":0.00043002918,"threshold_uncertainty_score":0.009380996},"labels":[],"label_agreement":null},{"id":"W4416141356","doi":"10.1093/neuonc/noaf201.0098","title":"BIOM-10. PREDICTION OF BRAIN METASTASIS DEVELOPMENT FROM LUNG ADENOCARCINOMA USING DNA METHYLOMES AND THEIR NON-INVASIVE DETECTION IN CSF AND PLASMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Thompson Rivers University","funders":"","keywords":"DNA methylation; Nomogram; Cerebrospinal fluid; Adenocarcinoma; Lung cancer; Stage (stratigraphy); Brain metastasis","score_opus":0.02482775322553555,"score_gpt":0.28683923490703,"score_spread":0.26201148168149446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97675073,0.0010756184,0.014014509,0.0003661842,0.000045177127,0.00008711193,0.0058682966,0.0004905299,0.0013017306],"genre_scores_gemma":[0.9888286,0.00014955061,0.0059708306,0.00004385887,0.000017604896,0.000058090987,0.004165385,0.000021355485,0.0007447583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931943,0.00025333642,0.00006109165,0.00018012413,0.00011372601,0.000072285206],"domain_scores_gemma":[0.9976802,0.0014002728,0.00039580706,0.00011325451,0.0002257696,0.00018465499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021920362,0.0010589386,0.000596097,0.0015475287,0.00028312707,0.0009924949,0.0005175188,0.0006272697,0.0018402289],"category_scores_gemma":[0.0039052072,0.0002843452,0.0010668727,0.00064670236,0.00023995027,0.0004325455,0.0007138613,0.0007563016,0.00073567586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013100394,0.00018261129,0.9280027,0.0001315922,0.00051847316,0.00007973056,0.000055334138,0.023055479,0.006466265,0.00010370917,0.0012229318,0.03887115],"study_design_scores_gemma":[0.0001014863,0.0012903552,0.4689882,0.000076664204,0.00043933408,0.00065863266,0.00016966171,0.5109968,0.013420733,0.001024692,0.0027698574,0.00006349578],"about_ca_topic_score_codex":0.0044434327,"about_ca_topic_score_gemma":0.0066328538,"teacher_disagreement_score":0.0044434327,"about_ca_system_score_codex":0.00058634946,"about_ca_system_score_gemma":0.00061857514,"threshold_uncertainty_score":0.011592746},"labels":[],"label_agreement":null},{"id":"W4416141369","doi":"10.1093/neuonc/noaf201.0312","title":"STEM-04. LONGITUDINAL DNA METHYLATION CHANGE FUELS DISEASE PROGRESSION THROUGH ALTERED CELL STATE DIFFERENTIATION IN IDH-MUTANT GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"DNA methylation; Epigenetics; CpG site; Bisulfite sequencing; Methylation; Glioma; Differentially methylated regions; Epigenetics of physical exercise; Histone","score_opus":0.04711558661739263,"score_gpt":0.34393171104174813,"score_spread":0.2968161244243555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962525,0.00031319706,0.0013940062,0.000034959005,0.0000048027828,0.000013948126,0.0015315735,0.00008018674,0.00037488606],"genre_scores_gemma":[0.9964175,0.00011690031,0.00087574247,0.000030237874,0.0000019060924,0.000020828,0.0016505511,0.000016432146,0.0008699958],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990845,0.0000069760017,0.0000044503067,0.00003512221,0.000027772912,0.000017263153],"domain_scores_gemma":[0.9998362,0.000020772804,0.000056522582,0.000015466214,0.000031712163,0.00003930281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023842756,0.00015529108,0.00024430593,0.0004966718,0.00017782005,0.00042161145,0.00018765691,0.00020975045,0.001919823],"category_scores_gemma":[0.00026740786,0.00014969046,0.00019821367,0.00033429262,0.00021133816,0.00020913081,0.00031530162,0.00029566154,0.0003505019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005717556,0.0000563224,0.090016626,0.00007812315,0.00005281562,0.000091602844,0.00027302006,0.00058809906,0.8930339,0.00025143655,0.00027745098,0.014708866],"study_design_scores_gemma":[0.000013842939,0.00059590343,0.7055616,0.000013029661,0.0000819409,0.00045276043,0.00035728706,0.0046920897,0.28478548,0.00050743576,0.002920807,0.00001778545],"about_ca_topic_score_codex":0.0023022802,"about_ca_topic_score_gemma":0.0037773058,"teacher_disagreement_score":0.0023022802,"about_ca_system_score_codex":0.00046944746,"about_ca_system_score_gemma":0.00029224475,"threshold_uncertainty_score":0.0064225197},"labels":[],"label_agreement":null},{"id":"W4416141370","doi":"10.1093/neuonc/noaf201.0350","title":"CSIG-16. CIC-FUSION ONCOPROTEINS COOPERATE WITH JAK/STAT1/3 SIGNALING TO DRIVE CIC-REARRANGED SARCOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Transcription factor; Effector; Histone; Fusion protein; STAT1; Promoter; Transcription (linguistics); H3K4me3","score_opus":0.016739496154207032,"score_gpt":0.29848277607129087,"score_spread":0.2817432799170838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969894,0.00043737632,0.00053101935,0.000086993285,0.000020478625,0.000032342385,0.0005342653,0.000082868544,0.0012853304],"genre_scores_gemma":[0.99770206,0.0000915616,0.00049520587,0.000028068729,0.0000023092393,0.00001618901,0.0006474928,0.0000067610354,0.0010103668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998473,0.000021018923,0.000016199378,0.000021854845,0.000041516938,0.00005209069],"domain_scores_gemma":[0.9998952,0.00002024073,0.00002387888,0.000019703244,0.0000051221796,0.000035914163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014814822,0.00024853132,0.00021888119,0.00024863868,0.00014845764,0.00032351914,0.00017237208,0.00028638734,0.0016102699],"category_scores_gemma":[0.000093437724,0.00012840318,0.00025674046,0.0002226056,0.00023952305,0.000105137224,0.00017530457,0.00053069234,0.0006280342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017066095,0.00010466924,0.00091383466,0.000026074566,0.000008397277,0.00016543409,0.000015642318,0.00024365517,0.9964587,0.00022591853,0.00018545875,0.0014814899],"study_design_scores_gemma":[0.0000857933,0.00079630414,0.013365671,0.000005109741,0.000021865411,0.001329339,0.000045423512,0.0034502086,0.9764435,0.00012507827,0.004326498,0.000005127549],"about_ca_topic_score_codex":0.0006860678,"about_ca_topic_score_gemma":0.0012015164,"teacher_disagreement_score":0.0016102699,"about_ca_system_score_codex":0.00044633195,"about_ca_system_score_gemma":0.00024347231,"threshold_uncertainty_score":0.0053869486},"labels":[],"label_agreement":null},{"id":"W4416141378","doi":"10.1093/neuonc/noaf201.0309","title":"STEM-01. AN OSMR-CLIC1 CROSS TALK DRIVES KEY ONCOGENIC PATHWAYS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University of Ottawa","funders":"","keywords":"Signal transduction; Downregulation and upregulation; Phosphorylation; STAT3; Receptor; Transcription factor; HEK 293 cells; Activator (genetics)","score_opus":0.028922849844034117,"score_gpt":0.33722473561364363,"score_spread":0.30830188576960954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748606,0.0014966873,0.0032177144,0.0003089281,0.000053991615,0.00005178076,0.003588708,0.00049564656,0.00330041],"genre_scores_gemma":[0.9927321,0.0005225603,0.0011493504,0.00019916963,0.000008288429,0.000043389144,0.0028279168,0.000042707776,0.00247456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979585,0.000011974429,0.00001323762,0.000049961684,0.00006896166,0.00005994773],"domain_scores_gemma":[0.9998915,0.000010724316,0.00003835496,0.000008299146,0.000015227246,0.000035775996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013889653,0.00025012737,0.00031395987,0.00041523005,0.00028274,0.000580677,0.00023494712,0.0003301952,0.002943224],"category_scores_gemma":[0.00011777379,0.00015045231,0.0003092457,0.0003499535,0.00027162864,0.0001969986,0.00034298236,0.0005630527,0.00075963687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013519156,0.00002139794,0.0014974701,0.00008241302,0.000009702384,0.00016027043,0.00003253031,0.00011501123,0.994716,0.00038611714,0.0003072118,0.0025366268],"study_design_scores_gemma":[0.00003231429,0.00028824958,0.049776103,0.000026288271,0.00005866028,0.00095675484,0.00025337338,0.005055154,0.9296852,0.0004491812,0.013404275,0.000014381696],"about_ca_topic_score_codex":0.0009298384,"about_ca_topic_score_gemma":0.001359079,"teacher_disagreement_score":0.002943224,"about_ca_system_score_codex":0.00066629675,"about_ca_system_score_gemma":0.0003418372,"threshold_uncertainty_score":0.009846032},"labels":[],"label_agreement":null},{"id":"W4416141380","doi":"10.1093/neuonc/noaf201.0304","title":"CNSC-97. ELECTROCORTICOGRAPHIC ANALYSIS AND DETECTION OF SPEECH NETWORKS IN GLIOMA-INFILTRATED CORTEX","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon City Hospital","funders":"","keywords":"Electrocorticography; Auditory cortex; Human brain; Cortex (anatomy); Electrophysiology; Decoding methods; Electroencephalography; Brain mapping; Encoding (memory); Neural activity","score_opus":0.011568924734751714,"score_gpt":0.30870041116965763,"score_spread":0.2971314864349059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8984985,0.0016145824,0.011711701,0.00033223286,0.00013980997,0.00052573415,0.07707699,0.0019911285,0.008109348],"genre_scores_gemma":[0.86625355,0.0007038404,0.010389189,0.00013169882,0.000076887554,0.0006317168,0.117580056,0.00033592837,0.0038970364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995035,0.00008188731,0.00006495759,0.000115921306,0.00016790634,0.00006582302],"domain_scores_gemma":[0.998468,0.00022782882,0.00026708128,0.00025621886,0.00048109307,0.00029970935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010790717,0.00069078535,0.0005608094,0.0015000248,0.0002519344,0.0008636552,0.000730313,0.00039885342,0.0037515836],"category_scores_gemma":[0.0023425014,0.00021510113,0.00046049154,0.00093903753,0.00023565876,0.0001946722,0.0007716093,0.00027165326,0.002786536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01296805,0.00079272065,0.46571285,0.0012347971,0.0011495758,0.0038122474,0.0004314319,0.010675652,0.12971872,0.001037122,0.06917933,0.30328754],"study_design_scores_gemma":[0.00071093946,0.0013883922,0.8516387,0.00017510453,0.0003729032,0.0057882816,0.00029144526,0.030429967,0.0733086,0.0009797411,0.034811836,0.00010408037],"about_ca_topic_score_codex":0.007959638,"about_ca_topic_score_gemma":0.009912453,"teacher_disagreement_score":0.007959638,"about_ca_system_score_codex":0.0006457791,"about_ca_system_score_gemma":0.0014313973,"threshold_uncertainty_score":0.015826583},"labels":[],"label_agreement":null},{"id":"W4416141391","doi":"10.1093/neuonc/noaf201.0331","title":"STEM-24. SINGLE CELL CRISPR/CAS-9 LINEAGE TRACING REVEALS EVOLUTIONARY FITNESS, EXPANSION AND PLASTICITY AXES IN ADULT DIFFUSE GLIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Lineage (genetic); Transcriptome; Gene; Glioma; Phylogenetic tree; RNA; Gene expression profiling; Phenotype; Cell","score_opus":0.019319277979320752,"score_gpt":0.2822541338996811,"score_spread":0.26293485592036037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508876,0.00012787126,0.0039252853,0.000009617473,0.0000010045003,0.000010000254,0.0005002393,0.00005801046,0.00027931592],"genre_scores_gemma":[0.99535805,0.000105504674,0.0031701897,0.000008497925,8.678321e-7,0.000011690945,0.00079386483,0.000015371912,0.00053602643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989665,0.0000082516635,0.000008154036,0.000032583404,0.000038567498,0.000015837686],"domain_scores_gemma":[0.99987113,0.000019579911,0.0000559603,0.00001517686,0.000017561499,0.000020676405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018192339,0.00014011195,0.00016325753,0.00038495354,0.00013349153,0.0003179074,0.0001109032,0.00011656301,0.00050658017],"category_scores_gemma":[0.00018259577,0.00011890674,0.00012258139,0.00026921977,0.00019052428,0.000101616264,0.00013110391,0.0001829757,0.00015702442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018004504,0.000017639999,0.020667871,0.000028836917,0.000012550083,0.000105098996,0.00007986586,0.00090785447,0.9687043,0.0001810765,0.000048303576,0.009066583],"study_design_scores_gemma":[0.000012435038,0.00034906124,0.23024695,0.000008232222,0.000036902384,0.0011751957,0.0001225908,0.012855251,0.75255543,0.00029711274,0.0023261907,0.000014705139],"about_ca_topic_score_codex":0.0018918224,"about_ca_topic_score_gemma":0.0043603117,"teacher_disagreement_score":0.0018918224,"about_ca_system_score_codex":0.0003085386,"about_ca_system_score_gemma":0.00017661003,"threshold_uncertainty_score":0.0037617087},"labels":[],"label_agreement":null},{"id":"W4416141406","doi":"10.1093/neuonc/noaf201.0101","title":"BIOM-13. A GENOME-WIDE IN VIVO CRISPR ACTIVATION SCREEN IDENTIFIES BACE1 AS A THERAPEUTIC VULNERABILITY OF LUNG CANCER BRAIN METASTASIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Concordia University of Edmonton; University of Calgary; Hospital for Sick Children; McMaster University","funders":"","keywords":"Brain metastasis; CRISPR; In vivo; Metastasis; Lung cancer; Cancer; Brain tumor; Epidermal growth factor receptor","score_opus":0.027708638321145618,"score_gpt":0.36905291240828736,"score_spread":0.34134427408714174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927768,0.0028321939,0.043399926,0.0008836998,0.00019505997,0.00058591337,0.007135637,0.0018659432,0.015333616],"genre_scores_gemma":[0.96324193,0.0011676782,0.014868054,0.0003095311,0.000012183398,0.00022042767,0.004992224,0.00016382981,0.015024123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997069,0.000039806182,0.000027463348,0.000065432316,0.00009961274,0.00006077555],"domain_scores_gemma":[0.9998338,0.00004692834,0.000035430297,0.000017867758,0.000022756802,0.000043209537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003447899,0.0005459428,0.00053714064,0.00066760584,0.00035049923,0.0005450475,0.00042203875,0.00079622975,0.004532363],"category_scores_gemma":[0.00024967655,0.00027349603,0.0004291491,0.00025516792,0.0003531321,0.00015981284,0.00043380805,0.0008740179,0.00091390416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056078505,0.000048144677,0.00024475803,0.000045031396,0.00001261245,0.00011340092,0.000009523709,0.00009951132,0.9971673,0.00018392749,0.0001747636,0.0018449642],"study_design_scores_gemma":[0.000024398865,0.00037290234,0.0034255392,0.000010301722,0.000050094503,0.00085801486,0.000029512974,0.0018549513,0.9862168,0.00012604462,0.007019874,0.0000115904595],"about_ca_topic_score_codex":0.0014565159,"about_ca_topic_score_gemma":0.002419309,"teacher_disagreement_score":0.004532363,"about_ca_system_score_codex":0.00046024975,"about_ca_system_score_gemma":0.00045568214,"threshold_uncertainty_score":0.015162289},"labels":[],"label_agreement":null},{"id":"W4416141420","doi":"10.1093/neuonc/noaf201.0197","title":"BIOM-109. IMAGE-DERIVED FEATURES IMPROVE PROGNOSTIC MODELING IN POST-SURGICAL PATIENTS WITH IDH WILD-TYPE GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Glioblastoma; Proportional hazards model; Glioma; Cohort; Survival analysis; Isocitrate dehydrogenase; Radiomics; Prognostic model; Cancer","score_opus":0.008705603915652012,"score_gpt":0.2707867205129449,"score_spread":0.2620811165972929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407274,0.00012990758,0.0039482764,0.00017078879,0.000011178741,0.000019273219,0.0011508565,0.00011832394,0.00037864814],"genre_scores_gemma":[0.9967359,0.000034083838,0.0016589867,0.00001620778,0.0000088642,0.0000101127725,0.0013087376,0.000012864154,0.00021415409],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997665,0.0000863857,0.000018900239,0.00006421067,0.00003184095,0.000032089552],"domain_scores_gemma":[0.99928015,0.0003387283,0.00014602928,0.000088369845,0.00008060666,0.000066073066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010461769,0.00051746506,0.0005992565,0.0006761682,0.00017869438,0.0009096182,0.0003871213,0.00031489815,0.0019708476],"category_scores_gemma":[0.0023901614,0.00017961701,0.0007007599,0.0004830629,0.00019583858,0.00032200062,0.00045766958,0.00045833408,0.0005944267],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018022225,0.00024524357,0.9072353,0.00007311834,0.00045640362,0.00018798241,0.000096236705,0.022498319,0.006039367,0.0002139075,0.0014772261,0.059674628],"study_design_scores_gemma":[0.000060425322,0.0006397421,0.6473209,0.000024294213,0.00026592772,0.0003869783,0.00014008369,0.34597132,0.0033446392,0.0007851418,0.0010225843,0.00003799818],"about_ca_topic_score_codex":0.004326368,"about_ca_topic_score_gemma":0.005144548,"teacher_disagreement_score":0.004326368,"about_ca_system_score_codex":0.00041337937,"about_ca_system_score_gemma":0.0005018258,"threshold_uncertainty_score":0.008602381},"labels":[],"label_agreement":null},{"id":"W4416141431","doi":"10.1093/neuonc/noaf201.0593","title":"DNAR-02. Nuclear potassium governs nuclear integrity and tumour growth in medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Potassium channel; Nuclear pore; Potassium; Cytoplasm; Immune system; Cell nucleus; Nuclear DNA","score_opus":0.009771844142138776,"score_gpt":0.25743455742530286,"score_spread":0.24766271328316408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950848,0.0009996307,0.0018052142,0.00011076479,0.000017312701,0.000020542762,0.00048433372,0.00011639078,0.0013609531],"genre_scores_gemma":[0.997614,0.00018727429,0.00061019853,0.000025191533,0.0000021324115,0.000010279547,0.00029719464,0.000013315313,0.0012403913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998367,0.000018779887,0.000015080941,0.00003308362,0.00006153772,0.000034783934],"domain_scores_gemma":[0.99983215,0.000012228246,0.00008046511,0.0000138654605,0.000013809007,0.000047501682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014627317,0.00019000581,0.00019176179,0.000214053,0.00013548137,0.00028876608,0.00015612075,0.00020980767,0.0012051597],"category_scores_gemma":[0.00013427474,0.00008769128,0.00014230696,0.00010200431,0.0002564701,0.00016417215,0.00016811409,0.0004025071,0.00040061394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110965055,0.0000144911255,0.0009341352,0.00002093741,0.0000032623245,0.00004158317,0.000009228723,0.000048986018,0.9978522,0.00008553577,0.000036408353,0.00084227615],"study_design_scores_gemma":[0.000031140095,0.00045197504,0.026854906,0.000011732052,0.000024684072,0.00075916987,0.000086839806,0.0018032476,0.9664659,0.000116064395,0.003386485,0.000007885547],"about_ca_topic_score_codex":0.0010403869,"about_ca_topic_score_gemma":0.0019537366,"teacher_disagreement_score":0.0012051597,"about_ca_system_score_codex":0.00060992024,"about_ca_system_score_gemma":0.000251165,"threshold_uncertainty_score":0.0044252872},"labels":[],"label_agreement":null},{"id":"W4416141494","doi":"10.1093/neuonc/noaf201.0247","title":"CNSC-39. USE OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Focused ultrasound; Drug delivery; Glioma; Immune system; Targeted drug delivery; Sonication; Immunohistochemistry; Ultrasound","score_opus":0.022605286734880537,"score_gpt":0.260732491401749,"score_spread":0.23812720466686843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666607,0.01636099,0.0051173246,0.0004206236,0.00021603562,0.0007284061,0.00086612924,0.00033172534,0.009298114],"genre_scores_gemma":[0.98447466,0.005825783,0.00503088,0.00023678107,0.000045049575,0.00028176696,0.0010570495,0.000032393207,0.0030156826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998665,0.000017727532,0.0000058633173,0.00003069394,0.000046175996,0.000033060034],"domain_scores_gemma":[0.9999331,0.000007829167,0.000014215958,0.0000060306943,0.000014342219,0.00002456932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021468336,0.00041277666,0.00036354276,0.0004161651,0.00016197504,0.0001596715,0.00034175316,0.00033402152,0.0015092015],"category_scores_gemma":[0.00014364356,0.00010433743,0.0003172852,0.00022203305,0.00029450137,0.00014579638,0.00017397424,0.00056947785,0.00035663508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017927118,0.0007769334,0.0006597512,0.0005579122,0.000037440917,0.00045904933,0.0000552069,0.0006930301,0.93203485,0.00028540392,0.0013511885,0.06129655],"study_design_scores_gemma":[0.0010026623,0.03857037,0.014701473,0.00011116187,0.00023126599,0.0025173344,0.00008456635,0.003169978,0.90802133,0.00016751567,0.031376183,0.000046126333],"about_ca_topic_score_codex":0.0045410497,"about_ca_topic_score_gemma":0.0065310705,"teacher_disagreement_score":0.0045410497,"about_ca_system_score_codex":0.00036815717,"about_ca_system_score_gemma":0.000700816,"threshold_uncertainty_score":0.00902921},"labels":[],"label_agreement":null},{"id":"W4416141508","doi":"10.1093/neuonc/noaf201.0054","title":"EPCO-55. ALTERNATIVE RNA SPLICING ANALYSIS IDENTIFIES PATTERNS UNDERLYING MALIGNANT TRANSFORMATION AND THERAPEUTIC RESPONSE IN PERIPHERAL NERVE TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Selumetinib; Transcriptome; Malignant transformation; Exon; Neurofibromatosis; Alternative splicing; SOX10; Melanoma; Exon skipping","score_opus":0.03727218106995333,"score_gpt":0.33433195140870003,"score_spread":0.2970597703387467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565685,0.00037367188,0.00051825104,0.000040318962,0.000009164527,0.000021138028,0.0023931782,0.00003862563,0.00094892],"genre_scores_gemma":[0.9921055,0.00016169122,0.0012336563,0.00009057332,0.000007779281,0.000041817675,0.0052074194,0.00001973817,0.0011318648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99972194,0.000024645793,0.000024631036,0.000094586416,0.00008101037,0.000053086616],"domain_scores_gemma":[0.9996176,0.000059970436,0.0001396397,0.000043170498,0.00007182622,0.0000677411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030690012,0.00016600934,0.00019487798,0.00079814973,0.00029405134,0.00041681147,0.00019432594,0.00027870908,0.0021986575],"category_scores_gemma":[0.00049759966,0.00009530979,0.00020291825,0.00052203174,0.00020962072,0.00010018086,0.00020365248,0.00021917107,0.00045071324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002006256,0.00013430833,0.4633692,0.00016466396,0.00013704853,0.0009077591,0.00018738028,0.00051122066,0.5076593,0.00022538449,0.0019747592,0.022722695],"study_design_scores_gemma":[0.000029677029,0.00034958468,0.9437371,0.000018090552,0.000081524675,0.0021281135,0.00011685935,0.0011801971,0.048383597,0.000072417904,0.0038927482,0.000010085302],"about_ca_topic_score_codex":0.0028760934,"about_ca_topic_score_gemma":0.006059997,"teacher_disagreement_score":0.0028760934,"about_ca_system_score_codex":0.00042276652,"about_ca_system_score_gemma":0.00017752714,"threshold_uncertainty_score":0.007355273},"labels":[],"label_agreement":null},{"id":"W4416141534","doi":"10.1093/neuonc/noaf201.0334","title":"STEM-27. TRACING THE ORIGINS OF H3.3K27M MUTANT DIFFUSE MIDLINE GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Forebrain; Hindbrain; Glioma; Corticogenesis; Neurogenesis; Fate mapping; Mutant; Mutation","score_opus":0.022660209580777045,"score_gpt":0.3102490899853226,"score_spread":0.28758888040454555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671194,0.00082076894,0.020124352,0.00007636955,0.00002757299,0.0000882701,0.006213116,0.0005284337,0.0050017578],"genre_scores_gemma":[0.9730733,0.0006230136,0.016232107,0.00006828675,0.000005497981,0.00007778269,0.003527997,0.00017451106,0.00621757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999337,0.000004053347,0.0000036527138,0.000020484584,0.00002059418,0.000017424629],"domain_scores_gemma":[0.9999132,0.000009732839,0.000023066748,0.000008376178,0.000015866159,0.000029711935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010542485,0.00016639713,0.00014256257,0.0005457243,0.000204441,0.00034008955,0.00016037385,0.00021596157,0.001963434],"category_scores_gemma":[0.00007246065,0.00015293785,0.00018231932,0.00034868138,0.00016500628,0.00012681537,0.00021811205,0.00031359194,0.0009419611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008335422,0.000011096294,0.0029153961,0.00003083768,0.0000046721666,0.00011656036,0.00006466793,0.00028291973,0.9924555,0.00030791442,0.00015961917,0.0035674341],"study_design_scores_gemma":[0.000010896721,0.0001597069,0.04784359,0.00001629854,0.000016431057,0.00040997998,0.00015933797,0.0061940416,0.9363801,0.00020846895,0.008593648,0.000007534503],"about_ca_topic_score_codex":0.0025113355,"about_ca_topic_score_gemma":0.0064321244,"teacher_disagreement_score":0.0025113355,"about_ca_system_score_codex":0.00039317622,"about_ca_system_score_gemma":0.00023616958,"threshold_uncertainty_score":0.0065683722},"labels":[],"label_agreement":null},{"id":"W4416141550","doi":"10.1093/neuonc/noaf201.0145","title":"BIOM-57. ANTITHROMBOTIC THERAPY IN PATIENTS WITH BRAIN TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Antithrombotic; Cancer; Thrombosis; Guideline; Incidence (geometry); Renal cell carcinoma; Retrospective cohort study; Melanoma; Systemic therapy","score_opus":0.011765947489114572,"score_gpt":0.28788856277564506,"score_spread":0.2761226152865305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5131979,0.38075316,0.001562783,0.019898167,0.0023374127,0.0002732028,0.008324147,0.00020021906,0.073453024],"genre_scores_gemma":[0.90712565,0.07349614,0.002540318,0.004825593,0.0012080158,0.00026139454,0.0050814818,0.000033039538,0.0054283706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946207,0.00012528914,0.000114092494,0.000061716746,0.00016833965,0.00006846101],"domain_scores_gemma":[0.9986039,0.0002677264,0.0006103949,0.00003801755,0.00023591626,0.000244007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059038703,0.00020900102,0.0005701975,0.00070454157,0.00026198392,0.0006315133,0.00021587139,0.00031321723,0.0058700144],"category_scores_gemma":[0.0033337749,0.0000839938,0.0006093709,0.0012565299,0.00014573787,0.000281616,0.00038725286,0.0009156766,0.0012505233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025027911,0.00038834786,0.55171716,0.0030521133,0.00064753287,0.0007248751,0.00013453339,0.0003050716,0.00095671014,0.0014276911,0.03017739,0.40796572],"study_design_scores_gemma":[0.00075522676,0.001149373,0.8855702,0.004707962,0.0015597394,0.0045402367,0.0003619863,0.0011768389,0.0012519574,0.0032200566,0.09564705,0.000059427377],"about_ca_topic_score_codex":0.0022815352,"about_ca_topic_score_gemma":0.002691045,"teacher_disagreement_score":0.0058700144,"about_ca_system_score_codex":0.00060902396,"about_ca_system_score_gemma":0.0017261361,"threshold_uncertainty_score":0.019637167},"labels":[],"label_agreement":null},{"id":"W4416376916","doi":"10.1093/neuonc/noaf237","title":"A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Meningioma; DNA; MEDLINE; Adjuvant; Identification (biology); DNA sequencing","score_opus":0.14314955257997855,"score_gpt":0.4345056984295856,"score_spread":0.291356145849607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416376916","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066154394,0.00046741127,0.98790646,0.002047792,0.00006376614,0.00010367278,0.0004998758,0.00043442493,0.0018612392],"genre_scores_gemma":[0.30829498,0.0011032278,0.6853291,0.000713822,0.00027684722,0.00084167166,0.0014141249,0.00023390976,0.0017923574],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99834776,0.0009508187,0.00014177164,0.00023764439,0.00021644929,0.000105607534],"domain_scores_gemma":[0.9942973,0.0043744696,0.000465587,0.00023476918,0.0003863516,0.00024143743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005807367,0.0012035719,0.001318933,0.0017702618,0.00073867105,0.002616862,0.0029945623,0.0018397692,0.0024776242],"category_scores_gemma":[0.015287515,0.00085873937,0.0024808568,0.0009870679,0.0010378452,0.0010863065,0.0026945355,0.0023736435,0.00049211504],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003592738,0.0000481055,0.0019252674,0.0000630941,0.00016055931,0.00013134273,0.00010153513,0.95146596,0.00025158696,0.033924863,0.0009818882,0.010909848],"study_design_scores_gemma":[0.000011600971,0.000011954453,0.0001161043,0.000021092303,0.00001895309,0.00002070457,0.000014676083,0.96837234,0.00004732156,0.030315597,0.0010385655,0.00001114185],"about_ca_topic_score_codex":0.02894741,"about_ca_topic_score_gemma":0.02936858,"teacher_disagreement_score":0.02894741,"about_ca_system_score_codex":0.002303093,"about_ca_system_score_gemma":0.0036766063,"threshold_uncertainty_score":0.05755782},"labels":[],"label_agreement":null},{"id":"W7117146517","doi":"10.1093/neuonc/noaf283","title":"Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Brain Tumour Charity; Deutsches Krebsforschungszentrum","keywords":"Identification (biology); Risk stratification; Clinical trial; Therapeutic approach; Precision medicine; MEDLINE","score_opus":0.0231861082479438,"score_gpt":0.3266195862632819,"score_spread":0.3034334780153381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117146517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513406,0.0017364763,0.001327678,0.00032105276,0.000008817083,0.000037254154,0.00037037834,0.000027923501,0.0010363354],"genre_scores_gemma":[0.99802196,0.00032547183,0.0010426955,0.00005014938,0.0000118511625,0.000018205788,0.00042328474,0.000004579299,0.00010173091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980026,0.000043763088,0.000021195548,0.000053542393,0.00004019375,0.00004111734],"domain_scores_gemma":[0.9995535,0.00009152319,0.00018850414,0.000023381777,0.000063227206,0.000079746154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006863323,0.0003162014,0.00037829913,0.0009539075,0.0002910272,0.0004852777,0.00025515308,0.00037575336,0.00097521755],"category_scores_gemma":[0.0013250312,0.000080422906,0.00030459877,0.0005321768,0.0003288616,0.00034249338,0.0005133516,0.0003313595,0.00020263405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000701999,0.00003709512,0.9608293,0.00006972916,0.00006811051,0.00021372252,0.00019378819,0.000668145,0.01094859,0.00022270578,0.0003184098,0.025728386],"study_design_scores_gemma":[0.000034430344,0.00032888103,0.9915965,0.000039238428,0.00013066035,0.0012963706,0.00046807612,0.0017639318,0.002183028,0.0008329316,0.001312648,0.000013323213],"about_ca_topic_score_codex":0.0016449961,"about_ca_topic_score_gemma":0.0026947649,"teacher_disagreement_score":0.0016449961,"about_ca_system_score_codex":0.00045744126,"about_ca_system_score_gemma":0.0006792736,"threshold_uncertainty_score":0.003629744},"labels":[],"label_agreement":null}]}